Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	15.0	35.1	13.4	22.0	16.6	19.9	16.5	19.2	18.4	17.6	16.4	22.6	20.9	15.4	19.3	26.1	18.2	25.3	19.4	20.7	13.2	11.8	20.4	26.0	13.4	23.4	19.3	10.1	19.7	27.3	33.1	27.3	23.6	15.8	17.3	19.3	21.5	22.8	18.5	19.7	22.2	17.5	21.2	16.4	22.0	19.1	26.6	19.5	39.1	19.5	24.6	24.4	17.2	16.9	15.3	17.2	8.2	14.7	10.0	16.7	10.1	10.3	31.5	24.6	15.1	11.7	14.2	15.8	11.8	12.8	29.8	17.2	21.4	22.0	24.8	20.4	15.0	16.9	15.1	42.9	31.5	17.6	15.7	27.7	20.2	13.9	21.5	11.9	17.8	15.3	13.6	15.9	19.7	19.2	16.2	23.4	21.3	26.7	28.8	14.4	33.5	28.0	18.5	16.9	12.2	22.0	27.5	16.4	27.8	21.1	8.5	13.2	16.9	8.7	19.7	9.1	16.4	25.3	15.6	10.6	14.2	21.5	11.3	12.5	12.9	16.3	22.6	11.4	15.5	16.3	1.2	12.1	8.2	13.7	14.0	16.5	15.2	12.3	12.6	13.7	15.3	16.7	16.2	1.1	10.0	14.7	17.2	12.6	10.1	13.4	16.6	19.2	18.4	13.2	11.8	19.3	10.1	15.8	19.5	11.9	5.6	10.4	16.1	6.5	11.3	5.9	15.3	6.7	7.9	14.0	15.7	53.6	11.6	17.4	11.4	9.1	9.8	23.3	16.1	43.4	12.2	8.6	8.1	11.5	25.1	1.6	8.1	10.4	9.1	18.3	16.4	10.8	10.1	10.8	11.5	17.4	9.4	13.5	12.0	15.4	14.7	19.4	11.3	26.5	45.3	6.5	30.6	10.2	16.2	8.0
AACS	"ACSF1, FLJ12389, SUR-5"	ENSG00000081760	"Acetoacetyl-CoA synthetase"	Q86V21	12	125065379-125143333	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058815	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA058815: AB_2683826"	"unprognostic (1.28e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-3)"	"unprognostic (6.60e-6)"	"unprognostic (3.03e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.71e-2)"	"unprognostic (6.80e-2)"	21.1	6.5	9.0	10.5	13.0	2.5	33.7	6.6	22.0	11.7	9.3	5.3	7.4	12.9	5.2	7.7	22.3	6.6	12.9	5.8	8.1	5.6	6.8	3.3	4.9	4.9	5.1	13.1	4.9	9.7	5.8	6.7	4.8	10.0	6.7	8.6	5.1	33.7	12.9	3.7	26.9	8.7	4.5	4.2	4.3	12.7	9.7	3.6	6.8	7.6	12.2	8.7	5.0	9.9	3.0	11.8	6.9	2.3	5.8	5.7	3.8	14.5	14.5	6.3	8.6	23.4	15.3	10.6	11.8	11.3	14.0	12.6	18.7	9.7	9.0	12.2	14.2	6.1	15.9	11.8	12.7	7.6	9.7	10.8	7.2	9.7	14.2	19.5	5.1	7.3	16.9	10.4	11.9	12.1	17.6	10.2	5.3	5.0	5.6	8.9	26.6	5.9	6.8	8.0	15.3	17.2	1.1	16.1	12.4	14.3	22.2	17.0	4.9	12.5	19.8	9.1	6.5	14.8	11.3	9.7	6.8	10.8	7.6	9.0	12.7	7.2	9.8	8.5	8.4	7.4	6.9	2.3	6.7	4.2	0.7	5.4	3.0	3.9	3.2	2.8	1.7	5.7	3.8	0.3	5.8	0.8	11.8	2.4	3.8	9.0	13.0	6.6	22.0	8.1	5.6	5.1	13.1	10.0	3.6	6.0	12.9	0.8	4.9	14.7	16.4	7.3	12.7	0.0	5.7	5.2	25.5	1.8	6.6	9.5	54.0	5.8	9.9	0.0	9.5	7.4	11.4	9.4	2.3	2.5	4.1	6.4	24.2	0.6	3.2	14.6	8.6	2.8	5.0	5.4	20.1	5.4	8.7	5.8	4.9	6.2	20.1	0.0	7.6	12.7	5.4	24.6	2.1	9.2	15.1	4.9
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 56.5"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 60.6;Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.0	3.1	9.2	2.2	9.0	0.9	4.7	0.8	10.8	8.3	4.7	10.3	2.9	1.9	9.7	5.8	2.8	5.7	3.9	2.8	7.2	6.4	6.3	56.5	4.7	1.1	8.2	8.0	4.7	4.6	7.6	8.9	2.2	6.0	13.3	5.0	6.6	1.7	5.4	3.6	1.8	2.0	7.0	7.0	2.0	3.2	7.2	9.2	0.9	7.0	1.2	1.3	5.5	4.9	0.4	0.4	0.0	0.7	0.0	0.7	0.0	2.2	5.5	16.7	0.0	3.3	13.0	6.0	5.7	2.8	3.3	3.3	5.3	0.6	0.0	0.9	6.3	4.3	1.9	7.4	2.7	2.3	0.0	6.4	0.0	6.2	8.9	2.7	0.0	2.4	5.3	1.6	2.7	3.5	9.1	3.1	7.5	0.9	0.1	12.6	5.6	2.7	0.1	12.6	6.2	5.0	0.0	5.2	0.0	2.9	10.0	13.5	15.7	4.5	1.1	5.4	5.6	0.0	1.1	2.1	8.4	9.0	9.5	8.8	0.0	0.0	0.0	8.4	0.0	9.8	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.4	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	9.2	9.0	0.8	10.8	7.2	6.4	8.2	8.0	6.0	9.2	0.0	5.1	0.0	2.6	0.8	5.1	1.1	2.5	14.7	3.4	0.0	2.0	1.4	0.0	1.3	0.4	0.5	0.0	0.0	1.9	60.6	2.4	3.6	0.0	22.9	1.4	0.0	6.4	0.0	0.3	0.6	1.1	0.6	1.7	0.0	1.3	3.2	0.9	0.0	2.1	6.5	8.2	6.5	2.2	2.4	12.5	0.4	4.7	0.0	2.3	1.4
AAGAB	"FLJ11506, p34"	ENSG00000103591	"Alpha and gamma adaptin binding protein"	Q6PD74	15	67201033-67255195	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039371, HPA040174"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA039371: AB_10805476, HPA040174: AB_10805605"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (1.53e-1)"	19.3	23.6	17.0	15.6	22.5	15.6	20.3	13.3	29.8	16.7	23.6	14.7	24.1	13.3	18.1	24.7	22.3	14.6	16.1	14.8	15.9	22.5	29.5	22.2	15.2	15.4	17.7	20.2	14.4	18.0	29.9	39.1	16.0	31.5	16.9	29.7	14.9	19.3	19.0	33.4	14.3	21.9	18.4	13.8	18.2	20.1	23.8	13.4	25.9	28.8	18.1	21.4	19.8	14.1	16.1	23.9	28.4	24.7	27.7	26.8	20.1	18.3	33.3	24.0	24.6	23.9	19.5	12.0	19.3	28.6	23.5	27.0	24.6	20.0	17.7	19.8	20.3	29.5	37.1	49.9	22.6	24.6	24.6	23.6	16.8	25.0	10.0	25.9	28.5	19.7	19.0	31.2	17.4	37.5	15.7	18.5	23.5	34.7	25.1	22.8	22.4	17.3	12.2	20.6	23.0	12.1	19.5	30.8	21.4	21.5	43.4	34.4	22.0	23.2	16.7	27.3	22.0	27.3	21.8	19.3	21.4	25.9	19.0	26.9	13.1	43.9	26.5	20.3	26.7	21.3	28.4	18.9	18.5	23.5	24.6	26.8	16.1	20.8	22.1	23.9	12.5	17.7	19.4	10.1	27.7	24.7	17.7	25.1	20.1	17.0	22.5	13.3	29.8	15.9	22.5	17.7	20.2	31.5	13.4	3.0	4.8	13.8	14.3	10.6	12.5	11.2	5.1	18.7	17.0	26.2	25.5	14.1	14.9	23.4	7.6	12.0	20.0	0.0	27.3	12.2	10.3	19.0	10.4	11.9	14.4	17.5	15.1	6.2	12.4	6.4	7.2	9.5	6.8	25.2	14.3	13.7	19.6	17.8	10.6	17.0	17.7	12.9	11.3	35.2	37.3	12.0	13.8	15.0	13.5	21.1
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 109.7"	"Cell type enhanced"	"Detected in all"	9	"Cone photoreceptor cells: 732.4;Rod photoreceptor cells: 621.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	5.1	5.9	11.0	5.7	11.9	7.8	6.9	25.2	26.5	4.8	4.2	3.9	6.3	3.8	4.7	7.1	3.8	4.9	4.3	7.9	14.4	12.8	7.2	3.1	7.5	6.8	9.4	11.6	3.3	6.7	109.7	10.3	6.9	10.2	5.0	4.6	4.7	3.6	12.3	6.8	3.7	3.7	5.4	9.3	5.5	5.4	4.1	6.9	4.7	16.0	2.1	5.3	4.9	5.8	1.0	0.8	4.1	3.9	2.8	5.6	1.3	16.8	10.1	9.3	9.0	8.9	9.9	29.9	13.7	10.9	8.3	7.4	10.2	6.7	0.6	3.4	17.9	11.4	7.9	7.1	7.1	17.0	12.5	3.0	9.1	6.1	6.9	8.1	6.4	21.7	8.5	6.3	15.6	20.3	6.8	17.6	8.6	1.9	9.5	14.4	2.8	5.9	3.4	4.4	3.1	5.6	3.9	10.0	1.4	6.6	35.3	3.1	4.9	7.9	6.1	7.1	6.4	3.6	9.1	17.5	18.7	12.5	13.4	13.5	9.3	2.4	1.0	15.6	10.9	12.7	2.5	1.4	0.6	4.5	0.6	4.2	0.4	4.0	3.0	0.8	1.0	5.6	4.5	4.1	2.8	3.9	0.7	3.1	1.3	11.0	11.9	25.2	26.5	14.4	12.8	9.4	11.6	10.2	6.9	32.8	38.8	3.0	17.4	14.2	235.7	71.2	99.3	10.7	23.9	136.1	732.4	65.1	36.5	37.7	19.2	43.8	67.4	23.3	57.5	45.9	24.0	51.4	20.7	30.1	51.9	289.2	69.3	93.9	98.0	23.3	35.4	45.1	10.1	50.5	26.9	42.5	48.8	26.4	43.9	53.7	621.3	19.4	29.2	45.9	51.3	8.7	178.4	135.1	14.6	50.6
AAMDC	"C11orf67, CK067, FLJ21035, PTD015"	ENSG00000087884	"Adipogenesis associated Mth938 domain containing"	Q9H7C9	11	77821109-77918432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 73.6"	"Low region specificity"	"Detected in all"							"HPA037918, HPA037919"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037918: AB_2675737, HPA037919: AB_2675738"	"unprognostic (3.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (6.02e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.84e-2)"	18.8	42.2	7.5	7.5	11.4	5.2	16.2	10.9	8.6	13.8	15.8	9.5	16.9	10.1	18.0	9.5	12.4	13.4	11.8	35.0	7.5	6.4	12.8	15.5	11.8	3.5	13.0	6.8	14.3	18.1	6.9	11.1	7.9	9.9	12.6	8.3	10.0	16.7	14.5	155.8	13.0	13.6	21.0	15.3	7.4	14.2	14.4	13.1	6.5	14.1	15.7	5.0	14.4	17.0	8.1	13.2	43.3	11.9	13.7	18.0	6.4	7.8	6.4	10.0	7.1	29.3	20.4	2.7	13.0	8.9	11.8	14.8	73.6	11.9	5.3	12.7	21.8	11.7	4.4	15.0	8.7	14.1	12.2	12.1	5.1	11.1	13.5	14.4	2.8	4.6	27.1	6.0	12.4	6.6	11.0	35.0	7.1	5.8	8.6	24.9	9.2	6.0	11.4	4.7	22.0	11.0	5.8	17.2	5.1	15.6	4.7	3.5	13.4	16.5	7.2	9.2	15.6	11.1	5.7	36.4	12.5	6.8	23.6	4.3	9.3	14.5	9.7	4.8	4.7	6.9	43.3	11.9	12.3	6.1	6.6	7.8	7.0	11.9	10.0	12.7	8.1	10.4	7.8	6.9	13.7	6.4	13.2	18.0	6.4	7.5	11.4	10.9	8.6	7.5	6.4	13.0	6.8	9.9	13.1	77.4	23.1	12.7	70.3	57.1	10.1	103.7	63.7	44.2	25.0	75.0	3.9	21.7	122.7	56.1	47.2	50.1	92.1	0.0	64.0	37.5	60.8	57.8	40.4	94.8	39.9	11.1	21.8	93.9	31.4	27.5	63.3	28.7	79.2	82.0	49.3	57.0	62.2	98.2	60.5	133.6	12.6	45.3	59.7	89.5	53.2	88.1	13.2	17.5	57.2	63.6
AAR2	"bA234K24.2, C20orf4"	ENSG00000131043	"AAR2 splicing factor homolog"	Q9Y312	20	36236459-36270918	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034220, HPA048645"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB034220: AB_1564205, HPA048645: AB_2680475"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.54e-3)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (5.09e-2)"	"unprognostic (6.84e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	18.8	22.3	9.8	11.6	14.0	18.4	20.0	11.3	19.0	17.0	21.9	21.3	12.9	12.3	27.3	21.3	16.1	19.7	16.5	16.2	9.9	9.2	16.2	22.2	15.5	23.1	13.2	12.5	19.5	21.0	19.5	9.5	20.6	13.6	22.8	14.3	20.3	22.7	18.7	19.3	21.9	17.8	23.2	13.0	16.8	20.4	38.5	10.8	28.8	17.8	17.1	15.6	23.1	19.4	20.6	27.5	28.4	30.1	31.7	30.9	28.7	11.8	14.3	13.4	15.3	23.0	15.4	11.0	11.6	15.5	27.7	21.7	32.2	16.2	8.3	16.5	16.9	21.4	17.1	21.9	22.4	17.6	7.4	13.0	26.0	9.6	19.4	17.3	17.7	13.2	18.8	31.8	19.8	15.0	13.8	16.8	16.5	16.1	16.4	14.9	14.5	24.4	21.5	11.5	18.0	23.6	13.7	22.4	18.8	15.5	9.3	15.5	16.7	17.4	46.3	14.7	13.0	26.7	19.0	11.9	26.0	16.6	15.3	14.5	14.6	18.4	16.3	18.5	11.8	13.6	28.4	25.5	22.9	25.8	27.3	25.8	19.0	24.3	24.7	27.5	20.6	30.9	26.2	5.2	31.7	30.1	22.4	27.5	28.7	9.8	14.0	11.3	19.0	9.9	9.2	13.2	12.5	13.6	10.8	6.0	12.2	11.0	8.4	5.0	4.7	5.1	10.2	12.0	4.5	8.7	7.9	17.7	10.0	16.4	2.3	11.2	6.4	0.0	18.1	13.6	9.3	8.9	16.1	10.4	13.0	14.3	10.9	10.4	16.2	3.1	10.3	8.4	10.1	10.8	10.6	5.7	14.2	5.8	14.2	6.8	2.8	6.5	9.8	14.4	14.4	6.6	15.6	7.7	9.8	7.4
AARD	"C8orf85, LOC441376"	ENSG00000205002	"Alanine and arginine rich domain containing protein"	Q4LEZ3	8	116938199-116944487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 18.4;testis: 43.6"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 22.2;granulocytes: 13.9;Spermatocytes: 27.6"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 27.0"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.8;JURKAT: 6.8;SK-BR-3: 11.2;U-2 OS: 5.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"midbrain: 7.3"	HPA068290			Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA068290: "	"unprognostic (5.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.28e-8)"	"unprognostic (3.42e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.29e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.20e-1)"	"unprognostic (2.23e-6)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.77e-2)"	"unprognostic (5.27e-4)"	0.4	0.8	0.7	1.8	1.2	0.3	4.9	0.0	0.9	0.3	4.5	0.0	0.0	0.2	1.1	0.8	8.1	0.2	0.4	0.1	0.5	0.6	1.3	0.1	2.9	1.0	0.4	0.5	0.1	0.1	0.1	0.0	0.6	0.5	8.4	0.7	4.0	2.1	0.2	0.2	1.1	0.8	18.4	0.1	0.3	7.2	43.6	0.1	0.0	0.2	0.2	0.5	10.2	5.6	1.1	1.0	3.3	0.9	1.5	2.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.5	0.0	0.2	0.1	2.3	0.0	0.2	0.4	0.0	0.1	0.1	0.2	0.0	6.8	0.0	2.3	0.1	0.4	0.8	0.1	1.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	1.9	0.3	0.0	11.2	0.0	0.2	0.5	0.0	0.0	0.1	5.5	0.2	0.0	1.6	4.1	0.0	2.9	0.1	0.3	3.3	0.9	0.6	0.6	0.4	0.3	0.6	0.5	0.4	0.2	1.1	0.5	0.6	3.1	1.5	0.6	1.0	2.0	0.1	0.7	1.2	0.0	0.4	0.5	0.6	0.4	0.5	0.5	0.1	11.9	22.2	0.0	0.2	0.7	0.5	0.8	0.0	1.4	9.1	7.0	0.0	0.1	1.7	0.0	7.5	0.0	0.0	0.0	0.0	0.6	0.4	0.8	13.9	0.0	0.0	1.6	0.0	0.0	0.0	7.9	3.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	10.5	0.0	0.0	0.5	27.6	6.0	0.5	0.2	0.0	0.0	0.3
AARSD1	MGC2744	ENSG00000266967	"Alanyl-tRNA synthetase domain containing 1"	Q9BTE6	17	42950526-42964498	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021408, HPA022869, HPA023714"	Supported		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (2.85e-3)"	"unprognostic (9.78e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.67e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.69e-3)"	11.2	13.5	16.2	9.9	20.5	9.1	13.7	20.5	25.2	13.2	10.5	11.9	14.3	8.3	15.6	14.8	12.6	13.9	12.7	21.7	14.8	15.7	13.6	16.0	8.0	10.2	14.1	21.7	18.2	29.6	16.7	12.4	9.5	19.2	12.5	11.7	13.1	16.6	13.0	41.1	10.1	8.1	15.6	11.1	9.7	11.3	58.4	9.5	8.8	14.4	20.6	14.4	10.0	10.0	17.2	18.4	2.3	15.1	14.5	16.3	9.2	14.3	19.8	15.4	15.3	18.7	18.0	11.7	15.7	13.2	18.3	12.2	17.2	12.1	39.0	0.7	16.3	11.2	12.3	21.2	23.6	21.0	13.0	16.7	15.3	21.4	9.1	24.7	30.3	8.6	16.3	12.8	12.6	32.1	12.6	14.7	17.7	27.9	8.3	17.3	8.2	30.0	21.4	10.6	19.9	9.9	19.7	31.5	40.0	18.0	13.6	19.9	12.4	7.5	7.8	19.9	17.4	21.1	25.2	13.8	18.8	17.0	9.6	21.7	13.1	16.6	24.1	12.5	18.7	20.1	2.3	10.6	0.8	12.3	15.1	16.2	15.4	12.9	14.6	17.1	17.2	16.3	15.7	0.3	14.5	12.6	18.4	12.2	9.2	16.2	20.5	20.5	25.2	14.8	15.7	14.1	21.7	19.2	9.5	11.9	8.0	23.8	7.0	7.3	22.2	0.6	5.1	12.0	14.8	14.0	31.4	7.6	3.3	6.7	55.5	6.7	5.4	0.0	5.2	7.8	8.8	6.4	4.7	3.4	4.6	14.3	11.5	5.5	3.8	15.9	12.0	5.2	3.3	5.4	4.9	6.0	3.4	5.8	10.3	4.1	16.1	0.0	9.5	39.6	21.5	4.0	2.3	11.5	9.3	6.3
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948875-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 137.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	8.2	6.8	5.7	11.4	9.8	14.4	7.1	7.5	6.9	7.5	8.8	9.2	7.5	6.2	9.7	6.3	7.6	8.2	7.5	9.8	5.9		7.6	8.7	6.8	11.0	10.1	4.5	11.1	8.8	8.5	5.2	11.1	8.3	7.1	8.6	4.6	6.7	9.2	13.0	8.3	8.5	8.5	7.9	11.2	7.0	8.7	10.2	18.5	9.5	7.2	13.1	10.4	13.5	19.4	18.8	32.1	27.3	20.5	27.2	19.0	20.8	33.7	7.3	14.7	9.9	11.5	13.5	13.4	9.8	15.3	13.6	23.1	14.6	37.7	17.1	11.6	24.6	18.4	27.7	15.4	20.7	19.1	20.7	17.5	13.3	16.1	12.1	28.1	14.9	10.1	27.7	19.7	17.6	13.6	11.0	18.4	24.2	11.3	13.2	15.2	30.9	21.3	9.3	12.0	12.9	20.0	22.1	20.2	12.7	18.4	15.9	6.9	19.7	8.1	18.0	16.8	14.1	14.5	12.3	11.8	20.0	25.0	42.0	12.8	18.2	28.4	14.7	21.0	20.8	14.2	20.2	32.1	23.9	27.3	23.5	18.0	21.5	25.0	18.8	19.4	19.6	19.6	26.1	20.5	25.9	17.4	27.2	19.0											20.8	28.8	32.8	36.7	38.8	12.4	16.1	28.1	36.1	40.9	24.4	21.6	62.0	8.3	31.9	21.4	24.3	32.8	23.3	41.6	49.6	22.2	22.9	46.2	13.9	41.7	17.5	15.4	8.6	24.5	50.0	21.9	36.5	27.0	64.9	22.6	26.9	40.2	25.9	21.9	36.9	22.5	32.3	37.3	47.2	30.2	38.3	137.1	42.4	29.3	33.1
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781002-104928237	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 98.3;Hepatocytes: 162.2;Kupffer cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.0;U-87 MG: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: AB_2683396"	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	25.7	38.1	6.3	9.8	13.1	15.8	23.0	2.3	8.5	8.2	14.8	8.0	6.5	4.4	7.8	9.6	7.0	7.9	13.6	10.7	7.5	3.7	7.1	33.3	12.7	29.4	18.9	2.3	8.7	5.4	1.8	3.3	20.1	10.2	9.4	9.4	7.7	6.3	8.7	21.3	12.1	8.1	25.2	16.1	12.8	7.3	8.8	8.0	16.9	5.8	2.2	5.0	16.4	20.0	1.8	0.2	11.6	1.5	0.1	0.6	0.1	0.0	2.7	2.2	0.0	6.5	2.5	2.0	2.8	10.9	0.9	1.0	0.4	0.4	3.8	3.1	2.8	10.7	0.0	1.2	0.1	0.8	0.0	0.0	0.4	0.9	9.5	11.8	0.0	6.7	17.0	0.7	11.1	0.2	10.6	1.0	0.3	0.0	9.8	0.2	0.3	2.3	5.2	3.1	0.5	0.8	0.0	0.0	0.2	1.8	1.8	0.3	0.1	2.9	0.5	0.6	4.5	0.0	1.9	1.0	3.0	0.2	3.9	3.1	3.8	1.8	2.3	39.0	0.0	0.0	2.2	0.8	11.6	0.2	1.0	0.2	1.2	0.3	0.0	0.2	1.8	0.6	0.0	10.6	0.1	1.5	0.1	0.1	0.1	6.3	13.1	2.3	4.0	7.5	3.7	18.9	2.3	10.2	8.0	98.3	9.4	5.1	4.8	26.4	11.9	7.8	12.7	2.7	9.1	10.4	45.2	21.2	0.0	3.8	1.5	9.3	3.2	0.0	1.4	4.6	28.8	3.1	46.1	162.2	63.2	0.0	8.7	25.2	103.3	0.7	28.7	31.4	25.3	2.8	2.4	0.1	4.9	3.5	26.5	17.0	5.5	45.3	16.4	1.2	0.7	16.9	7.4	4.4	2.3	8.9
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 11.4;Suprabasal keratinocytes: 33.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.7;SK-BR-3: 13.4;T-47d: 7.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.7	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.4	0.0	0.1	7.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	11.4	0.0	0.4	0.0	0.0	3.4	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.1	0.3	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.7	0.0	0.0	0.0	0.2	0.5	0.2	33.8	2.9	0.0	0.0	2.2
ABCA13	"FLJ33876, FLJ33951"	ENSG00000179869	"ATP binding cassette subfamily A member 13"		7	48171458-48647496	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 64.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.7;LHCN-M2: 3.7;U-2 OS: 10.4;U-266/84: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063601			Approved	Vesicles,Centrosome,Cytosol		NA	NA			Vesicles	"Centrosome, Cytosol"	"HPA063601: AB_2685057"	"unprognostic (8.97e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.03e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.2	0.1	0.3	1.0	35.4	0.7	0.0	1.1	1.2	0.3	0.4	0.0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0.0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0.0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0.0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.3	1.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	1.9	0.6	1.2	2.1	0.0	8.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	1.0	0.8	0.0	0.3	0.0	0.1	3.7	0.0	0.0	0.1	0.1	0.0	2.1	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.0	0.6	10.4	0.4	1.5	3.1	4.2	0.0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1.0	0.3	0.6	0.1	0.2	0.1	1.0	0.0	1.1	1.8	0.2	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.0	0.0	64.3	9.1	1.8	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.2	0.0	0.0	0.0	0.3	0.1
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;lung: 75.8"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 382.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.3	6.2	12.9	3.4	15.3	1.6	7.0	21.9	30.8	3.0	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6.0	4.7	18.3	5.3	2.1	4.9	8.5	5.0	5.0	4.2	2.5	5.0	11.3	3.7	3.0	7.2	6.1	5.6	16.2	0.5	6.4	3.0	1.3	0.2	0.5	0.0	0.6	2.0	1.5	0.4	0.3	9.7	1.8	15.1	0.4	0.0	0.1	2.6	0.6	1.0	1.1	1.3	1.5	0.1	3.8	1.2	0.9	0.2	8.7	0.1	0.3	15.2	5.8	1.0	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	6.2	14.7	0.1	10.4	0.0	0.0	12.9	0.0	1.0	2.0	2.3	4.7	2.4	0.3	1.7	8.7	0.3	21.2	15.3	1.8	10.7	0.2	0.8	34.9	0.9	4.2	0.1	0.5	4.1	4.3	2.8	1.2	0.0	2.1	5.2	0.1	0.0	0.1	0.0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0.0	2.0	0.6	0.0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1	65.5	382.0	0.0	0.4	0.6	16.5	5.1	2.5	4.0	17.0	17.4	11.8	0.0	0.0	4.6	7.7	4.2	0.2	0.0	3.3	0.0	1.4	1.9	27.8	0.9	0.9	17.5	5.2	2.5	2.7	2.7	1.7	1.6	1.7	2.8	0.7	6.9	2.4	0.0	3.2	1.5	9.5	6.5	3.1	1.9	14.0	1.4	0.0	2.5	0.6	0.1
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992835-94121132	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 142.7"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	13	"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.7	0.0	0.3	0.2	0.4	0.0	1.1	0.2	0.9	0.7	0.2	3.2	0.2	3.7	0.2	12.9	0.2	0.6	0.2	0.2	2.0	0.2	6.7	1.2	0.4	0.3	0.3	0.2	0.3	0.2	0.0	0.2	0.8	25.5	0.3	0.0	142.7	0.2	2.1	0.2	3.5	4.2	0.2	0.2	0.2	0.1	2.1	0.2	0.2	0.7	0.2	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	11.2	0.5	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.7	3.5	1.2	0.6	0.0	0.0	0.5	0.0	0.5	0.0	0.2	1.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	2.0	0.0	0.0	0.2	0.3	0.3	0.5	0.5	0.0	0.0	1.0	4.2	0.2	5.1	0.4	0.0	0.2	0.3	2.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.9	2.0	0.2	0.3	0.2	25.5	0.2	0.0	0.6	0.0	0.2	0.1	14.3	0.8	0.0	2.7	0.0	7.0	424.1	0.1	0.0	0.0	8.5	0.8	0.0	0.0	0.0	1.1	0.2	1.5	0.0	0.0	0.1	9.5	0.0	0.6	0.0	15.5	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.4	0.0	455.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5
ABCA5	EST90625	ENSG00000154265	"ATP binding cassette subfamily A member 5"	Q8WWZ7	17	69244311-69327244	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022032, HPA062904"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022032: AB_1844427, HPA062904: AB_2732692"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.05e-4)"	"unprognostic (3.05e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.52e-2)"	10.5	8.6	6.7	3.8	9.8	6.0	12.7	35.6	12.4	8.8	9.6	4.3	13.5	9.7	6.0	7.7	8.6	6.6	4.6	5.2	5.3	6.2	7.9	21.7	4.9	3.3	4.1	7.9	6.9	20.3	13.0	35.9	5.3	13.6	7.4	10.6	15.5	8.2	11.4	52.8	24.0	15.5	3.4	7.6	4.3	8.9	9.0	3.9	1.7	7.9	10.3	5.9	5.5	8.1	4.2	3.9	4.5	0.7	3.0	4.2	1.2	4.2	2.0	1.6	2.5	7.9	5.7	0.5	4.5	4.9	4.7	7.0	0.6	1.6	0.0	2.4	3.9	3.7	6.4	1.0	3.7	5.3	0.1	3.0	0.0	4.8	3.0	10.5	0.0	2.7	5.6	4.6	2.0	5.4	1.0	10.2	1.6	0.0	1.7	0.4	3.7	2.6	0.0	1.6	1.6	3.0	0.3	0.1	0.4	0.9	7.2	8.9	1.4	16.1	7.4	4.6	1.5	7.6	2.7	7.4	5.3	1.5	4.9	0.9	9.2	0.2	0.3	2.2	0.0	4.8	0.7	0.7	4.5	3.1	0.2	4.2	2.4	4.0	3.4	0.5	4.2	2.1	3.4	1.9	3.0	0.1	3.9	2.4	1.2	6.7	9.8	35.6	12.4	5.3	6.2	4.1	7.9	13.6	3.9	17.9	16.9	10.2	30.0	58.2	127.4	22.1	28.1	49.5	14.8	36.6	110.0	11.6	5.0	9.2	14.9	17.1	72.6	0.0	8.6	4.9	18.8	32.6	13.9	89.4	6.2	100.1	108.2	18.4	4.8	9.5	59.0	8.9	96.2	47.7	65.8	49.9	12.8	38.6	43.2	10.2	117.6	90.5	24.0	103.0	47.0	46.9	19.8	13.8	26.6	34.4
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867292-68955392	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Leydig cells: 465.4;Muller glia cells: 138.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 16.6;ASC TERT1: 37.0;HSkMC: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	29.1	25.2	10.0	3.4	27.2	0.5	15.1	3.2	15.4	7.3	12.8	29.9	3.9	5.4	10.2	13.0	12.4	17.6	14.3	30.0	12.5	5.5	8.1	26.6	15.2	1.3	37.8	9.2	44.7	5.1	4.5	14.8	7.6	22.2	10.3	14.3	16.4	9.8	7.9	8.9	4.9	9.9	7.1	28.2	9.9	11.5	15.8	42.7	0.0	13.0	14.2	2.8	13.6	20.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	16.6	37.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	6.1	0.0	0.0	27.9	0.0	0.4	0.0	0.2	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.0	27.2	3.2	15.4	12.5	5.5	37.8	9.2	22.2	42.7	47.6	0.6	0.0	1.3	5.4	1.4	12.5	0.0	0.0	7.9	0.0	2.0	0.1	0.0	0.0	4.2	4.2	0.0	0.0	0.0	0.1	35.3	0.3	1.1	35.8	0.9	4.8	0.0	7.4	1.9	4.3	465.4	1.8	1.7	0.0	0.0	138.5	0.0	0.0	66.1	0.0	2.1	38.8	6.2	1.1	1.2	4.1	0.2	0.0	0.0	0.2
ABCA9	EST640918	ENSG00000154258	"ATP binding cassette subfamily A member 9"	Q8IUA7	17	68974488-69061064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 42.5"	"Cell type enhanced"	"Detected in many"	22	"Ito cells: 26.4;Leydig cells: 89.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"ASC diff: 14.5;ASC TERT1: 31.1;HSkMC: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052113, HPA054823"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA052113: AB_2732573, HPA054823: AB_2682615"	"unprognostic (3.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.51e-4)"	"unprognostic (1.83e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.77e-6)"	"unprognostic (5.32e-4)"	"unprognostic (7.22e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-3)"	42.5	4.2	1.2	5.5	2.8	1.7	14.1	2.7	2.6	13.4	17.4	2.6	6.8	1.7	15.5	11.8	25.5	8.8	7.2	15.0	2.1	1.9	2.5	7.6	5.6	2.1	7.8	2.0	25.2	2.3	1.7	2.8	1.1	4.4	13.9	3.8	4.1	5.7	4.7	12.4	5.4	3.7	11.9	3.8	1.6	4.8	10.9	2.1	1.0	7.6	9.9	2.5	20.4	18.7	1.8	0.9	2.9	0.8	1.2	1.3	0.0	0.2	0.4	0.5	0.6	14.5	31.1	0.5	0.3	0.3	0.0	0.2	0.4	0.4	0.4	0.1	0.5	0.3	0.4	0.3	0.5	0.2	0.2	0.4	0.5	1.3	0.4	1.6	0.6	0.9	11.1	0.4	2.3	0.2	0.6	3.1	0.4	0.5	1.1	0.2	0.2	0.2	1.4	0.3	0.1	0.3	1.5	0.1	0.2	0.1	1.3	0.6	0.5	0.4	0.3	0.3	0.4	0.3	0.5	1.3	0.9	0.4	1.7	0.3	1.0	0.3	0.3	0.3	0.3	1.5	1.7	0.8	1.4	1.3	0.6	1.3	1.1	0.8	0.5	0.9	1.8	1.3	1.3	2.9	1.2	0.5	0.7	0.4	0.0	1.2	2.8	2.7	2.6	2.1	1.9	7.8	2.0	4.4	2.1	0.0	1.0	0.0	0.2	1.5	5.4	2.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.4	0.0	0.0	0.0	10.6	0.1	0.0	9.9	0.2	0.0	0.0	26.4	1.8	2.1	89.2	0.6	0.0	0.0	0.0	12.1	0.3	0.0	14.5	0.0	6.1	12.9	1.4	1.2	0.6	1.4	0.0	0.0	0.0	0.1
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8"									"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	9.3	16.7	1.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.4	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6	0.0	4.8	5.9	0.1	0.7	0.6	2.8	104.4	1.4	1.2	47.1	0.0	5.0	5.0	10.2	21.6	23.1	174.5	23.3	1.6	0.1	0.5	0.1	3.5	32.6	0.4	0.0	0.0	3.7	1.2	2.5	0.9	0.8	0.0	0.0	8.9	0.0	11.4	77.2	0.0	44.0	0.9	0.0	0.8	0.5	0.4	0.5	8.2	27.3	1.7	0.1
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 235.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.0;WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	12.0	0.0	0.6	2.2	0.5	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.8	0.2	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4	0.0	0.3	23.1	0.0	0.9	0.0	9.3	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.2	1.5	0.0	0.0	235.3	0.5	36.5	0.0	5.5	5.4	0.2	0.0	0.0	10.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.5	0.1	0.4	0.1	0.0	0.0	0.0
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209766-219219017	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 4.0;Club cells: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"		NA	NA		22000	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.1	8.4	8.2	3.9	13.5	10.2	9.2	7.6	9.1	6.9	7.6	5.4	8.3	8.1	7.1	10.1	9.0	8.4	8.5	9.5	5.6	8.2	6.9	16.2	7.2	4.9	9.8	7.6	13.1	7.1	8.0	6.0	3.7	9.2	9.2	4.2	6.0	5.6	11.3	24.0	5.5	8.0	9.5	9.2	3.2	6.8	19.5	7.7	0.8	9.9	11.3	4.7	14.8	6.0	2.8	5.6	1.3	1.1	1.2	3.2	2.4	0.1	9.9	2.0	12.5	14.0	5.0	12.3	3.7	3.4	4.1	4.1	15.2	2.1	0.1	19.1	3.6	2.2	21.4	0.2	1.5	1.3	6.3	2.2	15.5	10.9	27.9	16.9	0.0	5.2	7.3	1.8	2.7	0.0	6.1	7.1	2.1	13.1	1.9	2.7	5.1	1.0	0.1	3.1	23.0	4.1	5.2	6.3	0.6	2.2	0.2	7.4	7.9	7.7	18.3	8.1	8.0	5.5	0.3	3.2	5.5	0.2	7.4	4.3	5.0	4.0	0.0	6.2	0.1	7.3	1.3	1.1	0.0	1.7	0.9	0.5	2.8	1.3	0.7	0.9	2.3	3.2	2.1	0.0	1.2	0.8	5.6	1.1	2.4	8.2	13.5	7.6	9.1	5.6	8.2	9.8	7.6	9.2	7.7	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	4.0	2.3	0.0	0.0	0.2	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.7	0.0	0.2	0.9	0.2	0.3	0.2	0.0	0.0	0.0
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051554-75156732	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	15.1	18.0	12.3	14.7	14.3	13.0	14.6	26.0	16.2	11.6	15.2	12.0	13.7	19.0	14.7	13.6	14.7	11.7	10.0	21.4	11.7	7.1	15.6	22.4	12.2	15.9	13.0	8.5	16.4	12.4	14.7	22.6	11.5	14.0	10.6	15.4	9.5	12.9	15.5	34.6	15.3	15.9	14.9	12.2	13.9	14.8	5.4	16.2	19.7	12.4	19.3	16.0	13.9	13.3	19.4	19.3	7.0	18.7	12.2	21.5	12.4	11.6	11.3	11.7	14.7	7.7	19.2	5.6	8.2	9.2	7.5	12.9	14.1	17.2	18.2	15.8	6.7	15.8	12.1	22.4	10.4	12.8	19.6	18.7	12.3	22.8	10.4	6.3	19.8	10.7	13.6	9.9	10.1	13.3	14.9	16.2	16.7	13.3	23.6	8.1	7.0	14.9	14.6	19.8	18.4	15.9	15.2	22.4	21.3	9.7	11.6	13.9	9.3	19.3	17.8	11.0	19.3	8.0	14.0	8.4	7.7	15.0	16.0	7.9	7.7	19.5	16.5	7.5	23.9	8.1	5.9	18.7	7.0	11.5	17.7	12.3	18.1	12.8	12.4	19.3	19.4	21.5	16.0	2.2	12.2	13.4	11.9	17.4	12.4	12.3	14.3	26.0	16.2	11.7	7.1	13.0	8.5	14.0	16.2	8.9	7.2	15.2	12.1	14.1	9.2	43.6	10.2	10.7	7.9	10.4	5.9	19.5	10.0	14.8	0.3	11.1	8.5	0.0	11.6	9.8	12.7	9.0	21.9	11.5	17.9	23.8	13.3	9.8	19.7	0.4	13.6	14.9	10.1	16.2	9.8	12.0	10.6	5.8	12.4	15.9	7.6	32.3	12.4	3.8	9.4	14.1	18.7	13.1	17.8	9.5
ABCB8	"EST328128, M-ABC1, MABC1"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	12.6	22.8	14.4	13.8	22.0	12.2	8.5	24.9	24.8	16.3	12.3	22.2	10.4	19.3	16.5	14.9	17.6	12.9	11.5	13.0	14.5	12.8	14.5	33.5	11.7	13.3	19.1	17.9	13.3	12.6	15.4	20.1	23.6	15.9	12.3	9.5	12.5	11.1	12.8	11.2	13.7	14.7	12.7	13.3	11.5	13.1	13.6	19.5	14.0	18.4	11.7	10.6	9.6	10.4	4.4	10.4	10.3	6.7	4.0	7.5	3.6	12.5	19.8	5.1	16.1	8.1	4.7	10.2	6.6	6.9	10.6	11.2	7.9	21.1	6.6	8.9	7.0	12.8	13.3	7.4	13.8	4.7	8.2	8.1	5.2	7.9	9.4	5.3	4.0	13.1	8.1	10.5	12.6	5.2	3.9	10.6	14.7	27.4	9.1	7.9	28.1	15.3	7.6	3.4	9.5	22.6	7.3	3.2	23.5	7.1	5.4	4.9	9.9	7.1	20.2	6.4	4.1	8.0	5.3	6.5	9.9	2.6	7.1	9.9	9.2	4.6	4.7	14.0	9.7	10.1	10.3	4.5	3.4	7.5	6.7	5.2	4.4	5.3	6.1	6.3	3.5	4.9	6.9	1.1	4.0	4.7	10.4	5.6	3.6	14.4	22.0	24.9	24.8	14.5	12.8	19.1	17.9	15.9	19.5	11.9	0.6	11.7	5.2	3.3	22.7	6.7	12.7	1.4	1.2	10.4	35.3	32.5	3.3	13.7	1.8	3.4	24.1	0.0	17.6	18.5	6.5	7.1	50.6	21.2	25.1	28.6	0.0	5.5	8.1	1.9	6.1	5.9	8.5	11.8	8.7	11.2	17.7	7.8	11.7	12.8	32.9	25.8	5.9	8.8	15.4	6.5	68.4	7.5	10.6	5.1
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019829-95301475	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 35.0"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2"	"Low region specificity"	"Detected in all"							HPA002476	Enhanced		Approved	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"	"Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	3.2	1.7	3.8	11.8	4.7	2.9	6.2	1.0	4.6	4.4	11.6	10.3	3.9	4.1	5.8	16.4	3.0	8.6	10.3	3.5	5.7	3.9	19.6	1.9	13.8	7.4	6.6	2.2	7.2	3.5	7.0	2.8	1.8	7.4	35.0	7.3	6.0	3.3	5.2	7.6	4.5	7.4	11.1	6.5	3.8	8.2	3.8	7.0	3.4	6.6	3.1	5.8	25.6	13.4	3.6	4.1	1.0	4.8	4.1	3.6	3.4	4.5	8.0	1.3	2.4	2.5	3.3	0.3	3.6	3.7	3.3	2.8	11.1	3.4	2.5	2.4	4.9	2.4	6.2	2.0	1.8	4.1	7.5	3.1	61.8	2.5	2.2	5.1	7.0	67.7	2.5	0.8	2.3	4.8	4.7	4.2	2.8	6.4	0.1	4.4	1.4	1.3	1.1	1.5	5.5	1.9	1.9	3.7	6.6	18.2	10.3	3.3	2.4	1.2	0.2	2.5	1.5	0.0	3.8	6.9	3.5	2.2	2.9	4.3	0.0	0.0	1.0	6.6	4.0	1.7	0.6	1.2	0.4	3.2	1.2	2.7	3.6	2.6	3.6	4.1	2.7	1.6	3.5	1.0	4.1	4.8	0.7	3.3	3.4	3.8	4.7	1.0	4.6	5.7	3.9	6.6	2.2	7.4	7.0	8.9	28.3	3.7	6.2	3.8	0.0	3.1	5.1	6.7	11.4	22.7	21.6	0.1	0.0	5.2	3.2	11.3	1.4	0.0	2.6	0.4	3.9	38.5	53.1	0.0	3.8	0.0	0.0	2.5	1.0	1.7	6.4	6.3	1.7	19.0	3.2	0.3	4.1	9.3	1.8	32.7	0.7	0.0	3.9	0.6	9.1	6.6	0.2	2.2	7.8	3.7
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184018015	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	7.9	11.2	24.7	9.6	26.2	12.0	6.7	42.8	28.6	7.7	11.4	12.0	13.4	6.8	14.1	7.0	17.1	6.1	11.6	16.0	19.1	13.7	12.8	3.6	9.4	7.3	20.5	18.5	11.8	4.9	22.4	20.5	10.8	21.7	10.6	14.4	31.1	7.4	9.3	41.0	14.5	8.5	10.5	12.9	16.3	48.5	9.4	20.9	9.3	5.5	7.3	7.4	18.1	12.7	4.2	3.5	15.8	4.5	5.0	7.0	4.5	7.3	4.1	9.4	11.2	9.4	10.7	14.6	6.0	4.7	5.4	5.9	6.3	5.7	8.0	14.1	5.7	8.2	29.9	11.6	6.6	7.1	8.7	11.2	16.9	10.3	5.7	3.9	5.1	13.2	17.0	6.7	5.8	3.8	11.1	6.3	23.7	15.7	11.1	9.2	19.5	14.1	5.9	9.7	13.4	7.9	9.8	3.1	4.7	19.6	48.0	17.2	10.2	6.1	33.9	10.1	12.7	20.5	1.6	7.2	6.3	6.2	8.0	8.2	4.3	8.3	7.4	4.6	10.3	6.4	10.7	4.5	7.7	7.0	2.1	4.5	3.2	4.0	3.1	3.5	4.2	4.6	6.3	15.8	5.0	3.5	1.3	5.0	4.5	24.7	26.2	42.8	28.6	19.1	13.7	20.5	18.5	21.7	20.9	8.9	4.0	1.9	12.9	7.9	34.3	31.9	2.5	56.2	46.6	41.8	184.6	2.7	6.6	5.0	4.8	6.7	9.5	0.0	4.0	3.9	8.0	10.9	4.7	2.4	39.9	31.8	56.9	5.5	27.9	2.2	7.5	11.2	11.8	6.4	6.3	9.4	6.1	9.3	7.4	2.7	122.3	0.0	8.6	3.1	14.7	10.7	3.8	5.0	7.2	50.3
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;pancreas: 25.5;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 39.2;Intestinal endocrine cells: 21.0"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 4.7;AN3-CA: 3.8;SCLC-21H: 6.7"					"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA			Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	1.3	6.7	4.4	0.8	6.1	0.9	4.0	28.0	12.3	3.0	1.3	2.6	7.7	1.9	3.1	3.7	0.8	1.2	0.9	2.9	5.1	4.8	1.0	0.8	2.9	0.8	3.6	7.2	0.9	25.5	1.0	26.6	1.6	8.5	2.8	1.3	0.7	0.9	8.5	2.3	1.1	1.5	1.3	4.0	0.9	3.5	1.1	2.3	0.0	6.2	0.0	0.8	0.7	0.8	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	4.7	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.4	6.1	28.0	12.3	5.1	4.8	3.6	7.2	8.5	2.3	0.0	0.0	0.0	0.0	0.0	39.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	21.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.0	1.2	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.0	0.1
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797401-21942529	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 47.6;Hepatocytes: 84.7;Sertoli cells: 129.4;Smooth muscle cells: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.6;BJ hTERT+: 10.1;CACO-2: 16.0;HSkMC: 21.0;U-138 MG: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	21.6	4.7	5.5	2.6	5.4	1.2	25.8	1.5	8.6	12.4	6.8	4.8	5.1	3.0	15.3	6.3	9.1	9.5	9.6	26.2	5.7	2.6	5.6	31.1	6.2	2.7	2.9	4.2	11.8	5.8	1.7	2.7	2.8	5.5	7.0	1.6	10.8	4.8	8.4	33.2	3.3	4.1	17.1	4.9	3.5	9.1	3.4	4.2	0.1	6.3	14.5	1.2	9.5	8.4	1.6	0.9	1.8	0.8	0.5	0.9	0.0	0.6	0.1	7.5	0.2	17.6	8.0	0.2	4.1	10.1	4.5	2.3	16.0	0.7	0.3	0.8	0.4	0.5	0.2	0.0	0.0	4.7	0.2	0.1	0.3	0.5	0.2	0.0	0.3	0.4	21.0	0.0	4.5	1.7	0.3	0.0	0.3	0.2	0.9	0.2	0.9	0.2	0.2	1.0	0.8	0.4	0.3	0.2	0.2	0.0	0.8	0.3	1.2	0.2	0.4	0.1	1.2	0.8	0.2	0.2	17.5	1.3	1.5	5.3	0.8	0.8	0.3	4.3	0.2	0.3	0.9	0.5	0.4	0.9	0.4	0.6	0.7	0.7	0.7	0.2	1.6	0.6	0.8	1.8	0.5	0.8	0.9	0.4	0.0	5.5	5.4	1.5	8.6	5.7	2.6	2.9	4.2	5.5	4.2	32.8	47.6	0.0	1.0	3.1	0.4	27.8	0.0	36.1	39.8	0.0	0.0	0.2	0.0	0.0	0.2	4.9	0.0	0.0	0.2	0.1	10.6	0.4	22.1	84.7	0.1	1.6	0.0	11.1	3.3	0.0	0.3	2.1	10.1	0.0	0.0	13.1	0.1	0.0	0.4	0.0	1.1	129.4	47.2	0.5	0.7	1.9	0.2	0.0	0.0	1.4
ABCF3	EST201864	ENSG00000161204	"ATP binding cassette subfamily F member 3"	Q9NUQ8	3	184186023-184194012	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036332	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA036332: AB_10603571"	"unprognostic (1.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.53e-2)"	13.0	47.0	18.9	10.6	19.7	12.4	12.7	23.0	27.2	15.3	12.1	15.4	33.8	13.1	13.5	11.1	16.1	15.0	10.8	22.9	15.4	16.8	16.5	22.3	12.1	12.7	15.4	15.1	17.8	19.7	41.6	17.9	16.0	19.8	13.3	11.8	15.5	21.4	30.1	33.8	15.2	12.8	10.8	12.3	14.9	13.3	12.6	18.6	8.8	15.4	14.4	14.2	12.5	13.8	16.1	16.4	13.9	19.4	14.5	25.4	21.5	21.9	13.6	7.8	15.0	22.8	12.8	15.4	16.0	17.9	21.7	17.1	23.2	8.8	13.3	32.4	17.1	25.5	21.1	12.1	16.8	11.3	16.9	11.6	11.4	11.9	13.6	19.2	12.8	11.7	18.8	15.5	15.3	15.3	12.8	15.5	11.7	10.5	16.1	15.3	26.5	12.5	8.2	11.8	22.8	18.9	12.6	13.0	22.3	11.9	13.3	13.5	7.8	16.5	31.8	14.7	8.9	43.0	11.3	15.1	11.7	12.7	18.2	23.6	18.2	17.5	17.1	18.1	12.8	14.3	5.3	18.6	13.9	22.7	19.4	23.5	16.0	20.1	18.7	16.4	16.1	25.4	20.5	9.3	14.5	19.1	10.1	17.2	21.5	18.9	19.7	23.0	27.2	15.4	16.8	15.4	15.1	19.8	18.6	8.9	1.3	14.9	9.2	12.9	15.7	10.5	12.7	4.0	4.5	14.0	13.7	32.3	24.9	18.7	6.1	9.2	19.0	0.0	19.5	21.8	10.8	7.8	9.2	18.1	18.8	19.1	10.9	14.1	10.3	7.6	11.5	8.1	15.1	28.9	12.7	13.7	17.3	10.2	11.0	23.7	20.6	6.5	7.3	10.7	14.7	8.9	36.6	15.4	13.1	11.5
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7"									"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.6	18.8	5.6	0.0	0.2	0.0	32.9	0.7	0.6	1.0	1.6	4.1	0.2	0.0	0.2	0.1	2.4	5.5	0.1	0.5	1.4	5.3	0.8	0.2	0.1	5.6	0.0	0.2	0.0	0.1	2.3	2.2	0.1	0.5	1.7	0.4	0.4	0.0	0.6	10.9	2.6	0.0	1.9	25.5	0.0	1.2	0.0	16.5	0.0	4.0	0.0	0.2	3.9	0.4	0.5	12.7	0.1	0.0	0.0	0.7	0.7	0.2	0.0	5.2	1.9	0.0	1.4	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5	3.0	1.4	0.5	0.2	3.4	0.0	1.1	0.0	1.4	0.0	0.0	0.0	14.3	1.7	0.0	2.6	9.0	135.7	0.0	0.2	47.1	2.1	0.2	5.7	25.0	105.8	0.0	2.9	13.5	1.0	0.4	1.1	1.1	5.0	0.0	2.9	0.9	0.1	35.1	0.4	4.5	0.2	0.0	1.4	0.9	3.4	0.4	31.5	0.8	0.8	0.1
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882987	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 62.4;liver: 64.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 24.1"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.1	0.4	0.1	21.2	0.0	0.0	24.0	0.1	0.1	0.1	0.1	1.7	0.1	0.2	0.3	0.2	64.4	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	62.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.6	2.1	0.3	0.5	0.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	14.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	2.1	0.3	0.4	0.7	0.3	0.5	0.5	0.6	0.5	0.1	0.7	0.8	0.7	1.7	0.5	0.3	0.6	0.3	0.2	0.2	0.3	0.1	0.4	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	1.2	1.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABHD10	FLJ11342	ENSG00000144827	"Abhydrolase domain containing 10"	Q9NUJ1	3	111979010-111993363	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036991, HPA036992, HPA066081"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No		85000	Mitochondria		"HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610"	"unprognostic (1.65e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.76e-2)"	8.5	18.3	17.5	8.1	27.5	7.6	12.4	23.2	23.2	9.9	11.3	13.7	8.6	9.4	9.4	42.4	7.0	12.5	8.4	19.8	18.6	19.6	39.1	26.6	9.7	14.0	17.0	21.6	16.8	12.1	8.8	26.1	8.8	19.1	17.1	12.3	12.6	19.8	12.0	10.4	8.2	8.6	8.9	14.8	12.4	11.6	12.6	15.1	16.6	25.3	6.7	12.6	8.7	7.9	18.3	19.7	17.7	14.8	7.8	12.7	10.8	18.7	16.3	18.0	5.9	10.4	14.0	9.7	19.9	10.5	16.4	15.8	16.8	10.9	17.0	11.2	8.3	11.2	10.4	7.9	11.0	22.5	5.7	10.0	14.0	8.0	14.5	8.3	28.0	15.1	8.5	8.3	8.4	21.2	11.3	17.5	20.4	6.4	7.3	17.9	6.3	26.4	13.1	11.7	20.9	25.9	23.9	11.5	7.8	17.0	8.2	12.1	8.9	15.9	11.6	18.5	7.4	13.0	10.3	9.8	9.8	12.6	7.0	10.3	11.7	4.1	29.0	9.9	15.4	10.4	17.7	11.8	17.5	7.4	14.8	12.7	18.3	9.3	8.4	19.7	15.9	12.0	10.5	1.8	7.8	11.6	12.5	8.8	10.8	17.5	27.5	23.2	23.2	18.6	19.6	17.0	21.6	19.1	15.1	0.0	4.5	17.1	8.5	6.3	20.8	20.0	7.6	18.7	9.1	10.4	7.9	15.2	29.9	4.3	0.7	7.5	5.3	0.0	6.9	12.2	9.4	5.4	9.2	22.5	12.6	39.7	11.6	11.6	20.8	1.9	9.8	11.2	10.1	2.8	10.9	18.9	4.7	2.9	7.1	27.8	12.6	0.0	10.7	29.6	34.3	7.2	4.6	10.9	10.5	4.2
ABHD13	"bA153I24.2, BEM46L1, C13orf6, FLJ14906"	ENSG00000139826	"Abhydrolase domain containing 13"	Q7L211	13	108218379-108234255	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032143, HPA032144"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA032143: AB_2674178, HPA032144: AB_10602304"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.62e-2)"	13.6	12.5	13.8	14.3	14.2	26.7	14.9	17.0	15.5	13.6	17.0	6.8	14.5	13.8	16.3	21.0	15.2	13.5	13.8	12.9	11.7	10.4	12.5	20.1	15.4	14.8	10.1	10.4	13.2	12.4	9.6	14.1	16.5	11.1	13.0	15.0	10.5	14.7	18.1	12.9	12.7	16.7	13.7	10.1	20.0	13.9	8.9	8.2	26.4	15.4	11.3	14.5	13.3	18.6	8.5	8.9	19.2	10.4	11.8	11.8	10.1	9.0	3.8	10.2	5.6	8.0	9.5	4.9	9.0	9.1	7.9	9.5	5.8	8.7	7.7	9.5	7.0	7.8	8.3	7.5	10.4	12.7	10.3	6.6	9.4	5.4	5.7	8.0	19.4	11.6	9.7	10.0	6.2	8.1	7.5	9.3	10.7	5.0	4.4	8.1	3.8	9.4	8.2	4.8	13.5	4.5	8.1	7.3	4.5	11.2	8.2	7.7	9.6	4.8	8.0	9.7	9.4	7.4	18.1	9.7	5.7	5.9	6.6	6.0	8.5	6.7	8.4	13.4	12.2	10.2	8.7	10.4	19.2	8.0	9.5	11.8	8.5	10.9	9.5	8.9	8.1	10.5	8.7	11.3	11.8	8.4	6.7	10.2	10.1	13.8	14.2	17.0	15.5	11.7	10.4	10.1	10.4	11.1	8.2	20.8	11.0	23.1	17.8	39.4	12.5	6.1	22.9	8.1	9.1	10.4	0.0	18.2	8.3	16.4	13.8	17.2	11.8	0.0	18.5	12.2	20.3	17.8	13.9	24.5	17.6	17.5	29.3	19.0	17.3	14.3	14.4	18.7	25.3	17.2	11.7	11.8	16.0	11.5	16.3	10.0	11.6	19.4	18.8	12.8	10.9	44.7	17.8	24.5	10.0	19.0
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		2600000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favorable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	40.0	34.2	6.2	19.8	7.5	11.4	25.2	10.7	7.0	21.9	33.6	8.6	32.1	30.3	19.6	21.7	27.7	22.0	32.9	12.2	6.2	5.8	42.6	78.4	21.5	35.1	7.8	7.3	29.5	45.0	14.2	15.2	11.4	6.7	30.9	20.2	29.1	39.4	35.0	11.7	16.0	58.7	22.6	8.9	23.3	18.7	11.2	6.2	26.0	35.3	15.2	32.5	24.6	16.9	24.9	15.5	12.5	9.4	9.9	27.2	14.0	10.3	8.8	0.7	10.4	28.8	25.7	2.7	4.1	4.8	7.6	8.9	6.5	20.5	11.6	3.3	14.3	3.5	5.2	6.4	5.9	5.8	15.8	6.9	18.3	7.7	25.5	15.5	10.2	18.9	33.2	20.4	7.7	10.5	11.7	9.2	17.7	10.6	18.6	14.7	10.1	4.5	7.8	1.0	11.3	22.6	11.6	1.4	52.4	13.8	4.2	4.4	4.7	10.4	19.4	33.0	1.6	27.9	7.0	8.7	4.0	19.1	9.1	2.4	23.7	11.1	4.8	8.8	32.8	7.0	12.5	9.4	4.2	18.3	7.6	27.2	24.9	23.0	22.4	15.5	18.7	23.4	21.3	0.8	9.9	4.8	11.3	16.3	14.0	6.2	7.5	10.7	7.0	6.2	5.8	7.8	7.3	6.7	6.2	6.0	25.8	75.9	43.7	26.9	12.4	3.2	56.0	24.1	9.1	66.3	13.7	13.4	124.3	28.2	1.4	33.6	100.6	0.0	40.7	15.9	35.2	36.3	50.7	104.1	49.3	7.9	72.9	30.7	50.2	0.5	60.1	36.2	52.3	32.5	83.5	7.7	25.4	66.2	43.9	216.2	37.1	38.8	41.0	0.5	3.4	26.6	9.8	59.8	107.0	52.8
ABHD15		ENSG00000168792	"Abhydrolase domain containing 15"	Q6UXT9	17	29560547-29567137	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA014470	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Cytosol"		"HPA014470: AB_1852993"	"unprognostic (1.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.45e-2)"	22.6	3.5	4.9	6.0	3.2	5.4	21.6	2.9	4.1	3.8	8.8	4.2	4.4	8.5	4.2	3.1	4.1	4.3	7.8	6.6	2.1	1.9	8.4	21.2	5.6	12.7	2.7	3.9	2.8	10.9	8.8	8.5	3.2	4.3	4.0	5.0	3.6	4.5	4.6	2.1	3.4	12.7	5.5	3.3	9.1	6.3	1.4	4.6	1.6	5.2	2.7	6.0	5.6	9.1	2.0	17.0	11.1	0.4	7.2	5.0	0.7	3.8	15.0	1.9	5.3	20.6	9.0	7.9	5.3	5.9	5.3	4.9	3.4	2.0	5.7	3.9	5.7	9.4	10.6	6.6	2.3	2.9	17.7	5.0	2.3	7.4	4.3	6.3	5.9	10.7	6.7	6.2	5.1	0.9	3.9	3.8	3.4	3.0	5.5	2.8	5.2	5.6	6.9	0.4	13.0	4.5	13.1	7.3	13.2	9.5	5.9	1.3	2.2	8.0	3.6	2.0	2.1	9.1	13.7	4.7	3.1	3.9	7.7	4.6	9.3	6.2	3.0	6.1	3.7	6.5	11.1	0.4	1.8	1.9	0.2	5.0	1.0	1.0	1.7	1.0	2.0	0.3	1.0	0.5	7.2	0.2	17.0	0.9	0.7	4.9	3.2	2.9	4.1	2.1	1.9	2.7	3.9	4.3	4.6	3.0	5.5	5.6	1.1	1.1	0.0	2.0	5.1	5.3	4.5	7.0	0.0	0.9	0.0	2.8	0.2	1.4	8.3	0.0	6.6	1.0	3.8	1.2	2.3	25.3	6.6	1.6	6.9	3.7	6.7	0.2	4.4	8.2	5.0	3.6	6.3	0.9	4.8	0.0	4.2	5.4	0.7	0.0	2.0	0.5	0.4	2.0	0.2	14.4	6.3	1.1
ABHD17A	"C19orf27, FAM108A1, MGC5244"	ENSG00000129968	"Abhydrolase domain containing 17A"	Q96GS6	19	1876810-1885547	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043270, HPA047226, HPA069225"	Uncertain		Approved	"Nuclear speckles,Vesicles"		NA	NA			Vesicles	"Nuclear speckles"	"HPA043270: AB_2678401, HPA047226: AB_2679991, HPA069225: "	"unprognostic (3.77e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.60e-2)"	28.1	11.9	26.6	8.9	23.9	10.0	6.8	16.4	29.4	9.0	14.1	15.3	10.3	16.5	8.8	7.0	9.9	7.1	11.7	12.9	30.9	14.4	11.9	8.2	13.0	9.1	19.0	16.7	9.4	16.6	3.8	7.7	13.4	13.2	13.9	2.1	8.4	21.0	11.2	47.4	20.7	15.8	5.2	25.5	25.7	23.3	12.1	7.9	10.9	11.4	9.6	7.1	6.3	7.3	4.5	1.5	5.9	1.5	4.7	8.5	1.0	16.7	5.8	1.7	6.6	3.1	3.8	13.2	11.3	3.5	3.1	3.1	2.7	2.9	8.2	4.6	2.4	0.7	10.5	1.1	4.4	0.1	19.0	25.0	6.1	2.2	7.4	4.5	6.0	20.8	4.1	3.5	1.7	1.2	2.0	6.5	8.3	10.4	9.3	2.2	9.4	10.9	12.0	12.8	3.2	13.1	12.8	5.8	12.3	2.2	3.4	7.8	18.0	5.9	6.4	10.7	0.4	6.6	11.1	12.4	3.7	8.7	15.2	11.0	37.4	22.4	6.9	8.5	8.1	6.1	2.5	1.5	5.9	8.5	0.9	6.2	4.5	3.9	5.5	1.5	2.4	4.1	4.4	1.7	4.7	1.0	1.5	3.5	1.0	26.6	23.9	16.4	29.4	30.9	14.4	19.0	16.7	13.2	7.9	3.0	7.2	31.2	18.9	28.6	40.6	3.0	28.1	1.4	7.9	14.0	37.3	59.5	8.3	27.9	4.8	47.9	44.2	23.3	32.7	33.7	26.8	25.1	10.3	18.7	55.3	52.4	29.3	55.9	28.5	4.0	27.9	25.8	25.3	26.2	27.8	45.9	34.1	27.9	34.3	15.9	29.8	12.9	16.4	12.3	22.9	40.1	54.9	96.5	25.1	26.6
ABHD18	"C4orf29, FLJ21106"	ENSG00000164074	"Abhydrolase domain containing 18"	Q0P651	4	127965306-128039927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050168, HPA051676"	Approved		Approved	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"		"HPA050168: AB_2681040, HPA051676: AB_2681571"	"unprognostic (1.91e-1)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.74e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.32e-2)"	"prognostic favorable (9.13e-4)"	7.6	8.2	7.4	13.2	10.5	9.9	8.4	14.1	7.9	7.1	13.6	8.6	8.3	13.7	9.2	9.8	7.2	7.8	9.6	25.1	7.0	7.5	9.1	15.7	9.2	12.0	7.2	5.2	10.8	24.5	8.0	16.3	7.0	8.4	6.8	10.2	7.5	8.9	11.1	18.7	10.6	19.0	9.8	9.7	10.0	8.2	4.0	8.1	18.2	9.2	10.9	10.5	8.4	7.5	10.2	8.8	14.2	7.1	5.2	8.8	3.5	3.5	2.9	3.7	4.5	2.9	4.1	5.5	3.6	2.9	3.2	4.2	6.8	6.3	9.7	5.9	1.4	2.9	3.5	7.7	4.2	3.5	8.0	2.5	7.1	4.7	5.4	4.1	12.0	9.0	3.4	2.9	3.4	2.2	3.8	5.6	7.4	11.7	7.1	2.9	6.4	15.7	5.7	3.8	7.6	2.9	8.8	1.3	6.2	4.7	3.7	8.5	3.1	3.4	6.1	3.7	5.5	5.2	5.0	4.8	2.0	2.7	5.2	3.4	12.7	12.6	11.5	3.5	13.0	3.3	11.1	7.1	9.5	6.3	5.9	4.6	6.8	8.0	7.3	5.7	10.2	8.7	8.8	14.2	5.2	4.2	8.8	8.2	3.5	7.4	10.5	14.1	7.9	7.0	7.5	7.2	5.2	8.4	8.1	6.0	12.5	5.3	8.0	0.0	13.0	0.0	5.1	6.7	10.3	7.0	19.6	4.5	0.0	4.0	2.8	3.0	8.5	0.0	6.4	3.9	2.1	10.7	1.1	20.2	6.7	17.5	5.8	9.2	17.0	0.9	5.8	10.9	0.0	3.6	11.7	6.5	6.5	3.5	5.3	6.2	17.4	12.9	0.0	5.5	3.6	0.0	7.7	5.0	10.1	7.8
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2"	P08910	15	89087459-89202360	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 303.3;Hepatocytes: 272.0;Late spermatids: 360.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 29.0;neutrophil: 22.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.0"	"Cell line enriched"	"Detected in all"	4	"HEL: 85.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	13.2	24.8	14.8	9.5	19.3	15.6	11.7	25.2	23.4	10.7	16.1	12.0	6.5	23.4	18.2	34.7	9.0	12.1	32.2	24.5	12.2	11.3	11.8	76.4	22.2	11.2	11.1	14.8	13.1	28.3	11.2	18.1	5.6	19.8	22.9	9.6	22.6	11.8	10.0	19.3	7.5	18.5	11.4	8.3	14.2	35.8	42.9	7.6	7.7	8.6	8.1	12.1	13.5	10.4	1.1	3.0	29.0	7.0	4.7	3.5	2.5	8.1	15.8	3.9	4.2	7.7	10.4	2.1	5.5	16.5	5.3	5.0	3.9	14.2	2.3	6.4	6.9	14.6	10.9	8.6	6.7	7.5	12.2	3.8	85.1	3.7	3.0	3.9	5.8	20.0	5.3	4.8	18.8	12.1	8.7	6.4	5.3	7.5	7.3	14.5	3.4	3.6	1.4	1.7	19.2	4.7	5.2	8.2	17.7	7.1	12.9	6.7	10.1	10.5	4.9	8.8	3.7	5.5	4.6	9.8	18.6	6.3	6.7	13.8	6.0	11.9	2.8	15.2	5.4	14.4	3.1	5.6	29.0	1.6	4.8	0.9	1.1	1.5	1.5	3.0	1.1	1.4	1.5	22.7	4.7	7.0	2.4	3.5	2.5	14.8	19.3	25.2	23.4	12.2	11.3	11.1	14.8	19.8	7.6	89.3	113.5	3.0	42.1	16.6	23.6	42.1	163.1	95.0	100.1	40.1	17.7	3.6	1.7	43.2	303.3	25.9	52.7	23.3	74.0	6.2	25.7	185.3	57.9	272.0	39.6	19.1	46.9	22.7	53.9	360.0	30.5	37.9	55.6	12.6	45.6	51.3	79.4	31.3	56.3	11.3	14.4	77.6	50.5	77.4	9.8	15.3	2.2	22.5	31.7	70.1
ABHD3	LABH3	ENSG00000158201	"Abhydrolase domain containing 3"	Q8WU67	18	21650897-21704805	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 54.7;RPMI-8226: 60.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010729	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	Vesicles	"HPA010729: AB_1844449"	"unprognostic (1.46e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.58e-2)"	9.2	5.4	12.0	14.2	10.7	8.6	20.7	19.5	11.1	6.4	34.2	4.8	5.1	23.8	6.0	5.4	12.7	7.8	13.5	7.1	8.8	8.5	8.7	21.7	12.8	21.3	11.5	5.0	9.4	8.8	10.7	11.8	10.8	16.6	6.9	37.1	14.7	10.3	4.1	10.1	3.8	45.3	5.5	12.3	17.9	19.0	4.4	10.8	20.9	12.9	6.7	13.7	9.2	25.5	7.1	6.1	33.0	23.3	7.1	17.6	9.1	7.5	5.5	5.4	3.4	3.4	2.3	0.0	5.0	2.0	3.5	4.8	5.7	7.8	21.7	9.1	1.6	16.0	25.1	8.7	4.1	5.0	13.6	6.0	2.3	9.3	9.8	5.2	10.2	7.9	2.0	4.8	5.2	2.4	1.8	2.3	7.5	6.0	12.9	3.1	3.0	9.9	11.4	2.6	24.2	12.9	54.7	4.1	60.9	9.8	7.3	4.5	2.0	11.3	10.1	2.8	6.1	3.1	18.1	1.8	3.5	5.0	6.1	7.6	14.6	9.4	22.3	4.4	13.4	7.9	29.1	10.2	11.4	11.1	17.9	8.5	7.1	10.0	10.6	6.1	5.1	8.2	10.3	33.0	7.1	23.3	4.2	17.6	9.1	12.0	10.7	19.5	11.1	8.8	8.5	11.5	5.0	16.6	10.8	8.9	9.4	22.4	33.1	29.8	13.4	3.6	45.9	16.0	7.9	3.5	45.2	23.7	1.7	47.1	3.1	9.6	90.1	0.0	24.3	19.9	15.1	42.5	11.5	26.1	56.1	0.0	34.9	12.3	24.7	1.1	6.9	28.6	30.4	17.2	46.9	9.4	35.8	46.5	6.0	7.7	13.6	12.9	15.9	3.5	8.5	13.2	78.8	38.3	23.5	28.7
ABHD4	FLJ12816	ENSG00000100439	"Abhydrolase domain containing 4"	Q8TB40	14	22598237-22613215	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000600	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000600: AB_1078081"	"unprognostic (5.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.03e-2)"	17.2	24.9	12.8	6.4	14.5	10.0	20.5	12.3	13.9	19.4	14.7	21.4	37.5	13.4	26.0	26.2	28.6	14.4	22.4	16.4	14.1	10.4	23.9	17.0	13.6	8.7	18.9	12.9	15.4	11.4	14.8	12.2	15.9	15.5	19.3	12.8	22.2	13.9	35.5	17.9	14.2	26.3	22.8	18.5	11.9	18.5	45.0	16.4	5.1	25.1	11.1	14.7	23.2	20.7	3.8	2.8	18.6	4.2	4.4	6.0	3.4	7.8	13.2	5.4	4.9	44.0	16.0	5.2	3.5	18.2	8.9	16.7	8.0	12.6	0.7	9.4	15.5	9.6	15.4	3.4	9.2	7.3	5.8	1.2	2.9	9.2	26.3	20.1	0.4	10.7	20.3	7.2	11.7	10.0	18.7	9.2	5.5	2.1	14.4	8.2	4.3	0.2	0.4	6.6	32.1	9.7	2.1	4.8	3.2	10.4	8.4	0.3	1.1	23.9	8.5	9.1	11.3	3.3	0.8	6.5	3.9	5.4	6.3	1.4	15.6	8.1	0.2	2.9	0.6	3.1	18.6	4.2	6.6	6.0	3.2	5.0	3.8	3.9	3.9	2.8	2.4	1.3	2.6	17.4	4.4	2.9	0.4	2.3	3.4	12.8	14.5	12.3	13.0	14.1	10.4	18.9	12.9	15.5	16.4	11.9	3.5	3.2	5.8	2.9	3.0	5.2	15.3	0.0	2.3	3.5	3.9	5.0	8.3	10.7	3.2	5.9	9.8	0.0	10.3	1.5	5.0	6.9	4.7	7.3	6.4	7.9	5.8	8.6	4.7	3.2	5.2	3.8	1.7	13.6	6.1	7.5	8.8	10.5	7.8	4.2	3.1	6.5	6.2	0.7	0.5	2.4	22.4	5.3	2.8	9.3
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 70.3"	"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 171.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 26.1;monocytes: 7.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	26.5	10.5	5.2	7.4	12.2	32.2	70.3	8.5	10.3	7.6	10.2	10.5	5.9	7.4	4.6	4.0	22.7	3.7	10.4	9.8	7.4	4.5	10.1	18.4	14.1	8.7	18.5	4.6	4.2	12.8	9.1	8.6	20.2	14.9	5.8	6.7	4.4	21.1	7.4	10.4	24.8	15.1	8.1	19.0	7.0	8.9	8.1	12.5	3.3	13.2	9.9	6.7	11.2	16.0	1.7	3.6	26.1	7.6	0.9	2.4	2.5	8.5	3.0	3.6	3.8	15.2	5.8	7.5	34.9	13.9	9.6	7.2	4.7	3.0	7.1	4.8	10.9	8.5	2.8	5.7	8.5	9.8	25.8	5.5	18.2	11.6	3.2	7.6	4.1	5.9	6.4	29.5	16.1	13.8	8.4	16.0	4.8	10.8	5.4	21.3	4.6	2.9	2.9	9.7	6.8	9.8	1.3	10.4	4.1	12.4	17.0	4.4	6.0	15.3	8.3	3.6	4.0	8.9	3.5	8.8	8.5	6.7	15.7	15.1	4.9	13.6	3.4	9.0	7.5	6.6	26.1	7.6	4.4	1.2	3.7	1.0	1.7	0.9	1.4	3.6	1.2	0.8	1.3	21.0	0.9	2.7	0.9	2.4	2.5	5.2	12.2	8.5	10.3	7.4	4.5	18.5	4.6	14.9	12.5	23.8	43.8	8.5	23.5	35.4	11.3	9.7	15.3	17.4	25.0	26.2	25.5	13.3	28.2	49.4	13.5	16.9	64.4	23.3	53.5	21.2	16.2	21.6	16.1	11.3	16.6	3.2	34.9	14.7	26.6	12.9	4.9	30.4	6.8	16.2	17.1	12.4	61.4	24.6	5.3	31.4	14.7	0.0	26.8	35.6	43.9	35.8	171.7	15.8	18.2	41.1
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6"	Q9BV23	3	58237506-58295693	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	8.3	10.0	11.6	4.6	14.0	1.0	5.8	17.7	22.5	3.7	8.1	30.0	10.3	26.3	4.7	10.8	4.8	6.9	4.4	4.1	19.0	9.2	24.3	43.4	6.3	5.2	18.6	12.2	4.1	2.4	4.8	15.2	4.8	19.0	4.4	8.1	10.5	3.0	12.9	3.1	17.2	33.5	6.8	24.0	22.8	9.0	3.1	14.3	2.0	6.6	2.1	5.4	4.6	4.1	3.9	7.0	2.1	9.3	0.7	2.6	1.1	2.0	7.7	1.1	5.0	14.5	2.6	13.4	5.4	4.8	5.7	7.7	4.0	2.8	3.9	0.5	2.9	17.6	6.0	5.2	2.4	5.1	6.6	2.6	3.3	5.2	5.5	4.9	1.0	17.6	2.5	11.1	5.2	2.5	6.7	3.2	6.5	3.9	9.0	4.6	1.5	6.7	0.4	3.7	16.7	17.0	2.5	2.3	8.7	8.7	2.8	6.7	2.7	5.9	3.3	11.1	2.3	2.2	2.7	3.4	4.1	4.5	10.1	6.4	2.6	7.6	0.1	10.5	9.9	5.6	0.0	2.8	2.1	2.1	9.3	2.0	3.9	1.2	2.6	4.6	3.0	1.2	1.5	0.0	0.7	6.2	7.0	1.4	1.1	11.6	14.0	17.7	22.5	19.0	9.2	18.6	12.2	19.0	14.3	0.0	2.6	8.8	2.6	7.7	13.8	4.8	0.0	17.4	5.7	3.5	3.9	2.2	1.7	2.9	0.8	7.8	13.6	0.0	1.6	0.4	2.1	1.3	10.5	53.3	8.1	14.3	0.0	26.4	14.6	0.4	6.4	9.6	3.3	14.4	2.2	10.8	1.6	0.0	7.8	15.4	3.0	0.0	3.5	0.5	2.3	21.5	0.5	3.2	4.5	2.0
ABHD8	"FLJ11743, MGC14280, MGC2512"	ENSG00000127220	"Abhydrolase domain containing 8"	Q96I13	19	17292131-17310236	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 114.8;Horizontal cells: 68.3;Late spermatids: 221.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 28.4;U-266/70: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037658, HPA058209"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA037658: AB_10672602, HPA058209: AB_2683638"	"unprognostic (4.71e-3)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (7.45e-3)"	"unprognostic (7.09e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.77e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.24e-2)"	5.4	14.7	24.7	6.0	23.6	6.4	3.7	20.3	34.0	4.6	5.4	4.1	6.1	4.6	5.9	3.7	3.9	6.2	5.4	6.8	22.0	17.5	6.1	12.4	7.3	6.5	12.3	17.1	9.3	11.0	11.4	9.1	8.9	9.0	7.9	1.6	8.5	12.6	11.6	11.4	6.8	3.6	4.6	4.6	7.7	6.5	19.6	6.9	4.8	6.6	3.2	3.8	4.8	4.6	1.3	6.0	5.6	4.8	3.2	3.6	1.7	11.4	3.3	1.7	6.7	2.2	0.7	18.1	2.3	3.2	2.5	3.3	2.9	7.9	0.8	3.2	1.8	4.0	1.6	1.6	4.0	0.5	13.5	11.1	3.7	5.0	4.9	7.3	0.2	5.3	2.1	2.5	4.3	0.5	4.0	1.9	6.6	3.3	6.6	1.0	0.6	4.5	0.6	3.2	1.9	28.4	6.8	5.3	3.3	2.2	1.1	2.1	11.3	5.2	1.7	7.2	1.5	7.2	6.6	1.1	2.4	5.2	12.0	4.1	21.7	16.3	4.1	8.0	4.5	2.1	0.1	4.8	5.6	2.5	3.7	1.7	0.7	3.6	2.1	6.0	1.3	2.9	2.6	3.0	3.2	4.0	2.9	2.5	1.7	24.7	23.6	20.3	34.0	22.0	17.5	12.3	17.1	9.0	6.9	0.0	2.2	3.0	4.6	3.4	51.4	1.8	7.6	0.0	3.4	7.0	17.7	15.8	6.6	12.4	114.8	3.6	0.5	0.0	7.5	7.4	7.3	5.2	4.6	12.5	19.9	68.3	6.9	1.8	7.6	221.4	11.5	6.0	1.7	26.2	3.1	27.9	7.4	2.9	24.1	7.8	30.3	6.5	3.5	18.4	1.4	3.6	20.7	3.8	1.4	2.8
ABI1	"ABI-1, E3B1, SSH3BP1"	ENSG00000136754	"Abl interactor 1"	Q8IZP0	10	26746593-26861087	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 218.7;Suprabasal keratinocytes: 236.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008375, HPA068407"	Approved		Approved	"Plasma membrane"		NA	NA		400000	"Plasma membrane"		"CAB008375: AB_592744, HPA068407: AB_2685983"	"unprognostic (2.83e-3)"	"unprognostic (8.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	24.0	14.0	32.0	28.1	32.6	54.1	21.4	28.2	35.5	22.5	22.7	19.8	14.8	24.8	23.9	15.4	45.1	20.3	21.6	14.1	47.3	23.1	21.9	17.8	22.5	32.1	25.0	26.4	25.3	17.0	19.1	14.4	22.7	20.9	19.1	24.8	26.7	30.9	17.0	16.6	33.0	26.0	21.6	27.5	25.5	23.9	12.4	20.5	43.5	18.8	27.3	40.9	25.2	30.3	36.1	26.8	51.5	28.0	20.5	44.5	31.5	23.7	13.3	10.9	10.7	16.6	20.4	16.4	24.1	16.4	17.8	20.8	15.6	28.1	43.6	12.4	25.5	11.4	26.7	13.1	15.6	19.9	29.1	11.7	19.1	9.1	11.0	11.3	9.2	19.4	13.9	19.9	17.4	10.4	20.8	21.5	14.6	14.1	27.9	18.2	10.2	21.7	8.8	9.0	14.8	6.4	23.6	20.3	28.1	18.9	11.0	9.1	9.7	20.0	19.6	20.1	14.6	12.6	14.8	26.7	13.7	16.8	17.3	12.3	6.3	10.0	51.9	19.7	23.8	9.8	35.5	23.8	51.5	27.0	28.0	25.8	36.1	25.9	30.0	26.8	28.6	24.4	26.5	37.9	20.5	26.7	22.3	44.5	31.5	32.0	32.6	28.2	31.9	47.3	23.1	25.0	26.4	20.9	20.5	38.7	33.6	47.0	115.9	218.7	9.0	20.7	33.1	77.6	58.0	24.4	2.0	30.2	11.6	46.6	9.9	39.4	52.3	0.0	46.0	39.6	47.2	106.9	56.6	23.6	68.6	15.9	43.1	35.0	76.6	4.2	20.4	67.7	87.7	83.8	48.7	42.6	61.4	46.3	20.8	31.5	9.7	32.3	49.1	12.1	8.5	236.6	64.5	62.5	39.1	163.3
ABI2	"ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2"	ENSG00000138443	"Abl interactor 2"	Q9NYB9	2	203328219-203447723	"Predicted intracellular proteins"	"Host-virus interaction, Neurogenesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070567	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA070567: AB_2686281"	"unprognostic (5.26e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-3)"	"unprognostic (7.05e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	8.6	11.6	28.8	7.7	41.8	2.8	12.8	24.4	50.7	17.2	11.5	18.7	8.4	5.1	23.3	16.1	10.5	19.4	11.4	25.1	26.0	24.0	17.8	6.3	13.4	6.4	19.1	30.2	24.3	6.5	18.6	21.5	15.9	17.6	16.4	9.5	11.7	7.1	20.3	5.9	6.4	6.9	21.2	18.8	10.2	6.9	22.2	16.8	11.6	22.2	3.2	7.3	10.2	8.4	1.7	13.8	0.4	3.7	3.9	5.3	3.4	7.2	11.2	40.2	25.3	9.5	16.4	8.8	12.6	11.2	11.0	12.7	10.3	13.7	0.0	8.7	14.8	15.3	8.0	18.2	13.3	21.9	3.6	10.4	18.2	12.0	8.0	14.6	7.8	8.3	11.6	6.4	20.0	15.6	31.8	20.3	20.9	12.8	16.3	19.3	13.1	19.5	7.4	20.8	6.8	25.0	12.9	20.3	1.3	11.3	7.5	16.1	21.2	2.4	7.4	14.0	31.7	9.7	9.1	15.1	20.2	17.1	10.8	13.7	11.5	10.5	10.0	21.8	3.2	12.8	0.2	1.5	0.0	3.8	1.7	4.1	1.7	4.3	4.4	4.3	1.7	5.3	4.5	0.4	3.9	3.7	13.8	4.6	3.4	28.8	41.8	24.4	45.2	26.0	24.0	19.1	30.2	17.6	16.8	50.6	24.5	13.0	49.7	26.8	105.5	50.4	25.5	83.0	35.2	50.6	153.2	18.7	28.2	19.2	102.1	33.4	9.5	0.0	11.6	14.1	50.4	34.8	15.1	9.8	14.0	96.9	47.3	57.7	11.1	62.2	43.1	22.6	47.2	22.6	8.6	78.1	13.9	17.5	59.4	28.0	93.6	25.8	56.7	71.0	49.9	22.8	16.5	17.5	18.0	32.3
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099327-179229684	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 32.3;TIME: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212"	"unprognostic (3.05e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (8.40e-4)"	14.3	5.2	8.6	7.4	13.7	3.7	8.3	14.9	10.6	9.2	6.6	5.8	4.5	4.0	5.4	4.7	3.9	4.3	18.8	6.8	9.7	3.9	4.9	4.3	11.5	3.7	6.5	6.1	5.6	8.4	9.2	8.4	6.1	8.1	5.1	5.2	5.8	4.5	4.4	5.2	6.6	3.7	6.9	6.2	3.9	4.7	9.2	8.6	3.6	5.8	3.1	3.6	6.7	11.2	2.8	2.0	3.8	1.2	1.8	2.2	0.6	10.1	5.6	3.7	2.5	3.2	7.4	2.3	11.3	9.3	13.9	10.1	4.1	3.1	5.9	8.4	8.0	9.6	5.1	5.4	3.8	19.8	3.7	4.9	2.8	5.1	2.0	5.9	3.1	0.9	6.8	5.0	19.8	32.3	6.0	15.4	3.0	6.7	1.7	18.1	2.7	2.5	1.7	3.6	2.0	1.8	3.7	6.3	2.9	4.7	1.6	2.3	5.2	9.4	3.0	23.2	5.9	2.7	2.6	30.1	14.5	10.8	6.9	18.1	3.1	3.9	6.1	6.8	1.8	13.9	3.8	1.2	0.4	2.2	0.4	1.0	1.8	1.4	1.4	0.9	2.8	1.9	2.0	2.6	1.8	0.5	2.0	0.8	0.6	8.6	13.7	14.9	10.6	9.7	3.9	6.5	6.1	8.1	8.6	20.8	26.6	12.4	33.8	41.7	36.0	7.0	17.8	6.7	10.3	10.4	157.1	7.7	10.0	12.7	14.0	46.7	9.7	0.0	11.9	6.7	36.0	32.7	16.2	14.5	21.0	23.8	25.9	33.7	32.7	21.4	14.1	36.5	65.8	12.6	9.6	9.8	30.1	14.4	12.7	8.4	34.1	6.5	29.3	18.2	26.3	33.5	8.7	10.1	13.9	20.7
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 58.4"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 57.0;Hepatocytes: 97.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 25.1;HHSteC: 25.7;HSkMC: 29.6;hTERT-HME1: 29.6;hTERT-RPE1: 24.8;TIME: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	45.9	6.0	7.9	3.5	9.8	1.2	35.0	29.7	12.5	9.1	4.7	11.6	7.0	2.9	4.9	8.9	15.6	5.8	6.1	58.4	8.5	10.2	17.0	48.1	9.1	4.8	9.9	5.9	2.6	2.4	39.3	3.1	26.1	14.3	6.5	4.7	7.7	3.0	9.9	24.3	3.5	3.7	8.7	14.0	5.0	2.7	2.3	3.3	0.1	4.2	8.9	4.5	8.8	14.6	0.0	0.6	2.2	0.3	0.0	0.0	6.8	7.2	1.5	0.0	0.0	13.1	25.1	0.0	5.1	14.3	2.9	5.1	0.0	5.1	0.0	0.8	6.4	15.6	0.1	0.0	5.9	5.8	0.0	0.0	0.0	0.3	0.1	25.7	0.0	0.0	29.6	1.6	10.5	29.6	24.8	13.1	0.0	0.0	2.3	17.0	2.8	0.0	0.0	0.0	0.4	20.1	0.0	0.0	0.0	16.4	5.0	2.0	0.0	1.0	0.3	2.7	0.4	0.4	0.0	32.8	6.2	1.4	6.4	8.6	0.0	0.0	0.0	10.8	0.0	17.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	6.8	7.9	9.8	29.7	12.5	8.5	10.2	9.9	5.9	14.3	3.3	0.0	3.0	4.7	1.0	1.3	1.1	57.0	28.1	4.0	1.2	0.0	0.0	0.1	5.0	6.8	1.8	20.2	0.0	0.0	3.0	0.6	2.1	2.2	1.1	97.0	9.3	27.0	0.0	20.3	11.9	0.0	0.3	0.8	5.0	0.0	0.0	19.7	14.9	0.0	0.7	18.3	21.8	0.0	2.3	1.7	2.3	1.4	0.3	0.0	0.0	4.9
ABR	MDB	ENSG00000159842	"Active BCR-related"	Q12979	17	1003518-1229021	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.6"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"basophil: 8.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.8;hTERT-RPE1: 20.2;LHCN-M2: 12.6;RPMI-8226: 10.8;TIME: 20.9;U-251 MG: 21.0;U-698: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053618, HPA054824"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA053618: AB_2682208, HPA054824: AB_2682616"	"unprognostic (1.69e-1)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.20e-3)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.74e-2)"	12.9	5.8	31.8	18.0	28.7	6.0	5.8	7.0	43.6	6.6	19.9	12.0	2.3	9.4	7.9	4.0	11.0	6.1	6.7	26.6	24.0	16.9	6.8	4.0	9.3	6.9	14.1	27.0	3.9	5.0	8.3	6.0	7.2	11.3	4.6	21.6	19.4	23.7	3.4	2.9	5.9	11.9	25.1	8.1	8.1	13.6	3.8	11.3	2.9	7.0	2.3	18.0	7.2	7.4	0.3	0.7	8.9	0.8	0.0	0.8	0.0	0.5	0.6	0.2	0.0	0.9	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.0	18.8	0.3	0.1	0.8	0.0	2.0	0.0	0.4	5.8	10.2	0.0	0.2	0.0	0.4	2.3	6.7	0.2	0.0	0.1	6.7	20.2	0.0	0.0	0.0	0.0	12.6	0.7	0.0	2.5	0.1	0.4	0.1	0.1	0.0	10.8	0.1	0.2	0.2	0.3	0.0	0.0	1.0	0.0	5.9	2.9	20.9	0.1	0.2	2.1	21.0	0.0	0.2	15.4	1.0	4.1	0.4	8.9	0.3	1.0	0.2	0.8	0.4	0.1	0.3	0.0	0.7	0.3	0.0	0.3	0.9	0.0	0.4	0.0	0.8	0.0	31.8	28.7	7.0	43.6	24.0	16.9	14.1	27.0	11.3	11.3	29.8	21.1	7.8	15.2	15.1	60.3	21.8	25.5	10.7	17.0	1.8	2.0	1.9	0.0	15.6	33.8	21.5	39.3	0.0	5.5	2.5	13.4	17.6	18.5	0.8	27.7	11.1	14.5	18.4	24.0	112.5	12.7	28.3	18.6	18.0	35.9	29.4	29.8	25.9	8.9	5.8	18.0	38.8	21.7	1.9	7.5	14.8	1.8	13.8	49.9	22.6
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028682-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.9"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 308.6;Proximal tubular cells: 337.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 77.9;U-937: 75.7"	"Low region specificity"	"Detected in all"							HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		7400000	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	12.2	4.2	12.0	25.5	10.1	23.1	22.1	1.8	19.0	6.5	28.4	2.4	10.6	22.6	10.3	43.8	23.5	6.0	10.9	7.9	15.1	7.1	29.0	26.8	14.0	39.0	5.5	10.3	5.1	9.5	10.3	9.3	12.9	4.8	8.2	26.9	4.3	19.9	9.7	2.3	12.8	35.5	7.1	5.1	45.6	13.7	20.1	5.0	60.2	13.2	19.2	26.0	23.0	9.0	17.1	37.2	30.5	82.9	24.6	48.8	51.8	11.2	6.0	15.5	14.4	6.2	9.7	17.0	9.0	6.4	6.8	14.0	13.4	13.2	0.0	16.4	8.8	29.4	17.1	13.6	19.4	7.9	29.9	25.1	43.9	3.4	4.6	9.0	73.2	20.2	8.7	16.4	9.1	7.5	12.3	35.5	31.0	5.5	15.4	19.4	23.6	45.6	77.9	18.5	17.6	11.8	29.5	9.5	3.5	18.2	33.4	34.7	3.8	6.1	17.2	28.0	22.9	6.8	55.0	26.4	4.3	3.7	9.0	15.9	8.4	23.8	3.0	5.5	75.7	12.8	30.5	31.7	18.9	29.8	55.8	46.1	15.3	48.8	38.1	33.8	17.1	47.7	44.3	8.6	24.6	82.9	37.2	43.5	51.8	12.0	10.1	1.8	19.0	15.1	7.1	5.5	10.3	4.8	5.0	17.9	26.9	128.7	58.7	124.0	0.2	2.8	30.6	20.1	22.7	41.8	0.0	69.4	51.4	124.4	2.6	35.9	215.0	0.0	127.3	176.9	29.2	47.3	79.5	178.9	308.6	0.0	41.3	49.1	193.8	9.4	4.4	118.3	82.7	71.3	101.8	34.9	147.3	167.5	12.0	337.1	1.3	32.3	17.4	1.4	2.1	78.7	40.6	137.1	116.5	103.7
ABT1	Esf2	ENSG00000146109	"Activator of basal transcription 1"	Q9ULW3	6	26596952-26600744	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077039			Approved	Vesicles		NA	NA			Vesicles		"HPA077039: AB_2732328"	"unprognostic (1.32e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (3.80e-4)"	13.1	11.0	11.2	14.6	10.7	28.9	13.0	15.8	14.1	13.3	12.1	9.8	13.5	14.5	16.2	14.3	19.4	13.9	9.0	10.8	9.6	7.6	10.1	19.1	11.4	20.4	9.5	9.3	14.2	18.2	8.4	10.9	19.6	8.3	13.5	10.1	9.3	13.4	12.0	16.1	18.2	15.6	9.2	6.3	23.2	13.5	17.9	9.4	23.9	13.1	17.4	22.4	12.9	13.2	32.0	18.5	29.1	20.1	24.9	34.7	37.0	12.6	6.6	9.3	16.0	5.2	5.5	13.6	7.5	7.7	11.4	11.2	11.9	5.6	18.5	17.2	6.1	9.1	8.1	10.7	10.9	6.7	10.2	21.8	12.2	6.0	22.1	8.4	16.6	12.4	7.2	10.2	9.1	5.4	5.3	9.9	14.7	21.1	12.5	6.3	12.8	19.1	21.2	9.5	8.1	8.9	11.6	7.5	19.5	7.1	10.3	12.2	9.8	4.6	12.2	17.8	5.1	11.7	13.5	8.4	8.8	6.4	6.9	15.0	14.7	21.6	16.8	4.1	20.6	13.3	29.1	20.1	24.0	32.8	18.1	31.4	31.2	32.3	32.7	18.5	32.0	34.7	31.2	17.4	24.9	18.0	17.1	34.1	37.0	11.2	10.7	15.8	14.1	9.6	7.6	9.5	9.3	8.3	9.4	14.9	13.3	52.3	27.6	53.1	16.8	5.6	20.4	18.7	15.9	10.4	2.0	79.8	34.9	29.8	33.9	35.1	16.3	0.0	34.0	80.3	20.7	16.1	27.8	21.2	36.8	14.3	32.6	17.8	15.4	58.5	25.6	22.9	15.1	25.2	23.4	20.9	28.3	21.0	22.3	19.1	15.4	19.4	23.2	22.3	36.4	52.2	91.5	58.6	30.2	27.0
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150988-34358008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 31.6"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 16.2;Syncytiotrophoblasts: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"eosinophil: 8.1;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA020065: AB_1844459, HPA030699: AB_2673576"	"unprognostic (3.00e-1)"	"prognostic unfavorable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	3.1	13.7	4.8	2.7	6.7	3.2	2.2	5.0	5.8	8.0	8.5	10.6	18.2	11.7	7.4	6.3	4.4	4.1	3.2	13.0	4.7	3.9	8.4	8.0	2.9	2.7	9.0	1.5	2.8	2.2	0.3	2.8	8.1	15.8	4.5	3.6	7.5	8.7	31.6	19.4	5.6	20.2	3.6	20.2	1.2	3.0	3.1	7.7	6.4	2.1	3.5	2.8	3.4	5.0	0.0	2.8	8.1	0.4	0.0	0.1	0.1	4.0	12.0	4.9	1.3	1.3	0.1	4.9	2.4	1.9	2.1	4.1	2.9	3.0	0.1	4.1	3.0	12.7	7.8	2.7	2.7	1.7	0.1	6.6	0.0	7.1	12.7	0.7	6.4	0.9	0.7	1.5	4.2	1.8	7.8	0.0	0.5	1.3	0.3	1.3	10.1	0.2	7.8	6.1	6.0	6.6	1.2	2.9	4.5	7.6	9.7	6.2	5.1	6.0	18.7	4.7	3.4	4.0	2.8	0.6	2.4	0.4	7.4	4.3	0.7	0.3	0.1	5.5	1.8	7.3	0.0	0.1	8.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.1	0.1	4.8	6.7	5.0	5.6	4.7	3.9	9.0	1.5	15.8	7.7	0.0	2.9	0.8	2.3	4.1	2.8	7.4	5.1	0.0	0.0	12.2	0.0	1.9	5.0	4.5	0.8	0.6	10.3	0.0	3.9	0.9	5.5	5.8	1.1	5.7	0.7	0.0	6.9	0.0	1.0	0.0	1.1	0.8	1.7	16.2	1.6	6.2	7.3	0.8	5.6	1.1	0.3	0.0	3.3	0.5	0.6	4.3	23.7	0.0	1.3	6.0
AC003006.1		ENSG00000269026			19	57682045-57753575	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ: 2.1;HEK 293: 2.8;HL-60: 3.5;RT4: 2.8;U-266/84: 5.4;U-698: 2.0"									HPA068553			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068553: AB_2686002"	"unprognostic (2.74e-1)"				"unprognostic (1.47e-1)"					"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.61e-1)"		"unprognostic (4.82e-2)"	"unprognostic (1.46e-1)"	2.4	1.3	1.3	3.2	1.9	1.7	2.3	7.7	1.6	1.8	2.0	2.4	3.4	3.0	3.0	2.0	1.4	2.3	2.1	2.0	1.5	1.2	1.3	1.9	1.5	4.4	1.3	0.7	5.2	4.4	1.2	2.3	1.7	1.5	1.6	1.2	2.2	4.5	3.5	3.4	2.0	1.4	2.5	1.9	2.8	3.4	8.1	1.9	5.6	2.5	1.6	4.2	2.8	2.0	1.6	1.1	1.7	1.3	4.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.1	0.0	0.7	0.0	1.6	0.0	0.4	0.6	0.0	0.0	0.0	0.7	0.7	0.0	0.8	2.8	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.8	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.3	0.0	5.4	2.0	0.0	0.0	0.0	0.3	1.3	0.6	0.4	0.0	1.3	1.6	0.7	1.5	0.5	1.0	1.1	0.5	1.7	4.0	0.2	1.1	0.6	0.2	1.3	1.9	7.7	1.6	1.5	1.2	1.3	0.7	1.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC004556.1		ENSG00000276345			Unmapped	2585-11802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 13.0"	"Cell type enhanced"	"Detected in many"	17	"Distal tubular cells: 26.6;Hofbauer cells: 22.3;Kupffer cells: 73.1"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 25.6;K-562: 21.5;MOLT-4: 24.1;NB-4: 46.5;PC-3: 43.4;WM-115: 31.2"									HPA050406	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"																		0.9	0.0		0.9		0.0	8.3		3.7	0.0	3.8			0.0	1.3	5.9	0.0	1.5	1.7	9.3			1.6	3.0	0.0	0.0			2.4	2.0	0.0		0.0		1.5	0.0		2.2	0.0	6.1	1.4	3.6	0.0		0.9	1.2	0.0			0.3		0.0	1.4		2.8	4.7	13.0	9.6	3.2	6.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	8.4	12.0	13.0	9.4	25.6	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	14.4	0.0	8.7	13.4	21.5	11.8	0.1	0.1	24.1	46.5	0.0	0.0	43.4	0.1	7.6	0.0	12.1	7.3	0.0	0.1	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	31.2	13.0	5.6	3.1	2.8	9.6	2.4	2.5	4.5	6.0	4.1	2.8	4.5	5.2	1.0	3.2	4.0	4.7	5.9	4.0											0.0	0.0	8.7	0.1	0.0	0.0	0.0	2.5	4.0	2.3	17.4	0.0	2.8	26.6	0.0	0.9	0.0	0.0	0.0	0.3	10.9	0.0	0.0	0.0	1.1	22.3	0.0	0.0	17.2	73.1	2.8	3.7	0.2	0.0	0.0	1.1	0.0	0.1	0.2	0.4	6.9	0.0	0.0	0.0	3.5	5.9	0.0	3.3	3.8	0.4	0.1
AC004691.2		ENSG00000250424			7	30852273-30923812	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.3;ASC diff: 1.1;SH-SY5Y: 1.9;SK-BR-3: 1.3"									"HPA019206, HPA030130"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA019206: AB_1844965, HPA030130: AB_10601565"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"			"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.72e-4)"		"unprognostic (5.13e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.76e-1)"		"unprognostic (2.49e-1)"	"unprognostic (3.71e-2)"	0.8	0.2	0.0	0.0	0.4	0.2	0.6	0.0	0.3	1.1	1.3			1.4	1.4	1.5	0.7	2.4	3.1	0.8	0.0	0.1	0.5	0.0	1.1	0.0	0.0		0.6	2.2	0.0	0.3	0.0		0.7	0.2		0.7	1.2	0.4	0.3	0.4	2.3	0.0	0.0	0.9	0.1			0.7		0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.3	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.6	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC004922.1		ENSG00000284292			7	99325879-99394653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	25	"Club cells: 4.5;Exocrine glandular cells: 1.3;granulocytes: 1.1"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004334	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"																		6.0	5.2	4.2	9.4	6.2	6.9	7.8	3.2	9.1	5.3	6.6	4.6	5.6	13.8	5.8	3.8	5.3	5.0	4.5	4.9	7.1		4.1	6.3	4.6	8.1	3.2	6.0	3.9	6.4	3.0	4.1	5.2	6.2	5.0	3.1	4.9	3.3	5.4	4.6	2.4	9.6	4.2	3.0	6.5	7.0	3.9	3.2	2.9	6.0	6.4	4.4	4.6	4.1	7.9	13.0	18.1	16.3	5.1	11.9	18.0	4.2	4.0	0.4	1.0	0.6	2.8	5.1	3.3	1.8	3.0	3.2	7.2	5.9	4.4	10.9	3.5	3.8	2.8	1.2	3.8	0.6	2.2	7.5	2.5	2.9	1.9	0.9	2.7	3.1	2.7	1.1	3.1	1.2	0.7	4.4	2.3	3.9	4.0	2.1	7.9	4.9	1.2	2.6	1.7	11.9	2.1	1.1	1.5	0.6	2.0	1.1	1.0	2.8	4.6	8.4	0.7	2.2	1.7	2.9	4.9	2.6	7.2	4.3	0.0	2.3	4.7	3.0	4.2	5.7	9.2	15.5	18.1	7.1	16.3	5.1	7.3	7.0	6.9	13.0	7.9	6.1	6.1	13.9	5.1	15.0	8.9	11.9	18.0											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC005324.3		ENSG00000251537			17	15571491-15651653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"esophagus: 23.3;tongue: 21.1;vagina: 17.9"	"Group enriched"	"Detected in some"	11	"Club cells: 1.2;Pancreatic endocrine cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.6;HeLa: 3.1;OE19: 2.2"									"HPA023623, HPA066431"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (3.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.80e-11)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.09e-1)"	7.5	2.8	0.9	1.5	1.0	1.0	7.7	0.9	1.0	5.3	2.2	1.3	0.0	2.1	0.7	1.5	23.3	0.8	4.0	2.6	0.8	0.9	0.9	1.0	2.1	1.6	3.7	0.0	0.7	1.0	0.8	0.7	12.4	2.7	1.4	0.9	0.2	2.4	1.1	2.9	4.4	1.6	2.1	1.5	1.0	2.8	1.8	1.0	1.6	1.8	21.1	17.5	3.2	17.9	0.6	0.6	0.0	0.1	0.0	0.5	0.0	0.6	3.5	0.1	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	3.1	0.1	0.1	1.0	0.0	6.6	0.0	0.0	0.1	1.0	0.2	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.4	1.0	0.0	0.0	0.6	0.4	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.9	1.0	0.8	0.9	3.7	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC005726.1		ENSG00000258472			17	28455752-28614197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	5	"brain: 16.8"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.4;Ciliated cells: 10.7;Club cells: 10.3;Collecting duct cells: 3.5;granulocytes: 5.8;Proximal tubular cells: 9.0;Syncytiotrophoblasts: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.5;CACO-2: 2.1;Karpas-707: 3.5;PC-3: 3.2;THP-1: 3.5"									HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: AB_2679710"	"unprognostic (1.26e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (7.25e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.58e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.49e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-4)"	0.5	0.6	6.3	0.4	16.4	1.6	0.5	3.5	16.8	2.8	0.9	0.0	0.0	1.6	1.3	0.6	1.4	2.3	2.4	1.0	5.1	3.6	0.9	1.5	3.6	0.5	1.6	6.6	0.8	3.6	0.2	3.1	0.4	6.9	1.0	0.2	3.6	0.5	0.2	0.6	0.5	0.5	0.8	1.1	0.5	1.0	0.6	2.1	0.0	2.6	0.0	1.3	3.5	0.5	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.5	0.2	0.8	0.0	0.0	0.2	0.3	0.0	0.2	0.0	2.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.5	3.5	0.0	0.5	0.0	1.0	0.0	0.0	3.2	0.3	0.0	0.0	0.2	1.3	0.0	0.4	0.3	0.9	0.0	0.0	0.6	3.5	0.0	0.8	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.3	16.4	3.5	16.8	5.1	3.6	1.6	6.6	6.9	2.1	8.9	10.4	0.0	0.0	0.0	0.0	0.0	0.0	10.7	10.3	3.5	0.0	1.3	1.7	1.1	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	5.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.0	0.8	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0
AC007325.2		ENSG00000277196			Unmapped	138082-161852	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 12.8;skin 1: 12.6"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 5.1;Distal tubular cells: 6.6"									"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"	"Group enriched"	"Detected in some"	13	"OE19: 84.6;RPTEC TERT1: 44.7"									HPA020361	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"																		0.0	0.0		0.0		0.0	0.6		6.4	0.0	0.0			11.1	0.0	0.0	2.1	0.0	0.0	2.8			4.5	1.6	7.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.3	3.0	12.6	12.8	0.0		0.0	0.0	0.0			1.1		1.8	0.5		0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.6	1.2	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.1	0.0	0.0	2.4	4.5	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.1	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	84.6	0.0	0.0	0.0	0.0	44.7	0.1	0.1	0.1	0.0	1.7	0.3	4.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
AC008397.2		ENSG00000285188	"CAMP-specific 3',5'-cyclic phosphodiesterase 4C "	Q08493	19	18207961-18255419	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 22.4;intestine: 15.6;pancreas: 14.2"	"Group enriched"	"Detected in some"	8	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 8.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;U-2197: 1.6;U-87 MG: 4.8"									"HPA048975, HPA054218"	Uncertain		Approved	"Midbody ring,Centrosome,Cytosol"		NA	NA			"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "																		0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.2	1.9	15.6	0.0	0.0	1.3	1.1	3.6	4.0	1.0	22.4	0.6	0.0		0.6	0.0	2.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.8	0.0	0.0	1.7	0.0	2.1	1.1	3.7	0.0	8.0	0.6	0.0	0.4	7.1	0.2	0.0	0.0	0.4	0.8	4.1	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	3.7	0.1	0.0	0.0	0.2	0.0	0.3	0.3	0.4	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.9	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.7	0.1	0.2	0.0	0.0	0.2	1.6	0.0	0.3	0.2	0.1	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											8.9	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC008687.1		ENSG00000267335			19	49022953-49036895	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"pancreas: 8.2;pituitary gland: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 7.4;U-251 MG: 10.6"									HPA038925	Uncertain		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA038925: AB_2676272"																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	8.2	0.0	19.9	0.5		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.9	0.2	0.1	0.2	0.0	1.9	0.0	0.0	0.1	0.3	0.1	1.2	0.0	0.3	0.0	0.3	1.1	0.0	0.0	0.6	0.2	0.9	0.0	0.9	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.2	0.5	0.2	0.0	0.0	0.1	0.2	1.2	0.2	0.0	0.0	0.0	0.7	0.2	0.1	0.4	0.1	0.5	0.0	0.2	0.4	0.0	2.7	2.3	0.7	10.6	0.5	2.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC008695.1		ENSG00000273217			5	131425891-131796983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 11.1"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;HeLa: 1.3;HL-60: 1.4;HMC-1: 2.8;U-937: 1.7"									"HPA037982, HPA037983"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: AB_2675769"																		4.0	2.5	3.6	2.4	4.3	3.8	2.9	3.4	4.1	2.7	2.7	3.8	2.1	2.4	3.5	2.4	2.5	2.5	2.4	2.6	2.5	2.5	2.5	2.5	2.6	3.5	5.8	2.6	4.0	2.5	2.4	6.1	4.5	3.5	2.5	2.4	1.4	2.5	2.4	4.2	2.5	2.5	3.0	3.3	2.5	2.5	4.2	5.2	2.4	2.5	1.1	2.4	3.0	4.0	2.0	0.3	2.3	0.9	2.4	11.1	2.8	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	1.7	0.0	0.6	0.9	2.3	3.3	0.4	5.7	1.4	3.6	3.8	0.3	2.0	11.1	5.0	0.6	2.4	0.9	0.0	2.8	2.8	3.6	4.3	3.4	4.1	2.5	2.5	5.8	2.6	3.5	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC010422.5		ENSG00000269590			19	12664828-12669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"	33	"Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 14.1;RT4: 7.4;U-138 MG: 5.3"									HPA065685	Uncertain		Approved	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Nuclear membrane, Endoplasmic reticulum"		"HPA065685: AB_2685531"																		4.5	8.7	3.7	5.1	3.8	3.1	7.5	5.1	8.3	5.6	5.8	3.6	5.9	11.3	4.5	6.7	6.9	5.4	7.8	5.5	4.2	4.1	6.0	8.3	8.0	13.1	3.5	2.4	6.4	13.2	2.3	3.8	7.5	2.2	6.9	2.8	3.3	8.2	6.2	10.9	6.0	5.9	4.6	3.7	4.1	3.8	4.5	2.6	2.7	10.4	6.9	3.9	4.7	7.1	1.2	0.0	6.7	0.2	0.0	0.2	0.5	2.1	0.0	0.0	3.3	0.0	0.8	1.0	0.0	0.0	0.0	0.7	0.0	1.4	0.0	2.3	0.0	0.4	1.3	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.4	1.3	0.2	0.0	0.0	0.1	0.3	3.8	0.0	14.1	3.5	0.4	0.9	0.0	0.0	1.4	0.0	0.0	1.1	7.4	2.1	1.9	0.0	1.7	0.3	0.0	2.4	0.7	0.0	5.3	0.1	1.9	2.2	2.3	3.1	1.4	4.7	0.8	2.1	2.0	0.2	1.8	0.1	0.1	0.0	1.2	0.0	0.2	0.0	0.8	0.0	0.1	6.7	0.0	0.2	0.0	0.1	0.5	3.7	3.8	5.1	4.4	4.2	4.1	3.5	2.4	2.2	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011005.1		ENSG00000230626			7	129126518-129130793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	8	"testis: 7.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7;MCF7: 2.3;RT4: 1.9"									HPA051993	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051993: AB_2681685"	"unprognostic (2.03e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.36e-5)"	"unprognostic (3.43e-2)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	7.8			0.0		0.0	0.0		0.6	0.4	0.9	0.3	0.7	0.6	0.1	0.2	0.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.7	1.7	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.5	0.0	2.3	0.4	0.1	0.2	0.1	0.5	0.2	0.0	0.0	0.0	1.9	0.3	0.1	0.0	0.0	0.8	0.1	0.0	0.7	0.0	0.2	0.0	0.9	0.3	0.2	0.1	0.3	0.4	0.0	0.0	0.5	0.3	0.9	0.3	0.3	0.5	0.4	0.3	0.6	0.4	0.6	0.4	0.4	0.8	0.7	0.2	0.0	0.5	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011195.2		ENSG00000266826			17	58660424-58692018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	99	"testis: 48.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;BEWO: 1.0"									"HPA000634, HPA001004"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA000634: AB_1079102, HPA001004: AB_1079104"					"unprognostic (3.14e-2)"					"unprognostic (1.59e-1)"		"unprognostic (2.37e-1)"		"unprognostic (8.67e-2)"	"unprognostic (1.13e-1)"		"unprognostic (2.94e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	48.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.0	3.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011455.2		ENSG00000269547			19	38915404-38949855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.6;ovary: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.7;A549: 5.2;AN3-CA: 2.8;T-47d: 4.4;U-251 MG: 6.4"									"HPA052730, HPA056957"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"										"unprognostic (6.10e-2)"			"unprognostic (3.79e-2)"					1.3	2.6	0.3	1.7	0.3	0.0	0.1	0.4	1.1	0.3	0.1			0.0	1.2	0.5	0.1	0.4	0.8	1.1	0.1	0.1	1.6	1.1	0.2	0.0	0.2		3.0	0.6	0.0	0.1	0.5		0.2	0.0		0.1	0.0	0.2	0.2	0.2	0.0	0.3	0.1	0.1	0.5			0.1		0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.2	0.0	2.8	0.9	0.0	0.5	0.0	0.3	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.3	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.5	0.3	1.2	0.5	0.5	0.0	1.2	0.3	2.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	0.2	0.0	1.4	1.4	0.0	6.4	0.0	0.6	0.0	2.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012476.1		ENSG00000285396			15	40695129-40732158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	5	"lymphoid tissue: 19.5;testis: 16.7"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA039310	Approved		Approved	"Nucleoli rim,Cytosol"		NA	NA			"Nucleoli rim"	Cytosol	"HPA039310: AB_2676434"																		0.4	0.8	0.0	4.2	0.0	0.9	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.8	2.1	0.2	1.4	0.9	0.0		0.2	0.3	0.8	0.9	0.0	0.0	0.3	0.5	0.9	0.0	3.9	0.0	0.1	0.0	0.0	0.3	0.0	1.8	0.9	1.2	0.0	0.2	3.0	1.6	16.7	0.0	19.5	0.1	2.1	6.1	0.0	0.0	1.3	1.0	2.3	0.4	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.5	1.2	0.2	1.0	0.2	1.1	0.3	0.4	1.3	0.2	0.3	2.3	1.2	0.1	1.0	0.3	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC023055.1		ENSG00000257390			12	55757275-55827546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	13	"blood: 6.4;testis: 12.9"	"Group enriched"	"Detected in some"	16	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 4.6;Ciliated cells: 6.7;Club cells: 2.3;granulocytes: 2.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 6.5"									"HPA017653, HPA030902, HPA030903"	Uncertain		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA017653: AB_1847799, HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (8.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-5)"	"unprognostic (6.36e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-3)"	0.3	0.1	0.1	0.0	0.1	0.6	0.0	0.3	0.4	0.0	0.1			0.3	0.0	0.6	0.2	0.1	0.7	0.2	0.2	0.1	0.1	0.3	0.1	0.5	0.2		0.0	0.1	0.4	0.1	0.0		0.3	0.7		0.0	0.0	0.4	0.2	0.7	0.0	0.1	0.1	0.2	12.9			0.0		0.3	0.4	0.0	6.4	4.1	5.3	5.9	5.7	5.8	4.7	0.3	0.0	2.8	4.1	3.1	0.0	3.2	1.7	1.4	0.3	1.2	1.1	0.8	3.1	0.6	2.0	1.2	1.5	2.5	3.1	1.3	0.0	2.7	2.2	0.6	0.3	1.2	2.7	2.9	0.7	0.0	1.4	0.6	0.0	0.4	1.7	1.3	0.0	0.6	0.0	1.6	2.4	4.5	3.0	0.0	2.9	3.2	1.8	1.7	0.8	4.3	1.3	0.9	4.5	6.5	1.7	1.1	1.1	0.0	0.0	0.3	0.6	0.9	0.0	2.3	1.8	0.8	0.3	0.6	2.8	2.6	5.3	5.6	3.2	3.5	6.4	4.9	4.5	4.1	3.5	3.9	5.8	1.5	5.7	5.9	2.7	5.2	4.7											6.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	6.7	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC023509.3		ENSG00000267281			12	53506688-53625979	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 3.0;Club cells: 3.4;Collecting duct cells: 1.8;granulocytes: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.5"									HPA003384	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (1.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.37e-4)"	"unprognostic (6.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.91e-2)"	"unprognostic (2.26e-7)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.77e-3)"	4.5	2.4	3.9	2.0	6.0	4.5	4.6	14.9	5.2	3.3	2.7	7.8	2.1	1.4	4.5	1.8	3.2	3.6	3.8	3.7	4.4	2.8	2.4	3.8	7.0	3.6	6.8	2.3	5.1	3.5	1.4	3.6	2.9	5.1	3.3	3.5	3.1	3.0	4.3	4.5	3.4	2.4	5.7	4.7	2.9	3.1	4.7	6.6	1.9	2.4	1.7	4.1	5.9	2.5	0.7	1.4	2.9	2.2	0.2	2.5	0.5	0.6	4.5	0.0	0.5	1.8	2.3	0.0	0.0	1.5	1.6	0.3	0.5	0.7	1.7	0.4	0.0	0.0	1.4	0.3	1.2	1.3	1.8	0.9	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.5	0.9	0.0	0.0	2.0	1.9	0.0	1.8	0.0	0.0	0.0	0.2	0.8	0.2	0.7	0.3	0.0	0.5	0.0	0.2	0.0	1.4	0.0	0.0	0.3	1.3	2.3	1.8	0.0	0.6	0.6	0.0	0.3	0.0	0.6	1.5	0.8	0.9	0.0	2.9	1.7	0.5	2.5	2.2	0.5	0.2	0.2	0.4	0.9	0.7	0.0	0.4	2.4	0.2	0.0	1.4	0.3	0.5	3.9	6.0	14.9	5.2	4.4	2.8	6.8	2.3	5.1	6.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.8	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AC026464.4		ENSG00000260914			16	69299682-69322700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 28.3"	"Cell type enriched"	"Detected in single"	11	"Alveolar cells type 2: 1.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060092			Approved	Midbody		NA	NA			Midbody		"HPA060092: AB_2684203"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-1)"			"unprognostic (7.34e-2)"	"unprognostic (8.50e-2)"		"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"		"unprognostic (3.50e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.51e-4)"	"unprognostic (1.69e-1)"		"unprognostic (2.76e-1)"	"unprognostic (5.11e-2)"	5.6	3.4	1.0	2.7	2.2	2.3	4.8	15.1	6.8	5.5	4.5			3.1	9.1	0.6	5.0	7.5	2.0	5.0	1.0	1.3	3.3	1.4	7.3	2.4	1.0		6.4	5.7	7.1	3.9	3.0		3.0	2.7		3.7	3.0	19.4	6.4	4.6	3.5	1.2	4.4	3.1	1.3			5.3		3.0	4.5	5.1	17.5	19.5	24.9	19.1	15.9	28.3	21.1	22.5	20.0	23.6	22.2	18.2	19.3	13.3	28.6	19.4	30.6	20.2	25.4	12.5	21.5	30.0	22.9	15.6	17.6	22.4	19.5	19.6	13.2	10.7	17.0	11.0	12.6	23.0	21.3	18.1	16.3	26.9	25.3	28.0	17.4	25.2	18.6	21.5	10.7	24.8	29.5	21.2	10.4	19.1	14.8	9.7	32.6	13.5	28.6	14.3	14.6	24.6	13.7	38.4	12.8	16.4	15.1	18.1	15.1	26.4	28.6	20.5	24.5	21.5	37.1	26.6	50.6	28.9	8.0	34.0	11.1	17.7	24.9	23.6	14.1	22.0	17.5	21.2	28.3	19.5	15.7	21.8	21.3	12.4	15.9	19.1	13.4	19.9	21.1											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC073610.3		ENSG00000272822			12	48903503-48957365	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.9;hTERT-RPE1: 8.0"									HPA068942			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA068942: AB_2732124"	"unprognostic (7.48e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.01e-12)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.06e-2)"	6.8	3.4	10.5	2.2	20.7	3.6	4.6	7.7	27.5	6.4	4.9	6.3	2.6	2.2	9.7	7.3	5.1	4.7	7.6	7.2	8.8	7.2	5.0	4.1	5.5	5.5	5.7	13.7	6.1	7.4	2.2	5.3	3.3	10.6	5.4	4.6	3.5	4.8	4.5	3.4	4.4	4.2	10.6	4.6	4.7	4.0	8.4	4.3	3.3	5.0	2.3	4.4	4.9	3.9	0.8	1.8	1.1	1.1	1.3	3.2	2.0	1.0	0.4	3.8	2.9	4.1	1.6	0.0	1.6	7.9	2.3	1.0	0.0	1.1	1.1	2.4	1.4	2.5	0.4	1.4	0.0	2.1	5.1	0.6	1.1	0.6	0.0	2.8	0.0	1.1	0.4	2.0	0.6	1.3	8.0	1.0	1.9	0.1	1.4	1.3	0.4	0.2	0.6	0.0	2.1	1.1	2.2	0.6	0.2	0.2	0.3	1.9	0.5	0.9	0.7	0.8	0.7	0.2	0.5	4.3	0.7	0.5	0.2	0.5	2.0	0.3	0.7	1.8	1.1	0.4	0.9	1.1	0.3	2.7	0.4	3.2	0.6	0.9	1.8	0.9	0.8	2.3	2.6	1.1	1.3	0.4	1.8	0.5	2.0	10.5	20.7	7.7	27.5	8.8	7.2	5.7	13.7	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
AC073896.1		ENSG00000144785			12	56285916-56316059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"Club cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 25.7"									"HPA038466, HPA068007"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA038466: AB_10672646, HPA068007: "	"unprognostic (3.07e-2)"	"unprognostic (9.89e-3)"	"unprognostic (8.23e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.63e-1)"		"unprognostic (2.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.26e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.93e-1)"	6.4	12.2	6.7	7.8	7.4	4.5	5.4	12.4	13.6	7.2	20.3	7.2	13.3	15.3	6.5	10.9	6.9	5.7	5.9	8.3	5.0	5.5	8.5	18.1	5.3	5.1	6.4	6.6	8.5	20.5	6.9	12.5	13.2	6.6	7.1	4.8	5.6	15.5	10.9	8.6	5.9	8.3	2.9	7.5	10.6	10.0	5.8	6.1	3.4	12.5	4.3	4.6	5.4	4.8	22.5	19.3	7.9	13.2	9.7	12.5	18.8	6.5	3.8	4.9	6.7	3.0	1.9	5.1	9.7	3.1	3.3	1.8	0.8	5.6	3.0	22.7	2.3	2.1	14.4	6.3	1.0	2.0	7.8	4.3	1.0	4.4	2.9	0.2	7.5	11.8	3.4	0.4	2.4	0.2	3.9	4.0	6.4	2.8	3.3	1.6	1.8	4.1	4.1	14.4	1.6	11.3	18.6	7.0	4.8	0.6	1.8	8.5	11.3	2.8	9.6	9.4	1.2	5.1	15.4	0.0	9.0	5.8	5.0	14.3	11.0	25.7	7.7	15.2	6.5	11.1	7.9	7.6	4.1	12.4	13.2	10.0	22.5	7.7	12.5	15.1	19.0	9.0	11.8	1.6	9.7	6.6	19.3	11.4	18.8	6.7	7.4	12.4	8.3	5.0	5.5	6.4	6.6	6.6	6.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC091959.3		ENSG00000275740			5	146203550-146339251	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"testis: 21.6"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 8.9;Club cells: 7.9;granulocytes: 3.5;monocytes: 5.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (6.42e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.05e-2)"		"unprognostic (4.95e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.24e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.12e-2)"	3.6	2.8	4.0	5.7	5.4	8.0	3.4	6.5	5.4	4.6	5.1	2.9	3.5	6.0	4.8	2.3	4.9	4.4	2.8	3.6	3.7		3.1	4.1	3.3	5.0	3.6	4.1	5.9	3.3	5.5	4.3	4.1	4.0	4.3	3.4	3.0	3.5	3.4	7.3	2.2	4.6	5.8	3.7	4.3	4.2	21.6	3.8	8.4	5.8	4.0	4.7	5.6	3.9	16.1	12.5	17.6	13.3	11.8	15.0	8.4	6.0	9.9	4.8	4.6	1.5	1.5	4.4	7.7	4.7	9.2	9.5	10.6	4.8	7.0	4.6	4.1	5.7	4.6	7.1	6.7	7.8	13.4	3.9	8.1	4.8	1.1	1.1	9.7	8.1	2.2	0.9	8.6	5.3	1.5	2.7	2.7	10.8	4.7	2.7	2.7	7.8	0.0	4.4	2.6	6.5	8.0	9.2	3.9	0.7	7.8	4.7	3.5	11.1	2.5	3.8	1.7	7.9	1.4	5.4	4.9	5.9	6.0	7.5	5.5	12.2	11.4	5.6	5.8	5.4	17.6	8.8	16.6	13.6	8.7	15.0	12.9	12.5	10.4	9.0	16.1	13.3	12.9	12.8	11.8	13.3	12.5	10.8	8.4											8.9	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.9	1.8	0.0	0.4	1.7	1.6	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC092718.3		ENSG00000260643			16	81053587-81096296	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Ciliated cells: 16.0;Club cells: 4.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA041368	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041368: AB_10804001"	"unprognostic (3.87e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.56e-3)"	"unprognostic (3.03e-1)"	5.1	2.7	4.4	1.6	6.3	1.0	2.6	2.6	10.3	1.8	1.3	5.9	5.5	0.8	3.4	7.6	1.3	7.0	1.9	3.4	5.0		6.1	6.0	1.8	1.6	6.8	6.2	2.9	3.6	5.0	2.2	4.0	7.6	2.9	1.3	3.7	3.3	2.6	8.4	1.8	1.1	2.3	5.3	1.4	2.0	5.8	7.2	2.0	15.0	1.6	0.9	1.5	0.0	4.5	5.1	1.5	1.3	3.9	3.6	2.1	4.2	3.4	5.3	3.7	12.2	4.5	5.6	2.3	1.0	2.0	0.3	0.4	5.1	0.8	4.7	1.0	4.5	3.6	3.2	1.4	2.9	1.6	5.7	0.9	1.7	3.2	4.3	3.1	2.9	5.3	6.4	3.1	2.8	5.7	2.0	6.5	3.9	0.4	2.7	4.7	4.3	14.0	2.7	3.5	1.8	12.4	1.1	2.2	7.8	1.7	4.2	4.2	2.6	1.1	4.2	5.9	1.2	5.0	2.4	0.9	2.0	2.5	1.8	3.1	3.4	5.7	2.6	2.3	2.2	1.5	1.1	1.0	3.6	0.8	3.5	4.5	2.3	1.3	2.9	3.5	3.3	2.4	0.9	3.9	1.3	5.1	0.6	2.1											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	16.0	4.5	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC092718.8		ENSG00000284512			16	81022316-81096284	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"testis: 20.6"	"Cell type enriched"	"Detected in single"	11	"Alveolar cells type 2: 1.1"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA041368	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA041368: AB_10804001"																		1.4	1.9	3.2	2.1	4.7	4.0	1.7	1.8	6.9	1.4	1.3	4.4	4.0	1.4	2.0	4.2	1.3	1.7	1.6	2.4	3.7		2.5	4.2	1.4	1.9	5.1	4.7	2.2	2.5	3.6	1.4	1.7	5.7	4.0	1.3	2.6	2.3	1.7	3.2	1.9	1.6	1.3	3.9	1.5	1.7	20.6	5.4	1.2	4.5	0.9	1.2	1.7	0.0	1.9	2.8	2.3	1.0	1.7	2.1	0.9	1.3	0.7	1.9	1.6	0.3	0.0	1.6	2.4	0.2	0.5	0.1	1.2	1.9	1.8	1.0	0.6	0.9	2.8	0.1	0.1	0.5	0.3	1.1	1.1	2.5	1.8	0.2	1.8	3.4	0.6	0.2	0.4	0.0	1.0	0.0	2.2	1.0	3.3	0.0	3.7	1.6	4.0	1.9	0.7	1.1	1.6	1.3	0.5	0.2	0.8	2.8	0.8	1.8	1.2	0.4	1.0	1.2	0.5	0.3	1.7	2.0	1.3	1.1	1.6	0.8	3.4	0.6	0.8	0.8	1.9	1.0	0.6	1.2	0.6	1.0	1.1	0.9	2.1	0.6	1.9	1.2	1.5	2.3	1.7	0.9	2.8	1.8	0.9											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC093827.5		ENSG00000285458	"Uncharacterized protein C4orf36 "	Q96KX1	4	86886472-86936178	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 11.9;Ciliated cells: 14.7;Club cells: 3.4;Distal tubular cells: 5.0"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.2"									HPA057434	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057434: AB_2683438"																		2.0	2.0	4.4	0.9	8.1	1.5	3.4	1.0	4.5	2.0	1.3	9.7	2.2	1.6	1.8	3.7	2.2	1.6	1.1	6.8	4.6		3.0	0.8	1.5	0.3	8.9	3.7	1.8	1.2	3.3	1.6	1.6	5.8	2.5	1.8	2.6	2.0	2.4	4.8	5.1	1.6	3.0	8.9	1.2	2.1	3.2	8.2	0.0	3.9	2.4	0.3	1.6	0.0	2.0	2.8	3.3	1.8	2.0	3.1	0.6	2.9	1.8	0.9	1.3	2.8	2.5	1.4	2.7	2.8	0.9	1.4	1.3	4.9	0.5	2.5	1.8	2.3	2.0	1.3	1.6	1.1	2.3	1.0	2.3	2.2	1.3	1.6	3.6	1.5	1.7	4.2	0.9	3.2	1.5	0.8	1.2	1.6	12.2	0.5	0.9	1.5	1.4	2.1	2.8	1.2	2.9	1.2	2.6	2.9	2.1	1.0	1.8	2.1	2.1	2.4	1.4	3.8	2.6	1.0	2.3	3.1	1.0	1.6	4.4	2.0	4.0	1.9	1.7	1.2	1.6	1.7	1.5	2.0	1.8	2.5	1.6	1.4	2.0	1.5	2.0	1.9	3.1	3.3	2.0	1.3	2.8	0.7	0.6											11.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	14.7	3.4	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC105001.2		ENSG00000258724			8	10725399-10839847	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.1;HBEC3-KT: 2.5;SiHa: 2.2"					"Not detected"	"Not detected"			HPA009065	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"									"unprognostic (2.57e-1)"					"unprognostic (6.34e-2)"				6.7	2.7	1.9	3.7	3.1	1.7	2.7	2.9	3.9	9.8	3.1	2.6	0.9	3.3	3.6	1.7	4.0	2.1	3.1	3.2	2.0	1.9	2.2	4.8	4.7	2.2	2.8	2.1	3.8	4.1	1.7	2.3	3.3	4.2	2.7	1.8	3.6	3.4	2.0	8.7	4.6	3.0	2.1	2.5	3.3	3.2	6.3	1.7	4.6	2.6	4.3	3.8	2.2	15.2	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.3	0.0	0.1	0.2	0.4	0.0	0.1	0.0	0.3	6.1	0.4	2.5	0.0	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.2	1.2	0.0	0.0	0.3	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.3	0.2	0.0	0.1	1.0	0.1	0.1	0.3	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	3.1	2.9	3.9	2.0	1.9	2.8	2.1	4.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC116366.3		ENSG00000283782			5	132410832-132646079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 7.5;Ciliated cells: 22.7;Club cells: 11.4;monocytes: 10.8"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA052291	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052291: AB_2681786"																		4.8	4.8	2.6	11.9	4.4	1.9	5.3	4.2	6.0	6.3	6.3	4.0	6.0	5.6	4.2	7.0	3.2	4.9	7.4	4.0	3.2		5.8	6.5	10.4	9.8	4.1	2.8	8.6	3.4	5.7	6.3	3.5	3.9	5.6	4.7	6.2	4.3	5.8	4.7	1.7	8.0	6.1	4.4	9.3	4.6	1.9	4.7	7.6	5.7	2.4	9.6	4.4	8.3	5.0	3.5	7.4	3.1	5.1	9.0	3.7	3.3	0.2	1.0	1.5	8.4	8.7	4.5	3.5	3.4	6.4	6.1	0.2	7.2	2.9	2.0	4.2	11.2	2.3	4.7	0.9	5.7	6.1	0.7	4.1	0.9	0.7	12.3	2.5	2.6	4.9	1.8	4.4	9.3	6.4	4.5	3.2	0.7	7.8	7.4	0.1	7.7	3.0	2.1	2.2	1.2	7.2	3.6	9.8	1.8	0.6	1.5	1.5	2.2	1.7	3.0	2.4	0.2	3.4	5.7	2.9	1.8	2.0	1.9	11.0	5.7	3.6	3.5	8.1	1.6	3.8	1.9	7.4	9.0	3.1	5.0	5.0	4.9	6.4	1.1	5.0	5.4	6.2	4.9	5.1	2.8	3.5	5.7	3.7											20.8	7.5	0.0	0.0	0.0	0.0	0.0	0.0	22.7	11.4	3.5	0.0	0.0	1.7	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	10.8	0.0	0.0	1.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC118553.2		ENSG00000283761			1	99970011-100083321	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.6;Ciliated cells: 9.4;Club cells: 2.3"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA073681			Approved	Vesicles		NA	NA			Vesicles		"HPA073681: AB_2686625"																		2.5	1.9	1.9	6.5	2.0	3.0	6.3	2.3	4.0	3.1	8.2	1.4	6.3	3.3	3.1	3.9	5.9	3.1	4.6	2.1	1.4		3.8	6.1	7.1	3.9	2.1	1.8	4.2	5.2	3.0	2.8	4.4	3.3	3.5	4.2	1.6	5.8	8.9	2.2	1.5	17.6	5.9	2.1	1.8	2.8	4.6	1.5	10.2	2.9	2.5	3.1	3.5	3.8	4.4	8.7	9.1	7.8	9.1	8.6	6.7	0.9	1.2	1.6	0.5	0.0	1.1	1.5	2.4	1.0	2.4	5.0	0.8	3.5	0.2	6.0	3.6	5.0	3.9	4.7	1.7	3.1	1.6	2.4	3.9	6.9	0.2	0.5	0.8	0.8	0.0	1.6	4.6	4.1	1.3	2.9	0.7	3.1	2.2	1.4	2.1	3.9	0.2	0.1	3.6	2.0	0.9	3.8	1.7	1.4	1.9	1.1	1.4	1.9	1.2	1.0	1.6	1.0	0.1	0.9	1.5	2.6	1.4	2.6	1.3	5.0	0.7	1.9	1.9	0.6	9.1	7.5	5.0	6.9	7.8	7.9	4.4	7.2	8.2	8.7	2.9	6.9	5.9	1.1	9.1	4.5	6.7	8.6	6.7											6.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	9.4	2.3	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC131097.2		ENSG00000216921			2	241893985-241902551	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"pancreas: 27.6;tongue: 59.2"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 7.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 4.1;MCF7: 1.8;REH: 6.3;SCLC-21H: 4.1"									HPA073342			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073342: "	"unprognostic (9.31e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.75e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.29e-1)"	2.7	0.3	4.9	0.6	4.4	0.2	1.6	1.7	2.4	0.8	0.6	0.6	0.6	0.1	0.6	0.6	3.8	0.5	0.9	0.6	2.1	2.3	0.6	0.6	0.6	0.6	3.9	0.6	1.4	27.6	0.0	0.6	0.6	0.6	2.6	0.0	0.6	4.4	4.0	3.7	2.6	0.6	0.6	0.6	0.6	0.1	0.8	0.6	1.1	6.4	59.2	2.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.5	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.5	0.6	0.0	1.8	1.4	0.2	0.5	0.0	0.0	6.3	0.0	0.6	0.0	0.0	4.1	0.1	0.0	0.6	0.0	0.9	0.0	0.9	1.2	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.4	1.7	2.4	2.1	2.3	3.9	0.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC131160.1		ENSG00000283765			3	183815568-183884889	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 12.1"									HPA019545	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019545: AB_1855796"																		3.8	3.8	2.9	2.2	3.8	3.2	2.3	2.8	12.7	2.4	2.9	3.3	2.3	1.2	2.2	3.1	4.5	1.7	2.6	4.2	3.0		2.5	3.3	2.8	3.7	2.3	2.5	2.3	7.9	3.2	2.5	2.0	2.3	2.3	3.1	3.6	5.4	5.1	9.7	3.2	3.8	6.0	1.7	2.2	2.2	7.1	2.2	2.8	2.6	3.5	3.3	3.0	0.5	1.0	1.0	3.1	1.2	0.2	1.0	0.6	1.4	0.0	1.6	0.5	0.4	0.4	0.0	1.1	0.7	0.7	0.5	3.7	0.2	1.6	0.2	0.5	1.8	0.0	4.5	0.4	1.9	1.8	1.6	2.4	1.2	1.2	0.0	1.3	0.4	1.0	0.9	1.0	0.0	0.1	0.0	2.6	0.5	1.8	2.4	2.4	2.8	0.1	2.7	0.0	0.3	2.9	1.0	3.2	0.5	2.2	1.8	1.7	0.5	1.7	1.5	0.0	12.1	0.0	0.0	0.0	2.0	0.2	1.4	2.8	3.6	2.3	0.8	3.0	0.9	0.0	1.0	3.1	1.0	0.5	0.9	1.0	0.4	0.5	0.1	0.4	0.8	0.6	1.1	0.2	1.2	1.0	0.3	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC134980.5		ENSG00000285472			15	22015233-22095857	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	103	"testis: 10.2"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.3"									HPA057442	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA057442: AB_2683442"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	10.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC135050.2		ENSG00000255439			16	31083439-31094956	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042720	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.84e-8)"	"unprognostic (4.96e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.29e-4)"	4.5	2.6	1.6	4.8	1.7	3.0	6.4	1.9	2.6	5.4	3.9	3.3	3.2	3.3	5.1	5.9	3.7	4.0	4.9	3.7	1.8	1.8	6.9	47.1	3.6	3.7	2.4	1.1	5.6	14.1	4.6	3.1	4.8	2.3	4.8	2.2	4.4	8.3	3.8	2.0	7.8	6.0	6.3	1.8	4.3	3.5	3.6	1.5	3.0	5.7	2.4	2.6	6.5	3.9	2.3	2.6	2.9	2.7	1.4	3.8	2.0	1.2	1.2	0.0	1.2	2.7	3.6	0.3	3.7	0.9	0.0	0.5	0.6	0.7	0.7	1.9	0.3	0.0	0.5	0.0	0.4	0.0	0.4	1.7	1.5	1.2	0.5	0.0	0.0	1.5	1.0	0.6	0.6	0.0	0.6	0.0	1.1	0.0	1.5	0.3	1.2	1.0	3.1	0.3	0.1	1.6	2.9	0.2	1.1	0.0	0.8	1.0	0.9	1.8	1.0	1.9	0.0	0.0	0.4	0.0	1.2	0.0	3.2	0.9	3.6	0.8	0.0	2.9	0.9	0.4	0.8	1.6	2.9	2.7	1.6	3.5	2.3	3.4	3.8	2.3	1.8	2.1	2.8	1.5	1.4	2.7	2.6	3.4	2.0	1.6	1.7	1.9	2.6	1.8	1.8	2.4	1.1	2.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC136612.1		ENSG00000275869	"TP53 target 3 family member E "		Unmapped	933862-936467	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"epididymis: 2.1;testis: 6.8"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.8;HMC-1: 1.6;K-562: 2.9;U-2 OS: 2.5;U-266/84: 3.8"									"HPA047832, HPA060916"			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA047832: , HPA060916: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	2.1	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.3	0.0		0.7		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	6.8			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.5	0.7	0.0	0.4	0.0	0.0	2.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.3	0.7	0.4	0.5	0.0	0.0	0.4	2.5	0.2	0.0	1.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.7	0.4	0.0	0.5	0.0	0.0	0.6	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
AC138696.1		ENSG00000264668			8	143247110-143276403	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.8"									"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (2.24e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-3)"		"unprognostic (1.87e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.06e-1)"	3.6	4.8	6.2	2.5	4.4	1.5	2.5	5.8	7.3	3.3	3.8	4.7	2.5	2.6	5.7	2.7	2.8	7.8	2.0	2.7	6.2	4.8	2.6	1.9	2.7	2.5	4.8	3.0	5.8	6.8	4.6	4.5	2.2	4.2	3.0	2.2	3.8	3.6	3.9	4.7	1.8	3.1	3.2	3.7	2.7	2.7	3.5	3.6	1.5	2.7	1.5	2.6	3.6	4.4	0.6	0.6	0.0	0.2	0.9	2.1	0.1	1.4	0.0	0.0	0.8	4.8	0.3	0.5	1.4	3.0	1.6	0.6	0.0	1.9	0.2	0.8	0.3	0.3	0.7	0.0	0.6	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.3	0.7	2.8	1.3	0.0	1.0	0.5	0.9	1.1	0.0	0.1	0.0	0.0	3.3	0.0	3.0	0.4	0.9	1.6	2.8	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	1.0	0.9	0.0	0.0	0.7	3.0	0.1	2.3	0.8	1.6	1.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.9	0.2	0.6	0.3	0.1	6.2	4.4	5.8	7.3	6.2	4.8	4.8	3.0	4.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC138811.2		ENSG00000260342			16	18788063-18801519	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"blood: 51.6;testis: 43.2"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 2: 3.5;Ciliated cells: 9.4;Club cells: 4.5;granulocytes: 2.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.6;HDLM-2: 34.8"									HPA045307	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045307: AB_10961042"	"unprognostic (1.03e-2)"	"unprognostic (8.89e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.18e-4)"	"unprognostic (2.92e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.95e-2)"	5.0	5.8	7.8	7.0	12.6	4.6	4.4	9.4	17.0	3.8	13.5	6.3	2.3	1.9	4.2	3.1	5.6	3.5	3.8	4.8	6.9	4.8	6.4	12.1	4.3	4.0	6.6	10.6	4.1	9.3	10.8	3.6	4.0	17.1	3.6	4.1	9.6	4.1	4.1	12.0	4.0	5.9	5.5	7.0	6.0	14.6	43.2	4.0	7.5	4.5	1.6	4.1	4.7	3.9	29.2	51.6	29.0	25.8	37.2	49.0	48.3	11.6	2.3	2.0	12.2	0.7	0.3	0.4	12.6	0.7	1.2	1.6	8.3	14.9	3.1	28.6	2.9	3.1	13.9	4.4	1.8	3.6	34.8	1.3	3.3	5.3	2.2	0.0	15.8	8.2	0.7	0.4	4.2	0.0	1.2	0.7	1.5	6.7	12.1	1.3	0.0	5.5	0.2	1.1	0.7	0.3	21.1	4.5	1.6	0.8	7.0	6.4	0.7	16.3	4.3	1.1	1.1	7.8	0.3	13.1	5.7	8.9	5.6	13.0	3.3	16.5	7.2	8.1	1.9	13.2	29.0	25.8	15.0	43.5	18.0	34.2	29.0	34.9	41.5	24.5	29.2	29.8	32.9	20.1	37.2	22.9	51.6	49.0	48.3	7.8	12.6	9.4	17.0	6.9	4.8	6.6	10.6	17.1	4.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	9.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC138894.1		ENSG00000261832			16	28456371-28492098	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 3.5;Ciliated cells: 9.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.0;BEWO: 1.3;hTCEpi: 3.4;NB-4: 1.4;REH: 1.0"									HPA053611	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.93e-3)"	"unprognostic (8.88e-3)"	"unprognostic (4.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.82e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.74e-1)"	0.0	0.0		0.6		0.0	0.0		0.5	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.4	0.0	0.0		0.3		0.2	0.1		0.0	0.0	0.0	0.6	0.0	0.8		0.3	0.5	0.0			0.1		0.0	0.3		0.2	0.1	0.3	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	1.4	0.4	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.5	0.3	0.3	0.0	0.0	0.2	0.0											6.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	9.4	1.2	0.0	0.0	0.8	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0
AC138969.1		ENSG00000183889	"Nuclear pore complex-interacting protein family member A5 isoform 2 "		16	16317444-16350590	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 3.0;Ciliated cells: 5.3;Club cells: 7.9;granulocytes: 8.1;monocytes: 2.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.3;T-cells: 2.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 64.2"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.91e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.45e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.04e-6)"	"unprognostic (6.04e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.22e-3)"	5.2	6.4	9.8	2.9	7.1	6.5	5.5	35.6	12.6	4.6	9.3			2.7	11.3	17.9	7.0	10.9	9.9	5.5	11.0	9.0	4.6	4.5	6.3	5.3	5.9		16.4	5.6	12.2	17.9	3.3		7.4	11.0		5.4	8.5	10.1	19.0	5.0	12.5	4.4	6.2	5.0	7.4			6.6		7.3	4.4	4.9	4.3	0.8	0.4	0.7	0.2	2.7	0.7	7.9	5.7	15.7	14.8	22.5	21.4	11.0	16.3	8.0	8.6	11.5	3.9	4.8	6.5	15.6	17.9	7.0	14.1	9.9	6.7	13.1	2.6	9.4	15.1	39.2	25.9	23.1	9.5	64.2	19.8	43.1	13.5	22.7	16.9	5.6	12.2	5.5	21.9	12.6	13.5	15.4	35.4	7.2	7.4	3.9	18.7	6.5	6.6	13.7	26.7	9.9	10.3	8.0	12.0	26.0	11.9	12.8	29.2	3.8	13.6	8.1	8.4	6.1	10.1	18.2	12.4	7.7	10.3	7.0	0.0	0.7	0.4	2.7	0.1	0.8	4.3	2.0	2.3	0.1	1.1	1.5	0.6	0.0	0.2	0.6	0.8	1.1	0.7											3.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.9	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	8.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC240274.1		ENSG00000271254			Unmapped	4612-29626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Spermatocytes: 132.8;Spermatogonia: 61.7"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "																		1.1	5.4		0.7		0.5	1.0		1.0	1.6	3.1			2.3	2.6	1.7	0.8	2.9	1.4	0.3			2.0	0.4	1.4	0.0			5.4	0.0	7.0		1.8		1.3	3.5		1.0	0.8	0.7	1.1	3.9	2.3		1.2	0.5	6.9			1.3		0.2	0.7		2.1	1.4	2.7	2.1	6.4	3.1	0.9	11.0	14.8	16.7	11.8	5.6	6.2	3.8	16.8	10.2	15.7	13.3	5.3	4.3	8.8	1.3	15.4	5.4	6.3	6.4	3.1	21.3	5.8	13.2	2.4	8.1	7.3	7.6	7.5	5.2	4.0	4.6	8.9	7.2	10.2	4.4	14.5	10.5	3.0	6.1	15.2	9.2	3.2	2.6	1.6	35.8	16.7	10.7	1.2	3.8	6.2	12.5	20.3	16.6	14.0	6.9	5.1	12.6	2.3	5.9	9.7	10.0	24.1	7.5	3.6	12.0	7.4	2.4	11.6	3.4	2.7	1.7	2.7	1.7	2.1	3.1	1.5	1.0	1.1	0.7	2.1	1.8	1.9	2.0	6.4	1.5	1.4	0.1	0.9											20.8	12.3	0.0	1.7	0.0	2.0	0.0	0.0	20.1	7.9	0.0	3.9	7.3	1.7	2.1	15.2	0.1	1.6	0.0	2.3	13.2	0.9	0.8	14.0	2.4	5.8	0.0	0.0	2.5	2.5	4.3	15.5	2.9	0.0	1.8	5.5	2.2	2.2	3.5	17.3	1.5	1.3	6.5	0.0	132.8	61.7	0.0	2.2	0.0	4.5	0.9
AC245033.1		ENSG00000260836			15	82536788-82573194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	5	"brain: 11.3"	"Group enriched"	"Detected in some"	240	"Alveolar cells type 1: 29.8;Alveolar cells type 2: 42.6;Ciliated cells: 20.1;Club cells: 15.9;granulocytes: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 19.0"									HPA055060	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Nucleoli, Cytosol"	"HPA055060: AB_2682686"									"unprognostic (2.91e-2)"									1.5	0.9	5.3	0.9	7.1	0.9	1.3	6.1	11.3	0.9	1.0	1.4	0.0	0.9	0.9	0.9	1.5	0.9	0.9	1.3	3.9	1.6	0.9	1.0	1.1	0.9	3.2	6.1	0.9	1.0	0.9	2.0	1.0	7.3	1.1	1.1	1.9	0.9	0.9	2.0	0.9	1.4	0.9	2.4	1.1	0.9	1.4	1.7	0.0	1.0	0.0	1.0	1.7	0.8	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.7	0.7	19.0	0.3	0.0	0.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.1	6.1	11.3	3.9	1.6	3.2	6.1	7.3	1.7	29.8	42.6	0.0	0.0	0.0	0.0	0.0	0.0	20.1	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Mitochondria		NA	NA		15000	Mitochondria	"Nucleoplasm, Centrosome"	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.2	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	1.8	3.3	4.2	1.3	0.5	10.5	5.3	5.2	2.2	11.9	6.2	0.4	23.6	10.3	2.0	1.7	0.1	1.2	3.9	13.3	4.2	0.0	1.7	4.2	7.2	12.0	1.3	6.6	3.0	5.3	2.7	1.4	7.3	11.5	0.7	4.0	6.2	0.0	9.8	0.6	5.0	8.2	4.4	0.1	3.1	3.0	0.5	10.0	5.6	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4	11.9	10.7	10.2	10.2	6.0	1.1	32.5	30.6	2.7	5.7	17.4	0.0	60.7	43.1	26.8	15.8	14.2	312.7	23.3	28.4	26.2	16.9	7.1	19.5	154.5	47.4	1.6	43.8	12.9	27.2	26.3	19.8	11.1	16.9	32.5	94.5	13.0	25.9	154.3	17.0	74.9	0.7	6.5	13.0	29.1	8.3	4.0	63.2	20.3	144.6	9.0
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.4;bone marrow: 30.3;lymphoid tissue: 51.5"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 2487.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 17.5;HDLM-2: 23.1;JURKAT: 32.7;Karpas-707: 22.9;NB-4: 28.3;U-937: 18.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075570	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favorable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"	2.6	0.6	0.6	31.4	1.3	30.3	1.1	1.0	1.2	1.4	4.5	0.4	0.4	3.2	0.9	1.5	3.3	2.0	3.1	1.4	0.6	0.6	2.9	2.3	7.3	29.3	2.7	0.1	1.0	0.7	0.0	0.8	0.5	1.2	1.8	1.5	1.7	9.6	1.3	0.5	1.2	19.2	0.8	1.3	44.9	3.7	1.4	0.9	51.5	2.5	1.0	33.9	3.7	1.8	17.8	13.3	22.4	5.9	23.7	29.4	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	17.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	6.6	0.1	0.0	0.0	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	22.9	0.0	0.0	10.6	28.3	0.3	0.0	0.0	11.3	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.1	0.0	0.0	7.1	6.0	8.0	0.1	18.7	0.0	17.0	5.9	22.4	24.6	1.8	27.5	16.6	25.8	26.1	10.5	17.8	22.7	22.4	17.7	23.7	0.2	13.3	29.4	16.1	0.6	1.3	1.0	1.2	0.6	0.6	2.7	0.1	1.2	0.9	8.9	8.5	123.3	5.5	7.3	14.8	26.2	10.2	28.1	11.4	5.2	17.7	3.1	6.6	3.5	485.0	7.1	1.3	0.0	3.0	2.2	12.2	3.7	39.3	4.9	7.7	0.0	3.5	6.7	23.4	2487.1	18.7	24.9	23.6	19.0	2.0	9.6	4.6	0.0	14.5	3.6	19.3	19.4	8.5	14.2	10.7	6.5	3.7	282.4	1.0	3.0
ACAP2	"CENTB2, CNT-B2, KIAA0041"	ENSG00000114331	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 2"	Q15057	3	195274736-195443078	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 59.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034807, HPA034808"	Supported		Approved	Endosomes		NA	NA		9300	Endosomes		"HPA034807: AB_10669896, HPA034808: AB_10673103"	"unprognostic (9.13e-2)"	"unprognostic (1.75e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.54e-2)"	25.8	11.7	16.3	26.8	14.4	35.7	19.1	27.0	15.1	22.2	19.4	13.1	12.1	14.3	18.2	13.6	28.3	14.8	14.8	11.5	14.1	11.8	14.2	14.3	18.2	25.8	13.9	11.4	20.9	11.8	16.6	24.2	15.7	16.1	14.5	17.6	15.3	16.7	16.9	10.6	21.1	18.6	15.2	15.3	32.9	13.9	14.9	13.5	30.6	22.2	16.1	27.0	17.4	20.6	12.5	9.2	59.4	15.7	4.5	7.7	5.9	14.9	5.7	9.5	9.4	15.7	19.6	14.2	12.3	16.8	9.3	9.6	8.2	8.8	16.5	30.3	11.4	8.9	9.5	7.1	6.1	13.6	18.7	4.4	16.7	6.3	3.4	15.7	22.9	12.2	15.2	10.3	9.2	20.8	8.0	10.1	9.5	8.1	16.9	13.3	8.7	14.3	8.3	5.8	8.6	8.3	17.0	11.5	12.1	6.5	13.9	10.5	5.1	13.4	12.3	14.6	8.6	23.1	13.5	17.7	11.7	6.7	15.4	14.3	9.9	21.1	37.5	8.8	24.3	12.4	13.1	15.7	14.3	7.7	13.3	6.1	10.1	7.5	6.0	8.7	12.5	6.3	6.4	59.4	4.5	15.1	9.2	6.6	5.9	16.3	14.4	27.0	14.2	14.1	11.8	13.9	11.4	16.1	13.5	41.7	36.3	35.9	27.4	39.5	54.6	18.1	22.9	44.2	40.9	29.6	72.6	17.7	16.6	20.7	6.0	56.3	42.5	23.3	21.2	18.4	43.5	31.3	38.2	28.3	56.4	114.4	49.5	46.1	105.9	5.8	43.1	68.8	33.7	26.2	38.1	32.3	24.5	49.5	35.3	23.6	93.9	58.2	37.6	38.1	25.6	45.2	24.3	48.5	30.5	34.8
ACAP3	"CENTB5, KIAA1716"	ENSG00000131584	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 3"	Q96P50	1	1292376-1309609	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 148.4;Cone photoreceptor cells: 98.2;Rod photoreceptor cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049317, HPA058381"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA049317: AB_2680710, HPA058381: AB_2683699"	"unprognostic (5.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	8.7	7.8	16.4	4.2	24.5	10.4	7.3	42.0	23.6	6.4	6.4	11.5	4.3	7.9	5.9	4.2	10.6	3.7	5.1	7.9	19.5	8.7	4.8	4.9	4.7	4.0	13.0	15.4	5.5	8.2	5.1	11.2	4.3	10.4	5.8	3.4	5.6	14.6	7.7	14.2	26.5	7.7	11.8	8.1	6.0	8.0	3.1	12.8	3.1	2.7	4.5	3.5	5.6	6.4	0.9	1.2	1.5	2.0	0.0	1.4	0.7	5.3	6.0	2.8	4.8	7.1	4.9	3.0	13.5	4.4	3.9	3.0	7.6	4.6	5.9	7.0	7.5	3.9	12.3	2.7	3.6	0.9	6.6	12.0	2.5	22.3	14.3	4.9	5.0	6.2	3.4	2.9	3.3	2.1	3.6	1.8	7.0	6.8	8.2	4.4	7.4	10.5	7.2	2.9	7.2	14.0	10.2	6.4	22.7	2.3	2.9	21.4	15.1	8.1	5.0	12.7	2.6	5.4	3.9	5.9	7.3	5.1	5.8	4.7	6.6	4.7	5.1	10.1	13.3	3.1	0.0	1.4	1.5	1.3	2.0	0.0	0.9	1.0	0.6	1.2	0.8	1.4	1.2	0.2	0.0	1.4	1.0	0.5	0.7	16.4	24.5	42.0	22.1	19.5	8.7	13.0	15.4	10.4	12.8	0.0	6.6	10.0	5.2	28.5	148.4	22.4	17.8	2.7	1.2	1.8	98.2	7.4	3.3	8.2	1.9	6.3	12.4	0.0	4.3	6.8	9.1	4.9	0.0	12.1	6.2	50.9	31.0	14.1	19.0	5.8	14.1	8.3	8.5	1.0	11.9	23.8	9.6	9.5	12.4	5.9	208.8	6.5	14.3	4.2	9.5	29.9	8.5	10.2	10.9	8.1
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159760328-159779055	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 20.4;liver: 31.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 168.5;Exocrine glandular cells: 155.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 48.1"					"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		16000000	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	1.6	2.6	2.7	1.5	1.7	1.6	2.2	2.2	6.3	2.1	4.3			3.2	1.4	4.8	5.7	1.0	0.7	0.7	2.9	3.6	3.0	31.0	1.8	2.5	2.9		2.1	0.7	1.3	1.2	0.9		4.2	3.9		2.3	0.5	0.1	2.4	1.6	1.4	5.1	1.1	1.7	6.6			0.9		4.2	1.1	2.6	13.3	9.5	12.3	8.4	10.0	20.4	12.2	6.7	6.3	42.7	16.3	6.1	11.3	1.4	5.9	7.1	14.1	24.4	24.5	8.6	5.6	3.0	4.7	48.1	6.5	17.7	46.2	16.7	3.3	18.1	13.1	10.2	40.6	6.1	7.6	3.5	6.1	3.4	23.3	10.0	2.1	6.9	16.0	14.1	9.6	8.5	11.9	13.0	12.1	14.3	6.7	4.6	8.1	9.6	17.4	32.9	8.7	11.4	6.5	6.9	4.5	2.4	2.0	8.5	15.1	4.3	5.2	4.5	7.3	15.2	4.6	8.4	13.8	1.5	14.9	7.8	6.1	7.1	12.3	13.9	8.4	13.7	13.3	15.9	13.8	9.5	13.3	16.0	12.3	3.2	10.0	5.6	8.7	20.4	12.2											11.9	35.5	24.6	29.0	23.2	14.0	1.2	40.8	20.1	21.6	19.2	2.0	44.4	59.7	47.3	168.5	10.9	23.5	0.0	155.7	84.2	22.6	31.4	12.7	55.7	46.8	12.7	16.4	12.9	10.5	110.0	12.7	23.1	28.7	92.8	21.4	21.8	47.0	17.5	18.0	33.8	19.6	0.0	34.0	14.7	48.7	18.3	29.4	26.6	23.3	27.6
ACBD4	FLJ13322	ENSG00000181513	"Acyl-CoA binding domain containing 4"	Q8NC06	17	45132600-45144181	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051772	Approved		Approved	Nucleoplasm,Vesicles		Yes	No			"Nucleoplasm, Vesicles"		"HPA051772: AB_2681603"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (2.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.53e-4)"	7.5	9.5	8.1	8.5	15.3	3.5	6.7	10.8	10.9	8.6	19.6	4.9	14.4	25.9	9.2	6.8	8.3	10.1	10.7	6.2	8.1	6.8	12.3	43.1	6.3	8.0	6.1	11.1	10.4	14.2	13.6	8.5	5.4	6.3	11.1	5.4	9.9	12.3	13.6	5.4	7.5	29.0	10.3	4.8	8.3	7.3	2.5	6.3	3.9	11.3	4.4	7.3	8.5	7.2	8.8	3.5	5.6	4.3	6.3	7.7	5.4	5.9	11.6	1.5	3.3	2.7	5.2	4.1	2.2	4.7	3.7	7.3	4.5	8.4	6.3	5.8	3.2	2.2	5.7	2.0	3.8	1.5	9.1	4.6	3.1	7.5	8.9	6.1	1.2	8.7	5.1	3.6	1.3	1.9	12.7	3.6	5.9	2.0	10.2	1.8	4.0	4.4	1.6	0.2	6.3	3.2	3.7	0.3	14.0	9.2	3.8	2.5	1.1	1.6	2.4	6.4	0.8	15.6	2.2	1.3	0.9	2.9	1.4	1.4	16.0	4.4	1.9	5.4	1.6	1.6	5.5	3.8	5.6	5.3	4.3	5.7	6.8	6.2	5.9	3.5	8.8	6.7	7.7	1.0	6.3	2.8	2.2	7.1	5.4	8.1	15.3	10.8	10.9	8.1	6.8	6.1	11.1	6.3	6.3	3.0	4.8	2.9	5.7	1.6	14.6	8.0	17.8	1.4	0.0	3.5	21.6	5.5	6.6	5.7	1.3	5.3	10.5	0.0	6.3	1.0	4.3	3.8	8.1	20.8	4.6	11.1	5.8	4.9	1.6	2.7	6.4	1.7	3.3	5.4	5.8	12.3	5.2	10.5	7.1	15.1	15.8	6.5	7.2	0.7	3.8	1.6	5.3	4.4	7.0	1.7
ACBD6	MGC2404	ENSG00000230124	"Acyl-CoA binding domain containing 6"	Q9BR61	1	180269653-180502954	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 143.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028179, HPA028457"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028179: AB_10601788, HPA028457: "	"unprognostic (3.12e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-1)"	6.5	7.5	7.3	9.7	7.7	9.1	7.1	17.4	8.1	8.0	5.2	6.5	9.6	5.8	8.6	7.6	5.4	6.0	7.1	8.9	6.6		6.8	5.5	6.8	11.2	6.1	7.9	10.5	9.7	6.8	10.5	11.3	5.8	6.8	5.0	6.5	7.2	7.6	9.5	6.3	5.2	7.8	4.0	6.8	6.1	18.2	7.3	8.1	8.1	7.7	7.1	7.6	6.9	11.5	14.5	2.7	13.3	16.4	10.9	7.7	21.2	15.8	13.6	10.0	9.5	16.6	28.5	9.8	19.7	17.1	15.5	22.3	15.6	18.8	20.3	9.6	8.4	15.3	10.0	18.1	10.9	14.2	19.5	14.8	14.3	12.7	24.5	25.3	13.4	15.0	25.9	10.6	16.7	15.0	19.0	15.3	23.2	15.3	13.7	19.3	21.6	23.9	15.0	14.5	7.5	21.8	11.3	35.9	14.5	11.1	21.4	27.4	13.1	22.0	13.1	14.2	23.1	18.9	15.3	12.8	15.4	15.6	21.1	32.4	16.7	42.7	14.0	15.6	15.1	1.9	8.4	2.7	9.3	13.3	10.7	11.5	8.0	7.9	14.5	8.8	10.0	10.9	0.6	16.4	10.0	11.8	7.4	7.7											29.8	24.1	29.2	23.8	18.9	50.3	40.9	17.8	34.8	39.8	15.7	37.3	143.2	34.9	32.0	69.5	28.1	4.2	0.0	36.3	31.1	30.4	19.4	18.6	11.6	38.5	49.3	18.7	20.9	11.1	43.0	47.5	25.5	35.4	34.3	18.7	36.3	29.4	14.0	47.7	38.9	5.8	58.2	26.4	104.2	59.8	19.6	70.6	22.5	24.7	15.2
ACBD7	"bA455B2.2, FLJ38219"	ENSG00000176244	"Acyl-CoA binding domain containing 7"	Q8N6N7	10	15077523-15088776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 35.3"	"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 4.1;Intestinal endocrine cells: 1.7;Late spermatids: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 24.2;MOLT-4: 20.4;U-266/84: 15.3;U-698: 17.6"	"Region enriched"	"Detected in many"	5	"olfactory region: 21.6"	"Low region specificity"	"Detected in all"			"HPA043326, HPA062478"			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043326: AB_2678429, HPA062478: AB_2684777"	"unprognostic (2.15e-1)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-3)"	"unprognostic (6.53e-3)"	"unprognostic (7.30e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.18e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.90e-2)"	1.1	1.1	25.0	1.5	27.1	3.9	8.3	12.9	35.3	1.1	1.4	9.3	0.0	2.5	1.4	2.7	1.7	4.4	1.7	1.2	25.3	9.8	1.4	1.7	1.4	2.1	15.0	16.2	1.7	1.5	1.5	0.7	1.3	14.0	1.5	1.6	0.0	4.7	1.4	2.0	3.0	1.9	1.3	6.6	1.6	1.8	5.9	11.7	2.9	4.2	0.0	1.7	1.4	0.5	1.7	1.5	3.8	0.6	2.1	1.1	0.2	2.5	0.6	9.8	4.7	0.6	0.4	1.2	0.7	0.6	1.8	3.0	2.8	3.0	2.3	3.4	2.3	2.5	0.6	5.8	1.8	2.6	5.1	8.0	2.4	0.7	1.5	0.1	0.4	1.0	0.1	0.1	0.6	0.1	2.6	2.4	24.2	1.9	2.8	1.9	7.8	20.4	2.2	4.9	0.6	1.7	11.0	3.5	5.3	1.2	1.0	8.1	4.9	2.5	5.6	1.1	3.9	8.0	0.6	0.7	0.4	5.4	1.0	2.1	7.7	15.3	17.6	1.6	0.4	0.7	3.8	0.6	0.8	1.1	0.6	0.9	1.3	0.6	0.6	0.3	1.7	1.1	1.1	3.7	2.1	0.5	1.5	0.5	0.2	25.0	27.1	12.9	21.8	25.3	9.8	15.0	16.2	14.0	11.7	0.0	1.1	0.0	0.1	0.1	0.1	0.0	0.0	2.7	0.0	0.0	2.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.0	0.1
ACCS	"ACS, PHACS"	ENSG00000110455	"1-aminocyclopropane-1-carboxylate synthase homolog (inactive)"	Q96QU6	11	44065925-44084222	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018873, HPA021654"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA018873: AB_1855273, HPA021654: AB_1855274"	"unprognostic (3.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.86e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (6.51e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.92e-2)"	10.6	17.0	6.2	34.7	5.3	10.3	11.1	4.5	6.0	10.0	8.0	6.9	15.5	5.9	14.8	29.9	6.5	15.7	18.8	5.8	4.9	2.5	10.2	17.7	32.5	7.5	6.7	4.2	11.6	13.1	4.0	16.1	2.8	7.0	10.9	8.0	10.7	10.3	14.4	4.7	7.8	9.7	9.5	6.1	14.6	9.7	10.2	5.2	6.1	12.7	4.3	7.1	10.5	8.3	2.7	6.9	8.1	4.8	1.4	2.2	2.7	4.4	9.8	0.0	1.1	2.7	4.8	0.0	2.3	3.0	2.1	2.3	0.8	6.2	1.6	1.8	5.1	0.0	7.4	2.6	0.5	1.2	0.5	2.8	6.8	3.2	0.1	5.0	0.0	0.0	5.4	9.3	2.7	1.2	3.0	3.9	0.0	5.3	0.0	6.4	3.2	0.0	2.6	3.8	5.5	1.4	6.0	0.0	0.0	5.4	2.8	1.3	4.0	2.3	1.3	2.7	2.6	9.7	4.2	4.2	2.4	2.7	4.0	1.2	0.0	0.0	0.2	6.1	0.0	2.6	1.3	4.3	8.1	1.3	4.8	1.3	2.0	1.3	2.2	6.9	2.7	1.9	1.1	0.1	1.4	3.9	5.1	1.9	2.7	6.2	5.3	4.5	6.0	4.9	2.5	6.7	4.2	7.0	5.2	11.9	24.3	1.9	2.5	2.4	2.1	2.2	2.5	2.7	10.3	8.7	0.0	2.2	0.0	2.2	1.7	5.3	5.9	0.0	3.8	0.4	3.3	2.4	9.2	6.7	5.1	0.0	6.9	8.6	7.3	1.9	8.9	6.1	0.0	7.2	8.3	2.9	2.5	8.2	7.1	5.9	0.9	0.0	2.8	0.7	1.7	1.9	1.6	3.8	7.0	1.3
ACCSL		ENSG00000205126	"1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like"	Q4AC99	11	44047981-44059977	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.6;testis: 2.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	22	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 4.1;U-266/70: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065042			Approved	Cytosol		NA	NA			Cytosol		"HPA065042: "					"unprognostic (2.37e-2)"				"unprognostic (2.91e-1)"				"unprognostic (9.76e-5)"	"unprognostic (7.42e-2)"				0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0			0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	2.0			0.0		0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 205.6"	"Group enriched"	"Detected in many"	25	"Early spermatids: 470.5;Late spermatids: 1015.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Group enriched"	"Detected in many"	23	"B-cells: 3.7;monocytes: 2.0;T-cells: 1.9"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 36.7;HUVEC TERT2: 18.7"									"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	92000000	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	6.8	2.0	0.5	2.4	4.2	0.0	2.9	0.5	1.1	5.3	83.2	0.7	37.7	46.4	4.5	5.1	1.7	1.5	4.4	4.7	0.6	0.7	2.6	1.4	16.3	2.2	0.4	0.7	1.4	3.0	3.6	3.6	3.6	0.8	3.4	1.4	1.7	2.5	20.1	3.6	1.3	205.6	2.4	0.6	1.4	1.9	32.6	1.3	0.5	6.9	3.1	2.2	1.7	1.6	3.7	0.1	0.0	2.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	1.5	36.7	0.4	1.3	2.7	0.0	0.0	0.5	3.2	0.7	1.1	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.7	3.5	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.6	18.7	0.0	3.1	0.0	0.0	0.6	0.0	0.8	0.3	6.3	0.4	0.1	0.2	0.5	0.0	0.0	4.6	3.2	0.0	0.0	0.0	0.7	1.6	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.9	3.7	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.5	4.2	0.5	1.1	0.6	0.7	0.4	0.7	0.8	1.3	0.0	3.5	0.0	1.5	1.3	3.1	1.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	3.4	470.5	13.5	29.6	0.0	0.4	0.1	1.0	6.0	6.9	0.0	4.4	0.0	17.3	2.5	18.5	1015.1	4.0	5.1	3.3	0.0	8.7	1.9	0.7	10.2	2.5	10.7	1.0	0.0	0.9	8.1	3.4	0.1	0.1	0.9	8.6	2.1
ACHE	YT	ENSG00000087085	"Acetylcholinesterase (Cartwright blood group)"	P22303	7	100889994-100896974	"Blood group antigen proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter degradation"	"Blood group antigen, Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 43.8;skeletal muscle: 98.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 45.5;Erythroid cells: 46.7;Exocrine glandular cells: 34.7;Horizontal cells: 52.4;Paneth cells: 52.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.2;CACO-2: 12.9;K-562: 15.2;Karpas-707: 25.2;U-2 OS: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027098			Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		650000	"Golgi apparatus"	Vesicles	"HPA027098: AB_2672111"	"unprognostic (2.23e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.80e-3)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.88e-5)"	"unprognostic (2.95e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.38e-2)"	1.4	4.8	5.8	3.5	16.1	10.3	1.4	22.8	11.8	1.4	4.2	2.7	1.4	5.7	1.9	2.6	2.8	1.8	3.1	4.5	5.5	43.8	1.4	1.8	1.8	5.9	22.2	4.8	1.7	1.6	7.0	3.2	2.0	37.9	3.3	3.4	4.6	6.5	3.3	98.2	1.4	7.9	1.9	8.7	2.3	2.1	1.9	2.6	3.5	1.6	15.9	3.2	2.1	1.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.2	0.5	0.0	8.2	0.3	0.0	0.1	0.2	12.9	0.3	0.0	0.5	0.0	1.2	0.4	2.2	0.1	0.0	4.4	0.5	0.2	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.1	15.2	25.2	0.1	3.6	0.0	0.1	1.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	1.0	0.0	3.7	0.0	0.0	0.1	0.7	6.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	16.1	22.8	11.8	5.5	43.8	22.2	4.8	37.9	2.6	0.0	0.0	0.0	21.7	0.7	7.2	4.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	6.2	0.0	2.3	45.5	46.7	34.7	1.9	4.2	17.2	0.0	0.0	0.7	52.4	3.4	1.3	0.0	0.0	0.6	0.0	1.7	8.2	7.6	11.9	30.0	52.6	0.7	1.0	4.3	0.0	3.3	3.9	4.5	0.9	5.9	0.0	3.3	11.2
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 96.2;salivary gland: 74.8"	"Group enriched"	"Detected in many"	10	"Cytotrophoblasts: 26.5;Extravillous trophoblasts: 87.8;Syncytiotrophoblasts: 61.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 7.3;NK-cell: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.3;NK-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 32.2;HEL: 10.3;SK-BR-3: 17.2;U-937: 6.5"	"Group enriched"	"Detected in many"	9	"amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6"	"Not detected"	"Not detected"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"HPA013819: AB_1846126, HPA073493: AB_2686610"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	10.4	0.9	0.4	0.7	0.5	0.4	5.3	0.2	0.4	2.9	1.8	0.1	0.6	0.7	2.0	5.2	2.5	2.4	1.2	1.0	0.5	0.4	1.1	14.5	1.5	1.0	0.5	0.2	0.9	0.7	0.3	0.6	96.2	0.2	1.1	2.0	0.3	74.8	0.4	2.1	2.5	1.0	3.2	0.7	1.1	0.9	1.5	0.1	0.4	3.8	2.3	2.0	3.2	4.1	0.8	0.4	7.3	0.6	2.2	0.4	0.3	0.1	0.0	0.1	0.2	1.5	0.1	32.2	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	10.3	0.2	1.8	0.0	0.1	1.2	0.3	0.3	0.0	0.0	0.0	0.0	0.3	1.3	0.2	0.2	0.2	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.4	4.5	0.1	0.1	0.8	17.2	0.0	1.9	1.7	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	6.5	0.1	0.7	0.2	7.3	0.4	0.5	0.1	0.2	0.1	0.2	0.4	0.8	0.3	0.3	1.0	2.2	0.6	0.3	0.1	0.3	0.4	0.5	0.2	0.4	0.5	0.4	0.5	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.6	2.5	1.4	0.0	0.0	2.0	26.5	1.7	0.0	1.9	1.4	2.0	0.0	0.0	87.8	1.8	0.4	2.3	5.8	4.6	1.6	1.7	3.7	0.3	1.1	0.3	0.2	0.0	0.0	0.1	2.5	0.6	0.0	1.1	0.3	0.9	0.0	0.0	4.5	3.3	0.0	61.6	0.5	0.4	0.1
ACKR3	"CMKOR1, CXCR7, GPR159, RDC1"	ENSG00000144476	"Atypical chemokine receptor 3"	P25106	2	236567787-236582358	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 19.6;Club cells: 21.6;Endothelial cells: 44.5;Fibroblasts: 27.8;Ito cells: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 6.1;T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 23.4;MCF7: 17.2;RT4: 68.3;SiHa: 20.9;U-2197: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032003, HPA049718"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA032003: AB_2674107, HPA049718: AB_2680859"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-3)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (9.71e-2)"	"unprognostic (8.57e-3)"	"prognostic unfavorable (2.93e-4)"	56.1	2.9	5.4	6.9	5.6	1.7	28.5	2.2	6.4	10.7	15.2	8.9	9.1	5.7	9.9	20.4	23.6	14.6	15.3	30.2	8.4	3.0	3.8	29.6	10.9	7.2	3.8	6.5	19.3	25.7	2.2	10.7	59.6	8.4	14.2	12.8	25.2	8.9	8.9	36.4	16.0	15.7	32.6	7.2	70.9	12.6	9.4	5.5	0.2	34.3	22.3	8.6	59.2	17.8	1.0	0.2	0.1	0.5	6.1	6.1	0.6	0.0	0.0	1.4	0.0	2.4	0.0	10.0	0.5	0.3	0.5	1.0	0.1	0.0	0.0	1.1	0.0	3.8	14.7	0.0	5.2	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.6	13.4	0.0	0.0	3.3	2.4	0.0	0.2	0.0	0.0	17.2	0.0	0.0	2.3	0.0	0.1	0.0	1.6	0.1	0.0	68.3	0.0	0.0	20.9	0.1	0.0	5.5	0.0	0.0	0.0	0.1	5.4	71.8	0.0	0.3	0.0	0.0	0.2	1.4	0.1	0.0	0.1	0.0	4.1	0.3	6.1	0.6	2.1	5.0	0.2	1.0	1.8	2.3	0.1	6.1	0.5	0.0	3.1	0.6	5.4	5.6	2.2	6.4	8.4	3.0	3.8	6.5	8.4	5.5	8.9	4.5	0.5	0.1	19.6	1.3	6.9	0.0	6.7	21.6	0.0	0.0	0.0	0.0	0.2	1.0	44.5	0.7	0.0	9.3	0.2	27.8	0.2	5.8	0.9	0.8	0.0	0.0	17.8	2.5	0.2	1.4	4.0	1.7	1.0	0.0	0.0	0.9	0.8	1.1	0.6	0.0	0.0	15.0	0.3	0.4	13.9	0.2	0.0	0.0	0.9
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 174.5;Proximal tubular cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		8000000	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	41.4	27.2	9.6	7.1	9.4	1.5	30.1	8.9	8.1	9.3	19.7	6.2	6.4	21.9	12.8	14.6	12.8	7.2	8.9	15.1	6.5	7.6	40.5	80.9	9.2	9.4	6.1	6.2	14.1	27.9	8.9	8.7	11.3	7.7	10.7	9.8	11.7	11.7	9.5	11.2	5.5	28.4	14.5	6.0	6.4	13.5	11.4	5.9	6.0	18.4	7.2	5.1	13.9	11.7	4.7	7.1	21.4	8.8	4.7	7.4	6.2	9.5	8.7	6.8	10.7	53.1	28.8	3.1	18.1	44.5	8.3	6.6	9.2	3.0	1.9	5.8	18.9	22.8	1.3	13.5	17.3	16.8	6.0	3.6	14.0	9.5	10.0	26.7	1.3	5.6	25.0	5.3	21.4	15.1	25.7	21.5	7.4	5.0	4.1	23.7	2.5	7.4	6.7	7.1	6.0	9.4	5.8	10.1	1.9	31.7	8.8	0.9	2.8	18.8	0.7	1.9	7.6	4.4	3.4	23.2	30.4	10.3	10.1	4.7	2.1	3.9	3.8	21.2	4.7	2.6	21.4	8.7	2.4	7.4	8.8	6.4	4.7	5.2	5.7	7.1	4.2	6.8	7.0	1.0	4.7	7.2	3.4	2.8	6.2	9.6	9.4	8.9	8.1	6.5	7.6	6.1	6.2	7.7	5.9	3.0	25.5	7.5	6.9	3.9	18.8	39.8	45.9	8.1	9.1	22.7	21.6	39.8	16.6	14.3	6.3	18.2	29.7	0.0	35.8	17.8	21.6	11.2	2.3	174.5	13.3	31.8	4.7	14.1	12.7	5.1	21.9	7.2	6.8	2.8	32.4	30.7	23.2	21.0	21.9	160.8	13.9	19.4	22.3	6.1	16.2	4.6	44.7	8.7	26.9	7.1
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41469125-41528989	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 121.0;skeletal muscle: 157.9"	"Cell type enhanced"	"Detected in all"	5	"Proximal tubular cells: 244.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		NA	NA		4000000	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	22.8	18.5	41.4	11.1	38.2	9.8	12.2	21.0	43.5	12.2	25.4	27.7	12.3	45.1	9.5	9.9	17.5	15.7	11.1	121.0	33.8	24.2	37.9	22.2	10.0	11.1	27.6	32.7	8.6	17.2	48.5	7.6	9.1	24.9	12.5	20.0	14.7	20.1	15.2	157.9	9.8	46.6	12.5	28.6	10.0	21.0	9.6	23.1	9.5	16.0	42.7	12.0	12.3	8.8	22.9	28.1	7.3	36.6	15.8	16.4	19.4	13.9	16.2	16.3	33.7	28.2	18.4	22.9	12.8	16.3	21.6	20.2	23.9	18.2	32.0	21.0	19.1	18.1	32.1	30.3	23.5	11.4	21.2	21.6	15.5	22.7	25.4	24.6	41.3	23.8	32.6	18.9	22.4	23.9	16.7	21.4	17.1	20.0	35.0	17.0	26.1	21.1	14.0	11.1	79.8	32.6	28.6	11.2	44.4	27.9	27.7	11.7	10.0	31.6	37.3	23.8	14.0	21.7	22.1	15.2	18.5	20.7	16.8	14.0	20.8	25.8	22.4	29.9	18.1	19.9	4.5	21.1	7.3	14.7	31.3	14.0	22.9	12.5	15.8	28.1	20.2	14.2	14.6	5.3	15.8	36.6	11.2	16.4	19.4	41.4	38.2	21.0	43.5	33.8	24.2	27.6	32.7	24.9	23.1	23.8	35.1	48.4	42.0	16.7	52.7	8.1	53.5	38.8	18.2	57.6	76.6	84.6	111.0	47.3	10.7	21.1	193.9	23.3	37.3	50.2	22.9	31.1	40.3	50.4	81.0	50.9	51.1	16.5	27.5	6.8	22.5	35.7	33.7	87.4	92.9	56.0	39.9	87.7	26.2	244.6	62.4	58.2	31.1	23.6	36.4	14.1	161.6	34.6	88.8	55.9
ACOT1	"ACH2, CTE-1, LACH2"	ENSG00000184227	"Acyl-CoA thioesterase 1"	Q86TX2	14	73537114-73543794	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.6"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.2;T-47d: 25.1"									HPA043705	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626"	"unprognostic (4.74e-3)"	"unprognostic (3.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.16e-1)"	"prognostic favorable (5.09e-8)"	"unprognostic (1.35e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	8.5	7.2	5.1	3.7	3.9	1.0	13.7	2.0	7.7	3.0	5.8	4.1	0.9	5.3	6.8	8.8	2.7	3.4	1.8	11.3	4.3	3.6	16.4	27.6	9.0	0.9	3.2	6.0	4.5	1.4	2.9	0.9	4.1	5.6	5.5	3.4	2.4	2.7	6.1	10.7	3.8	12.9	13.0	1.9	1.0	3.4	2.7	2.4	0.9	1.8	5.0	1.9	5.6	1.7	3.8	5.7	1.0	1.7	4.2	6.3	3.1	4.2	5.0	1.9	0.1	9.9	6.1	0.1	1.3	5.4	4.5	8.2	1.9	2.1	0.0	0.0	3.6	0.0	2.5	0.0	0.9	2.2	2.3	1.6	2.7	1.2	18.2	9.6	0.1	3.0	7.9	0.4	3.6	0.0	0.1	2.0	0.0	0.0	0.0	3.5	1.6	0.3	0.5	1.9	0.6	1.9	5.1	3.9	0.1	4.4	4.7	2.3	3.8	4.2	12.4	6.8	0.4	25.1	6.2	2.2	2.5	3.2	2.3	0.0	0.0	0.0	1.3	3.6	0.0	4.0	0.1	1.3	1.0	6.0	1.7	4.9	3.8	5.5	4.7	5.7	2.6	4.8	5.3	0.2	4.2	1.5	3.2	6.3	3.1	5.1	3.9	2.0	7.7	4.3	3.6	3.2	6.0	5.6	2.4	0.0	2.7	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.0	0.0	0.0	7.2	0.2	0.3	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.4	0.8	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81330005-81394179	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 49.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 37.1"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037723, HPA037724"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037723: AB_10672606, HPA037724: AB_2675631"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.2	49.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.5	0.1	0.0	0.1	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.4	0.0	0.0	0.6	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.7"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 754.9;Proximal tubular cells: 372.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019881, HPA057134"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA019881: AB_1857978, HPA057134: "	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	10.0	9.7	13.5	7.0	14.5	4.7	7.9	8.2	13.1	5.8	12.8	5.6	5.9	9.4	5.2	6.2	5.4	5.9	9.9	24.2	11.1	11.6	26.3	41.7	7.0	7.1	13.8	10.6	6.4	9.7	8.9	12.2	6.3	12.3	9.8	11.0	4.0	7.4	6.4	15.7	8.2	8.6	5.5	10.1	6.8	8.1	19.8	8.8	10.5	8.7	8.5	5.2	6.9	4.7	12.8	8.7	11.5	10.5	7.8	12.0	8.8	4.3	5.6	5.7	10.3	8.2	10.3	3.2	3.6	4.3	2.6	4.2	7.5	5.6	8.1	12.3	4.1	14.0	4.8	5.0	7.3	4.1	12.7	4.6	7.6	5.8	5.2	4.1	4.8	3.5	5.9	7.2	3.5	7.0	6.5	6.2	8.4	12.1	4.3	5.2	4.5	8.7	9.4	3.9	8.6	4.5	7.5	5.1	10.2	8.8	4.1	11.5	4.0	4.2	14.4	10.1	7.0	9.9	4.0	7.2	4.8	2.7	1.3	3.4	8.2	20.8	8.2	5.0	17.6	14.3	6.9	10.2	6.4	8.8	10.5	12.0	12.8	9.9	10.0	8.7	8.7	11.7	10.2	11.5	7.8	9.9	7.0	9.5	8.8	13.5	14.5	8.2	13.1	11.1	11.6	13.8	10.6	12.3	8.8	62.5	32.4	18.2	21.9	15.2	15.6	80.7	43.3	40.2	25.0	29.6	15.7	46.4	134.3	36.6	754.9	21.5	50.1	0.0	35.3	23.9	19.9	21.9	13.9	199.8	79.5	4.8	52.6	21.5	21.2	100.1	18.1	27.8	25.3	112.8	85.9	34.6	30.9	101.7	22.6	372.2	30.4	25.8	15.5	41.9	20.4	20.6	33.4	16.2	62.8	21.7
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 60.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	41.4	16.5	5.9	6.4	5.3	2.7	13.4	3.3	8.7	7.8	11.9	4.6	4.0	12.8	13.9	10.6	9.4	8.3	8.8	35.1	4.5	4.0	25.0	60.5	6.2	4.4	4.3	5.4	6.2	8.1	6.4	2.7	7.9	4.3	8.5	6.2	6.9	7.3	6.8	50.7	3.9	12.0	16.3	3.2	4.3	7.4	5.7	3.7	5.3	7.4	11.6	3.9	11.3	4.6	9.7	13.8	1.8	4.4	9.0	19.0	8.1	11.2	11.0	2.3	9.7	10.3	4.0	0.4	6.0	14.0	9.8	13.0	7.8	7.5	0.0	4.4	3.2	5.1	6.2	0.0	0.6	5.2	14.2	13.9	6.8	4.5	26.8	6.7	0.0	19.3	9.1	0.0	3.7	0.0	9.6	4.2	0.0	0.0	0.0	8.4	4.7	1.0	7.7	3.3	1.3	16.7	16.1	9.8	0.1	3.6	4.7	10.1	12.2	14.8	11.5	12.0	1.1	27.6	5.4	7.6	8.6	21.6	5.5	5.7	0.0	0.0	4.0	7.2	0.0	8.1	1.5	3.7	1.8	14.6	4.4	10.7	9.7	13.7	11.1	13.8	7.9	12.4	13.5	0.1	9.0	3.9	8.5	19.0	8.1	5.9	5.3	3.3	8.7	4.5	4.0	4.3	5.4	4.3	3.7	0.0	5.4	1.7	1.0	1.4	0.9	43.0	7.6	4.0	1.2	7.0	9.8	4.6	11.6	18.3	1.0	3.6	16.2	0.0	29.2	2.3	3.9	0.3	13.8	25.8	13.9	1.6	15.1	3.7	4.0	0.4	5.5	2.0	5.0	30.7	15.1	3.3	19.0	5.8	7.8	16.5	4.5	6.5	4.2	0.4	4.3	0.4	6.9	5.7	19.7	0.4
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6394391	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Cell type enhanced"	"Detected in many"	8	"granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 20.5;plasmacytoid DC: 19.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		29000	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	4.7	13.3	25.8	10.8	29.8	7.7	3.9	23.9	50.0	4.4	18.3	11.3	0.5	33.2	5.1	3.8	14.3	4.4	5.3	6.3	27.8	43.9	29.4	9.1	8.6	12.3	36.0	20.7	5.3	4.0	1.9	18.5	7.4	49.9	5.6	13.5	6.6	4.1	4.9	1.5	9.4	33.2	14.3	14.2	8.9	6.2	13.1	6.9	9.0	2.3	6.5	11.6	9.1	6.6	1.0	19.4	0.4	0.6	20.5	4.4	2.8	23.7	20.7	20.4	22.0	4.7	7.8	7.7	20.5	10.6	30.4	18.2	71.4	7.7	29.1	15.1	16.6	23.5	23.5	32.9	54.7	11.4	25.5	28.7	15.3	16.4	25.3	19.3	17.9	12.7	6.9	10.5	25.1	29.8	8.1	17.0	36.5	12.4	6.3	16.0	27.7	37.3	19.0	10.2	23.9	48.0	44.6	23.5	19.7	17.1	9.1	11.2	31.7	18.4	28.3	65.2	10.5	10.1	8.4	27.5	27.7	16.2	27.4	32.3	5.3	21.6	40.9	17.5	31.3	16.8	0.0	0.1	0.1	4.1	0.6	1.0	1.0	3.4	3.6	2.9	0.4	1.2	2.3	0.4	20.5	0.5	19.4	4.4	2.8	25.8	29.8	23.9	50.0	27.8	43.9	36.0	20.7	49.9	6.9	6.0	25.5	13.7	13.3	28.2	33.6	8.1	12.7	1.4	7.9	8.7	9.8	15.1	13.3	19.1	73.6	15.6	70.9	0.0	6.2	23.1	14.2	7.0	137.0	13.4	26.8	44.5	4.6	5.5	4.0	118.5	3.4	16.9	37.1	25.2	88.8	10.6	16.5	29.1	6.7	214.2	15.6	0.0	6.2	38.2	26.7	25.7	14.4	21.4	48.7	19.5
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857406	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	7.0	22.6	23.5	10.9	24.3	16.5	8.7	14.4	32.6	6.8	17.1	13.5	9.9	23.3	6.5	13.1	15.8	12.2	10.1	27.0	22.8	19.3	15.3	19.0	9.7	12.1	22.1	19.0	8.3	17.4	5.9	11.4	8.1	19.5	9.6	14.3	10.4	14.4	7.3	21.7	16.7	22.2	7.3	14.6	9.1	16.7	12.8	11.1	17.1	12.4	8.6	12.2	10.9	7.2	20.5	27.0	31.0	26.2	11.2	22.5	18.8	7.7	9.3	3.2	6.4	9.0	5.5	5.6	5.3	4.3	7.4	6.9	13.6	10.8	9.7	23.9	7.2	17.1	15.2	6.1	13.1	2.5	7.2	10.7	9.7	12.5	13.0	8.1	9.3	9.1	6.4	10.1	7.1	5.1	11.0	4.5	11.4	8.6	12.1	5.2	21.8	13.2	12.1	5.6	15.2	24.9	6.4	5.9	17.4	7.8	8.8	11.0	5.2	11.6	29.8	18.1	5.2	16.4	22.8	5.2	18.3	4.1	9.4	8.7	10.3	15.2	6.1	22.7	9.8	9.7	20.0	26.2	31.0	18.8	25.0	17.1	20.5	18.1	17.0	27.0	19.3	16.1	17.3	18.7	11.2	23.4	17.0	22.5	18.8	23.5	24.3	14.4	32.6	22.8	19.3	22.1	19.0	19.5	11.1	32.8	13.1	13.4	10.4	5.5	17.5	9.4	10.2	17.4	9.1	12.2	15.7	27.1	54.7	19.6	30.4	8.2	74.4	0.0	18.1	16.7	7.2	11.9	13.9	22.2	24.7	7.9	18.5	11.6	16.5	58.7	9.2	13.0	10.1	26.2	34.3	15.2	19.9	59.6	8.1	57.5	19.5	12.9	8.5	25.9	8.7	6.9	16.2	14.6	27.0	11.6
ACOT9	"ACATE2, CGI-16, MT-ACT48"	ENSG00000123130	"Acyl-CoA thioesterase 9"	Q9Y305	X	23702253-23766475	"Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 296.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA035533	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035533: AB_10696506"	"unprognostic (5.69e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	19.1	15.9	6.3	14.1	7.7	10.5	29.2	6.5	13.6	15.4	16.3	5.4	17.6	11.5	21.2	16.1	12.0	14.5	15.5	35.7	5.7	7.7	12.8	15.5	23.6	36.0	7.3	8.6	13.4	16.6	9.1	7.8	13.3	12.7	12.8	12.7	13.9	16.3	23.0	28.8	10.4	12.5	35.7	13.8	15.8	15.0	7.1	4.5	3.8	15.1	11.4	9.7	15.9	14.4	5.5	16.4	11.1	26.5	6.0	10.0	8.4	26.1	17.9	7.8	17.1	12.8	14.7	3.9	20.8	18.0	20.6	20.0	15.8	23.7	1.3	13.3	23.1	27.8	16.0	9.8	26.4	28.7	6.1	14.9	8.9	18.7	11.4	17.3	3.4	11.3	12.9	18.1	24.1	27.5	13.5	30.1	0.2	5.6	9.0	22.2	9.1	4.8	8.4	11.3	10.3	21.8	5.1	29.7	11.1	24.4	9.7	1.5	7.5	22.6	9.5	13.3	30.2	10.7	4.6	27.9	17.2	11.4	24.9	11.3	2.2	5.1	0.1	12.7	3.4	14.5	9.1	16.1	11.1	5.6	22.2	7.6	5.5	7.0	6.3	16.4	4.6	2.3	5.3	8.4	6.0	26.5	2.8	10.0	8.4	6.3	7.7	6.5	13.6	5.7	7.7	7.3	8.6	12.7	4.5	44.7	33.0	11.4	38.4	17.9	4.3	37.2	15.3	28.1	35.2	15.7	23.6	3.6	5.0	60.6	0.7	35.1	10.5	0.0	45.6	9.3	28.3	31.5	35.9	11.3	39.9	4.8	2.4	35.6	33.3	0.0	16.7	63.3	32.1	296.6	8.7	10.0	62.9	11.8	24.1	25.0	9.3	25.8	20.3	1.8	9.6	9.4	2.5	22.3	9.4	32.8
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 185.5;Hepatocytes: 244.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 35.3;RT4: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		NA	NA		160000	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.4	7.7	2.5	3.8	13.3	5.6	35.3	4.0	4.0	4.8	5.5	5.4	9.0	3.1	4.3	6.8	4.5	3.3	10.7	4.2	7.6	2.8	3.2	4.0	4.4	17.7	7.2	3.4	2.6	9.3	3.3	5.4	3.6	5.1	12.0	4.3	4.1	3.1	5.3	16.1	7.6	2.5	1.9	13.5	6.7	4.2	7.7	3.6	8.1	47.5	3.1	4.6	11.4	17.8	3.8	8.7	10.9	3.9	7.9	6.7	4.9	5.4	3.8	5.1	3.5	1.2	3.9	3.2	3.9	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3	26.8	20.6	3.0	13.1	11.9	23.8	38.6	48.4	14.7	18.2	22.7	21.6	32.5	18.3	19.8	8.4	14.6	185.5	23.3	35.6	39.3	17.0	27.2	16.2	244.8	23.1	17.5	33.1	22.1	31.8	6.5	27.6	19.9	13.5	25.2	35.0	64.2	31.5	87.7	44.2	74.6	28.4	0.0	16.4	5.6	10.7	26.5	36.2	10.2	32.4	22.6
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537319	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 70.5"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 75.4;Proximal tubular cells: 33.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;ASC TERT1: 20.7;fHDF/TERT166: 6.7;Hep G2: 8.0;HSkMC: 13.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		190000	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	4.0	5.3	1.9	3.8	2.5	0.1	3.4	1.6	2.1	4.4	10.2	2.7	9.5	10.0	9.0	6.2	3.8	4.4	4.8	8.8	2.4	1.4	17.1	70.5	2.8	0.7	2.0	1.7	5.1	2.9	3.8	3.0	1.4	4.0	7.2	3.4	11.4	3.0	5.9	4.2	1.7	13.7	10.6	2.5	0.9	2.6	4.0	2.0	1.0	7.7	2.7	1.6	5.4	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.5	20.7	3.6	2.3	0.2	0.0	0.3	0.6	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	1.8	0.0	0.0	13.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	1.6	2.1	2.4	1.4	2.0	1.7	4.0	2.0	3.0	4.3	0.5	7.2	0.6	0.2	14.4	0.0	0.0	1.2	3.5	0.0	0.6	13.3	0.3	0.1	1.1	5.4	0.0	1.7	0.2	5.0	0.8	1.1	75.4	5.3	1.6	2.9	4.3	2.2	1.4	10.0	0.8	0.0	0.0	4.7	10.0	0.5	0.0	8.1	33.8	0.8	6.5	3.4	0.2	0.5	0.3	0.7	0.0	3.6	0.8
ACOX3		ENSG00000087008	"Acyl-CoA oxidase 3, pristanoyl"	O15254	4	8366282-8440723	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Syncytiotrophoblasts: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035840, HPA035841"	Uncertain		Approved	Peroxisomes		NA	NA			Peroxisomes		"HPA035840: AB_10696514, HPA035841: AB_10671940"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	9.6	12.0	9.9	7.4	10.9	5.0	15.5	11.7	12.8	12.2	9.9	11.5	11.2	10.8	10.7	12.3	32.0	9.2	7.4	20.6	9.0	6.7	8.3	18.0	8.9	7.4	10.3	8.4	9.8	15.4	10.0	14.8	28.9	10.2	13.4	8.0	12.0	19.1	11.2	8.2	14.8	10.5	18.6	7.2	7.6	12.7	5.0	11.6	9.0	11.5	7.4	14.2	14.8	16.0	4.6	16.8	2.6	12.0	7.3	8.0	6.9	6.3	6.9	7.8	10.3	8.4	14.3	12.7	8.0	11.1	13.8	12.0	3.4	8.5	8.5	8.7	16.4	18.6	3.9	3.3	10.4	10.7	2.9	3.3	3.7	5.8	10.5	13.9	7.4	7.0	14.3	9.0	12.3	4.8	9.9	16.2	9.5	4.9	7.8	11.8	5.8	7.9	11.0	4.3	8.1	12.0	8.4	12.8	10.1	8.4	8.9	3.8	8.7	10.3	5.3	5.3	6.7	5.3	10.7	15.6	13.6	4.4	5.5	8.4	5.9	3.9	3.8	17.3	9.4	8.6	0.0	10.6	2.6	5.2	12.0	5.4	4.6	6.1	6.6	14.0	4.5	5.6	5.8	2.5	7.3	10.6	16.8	8.0	6.9	9.9	10.9	11.7	12.8	9.0	6.7	10.3	8.4	10.2	11.6	6.0	5.1	6.4	6.8	3.9	8.6	8.5	7.6	4.0	4.5	10.4	31.4	19.8	3.3	13.9	2.2	3.9	11.8	0.0	11.9	8.2	5.8	7.8	0.0	9.9	8.9	1.6	1.7	5.5	3.2	2.1	6.4	4.2	5.0	8.2	4.9	4.1	15.1	9.9	10.6	5.1	15.8	0.0	6.2	1.2	1.9	5.1	62.4	5.0	6.7	10.0
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732573-111118222	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 29.7;lung: 20.8;placenta: 23.8"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 27.4"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA035392: AB_2674604, HPA035393: AB_2674605"	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.48e-4)"	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0.0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1.0	0.6	4.1	1.1	0.7	0.6	0.3	9.1	0.0	0.2	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.2	0.2	0.1	0.2	1.0	0.0	0.0	0.0	0.2	3.2	0.2	0.4	0.2	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.3	0.0	0.4	1.4	1.4	0.1	3.3	0.7	0.4	3.1	0.1	0.4	0.1	0.2	16.5	0.0	21.3	2.0	0.4	0.1	0.4	0.1	0.7	0.2	1.0	0.3	0.2	0.4	0.2	0.1	14.4	3.7	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1.0	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0.0	27.4	0.0	0.2	0.2	0.6	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.1	0.0	1.2	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.3	0.9	2.2	0.3	0.0	0.0	0.0	0.7
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 913.9;Late spermatids: 1666.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		3700000	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	22.3	59.7	38.0	20.8	40.3	38.0	33.0	27.9	43.7	23.1	29.7	27.4	24.4	31.1	25.2	36.2	24.8	29.5	26.9	27.4	34.6	33.7	42.1	54.8	24.7	29.4	31.5	34.6	33.7	53.0	28.4	43.9	39.7	39.7	27.0	32.8	28.5	46.0	23.8	35.4	21.6	34.5	24.2	28.6	28.1	34.2	38.3	21.2	33.0	32.5	32.8	29.8	22.7	20.3	33.9	20.3	17.3	23.0	35.3	41.0	33.1	17.8	26.6	41.5	22.8	18.8	18.8	33.7	21.7	23.1	21.7	19.2	36.5	18.0	11.2	16.9	20.3	28.5	17.5	40.3	23.6	19.6	27.3	41.0	32.8	24.1	79.8	26.1	37.2	18.9	19.2	21.5	20.3	25.2	23.0	24.6	42.0	33.1	21.9	25.6	24.2	40.0	36.0	50.1	47.2	30.0	26.6	42.1	25.6	33.9	25.5	45.3	44.8	13.5	32.0	43.4	28.3	18.9	19.9	20.3	23.9	15.9	19.7	32.7	29.8	59.1	34.9	28.3	32.2	28.1	17.3	19.8	17.1	30.1	22.7	39.7	33.9	34.3	34.4	17.7	31.1	41.0	39.7	3.5	35.3	23.0	20.3	35.6	33.1	38.0	40.3	27.9	43.7	34.6	33.7	31.5	34.6	39.7	21.2	41.7	88.5	101.3	80.3	70.3	51.3	74.2	109.5	129.8	67.1	64.6	7.9	179.7	228.8	194.3	913.9	64.7	84.9	163.5	146.5	234.8	71.9	111.0	68.2	112.0	123.7	27.0	79.2	50.3	57.7	1666.6	87.5	74.7	77.6	116.4	107.9	64.8	155.5	108.7	86.7	241.7	43.6	90.5	79.3	111.8	121.7	79.7	157.0	93.8	114.3	108.3
ACRBP	"CT23, OY-TES-1, SP32"	ENSG00000111644	"Acrosin binding protein"	Q8NEB7	12	6638075-6647460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 170.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 884.1;Late spermatids: 605.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 11.0;monocytes: 17.6"	"Cell line enhanced"	"Detected in some"		"HEL: 5.5;HMC-1: 7.3;U-266/70: 16.3;U-266/84: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039081, HPA039082"	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA039081: AB_10670920, HPA039082: AB_10671036"	"unprognostic (7.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-4)"	0.8	0.4	0.3	0.9	0.8	2.5	0.5	1.3	0.6	0.4	1.6	0.6	0.5	2.2	0.4	4.2	0.5	0.6	1.7	1.0	0.6	0.3	0.9	0.7	0.8	3.6	0.4	0.3	0.4	1.5	0.0	0.5	0.4	0.8	0.7	0.4	0.8	0.5	0.1	0.3	0.4	3.3	0.6	0.6	2.3	0.6	170.4	0.3	0.5	3.9	0.3	0.8	0.7	0.5	1.2	11.0	1.6	17.6	0.3	0.1	6.5	0.2	0.1	0.9	2.7	1.0	1.3	1.4	0.0	0.0	0.1	0.1	0.0	1.9	0.3	0.9	0.2	0.1	0.0	0.5	0.0	0.2	0.6	0.0	5.5	0.6	0.0	2.1	0.1	7.3	0.1	3.7	1.0	0.1	0.7	0.6	1.9	3.6	0.0	0.1	0.4	0.2	1.9	1.7	4.5	0.0	0.3	0.1	0.3	0.6	0.1	1.1	0.2	0.0	0.7	1.2	1.4	0.0	2.0	0.8	0.1	0.8	0.6	0.0	16.3	10.7	0.5	0.6	2.0	0.0	0.9	7.7	0.7	0.1	9.8	0.0	0.8	0.0	0.0	11.0	1.2	0.1	0.1	1.6	0.3	17.6	2.8	0.0	6.5	0.3	0.8	1.3	0.6	0.6	0.3	0.4	0.3	0.8	0.3	0.0	2.2	0.0	0.2	0.1	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	884.1	0.5	1.2	0.0	0.4	0.2	0.4	0.0	5.8	0.0	9.0	0.0	0.0	2.5	11.7	605.9	7.5	3.9	0.0	0.0	0.9	1.0	0.2	0.9	4.2	0.8	1.5	6.5	0.1	127.7	7.2	0.0	0.1	0.0	0.9	0.1
ACSBG1	"BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352"	ENSG00000103740	"Acyl-CoA synthetase bubblegum family member 1"	Q96GR2	15	78167468-78245688	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 11.4;brain: 40.5;skin 1: 19.9"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 26.8;Spermatogonia: 7.7"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.1;SK-MEL-30: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041642, CAB045955, HPA058869"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.42e-2)"	1.1	11.4	16.9	1.5	26.9	4.5	3.8	6.6	27.0	1.1	1.2	10.5	0.0	1.6	1.2	2.3	1.3	5.9	1.3	1.1	16.4	8.5	1.0	1.0	1.7	1.6	21.1	13.9	1.2	1.0	0.9	0.3	1.1	32.9	2.0	1.1	0.0	1.5	1.4	1.2	19.9	1.5	1.2	40.5	1.3	1.2	5.4	19.0	0.0	1.2	0.0	1.1	1.5	0.2	0.4	3.9	1.2	0.2	0.6	0.2	1.5	0.8	0.1	1.6	2.4	0.0	0.0	0.6	0.5	0.0	0.5	0.1	0.5	0.6	0.8	0.2	0.1	0.6	0.9	0.1	0.3	0.2	0.4	1.4	0.7	1.4	0.7	0.0	0.7	1.6	0.6	0.0	0.4	0.2	0.5	0.2	1.0	0.5	1.1	0.1	0.4	0.6	1.4	8.1	0.7	0.3	0.3	1.0	0.5	0.0	1.0	0.6	0.9	0.4	1.0	3.8	1.0	0.5	0.5	1.0	0.6	0.6	0.5	0.3	0.9	0.3	0.9	0.3	0.6	1.6	0.4	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.4	0.2	0.1	1.2	0.6	0.2	3.9	0.0	1.5	16.9	26.9	6.6	17.9	16.4	8.5	21.1	13.9	32.9	19.0	0.0	1.3	0.0	0.3	1.0	2.1	2.0	0.0	26.8	4.5	0.0	3.9	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.9	0.9	7.7	0.5	0.3	0.0	0.0	0.3
ACSL3	"ACS3, FACL3, PRO2194"	ENSG00000123983	"Acyl-CoA synthetase long chain family member 3"	O95573	2	222860934-222944639	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 206.1"	"Cell type enhanced"	"Detected in all"	9	"Horizontal cells: 494.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 94.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011315, HPA071021"	Approved		Approved	"Nucleoli,Nucleoli rim,Lipid droplets"		NA	NA			"Nucleoli, Nucleoli rim"	"Lipid droplets"	"HPA011315: AB_1848344, HPA071021: AB_2686335"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.35e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.75e-4)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (3.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.60e-1)"	14.7	17.0	22.8	9.9	26.0	16.3	51.5	19.4	45.9	15.3	16.5	16.1	11.6	12.7	10.9	18.4	28.3	9.0	11.8	22.7	20.9	22.8	17.9	22.3	15.6	10.5	19.6	21.2	11.7	10.3	206.1	8.8	19.1	24.4	44.4	16.7	14.4	34.2	15.5	19.1	11.4	12.7	12.2	22.2	9.7	28.3	13.7	14.2	13.5	17.3	11.2	8.7	14.6	15.4	15.0	22.5	21.8	16.8	16.6	20.1	16.5	10.1	17.9	27.4	29.8	12.0	29.8	7.6	12.9	33.6	15.5	32.7	16.1	26.1	4.8	7.5	12.3	33.5	29.9	5.9	28.7	20.1	8.7	11.2	11.4	14.5	17.9	26.5	7.5	5.6	15.3	40.8	25.6	44.7	11.9	16.8	8.5	21.5	18.6	21.8	21.5	14.6	8.8	13.9	23.0	9.3	8.0	23.2	8.2	22.3	41.6	14.5	10.7	7.6	20.6	94.2	22.1	10.3	18.4	11.6	10.4	16.6	8.9	9.4	6.6	3.2	16.8	11.1	7.1	31.4	16.6	14.6	21.8	20.1	16.8	19.3	11.6	12.8	14.6	15.7	15.0	18.7	16.7	21.8	16.6	15.9	22.5	9.5	16.5	22.8	26.0	19.4	45.9	20.9	22.8	19.6	21.2	24.4	14.2	32.8	58.5	16.4	65.8	41.3	91.7	51.2	40.8	37.5	44.3	34.9	72.6	32.9	6.6	28.6	31.0	38.3	33.1	23.3	27.3	8.4	36.3	113.5	26.5	47.9	33.5	494.2	20.1	36.2	50.2	18.9	24.2	42.9	45.5	32.5	32.3	205.8	32.5	38.6	33.6	12.5	51.8	45.3	51.8	50.2	49.9	42.7	50.7	27.7	46.5	102.1
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Alveolar cells type 2: 210.9;granulocytes: 598.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 81.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		100000	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	29.5	31.1	16.3	25.5	18.0	9.2	30.0	13.9	22.8	34.7	10.5	8.8	4.6	10.0	13.7	11.7	11.2	10.7	20.1	20.3	27.6	20.3	31.2	9.6	27.8	29.6	15.2	19.0	13.1	8.8	16.7	12.9	33.9	21.1	9.7	9.7	8.0	10.7	11.0	42.5	9.1	9.0	15.8	24.6	17.0	12.9	17.7	9.7	9.5	12.8	8.5	11.9	19.5	21.0	2.2	6.5	20.3	10.9	2.2	4.0	3.8	13.9	4.5	5.6	6.0	21.1	13.2	4.4	20.5	22.7	20.0	20.9	4.4	9.7	10.0	8.0	14.8	24.6	4.0	4.8	19.7	31.6	3.5	5.0	39.4	6.4	46.6	9.7	9.3	81.7	11.4	7.7	22.8	16.7	11.6	15.0	6.4	1.1	12.3	22.9	0.9	8.1	12.3	7.0	3.1	8.2	5.9	10.3	8.2	28.7	4.5	3.7	2.8	24.5	0.0	12.6	11.5	0.3	10.0	27.7	18.3	5.2	28.9	18.8	6.1	7.0	9.4	32.3	20.9	11.6	15.5	7.0	20.3	2.8	9.8	2.0	2.2	2.5	2.2	6.5	2.2	2.0	2.4	19.8	2.2	10.9	2.6	4.0	3.8	16.3	18.0	13.9	22.6	27.6	20.3	15.2	19.0	21.1	9.7	71.5	210.9	20.6	16.2	19.8	34.7	32.3	10.2	17.4	64.8	69.8	2.0	5.7	43.1	24.1	1.2	28.6	0.7	23.3	22.2	29.6	17.9	10.6	598.2	1.7	22.2	6.4	7.5	17.8	68.3	2.0	5.2	45.1	15.1	64.9	2.9	11.7	26.4	1.4	9.6	10.0	14.5	0.0	22.3	3.9	3.8	7.0	26.4	13.8	1.7	12.4
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 266.6;Paneth cells: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		22000	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.6	0.3	0.2	0.0	0.8	0.1	1.0	0.3	2.3	0.0	0.2	10.6	43.3	14.2	2.6	0.6	2.1	0.1	0.0	0.0	0.2	11.9	0.0	11.1	0.4	18.5	2.8	17.2	18.8	1.9	0.0	0.2	0.0	0.8	0.8	0.0	0.0	6.5	0.0	0.0	0.0	7.9	0.0	9.8	0.4	3.9	0.0	8.7	1.2	44.2	0.0	0.3	17.3	6.6	0.0	0.0	0.0	9.7	12.5	0.1	0.1	0.7	0.7	4.7	0.0	6.9	0.4	21.6	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5	11.9	43.5	21.6	7.4	3.4	0.0	1.4	12.7	5.3	33.0	0.0	3.9	1.6	0.0	12.0	65.8	24.5	266.6	0.0	5.6	1.9	1.7	5.7	17.3	79.9	16.7	0.0	39.2	16.0	19.2	29.7	14.7	23.5	3.3	4.6	84.3	0.0	29.0	93.1	11.3	0.0	1.2	0.0	1.4	1.7	1.4	1.5	0.6	14.9	90.6	41.4
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.4"	"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 98.3;Mucus-secreting cells: 80.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"	30.3	12.6	2.8	9.2	7.0	1.9	12.4	5.6	7.0	6.8	21.0	10.6	8.3	21.4	6.6	7.0	8.1	4.5	7.7	24.8	2.9	2.5	11.2	15.7	11.7	3.2	6.8	3.2	5.1	3.2	4.7	2.5	4.6	5.5	3.4	10.4	3.5	9.8	6.8	63.4	6.8	24.1	3.0	6.1	2.7	13.4	3.1	7.1	1.1	3.9	7.3	3.0	6.5	6.1	0.7	12.6	17.0	11.6	0.3	3.0	4.7	11.9	1.6	1.2	1.6	8.5	9.0	12.4	7.1	5.5	2.0	3.5	4.3	6.6	0.0	8.1	3.1	7.7	9.0	2.9	17.9	1.5	0.1	2.8	16.6	0.8	2.0	6.2	1.6	9.1	6.1	3.9	2.9	2.8	2.9	3.1	1.2	10.5	1.3	2.7	1.4	0.5	7.3	0.8	3.6	20.3	4.4	7.8	26.2	6.8	1.2	1.1	5.4	8.7	6.4	6.9	3.4	3.1	3.6	11.7	2.4	3.3	4.3	2.3	11.3	8.2	3.8	6.7	2.6	1.9	17.0	11.6	3.0	0.6	7.2	0.5	0.4	1.6	0.7	12.6	0.7	3.0	1.5	6.5	0.3	3.4	2.1	1.1	4.7	2.8	7.0	5.6	7.0	2.9	2.5	6.8	3.2	5.5	7.1	11.9	40.9	3.0	8.5	6.9	6.0	70.4	25.5	5.3	13.6	10.4	5.9	13.6	10.0	16.5	7.2	13.2	98.3	23.3	29.5	8.5	8.9	8.8	9.2	44.8	14.7	7.9	7.5	10.4	17.2	6.0	10.6	13.8	13.5	19.8	80.6	8.8	18.1	60.0	4.2	51.2	3.4	12.9	9.9	11.6	7.3	9.5	17.5	5.0	60.0	8.9
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562880-179588408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 197.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	18.8	17.9	9.9	23.4	16.8	8.7	21.3	8.7	9.6	16.8	21.3	15.3	15.6	14.5	24.8	16.4	23.2	16.3	14.9	24.2	8.7	7.4	19.6	18.6	14.6	17.4	16.7	5.4	24.8	20.9	13.7	23.4	20.1	13.7	17.7	23.5	10.4	19.0	17.4	12.8	19.4	19.8	16.1	14.8	19.3	16.7	47.5	17.0	46.1	21.9	20.4	23.8	18.7	22.7	17.5	19.8	8.0	16.1	14.5	22.4	13.8	46.2	14.0	34.9	18.4	13.4	14.7	27.4	18.7	14.6	34.9	29.6	31.6	22.8	36.2	33.6	17.5	40.6	21.4	30.5	23.0	43.5	35.8	25.4	29.6	15.5	23.9	15.3	36.7	18.6	10.2	23.6	22.5	19.0	11.0	19.8	21.9	23.0	20.7	25.1	31.6	32.1	22.7	31.0	42.0	31.4	30.2	29.2	66.9	27.6	18.7	28.7	20.5	28.8	28.8	28.8	18.2	56.2	30.3	14.9	24.9	21.5	25.5	56.3	13.5	20.1	55.5	13.8	39.1	27.4	3.3	11.3	8.0	15.1	14.3	20.0	17.5	17.5	17.4	19.8	13.7	19.2	19.4	1.5	14.5	16.1	11.2	22.4	13.8	9.9	16.8	8.7	9.6	8.7	7.4	16.7	5.4	13.7	17.0	20.8	23.9	24.3	37.3	41.9	4.8	6.0	28.1	30.8	23.9	26.2	7.9	42.0	29.9	42.1	15.5	20.7	13.0	0.0	39.2	57.0	28.9	28.3	13.9	14.0	30.6	0.0	29.2	12.3	18.6	11.4	30.0	16.7	28.7	33.3	24.6	16.3	32.2	17.5	28.3	17.9	12.3	25.8	23.6	197.2	97.8	40.1	25.6	19.2	36.2	35.1
ACTL6B	"ACTL6, BAF53B"	ENSG00000077080	"Actin like 6B"	O94805	7	100643097-100656461	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 43.6"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 7.7;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 2.1"	"Group enriched"	"Detected in some"	11	"glioma: 3.9;pancreatic cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	75	"SCLC-21H: 21.5;SH-SY5Y: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045126	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	NA			"Nucleoli rim, Mitotic chromosome"		"HPA045126: AB_10961265"	"unprognostic (3.31e-2)"	"unprognostic (6.89e-2)"		"unprognostic (4.59e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.27e-3)"	"unprognostic (4.81e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-4)"	"unprognostic (1.64e-1)"	"unprognostic (6.84e-2)"		"unprognostic (2.01e-2)"	1.1	3.8	9.4	1.1	17.4	1.1	1.0	25.9	43.6	1.0	1.2	0.8	0.0	1.3	1.0	1.0	1.0	1.0	1.0	1.0	9.7	9.9	1.1	1.0	1.1	1.0	5.3	12.2	1.0	2.2	1.0	7.0	1.0	9.4	1.0	1.1	0.3	1.0	1.0	1.0	1.1	1.2	1.1	1.6	1.0	2.0	1.7	1.9	0.0	1.1	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	17.4	25.9	26.8	9.7	9.9	5.3	12.2	9.4	1.9	0.0	0.0	0.0	0.0	0.0	7.7	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0
ACTL8	CT57	ENSG00000117148	"Actin like 8"	Q9H568	1	17755313-17827063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	42	"testis: 23.6"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 42.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-266/84: 72.4"									HPA027176			Approved	Cytosol		NA	NA			Cytosol		"HPA027176: AB_1844553"	"unprognostic (1.79e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.89e-1)"		"unprognostic (1.43e-1)"	"unprognostic (5.49e-2)"		"unprognostic (4.68e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.2	0.0	0.7	0.0	0.0	2.9	1.8	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	72.4	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	42.7	0.0	0.0	0.0	0.6	0.0
ACTN1		ENSG00000072110	"Actinin alpha 1"	P12814	14	68874143-68979440	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 304.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 71.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004303, HPA006035"	Approved		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		780000000	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB004303: AB_626633, HPA006035: AB_1078095"	"unprognostic (4.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (9.08e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (8.00e-4)"	27.6	10.8	18.7	33.1	28.4	31.0	38.8	4.1	20.0	30.5	101.8	3.1	43.7	11.6	80.3	24.6	48.3	38.7	53.3	31.2	9.9	6.2	11.2	20.3	23.9	23.1	4.7	15.0	27.8	12.4	2.3	7.9	22.0	8.7	43.2	26.4	11.1	30.1	72.7	7.1	14.6	25.9	135.4	10.3	19.4	52.3	9.5	9.6	7.0	9.3	9.9	11.3	81.1	53.1	0.0	8.8	71.8	12.5	0.7	22.0	14.9	85.1	26.3	16.2	12.3	28.8	19.1	60.9	75.3	72.2	79.3	59.3	21.0	19.8	0.0	26.5	74.3	32.0	37.2	12.8	79.4	100.3	0.4	3.8	11.6	13.8	17.5	52.0	8.3	1.4	24.3	15.6	49.2	56.1	57.1	43.4	4.8	5.5	0.1	62.1	24.2	0.9	17.7	12.7	21.5	20.1	5.8	30.2	3.2	30.2	22.5	5.8	7.0	65.4	9.9	18.2	51.2	14.8	16.9	54.7	112.7	44.9	13.0	65.5	11.7	4.5	0.3	32.6	11.5	59.2	11.2	12.5	25.6	1.1	5.7	1.4	0.0	4.6	2.5	8.8	0.0	22.0	18.7	71.8	0.7	1.6	0.4	1.8	14.9	18.7	28.4	4.1	20.0	9.9	6.2	4.7	15.0	8.7	9.6	35.7	33.8	3.4	113.1	106.0	70.3	54.6	48.4	36.1	29.6	40.1	231.7	130.6	3.3	153.8	29.8	133.1	4.5	46.7	126.5	304.9	96.9	72.4	7.0	87.3	76.3	17.5	37.0	130.8	82.0	7.0	33.1	65.6	28.7	116.4	48.6	4.7	162.5	31.6	230.9	6.3	85.7	174.6	230.4	9.7	11.7	52.2	56.0	17.5	44.3	58.4
ACTN4	FSGS1	ENSG00000130402	"Actinin alpha 4"	O43707	19	38647649-38731583	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001873, HPA006035"	Supported		Approved	"Nuclear bodies,Actin filaments,Cytosol"		NA	NA		230000000	"Nuclear bodies, Actin filaments"	Cytosol	"HPA001873: AB_1078096, HPA006035: AB_1078095"	"unprognostic (1.03e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.25e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.52e-2)"	38.3	39.2	19.2	30.1	24.4	28.1	34.1	16.6	26.6	45.2	47.9	31.8	23.4	51.0	70.1	22.2	61.4	37.9	41.5	25.0	19.6	16.2	48.4	34.1	39.5	17.7	27.8	18.7	33.6	34.1	17.8	21.0	65.9	21.8	33.7	22.4	29.2	41.4	35.4	16.0	40.4	69.4	54.0	32.9	40.8	34.3	13.4	24.6	11.6	29.2	30.5	42.9	40.3	41.1	2.6	8.5	12.9	5.7	17.5	9.7	5.6	45.0	92.0	13.5	6.4	7.8	9.5	26.8	20.5	27.7	30.5	24.6	33.0	35.0	10.0	49.3	45.8	20.1	21.6	8.2	32.4	9.1	24.6	8.5	14.1	42.4	28.5	17.2	10.3	17.6	15.7	10.8	26.6	17.9	27.9	18.8	3.2	16.4	10.8	23.3	23.5	3.3	6.9	9.5	32.0	21.8	10.1	12.6	5.2	33.0	47.2	10.1	5.9	37.1	29.7	13.5	11.0	12.2	12.4	32.0	34.9	17.0	16.7	68.1	4.8	10.9	8.3	30.9	11.0	62.4	4.5	5.1	10.9	9.7	5.7	7.8	2.4	4.5	9.7	4.6	2.6	0.8	3.3	12.9	17.5	4.6	8.5	7.1	5.6	19.2	24.4	16.6	26.6	19.6	16.2	27.8	18.7	21.8	24.6	166.7	126.4	42.4	207.1	208.5	22.7	6.4	155.4	60.2	92.1	144.8	13.7	98.7	16.6	365.0	2.2	134.9	407.6	46.7	359.3	199.5	77.2	206.6	71.6	102.0	64.3	22.3	155.5	128.3	61.9	2.3	38.3	59.0	43.9	214.6	286.1	119.2	403.9	205.1	67.1	64.3	30.5	187.5	173.6	27.6	11.9	177.2	140.5	81.2	173.4	281.0
ACTR10	"ACTR11, Arp10, Arp11, HARP11"	ENSG00000131966	"Actin related protein 10 homolog"	Q9NZ32	14	58200080-58235636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000699			Approved	"Vesicles,Plasma membrane,Focal adhesion sites"		NA	NA			"Vesicles, Plasma membrane, Focal adhesion sites"		"HPA000699: "	"prognostic unfavorable (3.24e-4)"	"unprognostic (4.61e-2)"	"unprognostic (6.22e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (3.20e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (8.48e-8)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.48e-2)"	31.5	22.8	23.8	12.5	27.2	15.8	23.4	16.2	32.3	16.4	23.3	13.6	16.1	10.1	18.2	18.3	18.3	17.6	14.8	27.3	21.8	28.4	20.5	15.4	17.7	16.7	32.5	26.7	19.4	18.5	19.2	18.9	21.3	33.7	22.2	15.2	14.6	35.8	17.6	21.4	26.4	12.8	21.0	18.5	17.5	14.1	13.8	9.7	14.6	18.2	13.2	14.4	13.7	16.3	7.4	5.9	15.8	9.8	7.2	12.0	5.1	3.4	1.9	3.9	1.6	13.4	6.5	2.0	2.7	3.1	4.5	5.3	2.9	4.0	5.1	3.9	5.7	2.5	3.5	5.1	4.0	6.1	2.8	12.9	2.0	3.7	5.5	11.4	3.5	3.0	8.3	5.9	3.8	7.5	3.7	5.8	3.1	1.6	4.2	8.4	9.4	4.7	13.2	2.0	3.3	18.0	3.2	6.9	3.1	7.9	4.4	2.2	2.5	5.2	4.1	12.7	4.7	7.2	6.0	4.9	4.6	9.4	4.2	2.3	2.4	1.5	5.4	5.0	2.8	2.6	15.8	7.3	10.3	8.4	8.9	12.0	7.4	9.6	8.2	5.3	5.6	10.0	10.2	9.9	7.2	9.8	5.9	6.7	5.1	23.8	27.2	16.2	32.3	21.8	28.4	32.5	26.7	33.7	9.7	56.6	43.6	39.5	61.8	47.4	67.4	72.6	38.2	44.2	33.0	48.8	27.5	94.0	106.1	72.0	6.3	50.9	47.7	46.7	52.4	64.0	71.0	55.6	42.7	28.7	68.6	54.0	32.2	47.3	34.9	8.2	81.7	44.1	70.9	56.9	42.7	84.3	64.7	24.6	75.3	91.6	58.2	77.6	61.8	118.4	56.8	56.2	130.4	42.6	34.0	48.5
ACTR1A	"ARP1, Arp1A"	ENSG00000138107	"ARP1 actin related protein 1 homolog A"	P61163	10	102461881-102502711	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037193, HPA047443"	Approved		Approved	Microtubules		NA	NA		4900000	Microtubules		"CAB037193: AB_258253, HPA047443: AB_2680049"	"unprognostic (9.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.13e-1)"	32.1	28.7	35.6	23.3	42.2	19.6	20.5	28.3	62.5	26.3	33.1	40.0	12.0	23.3	26.6	24.7	27.6	20.1	22.7	44.9	36.4	40.6	23.6	23.1	28.1	18.8	41.1	32.9	18.9	22.4	38.4	23.4	29.9	55.3	26.2	26.9	23.2	19.4	34.9	65.7	26.0	23.1	43.2	36.9	20.6	23.8	29.5	25.7	33.6	18.6	24.7	25.3	28.9	20.2	10.5	22.7	23.4	29.7	12.9	18.5	18.9	20.9	25.6	31.0	31.8	38.7	30.9	12.4	26.9	48.0	42.4	39.5	13.9	17.0	14.3	20.7	39.8	21.0	21.0	29.7	33.2	29.6	18.4	20.4	19.1	15.0	20.4	28.0	14.7	17.8	31.5	24.5	38.7	27.9	43.0	54.5	23.9	15.6	14.5	41.9	17.5	26.6	25.5	12.3	16.5	23.4	20.6	40.0	9.1	34.2	11.6	11.1	24.4	16.1	9.6	19.2	28.3	35.3	10.2	39.3	20.7	20.0	22.8	26.8	14.8	15.0	16.8	21.8	26.0	12.4	15.9	22.1	23.4	18.5	28.5	15.3	10.5	13.3	17.9	22.7	9.6	11.1	12.5	17.8	12.9	29.7	11.7	18.1	18.9	35.6	42.2	28.3	62.5	36.4	40.6	41.1	32.9	55.3	25.7	53.6	43.7	21.2	21.2	30.0	23.0	45.4	15.3	18.7	21.6	26.2	15.7	46.3	46.4	71.0	41.0	41.4	41.9	0.0	67.5	52.7	35.6	21.5	31.2	21.2	65.4	25.4	38.1	29.4	35.1	39.8	30.8	42.0	49.0	94.6	21.5	30.9	72.4	31.6	33.9	29.3	21.5	45.3	42.8	51.6	11.0	28.2	87.5	30.9	19.6	20.1
ACTR1B	"Arp1B, CTRN2"	ENSG00000115073	"ARP1 actin related protein 1 homolog B"	P42025	2	97655963-97664107	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047443			Approved	Microtubules		NA	NA		1500000	Microtubules		"HPA047443: AB_2680049"	"unprognostic (5.26e-2)"	"unprognostic (8.91e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.21e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (4.69e-4)"	15.4	26.3	22.3	13.1	28.3	19.1	15.7	31.6	57.6	17.2	17.8	18.1	17.7	20.3	19.5	15.3	19.1	23.6	21.4	32.6	22.9	18.6	18.0	20.6	16.3	15.6	19.2	24.5	23.0	29.6	31.5	16.3	11.7	18.8	17.4	12.8	16.8	24.8	23.1	43.9	21.1	19.4	22.2	14.1	22.8	18.9	10.1	16.2	14.2	20.3	16.2	13.6	17.6	13.6	11.7	16.2	14.1	14.2	10.7	22.1	11.6	21.6	11.9	11.6	15.2	21.6	17.6	33.6	20.7	31.6	14.9	12.6	9.3	11.8	15.7	19.6	21.1	16.0	11.9	9.3	23.8	6.3	31.4	15.6	11.6	11.3	25.5	16.9	9.3	18.6	17.4	17.9	9.4	29.4	22.5	16.6	19.8	8.1	19.1	22.1	24.0	17.8	11.7	11.7	16.6	16.2	10.1	17.0	25.8	23.5	17.2	13.7	10.2	10.0	20.5	15.0	15.7	16.2	14.9	17.2	10.0	15.6	10.5	8.5	24.9	10.8	5.6	29.8	13.5	8.9	6.6	11.4	14.1	15.6	10.1	12.1	11.7	17.1	15.6	16.2	11.5	14.5	15.5	4.5	10.7	14.2	6.5	22.1	11.6	22.3	28.3	31.6	57.6	22.9	18.6	19.2	24.5	18.8	16.2	17.9	15.6	26.7	25.9	12.0	36.8	27.7	17.8	9.4	13.6	21.0	11.8	24.3	29.9	58.1	11.1	27.0	29.3	0.0	50.7	48.8	20.1	31.3	29.9	13.4	26.6	52.4	24.8	30.1	14.0	9.4	22.5	18.0	21.9	83.8	31.2	23.8	43.7	35.1	25.1	31.4	26.9	38.8	30.8	11.8	28.1	14.3	13.6	35.0	38.1	35.5
ACTR2	ARP2	ENSG00000138071	"ARP2 actin related protein 2 homolog"	P61160	2	65227753-65271253	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005083, HPA015050"	Approved		Approved	Cytosol		NA	NA		76000000	Cytosol		"CAB005083: AB_2221848, HPA015050: AB_1844556"	"unprognostic (2.23e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (3.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.03e-2)"	31.7	22.3	40.0	58.1	46.1	41.0	24.9	38.5	53.8	24.9	39.3	19.2	16.1	29.1	23.9	18.9	39.5	17.8	26.0	28.9	39.5	35.6	25.8	30.3	32.0	63.1	36.8	39.4	20.9	19.3	19.8	19.6	31.2	30.2	21.1	40.2	16.0	26.7	19.3	28.8	21.2	33.1	29.7	42.6	56.6	29.6	13.7	28.1	59.6	20.9	19.4	69.2	31.9	25.2	21.2	44.9	54.9	53.2	21.3	25.2	59.3	36.4	30.7	29.3	31.4	31.2	42.5	30.6	51.7	39.7	39.9	27.8	34.4	29.9	80.9	26.5	56.3	25.0	27.5	25.2	35.8	65.3	46.6	21.1	89.4	21.8	32.3	35.6	83.8	104.5	36.7	28.1	44.4	42.9	32.2	48.9	28.4	37.9	29.5	66.0	27.0	43.7	43.8	24.4	33.3	22.2	47.5	38.0	33.7	45.6	47.6	15.0	24.6	33.5	38.2	35.4	27.7	23.6	56.2	65.3	44.0	26.9	28.8	56.3	22.7	20.9	115.0	37.8	82.0	49.7	54.3	38.9	45.3	23.6	51.5	25.2	21.2	21.2	22.1	44.9	18.0	16.7	23.3	54.9	21.3	53.2	16.8	23.5	59.3	40.0	46.1	38.5	53.8	39.5	35.6	36.8	39.4	30.2	28.1	80.4	111.6	136.8	71.7	66.3	77.0	65.9	48.4	108.4	77.3	92.5	62.8	71.7	43.1	90.0	29.2	109.9	187.6	0.0	111.8	119.6	73.2	98.2	183.9	89.4	243.0	98.5	106.4	111.1	406.7	68.0	60.4	280.8	84.4	189.4	124.2	80.7	125.1	196.0	70.0	71.7	76.6	122.9	96.6	23.6	47.2	79.3	104.0	175.7	110.8	175.4
ACTR6	"ARP6, FLJ13433"	ENSG00000075089	"ARP6 actin related protein 6 homolog"	Q9GZN1	12	100199122-100241865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038587, HPA038588"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA038587: AB_10670781, HPA038588: AB_10672719"	"unprognostic (1.24e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (7.70e-9)"	"unprognostic (4.11e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.40e-2)"	7.6	8.0	12.6	6.6	13.8	5.6	20.5	14.8	20.2	10.3	9.9	10.2	6.9	7.5	8.6	7.2	10.4	9.6	5.9	8.1	15.2	15.7	12.3	12.5	8.2	11.6	13.8	15.4	9.9	5.9	15.8	14.0	11.6	21.2	11.0	10.6	6.7	7.7	12.2	8.3	6.8	9.2	8.3	12.8	9.6	7.3	13.9	14.6	13.4	9.6	5.8	11.9	11.6	8.6	6.1	6.1	4.6	5.8	7.9	10.9	6.6	18.0	7.1	9.0	11.0	9.0	11.1	18.5	5.1	8.9	8.5	5.8	5.1	5.3	9.5	7.1	8.0	8.0	5.9	13.2	8.3	15.5	9.0	11.9	5.8	7.2	5.4	9.8	8.9	6.0	6.6	10.1	7.2	9.3	13.0	11.5	13.9	10.1	3.8	11.8	3.9	11.9	10.0	8.8	7.0	8.9	7.3	8.8	11.1	11.5	10.4	7.9	13.8	9.3	19.8	9.1	9.6	12.9	8.5	5.8	5.2	3.8	6.9	5.4	6.4	16.2	12.2	3.6	5.9	7.5	3.8	2.8	4.6	8.0	5.8	9.9	6.0	8.8	7.5	4.1	6.1	10.9	10.0	2.1	7.9	4.5	6.1	7.7	6.6	12.6	13.8	14.8	20.2	15.2	15.7	13.8	15.4	21.2	14.6	14.9	15.3	10.1	32.9	20.4	31.8	31.3	5.1	32.1	14.8	22.7	17.7	49.3	39.7	17.9	95.8	19.5	8.9	23.3	10.5	57.0	22.6	20.7	32.3	13.7	20.8	31.8	12.0	14.7	19.9	23.7	18.7	18.5	30.4	19.8	9.8	24.1	12.4	10.7	21.2	53.1	29.9	32.3	25.4	36.4	22.6	17.2	80.3	33.8	11.3	26.9
ACTR8	INO80N	ENSG00000113812	"ARP8 actin related protein 8 homolog"	Q9H981	3	53867066-53882202	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 28.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA065236: AB_2685442"	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	13.2	11.2	19.8	12.6	20.0	11.3	12.9	25.6	24.5	13.7	12.4	13.9	10.5	9.9	14.1	14.3	14.1	12.8	11.3	24.3	18.2	13.7	17.9	11.8	12.4	17.0	17.7	15.5	15.0	15.8	21.9	22.0	14.8	16.0	13.0	16.8	12.5	14.2	12.6	20.1	14.5	11.9	15.3	16.1	14.4	12.6	27.5	19.9	19.9	16.8	10.5	19.2	16.1	11.8	6.1	6.3	28.8	7.1	8.6	8.5	4.4	6.5	8.1	15.9	13.1	13.1	16.5	11.9	15.5	19.8	21.0	16.8	12.6	8.0	20.0	4.6	21.3	15.5	5.6	11.9	10.7	20.0	8.1	4.9	19.9	12.6	13.4	15.5	21.1	17.9	12.9	11.0	21.7	13.7	16.3	16.2	10.7	8.9	7.0	21.1	7.6	7.0	12.6	14.8	9.5	12.9	9.3	9.9	12.0	15.9	18.4	4.7	13.7	10.1	8.8	8.9	15.7	5.7	11.8	11.0	16.1	10.5	14.7	14.0	19.6	24.9	20.5	11.9	15.5	10.0	28.8	4.7	5.8	5.8	7.1	5.8	6.1	5.4	5.5	6.3	3.8	5.7	6.1	2.4	8.6	4.2	4.6	8.5	4.4	19.8	20.0	25.6	24.5	18.2	13.7	17.7	15.5	16.0	19.9	3.0	7.7	7.8	6.1	6.9	6.5	17.8	10.2	2.7	4.5	3.5	3.9	10.4	18.3	13.2	35.7	7.7	5.2	0.0	13.7	9.4	7.1	5.7	5.7	4.7	10.2	1.6	10.4	7.4	6.3	71.4	10.0	8.2	5.0	13.6	9.0	7.0	11.6	2.9	9.2	15.9	4.7	0.0	9.2	17.6	15.4	5.6	8.6	12.2	5.7	5.4
ACTRT3	ARPM1	ENSG00000184378	"Actin related protein T3"	Q9BYD9	3	169766921-169769895	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"testis: 57.4"	"Cell type enriched"	"Detected in many"	9	"Early spermatids: 728.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;HSkMC: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA035817, HPA035818"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035817: AB_10671938, HPA035818: AB_2674801"	"unprognostic (2.35e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.22e-1)"	1.0	0.7	0.9	0.4	1.1	0.5	1.5	2.4	1.3	1.0	0.5	0.5	1.3	0.7	0.7	1.4	0.6	1.4	0.5	0.7	0.7	0.9	1.8	1.7	0.7	0.6	1.0	0.4	1.1	0.3	0.8	1.0	0.7	1.1	1.0	0.4	0.6	0.5	1.3	0.7	0.3	0.5	1.0	0.6	0.1	0.8	57.4	0.7	0.2	1.0	0.1	0.5	1.5	3.1	1.2	0.5	0.0	0.0	0.0	3.4	0.4	3.6	2.2	0.2	1.1	16.0	5.2	0.0	4.4	2.6	2.7	2.3	0.0	4.6	0.0	6.1	4.9	1.8	2.3	1.2	2.1	2.8	2.7	1.6	8.4	1.9	0.4	2.6	0.9	0.7	10.3	0.5	3.3	0.6	1.8	4.9	1.0	0.0	0.0	4.8	1.8	0.3	0.1	3.9	3.1	4.6	0.7	0.0	0.1	2.9	0.9	2.9	2.0	5.2	1.3	0.1	0.5	2.2	3.6	2.2	0.0	0.0	2.2	0.0	0.5	0.2	0.2	1.1	0.0	0.5	0.0	0.0	0.0	0.7	0.0	3.4	1.2	0.0	1.1	0.5	1.1	0.4	0.4	0.0	0.0	0.0	0.5	0.0	0.4	0.9	1.1	2.4	1.3	0.7	0.9	1.0	0.4	1.1	0.7	0.0	1.0	0.0	0.7	0.3	1.0	0.6	0.0	2.7	2.3	0.0	2.0	1.4	1.7	2.0	728.6	0.7	0.0	0.0	1.8	1.1	1.4	0.4	1.1	1.7	1.4	3.2	0.0	1.8	0.6	82.5	8.9	0.6	1.7	0.0	0.1	1.4	1.3	0.0	5.3	2.5	1.1	12.9	1.9	5.5	4.0	0.0	0.7	0.0	0.4	0.3
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951667-51997078	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB026126: , HPA063761: AB_2685115"	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	11.1	7.4	12.0	6.4	14.6	7.9	14.3	14.2	24.4	8.6	16.7	5.1	28.0	19.2	6.7	13.1	14.4	10.9	11.1	7.6	11.2	10.5	24.6	21.0	10.3	7.1	8.1	14.7	7.1	35.1	24.9	10.9	7.5	7.3	10.0	17.1	8.7	21.7	34.3	11.7	30.6	19.8	8.2	5.8	6.7	17.2	10.6	4.8	3.9	9.9	5.8	8.4	10.1	12.1	0.5	1.3	6.8	4.0	0.1	1.6	0.6	6.4	14.1	11.0	6.0	12.6	9.9	6.2	7.3	8.3	7.8	5.9	28.4	10.0	2.8	10.2	7.9	8.6	11.4	10.4	8.8	8.1	4.1	12.3	6.9	3.5	8.8	14.4	11.2	26.0	19.3	11.5	8.8	11.1	8.3	10.9	10.3	7.4	8.8	6.9	13.1	10.6	9.7	10.6	13.6	4.9	5.7	8.5	3.6	21.9	9.8	14.0	11.6	7.8	11.2	5.1	8.1	12.4	7.3	6.9	5.4	8.2	6.0	3.5	5.4	3.7	3.9	5.8	5.4	6.9	4.5	2.2	6.8	0.7	3.3	1.0	0.1	0.6	0.7	1.3	0.5	1.6	0.9	1.9	0.1	4.0	0.7	1.0	0.6	12.0	14.6	14.2	24.4	11.2	10.5	8.1	14.7	7.3	4.8	3.0	12.0	3.4	9.2	16.6	41.6	5.4	22.9	13.4	14.8	24.4	27.5	0.5	3.3	12.7	2.3	9.8	23.9	0.0	12.5	0.6	5.7	12.2	10.5	19.5	3.7	35.0	23.6	14.7	16.7	6.3	9.2	7.7	6.8	2.8	32.6	10.6	12.7	24.6	8.9	16.5	23.8	6.5	15.9	3.9	16.5	22.1	0.5	2.5	22.6	11.2
ACVR2A	"ACTRII, ACVR2"	ENSG00000121989	"Activin A receptor type 2A"	P27037	2	147844517-147930826	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 21.0;RH-30: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046997	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046997: AB_10970077"	"unprognostic (4.55e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-3)"	"unprognostic (8.73e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.99e-2)"	12.0	6.0	13.6	8.2	9.9	3.8	10.7	14.5	14.2	10.2	14.1	4.7	9.7	10.4	9.3	9.9	13.6	7.6	17.7	5.6	10.0	9.0	9.0	10.3	7.5	4.7	5.9	10.6	7.6	9.8	8.6	15.9	10.6	7.3	12.2	9.1	7.6	12.2	12.0	19.6	29.5	17.8	13.8	5.4	6.5	9.3	11.0	6.4	1.5	9.5	6.9	6.8	13.5	11.8	0.7	3.0	0.5	3.6	7.7	4.6	1.4	1.3	1.6	10.0	3.7	5.9	3.8	4.1	3.1	3.7	5.3	9.3	4.3	6.0	0.0	2.8	4.9	1.9	4.7	9.1	4.5	6.8	1.0	5.5	0.6	2.8	7.4	21.0	0.6	0.7	6.3	5.7	3.4	6.8	4.1	4.0	1.2	1.4	2.6	3.6	3.5	0.3	0.5	11.3	4.0	2.6	0.1	17.5	0.9	4.2	8.5	9.9	5.6	2.6	3.1	3.8	4.5	1.9	1.0	3.1	4.9	5.8	4.6	2.1	0.7	0.2	1.8	3.0	0.3	3.9	0.4	3.0	0.5	1.2	3.6	0.5	0.3	4.6	2.1	2.3	0.7	3.0	0.7	0.1	7.7	3.1	3.0	0.4	1.4	13.6	9.9	14.5	14.2	10.0	9.0	5.9	10.6	7.3	6.4	6.0	6.5	0.5	6.7	26.4	15.8	7.8	10.2	8.1	11.4	7.0	13.7	3.9	1.7	5.0	4.1	9.8	13.2	0.0	5.6	2.1	13.5	6.7	0.0	8.6	4.7	11.1	8.6	12.9	9.4	0.8	9.2	7.6	10.1	8.2	13.8	3.7	6.3	8.6	10.6	5.0	8.5	32.3	14.4	13.8	12.8	26.1	4.5	5.1	8.5	7.1
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053221-75069483	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		92000	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	8.7	27.4	23.0	13.9	20.4	12.7	16.2	24.0	25.2	10.6	14.9	14.8	14.3	11.3	10.2	26.9	11.6	21.4	7.1	10.8	19.9	30.2	12.2	5.2	10.9	17.6	28.7	19.3	9.1	7.0	8.9	38.2	10.4	24.4	10.0	19.8	9.4	9.7	12.9	22.3	24.4	11.3	11.4	27.5	10.9	14.0	16.7	22.9	8.3	20.2	10.3	19.0	7.5	12.0	10.6	7.6	12.3	6.6	10.0	17.8	5.1	24.8	13.7	19.8	12.1	8.0	9.4	11.0	14.3	5.6	14.6	20.8	13.8	28.1	27.5	8.8	5.9	8.7	22.4	13.0	6.3	23.9	39.9	16.0	17.8	36.1	9.7	4.8	11.2	18.7	5.2	9.1	20.1	10.4	9.4	19.1	26.1	14.0	33.2	19.1	17.0	25.1	20.9	6.0	21.8	13.8	20.2	26.1	12.8	20.5	13.2	36.3	14.7	9.8	6.7	22.2	9.8	14.8	11.1	9.0	10.0	18.5	20.1	15.3	7.9	16.0	28.8	15.3	13.2	10.7	3.9	2.2	12.3	8.6	4.3	9.7	10.0	14.5	9.9	3.8	10.6	12.2	11.3	0.9	10.0	6.6	7.6	17.8	5.1	23.0	20.4	24.0	25.2	19.9	30.2	28.7	19.3	24.4	22.9	6.0	7.8	18.2	36.9	25.4	31.8	17.9	35.7	80.3	19.4	62.8	11.8	19.4	33.2	16.7	18.7	25.1	15.8	70.0	16.2	27.5	20.2	16.2	11.5	4.3	19.1	41.3	28.9	6.7	3.8	7.0	15.5	11.7	37.1	10.0	22.3	16.1	18.0	20.1	15.6	17.3	29.9	25.8	25.8	90.7	15.8	21.0	11.4	22.3	32.3	31.1
ACYP2		ENSG00000170634	"Acylphosphatase 2"	P14621	2	53970838-54305300	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 116.4"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035301	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA035301: AB_10670291"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.90e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.24e-2)"	12.9	24.0	31.0	4.6	33.9	5.6	10.1	15.5	29.3	6.7	6.2	19.4	4.4	6.2	6.7	10.5	6.6	7.1	7.3	39.6	29.1	28.4	8.8	18.7	7.2	7.5	35.7	18.2	5.7	10.3	9.1	9.7	5.9	28.1	10.4	4.8	6.3	11.5	8.4	116.4	6.6	5.6	6.9	35.7	7.8	7.5	6.5	22.7	3.5	8.2	22.9	6.4	8.2	4.1	20.9	23.7	24.1	10.2	12.6	15.9	8.9	7.7	4.3	4.6	3.8	16.8	13.3	4.2	9.3	7.0	5.8	5.1	1.0	5.6	15.1	24.7	9.2	5.8	6.6	2.5	7.8	5.4	13.0	10.3	11.6	4.7	11.5	6.9	9.7	5.6	9.6	14.6	4.1	6.9	11.8	2.6	7.8	4.8	8.1	12.2	4.9	6.0	12.0	5.2	6.1	5.4	4.8	4.4	8.5	13.6	7.1	13.3	8.8	11.3	7.1	4.2	1.8	2.6	8.9	9.3	8.2	7.9	3.6	8.6	17.1	9.4	8.4	11.9	16.6	9.0	24.1	10.2	19.8	13.4	9.0	11.9	20.9	13.4	12.7	14.7	19.7	15.9	13.4	8.5	12.6	8.8	23.7	11.6	8.9	31.0	33.9	15.5	29.3	29.1	28.4	35.7	18.2	28.1	22.7	14.9	13.2	27.4	34.8	18.2	14.8	159.9	25.5	25.4	21.6	17.4	9.8	12.0	53.0	19.2	60.2	23.2	19.1	23.3	33.4	5.0	14.9	30.3	19.6	58.0	27.9	27.0	29.4	26.4	35.8	48.4	12.4	30.9	21.9	21.6	25.3	53.2	29.4	17.5	29.0	36.5	28.8	51.8	26.4	19.2	9.7	18.6	8.6	17.0	18.0	35.7
ADAL		ENSG00000168803	"Adenosine deaminase like"	Q6DHV7	15	43330657-43354555	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 76.6;Rod photoreceptor cells: 77.1;Spermatogonia: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039879, HPA048175, HPA058795"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			Nucleoplasm	"Nuclear speckles, Vesicles"	"HPA039879: , HPA048175: AB_2680298, HPA058795: "	"unprognostic (1.65e-2)"	"unprognostic (1.53e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (7.64e-9)"	"unprognostic (2.37e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.44e-2)"	6.9	7.9	10.0	4.6	12.4	4.7	7.1	9.0	11.3	4.0	6.2	9.9	4.2	6.9	6.8	11.0	5.1	4.3	4.7	23.8	9.3	10.3	14.1	10.6	4.2	5.2	10.5	9.0	4.6	5.2	15.6	10.6	3.4	10.7	7.7	5.9	11.8	4.9	8.0	20.9	3.5	8.6	8.8	14.0	4.7	4.7	12.5	9.2	4.4	13.0	9.7	5.6	6.1	3.6	5.0	7.3	8.8	4.6	5.0	8.7	3.0	4.7	2.5	9.8	10.5	4.1	5.5	4.5	5.5	5.8	8.9	13.9	9.8	2.4	5.8	9.5	6.2	11.9	5.2	0.0	4.0	8.0	5.6	6.5	13.5	16.2	8.0	5.8	0.0	10.3	7.1	7.9	6.5	6.8	5.8	1.9	13.4	14.3	11.3	9.7	3.3	8.3	6.7	3.9	5.2	3.6	10.9	14.3	8.5	8.3	2.9	12.5	8.4	9.4	8.3	8.4	5.5	8.8	9.4	2.4	15.8	7.4	12.0	11.6	11.9	19.7	2.3	8.9	14.5	12.9	8.8	3.3	7.7	5.9	4.6	4.7	5.0	5.5	5.0	4.5	5.0	5.8	7.0	2.3	5.0	3.9	7.3	8.7	3.0	10.0	12.4	9.0	11.3	9.3	10.3	10.5	9.0	10.7	9.2	8.9	9.3	12.5	7.9	6.3	39.1	42.8	10.2	12.0	5.7	17.4	76.6	6.4	49.7	7.8	9.3	6.9	8.7	0.0	7.3	5.5	7.6	7.8	7.0	27.2	7.5	39.7	7.5	10.4	5.4	9.6	8.9	11.2	8.5	3.6	7.3	33.0	5.4	0.0	8.1	24.8	77.1	6.5	8.0	33.7	66.1	3.9	2.2	9.2	9.9	2.4
ADAM19	MLTNB	ENSG00000135074	"ADAM metallopeptidase domain 19"	Q9H013	5	157395534-157575775	"Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.4;smooth muscle: 46.1"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 69.2;Cone photoreceptor cells: 58.9;Extravillous trophoblasts: 72.0;monocytes: 134.3;Rod photoreceptor cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 32.3;eosinophil: 37.5;memory B-cell: 14.1;naive B-cell: 15.8;neutrophil: 20.1;plasmacytoid DC: 18.5"	"Group enriched"	"Detected in many"	5	"B-cells: 15.8;dendritic cells: 18.5;granulocytes: 37.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.7;U-251 MG: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055537			Approved	Vesicles		NA	NA			Vesicles		"HPA055537: AB_2797253"	"unprognostic (4.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.90e-12)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-2)"	3.7	2.5	1.3	49.4	1.5	4.8	2.8	6.9	2.4	4.4	15.1	1.1	3.6	3.9	8.6	5.9	4.6	5.9	14.7	18.9	1.6	1.7	1.6	4.3	9.1	19.2	1.6	1.0	3.0	0.5	0.0	1.4	33.0	3.4	5.9	4.9	5.0	6.8	4.6	3.9	0.8	14.0	46.1	2.8	16.8	7.7	1.3	0.5	5.6	3.1	3.3	29.4	17.0	3.9	15.8	18.5	37.5	3.9	0.1	4.4	2.2	11.1	1.7	3.4	0.0	0.2	0.2	22.3	13.3	4.7	8.3	6.2	5.8	9.1	5.8	0.7	6.8	1.7	9.5	0.5	0.8	7.6	31.7	0.3	0.0	0.9	0.7	2.0	0.0	0.0	1.6	0.0	6.5	1.3	9.9	9.4	0.0	1.6	0.8	17.7	0.0	0.0	0.0	3.7	0.0	5.8	0.1	19.9	4.8	0.9	0.1	1.6	1.0	0.0	4.8	0.7	14.4	0.0	0.2	14.3	9.0	9.7	2.0	60.2	3.6	0.1	20.8	2.0	0.0	4.0	32.3	3.9	37.5	0.4	0.3	1.0	14.1	4.4	1.0	1.1	15.8	0.1	0.1	20.1	0.1	0.0	18.5	4.4	2.2	1.3	1.5	6.9	2.3	1.6	1.7	1.6	1.0	3.4	0.5	6.0	1.1	69.2	0.0	1.9	32.2	3.3	0.0	0.0	1.2	3.5	58.9	0.7	0.0	0.5	3.4	3.9	0.0	0.0	1.3	72.0	4.7	0.1	0.0	8.6	1.5	14.3	0.0	6.2	14.4	1.1	5.2	6.7	1.7	134.3	0.0	2.0	1.6	0.0	7.4	0.0	47.3	6.5	5.2	0.0	1.5	1.3	7.0	10.2	0.0	0.1
ADAM22	MDC2	ENSG00000008277	"ADAM metallopeptidase domain 22"	Q9P0K1	7	87934143-88202889	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.9"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 30.7;Cone photoreceptor cells: 21.6;Horizontal cells: 14.3;Rod photoreceptor cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 36.3;SH-SY5Y: 34.6;U-266/84: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050325, CAB079064"		Supported	Approved	"Cell Junctions"	"Intracellular and membrane"	NA	NA		78000	"Cell Junctions"		"CAB079064: , HPA050325: AB_2681087"	"unprognostic (1.20e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.61e-4)"	"unprognostic (4.70e-2)"	2.9	11.7	10.9	1.5	15.7	1.5	2.1	46.9	36.4	8.6	2.3	6.2	1.6	1.3	6.3	11.2	1.6	3.7	3.7	3.0	14.0	10.6	5.5	0.8	2.0	2.9	8.8	14.4	5.6	1.8	4.5	3.7	0.9	17.0	14.5	2.3	2.9	1.5	7.1	3.3	1.8	1.9	5.0	8.2	2.9	1.4	2.7	5.7	2.8	4.5	0.0	1.9	2.1	2.9	0.4	1.2	1.9	0.0	0.5	1.6	0.1	1.1	0.3	2.1	2.6	0.6	0.1	1.6	0.0	0.2	0.1	0.2	2.2	3.6	3.2	0.9	0.0	1.5	0.0	3.0	0.0	0.0	8.7	4.0	2.4	2.3	0.6	0.0	2.9	0.0	0.3	0.0	0.0	0.1	2.8	0.2	3.5	0.1	36.3	0.1	2.8	3.7	0.6	5.1	0.2	1.1	2.2	8.4	4.6	0.0	1.7	11.6	34.6	1.8	0.0	0.3	1.7	1.5	0.3	0.0	2.2	1.5	0.4	1.5	8.4	13.9	2.5	1.8	6.1	3.1	1.9	0.0	0.0	1.0	0.0	0.1	0.4	0.3	1.0	0.0	0.3	1.6	1.2	0.2	0.5	0.0	1.2	0.0	0.1	10.9	15.7	46.9	21.8	14.0	10.6	8.8	14.4	17.0	5.7	0.0	1.3	0.0	1.8	0.5	30.7	2.9	0.0	1.4	1.2	1.8	21.6	0.3	1.7	0.0	5.9	0.7	0.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.1	14.3	1.2	0.0	0.0	1.1	2.3	0.0	1.7	0.0	0.8	1.4	0.0	1.5	2.5	0.8	10.6	0.0	0.9	0.5	1.1	0.4	0.0	0.5	1.0	0.1
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 24.8;OE19: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.8	0.2	0.8	0.0	0.8	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	7.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1	3.0	5.9	115.5	2.2	0.8	0.0	0.9	25.5	17.4	62.6	3.5	0.0	0.3	0.0	7.1	0.9	0.7	0.5	0.0	3.1	8.1	1.1	2.0	2.3	0.0	9.0	0.0	0.0	0.0	12.3	1.8	0.6	32.1	5.0	5.4	0.1	0.0	32.8	0.0	0.4	3.6	0.0	6.5	0.3	0.2	0.1	0.5	0.5	6.9	0.9	6.3
ADAM32		ENSG00000197140	"ADAM metallopeptidase domain 32"	Q8TC27	8	39106990-39284911	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 47.0"	"Cell type enhanced"	"Detected in many"	27	"Early spermatids: 134.9;Late spermatids: 35.0;Spermatocytes: 21.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA044156, HPA062151"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA044156: AB_10796798, HPA062151: AB_2684699"	"unprognostic (2.13e-1)"	"unprognostic (6.92e-2)"	"unprognostic (4.63e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-7)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.34e-3)"	"unprognostic (7.82e-2)"	0.6	0.6	0.3	0.2	0.4	0.4	0.6	0.3	0.5	0.6	0.3	0.2	0.2	0.0	0.3	0.8	0.2	0.3	0.5	0.4	0.3	0.7	0.2	0.2	0.2	0.2	0.3	0.6	0.5	1.2	0.1	0.2	0.2	0.4	0.3	0.4	0.4	0.2	0.7	0.2	0.8	0.3	0.2	0.2	0.5	0.1	47.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.9	0.2	1.5	0.4	2.6	0.9	0.0	0.7	0.3	0.1	0.4	2.0	0.2	0.2	1.3	0.4	1.2	0.4	0.1	2.6	0.0	0.5	2.4	0.1	0.2	0.5	0.0	1.5	0.1	0.3	0.0	2.2	0.3	0.3	0.2	0.8	2.7	0.2	0.1	0.0	1.9	0.1	0.3	0.2	0.5	1.3	2.8	0.4	0.6	0.0	1.4	0.0	0.2	0.1	0.0	0.1	0.3	1.0	0.4	0.2	0.4	0.0	0.3	1.1	0.0	0.0	2.6	3.8	0.1	1.4	0.0	0.4	0.1	0.9	0.1	0.7	1.5	0.4	0.2	0.7	0.4	0.3	0.9	0.6	0.9	0.1	0.8	0.7	0.8	1.0	2.6	0.4	0.2	0.2	0.0	0.3	0.4	0.3	0.5	0.3	0.7	0.3	0.6	0.4	0.2	0.0	0.0	0.0	1.0	0.8	8.0	1.4	0.0	1.4	0.0	1.8	17.7	0.2	0.0	0.2	134.9	1.0	0.0	0.0	1.2	0.1	1.9	1.3	0.0	0.4	0.4	0.0	4.1	0.6	0.0	35.0	2.6	0.0	0.0	0.0	0.7	1.1	2.0	0.0	2.8	0.0	4.2	0.0	0.7	21.9	1.8	0.0	0.1	0.0	1.1	1.0
ADAM33	"C20orf153, dJ964F7.1, DKFZp434K0521"	ENSG00000149451	"ADAM metallopeptidase domain 33"	Q9BZ11	20	3667965-3682246	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 55.7;smooth muscle: 58.0"	"Cell type enhanced"	"Detected in some"	12	"Fibroblasts: 23.2;Leydig cells: 21.0;Peritubular cells: 9.6;Smooth muscle cells: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 31.3;ASC TERT1: 40.6;BJ: 13.8;BJ hTERT+: 23.7;fHDF/TERT166: 14.1;U-2197: 18.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low region specificity"	"Detected in all"			"HPA067152, HPA071758"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA067152: AB_2685791, HPA071758: "	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.43e-4)"	"unprognostic (7.14e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.75e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-5)"	"unprognostic (3.10e-3)"	10.0	1.5	4.6	9.2	2.6	0.0	20.2	2.8	2.7	55.7	29.5	2.2	20.9	4.7	44.3	12.3	17.0	16.9	17.5	5.3	5.0	0.9	0.9	0.5	3.6	2.2	4.9	3.0	11.8	1.6	0.0	1.6	5.4	7.0	22.8	5.5	3.7	4.2	27.1	3.5	4.8	9.1	58.0	3.3	1.9	9.9	5.4	3.5	0.1	4.0	10.1	2.0	24.9	36.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	40.6	0.1	13.8	23.7	4.1	8.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	6.9	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.1	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.6	2.6	2.8	2.7	5.0	0.9	4.9	3.0	7.0	3.5	0.0	0.0	0.0	0.1	4.8	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.2	23.2	0.2	0.0	0.0	0.5	0.0	0.0	3.1	0.0	0.0	21.0	0.6	3.3	0.0	0.0	3.3	0.0	0.0	9.6	0.0	0.0	6.5	15.1	0.6	0.5	2.8	0.5	0.0	0.0	0.0
ADAM9	"CORD9, KIAA0021, MCMP, MDC9, Mltng"	ENSG00000168615	"ADAM metallopeptidase domain 9"	Q13443	8	38996869-39105144	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 140.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 11.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004000			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted - unknown location"	NA	NA		640000	Vesicles	"Endoplasmic reticulum"	"HPA004000: AB_1844584"	"prognostic unfavorable (1.14e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (5.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.80e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-2)"	36.7	25.0	14.7	21.7	13.6	10.4	17.1	20.9	14.4	21.8	24.4	13.2	21.8	19.4	24.9	19.8	24.1	15.5	31.7	28.5	12.5	10.1	29.4	11.6	39.2	20.3	19.2	12.9	17.6	11.1	37.5	10.4	30.1	15.8	23.8	23.8	15.4	44.5	21.4	18.3	12.8	25.4	32.8	22.0	25.7	33.2	13.7	12.7	2.4	24.0	14.9	11.7	34.8	19.2	0.6	8.1	3.4	11.4	3.1	0.8	2.8	41.2	29.9	11.8	7.2	19.2	61.9	15.4	56.1	61.4	31.5	29.5	14.2	30.0	2.1	21.2	38.6	32.2	17.7	5.0	39.6	61.1	2.0	5.1	2.2	20.8	12.2	38.8	1.6	4.8	47.5	23.5	31.0	35.3	60.1	42.9	3.6	4.3	14.1	65.5	4.0	1.6	1.0	1.7	29.5	9.7	1.4	21.4	7.2	51.2	11.8	1.6	2.4	14.9	18.0	13.6	13.3	14.5	3.0	73.6	24.1	23.2	45.5	25.6	4.5	6.9	2.3	40.0	2.7	16.4	1.4	11.4	2.2	0.6	6.1	0.3	0.1	0.3	0.8	8.1	0.6	0.1	0.6	3.4	3.1	2.6	2.7	0.4	2.8	14.7	13.6	20.9	14.4	12.5	10.1	19.2	12.9	15.8	12.7	44.7	35.4	8.2	50.9	31.9	18.5	45.6	25.5	14.7	39.8	33.2	19.6	17.9	3.3	80.4	10.3	23.6	20.8	0.0	100.4	80.2	38.5	85.4	4.7	6.7	104.9	4.8	10.3	26.4	54.2	5.1	26.4	39.7	20.3	22.6	26.3	15.2	140.3	25.9	23.3	36.6	23.8	12.9	32.5	4.3	2.0	18.7	28.7	4.1	25.8	75.5
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835747-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 112.8"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 211.3;Sertoli cells: 207.0;Smooth muscle cells: 366.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	85	"NK-cells: 9.0;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 62.1;BJ: 72.4;hTEC/SVTERT24-B: 49.9;hTERT-HME1: 45.5;RPTEC TERT1: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		1900000	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	70.6	13.4	8.2	18.7	14.0	0.7	29.0	6.3	9.2	22.0	18.2	9.5	4.8	3.3	27.7	25.8	30.0	45.8	62.3	40.9	7.6	4.8	15.4	22.8	25.0	10.9	12.7	3.7	112.8	9.3	6.3	7.6	56.8	13.2	23.3	16.5	7.8	5.8	8.1	25.7	6.1	16.2	46.4	10.2	7.2	16.8	12.8	11.4	0.0	14.3	18.1	2.7	32.7	45.3	0.0	0.0	0.0	0.0	9.0	8.0	1.4	0.0	0.0	1.1	0.0	62.1	15.4	3.8	72.4	25.3	12.5	8.3	0.0	0.0	0.0	5.0	22.9	0.3	1.3	0.8	3.7	22.1	0.0	23.0	0.0	7.5	0.0	11.9	2.9	0.0	17.2	0.0	49.9	45.5	3.0	5.1	0.7	1.2	0.0	37.1	0.0	0.3	0.0	4.1	0.0	2.9	0.0	28.6	0.2	42.4	4.0	0.0	5.6	3.4	0.0	0.4	2.7	0.1	0.7	5.2	17.8	0.9	27.8	10.7	0.1	0.0	0.0	14.7	0.0	5.4	0.0	0.0	0.0	8.0	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.0	1.5	0.0	9.0	0.0	0.0	0.0	1.4	8.2	14.0	6.3	9.2	7.6	4.8	12.7	3.7	13.2	11.4	6.0	31.4	0.0	31.2	107.6	0.5	151.1	7.6	5.3	14.8	54.1	0.0	44.4	1.7	29.9	1.3	165.7	0.0	0.0	18.6	211.3	148.2	23.5	2.3	1.3	14.7	0.0	0.0	124.0	6.0	2.2	100.9	4.8	50.6	1.0	0.0	31.7	24.2	0.0	39.3	2.2	2.2	207.0	366.0	0.5	1.0	36.4	45.9	5.0	0.0	13.3
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892192	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	16	"Ito cells: 17.8;Leydig cells: 20.4;Peritubular cells: 16.6;Sertoli cells: 51.8;Smooth muscle cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 20.2;hTERT-RPE1: 36.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"	NA	NA			Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: AB_2732278"	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (6.78e-4)"	13.7	5.4	0.2	2.5	0.8	0.0	17.6	0.3	1.0	6.0	3.0	2.3	2.6	0.6	13.0	4.4	1.4	3.1	5.9	1.4	0.3	0.6	2.0	2.1	9.4	4.2	1.2	0.2	4.9	8.7	1.2	0.9	5.5	2.1	6.7	1.4	2.7	4.4	4.2	4.1	2.0	1.6	9.4	6.5	0.6	1.8	5.0	0.3	0.1	2.6	4.1	1.6	4.3	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.3	10.4	0.0	15.4	7.3	0.0	5.4	13.9	7.1	8.8	0.0	0.0	0.0	0.0	3.7	12.6	0.3	0.2	7.0	10.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	5.8	0.0	20.2	5.3	36.2	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	12.2	15.6	0.1	3.2	1.8	1.3	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	1.0	0.3	0.6	1.2	0.2	2.1	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.2	3.3	0.4	0.0	0.0	0.2	0.2	12.8	0.1	0.0	0.0	0.5	0.0	0.0	17.8	0.3	2.5	20.4	0.0	6.8	0.0	0.0	6.7	0.2	0.0	16.6	2.2	0.2	51.8	14.2	0.2	1.7	0.6	0.7	0.0	0.0	0.1
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 53.7"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 7.6;Early spermatids: 20.6;Ito cells: 8.0;Late spermatids: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"SuSa: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1300000000	38000000	Vesicles		"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	1.4	1.0	3.1	1.4	3.7	0.5	1.4	6.6	4.2	1.4	1.4	1.4	1.4	4.1	1.6	4.0	1.4	2.1	1.5	1.7	3.4	2.2	1.8	53.7	4.8	1.4	2.1	1.4	2.3	1.8	2.2	4.2	1.7	1.6	1.6	1.1	1.6	2.5	2.0	2.6	2.9	4.4	1.4	2.0	1.4	5.5	3.8	1.4	1.4	1.7	1.4	1.4	1.7	1.4	0.3	0.0	2.3	0.0	0.0	0.5	0.1	0.0	1.3	3.3	4.6	2.7	2.4	1.2	1.1	0.9	0.4	0.6	0.5	3.6	0.4	1.5	0.8	1.1	0.6	0.3	0.6	0.1	1.9	3.0	0.4	1.3	0.7	1.9	0.1	1.1	6.4	1.6	0.5	1.2	2.2	0.3	2.3	0.1	1.4	0.5	5.5	0.1	1.5	3.5	1.9	2.0	0.4	0.4	1.6	1.5	1.4	2.1	6.8	2.3	1.3	1.8	7.1	5.8	0.6	0.8	2.4	1.4	1.6	0.0	2.5	0.6	0.5	2.0	0.4	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	3.7	6.6	4.2	3.4	2.2	2.1	1.4	1.6	1.4	0.0	1.3	0.0	0.1	0.2	1.4	3.6	7.6	0.0	3.4	0.0	0.0	0.1	1.7	0.6	20.6	0.3	1.0	0.0	0.3	0.2	0.8	0.4	0.0	1.5	0.2	3.2	1.2	8.0	0.0	10.2	0.9	0.0	0.0	0.0	1.3	1.9	0.3	1.4	1.4	0.7	1.7	0.0	0.4	4.7	3.8	0.4	0.1	0.0	0.6	0.3
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.4"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 9.6;Fibroblasts: 8.2;Leydig cells: 4.6;Melanocytes: 3.3;Smooth muscle cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.6;ASC TERT1: 22.1;EFO-21: 18.4;hTERT-RPE1: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol		"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.63e-5)"	47.4	1.1	0.2	1.7	0.3	0.1	14.5	0.1	0.8	3.4	3.8	0.8	3.0	0.6	3.7	9.8	3.8	9.3	9.1	12.6	0.4	0.3	9.1	0.4	6.6	5.6	0.8	0.2	7.0	1.6	0.9	1.0	16.4	1.3	3.7	2.1	10.9	1.0	1.3	1.6	4.1	3.1	6.9	1.4	1.9	4.9	2.4	0.6	0.7	9.8	2.5	0.8	8.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.4	36.6	22.1	0.0	1.3	2.6	0.5	0.1	0.2	0.6	0.0	18.4	0.1	1.3	3.4	0.3	0.3	0.1	0.0	0.8	0.0	1.6	0.0	0.3	0.0	0.0	7.2	0.0	0.3	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.0	2.8	0.0	2.0	0.0	0.0	0.0	0.3	0.0	5.9	0.0	0.0	2.7	1.9	0.0	0.0	0.3	4.3	3.5	1.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.8	0.2	1.3	0.6	0.0	0.0	0.0	0.1	0.5	0.0	9.6	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.5	8.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.6	0.0	3.3	0.0	0.5	0.0	0.7	0.0	0.7	0.8	0.0	0.0	3.3	0.1	0.3	0.3	0.7	0.0	2.1	0.0
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;ovary: 16.3"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 7.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;cerebral cortex: 5.2"	"Cell type enriched"	"Detected in single"	10	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"	Yes	No			"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	7.4	0.4	1.8	0.5	2.8	0.6	1.0	20.4	5.2	2.6	0.9	0.1	3.7	0.6	2.3	11.0	1.9	1.1	8.8	0.9	1.7	0.5	5.4	0.6	0.9	0.2	0.5	1.9	16.3	6.3	0.0	0.5	0.2	2.2	0.7	0.4	0.0	0.4	0.8	0.5	0.5	0.6	10.4	0.6	0.4	0.6	0.8	0.0	0.0	0.8	0.0	0.1	3.4	1.5	0.2	0.1	0.3	0.0	3.6	0.2	0.0	2.5	2.7	2.7	0.1	0.2	0.6	0.2	0.1	0.1	0.6	0.9	0.1	2.4	0.1	3.3	0.0	4.7	0.2	0.0	0.0	0.8	0.1	1.6	0.1	3.8	0.0	0.0	0.3	0.1	0.0	0.0	6.1	0.2	0.7	0.0	0.3	0.8	0.4	1.1	0.1	0.1	0.3	1.7	0.1	2.5	0.5	3.2	0.1	0.1	0.0	1.1	0.1	0.1	0.1	0.2	5.6	0.1	0.2	0.1	3.2	4.8	8.9	2.1	0.5	0.2	0.1	4.6	0.1	0.4	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.3	3.6	0.0	0.0	0.0	0.0	1.8	2.8	20.4	5.2	1.7	0.5	0.5	1.9	2.2	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAMTS17	"FLJ16363, FLJ32769"	ENSG00000140470	"ADAM metallopeptidase with thrombospondin type 1 motif 17"	Q8TE56	15	99971589-100342005	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Deafness, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 111.4;Horizontal cells: 20.6;Late spermatids: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HEK 293: 7.4;JURKAT: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062487			Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm		"HPA062487: AB_2684780"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.43e-2)"	1.2	2.0	3.6	2.7	3.1	1.5	1.9	0.7	4.5	1.9	2.1	2.9	6.4	2.5	4.9	1.9	5.1	2.9	1.9	2.2	3.4	1.6	2.2	15.7	10.5	2.0	1.6	1.0	3.0	12.2	0.3	3.5	1.6	1.7	1.9	2.1	2.7	8.3	4.7	13.5	5.0	2.8	6.6	2.1	2.5	3.6	4.0	2.0	20.1	1.9	2.7	2.1	2.7	2.1	0.1	0.0	1.4	0.1	0.2	0.8	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.1	1.3	0.2	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	25.8	0.0	0.1	0.1	0.6	2.2	0.4	0.2	1.2	1.1	0.0	0.6	2.8	0.0	0.3	2.3	0.4	0.3	2.8	3.7	0.6	0.0	0.4	0.4	0.0	0.9	0.7	0.0	0.4	0.0	0.0	0.0	0.5	3.4	1.4	0.0	0.0	0.1	0.0	0.5	0.0	0.8	0.2	0.0	0.1	0.5	0.5	0.4	0.2	0.1	0.0	0.0	0.1	3.6	3.1	0.7	4.5	3.4	1.6	1.6	1.0	1.7	2.0	0.0	0.0	0.0	0.6	0.9	0.9	3.4	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	111.4	0.7	0.1	0.0	0.7	0.0	0.8	1.7	0.0	3.9	6.1	20.6	0.0	0.0	0.6	51.8	2.0	0.0	0.0	0.0	0.3	2.3	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.9	1.4	0.5	0.1	1.3	0.3	0.8
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435114	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adipose tissue: 16.1;brain: 31.9;placenta: 27.6"	"Group enriched"	"Detected in some"	6	"Muller glia cells: 16.4;Rod photoreceptor cells: 8.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.2;HUVEC TERT2: 8.9;SuSa: 12.5;U-87 MG: 5.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"	Yes	NA			"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	16.1	0.6	1.1	0.8	5.1	0.4	3.2	31.9	3.3	2.2	0.4	8.2	0.0	0.5	1.6	0.4	0.5	0.7	1.1	0.4	2.0	1.3	0.5	0.3	0.5	0.5	1.8	1.4	0.5	0.8	0.4	1.4	27.6	6.4	1.0	0.4	0.2	2.1	0.5	1.0	0.4	0.4	1.2	3.7	0.3	0.3	0.7	2.4	0.0	0.4	0.0	0.3	0.8	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.5	0.0	0.5	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.1	31.9	3.3	2.0	1.3	1.8	1.4	6.4	2.4	0.0	0.0	0.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.8	2.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"	Q8TE59	5	129460265-129738683	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 15.3;Syncytiotrophoblasts: 4.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 12.0;SH-SY5Y: 27.6"	"Region enriched"	"Detected in single"	5	"olfactory region: 4.8"	"Low region specificity"	"Detected in all"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"	Yes	NA			"Vesicles, Midbody"		"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.2	1.2	0.7	0.6	3.6	0.1	0.2	0.0	4.9	16.6	0.5	1.2	0.0	0.4	14.6	0.3	1.5	2.6	0.8	0.5	1.0	0.8	0.7	0.1	0.2	0.2	0.5	4.3	2.8	0.2	0.2	0.1	5.3	1.8	0.4	0.6	0.9	1.1	0.2	0.8	0.2	0.3	9.0	1.0	0.2	0.2	0.4	0.8	0.0	0.1	1.8	0.1	0.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	12.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.6	0.0	4.9	1.0	0.8	0.5	4.3	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	15.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.0	0.0	0.0
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110851-179345430	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Ito cells: 28.8;Kupffer cells: 58.6;Sertoli cells: 25.8;Smooth muscle cells: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.0;ASC TERT1: 14.0;BJ: 12.3;fHDF/TERT166: 14.5;HHSteC: 45.5;HSkMC: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	24.2	4.3	0.9	5.8	0.7	0.7	29.1	0.9	2.3	16.3	10.1	0.4	3.9	2.7	12.0	9.5	6.0	7.2	9.5	10.1	0.7	1.2	4.2	7.4	13.1	25.9	1.0	1.3	6.3	2.7	1.0	8.7	15.1	2.4	6.0	2.6	3.8	2.5	3.8	3.8	4.6	4.6	13.8	0.7	16.5	4.2	4.3	0.5	0.8	3.2	5.9	1.2	8.8	14.7	1.4	1.3	2.1	0.3	0.8	0.6	0.1	0.0	0.0	0.0	0.3	14.0	14.0	0.0	12.3	2.1	4.7	5.0	0.0	0.0	0.0	0.1	14.5	0.3	0.0	0.7	0.0	2.0	0.0	0.7	0.0	0.0	0.9	45.5	0.0	0.0	36.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.5	0.0	0.0	0.1	0.8	0.0	4.0	0.0	7.9	1.2	10.3	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.5	0.3	0.4	0.6	0.2	0.3	0.6	0.5	0.4	1.3	1.4	0.5	0.5	2.1	0.8	0.1	0.8	0.5	0.1	0.9	0.7	0.9	2.3	0.7	1.2	1.0	1.3	2.4	0.5	0.0	0.6	0.0	0.3	1.9	0.0	1.2	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.1	13.5	0.2	1.1	0.5	3.9	0.0	0.0	28.8	58.6	2.1	4.6	2.9	0.0	0.0	0.0	0.0	0.8	0.0	12.0	0.0	0.0	25.8	16.1	0.5	2.6	2.4	0.0	0.0	0.0	0.1
ADAMTS3	"ADAMTS-4, KIAA0366"	ENSG00000156140	"ADAM metallopeptidase with thrombospondin type 1 motif 3"	O15072	4	72280969-72569386	"Cancer-related genes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 13.7;Leydig cells: 18.4;Rod photoreceptor cells: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.6;AN3-CA: 7.3;HEL: 12.9;K-562: 11.0;SH-SY5Y: 6.6;U-2 OS: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021368, HPA021369"	Uncertain		Approved	"Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA			"Intermediate filaments"		"HPA021368: AB_2670681, HPA021369: AB_2670682"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.92e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-4)"	5.3	2.6	3.3	4.4	5.6	2.1	7.8	0.3	4.6	4.4	2.3	1.1	1.9	0.5	9.6	14.4	1.0	7.5	1.9	2.8	1.3	0.9	4.7	2.7	3.1	2.0	0.7	2.2	7.5	1.0	12.4	1.1	8.2	2.2	2.6	1.1	3.9	1.4	3.4	0.8	1.5	0.9	4.6	1.8	1.9	1.6	5.6	1.3	0.6	4.4	0.8	1.0	2.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	7.3	0.1	0.3	0.1	0.6	2.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.6	0.0	1.8	0.0	1.6	12.9	1.0	0.0	0.2	0.0	0.0	1.7	0.1	0.6	0.1	3.1	0.0	0.0	11.0	0.0	0.0	0.0	1.1	0.0	2.0	0.0	3.8	0.0	2.5	0.0	4.3	0.0	0.5	6.6	0.0	0.5	0.2	1.4	0.1	0.1	0.1	5.4	8.1	0.0	0.6	0.0	0.0	0.0	1.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.6	0.3	4.6	1.3	0.9	0.7	2.2	2.2	1.3	0.0	4.3	0.0	1.0	0.5	0.8	0.8	0.0	0.0	2.3	1.8	13.7	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.2	1.6	0.7	1.1	0.0	0.0	0.0	0.0	2.5	0.0	1.3	18.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.2	0.2	11.9	0.0	0.7	1.0	0.4	0.0	0.0	0.0	0.0	0.0
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 51.4"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 62.4;Ductal cells: 67.2;Endothelial cells: 76.0;Glandular cells: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 9.4;RPTEC TERT1: 11.2;SH-SY5Y: 52.5;SuSa: 17.3;WM-115: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA			Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	51.4	4.7	5.6	12.0	11.5	0.5	15.2	3.9	8.0	10.4	10.4	2.8	7.2	1.6	13.9	5.6	6.8	7.7	8.2	29.6	5.7	2.7	9.0	3.1	11.5	7.7	6.8	0.3	17.4	9.9	17.2	2.4	30.5	12.4	7.4	3.2	0.7	3.5	4.3	10.8	2.6	3.2	12.2	12.6	4.4	4.6	3.1	5.9	0.0	6.4	3.7	1.6	19.6	29.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	3.6	1.0	0.0	0.0	0.2	0.0	9.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.0	0.4	0.0	0.0	1.0	0.0	11.2	0.1	0.0	52.5	0.0	0.0	0.0	17.3	0.0	0.2	2.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	11.5	3.9	8.0	5.7	2.7	6.8	0.3	12.4	5.9	3.0	4.5	0.0	62.4	15.5	0.0	5.9	5.1	0.0	4.5	36.6	2.0	0.6	0.0	67.2	0.8	76.0	0.0	0.0	2.9	0.5	35.3	51.3	0.0	0.0	5.8	0.0	1.2	23.4	0.3	0.0	2.3	3.0	25.3	0.0	1.4	0.0	27.6	0.0	2.1	6.3	0.0	0.0	38.9	0.3	0.2	11.8	1.4	0.0	0.4	26.6
ADAMTSL1	"ADAMTSR1, C9orf94, FLJ35283"	ENSG00000178031	"ADAMTS like 1"	Q8N6G6	9	17906563-18910950	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 50.7;retina: 39.3"	"Cell type enhanced"	"Detected in some"	9	"Early spermatids: 4.5;Leydig cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 35.1;HSkMC: 17.8;hTEC/SVTERT24-B: 18.4;LHCN-M2: 18.1;TIME: 57.9;U-138 MG: 28.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057437, HPA074973"	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA		74000000	Vesicles		"HPA057437: AB_2683440, HPA074973: "	"unprognostic (4.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.01e-4)"	"unprognostic (3.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.50e-2)"	6.3	7.6	0.5	5.9	0.8	0.0	4.4	3.9	1.5	14.3	5.2	0.6	6.5	1.6	50.7	12.0	9.0	5.2	4.4	2.9	1.6	1.0	3.4	1.0	1.9	2.2	0.4	1.2	4.9	1.3	0.1	3.9	0.8	0.9	8.4	4.6	39.3	3.1	5.6	0.5	2.0	2.7	13.3	0.7	0.9	5.0	2.3	0.0	0.0	2.0	1.7	1.5	2.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.3	0.0	5.1	35.1	0.0	1.0	4.5	4.1	9.5	0.0	0.0	0.0	0.0	12.3	1.5	0.0	1.8	0.2	12.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	17.8	0.0	18.4	0.0	15.9	7.7	0.0	0.0	0.0	18.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.9	28.2	0.7	0.7	4.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	3.9	1.5	1.6	1.0	0.4	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	4.5	0.8	1.3	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.1	0.0	0.0	1.3	0.0	1.5	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.4	1.9	0.9	0.1	0.1	0.0	0.8	0.0
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 30.4;heart muscle: 36.4"	"Cell type enhanced"	"Detected in some"	9	"Distal tubular cells: 5.0;Intestinal endocrine cells: 5.1;Ito cells: 8.0;Leydig cells: 4.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 5.9;RPMI-8226: 8.2;SH-SY5Y: 25.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		67000000	Vesicles		"HPA045634: AB_2679399, HPA053812: AB_2682271"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.6	30.4	5.5	1.8	5.4	0.7	0.9	6.4	9.3	1.6	1.6	8.8	0.9	2.4	1.9	4.9	1.8	1.8	11.0	36.4	4.7	4.0	15.1	24.8	11.3	6.8	5.7	4.9	6.9	7.9	1.4	8.6	2.6	9.9	4.3	1.1	4.5	5.4	3.8	5.5	0.9	2.6	1.8	5.1	3.5	2.3	3.2	6.8	0.0	6.5	1.3	1.3	2.2	6.0	0.3	0.2	1.0	0.2	0.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.4	0.0	0.9	0.6	8.2	0.0	0.0	1.2	25.7	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.8	0.4	0.0	0.2	0.0	0.3	5.5	5.4	6.4	9.3	4.7	4.0	5.7	4.9	9.9	6.8	0.0	0.3	0.0	0.1	0.1	1.8	2.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.3	0.0	1.6	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.9	0.2	0.0	5.1	8.0	0.0	0.7	4.4	0.2	0.0	0.0	0.0	0.2	0.2	0.0	2.8	0.6	0.3	6.5	1.6	0.0	0.2	0.3	0.0	0.0	0.7	0.1
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 157.1"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 113.3;Extravillous trophoblasts: 39.4;Syncytiotrophoblasts: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;monocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.2;BEWO: 63.6;HSkMC: 14.2;K-562: 20.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		47000000	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	14.4	2.4	0.8	8.9	1.4	2.2	13.2	0.7	1.1	11.0	8.2	1.5	3.9	2.2	9.7	8.1	19.7	11.1	6.6	10.7	1.0	0.2	3.4	14.9	13.3	2.3	1.4	0.4	14.5	1.8	0.2	1.3	157.1	3.4	9.4	2.4	19.1	5.7	2.3	21.1	5.4	6.0	17.4	2.2	3.9	8.9	3.3	1.1	0.8	3.8	15.5	4.8	19.1	15.9	0.0	0.5	2.3	3.5	0.0	0.1	0.6	6.7	0.1	0.1	1.2	6.2	30.2	63.6	6.5	5.7	3.9	2.2	0.5	2.6	0.0	1.3	4.4	0.0	3.4	0.2	0.9	1.6	0.5	0.1	1.9	0.7	2.7	5.0	0.0	0.9	14.2	0.2	0.9	2.2	3.3	0.0	0.0	20.3	0.2	0.6	0.1	0.0	0.3	1.1	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.2	2.0	5.0	0.0	3.3	1.4	3.5	1.2	0.2	1.8	2.7	0.1	0.6	0.1	1.4	0.2	1.2	0.1	0.0	1.6	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	3.5	0.0	0.0	0.6	0.8	1.4	0.7	1.1	1.0	0.2	1.4	0.4	3.4	1.1	0.0	1.0	0.8	2.1	2.2	1.0	2.0	7.6	1.4	0.0	0.0	0.0	113.3	0.0	1.1	0.4	3.5	0.0	0.0	0.5	39.4	15.5	1.3	2.3	9.2	28.7	0.0	0.0	1.3	22.6	0.0	27.9	16.5	3.3	25.2	0.0	2.4	7.4	0.0	3.2	0.0	2.4	0.0	1.4	0.0	0.9	2.5	83.2	0.0	0.1	1.7
ADAMTSL5	THSD6	ENSG00000185761	"ADAMTS like 5"		19	1505018-1513604	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 19.3"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 8.1;Leydig cells: 17.8;Peritubular cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044050			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"		"HPA044050: AB_10962625"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.37e-3)"	1.0	1.0	1.2	1.7	1.5	0.0	1.5	1.3	1.2	19.3	5.0	0.5	2.2	7.8	14.4	6.2	7.0	2.7	2.3	13.5	1.9	0.8	0.9	2.8	1.4	0.2	0.9	0.2	1.7	0.9	0.0	1.5	5.2	1.8	4.0	0.7	8.6	4.0	3.9	10.5	1.0	10.0	9.9	0.8	0.8	1.0	3.7	0.3	0.0	1.0	8.1	5.1	1.6	7.2	0.2	0.1	0.8	1.8	0.1	4.7	1.1	6.4	2.9	0.1	0.2	3.4	2.5	3.1	11.9	8.1	4.6	6.8	16.4	3.2	0.0	3.0	9.9	1.3	5.5	2.9	3.5	3.4	6.2	0.4	1.2	8.5	3.0	3.9	0.2	8.5	1.5	3.7	1.1	2.9	6.1	0.0	2.2	3.8	8.2	0.4	6.0	0.3	0.4	0.1	1.9	1.6	0.2	0.6	1.6	3.6	0.0	0.2	0.4	2.8	0.3	3.3	1.6	7.5	2.4	0.8	0.0	4.5	9.1	0.5	5.1	3.2	0.8	0.1	0.6	2.0	0.4	0.1	0.8	3.4	1.1	2.2	0.1	3.7	2.5	0.1	0.2	4.7	3.2	0.2	0.1	1.8	0.1	1.1	1.1	1.2	1.5	1.3	1.2	1.9	0.8	0.9	0.2	1.8	0.3	0.0	0.6	0.0	2.2	0.3	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.5	0.0	1.7	0.0	1.5	1.9	5.4	0.7	0.0	1.6	0.2	0.0	0.0	0.0	0.0	2.2	17.8	0.2	1.7	0.0	1.0	3.4	4.3	0.8	17.0	0.3	2.0	0.0	3.5	0.5	1.4	0.4	0.6	0.5	0.6	3.0
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897901-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;intestine: 30.8"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 56.4;Mucus-secreting cells: 30.1;Paneth cells: 34.3;Undifferentiated cells: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 31.2;CAPAN-2: 22.5;HMC-1: 21.6;OE19: 57.2;THP-1: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	3.0	2.1	32.9	8.9	25.9	8.1	1.2	13.8	41.8	3.6	30.8	30.3	1.7	16.7	2.6	1.3	4.5	4.2	6.2	3.9	36.1	17.7	6.5	1.6	5.8	3.3	28.0	20.1	0.7	5.4	3.7	1.3	3.0	19.3	1.9	20.6	0.9	3.0	3.1	0.8	2.0	22.8	7.7	36.1	7.4	16.3	1.1	19.3	0.0	4.8	0.4	2.3	5.1	1.0	1.3	5.5	3.4	11.7	1.6	6.8	3.7	31.2	1.1	0.0	1.1	0.4	0.0	0.3	1.0	0.0	0.3	0.1	12.4	22.5	0.0	3.1	0.1	0.0	14.3	1.7	2.4	0.1	0.1	1.3	0.0	1.9	7.0	0.5	0.2	21.6	0.5	6.7	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	10.0	0.0	8.4	1.0	57.2	0.0	4.2	0.0	0.1	1.7	7.6	0.9	0.3	0.9	0.4	0.1	0.1	8.1	36.7	0.1	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	6.5	1.1	1.1	7.6	3.4	6.8	8.1	3.3	1.3	2.0	6.1	5.5	1.1	0.6	3.1	3.4	1.6	11.7	0.4	0.9	3.7	32.9	25.9	13.8	33.4	36.1	17.7	28.0	20.1	19.3	19.3	0.0	13.0	3.2	2.5	0.9	4.2	7.7	7.6	8.1	2.3	7.0	0.0	0.1	8.3	3.7	0.0	0.5	56.4	0.0	4.0	0.4	1.4	2.0	6.9	0.4	11.1	0.0	15.5	0.0	21.6	0.0	0.0	13.7	10.1	0.0	30.1	1.2	12.4	34.3	0.0	5.9	0.6	0.0	1.0	0.3	0.9	1.1	0.6	4.4	26.9	3.3
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase, RNA specific B1"	P78563	21	45073853-45226560	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 59.9"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 52.9;Horizontal cells: 65.2;Muller glia cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 27.9;HHSteC: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	12.2	5.3	7.1	10.4	8.4	4.5	8.9	33.1	11.6	11.7	17.2	2.5	5.6	2.9	13.4	6.6	14.0	8.8	11.1	6.7	7.3	8.1	4.6	4.0	19.9	11.8	7.4	8.1	5.3	4.7	19.0	3.7	12.0	13.6	14.7	5.0	11.0	4.6	8.7	11.8	10.8	5.9	59.9	3.5	10.5	11.7	3.8	4.0	3.9	3.8	4.5	8.4	34.6	20.3	6.1	2.1	4.8	0.6	0.5	2.6	0.5	3.1	0.4	2.5	2.9	3.1	2.1	3.4	2.1	3.5	6.9	4.4	5.0	0.5	1.0	5.8	10.5	3.8	0.3	3.7	8.9	7.6	0.7	3.3	6.9	27.9	3.3	32.3	4.7	3.4	11.6	3.9	2.4	7.2	2.6	7.2	9.6	1.6	0.4	20.0	2.3	3.1	4.5	4.0	1.6	4.8	0.9	2.4	3.2	1.5	1.0	14.7	3.9	17.1	0.7	5.4	4.3	1.6	3.8	7.6	2.3	2.8	9.2	8.0	3.1	1.4	0.8	2.0	11.1	12.1	1.3	0.2	4.8	1.1	0.6	1.8	2.4	2.6	1.6	0.0	6.1	1.8	1.4	0.2	0.5	0.3	2.1	1.6	0.5	7.1	8.4	33.1	11.6	7.3	8.1	7.4	8.1	13.6	4.0	0.0	0.6	3.2	2.5	9.8	52.9	17.1	0.0	0.0	2.3	0.0	11.8	0.4	0.0	1.3	2.0	13.5	0.4	0.0	0.4	0.9	11.0	4.9	8.1	5.9	6.1	65.2	0.0	14.7	3.4	1.9	3.4	2.9	5.0	7.2	0.7	34.4	1.0	0.0	5.3	2.2	15.5	0.0	18.6	4.1	11.5	6.4	0.8	6.9	1.2	2.0
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase, tRNA specific 2"	Q7Z6V5	6	143422832-143450673	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	7.3	9.5	6.6	15.1	9.4	17.1	8.6	7.7	8.8	6.6	9.5	4.9	4.7	9.9	8.3	5.3	12.0	7.9	7.6	4.2	5.2	3.8	7.5	13.2	11.3	17.6	4.9	8.0	7.5	13.3	7.1	9.6	4.0	7.3	8.6	13.3	6.0	10.1	6.2	13.3	17.1	10.0	6.5	6.7	13.1	10.8	4.1	5.3	8.6	10.8	10.1	13.5	6.6	8.7	2.8	3.2	0.4	1.4	1.9	6.6	2.3	2.9	2.5	3.1	10.6	2.6	8.5	4.7	4.2	1.9	2.9	4.1	6.7	7.5	10.5	4.6	2.8	3.3	8.6	5.8	5.9	5.7	5.5	13.0	14.8	10.5	13.5	3.3	20.8	7.4	2.9	8.7	5.7	9.1	2.5	6.2	9.7	16.1	9.1	4.4	4.2	8.0	11.7	4.0	4.0	4.8	9.8	9.2	8.5	4.5	3.3	6.9	4.7	3.5	9.5	2.8	1.7	4.0	7.6	4.8	4.3	3.6	8.8	8.0	9.4	6.6	7.9	4.0	17.5	4.9	0.0	0.9	0.0	3.2	1.4	4.7	2.8	3.0	2.9	3.2	2.0	3.4	5.1	0.4	1.9	0.2	3.0	6.6	2.3	6.6	9.4	7.7	8.8	5.2	3.8	4.9	8.0	7.3	5.3	6.0	11.7	0.8	3.4	6.0	3.6	2.7	0.0	2.7	4.5	1.8	0.0	2.0	3.3	3.4	1.0	4.7	1.8	23.3	3.4	2.1	4.4	2.9	7.0	4.0	4.1	1.6	4.1	4.3	5.1	1.1	6.4	2.8	5.0	0.0	5.6	2.0	4.8	0.0	3.2	0.7	3.1	0.0	4.9	1.8	5.4	8.2	0.7	6.9	7.8	3.8
ADAT3	TAD3	ENSG00000213638	"Adenosine deaminase, tRNA specific 3"		19	1905378-1913447	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 5.5;Suprabasal keratinocytes: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 14.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.9"					"Low region specificity"	"Detected in all"			HPA058899	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA058899: AB_2683847"	"unprognostic (1.79e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.43e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.55e-3)"	6.5	7.4	4.7	5.6	7.9	5.0	6.5	7.3	10.6	4.5	12.4	18.2	7.7	31.0	6.0	7.4	12.1	7.3	7.1	4.4	4.8	3.7	9.4	7.8	6.2	4.4	8.1	4.9	8.7	7.5	3.4	8.6	9.0	10.4	8.3	5.3	7.8	16.1	7.0	5.4	18.3	20.5	3.0	12.5	8.9	15.6	5.5	7.3	3.1	8.8	3.3	6.5	3.2	7.7	2.2	14.0	0.3	1.3	4.9	2.6	0.7	4.8	1.3	0.7	1.0	0.4	0.0	6.2	1.8	0.3	0.7	1.0	2.0	1.5	2.9	0.7	0.2	0.4	3.2	0.2	0.2	0.0	7.0	12.9	0.7	2.9	2.6	0.3	1.3	9.2	0.0	0.2	0.8	0.0	0.1	0.6	0.8	8.0	1.6	0.4	1.0	2.3	4.2	6.8	0.2	8.8	7.8	1.2	4.7	0.8	1.3	2.8	6.7	2.2	5.2	2.4	0.3	4.0	1.0	1.6	0.7	2.9	2.6	3.8	2.8	2.6	2.5	0.6	1.3	1.6	0.3	1.3	0.0	1.6	0.6	1.6	1.0	2.3	2.5	1.8	2.2	1.7	2.6	0.3	4.9	1.1	14.0	2.3	0.7	4.7	7.9	7.3	10.6	4.8	3.7	8.1	4.9	10.4	7.3	0.0	1.0	1.5	1.1	5.5	0.0	0.6	2.5	2.7	0.0	0.0	0.0	1.3	1.7	1.0	0.0	0.6	3.5	0.0	0.6	1.9	1.0	0.2	0.0	0.8	1.6	0.0	1.2	3.1	1.2	0.2	0.0	0.9	0.0	1.0	0.9	0.0	0.5	3.5	0.7	2.9	0.0	0.0	0.3	0.9	1.6	9.7	3.8	0.0	1.5	0.7
ADCK5	FLJ35454	ENSG00000173137	"AarF domain containing kinase 5"	Q3MIX3	8	144373101-144393242	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025692, HPA028679"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA025692: AB_10599486, HPA028679: AB_10600226"	"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.31e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.90e-2)"	4.1	10.0	4.8	8.9	4.5	4.5	4.3	11.5	9.1	4.6	18.3	2.8	7.6	19.1	5.8	4.2	7.2	4.2	6.3	3.8	3.9	4.1	4.8	6.9	3.7	5.0	3.4	8.4	5.5	5.6	4.7	4.1	3.7	4.5	4.7	4.0	4.6	7.4	4.7	5.6	8.3	17.0	2.7	2.4	6.7	5.6	7.7	3.8	6.8	4.1	4.9	6.1	5.1	5.0	4.7	6.3	2.5	5.4	1.8	4.1	2.8	3.9	4.9	1.1	3.4	0.9	0.8	5.7	3.3	1.9	2.7	0.9	5.3	4.2	1.7	2.4	0.7	0.9	5.2	0.2	3.6	0.2	4.4	1.6	4.5	3.6	5.9	2.7	1.0	3.5	1.4	2.1	0.9	0.8	1.5	1.8	3.1	2.9	3.1	1.5	10.3	3.2	4.4	0.7	3.4	3.7	4.3	1.7	3.1	1.8	3.7	0.7	1.8	4.9	3.9	2.8	0.9	3.4	3.0	1.3	1.4	5.2	3.5	2.2	1.4	0.4	1.6	3.2	3.9	2.0	1.8	4.2	2.5	2.3	5.4	3.0	1.8	2.8	1.8	6.3	4.7	2.9	1.5	0.7	1.8	5.0	4.0	4.1	2.8	4.8	4.5	11.5	9.1	3.9	4.1	3.4	8.4	4.5	3.8	3.0	1.7	2.2	3.4	3.7	9.2	2.0	7.6	6.7	1.2	5.2	15.7	3.5	3.3	7.7	6.5	4.1	43.3	0.0	6.3	9.4	3.9	2.3	9.2	6.7	7.0	3.2	8.1	3.7	3.8	8.6	5.5	5.2	3.3	11.8	26.0	5.8	9.0	14.0	6.7	5.1	15.2	12.9	3.3	13.4	10.4	4.4	2.1	5.7	20.0	2.2
ADCY1	"AC1, DFNB44"	ENSG00000164742	"Adenylate cyclase 1"	Q08828	7	45574140-45723116	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, cAMP biosynthesis"	"Calmodulin-binding, Lyase"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0"	"Group enriched"	"Detected in many"	8	"Cone photoreceptor cells: 490.9;Rod photoreceptor cells: 145.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 15.3;SH-SY5Y: 17.6;SK-MEL-30: 20.3;WM-115: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018364, HPA068274"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB018364: AB_2223098, HPA068274: "	"unprognostic (9.41e-3)"	"unprognostic (7.30e-4)"	"unprognostic (9.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.74e-6)"	"unprognostic (2.49e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.23e-1)"	2.8	2.8	11.5	0.7	11.7	0.4	6.8	22.7	29.0	7.8	0.9	2.0	0.0	0.7	2.7	1.1	1.2	2.4	1.2	4.0	11.6	4.0	1.8	9.6	1.0	0.8	5.8	13.4	1.2	3.6	1.0	1.5	0.9	6.2	4.1	1.0	5.0	0.8	2.1	9.2	0.6	0.7	1.6	2.2	1.0	1.8	3.9	1.2	0.0	3.0	0.2	0.8	1.0	1.5	0.5	0.4	0.6	0.1	0.0	0.2	0.0	0.5	3.9	1.5	2.2	2.9	0.0	2.7	0.1	0.0	0.5	0.2	0.4	0.0	0.0	0.2	0.1	4.0	1.2	2.5	0.2	0.0	7.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	3.4	1.9	0.3	15.3	0.0	0.1	5.8	0.2	4.7	0.2	4.6	0.0	0.0	5.7	3.3	0.0	0.0	0.0	7.6	0.0	3.8	9.2	17.6	1.4	0.0	20.3	2.2	1.3	2.3	0.0	0.4	2.9	0.3	2.3	0.0	0.0	0.0	0.0	0.0	11.6	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	11.5	11.7	22.7	29.0	11.6	4.0	5.8	13.4	6.2	1.2	0.0	0.0	0.0	0.4	0.2	35.8	9.0	0.0	0.0	0.0	0.0	490.9	0.1	1.7	0.0	2.3	1.0	0.0	0.0	0.8	0.1	1.9	2.6	0.0	34.7	0.3	39.7	30.0	18.4	3.2	0.4	1.7	0.0	3.3	0.0	0.2	11.9	0.9	0.0	7.1	0.2	145.7	0.0	5.0	0.7	6.8	0.1	0.0	0.0	0.5	0.3
ADCY6	AC6	ENSG00000174233	"Adenylate cyclase 6"	O43306	12	48766194-48789037	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018365	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB018365: AB_2257941"	"unprognostic (1.18e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-3)"	"unprognostic (5.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.48e-2)"	25.9	9.6	14.1	12.4	7.5	0.8	19.7	15.0	17.0	9.8	15.2	5.5	16.2	12.3	13.2	12.8	6.2	9.5	17.6	37.5	9.9	8.3	11.3	5.6	8.5	4.7	5.6	11.0	14.6	17.4	15.8	9.1	9.5	8.9	11.1	12.6	11.8	19.9	12.0	7.3	10.2	13.9	9.1	4.7	2.9	13.5	4.0	5.5	0.6	11.1	6.8	3.8	7.8	14.9	1.8	0.4	1.4	0.4	0.5	0.4	0.5	5.9	11.6	13.4	8.4	14.1	7.1	14.5	7.4	7.4	9.0	6.3	20.6	20.2	0.0	16.9	6.4	3.6	4.8	3.9	4.9	3.2	0.0	6.0	5.5	15.8	3.7	8.1	0.0	4.5	9.0	6.1	7.5	2.8	16.5	8.1	0.3	0.7	2.0	6.6	10.3	0.0	0.2	4.6	9.1	5.5	1.9	5.1	3.3	10.1	18.7	2.0	8.3	7.6	30.4	6.6	5.9	23.7	1.5	9.3	8.4	6.1	4.4	3.2	3.1	1.6	0.2	7.6	0.0	3.8	1.4	0.4	0.4	0.3	0.2	0.2	1.1	0.3	0.2	0.3	1.8	0.4	0.3	0.9	0.5	0.4	0.4	0.2	0.5	14.1	7.5	15.0	17.0	9.9	8.3	5.6	11.0	8.9	5.5	0.0	5.4	0.8	2.8	2.4	7.4	6.7	10.2	1.4	5.7	17.4	19.6	5.4	0.0	5.6	0.4	6.0	26.4	0.0	3.5	2.2	5.7	6.2	1.1	6.0	1.9	9.5	8.1	4.9	0.3	0.5	10.6	1.1	6.8	1.0	24.4	5.6	8.0	31.6	8.9	2.9	8.6	19.4	16.7	1.2	1.3	1.8	4.2	0.0	19.7	5.8
ADCY7	"AC7, KIAA0037"	ENSG00000121281	"Adenylate cyclase 7"	P51828	16	50246137-50318135	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 34.7;granulocytes: 48.6;Hofbauer cells: 30.2;Kupffer cells: 61.4;Macrophages: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 23.3;HMC-1: 65.3;RPMI-8226: 32.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041218, HPA048241"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA041218: AB_2677365, HPA048241: AB_2680326"	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.59e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.52e-4)"	6.3	4.3	7.0	17.4	9.7	14.9	3.9	1.2	5.2	3.7	5.0	9.8	0.8	2.8	3.7	4.8	13.2	5.3	6.9	7.3	5.3	4.2	3.3	3.6	16.4	16.5	8.8	4.4	17.1	3.7	1.0	3.4	9.7	8.6	3.5	5.9	6.2	6.5	1.6	1.8	7.9	10.4	5.0	12.3	26.9	4.9	2.1	9.2	21.8	3.7	3.1	26.0	6.6	6.1	3.6	12.5	6.5	16.7	8.4	7.0	5.0	4.0	5.5	0.2	0.8	0.6	7.1	0.5	2.8	1.3	2.2	2.0	5.2	8.4	1.6	7.6	11.4	0.1	14.7	5.8	2.4	2.7	15.4	2.0	23.3	4.2	1.5	6.5	4.4	65.3	3.8	2.4	1.6	2.6	1.2	0.6	5.3	8.5	3.2	3.1	2.3	1.7	10.4	1.0	1.9	7.9	1.6	2.1	32.4	1.5	0.4	1.0	2.7	1.5	0.6	1.3	1.4	0.1	13.0	5.2	0.3	7.6	0.8	0.8	0.3	0.1	3.5	2.4	9.5	1.0	6.5	7.8	2.9	7.0	11.7	5.1	3.2	2.8	5.0	12.5	3.6	2.6	3.7	4.4	8.4	16.7	6.5	3.9	5.0	7.0	9.7	1.2	5.2	5.3	4.2	8.8	4.4	8.6	9.2	17.9	34.7	6.9	0.3	3.3	1.0	0.6	0.0	0.0	12.5	0.0	5.9	9.3	0.0	1.6	1.3	1.0	1.7	0.0	0.2	0.9	11.4	0.3	48.6	0.2	30.2	0.0	0.0	1.8	61.4	0.5	0.6	41.8	5.0	3.6	0.5	0.9	3.1	7.0	1.1	0.0	0.4	6.5	1.4	0.0	0.7	3.4	3.3	18.5	2.1	1.0
ADCY9	AC9	ENSG00000162104	"Adenylate cyclase 9"	O60503	16	3953387-4116185	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 36.4"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041328, HPA044225"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041328: AB_2677414, HPA044225: AB_2678863"	"unprognostic (1.78e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.24e-8)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-2)"	5.2	4.8	7.1	3.2	10.9	0.9	5.4	8.5	9.6	7.0	6.4	4.1	4.4	6.5	6.5	4.4	6.8	7.7	6.5	13.3	6.2	3.0	8.0	9.6	11.1	2.5	3.0	6.2	9.4	12.5	12.3	5.8	7.8	7.7	3.6	5.5	9.0	10.1	5.0	36.4	4.4	10.9	6.3	2.2	3.2	5.5	4.4	3.4	0.7	21.8	7.7	3.0	7.9	4.8	0.1	1.0	3.2	1.5	1.0	1.9	0.9	4.9	7.6	2.3	4.3	8.3	10.2	3.5	8.8	9.2	4.9	4.0	6.3	4.4	0.0	13.5	24.0	3.0	4.8	9.1	5.4	3.4	6.1	8.8	0.2	17.4	12.1	9.1	0.6	4.0	10.8	8.5	5.7	3.0	4.1	3.3	1.6	2.7	0.0	5.0	9.1	0.0	2.6	4.2	2.1	4.1	7.8	11.1	0.2	1.8	1.3	5.3	2.3	6.8	8.1	5.9	2.7	20.5	8.9	3.0	9.8	2.7	9.5	3.8	1.9	1.1	1.0	2.1	2.7	3.8	3.2	1.5	1.0	1.9	1.5	1.7	0.0	0.6	0.6	0.1	0.1	0.1	1.1	0.3	1.0	0.0	1.0	0.0	0.9	7.1	10.9	8.5	9.6	6.2	3.0	3.0	6.2	7.7	3.4	11.9	10.9	0.5	1.0	5.7	9.3	15.1	28.1	6.7	7.9	12.2	11.8	1.4	0.0	3.8	0.6	5.2	13.6	0.0	4.6	1.7	6.9	0.6	0.0	17.4	1.4	1.6	1.2	8.0	5.9	1.5	7.8	2.6	6.8	1.0	8.4	7.5	2.8	0.0	7.1	4.7	12.8	0.0	13.8	1.1	5.2	3.3	0.8	4.3	5.2	0.9
ADD2	ADDB	ENSG00000075340	"Adducin 2"	P35612	2	70607618-70768225	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 53.6;brain: 35.0"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 28.5;Erythroid cells: 70.0;Horizontal cells: 131.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 4.7;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	20	"B-cells: 4.7;monocytes: 4.4;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.3;JURKAT: 13.9;K-562: 18.7;NTERA-2: 36.9;RPMI-8226: 17.6;SCLC-21H: 18.4;U-251 MG: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009796, HPA034509, HPA034510"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		66000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.47e-7)"	"unprognostic (2.81e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-3)"	1.9	2.6	14.0	2.6	17.9	53.6	1.5	29.7	35.0	1.3	1.3	1.2	0.0	1.0	1.3	1.2	2.3	1.4	1.2	1.5	14.1	10.7	0.9	0.9	1.8	3.1	6.0	19.7	1.0	2.1	1.3	2.8	1.6	14.0	1.3	1.2	1.7	1.1	1.1	1.6	1.2	1.2	1.9	6.0	1.9	1.1	2.9	2.7	0.0	2.3	0.0	2.9	1.5	0.5	4.7	0.1	0.1	4.4	0.0	1.9	0.6	7.1	8.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.1	5.3	0.0	14.3	0.0	0.0	0.0	8.4	0.7	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.4	0.0	13.9	18.7	0.0	0.0	0.0	0.1	0.6	36.9	0.0	0.2	0.0	0.2	17.6	2.4	0.0	18.4	8.3	9.1	0.0	0.0	4.2	0.0	4.4	0.3	0.0	0.4	0.0	19.4	6.0	7.0	0.0	0.3	2.9	3.3	0.1	0.1	0.0	0.0	2.4	0.1	4.7	0.0	0.0	0.1	4.0	1.9	1.0	0.1	0.0	4.4	0.0	0.0	0.6	14.0	17.9	29.7	35.0	14.1	10.7	6.0	19.7	14.0	2.7	0.0	0.3	3.4	0.1	0.1	19.8	2.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	28.5	2.9	0.0	70.0	0.9	0.2	1.0	0.7	0.0	0.0	0.2	131.9	0.0	1.3	0.3	24.0	0.9	0.0	1.7	1.0	0.0	0.5	0.5	0.0	0.7	0.0	9.4	0.0	0.0	0.7	3.2	0.1	0.2	0.0	0.0	0.6
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 102.4;Kupffer cells: 83.8;T-cells: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA013707	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	Yes	10000000	930000	Cytosol		"HPA013707: AB_1846345"	"unprognostic (3.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.51e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.41e-2)"	17.7	8.9	2.5	23.0	4.0	55.3	14.3	1.1	5.2	21.7	15.9	12.9	0.5	12.9	56.9	18.5	11.6	19.1	27.1	16.4	3.0	2.4	10.7	15.5	30.3	41.1	6.3	3.2	10.7	16.2	2.4	3.3	18.2	5.9	11.3	9.0	6.9	17.0	3.6	12.5	6.0	22.2	36.2	4.2	56.9	15.0	6.9	4.9	24.3	8.6	3.7	22.5	34.7	12.4	3.9	13.3	95.3	43.2	22.8	25.8	23.3	30.8	21.9	0.2	21.0	9.3	15.3	3.3	21.4	34.5	15.4	16.9	6.2	31.3	3.5	21.7	27.5	22.0	7.3	5.7	10.4	6.9	19.2	6.4	6.9	32.5	2.7	11.5	14.9	32.3	6.7	0.3	15.7	5.4	5.0	1.5	6.1	9.0	27.7	16.8	6.9	0.9	20.0	0.6	24.5	27.3	2.0	9.2	16.1	5.2	2.7	0.2	0.7	12.2	17.5	15.2	0.5	4.5	13.8	3.7	5.2	8.7	21.7	35.2	0.0	0.1	0.2	18.7	26.7	19.5	42.0	18.6	95.3	25.8	36.7	17.3	3.9	13.1	17.8	13.3	2.6	9.4	12.8	82.7	22.8	43.2	6.4	9.0	23.3	2.5	4.0	1.1	5.2	3.0	2.4	6.3	3.2	5.9	4.9	32.8	102.4	15.9	7.4	0.0	0.2	3.1	12.7	50.9	31.8	0.0	0.0	2.7	0.0	15.1	0.0	4.5	10.2	23.3	19.1	36.8	4.8	9.8	70.9	1.5	47.0	0.0	4.7	26.4	83.8	1.0	6.1	50.6	0.0	2.8	34.7	2.3	17.9	21.0	4.6	0.7	1.2	25.8	17.2	0.5	5.7	0.0	6.6	152.3	31.8	14.1
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989309-19122637	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 202.4"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 5.1;Ciliated cells: 4.0;Glandular cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 4.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.3;BEWO: 7.9;HeLa: 6.5;NTERA-2: 6.8;SH-SY5Y: 7.1;U-2197: 15.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		7900000	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	4.4	0.3	0.4	0.9	0.2	0.2	2.8	0.1	0.2	0.8	1.0	0.1	6.6	0.2	0.5	202.4	0.9	6.9	1.4	1.8	0.6	0.6	0.7	0.9	1.7	3.1	0.2	0.2	0.9	0.9	24.8	1.9	0.6	0.3	3.2	0.2	1.6	9.6	0.8	0.6	0.3	1.4	0.6	0.2	1.2	3.5	4.7	0.2	2.7	1.8	0.6	1.9	1.1	1.5	0.1	0.2	0.9	0.6	0.0	0.2	0.0	0.2	6.3	0.0	0.0	0.1	1.0	7.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.5	0.0	6.5	0.3	0.9	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.3	6.8	0.0	2.1	0.0	0.1	4.5	0.0	1.3	2.4	7.1	1.6	0.1	0.0	1.2	0.1	0.1	0.1	0.2	0.4	15.7	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.9	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.6	0.1	0.0	0.0	0.4	0.2	0.1	0.2	0.6	0.6	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.8	5.1	4.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	3.0	0.0	0.4	0.0	3.2	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.5	1.8	0.0	1.4	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1
ADGRG5	"GPR114, PGR27"	ENSG00000159618	"Adhesion G protein-coupled receptor G5"	Q8IZF4	16	57542421-57591681	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 37.7;lymphoid tissue: 25.6"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 2.2;Kupffer cells: 1.2;monocytes: 1.8;T-cells: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HMC-1: 28.1;OE19: 9.2"	"Region enhanced"	"Detected in single"		"thalamus: 0.4"	"Not detected"	"Not detected"			HPA007133	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA007133: AB_1849253"	"unprognostic (6.11e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.09e-4)"	"unprognostic (3.80e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.69e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.32e-3)"	0.7	0.6	2.4	20.2	2.7	1.4	0.8	0.6	2.1	0.6	2.1	2.5	0.0	4.3	0.5	0.2	1.7	0.8	0.8	0.5	1.6	1.1	0.5	0.6	2.9	12.1	2.6	0.9	0.5	0.4	0.2	0.8	0.0	2.9	1.2	1.7	0.5	4.6	0.8	0.4	0.7	7.5	0.3	3.5	12.8	0.5	1.2	3.5	3.4	1.1	0.2	25.6	2.8	0.9	4.0	21.9	37.7	0.0	8.8	11.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.4	2.6	9.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	37.7	11.1	0.0	5.6	4.0	1.6	6.4	0.7	2.8	0.4	4.0	0.1	8.8	0.0	21.9	0.0	2.3	2.4	2.7	0.6	2.1	1.6	1.1	2.6	0.9	2.9	3.5	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.7	0.4	0.0
ADGRG7	"FLJ14454, GPR128"	ENSG00000144820	"Adhesion G protein-coupled receptor G7"	Q96K78	3	100609589-100695479	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"intestine: 58.4;liver: 26.9"	"Cell type enhanced"	"Detected in some"	25	"Collecting duct cells: 1.8;Enterocytes: 2.6;Hepatocytes: 10.4;Paneth cells: 4.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 2.9;CACO-2: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA056451			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA056451: "		"unprognostic (1.65e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.79e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"			"unprognostic (9.37e-3)"		"unprognostic (2.84e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"		"unprognostic (6.77e-2)"	0.1	0.2	0.1	0.5	0.1	1.2	0.1	0.1	0.1	0.9	17.1	0.1	0.1	25.7	0.3	0.1	0.2	0.9	0.3	0.2	0.1	0.1	0.1	26.9	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	1.7	0.1	0.1	0.1	0.1	0.2	58.4	0.8	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0
ADGRL2	"KIAA0786, LEC1, LPHH1, LPHN2"	ENSG00000117114	"Adhesion G protein-coupled receptor L2"	O95490	1	81306160-81992436	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 51.9;Cardiomyocytes: 43.9;Hepatocytes: 33.8;Horizontal cells: 31.8;Ito cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 63.8;hTEC/SVTERT24-B: 31.7;NTERA-2: 26.8;SH-SY5Y: 42.7;U-2197: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043447			Approved	"Plasma membrane,Cell Junctions"		NA	NA		280000	"Plasma membrane, Cell Junctions"		"HPA043447: AB_2678486"	"unprognostic (2.54e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.81e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.76e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.41e-2)"	8.9	10.5	21.1	3.6	20.9	0.0	8.8	1.5	45.8	7.5	7.0	1.4	1.2	2.7	6.1	8.6	12.0	12.0	11.5	17.6	12.2	6.6	10.9	18.7	32.7	3.5	3.5	22.8	18.8	4.9	20.3	11.8	24.4	6.2	15.6	5.4	9.4	19.1	10.1	2.0	6.3	6.1	6.0	3.2	10.0	7.6	2.0	3.3	0.6	22.4	15.0	5.0	6.5	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.4	63.8	0.0	7.9	9.1	0.8	1.5	3.5	0.6	0.7	0.0	0.0	0.0	17.5	8.1	1.8	2.5	5.0	6.7	0.5	0.1	10.4	0.0	1.8	4.4	3.0	0.0	0.1	7.7	0.4	31.7	3.2	4.4	10.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	26.8	0.0	1.9	0.0	8.8	0.0	14.5	0.9	3.2	42.7	0.0	1.8	0.0	18.9	0.1	18.8	6.8	6.5	7.4	29.2	2.2	0.0	0.0	0.0	3.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	20.9	1.5	45.8	12.2	6.6	3.5	22.8	6.2	3.3	3.0	2.1	0.0	6.5	0.0	51.9	43.9	10.2	0.0	5.7	5.2	5.9	0.3	0.0	3.7	1.0	27.2	0.0	0.0	1.5	0.2	9.1	8.9	0.0	33.8	0.7	31.8	0.0	40.5	6.0	1.3	21.6	0.9	0.0	0.0	1.1	20.6	1.0	0.0	16.6	7.0	2.4	19.4	3.7	0.5	3.0	0.0	0.3	0.0	0.7	2.4
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 95.3;pituitary gland: 35.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 90.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 18.1;NTERA-2: 9.5;SCLC-21H: 8.8;SuSa: 12.4;U-266/70: 10.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067503	Approved		Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA067503: AB_2685856"	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.5	95.3	21.9	0.6	19.8	0.8	2.2	13.9	14.7	0.7	1.0	3.1	1.2	0.7	0.6	0.9	1.0	0.6	6.3	0.6	26.5	1.5	10.6	19.4	5.5	0.5	1.1	7.0	0.6	1.3	1.1	35.4	2.4	4.9	1.1	1.0	4.9	0.7	2.4	0.6	1.5	0.7	0.6	0.4	0.7	1.0	1.1	5.3	0.0	4.2	0.0	0.7	5.4	0.4	4.1	2.2	8.4	1.7	1.7	3.4	0.4	0.4	1.6	12.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	1.3	0.1	0.2	0.3	0.0	0.3	0.1	18.1	0.1	0.0	0.7	3.4	3.1	1.4	1.0	0.0	0.2	0.1	0.0	3.8	0.0	0.1	0.1	0.0	0.1	7.3	2.0	0.0	1.5	0.1	0.1	9.5	2.2	3.2	0.0	0.3	1.6	0.0	0.4	8.8	2.2	2.6	1.7	0.1	12.4	4.7	0.0	0.6	0.3	1.5	0.4	0.8	10.7	3.0	0.4	0.6	0.1	0.0	4.9	1.7	4.8	2.0	1.3	3.2	2.5	2.2	2.6	0.9	4.1	3.4	1.8	8.4	1.7	1.0	2.2	2.7	0.4	21.9	19.8	13.9	14.7	26.5	1.5	1.1	7.0	4.9	5.3	23.8	17.9	0.0	4.8	0.0	26.4	2.0	5.1	13.4	10.3	5.2	249.4	2.3	1.7	1.4	35.8	0.8	0.0	0.0	3.8	1.5	1.2	2.9	0.0	12.4	0.2	9.5	7.0	0.0	0.3	38.5	0.6	0.0	0.0	1.8	0.0	8.6	2.7	0.0	0.4	12.0	90.0	0.0	0.2	1.9	2.8	0.0	3.4	0.0	0.4	8.6
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 212.0"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 11.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	212.0	0.0	0.0	0.0	7.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 8.1;Club cells: 10.3"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 4.0;HaCaT: 4.5"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	8.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
ADHFE1	"ADHFe1, FLJ32430"	ENSG00000147576	"Alcohol dehydrogenase, iron containing 1"	Q8IWW8	8	66430185-66471601	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	12.5	3.2	10.3	2.2	9.7	1.8	4.3	2.2	10.7	5.9	3.8	10.9	4.8	2.7	4.2	8.6	3.1	5.9	5.0	34.6	6.9	5.4	11.8	44.5	3.6	2.3	8.6	7.5	5.2	8.3	11.6	9.8	3.7	6.9	7.3	3.1	10.7	6.6	10.5	35.7	2.4	2.4	6.9	4.8	2.8	8.6	3.2	7.3	0.0	4.5	12.9	2.5	6.2	1.9	1.3	0.4	3.4	1.1	2.2	2.6	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.4	0.3	0.0	0.0	1.7	0.0	0.0	0.7	0.3	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	3.0	0.0	0.2	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.9	0.0	0.5	1.2	1.4	2.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.1	0.1	0.8	0.0	0.3	3.4	1.1	0.0	2.6	0.0	2.4	1.3	0.5	2.2	0.4	0.8	0.7	2.2	0.1	2.2	0.0	0.3	0.0	0.6	10.3	9.7	2.2	7.8	6.9	5.4	8.6	7.5	6.9	7.3	8.9	12.4	2.7	3.8	0.9	1.4	32.1	15.3	20.1	13.6	8.7	9.8	7.1	10.0	1.1	0.3	1.6	2.0	0.0	0.6	0.8	2.7	4.3	8.1	23.7	2.1	0.0	3.5	7.4	1.0	1.0	22.2	1.4	0.0	0.0	1.5	6.7	0.8	5.8	25.5	10.9	7.6	0.0	3.3	0.2	0.2	0.9	97.4	8.7	1.8	2.0
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497361-3519736	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 127.7"	"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 752.7;Hepatocytes: 1079.9;Proximal tubular cells: 1041.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	13.5	19.1	10.8	9.0	11.5	6.4	15.1	5.2	9.2	12.5	60.6	9.3	29.9	27.3	11.7	17.8	16.3	11.4	35.5	49.5	9.0	7.9	42.6	127.7	10.8	12.4	11.3	9.4	12.8	14.7	9.2	8.4	18.7	9.6	24.5	11.8	10.7	22.7	27.0	43.1	7.9	38.9	17.3	11.7	16.6	18.3	8.0	7.9	4.9	12.9	18.9	10.4	14.7	17.9	14.2	37.8	64.7	26.5	10.1	17.7	32.2	12.0	14.7	13.3	10.6	46.7	22.8	24.9	25.2	32.6	27.4	19.9	20.9	13.8	5.7	39.9	26.7	4.6	11.0	15.7	11.8	14.1	10.2	35.1	17.6	9.5	33.8	39.1	18.2	39.5	25.2	15.7	12.8	16.0	9.7	17.2	8.4	13.1	10.0	21.5	27.1	6.1	32.1	11.6	27.4	23.0	6.5	8.5	32.4	19.0	18.0	14.9	15.0	13.9	14.7	9.6	8.2	15.6	19.3	14.3	18.9	7.7	9.2	14.1	9.9	23.9	23.4	13.9	28.3	9.9	14.2	26.5	64.7	6.3	25.2	6.8	14.2	14.9	5.9	25.6	11.2	17.7	5.9	12.3	10.1	22.0	37.8	13.8	32.2	10.8	11.5	5.2	9.2	9.0	7.9	11.3	9.4	9.6	7.9	62.5	87.9	109.0	118.8	67.5	8.0	255.0	285.3	33.5	56.9	144.8	13.7	343.4	752.7	121.5	6.7	56.4	182.2	46.7	76.6	194.2	104.6	159.8	40.5	1079.9	211.6	7.9	54.8	164.5	143.1	16.8	126.8	60.1	194.0	117.2	123.2	123.6	76.7	181.4	197.7	1041.1	13.1	161.7	119.7	4.6	8.9	67.1	319.0	55.1	135.6	117.6
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968192-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 1712.2;Smooth muscle cells: 2588.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.9;naive CD8 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	11	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"A-431: 25.7;HaCaT: 66.5;PC-3: 36.3;RT4: 46.2"					"Low region specificity"	"Detected in many"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		580000	"Nucleoplasm, Cytosol"		"HPA026810: AB_2672003"																		123.4	9.5	15.7	21.4	6.1	1.5	109.7	1.6	8.4	44.3	65.3	6.8	21.6	66.2	25.3	34.6	24.3	34.7	29.9	24.8	17.3	6.1	20.3	10.3	32.5	5.4	10.5	9.3	54.7	12.6	7.2	11.7	8.7	7.2	38.6	7.0	23.6	41.5	38.8	30.5	23.7	69.5	19.8	9.6	10.0	12.2	12.5	9.9	1.2	29.7	38.6	8.3	39.5	41.6	0.0	0.3	0.0	0.3	0.0	3.9	0.6	25.7	0.3	0.0	0.0	2.1	12.7	1.8	9.0	9.7	0.0	0.0	0.9	3.3	0.0	0.3	11.0	0.6	66.5	0.0	2.1	0.1	0.9	0.0	0.0	2.7	0.2	1.2	0.0	0.4	0.3	4.1	0.0	5.9	0.9	3.6	0.3	0.1	3.6	0.3	3.2	0.1	0.7	0.1	0.5	36.3	0.1	0.0	0.3	0.4	46.2	1.6	0.1	3.0	13.8	0.1	0.0	17.0	0.3	9.8	0.3	2.1	1.7	0.0	0.5	0.4	0.0	0.7	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.3	0.0	3.9	2.8	0.0	0.0	0.0	0.0	0.2	0.6	15.7	6.1	1.6	7.9	17.3	6.1	10.5	9.3	7.2	9.9	1712.2	356.0	16.7	133.5	469.5	4.8	0.0	50.9	125.8	883.8	177.9	2.0	235.3	1145.6	5.7	8.2	494.5	1530.9	23.3	240.4	10.7	324.4	500.6	48.4	93.5	24.0	0.0	28.8	792.4	7.8	23.6	1212.4	52.8	578.6	174.1	95.1	265.3	201.2	1122.8	441.6	716.9	13.2	1448.7	2588.8	2.5	4.4	383.4	139.5	13.1	194.6	684.0
ADNP	"ADNP1, KIAA0784"	ENSG00000101126	"Activity dependent neuroprotector homeobox"	Q9H2P0	20	50888916-50931421	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006371	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006371: AB_1078105"	"unprognostic (3.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.68e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-1)"	23.7	26.5	32.2	28.1	29.3	21.3	32.4	46.0	35.4	26.3	24.2	23.0	34.2	18.4	32.6	38.7	27.8	28.4	25.5	19.9	27.2	21.1	23.7	22.7	27.9	29.0	29.0	28.5	38.8	21.7	49.2	32.4	23.5	25.6	27.4	22.4	26.1	25.3	30.6	31.8	28.6	25.6	28.6	23.9	28.6	24.9	33.4	28.2	50.2	28.4	17.4	31.1	32.1	33.1	16.4	28.7	15.0	24.6	15.1	30.9	8.1	20.9	19.8	37.6	19.8	18.8	18.5	16.2	15.6	17.7	30.8	22.6	28.4	16.5	27.4	20.5	18.7	16.1	24.0	31.6	29.9	36.3	13.1	11.3	19.6	22.1	21.8	18.2	31.1	17.0	17.5	37.2	18.8	34.0	22.4	20.4	16.9	25.8	19.4	19.4	21.2	30.6	20.7	18.8	18.2	15.9	28.6	20.9	20.0	18.0	28.3	31.3	23.6	35.8	51.5	26.3	25.6	24.5	29.2	17.3	27.4	29.6	20.7	16.8	14.1	16.4	46.6	15.4	18.3	18.7	15.0	12.3	10.6	20.8	18.5	22.5	13.6	23.4	19.0	13.9	16.4	23.4	30.9	6.3	15.1	24.6	28.7	15.4	8.1	32.2	29.3	46.0	35.4	27.2	21.1	29.0	28.5	25.6	28.2	8.9	19.5	18.0	29.5	53.2	39.0	30.7	40.8	10.7	23.9	14.0	23.6	26.4	14.9	19.0	21.4	29.2	18.0	0.0	19.0	18.1	29.3	29.1	17.3	25.9	19.0	36.5	35.6	25.8	22.4	24.8	29.1	18.3	38.8	14.4	31.8	27.7	23.4	21.0	37.4	17.3	33.7	38.8	27.6	26.7	26.4	45.5	18.5	27.7	32.0	34.4
ADNP2	"KIAA0863, ZNF508"	ENSG00000101544	"ADNP homeobox 2"	Q6IQ32	18	80109031-80147523	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007126	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA007126: AB_1080729"	"unprognostic (4.93e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.64e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (9.90e-4)"	"unprognostic (5.19e-2)"	11.3	8.8	9.1	7.6	10.4	40.5	10.9	8.4	12.5	7.7	8.6	14.4	7.1	10.8	10.2	13.5	12.5	10.0	11.1	10.2	9.8	7.0	8.4	11.3	10.3	11.6	8.0	10.4	12.7	10.4	12.7	12.4	11.4	10.4	9.2	8.2	12.6	9.1	8.9	4.0	16.5	9.7	13.1	10.1	8.7	11.2	24.4	6.7	14.3	10.1	8.1	10.4	11.3	10.8	2.4	2.3	1.7	3.0	1.4	4.4	1.5	11.2	8.8	18.4	13.5	4.2	6.0	13.9	8.2	9.3	9.7	12.3	8.2	5.7	0.1	3.2	6.5	12.2	10.3	17.9	10.5	10.6	10.2	8.9	15.8	6.8	9.0	7.7	23.1	17.7	6.1	9.9	9.9	13.6	6.5	9.8	18.2	15.2	16.8	5.7	7.9	21.2	4.7	12.5	5.0	10.3	8.0	20.6	8.0	5.8	15.1	12.6	16.1	9.3	9.1	6.4	9.4	8.9	17.6	6.5	11.6	29.1	4.8	8.9	6.0	11.0	23.4	7.8	9.7	7.8	0.0	1.1	0.7	3.4	1.7	2.4	2.4	4.4	2.9	0.6	1.1	2.4	4.1	1.7	1.4	3.0	2.3	2.1	1.5	9.1	10.4	8.4	12.5	9.8	7.0	8.0	10.4	10.4	6.7	17.9	18.1	2.9	21.0	35.0	19.0	14.9	10.2	5.3	11.4	3.5	25.5	8.0	0.0	6.8	6.7	11.3	10.7	0.0	9.5	6.7	11.4	19.3	11.5	16.3	8.2	23.8	21.4	16.0	9.7	7.2	6.9	11.0	13.5	1.8	14.4	8.6	9.0	13.9	11.0	5.7	29.2	0.0	14.5	38.4	36.9	37.8	8.1	8.6	12.1	26.2
ADPGK	"ADP-GK, DKFZp434B195"	ENSG00000159322	"ADP dependent glucokinase"	Q9BRR6	15	72751369-72785846	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045194, HPA058525"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		35000	Centrosome		"HPA045194: AB_10964638, HPA058525: AB_2683742"	"unprognostic (5.96e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.22e-4)"	"prognostic unfavorable (4.52e-7)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-2)"	15.3	13.5	6.7	16.4	10.7	23.1	13.2	7.8	11.7	10.2	11.3	14.9	11.2	8.9	9.5	14.3	11.1	11.0	12.0	9.3	7.0	9.0	13.3	12.8	18.7	19.8	11.7	6.3	10.7	15.2	4.9	9.1	18.2	13.4	14.2	13.7	20.4	15.8	9.8	7.5	10.9	13.1	8.9	9.8	21.4	10.5	10.7	8.8	19.6	12.0	7.8	21.2	12.3	9.6	14.2	32.0	22.2	30.3	13.8	13.0	22.6	6.8	14.3	7.6	9.0	17.3	13.2	10.3	19.9	19.5	20.9	29.1	8.0	18.0	12.9	14.9	12.4	20.8	18.6	21.6	10.4	15.7	12.7	14.7	9.6	4.2	7.5	11.1	22.1	14.4	14.3	6.1	11.0	10.3	10.3	12.1	10.1	10.1	22.1	12.6	4.3	6.8	9.9	11.4	13.6	6.7	8.1	12.4	17.8	10.8	8.0	5.5	5.7	18.2	7.5	9.6	12.5	7.2	26.8	9.9	10.5	8.8	39.7	18.0	22.4	42.7	12.8	18.4	21.8	17.4	22.2	30.3	21.9	10.6	21.0	13.0	14.2	9.7	10.7	32.0	12.5	8.5	9.8	12.0	13.8	17.1	24.4	7.6	22.6	6.7	10.7	7.8	11.7	7.0	9.0	11.7	6.3	13.4	8.8	17.9	33.0	73.1	17.0	13.6	17.9	2.6	2.5	14.7	19.4	19.2	13.7	33.6	6.6	23.4	12.1	17.9	13.2	0.0	15.4	50.9	22.6	31.3	48.4	22.2	72.8	14.3	7.5	17.8	79.5	4.2	20.1	63.6	25.3	143.3	15.2	12.9	19.0	19.8	14.5	10.3	26.6	19.4	12.2	16.8	25.8	15.8	34.9	34.6	19.3	21.9
ADPRH	ARH1	ENSG00000144843	"ADP-ribosylarginine hydrolase"	P54922	3	119579268-119589945	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.0;HEL: 11.5;HMC-1: 13.0;Karpas-707: 17.6;U-266/70: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001701, HPA036961"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB001701: , HPA036961: AB_2675405"	"prognostic favorable (2.42e-4)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.35e-2)"	14.3	8.5	2.3	10.9	4.6	2.5	14.8	1.2	2.4	7.1	6.2	4.7	14.6	1.9	7.9	6.2	5.0	5.4	6.6	8.4	2.3	2.4	5.1	5.5	17.4	18.9	3.7	2.7	3.6	11.9	8.1	2.8	23.0	4.0	6.3	3.9	6.8	6.5	14.5	19.7	3.1	6.4	8.8	4.7	13.6	5.1	4.1	3.6	5.3	7.4	5.8	12.0	7.1	6.9	8.2	8.0	13.3	13.0	3.4	9.6	4.9	1.6	2.0	0.5	0.0	1.7	1.9	0.0	1.4	0.3	1.2	1.6	0.6	1.3	0.4	0.6	2.1	0.0	0.1	1.4	0.0	1.2	16.0	0.1	11.5	0.2	0.0	2.8	0.0	13.0	2.8	0.0	0.6	0.0	0.5	5.0	0.0	1.0	17.6	7.6	0.5	0.0	2.7	4.8	0.1	4.0	0.0	5.7	0.7	0.7	0.6	0.3	0.0	0.0	0.1	4.3	0.7	3.1	7.2	4.1	0.0	0.8	3.2	0.3	17.2	3.8	0.0	2.1	0.0	3.1	7.8	13.0	13.3	0.6	12.0	0.6	8.2	1.4	1.3	8.0	4.9	0.2	0.6	0.4	3.4	9.2	7.0	9.6	4.9	2.3	4.6	1.2	2.4	2.3	2.4	3.7	2.7	4.0	3.6	8.9	7.5	4.5	0.7	0.7	0.6	4.1	2.5	2.7	4.5	3.5	3.9	4.8	1.7	2.2	0.8	8.4	0.0	0.0	2.9	3.2	1.1	0.9	10.4	1.3	8.4	0.0	0.0	5.5	9.4	0.4	0.3	10.6	1.7	7.2	0.1	0.8	2.4	0.0	2.8	0.8	4.6	0.0	2.9	0.5	0.2	0.6	9.8	1.3	0.0	0.1
ADPRHL1	ARH2	ENSG00000153531	"ADP-ribosylhydrolase like 1"	Q8NDY3	13	113399610-113453524	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 89.6;skeletal muscle: 68.1"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 122.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.7;T-47d: 26.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.6"	"Not detected"	"Not detected"			"HPA066478, HPA072123"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA066478: AB_2685673, HPA072123: "	"unprognostic (3.03e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.02e-1)"	1.8	1.0	0.6	0.2	1.1	0.0	0.8	0.5	3.0	0.4	1.4	0.3	0.0	0.9	0.4	4.0	2.2	1.9	0.7	89.6	0.5	0.8	0.2	0.4	0.5	0.1	0.7	1.1	0.5	1.5	0.0	1.8	1.4	0.3	0.9	0.5	0.0	1.9	0.1	68.1	0.9	3.0	0.2	0.5	0.3	1.0	1.3	0.0	0.1	0.7	21.8	0.6	0.3	0.5	1.9	2.8	1.7	1.6	1.1	2.5	1.0	4.0	9.6	1.0	3.0	3.1	5.0	2.7	1.5	0.7	0.5	0.4	2.7	9.9	1.4	5.7	1.7	2.8	2.2	3.8	0.2	0.4	1.4	1.6	4.1	2.3	0.7	1.0	0.3	1.7	1.7	2.3	3.2	0.4	0.4	0.1	3.6	1.2	0.4	4.0	8.7	0.6	2.4	2.2	10.4	5.1	6.3	2.5	3.6	1.0	0.4	14.7	3.4	1.0	4.8	1.2	1.2	26.4	0.5	0.3	0.1	1.8	4.4	0.5	1.4	1.1	4.7	2.9	0.8	2.1	0.4	1.2	0.1	0.1	1.6	1.8	1.9	0.8	2.5	2.8	0.8	1.4	1.5	1.7	1.1	1.3	0.5	1.3	1.0	0.6	1.1	0.5	3.0	0.5	0.8	0.7	1.1	0.3	0.0	0.0	5.8	0.0	1.9	1.1	1.3	122.4	0.0	8.1	4.5	0.0	0.0	3.2	0.0	2.8	1.1	1.6	3.8	0.0	2.9	2.2	1.5	2.3	0.0	1.0	0.5	1.6	4.1	1.3	0.3	1.3	0.0	0.5	1.7	0.0	5.1	2.1	1.4	5.8	1.4	0.3	1.7	0.0	0.5	1.8	2.6	2.3	2.1	0.0	3.2	2.8
ADRA2B	"ADRA2L1, ADRA2RL1, ADRARL1"	ENSG00000274286	"Adrenoceptor alpha 2B"	P18089	2	96112875-96116245	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.1;EFO-21: 3.3;HAP1: 1.8;NTERA-2: 1.8;SuSa: 3.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA066029, HPA074948"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA066029: AB_2685599, HPA074948: "	"unprognostic (6.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.93e-4)"	"unprognostic (1.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (6.80e-5)"	"unprognostic (4.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-2)"	4.9	2.2	0.3	0.4	2.2	1.2	8.1	0.1	0.7	4.5	4.0	1.9	0.2	0.5	1.3	7.5	4.3	0.8	3.2	6.1	0.5		2.9	7.5	0.3	0.2	4.4	0.0	5.0	2.3	1.0	0.0	1.3	3.3	3.3	0.4	0.9	1.8	2.9	8.0	0.3	1.2	2.1	0.6	4.8	0.7	2.6	1.9	0.0	2.1	1.8	0.0	3.8	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.3	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.7	0.0	0.1	1.8	0.1	0.3	0.0	0.0	0.4	0.0	0.3	1.4	0.0	0.0	1.2	0.0	3.1	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	1.0	0.0	2.0	0.0	1.4	1.2	1.8	0.0	0.4	0.0	0.2	0.0	0.7	0.0	0.0	0.5	0.1	0.4	0.9	0.0	0.0	0.3	0.0	2.4	3.1	0.3	0.0	1.7	0.9	1.7	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	32.3	8.0	0.0	0.2	1.3	0.3	0.0	0.0	0.3
ADRM1	"ARM1, GP110, Rpn13"	ENSG00000130706	"Adhesion regulating molecule 1"	Q16186	20	62302093-62308862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Late spermatids: 1352.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 113.5"					"Low region specificity"	"Detected in all"			HPA042266	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042266: AB_10794044"	"unprognostic (5.49e-2)"	"unprognostic (5.14e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.47e-2)"	22.9	22.9	14.8	23.4	16.8	30.5	17.0	24.1	29.3	14.7	16.9	18.8	12.4	24.0	19.9	15.3	23.9	14.0	20.4	24.6	14.6	15.1	21.7	54.5	15.7	22.1	15.5	13.4	17.2	34.9	9.5	13.4	27.6	21.4	14.8	7.9	14.8	21.0	18.3	86.6	26.4	19.5	17.3	15.4	23.5	20.1	30.0	10.1	23.8	16.4	29.1	29.4	17.3	14.6	79.2	67.2	69.4	78.0	51.7	77.6	70.9	33.9	38.1	10.7	22.8	10.2	7.5	29.1	22.5	15.3	42.2	16.9	113.5	36.0	18.3	41.1	12.8	24.1	38.4	13.4	33.0	13.0	21.3	27.5	44.4	27.6	59.8	17.3	22.9	42.4	9.5	20.3	27.5	11.0	7.0	16.3	18.2	32.4	20.0	9.7	45.7	28.7	44.9	36.2	16.5	56.9	23.1	18.8	29.0	11.3	25.6	19.2	23.9	24.2	38.5	27.0	7.6	26.8	25.3	23.9	42.2	44.7	41.1	45.0	42.7	33.6	24.4	44.4	23.1	30.5	48.3	66.3	69.4	66.0	78.0	58.9	79.2	59.8	62.7	67.2	75.5	45.1	51.4	62.2	51.7	65.0	62.7	77.6	70.9	14.8	16.8	24.1	29.3	14.6	15.1	15.5	13.4	21.4	10.1	32.8	25.1	83.4	87.4	131.7	31.3	16.5	53.5	32.1	30.7	62.8	17.7	212.4	97.8	167.4	291.0	91.6	138.0	46.7	184.0	146.0	94.9	83.7	41.5	89.8	134.3	31.8	55.5	94.5	71.8	1352.6	67.0	102.8	92.8	165.1	52.2	58.4	189.2	105.2	81.7	101.6	22.8	64.7	95.7	129.4	168.8	129.5	353.8	81.2	63.5	120.7
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	34.9	12.4	0.2	45.9	30.3	5.2	1.1	0.0	0.0	1.2	5.1	49.3	0.0	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	0.2	2.3	34.8	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	0.0	16.5	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.1	10.6	0.1	3.3	8.0	0.0	21.3	0.1	0.0	0.2	0.2	24.2	0.1	0.0	28.2	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6	0.0	4.5	6.7	5.4	30.7	0.2	15.5	0.0	4.0	2.3	7.0	0.0	1.7	0.0	0.8	2.0	14.4	0.0	0.0	0.0	2.6	159.0	2.4	2.3	0.0	3.1	0.0	0.0	38.6	1.9	9.5	140.4	3.8	81.0	1.0	0.0	0.1	0.7	0.0	478.4	0.6	0.6	38.8	174.1	2.4	4.5	24.0	2.9	0.7	0.0	2.0
AFAP1	"AFAP, AFAP-110"	ENSG00000196526	"Actin filament associated protein 1"	Q8N556	4	7758714-7939926	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 151.9;Extravillous trophoblasts: 100.0;Late spermatids: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.0;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"TIME: 41.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015642, CAB024712"	Enhanced		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA			"Actin filaments, Cytosol"	"Focal adhesion sites"	"CAB024712: , HPA015642: AB_1844632"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.44e-2)"	14.0	3.9	9.5	11.6	10.2	1.0	15.8	10.3	12.2	11.0	17.8	4.4	6.5	6.7	18.7	6.6	13.1	9.0	14.7	11.0	7.1	5.8	5.2	1.8	8.7	5.3	4.7	6.9	12.1	6.6	31.9	13.0	14.4	5.6	10.3	11.7	12.4	9.6	12.7	5.7	5.8	8.8	32.1	8.3	4.6	8.4	21.7	3.2	3.3	8.6	5.6	6.1	16.2	13.1	0.0	0.0	6.0	0.9	0.0	2.9	1.5	10.1	7.6	5.4	4.3	5.3	9.6	7.2	15.2	22.6	14.7	13.6	2.4	2.4	0.0	5.1	24.7	24.4	4.9	2.8	6.1	9.7	0.2	1.9	0.0	11.0	1.4	14.8	0.0	0.1	5.9	4.6	18.3	12.0	24.4	17.6	1.5	0.2	2.2	7.6	3.3	0.1	0.0	2.3	4.3	14.7	0.0	4.0	0.5	1.6	1.3	10.7	17.9	5.2	3.6	4.1	7.5	1.3	0.1	41.6	18.0	4.0	23.3	7.4	0.0	0.0	0.0	6.4	0.0	20.5	0.0	0.9	6.0	1.1	0.2	1.4	0.0	1.6	1.5	0.0	0.0	2.9	1.3	2.3	0.0	0.1	0.0	1.3	1.5	9.5	10.2	10.3	10.8	7.1	5.8	4.7	6.9	5.6	3.2	6.0	1.3	0.0	7.2	2.6	1.0	4.9	17.8	5.3	9.1	10.4	3.9	4.5	0.0	16.4	151.9	13.7	8.0	0.0	6.7	100.0	15.5	12.1	0.0	0.0	6.9	0.0	13.9	16.5	0.3	257.9	10.3	0.0	1.7	1.0	19.4	9.1	19.5	5.8	11.7	2.6	0.4	6.5	10.3	11.4	8.8	3.8	7.3	3.2	12.4	8.9
AFF1	"AF-4, AF4, MLLT2, PBM1"	ENSG00000172493	"AF4/FMR2 family member 1"	P51825	4	86935002-87141054	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 121.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 150.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069947			Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA069947: AB_2686219"	"unprognostic (1.01e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-2)"	33.7	16.6	8.0	11.8	9.5	19.5	26.5	6.5	12.2	20.2	21.0	10.5	18.9	11.1	27.4	16.6	15.8	18.6	15.3	22.4	10.3	5.3	27.6	15.5	18.4	12.9	9.3	5.5	24.7	19.0	28.6	18.5	121.7	9.5	16.8	14.3	27.0	16.0	25.6	58.8	18.6	16.2	20.3	11.5	13.9	15.0	6.7	10.3	17.0	38.8	21.1	13.9	19.5	26.5	11.3	14.6	21.1	5.4	5.1	8.8	2.8	7.9	7.3	6.1	6.4	10.1	12.1	8.6	8.0	11.8	6.1	9.2	7.7	14.8	9.0	11.0	9.8	7.8	3.6	9.6	12.1	8.5	15.4	3.8	18.8	19.1	6.4	7.8	18.0	14.9	9.8	8.8	10.5	9.3	8.9	22.5	7.6	11.5	25.6	2.6	2.1	16.2	5.2	8.1	13.3	2.6	12.9	3.6	11.5	18.1	7.6	13.9	2.5	12.3	8.1	3.9	13.4	4.8	15.1	11.3	11.4	10.4	6.9	4.4	22.2	12.3	15.6	9.4	20.8	4.1	3.5	5.4	11.7	6.7	4.1	7.4	8.0	8.8	6.6	6.0	11.3	4.7	4.4	21.1	5.1	2.2	14.6	7.5	2.8	8.0	9.5	6.5	12.2	10.3	5.3	9.3	5.5	9.5	10.3	38.7	57.2	25.4	12.5	21.4	44.7	96.4	40.8	40.2	31.8	87.2	212.1	0.9	3.3	11.6	6.6	38.8	30.8	46.7	10.9	3.8	14.6	24.9	23.3	27.7	11.3	17.5	31.0	65.1	43.0	5.4	27.0	25.6	21.9	8.2	40.8	22.0	11.1	31.7	26.9	40.9	150.1	25.8	15.6	3.5	6.4	27.7	27.5	15.2	25.3	14.4
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100142739	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.6"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 79.7;Horizontal cells: 44.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 16.2;naive B-cell: 27.5;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	16	"B-cells: 27.5;dendritic cells: 12.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;U-698: 35.1"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.2	2.4	6.0	40.2	6.1	10.3	16.6	20.5	9.9	4.2	4.2	1.8	0.8	1.2	8.9	1.7	4.1	4.1	2.3	4.9	6.3	6.2	1.8	2.4	7.6	23.3	5.4	6.8	7.5	1.1	0.3	5.2	6.9	4.4	18.9	2.3	5.5	6.6	3.3	1.0	1.0	5.9	8.6	6.6	43.6	4.8	6.0	2.5	34.7	1.7	0.7	42.0	7.4	2.7	27.5	12.8	0.2	0.2	0.9	1.2	0.4	0.1	0.0	10.0	3.5	0.0	0.4	0.0	1.4	0.3	3.0	1.0	0.0	0.0	23.7	0.1	1.5	7.6	0.1	0.2	0.0	1.8	6.0	2.9	0.0	0.1	0.0	0.2	0.1	6.8	0.6	0.0	6.2	0.1	7.7	0.0	1.3	0.1	0.0	0.0	0.1	1.9	0.3	1.3	0.0	1.6	3.2	0.0	0.1	0.0	0.0	9.9	3.5	0.1	0.1	6.4	1.3	11.9	10.9	3.9	9.5	2.6	0.3	1.5	0.2	0.0	35.1	8.8	0.8	0.8	0.2	0.2	0.0	0.0	0.2	0.2	16.2	0.1	0.0	2.9	27.5	1.2	0.0	0.1	0.9	0.2	12.8	0.0	0.4	6.0	6.1	20.5	9.9	6.3	6.2	5.4	6.8	4.4	2.5	6.0	29.7	79.7	0.4	1.5	15.0	9.6	0.0	0.0	6.8	0.0	11.8	0.2	0.0	0.0	25.7	1.2	0.0	0.0	0.0	0.1	4.7	14.7	0.0	0.8	1.4	44.5	22.0	0.6	7.0	28.0	10.0	12.9	13.5	0.0	0.3	8.9	0.0	0.0	19.8	0.8	1.4	0.0	6.9	5.1	7.0	1.1	0.1	2.2	0.0	0.1
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294894-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 10.7;Club cells: 9.1;Distal tubular cells: 8.3;Proximal tubular cells: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	4.9	7.3	7.6	6.5	6.6	4.3	5.7	6.2	7.3	4.1	5.7	7.3	6.9	8.9	3.7	4.9	5.5	5.1	4.8	9.4	6.3	4.9	11.0	7.6	9.1	4.8	7.3	7.4	4.1	5.2	11.6	6.9	4.7	6.1	3.9	7.0	5.5	4.7	5.4	9.0	4.2	6.3	4.0	5.6	4.4	6.0	25.4	6.5	5.6	6.6	4.1	4.5	4.8	4.3	5.7	3.0	5.1	7.2	4.2	4.4	1.7	3.5	1.9	4.7	8.2	4.8	7.1	4.6	3.9	5.9	6.6	6.5	7.4	4.4	6.3	5.3	6.1	7.8	2.0	5.9	5.9	7.4	3.6	3.5	7.5	2.4	8.6	4.8	6.6	3.7	6.6	4.9	4.9	8.0	4.2	3.5	4.8	7.5	3.0	6.1	3.3	1.2	6.2	3.0	6.0	3.7	4.4	6.3	3.6	8.2	3.9	5.1	4.5	3.3	4.7	8.7	6.5	3.8	13.0	4.3	4.0	1.0	3.5	4.5	2.1	3.2	4.9	5.0	7.9	6.1	0.0	3.1	5.1	2.0	2.2	2.6	4.8	3.2	3.8	2.7	5.7	4.4	2.9	0.8	4.2	7.2	3.0	4.1	1.7	7.6	6.6	6.2	7.3	6.3	4.9	7.3	7.4	6.1	6.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	10.7	9.1	3.5	0.0	5.1	8.3	2.7	0.0	0.0	0.0	0.0	3.3	4.1	0.0	0.0	2.3	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.9	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0
AFMID	"DKFZp686F03259, KF"	ENSG00000183077	Arylformamidase	Q63HM1	17	78187317-78207701	"Enzymes, Predicted intracellular proteins"	"Tryptophan catabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.7"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 68.8;Hepatocytes: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.5"	"Group enriched"	"Detected in all"	5	"B-cells: 5.1;dendritic cells: 6.7;monocytes: 14.5"	"Cell line enhanced"	"Detected in all"		"Hep G2: 62.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023861, HPA026536"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023861: AB_1844636, HPA026536: AB_1844637"	"unprognostic (3.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.65e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.59e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.79e-2)"	5.9	3.5	12.1	5.4	17.1	4.6	33.0	27.1	18.3	6.1	7.5	44.8	11.7	8.5	7.5	7.0	7.7	11.3	11.4	9.4	17.3	12.0	39.4	78.7	10.6	5.2	29.7	13.3	15.9	27.7	6.9	4.1	12.4	18.1	10.7	9.2	5.8	24.7	11.8	7.9	15.5	7.1	6.6	27.0	6.2	10.2	6.2	23.9	3.9	6.5	5.6	6.2	6.7	7.4	5.1	6.7	1.7	14.5	1.6	1.1	1.5	7.0	10.0	8.8	8.0	10.0	11.7	4.8	10.1	5.8	7.2	8.6	10.6	5.9	22.1	6.7	7.7	4.2	6.1	14.9	8.9	10.1	14.0	11.9	17.8	11.8	62.3	8.7	14.7	9.2	15.6	9.4	8.3	10.9	11.8	13.4	6.7	18.0	7.8	5.5	7.0	11.2	22.4	7.2	17.2	17.3	12.8	9.0	26.5	9.7	6.5	19.7	14.6	8.7	26.3	8.2	9.2	7.9	14.3	6.6	11.0	7.2	6.9	7.1	11.9	7.8	22.7	9.1	7.2	2.8	1.1	6.1	0.7	0.7	14.5	1.1	5.1	1.0	1.1	6.7	2.0	0.6	0.6	1.7	1.6	9.3	4.4	0.9	1.5	12.1	17.1	27.1	18.3	17.3	12.0	29.7	13.3	18.1	23.9	14.9	13.6	10.0	19.1	23.5	1.4	11.5	68.8	17.4	12.5	61.1	3.9	10.9	14.9	10.4	0.3	14.7	12.9	0.0	7.4	9.5	15.0	15.8	2.3	100.2	9.5	1.6	12.6	21.5	21.9	1.5	20.8	18.3	28.7	10.8	20.6	1.7	8.6	24.9	20.5	39.6	1.5	0.0	7.5	1.2	11.8	35.9	9.6	4.4	25.0	12.2
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 99.9;Proximal tubular cells: 38.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	190	"Hep G2: 219.7"	"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	930000	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	6.6	0.0	0.0	0.0	0.3	0.0	2.4	0.7	0.3	0.0	0.0	99.9	2.1	0.0	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.9;lymphoid tissue: 18.8"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 7.5;Horizontal cells: 7.9;Sertoli cells: 32.3;T-cells: 12.1"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Group enriched"	"Detected in many"	4	"amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 18.0;Karpas-707: 17.5;RH-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	3.8	1.8	34.3	11.8	40.2	8.1	0.7	48.2	55.9	0.6	2.1	1.2	0.0	2.0	1.5	0.9	1.6	0.8	2.8	4.3	37.6	8.9	1.2	0.8	2.2	13.5	6.3	3.1	1.2	2.4	1.7	1.2	1.7	2.5	1.0	1.2	0.7	4.5	0.9	8.3	2.1	2.2	0.8	2.1	10.0	2.1	0.9	0.7	18.8	0.9	1.5	16.6	2.9	0.6	1.9	1.4	6.3	1.2	2.3	6.3	1.7	3.0	4.5	8.7	2.5	0.0	0.0	5.0	2.1	0.4	0.0	0.2	0.5	2.9	7.9	0.6	0.0	1.6	1.9	0.0	0.0	0.0	8.6	1.3	8.7	0.7	1.4	0.0	8.9	18.0	0.0	0.0	0.0	0.0	3.7	0.0	9.3	0.0	17.5	0.0	5.3	15.7	5.7	1.4	0.9	4.6	6.5	43.8	5.7	0.0	2.6	2.5	9.1	1.1	1.6	1.8	0.0	1.1	6.3	4.8	2.4	4.1	4.6	1.5	7.4	4.4	3.9	4.4	5.9	4.1	6.0	0.8	1.0	4.8	1.2	5.1	1.9	4.8	5.1	1.4	1.6	2.0	3.0	6.3	2.3	0.7	1.2	6.3	1.7	34.3	40.2	48.2	35.4	37.6	8.9	6.3	3.1	2.5	0.7	3.0	0.6	4.1	0.2	0.0	7.5	2.2	2.5	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.2	0.4	0.2	2.3	0.0	1.4	7.9	0.0	0.6	0.6	0.7	0.0	1.6	0.0	3.6	0.3	0.1	0.1	0.0	0.7	0.0	1.9	32.3	1.2	0.7	0.4	0.4	0.0	12.1	0.1	0.0
AGBL3	"CCP3, MGC32955"	ENSG00000146856	"ATP/GTP binding protein like 3"	Q8NEM8	7	134986508-135147963	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 40.4;Spermatocytes: 19.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020397, HPA024150"	Uncertain		Approved	Cytosol		NA	No			Cytosol		"HPA020397: AB_2242453, HPA024150: AB_1844639"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.32e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.15e-4)"	"unprognostic (5.00e-3)"	"unprognostic (6.10e-4)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.11e-3)"	3.2	2.7	4.2	4.1	8.4	3.8	4.6	8.7	4.5	4.3	2.4	4.4	4.5	1.6	5.5	15.4	2.2	3.6	3.1	2.4	5.0	3.4	5.3	2.6	3.6	4.0	2.7	4.5	6.8	4.5	0.6	9.2	1.9	3.3	3.8	3.0	3.1	4.9	4.3	4.2	4.7	3.7	3.3	2.9	6.5	4.4	18.7	3.7	2.7	5.4	0.8	2.8	3.3	2.5	2.2	1.7	0.5	0.2	2.2	5.0	1.7	2.6	1.4	3.6	0.8	1.0	1.4	2.2	0.7	0.0	0.5	0.8	4.7	3.0	4.3	1.3	0.0	1.4	2.8	1.3	0.5	0.0	3.4	8.8	3.6	5.3	4.6	0.0	1.6	0.0	0.2	0.0	2.1	0.0	0.0	1.6	4.7	2.6	2.5	0.6	2.5	0.9	1.5	3.1	0.4	0.3	2.5	0.2	1.2	2.6	0.5	2.1	2.4	0.5	0.0	0.3	0.1	1.9	3.5	0.0	0.4	0.9	0.5	1.6	5.3	1.6	1.9	1.8	4.3	4.4	0.0	0.2	0.4	2.4	0.0	1.8	2.1	1.2	2.5	0.5	2.2	2.0	5.0	0.5	2.2	0.1	1.7	1.7	1.7	4.2	8.4	8.7	4.5	5.0	3.4	2.7	4.5	3.3	3.7	3.0	1.1	1.3	1.0	1.1	4.9	1.6	5.1	5.3	2.3	8.7	2.0	0.2	6.6	3.1	40.4	3.8	0.3	0.0	2.5	0.3	1.4	1.5	1.1	1.6	0.4	3.2	2.9	5.5	1.6	8.5	3.1	0.3	5.0	11.8	0.3	2.7	1.6	0.0	2.1	5.1	2.9	0.0	2.3	19.5	3.6	0.3	0.1	1.0	0.0	0.8
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 91.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 249.1;Late spermatids: 264.5;Spermatocytes: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	3.8	8.1	3.9	3.5	4.8	3.8	4.2	3.1	6.6	5.0	6.8	6.6	11.7	2.8	5.4	9.3	6.3	7.2	6.6	4.1	3.4	3.9	8.2	3.0	3.6	3.2	3.5	3.4	5.9	5.9	11.2	6.2	6.3	5.4	6.8	3.8	7.7	8.2	5.9	2.6	6.8	3.9	8.6	3.4	4.6	5.4	91.6	3.5	8.4	9.9	4.9	4.4	7.8	3.5	5.7	5.4	7.1	2.3	11.2	6.3	4.6	23.0	15.0	24.5	16.3	5.2	10.5	27.4	4.7	10.3	13.7	14.2	12.9	17.7	12.8	14.9	8.1	19.3	10.6	19.6	21.4	15.2	10.7	29.0	18.7	18.7	27.8	10.6	9.0	6.3	11.0	16.2	12.0	9.9	21.0	14.3	18.7	16.0	10.4	13.2	9.1	26.2	13.6	17.3	16.8	10.3	27.1	27.7	20.0	14.1	5.9	16.4	23.5	9.3	7.3	15.2	25.1	11.0	7.0	6.8	12.8	17.6	6.1	10.1	20.8	10.9	26.2	14.2	10.4	11.4	7.1	2.3	5.7	4.5	1.3	3.4	5.7	5.7	6.3	5.4	3.0	5.1	2.8	1.4	11.2	0.9	3.0	3.6	4.6	3.9	4.8	3.1	6.6	3.4	3.9	3.5	3.4	5.4	3.5	0.0	8.5	1.9	5.9	3.0	4.9	5.0	12.7	1.4	5.7	8.7	0.0	12.8	16.6	7.0	249.1	3.6	4.6	0.0	5.2	6.0	4.1	6.6	1.1	3.4	4.4	0.0	2.4	6.2	2.7	264.5	9.8	5.3	6.8	6.4	8.7	4.4	4.8	7.0	10.6	18.1	8.7	0.0	5.8	150.8	30.0	2.4	7.0	4.1	8.4	6.8
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184324	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 178.6"	"Cell type enriched"	"Detected in many"	18	"Alveolar cells type 1: 2224.3"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	140000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0.0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1.0	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.6	0.2	1.9	2.7	0.1	0.2	0.1	0.2	0.1	0.4	0.2	2.1	0.5	0.0	2.2	0.2	1.1	0.3	0.4	4.9	1.3	0.1	0.0	0.0	0.6	2.2	0.3	0.3	0.1	0.2	0.3	0.3	8.1	0.0	0.8	0.2	4.2	0.3	1.5	0.0	0.2	0.0	0.1	0.2	0.3	5.1	0.1	0.1	0.5	0.1	0.0	1.9	0.1	1.2	0.1	0.2	0.0	1.5	1.5	0.1	6.1	3.2	2.2	2.2	0.5	0.5	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.7	0.4	0.3	1.0	0.1	0.2	0.7	0.0	0.1	0.2	0.2	0.9	0.2	0.2	0.0	0.2	0.2	0.4	0.2	2224.3	120.3	1.7	1.1	0.8	4.8	3.4	5.1	8.1	37.5	1.8	0.0	0.9	0.0	1.5	0.0	2.6	0.5	0.0	0.8	0.8	1.6	2.3	16.3	1.8	1.2	6.4	0.0	2.5	9.0	0.2	1.7	4.9	1.7	2.8	1.4	7.4	0.8	2.9	1.1	0.2	4.1	6.5	1.7	0.0	0.7	1.6	1.8	5.0	0.9	0.8
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551189-141655244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 37.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: AB_2682164"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	8.7	12.0	11.9	8.0	19.0	5.9	10.6	21.3	23.7	8.8	8.9	10.2	8.8	6.4	16.8	17.1	9.5	11.9	6.8	24.5	16.1	12.3	16.0	10.5	8.4	10.0	11.8	18.8	10.8	8.0	15.7	13.3	9.9	14.2	10.1	13.4	10.6	13.5	10.7	8.4	6.8	8.8	15.0	13.9	12.2	9.0	12.9	9.0	7.8	9.8	8.4	15.6	8.4	8.5	4.6	6.4	0.4	5.5	37.9	10.3	5.7	12.4	13.5	13.4	11.0	10.6	13.2	9.1	13.2	12.9	21.2	21.2	10.5	9.6	14.0	11.8	12.6	20.0	9.3	18.7	15.4	22.9	16.5	16.6	13.0	6.4	10.4	15.8	9.0	7.0	14.7	13.6	18.6	18.2	9.9	16.2	16.1	19.3	20.0	10.2	12.5	24.3	4.1	14.2	9.6	15.2	15.7	2.3	41.9	13.6	10.6	11.7	16.1	13.7	16.6	13.6	14.1	8.9	9.9	9.1	9.8	7.7	13.1	19.0	15.2	15.0	6.7	16.2	4.2	27.0	0.0	2.6	0.4	9.1	5.5	6.5	4.6	7.4	10.3	6.4	2.5	5.5	9.6	0.2	37.9	3.2	2.5	7.2	5.7	11.9	19.0	21.3	23.7	16.1	12.3	11.8	18.8	14.2	9.0	0.0	5.9	3.7	5.1	2.7	10.7	16.8	5.1	6.7	5.7	12.2	7.9	13.4	8.3	6.3	10.0	5.8	2.0	0.0	6.1	6.7	5.4	2.6	8.1	4.5	6.1	14.3	0.0	3.1	4.7	8.5	6.4	4.7	6.8	18.0	2.9	9.8	4.6	0.0	9.9	6.1	16.4	0.0	6.2	4.6	4.9	2.4	7.7	11.4	5.6	2.7
AGO1	"EIF2C1, hAGO1"	ENSG00000092847	"Argonaute 1, RISC catalytic component"	Q9UL18	1	35869808-35930528	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067849			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Cytosol	"HPA067849: "	"unprognostic (2.35e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.61e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.77e-3)"	12.3	15.9	16.6	14.4	19.0	11.3	11.2	23.3	21.3	15.7	12.1	22.2	19.0	13.2	14.3	9.3	11.7	13.8	11.3	14.0	15.7	13.8	11.7	8.6	11.8	14.3	14.5	20.0	17.2	12.6	21.6	13.5	9.8	16.3	15.4	12.8	13.0	11.7	22.3	14.8	16.3	13.8	15.7	13.7	15.7	12.2	10.7	16.4	13.1	12.2	8.3	14.4	12.4	11.5	2.3	2.5	3.7	7.1	2.1	3.1	4.9	8.2	5.4	13.2	11.6	8.2	5.0	13.6	4.5	6.8	8.0	7.4	9.9	5.4	9.0	5.6	8.9	5.5	4.0	18.9	7.1	9.4	8.9	5.9	19.6	8.8	7.6	3.2	11.6	7.9	4.2	2.5	13.3	6.9	4.6	11.3	8.4	13.2	5.6	5.7	4.5	12.1	5.0	28.3	9.9	4.5	9.0	9.9	3.9	2.6	10.8	16.2	6.7	14.5	5.7	4.8	14.7	4.8	3.9	7.8	5.9	12.9	8.0	8.2	5.6	4.5	4.6	6.4	6.5	7.6	2.7	5.6	2.6	3.1	7.1	3.0	2.3	2.6	2.9	2.4	2.3	2.8	2.9	3.7	2.1	5.6	2.5	2.4	4.9	16.6	19.0	23.3	21.3	15.7	13.8	14.5	20.0	16.3	16.4	3.0	9.4	14.9	5.9	12.4	32.3	11.5	12.7	8.1	9.1	14.0	37.3	4.4	1.7	9.9	4.5	11.7	12.6	0.0	11.4	4.2	7.4	8.4	16.1	11.3	12.2	33.4	24.9	9.8	20.4	5.5	13.8	12.5	5.0	7.2	16.1	12.5	9.8	10.5	19.4	9.2	31.5	12.9	10.4	9.2	15.6	12.7	1.9	8.6	15.2	6.0
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute 2, RISC catalytic component"	Q9UKV8	8	140520156-140635619	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		35000000	"Cytoplasmic bodies"	Cytosol	"CAB019309: , HPA067849: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	11.2	6.6	7.7	9.9	13.1	16.2	25.0	9.9	11.4	7.5	9.2	12.1	12.8	5.3	10.2	10.4	10.6	8.6	8.8	12.4	8.8	5.3	6.9	7.4	13.2	12.5	13.4	5.0	11.8	8.4	13.2	8.8	9.9	10.7	7.5	6.9	5.6	8.1	12.6	37.1	14.1	7.5	15.0	11.7	6.9	10.0	5.9	12.7	11.1	8.6	8.2	8.9	10.4	18.4	2.5	2.1	6.4	2.6	2.4	3.0	1.5	12.8	10.6	10.9	12.4	7.1	8.4	9.2	8.1	5.9	3.6	4.5	11.7	3.9	14.7	10.2	7.8	3.9	8.7	18.4	8.7	8.1	8.3	9.6	17.2	18.2	7.4	6.5	7.1	5.9	5.7	7.9	10.0	10.5	5.0	8.4	9.3	18.0	9.3	11.8	19.4	12.2	5.6	8.0	8.8	18.5	12.6	9.2	6.6	4.6	13.3	12.8	9.3	12.6	4.3	9.0	11.7	11.1	10.3	11.7	6.3	17.6	9.9	12.9	8.2	2.7	10.4	4.7	12.9	9.3	1.8	2.6	0.7	2.7	2.3	3.0	1.3	2.6	2.3	2.1	2.5	2.7	2.7	6.4	2.4	2.3	1.5	2.1	1.5	7.7	13.1	9.9	11.4	8.8	5.3	13.4	5.0	10.7	12.7	20.8	21.4	18.4	57.8	19.5	24.7	19.4	10.2	24.1	36.4	14.0	41.2	36.5	6.6	23.4	15.7	24.8	9.7	70.0	15.6	17.2	23.7	85.4	16.2	12.4	13.3	39.7	23.3	25.8	23.8	10.0	34.5	19.0	5.0	22.6	22.7	30.6	29.0	17.5	43.5	7.4	29.6	32.3	13.1	3.2	1.4	20.8	66.1	25.4	19.6	78.7
AGO3	"EIF2C3, FLJ12765, hAGO3"	ENSG00000126070	"Argonaute 3, RISC catalytic component"	Q9H9G7	1	35930718-36072500	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048342, HPA067849, HPA075436"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750"	"unprognostic (4.10e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.39e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.81e-1)"	9.8	8.1	8.8	16.2	11.7	20.6	9.6	12.8	9.6	9.4	7.4	13.8	10.4	4.6	9.5	10.9	7.8	7.4	8.8	9.5	8.0	7.4	8.2	11.3	9.6	9.3	11.5	6.1	10.8	9.7	13.3	28.0	11.0	9.1	9.8	7.1	8.7	7.7	14.1	8.3	12.5	7.3	12.0	10.9	8.3	8.0	21.4	13.5	14.4	9.7	4.7	10.1	8.4	13.9	6.5	5.1	14.0	6.0	6.0	5.5	2.3	6.6	4.6	5.9	4.6	8.3	5.0	7.1	5.5	5.8	8.5	9.1	5.0	7.5	7.4	6.8	5.6	9.8	5.6	6.3	4.0	11.4	10.2	3.9	9.0	8.0	3.8	4.4	8.7	7.6	2.4	3.6	12.2	7.7	3.4	7.2	7.8	9.7	10.8	7.4	2.5	6.3	4.7	10.2	3.5	8.1	7.7	7.9	7.3	2.7	6.5	7.2	4.5	9.8	2.5	3.4	9.4	3.7	3.6	5.6	5.9	15.1	5.2	5.9	6.0	10.3	10.3	3.0	5.6	5.7	8.5	4.7	13.2	5.5	4.2	3.5	6.2	3.6	3.9	5.1	6.5	5.0	5.0	14.0	6.0	6.0	4.5	3.4	2.3	8.8	11.7	12.8	9.6	8.0	7.4	11.5	6.1	9.1	13.5	80.4	42.9	19.0	30.7	34.5	67.6	16.7	7.6	12.0	26.1	24.4	106.0	9.2	0.0	13.1	43.3	29.9	12.7	0.0	10.6	11.0	30.1	30.9	56.4	20.3	14.3	39.7	44.9	31.3	28.4	54.4	35.1	34.5	21.9	14.4	14.3	46.3	13.7	7.0	38.9	6.7	82.2	19.4	33.0	33.1	19.8	29.4	10.8	27.7	16.3	25.0
AGO4	"EIF2C4, FLJ20033, hAGO4, KIAA1567"	ENSG00000134698	"Argonaute 4, RISC catalytic component"	Q9HCK5	1	35808172-35857890	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 21.6"	"Low region specificity"	"Detected in all"							"CAB012179, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Cytosol	"CAB012179: , HPA067849: "	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.70e-5)"	"unprognostic (3.92e-3)"	"unprognostic (3.99e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-3)"	"unprognostic (4.91e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.58e-2)"	10.8	6.3	8.4	11.5	9.5	24.2	10.2	16.2	12.7	11.1	11.8	16.4	9.9	6.5	16.2	11.1	10.0	9.2	10.8	14.7	8.8	7.9	6.5	9.0	14.4	18.1	9.6	11.1	9.7	11.2	13.0	7.8	12.1	7.9	12.6	9.0	12.4	10.8	9.0	16.0	26.8	10.6	13.6	7.6	18.7	11.8	16.1	12.0	9.6	7.4	9.1	9.1	13.2	13.6	0.8	2.9	10.7	3.7	0.8	2.1	1.1	5.2	1.3	10.2	5.8	5.4	6.2	5.2	4.0	4.0	4.2	4.8	0.7	8.0	8.4	5.5	5.8	4.3	2.1	4.4	3.2	4.0	9.2	4.0	4.2	3.5	2.4	5.1	4.8	6.6	3.9	6.9	2.3	3.5	8.0	7.1	10.2	3.2	3.4	5.5	0.8	7.7	5.4	3.3	3.3	2.4	7.8	9.2	1.0	4.1	6.6	4.5	6.6	3.6	3.3	11.2	9.2	2.7	21.6	8.4	3.2	1.6	3.2	3.0	4.9	1.6	1.3	3.9	6.2	2.8	1.8	3.7	4.1	1.4	2.1	2.1	0.8	1.1	1.6	2.9	0.7	0.5	0.7	10.7	0.8	1.9	0.6	0.3	1.1	8.4	9.5	16.2	12.7	8.8	7.9	9.6	11.1	7.9	12.0	17.9	20.0	7.3	3.9	8.8	25.1	19.3	20.4	8.1	10.3	10.4	21.6	3.5	1.7	5.4	1.7	8.7	6.7	0.0	4.9	4.0	5.4	7.4	2.3	9.7	11.6	6.4	12.1	19.6	49.2	1.0	4.6	18.3	3.3	5.4	9.7	6.7	10.6	9.1	5.3	1.2	33.7	19.4	4.2	6.6	1.6	11.2	3.4	9.6	6.0	3.8
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA			"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: AB_2680411, HPA073355: AB_2686596"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	11.7	32.3	21.5	8.3	33.1	7.4	12.1	18.7	32.4	26.9	22.1	19.6	19.6	32.0	25.1	53.3	13.8	26.9	22.3	19.4	22.8	21.1	26.4	20.3	24.3	10.7	20.3	23.6	33.1	18.5	1.3	16.6	18.5	22.4	18.5	24.8	17.5	17.4	19.5	25.5	9.1	46.9	17.9	18.6	11.7	27.8	27.7	17.4	12.1	33.4	9.0	14.6	19.3	12.7	6.7	13.8	13.2	9.6	8.9	10.1	5.7	0.0	0.1	13.5	0.0	35.3	23.8	12.5	0.0	0.0	0.0	0.0	27.5	0.0	0.0	11.6	33.7	9.5	3.3	29.1	9.6	0.0	0.0	22.5	0.0	0.0	29.0	0.0	0.0	27.3	13.3	12.4	0.0	12.6	29.0	8.2	23.0	17.3	17.7	29.2	7.3	0.0	6.3	0.0	0.0	4.2	0.1	0.0	0.1	8.8	0.0	0.0	0.0	13.4	4.3	15.1	14.6	16.9	0.0	5.8	0.0	5.0	0.0	0.0	10.6	10.1	4.4	17.4	0.0	0.0	2.7	5.7	13.2	9.2	9.6	8.7	6.7	5.8	10.1	10.3	5.9	5.0	7.3	11.0	8.9	6.6	13.8	7.8	5.7	21.5	33.1	18.7	32.4	22.8	21.1	20.3	23.6	22.4	17.4	14.9	18.1	19.4	9.5	8.0	26.4	3.1	12.7	12.0	7.9	34.9	11.8	28.8	5.0	16.4	52.8	13.5	30.7	0.0	12.4	25.8	14.4	11.5	12.7	27.1	22.0	30.2	28.3	18.4	17.4	64.8	12.4	17.4	8.5	5.4	24.1	34.1	13.6	21.0	20.1	22.3	17.0	0.0	20.8	45.5	20.6	3.1	12.8	12.1	20.4	10.5
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687423	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 71.5;liver: 63.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 930.5;Paneth cells: 350.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019544	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	71.5	5.3	2.3	8.1	2.2	8.4	35.2	2.0	3.0	7.4	20.2	2.2	5.9	31.3	4.7	7.1	11.7	4.1	15.8	12.4	2.8	2.4	10.9	63.1	12.1	11.1	2.5	2.8	5.3	47.7	2.5	6.2	4.9	2.6	5.5	3.3	8.9	12.9	6.2	9.5	7.0	33.6	4.0	1.9	6.8	11.0	5.2	1.9	5.1	13.4	7.0	8.8	6.6	4.9	7.0	20.3	33.2	28.4	2.1	2.5	9.8	14.7	20.8	2.4	11.5	17.9	5.6	10.5	9.8	7.8	6.7	5.1	23.6	29.2	4.9	22.1	5.6	10.9	40.1	3.5	6.1	0.7	50.5	15.9	7.2	8.6	5.1	12.3	7.5	17.6	5.3	8.5	5.7	3.0	5.8	3.5	6.6	8.7	0.8	2.8	26.6	0.5	23.5	6.3	27.2	37.8	11.1	8.9	26.9	7.9	9.3	5.5	8.9	12.7	13.4	16.1	2.0	8.5	29.8	6.8	8.9	9.2	2.9	6.2	1.2	0.1	3.1	0.1	16.3	8.9	6.0	28.4	33.2	2.2	25.3	2.1	4.1	1.9	2.5	14.9	7.0	1.6	1.8	19.1	2.1	22.2	20.3	2.3	9.8	2.3	2.2	2.0	3.0	2.8	2.4	2.5	2.8	2.6	1.9	14.9	59.7	17.6	50.1	40.2	2.1	34.7	68.8	10.7	18.2	69.8	0.0	6.7	46.4	135.1	138.9	26.4	930.5	0.0	193.7	28.9	36.3	80.5	13.8	203.0	114.8	38.1	34.3	22.1	50.6	271.0	24.7	62.8	129.9	36.9	126.5	13.3	140.9	350.7	19.1	33.5	3.6	45.3	29.6	1.1	36.6	71.0	5.7	20.3	115.8	138.0
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129979-161274061	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.0"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 51.8;Late spermatids: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 19.8;HEL: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	5.6	4.2	10.5	3.5	19.1	8.0	4.5	9.6	26.6	5.3	4.2	35.6	1.0	2.6	10.7	4.5	5.2	7.2	8.0	2.9	14.2	11.8	5.2	2.0	6.1	2.0	25.8	12.4	10.0	2.3	1.3	9.8	14.6	27.4	3.7	4.4	0.7	2.7	4.9	2.1	1.9	2.5	8.5	49.0	5.2	3.0	4.2	19.8	0.6	4.8	2.0	2.2	4.0	3.8	1.1	1.9	0.6	3.5	5.8	7.0	2.1	0.3	0.8	19.8	3.9	3.7	7.6	0.8	0.7	0.2	1.5	2.5	1.1	3.5	0.5	1.4	3.1	9.2	0.3	3.6	3.0	1.4	2.2	6.2	14.8	3.5	0.0	2.9	0.1	2.1	9.1	1.5	4.0	2.1	7.1	4.6	2.3	7.3	6.8	1.8	0.0	1.0	1.6	4.7	0.0	7.5	0.0	0.9	0.4	4.3	0.3	11.5	4.4	3.0	1.6	0.8	8.1	0.8	1.0	5.1	2.1	2.6	1.4	3.3	0.5	0.7	0.0	7.8	0.8	1.3	0.0	3.5	0.0	7.0	2.8	2.3	0.4	3.3	4.1	1.9	1.1	1.7	2.7	0.6	5.8	2.5	1.5	2.9	2.1	10.5	19.1	9.6	15.8	14.2	11.8	25.8	12.4	27.4	19.8	3.0	5.6	5.2	4.6	2.9	1.0	4.0	2.5	10.7	5.7	5.2	0.0	16.0	0.0	4.3	51.8	12.2	0.0	0.0	7.0	10.7	11.3	0.8	10.5	0.4	16.7	0.0	1.7	9.8	7.6	44.8	5.5	15.4	3.3	11.8	0.0	4.0	5.9	0.0	8.1	0.3	0.9	19.4	6.2	3.6	2.9	2.3	18.5	7.4	0.0	3.2
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859405-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 40.5;intestine: 99.1"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 1287.5;Club cells: 422.0;Enterocytes: 526.8;Mucus-secreting cells: 499.0;Paneth cells: 524.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"OE19: 27.2;T-47d: 86.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		31000	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.0	0.6	7.5	0.7	0.0	13.1	0.7	0.6	4.4	45.8	0.6	0.6	29.2	1.2	5.4	0.9	40.5	11.8	0.6	0.6	0.3	1.5	0.6	26.3	0.6	0.6	0.6	5.1	1.9	0.0	12.9	2.8	1.9	1.1	38.9	0.6	9.4	0.6	0.6	0.3	99.1	1.2	0.8	0.6	17.1	1.0	0.6	0.6	1.4	1.9	3.9	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	27.2	0.0	0.0	0.0	0.5	2.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	86.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.6	0.6	0.3	0.6	0.6	1.9	0.6	309.7	310.7	0.0	9.4	2.4	0.0	0.0	35.7	1287.5	422.0	27.9	0.0	1.4	1.7	20.8	0.0	0.0	526.8	0.0	65.4	1.2	0.2	4.4	19.7	0.0	0.5	0.0	108.2	0.0	0.0	0.0	0.3	0.7	0.0	1.0	499.0	0.0	10.6	524.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.5	1.8	0.0	345.5	94.0
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020123-1056118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 79.0;Collecting duct cells: 148.3;Ductal cells: 85.5;Pancreatic endocrine cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.4;EFO-21: 54.1;HaCaT: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		15000000	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	10.2	2.8	13.0	5.3	12.4	2.9	8.3	2.3	24.0	11.3	8.5	20.5	8.9	9.8	8.2	14.5	8.8	11.4	37.2	8.1	10.9	8.3	36.0	9.3	18.1	2.3	9.3	7.0	7.6	25.2	5.7	5.0	11.0	12.7	8.7	2.5	13.6	26.5	10.8	4.7	18.6	11.2	3.9	7.7	7.2	14.1	7.5	8.1	6.4	27.0	9.5	7.6	13.7	6.2	0.0	0.1	0.0	0.5	0.0	1.1	0.1	27.0	16.8	3.3	10.9	0.5	0.7	29.4	13.7	4.4	9.2	5.6	14.1	46.4	0.5	54.1	2.1	4.5	47.1	1.1	16.9	1.1	1.0	6.4	0.0	22.0	14.8	3.9	0.3	5.5	2.4	7.3	2.9	6.4	12.8	1.6	0.4	5.6	0.1	0.7	22.2	0.2	3.8	7.0	8.7	12.3	4.3	6.4	4.0	16.1	12.1	0.8	6.5	27.8	30.1	26.5	3.3	26.5	2.1	23.9	11.3	40.0	1.5	11.0	0.3	0.2	1.0	7.1	2.5	3.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	13.0	12.4	2.3	22.0	10.9	8.3	9.3	7.0	12.7	8.1	23.8	9.1	2.4	7.5	13.4	0.8	2.2	79.0	5.3	14.8	148.3	7.9	1.1	1.7	85.5	0.1	17.9	18.6	0.0	14.5	4.6	5.6	15.4	2.3	8.9	3.9	4.8	6.4	13.5	2.1	0.8	5.2	3.1	23.6	27.1	10.4	10.0	62.9	14.0	2.5	11.3	5.4	6.5	8.5	0.5	9.6	5.3	1.0	1.0	18.4	13.7
AGTPBP1	"CCP1, KIAA1035, Nna1"	ENSG00000135049	"ATP/GTP binding protein 1"	Q9UPW5	9	85546539-85742029	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.2"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057208, HPA071094"	Approved		Approved	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA057208: AB_2683370, HPA071094: "	"unprognostic (2.15e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.26e-3)"	"unprognostic (5.69e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.25e-1)"	7.9	5.7	13.1	8.6	14.6	48.2	6.0	14.2	21.4	5.1	5.0	21.6	1.8	3.8	5.0	4.2	5.4	4.2	5.3	11.2	17.3	13.5	6.8	4.5	11.9	16.0	18.8	14.5	3.5	6.4	8.0	4.8	6.0	23.5	4.9	5.9	7.4	3.9	3.4	13.6	6.0	4.3	6.4	24.1	12.8	5.3	12.5	14.4	8.8	5.8	4.3	7.8	5.7	3.8	1.6	10.7	20.3	9.5	4.5	6.6	5.7	2.9	5.7	16.9	6.7	3.5	3.8	6.4	4.4	3.8	4.5	5.2	3.0	5.1	18.4	3.8	4.6	8.0	1.7	7.8	5.6	4.3	19.5	6.9	3.1	6.9	5.4	7.3	14.1	3.7	3.6	6.6	4.2	14.5	2.9	7.2	9.5	3.9	14.8	2.0	4.6	11.0	8.4	11.7	10.6	4.0	10.1	6.2	5.6	7.9	3.2	20.4	14.5	5.0	5.5	9.1	16.8	2.1	4.6	7.1	2.9	5.2	18.5	5.2	10.1	8.4	8.4	6.2	13.9	5.9	20.3	9.5	8.3	6.6	5.7	6.4	1.6	3.3	5.1	10.7	1.2	2.7	5.2	14.0	4.5	4.3	1.7	3.4	5.7	13.1	14.6	14.2	21.4	17.3	13.5	18.8	14.5	23.5	14.4	59.6	13.8	5.4	2.3	7.0	29.1	39.1	0.0	18.7	21.6	3.5	96.2	3.7	6.6	4.8	44.2	7.5	2.7	0.0	3.5	3.5	4.5	3.7	25.5	3.6	7.2	33.4	7.5	10.4	38.6	49.1	1.7	22.6	3.3	9.0	4.9	16.0	4.6	0.0	2.5	6.1	56.8	12.9	7.2	25.0	27.2	9.4	2.4	20.8	3.8	1.6
AHCYL1	"IRBIT, PPP1R78, XPVKONA"	ENSG00000168710	"Adenosylhomocysteinase like 1"	O43865	1	109984686-110023741	"Predicted intracellular proteins"	"One-carbon metabolism"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042589	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA042589: AB_10793885"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-3)"	24.0	25.7	61.7	11.7	71.2	4.8	19.7	33.2	61.4	26.7	26.3	47.7	17.7	46.5	21.0	36.0	18.3	28.0	24.7	13.9	51.6	57.2	38.6	25.4	16.5	10.5	72.3	49.9	17.6	27.1	53.0	16.3	20.6	55.7	17.3	19.7	9.7	17.9	25.8	27.1	14.2	22.9	21.8	48.8	12.1	19.6	10.2	47.5	6.8	28.6	8.6	13.4	16.7	15.3	8.0	6.2	8.7	9.3	3.9	8.2	3.7	22.7	19.4	18.3	18.9	44.3	26.1	30.2	18.1	20.5	17.2	17.0	15.0	13.2	9.7	15.5	26.7	13.1	14.7	16.2	20.7	22.8	81.2	14.0	16.0	25.2	15.8	46.0	13.7	11.3	26.6	13.1	21.4	31.4	42.0	21.6	16.5	11.5	19.7	17.7	18.1	11.4	6.8	21.6	32.2	15.0	12.4	38.1	10.7	37.6	23.1	17.9	11.6	28.1	33.7	37.7	29.2	18.0	13.8	18.6	16.6	16.3	19.5	16.0	16.3	6.7	8.3	34.1	15.1	33.8	5.0	8.8	7.7	4.3	9.3	4.4	6.8	4.4	5.7	6.2	8.0	4.6	4.4	8.7	3.9	6.3	5.7	8.2	3.7	61.7	71.2	33.2	51.5	51.6	57.2	72.3	49.9	55.7	47.5	32.8	64.0	27.3	82.1	79.2	59.7	41.9	107.0	33.5	34.2	111.7	210.1	72.2	106.1	110.2	22.2	52.0	80.5	23.3	97.7	41.1	77.1	89.9	31.1	135.4	38.2	60.4	82.1	64.4	67.4	22.3	86.6	50.2	59.1	34.3	66.6	96.8	88.6	38.6	76.7	118.7	100.2	45.3	90.1	25.8	13.5	94.7	83.9	28.0	71.2	97.0
AHCYL2	KIAA0828	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 72.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 75.8;Enterocytes: 114.1;Muller glia cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	4.3	6.6	12.8	5.9	20.3	1.5	4.3	7.2	16.9	7.1	61.8	13.3	5.1	23.1	6.1	3.3	5.7	4.4	22.7	3.4	16.5	9.6	11.9	3.4	26.1	4.2	10.7	14.9	5.7	5.8	9.1	12.8	5.1	19.8	5.0	72.4	24.3	15.0	3.3	20.7	9.8	15.0	5.3	11.4	2.9	16.5	8.1	9.6	4.6	24.1	4.0	4.0	5.4	4.7	0.9	1.3	2.0	2.5	3.3	5.0	0.5	2.7	4.3	8.3	4.9	2.2	3.3	1.7	2.1	3.0	2.4	2.2	2.5	1.8	1.6	2.2	2.3	5.2	1.9	4.1	3.4	2.7	73.5	5.1	3.9	4.8	2.0	1.3	2.8	5.0	3.0	4.4	1.9	3.0	4.1	4.8	3.2	1.7	9.3	3.1	2.5	4.2	3.7	4.1	2.7	3.0	2.8	2.2	4.4	4.9	3.6	3.8	2.4	4.9	2.1	2.9	7.2	2.0	2.1	2.7	2.1	1.2	5.5	2.2	3.9	4.4	2.2	5.4	3.1	3.2	0.1	1.2	2.0	0.9	2.5	1.2	0.9	1.5	0.7	1.3	0.5	1.3	0.5	0.4	3.3	1.2	0.4	5.0	0.5	12.8	20.3	7.2	16.9	16.5	9.6	10.7	14.9	19.8	9.6	56.6	75.8	3.4	4.5	13.9	9.4	4.5	17.8	5.3	19.4	5.2	5.9	8.4	10.0	3.6	61.0	3.9	114.1	0.0	4.9	2.2	3.1	6.2	5.7	4.9	3.9	4.8	8.7	4.3	8.3	20.3	3.7	5.1	23.6	7.2	29.7	87.7	4.5	30.8	6.3	15.7	5.0	6.5	1.2	4.6	2.4	8.5	12.7	3.2	32.7	13.9
AIDA	"C1orf80, FLJ12806"	ENSG00000186063	"Axin interactor, dorsalization associated"	Q96BJ3	1	222668013-222713210	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027935	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA027935: AB_10602226"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	37.7	20.7	22.6	20.2	28.1	9.8	33.7	19.8	20.4	28.7	32.6	13.3	20.1	13.7	22.3	32.7	31.5	17.9	22.7	43.2	21.6	23.8	27.9	27.6	30.5	25.0	25.2	17.0	25.4	21.0	16.4	22.5	26.0	25.7	29.6	20.5	13.7	16.1	24.9	20.2	14.9	19.5	33.3	27.5	24.9	19.7	23.1	22.5	21.1	30.5	13.5	27.9	42.0	39.7	14.2	6.7	4.4	4.4	3.3	9.1	3.8	18.2	14.1	16.8	18.0	47.8	45.2	18.4	34.3	36.8	24.6	22.7	16.0	15.7	9.8	17.4	40.5	19.0	11.3	20.7	22.7	30.1	14.6	7.6	12.4	17.0	15.3	25.2	15.2	7.3	27.4	20.4	29.2	28.4	26.6	29.9	12.6	18.7	13.9	46.1	6.8	9.9	9.4	41.9	20.8	30.3	10.8	47.4	14.2	28.4	12.4	11.1	18.6	22.9	13.6	20.8	27.1	11.1	9.5	23.7	33.2	16.4	32.1	40.3	10.4	19.5	8.8	30.8	9.6	32.5	4.4	2.6	2.6	5.7	4.0	4.9	13.7	7.3	6.2	2.4	14.2	7.6	5.8	1.5	3.3	4.4	6.7	9.1	3.8	22.6	28.1	19.8	20.4	21.6	23.8	25.2	17.0	25.7	22.5	20.8	37.5	39.7	31.9	28.8	17.4	7.5	15.3	38.8	20.5	31.4	31.4	17.3	24.9	34.0	14.2	47.6	16.2	23.3	32.8	46.9	47.4	44.9	3.5	31.0	28.3	22.3	34.7	44.8	32.3	16.7	55.8	29.7	35.4	74.9	21.2	22.9	42.9	21.0	47.7	42.5	13.4	32.3	50.5	35.9	15.1	26.5	7.6	24.0	19.0	25.1
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor, mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 41.9"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 57.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.92e-4)"	32.9	7.8	3.1	6.6	5.9	1.3	41.9	5.0	3.7	3.5	9.0	2.1	22.1	7.6	4.5	9.6	9.1	4.0	7.6	19.7	2.8	4.1	10.2	18.2	8.1	4.0	2.9	2.4	7.5	3.6	3.9	3.1	5.2	3.5	6.4	5.9	9.2	5.8	15.2	9.1	2.8	9.9	7.8	3.7	5.9	6.5	3.1	2.1	1.0	10.8	6.4	7.3	11.8	15.7	3.4	0.7	1.5	1.0	7.8	3.5	1.2	8.8	15.4	0.4	4.0	9.3	3.5	0.1	3.5	8.8	7.3	8.3	11.9	17.2	1.3	9.1	4.9	9.7	9.6	4.3	1.2	2.0	17.2	0.7	0.0	9.1	57.7	20.0	0.1	2.2	4.7	2.9	11.7	2.5	4.6	3.2	0.6	6.7	7.6	3.7	11.2	0.4	0.4	1.6	7.1	5.0	0.2	1.4	4.2	3.9	6.5	1.3	0.3	6.5	5.7	10.0	0.6	0.2	2.4	4.0	0.1	9.0	5.4	10.3	5.7	10.6	2.4	4.9	0.3	4.8	1.5	0.9	1.0	3.5	0.8	3.1	3.4	1.2	3.0	0.7	2.9	1.7	2.7	1.0	7.8	1.0	0.5	2.4	1.2	3.1	5.9	5.0	3.7	2.8	4.1	2.9	2.4	3.5	2.1	6.0	13.1	2.2	11.6	2.1	5.5	11.7	10.2	9.4	10.3	17.4	0.0	12.6	3.3	35.2	19.5	2.3	32.9	0.0	19.3	2.5	6.3	12.0	11.5	20.2	10.5	1.6	11.5	2.5	1.8	33.7	4.9	3.5	8.5	59.5	6.0	4.5	31.0	17.5	4.2	11.5	1.7	19.4	13.0	3.2	3.2	1.3	15.6	5.1	9.0	14.8
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143340304	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.7"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 202.6;Proximal tubular cells: 212.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	18.4	14.9	20.1	5.6	18.7	13.0	16.8	15.6	22.3	8.1	15.1	26.6	7.9	22.3	7.7	18.8	14.7	16.7	14.2	21.9	21.7	26.0	51.4	115.7	8.6	5.7	23.3	15.7	17.1	14.2	9.7	19.2	6.3	25.7	12.5	9.7	21.1	11.5	12.8	10.1	8.2	25.6	8.9	28.6	9.4	8.7	10.0	14.7	1.7	23.0	11.2	11.3	14.5	10.5	6.4	19.0	8.2	18.7	6.3	10.0	5.7	9.4	7.1	6.7	18.8	9.6	8.5	2.3	8.2	18.3	8.2	20.1	10.5	27.9	6.3	11.8	18.9	12.1	13.5	8.1	27.1	20.4	18.5	17.9	1.5	11.0	43.5	14.3	13.5	0.9	10.1	27.8	10.4	44.5	29.8	3.2	8.7	1.1	22.2	21.0	12.6	4.1	3.4	12.6	10.7	8.2	6.0	18.2	10.5	32.9	21.6	23.7	13.2	10.7	10.1	4.8	12.0	10.6	31.5	1.0	7.9	8.5	7.8	10.1	29.6	23.5	0.5	19.4	3.2	8.1	5.8	3.9	5.9	4.4	16.8	10.0	6.4	8.2	6.7	19.0	4.2	8.8	6.8	8.2	6.3	18.7	1.9	5.7	5.7	20.1	18.7	15.6	22.3	21.7	26.0	23.3	15.7	25.7	14.7	14.9	23.0	21.7	44.8	22.1	63.0	65.1	76.5	57.6	35.2	48.8	23.6	56.8	44.7	47.3	9.7	28.1	17.9	23.3	27.4	6.9	41.9	39.0	36.8	202.6	29.0	50.9	37.9	31.3	26.1	5.6	29.7	27.8	52.3	23.4	25.0	69.0	25.6	26.6	36.0	212.5	31.0	32.3	36.0	3.6	12.3	40.0	90.4	20.4	28.1	43.8
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009245-6023834	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol		NA	NA		8200	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.09e-4)"	10.2	11.2	6.3	6.9	7.3	5.3	11.2	5.3	11.0	5.6	14.9	10.2	7.1	22.8	8.9	10.8	11.2	7.7	8.7	17.7	6.5	5.8	18.6	30.7	6.8	15.1	6.8	8.2	7.5	9.6	12.3	4.5	9.0	7.6	6.1	12.2	6.6	13.6	9.0	66.1	10.3	21.0	9.8	7.2	9.4	7.5	20.4	5.1	9.3	12.9	28.4	9.1	8.2	6.6	19.0	37.3	13.8	30.0	17.8	17.7	16.1	26.1	29.7	10.1	14.4	10.7	11.7	34.4	14.9	10.0	24.4	18.2	32.4	17.4	32.2	14.0	15.2	27.9	29.2	34.1	22.3	15.2	10.4	25.8	17.8	17.5	24.2	33.1	25.0	16.1	18.0	33.0	22.0	36.1	4.1	18.2	13.6	24.9	10.7	17.8	41.5	10.8	45.5	41.0	13.0	21.6	24.3	22.4	27.2	35.7	12.2	20.2	19.1	15.0	30.3	20.3	13.4	28.3	20.4	15.2	14.0	34.9	23.2	32.4	13.7	20.7	27.8	11.7	35.8	22.6	13.8	25.0	7.6	17.7	30.0	15.0	19.0	12.2	14.0	37.3	13.3	12.2	12.8	2.5	17.8	22.1	23.9	13.0	16.1	6.3	7.3	5.3	11.0	6.5	5.8	6.8	8.2	7.6	5.1	8.9	9.3	13.7	15.6	9.6	9.6	1.7	28.1	25.4	17.0	12.2	5.9	42.3	59.7	47.3	99.1	15.8	18.7	0.0	49.8	47.9	11.5	12.2	11.6	30.6	44.3	6.4	6.4	13.5	19.2	61.8	18.4	16.6	18.6	50.5	15.4	16.4	34.2	10.5	17.0	54.2	9.1	12.9	15.1	55.6	21.1	10.2	33.1	10.2	35.9	16.5
AJM1	"ajm-1, C9orf172"	ENSG00000232434	"Apical junction component 1 homolog"	C9J069	9	136844415-136848801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;testis: 15.0"	"Cell type enhanced"	"Detected in some"	23	"Collecting duct cells: 5.2;Ductal cells: 1.4;granulocytes: 1.1;Pancreatic endocrine cells: 1.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 22.7"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.9;monocytes: 1.6;T-cells: 1.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA021200	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"		"HPA021200: AB_10601695"	"unprognostic (3.30e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.68e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.00e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.07e-3)"	"unprognostic (7.27e-2)"	1.1	1.9	4.6	1.3	6.3	1.4	1.1	22.7	7.9	1.1	4.0	1.1	1.1	3.3	1.2	1.1	1.1	0.3	1.1	1.2	4.4	3.1	1.1	1.1	1.1	1.1	2.1	1.1	1.1	7.6	1.1	5.2	1.1	1.1	2.6	1.1	1.1	2.0	2.2	3.9	1.5	4.3	1.1	1.3	3.6	2.3	15.0	1.1	1.1	1.1	1.1	1.1	2.6	1.1	0.2	3.9	0.1	1.6	0.2	1.9	0.8	3.7	3.0	0.4	1.1	0.5	0.4	4.9	3.0	0.5	0.4	0.2	1.0	2.0	2.3	2.6	0.8	1.0	4.2	0.4	1.1	0.0	5.8	2.2	0.6	5.6	0.9	1.7	1.3	4.2	0.9	1.5	0.5	0.3	2.5	0.2	1.1	3.5	1.5	0.7	4.1	0.4	4.5	1.2	3.1	3.9	2.8	0.9	7.3	0.9	0.7	7.4	2.6	1.9	7.6	4.0	0.6	6.0	2.8	3.1	5.0	3.5	1.7	1.8	6.6	4.5	0.8	8.8	4.6	1.2	0.0	1.6	0.1	1.9	1.0	0.4	0.2	0.5	0.9	1.5	0.0	0.2	0.9	0.1	0.2	1.5	3.9	0.1	0.8	4.6	6.3	22.7	6.8	4.4	3.1	2.1	1.1	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AJUBA	"JUB, MGC15563"	ENSG00000129474	"Ajuba LIM protein"	Q96IF1	14	22971174-22982642	"Cancer-related genes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 55.0"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 42.2;Sertoli cells: 32.3;Suprabasal keratinocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 49.9;hTCEpi: 52.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006171	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA006171: AB_1852044"	"unprognostic (1.15e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.07e-1)"	2.9	2.0	1.1	2.4	1.8	0.0	4.1	1.1	1.6	11.1	2.0	1.6	4.9	0.5	8.8	4.4	12.3	4.7	7.9	3.2	2.3	0.6	15.6	55.0	8.5	2.2	1.5	1.3	8.2	5.6	5.5	1.4	12.5	2.6	9.2	1.1	7.1	5.5	11.0	1.5	31.3	1.7	4.3	0.5	2.9	2.6	4.1	1.3	7.1	15.4	5.3	6.6	3.7	10.0	1.3	1.0	2.6	1.2	2.9	2.5	0.6	10.4	12.4	16.6	6.4	1.6	2.9	13.3	10.3	13.6	24.2	21.7	26.4	10.9	0.2	10.8	21.2	16.7	34.0	12.7	49.9	29.6	1.0	1.1	0.8	20.1	29.7	19.0	1.1	0.7	9.3	52.3	10.1	39.0	17.2	9.2	1.9	0.4	0.6	22.3	8.4	1.0	1.2	1.0	19.6	17.1	2.8	13.8	0.2	24.2	16.3	0.0	1.4	31.1	9.2	2.0	14.1	12.8	1.0	8.2	10.5	21.2	1.7	9.8	0.1	0.3	0.1	1.6	0.9	4.7	2.2	1.2	0.5	1.4	0.5	0.5	0.4	1.2	2.5	0.4	1.3	1.5	0.9	2.6	2.9	0.8	1.0	0.2	0.6	1.1	1.8	1.1	1.6	2.3	0.6	1.5	1.3	2.6	1.3	17.9	5.4	0.0	12.1	42.2	0.0	4.0	15.3	4.0	9.1	7.0	0.0	8.2	5.0	13.1	4.3	5.0	0.0	0.0	12.9	9.4	5.4	3.4	0.0	14.0	1.5	0.0	0.0	1.8	0.0	3.8	3.4	0.7	3.3	0.0	0.3	7.7	24.1	0.0	0.7	17.8	0.0	32.3	12.7	6.0	2.5	43.3	3.3	0.0	0.9	4.3
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018479, CAB079913"	Approved		Approved	Mitochondria		NA	NA		5500000	Mitochondria		"CAB079913: AB_2546087, HPA018479: AB_1844676"	"prognostic favorable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	24.9	27.1	16.0	27.6	20.3	18.3	24.2	19.1	17.6	21.4	31.3	24.6	22.4	36.6	20.6	22.8	31.6	17.6	25.0	33.9	15.1	14.5	51.2	46.5	17.9	18.2	23.1	9.9	24.3	23.2	27.2	16.2	18.6	19.7	22.4	31.8	20.4	31.4	21.5	73.8	20.6	37.1	18.7	25.9	24.7	24.0	29.3	25.0	40.2	37.4	34.4	28.7	26.7	23.3	31.7	51.9	50.9	41.2	27.4	24.4	43.1	45.7	20.3	19.2	22.3	13.3	16.7	19.5	25.8	20.0	38.9	40.9	39.0	41.5	85.2	30.7	19.1	27.9	33.2	44.6	43.9	41.9	37.2	32.6	56.4	39.1	29.7	31.2	100.3	32.0	16.5	33.2	33.3	67.3	21.7	26.5	36.0	59.9	32.1	23.1	23.0	37.9	55.5	26.8	44.1	31.2	44.3	32.7	56.1	38.3	27.6	28.3	16.6	29.5	32.8	82.3	23.8	26.6	71.4	19.4	23.6	28.5	36.3	48.3	33.5	43.8	79.4	32.0	95.0	27.2	11.0	41.2	50.9	22.0	37.4	23.0	31.7	20.6	20.6	51.9	27.7	21.2	19.8	11.3	27.4	31.5	39.1	24.4	43.1	16.0	20.3	19.1	17.6	15.1	14.5	23.1	9.9	19.7	25.0	47.6	66.5	38.7	80.7	111.2	21.1	86.7	71.4	46.8	83.0	106.4	78.5	137.4	217.2	94.6	81.6	64.2	135.8	0.0	107.9	138.4	58.1	76.3	39.3	127.8	84.9	7.9	48.5	31.9	41.6	29.1	43.4	51.1	82.7	58.7	70.5	20.1	99.6	51.8	41.4	362.4	38.8	51.8	59.5	97.9	21.1	107.3	181.1	37.4	94.5	113.8
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282051-77559969	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.5"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 137.0;Extravillous trophoblasts: 30.0;Spermatogonia: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 10.9;naive CD4 T-cell: 14.2"	"Group enriched"	"Detected in many"	15	"dendritic cells: 10.9;T-cells: 14.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.3;BJ: 20.7;fHDF/TERT166: 23.6;LHCN-M2: 59.3;U-2 OS: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: AB_2683383"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.8	2.1	43.8	1.9	35.7	3.7	14.1	1.3	95.5	2.0	1.8	20.4	0.0	1.8	1.6	1.5	1.8	1.8	1.7	1.5	35.8	11.8	2.0	1.2	1.4	2.5	13.0	41.1	1.5	2.1	2.4	1.4	1.8	11.4	2.7	1.8	0.0	3.1	2.7	1.3	2.4	1.7	1.7	14.2	2.4	2.9	7.3	13.9	0.0	1.7	0.0	2.1	1.5	0.4	0.8	10.9	0.7	0.7	0.1	14.2	1.9	0.0	1.1	0.9	0.0	11.2	30.3	0.4	20.7	4.4	3.4	1.4	0.1	0.5	0.1	0.1	23.6	1.3	0.1	0.0	0.0	1.7	0.7	0.2	0.1	0.1	0.0	0.5	0.1	0.0	3.7	0.1	0.6	1.3	12.0	9.7	0.1	0.2	0.2	59.3	0.2	0.0	0.1	1.2	5.5	7.5	0.5	2.2	0.3	9.2	0.3	4.6	1.1	0.0	0.0	1.3	0.1	0.1	0.1	2.4	8.2	18.6	0.4	0.6	4.8	4.3	0.0	1.6	1.0	3.0	0.7	0.7	0.0	3.4	0.1	0.5	0.8	3.2	1.6	10.9	0.8	14.2	7.8	0.5	0.1	0.2	1.2	1.4	1.9	43.8	35.7	1.3	47.1	35.8	11.8	13.0	41.1	11.4	13.9	0.0	0.0	0.0	0.5	0.2	0.5	1.2	0.0	0.0	0.0	1.8	0.0	0.9	6.6	0.2	137.0	1.1	0.0	0.0	0.6	30.0	1.2	2.2	0.0	0.0	2.2	12.7	11.5	0.6	0.0	16.1	1.1	0.4	3.3	0.0	0.0	0.0	0.1	0.0	0.7	4.5	0.2	0.0	3.1	6.5	72.5	0.3	2.4	1.5	0.0	0.1
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 216.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"		No	No			"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	27.6	27.7	25.1	16.9	25.4	14.8	23.3	21.5	23.6	17.6	22.7	11.3	16.4	18.3	18.3	30.4	26.7	15.4	15.1	17.9	23.2	22.2	30.2	42.3	17.0	18.7	20.9	16.2	18.8	17.2	15.8	26.3	21.5	23.3	18.2	20.6	12.3	14.5	14.6	41.4	11.9	24.0	16.7	19.6	21.8	17.0	46.1	17.5	25.2	24.3	24.2	18.8	19.7	13.7	22.2	22.0	14.3	15.9	16.6	21.2	10.0	17.1	9.6	12.6	16.8	20.6	13.7	23.6	25.9	9.7	12.8	15.9	26.7	14.9	36.9	24.6	11.7	30.5	5.8	19.7	12.4	19.5	15.1	9.4	18.1	20.4	20.4	16.9	21.5	7.9	8.0	16.4	12.7	18.2	12.2	8.2	21.2	16.9	12.2	16.4	20.0	19.8	14.6	10.4	8.6	6.4	23.3	15.6	20.4	20.0	14.0	6.5	6.4	13.4	10.8	18.6	10.7	11.5	24.3	10.8	9.6	15.4	17.8	21.4	14.7	30.5	32.7	12.4	31.7	12.4	13.7	13.0	14.3	15.5	15.9	16.1	22.2	18.4	19.3	18.0	18.1	20.1	21.2	2.1	16.6	14.2	22.0	18.1	10.0	25.1	25.4	21.5	23.6	23.2	22.2	20.9	16.2	23.3	17.5	20.8	35.4	37.1	87.7	0.0	18.7	49.5	17.8	33.5	30.7	22.7	9.8	72.3	157.5	66.4	145.7	28.1	24.8	0.0	67.7	77.3	45.1	82.1	19.8	41.0	62.2	19.1	9.4	27.6	25.3	216.1	31.1	35.2	0.0	50.5	24.5	36.8	52.7	29.1	30.1	110.2	20.0	51.8	65.6	42.4	42.4	0.0	55.4	25.9	41.3	76.3
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"		Yes	No			"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	20.5	24.2	22.5	19.4	25.5	16.1	21.2	22.8	27.9	21.2	19.4	17.4	13.4	16.1	22.3	15.9	18.5	19.2	18.4	14.4	20.1	17.9	22.7	14.9	18.5	24.3	22.4	23.2	24.3	16.2	28.0	20.3	20.3	19.2	19.5	20.3	16.1	17.8	21.3	13.7	17.5	18.5	22.9	19.0	28.6	20.2	22.9	24.2	25.9	26.0	9.1	20.5	22.2	22.7	7.3	6.1	24.4	10.3	5.1	7.9	3.0	8.7	10.5	7.0	4.9	9.3	11.8	13.0	10.2	11.0	11.4	13.7	11.4	5.3	7.5	6.9	8.1	9.9	9.3	9.0	8.5	15.6	6.2	7.7	6.4	10.3	5.5	8.8	4.6	10.6	9.9	10.7	10.4	12.9	12.8	9.1	9.2	4.1	3.8	11.8	6.3	8.6	6.9	4.6	12.2	3.6	5.7	23.0	3.9	9.5	5.6	2.4	7.2	11.7	5.5	9.7	45.2	13.4	5.2	8.0	8.8	7.3	7.5	9.4	4.7	5.0	9.2	11.7	5.6	8.5	3.6	7.3	8.8	6.7	10.3	6.1	6.0	6.5	7.2	6.1	7.3	7.9	7.0	24.4	5.1	9.3	4.6	4.9	3.0	22.5	25.5	22.8	27.9	20.1	17.9	22.4	23.2	19.2	24.2	3.0	10.5	23.8	8.2	6.3	24.2	7.7	10.2	18.7	13.6	5.2	15.7	11.8	1.7	8.1	10.1	10.0	11.8	0.0	6.2	9.3	8.2	12.9	9.3	11.1	14.2	31.8	6.9	16.0	28.9	8.5	14.1	22.0	5.0	21.6	10.6	10.9	7.0	14.8	13.1	4.5	23.0	19.4	9.9	15.1	25.3	6.8	11.7	17.3	10.3	9.8
AKAP17A	"721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y"	ENSG00000197976	"A-kinase anchoring protein 17A"	Q02040	X	1591593-1602514	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043247, HPA051020"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA043247: AB_10964776, HPA051020: AB_2681314"	"unprognostic (4.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.25e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (2.42e-4)"	"unprognostic (1.55e-3)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.03e-2)"	"prognostic favorable (1.11e-5)"	7.4	10.3	28.1	14.5	42.3	18.0	24.5	27.5	25.2	32.8	7.2	2.5	2.5	14.2	40.9	9.7	9.2	9.1	7.4	12.5	27.1	3.4	20.3	16.4	12.2	15.4	37.6	27.1	38.0	15.6	5.2	31.0	42.7	33.7	12.6	4.3	2.5	17.0	7.8	6.9	12.3	11.6	3.2	27.8	21.4	14.2	7.0	37.2	2.5	16.1	2.5	8.9	6.8	47.6	1.8	1.8	7.0	1.0	1.3	1.6	0.4	9.6	12.5	10.0	11.3	4.9	6.3	24.5	10.5	4.3	8.5	7.2	13.8	9.0	14.6	6.8	5.2	12.0	8.5	6.0	5.2	5.1	12.0	20.8	18.2	12.0	12.8	10.6	7.0	30.6	5.6	9.8	6.3	7.0	10.1	5.8	7.4	11.3	9.3	4.9	6.4	15.5	30.5	14.9	2.2	10.8	11.8	11.9	12.2	5.7	6.8	11.2	16.4	8.2	13.4	12.7	8.6	8.7	12.9	11.2	13.3	6.1	11.4	9.1	40.2	6.7	20.3	5.4	11.5	3.5	7.0	1.0	1.9	0.8	0.5	0.9	1.8	1.0	1.6	0.6	1.2	0.8	0.8	4.1	1.3	0.8	1.8	0.5	0.4	28.1	42.3	27.5	25.2	27.1	3.4	37.6	27.1	33.7	37.2	23.8	25.9	29.8	31.3	39.4	23.2	9.9	7.6	10.7	21.6	12.2	9.8	20.9	11.6	17.7	40.2	26.1	21.4	0.0	13.4	24.6	26.6	35.0	25.3	19.5	20.2	15.9	21.7	29.4	20.6	11.0	35.9	36.0	38.8	27.9	23.5	23.7	19.9	24.6	29.7	5.7	13.9	0.0	25.5	16.3	30.3	41.3	60.8	37.0	20.0	42.9
AKAP5	"AKAP75, AKAP79"	ENSG00000179841	"A-kinase anchoring protein 5"	P24588	14	64465499-64474503	"Plasma proteins, Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 39.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 63.8;Mucus-secreting cells: 24.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"basophil: 5.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.1"					"Group enriched"	"Detected in all"	5	"amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3"	"CAB004308, HPA053891"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004308: AB_626655, HPA053891: AB_2682294"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.44e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.49e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.45e-2)"	0.7	0.8	17.3	2.2	39.1	1.0	1.1	2.9	21.8	0.7	5.9	0.2	0.0	1.1	2.3	0.6	1.0	0.8	1.6	0.6	9.9	1.4	2.4	1.2	3.0	2.9	1.3	9.2	0.7	0.5	1.5	1.3	1.8	0.9	1.0	6.1	0.0	0.7	1.0	0.6	1.0	2.4	2.2	0.7	2.0	1.1	0.7	1.3	0.1	1.1	0.0	2.5	1.4	0.7	0.7	0.4	5.7	0.3	0.9	1.0	0.2	1.7	1.4	1.7	1.0	0.6	0.1	5.7	1.3	0.6	1.6	2.1	14.1	4.4	1.3	2.7	1.0	0.2	0.6	3.7	0.3	1.6	2.6	3.1	4.3	2.6	1.2	0.1	0.5	0.6	0.6	0.1	1.1	0.0	2.9	0.6	3.2	0.5	1.0	1.0	1.0	3.4	0.3	1.3	0.2	0.7	4.2	0.8	0.3	2.6	1.6	4.4	2.0	1.5	0.1	0.4	5.5	1.3	0.3	0.8	1.9	5.8	0.2	2.2	3.0	3.3	3.2	1.3	0.5	0.3	5.7	0.3	0.2	1.0	0.1	0.2	0.5	0.3	0.9	0.2	0.7	0.4	0.5	0.7	0.9	0.1	0.4	0.1	0.2	17.3	39.1	2.9	19.9	9.9	1.4	1.3	9.2	0.9	1.3	6.0	3.7	0.5	1.3	0.8	7.0	0.9	2.5	0.0	0.0	0.0	7.9	0.5	0.0	0.5	1.6	0.8	0.9	0.0	0.2	1.4	1.5	1.0	63.8	0.8	0.4	7.9	0.0	0.6	0.8	0.5	0.0	1.3	1.7	0.0	24.0	0.5	0.6	0.0	0.0	0.7	7.9	0.0	0.4	0.5	4.3	0.6	0.6	10.2	4.6	0.7
AKAP7	"AKAP15, AKAP18"	ENSG00000118507	"A-kinase anchoring protein 7"	"O43687, Q9P0M2"	6	131135666-131283535	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 39.4;pancreas: 37.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.4;RPTEC TERT1: 17.0;RT4: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027172, HPA027200, HPA028327"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353"	"unprognostic (2.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.03e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.56e-4)"	5.7	39.4	16.1	6.2	11.2	6.3	4.7	16.6	15.4	6.0	12.9	4.9	4.1	19.9	4.5	4.1	3.0	4.9	6.8	4.4	12.0	9.9	5.6	15.7	6.2	11.6	8.1	11.7	7.2	37.5	3.1	3.5	2.8	7.2	10.0	13.3	2.9	3.4	4.8	9.8	2.3	12.4	5.2	6.2	6.2	3.7	5.8	6.4	18.9	4.2	2.1	5.5	8.6	4.3	4.4	1.8	9.5	3.4	3.2	14.9	5.0	0.8	1.5	5.6	2.7	3.1	6.7	3.9	2.3	3.8	4.0	5.3	1.9	1.5	0.1	4.4	4.0	3.0	0.0	1.6	2.5	2.9	0.0	2.3	5.6	1.8	8.3	4.5	0.2	1.8	5.7	1.8	2.5	3.3	3.7	4.1	3.3	0.9	8.1	3.8	1.5	2.4	1.4	19.4	0.5	2.1	5.0	3.7	0.1	17.0	18.8	0.1	2.0	3.2	0.3	7.6	3.4	1.3	11.7	1.4	1.9	2.6	5.3	5.8	7.6	0.0	1.3	4.5	5.7	4.2	9.5	1.5	0.2	6.8	2.9	10.5	2.6	9.4	9.1	1.8	4.4	14.9	9.3	0.4	3.2	3.4	0.1	3.2	5.0	16.1	11.2	16.6	15.4	12.0	9.9	8.1	11.7	7.2	6.4	17.9	7.8	10.9	7.0	5.6	20.9	9.0	124.9	1.4	2.3	5.2	15.7	6.4	16.6	21.9	3.9	4.8	14.7	23.3	3.6	8.3	5.9	6.7	10.4	34.7	7.7	7.9	1.2	8.0	11.0	1.3	7.8	9.3	1.7	0.0	14.4	37.6	2.7	31.5	5.3	15.2	11.5	0.0	6.9	3.5	9.1	3.6	3.9	17.5	16.6	3.7
AKIRIN1	"C1orf108, FLJ12666"	ENSG00000174574	"Akirin 1"	Q9H9L7	1	38991223-39006059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 1447.5;Late spermatids: 943.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051871	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA051871: AB_2681646"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.77e-3)"	"unprognostic (5.17e-2)"	30.2	20.8	28.3	21.1	29.4	43.1	16.8	17.6	30.3	16.2	23.3	35.0	20.4	15.9	20.6	29.5	19.8	19.5	28.6	40.8	30.1	34.0	29.2	35.0	19.8	25.5	32.1	21.0	17.0	18.2	25.9	34.5	19.5	31.3	25.5	25.0	20.3	18.2	25.7	20.7	12.0	19.2	28.2	41.8	20.5	24.3	68.0	23.6	25.6	24.5	11.2	27.1	22.6	22.4	14.8	22.7	43.1	15.8	29.3	28.6	20.1	16.4	7.7	33.2	27.0	16.2	19.3	23.5	19.4	20.4	19.6	20.1	19.6	13.8	13.1	18.1	18.4	14.1	11.6	32.0	17.4	31.7	19.5	16.0	38.8	11.7	24.9	21.5	36.8	21.3	19.8	22.8	25.5	21.1	17.6	18.1	17.2	26.3	13.1	24.5	6.7	15.6	15.9	69.9	12.5	12.9	25.0	24.1	13.0	21.8	20.3	22.9	15.7	21.5	11.4	42.0	54.3	10.6	19.1	16.0	12.0	19.5	13.0	19.6	19.0	24.4	28.1	20.7	21.9	20.4	12.2	15.8	33.2	14.6	13.5	22.4	14.8	24.1	22.6	22.7	13.0	28.6	18.3	43.1	29.3	15.0	17.1	21.7	20.1	28.3	29.4	17.6	30.3	30.1	34.0	32.1	21.0	31.3	23.6	59.6	44.0	57.9	73.6	122.5	43.4	42.7	28.1	25.4	40.9	36.6	45.2	66.3	79.6	41.6	1447.5	35.9	34.6	46.7	35.5	58.5	56.4	57.9	47.3	31.4	40.1	52.4	90.8	28.8	40.3	943.7	40.9	47.8	40.5	101.0	32.3	47.2	39.9	31.7	42.8	28.4	42.1	51.8	47.4	71.1	89.7	121.1	140.1	47.3	28.1	70.7
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108858228	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	57	"testis: 12.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 58.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HBEC3-KT: 1.3;hTCEpi: 4.0;hTERT-HME1: 2.2;LHCN-M2: 1.2"									"HPA030270, HPA030271, HPA030272"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.9	0.6	0.0	0.9	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	3.5	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	58.5	1.0	0.0	0.0	0.2	0.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.6	2.3	0.0	1.7	0.0	0.3	0.6	0.3	0.0	1.1	0.0	0.0	0.0	0.7	0.5	0.7	0.1	0.6	0.0	0.4	0.0
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.4	15.4	19.5	45.7	17.1	34.5	9.9	12.7	40.6	15.7	22.3	17.9	21.1	22.9	28.5	16.1	16.3	20.6	23.5	20.2	43.3	39.6	30.3	26.4	38.0	25.8	21.6	40.2	32.3	39.4	29.6	12.0	32.5	20.0	11.9	32.4	13.2	23.7	53.3	16.3	37.4	26.1	47.1	48.6	22.5	26.0	15.0	16.9	67.5	24.7	31.3	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.4	29.9	19.1	15.5	39.5	6.7	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1	44.7	49.4	132.5	80.9	43.7	20.8	32.3	96.8	60.2	53.4	75.0	35.3	93.6	154.2	163.4	4.1	51.7	130.2	0.0	136.9	121.2	79.9	92.3	108.6	269.4	347.1	15.9	113.6	74.9	110.8	5.9	63.3	159.5	77.6	161.5	133.1	26.5	118.5	151.9	52.6	1001.5	34.9	6.5	49.5	3.2	27.2	41.0	56.8	53.3	166.2	98.2
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 135.0;Hepatocytes: 341.7;Pancreatic endocrine cells: 140.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"	"Group enriched"	"Detected in some"	4	"A549: 130.6;ASC diff: 162.1;Hep G2: 243.7;OE19: 168.2;RT4: 74.6"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	130.6	0.1	13.8	162.1	5.6	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	0.6	3.6	0.0	0.6	0.0	0.0	0.0	0.0	36.8	243.7	0.3	0.0	0.0	14.5	8.2	0.6	0.6	0.0	0.0	0.0	5.0	0.0	1.3	0.2	0.0	0.0	0.0	168.2	0.0	0.0	0.0	2.1	1.2	74.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.8	0.0	0.0	0.0	0.0	1.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6	11.9	3.2	0.0	3.2	10.5	1.8	3.7	135.0	18.7	19.4	0.0	0.0	0.0	0.0	12.3	18.3	8.7	9.3	0.0	93.5	0.1	15.0	4.5	0.0	341.7	0.1	3.2	1.7	12.3	13.7	5.6	73.4	1.1	8.5	1.0	2.8	33.8	140.7	7.0	73.9	2.6	2.6	0.0	7.6	0.3	0.3	11.8	0.0	1.3	7.4	79.1
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.1;intestine: 52.3"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 261.7;Exocrine glandular cells: 644.1;Pancreatic endocrine cells: 362.8;Proximal tubular cells: 434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 50.1;gdT-cell: 26.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 115.0;ASC diff: 66.2;Hep G2: 48.3;OE19: 226.4;RT4: 45.4"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		11000000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	16.6	6.6	3.2	3.2	3.9	3.5	12.8	3.2	3.9	3.2	17.3	3.2	3.2	52.3	3.2	3.2	6.0	4.5	32.2	4.8	4.4	1.0	20.1	34.4	5.5	3.2	3.2	3.2	3.2	4.2	1.8	3.2	3.2	4.2	3.2	11.4	3.2	4.4	3.2	13.0	2.6	31.1	4.2	3.2	3.2	28.6	3.2	3.2	3.2	3.2	3.2	3.2	12.3	3.2	0.1	9.6	50.1	0.7	4.6	26.7	9.7	0.0	115.0	0.0	33.6	66.2	23.8	0.0	0.0	1.6	0.0	0.1	3.4	1.9	0.0	6.2	1.5	3.4	0.9	0.1	2.3	0.0	0.2	0.0	0.2	35.6	48.3	0.3	0.0	0.0	13.2	4.7	1.5	0.0	1.9	2.2	0.2	0.7	0.0	3.0	0.2	0.7	0.1	0.0	226.4	0.3	0.2	0.7	3.4	11.3	45.4	0.0	0.2	16.5	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.3	6.9	0.2	0.0	0.0	0.0	3.8	4.5	0.3	50.1	0.7	1.1	26.7	0.2	1.7	0.0	5.0	4.8	0.5	0.1	3.2	2.4	1.9	4.6	0.3	9.6	4.9	9.7	3.2	3.9	3.2	3.9	4.4	1.0	3.2	3.2	4.2	3.2	41.7	4.0	1.5	1.1	10.6	1.7	3.6	0.0	88.3	61.4	34.9	0.0	0.1	36.5	85.3	2.9	61.2	261.7	0.0	644.1	0.0	13.8	0.7	5.7	0.0	1.6	1.6	18.4	0.0	0.0	2.1	72.5	19.0	20.3	5.4	31.0	121.7	362.8	121.1	100.4	434.1	3.6	25.8	8.0	0.3	0.7	9.4	0.0	0.0	103.0	27.3
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 437.4"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HDLM-2: 11.6;OE19: 5.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.1	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	45.9	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	23.3	0.6	0.0	0.0	0.0	0.0	437.4	0.0	0.0	0.0	14.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138117986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 103.2"	"Group enriched"	"Detected in some"	41	"Early spermatids: 50.2;Hepatocytes: 96.2;Late spermatids: 85.4"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 16.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	2.7	0.5	0.7	0.7	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.3	16.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.4	0.3	0.2	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.3	0.3	2.7	0.5	0.6	0.4	0.4	0.3	0.6	0.4	0.4	0.3	1.1	0.5	0.7	1.8	0.7	0.5	0.5	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	50.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	96.2	0.4	0.0	0.0	1.3	1.9	85.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.1
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282558-19289250	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 48.5;liver: 27.4;pancreas: 59.0;stomach 1: 35.5"	"Cell type enhanced"	"Detected in many"	19	"Cholangiocytes: 178.3;Enterocytes: 187.5;Proximal tubular cells: 542.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	4	"OE19: 11.3;SK-BR-3: 18.4"									HPA064638			Approved	Cytosol		NA	NA		1000000	Cytosol		"HPA064638: AB_2685307"	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	0.7	0.4	0.7	0.7	0.7	0.0	0.7	0.7	0.9	0.7	5.1	0.7	0.7	48.5	0.7	1.3	0.7	0.0	6.9	0.7	0.7	0.2	13.4	27.4	0.7	0.7	0.7	0.7	1.0	59.0	0.0	0.7	0.7	0.7	0.7	3.0	0.7	0.7	0.7	0.7	0.2	27.0	0.7	0.7	0.7	35.5	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.3	1.9	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.4	0.4	0.2	1.8	0.1	0.1	0.2	0.1	0.4	1.4	0.2	0.3	0.3	0.0	0.6	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.8	0.1	0.1	0.3	0.3	0.2	0.3	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.5	0.4	1.4	0.3	11.3	0.6	0.7	0.1	1.4	0.0	0.3	0.9	1.4	0.3	18.4	0.4	0.1	3.3	0.4	0.3	0.3	0.2	1.0	0.3	1.3	0.3	0.3	0.5	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.2	0.7	0.7	0.7	0.7	0.0	0.0	3.5	0.6	0.7	0.4	0.8	178.3	4.0	0.0	27.9	0.0	0.4	101.2	3.8	2.7	0.2	187.5	0.0	28.4	0.2	0.0	1.1	4.6	92.4	0.3	0.0	20.0	5.5	1.9	3.1	0.3	0.3	0.0	0.0	51.4	3.5	17.3	81.8	0.4	542.3	1.1	0.0	0.4	1.1	0.9	0.5	0.5	0.0	99.7	0.3
AKT1	"AKT, PKB, PRKBA, RAC"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 30.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 30.7"	"Cell line enhanced"	"Detected in all"		"MCF7: 115.3"	"Low region specificity"	"Detected in all"							"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	31.7	45.4	22.9	24.2	23.6	20.3	40.0	20.9	29.5	24.7	32.6	20.0	30.8	22.5	27.0	21.5	33.0	25.5	30.3	47.7	22.9	19.1	26.3	49.2	31.3	21.0	22.1	14.7	25.9	43.0	20.3	16.7	28.4	21.5	31.1	18.2	25.3	30.4	36.1	23.8	20.4	24.0	40.5	17.5	35.4	32.6	16.2	18.8	26.3	32.7	22.4	29.3	36.7	35.9	3.2	5.2	30.7	5.8	5.7	6.2	3.0	15.4	30.8	25.5	37.9	19.7	20.5	28.5	28.4	34.6	42.0	33.7	20.2	18.7	18.7	21.9	38.9	21.4	20.1	18.0	26.4	18.3	42.6	7.3	14.1	18.4	21.7	21.9	23.0	36.9	29.3	22.3	21.0	14.0	20.2	31.4	18.4	12.3	20.8	26.9	115.3	28.9	29.4	6.6	30.3	22.1	27.3	23.6	12.7	19.4	38.4	29.3	24.3	23.7	31.0	17.8	11.9	40.6	34.3	25.0	28.2	13.5	40.1	28.5	22.6	10.9	16.1	23.8	19.5	33.9	3.3	5.3	30.7	5.4	5.2	4.0	2.9	4.8	6.2	3.6	3.2	2.5	5.7	11.8	5.7	5.8	5.2	4.7	3.0	22.9	23.6	20.9	29.5	22.9	19.1	22.1	14.7	21.5	18.8	14.9	24.3	13.4	13.8	11.0	24.3	13.8	40.8	5.3	11.4	21.0	11.8	15.1	11.6	21.0	1.2	19.6	22.2	0.0	30.3	25.7	18.8	34.2	2.3	38.4	20.2	39.7	28.8	24.5	23.7	3.1	26.4	18.1	10.1	17.2	36.1	35.8	43.4	17.3	29.0	13.9	24.0	25.8	11.8	0.9	5.1	12.2	19.6	18.1	26.9	30.8
AKT2		ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 109.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: AB_2685278"	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	31.1	20.3	15.4	17.6	15.2	21.3	18.2	46.3	18.2	23.3	18.2	23.4	21.2	12.3	22.8	28.0	22.1	22.7	14.0	23.1	15.4	10.0	23.0	62.5	14.6	17.8	17.9	13.3	27.8	24.5	21.1	24.0	17.5	14.7	19.7	12.3	26.8	18.5	24.3	48.5	18.3	17.1	20.0	16.8	18.7	15.5	21.3	15.7	26.6	52.6	29.5	23.6	19.6	19.9	6.3	8.8	7.7	4.4	3.2	4.9	2.4	22.8	56.3	21.5	22.1	26.8	32.8	11.9	15.3	22.6	31.7	28.3	24.8	21.3	23.3	13.6	33.6	13.3	10.0	23.8	31.8	20.4	22.3	27.1	15.3	35.7	15.5	16.8	17.5	18.4	30.2	19.1	21.5	20.4	25.1	6.9	25.7	19.6	24.5	17.6	19.0	27.8	8.5	11.6	25.4	15.1	18.5	11.7	16.8	24.7	37.4	29.6	18.1	15.7	26.8	12.7	23.0	21.2	22.6	6.8	19.4	19.2	17.3	23.9	22.8	19.5	19.1	18.9	20.8	15.8	7.6	4.4	3.6	4.5	2.0	4.5	3.9	3.6	3.0	3.0	6.3	3.5	4.9	7.7	3.2	2.6	8.8	2.7	2.4	15.4	15.2	46.3	18.2	15.4	10.0	17.9	13.3	14.7	15.7	14.9	12.8	36.4	20.9	21.2	67.1	26.8	28.1	12.0	10.3	57.6	39.3	25.4	18.3	18.1	2.9	17.0	18.8	0.0	26.0	20.6	22.1	24.5	13.9	74.6	19.3	57.2	18.5	12.9	19.7	7.4	39.7	13.5	21.9	19.8	19.0	52.5	20.4	19.2	25.1	18.3	109.8	19.4	23.3	11.6	16.2	24.0	32.4	17.1	20.1	24.4
AL021546.1		ENSG00000111780			12	120438198-120460006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.9;HEK 293: 12.5;U-266/84: 11.1"									HPA062394	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062394: AB_2684749"		"unprognostic (3.79e-2)"			"unprognostic (1.74e-1)"	"unprognostic (2.79e-1)"		"unprognostic (2.90e-1)"		"unprognostic (1.71e-1)"		"unprognostic (1.33e-1)"	"unprognostic (9.54e-4)"	"unprognostic (2.04e-1)"				4.8	6.0	12.8	3.6	11.6	4.7	4.5	8.4	14.8	4.6	16.3	4.2	3.3	3.6	5.1	3.6	6.0	7.1	3.6	6.7	8.9	6.3	11.5	12.1	5.3	4.2	10.5	7.2	9.6	10.3	3.6	4.9	5.8	11.6	6.5	3.6	3.1	5.4	4.3	4.3	4.1	11.4	3.6	5.9	9.2	7.1	4.8	7.7	3.5	6.3	3.8	4.0	6.6	5.1	6.5	12.9	5.8	10.7	2.8	7.4	4.3	2.2	3.1	0.0	0.7	0.0	0.0	0.0	2.1	0.4	0.5	0.0	9.9	0.0	0.6	3.8	0.0	1.0	1.0	0.0	0.5	0.0	1.8	12.5	0.8	0.0	0.0	0.0	4.3	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	0.0	3.6	0.4	0.4	0.0	5.0	2.0	1.4	1.1	0.0	0.0	5.3	0.4	3.3	1.0	0.0	0.0	1.0	0.5	2.8	1.7	0.5	0.0	1.5	1.1	11.1	4.0	0.7	1.5	0.0	2.0	5.8	5.8	6.5	10.7	7.4	6.5	4.0	7.4	12.9	6.0	4.5	4.0	1.7	2.8	8.1	10.0	7.2	4.3	12.8	11.6	8.4	14.8	8.9	6.3	10.5	7.2	11.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL031777.3		ENSG00000282988			6	26195595-26199293	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 184.8"	"Cell type enhanced"	"Detected in some"	22	"Cytotrophoblasts: 4.4;Extravillous trophoblasts: 4.1;granulocytes: 3.5;Hofbauer cells: 7.2;Syncytiotrophoblasts: 17.3"									"Cell type enriched"	"Detected in many"	4	"neutrophil: 18.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.7"	"Cell line enhanced"	"Detected in some"		"K-562: 7.9;SiHa: 7.5;U-2 OS: 5.7;U-266/70: 9.5;U-266/84: 6.3"									HPA041189	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"																		1.3	1.3	0.1	10.9	0.2	13.1	4.8	0.3	0.7	3.9	3.4	0.0	2.2	0.7	1.0	2.2	7.1	1.2	1.9	4.2	0.0		1.0	1.1	3.5	12.7	0.0	0.1	2.4	1.2	0.7	0.0	3.4	0.4	2.9	0.9	0.9	1.1	3.2	0.7	0.7	3.2	1.5	2.6	8.5	1.7	4.3	0.1	184.8	0.9	3.9	11.4	4.0	0.0	2.7	1.1	18.7	1.0	0.6	1.1	0.7	0.8	0.5	0.2	0.7	0.2	0.1	0.0	0.7	0.1	1.5	0.4	0.6	0.9	0.8	2.4	0.0	0.2	1.2	0.3	0.0	0.0	2.6	0.3	0.7	2.5	1.5	0.0	0.2	0.8	1.2	0.0	0.8	0.5	0.1	0.2	0.4	7.9	1.6	0.0	1.1	2.9	1.7	0.2	2.5	2.4	0.7	0.2	4.4	0.0	0.0	0.9	0.2	7.5	0.0	0.5	0.0	4.8	0.0	0.8	0.8	5.7	0.0	0.2	9.5	6.3	0.9	0.6	2.2	0.3	4.3	0.0	1.2	0.3	0.3	0.4	0.9	0.6	0.6	0.4	2.7	0.5	0.8	18.7	0.6	1.0	1.1	1.1	0.7											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	1.6	0.0	0.0	0.0	0.0	0.2	4.1	0.0	0.0	3.5	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0
AL132671.2		ENSG00000282218			6	117318211-117573571	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"epididymis: 3.7;lung: 2.6"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	37	"U-138 MG: 14.5"									HPA019477	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA019477: AB_1849890"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	3.7	0.0	0.0	0.0	0.0			0.0	0.0	2.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL132780.3		ENSG00000259132			14	22946270-22982258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"Alveolar cells type 1: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 28.1"									HPA029803	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA029803: AB_10601428"																		4.8	6.2	4.5	4.7	5.5	6.6	5.3	3.5	2.4	16.1	7.1	2.3	7.1	5.5	12.4	9.2	16.2	6.6	11.2	6.0	4.6	3.8	20.4	24.5	10.5	7.9	5.3	1.9	11.8	13.8	0.0	3.5	18.1	3.8	13.1	6.1	10.4	5.7	16.0	6.2	8.8	4.5	3.5	4.5	11.3	4.5	6.0	1.9	10.3	22.1	7.7	9.6	5.0	7.9	3.3	5.7	10.2	5.9	1.1	4.1	2.8	4.1	8.9	6.2	2.0	6.1	7.2	4.0	0.7	5.8	3.7	3.8	3.0	3.1	0.0	2.4	6.8	2.1	1.6	2.9	3.1	2.6	0.0	0.7	1.3	6.8	28.1	4.0	3.2	2.6	3.2	8.2	2.9	7.0	8.1	5.1	7.4	0.0	6.1	4.0	16.8	7.0	12.0	3.0	6.9	1.9	3.4	4.4	3.8	10.3	8.4	3.5	2.0	2.8	3.6	1.7	4.5	5.5	7.1	1.0	4.7	3.4	1.9	3.5	6.0	7.3	6.3	1.6	3.2	2.9	0.5	5.9	2.1	2.5	4.2	1.2	2.7	1.8	2.1	5.7	3.3	3.4	1.7	10.2	1.1	2.9	2.6	4.1	2.8	4.5	5.5	3.5	2.4	4.6	3.8	5.3	1.9	3.8	1.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL136295.1		ENSG00000254692			14	24189157-24213473	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.0;granulocytes: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA059249	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA059249: AB_2683959"						"unprognostic (3.45e-2)"												7.6	12.3	11.5	7.0	13.0	2.9	12.0	5.4	9.7	12.0	8.1	8.0	7.9	6.8	7.3	20.6	10.4	9.5	7.1	10.3	10.2	8.8	11.4	11.4	7.0	7.1	13.0	9.1	7.9	7.9	23.2	5.3	9.1	12.1	8.8	10.9	5.3	8.6	10.4	9.0	8.8	9.2	15.3	11.3	7.7	5.9	7.2	10.0	9.4	10.1	4.8	6.6	11.2	8.2	0.0	2.1	2.5	3.3	0.8	3.5	0.6	1.3	5.9	3.7	4.1	18.6	11.5	0.8	0.4	8.6	6.6	8.0	2.2	9.3	0.9	0.3	10.6	7.2	4.4	4.2	4.5	10.8	0.7	0.0	0.3	3.3	9.3	12.6	2.4	2.5	9.3	13.9	5.9	19.1	13.6	4.1	1.3	0.0	7.7	9.9	10.3	1.2	1.9	2.0	18.9	0.0	1.3	1.7	2.4	15.2	5.1	1.2	0.9	1.2	13.2	4.2	5.5	5.8	5.1	2.0	5.8	2.0	2.1	2.9	1.8	1.1	1.4	2.8	1.4	7.5	0.0	1.0	2.2	0.6	2.2	0.0	0.0	0.4	0.6	2.1	0.0	0.5	1.2	2.5	0.8	3.3	1.1	3.5	0.6	11.5	13.0	5.4	9.7	10.2	8.8	13.0	9.1	12.1	10.0	6.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL136454.1		ENSG00000231767			1	192716132-192716653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 13.4;Club cells: 30.7;Distal tubular cells: 36.5;granulocytes: 33.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 7.5;SK-MEL-30: 6.6;THP-1: 7.8"									"HPA041344, HPA049132, HPA054087"	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.09e-2)"	"unprognostic (7.80e-3)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (3.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.62e-2)"	1.7	0.9	0.3	2.3	0.6	1.9	2.6	0.9	0.9	1.3	0.7	0.0	3.9	2.8	1.8	2.5	0.8	0.7	1.8	0.8	0.5		1.2	0.4	1.3	3.3	1.7	0.2	2.6	7.3	0.0	0.0	0.6	0.8	1.5	0.0	0.4	5.9	4.2	3.4	0.1	1.6	0.6	0.7	3.0	1.2	0.4	1.0	0.2	0.6	2.5	0.8	3.0	2.3	6.1	2.6	1.3	1.9	4.5	7.4	6.4	1.7	0.7	0.5	1.1	0.5	0.0	4.4	0.2	1.0	0.0	0.6	0.0	1.3	0.4	4.4	0.0	0.3	1.8	0.3	0.5	0.0	1.4	0.9	0.8	0.9	3.3	0.4	1.2	2.3	0.5	0.8	0.3	0.0	0.1	0.3	0.4	0.2	1.3	0.0	0.9	1.5	7.5	1.9	0.2	0.4	1.7	0.5	1.0	0.6	2.2	1.4	2.7	0.3	2.7	6.6	0.2	1.7	7.8	0.9	1.1	2.1	1.4	4.0	2.6	1.8	1.5	1.4	1.2	0.2	1.3	1.4	0.7	3.2	1.9	4.6	6.1	5.7	3.5	2.6	5.8	7.4	7.0	0.4	4.5	1.4	2.4	3.6	6.4											8.9	8.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	30.7	1.8	0.0	0.0	36.5	1.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL139011.2		ENSG00000258465			1	160217464-160285130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"Alveolar cells type 2: 1.6;Club cells: 3.4;granulocytes: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0"									"HPA027218, HPA027381, HPA044837"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496"	"unprognostic (4.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.04e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-3)"	8.6	4.0	3.7	3.0	10.2	2.0	4.4	15.4	11.4	4.8	4.7	8.6	2.5	3.5	6.3	4.2	5.3	6.4	4.6	16.7	3.8	3.9	6.2	10.8	4.1	3.2	3.6	5.9	7.6	4.0	6.7	4.1	5.0	9.1	5.5	3.5	6.1	5.5	3.0	14.6	4.0	4.2	7.8	4.1	3.7	4.3	4.8	4.1	2.5	7.9	3.8	3.4	5.8	4.7	5.8	8.9	6.7	6.5	8.0	5.0	8.0	0.1	2.1	0.3	0.5	6.7	1.9	0.6	0.9	5.9	3.3	0.8	0.0	0.8	0.2	6.6	1.0	5.2	0.8	1.1	0.2	0.0	6.0	0.0	0.3	0.7	0.2	3.4	0.0	0.3	3.2	0.2	3.0	3.4	3.5	0.5	0.8	1.0	4.7	0.5	0.3	1.1	0.0	0.3	0.6	0.6	0.5	0.0	0.3	0.3	0.8	0.6	0.8	0.2	1.4	0.0	1.0	2.8	5.6	0.0	0.8	0.8	0.0	0.2	0.8	3.4	0.5	0.4	0.3	0.3	6.4	6.3	6.2	3.6	6.5	5.0	5.8	4.4	4.7	8.9	3.9	2.5	3.2	6.7	8.0	6.3	2.5	4.9	8.0	3.7	10.2	15.4	11.4	3.8	3.9	3.6	5.9	9.1	4.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AL139260.3		ENSG00000274944			1	38864501-38881617	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 7.3;testis: 15.5"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 8.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA041188, HPA078331"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (8.00e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-3)"	"unprognostic (4.27e-4)"	"unprognostic (4.64e-7)"	"unprognostic (2.59e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.54e-3)"	"unprognostic (6.09e-6)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-3)"	1.2	0.0	0.4	1.3	0.9	0.0	0.4	0.4	1.0	0.4	3.3	0.6	0.4	2.0	0.4	0.4	3.0	0.0	0.4	0.4	0.4		0.5	1.5	0.4	2.7	0.4	0.4	0.4	0.4	0.0	0.4	0.8	0.6	0.4	2.3	1.8	2.3	0.4	0.4	1.5	2.1	0.4	0.4	0.4	2.4	15.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3.0	7.3	2.8	4.0	0.0	1.7	0.0	12.4	1.3	3.3	0.0	0.6	0.0	3.6	0.4	0.0	0.0	0.5	6.7	13.3	2.4	11.3	0.2	0.5	9.2	0.0	0.9	0.0	7.9	2.1	2.8	2.5	2.2	0.0	17.0	5.0	0.0	0.0	1.6	1.1	1.5	2.0	0.5	6.4	4.6	1.7	3.3	6.8	16.1	6.5	9.8	7.7	7.9	8.0	12.6	0.0	7.0	6.3	3.4	7.7	7.3	1.5	3.6	4.2	5.2	5.8	2.3	6.5	6.3	11.5	1.5	11.7	9.4	5.7	7.4	2.6	0.0	1.3	0.2	0.5	1.9	1.1	3.0	0.2	0.5	4.2	2.0	0.4	0.4	2.8	0.0	4.0	7.3	1.7	0.0											0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL162231.1		ENSG00000187186			9	34664163-34666112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 68.6"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 34.9;Distal tubular cells: 21.6;Proximal tubular cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"					"Low region specificity"	"Detected in all"			HPA069617	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Nucleoli, Endoplasmic reticulum"	"HPA069617: AB_2686161"	"unprognostic (8.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.39e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.00e-2)"	3.0	6.9	12.1	2.1	21.6	1.8	2.9	6.9	20.2	2.3	1.8	1.9	1.1	2.8	4.0	13.9	1.8	1.8	2.2	9.1	11.8	9.5	4.9	2.5	2.2	1.4	9.6	12.2	7.8	6.2	3.4	13.1	2.3	7.0	3.7	1.2	1.8	4.6	2.1	21.9	2.2	2.0	3.8	5.0	1.0	1.4	68.6	5.3	0.6	3.5	2.0	0.7	1.5	2.5	4.0	11.8	12.0	2.5	3.5	2.9	1.6	0.3	6.0	5.6	7.2	4.6	2.3	5.0	4.8	1.4	3.0	3.5	1.0	2.4	0.0	0.6	3.2	6.0	1.4	3.6	1.7	0.5	12.9	0.6	0.0	28.3	1.7	1.1	2.6	4.5	2.4	2.0	1.8	1.9	4.2	0.8	7.4	3.2	7.4	2.2	0.0	0.5	2.6	4.6	5.3	1.6	0.0	5.3	0.9	5.4	0.0	5.8	9.3	3.4	1.1	8.0	3.3	2.8	7.4	1.1	10.7	14.8	3.4	1.1	7.9	2.6	1.0	13.2	1.5	14.6	12.0	2.5	2.6	1.8	1.3	1.7	4.0	2.3	1.0	0.8	1.6	2.9	1.5	3.5	3.5	0.8	11.8	2.0	1.6	12.1	21.6	6.9	20.2	11.8	9.5	9.6	12.2	7.0	5.3	8.9	9.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.5	34.9	0.0	11.6	21.6	12.0	0.0	0.0	0.0	0.0	9.4	10.4	0.0	0.0	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	9.0	0.0	0.0	10.8	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
AL358113.1		ENSG00000285130			9	69035750-69255187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.9;Ciliated cells: 2.7;Club cells: 1.2"									"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.9;HUVEC TERT2: 2.2;REH: 9.8;U-2 OS: 2.2"									"HPA001813, HPA068304, HPA070714"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane, Cell Junctions"		"HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161"																		1.6	4.3	2.5	1.9	2.1	2.6	2.8	3.6	2.5	1.6	2.8	3.0	2.7	1.6	2.2	1.6	1.6	3.4	1.6	5.8	1.3		2.1	8.8	2.1	3.2	2.8	1.7	3.7	9.4	1.6	1.7	1.6	2.4	4.0	1.6	2.9	2.8	3.2	7.5	1.6	3.0	4.5	1.6	3.1	3.1	3.4	2.1	0.0	2.6	2.0	2.1	2.4	1.3	0.1	1.3	0.1	2.8	0.0	2.6	0.4	0.4	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.7	0.3	0.0	2.9	0.2	1.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	2.2	1.5	0.1	0.0	0.2	0.0	1.2	0.2	0.8	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.4	0.0	0.4	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.2	2.6	0.2	0.1	1.3	0.1	1.0	0.1	0.6	0.3	0.1	0.0	2.8	1.3	2.6	0.4											3.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AL360181.3		ENSG00000254536			10	133390834-133420495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 23.7"									"HPA037826, HPA037827"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA037826: AB_2675692, HPA037827: AB_10670959"	"unprognostic (3.71e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.06e-2)"	"unprognostic (9.86e-4)"	0.5	0.2	0.7	1.3	0.2	1.0	0.1	2.3	0.8	0.2	0.5			3.6	0.2	0.0	4.3	0.2	0.8	0.4	0.5	0.0	0.4	2.1	0.3	2.4	0.4		0.3	2.2	0.7	0.4	0.0		1.3	0.4		0.9	1.1	0.7	1.1	2.0	0.0	0.3	1.5	0.3	3.8			0.1		1.1	0.1	1.0	3.0	1.5	0.4	0.9	1.6	1.0	1.4	0.7	0.0	0.2	2.8	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.9	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.3	1.3	0.6	0.4	1.1	0.2	0.4	0.1	0.0	0.3	0.0	0.2	0.5	0.0	0.1	0.0	23.7	0.1	0.4	0.1	1.3	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.2	0.9	0.0	0.1	0.6	0.0	0.0	5.1	1.6	0.3	0.2	0.0	0.1	0.0	0.4	0.4	0.7	0.6	0.6	3.0	0.7	1.0	1.5	1.9	0.8	0.5	0.0	1.6	0.9	1.3	0.7	1.4											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL512785.2		ENSG00000254706			1	162365407-162383531	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 10.3;U-266/70: 5.7"									HPA074060			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074060: "	"unprognostic (1.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.50e-1)"		"unprognostic (9.12e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.57e-1)"		"unprognostic (3.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.07e-2)"		"unprognostic (1.19e-2)"	"unprognostic (6.10e-2)"	0.9	1.0	0.0	0.2	0.0	1.3	2.7	0.6	0.0	2.6	2.8			2.3	1.5	0.0	1.1	1.4	2.7	0.7	0.1	0.1	2.0	4.6	0.6	0.1	0.3		0.2	4.3	0.0	0.4	0.6		1.3	0.2		5.5	6.3	0.2	1.5	1.2	0.6	0.9	0.0	3.5	2.0			0.0		0.0	1.7	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.6	4.7	0.0	4.0	3.3	0.3	0.0	0.0	0.2	0.6	0.2	0.0	2.5	2.4	0.0	5.0	0.0	1.4	0.5	0.0	0.8	0.0	0.0	3.7	10.3	0.1	4.1	0.2	0.4	0.0	0.9	0.3	0.0	0.3	1.0	0.4	1.1	1.2	0.2	0.2	3.4	0.1	0.0	1.1	2.7	3.6	0.4	0.0	0.0	2.2	3.5	2.1	2.1	1.7	0.6	2.4	0.8	5.1	0.0	3.0	0.1	0.9	0.0	1.8	5.7	0.0	0.0	0.5	0.2	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL592490.1		ENSG00000197991			13	61409858-61427849	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"brain: 1.6;testis: 2.3"	"Group enriched"	"Detected in some"	32	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062669			Approved	"Vesicles,Cytokinetic bridge"		NA	NA			Vesicles	"Cytokinetic bridge"	"HPA062669: AB_2732687"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL645922.1		ENSG00000244255			6	31927698-31952048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	7	"liver: 115.5"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 9.4;Club cells: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;Hep G2: 1.6;Karpas-707: 2.4;U-266/84: 1.0"									"HPA000951, HPA001817, HPA001832"	Approved		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"		NA	NA			"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"							"unprognostic (7.68e-2)"							"unprognostic (1.86e-2)"				5.3	0.9	0.6	2.9	0.7	0.3	3.9	0.6	0.7	0.7	3.7	0.3	0.0	0.8	0.9	3.0	0.9	1.1	0.8	4.4	0.7	0.6	10.8	115.5	15.8	9.7	0.7	0.0	1.5	0.7	0.3	0.7	5.0	0.6	0.8	0.6	1.1	0.8	0.3	0.8	0.7	4.3	1.5	0.8	9.7	1.3	1.3	0.0	0.3	0.7	0.0	1.3	1.5	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.6	0.7	0.7	0.6	0.7	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL669918.1		ENSG00000250264			6	32813767-32838822	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 17.2;HDLM-2: 11.4;HEL: 12.4"									HPA001312	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Nuclear speckles, Endoplasmic reticulum"		"HPA001312: AB_1080206"	"unprognostic (6.13e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.62e-1)"		"unprognostic (9.88e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	6.5	3.6	2.8	25.5	3.1	3.8	3.6	3.1	3.3	4.8	7.7	3.5	1.0	5.7	4.6	2.5	4.8	3.6	5.7	3.5	2.1	2.6	5.3	10.0	8.5	12.6	3.2	2.8	4.7	2.1	1.7	5.0	2.4	3.6	3.8	3.1	3.6	7.0	1.4	2.5	3.3	15.1	2.7	2.8	18.1	12.3	2.5	3.1	14.0	7.5	3.2	10.6	3.8	3.9	8.6	5.5	8.1	4.8	2.3	4.6	5.1	2.1	3.2	0.0	0.7	1.6	1.7	0.5	0.6	0.3	0.0	0.6	0.0	3.3	17.2	2.0	0.2	0.2	7.8	1.6	1.7	0.6	11.4	0.2	12.4	2.1	0.3	0.5	0.0	0.5	0.0	0.9	0.5	0.2	0.0	0.0	1.9	3.1	2.9	0.2	0.6	1.4	0.9	0.2	0.0	2.9	6.0	0.6	5.5	0.0	0.0	0.3	0.3	0.5	5.3	1.4	0.0	5.1	1.3	0.0	1.3	1.9	0.4	0.7	1.4	2.8	7.6	0.7	3.6	0.4	1.6	3.1	6.1	3.5	3.2	3.4	8.0	2.8	3.9	5.5	8.6	2.1	4.6	8.1	2.3	4.8	5.2	4.2	5.1	2.8	3.1	3.1	3.3	2.1	2.6	3.2	2.8	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH16A1	MGC10204	ENSG00000161618	"Aldehyde dehydrogenase 16 family member A1"	Q8IZ83	19	49453169-49471048	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059488	Approved		Approved	Mitochondria		NA	NA		910000	Mitochondria		"HPA059488: AB_2684037"	"unprognostic (2.39e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.23e-3)"	13.3	11.0	6.9	16.9	9.6	13.3	10.5	6.0	8.2	12.3	14.2	6.6	7.4	21.0	12.5	7.7	11.4	9.9	15.3	6.2	4.8	3.0	10.5	22.0	8.7	14.2	12.1	3.1	8.9	15.1	6.5	6.0	10.8	8.5	7.8	4.0	6.2	8.0	9.6	6.5	15.2	19.9	5.6	5.2	21.8	12.4	4.5	9.6	16.8	9.4	10.6	14.6	9.6	9.9	13.2	12.0	12.0	19.8	5.8	7.4	4.5	11.5	15.7	3.8	8.9	1.7	1.2	12.4	7.4	2.4	5.8	6.0	8.0	4.4	17.5	11.9	1.0	1.3	8.0	1.5	4.3	0.7	10.9	9.1	13.5	5.6	11.5	2.5	8.2	30.4	2.1	2.5	2.8	2.2	1.1	3.7	6.0	9.4	18.1	1.4	11.7	5.9	23.5	8.1	5.0	0.0	9.9	5.4	13.0	2.8	13.7	6.7	7.7	6.7	7.5	6.1	0.9	6.8	9.5	8.4	8.6	5.7	3.9	8.2	15.2	17.5	5.0	2.1	11.7	6.0	7.6	7.1	12.0	6.8	17.7	7.4	12.5	6.8	7.4	11.3	13.2	6.3	6.4	1.3	5.8	19.8	12.0	5.4	4.5	6.9	9.6	6.0	8.2	4.8	3.0	12.1	3.1	8.5	9.6	6.0	7.8	18.6	22.3	8.9	7.2	3.5	15.3	12.0	4.5	10.4	7.9	30.8	5.0	18.8	1.2	13.5	30.2	0.0	21.3	25.9	16.0	10.3	17.3	13.7	40.0	1.6	12.6	13.5	25.6	2.3	25.9	18.9	15.1	36.1	11.3	6.7	15.0	20.1	7.8	19.0	5.2	19.4	8.6	2.1	13.6	9.3	33.8	12.2	15.6	30.4
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917390-134950122	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 26.2;liver: 90.1"	"Cell type enhanced"	"Detected in some"	22	"Collecting duct cells: 29.6;Hepatocytes: 129.5;Proximal tubular cells: 94.1"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.6;RPTEC TERT1: 6.4;U-266/70: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		24000	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	0.3	0.3	0.8	0.3	1.0	0.6	0.3	1.9	0.9	0.3	0.6	0.3	0.3	0.2	0.3	0.6	0.3	0.1	0.3	0.3	1.4	0.6	26.2	90.1	0.3	0.3	1.1	0.4	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.8	0.3	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.3	1.5	1.1	5.9	0.9	2.3	1.3	0.6	0.2	1.1	1.6	0.8	0.5	0.2	1.4	0.4	0.5	0.1	1.0	0.5	0.7	0.4	0.6	0.0	0.4	1.1	1.1	0.1	0.9	1.2	5.6	3.7	3.9	5.3	0.6	1.5	2.0	1.6	1.8	0.4	0.9	1.2	0.4	1.8	5.4	2.2	0.2	0.1	1.8	2.4	0.3	0.4	1.1	0.1	0.5	0.5	6.4	0.8	1.7	0.6	0.3	0.1	1.3	0.5	0.9	0.3	0.4	0.8	3.2	1.3	1.5	5.6	1.7	0.9	0.7	1.4	0.5	5.9	0.9	0.9	1.3	0.3	0.5	1.0	1.2	0.7	0.1	1.5	1.1	0.9	2.4	2.3	0.4	1.1	1.2	0.6	0.8	1.0	1.9	0.9	1.4	0.6	1.1	0.4	0.3	0.3	3.0	1.1	2.2	0.2	0.0	1.8	0.3	2.5	0.0	1.2	29.6	0.0	0.2	16.6	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.4	0.1	0.0	129.5	0.1	3.2	0.0	3.1	1.3	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.0	0.0	0.0	94.1	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Group enriched"	"Detected in some"	13284	"Cardiomyocytes: 1628.0;Cytotrophoblasts: 1088.2;Extravillous trophoblasts: 1710.3;Hofbauer cells: 1077.0;Syncytiotrophoblasts: 1138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Approved	Cytosol		NA	NA		1200000000	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.8	104.7	31.5	101.2	48.3	55.1	100.7	84.1	87.6	85.8	107.3	74.0	107.1	94.7	137.9	84.8	47.1	106.1	63.2	183.3	63.0	41.6	83.1	77.5	84.0	163.3	75.5	112.6	83.2	75.5	64.7	96.3	64.7	141.5	63.1	44.7	66.6	62.5	90.9	198.0	68.4	93.0	78.4	54.0	88.3	102.2	50.6	211.6	106.8	79.1	63.1	44.4	52.4	221.3	78.4	41.1	94.1	76.4	75.0	126.7	50.6	69.1	90.9	123.6	84.3	86.6	235.7	109.4	100.0	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	1628.0	0.0	0.0	0.0	0.0	0.0	1088.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1710.3	0.0	0.0	0.0	0.0	1077.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1138.4	0.0	0.0	0.0
ALDOA		ENSG00000285043	"Aldolase, fructose-bisphosphate A"	P04075	16	30053090-30070420	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 1558.3"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA004177	Uncertain		Approved	Cytosol		NA	NA		1200000000	Cytosol		"HPA004177: AB_1078128"																		1.8	0.9	2.7	1.1	5.0	2.1	7.2	0.7	7.7	4.9	1.5	2.0	2.4	0.0	2.5	3.9	0.9	3.6	1.6	5.3	2.3		1.3	0.0	2.3	2.0	0.8	4.4	2.2	0.8	0.8	3.0	1.4	4.0	2.4	0.5	2.8	1.6	7.5	10.6	0.6	0.1	1.9	0.4	1.7	1.3	11.6	0.8	1.2	4.7	0.2	2.7	1.2	1.0	7.0	6.6	0.9	6.2	4.2	8.5	12.5	3.8	8.9	1.9	6.2	1.5	5.2	1.5	4.1	7.0	5.5	21.8	3.6	5.1	24.7	6.0	6.8	1.8	6.4	14.1	11.1	3.8	4.4	8.0	6.0	8.3	6.0	11.6	10.6	2.3	5.1	0.5	10.8	12.4	4.5	7.8	4.0	1.2	7.2	13.5	3.9	5.0	8.1	2.1	1.7	5.6	7.7	4.0	22.7	15.3	0.7	6.2	5.1	1.0	1.7	1.5	0.6	5.2	4.0	1.7	8.1	2.5	3.7	5.4	7.4	5.5	8.1	7.7	11.5	3.5	0.1	6.2	0.1	5.3	2.6	7.4	7.0	7.0	5.7	6.6	6.2	8.5	6.6	0.9	4.2	2.3	5.6	5.4	12.5											11.9	25.9	269.9	530.0	703.6	362.0	0.0	315.9	36.1	40.9	40.1	111.9	0.0	94.5	100.6	190.1	242.7	1558.3	46.7	66.6	0.0	38.0	448.8	200.0	94.7	0.0	692.8	311.1	289.1	683.7	930.6	352.7	289.5	877.3	70.3	597.6	553.3	106.3	971.1	380.8	45.3	219.0	478.6	664.3	23.8	81.3	598.3	0.0	258.9	731.1	912.8
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 100.1;Horizontal cells: 259.0;Rod photoreceptor cells: 259.1"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 63.4;U-266/70: 43.8;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.5	0.5	3.5	14.7	7.4	7.6	0.7	3.9	8.8	3.0	18.5	4.4	0.7	3.5	4.6	3.4	0.8	9.9	2.4	24.1	5.6	3.1	2.3	6.8	2.8	7.5	6.9	2.5	8.0	7.0	3.4	0.3	6.0	0.4	1.3	7.3	4.6	19.1	2.6	3.6	2.9	8.3	5.5	1.6	3.9	2.4	0.4	63.4	0.4	1.0	9.4	16.7	2.2	18.1	0.1	5.8	9.8	5.6	0.9	0.3	1.4	0.5	0.6	43.8	12.5	2.6	28.6	7.1	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4	0.0	12.0	9.3	17.7	6.6	72.2	19.0	5.1	0.0	7.9	7.0	100.1	1.2	3.3	14.2	0.8	8.4	22.7	0.0	8.9	3.9	7.1	4.4	12.7	50.8	4.4	259.0	20.7	16.5	4.7	0.8	8.6	3.7	23.6	58.7	8.7	81.4	11.6	14.0	9.6	1.6	259.1	12.9	17.6	0.4	3.2	9.5	1.3	17.0	3.3	8.0
ALG1	"CDG1K, HMAT1, HMT-1, Mat-1"	ENSG00000033011	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase"	Q9BT22	16	5033960-5087379	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060392	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.66e-2)"	"unprognostic (5.18e-1)"	"prognostic favorable (5.79e-4)"	"unprognostic (1.55e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.58e-3)"	"unprognostic (3.86e-2)"	11.0	22.2	8.7	10.8	12.8	6.6	12.8	9.3	18.8	13.7	16.4	14.9	10.1	14.7	12.1	17.0	11.7	12.4	14.3	8.1	8.8	10.4	18.9	31.6	9.9	12.7	10.5	6.5	10.1	27.9	21.5	13.6	10.7	14.6	10.8	17.2	15.5	20.6	12.0	7.3	9.1	12.8	12.1	9.4	16.2	16.5	19.4	11.4	16.0	15.0	8.7	14.5	12.1	8.7	20.7	24.3	7.8	23.3	20.9	26.5	31.7	6.5	17.8	4.5	8.4	17.2	10.3	8.3	14.7	20.7	19.2	19.3	14.7	24.2	13.9	12.7	18.7	8.0	17.6	12.3	14.5	13.1	11.4	13.9	7.8	14.8	30.3	14.1	13.6	13.7	12.4	11.0	15.1	9.6	7.6	11.4	11.3	9.7	18.2	14.2	17.7	8.7	16.7	17.0	11.9	10.2	16.2	6.2	38.7	12.0	7.1	7.6	7.7	15.7	24.6	8.4	6.3	16.0	11.1	10.9	9.0	8.3	45.5	12.3	13.3	16.0	9.4	7.4	14.6	12.7	3.3	23.3	7.8	26.5	21.6	23.1	19.8	22.9	25.4	24.3	20.7	21.0	23.7	1.5	20.9	21.2	21.2	21.6	31.7	8.7	12.8	9.3	18.8	8.8	10.4	10.5	6.5	14.6	11.4	14.9	6.7	14.0	2.8	2.2	7.1	0.6	12.7	12.0	7.9	7.0	11.8	13.9	3.3	15.9	8.2	4.5	8.4	0.0	24.6	16.8	7.2	3.4	1.1	15.5	19.6	3.2	12.9	9.2	8.2	23.0	8.9	5.9	10.1	6.4	17.7	7.2	18.4	10.5	6.3	8.7	5.0	6.5	1.4	25.9	17.2	1.4	7.1	8.7	18.0	3.5
ALG10	"ALG10A, DIE2, FLJ14751"	ENSG00000139133	"ALG10, alpha-1,2-glucosyltransferase"	Q5BKT4	12	34022281-34029694	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.88e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.29e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.45e-2)"	6.2	7.0	2.7	5.4	5.9	6.9	6.9	4.0	5.5	5.3	4.6	3.8	3.6	3.4	10.3	5.5	6.0	6.2	3.7	4.6	2.6	2.9	4.6	5.7	5.4	6.7	4.1	1.7	7.1	7.8	7.5	6.1	7.2	3.5	5.8	4.1	8.7	9.0	4.4	4.6	5.1	5.0	4.0	3.5	6.1	5.1	8.0	3.6	17.2	6.2	3.0	9.8	5.8	4.8	2.7	1.8	4.5	2.7	2.1	3.8	1.6	4.5	5.4	3.5	5.8	4.2	3.3	12.4	4.4	4.1	4.8	8.6	7.9	11.0	6.9	6.5	2.2	7.1	6.9	6.6	5.6	6.5	11.0	6.3	6.4	5.7	3.1	1.7	9.2	6.7	3.6	3.3	10.1	7.7	2.3	3.2	6.2	9.6	11.7	3.9	6.2	5.9	5.1	13.1	2.7	6.8	5.3	12.7	7.0	2.6	6.8	3.1	2.5	7.7	3.3	5.5	10.5	7.9	2.5	6.8	6.6	9.8	8.8	5.5	6.4	11.5	13.3	4.6	3.7	5.2	0.0	2.7	4.5	1.9	1.2	3.0	2.5	2.6	1.1	1.8	2.7	3.1	3.8	0.4	2.1	1.2	1.8	3.0	1.6	2.7	5.9	4.0	5.5	2.6	2.9	4.1	1.7	3.5	3.6	6.0	0.3	3.0	2.5	1.3	3.5	0.8	2.5	4.0	3.4	5.2	3.9	6.4	1.7	1.9	0.6	2.1	1.0	0.0	3.3	4.7	2.1	0.6	1.1	2.4	2.9	1.6	1.2	0.6	2.7	0.0	1.4	2.1	0.0	4.6	1.9	3.7	2.6	0.0	1.1	1.1	4.1	0.0	1.0	7.5	3.0	2.4	2.6	4.3	1.7	1.4
ALG10B	KCR1	ENSG00000175548	"ALG10B, alpha-1,2-glucosyltransferase"	Q5I7T1	12	38316578-38329728	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (4.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.58e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	8.2	8.5	4.3	4.9	7.0	6.6	9.1	5.3	7.2	6.1	4.4	5.4	9.5	4.2	8.5	6.7	6.9	6.4	6.0	5.8	5.0	2.7	5.9	6.6	6.5	7.3	6.6	4.8	8.7	9.6	8.7	7.8	11.6	4.3	6.1	4.5	10.5	9.3	9.7	5.8	7.7	6.5	4.6	4.5	7.5	6.4	8.9	5.0	10.5	7.4	5.6	6.6	7.7	6.8	3.6	2.6	2.0	2.0	1.4	4.1	1.2	5.0	4.7	6.2	6.2	3.1	5.8	6.4	4.0	2.1	5.4	4.8	1.7	15.3	7.7	7.0	2.0	4.0	5.3	5.4	4.4	7.8	5.1	6.9	8.1	8.1	3.4	3.4	10.8	5.7	3.2	5.8	7.6	5.6	4.8	3.9	9.8	9.1	4.7	4.5	3.8	7.2	8.6	7.8	0.5	4.7	2.4	13.3	6.1	4.6	6.3	1.8	6.4	7.0	2.4	4.8	6.9	10.7	4.4	3.3	5.7	6.6	5.0	5.0	3.7	9.5	12.3	4.8	7.6	7.1	1.2	1.5	2.0	1.1	2.0	2.2	1.8	1.1	1.8	1.1	3.6	2.2	2.7	0.6	1.4	1.4	2.6	4.1	1.2	4.3	7.0	5.3	7.2	5.0	2.7	6.6	4.8	4.3	5.0	6.0	11.5	0.5	3.5	1.8	12.9	3.0	0.0	6.7	9.1	3.5	31.4	15.2	6.6	3.6	0.2	4.9	1.2	0.0	5.0	8.2	3.5	2.4	1.1	5.9	4.2	9.5	0.0	6.2	1.5	1.5	3.7	1.9	1.7	0.0	2.5	8.9	3.5	2.0	5.3	2.2	12.4	6.5	1.4	8.3	3.4	1.6	6.8	1.3	2.5	2.3
ALG12	"CDG1G, ECM39"	ENSG00000182858	"ALG12, alpha-1,6-mannosyltransferase"	Q9BV10	22	49900229-49918458	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003076, HPA051665"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003076: AB_2666777, HPA051665: AB_2681566"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.39e-3)"	"prognostic favorable (6.09e-4)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.60e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.32e-2)"	9.8	13.3	9.6	11.3	11.2	8.5	9.9	16.0	12.7	10.9	11.7	16.2	15.7	18.0	13.2	11.5	12.1	11.4	11.0	12.0	10.0	5.8	14.1	22.8	10.8	9.2	11.6	7.9	11.8	17.5	14.7	10.6	11.3	10.9	13.5	7.1	12.2	19.4	10.2	8.7	11.5	14.8	7.7	8.9	11.5	14.5	6.5	14.9	12.6	24.5	10.5	12.8	12.1	10.3	7.6	7.8	17.7	9.4	16.1	12.7	7.9	7.0	7.1	7.5	12.5	14.5	6.8	8.4	7.4	6.7	8.8	7.1	11.6	10.2	3.8	6.8	6.6	9.6	12.9	9.2	8.8	4.4	6.0	13.5	3.5	11.9	11.7	16.4	8.7	7.7	10.2	9.1	8.6	12.4	9.7	8.4	8.7	4.3	9.6	4.6	16.1	8.4	7.1	7.2	9.4	6.6	14.2	9.5	10.0	9.2	8.1	5.1	8.4	11.8	22.5	9.2	10.6	9.2	7.8	6.5	9.8	7.5	6.8	5.6	8.5	3.9	5.0	10.9	6.7	9.3	17.7	8.8	7.4	12.4	8.2	12.7	5.3	9.8	12.2	7.7	7.6	8.3	9.3	6.9	16.1	9.4	7.8	12.3	7.9	9.6	11.2	16.0	12.7	10.0	5.8	11.6	7.9	10.9	14.9	8.9	1.9	8.1	9.0	3.7	5.4	1.2	2.5	5.3	7.9	17.4	2.0	17.2	3.3	14.4	4.7	6.9	15.5	0.0	11.7	19.0	7.8	8.8	8.1	11.9	15.8	3.2	6.4	7.4	8.6	3.0	8.1	6.1	10.1	10.8	11.2	3.4	10.1	7.0	7.8	5.5	5.1	0.0	3.3	8.6	9.4	5.3	22.0	12.9	13.7	8.1
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13, UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002853, HPA005498"	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA002853: AB_1078131, HPA005498: "	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	20.6	23.0	18.4	23.2	23.2	19.3	24.8	20.9	25.5	21.1	23.3	21.6	22.0	18.0	26.3	28.5	18.3	22.5	22.2	16.8	16.6	16.2	23.5	31.1	19.7	28.4	22.4	16.1	24.2	18.8	13.0	41.7	18.7	19.5	26.7	26.5	16.3	19.5	25.6	11.2	25.2	25.7	23.5	21.6	31.4	20.1	19.0	20.3	23.6	24.5	14.6	25.8	18.3	20.9	10.2	14.4	21.7	12.5	3.4	11.1	7.1	10.9	12.4	11.1	7.0	7.2	10.4	6.3	8.9	9.2	11.5	14.3	12.4	11.5	9.5	17.1	12.3	23.8	6.3	13.2	6.3	12.1	6.8	8.8	5.2	14.0	14.1	10.7	9.5	21.0	12.3	11.8	9.2	20.0	12.0	12.5	10.9	11.6	27.4	11.4	27.8	8.0	8.6	10.2	32.8	17.0	6.2	7.1	13.2	18.3	16.9	6.7	9.8	12.7	7.7	7.7	11.6	6.9	9.2	8.4	9.9	4.9	12.8	17.0	13.2	21.9	15.3	10.6	12.6	7.5	21.7	12.4	12.2	7.8	12.5	7.6	8.4	8.9	7.6	14.4	10.2	11.1	9.1	2.5	3.4	9.4	7.5	10.7	7.1	18.4	23.2	20.9	25.5	16.6	16.2	22.4	16.1	19.5	20.3	14.9	31.5	32.3	54.9	31.3	12.7	15.1	20.4	34.8	25.0	17.4	9.8	22.8	38.1	27.8	14.0	38.3	32.8	0.0	45.1	32.1	22.1	46.9	109.4	26.7	37.3	11.1	25.4	23.4	36.4	6.8	19.8	44.5	27.0	35.1	42.8	12.8	44.6	41.2	15.2	44.0	14.8	25.8	39.0	9.9	16.3	30.9	40.7	34.5	28.5	55.9
ALG14	MGC19780	ENSG00000172339	"ALG14, UDP-N-acetylglucosaminyltransferase subunit"	Q96F25	1	94974407-95072945	"Disease related genes, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031829	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA031829: AB_2674062"	"unprognostic (7.79e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.93e-1)"	5.8	13.2	6.8	4.1	8.5	4.6	6.8	5.6	8.0	5.5	7.5	8.5	7.0	8.5	5.4	11.3	5.7	4.8	6.1	6.3	7.0	7.2	8.9	15.1	5.3	7.5	8.2	4.7	5.3	12.6	5.8	6.6	6.3	8.4	5.1	8.7	6.9	14.5	9.8	7.2	5.0	9.2	4.4	9.4	5.8	6.0	10.0	4.2	3.7	8.5	6.2	5.3	4.8	4.2	4.9	5.8	3.1	3.9	2.8	3.8	1.9	5.2	3.3	2.8	2.5	2.2	3.8	2.5	3.8	4.1	3.9	3.3	3.9	1.8	2.7	4.0	4.7	4.7	3.6	3.2	3.6	4.7	5.7	5.5	1.5	3.6	5.9	3.6	3.6	1.0	4.1	3.7	2.9	2.9	3.2	3.3	3.6	2.9	3.6	3.7	2.5	3.8	2.3	1.7	5.2	4.8	2.4	5.7	2.9	4.4	3.0	2.5	3.2	2.1	7.2	6.3	2.2	3.2	3.1	2.6	2.5	2.8	4.4	7.9	2.3	2.2	2.4	1.8	1.8	2.0	3.1	3.2	1.1	2.5	3.9	2.4	4.9	3.1	3.1	4.5	4.4	2.9	3.0	2.7	2.8	1.9	5.8	3.8	1.9	6.8	8.5	5.6	8.0	7.0	7.2	8.2	4.7	8.4	4.2	0.0	12.6	5.2	10.9	10.4	14.8	7.3	10.2	8.1	11.4	15.7	5.9	28.7	16.6	21.4	5.4	8.0	19.2	23.3	46.6	23.6	21.1	9.2	1.1	30.6	17.2	7.9	4.1	14.7	6.3	6.5	13.3	10.8	30.4	11.8	11.1	28.5	21.0	25.9	9.6	34.3	12.9	32.3	12.5	33.6	22.6	7.5	21.1	4.4	24.9	9.1
ALG5	bA421P11.2	ENSG00000120697	"ALG5, dolichyl-phosphate beta-glucosyltransferase"	Q9Y673	13	36949775-37000261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007989	Approved		Approved	Cytosol		No	No			Cytosol		"HPA007989: AB_1078132"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (7.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.86e-1)"	14.7	18.2	11.8	14.0	14.2	11.3	19.9	10.9	13.7	16.7	16.5	10.3	34.2	13.0	13.5	34.8	11.7	12.4	12.9	13.1	10.0	10.5	18.1	36.7	19.1	28.0	16.1	12.8	11.8	60.4	11.8	11.6	17.0	12.1	12.9	20.8	7.3	30.2	37.0	9.0	11.0	12.6	10.9	15.1	12.9	17.6	7.2	14.2	15.4	25.5	12.1	12.4	12.4	11.1	19.1	45.5	17.7	24.8	22.1	25.2	26.9	9.6	13.0	12.0	12.3	33.1	22.2	8.8	26.8	28.5	22.7	18.6	25.4	33.7	13.9	11.1	16.2	19.3	23.9	14.8	20.4	21.2	14.8	29.0	31.9	10.8	15.9	32.4	27.0	16.7	23.3	30.1	18.1	24.3	14.9	17.3	15.6	14.6	17.3	20.5	17.3	18.2	21.6	12.3	60.8	10.6	22.2	14.8	34.0	24.1	18.3	9.6	18.7	11.3	21.0	15.5	9.5	12.7	26.9	13.2	12.7	7.2	14.0	17.0	14.8	11.4	18.2	19.6	17.2	21.0	17.7	24.1	10.0	24.4	24.8	24.6	19.1	23.0	24.4	23.6	17.0	21.2	23.2	2.7	22.1	20.2	45.5	25.2	26.9	11.8	14.2	10.9	13.7	10.0	10.5	16.1	12.8	12.1	14.2	47.6	44.6	33.5	34.8	30.8	16.4	9.7	81.5	22.7	31.8	50.6	9.8	71.9	19.9	78.2	27.2	40.9	34.9	0.0	121.6	63.8	57.3	47.1	28.8	63.8	63.1	11.1	34.7	32.5	37.8	17.9	37.2	44.2	75.9	39.7	51.8	33.6	80.6	45.6	36.0	43.5	23.5	45.3	44.3	47.0	21.3	26.5	68.0	41.5	66.2	37.2
ALG6		ENSG00000088035	"ALG6, alpha-1,3-glucosyltransferase"	Q9Y672	1	63367590-63438562	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062536, HPA076130"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062536: AB_2684792, HPA076130: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	9.7	13.7	9.3	13.5	13.5	8.8	11.6	12.2	12.6	9.9	11.8	10.1	9.0	12.1	11.0	14.3	16.7	9.6	9.1	9.9	11.2	7.1	10.3	14.6	10.0	13.4	8.2	11.1	10.8	11.5	10.6	10.0	14.1	11.6	8.9	14.0	10.2	12.9	11.9	8.0	13.7	13.5	7.5	10.5	14.5	10.0	6.9	8.7	25.9	9.7	8.5	21.7	10.0	11.6	7.5	7.9	24.2	7.4	7.4	10.6	5.6	5.3	4.8	8.5	7.7	10.2	8.8	11.2	6.3	2.2	3.3	3.8	5.6	5.4	13.9	15.2	5.2	14.6	10.3	12.4	10.1	6.0	15.6	9.8	10.7	5.5	4.6	5.0	12.7	9.3	7.3	6.1	8.1	3.0	6.1	12.5	14.2	11.3	11.2	7.7	7.0	12.2	10.7	26.0	14.6	7.2	12.5	12.0	16.4	9.5	7.4	7.9	4.3	16.8	17.5	16.5	16.3	9.7	7.2	6.8	5.5	5.5	11.6	8.1	9.5	13.3	11.5	5.3	12.7	18.4	24.2	7.4	13.6	8.8	6.6	10.6	7.5	7.2	8.5	7.9	5.6	8.7	9.1	4.3	7.4	6.4	6.5	9.4	5.6	9.3	13.5	12.2	12.6	11.2	7.1	8.2	11.1	11.6	8.7	8.9	3.7	7.5	8.0	9.7	5.6	2.8	10.2	4.0	7.9	3.5	3.9	39.5	1.7	10.5	1.9	5.8	5.8	0.0	7.8	23.6	8.2	5.4	9.2	9.2	13.7	6.4	4.1	8.0	5.9	1.7	6.4	7.5	15.1	0.0	7.8	4.9	6.5	0.0	4.6	5.9	5.1	6.5	5.1	12.1	15.9	9.7	22.4	13.8	9.3	6.4
ALG8	MGC2840	ENSG00000159063	"ALG8, alpha-1,3-glucosyltransferase"	Q9BVK2	11	78100936-78139660	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051898	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051898: AB_2681656"	"unprognostic (1.37e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.38e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.37e-2)"	20.2	24.5	18.0	11.2	22.3	9.7	23.7	13.8	17.9	16.5	15.0	20.7	23.9	10.3	14.5	30.9	13.3	18.4	12.3	13.0	15.9	16.0	24.9	40.8	12.8	15.7	16.0	11.6	22.9	23.4	24.2	23.6	21.7	17.1	15.5	19.0	17.6	23.2	19.5	8.2	13.3	13.3	14.8	17.6	13.8	13.1	38.9	16.5	18.2	29.7	13.1	17.4	13.2	11.2	21.9	19.4	3.0	20.3	18.2	19.0	14.9	8.9	24.6	23.6	20.2	20.5	14.4	12.7	13.1	19.7	22.5	21.8	46.6	32.7	20.9	24.3	15.7	29.5	25.7	27.5	18.9	36.4	15.0	16.5	25.2	21.7	20.9	13.3	24.0	16.8	11.5	12.2	26.3	13.1	12.9	16.3	19.0	31.2	21.6	30.1	13.0	20.0	27.1	26.3	60.1	12.9	21.4	10.9	49.8	22.6	13.8	6.9	17.4	18.9	30.7	9.5	22.5	34.3	19.0	10.0	15.3	17.8	34.4	11.3	15.5	30.1	30.9	8.5	23.6	26.4	0.3	17.5	3.0	15.7	19.5	17.5	21.9	16.0	16.1	19.4	16.6	19.0	17.2	1.1	18.2	20.3	18.7	13.0	14.9	18.0	22.3	13.8	17.9	15.9	16.0	16.0	11.6	17.1	16.5	11.9	12.3	25.2	20.6	9.3	13.9	6.3	25.5	10.7	13.6	19.2	17.7	44.1	5.0	18.7	10.7	14.3	6.0	0.0	22.1	52.0	15.3	15.6	11.5	36.4	27.9	15.9	7.5	11.1	14.0	9.8	16.7	17.3	25.3	4.6	15.5	8.2	16.4	5.8	14.9	14.6	12.9	0.0	15.2	115.0	39.1	7.9	27.3	14.9	14.0	15.7
ALG9	DIBD1	ENSG00000086848	"ALG9, alpha-1,2-mannosyltransferase"	Q9H6U8	11	111782195-111871581	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038575	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038575: AB_10672718"	"unprognostic (1.48e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.34e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.07e-3)"	"unprognostic (5.11e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.10e-2)"	19.9	13.5	11.8	11.4	17.9	9.0	16.8	19.3	19.3	16.9	13.7	15.6	15.7	16.2	19.1	15.7	13.8	12.5	14.0	14.3	11.6	13.7	13.7	17.7	12.3	13.5	12.2	11.2	19.2	29.9	21.0	16.5	20.3	14.6	14.7	14.9	17.5	34.3	20.1	11.7	17.3	13.2	15.8	13.2	13.0	14.1	25.0	9.8	15.3	17.4	10.9	15.2	13.8	14.2	7.8	9.5	7.0	7.9	7.1	12.2	6.5	9.9	10.1	19.8	19.4	12.3	11.8	15.0	13.0	10.6	10.8	11.7	17.2	17.0	16.1	18.5	14.6	13.6	18.7	10.3	15.7	15.2	12.4	8.1	12.2	5.9	12.6	14.3	13.7	8.5	10.2	10.6	11.2	11.1	15.5	10.3	12.5	12.2	25.2	17.6	7.3	13.7	12.2	6.5	13.9	11.2	12.6	17.6	31.3	11.8	8.9	9.7	16.7	11.4	17.5	7.0	14.4	18.9	5.6	10.2	22.7	16.0	11.0	14.0	8.2	6.1	15.1	9.4	17.1	15.3	6.7	5.8	7.0	8.5	7.9	9.4	7.8	8.0	8.8	9.5	6.6	12.2	7.3	2.3	7.1	6.9	9.4	7.7	6.5	11.8	17.9	19.3	19.3	11.6	13.7	12.2	11.2	14.6	9.8	0.0	4.1	2.9	1.2	1.8	9.4	5.0	2.5	1.4	4.5	7.0	7.9	3.0	3.3	6.3	4.3	2.1	3.2	0.0	6.1	11.4	2.8	1.2	0.0	5.8	2.7	14.3	4.1	2.5	1.2	3.5	4.4	2.3	0.0	3.6	3.4	5.4	5.9	3.5	3.5	2.2	10.3	6.5	4.1	3.7	5.5	1.4	7.6	2.5	3.9	0.6
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase"	Q96Q83	11	43880811-43920266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 78.8;Late spermatids: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	17.6	14.2	14.3	13.2	16.7	8.6	26.5	21.2	22.7	19.1	15.7	19.5	12.8	13.2	22.6	31.2	16.2	20.0	16.4	12.5	14.3	13.4	15.6	25.8	15.1	17.3	15.0	14.4	21.8	23.5	22.1	16.6	9.1	15.6	19.1	16.6	19.5	25.5	19.1	29.1	20.2	15.0	18.3	14.8	17.8	17.0	17.3	12.1	14.5	16.4	21.4	22.2	15.2	17.4	14.9	18.5	21.2	21.0	17.1	21.3	13.8	7.4	13.0	5.2	0.0	10.1	13.0	0.0	9.1	20.2	18.3	18.0	6.1	5.8	1.1	5.8	13.7	9.9	10.2	7.1	15.7	17.0	0.0	24.9	10.9	8.8	12.8	25.1	20.0	14.6	13.7	27.3	8.1	39.4	7.6	13.1	21.5	15.4	11.9	9.0	8.9	17.9	10.3	9.5	7.9	19.1	5.2	11.2	14.0	11.0	11.7	9.7	7.8	7.0	11.1	16.7	4.8	16.1	12.3	9.2	10.4	5.8	17.0	13.0	10.8	11.3	12.1	15.5	8.5	8.5	21.2	12.9	7.1	17.0	14.1	16.2	14.4	17.4	15.1	18.5	14.9	21.3	18.9	2.3	17.1	21.0	16.3	16.2	13.8	14.3	16.7	21.2	22.7	14.3	13.4	15.0	14.4	15.6	12.1	14.9	10.4	11.1	9.1	9.2	10.0	5.6	12.7	16.0	10.3	15.7	3.9	3.1	26.6	17.0	78.8	13.7	9.2	0.0	28.4	4.0	9.7	6.6	7.0	11.3	16.7	9.5	9.1	14.7	10.7	69.5	15.0	13.1	16.9	15.4	12.7	17.2	23.0	7.0	9.9	14.1	10.5	6.5	19.6	18.7	9.5	6.1	1.8	14.9	13.1	5.0
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 130.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavorable (5.69e-4)"	18.0	19.5	17.1	14.6	21.9	19.1	26.2	23.4	25.3	18.2	21.8	20.1	18.8	15.1	22.1	12.1	17.3	30.5	18.7	45.8	16.5	18.9	16.0	24.2	14.7	16.9	19.0	16.9	20.9	25.0	22.7	20.2	14.8	15.4	19.4	8.9	19.9	23.7	21.1	130.4	12.7	16.9	20.4	15.3	18.8	16.2	29.7	17.6	26.8	23.5	19.5	13.7	26.8	44.8	11.5	8.9	17.6	10.6	7.6	17.0	5.7	33.1	32.0	13.0	23.4	19.1	13.3	11.3	16.0	19.8	26.3	24.5	36.1	8.8	21.0	23.7	17.6	13.9	21.9	19.6	16.9	13.6	23.9	26.7	15.4	18.2	20.1	17.8	11.1	20.7	12.7	11.5	19.7	11.7	16.7	15.2	16.4	16.7	9.6	14.6	24.6	23.9	12.4	11.0	13.9	16.4	21.7	25.7	36.8	7.7	11.4	13.4	17.7	20.0	13.9	18.2	42.7	14.0	9.6	15.4	25.4	17.7	37.2	31.3	11.2	8.5	12.7	46.1	18.2	16.6	4.3	7.2	17.6	15.1	7.4	14.0	7.9	13.6	17.0	8.9	11.5	10.9	11.0	4.6	7.6	10.6	6.6	7.9	5.7	17.1	21.9	23.4	25.3	16.5	18.9	19.0	16.9	15.4	17.6	32.8	25.7	39.8	24.5	57.5	79.0	78.7	25.5	28.1	18.2	26.2	37.3	28.1	71.3	24.0	48.1	37.6	35.4	46.7	27.3	36.7	47.3	36.0	41.4	52.9	29.7	112.8	58.5	27.6	39.9	29.1	38.0	25.6	47.2	17.2	41.8	72.5	28.5	42.4	48.8	81.8	52.8	19.4	44.3	106.7	98.2	48.9	26.3	48.4	31.6	21.6
ALKBH6	MGC15677	ENSG00000239382	"AlkB homolog 6"	Q3KRA9	19	36009120-36014239	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073835, HPA074340"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA073835: AB_2686637, HPA074340: AB_2686680"	"unprognostic (1.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.86e-5)"	"unprognostic (6.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (8.78e-4)"	"unprognostic (1.77e-2)"	"unprognostic (2.31e-5)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.05e-3)"	8.4	7.0	14.1	6.4	15.2	6.8	6.3	7.8	18.9	5.8	8.2	7.8	2.5	6.6	6.5	6.6	6.5	8.2	7.7	9.2	13.0	14.9	5.7	12.6	6.8	8.7	14.8	12.5	5.4	3.4	8.2	8.5	6.2	19.5	9.7	4.6	6.5	8.7	9.9	6.3	5.8	6.4	8.5	10.5	8.9	9.6	4.2	4.9	5.7	6.2	3.7	8.4	7.2	4.7	18.1	13.5	29.5	15.0	15.7	19.5	9.4	10.3	11.1	4.2	6.2	6.6	4.0	7.1	10.3	6.9	12.1	12.3	4.6	5.5	9.1	16.5	5.7	6.3	4.1	4.4	11.9	6.4	14.3	8.0	5.2	4.2	4.9	7.5	4.5	16.0	6.0	8.6	10.0	3.4	4.2	8.2	13.9	8.1	6.9	6.5	10.8	10.8	5.9	3.3	10.8	7.2	6.9	5.8	6.5	8.7	4.6	5.1	5.3	7.0	8.5	8.6	6.2	6.7	10.2	3.5	6.3	9.3	14.3	10.0	13.0	7.7	6.4	13.7	5.1	6.7	29.5	11.4	27.3	17.1	15.0	13.0	18.1	15.5	16.1	9.6	14.6	13.2	12.8	9.6	15.7	11.7	13.5	19.5	9.4	14.1	15.2	7.8	18.9	13.0	14.9	14.8	12.5	19.5	4.9	3.0	1.7	11.5	10.4	6.1	6.0	1.4	10.2	0.0	1.2	17.4	0.0	16.3	5.0	9.6	4.7	4.7	7.7	23.3	8.1	13.8	6.9	7.1	0.0	12.9	9.3	9.5	12.6	8.0	4.9	4.0	10.3	7.9	8.5	19.8	9.6	4.9	10.7	14.0	4.2	8.7	3.3	6.5	9.6	3.1	2.5	4.4	15.9	15.8	8.0	8.8
ALMS1	KIAA0328	ENSG00000116127	"ALMS1, centrosome and basal body associated protein"		2	73385758-73610793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 23.2"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 55.4;Late spermatids: 63.9;Rod photoreceptor cells: 38.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RH-30: 24.2"					"Low region specificity"	"Detected in all"			"HPA035276, HPA043200"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"	Nucleoplasm	"HPA035276: , HPA043200: AB_10796689"	"unprognostic (2.86e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.91e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.58e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	3.4	1.7	3.0	6.5	5.5	6.3	3.9	5.5	4.5	6.0	4.0	5.4	4.3	2.0	7.4	3.9	2.2	7.9	4.3	1.6	3.4		3.5	2.1	2.7	2.5	2.0	5.0	11.0	4.0	6.1	6.6	3.2	3.6	3.6	3.3	4.7	2.3	5.8	2.3	1.8	2.4	4.2	3.2	2.1	2.8	23.2	3.4	6.7	5.1	1.9	3.2	2.9	4.1	0.8	1.3	1.3	0.4	0.5	1.2	0.0	8.5	3.4	6.3	4.6	2.5	4.1	3.9	2.9	3.2	4.8	3.6	3.7	1.2	8.1	1.8	4.9	6.4	3.8	10.6	3.3	7.3	4.8	2.9	5.3	3.7	3.0	2.1	7.4	2.6	3.1	2.0	6.7	3.3	2.3	4.3	7.5	6.0	4.3	4.0	2.5	7.0	3.4	8.1	2.4	3.1	7.8	24.2	3.4	1.2	3.1	5.1	6.1	6.7	1.1	2.7	5.1	1.4	1.8	2.7	6.8	7.1	5.4	7.0	5.0	2.5	8.6	2.6	4.2	3.0	0.0	0.1	1.3	1.2	0.2	0.3	0.2	0.6	0.1	0.1	0.8	0.4	0.6	0.0	0.5	0.4	1.3	0.1	0.0											6.0	9.3	0.0	2.6	2.2	23.1	5.8	2.5	21.4	12.5	10.4	23.6	2.6	0.0	3.9	55.4	8.6	3.8	0.0	3.0	2.2	4.8	3.9	4.7	2.1	2.8	20.6	7.0	0.6	3.0	63.9	7.5	3.1	3.3	2.8	5.6	5.7	2.9	0.0	8.5	1.1	38.5	6.5	3.9	25.2	24.4	2.9	1.6	2.5	4.6	1.8
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 1.8;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 17.5;HEL: 28.0"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		5800000	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.5	2.9	1.3	1.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	2.6	0.6	0.9	0.6	0.0	1.0	2.2	0.0	0.1	0.0	1.9	2.3	28.0	3.9	1.9	0.1	0.2	4.6	0.0	0.0	0.0	0.0	1.7	0.0	1.9	1.8	1.0	0.0	0.2	0.3	0.6	0.9	0.1	0.6	1.0	0.6	0.4	0.0	2.2	0.1	0.6	0.5	0.6	0.2	1.8	1.0	0.7	3.2	1.5	0.9	1.5	0.7	0.5	0.2	0.5	0.9	2.1	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 30.2"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 1.6;Glandular cells: 2.0;Pancreatic endocrine cells: 3.6;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.9"	"Group enriched"	"Detected in many"	8	"basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1"	"Group enriched"	"Detected in some"	5	"gdT-cell: 1.0;naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"A-431: 6.6;HBEC3-KT: 10.8;hTCEpi: 8.0;hTERT-HME1: 15.1;T-47d: 4.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.1	0.0	0.1	0.1	1.1	0.0	1.6	1.4	2.3	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	1.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.2	6.6	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.4	0.1	0.5	0.2	0.2	0.1	3.2	0.5	0.9	10.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.0	0.2	15.1	0.0	0.0	1.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	0.0	4.8	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	1.4	2.3	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.9	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	1.6	0.9	0.0	0.0	0.7
ALPI		ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456123-232460032	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	406	"intestine: 133.2"	"Group enriched"	"Detected in some"	6	"Enterocytes: 45.5;Paneth cells: 17.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"CACO-2: 12.7"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	63.0	0.0	0.0	57.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.1	0.1	133.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	17.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0
ALPK1	"FLJ22670, KIAA1527, Lak"	ENSG00000073331	"Alpha kinase 1"	Q96QP1	4	112285509-112442620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA027435, HPA027443"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA027435: AB_10599614, HPA027443: AB_10599421"	"unprognostic (6.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.17e-4)"	15.1	10.6	5.3	8.3	7.7	17.3	9.3	1.3	5.9	10.8	9.5	5.8	3.0	4.5	9.8	9.2	8.8	9.2	7.5	6.1	6.1	2.3	10.8	13.4	13.2	11.4	9.7	1.0	17.4	9.7	11.0	14.0	11.5	6.6	14.0	7.8	9.6	10.4	6.8	5.0	11.8	12.1	11.3	16.6	16.2	7.4	4.2	8.5	13.7	12.4	4.7	13.7	13.6	11.6	0.9	3.2	16.3	4.3	0.4	0.8	1.2	1.6	5.0	1.6	0.3	6.6	10.6	2.0	1.9	3.5	2.6	3.3	0.5	7.7	5.1	3.3	3.3	5.3	1.1	1.7	3.0	3.9	6.5	1.7	3.6	2.0	0.4	10.6	2.2	2.2	13.1	8.6	3.8	7.9	5.9	1.0	2.7	0.9	8.9	5.0	3.1	1.3	2.0	0.4	3.7	1.3	0.6	1.1	1.6	3.9	1.9	0.5	0.8	1.8	6.6	2.9	0.3	3.0	4.1	1.9	2.4	2.1	3.7	1.3	2.3	0.7	4.4	5.7	4.6	2.1	1.3	3.2	1.4	0.2	4.3	0.6	0.8	0.6	0.1	3.2	0.9	0.8	0.6	16.3	0.4	1.9	0.5	0.0	1.2	5.3	7.7	1.3	5.9	6.1	2.3	9.7	1.0	6.6	8.5	11.9	20.3	0.9	9.4	2.6	0.2	3.1	0.0	20.1	13.6	5.2	0.0	4.0	0.0	5.6	7.5	5.5	7.0	0.0	5.8	2.6	4.1	7.1	5.8	5.8	8.7	0.0	1.2	5.5	14.8	1.6	3.4	14.0	6.8	10.0	8.5	11.3	6.3	8.6	7.1	4.0	0.2	6.5	5.1	0.7	0.5	4.0	6.1	2.2	5.7	10.3
ALPK2	HAK	ENSG00000198796	"Alpha kinase 2"	Q86TB3	18	58481247-58628957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4"	"Cell type enhanced"	"Detected in some"	19	"Cardiomyocytes: 79.2;Cone photoreceptor cells: 45.2;monocytes: 31.5"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 26.6;BJ hTERT+: 16.2;fHDF/TERT166: 24.0;U-138 MG: 13.5"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	"unprognostic (7.35e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (5.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-2)"	0.8	0.0	0.1	2.8	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.8	0.0	0.4	35.3	0.1	0.0	5.2	2.8	0.1	3.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.2	0.4	0.1	35.3	0.3	0.6	0.1	0.1	0.2	1.2	0.6	0.1	5.5	0.3	12.4	7.9	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	7.0	0.5	0.0	0.2	1.8	0.1	26.6	16.2	11.2	9.7	1.7	0.0	0.0	2.8	24.0	1.5	0.0	0.0	0.0	11.5	5.8	0.0	0.0	2.2	0.9	1.5	0.0	0.0	1.6	0.0	3.4	0.1	0.3	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	4.5	0.0	0.0	0.0	13.5	6.0	1.8	4.5	10.9	9.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	79.2	0.0	0.0	0.0	0.0	45.2	0.0	1.7	0.4	14.2	0.0	0.0	0.0	0.6	0.0	0.7	0.1	0.0	2.4	0.5	1.6	0.0	0.6	0.0	15.3	0.3	0.9	0.0	31.5	0.0	2.9	0.3	0.2	0.0	9.8	0.5	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	"Alpha kinase 3"	Q96L96	15	84816680-84873482	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 18.4;skeletal muscle: 47.6"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 52.4;Cholangiocytes: 20.4;Exocrine glandular cells: 17.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;HDLM-2: 7.1;HUVEC TERT2: 10.2;LHCN-M2: 13.9;NTERA-2: 8.5;RH-30: 25.0;THP-1: 6.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026558	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026558: AB_1844774"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (1.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.87e-2)"	3.7	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.5	1.4			0.0	0.1	1.7	0.8	0.2	0.3	18.4	0.0	0.6	1.6	1.3	1.0	0.0	0.1		0.0	2.1	8.8	6.9	0.6		0.4	0.0		0.4	0.2	47.6	0.0	0.2	0.8	0.0	0.0	1.2	0.0			0.6		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.1	0.1	0.1	0.2	0.0	9.5	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	7.1	1.1	1.1	0.2	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.1	10.2	0.0	0.0	0.0	13.9	0.5	0.0	0.1	8.5	0.2	0.0	0.0	25.0	0.1	0.0	2.6	0.0	0.1	0.0	1.3	0.0	1.3	0.0	6.1	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0											6.0	2.4	0.5	0.0	0.8	3.1	52.4	20.4	0.0	1.2	8.7	15.7	0.2	0.0	3.1	0.1	4.5	0.0	0.0	17.3	0.6	1.5	0.5	1.1	1.5	7.9	0.0	8.7	2.5	0.3	0.0	0.0	1.9	3.3	8.2	0.3	0.9	13.6	0.2	0.0	1.7	3.0	0.0	8.3	0.2	3.1	0.1	0.6	0.0	0.3	0.8
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 2: 88.5;Hepatocytes: 25.3;Ito cells: 25.8;Proximal tubular cells: 44.8;Rod photoreceptor cells: 28.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 53.1;hTEC/SVTERT24-B: 41.5;LHCN-M2: 30.2;SCLC-21H: 26.4;SuSa: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		7300000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	2.0	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.7	2.3	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.6	0.0	1.1	1.1	0.5	0.0	0.2	53.1	0.0	41.5	0.1	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	12.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	26.4	0.3	0.0	0.0	0.1	14.8	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7	3.0	88.5	0.5	0.5	0.1	2.6	2.0	0.0	1.4	10.3	0.0	0.0	0.0	6.6	0.0	1.2	7.1	0.0	23.3	0.0	0.3	0.3	1.5	7.0	25.3	0.1	1.6	0.0	25.8	1.0	4.4	0.3	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	44.8	28.1	0.0	1.0	0.3	13.6	0.4	1.3	0.0	0.0	0.3
ALPP		ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378534-232382889	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"placenta: 240.2"	"Group enriched"	"Detected in some"	19	"Alveolar cells type 1: 11.9;Club cells: 3.4;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HaCaT: 88.1;SiHa: 24.3"									"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	240.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.5	1.6	0.5	1.1	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	24.3	8.6	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	0.2	0.5	0.3	0.3	0.3	0.1	1.0	0.4	0.4	1.6	1.1	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	5.6	0.0	0.0	0.0
ALPPL2		ENSG00000163286	"Alkaline phosphatase, placental like 2"	P10696	2	232406843-232410714	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.2;lung: 9.4"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 1: 6.0;Ciliated cells: 1.4;Club cells: 2.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 21.4;HaCaT: 15.7;SuSa: 25.7"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.4	21.4	0.0	0.0	0.0	0.0	15.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0
ALS2	ALS2CR6	ENSG00000003393	"ALS2, alsin Rho guanine nucleotide exchange factor"	Q96Q42	2	201700554-201781189	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.8"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 66.8"	"Group enriched"	"Detected in many"	6	"basophil: 19.0;eosinophil: 5.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 19.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 53.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 158.8"	HPA046588	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA046588: AB_2679709"	"unprognostic (3.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.84e-1)"	6.9	5.3	8.2	4.2	14.7	7.8	8.1	66.8	15.6	5.9	5.6	10.1	5.5	7.4	10.3	10.7	4.7	6.7	6.4	19.9	8.3	7.3	10.4	18.3	7.9	4.1	6.8	11.0	6.8	5.6	8.8	16.8	7.2	13.6	6.6	6.0	8.5	5.2	5.5	12.2	6.9	8.4	7.4	8.3	5.3	6.7	6.1	9.0	3.5	7.5	5.9	4.5	5.5	5.3	1.2	1.0	19.0	1.2	1.7	1.8	0.7	5.1	3.6	8.8	8.2	6.0	6.5	6.6	9.2	12.4	12.2	14.2	8.4	5.1	0.6	4.0	9.6	8.3	5.3	5.0	9.3	15.5	1.7	5.1	12.2	3.5	4.8	7.4	9.6	53.0	5.6	5.2	10.2	8.8	9.5	12.3	4.9	5.8	3.7	9.2	4.1	3.4	12.7	7.3	3.2	5.5	2.8	4.9	1.8	7.7	7.1	4.1	5.4	5.3	5.8	8.2	22.1	3.7	4.0	7.3	10.8	5.2	3.7	4.6	4.1	5.6	2.1	7.9	1.9	6.8	19.0	0.7	5.5	1.7	1.2	1.8	1.2	1.2	1.2	1.0	1.2	1.3	1.5	0.6	1.7	0.8	0.5	1.8	0.7	8.2	14.7	66.8	15.6	8.3	7.3	6.8	11.0	13.6	9.0	11.9	18.4	1.9	3.3	4.7	14.7	26.3	7.6	13.4	3.4	8.7	27.5	4.6	0.0	5.6	13.0	7.7	5.2	0.0	2.8	2.4	5.9	3.8	45.1	17.1	4.9	7.9	4.6	15.4	3.5	5.3	7.2	5.3	0.0	1.0	6.7	6.8	5.9	3.7	7.8	4.8	14.7	0.0	4.1	6.5	2.8	5.3	5.6	4.3	3.8	3.3
ALS2CR12		ENSG00000155749	"Amyotrophic lateral sclerosis 2 chromosome region 12"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.3;epididymis: 14.4;testis: 29.9"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 99.0;Early spermatids: 82.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 14.3"	"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.0;U-2197: 9.6"					"Low region specificity"	"Detected in many"			HPA035793			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.8	0.9	1.5	0.7	3.6	4.3	0.5	0.7	1.1	0.9	0.6	7.6	0.4	0.3	0.7	14.4	1.1	9.9	0.9	4.7	2.1	2.6	1.3	0.7	3.7	1.4	1.0	1.3	5.3	0.7	1.2	1.3	0.9	14.3	0.4	0.9	0.5	0.7	0.7	1.4	1.1	0.9	0.9	0.9	0.8	0.5	29.9	1.3	0.4	1.7	0.4	0.5	0.6	0.4	1.8	0.5	7.3	1.1	2.8	1.5	0.4	0.3	0.4	2.1	1.5	5.7	2.2	0.1	1.5	0.5	1.3	0.9	0.0	0.5	0.7	1.2	2.2	1.0	2.0	0.8	0.2	0.6	1.2	0.2	0.3	2.5	0.7	1.1	2.1	1.9	1.1	0.6	1.3	0.3	1.7	0.2	2.5	1.0	2.9	1.3	0.0	1.1	1.8	0.6	0.8	1.2	0.5	1.0	1.3	0.8	0.5	0.5	1.3	1.6	0.0	7.0	2.2	1.5	2.5	1.6	2.9	1.7	9.6	1.0	1.6	3.1	1.0	2.8	1.0	1.3	5.4	1.1	1.0	1.5	0.5	0.7	0.6	1.0	0.9	0.5	1.8	1.2	1.4	7.3	2.8	0.6	0.4	0.6	0.4	1.5	3.6	0.7	1.0	2.1	2.6	1.0	1.3	14.3	1.3	0.0	0.3	0.0	0.0	0.5	5.4	5.7	0.0	99.0	9.1	0.0	9.8	0.0	3.3	0.0	82.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.3	1.6	0.0	0.0	0.0	16.0	0.6	0.0	0.0	1.0	0.0	0.8	0.1	0.0	0.0	0.0	1.4	0.0	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.1
ALX3	FND	ENSG00000156150	"ALX homeobox 3"	O95076	1	110059994-110070700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 19.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 2.4;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"olfactory region: 14.8"	"Low region specificity"	"Detected in single"			HPA074290			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA074290: "	"unprognostic (4.28e-1)"				"unprognostic (4.41e-2)"			"unprognostic (2.91e-1)"		"unprognostic (2.48e-2)"					"unprognostic (1.31e-1)"			0.5	1.8	1.2	1.0	2.7	0.8	2.6	0.9	4.1	0.7	0.4	1.2	0.3	1.6	2.7	0.9	2.6	2.6	1.7	0.7	1.3	1.5	0.8	0.4	1.0	2.3	0.5	1.9	3.1	1.0	0.2	5.3	0.7	0.5	0.8	0.0	19.3	2.0	0.3	2.8	8.0	2.7	0.3	0.4	2.4	0.8	1.8	0.6	0.3	2.1	1.8	0.3	1.4	2.4	0.4	0.0	1.4	0.1	0.0	2.0	0.2	3.3	1.7	4.3	6.3	0.0	0.0	8.1	8.5	11.2	0.0	0.0	3.4	1.5	1.8	3.5	0.1	1.3	5.1	0.0	0.0	0.0	4.5	6.2	1.1	3.9	2.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	4.4	0.0	3.5	2.9	0.5	0.0	3.9	1.4	1.6	4.5	2.4	4.8	3.1	5.4	1.5	0.0	4.5	5.3	7.4	3.9	6.0	5.7	4.8	2.7	3.2	3.3	5.1	4.4	6.4	2.1	3.3	1.2	2.0	5.4	4.8	3.5	0.8	0.1	1.4	0.1	0.0	0.3	0.2	1.1	0.4	0.0	0.4	0.1	2.0	0.0	0.0	0.1	0.0	0.1	0.2	1.2	2.7	0.9	4.1	1.3	1.5	0.5	1.9	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 17.8;Late spermatids: 18.9;Proximal tubular cells: 33.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 59.8;U-266/84: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		65000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.1	6.6	3.7	4.8	2.6	4.1	6.4	5.5	4.1	2.5	1.9	21.6	5.0	1.3	2.9	7.8	9.7	1.9	0.9	4.0	2.6	4.1	3.5	3.1	4.8	6.2	1.8	1.9	1.0	6.2	2.0	3.3	1.2	3.6	2.8	2.7	1.2	4.9	7.5	3.0	1.6	2.4	3.3	3.0	10.8	1.9	6.3	2.1	11.3	20.7	2.1	2.9	9.1	6.5	5.5	3.2	5.0	1.9	5.2	8.4	1.9	2.1	4.4	59.8	31.1	2.4	2.4	3.9	6.2	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1	3.0	2.6	0.0	0.4	0.3	3.3	0.9	7.6	4.0	5.7	1.8	0.0	0.9	5.0	0.7	8.1	0.8	5.0	0.0	3.3	0.9	1.1	0.6	0.0	17.8	0.9	4.8	4.1	1.3	1.2	18.9	0.6	0.8	0.0	1.8	4.5	10.6	2.4	3.5	2.1	33.2	0.8	0.0	0.5	0.7	0.7	0.5	0.2	0.8	4.0	0.3
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEK 293: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	2.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.1	0.0	1.2	0.2	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	0.0	2.0	0.0	0.4	0.1	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078472	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"liver: 592.2"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 9824.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	154	"Hep G2: 168.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		71000000000	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.1	0.0	0.0	1.7	592.2	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	168.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	42.0	0.6	1.3	0.0	0.0	2035.7	0.0	1.2	1.8	0.0	0.0	3.3	105.1	19.2	0.0	0.4	256.9	25.3	0.3	0.1	0.4	0.0	9824.4	0.7	0.0	2.4	175.6	182.3	40.5	0.6	0.0	0.0	6.4	0.9	0.0	22.8	1.1	0.0	9.9	0.0	0.0	0.0	0.2	0.1	0.4	1.1	3.8	1.0	0.3
AMBRA1	"DCAF3, FLJ20294, KIAA1736, WDR94"	ENSG00000110497	"Autophagy and beclin 1 regulator 1"	Q9C0C7	11	46396414-46594125	"Predicted intracellular proteins"	"Autophagy, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017825, HPA038535"	Approved		Approved	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"CAB017825: , HPA038535: AB_2676068"	"unprognostic (1.76e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.98e-2)"	15.4	26.4	15.8	18.4	20.6	19.4	20.5	25.6	24.6	16.6	15.4	23.5	12.0	18.9	18.7	15.1	15.5	18.0	15.5	13.1	14.5	11.4	13.7	14.6	14.7	15.0	15.5	18.4	21.4	13.7	33.5	23.2	17.8	15.8	15.3	14.0	20.2	17.0	20.4	18.7	25.8	17.0	17.4	12.7	17.4	15.7	18.9	17.4	26.3	16.9	10.8	18.2	14.6	14.9	3.4	3.0	12.9	2.9	2.0	4.5	2.2	6.9	18.8	13.0	14.0	13.8	10.4	8.1	7.0	13.4	11.4	12.0	14.2	12.2	14.1	7.2	12.3	13.6	12.7	6.5	12.3	8.5	12.2	21.1	9.6	11.9	18.0	9.0	13.8	12.3	14.3	9.8	7.2	13.8	12.5	11.8	12.3	16.4	9.8	8.4	17.2	17.5	9.7	21.7	15.8	10.3	17.3	17.8	7.8	11.0	12.6	10.5	11.7	12.0	13.9	12.7	8.9	14.3	9.4	12.5	10.6	9.5	12.2	10.4	11.1	8.8	14.8	9.4	7.8	9.3	12.9	2.9	2.2	3.8	1.5	3.2	3.4	2.8	2.9	2.8	3.4	2.9	2.6	3.4	2.0	2.6	3.0	4.5	2.2	15.8	20.6	25.6	24.6	14.5	11.4	15.5	18.4	15.8	17.4	3.0	6.4	3.4	2.2	3.7	6.6	6.7	7.6	4.0	4.5	0.0	2.0	3.2	0.0	5.9	9.3	3.7	8.8	0.0	8.0	1.8	4.1	3.4	4.6	3.2	4.5	4.8	9.2	3.1	4.4	5.2	4.9	3.1	5.0	2.8	7.2	3.0	6.7	6.8	7.4	2.9	5.6	12.9	2.7	1.8	0.9	4.0	5.7	4.9	5.2	3.4
AMD1	SAMDC	ENSG00000123505	"Adenosylmethionine decarboxylase 1"	P17707	6	110874770-110895713	"Enzymes, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 104.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029281, HPA029282"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029281: AB_10600101, HPA029282: AB_10599965"	"prognostic unfavorable (3.87e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.71e-2)"	16.7	15.2	29.7	16.9	35.6	38.1	17.8	27.3	34.2	18.6	18.6	45.7	12.5	14.9	18.9	14.2	28.9	14.7	17.5	18.5	32.5	21.5	25.2	16.9	16.9	18.5	39.0	22.0	16.9	20.2	21.8	26.2	33.8	32.7	104.7	19.4	12.8	17.5	19.2	15.3	14.5	13.5	18.4	38.3	16.7	18.4	15.8	46.0	19.4	25.5	20.1	24.6	12.6	16.8	6.6	12.9	42.0	14.0	6.1	9.2	6.5	20.8	14.3	17.5	33.1	26.5	16.9	22.9	30.1	33.4	23.5	27.7	22.7	13.2	36.9	14.6	19.0	25.0	14.4	41.3	27.2	32.4	21.6	23.9	38.2	13.0	23.8	15.8	32.9	22.9	11.3	25.2	16.2	32.8	8.2	20.4	19.0	28.5	32.2	39.5	12.6	43.7	25.3	21.5	20.8	13.1	24.1	17.6	21.9	26.6	28.0	22.5	16.0	18.3	23.3	26.5	14.9	15.0	28.2	13.4	15.6	11.8	83.0	32.4	8.8	14.3	37.7	18.0	26.4	20.0	15.0	9.8	14.7	7.6	11.6	8.9	6.3	7.6	8.7	12.9	6.6	9.2	9.0	42.0	6.1	14.0	5.8	8.8	6.5	29.7	35.6	27.3	34.2	32.5	21.5	39.0	22.0	32.7	46.0	35.7	72.7	96.8	225.1	280.1	92.0	87.2	86.6	30.8	108.1	52.4	56.9	32.2	124.3	65.9	25.2	75.1	78.4	70.0	59.9	125.5	124.4	304.0	93.3	52.5	68.2	73.1	119.2	47.9	101.7	37.7	40.6	70.6	124.9	74.9	52.0	241.3	72.3	49.3	47.0	70.8	99.1	19.4	119.5	83.5	72.8	251.9	45.7	59.8	63.1	119.5
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943293-95968716	"Enzymes, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 99.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 125.2"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		410000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.1	5.7	0.5	2.4	0.8	2.0	0.9	0.5	1.3	0.7	0.7	0.6	0.4	1.9	0.9	0.5	0.8	0.5	0.7	1.1	0.6	0.5	4.4	99.0	1.3	1.4	0.5	0.4	0.7	1.1	0.0	1.2	0.6	1.0	0.7	0.0	0.8	1.3	0.7	11.3	2.2	1.9	0.6	0.6	2.9	1.9	6.2	0.5	0.7	0.6	0.7	0.7	0.8	0.9	1.5	1.2	3.7	3.8	5.7	1.6	1.4	19.5	4.3	0.3	2.8	0.1	0.0	4.4	0.6	0.2	0.3	0.6	1.9	2.5	1.7	1.9	0.0	1.1	3.7	0.1	0.0	0.1	6.8	0.7	1.9	3.0	3.8	0.0	2.5	21.5	0.0	0.1	0.3	0.0	0.1	0.1	1.7	1.3	26.6	0.0	3.0	1.6	4.8	2.0	0.7	1.0	3.5	0.1	2.2	0.0	1.8	2.2	3.2	17.8	20.0	2.3	0.0	2.1	3.6	0.0	2.8	9.7	3.5	2.4	21.5	25.2	2.7	1.9	5.2	3.1	0.3	1.6	3.7	1.2	1.4	1.1	1.5	0.6	1.6	1.2	1.0	1.0	1.1	1.2	5.7	3.8	0.6	0.3	1.4	0.5	0.8	0.5	0.6	0.6	0.5	0.5	0.4	1.0	0.5	0.0	0.3	2.2	0.2	0.3	0.0	0.4	0.0	0.0	1.2	3.5	0.0	0.5	3.3	0.1	0.6	0.3	0.0	0.0	1.0	0.1	0.3	0.0	0.0	125.2	4.1	1.6	1.7	11.1	3.7	0.0	0.3	1.1	3.3	0.0	0.0	1.9	0.3	0.0	0.0	23.2	0.0	0.0	0.0	1.2	1.9	0.3	0.2	2.9	0.0	0.1
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		69000	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	12.8	16.9	8.6	11.4	10.1	12.7	10.9	7.3	16.0	9.4	8.8	11.1	11.3	19.5	10.4	11.9	8.4	9.0	14.6	11.8	7.1	4.8	15.3	10.5	20.0	15.8	9.8	11.3	8.1	10.1	6.5	7.5	10.7	8.9	8.6	2.4	10.9	16.1	9.6	10.2	15.0	19.1	7.2	8.3	22.2	11.5	25.7	7.9	7.3	9.9	11.0	8.9	9.3	8.0	9.8	17.1	16.6	15.8	4.9	8.1	4.8	6.5	8.8	1.9	4.0	2.1	1.7	14.3	5.9	2.5	4.7	5.9	6.3	11.6	3.0	4.2	1.1	10.1	6.0	1.1	1.6	0.1	3.8	5.3	4.3	7.9	8.2	8.0	3.1	14.1	4.0	1.7	3.4	0.5	1.2	2.9	8.5	9.8	7.2	1.9	15.6	5.1	8.6	4.1	0.5	6.8	19.7	3.0	11.0	1.3	3.6	7.3	7.2	3.8	9.2	15.5	0.3	9.5	0.8	4.0	5.3	8.1	10.5	3.0	15.2	9.7	5.9	5.9	5.9	6.6	9.9	6.1	16.5	7.4	15.8	5.5	9.8	5.9	5.3	2.3	7.4	5.0	4.2	16.6	4.9	15.2	17.1	8.1	4.8	8.6	10.1	7.3	16.0	7.1	4.8	9.8	11.3	8.9	7.9	3.0	12.3	13.1	4.6	7.9	9.0	2.0	7.6	5.3	2.3	5.2	5.9	14.1	5.0	24.6	45.6	7.1	18.1	0.0	14.7	23.4	8.0	6.0	6.9	10.4	104.3	22.3	12.1	18.4	33.6	16.0	9.8	15.9	18.6	34.3	9.0	10.8	16.8	14.4	6.0	38.1	12.0	0.0	4.4	7.7	17.2	7.9	23.3	15.3	7.0	3.8
AMER1	"FAM123B, FLJ39827, RP11-403E24.2, WTX"	ENSG00000184675	"APC membrane recruitment protein 1"	Q5JTC6	X	64185117-64205744	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 4.5;Cholangiocytes: 5.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065214, HPA065265"	Approved		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Nuclear bodies"	"Vesicles, Plasma membrane"	"HPA065214: AB_2685435, HPA065265: AB_2685450"	"unprognostic (1.56e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.89e-1)"	3.0	3.4	3.0	2.8	5.6	2.3	3.0	8.8	4.9	6.8	4.7	3.1	7.8	3.3	9.8	11.3	6.9	5.2	2.4	3.5	3.0	3.4	4.2	7.1	2.8	2.6	4.5	1.6	15.5	8.1	5.1	3.9	2.0	6.3	4.5	3.2	6.8	7.0	5.3	9.0	4.8	3.7	6.6	2.9	3.7	5.1	1.4	4.3	2.4	3.4	6.5	3.4	4.3	5.7	0.4	0.2	0.0	0.3	2.0	1.0	0.1	3.0	2.2	5.8	4.6	2.2	2.2	4.6	1.4	1.2	2.1	1.3	7.2	1.0	5.7	1.9	2.9	1.6	4.2	12.2	4.0	2.0	2.6	2.4	3.5	4.5	4.6	1.6	7.4	0.9	3.0	5.3	1.6	3.2	1.7	1.2	4.5	5.3	5.8	1.1	3.5	4.8	4.0	15.4	3.8	4.3	11.5	9.4	4.1	1.0	0.9	2.6	3.9	3.6	4.9	1.9	5.0	1.6	2.1	0.8	2.6	5.9	6.6	1.9	3.0	2.0	4.4	1.2	8.4	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.4	0.0	0.4	0.0	0.3	1.0	0.0	0.0	2.0	0.0	0.2	0.9	0.1	3.0	5.6	8.8	4.9	3.0	3.4	4.5	1.6	6.3	4.3	0.0	0.0	0.0	0.6	1.9	4.5	2.3	5.1	0.0	0.0	0.0	2.0	0.8	0.0	1.0	0.0	1.0	0.5	0.0	1.4	0.6	0.8	0.4	0.0	1.9	0.3	0.0	1.2	2.5	1.5	0.0	2.3	0.1	1.7	0.0	0.9	0.2	0.5	0.0	3.9	0.6	0.7	6.5	1.2	0.0	0.2	2.3	0.6	0.5	1.3	0.7
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755435-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 30.1"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 6.2;Horizontal cells: 3.2;Intestinal endocrine cells: 14.6;Rod photoreceptor cells: 5.0"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebellum: 30.1"	"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: AB_2682423"	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.5	2.4	4.8	0.7	6.0	0.8	0.5	30.1	13.9	0.5	0.8	0.0	0.0	2.0	0.6	0.5	0.5	0.5	0.5	0.5	2.7	4.3	0.5	0.5	0.5	0.6	1.8	5.6	0.6	3.3	0.4	3.4	0.5	3.0	0.6	0.8	0.7	0.5	0.5	0.5	0.7	1.2	0.5	0.8	0.6	2.5	1.6	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.3	0.3	1.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.1	0.2	1.5	0.2	0.1	0.3	0.1	0.0	4.8	6.0	30.1	10.3	2.7	4.3	1.8	5.6	3.0	0.7	0.0	0.0	0.0	0.0	0.0	6.2	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	14.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425538	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 124.0;Hepatocytes: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	13.9	25.9	21.3	10.6	23.8	14.1	28.7	12.6	25.0	17.2	21.0	24.5	18.5	21.6	16.6	25.2	20.8	15.3	13.7	17.6	20.6	20.2	35.2	50.0	13.3	19.3	22.3	14.3	20.5	14.0	33.3	13.0	41.6	18.9	14.9	11.8	23.8	12.6	18.6	71.6	11.9	18.8	16.0	25.0	14.3	12.2	36.8	17.5	14.6	18.6	10.1	19.3	15.5	16.9	18.3	10.6	21.4	13.1	11.7	9.7	4.0	17.7	24.8	10.8	19.9	33.9	19.1	9.5	19.2	23.8	26.1	20.5	22.0	16.9	46.3	22.2	25.9	15.4	16.6	16.6	14.9	24.9	10.3	17.0	14.0	10.2	23.6	29.7	10.8	16.2	22.1	21.7	20.8	24.9	18.5	15.2	13.6	14.5	6.4	18.9	11.2	16.2	11.6	5.1	9.2	17.0	18.4	21.9	17.4	16.1	18.6	10.9	8.3	45.1	15.8	14.5	11.1	47.6	11.4	19.6	24.6	13.5	12.4	12.9	13.8	12.1	24.6	17.9	7.9	11.2	21.4	8.5	10.9	6.9	9.9	9.7	18.3	8.7	7.1	7.8	15.6	9.1	9.5	10.5	11.7	13.1	10.6	9.0	4.0	21.3	23.8	12.6	25.0	20.6	20.2	22.3	14.3	18.9	17.5	8.9	7.0	28.6	15.3	22.9	17.3	18.2	30.6	1.4	9.1	94.2	37.3	20.9	21.6	18.1	124.0	20.4	37.5	0.0	37.1	5.8	28.2	27.6	8.1	146.0	15.4	30.2	23.8	39.3	62.3	81.3	38.0	22.3	28.7	15.4	25.9	45.2	27.4	21.0	32.2	42.8	41.0	12.9	26.9	32.0	10.8	18.2	20.4	15.2	19.8	17.2
AMH	MIS	ENSG00000104899	"Anti-Mullerian hormone"	P03971	19	2249309-2252073	"Disease related genes, Predicted secreted proteins"	"Differentiation, Gonadal differentiation"	"Growth factor"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 35.7"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 14.3;Horizontal cells: 7.9;Late spermatids: 6.0;Muller glia cells: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 17.8;NTERA-2: 6.8;REH: 7.1;SH-SY5Y: 8.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA066973			Approved	Vesicles,Aggresome	"Secreted to blood"	NA	NA		56000	"Vesicles, Aggresome"		"HPA066973: AB_2732754"	"unprognostic (8.10e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (8.73e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.34e-2)"	"unprognostic (8.73e-8)"	"unprognostic (4.64e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.76e-1)"	0.3	0.2	1.0	0.3	2.8	0.3	0.3	4.8	1.4	0.3	0.5	0.3	0.3	0.2	0.4	0.6	0.3	0.2	0.3	0.3	0.5	1.3	0.3	0.3	0.4	0.5	0.3	0.3	1.1	0.7	0.2	3.5	0.4	0.3	0.3	0.2	0.3	0.3	0.3	2.6	0.4	0.6	0.3	0.3	0.5	0.6	35.7	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.1	0.4	0.0	0.0	4.5	0.7	0.0	0.0	0.0	0.1	0.2	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	17.8	0.1	0.6	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.6	0.5	0.0	0.5	0.1	1.3	6.8	0.0	1.6	7.1	1.5	0.9	0.0	0.2	0.5	8.2	0.1	0.0	1.5	0.0	0.9	0.0	0.8	0.6	1.4	0.9	2.5	5.0	3.6	0.8	0.3	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	4.8	1.4	0.5	1.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.1	14.3	0.8	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.3	0.6	0.1	0.5	0.0	0.2	0.2	0.4	0.1	0.0	0.2	0.1	7.9	1.2	0.6	0.0	6.0	1.4	0.0	0.0	0.0	0.7	7.2	0.0	0.0	0.4	0.2	2.2	0.0	0.1	0.5	0.4	0.1	0.0	0.0	0.6	0.1
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.1;ovary: 38.2;testis: 15.2"	"Group enriched"	"Detected in some"	4	"granulocytes: 25.4;Ito cells: 12.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"HEL: 28.3;K-562: 15.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"hippocampal formation: 14.3"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.3	27.1	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.6	0.4	0.2	0.4	0.8	0.2	0.0	0.2	1.1	0.3	0.2	0.2	0.2	38.2	8.8	0.1	0.2	0.2	0.3	0.4	0.0	0.2	0.2	0.2	2.5	0.0	0.4	0.5	0.2	3.7	0.3	15.2	0.2	0.2	0.2	0.5	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	28.3	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	2.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	25.4	0.0	0.1	0.0	0.0	12.3	2.2	1.3	4.6	0.0	0.0	0.0	0.0	0.0	4.6	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.0
AMIGO1	"AMIGO, KIAA1163"	ENSG00000181754	"Adhesion molecule with Ig like domain 1"	Q86WK6	1	109504175-109509738	"Predicted membrane proteins, Transporters"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.9"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 27.9;Rod photoreceptor cells: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5"	"Group enriched"	"Detected in many"	21	"NK-cells: 1.9;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.6;SK-BR-3: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046152	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046152: AB_2679559"	"unprognostic (1.35e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	5.3	14.8	11.8	3.7	19.1	1.0	4.7	23.4	33.9	4.8	6.6	4.8	4.0	3.2	5.7	16.4	4.1	4.9	4.3	11.0	12.2	14.3	7.6	3.5	6.4	5.2	9.9	15.0	12.8	9.2	21.1	8.1	3.0	15.6	9.2	3.7	10.3	9.6	11.1	22.4	3.3	4.1	6.5	6.0	4.6	5.0	4.1	5.3	1.7	9.1	1.9	4.6	4.5	3.8	0.1	0.0	0.0	0.1	1.9	5.4	0.9	2.6	1.2	2.7	9.5	3.6	1.5	3.4	4.4	2.2	5.1	2.4	0.5	0.1	0.2	1.2	2.8	1.2	1.4	7.3	0.3	4.3	1.0	0.6	0.0	1.7	0.8	2.9	2.1	5.4	0.7	3.2	1.7	0.0	0.5	1.2	1.5	2.1	0.0	0.1	4.4	0.4	4.4	1.7	2.2	3.0	0.7	0.0	0.4	5.9	1.3	9.6	3.2	1.0	12.6	3.5	1.2	3.6	3.1	1.1	0.2	5.9	3.4	1.8	0.2	0.0	0.0	1.9	0.0	2.7	0.0	0.0	0.0	1.5	0.1	1.6	0.1	2.2	2.5	0.0	0.0	5.4	3.9	0.0	1.9	0.0	0.0	1.5	0.9	11.8	19.1	23.4	33.9	12.2	14.3	9.9	15.0	15.6	5.3	3.0	1.3	0.0	0.4	0.6	27.9	6.7	2.5	0.0	0.0	3.5	3.9	1.0	0.0	1.0	0.0	0.8	1.0	0.0	0.8	0.1	0.6	1.1	0.0	0.8	0.2	4.8	4.6	0.6	0.0	0.0	2.0	0.0	0.0	1.0	0.7	7.1	0.7	0.9	5.3	0.5	8.8	0.0	1.0	0.7	0.9	0.4	0.2	0.0	1.5	0.3
AMIGO2	"ALI1, DEGA"	ENSG00000139211	"Adhesion molecule with Ig like domain 2"	Q86SJ2	12	47075707-47079951	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 58.0;Ito cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.9;fHDF/TERT166: 39.3;hTERT-RPE1: 69.7;LHCN-M2: 39.3;RT4: 53.8;U-2 OS: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054004, HPA059601"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	Yes		160000	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA054004: AB_2682339, HPA059601: AB_2684078"	"unprognostic (2.63e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.29e-3)"	5.6	11.9	5.4	4.0	8.8	1.4	14.5	1.6	6.5	18.3	20.3	3.5	1.9	1.6	19.7	12.4	3.1	21.2	12.4	3.4	2.7	7.5	4.3	2.9	11.9	6.7	2.9	5.1	43.4	2.3	2.0	9.5	7.6	16.2	12.8	5.6	6.7	3.1	7.1	1.5	2.3	7.1	21.0	3.0	9.8	3.5	13.1	3.6	1.6	2.5	4.1	4.5	16.6	15.1	2.8	7.4	0.1	0.2	6.6	14.2	4.3	9.0	22.5	1.4	0.0	0.5	0.0	3.7	3.1	8.5	1.0	0.8	0.0	40.9	0.0	10.3	39.3	25.8	13.6	0.0	25.1	1.2	1.7	0.1	0.0	2.2	0.0	0.8	0.2	0.3	0.2	4.4	26.9	13.3	69.7	3.2	0.2	1.7	0.0	39.3	0.4	0.7	0.0	0.9	4.5	5.7	0.0	10.1	0.0	11.6	53.8	4.1	0.0	16.2	1.9	0.1	0.8	2.4	0.2	0.8	0.5	32.6	0.3	25.1	0.3	0.0	0.0	2.1	0.7	0.6	0.0	0.1	0.0	4.0	0.2	5.4	2.8	6.2	6.2	0.6	1.3	14.2	11.1	0.1	6.6	0.0	7.4	3.6	4.3	5.4	8.8	1.6	6.5	2.7	7.5	2.9	5.1	16.2	3.6	8.9	1.9	5.9	10.4	2.2	21.1	0.8	0.0	2.7	6.8	1.8	0.0	0.7	1.7	4.3	1.2	4.5	0.0	0.0	17.0	23.1	6.7	5.2	6.9	0.8	4.4	0.0	58.0	30.7	3.8	0.9	2.3	2.3	1.7	8.2	2.5	14.9	26.7	0.8	0.7	0.0	4.1	0.0	25.5	0.3	0.7	0.4	7.1	4.4	0.2	13.4
AMMECR1L	MGC4268	ENSG00000144233	"AMMECR1 like"	Q6DCA0	2	127861630-127885922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 45.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000590, HPA057234"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000590: AB_2666037, HPA057234: AB_2683376"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.92e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (8.91e-2)"	7.8	6.4	5.2	5.2	5.2	5.0	7.1	5.7	5.2	7.6	5.5	5.2	5.2	4.6	8.7	5.2	6.4	6.9	5.9	5.2	5.2	3.3	5.2	7.7	5.6	5.2	5.2	5.2	7.6	8.8	7.6	5.2	7.3	5.2	6.4	5.7	45.9	5.9	5.2	5.2	7.2	5.8	7.5	5.2	6.8	6.1	7.9	5.2	5.2	6.1	5.2	5.4	5.8	7.3	4.2	5.4	9.0	3.7	3.5	6.1	3.2	12.3	8.3	17.1	14.0	16.2	13.2	16.2	14.6	13.3	16.1	14.6	18.4	9.3	12.1	9.8	14.4	7.6	12.3	16.5	12.2	17.8	14.2	12.1	15.2	12.3	10.4	19.4	15.1	15.7	14.6	26.7	19.8	26.7	15.5	16.9	12.4	13.9	12.1	13.0	8.7	14.0	14.6	13.5	9.5	15.3	14.8	13.7	6.8	12.8	10.8	11.3	12.8	12.1	18.9	29.4	14.6	8.8	10.5	16.7	20.0	18.7	9.3	11.0	10.2	15.0	12.4	9.6	9.7	13.2	1.6	3.2	9.0	4.7	3.7	6.1	3.6	4.5	4.1	4.8	4.2	4.1	3.8	4.3	3.5	3.7	5.4	4.2	3.2	5.2	5.2	5.7	5.2	5.2	3.3	5.2	5.2	5.2	5.2	17.9	7.2	8.2	7.4	16.0	5.1	11.2	7.6	18.7	11.4	3.5	5.9	4.4	0.0	5.2	10.1	6.7	6.3	0.0	4.9	5.8	11.0	10.9	6.9	14.3	3.9	1.6	5.2	8.0	6.6	12.4	6.4	6.1	5.0	1.8	11.6	4.3	7.3	7.0	7.8	4.1	5.5	0.0	8.0	6.3	10.4	13.8	6.4	2.5	9.1	12.5
AMN1		ENSG00000151743	"Antagonist of mitotic exit network 1 homolog"	Q8IY45	12	31671137-31729174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.5"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 268.2;Late spermatids: 111.1;Spermatocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 27.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046157, HPA062290"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA046157: AB_10965846, HPA062290: AB_2684739"	"unprognostic (2.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.60e-3)"	"unprognostic (4.08e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-1)"	5.3	9.9	24.8	6.1	20.9	3.1	9.0	13.8	28.3	9.6	4.3	11.1	2.9	3.8	10.8	7.9	6.0	17.0	6.9	10.1	22.4	20.9	11.3	5.8	6.5	10.3	19.6	15.2	16.0	8.2	8.5	16.1	5.4	14.8	8.9	4.3	8.9	5.9	7.8	12.8	5.4	4.1	7.3	19.4	8.4	8.4	46.5	16.2	11.7	7.9	4.2	9.0	7.7	5.5	12.3	6.6	27.4	2.7	4.7	9.8	3.4	3.5	7.7	6.3	0.7	6.1	7.9	3.7	3.7	5.8	2.6	5.1	4.0	14.1	1.8	8.5	3.3	20.1	2.0	2.9	4.4	5.4	3.0	3.7	6.2	2.8	5.7	11.0	3.3	3.2	5.2	7.3	4.5	6.4	20.1	14.9	9.6	5.4	5.8	10.0	2.2	1.8	2.6	8.7	7.7	3.7	2.7	10.1	2.9	6.0	8.0	10.1	8.4	4.9	1.3	7.7	14.3	11.9	3.7	8.4	4.5	3.7	3.7	6.8	6.4	6.1	6.3	5.6	3.1	8.4	4.3	2.7	3.3	4.3	1.9	4.3	12.3	4.5	4.6	2.1	11.5	9.8	5.9	27.4	4.7	1.6	6.6	6.7	3.4	24.8	20.9	13.8	28.3	22.4	20.9	19.6	15.2	14.8	16.2	6.0	2.4	19.9	18.4	8.2	10.7	3.1	5.1	13.4	5.7	15.7	25.5	5.7	23.2	7.9	268.2	9.8	2.0	0.0	6.2	4.6	7.4	13.9	7.0	3.2	7.6	28.6	13.8	7.4	6.9	111.1	9.5	4.8	15.1	2.8	1.7	10.1	9.1	0.0	12.7	7.9	40.5	0.0	12.3	84.7	16.4	11.0	6.1	7.5	2.0	23.5
AMOTL1	JEAP	ENSG00000166025	"Angiomotin like 1"	Q8IY63	11	94706431-94876753	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.2"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3;NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 36.6;WM-115: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001196	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		11000	Cytosol	"Cell Junctions"	"HPA001196: AB_1078147"	"unprognostic (2.21e-1)"	"unprognostic (5.25e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.03e-6)"	"unprognostic (7.47e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.29e-2)"	14.4	5.7	3.3	6.9	4.0	0.6	9.2	3.7	4.8	12.8	15.4	2.7	9.1	2.2	16.4	11.4	19.3	7.5	10.9	10.1	3.1	3.9	4.4	4.8	10.0	2.5	3.2	2.5	7.3	10.8	13.5	13.9	25.4	3.5	18.7	4.0	11.3	8.9	13.6	78.2	11.7	4.8	32.8	2.6	6.2	8.1	7.1	1.8	12.9	8.6	21.9	10.1	24.4	9.5	2.3	1.0	0.0	0.7	2.3	0.1	0.5	18.3	5.2	14.0	0.0	15.1	13.2	6.7	10.2	17.8	4.7	5.5	9.6	0.5	0.8	5.0	13.8	3.8	23.9	6.6	36.6	4.9	1.4	5.1	9.9	5.4	0.0	3.5	2.1	0.0	7.8	22.7	16.0	26.8	12.1	9.7	3.9	24.9	0.9	11.0	5.3	6.7	1.3	2.1	0.0	3.5	0.0	25.5	1.5	6.6	7.7	10.7	12.9	0.6	14.1	3.6	9.9	0.7	3.1	8.9	12.9	9.5	0.2	7.0	0.5	0.0	5.2	3.6	0.0	35.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.6	2.3	0.0	0.0	0.0	2.3	0.2	1.0	0.0	0.5	3.3	4.0	3.7	3.0	3.1	3.9	3.2	2.5	3.5	1.8	32.8	28.3	0.9	15.3	31.5	1.9	39.3	7.6	5.3	13.6	7.0	3.9	25.5	0.0	14.1	104.0	28.1	0.0	0.0	14.6	12.7	38.7	10.8	2.3	15.3	4.3	14.3	0.0	28.8	4.3	25.4	7.5	4.7	10.1	1.8	0.0	15.0	12.1	0.0	11.7	2.9	1.1	12.9	26.7	17.0	12.7	23.5	23.3	1.5	0.0	6.4
AMOTL2	LCCP	ENSG00000114019	"Angiomotin like 2"	Q9Y2J4	3	134355874-134375479	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Suprabasal keratinocytes: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063027			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA063027: AB_2684924"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.01e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.17e-2)"	49.4	9.5	9.2	8.8	22.6	0.6	29.0	6.1	19.3	25.7	13.5	47.7	7.9	6.9	24.2	10.2	19.4	19.1	18.2	14.0	13.1	7.6	21.4	10.4	20.4	8.5	25.5	15.1	12.6	21.3	11.1	3.4	27.6	16.6	21.0	4.9	20.3	13.8	14.8	11.5	19.8	8.2	27.8	17.7	15.9	12.6	7.6	28.1	0.1	18.6	15.9	8.6	15.1	31.8	0.0	0.0	0.2	0.0	0.0	0.2	0.0	25.4	10.9	7.8	8.3	8.0	10.5	68.8	25.8	15.1	25.0	12.3	34.3	7.7	0.0	33.8	17.6	13.2	19.5	5.0	6.9	10.2	0.0	0.5	0.0	6.0	3.5	16.2	0.0	0.0	14.7	21.8	9.3	10.1	9.0	11.6	0.2	0.2	0.0	15.4	8.0	0.0	0.0	10.0	5.3	4.4	0.0	10.4	0.1	14.9	5.9	1.2	3.2	20.9	24.6	17.3	17.5	23.4	0.2	19.6	16.4	14.5	10.9	15.9	0.0	0.0	0.0	5.9	0.0	17.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.2	22.6	6.1	19.3	13.1	7.6	25.5	15.1	16.6	28.1	56.6	15.9	0.0	14.9	64.8	9.5	13.0	58.6	10.7	5.7	17.4	17.7	17.7	14.9	22.7	3.6	24.3	7.3	0.0	11.3	28.9	30.5	20.3	1.1	21.5	2.6	1.6	12.0	54.6	1.6	8.0	33.1	3.3	13.5	0.0	3.9	10.0	35.7	3.5	18.7	15.1	4.1	12.9	23.6	0.3	0.4	113.8	20.7	0.0	3.7	21.4
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.2;skeletal muscle: 61.0"	"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.7;CAPAN-2: 19.3;HMC-1: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	2.9	13.7	5.3	13.8	14.0	39.2	2.3	2.3	7.8	3.3	3.4	19.6	0.7	4.7	3.1	4.2	5.2	8.0	4.6	2.1	7.4	7.1	4.2	1.5	4.5	12.7	15.2	5.7	2.3	2.5	24.9	14.5	3.7	11.2	5.5	4.9	4.3	4.7	2.8	61.0	10.8	5.0	3.1	12.8	8.3	4.6	1.4	12.6	14.8	2.7	7.6	14.2	6.1	5.1	7.6	3.9	17.0	6.0	3.3	5.3	2.3	7.6	1.1	0.3	0.1	4.1	2.9	0.4	6.9	24.7	1.7	1.8	3.8	19.3	2.8	0.7	3.1	6.8	4.8	0.1	6.5	5.1	6.9	0.2	6.8	1.0	0.5	1.4	9.2	20.5	10.8	10.2	3.4	4.4	4.3	0.7	4.6	10.3	3.0	5.6	0.2	5.4	12.1	0.9	0.6	6.8	2.0	9.0	9.9	0.3	6.5	2.9	1.5	1.5	0.2	0.4	0.6	0.2	3.1	1.9	7.9	0.1	5.4	0.2	2.7	1.5	3.0	9.0	9.2	0.2	6.6	6.0	17.0	2.3	3.8	5.3	7.6	3.3	2.5	3.9	5.8	3.7	2.5	8.3	3.3	1.6	2.5	1.9	2.3	5.3	14.0	2.3	7.8	7.4	7.1	15.2	5.7	11.2	12.6	0.0	4.6	5.2	8.9	11.1	20.7	5.6	7.6	12.0	7.9	14.0	2.0	0.7	14.9	2.4	7.0	1.0	1.7	46.7	1.4	1.1	1.4	17.1	11.5	0.6	13.4	0.0	9.8	1.8	14.3	14.2	0.9	9.1	3.3	13.6	3.2	6.8	3.9	2.9	0.0	1.0	1.3	0.0	1.7	0.2	0.5	10.9	1.0	2.9	2.2	16.1
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631567	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 57.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 53.7;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 54.5"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 31.2;ASC TERT1: 18.5;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 14.4;GAMG: 21.3;HBF TERT88: 11.1;U-138 MG: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.8	2.4	17.4	2.5	17.7	1.0	2.8	29.7	57.2	7.7	2.2	1.8	0.0	1.4	5.1	4.7	4.5	5.7	4.2	6.5	13.5	16.0	3.7	1.4	1.6	1.3	10.4	20.4	1.7	2.9	1.2	12.6	1.0	26.5	2.4	2.5	4.8	1.5	4.2	2.9	1.3	1.9	5.0	4.9	1.9	2.0	3.5	1.5	0.0	1.2	0.2	1.1	2.9	1.7	0.2	1.6	0.0	0.8	0.7	2.9	0.2	0.0	0.0	7.9	0.0	31.2	18.5	0.0	1.1	0.0	12.1	14.4	0.0	0.0	0.0	0.0	2.2	21.3	0.0	0.0	0.0	11.1	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.1	0.0	0.1	4.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	11.8	8.4	4.1	4.5	0.0	0.1	0.0	8.0	0.1	10.6	0.0	0.8	0.0	2.9	0.2	1.7	0.0	1.0	1.5	0.2	0.2	0.4	2.0	0.0	0.7	0.2	1.6	0.2	0.2	17.4	17.7	29.7	32.9	13.5	16.0	10.4	20.4	26.5	1.5	0.0	0.0	0.5	0.1	0.2	53.7	6.3	0.0	0.0	0.0	0.0	82.5	0.0	1.7	0.1	7.7	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.6	0.0	5.5	14.2	10.2	2.6	0.0	0.0	0.0	0.0	4.7	0.1	0.0	4.6	0.0	54.5	6.5	3.0	0.4	3.0	0.3	0.0	0.0	0.0	0.0
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416775-49422753	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.4;Hep G2: 29.9;NTERA-2: 5.4;SH-SY5Y: 7.9;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	10.9	6.6	8.0	8.8	6.0	6.6	16.7	10.4	8.4	10.0	7.4	21.3	10.9	9.2	11.1	3.4	9.7	13.0	16.6	7.4	2.0	21.4	41.2	5.6	2.3	7.6	8.3	14.5	18.5	16.3	10.4	2.5	10.7	9.1	10.1	12.2	9.8	20.0	3.8	5.4	11.0	7.1	5.8	7.9	8.1	2.6	7.4	1.7	8.7	0.4	1.8	6.2	8.1	0.7	5.4	4.7	3.2	8.9	1.6	2.3	0.1	0.5	0.7	0.1	0.4	0.0	10.4	0.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.2	0.0	0.2	0.1	0.4	0.1	0.2	0.2	0.0	0.3	29.9	1.1	0.0	0.1	0.3	0.7	0.0	0.4	1.1	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.2	5.4	0.0	0.1	0.0	0.1	0.2	0.7	0.2	0.0	7.9	0.1	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	3.2	4.7	0.0	1.9	0.1	0.6	0.0	0.0	5.4	0.7	1.6	1.5	0.3	8.9	0.7	0.5	0.0	2.3	6.6	8.8	16.7	10.4	7.4	2.0	7.6	8.3	10.7	7.4	3.0	11.6	3.7	11.4	2.5	17.2	18.3	17.8	6.7	7.9	0.0	19.6	22.7	0.0	0.7	1.7	2.7	19.7	0.0	0.6	6.5	4.7	10.1	7.0	37.3	4.4	7.9	12.2	3.1	2.7	1.6	9.8	3.5	5.0	0.0	16.2	21.5	0.5	14.0	6.0	0.7	17.7	6.5	4.3	1.4	0.4	2.4	8.6	5.7	31.1	8.6
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68247574-68257164	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 585.3;Late spermatids: 1307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: AB_2681818"	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	22.3	21.3	29.3	13.7	43.3	14.2	20.8	29.2	35.8	19.8	19.8	20.3	19.6	11.9	19.0	25.3	22.3	24.6	17.7	33.6	26.8	23.7	26.8	16.6	14.1	22.4	26.0	27.0	23.4	20.4	29.4	25.4	18.9	28.3	21.1	15.0	19.0	17.9	25.1	39.9	15.5	13.5	19.3	27.8	16.6	15.7	77.2	20.5	15.5	28.4	20.6	22.4	20.2	14.9	20.9	17.2	31.4	21.1	34.8	31.2	19.7	23.4	26.1	22.1	18.7	17.0	29.6	34.8	17.0	23.0	29.6	24.9	10.7	15.1	35.1	19.2	26.3	27.9	11.6	18.0	50.1	38.9	12.4	17.0	12.9	11.6	20.8	32.2	11.7	22.3	25.2	56.3	27.5	51.3	29.3	29.9	30.2	13.2	22.5	37.4	17.4	26.4	10.9	10.4	12.5	24.4	10.1	60.2	26.3	17.8	12.4	22.3	17.5	15.8	32.6	31.7	47.6	25.7	8.1	15.5	39.9	19.0	14.3	18.4	31.6	29.0	60.6	28.1	16.7	20.1	31.4	14.4	19.6	22.1	16.6	28.6	17.4	27.3	29.0	17.2	20.9	24.4	26.3	25.2	34.8	21.1	15.7	31.2	19.7	29.3	43.3	29.2	35.8	26.8	23.7	26.0	27.0	28.3	20.5	11.9	14.1	28.3	32.0	16.6	13.3	73.2	22.9	57.6	21.6	22.7	7.9	54.0	92.9	25.1	585.3	25.4	8.9	0.0	22.9	56.9	31.5	18.0	32.4	13.7	37.1	17.5	20.3	22.7	19.9	1307.8	33.4	36.7	54.0	56.9	16.8	56.2	24.4	12.9	30.8	48.5	11.6	19.4	27.2	187.0	54.0	19.7	28.6	51.1	15.8	15.9
ANAPC1	"APC1, MCPR, TSG24"	ENSG00000153107	"Anaphase promoting complex subunit 1"	Q9H1A4	2	111611639-111884690	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Cancer-related genes, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036329, HPA036330, HPA042998"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA036329: AB_10670714, HPA036330: AB_2675065, HPA042998: AB_2678263"	"unprognostic (1.74e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.49e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	4.9	4.4	3.2	6.1	4.4	4.3	5.8	6.0	4.6	4.9	6.0			5.6	5.6	2.5	6.5	5.2	3.4	4.5	3.5	3.2	3.8	4.0	4.1	7.5	3.0		6.7	5.3	8.7	4.1	4.8		4.1	7.3		4.7	3.7	7.5	5.2	5.5	4.8	2.9	6.0	4.5	6.5			3.9		8.4	5.4	4.9	6.3	5.6	0.7	3.0	6.4	8.7	4.5	18.4	13.1	14.8	10.3	6.2	8.3	14.5	11.2	8.0	13.8	12.1	26.2	11.9	31.3	9.1	10.0	16.5	15.8	22.2	12.2	17.5	14.0	12.6	33.6	12.6	14.1	6.4	36.5	12.1	5.7	5.8	20.3	19.1	6.9	12.5	15.6	31.5	13.8	9.3	7.7	21.1	9.2	22.3	7.5	11.3	22.1	17.2	17.9	7.5	17.7	12.1	7.1	11.4	10.1	9.6	10.3	6.5	12.4	8.8	11.4	13.0	9.7	11.5	10.7	21.3	28.7	9.6	15.4	9.8	0.0	2.7	0.7	5.9	3.0	8.7	6.3	5.3	5.0	5.6	4.2	8.6	7.3	0.5	6.4	2.4	2.2	2.3	4.5											3.0	8.0	19.3	15.5	12.7	10.9	6.9	7.6	6.7	3.4	3.5	13.7	10.4	5.0	5.4	5.0	8.8	5.2	0.0	5.1	11.0	8.0	13.2	8.1	11.4	7.8	19.1	10.9	8.0	8.9	6.3	9.5	9.1	6.8	5.4	11.1	7.1	5.8	3.5	8.9	7.7	15.3	12.9	10.3	18.1	19.4	17.7	5.6	13.8	13.8	18.6
ANAPC10	"APC10, DKFZP564L0562, DOC1"	ENSG00000164162	"Anaphase promoting complex subunit 10"	Q9UM13	4	144831908-145098541	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044547	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA044547: AB_2678979"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.55e-2)"	19.0	15.6	16.4	11.9	22.1	14.0	23.4	29.8	24.6	19.3	14.4	16.6	10.6	7.1	19.3	21.3	13.8	17.5	12.5	21.4	17.2	17.6	21.2	21.0	15.8	15.0	18.1	16.2	19.9	14.2	15.1	28.6	19.6	25.9	15.4	16.7	15.9	14.5	15.5	23.8	13.7	11.7	19.4	20.2	14.8	13.1	27.3	20.5	20.4	19.2	13.3	16.7	15.4	15.5	13.5	13.9	18.2	8.4	14.1	15.1	6.7	9.1	5.2	14.0	5.2	13.3	14.3	9.1	11.1	11.8	15.0	10.8	11.6	12.7	14.4	7.3	8.4	10.6	5.7	11.7	15.8	15.3	12.2	9.2	7.7	4.0	9.5	16.9	15.8	9.0	11.8	10.9	12.0	19.1	11.9	12.0	15.9	21.2	18.9	15.0	6.8	27.1	19.0	9.2	11.0	11.7	12.8	11.7	8.3	16.2	6.0	9.5	7.8	8.0	6.5	14.3	13.3	6.1	13.2	9.6	9.4	6.2	9.1	14.9	15.7	17.2	21.8	13.1	20.1	12.6	18.2	6.8	8.6	11.9	8.4	12.0	13.5	12.8	12.2	9.4	10.9	13.0	12.9	2.0	14.1	8.2	13.9	15.1	6.7	16.4	22.1	29.8	24.6	17.2	17.6	18.1	16.2	25.9	20.5	11.9	13.4	18.6	19.9	14.4	8.3	14.1	5.1	22.7	19.4	14.0	0.0	32.6	39.7	20.4	45.0	20.2	7.7	0.0	22.8	30.5	14.3	19.9	25.4	15.3	31.0	4.8	2.9	19.0	11.1	14.9	31.4	20.5	10.1	33.3	12.0	15.4	22.4	12.4	25.5	37.2	8.8	32.3	20.6	111.9	38.5	17.3	24.7	20.8	12.1	22.2
ANAPC13	"APC13, DKFZP566D193, SWM1"	ENSG00000129055	"Anaphase promoting complex subunit 13"	Q9BS18	3	134477706-134486716	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 393.0;Proximal tubular cells: 267.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046114	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA046114: AB_10961429"	"unprognostic (2.84e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (2.98e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (3.57e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.44e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (2.66e-7)"	"unprognostic (3.10e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.16e-1)"	35.5	29.5	29.0	10.8	24.0	9.7	26.2	14.6	26.7	21.3	20.0	14.8	19.6	13.2	18.7	46.5	24.5	19.2	19.3	37.5	25.3	36.3	47.1	54.4	22.1	17.3	33.3	13.3	30.1	36.0	29.6	34.3	34.8	29.2	29.1	18.3	23.4	30.5	22.6	36.8	14.4	25.4	20.7	23.2	19.2	20.1	20.4	12.4	14.1	44.3	22.2	13.4	27.3	16.9	25.5	26.9	69.4	30.5	18.7	30.0	22.8	21.1	13.3	21.0	17.9	35.8	47.6	16.2	27.6	25.5	20.2	19.1	16.6	12.6	14.4	60.0	40.4	24.4	12.5	19.6	19.7	29.2	7.2	9.1	14.7	10.8	27.7	25.8	24.0	10.5	31.6	21.6	20.3	38.1	22.7	31.3	14.1	19.5	12.3	63.7	27.2	12.2	23.6	14.3	36.7	13.0	9.8	16.5	26.2	39.4	13.2	8.6	14.1	24.5	9.0	24.0	23.5	22.5	23.6	21.8	28.2	11.4	39.5	12.1	13.6	14.7	29.8	17.3	13.3	24.0	28.9	28.3	24.2	16.4	30.5	21.3	25.5	24.6	21.4	26.9	18.6	30.0	25.2	69.4	18.7	29.6	20.5	20.5	22.8	29.0	24.0	14.6	26.7	25.3	36.3	33.3	13.3	29.2	12.4	32.8	43.1	47.7	44.5	37.4	40.5	107.7	56.0	49.5	20.5	80.3	11.8	81.7	393.0	47.8	34.9	60.7	30.8	0.0	47.0	87.8	59.7	60.7	17.4	58.7	70.2	19.1	39.2	50.3	63.1	66.9	46.9	40.0	92.8	13.6	36.6	50.4	36.3	39.1	41.4	267.1	26.5	19.4	61.3	39.2	65.8	44.3	58.8	34.5	32.7	45.2
ANAPC15	"APC15, C11orf51, DKFZP564M082, HSPC020"	ENSG00000110200	"Anaphase promoting complex subunit 15"	P60006	11	72106378-72112780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036596	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA036596: AB_10671961"	"unprognostic (1.17e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (9.18e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.08e-2)"	10.7	14.9	29.5	13.8	30.1	40.3	14.0	9.1	32.5	9.9	20.0	13.7	13.2	14.9	15.3	19.9	17.2	13.4	13.3	22.2	23.6	19.8	16.0	16.9	12.2	19.5	25.2	20.6	8.0	16.6	9.4	11.7	12.7	19.3	17.4	20.5	11.6	18.2	20.6	41.5	14.1	14.8	21.8	17.7	14.4	15.1	22.1	12.6	22.5	21.6	23.1	20.9	12.8	9.4	27.0	45.6	39.9	52.7	20.5	44.0	35.5	19.6	29.7	24.4	15.4	7.2	11.8	11.5	21.0	19.3	33.9	22.6	34.7	21.5	26.6	20.5	29.9	16.5	33.5	36.7	39.3	32.1	17.0	17.4	30.2	34.0	22.4	8.6	29.3	28.3	12.3	15.6	19.2	25.8	12.8	22.2	37.5	21.8	18.5	22.0	33.8	56.3	27.3	19.7	41.7	17.2	23.9	60.6	18.0	29.1	13.7	17.3	15.1	21.5	21.2	33.3	13.7	24.8	15.7	20.0	15.6	20.6	30.8	22.1	19.0	18.4	33.9	9.6	23.6	8.7	7.5	52.7	39.9	24.0	33.4	25.4	27.0	30.9	27.9	45.6	19.9	37.1	33.9	21.7	20.5	30.4	36.6	44.0	35.5	29.5	30.1	9.1	32.5	23.6	19.8	25.2	20.6	19.3	12.6	14.9	13.9	33.5	62.0	37.2	30.5	2.8	12.7	40.2	35.2	22.7	25.5	72.2	104.5	44.3	13.8	19.6	61.2	0.0	89.5	62.0	19.8	46.4	30.0	37.8	71.7	12.7	47.5	19.0	44.0	9.1	6.4	47.5	25.3	51.3	52.0	22.6	43.9	54.5	21.5	83.0	32.0	19.4	29.7	92.2	129.0	35.9	39.0	41.5	65.5	51.5
ANAPC4	APC4	ENSG00000053900	"Anaphase promoting complex subunit 4"	Q9UJX5	4	25377213-25418498	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032519, HPA038395, HPA038396"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB032519: AB_2274023, HPA038395: AB_10794632, HPA038396: AB_10795356"	"unprognostic (1.36e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.06e-3)"	"prognostic favorable (5.73e-7)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.18e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.86e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (1.12e-6)"	12.2	15.4	14.5	15.7	14.9	14.7	14.5	16.4	16.4	22.7	13.0	14.8	25.4	10.5	29.2	21.4	13.0	32.3	11.0	10.7	12.6	10.6	12.6	13.0	13.0	16.6	15.8	10.4	18.8	15.3	15.3	22.4	13.7	13.5	15.4	15.5	14.7	13.3	36.5	12.3	13.0	14.4	23.4	16.2	18.2	13.0	9.6	14.2	19.6	13.4	7.3	15.9	18.3	13.4	8.5	6.4	13.8	11.3	9.4	13.8	6.0	12.4	7.3	12.9	13.5	13.7	15.3	18.6	14.9	11.2	14.1	13.7	11.7	20.0	20.5	8.0	12.7	18.1	10.1	13.7	12.6	16.4	7.2	10.6	19.9	13.1	10.9	9.2	15.4	16.3	11.8	9.5	12.5	7.6	10.1	12.2	18.2	28.6	6.2	17.9	9.7	19.8	25.2	18.0	11.0	9.2	14.3	21.8	15.2	11.9	13.6	14.6	8.7	11.1	6.7	9.2	13.9	9.9	16.7	12.4	12.2	7.7	9.3	17.1	8.3	14.4	19.6	13.1	22.1	11.4	1.8	7.4	13.8	10.1	8.7	13.8	8.5	9.1	11.8	6.4	7.0	8.3	10.3	3.0	9.4	11.3	4.1	11.0	6.0	14.5	14.9	16.4	16.4	12.6	10.6	15.8	10.4	13.5	14.2	8.9	12.6	4.2	15.2	11.4	12.1	11.5	12.7	65.6	18.2	7.0	9.8	46.1	5.0	8.6	3.3	9.0	7.4	0.0	10.5	10.3	11.6	5.8	24.3	6.4	15.4	20.6	12.1	14.1	14.5	2.5	9.5	11.0	16.9	11.8	7.7	11.6	7.3	3.5	14.2	4.5	12.9	19.4	9.9	11.4	14.0	8.2	19.9	17.5	11.3	6.5
ANAPC5	APC5	ENSG00000089053	"Anaphase promoting complex subunit 5"	Q9UJX4	12	121308245-121399896	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039457, HPA039801"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039457: AB_10795676, HPA039801: AB_2676687"	"unprognostic (3.41e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.35e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (2.31e-5)"	"unprognostic (1.63e-1)"	"unprognostic (6.91e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.93e-3)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (2.01e-9)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.28e-1)"	28.9	26.9	23.2	24.1	37.3	29.3	31.3	34.1	38.1	28.2	26.3	57.0	21.8	22.3	33.7	28.4	26.0	34.2	20.8	24.8	25.4	21.6	23.6	33.5	22.2	31.6	53.8	25.1	30.0	40.1	27.4	34.1	22.3	34.3	22.9	29.6	24.9	47.3	24.7	48.6	29.2	23.9	26.1	36.5	30.0	27.6	18.2	45.5	36.5	27.5	32.1	37.7	26.3	25.9	30.7	36.4	27.0	32.1	34.9	38.7	42.0	27.7	39.3	17.7	12.6	31.2	34.6	31.2	27.0	30.9	31.5	28.3	31.3	14.4	37.9	27.9	39.3	12.9	23.9	41.0	26.6	25.2	32.6	45.6	34.5	25.6	35.8	34.2	49.9	34.5	34.6	25.4	32.2	25.8	29.2	39.7	33.7	43.5	23.0	25.3	39.9	43.1	49.0	28.0	27.5	43.3	38.4	25.9	48.9	22.9	28.9	22.5	22.6	40.2	16.8	27.4	21.5	40.2	47.8	24.9	21.3	15.3	14.5	22.1	29.7	30.0	44.5	28.0	37.7	26.2	18.6	30.7	27.0	26.6	32.1	32.4	30.7	30.3	32.5	36.4	23.9	30.6	29.0	7.5	34.9	27.3	24.2	38.7	42.0	23.2	37.3	34.1	38.1	25.4	21.6	53.8	25.1	34.3	45.5	38.7	59.2	66.3	57.9	58.3	59.3	43.2	20.4	104.4	66.0	52.4	53.0	76.6	59.7	42.2	18.2	53.7	39.2	70.0	77.0	87.6	63.3	47.3	65.9	57.2	49.3	73.1	81.8	41.7	46.3	27.6	74.2	48.5	45.5	86.6	46.8	37.6	53.3	38.6	59.8	55.9	55.9	51.8	61.8	48.6	79.0	56.7	68.5	76.2	66.1	44.7
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	15.6	20.3	17.8	14.7	25.1	12.2	19.9	24.8	25.1	20.6	16.2	16.8	12.2	11.9	21.4	19.8	34.2	20.9	15.6	18.8	19.1	18.5	21.4	16.8	16.6	20.8	16.2	22.1	18.1	16.7	26.6	14.9	9.6	17.6	21.8	18.9	16.4	19.7	21.3	29.7	16.0	13.3	24.0	17.1	16.8	14.9	36.3	16.3	25.8	23.2	24.5	22.2	19.2	22.5	14.9	17.7	17.6	15.1	20.1	22.4	12.5	18.7	25.9	18.9	16.1	19.9	10.1	10.8	13.2	12.0	24.4	17.0	26.4	12.1	30.0	13.4	17.7	14.1	19.1	28.2	18.1	24.9	16.0	22.7	26.5	19.2	21.8	14.5	23.7	12.6	11.0	13.0	21.1	14.1	17.4	23.6	21.6	41.6	6.2	19.1	20.1	35.8	17.7	16.5	18.4	22.6	27.7	18.8	35.7	16.5	24.1	24.7	14.2	20.6	16.3	21.6	17.5	34.4	21.5	14.8	14.6	13.7	12.9	15.5	10.9	22.1	40.5	16.3	20.3	16.8	14.3	10.5	17.6	17.2	15.1	20.2	13.3	18.5	16.5	17.7	14.9	15.5	16.5	8.3	20.1	13.1	9.7	22.4	12.5	17.8	25.1	24.8	25.1	19.1	18.5	16.2	22.1	17.6	16.3	14.9	13.6	11.2	18.2	9.0	18.1	15.9	12.7	14.7	25.0	12.2	19.6	10.3	10.0	15.4	5.7	13.5	7.4	0.0	13.1	8.1	9.4	15.1	15.1	13.5	19.4	20.6	10.4	11.6	15.9	8.5	17.0	10.3	16.9	9.0	10.2	16.7	13.1	7.0	20.5	11.9	22.2	12.9	11.2	79.8	34.1	11.7	6.1	15.2	14.5	15.5
ANGEL1	"Ccr4e, KIAA0759"	ENSG00000013523	"Angel homolog 1"	Q9UNK9	14	76786178-76826246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 45.0;Late spermatids: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000948	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA000948: AB_2227189"	"unprognostic (4.81e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (9.24e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.32e-2)"	7.2	13.0	14.7	8.1	16.4	4.3	9.0	10.0	16.6	7.2	7.1	17.9	3.3	6.6	11.0	18.8	5.1	9.1	8.0	11.6	15.1	10.8	7.0	11.3	10.5	8.6	22.5	11.7	15.2	35.8	13.1	18.9	7.7	14.5	6.7	8.2	11.7	10.7	6.7	8.1	4.7	6.3	9.2	16.5	18.6	11.5	27.5	14.9	6.1	9.3	4.6	7.8	7.2	5.3	9.0	9.3	1.9	8.3	6.6	10.2	6.7	9.5	10.4	11.6	10.4	9.5	8.7	10.8	5.7	8.3	6.0	7.7	9.9	13.6	17.5	8.5	5.0	8.2	12.1	11.0	10.3	10.1	7.3	9.9	10.5	6.5	7.6	6.2	5.6	6.7	9.2	12.9	5.6	11.1	8.6	15.1	18.7	10.4	4.6	6.2	18.6	10.1	8.5	13.3	15.3	13.9	12.3	7.9	10.3	9.1	13.6	16.5	7.3	8.7	12.0	5.4	11.0	23.5	5.9	7.2	7.0	6.2	5.2	4.7	12.0	9.0	10.8	6.0	9.9	8.7	0.7	5.9	1.9	7.9	6.7	9.6	9.0	7.1	7.4	9.3	7.7	10.2	7.5	1.8	6.6	8.3	6.2	5.7	6.7	14.7	16.4	10.0	15.0	15.1	10.8	22.5	11.7	14.5	14.9	6.0	10.9	4.5	1.4	1.0	2.2	6.1	10.2	0.0	2.3	3.5	9.8	1.3	0.0	2.9	45.0	5.8	1.3	0.0	2.8	2.3	1.9	2.3	1.1	8.1	6.4	0.0	4.1	6.2	4.7	52.1	2.0	4.3	1.7	0.0	4.1	4.3	2.5	0.0	4.6	1.0	8.0	6.5	1.4	17.4	3.2	0.4	1.0	2.5	3.7	1.0
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015826	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		NA	NA			Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavorable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.20e-4)"	11.4	11.7	18.0	10.8	32.6	9.5	17.8	21.6	22.7	14.5	9.3	16.9	8.6	8.6	14.8	14.2	10.2	12.2	10.4	9.2	17.4	13.8	13.3	13.0	11.0	15.8	17.0	13.9	19.1	10.5	15.5	14.8	10.8	13.8	14.5	11.0	12.3	9.8	11.2	11.0	15.1	10.7	12.2	14.9	15.5	10.5	9.0	15.9	19.5	14.0	7.9	14.9	10.8	9.7	7.8	7.2	7.6	5.9	14.1	11.3	6.7	8.7	7.0	11.4	9.7	8.7	12.9	10.2	7.2	12.0	11.5	11.5	4.7	6.5	8.5	6.6	7.1	6.4	6.9	13.1	6.9	11.7	15.9	7.9	8.5	5.6	4.6	9.6	8.4	10.2	7.9	8.9	9.0	9.3	9.8	9.7	7.7	9.8	8.8	13.2	2.9	9.6	5.7	26.9	4.8	5.1	4.9	20.5	8.9	9.0	5.9	5.6	16.3	8.6	11.7	13.3	12.7	9.0	6.2	7.2	9.5	5.1	11.7	10.9	6.5	6.2	5.7	10.7	6.3	8.7	7.4	5.9	7.6	7.4	5.5	9.1	7.8	9.2	7.6	7.2	5.3	9.8	8.1	4.0	14.1	4.4	4.4	11.3	6.7	18.0	32.6	21.6	22.7	17.4	13.8	17.0	13.9	13.8	15.9	44.7	9.8	14.6	7.5	6.2	21.3	12.6	17.8	28.1	15.9	12.2	9.8	12.8	10.0	8.7	1.2	11.3	6.7	0.0	9.2	12.6	10.6	8.8	16.2	11.5	10.5	27.0	6.4	11.6	19.2	1.5	14.4	11.3	3.3	10.8	9.2	13.4	8.4	7.0	13.1	13.5	17.6	19.4	9.0	7.4	16.2	6.0	9.2	18.1	8.8	6.2
ANGPTL2	"ARP2, HARP"	ENSG00000136859	"Angiopoietin like 2"	Q9UKU9	9	127087332-127122883	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 66.4;Leydig cells: 19.2;Smooth muscle cells: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.4;ASC TERT1: 28.2;BJ hTERT+: 58.2;HSkMC: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040933, HPA041299"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	2510000	770000	"Golgi apparatus"		"HPA040933: AB_10795530, HPA041299: AB_10794552"	"unprognostic (5.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.07e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.15e-2)"	56.6	4.9	3.3	13.5	4.7	0.0	29.0	8.2	16.5	34.9	26.8	19.5	4.4	6.2	29.9	19.8	12.6	13.1	34.9	28.4	4.6	3.4	4.3	6.1	8.3	3.8	9.3	2.9	38.4	2.2	1.6	1.5	8.7	9.6	22.9	7.8	3.4	7.1	12.1	41.9	11.4	10.0	37.4	6.3	26.6	12.7	8.7	8.5	1.7	6.4	27.0	6.4	38.7	20.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.9	0.0	41.4	28.2	2.5	2.1	58.2	2.6	2.4	0.0	0.0	0.0	1.9	5.8	0.5	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.1	8.9	0.0	0.0	28.4	0.0	5.3	0.0	8.3	7.5	0.6	0.0	0.0	1.8	0.0	0.0	1.1	5.2	0.0	0.2	4.3	7.6	0.4	0.6	0.0	2.5	2.8	0.0	0.0	0.0	1.0	0.0	0.0	2.3	9.6	1.2	13.6	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.7	8.2	9.0	4.6	3.4	9.3	2.9	9.6	8.5	8.9	3.7	0.0	6.6	12.7	14.5	12.9	0.0	2.7	0.0	0.0	2.0	0.8	0.0	0.2	0.7	11.7	0.0	0.0	0.0	0.7	66.4	1.3	0.0	0.0	1.2	0.0	0.0	2.5	0.0	1.3	19.2	0.3	6.8	0.0	0.0	1.6	1.0	0.0	6.0	1.4	0.3	0.0	25.2	0.2	0.0	9.7	2.2	0.0	0.0	0.6
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374373	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 55.5;liver: 68.4;pancreas: 51.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 145.0;Pancreatic endocrine cells: 173.2;Peritubular cells: 123.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 5.8;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.4;HBEC3-KT: 65.4;LHCN-M2: 17.7;TIME: 33.0;U-138 MG: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	7750000	1500000	"Nucleoplasm, Vesicles"		"CAB033770: AB_2057427, HPA007879: AB_1078158"	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	55.5	9.6	23.3	13.5	24.7	2.3	33.0	5.1	37.6	3.3	11.8	9.2	0.3	10.6	5.9	1.5	11.8	3.2	8.8	11.4	17.1	5.5	9.4	68.4	9.0	2.7	21.4	3.1	2.9	51.7	2.3	3.3	21.4	36.8	6.7	2.1	2.5	3.9	3.7	5.9	6.5	23.5	6.0	20.6	2.5	4.4	3.7	27.7	0.0	7.1	2.5	3.5	10.7	6.0	0.5	0.3	5.8	0.4	0.8	0.6	0.2	0.0	0.6	0.3	0.9	16.4	3.6	0.1	1.2	0.1	0.2	0.0	0.0	6.0	0.0	9.0	2.5	1.3	0.8	0.0	65.4	0.1	0.5	0.1	0.1	0.2	0.1	0.3	0.0	0.0	1.7	0.2	10.0	0.2	1.8	5.0	0.1	0.3	0.2	17.7	0.5	0.0	0.5	0.1	0.0	0.5	0.3	0.0	0.2	3.2	1.2	0.0	0.1	7.5	0.8	1.1	0.4	1.9	0.1	33.0	19.4	0.1	9.8	0.0	0.0	0.0	0.0	13.3	0.0	3.6	5.8	0.4	0.9	0.4	0.2	0.3	0.5	0.5	0.4	0.2	0.4	0.3	0.3	2.3	0.8	0.2	0.3	0.6	0.2	23.3	24.7	5.1	37.6	17.1	5.5	21.4	3.1	36.8	27.7	35.7	4.3	0.5	32.6	12.5	0.1	3.6	2.5	4.0	10.3	14.0	0.0	5.4	0.0	91.5	0.5	17.6	26.4	0.0	15.3	96.9	44.0	38.8	2.3	145.0	7.4	0.0	0.0	20.9	1.6	0.4	81.4	6.1	8.5	3.6	8.6	4.1	173.2	7.0	123.8	3.7	0.0	32.3	98.2	0.0	0.9	10.0	33.5	1.9	1.7	72.4
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 81.0"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 96.9"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"Hep G2: 26.8;MCF7: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	320000	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	8.0	0.1	0.0	0.6	0.0	0.0	5.1	0.0	0.1	0.1	5.7	0.0	0.0	0.2	0.1	0.8	0.1	0.1	1.0	0.6	0.0	0.0	1.5	81.0	0.1	3.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.8	0.1	0.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.7	26.8	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	15.5	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.7	0.0	0.2	0.0	0.2	0.3	0.7	0.0	0.3	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	96.9	0.1	0.0	0.0	6.7	5.9	1.3	0.9	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ANKAR	FLJ25415	ENSG00000151687	"Ankyrin and armadillo repeat containing"	Q7Z5J8	2	189674290-189761193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 2.3;testis: 9.0"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 63.4;Late spermatids: 36.4;Rod photoreceptor cells: 48.1"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"TIME: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036168	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Centriolar satellite"	Nucleoplasm	"HPA036168: AB_10673345"	"unprognostic (2.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	0.2	0.4	0.2	0.0	0.2	0.0	0.4	0.2	0.2	0.2	0.2			0.0	0.3	0.7	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.4	0.2	0.5	0.2		0.2	0.2	1.2	0.3	0.1		0.5	0.3		0.4	0.0	0.2	0.2	0.3	0.0	0.2	0.2	0.6	9.0			0.6		0.1	0.2	0.2	2.3	0.3	0.5	0.4	0.0	0.6	0.1	0.6	0.5	0.4	0.5	0.4	1.1	0.0	0.0	0.7	0.2	0.5	0.9	1.1	0.3	0.3	1.0	0.1	0.8	0.7	0.0	0.3	1.0	0.6	0.6	0.5	1.3	0.0	1.8	0.2	1.3	0.2	0.3	1.4	0.2	0.0	0.0	0.1	0.9	0.3	0.4	0.0	0.5	0.0	0.8	0.7	0.3	0.4	0.0	0.6	2.3	0.0	0.0	0.5	0.3	0.8	0.1	2.4	1.8	2.7	0.8	1.1	0.0	0.0	1.1	0.4	0.1	0.5	0.1	0.2	0.0	0.0	0.5	0.6	0.4	0.1	0.6	0.3	0.1	0.1	2.3	0.2	0.5	0.0	0.0	0.3	0.3	0.0	0.1											3.0	5.1	0.5	5.6	1.1	12.0	4.1	2.5	1.4	3.4	10.4	13.7	1.2	1.7	3.0	63.4	6.8	3.4	0.0	3.7	0.9	4.6	3.6	0.0	2.1	2.1	3.2	0.0	3.7	1.3	36.4	20.1	4.0	6.8	1.0	4.5	8.9	3.5	5.5	13.1	2.1	48.1	6.5	3.3	11.1	4.7	1.1	0.1	4.4	3.8	3.5
ANKDD1A	FLJ25870	ENSG00000166839	"Ankyrin repeat and death domain containing 1A"	Q495B1	15	64911902-64958700	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Leydig cells: 57.2;Muller glia cells: 36.1;Peritubular cells: 73.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.2;RT4: 14.4;U-266/84: 18.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 29.1"	HPA040757	Approved		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA040757: AB_10960566"	"unprognostic (3.72e-4)"	"unprognostic (1.86e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.78e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.11e-3)"	"unprognostic (5.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.64e-2)"	3.9	12.4	7.9	3.7	9.5	3.2	2.3	7.9	9.4	4.3	2.2	0.6	3.5	1.9	4.7	7.6	5.1	5.9	3.9	3.6	8.3	3.9	2.0	1.3	4.4	6.3	4.2	9.8	5.8	7.6	3.5	4.4	5.4	3.5	3.3	0.5	2.4	3.3	4.2	1.5	4.9	2.4	6.5	3.0	14.2	2.6	8.6	1.1	0.0	3.8	0.9	1.6	5.1	4.0	1.0	1.5	1.4	1.9	6.8	4.0	0.8	1.0	2.9	1.4	1.3	2.2	1.7	5.7	1.3	3.5	1.4	2.0	1.6	1.4	1.3	1.5	2.9	1.2	1.4	2.9	0.2	1.1	0.7	0.8	1.4	3.0	1.1	1.6	1.1	2.3	1.3	0.4	0.9	0.5	0.8	1.0	1.3	0.2	19.2	0.4	2.7	0.5	2.1	1.7	0.5	1.3	0.8	0.8	9.1	0.1	14.4	2.9	3.5	0.7	1.0	1.3	1.3	1.1	1.1	1.4	2.6	2.7	2.3	1.3	5.3	18.6	1.0	2.9	2.6	0.8	1.0	0.9	0.1	2.1	1.9	0.8	1.0	1.1	3.2	1.5	0.7	0.8	0.8	1.4	6.8	1.8	0.0	4.0	0.8	7.9	9.5	7.9	9.4	8.3	3.9	4.2	9.8	3.5	1.1	0.0	2.2	0.0	4.9	4.9	9.4	1.2	0.0	0.0	1.2	0.0	11.8	2.7	0.0	0.7	0.8	8.0	0.0	0.0	1.9	4.6	7.0	2.2	5.7	0.0	4.9	3.2	1.2	1.3	5.4	0.9	57.2	7.9	10.1	0.0	0.0	36.1	4.2	0.0	73.9	0.0	6.6	12.9	13.9	1.4	1.1	3.1	1.8	4.1	0.0	4.1
ANKEF1	"ANKRD5, dJ839B4.6, FLJ21669"	ENSG00000132623	"Ankyrin repeat and EF-hand domain containing 1"	Q9NU02	20	9986126-10058303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.0;testis: 22.7"	"Group enriched"	"Detected in many"	13	"Early spermatids: 319.3;Late spermatids: 291.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 17.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA041151	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Nucleoli fibrillar center, Plasma membrane, Cytosol"		"HPA041151: AB_10796569"	"unprognostic (4.72e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.38e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.73e-2)"	"prognostic favorable (4.44e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (3.11e-1)"	5.6	2.9	1.4	2.3	2.4	0.5	3.7	5.7	2.0	2.7	3.1	0.8	11.3	2.9	1.9	4.2	4.7	4.9	4.0	3.2	2.3	2.5	5.7	6.7	2.3	1.3	1.5	1.1	3.6	25.0	5.3	13.6	1.7	4.1	3.4	3.0	3.0	4.2	13.0	1.7	2.9	3.6	1.0	1.2	1.8	5.1	22.7	1.0	3.2	8.6	2.5	3.9	2.1	2.6	2.5	1.6	0.7	0.1	1.5	5.4	1.3	10.0	10.3	1.4	2.5	2.1	1.2	5.9	1.9	0.1	1.8	0.9	5.9	9.1	0.0	3.1	0.4	10.8	8.7	1.8	12.0	2.2	0.0	1.6	1.3	2.0	5.5	1.4	1.1	0.2	3.7	8.6	1.5	1.7	4.2	1.5	3.9	3.8	8.9	0.4	3.1	1.6	0.0	4.3	12.0	2.4	0.0	0.0	6.8	4.4	6.5	7.7	3.9	4.6	10.2	0.0	3.6	8.9	0.9	1.1	1.3	1.4	0.1	1.9	9.2	17.8	1.5	2.6	0.3	1.7	0.0	0.0	0.0	2.8	0.1	5.4	2.5	3.3	2.6	0.2	2.3	4.1	3.0	0.7	1.5	0.0	1.6	3.8	1.3	1.4	2.4	5.7	2.0	2.3	2.5	1.5	1.1	4.1	1.0	3.0	4.1	0.0	2.1	0.2	1.2	1.5	0.0	24.1	2.3	7.0	0.0	1.9	1.7	4.0	319.3	0.7	2.2	0.0	5.4	1.5	0.2	1.6	1.1	7.8	1.1	3.2	5.1	0.0	0.3	291.0	3.1	1.4	0.0	0.0	4.6	1.0	5.4	4.5	3.9	2.1	4.8	0.0	0.1	5.0	2.4	0.3	1.3	1.3	3.4	1.3
ANKFN1	FLJ38335	ENSG00000153930	"Ankyrin repeat and fibronectin type III domain containing 1"	Q8N957	17	55882301-56511659	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 34.8;Early spermatids: 13.6;Late spermatids: 7.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 8.1;MOLT-4: 16.8;T-47d: 5.8;U-2197: 5.6"					"Low region specificity"	"Detected in many"			"HPA021566, HPA022538, HPA048953"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: "	"unprognostic (6.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.38e-5)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.44e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-2)"	3.9	1.0	5.5	0.5	10.2	0.5	1.2	2.6	4.7	19.9	0.7	11.4	0.5	0.7	0.8	3.4	0.7	10.9	0.9	0.5	6.8	4.6	0.7	0.6	2.0	0.6	6.3	3.7	0.5	0.5	0.5	1.0	2.1	11.8	0.9	0.8	0.0	0.7	0.8	0.6	5.2	0.8	0.5	7.5	0.6	1.1	3.6	10.0	0.0	0.6	0.0	0.5	3.2	5.3	0.2	0.5	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.3	0.2	0.3	0.0	2.9	0.2	0.3	0.0	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.1	0.4	16.8	0.0	0.0	0.9	0.7	0.1	0.0	0.1	0.0	0.1	1.5	0.0	1.7	0.0	0.3	0.1	5.8	0.0	0.0	0.0	0.4	5.6	0.1	1.5	0.3	0.0	0.8	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.3	0.1	0.5	0.0	0.0	5.5	10.2	2.6	4.7	6.8	4.6	6.3	3.7	11.8	10.0	0.0	0.6	0.0	0.1	0.5	0.0	0.6	0.0	34.8	0.0	0.0	0.0	0.3	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.6	0.0	1.7	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	6.5	0.3	5.9	2.1	0.4	2.4	0.0	0.0	0.9
ANKH	"ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1"	ENSG00000154122	"ANKH inorganic pyrophosphate transport regulator"	Q9HCJ1	5	14704800-14871785	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Phosphate transport, Transport"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 119.8;Hofbauer cells: 162.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068104			Approved	Cytosol		NA	NA			Cytosol		"HPA068104: AB_2685954"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.76e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.46e-2)"	8.5	9.7	15.2	8.0	17.0	5.9	9.2	29.1	25.9	4.4	10.9	19.5	3.4	14.4	6.5	4.7	6.8	7.2	8.4	27.0	15.9	14.9	7.4	18.1	6.3	9.6	19.7	17.1	14.9	13.1	19.6	19.2	7.3	15.4	29.5	10.3	16.1	11.7	8.6	31.0	17.4	14.9	7.6	22.6	6.3	6.5	2.0	15.3	9.3	9.5	12.7	11.8	6.4	6.3	2.5	0.6	0.7	1.4	0.6	7.0	0.7	3.8	2.9	3.8	0.6	7.9	18.8	1.8	3.8	7.6	1.5	1.5	2.3	5.0	9.1	8.9	5.1	3.5	2.5	2.5	4.1	1.7	3.6	6.3	0.2	27.6	6.2	2.6	2.2	0.7	5.9	7.3	4.5	5.2	5.2	3.0	6.8	1.9	19.7	4.8	5.2	3.7	7.1	1.5	5.1	3.3	5.3	1.8	8.2	0.0	1.3	9.3	2.5	18.3	3.0	4.0	3.6	0.1	0.8	3.0	3.9	4.0	6.4	6.8	5.2	4.8	7.1	13.5	8.2	16.1	0.7	0.4	0.1	2.4	0.7	4.0	2.5	5.0	3.9	0.6	2.1	5.7	2.6	0.5	0.6	1.4	0.6	7.0	0.7	15.2	17.0	29.1	25.9	15.9	14.9	19.7	17.1	15.4	15.3	23.8	15.5	11.5	72.4	22.3	53.3	63.0	2.5	9.4	14.8	7.0	119.8	58.3	5.0	1.7	1.1	23.5	47.0	93.5	10.3	3.1	22.5	50.7	17.3	31.4	162.5	19.1	40.1	9.8	59.0	1.4	4.6	30.3	10.1	0.0	31.7	18.8	6.8	28.1	29.7	9.8	47.3	0.0	13.9	2.6	5.9	9.4	35.1	19.1	30.4	13.2
ANKLE2	"KIAA0692, Lem4, LEMD7"	ENSG00000176915	"Ankyrin repeat and LEM domain containing 2"	Q86XL3	12	132725503-132761888	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 154.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003602, HPA074838"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Endoplasmic reticulum, Plasma membrane"		"HPA003602: AB_1858349, HPA074838: "	"unprognostic (4.43e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.97e-6)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.90e-8)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.92e-3)"	"unprognostic (2.09e-1)"	20.1	26.4	14.9	21.3	17.6	27.2	21.8	23.3	20.4	15.6	15.4	19.6	15.1	14.6	18.9	16.8	23.7	18.6	17.0	16.5	12.4	10.7	16.3	16.3	21.6	24.1	16.0	11.3	20.7	18.1	17.2	22.3	18.3	15.2	17.2	13.9	16.7	19.1	15.7	19.9	27.3	22.8	18.5	13.4	27.4	16.8	43.7	14.1	31.4	17.4	15.8	27.9	16.4	28.6	4.8	3.3	7.7	2.2	4.7	5.5	1.4	19.7	18.5	19.4	12.0	11.3	17.8	24.3	24.2	18.1	24.3	18.7	21.1	13.6	15.6	12.7	21.2	16.3	23.9	16.9	22.1	23.3	6.6	21.0	19.8	31.1	9.9	12.6	21.2	14.0	16.5	22.6	23.1	17.2	45.1	17.3	12.9	17.8	6.1	24.8	14.2	19.8	35.2	16.4	9.8	17.8	22.8	12.7	6.5	17.5	25.9	23.9	14.7	31.2	13.2	10.6	19.0	23.2	15.4	24.7	29.3	21.1	15.5	26.9	11.5	11.3	19.1	22.7	14.2	16.4	1.4	2.2	7.7	3.6	2.1	4.8	4.8	5.3	5.5	3.3	4.3	5.0	4.1	1.3	4.7	2.2	3.2	4.7	1.4	14.9	17.6	23.3	20.4	12.4	10.7	16.0	11.3	15.2	14.1	68.5	24.5	25.4	82.7	59.8	30.8	22.9	28.1	20.1	55.7	29.6	43.2	25.0	1.7	29.1	63.9	32.7	20.2	0.0	28.1	29.6	26.8	92.4	18.4	12.1	17.7	30.2	20.0	19.0	15.1	14.0	23.3	33.1	32.1	42.3	16.9	24.7	66.6	20.9	26.5	6.4	38.7	25.8	34.8	131.6	52.4	63.7	30.6	37.3	18.6	154.8
ANKMY1	"FLJ20499, ZMYND13"	ENSG00000144504	"Ankyrin repeat and MYND domain containing 1"	Q9P2S6	2	240479422-240569209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 147.5;Late spermatids: 162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA026620, HPA048869"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026620: AB_1844834, HPA048869: "	"unprognostic (2.89e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.46e-1)"	"unprognostic (3.97e-5)"	"unprognostic (8.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.59e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.20e-4)"	4.5	4.3	5.2	9.0	7.9	9.8	5.8	6.4	7.3	7.2	5.7	10.3	10.8	5.8	6.6	9.0	5.3	21.8	9.2	3.6	6.1	4.3	5.1	5.1	6.3	7.2	8.7	4.8	7.3	8.0	6.6	5.4	6.4	6.4	5.8	5.1	5.1	6.9	13.6	5.0	7.2	6.2	5.8	6.3	7.3	8.4	45.0	6.7	6.0	6.0	3.4	10.7	5.8	6.0	7.4	4.2	6.9	3.4	2.0	7.5	3.4	5.3	11.7	2.5	4.7	2.3	3.3	10.6	2.5	3.9	2.1	2.9	3.7	11.0	5.3	0.5	2.8	3.2	5.8	4.9	6.0	2.5	9.8	4.0	10.5	5.7	9.8	1.9	5.8	10.1	5.3	14.7	2.0	14.1	6.5	2.2	8.5	9.7	6.8	3.6	5.1	5.3	9.6	2.1	9.2	7.0	15.2	7.7	8.4	3.3	11.5	6.0	4.4	2.1	5.6	7.8	3.2	4.8	9.0	2.7	8.0	2.7	3.1	4.4	15.8	3.9	5.1	4.5	8.9	6.1	0.1	3.3	6.9	7.5	2.6	4.3	4.7	4.8	4.7	4.2	7.4	7.1	5.1	1.3	2.0	3.4	2.8	1.5	3.4	5.2	7.9	6.4	7.3	6.1	4.3	8.7	4.8	6.4	6.7	0.0	7.2	2.7	1.6	0.8	3.4	1.8	2.5	30.8	10.3	3.5	3.9	2.8	1.7	2.2	147.5	2.8	4.3	0.0	3.7	1.6	1.5	2.0	5.7	5.5	2.5	3.2	4.1	3.1	7.0	162.8	3.7	4.0	0.0	4.6	4.6	1.9	2.5	0.0	2.8	2.6	3.5	0.0	1.3	14.7	8.8	1.9	2.4	4.4	4.9	1.4
ANKMY2	"DKFZP564O043, ZMYND20"	ENSG00000106524	"Ankyrin repeat and MYND domain containing 2"	Q8IV38	7	16599776-16645817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067100			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA067100: AB_2685777"	"unprognostic (3.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (5.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.85e-2)"	9.6	10.3	14.5	6.6	30.1	10.0	11.8	14.6	28.7	12.4	13.6	9.0	13.3	12.2	10.8	10.4	9.4	13.1	11.1	30.2	18.5	12.7	13.3	8.9	9.4	6.7	12.7	21.2	21.5	9.6	13.2	14.9	7.3	20.4	11.3	14.1	11.8	11.4	16.3	17.3	8.5	13.5	14.4	11.9	8.8	19.1	8.0	7.8	8.9	17.7	7.5	7.1	14.6	11.6	6.7	4.9	18.5	8.9	10.6	10.2	5.2	10.5	9.0	12.3	12.2	11.7	12.3	6.6	12.9	15.8	10.0	15.4	15.0	16.2	2.1	15.1	13.5	20.9	11.1	8.3	4.9	15.0	4.7	5.7	19.1	10.8	6.7	7.6	14.2	7.4	10.6	2.6	10.0	10.1	13.9	9.0	13.0	19.6	3.5	14.1	2.8	6.0	9.9	8.2	32.7	10.7	9.9	11.1	5.1	15.5	9.2	7.8	4.7	8.7	6.4	5.2	12.0	7.6	12.8	5.5	7.7	6.9	17.2	8.8	12.9	9.4	3.3	11.9	11.7	12.3	18.5	3.2	14.3	10.0	4.3	9.6	6.7	8.2	10.2	4.9	6.7	6.9	8.2	2.7	10.6	8.9	4.7	8.3	5.2	14.5	30.1	14.6	28.7	18.5	12.7	12.7	21.2	20.4	7.8	3.0	10.8	3.7	9.1	4.1	13.2	33.4	12.7	40.2	19.4	10.4	5.9	11.7	18.3	5.8	18.4	5.8	14.9	0.0	8.0	9.4	11.8	5.1	5.8	5.0	8.0	7.9	18.5	3.7	4.8	26.3	11.8	5.0	13.5	7.2	14.1	16.0	4.9	10.5	12.7	9.7	18.2	25.8	14.6	3.7	4.1	3.6	14.2	6.2	15.0	5.4
ANKRA2		ENSG00000164331	"Ankyrin repeat family A member 2"	Q9H9E1	5	73552335-73565686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003968, HPA065263"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003968: , HPA065263: AB_2685449"	"unprognostic (1.75e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.13e-3)"	13.0	19.4	11.9	9.2	17.1	18.7	20.9	22.8	18.3	15.7	13.5	16.6	13.1	15.0	20.0	21.0	13.3	18.5	15.0	12.2	18.1	15.8	9.6	15.9	20.7	13.9	20.6	12.3	23.3	19.7	11.4	30.2	15.4	23.1	19.8	16.4	17.5	19.0	14.3	14.5	13.4	15.3	17.8	30.7	13.0	16.2	10.3	15.8	18.1	22.2	4.5	14.7	14.9	13.3	10.7	5.9	16.9	7.4	7.0	15.5	7.3	5.1	3.9	5.8	6.1	10.6	16.2	17.7	7.1	10.6	6.2	9.3	1.2	8.0	4.8	5.7	7.0	7.0	3.7	2.7	12.6	8.9	10.1	4.8	4.2	3.0	5.5	8.3	2.5	8.3	16.7	17.1	7.4	7.7	11.6	6.9	6.4	4.1	8.1	7.1	3.1	4.3	6.5	3.1	1.9	2.9	2.6	6.2	6.6	4.8	6.4	7.8	6.1	5.4	4.3	8.4	9.3	6.5	4.2	8.6	2.5	3.0	4.0	5.1	16.0	11.5	4.1	6.2	4.1	7.2	16.9	5.7	11.3	8.7	4.6	10.5	10.7	10.2	12.1	4.9	8.4	15.5	14.2	9.0	7.0	7.4	5.9	11.7	7.3	11.9	17.1	22.8	18.3	18.1	15.8	20.6	12.3	23.1	15.8	3.0	8.6	26.7	25.9	14.1	25.6	7.7	35.7	16.0	12.5	17.4	9.8	22.6	23.2	10.6	0.9	12.1	16.1	23.3	14.6	18.8	13.1	25.9	18.5	19.5	9.2	22.3	23.2	16.0	16.2	1.7	30.2	11.1	11.8	12.6	19.4	15.6	14.7	18.4	27.3	14.0	21.5	25.8	14.4	23.0	15.1	10.8	40.8	18.1	16.2	31.3
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921276	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	81	"heart muscle: 398.9;skeletal muscle: 333.3"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 12578.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 104.9;hTERT-RPE1: 57.1;LHCN-M2: 128.8;SuSa: 41.0;TIME: 179.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoli fibrillar center"	Nucleoplasm	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	1.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.1	1.5	0.1	0.1	398.9	0.0	0.0	0.1	0.1	4.5	0.2	0.0	0.0	0.1	0.4	0.1	0.1	0.7	0.1	0.9	0.1	0.0	0.8	0.1	333.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	2.9	1.6	0.5	0.3	0.0	0.4	0.5	1.9	0.6	0.9	0.4	0.2	2.9	0.8	0.5	0.0	0.4	0.5	0.0	1.7	0.1	0.5	0.9	38.0	1.4	0.0	104.9	0.1	4.0	1.0	0.1	0.2	1.3	0.1	0.1	0.0	0.2	11.7	2.3	0.0	0.0	3.7	0.0	0.7	1.8	57.1	35.8	0.0	0.0	0.0	128.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	8.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	41.0	0.0	0.1	179.4	0.3	13.8	0.2	14.1	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.2	0.4	0.4	0.3	0.7	0.9	0.6	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	848.6	37.7	0.0	1.3	0.0	0.0	12578.5	10.2	1.4	9.1	0.0	0.0	0.1	0.0	19.0	2.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	3.5	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1
ANKRD10	FLJ20093	ENSG00000088448	"Ankyrin repeat domain 10"	Q9NXR5	13	110878540-110915069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034211, HPA038878, HPA038879"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			Microtubules	Cytosol	"CAB034211: AB_2058024, HPA038878: AB_2676252, HPA038879: AB_2676253"	"unprognostic (3.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.97e-3)"	"unprognostic (9.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.25e-6)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.41e-6)"	35.1	23.1	19.1	36.8	21.5	44.3	49.7	26.2	19.3	34.9	31.9	33.1	30.6	25.4	44.2	55.6	20.1	28.8	31.7	25.3	18.0	18.3	32.5	27.9	30.8	33.3	28.5	13.9	37.3	34.1	18.8	36.2	41.9	21.9	38.1	30.5	37.4	27.3	29.4	79.3	28.4	30.5	33.1	27.3	48.9	25.9	18.2	23.4	35.4	30.4	27.8	33.4	33.1	45.1	30.8	21.2	20.5	16.6	18.6	24.5	15.8	12.4	10.5	24.2	20.2	18.6	18.1	10.8	8.5	17.9	8.5	10.6	10.9	24.6	17.3	18.7	6.4	13.9	29.0	10.4	8.0	11.6	41.3	15.5	20.6	23.5	22.5	7.4	29.6	18.0	17.1	12.2	6.0	8.9	18.0	11.5	17.4	9.0	11.9	23.0	3.7	17.0	33.1	13.4	27.7	6.5	26.4	8.9	17.1	23.4	13.9	19.4	14.5	6.4	11.4	13.4	19.0	8.2	37.9	9.9	10.1	8.4	4.9	8.6	14.9	15.8	10.0	19.0	14.6	15.8	20.5	16.6	13.7	21.0	13.1	17.7	28.0	19.8	17.0	21.2	30.8	21.4	22.9	10.3	18.6	13.1	19.8	24.5	15.8	19.1	21.5	26.2	19.3	18.0	18.3	28.5	13.9	21.9	23.4	14.9	53.7	35.3	31.3	83.8	31.7	31.1	43.3	44.2	54.6	36.6	51.1	34.9	16.6	42.2	5.8	78.9	36.0	0.0	43.4	36.8	86.9	44.8	29.0	39.9	42.8	30.2	40.3	47.9	43.7	3.7	36.2	54.3	69.2	50.5	51.0	27.7	35.6	37.4	48.4	35.6	49.5	51.8	92.6	24.4	19.8	68.0	32.5	44.7	52.3	36.6
ANKRD12	"FLJ20053, GAC-1, KIAA0874"	ENSG00000101745	"Ankyrin repeat domain 12"	Q6UB98	18	9136228-9285985	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040705	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040705: AB_10673301"	"unprognostic (2.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.03e-2)"	17.0	10.9	22.2	23.1	26.1	19.6	15.4	48.1	25.4	17.8	18.8	10.1	18.2	13.7	14.6	15.4	16.1	12.1	16.1	12.3	19.9	13.5	14.7	16.5	14.6	22.1	20.2	18.3	16.3	16.7	15.5	16.4	19.2	17.4	15.9	13.6	9.5	15.7	20.6	25.8	21.8	18.1	17.2	21.3	20.3	15.3	29.3	23.8	11.4	18.2	13.0	19.5	24.2	22.6	18.7	19.2	51.2	10.7	8.8	19.0	5.2	4.2	2.9	4.0	2.6	6.4	6.6	3.2	6.6	6.2	2.4	3.3	2.6	3.3	5.9	3.9	4.5	7.3	3.9	2.9	2.6	6.5	6.2	3.6	2.7	2.1	3.8	4.7	6.3	8.7	3.4	5.8	3.4	5.5	5.4	4.0	3.5	6.1	46.8	5.8	2.4	4.2	4.3	1.5	10.5	3.0	3.8	5.6	21.5	3.1	6.8	9.3	3.4	6.5	3.2	4.7	3.7	4.0	5.3	8.6	17.7	8.2	14.1	6.1	13.7	21.1	11.0	8.7	3.4	6.6	27.4	8.7	25.5	14.5	7.7	16.1	18.7	18.7	13.9	5.9	17.3	19.0	14.8	51.2	8.8	10.7	19.2	13.0	5.2	22.2	26.1	48.1	25.4	19.9	13.5	20.2	18.3	17.4	23.8	259.1	252.1	212.5	167.3	96.2	295.2	122.2	76.5	112.4	180.9	64.6	492.8	36.1	16.6	83.3	150.6	136.7	122.5	70.0	72.2	31.7	114.1	175.8	178.3	57.2	58.3	270.1	88.9	119.7	80.5	178.4	124.8	126.0	86.0	167.7	80.4	131.0	84.0	75.9	133.0	29.3	294.9	109.9	138.1	215.6	153.7	83.9	65.3	191.8	63.5	140.5
ANKRD13D		ENSG00000172932	"Ankyrin repeat domain 13D"	Q6ZTN6	11	67288547-67302485	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039950	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA039950: AB_10796337"	"unprognostic (1.10e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (5.73e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.74e-2)"	9.1	9.1	18.2	18.1	17.6	80.8	18.9	20.2	18.7	9.0	7.6	7.7	13.7	8.0	9.0	10.4	14.6	10.2	11.9	8.8	20.2	14.0	8.3	4.5	12.4	20.8	12.4	11.4	9.4	7.7	6.0	17.0	9.2	10.7	12.7	4.5	10.9	17.5	12.0	4.2	28.1	8.6	9.9	9.6	24.1	8.9	6.8	12.0	9.6	6.4	6.2	14.4	14.3	13.4	2.6	8.1	11.4	4.6	3.8	6.7	1.9	6.3	4.5	3.4	8.1	5.2	5.1	6.4	3.9	3.8	4.6	2.9	5.3	7.0	6.9	6.6	4.4	6.2	10.6	2.5	5.0	0.7	9.7	3.0	5.8	6.8	3.0	8.1	6.4	23.5	5.5	7.9	4.1	5.3	6.9	4.3	7.0	4.1	8.4	4.0	10.3	8.6	49.8	3.9	9.8	5.7	21.6	3.7	4.8	6.5	8.7	4.0	6.8	3.4	10.2	27.2	2.7	10.5	18.3	5.5	7.3	4.7	7.4	5.1	8.5	6.1	4.1	9.6	18.0	4.7	7.2	3.3	11.4	6.7	4.6	4.4	2.6	3.8	5.4	1.9	2.4	2.4	5.8	10.8	3.8	3.8	8.1	2.8	1.9	18.2	17.6	20.2	18.7	20.2	14.0	12.4	11.4	10.7	12.0	0.0	22.6	9.3	10.5	12.6	49.4	4.5	2.5	18.7	10.3	15.7	70.7	6.9	1.7	7.8	17.6	14.2	2.6	0.0	6.0	6.4	13.6	15.3	24.3	2.4	17.5	39.7	10.4	25.2	48.3	5.1	20.4	28.1	11.8	14.4	6.2	25.2	7.9	2.9	15.9	1.4	45.9	12.9	12.1	2.8	5.5	22.0	6.3	29.9	6.9	15.7
ANKRD16	DKFZP434N1511	ENSG00000134461	"Ankyrin repeat domain 16"	Q6P6B7	10	5861617-5889906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037920, HPA037921"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA037920: AB_10671381, HPA037921: AB_2675740"	"unprognostic (1.90e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.06e-2)"	"unprognostic (7.64e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.93e-2)"	6.2	7.2	9.8	7.1	13.9	3.9	8.4	12.9	16.6	10.9	7.3	10.0	7.9	7.3	12.7	11.6	6.3	13.6	10.8	5.7	8.6	7.7	6.2	7.3	4.9	6.5	7.8	7.8	14.7	12.6	10.0	7.2	4.0	8.0	8.4	6.0	9.3	8.3	7.7	6.6	14.8	5.3	9.3	6.3	6.3	10.0	13.6	11.2	7.3	7.1	5.4	7.2	7.7	7.7	2.6	2.7	1.4	1.1	2.1	2.2	0.8	7.5	9.1	4.2	8.7	4.5	3.3	6.3	2.3	1.8	4.2	3.7	11.1	4.0	8.1	3.3	3.9	1.6	7.9	5.2	6.0	1.9	2.8	8.0	5.0	4.2	10.1	5.7	3.1	3.6	5.1	4.6	3.8	3.0	3.4	4.6	8.5	6.7	2.5	2.9	10.4	11.4	5.3	3.5	10.2	6.5	8.7	2.8	16.3	4.7	4.9	2.6	5.7	4.8	6.0	5.3	3.6	8.4	6.3	2.9	2.5	3.2	5.5	3.2	13.9	6.3	5.3	5.2	3.0	2.7	1.4	1.1	0.3	0.9	0.5	0.8	2.0	0.7	1.3	1.3	2.6	2.2	0.9	1.1	2.1	0.8	2.7	1.2	0.8	9.8	13.9	12.9	16.6	8.6	7.7	7.8	7.8	8.0	11.2	3.0	2.2	0.8	6.0	4.1	13.2	2.0	10.2	0.0	2.3	3.5	5.9	3.9	11.6	1.8	6.8	2.7	4.0	0.0	1.9	2.6	5.1	4.5	0.0	3.4	2.8	25.4	4.1	2.5	0.6	11.0	5.2	1.6	3.3	4.6	2.0	7.0	0.8	0.0	3.5	6.7	13.5	0.0	3.1	8.9	8.0	5.0	1.3	1.5	5.4	3.2
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	19.6	20.2	28.9	23.2	32.4	10.3	24.8	41.2	29.9	22.8	19.4	21.2	19.5	18.2	19.3	24.2	22.2	23.5	18.8	20.4	23.4	21.6	25.3	25.3	18.0	17.4	22.3	19.4	23.4	22.8	40.2	34.6	23.2	31.8	19.7	24.2	21.5	23.1	23.1	32.7	22.2	18.5	20.7	18.0	17.7	19.2	13.5	25.1	22.3	22.7	15.9	21.1	21.1	18.9	4.5	7.6	3.2	2.8	9.3	5.3	1.7	12.3	13.6	21.7	17.1	24.5	21.6	11.9	18.2	21.5	16.4	15.9	16.5	16.3	33.6	15.2	18.6	8.7	10.4	27.1	16.1	22.8	13.0	11.5	22.8	14.8	23.9	13.1	29.8	14.1	18.2	17.6	23.5	18.8	17.1	21.8	13.8	31.9	12.4	19.6	11.4	24.4	10.6	14.1	16.0	13.8	19.5	23.9	13.9	17.5	18.7	21.1	14.3	17.6	19.9	9.5	17.7	10.7	11.8	26.2	17.4	16.7	15.5	14.2	10.4	5.2	25.7	14.1	13.1	17.7	2.3	2.8	3.0	5.3	1.8	2.7	3.0	3.3	3.6	2.3	4.5	3.2	3.6	3.2	9.3	2.1	7.6	2.0	1.7	28.9	32.4	41.2	29.9	23.4	21.6	22.3	19.4	31.8	25.1	44.7	48.2	16.6	32.2	67.7	55.9	71.9	33.1	22.7	48.9	38.4	115.8	24.2	6.6	26.7	4.0	47.7	39.9	0.0	25.0	20.0	36.8	36.1	30.1	45.3	23.8	65.2	43.4	40.5	26.7	4.2	32.5	26.4	27.0	22.6	40.3	32.1	25.1	17.3	35.3	19.8	77.0	19.4	28.2	24.7	28.7	71.0	28.3	24.9	41.9	42.2
ANKRD18B	bA255A11.3	ENSG00000230453	"Ankyrin repeat domain 18B"	A2A2Z9	9	33524394-33573009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.9;testis: 26.9"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 16.0;Early spermatids: 23.8;Muller glia cells: 23.4;Spermatocytes: 37.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Approved	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-2)"	"unprognostic (6.43e-5)"	"unprognostic (4.89e-2)"	"unprognostic (9.75e-4)"	"unprognostic (8.25e-2)"	"unprognostic (5.18e-2)"	1.5	0.9	4.3	0.1	0.4	0.2	1.3	12.9	3.9	0.3	0.2	0.2	0.1	0.0	0.5	1.0	2.1	1.0	0.9	0.3	2.1	1.3	0.1	0.4	0.7	0.1	1.0	1.4	0.1	0.1	0.1	1.6	1.3	2.6	2.0	0.3	0.2	0.2	0.1	1.4	5.5	0.2	0.1	1.0	0.9	0.0	26.9	0.1	0.1	0.9	1.6	0.7	1.2	1.1	0.5	0.8	0.1	0.2	0.0	0.8	0.1	7.5	8.5	0.7	0.2	0.3	1.4	0.7	1.6	1.7	2.1	2.3	1.6	0.2	0.2	0.4	0.2	2.3	1.7	4.6	1.6	2.9	0.1	4.6	8.2	9.9	3.1	0.0	2.7	0.6	1.1	4.5	2.9	7.6	0.9	3.9	0.0	4.5	2.1	2.6	1.3	0.2	20.8	7.3	0.3	3.7	0.0	10.5	1.5	1.2	1.8	0.2	7.3	3.5	0.4	0.6	6.8	6.0	10.1	3.9	1.7	7.6	3.5	3.0	1.2	0.8	0.1	0.8	0.1	1.2	0.0	0.1	0.1	0.3	0.1	0.7	0.4	0.2	0.6	0.0	0.5	0.4	0.8	0.1	0.0	0.2	0.8	0.1	0.1	4.3	0.4	12.9	3.9	2.1	1.3	1.0	1.4	2.6	0.1	0.0	0.0	0.0	4.4	1.8	2.6	2.4	2.5	16.0	3.4	1.8	0.0	0.0	0.0	0.6	23.8	0.0	0.3	0.0	0.4	0.2	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.6	0.6	0.1	0.0	0.0	1.6	23.4	0.3	1.4	0.7	0.0	4.3	0.0	0.0	37.6	1.7	2.9	0.0	0.0	1.0	3.5
ANKRD20A1	"ANKRD20A, DKFZp434A171"	ENSG00000260691	"Ankyrin repeat domain 20 family member A1"	Q5TYW2	9	67859147-67902094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;testis: 6.5"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 3.0;Cardiomyocytes: 2.6;Ciliated cells: 4.0;Spermatocytes: 6.3"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 7.1;U-266/70: 11.7;U-266/84: 3.9"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: "	"unprognostic (4.92e-1)"	"unprognostic (4.31e-3)"			"unprognostic (3.97e-1)"			"unprognostic (2.30e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"		0.1	0.0		0.0		0.3	0.1		0.8	0.3	0.2			0.0	0.0	0.1	0.3	0.3	0.0	0.0			0.2	0.1	0.0	0.0			0.0	1.1	0.0		0.0		0.1	0.9		0.2	0.1	0.0	0.4	0.1	0.3		0.8	0.0	6.5			0.5		0.0	0.0		0.0	0.0	2.3	0.1	0.1	0.3	0.0	0.2	0.4	1.4	0.6	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.4	0.9	1.0	0.4	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.2	1.8	0.4	7.1	0.0	0.0	1.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	2.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.3	0.6	1.0	11.7	3.9	0.0	0.5	0.0	1.9	0.0	0.0	2.3	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0											3.0	1.3	0.0	0.0	0.0	0.0	2.6	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	1.1	0.0	1.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	6.3	1.9	0.0	0.0	0.0	0.9	0.0
ANKRD20A2		ENSG00000183148	"Ankyrin repeat domain 20 family member A2"	Q5SQ80	9	40223285-40266392	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	4	"testis: 7.6"	"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 1.7;granulocytes: 1.1;Spermatocytes: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 16.7;U-266/70: 2.8;U-266/84: 5.0"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: "					"unprognostic (4.24e-3)"									"unprognostic (9.19e-2)"				0.1	0.1	0.4	0.0	1.4	0.2	0.3	1.0	1.2	0.1	0.4			0.0	0.0	0.5	1.2	0.7	0.1	1.9	0.7	0.7	0.3	0.2	1.2	0.0	0.4		0.0	1.4	1.1	0.8	0.0		0.4	1.1		1.1	0.4	0.3	0.2	0.1	0.0	0.1	1.5	0.0	7.6			0.5		0.0	0.0	0.3	0.1	0.9	0.9	0.0	0.0	0.6	0.0	0.2	1.3	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.6	16.7	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	2.8	5.0	0.0	0.0	0.0	0.8	0.1	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0											0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.2	0.0	0.0	0.1
ANKRD20A3		ENSG00000276203	"Ankyrin repeat domain 20 family member A3"	Q5VUR7	9	66106815-66153135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 1.1;lung: 1.3;testis: 2.0"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 5.3;Horizontal cells: 4.8;Spermatocytes: 16.4;Spermatogonia: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HDLM-2: 5.2;RPTEC TERT1: 1.4;WM-115: 1.3"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: "					"unprognostic (4.27e-2)"													0.1	0.0		0.0		0.0	0.4		0.0	0.0	0.0			0.0	0.0	0.0	1.1	0.1	0.0	0.0			0.0	0.0	1.3	0.1			0.0	0.0	0.0		0.0		0.0	0.5		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	2.0			0.2		0.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.5	0.0	0.1	0.1	0.0	5.2	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.0	0.0	1.1	0.2	0.8	1.8	0.0	5.3	0.0	0.0	3.9	0.0	0.0	0.0	2.0	0.0	1.0	0.0	0.9	0.0	0.0	0.6	3.5	0.0	0.1	4.8	0.0	0.6	1.3	1.8	0.3	0.0	0.0	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.1	16.4	6.5	0.1	0.0	0.0	0.2	1.0
ANKRD20A4		ENSG00000172014	"Ankyrin repeat domain 20 family member A4"	Q4UJ75	9	64369394-64413142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Spermatocytes: 40.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.4;Karpas-707: 4.3"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: "	"unprognostic (3.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.69e-2)"		"unprognostic (2.56e-1)"		"unprognostic (9.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.84e-2)"	1.5	1.0	0.7	0.2	1.6	3.9	0.9	2.3	1.9	0.3	0.9			0.6	0.5	0.2	1.7	0.5	0.2	1.7	0.8	1.0	0.7	0.1	1.1	0.1	0.6		1.4	2.4	0.0	0.9	1.0		0.4	1.4		0.9	0.0	0.4	0.6	1.2	0.0	0.3	1.0	0.9	2.1			0.7		0.0	0.3	0.6	0.0	1.4	1.7	0.0	0.0	0.8	0.0	0.7	0.4	2.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	1.0	0.3	1.9	0.2	0.0	4.4	1.4	1.3	0.4	0.7	0.0	1.0	2.0	0.0	0.0	0.1	0.1	0.5	0.6	2.8	3.0	4.3	0.1	0.3	0.8	0.2	0.3	2.5	0.9	0.0	1.0	0.6	0.8	0.5	1.9	0.6	0.2	0.1	2.0	0.5	1.9	0.2	0.9	0.0	1.8	0.5	0.1	0.9	0.6	1.0	0.4	0.0	0.4	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.4	0.0	0.0											3.0	0.0	0.0	0.8	0.5	1.5	5.5	0.0	2.7	0.0	0.0	2.0	0.3	0.0	0.1	2.3	0.4	5.9	0.0	3.2	0.1	0.4	0.4	1.1	0.0	0.0	1.6	2.9	0.6	1.2	0.8	0.0	0.7	0.0	0.0	2.5	0.6	0.8	3.5	1.1	0.1	0.3	0.0	0.9	40.3	2.7	0.5	0.2	1.7	1.7	2.3
ANKRD20A8P	ANKRD20B	ENSG00000229089	"Ankyrin repeat domain 20 family member A8, pseudogene"	Q5CZ79	2	94811046-94857282	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 3.2;thyroid gland: 5.0"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.7;Cardiomyocytes: 3.0;Club cells: 9.1;granulocytes: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"RT4: 2.8;U-2 OS: 9.8"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: "								"unprognostic (3.08e-1)"		"unprognostic (3.86e-1)"		"unprognostic (3.79e-2)"	"unprognostic (1.30e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.38e-2)"		1.1	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.4	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.9	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.2			5.0		0.0	0.0		0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	1.7	0.0	0.0	0.0	0.0	3.0	0.0	1.4	9.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD22	MGC22805	ENSG00000152766	"Ankyrin repeat domain 22"	Q5VYY1	10	88822132-88851818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.2;stomach 1: 27.6;tongue: 29.0"	"Cell type enhanced"	"Detected in many"	16	"Basal keratinocytes: 33.1;Suprabasal keratinocytes: 89.8;Urothelial cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 15.4"	"Group enriched"	"Detected in many"	13	"granulocytes: 15.4;monocytes: 6.8"	"Cell line enhanced"	"Detected in some"		"A-431: 8.5;CAPAN-2: 27.2;HL-60: 8.0;OE19: 20.7;RT4: 18.4;T-47d: 12.5;U-937: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012922	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012922: AB_1844838"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-3)"	"unprognostic (9.73e-3)"	"prognostic favorable (8.73e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.21e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (1.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.01e-3)"	0.4	0.5	2.3	8.4	3.6	5.3	2.3	0.3	3.2	6.7	6.7	0.5	0.0	2.0	0.3	0.2	21.9	0.3	4.3	1.1	4.0	0.6	6.0	1.6	1.3	6.1	3.6	0.2	0.3	40.2	0.1	1.6	0.2	2.7	2.0	7.2	0.1	3.7	0.0	0.3	18.5	2.1	1.3	7.4	8.8	27.6	0.3	1.4	7.9	0.3	29.0	14.6	4.4	8.6	0.1	0.4	15.4	6.8	0.5	0.8	1.2	8.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.1	0.1	0.0	0.0	6.7	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.7	6.4	0.1	20.7	0.1	0.0	0.0	0.0	0.1	18.4	0.0	0.0	0.0	1.3	0.0	0.0	12.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.1	0.1	4.8	2.5	0.1	6.8	0.0	0.0	0.4	0.1	0.4	0.1	0.8	0.2	15.4	0.5	1.2	0.4	0.0	1.2	2.3	3.6	0.3	3.2	4.0	0.6	3.6	0.2	2.7	1.4	0.0	3.0	0.0	16.2	33.1	0.0	0.1	10.2	0.0	1.2	7.0	0.0	0.0	0.0	2.6	0.0	0.0	6.4	0.0	5.2	0.0	0.7	10.4	0.0	0.0	2.4	0.0	1.7	0.0	7.2	0.0	0.3	12.3	1.7	1.0	11.8	0.0	4.5	20.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	89.8	0.0	0.7	11.2	29.8
ANKRD26	"KIAA1074, THC2"	ENSG00000107890	"Ankyrin repeat domain 26"	Q9UPS8	10	26991914-27100498	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 188.5;Rod photoreceptor cells: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040654, HPA041460"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA040654: AB_10795370, HPA041460: AB_10795120"	"unprognostic (1.92e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.99e-1)"	6.5	7.2	11.8	5.0	18.2	3.8	9.2	16.9	15.7	7.3	6.7	4.6	6.3	4.6	8.7	7.8	6.0	7.0	5.9	8.6	11.0	5.6	7.4	6.7	5.5	8.3	9.0	10.7	10.0	6.2	10.1	24.4	7.5	9.9	7.6	7.2	6.6	7.0	8.6	14.1	7.0	5.4	6.0	7.0	6.6	5.6	9.7	8.4	6.4	9.1	4.7	6.2	7.0	7.3	3.4	5.0	1.7	1.0	3.4	4.6	0.5	7.9	5.2	9.5	5.9	6.2	7.4	4.4	9.6	3.7	8.9	8.6	5.0	5.7	18.5	3.2	4.5	6.7	8.6	9.4	4.6	10.8	7.9	7.5	1.3	7.3	8.4	4.5	4.3	2.0	5.7	3.9	9.1	3.3	8.4	8.0	5.8	13.2	5.3	9.8	4.8	5.3	4.2	4.1	3.3	3.4	6.0	13.2	4.7	6.5	2.8	9.1	5.0	8.8	2.5	9.5	7.6	8.6	2.8	6.4	8.4	5.7	9.9	5.6	2.4	2.9	11.7	6.8	11.1	3.4	1.7	1.0	0.2	2.3	0.7	2.0	2.8	2.7	2.5	1.2	3.4	4.6	3.9	0.6	3.4	1.0	5.0	1.4	0.5	11.8	18.2	16.9	15.7	11.0	5.6	9.0	10.7	9.9	8.4	20.8	30.3	10.9	7.2	3.8	67.3	63.2	5.1	69.6	28.4	3.5	188.5	20.1	5.0	11.0	10.2	22.6	9.6	0.0	11.4	11.4	14.6	4.7	4.7	6.8	10.3	74.7	20.1	14.1	5.4	3.1	28.1	5.6	3.3	10.0	9.3	55.3	11.0	2.9	25.5	4.3	127.0	32.3	10.8	52.7	56.0	6.9	11.4	10.2	13.0	3.1
ANKRD27	"DKFZp434L0718, FLJ00040, VARP"	ENSG00000105186	"Ankyrin repeat domain 27"	Q96NW4	19	32597007-32676597	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 53.0"	"Low region specificity"	"Detected in all"							HPA042769	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA042769: AB_10796584"	"unprognostic (2.16e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (9.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-2)"	13.1	10.5	14.3	12.2	16.3	12.1	13.3	18.6	19.3	12.7	20.7	14.4	9.4	10.2	15.0	12.6	19.8	11.0	10.5	12.3	12.6	12.5	13.4	6.2	13.7	13.5	15.3	12.0	12.5	9.7	12.8	11.5	18.6	17.6	17.4	16.5	14.5	13.2	19.6	26.0	16.5	14.1	16.2	15.3	12.0	14.9	22.6	14.3	24.6	18.9	10.7	17.2	23.9	17.5	5.5	8.8	20.0	11.0	19.6	13.2	8.6	12.2	14.1	4.6	8.2	9.6	7.4	11.3	7.1	7.2	7.8	10.3	11.1	7.5	13.4	6.6	8.9	8.2	7.6	11.7	8.7	13.0	18.1	5.9	53.0	5.3	9.1	12.0	20.3	19.2	5.4	11.6	8.4	13.7	5.4	7.8	10.0	14.1	30.4	5.9	12.0	7.8	17.6	2.4	15.5	5.5	11.7	6.2	4.9	6.2	11.9	8.5	3.5	6.9	11.8	8.3	6.4	4.9	9.9	7.2	8.5	9.1	7.8	10.8	7.9	4.7	9.2	8.5	20.0	5.4	20.0	7.7	19.3	10.4	11.0	13.2	5.5	10.7	11.5	8.8	5.5	8.5	8.9	6.5	19.6	8.6	4.3	9.1	8.6	14.3	16.3	18.6	19.3	12.6	12.5	15.3	12.0	17.6	14.3	14.9	10.3	5.4	4.8	13.9	8.4	7.9	10.2	4.0	4.5	8.7	19.6	11.5	0.0	2.8	3.5	5.9	7.8	0.0	5.1	9.2	7.0	7.8	11.5	3.6	7.2	11.1	8.7	4.3	10.8	10.8	10.0	7.4	15.1	2.8	9.5	4.1	5.8	9.0	8.9	5.4	13.4	0.0	11.3	3.8	16.2	13.6	12.7	8.7	7.7	7.3
ANKRD29	FLJ25053	ENSG00000154065	"Ankyrin repeat domain 29"	Q8N6D5	18	23598926-23662885	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 202.5;Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 1.1;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.6;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.7;BJ hTERT+: 12.1;hTCEpi: 12.0;PC-3: 11.5;U-2197: 15.0;U-87 MG: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041272, HPA049419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA041272: AB_2677387, HPA049419: AB_2680757"	"unprognostic (4.52e-3)"	"unprognostic (8.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (1.92e-5)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.98e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.54e-1)"	"prognostic favorable (7.20e-5)"	"unprognostic (1.10e-2)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.64e-5)"	11.8	6.1	8.9	6.6	6.6	0.2	9.9	1.9	15.1	8.4	3.0	3.7	3.0	1.2	13.1	6.4	6.5	9.6	4.4	4.9	9.8	5.3	2.5	1.6	25.2	14.6	8.7	6.2	12.4	0.8	18.4	6.0	0.3	17.9	7.0	1.8	4.3	5.1	7.5	3.2	3.2	4.5	9.8	3.2	2.0	11.7	2.9	3.1	1.6	2.3	5.5	11.1	4.8	9.1	0.0	1.6	0.0	0.0	0.0	1.1	0.0	1.6	4.8	0.0	0.0	1.2	12.7	0.1	4.8	12.1	1.9	2.4	2.2	0.4	0.0	0.7	2.2	9.5	2.4	0.0	6.3	0.4	0.1	4.4	0.0	3.1	0.1	0.2	0.0	0.3	3.3	12.0	1.9	3.2	1.8	1.2	0.0	0.0	0.2	3.2	0.5	0.0	0.0	0.8	4.0	11.5	0.0	0.3	1.1	3.0	1.7	0.7	5.9	1.2	0.2	0.1	0.2	1.4	0.0	2.8	0.3	1.7	15.0	4.2	0.0	0.0	0.0	15.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	8.9	6.6	1.9	15.1	9.8	5.3	8.7	6.2	17.9	3.1	202.5	27.6	0.0	7.4	4.5	4.2	7.1	5.1	2.7	10.3	1.8	62.8	0.0	5.0	1.8	30.7	19.4	0.4	0.0	1.0	0.0	2.0	4.4	3.5	0.9	2.3	39.7	1.7	9.2	0.6	20.2	6.6	2.4	6.8	0.0	0.5	0.9	6.8	0.2	19.1	8.6	3.7	12.9	38.7	2.7	2.0	2.5	0.0	0.0	0.9	2.7
ANKRD33B		ENSG00000164236	"Ankyrin repeat domain 33B"	A6NCL7	5	10564330-10657816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.3"	"Cell type enriched"	"Detected in many"	5	"Cone photoreceptor cells: 329.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.1;memory B-cell: 1.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.4;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HMC-1: 18.5"	"Group enriched"	"Detected in many"	9	"amygdala: 13.6;basal ganglia: 16.9;cerebral cortex: 26.5;hippocampal formation: 22.4;olfactory region: 16.5"	"Group enriched"	"Detected in all"	6	"amygdala: 13.7;basal ganglia: 24.2;cerebral cortex: 30.1;hippocampal formation: 25.2;olfactory region: 26.0"	HPA056974	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA056974: AB_2683295"	"unprognostic (6.19e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.16e-5)"	"unprognostic (1.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.47e-2)"	3.8	1.1	6.3	8.6	9.3	13.2	3.6	1.4	25.3	5.2	3.2	0.1	0.4	0.9	7.8	1.1	3.3	5.4	1.9	7.0	8.4	2.3	10.0	1.5	3.0	5.4	2.0	7.5	1.7	2.7	0.5	1.7	3.5	1.3	3.5	2.0	12.7	2.3	4.4	9.0	11.3	3.3	6.9	1.7	11.1	3.1	5.2	1.1	7.2	1.6	12.5	7.2	4.9	16.6	1.4	0.0	2.1	0.0	0.0	0.4	0.4	2.5	3.8	0.2	0.3	9.0	4.3	11.4	0.7	1.2	1.5	1.8	4.7	2.1	14.0	12.8	2.4	1.8	2.6	1.3	1.3	1.7	27.4	0.9	5.5	3.4	0.0	4.1	4.2	18.5	2.1	1.0	0.8	5.2	0.3	1.9	1.0	1.2	6.8	0.4	0.0	0.2	5.0	3.0	0.0	1.1	1.1	2.9	0.4	5.1	1.8	0.0	0.1	0.0	0.2	0.4	10.0	0.0	5.2	5.4	0.9	5.6	4.6	1.3	8.0	8.7	1.2	0.2	6.8	0.3	0.0	0.0	2.1	0.2	0.0	0.0	1.4	0.4	0.1	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.4	6.3	9.3	1.4	25.3	8.4	2.3	2.0	7.5	1.3	1.1	11.9	1.0	1.9	1.7	0.3	14.4	4.5	0.0	0.0	1.2	3.5	329.9	1.0	1.7	1.8	4.9	2.3	0.0	0.0	0.2	0.8	5.0	3.1	0.0	0.0	0.2	6.4	0.0	2.5	0.0	0.0	1.4	0.7	1.7	26.2	0.0	5.8	0.2	0.0	0.0	18.3	67.9	0.0	0.2	0.0	1.9	1.0	0.5	0.5	0.0	1.7
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 31.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 2.0;Collecting duct cells: 3.5;Intestinal endocrine cells: 1.7;Kupffer cells: 3.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enriched"	"Detected in many"	6	"basal ganglia: 31.0"	"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.2"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.1	0.3	0.9	1.5	31.0	5.7	0.3	0.0	0.9	0.5	0.1	0.4	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.0	4.1	2.8	0.1	0.2	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.4	1.0	0.1	1.0	5.1	0.0	0.1	0.0	4.6	0.1	0.0	0.0	0.0	7.2	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	46.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	0.9	31.0	0.0	0.9	1.0	4.1	1.2	0.2	0.7	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.7	0.0	3.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
ANKRD34C		ENSG00000235711	"Ankyrin repeat domain 34C"	P0C6C1	15	79293285-79298235	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 5.8;skin 1: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"SCLC-21H: 14.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045329			Approved	Mitochondria		NA	NA			Mitochondria		"HPA045329: AB_2679291"	"unprognostic (3.20e-1)"			"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"						"unprognostic (1.81e-1)"		"unprognostic (3.42e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.48e-1)"			0.5	0.3	0.6	0.0	0.5	0.0	0.0	5.8	5.0	0.5	0.0			0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.9	5.0	0.1	0.0	0.3	0.0	2.4		0.0	0.7	0.1	1.2	0.0		0.1	0.1		0.0	0.2	0.2	3.0	0.1	0.0	0.3	0.0	0.1	0.1			0.1		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 42.4"	"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 33.6;Muller glia cells: 39.3;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.0;THP-1: 7.4;TIME: 9.4;U-87 MG: 9.4;U-937: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favorable (9.35e-4)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	2.1	1.2	3.3	1.0	3.7	0.4	3.6	12.1	7.4	16.1	1.7	0.8	0.3	0.5	2.1	1.3	11.4	2.5	1.1	0.8	3.4	3.6	0.4	1.4	0.8	0.5	3.7	3.4	2.8	0.5	0.2	0.3	0.3	8.0	2.5	0.8	0.3	4.2	2.3	5.2	42.4	0.7	1.8	2.0	0.4	1.2	0.8	0.3	0.7	0.3	14.9	13.6	2.3	7.7	0.0	1.3	0.3	5.5	1.5	2.9	1.9	0.1	0.0	0.0	0.0	2.5	11.0	0.3	1.6	4.0	0.5	1.3	0.4	0.0	0.0	0.3	1.3	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	1.3	3.1	0.1	3.8	0.5	0.3	0.1	0.1	0.5	0.0	0.0	0.0	2.4	0.0	0.0	4.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	8.2	0.0	0.0	5.5	0.0	2.0	2.0	0.3	0.0	0.8	2.9	0.7	0.0	0.6	1.9	0.3	1.5	0.4	1.3	1.5	1.9	3.3	3.7	12.1	7.4	3.4	3.6	3.7	3.4	8.0	0.3	0.0	0.0	0.0	14.7	4.0	1.5	1.2	2.5	4.0	1.2	1.8	0.0	0.1	0.0	0.0	3.6	1.0	0.0	0.0	0.4	0.1	20.2	8.0	19.5	8.6	8.7	0.0	0.0	1.8	1.6	4.7	33.6	1.1	5.0	0.0	0.0	39.3	0.1	0.0	47.7	0.0	1.4	0.0	5.2	0.0	0.9	10.8	0.2	7.5	0.0	12.9
ANKRD36	UNQ2430	ENSG00000135976	"Ankyrin repeat domain 36"	A6QL64	2	97113496-97264521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 71.9;Spermatocytes: 72.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.9"									"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (4.24e-3)"	"unprognostic (7.59e-2)"	"unprognostic (6.15e-3)"	"unprognostic (9.86e-2)"	"unprognostic (9.83e-3)"	"unprognostic (5.25e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.75e-1)"	5.1	3.3	8.8	6.0	14.5	22.0	6.8	20.5	10.2	5.6	4.6	4.8	2.2	3.0	8.5	7.7	2.4	6.0	3.8	3.9	7.6	3.3	3.2	1.8	5.0	5.0	4.0	11.3	8.9	5.1	5.3	9.2	2.3	6.8	4.8	5.2	4.7	4.3	3.1	2.2	5.9	4.3	4.7	3.7	5.9	5.1	13.3	8.2	5.6	5.4	2.1	3.7	4.0	4.9	9.9	11.7	9.3	3.3	4.9	9.2	1.7	6.2	1.5	5.1	3.2	1.1	2.6	2.4	2.4	1.7	1.9	1.9	1.6	3.2	8.0	1.6	2.3	1.5	3.1	1.9	2.1	1.6	3.8	2.8	6.0	6.8	2.9	0.5	4.4	2.6	1.7	1.4	1.4	2.4	3.0	3.4	11.2	4.1	13.9	0.8	1.1	5.5	5.8	1.2	0.5	2.9	5.3	2.1	2.2	1.4	3.0	3.6	2.6	2.5	1.5	0.8	2.9	1.6	2.5	5.2	5.4	5.3	6.2	2.8	8.2	3.5	6.5	3.1	6.4	1.8	9.3	2.6	3.5	9.2	1.2	9.1	9.9	8.4	7.3	1.2	9.9	8.6	9.2	3.9	4.9	3.3	11.7	7.0	1.7	8.8	14.5	20.5	10.2	7.6	3.3	4.0	11.3	6.8	8.2	41.7	27.2	12.9	8.0	14.0	47.0	19.1	0.0	44.2	27.3	7.0	70.7	0.9	0.0	5.7	53.0	19.6	2.0	0.0	15.9	4.8	14.4	5.5	25.5	0.8	4.5	20.6	13.2	9.8	4.6	5.3	24.2	17.3	37.1	4.6	6.8	13.0	9.3	3.4	17.0	1.4	71.9	0.0	23.1	72.1	11.9	8.2	0.3	25.4	8.5	12.9
ANKRD36B	"FLJ21281, KIAA1641"	ENSG00000196912	"Ankyrin repeat domain 36B"	Q8N2N9	2	97492663-97589965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4"	"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 49.5"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.03e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.20e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.13e-6)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.71e-3)"	"unprognostic (6.98e-2)"	1.0	1.5	2.0	2.8	7.0	16.4	3.3	6.8	6.7	1.4	1.7	1.6	0.2	1.3	3.8	2.0	0.5	2.0	2.1	0.8	3.1		1.1	0.4	2.2	2.3	4.3	6.2	3.8	1.7	1.8	3.3	0.7	3.9	1.8	2.7	1.0	2.6	3.0	0.7	3.6	2.1	1.9	1.9	1.7	1.7	7.5	4.0	4.2	1.3	2.8	2.1	1.2	0.8	3.5	2.6	3.4	0.7	2.6	3.0	0.3	3.6	2.3	2.7	2.3	1.6	3.6	1.7	2.6	1.7	1.7	1.9	2.2	4.5	5.2	1.4	2.1	1.6	1.7	1.7	1.2	1.8	1.5	4.2	4.1	4.7	1.6	1.2	3.2	2.4	2.4	2.1	2.1	3.5	4.0	2.2	10.7	5.5	4.4	2.0	0.9	4.0	5.8	1.3	0.8	2.7	5.0	1.3	1.8	1.8	2.3	3.0	4.3	1.9	1.6	1.4	3.6	2.6	3.0	3.3	3.0	3.5	3.5	3.4	6.1	7.7	4.8	1.8	4.3	1.5	3.4	0.7	0.9	2.2	0.3	2.0	2.2	2.6	1.8	0.3	3.5	3.0	2.3	0.5	2.6	0.2	2.6	1.3	0.3											11.9	16.7	6.2	6.2	0.0	34.4	12.2	2.5	30.8	31.8	8.7	19.6	1.3	0.0	6.9	39.2	6.8	2.6	0.0	11.9	3.0	2.6	4.5	22.0	0.6	2.9	15.9	13.8	3.1	2.7	3.6	11.8	3.9	0.0	10.0	9.0	9.5	8.7	4.0	7.1	0.5	35.1	6.5	1.4	49.5	6.8	0.0	0.1	13.8	5.8	10.4
ANKRD36C	DKFZp667P0924	ENSG00000174501	"Ankyrin repeat domain 36C"	Q5JPF3	2	95836919-95991831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.6"	"Cell type enhanced"	"Detected in many"	9	"Exocrine glandular cells: 514.5;Pancreatic endocrine cells: 319.5;Urothelial cells: 431.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 25.5"									"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.35e-6)"	"unprognostic (9.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	2.2	1.0	4.2	1.8	4.1	13.2	5.3	8.0	5.8	3.1	3.1	0.5	2.8	0.7	3.2	1.9	1.8	2.6	4.0	1.5	3.3	1.8	1.2	0.8	2.0	2.7	1.6	1.7	5.6	3.1	1.2	3.9	0.9	3.1	1.6	2.1	2.1	9.2	1.5	0.9	2.9	2.6	1.5	1.9	2.4	4.5	10.1	1.1	2.8	1.6	2.4	4.0	2.5	2.2	11.1	19.6	18.1	2.0	7.2	12.5	0.7	6.6	1.3	2.8	1.9	1.8	4.9	1.0	1.6	1.1	2.1	2.7	1.5	1.5	6.6	2.1	1.1	2.1	1.5	2.5	1.2	2.7	3.8	3.3	2.7	3.2	1.9	0.4	7.8	2.0	1.4	1.0	1.6	0.8	2.1	3.5	9.6	2.6	8.4	2.3	0.9	6.0	2.9	0.6	0.3	25.5	3.2	2.1	2.7	1.0	1.3	2.5	2.2	1.0	1.7	1.1	1.1	0.8	1.9	3.9	2.6	2.9	2.0	1.9	3.2	2.6	7.2	0.7	5.4	1.0	18.1	2.0	1.5	12.5	0.3	8.1	9.2	10.0	8.1	1.4	11.1	8.7	8.5	0.1	7.2	0.5	19.6	8.3	0.7	4.2	4.1	8.0	5.8	3.3	1.8	1.6	1.7	3.1	1.1	35.7	24.0	8.3	28.7	9.5	80.2	21.4	5.1	61.6	79.6	8.7	74.6	0.2	0.0	187.2	85.1	14.3	7.4	23.3	514.5	0.7	15.0	147.9	31.4	1.3	6.9	31.8	20.2	8.0	6.7	8.4	30.2	13.0	13.5	40.5	53.0	17.5	319.5	7.4	34.3	0.3	74.8	19.4	17.0	86.7	12.4	6.5	0.2	28.8	13.0	431.0
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 135.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: AB_2683614"	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	7.7	8.9	11.0	3.9	15.2	3.3	10.9	9.9	20.9	17.2	7.5	6.0	5.4	4.8	4.9	4.1	35.8	8.0	4.8	13.6	12.0	9.6	6.4	14.2	12.4	3.0	12.3	5.8	14.8	13.5	1.7	11.7	10.7	16.8	24.1	7.0	8.4	35.4	21.9	22.1	7.3	4.9	5.0	16.1	4.6	5.2	8.7	14.2	1.5	14.2	18.6	12.2	14.3	22.8	7.7	4.2	10.2	3.9	3.2	8.1	3.0	6.2	0.9	0.7	3.6	4.9	3.1	3.4	2.9	2.2	2.1	4.7	1.5	1.8	3.0	1.2	5.3	4.4	2.4	3.4	3.7	2.7	8.5	0.9	2.0	3.2	4.5	2.1	1.9	4.7	0.6	4.0	2.0	2.8	15.7	2.7	2.0	3.1	5.1	5.9	1.6	1.6	7.5	1.0	0.6	5.0	0.5	1.0	8.2	2.6	0.5	5.0	8.9	2.0	2.0	8.6	2.7	1.8	1.2	3.5	4.6	3.7	2.6	3.3	9.6	2.8	1.3	13.1	1.4	5.3	0.4	3.8	10.2	5.5	3.5	4.7	7.6	4.3	8.1	2.6	7.7	3.3	4.7	2.0	3.2	3.9	4.2	5.1	3.0	11.0	15.2	9.9	20.9	12.0	9.6	12.3	5.8	16.8	14.2	20.8	23.7	16.6	23.8	52.8	24.8	1.2	0.0	101.7	22.7	8.7	27.5	15.7	21.6	17.9	3.7	11.7	61.7	23.3	20.0	36.6	28.6	40.4	63.2	20.4	13.8	9.5	115.1	10.4	6.7	2.0	8.6	24.5	135.0	28.9	93.8	89.4	40.5	35.1	11.0	15.7	103.2	6.5	35.0	13.3	15.1	42.0	70.6	11.7	31.3	16.2
ANKRD39	MGC41816	ENSG00000213337	"Ankyrin repeat domain 39"	Q53RE8	2	96836611-96858095	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042678	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA042678: AB_10794532"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (9.53e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.12e-3)"	"prognostic favorable (6.12e-5)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (6.78e-9)"	"unprognostic (3.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.21e-4)"	8.9	16.2	17.1	9.2	19.2	12.0	6.9	29.4	20.8	7.4	8.3	15.0	7.2	11.2	11.7	5.9	7.6	10.9	7.9	17.6	14.8	14.7	6.5	12.6	7.6	13.0	13.5	14.0	7.3	11.2	11.7	14.2	7.4	13.4	10.4	5.6	10.3	9.5	10.1	6.3	10.9	8.4	9.5	10.7	8.9	7.9	3.7	13.0	5.4	6.3	4.3	8.7	9.0	5.8	15.5	29.0	7.1	9.0	14.4	27.8	8.7	6.4	4.2	2.4	5.3	0.8	1.6	5.9	5.0	2.3	6.3	4.8	10.4	2.7	4.1	7.4	3.6	5.0	2.8	3.1	4.7	1.4	4.7	9.3	2.9	3.8	14.1	4.2	6.6	7.2	3.1	2.8	5.7	2.2	2.3	4.5	8.6	6.1	73.5	2.3	10.1	6.2	5.2	3.1	2.2	9.8	4.7	1.7	23.0	3.2	3.3	5.6	3.7	3.6	8.5	6.3	2.3	2.5	3.6	2.2	3.9	3.9	4.4	8.8	3.8	4.1	6.7	4.0	7.6	4.1	7.1	6.9	5.3	19.6	8.3	16.4	15.5	19.4	17.2	6.8	13.6	10.8	13.3	3.5	14.4	9.0	29.0	27.8	8.7	17.1	19.2	29.4	20.8	14.8	14.7	13.5	14.0	13.4	13.0	6.0	6.2	15.2	17.4	8.4	22.4	15.9	22.9	45.5	11.4	8.7	3.9	39.8	21.6	26.0	4.0	12.0	12.9	0.0	27.9	33.6	16.9	10.0	12.7	24.6	26.7	31.8	17.9	9.8	9.9	2.0	11.5	10.8	27.0	8.2	17.9	14.6	32.4	8.6	13.8	20.7	27.7	25.8	24.0	12.5	17.8	15.6	18.1	24.9	16.8	13.6
ANKRD40	MGC15396	ENSG00000154945	"Ankyrin repeat domain 40"	Q6AI12	17	50693190-50707924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021668, HPA021759, HPA074884"	Uncertain		Approved	"Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoli fibrillar center, Cytosol"	"HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: "	"unprognostic (2.73e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	25.1	13.0	39.1	9.3	44.1	4.4	20.2	13.7	27.0	12.3	11.3	42.9	7.8	7.4	14.6	9.2	11.9	9.2	10.4	14.8	42.1	29.0	11.5	11.2	14.1	9.6	58.5	15.1	13.8	10.9	19.0	4.9	14.4	26.1	12.2	10.7	7.6	8.8	16.7	59.2	7.8	7.7	17.9	67.2	12.2	9.1	6.4	34.1	4.7	10.9	8.6	8.9	10.6	16.4	9.5	13.3	6.6	10.8	9.6	13.8	3.8	18.9	18.3	16.6	16.6	23.9	19.9	14.5	17.1	18.8	20.1	19.0	38.6	9.7	20.1	24.0	21.9	21.6	10.8	23.6	13.9	32.8	18.5	15.2	27.5	11.9	18.9	13.1	19.1	11.7	17.0	14.3	19.5	24.5	14.7	15.7	16.7	15.5	20.3	16.5	14.8	23.8	6.9	18.3	15.4	17.3	16.3	30.0	14.3	15.7	16.4	8.8	24.6	9.5	13.1	18.3	30.1	15.1	12.8	19.1	27.3	21.6	14.1	21.8	21.5	19.6	18.3	15.0	7.4	22.2	6.6	7.1	2.8	10.9	10.3	12.4	9.5	12.2	12.3	6.6	9.4	11.5	13.8	1.8	9.6	10.8	13.3	8.5	3.8	39.1	44.1	13.7	27.0	42.1	29.0	58.5	15.1	26.1	34.1	14.9	10.7	16.2	21.0	40.1	14.2	28.6	7.6	4.0	3.4	17.4	3.9	14.2	23.2	16.2	1.7	28.1	8.0	0.0	15.0	17.0	18.3	19.2	9.2	16.6	16.6	33.4	5.8	29.4	22.2	0.9	31.7	20.2	25.3	9.0	12.3	15.3	16.3	10.5	35.3	17.4	9.8	45.3	26.1	19.3	23.9	29.1	8.9	19.2	12.8	21.1
ANKRD42	"FLJ37874, PPP1R79, SARP"	ENSG00000137494	"Ankyrin repeat domain 42"	Q8N9B4	11	83193739-83260694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 73.6;Early spermatids: 123.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039917	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039917: AB_10672894"	"unprognostic (6.59e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.90e-1)"	5.6	14.5	13.9	5.4	22.1	8.3	7.1	4.8	15.1	8.2	5.4	3.0	11.6	5.8	6.9	22.2	5.6	17.2	8.7	5.4	18.1	13.4	12.3	5.2	7.4	4.5	8.2	12.4	9.9	8.6	16.8	17.9	4.5	13.1	8.4	4.8	6.5	6.7	10.3	6.1	6.2	5.3	6.7	8.7	4.8	6.4	41.8	5.3	1.0	13.0	1.5	4.5	6.8	16.1	7.1	4.8	7.9	11.1	5.8	4.3	2.1	3.9	6.9	3.3	6.8	10.7	11.2	3.0	8.1	6.3	4.8	3.0	4.2	4.8	1.7	10.5	7.2	9.7	8.5	3.5	5.5	4.0	2.2	2.8	2.8	9.4	2.7	7.4	7.8	6.6	6.6	6.6	12.1	6.5	9.4	4.9	2.8	8.1	1.6	6.9	5.8	1.1	8.6	2.8	6.1	4.4	1.9	5.0	2.0	16.0	4.7	2.7	3.5	10.5	6.6	2.1	4.6	9.9	4.4	7.1	7.5	5.2	27.2	3.7	2.1	4.7	3.3	5.9	4.9	3.1	7.9	3.6	4.3	4.1	4.1	2.8	7.1	3.7	4.3	4.8	5.2	1.9	3.0	3.0	5.8	11.1	2.0	1.4	2.1	13.9	22.1	4.8	15.1	18.1	13.4	8.2	12.4	13.1	5.3	8.9	13.6	3.2	17.5	10.0	3.0	6.7	7.6	73.6	7.9	7.0	37.3	2.7	8.3	6.6	123.0	7.1	3.6	0.0	5.8	2.7	8.7	10.0	12.8	3.8	4.4	1.6	2.9	9.2	8.2	53.0	8.1	9.0	6.8	6.4	3.2	6.7	5.4	3.6	9.9	11.4	21.3	12.9	8.7	38.6	18.1	13.4	4.6	7.0	3.1	11.2
ANKRD44	PP6-ARS-B	ENSG00000065413	"Ankyrin repeat domain 44"	Q8N8A2	2	196967017-197311173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 34.7;lymphoid tissue: 38.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 93.2;Macrophages: 60.1;T-cells: 81.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.6;HMC-1: 20.7;Karpas-707: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030122, HPA056549"	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"HPA030122: AB_10600980, HPA056549: AB_2683170"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.67e-2)"	6.0	6.0	4.9	29.4	8.8	12.5	4.3	3.7	5.1	8.6	6.7	10.8	3.9	3.2	6.5	3.9	4.3	4.9	7.6	6.4	6.4	4.7	5.6	4.5	15.4	36.7	9.4	4.7	5.1	3.5	6.0	6.1	6.4	6.4	5.0	4.8	7.4	8.0	4.7	2.9	3.0	12.6	9.6	8.0	17.8	5.6	7.1	8.9	38.2	5.1	3.0	27.0	9.0	9.8	15.7	9.4	34.7	11.4	12.0	13.4	6.3	1.0	0.6	1.6	1.7	3.9	1.6	0.3	2.5	1.1	1.3	1.2	0.4	0.6	9.0	1.1	2.1	2.3	0.1	0.6	0.5	1.0	26.6	2.3	0.3	3.2	0.1	0.2	6.5	20.7	0.8	0.3	1.3	0.1	1.9	1.7	2.2	1.5	15.0	1.9	1.5	3.1	5.3	0.2	0.3	1.7	5.7	1.9	12.3	3.1	0.8	1.7	7.4	0.8	0.6	7.0	1.3	0.9	6.4	9.3	4.6	2.5	1.3	1.8	3.7	4.4	11.4	3.1	8.2	2.6	21.8	9.5	21.0	13.1	9.8	12.4	11.6	9.8	11.1	9.4	15.7	11.3	13.4	34.7	12.0	11.4	6.2	9.3	6.3	4.9	8.8	3.7	5.1	6.4	4.7	9.4	4.7	6.4	8.9	14.9	19.2	93.2	4.0	3.1	5.0	7.8	25.5	12.0	13.6	10.4	3.9	3.9	1.7	3.0	10.6	6.7	1.1	0.0	4.0	0.7	5.8	3.2	52.0	7.4	16.4	3.2	2.4	44.2	57.8	12.9	14.4	60.1	35.4	19.8	1.1	10.8	3.8	3.5	16.6	1.1	11.1	19.4	6.1	3.0	3.6	3.1	1.1	81.3	0.8	4.3
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 33.5;Cone photoreceptor cells: 35.3;Early spermatids: 19.6;Late spermatids: 9.9;Spermatocytes: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.5;GAMG: 4.1;HBF TERT88: 4.3;SH-SY5Y: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	12.0	0.0	0.0	1.0	2.1	0.1	4.2	3.8	6.5	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.4	0.1	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.8	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2	0.0	1.7	0.0	0.2	0.2	0.5	0.7	0.0	33.5	1.2	5.2	35.3	0.2	1.7	0.6	19.6	1.5	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	9.9	1.7	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.4	0.5	1.8	0.0	0.3	28.6	4.9	0.0	0.1	0.0	0.0	0.1
ANKRD46		ENSG00000186106	"Ankyrin repeat domain 46"	Q86W74	8	100509752-100559784	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013758	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA013758: AB_10962626"	"unprognostic (3.71e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.08e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-3)"	13.0	29.7	25.8	6.0	23.4	1.6	11.1	25.2	34.2	12.2	6.9	13.9	7.6	7.6	9.7	12.8	9.6	8.9	5.9	14.5	24.0	25.9	23.8	29.5	8.0	6.8	21.7	25.2	17.6	13.6	10.7	10.8	15.2	24.5	10.6	7.1	7.7	11.7	10.7	40.3	8.3	8.1	9.5	20.6	7.9	8.4	6.1	14.6	9.4	14.7	6.1	7.9	8.2	7.6	11.3	7.9	10.4	6.0	12.7	15.8	8.7	5.5	7.0	10.6	5.9	8.1	4.8	11.7	7.3	3.3	5.6	4.8	10.1	3.4	17.6	13.8	2.5	1.8	4.3	10.7	5.4	6.0	6.2	9.4	21.9	3.5	7.9	4.8	5.1	2.8	3.4	10.0	3.6	6.0	6.1	6.9	12.3	11.5	5.7	5.3	6.3	23.8	9.5	7.7	14.4	5.2	18.5	3.5	11.7	8.2	6.0	11.6	11.8	3.1	5.8	4.6	13.2	8.6	8.9	5.1	2.6	2.9	3.8	2.8	13.5	12.8	14.5	2.8	16.8	4.1	10.4	6.0	6.1	12.5	3.2	15.2	11.3	12.0	10.9	7.9	9.5	15.8	13.5	1.5	12.7	5.1	7.4	11.2	8.7	25.8	23.4	25.2	34.2	24.0	25.9	21.7	25.2	24.5	14.6	6.0	3.8	12.0	9.0	9.6	28.0	13.7	7.6	4.0	1.2	21.0	17.7	27.0	24.9	7.2	0.8	11.4	8.4	0.0	5.3	11.8	12.0	9.1	4.6	30.4	9.8	63.5	7.0	17.2	7.2	1.1	19.5	3.4	10.1	8.2	8.1	46.0	3.3	8.4	24.8	39.6	28.0	25.8	11.8	8.1	15.1	12.4	19.6	10.0	8.6	7.9
ANKRD49	"FGIF, FLJ20189, GBIF"	ENSG00000168876	"Ankyrin repeat domain 49"	Q8WVL7	11	94493629-94499583	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040273, HPA048137"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA040273: AB_10674991, HPA048137: AB_2680279"	"unprognostic (1.52e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.46e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.21e-3)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (6.32e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.40e-2)"	"prognostic favorable (6.16e-4)"	9.8	9.0	10.2	10.7	10.8	19.6	12.7	18.6	10.9	15.6	14.8	4.5	9.5	11.2	15.1	19.6	13.2	8.2	7.9	5.7	9.5	6.9	13.3	11.0	10.4	17.5	7.2	8.5	12.3	15.6	9.1	27.9	16.3	7.7	12.6	13.1	7.7	12.1	10.7	7.9	8.8	19.2	9.6	12.5	21.3	12.1	5.3	8.5	22.6	18.0	9.9	19.2	11.9	9.3	20.5	17.7	34.7	15.1	17.3	19.6	10.5	6.4	2.9	7.6	6.5	7.5	9.6	9.2	10.2	9.1	10.7	12.7	14.2	12.7	17.0	15.7	7.2	9.3	14.1	9.2	6.9	8.6	13.3	7.4	14.7	11.4	4.8	8.6	12.9	11.8	6.7	17.4	8.2	11.5	7.9	8.4	15.1	13.9	10.1	7.0	4.4	13.7	23.4	4.4	12.2	7.3	11.1	8.5	8.5	10.1	6.8	7.5	7.8	7.0	7.0	6.3	14.2	14.2	8.7	5.2	9.7	6.8	10.6	5.1	5.9	13.6	18.1	3.2	15.6	5.5	34.7	15.1	12.6	14.9	12.5	16.3	20.5	15.9	13.1	11.4	19.6	19.6	17.9	27.1	17.3	9.3	17.7	19.1	10.5	10.2	10.8	18.6	10.9	9.5	6.9	7.2	8.5	7.7	8.5	11.9	9.4	31.8	9.7	4.9	15.9	5.3	17.8	8.1	17.0	24.4	13.7	25.3	18.3	16.9	4.4	13.5	27.1	46.7	20.0	13.5	13.3	9.6	19.8	16.6	12.2	11.1	12.9	16.0	28.9	1.5	33.1	17.8	10.1	13.6	20.3	20.2	18.8	30.3	22.3	12.6	14.5	25.8	11.8	22.3	18.8	5.9	23.5	35.0	21.1	5.1
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664052-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.4;monocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.2;HUVEC TERT2: 22.1;TIME: 55.6"					"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	10.1	4.8	6.6	8.2	6.8	4.7	7.6	4.0	8.3	17.1	10.0	4.3	8.7	3.7	17.5	7.4	11.4	5.9	10.2	7.3	6.2	6.5	9.8	6.9	13.4	5.4	5.5	6.5	9.0	5.2	12.5	3.9	17.1	6.2	19.1	6.9	6.7	7.7	7.9	3.2	12.9	7.9	14.2	4.8	7.1	8.2	16.8	4.8	15.4	9.2	5.8	4.4	16.5	10.9	0.1	2.4	0.5	3.8	0.4	0.1	0.4	2.3	4.3	12.3	5.7	9.8	6.3	1.2	6.0	5.1	3.1	2.0	1.9	3.0	0.0	1.9	8.5	2.8	2.1	8.1	4.6	5.5	0.0	1.7	1.9	5.6	1.8	7.0	3.2	2.5	6.3	6.3	4.9	22.2	5.9	22.1	2.2	3.5	4.2	5.9	5.3	4.0	1.1	2.5	3.4	6.4	3.3	3.8	0.5	3.9	9.6	3.5	4.4	4.1	2.6	4.8	5.3	2.8	2.7	55.6	6.7	5.2	3.2	5.1	3.1	0.0	0.8	3.0	1.4	7.6	0.0	1.5	0.5	0.0	3.8	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.4	2.3	0.9	0.0	0.4	6.6	6.8	4.0	8.3	6.2	6.5	5.5	6.5	6.2	4.8	29.8	18.2	0.5	15.0	35.8	2.8	8.4	15.3	8.1	6.8	5.2	0.0	1.9	0.0	8.8	35.0	14.5	3.8	0.0	17.2	23.7	15.5	12.9	4.7	6.8	4.8	20.6	8.1	31.9	10.0	45.7	6.4	8.7	10.1	2.8	3.1	2.9	13.7	2.9	11.3	3.3	1.0	0.0	18.6	16.8	9.7	26.8	3.4	0.0	4.5	15.8
ANKRD52	"FLJ34236, PP6-ARS-C"	ENSG00000139645	"Ankyrin repeat domain 52"	Q8NB46	12	56237807-56258391	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043815	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA043815: AB_10961762"	"unprognostic (6.25e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (6.31e-2)"	10.7	23.2	12.3	13.2	19.6	12.1	10.8	23.1	23.5	10.8	11.6	15.6	9.1	11.9	13.8	8.9	10.9	11.5	12.7	12.0	12.7	13.4	13.2	8.3	9.8	12.3	13.3	14.7	14.6	14.1	28.4	14.5	12.6	22.8	11.9	12.1	14.8	11.6	13.6	30.8	15.8	13.0	15.8	8.8	11.9	10.9	8.5	13.5	10.5	12.4	11.4	13.4	12.3	11.8	1.1	1.1	2.4	0.6	0.3	1.2	0.5	11.7	29.2	13.0	23.5	10.6	8.4	9.2	23.6	10.5	21.2	9.6	18.9	6.6	12.6	15.1	23.0	7.4	15.4	14.3	10.3	12.3	12.1	14.5	22.6	19.0	7.2	7.3	17.7	13.2	8.6	11.7	19.7	10.0	15.6	12.3	10.4	9.2	6.9	19.8	16.4	14.2	5.9	5.4	7.7	13.5	11.2	9.0	5.0	14.0	15.1	9.9	9.0	25.7	16.5	9.4	10.5	13.3	6.9	16.9	22.2	19.5	12.4	14.7	6.4	8.4	6.2	22.8	5.9	14.4	2.4	0.6	0.9	1.2	0.1	1.0	0.8	0.4	0.7	0.3	1.1	0.6	0.7	0.3	0.3	0.4	1.1	0.3	0.5	12.3	19.6	23.1	23.5	12.7	13.4	13.3	14.7	22.8	13.5	6.0	4.0	4.7	2.9	10.0	4.7	5.6	2.5	0.0	0.0	12.2	25.5	5.1	0.0	8.4	0.3	4.8	8.3	0.0	8.0	6.2	5.3	4.5	1.1	6.0	6.2	7.9	9.2	6.2	6.5	0.8	5.8	3.9	10.1	4.6	6.8	3.7	12.4	9.0	4.6	5.8	6.1	0.0	5.2	6.7	8.1	9.5	3.1	4.8	7.3	3.7
ANKRD54	LIAR	ENSG00000100124	"Ankyrin repeat domain 54"	Q6NXT1	22	37830855-37849327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071287	Approved		Approved	Nucleoplasm,Microtubules,Midbody		Yes	No			"Microtubules, Midbody"	Nucleoplasm	"HPA071287: AB_2686380"	"unprognostic (5.36e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.38e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-3)"	7.8	14.8	18.4	7.9	15.8	7.5	9.1	20.0	19.5	13.5	11.9	14.1	17.4	9.8	11.2	14.9	13.6	33.5	11.4	8.9	17.1	20.6	13.0	11.9	9.3	8.1	14.2	12.1	19.0	24.6	15.3	16.4	7.9	14.8	13.1	9.4	13.4	19.1	16.3	9.3	11.8	9.5	13.5	11.7	7.5	8.9	23.7	11.0	12.3	18.2	8.7	9.8	11.6	13.9	6.2	6.7	3.5	10.0	12.8	6.9	3.8	10.9	11.1	9.4	13.8	12.7	7.1	5.0	15.2	11.7	25.8	15.8	7.0	4.3	10.6	6.3	9.9	8.3	9.8	12.0	8.4	12.5	8.5	24.2	5.3	10.1	16.7	11.3	10.5	12.8	6.4	8.8	13.9	8.2	6.3	15.7	7.9	7.0	7.4	11.7	11.5	10.2	12.1	2.7	14.7	10.2	11.9	11.5	6.6	14.2	3.6	16.4	8.8	12.7	11.3	18.0	4.4	11.6	16.7	9.1	15.0	16.2	7.8	11.1	8.3	6.7	8.4	12.5	9.0	10.8	2.6	5.4	2.4	6.8	6.4	6.8	4.5	6.6	5.2	6.7	6.2	6.9	3.4	3.5	12.8	10.0	6.7	2.8	3.8	18.4	15.8	20.0	19.5	17.1	20.6	14.2	12.1	14.8	11.0	11.9	16.4	13.9	9.0	14.1	17.4	7.1	22.9	33.5	11.4	17.4	27.5	18.3	33.2	14.5	5.0	9.0	15.5	0.0	12.7	15.1	10.4	8.9	9.2	9.6	11.6	25.4	8.6	11.1	8.1	6.0	16.7	9.5	10.1	8.2	12.6	16.9	11.3	15.2	20.1	14.7	22.1	6.5	14.4	54.6	39.2	15.4	14.1	16.0	14.4	8.8
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099678-56233359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 143.8;Ito cells: 52.8"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3"	"Group enriched"	"Detected in many"	67	"granulocytes: 13.1;T-cells: 14.3"	"Group enriched"	"Detected in some"	6	"HEL: 24.5;HMC-1: 12.7;NB-4: 16.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA051049: AB_2681326, HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.9	0.5	3.3	1.3	20.0	1.4	0.5	0.5	6.7	0.3	0.5	1.5	0.0	0.5	0.3	0.2	0.6	0.6	0.8	0.4	4.3	7.8	1.1	5.7	0.6	6.1	2.3	3.5	0.5	0.3	0.2	0.5	1.4	9.9	0.3	0.7	0.7	2.1	0.3	0.3	0.9	2.4	0.5	4.1	3.0	0.7	16.7	1.8	0.0	0.4	0.0	3.8	1.0	0.3	0.0	0.0	13.1	0.2	0.0	14.3	2.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	24.5	0.1	0.9	0.0	1.1	12.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	2.0	0.8	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.3	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.4	0.3	12.6	0.2	13.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	14.3	0.5	1.2	0.0	0.0	0.0	0.6	2.1	3.3	20.0	0.5	6.7	4.3	7.8	2.3	3.5	9.9	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	143.8	1.0	0.0	0.0	0.2	0.3	0.6	0.0	2.3	0.5	0.6	0.0	0.0	52.8	4.1	14.1	0.6	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.7	0.2	0.0	0.0	0.0	3.2	0.5	0.0	1.0	2.2	0.0	0.1
ANKRD63		ENSG00000230778	"Ankyrin repeat domain 63"	C9JTQ0	15	40281444-40282586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"basal ganglia: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HEK 293: 5.5;HEL: 2.7;NB-4: 1.9;SCLC-21H: 2.0;THP-1: 4.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 50.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.3"	HPA066743			Approved	Mitochondria		NA	NA			Mitochondria		"HPA066743: "					"unprognostic (9.36e-2)"					"unprognostic (7.45e-2)"				"unprognostic (8.32e-2)"	"unprognostic (4.42e-1)"			0.2	0.2	1.8	0.4	22.4	0.2	0.2	0.3	4.7	0.2	0.2	0.0	0.0	0.2	0.3	0.2	0.2	0.7	0.3	0.5	0.3	0.4	1.3	0.2	0.2	0.3	0.3	1.1	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.5	0.2	0.0	0.7	0.3	0.7	1.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.5	2.7	1.1	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.1	0.0	0.0	0.2	1.9	0.2	0.0	0.4	1.4	0.0	0.4	0.0	0.1	2.0	0.2	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	22.4	0.3	2.8	0.3	0.4	0.3	1.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD65		ENSG00000235098	"Ankyrin repeat domain 65"	E5RJM6	1	1418420-1421769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;fallopian tube: 33.6"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"myeloid DC: 4.8;plasmacytoid DC: 10.4"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 10.4"	"Group enriched"	"Detected in some"	7	"Hep G2: 20.3;RT4: 20.0;SCLC-21H: 27.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065720	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065720: AB_2685545"	"unprognostic (2.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.64e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.76e-2)"	4.6	1.1	12.4	2.8	20.8	0.4	4.2	8.0	13.3	6.7	4.8	21.0	3.7	2.2	4.0	5.6	6.7	33.6	2.7	2.2	12.0	8.6	1.9	0.9	9.9	7.1	37.8	8.2	6.9	13.3	1.1	0.6	6.3	13.7	8.9	1.8	2.1	14.0	21.2	2.8	4.8	2.1	3.8	16.7	1.4	4.3	3.1	28.0	4.2	1.8	1.0	6.3	13.2	3.3	0.5	10.4	0.3	0.3	0.0	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.5	0.0	2.6	0.2	2.5	0.0	0.3	0.2	0.0	0.0	20.3	0.5	0.0	0.0	0.2	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	2.7	0.0	0.0	20.0	27.7	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	4.8	0.5	0.1	0.4	0.0	0.0	0.0	10.4	0.0	0.2	12.4	20.8	8.0	13.3	12.0	8.6	37.8	8.2	13.7	28.0	20.8	25.3	0.0	11.4	1.9	8.4	0.6	12.7	56.2	20.5	1.8	0.0	21.2	8.3	12.9	0.0	5.0	0.0	0.0	27.8	0.4	3.8	7.3	8.1	0.6	2.0	7.9	1.7	1.8	0.6	0.0	19.2	2.9	3.3	1.8	0.0	16.0	12.0	0.0	27.3	0.3	2.2	0.0	2.6	0.4	0.3	2.8	14.1	0.0	0.0	7.9
ANKS1A	"ANKS1, KIAA0229"	ENSG00000064999	"Ankyrin repeat and sterile alpha motif domain containing 1A"	Q92625	6	34889265-35091413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 74.5;Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036768, HPA036769"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036768: AB_10670923, HPA036769: AB_10672473"	"unprognostic (3.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.79e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (1.18e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.80e-2)"	13.6	15.6	11.8	10.5	20.7	5.0	11.5	19.2	19.9	8.8	20.3	11.6	33.9	9.8	10.2	11.0	15.4	19.8	9.9	14.8	11.7	8.0	10.3	11.6	14.5	8.0	15.0	8.8	14.6	11.0	13.9	12.8	27.3	12.8	9.3	8.7	19.7	8.5	30.4	14.8	11.6	10.9	13.9	10.6	18.6	12.3	23.6	13.9	9.5	11.3	4.2	9.1	22.7	9.9	1.3	3.4	2.4	4.3	0.5	1.5	1.1	8.1	3.6	8.4	8.1	3.8	3.5	12.9	3.4	3.8	3.8	5.0	10.1	4.9	5.4	5.4	3.3	7.3	8.3	9.7	9.1	4.2	4.3	11.4	3.9	4.7	7.6	2.3	6.2	3.9	4.3	8.4	4.9	6.2	4.4	9.1	6.0	6.7	2.5	3.6	5.4	3.7	7.0	6.1	10.5	4.4	4.8	4.4	5.8	8.3	15.7	32.8	8.2	4.9	8.0	25.0	11.0	6.1	7.2	7.9	4.1	5.2	4.2	4.9	3.8	5.8	2.6	3.2	9.4	11.4	0.0	2.0	1.2	0.9	2.9	1.2	1.3	0.8	1.5	1.5	0.5	1.0	0.8	2.4	0.5	4.3	3.4	1.0	1.1	11.8	20.7	19.2	19.9	11.7	8.0	15.0	8.8	12.8	13.9	74.5	10.7	4.6	6.7	10.8	27.5	21.2	12.7	29.4	9.1	12.2	60.9	7.4	0.0	6.6	11.3	34.4	11.8	0.0	5.1	6.3	8.5	9.5	2.3	4.9	9.8	7.9	12.7	50.3	26.9	8.1	11.8	10.1	5.0	4.6	11.3	21.8	8.6	5.8	28.3	5.6	44.8	19.4	8.9	5.8	4.9	17.9	10.4	2.5	7.7	11.5
ANKS1B	"AIDA-1, ANKS2, cajalin-2, EB-1"	ENSG00000185046	"Ankyrin repeat and sterile alpha motif domain containing 1B"	Q7Z6G8	12	98726457-99984654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 66.2;skeletal muscle: 28.2"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 136.4;Horizontal cells: 28.6;Late spermatids: 63.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 12.1;ASC TERT1: 7.1;SCLC-21H: 13.2"									"HPA044628, HPA078230"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA044628: , HPA078230: "	"unprognostic (5.50e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.97e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.75e-3)"	2.3	4.5	21.4	1.7	41.2	1.2	3.7	21.0	66.2	3.3	2.3	27.5	0.0	1.5	3.3	2.4	3.9	4.4	2.2	2.2	28.3	17.3	5.4	1.8	2.0	1.6	20.3	24.8	9.7	2.1	1.9	4.4	2.7	16.0	4.1	2.1	0.1	3.8	3.7	28.2	1.9	1.6	3.3	25.8	2.0	1.8	7.6	23.0	0.0	6.3	0.0	1.3	2.1	0.8	2.1	2.4	5.3	3.1	3.1	8.3	1.3	0.3	2.5	12.1	2.9	4.9	7.1	0.7	0.0	1.2	0.9	0.9	0.3	0.9	1.0	0.5	1.8	3.7	0.5	0.1	0.1	0.3	1.5	0.8	0.1	0.8	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.9	0.2	0.7	0.5	0.5	3.5	0.1	2.2	0.9	0.0	0.3	0.1	0.0	13.2	1.4	1.1	3.9	1.5	1.0	4.5	0.1	0.1	1.1	1.1	0.7	0.7	0.1	0.7	0.6	1.1	0.3	1.1	5.3	1.4	2.1	1.7	2.1	2.5	1.9	2.9	1.6	1.3	2.1	2.4	2.3	3.9	3.1	3.1	2.4	8.3	1.3	21.4	41.2	21.0	27.9	28.3	17.3	20.3	24.8	16.0	23.0	3.0	3.8	0.0	1.1	1.0	13.7	2.5	0.0	5.3	2.3	8.7	17.7	0.3	0.0	0.1	136.4	0.7	0.0	0.0	0.0	0.2	3.2	0.4	1.1	0.2	0.5	28.6	0.0	0.6	0.0	63.3	1.1	0.8	5.0	0.0	0.0	1.7	0.0	0.0	5.6	2.6	2.8	6.5	1.4	4.7	4.5	1.3	0.7	1.0	0.0	0.6
ANKS3	"FLJ32345, FLJ32767, KIAA1977"	ENSG00000168096	"Ankyrin repeat and sterile alpha motif domain containing 3"	Q6ZW76	16	4696510-4734378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 98.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041409, HPA041482"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041409: AB_10794375, HPA041482: AB_10795594"	"unprognostic (3.02e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-3)"	6.9	10.1	7.4	6.4	12.0	4.2	8.9	14.5	11.1	8.1	9.3	8.2	5.0	6.2	8.7	6.7	8.2	9.3	6.8	5.6	8.3	8.5	10.5	5.0	5.8	8.6	10.0	10.9	15.7	16.5	6.8	14.2	5.6	9.7	9.1	3.2	10.9	14.4	10.2	7.7	8.3	4.8	11.7	7.0	5.2	6.1	8.0	7.5	3.2	9.4	3.4	4.7	7.6	7.5	3.3	5.3	0.0	1.6	1.3	3.8	1.1	1.9	23.2	3.0	6.6	5.9	4.9	7.0	8.7	7.1	8.1	7.3	12.0	4.9	4.4	11.0	5.8	3.2	3.9	6.5	4.7	3.6	5.7	12.5	4.0	10.8	2.9	6.4	2.1	3.6	3.0	5.1	7.8	7.5	4.9	1.5	2.9	9.4	1.4	4.8	7.1	4.2	7.9	8.1	2.9	4.5	6.8	7.5	7.9	6.2	2.4	9.8	9.5	4.5	6.6	3.7	1.8	6.6	2.8	2.7	6.0	8.1	11.1	4.4	6.9	12.3	6.6	3.2	2.3	6.8	0.0	1.1	0.0	2.4	1.6	2.9	3.3	2.7	1.7	1.9	3.3	3.8	2.5	0.0	1.3	1.4	5.3	1.7	1.1	7.4	12.0	14.5	11.1	8.3	8.5	10.0	10.9	9.7	7.5	6.0	14.7	4.7	12.4	6.8	42.9	3.2	10.2	12.0	9.1	21.0	104.1	9.6	16.6	15.3	5.5	7.5	7.8	0.0	7.4	7.2	11.0	10.5	0.0	5.7	6.9	47.7	8.6	8.6	2.1	4.2	25.0	6.0	10.1	15.4	10.4	12.4	9.9	14.8	26.5	11.3	98.5	6.5	13.5	24.1	25.8	8.4	5.6	13.1	10.7	6.2
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233665-21253845	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 64.5;kidney: 16.2;liver: 15.0"	"Group enriched"	"Detected in some"	14	"Enterocytes: 78.6;Hepatocytes: 24.1;Intestinal endocrine cells: 24.1;Mucus-secreting cells: 34.5;Paneth cells: 31.7;Proximal tubular cells: 28.1;Undifferentiated cells: 21.9"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;HDLM-2: 5.4;Hep G2: 12.8;OE19: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.1	0.1	0.1	4.3	0.2	0.0	0.1	0.9	0.1	0.1	26.9	0.0	0.0	9.3	0.1	1.5	0.1	0.1	9.2	0.1	0.1	0.1	16.2	15.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	7.6	0.0	0.1	0.0	0.5	0.1	64.5	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.6	2.0	0.4	1.1	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.1	0.0	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	3.3	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.5	0.4	0.4	0.3	0.3	0.2	0.5	0.3	0.2	0.1	0.8	0.4	0.4	2.0	1.1	0.2	0.6	0.3	0.1	0.1	0.2	0.9	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.2	0.6	2.5	0.0	1.2	1.8	0.0	0.0	0.0	0.0	0.7	0.1	78.6	0.0	1.5	0.0	0.0	0.3	1.1	24.1	0.0	0.0	24.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	34.5	1.2	1.2	31.7	0.0	28.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.5	21.9	0.3
ANKS6	"ANKRD14, FLJ36928, NPHP16, SAMD6"	ENSG00000165138	"Ankyrin repeat and sterile alpha motif domain containing 6"	Q68DC2	9	98731329-98796965	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008355	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA008355: AB_2058277"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.31e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.94e-2)"	"prognostic favorable (3.44e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.68e-1)"	5.0	3.7	5.8	4.3	9.9	1.8	4.8	31.2	9.5	7.3	6.5	9.4	2.6	5.9	6.0	7.4	7.5	7.8	7.7	2.9	6.9	6.1	7.7	1.8	7.2	3.4	10.1	4.4	9.6	18.1	10.0	2.8	2.8	11.4	3.6	7.3	4.2	3.1	3.5	3.3	4.4	5.4	8.9	6.1	2.5	7.7	6.1	9.2	1.8	13.4	2.4	4.5	5.4	6.4	0.9	0.0	0.0	0.1	0.0	2.1	0.2	5.2	7.9	7.3	12.8	6.1	5.0	4.9	3.8	6.6	4.3	5.2	4.3	3.8	9.7	2.9	5.4	6.2	15.6	5.3	6.4	2.3	13.5	5.5	2.3	4.7	1.8	6.0	1.2	1.6	6.1	8.1	5.9	6.0	5.3	4.9	9.0	16.3	2.3	3.3	8.7	0.5	2.5	11.5	23.5	8.6	6.5	18.1	0.7	7.7	3.3	4.7	5.4	1.6	9.4	4.3	6.2	0.0	2.7	4.9	4.5	4.9	12.2	3.7	4.5	7.6	1.6	6.3	4.4	6.4	0.0	0.1	0.0	1.3	0.0	0.7	0.9	0.7	2.1	0.0	0.6	1.8	0.9	0.0	0.0	0.0	0.0	1.1	0.2	5.8	9.9	31.2	9.5	6.9	6.1	10.1	4.4	11.4	9.2	6.0	8.0	2.4	0.7	1.5	6.1	4.4	12.7	5.3	4.5	12.2	7.9	2.3	3.3	3.6	2.9	3.1	4.2	0.0	7.7	2.5	3.4	3.4	1.1	1.5	1.6	0.0	4.7	1.8	1.5	4.9	2.6	1.1	0.0	1.0	6.8	1.4	7.0	3.5	4.2	5.0	0.6	0.0	2.3	4.2	4.9	1.0	0.9	2.1	7.6	2.4
ANKZF1	"FLJ10415, ZNF744"	ENSG00000163516	"Ankyrin repeat and zinc finger domain containing 1"	Q9H8Y5	2	219229757-219236669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035208	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035208: AB_10602229"	"unprognostic (5.23e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.27e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (3.87e-2)"	"unprognostic (9.68e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-3)"	10.1	11.1	14.8	19.0	19.8	13.7	12.9	38.4	25.9	13.8	15.4	17.5	21.7	17.5	14.3	14.7	17.1	21.1	11.7	13.8	12.7	9.6	15.2	15.8	13.2	23.2	19.6	13.5	19.6	19.0	12.3	22.7	11.3	16.4	16.6	10.4	13.6	18.2	22.7	18.9	21.7	19.5	9.5	18.5	21.0	15.1	8.7	18.8	18.7	14.0	8.8	19.8	16.8	16.2	11.7	8.3	10.7	10.6	20.6	17.8	11.0	19.5	3.9	5.2	7.6	7.2	5.9	20.5	6.5	6.5	9.0	11.4	9.5	8.3	4.1	11.6	2.7	9.9	14.4	6.9	11.0	6.6	8.6	7.1	9.1	11.6	8.8	7.1	5.6	9.0	6.0	21.9	6.7	10.6	14.8	6.1	10.8	15.3	9.5	4.5	8.6	8.7	14.7	8.5	8.0	7.1	8.9	6.2	13.2	4.9	5.0	6.7	6.2	6.6	15.6	12.5	13.5	4.0	13.7	6.5	7.4	5.7	5.9	8.1	20.9	11.8	7.4	12.6	8.5	3.2	8.4	7.7	8.8	14.6	7.5	15.4	11.0	14.7	14.4	7.8	11.7	17.8	16.3	10.7	20.6	10.6	8.3	14.0	11.0	14.8	19.8	38.4	25.9	12.7	9.6	19.6	13.5	16.4	18.8	14.9	15.0	12.3	13.1	8.2	34.6	8.1	10.2	54.9	22.7	12.2	29.5	8.7	11.6	17.4	3.8	7.9	16.3	23.3	10.9	18.1	7.4	12.2	21.8	10.9	6.6	30.2	9.2	6.2	10.0	3.1	22.2	9.3	10.1	12.6	19.3	22.3	13.7	17.5	15.6	9.6	53.8	6.5	6.4	9.6	15.9	8.7	9.7	31.9	16.6	9.2
ANXA10	ANX14	ENSG00000109511	"Annexin A10"	Q9UJ72	4	168092515-168187690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 33.5;stomach 1: 105.3"	"Group enriched"	"Detected in some"	14	"Exocrine glandular cells: 153.7;Hepatocytes: 62.3;Pancreatic endocrine cells: 198.3"	"Group enriched"	"Detected in many"	5	"pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 72.5;PC-3: 32.8;RT4: 44.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA005469, HPA074650"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Nucleoplasm, Nucleoli"	Vesicles	"HPA005469: AB_1844849, HPA074650: "	"unprognostic (2.29e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.29e-2)"	"prognostic favorable (3.64e-6)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-1)"	"unprognostic (8.61e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-3)"	"unprognostic (8.41e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.89e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.4	0.1	4.2	0.1	0.1	0.5	0.0	33.5	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	1.5	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	105.3	0.1	0.1	0.1	0.1	0.1	0.1	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	32.8	0.0	0.1	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	10.2	0.0	2.3	0.0	2.0	0.0	0.0	3.5	7.3	0.0	0.0	0.0	153.7	0.0	0.0	0.6	0.0	62.3	0.0	0.0	0.0	1.3	2.7	0.0	0.0	0.0	0.0	1.0	0.4	0.0	198.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 180.9;Intestinal endocrine cells: 43.0;Mucus-secreting cells: 139.9"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Region enhanced"	"Detected in single"		"midbrain: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 23.8;HDLM-2: 12.3"					"Low region specificity"	"Detected in all"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.1	0.3	0.7	0.5	0.0	0.4	0.1	0.4	0.2	30.3	0.4	41.9	66.5	1.1	2.6	0.2	13.3	38.7	0.1	0.5	0.6	2.1	4.3	0.1	0.1	3.0	0.1	0.9	0.3	0.0	0.1	0.1	0.7	1.1	8.1	0.2	0.2	20.7	0.1	0.1	108.6	0.4	8.0	0.1	0.7	2.3	0.3	0.1	0.1	0.1	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.0	1.4	1.4	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.5	0.6	3.0	0.1	0.7	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.3	180.9	5.3	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	43.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	139.9	0.0	0.1	18.7	0.0	18.5	9.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	20.0	0.0
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		16000000	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	91.7	29.8	4.9	23.5	7.1	6.6	50.1	4.5	5.6	65.1	39.1	8.6	38.2	26.4	38.3	40.3	158.8	26.2	54.9	29.9	4.7	5.5	36.7	28.5	62.0	46.6	10.8	5.7	23.3	94.3	29.7	12.8	84.1	25.7	29.5	35.2	31.7	74.7	27.9	22.7	77.3	71.9	37.1	15.1	32.6	25.6	18.7	7.1	14.6	31.0	122.7	81.4	34.0	87.4	35.5	209.6	183.3	138.0	15.2	83.9	150.8	144.7	161.6	8.5	3.8	116.8	187.4	37.1	173.0	111.6	109.9	96.5	76.6	69.9	0.3	142.5	223.8	82.7	154.9	38.0	324.9	120.6	30.8	4.0	2.9	77.8	29.7	70.4	0.1	2.1	91.5	88.7	78.1	168.4	132.2	204.9	2.1	11.5	16.9	234.8	16.8	0.6	8.5	18.5	123.9	125.9	1.7	46.9	8.1	194.9	88.2	11.2	6.3	68.4	15.6	67.9	92.0	33.4	6.0	233.6	93.8	127.8	314.4	169.8	6.3	20.7	2.8	88.3	1.6	186.5	183.3	138.0	17.7	33.4	122.6	36.5	35.5	38.5	38.5	209.6	16.9	4.5	18.1	3.9	15.2	129.1	32.0	83.9	150.8	4.9	7.1	4.5	5.6	4.7	5.5	10.8	5.7	25.7	7.1	1989.1	372.8	135.8	2699.6	2231.6	2.1	19.9	922.3	1675.6	1452.5	532.1	0.0	1604.6	11.6	3597.2	77.7	904.5	724.0	23.3	2130.9	2200.2	1229.1	3363.5	101.8	70.0	1517.4	0.0	99.2	465.3	432.0	90.7	714.0	1131.8	1344.5	1757.5	521.7	18.0	3399.7	582.2	600.4	22.4	6.8	181.1	774.1	7.0	17.7	2032.4	961.8	162.4	580.5	3656.9
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039081-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 28.9;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 27.5;Ito cells: 22.1;Kupffer cells: 18.7;T-cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 10.1;JURKAT: 12.3;MOLT-4: 10.8;REH: 11.3;U-937: 41.9"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	5.5	1.6	1.3	8.8	4.1	13.1	8.6	1.0	1.5	5.7	4.1	2.0	1.8	2.5	3.6	3.9	4.6	3.7	2.9	2.2	1.7	1.3	2.4	1.4	7.2	19.0	2.6	0.5	2.0	1.1	0.7	1.8	2.6	1.4	5.7	2.2	2.1	2.9	1.9	4.4	2.2	7.5	3.2	1.9	14.9	2.4	2.3	2.0	25.1	3.1	1.8	13.4	5.2	5.6	8.9	1.4	1.5	2.1	6.5	28.9	7.7	0.7	0.7	0.6	0.4	1.1	3.0	0.2	0.2	0.1	0.1	0.3	1.4	0.9	2.8	2.5	0.5	0.8	0.3	1.8	0.2	0.1	4.6	1.4	0.9	1.9	0.6	1.5	1.0	0.4	10.1	0.1	0.8	0.1	0.0	5.6	12.3	0.6	3.6	0.7	1.0	10.8	1.5	0.0	0.6	5.5	11.3	1.4	1.6	0.3	0.4	2.2	0.0	1.0	0.2	0.2	0.1	0.3	1.9	3.5	0.2	0.0	0.3	0.9	1.6	2.3	1.1	1.3	41.9	0.5	1.5	1.1	0.5	16.0	0.7	18.6	8.7	16.6	17.5	1.0	8.9	28.9	21.2	0.9	6.5	2.1	1.4	17.7	7.7	1.3	4.1	1.0	1.5	1.7	1.3	2.6	0.5	1.4	2.0	0.0	16.4	27.5	1.6	3.3	0.0	1.2	2.5	2.7	2.3	0.0	0.0	0.4	0.0	0.2	3.0	15.4	0.2	0.0	0.0	0.9	4.1	1.2	14.0	0.8	7.6	0.0	1.7	22.1	18.7	1.3	1.4	6.9	6.8	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	2.8	0.7	0.8	1.9	0.3	60.4	0.5	0.9
ANXA4	ANX4	ENSG00000196975	"Annexin A4"	P09525	2	69644425-69827100	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 212.1;pancreas: 160.1"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 1936.3;Ductal cells: 852.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 68.0;Hep G2: 71.0;RPTEC TERT1: 99.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB005076, HPA007393, CAB017560"	Enhanced		Approved	Cytosol		NA	NA		580000	Cytosol		"CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168"	"prognostic unfavorable (8.55e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (7.23e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.97e-2)"	18.7	5.9	4.2	12.2	4.3	4.1	9.7	1.3	3.0	16.9	32.7	5.3	12.9	43.2	22.8	11.5	16.1	11.9	212.1	6.8	4.3	3.1	36.2	30.9	19.2	5.9	5.1	2.4	12.3	160.1	5.8	3.3	50.9	11.8	18.1	14.9	10.3	11.7	11.4	6.9	12.9	85.7	12.3	6.5	7.2	16.9	5.6	3.6	4.0	24.7	12.9	8.3	11.0	13.2	17.6	21.3	27.6	23.7	3.6	10.3	8.9	10.8	39.4	0.5	4.9	30.3	26.2	1.8	10.5	15.9	4.3	6.1	5.9	19.5	3.5	68.0	17.1	12.9	16.8	3.8	16.9	4.5	10.0	3.2	5.4	3.6	71.0	21.5	1.8	7.0	15.5	16.7	5.8	14.2	10.2	11.1	1.7	0.3	3.2	11.8	9.8	2.8	3.4	0.9	44.1	5.4	2.9	1.1	4.3	99.5	15.7	0.8	3.7	11.6	16.1	15.8	6.0	5.3	24.5	16.0	8.0	3.9	10.6	5.8	1.3	1.4	0.1	12.4	9.3	5.4	27.6	14.8	11.9	10.3	17.4	7.8	17.6	5.3	7.7	21.3	15.9	0.9	5.8	2.0	3.6	23.7	6.4	5.9	8.9	4.2	4.3	1.3	3.0	4.3	3.1	5.1	2.4	11.8	3.6	190.6	117.9	20.5	84.8	65.9	7.2	9.8	1936.3	278.4	133.1	80.3	5.9	74.2	187.3	852.8	12.6	41.2	479.2	0.0	308.4	326.2	105.4	51.9	108.6	59.2	193.0	7.9	17.9	27.0	44.2	6.5	59.8	61.9	87.7	107.4	167.5	40.5	315.1	293.7	86.7	253.0	56.9	6.5	52.0	11.5	3.6	69.5	367.6	32.5	132.9	90.2
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667955-121697113	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 989.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		NA	NA		6100000	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.01e-5)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (9.29e-7)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.26e-4)"	130.1	65.6	24.6	43.2	26.1	15.3	151.3	10.0	17.9	85.9	35.6	33.8	45.1	17.5	64.4	45.9	42.8	42.4	54.7	46.8	22.5	25.1	62.2	73.1	68.0	49.3	37.8	16.4	62.6	52.1	25.7	55.3	135.8	40.8	57.1	29.8	56.1	83.7	49.8	23.1	28.0	30.1	68.3	51.5	67.9	39.4	33.3	27.8	15.9	61.8	32.5	31.2	57.3	69.8	13.9	80.0	37.2	87.3	4.8	29.9	64.7	30.9	23.0	31.3	17.3	151.1	115.4	34.2	110.1	98.2	57.1	51.2	16.7	13.5	2.3	19.9	151.0	40.0	11.0	19.9	48.7	53.7	22.1	11.4	6.9	21.7	45.4	86.6	14.9	12.0	66.5	23.7	48.6	48.0	65.3	75.3	1.6	6.8	18.7	144.2	20.5	15.1	5.1	16.1	28.0	48.2	0.5	71.7	4.7	95.9	4.6	8.0	9.7	39.7	15.5	100.2	64.9	13.6	17.9	55.6	91.0	44.5	65.0	32.7	16.8	20.3	5.2	58.2	8.1	106.9	9.2	74.0	37.2	11.9	87.3	15.5	13.9	18.2	14.8	80.0	8.8	6.1	8.8	17.1	4.8	79.7	9.7	29.9	64.7	24.6	26.1	10.0	17.9	22.5	25.1	37.8	16.4	40.8	27.8	226.3	227.0	73.7	202.4	177.1	4.9	75.9	209.0	279.7	232.0	125.6	23.6	989.9	252.0	588.9	12.3	263.9	14.2	0.0	297.2	883.6	492.7	311.2	142.3	46.9	681.5	12.7	46.7	191.5	406.3	27.8	351.8	564.0	334.0	369.7	81.0	152.9	380.8	32.0	344.4	128.7	28.3	291.1	342.1	9.5	14.1	123.1	954.0	91.3	35.2	131.9
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100712-151157882	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 703.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 106.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		970000	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	78.3	38.2	22.2	44.7	38.3	28.6	109.1	22.0	70.0	37.4	50.2	13.3	34.1	12.5	52.2	34.2	27.0	39.5	39.0	53.0	28.7	37.8	22.1	54.7	33.7	66.7	38.6	30.0	54.9	27.6	8.2	41.4	47.4	62.5	39.3	24.0	36.7	19.7	60.7	85.4	16.6	30.7	82.8	16.8	41.4	31.3	16.8	7.2	44.6	25.5	34.7	50.1	53.0	51.4	36.4	22.4	15.0	15.3	47.0	58.1	50.1	0.3	3.8	24.6	36.3	106.1	48.5	6.7	49.5	58.7	37.2	51.8	13.0	1.9	3.3	17.4	63.0	30.6	0.0	19.0	23.3	37.8	13.3	6.8	1.9	7.8	24.4	35.7	12.0	12.0	60.1	0.1	31.6	5.1	55.8	47.3	23.1	2.6	46.1	87.7	11.8	22.1	18.5	6.9	0.1	11.0	14.5	76.0	3.6	5.5	0.0	1.5	6.4	5.1	35.1	21.3	40.2	60.1	22.7	41.5	35.0	10.6	2.5	12.9	25.8	35.1	0.5	19.0	56.2	5.6	13.8	15.3	15.0	58.1	10.3	38.6	35.0	43.4	52.6	22.4	36.4	30.4	36.9	3.3	47.0	4.6	5.5	34.8	50.1	22.2	38.3	22.0	70.0	28.7	37.8	38.6	30.0	62.5	7.2	14.9	22.4	101.1	11.4	9.7	15.2	49.2	7.6	6.7	0.0	22.7	5.9	54.7	21.6	5.4	35.0	27.8	0.3	23.3	15.2	28.6	64.5	7.2	54.5	119.4	69.2	14.3	20.5	73.6	41.2	35.0	114.2	32.6	52.3	703.3	0.6	42.9	18.1	0.3	198.7	35.6	109.8	226.4	105.6	2.7	1.0	7.0	148.2	109.7	1.9	1.1
ANXA7	ANX7	ENSG00000138279	"Annexin A7"	P20073	10	73375101-73414076	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 438.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 124.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004312, HPA064290"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		540000	Nucleoplasm	Cytosol	"CAB004312: AB_626681, HPA064290: AB_2685233"	"unprognostic (1.48e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.06e-2)"	27.4	27.1	28.0	18.5	28.7	24.1	29.3	23.5	33.1	25.2	21.1	25.0	15.5	13.0	25.1	28.2	24.7	19.7	20.7	36.6	27.2	26.8	39.4	40.8	21.5	33.0	26.0	28.8	26.2	24.2	103.3	28.1	23.3	24.9	24.1	25.4	22.8	26.0	25.3	75.4	21.5	17.3	32.3	25.4	21.3	18.0	11.7	15.5	17.1	30.2	28.2	26.7	27.6	20.5	35.3	36.4	53.0	34.9	33.0	44.4	42.5	24.7	17.9	7.0	17.1	27.5	27.1	15.3	16.6	43.7	21.7	18.4	26.2	29.4	9.9	16.9	31.2	14.3	20.8	13.0	19.6	21.6	24.4	9.7	14.0	9.0	23.2	24.3	19.9	6.4	16.8	19.1	27.1	48.7	19.1	19.2	10.8	18.1	28.2	27.6	19.8	11.2	12.8	7.8	14.8	124.5	9.3	20.0	18.0	37.6	15.2	5.6	7.8	18.6	43.1	15.6	10.3	26.9	10.6	17.9	8.9	16.1	26.8	21.3	18.3	25.9	14.0	21.0	25.8	6.8	53.0	34.9	45.1	22.2	26.2	30.1	35.3	34.4	27.7	36.4	24.0	31.5	27.7	35.4	33.0	25.6	15.6	44.4	42.5	28.0	28.7	23.5	33.1	27.2	26.8	26.0	28.8	24.9	15.5	62.5	47.8	60.3	122.2	76.5	30.6	118.6	63.7	88.3	48.9	89.0	13.7	182.8	164.2	134.1	6.4	80.4	61.4	23.3	132.0	94.9	102.4	102.2	105.2	113.2	105.4	9.5	184.2	56.4	82.6	3.6	126.8	86.9	81.0	438.2	73.6	57.2	111.8	42.1	164.1	200.8	21.6	25.8	92.7	20.5	33.6	80.8	148.3	76.1	67.3	127.8
ANXA8	ANX8	ENSG00000265190	"Annexin A8"	P13928	10	47460162-47484158	"Predicted intracellular proteins"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"esophagus: 41.6;skin 1: 60.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 92.3;Ciliated cells: 25.4;Club cells: 73.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"					"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 73.7;HBEC3-KT: 107.5;hTCEpi: 60.8;hTERT-HME1: 23.2;RT4: 27.0"									"HPA045246, HPA047451"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (8.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.55e-15)"	"unprognostic (1.04e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	0.1	0.0	0.1	3.7	0.1	0.0	2.3	0.1	0.1	2.9	0.4	0.1	0.1	0.0	0.1	1.3	41.6	0.2	0.1	0.1	0.1		0.1	0.1	2.4	0.1	0.1	0.1	0.4	0.1	0.0	0.1	7.7	0.1	1.2	0.0	0.3	0.1	1.8	0.1	60.7	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	2.5	9.5	10.2	0.1	0.0	5.5	1.1	2.1	0.7	0.0	0.5	20.5	2.6	0.0	0.0	0.0	0.0	6.1	0.4	0.0	0.0	0.0	1.3	5.9	0.0	0.4	0.1	0.3	73.7	0.0	107.5	0.0	4.7	0.0	0.0	6.7	0.0	4.4	0.0	0.2	0.0	60.8	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	10.7	3.1	0.0	1.6	0.0	0.5	0.0	0.0	6.4	0.1	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5											92.3	8.2	0.0	9.1	1.0	0.0	1.6	5.1	25.4	73.9	3.5	0.0	5.7	0.0	3.2	0.4	0.4	0.7	0.0	0.4	7.2	0.5	1.1	1.1	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.8	5.1	0.0	0.0	15.7
ANXA8L1	"ANXA8L2, bA145E20.2, bA301J7.3"	ENSG00000264230	"Annexin A8 like 1"	Q5VT79	10	46375627-46391784	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 75.4;tongue: 34.2"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 26.8;Cholangiocytes: 17.8;Ciliated cells: 20.1;Club cells: 36.4;Extravillous trophoblasts: 14.1"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	5	"classical monocyte: 3.2;myeloid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;monocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 72.8;HBEC3-KT: 110.8;hTCEpi: 29.4;SiHa: 26.2"									"HPA045246, HPA047451"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (3.67e-3)"	"unprognostic (4.56e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.94e-3)"	"unprognostic (8.33e-5)"	"unprognostic (3.43e-1)"	"unprognostic (8.26e-10)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	4.8	0.0	0.0	5.6	0.3	0.0	0.0	0.0	0.7	1.2	35.9	1.2	0.0	0.9	0.0		0.0	0.1	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.9	0.0	0.0	1.1	0.7	0.0	75.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	34.2	13.3	6.9	0.6	0.0	5.0	0.8	3.2	0.5	0.0	0.5	14.5	3.7	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.3	2.6	0.0	0.1	0.0	0.1	72.8	0.0	110.8	0.0	6.2	0.0	0.0	7.1	0.0	2.6	0.0	0.1	0.0	29.4	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	16.9	0.0	0.0	26.2	2.3	0.0	1.4	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5											26.8	1.4	0.0	3.1	0.0	0.0	3.0	17.8	20.1	36.4	0.0	0.0	7.2	0.0	0.7	0.1	0.0	2.0	0.0	0.2	14.1	0.8	1.7	0.0	0.0	0.6	0.0	0.0	0.6	0.0	1.3	0.3	0.0	0.0	0.0	0.1	0.1	5.6	0.3	0.0	0.0	0.0	12.9	0.0	0.2	1.0	1.0	5.3	0.0	0.1	3.0
ANXA9	ANX31	ENSG00000143412	"Annexin A9"	O76027	1	150982017-150995634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 62.0;seminal vesicle: 78.1"	"Cell type enhanced"	"Detected in many"	15	"Cholangiocytes: 45.9;Hepatocytes: 14.9;Proximal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.5;Hep G2: 14.6;MCF7: 19.5;OE19: 17.0;T-47d: 48.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028404, HPA028698"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA028404: AB_10599190, HPA028698: AB_10600227"	"unprognostic (4.06e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.93e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.74e-6)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.72e-2)"	2.4	1.1	1.2	0.9	1.2	0.3	2.6	1.3	2.5	2.3	0.9	0.6	62.0	1.4	6.0	11.6	10.7	2.3	12.5	1.9	1.4	1.0	12.1	15.8	1.2	0.5	1.8	0.8	1.8	32.0	9.9	1.2	0.7	1.3	4.1	0.0	1.2	2.5	78.1	0.9	18.9	1.2	0.9	3.2	1.0	1.3	3.6	0.6	1.3	10.4	9.1	21.1	4.5	4.4	0.5	3.8	2.5	3.1	0.1	0.8	0.8	4.0	0.9	1.4	1.4	0.0	0.0	4.1	0.3	0.2	0.0	0.0	12.1	14.5	0.1	0.8	0.0	0.4	2.4	0.0	0.2	0.0	1.2	1.4	2.0	1.4	14.6	0.0	0.7	0.9	0.0	0.1	0.0	0.0	3.2	0.0	0.6	0.9	4.4	0.0	19.5	0.1	1.0	0.3	17.0	0.2	0.9	0.2	4.8	0.0	5.7	2.2	1.2	0.9	10.0	0.5	0.8	48.4	1.2	1.5	0.3	0.4	0.2	0.2	1.3	4.1	6.3	2.1	1.3	1.1	0.0	3.1	1.8	0.1	1.8	0.8	0.5	0.3	0.5	3.8	0.1	0.8	0.2	2.5	0.1	0.4	0.0	0.0	0.8	1.2	1.2	1.3	0.9	1.4	1.0	1.8	0.8	1.3	0.6	0.0	0.6	0.0	0.3	0.1	0.0	0.3	45.9	1.4	0.0	12.2	0.0	1.7	3.3	10.1	0.7	0.0	0.0	0.0	6.8	0.2	0.6	0.1	1.1	14.9	1.8	0.0	0.0	0.0	0.8	0.0	1.4	0.0	1.7	0.0	0.0	0.0	3.1	0.0	1.1	33.2	0.0	0.0	0.1	6.1	0.1	0.0	1.3	0.0	0.4	4.9
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	18	"ASC diff: 85.5"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	85.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.3	1.5	0.1	0.1	4.7	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3	3.0	8.9	0.8	0.0	2.6	0.0	3.2	0.0	1.4	3.4	0.0	0.0	0.1	0.0	0.1	3.8	4.7	0.0	0.0	0.2	0.1	2.6	0.2	1.1	0.0	1.1	0.0	0.0	22.7	3.0	2.1	3.1	0.5	3.3	0.0	0.0	0.4	0.1	0.0	70.4	0.7	0.5	116.4	56.5	0.9	0.7	1.6	0.2	0.0	0.0	0.3
AP001273.2		ENSG00000284057			11	93741664-93812378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 8.1"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 6.5"									"HPA040511, HPA046619"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA040511: AB_10795369, HPA046619: "																		2.4	3.0	1.8	4.2	3.4	0.6	2.7	2.8	2.4	3.6	6.1	3.5	3.6	8.2	2.6	3.0	2.9	2.5	3.3	4.0	2.0		16.9	17.6	3.6	1.7	3.9	1.9	4.8	5.4	5.3	5.9	2.8	3.2	4.5	2.7	4.2	3.8	2.8	4.2	3.7	11.1	2.9	4.5	1.9	3.7	2.6	3.6	4.2	5.7	2.0	1.8	3.0	1.0	2.7	2.9	4.4	2.9	3.0	3.8	2.0	0.2	0.0	4.5	0.8	3.3	0.0	0.6	0.0	1.4	0.9	1.9	1.5	1.1	0.3	4.0	2.4	0.0	1.7	5.0	0.7	0.0	1.3	0.0	0.0	1.5	0.0	0.8	0.0	0.9	0.0	0.7	0.0	0.5	3.4	0.0	2.6	0.9	0.5	5.2	0.0	2.1	3.5	1.9	6.5	0.0	1.0	2.6	1.7	4.8	0.0	0.3	0.4	0.0	1.3	3.5	3.8	2.0	0.9	2.2	0.0	0.8	0.7	1.8	0.9	0.9	3.7	0.3	1.1	1.6	2.9	2.9	4.4	3.2	2.1	3.0	2.7	2.6	2.6	2.9	1.0	2.9	3.6	4.4	3.0	2.3	1.5	3.8	2.0											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP001781.2		ENSG00000258529			11	111786286-111879425	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 6.0;HeLa: 4.7;U-698: 4.5"									HPA038575	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038575: AB_10672718"																		2.2	0.2	1.7	2.8	2.2	2.9	2.5	0.4	2.7	0.4	3.6	1.9	1.0	2.9	2.0	2.1	0.9	0.9	2.0	0.9	3.0		1.2	0.7	2.6	4.1	1.3	1.1	1.5	1.2	1.7	0.4	0.4	2.2	1.2	2.5	1.5	2.8	0.2	1.2	4.1	0.6	1.3	2.2	3.6	2.1	5.6	1.5	5.7	1.3	0.7	3.7	0.2	0.0	1.6	2.0	1.3	1.6	1.7	3.6	2.9	0.3	0.1	1.3	1.3	0.0	1.8	0.4	1.8	0.1	0.3	0.0	6.0	0.0	0.2	0.9	0.0	1.6	2.3	0.0	0.0	1.3	0.5	0.0	3.4	4.7	0.4	0.0	0.0	0.8	2.5	2.2	1.7	3.4	1.0	0.0	2.0	0.3	2.2	0.0	0.0	1.3	2.6	0.5	0.0	0.0	0.0	0.0	1.7	1.0	1.9	0.0	0.0	1.7	0.0	0.0	0.0	1.2	1.3	0.2	2.4	0.7	1.2	0.0	1.7	1.3	4.5	0.7	3.1	0.4	1.0	1.0	1.3	3.3	1.6	2.2	1.4	2.6	2.1	1.6	1.6	3.6	1.5	0.1	1.7	1.3	2.0	0.9	2.9											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP002495.1		ENSG00000254469	"Putative short transient receptor potential channel 2-like protein "	Q6ZNB5	11	71865509-71928654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 2.7;Cytotrophoblasts: 4.7;Extravillous trophoblasts: 2.1;Hofbauer cells: 1.8;Syncytiotrophoblasts: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA051121, HPA051124"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		NA	NA			Nucleoli	"Mitotic chromosome"	"HPA051121: AB_2681349, HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	5.8	6.9	8.2	7.7	7.3	9.1	7.3	7.4	8.7	7.5	6.3	11.6	21.7	6.1	9.2	13.2	6.2	7.2	5.0	4.8	6.4	4.9	7.6	5.1	5.4	8.9	6.8	5.4	12.1	7.2	7.4	12.7	4.8	6.6	7.2	8.5	10.4	7.9	15.7	5.9	8.8	7.5	6.4	6.5	7.9	6.9	9.7	11.9	11.6	8.7	3.6	12.2	7.1	6.8	6.0	7.5	3.4	4.5	1.8	8.5	3.2	2.8	6.4	5.1	4.8	1.9	2.0	3.2	3.3	2.5	3.5	3.3	7.6	7.3	6.2	3.0	2.1	4.2	9.2	5.4	3.4	3.9	9.0	4.7	10.0	7.2	4.5	1.4	4.8	3.4	2.6	1.6	5.7	4.6	2.8	5.2	8.8	6.7	9.2	3.5	5.8	4.8	3.5	5.6	9.8	4.7	4.0	18.7	4.3	3.7	3.6	7.6	7.8	4.8	4.5	10.1	3.9	6.5	2.4	4.9	2.7	4.8	5.2	2.0	5.7	9.1	7.7	4.7	5.1	4.4	3.4	3.0	2.5	4.6	4.5	2.9	4.2	8.5	6.3	3.5	6.0	8.2	6.8	2.6	1.8	2.7	7.5	7.1	3.2	8.2	7.3	7.4	8.7	6.4	4.9	6.8	5.4	6.6	11.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
AP003419.1		ENSG00000256514			11	67351572-67373584	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 2.7;Club cells: 3.4;granulocytes: 3.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.6"									HPA078008			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA078008: "										"unprognostic (1.64e-3)"			"unprognostic (1.63e-1)"			"unprognostic (2.44e-1)"		3.8	1.3	1.2	12.0	1.3	2.1	5.9	0.8	1.2	10.8	6.4	1.5	3.5	1.5	16.4	5.2	4.7	1.8	6.7	3.7	0.8		14.5	9.4	4.6	6.2	0.9	1.3	12.3	6.7	1.0	1.1	10.7	3.2	3.0	8.9	3.5	2.4	2.7	3.7	2.4	1.9	5.0	1.5	7.4	3.2	3.6	1.0	1.1	5.1	9.5	14.9	4.7	2.1	4.8	17.4	2.7	4.8	3.4	18.6	9.0	0.4	1.6	1.6	2.4	21.7	28.5	0.3	2.3	18.2	6.1	5.8	0.0	32.6	0.4	3.7	30.5	7.2	2.2	2.1	21.6	4.4	0.0	0.0	1.7	0.0	0.0	27.3	0.5	4.1	29.8	21.4	14.1	28.2	28.0	16.5	5.7	0.1	9.1	24.2	0.0	2.9	2.2	0.4	27.9	0.0	2.2	3.2	3.0	20.4	0.1	0.2	0.5	2.1	3.4	6.8	9.0	7.2	3.2	6.1	8.5	0.0	5.4	1.3	0.0	0.0	3.2	20.7	1.5	4.4	2.7	0.8	2.4	10.4	2.3	10.8	2.8	17.7	18.6	1.4	4.8	16.7	14.4	1.1	3.4	4.8	17.4	16.2	9.0											0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 beta 1 subunit"	Q10567	22	29327680-29423179	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 116.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		1000000	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	22.2	25.8	28.0	32.3	35.2	29.9	17.2	37.3	43.1	17.2	23.9	26.5	23.9	32.1	14.8	18.4	46.4	17.7	22.0	16.6	24.4	30.4	24.2	25.8	21.2	37.2	29.4	24.1	12.7	28.4	48.2	31.1	32.3	31.9	27.3	21.8	24.1	29.5	31.2	31.3	34.0	28.7	19.3	22.4	33.0	24.9	23.4	16.7	25.2	21.6	25.5	37.4	25.6	21.0	12.2	16.9	3.1	17.3	4.0	5.8	11.6	26.4	15.1	15.7	16.7	12.0	8.8	19.6	18.6	20.8	22.9	22.0	23.1	10.9	14.6	12.4	21.1	10.8	23.8	22.5	31.4	14.6	18.8	32.8	24.2	19.6	13.1	13.4	34.5	33.6	12.7	11.7	21.9	17.7	10.6	31.8	5.5	16.5	17.9	15.2	28.9	14.6	11.4	12.2	39.2	17.2	27.9	17.3	38.9	16.2	60.2	24.9	17.6	23.1	27.1	11.6	11.2	22.0	15.8	27.4	26.5	16.4	15.1	19.4	19.5	10.1	26.8	18.8	15.1	15.4	0.0	15.5	3.1	5.8	17.3	5.8	10.1	3.9	4.9	16.9	12.2	3.2	3.2	1.7	4.0	17.3	5.2	5.2	11.6	28.0	35.2	37.3	43.1	24.4	30.4	29.4	24.1	31.9	16.7	11.9	16.0	31.4	7.7	6.4	25.7	14.5	28.1	9.4	11.4	21.0	37.3	42.2	19.9	40.6	6.3	16.7	63.6	23.3	35.1	25.4	7.8	16.3	4.7	29.2	116.9	42.9	20.7	41.7	83.2	10.4	10.9	34.0	11.8	26.2	22.1	26.2	48.1	26.4	11.7	18.8	37.8	6.5	6.9	22.1	13.6	8.0	57.1	15.2	26.2	15.2
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 alpha 2 subunit"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		93000	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: AB_2678283"	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	21.9	11.1	20.2	8.7	20.7	18.4	23.2	50.9	32.4	17.5	13.9	9.5	10.4	16.8	16.3	8.5	12.2	21.5	10.1	14.7	22.6	20.0	19.4	16.3	13.3	18.1	16.1	21.1	11.2	14.7	7.8	15.5	16.3	16.9	15.5	16.3	11.5	21.7	14.7	13.3	16.5	12.0	18.5	18.1	34.5	17.0	16.4	6.7	12.4	12.1	5.0	9.1	10.5	10.5	3.4	3.7	6.8	4.6	3.4	5.4	1.7	5.5	2.5	3.0	8.8	11.4	11.7	7.4	8.0	2.7	4.9	4.0	0.9	6.0	5.8	7.0	9.5	4.6	7.3	7.0	4.4	3.2	4.2	18.3	1.7	7.7	3.1	4.5	2.2	4.2	13.8	4.8	2.4	4.9	12.0	6.8	3.9	5.9	4.5	5.0	0.5	2.0	2.5	1.7	7.1	14.3	3.6	2.0	6.3	7.4	5.1	9.5	8.1	8.9	7.3	1.1	5.3	4.3	0.8	10.6	1.6	1.9	2.2	4.0	3.6	2.9	4.3	3.0	2.9	2.4	3.3	4.6	3.8	3.1	4.6	1.8	1.7	3.2	1.8	3.7	3.4	3.4	3.5	6.8	3.4	3.8	3.7	5.4	1.7	20.2	20.7	50.9	32.4	22.6	20.0	16.1	21.1	16.9	6.7	35.7	17.9	12.7	10.5	12.7	45.7	11.3	22.9	20.1	14.8	59.3	56.9	33.3	33.2	32.3	35.0	28.7	39.6	23.3	15.9	35.6	25.3	20.9	26.5	52.5	68.3	95.3	33.7	81.0	78.2	20.9	31.9	26.9	8.5	30.7	27.3	29.4	24.3	20.1	26.2	42.7	64.8	25.8	14.4	46.9	25.1	9.9	23.8	20.8	32.0	9.7
AP3B1	"ADTB3A, HPS2"	ENSG00000132842	"Adaptor related protein complex 3 beta 1 subunit"	O00203	5	78000525-78294755	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Disease mutation, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038737, HPA045458"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA038737: AB_10670788, HPA045458: AB_2679333"	"unprognostic (9.14e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.37e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (7.97e-6)"	"unprognostic (1.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.39e-2)"	30.1	19.9	16.5	23.1	20.7	16.5	19.0	15.2	16.6	21.7	20.8	17.4	21.1	17.0	21.2	50.3	26.5	14.6	14.2	16.6	15.6	15.1	28.3	13.7	16.1	27.1	22.2	11.4	18.3	22.0	29.4	36.1	20.1	17.4	18.8	25.6	15.0	23.3	18.8	12.9	18.9	24.8	18.1	20.2	25.5	19.1	13.0	20.9	38.0	24.0	18.6	22.9	19.4	18.2	26.2	10.1	9.0	9.2	5.2	6.7	4.5	20.0	16.2	18.8	25.8	22.6	27.2	16.5	22.8	26.6	20.5	28.0	12.4	17.8	21.2	13.5	28.0	17.2	14.9	18.1	38.2	26.4	24.1	12.8	14.9	14.8	22.6	13.3	13.0	19.5	19.7	14.2	17.4	17.6	19.9	26.0	4.4	10.4	14.0	35.7	12.4	16.8	21.2	9.9	15.1	9.7	17.6	33.0	29.4	30.6	19.3	6.6	10.6	21.0	13.7	19.6	16.2	16.6	22.4	26.2	15.5	12.3	18.7	22.8	10.8	16.6	14.5	20.2	19.4	19.6	8.5	7.3	6.3	6.0	7.5	6.7	18.5	5.1	6.2	10.1	26.2	4.4	5.6	9.0	5.2	9.2	8.6	6.0	4.5	16.5	20.7	15.2	16.6	15.6	15.1	22.2	11.4	17.4	20.9	41.7	28.9	51.7	18.1	14.1	16.2	22.4	5.1	30.8	37.5	29.6	21.6	26.3	21.6	28.5	9.1	22.8	29.0	0.0	33.1	32.1	20.5	19.7	31.3	14.8	34.9	19.1	18.4	24.5	36.5	15.6	14.7	33.9	25.3	57.7	31.0	25.3	34.9	23.0	15.6	19.4	27.1	25.8	15.5	11.4	9.6	20.6	24.9	18.7	25.2	18.2
AP3B2	NAPTB	ENSG00000103723	"Adaptor related protein complex 3 beta 2 subunit"	Q13367	15	82659281-82709914	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 17.0;Cone photoreceptor cells: 25.5;Horizontal cells: 12.7;Intestinal endocrine cells: 13.4;Rod photoreceptor cells: 56.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RT4: 11.8;SCLC-21H: 19.3;SH-SY5Y: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039467, HPA039818"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039467: AB_10795143, HPA039818: AB_10795299"	"unprognostic (3.17e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.48e-6)"	"unprognostic (8.44e-2)"	"unprognostic (7.62e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.43e-2)"	1.5	5.4	17.0	2.0	15.5	2.4	1.6	32.3	35.8	1.6	1.6	2.7	0.0	1.8	2.0	2.2	1.6	1.4	1.4	1.1	12.1	11.0	1.3	1.2	1.3	1.6	5.7	18.6	1.8	2.7	8.3	12.3	1.4	16.0	1.7	1.5	3.5	1.7	2.0	1.1	1.8	1.5	1.8	3.7	1.3	2.1	2.6	2.7	0.0	1.7	0.0	1.9	1.8	0.6	1.0	0.5	3.2	1.0	1.1	0.9	0.2	0.2	0.2	5.2	2.0	0.5	0.1	4.6	0.3	0.0	0.6	0.1	0.5	0.5	0.5	3.5	0.1	1.1	0.7	0.5	0.0	0.1	1.6	0.5	0.3	0.5	0.2	0.3	0.4	1.2	0.5	0.6	0.1	0.2	0.3	0.1	1.9	0.6	0.5	0.1	0.8	0.3	0.4	6.0	0.1	0.2	0.3	0.1	0.1	0.0	11.8	19.3	14.9	2.9	0.8	1.3	0.6	0.2	1.0	0.3	0.4	0.8	0.3	1.0	1.0	5.7	0.5	1.4	0.3	0.9	0.7	1.0	0.5	0.6	0.4	0.3	0.6	0.5	0.3	0.1	1.0	0.9	0.5	3.2	1.1	0.6	0.5	0.3	0.2	17.0	15.5	32.3	25.6	12.1	11.0	5.7	18.6	16.0	2.7	0.0	0.6	0.0	1.9	0.3	17.0	0.8	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.3	0.1	0.4	0.8	0.0	0.0	0.1	12.7	13.4	0.0	0.0	5.7	0.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.5	56.5	0.0	0.4	8.1	3.0	0.1	0.0	0.0	0.0	0.8
AP3D1	ADTD	ENSG00000065000	"Adaptor related protein complex 3 delta 1 subunit"	O14617	19	2100988-2164468	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA074408			Approved	Cytosol		No	No		10000	Cytosol		"HPA074408: AB_2686686"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (4.24e-2)"	"unprognostic (8.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.37e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (8.11e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.73e-2)"	22.4	30.3	27.6	26.0	31.5	18.6	27.1	38.1	41.5	24.8	23.1	22.3	30.1	27.1	27.9	23.9	28.1	26.3	22.6	32.6	25.6	23.6	28.6	45.5	23.5	29.7	19.7	29.8	24.4	55.3	32.1	39.8	26.8	25.1	23.1	18.0	25.9	35.1	28.6	42.6	21.2	26.2	25.7	16.5	25.0	25.9	33.2	21.2	23.6	34.6	19.3	22.5	27.8	23.5	4.1	11.0	5.1	5.0	7.8	8.4	2.9	32.2	33.6	20.3	30.6	26.0	22.1	24.7	26.3	25.9	28.1	25.6	38.1	17.9	17.7	15.2	38.9	34.4	22.1	29.2	31.8	18.6	25.5	27.7	22.8	21.9	29.8	45.3	24.6	30.5	27.1	21.4	29.1	42.8	23.8	27.2	12.8	23.4	61.8	24.6	23.6	23.8	13.4	30.2	22.3	21.7	25.6	22.1	23.5	21.1	46.6	28.8	24.0	23.7	25.1	44.3	19.6	24.3	28.8	35.1	26.8	11.4	36.2	30.4	52.4	50.5	22.6	36.6	16.4	26.6	0.3	4.9	3.9	5.3	5.0	8.4	3.5	5.2	6.3	5.6	4.1	4.3	5.3	5.1	7.8	4.1	11.0	3.0	2.9	27.6	31.5	38.1	41.5	25.6	23.6	19.7	29.8	25.1	21.2	56.6	63.9	17.1	33.7	18.0	63.0	60.7	45.9	22.7	37.5	38.4	33.4	44.8	18.3	48.1	58.7	32.2	59.6	0.0	63.4	58.0	31.5	49.3	16.2	46.1	57.4	46.1	45.9	31.9	25.9	49.2	35.1	37.6	37.1	16.2	41.5	59.4	61.9	44.6	35.7	30.6	41.1	19.4	28.1	72.4	116.5	20.5	65.2	27.7	43.7	53.9
AP3S1	CLAPS3	ENSG00000177879	"Adaptor related protein complex 3 sigma 1 subunit"	Q92572	5	115841481-115914081	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049270	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA049270: AB_2680696"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.57e-8)"	"unprognostic (2.73e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-1)"	22.0	13.8	28.6	15.0	28.6	33.0	26.1	21.7	30.8	30.8	22.5	10.4	60.4	17.6	20.6	27.6	23.4	16.7	17.0	17.0	30.7	21.1	11.7	23.8	12.7	18.3	23.7	19.4	23.3	34.8	9.1	20.9	20.9	19.8	15.3	20.8	9.7	26.8	64.1	8.5	15.7	28.9	28.7	20.6	11.5	12.8	26.9	13.2	12.1	19.0	12.7	20.1	21.6	19.7	20.1	23.8	39.8	21.9	11.8	17.1	15.4	19.9	5.1	16.8	8.4	43.4	71.3	11.0	23.4	32.6	20.7	36.7	9.8	18.7	15.2	13.2	29.1	18.4	5.8	9.2	38.9	31.0	45.1	15.9	6.7	6.8	14.7	24.8	9.5	13.2	31.5	31.1	16.4	15.6	21.7	20.9	23.5	7.1	11.7	26.9	4.1	11.5	12.0	10.3	9.6	9.7	14.2	24.0	26.6	19.8	5.8	5.9	8.2	33.4	6.4	19.2	15.1	11.2	10.8	14.4	28.0	17.1	20.9	15.5	8.7	9.3	18.0	23.0	22.0	10.3	17.6	18.5	39.8	10.9	21.9	17.0	20.1	13.8	14.8	15.4	13.0	12.3	12.4	26.7	11.8	19.0	23.8	17.1	15.4	28.6	28.6	21.7	30.8	30.7	21.1	23.7	19.4	19.8	13.2	20.8	21.6	70.7	83.1	180.3	35.7	21.5	43.3	18.7	17.0	43.6	23.6	67.6	59.7	84.5	93.7	65.3	174.5	23.3	74.6	264.6	188.4	82.3	80.9	77.3	136.0	25.4	73.1	62.0	99.6	164.9	160.2	110.4	109.6	87.4	103.7	14.1	98.1	98.2	104.7	120.7	71.2	32.3	148.2	104.4	86.7	199.2	107.7	106.5	61.3	84.5
AP3S2	sigma3b	ENSG00000157823	"Adaptor related protein complex 3 sigma 2 subunit"	P59780	15	89830599-89894638	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049270	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA049270: AB_2680696"	"unprognostic (1.46e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (5.55e-16)"	"unprognostic (7.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.67e-3)"	18.0	20.9	18.4	7.9	20.2	6.7	14.3	16.8	24.7	13.5	13.2	20.4	13.4	7.9	9.9	12.6	15.3	13.2	12.8	22.2	16.6	19.4	27.3	29.3	11.6	8.6	19.8	14.6	15.2	20.0	36.4	17.3	15.3	19.2	11.5	14.4	21.6	10.8	16.6	43.3	9.5	12.8	13.2	20.1	11.5	10.8	10.9	12.8	12.2	19.4	9.2	12.8	11.7	8.9	6.0	10.1	13.9	16.4	7.2	7.4	7.8	5.1	24.7	13.3	13.9	26.9	18.6	11.2	22.9	29.5	29.6	24.1	10.5	13.6	4.6	20.7	15.1	19.7	12.1	22.5	12.8	23.4	19.6	11.3	14.2	11.1	13.6	11.2	6.1	8.8	12.4	16.0	8.2	16.6	16.3	15.2	12.0	11.1	13.0	19.0	11.2	10.2	3.2	14.7	26.5	4.7	6.0	13.4	9.5	16.7	14.5	10.1	8.9	27.0	16.7	15.7	29.4	10.5	5.3	6.3	16.0	7.7	24.5	7.5	11.2	34.8	11.2	14.1	7.3	9.4	3.9	14.6	6.9	5.0	13.0	7.3	3.9	7.0	7.1	10.1	6.0	5.6	3.9	13.9	7.2	16.4	6.8	7.4	7.8	18.4	20.2	16.8	24.7	16.6	19.4	19.8	14.6	19.2	12.8	11.9	19.1	6.9	3.7	3.0	18.3	15.3	12.7	10.7	14.8	5.2	33.4	8.1	8.3	11.3	2.1	4.4	19.6	0.0	14.0	3.6	4.7	5.4	8.1	13.9	5.7	17.5	13.8	8.0	10.3	2.5	6.6	8.3	8.5	15.4	11.7	13.7	11.8	14.4	7.1	10.9	28.2	0.0	5.0	11.5	6.8	2.5	5.4	5.2	14.2	3.2
AP4B1	"BETA-4, SPG47"	ENSG00000134262	"Adaptor related protein complex 4 beta 1 subunit"	Q9Y6B7	1	113894748-113905201	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 40.3"					"Low region specificity"	"Detected in all"			"HPA028162, HPA028652"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA028162: AB_10610976, HPA028652: AB_10601451"	"unprognostic (8.90e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (8.60e-7)"	"unprognostic (3.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (5.08e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.55e-2)"	9.5	8.8	11.5	18.3	19.1	23.3	11.4	23.1	16.7	12.4	13.3	14.1	4.1	16.4	12.5	18.5	12.2	10.5	12.6	11.0	12.2	11.4	9.2	8.2	9.5	16.4	15.3	13.2	16.1	14.1	8.1	19.7	7.6	13.4	9.4	16.8	14.0	10.7	8.3	13.0	13.9	13.6	11.9	14.2	20.0	10.6	10.5	14.7	13.7	11.6	7.7	17.2	9.9	12.5	11.8	12.8	14.0	10.9	11.7	16.6	9.3	6.5	5.9	6.7	6.8	10.2	8.5	3.8	6.0	5.6	7.8	9.6	4.0	4.5	12.8	9.7	7.6	4.4	5.9	7.5	7.8	9.7	10.2	6.2	10.4	9.3	5.3	5.8	11.5	10.6	9.9	3.9	15.4	9.7	4.9	13.5	13.0	7.5	11.5	10.1	40.3	9.1	12.0	5.9	4.5	11.9	8.9	13.5	7.4	7.7	3.3	6.7	5.0	7.0	11.2	4.3	6.1	3.7	9.3	12.3	9.6	8.5	10.5	11.5	9.2	8.9	14.2	14.5	15.1	14.7	14.0	10.0	8.2	15.5	10.9	16.6	9.7	12.3	13.2	12.8	11.8	13.9	12.0	1.1	11.7	8.3	9.3	10.3	9.3	11.5	19.1	23.1	16.7	12.2	11.4	15.3	13.2	13.4	14.7	3.0	7.9	3.4	3.5	3.2	7.4	7.0	2.5	2.7	12.5	3.5	29.5	3.3	1.7	6.7	3.1	7.1	6.2	70.0	23.4	3.3	4.4	2.9	2.3	3.0	4.8	7.9	2.9	6.2	9.7	1.5	2.6	6.1	6.8	3.6	4.3	3.9	10.4	6.0	4.6	3.0	20.3	12.9	5.6	11.6	8.9	3.1	1.4	15.0	6.9	2.7
AP5B1	"AP-5, DKFZp761E198, PP1030"	ENSG00000254470	"Adaptor related protein complex 5 beta 1 subunit"	Q2VPB7	11	65775893-65780802	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.6"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	16	"neutrophil: 22.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 22.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065739, HPA067880"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Golgi apparatus"	"HPA065739: AB_2685550, HPA067880: AB_2685914"	"unprognostic (3.64e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.67e-1)"	11.2	6.8	5.3	10.2	8.2	48.6	10.3	10.7	9.1	6.3	6.7	4.0	6.9	9.6	9.8	6.8	13.2	7.2	8.2	6.6	5.7	3.5	7.7	9.3	11.3	13.3	6.0	5.5	4.5	16.1	9.9	5.5	14.8	5.3	6.4	4.2	8.0	10.9	10.7	11.9	10.3	9.5	5.1	5.6	13.0	7.9	3.1	6.2	9.2	7.9	7.4	7.8	11.0	6.5	0.2	0.3	22.5	1.3	0.3	0.4	0.5	10.1	7.9	1.8	10.3	4.9	2.5	14.8	4.3	4.1	4.5	3.6	6.8	4.7	5.8	8.3	3.7	8.4	12.1	5.0	3.3	1.4	9.2	8.7	5.3	8.9	3.3	4.0	6.8	11.1	4.8	6.2	3.1	1.6	3.5	3.5	10.1	11.9	7.6	2.3	7.0	4.3	6.8	3.6	2.4	8.9	13.9	0.3	12.7	3.3	11.5	2.4	4.3	3.2	2.0	19.3	2.1	3.9	10.0	5.5	8.3	7.5	10.6	4.4	7.8	7.9	5.8	5.9	5.8	8.0	0.6	1.3	0.5	0.4	0.8	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2	22.5	0.3	1.0	0.2	0.1	0.5	5.3	8.2	10.7	9.1	5.7	3.5	6.0	5.5	5.3	6.2	0.0	9.1	5.2	10.1	2.2	5.2	1.4	5.1	1.4	0.0	7.0	13.7	6.1	1.7	7.4	1.1	2.2	9.5	0.0	11.6	14.8	2.6	4.8	2.3	5.8	13.4	11.1	2.9	1.8	8.1	0.0	0.6	6.1	6.8	7.2	2.2	3.9	8.7	6.2	3.5	6.9	9.6	0.0	3.7	0.2	3.6	1.9	29.2	4.4	3.0	9.5
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645141-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	10.5	4.7	10.3	11.0	11.0	36.1	8.8	13.4	11.5	10.8	11.6	8.2	5.5	7.0	10.6	7.5	6.2	6.3	11.6	5.8	10.2	8.6	5.8	6.8	11.8	11.2	8.8	6.7	10.8	7.4	5.7	6.2	10.1	8.2	9.1	12.9	8.5	8.2	6.4	6.0	7.5	14.9	7.2	10.9	15.9	8.6	6.1	9.3	15.7	7.0	3.9	14.2	9.5	9.0	2.8	6.3	33.0	8.7	1.1	1.9	1.5	4.4	6.6	20.4	7.8	7.0	12.4	5.6	11.2	8.3	8.5	8.6	4.3	3.2	6.7	3.2	9.3	3.2	7.3	14.2	8.1	10.7	4.7	5.7	12.2	6.3	5.3	2.4	11.8	15.7	5.1	2.5	8.6	4.5	9.4	14.5	4.7	5.6	3.4	12.4	1.3	6.3	12.4	5.6	5.0	3.9	7.9	16.3	2.1	5.0	7.9	3.0	5.1	8.7	3.7	3.2	13.1	6.4	17.8	11.2	5.8	4.5	6.5	3.6	2.3	4.4	7.4	2.2	16.7	7.6	6.2	8.7	7.2	1.9	3.6	1.5	2.4	1.4	1.1	6.3	2.8	1.4	0.9	33.0	1.1	3.6	4.6	0.9	1.5	10.3	11.0	13.4	11.5	10.2	8.6	8.8	6.7	8.2	9.3	11.9	8.0	5.9	4.8	3.4	6.4	1.4	2.5	5.3	4.5	7.0	13.7	3.3	0.0	7.6	0.6	9.2	14.4	0.0	7.0	6.6	8.2	7.3	5.8	5.5	10.5	4.8	11.5	14.1	39.2	0.8	5.5	26.0	10.1	6.4	16.4	2.5	14.3	19.2	4.9	1.5	10.2	0.0	5.2	3.9	11.1	2.9	1.6	9.6	11.5	9.0
APBA3	"mint3, X11L2"	ENSG00000011132	"Amyloid beta precursor protein binding family A member 3"	O96018	19	3750819-3761699	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045577	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA045577: AB_10964881"	"unprognostic (3.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (6.64e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (1.83e-4)"	10.2	7.8	5.4	12.7	8.3	6.3	7.6	8.6	7.2	7.8	8.6	10.5	11.9	11.7	9.0	4.0	8.0	6.9	7.8	7.1	5.1	4.3	8.8	14.2	7.0	12.9	11.9	7.3	10.7	10.3	4.6	10.0	7.2	7.1	8.0	3.0	6.7	16.8	9.6	20.5	8.6	11.7	8.5	6.1	14.1	11.7	6.0	9.1	13.2	11.5	7.2	11.8	8.0	7.1	13.0	8.1	10.8	7.1	6.5	18.8	8.2	7.4	5.7	1.2	2.2	2.5	1.9	6.1	4.8	3.0	2.5	3.7	5.2	2.4	5.0	4.3	1.9	6.2	3.4	1.4	4.1	0.6	18.5	4.3	2.9	3.9	3.8	7.9	1.9	11.0	3.7	5.0	3.4	2.1	2.2	3.6	5.1	4.7	8.2	1.1	4.1	5.7	7.1	3.5	2.5	8.2	5.9	2.6	8.3	1.8	4.8	4.5	4.7	3.0	4.4	6.9	0.9	1.9	4.2	5.8	4.6	4.3	7.7	6.1	17.0	6.2	4.7	4.1	5.7	4.5	8.7	7.1	10.8	13.8	5.5	12.8	10.2	13.6	13.5	8.1	13.0	9.0	10.5	10.4	6.5	4.6	7.7	18.8	8.2	5.4	8.3	8.6	7.2	5.1	4.3	11.9	7.3	7.1	9.1	6.0	6.4	11.8	5.6	3.8	4.1	4.2	5.1	1.4	3.4	7.0	7.9	8.8	6.6	13.6	0.6	5.8	8.8	0.0	8.0	8.3	6.9	8.3	2.3	7.3	7.9	3.2	4.6	7.4	4.7	0.0	5.8	4.6	5.0	23.4	7.8	3.8	10.6	5.8	2.8	9.1	6.4	6.5	5.2	1.9	6.6	6.6	12.8	13.1	5.9	5.8
APBB2	"FE65L, FE65L1, MGC35575"	ENSG00000163697	"Amyloid beta precursor protein binding family B member 2"	Q92870	4	40810027-41216714	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 74.5;Horizontal cells: 58.8;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 9.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 41.7;TIME: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023542	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA023542: AB_1844909"	"unprognostic (4.43e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (5.91e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.19e-3)"	"unprognostic (9.35e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.61e-1)"	35.1	9.1	18.4	5.1	25.5	7.2	20.9	7.6	30.1	13.9	10.8	42.9	8.3	7.9	14.2	5.9	9.0	11.6	15.8	18.8	19.4	15.1	17.0	13.9	17.5	6.7	34.3	16.8	31.5	10.1	9.8	10.2	16.3	29.8	8.4	8.2	13.7	7.6	10.3	22.4	10.6	6.0	14.4	30.7	13.2	10.1	8.8	35.1	2.3	32.9	5.3	5.4	11.8	15.4	9.4	0.3	0.6	0.4	0.2	0.1	0.4	5.3	2.7	6.2	8.6	21.3	16.4	13.7	10.4	13.6	4.2	7.4	9.5	11.4	9.9	5.9	4.6	12.7	1.6	11.0	14.4	7.7	0.3	2.2	0.1	6.7	6.3	20.7	5.5	0.3	24.4	7.8	12.5	13.0	18.0	41.7	5.7	0.3	0.2	27.0	4.7	1.8	1.0	5.1	2.8	5.2	14.8	17.9	11.5	6.2	2.5	8.3	4.8	3.3	2.0	2.1	7.6	5.0	0.6	55.2	6.0	17.4	4.1	18.0	2.5	5.1	12.0	6.6	9.1	7.1	0.6	0.4	0.2	0.1	0.1	0.1	0.7	0.1	0.1	0.3	9.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.4	18.4	25.5	7.6	24.6	19.4	15.1	34.3	16.8	29.8	35.1	74.5	12.6	0.8	3.6	9.5	6.2	13.6	15.3	4.0	7.9	8.7	5.9	12.6	6.6	3.6	13.9	32.4	4.6	0.0	5.6	2.1	18.8	2.1	1.1	12.1	2.7	58.8	2.9	45.4	5.6	15.2	33.1	3.1	6.8	0.0	3.8	11.2	5.4	4.9	35.0	4.8	7.2	58.2	24.7	3.6	9.8	10.5	5.0	0.5	6.4	2.7
APC	"DP2, DP2.5, DP3, PPP1R46"	ENSG00000134982	"APC, WNT signaling pathway regulator"	P25054	5	112707498-112846239	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.9"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 169.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013349, HPA013362"	Supported		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA013349: AB_1844913, HPA013362: "	"unprognostic (4.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	7.2	5.4	40.9	6.4	21.7	8.5	6.3	19.1	39.7	6.8	7.1	10.3	2.0	6.6	6.3	3.9	8.4	5.0	5.5	7.4	37.9	12.9	6.9	6.2	6.7	5.6	23.6	20.7	7.6	4.6	13.8	7.2	5.5	39.1	5.9	6.9	4.0	4.0	4.9	7.0	6.1	8.8	8.1	19.1	6.2	5.4	5.3	20.6	3.6	6.5	2.7	6.2	6.2	3.9	3.8	3.0	12.9	2.9	3.0	3.4	1.1	8.3	7.7	12.9	9.4	10.6	8.9	5.3	13.6	6.5	7.6	9.0	6.1	6.8	16.2	13.2	17.3	11.7	6.9	13.2	11.1	12.5	9.7	9.0	12.3	11.2	4.7	5.2	6.2	6.7	7.4	7.7	12.8	8.5	5.3	10.5	7.8	15.1	5.6	10.9	5.8	7.1	3.1	4.6	4.6	2.8	6.0	16.0	7.9	7.0	10.7	13.1	7.9	12.9	5.0	5.5	5.5	7.0	5.1	16.7	15.4	7.4	15.1	10.3	4.4	6.6	6.4	8.5	11.5	8.6	10.4	2.9	5.0	3.4	1.4	2.9	3.1	1.8	2.1	2.3	3.8	2.9	2.8	12.9	3.0	2.5	3.0	1.6	1.1	40.9	21.7	19.1	31.4	37.9	12.9	23.6	20.7	39.1	20.6	47.6	17.6	10.8	8.3	10.0	169.9	48.4	12.7	20.1	26.1	0.0	62.8	4.4	0.0	16.7	6.3	21.0	24.6	0.0	17.0	5.3	10.2	10.3	18.5	12.1	13.8	74.7	26.4	28.8	14.9	4.4	16.4	14.8	16.9	19.0	15.5	21.8	16.3	25.9	18.4	4.2	37.9	38.8	14.3	14.9	26.7	10.2	2.4	10.7	14.2	7.6
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916499	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		77000	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	23.2	29.8	12.0	13.7	18.7	9.6	15.8	7.6	12.6	12.7	13.8	17.9	16.8	10.5	15.3	10.8	12.2	13.9	12.1	15.4	14.5	11.7	24.8	21.8	16.2	14.4	21.5	11.7	13.2	19.7	13.4	10.3	12.5	21.1	14.1	12.6	10.4	18.5	20.4	48.7	6.8	13.9	16.0	27.8	13.9	19.1	9.7	21.1	23.9	19.0	12.9	11.5	19.0	16.1	14.2	25.6	14.9	19.8	17.5	15.8	10.6	8.6	9.3	11.0	2.6	9.0	9.0	4.9	12.8	12.3	12.6	14.4	5.5	7.6	26.6	7.8	4.7	13.0	10.4	20.1	8.6	16.3	16.3	19.1	13.7	9.9	13.9	13.9	38.0	10.5	8.8	6.4	8.0	13.2	5.6	10.3	15.5	32.2	16.4	8.7	8.3	18.1	17.5	8.8	11.8	22.0	11.7	32.3	9.1	13.0	12.5	9.3	4.5	16.1	12.9	15.7	5.5	13.5	11.8	8.6	9.5	9.6	24.3	3.1	16.1	12.0	30.0	11.8	8.1	12.1	4.7	16.9	14.9	11.0	17.5	13.6	14.2	13.4	11.9	25.6	13.4	13.8	11.7	4.1	17.5	19.8	16.5	15.8	10.6	12.0	18.7	7.6	12.6	14.5	11.7	21.5	11.7	21.1	21.1	32.8	26.7	21.4	29.7	22.1	22.7	19.8	40.8	48.2	28.4	17.4	3.9	31.1	159.2	23.6	5.4	20.4	30.7	23.3	28.4	20.1	20.0	35.6	19.7	21.2	67.0	17.5	34.1	22.1	46.7	7.4	22.2	39.5	20.3	66.7	30.2	16.6	21.6	24.6	23.3	70.8	21.9	38.8	25.8	22.8	24.0	23.1	22.1	24.1	38.3	41.1
APLP1	APLP	ENSG00000105290	"Amyloid beta precursor like protein 1"	P51693	19	35867899-35879791	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Endocytosis"	Heparin-binding	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 147.5"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 142.9;Horizontal cells: 152.6"	"Cancer enhanced"	"Detected in many"		"glioma: 63.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 25.4;AN3-CA: 47.1;EFO-21: 24.9;HMC-1: 24.3;SCLC-21H: 27.4;SH-SY5Y: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028970, HPA028971"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		3900000	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA028970: AB_2672847, HPA028971: AB_10601334"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.36e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (7.32e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-11)"	"unprognostic (1.38e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (2.65e-5)"	2.6	15.6	37.0	2.9	47.9	1.6	1.6	13.1	147.5	2.4	2.6	91.6	0.0	2.0	2.3	2.1	2.2	2.3	4.3	6.0	53.2	37.4	2.4	1.5	2.4	2.1	54.6	24.6	1.9	32.1	5.6	17.6	1.9	38.4	2.3	2.6	3.3	2.4	2.4	1.5	2.0	2.4	2.9	118.2	1.7	9.6	5.7	36.9	0.0	2.2	0.0	2.2	2.1	0.1	1.5	0.4	2.2	0.7	3.0	0.6	0.2	1.4	10.6	25.4	47.1	2.4	1.0	3.3	2.2	1.1	2.5	0.3	2.5	1.4	0.2	24.9	5.5	8.2	0.7	7.8	0.5	1.7	17.7	0.9	0.1	3.1	1.4	0.7	0.0	24.3	1.1	0.6	1.0	0.0	9.4	0.8	1.8	0.9	0.4	7.2	2.3	0.0	0.0	1.2	4.3	6.2	2.4	0.1	0.3	0.4	0.3	27.4	27.8	8.2	1.1	0.3	7.2	6.1	1.3	0.6	17.1	9.8	9.6	1.4	1.1	0.4	0.1	11.2	0.3	8.6	2.2	0.7	0.4	0.4	0.5	0.3	0.7	0.4	0.6	0.2	1.5	0.5	0.6	2.1	3.0	0.7	0.4	0.2	0.2	37.0	47.9	13.1	54.6	53.2	37.4	54.6	24.6	38.4	36.9	6.0	0.0	0.0	2.4	1.1	142.9	4.8	0.0	0.0	0.0	0.0	11.8	0.3	0.0	2.1	25.2	2.8	0.0	0.0	3.8	4.1	2.1	1.8	0.0	0.0	0.4	152.6	33.6	1.3	0.3	8.5	1.1	0.5	5.0	0.0	0.0	11.9	4.4	0.0	0.0	0.0	24.2	0.0	1.7	9.7	22.2	0.5	0.3	0.0	0.0	1.2
APLP2	"APPH, APPL2"	ENSG00000084234	"Amyloid beta precursor like protein 2"	Q06481	11	130069837-130144811	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 52.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039319	Approved		Approved	Vesicles		NA	NA		480000	Vesicles		"HPA039319: AB_10673141"	"unprognostic (2.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.33e-9)"	"unprognostic (3.20e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.42e-2)"	72.4	32.9	41.4	29.8	48.5	35.2	43.9	106.0	61.4	39.8	44.9	29.0	31.8	56.6	48.7	42.4	36.2	37.9	51.1	55.6	35.6	49.7	79.2	73.8	82.2	27.3	39.7	43.0	42.0	28.4	76.9	22.3	67.6	48.2	63.4	39.0	105.5	35.4	65.9	17.3	27.3	52.1	46.0	40.9	24.3	33.2	18.2	26.0	12.5	128.7	21.0	17.0	51.0	46.7	12.3	26.0	36.5	52.5	3.6	4.7	25.8	17.6	14.9	26.8	24.0	112.3	74.0	33.5	50.4	61.5	25.2	21.4	110.4	129.2	8.8	132.4	122.7	27.7	45.7	20.6	48.0	14.4	13.7	17.1	15.1	10.9	42.3	17.3	45.5	30.9	49.6	31.4	22.2	42.4	132.3	77.4	2.8	14.4	18.9	41.5	17.5	2.2	20.4	15.6	21.4	25.0	5.8	6.2	8.5	67.2	49.3	9.4	20.5	60.8	32.2	7.8	47.8	49.2	42.2	133.2	27.2	18.5	42.3	24.3	2.9	4.1	20.6	30.7	41.8	19.3	8.7	52.5	14.3	4.5	28.8	3.4	3.4	3.3	4.2	26.0	12.3	2.5	3.3	36.5	3.6	20.8	2.4	4.7	25.8	41.4	48.5	106.0	61.4	35.6	49.7	39.7	43.0	48.2	26.0	875.4	416.5	72.9	138.7	94.7	779.6	197.0	290.4	250.3	447.0	383.8	665.6	678.4	44.7	245.4	11.2	182.9	301.3	46.7	94.3	90.9	217.7	184.7	96.4	435.7	560.4	227.2	89.2	98.8	296.4	9.1	155.1	309.8	91.1	100.0	141.0	413.6	188.5	171.4	201.5	224.3	490.3	187.5	202.8	102.7	283.4	95.7	775.5	52.3	119.9	201.2
APMAP	"BSCv, C20orf3"	ENSG00000101474	"Adipocyte plasma membrane associated protein"	Q9HDC9	20	24962925-24992979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.8;liver: 100.5"	"Cell type enhanced"	"Detected in all"	11	"Cytotrophoblasts: 255.8;Hepatocytes: 247.3;Syncytiotrophoblasts: 628.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012863, HPA064700"	Uncertain		Approved	"Plasma membrane"		NA	NA		80000000	"Plasma membrane"		"HPA012863: AB_1845683, HPA064700: AB_2685328"	"unprognostic (4.07e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.99e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.51e-2)"	43.5	13.0	14.8	12.4	16.1	44.5	23.1	47.3	22.7	11.7	12.3	15.7	17.9	8.9	14.8	31.8	7.5	13.0	13.4	10.2	18.2	20.9	12.9	100.5	14.4	15.9	15.4	17.2	12.3	12.2	18.9	20.2	28.3	17.0	12.5	12.4	11.6	10.6	18.7	9.8	14.0	9.3	13.8	13.7	16.9	10.2	19.9	15.4	10.6	57.9	5.7	9.2	13.0	10.6	5.2	13.9	93.8	13.9	43.2	53.4	40.1	22.9	39.8	20.5	30.7	39.9	21.8	20.8	30.0	32.9	29.0	30.1	23.5	40.8	9.5	35.1	36.0	53.0	42.4	18.7	34.9	34.1	12.7	14.6	10.5	14.4	47.7	31.4	20.5	25.3	29.5	49.5	34.0	24.5	40.0	41.2	15.7	12.4	42.9	28.1	34.5	14.1	23.1	12.9	36.7	36.3	11.7	68.1	19.8	30.9	21.1	33.6	13.0	30.9	53.5	33.2	22.3	19.0	17.2	36.1	34.9	31.3	29.5	44.7	24.4	27.0	10.5	18.4	31.2	33.1	7.4	13.9	26.1	53.4	13.4	33.0	5.1	15.1	38.8	13.9	5.2	11.9	30.9	93.8	43.2	9.0	6.8	9.9	40.1	14.8	16.1	47.3	22.7	18.2	20.9	15.4	17.2	17.0	15.4	17.9	28.3	27.4	38.9	21.6	49.0	14.5	45.9	24.1	21.6	47.1	9.8	255.8	14.9	60.3	22.9	34.6	17.0	23.3	39.8	32.6	32.9	31.8	34.7	247.3	84.5	15.9	17.2	38.6	45.7	27.7	60.1	81.5	43.9	161.5	17.3	35.4	35.7	19.9	77.1	13.0	18.3	38.8	34.0	52.1	79.8	17.6	628.2	145.4	24.7	24.2
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837950	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 573.5"	"Cell type enriched"	"Detected in many"	33	"Hepatocytes: 19896.2"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;T-cells: 2.4"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 253.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1450000000000	220000000000	Vesicles	Cytosol	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	24.6	0.2	0.2	55.6	0.2	0.3	0.2	0.1	0.3	1.3	0.2	0.0	0.2	573.5	0.2	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	127.9	0.2	0.2	0.4	0.3	11.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.5	3.6	0.0	0.7	0.7	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	253.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	1.3	1.6	0.0	0.2	0.4	1.7	0.7	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	2.4	0.7	0.3	0.0	0.2	1.8	0.8	0.5	0.8	1.7	0.0	0.7	0.0	3.6	2.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	3.5	174.9	0.2	0.1	0.6	24.6	596.2	0.0	2.3	0.0	0.0	0.4	0.0	0.1	30.6	1.9	0.9	256.9	1.0	1.1	1.5	0.1	2.3	19896.2	3.1	0.0	1.7	472.6	569.9	110.5	20.8	0.6	0.0	0.0	0.5	0.1	0.2	0.3	4.6	2.2	0.6	6.5	0.7	10.3	9.1	0.5	3.5	2.9	0.3	0.3
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823306	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 593.6"	"Cell type enriched"	"Detected in single"	618	"Hepatocytes: 61.8"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.1;CACO-2: 8.2;Hep G2: 7.7;NB-4: 7.5;RPMI-8226: 12.0;SH-SY5Y: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	61200000000	140000000000	Vesicles		"CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	293.8	0.0	0.0	175.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	593.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	145	"intestine: 224.8;liver: 442.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 2874.2"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 155.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	89000000000	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	0.3	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.1	0.1	68.9	0.0	0.0	24.9	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.1	442.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	224.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.9	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	14.6	293.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.0	2874.2	0.1	0.0	0.0	51.5	53.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
APOBEC3B	"FLJ21201, PHRBNL"	ENSG00000179750	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3B"	Q9UH17	22	38982347-38992804	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.1"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 4.7;Ductal cells: 7.3;Melanocytes: 6.8;Pancreatic endocrine cells: 5.7;Urothelial cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 10.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 60.7;Karpas-707: 68.8"									"HPA056980, HPA066719"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (2.92e-2)"	"prognostic favorable (2.58e-5)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.47e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-1)"	1.6	2.3	0.3	4.4	2.2	20.1	1.4	0.3	1.2	2.3	9.9	0.7	0.3	5.8	2.0	2.4	4.6	1.2	2.2	1.6	0.6	0.2	3.6	0.9	2.5	4.3	0.3	0.3	1.7	5.7	0.4	0.3	6.4	0.8	2.1	10.0	1.3	4.8	0.3	4.1	1.9	8.8	1.0	0.7	10.4	3.8	2.0	0.3	5.9	3.3	0.3	12.0	2.0	2.4	10.2	0.8	1.7	5.8	2.2	3.8	5.9	60.7	6.8	2.6	16.4	0.3	1.5	4.5	5.6	4.9	10.8	14.2	13.0	11.1	0.6	5.1	5.6	15.9	26.1	0.3	1.1	10.9	21.9	0.6	17.5	1.5	3.4	0.1	14.5	10.6	0.6	0.1	11.2	0.5	2.2	4.1	0.0	9.8	68.8	16.6	1.6	0.0	8.1	0.0	5.8	6.1	0.4	26.3	21.8	2.2	10.2	0.4	0.0	0.0	0.0	3.7	0.4	8.1	4.2	2.5	11.9	20.8	1.8	0.1	15.3	4.2	0.0	8.5	16.2	24.1	0.5	1.3	0.0	0.3	5.8	0.0	10.2	0.8	0.5	0.8	3.2	0.0	0.4	1.7	2.2	1.8	0.1	3.8	5.9	0.3	2.2	0.3	1.2	0.6	0.2	0.3	0.3	0.8	0.3	0.0	1.7	0.8	2.2	4.7	0.0	0.2	0.0	1.4	2.3	0.0	0.0	0.3	0.0	7.3	0.0	0.0	0.5	0.0	1.6	1.9	0.4	1.2	0.0	0.0	1.8	0.0	0.0	0.0	1.6	0.0	0.0	1.6	6.8	1.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.7	0.0	0.6	9.5
APOBEC3C	"APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI"	ENSG00000244509	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3C"	Q9NRW3	22	39014083-39020352	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 114.8"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB033048, HPA071523"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB033048: AB_2057401, HPA071523: AB_2686409"	"unprognostic (1.79e-3)"	"prognostic favorable (1.08e-5)"	"unprognostic (4.32e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (8.91e-10)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.52e-3)"	13.3	28.0	2.3	15.6	3.4	9.2	8.0	1.1	2.0	21.4	13.1	4.2	27.5	4.5	18.2	23.5	19.6	20.9	13.8	13.0	2.2	2.0	6.3	4.5	11.7	20.9	3.3	2.0	26.4	5.3	0.7	3.3	7.7	3.2	20.7	12.0	12.9	12.3	114.8	3.4	6.9	11.8	17.2	4.2	32.2	8.1	45.6	2.4	16.2	8.7	17.0	45.5	21.8	12.7	48.1	19.7	49.3	42.6	35.2	61.3	26.2	10.6	10.5	1.8	20.8	11.7	24.3	9.1	7.9	15.4	11.6	15.6	10.0	12.2	31.8	5.3	15.5	7.4	11.0	1.8	33.3	11.4	12.0	9.0	30.6	0.5	8.3	12.7	19.9	30.8	26.3	19.4	15.2	3.8	5.8	6.5	0.2	18.7	40.6	23.3	0.1	7.9	10.8	2.8	0.1	23.2	13.9	4.8	26.4	7.7	14.2	0.5	1.4	11.4	0.0	5.7	4.8	0.1	7.3	3.3	6.3	10.8	3.3	3.4	11.0	11.3	2.6	19.3	12.9	16.3	13.6	20.3	49.3	61.3	40.2	42.2	44.6	33.6	54.6	19.7	48.1	11.5	41.1	2.7	35.2	42.6	16.7	30.5	26.2	2.3	3.4	1.1	2.0	2.2	2.0	3.3	2.0	3.2	2.4	3.0	21.0	91.0	37.0	22.3	0.0	17.3	28.1	13.4	12.5	7.0	0.0	3.2	0.0	25.1	1.9	8.9	11.9	116.8	1.2	1.5	27.8	15.7	55.4	0.8	53.0	0.0	25.3	28.8	42.1	4.1	53.5	30.8	42.2	70.3	16.2	24.7	7.9	12.7	35.7	1.0	0.2	25.8	28.8	1.6	1.5	14.3	1.6	91.6	16.1	44.2
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 714.1"	"Cell type enriched"	"Detected in some"	60	"Hepatocytes: 64257.6"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 28.5;Hep G2: 77.0"					"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	97000000000	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	91.3	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	28.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	77.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.3	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	100.1	0.0	0.0	0.0	0.0	858.6	0.0	0.0	0.0	0.0	0.0	3.3	0.0	3.8	0.0	0.0	1074.6	0.4	0.3	0.0	0.0	0.0	64257.6	1.0	0.0	0.0	825.6	1072.7	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.2	0.0	0.0
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568702-195584205	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"breast: 840.7"	"Group enriched"	"Detected in many"	5	"Leydig cells: 1923.5;Melanocytes: 975.2;Peritubular cells: 934.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 6.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 6.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 239.5;ASC TERT1: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	98900000000	220000000000	"Plasma membrane"		"HPA040520: AB_2677020"	"prognostic favorable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.71e-3)"	134.4	15.2	39.7	5.7	39.9	3.4	840.7	14.7	66.1	75.0	16.4	79.7	10.9	12.9	36.6	30.0	46.1	42.9	36.4	124.7	45.5	29.2	8.5	3.5	11.8	6.5	96.9	28.2	19.4	28.3	9.0	14.3	59.6	50.9	39.7	13.1	99.1	152.5	35.1	110.4	66.0	7.2	30.4	81.6	3.6	28.7	32.0	56.5	0.0	87.7	42.2	6.6	62.1	95.7	6.7	0.1	0.4	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	239.5	129.1	0.3	2.0	0.5	0.0	0.0	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.5	1.4	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	2.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	25.9	0.4	0.1	0.0	0.1	0.1	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	39.7	39.9	14.7	39.5	45.5	29.2	96.9	28.2	50.9	56.5	0.0	8.3	0.0	14.6	128.8	0.0	31.1	0.0	40.2	104.6	5.2	0.0	4.1	0.0	0.2	9.1	55.0	0.0	0.0	0.0	5.0	271.0	22.1	0.0	0.0	12.4	0.0	44.5	30.1	0.3	22.5	1923.5	6.2	975.2	1.8	0.9	0.0	1.9	0.0	934.8	0.1	0.0	19.4	80.9	3.8	3.8	89.6	4.9	0.0	0.6	37.7
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905754-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Hyperlipidemia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 226.8;liver: 508.1"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 7873.9;Hofbauer cells: 6293.2;Muller glia cells: 7584.1;Peritubular cells: 4660.8;Proximal tubular cells: 5645.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 167.1;CACO-2: 39.6;Hep G2: 77.6;HSkMC: 122.5;SK-MEL-30: 155.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	51800000000	63000000000	Vesicles		"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	76.8	226.8	78.4	14.6	106.8	9.7	12.8	26.6	109.8	13.6	15.1	40.3	0.8	7.7	9.4	10.9	2.6	4.3	17.1	6.9	41.4	57.9	121.8	508.1	21.5	46.0	104.0	34.5	23.5	5.2	2.7	4.9	17.2	54.1	6.6	5.2	11.2	8.5	3.4	5.7	33.0	10.2	3.6	35.1	89.2	13.4	12.6	33.9	4.9	6.0	1.3	8.6	11.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.2	167.1	6.8	6.0	0.1	0.3	0.7	0.1	39.6	0.2	0.1	0.8	0.0	0.8	0.5	1.1	0.1	0.0	0.1	0.3	0.2	0.1	77.6	17.2	0.5	0.2	122.5	0.2	1.3	0.1	1.3	0.0	0.0	10.2	0.2	0.1	0.2	0.1	0.2	20.9	0.2	0.1	0.2	0.7	0.1	0.2	0.0	0.4	0.2	0.3	0.1	155.3	12.1	14.3	4.4	0.2	1.1	0.2	0.1	0.1	0.5	0.6	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.4	106.8	26.6	53.4	41.4	57.9	104.0	34.5	54.1	33.9	0.0	10.9	128.8	14.4	830.7	52.9	1.6	384.7	0.0	5.7	216.3	39.3	36.4	578.6	1.8	57.6	21.1	0.3	163.5	0.6	28.5	329.7	3.9	179.1	7873.9	6293.2	36.5	0.0	191.5	425.6	179.9	2434.6	240.8	2353.4	122.6	0.3	7584.1	0.8	0.0	4660.8	5645.5	238.0	219.9	382.4	13.0	8.5	1472.8	62.1	122.2	1.2	4.2
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 7.9;Intestinal endocrine cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.3;HDLM-2: 46.5;HSkMC: 7.6;K-562: 9.9;SCLC-21H: 21.4"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA049797: AB_2680887, HPA055435: AB_2682816"	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favorable (2.40e-6)"	2.3	0.8	1.1	2.7	1.3	0.0	2.3	0.9	1.0	2.4	1.2	0.7	0.7	2.2	2.0	0.7	2.4	3.1	3.2	2.8	0.8	1.0	10.3	1.1	7.3	1.7	1.0	0.7	4.2	0.9	0.0	1.9	3.0	1.2	9.0	1.5	1.8	2.9	1.6	1.0	1.6	5.4	2.1	2.3	1.1	2.3	0.7	1.2	7.1	1.1	0.7	2.3	7.4	1.4	0.4	3.8	0.6	4.3	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.9	8.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	46.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.3	0.0	9.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	21.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	4.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	3.8	0.3	0.0	0.0	0.2	0.8	0.2	0.0	0.0	1.2	1.1	1.3	0.9	1.0	0.8	1.0	1.0	0.7	1.2	1.2	0.0	7.9	0.0	0.9	1.1	0.2	1.1	2.5	4.0	3.4	0.0	0.0	0.4	3.3	0.1	0.0	3.8	0.0	0.0	0.6	0.6	6.3	1.2	2.3	0.0	2.4	1.6	14.3	1.3	4.5	0.0	2.6	5.3	0.0	1.8	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	1.4	0.0	0.0	1.0	5.1	0.0	0.1	1.4
APOL6	"APOL-VI, APOLVI"	ENSG00000221963	"Apolipoprotein L6"	Q9BWW8	22	35648395-35668409	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB028574, HPA029165, HPA029167"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832"	"unprognostic (7.25e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.76e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (6.61e-4)"	40.6	9.2	4.8	18.8	5.5	10.1	32.3	1.9	4.2	7.4	17.9	4.1	5.0	14.0	8.8	9.5	9.8	5.9	12.5	9.3	4.0	4.3	15.4	36.9	15.8	17.0	4.6	2.2	17.0	4.7	3.7	5.1	8.9	5.9	11.7	8.9	6.4	10.1	5.6	7.4	3.6	36.6	6.4	7.6	19.5	10.1	2.5	4.5	12.7	24.8	7.7	13.4	8.5	14.1	1.2	2.8	9.2	9.0	5.9	9.1	4.2	7.2	2.3	0.2	0.9	18.1	9.1	10.2	3.1	8.2	10.2	12.9	1.1	8.2	10.0	1.5	8.0	7.5	9.4	0.0	5.0	2.7	18.9	0.1	4.2	1.5	2.3	14.3	5.8	7.4	11.6	3.4	3.5	2.0	2.3	2.1	4.6	0.4	18.3	1.9	0.7	8.1	1.8	0.3	0.5	3.1	3.4	4.0	4.8	4.5	16.6	0.2	0.1	4.9	4.2	5.6	0.7	0.7	6.8	2.2	2.5	1.5	1.7	1.6	9.7	7.7	1.0	4.8	9.3	3.6	6.4	5.6	2.9	9.1	8.9	7.7	1.2	6.1	7.2	2.8	1.0	6.0	6.7	9.2	5.9	9.0	0.3	6.3	4.2	4.8	5.5	1.9	4.2	4.0	4.3	4.6	2.2	5.9	4.5	65.5	29.3	17.5	9.9	7.1	0.1	6.6	38.2	40.2	40.9	12.2	0.0	6.7	8.3	30.0	10.4	23.9	70.1	0.0	36.3	26.7	19.5	29.2	36.8	105.8	31.4	0.0	45.4	41.7	43.9	4.6	24.2	30.8	8.5	23.4	48.8	3.1	38.3	42.1	17.7	23.8	0.0	0.0	13.4	0.2	0.2	4.5	2.1	51.7	25.8	43.1
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 109.5"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 140.0;Erythroid cells: 70.0;Ito cells: 65.7;Muller glia cells: 64.4;Sertoli cells: 109.9;Smooth muscle cells: 101.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 26.2;HDLM-2: 13.2;hTERT-RPE1: 10.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 5.8;olfactory region: 24.7"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Approved	"Nucleoplasm,Plasma membrane"		No	No			"Nucleoplasm, Plasma membrane"		"HPA052462: AB_2681841, HPA058882: AB_2683844"	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	109.5	8.8	11.2	9.2	17.7	0.6	34.4	9.8	17.5	25.5	9.0	7.7	2.9	2.5	7.1	7.0	18.8	14.0	18.7	22.3	13.0	11.8	7.4	9.3	7.1	3.4	16.6	3.3	10.0	12.8	17.2	4.7	44.8	16.7	7.2	7.1	8.1	4.4	3.7	16.6	7.4	6.0	28.0	13.9	4.7	5.3	5.4	12.4	5.7	34.4	9.9	3.3	10.9	7.1	2.3	1.7	4.8	0.9	0.8	2.7	0.3	4.3	0.1	26.2	0.8	0.8	1.5	0.2	4.2	7.0	4.3	6.3	1.7	4.6	1.3	0.4	1.6	1.5	1.4	1.0	0.2	7.3	13.2	1.0	0.4	1.3	0.0	1.6	0.6	0.4	1.0	1.2	1.5	3.4	10.9	3.2	2.4	0.4	1.8	2.2	0.9	0.7	0.7	0.1	1.0	0.8	2.0	0.5	0.6	0.5	0.4	2.3	2.4	4.0	0.4	9.6	0.4	0.1	2.1	3.9	1.0	1.4	5.8	3.8	1.3	0.6	1.0	1.5	2.8	4.9	4.8	0.9	0.7	0.9	0.4	1.1	2.2	2.0	1.3	0.6	2.3	1.6	1.0	4.4	0.8	0.6	1.7	2.7	0.3	11.2	17.7	9.8	17.5	13.0	11.8	16.6	3.3	16.7	12.4	6.0	4.0	21.4	2.2	16.1	4.2	7.0	7.6	8.1	9.1	0.0	3.9	1.5	0.0	0.9	1.6	140.0	1.1	70.0	0.4	1.1	8.4	3.7	7.0	1.6	5.1	3.2	3.5	65.7	14.5	1.1	4.0	5.7	27.0	3.6	4.7	64.4	0.8	0.0	0.4	0.3	3.3	109.9	101.3	3.2	0.7	13.6	0.8	20.8	6.3	2.8
APOM	"ApoM, G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 94.6"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 596.8;Proximal tubular cells: 592.0"	"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.3"	"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7400000000	18000000000	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	1.3	1.5	1.8	1.5	1.6	6.8	1.9	1.3	2.0	1.3	1.8	2.2	1.9	2.4	2.3	3.0	1.6	1.5	1.4	1.5	1.5	1.3	15.2	94.6	1.0	3.6	1.7	1.9	3.7	3.3	1.4	1.9	0.7	1.6	1.1	0.9	2.1	3.1	1.6	2.2	2.4	2.4	1.5	2.4	1.3	1.4	6.6	1.1	3.6	2.7	1.7	3.1	1.1	1.0	3.3	1.6	5.8	2.1	1.0	2.2	1.0	2.2	1.1	2.5	4.1	2.1	2.5	0.5	1.5	2.7	1.0	2.4	1.5	3.2	3.4	0.8	2.7	2.0	3.6	1.5	1.6	2.1	2.1	2.6	2.4	1.8	3.2	3.3	4.3	1.2	3.3	1.6	1.0	3.0	2.2	0.9	3.4	4.3	2.2	2.7	3.3	3.6	4.2	2.2	1.6	0.5	2.2	1.8	3.9	2.8	3.2	2.2	1.0	2.2	0.2	1.8	1.2	4.5	3.1	0.4	1.5	0.5	2.9	0.6	4.0	3.5	4.1	1.3	6.6	0.6	5.8	1.9	1.7	1.1	0.9	1.7	3.3	1.3	1.1	1.6	1.9	1.7	1.8	1.7	1.0	2.1	1.4	2.2	1.0	1.8	1.6	1.3	1.8	1.5	1.3	1.7	1.9	1.6	1.1	0.0	6.1	14.3	4.6	5.7	1.2	1.4	10.2	2.7	2.3	14.0	3.9	1.6	64.6	3.5	42.6	1.4	9.3	0.0	6.1	0.8	4.3	3.2	4.7	596.8	4.8	0.0	4.1	6.7	11.4	29.3	8.6	3.4	5.0	0.0	2.5	13.2	5.1	3.1	6.0	592.0	2.3	0.0	2.7	19.1	5.5	5.6	1.0	8.7	3.3	3.7
APOO	"FAM121B, MGC4825, Mic23, MIC26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907934	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 152.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	5.6	13.1	25.5	5.4	21.2	4.4	9.0	18.5	30.9	9.1	10.9	8.5	5.5	9.2	7.2	13.5	7.2	13.6	6.1	38.4	26.0	23.8	29.5	12.2	5.5	6.6	24.9	17.5	7.1	9.0	20.1	15.8	7.1	21.5	9.3	12.5	11.7	14.6	10.4	26.0	4.3	7.6	7.8	18.1	5.4	10.3	10.5	6.8	7.7	13.3	10.4	7.2	6.3	5.8	9.8	14.2	8.5	13.3	7.8	15.0	6.6	14.7	13.5	22.7	15.8	3.8	8.7	3.6	7.4	9.1	15.8	16.7	8.0	7.1	12.8	9.3	6.8	20.6	12.2	28.6	14.8	17.6	13.5	20.3	6.5	13.4	12.6	9.0	16.3	7.3	9.7	8.8	17.4	13.0	8.5	11.0	16.1	9.1	14.5	14.6	13.9	16.4	17.6	20.7	19.4	21.9	12.7	11.3	30.7	30.9	7.6	15.4	11.2	16.1	15.4	15.8	23.3	26.6	7.3	2.7	10.2	6.2	36.5	11.2	11.3	19.8	11.6	16.5	8.1	14.9	8.5	4.2	1.5	11.5	13.3	15.0	9.8	12.7	11.3	12.0	8.3	10.3	10.1	2.5	7.8	12.6	14.2	11.5	6.6	25.5	21.2	18.5	30.9	26.0	23.8	24.9	17.5	21.5	6.8	14.9	7.8	15.6	14.2	12.5	19.3	55.7	25.5	87.0	9.1	22.7	13.7	16.6	152.5	24.6	16.8	8.7	14.4	0.0	14.1	7.3	12.6	14.5	3.5	11.9	20.3	19.1	6.9	9.8	10.1	11.7	10.6	11.2	27.0	55.9	17.6	40.5	12.0	18.4	14.9	67.7	23.7	6.5	6.2	14.0	50.7	6.0	10.4	10.0	20.9	15.4
APOOL	"AAIR8193, CXorf33, FAM121A, Mic27, UNQ8193"	ENSG00000155008	"Apolipoprotein O like"	Q6UXV4	X	85003826-85093316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA000612	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA000612: AB_1078594"	"prognostic unfavorable (2.68e-5)"	"unprognostic (2.72e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (4.27e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.77e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.35e-12)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.11e-2)"	"unprognostic (7.51e-2)"	9.9	13.2	6.2	5.2	11.2	4.5	8.6	4.3	11.9	7.8	8.2	7.1	6.6	8.2	8.6	8.4	14.0	7.7	6.3	16.1	8.3	6.8	16.2	20.1	6.7	4.3	8.4	7.4	8.0	14.2	17.0	12.9	7.3	14.0	7.8	9.2	7.4	9.9	6.4	20.4	9.2	10.4	8.9	8.8	4.9	9.2	4.6	8.2	7.3	12.7	11.1	5.6	11.0	9.4	7.8	5.9	7.1	6.7	3.6	5.2	2.1	11.5	9.5	6.5	7.9	16.6	11.4	7.4	7.8	7.4	6.6	7.9	8.3	7.4	8.4	8.7	8.2	15.9	8.7	19.6	7.5	11.5	9.0	8.0	8.9	11.9	7.4	9.9	16.3	8.8	12.2	9.9	11.7	19.4	6.6	9.4	11.3	16.1	13.6	10.5	8.9	6.5	4.8	5.7	9.1	14.5	7.4	14.9	8.5	7.0	9.1	0.6	9.1	14.9	11.9	7.2	7.7	7.7	6.3	11.0	8.0	12.3	17.2	8.8	6.4	27.1	8.4	9.1	12.8	7.7	7.1	4.7	3.4	4.7	6.7	3.9	7.8	4.4	3.6	5.0	4.5	5.2	4.7	1.0	3.6	5.5	5.9	3.0	2.1	6.2	11.2	4.3	11.9	8.3	6.8	8.4	7.4	14.0	8.2	14.9	15.5	9.3	11.2	4.9	25.7	45.1	15.3	10.7	9.1	19.2	13.7	13.8	11.6	15.6	0.0	11.7	9.8	0.0	12.2	9.6	7.1	20.2	20.8	41.2	10.2	20.6	35.6	14.1	12.4	0.2	12.7	10.9	0.0	3.6	15.0	15.1	14.9	16.4	14.5	24.8	15.6	19.4	8.9	2.4	7.2	3.0	16.2	4.5	14.7	14.8
APP	AD1	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880550-26171128	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 24.0"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 24.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		15000000	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.79e-6)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.08e-3)"	44.8	92.5	89.9	26.3	109.3	21.2	79.9	64.5	139.1	51.7	63.4	86.9	72.0	39.7	52.2	57.2	33.0	57.6	63.4	69.1	104.6	97.7	102.2	54.5	50.2	12.9	97.4	95.8	58.9	57.1	36.4	34.1	79.7	83.2	49.2	59.6	48.9	47.2	66.6	17.2	38.2	34.9	69.3	109.0	26.3	37.9	32.2	67.5	13.9	85.0	21.5	16.7	52.5	58.4	1.5	24.0	0.9	3.9	0.3	1.5	1.8	31.2	40.4	44.3	36.9	60.4	75.0	47.9	63.4	84.6	32.2	37.9	23.2	76.7	0.0	73.9	49.6	42.0	21.4	27.0	74.5	27.3	1.1	21.8	0.0	24.4	16.3	59.0	29.6	1.6	67.5	82.4	37.7	69.3	133.1	144.0	13.0	0.0	3.2	50.5	35.0	0.5	0.3	34.8	51.2	36.1	19.4	42.7	26.0	109.0	22.0	22.6	33.0	68.0	44.8	31.8	63.1	39.6	32.3	153.9	71.7	30.4	26.1	29.9	19.6	0.2	0.3	58.3	0.1	68.8	0.4	3.9	0.0	0.1	1.2	0.2	0.5	1.4	0.5	3.4	1.5	1.5	0.4	0.9	0.3	0.9	24.0	0.3	1.8	89.9	109.3	64.5	124.6	104.6	97.7	97.4	95.8	83.2	67.5	101.3	43.6	31.5	195.4	161.4	26.5	130.8	282.8	120.5	119.4	476.3	27.5	341.9	48.0	308.0	33.6	371.9	139.3	0.0	158.2	112.6	202.6	156.7	8.1	105.8	67.9	79.4	156.1	527.9	77.8	43.7	224.6	45.9	153.5	92.8	307.0	330.4	178.5	181.4	279.0	124.0	22.1	116.4	133.6	37.0	87.7	92.8	461.7	25.5	256.5	110.0
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 59.9"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 2.5;granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 16.0;HMC-1: 6.7;K-562: 18.3;SH-SY5Y: 4.4"					"Low region specificity"	"Detected in many"			"HPA062621, HPA065947"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	36.0	0.0	0.0	37.2	0.2	0.3	0.1	4.3	0.5	0.7	0.4	0.0	0.0	0.1	2.2	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	59.9	0.0	0.0	2.7	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610355	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 60.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 30.5;Late spermatids: 51.4;Muller glia cells: 29.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.8;GAMG: 12.3;Hep G2: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	14.5	4.2	0.8	3.5	0.6	1.1	5.0	4.8	0.6	22.4	2.1	0.7	24.7	0.8	1.2	0.5	0.9	2.4	0.7	2.5	4.5	5.2	13.9	0.6	0.9	3.4	3.4	9.3	3.6	0.9	1.8	3.5	3.4	3.9	2.1	3.8	0.8	0.7	1.0	1.0	60.1	0.6	1.5	1.0	2.3	7.4	1.7	0.0	1.6	0.2	0.4	0.8	0.6	2.0	0.1	0.3	0.1	2.0	2.3	0.8	1.0	3.3	1.4	2.2	3.2	0.8	1.4	1.7	0.8	1.6	0.7	7.8	1.6	1.6	0.8	0.7	12.3	1.0	0.5	0.1	0.8	4.8	1.3	1.3	1.1	13.0	1.0	2.7	1.5	0.8	0.3	0.9	0.2	1.9	0.3	0.4	0.8	1.0	1.8	1.6	1.0	1.8	1.4	7.5	3.0	1.4	3.5	0.6	0.9	1.2	1.4	1.0	2.1	0.4	0.8	1.1	1.6	0.4	0.9	1.3	4.1	2.5	1.1	1.1	0.8	1.3	0.4	0.2	1.8	0.0	0.0	0.3	1.9	0.0	1.3	0.3	0.8	1.5	0.1	2.0	2.3	0.7	0.0	2.0	0.1	0.1	0.1	0.8	4.2	3.5	5.0	4.8	2.5	4.5	3.4	3.4	3.4	1.7	0.0	0.0	0.0	0.7	0.1	7.5	0.4	7.6	0.0	0.0	1.8	0.0	6.6	0.0	1.2	30.5	0.3	15.8	0.0	3.4	10.1	0.9	1.2	4.6	21.5	1.0	0.0	4.1	0.0	0.3	51.4	14.4	0.0	1.7	0.0	3.1	29.1	3.7	3.1	10.6	15.3	5.0	0.0	0.7	35.9	5.8	0.1	13.3	0.0	5.6	0.1
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961870-49965681	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"salivary gland: 217.9;testis: 76.2"	"Group enriched"	"Detected in many"	8	"Early spermatids: 1235.0;Late spermatids: 3096.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 70.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065008	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favorable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	0.2	0.1	0.4	0.2	1.1	0.0	3.8	0.4	0.3	3.0	0.3	0.4	0.3	3.2	0.6	0.8	3.8	0.1	15.6	1.0	0.3	0.3	0.2	0.2	2.3	0.2	0.7	0.2	0.2	0.8	0.1	0.4	0.2	0.3	0.5	0.0	0.4	217.9	0.6	0.9	23.5	0.3	0.6	0.2	0.2	12.0	76.2	0.3	0.2	0.3	2.8	11.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	70.7	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.4	0.3	0.3	0.3	0.7	0.2	0.3	0.3	53.6	1.9	0.0	0.4	1.1	0.5	0.3	0.0	8.1	37.5	7.0	0.0	0.0	0.0	0.0	1235.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3096.0	26.4	0.0	280.0	0.0	0.0	45.4	4.3	0.0	18.0	0.0	1.4	19.4	0.3	76.9	15.2	0.6	0.0	0.0	0.0	0.7
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561100-47571920	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046188, HPA066326"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA046188: AB_2679578, HPA066326: AB_2685659"	"unprognostic (1.21e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.45e-6)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.71e-2)"	22.2	24.2	10.9	16.5	15.5	41.9	19.5	16.0	13.7	18.0	23.2	21.1	24.1	17.8	21.3	18.4	19.4	18.7	21.0	28.6	12.8	7.3	28.0	49.6	21.8	20.2	16.4	9.5	23.4	35.1	28.1	16.9	25.3	13.5	23.5	15.8	25.4	22.1	18.5	60.8	18.9	23.8	18.6	11.2	27.4	24.2	10.2	16.3	27.7	23.1	23.9	27.3	20.2	16.9	23.9	34.3	36.1	38.4	22.4	29.1	27.5	20.3	29.3	12.6	20.2	19.2	15.3	17.0	17.2	18.2	25.7	23.7	23.9	25.0	12.1	14.1	23.0	21.6	28.7	22.2	23.7	14.8	22.3	26.1	12.1	31.1	12.3	27.0	24.0	37.2	20.1	24.2	24.5	21.5	17.0	19.7	15.4	22.5	23.9	17.4	34.4	17.4	25.9	18.1	17.2	32.8	16.2	16.4	27.3	14.7	19.5	14.3	11.0	18.5	17.1	10.1	20.8	32.2	18.2	18.7	16.7	18.8	33.3	17.3	31.0	19.8	9.4	22.2	27.2	13.3	23.9	29.0	36.1	29.1	35.4	26.9	21.4	25.5	26.7	34.3	23.9	22.7	26.7	23.6	22.4	38.4	24.7	25.1	27.5	10.9	15.5	16.0	13.7	12.8	7.3	16.4	9.5	13.5	16.3	14.9	36.4	18.8	19.6	14.0	4.0	23.6	30.6	8.1	10.3	17.4	9.8	27.3	19.9	24.2	1.1	17.9	37.6	0.0	29.9	25.3	15.5	19.0	16.1	35.8	24.8	12.7	30.5	22.7	22.7	3.0	16.1	21.7	32.1	55.1	36.8	13.3	23.6	40.2	16.6	22.1	8.2	19.4	18.6	5.6	10.2	14.2	37.3	27.4	26.6	21.6
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		39000	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: AB_2686262"	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.41e-4)"	"unprognostic (7.56e-3)"	19.2	29.6	28.8	32.9	29.1	51.1	17.9	34.0	37.5	19.6	16.8	26.6	20.0	17.4	23.7	20.0	21.1	30.3	26.1	20.3	27.7	14.4	20.9	16.6	35.5	27.8	27.5	17.8	28.8	18.9	14.3	31.0	20.9	23.0	21.3	11.2	18.1	19.9	19.0	12.9	27.5	23.6	17.1	25.6	53.8	16.2	23.5	32.3	18.8	24.7	14.0	18.6	28.4	19.6	3.3	7.4	24.0	22.5	6.1	4.4	6.4	7.2	15.5	5.9	7.2	25.3	17.2	8.9	10.0	18.1	11.4	11.4	21.1	19.4	16.2	20.2	16.8	15.5	24.6	9.0	23.9	4.9	19.0	10.6	13.7	14.6	29.1	17.5	9.3	38.5	18.3	25.5	18.7	9.0	14.3	12.1	11.9	11.4	6.5	5.3	15.0	14.1	32.4	3.7	13.1	10.0	13.8	9.0	7.9	10.7	23.2	6.2	12.5	7.3	10.9	32.3	7.9	9.5	21.2	14.3	16.2	11.3	16.4	6.1	10.5	5.1	8.5	8.6	13.9	8.6	7.5	11.0	13.3	4.4	18.7	2.6	3.3	2.9	3.3	7.4	2.6	2.3	2.7	24.0	6.1	22.5	2.5	3.1	6.4	28.8	29.1	34.0	37.5	27.7	14.4	27.5	17.8	23.0	32.3	26.8	28.8	11.5	8.0	6.5	4.1	2.0	5.1	8.1	3.4	15.7	31.4	7.0	8.3	13.1	49.1	4.4	11.6	0.0	6.4	7.7	16.7	4.7	10.4	10.2	37.8	0.0	22.3	12.9	43.1	4.4	19.2	39.0	8.5	10.8	13.9	8.6	10.7	7.0	14.2	4.7	2.9	0.0	6.1	0.3	2.5	4.6	4.1	6.7	12.1	6.7
ARAP2	"CENTD1, PARX"	ENSG00000047365	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2"	Q8WZ64	4	35948221-36244509	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 142.9;Early spermatids: 113.2;Late spermatids: 89.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.0;hTCEpi: 11.3;MOLT-4: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035925	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Actin filaments"	"HPA035925: AB_10672075"	"unprognostic (2.97e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	5.2	2.5	16.3	9.1	27.5	32.5	5.2	4.8	20.8	4.2	5.1	18.3	0.3	8.5	3.5	4.1	12.7	3.5	9.2	2.5	16.0	9.5	3.9	8.8	12.7	13.7	24.4	12.1	1.9	6.8	8.2	5.1	3.5	18.4	2.9	5.8	0.7	5.8	3.3	1.4	16.1	8.2	4.4	15.3	10.4	5.8	5.9	32.0	26.4	22.4	4.0	10.2	6.2	7.2	2.4	1.7	0.6	5.8	8.6	5.7	0.7	7.3	0.6	0.7	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.6	12.0	3.5	2.9	0.3	0.0	2.8	1.1	5.8	0.0	0.0	6.6	0.1	2.4	0.2	1.5	4.6	0.0	0.4	11.3	0.0	2.5	4.4	0.0	9.7	0.2	0.6	0.0	3.1	10.7	3.8	0.8	5.1	2.3	5.5	0.0	4.0	8.3	7.5	6.5	0.0	0.4	1.8	2.4	0.4	5.0	1.4	0.0	2.0	6.7	0.0	1.0	0.0	0.0	6.8	0.8	5.3	1.7	0.0	0.8	0.0	5.7	2.7	5.3	2.4	3.2	3.9	0.4	1.4	1.1	2.9	0.6	8.6	5.8	1.7	1.5	0.7	16.3	27.5	4.8	20.8	16.0	9.5	24.4	12.1	18.4	32.0	142.9	21.8	22.6	24.0	34.8	0.3	1.7	10.2	20.1	43.3	7.0	0.0	0.1	6.6	7.2	113.2	13.5	14.6	0.0	8.6	0.2	4.5	28.3	9.2	3.8	7.3	0.0	2.9	3.1	32.3	89.9	2.6	17.8	5.0	16.2	9.2	5.4	15.9	17.5	0.7	4.1	1.0	0.0	1.4	3.2	1.9	59.0	0.7	42.4	6.4	46.4
ARC	"Arg3.1, KIAA0278"	ENSG00000198576	"Activity regulated cytoskeleton associated protein"	Q7LC44	8	142611044-142614472	"Predicted intracellular proteins"	"Endocytosis, Transport"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.8;seminal vesicle: 67.7"	"Cell type enriched"	"Detected in many"	11	"Intestinal endocrine cells: 157.5"	"Cancer enriched"	"Detected in many"	12	"glioma: 36.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.9;HEK 293: 8.5;SCLC-21H: 20.4;U-2 OS: 9.9;U-87 MG: 11.2"	"Group enriched"	"Detected in many"	5	"amygdala: 48.9;basal ganglia: 51.6;cerebral cortex: 144.6;hippocampal formation: 99.8;olfactory region: 50.5"	"Group enriched"	"Detected in many"	7	"basal ganglia: 25.3;cerebral cortex: 87.7;hippocampal formation: 55.8;olfactory region: 47.5"	"HPA056430, CAB079013"		Supported	Approved	Vesicles,Microtubules		NA	NA			"Vesicles, Microtubules"		"CAB079013: , HPA056430: AB_2683130"	"unprognostic (1.40e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.87e-4)"	"unprognostic (6.83e-2)"	"unprognostic (8.12e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.07e-2)"	"unprognostic (9.43e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.35e-2)"	18.1	15.9	6.1	1.0	6.5	0.7	1.0	0.8	17.0	1.5	0.9	4.2	11.8	0.8	1.4	1.8	0.9	1.2	3.5	0.5	13.9	7.1	1.5	0.7	2.7	0.4	2.4	2.1	0.5	6.2	0.4	25.8	1.8	4.0	1.0	0.6	0.0	0.5	67.7	0.5	3.5	0.7	0.9	1.2	0.7	2.1	0.6	1.1	0.0	1.5	0.8	1.9	0.6	1.5	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.1	0.3	6.9	0.1	0.8	0.0	1.5	0.0	0.3	0.1	0.1	0.0	0.0	0.9	0.2	0.2	0.1	0.5	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	2.9	0.0	0.0	3.2	1.2	1.5	0.0	0.7	0.0	0.0	0.0	20.4	4.8	0.5	0.0	0.2	0.0	0.0	0.1	0.0	1.1	9.9	0.7	0.2	1.9	0.0	0.0	11.2	0.0	2.9	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	6.5	0.8	17.0	13.9	7.1	2.4	2.1	4.0	1.1	0.0	4.0	0.0	11.1	4.5	7.7	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	2.8	0.4	0.0	0.0	0.3	7.4	13.8	0.0	0.0	1.5	3.2	157.5	1.8	0.8	0.0	0.3	1.0	6.8	0.0	1.7	7.8	0.1	0.0	1.8	0.0	2.7	0.0	10.3	0.2	0.7	5.6	0.1	0.7	1.2	2.2
ARCN1	COPD	ENSG00000095139	"Archain 1"	P48444	11	118572390-118603033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037573, HPA044874"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		340000	Vesicles	"Golgi apparatus, Cytosol"	"HPA037573: AB_10696938, HPA044874: AB_2679126"	"unprognostic (1.46e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.56e-3)"	46.9	37.4	26.7	30.3	32.9	15.0	35.7	34.4	38.8	48.8	36.7	37.3	39.9	36.0	39.8	61.6	38.6	32.6	38.0	39.5	28.7	30.6	39.1	61.4	34.0	27.3	30.4	24.7	45.1	65.2	49.7	64.7	46.0	38.3	42.4	39.6	29.3	62.0	46.9	25.8	31.9	47.1	41.9	34.3	34.9	38.1	37.9	29.7	39.0	44.1	29.3	39.2	46.9	42.1	22.7	29.1	46.2	33.0	34.1	39.5	26.7	24.7	20.7	36.3	26.5	44.7	47.8	19.6	62.3	55.4	28.2	33.8	65.2	32.8	26.0	53.5	69.5	40.9	33.4	40.5	36.6	39.4	35.8	18.9	55.9	15.0	35.5	50.8	34.3	32.7	41.6	30.5	46.6	43.5	39.7	42.7	25.8	28.7	36.6	53.1	39.7	30.8	30.5	22.8	51.4	27.7	26.9	35.3	39.6	34.2	26.8	24.9	25.0	34.7	33.8	17.6	35.1	43.0	30.7	39.0	35.7	17.6	33.7	28.8	21.5	19.0	37.9	21.0	32.2	42.3	46.2	26.4	26.3	30.5	33.0	39.5	22.7	30.2	29.3	29.1	20.7	29.1	26.6	23.1	34.1	32.1	24.4	28.3	26.7	26.7	32.9	34.4	38.8	28.7	30.6	30.4	24.7	38.3	29.7	32.8	42.8	17.5	25.2	28.0	19.4	40.3	30.6	48.2	45.5	29.6	3.9	13.9	8.3	32.0	9.5	32.1	50.4	0.0	32.8	30.7	36.6	44.9	38.1	51.8	26.5	17.5	38.6	35.6	36.5	5.6	44.5	24.8	21.9	45.1	66.8	15.7	39.0	28.1	38.9	27.0	11.7	19.4	38.9	40.0	50.4	30.4	25.3	24.9	34.6	42.9
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445134-74455009	"Cancer-related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 83.5"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 759.9;Basal keratinocytes: 994.1;Enterocytes: 632.3;granulocytes: 633.9;Urothelial cells: 1407.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 11.6;NK-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 42.8;HBEC3-KT: 74.1;hTCEpi: 75.5;hTERT-HME1: 161.4;MCF7: 46.5"	"Region enriched"	"Detected in single"	4	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	19.5	1.1	0.4	9.2	2.1	28.9	20.3	0.3	0.4	5.7	6.7	0.2	0.2	0.7	1.7	1.6	22.3	6.0	34.8	13.6	0.5	0.4	2.5	1.7	14.4	13.3	0.4	0.0	5.8	1.0	0.0	7.8	83.5	1.3	1.9	5.0	1.4	3.9	0.9	9.9	3.4	10.0	1.5	1.0	11.3	5.3	4.6	0.0	1.6	1.2	13.4	13.6	8.7	4.6	0.4	0.8	11.6	0.0	3.3	0.4	0.1	1.7	12.2	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.3	42.8	6.8	0.0	0.9	0.0	0.0	1.9	0.0	74.1	0.7	0.0	0.0	0.0	0.3	2.0	23.0	0.2	0.0	0.7	75.5	4.4	161.4	0.1	0.0	0.0	0.1	0.0	1.6	46.5	0.0	0.0	0.0	8.8	4.9	0.0	0.0	0.0	4.2	0.3	0.0	0.0	2.5	0.1	0.0	0.0	1.3	0.0	0.1	0.0	1.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	8.2	0.0	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.4	0.2	0.0	0.1	3.3	0.0	0.1	0.0	0.1	0.4	2.1	0.3	0.4	0.5	0.4	0.4	0.0	1.3	0.0	184.6	339.4	82.8	759.9	994.1	0.0	30.5	71.4	92.3	310.5	48.8	0.0	1.3	0.0	52.7	45.1	3.9	632.3	0.0	8.6	1.2	28.2	73.6	633.9	2.9	31.8	0.0	39.8	10.4	189.5	5.9	0.3	134.1	32.1	1.8	188.0	0.0	301.5	221.0	1.1	0.5	0.0	19.4	4.4	52.0	45.0	299.4	0.9	149.6	119.9	1407.8
ARF1		ENSG00000143761	"ADP ribosylation factor 1"	P84077	1	228082660-228099212	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB007742	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB007742: AB_562043"	"unprognostic (9.54e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.73e-1)"	"unprognostic (8.95e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.94e-1)"	72.0	70.1	64.8	51.0	82.5	111.1	59.3	50.0	116.9	76.0	76.7	53.5	63.6	73.6	71.1	63.3	81.1	66.8	58.5	101.1	70.3	65.9	81.7	135.9	77.4	55.6	52.7	56.5	73.5	109.2	64.9	79.7	129.6	61.4	70.1	55.7	67.8	106.7	68.6	96.5	57.5	91.6	54.7	45.9	81.5	66.0	73.0	33.8	75.6	102.9	60.5	76.5	72.6	57.6	37.4	73.3	111.7	70.0	41.5	64.7	110.7	64.1	44.4	36.5	36.2	42.2	53.4	60.7	56.9	61.0	63.3	55.6	52.5	61.8	32.7	61.2	60.6	29.5	41.6	44.7	55.7	31.8	48.1	71.3	31.8	31.3	52.2	81.7	45.9	47.5	51.0	68.0	58.3	61.5	54.0	62.4	37.4	60.9	75.1	60.9	46.2	46.6	68.0	46.8	90.7	90.9	37.8	32.3	101.9	44.7	33.3	51.6	45.6	36.7	111.5	63.4	13.2	76.6	93.4	55.8	46.6	37.0	67.7	85.3	71.0	39.6	44.9	64.1	39.2	93.9	104.5	70.0	77.2	53.1	66.5	64.7	37.4	45.7	49.1	54.5	34.9	36.2	39.4	111.7	41.5	63.0	73.3	51.8	110.7	64.8	82.5	50.0	116.9	70.3	65.9	52.7	56.5	61.4	33.8	160.8	159.4	184.0	242.8	233.2	114.0	114.2	104.4	214.2	168.4	109.9	43.2	328.6	195.6	344.6	194.6	176.5	349.6	46.7	355.5	480.3	217.0	287.7	192.9	110.7	362.5	149.4	220.8	138.7	177.0	322.5	212.3	230.8	285.1	408.4	315.0	144.2	328.8	293.4	213.6	122.7	61.1	226.4	208.9	174.2	166.0	249.9	565.9	208.8	250.8	292.8
ARFGEF2	BIG2	ENSG00000124198	"ADP ribosylation factor guanine nucleotide exchange factor 2"	Q9Y6D5	20	48921890-49036693	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 95.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026078, CAB026382"	Supported		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026382: , HPA026078: AB_1844983"	"unprognostic (1.50e-2)"	"unprognostic (9.56e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.94e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.15e-7)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.90e-2)"	12.9	29.8	9.4	16.6	15.9	15.6	18.7	14.2	21.8	12.7	15.6	12.5	19.2	15.8	13.8	12.4	15.2	10.4	12.8	19.2	11.1	11.0	17.1	20.1	11.5	14.3	11.5	12.6	12.2	21.6	95.3	17.1	15.4	16.1	12.6	17.6	13.4	15.1	24.7	16.2	15.5	16.5	11.6	11.9	14.0	17.4	23.2	8.5	15.5	23.6	11.6	16.0	16.1	11.6	2.5	2.4	7.3	1.7	1.8	2.8	1.0	9.5	11.0	5.1	3.3	9.6	8.8	12.9	8.0	10.8	21.3	10.5	20.0	11.2	13.6	12.2	11.5	19.4	11.5	10.1	12.7	18.5	5.0	3.7	10.1	11.2	18.4	12.4	12.3	11.7	9.0	14.0	14.2	14.9	7.7	14.9	6.6	7.7	13.7	11.3	4.3	7.7	6.8	5.0	11.0	10.1	8.1	13.3	16.6	11.1	13.8	4.6	5.5	23.3	38.4	15.3	6.4	15.4	12.8	18.6	20.6	9.4	10.4	7.4	20.9	18.8	10.1	13.4	6.7	6.9	7.3	1.7	0.7	1.6	1.1	2.8	1.6	1.9	1.8	2.4	2.5	2.7	2.4	0.5	1.8	1.1	2.4	0.5	1.0	9.4	15.9	14.2	21.8	11.1	11.0	11.5	12.6	16.1	8.5	17.9	21.3	13.7	11.9	10.1	14.5	33.1	20.4	12.0	21.6	10.4	13.7	8.6	1.7	8.5	12.6	17.5	21.6	23.3	11.5	7.7	10.3	18.9	15.0	23.1	9.7	11.1	12.0	24.5	14.8	18.7	9.5	11.2	10.1	12.6	22.6	6.2	13.3	20.1	10.6	10.5	15.7	6.5	8.0	25.6	19.6	13.6	25.1	6.4	18.4	12.4
ARFIP1	HSU52521	ENSG00000164144	"ADP ribosylation factor interacting protein 1"	P53367	4	152779937-152918463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005080, HPA037375, HPA063759"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.49e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (2.83e-10)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.22e-3)"	17.8	15.6	12.2	22.6	13.2	2.8	22.3	15.7	12.3	22.8	25.3	17.5	25.6	20.9	21.1	23.8	23.4	17.6	20.8	11.9	12.6	13.2	23.6	15.3	20.3	14.9	16.1	9.5	22.9	18.8	20.4	22.5	29.0	13.5	23.8	26.4	19.1	19.6	23.9	12.7	19.1	29.9	18.5	18.3	18.5	20.2	12.7	13.9	14.7	23.9	10.2	17.9	24.3	20.4	8.4	10.9	35.7	13.8	12.3	7.6	7.7	13.2	9.9	13.8	13.5	21.8	22.3	17.1	15.9	22.5	16.1	15.4	11.5	27.8	10.6	5.3	22.1	12.4	9.5	14.3	16.1	20.1	8.9	8.9	10.5	10.1	11.4	15.4	19.7	22.2	15.7	17.9	13.7	13.6	17.5	14.8	6.2	12.3	23.0	22.5	15.4	11.0	11.0	11.6	16.6	10.1	6.4	7.8	9.8	29.1	17.8	17.5	14.4	12.0	22.7	15.8	14.1	20.3	10.6	9.1	15.6	11.1	15.1	11.2	25.3	20.8	14.5	19.8	19.8	21.5	12.1	12.0	17.9	6.7	13.8	6.7	8.4	5.3	5.5	10.9	7.7	4.1	5.5	35.7	12.3	12.6	1.3	7.6	7.7	12.2	13.2	15.7	12.3	12.6	13.2	16.1	9.5	13.5	13.9	6.0	25.6	10.4	15.8	26.3	17.3	8.1	28.1	25.4	21.6	36.6	0.0	24.5	23.2	23.7	30.8	19.9	26.4	0.0	15.9	21.2	22.4	21.3	22.0	17.8	19.1	17.5	37.3	19.0	22.2	19.7	20.8	18.5	20.3	5.4	34.5	32.0	19.3	24.6	20.5	24.5	23.6	32.3	18.9	25.5	31.9	29.6	36.7	11.4	29.7	29.4
ARFIP2	POR1	ENSG00000132254	"ADP ribosylation factor interacting protein 2"	P53365	11	6474683-6481479	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032985, HPA038156"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"		"CAB032985: AB_2058811, HPA038156: AB_10697243"	"unprognostic (2.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.48e-3)"	13.3	20.5	19.7	15.2	19.4	12.6	33.0	24.0	32.0	24.5	22.9	16.4	29.5	20.2	17.5	23.1	22.0	25.5	21.5	13.2	16.5	17.2	21.3	32.7	17.5	13.0	15.5	22.0	20.3	36.0	36.1	29.9	27.3	16.8	30.9	31.2	18.6	46.6	29.4	12.1	21.6	23.5	17.8	14.9	15.0	31.2	14.9	16.0	12.3	28.4	16.3	24.2	16.0	19.8	11.5	17.4	7.8	12.7	15.6	15.5	10.8	14.2	19.0	11.6	11.8	18.2	17.1	16.6	11.5	31.4	25.9	31.0	17.9	23.9	11.5	4.9	23.2	14.5	20.3	14.7	24.6	21.7	8.9	26.0	6.2	25.2	17.1	22.0	10.0	12.8	18.1	19.7	12.5	30.3	19.0	16.4	11.0	9.8	13.6	16.8	28.0	11.8	11.4	19.6	32.1	21.6	9.1	6.5	10.9	18.0	14.8	15.4	18.7	14.0	62.6	7.2	11.1	25.8	9.3	10.4	11.1	10.7	11.5	8.5	20.4	9.1	7.0	19.9	6.2	12.6	7.4	12.7	7.8	15.5	8.8	15.2	10.7	14.6	12.7	17.4	11.5	14.5	14.8	5.3	15.6	5.4	13.6	14.7	10.8	19.7	19.4	24.0	32.0	16.5	17.2	15.5	22.0	16.8	16.0	6.0	5.4	21.6	37.4	24.8	31.5	3.9	28.1	10.7	7.9	12.2	27.5	68.9	49.7	42.8	17.9	17.9	60.6	0.0	74.5	52.8	24.9	63.7	32.2	17.1	24.8	20.6	60.5	20.3	9.1	30.2	19.0	15.7	23.6	33.3	78.2	31.3	48.5	52.6	23.0	26.0	27.9	25.8	17.5	32.9	16.4	28.1	94.1	16.2	40.6	54.8
ARHGAP1	"CDC42GAP, p50rhoGAP, RhoGAP"	ENSG00000175220	"Rho GTPase activating protein 1"	Q07960	11	46677080-46700615	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004689, HPA008285"	Approved	Approved	Approved	Vesicles		NA	NA		16000000	Vesicles		"HPA004689: AB_1078194, HPA008285: AB_1078195"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.24e-2)"	39.9	23.0	17.5	21.3	24.0	17.5	25.8	9.5	30.1	35.6	23.9	42.9	13.1	15.2	43.0	23.9	36.8	31.0	40.2	63.3	23.0	14.8	19.8	19.4	17.9	22.0	17.5	17.7	32.6	17.0	18.6	16.7	32.0	17.1	36.3	20.0	33.8	21.6	39.3	15.1	26.9	19.5	58.5	18.1	29.0	21.4	21.4	24.1	21.0	20.0	16.2	27.2	59.5	27.1	7.9	17.1	18.8	33.4	11.6	14.3	10.3	7.1	18.1	9.1	12.8	45.3	33.4	10.7	15.9	16.3	14.7	13.5	10.8	9.5	10.5	8.7	32.6	13.3	18.0	7.2	24.4	11.1	7.2	7.8	11.5	9.3	12.7	14.9	9.7	17.2	44.1	15.3	11.3	14.2	15.3	12.6	8.7	7.5	9.9	17.9	26.0	6.5	9.7	23.4	24.8	9.4	7.8	13.0	15.4	14.0	27.2	3.3	10.4	14.6	22.8	6.1	13.8	28.6	11.2	15.7	27.3	8.5	32.1	16.0	10.5	11.5	7.9	25.6	16.5	12.7	12.0	16.3	15.6	14.3	28.2	10.2	7.7	11.3	12.1	16.1	7.9	9.9	11.2	18.8	11.6	33.4	17.1	13.4	10.3	17.5	24.0	9.5	30.1	23.0	14.8	17.5	17.7	17.1	24.1	17.9	18.9	18.8	13.8	7.6	11.2	45.2	10.2	2.7	12.5	27.9	25.5	21.6	3.3	19.3	0.3	14.3	20.6	0.0	24.3	27.0	18.9	11.0	18.5	24.6	25.1	15.9	18.7	26.4	23.4	0.9	21.9	15.1	8.5	22.6	29.7	9.4	21.2	17.5	33.2	10.9	14.0	58.2	42.0	3.2	3.4	11.4	13.8	19.1	17.2	14.4
ARHGAP10	"FLJ20896, FLJ41791, GRAF2"	ENSG00000071205	"Rho GTPase activating protein 10"	A1A4S6	4	147732063-148072780	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 127.4;monocytes: 96.4;Peritubular cells: 113.8;Rod photoreceptor cells: 129.8;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	9	"cerebellum: 154.3"	HPA039589			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039589: "	"unprognostic (8.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (8.15e-5)"	"prognostic unfavorable (6.26e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.09e-2)"	31.2	7.9	2.3	11.3	3.2	2.0	27.8	1.8	3.7	20.1	23.9	1.9	13.2	3.4	15.4	17.6	25.2	17.6	20.3	20.0	2.8	1.6	9.6	4.8	11.8	8.3	3.8	1.9	19.9	7.8	20.8	4.7	7.5	9.9	19.8	6.0	16.0	6.7	17.0	37.5	12.3	8.9	58.0	5.2	9.7	15.9	11.2	2.5	8.7	9.9	12.4	7.9	28.7	24.9	0.0	2.6	14.0	1.5	4.1	9.7	2.1	9.8	4.0	2.2	4.5	16.7	22.8	22.7	13.7	11.4	8.8	6.9	10.3	5.7	0.0	2.3	11.6	7.4	4.9	7.9	11.2	10.7	5.4	5.3	3.3	3.1	0.3	25.8	3.3	4.0	11.8	8.8	11.0	9.4	11.2	10.6	2.9	0.5	18.7	15.7	12.0	2.0	0.0	2.0	6.6	2.0	3.8	6.2	11.5	6.1	9.1	5.3	2.5	3.6	14.4	3.8	9.8	1.8	0.3	10.6	8.3	6.4	5.0	6.5	7.0	0.8	0.0	12.7	0.4	7.3	0.0	1.5	14.0	5.2	0.0	9.7	0.0	3.9	5.7	2.6	0.0	1.1	5.7	0.2	4.1	0.0	0.0	4.6	2.1	2.3	3.2	1.8	3.7	2.8	1.6	3.8	1.9	9.9	2.5	3.0	2.6	0.0	6.9	12.8	3.8	58.3	5.1	0.0	2.3	1.8	41.2	24.2	0.0	4.2	7.8	9.0	0.0	0.0	13.5	41.5	17.5	3.3	1.1	11.3	20.5	3.2	0.0	6.2	3.9	6.2	127.4	12.8	5.0	96.4	0.0	7.7	14.2	0.0	113.8	11.7	129.8	142.3	59.0	3.9	16.1	8.9	10.6	12.5	1.1	2.4
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639949	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4;lymphoid tissue: 35.0"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 20.0;Spermatocytes: 24.4;Spermatogonia: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040830, HPA066481"	Enhanced		Approved	Nucleoli,Cytosol		No	Yes			Cytosol	Nucleoli	"HPA040830: AB_10805830, HPA066481: "	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.05e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.9	1.5	2.0	17.2	2.9	16.4	3.3	1.1	3.9	1.6	5.4	1.6	0.5	4.3	2.3	0.5	7.5	0.5	4.1	1.4	2.2	1.9	0.8	1.2	2.0	9.4	4.4	0.8	0.8	3.1	0.9	1.0	4.7	2.0	1.2	6.7	0.8	2.0	0.5	1.7	3.2	9.6	3.3	8.9	5.0	2.6	6.4	1.9	35.0	1.0	5.3	10.3	2.6	2.7	0.9	1.7	2.6	1.8	0.5	3.8	1.1	23.5	25.4	20.3	13.4	1.4	3.8	12.2	23.9	13.8	22.8	17.6	17.5	12.0	13.7	7.6	14.0	26.1	17.5	14.3	12.5	30.8	26.9	8.3	43.4	22.9	8.9	0.5	32.3	17.4	1.2	1.5	18.3	14.5	4.3	16.8	27.0	30.0	32.6	26.4	9.6	16.9	10.8	12.7	19.7	14.9	20.1	45.5	10.7	8.1	12.5	19.6	13.5	25.1	13.0	5.4	11.0	18.5	31.0	12.9	30.8	22.8	12.9	25.4	11.9	18.8	37.8	13.2	38.4	26.9	0.1	1.1	2.6	2.3	1.8	0.9	0.9	3.8	3.3	1.7	0.7	1.5	2.0	0.0	0.5	0.3	0.6	2.8	1.1	2.0	2.9	1.1	3.9	2.2	1.9	4.4	0.8	2.0	1.9	0.0	2.9	1.5	0.9	4.2	0.0	0.8	5.1	1.4	2.3	1.8	0.0	2.5	0.0	0.8	2.9	1.1	0.5	0.0	0.7	20.0	1.1	1.0	0.0	1.0	8.0	0.0	0.0	2.5	4.1	3.4	0.6	3.2	0.0	3.6	3.7	0.0	0.5	1.1	0.4	0.2	0.9	6.5	0.9	24.4	18.6	1.9	2.6	3.2	5.1	1.4
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710225	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 362.7;granulocytes: 240.9;Syncytiotrophoblasts: 177.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 92.9;LHCN-M2: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		840000	"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	23.8	32.2	4.1	14.1	4.0	1.7	19.7	2.5	2.4	9.6	19.5	2.9	12.0	13.3	7.8	25.8	5.8	15.7	11.8	16.9	4.4	6.8	33.2	4.5	38.8	15.5	4.1	1.4	8.0	38.2	10.6	22.0	16.7	12.2	9.6	8.2	10.4	16.7	24.2	12.1	5.4	40.6	6.5	9.0	15.8	15.1	10.9	3.8	5.1	12.7	12.1	6.4	10.3	5.8	2.9	11.8	13.0	5.9	2.5	5.8	6.0	1.9	4.3	0.4	0.6	4.2	6.0	3.5	14.6	11.2	6.5	4.3	2.2	3.2	1.6	7.2	9.8	2.0	2.5	3.1	4.8	12.1	1.5	1.3	10.4	3.4	12.8	6.0	1.5	92.9	3.8	0.7	11.7	10.5	13.6	18.4	0.0	5.5	4.0	26.1	0.5	0.0	1.5	0.4	3.6	1.0	0.0	2.0	3.0	19.8	1.1	0.0	0.0	1.2	2.0	7.2	2.2	2.2	1.8	14.0	6.8	0.9	0.5	11.7	1.8	1.3	1.0	2.3	2.8	9.4	8.9	5.2	13.0	5.3	5.9	3.3	2.9	2.8	5.8	4.8	1.7	0.5	2.9	4.0	2.5	3.1	11.8	2.7	6.0	4.1	4.0	2.5	2.4	4.4	6.8	4.1	1.4	12.2	3.8	53.6	36.1	12.9	16.2	11.6	0.0	3.1	15.3	362.7	50.0	36.6	2.0	73.2	127.6	38.7	17.9	35.4	23.6	0.0	105.3	16.5	19.2	20.3	240.9	4.4	101.2	0.0	12.6	11.6	45.7	13.8	3.4	131.1	6.8	18.0	19.9	14.3	82.5	24.6	1.1	20.3	0.6	25.8	11.9	3.4	1.2	11.3	177.5	25.4	28.3	15.9
ARHGAP20	KIAA1391	ENSG00000137727	"Rho GTPase activating protein 20"	Q9P2F6	11	110577042-110713189	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Leydig cells: 45.1;Peritubular cells: 34.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.0;ASC TERT1: 7.7;HHSteC: 5.1;SiHa: 6.4;U-2197: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038458, HPA038459, HPA076303"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038458: AB_10672517, HPA038459: AB_2676022, HPA076303: AB_2686792"	"unprognostic (1.69e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.47e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.82e-5)"	"unprognostic (1.84e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.21e-3)"	"unprognostic (4.10e-2)"	14.4	4.6	5.9	2.6	13.0	0.6	8.4	7.7	12.0	9.1	3.7	1.9	9.2	2.0	8.3	7.0	4.4	6.2	4.4	1.3	4.8	6.2	1.2	3.4	7.6	2.3	3.4	6.3	4.3	0.8	1.6	2.0	3.4	5.8	7.7	5.5	9.7	2.7	16.8	2.0	2.2	2.9	12.1	3.0	2.7	3.9	14.1	2.2	0.0	8.9	2.1	1.9	6.3	4.9	1.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	7.7	0.0	1.0	3.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.3	0.0	5.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.3	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.0	0.0	0.1	0.0	1.9	0.8	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	13.0	7.7	12.0	4.8	6.2	3.4	6.3	5.8	2.2	0.0	2.9	0.0	3.5	0.7	5.8	0.8	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	8.4	1.4	0.0	0.0	0.3	0.1	3.1	0.8	1.1	2.1	0.2	3.2	0.0	9.2	1.0	2.6	45.1	1.4	3.3	0.0	0.0	0.4	0.4	0.0	34.3	0.0	1.3	0.0	1.8	2.9	10.4	0.4	0.6	0.0	0.0	0.7
ARHGAP21	"ARHGAP10, KIAA1424"	ENSG00000107863	"Rho GTPase activating protein 21"	Q5T5U3	10	24583609-24723668	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.8"	"Cell type enhanced"	"Detected in all"	7	"Muller glia cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036610, HPA057861"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Cell Junctions, Actin filaments"	"Plasma membrane"	"HPA036610: AB_10669910, HPA057861: AB_2683546"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	19.6	13.6	34.5	7.1	38.5	4.7	15.6	37.9	39.3	16.2	12.0	39.1	4.4	9.4	14.8	6.0	8.4	14.0	13.5	15.0	43.1	25.2	8.5	9.8	15.7	3.5	42.3	24.0	25.5	11.0	12.4	9.7	12.1	27.3	8.2	14.1	6.7	16.0	9.1	10.9	4.7	11.5	13.7	54.8	6.0	19.5	10.4	43.7	2.7	9.8	3.7	4.2	9.2	9.3	0.2	1.6	3.6	1.9	1.0	2.0	1.0	23.0	10.2	25.1	21.3	17.7	25.6	8.6	16.6	11.0	10.2	14.4	7.4	14.7	4.3	5.7	26.3	15.8	15.3	13.2	16.6	15.0	14.1	8.4	25.3	22.0	5.3	10.6	0.0	3.9	10.4	18.2	13.3	14.5	15.2	17.5	6.5	10.7	38.8	20.0	4.5	12.0	0.8	3.8	8.3	5.5	2.6	8.9	2.4	6.9	4.1	4.3	4.4	11.3	6.3	13.5	7.7	6.6	3.6	19.3	14.7	9.4	16.0	11.9	4.3	7.6	3.0	15.1	4.4	9.8	3.6	0.8	1.6	0.5	1.9	0.4	0.2	0.6	1.6	1.3	0.0	2.0	1.2	0.1	1.0	0.9	1.6	1.0	1.0	34.5	38.5	37.9	36.1	43.1	25.2	42.3	24.0	27.3	43.7	80.4	22.0	5.2	10.4	26.3	127.8	32.7	20.4	34.8	61.4	5.2	64.8	19.4	1.7	18.9	4.3	25.3	34.0	23.3	23.9	15.9	47.4	17.6	16.2	18.7	12.1	125.5	15.5	20.9	25.3	5.3	86.0	24.4	18.6	7.2	26.8	217.5	27.9	26.0	55.9	5.7	53.2	25.8	19.4	25.1	33.0	17.7	10.5	10.0	23.4	24.0
ARHGAP23	KIAA1501	ENSG00000275832	"Rho GTPase activating protein 23"	Q9P227	17	38419280-38512392	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.4"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 56.6;Ito cells: 51.5"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 77.1;RT4: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019818, HPA047291"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"HPA019818: AB_1844993, HPA047291: AB_2680012"	"unprognostic (3.35e-1)"	"unprognostic (5.11e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.50e-3)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.38e-5)"	"unprognostic (8.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.25e-1)"	4.3	2.7	11.7	3.5	32.1	4.2	1.7	3.6	20.1	4.4	1.4	52.4	0.0	1.0	5.1	1.5	13.3	4.0	3.6	7.8	12.6		1.6	0.5	5.7	1.3	42.3	12.6	6.1	0.8	1.5	0.0	9.5	20.2	3.7	0.9	0.9	0.7	6.6	2.1	16.3	1.1	5.5	16.3	10.5	0.5	5.2	39.0	1.4	0.9	0.5	5.0	11.6	2.3	0.0	0.8	0.0	0.1	0.0	0.1	0.1	8.2	4.4	4.0	1.3	2.5	8.5	5.0	11.3	12.8	10.0	5.8	14.7	14.5	0.1	9.4	26.3	5.0	77.1	0.4	16.0	7.1	0.9	0.8	0.0	14.1	0.1	12.8	0.8	0.0	4.9	3.1	7.2	4.6	8.2	10.2	1.5	0.1	2.2	5.6	0.0	2.4	1.5	2.4	0.3	1.7	4.3	8.7	2.7	4.2	30.0	0.9	2.3	6.8	0.0	0.1	5.9	1.7	1.9	14.8	16.9	5.9	3.4	3.0	1.7	1.7	0.4	4.2	2.0	14.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1											11.9	1.0	0.0	14.3	8.9	56.6	16.3	2.5	1.4	15.9	3.5	0.0	20.8	0.0	2.6	6.7	24.5	0.0	23.3	1.2	2.1	14.3	5.3	0.0	0.2	4.2	25.4	0.0	51.5	3.7	15.8	8.3	0.9	1.7	0.0	0.2	7.5	4.4	0.0	6.7	0.0	3.3	0.0	7.2	17.6	1.9	22.6	13.8	0.0	0.0	35.6
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475114-86002670	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 62.5"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 105.7;Distal tubular cells: 192.3;Proximal tubular cells: 165.1;Syncytiotrophoblasts: 194.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5"	"Group enriched"	"Detected in many"	4	"B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.4;ASC TERT1: 22.1;HHSteC: 21.3;HUVEC TERT2: 39.2;RPTEC TERT1: 22.0;TIME: 27.6;U-138 MG: 19.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	21.3	1.9	5.3	16.4	7.9	10.7	17.6	1.8	9.4	5.8	6.2	8.4	2.4	4.8	9.2	7.3	7.7	3.9	7.1	16.8	6.3	7.3	62.5	6.0	9.9	23.8	11.0	3.3	4.1	21.5	6.9	8.2	13.9	9.0	6.7	4.3	8.7	9.0	5.8	7.6	6.2	8.7	13.2	19.8	33.6	15.9	2.8	6.7	2.1	17.8	6.5	24.2	13.0	5.2	23.1	6.5	2.8	8.0	0.0	0.0	1.4	0.9	1.9	1.4	0.0	36.4	22.1	1.5	6.9	9.2	1.7	2.7	0.0	0.0	0.9	2.4	15.4	2.1	0.0	0.0	2.9	3.6	0.0	0.3	1.1	0.2	0.0	21.3	0.1	0.0	16.1	0.3	3.3	1.5	7.8	39.2	0.0	2.0	0.1	14.9	0.0	0.0	0.0	0.1	0.4	3.6	0.1	7.3	3.6	22.0	0.0	0.7	0.7	0.7	1.1	2.4	1.6	0.1	0.0	27.6	19.7	0.4	1.4	0.1	0.1	0.0	1.2	3.3	0.7	6.4	0.0	8.0	0.0	0.0	1.5	0.0	23.1	0.0	0.0	1.9	18.4	0.0	0.0	2.8	0.0	1.1	6.5	0.0	1.4	5.3	7.9	1.8	9.4	6.3	7.3	11.0	3.3	9.0	6.7	53.6	24.5	105.7	2.4	7.2	3.7	22.1	43.3	25.4	10.3	43.6	5.9	36.9	192.3	7.0	17.7	4.9	0.0	0.0	10.3	22.3	17.9	2.2	1.1	6.6	10.1	104.9	2.4	5.5	24.7	6.8	15.5	12.9	18.6	0.0	2.5	40.3	7.3	2.9	11.7	165.1	6.2	6.5	14.0	5.2	4.1	5.5	194.7	0.9	3.0	1.7
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 94.2;lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in many"	19	"B-cells: 49.9;granulocytes: 196.2;T-cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 94.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 75.2"	"Group enriched"	"Detected in many"	4	"amygdala: 3.2;basal ganglia: 7.8;cerebral cortex: 8.5;hippocampal formation: 6.4"	"Low region specificity"	"Detected in many"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	7.4	3.5	2.6	33.1	3.6	14.6	5.7	0.9	3.2	3.1	4.9	6.7	1.6	2.5	4.0	10.5	3.5	3.5	7.2	4.3	2.8	2.3	5.7	4.6	12.9	39.0	5.9	1.9	8.1	2.2	0.6	3.1	4.5	4.2	3.7	4.2	3.1	5.7	1.5	2.0	3.3	14.3	3.5	6.3	48.7	3.4	2.2	3.3	20.9	4.0	2.3	40.6	6.1	4.7	23.6	7.5	94.2	12.5	22.8	26.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.1	0.0	0.0	0.7	0.0	5.8	0.0	0.6	0.0	18.7	0.0	0.0	0.3	4.1	75.2	0.0	0.7	0.1	2.4	0.0	0.0	6.4	0.1	6.8	0.0	0.0	4.7	13.1	0.3	0.0	0.0	5.2	1.2	0.2	0.0	1.5	1.2	0.1	0.0	0.0	0.4	0.4	0.0	3.4	1.0	0.0	0.2	0.0	0.1	14.9	7.9	4.7	0.0	9.3	0.1	27.5	8.7	72.8	26.3	10.9	16.4	23.6	11.8	22.7	5.3	14.5	8.5	15.0	94.2	22.8	12.5	7.5	14.2	15.7	2.6	3.6	0.9	3.2	2.8	2.3	5.9	1.9	4.2	3.3	3.0	19.6	49.9	9.3	4.9	0.6	1.4	2.5	9.4	3.4	0.0	0.0	0.3	1.7	0.0	1.5	14.1	0.0	0.0	0.2	0.2	0.9	1.0	196.2	0.6	39.1	0.0	2.9	12.9	22.8	2.2	1.4	21.0	1.7	38.7	0.3	0.3	0.0	0.0	2.5	0.0	0.0	6.5	1.9	0.7	1.3	1.3	0.2	57.3	0.0	2.4
ARHGAP26	"GRAF, KIAA0621, OPHN1L, OPHN1L1"	ENSG00000145819	"Rho GTPase activating protein 26"	Q9UNA1	5	142770377-143229011	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"neutrophil: 19.6;NK-cell: 5.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 19.6;NK-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035106, HPA035107"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA035106: AB_2674465, HPA035107: AB_10669855"	"prognostic favorable (2.05e-4)"	"prognostic favorable (1.36e-4)"	"prognostic favorable (6.95e-4)"	"prognostic favorable (5.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (9.43e-3)"	"unprognostic (7.19e-3)"	"unprognostic (8.65e-2)"	"unprognostic (3.21e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.88e-6)"	13.3	5.7	18.4	18.6	22.7	33.9	13.0	29.2	23.9	15.9	14.2	7.5	9.9	13.2	9.4	10.9	7.6	18.5	16.4	17.0	12.8	10.5	8.0	7.7	20.0	8.8	12.9	15.4	4.8	5.5	4.8	15.1	22.4	11.9	8.5	14.8	8.8	14.6	11.2	14.0	8.5	12.6	11.1	12.6	18.9	17.0	16.1	12.2	10.3	10.0	5.4	13.6	9.4	10.6	0.3	2.0	19.6	2.8	5.8	3.0	1.0	6.9	14.0	3.9	3.6	5.8	6.4	6.0	0.8	1.2	3.4	5.9	19.1	15.8	1.0	6.9	2.2	10.3	3.3	1.9	6.6	4.2	14.3	2.2	0.0	1.8	12.1	3.7	10.2	1.4	2.3	11.6	6.2	14.3	2.7	5.0	4.8	0.2	39.7	1.0	1.1	5.8	4.2	1.8	10.3	3.6	2.2	5.8	16.6	9.9	10.7	1.5	2.4	1.8	1.9	3.2	3.1	1.0	3.1	9.6	1.8	2.6	0.2	3.6	1.8	5.7	0.2	4.8	9.7	2.5	2.9	2.8	1.6	3.0	1.7	1.3	0.2	0.6	1.8	2.0	0.3	0.2	0.8	19.6	5.8	1.0	0.5	0.2	1.0	18.4	22.7	29.2	23.9	12.8	10.5	12.9	15.4	11.9	12.2	14.9	22.7	2.9	13.9	6.2	9.5	33.7	25.5	12.0	12.5	0.0	7.9	1.1	0.0	15.6	62.7	31.7	30.5	0.0	18.9	0.7	11.6	26.2	25.5	4.3	21.6	71.5	3.5	30.1	49.8	105.1	6.1	31.8	10.1	6.4	26.2	6.3	16.0	21.5	13.4	4.4	54.5	45.3	12.7	1.9	11.3	4.8	1.6	22.7	21.7	31.9
ARHGAP27	"CAMGAP1, FLJ43547, SH3D20, SH3P20"	ENSG00000159314	"Rho GTPase activating protein 27"	Q6ZUM4	17	45393902-45434421	"Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 38.8"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 60.1;Paneth cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 12.4;HMC-1: 11.6;OE19: 14.6;RT4: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023919, HPA053053"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023919: AB_2059402, HPA053053: AB_2682027"	"unprognostic (9.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.21e-4)"	6.0	3.1	4.9	21.9	8.7	15.0	5.5	5.2	6.3	9.3	23.1	6.4	2.7	14.9	3.2	7.8	35.0	4.5	17.4	7.0	7.5	3.2	11.0	2.4	10.5	24.1	8.2	2.4	2.4	3.5	4.3	4.0	9.7	7.5	6.1	13.0	3.8	13.6	9.1	2.6	11.6	38.8	3.8	10.2	28.6	8.8	2.9	8.0	29.4	6.3	5.8	34.1	8.0	15.0	4.1	7.8	10.4	11.2	1.9	3.1	3.5	4.3	4.3	0.1	1.3	0.6	0.3	12.4	0.0	0.2	0.3	0.1	3.8	8.7	4.0	8.5	0.3	1.9	2.8	0.5	0.8	0.2	8.0	2.7	0.2	1.6	2.4	0.1	0.0	11.6	0.6	3.5	0.0	1.3	0.4	2.6	4.3	1.0	7.2	0.3	3.0	3.7	1.3	0.2	14.6	3.6	3.1	0.2	1.3	2.8	18.8	0.6	0.4	0.5	3.7	0.2	1.5	2.9	7.3	4.1	0.0	1.1	0.0	0.4	9.0	5.8	0.8	0.2	1.1	0.0	1.0	4.7	4.2	2.8	9.3	1.8	4.1	1.7	3.1	4.5	3.4	1.4	1.4	10.4	1.9	11.2	7.8	2.3	3.5	4.9	8.7	5.2	6.3	7.5	3.2	8.2	2.4	7.5	8.0	6.0	19.1	20.6	15.4	9.2	2.6	9.8	17.8	2.7	7.9	17.4	3.9	6.4	3.3	4.9	0.8	20.2	60.1	0.0	3.0	8.9	2.5	21.5	4.6	1.5	13.3	1.6	18.4	16.5	38.7	0.9	0.3	16.4	6.8	1.0	29.2	1.2	11.8	59.6	0.0	5.0	1.4	0.0	3.1	2.3	1.9	7.5	11.8	14.9	32.0	47.8
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 271.0;Glandular cells: 419.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	38	"monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"A-431: 48.5;hTERT-HME1: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	28.1	3.2	7.2	6.8	10.6	0.3	24.4	34.9	11.5	11.9	7.4	2.3	9.0	2.8	10.3	8.1	6.9	8.2	9.1	15.9	7.8	5.2	27.7	21.1	23.0	8.2	6.7	3.6	11.5	6.5	12.8	7.4	22.9	10.0	12.2	4.7	11.7	20.7	10.4	10.3	13.5	5.4	8.0	6.4	26.0	8.8	7.7	7.0	2.2	22.7	8.9	3.8	10.6	14.8	0.0	0.0	0.0	3.7	0.0	0.0	0.3	48.5	2.0	3.0	0.0	10.6	25.2	10.8	16.3	26.5	13.8	20.2	5.8	2.4	0.0	36.7	32.6	15.8	10.4	0.1	11.1	28.5	0.0	1.6	0.2	2.8	2.6	1.0	0.0	0.0	4.9	2.0	10.5	43.7	16.3	37.2	0.0	0.0	0.0	13.7	1.6	0.9	0.0	3.9	0.2	33.4	0.6	2.5	0.0	29.1	4.3	0.0	0.6	10.0	7.8	0.7	12.2	2.3	0.1	33.3	8.4	11.5	12.9	12.5	0.0	0.0	0.0	1.6	0.0	0.4	0.0	1.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	7.2	10.6	34.9	11.5	7.8	5.2	6.7	3.6	10.0	7.0	47.6	17.3	2.9	135.8	20.8	9.7	19.9	25.5	9.4	33.0	123.9	17.7	21.9	46.4	71.3	49.8	271.0	0.0	0.0	14.7	90.4	34.4	419.1	3.5	51.3	2.6	87.4	0.0	176.8	18.6	16.2	22.7	5.6	25.3	0.0	0.9	95.2	37.1	0.0	20.5	47.5	80.7	187.5	197.8	66.2	123.5	15.1	11.8	4.3	0.4	45.2
ARHGAP33	"FLJ39019, SNX26, TCGAP"	ENSG00000004777	"Rho GTPase activating protein 33"	O14559	19	35774532-35788822	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 23.6;Cone photoreceptor cells: 23.6;Horizontal cells: 19.1;Rod photoreceptor cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030117, HPA030118"	Supported		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA030117: AB_10599306, HPA030118: AB_10601238"	"unprognostic (1.44e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.61e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (3.09e-8)"	"unprognostic (5.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-2)"	4.8	7.6	17.2	6.6	21.9	27.8	4.0	18.1	27.1	6.0	3.8	22.0	2.8	6.8	8.4	2.9	3.6	6.1	4.9	4.5	14.9	11.7	3.8	2.0	4.7	8.7	18.4	13.8	11.8	7.3	6.2	13.2	3.3	12.7	5.8	2.9	6.8	8.9	6.2	4.7	12.9	6.0	4.0	15.4	7.8	7.2	18.2	17.9	12.2	6.8	2.3	4.2	3.1	5.3	0.1	0.0	0.7	0.0	0.0	0.4	0.0	4.9	3.1	8.9	6.7	0.3	0.9	0.7	4.0	0.5	1.5	1.1	1.3	3.7	2.9	1.5	1.1	1.3	1.3	1.1	1.1	0.6	9.0	2.0	4.2	4.1	1.2	0.4	1.5	33.6	1.3	0.2	1.2	0.4	1.3	0.9	11.6	2.0	12.7	1.3	3.8	10.2	4.1	2.0	1.8	1.4	14.0	1.4	1.4	0.7	0.8	8.9	5.5	1.8	3.3	0.6	1.2	4.7	4.1	1.7	6.4	6.3	3.3	4.7	11.3	2.1	2.9	2.3	4.9	4.0	0.0	0.0	0.3	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	17.2	21.9	18.1	27.1	14.9	11.7	18.4	13.8	12.7	17.9	0.0	0.6	0.0	0.8	1.4	23.6	1.7	5.1	4.0	4.5	1.8	23.6	0.3	0.0	0.4	8.0	0.8	0.3	0.0	0.6	1.0	1.4	0.6	4.7	0.8	1.0	19.1	3.4	0.0	0.3	6.3	3.7	0.0	0.0	0.0	1.7	10.1	0.6	0.0	2.8	0.0	29.9	0.0	2.3	11.6	5.6	1.5	0.3	4.8	2.5	0.3
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058242-131089883	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	164	"SH-SY5Y: 64.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 104.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1"	"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		6.9	58.4	1.4	0.2	3.6	0.1	1.0	0.0	2.7	0.5	0.2	0.0	0.0	0.1	0.1	2.0	0.3	0.2	0.2	0.1	1.0	25.5	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	50.3	0.3	5.4	0.3	0.2	0.6	0.2	0.2	13.7	0.1	0.1	0.1	0.8	0.1	0.2	0.6	0.0	0.5	0.5	4.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	64.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.6	0.0	0.4	1.0	25.5	0.5	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0
ARHGAP39	"CrGAP, KIAA1688, Vilse"	ENSG00000147799	"Rho GTPase activating protein 39"	Q9C0H5	8	144529179-144605816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.8"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Rod photoreceptor cells: 23.7"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044491			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			Cytosol	"Nucleoplasm, Microtubules, Cytokinetic bridge"	"HPA044491: AB_10794775"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-7)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.97e-2)"	1.1	1.9	3.6	1.0	3.5	0.0	1.2	6.2	7.0	2.0	2.0			2.4	1.7	1.2	1.4	7.0	0.9	0.4	5.3	4.4	1.8	0.2	1.5	0.3	3.3		0.9	2.9	2.0	4.0	0.9		2.1	0.9		3.5	2.3	0.6	2.6	2.4	0.6	7.2	0.9	1.2	12.8			2.8		0.1	0.5	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	7.6	7.6	3.6	5.6	0.7	0.6	7.0	2.0	0.6	2.5	1.6	4.9	4.5	0.8	5.2	0.8	2.6	6.5	1.8	1.9	0.5	0.0	6.8	0.1	5.0	3.1	1.2	0.0	0.8	0.5	3.1	3.2	1.3	1.3	0.8	0.3	7.0	0.0	1.0	12.4	4.2	0.0	3.8	3.1	10.9	3.9	2.9	2.9	2.0	3.9	10.5	7.4	5.8	2.0	3.4	1.4	8.6	1.1	1.9	1.9	0.1	6.3	4.1	0.0	0.1	0.3	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											3.0	2.9	0.0	0.5	3.3	7.1	1.6	0.0	20.1	3.4	3.5	19.6	0.4	0.0	2.2	2.1	0.7	3.9	0.0	2.1	0.7	1.3	1.1	0.0	1.3	0.4	3.2	0.0	1.3	0.0	2.5	2.0	0.0	5.0	0.0	3.6	3.5	1.1	8.6	7.8	1.4	23.7	6.5	1.5	8.1	7.7	2.6	0.5	0.0	4.3	0.6
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.8;lymphoid tissue: 48.4"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 71.1;Kupffer cells: 73.8;Macrophages: 43.6;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.2;Karpas-707: 26.9;MOLT-4: 25.3;RPMI-8226: 49.8;THP-1: 24.3;U-698: 23.2;U-937: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001012, HPA001083"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Nucleoplasm	"HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favorable (3.94e-5)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	7.0	4.8	5.3	24.3	5.8	44.8	5.0	4.5	3.2	3.1	6.5	5.2	2.1	6.0	3.9	7.0	4.4	5.2	6.5	4.2	4.5	3.2	7.4	4.9	13.4	29.1	5.2	0.9	2.6	2.3	0.9	3.5	9.0	4.8	4.2	3.0	5.7	7.5	1.8	1.6	1.8	18.0	3.9	5.9	48.4	4.9	3.6	4.2	43.2	4.2	1.6	29.0	7.1	3.6	10.8	17.7	18.7	30.5	8.5	15.7	12.6	0.4	0.1	0.2	1.7	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.1	12.5	26.2	1.6	0.0	0.2	0.2	1.3	0.0	0.0	7.1	1.0	10.2	0.1	0.5	1.1	18.6	17.3	0.0	0.1	0.0	0.1	0.1	2.6	6.6	0.0	26.9	0.1	1.3	25.3	0.3	0.8	0.1	0.0	12.0	3.5	49.8	0.1	0.2	2.4	3.6	0.2	0.6	0.2	0.3	5.9	24.3	0.5	0.1	0.3	0.2	0.1	16.3	13.9	23.2	0.2	21.7	0.0	5.1	14.1	18.7	15.7	23.1	10.9	10.8	11.2	12.4	14.1	10.4	10.1	10.1	12.0	8.5	30.5	17.7	12.6	12.6	5.3	5.8	4.5	3.2	4.5	3.2	5.2	0.9	4.8	4.2	8.9	33.9	40.2	0.5	3.1	9.8	30.4	2.5	13.4	4.5	17.4	3.9	1.7	5.0	0.7	0.1	10.6	3.9	0.0	0.6	1.2	2.1	0.4	33.5	0.5	71.1	3.2	4.6	4.3	73.8	0.0	0.9	43.6	10.1	12.6	2.1	1.3	0.1	0.0	0.0	0.6	4.4	0.0	0.9	0.5	4.9	1.5	1.1	48.4	3.9	0.4
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 18.6;epididymis: 38.0;skin 1: 26.7"	"Cell type enhanced"	"Detected in some"	12	"Collecting duct cells: 3.5;Early spermatids: 3.2;Late spermatids: 2.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;HBEC3-KT: 12.2;RPTEC TERT1: 10.8;SK-BR-3: 11.6;T-47d: 14.0"	"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		No	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.3	0.3	0.3	0.0	18.6	0.3	0.5	1.6	0.3	0.4	5.2	0.8	0.6	38.0	15.8	0.0	0.9	0.3	0.3	0.1	4.1	0.3	1.8	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	3.0	0.0	0.3	1.9	5.1	0.3	26.7	0.3	0.7	0.3	0.3	2.6	1.2	0.6	0.3	0.3	5.2	6.6	3.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.1	0.1	0.8	0.0	3.4	0.0	0.0	0.0	0.0	12.2	0.2	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	11.6	0.0	1.5	14.0	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.3	0.3	0.6	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	3.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.2
ARHGAP42	"AD031, FLJ32810, GRAF3, TMEM133"	ENSG00000165895	"Rho GTPase activating protein 42"	"A6NI28, Q9H2Q1"	11	100687653-100993941	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 38.0"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7;Early spermatids: 72.6;Rod photoreceptor cells: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.1;RH-30: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039924, HPA060528"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA039924: AB_10674428, HPA060528: AB_2684308"	"unprognostic (1.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.03e-1)"	11.1	4.9	6.8	8.9	5.8	0.9	10.4	3.0	7.0	9.8	8.3	4.1	2.3	9.9	11.4	7.7	4.3	5.6	9.5	6.5	8.8	3.8	11.9	12.7	13.7	5.1	6.3	5.3	4.8	2.6	9.1	6.0	38.0	5.9	4.8	8.4	25.5	5.1	3.8	9.0	7.2	12.1	5.8	8.7	8.2	11.7	4.1	6.7	12.7	10.9	7.4	3.8	5.5	7.9	1.5	2.5	0.0	0.0	0.7	0.4	0.3	0.5	3.6	4.6	0.1	2.6	3.5	3.2	0.6	0.9	1.1	2.1	4.4	23.1	0.7	6.5	1.7	4.1	7.8	2.3	1.7	1.1	0.0	2.0	11.2	9.1	1.5	4.6	0.1	0.0	3.3	2.2	4.3	0.7	2.6	1.7	2.8	0.4	0.0	3.5	0.6	1.2	0.0	5.6	6.4	5.7	3.4	16.0	0.4	5.4	15.0	2.5	1.6	7.7	0.3	6.1	10.0	0.8	1.4	3.0	3.0	3.7	3.6	1.7	3.3	0.0	4.5	3.5	2.7	13.1	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.3	6.8	5.8	3.0	7.0	8.8	3.8	6.3	5.3	5.9	6.7	44.7	4.0	5.1	4.8	2.2	2.6	4.2	10.2	16.0	21.6	3.5	23.6	0.6	1.7	4.1	72.6	2.9	10.0	23.3	3.3	1.8	4.5	10.0	0.0	5.9	1.3	1.6	1.7	9.2	0.3	27.0	1.1	2.2	10.1	0.0	2.8	31.8	6.5	5.7	2.5	15.8	60.0	38.8	12.3	1.9	1.6	3.0	5.4	0.0	2.4	17.3
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 267.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA046993: AB_2679895, HPA056507: AB_2683158"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	11.3	13.1	29.8	8.4	26.1	4.0	13.0	39.1	29.2	14.2	14.6	11.5	7.9	16.0	13.2	11.9	31.5	11.1	15.3	28.0	29.5	19.6	20.8	14.5	12.8	5.9	26.8	23.4	23.3	13.5	21.8	27.6	16.9	24.2	14.7	12.3	9.2	26.0	14.5	11.5	14.0	17.3	13.4	26.6	18.7	13.3	20.4	30.6	8.8	32.5	7.7	8.0	15.6	25.8	7.3	9.0	1.5	1.8	6.8	7.4	2.3	19.0	15.5	15.5	22.7	20.4	14.3	8.9	11.9	14.7	7.2	10.9	19.7	18.7	5.6	10.6	15.0	12.2	20.3	14.7	12.8	14.2	5.6	8.6	8.5	9.6	28.8	13.9	5.1	5.1	15.9	26.0	6.8	25.5	17.9	8.8	10.7	7.5	16.8	11.7	10.0	11.2	0.2	7.7	21.2	18.7	12.2	19.0	1.1	15.9	50.9	24.0	9.4	31.9	17.2	24.1	18.0	17.8	0.3	14.2	13.4	20.3	11.1	8.7	6.4	12.5	0.8	6.8	5.5	36.6	1.5	1.8	0.0	4.0	0.8	4.8	7.3	7.0	3.7	6.1	7.1	7.4	4.3	0.6	6.8	1.3	9.0	5.7	2.3	29.8	26.1	39.1	29.2	29.5	19.6	26.8	23.4	24.2	30.6	178.6	60.0	8.7	112.0	83.7	78.5	267.9	53.5	62.9	76.2	55.8	108.0	20.8	46.4	45.5	30.6	29.2	76.6	46.7	40.4	10.4	47.7	94.2	4.7	45.6	15.8	62.0	59.4	36.8	15.2	47.7	96.7	33.3	64.1	19.8	49.4	93.1	55.1	77.2	94.4	48.0	87.6	58.2	56.6	94.1	58.3	61.5	11.2	20.3	44.5	133.8
ARHGAP8	"BPGAP1, FLJ20185"	ENSG00000241484	"Rho GTPase activating protein 8"	P85298	22	44752558-44862788	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.3"	"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 18.6;Ductal cells: 23.6;Pancreatic endocrine cells: 23.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 12.4;BEWO: 23.4;CACO-2: 14.8;HEK 293: 20.2;MCF7: 20.9;SK-BR-3: 20.2"									HPA069694	Approved		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA069694: AB_2686173"	"unprognostic (4.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.88e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.78e-3)"	"unprognostic (9.58e-2)"	"unprognostic (7.65e-6)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.22e-2)"	0.5	0.1	1.7	5.6	0.4	0.2	7.5	0.3	0.4	2.2	10.6	0.6	29.3	1.2	2.6	13.0	5.7	6.1	11.5	0.3	0.3	0.4	18.2	0.9	3.9	0.3	0.3	0.3	0.9	14.6	4.5	5.2	22.4	1.2	10.0	5.7	1.9	28.4	24.8	0.3	1.4	3.6	1.2	0.3	6.7	4.3	3.0	0.3	0.7	15.2	2.4	4.9	2.0	1.8	0.2	0.7	0.2	0.4	0.1	2.2	0.3	12.4	0.1	0.2	0.1	0.0	0.2	23.4	0.1	1.5	0.0	0.1	14.8	6.7	0.1	0.8	0.0	0.2	9.3	4.4	10.7	0.1	0.0	20.2	0.0	0.3	0.1	0.0	0.0	0.2	0.1	4.7	0.1	0.2	0.3	0.0	0.2	0.4	0.3	0.0	20.9	0.0	0.0	3.1	9.4	0.0	0.0	0.0	0.2	5.7	8.5	1.3	0.0	0.0	20.2	0.4	5.3	8.7	0.1	0.1	0.0	0.7	0.1	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.6	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.0	0.7	2.2	0.3	1.7	0.4	0.3	0.4	0.3	0.4	0.3	0.3	1.2	0.3	3.0	12.2	0.0	18.6	0.6	0.4	0.8	5.1	4.0	6.8	17.4	3.9	16.5	0.0	23.6	2.3	1.0	2.6	0.0	9.4	0.9	1.3	16.8	0.0	0.0	2.7	0.0	6.9	0.0	0.6	2.5	0.3	0.0	0.0	0.0	7.6	0.5	23.2	3.5	0.4	1.4	0.3	0.0	0.7	0.0	3.9	0.3	5.8	1.0	12.3	15.6
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472255-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.9;bone marrow: 48.1;lymphoid tissue: 50.4"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 56.4;Hofbauer cells: 36.3;Kupffer cells: 39.0;Macrophages: 34.2;T-cells: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 76.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 76.9"	"Cell line enhanced"	"Detected in some"		"HEL: 11.2;HMC-1: 50.1;THP-1: 14.4;U-937: 11.4"					"Low region specificity"	"Detected in some"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	5.1	2.5	5.1	33.0	8.0	48.1	4.4	3.7	4.8	1.8	5.4	2.5	0.5	3.6	1.6	1.7	2.7	4.4	4.8	2.4	4.2	1.8	3.5	3.8	11.2	24.1	8.1	0.6	1.2	2.2	0.3	1.5	2.3	5.8	2.5	5.1	2.4	6.0	1.3	0.9	1.4	18.6	2.6	8.5	50.4	3.9	8.8	6.4	19.0	2.6	3.2	28.5	4.7	2.2	8.9	18.9	76.9	17.0	13.1	13.3	11.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.9	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	11.2	0.0	0.0	0.4	6.5	50.1	0.3	0.0	0.0	0.1	0.0	0.0	5.9	0.2	3.3	0.0	0.0	8.9	8.9	0.4	0.0	0.0	3.7	4.3	1.8	0.0	0.0	1.6	1.4	0.0	0.0	0.1	0.2	0.0	14.4	0.3	0.0	0.1	0.0	0.0	4.0	2.7	5.4	0.1	11.4	0.2	8.4	16.6	45.1	9.0	17.0	6.2	7.1	9.9	8.1	13.9	8.9	13.3	9.6	76.9	13.1	12.8	18.9	12.1	11.8	5.1	8.0	3.7	4.8	4.2	1.8	8.1	0.6	5.8	6.4	0.0	23.5	22.6	0.0	1.3	0.0	1.2	0.0	4.0	2.3	0.0	2.0	0.3	0.0	0.0	56.4	1.8	0.0	0.0	0.0	0.4	1.3	0.2	11.5	1.1	36.3	0.0	0.0	4.3	39.0	28.4	1.7	34.2	0.0	10.0	0.0	0.0	0.2	0.0	0.0	0.3	0.7	0.0	0.5	28.8	8.5	1.3	0.2	110.8	0.1	0.1
ARHGDIG	RHOGDI-3	ENSG00000242173	"Rho GDP dissociation inhibitor gamma"	Q99819	16	268727-283010	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 60.4;intestine: 31.7;pancreas: 45.3"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 3.3;Exocrine glandular cells: 9.9;Pancreatic endocrine cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.2;HEK 293: 18.8;MCF7: 24.2;SCLC-21H: 8.5;SH-SY5Y: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078260			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA078260: AB_2732375"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.86e-6)"	"unprognostic (2.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.32e-2)"	3.7	3.1	37.3	1.8	15.6	1.0	1.1	43.3	60.4	1.0	1.8	3.7	0.0	31.7	1.1	2.3	1.1	1.0	0.9	3.6	29.0	27.4	1.0	0.9	1.0	1.0	21.2	21.4	1.0	45.3	0.9	1.7	2.4	12.7	1.1	1.2	0.6	1.3	1.3	2.0	0.9	12.0	1.3	8.6	1.0	9.3	2.0	2.0	0.0	0.9	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.1	2.0	0.0	0.6	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.0	0.7	0.4	0.0	0.1	5.2	0.0	0.0	0.0	18.8	0.0	0.3	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.2	0.0	1.2	0.2	0.0	24.2	0.0	0.3	2.6	1.3	0.0	0.0	0.0	0.4	0.0	0.0	8.5	10.5	0.1	0.1	0.0	0.3	1.8	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.3	15.6	43.3	43.8	29.0	27.4	21.2	21.4	12.7	2.0	0.0	0.0	0.0	0.0	0.3	3.3	0.8	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	0.4	0.0	1.3	0.0	9.9	0.2	0.4	0.0	0.0	0.0	0.4	0.0	1.2	1.3	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.9	6.4	0.3	0.0	0.0	2.7	0.0	0.2	0.2	2.5	0.0	0.3	0.0	0.9	0.0
ARHGEF10	"Gef10, KIAA0294"	ENSG00000104728	"Rho guanine nucleotide exchange factor 10"	O15013	8	1823976-1958641	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024649	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024649: AB_1845002"	"unprognostic (2.51e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.46e-2)"	13.5	8.2	11.1	6.9	18.4	1.8	9.7	3.5	14.2	11.6	10.8	20.4	9.3	3.2	19.5	7.1	7.2	8.9	8.0	19.0	13.5	7.9	6.5	2.3	17.7	5.4	17.0	8.6	9.6	5.8	4.9	4.6	9.9	13.4	9.3	5.7	10.2	7.5	10.4	3.8	14.2	5.3	15.0	18.0	5.7	8.4	19.1	21.0	1.6	8.4	4.4	4.1	10.2	19.9	0.0	0.0	0.0	0.0	1.4	0.7	0.1	6.4	8.2	7.9	3.3	6.6	9.8	1.7	8.5	7.2	6.7	7.3	2.6	3.0	0.0	1.3	11.8	11.1	4.9	7.1	10.7	8.4	0.0	2.8	2.8	7.2	0.0	6.3	0.0	1.8	7.1	6.1	6.8	6.2	10.2	12.7	2.2	3.1	0.0	7.6	3.5	4.1	0.8	6.0	4.8	4.4	0.3	7.4	0.0	4.9	2.3	1.4	1.8	6.7	0.2	4.2	10.3	3.4	1.6	15.2	6.6	3.8	0.1	8.2	0.0	2.7	0.0	5.1	6.2	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.2	0.1	11.1	18.4	3.5	14.2	13.5	7.9	17.0	8.6	13.4	21.0	3.0	5.5	0.0	10.3	34.1	5.3	11.8	12.7	1.4	4.5	7.0	9.8	0.5	0.0	6.9	13.7	23.5	0.5	0.0	1.7	0.8	29.2	17.0	0.0	0.9	1.4	20.6	1.2	16.5	0.6	16.5	32.5	2.7	21.9	0.0	4.1	15.5	8.6	0.0	24.8	0.3	9.9	0.0	22.7	32.7	18.3	13.2	0.2	1.3	1.9	4.1
ARHGEF10L	"FLJ10521, KIAA1626"	ENSG00000074964	"Rho guanine nucleotide exchange factor 10 like"	Q9HCE6	1	17539835-17697874	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 50.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	40	"classical monocyte: 13.1;intermediate monocyte: 13.0;myeloid DC: 9.7;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	46	"dendritic cells: 9.7;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026426, HPA026440, HPA028115"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles, Cytosol"		"HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285"	"unprognostic (4.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.13e-5)"	"unprognostic (3.61e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.21e-3)"	9.5	6.1	6.2	6.1	6.2	0.7	7.8	31.7	7.5	8.5	13.4	7.1	9.9	9.0	7.7	11.2	14.4	6.4	11.7	16.0	5.7	6.1	16.4	50.7	7.8	2.2	6.3	3.8	5.3	30.2	8.1	2.7	3.3	9.1	6.6	7.4	9.6	13.2	12.3	33.4	13.4	9.7	10.5	5.9	5.4	6.5	3.9	5.9	0.4	10.4	7.4	2.9	9.6	11.9	0.0	9.7	0.2	13.1	0.0	0.0	4.5	5.3	6.1	7.8	2.7	13.3	4.5	5.2	3.6	7.2	4.4	3.7	6.3	16.1	0.0	6.9	6.8	6.1	4.1	1.1	1.9	0.9	0.1	2.0	0.0	6.2	17.7	3.0	0.0	0.0	6.0	3.8	2.7	0.7	8.8	0.8	0.0	0.0	0.1	12.1	5.0	0.0	0.1	3.4	8.1	0.0	0.0	3.1	1.9	9.3	11.1	11.4	8.4	2.8	2.0	8.3	2.3	7.6	6.4	0.0	3.8	4.6	4.5	1.5	0.0	1.6	0.0	5.9	0.1	2.0	0.0	13.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	4.5	6.2	6.2	31.7	7.5	5.7	6.1	6.3	3.8	9.1	5.9	3.0	6.1	0.5	4.6	5.0	12.7	31.1	20.4	1.4	9.1	29.6	2.0	0.4	8.3	12.1	8.9	2.7	18.6	0.0	17.5	0.4	6.2	5.5	0.0	35.4	22.2	9.5	36.2	3.1	5.1	6.9	4.6	15.0	3.3	2.8	41.8	12.8	12.3	21.0	6.3	15.5	5.3	12.9	11.4	2.1	1.5	7.5	0.8	0.0	41.6	8.8
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045370	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 47.5;Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	11.9	13.0	17.5	11.6	13.4	4.3	12.3	28.8	22.4	12.3	13.2	9.2	22.0	14.4	14.7	11.9	13.1	12.2	14.3	13.2	13.6	16.0	10.9	7.6	12.7	8.0	13.9	13.7	15.6	11.0	31.7	15.4	12.3	13.1	11.4	12.9	14.5	9.3	25.1	14.7	11.2	23.3	15.2	9.1	9.8	11.9	20.9	9.9	1.0	14.9	5.3	6.3	13.2	12.6	0.4	0.9	3.3	2.8	0.0	1.0	0.7	7.0	14.0	12.0	9.1	16.0	8.3	13.7	7.0	10.5	11.0	8.1	9.4	7.5	0.9	12.3	12.3	8.4	7.7	8.1	7.3	6.1	10.1	5.0	3.5	8.3	6.1	9.3	7.1	12.5	12.7	8.0	10.1	7.9	8.3	7.9	3.1	5.7	0.6	7.3	9.2	1.8	3.9	14.9	11.2	8.6	0.2	5.9	3.9	5.4	11.6	2.3	13.7	15.1	12.2	12.8	10.9	10.9	16.2	11.8	11.3	7.2	9.9	7.2	10.1	6.2	0.7	7.2	0.9	37.4	0.0	1.4	0.0	0.0	2.8	0.0	0.4	0.6	0.0	0.9	0.0	0.6	1.0	3.3	0.0	1.5	0.0	0.3	0.7	17.5	13.4	28.8	22.4	13.6	16.0	13.9	13.7	13.1	9.9	3.0	3.4	0.8	2.3	1.0	47.5	11.8	0.0	1.4	2.3	1.8	88.4	1.5	1.7	1.0	5.3	3.5	14.6	0.0	1.4	0.5	3.0	3.2	9.2	4.9	3.6	20.6	5.2	2.5	7.5	6.7	4.4	4.0	1.7	0.0	4.0	12.3	1.1	5.1	4.2	0.8	54.7	0.0	4.1	3.0	4.8	1.8	1.3	0.0	3.9	2.2
ARHGEF12	"KIAA0382, LARG"	ENSG00000196914	"Rho guanine nucleotide exchange factor 12"	Q9NZN5	11	120336914-120489936	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.2;NK-cells: 1.5;T-cells: 1.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018911, CAB025581"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"CAB025581: , HPA018911: AB_1845003"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.91e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (5.43e-6)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	17.6	19.2	27.6	8.3	32.5	5.9	19.6	40.4	41.5	21.7	16.4	12.4	15.7	14.9	17.5	15.9	17.8	18.6	17.3	23.4	21.8	17.7	41.2	38.8	24.1	6.5	15.8	26.3	16.3	16.9	55.8	17.2	25.4	21.1	16.8	17.8	20.7	16.7	20.0	24.1	29.0	14.8	18.6	10.8	12.4	19.0	6.7	13.0	3.0	31.3	15.0	10.9	19.4	22.9	0.3	0.3	2.2	0.1	1.5	1.0	0.4	13.2	11.1	14.9	14.3	20.2	20.2	6.2	15.6	17.7	9.5	12.1	13.0	9.7	1.1	19.2	27.8	16.8	9.9	19.1	19.7	18.6	10.9	9.4	21.5	12.0	9.9	18.1	0.0	16.0	19.3	14.3	20.8	23.2	21.0	28.7	11.7	18.1	44.1	23.9	9.2	0.0	0.0	4.1	17.1	9.6	4.7	17.1	4.2	23.3	23.0	11.0	13.6	21.8	18.3	5.7	9.3	15.6	1.7	28.4	21.1	9.0	13.7	11.3	13.0	5.2	7.3	8.7	2.8	15.9	2.2	0.0	0.0	1.0	0.1	0.2	0.3	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.5	0.1	0.3	0.7	0.4	27.6	32.5	40.4	41.5	21.8	17.7	15.8	26.3	21.1	13.0	68.5	79.7	12.3	48.8	80.4	124.2	79.1	58.6	52.2	67.1	92.5	174.7	13.7	29.9	34.0	5.0	74.1	47.9	23.3	43.8	8.3	45.2	80.8	10.5	105.8	6.1	85.8	36.4	81.0	27.2	11.5	27.6	17.4	49.0	10.8	44.1	42.4	44.6	49.0	31.5	60.7	84.8	25.8	70.9	13.5	11.9	74.4	24.0	17.5	34.8	95.3
ARHGEF17	"KIAA0337, p164-RhoGEF, TEM4"	ENSG00000110237	"Rho guanine nucleotide exchange factor 17"	Q96PE2	11	73308289-73369388	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Sertoli cells: 84.1;Smooth muscle cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.0;plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007991	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007991: AB_1845005"	"unprognostic (2.36e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.27e-5)"	"unprognostic (6.96e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-3)"	"unprognostic (7.12e-3)"	"unprognostic (6.85e-3)"	"unprognostic (3.42e-3)"	16.7	10.0	18.1	7.0	43.0	2.5	11.1	31.8	35.1	17.1	16.7	9.5	3.5	4.3	20.4	12.6	8.3	14.3	13.9	21.0	13.7	11.4	12.9	2.6	14.8	4.1	8.5	23.1	15.5	5.6	24.7	7.8	18.5	19.6	13.6	4.5	11.4	6.9	23.3	7.3	4.7	7.5	17.9	6.9	7.6	10.5	4.8	13.5	0.8	18.1	3.3	2.2	11.7	10.1	0.0	1.5	0.2	0.2	0.0	0.2	0.0	4.7	5.6	12.2	14.2	9.6	8.2	7.5	13.3	19.4	13.5	8.5	15.3	4.1	0.0	9.5	24.7	6.1	7.5	4.0	5.3	5.5	8.4	1.2	0.0	9.1	5.7	11.1	0.3	0.2	14.1	6.2	7.9	4.7	8.6	10.0	0.6	0.4	0.1	7.3	6.6	0.1	8.3	1.6	3.1	1.2	2.0	14.1	0.3	8.3	3.3	7.9	6.1	11.3	13.3	15.5	11.7	22.6	3.9	6.4	6.5	13.6	2.7	4.2	0.8	0.1	0.0	2.2	0.9	9.9	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	18.1	43.0	31.8	35.1	13.7	11.4	8.5	23.1	19.6	13.5	14.9	12.3	0.0	1.9	3.1	7.1	21.0	7.6	4.0	9.1	7.0	0.0	6.1	0.0	5.6	1.0	6.3	0.0	0.0	0.6	3.9	12.2	2.5	0.0	0.4	1.9	22.3	1.2	12.3	0.0	1.1	10.0	2.3	1.7	1.8	0.3	10.4	1.6	0.0	19.1	3.1	1.3	84.1	53.6	1.8	9.4	2.4	5.1	0.0	0.8	1.4
ARHGEF19	"FLJ33962, WGEF"	ENSG00000142632	"Rho guanine nucleotide exchange factor 19"	Q8IW93	1	16197854-16212609	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 13.5;T-47d: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068108			Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"HPA068108: AB_2685956"	"unprognostic (2.19e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-2)"	"prognostic favorable (6.53e-4)"	"unprognostic (4.01e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (3.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.80e-1)"	3.0	7.4	0.6	2.6	1.8	0.7	3.9	1.4	0.8	7.8	4.9	0.9	12.9	2.2	4.7	8.5	22.1	4.4	2.1	2.0	0.7	0.3	3.3	1.0	5.2	1.4	0.8	0.6	5.3	10.6	1.5	1.2	3.1	1.4	7.7	0.8	3.2	19.5	11.6	1.4	17.1	3.2	2.5	0.7	3.1	4.1	2.3	0.5	2.6	15.0	14.6	14.5	5.5	7.5	2.9	2.4	1.6	1.6	2.7	3.7	1.8	13.5	3.9	2.3	4.3	0.3	1.4	0.9	3.8	3.7	2.3	2.9	6.2	2.4	0.0	3.1	3.8	1.6	11.7	0.9	1.4	0.6	2.5	0.4	1.4	9.5	0.5	5.2	0.8	5.2	4.0	0.8	6.1	1.6	0.5	0.7	4.9	2.8	3.6	0.9	3.2	1.7	1.9	0.6	2.3	4.5	6.1	1.9	3.6	0.8	1.0	1.6	2.7	2.9	1.8	0.6	0.3	20.8	2.9	1.7	0.0	7.3	3.6	0.0	3.6	5.5	1.0	0.0	4.0	5.8	0.0	1.6	1.6	3.6	0.9	3.7	2.9	3.0	2.7	2.3	2.3	3.0	1.7	0.2	2.7	0.1	2.4	1.8	1.8	0.6	1.8	1.4	0.8	0.7	0.3	0.8	0.6	1.4	0.5	6.0	5.9	0.8	6.7	4.1	0.0	0.4	2.5	4.0	7.9	0.0	0.0	1.6	0.0	4.6	0.2	3.6	2.0	0.0	5.0	4.4	4.8	1.9	9.2	1.3	2.2	0.0	0.0	7.4	2.4	0.0	7.2	1.5	3.3	1.8	4.0	6.6	4.1	3.5	3.2	1.0	0.2	0.0	2.7	1.4	5.8	6.8	1.0	6.4	3.8	5.0
ARHGEF25	"GEFT, p63RhoGEF"	ENSG00000240771	"Rho guanine nucleotide exchange factor 25"	Q86VW2	12	57610180-57619379	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 17.5;Leydig cells: 23.0;Peritubular cells: 43.2;Sertoli cells: 25.8;Smooth muscle cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 26.2;cerebellum: 54.2;cerebral cortex: 47.7;hippocampal formation: 59.8;olfactory region: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 22.8;RH-30: 49.9;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052016	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA052016: AB_2681695"	"unprognostic (8.43e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.13e-3)"	"unprognostic (6.95e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.20e-7)"	"unprognostic (1.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.22e-3)"	10.4	7.6	26.2	6.1	11.1	0.5	10.5	54.2	47.7	15.4	41.1	3.6	19.8	6.3	40.0	27.0	17.9	24.3	13.9	11.5	59.8	10.5	4.6	1.7	7.6	3.6	7.5	39.3	22.6	3.7	4.9	7.8	5.8	11.2	23.5	12.0	6.1	7.9	49.2	6.3	3.5	10.3	40.7	8.9	7.9	15.0	4.6	6.2	0.0	4.2	3.7	3.1	21.8	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	15.9	9.9	0.0	0.0	1.3	4.8	14.1	6.3	7.8	1.9	3.0	1.3	4.1	8.7	2.9	0.1	6.1	0.2	5.3	4.3	5.3	2.7	2.1	4.1	4.6	0.0	7.4	4.5	1.3	2.8	0.4	22.8	2.4	0.7	5.6	6.1	4.6	1.1	0.9	0.1	10.2	0.1	0.1	0.0	49.9	0.2	0.3	0.2	9.3	22.7	0.9	0.4	1.7	5.9	1.6	3.2	0.0	5.7	5.5	3.7	1.7	12.9	1.9	0.0	4.8	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	11.1	54.2	47.7	59.8	10.5	7.5	39.3	11.2	6.2	0.0	0.0	0.0	1.8	1.8	17.5	12.3	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.7	0.2	2.1	0.0	0.0	1.2	0.4	8.7	0.7	0.0	0.0	0.4	7.9	0.0	10.4	0.0	0.2	23.0	0.0	0.0	0.0	0.0	3.5	0.5	0.0	43.2	0.3	2.8	25.8	30.9	0.5	1.1	1.0	0.2	0.0	0.0	0.4
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 315.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 10.0;U-251 MG: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: AB_2680671"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	11.2	4.0	9.1	5.8	8.7	1.0	9.8	5.6	17.8	9.2	20.0	6.5	3.3	10.3	5.9	3.1	12.0	8.3	17.6	4.1	8.7	4.6	3.1	22.0	18.6	1.0	5.4	6.3	5.3	27.1	13.9	2.9	4.7	12.2	5.3	3.7	4.4	4.1	5.5	1.5	7.0	11.5	12.7	9.7	1.6	12.3	7.4	5.5	0.0	4.1	2.5	2.0	7.4	11.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	5.3	3.1	6.1	4.2	2.7	0.4	0.1	0.3	0.0	1.6	1.8	2.5	0.4	2.5	0.4	0.1	2.8	6.3	3.1	1.5	2.8	0.0	8.1	0.0	2.3	0.8	2.5	0.8	0.1	0.9	0.1	1.9	0.3	0.9	0.1	2.6	0.0	0.0	1.0	6.2	1.1	0.1	3.9	1.2	2.7	0.0	10.0	0.0	0.5	3.5	2.3	0.7	0.7	8.8	1.3	3.3	5.4	0.4	0.0	0.9	4.0	0.0	18.1	2.6	0.4	0.0	1.6	0.0	6.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.1	8.7	5.6	10.1	8.7	4.6	5.4	6.3	12.2	5.5	315.6	29.8	0.9	7.9	17.3	9.4	1.2	20.4	21.4	17.0	3.5	3.9	1.4	0.0	1.9	9.1	3.0	2.6	0.0	2.2	1.0	8.1	6.7	4.7	44.5	0.6	4.8	0.0	8.6	2.8	1.7	9.8	0.9	3.3	1.8	4.5	70.3	1.7	2.9	17.7	0.0	50.2	0.0	4.2	2.9	32.4	20.7	5.1	5.7	1.7	5.3
ARHGEF28	"p190RhoGEF, RGNEF, RIP2"	ENSG00000214944	"Rho guanine nucleotide exchange factor 28"	Q8N1W1	5	73626158-73941993	"Predicted intracellular proteins"	Differentiation	"Guanine-nucleotide releasing factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 46.8;Muller glia cells: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.2;memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.4;LHCN-M2: 35.3;TIME: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037602	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Microtubules, Cytosol"	"Plasma membrane"	"HPA037602: AB_10672282"	"unprognostic (1.97e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.91e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.98e-4)"	3.4	17.7	3.0	2.7	1.4	0.0	7.7	2.3	2.3	9.7	6.7	1.1	8.6	2.3	11.9	9.7	7.1	7.5	12.0	1.5	1.4	1.9	43.0	5.5	5.5	0.3	1.7	3.2	14.5	19.2	0.2	7.0	1.1	2.5	5.1	2.8	4.3	20.0	9.5	0.9	11.1	3.9	2.7	3.3	2.0	14.8	2.0	1.0	4.1	10.5	6.0	6.0	3.4	6.2	0.0	0.0	0.0	0.0	0.6	1.2	0.1	11.1	7.9	0.0	1.0	1.0	1.4	0.0	4.1	8.2	5.2	5.2	2.3	4.8	0.0	8.8	1.4	11.9	3.8	0.5	6.6	7.9	0.1	1.1	0.2	1.2	10.1	8.3	0.0	0.0	1.3	2.7	8.1	38.4	9.8	17.0	0.2	0.0	0.0	35.3	1.0	0.0	0.0	0.1	2.9	3.2	0.0	2.1	1.3	14.2	6.8	0.7	1.5	2.0	0.3	0.2	0.0	1.7	0.0	22.6	2.6	3.5	0.2	3.8	0.4	0.0	0.0	3.9	0.5	1.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.1	3.0	1.4	2.3	2.3	1.4	1.9	1.7	3.2	2.5	1.0	26.8	13.1	0.0	12.3	22.9	0.7	1.8	28.1	46.8	12.5	29.6	0.0	0.1	13.3	12.3	2.9	8.5	3.0	0.0	9.6	0.2	1.3	9.3	1.1	6.7	0.3	12.7	10.9	1.8	0.3	1.7	9.5	1.3	1.7	1.0	9.6	36.2	17.9	5.7	5.3	18.3	1.0	6.5	3.8	0.7	0.4	22.3	0.1	0.0	6.9	14.9
ARHGEF3	"DKFZP434F2429, GEF3, STA3, XPLN"	ENSG00000163947	"Rho guanine nucleotide exchange factor 3"	Q9NR81	3	56727418-57079329	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"T-cells: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 35.6;RPMI-8226: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034715, HPA064945"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA034715: AB_10600780, HPA064945: AB_2685389"	"unprognostic (1.84e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (8.25e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (9.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.99e-2)"	"prognostic favorable (1.96e-7)"	"unprognostic (8.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-2)"	14.5	33.0	8.3	14.2	22.8	6.4	13.5	24.0	31.1	12.8	12.9	8.8	8.2	4.8	29.6	14.4	16.2	17.8	16.6	9.3	19.0	12.0	19.5	3.9	18.1	19.5	9.3	18.4	20.6	36.9	29.8	30.4	15.5	18.3	11.6	10.5	19.9	18.6	12.3	7.7	10.8	9.1	26.1	9.7	14.9	11.3	10.2	5.8	33.4	10.9	10.2	20.4	13.9	11.2	8.4	4.4	4.9	9.3	11.9	32.7	20.8	9.6	3.4	0.5	3.2	1.1	0.9	6.9	1.0	0.9	1.1	1.4	1.6	9.2	5.0	1.0	1.9	10.7	5.0	3.0	12.7	1.2	7.3	1.4	4.1	2.2	35.6	2.8	0.0	4.6	4.2	8.4	0.9	1.4	10.0	10.5	5.4	1.1	11.3	2.4	1.4	13.7	0.5	0.9	7.8	5.3	0.0	3.8	37.0	8.3	5.3	0.6	1.6	6.2	4.6	2.7	3.7	1.2	4.3	4.8	0.5	2.6	2.2	1.6	14.5	5.6	18.4	9.1	5.0	4.4	4.9	7.1	1.1	32.7	8.0	24.5	8.4	25.2	28.5	4.4	5.6	20.7	25.2	2.7	11.9	9.3	1.9	20.7	20.8	8.3	22.8	24.0	31.1	19.0	12.0	9.3	18.4	18.3	5.8	14.9	21.9	10.7	8.2	9.8	9.6	8.7	0.0	8.1	6.8	22.7	3.9	9.4	10.0	8.6	15.7	23.0	1.1	0.0	8.7	6.3	12.2	14.3	12.8	0.0	7.2	0.0	9.2	12.3	28.4	10.9	16.4	15.8	10.1	5.4	0.7	8.9	7.8	0.0	22.6	6.9	1.1	0.0	4.2	1.7	2.7	13.0	10.0	44.8	2.6	10.7
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889841-38975449	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 42.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 25.0;Late spermatids: 21.2;Spermatocytes: 30.7;Spermatogonia: 34.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 42.5"	"Cell type enriched"	"Detected in single"	8	"eosinophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Group enriched"	"Detected in some"	4	"BEWO: 9.0;HeLa: 4.0;SiHa: 11.2"	"Region enriched"	"Detected in single"	32	"cerebellum: 314.4"	"Region enriched"	"Detected in all"	11	"cerebellum: 47.0"	"HPA034661, HPA041051"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA034661: AB_10669679, HPA041051: AB_2677274"	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.3	4.0	3.7	1.0	8.6	0.0	1.7	42.5	3.4	2.3	0.7	0.6	0.7	0.1	2.8	5.1	0.7	2.2	1.4	0.8	3.3	3.6	1.4	0.2	1.2	0.5	2.0	2.9	6.8	0.2	2.2	3.5	0.8	3.2	1.7	0.6	0.8	0.4	1.2	0.4	1.3	0.6	1.0	1.5	0.5	0.9	10.1	2.4	0.2	1.4	0.2	0.4	1.2	0.6	0.2	0.1	6.7	0.8	0.0	0.2	0.1	0.3	0.0	0.4	0.2	0.2	0.2	9.0	0.8	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.3	4.0	0.3	0.7	0.4	0.3	0.8	1.0	0.5	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.4	0.5	0.3	11.2	0.4	0.0	1.1	0.0	0.3	0.6	0.2	1.5	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.1	0.0	0.6	6.7	0.0	0.8	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	3.7	8.6	42.5	3.4	3.3	3.6	2.0	2.9	3.2	2.4	0.0	1.0	0.0	0.1	0.0	2.5	0.4	0.0	5.3	1.2	0.0	0.0	0.8	0.0	0.1	25.0	0.3	0.0	0.0	0.0	1.3	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	21.2	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	3.2	0.2	3.1	0.0	0.7	30.7	34.3	0.1	0.5	0.0	0.0	0.2
ARHGEF37	FLJ41603	ENSG00000183111	"Rho guanine nucleotide exchange factor 37"	A1IGU5	5	149551947-149634968	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 66.1;seminal vesicle: 73.8"	"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 9.0;neutrophil: 4.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 10.1;HaCaT: 18.5;hTCEpi: 24.5"	"Region enhanced"	"Detected in some"		"cerebellum: 9.5"	"Low region specificity"	"Detected in all"			"HPA043885, HPA053487"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA043885: AB_2678715, HPA053487: AB_2682167"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.16e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.10e-1)"	2.5	2.7	10.8	1.9	13.2	3.0	16.8	6.7	7.1	4.0	10.2	17.5	66.1	4.5	4.4	9.5	7.6	7.4	4.6	6.4	12.8	9.5	4.6	1.4	4.3	1.0	19.1	5.8	2.2	7.0	29.6	5.3	3.6	12.3	16.0	5.2	12.0	23.2	73.8	11.9	29.3	4.8	7.0	31.7	1.0	11.7	4.8	15.1	0.7	2.1	4.8	3.4	6.4	5.4	0.7	1.1	9.0	1.2	0.2	0.8	0.0	3.0	1.2	0.8	3.6	0.2	0.4	2.1	0.4	0.6	0.6	0.6	0.0	4.0	0.4	10.1	0.4	1.1	18.5	0.3	1.8	1.2	0.8	0.9	0.3	1.9	0.2	0.7	0.0	0.5	0.5	24.5	1.9	2.4	2.0	3.0	1.3	0.4	0.7	0.0	0.4	0.5	0.6	0.2	7.5	2.2	0.3	0.4	0.0	4.1	1.5	1.5	3.6	2.2	0.2	0.3	0.4	5.5	0.1	2.4	0.2	0.7	0.0	0.5	0.5	1.0	0.3	0.7	0.1	2.6	9.0	0.9	0.5	0.4	1.2	0.5	0.2	0.3	0.3	0.3	0.7	0.8	0.6	4.9	0.2	0.5	1.1	0.2	0.0	10.8	13.2	6.7	7.1	12.8	9.5	19.1	5.8	12.3	15.1	0.0	5.0	3.7	8.4	6.1	4.1	14.8	15.3	6.7	6.8	8.7	3.9	4.9	0.0	3.2	4.2	6.0	12.6	0.0	4.5	1.2	2.1	9.6	6.9	2.6	2.8	4.8	10.9	6.7	2.8	1.0	1.7	3.7	3.3	4.6	6.1	40.8	4.1	8.0	9.9	1.3	7.3	6.5	4.1	13.2	5.5	8.4	3.8	4.4	7.5	4.5
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 35.5"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 33.6;Ciliated cells: 45.5;Club cells: 18.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 3.0;RPTEC TERT1: 16.4;SK-BR-3: 9.0;T-47d: 9.3"					"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.2	0.2	0.2	3.2	0.2	0.0	10.8	0.2	0.2	3.5	7.6	0.0	1.6	2.3	1.4	15.7	0.4	1.1	11.7	0.2	0.2	0.2	13.8	0.4	16.1	0.0	0.2	0.0	1.3	12.9	0.0	35.5	0.4	0.0	14.6	5.6	0.2	13.9	0.5	0.2	1.0	9.6	0.0	0.2	0.2	4.1	0.6	0.0	0.0	8.0	0.7	2.0	0.5	0.4	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.1	16.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	6.0	33.6	0.0	0.9	0.0	0.0	1.4	2.5	45.5	18.2	12.2	0.0	0.1	8.3	4.2	1.2	0.0	4.1	0.0	5.0	0.1	0.0	13.9	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	7.7	0.0	3.3	5.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.0	0.4
ARHGEF6	"alpha-PIX, alphaPIX, Cool-2, Cool2, KIAA0006, MRX46"	ENSG00000129675	"Rac/Cdc42 guanine nucleotide exchange factor 6"	Q15052	X	136665547-136782088	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	18	"Cardiomyocytes: 54.5;granulocytes: 188.3;Kupffer cells: 44.7"	"Cancer enhanced"	"Detected in all"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.0;HL-60: 27.4;HMC-1: 104.4;JURKAT: 28.7;U-937: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003578	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA003578: AB_1078203"	"unprognostic (9.64e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.08e-2)"	"unprognostic (7.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-3)"	22.0	10.4	16.9	15.3	15.4	14.8	13.9	6.4	14.6	6.4	8.3	12.8	3.7	4.0	8.4	6.1	4.4	4.5	9.5	27.0	21.7	13.6	5.0	4.5	13.8	20.6	20.7	10.2	9.5	2.7	8.8	4.8	24.4	15.1	6.4	6.3	8.4	6.2	5.1	37.5	4.3	9.6	9.3	14.6	20.2	6.4	3.2	14.6	2.6	4.1	8.6	20.5	8.8	7.9	3.1	8.8	31.5	8.8	5.5	9.9	6.2	0.2	0.0	1.0	0.0	2.3	5.8	0.0	0.3	1.8	0.3	1.6	0.0	0.0	1.0	0.4	1.5	1.6	0.1	1.2	0.0	0.3	5.1	0.4	22.0	0.0	0.0	0.8	27.4	104.4	6.3	0.0	1.1	0.0	2.0	0.6	28.7	0.1	4.3	3.9	0.0	12.8	16.8	0.9	0.0	0.4	4.9	7.4	0.0	0.3	5.5	0.0	1.3	0.0	0.2	0.8	0.5	0.6	11.4	0.1	1.5	0.2	1.8	1.4	0.7	0.0	10.5	7.0	29.3	2.0	20.2	7.2	31.5	6.8	8.8	8.0	3.1	7.6	5.5	8.8	2.6	7.0	6.1	4.2	5.5	6.8	2.8	9.9	6.2	16.9	15.4	6.4	14.0	21.7	13.6	20.7	10.2	15.1	14.6	6.0	12.8	13.2	0.8	1.0	0.5	54.5	0.0	1.4	3.4	1.8	0.0	0.2	1.7	0.4	11.0	8.4	0.0	0.0	1.6	0.2	5.3	0.4	188.3	1.3	13.2	12.7	0.0	12.3	44.7	20.0	13.8	26.2	3.3	11.8	0.1	2.8	1.0	0.0	13.8	0.3	0.3	12.9	10.8	0.5	0.6	1.5	0.3	22.3	0.0	0.6
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298385-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	15.1	8.5	17.3	15.1	22.2	34.5	13.4	45.9	27.0	12.8	12.0	7.9	12.7	10.2	11.6	9.7	10.1	10.7	10.7	10.0	13.3	11.5	11.3	21.7	12.0	15.8	9.6	18.7	15.3	11.4	17.2	22.9	11.3	17.3	10.8	10.6	6.4	10.8	13.5	10.6	13.2	12.3	12.5	11.0	15.3	10.2	7.9	15.0	15.0	12.6	4.5	12.8	13.8	11.9	15.1	7.5	42.7	14.1	10.7	11.1	3.6	6.7	5.7	16.0	7.9	7.9	9.6	8.1	8.1	6.9	5.5	8.7	6.7	10.7	16.3	8.6	6.8	5.3	7.8	7.0	3.9	8.1	11.4	4.5	7.4	6.4	6.4	4.8	15.5	10.7	7.2	4.3	5.3	5.5	8.8	8.7	9.5	8.3	13.5	5.8	9.1	11.2	14.0	3.1	6.6	6.9	11.6	13.8	4.8	5.9	12.0	13.8	11.9	13.7	6.9	9.6	8.2	11.8	14.3	12.3	9.4	7.4	7.5	3.7	4.4	3.3	15.0	5.6	9.9	4.7	19.3	7.6	21.7	8.5	7.8	9.5	11.6	10.3	8.8	5.6	15.1	11.1	10.8	42.7	10.7	14.1	7.5	7.2	3.6	17.3	22.2	45.9	27.0	13.3	11.5	9.6	18.7	17.3	15.0	77.4	85.3	20.4	20.9	34.1	91.9	45.6	15.3	8.1	40.9	26.2	49.1	16.0	16.6	19.0	13.5	41.6	29.5	23.3	19.0	18.3	27.2	20.2	63.6	37.6	29.9	106.5	21.9	33.2	40.4	5.3	33.6	50.9	25.3	68.5	30.9	64.2	20.9	36.8	33.9	11.9	63.2	19.4	25.5	37.6	24.7	29.2	17.0	54.9	29.8	15.5
ARID4B	"BCAA, BRCAA1, RBP1L1, SAP180"	ENSG00000054267	"AT-rich interaction domain 4B"	Q4LE39	1	235131634-235328219	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027205, HPA027333"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoplasm	"HPA027205: , HPA027333: AB_1845013"	"unprognostic (2.62e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.84e-3)"	15.3	13.8	14.9	19.0	22.5	34.1	15.9	32.8	17.6	19.7	13.4	19.2	18.2	9.1	18.7	18.1	12.0	15.0	15.2	10.6	15.2	14.5	13.1	14.0	15.5	22.3	26.9	13.9	21.8	16.8	23.8	25.7	14.7	20.3	17.9	10.7	12.0	16.7	17.0	12.3	12.3	14.2	14.6	19.8	19.8	14.7	19.5	23.4	33.7	20.2	8.2	18.9	18.2	18.6	17.1	11.7	35.9	11.8	16.6	17.0	6.0	12.2	9.2	16.2	12.5	11.9	12.5	13.3	14.0	12.3	9.7	9.5	9.5	13.1	14.4	16.3	10.5	6.9	10.9	13.1	5.9	14.1	18.5	14.2	11.6	11.1	7.9	9.1	12.4	17.1	8.4	8.0	11.9	10.2	12.7	13.1	9.2	15.0	20.7	9.1	5.5	18.5	11.3	14.8	8.8	6.1	6.9	11.5	12.0	10.6	10.3	13.2	18.3	17.8	14.8	13.8	4.9	15.6	20.1	18.0	12.0	9.1	14.6	13.6	20.2	16.0	14.4	8.2	9.1	16.0	24.6	7.1	19.5	16.1	7.6	14.7	15.6	17.0	13.7	6.8	17.1	16.9	14.4	35.9	16.6	11.8	11.7	13.6	6.0	14.9	22.5	32.8	17.6	15.2	14.5	26.9	13.9	20.3	23.4	95.3	99.9	54.7	68.9	110.4	111.2	62.2	35.7	91.0	101.2	29.6	113.9	55.7	16.6	62.0	329.6	108.9	41.9	46.7	41.8	58.1	114.7	81.5	105.3	23.1	39.4	106.5	86.4	65.7	52.4	349.2	93.7	99.4	79.2	108.2	45.8	77.7	57.3	49.9	72.9	15.0	150.5	45.3	129.6	212.6	167.8	93.1	131.0	129.6	39.6	111.5
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901300-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.6"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 860.1;Smooth muscle cells: 627.3;Syncytiotrophoblasts: 769.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	43.3	5.6	7.8	13.8	9.9	4.2	22.6	3.3	11.5	27.5	14.0	9.5	4.4	6.8	29.4	10.4	14.0	15.6	27.2	16.0	5.9	5.1	14.6	5.7	14.6	14.4	11.8	6.5	18.6	4.3	14.7	11.4	22.4	9.4	16.6	8.2	6.9	14.5	7.3	88.6	15.0	12.1	29.4	10.4	12.7	9.4	7.7	10.5	8.6	7.5	11.7	18.0	22.5	17.1	21.2	1.0	4.3	3.6	5.7	14.7	2.6	0.8	0.3	2.3	5.9	5.2	14.0	0.4	16.9	45.7	12.1	9.5	20.5	0.9	1.4	4.1	16.2	1.7	5.6	8.1	2.5	14.6	5.3	2.4	0.8	4.1	5.1	9.7	0.2	10.1	17.6	1.3	7.1	8.1	10.4	1.4	2.9	0.7	2.3	3.9	2.9	5.5	0.4	0.4	3.9	5.4	6.7	3.9	0.4	7.9	9.2	1.3	1.7	7.5	4.1	4.9	5.5	3.5	0.2	1.3	6.7	9.1	10.1	4.2	0.1	0.0	4.4	5.8	0.3	2.1	4.3	0.6	0.4	7.3	1.4	0.9	19.0	10.5	6.3	1.0	21.2	6.9	4.5	1.2	5.7	3.6	0.5	14.7	2.6	7.8	9.9	3.3	11.5	5.9	5.1	11.8	6.5	9.4	10.5	122.1	57.7	77.2	286.1	860.1	43.7	59.7	12.7	50.9	120.6	48.8	0.0	138.5	84.6	43.9	23.9	62.4	4.7	23.3	12.8	104.6	292.5	224.3	23.2	5.1	46.6	69.9	34.9	106.8	33.2	10.0	140.4	39.6	131.6	60.5	13.2	19.3	30.6	20.9	57.0	145.5	2.8	129.4	627.3	5.7	0.5	417.5	769.7	77.6	30.2	122.9
ARIH1	"ARI, HARI, HHARI, UBCH7BP"	ENSG00000166233	"Ariadne RBR E3 ubiquitin protein ligase 1"	Q9Y4X5	15	72474326-72602985	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003295, HPA073245"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA003295: AB_1845017, HPA073245: AB_2686587"	"unprognostic (3.31e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.70e-2)"	15.3	15.6	11.4	17.4	15.5	24.6	13.3	20.4	21.5	15.8	14.5	10.4	14.0	17.0	21.1	11.2	14.2	12.3	14.4	19.7	10.5	10.5	10.9	10.5	13.7	9.3	10.1	15.0	17.3	13.5	12.9	14.0	15.4	12.6	14.0	7.6	13.0	13.2	13.1	68.3	16.3	13.5	15.8	10.7	11.4	12.5	55.2	10.0	16.9	11.7	13.0	12.7	18.4	20.4	1.9	1.1	4.6	1.5	2.1	2.5	0.3	9.4	9.9	9.8	5.7	5.1	3.6	11.5	10.6	3.9	4.8	3.3	10.0	8.1	9.2	16.0	4.5	17.0	13.5	10.0	5.5	2.7	16.4	6.9	7.0	12.2	6.6	3.6	10.4	8.1	4.2	1.9	5.3	6.9	4.6	3.5	6.8	7.3	11.0	4.7	6.1	10.0	4.0	10.6	3.4	3.6	11.4	11.9	5.2	2.7	15.8	9.2	10.5	13.8	6.2	16.3	13.5	5.0	12.0	9.1	8.0	11.1	30.7	14.8	11.6	23.2	10.8	5.3	9.5	8.4	4.6	1.0	2.2	1.7	1.5	1.5	0.7	1.3	1.1	0.7	1.9	1.6	1.5	3.4	2.1	0.7	1.1	2.5	0.3	11.4	15.5	20.4	14.0	10.5	10.5	10.1	15.0	12.6	10.0	17.9	30.7	20.4	42.7	58.8	62.5	41.5	20.4	29.4	30.7	17.4	86.4	15.9	3.3	17.2	84.9	33.4	23.6	0.0	16.2	16.9	29.1	45.9	43.7	24.7	16.7	58.8	44.6	41.1	23.7	41.4	26.4	21.3	15.1	10.0	22.7	24.7	20.6	20.1	25.8	12.2	60.6	19.4	46.1	40.7	29.7	52.2	34.1	30.5	20.9	52.0
ARL13A	ARL13	ENSG00000174225	"ADP ribosylation factor like GTPase 13A"	Q5H913	X	100969708-100990829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 16.6"	"Group enriched"	"Detected in some"	23	"Early spermatids: 58.2;Late spermatids: 44.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.7"									"HPA037377, HPA037378"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA037377: AB_2675442, HPA037378: AB_10670932"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.37e-4)"	"unprognostic (2.14e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.6	0.0	0.5	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	1.2	0.4	0.1	0.1	0.2	0.3	16.6	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.8	0.2	0.0	0.4	0.1	0.5	0.0	1.1	1.9	0.1	0.6	0.0	0.0	0.5	0.3	0.1	0.0	0.0	6.7	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	1.2	1.1	0.7	0.0	1.7	0.1	0.0	0.0	0.0	0.4	0.4	0.3	0.9	0.3	0.0	0.1	0.7	0.0	0.2	0.0	0.4	1.6	0.0	0.1	0.7	0.0	0.4	0.0	0.1	1.2	0.3	0.1	0.0	0.3	2.0	0.6	0.3	0.0	0.0	0.3	0.2	0.2	1.3	0.3	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.5	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	0.0
ARL15	"ARFRP2, FLJ20051"	ENSG00000185305	"ADP ribosylation factor like GTPase 15"	Q9NXU5	5	53883945-54310582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 46.4;Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044604, HPA063820"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Golgi apparatus"	"Plasma membrane, Cell Junctions"	"HPA044604: AB_10960542, HPA063820: AB_2685131"	"unprognostic (2.18e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.35e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.08e-1)"	22.0	19.9	13.4	13.1	10.5	2.2	20.1	15.7	22.4	29.9	15.6	5.9	8.7	13.9	32.2	9.9	13.2	12.7	20.5	20.1	19.7	13.2	23.9	12.8	14.4	13.9	11.3	11.2	9.8	7.8	3.5	28.0	31.4	12.3	14.3	15.4	15.3	19.6	12.1	5.2	16.9	12.7	26.7	15.1	15.2	11.1	14.2	10.5	17.4	13.4	13.9	10.8	19.1	13.6	2.0	5.0	7.4	3.5	1.4	4.8	2.3	1.9	3.9	6.0	10.1	6.0	5.3	7.5	6.3	9.5	6.3	13.5	14.9	4.9	17.4	10.3	6.1	7.1	4.8	9.0	10.3	8.9	2.3	9.4	24.0	5.5	1.3	1.5	2.3	28.1	7.5	7.1	10.4	7.2	10.1	15.2	4.5	21.5	2.8	4.1	4.2	4.4	2.2	2.0	0.8	2.5	4.0	6.4	0.4	8.9	21.0	7.6	3.9	8.0	4.4	5.0	12.1	4.8	2.9	7.7	3.9	6.1	2.9	4.5	1.1	1.1	19.9	6.0	6.4	6.4	2.7	3.5	4.6	2.9	3.2	1.7	2.0	2.0	2.1	5.0	1.6	2.1	1.7	7.4	1.4	2.3	0.7	4.8	2.3	13.4	10.5	15.7	22.4	19.7	13.2	11.3	11.2	12.3	10.5	3.0	7.7	0.9	6.9	8.7	5.0	6.3	7.6	4.0	3.4	12.2	13.7	46.4	18.3	2.8	1.8	27.5	4.9	0.0	4.2	2.6	5.0	4.8	2.3	4.0	7.5	1.6	20.1	17.8	7.6	1.1	4.0	7.4	1.7	0.0	6.7	2.8	5.6	8.2	3.5	5.7	2.8	6.5	3.5	0.7	2.8	8.8	35.7	4.3	6.6	6.0
ARL2	ARFL2	ENSG00000213465	"ADP ribosylation factor like GTPase 2"	P36404	11	65014113-65022184	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 847.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044610	Supported		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol"	"HPA044610: AB_10964207"	"unprognostic (9.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-3)"	"unprognostic (6.43e-2)"	"unprognostic (6.87e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.24e-2)"	39.6	32.0	37.3	17.7	78.7	19.8	26.8	16.1	46.5	21.2	23.5	34.7	13.4	23.9	26.8	20.2	23.7	35.2	22.4	52.6	34.8	32.7	33.8	6.6	23.1	14.8	36.1	38.2	27.2	29.9	22.5	15.4	25.5	32.7	25.3	15.5	30.3	26.9	33.1	78.3	19.6	23.4	28.2	44.9	16.7	18.9	31.4	28.7	7.9	26.3	23.6	12.9	24.7	22.8	43.7	37.8	18.7	21.8	21.0	40.7	34.7	36.1	57.7	17.9	26.4	48.6	36.9	16.3	17.8	41.3	25.6	25.3	16.3	25.0	14.0	34.1	25.1	39.0	23.3	18.8	31.4	12.2	14.6	29.5	14.1	26.0	24.6	37.2	17.1	12.8	29.0	26.3	21.3	47.8	37.4	34.0	16.9	33.2	26.1	17.2	42.8	14.1	38.5	28.0	17.2	47.1	7.5	19.6	33.6	27.5	15.8	33.3	18.8	15.3	15.9	50.2	17.6	16.6	21.0	25.6	48.3	16.3	38.3	18.4	9.0	12.6	8.6	22.8	24.7	39.2	10.2	21.8	18.7	34.8	21.2	37.6	43.7	32.2	33.6	27.6	37.3	36.8	40.7	2.8	21.0	12.4	37.8	20.6	34.7	37.3	78.7	16.1	46.5	34.8	32.7	36.1	38.2	32.7	28.7	20.8	35.8	37.0	78.1	72.4	72.3	89.8	50.9	32.1	52.4	78.5	27.5	165.9	227.1	118.2	362.1	147.4	126.8	46.7	66.9	164.2	116.5	55.8	93.5	17.1	87.0	65.2	80.0	119.1	47.3	847.8	66.4	70.8	168.7	138.9	56.4	119.5	81.6	95.1	66.8	340.4	40.2	64.7	111.8	98.4	65.3	72.4	89.7	39.2	87.9	60.9
ARL3	ARFL3	ENSG00000138175	"ADP ribosylation factor like GTPase 3"	P36405	10	102673731-102714407	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036292, HPA063596"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		17000	Centrosome	Nucleoplasm	"HPA036292: AB_10673618, HPA063596: AB_2685053"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.99e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.71e-6)"	"unprognostic (5.62e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-1)"	8.8	13.8	24.8	6.6	29.4	2.9	11.4	24.1	32.9	14.1	8.9	9.6	8.2	6.8	17.1	16.7	10.2	23.0	8.3	29.9	19.9	21.4	22.7	8.1	9.6	5.5	20.2	16.0	25.2	9.9	18.9	21.0	7.7	17.6	12.1	7.7	21.5	8.8	14.5	7.9	7.9	6.4	13.4	14.2	5.3	9.0	13.6	9.3	4.1	17.3	5.5	7.2	16.0	13.8	5.0	7.8	14.9	8.1	4.5	11.1	5.8	8.4	14.6	20.1	14.7	9.4	14.0	3.5	6.7	10.3	8.2	9.0	5.0	4.4	3.5	6.5	10.8	9.9	6.3	7.6	9.0	10.3	9.2	7.9	5.7	10.4	4.7	10.1	2.6	5.8	7.1	7.6	11.3	6.7	21.9	9.3	7.1	2.5	3.6	13.6	8.7	5.4	4.2	7.7	5.4	5.8	4.5	14.9	3.1	10.9	4.5	7.1	15.5	5.1	1.1	7.9	11.6	26.8	2.6	5.3	5.6	7.9	11.3	9.2	2.5	5.0	6.5	14.8	7.9	4.8	2.3	8.1	2.7	4.5	6.5	11.1	5.0	7.8	6.5	7.8	3.5	4.8	5.7	14.9	4.5	5.5	5.7	5.2	5.8	24.8	29.4	24.1	25.6	19.9	21.4	20.2	16.0	17.6	9.3	50.6	35.3	24.6	62.4	28.5	163.4	124.2	25.5	234.2	69.4	59.3	110.0	37.6	198.9	63.3	31.0	37.3	8.7	0.0	38.5	31.6	63.5	46.4	32.3	23.7	54.8	92.2	71.9	38.1	15.3	15.4	56.1	32.0	72.6	102.8	28.8	161.1	29.6	11.5	97.9	174.9	241.8	25.8	102.0	184.2	20.1	27.7	27.0	20.1	26.6	42.6
ARL4D	ARF4L	ENSG00000175906	"ADP ribosylation factor like GTPase 4D"	P49703	17	43398959-43401137	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 199.3;Early spermatids: 164.5;Rod photoreceptor cells: 232.6;Suprabasal keratinocytes: 222.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 18.5;myeloid DC: 4.9;naive B-cell: 18.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 26.1;hTCEpi: 33.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"basal ganglia: 9.7;cerebral cortex: 11.2;hippocampal formation: 7.5;olfactory region: 8.6"	HPA060379	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA060379: AB_2684269"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-2)"	"prognostic favorable (1.16e-5)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (9.25e-4)"	7.4	3.3	2.5	3.4	6.4	0.8	6.7	3.7	8.9	20.9	10.4	1.1	4.6	1.5	15.2	6.6	38.4	15.6	7.0	6.8	2.6	2.0	21.6	26.0	6.0	1.2	1.3	2.8	12.6	1.5	1.1	15.1	6.9	2.3	10.8	2.7	22.0	14.0	11.6	2.9	16.8	2.2	22.0	1.0	9.0	3.3	17.3	0.5	0.5	52.5	13.9	10.5	23.3	14.5	18.9	4.9	1.1	2.4	1.1	3.3	2.6	3.7	4.7	3.0	2.3	5.7	7.9	1.3	9.1	9.4	6.5	8.5	4.1	16.5	0.0	4.6	9.8	4.4	10.2	2.0	13.9	4.5	0.8	3.3	0.3	3.8	9.5	26.1	1.0	0.9	8.7	33.9	9.5	20.6	5.9	2.7	1.0	0.6	0.2	6.3	0.2	2.2	2.1	3.1	0.3	4.4	3.9	0.7	0.4	10.9	8.1	3.5	2.5	7.2	0.1	6.7	6.7	13.5	3.6	0.5	9.4	3.0	12.1	2.7	0.9	0.4	0.0	11.6	0.8	3.1	0.0	1.6	1.1	3.2	2.4	2.0	18.5	2.7	2.9	4.9	18.9	3.0	3.3	0.0	1.1	0.8	1.4	0.6	2.6	2.5	6.4	3.7	8.9	2.6	2.0	1.3	2.8	2.3	0.5	0.0	1.7	17.2	38.4	199.3	120.4	6.7	5.1	5.3	11.4	125.6	110.0	35.6	64.6	2.3	164.5	24.3	0.2	0.0	1.6	19.3	48.7	4.7	0.0	25.9	7.0	15.9	11.3	22.1	5.4	34.2	14.7	2.2	25.3	1.0	2.5	47.3	3.2	0.0	21.2	12.6	232.6	12.9	28.6	13.9	9.4	222.5	88.2	8.2	2.5	74.5
ARL6	"BBS3, RP55"	ENSG00000113966	"ADP ribosylation factor like GTPase 6"	Q9H0F7	3	97764521-97801242	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 22.7;Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 54.6;Spermatocytes: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019361	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA019361: AB_1845028"	"unprognostic (1.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.88e-2)"	"unprognostic (5.55e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (9.49e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.97e-1)"	5.5	9.2	8.8	3.6	18.6	1.6	6.0	10.0	17.7	6.5	4.9	5.0	7.3	2.7	7.9	7.3	5.3	11.9	6.2	5.9	17.1	11.0	13.2	4.4	8.4	3.9	8.9	14.1	6.4	5.6	22.6	22.3	5.0	12.9	7.1	4.6	7.3	9.1	6.5	2.9	5.2	3.2	7.2	8.0	4.7	5.0	10.9	9.0	4.2	9.1	2.0	3.8	5.6	5.1	2.7	1.0	0.5	1.0	4.1	4.8	1.6	7.7	4.4	4.0	3.3	10.1	7.1	1.0	5.1	4.8	4.5	5.8	1.6	3.1	4.2	4.9	2.4	7.4	3.8	5.1	5.8	9.2	5.2	3.1	1.2	3.3	1.7	4.9	5.3	2.8	3.6	4.2	6.0	1.5	4.0	4.4	5.5	1.4	0.8	7.2	2.8	3.0	2.6	5.0	4.1	5.0	1.5	4.2	2.5	5.1	2.2	22.0	11.7	4.4	3.0	9.2	2.8	3.6	2.1	3.3	4.5	3.9	3.9	6.8	3.5	4.2	4.9	8.3	2.9	5.4	0.5	0.5	0.2	2.4	0.7	4.8	1.9	2.1	2.5	0.9	2.7	3.6	3.0	0.0	4.1	1.0	1.0	3.6	1.6	8.8	18.6	10.0	17.7	17.1	11.0	8.9	14.1	12.9	9.0	3.0	2.2	0.5	2.8	2.9	11.0	1.8	0.0	22.7	5.7	8.7	25.5	1.1	3.3	3.4	15.0	2.9	0.0	0.0	2.2	1.7	2.3	1.7	0.0	2.6	1.6	4.8	2.4	4.9	1.3	3.7	3.7	0.8	1.7	0.0	1.3	6.5	2.0	2.0	3.9	8.2	54.6	6.5	3.3	30.4	5.3	1.8	0.6	1.5	1.2	1.4
ARL6IP1	"AIP1, ARL6IP, ARMER, KIAA0069, SPG61"	ENSG00000170540	"ADP ribosylation factor like GTPase 6 interacting protein 1"	Q15041	16	18791667-18801678	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA045307	Uncertain		Approved	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"HPA045307: AB_10961042"	"unprognostic (2.42e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (6.32e-3)"	"unprognostic (5.36e-3)"	29.6	40.9	75.9	16.5	62.0	40.2	26.2	76.5	93.0	19.5	31.5	28.6	13.8	31.4	16.7	29.7	19.8	20.5	30.2	8.8	65.7	70.1	35.1	80.7	18.0	27.0	65.2	44.6	24.7	18.6	45.1	13.4	20.3	68.6	18.1	29.0	40.9	18.6	17.4	8.3	14.8	27.5	16.0	43.0	20.4	27.8	28.1	20.4	33.1	26.2	11.3	24.9	27.8	14.2	41.2	57.2	40.1	32.4	44.1	67.7	63.0	48.3	44.2	58.8	45.9	21.1	13.6	52.6	28.3	27.3	44.0	35.2	27.1	117.2	42.3	51.9	27.1	29.6	53.1	42.1	19.9	51.2	54.1	19.0	30.0	27.3	73.7	16.8	42.4	32.1	11.3	19.4	30.4	31.9	32.6	43.9	25.0	32.7	44.1	84.6	43.8	29.8	32.1	72.2	42.4	15.1	50.8	73.8	35.9	47.2	27.3	35.8	40.7	62.2	39.0	27.9	41.4	80.0	42.9	24.2	28.9	27.2	20.5	50.5	15.0	26.6	51.0	25.8	29.0	55.8	40.1	32.4	20.9	48.7	30.0	44.7	41.2	43.2	52.4	32.0	38.3	38.5	45.8	27.7	44.1	30.9	57.2	67.7	63.0	75.9	62.0	76.5	93.0	65.7	70.1	65.2	44.6	68.6	20.4	62.5	47.7	99.8	227.5	331.0	171.8	27.4	341.4	91.0	61.4	272.2	123.7	218.9	147.6	292.3	62.1	144.0	214.0	677.5	180.9	329.7	163.0	191.1	134.8	383.9	223.1	84.2	140.0	177.4	230.1	29.6	78.6	248.9	190.6	385.9	155.5	189.5	210.1	217.5	104.3	161.1	161.3	90.5	101.1	73.5	56.8	285.4	273.1	186.2	246.9	307.2
ARL6IP4	"SFRS20, SR-25, SRp25, SRrp37"	ENSG00000182196	"ADP ribosylation factor like GTPase 6 interacting protein 4"	Q66PJ3	12	122980060-122982913	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA052098	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA052098: AB_2681724"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.04e-3)"	"unprognostic (6.48e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.03e-5)"	"unprognostic (4.01e-2)"	"unprognostic (8.41e-8)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.43e-2)"	"prognostic favorable (1.08e-4)"	42.1	59.6	63.3	35.7	46.8	55.3	40.3	36.9	55.9	36.7	43.0	32.2	38.9	43.7	33.8	30.7	38.9	42.9	40.1	57.0	42.8	40.9	45.2	59.1	33.9	51.6	45.2	38.3	50.0	94.4	30.0	34.7	29.7	35.1	38.9	24.7	39.7	59.7	41.2	131.1	30.7	44.9	64.3	36.1	38.1	41.6	35.2	27.7	35.5	39.1	43.4	39.9	39.5	39.9	54.4	72.4	58.1	81.5	46.5	59.6	61.3	49.0	53.6	35.3	23.6	24.8	32.9	27.7	28.3	34.1	42.6	32.4	26.4	20.9	46.9	35.6	35.8	19.9	26.0	28.1	45.9	19.0	41.5	29.3	77.9	47.5	51.8	47.8	42.4	34.4	34.0	37.1	32.7	43.1	46.8	46.8	37.9	34.5	22.8	34.0	57.9	49.3	77.2	27.7	29.7	34.0	37.6	38.8	55.4	36.8	41.9	34.3	41.1	26.7	44.8	65.1	16.1	58.7	55.3	41.8	24.7	45.0	23.5	35.2	49.0	23.6	53.4	35.6	49.8	30.8	32.9	58.4	58.1	47.4	72.2	51.0	54.4	57.0	52.5	72.4	50.6	55.1	49.4	16.1	46.5	81.5	49.3	59.6	61.3	63.3	46.8	36.9	55.9	42.8	40.9	45.2	38.3	35.1	27.7	86.4	116.6	229.3	258.2	181.7	102.3	0.0	173.3	87.0	80.8	200.7	41.2	248.7	437.7	251.9	151.9	255.7	444.9	46.7	552.1	221.9	252.2	285.2	160.8	400.6	340.2	92.2	214.5	213.6	390.7	256.2	206.0	341.0	357.7	480.7	268.3	146.1	343.4	291.0	170.1	721.8	106.3	174.6	249.2	209.1	156.8	177.7	200.9	256.7	288.4	330.8
ARL6IP5	"DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b"	ENSG00000144746	"ADP ribosylation factor like GTPase 6 interacting protein 5"	O75915	3	69084944-69106066	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015540, CAB019321"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		19000000	"Endoplasmic reticulum"		"CAB019321: , HPA015540: AB_1852061"	"unprognostic (8.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.31e-2)"	53.2	53.2	44.0	37.4	48.5	21.3	51.5	32.9	62.1	48.1	31.9	41.5	16.8	21.1	33.8	40.0	38.5	34.5	37.3	76.0	42.9	51.0	43.3	28.4	44.9	43.7	53.1	30.7	28.9	23.3	18.3	36.3	50.6	81.7	49.2	31.8	32.1	54.9	35.6	69.3	18.5	30.3	37.0	51.6	40.7	27.9	21.4	46.1	32.5	39.9	32.7	45.2	46.9	30.2	57.3	40.4	91.5	57.5	41.4	74.8	114.8	15.2	10.6	13.1	9.6	68.3	64.0	16.6	15.8	35.8	12.3	14.5	5.3	37.4	3.0	5.3	27.1	23.1	12.2	10.7	18.2	10.6	59.8	10.0	10.5	18.0	8.1	17.6	8.9	52.1	46.0	32.9	11.3	14.4	43.7	37.6	10.1	4.6	28.7	29.8	8.8	9.7	11.8	3.4	35.6	10.0	8.6	12.0	28.0	60.7	25.7	3.3	8.7	15.7	17.1	20.6	13.5	11.3	14.3	36.7	8.2	6.5	20.7	17.1	25.8	36.1	5.6	27.2	22.4	13.2	81.4	57.5	91.5	52.3	51.4	40.1	57.3	73.9	66.5	40.4	43.9	63.1	66.2	24.0	41.4	43.0	25.6	74.8	114.8	44.0	48.5	32.9	62.1	42.9	51.0	53.1	30.7	81.7	46.1	163.8	103.0	121.2	73.7	64.7	192.5	338.6	84.1	117.8	116.0	89.0	176.7	275.4	21.6	231.6	8.1	130.0	85.8	70.0	188.9	320.0	170.5	132.5	322.8	62.5	267.8	116.0	40.4	118.4	223.5	12.7	191.8	306.3	258.1	527.6	54.0	207.9	194.4	84.2	246.1	66.8	224.8	187.5	100.4	8.1	2.5	64.5	149.2	256.0	66.9	73.3
ARL6IP6	MGC33864	ENSG00000177917	"ADP ribosylation factor like GTPase 6 interacting protein 6"	Q8N6S5	2	152717893-152761253	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.7"	"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 127.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 50.7;eosinophil: 45.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 50.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014743	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane"	Cytosol	"HPA014743: AB_1845030"	"unprognostic (4.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (5.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.57e-1)"	"unprognostic (7.39e-2)"	6.1	5.1	8.4	4.2	10.1	14.5	9.4	6.6	11.4	4.7	5.7	10.1	7.9	6.5	5.6	2.5	7.8	5.1	5.6	3.2	11.4	4.9	3.3	2.3	7.2	7.2	15.9	7.4	6.9	3.3	2.6	8.3	10.2	12.9	4.6	4.1	3.4	4.9	4.8	9.7	8.2	6.1	4.7	12.4	8.7	6.0	7.3	13.5	2.5	4.1	4.6	5.4	6.3	18.9	5.7	7.4	50.7	3.5	2.6	5.6	3.6	8.3	5.1	12.5	3.5	3.1	3.8	19.4	10.2	4.1	8.6	10.8	13.5	12.2	14.7	10.3	4.3	4.1	9.6	6.6	4.5	8.9	23.0	14.0	12.0	5.1	12.0	4.2	9.9	11.3	2.8	5.3	9.3	7.5	3.3	6.4	11.0	13.3	9.5	6.6	6.0	10.2	10.7	12.1	2.6	11.6	11.8	12.4	11.8	3.6	6.2	11.0	11.8	9.3	0.9	8.1	4.5	4.2	7.5	8.8	13.7	9.3	9.5	8.9	9.1	9.1	11.9	6.6	8.5	11.2	50.7	2.8	45.4	4.1	3.0	4.2	5.7	4.2	4.1	3.2	4.9	4.3	3.7	7.5	2.6	3.5	7.4	5.6	3.6	8.4	10.1	6.6	11.4	11.4	4.9	15.9	7.4	12.9	13.5	14.9	10.6	31.2	40.7	94.6	5.6	3.9	20.4	17.4	15.9	10.4	3.9	127.9	14.9	23.8	9.4	27.2	12.3	0.0	16.4	114.2	39.0	25.6	26.5	4.7	35.6	7.9	13.3	21.5	27.9	14.2	18.1	34.9	43.9	56.9	21.6	17.2	18.4	17.5	15.9	7.7	14.7	32.3	26.0	21.3	24.3	93.2	90.6	45.0	22.6	48.9
ARL9		ENSG00000196503	"ADP ribosylation factor like GTPase 9"	Q6T311	4	56505209-56525481	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;testis: 12.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 81.2;Late spermatids: 192.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;REH: 8.7;SCLC-21H: 9.2"					"Low region specificity"	"Detected in all"			HPA072942	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA072942: AB_2686561"	"unprognostic (9.91e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.79e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	1.3	1.1	4.4	0.8	4.9	3.4	2.0	1.5	7.1	1.3	1.3	0.6	2.4	1.0	2.0	1.1	1.1	1.2	2.4	0.8	3.9	3.2	0.5	0.5	0.6	1.0	1.3	2.9	3.0	0.4	0.4	1.6	0.3	8.7	2.2	1.0	1.9	0.9	3.8	0.4	4.1	1.0	3.7	2.5	0.8	1.0	12.6	0.6	0.1	1.1	1.2	0.7	1.5	2.5	2.1	2.2	1.6	0.4	1.4	1.4	0.1	0.0	0.5	0.6	0.5	1.2	2.9	0.1	0.9	0.5	2.1	2.1	0.5	0.7	0.7	0.0	1.5	0.1	0.2	0.4	0.2	1.2	0.1	0.1	0.3	0.0	0.1	2.8	0.3	0.7	4.4	0.7	1.9	0.4	0.4	2.1	0.2	0.2	0.9	2.0	0.0	0.3	0.1	2.2	0.1	1.3	8.7	0.0	0.1	0.1	0.3	9.2	0.1	0.3	0.4	0.2	0.2	0.2	0.1	0.4	0.3	0.4	0.0	0.1	0.4	0.4	0.4	0.1	0.0	0.3	0.8	0.4	0.4	0.7	0.4	0.4	1.0	1.2	1.0	0.3	2.1	1.4	0.6	1.6	1.4	0.4	2.2	1.0	0.1	4.4	4.9	1.5	7.1	3.9	3.2	1.3	2.9	8.7	0.6	0.0	1.4	0.0	0.8	5.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	81.2	0.2	0.0	0.0	0.2	0.1	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.3	192.4	1.4	0.0	5.0	0.0	0.3	1.0	0.6	0.0	1.1	0.3	0.0	0.0	0.2	12.2	0.9	1.4	0.0	0.0	0.4	0.3
ARMC1	"Arcp, FLJ10511"	ENSG00000104442	"Armadillo repeat containing 1"	Q9NVT9	8	65602456-65634217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026085	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA026085: AB_1845031"	"prognostic unfavorable (4.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (8.18e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.66e-1)"	16.2	16.5	25.5	13.1	25.6	11.5	19.2	30.4	32.3	17.1	19.0	22.6	10.2	15.8	19.7	17.8	17.7	14.1	12.3	21.6	26.9	24.0	22.9	23.5	12.6	18.1	24.5	18.7	20.4	15.2	18.4	18.9	16.7	27.1	19.2	17.6	13.1	15.1	18.8	22.2	11.6	15.3	22.5	27.5	15.0	14.5	10.0	18.9	20.7	15.4	10.4	20.0	20.4	14.0	8.8	6.1	20.7	7.9	9.6	10.5	5.8	22.7	16.3	15.9	14.8	15.8	14.5	11.6	20.5	15.3	21.8	16.1	11.9	18.5	35.5	5.2	18.5	23.7	15.3	28.4	16.5	29.7	20.1	14.8	27.5	10.4	17.3	21.1	10.3	15.0	13.2	19.1	17.9	24.7	17.2	22.3	25.3	28.3	25.3	23.3	14.6	38.1	13.6	16.5	28.5	18.1	22.2	19.9	12.5	17.2	10.8	11.8	12.8	12.9	16.4	19.3	16.9	26.3	12.2	13.2	20.7	15.2	15.6	19.1	18.8	19.8	24.0	19.6	19.3	20.0	20.7	4.8	6.1	7.6	7.9	10.5	8.8	9.1	9.1	6.1	6.8	9.4	9.3	0.6	9.6	7.2	5.3	9.5	5.8	25.5	25.6	30.4	32.3	26.9	24.0	24.5	18.7	27.1	18.9	38.7	20.1	24.4	9.6	14.1	23.1	28.3	12.7	16.0	27.3	15.7	21.6	29.7	46.4	22.5	6.2	16.3	15.7	23.3	24.4	37.1	21.1	14.3	10.4	21.3	22.4	19.1	22.4	26.4	15.1	4.3	24.2	16.9	20.3	28.9	18.5	44.1	23.2	10.5	31.5	32.1	20.5	6.5	25.5	31.8	21.7	16.2	31.5	20.1	21.7	7.6
ARMC12	"C6orf81, FLJ25390"	ENSG00000157343	"Armadillo repeat containing 12"	Q5T9G4	6	35737032-35749079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 60.2"	"Group enriched"	"Detected in some"	65	"Early spermatids: 374.1;Late spermatids: 785.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 7.3;HSkMC: 9.7;MOLT-4: 6.6;U-698: 7.2"	"Not detected"	"Not detected"							"HPA030895, HPA075457, HPA075777"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA030895: AB_10602114, HPA075457: , HPA075777: "	"unprognostic (1.94e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.52e-2)"	"unprognostic (6.36e-4)"	"unprognostic (8.99e-2)"	"unprognostic (1.17e-12)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.09e-1)"	0.5	0.4	0.9	0.5	1.2	0.7	0.7	0.5	0.9	0.6	0.5	0.5	0.5	0.0	0.5	5.8	0.5	0.6	0.8	0.5	0.7	0.9	0.5	1.4	0.5	1.1	0.7	0.5	1.0	0.5	0.1	4.8	0.5	0.5	1.1	0.3	0.6	0.5	1.0	0.5	0.5	0.5	0.6	0.5	0.8	0.1	60.2	0.5	0.5	0.7	0.5	0.6	0.5	0.5	0.1	2.9	0.0	1.0	0.2	3.2	0.4	0.0	0.5	3.2	3.8	7.3	3.4	0.0	0.1	0.2	0.3	0.4	0.1	0.2	0.7	0.1	0.1	1.1	0.1	1.1	0.2	0.2	1.6	0.9	0.4	0.1	0.1	3.8	0.0	0.0	9.7	2.3	0.1	1.3	3.7	0.7	2.8	0.1	4.5	1.1	0.4	6.6	0.8	0.5	0.0	0.2	3.0	0.0	0.0	0.8	0.0	0.9	3.2	0.0	0.0	0.5	1.5	2.0	0.3	0.0	0.6	0.3	0.1	0.0	1.0	0.3	7.2	0.3	4.0	0.3	0.0	1.0	0.0	0.1	0.0	1.2	0.0	1.2	0.5	0.7	0.1	0.7	3.2	0.0	0.2	0.1	2.9	0.0	0.4	0.9	1.2	0.5	0.6	0.7	0.9	0.7	0.5	0.5	0.5	0.0	0.0	0.0	1.7	0.8	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	374.1	0.6	0.0	0.0	0.0	0.0	0.4	0.5	0.0	2.4	0.0	0.0	0.0	0.0	1.6	785.6	7.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	3.9	0.1	0.1	0.0	0.5	8.9	5.4	0.1	0.0	0.0	0.0	0.3
ARMC2	"bA787I22.1, DKFZp434P0714"	ENSG00000118690	"Armadillo repeat containing 2"	Q8NEN0	6	108848416-108974472	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.8"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 88.3;Early spermatids: 89.1;Late spermatids: 112.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA025809, HPA053696"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025809: AB_1845032, HPA053696: AB_2682233"	"unprognostic (4.42e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.19e-5)"	"unprognostic (7.55e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.38e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	6.0	5.2	13.3	5.6	19.6	7.8	7.3	9.6	14.7	7.4	4.2	7.9	2.1	2.0	8.2	11.9	3.7	21.5	5.4	9.4	12.2	7.0	4.6	2.8	8.8	4.0	4.0	11.8	6.1	3.3	9.9	20.0	7.0	16.7	4.4	4.9	5.7	3.8	5.2	3.7	5.3	3.5	4.4	6.3	5.8	4.9	31.8	7.1	2.4	11.0	2.8	4.3	4.0	5.0	2.7	4.6	9.5	4.7	4.8	7.0	1.6	3.4	2.1	10.3	6.5	5.1	6.4	2.3	2.1	2.9	5.4	7.2	3.1	3.1	5.4	2.7	3.4	8.3	3.0	5.6	4.2	9.4	1.5	4.8	5.1	4.7	3.2	2.8	7.8	2.3	7.3	5.9	6.2	1.8	7.2	5.0	16.6	2.1	8.4	5.5	2.6	6.7	7.1	3.2	3.3	2.6	7.7	8.5	4.4	4.9	4.1	14.4	5.3	7.3	1.9	5.1	6.0	3.7	4.0	2.5	4.6	2.4	3.8	2.8	3.9	5.2	4.6	7.8	5.5	5.7	4.3	3.5	0.9	3.4	4.7	3.2	1.4	2.7	3.7	2.8	2.7	1.6	3.9	9.5	4.8	3.7	4.6	7.0	1.6	13.3	19.6	9.6	14.7	12.2	7.0	4.0	11.8	16.7	7.1	8.9	3.0	0.0	1.1	0.9	1.5	4.3	2.5	88.3	18.2	0.0	0.0	1.3	0.0	0.8	89.1	1.2	0.0	0.0	0.8	1.7	1.3	0.8	0.0	0.2	3.2	1.6	1.7	0.6	3.7	112.4	6.4	1.3	5.0	0.0	0.3	1.8	0.7	0.0	9.6	1.2	5.2	0.0	2.3	27.6	5.5	1.3	0.5	2.9	0.5	0.7
ARMC5	FLJ13063	ENSG00000140691	"Armadillo repeat containing 5"	Q96C12	16	31458080-31467166	"Disease related genes, Predicted intracellular proteins"			"Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041524, HPA063706"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA041524: AB_10796676, HPA063706: AB_2685098"	"unprognostic (1.37e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.14e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.97e-6)"	"unprognostic (4.70e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	8.3	8.1	6.6	8.1	11.6	35.3	8.4	13.1	13.6	5.3	5.7	7.8	5.5	9.7	9.1	6.0	8.4	7.1	4.9	6.6	8.4	7.5	6.7	16.1	8.4	7.3	8.9	5.4	8.6	9.3	9.2	9.4	7.3	9.1	7.2	2.9	6.5	10.4	5.8	14.2	13.2	8.3	4.5	5.9	8.6	8.0	6.0	8.9	6.8	9.9	6.8	5.3	5.1	16.8	4.0	10.0	2.8	3.1	9.8	4.9	3.2	2.9	4.7	2.1	3.0	1.3	1.0	5.3	3.9	1.7	2.3	1.9	4.4	3.1	2.9	8.2	2.2	2.3	4.5	2.4	3.5	0.4	4.1	6.0	1.3	7.1	10.1	2.5	8.8	8.9	2.4	4.0	2.3	0.6	2.6	3.5	4.9	6.5	7.1	1.6	7.4	3.3	35.4	3.3	1.3	3.0	5.9	3.0	10.8	1.7	3.5	6.7	5.9	3.6	4.9	2.7	1.3	3.2	10.5	6.5	5.0	3.7	2.0	3.2	6.5	5.6	1.8	3.3	7.4	3.5	2.8	3.1	0.9	4.9	1.6	4.1	4.0	3.8	3.8	4.1	3.5	3.4	3.8	1.8	9.8	1.7	10.0	4.6	3.2	6.6	11.6	13.1	13.6	8.4	7.5	8.9	5.4	9.1	8.9	6.0	14.7	4.5	7.9	5.8	3.9	5.6	10.2	1.4	7.9	0.0	5.9	6.2	3.3	4.7	1.0	8.5	10.3	0.0	4.0	4.6	5.8	5.6	9.2	23.6	5.3	12.7	7.5	6.2	4.8	0.0	4.0	3.0	1.7	2.8	5.2	6.8	3.3	3.6	5.3	3.7	5.2	0.0	6.4	3.9	6.1	5.5	9.6	5.0	3.8	4.8
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing, X-linked 1"	Q9P291	X	101550531-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.9;ASC TERT1: 24.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;LHCN-M2: 24.4;RH-30: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000268, HPA005685, CAB020695"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			Mitochondria	"Nucleoplasm, Cytosol"	"CAB020695: , HPA000268: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	17.5	29.8	13.6	7.4	16.5	2.7	18.9	13.4	21.5	24.4	18.7	9.6	15.9	6.2	27.3	19.0	12.3	16.3	14.8	26.6	13.3	18.4	12.1	3.8	11.6	4.4	13.7	14.6	42.6	10.2	20.1	18.0	12.5	16.4	25.8	7.0	13.0	12.0	21.1	22.7	8.1	7.6	26.3	9.1	11.4	10.0	8.1	10.5	3.5	14.0	11.6	3.3	26.8	29.7	0.2	9.9	0.5	4.3	2.1	3.7	2.1	0.7	0.2	5.6	0.0	26.9	24.2	0.0	8.7	17.2	11.0	27.8	0.0	0.1	0.0	7.5	13.4	12.1	0.7	0.0	1.2	6.2	0.0	0.0	5.0	1.7	0.0	14.2	0.0	0.0	20.2	1.7	8.3	0.0	9.1	6.6	0.0	0.1	0.1	24.4	0.3	0.0	0.0	8.0	0.0	0.0	0.0	30.8	0.0	7.5	0.0	5.5	4.6	0.0	0.1	15.0	1.6	0.9	3.7	8.7	6.7	3.5	19.4	0.1	0.0	0.1	0.0	6.5	0.0	4.1	0.0	4.3	0.5	0.0	3.9	0.7	0.0	0.6	0.3	9.9	0.2	1.5	3.7	0.1	2.1	1.1	5.1	0.9	2.1	13.6	16.5	13.4	19.9	13.3	18.4	13.7	14.6	16.4	10.5	23.8	6.1	0.0	23.8	29.5	26.3	54.8	7.6	5.3	5.7	22.7	5.9	1.4	11.6	14.6	0.3	23.2	0.5	0.0	6.0	2.1	52.1	21.0	24.2	0.4	23.6	20.6	5.2	17.8	9.4	0.9	43.7	11.0	55.6	6.4	1.0	31.1	7.5	0.0	41.8	11.4	13.3	45.3	48.4	1.7	0.7	19.1	2.2	1.0	0.6	7.4
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing, X-linked 2"	Q7L311	X	101655281-101659891	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 92.7"	"Cell type enhanced"	"Detected in many"	7	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	7.7	21.5	12.5	6.7	19.9	1.0	14.2	17.6	17.5	17.1	11.4	8.2	38.8	3.7	18.4	92.7	6.2	16.7	12.5	18.8	13.2	17.1	13.3	2.6	8.3	4.9	11.8	13.3	28.8	9.8	34.1	38.9	15.4	12.4	17.6	5.3	9.7	23.6	41.8	3.8	3.2	6.2	19.3	9.0	10.9	8.3	6.3	10.7	1.4	35.1	3.6	4.3	13.9	18.9	7.6	1.6	0.0	1.4	4.3	4.4	1.9	0.0	0.0	14.9	0.1	13.3	12.1	0.1	16.3	20.5	0.4	0.4	0.0	6.3	0.0	0.0	21.4	0.0	0.4	0.0	0.3	0.1	0.0	0.5	0.0	17.5	0.0	14.1	0.1	0.0	19.1	5.2	12.8	0.1	20.2	17.3	0.0	0.0	0.1	48.1	0.0	0.0	0.2	34.7	0.9	0.1	4.0	26.6	0.0	0.8	0.0	6.0	11.1	0.0	0.0	0.4	27.9	7.6	0.0	3.8	18.4	19.6	11.5	0.1	0.0	0.0	0.0	16.8	0.0	0.3	0.0	0.7	0.0	1.6	1.4	0.7	5.1	1.5	1.5	1.1	7.6	4.2	4.4	0.0	4.3	0.9	1.6	0.9	1.9	12.5	19.9	17.6	17.5	13.2	17.1	11.8	13.3	12.4	10.7	14.9	5.4	4.4	13.8	3.8	11.2	22.2	7.6	2.7	15.9	31.4	7.9	1.0	3.3	8.0	0.1	13.0	0.0	0.0	1.8	0.4	20.2	13.8	2.3	0.4	3.6	1.6	8.7	16.0	2.1	0.4	22.5	4.0	5.0	11.8	2.2	7.0	3.1	0.0	23.0	4.2	9.7	58.2	26.4	1.4	1.1	2.6	4.2	2.5	1.2	6.2
ARMCX3	"ALEX3, GASP6"	ENSG00000102401	"Armadillo repeat containing, X-linked 3"	Q9UH62	X	101622797-101627843	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000325, HPA000967, HPA001530"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349"	"unprognostic (1.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.23e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-2)"	21.0	39.2	26.6	14.8	32.9	8.5	20.5	20.5	36.9	30.6	18.8	21.0	37.1	13.3	26.9	67.8	12.7	17.1	22.0	31.7	28.0	26.6	24.0	17.8	19.1	12.7	27.8	29.6	26.7	38.2	62.0	37.9	28.5	35.4	29.1	14.8	13.6	34.8	31.6	25.5	7.9	13.8	24.6	25.7	24.1	19.0	9.2	22.8	8.2	31.9	17.1	13.7	21.4	21.3	11.6	18.8	25.2	11.8	10.2	14.8	9.4	8.8	6.0	16.4	9.1	37.8	42.2	3.7	19.5	18.8	8.6	24.9	7.1	8.2	3.4	11.2	22.7	17.5	1.7	12.3	7.1	10.5	6.7	7.8	6.3	20.4	10.2	30.0	6.1	15.0	23.3	9.6	10.3	11.1	21.6	16.2	3.8	4.8	30.2	23.3	3.9	5.0	0.2	8.3	16.2	1.3	6.4	21.4	3.0	12.0	3.7	7.6	6.5	9.4	0.6	20.2	23.8	7.1	6.3	22.7	11.4	7.4	25.7	3.8	24.5	6.6	0.0	17.3	4.9	9.6	25.2	11.2	9.5	10.9	11.3	14.8	11.6	10.8	9.5	11.3	7.9	12.2	8.5	4.1	10.2	11.8	18.8	6.6	9.4	26.6	32.9	20.5	36.9	28.0	26.6	27.8	29.6	35.4	22.8	41.7	29.7	51.4	69.7	33.7	60.9	87.7	56.0	14.7	34.2	71.5	55.0	47.1	31.5	41.8	0.5	61.9	17.9	46.7	26.6	17.4	93.4	96.0	76.3	43.1	44.4	58.8	78.9	51.5	46.4	1.1	59.8	60.8	92.8	22.6	46.0	98.2	30.2	24.6	68.2	33.5	12.2	32.3	93.7	1.9	0.4	18.7	96.1	34.6	28.6	71.5
ARMCX4	"CXorf35, GASP4, MGC40053"	ENSG00000196440	"Armadillo repeat containing, X-linked 4"		X	101418287-101533459	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"parathyroid gland: 10.8"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 24.7;Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000429, HPA051930"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000429: AB_1078210, HPA051930: AB_2681665"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.81e-3)"	"unprognostic (7.28e-2)"	"unprognostic (3.67e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.29e-1)"	"prognostic favorable (8.20e-5)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.92e-2)"	1.5	4.6	1.9	0.8	2.7	0.3	2.9	3.2	5.7	2.4	1.7			0.6	4.0	2.8	0.7	2.8	1.1	1.2	2.0	2.9	1.2	0.5	1.5	0.5	1.9		8.5	1.4	10.8	4.3	1.6		4.1	1.6		1.2	5.7	1.6	2.1	1.5	2.8	1.4	1.3	1.3	0.4			2.4		0.5	2.1	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	2.3	0.6	8.2	0.0	4.0	4.2	0.8	5.6	4.4	4.6	9.0	1.9	0.8	0.0	2.2	8.3	0.1	1.0	0.0	0.1	7.6	0.0	0.9	0.6	2.3	0.0	2.3	0.0	3.1	2.6	0.4	10.0	0.0	0.0	8.0	0.0	0.0	0.7	2.0	0.0	0.3	0.3	6.0	0.8	0.0	0.4	6.8	0.0	1.2	1.4	5.6	5.1	0.8	0.0	3.0	1.4	0.6	1.2	3.0	2.1	1.3	6.4	0.0	0.0	0.0	0.0	3.9	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0											3.0	5.0	0.5	6.3	2.2	24.7	8.7	0.0	14.7	11.4	26.2	7.9	1.4	14.9	2.2	0.2	7.7	2.6	0.0	2.0	0.6	7.0	8.5	3.5	2.1	2.0	22.3	2.9	4.3	4.6	0.4	9.8	2.0	16.9	2.8	2.7	10.8	2.1	3.5	11.7	4.4	7.4	0.0	11.4	1.0	1.2	3.0	1.3	1.8	3.6	3.9
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing, X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.6	13.2	11.4	7.0	17.3	6.4	13.8	24.3	19.8	11.2	9.5	8.7	13.1	7.9	13.3	12.5	10.1	11.9	7.5	7.8	11.1	6.3	10.0	15.5	8.3	6.9	8.1	12.9	16.5	25.3	14.5	26.4	6.1	12.8	16.6	11.9	9.2	13.4	11.0	6.1	9.9	10.4	10.8	7.0	10.2	11.7	6.1	8.4	9.5	15.3	7.0	9.6	10.4	9.8	9.7	9.3	2.5	9.8	7.1	15.9	8.5	8.1	7.3	17.4	9.2	7.8	8.8	9.8	8.0	6.2	9.4	16.7	8.7	10.1	0.0	9.8	8.0	10.7	7.1	15.5	7.6	10.7	0.0	6.2	8.2	9.3	7.2	10.1	14.9	9.6	10.9	9.9	8.1	9.8	7.6	9.5	0.0	7.9	0.0	12.4	7.2	10.5	1.8	7.8	14.0	14.0	10.4	42.6	0.0	7.0	11.3	8.3	7.4	14.3	7.5	11.4	5.2	5.1	7.2	9.6	7.0	6.2	7.9	5.7	0.0	5.8	0.0	5.5	15.2	17.9	0.0	9.5	2.5	12.0	9.8	11.5	9.7	11.3	9.4	9.3	6.0	15.9	12.3	0.8	7.1	6.0	8.1	7.7	8.5	11.4	17.3	24.3	19.8	11.1	6.3	8.1	12.9	12.8	8.4	6.0	5.8	4.7	10.7	4.9	16.0	3.5	5.1	17.4	9.1	8.7	19.6	4.9	18.3	7.9	0.2	7.2	7.4	0.0	8.5	3.0	5.2	9.0	1.1	8.3	5.4	1.6	9.2	6.2	7.3	0.0	7.8	6.7	8.5	1.8	11.4	6.2	7.8	2.9	5.6	9.1	19.3	0.0	6.2	1.7	6.1	5.0	3.1	6.2	8.6	9.4
ARMCX6	"FLJ20811, GASP10"	ENSG00000198960	"Armadillo repeat containing, X-linked 6"	Q7L4S7	X	101615118-101618001	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043030, HPA048125"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear membrane"	"HPA043030: AB_2678277, HPA048125: AB_2680275"	"unprognostic (1.20e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.38e-2)"	15.1	17.2	11.7	12.1	12.1	7.6	12.7	10.9	12.1	18.7	12.0	15.4	22.6	6.7	17.3	25.9	17.3	14.1	12.4	15.6	11.3	12.6	14.1	12.2	11.2	12.1	13.1	10.3	21.3	27.2	23.4	21.0	16.3	13.1	17.7	9.0	11.8	39.2	23.5	6.5	11.3	10.4	17.1	16.7	22.6	10.6	9.0	11.4	17.9	17.3	9.7	19.3	18.8	13.7	12.8	14.1	10.0	7.0	8.1	8.7	6.4	6.6	7.9	12.4	7.0	25.4	15.1	2.4	14.1	13.7	12.6	24.7	4.8	6.5	7.1	14.4	13.2	13.2	7.0	12.0	5.7	9.9	6.1	7.3	6.7	11.0	6.3	11.7	6.5	8.4	9.4	5.8	7.7	4.0	17.6	12.8	3.7	5.5	9.2	18.9	16.4	9.5	0.0	8.9	8.7	1.6	9.8	16.6	2.6	9.1	0.9	6.8	6.4	8.2	0.0	10.5	9.9	5.8	3.1	9.9	15.4	6.9	21.4	3.2	11.4	6.1	0.0	4.6	1.7	5.0	10.0	3.8	6.3	6.5	7.0	8.7	12.8	7.0	7.3	8.1	9.1	8.4	7.8	0.5	8.1	5.0	14.1	3.9	6.4	11.7	12.1	10.9	12.1	11.3	12.6	13.1	10.3	13.1	11.4	8.9	7.8	28.4	14.8	11.8	4.8	8.1	12.7	1.4	6.8	29.6	15.7	31.9	19.9	36.6	0.4	25.1	3.1	0.0	24.2	14.6	30.1	15.7	13.9	13.4	60.4	9.5	15.7	23.4	19.6	1.3	17.3	28.6	35.4	30.7	15.5	28.2	25.6	14.0	18.7	17.2	4.1	25.8	15.6	2.6	2.2	14.1	28.8	33.1	13.8	15.9
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		3200000	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	15.5	15.8	10.7	11.5	16.2	3.9	20.5	17.5	18.2	13.7	12.8	7.5	9.9	14.7	13.0	13.4	11.5	10.6	9.0	13.4	11.4	13.0	34.7	33.2	15.4	15.0	10.9	8.6	15.3	7.7	7.7	13.8	26.7	18.6	11.6	14.2	9.2	8.8	10.6	14.9	7.0	16.2	11.8	10.6	16.2	10.9	10.8	9.4	13.2	26.5	11.9	14.0	14.1	10.6	9.6	12.3	26.9	18.6	10.8	13.2	10.8	8.2	6.3	13.3	11.9	10.9	17.2	21.5	15.5	13.5	13.0	17.3	16.4	6.8	12.3	10.4	10.9	11.9	8.4	39.3	11.6	22.0	13.6	12.3	8.9	7.5	19.0	13.6	16.6	11.2	13.8	8.2	17.4	10.3	10.8	18.4	9.3	12.7	15.9	16.2	34.3	10.4	16.0	22.7	8.1	5.3	13.8	11.5	9.7	39.8	10.5	5.5	3.6	12.9	12.2	7.9	24.9	34.6	13.1	15.2	6.4	8.9	23.5	12.3	7.4	9.3	14.7	11.3	20.6	7.4	22.8	14.7	26.9	7.8	18.6	10.3	9.6	10.2	8.3	12.3	7.1	9.5	8.7	12.2	10.8	16.6	4.6	13.2	10.8	10.7	16.2	17.5	18.2	11.4	13.0	10.9	8.6	18.6	9.4	23.8	36.8	8.9	7.0	0.0	8.9	16.5	7.6	20.1	11.4	22.7	7.9	26.6	38.1	17.4	0.9	7.7	12.9	23.3	15.6	32.5	8.4	5.6	3.5	43.3	30.5	7.9	4.7	17.2	35.4	2.3	17.8	24.7	0.0	31.5	10.6	14.5	16.3	7.0	13.8	56.4	19.8	0.0	13.7	18.9	17.0	0.0	30.1	12.8	13.8	8.4
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325910-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		2400000	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	36.6	39.8	40.2	25.2	41.0	18.7	49.1	32.3	55.9	40.0	43.6	32.3	37.9	50.1	30.4	45.9	58.3	43.3	32.1	65.3	45.9	43.5	30.6	41.2	29.6	32.2	38.6	39.7	47.2	41.9	30.9	31.4	31.8	40.6	28.2	44.2	33.9	31.7	36.7	20.9	46.1	55.0	31.9	27.9	26.8	53.1	28.6	25.1	23.7	44.4	41.8	31.6	31.5	33.9	11.1	16.1	33.2	29.1	10.9	12.6	9.9	45.5	24.8	28.2	12.9	26.3	44.9	24.0	32.8	38.5	33.4	33.4	27.8	52.6	16.0	48.5	39.7	49.5	19.4	37.0	47.5	40.5	7.9	31.1	8.5	18.5	22.4	29.0	10.0	11.2	41.7	26.6	43.1	46.0	39.7	54.7	13.2	21.3	18.5	51.3	66.6	16.8	13.4	26.5	51.0	56.2	9.9	19.5	19.5	24.8	27.7	29.2	24.9	32.1	46.1	43.6	49.9	23.0	14.8	42.4	42.9	38.4	75.5	52.2	7.2	13.3	22.7	37.0	22.6	56.2	33.2	18.9	31.9	9.8	28.6	7.6	11.0	9.3	12.6	16.1	11.1	12.1	9.1	23.8	10.9	29.1	11.7	12.1	9.9	40.2	41.0	32.3	55.9	45.9	43.5	38.6	39.7	40.6	25.1	47.6	40.3	44.7	107.8	36.9	36.8	41.2	86.6	64.3	34.2	55.8	17.7	167.1	114.4	166.9	15.6	83.7	206.9	116.8	242.7	281.6	45.8	130.5	12.7	70.0	73.9	31.8	71.2	92.1	68.9	20.6	61.9	41.2	75.9	60.5	155.3	53.9	324.8	150.8	63.3	116.3	29.0	181.1	159.3	117.8	120.8	41.9	108.5	26.7	144.4	216.4
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635757	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 154.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		15000000	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	46.6	25.1	24.9	57.5	24.3	25.2	28.9	13.8	24.8	26.6	42.3	26.5	18.6	40.8	39.0	26.7	44.5	29.3	24.6	36.8	28.2	22.3	28.8	29.7	52.3	58.3	28.4	18.7	27.3	21.5	12.4	18.2	84.8	20.0	23.2	29.2	17.0	25.4	16.5	16.4	25.2	47.3	32.8	46.0	79.9	35.6	21.7	23.5	61.2	27.5	22.7	52.8	30.6	30.8	27.4	68.9	154.0	96.6	30.7	40.7	124.3	51.8	28.8	24.8	17.0	20.5	29.3	59.3	71.3	55.0	31.1	25.4	26.0	36.8	47.7	81.2	41.0	20.1	36.1	17.4	24.3	16.5	68.7	15.6	28.8	39.2	22.4	33.4	41.8	56.3	35.4	25.9	37.6	29.9	35.7	36.4	33.8	21.9	39.6	40.2	21.3	39.0	11.3	23.6	40.3	11.1	36.3	22.0	46.0	17.4	26.9	10.8	28.9	74.3	32.1	27.6	27.1	32.2	37.4	81.1	45.4	23.6	50.8	68.6	47.2	52.1	32.7	35.8	30.2	34.9	79.3	80.0	124.1	34.8	89.8	27.7	27.4	34.2	35.5	68.9	24.4	37.1	37.6	154.0	30.7	96.6	32.5	40.7	124.3	24.9	24.3	13.8	21.1	28.2	22.3	28.4	18.7	20.0	23.5	348.4	174.9	170.6	139.1	221.2	29.2	25.0	142.7	81.7	120.6	78.5	13.7	419.1	140.9	316.3	26.2	168.2	202.4	0.0	245.8	625.6	206.8	137.2	247.7	72.7	547.8	36.5	193.8	182.3	533.2	18.6	116.5	649.2	241.3	607.8	124.2	50.0	287.4	192.9	172.5	110.5	24.5	239.3	277.9	83.0	95.6	214.0	166.8	309.6	117.5	206.4
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 2.8;Cardiomyocytes: 3.4;Early spermatids: 1.6;Late spermatids: 2.2"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 146.9"	"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 12.1"	"Cell line enhanced"	"Detected in some"		"JURKAT: 46.2;MOLT-4: 27.1;REH: 15.0;RH-30: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017303	Enhanced	Supported	Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		1.2	1.3	12.3	1.5	146.9	4.6	1.1	27.8	67.9	1.1	1.4	0.3	0.0	1.3	1.1	1.1	3.2	1.1	1.1	1.1	6.8	2.8	2.0	2.9	1.2	1.2	3.9	11.5	1.1	1.1	1.1	1.9	1.1	6.7	2.0	1.5	0.0	1.1	1.3	43.6	1.1	1.4	1.1	0.8	1.2	1.1	1.1	14.8	41.2	1.5	3.5	1.5	1.1	0.1	0.1	12.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.2	0.0	46.2	0.0	0.1	1.1	0.0	27.1	0.0	0.0	0.0	1.1	15.0	8.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	12.3	146.9	27.8	14.7	6.8	2.8	3.9	11.5	6.7	14.8	0.0	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ARRDC2	"CLONE24945, PP2703"	ENSG00000105643	"Arrestin domain containing 2"	Q8TBH0	19	18001132-18014102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.7"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053788, HPA074216"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053788: AB_2682262, HPA074216: "	"unprognostic (8.10e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.20e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.81e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.87e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.91e-4)"	"prognostic favorable (2.92e-4)"	26.7	5.3	10.4	12.5	34.6	39.3	27.7	3.2	19.5	10.9	9.6	28.3	7.3	6.9	7.6	4.7	8.1	8.5	13.1	8.5	14.1	8.2	10.7	9.8	22.6	19.0	47.5	9.0	4.9	6.2	18.7	5.7	8.1	20.1	10.1	7.2	6.0	15.3	11.6	60.7	9.4	13.3	6.7	16.8	18.7	12.1	3.2	32.9	10.5	14.3	4.9	19.1	9.3	11.3	5.9	3.1	3.7	6.3	7.2	16.0	4.7	5.8	10.7	0.2	5.4	4.5	4.1	4.2	3.4	9.8	2.9	2.9	2.4	11.6	11.0	9.8	2.9	4.7	4.0	4.3	3.1	2.3	7.1	6.3	8.4	8.3	3.3	4.1	6.3	12.4	4.4	5.0	3.3	5.1	5.4	4.9	7.1	9.6	0.3	2.7	9.1	4.8	17.5	1.3	13.2	17.7	28.3	0.1	8.2	4.2	5.5	2.6	2.6	5.6	5.7	5.7	0.9	3.4	16.3	10.4	5.0	3.9	16.9	4.3	0.8	0.0	12.4	8.1	24.2	3.9	3.7	6.3	3.7	4.0	5.2	2.8	3.9	6.7	5.1	3.1	5.9	16.0	8.4	2.4	7.2	5.4	2.0	5.0	4.7	10.4	34.6	3.2	19.5	14.1	8.2	47.5	9.0	20.1	32.9	14.9	16.2	24.9	14.4	5.7	0.4	6.2	53.5	16.0	7.9	8.7	0.0	0.6	1.7	8.3	0.7	27.0	6.6	0.0	5.6	7.1	7.8	19.7	26.5	5.4	16.7	0.0	17.7	15.4	24.0	1.0	4.4	39.6	5.0	8.2	8.7	0.9	10.8	7.8	7.1	0.3	0.4	12.9	14.6	0.5	3.7	6.1	1.0	20.8	5.2	23.1
ARSB		ENSG00000113273	"Arylsulfatase B"	P15848	5	78777209-78986087	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 17.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.2;monocytes: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037770, HPA037771"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA037770: AB_10671719, HPA037771: AB_10671720"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.57e-3)"	"unprognostic (9.88e-2)"	"unprognostic (6.54e-3)"	"prognostic unfavorable (3.42e-4)"	15.2	8.4	7.7	9.9	8.9	9.4	11.4	6.2	10.4	7.8	8.7	10.8	2.6	4.0	14.1	6.7	8.6	6.7	12.0	13.0	7.7	5.8	23.2	9.3	10.8	17.2	7.1	6.1	6.1	9.6	10.7	6.1	14.7	7.1	7.5	10.5	12.1	5.2	9.3	5.3	3.4	6.0	18.0	8.3	10.9	7.9	4.1	5.6	7.2	6.4	4.0	6.2	10.3	5.6	1.2	5.5	17.2	5.7	0.1	0.6	1.6	2.3	5.6	9.0	2.9	22.0	8.7	8.3	13.1	11.5	9.7	12.0	4.9	4.3	2.7	14.1	12.7	14.8	1.9	3.4	3.7	9.6	23.3	2.6	4.4	5.9	18.7	5.0	4.9	5.3	10.1	1.2	10.2	3.4	8.1	11.4	1.7	0.9	6.4	9.8	4.5	2.3	9.2	2.7	0.5	2.9	3.4	5.4	2.9	6.1	3.0	3.2	7.4	9.8	3.1	5.7	6.6	3.4	12.8	7.5	8.7	5.0	3.9	11.6	5.5	9.9	3.6	10.6	10.6	19.8	10.5	5.7	17.2	0.6	4.6	0.4	1.2	0.3	0.3	5.5	1.1	0.2	0.4	3.3	0.1	3.7	4.0	0.5	1.6	7.7	8.9	6.2	10.4	7.7	5.8	7.1	6.1	7.1	5.6	0.0	1.3	3.0	1.3	0.7	3.0	5.8	2.5	4.0	0.0	3.5	5.9	1.8	3.3	3.1	0.4	4.3	0.6	0.0	7.9	4.0	9.3	1.9	0.0	3.4	15.4	6.4	1.2	13.5	23.4	0.2	4.0	12.6	13.5	15.4	5.6	3.0	4.4	3.5	3.5	17.2	2.7	6.5	3.1	1.1	1.9	1.1	2.2	2.9	1.9	0.9
ARSD		ENSG00000006756	"Arylsulfatase D"	P51689	X	2903970-2929351	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 98.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 16.5"					"Low region specificity"	"Detected in many"			"HPA004694, HPA063835"	Approved		Approved	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"HPA004694: AB_1078221, HPA063835: AB_2685132"	"unprognostic (3.92e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (5.90e-3)"	"unprognostic (6.32e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.18e-2)"	"unprognostic (3.93e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.11e-3)"	8.1	5.6	3.7	10.1	3.5	2.3	14.2	3.2	5.0	14.7	15.4	5.8	27.4	11.9	8.9	19.2	9.3	16.6	16.8	8.7	5.7	3.6	34.1	23.8	13.1	11.3	3.1	3.3	13.0	48.1	8.5	3.9	16.2	8.7	11.5	8.5	7.8	15.8	30.9	1.6	5.9	22.3	12.0	4.5	5.7	19.5	5.2	3.3	1.8	12.9	5.6	7.1	12.4	6.9	2.1	6.3	5.7	8.5	3.0	2.6	3.2	4.4	7.9	2.2	10.2	9.2	5.3	0.1	2.6	4.7	1.1	0.7	0.5	15.3	0.0	16.5	5.1	12.2	0.0	0.4	1.3	1.0	0.1	0.0	0.0	0.0	2.5	5.1	0.0	6.1	8.4	4.2	2.3	2.4	7.5	7.6	0.0	0.0	0.0	5.0	10.8	0.0	1.1	1.8	13.7	3.3	1.8	0.0	0.1	8.2	0.1	0.0	5.7	3.5	4.2	2.6	5.9	11.3	8.5	6.9	0.0	0.3	0.8	1.2	0.1	0.0	0.0	7.5	5.3	5.8	2.1	8.5	5.7	2.6	7.1	1.0	2.1	1.3	2.0	6.3	1.4	0.3	1.5	1.5	3.0	2.7	4.4	0.4	3.2	3.7	3.5	3.2	5.0	5.7	3.6	3.1	3.3	8.7	3.3	17.9	31.3	2.9	10.8	4.4	4.1	4.8	73.9	25.4	26.1	41.8	0.0	17.6	16.6	29.9	0.6	10.5	39.2	0.0	46.6	19.9	5.8	19.0	16.1	98.3	16.2	0.0	65.3	8.6	12.1	0.7	5.8	11.7	13.5	13.6	55.8	5.4	36.6	35.1	6.3	22.8	1.0	6.5	5.3	1.2	3.0	6.4	21.7	4.3	57.7	14.3
ARSI	"FLJ16069, SPG66"	ENSG00000183876	"Arylsulfatase family member I"	Q5FYB1	5	150296343-150339307	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.2"	"Cell type enhanced"	"Detected in some"	19	"Basal keratinocytes: 10.8;granulocytes: 4.6;Melanocytes: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 9.5;HaCaT: 18.5;Hep G2: 11.4;hTEC/SVTERT24-B: 18.6;U-87 MG: 23.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA038386, HPA038398"	Uncertain		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA038386: AB_10669781, HPA038398: AB_2675995"	"unprognostic (6.08e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.77e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.39e-7)"	"unprognostic (7.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.19e-4)"	2.0	0.5	2.1	4.3	2.0	0.9	0.5	0.7	2.0	4.9	2.1	0.6	0.3	1.0	5.0	1.2	4.2	3.6	2.2	2.4	1.7	1.1	1.4	0.8	6.2	0.4	2.5	1.0	3.3	0.8	0.0	1.8	24.2	2.0	5.5	0.8	6.9	0.8	1.5	1.4	9.2	1.0	5.6	6.6	1.2	1.6	1.1	1.0	0.8	0.6	9.2	1.6	5.2	4.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	2.2	0.6	0.0	0.0	0.5	0.0	4.7	7.1	9.5	6.9	0.6	1.1	0.0	1.9	6.7	0.8	18.5	0.1	3.1	3.3	0.0	0.0	0.0	0.2	11.4	0.9	0.0	0.0	0.5	2.0	18.6	0.5	6.4	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.8	0.5	0.7	6.9	0.0	0.0	0.0	0.1	6.3	0.2	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	2.0	0.7	2.0	1.7	1.1	2.5	1.0	2.0	1.0	0.0	0.0	0.0	0.0	10.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.9	0.0	4.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	20.3	0.0	0.0	2.0	0.5	0.0	0.4	0.8	0.2	0.0	0.8	0.0	0.7	4.1	1.1	0.0	0.0	0.0
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555074-95605064	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	8.5	10.2	6.9	4.8	7.6	4.7	7.6	14.2	12.3	8.9	8.6	4.3	9.6	5.1	8.5	9.6	6.7	7.4	6.9	8.5	7.9	7.1	11.5	9.7	7.4	5.6	8.4	9.9	12.8	11.7	29.3	14.5	11.2	7.2	10.7	5.9	7.3	6.7	11.2	5.5	8.4	5.4	6.7	8.8	5.5	9.7	4.5	7.5	10.6	15.8	2.8	4.5	9.2	14.0	6.7	2.7	10.0	1.6	3.9	9.2	2.3	3.4	2.2	4.6	4.6	23.2	12.1	6.7	10.9	6.3	4.3	8.8	2.8	5.4	4.7	5.7	3.7	7.7	3.3	4.0	6.9	9.4	5.0	5.9	3.7	5.5	4.5	6.8	2.0	3.0	8.9	6.2	6.5	4.2	9.0	6.9	6.4	3.7	5.1	9.4	1.6	5.6	3.9	6.0	1.1	10.5	3.5	7.4	7.4	9.8	0.8	3.3	3.3	6.7	2.2	6.5	6.7	6.2	2.2	12.4	6.8	5.5	10.5	6.6	4.4	7.4	5.6	6.8	5.5	25.2	10.0	1.6	2.5	5.3	1.5	6.1	5.3	6.0	6.7	0.8	6.7	9.2	6.9	1.5	3.9	1.0	2.7	4.5	2.3	6.9	7.6	14.2	12.3	7.9	7.1	8.4	9.9	7.2	7.5	3.0	2.1	2.7	7.4	3.9	8.1	3.9	2.5	5.3	2.3	7.0	11.8	9.0	3.3	3.0	6.3	5.4	2.5	0.0	2.2	43.9	10.4	4.5	23.0	12.1	3.9	9.5	2.9	3.7	3.1	1.8	10.0	5.2	5.0	6.4	1.8	13.2	1.9	3.5	11.0	4.5	9.1	0.0	8.3	2.2	7.9	6.0	4.2	9.6	3.0	1.6
ART4	"CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (Dombrock blood group)"	Q93070	12	14825569-14843533	"Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8"	"Cell type enhanced"	"Detected in many"	20	"Erythroid cells: 93.5;Hepatocytes: 21.3;Ito cells: 55.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.2;HEL: 10.3;Hep G2: 6.1;HUVEC TERT2: 23.4"	"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"Low region specificity"	"Detected in single"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"	NA	NA		11000000	"Rods & Rings"		"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.7	2.0	0.2	1.7	0.2	2.4	2.1	0.2	0.2	1.4	1.3	0.1	1.9	0.0	1.1	3.7	3.1	1.9	6.1	10.1	0.2	0.2	6.6	33.7	2.1	17.0	0.2	0.0	1.3	1.9	0.0	0.4	17.8	0.3	0.8	0.2	0.0	0.7	0.4	1.9	0.5	0.8	1.5	0.2	17.8	0.5	1.4	0.0	0.1	4.6	1.3	1.3	1.3	1.2	0.6	0.6	1.4	0.4	0.6	1.3	0.3	0.0	0.0	0.2	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	6.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.4	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.6	0.5	1.3	1.4	0.6	0.2	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.6	0.0	0.8	0.2	1.8	1.4	12.7	0.0	0.0	1.8	11.8	0.1	0.0	0.7	0.4	2.8	0.0	93.5	1.8	1.4	1.9	0.1	0.0	21.3	0.1	0.0	0.0	55.3	7.5	0.0	1.7	0.6	1.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	12.6	6.5	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3
AS3MT	CYT19	ENSG00000214435	"Arsenite methyltransferase"	Q9HBK9	10	102869516-102901899	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 92.8;parathyroid gland: 30.0"	"Cell type enhanced"	"Detected in single"	20	"Club cells: 1.2"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AF22: 14.3;REH: 27.2;SH-SY5Y: 14.6;T-47d: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017856	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA017856: AB_1847420"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.02e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-10)"	"unprognostic (1.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	2.0	92.8	3.7	0.7	8.6	0.5	2.6	4.5	6.4	4.0	2.0	2.2	0.4	1.3	3.8	3.2	2.1	2.1	5.2	10.0	5.7	3.1	7.4	22.4	1.7	0.9	2.8	4.4	3.9	8.7	30.0	2.4	0.5	4.6	4.2	0.8	8.9	2.2	3.4	6.0	1.8	1.3	3.9	2.7	5.6	1.7	3.5	1.6	0.3	3.2	1.0	0.7	1.8	1.8	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	3.9	14.3	8.9	0.3	0.3	2.6	4.1	3.5	6.2	7.6	10.6	0.6	0.2	1.2	5.4	0.3	0.2	12.1	0.7	6.4	0.0	3.5	0.0	1.7	10.4	4.1	0.2	0.1	1.9	1.6	0.8	0.0	11.2	0.2	13.2	0.0	0.2	5.5	0.1	2.4	0.3	6.8	0.0	0.6	27.2	0.0	0.1	1.3	0.1	0.4	14.6	0.0	0.2	1.9	4.9	22.7	0.3	0.1	1.3	0.0	2.0	0.0	0.3	0.2	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.7	8.6	4.5	6.4	5.7	3.1	2.8	4.4	4.6	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASAH2		ENSG00000188611	"N-acylsphingosine amidohydrolase 2"	Q9NR71	10	50182778-50248610	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"intestine: 43.9"	"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 6.0;Muller glia cells: 10.2;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA061171	Supported		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA		1200000	"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (3.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	0.3	1.1	0.6	0.2	0.9	0.0	0.5	0.5	1.3	1.7	0.5			43.9	0.7	0.3	0.7	0.5	0.2	0.9	0.5	1.4	0.6	1.6	0.4	0.2	1.2		1.4	1.5	0.3	1.0	0.4		0.5	0.3		0.9	0.2	0.8	0.7	33.4	0.7	0.6	0.2	2.5	1.1			0.6		0.1	1.0	0.5	0.9	0.9	0.0	0.0	0.0	2.2	0.1	1.8	1.4	1.6	2.2	2.9	1.1	2.0	2.0	1.3	3.8	3.5	1.0	4.6	0.0	2.2	2.7	3.1	1.7	2.1	0.7	4.7	2.3	3.8	1.3	3.8	2.9	1.8	0.4	0.2	0.4	2.6	6.6	7.5	0.5	0.8	0.0	2.5	1.2	2.5	1.5	1.4	0.1	4.8	0.0	4.1	0.0	6.4	1.6	2.1	0.3	2.7	7.3	2.5	1.8	3.3	3.9	1.5	1.0	2.0	1.9	4.4	4.7	6.1	1.9	0.2	0.0	5.5	0.0	1.7	0.0	0.0	0.0	0.7	0.0	2.2	0.9	0.4	1.7	0.0	0.1	1.4	2.1	0.0	0.0	0.0	0.9	0.6	0.1											0.0	0.0	0.0	0.2	0.3	1.8	3.0	0.0	0.0	1.2	0.0	2.0	0.3	0.0	1.1	4.1	0.1	1.3	0.0	1.3	0.2	0.4	0.2	0.0	1.8	0.2	1.6	0.0	0.6	0.0	6.0	1.1	0.0	0.0	0.0	1.2	10.2	1.4	0.0	1.4	0.6	1.8	6.5	0.9	0.9	0.8	0.1	0.2	0.0	0.6	0.1
ASAH2B	"ASAH2C, ASAH2L, bA449O16.3, bA98I6.3"	ENSG00000204147	"N-acylsphingosine amidohydrolase 2B"	P0C7U1	10	50739318-50816495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"intestine: 27.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 19.2"									HPA061171	Supported		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (6.86e-3)"	"unprognostic (1.91e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	2.8	8.3	6.5	3.3	10.7	2.3	4.6	4.4	14.5	4.0	4.5	1.5	3.8	27.5	5.1	6.2	4.4	4.8	4.3	7.8	7.2	9.0	7.3	12.2	3.7	2.9	5.7	8.3	5.6	7.6	8.8	12.8	2.1	7.4	6.3	5.3	7.0	6.6	4.4	5.7	3.0	16.0	4.4	3.9	3.0	6.4	5.2	2.0	2.7	5.6	6.8	4.8	3.8	3.4	1.4	3.2	0.5	0.1	0.7	6.0	1.5	1.9	2.0	3.1	5.2	1.1	2.6	2.5	9.7	5.3	5.9	4.9	6.8	4.9	0.1	3.7	2.1	2.0	2.0	3.6	4.1	4.8	3.7	4.0	1.3	5.8	4.5	3.9	1.7	1.9	3.3	4.8	5.6	8.7	1.9	1.2	0.0	6.2	2.5	4.8	4.3	2.8	0.2	4.0	5.5	19.2	0.1	7.3	2.4	3.5	7.2	6.0	12.1	3.3	4.1	3.4	3.5	6.9	1.2	6.4	2.5	11.6	5.3	11.4	3.0	0.4	0.0	12.8	0.0	4.3	0.5	0.1	0.0	2.2	0.0	6.0	0.7	3.5	2.5	0.0	1.4	4.9	4.5	0.4	0.7	0.1	3.2	3.9	1.5	6.5	10.7	4.4	14.5	7.2	9.0	5.7	8.3	7.4	2.0	3.0	0.6	0.5	0.8	1.4	5.5	4.9	2.5	1.4	1.2	5.2	7.9	1.3	5.0	4.1	0.1	1.5	2.0	0.0	4.1	1.2	1.8	1.1	0.0	6.8	0.3	0.0	6.4	1.8	0.0	0.8	1.7	0.0	1.7	0.0	5.1	4.0	3.3	3.4	1.1	4.1	4.4	0.0	2.1	3.7	1.8	0.4	0.5	2.2	4.1	0.8
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443660	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Early spermatids: 156.9;Late spermatids: 319.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 13.0;monocytes: 6.6"	"Cell line enhanced"	"Detected in all"		"TIME: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		25000	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.63e-8)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	34.1	17.2	10.5	9.5	12.5	29.7	19.8	6.4	21.8	19.3	8.9	9.1	6.6	4.4	15.6	18.9	10.5	11.8	14.5	17.5	10.0	11.0	7.9	7.6	26.2	12.9	11.3	8.0	15.2	6.8	21.7	8.2	27.3	15.2	9.9	7.2	13.9	6.2	13.9	13.0	12.1	8.4	16.6	11.9	26.1	8.0	21.7	9.7	5.6	12.3	10.6	14.5	12.9	21.2	1.5	4.1	13.0	6.6	0.7	1.6	1.1	15.5	11.7	17.1	9.6	14.9	22.1	13.7	16.7	29.1	20.4	21.8	5.9	5.9	3.6	11.9	24.2	13.6	3.9	8.7	14.6	28.6	5.6	5.3	6.2	6.9	7.6	38.2	2.7	1.9	20.7	4.8	10.8	18.0	22.1	21.4	2.1	3.2	14.4	17.8	4.6	3.5	2.7	4.3	7.7	10.6	5.0	3.0	2.4	5.2	8.4	4.9	15.9	12.3	7.5	8.8	15.0	6.3	6.1	62.6	16.4	7.9	6.4	24.5	13.2	3.0	2.5	12.1	3.9	18.2	0.0	2.4	1.6	0.7	2.4	0.4	1.5	1.2	1.0	4.1	1.3	1.6	1.0	13.0	0.7	6.6	0.4	0.8	1.1	10.5	12.5	6.4	14.6	10.0	11.0	11.3	8.0	15.2	9.7	3.0	7.5	14.3	18.6	42.4	18.5	31.3	12.7	2.7	13.6	3.5	15.7	35.8	3.3	9.1	156.9	106.7	3.5	23.3	7.5	32.0	42.0	21.7	9.2	7.4	54.2	58.8	12.6	90.9	55.3	319.2	36.2	54.3	42.2	55.9	3.9	9.5	9.1	3.5	51.6	3.4	7.2	77.6	58.7	29.0	94.8	39.3	39.0	12.9	3.5	17.4
ASB1	ASB-1	ENSG00000065802	"Ankyrin repeat and SOCS box containing 1"	Q9Y576	2	238426742-238452250	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003508	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003508: AB_1845065"	"unprognostic (1.02e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (4.04e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-1)"	9.2	8.4	17.0	10.9	19.7	3.8	7.7	9.3	18.4	7.1	8.7	16.2	7.8	5.8	12.0	5.9	7.5	9.3	7.8	22.0	16.1	14.7	8.0	6.2	7.6	10.5	18.0	12.7	15.3	6.6	15.1	8.8	4.9	15.6	9.8	7.2	9.3	5.4	12.1	26.2	8.3	7.8	11.8	18.8	7.8	7.6	14.0	11.3	9.0	8.2	9.3	11.7	7.1	6.5	5.5	4.2	1.4	1.1	3.0	6.7	1.9	4.9	7.1	9.8	7.8	6.3	6.6	7.9	13.6	9.0	8.1	9.2	3.4	3.5	4.3	1.9	12.7	18.3	5.4	9.6	21.5	13.0	10.8	7.9	5.4	6.4	8.5	14.6	7.4	7.2	7.0	9.9	23.9	32.5	12.9	3.5	7.6	11.3	2.9	15.0	3.3	4.0	7.8	10.4	4.3	6.1	5.8	19.9	2.8	5.9	6.7	7.9	10.7	4.2	3.1	7.0	6.1	2.3	7.9	7.5	14.9	9.7	11.6	26.9	10.6	6.5	7.4	23.4	2.3	7.4	0.0	0.8	1.4	6.7	1.1	3.5	5.5	4.7	6.5	0.9	3.3	4.1	4.9	0.3	3.0	0.6	4.2	5.5	1.9	17.0	19.7	9.3	18.4	16.1	14.7	18.0	12.7	15.6	11.3	8.9	3.0	14.1	23.6	7.0	10.6	40.0	20.4	14.7	6.8	8.7	3.9	11.2	1.7	15.7	27.1	3.8	5.1	23.3	18.1	23.0	14.5	14.7	16.1	9.9	23.2	9.5	12.2	4.9	14.2	15.0	7.2	9.5	6.8	14.4	5.2	8.0	22.5	17.3	13.8	10.2	5.7	25.8	12.7	37.9	35.5	5.9	4.8	15.8	6.0	11.6
ASB13	"FLJ13134, MGC19879"	ENSG00000196372	"Ankyrin repeat and SOCS box containing 13"	Q8WXK3	10	5638867-5666595	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 44.9;Hepatocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 30.0;RPMI-8226: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048293, HPA061742"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA048293: AB_2680344, HPA061742: AB_2684599"	"unprognostic (3.64e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	7.7	14.0	5.8	5.8	7.3	2.7	10.8	12.2	18.2	7.4	23.7	7.3	6.9	21.6	6.5	11.0	7.5	11.8	9.6	7.9	5.3	5.8	18.4	28.5	5.4	14.7	5.8	5.5	13.6	8.4	2.8	5.9	3.3	8.7	6.7	5.9	41.1	6.1	6.3	8.1	8.1	26.4	5.1	5.1	7.0	6.9	4.7	4.9	2.1	4.6	7.0	11.7	9.3	8.6	2.3	10.8	0.4	9.5	0.8	3.5	5.2	4.7	6.1	2.7	11.8	11.5	3.1	4.7	0.8	2.2	2.7	3.5	5.2	9.1	30.0	7.4	1.8	1.1	7.5	6.2	6.2	0.5	1.4	10.5	4.3	3.8	4.0	7.3	3.9	0.4	5.0	10.0	1.7	2.3	3.3	2.5	8.0	5.3	0.6	0.8	3.4	4.6	3.6	5.6	14.2	3.7	1.9	0.2	31.9	3.8	7.7	5.3	12.4	5.8	3.9	9.4	0.8	12.3	5.0	0.6	1.7	2.9	7.0	2.5	1.4	3.7	20.1	5.2	10.1	1.3	0.0	9.5	0.2	1.2	6.7	2.1	1.5	3.5	1.5	10.8	2.3	3.5	1.6	0.4	0.8	5.0	0.3	0.9	5.2	5.8	7.3	12.2	18.2	5.3	5.8	5.8	5.5	8.7	4.9	0.0	7.2	0.0	1.5	1.4	44.9	6.9	7.6	6.7	5.7	1.8	17.7	4.6	5.0	4.6	0.6	3.7	18.4	0.0	4.0	1.2	5.8	2.3	3.5	52.1	6.5	15.9	4.1	3.7	11.9	0.0	12.4	4.5	8.5	1.8	6.5	8.5	3.8	11.2	20.1	25.4	11.4	6.5	8.1	0.2	2.2	1.5	1.7	2.5	11.7	1.0
ASB16	FLJ30165	ENSG00000161664	"Ankyrin repeat and SOCS box containing 16"	Q96NS5	17	44170447-44179083	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.4;tongue: 17.6"	"Cell type enhanced"	"Detected in some"	13	"Horizontal cells: 1.6;Ito cells: 1.3;Rod photoreceptor cells: 2.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"cerebellum: 11.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066834	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA066834: AB_2685732"	"unprognostic (2.72e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.23e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.53e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.07e-3)"	0.9	0.6	0.2	1.3	0.3	1.2	0.5	11.4	0.7	0.6	1.2	0.3	0.9	1.3	1.3	1.9	1.1	1.0	0.6	12.6	0.7	0.4	0.8	0.4	0.7	1.9	0.6	0.2	1.1	7.0	1.6	1.8	0.3	0.8	1.7	0.0	2.7	1.2	0.1	38.4	1.9	1.3	4.1	0.2	1.8	1.3	0.6	0.3	0.0	0.9	17.6	1.1	1.6	1.5	4.4	2.9	9.6	2.4	4.0	4.5	2.7	2.1	4.1	4.9	4.6	0.0	0.0	4.0	4.5	0.0	0.0	0.0	3.1	2.4	3.3	2.8	0.0	1.0	5.1	0.0	0.0	0.0	5.1	7.3	2.1	7.1	3.4	0.0	2.2	6.6	0.0	0.0	0.0	0.0	1.3	0.0	5.0	3.8	8.3	0.0	3.5	2.6	4.1	1.5	0.8	4.9	8.3	4.8	4.9	0.0	3.3	5.1	2.8	2.1	0.6	0.7	1.5	6.4	2.1	2.2	6.2	5.7	3.8	2.8	12.7	6.2	3.1	1.4	3.2	4.1	4.0	2.4	9.6	3.1	2.2	3.7	4.4	3.3	3.0	1.2	3.8	4.5	2.8	7.3	4.0	1.9	2.9	3.2	2.7	0.2	0.3	11.4	0.6	0.7	0.4	0.6	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
ASB2	ASB-2	ENSG00000100628	"Ankyrin repeat and SOCS box containing 2"	Q96Q27	14	93934153-93976791	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.9"	"Cell type enhanced"	"Detected in some"	17	"Cardiomyocytes: 40.8;Early spermatids: 26.4;Late spermatids: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	8	"eosinophil: 23.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.8;RPMI-8226: 8.0;U-266/70: 24.0;U-266/84: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001546			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA001546: AB_1078224"	"unprognostic (5.65e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.62e-6)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.49e-7)"	"unprognostic (2.51e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.27e-1)"	3.1	0.5	0.2	7.9	0.8	0.4	0.5	0.2	1.7	7.4	14.0	0.0	4.6	2.2	11.9	5.7	7.2	6.5	7.7	17.2	0.2	0.2	0.3	0.3	0.8	2.3	0.3	0.6	2.3	0.3	0.3	0.2	0.3	0.5	8.5	1.5	1.5	1.6	5.8	96.9	0.5	4.4	24.4	0.3	1.5	5.0	0.3	0.0	0.0	0.7	25.7	4.7	14.3	4.5	0.9	2.6	23.1	3.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	24.0	5.3	0.8	0.2	2.5	0.5	0.0	0.0	23.1	0.8	1.0	0.1	0.9	0.8	1.7	2.6	0.2	0.1	0.2	0.0	0.0	3.0	0.1	1.1	0.5	0.2	0.8	0.2	1.7	0.2	0.2	0.3	0.6	0.5	0.0	0.0	0.0	1.4	0.0	0.3	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	26.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	20.6	0.3	1.0	1.7	9.0	0.0	0.9	0.3	0.0	0.4	0.0	1.1	0.0	3.1	0.9	5.9	0.1	2.4	6.9	0.0	0.1
ASB5		ENSG00000164122	"Ankyrin repeat and SOCS box containing 5"	Q8WWX0	4	176213673-176277571	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 133.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 229.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 165.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028870			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA028870: AB_10611679"					"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-4)"		"unprognostic (1.90e-1)"			"unprognostic (7.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"		"unprognostic (6.80e-3)"	2.3	0.0	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.3	3.5	0.0	0.0	0.1	0.2	6.3	7.9	0.0	0.4	1.3	0.2	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.6	1.3	0.0	8.0	0.1	133.4	0.0	0.5	23.5	1.0	0.0	2.0	2.2	0.0	0.0	2.3	31.4	2.2	15.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.0	3.6	7.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	229.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0
ASB7		ENSG00000183475	"Ankyrin repeat and SOCS box containing 7"	Q9H672	15	100602534-100651705	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003300	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA003300: AB_1845071"	"unprognostic (1.38e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	8.6	8.9	8.9	15.5	11.9	20.2	10.2	12.7	10.2	10.3	12.1	8.1	13.5	8.3	11.6	12.5	10.0	10.9	9.5	7.0	10.4	8.3	12.5	12.1	8.8	12.9	10.6	6.7	11.2	11.0	13.7	11.8	14.0	9.4	10.1	11.8	7.6	10.3	11.3	8.0	9.5	15.5	11.2	9.7	10.4	8.3	13.8	9.2	21.2	11.5	9.6	11.1	11.6	9.2	6.6	7.0	13.6	8.0	5.5	9.4	6.3	6.2	14.0	6.4	7.7	8.6	9.3	7.5	7.0	12.6	11.6	12.2	8.4	12.8	10.3	6.4	8.9	11.5	14.1	8.9	9.0	12.2	7.2	9.6	13.7	9.3	8.3	13.0	8.0	12.1	8.9	10.1	9.5	15.7	11.2	10.7	11.4	8.0	8.7	6.6	6.8	6.2	8.1	6.1	14.1	6.8	8.5	14.0	8.5	11.5	14.2	6.4	9.2	10.7	10.5	14.4	12.8	7.4	10.1	8.1	10.3	9.6	7.1	9.7	10.5	21.6	9.9	7.9	7.4	8.0	1.7	8.0	13.6	7.6	6.5	6.1	6.3	6.7	9.3	7.0	6.6	9.4	6.7	7.3	5.5	4.1	4.5	7.7	6.3	8.9	11.9	12.7	10.2	10.4	8.3	10.6	6.7	9.4	9.2	0.0	4.8	3.2	2.1	5.8	4.0	3.4	10.2	9.4	6.8	3.5	5.9	3.1	1.7	5.3	1.7	3.7	8.4	0.0	4.3	2.1	3.3	4.3	10.4	6.8	5.0	12.7	8.1	6.2	6.3	1.7	4.6	4.8	3.3	2.8	6.6	3.3	4.6	8.2	4.9	6.2	4.6	0.0	3.5	8.9	6.1	4.0	4.9	6.1	5.5	4.7
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	17.2	23.3	23.2	13.3	25.9	10.9	20.9	27.4	23.8	21.2	12.4	25.7	19.6	9.5	16.9	21.3	16.4	17.2	16.0	26.4	24.7	21.6	18.6	24.3	12.7	19.8	35.2	14.9	21.9	24.8	19.3	22.0	14.5	28.2	15.4	12.9	13.1	11.9	19.5	25.7	14.8	12.5	18.0	35.4	16.9	13.7	20.9	34.5	20.8	17.8	9.4	20.9	18.0	15.7	24.9	22.9	25.4	14.9	19.7	24.2	14.6	13.4	17.7	13.5	25.5	18.7	19.6	10.3	8.2	17.6	14.0	17.3	19.2	48.6	18.2	16.9	11.9	10.2	17.5	10.8	16.5	15.2	12.8	9.6	11.4	14.6	17.7	16.9	12.5	12.1	18.4	36.2	15.0	21.1	19.4	17.1	20.1	15.8	22.7	14.9	12.8	16.4	17.3	7.1	9.8	4.3	9.3	10.9	13.3	24.1	9.1	12.8	9.2	11.4	29.4	22.2	12.0	10.1	8.5	16.2	7.1	13.5	5.6	8.6	14.1	18.2	22.0	11.4	28.6	5.5	16.5	14.9	25.4	14.5	14.7	14.4	24.3	17.2	15.2	15.1	24.9	24.2	21.9	9.4	19.7	11.5	22.9	21.6	14.6	23.2	25.9	27.4	23.8	24.7	21.6	35.2	14.9	28.2	34.5	8.9	4.3	18.4	13.0	5.6	11.5	19.7	5.1	5.3	7.9	12.2	13.7	14.9	19.9	17.7	22.1	10.8	4.5	23.3	17.8	16.4	12.8	6.0	12.7	17.7	15.8	23.8	3.5	7.4	28.5	10.0	19.0	7.9	18.6	27.9	4.9	17.7	13.3	4.5	19.4	9.2	13.9	12.9	17.9	28.9	20.6	6.0	12.7	16.6	4.7	8.2
ASCC2	"ASC1p100, DKFZp586O0223, FLJ21588"	ENSG00000100325	"Activating signal cointegrator 1 complex subunit 2"	Q9H1I8	22	29788608-29838304	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 128.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001439, HPA052879"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA001439: AB_1078229, HPA052879: AB_2732577"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.97e-3)"	"unprognostic (5.19e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.05e-3)"	19.5	24.2	13.1	22.1	15.1	32.3	23.1	13.4	14.0	16.8	16.9	17.9	22.5	16.5	17.1	17.7	31.1	14.6	19.0	17.7	10.8	8.2	15.8	35.3	19.2	20.2	15.4	9.1	16.2	18.4	17.5	20.6	23.2	12.5	20.1	17.8	17.6	22.2	30.9	50.0	21.7	22.3	14.2	12.9	22.7	25.8	41.0	13.0	28.9	21.9	25.0	26.6	19.1	21.2	11.3	21.1	28.5	27.6	17.3	18.8	10.9	19.7	11.5	12.5	16.9	18.8	16.7	18.0	20.6	15.9	21.4	21.5	13.4	10.7	19.7	14.9	19.8	13.6	24.0	16.0	23.4	18.1	25.2	28.0	16.9	14.6	16.0	23.6	30.3	51.5	17.9	21.3	24.3	22.4	12.6	18.7	13.3	17.4	19.2	19.3	24.4	18.5	16.0	9.1	27.9	15.7	22.4	15.4	20.6	13.1	32.7	19.4	17.1	19.1	21.1	15.3	13.4	15.0	15.9	18.4	30.0	5.1	18.1	20.3	23.0	17.5	23.4	17.5	17.0	21.6	18.2	16.7	28.5	18.8	27.6	16.8	11.3	14.2	15.8	21.1	8.9	14.7	14.8	5.1	17.3	22.5	12.0	16.4	10.9	13.1	15.1	13.4	14.0	10.8	8.2	15.4	9.1	12.5	13.0	17.9	14.3	24.0	18.4	26.7	9.0	16.5	25.5	18.7	18.2	38.4	3.9	37.6	10.0	24.0	92.7	20.5	38.5	23.3	21.6	52.8	23.3	15.9	34.6	23.2	27.5	4.8	14.9	17.8	24.8	128.4	28.7	33.0	27.0	22.6	17.2	11.8	22.4	24.6	23.3	15.2	13.6	19.4	16.0	39.1	19.2	34.4	37.1	35.9	20.3	30.8
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	15.9	15.4	10.9	15.5	14.5	13.6	13.4	16.1	11.7	16.7	13.2	7.7	10.1	11.4	16.4	12.9	18.4	11.3	11.1	14.9	9.7	8.4	10.4	28.3	12.6	13.1	13.1	7.6	13.8	15.1	25.0	38.6	26.1	10.4	16.4	17.1	6.4	15.4	14.0	13.6	15.3	16.1	12.2	15.5	17.7	11.5	11.7	12.4	25.0	10.6	11.6	15.2	16.0	17.9	8.5	9.4	5.9	6.4	6.0	7.8	1.8	7.1	8.9	13.4	8.2	15.0	19.2	20.8	31.2	20.1	10.8	12.5	18.1	5.7	21.9	6.1	20.9	8.6	16.0	11.5	27.7	17.5	13.8	9.8	16.6	16.6	11.8	13.8	17.5	12.8	17.4	14.2	15.7	20.0	10.2	19.8	9.1	19.5	10.0	29.7	6.9	8.7	5.3	7.0	13.7	6.8	10.5	10.2	8.1	10.6	20.2	8.8	6.6	12.9	11.8	5.4	24.9	6.5	10.0	27.1	12.0	9.1	10.4	13.1	4.3	4.0	19.5	8.7	13.2	12.5	5.9	3.9	2.4	6.7	6.4	7.8	5.8	5.6	6.0	4.1	8.5	6.5	6.2	0.3	6.0	5.2	9.4	4.3	1.8	10.9	14.5	16.1	11.7	9.7	8.4	13.1	7.6	10.4	12.4	29.8	19.8	36.0	39.8	22.7	25.2	28.6	20.4	33.5	39.8	3.5	21.6	20.4	10.0	20.1	6.1	18.0	14.6	23.3	21.5	57.6	23.6	58.3	20.9	28.8	15.8	27.0	13.3	8.6	19.6	1.5	21.3	20.7	5.0	15.4	16.4	16.4	22.7	11.0	16.3	9.7	30.3	6.5	26.4	47.4	20.0	24.0	31.8	23.5	17.1	49.7
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957686-102960516	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.3;liver: 23.0;pituitary gland: 29.4"	"Cell type enriched"	"Detected in some"	7	"Intestinal endocrine cells: 34.9"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"SCLC-21H: 33.4;SH-SY5Y: 18.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA029217: AB_10669595, HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.9	2.8	11.1	0.7	6.9	0.7	0.7	3.3	19.3	1.3	0.9	6.6	0.0	0.9	1.0	0.8	0.7	2.2	0.8	0.7	8.5	5.8	0.8	23.0	1.7	1.4	7.6	4.7	1.6	0.9	0.7	29.4	0.8	13.9	1.1	1.0	0.0	0.7	0.8	0.8	0.7	0.8	0.9	18.7	0.7	3.2	0.9	7.3	6.0	1.0	0.0	0.8	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	18.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	6.9	3.3	10.7	8.5	5.8	7.6	4.7	13.9	7.3	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.1	4.8	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 171.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1020.7"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 13.7;monocytes: 39.1"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 104.5"	"Region enriched"	"Detected in many"	9	"cerebellum: 49.4"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Intracellular and membrane"	NA	NA			Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	0.2	0.1	0.8	0.9	0.6	0.6	0.2	2.8	1.8	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.7	0.1	0.8	0.8	0.1	171.0	0.7	0.3	0.4	1.2	0.1	0.3	0.9	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.3	0.3	0.5	0.2	2.9	0.2	0.1	1.4	0.1	0.1	0.3	0.1	0.2	13.7	2.1	39.1	0.1	0.3	10.1	0.0	0.1	2.0	0.9	0.0	0.0	0.1	0.1	0.2	0.2	0.3	3.5	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.3	104.5	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.1	1.8	1.6	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.1	39.1	0.1	0.1	17.9	0.3	0.1	0.0	0.0	13.7	0.2	0.1	0.1	1.1	0.1	4.5	0.6	0.1	10.1	0.8	0.6	2.8	1.8	0.8	0.8	0.4	1.2	0.7	0.2	0.0	6.6	13.0	1.0	2.9	31.7	1.2	73.9	1.4	2.3	3.5	151.2	3.2	3.3	0.8	212.5	12.7	0.3	23.3	0.2	3.6	2.0	0.8	0.0	1020.7	41.3	14.3	15.0	23.9	110.6	80.2	2.3	18.3	0.0	0.0	0.7	2.6	0.4	0.6	1.1	1.6	39.8	0.0	0.4	4.5	7.8	4.3	10.4	0.7	1.0	2.4
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 154.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 660.0"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 36.9;myeloid DC: 21.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 21.7;monocytes: 36.9"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 107.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		4700000	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	0.2	0.0	0.3	1.4	0.1	1.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	3.4	0.2	0.2	0.0	0.2	154.1	0.5	4.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	21.7	0.5	36.9	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	36.9	0.2	0.0	3.8	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	9.5	0.3	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.0	9.0	14.0	0.0	0.0	0.0	0.0	152.8	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	23.3	0.0	0.1	0.0	0.1	2.3	660.0	6.9	0.0	6.8	16.0	35.5	0.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.5	0.0	0.0
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155562807	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	20.1	10.1	12.1	17.7	14.5	12.3	14.5	23.6	15.5	15.4	17.7	15.5	20.4	8.2	18.7	12.5	12.5	12.2	10.0	11.0	11.8	10.6	13.0	8.9	10.6	9.4	16.6	11.5	23.5	10.0	24.4	22.6	12.9	13.2	18.9	10.7	10.7	11.8	22.2	21.8	12.8	12.8	17.4	14.5	8.6	10.4	7.8	14.3	15.6	16.8	7.1	10.6	17.8	19.9	11.0	5.7	16.5	5.3	8.6	10.7	1.7	13.6	11.7	7.7	6.6	17.4	18.7	8.7	11.1	11.6	7.6	6.4	8.7	9.1	6.1	11.2	14.5	5.8	14.2	12.1	9.7	12.0	6.0	7.8	7.5	11.6	4.7	8.4	8.3	5.9	11.5	10.8	12.7	12.5	11.5	9.0	6.0	10.7	9.2	12.6	10.7	5.6	4.5	7.3	17.0	11.4	5.2	15.9	7.0	8.4	15.1	7.9	11.7	17.5	15.8	8.6	8.4	12.7	18.2	13.8	11.7	12.6	11.1	13.6	8.6	4.9	9.7	9.1	6.3	10.1	16.5	5.3	11.0	8.3	3.2	7.9	10.0	7.8	6.3	2.5	11.0	10.7	5.5	12.8	8.6	3.5	5.7	8.6	1.7	12.1	14.5	23.6	15.2	11.8	10.6	16.6	11.5	13.2	14.3	56.6	88.1	42.2	92.1	92.3	138.8	87.3	43.3	45.5	96.7	48.8	190.5	40.3	14.9	37.0	14.5	82.3	61.6	23.3	34.5	22.1	98.4	94.0	78.6	28.8	21.6	108.1	64.8	59.5	40.8	12.1	94.6	55.1	50.6	62.3	49.5	77.4	31.8	59.1	111.7	23.9	119.9	97.0	97.6	85.7	46.2	97.9	63.7	68.9	46.6	109.1
ASIC1	"ACCN2, BNaC2, hBNaC2"	ENSG00000110881	"Acid sensing ion channel subunit 1"	P78348	12	50057548-50083611	"FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 43.7"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 3.1;Ciliated cells: 6.7;Club cells: 2.3;Horizontal cells: 3.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.0;SH-SY5Y: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058870			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"		"HPA058870: AB_2683841"	"unprognostic (5.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.97e-7)"	"unprognostic (7.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-5)"	2.5	1.7	13.9	1.8	20.3	0.8	2.9	20.1	43.7	5.3	3.1	12.8	0.3	2.3	2.5	1.2	3.4	3.6	4.0	2.2	12.3	14.3	1.6	0.9	1.3	1.3	12.9	8.5	1.4	1.4	5.2	0.5	1.5	10.2	4.5	2.5	1.8	5.6	3.4	1.3	1.5	2.5	3.6	5.4	1.1	4.3	1.4	11.0	0.4	1.1	0.0	1.0	2.6	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.9	4.3	5.7	12.9	1.7	2.7	3.2	1.4	3.7	2.5	2.5	3.0	1.5	1.2	3.0	0.8	1.5	2.0	5.6	4.7	1.4	1.2	15.4	3.9	6.1	1.8	2.5	5.7	14.5	6.8	2.3	0.4	0.6	23.0	0.4	15.2	2.5	0.1	2.0	2.4	5.5	11.3	2.4	4.4	7.6	5.6	5.4	2.6	1.2	0.2	8.5	17.9	3.2	1.1	2.0	1.0	7.0	3.8	0.4	2.5	8.4	1.7	0.7	0.0	0.0	0.0	3.2	5.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	13.9	20.3	20.1	18.3	12.3	14.3	12.9	8.5	10.2	11.0	0.0	0.0	0.0	0.2	0.0	3.1	0.9	0.0	6.7	2.3	1.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.6	0.0	0.0	0.3	3.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.1	0.8	0.5	0.0	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.1
ASIC3	"ACCN3, DRASIC, TNaC1"	ENSG00000213199	"Acid sensing ion channel subunit 3"	Q9UHC3	7	151048292-151052756	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Cell type enhanced"	"Detected in some"	18	"Cone photoreceptor cells: 11.8;Early spermatids: 11.6;Late spermatids: 43.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 17.2;U-266/84: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049155, HPA054805"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA049155: AB_2680657, HPA054805: AB_2732588"	"unprognostic (8.71e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.45e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-12)"	"unprognostic (1.49e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.31e-3)"	2.6	2.4	6.8	0.9	27.1	1.5	1.3	20.1	15.4	3.6	2.3	0.9	0.5	2.9	4.9	3.5	0.6	2.4	1.9	2.4	6.5	5.3	1.5	1.3	2.7	1.9	4.2	9.9	3.0	1.4	1.4	7.1	1.8	6.2	1.9	1.8	0.7	1.7	1.4	9.0	3.5	2.7	2.4	6.0	2.1	2.8	10.2	2.2	0.5	1.1	0.5	1.9	0.9	1.2	0.0	0.0	0.0	0.8	0.0	0.7	0.0	1.3	3.6	1.7	2.4	3.3	0.0	7.4	0.4	0.0	0.3	0.4	0.7	1.6	0.9	0.4	0.2	1.6	2.3	0.9	0.0	0.7	7.8	4.2	1.6	2.7	0.0	0.0	0.1	3.9	0.5	0.5	0.2	0.0	2.6	0.1	0.9	3.8	6.4	0.5	6.0	0.3	0.4	1.7	0.1	2.8	2.9	1.6	0.5	0.3	1.3	2.2	8.6	0.6	0.4	4.1	4.6	1.7	0.4	0.1	1.5	2.2	4.0	1.0	17.2	9.1	0.1	2.1	5.7	1.4	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.8	27.1	20.1	15.4	6.5	5.3	4.2	9.9	6.2	2.2	0.0	0.3	0.0	0.0	0.6	8.6	1.6	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.2	11.6	0.3	0.3	0.0	0.3	0.1	0.5	0.2	9.2	0.6	0.6	6.4	0.0	0.0	0.6	43.6	1.4	0.3	0.0	1.0	0.0	1.9	0.3	0.0	1.8	0.3	5.0	0.0	0.0	9.2	5.1	0.6	0.6	0.0	0.2	0.1
ASIC4	"ACCN4, BNAC4"	ENSG00000072182	"Acid sensing ion channel subunit family member 4"	Q96FT7	2	219514170-219538772	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.7;pituitary gland: 20.6"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 200.8;Cone photoreceptor cells: 163.0"	"Cancer enriched"	"Detected in single"	38	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"HEL: 19.1;HMC-1: 5.8;K-562: 10.9;SH-SY5Y: 5.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 65.5"	"Low region specificity"	"Detected in many"			"HPA036042, HPA057078"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite"		NA	NA			"Golgi apparatus, Centriolar satellite"	"Nucleoplasm, Plasma membrane"	"HPA036042: AB_10672998, HPA057078: "	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.90e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-8)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.48e-2)"	0.8	3.3	4.9	0.6	4.7	0.5	0.6	6.9	17.7	1.0	0.5	1.6	0.0	0.5	0.8	0.6	0.5	0.6	0.6	0.6	3.9	4.5	0.5	0.6	0.9	0.6	4.8	2.9	0.5	0.5	0.5	20.6	0.6	3.0	0.6	0.5	4.9	0.6	0.8	0.5	0.6	0.5	0.7	1.9	0.6	0.7	1.6	3.1	0.0	0.5	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.7	6.9	4.9	3.9	4.5	4.8	2.9	3.0	3.1	0.0	0.0	0.0	1.6	0.1	200.8	0.8	0.0	0.0	0.0	0.0	163.0	1.8	0.0	0.0	2.8	0.1	0.3	0.0	0.3	0.7	0.7	0.5	18.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	8.4	0.0	2.9	0.4	0.0	9.5	0.0	0.4	0.2	0.6	0.3	2.4	0.0	0.4	0.3
ASL		ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075798-66093558	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 226.8;Hepatocytes: 477.5;Paneth cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		10000000	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	5.6	4.8	4.0	8.0	4.3	7.3	5.9	7.2	7.4	5.5	17.2	3.7	7.8	20.8	5.0	7.1	7.7	4.9	19.5	4.3	3.7	4.3	16.0	99.5	8.1	4.5	4.4	6.2	5.9	10.4	3.3	5.8	3.3	7.2	5.4	12.4	5.8	7.1	5.7	2.4	4.1	16.6	3.4	3.2	8.6	12.6	2.1	3.5	1.2	7.1	7.9	5.9	5.2	5.9	8.6	19.3	20.7	18.4	30.4	9.2	10.7	18.2	7.5	4.1	14.8	9.5	7.3	9.0	12.8	11.2	18.3	16.7	16.9	22.6	5.6	20.5	16.8	13.3	5.0	2.6	21.7	5.3	4.6	3.4	7.4	7.3	26.1	17.7	8.4	21.7	13.7	7.9	12.8	20.5	4.6	18.0	4.0	13.1	10.7	10.1	13.0	1.7	11.6	6.2	22.8	9.7	4.5	4.3	19.3	13.3	11.0	7.1	9.7	11.7	40.8	4.4	4.4	17.8	7.6	20.4	23.2	12.0	9.2	16.5	11.7	6.1	7.3	21.9	16.0	18.7	12.1	18.1	20.7	7.7	18.4	6.5	8.6	5.2	6.1	19.3	5.6	3.7	4.0	4.0	30.4	13.8	1.2	9.2	10.7	4.0	4.3	7.2	7.4	3.7	4.3	4.4	6.2	7.2	3.5	17.9	52.0	20.8	16.7	4.8	12.5	7.1	132.5	38.8	15.9	29.6	21.6	19.3	44.7	51.9	3.5	25.6	226.8	0.0	192.3	35.3	14.5	13.1	44.9	477.5	40.4	14.3	51.9	35.6	39.6	4.9	8.6	16.1	8.5	61.3	87.3	6.5	99.6	217.5	7.8	174.9	12.2	12.9	13.9	3.0	5.8	3.8	18.7	27.5	126.5	20.6
ASNSD1	"FLJ20752, NBLA00058, NS3TP1"	ENSG00000138381	"Asparagine synthetase domain containing 1"	"L0R819, Q9NWL6"	2	189661385-189670831	"Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036132, HPA036133, HPA075042"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036132: AB_2674960, HPA036133: AB_10696650, HPA075042: AB_2686731"	"unprognostic (1.32e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.15e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.98e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	23.1	22.4	25.5	15.9	24.7	25.5	29.1	41.0	29.4	22.7	19.5	14.1	18.1	18.0	23.6	17.3	18.2	20.6	18.2	23.9	22.9	26.0	25.0	31.9	16.9	22.3	24.2	22.6	33.2	22.4	20.8	36.8	26.8	29.1	19.6	16.5	13.2	18.2	18.6	52.4	14.0	15.4	23.9	27.8	22.0	18.1	14.0	21.8	20.1	25.0	19.8	20.8	22.4	23.6	15.9	11.0	41.9	11.2	21.5	24.5	15.2	13.4	10.5	22.2	18.6	24.2	23.6	19.5	29.3	27.6	31.7	31.6	26.2	9.6	26.8	17.8	25.1	15.0	11.2	23.9	20.3	37.3	28.2	26.7	24.9	20.1	26.3	26.9	24.5	14.0	24.1	15.1	27.8	24.5	20.2	28.4	18.5	23.1	20.2	29.4	17.7	29.0	26.2	33.2	20.8	41.3	16.5	20.0	25.5	17.8	19.1	25.4	16.1	21.2	15.7	24.9	29.3	22.6	22.7	22.1	25.7	20.0	21.7	28.8	29.7	40.0	47.0	21.8	14.6	22.8	24.6	11.2	41.9	17.7	9.4	21.5	15.8	19.5	19.0	11.0	15.9	23.3	20.8	20.4	21.5	10.3	10.1	24.5	15.2	25.5	24.7	41.0	29.4	22.9	26.0	24.2	22.6	29.1	21.8	50.6	27.5	45.5	20.4	26.7	19.3	37.6	20.4	36.1	39.8	15.7	11.8	58.7	69.6	30.2	4.1	29.1	17.7	0.0	39.1	34.4	35.2	20.0	18.5	48.0	29.2	14.3	34.5	29.4	26.6	4.6	37.7	28.0	16.9	27.1	23.3	29.4	31.7	8.6	31.8	45.3	23.4	45.3	32.3	27.7	32.4	24.8	100.2	41.5	24.7	17.5
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503419	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.3;kidney: 33.2"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 24.4;Leydig cells: 46.1;Melanocytes: 43.9;Peritubular cells: 45.3;Proximal tubular cells: 65.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.3;ASC TERT1: 6.5;CACO-2: 5.5;HSkMC: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	10.9	4.1	14.5	1.8	37.6	1.7	3.3	3.0	19.4	6.2	3.6	35.2	3.1	9.7	4.1	5.5	4.5	5.0	3.3	2.2	21.9	11.0	33.2	12.6	3.2	1.3	50.2	11.3	2.9	1.0	0.9	0.9	3.1	18.9	4.0	4.6	2.6	1.9	4.8	9.3	4.6	13.3	2.9	22.4	4.6	3.9	5.6	51.3	0.0	1.8	1.1	0.8	4.5	3.5	1.7	1.2	3.6	0.7	1.6	1.3	0.2	0.4	0.2	0.9	0.7	8.3	6.5	0.5	0.4	0.3	0.3	0.3	5.5	0.3	1.1	0.3	1.0	0.5	0.5	0.5	0.3	0.4	2.9	0.3	0.5	0.9	0.4	0.9	0.7	0.8	11.7	0.6	0.7	0.2	0.4	0.1	0.7	0.6	2.0	0.4	0.4	0.4	1.0	0.8	0.4	0.5	0.4	0.5	0.9	0.4	1.7	0.7	0.5	1.6	0.6	1.3	0.8	0.6	0.3	0.6	1.0	0.7	0.7	0.4	1.2	0.6	0.7	0.4	0.6	0.8	3.4	0.7	0.8	1.2	0.6	1.0	1.1	1.0	0.9	0.5	1.7	1.2	1.3	3.6	1.6	0.7	1.2	0.5	0.2	14.5	37.6	3.0	19.4	21.9	11.0	50.2	11.3	18.9	51.3	8.9	1.0	0.0	1.2	4.6	0.4	0.8	5.1	0.0	1.2	24.4	0.0	0.0	6.6	0.0	2.8	0.5	1.0	0.0	0.2	0.1	7.4	0.3	0.0	10.2	0.2	7.9	2.4	4.9	1.5	0.5	46.1	0.8	43.9	0.0	0.1	3.4	0.0	0.0	45.3	65.3	0.5	0.0	4.2	4.8	0.6	1.5	0.1	0.0	1.2	1.7
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.9;kidney: 24.7;liver: 59.8"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 137.5;Proximal tubular cells: 442.0"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;MOLT-4: 15.9;SH-SY5Y: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042631, HPA042654"	Approved		Approved	Nucleoplasm,Cytosol		Yes	NA		51000	Nucleoplasm	Cytosol	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	1.3	3.2	11.7	1.6	16.2	1.3	0.9	7.4	26.9	0.9	1.0	8.9	0.0	6.9	1.1	0.9	1.2	0.9	2.3	1.2	12.9	8.3	24.7	59.8	1.1	1.6	9.2	9.8	0.9	1.5	0.9	7.7	0.9	4.1	1.2	0.9	1.0	2.3	0.9	1.1	1.8	2.9	0.9	5.1	1.4	1.1	1.1	6.6	1.3	1.7	0.0	0.9	1.1	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.6	0.0	0.6	3.8	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	1.6	0.0	1.6	15.9	0.1	0.0	0.5	0.3	0.3	0.3	1.1	0.0	0.2	1.8	9.5	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	3.7	0.7	2.0	0.2	2.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.7	16.2	7.4	26.9	12.9	8.3	9.2	9.8	4.1	6.6	0.0	0.0	0.9	0.0	0.0	22.8	0.3	2.5	0.0	0.0	8.7	3.9	0.0	38.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.5	0.0	0.0	6.8	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	442.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Abnormal spindle microtubule assembly"	Q8IZT6	1	197084128-197146694	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 62.8"	"Cell type enhanced"	"Detected in many"	16	"Erythroid cells: 70.0;Spermatocytes: 32.6;Spermatogonia: 30.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"plasmacytoid DC: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;T-cells: 2.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB017816			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.7	0.7	0.2	12.4	0.4	13.8	1.5	0.2	0.4	1.2	2.8	0.2	0.2	2.8	0.3	1.5	8.7	0.2	0.4	0.6	0.2	0.2	0.5	1.3	1.9	7.0	0.3	0.2	0.5	0.3	0.0	0.2	1.8	0.5	0.4	2.8	0.3	1.5	0.2	0.5	4.6	3.1	0.8	0.5	4.3	1.7	6.3	0.2	62.8	0.3	5.0	6.9	1.2	2.3	0.0	1.5	0.0	0.0	0.3	2.4	0.0	20.1	11.3	18.3	11.2	1.1	2.5	6.9	16.1	11.3	16.0	12.7	7.8	15.7	20.5	5.7	12.6	7.0	20.3	15.7	6.4	20.0	18.5	11.9	14.4	26.5	7.5	0.2	21.5	10.3	0.2	0.6	12.8	9.0	4.1	16.8	16.6	18.0	24.4	16.4	7.9	17.2	10.0	8.3	16.2	3.1	13.2	25.2	15.1	5.8	5.5	9.6	13.7	22.9	11.8	5.1	11.8	13.2	8.9	12.8	9.9	9.7	17.0	29.2	7.0	9.5	11.9	7.8	5.9	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	2.4	0.0	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.5	0.2	0.0	0.6	3.7	0.6	5.5	0.0	1.0	0.0	0.0	1.2	1.8	0.0	6.4	0.0	0.3	2.9	0.3	0.3	70.0	0.0	13.2	1.3	0.7	1.1	1.0	9.3	0.0	0.0	1.8	4.0	3.3	0.6	3.1	0.0	1.0	1.5	0.5	0.4	0.0	1.4	0.0	0.3	0.0	0.0	32.6	30.2	3.0	3.1	4.9	4.9	1.7
ASPRV1	"FLJ25084, SASPase, Taps"	ENSG00000244617	"Aspartic peptidase retroviral like 1"	Q53RT3	2	69960089-69962265	"Plasma proteins, Predicted membrane proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 75.3"	"Cell type enhanced"	"Detected in some"	18	"Spermatogonia: 3.0;Suprabasal keratinocytes: 9.4"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 23.1;melanoma: 35.1"					"Cell type enriched"	"Detected in some"	6	"neutrophil: 11.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"REH: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034809, HPA034810"	Enhanced		Approved	Cytosol		NA	NA		83000	Cytosol		"HPA034809: AB_2674343, HPA034810: AB_10601456"	"unprognostic (4.75e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.43e-2)"	0.2	0.2	0.5	0.1	0.6	0.0	5.5	0.8	0.4	0.3	0.0			0.3	0.3	0.6	0.0	0.4	0.1	0.1	0.6	0.7	0.2	0.0	0.1	0.1	0.7		0.9	0.0	0.0	0.5	0.1		0.1	0.0		0.0	0.2	1.0	75.3	0.2	0.2	1.0	0.4	0.1	0.4			0.0		0.1	0.0	0.6	0.1	1.2	11.2	0.1	0.3	0.9	0.5	0.1	0.7	1.8	3.5	2.3	0.9	0.5	0.4	0.7	0.5	0.3	1.2	0.1	1.3	0.3	0.3	0.4	0.5	1.6	0.2	0.4	2.4	4.7	2.8	0.4	1.2	0.9	2.3	2.0	1.1	0.7	0.4	0.8	0.7	0.4	3.1	1.0	3.6	0.4	0.5	2.0	5.2	1.8	0.4	0.4	8.9	1.0	0.5	0.1	0.1	2.0	0.5	0.2	1.4	1.4	0.4	0.1	1.0	0.3	0.1	1.8	0.1	0.3	3.9	2.4	2.7	0.2	1.6	2.0	0.0	0.1	1.9	0.7	0.1	0.7	0.0	0.3	0.6	0.1	0.1	0.2	0.6	11.2	0.3	0.1	1.2	0.9	0.5											0.0	0.0	0.0	0.1	0.3	1.1	1.2	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.1	0.3	0.4	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.2	0.9	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.7	0.7	1.4	0.0	0.0	1.1	3.0	9.4	0.3	0.0	0.0	0.1
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase like 1"	Q7L266	11	62337448-62393412	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.4;cervix, uterine: 68.7;testis: 57.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 275.4;Late spermatids: 421.8;Spermatocytes: 320.2"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 51.4;eosinophil: 52.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 52.4;monocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 30.5;HAP1: 29.4;RPTEC TERT1: 26.0;SCLC-21H: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		NA	NA			Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	3.6	2.6	27.8	3.8	37.0	7.1	4.6	12.3	22.3	68.7	7.9	9.9	2.0	4.1	15.3	7.9	1.4	36.8	9.5	1.7	19.5	19.0	23.8	2.4	6.6	3.3	30.8	11.8	1.6	5.1	1.5	5.7	2.3	16.4	8.6	9.9	4.9	6.4	4.8	2.3	1.2	3.1	3.0	9.6	2.4	5.6	57.6	11.3	2.8	3.7	0.0	3.0	2.9	1.0	0.5	8.2	52.4	14.2	2.5	0.7	4.9	0.8	6.7	7.4	9.6	0.0	0.0	5.8	0.8	0.3	1.3	1.2	11.0	3.0	0.7	30.5	0.1	3.3	0.6	29.4	0.3	1.5	1.1	12.1	0.4	9.1	8.0	0.2	8.1	11.0	0.3	0.1	0.6	0.1	0.4	13.8	16.7	8.2	7.6	0.3	12.8	21.8	5.4	10.1	4.6	5.3	8.9	4.4	4.1	26.0	2.1	40.1	5.7	5.7	9.9	4.9	8.0	5.3	4.1	0.7	0.1	5.6	0.4	3.3	11.7	11.1	1.0	0.3	4.2	3.4	51.4	14.2	52.4	0.6	10.3	0.4	0.5	0.2	0.7	8.2	0.4	0.5	0.7	3.3	2.5	7.2	1.4	0.1	4.9	27.8	37.0	12.3	22.3	19.5	19.0	30.8	11.8	16.4	11.3	6.0	26.7	10.4	1.9	3.1	21.7	1.6	53.5	1.4	3.4	21.0	31.4	1.4	112.7	25.5	275.4	23.3	4.1	0.0	19.3	1.8	3.8	54.4	76.5	2.6	22.5	15.9	45.3	31.9	9.1	421.8	8.1	27.7	1.7	0.0	35.8	78.6	8.8	5.8	6.7	99.6	37.4	12.9	2.3	320.2	48.6	1.1	0.7	6.9	26.0	5.3
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 457.5;Hepatocytes: 809.9;Proximal tubular cells: 889.6;Urothelial cells: 385.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 87.4;HaCaT: 82.8;hTCEpi: 80.5;RPMI-8226: 134.1;THP-1: 100.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		4500000	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.7	1.1	1.3	2.2	8.9	22.7	4.3	14.0	87.4	2.8	8.5	5.0	3.3	0.0	9.5	28.9	0.8	82.8	5.8	0.5	1.9	2.0	2.6	0.0	1.8	12.8	31.0	1.7	0.1	15.0	80.5	4.5	8.1	0.0	0.1	37.6	0.4	52.2	2.8	58.1	0.6	24.5	1.8	60.2	2.6	0.1	1.5	134.1	7.6	5.8	33.8	0.5	50.0	52.7	3.9	5.4	36.2	100.4	0.0	1.1	7.0	0.2	1.2	8.7	8.3	2.9	22.0	13.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2	23.8	25.8	33.7	45.3	62.6	0.0	5.0	94.3	20.1	50.0	45.4	0.0	159.6	112.7	79.7	0.8	23.2	457.5	0.0	98.3	5.0	15.7	85.0	5.7	809.9	12.7	0.0	11.5	35.0	18.0	2.7	28.7	2.6	3.3	2.8	129.1	4.8	73.5	143.8	117.4	889.6	0.3	0.0	10.8	1.1	2.0	15.3	120.5	12.5	77.1	385.2
ASTE1	HT001	ENSG00000034533	"Asteroid homolog 1"	Q2TB18	3	131013875-131027649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037010, HPA037011"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA037010: AB_10673629, HPA037011: AB_10696929"	"unprognostic (7.42e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (2.27e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-2)"	10.1	9.2	6.8	11.7	9.5	10.2	10.3	9.3	9.4	11.9	14.3	13.1	7.1	10.4	12.4	11.4	7.7	9.3	9.4	6.1	8.5	7.1	7.2	10.9	7.4	11.9	11.3	9.7	11.1	12.9	10.7	14.0	8.0	8.8	7.9	10.8	8.2	7.2	8.2	4.9	7.4	16.6	8.9	9.7	12.0	8.7	12.1	8.0	17.7	12.9	6.9	13.8	8.3	7.8	9.8	9.1	25.1	12.1	17.6	19.9	7.0	10.2	7.4	4.9	5.0	8.8	9.3	2.2	5.8	5.1	7.1	7.3	12.2	4.3	11.3	8.9	5.6	6.0	11.4	9.7	4.8	10.7	6.1	5.8	6.7	4.0	5.6	8.9	10.4	4.0	6.1	6.6	5.7	5.4	6.1	5.9	9.5	5.8	5.8	7.3	7.0	9.0	5.3	4.5	12.2	7.5	9.8	6.9	9.9	5.8	6.4	8.4	7.7	10.9	2.6	7.9	5.0	6.7	7.2	4.1	8.0	5.4	13.3	4.6	7.4	6.5	15.2	6.2	9.0	4.0	25.1	8.4	16.9	13.8	9.5	14.5	9.6	15.2	12.0	9.1	9.8	19.9	14.5	6.1	17.6	12.1	6.6	16.7	7.0	6.8	9.5	9.3	9.4	8.5	7.1	11.3	9.7	8.8	8.0	11.9	4.3	4.2	3.5	2.9	9.1	1.7	2.5	1.4	7.9	3.5	13.7	5.1	5.0	4.4	25.5	5.8	9.3	0.0	5.1	4.2	3.7	2.4	8.1	4.4	4.2	3.2	6.4	5.5	2.2	9.3	6.6	5.9	1.7	2.8	4.7	6.9	2.8	5.8	4.6	3.7	12.7	0.0	5.1	1.8	5.1	1.3	3.3	11.5	6.6	2.5
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 19.9;brain: 52.5"	"Cell type enhanced"	"Detected in some"	20	"Horizontal cells: 22.3;Late spermatids: 9.9;Rod photoreceptor cells: 8.8"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.0;NTERA-2: 4.6;SCLC-21H: 2.8;U-2 OS: 3.7;U-266/84: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA074112: AB_2686662"	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	1.4	19.9	21.5	1.6	23.8	1.1	1.7	15.0	52.5	1.3	1.5	7.4	1.9	1.5	2.3	5.4	1.2	3.2	1.9	1.7	17.4	13.7	1.3	1.4	1.4	1.2	8.5	18.8	8.9	1.7	1.2	8.2	1.6	9.8	2.4	1.6	2.2	2.0	3.3	1.3	1.1	1.5	2.2	5.8	3.6	1.2	1.9	7.2	0.0	1.2	0.0	1.5	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	23.8	15.0	27.2	17.4	13.7	8.5	18.8	9.8	7.2	0.0	0.0	0.0	0.0	0.1	4.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	22.3	0.0	1.8	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	8.8	0.0	0.1	4.2	0.2	0.0	0.1	0.0	0.0	0.0
ASTN2	KIAA0634	ENSG00000148219	"Astrotactin 2"	O75129	9	116425225-117415070	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Early spermatids: 119.3;Late spermatids: 157.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027035	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA027035: AB_1845122"	"unprognostic (3.25e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.93e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	4.1	11.9	13.0	3.3	14.9	4.4	5.3	17.2	25.5	5.6	4.6	20.0	5.5	4.6	3.8	5.3	3.2	9.6	3.4	18.6	13.5	16.3	5.5	5.2	3.0	3.0	15.4	19.4	4.0	7.4	5.6	10.7	2.6	16.1	29.2	4.2	6.7	6.1	13.6	7.7	3.5	5.2	3.6	11.3	3.1	4.1	16.7	16.9	1.9	2.4	0.9	2.4	3.6	3.0	2.3	1.3	2.5	0.7	7.8	10.3	1.3	2.5	7.8	3.1	4.7	5.2	4.8	10.4	3.8	1.5	1.7	1.9	5.4	3.0	5.8	4.5	2.5	6.3	0.9	7.6	0.4	2.1	3.1	2.0	2.2	3.7	11.1	2.0	1.4	4.2	6.5	0.7	5.2	0.4	3.7	1.2	6.9	2.7	4.3	5.2	2.6	2.7	1.1	9.1	6.9	4.7	3.3	18.4	1.7	5.3	8.3	4.3	24.9	4.6	1.5	3.2	10.5	10.4	0.9	2.4	4.0	6.5	3.9	3.3	6.3	3.6	5.5	7.1	1.4	16.9	2.5	0.6	0.6	3.9	0.4	4.8	2.0	4.2	3.2	0.3	2.3	4.0	3.3	2.4	7.8	0.7	1.3	10.3	1.3	13.0	14.9	17.2	23.2	13.5	16.3	15.4	19.4	16.1	16.9	6.0	6.2	0.0	3.6	1.1	2.1	19.3	2.5	17.4	7.9	1.8	9.8	0.4	3.3	0.7	119.3	0.7	0.7	0.0	1.0	0.3	3.6	12.1	5.8	1.8	2.5	9.5	12.1	0.6	0.0	157.4	2.6	0.3	0.0	0.0	0.9	3.3	0.7	2.6	5.3	5.7	4.7	0.0	3.8	5.1	13.0	0.5	0.2	2.5	1.7	2.0
ASXL1	KIAA0978	ENSG00000171456	"Additional sex combs like 1, transcriptional regulator"	Q8IXJ9	20	32358330-32439319	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor"	"Cancer-related genes, Craniosynostosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064156			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA064156: AB_2685200"	"unprognostic (1.49e-1)"	"unprognostic (5.97e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (6.69e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (2.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.06e-1)"	24.3	19.6	19.0	35.0	18.2	39.0	24.7	28.3	23.8	32.4	22.7	17.7	16.9	15.6	32.4	22.2	14.3	20.5	21.6	17.9	19.7	10.7	21.2	25.2	27.3	26.7	20.3	14.7	28.1	27.1	21.2	16.3	19.8	18.2	20.6	16.4	16.6	17.4	23.3	25.5	18.2	21.8	21.8	12.2	28.2	19.7	32.1	23.0	47.4	26.8	15.8	29.0	23.2	35.3	9.8	3.1	1.3	0.8	1.7	14.6	1.9	22.9	13.3	20.9	11.6	9.6	12.0	18.2	15.4	13.2	26.9	19.9	39.6	14.8	21.7	9.9	19.0	25.6	16.0	17.6	14.8	22.0	32.5	9.6	34.6	21.1	21.6	8.6	14.4	14.4	13.3	9.9	18.7	14.1	13.3	14.8	17.9	16.7	11.8	12.5	7.0	19.7	11.6	5.0	10.7	15.4	11.5	25.1	9.4	11.0	11.1	9.6	15.1	27.9	9.3	12.2	11.6	13.3	10.2	15.3	28.6	25.0	13.2	17.1	13.8	14.7	16.0	14.5	38.4	10.9	0.0	0.8	1.3	4.4	0.7	3.5	9.8	5.2	5.6	0.7	5.8	5.8	5.9	0.9	1.7	0.7	3.1	14.6	1.9	19.0	18.2	28.3	23.8	19.7	10.7	20.3	14.7	18.2	23.0	47.6	38.1	41.7	41.8	35.5	18.7	18.5	15.3	21.4	25.0	26.2	49.1	16.2	21.6	12.4	73.4	61.8	21.2	0.0	10.8	12.8	37.0	40.7	17.4	29.3	18.3	17.5	6.9	34.4	16.8	61.5	23.6	23.6	74.2	10.0	12.1	12.6	14.1	11.5	13.8	22.1	30.4	6.5	44.0	25.6	13.5	26.7	4.9	41.5	15.5	32.6
ASZ1	"ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3"	ENSG00000154438	"Ankyrin repeat, SAM and basic leucine zipper domain containing 1"	Q8WWH4	7	117363222-117428123	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 15.7"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 87.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"Daudi: 4.0;U-266/70: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020558	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020558: AB_1845123"								"unprognostic (4.30e-1)"				"unprognostic (1.87e-1)"			"unprognostic (1.42e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	87.1	20.1	0.0	0.0	0.0	0.0	0.1
ATAD1	FLJ14600	ENSG00000138138	"ATPase family, AAA domain containing 1"	Q8NBU5	10	87751512-87841343	"Enzymes, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 802.3;Late spermatids: 1314.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037569	Uncertain		Approved	"Nucleoli rim,Mitochondria"		NA	NA			"Nucleoli rim"	Mitochondria	"HPA037569: AB_10672496"	"unprognostic (9.92e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.67e-2)"	"prognostic favorable (3.98e-6)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.22e-2)"	16.2	21.3	20.4	15.1	26.2	8.0	19.4	22.4	29.8	19.2	15.9	14.4	16.0	13.5	19.6	17.0	17.3	14.8	13.3	39.9	20.4	22.2	20.6	22.1	14.1	14.2	20.4	17.1	19.1	12.6	25.6	24.9	30.2	31.2	24.3	18.4	19.8	15.8	20.4	32.1	14.4	14.1	18.4	18.2	12.5	14.0	19.8	14.7	18.0	20.1	18.5	15.7	18.9	15.2	9.0	7.3	6.7	7.6	9.8	13.5	7.4	9.9	9.4	12.0	11.4	14.5	12.8	9.1	10.1	16.7	10.4	11.7	8.4	28.8	9.6	7.7	8.4	6.1	16.5	10.0	8.6	12.1	8.5	13.5	7.9	13.1	10.4	17.2	21.4	5.4	12.7	23.9	11.0	27.3	19.0	6.9	9.7	7.6	12.5	11.5	6.0	13.7	14.5	8.9	7.7	6.6	9.4	7.6	10.5	15.9	7.6	7.6	16.7	8.9	6.3	20.2	12.7	16.6	10.1	8.4	9.5	8.4	6.4	13.1	16.8	15.4	12.3	10.5	14.9	7.3	6.7	3.8	5.7	9.2	5.9	13.5	9.0	10.3	11.4	7.3	7.6	11.8	11.6	2.2	9.8	7.6	5.5	9.3	7.4	20.4	26.2	22.4	29.8	20.4	22.2	20.4	17.1	31.2	14.7	50.6	28.3	26.2	34.8	23.8	46.9	66.0	25.5	40.2	25.0	21.0	33.4	32.0	19.9	34.6	802.3	18.5	22.5	0.0	24.4	24.9	28.9	35.7	28.8	24.5	24.0	66.7	21.9	12.9	14.8	1314.1	33.1	25.4	30.4	15.4	23.3	53.3	31.9	26.4	44.2	23.7	46.8	58.2	38.7	58.1	20.9	26.3	73.9	29.9	22.1	44.1
ATAD3C	FLJ34599	ENSG00000215915	"ATPase family, AAA domain containing 3C"	Q5T2N8	1	1449689-1470158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 17.5;Collecting duct cells: 19.2;Distal tubular cells: 38.1"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 16.5"									HPA065305			Approved	Mitochondria		NA	NA			Mitochondria		"HPA065305: AB_2685459"	"unprognostic (9.23e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.79e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.12e-3)"	0.7	0.0	2.1	1.7	2.3	0.7	2.7	0.3	1.5	1.3	1.8			0.9	1.4	2.6	0.7	2.5	1.3	0.4	2.8	1.5	3.1	4.9	2.2	0.7	2.6		1.1	5.0	0.1	1.5	0.3		4.0	0.6		5.4	4.5	0.2	1.2	0.5	1.3	4.3	0.5	0.5	0.7			4.1		0.9	2.2	0.9	2.1	0.6	2.9	0.6	1.6	4.3	0.7	0.3	0.0	0.3	0.5	0.5	0.1	0.4	0.1	0.1	0.2	0.1	1.6	3.3	0.3	0.4	0.1	0.1	0.4	1.3	0.5	0.1	0.1	1.3	0.3	0.9	2.0	0.2	0.3	0.3	0.0	0.2	0.2	1.0	0.1	0.0	0.4	0.3	3.9	0.1	0.9	0.5	1.0	0.6	0.1	0.2	0.4	0.1	16.5	1.1	0.4	2.8	1.0	0.0	0.6	0.2	3.0	3.6	0.3	0.3	0.2	0.3	0.5	0.2	1.9	2.7	0.6	0.2	0.4	0.1	2.9	0.6	1.1	1.1	0.4	4.3	2.1	1.5	1.3	0.1	1.3	1.9	1.4	2.5	1.6	0.3	0.6	2.0	0.7											6.0	17.5	0.8	3.2	3.1	4.3	3.3	0.0	1.4	3.4	19.2	15.7	0.7	38.1	4.6	0.3	3.6	0.6	0.0	8.0	0.2	1.0	3.5	3.5	5.9	1.6	6.4	4.1	3.1	2.1	1.1	1.1	1.3	3.3	0.0	1.6	2.8	4.5	0.0	4.6	10.8	8.0	0.0	1.0	0.5	0.9	5.0	0.7	2.9	1.2	2.2
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family, AAA domain containing 5"	Q96QE3	17	30831970-30895869	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.0;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 32.2;Spermatogonia: 35.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"	Yes	No			Nucleoplasm	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	2.0	1.2	1.1	8.1	3.8	19.0	2.4	9.6	3.2	2.7	3.3	1.2	0.7	2.8	2.1	2.5	4.0	2.0	1.7	1.4	1.8	1.3	1.9	1.4	2.3	6.4	1.9	2.7	3.0	1.7	1.3	3.1	5.3	2.3	1.8	3.1	0.6	2.1	1.2	1.3	4.5	3.4	1.5	1.5	6.3	2.2	4.0	2.6	29.9	1.8	2.7	5.3	1.8	2.7	2.3	2.1	3.1	1.3	3.0	1.6	0.3	4.8	4.0	9.6	9.1	0.2	1.0	3.8	4.2	2.2	4.7	6.8	4.4	3.4	12.9	4.1	2.0	3.2	8.8	6.2	3.2	8.6	2.9	5.4	7.8	5.2	3.0	0.1	15.2	6.4	0.4	0.4	7.0	2.4	0.9	2.4	12.7	12.1	10.9	3.1	2.8	16.9	7.5	5.6	3.5	1.9	11.6	18.2	6.2	1.2	5.1	5.6	5.0	4.8	2.7	2.5	5.5	5.2	6.8	1.9	5.9	7.9	8.3	7.6	3.6	3.8	16.3	2.6	7.2	5.7	1.2	1.0	1.4	1.6	1.3	0.9	1.2	0.9	1.2	0.7	2.3	1.1	1.2	3.1	3.0	0.6	2.1	1.4	0.3	1.1	3.8	9.6	3.2	1.8	1.3	1.9	2.7	2.3	2.6	3.0	2.6	13.3	3.2	4.1	18.5	2.7	0.0	4.0	3.4	3.5	0.0	13.2	0.0	2.7	12.9	2.9	2.2	0.0	2.5	20.4	3.9	1.6	3.5	0.5	7.3	11.1	0.0	2.5	3.2	4.6	3.4	7.2	6.8	10.8	4.5	3.9	2.9	2.9	2.1	0.3	19.9	0.0	6.2	32.2	35.1	4.0	6.6	5.3	9.3	1.4
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 67.3;Late spermatids: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.9;AN3-CA: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Golgi apparatus, Cytosol"		"HPA046816: AB_2679822, HPA050999: AB_2681303"	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.35e-4)"	4.8	3.8	16.8	5.4	16.8	4.4	4.1	12.5	20.7	5.5	4.9	16.3	3.0	4.6	10.2	21.0	3.2	8.3	5.4	3.9	15.7	15.9	4.4	3.8	3.9	4.8	14.0	12.2	10.1	4.4	4.4	10.6	4.3	13.0	9.8	5.3	4.1	5.4	4.0	4.5	6.9	6.1	4.9	13.5	4.3	7.9	7.0	12.8	3.3	4.3	1.7	5.6	4.0	3.8	1.7	2.6	2.6	1.7	0.7	2.1	0.8	2.0	1.1	10.9	8.1	1.5	1.1	0.4	0.3	0.1	0.4	0.8	2.9	2.1	0.3	1.7	1.7	3.4	2.4	4.0	1.4	0.1	1.5	4.7	0.1	0.4	2.7	0.7	0.2	1.3	2.2	0.9	0.7	0.0	1.3	0.9	5.6	1.6	0.2	2.0	1.8	1.6	0.7	0.7	3.3	0.2	0.9	0.3	0.6	2.0	3.0	0.6	4.3	0.7	1.0	0.7	0.3	4.4	0.5	0.8	3.1	2.2	0.1	0.8	1.6	2.1	1.0	2.5	4.8	3.2	2.6	1.7	1.3	0.8	1.5	1.0	1.7	1.0	0.8	1.6	1.2	2.1	1.6	0.3	0.7	1.1	2.6	0.9	0.8	16.8	16.8	12.5	20.7	15.7	15.9	14.0	12.2	13.0	12.8	0.0	1.0	0.0	12.1	4.9	9.3	1.3	5.1	5.3	1.2	14.0	9.8	9.9	6.6	9.5	67.3	4.9	7.3	0.0	3.9	5.7	6.2	9.0	1.1	1.6	5.3	1.6	17.2	3.7	1.8	33.6	3.7	3.7	0.0	12.6	9.3	11.5	7.5	10.5	8.1	3.7	9.6	6.5	4.2	9.9	9.3	4.6	7.4	5.0	10.2	12.3
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA		31000000	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	11.7	19.4	23.1	13.7	29.4	24.9	14.3	20.2	19.1	17.8	20.2	15.4	9.8	11.2	19.2	32.7	20.0	27.7	15.4	11.0	19.4	11.4	13.5	14.0	15.6	17.0	20.6	16.5	22.6	18.4	38.1	16.1	21.1	16.9	16.8	18.8	14.1	16.2	14.0	7.1	17.8	15.9	9.4	12.8	22.8	20.2	19.5	17.0	21.7	21.2	11.8	21.0	18.0	16.4	4.4	5.7	6.6	4.1	5.6	4.9	4.4	0.7	2.9	8.1	3.0	6.0	6.8	2.9	3.3	3.1	7.3	9.1	9.4	15.7	14.3	11.5	29.1	10.5	4.6	10.9	21.8	5.3	2.9	12.0	1.0	15.1	10.0	19.9	1.1	17.4	11.4	9.7	1.3	20.2	18.4	19.7	26.9	18.9	19.0	18.5	7.4	10.0	7.0	2.4	14.0	0.5	0.7	3.5	6.4	6.5	1.4	0.5	0.8	14.2	7.7	19.2	3.7	24.2	1.8	8.5	4.0	4.4	6.4	9.8	19.1	8.2	6.7	9.2	6.6	9.8	6.6	2.2	1.9	4.9	4.1	4.7	4.4	2.8	2.3	5.7	3.4	1.8	3.5	2.5	5.6	3.7	3.8	4.5	4.4	23.1	29.4	20.2	19.1	19.4	11.4	20.6	16.5	16.9	17.0	11.9	14.6	95.8	29.3	22.0	84.7	1.7	45.9	28.1	10.3	52.4	90.3	71.4	5.0	39.2	2.4	30.3	49.8	0.0	37.3	41.1	28.7	30.1	16.1	18.3	46.0	41.3	51.5	37.4	39.0	3.2	65.6	45.4	30.4	53.3	48.7	43.1	31.4	49.1	48.8	11.3	83.5	58.2	28.4	71.1	55.1	22.1	74.6	74.8	52.7	35.4
ATF7	ATFA	ENSG00000170653	"Activating transcription factor 7"	P17544	12	53507856-53626410	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003384	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.59e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.28e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.17e-1)"	22.6	12.2	18.3	14.6	25.3	11.4	21.5	56.1	22.9	17.8	17.7	31.6	12.1	10.5	21.5	13.0	19.7	14.6	15.6	18.8	20.1	9.5	15.1	12.3	18.0	10.3	28.2	12.9	23.5	15.6	15.3	17.3	15.4	22.2	17.1	18.6	15.6	21.9	13.4	23.1	20.9	12.2	24.5	22.3	11.4	16.1	12.4	27.5	11.4	15.2	10.8	13.1	18.1	18.4	11.5	11.4	14.2	19.5	15.5	11.5	9.3	10.0	19.5	10.4	11.4	19.9	25.5	6.9	12.1	12.6	13.5	9.0	14.0	15.7	15.8	16.1	14.9	5.5	12.6	8.1	13.4	12.4	15.2	10.3	13.6	22.5	14.9	13.4	17.4	10.2	19.9	17.6	16.8	19.1	22.5	26.4	8.6	15.5	14.6	20.1	18.6	10.4	12.2	10.3	11.4	10.6	13.9	12.5	15.2	20.3	13.0	8.7	9.3	18.5	13.7	19.2	10.6	18.3	10.8	19.4	16.1	11.4	12.8	10.9	7.2	8.6	10.1	13.2	16.5	14.7	12.9	14.8	14.2	8.6	19.5	8.7	10.8	11.5	8.4	11.4	11.5	8.5	9.9	9.3	15.5	14.3	7.8	10.8	9.3	18.3	25.3	56.1	22.9	20.1	9.5	28.2	12.9	22.2	27.5	11.9	15.9	15.9	19.8	19.7	8.2	13.6	25.5	13.4	10.3	14.0	23.6	19.3	31.5	26.8	29.2	25.1	15.8	0.0	27.5	19.6	17.7	30.9	28.8	12.5	22.3	9.5	17.9	27.6	21.9	26.4	25.0	17.3	23.6	16.2	19.1	22.1	21.8	14.0	23.0	37.9	9.6	25.8	23.7	8.1	16.3	25.2	23.3	17.9	19.9	24.1
ATG10	"APG10L, DKFZP586I0418, FLJ13954"	ENSG00000152348	"Autophagy related 10"	Q9H0Y0	5	81972025-82276857	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044163	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA044163: AB_2678842"	"unprognostic (1.20e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.43e-1)"	8.2	9.2	8.4	6.3	13.6	8.4	11.7	11.3	15.4	7.2	8.9	14.7	7.5	5.5	12.0	13.7	10.9	7.2	7.3	8.0	8.4	7.9	9.3	10.4	7.1	8.3	10.3	13.5	5.8	9.9	23.0	9.5	7.9	11.3	9.6	10.2	12.4	8.6	9.6	10.3	10.9	6.0	9.1	10.4	6.7	7.1	27.0	8.9	22.8	11.7	4.6	9.9	9.2	8.2	7.6	11.4	12.2	9.3	9.2	8.9	6.0	3.4	9.2	6.0	17.0	4.0	7.7	15.3	4.0	3.2	2.9	4.5	2.7	12.5	6.0	3.4	6.4	22.4	2.0	4.3	8.9	3.9	10.2	3.1	6.6	8.7	2.8	3.9	3.4	5.5	7.1	6.1	4.3	3.6	4.5	5.5	13.0	7.9	5.2	10.6	6.9	7.8	4.0	8.5	2.5	6.0	5.9	8.6	14.4	7.5	4.8	8.9	12.8	6.5	3.6	7.4	10.7	7.0	6.5	4.3	5.6	5.2	2.8	8.3	7.0	11.7	8.3	7.4	8.3	8.9	3.3	9.3	12.2	8.4	8.8	7.9	5.9	7.5	7.7	11.4	7.6	7.2	8.9	12.1	9.2	6.5	8.8	7.4	6.0	8.4	13.6	11.3	15.4	8.4	7.9	10.3	13.5	11.3	8.9	14.9	14.1	6.0	15.3	22.0	16.1	7.0	12.7	9.4	18.2	12.2	9.8	22.1	13.3	13.4	56.8	11.3	7.8	0.0	16.0	38.5	13.5	10.0	10.5	11.9	15.9	17.5	9.2	9.2	11.9	69.6	6.4	17.8	30.4	20.8	7.6	11.4	14.5	9.9	9.6	13.5	14.7	0.0	13.4	45.1	18.1	28.0	17.6	15.2	10.9	11.2
ATG13	KIAA0652	ENSG00000175224	"Autophagy related 13"	O75143	11	46617527-46674818	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039350			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039350: AB_10673142"	"unprognostic (3.66e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.47e-1)"	13.8	15.8	20.2	11.9	27.3	25.8	12.5	32.8	37.0	13.2	12.6	39.5	9.2	14.3	12.9	16.8	14.9	16.6	14.5	17.8	19.5	16.3	14.3	21.1	11.5	13.6	31.8	18.2	15.6	19.7	24.4	23.1	13.5	27.2	12.8	12.0	21.3	17.0	13.5	20.9	16.3	12.4	12.3	15.7	16.2	16.5	60.6	34.9	14.8	18.6	8.8	15.8	12.5	13.0	15.8	20.0	38.9	24.0	17.0	24.7	20.3	13.8	25.5	19.6	11.5	27.3	32.1	19.8	16.2	28.7	20.0	25.7	17.3	13.9	13.0	11.5	24.4	26.0	17.0	18.8	21.9	20.3	24.6	35.9	14.0	17.8	30.4	30.7	18.6	24.3	38.6	26.2	13.8	30.5	28.6	19.7	30.4	24.4	29.8	17.9	20.8	18.5	27.6	24.5	25.5	22.1	17.7	25.4	22.8	13.4	15.3	18.7	18.8	22.4	18.0	23.9	19.7	25.7	38.5	19.4	24.7	15.1	22.7	17.6	27.2	30.1	16.5	30.6	16.9	18.1	21.2	20.7	26.9	21.3	24.0	17.2	15.8	19.2	16.8	20.0	12.7	16.6	18.3	38.9	17.0	18.7	14.9	24.7	20.3	20.2	27.3	32.8	37.0	19.5	16.3	31.8	18.2	27.2	34.9	14.9	15.2	10.4	10.0	8.2	22.0	12.4	5.1	2.7	10.3	12.2	37.3	8.7	6.6	16.3	35.8	11.7	19.0	46.7	28.1	18.9	8.4	17.1	8.1	19.4	13.5	31.8	17.2	12.9	15.2	36.4	10.6	13.5	11.8	22.6	19.5	15.2	26.0	12.2	10.6	11.2	29.7	12.9	13.7	31.1	10.4	10.0	22.1	10.9	10.4	14.3
ATG16L1	"APG16L, ATG16A, ATG16L, FLJ10035, WDR30"	ENSG00000085978	"Autophagy related 16 like 1"	Q676U5	2	233210051-233295674	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012577, HPA063900"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA012577: AB_1845155, HPA063900: AB_2685146"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.93e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.08e-1)"	7.7	8.1	7.8	15.7	16.4	28.2	11.9	25.3	22.7	9.8	12.0	13.5	7.4	11.4	12.3	14.8	11.8	8.4	9.7	11.3	9.6	9.0	10.0	15.0	8.0	11.4	10.9	9.4	9.7	12.8	11.6	6.6	8.6	12.3	13.2	13.8	9.4	11.8	10.7	19.4	16.9	11.5	10.7	9.7	12.1	13.0	16.7	9.2	13.8	12.3	10.2	14.3	11.7	12.5	3.3	2.1	4.4	6.2	6.0	7.3	3.1	10.8	11.5	4.1	6.9	10.7	7.8	13.1	9.9	7.9	8.9	8.4	8.4	7.8	2.8	3.6	8.2	11.6	5.5	9.1	4.8	7.9	5.4	7.8	6.5	7.4	13.3	8.1	5.4	8.3	4.2	8.5	10.4	8.5	5.6	8.6	3.9	6.7	2.8	7.8	8.9	5.6	10.7	17.5	10.6	12.8	4.0	9.5	2.3	7.9	7.1	8.4	5.8	6.8	8.4	5.1	6.9	5.0	5.8	10.1	5.6	4.6	8.9	8.3	6.3	3.3	5.2	9.2	5.5	8.9	0.0	2.5	4.4	7.3	2.0	6.0	3.3	5.0	6.4	2.1	3.2	5.6	5.5	1.7	6.0	6.2	1.1	5.6	3.1	7.8	16.4	25.3	22.7	9.6	9.0	10.9	9.4	12.3	9.2	6.0	8.0	7.4	4.2	8.0	5.7	3.6	2.5	14.7	11.4	5.2	3.9	4.3	5.0	6.1	0.7	5.6	8.1	0.0	6.0	5.1	4.7	5.6	9.2	8.3	4.8	1.6	8.6	7.4	5.7	1.3	3.7	3.9	10.1	6.4	4.6	7.2	12.1	7.0	3.5	4.5	15.7	6.5	6.5	9.7	15.6	11.5	3.1	13.8	7.3	4.5
ATG4A	"APG4A, AUTL2"	ENSG00000101844	"Autophagy related 4A cysteine peptidase"	Q8WYN0	X	108091668-108154671	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 40.9"					"Low region specificity"	"Detected in all"			"HPA036374, HPA064759"	Uncertain		Approved	"Actin filaments,Microtubules"		NA	NA			Microtubules	"Actin filaments"	"HPA036374: AB_10672354, HPA064759: AB_2685346"	"prognostic unfavorable (1.36e-5)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.03e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.20e-2)"	8.2	11.8	6.4	6.1	8.0	6.1	7.4	9.7	6.2	6.8	10.0	5.5	8.6	10.3	6.9	10.4	10.6	5.4	6.5	10.9	4.3	3.2	15.3	23.4	10.8	8.2	6.9	5.7	4.7	22.3	8.2	13.1	7.9	7.2	6.6	11.3	6.7	17.2	6.2	18.8	6.3	18.7	7.2	6.7	10.5	12.9	3.1	8.2	12.0	12.0	7.4	10.5	7.4	7.8	8.7	9.8	18.7	9.9	10.0	11.9	7.4	5.9	2.9	1.9	3.6	18.8	6.4	2.4	8.4	5.2	4.3	5.1	2.4	3.3	6.6	7.6	6.6	7.0	2.9	5.7	6.1	6.5	11.0	6.2	2.7	5.2	1.5	4.1	5.9	9.1	6.7	6.5	5.3	2.1	4.1	40.9	9.2	8.5	20.9	7.9	5.4	5.5	5.4	3.6	11.0	8.6	3.8	3.3	9.4	6.3	5.3	2.7	2.1	5.3	6.6	3.5	6.2	3.2	5.4	11.3	2.5	1.2	9.1	4.5	9.7	11.0	7.1	5.3	6.7	3.8	18.7	7.0	13.1	11.6	9.9	8.3	8.7	8.9	10.9	9.8	7.6	7.0	11.9	2.2	10.0	6.7	4.6	9.2	7.4	6.4	8.0	9.7	6.2	4.3	3.2	6.9	5.7	7.2	8.2	3.0	10.1	5.2	4.1	4.5	2.5	17.0	7.6	17.4	6.8	5.2	3.9	5.3	23.2	8.3	5.6	8.5	13.5	0.0	15.5	6.4	5.2	6.9	3.5	12.1	8.0	1.6	6.4	8.6	4.3	7.0	2.6	6.1	13.5	2.8	7.2	7.8	13.0	5.8	7.1	18.8	4.8	0.0	8.0	2.3	3.8	4.5	8.7	9.5	3.5	6.3
ATG4B	"Apg4B, AUTL1, DKFZp586D1822, KIAA0943"	ENSG00000168397	"Autophagy related 4B cysteine peptidase"	Q9Y4P1	2	241637213-241673857	"Enzymes, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037195, HPA069803"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB037195: AB_1078237, HPA069803: AB_2686200"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.60e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.64e-4)"	10.9	16.5	19.6	16.6	21.3	31.3	15.1	34.8	25.7	13.5	18.7	21.7	23.2	14.6	33.5	24.0	26.7	17.7	18.8	19.5	20.5	21.5	17.2	15.5	15.8	19.4	29.2	19.7	17.3	19.2	18.7	27.4	15.4	20.3	20.5	18.9	20.8	22.8	14.2	17.2	26.6	21.1	18.9	23.1	18.7	15.5	28.0	21.4	21.2	18.2	7.3	21.9	15.3	14.4	16.5	20.3	18.9	18.6	11.4	19.6	16.8	8.7	13.6	19.5	15.0	19.5	14.2	19.3	12.8	14.0	16.6	13.8	14.9	15.5	6.7	5.8	23.0	13.4	12.9	18.5	24.4	16.1	14.3	18.8	19.8	22.0	32.2	25.4	11.4	11.1	14.1	17.0	18.6	18.0	17.7	17.1	26.1	16.8	10.3	18.8	21.4	20.4	20.1	22.7	15.7	14.5	35.2	17.9	10.1	13.0	28.3	19.5	13.5	10.9	14.5	15.3	16.6	16.0	16.8	18.6	15.8	10.8	10.5	13.8	11.6	12.1	25.7	19.2	14.2	14.8	4.6	18.6	18.9	18.7	15.5	15.5	15.7	15.2	16.5	20.3	16.5	19.6	14.7	14.8	11.4	16.2	16.3	19.3	16.8	19.6	21.3	34.8	25.7	20.5	21.5	29.2	19.7	20.3	21.4	29.8	35.6	22.7	23.7	21.6	21.6	14.1	33.1	10.7	13.6	26.2	31.4	31.0	16.6	32.4	12.9	23.6	57.6	23.3	34.9	23.5	23.5	30.3	18.5	24.9	29.3	39.7	34.4	24.5	27.8	19.8	20.4	31.5	27.0	64.1	34.3	30.2	33.1	28.1	23.3	18.2	25.2	19.4	23.4	44.0	53.5	22.2	45.1	33.0	27.0	27.5
ATG4C	"APG4C, AUTL1, AUTL3, FLJ14867"	ENSG00000125703	"Autophagy related 4C cysteine peptidase"	Q96DT6	1	62784135-62865513	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007049	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007049: AB_1845159"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (9.83e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	8.8	9.8	19.4	11.3	32.8	6.0	9.2	16.7	23.4	10.6	9.5	29.8	7.2	7.7	9.6	7.2	8.6	8.0	10.4	7.2	23.7	15.5	13.5	12.6	9.2	13.7	42.6	16.5	10.3	11.2	15.5	11.3	15.0	22.4	8.0	10.6	4.9	10.8	8.0	6.4	6.3	7.8	11.2	26.5	13.3	8.6	8.9	40.4	11.0	12.0	3.7	12.4	13.4	6.8	20.6	19.4	16.0	10.9	7.0	9.4	6.7	7.6	6.1	9.5	8.3	12.5	13.5	9.5	11.5	7.8	11.1	12.5	4.5	6.1	16.3	8.9	5.8	13.0	5.9	11.3	8.7	16.1	12.2	10.4	18.3	6.5	5.8	8.9	14.8	12.3	11.1	6.2	11.8	5.6	10.8	13.3	18.0	15.5	13.3	9.3	3.6	14.9	5.7	13.9	11.0	10.1	17.9	22.8	11.5	8.0	5.6	12.9	6.5	7.6	14.4	14.8	17.2	7.0	7.0	5.2	8.9	8.7	15.0	12.6	11.6	15.6	13.3	10.2	14.7	10.7	16.0	10.9	8.5	4.8	8.8	6.6	20.6	6.6	5.6	19.4	19.1	9.4	7.7	1.6	7.0	5.0	11.6	5.7	6.7	19.4	32.8	16.7	23.4	23.7	15.5	42.6	16.5	22.4	40.4	6.0	8.8	28.4	6.2	4.4	5.1	8.1	10.2	1.4	9.1	7.0	2.0	33.2	16.6	6.4	1.3	11.6	3.6	0.0	7.3	24.5	8.4	4.1	11.5	8.9	31.5	4.8	5.8	13.5	18.6	1.4	8.1	20.5	8.5	30.7	4.4	9.7	4.5	4.5	9.2	19.9	5.1	6.5	7.6	30.5	13.3	3.4	24.3	9.6	6.6	2.7
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	6.4	10.8	5.1	9.2	7.8	35.0	6.3	15.6	14.9	6.2	18.4	9.8	8.1	26.0	6.1	7.2	18.4	5.5	7.6	15.4	4.6	4.9	14.5	8.8	7.3	9.8	9.6	6.4	7.0	16.1	8.2	12.1	6.9	7.3	9.7	7.3	7.8	11.5	8.5	31.5	17.7	27.3	4.0	4.5	12.0	10.5	29.0	8.8	19.9	9.8	16.4	10.5	7.5	9.6	2.0	7.6	5.7	1.6	2.2	3.6	1.4	7.0	4.7	6.6	8.9	1.2	1.0	5.1	4.3	4.3	6.2	6.8	7.9	2.3	4.5	8.2	0.5	4.7	11.1	4.1	3.7	0.8	4.4	10.7	12.0	11.5	4.4	4.1	4.8	12.3	1.0	7.7	5.3	1.9	1.6	1.8	9.9	8.9	11.0	1.9	11.3	14.1	29.3	10.0	3.2	12.9	10.4	4.1	8.0	3.5	9.5	24.8	9.6	6.4	12.5	4.9	1.2	7.7	11.8	3.4	9.5	6.0	19.0	9.6	9.8	6.6	5.3	8.1	9.3	10.7	3.0	1.6	5.7	2.1	1.5	3.1	2.0	2.5	2.3	1.1	1.0	2.5	3.4	0.5	2.2	0.7	7.6	3.6	1.4	5.1	7.8	15.6	14.9	4.6	4.9	9.6	6.4	7.3	8.8	8.9	10.0	8.8	18.9	27.1	15.0	0.4	17.8	2.7	1.2	1.8	13.7	23.7	11.6	14.3	51.1	4.1	90.5	23.3	14.4	5.4	10.1	17.3	6.9	9.7	11.7	27.0	21.4	5.5	12.0	6.8	8.1	8.7	11.8	19.0	28.4	10.6	16.6	38.2	4.2	16.8	17.6	12.9	16.0	63.1	19.6	27.4	30.6	21.3	23.3	29.3
ATG5	"APG5, APG5L, ASP, hAPG5"	ENSG00000057663	"Autophagy related 5"	Q9H1Y0	6	106045423-106325791	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Host-virus interaction, Immunity"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034432, CAB037309, HPA042973"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA			Centrosome		"CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246"	"unprognostic (1.21e-3)"	"unprognostic (6.53e-3)"	"unprognostic (2.68e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.42e-2)"	18.0	28.5	16.1	15.6	17.2	9.4	21.4	16.0	21.4	23.0	20.9	10.5	14.1	16.9	21.5	23.2	16.7	20.6	12.8	14.0	15.1	15.4	20.5	23.6	15.4	18.1	14.7	15.8	21.0	16.7	12.8	23.3	26.9	17.0	22.9	20.6	11.0	16.5	21.7	20.4	10.9	28.6	19.7	14.9	20.3	16.4	13.0	10.2	23.3	24.9	14.7	18.0	20.7	21.0	7.3	6.8	11.6	10.5	6.5	12.9	4.9	8.2	3.6	6.0	8.1	14.0	15.0	6.3	8.8	14.1	13.0	16.0	3.5	5.0	5.8	7.1	13.4	14.7	5.9	8.7	12.9	23.0	2.5	4.9	6.8	4.5	4.4	14.9	8.0	3.5	11.6	14.4	9.3	11.8	17.6	13.7	5.4	9.8	5.8	14.7	3.8	3.3	9.7	6.9	10.8	4.9	3.4	14.2	4.5	14.1	5.9	4.6	4.3	5.4	10.2	8.0	11.3	5.0	15.5	11.3	5.1	2.9	5.9	15.0	2.4	2.3	5.4	18.9	11.0	9.3	5.1	6.5	11.6	4.8	7.7	12.9	7.3	8.5	6.6	6.8	5.2	9.3	7.9	5.5	6.5	10.5	2.6	9.0	4.9	16.1	17.2	16.0	21.4	15.1	15.4	14.7	15.8	17.0	10.2	20.8	17.6	31.9	25.7	23.4	13.5	16.2	22.9	24.1	34.2	24.4	15.7	40.8	24.9	34.0	26.6	23.2	39.5	0.0	39.3	52.7	23.5	33.0	19.7	18.7	34.1	19.1	18.5	21.5	27.2	9.5	19.0	26.9	21.9	53.3	36.4	17.1	32.5	59.6	17.0	30.7	17.2	25.8	29.7	25.0	38.2	23.7	55.6	34.1	30.0	39.1
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		13000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	27.0	18.6	14.8	21.1	21.9	37.5	16.6	14.1	29.2	16.4	15.2	26.2	13.4	11.6	28.9	15.9	18.9	17.4	15.1	12.3	14.0	13.1	13.1	11.8	18.4	18.8	14.8	17.1	15.5	13.1	18.7	23.0	18.7	21.6	12.9	17.8	19.3	16.6	11.6	15.8	22.2	16.9	18.3	16.6	19.7	13.1	19.7	13.9	17.7	12.7	12.2	21.6	16.5	15.2	4.0	23.8	31.3	39.7	5.9	4.8	14.2	18.4	14.6	6.5	3.4	11.5	15.2	32.4	17.4	22.7	17.4	20.3	6.2	16.8	8.5	10.6	15.4	18.1	5.7	7.2	24.4	30.0	7.5	9.1	6.1	14.1	7.4	15.2	17.6	20.3	15.6	11.3	33.7	21.2	18.0	24.0	5.4	9.0	7.0	24.1	12.0	5.0	8.2	5.1	8.5	18.9	6.3	7.8	7.5	13.1	13.3	5.8	5.7	12.4	10.5	6.7	8.4	11.4	17.2	16.3	14.3	10.4	9.4	24.3	4.5	11.7	14.3	23.2	16.6	19.3	13.1	39.7	24.5	4.8	22.9	3.7	4.0	4.0	4.5	23.8	3.7	3.5	4.2	31.3	5.9	16.3	4.2	3.4	14.2	14.8	21.9	14.1	29.2	14.0	13.1	14.8	17.1	21.6	13.9	0.0	9.8	6.1	6.1	9.8	11.1	3.9	0.0	12.0	5.7	7.0	17.7	13.7	6.6	10.0	41.0	10.5	6.9	23.3	11.3	14.0	8.9	5.5	14.9	7.8	50.1	19.1	10.9	20.9	20.3	78.6	9.5	19.9	3.3	9.0	7.0	9.3	12.7	7.0	9.2	5.4	12.5	6.5	5.1	19.5	11.5	6.8	16.0	10.0	7.3	7.3
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311817-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 144.4;Extravillous trophoblasts: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		3400000	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	19.4	27.4	21.1	23.0	28.4	16.9	24.8	12.1	32.3	20.6	26.7	29.1	18.1	23.4	27.9	15.6	19.1	21.9	19.1	18.2	20.3	21.1	23.1	35.6	17.3	36.1	29.7	19.9	23.4	32.9	25.1	21.1	31.1	24.4	21.9	35.9	19.5	14.4	29.4	35.5	17.0	20.6	26.7	21.7	29.0	20.4	15.0	28.0	46.3	16.1	13.5	35.3	27.6	18.0	21.7	13.4	2.9	8.9	19.6	22.8	10.0	20.5	31.1	17.4	29.5	23.4	23.7	8.7	21.0	18.3	24.0	27.6	60.0	32.2	29.9	26.0	21.9	33.8	21.6	38.2	31.7	34.5	22.3	36.9	36.4	26.7	53.7	30.3	45.6	18.7	20.0	24.3	32.1	38.8	16.6	16.0	29.0	47.0	25.0	33.0	30.3	39.7	22.2	66.8	32.9	17.5	36.9	25.0	26.8	25.5	33.2	27.3	18.9	16.9	20.8	23.7	40.4	34.1	16.2	14.1	20.4	21.1	26.3	13.2	31.6	41.2	62.1	17.7	25.4	29.4	2.9	6.0	0.1	13.2	8.9	22.8	21.7	18.6	20.0	13.4	13.2	18.9	17.5	0.7	19.6	7.4	11.7	17.7	10.0	21.1	28.4	12.1	32.3	20.3	21.1	29.7	19.9	24.4	28.0	11.9	17.1	19.3	23.5	13.4	9.6	18.5	25.5	26.8	19.4	22.7	3.9	144.4	23.2	32.2	0.8	6.3	13.5	0.0	42.8	132.7	23.3	16.1	24.3	18.7	46.4	9.5	18.5	4.3	15.0	0.0	22.2	18.7	28.7	32.5	29.9	20.6	30.0	21.0	32.2	44.0	12.8	25.8	19.8	3.2	40.3	7.4	79.8	21.5	52.7	17.4
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"intestine: 29.5"	"Cell type enriched"	"Detected in some"	36	"Mucus-secreting cells: 198.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HL-60: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA049400: "			"prognostic favorable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.1	6.4	0.1	0.0	0.1	0.1	0.1	0.1	22.5	0.0	0.0	8.8	0.1	0.0	0.1	0.1	2.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	15.0	0.0	0.1	0.0	0.0	0.1	29.5	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.2	0.5	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0
ATOX1	HAH1	ENSG00000177556	"Antioxidant 1 copper chaperone"	O00244	5	151742316-151772532	"Predicted intracellular proteins"	"Copper transport, Ion transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 744.7;Proximal tubular cells: 898.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055036			Approved	"Nucleoplasm,Plasma membrane"		NA	NA		27000	Nucleoplasm	"Plasma membrane"	"HPA055036: "	"unprognostic (5.55e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.53e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-1)"	27.0	37.2	43.1	25.6	40.4	23.4	39.1	22.8	38.5	29.0	23.9	29.7	32.3	30.2	21.4	37.6	28.4	24.5	33.4	27.7	37.5	45.7	50.5	96.1	21.3	48.9	54.3	37.0	16.2	29.0	31.5	23.0	25.6	35.2	25.7	24.4	25.0	34.7	29.8	12.8	26.3	31.6	28.1	46.5	34.1	21.0	28.7	33.8	24.5	36.3	29.7	44.8	27.2	22.1	22.5	49.9	43.3	54.8	20.1	22.8	24.2	14.1	23.3	13.7	9.5	36.6	30.0	18.1	25.6	29.0	25.8	35.2	31.5	30.6	28.5	31.2	43.8	57.9	13.2	16.6	64.1	21.2	18.3	28.4	12.5	15.1	32.0	34.1	17.2	14.3	38.7	13.5	32.3	21.3	19.1	37.7	17.9	10.3	84.2	39.0	34.7	12.7	38.2	7.8	31.7	48.9	7.8	15.8	44.0	24.7	12.3	18.0	10.6	21.9	62.6	95.4	16.2	30.6	21.1	42.2	26.8	21.3	32.6	44.3	69.6	61.1	17.0	36.3	11.7	110.2	27.5	48.7	43.3	18.3	54.8	16.7	22.5	16.6	15.8	39.1	16.2	13.2	14.3	36.4	20.1	37.4	49.9	22.8	24.2	43.1	40.4	22.8	38.5	37.5	45.7	54.3	37.0	35.2	33.8	53.6	54.1	119.1	60.7	60.1	20.6	93.1	175.8	60.2	37.5	200.7	13.7	132.7	459.3	179.7	119.0	146.1	314.3	70.0	138.4	184.0	143.5	107.5	72.6	744.7	575.7	23.8	144.8	249.2	183.4	241.2	76.8	138.6	226.0	621.2	138.5	98.0	246.1	221.7	97.2	898.1	22.2	90.5	140.1	71.6	147.1	93.1	99.3	57.9	140.1	99.5
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485288-47593486	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 55.7"	"Cell type enhanced"	"Detected in many"	11	"Leydig cells: 57.5;Syncytiotrophoblasts: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 31.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 24.4"									HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	8.1	9.7	7.6	6.8	8.0	1.4	6.9	3.9	7.5	10.2	7.4	5.2	10.4	4.5	12.9	10.1	15.2	6.7	8.6	7.4	7.3	4.0	14.5	5.8	9.4	6.7	7.0	4.8	10.0	6.2	16.9	18.6	55.7	8.1	8.1	4.5	7.7	7.5	11.5	2.8	14.8	6.0	11.4	8.9	12.7	7.6	3.9	7.3	3.6	10.7	5.4	9.2	9.9	13.1	3.6	1.8	31.5	2.9	1.0	0.9	0.6	1.4	1.0	2.3	1.6	6.7	7.3	0.4	10.4	12.6	5.0	9.0	5.4	9.0	4.6	3.9	16.8	8.5	2.7	24.4	8.7	7.7	1.8	1.9	3.7	1.7	0.3	6.0	1.1	2.3	6.3	6.7	9.8	6.5	16.5	8.4	2.3	0.0	2.5	13.6	0.5	2.4	0.7	0.8	0.0	1.3	2.8	5.3	0.0	9.1	1.8	1.5	2.9	4.8	1.2	3.1	5.4	2.2	1.2	12.7	12.4	2.5	1.1	4.5	1.1	0.8	0.0	6.1	6.9	3.9	31.5	1.4	0.1	0.6	2.3	0.9	1.3	0.2	0.3	1.8	3.6	0.0	0.4	0.7	1.0	2.9	1.1	0.3	0.6	7.6	8.0	3.9	7.5	7.3	4.0	7.0	4.8	8.1	7.3	8.9	6.9	15.0	7.9	17.1	10.9	3.6	0.0	2.7	2.3	15.7	29.5	27.1	1.7	4.3	1.6	14.0	1.6	0.0	4.1	7.4	11.8	5.8	2.3	4.9	11.7	12.7	9.2	17.8	16.1	0.6	57.5	9.1	6.8	7.2	4.3	28.8	2.7	2.5	23.7	9.1	8.9	25.8	9.8	0.4	2.7	23.6	147.8	11.5	3.7	6.5
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793500-182921635	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	16.8	7.9	7.7	19.7	9.8	35.4	17.0	18.4	9.4	20.5	21.6	8.9	14.3	13.6	15.0	11.7	37.3	11.8	12.7	21.1	6.9	5.9	13.7	14.3	19.4	20.3	10.3	5.7	15.2	14.6	21.0	26.0	8.0	8.3	16.8	16.9	9.8	19.7	13.8	13.1	21.8	22.8	16.5	11.3	23.4	27.6	22.8	8.9	49.0	10.8	20.4	21.9	22.7	25.5	3.6	4.2	7.5	1.8	3.0	3.4	1.3	22.7	3.3	7.2	10.0	15.3	16.8	6.6	10.5	14.5	8.2	9.6	8.1	11.8	10.6	18.0	15.1	17.1	13.8	8.5	10.8	14.3	23.4	6.8	25.4	4.4	1.7	8.9	20.0	16.3	11.3	12.3	9.2	13.3	12.1	12.8	16.9	9.0	32.9	13.2	7.7	16.6	6.4	5.1	12.9	6.4	6.9	21.0	12.7	9.9	19.1	4.3	7.7	29.3	3.7	12.8	6.8	4.1	14.9	12.6	12.5	13.5	10.7	18.2	45.0	40.2	19.8	8.6	8.6	7.3	7.5	1.7	7.2	3.1	1.8	3.0	3.6	2.7	3.1	1.9	2.4	2.3	3.4	6.8	3.0	1.7	4.2	2.0	1.3	7.7	9.8	18.4	9.4	6.9	5.9	10.3	5.7	8.3	8.9	14.9	10.4	9.7	20.0	30.5	11.4	15.9	17.8	6.7	11.4	19.2	13.7	9.6	0.0	10.9	27.7	14.5	26.1	46.7	14.4	3.2	14.9	34.3	10.5	13.6	9.2	36.5	6.4	14.1	17.8	19.9	17.8	17.7	13.5	5.4	27.5	8.1	20.8	27.1	19.8	6.2	28.3	19.4	16.5	15.4	10.7	39.0	8.0	24.9	20.4	44.2
ATP12A	"#945, 2, ATP1AL1, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680411-24712493	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.3;lymphoid tissue: 38.4"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 5.3;Club cells: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	5	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	8	"SuSa: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.2	1.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	12.3	0.1	0.0	0.1	0.3	0.2	8.8	0.1	6.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	5.8	0.4	0.3	2.2	0.0	0.4	0.0	0.1	9.8	0.1	0.0	0.1	0.1	0.1	1.0	0.0	1.2	0.2	2.9	38.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.2	1.3	0.3	0.2	0.1	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	5.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.2
ATP13A1	"ATP13A, CGI-152, FLJ31858, KIAA1825"	ENSG00000105726	"ATPase 13A1"	Q9HD20	19	19645198-19663693	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031798, HPA049717"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA031798: AB_2674048, HPA049717: AB_2680858"	"unprognostic (2.08e-1)"	"unprognostic (4.92e-2)"	"unprognostic (4.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.40e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.43e-3)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-1)"	13.7	20.8	18.6	22.6	20.4	16.0	15.4	19.9	22.4	16.6	15.3	18.9	11.7	20.5	19.1	13.3	17.5	17.4	15.8	11.4	14.4	11.5	17.6	22.9	15.6	23.9	21.6	14.5	24.6	23.4	38.1	21.0	15.4	15.7	16.8	15.0	18.4	18.9	16.8	13.5	17.0	23.2	13.2	16.1	29.9	18.1	16.7	20.7	24.7	23.1	11.0	22.2	15.4	15.6	3.1	8.1	4.1	10.8	1.8	4.5	2.6	12.3	17.4	9.6	20.7	15.4	10.3	26.1	11.2	15.7	9.7	9.9	16.6	21.1	17.1	19.3	13.2	5.5	6.9	14.5	14.3	5.3	6.2	30.1	9.3	17.4	13.0	15.9	17.6	27.8	14.8	13.5	10.5	12.7	10.8	7.0	12.5	16.0	38.3	9.6	20.4	11.8	12.7	17.5	15.4	21.4	9.4	6.8	38.0	10.3	17.2	13.3	22.5	10.3	16.7	11.6	4.7	10.5	19.3	11.1	20.6	3.1	23.3	13.4	31.2	18.6	10.2	14.4	22.7	15.4	0.0	4.2	4.1	3.9	7.4	4.2	3.1	4.5	4.1	8.1	2.7	3.0	3.7	0.1	1.8	10.8	6.3	3.7	2.6	18.6	20.4	19.9	22.4	14.4	11.5	21.6	14.5	15.7	20.7	8.9	8.0	20.4	6.7	5.3	10.5	4.7	10.2	2.7	3.4	14.0	17.7	16.5	1.7	16.9	8.1	6.8	26.2	0.0	15.7	15.4	8.2	10.0	5.7	12.1	18.3	4.8	17.9	11.1	12.1	3.6	13.0	9.2	6.8	11.8	19.8	12.0	14.5	20.4	9.2	6.2	10.7	6.5	5.4	12.1	14.3	5.4	12.8	7.5	17.7	5.5
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	27.1	14.4	9.0	20.8	12.7	17.5	22.8	15.3	13.8	12.1	13.4	10.8	17.2	11.4	16.2	13.2	12.4	11.3	17.1	37.8	9.6	8.1	29.7	56.9	22.1	11.6	10.1	8.3	13.2	11.4	37.6	10.6	28.9	10.6	11.8	12.6	12.9	16.7	15.9	11.8	7.7	15.0	12.1	9.0	17.1	16.3	8.8	8.4	18.9	37.1	12.0	12.7	17.8	16.1	1.9	2.4	2.3	2.3	2.2	4.7	1.0	49.1	5.6	10.0	9.5	11.4	17.8	24.4	16.9	18.4	18.4	33.5	30.8	12.0	19.4	50.3	24.3	61.0	16.7	9.6	16.8	42.8	64.7	8.3	10.7	7.4	6.5	19.8	34.8	28.1	8.1	7.5	38.2	24.9	30.2	9.5	12.0	12.3	39.3	22.3	8.4	14.0	6.9	9.5	16.1	9.7	12.8	21.6	11.6	15.6	15.7	15.4	8.1	17.9	18.6	12.5	8.8	35.7	24.4	12.4	22.5	18.7	44.6	31.5	25.9	46.7	34.5	44.6	20.7	15.5	1.8	1.7	2.3	1.8	2.3	2.2	1.9	1.7	2.8	2.4	1.1	2.5	2.5	0.3	2.2	0.9	1.6	4.7	1.0	9.0	12.7	15.3	13.8	9.6	8.1	10.1	8.3	10.6	8.4	47.6	35.1	27.9	35.7	73.3	24.1	34.6	96.8	24.1	37.5	47.1	19.6	25.7	3.3	56.7	1.9	46.6	20.8	0.0	60.7	16.3	46.0	62.6	8.1	112.9	37.1	14.3	29.4	49.1	35.1	1.1	9.5	48.5	59.1	8.2	21.5	10.3	76.7	20.4	12.4	39.8	13.3	12.9	36.0	14.0	7.0	62.2	54.0	20.1	19.9	58.3
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193402077-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2"	"Cell type enhanced"	"Detected in many"	19	"Alveolar cells type 1: 59.6;Alveolar cells type 2: 19.6;Cholangiocytes: 12.7;Ciliated cells: 13.4;Club cells: 22.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051932			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.6	0.7	11.2	0.6	11.1	0.6	17.8	2.6	10.1	1.8	2.2	8.4	9.0	0.9	0.6	46.4	11.8	2.7	4.3	0.6	11.1	5.1	0.8	0.7	22.0	0.8	7.5	7.7	0.8	3.9	52.5	3.5	0.6	9.0	0.6	3.2	0.5	4.5	16.7	0.6	11.2	0.6	0.7	6.1	0.7	7.6	0.8	7.5	0.0	51.2	7.8	9.5	0.6	3.7	0.4	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	9.4	0.2	0.1	1.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	1.9	1.0	1.5	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	11.2	11.1	2.6	10.1	11.1	5.1	7.5	7.7	9.0	7.5	59.6	19.6	0.0	0.0	0.1	1.9	0.4	12.7	13.4	22.7	0.0	0.0	0.8	0.0	2.1	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	1.1	0.0	0.2	1.6	0.0	1.8	0.8	0.8	0.0	0.6	1.7	0.0	1.5	0.6	1.2	1.7	0.4	0.2	0.9	0.0	0.0	0.7	1.2	1.4	0.6	0.8	1.7	0.0
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 13.7;Late spermatids: 2.9;Rod photoreceptor cells: 4.6;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Not detected"	"Not detected"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.8	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	3.2	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.6	4.1	1.1	0.6	0.5	4.9	0.2	14.3	5.2	6.5	0.3	9.7	10.9	6.1	9.7	1.8	7.4	16.9	6.8	5.7	0.0	0.6	6.2	4.9	3.3	4.5	3.4	3.7	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.8	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.3	0.0	0.0	0.0	0.0	13.7	0.3	0.0	0.1	1.0	0.0	0.5	0.0	0.2	0.1	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.0	0.1	0.5	0.2	0.3	0.0	0.0	4.6	0.0	0.0	1.8	3.0	0.1	0.6	0.0	0.6	0.0
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.0;salivary gland: 35.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 42.2;Ciliated cells: 72.3;Mucus-secreting cells: 62.9;Undifferentiated cells: 69.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.5;OE19: 26.0;RT4: 11.4;SK-BR-3: 20.2;T-47d: 6.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.3	0.0	2.1	8.0	1.5	6.1	2.5	0.2	2.0	3.5	23.0	0.5	1.9	16.3	1.8	1.9	2.7	4.0	18.8	0.4	1.8	1.9	2.6	0.2	21.9	0.2	1.3	0.7	1.3	0.5	0.0	2.9	4.8	0.7	7.9	21.9	1.0	35.8	0.2	0.9	15.2	14.5	0.5	0.6	0.2	3.4	0.4	0.4	0.3	8.2	2.2	8.1	4.8	7.8	0.0	0.0	2.7	0.0	0.0	0.1	0.0	3.6	0.2	0.4	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	3.4	3.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	26.0	0.1	0.0	0.0	0.1	0.0	11.4	2.9	0.0	0.0	20.2	0.1	0.5	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	2.0	1.8	1.9	1.3	0.7	0.7	0.4	29.8	42.2	0.0	12.3	0.6	1.4	0.6	2.5	72.3	29.6	0.0	0.0	1.9	0.0	7.2	3.0	0.6	15.4	0.0	2.3	2.2	0.3	21.6	9.2	0.0	0.2	0.0	32.8	0.0	0.0	1.1	0.0	0.7	1.7	0.0	62.9	1.3	3.1	17.3	0.0	1.9	5.6	0.0	0.5	0.7	0.6	1.0	20.1	0.0	69.5	9.5
ATP5MF-PTCD1	ATP5J2-PTCD1	ENSG00000248919	"ATP5MF-PTCD1 readthrough"		7	99419749-99466197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"Ciliated cells: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020106, HPA047679"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020106: AB_2176551, HPA047679: AB_2680119"	"unprognostic (1.15e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.84e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.50e-2)"	9.3	10.3	7.5	8.6	9.2	1.2	8.1	8.2	13.0	9.6	12.4	3.6	9.2	8.7	10.4	8.1	14.8	11.0	8.3	18.6	8.3	6.7	14.5	23.6	7.0	7.8	6.2	10.2	9.0	15.6	11.5	7.1	8.3	8.3	12.3	7.2	6.8	13.9	12.1	35.7	8.7	15.0	8.4	6.7	8.3	8.9	14.2	5.4	12.7	8.7	24.8	8.6	14.1	10.4	4.2	8.7	1.8	8.3	6.2	6.1	6.8	5.5	6.1	5.1	14.4	6.3	3.7	10.9	3.8	4.6	9.7	8.8	23.3	9.2	7.3	9.5	3.6	9.0	5.5	8.7	7.9	4.1	8.1	8.2	4.2	4.1	4.8	6.7	5.7	4.5	6.3	7.1	8.7	7.1	3.6	4.0	8.6	13.9	11.1	6.2	11.6	13.1	7.5	9.0	9.6	7.9	7.1	4.8	19.3	5.2	1.9	6.7	6.7	8.2	14.0	8.3	3.6	6.9	9.1	2.4	6.8	6.1	14.2	10.0	8.9	7.6	11.5	5.0	6.5	12.1	1.8	6.3	1.7	5.5	8.3	5.8	3.6	4.6	4.6	8.7	4.2	4.9	6.1	0.5	6.2	4.8	4.3	3.5	6.8	7.5	9.2	8.2	13.0	8.3	6.7	6.2	10.2	8.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP5PO	"ATP5O, ATPO, OSCP"	ENSG00000241837	"ATP synthase peripheral stalk subunit OSCP"	P48047	21	33903453-33915980	"Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Distal tubular cells: 1520.3;Proximal tubular cells: 981.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB016209, HPA041394"	Enhanced		Approved	Mitochondria		NA	NA		4000000	Mitochondria		"CAB016209: AB_631361, HPA041394: AB_2677450"	"unprognostic (2.08e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.89e-3)"	32.6	26.8	49.3	27.7	43.5	34.9	37.8	35.0	44.8	28.7	45.0	21.6	24.2	48.2	25.1	34.3	44.2	28.9	30.3	139.4	40.8	36.7	61.3	57.5	20.6	31.5	45.6	38.4	38.0	40.1	29.5	19.2	25.1	46.4	32.5	52.4	27.2	38.8	28.6	130.6	28.7	57.5	34.8	29.3	27.3	43.2	25.4	20.1	42.7	37.4	98.0	36.2	39.4	26.5	71.9	94.0	48.5	71.5	46.8	73.3	112.2	41.5	19.5	54.4	53.3	37.4	48.0	60.6	23.8	41.8	40.1	39.3	57.2	40.4	55.8	20.5	36.1	39.9	23.6	58.6	81.3	47.5	41.5	58.5	83.6	31.2	56.8	43.1	63.3	29.0	48.8	49.8	38.8	63.7	45.2	55.1	46.1	67.1	72.4	51.5	42.8	48.2	62.2	62.1	105.6	57.8	49.8	53.8	105.2	109.8	37.0	44.0	25.5	40.9	61.2	54.1	49.3	61.7	70.0	31.1	26.4	31.5	47.0	26.9	47.8	52.2	58.4	48.6	108.7	38.0	33.4	69.9	48.5	44.5	71.5	53.0	71.9	58.8	52.9	94.0	59.0	73.3	61.5	17.2	46.8	62.6	55.9	70.1	112.2	49.3	43.5	35.0	44.8	40.8	36.7	45.6	38.4	46.4	20.1	226.3	164.6	0.0	0.0	0.0	0.0	0.0	0.0	187.4	223.0	211.1	0.0	511.4	1520.3	335.0	0.0	0.0	0.0	0.0	367.3	532.1	0.0	0.0	105.8	0.0	543.7	0.0	0.0	0.0	0.0	0.0	0.0	80.4	0.0	380.5	0.0	0.0	302.9	0.0	0.0	981.3	0.0	0.0	0.0	0.0	0.0	0.0	453.3	0.0	0.0	0.0
ATP5S	"ATPW, HSU79253"	ENSG00000125375	"ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)"	Q99766	14	50312326-50335558	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 234.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046967, HPA062690"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA046967: AB_2679880, HPA062690: AB_2684836"	"unprognostic (2.24e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.53e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (5.73e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.37e-8)"	"unprognostic (5.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.95e-1)"	5.5	5.0	8.4	6.0	12.5	10.0	7.0	5.6	11.0	5.9	5.2	13.9	7.9	9.4	7.0	7.6	7.9	6.0	5.7	9.0	8.8	9.0	6.8	5.0	5.4	6.6	10.0	10.5	6.3	7.3	3.3	11.2	3.5	10.1	5.6	4.6	8.3	5.6	4.7	11.6	11.7	6.5	3.6	12.4	5.4	5.4	19.8	10.3	5.1	10.1	8.0	6.1	5.1	5.1	17.0	14.2	15.4	14.1	9.2	12.9	9.6	7.9	2.0	3.8	2.1	4.7	8.5	12.0	2.9	3.7	5.0	7.3	3.3	6.0	9.1	2.7	4.7	3.4	4.9	1.3	2.7	3.1	5.2	2.4	4.8	4.1	13.9	1.1	7.1	7.4	7.6	6.7	0.7	1.4	2.1	3.6	6.7	1.6	16.1	3.4	7.2	1.7	5.3	2.5	6.3	4.2	5.2	5.6	4.7	2.4	11.4	5.5	3.5	2.4	7.6	5.4	1.6	8.1	3.7	2.2	6.4	9.1	3.9	3.0	8.1	5.3	5.3	1.0	5.4	5.1	9.8	10.4	15.4	11.4	11.4	10.0	17.0	9.4	11.0	7.7	14.1	11.9	12.9	1.1	9.2	14.1	14.2	10.8	9.6	8.4	12.5	5.6	11.0	8.8	9.0	10.0	10.5	10.1	10.3	20.8	20.5	18.2	24.5	13.6	25.6	57.7	17.8	37.5	22.7	24.4	21.6	30.9	28.2	25.5	234.6	18.6	18.0	23.3	37.3	20.1	16.7	20.9	40.5	21.2	25.1	35.0	23.7	16.5	23.7	98.5	24.7	26.0	15.1	31.5	21.0	27.3	25.0	14.4	15.6	28.9	61.8	19.4	18.6	38.2	20.6	17.9	34.9	23.2	26.8	30.3
ATP6AP1L		ENSG00000205464	"ATPase H+ transporting accessory protein 1 like"	Q52LC2	5	82279462-82386977	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 27.5;Early spermatids: 20.6"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 15.7"									HPA053771	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA053771: AB_2682257"	"unprognostic (1.64e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	1.6	1.0	2.6	0.2	2.4	0.6	0.7	2.5	2.1	1.8	1.2			0.1	1.5	0.1	1.4	2.4	1.7	2.0	2.7	1.8	0.8	1.4	1.5	0.7	2.5		4.4	2.4	0.1	2.0	0.7		1.4	0.6		2.6	2.5	3.3	5.1	0.2	0.6	2.7	0.8	1.8	3.8			1.5		0.4	0.9	0.5	0.1	1.3	0.0	0.1	1.5	1.2	0.0	0.1	0.0	0.1	1.0	0.6	0.3	0.0	0.1	0.3	0.4	0.9	0.1	0.0	0.0	0.0	0.9	1.3	0.0	0.3	2.9	0.0	1.3	0.6	0.5	0.2	0.3	2.3	0.2	0.0	2.1	1.1	0.0	2.6	0.2	0.5	0.2	0.7	1.2	0.0	0.2	15.7	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.7	1.2	0.0	1.5	0.0	1.3	0.0	0.0											0.0	1.6	0.5	2.3	1.9	12.1	2.4	0.0	14.7	1.2	5.2	27.5	6.1	1.7	2.6	20.6	1.8	1.3	0.0	2.9	2.7	3.8	1.2	2.3	1.6	1.2	1.6	1.2	4.9	1.5	16.6	4.4	1.3	0.0	1.0	1.8	10.6	2.6	0.0	2.8	1.1	14.2	0.0	1.4	14.0	5.5	1.3	2.9	1.9	1.1	1.3
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712318-123761755	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 71.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	13.5	9.4	7.2	13.0	9.9	15.5	11.5	16.2	9.8	8.9	13.1	13.0	9.0	16.0	13.4	8.8	9.1	10.4	10.4	13.6	8.0	7.9	8.9	13.7	13.1	16.6	12.8	6.9	9.7	18.1	8.1	10.4	10.2	9.1	9.8	12.0	9.8	24.5	10.0	13.0	20.5	15.8	12.3	9.4	13.1	15.9	15.9	10.8	24.0	10.3	8.6	17.5	11.0	10.3	2.3	3.4	13.1	1.5	2.1	2.7	0.9	3.3	8.4	8.8	11.8	5.2	5.0	5.4	4.0	4.7	5.2	5.7	6.2	2.7	12.8	2.8	5.4	5.5	7.1	11.4	4.2	3.9	8.7	6.4	18.4	6.7	3.6	8.2	11.7	37.8	4.5	3.7	6.1	6.6	5.2	4.5	10.1	11.1	2.3	5.7	9.2	11.0	14.3	9.2	5.0	5.6	10.6	7.6	4.1	5.0	8.3	5.3	9.0	6.8	4.7	6.0	4.7	4.9	8.5	6.5	6.6	2.5	8.1	6.7	7.6	8.4	11.9	5.5	7.1	5.6	6.4	0.9	13.1	2.1	0.9	1.5	1.3	2.1	1.8	1.1	2.3	1.9	2.7	2.4	2.1	1.5	3.4	1.4	0.9	7.2	9.9	16.2	9.8	8.0	7.9	12.8	6.9	9.1	10.8	6.0	14.1	16.0	6.8	9.0	18.1	7.9	17.8	8.1	9.1	8.7	11.8	4.7	0.0	7.4	7.9	8.9	10.5	0.0	9.5	4.6	8.0	12.1	71.8	9.5	7.4	11.1	12.7	14.1	10.8	3.1	8.1	11.7	1.7	10.0	10.1	12.2	6.7	8.0	8.9	3.7	27.6	6.5	8.9	19.5	11.5	12.4	5.7	13.1	9.9	10.6
ATP6V0B	"ATP6F, HATPL, VMA16"	ENSG00000117410	"ATPase H+ transporting V0 subunit b"	Q99437	1	43974487-43978295	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 173.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044281			Approved	Cytosol		NA	NA			Cytosol		"HPA044281: "	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.23e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (6.13e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (5.55e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (8.87e-4)"	20.4	35.7	35.4	21.8	35.3	84.2	28.5	29.1	56.4	23.3	28.3	32.2	26.7	19.2	13.9	35.6	21.9	20.0	22.0	24.8	41.2	44.7	47.6	56.3	25.8	28.5	43.6	31.5	12.9	87.0	32.5	36.3	35.0	33.9	27.0	32.0	32.4	34.8	22.2	27.9	20.1	20.2	19.1	34.8	33.2	25.2	15.3	24.8	16.3	38.7	19.5	24.7	23.2	16.5	23.7	58.0	173.6	78.0	8.8	14.2	87.6	23.7	23.2	19.3	24.2	29.7	15.7	23.6	21.4	31.8	41.6	36.0	24.9	26.0	22.1	19.8	22.6	49.4	19.7	45.0	32.2	19.6	20.7	46.9	27.6	40.1	35.8	47.1	42.9	53.7	19.3	42.5	45.8	40.6	26.7	20.0	31.0	27.5	48.5	34.0	25.1	17.7	71.5	31.8	34.5	49.6	25.1	18.5	60.2	43.3	29.3	45.5	22.5	14.4	57.1	53.6	22.8	23.4	77.2	10.1	21.5	18.3	38.7	51.4	39.3	57.7	24.5	29.2	61.2	33.5	31.9	78.0	64.2	13.2	48.1	13.0	23.7	14.2	12.7	48.1	19.1	10.8	10.9	173.6	8.8	44.0	58.0	13.7	87.6	35.4	35.3	29.1	56.4	41.2	44.7	43.6	31.5	33.9	24.8	74.5	137.9	144.5	130.3	298.3	238.3	92.4	122.3	100.4	66.0	268.7	96.2	165.0	170.8	307.8	2.7	147.4	174.0	23.3	286.0	191.3	151.0	308.8	203.1	213.0	743.7	122.3	214.8	101.3	356.6	8.6	73.1	420.3	266.6	357.1	190.7	203.9	311.9	371.7	61.5	175.0	164.2	77.6	135.2	133.6	224.9	313.3	415.2	116.5	165.6	262.4
ATP6V0C	"ATP6C, ATP6L, ATPL, VATL, Vma3"	ENSG00000185883	"ATPase H+ transporting V0 subunit c"	P27449	16	2513870-2520218	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 58.3;Ciliated cells: 45.5;Club cells: 33.0;granulocytes: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065100			Approved	Cytosol		NA	NA			Cytosol		"HPA065100: AB_2685421"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"prognostic favorable (1.07e-6)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.04e-2)"	56.5	68.2	61.2	53.6	83.5	87.2	24.1	76.0	156.7	27.7	42.9	39.2	25.2	55.2	28.0	21.9	48.7	25.6	23.0	32.5	64.3	70.1	78.0	37.3	40.5	37.1	55.4	74.2	27.2	42.7	41.9	52.3	35.1	70.4	35.7	19.5	40.1	54.3	30.3	108.8	38.7	52.8	18.3	41.9	48.3	59.0	30.4	29.4	25.1	25.7	34.7	29.2	20.8	29.6	15.9	28.2	50.6	42.5	13.0	16.1	18.2	29.7	31.9	17.3	24.6	21.9	10.9	41.3	44.1	13.9	18.5	17.8	29.7	38.6	15.0	40.6	21.1	31.7	36.2	18.4	26.2	9.3	38.3	54.8	17.2	25.7	36.3	31.1	27.2	53.0	19.7	19.6	23.4	12.3	18.8	13.2	16.9	40.6	28.8	16.0	58.0	27.4	71.1	33.5	19.6	39.2	44.0	15.0	47.1	32.5	17.7	56.4	45.8	37.1	43.1	35.3	16.1	41.5	34.8	31.5	29.8	35.5	44.8	31.5	53.7	65.5	27.5	26.2	20.1	30.1	22.1	32.6	50.6	14.8	36.3	15.1	15.9	13.4	16.1	20.4	15.4	15.6	13.5	43.7	13.0	42.5	28.2	13.2	18.2	61.2	83.5	76.0	123.3	64.3	70.1	55.4	74.2	70.4	29.4	23.8	58.3	0.5	0.1	0.9	0.5	0.0	0.0	45.5	33.0	1.8	0.0	0.5	0.0	0.5	0.0	0.1	3.2	0.0	0.2	0.7	0.5	0.0	16.3	0.5	0.9	0.0	0.0	1.8	1.8	0.0	0.6	0.7	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.5	0.7	0.0	0.1	0.4	1.0	0.9	1.0	0.7	0.9	0.1
ATP6V0D2	"ATP6D2, FLJ38708, VMA6"	ENSG00000147614	"ATPase H+ transporting V0 subunit d2"	Q8N8Y2	8	85987323-86154228	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 56.8"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 177.4"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 36.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 5.6;SuSa: 9.2;U-87 MG: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055327, HPA058496"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA055327: AB_2682784, HPA058496: "	"unprognostic (3.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.36e-5)"	"unprognostic (4.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	6.6	0.3	0.2	1.3	0.3	0.8	0.3	0.2	0.2	0.2	1.5	0.0	11.9	0.7	0.2	1.0	0.2	0.2	0.1	0.2	0.3	0.3	56.8	0.3	12.2	1.2	0.5	0.0	0.8	0.2	0.3	0.2	0.2	0.0	0.8	2.0	5.7	1.1	1.2	0.2	0.9	1.0	0.0	0.3	0.4	0.3	0.2	0.0	1.0	0.4	0.3	0.6	0.3	0.2	2.2	1.7	4.6	1.0	2.0	1.5	0.3	0.5	1.2	0.6	0.7	0.0	0.5	2.3	0.0	0.0	1.0	0.3	0.3	0.4	0.3	0.2	0.0	1.6	2.5	0.7	1.6	0.4	0.4	0.1	0.8	1.7	0.1	0.0	0.7	1.4	0.6	0.1	0.9	0.7	1.9	0.4	0.3	0.4	0.7	0.5	0.9	0.0	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0.0	1.1	3.4	0.3	0.1	0.8	5.6	9.2	1.8	0.1	0.3	0.6	0.8	0.7	0.5	0.4	0.2	0.6	8.6	0.6	0.7	2.6	1.0	0.8	1.1	0.5	0.8	1.2	1.0	0.9	0.5	2.2	1.5	1.3	4.6	2.0	1.0	1.7	0.9	0.3	0.2	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	7.0	29.5	0.0	177.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.5	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747019-113812056	"Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 467.9;Late spermatids: 569.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.6"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		2700000	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	12.8	19.8	24.1	10.4	33.2	7.4	12.7	34.8	52.8	14.0	11.1	10.3	5.6	9.3	7.5	8.2	13.2	10.0	10.8	4.7	26.2	38.2	47.9	18.2	12.3	11.4	25.4	25.0	6.2	10.5	39.3	13.5	12.3	52.0	11.2	11.8	14.7	18.0	8.4	4.5	12.6	7.9	8.2	13.6	13.7	10.9	8.9	8.3	9.6	21.0	5.7	13.6	10.2	8.2	3.8	16.4	33.6	15.4	3.8	3.4	6.0	25.4	11.6	14.6	12.7	30.9	13.8	15.6	13.8	21.1	14.5	20.1	21.8	20.5	20.9	32.9	20.1	16.1	16.6	33.0	18.2	19.1	9.5	9.1	18.5	18.0	16.8	25.5	13.6	21.7	18.6	12.6	18.8	13.2	22.6	23.6	10.6	21.1	15.8	21.5	16.7	9.9	6.1	18.3	17.8	14.6	8.6	10.6	23.7	39.8	24.3	28.3	10.4	24.2	16.5	18.1	21.0	25.0	11.0	21.7	13.6	10.1	9.3	8.2	16.6	17.8	19.3	26.6	17.2	15.0	9.2	15.4	5.2	2.8	11.7	2.6	3.8	2.6	2.7	16.4	2.9	2.5	2.9	33.6	3.8	9.5	4.6	3.4	6.0	24.1	33.2	34.8	52.8	26.2	38.2	25.4	25.0	52.0	8.3	26.8	28.3	28.9	13.2	27.0	92.7	7.9	33.1	14.7	19.4	94.2	39.3	18.1	69.6	25.2	467.9	26.0	24.0	0.0	23.9	18.8	17.8	28.2	10.4	64.4	67.8	95.3	53.6	36.2	95.4	569.6	16.7	67.0	43.9	49.5	25.8	42.1	22.3	24.6	21.5	62.8	37.3	6.5	14.6	25.3	14.3	41.9	36.7	17.1	21.3	21.1
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935868-70965431	"Disease related genes, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 37.9;placenta: 29.0;salivary gland: 106.9"	"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 143.1;Distal tubular cells: 41.4;Extravillous trophoblasts: 41.7;Melanocytes: 28.7;Syncytiotrophoblasts: 54.2"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	12	"monocytes: 1.4;T-cells: 1.0"	"Group enriched"	"Detected in some"	9	"BEWO: 13.8;HaCaT: 12.7;SK-BR-3: 31.3"	"Not detected"	"Not detected"							"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA			"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	0.6	0.0	0.1	0.1	0.1	0.0	4.4	0.8	0.2	12.2	0.1	0.1	6.9	0.1	0.5	0.4	0.5	5.0	0.1	0.3	0.1	0.0	37.9	0.1	2.1	0.1	0.1	0.1	2.0	1.1	0.0	1.7	29.0	0.1	0.6	0.0	7.4	106.9	1.1	0.1	11.8	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.3	0.1	1.6	1.1	0.1	0.2	0.0	0.0	0.0	1.4	0.0	1.0	0.0	0.2	0.2	0.4	0.8	1.7	2.0	13.8	0.2	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.8	0.0	12.7	0.4	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.3	0.9	0.4	31.3	0.0	1.8	0.3	0.0	0.3	0.4	0.1	0.6	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.8	0.2	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	1.8	0.1	0.8	0.4	0.0	1.4	1.2	0.0	7.9	143.1	41.4	0.0	0.6	0.6	0.0	0.0	0.5	41.7	0.7	0.7	0.0	0.0	10.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.3	0.5	0.0	1.1	0.0	3.4	0.0	0.3	0.4	1.3	0.4	54.2	0.0	0.0	0.6
ATP6V1D	"ATP6M, VATD, VMA8"	ENSG00000100554	"ATPase H+ transporting V1 subunit D"	Q9Y5K8	14	67294371-67360265	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031515, HPA057316"	Enhanced		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA031515: AB_10600785, HPA057316: AB_2683409"	"unprognostic (1.10e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.60e-13)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.44e-2)"	18.2	51.9	43.9	13.8	47.7	9.9	15.9	23.6	54.1	13.1	19.9	13.5	20.9	16.2	13.8	30.2	33.6	17.9	14.8	52.6	39.8	45.2	52.0	19.9	14.5	11.8	39.7	44.9	10.4	12.4	21.8	28.8	17.2	39.6	21.4	20.3	10.8	15.7	18.1	31.8	14.7	16.8	16.1	29.4	9.7	17.8	14.0	23.0	14.7	34.1	25.2	15.3	16.6	17.0	14.7	35.0	39.2	34.5	17.9	28.5	23.9	62.0	12.9	26.5	16.6	17.7	18.8	18.7	48.0	22.1	29.4	24.6	14.8	21.9	5.1	20.1	28.7	28.2	23.4	14.4	22.4	39.8	22.1	9.9	5.4	17.9	12.0	32.5	5.3	19.8	13.5	16.4	20.6	15.6	32.5	18.4	13.6	11.9	15.7	42.2	15.0	15.4	12.0	19.1	22.6	15.5	12.0	22.0	8.1	39.1	24.6	33.2	14.6	30.9	20.1	41.3	25.0	28.5	15.7	29.6	44.2	32.3	21.1	30.7	16.8	12.1	7.2	44.2	10.8	24.5	32.2	34.5	37.3	18.6	33.6	15.7	14.7	20.1	20.0	35.0	14.5	15.1	16.8	39.2	17.9	33.3	26.7	28.5	23.9	43.9	47.7	23.6	54.1	39.8	45.2	39.7	44.9	39.6	23.0	50.6	50.0	34.2	59.3	85.5	56.9	137.6	43.3	182.0	63.7	78.5	51.1	84.1	310.0	120.5	149.9	33.7	68.6	93.5	42.7	73.5	53.9	61.4	40.4	40.0	114.2	82.6	52.2	20.3	37.5	68.5	30.5	59.4	75.9	57.7	39.8	86.6	96.8	63.1	47.7	271.8	92.4	12.9	27.8	77.2	60.9	120.9	172.2	35.9	33.7	102.9
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628818	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 391.3;Syncytiotrophoblasts: 400.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm		NA	NA		61000	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944"	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (4.18e-4)"	"prognostic favorable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	32.8	45.9	59.5	20.4	69.0	24.9	31.5	48.9	90.3	30.2	26.7	34.5	25.2	17.6	27.7	44.4	37.5	26.7	26.7	67.4	58.9	55.4	71.7	26.1	31.7	24.5	54.5	52.3	27.0	15.8	48.3	29.6	46.2	69.8	31.1	32.0	24.1	21.5	42.1	48.5	26.9	19.1	38.1	53.7	23.9	23.8	20.2	32.4	17.5	31.9	26.1	32.5	32.1	22.0	24.2	26.3	55.3	34.8	22.6	29.4	30.1	21.7	19.8	18.0	17.4	59.9	32.4	19.7	29.1	38.8	37.0	43.0	24.6	18.0	13.6	25.0	38.8	47.5	34.5	28.0	25.5	33.1	26.1	31.7	24.5	19.8	32.9	87.7	28.2	42.5	40.6	50.1	35.7	26.1	41.6	31.2	17.4	30.6	28.0	63.0	22.6	24.4	20.5	13.1	48.7	28.0	14.3	26.2	8.1	61.4	34.5	13.2	23.0	26.6	18.9	62.6	36.7	18.3	32.7	26.6	26.1	13.8	32.5	21.5	27.4	48.1	17.3	42.0	13.8	35.0	45.2	32.9	55.3	21.4	30.8	20.8	24.2	21.9	20.5	26.3	19.0	20.8	21.5	44.3	22.6	34.8	25.4	29.4	30.1	59.5	69.0	48.9	90.3	58.9	55.4	54.5	52.3	69.8	32.4	71.5	74.4	66.3	65.8	37.3	53.1	103.3	86.6	80.3	53.4	130.9	25.5	202.2	391.3	124.1	6.9	68.0	66.0	23.3	104.7	118.4	63.5	55.0	86.8	40.9	161.1	50.9	40.3	70.0	71.1	12.5	87.2	106.2	75.9	170.5	45.1	93.9	121.5	73.7	91.9	264.4	32.5	58.2	83.4	71.0	67.3	45.0	400.7	65.0	28.6	80.6
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587746-114598373	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		150000	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	34.8	66.4	41.5	36.7	38.0	56.6	56.6	37.5	49.4	45.2	34.2	23.4	42.3	26.7	43.7	91.0	57.5	32.3	39.2	45.4	40.8	52.5	84.9	65.9	45.3	50.0	52.2	39.5	49.2	55.9	39.5	79.4	77.8	44.7	65.3	33.2	49.2	63.2	45.1	54.9	40.8	33.2	31.7	35.6	66.5	52.7	58.3	25.6	51.7	65.2	53.5	53.4	45.8	40.1	99.9	81.6	96.6	67.9	50.0	85.1	121.6	18.2	17.6	36.2	8.8	30.1	21.8	33.6	28.5	22.6	23.6	17.0	23.6	22.0	17.7	24.9	20.3	44.1	41.4	27.0	21.5	19.9	14.0	18.6	17.0	22.3	34.2	42.1	37.8	31.5	27.9	57.9	18.9	23.6	24.8	22.3	28.7	32.5	37.6	32.2	39.6	36.4	23.9	42.8	52.2	33.2	35.4	23.2	28.3	48.4	31.4	27.3	34.9	38.4	67.2	101.2	36.5	54.4	44.9	29.7	19.3	15.3	30.0	31.9	50.7	99.4	30.9	24.8	22.7	26.4	78.3	67.9	96.6	46.7	63.9	57.9	99.9	65.6	56.0	50.9	94.2	85.1	67.1	87.3	50.0	65.8	81.6	76.5	121.6	41.5	38.0	37.5	49.4	40.8	52.5	52.2	39.5	44.7	25.6	148.9	142.4	298.6	409.4	461.0	169.7	124.8	155.4	207.5	149.0	314.0	39.3	304.8	822.3	322.2	78.2	218.7	155.2	93.5	229.3	273.5	294.0	644.3	261.0	292.4	487.8	155.7	346.4	198.9	353.7	42.3	283.3	376.1	469.0	820.6	271.3	242.1	355.1	164.9	235.8	828.3	125.3	232.8	269.9	334.2	301.9	504.0	633.4	276.3	162.4	656.9
ATP6V1H	"CGI-11, SFD, SFDalpha, SFDbeta, VMA13"	ENSG00000047249	"ATPase H+ transporting V1 subunit H"	Q9UI12	8	53715557-53843558	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009532, HPA023421"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		48000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB009532: AB_667834, HPA023421: AB_1845202"	"unprognostic (1.67e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.30e-2)"	"prognostic favorable (1.46e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	14.1	25.1	42.2	9.7	41.5	14.0	15.8	22.5	46.2	14.6	12.1	12.0	10.5	8.3	13.7	19.3	18.1	13.1	11.6	17.2	39.0	25.5	36.6	11.3	13.8	11.1	21.4	30.0	15.0	11.7	27.0	20.0	14.0	30.0	19.6	12.0	12.7	16.4	18.2	17.3	14.4	8.3	14.6	14.7	10.2	13.3	10.8	11.3	15.3	30.0	11.5	12.3	15.3	11.0	12.0	16.3	30.6	17.0	18.8	17.7	9.3	19.2	13.5	12.3	13.3	21.9	14.0	10.5	21.4	19.2	24.6	24.8	12.5	22.3	12.2	20.1	17.2	33.6	30.2	20.3	26.5	21.7	19.1	16.5	13.4	14.1	15.2	31.8	8.6	15.0	20.9	32.9	16.8	26.3	23.1	16.4	14.0	16.9	6.0	31.2	13.4	13.5	13.6	12.1	15.8	8.0	11.7	5.0	7.7	34.8	25.8	9.9	16.4	12.3	22.1	33.3	14.4	28.1	7.3	19.1	10.9	10.0	26.0	11.6	12.8	12.8	14.2	26.3	11.7	11.8	19.0	11.5	30.6	11.5	13.0	13.1	12.0	14.2	13.7	16.3	10.8	13.8	14.3	13.8	18.8	17.0	13.4	17.7	9.3	42.2	41.5	22.5	46.2	39.0	25.5	21.4	30.0	30.0	11.3	35.7	20.6	45.5	34.9	26.3	65.4	25.0	28.1	28.1	37.5	55.8	106.0	58.8	89.5	44.6	6.6	20.4	29.0	0.0	27.2	36.4	26.2	27.6	15.1	20.3	58.3	58.8	33.9	30.7	34.6	6.2	40.0	49.3	28.7	37.9	16.0	52.6	36.9	27.5	45.3	44.2	68.3	19.4	20.3	15.0	47.2	27.5	83.6	39.2	19.6	31.1
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803101	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5"	"Low region specificity"	"Detected in many"							"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	3.8	2.3	0.0	1.8	0.0	0.0	3.4	0.0	0.3	4.5	21.3			8.9	2.4	0.8	6.7	2.6	4.8	1.8	0.2	0.0	2.1	3.0	3.6	0.0	0.1		0.7	10.7	2.7	1.1	1.3		6.0	19.3		5.8	2.8	0.4	3.6	11.1	2.0	0.2	1.2	13.3	0.0			5.7		0.2	12.8	5.4	6.0	2.0	4.7	2.1	0.7	1.3	0.3	10.2	3.5	0.1	0.1	3.6	6.6	5.0	19.9	19.4	21.0	13.1	2.6	8.9	0.7	6.0	27.5	8.3	15.2	0.1	4.2	24.7	0.2	0.4	0.1	0.9	0.9	1.1	0.2	0.1	1.0	3.8	6.3	11.1	15.5	11.0	0.2	0.1	0.4	12.1	4.9	0.2	0.2	0.2	11.0	1.0	0.1	0.1	0.2	2.9	58.5	0.4	0.3	0.4	12.3	0.1	0.5	3.8	0.6	12.6	17.1	0.6	2.7	4.6	0.2	0.1	0.2	0.4	0.2	0.9	0.8	2.1	0.5	1.3	0.9	1.0	2.7	1.0	0.7	0.5	6.0	0.9	1.0	4.7	0.7	1.2	2.0	0.4	0.3											17.9	18.2	4.5	44.8	6.9	0.7	4.0	33.1	40.2	48.9	38.4	0.0	17.1	0.0	20.8	2.0	26.8	198.4	0.0	45.9	1.9	5.1	74.4	4.6	16.8	2.3	6.4	65.7	30.1	3.8	0.0	0.3	1.3	6.8	1.0	179.9	0.2	33.7	74.8	0.0	0.1	1.1	12.9	17.6	0.3	1.2	14.3	9.2	1.5	138.5	100.6
ATPAF1	"ATP11, Atp11p, FLJ22351"	ENSG00000123472	"ATP synthase mitochondrial F1 complex assembly factor 1"	Q5TC12	1	46632737-46673867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 73.4"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 236.9;Early spermatids: 241.4;Late spermatids: 261.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028382, HPA044950"	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA028382: AB_2672574, HPA044950: AB_2679151"	"unprognostic (1.34e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.33e-7)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.62e-1)"	20.6	32.0	32.9	7.5	34.5	7.9	14.0	15.9	31.0	11.1	15.2	16.1	9.3	12.0	7.8	10.8	10.6	9.8	9.0	73.4	22.3	20.8	33.3	31.9	7.5	8.6	28.2	24.9	10.6	18.8	39.5	14.6	11.0	28.5	11.6	16.9	11.9	15.9	10.8	66.9	5.7	11.7	12.7	18.6	6.9	12.8	13.4	18.2	10.8	13.0	13.1	9.4	9.8	6.1	3.1	2.4	5.8	4.2	9.2	6.6	1.8	20.8	17.0	23.0	20.5	25.2	20.4	19.3	15.6	19.6	23.5	19.0	13.6	9.1	12.4	21.0	19.7	20.9	16.2	36.2	20.3	31.8	27.1	28.6	21.9	21.2	23.6	20.3	21.6	1.3	19.9	24.4	25.1	22.0	18.8	14.7	23.3	10.0	24.6	17.9	18.9	31.8	12.0	36.2	18.1	25.7	13.8	6.2	26.9	26.8	16.6	27.3	20.4	26.5	28.2	40.7	27.8	26.0	30.5	12.7	8.1	20.0	16.2	21.2	30.6	27.7	8.5	13.3	8.4	15.1	0.0	2.5	5.8	3.5	4.2	4.6	3.1	3.7	4.0	2.4	1.7	5.2	2.4	2.1	9.2	1.7	1.8	6.6	1.8	32.9	34.5	15.9	31.0	22.3	20.8	28.2	24.9	28.5	18.2	3.0	15.2	20.4	17.4	8.4	34.1	236.9	22.9	8.1	12.5	29.6	25.5	54.8	145.9	19.3	241.4	11.3	22.6	0.0	17.5	23.1	16.9	15.2	16.1	37.5	32.6	44.5	18.5	8.0	16.4	261.4	17.5	11.1	23.6	10.8	33.8	29.9	12.2	10.5	25.1	85.7	23.3	25.8	29.3	25.6	40.1	11.8	39.2	12.5	43.6	16.1
ATRN	"DPPT-L, MGCA"	ENSG00000088812	Attractin	O75882	20	3471040-3651122	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008853	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		39000000000	Cytosol		"HPA008853: AB_1078248"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.19e-6)"	"unprognostic (3.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.91e-2)"	12.1	22.8	14.9	7.4	20.7	5.7	13.0	18.4	29.3	13.5	22.8	18.3	7.4	39.9	12.2	12.2	9.3	9.2	12.4	14.8	13.6	14.7	18.4	45.2	10.6	7.1	12.8	18.9	11.5	17.7	40.3	13.4	16.5	16.1	10.1	9.5	12.2	14.0	10.7	11.7	13.6	31.1	11.3	15.2	9.7	17.1	16.2	12.3	5.4	24.1	7.5	7.1	12.0	9.8	3.6	5.7	5.7	6.5	3.0	4.8	1.9	17.9	16.9	10.1	8.4	17.9	29.3	12.9	12.0	17.1	12.7	10.8	7.2	12.3	0.0	8.1	16.8	15.6	25.2	6.8	26.2	17.0	2.0	5.8	5.6	4.7	15.6	10.8	11.9	3.8	15.6	21.3	13.4	13.0	15.9	16.4	3.9	8.8	8.8	12.3	5.1	4.8	4.5	6.7	5.9	10.2	4.0	23.4	13.4	11.6	12.8	6.0	9.3	12.0	22.4	16.4	10.3	12.0	11.4	20.1	13.5	8.0	14.2	11.8	6.2	8.7	0.0	8.3	8.0	13.5	5.7	6.5	3.6	4.8	5.6	2.3	2.8	2.7	3.0	5.7	3.6	4.4	3.7	0.0	3.0	5.7	5.3	3.4	1.9	14.9	20.7	18.4	29.3	13.6	14.7	12.8	18.9	16.1	12.3	14.9	7.2	7.3	3.8	5.7	22.1	10.4	22.9	6.7	5.7	10.4	35.3	6.4	1.7	6.4	6.3	8.4	6.1	0.0	12.5	7.2	9.3	6.1	6.9	39.5	9.6	35.0	9.2	20.9	13.9	2.5	11.5	6.3	6.8	6.4	10.2	12.7	10.7	15.3	7.4	7.9	18.2	32.3	5.2	16.7	21.7	6.4	4.2	5.0	10.5	3.1
ATRNL1	"ALP, FLJ45344, KIAA0534"	ENSG00000107518	"Attractin like 1"	Q5VV63	10	115093365-115948992	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 40.4;Early spermatids: 37.4;Ito cells: 32.5;Late spermatids: 28.8;Spermatocytes: 41.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.5;RH-30: 13.7;U-266/70: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038070	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA		33000000	"Nucleoplasm, Mitochondria"		"HPA038070: AB_10697237"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.08e-3)"	0.9	11.7	8.6	0.7	15.9	0.3	2.1	2.2	26.0	0.9	2.3	2.1	1.1	0.8	12.0	1.1	1.5	1.0	0.8	2.9	9.3	5.8	4.8	2.9	0.6	1.0	4.0	15.7	17.5	2.3	0.3	11.1	3.3	8.4	6.9	0.9	2.0	1.8	8.3	3.8	0.6	1.0	13.4	2.0	0.8	0.9	13.0	2.5	0.0	2.0	0.0	0.9	1.1	1.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.2	20.5	0.0	0.0	0.0	0.1	0.4	3.0	4.4	0.1	0.1	0.0	1.4	0.5	4.2	0.0	1.1	0.0	3.5	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	8.6	0.0	8.6	0.0	6.9	9.4	0.2	8.0	0.0	6.7	0.0	0.1	5.9	13.7	8.9	3.1	0.0	3.4	9.9	0.0	0.0	0.2	3.8	1.2	0.0	0.0	0.0	2.5	0.0	2.9	11.3	0.0	3.3	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	15.9	2.2	26.0	9.3	5.8	4.0	15.7	8.4	2.5	0.0	0.0	0.0	0.1	0.6	40.4	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.6	37.4	0.0	0.0	0.0	0.3	0.0	1.1	0.1	0.0	0.0	2.2	9.5	0.0	32.5	3.2	28.8	1.4	0.0	0.0	0.0	0.0	4.0	0.5	0.0	0.7	0.3	4.4	0.0	0.4	41.3	5.3	0.1	0.2	0.0	0.0	0.0
ATXN10	"E46L, FLJ37990, SCA10"	ENSG00000130638	"Ataxin 10"	Q9UBB4	22	45671798-45845307	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049531	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA049531: AB_2680806"	"unprognostic (5.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.48e-2)"	"unprognostic (6.98e-2)"	18.1	33.3	40.2	20.6	40.5	20.9	38.5	31.7	75.3	28.5	20.6	20.9	22.0	13.8	28.8	23.9	27.5	33.6	23.3	42.3	44.5	42.4	32.0	37.0	30.5	38.8	35.6	41.2	35.4	33.5	39.7	32.6	28.1	38.1	28.3	21.8	18.0	22.6	30.1	47.5	18.3	13.6	29.7	38.3	18.3	18.5	31.5	22.3	34.0	37.2	21.8	28.7	26.8	21.8	23.3	52.2	28.1	40.4	25.2	31.0	33.3	41.3	21.4	41.6	25.1	19.1	28.8	22.4	47.3	50.5	33.8	37.2	10.7	27.8	42.7	19.6	47.3	17.4	24.7	30.0	31.5	36.6	7.8	31.0	20.0	41.3	20.5	27.6	53.4	15.0	29.6	22.0	17.6	27.7	41.4	24.7	19.8	14.6	23.7	51.2	17.6	29.0	24.0	27.5	23.4	16.6	42.0	16.0	34.6	43.1	39.6	23.1	36.2	29.4	17.7	32.0	32.9	26.7	28.6	22.5	34.3	12.8	12.2	15.5	23.4	14.1	34.4	21.3	22.5	36.3	19.0	31.7	28.1	23.4	37.6	31.0	23.3	23.3	28.3	52.2	22.6	25.7	24.8	1.5	25.2	40.4	18.5	21.9	33.3	40.2	40.5	31.7	75.3	44.5	42.4	35.6	41.2	38.1	22.3	32.8	25.7	30.5	107.7	44.9	67.9	77.5	68.8	58.9	42.1	55.8	19.6	90.0	58.0	72.1	42.5	42.6	15.9	46.7	60.7	89.4	55.5	67.5	38.2	48.6	63.4	66.7	57.9	33.2	52.7	30.9	53.2	45.5	23.6	62.3	32.0	70.5	50.1	24.6	71.1	51.6	43.1	45.3	38.1	108.0	105.2	36.3	43.7	34.8	46.1	79.0
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106625	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124"	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	17.8	10.3	10.2	9.1	11.6	14.3	12.8	18.7	12.1	16.0	11.8	12.2	11.9	6.4	17.9	12.4	17.7	9.5	11.2	10.4	9.0	9.9	9.9	16.0	12.3	11.6	16.3	9.5	14.0	10.3	11.9	17.2	11.7	13.8	15.8	11.7	8.6	11.4	10.2	6.1	21.0	8.7	20.6	16.5	12.6	9.0	14.8	14.3	16.2	11.5	12.0	15.6	15.4	13.6	9.8	14.5	11.4	18.8	7.0	8.5	5.3	5.6	11.1	10.1	9.3	14.7	14.4	19.7	6.4	10.5	8.2	11.5	8.1	15.7	11.5	12.8	10.5	9.7	9.9	7.7	14.1	18.2	13.1	2.3	4.9	5.4	11.8	12.1	8.6	8.8	11.6	12.6	14.3	15.0	11.0	12.6	12.9	6.5	8.6	12.4	22.0	9.0	7.8	7.1	18.8	9.2	7.2	18.5	6.5	10.5	12.8	3.4	6.0	15.6	6.6	8.8	14.1	12.3	6.1	6.7	8.1	11.9	5.2	3.4	7.5	12.5	10.6	6.0	8.5	4.7	11.4	13.4	9.4	5.9	14.5	7.0	7.1	6.9	6.5	14.5	9.8	7.6	8.5	11.3	7.0	18.8	8.4	6.8	5.3	10.2	11.6	18.7	12.1	9.0	9.9	16.3	9.5	13.8	14.3	14.9	14.3	18.1	26.1	22.6	32.4	17.3	17.8	12.0	12.5	40.1	47.1	17.4	13.3	17.7	18.3	43.4	11.7	0.0	15.0	23.8	25.4	29.1	23.2	19.1	20.8	25.4	15.4	39.3	27.2	18.5	62.7	31.8	21.9	30.7	16.0	20.6	17.6	17.5	61.2	14.6	45.6	45.3	35.8	30.5	60.9	26.5	21.2	23.0	19.4	25.1
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000163635	"Ataxin 7"	O15265	3	63898399-64003453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.4"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA034989: AB_10602596"	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	8.8	6.4	4.9	14.5	7.4	19.7	8.9	10.2	6.5	9.5	10.7	4.9	6.7	8.0	10.9	9.2	9.2	7.5	11.4	7.5	5.0	4.3	6.3	8.2	10.2	19.9	6.1	3.1	12.4	21.7	15.3	10.9	15.1	6.0	8.2	8.1	15.1	12.2	7.8	9.6	10.6	12.5	9.2	5.7	11.1	7.2	14.6	6.7	55.4	8.8	8.5	24.2	8.4	10.2	0.9	0.5	11.1	0.5	2.6	5.9	1.1	6.0	4.9	5.0	4.1	5.8	6.6	6.6	3.5	6.5	7.5	6.1	6.9	5.9	5.8	2.1	6.8	8.1	4.0	6.4	6.6	8.0	15.2	2.6	10.1	5.8	2.1	2.9	4.2	12.2	6.3	3.6	11.1	12.4	5.6	5.6	9.6	3.8	17.7	4.6	14.4	8.9	3.5	3.4	4.1	2.2	3.8	4.6	7.0	3.7	7.2	2.0	3.7	7.8	5.2	7.1	4.2	3.6	6.1	7.7	6.5	8.9	9.5	8.1	8.0	8.1	6.4	7.7	7.1	6.2	11.1	0.3	0.9	3.2	0.5	2.6	0.0	5.9	3.4	0.1	0.9	5.7	3.7	1.2	2.6	0.1	0.5	4.7	1.1	4.9	7.4	10.2	6.5	5.0	4.3	6.1	3.1	6.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.1	0.0	0.0	0.0
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000285258	"Ataxin 7"	O15265	3	63864557-64003462	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.9"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 72.4"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034989: AB_10602596"																		0.4	0.0		1.5		2.8	1.3		0.0	2.0	0.7			0.0	2.0	2.0	0.0	0.9	0.8	0.0			1.0	0.9	0.9	2.1			0.5	1.0	3.0		1.9		0.9	0.9		0.5	0.6	0.3	3.1	0.8	0.3		1.5	1.0	0.0			0.8		1.8	0.1		4.9	3.6	8.9	1.9	2.5	4.3	0.7	2.4	0.1	3.5	3.3	3.3	6.1	3.3	3.0	2.5	4.1	5.6	1.5	3.2	6.9	1.1	2.1	4.8	2.8	3.4	2.3	4.9	6.6	2.6	6.3	4.3	2.5	4.6	4.6	5.8	1.9	6.9	5.2	6.8	4.2	2.9	3.9	2.3	9.8	2.9	13.2	3.0	4.0	2.2	1.6	0.8	5.8	2.9	2.5	2.6	3.4	1.1	1.7	6.0	4.9	3.9	2.9	1.4	6.7	4.0	6.1	3.3	3.6	4.7	5.4	4.8	4.3	2.4	4.8	3.6	5.7	1.9	2.7	2.5	1.2	2.9	4.9	2.9	2.4	1.6	4.3	3.5	2.5	8.9	2.5	1.4	3.6	4.3	0.7											8.9	7.8	5.7	20.9	38.7	67.5	0.0	33.1	8.1	5.7	5.2	96.2	0.0	0.0	2.5	11.6	15.5	24.4	0.0	3.7	0.0	4.1	20.9	14.9	17.4	0.0	23.8	25.3	33.7	34.3	6.2	11.8	10.2	11.8	8.2	19.4	28.6	2.0	27.1	12.4	0.3	72.4	0.0	19.6	12.5	15.3	40.4	0.0	40.6	18.2	34.4
ATXN7L1	"ATXN7L4, KIAA1218, MGC33190"	ENSG00000146776	"Ataxin 7 like 1"	Q9ULK2	7	105605067-105876604	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 68.4;Late spermatids: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021448	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021448: AB_1845213"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.01e-1)"	10.8	10.7	10.3	12.1	16.6	7.7	10.6	24.7	13.4	13.3	11.7	9.7	12.3	7.9	9.2	9.1	9.6	11.7	8.4	6.4	8.5	6.2	14.1	12.3	7.8	15.6	7.1	7.3	13.3	7.2	11.2	17.8	10.8	6.9	10.1	11.6	8.3	11.4	12.1	5.2	12.2	10.9	9.7	6.9	10.4	9.8	20.8	9.9	12.4	11.8	4.6	17.9	11.3	11.7	3.9	3.1	4.3	4.8	4.2	14.5	3.4	2.9	3.9	8.4	3.9	5.2	6.1	2.6	5.2	5.2	4.7	4.4	3.8	5.6	1.2	4.1	5.4	4.1	2.7	4.7	5.3	3.4	16.1	3.1	3.9	2.9	3.6	3.1	6.3	13.0	4.2	4.4	3.1	3.1	3.4	4.2	2.8	4.6	2.6	3.8	6.9	3.4	3.5	15.5	8.0	3.9	3.4	2.8	0.8	3.5	2.9	5.2	3.5	3.7	7.3	7.3	8.6	3.8	6.4	10.5	7.3	3.4	6.0	2.0	0.6	0.0	0.1	4.6	9.8	7.3	2.3	4.2	4.3	2.9	4.8	2.1	3.9	7.5	6.4	3.1	3.6	8.2	4.7	1.4	4.2	2.8	2.1	14.5	3.4	10.3	16.6	24.7	13.4	8.5	6.2	7.1	7.3	6.9	9.9	0.0	4.6	3.6	4.7	4.5	8.2	2.4	2.5	16.0	2.3	5.2	2.0	5.6	5.0	3.3	68.4	3.6	10.8	0.0	2.3	3.1	4.9	5.1	4.7	13.4	6.5	7.9	5.2	6.7	10.3	39.7	6.1	6.3	8.5	7.2	8.2	2.0	3.7	10.5	4.2	29.8	0.6	6.5	4.2	7.9	1.7	3.4	4.5	8.7	8.1	3.3
ATXN7L2	"FLJ00381, MGC46534"	ENSG00000162650	"Ataxin 7 like 2"	Q5T6C5	1	109483479-109492804	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029827, HPA054952"	Uncertain		Approved	"Nucleoli rim,Vesicles,Cytosol"		NA	NA			"Nucleoli rim"	"Vesicles, Cytosol"	"HPA029827: AB_10602390, HPA054952: AB_2682647"	"unprognostic (4.53e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.77e-4)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.94e-3)"	4.2	5.2	7.5	4.0	9.2	10.2	2.6	15.2	10.9	2.8	2.8	5.1	1.2	2.7	4.4	1.8	2.8	3.3	3.8	2.0	6.5	3.3	3.4	3.0	3.4	3.8	5.7	7.0	7.3	2.4	1.6	9.9	2.5	4.7	2.2	1.4	5.7	1.8	3.2	13.3	3.5	3.1	2.0	3.1	5.4	2.9	8.8	4.8	2.7	4.2	1.0	2.6	3.2	2.4	2.4	1.3	2.4	2.4	2.7	5.6	2.2	2.2	1.7	1.2	4.6	1.6	2.9	3.2	1.6	2.1	3.4	2.3	3.6	1.5	5.8	2.6	2.0	0.9	2.5	2.4	2.2	0.4	5.3	3.4	3.2	3.6	1.6	1.0	4.8	7.6	3.1	1.2	3.5	0.0	1.4	0.8	6.3	5.4	3.3	0.6	7.0	8.4	6.3	7.0	2.3	2.5	6.0	2.9	4.1	1.2	2.3	10.7	4.3	1.7	5.7	2.6	0.3	1.0	5.0	0.3	2.4	7.1	2.2	6.4	2.2	1.4	5.5	2.8	4.0	6.0	0.0	1.9	2.4	5.4	2.4	5.0	2.3	4.3	5.6	1.3	2.4	4.0	3.8	1.9	2.7	1.6	1.0	3.8	2.2	7.5	9.2	15.2	10.9	6.5	3.3	5.7	7.0	4.7	4.8	0.0	0.3	0.8	1.4	0.6	3.2	1.6	2.5	0.0	2.3	1.8	2.0	1.2	0.0	1.2	1.8	0.9	0.6	0.0	1.6	1.2	1.5	0.4	4.6	1.0	0.5	3.2	1.7	1.8	1.2	0.0	1.1	0.8	0.0	0.0	1.0	1.6	1.4	0.9	1.4	0.6	1.6	0.0	1.0	3.8	3.8	0.6	2.6	2.5	0.9	0.6
ATXN7L3	DKFZp761G2113	ENSG00000087152	"Ataxin 7 like 3"	Q14CW9	17	44191805-44200113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064316	Supported		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA064316: AB_2685243"	"unprognostic (2.37e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (2.86e-3)"	"unprognostic (6.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.40e-1)"	14.0	12.9	36.7	18.9	25.1	23.8	11.9	23.0	53.1	13.2	16.1	11.3	16.7	19.1	14.3	16.9	22.3	14.2	14.9	12.4	30.7	24.8	12.4	12.6	14.3	20.8	22.7	32.1	13.2	13.7	16.3	17.1	18.8	23.6	13.0	15.3	7.9	16.9	18.5	11.3	19.0	16.5	16.1	15.1	17.6	15.5	17.0	14.1	13.9	14.3	11.3	21.3	16.7	22.4	5.1	4.4	6.7	3.2	1.3	4.8	2.6	16.9	28.7	31.8	20.6	22.2	22.1	17.3	20.9	23.3	26.7	25.3	21.9	19.3	29.8	16.8	23.4	24.7	18.7	24.7	19.6	22.5	34.7	24.6	20.2	23.7	24.3	21.9	31.5	41.1	24.9	30.0	22.4	23.7	28.4	25.8	23.1	27.0	18.7	17.5	12.8	37.7	24.0	23.8	15.3	22.6	26.1	30.7	22.3	21.5	24.4	20.2	25.7	12.3	10.9	21.3	46.2	26.7	28.1	22.1	27.0	28.3	14.0	19.4	22.7	29.4	36.1	17.8	13.7	15.7	1.4	3.2	3.7	4.8	2.2	2.9	3.6	3.8	3.0	2.7	5.1	2.9	3.6	6.7	1.3	2.3	4.4	2.0	2.6	36.7	25.1	23.0	53.1	30.7	24.8	22.7	32.1	23.6	14.1	3.0	3.0	4.8	4.4	6.4	16.5	5.3	5.1	4.0	4.5	17.4	15.7	5.1	3.3	6.5	12.7	8.0	14.8	0.0	11.2	6.0	6.2	6.9	2.3	7.3	7.3	27.0	13.8	12.3	10.8	25.8	8.3	7.6	5.0	10.8	11.9	7.6	11.5	11.5	5.3	3.6	13.1	6.5	6.2	6.4	8.9	9.3	11.4	5.4	9.3	7.5
ATXN7L3B	lnc-SCA7	ENSG00000253719	"Ataxin 7 like 3B"	Q96GX2	12	74537827-74545430	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056612			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056612: AB_2683190"	"unprognostic (3.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.81e-3)"	"unprognostic (7.12e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.25e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.15e-2)"	12.4	17.9	29.7	13.1	34.2	15.6	20.9	44.1	52.1	18.2	15.8	20.6	12.9	18.5	19.9	24.3	14.8	31.6	14.7	16.1	27.6	35.0	22.2	18.6	15.3	17.6	26.0	32.2	31.5	20.9	23.3	18.3	20.8	31.2	21.6	18.1	22.3	20.4	21.0	18.1	16.4	16.9	17.0	20.0	17.2	34.2	8.1	18.5	27.8	23.1	9.5	20.2	14.8	13.2	5.6	9.1	13.7	11.5	8.2	14.8	8.4	9.4	7.5	25.1	15.8	15.9	15.0	10.7	9.1	9.1	10.8	8.5	8.6	5.3	13.8	7.2	9.0	7.2	9.6	12.9	8.8	9.0	12.7	10.2	18.4	7.7	13.0	15.2	18.2	3.9	17.2	20.5	8.2	13.6	18.9	12.4	16.1	22.7	7.0	8.8	13.7	20.1	13.0	14.2	13.1	7.2	15.8	13.5	12.4	9.9	15.6	39.5	24.9	10.3	12.2	14.3	16.9	28.8	12.0	10.6	10.4	9.2	6.1	5.6	8.3	7.7	18.0	4.5	6.7	10.4	13.7	9.5	12.5	5.6	9.0	6.7	4.4	8.5	6.2	9.1	5.6	14.8	8.0	2.7	8.2	11.5	5.1	6.1	8.4	29.7	34.2	44.1	52.1	27.6	35.0	26.0	32.2	31.2	18.5	68.5	31.6	13.7	33.4	16.4	86.9	46.2	45.9	170.0	66.0	36.6	31.4	47.5	26.6	34.8	0.6	33.8	24.5	23.3	28.4	31.6	25.2	38.1	44.0	25.2	19.3	49.3	34.8	29.4	20.7	1.3	34.8	19.8	20.3	19.0	36.4	95.6	46.1	17.5	35.3	27.2	75.5	19.4	16.7	11.8	14.9	19.9	37.6	21.8	32.8	34.3
AUP1		ENSG00000115307	"AUP1, lipid droplet regulating VLDL assembly factor"	Q9Y679	2	74526645-74529939	"Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007674	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA007674: AB_1078251"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (2.97e-9)"	"unprognostic (9.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.96e-2)"	18.8	21.7	13.9	15.5	16.9	9.4	24.2	18.0	16.7	25.7	28.2	14.6	18.4	14.0	14.6	17.8	25.6	15.4	12.5	14.1	11.8	11.2	19.2	44.5	14.4	21.1	18.4	8.0	11.8	44.2	26.4	14.1	20.6	15.1	13.6	25.9	13.5	29.8	17.6	34.6	25.2	31.3	18.0	12.2	18.2	26.0	10.6	14.4	13.5	19.0	11.7	19.9	16.7	13.5	26.3	38.0	30.6	46.3	20.7	31.6	36.4	15.1	22.7	5.8	9.9	34.7	17.3	16.0	11.0	25.3	20.4	10.7	35.4	10.9	15.5	7.8	21.4	38.8	18.6	25.0	19.3	14.5	13.3	23.8	23.0	11.6	29.5	36.7	12.0	11.9	22.9	42.6	30.8	28.6	11.8	21.3	20.2	30.3	21.5	21.7	21.8	12.4	14.4	15.0	58.5	19.5	16.0	24.0	45.5	22.8	12.9	9.3	10.5	10.9	33.7	26.1	9.9	14.8	19.1	8.1	16.5	10.2	4.0	17.4	5.4	8.7	19.0	19.8	16.2	29.1	28.4	39.3	30.6	25.0	46.3	30.2	24.3	26.4	27.3	38.0	26.3	22.1	24.7	19.1	20.7	40.4	35.8	31.6	36.4	13.9	16.9	18.0	16.7	11.8	11.2	18.4	8.0	15.1	14.4	62.5	39.4	71.5	92.4	65.0	32.0	29.5	63.7	32.1	45.5	64.6	13.7	119.5	19.9	114.5	16.9	64.6	148.5	23.3	181.0	166.6	79.4	112.4	86.7	93.6	145.8	35.0	70.9	41.7	72.1	22.0	41.1	89.5	92.8	62.3	95.5	74.6	135.1	112.2	35.7	52.8	33.4	58.2	59.8	85.0	60.7	68.8	187.2	80.9	105.4	119.9
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"AUTS2, activator of transcription and developmental regulator"	Q8WXX7	7	69598296-70793495	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.6;naive B-cell: 11.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 28.1;REH: 27.4;SCLC-21H: 38.5;SH-SY5Y: 20.9;T-47d: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	10.3	7.3	29.3	11.6	30.3	9.3	20.3	14.3	19.1	10.5	14.0	17.3	4.1	8.9	10.5	12.4	13.7	8.0	16.6	5.6	22.2	12.9	14.6	19.7	14.7	6.1	14.8	12.3	17.2	6.0	9.9	17.4	5.7	18.9	14.6	13.1	9.9	52.1	8.3	14.9	23.3	18.8	13.6	10.2	8.2	11.3	10.0	20.6	10.5	6.7	7.9	8.9	13.0	10.8	11.6	3.2	0.8	0.2	1.5	2.2	0.7	0.1	2.5	28.1	1.5	1.8	1.1	0.3	1.7	0.0	0.1	0.1	9.5	0.1	4.1	0.6	1.7	0.1	9.1	3.4	3.8	0.8	18.6	7.5	2.0	2.6	0.1	0.8	0.0	0.1	2.9	5.2	4.2	1.0	1.0	0.0	4.5	0.1	2.2	2.4	1.6	0.4	0.8	20.0	6.2	0.0	27.4	13.7	11.6	0.0	4.1	38.5	20.9	1.8	3.1	0.0	12.7	26.3	0.0	0.0	0.1	9.4	3.0	17.2	0.0	0.0	14.2	0.0	0.0	0.0	0.8	0.2	0.2	1.6	0.1	2.2	8.6	1.1	1.5	0.7	11.6	0.2	0.9	0.5	1.5	0.1	3.2	0.2	0.7	29.3	30.3	14.3	19.1	22.2	12.9	14.8	12.3	18.9	20.6	17.9	31.0	10.7	17.8	25.3	35.0	19.0	10.2	12.0	19.4	8.7	15.7	1.0	5.0	9.8	26.8	8.3	16.3	0.0	1.1	0.1	11.3	21.3	0.0	24.5	0.7	60.4	27.7	16.0	3.1	14.8	14.7	4.3	16.9	1.0	20.8	14.3	2.6	14.0	13.8	9.8	22.5	25.8	7.4	11.3	15.4	14.1	1.1	19.2	22.7	20.3
AVEN	PDCD12	ENSG00000169857	"Apoptosis and caspase activation inhibitor"	Q9NQS1	15	33866227-34039176	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 31.9;Extravillous trophoblasts: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020863	Approved		Approved	"Plasma membrane,Actin filaments,Centrosome"		NA	NA			"Plasma membrane, Actin filaments"	Centrosome	"HPA020863: AB_1845219"	"unprognostic (1.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.77e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (5.29e-10)"	"unprognostic (7.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-3)"	11.0	11.1	7.1	8.7	7.7	5.2	16.1	14.4	8.8	9.6	12.4	6.8	8.6	9.0	13.4	9.5	11.5	8.9	10.6	35.0	6.9	8.7	5.8	16.7	8.0	6.0	8.6	6.8	10.3	41.0	3.6	9.0	15.0	8.3	10.6	12.2	5.4	9.8	11.8	25.7	9.3	9.9	15.3	8.1	7.3	10.9	14.1	6.1	9.9	5.4	11.6	9.4	11.6	15.0	1.2	6.1	0.2	1.7	1.2	2.3	0.3	8.3	13.6	14.1	4.6	11.5	13.1	8.4	21.4	19.2	17.1	11.0	3.7	5.9	7.8	13.2	18.0	13.1	5.7	6.4	13.9	14.1	7.6	4.2	13.5	8.9	10.4	17.2	13.5	9.9	10.9	27.5	10.0	24.4	20.6	18.3	4.1	13.3	11.5	23.8	8.9	5.3	23.3	6.6	11.3	4.7	8.1	7.9	16.7	13.9	11.1	7.5	9.1	11.9	6.2	5.8	6.1	6.7	15.0	12.9	15.1	5.2	6.4	17.6	11.3	8.9	16.5	7.2	16.0	8.0	0.0	0.8	0.0	1.6	1.7	2.0	1.2	1.7	0.6	0.6	0.6	0.8	1.1	0.2	1.2	0.7	6.1	2.3	0.3	7.1	7.7	14.4	8.8	6.9	8.7	8.6	6.8	8.3	6.1	3.0	4.0	3.0	6.2	5.0	5.4	31.9	2.5	1.4	0.0	0.0	5.9	9.7	0.0	1.4	6.8	7.1	6.7	0.0	7.3	35.3	5.0	10.6	0.0	15.8	6.4	7.9	4.6	4.3	1.6	4.8	6.9	2.7	3.3	3.6	7.2	6.7	6.3	7.0	9.9	3.0	5.5	6.5	3.8	2.1	8.3	8.4	7.9	5.7	6.2	9.5
AVL9	KIAA0241	ENSG00000105778	"AVL9 cell migration associated"	Q8NBF6	7	32495426-32588721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050957	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA050957: AB_2681289"	"unprognostic (2.33e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.14e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	12.0	15.8	17.4	16.7	22.9	12.2	15.6	24.1	25.7	14.2	22.5	12.9	14.0	18.8	13.1	18.6	12.4	12.9	11.6	8.8	16.6	20.0	15.6	11.9	12.0	14.1	14.5	15.1	13.8	15.9	12.7	15.9	16.3	17.3	14.4	26.2	15.4	15.2	12.8	12.6	11.6	19.9	12.2	11.5	14.3	17.4	10.0	10.3	21.3	19.3	6.6	15.8	12.9	11.0	12.5	9.9	27.4	10.7	5.1	10.9	9.4	9.4	8.3	8.7	11.7	5.3	7.6	6.1	8.5	11.3	8.4	11.3	6.5	12.7	11.9	0.1	7.4	32.5	7.8	8.3	8.4	14.3	5.1	5.1	8.9	5.7	7.0	19.4	15.1	11.7	8.2	8.3	10.7	12.3	9.3	12.4	9.6	21.7	11.0	26.3	9.7	6.1	12.7	9.8	13.1	7.4	5.9	9.7	9.0	8.9	16.0	18.8	12.0	7.1	17.7	7.6	12.2	12.6	13.9	9.4	8.8	10.4	6.9	7.4	25.5	22.1	19.0	17.3	14.4	19.1	12.8	10.7	15.5	10.6	8.4	9.1	9.9	8.8	9.9	8.2	12.5	10.9	9.5	27.4	5.1	7.9	9.9	8.0	9.4	17.4	22.9	24.1	25.7	16.6	20.0	14.5	15.1	17.3	10.3	6.0	9.4	15.9	9.1	10.2	32.8	6.1	12.7	14.7	11.4	12.2	58.9	13.5	3.3	11.2	4.6	9.5	26.2	0.0	15.0	11.6	9.3	16.4	17.3	11.1	13.1	30.2	21.5	11.6	28.6	1.8	9.5	14.6	11.8	5.4	28.5	13.8	20.1	28.1	8.9	13.1	38.6	6.5	10.0	8.1	7.5	9.3	14.6	16.2	24.7	20.1
AVPI1	"PP5395, VIP32, VIT32"	ENSG00000119986	"Arginine vasopressin induced 1"	Q5T686	10	97677424-97687323	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 211.2;Syncytiotrophoblasts: 162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.0;HHSteC: 30.0;hTCEpi: 56.5;SK-MEL-30: 45.6;U-2197: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037649	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA037649: AB_10671879"	"unprognostic (4.57e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-2)"	"unprognostic (7.34e-3)"	"unprognostic (8.56e-3)"	"unprognostic (2.29e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.83e-3)"	21.5	27.4	5.1	4.7	8.5	3.3	11.0	6.3	17.7	13.0	18.6	3.6	4.8	10.7	5.8	8.2	16.3	6.5	19.9	8.5	5.5	5.8	5.6	29.9	17.1	1.7	7.3	5.6	43.3	10.8	4.1	7.2	19.3	8.0	15.3	15.0	13.6	10.7	13.8	8.3	35.5	15.3	8.5	12.6	11.9	12.7	8.4	2.5	1.3	8.2	9.7	7.6	22.0	16.6	3.5	12.4	2.3	7.1	2.0	5.0	3.0	9.0	23.9	0.1	3.5	5.0	2.3	4.9	4.4	24.4	6.1	9.3	4.4	11.4	0.2	3.2	2.5	4.4	9.6	1.8	7.7	2.3	0.2	2.1	0.6	29.0	12.3	30.0	0.6	0.7	3.6	56.5	4.6	12.1	5.6	0.8	0.8	1.3	0.5	3.3	7.8	0.4	0.7	0.8	2.5	2.2	0.3	2.7	0.3	6.0	5.0	0.4	1.0	15.4	5.5	45.6	0.8	4.2	0.7	1.3	1.5	2.9	33.0	1.1	1.1	0.7	0.1	5.5	1.9	0.9	0.0	7.1	2.3	5.0	6.1	2.3	3.5	3.3	3.7	12.4	2.2	3.6	4.4	0.7	2.0	0.5	2.4	2.9	3.0	5.1	8.5	6.3	17.7	5.5	5.8	7.3	5.6	8.0	2.5	17.9	14.7	1.4	58.4	85.3	9.6	6.7	30.6	13.4	17.0	36.6	5.9	126.4	36.5	16.0	51.3	6.0	96.5	0.0	21.5	57.2	30.8	25.7	5.8	38.1	39.2	12.7	30.5	22.7	16.7	211.2	9.5	40.5	79.2	9.0	38.3	125.0	29.4	66.6	13.8	9.1	12.7	6.5	29.8	2.7	1.6	94.7	162.8	9.6	58.7	83.6
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976157	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 158.8;salivary gland: 270.5"	"Group enriched"	"Detected in many"	6	"Glandular cells: 2272.6;Hepatocytes: 3981.0"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.8;Karpas-707: 9.6;OE19: 49.6;RPMI-8226: 38.9;T-47d: 13.0"	"Region enriched"	"Detected in single"	4	"olfactory region: 0.9"					"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	160000000000	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	6.4	0.0	1.1	1.3	1.7	0.0	64.1	1.1	1.4	1.1	1.4	1.5	0.9	1.4	0.9	1.2	1.3	0.0	2.2	9.0	1.2	0.4	18.0	158.8	3.0	0.9	2.7	1.2	1.0	55.3	0.0	0.9	1.0	1.3	62.4	0.0	1.6	270.5	2.5	1.0	11.5	1.5	0.9	1.1	0.9	14.4	1.2	1.7	0.9	1.0	3.0	3.2	1.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.2	4.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	1.6	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.4	0.0	49.6	0.0	0.0	0.5	38.9	0.0	0.0	0.0	0.6	0.2	7.9	3.8	0.0	13.0	0.0	0.0	0.1	0.0	0.6	0.3	0.6	0.2	0.1	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.1	1.4	1.2	0.4	2.7	1.2	1.3	1.7	20.8	187.7	32.0	321.8	3.8	0.0	94.8	420.4	5.3	50.0	5.2	2.0	0.0	39.7	11.0	1.3	0.4	8.5	46.7	221.1	0.0	0.2	2272.6	3.5	3981.0	0.0	0.0	11.9	58.3	79.1	3.1	0.9	0.3	59.1	3.6	5.4	22.6	173.5	5.8	0.0	512.3	0.2	0.0	1.1	4.3	0.4	8.4	0.0	15.2	6.3	497.4
AZIN1	"OAZI, OAZIN, ODC1L"	ENSG00000155096	"Antizyme inhibitor 1"	O14977	8	102826357-102893864	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027948	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA027948: AB_10602391"	"unprognostic (1.16e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.68e-1)"	29.4	31.4	42.1	30.5	33.3	62.5	43.8	35.1	56.7	30.3	33.7	23.0	22.4	33.3	23.2	19.8	27.5	33.2	22.5	25.8	42.0	36.0	20.5	38.4	39.3	46.0	36.5	37.2	22.5	94.0	21.0	42.1	90.2	45.9	27.6	27.8	16.5	27.3	32.1	23.8	18.9	43.8	29.9	62.6	20.2	25.9	17.6	14.4	23.9	34.9	21.4	29.6	31.8	50.0	24.4	28.9	35.6	32.9	19.8	25.6	28.8	67.0	17.8	28.6	20.2	27.6	18.9	17.1	31.8	36.6	22.9	23.7	18.6	47.8	31.4	25.8	25.8	14.3	25.9	24.8	24.5	36.9	53.7	12.5	31.5	7.0	15.1	34.9	16.8	26.8	13.1	29.9	15.9	40.5	20.5	15.7	18.6	23.6	27.2	36.0	19.5	41.9	11.8	31.8	51.2	27.0	19.1	30.0	17.8	23.6	31.6	46.0	72.7	10.6	21.6	30.5	48.6	28.7	17.9	18.4	18.6	19.0	30.1	25.4	27.1	22.9	45.3	22.1	25.5	25.5	32.7	28.7	33.8	17.3	32.9	20.3	24.4	22.6	16.4	28.9	15.6	18.8	17.8	35.6	19.8	31.3	22.9	25.6	28.8	42.1	33.3	35.1	56.7	42.0	36.0	36.5	37.2	45.9	14.4	56.6	23.0	51.4	125.4	83.3	26.6	44.4	28.1	108.4	43.3	40.1	35.3	122.5	44.7	32.5	50.5	24.3	61.7	46.7	42.9	44.4	71.0	91.5	68.0	61.0	48.4	22.3	81.5	33.2	74.6	80.6	46.1	50.3	60.8	43.3	68.9	45.8	61.4	37.4	30.4	35.8	38.6	19.4	62.8	31.0	33.6	72.0	219.0	45.7	58.2	100.9
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105384	"Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 36.8"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 52.9;Cardiomyocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;NK-cell: 16.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.9;NK-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.2;RT4: 52.6"	"Low region specificity"	"Detected in all"							HPA041204			Approved	Vesicles		NA	NA		290000	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	3.8	5.4	14.0	3.0	24.5	3.1	7.4	17.2	24.7	15.5	2.3	5.5	2.6	1.5	8.3	6.9	5.4	10.4	7.1	36.8	15.4	21.6	14.3	1.0	10.8	3.5	11.3	16.2	13.8	7.8	6.5	8.5	10.0	17.7	8.9	2.0	7.5	14.8	6.7	1.1	2.2	1.9	7.2	7.6	4.2	7.5	6.2	5.0	1.1	19.5	2.3	3.9	10.5	4.7	1.4	1.4	4.9	0.2	16.7	0.7	0.5	6.7	0.2	3.1	0.1	0.3	1.0	0.1	3.7	3.3	8.2	2.8	4.4	5.1	0.0	15.1	3.1	4.9	1.5	0.0	6.6	2.7	0.1	0.0	3.7	2.8	0.0	4.8	0.1	0.1	10.1	2.0	2.2	0.5	6.4	12.1	0.0	0.0	0.0	3.3	10.9	0.0	0.0	7.5	0.1	17.2	0.1	0.0	0.1	3.9	52.6	6.3	0.0	9.5	3.5	2.7	1.4	14.5	5.5	0.0	0.1	6.6	0.2	0.1	1.5	0.0	0.0	5.8	0.0	0.0	4.9	0.2	0.0	0.4	0.1	0.4	1.4	0.2	0.4	1.4	0.3	0.5	0.7	0.4	16.7	0.0	1.0	0.0	0.5	14.0	24.5	17.2	24.7	15.4	21.6	11.3	16.2	17.7	5.0	17.9	2.1	3.4	4.2	4.4	52.9	51.9	0.0	2.7	10.3	14.0	11.8	18.5	10.0	3.0	0.6	6.8	0.0	0.0	7.4	10.2	16.9	4.9	10.3	0.0	8.4	6.4	1.7	6.7	1.3	1.7	6.6	4.6	10.1	7.2	0.0	10.8	7.2	0.0	4.9	13.6	7.2	0.0	13.3	3.7	16.8	2.3	4.2	1.8	0.4	4.1
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235449923-235504481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 35.7"	"Cell type enriched"	"Detected in many"	7	"Cone photoreceptor cells: 237.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012502, HPA050662"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA012502: AB_1845228, HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	5.0	6.3	3.9	4.3	5.1	1.3	8.4	4.7	4.5	5.4	7.6	3.5	5.1	3.3	8.0	8.7	10.3	6.1	9.7	7.9	2.8	2.9	3.7	4.6	3.7	3.1	3.0	3.2	5.9	35.7	9.8	8.9	4.5	4.7	8.3	5.8	8.5	8.7	7.3	21.6	6.1	6.9	16.9	2.5	3.3	9.2	5.8	3.9	4.7	7.1	7.0	5.0	9.7	5.9	1.5	5.7	2.4	2.7	1.9	1.9	1.3	9.9	6.5	7.2	10.7	11.7	9.9	17.4	8.7	7.9	6.6	6.1	5.0	8.9	5.2	11.5	9.9	4.3	12.6	14.0	10.2	8.2	10.2	9.7	3.3	8.3	5.7	7.4	10.7	3.7	7.1	6.6	6.8	16.5	5.0	10.1	14.1	8.0	7.0	6.2	4.7	6.7	3.9	10.3	6.3	3.7	7.4	12.0	13.2	4.2	11.8	9.3	11.9	15.1	5.7	7.5	3.1	11.0	10.9	9.9	5.8	9.6	9.8	11.6	10.2	8.4	3.2	3.8	7.7	13.4	2.4	2.3	1.1	1.1	2.7	1.7	1.5	0.8	1.9	5.7	1.1	1.0	1.3	0.2	1.9	2.5	3.1	0.5	1.3	3.9	5.1	4.7	4.5	2.8	2.9	3.0	3.2	4.7	3.9	8.9	5.3	6.4	25.1	27.7	18.9	5.4	2.5	5.3	4.5	5.2	237.6	17.0	0.0	5.8	13.0	6.7	7.3	0.0	6.1	5.6	8.1	23.5	5.7	4.4	3.5	27.0	8.6	4.3	3.1	4.5	9.8	7.9	1.7	9.0	4.6	7.8	7.6	4.3	15.2	0.8	17.3	0.0	14.4	16.6	34.1	26.0	18.8	5.3	5.2	31.0
B3GALT2	beta3Gal-T2	ENSG00000162630	"Beta-1,3-galactosyltransferase 2"	O43825	1	193179045-193186654	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;gallbladder: 19.0;heart muscle: 25.1"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 47.7;Cardiomyocytes: 27.8;Cholangiocytes: 15.3;Leydig cells: 29.4;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 11.9"	"Lineage enriched"	"Detected in single"	57	"T-cells: 11.9"	"Group enriched"	"Detected in some"	4	"AF22: 16.4;ASC TERT1: 7.5;LHCN-M2: 11.1;WM-115: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078659			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA078659: AB_2686887"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.34e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.14e-4)"	"unprognostic (4.41e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-3)"	0.7	2.0	11.3	1.3	8.9	0.7	0.9	1.4	32.9	0.8	1.7	1.2	0.9	1.6	0.6	1.8	1.2	0.7	19.0	25.1	10.1	7.9	1.7	0.8	2.6	0.7	5.7	19.1	13.8	0.8	0.4	0.9	0.9	5.0	6.5	2.0	0.3	0.5	7.1	0.6	0.7	4.1	0.8	6.5	1.4	2.1	1.4	4.7	0.0	1.8	0.0	1.6	2.0	0.7	0.0	0.2	0.1	0.0	0.0	11.9	0.3	0.0	0.0	16.4	0.0	0.4	7.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.4	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.3	11.3	8.9	1.4	32.9	10.1	7.9	5.7	19.1	5.0	4.7	0.0	0.3	0.0	0.0	0.2	47.7	27.8	15.3	4.0	0.0	1.8	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	2.3	0.0	0.2	7.9	2.9	1.3	0.3	0.0	29.4	0.1	0.0	0.0	0.3	1.7	0.4	0.0	19.8	0.0	5.8	0.0	0.4	0.0	0.0	0.3	0.0	5.1	0.4	0.0
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196113-62224731	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		43000000	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	18.9	14.3	8.6	10.8	23.0	41.6	17.5	3.1	14.1	18.4	17.9	7.4	5.6	17.9	19.8	8.0	24.5	8.7	18.1	20.9	7.6	11.5	24.4	14.2	23.9	13.9	9.7	7.1	9.0	43.2	5.4	25.9	22.8	9.5	7.5	16.3	14.4	17.2	6.0	5.2	13.0	21.7	16.3	7.6	14.6	12.0	7.0	10.6	27.0	15.6	8.5	18.5	11.8	14.7	8.4	6.8	28.3	5.6	20.3	19.3	8.2	7.8	5.4	8.2	3.6	9.0	4.1	23.7	7.6	8.5	6.1	8.2	11.1	12.6	8.5	7.0	7.1	8.6	7.5	5.2	6.4	10.6	17.6	4.2	20.8	2.6	6.5	6.8	12.4	9.4	4.9	12.1	11.7	4.2	4.3	9.1	5.9	11.3	5.3	7.3	5.9	23.6	18.6	7.8	14.2	2.2	43.4	5.7	4.6	11.6	7.7	8.0	5.9	5.4	11.7	8.7	13.8	3.3	14.7	10.3	7.4	6.5	12.5	7.5	15.1	5.3	36.5	5.8	21.6	7.1	7.2	4.5	28.3	11.0	4.4	15.6	7.6	8.2	19.3	5.5	8.4	9.9	14.4	11.3	20.3	5.6	6.8	13.2	8.2	8.6	23.0	3.1	14.1	7.6	11.5	9.7	7.1	9.5	10.6	59.6	9.8	25.1	27.0	63.4	16.0	8.7	17.8	5.3	3.4	17.4	0.0	31.1	19.9	20.8	0.1	21.0	17.3	46.7	50.7	30.1	35.3	23.6	3.5	15.5	51.9	0.0	9.1	37.4	22.7	0.2	2.3	20.4	33.7	24.4	19.1	8.1	37.8	21.8	2.1	18.9	2.4	64.7	52.3	0.2	1.5	56.7	54.6	17.5	11.9	34.6
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203543-122208952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 16.3;skin 1: 8.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.7	3.2	7.3	0.8	6.8	4.6	0.8	16.3	9.1	0.5	0.7	0.5	0.0	1.0	0.6	0.7	1.8	1.1	1.1	0.8	4.9	4.0	6.1	0.6	1.1	0.9	1.5	7.3	0.8	0.8	0.8	1.9	0.8	4.0	0.7	0.6	1.0	1.7	0.7	1.1	8.5	1.0	0.6	0.6	1.0	0.7	2.0	0.3	0.0	0.8	0.3	0.8	0.6	0.5	0.8	1.0	0.8	1.7	0.4	1.9	0.4	5.5	1.0	0.4	2.2	0.2	0.1	1.0	0.1	0.0	0.3	0.7	3.5	0.5	0.5	1.0	0.0	0.4	2.0	2.7	2.2	0.2	8.2	2.8	0.2	1.5	0.3	0.6	0.7	1.1	0.7	9.9	0.1	0.5	0.8	0.0	2.0	1.6	0.7	0.2	4.9	0.0	0.7	0.6	0.2	2.0	0.4	0.6	1.0	1.4	0.6	1.4	1.8	1.6	1.0	0.5	0.9	7.6	0.1	0.1	0.5	2.8	0.5	0.3	0.6	5.0	1.2	0.5	0.8	0.3	0.8	0.4	0.2	0.8	0.1	0.4	0.8	1.3	0.2	0.2	0.5	1.9	0.2	0.5	0.4	1.7	1.0	0.6	0.4	7.3	6.8	16.3	8.1	4.9	4.0	1.5	7.3	4.0	0.3	0.0	2.6	0.0	0.7	1.1	0.1	0.4	0.0	1.4	1.2	0.0	0.0	0.4	1.7	1.0	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.4	0.6	0.0	6.1	0.1	0.0	0.2	0.5	2.6	1.3	0.5	0.5	0.3	0.4
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.1	1.5	8.7	5.3	7.3	21.6	7.9	0.2	0.4	1.7	1.4	3.2	8.5	0.0	1.0	0.0	30.4	7.4	8.9	25.2	1.4	0.0	5.5	0.8	0.7	0.0	9.3	8.1	4.0	10.1	30.7	1.3	23.0	2.3	15.7	0.0	9.2	0.0	13.8	0.0	0.0	2.6	3.6	9.5	14.0	2.5	4.4	0.0	5.3	4.5	0.4	8.3	4.5	0.0	1.9	4.1	0.0	9.9	23.1	0.4	3.4	0.5	3.9	0.0	0.0	0.0	3.3	19.2	8.6	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3	6.0	17.4	0.0	55.5	57.9	7.1	2.0	12.7	101.7	27.3	5.2	21.6	24.4	1.7	15.7	9.9	10.0	77.7	0.0	10.5	9.4	7.4	42.6	13.9	0.4	25.3	3.2	36.7	3.1	9.7	19.2	1.4	50.1	11.8	11.8	73.1	3.2	25.3	42.1	0.4	4.3	12.7	0.0	3.4	0.9	0.4	74.2	132.0	0.7	26.9	125.2
B3GNT7	beta3GnT7	ENSG00000156966	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7"	Q8NFL0	2	231395543-231401164	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.7;intestine: 41.2"	"Cell type enhanced"	"Detected in many"	12	"Intestinal endocrine cells: 99.1;Mucus-secreting cells: 119.1;Undifferentiated cells: 275.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 15.0;HEL: 11.8;THP-1: 10.5;WM-115: 18.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013881, HPA035625, HPA035626"	Enhanced		Approved	"Golgi apparatus,Mitotic spindle,Cytosol"	"Intracellular and membrane"	NA	NA		2100000	"Golgi apparatus"	"Mitotic spindle, Cytosol"	"HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (3.57e-1)"	3.0	10.3	5.3	2.3	4.9	5.5	1.9	0.9	3.2	1.2	28.0	3.8	0.8	12.2	1.6	3.5	1.9	3.6	93.7	26.8	4.2	4.4	1.4	1.3	17.7	1.8	4.0	2.0	13.0	18.9	6.7	8.9	10.7	3.2	1.6	35.5	2.0	4.0	2.3	0.4	2.4	41.2	1.1	1.9	6.7	17.1	1.6	2.2	1.2	4.2	1.7	3.9	1.2	0.6	7.1	4.2	0.4	0.3	19.9	2.0	0.5	0.5	2.1	0.2	0.4	0.1	0.2	0.8	0.2	0.8	0.1	0.1	1.0	15.0	1.7	4.6	0.2	0.1	3.9	0.2	0.0	0.1	0.2	0.4	11.8	0.3	0.7	0.1	0.1	0.6	0.1	1.1	0.1	0.2	0.8	0.2	0.3	0.3	0.3	0.1	0.6	0.1	0.5	4.9	5.8	2.6	0.2	0.0	0.2	0.5	1.3	0.4	0.6	0.2	1.3	0.5	5.7	0.5	10.5	0.2	0.3	0.3	0.2	0.1	1.8	0.6	0.5	0.3	0.1	18.2	0.3	0.0	0.4	2.0	0.3	0.4	7.1	0.0	0.2	4.2	5.1	0.1	0.5	0.1	19.9	0.3	2.1	0.1	0.5	5.3	4.9	0.9	3.2	4.2	4.4	4.0	2.0	3.2	2.2	38.7	24.6	2.2	1.2	2.1	0.2	0.8	84.1	75.0	33.0	1.8	2.0	0.4	0.0	13.5	0.3	0.7	75.7	0.0	73.7	52.0	2.2	11.2	9.2	0.0	9.0	0.0	99.1	3.7	7.0	0.9	1.4	13.6	3.3	4.6	119.1	0.5	58.2	46.0	7.8	0.1	1.6	0.0	1.4	0.7	1.3	2.4	1.7	6.9	275.6	13.2
B3GNT9	MGC4655	ENSG00000237172	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9"	Q6UX72	16	67148105-67151214	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 10.6;Peritubular cells: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.5;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"SiHa: 24.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052743, HPA062734"	Approved		Approved	"Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA052743: AB_2681934, HPA062734: AB_2684854"	"unprognostic (2.56e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.56e-3)"	5.6	7.3	5.0	5.2	7.1	0.6	7.2	0.9	8.8	12.6	5.7	12.4	12.6	3.5	11.7	11.3	6.6	11.4	11.4	11.4	6.0	3.9	7.0	5.0	7.3	4.6	12.2	5.3	20.6	3.1	34.7	17.9	7.9	5.5	12.0	3.6	16.6	8.9	15.9	2.1	4.7	4.4	8.0	5.3	5.0	6.1	9.7	7.1	0.8	25.2	4.6	3.9	8.6	7.9	0.1	1.5	0.2	0.1	0.0	1.9	0.1	2.2	4.1	0.3	0.4	13.5	14.0	0.5	10.6	17.1	6.9	8.9	1.8	0.4	0.3	0.7	16.3	2.9	5.2	0.1	0.5	3.8	3.5	1.5	0.3	4.6	1.6	10.9	0.2	0.2	11.6	4.0	6.7	0.2	17.2	0.9	0.2	0.4	1.3	10.7	1.2	1.2	0.6	2.5	1.7	3.7	3.4	6.2	2.0	1.0	2.8	2.4	5.3	24.0	0.1	0.3	2.1	0.6	1.8	2.1	12.4	0.5	12.3	4.7	1.6	1.1	0.4	15.4	0.6	6.0	0.0	0.1	0.2	0.9	0.0	1.1	0.1	1.9	1.6	0.2	0.0	0.4	0.2	0.0	0.0	0.0	1.5	0.6	0.1	5.0	7.1	0.9	8.8	6.0	3.9	12.2	5.3	5.5	7.1	6.0	5.3	0.0	3.2	2.9	1.1	2.8	7.6	4.0	2.3	3.5	0.0	0.2	0.0	1.2	4.4	1.1	0.1	0.0	1.5	0.3	8.0	2.5	0.0	0.0	1.4	0.0	2.4	5.5	0.8	3.6	10.6	0.7	1.7	0.0	0.7	0.3	0.9	0.0	12.7	0.5	0.0	6.5	4.2	0.5	2.1	3.6	0.7	0.0	0.6	0.9
B3GNTL1	B3GNT8	ENSG00000175711	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1"	Q67FW5	17	82942155-83051810	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 17.4;Late spermatids: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.9;HL-60: 18.6;THP-1: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023585, HPA024547"	Supported		Approved	"Nucleoli,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli, Nucleoli fibrillar center"	Vesicles	"HPA023585: AB_2061075, HPA024547: AB_1845240"	"unprognostic (1.51e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.61e-7)"	"unprognostic (9.95e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (4.17e-9)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.39e-3)"	3.7	4.3	6.5	7.2	13.9	17.7	4.0	6.4	10.7	4.7	3.6	4.2	1.7	4.7	6.3	6.1	3.7	8.3	3.9	6.2	6.9	4.7	2.9	3.4	4.4	5.6	3.8	7.1	6.6	7.6	1.7	6.1	3.9	7.1	4.6	2.8	3.7	5.6	4.5	5.0	4.4	3.3	5.1	4.4	6.6	4.9	4.0	3.7	6.9	4.4	4.8	3.3	4.3	3.8	3.7	8.8	16.9	5.7	2.4	11.2	3.3	8.2	5.5	0.1	2.7	1.5	4.9	3.4	3.0	2.7	3.5	2.7	3.3	17.9	4.0	5.9	3.7	8.5	1.6	1.4	0.0	3.0	6.2	3.6	8.5	8.2	11.0	5.6	18.6	0.3	1.8	1.5	2.1	3.5	1.7	4.2	6.4	3.7	3.9	2.8	1.8	5.2	7.1	1.3	5.6	4.0	6.8	0.7	0.3	2.0	1.8	1.7	0.6	2.5	1.9	2.5	2.6	0.0	17.9	6.9	6.8	4.6	1.0	5.3	0.8	1.9	3.0	7.5	2.4	0.9	2.6	5.7	0.9	2.7	5.0	4.1	2.8	4.3	3.0	8.8	3.7	3.8	4.6	16.9	2.4	2.5	3.5	11.2	3.3	6.5	13.9	6.4	10.7	6.9	4.7	3.8	7.1	7.1	3.7	3.0	5.0	1.3	1.7	0.9	3.9	1.7	2.5	17.4	6.8	5.2	3.9	5.1	1.7	1.6	11.7	1.5	0.3	0.0	0.8	2.1	3.0	1.5	6.9	1.0	7.2	3.2	1.2	1.8	8.1	15.2	2.8	6.7	1.7	3.6	1.2	1.1	1.9	2.9	4.6	2.2	3.4	0.0	1.2	0.7	4.3	1.5	1.6	6.4	2.7	2.0
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		12000	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	18.6	8.6	34.5	10.1	22.4	4.6	15.6	8.1	35.7	18.4	16.1	16.1	10.7	9.4	13.3	8.5	20.2	11.4	11.9	23.3	25.3	18.9	8.4	24.2	7.7	4.4	18.9	15.6	15.3	39.5	9.9	10.6	9.9	12.7	13.5	10.4	8.7	21.4	21.5	41.0	19.5	9.4	21.3	16.1	5.2	11.2	11.4	11.3	1.9	9.0	12.1	10.1	16.5	11.7	1.7	0.4	0.1	0.6	0.2	2.6	0.7	20.1	14.7	15.3	26.1	20.9	18.7	15.4	22.8	18.8	18.2	16.7	9.7	17.7	13.2	11.7	36.4	16.7	14.0	13.7	23.3	8.5	13.3	26.0	8.8	10.2	22.1	16.9	8.4	0.3	16.3	27.3	13.0	26.7	19.2	21.0	5.3	16.6	8.6	14.2	14.5	4.4	8.4	21.4	14.4	18.4	15.7	20.6	20.7	12.9	9.4	27.9	23.2	10.0	31.6	15.3	8.0	13.7	10.0	16.5	31.7	40.6	21.9	25.4	3.1	6.0	5.6	14.2	6.4	21.1	0.0	0.2	0.0	2.6	0.6	2.4	1.7	1.2	2.2	0.4	0.5	0.0	2.0	0.1	0.2	0.1	0.2	1.1	0.7	34.5	22.4	8.1	35.7	25.3	18.9	18.9	15.6	12.7	11.3	0.0	12.0	0.8	8.4	6.9	13.5	12.2	7.6	2.7	4.5	14.0	3.9	1.6	1.7	12.6	14.0	7.4	5.8	0.0	17.4	6.6	10.6	10.5	0.0	17.8	2.1	17.5	15.6	4.3	0.6	5.4	15.3	1.8	3.3	2.8	19.7	7.5	21.8	7.0	11.7	8.6	12.0	6.5	6.1	3.5	13.0	11.0	0.5	1.3	13.3	14.9
BAALC		ENSG00000164929	"BAALC, MAP3K1 and KLF4 binding"	Q8WXS3	8	103140710-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 121.3"	"Cell type enhanced"	"Detected in many"	16	"Ito cells: 27.0;Muller glia cells: 94.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"NK-cell: 6.9"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"AF22: 24.9;BJ hTERT+: 8.7;SCLC-21H: 13.6;SH-SY5Y: 10.0;U-87 MG: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: AB_2685971"	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	7.8	11.1	42.3	3.2	51.9	3.9	3.0	12.5	121.3	2.8	2.9	18.9	0.0	2.3	3.0	2.0	2.2	4.6	2.9	3.2	38.1	34.5	2.8	3.4	4.9	2.6	48.3	25.1	2.7	2.6	1.9	5.2	5.7	41.4	2.0	2.9	0.0	2.1	2.4	3.0	2.7	2.8	3.1	51.2	8.8	2.4	2.6	24.6	0.0	2.8	0.0	2.2	2.8	0.3	0.2	0.1	0.0	0.0	6.9	0.1	0.4	0.2	1.4	24.9	0.2	0.2	7.4	0.0	1.3	8.7	0.0	0.1	0.2	0.0	0.1	0.2	4.7	0.1	0.4	0.4	0.0	0.0	0.0	1.5	0.2	0.3	0.0	0.6	0.0	0.5	1.5	1.4	0.3	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.6	0.1	0.5	0.1	0.1	0.5	0.0	0.0	13.6	10.0	0.3	0.0	0.0	2.3	0.1	0.1	1.4	7.9	0.5	0.2	0.5	0.0	0.1	0.1	37.1	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.4	42.3	51.9	12.5	43.6	38.1	34.5	48.3	25.1	41.4	24.6	0.0	2.6	0.0	0.7	4.8	2.5	0.6	12.7	17.4	1.2	0.0	0.0	0.0	6.6	17.6	3.0	18.8	0.0	0.0	21.5	0.0	2.6	0.4	0.0	0.5	1.0	0.0	17.0	27.0	2.2	5.6	1.4	0.7	13.5	8.2	0.0	94.5	6.5	0.0	0.0	0.0	2.9	0.0	3.0	0.0	0.1	3.4	0.0	1.7	0.0	0.8
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 165.1;Late spermatids: 300.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 46.7;monocytes: 15.2"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	23.3	7.8	7.9	15.5	13.1	44.7	10.3	4.7	8.8	13.5	12.8	9.6	6.7	9.9	16.0	10.0	18.6	8.9	15.6	10.7	8.0	5.8	11.7	17.6	25.2	21.9	10.8	5.5	9.5	12.5	5.3	9.2	28.8	11.1	14.9	7.8	9.2	12.2	5.3	30.7	22.9	17.9	15.9	16.0	22.9	9.5	20.6	11.1	14.3	11.3	12.6	14.0	19.4	15.8	4.0	7.6	46.7	15.2	2.1	4.4	4.0	7.6	3.1	9.7	2.5	7.6	22.2	6.1	8.4	20.1	8.1	9.1	6.4	10.6	9.1	6.8	7.6	8.5	4.0	5.8	11.2	14.4	7.5	4.8	28.0	6.5	6.6	10.1	8.0	10.5	11.4	17.2	15.9	23.8	9.6	4.2	5.0	14.1	48.1	11.1	2.7	6.8	4.7	14.9	3.0	3.2	7.0	23.0	11.7	4.3	6.0	4.0	4.6	4.5	8.6	10.6	10.1	6.3	9.8	10.7	8.0	11.1	8.6	4.2	27.9	17.8	9.8	6.5	10.0	23.9	17.9	15.2	11.3	1.6	12.4	1.3	3.2	2.7	1.4	7.6	4.0	3.9	1.9	46.7	2.1	13.3	1.8	4.4	4.0	7.9	13.1	4.7	8.8	8.0	5.8	10.8	5.5	11.1	11.1	26.8	15.4	19.9	36.3	52.4	17.0	19.0	17.8	16.0	27.3	14.0	17.7	11.1	6.6	16.3	165.1	28.5	21.5	0.0	14.0	13.5	23.3	45.2	45.3	15.7	19.4	12.7	29.6	28.8	52.8	300.7	12.4	74.4	20.3	39.7	16.5	10.6	22.1	14.0	13.4	9.8	11.9	32.3	23.6	21.8	17.9	50.7	33.2	13.8	9.3	37.3
BAG2		ENSG00000112208	"BCL2 associated athanogene 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 67.0;urinary bladder: 51.0"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 76.8;Early spermatids: 102.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.4	3.5	3.7	8.7	2.8	1.2	4.6	4.1	3.4	18.4	24.5	0.8	14.8	1.9	29.4	9.5	13.4	5.9	6.9	17.2	3.3	3.5	3.7	3.8	4.1	2.3	3.3	2.3	15.4	1.5	0.6	4.5	6.7	3.4	23.7	4.3	2.6	1.5	15.1	9.9	1.7	5.7	67.0	3.4	1.3	7.4	6.7	2.6	1.6	7.6	6.0	1.9	51.0	17.1	5.9	1.4	0.9	0.4	3.3	6.1	1.9	9.5	5.3	2.2	7.9	5.6	16.1	6.3	15.4	14.7	11.1	10.7	6.8	4.9	3.2	14.8	24.3	9.1	1.7	12.8	1.3	10.7	10.1	9.4	9.3	8.0	15.3	8.6	8.1	2.1	7.8	0.7	9.1	8.6	6.7	8.6	7.4	18.6	4.5	10.9	0.7	5.7	6.8	8.5	0.2	5.5	5.3	6.3	6.3	13.3	1.5	2.9	2.6	6.9	0.5	5.5	10.8	1.2	7.1	11.7	6.4	10.4	13.4	15.2	3.1	2.9	7.0	5.6	3.2	0.6	0.1	0.3	0.9	3.3	0.4	3.9	5.9	3.1	3.3	1.4	4.3	6.1	5.1	0.3	3.3	0.1	0.5	3.2	1.9	3.7	2.8	4.1	3.4	3.3	3.5	3.3	2.3	3.4	2.6	3.0	3.0	20.8	4.4	2.2	6.0	33.9	0.0	6.7	2.3	3.5	11.8	76.8	1.7	8.4	102.4	3.6	0.3	0.0	3.0	11.5	50.7	7.0	4.6	13.2	13.1	9.5	1.7	1.8	3.1	24.6	28.7	4.0	6.8	14.4	0.2	6.1	6.8	0.6	36.4	22.7	15.5	6.5	35.4	43.2	6.8	3.3	15.8	8.4	0.6	1.8
BAG5		ENSG00000166170	"BCL2 associated athanogene 5"	Q9UL15	14	103556544-103562831	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.8"	"Group enriched"	"Detected in many"	18	"Early spermatids: 1517.7;Late spermatids: 1363.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016429	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA016429: AB_1845261"	"unprognostic (3.02e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.80e-2)"	"prognostic favorable (1.58e-8)"	"unprognostic (2.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.53e-1)"	16.0	6.7	8.4	8.1	9.4	13.2	10.6	14.8	10.6	11.5	10.1	10.6	9.5	7.0	11.7	9.5	13.6	9.3	7.4	7.3	8.9	8.4	13.5	8.5	8.8	9.3	8.7	7.6	11.4	7.0	9.0	13.2	16.1	10.3	10.3	8.4	8.2	10.4	11.2	9.3	13.1	11.5	10.7	9.7	11.9	8.4	69.8	8.6	11.1	17.0	10.7	11.8	11.7	9.4	10.1	15.3	22.8	21.2	14.7	14.2	12.7	14.8	13.5	16.1	14.4	14.9	15.2	18.1	17.0	11.9	12.2	11.4	11.1	17.5	26.2	15.1	16.6	11.3	21.4	12.8	18.0	19.5	12.0	9.6	17.3	15.8	8.3	9.5	22.6	17.7	10.7	23.3	12.8	16.0	11.2	12.6	18.1	13.8	19.3	16.4	17.8	21.0	10.1	9.6	22.4	16.5	21.5	20.3	11.1	19.9	37.9	18.7	12.5	19.9	16.2	12.9	11.3	21.0	12.2	16.9	13.3	11.6	20.8	17.3	13.3	20.8	30.8	15.1	11.8	16.6	22.8	14.1	12.8	11.6	15.7	13.9	8.3	12.8	10.8	15.3	10.1	14.2	12.9	10.7	14.7	21.2	7.2	11.3	12.7	8.4	9.4	14.8	10.6	8.9	8.4	8.7	7.6	10.3	8.6	41.7	22.4	14.7	37.9	61.2	33.1	19.9	10.2	44.2	52.4	33.2	25.5	21.0	56.3	22.2	1517.7	34.2	17.1	0.0	16.6	14.3	26.3	32.2	31.2	20.3	18.5	71.5	30.4	53.4	26.7	1363.6	46.1	24.1	30.4	10.8	21.9	45.7	20.5	15.3	62.9	24.8	33.8	32.3	19.8	36.3	41.3	78.4	34.1	26.6	20.0	58.6
BAHCC1	"BAHD2, KIAA1447"	ENSG00000266074	"BAH domain and coiled-coil containing 1"		17	81395475-81466332	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 22.2"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 47.8;Cone photoreceptor cells: 21.6;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"eosinophil: 1.4;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.1;granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 11.0;MOLT-4: 13.6;NB-4: 46.8;REH: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023386, HPA076910"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA023386: AB_1859537, HPA076910: AB_2732325"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.78e-2)"	5.9	4.8	5.0	3.0	8.3	8.1	3.6	22.2	7.4	5.1	3.1	10.6	1.1	6.0	4.5	2.3	2.5	3.8	5.6	2.2	4.8		2.8	1.1	4.4	1.1	8.5	5.7	6.0	4.3	5.3	3.2	1.6	4.9	4.4	1.5	9.5	6.1	3.8	6.2	4.4	5.5	4.0	3.2	4.9	3.6	4.4	10.4	9.6	2.5	1.6	0.5	3.7	4.4	0.0	1.1	1.4	0.1	0.0	0.0	0.0	1.7	3.0	2.2	7.3	0.8	1.2	1.0	1.3	1.1	0.7	0.4	0.5	0.8	0.0	2.0	1.5	1.0	1.8	1.0	0.8	0.1	0.0	3.3	2.4	0.7	0.9	0.7	11.0	2.3	2.0	0.3	0.6	0.6	1.1	0.8	2.8	1.7	0.0	0.3	1.0	13.6	46.8	0.1	1.1	2.0	14.3	1.5	0.0	0.9	0.1	10.2	1.6	1.6	0.0	5.8	0.2	0.3	8.8	1.0	4.0	0.5	2.1	0.6	0.0	0.0	0.0	0.0	5.1	0.7	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0											6.0	9.6	0.0	1.4	0.0	47.8	5.8	15.3	4.0	6.8	3.5	21.6	0.1	1.7	2.8	0.5	4.7	3.2	0.0	3.7	0.1	4.3	1.3	0.0	3.0	0.5	31.8	8.1	4.9	5.1	0.0	6.9	1.3	0.0	1.0	4.2	7.5	1.6	0.0	5.3	0.8	16.8	0.0	2.0	1.5	7.8	0.0	0.0	0.0	4.5	0.7
BAMBI	NMA	ENSG00000095739	"BMP and activin membrane bound inhibitor"	Q13145	10	28677342-28682939	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 46.8;seminal vesicle: 52.4"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 40.8;Muller glia cells: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 34.0;SK-MEL-30: 40.6;SuSa: 79.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010819, HPA010866"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Lipid droplets"		NA	NA			Vesicles	"Nucleoli fibrillar center, Lipid droplets"	"HPA010819: AB_2668371, HPA010866: AB_10601686"	"unprognostic (7.02e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (5.25e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.10e-2)"	2.0	24.7	6.7	1.8	6.9	3.0	13.6	2.2	6.3	3.9	2.3	12.9	15.5	1.1	10.1	2.0	1.1	2.8	3.0	22.8	6.7	6.4	11.2	12.9	5.7	3.1	12.0	2.9	46.8	3.9	7.4	4.5	20.9	10.5	6.5	2.8	30.4	3.8	52.4	1.2	2.7	1.1	12.7	10.8	9.0	2.3	4.8	7.9	0.1	0.6	2.1	1.3	13.8	11.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.2	8.6	0.8	0.4	1.0	0.0	5.2	2.1	0.7	3.3	2.1	34.0	3.6	0.1	1.3	1.5	2.0	2.5	2.1	0.3	1.5	2.1	4.7	8.0	1.3	12.9	1.2	0.4	10.7	0.7	0.5	2.2	0.3	20.9	0.5	0.4	4.5	3.9	0.6	14.1	0.0	0.6	15.6	7.2	2.1	0.0	1.6	0.7	2.7	8.2	1.4	1.1	2.8	16.5	40.6	79.5	4.8	0.6	0.0	2.2	1.6	3.6	1.0	0.1	2.9	0.0	0.2	1.8	14.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.7	6.9	2.2	4.8	6.7	6.4	12.0	2.9	10.5	7.9	8.9	5.1	1.7	4.8	3.5	5.1	19.6	40.8	1.4	3.4	10.4	3.9	11.0	1.7	16.1	0.0	3.1	2.0	0.0	0.2	13.7	21.0	16.5	1.1	11.5	5.8	6.4	25.7	19.6	0.6	1.0	3.1	1.4	15.1	1.0	3.4	39.2	7.7	4.3	2.1	13.0	5.2	0.0	4.4	1.7	7.6	1.1	7.1	1.3	1.9	6.4
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0"	"Cell type enriched"	"Detected in many"	6	"B-cells: 268.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	15	"memory B-cell: 61.4;naive B-cell: 46.2"	"Lineage enriched"	"Detected in many"	17	"B-cells: 61.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.4;HEL: 8.1;HL-60: 7.3;U-266/70: 25.0"	"Low region specificity"	"Detected in many"							HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	3.3	2.9	0.7	45.4	0.9	2.0	1.9	2.1	0.7	0.7	1.3	0.7	1.4	0.7	0.4	1.2	6.0	1.0	1.6	0.9	0.8	0.7	2.0	0.5	4.9	30.3	0.7	0.2	0.9	0.6	0.0	3.7	0.5	0.6	2.2	1.1	0.5	7.7	1.8	0.4	0.6	18.0	0.3	0.8	67.0	2.5	1.3	0.7	4.8	5.5	0.4	42.3	6.5	1.1	61.4	2.0	3.6	0.3	0.2	0.0	2.1	0.0	2.3	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.3	0.5	0.0	3.6	10.4	1.0	0.0	0.0	0.1	0.1	1.1	0.3	0.0	0.0	8.1	2.1	0.0	0.1	7.3	0.0	0.5	0.3	0.0	0.0	0.9	0.1	0.0	0.0	3.1	0.5	0.4	0.0	0.4	0.0	0.3	4.4	0.1	0.5	0.0	0.3	4.8	2.1	0.0	0.2	0.1	0.0	0.0	0.4	1.9	1.0	0.0	0.5	0.0	0.0	25.0	0.0	1.7	0.1	4.1	0.0	1.5	0.3	3.6	0.0	0.1	0.0	61.4	0.0	0.0	2.0	46.2	0.0	0.0	0.1	0.2	0.0	1.0	0.0	2.1	0.7	0.9	2.1	0.7	0.8	0.7	0.7	0.2	0.6	0.7	41.7	21.9	268.2	2.1	0.1	0.2	0.4	0.0	2.7	17.0	3.5	0.0	1.8	0.0	0.2	1.9	0.4	0.0	0.0	0.2	0.6	1.0	5.2	1.1	0.0	1.2	0.0	0.0	0.0	2.7	1.8	0.0	7.7	5.0	0.0	0.0	1.1	2.5	0.2	0.4	2.4	0.0	0.0	0.0	1.4	3.2	1.0	0.2	2.5	0.4	4.0
BARX1		ENSG00000131668	"BARX homeobox 1"	Q9HBU1	9	93951622-93955372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 59.7"	"Cell type enhanced"	"Detected in single"	23	"Early spermatids: 2.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 15.6;HMC-1: 37.3;NTERA-2: 11.0;THP-1: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055858			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA055858: AB_2682947"	"unprognostic (6.19e-4)"	"unprognostic (4.81e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.16e-6)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.23e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.68e-13)"	"unprognostic (7.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.16e-2)"	4.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.2	2.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.4	1.5	0.0	0.2	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	59.7	5.6	0.0	0.0	0.5	12.3	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	11.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	3.2	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0
BATF2	MGC20410	ENSG00000168062	"Basic leucine zipper ATF-like transcription factor 2"	Q8N1L9	11	64987943-64997045	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 8.4;Mucus-secreting cells: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.6;neutrophil: 9.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.6;monocytes: 6.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 11.4;BJ hTERT+ SV40 Large T+ RasG12V: 17.5;GAMG: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062496	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA062496: AB_2684783"	"unprognostic (5.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.39e-5)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.17e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.12e-2)"	2.8	5.3	2.4	8.3	3.3	0.4	3.2	1.0	3.4	2.0	8.9	1.9	7.2	8.8	2.1	2.8	2.3	2.9	9.3	2.2	1.9	1.7	10.0	5.4	7.8	2.7	2.2	2.4	3.2	17.3	0.7	3.1	3.0	5.9	7.9	6.7	4.2	14.0	5.1	4.8	0.5	14.0	2.7	2.1	18.7	5.1	0.9	1.7	0.9	16.5	1.0	3.4	3.9	1.2	1.3	0.3	9.6	6.6	0.1	0.1	0.9	1.2	0.8	0.1	0.0	0.1	0.5	0.0	0.4	5.4	11.4	17.5	1.5	4.7	0.0	2.2	0.7	15.6	0.1	0.0	1.3	0.8	0.1	0.3	1.6	0.0	3.9	4.3	0.0	1.0	0.3	0.4	1.5	1.9	0.4	2.7	0.1	3.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.5	0.0	1.1	0.4	1.4	0.1	0.1	0.0	0.4	0.3	5.4	0.1	0.5	0.8	2.0	0.6	0.6	1.0	0.0	0.0	0.1	0.4	0.9	0.5	0.5	0.0	2.6	1.1	0.0	6.6	0.0	1.3	0.0	0.1	0.3	0.4	0.0	0.0	9.6	0.1	3.1	0.0	0.0	0.9	2.4	3.3	1.0	3.4	1.9	1.7	2.2	2.4	5.9	1.7	3.0	1.3	3.7	0.6	0.0	0.0	0.5	5.1	4.0	2.3	1.8	0.0	0.0	1.7	4.6	0.9	1.5	8.4	0.0	5.8	0.2	0.9	0.2	0.0	0.8	3.8	0.0	2.4	5.5	2.7	1.7	0.0	1.0	0.0	1.0	8.0	0.8	4.6	7.0	0.7	3.3	0.1	0.0	1.5	0.1	0.6	0.0	0.0	0.0	6.3	1.1
BAZ2B	WALp4	ENSG00000123636	"Bromodomain adjacent to zinc finger domain 2B"	Q9UIF8	2	159318979-159616692	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 292.6;Rod photoreceptor cells: 350.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 24.1;neutrophil: 54.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 54.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019819, HPA059292"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019819: AB_1845282, HPA059292: AB_2683968"	"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.14e-2)"	16.7	20.7	22.1	12.7	37.7	23.5	16.5	30.3	28.5	25.8	18.3	30.0	19.4	12.4	25.4	17.7	16.6	19.2	19.3	13.4	26.1	13.1	13.3	12.3	18.1	9.8	37.2	20.4	33.4	16.4	27.1	45.4	14.9	29.5	17.1	12.4	13.0	19.0	24.6	19.2	12.7	14.5	20.0	42.3	14.4	14.4	18.6	48.9	6.5	19.0	9.1	9.6	18.6	19.2	2.4	5.9	54.6	7.0	4.7	2.7	1.4	3.6	7.3	25.2	15.2	7.6	12.2	4.4	7.8	9.6	4.3	5.1	11.1	10.2	6.3	13.4	7.6	4.3	8.5	10.0	10.6	6.8	2.1	5.7	11.5	12.7	1.5	5.0	7.8	8.0	9.5	11.7	10.7	11.8	15.8	22.1	3.9	12.5	1.2	6.8	4.3	2.7	4.8	8.3	0.7	6.4	6.4	8.1	4.3	8.7	13.3	16.7	14.6	15.4	1.9	9.1	13.5	2.9	21.5	21.8	7.8	15.8	3.2	5.2	4.7	0.4	7.0	7.2	8.5	4.9	24.1	7.0	8.8	2.7	3.0	2.2	1.5	1.6	2.7	4.4	2.4	1.1	1.7	54.6	4.7	2.6	5.9	1.7	1.4	22.1	37.7	30.3	28.5	26.1	13.1	37.2	20.4	29.5	48.9	92.3	148.1	29.6	60.8	29.0	86.6	49.4	58.6	93.7	85.3	64.6	292.6	16.0	8.3	42.8	118.0	64.1	41.6	23.3	33.7	5.4	30.0	44.2	69.6	25.9	22.6	89.0	95.8	58.9	53.8	22.7	55.0	50.5	13.5	59.5	45.4	116.6	43.6	49.2	32.9	7.5	350.6	12.9	23.6	123.2	15.1	32.9	22.3	30.5	40.3	81.3
BBC3	"JFY1, PUMA"	ENSG00000105327	"BCL2 binding component 3"	"Q96PG8, Q9BXH1"	19	47220822-47232766	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 104.3;Glandular cells: 98.1;Suprabasal keratinocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 19.0;NB-4: 21.8"									"CAB007752, HPA070403"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB007752: AB_562336, HPA070403: "	"unprognostic (4.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (2.62e-5)"	6.8	5.4	4.0	4.7	2.9	9.4	6.5	14.0	7.2	6.3	8.9	1.4	2.3	5.9	5.4	3.7	8.2	5.0	8.0	5.8	4.9	3.9	4.6	5.9	19.0	11.8	3.6	4.3	5.2	11.8	1.6	2.5	5.6	3.4	9.8	4.9	4.5	9.2	4.2	28.6	9.4	6.6	5.7	2.8	7.4	7.9	3.2	3.0	13.3	6.2	1.7	3.2	8.2	3.0	0.2	0.4	6.4	1.0	1.0	1.1	0.3	2.4	5.3	5.9	1.2	1.4	2.7	14.4	3.8	5.2	0.9	2.3	1.5	4.0	9.3	1.7	0.9	1.6	0.8	0.8	3.4	0.1	6.0	10.3	2.6	1.8	10.2	19.0	0.4	8.8	6.5	5.5	2.0	1.8	2.4	6.6	2.8	6.7	5.9	0.6	5.4	1.0	21.8	3.7	4.1	0.7	2.6	0.8	10.7	0.2	0.8	1.0	8.9	1.7	3.6	11.4	4.9	1.2	7.3	4.4	1.1	7.3	0.1	1.2	9.6	2.1	5.8	1.7	1.4	4.0	6.1	0.9	0.5	0.9	1.0	0.8	0.2	0.2	0.6	0.4	0.0	1.1	0.7	6.4	1.0	0.8	0.1	0.5	0.3	4.0	2.9	14.0	5.7	4.9	3.9	3.6	4.3	3.4	3.0	8.9	9.0	16.4	66.9	104.3	5.5	2.4	10.2	0.0	4.5	7.0	0.0	3.5	0.0	40.9	10.7	7.0	29.7	0.0	34.2	4.0	6.6	98.1	12.7	3.2	6.7	0.0	20.5	1.8	9.7	2.4	5.8	17.3	60.8	13.6	20.7	2.7	47.6	21.8	3.9	2.1	4.0	6.5	26.4	0.5	1.3	125.3	17.2	27.7	19.1	48.3
BBOF1	"C14orf45, CCDC176"	ENSG00000119636	"Basal body orientation factor 1"	Q8ND07	14	74019353-74082863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.7"	"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 326.6;Early spermatids: 164.7;Late spermatids: 84.6;Spermatocytes: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA003090, HPA003136, HPA075108"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: "	"unprognostic (1.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.04e-3)"	5.3	3.5	9.4	4.1	12.5	6.0	8.4	4.3	12.5	7.7	6.5	4.4	8.5	2.5	8.2	16.4	6.1	24.1	6.6	4.8	11.5	8.2	10.6	2.8	7.6	2.2	7.3	9.2	5.8	3.2	6.1	17.4	3.0	22.3	6.4	4.2	5.8	4.4	8.9	5.3	3.7	2.7	7.7	13.8	1.8	3.9	37.7	6.7	2.5	14.5	2.6	2.6	7.0	3.4	1.5	5.0	2.4	0.1	2.1	4.2	3.0	4.8	2.8	1.2	8.0	5.4	12.0	1.0	4.2	6.0	4.3	4.1	1.0	3.3	4.7	1.2	5.1	1.8	1.2	1.6	0.7	4.9	0.7	0.9	0.5	2.7	1.0	4.6	2.3	0.3	5.7	4.0	9.6	1.2	6.8	1.5	8.9	2.5	0.9	3.1	3.8	7.4	1.2	0.4	0.4	2.0	2.7	3.1	0.8	7.4	1.2	4.9	3.1	8.2	3.3	2.2	1.3	8.5	0.2	3.5	5.3	3.8	7.1	1.2	1.8	4.2	2.9	15.7	0.3	1.5	2.4	0.1	0.2	3.4	0.0	4.0	1.3	3.2	2.2	0.2	1.5	4.2	3.4	2.4	2.1	0.0	5.0	0.6	3.0	9.4	12.5	4.3	12.5	11.5	8.2	7.3	9.2	22.3	6.7	11.9	7.2	0.0	4.2	0.0	7.2	0.0	5.1	326.6	55.7	3.5	27.5	1.6	13.3	7.3	164.7	2.2	0.4	23.3	3.1	2.2	3.0	3.9	1.1	2.5	2.0	6.4	2.4	4.9	0.6	84.6	10.0	1.7	0.0	1.0	3.2	5.7	2.4	0.0	5.6	14.4	27.4	0.0	0.0	82.2	13.0	0.0	0.8	3.2	0.8	2.8
BCAM	"CD239, LU"	ENSG00000187244	"Basal cell adhesion molecule (Lutheran blood group)"	P50895	19	44809059-44821421	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 101.8"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 519.9;Cytotrophoblasts: 537.1;Syncytiotrophoblasts: 362.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 493.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.4;HaCaT: 64.1;SK-BR-3: 60.2;T-47d: 34.1;U-2 OS: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005654	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		16000000	"Nucleoli fibrillar center"		"HPA005654: AB_2667378"	"unprognostic (5.63e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.94e-6)"	"unprognostic (1.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.97e-3)"	28.9	7.2	4.9	8.1	5.4	1.4	33.1	3.4	8.7	33.5	8.5	4.4	17.8	5.7	24.8	26.5	15.6	46.3	23.2	23.8	4.5	4.2	101.8	13.2	41.6	5.8	4.4	6.5	30.4	17.8	5.8	9.8	28.7	7.0	42.7	2.4	21.4	17.8	27.3	16.7	12.7	7.4	12.5	3.8	14.2	9.6	13.6	2.6	5.7	93.0	23.7	8.5	14.2	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	9.4	0.2	26.2	0.1	0.1	31.4	2.8	1.3	2.3	1.5	14.1	18.0	0.0	14.5	0.3	0.1	64.1	2.3	16.0	0.7	0.0	1.6	0.0	1.9	19.5	5.3	0.0	3.5	2.6	6.2	0.8	0.9	7.5	1.4	0.0	1.5	0.1	0.3	3.7	0.1	0.2	2.9	2.1	3.3	0.1	3.1	0.7	19.6	4.6	0.0	0.1	11.6	60.2	0.7	3.0	34.1	1.0	3.8	0.6	29.5	0.7	1.3	0.1	0.3	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	5.4	3.4	8.7	4.5	4.2	4.4	6.5	7.0	2.6	6.0	10.5	0.5	101.3	36.1	0.6	9.0	38.2	2.7	18.2	519.9	0.0	537.1	69.6	23.4	0.8	63.2	5.1	0.0	3.5	27.0	13.6	65.7	0.0	27.0	38.8	0.0	50.0	39.9	5.9	0.8	27.3	8.0	15.1	0.0	4.7	26.3	14.4	17.5	14.2	123.1	0.5	155.2	124.6	2.2	14.9	21.5	362.4	0.0	10.5	34.4
BCAP29	"BAP29, DKFZp686M2086"	ENSG00000075790	"B cell receptor associated protein 29"	Q9UHQ4	7	107579977-107629170	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029215, HPA049694"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA029215: AB_10602331, HPA049694: AB_2680854"	"unprognostic (3.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.42e-3)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.43e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.81e-1)"	25.6	16.0	17.6	13.7	21.3	11.0	24.0	15.9	33.8	30.5	18.9	10.3	13.6	10.4	27.4	12.3	23.3	13.5	14.7	34.0	18.9	17.0	16.7	24.4	17.3	10.6	20.3	28.7	14.6	12.3	20.8	14.8	23.6	25.7	18.5	19.3	10.0	12.1	17.0	22.9	13.6	13.6	24.0	28.1	12.8	14.6	40.0	13.7	6.3	51.4	13.8	9.8	20.5	20.8	6.6	6.3	20.0	12.4	5.1	6.5	4.3	18.9	5.0	7.9	4.1	17.0	20.2	6.4	21.4	18.6	10.5	11.6	5.5	20.3	3.7	15.2	16.0	18.5	9.5	4.8	10.1	14.6	12.5	5.2	9.1	7.8	5.3	16.8	10.4	12.6	13.0	7.4	13.4	11.0	24.7	28.4	6.8	15.3	10.7	20.7	12.9	6.6	8.8	4.7	6.9	7.8	6.0	10.7	11.7	15.8	9.9	3.4	11.0	20.7	17.9	15.8	10.5	6.8	10.2	30.3	31.0	14.3	27.2	29.6	8.2	21.1	8.8	23.2	9.6	22.6	20.0	6.4	13.0	5.4	7.4	5.5	6.6	4.5	5.7	6.3	5.2	2.7	5.1	2.2	5.1	12.4	6.1	6.5	4.3	17.6	21.3	15.9	33.8	18.9	17.0	20.3	28.7	25.7	13.7	62.5	45.7	19.1	44.3	34.2	31.4	99.3	15.3	32.1	34.2	22.7	9.8	28.2	13.3	40.3	198.1	89.9	22.6	46.7	64.6	44.0	48.3	97.8	56.6	39.4	46.1	7.9	21.5	62.6	29.8	66.5	56.7	40.5	35.4	39.7	32.4	30.9	57.9	31.6	83.8	17.0	22.5	77.6	55.3	226.6	29.8	33.9	59.2	24.5	45.9	62.9
BCAR1	"CAS, CASS1, Crkas, P130Cas"	ENSG00000050820	"BCAR1, Cas family scaffolding protein"	P56945	16	75228187-75268053	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000443, HPA042282"	Approved	Approved	Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB000443: , HPA042282: AB_2677929"	"unprognostic (5.44e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.43e-3)"	"prognostic unfavorable (9.11e-5)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.20e-1)"	16.6	12.3	14.3	8.4	19.5	1.8	11.5	29.1	26.7	16.7	22.7	31.5	9.1	28.6	17.5	11.0	9.6	10.8	20.4	17.8	14.2	9.4	21.3	17.3	15.9	4.9	18.9	13.5	11.3	31.0	9.2	13.2	28.1	13.9	10.9	7.9	14.6	25.7	12.5	37.4	7.2	25.7	8.6	10.4	28.9	28.7	17.3	20.1	0.2	11.8	9.7	6.3	13.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	16.4	8.0	2.6	3.1	2.8	15.4	13.0	7.5	9.5	7.5	21.0	14.1	0.8	17.2	14.4	10.6	8.1	2.7	14.9	2.7	0.0	9.2	0.0	10.0	17.5	7.8	0.0	6.7	8.7	7.4	11.3	5.6	5.6	25.7	0.0	8.3	0.4	5.6	22.4	0.0	0.6	10.6	7.1	10.9	0.3	3.6	3.4	8.7	12.1	9.8	14.1	12.4	2.9	5.0	4.0	6.7	2.2	23.2	16.0	13.9	3.9	19.1	3.5	1.9	0.2	10.1	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	19.5	29.1	26.7	14.2	9.4	18.9	13.5	13.9	20.1	20.8	5.8	2.2	51.8	24.8	13.4	20.7	25.5	4.0	13.6	21.0	5.9	38.1	23.2	45.7	13.5	54.0	56.1	0.0	53.7	20.9	26.0	47.8	9.2	17.9	5.5	12.7	33.5	42.4	1.2	18.0	15.3	2.5	30.4	1.0	35.4	12.3	55.9	52.6	31.5	30.0	4.7	19.4	67.4	14.0	14.7	15.4	30.2	0.0	22.6	54.5
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3, NSP family adaptor protein"	O75815	1	93561786-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 59.5"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 102.8;Extravillous trophoblasts: 70.7;Sertoli cells: 71.1;Urothelial cells: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4;memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavorable (8.41e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic unfavorable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	26.0	10.4	10.1	11.6	14.2	0.9	23.1	8.6	8.1	10.2	14.1	10.0	6.2	12.4	5.7	5.9	8.9	9.4	15.5	10.6	10.6	8.0	15.5	11.0	12.8	11.8	11.7	5.6	11.2	4.1	4.5	4.6	59.5	10.6	11.2	15.7	10.1	20.5	14.5	19.5	13.3	14.8	10.6	9.7	5.4	15.2	7.3	8.0	2.6	10.0	6.6	11.7	12.7	17.7	4.5	1.7	4.4	1.1	0.0	0.3	0.1	15.3	6.6	12.4	0.9	5.4	4.2	10.7	15.9	27.8	13.1	8.1	1.1	11.5	2.5	5.5	24.5	17.1	9.6	0.3	20.6	11.5	1.1	0.3	0.0	4.8	2.8	9.7	0.1	0.0	5.0	22.8	13.6	46.2	12.7	14.4	0.3	0.4	0.1	35.5	2.3	0.3	0.0	3.9	6.7	22.9	1.0	17.9	0.3	34.4	19.5	0.4	1.0	7.7	8.3	9.9	5.0	9.3	0.6	16.9	19.6	5.0	8.3	21.0	1.3	0.5	0.3	2.9	0.0	7.1	4.4	0.0	0.1	0.0	1.1	0.0	4.5	0.1	0.0	0.8	2.5	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.1	10.1	14.2	8.6	8.1	10.6	8.0	11.7	5.6	10.6	8.0	3.0	7.4	7.4	102.8	8.8	1.0	6.7	7.6	10.7	9.1	14.0	0.0	23.0	23.2	11.1	8.4	17.3	20.2	0.0	5.6	70.7	9.3	24.4	3.5	9.4	10.3	20.6	14.3	5.5	4.3	11.2	9.5	8.1	18.6	16.2	20.7	4.3	17.7	20.7	1.1	15.6	0.4	71.1	19.3	3.2	2.9	8.9	15.8	0.0	10.0	114.7
BCAS1	"AIBC1, NABC1"	ENSG00000064787	"Breast carcinoma amplified sequence 1"	O75363	20	53936777-54070594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 134.0;intestine: 40.3;stomach 1: 85.5"	"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 100.4;Enterocytes: 78.0;Mucus-secreting cells: 285.2;Paneth cells: 94.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"OE19: 20.6;RT4: 41.6;SK-BR-3: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033558, HPA051816, HPA054745"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.77e-3)"	1.3	1.0	49.8	3.8	63.4	0.9	2.8	5.4	37.2	5.1	36.9	97.6	0.0	10.7	1.6	2.1	4.7	1.7	5.4	0.9	51.6	35.6	1.7	0.9	2.4	1.1	75.3	14.7	0.9	1.0	0.8	0.3	0.9	69.7	19.1	40.3	0.0	2.9	1.0	0.9	1.1	17.1	2.4	134.0	1.1	85.5	2.5	49.2	0.0	0.8	0.0	4.1	21.8	1.1	1.6	0.2	1.0	0.2	0.3	5.7	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	0.0	0.0	0.0	20.6	0.0	0.5	0.0	0.2	0.0	41.6	0.0	0.0	0.0	87.1	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.5	0.2	0.1	0.5	0.2	3.0	1.6	1.0	0.3	0.0	0.5	0.2	0.1	1.0	0.3	0.2	0.2	5.7	0.2	49.8	63.4	5.4	32.3	51.6	35.6	75.3	14.7	69.7	49.2	8.9	0.6	1.3	5.9	0.7	0.0	2.0	5.1	100.4	22.7	3.5	0.0	0.1	1.7	0.9	13.2	0.1	78.0	0.0	20.6	0.1	0.9	33.5	4.6	0.0	0.1	0.0	8.1	0.6	0.0	13.6	0.3	1.6	15.1	0.0	285.2	0.9	13.8	94.5	0.0	0.0	0.5	0.0	0.3	10.5	5.3	0.3	0.0	0.7	33.5	44.2
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2, pre-mRNA processing factor"	O75934	1	114567557-114581639	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"		NA	NA			"Nuclear speckles, Centrosome"		"HPA067881: AB_2685915"	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (4.27e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.87e-1)"	23.2	28.0	36.7	17.6	34.1	43.0	25.0	30.4	40.6	21.3	19.7	16.5	17.3	16.7	22.9	33.2	26.0	16.6	20.7	24.5	31.6	41.8	28.7	32.9	17.5	22.4	37.0	28.8	26.8	18.2	22.9	32.5	17.4	39.0	24.1	21.0	13.9	19.5	26.7	38.4	19.0	19.0	20.1	26.9	20.8	18.3	21.2	24.6	20.0	27.8	24.5	22.1	31.1	19.5	30.4	24.8	30.9	22.6	35.4	40.1	32.9	19.3	7.1	14.7	13.9	7.8	9.1	22.0	14.6	11.3	19.4	20.0	9.9	8.0	17.2	20.2	9.4	13.1	9.4	17.0	14.4	27.0	15.6	15.3	9.0	14.1	14.3	14.2	22.7	9.8	8.3	15.9	20.0	24.8	9.1	12.6	18.8	17.2	12.9	15.9	118.8	20.2	16.9	25.5	11.9	16.2	14.5	26.0	12.0	13.6	17.0	19.2	12.8	18.2	14.1	22.4	12.7	12.4	18.0	11.1	11.9	15.9	23.8	27.4	14.1	14.5	27.9	23.2	19.0	44.8	21.6	18.5	30.9	29.3	21.9	40.1	30.4	36.7	35.7	19.4	26.7	38.2	37.2	17.6	35.4	22.6	24.8	35.8	32.9	36.7	34.1	30.4	40.6	31.6	41.8	37.0	28.8	39.0	24.6	26.8	38.4	63.6	94.6	69.1	63.3	63.3	28.1	42.8	36.4	47.1	35.3	67.4	81.2	56.2	17.0	43.9	22.2	23.3	58.4	73.6	49.8	51.7	99.1	27.7	58.7	36.5	47.9	27.0	31.0	13.7	36.8	54.3	64.1	50.5	30.7	70.3	45.0	31.1	41.1	72.5	55.6	38.8	78.0	57.0	37.7	55.5	84.7	66.0	31.3	106.5
BCAS3	FLJ20128	ENSG00000141376	"BCAS3, microtubule associated cell migration factor"	Q9H6U6	17	60677453-61392838	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 203.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052409, HPA057289"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA052409: AB_2681821, HPA057289: AB_2683399"	"unprognostic (2.84e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.52e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (2.55e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	12.1	15.9	13.9	8.3	24.1	8.8	11.6	21.5	30.8	12.9	11.4	32.2	12.6	7.1	20.6	18.6	14.3	21.1	11.3	11.7	15.8	14.3	17.1	18.3	13.6	8.5	19.2	18.6	11.9	13.5	26.5	16.9	14.7	24.3	17.1	9.3	16.1	13.6	14.3	20.3	17.0	8.4	13.6	16.3	10.8	11.7	20.2	20.0	16.6	13.7	7.6	13.9	17.0	11.9	9.1	6.9	26.8	8.0	11.7	12.9	6.4	3.3	8.2	4.2	14.1	8.6	7.3	4.9	3.5	4.8	3.6	4.6	5.5	7.4	1.3	6.0	5.9	5.0	2.6	2.4	2.9	4.7	3.0	9.4	3.2	4.6	5.0	4.8	1.6	2.8	8.6	3.4	3.0	5.5	7.2	4.2	5.1	2.7	6.6	3.2	43.3	4.6	1.2	4.4	16.2	9.3	5.7	5.7	6.0	3.0	12.7	6.3	5.3	7.1	2.1	5.0	14.8	7.7	2.4	3.9	4.8	4.1	2.0	1.6	15.4	12.7	5.6	5.7	1.2	3.7	15.8	7.8	11.7	12.1	6.7	9.8	9.1	8.4	9.2	6.9	8.4	9.3	7.5	26.8	11.7	8.0	4.9	12.9	6.4	13.9	24.1	21.5	30.8	15.8	14.3	19.2	18.6	24.3	20.0	6.0	12.2	2.7	7.8	4.5	13.0	11.2	5.1	48.2	12.5	15.7	9.8	5.9	8.3	3.6	38.8	8.5	3.6	0.0	3.1	4.3	5.0	3.6	16.1	8.6	3.7	3.2	6.9	12.9	5.6	203.3	6.9	4.7	1.7	7.2	4.6	30.3	3.2	4.8	19.8	23.0	13.4	12.9	14.4	11.1	4.7	4.8	6.3	11.8	2.6	6.9
BCAS4	"CNOL, FLJ20495"	ENSG00000124243	"Breast carcinoma amplified sequence 4"	Q8TDM0	20	50794894-50882676	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.9;lymphoid tissue: 31.6"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 114.6;B-cells: 70.5;granulocytes: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.9;naive B-cell: 28.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.9;U-698: 34.6"					"Low region specificity"	"Detected in all"			HPA038812	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA038812: AB_10795141"	"unprognostic (3.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.30e-2)"	1.8	2.3	7.3	29.1	12.9	3.9	4.5	6.2	12.8	4.8	4.2	2.3	4.2	2.4	5.4	7.2	4.7	3.6	3.8	3.1	13.8	7.5	7.0	1.4	3.8	28.5	7.1	9.2	3.0	3.6	9.2	5.4	5.0	5.2	7.7	1.9	8.8	4.9	7.1	2.1	2.1	8.6	6.0	2.0	12.2	4.5	5.1	2.2	9.2	5.9	0.0	31.6	7.6	5.3	28.9	7.0	0.6	0.1	6.9	12.9	5.3	4.9	8.9	0.7	3.9	1.4	3.7	1.5	6.4	5.8	4.6	3.3	4.2	3.0	38.9	2.4	2.7	9.3	7.4	4.4	9.3	2.7	2.5	3.9	0.2	3.5	3.5	2.0	0.0	0.2	1.2	5.4	3.5	1.7	5.8	0.2	3.1	0.1	0.2	1.6	17.3	1.5	0.1	3.2	0.7	7.2	12.2	1.2	0.4	2.1	4.5	4.0	4.1	10.0	9.6	0.2	3.5	19.0	0.4	0.2	5.0	7.3	5.0	1.5	0.6	2.9	34.6	2.0	0.3	0.4	0.6	0.1	0.1	6.2	0.1	3.5	28.9	3.8	7.5	0.1	28.7	12.9	10.3	0.6	6.9	0.1	7.0	3.1	5.3	7.3	12.9	6.2	12.8	13.8	7.5	7.1	9.2	5.2	2.2	20.8	114.6	70.5	24.1	1.8	5.8	14.8	5.1	37.5	33.0	8.7	2.0	24.9	34.9	9.7	1.3	1.6	0.0	0.0	2.7	3.1	14.6	11.2	104.6	0.2	2.6	7.9	32.2	1.3	1.5	0.4	1.4	1.4	5.0	1.8	2.2	6.9	6.3	0.0	2.8	3.3	5.5	6.5	14.6	3.0	10.6	2.0	9.2	25.8	1.2	21.3
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038011: AB_2675784"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	24.0	25.0	27.9	28.8	28.0	32.3	33.4	28.0	30.2	20.8	23.0	15.0	27.8	19.7	21.1	35.9	27.6	21.3	17.9	28.7	28.7	21.3	35.0	45.9	19.0	27.6	23.6	22.0	28.0	29.2	19.8	27.6	19.8	33.5	27.3	26.3	14.4	34.7	26.7	132.7	19.3	23.5	29.7	35.6	27.2	28.2	28.6	24.1	24.6	26.0	32.0	28.7	24.0	47.9	30.9	30.7	16.1	35.4	26.0	33.8	19.0	54.8	28.5	32.4	35.8	18.5	20.4	27.1	29.5	28.3	36.5	34.0	46.6	36.9	38.6	18.6	27.0	27.5	30.5	55.3	41.8	51.2	35.5	37.5	38.8	24.6	51.4	23.4	53.2	24.7	20.9	25.3	43.5	46.1	27.8	34.7	36.5	42.8	19.8	30.9	32.8	34.4	53.8	25.0	46.3	43.1	33.0	34.1	23.1	32.3	26.4	17.2	17.6	22.0	36.2	36.2	27.6	19.5	23.7	23.2	17.1	30.1	25.1	53.1	20.3	22.6	57.4	33.5	27.8	13.1	12.4	28.7	16.1	24.6	34.7	33.8	30.9	28.2	26.8	30.7	28.9	31.9	28.6	4.7	26.0	35.4	26.5	29.7	19.0	27.9	28.0	28.0	30.2	28.7	21.3	23.6	22.0	33.5	24.1	59.6	61.1	29.0	39.2	59.4	23.5	74.2	22.9	92.3	78.5	22.7	21.6	35.7	66.3	28.3	8.2	26.2	18.0	23.3	38.0	30.2	29.3	38.3	25.5	42.9	32.0	15.9	24.8	24.5	28.9	7.7	34.2	29.8	21.9	35.1	20.2	25.8	38.2	14.0	29.4	48.8	23.1	25.8	31.5	79.8	108.7	45.7	28.3	24.9	31.1	42.9
BCDIN3D		ENSG00000186666	"BCDIN3 domain containing RNA methyltransferase"	Q7Z5W3	12	49836039-49843129	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039911	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA039911: AB_10673021"	"unprognostic (2.21e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.96e-3)"	"prognostic favorable (3.24e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (2.31e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.06e-4)"	5.6	9.3	6.9	6.0	8.4	2.6	7.8	8.9	9.0	6.1	6.0	7.2	6.9	4.9	8.3	7.5	9.1	7.7	4.9	5.3	5.9	4.5	7.3	10.5	4.5	8.3	9.8	4.8	8.5	11.9	8.4	12.7	6.5	6.6	8.7	5.7	5.2	15.4	6.9	32.8	7.6	8.4	5.3	7.6	9.3	8.4	5.3	7.7	15.2	9.9	4.2	10.8	7.4	6.0	9.9	5.0	5.9	6.6	6.2	10.3	4.6	3.4	4.9	4.7	7.3	9.9	5.8	4.9	4.7	6.2	5.0	5.2	2.6	9.0	3.0	5.4	2.1	3.8	4.6	4.7	2.8	2.8	10.4	6.3	4.2	3.8	1.6	7.9	4.8	4.2	3.1	11.2	3.5	5.0	6.3	2.3	6.5	7.5	8.3	3.1	8.6	5.3	7.7	4.7	7.5	8.7	5.6	4.4	5.9	4.9	3.1	6.5	9.1	5.6	9.1	6.7	3.9	11.4	5.3	2.6	4.2	3.2	6.3	2.5	7.9	6.8	5.7	4.5	3.5	2.8	5.9	5.4	2.8	7.6	6.5	10.1	9.9	9.4	7.2	5.0	9.1	10.3	9.7	4.6	6.2	6.6	3.0	7.8	4.6	6.9	8.4	8.9	9.0	5.9	4.5	9.8	4.8	6.6	7.7	29.8	23.5	12.6	7.6	1.9	6.7	2.4	2.5	18.7	11.4	1.8	0.0	11.0	11.6	8.2	1.7	2.9	4.3	0.0	8.5	6.0	5.0	5.7	10.4	6.4	5.0	4.8	1.7	4.3	4.9	0.7	7.8	4.8	0.0	1.0	5.5	7.1	5.8	6.0	6.0	6.7	5.8	0.0	4.1	8.2	10.0	2.8	6.4	10.0	5.0	2.0
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"B cell CLL/lymphoma 11B"	Q9C0K0	14	99169287-99271524	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6"	"Group enriched"	"Detected in many"	8	"Basal keratinocytes: 55.8;Suprabasal keratinocytes: 62.4;T-cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 13.7"	"Group enriched"	"Detected in many"	8	"gdT-cell: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.4"	"Group enriched"	"Detected in some"	6	"JURKAT: 24.7;MOLT-4: 29.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.3	0.4	4.4	6.6	13.7	5.2	1.3	0.3	3.8	0.8	1.3	0.1	0.0	2.3	1.9	0.8	3.9	0.3	3.0	0.8	4.8	1.0	0.3	0.5	1.1	10.8	0.8	2.6	0.2	0.1	0.0	0.1	0.0	0.6	0.6	1.7	0.3	5.0	0.7	0.1	17.6	3.0	0.2	0.7	4.9	2.1	0.4	1.6	25.4	0.9	1.5	8.8	2.0	2.3	0.0	0.0	0.1	0.0	0.5	7.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.0	24.7	0.0	2.8	0.0	1.6	29.5	0.4	0.3	2.2	0.0	4.6	0.0	0.0	0.0	1.6	2.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.8	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.1	3.3	0.0	3.0	0.0	4.5	3.7	0.0	0.0	7.4	4.9	0.0	0.5	0.0	0.0	3.0	1.1	4.4	13.7	0.3	3.8	4.8	1.0	0.8	2.6	0.6	1.6	3.0	0.0	2.7	1.6	55.8	0.1	3.1	5.1	0.0	1.2	0.0	0.0	0.1	1.7	0.3	0.0	0.1	4.3	0.0	0.4	0.0	1.1	0.2	4.7	0.0	0.2	0.0	1.2	4.3	1.2	0.2	0.6	0.7	5.0	0.0	2.6	0.0	0.7	4.3	0.0	0.3	0.0	0.0	3.3	0.7	4.9	62.4	0.0	48.4	6.9	0.6
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2, apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.3;MAIT T-cell: 7.6;memory B-cell: 5.2;memory CD4 T-cell: 6.3;memory CD8 T-cell: 3.8;naive B-cell: 4.1;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.5;T-reg: 6.7"	"Group enriched"	"Detected in many"	8	"B-cells: 5.2;T-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 22.8;U-266/70: 79.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.9	3.0	10.1	15.7	9.4	5.3	24.6	4.7	8.4	14.8	7.8	7.4	9.1	5.0	17.1	9.3	4.7	12.2	9.2	6.5	10.0	8.1	8.5	2.3	5.0	14.6	10.8	5.6	18.2	2.9	19.6	7.0	22.4	9.2	8.4	5.9	10.8	5.4	15.7	20.0	6.3	10.5	8.6	9.3	17.8	5.4	3.5	10.5	21.0	35.6	2.9	13.4	7.9	16.4	5.2	0.3	0.7	0.2	0.7	7.6	1.9	0.5	0.1	2.3	1.8	2.8	0.4	0.8	0.2	0.2	0.8	0.5	1.1	0.1	0.0	0.4	0.2	1.5	0.1	2.1	0.3	0.4	13.6	0.4	0.1	0.6	0.2	0.5	12.4	1.8	0.5	0.2	0.9	1.9	0.3	0.2	1.4	0.2	22.8	0.4	0.4	2.6	5.4	0.5	0.2	0.4	11.7	0.5	8.8	3.9	1.9	1.9	1.8	0.0	0.0	2.8	0.5	0.1	10.5	0.1	3.0	1.0	0.3	1.5	79.4	10.4	0.9	0.5	8.8	1.7	0.7	0.0	0.0	2.3	0.0	7.6	5.2	6.3	3.8	0.1	4.1	5.1	4.5	0.1	0.7	0.2	0.3	6.7	1.9	10.1	9.4	4.7	8.4	10.0	8.1	10.8	5.6	9.2	10.5	0.0	0.6	41.9	30.2	17.3	1.0	15.4	17.8	0.0	3.4	7.0	0.0	8.5	13.3	2.5	0.2	3.5	0.8	0.0	0.0	0.9	10.3	31.5	15.1	1.5	8.3	0.0	5.2	3.7	10.4	2.1	8.1	16.9	43.9	29.7	9.9	18.9	0.3	0.0	13.1	13.5	0.5	25.8	10.8	0.3	0.6	15.4	41.1	28.7	10.6	39.2
BCL2L1	"Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52"	ENSG00000171552	"BCL2 like 1"	Q07817	20	31664452-31723989	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Endocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035734, CAB072801"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB072801: , HPA035734: AB_2674757"	"unprognostic (2.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.82e-3)"	"prognostic favorable (9.57e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.89e-5)"	"unprognostic (9.67e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.32e-2)"	30.8	21.4	25.1	16.4	34.3	57.0	40.7	27.7	40.7	28.2	22.6	37.0	13.0	31.3	18.7	12.2	36.9	31.5	35.9	26.9	27.0	23.7	42.6	39.3	40.6	17.8	43.4	24.3	11.5	28.5	17.5	22.8	29.0	33.4	24.8	21.4	31.5	33.8	21.5	21.9	26.1	30.4	19.2	28.8	26.6	28.0	30.2	38.4	56.4	25.8	15.4	20.7	24.5	22.4	3.9	7.8	17.0	8.9	12.5	27.2	16.5	64.0	38.2	7.1	6.8	38.0	27.5	22.6	15.3	25.1	16.1	15.4	90.1	31.1	10.5	39.2	22.1	31.2	21.7	9.4	43.4	11.4	11.0	2.4	48.0	8.2	44.8	28.5	4.8	28.5	19.7	18.1	20.3	44.2	21.8	23.0	18.4	29.7	8.0	54.3	18.3	14.1	4.6	9.7	31.8	34.1	8.9	21.3	33.3	65.8	17.9	18.3	8.6	18.8	18.6	8.8	13.5	36.9	5.5	31.8	20.3	23.5	8.1	27.5	5.3	29.7	8.7	29.9	21.1	12.8	17.0	8.1	15.4	27.2	8.2	21.0	3.9	12.4	18.1	7.8	3.7	5.7	13.0	9.8	12.5	8.9	4.7	13.8	16.5	25.1	34.3	27.7	40.7	27.0	23.7	43.4	24.3	33.4	38.4	14.9	11.6	8.2	49.1	16.4	21.1	9.0	101.9	21.4	5.7	36.6	43.2	22.9	72.9	88.0	6.3	31.5	38.7	93.5	56.7	9.6	15.0	56.5	12.7	32.5	33.2	27.0	23.7	20.9	17.2	4.2	17.5	12.2	16.9	127.2	22.5	15.8	125.9	17.5	40.3	57.4	27.1	45.3	20.2	26.5	12.6	8.5	15.8	30.5	18.5	125.1
BCL2L12		ENSG00000126453	"BCL2 like 12"	Q9HB09	19	49665142-49673916	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020856	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA020856: AB_1845320"	"unprognostic (2.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.87e-3)"	"unprognostic (6.12e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (8.75e-5)"	"unprognostic (8.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.56e-1)"	6.7	6.5	2.8	15.3	3.3	12.6	7.9	1.2	3.2	8.8	11.8	2.9	9.3	8.3	8.2	9.1	14.0	7.2	11.3	9.5	3.3	1.8	8.1	15.3	12.0	15.5	3.7	2.2	9.2	18.0	3.2	2.6	21.5	3.8	9.0	5.8	6.3	10.6	9.4	12.5	6.5	9.0	8.1	3.4	14.8	8.9	10.0	3.8	29.8	6.6	18.1	15.1	8.4	7.0	13.9	22.4	13.4	9.8	12.0	13.6	5.6	33.1	20.2	16.4	30.6	4.2	4.1	19.1	18.9	7.6	19.0	20.3	28.1	18.2	18.7	9.1	6.3	10.6	16.5	14.9	12.4	10.4	23.4	32.6	17.3	13.8	19.5	3.8	17.7	21.1	5.0	6.0	21.2	6.1	3.8	12.6	24.6	44.0	24.2	10.0	18.8	21.3	30.7	21.0	19.7	26.2	27.6	17.4	20.2	8.2	16.3	0.3	9.6	19.3	26.1	13.4	12.2	10.9	22.8	7.6	21.4	25.5	15.0	30.9	20.4	31.4	35.7	9.1	25.2	21.2	9.6	6.8	13.4	11.4	9.8	13.6	13.9	12.3	11.0	6.0	11.6	11.9	11.6	9.2	12.0	7.1	22.4	12.4	5.6	2.8	3.3	1.2	3.2	3.3	1.8	3.7	2.2	3.8	3.8	8.9	13.3	13.7	29.2	28.6	0.8	4.5	12.7	6.7	12.5	5.2	0.0	53.9	6.6	22.6	5.5	10.2	6.1	46.7	22.6	106.1	23.2	19.8	9.2	12.4	31.8	0.0	6.4	6.7	8.8	2.7	6.1	15.4	25.3	28.9	12.9	3.3	26.4	8.7	5.6	8.2	1.1	12.9	10.8	10.4	18.7	16.9	46.6	12.9	19.6	19.6
BCL3	"BCL4, D19S37"	ENSG00000069399	"B cell CLL/lymphoma 3"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.0;Karpas-707: 22.4;SiHa: 28.7;U-266/70: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody		Yes	No			Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: AB_2680074"	"prognostic favorable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	17.7	13.0	4.0	21.1	5.6	35.2	18.7	1.4	4.7	11.7	14.9	2.4	5.9	24.5	10.4	9.7	27.1	12.5	22.7	20.1	3.9	2.0	17.8	52.1	36.4	20.5	4.3	0.5	26.5	13.2	2.4	9.2	9.5	5.6	16.0	8.0	8.8	13.7	13.7	20.2	9.0	35.5	11.5	6.5	41.6	15.0	8.3	4.0	6.5	13.9	22.9	37.0	18.7	11.9	1.3	2.6	16.5	2.4	1.8	1.5	0.7	3.9	13.6	0.3	7.2	2.6	5.5	0.7	2.4	2.6	1.5	2.2	2.8	7.2	3.9	5.6	4.8	8.0	4.4	0.9	4.1	1.0	27.0	0.2	0.5	7.1	3.6	6.3	0.3	11.6	9.6	3.2	3.4	4.3	7.1	4.1	0.0	0.5	22.4	0.9	3.3	0.0	3.0	0.3	6.0	5.7	1.8	2.7	1.4	6.9	8.2	0.0	0.4	28.7	14.7	0.7	0.5	5.1	3.0	6.9	4.9	5.1	7.6	0.9	21.3	8.3	4.0	9.1	0.5	3.7	0.2	2.4	4.2	0.7	1.6	1.0	1.3	0.9	1.1	2.1	1.1	0.5	0.6	16.5	1.8	0.9	2.6	1.5	0.7	4.0	5.6	1.4	4.7	3.9	2.0	4.3	0.5	5.6	4.0	17.9	53.0	18.6	32.7	41.4	1.7	2.4	25.5	18.7	31.8	12.2	0.0	0.3	8.3	26.4	9.3	39.0	55.4	0.0	58.8	5.9	33.8	37.5	36.9	31.7	13.9	7.9	20.6	35.6	31.1	1.3	12.4	45.8	38.8	36.9	31.6	2.3	42.1	35.1	4.2	17.7	0.5	6.5	57.5	0.5	1.2	53.3	1.1	14.6	22.9	44.4
BCL6B	"BAZF, ZBTB28, ZNF62"	ENSG00000161940	"B cell CLL/lymphoma 6B"	Q8N143	17	7023020-7030290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Endothelial cells: 32.1;Ito cells: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 7.8;HMC-1: 24.0;HUVEC TERT2: 42.7;TIME: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059147, HPA075112"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA059147: AB_2683928, HPA075112: AB_2732279"	"unprognostic (5.61e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (8.56e-5)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.26e-2)"	23.9	4.0	2.5	4.4	3.4	0.0	11.5	2.0	4.1	5.2	3.9	2.3	1.2	2.5	9.7	3.9	4.0	4.2	10.8	12.7	2.4	2.4	6.0	6.1	26.2	5.2	3.4	0.8	7.4	3.0	2.4	4.7	15.9	4.9	6.8	1.8	4.5	4.6	2.9	8.6	3.5	4.0	6.3	2.9	17.9	3.4	2.3	2.4	0.5	10.0	8.2	2.5	6.6	28.6	1.1	0.6	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.2	0.0	24.0	0.0	0.0	0.0	0.0	0.0	42.7	0.1	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	16.7	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	3.4	2.0	4.1	2.4	2.4	3.4	0.8	4.9	2.4	3.0	6.2	0.0	0.0	1.9	0.0	2.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.0	23.9	3.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.3	1.5	1.1	0.1	0.0	0.0	0.1
BCL7A	BCL7	ENSG00000110987	"BCL tumor suppressor 7A"	Q4VC05	12	122019422-122062044	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 8.4;plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	10	"B-cells: 8.4;dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 26.2;MOLT-4: 19.2;U-698: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019762	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA019762: AB_10962489"	"unprognostic (3.27e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (5.18e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.86e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.51e-2)"	3.8	3.7	13.0	9.8	14.5	9.9	6.5	19.8	18.2	6.7	4.2	6.8	3.3	3.6	6.0	7.4	3.3	10.3	4.3	9.4	9.5	7.5	10.7	5.3	5.1	19.4	6.6	15.9	4.9	11.7	8.3	6.1	2.8	6.8	6.3	3.8	3.8	8.2	7.2	12.8	8.2	3.4	4.1	5.1	6.5	4.4	3.1	7.9	26.4	11.1	3.5	15.8	6.9	5.4	8.4	9.7	0.1	0.1	0.5	0.9	0.6	1.7	2.4	8.0	5.6	0.5	0.3	1.7	1.0	1.1	1.7	1.5	1.0	0.7	26.2	2.9	0.8	1.0	2.3	5.8	5.5	1.5	0.0	9.5	1.3	0.2	1.4	1.7	4.0	2.3	1.3	5.3	1.2	7.2	2.0	2.1	12.3	5.9	0.0	1.0	3.6	19.2	0.3	2.9	2.4	4.1	10.6	2.8	0.3	3.2	4.5	8.0	9.0	1.3	0.3	3.3	2.0	5.4	3.3	1.9	0.3	1.7	3.0	1.7	2.7	1.8	30.3	0.5	2.6	1.8	0.1	0.0	0.0	0.1	0.0	0.0	2.9	0.2	0.2	2.2	8.4	0.9	0.6	0.1	0.5	0.1	9.7	0.0	0.6	13.0	14.5	19.8	18.0	9.5	7.5	6.6	15.9	6.8	7.9	20.8	8.6	37.2	47.6	31.9	38.8	25.8	38.2	14.7	22.7	36.6	17.7	1.0	49.7	25.7	6.1	3.1	1.7	0.0	9.5	0.8	8.7	26.5	10.4	16.8	3.2	101.7	20.6	4.3	3.5	9.8	13.0	8.5	11.8	5.4	8.0	5.6	10.5	7.0	7.4	18.9	13.5	6.5	15.6	0.5	4.3	26.3	0.5	0.0	11.4	26.0
BCL7B		ENSG00000106635	"BCL tumor suppressor 7B"	Q9BQE9	7	73536356-73558002	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Wnt signaling pathway"		"Allergen, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049943, HPA058069"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049943: AB_2680963, HPA058069: AB_2683594"	"unprognostic (2.79e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.32e-1)"	24.3	13.6	19.2	10.3	21.7	44.1	21.2	10.2	24.2	10.8	21.4	10.3	12.5	11.2	12.1	12.2	13.1	9.7	12.2	28.7	17.6	14.0	15.2	16.6	15.9	11.5	12.8	13.7	7.9	9.9	13.9	16.1	15.3	13.1	11.7	10.7	14.9	10.4	14.9	43.2	7.7	16.5	20.8	9.3	14.2	15.2	15.8	10.6	11.9	13.7	9.3	11.6	16.4	12.5	13.2	14.6	14.4	15.4	17.1	12.8	5.7	18.5	9.4	5.4	11.0	4.4	6.0	9.6	20.6	14.7	14.7	11.7	10.4	16.4	19.3	4.3	13.1	17.3	7.7	4.9	9.4	12.3	19.2	9.4	10.0	5.8	5.5	11.1	14.3	25.7	4.5	8.1	13.2	13.2	5.5	9.1	6.9	14.9	13.7	8.2	15.4	26.1	15.8	12.8	10.5	23.9	13.5	7.1	17.4	9.8	12.9	15.4	16.1	16.2	15.9	13.0	3.3	11.1	15.0	12.6	17.6	14.6	10.3	21.2	12.8	10.7	28.9	16.2	19.7	18.4	10.3	12.0	14.4	10.1	13.6	12.0	10.2	11.5	12.8	11.8	13.2	12.0	10.6	7.0	17.1	15.4	14.6	9.1	5.7	19.2	21.7	10.2	24.2	17.6	14.0	12.8	13.7	13.1	10.6	29.8	16.5	31.6	71.7	57.5	27.0	27.7	17.8	12.0	15.9	15.7	5.9	59.7	46.4	37.9	5.2	31.9	47.7	0.0	40.1	35.9	32.0	54.5	32.3	17.1	45.7	39.7	33.1	25.8	22.4	5.9	23.9	39.6	30.4	45.1	29.3	22.9	49.1	49.1	28.7	33.5	15.3	45.3	46.7	60.8	68.5	50.4	85.1	55.4	35.3	58.1
BCL7C		ENSG00000099385	"BCL tumor suppressor 7C"	Q8WUZ0	16	30833626-30894960	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 184.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018676, HPA052654"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018676: AB_1845322, HPA052654: AB_2681903"	"unprognostic (2.27e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.85e-1)"	18.5	13.5	14.2	19.1	16.2	21.3	24.8	16.1	12.4	24.1	22.1	13.3	21.6	14.3	21.2	18.9	23.2	19.0	27.5	24.4	13.1	14.4	22.3	12.6	13.2	19.6	17.1	9.3	28.2	14.1	11.1	15.9	17.1	17.1	25.4	10.7	19.3	20.3	22.3	23.4	21.7	20.2	31.3	13.7	15.0	16.8	24.9	13.6	10.5	26.5	17.7	20.5	20.5	32.0	7.2	6.6	7.0	5.2	5.7	10.2	3.7	21.2	12.5	14.2	32.8	10.8	17.3	8.5	16.8	14.2	16.8	12.3	10.6	13.9	1.4	19.9	21.0	9.9	11.5	7.2	14.7	11.4	14.9	25.3	5.0	10.3	17.7	16.1	9.0	11.3	18.7	19.5	12.5	6.8	9.4	16.6	11.0	11.8	8.9	15.8	28.1	9.3	23.4	7.3	12.2	20.3	20.6	14.4	19.1	8.9	7.9	9.2	14.9	15.6	13.1	10.4	9.1	21.5	13.8	11.4	23.2	23.1	14.5	13.7	8.3	7.5	9.7	15.5	15.3	17.1	6.2	5.2	7.0	9.2	3.5	10.2	7.2	7.9	10.1	4.5	7.1	7.1	8.4	4.2	5.7	3.7	6.6	8.2	3.7	14.2	16.2	16.1	12.4	13.1	14.4	17.1	9.3	17.1	13.6	11.9	10.7	24.5	65.4	35.1	10.0	15.1	33.1	9.4	13.6	68.0	5.9	44.4	184.1	29.8	17.9	44.4	33.8	23.3	30.9	46.1	66.6	43.2	2.3	20.2	50.4	12.7	35.8	35.0	23.5	19.6	51.8	41.0	52.3	89.2	34.6	29.6	38.8	17.5	48.4	62.8	9.8	19.4	38.9	2.6	3.4	37.3	20.9	41.5	53.7	57.0
BCL9		ENSG00000116128	"B cell CLL/lymphoma 9"	O00512	1	147541412-147626216	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020274	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA020274: AB_2670400"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	4.5	7.8	10.2	5.9	9.2	3.1	4.8	22.3	12.6	18.2	9.4	8.1	10.9	5.3	23.9	15.9	6.8	18.9	5.2	8.3	8.0	7.4	9.6	4.3	5.0	4.0	5.9	8.7	17.0	6.1	14.6	10.6	4.5	6.8	10.5	7.9	11.8	8.1	13.2	7.9	7.8	5.5	15.7	5.4	3.8	7.6	6.1	6.5	22.4	7.8	8.0	6.0	9.6	8.0	0.4	0.0	0.6	0.3	0.1	2.6	1.0	2.9	2.9	20.6	15.3	2.3	2.8	4.0	2.4	3.9	2.7	2.6	3.8	4.5	2.8	5.5	2.3	4.5	2.4	13.0	4.4	2.5	6.7	3.6	1.3	3.1	2.5	2.0	0.8	4.1	2.7	3.8	3.2	2.3	4.8	4.1	9.4	2.6	4.6	2.3	6.7	7.0	0.6	24.3	6.0	6.4	7.5	5.2	5.5	10.4	3.3	5.6	12.2	2.7	5.1	4.7	19.8	6.4	1.3	3.0	1.9	9.0	5.3	3.8	20.9	5.3	5.4	4.8	0.8	9.1	0.0	0.3	0.6	1.0	0.0	0.9	0.2	1.2	1.2	0.0	0.4	2.6	1.6	0.2	0.1	0.1	0.0	0.9	1.0	10.2	9.2	22.3	12.6	8.0	7.4	5.9	8.7	6.8	6.5	0.0	2.1	0.0	5.2	2.7	7.9	4.7	7.6	2.7	2.3	12.2	2.0	1.8	10.0	3.4	9.0	2.8	1.8	0.0	4.0	2.0	4.6	7.6	8.1	2.6	1.1	6.4	27.2	6.2	2.8	4.2	8.9	0.4	0.0	1.0	10.9	4.3	3.8	0.0	7.4	4.9	2.8	0.0	3.8	3.2	6.8	3.1	1.7	0.5	6.9	2.7
BCLAF3	CXorf23	ENSG00000173681	"BCLAF1 and THRAP3 family member 3"	A2AJT9	X	19912860-19970298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 14.2;Club cells: 13.6;Collecting duct cells: 8.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027215	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027215: AB_1847358"	"unprognostic (2.46e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.30e-2)"	"prognostic favorable (5.56e-4)"	4.3	2.4	3.7	2.8	3.4	2.5	4.6	8.1	3.4	3.4	4.5			2.6	5.0	8.1	2.8	3.6	3.6	2.7	4.0	3.2	3.8	2.0	3.8	3.2	3.7		5.1	3.2	7.1	3.3	2.5		4.6	5.4		3.1	4.9	3.9	5.3	4.1	3.4	4.2	4.1	3.1	1.8			4.2		3.3	4.2	3.9	2.8	2.3	4.8	1.4	1.4	1.6	0.3	5.6	4.5	6.3	10.5	5.6	8.0	3.5	5.3	4.4	3.4	4.8	4.1	6.2	5.8	3.2	6.2	6.1	4.2	5.5	3.9	6.6	3.8	4.5	3.8	4.8	4.0	8.0	5.1	6.5	7.1	6.1	3.8	5.2	8.0	3.9	4.7	2.7	13.9	3.9	4.3	3.6	3.4	5.5	5.4	5.8	1.5	6.3	7.7	9.1	5.7	3.9	5.9	6.6	5.6	5.3	12.1	6.7	4.6	7.2	5.8	2.9	13.9	3.8	4.4	3.4	4.8	5.0	2.9	5.0	4.1	0.9	1.8	1.5	1.2	1.6	1.2	1.2	1.5	0.7	2.8	1.2	1.4	4.8	1.4	1.4	2.3	0.5	0.3											14.9	14.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	13.6	8.7	0.0	3.3	1.7	5.5	0.0	0.0	0.0	0.0	3.1	3.2	0.0	0.0	5.8	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	2.8	0.0	0.0	5.7	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR, RhoGEF and GTPase activating protein"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	14.5	8.4	24.0	9.1	41.2	26.7	10.5	14.2	26.5	13.6	9.7	10.3	10.6	8.7	9.2	13.9	19.3	10.8	8.3	7.8	20.9	13.0	16.3	8.3	11.3	10.9	16.0	15.6	8.8	12.9	14.5	14.9	15.7	14.2	7.0	6.8	8.3	15.5	9.7	3.4	12.8	8.7	9.0	9.5	9.1	14.0	9.6	15.4	11.8	16.6	5.5	9.2	9.2	8.8	1.5	0.8	1.2	1.0	2.8	6.6	2.5	19.0	8.2	12.7	13.0	7.6	5.2	19.2	6.9	6.5	6.4	5.2	14.4	7.7	13.3	12.9	5.9	6.2	19.6	1.3	19.2	1.8	25.4	13.2	11.6	11.3	11.4	9.9	10.7	6.1	4.4	13.0	9.5	8.4	11.4	22.3	9.6	44.4	6.3	2.9	12.5	10.0	8.4	10.7	15.1	8.1	13.2	5.1	8.7	9.9	12.1	11.7	11.1	12.6	10.9	5.2	8.5	6.9	8.8	25.1	3.8	0.4	6.2	5.7	1.4	5.8	4.7	9.9	8.1	5.9	0.0	1.0	0.0	6.6	0.4	2.3	1.4	3.3	3.3	0.8	1.5	2.6	3.6	1.2	2.8	1.0	0.8	1.6	2.5	24.0	41.2	14.2	24.9	20.9	13.0	16.0	15.6	14.2	15.4	8.9	11.5	3.0	9.5	13.7	24.0	7.3	20.4	2.7	19.4	17.4	21.6	10.5	8.3	12.4	3.9	22.4	11.1	0.0	14.1	5.9	7.3	10.2	10.4	18.4	6.0	22.3	19.1	62.0	10.8	7.7	8.1	5.4	5.0	6.4	12.0	13.4	21.8	5.8	5.3	14.3	8.0	0.0	8.6	1.6	6.8	13.8	9.0	9.2	11.2	11.5
BDH1	"BDH, SDR9C1"	ENSG00000161267	"3-hydroxybutyrate dehydrogenase 1"	Q02338	3	197509783-197573323	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 156.0"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 20.3;U-937: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030947, HPA058709"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030947: AB_10669548, HPA058709: AB_2683797"	"unprognostic (2.72e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.86e-7)"	"unprognostic (2.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (7.12e-8)"	"unprognostic (5.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.02e-1)"	3.5	2.8	6.6	5.2	11.2	4.7	4.6	18.1	13.8	4.0	13.9	4.6	6.3	9.6	2.1	3.6	12.9	5.5	6.1	19.6	6.3	5.8	6.0	156.0	2.0	4.2	5.9	9.1	3.0	2.8	5.8	3.6	1.4	7.7	4.5	11.1	6.2	8.6	4.4	7.3	8.0	13.7	2.4	3.5	2.3	4.7	1.8	3.6	5.4	5.2	11.3	7.4	3.6	3.6	6.1	4.6	2.9	1.6	4.7	9.9	4.0	10.4	1.4	0.6	5.4	0.9	0.0	0.0	1.2	1.0	5.4	3.1	9.4	3.5	0.0	15.6	0.3	0.4	4.9	4.7	2.5	2.1	0.1	0.0	5.5	3.6	3.2	4.0	12.3	5.8	1.6	2.9	2.1	4.6	0.5	1.3	6.3	0.0	4.2	0.1	18.6	9.5	8.3	4.1	20.3	1.9	9.0	2.0	14.3	5.8	4.8	9.9	4.3	3.8	0.5	2.0	0.2	12.5	10.3	0.1	0.3	1.8	0.0	9.8	4.8	9.1	0.1	0.3	35.0	0.6	2.9	1.6	0.6	5.9	0.2	8.2	6.1	6.5	5.3	4.2	5.5	9.9	5.9	0.0	4.7	0.3	4.6	4.2	4.0	6.6	11.2	18.1	13.8	6.3	5.8	5.9	9.1	7.7	3.6	3.0	6.5	8.0	8.1	8.2	20.4	35.0	17.8	49.5	10.3	12.2	19.6	1.6	44.7	4.7	7.8	1.5	56.7	0.0	4.9	3.6	5.1	6.8	1.1	92.8	7.2	17.5	26.2	4.9	3.3	10.3	5.2	5.5	15.1	0.0	38.7	16.2	2.2	31.6	3.9	12.1	32.8	0.0	5.4	14.1	4.7	9.5	1.6	9.6	56.2	11.9
BEGAIN	KIAA1446	ENSG00000183092	"Brain enriched guanylate kinase associated"	Q9BUH8	14	100537147-100587413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9"	"Cell type enriched"	"Detected in many"	15	"Horizontal cells: 135.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 6.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.8"	"Group enriched"	"Detected in some"	7	"HeLa: 21.8;SH-SY5Y: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002899			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA002899: AB_1078277"	"unprognostic (2.98e-4)"	"unprognostic (2.75e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.77e-3)"	"unprognostic (1.93e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-1)"	1.8	5.5	16.4	1.1	10.8	6.4	1.5	24.9	21.6	1.3	1.3	0.9	0.0	4.6	2.0	1.8	1.4	3.0	2.5	1.5	15.3	7.1	0.9	0.8	1.0	1.3	4.4	6.0	3.5	13.0	2.3	8.2	3.1	3.6	2.6	0.9	2.1	2.8	2.7	0.9	1.3	3.0	1.7	2.0	3.3	1.0	2.6	1.4	5.4	1.0	0.4	1.3	0.8	0.6	0.6	1.0	6.8	1.5	0.0	0.4	0.1	0.3	1.3	0.7	4.5	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.2	0.2	1.0	0.1	0.2	0.0	0.0	0.0	0.4	2.0	21.8	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.5	0.0	0.0	0.3	0.2	0.0	0.0	1.7	0.1	0.6	0.5	0.1	0.7	0.0	0.1	2.7	0.0	0.0	1.2	53.1	1.2	0.0	1.2	0.0	0.3	5.4	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	3.8	1.0	0.1	1.3	0.1	6.8	0.0	1.5	0.0	0.6	0.4	0.0	0.0	0.2	0.1	0.0	0.6	0.0	1.4	1.0	0.0	0.1	16.4	10.8	24.9	17.3	15.3	7.1	4.4	6.0	3.6	1.4	0.0	1.1	0.0	1.4	2.2	1.5	1.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.0	0.3	0.6	0.7	0.0	6.9	0.2	1.4	0.5	9.2	0.0	0.2	135.1	0.0	0.0	0.0	0.6	1.7	0.7	1.7	1.8	0.0	0.7	4.1	0.0	6.3	0.0	2.4	0.0	0.3	0.9	0.4	1.8	0.1	0.0	0.2	0.3
BEND3	KIAA1553	ENSG00000178409	"BEN domain containing 3"	Q5T5X7	6	107065182-107115269	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 12.6"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 5.9;Late spermatids: 5.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 12.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017891, HPA062067"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017891: AB_2064595, HPA062067: AB_2684675"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.37e-8)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-1)"	1.8	1.9	1.4	1.8	2.5	1.8	5.6	4.0	2.2	1.6	3.6	1.3	0.8	3.0	2.4	4.2	2.5	2.3	3.6	3.8	1.1	1.3	3.1	4.4	2.0	1.5	1.8	0.8	1.9	12.6	1.8	2.3	1.5	3.3	2.6	3.9	1.3	3.4	1.0	5.0	1.4	4.1	2.5	1.8	2.8	5.0	4.6	1.5	2.4	1.9	3.9	3.6	2.2	1.2	1.5	1.3	2.0	1.0	0.8	1.7	0.4	2.8	4.1	11.3	6.4	1.3	1.0	9.3	1.1	1.5	1.5	1.8	4.6	2.1	8.4	2.9	2.9	2.6	2.8	12.2	6.3	2.5	3.3	6.1	2.3	3.0	5.1	1.1	6.0	3.0	2.5	2.6	2.2	3.2	1.2	1.9	4.0	6.3	3.5	1.9	5.7	5.1	4.6	15.8	7.1	2.6	7.0	3.3	5.5	2.4	8.4	11.5	5.6	3.6	6.1	2.3	6.0	3.6	4.8	2.2	4.1	3.9	1.9	5.4	2.4	3.2	8.6	1.4	4.7	3.2	2.0	0.8	1.5	1.2	1.0	0.9	1.5	1.1	1.1	0.5	1.1	0.8	1.7	1.6	0.8	1.0	1.3	1.2	0.4	1.4	2.5	4.0	1.8	1.1	1.3	1.8	0.8	3.3	1.5	3.0	2.4	0.0	0.8	2.6	1.4	2.8	0.0	1.4	2.3	0.0	5.9	0.8	0.0	0.8	4.2	0.8	0.4	0.0	1.5	1.2	0.6	1.0	0.0	0.6	0.6	0.0	1.2	0.0	1.0	5.2	0.9	0.5	0.0	0.0	2.2	0.2	0.9	0.0	0.0	0.8	1.4	0.0	2.1	0.6	2.5	2.6	0.7	0.0	3.0	0.7
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110938-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 26.7"	"Group enriched"	"Detected in some"	7	"Muller glia cells: 10.2;Spermatogonia: 35.8"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"memory B-cell: 1.1;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 23.9;HEK 293: 5.8;HEL: 14.6;MOLT-4: 8.9;SuSa: 11.8;U-698: 9.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.4	0.3	3.9	5.0	1.0	1.6	0.3	0.2	2.6	0.2	0.6	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.4	0.3	2.8	1.9	0.3	0.5	1.0	3.7	2.8	1.1	0.6	0.3	0.1	3.8	0.8	1.8	6.4	0.7	0.2	0.8	0.2	0.2	0.2	2.8	0.4	0.4	4.8	0.5	26.7	0.3	4.8	0.3	0.0	3.0	0.7	2.3	3.3	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	23.9	0.0	0.0	0.0	5.8	14.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	4.9	0.0	0.0	0.0	0.0	8.9	0.0	4.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	3.9	1.0	0.2	2.6	2.8	1.9	2.8	1.1	1.8	0.3	0.0	0.0	0.9	0.1	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.2	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	35.8	0.0	0.0	0.0	0.0	0.0
BEND5	"C1orf165, FLJ11588"	ENSG00000162373	"BEN domain containing 5"	Q7L4P6	1	48727523-48776969	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 46.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 7.1;naive B-cell: 10.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.1"	"Cell line enhanced"	"Detected in some"		"AF22: 4.2;HDLM-2: 13.6;JURKAT: 5.4;MOLT-4: 5.6;NTERA-2: 3.2;REH: 7.8;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in many"							"HPA054347, HPA058007"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA054347: AB_2682456, HPA058007: AB_2683577"	"prognostic favorable (2.50e-5)"	"unprognostic (1.36e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.68e-2)"	"prognostic favorable (8.30e-6)"	2.7	5.4	6.5	5.6	7.7	3.0	3.1	2.1	15.5	4.8	5.0	2.8	3.5	1.6	5.0	4.9	2.3	4.3	6.0	4.0	6.0	5.1	6.5	0.8	3.0	5.9	5.4	9.7	12.8	2.8	1.9	5.9	1.4	14.7	3.9	1.6	3.3	2.5	4.3	6.6	1.9	2.6	2.6	3.2	6.4	2.9	2.6	1.9	11.3	4.3	0.5	4.1	4.4	2.9	10.1	1.9	0.2	0.0	1.1	2.0	0.6	0.0	0.0	4.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	0.0	5.6	0.2	3.2	0.0	0.0	7.8	1.4	0.0	0.1	1.5	1.4	3.8	0.0	0.0	0.3	1.6	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.2	1.9	10.1	2.0	1.2	0.2	1.1	0.0	1.9	0.0	0.6	6.5	7.7	2.1	15.5	6.0	5.1	5.4	9.7	14.7	1.9	6.0	1.9	5.9	4.6	1.6	12.3	5.3	12.7	9.4	7.9	5.2	15.7	0.3	46.4	4.6	7.5	6.3	0.0	0.0	1.6	0.4	5.4	0.9	1.1	0.0	0.2	7.9	11.6	1.8	0.0	3.6	12.0	0.5	3.3	0.0	0.6	18.0	2.4	5.5	20.1	19.2	14.9	6.5	3.4	3.2	8.1	1.9	0.1	0.0	1.5	1.4
BEND6	"bA203B9.1, C6orf65, FLJ30162"	ENSG00000151917	"BEN domain containing 6"	Q5SZJ8	6	56955126-57027342	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 33.0"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 68.2;Horizontal cells: 39.7"	"Cancer enriched"	"Detected in many"	6	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 11.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.2;fHDF/TERT166: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031605, HPA052973"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA031605: AB_10602395, HPA052973: AB_2682002"	"unprognostic (4.27e-1)"	"unprognostic (7.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.18e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.84e-6)"	"unprognostic (9.27e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.98e-3)"	1.5	3.1	12.0	2.0	10.7	1.0	1.1	29.2	29.7	5.8	1.7	2.5	0.6	0.8	3.2	1.3	1.8	1.1	5.2	3.1	11.2	10.0	1.0	0.5	1.0	1.2	11.3	8.6	2.9	0.8	2.8	1.1	2.7	33.0	3.4	2.2	0.2	1.0	3.4	4.3	1.5	1.2	4.8	7.2	1.2	1.3	1.5	4.1	0.0	1.3	0.0	1.3	3.9	1.6	0.0	11.1	0.0	0.0	2.1	0.0	0.1	3.4	1.5	0.8	0.4	12.1	20.2	3.3	10.4	10.1	4.7	5.4	0.1	1.6	0.0	3.4	18.4	6.5	0.4	1.2	0.5	5.9	1.5	0.6	2.2	4.9	0.2	3.2	6.3	0.1	8.7	2.9	6.4	2.9	8.0	3.1	8.7	2.8	6.0	9.4	3.5	3.8	1.6	2.9	0.1	0.8	0.0	0.1	1.6	1.7	3.4	4.1	4.1	6.9	0.9	0.8	4.2	0.2	3.8	3.9	14.2	0.4	9.6	2.2	8.3	9.1	2.7	8.3	4.4	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.1	0.0	11.1	0.0	0.1	12.0	10.7	29.2	20.8	11.2	10.0	11.3	8.6	33.0	4.1	0.0	0.0	0.0	0.2	0.8	68.2	3.6	0.0	0.0	1.2	0.0	3.9	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.2	6.9	0.6	0.0	0.0	0.1	39.7	0.0	1.8	0.0	0.6	1.7	2.1	3.3	0.0	0.0	3.7	0.3	0.0	2.8	0.3	4.1	0.0	1.9	0.5	4.1	0.9	0.0	0.0	0.0	0.0
BEND7	"C10orf30, FLJ40283"	ENSG00000165626	"BEN domain containing 7"	Q8N7W2	10	13438484-13528974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 129.1;Late spermatids: 176.1"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037835	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		Yes	No			"Nucleoplasm, Nucleoli fibrillar center, Vesicles"		"HPA037835: AB_10669722"	"unprognostic (6.22e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.20e-3)"	2.3	1.7	1.1	0.3	1.3	0.0	3.0	5.4	0.8	3.0	3.6			7.4	2.9	6.2	0.5	5.7	2.6	1.5	0.8	1.4	8.4	3.6	3.3	0.0	1.2		3.3	5.4	9.8	4.4	1.5		2.1	2.6		5.3	2.6	4.5	0.8	8.7	2.4	0.6	0.9	3.5	8.1			11.2		0.0	2.1	1.4	0.0	0.0	2.7	0.0	0.1	0.0	0.0	7.6	4.4	5.6	2.4	0.1	0.0	7.3	2.9	0.1	8.5	5.0	3.5	14.4	0.0	4.1	6.4	4.2	0.4	8.0	2.2	7.3	0.0	7.2	0.1	0.0	10.8	3.2	0.0	0.0	0.2	5.0	1.3	0.0	13.7	8.1	1.4	4.4	0.0	7.4	5.7	0.1	0.0	2.5	0.1	1.0	0.0	4.0	0.0	6.0	1.3	0.5	4.3	8.7	0.0	0.2	7.7	0.2	3.6	6.7	1.7	11.2	10.4	4.0	0.0	0.0	0.0	2.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0											20.8	12.3	2.2	15.3	3.1	14.2	8.9	28.1	14.7	15.9	19.2	7.9	1.9	3.3	11.2	129.1	9.8	8.7	0.0	14.1	2.1	5.8	19.6	5.8	8.2	2.4	1.6	7.5	16.0	7.9	176.1	4.6	2.1	3.3	1.8	10.4	19.0	17.4	6.2	5.6	41.7	31.7	0.0	7.5	15.3	17.8	1.6	2.1	5.7	9.0	26.7
BET1L	"GOLIM3, GS15"	ENSG00000177951	"Bet1 golgi vesicular membrane trafficking protein like"	Q9NYM9	11	167784-207428	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039819	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Golgi apparatus"	Nucleoplasm	"HPA039819: AB_10673020"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.49e-2)"	18.6	20.3	11.4	23.4	15.2	9.2	19.2	14.4	19.8	22.3	18.0	21.0	34.1	17.0	23.4	28.6	16.2	21.7	25.3	18.7	11.6	12.6	21.4	30.3	20.4	20.4	14.9	13.7	33.8	62.2	29.3	31.4	17.3	15.8	27.3	18.0	24.4	35.1	28.0	11.6	18.6	22.4	26.1	13.4	22.3	21.8	27.4	10.5	18.4	27.0	15.6	22.4	25.8	21.0	18.1	12.3	34.3	15.1	15.1	22.5	15.9	18.5	15.5	9.2	11.4	28.7	25.4	13.4	19.9	26.2	21.4	22.0	19.3	18.0	16.5	9.7	35.9	15.4	17.4	10.6	18.2	16.4	12.7	11.5	15.2	8.2	19.4	26.6	17.2	29.7	28.5	24.5	12.6	33.9	24.9	14.4	11.7	22.1	17.3	13.6	10.1	12.5	10.9	14.1	27.1	17.6	13.1	13.7	11.1	17.6	8.3	10.1	12.2	17.7	28.7	19.3	13.9	14.7	13.6	15.9	16.6	7.7	6.7	9.7	30.5	13.9	14.5	22.5	14.5	15.1	27.0	10.4	34.3	16.7	15.1	20.0	18.1	19.3	17.0	10.5	15.1	22.5	17.3	24.5	15.1	13.2	12.3	14.6	15.9	11.4	15.2	14.4	19.8	11.6	12.6	14.9	13.7	15.8	10.5	11.9	14.2	6.7	14.7	8.2	6.4	14.0	12.7	6.7	4.5	14.0	7.9	13.5	18.3	11.3	46.5	9.2	28.5	0.0	20.3	20.8	15.4	22.9	36.9	33.1	20.4	3.2	7.5	17.8	18.0	91.1	20.4	14.6	6.8	12.6	19.3	8.2	16.7	23.0	17.7	24.5	8.9	6.5	11.7	41.4	14.9	10.2	22.0	15.8	13.3	19.3
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064240	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 150.2;pituitary gland: 64.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 321.5;Horizontal cells: 343.2;Muller glia cells: 473.7;Rod photoreceptor cells: 119.7"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 60.3;HBF TERT88: 67.4;HL-60: 147.5;hTERT-RPE1: 104.5;SCLC-21H: 46.2;U-937: 46.2"									"HPA045384, HPA078630"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045384: AB_2679305, HPA078630: "	"prognostic favorable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.34e-2)"	1.8	37.4	66.4	2.8	65.1	16.3	1.9	44.7	150.2	1.8	3.0	6.2	0.0	3.3	7.7	25.2	1.6	10.1	1.8	3.6	77.4	81.0	4.5	3.0	2.1	1.7	38.9	67.8	9.5	30.9	48.1	64.3	1.5	35.8	3.8	3.1	4.7	2.2	2.9	1.3	1.5	3.9	3.3	24.3	2.3	5.0	27.5	12.0	0.0	12.1	0.0	1.5	1.5	0.4	2.4	0.2	6.4	0.5	1.7	3.1	1.5	0.0	0.0	3.7	0.0	0.0	0.0	0.1	2.1	0.0	40.6	60.3	0.0	0.0	0.0	0.0	15.1	13.0	0.0	0.0	0.0	67.4	0.0	0.1	12.3	0.0	8.0	0.7	147.5	0.2	0.9	0.0	8.8	0.0	104.5	0.0	11.8	0.0	0.0	8.1	0.0	27.7	0.0	33.6	9.3	6.0	0.0	0.0	0.7	0.0	0.0	46.2	26.6	0.0	0.0	0.1	0.6	0.0	41.7	0.0	0.0	13.9	0.1	1.5	7.2	0.2	0.0	5.4	46.2	2.6	0.6	0.5	6.4	0.7	0.1	0.7	1.2	2.0	1.2	0.1	2.4	3.1	1.4	1.2	1.7	0.4	0.2	0.9	1.5	66.4	65.1	44.7	89.0	77.4	81.0	38.9	67.8	35.8	12.0	0.0	0.3	0.5	7.8	7.7	321.5	8.2	20.4	0.0	1.2	5.2	37.3	0.3	61.3	6.4	9.3	2.8	0.4	0.0	11.5	0.1	0.4	6.9	0.0	0.0	1.3	343.2	76.4	28.8	7.5	16.7	7.5	0.3	6.8	1.8	0.4	473.7	10.3	2.3	2.5	12.7	119.7	0.0	2.2	15.4	14.7	5.6	0.5	0.0	0.9	1.4
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494939-153509554	"Disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Peritubular cells: 735.8;Sertoli cells: 1461.7;Smooth muscle cells: 411.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 46.6;BJ hTERT+: 60.2;fHDF/TERT166: 84.0;HSkMC: 44.1;hTEC/SVTERT24-B: 35.7;HUVEC TERT2: 84.3;U-138 MG: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		2500000	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	41.1	39.7	8.1	23.2	14.6	0.4	20.2	5.6	14.3	76.7	12.0	18.7	16.7	6.0	63.4	31.7	21.1	23.6	86.7	133.0	8.9	5.2	67.6	78.1	77.6	29.4	8.9	16.3	39.6	16.8	5.1	26.7	131.1	15.0	33.6	7.0	48.3	20.4	38.2	17.0	31.0	8.6	56.9	5.9	101.3	10.0	28.0	15.8	3.9	45.3	29.9	14.6	34.5	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	4.9	11.0	0.1	46.6	60.2	8.6	2.8	5.8	0.0	0.0	8.6	84.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	4.2	0.0	0.0	44.1	0.3	35.7	1.6	4.4	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.8	0.1	0.0	17.8	38.3	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	14.6	5.6	14.3	8.9	5.2	8.9	16.3	15.0	15.8	3.0	9.3	0.0	1.0	92.5	0.0	6.7	5.1	2.7	4.5	8.7	0.0	13.9	1.7	2.4	1.4	48.7	0.0	0.0	0.2	33.9	142.9	2.3	3.5	1.0	4.0	3.2	0.0	198.2	3.1	4.0	137.0	6.2	33.7	3.6	0.0	0.0	1.8	0.0	735.8	0.3	0.1	1461.7	411.6	0.6	1.1	47.3	47.6	4.9	0.0	1.4
BHLHA15	"bHLHa15, BHLHB8, MIST1"	ENSG00000180535	"Basic helix-loop-helix family member a15"	Q7RTS1	7	98211427-98212979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"pancreas: 145.8;salivary gland: 95.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.7"	"Group enriched"	"Detected in some"	8	"Karpas-707: 17.1;RPMI-8226: 31.7;U-266/70: 37.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034083, HPA047834"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"CAB034083: AB_2065216, HPA047834: AB_2680172"	"unprognostic (2.80e-2)"	"unprognostic (9.45e-3)"	"unprognostic (8.10e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.10e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.70e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.25e-3)"	0.1	0.1	0.2	0.8	0.2	0.0	0.1	0.1	0.2	0.3	1.2	0.0	3.5	0.9	0.1	0.1	0.4	0.1	0.8	0.1	0.3	0.2	0.3	4.7	0.5	1.8	0.1	0.0	0.0	145.8	0.0	0.4	0.0	0.0	1.6	0.1	0.0	95.2	6.8	0.4	0.2	0.8	0.0	0.1	1.9	6.2	0.1	0.0	0.0	0.2	1.2	2.7	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	1.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	17.1	0.0	0.3	0.0	0.0	0.5	1.2	0.5	0.2	0.0	31.7	0.0	0.0	1.9	0.7	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	37.9	2.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BHLHE41	"BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120026-26125127	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.9"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 333.3;Cone photoreceptor cells: 172.8;Horizontal cells: 236.8;Muller glia cells: 283.4;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	35	"memory B-cell: 5.3;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	54	"B-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.8;Karpas-707: 14.3;RT4: 44.7;U-266/70: 19.2;U-87 MG: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA056035: AB_2683017, HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favorable (1.09e-4)"	7.0	11.7	23.8	5.8	32.3	1.2	10.7	22.9	26.9	30.6	7.6	33.3	3.0	2.8	6.9	15.6	3.2	34.5	14.1	14.7	25.9	19.6	3.8	1.4	9.1	6.0	38.9	14.0	10.9	6.4	6.2	11.2	8.3	28.3	8.2	9.1	19.0	13.4	11.7	58.9	3.8	4.3	4.3	49.6	6.2	4.4	4.0	44.0	0.9	43.6	6.4	13.3	16.5	6.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	7.6	3.5	1.7	0.8	1.3	0.1	0.5	0.0	4.8	0.0	0.7	1.5	11.4	4.0	0.1	0.6	0.4	0.0	0.6	0.3	0.0	0.0	0.3	1.9	0.1	0.5	0.4	2.8	5.5	33.8	0.0	0.0	0.0	14.3	0.8	0.4	0.0	1.3	3.7	1.3	2.8	0.0	0.6	10.9	1.8	44.7	0.0	0.0	0.5	0.2	10.1	0.2	0.0	0.0	2.3	2.6	3.1	0.3	2.0	19.2	11.0	0.0	16.5	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	32.3	22.9	26.9	25.9	19.6	38.9	14.0	28.3	44.0	0.0	0.6	22.9	50.0	5.4	333.3	33.5	33.1	42.8	10.3	27.9	172.8	22.2	0.0	35.8	0.2	4.8	10.8	0.0	19.8	2.4	18.8	38.9	5.7	0.0	71.2	236.8	12.6	3.1	2.7	0.4	27.9	35.2	13.5	47.7	3.0	283.4	13.9	5.7	25.1	2.1	289.4	6.5	6.6	0.5	0.4	2.9	5.9	0.0	3.3	52.5
BHMG1	HMGDC	ENSG00000237452	"Basic helix-loop-helix and HMG-box containing 1"	C9JSJ3	19	45733251-45764534	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	33	"testis: 17.8"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 24.2;Spermatogonia: 22.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Daudi: 3.5;K-562: 8.3"					"Not detected"	"Not detected"			HPA049521	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049521: AB_2680803"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.08e-1)"	"unprognostic (6.53e-12)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.87e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.0	3.5	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	8.3	0.3	0.0	1.3	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.3	0.9	0.4	0.2	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	24.2	22.0	0.0	0.0	0.0	0.0	0.0
BICC1		ENSG00000122870	"BicC family RNA binding protein 1"	Q9H694	10	58513140-58831437	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 119.8;Collecting duct cells: 82.0;Distal tubular cells: 66.3;Ductal cells: 87.3;Leydig cells: 65.9;Proximal tubular cells: 113.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 25.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"basophil: 8.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"A549: 19.9;BJ hTERT+: 21.1;CACO-2: 31.3;RPTEC TERT1: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070797			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA070797: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.79e-2)"	"unprognostic (6.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.40e-3)"	"unprognostic (7.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.94e-2)"	11.8	5.7	1.1	5.7	1.5	0.2	9.4	0.5	2.5	9.8	5.1	1.1	4.8	1.0	7.8	12.3	8.1	7.1	11.6	12.1	1.1	1.4	43.0	2.5	5.8	5.2	0.9	2.2	19.0	24.2	0.8	4.6	3.2	2.1	7.8	3.9	18.7	4.8	4.1	22.4	6.5	2.8	6.0	3.9	2.7	3.2	4.9	0.8	0.8	5.1	7.5	3.2	8.6	10.4	0.1	1.1	8.7	0.3	1.0	0.2	0.1	0.0	19.9	0.3	0.0	6.4	8.3	0.0	13.1	21.1	11.9	14.3	31.3	4.2	0.0	13.8	13.3	3.1	0.2	2.1	2.3	16.7	0.0	2.0	0.0	2.6	0.0	4.1	0.0	0.0	12.9	0.7	9.3	10.1	14.9	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	1.3	0.0	5.0	0.0	49.5	2.4	0.0	2.5	0.0	0.1	1.1	0.8	0.0	0.2	0.0	2.9	2.7	0.5	1.6	0.0	0.0	0.0	8.4	0.0	2.7	8.7	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.2	1.0	0.3	0.9	0.1	0.1	1.1	1.5	0.5	2.5	1.1	1.4	0.9	2.2	2.1	0.8	0.0	0.3	0.5	1.1	6.4	0.1	2.2	119.8	17.4	2.3	82.0	0.0	0.4	66.3	87.3	4.0	0.4	0.0	0.0	3.1	0.2	29.2	2.0	0.0	0.5	2.7	0.0	3.5	5.5	0.6	2.2	65.9	0.5	20.3	1.8	1.0	7.5	22.7	0.0	47.0	113.1	0.2	6.5	13.7	0.0	2.1	4.1	3.4	0.0	0.8	0.1
BICD1		ENSG00000151746	"BICD cargo adaptor 1"	Q96G01	12	32106835-32383633	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.0"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 26.0;Cone photoreceptor cells: 35.3;Muller glia cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041309	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041309: AB_10804000"	"unprognostic (1.40e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-6)"	"unprognostic (5.93e-2)"	"unprognostic (4.57e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.36e-1)"	6.2	5.3	11.7	8.3	10.6	4.1	5.3	39.0	13.7	19.9	4.4	9.2	1.9	3.3	13.8	10.4	3.1	14.8	7.7	6.0	10.7	7.6	6.7	1.9	6.6	8.6	6.6	10.9	29.0	2.5	12.6	9.9	12.1	8.3	6.5	4.5	5.6	3.7	4.1	4.6	2.9	4.5	8.2	8.3	10.4	4.0	4.4	8.0	8.8	9.5	1.9	7.4	6.2	4.9	5.4	6.3	0.1	0.9	2.8	4.7	1.6	8.3	6.7	4.4	2.7	4.1	4.6	4.2	9.8	4.2	9.8	6.6	6.2	5.0	13.2	7.4	8.9	10.3	3.3	18.5	7.7	14.1	8.3	5.4	13.6	5.1	3.3	4.8	11.0	8.3	3.1	3.6	10.8	8.8	13.0	9.4	11.6	7.0	22.2	4.2	3.3	11.9	4.1	37.5	3.1	6.0	9.2	13.3	7.7	11.3	4.5	17.4	10.4	6.5	0.4	6.1	27.0	5.3	2.9	10.4	13.8	13.1	9.2	13.3	7.5	10.6	21.3	9.2	5.7	16.1	0.0	0.9	0.0	3.5	0.3	4.7	5.4	3.2	2.2	1.5	5.2	3.6	2.8	0.1	2.8	0.0	6.3	4.1	1.6	11.7	10.6	39.0	13.7	10.7	7.6	6.6	10.9	8.3	8.0	14.9	0.6	11.7	4.6	0.3	26.0	7.8	0.0	2.7	11.4	8.7	35.3	0.4	1.7	7.4	0.5	14.6	0.5	0.0	4.2	0.4	5.0	5.5	0.0	0.4	5.4	22.3	6.3	14.1	1.0	0.7	3.7	2.5	8.5	3.6	0.0	32.7	5.7	0.0	4.2	1.9	17.8	0.0	6.6	2.1	9.8	2.0	0.2	5.0	2.3	3.1
BICD2	KIAA0699	ENSG00000185963	"BICD cargo adaptor 2"	Q8TD16	9	92711363-92764812	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 65.5;Suprabasal keratinocytes: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023013, HPA024452"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA023013: AB_1845352, HPA024452: AB_1845353"	"unprognostic (9.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.39e-2)"	10.4	7.8	13.9	8.9	12.5	7.2	7.1	13.2	13.1	13.1	9.9	7.7	7.9	3.2	9.7	4.5	27.2	7.2	6.7	15.6	11.8	5.8	7.5	5.2	9.1	9.3	13.4	9.8	8.4	7.2	21.7	3.8	9.8	11.9	7.4	3.7	6.6	9.1	10.0	13.9	40.3	5.9	9.7	9.2	11.3	5.9	5.9	11.0	8.5	6.2	16.3	18.2	10.6	17.2	3.3	5.2	10.5	7.5	1.5	2.4	2.0	14.3	11.9	8.9	9.1	17.3	12.0	12.6	14.0	10.1	8.0	6.3	7.0	6.5	16.2	9.1	15.5	10.2	45.2	9.9	22.2	9.1	7.7	10.8	8.5	11.6	9.6	10.3	11.8	13.9	12.2	31.1	13.3	10.2	9.5	11.8	7.0	8.4	12.6	17.4	9.4	11.2	7.4	6.1	10.6	14.7	12.3	19.3	8.6	12.8	12.1	6.2	9.6	9.8	9.1	6.3	9.3	3.7	5.5	15.8	14.8	9.9	24.9	15.1	10.5	7.6	14.4	12.5	7.3	12.9	2.2	4.4	5.6	1.8	5.2	1.8	2.7	2.0	2.4	5.2	3.3	1.9	1.7	10.5	1.5	7.5	4.5	1.2	2.0	13.9	12.5	13.2	13.1	11.8	5.8	13.4	9.8	11.9	11.0	26.8	10.1	12.4	12.7	65.5	12.3	46.2	7.6	14.7	19.4	7.0	5.9	7.4	3.3	8.5	5.1	13.5	1.0	0.0	4.3	5.5	22.3	7.8	23.1	6.7	12.6	14.3	10.4	17.8	32.0	5.0	19.5	24.3	15.1	9.0	2.2	3.9	7.5	3.1	31.5	5.8	5.5	19.4	19.8	7.9	8.4	114.4	6.1	10.2	2.3	15.8
BICDL1	"BICDR-1, CCDC64, FLJ26450"	ENSG00000135127	"BICD family like cargo adaptor 1"	Q6ZP65	12	119989869-120094494	"Predicted intracellular proteins"	"Neurogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.9;skin 1: 20.5"	"Group enriched"	"Detected in some"	6	"Collecting duct cells: 12.2;Distal tubular cells: 19.9;Proximal tubular cells: 20.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 27.4;MCF7: 14.8;SCLC-21H: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061116	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA061116: AB_2684433"	"unprognostic (2.17e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-2)"	"unprognostic (6.81e-4)"	"prognostic favorable (3.15e-4)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (3.93e-5)"	"prognostic favorable (1.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-1)"	4.0	0.8	2.7	3.8	2.3	0.7	0.9	11.9	6.5	0.8	0.9			1.3	0.0	16.5	7.5	0.7	1.4	0.0	3.1	5.1	29.9	0.5	0.7	8.7	1.5		0.0	1.1	1.2	18.4	0.1		0.9	1.0		1.4	0.1	0.0	20.5	1.1	0.0	0.7	2.3	8.6	8.0			6.3		6.0	1.2	3.5	0.5	0.1	0.9	0.8	0.2	3.4	0.7	1.8	5.7	0.3	0.0	0.5	0.0	7.0	0.0	0.0	0.0	0.0	5.1	3.2	9.0	2.4	0.0	5.1	4.3	0.7	0.9	0.0	0.6	0.9	0.0	2.5	9.8	0.0	1.1	9.5	0.0	27.4	0.0	0.3	0.0	0.0	7.8	0.3	1.1	0.0	14.8	6.4	0.1	11.7	13.6	2.7	0.7	0.5	2.4	3.5	4.6	17.3	1.2	2.0	5.4	1.4	3.0	12.4	4.5	0.0	0.1	1.6	0.0	0.1	2.3	8.7	3.5	0.3	1.3	0.9	0.9	0.0	0.0	3.4	0.0	1.3	0.5	3.4	2.9	0.0	0.5	2.6	2.0	0.0	0.2	0.8	0.1	0.6	0.7											0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	12.2	0.0	0.5	19.9	0.8	0.0	0.0	0.0	0.0	2.9	0.6	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.7	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
BICDL2	CCDC64B	ENSG00000162069	"BICD family like cargo adaptor 2"	A1A5D9	16	3027682-3036926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.1;pancreas: 54.1"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 19.4;Ciliated cells: 22.7;Club cells: 22.7;Collecting duct cells: 15.7;Ductal cells: 27.6;Exocrine glandular cells: 43.8;Pancreatic endocrine cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.6;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.5"	"Cell line enhanced"	"Detected in some"		"A-431: 6.5;BEWO: 11.5;CAPAN-2: 10.6;HaCaT: 16.5;MCF7: 16.0;RT4: 7.6;SK-BR-3: 8.2;T-47d: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043251	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Intermediate filaments, Actin filaments, Cytosol"		"HPA043251: AB_10794925"	"unprognostic (2.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.06e-3)"	"unprognostic (9.65e-5)"	"unprognostic (5.79e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.32e-2)"	"prognostic favorable (9.04e-4)"	0.4	0.0	0.4	2.5	0.4	0.0	2.9	0.4	0.4	6.2	7.9	0.4	8.3	5.7	1.0	2.0	31.1	2.2	11.0	0.4	0.4	0.0	1.2	0.4	5.3	0.4	0.4	0.4	0.9	54.1	3.6	0.9	0.5	0.4	5.1	3.5	0.4	13.9	8.3	1.1	13.7	6.9	1.0	0.4	0.4	10.2	0.5	0.4	0.4	2.3	8.6	12.4	6.1	12.0	0.1	0.1	3.5	0.0	0.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	1.9	10.6	0.0	0.0	0.0	0.0	16.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.1	0.0	4.6	0.0	0.1	0.0	0.2	0.0	7.6	0.1	0.0	0.0	8.2	0.0	0.2	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.2	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	11.9	19.4	0.0	0.0	0.0	0.0	0.0	0.0	22.7	22.7	15.7	0.0	4.0	3.3	27.6	0.0	0.0	0.0	0.0	43.8	3.8	0.0	0.0	2.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	34.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	20.9	25.8	19.1	23.3	24.1	25.9	57.0	20.5	28.5	25.1	22.2	18.4	18.7	19.3	24.6	31.1	18.6	17.0	21.1	39.2	19.1	18.3	24.3	36.8	34.0	47.2	23.3	15.8	21.5	40.8	22.0	27.3	24.3	22.3	19.6	22.2	14.3	21.9	22.1	38.8	17.3	24.4	23.8	26.3	27.6	19.0	19.7	15.5	51.2	18.9	17.3	21.9	22.2	20.2	5.8	12.6	37.5	16.6	12.2	12.0	9.8	9.8	7.3	11.3	8.8	14.3	19.9	7.2	38.3	14.6	22.0	13.4	9.1	24.6	10.9	37.9	17.5	12.3	10.9	7.3	10.1	26.4	14.5	3.7	10.9	5.4	11.0	14.6	6.6	7.0	12.7	19.7	12.5	16.1	20.3	15.0	6.6	9.8	0.0	39.5	3.1	6.9	5.8	5.4	11.8	7.1	3.5	14.7	7.2	17.0	11.4	4.7	6.2	13.3	8.1	11.4	18.1	12.8	8.0	24.6	46.5	10.5	14.0	24.6	4.5	6.1	7.4	10.0	8.3	33.8	31.7	16.6	37.5	9.1	15.2	7.5	5.8	8.7	8.4	12.6	5.6	11.3	11.3	25.5	12.2	16.3	7.6	12.0	9.8	19.1	24.1	20.5	28.5	19.1	18.3	23.3	15.8	22.3	15.5	38.7	40.9	33.3	88.5	59.6	24.1	51.6	63.7	60.2	44.3	61.1	27.5	32.6	36.5	42.3	11.1	49.4	69.1	23.3	63.8	22.6	51.4	66.2	61.2	138.2	36.5	19.1	46.6	67.5	96.7	7.4	33.6	60.1	49.0	85.6	48.7	27.5	44.2	49.9	27.3	66.5	29.1	25.8	53.9	31.1	41.3	54.8	29.4	45.8	37.3	65.0
BIVM	FLJ20159	ENSG00000134897	"Basic, immunoglobulin-like variable motif containing"	Q86UB2	13	102799049-102841535	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.6;NK-cells: 6.3;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050126	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050126: AB_2681027"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.89e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-2)"	6.8	7.6	10.8	3.3	15.6	3.4	9.6	32.3	16.9	9.2	6.9	6.9	10.5	6.8	10.1	14.3	5.6	7.7	6.9	18.7	10.9	8.4	17.7	17.6	6.4	4.5	9.3	10.8	10.1	10.3	6.4	10.7	7.4	10.4	8.7	8.2	6.3	6.7	9.8	16.9	8.3	6.7	8.8	7.1	7.0	8.9	2.2	9.8	4.3	8.4	7.4	3.6	6.7	6.3	0.6	1.2	3.6	0.4	6.3	4.9	0.9	7.5	2.4	9.0	10.4	11.6	17.9	2.1	9.1	9.2	5.7	6.4	2.7	3.4	0.0	4.1	8.7	4.3	5.2	7.3	7.2	8.1	6.9	9.1	6.4	6.8	4.6	10.4	7.2	11.2	14.4	9.2	3.1	10.2	13.8	8.6	10.4	6.9	0.0	11.7	1.6	8.2	9.4	2.1	10.6	6.4	0.0	4.3	3.2	26.3	3.2	14.0	12.1	3.7	4.3	5.9	3.7	6.9	9.9	6.2	7.3	1.9	5.4	5.5	6.0	2.7	0.0	9.3	0.0	12.7	3.6	0.4	0.8	2.4	0.2	4.9	0.5	1.4	3.1	1.2	0.6	0.9	2.1	0.4	6.3	0.1	0.5	1.2	0.9	10.8	15.6	32.3	16.9	10.9	8.4	9.3	10.8	10.4	9.8	8.9	10.9	3.0	3.0	3.3	15.7	24.6	12.7	8.1	13.6	17.4	13.7	6.3	24.9	4.5	0.2	11.7	5.2	0.0	4.8	5.9	11.4	4.1	5.8	26.7	5.7	22.3	20.9	19.6	5.2	0.2	12.7	4.2	3.3	1.0	16.5	7.7	4.7	10.5	10.6	25.2	11.5	19.4	9.5	0.5	8.7	4.3	2.1	10.1	15.1	2.6
BLCAP	BC10	ENSG00000166619	"Bladder cancer associated protein"	P62952	20	37492472-37527931	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 102.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 72.5"	"Low region specificity"	"Detected in all"							HPA047390			Approved	Nucleoli		NA	NA			Nucleoli		"HPA047390: AB_2680025"	"unprognostic (1.05e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.28e-5)"	18.9	16.7	31.6	12.9	89.5	10.7	16.4	23.2	40.1	14.3	15.6	13.3	11.4	17.6	9.8	19.9	18.5	50.5	17.9	23.5	26.5	44.4	21.3	23.8	12.2	12.5	22.5	28.3	15.1	7.9	15.4	34.4	26.1	27.6	18.9	18.8	13.4	17.7	21.1	102.5	30.3	18.9	13.4	13.4	14.2	12.4	12.2	10.6	8.5	14.0	27.3	17.8	20.2	12.7	48.0	20.5	26.6	22.2	17.0	28.4	18.7	27.0	8.0	9.4	9.7	18.2	14.0	13.3	13.0	12.6	11.6	9.5	27.8	22.1	14.1	13.0	18.0	11.1	52.5	7.0	53.9	12.1	2.9	6.3	4.6	17.8	25.7	11.7	9.1	6.1	17.8	58.1	11.1	21.1	9.6	16.1	10.3	4.4	10.6	23.3	15.2	7.5	7.2	7.5	15.3	22.5	7.2	35.1	9.4	13.3	72.5	8.6	10.4	15.6	45.3	10.5	10.1	14.9	8.7	15.3	30.1	7.7	10.5	5.5	5.8	7.2	6.8	12.5	8.4	5.3	26.6	22.2	25.9	18.7	21.5	20.4	37.5	21.4	19.8	20.5	48.0	28.4	22.0	23.2	17.0	19.3	8.8	20.6	18.7	31.6	89.5	23.2	40.1	26.5	44.4	22.5	28.3	27.6	10.6	74.5	32.3	42.7	79.2	130.6	42.3	49.4	35.7	64.3	67.1	38.4	21.6	98.9	69.6	30.6	58.8	43.9	49.9	0.0	29.8	68.6	31.1	44.2	29.9	70.6	48.4	39.7	39.3	74.3	36.4	108.7	27.6	35.6	33.7	16.2	50.0	37.9	37.4	28.1	55.9	41.1	33.0	32.3	28.8	23.1	23.8	107.4	54.3	33.2	29.7	128.8
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248195-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 67.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		59000000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	11.2	8.3	9.0	17.1	10.2	8.5	14.2	12.1	14.5	10.5	9.8	8.5	9.6	6.7	13.1	12.2	15.7	8.4	10.1	9.7	7.5	7.2	13.6	7.5	13.6	20.3	9.5	8.5	8.8	15.3	15.0	8.3	14.6	9.2	8.4	8.5	7.3	12.8	9.5	15.0	67.5	10.0	15.7	11.1	13.2	9.2	12.4	8.6	24.7	9.3	15.5	13.6	10.8	11.7	4.6	6.6	0.9	5.7	9.8	17.3	6.3	10.2	16.2	15.6	10.8	10.7	11.5	7.6	9.5	5.9	15.1	13.0	23.7	3.0	30.4	17.0	7.7	6.8	7.1	33.8	13.0	12.8	8.0	26.6	18.6	14.5	20.1	15.7	33.9	11.5	13.6	0.9	11.8	6.8	12.4	22.1	25.5	39.7	12.4	6.2	7.7	42.0	24.8	15.0	0.0	7.6	36.4	40.6	20.1	12.0	9.1	36.1	12.9	8.4	16.5	10.4	28.2	11.2	17.5	14.0	9.3	18.8	4.1	16.8	15.0	30.9	41.1	7.1	0.0	12.4	0.0	5.7	0.9	10.5	3.9	17.3	4.6	12.6	13.7	6.5	4.2	11.6	12.3	0.7	9.8	1.9	6.6	12.4	6.3	9.0	10.2	12.1	14.5	7.5	7.2	9.5	8.5	9.2	8.6	3.0	13.0	12.3	14.0	14.2	18.2	16.5	12.7	6.7	2.3	10.4	11.8	41.1	6.6	14.9	8.2	17.9	8.9	0.0	12.2	31.7	13.3	8.5	43.8	6.6	22.1	12.7	17.2	28.3	21.8	5.2	15.0	10.4	10.1	10.0	7.6	10.9	8.9	8.6	23.3	17.0	16.0	6.5	15.3	9.7	16.7	11.0	23.0	18.7	10.7	5.9
BLOC1S3	"BLOS3, HPS8"	ENSG00000189114	"Biogenesis of lysosomal organelles complex 1 subunit 3"	Q6QNY0	19	45178745-45181801	"Disease related genes, Predicted intracellular proteins"			"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA050111, HPA070609"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA050111: AB_2681019, HPA070609: "	"unprognostic (1.17e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.94e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.89e-9)"	"unprognostic (1.92e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (6.86e-4)"	16.2	11.2	10.3	11.8	11.1	22.8	9.8	10.4	15.9	12.3	9.5	14.3	12.8	11.2	10.2	13.0	10.5	10.4	10.4	7.8	10.7	9.8	8.7	13.6	11.1	14.1	15.5	8.3	12.4	16.8	10.4	8.0	10.4	11.9	11.4	9.5	9.5	15.0	10.3	7.3	21.2	11.0	9.2	10.7	19.1	15.6	11.2	11.8	13.3	13.3	8.5	15.0	10.6	13.0	16.4	13.6	27.1	26.6	14.7	25.3	10.6	8.1	9.3	2.6	6.6	9.0	6.1	8.0	4.0	6.6	7.8	8.0	5.5	5.3	7.0	10.0	9.3	8.8	12.8	6.8	9.2	5.6	6.2	14.0	9.6	4.1	6.2	12.8	4.6	15.9	9.0	13.2	10.0	14.2	4.4	8.5	4.7	10.1	14.7	4.5	13.9	4.7	7.2	1.5	11.6	11.7	7.0	3.5	5.8	5.7	10.4	5.1	4.9	10.8	18.4	4.0	4.7	7.5	8.7	4.5	8.0	4.6	8.5	6.4	10.4	10.6	4.8	8.7	8.7	6.0	27.1	23.3	18.5	25.3	26.6	20.9	12.6	22.0	19.2	13.6	16.4	18.0	18.1	22.9	14.7	23.6	11.6	18.0	10.6	10.3	11.1	10.4	15.9	10.7	9.8	15.5	8.3	11.9	11.8	0.0	1.7	6.9	2.3	11.3	5.9	1.8	2.5	1.4	1.2	3.5	0.0	3.4	1.7	3.8	15.4	6.0	3.9	0.0	3.3	3.3	4.3	4.3	8.1	4.0	5.3	4.8	6.9	6.7	7.0	31.1	5.8	5.3	3.3	4.6	4.8	3.0	3.7	2.9	7.4	3.1	2.1	0.0	5.0	1.4	5.3	12.2	3.8	8.9	3.8	1.7
BLOC1S4	"BCAS4L, CNO, FLJ11230"	ENSG00000186222	"Biogenesis of lysosomal organelles complex 1 subunit 4"	Q9NUP1	4	6716055-6717671	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043840	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA043840: AB_10965701"	"unprognostic (3.09e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.24e-3)"	"unprognostic (5.62e-3)"	14.6	15.5	9.2	11.8	11.5	13.6	11.4	10.7	14.4	15.4	15.2	9.5	10.1	14.6	13.8	14.3	14.1	12.3	15.7	9.6	9.3	7.7	13.6	13.8	8.7	16.9	8.6	9.4	19.1	18.4	8.4	9.8	23.2	9.8	13.7	9.4	13.3	10.8	11.2	16.6	10.7	15.8	8.2	7.4	17.7	13.3	14.0	8.9	20.9	16.8	10.1	15.5	12.3	10.9	6.1	3.8	13.7	4.8	2.5	9.6	1.8	10.1	7.0	10.6	10.8	8.3	10.7	21.3	8.3	9.1	7.7	6.8	6.2	11.0	9.7	8.9	7.3	10.9	7.0	5.9	9.5	6.0	7.7	9.7	14.8	6.7	15.3	10.2	7.1	13.9	10.1	9.5	6.1	5.3	7.6	7.1	8.5	19.3	8.9	8.0	10.1	11.6	24.9	13.8	7.5	13.9	12.1	11.7	8.6	10.6	9.0	9.1	12.3	6.9	4.9	14.7	8.5	15.6	13.9	7.9	7.2	6.3	8.3	10.3	13.2	12.8	12.9	8.0	13.2	11.3	2.5	3.1	13.7	5.1	4.8	5.2	6.1	6.2	5.5	3.8	4.9	9.6	5.3	1.8	2.5	3.1	3.7	5.1	1.8	9.2	11.5	10.7	14.4	9.3	7.7	8.6	9.4	9.8	8.9	6.0	5.1	27.0	27.5	20.9	29.5	4.2	20.4	2.7	5.7	22.7	5.9	58.7	21.6	5.7	1.1	19.4	21.8	0.0	6.1	79.4	30.2	31.7	3.5	20.5	30.4	28.6	10.9	31.9	17.1	1.4	30.0	14.2	28.7	3.6	24.1	29.5	8.6	35.1	21.2	38.7	22.8	6.5	20.2	10.9	16.4	21.8	53.0	42.0	23.3	27.1
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465840	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.6"	"Cell type enhanced"	"Detected in all"	13	"Erythroid cells: 2523.0;Hofbauer cells: 895.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 73.4"	"Group enriched"	"Detected in all"	7	"dendritic cells: 54.8;monocytes: 73.4"	"Cell line enhanced"	"Detected in many"		"A549: 81.2;K-562: 73.7;OE19: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		440000000	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	36.9	17.9	10.9	12.8	12.2	137.6	28.9	3.5	10.9	17.0	26.7	7.7	18.5	20.9	14.1	19.6	45.3	14.6	19.0	31.0	8.2	8.6	31.8	72.4	37.3	30.0	11.7	9.6	21.3	19.4	5.7	5.6	32.2	13.8	22.9	7.7	17.5	27.1	22.1	43.4	16.7	26.4	22.1	9.7	47.1	31.1	7.6	7.9	6.6	24.3	42.9	24.4	29.9	22.1	8.6	54.8	9.1	73.4	4.0	5.3	34.4	34.2	81.2	1.1	12.1	11.3	10.9	9.6	4.3	12.7	5.9	11.5	15.9	31.1	11.5	33.5	7.7	19.2	11.0	4.1	9.4	1.2	19.5	3.5	17.5	12.2	9.6	26.1	0.2	5.1	10.6	17.9	7.9	4.4	6.0	6.2	4.3	73.7	20.9	6.9	53.2	0.9	1.0	0.3	64.3	22.7	8.1	3.8	18.6	7.4	23.1	0.0	1.8	13.1	34.7	13.2	1.6	33.7	2.6	6.7	15.8	16.9	24.2	2.3	11.4	13.4	4.3	41.1	6.9	6.1	5.0	73.4	2.6	4.6	33.7	4.4	8.6	4.0	4.0	54.8	5.4	4.2	3.3	9.1	4.0	16.9	11.5	5.3	34.4	10.9	12.2	3.5	10.9	8.2	8.6	11.7	9.6	13.8	7.9	205.4	126.9	50.2	283.1	114.9	10.9	116.8	180.9	95.0	73.9	92.5	5.9	76.7	225.5	197.9	7.2	54.2	483.6	2523.0	231.2	82.2	103.0	212.9	41.6	520.7	895.0	9.5	43.0	55.9	549.4	16.6	115.1	152.9	136.7	94.6	130.3	62.8	228.4	480.5	88.4	302.1	11.3	32.3	73.1	2.1	3.6	114.0	62.5	43.7	144.8	253.2
BMF	FLJ00065	ENSG00000104081	"Bcl2 modifying factor"	Q96LC9	15	40087890-40108892	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 81.0"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 12.7;monocytes: 14.4;Pancreatic endocrine cells: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 19.8;HMC-1: 22.4;hTERT-RPE1: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010120	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA010120: AB_1845385"	"unprognostic (2.94e-1)"	"unprognostic (4.92e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.83e-4)"	"prognostic unfavorable (6.32e-4)"	"unprognostic (1.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.06e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.35e-2)"	5.3	2.9	1.3	13.5	1.9	15.8	6.1	2.3	2.0	10.9	9.9	2.1	13.0	11.9	12.4	4.7	2.8	8.3	6.7	3.4	1.3	1.6	6.5	3.9	7.7	18.4	2.8	0.9	8.9	8.1	1.8	2.8	5.7	2.5	7.0	4.5	7.2	9.2	10.8	4.6	4.0	23.2	5.8	3.0	18.1	6.7	4.1	2.1	81.0	18.6	3.1	15.0	7.5	3.7	5.1	3.3	5.2	6.0	0.0	1.4	0.9	0.4	0.6	11.5	2.5	0.3	0.5	7.8	0.0	1.8	0.2	0.5	11.5	0.8	3.3	3.7	0.5	3.5	2.4	2.8	0.0	0.0	7.9	2.3	1.7	19.8	2.6	1.1	0.3	22.4	5.8	0.6	0.2	0.2	29.0	3.0	2.4	0.9	1.4	1.0	0.6	1.1	8.4	3.1	5.7	0.4	2.1	2.6	9.5	0.5	2.6	6.1	5.0	2.2	5.8	5.1	12.9	3.4	6.7	2.3	0.4	1.6	0.3	0.1	14.2	13.3	2.0	0.8	1.6	1.3	0.1	4.2	3.6	0.2	4.9	0.4	5.1	0.4	1.4	2.7	1.8	0.7	0.1	5.2	0.0	6.0	3.3	1.2	0.9	1.3	1.9	2.3	2.0	1.3	1.6	2.8	0.9	2.5	2.1	3.0	2.1	10.0	1.0	1.0	0.0	1.6	7.6	0.0	5.7	0.0	0.0	0.6	0.0	8.9	1.0	2.1	5.1	0.0	12.7	1.1	1.9	2.6	0.0	0.9	7.6	0.0	1.2	1.8	10.8	0.0	1.7	6.1	0.0	14.4	1.5	0.3	13.9	0.3	0.7	2.2	0.4	0.0	0.8	0.2	1.1	0.5	1.5	0.7	1.3	0.9
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321211-22331484	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 132.9;Late spermatids: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 89.1;U-937: 104.6"									"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	19.7	23.5	28.0	17.0	35.0	13.3	26.5	26.1	33.7	21.6	22.3	26.3	11.6	14.1	23.9	22.8	16.0	17.0	17.4	15.1	28.3	24.2	19.2	25.5	16.7	17.9	42.3	27.7	18.8	18.6	40.0	37.6	20.6	24.8	25.5	16.0	16.5	15.7	20.3	28.5	10.3	14.6	26.3	34.8	24.6	16.5	24.3	40.7	12.9	17.6	10.6	18.8	21.5	25.9	5.0	1.8	13.0	3.4	6.2	8.4	2.4	13.0	6.3	7.3	2.2	12.8	10.3	7.3	8.8	4.0	6.7	8.0	6.6	16.3	6.7	6.0	8.0	7.5	4.6	10.5	6.2	8.4	89.1	13.1	18.4	5.4	7.4	7.6	6.8	10.2	6.6	10.9	7.4	8.2	8.5	4.7	10.8	18.2	11.3	8.9	5.2	18.2	2.0	1.7	6.1	15.1	13.6	10.4	6.4	6.4	4.2	6.1	12.1	5.8	7.6	9.8	3.3	6.9	27.3	10.1	7.5	22.7	18.1	11.8	14.0	18.2	14.7	10.7	104.6	4.9	13.0	1.5	2.5	6.1	3.4	8.4	5.0	6.4	5.8	1.0	2.6	5.5	5.2	0.6	6.2	2.1	1.8	4.3	2.4	28.0	35.0	26.1	33.7	28.3	24.2	42.3	27.7	24.8	40.7	23.8	20.0	13.4	18.4	14.2	21.3	16.1	10.2	16.0	25.0	12.2	7.9	10.9	11.6	14.2	132.9	25.3	4.2	0.0	15.8	17.8	14.4	26.4	11.5	25.2	8.6	28.6	12.7	28.3	19.0	118.0	33.4	13.9	35.4	17.2	12.0	12.6	17.8	5.8	34.3	7.6	13.9	19.4	37.7	10.4	24.3	12.8	5.6	18.3	9.5	17.6
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726797-7881422	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.4"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 9.0;Ito cells: 19.0"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	8	"basophil: 4.0;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 59.0;Karpas-707: 30.6;SiHa: 25.7;TIME: 27.0;U-266/84: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	21000	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	10.5	1.5	1.7	1.3	2.8	0.0	7.7	0.2	1.1	2.5	2.7			1.9	2.1	0.0	1.5	1.1	1.6	3.8	1.7	1.4	6.6	1.4	5.8	0.7	2.2		5.8	0.1	0.0	2.8	17.4		1.5	2.2		1.1	2.2	1.4	1.7	2.0	2.0	1.9	3.4	3.4	1.5			0.5		1.8	2.9	1.7	0.3	0.4	4.0	0.0	0.0	0.2	2.1	0.3	0.9	0.1	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.4	0.6	0.1	0.4	0.0	0.0	0.0	2.0	5.6	8.7	0.5	0.3	0.3	6.0	0.0	0.0	0.2	1.0	3.8	59.0	0.0	0.0	30.6	0.0	0.1	0.0	0.0	0.3	0.2	4.2	0.2	0.0	5.3	0.2	0.0	4.4	0.0	25.7	0.0	0.0	3.9	0.0	0.0	27.0	0.0	1.7	0.1	0.8	3.9	13.4	0.0	0.9	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	0.0	0.2	0.0	2.1											0.0	0.3	0.0	0.0	0.2	0.0	2.8	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.5	9.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	19.0	1.0	1.8	0.0	0.0	1.7	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168748-57266629	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.0;thyroid gland: 44.3"	"Cell type enhanced"	"Detected in many"	16	"Cytotrophoblasts: 108.5;Muller glia cells: 38.0;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 42.0;MCF7: 48.6;OE19: 22.8;RPMI-8226: 18.6;SK-BR-3: 31.7;U-698: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"	NA	NA	248000		Vesicles	"Nucleoplasm, Nucleoli"	"HPA057757: AB_2683518"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	7.2	16.8	2.4	17.5	0.7	2.1	3.8	19.7	9.2	2.3	23.6	6.0	2.7	1.9	17.7	17.2	10.0	1.2	8.5	13.9	9.9	4.5	0.7	1.8	1.6	14.3	11.2	0.8	1.0	0.8	1.9	24.4	12.2	5.0	2.4	37.0	2.6	10.3	1.0	15.5	2.4	1.0	13.8	1.3	4.1	1.4	13.4	1.8	44.3	5.7	4.9	7.8	7.0	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	5.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.7	42.0	10.8	0.0	2.2	12.2	1.3	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.6	0.0	0.0	3.0	22.8	0.0	0.0	0.0	18.6	0.0	0.0	0.1	4.6	1.3	31.7	0.1	4.0	0.2	0.1	0.1	0.0	2.9	0.0	0.0	0.0	0.0	57.4	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	16.8	17.5	3.8	12.5	13.9	9.9	14.3	11.2	12.2	13.4	6.0	2.1	0.0	11.4	12.2	3.8	12.4	0.0	2.7	2.3	1.8	0.0	108.5	0.0	0.0	3.9	1.5	0.0	0.0	0.0	14.4	10.8	4.9	21.8	0.0	9.3	1.6	2.4	0.0	0.0	3.3	0.3	0.0	3.3	0.0	0.0	38.0	0.0	0.0	0.4	1.6	2.4	0.0	0.9	1.4	1.4	8.4	47.6	0.5	0.2	10.6
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932838	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB019398: "	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.05e-3)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (3.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.07e-1)"	8.9	7.0	9.4	7.9	12.4	0.9	10.7	14.1	9.2	19.4	20.6	10.9	7.7	6.2	16.3	12.3	8.4	10.9	10.8	11.0	7.7	6.1	8.2	4.6	7.4	2.9	7.3	7.6	16.1	10.6	10.0	14.0	7.4	8.5	12.8	9.3	10.9	12.6	14.2	8.4	11.3	9.8	16.5	12.2	3.4	12.1	7.8	9.2	0.3	19.4	7.8	5.7	16.0	11.4	1.8	1.1	3.6	0.8	0.9	1.4	0.3	7.3	3.7	14.3	12.1	7.5	4.8	2.5	7.4	7.7	4.3	5.1	6.2	6.4	2.2	3.4	9.4	3.1	7.8	6.3	8.0	6.4	2.4	3.6	2.8	3.5	10.3	4.0	3.8	19.7	4.2	3.4	5.8	4.3	6.4	0.0	4.1	4.4	1.5	5.0	3.1	2.6	3.1	7.7	2.6	1.7	0.0	5.6	0.0	8.9	6.9	1.4	4.6	8.2	4.2	4.9	18.2	7.1	1.9	3.7	3.1	5.0	6.4	6.8	0.4	6.8	2.8	2.7	2.6	2.5	2.0	0.8	0.6	1.4	0.5	0.9	1.8	1.4	1.2	0.3	1.5	1.0	1.1	3.6	0.9	0.6	1.1	0.7	0.3	9.4	12.4	14.1	9.2	7.7	6.1	7.3	7.6	8.5	9.2	32.8	24.8	0.0	6.7	10.8	6.0	19.0	10.2	13.4	9.1	10.4	19.6	10.0	1.7	9.8	0.6	2.1	9.0	0.0	8.1	0.7	13.3	12.9	15.0	7.2	2.7	11.1	17.3	8.0	4.0	1.7	31.1	3.5	8.5	1.0	13.6	12.9	7.7	3.5	29.4	4.7	19.0	6.5	14.1	2.3	3.6	8.5	4.2	0.0	10.0	4.2
BMT2	"C7orf60, DKFZp762M126, FLJ31818"	ENSG00000164603	"Base methyltransferase of 25S rRNA 2 homolog"	Q1RMZ1	7	112819147-112939916	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Collecting duct cells: 12.2;Extravillous trophoblasts: 24.3;Hofbauer cells: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044405, HPA050733"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA044405: AB_10959783, HPA050733: AB_2681223"	"unprognostic (5.26e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.61e-5)"	"unprognostic (1.50e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.22e-2)"	"unprognostic (9.10e-2)"	9.4	7.8	15.5	8.6	14.5	8.1	11.0	27.6	17.1	11.8	11.2	5.2	11.0	5.0	13.9	8.3	13.7	8.7	9.5	22.9	13.0	12.2	10.3	4.5	8.1	9.8	9.0	7.5	11.4	7.9	11.5	18.0	12.0	10.9	11.1	8.3	6.3	9.3	15.9	7.9	9.3	6.9	13.7	11.0	11.9	6.4	14.2	9.7	13.7	10.0	5.1	10.3	14.6	11.0	3.9	5.7	12.7	5.9	5.4	7.3	2.6	4.2	3.7	9.3	8.3	12.5	14.5	2.8	4.5	20.6	8.2	12.0	2.2	3.4	1.4	5.8	8.3	9.0	2.1	4.9	6.7	13.5	4.5	5.0	7.5	2.7	2.7	5.7	2.8	7.3	10.9	5.3	6.4	5.7	10.2	6.6	2.7	2.3	2.8	9.8	3.2	6.8	8.2	2.0	3.0	3.8	3.4	12.2	4.4	6.2	5.8	3.7	9.5	8.6	3.5	4.9	9.4	1.7	2.7	4.6	10.5	2.6	6.7	3.5	3.7	3.5	2.7	11.4	4.3	6.1	8.0	5.5	9.1	4.9	5.7	6.0	3.9	4.9	5.7	5.7	3.9	6.8	5.7	12.7	5.4	5.9	3.3	7.3	2.6	15.5	14.5	27.6	17.1	13.0	12.2	9.0	7.5	10.9	9.7	6.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	3.4	12.2	0.0	5.8	0.0	2.4	0.0	0.0	0.0	0.0	2.1	24.3	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.8	0.0	0.0	3.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 57.1"	"Group enriched"	"Detected in some"	9	"Endothelial cells: 18.5;Ito cells: 51.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 10.5"	"Cell line enriched"	"Detected in single"	121	"HUVEC TERT2: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	8.2	0.3	0.1	1.0	0.7	3.6	5.4	0.1	0.3	2.2	5.5	0.1	4.6	2.4	2.6	57.1	1.5	2.5	2.6	10.5	0.5	0.0	0.2	0.9	3.7	6.5	0.4	0.0	1.4	0.9	0.2	0.6	2.6	0.7	2.2	1.4	0.5	1.5	0.6	4.2	1.6	5.5	2.2	0.4	2.4	1.5	1.9	0.1	0.2	2.2	1.1	0.8	2.8	2.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.7	0.1	0.0	1.4	0.0	0.5	0.3	0.0	1.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.1	0.0	4.1	51.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1
BNIPL	"BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753"	ENSG00000163141	"BCL2 interacting protein like"	Q7Z465	1	151036570-151047600	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.5;skin 1: 68.6"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 14.9;Suprabasal keratinocytes: 49.9;Urothelial cells: 20.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	10	"T-47d: 33.1"	"Group enriched"	"Detected in some"	9	"basal ganglia: 1.4;cerebellum: 2.7"	"Low region specificity"	"Detected in some"			HPA019946			Uncertain	Cytosol		NA	NA			Cytosol		"HPA019946: AB_2732424"	"unprognostic (2.62e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.50e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.88e-4)"	"unprognostic (1.91e-1)"	"unprognostic (8.43e-11)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (6.81e-2)"	0.1	0.1	0.2	0.1	0.2	0.3	6.4	0.2	0.2	9.7	0.1	0.1	9.4	0.1	0.6	0.6	42.5	1.0	0.1	0.2	0.2	0.0	0.5	0.2	6.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	3.2	0.1	3.4	0.1	0.3	7.1	21.0	0.7	68.6	0.2	0.8	0.1	0.1	0.6	1.0	0.1	0.2	2.7	25.8	23.2	5.0	18.2	1.8	0.8	3.2	0.6	0.5	1.7	0.4	0.3	0.2	0.5	0.6	0.3	0.3	0.6	0.3	0.0	0.2	0.1	1.1	0.4	0.6	0.5	0.0	0.1	1.3	0.7	0.2	0.4	0.8	0.8	0.9	0.5	0.2	0.1	0.5	0.6	0.0	2.4	0.1	0.2	0.9	0.0	0.9	0.5	0.5	0.2	1.5	0.6	0.9	0.5	0.7	0.4	0.3	0.2	0.3	0.5	0.3	1.1	0.5	0.4	0.7	0.2	1.9	33.1	0.2	0.7	0.7	0.4	0.2	0.1	1.5	1.1	3.1	0.0	0.2	0.6	2.7	0.6	0.7	1.7	0.6	1.4	0.5	1.0	1.2	0.3	1.8	1.0	0.6	3.2	0.5	0.6	0.8	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.1	14.9	12.1	0.0	5.4	13.6	0.4	0.3	0.0	9.4	10.3	10.4	0.0	1.5	0.0	0.0	5.9	0.3	0.4	0.0	0.0	0.3	1.3	6.2	0.0	0.0	0.3	0.0	0.0	3.7	1.2	0.9	0.9	0.8	3.3	0.0	0.1	0.5	0.0	0.0	0.0	0.3	1.4	0.0	0.2	0.5	0.1	49.9	2.2	0.8	0.2	20.9
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135398-74147994	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 267.6;Distal tubular cells: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: AB_2682063"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	18.5	16.1	23.2	11.7	26.0	18.0	20.4	15.6	29.8	11.0	24.0	7.5	12.1	18.4	10.0	13.8	12.6	11.2	12.5	56.8	18.9	21.0	22.0	15.7	14.1	14.7	24.1	18.1	6.9	27.8	12.8	12.3	7.7	17.6	11.5	19.7	11.9	21.5	14.2	57.2	5.9	15.3	14.4	15.8	8.8	16.8	8.2	10.6	7.7	12.1	27.9	11.1	8.9	9.1	14.3	20.7	3.4	9.7	15.2	32.0	13.9	23.4	30.5	11.1	10.9	20.5	19.5	27.5	21.9	12.9	24.4	16.7	39.6	10.9	15.5	20.0	18.9	24.6	12.4	25.5	31.2	21.9	30.4	42.0	19.7	21.2	60.4	18.4	38.6	9.7	15.5	23.9	23.6	29.4	11.2	18.0	34.7	41.2	18.4	26.3	36.1	32.2	28.8	16.3	45.3	46.9	21.2	28.9	31.8	32.2	23.7	16.8	10.0	15.5	25.6	27.0	15.4	14.6	24.5	9.9	20.2	34.5	22.5	43.4	16.9	29.7	21.2	21.3	31.0	18.1	3.4	4.8	1.1	23.2	9.1	25.3	14.3	32.0	24.5	12.1	12.4	28.0	24.1	0.9	15.2	9.7	20.7	27.8	13.9	23.2	26.0	15.6	29.8	18.9	21.0	24.1	18.1	17.6	10.6	8.9	28.0	16.4	39.3	20.1	27.8	267.6	56.0	46.8	30.7	80.3	15.7	50.8	298.4	83.8	13.0	34.9	78.6	186.9	96.3	140.3	38.4	51.5	25.3	87.3	98.4	25.4	73.1	36.2	31.6	5.4	30.5	28.8	94.5	91.0	107.7	29.9	82.6	51.8	43.5	165.7	37.6	19.4	43.8	63.5	96.7	14.8	18.7	29.9	160.6	37.4
BORA	"C13orf34, FLJ22624"	ENSG00000136122	"Bora, aurora kinase A activator"	Q6PGQ7	13	72727749-72756198	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.5"	"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 9.8;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040866	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA040866: AB_10794868"	"unprognostic (9.93e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.32e-12)"	"unprognostic (7.04e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.28e-2)"	3.7	3.0	2.3	10.9	3.2	10.9	6.8	5.8	4.2	3.3	9.0	1.8	6.3	6.9	3.1	5.9	7.1	3.2	3.2	2.3	2.6	2.2	4.3	4.3	7.7	11.8	4.3	1.5	3.1	5.6	0.8	6.3	6.8	4.4	4.0	9.1	2.2	4.6	6.7	2.1	6.1	10.6	3.5	5.3	8.9	5.5	7.0	4.6	26.5	5.0	5.8	12.4	5.6	4.5	5.0	5.7	7.2	5.4	4.6	8.3	3.7	22.3	3.9	12.7	8.6	1.6	1.6	9.0	7.5	6.7	11.8	12.9	10.3	12.9	14.6	4.3	4.3	6.9	9.6	11.4	7.3	15.7	13.5	6.3	18.0	6.3	8.4	1.5	33.9	11.7	1.3	1.9	5.3	11.6	2.6	9.8	15.5	8.2	6.3	8.5	5.2	15.2	9.8	5.6	23.3	4.6	11.1	7.5	6.5	4.0	5.8	3.4	4.0	7.5	7.3	5.4	10.1	4.9	12.4	3.5	3.3	7.5	5.7	9.5	5.4	4.9	10.5	9.2	16.1	8.2	7.2	3.1	1.6	6.6	5.4	5.8	4.6	5.7	6.4	5.7	5.0	4.7	8.3	0.7	4.6	3.3	3.2	5.9	3.7	2.3	3.2	5.8	4.2	2.6	2.2	4.3	1.5	4.4	4.6	3.0	3.2	2.4	1.3	0.6	1.9	0.2	0.0	2.7	2.3	1.8	2.0	3.9	0.0	1.5	1.0	0.2	2.3	0.0	2.2	9.8	0.7	1.4	1.1	0.0	3.8	7.9	0.0	3.1	5.1	0.8	0.9	2.9	0.0	1.8	1.9	1.0	1.4	2.6	1.1	0.5	2.1	12.9	1.9	1.2	4.7	1.0	2.4	2.5	4.0	1.3
BORCS6	"C17orf59, FLJ20014"	ENSG00000196544	"BLOC-1 related complex subunit 6"	Q96GS4	17	8188333-8190907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045415, HPA060791"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA045415: AB_10964575, HPA060791: AB_2684367"	"unprognostic (2.11e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.84e-2)"	"unprognostic (9.91e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.10e-2)"	3.1	4.5	3.5	3.8	3.4	2.8	2.6	3.2	3.9	2.3	4.4			6.3	3.7	2.9	5.5	2.3	1.6	4.4	3.4	2.6	3.9	3.7	3.7	4.8	3.7		2.3	8.4	4.7	2.1	3.0		2.9	1.9		4.3	4.3	11.5	6.2	5.5	2.1	2.8	6.8	3.9	2.1			2.7		3.7	3.3	2.9	13.4	11.3	27.0	12.0	14.5	17.4	10.5	4.7	5.5	2.0	4.0	4.1	3.0	7.7	3.5	3.8	3.3	3.6	3.0	3.4	4.3	7.8	2.7	3.4	6.9	2.9	4.0	1.1	12.9	12.1	3.3	5.4	4.7	4.7	1.9	7.3	3.1	4.3	3.0	3.5	3.2	5.3	6.5	3.6	9.2	2.0	5.3	6.5	5.6	1.4	3.0	6.3	7.9	2.4	6.5	4.5	2.8	2.3	5.3	3.7	2.7	2.9	2.0	4.0	3.1	4.4	2.1	1.8	3.4	3.7	14.0	6.2	2.0	3.0	7.0	2.5	21.4	10.1	27.0	16.2	10.3	13.1	12.8	13.7	17.4	11.3	13.4	13.2	14.6	9.5	14.5	12.0	9.9	12.4	10.5											8.9	8.3	18.6	2.3	0.0	19.9	0.0	10.2	0.0	1.2	5.2	5.9	17.2	6.6	8.9	1.7	5.3	11.9	0.0	15.4	9.9	1.0	2.8	3.5	5.8	18.2	17.5	1.2	8.6	20.3	2.7	5.5	8.7	0.0	23.4	10.5	20.4	10.0	12.4	6.3	7.4	16.6	32.3	0.0	6.7	1.1	0.0	5.1	21.8	9.0	1.4
BORCS7	"C10orf32, FLJ40752"	ENSG00000166275	"BLOC-1 related complex subunit 7"	Q96B45	10	102854223-102864961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA037648	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA037648: AB_10673634"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.46e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.08e-8)"	"unprognostic (9.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-3)"	16.0	40.4	22.7	8.1	26.5	13.2	20.2	14.3	22.1	15.6	11.9	16.4	15.2	15.2	15.2	19.4	9.7	20.2	17.7	15.1	19.7	20.9	26.0	42.7	15.7	10.4	18.0	22.5	15.4	15.2	32.8	23.2	21.2	20.1	18.7	10.3	15.0	11.2	12.6	17.2	9.1	17.7	11.8	17.8	18.1	13.7	18.0	17.3	8.9	36.9	14.2	7.9	11.3	10.9	16.2	29.7	16.8	21.6	16.4	13.5	8.6	7.7	10.5	12.9	11.1	14.3	19.6	10.6	11.5	23.7	8.9	8.5	7.0	8.8	4.9	6.1	18.3	9.3	6.5	4.2	5.9	6.6	6.2	9.0	11.3	7.2	14.4	16.4	20.4	19.5	24.5	16.2	6.0	9.6	18.7	15.4	7.1	6.6	5.2	14.1	5.7	5.6	8.4	4.3	10.6	10.0	10.3	17.1	7.1	7.3	8.6	3.7	14.0	4.2	7.7	17.6	6.0	14.5	11.7	11.5	7.5	8.0	7.6	8.0	13.7	20.7	5.9	15.9	11.9	2.6	16.8	19.5	13.6	11.8	21.6	12.9	16.2	12.1	11.9	13.8	14.4	13.5	12.4	6.0	16.4	19.3	29.7	11.8	8.6	22.7	26.5	14.3	22.1	19.7	20.9	18.0	22.5	20.1	17.3	50.6	70.6	27.0	51.2	0.0	46.2	0.0	40.8	80.3	59.1	40.1	37.3	78.2	170.8	26.2	15.7	60.9	31.5	0.0	29.2	33.5	48.6	70.1	31.4	65.1	44.2	60.4	32.8	48.5	50.0	18.3	39.1	38.2	0.0	28.9	46.3	74.6	26.7	50.1	58.4	157.9	44.6	38.8	0.0	68.3	47.1	0.0	101.6	35.9	48.9	49.9
BORCS8	MEF2BNB	ENSG00000254901	"BLOC-1 related complex subunit 8"	Q96FH0	19	19176903-19192591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA045700	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA045700: AB_10968570"	"unprognostic (4.23e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.82e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.00e-2)"	11.3	17.0	25.0	12.9	26.8	12.2	13.3	19.3	31.0	10.1	13.5	17.3	14.5	15.5	12.9	15.8	13.8	14.0	14.8	17.9	23.9	30.0	16.0	14.1	12.0	14.0	26.3	12.2	10.5	10.1	11.7	20.1	11.3	15.6	10.9	15.3	13.6	12.4	15.5	12.0	9.6	9.5	13.0	13.9	11.9	11.2	11.1	12.9	12.4	13.0	11.1	13.8	10.9	8.5	8.7	9.8	25.6	14.6	5.0	7.1	6.7	9.7	5.5	9.1	7.4	9.9	5.4	9.1	10.3	8.7	16.2	15.0	9.6	9.6	7.2	14.4	11.9	12.7	6.4	9.8	12.6	7.7	3.9	12.5	5.4	12.5	10.2	8.1	3.9	7.7	6.5	9.4	12.4	6.2	7.3	14.2	12.4	9.7	10.5	17.1	17.6	14.8	9.1	4.9	11.7	12.1	7.1	3.6	8.2	14.0	6.0	18.5	10.2	9.4	6.2	7.6	7.3	6.8	7.6	7.2	5.6	8.3	19.0	15.5	6.6	7.8	8.3	11.1	6.7	11.4	10.6	9.6	16.0	4.9	13.7	4.8	8.7	5.7	5.6	7.4	6.3	4.7	5.2	25.6	5.0	14.6	9.8	7.1	6.7	25.0	26.8	19.3	31.0	23.9	30.0	26.3	12.2	15.6	12.9	11.9	22.9	13.7	12.0	0.0	15.5	0.0	28.1	24.1	13.6	14.0	9.8	27.4	36.5	34.2	2.6	9.7	16.6	0.0	28.6	29.2	3.1	15.0	9.3	15.3	35.2	17.5	10.5	12.9	26.3	4.5	7.2	17.5	0.0	43.3	12.4	10.6	32.6	10.5	6.3	29.8	13.3	0.0	0.0	32.2	21.5	0.0	33.1	15.0	12.5	15.3
BORCS8-MEF2B	MEF2BNB-MEF2B	ENSG00000064489	"BORCS8-MEF2B readthrough"		19	19145567-19192158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	19	"Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 11.1;U-266/70: 11.2"									HPA004734	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (2.74e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.29e-2)"	4.8	3.5	7.0	5.8	7.4	7.4	4.6	5.6	8.6	5.4	5.4	8.1	6.7	3.2	6.7	7.4	5.4	10.5	7.2	3.4	6.8	6.2	7.5	5.9	4.8	7.1	8.0	5.5	9.8	7.8	5.5	4.9	5.0	7.3	5.7	5.5	6.2	5.6	7.2	5.3	8.8	4.0	8.9	5.9	5.8	5.0	5.5	5.8	5.6	5.9	4.9	7.5	5.8	5.8	0.0	0.4	0.6	0.1	0.0	0.3	0.0	1.6	0.0	0.7	1.2	1.0	2.5	1.3	1.1	1.0	1.5	1.5	0.0	3.1	3.4	0.5	0.0	0.5	0.6	0.7	0.6	0.3	0.5	2.5	1.1	0.1	0.3	2.3	0.0	0.2	0.0	2.3	0.7	3.7	0.6	0.4	3.2	0.2	2.0	0.6	3.1	0.7	0.4	0.0	0.0	11.1	3.3	0.9	0.9	0.0	0.2	0.0	1.1	2.0	0.0	0.9	0.1	0.3	0.6	0.3	0.7	1.2	5.7	0.4	11.2	1.7	5.6	2.4	2.7	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	7.0	7.4	5.6	8.6	6.8	6.2	8.0	5.5	7.3	5.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646808-134679813	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 184.7"	"Group enriched"	"Detected in all"	5	"Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 38.0;RT4: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA		69000000	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favorable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favorable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	6.1	7.3	13.6	4.5	11.1	37.7	6.9	11.7	11.6	7.1	6.9	9.1	6.1	4.3	5.4	10.2	14.6	4.7	6.9	7.3	12.5	14.2	19.1	8.1	8.0	5.2	13.9	7.8	5.7	5.4	16.5	14.4	184.7	12.4	7.5	5.4	6.7	10.6	10.3	17.7	5.5	6.0	6.6	15.9	8.6	6.8	7.4	8.8	8.5	7.5	22.2	13.3	24.9	9.5	11.6	10.2	28.2	12.8	9.8	14.5	12.8	4.5	5.5	7.4	9.9	8.5	5.0	7.4	13.7	16.6	5.3	8.0	2.2	6.1	5.5	4.1	7.6	10.6	3.7	7.8	7.5	9.4	38.0	6.8	3.2	5.1	2.5	5.8	6.0	4.2	4.9	6.9	10.0	5.5	8.2	19.3	7.0	9.2	7.0	12.6	2.2	9.8	8.4	7.6	9.3	5.3	7.5	5.3	4.0	12.1	61.1	6.3	10.7	6.3	7.7	6.8	8.2	5.1	3.9	14.7	8.5	2.0	11.4	11.1	11.5	13.2	6.9	14.7	5.8	14.5	28.2	9.8	27.6	14.5	12.8	10.4	11.6	9.5	12.7	10.2	10.5	13.2	13.4	18.0	9.8	12.5	6.7	12.0	12.8	13.6	11.1	11.7	11.6	12.5	14.2	13.9	7.8	12.4	8.8	8.9	26.7	14.4	18.4	34.7	20.3	20.5	15.3	29.4	14.8	26.2	2.0	35.3	109.5	38.4	2.2	11.9	5.1	303.7	15.9	28.0	17.1	21.1	24.3	4.3	13.3	19.1	12.6	8.0	7.3	5.1	9.5	11.3	21.9	19.8	3.8	18.6	36.1	3.5	11.3	47.1	11.6	6.5	24.7	27.9	22.5	11.5	308.5	21.5	4.5	13.7
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 61.6;liver: 47.9"	"Cell type enhanced"	"Detected in many"	12	"Proximal tubular cells: 218.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		NA	NA		13000	Mitochondria		"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favorable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	12.8	9.8	8.4	5.1	12.1	4.0	8.1	6.0	10.1	6.7	19.4	6.3	4.5	19.8	6.1	17.8	8.8	7.1	8.2	6.8	7.5	9.6	61.6	47.9	3.8	4.9	7.8	5.9	5.1	9.8	4.8	8.4	3.7	10.3	5.9	6.4	6.4	8.4	4.1	12.0	6.4	29.1	7.0	6.9	2.7	6.5	7.0	3.8	4.9	4.6	8.8	5.6	6.2	5.6	15.8	13.1	7.3	11.2	11.1	11.7	6.5	13.9	11.0	18.0	16.0	11.3	10.6	8.6	7.1	12.0	15.9	14.0	13.0	15.0	16.6	14.3	11.7	14.8	13.8	16.2	16.5	37.0	19.7	10.5	8.1	8.3	16.8	3.6	10.0	4.4	8.5	7.6	15.6	23.1	9.8	23.3	13.3	7.2	8.5	24.5	20.5	12.2	6.0	13.4	14.7	24.7	12.8	20.2	16.5	12.8	15.8	17.3	13.6	10.6	5.7	27.5	23.1	17.4	4.9	8.2	19.9	16.5	11.8	13.2	7.1	21.6	13.7	4.3	5.8	22.4	7.3	8.7	0.1	7.7	11.2	9.9	15.8	8.9	7.6	13.1	11.8	8.5	11.7	1.0	11.1	6.3	7.3	4.7	6.5	8.4	12.1	6.0	10.1	7.5	9.6	7.8	5.9	10.3	3.8	6.0	9.4	4.7	8.7	7.9	11.6	3.9	35.7	45.5	14.8	15.7	19.6	23.1	59.7	24.9	0.4	7.1	17.1	0.0	11.8	27.7	12.2	7.5	2.3	62.1	19.8	15.9	15.4	3.7	1.8	0.7	13.8	10.5	30.4	21.6	10.1	11.0	17.9	10.8	13.1	218.9	7.2	6.5	9.5	6.7	21.5	8.2	11.7	5.3	16.3	6.8
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007600-33023709	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 218.0;salivary gland: 191.2"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 2.8;Glandular cells: 6.1;Hepatocytes: 1.5;Late spermatids: 7.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	552	"Hep G2: 69.5"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		68000	Vesicles		"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favorable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	191.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.6	218.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3
BPNT1		ENSG00000162813	"3'(2'), 5'-bisphosphate nucleotidase 1"	O95861	1	220057482-220090462	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048461	Approved		Approved	"Nuclear speckles"		NA	NA		170000	"Nuclear speckles"		"HPA048461: AB_2680404"	"unprognostic (6.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.19e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	11.1	24.1	12.7	22.2	17.2	2.9	13.4	13.7	16.5	12.9	27.9	15.9	14.4	30.5	10.6	8.0	14.9	11.5	16.1	11.6	11.3	10.8	31.0	17.0	11.5	21.5	14.0	10.6	13.5	8.6	14.1	20.2	12.7	11.9	9.6	22.5	11.8	22.2	12.2	7.6	10.6	49.0	12.3	17.6	12.0	12.9	10.4	13.3	15.6	13.8	12.6	28.8	13.5	10.4	18.9	10.9	11.6	8.5	12.1	13.8	7.6	11.8	9.8	7.4	5.9	13.2	10.6	11.0	16.0	7.8	13.8	12.8	12.9	24.1	60.2	21.1	10.4	6.4	8.6	14.9	13.4	11.2	21.6	17.3	10.8	12.7	15.9	7.7	28.8	10.2	9.9	6.4	20.4	7.6	8.6	10.8	17.4	18.8	6.0	13.1	6.7	16.5	7.9	6.3	9.6	12.1	11.9	21.3	17.0	17.1	16.3	13.7	11.3	20.2	24.3	13.2	7.5	19.1	10.0	18.0	8.6	6.7	11.9	19.8	10.6	25.5	28.5	7.7	10.8	19.4	11.6	7.8	5.0	11.0	8.5	8.7	18.9	11.3	11.0	9.0	14.1	13.8	10.2	1.1	12.1	7.8	10.9	11.5	7.6	12.7	17.2	13.7	16.5	11.3	10.8	14.0	10.6	11.9	13.3	26.8	19.2	20.8	9.9	3.0	12.5	11.1	15.3	10.7	17.0	14.0	9.8	11.9	11.6	15.3	1.9	4.2	50.6	0.0	13.9	11.4	7.2	5.8	3.5	11.3	8.6	6.4	18.5	4.9	5.7	2.4	8.9	8.3	10.1	7.2	12.6	10.1	15.8	24.6	12.7	21.7	11.2	12.9	6.6	12.5	12.6	4.4	21.1	7.0	15.5	10.7
BRAF	BRAF1	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924928	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001328, CAB004552, HPA071048"	Approved		Approved	Vesicles,Cytosol		No	No			Vesicles	Cytosol	"CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336"	"unprognostic (2.98e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.46e-2)"	13.1	12.1	20.1	16.5	20.4	27.8	14.2	29.9	21.5	12.4	12.3	9.5	12.5	9.3	15.3	17.0	11.8	11.5	12.0	13.6	13.2	12.2	13.7	12.8	15.9	13.3	9.9	17.8	16.8	13.2	28.9	24.8	13.7	15.3	14.5	11.0	10.7	11.6	16.6	12.9	15.6	10.5	13.0	10.9	12.3	12.0	24.9	12.2	13.5	16.6	7.5	12.1	18.6	18.1	2.6	1.9	7.5	2.4	7.0	5.6	1.1	5.5	4.7	6.9	8.3	8.4	11.0	11.1	6.2	6.6	5.0	7.2	5.1	6.0	9.5	4.8	6.4	8.0	3.1	6.1	4.9	9.3	8.8	5.0	6.2	4.6	4.7	7.2	10.0	6.2	7.3	5.6	5.3	11.1	7.4	5.8	7.1	9.7	17.1	8.8	2.9	13.3	10.5	6.4	5.4	3.0	8.7	5.9	7.7	4.9	10.7	8.1	6.8	7.2	4.4	6.5	7.1	4.1	6.8	8.6	5.5	4.2	11.7	5.0	19.8	11.2	15.2	8.9	10.1	5.9	3.3	2.0	7.5	3.1	1.7	2.1	2.6	3.0	2.4	1.6	2.6	5.6	2.8	4.1	7.0	2.4	1.9	2.7	1.1	20.1	20.4	29.9	21.5	13.2	12.2	9.9	17.8	15.3	12.2	20.8	34.2	19.5	20.3	19.2	29.1	12.7	5.1	24.1	25.0	24.4	33.4	12.4	6.6	10.9	55.6	17.1	7.5	0.0	8.6	10.3	13.1	23.9	24.3	8.7	7.9	23.8	18.4	8.6	14.8	30.8	15.3	17.2	15.1	10.0	8.1	11.8	12.5	6.6	9.6	9.6	32.5	6.5	17.3	33.7	23.0	21.0	63.2	17.5	8.1	23.8
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685986	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 224.1;Late spermatids: 273.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: AB_2683827"	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.8	9.9	9.8	7.2	11.6	26.5	9.6	10.0	12.8	8.3	9.3	10.0	8.0	8.6	10.1	7.0	9.4	8.4	7.3	8.8	8.6	8.7	8.4	9.3	7.9	9.7	9.2	8.5	9.7	7.8	9.4	10.4	9.8	12.0	8.3	9.0	6.7	8.9	9.7	19.1	12.7	9.3	9.1	11.1	9.6	7.9	55.9	10.1	12.4	9.5	5.6	10.4	10.2	11.8	12.7	11.7	25.7	13.5	16.6	18.5	11.6	9.9	14.6	12.0	13.7	12.8	10.8	20.0	13.9	11.7	16.2	12.5	19.6	6.9	19.1	8.4	13.1	9.2	12.2	16.7	11.4	17.4	12.2	10.8	23.6	9.1	13.1	16.2	20.7	16.0	12.2	16.2	14.0	22.8	14.0	14.0	13.3	24.5	6.3	13.3	12.5	17.2	20.0	16.1	10.5	15.4	16.0	13.0	17.0	10.7	20.9	14.9	11.0	16.3	13.9	13.6	14.4	15.3	13.2	12.9	10.4	9.7	9.4	9.8	16.1	20.3	21.1	9.9	11.5	11.4	16.1	13.0	24.0	14.7	13.5	14.3	12.7	15.4	14.7	11.7	12.5	14.6	14.8	25.7	16.6	10.6	8.4	18.5	11.6	9.8	11.6	10.0	12.8	8.6	8.7	9.2	8.5	12.0	10.1	20.8	9.1	7.5	8.2	10.0	8.1	10.6	17.8	13.4	10.3	10.4	27.5	11.4	5.0	11.0	224.1	9.3	12.8	0.0	6.6	12.6	8.5	9.9	8.1	7.9	9.3	3.2	9.2	8.6	6.4	273.6	12.4	11.3	3.3	20.8	10.6	7.8	11.8	10.5	12.7	11.9	11.5	6.5	10.7	49.2	33.7	11.0	18.8	10.1	9.3	11.2
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2, DNA repair associated"	P51587	13	32315474-32400266	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.2;testis: 16.9"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 23.3;monocytes: 31.5;Spermatocytes: 75.1;Spermatogonia: 82.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	2.4	1.0	0.6	13.8	0.6	11.6	3.2	0.6	0.6	1.8	4.0	0.2	0.2	1.4	1.5	2.7	3.0	1.0	0.7	2.1	0.6	0.7	1.0	1.4	3.5	5.3	0.7	0.5	1.4	3.3	0.4	0.7	7.0	0.8	0.9	2.0	0.1	1.8	0.3	3.3	1.8	3.2	0.8	2.1	6.6	1.5	16.9	0.1	23.2	0.9	4.8	4.2	1.3	1.7	1.3	1.9	0.4	0.2	1.5	0.8	0.0	4.0	3.5	6.1	4.6	0.6	1.6	6.2	4.3	2.7	5.0	4.6	8.3	5.3	14.2	2.9	2.1	6.9	5.4	5.0	2.5	9.7	9.2	2.7	9.0	2.2	3.2	0.2	12.8	4.5	0.4	0.3	9.2	6.4	0.5	4.1	7.2	5.9	4.9	5.7	4.6	10.3	7.6	7.2	4.6	1.9	10.1	15.7	2.7	1.3	4.3	2.3	4.4	5.2	2.3	2.1	2.2	2.7	6.4	3.2	5.8	6.2	6.4	6.0	1.9	2.9	7.3	3.0	5.1	5.5	0.1	0.2	0.2	0.3	0.2	0.1	0.9	0.4	0.2	0.2	1.3	0.6	0.8	0.4	1.5	0.2	1.9	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.7	0.7	0.5	0.8	0.1	8.9	1.6	1.9	2.8	2.3	0.0	1.6	0.0	4.0	2.3	0.0	0.0	9.1	0.0	1.8	4.3	3.6	1.0	23.3	1.4	9.1	3.5	0.6	3.5	0.8	8.2	0.0	1.2	2.5	6.7	2.5	2.0	13.2	3.3	31.5	3.0	0.2	1.1	1.5	1.1	0.6	0.0	12.9	2.0	75.1	82.4	1.1	4.6	3.8	5.3	1.4
BRD3	"KIAA0043, ORFX, RING3L"	ENSG00000169925	"Bromodomain containing 3"	Q15059	9	134030305-134068535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051830	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA051830: AB_2681627"	"unprognostic (3.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.00e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.42e-1)"	16.3	15.7	18.0	12.0	20.0	12.3	14.2	21.8	21.8	21.0	20.3	26.7	17.3	13.8	21.7	17.4	14.6	17.7	12.6	17.1	19.9	14.8	11.3	14.5	14.6	11.9	15.8	15.8	19.1	18.7	21.8	15.8	15.7	15.6	19.9	10.3	16.6	16.5	22.5	29.2	19.6	12.9	16.3	17.8	20.1	14.8	17.8	18.2	35.4	18.7	9.2	10.3	17.9	14.1	7.3	16.6	14.6	12.9	15.4	11.9	7.8	4.1	12.6	16.1	12.5	8.9	7.3	14.7	4.2	4.8	4.7	4.8	10.5	6.9	1.6	4.5	3.8	5.3	14.4	14.9	5.8	3.7	9.8	8.3	9.0	14.3	11.8	8.0	11.7	8.1	7.8	7.2	5.4	6.2	7.7	7.7	15.1	8.1	4.7	4.8	13.9	21.7	15.8	21.4	10.8	9.8	16.1	23.2	7.8	6.6	4.4	23.6	21.8	18.9	7.2	5.0	10.1	10.3	19.6	9.8	11.6	6.5	7.5	3.7	2.5	2.7	1.4	5.8	8.1	7.6	5.9	12.9	14.5	11.9	9.8	10.0	7.1	9.6	10.6	12.5	7.3	9.1	9.7	14.6	15.4	7.9	16.6	4.4	7.8	18.0	20.0	21.8	21.8	19.9	14.8	15.8	15.8	15.6	18.2	29.8	21.6	14.1	17.5	28.7	54.2	17.9	25.5	24.1	29.6	22.7	35.3	22.4	16.6	37.3	34.3	26.7	15.2	93.5	21.3	17.8	30.4	33.1	16.1	25.1	15.9	54.0	51.9	27.0	25.1	14.1	52.9	20.6	21.9	19.0	24.6	41.9	25.2	21.0	63.3	13.0	54.0	58.2	32.6	13.7	61.1	31.1	27.3	25.8	30.3	14.7
BRF1	"BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90"	ENSG00000185024	"BRF1, RNA polymerase III transcription initiation factor subunit"	Q92994	14	105209286-105315589	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051918, HPA074990"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"HPA051918: AB_2681663, HPA074990: "	"unprognostic (1.98e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.52e-4)"	"unprognostic (2.67e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.25e-6)"	"unprognostic (8.83e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.52e-1)"	12.1	11.8	15.2	11.0	15.9	9.2	8.2	21.7	25.9	10.4	9.6	24.7	11.0	11.8	11.0	7.0	9.1	15.4	10.5	10.6	16.4	19.1	10.0	9.8	11.3	11.2	19.1	14.5	14.4	20.8	18.0	16.6	9.3	18.3	12.1	6.9	13.2	15.8	11.0	21.8	12.4	12.3	12.5	21.2	12.0	10.5	11.1	14.8	9.9	9.7	6.1	9.5	8.9	7.6	3.3	6.4	4.0	7.4	4.9	3.6	2.8	7.3	16.6	7.1	15.6	6.4	7.2	7.5	11.1	6.8	9.5	7.7	11.7	11.3	5.8	10.9	7.2	4.6	15.0	8.5	7.1	5.2	15.7	9.4	6.8	8.6	5.4	7.2	8.1	15.0	6.9	5.9	5.7	7.0	4.8	6.8	11.8	8.1	4.4	4.6	22.9	9.5	10.3	5.4	12.2	17.9	17.1	5.0	5.7	4.7	17.9	23.1	17.2	11.1	8.8	9.4	3.5	20.2	11.3	10.0	7.4	6.4	13.9	8.5	8.9	6.7	5.3	8.9	6.7	10.0	0.7	2.3	4.0	3.6	2.2	2.5	3.2	2.5	3.5	2.5	3.3	3.4	2.9	1.0	4.9	7.4	6.4	3.1	2.8	15.2	15.9	21.7	25.9	16.4	19.1	19.1	14.5	18.3	14.8	3.0	5.1	5.9	5.9	6.6	16.4	7.2	2.5	12.0	6.8	3.5	15.7	10.2	3.3	5.0	1.9	6.8	8.6	0.0	6.0	7.4	6.6	6.4	2.3	10.2	6.1	28.6	9.2	9.8	5.4	0.7	6.1	6.4	8.5	4.6	10.2	8.3	4.2	7.0	4.2	5.6	18.4	0.0	7.3	7.0	13.6	7.8	7.8	10.7	9.0	4.1
BRI3BP	"BNAS1, HCCR-2, HCCRBP-3, KG19"	ENSG00000184992	"BRI3 binding protein"	Q8WY22	12	124993700-125031231	"Predicted membrane proteins, Transporters"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;U-698: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014957	Approved		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA014957: AB_1845447"	"unprognostic (1.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.44e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.55e-1)"	3.8	3.2	10.8	12.6	13.7	4.7	6.8	13.4	16.0	3.8	16.8	8.8	2.4	22.5	2.9	3.0	10.7	5.0	9.8	3.0	11.0	10.8	8.3	7.5	3.4	14.2	10.9	10.3	2.2	11.2	9.8	4.0	2.6	10.5	3.8	17.8	4.7	4.1	3.1	2.0	8.0	21.8	3.3	12.6	7.3	9.0	2.6	7.7	11.1	5.4	4.5	17.8	3.6	4.3	2.4	5.7	9.5	2.5	1.5	1.2	0.7	9.4	12.5	4.6	4.3	4.0	2.1	5.0	6.7	1.5	4.0	1.9	7.9	6.5	38.1	7.9	1.7	2.8	11.7	10.8	6.0	3.9	7.0	5.9	17.5	5.6	7.1	0.7	25.4	22.0	0.9	3.5	4.7	2.6	1.9	1.7	13.9	6.0	2.2	4.2	10.1	13.0	11.4	2.5	10.3	4.9	8.3	7.7	8.3	6.2	14.5	6.2	4.0	8.2	9.0	3.0	1.6	16.0	21.0	2.0	3.6	3.8	3.8	6.7	7.4	13.3	46.8	3.8	9.5	9.8	4.5	2.5	9.5	1.2	1.7	1.1	1.8	0.9	0.9	2.4	2.4	0.8	1.2	3.8	1.5	1.6	5.7	0.8	0.7	10.8	13.7	13.4	16.0	11.0	10.8	10.9	10.3	10.5	7.7	8.9	7.2	26.7	7.9	10.9	35.5	6.3	45.9	8.1	5.7	8.7	13.7	8.8	3.3	9.0	23.9	3.0	55.2	0.0	9.2	18.3	5.5	8.0	18.4	25.2	17.3	23.8	7.5	3.7	28.3	128.6	1.1	15.5	10.1	3.6	39.6	13.2	14.1	35.1	3.9	10.9	25.6	0.0	5.9	0.9	8.1	15.9	4.3	8.7	67.9	7.8
BRICD5	"C16orf79, MGC21830"	ENSG00000182685	"BRICHOS domain containing 5"	Q6PL45	16	2209253-2211950	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 29.7;testis: 42.8"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 10.7;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 11.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 29.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA063522			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Actin filaments"	Nucleoplasm	"HPA063522: AB_2685029"	"prognostic favorable (9.74e-4)"	"unprognostic (7.12e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.34e-3)"	"unprognostic (7.56e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (8.06e-5)"	2.0	4.0	3.2	3.7	4.9	3.0	2.0	29.7	5.3	2.0	2.0	2.0	2.0	5.4	2.8	2.0	2.0	1.6	2.0	2.9	3.5	4.4	2.9	2.0	2.1	4.6	3.1	2.8	2.0	3.0	2.2	3.6	2.9	2.5	2.4	0.5	9.9	3.7	4.0	9.1	2.7	5.2	2.0	3.3	6.3	2.7	42.8	2.0	2.4	6.1	2.0	2.0	2.0	2.0	0.8	0.6	2.3	0.8	0.8	1.7	0.4	2.8	5.6	7.7	4.4	1.2	1.3	14.1	2.7	0.5	1.5	2.3	7.1	7.0	1.6	1.8	0.5	1.8	7.6	1.0	1.0	1.1	5.2	3.4	1.7	13.4	1.8	0.7	0.7	4.4	1.5	2.1	2.3	0.5	2.3	0.9	6.4	1.9	4.0	0.6	7.6	4.8	10.8	7.5	0.9	3.2	14.8	5.8	5.0	1.7	2.2	5.4	4.9	2.7	3.4	2.6	3.7	3.4	4.0	2.2	7.4	6.0	6.4	2.3	12.1	5.2	4.0	1.4	4.5	3.5	0.4	0.7	2.2	0.6	0.8	0.3	0.3	0.3	0.1	0.6	0.8	1.7	0.4	2.3	0.8	0.2	0.4	0.4	0.4	3.2	4.9	29.7	5.3	3.5	4.4	3.1	2.8	2.5	2.0	3.0	4.1	0.0	0.5	0.3	10.7	0.4	0.0	4.0	0.0	5.2	23.6	1.6	0.0	0.8	2.1	1.1	1.8	0.0	0.5	0.7	1.0	0.8	4.6	1.0	1.1	4.8	1.2	1.8	2.2	5.9	1.1	2.5	1.7	1.0	1.2	4.3	0.7	0.0	2.5	0.3	11.0	0.0	0.5	3.9	1.9	1.0	0.7	0.0	2.3	0.4
BRK1	"C3orf10, HSPC300, MDS027"	ENSG00000254999	"BRICK1, SCAR/WAVE actin nucleating complex subunit"	Q8WUW1	3	10115592-10127190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 1965.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060391			Approved	"Nuclear speckles,Cell Junctions"		NA	NA		130000	"Nuclear speckles"	"Cell Junctions"	"HPA060391: AB_2684272"	"unprognostic (4.99e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.60e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.75e-3)"	67.1	47.6	53.4	40.4	57.1	52.4	62.9	33.4	69.5	52.8	58.6	36.1	47.3	37.9	63.2	68.3	73.0	59.4	70.8	54.4	42.6	45.3	66.8	57.3	49.3	53.2	43.3	53.6	62.7	57.8	38.8	39.2	44.4	40.7	60.8	51.8	41.5	84.2	53.1	62.7	57.0	46.5	74.3	37.2	47.0	57.2	65.2	34.2	50.2	83.3	62.4	64.8	63.0	61.0	67.4	89.7	76.1	75.4	47.2	61.0	89.1	30.6	36.8	39.2	20.4	65.7	71.8	93.0	45.7	45.6	42.9	42.7	25.2	36.1	35.4	21.8	52.5	37.7	16.1	28.2	46.3	47.1	39.0	39.0	48.8	42.5	37.6	37.4	46.4	37.0	47.1	44.8	48.0	35.0	56.6	59.9	29.9	31.6	41.5	64.7	67.4	30.0	37.2	45.2	43.7	46.7	29.1	40.4	38.4	56.4	50.9	15.2	26.5	36.7	32.1	36.9	40.8	52.1	40.7	54.0	43.3	33.1	50.5	40.6	23.9	64.1	79.8	62.6	63.8	35.5	54.1	75.4	75.9	56.5	72.4	50.3	67.4	55.0	53.1	84.3	67.4	50.1	54.4	76.1	47.2	70.9	89.7	61.0	89.1	53.4	57.1	33.4	69.5	42.6	45.3	43.3	53.6	40.7	34.2	59.6	65.2	192.9	249.1	234.3	35.8	112.3	242.0	80.3	80.8	193.7	19.6	217.7	417.8	328.3	849.5	294.2	166.8	93.5	317.6	231.0	237.3	296.5	172.8	204.5	385.0	44.5	286.9	207.5	335.1	1965.9	229.0	331.9	335.8	527.6	186.8	106.0	371.4	168.4	238.6	736.5	29.7	232.8	294.2	162.6	168.0	275.8	178.3	223.7	210.0	344.6
BRMS1	DKFZP564A063	ENSG00000174744	"Breast cancer metastasis suppressor 1"	Q9HCU9	11	66337333-66345125	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010824, HPA019637"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB010824: , HPA019637: AB_1845448"	"unprognostic (1.75e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.54e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-1)"	17.2	18.9	16.7	23.4	24.5	37.0	20.5	9.1	18.7	13.7	19.7	14.5	24.7	21.0	14.6	21.0	24.1	16.1	26.0	13.7	16.6	10.7	23.4	22.2	16.7	25.8	20.1	16.1	14.0	37.6	17.6	12.6	24.1	17.6	22.3	16.0	12.8	23.9	29.8	24.2	26.1	22.6	13.0	16.2	26.3	19.6	37.4	20.9	25.3	20.8	29.3	21.4	16.2	17.5	38.5	32.1	50.7	38.0	22.2	37.2	28.9	24.3	32.0	10.8	17.9	11.4	11.9	15.3	16.8	18.7	30.8	20.7	26.0	16.1	16.5	25.4	16.7	26.5	28.7	20.4	31.0	14.6	19.5	17.1	15.0	17.1	18.9	21.4	21.6	17.6	13.4	33.5	31.0	23.3	9.4	18.9	19.0	17.8	7.7	18.3	39.3	26.3	51.6	23.3	18.8	30.1	22.4	19.8	30.8	19.1	14.2	22.8	18.2	21.1	21.8	54.7	8.2	26.5	13.4	18.2	23.2	22.0	37.3	21.0	16.1	15.9	26.0	30.0	14.1	24.8	19.0	38.0	36.7	31.1	36.2	33.2	38.5	33.5	29.6	29.8	36.1	29.7	28.0	50.7	22.2	31.0	32.1	37.2	28.9	16.7	24.5	9.1	18.7	16.6	10.7	20.1	16.1	17.6	20.9	14.9	30.6	46.9	25.5	51.6	11.5	10.0	17.8	17.4	12.5	21.0	5.9	54.6	46.4	61.5	6.7	28.3	88.9	0.0	102.0	57.3	30.9	28.6	26.6	20.7	59.9	11.1	31.0	30.1	40.2	7.0	20.8	37.7	27.0	83.8	36.7	20.9	69.1	63.1	13.8	40.4	11.8	6.5	31.9	20.1	44.3	52.4	60.0	52.2	41.2	26.4
BROX	"C1orf58, FLJ32421"	ENSG00000162819	"BRO1 domain and CAAX motif containing"	Q5VW32	1	222712553-222735196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		190000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA031445: AB_10602697"	"unprognostic (1.27e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.50e-2)"	24.0	21.1	22.7	15.7	25.3	33.0	22.2	21.6	24.9	17.8	23.6	22.0	13.8	19.8	18.2	15.6	30.1	17.7	18.3	14.9	22.5	20.2	22.6	21.0	18.5	22.7	30.2	22.7	21.4	16.2	28.3	21.8	28.1	29.6	17.0	23.7	11.8	21.3	17.9	23.7	23.5	33.0	16.8	27.5	22.9	23.2	12.6	30.1	24.4	25.0	22.5	19.7	21.1	19.8	8.8	13.4	30.9	21.7	14.2	15.3	8.5	25.6	15.4	9.5	8.3	13.9	14.8	18.5	17.6	22.1	14.5	16.7	8.6	33.6	8.5	21.2	21.8	7.9	22.6	10.6	16.9	22.2	10.6	9.5	12.7	17.2	8.5	15.7	14.5	12.1	13.0	16.7	18.1	21.6	16.6	13.1	5.6	19.2	11.7	17.8	7.7	6.1	7.5	12.0	21.1	18.4	6.4	28.9	19.1	17.2	25.6	10.7	16.9	19.3	22.2	13.1	9.5	26.9	14.9	18.9	20.0	11.6	20.6	19.9	8.8	14.7	7.7	16.2	12.3	18.2	30.9	15.8	18.3	12.0	21.7	13.3	8.8	15.3	12.0	13.4	8.3	10.3	13.0	27.3	14.2	21.0	7.5	13.8	8.5	22.7	25.3	21.6	24.9	22.5	20.2	30.2	22.7	29.6	30.1	68.5	33.2	19.3	26.5	43.0	16.4	34.1	30.6	77.6	30.7	48.8	7.9	23.9	48.0	33.6	16.0	24.8	34.2	46.7	28.3	27.0	25.7	39.8	15.1	22.1	32.3	33.4	30.6	33.7	50.9	16.7	22.5	40.8	47.2	35.1	45.9	31.0	43.0	40.3	30.1	41.6	19.5	51.8	26.8	21.8	22.2	40.8	43.1	43.7	38.4	39.3
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	9.6	21.8	11.9	12.3	11.7	12.3	25.8	22.4	16.7	11.9	15.2	10.9	28.3	13.5	16.0	13.4	9.5	10.8	10.6	10.9	10.3	9.1	15.9	16.5	9.6	7.7	10.4	11.7	15.2	20.8	18.1	18.8	8.7	7.4	15.2	15.3	8.0	16.5	31.0	22.9	14.5	17.0	12.2	9.8	9.8	12.4	22.9	11.8	11.8	18.3	4.4	7.1	13.9	22.3	0.8	0.5	3.0	0.2	0.1	2.0	0.6	6.7	6.5	16.4	12.8	9.1	7.7	14.0	10.2	10.8	14.4	11.4	19.0	6.4	10.5	11.0	10.0	18.2	6.6	14.4	7.3	12.7	9.9	8.9	7.4	6.0	11.2	9.6	5.7	10.4	9.8	6.3	17.1	8.6	10.5	10.7	5.1	15.4	9.7	7.8	9.6	6.5	2.5	8.2	8.3	5.6	19.1	6.7	3.2	4.7	13.9	23.5	7.4	8.3	9.1	8.7	10.6	10.2	15.9	11.2	15.1	12.9	4.1	11.8	8.0	10.3	7.9	2.5	9.2	17.7	3.0	0.2	1.4	1.9	0.2	2.0	0.8	0.5	0.6	0.2	0.4	0.9	0.6	1.5	0.1	0.1	0.5	1.2	0.6	11.9	11.7	22.4	16.7	10.3	9.1	10.4	11.7	7.4	11.8	6.0	10.1	2.9	6.8	8.5	10.1	10.9	12.7	2.7	5.7	5.2	5.9	4.2	0.0	4.7	13.2	7.1	15.1	0.0	9.2	3.7	9.5	10.3	2.3	16.6	3.7	0.0	18.9	11.6	5.0	10.4	10.3	2.5	6.8	5.4	26.5	4.3	10.0	10.5	8.9	11.4	6.7	0.0	6.2	17.9	12.2	9.9	6.9	4.3	13.9	8.4
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 30.8;Enterocytes: 12.3;Horizontal cells: 36.5"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.2;SH-SY5Y: 23.6;WM-115: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.4	9.8	28.6	3.2	23.6	1.0	1.6	26.7	65.0	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3.0	2.3	3.9	6.5	33.4	20.0	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11.0	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1.0	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0.0	3.0	0.0	1.6	3.2	0.7	0.0	0.3	0.0	0.9	0.1	0.8	0.2	0.3	1.3	15.5	8.2	0.0	0.6	0.1	2.4	3.4	3.3	4.9	5.9	2.7	3.1	1.7	2.8	3.1	0.1	3.2	0.1	3.1	14.6	12.8	2.0	1.6	0.6	3.3	0.6	6.0	2.2	0.3	3.4	0.0	12.9	0.1	8.2	2.8	19.1	3.0	0.8	3.7	0.7	11.2	0.3	1.0	8.5	3.9	0.5	0.2	0.0	26.2	23.6	0.0	0.4	5.7	4.6	1.3	1.7	0.0	6.4	6.8	3.5	4.6	15.8	11.6	7.1	6.5	1.4	21.4	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	28.6	23.6	26.7	40.2	33.4	20.0	20.4	14.8	13.3	7.2	0.0	2.2	0.0	1.0	0.1	30.8	0.8	0.0	0.0	1.2	1.8	2.0	0.0	0.0	0.3	0.8	0.3	12.3	0.0	0.0	0.0	0.5	0.8	0.0	0.0	1.4	36.5	3.4	0.0	7.8	0.0	0.6	0.4	0.0	0.0	1.0	3.2	0.2	0.0	4.6	0.8	10.2	0.0	1.0	3.9	6.5	0.0	0.0	0.8	1.2	0.1
BRSK2	"C11orf7, PEN11B, STK29"	ENSG00000174672	"BR serine/threonine kinase 2"	Q8IWQ3	11	1389899-1462689	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 34.9;pancreas: 78.8"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 79.7;Cone photoreceptor cells: 33.4;Horizontal cells: 65.2;Muller glia cells: 24.5;Rod photoreceptor cells: 27.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;AN3-CA: 9.9;CACO-2: 7.9;HAP1: 7.4;NTERA-2: 15.3;SCLC-21H: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073690			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA073690: "	"unprognostic (5.47e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.42e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.17e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.86e-1)"	1.5	3.5	13.6	1.5	12.8	1.3	1.3	30.8	34.9	1.3	1.5	10.0	0.0	1.7	1.4	1.3	1.3	1.4	1.9	1.5	15.6	10.6	1.4	1.3	1.4	1.3	8.3	17.2	1.4	78.8	1.6	4.6	1.8	9.5	1.6	1.4	2.2	1.6	1.4	1.5	1.5	1.9	1.4	6.5	1.3	1.9	5.5	9.2	0.0	1.9	0.0	1.3	1.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	4.0	9.1	9.9	0.1	0.3	0.0	0.1	0.1	0.7	0.3	7.9	0.5	0.0	1.4	0.1	0.1	0.0	7.4	0.0	0.6	0.9	3.9	0.0	0.0	0.1	0.4	0.0	0.3	0.1	0.0	0.0	0.9	0.2	0.0	0.3	0.1	0.0	0.1	0.9	0.0	0.0	15.3	2.7	1.2	0.0	0.0	0.0	0.1	0.1	35.8	5.3	1.8	0.1	2.5	0.2	0.2	0.4	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	13.6	12.8	30.8	23.3	15.6	10.6	8.3	17.2	9.5	9.2	0.0	0.0	0.0	0.1	0.2	79.7	2.2	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.0	0.2	65.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	24.5	0.5	0.0	1.1	0.0	27.0	6.5	8.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	10.9	16.7	33.0	15.4	36.8	13.4	16.3	15.5	40.2	12.3	12.0	14.3	10.5	8.8	13.0	21.1	10.2	11.8	9.9	12.9	29.1	32.9	13.9	21.8	10.0	12.9	24.3	17.7	16.2	17.2	12.8	12.0	15.2	13.4	13.2	11.5	13.0	9.3	11.8	14.6	11.9	9.6	13.1	16.1	9.6	9.9	17.2	10.5	22.4	17.7	9.3	13.2	12.1	11.6	8.5	7.2	11.6	6.1	10.2	11.1	3.8	10.2	4.1	10.1	5.6	6.5	9.8	10.4	5.9	6.9	4.6	5.4	3.9	7.0	32.9	6.2	8.0	5.5	5.1	9.4	6.8	7.3	7.6	7.7	22.3	7.2	7.1	8.2	12.3	6.3	6.7	11.2	6.3	16.0	10.7	6.8	21.0	16.5	16.6	6.4	7.9	8.4	14.5	10.6	12.4	5.8	14.9	7.8	10.4	5.6	6.6	8.0	10.3	12.6	15.2	8.7	3.9	12.9	17.2	7.5	6.1	2.9	3.5	4.4	18.5	12.7	16.0	7.3	13.2	4.8	4.4	5.2	11.6	10.7	6.1	8.3	8.5	9.2	11.0	7.2	6.3	11.1	9.0	5.7	10.2	3.8	6.8	10.3	3.8	33.0	36.8	15.5	40.0	29.1	32.9	24.3	17.7	13.4	10.5	44.7	40.4	19.5	36.5	56.1	63.7	54.9	17.8	49.5	39.8	17.4	110.0	50.0	38.1	24.8	41.9	37.6	30.2	23.3	30.0	38.8	37.9	51.4	31.3	31.6	22.1	69.9	34.0	33.2	35.6	16.8	40.0	27.5	28.7	23.4	35.9	35.9	32.0	28.1	42.1	28.1	103.4	25.8	37.3	85.4	77.1	61.5	83.5	38.9	34.2	55.4
BRWD3	"FLJ38568, MRX93"	ENSG00000165288	"Bromodomain and WD repeat domain containing 3"	Q6RI45	X	80670854-80809688	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012802	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012802: AB_2066662"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.17e-3)"	"unprognostic (7.04e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-1)"	7.7	5.7	7.5	9.1	7.7	10.5	13.0	20.9	8.5	9.3	8.2	5.6	8.6	8.5	8.0	6.2	10.8	8.1	6.3	5.0	7.4	4.6	5.6	7.5	12.7	9.3	5.3	5.5	11.9	7.8	7.3	12.5	8.6	6.5	6.7	8.1	7.7	8.2	11.3	3.7	14.0	10.3	5.8	12.7	8.9	7.3	9.3	7.1	10.1	9.0	6.0	9.1	10.7	12.7	1.1	0.7	2.8	1.1	0.5	1.2	0.5	4.6	5.1	7.7	5.1	3.1	3.9	5.6	2.7	2.4	3.5	4.8	2.3	6.5	5.0	6.4	2.5	4.3	8.3	11.8	4.6	4.7	4.3	4.8	10.2	8.2	3.5	2.3	5.8	6.9	2.6	3.2	4.0	5.5	5.1	5.3	4.5	7.4	12.7	4.0	0.8	3.3	5.4	11.8	5.1	2.1	3.0	13.5	2.9	4.0	4.0	1.8	4.4	6.6	3.6	2.9	15.1	1.6	5.7	4.8	4.1	5.2	3.8	2.9	5.6	5.9	6.0	3.3	11.8	2.7	0.5	1.1	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.6	1.1	0.6	1.2	2.8	0.5	0.8	0.7	0.6	0.5	7.5	7.7	20.9	8.5	7.4	4.6	5.3	5.5	6.5	7.1	11.9	11.2	7.5	6.9	15.5	23.2	7.7	15.3	4.0	18.2	5.2	15.7	4.9	0.0	5.3	0.9	10.5	12.9	0.0	5.2	6.5	8.2	9.4	10.5	5.8	4.7	58.8	6.9	5.5	10.3	3.0	9.2	12.7	1.7	1.8	10.2	10.8	8.4	21.0	9.6	3.1	21.0	6.5	7.6	6.6	8.3	18.2	6.4	10.0	10.2	19.5
BSDC1	"FLJ10276, RP4-811H24.7"	ENSG00000160058	"BSD domain containing 1"	Q9NW68	1	32365103-32394731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 36.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 36.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031358, HPA031360"	Approved		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Plasma membrane"	"HPA031358: AB_2673841, HPA031360: AB_10601120"	"unprognostic (1.42e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.82e-5)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.07e-1)"	21.9	34.7	30.5	16.8	33.9	45.6	22.8	44.0	41.2	20.7	20.5	34.4	30.8	20.7	25.9	36.8	19.9	22.5	23.4	19.6	27.7	27.1	20.1	41.4	19.6	16.6	27.8	27.2	32.0	37.1	44.5	26.4	28.1	32.5	24.8	24.3	22.2	30.4	21.2	19.0	25.1	23.9	22.8	28.9	20.1	21.4	40.4	27.3	16.2	23.9	16.1	20.3	19.5	19.8	8.4	6.8	36.4	5.8	5.2	6.8	5.4	17.5	9.5	19.6	18.2	28.0	23.5	15.9	20.1	27.4	25.6	25.8	13.9	16.2	12.7	23.1	29.1	18.7	16.2	15.4	15.1	20.5	24.2	19.5	10.2	17.9	15.8	26.1	12.8	17.6	23.7	33.8	23.3	16.2	31.3	22.0	17.4	27.4	21.9	18.4	9.2	14.9	11.5	17.2	13.2	15.4	12.3	14.8	17.1	18.7	13.6	28.7	15.8	18.8	19.6	19.2	30.9	15.8	11.3	21.9	16.1	13.6	22.3	16.9	24.8	29.4	9.3	20.7	14.0	12.0	36.4	4.9	17.2	6.5	5.8	6.8	5.9	5.8	5.4	4.6	8.4	6.8	5.9	8.1	5.2	5.1	6.8	6.1	5.4	30.5	33.9	44.0	41.2	27.7	27.1	27.8	27.2	32.5	27.3	29.8	15.2	36.9	49.2	25.2	48.7	17.1	35.7	14.7	10.3	24.4	78.5	42.9	16.6	31.5	87.7	26.6	52.4	70.0	38.4	26.0	26.1	51.5	20.7	49.0	18.0	81.0	38.5	52.8	18.7	78.5	50.6	15.3	30.4	26.2	43.0	35.7	38.9	31.6	44.6	22.6	66.5	38.8	25.9	28.6	41.1	22.6	80.7	37.0	35.7	42.7
BSG	"CD147, EMMPRIN, OK"	ENSG00000172270	"Basigin (Ok blood group)"	P35613	19	571277-583493	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 1238.9;Syncytiotrophoblasts: 1384.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB002427, HPA036048, HPA074870"	Enhanced		Approved	Vesicles		NA	NA		3400000	Vesicles		"CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719"	"unprognostic (1.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.53e-3)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.54e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.61e-2)"	"prognostic favorable (1.95e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-1)"	53.0	74.8	60.0	33.3	73.0	86.3	42.3	36.2	103.0	41.7	93.4	57.8	37.3	50.1	56.0	62.2	35.1	48.8	52.0	205.8	58.5	45.9	78.5	39.1	36.1	22.6	57.6	44.0	51.3	64.2	28.2	48.2	96.2	57.9	49.5	39.6	109.4	44.0	48.4	97.4	38.1	45.5	52.9	34.9	28.3	63.9	76.8	30.4	31.8	61.9	45.9	31.2	48.5	31.5	22.0	43.8	89.4	58.7	30.9	44.5	65.5	63.3	85.6	40.8	91.7	121.6	52.3	86.8	52.8	66.0	63.7	55.5	68.2	68.7	22.7	61.3	47.7	17.4	103.5	41.4	64.1	22.1	47.7	88.7	15.6	72.4	92.2	76.9	37.7	73.6	54.4	65.1	36.6	40.9	76.8	45.7	21.3	73.5	107.6	37.4	113.8	27.4	72.3	95.8	41.1	43.8	55.2	33.4	74.9	75.3	47.6	63.4	57.6	109.6	44.2	78.3	38.1	46.4	116.6	50.2	61.2	38.9	101.3	79.6	69.4	69.8	21.6	116.0	52.3	75.7	32.0	58.7	62.0	44.5	45.2	39.5	22.0	30.2	42.6	39.9	18.3	23.1	29.1	89.4	30.9	48.3	43.8	35.1	65.5	60.0	73.0	36.2	103.0	58.5	45.9	57.6	44.0	57.9	30.4	20.8	26.9	96.8	148.3	185.3	141.6	73.6	104.4	61.6	43.3	272.2	192.4	1238.9	124.3	507.3	196.9	200.0	714.8	607.3	327.4	909.7	249.5	169.5	116.3	84.7	379.2	131.9	245.0	132.0	136.1	473.6	278.2	146.3	480.8	346.3	224.4	452.0	369.5	480.7	316.4	241.2	167.7	200.5	269.3	259.3	553.8	137.0	1384.0	132.0	328.6	155.8
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318413-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 61.8"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 4.6;Peritubular cells: 3.9;Suprabasal keratinocytes: 6.8;Urothelial cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 19.3;Hep G2: 10.2;MOLT-4: 12.9;PC-3: 9.1;RT4: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055898: AB_2682964, HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.9	1.1	3.7	2.4	6.6	3.3	2.7	4.6	10.2	6.8	1.0	2.2	3.2	1.1	1.3	1.5	24.1	0.8	1.2	1.0	2.9	9.4	3.7	1.4	1.0	4.0	8.3	3.0	0.6	1.2	61.8	3.2	2.0	19.0	3.1	1.0	1.7	6.2	1.6	0.9	8.4	1.6	1.0	4.9	1.5	1.0	1.1	1.2	24.8	14.4	9.5	9.0	2.3	7.9	0.3	1.3	2.8	0.8	0.3	7.2	1.2	0.1	19.3	3.9	0.0	1.5	0.4	0.0	0.4	0.0	0.2	0.0	0.2	3.1	0.0	4.8	0.1	1.8	7.0	3.9	7.3	0.2	0.0	1.2	0.0	0.1	10.2	0.0	0.1	0.0	1.6	3.1	0.0	2.3	3.0	0.5	8.0	0.0	0.0	0.1	0.6	12.9	1.5	4.0	0.4	9.1	0.0	6.2	0.0	0.0	8.7	5.0	1.9	0.0	0.2	0.0	0.4	0.4	0.5	0.8	0.0	0.2	0.0	1.5	0.0	0.0	0.0	5.1	2.0	0.0	1.3	0.8	1.1	2.1	0.3	7.2	0.1	2.4	1.4	1.3	0.3	3.0	2.7	2.8	0.3	0.6	0.2	1.1	1.2	3.7	6.6	4.6	10.2	2.9	9.4	8.3	3.0	19.0	1.2	0.0	0.0	0.0	3.1	4.6	1.0	1.7	0.0	0.0	3.4	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.8	0.0	0.5	0.3	1.6	3.4	0.0	0.8	0.0	0.6	2.0	0.0	0.0	0.0	0.3	0.2	0.0	3.9	0.6	0.3	0.0	1.1	0.0	0.0	6.8	0.3	0.0	0.0	3.8
BTBD6	BDPL	ENSG00000184887	"BTB domain containing 6"	Q96KE9	14	105248490-105251093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031355	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031355: AB_10611812"	"prognostic favorable (1.11e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.25e-4)"	"unprognostic (8.48e-3)"	"prognostic favorable (6.51e-5)"	"unprognostic (6.55e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.86e-2)"	"unprognostic (9.85e-2)"	25.9	9.4	19.9	9.4	17.7	11.8	53.4	18.1	27.0	13.6	14.6	5.4	15.2	14.1	9.9	14.7	17.4	11.4	13.6	19.8	17.9	12.9	9.7	12.3	17.7	11.3	11.3	15.9	13.1	5.6	7.7	12.4	7.7	9.5	13.1	11.7	11.6	20.5	12.6	73.0	19.4	14.3	14.4	6.1	9.3	13.7	24.7	6.2	8.2	9.3	31.3	10.6	11.5	22.3	2.4	2.7	4.6	1.6	0.6	8.1	1.1	17.7	14.3	7.8	20.7	25.2	17.6	0.0	16.5	15.0	25.6	17.5	11.1	16.4	5.6	10.1	24.0	5.3	24.0	15.0	15.9	12.7	14.5	12.2	4.1	20.8	0.0	17.3	12.5	8.0	18.2	22.0	11.8	9.6	10.0	20.4	19.0	0.0	0.1	13.6	25.3	13.1	5.1	3.3	16.9	24.7	14.2	0.0	5.2	9.7	19.7	12.9	5.5	15.5	12.5	12.2	5.7	25.6	16.1	13.6	20.7	0.5	30.2	20.4	3.7	5.0	2.7	21.3	5.8	16.0	0.6	1.1	4.6	4.1	1.6	4.0	2.4	4.3	4.2	1.1	1.3	3.3	2.3	0.7	0.6	1.2	2.7	8.1	1.1	19.9	17.7	18.1	27.0	17.9	12.9	11.3	15.9	9.5	6.2	23.8	18.7	1.5	22.6	10.4	23.3	21.0	17.8	20.1	21.6	10.4	5.9	2.2	18.3	5.1	9.8	13.5	20.8	0.0	0.0	3.1	9.6	22.7	24.3	12.8	6.7	19.1	19.5	9.8	7.6	25.6	8.6	8.9	11.8	2.8	24.7	14.8	0.8	14.4	7.1	7.8	16.4	12.9	8.2	8.9	7.9	11.0	1.8	7.5	16.9	20.0
BTBD7	"FLJ10648, FUP1"	ENSG00000011114	"BTB domain containing 7"	Q9P203	14	93237550-93333092	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049926, HPA053406"	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA049926: AB_2680956, HPA053406: AB_2682137"	"unprognostic (3.36e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.69e-6)"	"unprognostic (7.27e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.52e-2)"	11.1	8.4	10.2	11.0	11.6	11.8	9.9	14.1	11.6	11.9	10.4	14.3	10.9	8.2	11.4	8.0	13.2	10.9	10.8	9.6	8.9	5.4	13.3	8.7	10.6	7.5	10.1	7.8	11.6	10.1	26.1	10.2	18.0	10.3	9.2	10.5	8.0	10.8	10.3	13.0	11.3	12.0	11.0	7.4	9.5	8.9	20.0	10.7	9.1	15.4	6.7	9.1	13.5	15.5	1.6	1.7	4.4	1.3	0.5	1.5	0.2	7.5	5.8	7.3	3.9	5.8	7.7	10.5	6.7	6.6	6.0	4.7	5.2	6.5	3.9	5.2	9.9	4.4	7.3	7.1	14.9	10.1	4.6	3.1	4.1	4.4	3.8	2.9	7.0	4.7	6.4	4.6	7.4	8.7	5.4	9.4	3.0	3.9	5.1	8.6	6.7	2.8	2.0	4.7	5.4	7.5	8.0	10.9	1.9	9.2	25.1	9.2	5.6	7.4	3.4	3.2	7.7	6.8	4.8	12.6	5.8	5.6	5.3	5.0	4.0	3.4	4.7	5.2	3.6	6.8	3.1	0.7	4.4	1.4	0.7	0.4	1.5	1.0	1.3	0.6	1.6	0.9	1.0	1.8	0.5	1.3	1.7	1.5	0.2	10.2	11.6	14.1	11.6	8.9	5.4	10.1	7.8	10.3	10.7	47.6	23.0	18.2	23.5	28.7	25.9	17.8	33.1	18.7	14.8	52.4	35.3	18.3	11.6	27.9	34.8	35.0	22.6	0.0	21.2	18.5	27.2	36.7	24.3	15.1	15.3	25.4	27.6	43.6	27.3	37.7	21.9	21.1	10.1	33.3	22.7	29.5	33.2	23.0	37.1	32.3	29.0	12.9	43.2	24.5	32.1	32.2	25.6	19.8	24.7	62.6
BTBD9	"dJ322I12.1, KIAA1880"	ENSG00000183826	"BTB domain containing 9"	Q96Q07	6	38168451-38640148	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041930	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041930: AB_10795270"	"unprognostic (4.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.64e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.76e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (4.20e-13)"	"unprognostic (1.35e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.15e-2)"	5.3	6.6	17.9	5.4	23.9	9.1	5.1	9.8	20.4	5.7	6.6	7.8	7.1	6.3	7.2	5.4	7.8	13.0	7.5	9.2	15.6	11.5	8.4	3.8	12.5	7.4	8.9	13.7	11.5	4.8	28.6	12.9	5.6	10.5	6.8	7.8	7.0	5.3	6.4	7.8	7.4	8.7	6.8	6.1	5.3	5.7	10.2	7.7	4.1	8.5	3.0	7.6	7.5	5.2	5.2	3.9	12.7	5.5	5.0	5.6	2.6	5.9	5.1	8.1	10.1	6.0	8.4	5.8	6.4	8.4	7.0	7.5	6.0	3.5	3.7	4.2	9.6	9.5	4.3	4.4	9.1	8.3	10.3	8.7	7.8	5.2	2.6	4.7	7.9	16.2	6.4	6.9	9.5	9.0	6.4	12.0	6.7	3.8	6.1	7.0	3.7	5.6	2.8	2.1	6.1	4.4	3.3	5.7	7.0	6.7	15.1	10.3	7.3	6.0	5.9	5.8	6.0	6.2	5.4	7.8	6.9	4.3	7.5	6.6	3.6	3.0	4.3	5.4	4.9	7.4	12.7	2.7	4.5	3.8	3.8	5.3	3.9	3.8	3.4	2.5	5.2	4.8	4.3	6.7	5.0	5.5	3.9	5.6	2.6	17.9	23.9	9.8	20.4	15.6	11.5	8.9	13.7	10.5	7.7	3.0	13.2	1.4	2.0	4.0	11.6	10.3	10.2	2.7	9.1	8.7	7.9	2.5	5.0	3.6	14.3	3.6	11.7	0.0	5.1	1.3	3.2	2.5	0.0	2.1	2.2	4.8	4.7	9.8	3.5	18.9	2.8	3.5	1.7	0.0	4.5	5.2	4.9	3.7	3.2	5.1	5.1	0.0	3.8	2.2	2.7	5.1	3.9	5.0	5.1	2.7
BTF3L4	MGC23908	ENSG00000134717	"Basic transcription factor 3 like 4"	Q96K17	1	52056125-52090716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA067026	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA067026: AB_2685765"	"unprognostic (6.12e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (6.73e-8)"	"unprognostic (8.85e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.56e-2)"	22.3	29.1	20.6	14.8	22.1	26.7	26.2	25.5	52.3	17.5	12.8	17.2	8.4	7.1	19.5	16.7	20.3	19.6	12.5	28.4	23.7	22.4	18.5	20.8	19.6	38.8	20.4	23.8	29.2	47.6	21.0	24.3	19.1	16.7	15.7	12.6	16.5	26.4	13.5	36.9	19.3	9.8	22.4	23.1	14.1	14.2	19.2	14.6	20.7	22.9	13.6	20.4	19.0	16.2	23.2	34.1	32.2	36.0	21.3	28.2	27.9	28.0	6.8	33.5	17.5	18.1	23.3	34.7	27.8	28.0	31.9	34.4	12.4	14.7	26.2	28.0	19.5	37.7	16.4	32.3	21.7	40.9	18.1	22.6	30.0	12.5	18.5	49.6	33.2	20.8	23.9	30.0	29.5	41.7	26.5	25.2	21.7	22.6	16.7	28.6	12.0	22.9	19.7	59.6	21.8	15.0	15.2	39.0	30.8	30.8	22.6	26.4	29.9	32.5	30.1	40.0	38.8	27.2	35.6	18.4	18.0	19.5	23.2	32.7	29.3	48.3	25.6	15.6	25.9	22.6	24.1	35.4	32.2	15.0	36.0	20.1	23.2	21.7	15.4	34.1	22.1	25.4	19.4	15.1	21.3	31.0	16.1	28.2	27.9	20.6	22.1	25.5	52.3	23.7	22.4	20.4	23.8	16.7	14.6	32.8	18.2	57.0	77.6	95.7	41.1	40.3	43.3	40.2	31.8	66.3	31.4	99.7	142.6	93.1	81.2	49.3	16.0	93.5	69.0	113.3	65.9	74.4	22.0	66.1	115.8	36.5	50.2	45.4	117.9	13.6	67.0	77.6	74.2	55.9	28.5	42.6	74.2	28.1	52.3	110.7	28.6	58.2	77.3	111.6	14.3	140.0	122.0	50.7	33.3	87.5
BTG1	APRO2	ENSG00000133639	"BTG anti-proliferation factor 1"	P62324	12	92140278-92145897	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 190.7"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 2444.1;Suprabasal keratinocytes: 2626.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005972			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005972: AB_1078303"	"prognostic favorable (4.36e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (9.81e-2)"	52.0	22.1	11.5	58.3	13.4	126.9	114.4	66.8	10.4	41.7	40.1	5.5	21.9	15.5	30.1	22.0	28.7	27.9	39.9	49.2	11.9	8.1	22.2	58.1	85.6	190.7	10.4	8.2	29.1	64.2	17.6	17.1	23.4	13.3	28.7	18.1	21.0	19.0	25.9	31.6	70.6	34.3	26.0	24.6	77.1	26.4	19.0	8.9	148.9	15.7	14.3	58.2	54.2	35.2	58.3	6.6	94.3	14.0	47.1	95.2	26.1	7.0	8.8	9.7	1.1	36.3	50.4	4.2	7.9	17.4	5.3	5.3	5.2	2.4	7.5	1.6	8.3	8.4	4.8	3.2	8.8	9.9	9.0	6.8	1.5	6.1	2.7	36.8	5.5	2.6	43.0	26.7	12.1	37.5	23.5	10.6	5.0	5.2	10.0	6.0	7.2	3.9	17.7	2.3	7.7	10.0	13.4	5.4	2.3	16.3	14.6	5.4	10.8	9.8	7.6	25.5	7.8	32.0	12.8	3.4	6.0	1.8	4.6	4.8	13.8	7.4	12.5	4.7	4.4	6.7	22.3	13.6	94.3	17.0	10.6	20.1	44.5	34.3	29.8	6.6	58.3	95.2	39.1	52.3	47.1	14.0	6.2	39.2	26.1	11.5	13.4	66.8	10.4	11.9	8.1	10.4	8.2	13.3	8.9	89.3	164.0	1133.8	898.4	2444.1	509.3	99.7	695.5	18.7	63.7	165.7	184.6	344.9	271.9	357.5	306.7	258.8	666.0	140.2	222.2	261.3	225.7	728.6	288.8	235.3	359.2	400.5	434.2	206.2	468.4	134.9	265.8	682.9	933.0	1485.2	192.1	767.8	308.3	596.2	227.4	96.3	342.5	530.3	1116.5	68.9	113.5	2626.0	1122.8	1563.2	226.0	1040.3
BTG2	"APRO1, MGC126063, MGC126064, PC3, TIS21"	ENSG00000159388	"BTG anti-proliferation factor 2"	P78543	1	203305491-203309602	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 927.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.5;HMC-1: 39.2;RT4: 30.5;U-266/70: 60.7;U-266/84: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002355	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA002355: AB_1078304"	"prognostic favorable (8.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.86e-3)"	61.6	45.9	10.1	61.4	20.6	46.9	27.8	13.0	10.4	23.0	53.3	27.8	27.0	15.2	27.1	24.6	55.7	103.7	76.1	65.3	10.4	10.0	22.3	4.3	40.7	20.0	12.2	5.5	102.0	117.6	7.0	52.2	42.7	28.3	61.0	38.5	30.4	18.1	104.1	98.9	30.5	36.6	50.8	22.7	32.7	67.1	11.5	9.9	82.9	36.7	45.2	49.0	64.7	21.5	14.1	17.3	34.5	14.2	5.7	8.5	7.1	0.9	1.4	2.6	1.0	3.3	2.4	22.1	2.6	5.1	0.7	2.5	1.9	0.4	37.5	1.8	0.8	0.4	16.5	9.5	10.0	1.3	2.4	4.6	19.6	2.7	4.3	7.3	0.1	39.2	2.5	18.6	2.5	4.6	2.3	13.7	1.9	9.1	26.0	6.8	0.8	4.1	1.2	1.1	0.4	0.2	2.6	8.9	18.8	1.3	30.5	0.4	2.7	2.0	0.8	0.3	20.6	2.2	2.3	3.4	0.0	4.4	0.6	0.1	60.7	30.6	24.0	0.5	0.9	1.5	3.2	8.1	9.9	4.7	12.1	7.1	14.1	5.3	4.8	5.1	13.1	8.5	5.9	34.5	5.7	14.2	17.3	4.9	7.1	10.1	20.6	13.0	10.4	10.4	10.0	12.2	5.5	28.3	9.9	145.9	242.1	142.2	203.8	204.5	25.9	219.9	10.2	57.6	52.4	177.9	27.5	38.6	13.3	59.7	0.8	123.6	335.6	23.3	145.5	16.4	143.3	218.8	358.2	1.6	99.0	3.2	927.5	46.6	65.9	1.7	67.3	167.7	114.7	31.5	370.7	221.0	58.8	329.8	51.9	10.8	21.5	122.9	223.5	0.9	0.6	391.6	115.4	202.7	212.8	200.1
BTG4	"APRO3, PC3B"	ENSG00000137707	"BTG anti-proliferation factor 4"	Q9NY30	11	111467526-111512354	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 24.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 46.0;Late spermatids: 57.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.4;Karpas-707: 8.6;U-266/70: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057157			Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"HPA057157: AB_2683354"		"unprognostic (1.58e-1)"		"unprognostic (2.68e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.80e-4)"		"unprognostic (1.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.39e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.2	0.0	0.2	0.4	6.4	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.7	1.6	0.1	0.0	0.0	1.0	0.0	8.6	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.4	0.0	0.4	6.0	2.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.7	3.4	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	8.2	1.2	0.0	0.0	0.0	0.0	0.0
BTN2A1	"BT2.1, BTF1, BTN2.1"	ENSG00000112763	"Butyrophilin subfamily 2 member A1"	Q7KYR7	6	26457904-26476621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA019208	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA019208: AB_1845492"	"unprognostic (1.86e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.90e-3)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (4.52e-5)"	15.3	16.7	10.8	16.3	13.7	18.5	17.2	42.2	16.2	14.8	15.8	13.2	17.4	12.2	18.8	15.0	11.5	14.9	12.7	15.6	11.2	14.6	13.1	8.5	17.2	16.3	14.4	10.2	15.8	8.9	7.7	16.9	23.2	16.1	16.5	14.6	12.0	11.1	19.3	12.1	9.5	13.9	21.1	15.6	23.5	12.4	13.0	15.0	11.3	10.8	7.3	14.4	21.4	13.4	4.8	4.7	28.8	4.8	4.8	8.1	3.4	7.4	6.8	13.4	8.3	6.0	4.9	0.6	16.3	13.8	20.1	18.4	6.0	5.0	6.1	22.6	11.6	26.5	3.4	10.6	4.2	19.3	8.8	10.4	3.7	7.3	7.4	9.4	5.2	9.8	6.8	4.0	22.4	7.3	11.9	7.2	12.1	5.8	9.7	17.2	3.2	9.2	8.7	4.6	2.1	5.5	7.6	13.2	6.4	7.5	3.7	14.0	7.7	5.2	6.7	11.6	8.7	2.2	4.6	9.5	15.1	8.1	13.1	18.3	7.9	18.2	5.1	6.0	10.4	23.8	16.7	4.8	15.5	6.5	2.7	5.9	4.8	5.4	7.1	4.3	3.9	5.0	6.4	28.8	4.8	4.1	4.7	8.1	3.4	10.8	13.7	42.2	16.2	11.2	14.6	14.4	10.2	16.1	15.0	14.9	14.3	13.4	6.9	7.1	9.0	16.8	10.2	32.1	10.3	8.7	5.9	5.1	3.3	9.6	2.6	19.4	10.6	0.0	11.3	9.3	14.7	9.5	23.2	5.8	10.2	3.2	8.6	19.0	18.7	4.1	11.8	17.0	10.1	16.2	13.7	6.4	12.3	11.2	12.0	4.7	2.2	38.8	21.7	8.8	11.7	7.0	9.8	21.7	12.1	11.1
BTN2A2	"BT2.2, BTF2, BTN2.2"	ENSG00000124508	"Butyrophilin subfamily 2 member A2"	Q8WVV5	6	26383096-26394874	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.0"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.7;U-266/70: 28.3"									HPA051504	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA051504: AB_2681510"	"prognostic favorable (1.01e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	7.0	12.4	3.2	22.6	5.2	2.7	7.5	29.0	5.2	8.5	5.7	5.1	4.8	5.2	10.2	10.6	7.4	6.7	7.9	9.5	4.1	3.7	7.5	6.1	15.6	21.8	4.4	3.3	10.3	5.8	12.9	5.5	2.8	9.7	8.8	8.0	11.5	9.3	7.9	2.7	8.0	9.9	8.2	5.3	18.0	7.2	5.1	4.2	13.0	7.0	6.2	26.0	8.5	7.6	20.2	14.9	7.8	9.1	5.1	6.3	4.7	4.8	3.1	6.3	6.7	2.1	3.3	0.4	5.3	14.0	8.4	14.5	1.9	1.9	4.4	5.8	9.5	6.8	4.5	5.0	4.1	11.2	13.7	8.4	6.9	5.8	3.8	4.4	1.5	2.4	7.1	1.3	16.1	5.5	10.0	7.7	8.7	5.5	34.7	3.7	2.1	5.4	2.0	2.3	0.2	3.1	12.8	9.0	13.5	6.0	2.7	6.0	8.5	3.4	1.3	14.5	3.8	6.4	3.0	9.1	3.1	3.6	2.7	8.1	28.3	17.3	7.7	3.1	6.2	7.7	1.2	8.7	1.5	4.2	9.1	3.9	16.2	3.3	3.7	14.9	20.2	2.8	3.4	7.8	5.1	3.6	6.2	6.3	4.7	3.2	5.2	29.0	5.2	4.1	3.7	4.4	3.3	9.7	4.2	8.9	9.3	13.7	6.2	3.4	0.4	2.2	2.5	4.0	9.1	3.5	0.0	2.0	0.0	8.2	0.2	14.0	1.0	23.3	4.9	0.9	2.1	6.9	18.5	2.5	8.1	0.0	1.7	5.5	8.8	0.0	6.1	18.0	6.8	12.6	7.0	17.3	6.6	0.0	4.6	1.7	0.7	0.0	3.9	0.5	1.3	4.0	0.8	7.5	1.6	3.1
BTNL9	"BTN8, FLJ32535"	ENSG00000165810	"Butyrophilin like 9"	Q6UXG8	5	181040225-181061523	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.2;breast: 76.8"	"Cell type enriched"	"Detected in many"	5	"Ito cells: 138.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.8"	"Group enriched"	"Detected in many"	6	"B-cells: 3.8;granulocytes: 1.3"	"Group enriched"	"Detected in some"	4	"OE19: 7.5;U-698: 28.3"	"Not detected"	"Not detected"							HPA043429			Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane"	Vesicles	"HPA043429: AB_10961264"	"unprognostic (2.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.55e-9)"	"unprognostic (2.15e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-2)"	128.2	2.5	1.5	5.3	1.7	0.3	76.8	1.0	1.8	3.2	11.3	0.8	3.5	0.7	3.9	3.7	2.9	6.0	3.7	11.0	3.4	1.3	3.4	3.0	25.4	2.7	2.5	1.2	1.0	2.0	3.0	1.6	4.3	1.5	3.4	1.5	3.8	3.0	3.5	34.4	2.0	1.9	3.2	2.1	12.7	2.0	3.0	0.9	1.1	6.1	4.0	5.5	3.1	18.3	3.8	0.4	1.3	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.6	0.1	0.2	1.1	0.0	0.0	0.2	0.5	0.0	0.0	0.2	2.9	1.1	0.2	0.1	0.0	0.5	3.3	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.7	0.3	0.0	0.1	0.1	0.1	0.1	7.5	1.8	0.0	0.2	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.1	4.4	0.1	0.0	0.2	0.1	28.3	0.1	0.0	0.0	1.0	0.3	0.5	0.2	0.1	0.1	3.8	0.2	0.2	0.1	1.9	0.2	0.2	1.3	0.3	0.1	0.4	0.0	0.1	1.5	1.7	1.0	1.8	3.4	1.3	2.5	1.2	1.5	0.9	0.0	6.7	3.0	0.6	2.1	0.4	27.4	0.0	4.0	1.2	0.0	0.0	0.0	3.3	0.0	0.3	29.2	0.0	0.0	0.2	0.1	0.2	0.3	1.1	0.4	0.1	0.0	4.1	138.7	12.7	1.1	2.0	1.0	3.3	0.0	4.0	0.2	0.1	0.0	0.4	0.0	0.3	12.9	2.1	4.3	11.1	1.9	0.1	0.5	1.1	0.6
BTRC	"beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1"	ENSG00000166167	"Beta-transducin repeat containing E3 ubiquitin protein ligase"	Q9Y297	10	101354033-101557321	"Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031156, CAB032986"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB032986: AB_2243598, HPA031156: AB_2673764"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.23e-1)"	6.6	11.2	16.0	7.3	23.1	3.6	11.8	16.2	28.0	10.2	6.6	10.7	13.7	5.4	8.8	14.5	11.5	10.8	8.1	18.6	15.7	18.3	11.6	7.1	6.8	5.3	14.3	15.3	15.5	8.6	21.5	17.3	10.4	13.5	12.2	7.0	11.9	9.0	8.7	14.1	9.0	5.4	9.7	10.2	7.5	6.4	17.9	9.0	6.3	11.4	7.1	7.5	7.3	9.8	5.2	4.8	3.9	3.7	5.1	8.1	3.4	6.3	9.7	13.7	15.8	13.4	11.7	4.9	9.1	14.8	9.6	8.0	6.8	5.0	10.4	9.3	7.8	9.9	9.9	11.2	9.9	10.4	6.8	8.9	7.5	6.1	8.8	7.1	11.0	4.1	7.1	11.6	8.2	14.7	19.0	11.8	9.7	8.1	3.5	9.2	5.4	7.4	5.5	6.3	7.1	7.7	9.3	19.2	2.1	8.8	4.1	10.2	8.7	6.0	2.7	8.5	16.6	7.4	3.8	9.9	5.1	8.0	6.5	6.4	5.8	12.6	6.6	5.0	5.5	3.4	3.8	3.7	3.9	6.1	3.1	6.1	5.2	6.5	5.5	4.8	4.4	8.1	6.5	2.4	5.1	3.1	2.4	5.6	3.4	16.0	23.1	16.2	23.3	15.7	18.3	14.3	15.3	13.5	9.0	3.0	10.3	4.2	3.6	4.9	29.4	27.1	10.2	12.0	10.3	3.5	27.5	9.5	6.6	8.4	26.8	6.6	4.5	0.0	6.3	6.2	8.2	6.1	12.8	4.9	4.9	15.9	2.9	5.5	2.8	14.1	8.3	3.3	1.7	3.6	4.1	14.1	7.2	3.5	9.9	8.0	24.9	6.5	3.1	31.8	17.1	6.1	10.4	5.1	4.5	5.9
BUB1B-PAK6		ENSG00000259288	"BUB1B-PAK6 readthrough"		15	40217428-40276396	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in single"		"brain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031124	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"		"unprognostic (1.83e-1)"				"unprognostic (1.29e-3)"		"unprognostic (1.32e-1)"		"unprognostic (9.23e-2)"				"unprognostic (1.12e-1)"		"unprognostic (1.88e-1)"	"unprognostic (9.48e-2)"	0.0	0.0		0.0		0.0	0.0		1.5	0.0	0.0			0.0	0.6	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BUD31	"Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W"	ENSG00000106245	"BUD31 homolog"	P41223	7	99408641-99419616	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028943	Approved		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA			Nucleoplasm	"Microtubules, Centrosome"	"HPA028943: AB_10602396"	"unprognostic (1.68e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.71e-1)"	26.4	31.9	43.6	26.1	44.8	66.6	29.5	28.3	36.4	25.6	31.3	25.6	31.6	27.0	25.1	32.2	35.2	35.7	28.1	30.8	39.2	36.3	37.9	33.2	26.2	34.5	39.5	27.4	28.8	31.4	21.0	35.2	33.7	32.3	27.3	22.7	22.0	31.5	28.9	20.7	23.5	31.2	25.4	34.5	29.1	26.7	51.2	27.0	24.1	40.1	29.0	31.6	35.3	26.5	39.1	32.2	91.2	42.7	34.1	37.6	56.6	25.2	29.8	16.7	37.4	16.8	18.9	16.2	24.3	23.4	27.9	30.7	34.8	25.2	19.4	29.7	23.4	30.4	15.1	18.4	22.2	23.5	23.4	24.9	14.1	21.2	22.8	35.0	24.0	18.7	18.4	27.5	25.4	48.1	16.3	21.7	20.4	34.6	44.5	25.6	66.3	31.5	65.1	36.7	27.0	37.4	16.5	16.9	33.5	24.4	20.2	29.4	35.4	24.0	27.7	50.5	11.3	17.4	30.3	17.7	26.6	33.9	52.7	37.9	28.0	46.9	51.7	23.5	35.9	48.1	59.1	39.3	91.2	34.1	40.5	31.9	39.1	32.8	33.0	32.2	36.6	27.9	29.2	83.0	34.1	42.7	31.1	37.6	56.6	43.6	44.8	28.3	36.4	39.2	36.3	39.5	27.4	32.3	27.0	77.4	75.2	90.6	127.0	171.3	30.4	11.1	68.8	149.9	61.4	87.2	9.8	144.5	202.2	156.4	106.4	90.4	143.8	23.3	162.5	137.0	129.0	115.9	89.0	77.4	132.0	15.9	140.8	71.8	86.2	82.8	75.9	103.3	129.9	174.1	105.3	65.9	188.4	119.3	69.6	168.4	26.3	58.2	153.3	197.9	133.6	160.7	152.5	126.4	87.3	146.8
BZW1	"BZAP45, KIAA0005"	ENSG00000082153	"Basic leucine zipper and W2 domains 1"	Q7L1Q6	2	200810594-200827338	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 858.8;Late spermatids: 3073.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047288, HPA053272"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA047288: , HPA053272: "	"unprognostic (2.45e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (2.08e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-3)"	"unprognostic (3.98e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (4.49e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.97e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.24e-1)"	55.7	43.2	23.5	29.2	26.8	60.1	35.2	19.4	36.1	26.1	30.3	26.4	18.5	20.1	25.4	25.4	49.1	24.8	30.5	31.1	23.3	20.9	39.5	108.5	29.5	33.9	30.5	19.2	40.5	20.5	22.9	23.5	55.4	37.0	33.1	29.9	22.2	29.7	21.3	45.5	20.2	32.0	25.9	28.1	31.2	23.7	55.2	24.6	68.0	32.0	43.2	35.4	39.6	28.1	27.7	43.9	50.1	48.3	56.4	59.5	65.7	44.4	35.5	48.5	29.1	48.9	57.5	34.6	65.6	78.1	44.4	39.0	55.2	30.3	21.4	23.0	52.1	29.4	24.6	44.2	79.1	83.2	23.1	23.6	56.1	76.1	42.3	39.5	62.5	31.4	33.1	36.8	58.8	63.6	38.8	76.9	20.4	48.5	36.6	58.9	35.7	57.5	29.7	61.2	18.1	89.7	44.2	52.6	22.4	40.4	66.7	29.4	34.3	50.2	18.8	33.7	42.2	19.8	32.4	85.4	66.4	38.6	39.9	41.9	45.0	62.0	57.8	54.3	31.7	48.4	50.1	37.2	44.2	51.1	46.2	59.5	27.7	36.9	47.9	43.9	23.4	33.4	46.1	31.7	56.4	48.3	20.4	45.0	65.7	23.5	26.8	19.4	36.1	23.3	20.9	30.5	19.2	37.0	24.6	80.4	99.2	100.6	276.2	176.3	36.6	15.7	71.4	115.1	211.5	85.5	17.7	99.6	117.7	199.3	858.8	125.8	79.3	46.7	201.4	137.6	138.9	237.1	190.7	239.1	102.8	55.6	92.8	93.3	86.7	3073.0	94.6	150.2	118.1	423.0	79.5	109.8	321.4	70.2	90.2	127.7	31.9	97.0	116.9	160.7	145.7	171.4	163.3	128.0	71.8	299.2
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 104.4;skeletal muscle: 89.7"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 786.3;Syncytiotrophoblasts: 638.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Actin filaments, Cytosol"		"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavorable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	10.6	7.2	4.2	7.8	8.5	10.1	13.5	3.4	8.9	7.9	13.6	3.4	22.0	7.7	7.6	7.6	17.9	7.1	6.1	70.8	4.4	2.8	8.4	10.2	8.1	11.4	3.5	5.8	6.4	12.3	1.8	5.7	104.4	2.5	9.8	16.2	13.2	10.1	25.3	89.7	16.8	8.0	16.6	2.8	8.4	15.6	3.5	3.4	14.5	13.6	41.1	11.1	16.8	10.3	17.2	37.3	1.7	20.3	20.1	23.6	16.3	17.0	16.5	28.1	40.6	13.8	24.4	25.2	24.3	32.0	24.1	25.6	40.0	25.9	39.7	29.0	18.8	17.6	35.5	33.1	27.8	31.9	5.3	19.1	24.8	18.7	22.5	14.3	33.8	15.6	18.7	15.1	21.0	38.8	18.7	34.3	29.2	47.3	8.6	19.5	20.0	17.1	39.2	28.7	50.3	34.2	20.6	18.4	41.8	22.8	31.1	36.0	21.2	9.6	85.9	12.8	33.8	37.8	29.4	19.5	19.1	24.1	28.0	26.8	16.5	17.2	56.0	9.3	42.6	68.2	0.9	17.4	1.7	11.0	20.3	17.9	17.2	16.1	14.9	37.3	15.8	23.6	19.5	0.7	20.1	14.5	14.4	11.9	16.3	4.2	8.5	3.4	8.9	4.4	2.8	3.5	5.8	2.5	3.4	20.8	55.0	24.4	57.3	51.2	48.9	247.1	10.2	32.1	46.6	45.4	60.9	187.5	49.7	33.5	5.3	35.0	23.9	0.0	56.6	786.3	42.5	23.4	20.7	12.2	59.0	6.4	29.3	9.8	28.9	4.8	11.2	28.7	23.6	49.5	35.3	13.3	39.9	31.7	9.2	14.7	83.3	6.5	31.1	4.7	3.8	45.0	638.0	16.2	80.3	79.3
C10orf55	bA417O11.3	ENSG00000222047	"Chromosome 10 open reading frame 55"	Q5SWW7	10	73909969-73922777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"testis: 14.0"	"Cell type enhanced"	"Detected in some"	13	"Basal glandular cells: 6.4;Distal tubular cells: 6.6;Early spermatids: 11.8;Sertoli cells: 6.5;Urothelial cells: 5.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.1;CAPAN-2: 4.8;HaCaT: 4.9;hTERT-RPE1: 3.4;RPTEC TERT1: 7.6;U-251 MG: 3.3"									HPA045739	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045739: AB_10961861"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.68e-3)"	"unprognostic (5.61e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.90e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.13e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0			0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.7	0.0	0.0		0.0	0.0	0.1	0.0	0.0		0.0	0.4		0.0	1.1	0.5	1.0	0.0	0.0	0.0	0.1	0.0	14.0			0.1		0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	1.6	0.4	0.3	0.0	4.8	0.0	0.3	0.2	1.5	4.9	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.4	0.6	1.0	3.4	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.1	0.0	7.6	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	0.4	3.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	6.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.5	11.8	0.0	0.0	0.0	0.6	0.0	0.2	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	6.5	0.3	0.0	0.2	0.1	0.0	0.0	0.0	5.4
C10orf62	bA548K23.1	ENSG00000203942	"Chromosome 10 open reading frame 62"	Q5T681	10	97589727-97590934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"testis: 81.1"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 7737.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;Hep G2: 2.9;T-47d: 2.1"									HPA072947	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA072947: AB_2686562"		"unprognostic (3.66e-2)"		"unprognostic (3.97e-2)"	"unprognostic (2.81e-1)"		"unprognostic (5.36e-2)"		"unprognostic (3.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.63e-2)"		"unprognostic (2.53e-2)"	"unprognostic (2.04e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.8	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.5	2.9	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1574.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7737.3	36.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.3	0.0	6.5	0.0	33.1	18.8	0.0	0.0	0.0	0.0	0.0
C10orf67	"bA215C7.4, C10orf115, LINC01552, MGC46732"	ENSG00000179133	"Chromosome 10 open reading frame 67"	Q8IYJ2	10	23201916-23344845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 35.7;Ciliated cells: 49.5;Late spermatids: 23.1;Spermatocytes: 63.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 5.3;SiHa: 8.5"									HPA038131	Approved		Approved	Vesicles,Microtubules,Mitochondria		NA	No			"Vesicles, Microtubules, Mitochondria"		"HPA038131: AB_10670658"	"unprognostic (4.76e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.91e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.58e-2)"	0.1	0.1	1.3	1.7	2.6	0.2	0.0	0.1	1.9	0.3	0.5	0.4	1.3	0.5	0.2	4.6	0.1	7.3	0.2	3.2	1.6	1.4	5.0	0.5	4.0	0.3	0.9	0.5	1.8	0.3	0.4	9.0	0.1	1.2	0.1	0.0	0.2	0.1	0.1	0.6	1.9	0.4	0.0	0.7	0.2	0.1	13.8	0.6	0.0	0.6	0.7	0.1	0.1	0.1	1.1	1.1	1.0	0.5	1.1	4.2	0.0	1.5	0.1	1.9	0.2	0.0	0.5	0.4	0.2	0.1	2.0	1.7	0.1	2.4	0.2	0.2	1.6	0.2	5.3	0.2	0.7	1.7	0.5	0.4	0.1	0.7	0.4	1.0	0.1	0.0	0.6	1.7	0.7	1.0	0.2	0.0	0.2	0.2	0.8	0.0	0.3	0.1	0.5	0.9	0.1	0.1	0.1	0.2	0.4	1.7	0.4	0.9	0.4	8.5	0.4	0.1	0.3	0.3	0.3	0.2	0.4	1.5	0.4	0.1	1.1	0.2	0.1	2.5	0.2	0.1	1.0	0.5	0.6	0.7	0.3	0.6	1.1	1.5	0.8	0.1	1.0	1.1	1.0	0.8	1.1	0.3	1.1	4.2	0.0	1.3	2.6	0.1	1.9	1.6	1.4	0.9	0.5	1.2	0.6	35.7	3.7	0.0	0.0	2.5	0.1	1.1	0.0	49.5	3.4	0.0	0.0	0.0	1.7	0.2	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	12.2	0.8	6.5	0.0	63.7	2.1	1.1	0.0	0.0	0.0	0.0
C10orf71	FLJ45913	ENSG00000177354	"Chromosome 10 open reading frame 71"	Q711Q0	10	49299193-49327487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 104.2;tongue: 35.0"	"Cell type enriched"	"Detected in single"	478	"Cardiomyocytes: 47.8"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"K-562: 9.2;RH-30: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057556			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA057556: AB_2683467"				"unprognostic (1.25e-2)"		"unprognostic (3.97e-2)"		"unprognostic (4.16e-2)"		"unprognostic (5.58e-2)"		"unprognostic (1.66e-1)"		"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"			2.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	2.0	1.7	0.1	0.0	13.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	3.3	15.3	0.1	0.0	0.0	0.3	0.0	0.0	1.1	0.0	104.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.5	35.0	3.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C10orf76	FLJ13114	ENSG00000120029	"Chromosome 10 open reading frame 76"	Q5T2E6	10	101845599-102056193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050913, HPA053580"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA050913: AB_2681270, HPA053580: AB_2682198"	"unprognostic (5.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.55e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.87e-2)"	16.8	16.3	16.0	16.2	19.5	25.0	15.7	25.5	19.3	17.7	16.7	18.3	19.5	16.3	19.5	14.0	20.9	14.3	14.1	21.2	12.0	12.9	13.2	15.1	18.1	15.0	13.9	14.2	16.0	13.2	22.8	21.0	14.3	16.1	14.8	17.6	17.7	17.3	14.6	27.2	19.3	18.5	17.2	14.4	16.9	14.4	18.0	14.9	18.9	14.2	16.6	20.1	20.6	20.7	7.6	8.5	16.4	10.8	5.2	7.4	4.9	16.0	13.2	11.8	14.4	10.1	13.6	10.0	13.4	18.1	15.1	12.9	8.9	13.6	11.6	9.6	17.0	11.1	12.9	15.3	16.6	14.1	11.8	13.7	19.9	11.7	10.3	11.9	14.4	19.1	12.4	13.5	17.1	15.3	17.9	11.4	11.3	0.6	12.1	12.5	10.2	11.4	9.9	6.3	13.8	8.0	11.3	20.2	8.0	12.5	13.5	5.5	9.0	10.9	8.2	15.7	12.7	21.5	9.1	10.5	8.0	12.9	7.3	10.4	11.0	11.0	12.5	12.9	17.0	6.0	16.4	8.1	7.9	7.0	9.5	6.5	7.1	7.4	5.3	8.5	7.6	5.8	5.9	2.2	5.2	10.8	8.4	6.3	4.9	16.0	19.5	25.5	19.3	12.0	12.9	13.9	14.2	16.1	14.9	11.9	24.0	0.8	6.9	6.8	10.1	0.0	10.2	4.0	3.4	0.0	49.1	9.4	0.0	0.0	4.5	6.4	12.3	0.0	0.0	10.6	6.1	6.5	16.2	12.2	11.2	7.9	2.4	11.1	16.3	3.1	4.4	10.1	3.3	0.0	7.6	6.8	0.0	11.5	7.1	0.0	13.6	0.0	5.1	10.0	11.0	7.8	13.6	8.7	7.4	7.6
C10orf82	"Em:AC016825.4, MGC33547"	ENSG00000165863	"Chromosome 10 open reading frame 82"	Q8WW14	10	116663696-116670264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 12.7;testis: 44.7"	"Group enriched"	"Detected in some"	97	"Early spermatids: 967.9;Late spermatids: 1530.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	127	"basophil: 12.7"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 12.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Hep G2: 4.9;NTERA-2: 2.7;SuSa: 5.6;T-47d: 8.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043022			Approved	Mitochondria		Yes	NA			Mitochondria		"HPA043022: "	"unprognostic (9.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.52e-2)"		"unprognostic (3.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	0.4	1.1	0.4	0.9	1.2	0.2	1.0	0.8	3.3	0.4	0.7	0.0	1.0	0.3	0.3	1.5	1.2	0.3	0.3	0.5	0.4	1.3	0.5	0.3	0.2	0.2	0.4	0.9	3.2	0.9	0.2	1.2	0.3	4.1	1.1	0.4	0.6	1.8	1.1	0.2	0.4	0.6	0.7	2.0	0.3	0.4	44.7	0.0	0.0	3.3	0.0	0.2	0.4	1.9	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.8	3.3	0.4	1.3	0.4	0.9	4.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	967.9	0.1	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1530.3	8.3	0.0	1.7	0.0	0.8	0.0	0.1	0.0	4.9	0.0	0.0	12.9	0.0	10.2	7.8	0.0	0.0	0.0	0.6	0.3
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126670446	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3"	"Group enriched"	"Detected in some"	27	"Early spermatids: 96.0;Late spermatids: 93.2"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 49.5;U-2197: 15.1;U-266/84: 10.6;U-87 MG: 15.7;WM-115: 12.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	1.9	0.8	7.5	1.0	21.5	0.8	9.2	1.4	18.7	0.9	0.9	30.9	0.0	0.7	0.8	0.8	0.9	0.7	1.1	0.8	10.8	5.9	0.9	0.8	0.8	0.7	26.0	5.9	0.9	1.1	0.7	0.5	1.3	14.4	0.9	1.0	1.7	18.6	0.7	0.9	1.9	0.8	0.8	17.2	0.8	0.7	12.3	28.0	0.0	1.3	0.0	2.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.1	0.0	2.0	0.0	15.1	0.3	0.0	10.6	0.0	15.7	0.0	12.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	21.5	1.4	11.3	10.8	5.9	26.0	5.9	14.4	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	96.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	93.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.4	0.0	3.5	0.0	0.0	0.0
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295645-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0"	"Cell type enhanced"	"Detected in some"	23	"Cardiomyocytes: 60.5;granulocytes: 15.1;Kupffer cells: 14.3;Macrophages: 12.4;T-cells: 17.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 30.8;HL-60: 11.6;NB-4: 10.7;THP-1: 7.5;U-937: 13.1"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.5	0.4	0.7	8.7	0.5	30.4	0.7	0.2	0.7	1.5	0.8	1.7	0.8	0.2	1.6	1.3	0.7	1.0	5.4	15.6	0.4	0.4	1.0	1.3	5.2	8.5	2.2	0.9	0.7	0.6	0.0	0.8	0.8	1.0	0.8	0.8	1.4	9.3	0.1	0.4	0.8	3.3	0.6	1.4	16.0	2.0	0.9	1.0	6.4	1.1	2.7	11.5	1.0	0.9	2.6	7.3	29.5	23.2	9.5	10.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	30.8	0.0	0.1	0.3	11.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	13.1	0.0	29.5	6.3	18.7	10.6	13.1	7.3	2.0	3.6	8.4	7.3	2.6	5.4	7.5	5.5	9.5	23.2	0.7	2.6	6.4	0.7	0.5	0.2	0.7	0.4	0.4	2.2	0.9	1.0	1.0	0.0	6.2	1.9	0.0	0.3	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	15.1	0.0	3.4	0.0	0.0	1.3	14.3	0.0	0.0	12.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	17.5	0.0	0.0
C11orf24	DM4E3	ENSG00000171067	"Chromosome 11 open reading frame 24"	Q96F05	11	68261335-68272001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 65.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 63.4"									"HPA012411, HPA012748"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012411: , HPA012748: AB_1845526"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.91e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.60e-9)"	"unprognostic (2.18e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.67e-3)"	12.9	9.3	6.6	12.9	10.6	2.7	14.7	6.7	13.7	14.1	32.6	23.3	8.4	35.2	21.8	12.3	8.6	12.2	19.2	19.1	9.1	6.5	10.0	44.3	12.6	14.4	10.3	8.1	14.1	17.5	5.8	8.1	12.6	14.5	12.2	11.8	14.7	22.1	12.6	6.9	8.9	65.7	21.5	13.8	11.3	13.5	7.8	10.3	3.4	9.2	11.4	18.8	14.6	10.5	23.7	16.4	9.3	11.0	5.5	9.2	6.9	12.5	13.0	7.7	15.0	18.7	19.0	9.0	30.3	19.7	15.3	15.8	27.4	7.8	5.7	9.4	37.6	13.9	14.2	11.4	13.6	9.9	6.2	6.7	6.0	13.2	18.3	15.1	5.1	20.3	15.7	10.2	23.2	9.5	9.2	6.1	3.0	10.5	9.4	12.9	15.6	1.2	7.4	12.9	20.4	15.8	2.3	13.2	29.3	6.9	6.0	5.1	9.5	9.9	7.9	63.4	6.7	7.4	4.3	6.7	24.1	14.9	30.3	13.3	11.6	11.3	5.3	19.3	4.0	23.1	9.3	7.2	7.5	9.2	11.0	6.2	17.3	5.3	5.7	12.0	23.7	5.0	5.3	1.1	5.5	8.1	16.4	4.8	6.9	6.6	10.6	6.7	13.7	9.1	6.5	10.3	8.1	14.5	10.3	8.9	2.2	11.5	8.0	12.5	3.7	8.5	12.7	10.7	4.5	8.7	2.0	12.7	1.7	14.5	2.8	6.4	37.3	0.0	27.1	24.7	18.1	10.2	43.9	99.7	14.5	0.0	4.6	9.2	12.1	5.6	13.0	12.4	27.0	21.6	33.5	6.6	21.8	12.4	15.2	8.8	2.9	12.9	17.9	12.7	20.6	9.8	8.8	4.9	12.8	7.9
C11orf42	MGC34805	ENSG00000180878	"Chromosome 11 open reading frame 42"	Q8N5U0	11	6205566-6211132	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 27.9"	"Group enriched"	"Detected in some"	136	"Early spermatids: 149.9;Late spermatids: 529.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.2;HeLa: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063404	Enhanced		Approved	"Nuclear membrane,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear membrane, Vesicles"	"HPA063404: AB_2685006"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.49e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.30e-2)"	"unprognostic (6.47e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	1.0	1.2	0.1	0.2	0.1	0.1	1.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	2.0	0.9	0.1	0.1	0.1	0.3	27.9	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.5	2.5	0.4	1.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	2.1	0.8	0.6	0.1	0.0	0.3	1.9	0.0	0.0	0.0	0.6	4.2	0.0	4.8	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.9	0.4	0.0	0.8	0.9	0.4	1.5	0.3	1.3	0.8	1.2	0.2	0.0	0.4	1.2	0.3	0.2	1.1	0.5	0.6	0.4	0.9	0.4	1.0	0.4	2.0	0.3	0.5	1.1	0.4	0.7	1.8	0.4	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	529.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.0
C11orf45	"FLJ43646, MGC35558"	ENSG00000174370	"Chromosome 11 open reading frame 45"	Q8TAV5	11	128899565-128906035	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Hofbauer cells: 8.1;Kupffer cells: 4.1;Late spermatids: 5.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;monocytes: 1.8;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.4;U-937: 9.6"									HPA039716	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA039716: AB_10672892"	"unprognostic (8.32e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.97e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.55e-9)"	"unprognostic (2.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.87e-2)"	"unprognostic (7.22e-2)"	0.7	4.9	1.1	0.3	5.3	0.4	0.7	0.0	1.0	0.9	0.4			1.2	0.3	0.4	3.3	0.9	2.1	5.0	0.7	0.9	1.6	0.2	2.8	0.3	1.1		0.7	4.1	4.7	3.7	2.1		1.2	0.6		1.7	3.6	0.0	8.0	0.6	0.1	1.5	1.6	2.0	1.0			1.8		0.6	1.7	1.8	0.4	3.5	0.0	1.8	0.0	1.1	0.6	2.4	4.8	0.0	0.0	0.1	0.4	1.8	0.8	5.1	1.9	4.8	6.9	6.2	0.0	3.5	0.4	4.4	2.5	2.5	12.4	0.9	0.0	1.2	0.3	3.0	0.0	0.2	0.0	0.0	0.3	1.7	1.4	0.8	4.1	1.1	3.8	0.0	0.3	2.1	1.3	2.7	2.5	2.0	1.0	3.5	1.2	5.0	0.5	4.4	1.2	0.0	0.2	2.0	5.7	0.4	1.4	0.8	4.1	0.6	0.0	7.1	0.0	0.8	0.1	0.0	0.0	0.9	9.6	0.2	0.0	1.8	0.0	0.3	0.8	0.7	0.4	0.5	0.5	3.5	0.4	1.1	0.7	0.0	0.0	0.0	0.7	0.0	0.6											0.0	0.3	0.0	1.0	2.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.6	1.4	0.0	0.0	0.0	0.7	2.1	0.2	0.1	1.1	0.0	8.1	0.0	0.0	0.0	4.1	5.7	0.0	2.6	0.0	1.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.9	0.6	1.0	0.0	0.0	0.7
C11orf49	"FLJ22210, MGC4707"	ENSG00000149179	"Chromosome 11 open reading frame 49"	Q9H6J7	11	46936689-47164385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040051, HPA040280"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA040051: AB_10795412, HPA040280: AB_10795363"	"unprognostic (3.11e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.34e-3)"	5.2	9.4	20.9	6.0	27.6	2.9	10.0	18.3	36.3	15.8	11.5	16.5	7.2	11.3	12.7	14.5	7.6	33.1	9.7	10.3	21.0	26.0	13.1	3.5	11.2	5.9	18.7	20.3	15.2	12.4	21.6	21.0	7.2	23.0	11.0	11.7	12.2	8.9	13.9	4.2	23.9	10.6	12.9	12.7	5.6	14.5	19.0	11.4	11.3	15.1	5.1	7.5	8.2	7.1	15.8	16.4	7.6	8.8	15.6	16.2	11.8	5.5	15.3	19.4	15.6	10.3	15.8	5.3	6.0	14.2	14.2	16.6	3.7	9.6	5.0	6.9	13.4	16.8	7.9	10.3	15.4	11.7	9.4	14.4	7.2	18.4	5.9	17.0	8.1	9.2	9.5	10.7	6.7	9.2	26.7	15.4	11.8	5.5	6.4	10.1	11.8	12.2	7.1	8.2	14.3	7.7	4.4	5.8	5.2	22.3	5.7	14.1	19.8	8.2	8.1	7.5	11.4	14.2	4.5	3.8	7.7	6.1	13.4	9.7	5.8	4.7	4.2	19.5	1.8	9.8	7.6	7.0	5.8	13.6	8.8	16.2	15.8	12.9	15.9	16.4	11.3	13.8	14.5	0.1	15.6	5.9	15.3	12.5	11.8	20.9	27.6	18.3	36.3	21.0	26.0	18.7	20.3	23.0	11.4	8.9	25.3	9.1	14.2	11.6	22.3	7.0	10.2	65.6	23.9	22.7	17.7	16.6	39.7	25.8	35.6	9.2	16.8	0.0	18.0	11.3	13.8	9.3	15.1	1.8	8.7	35.0	18.4	7.4	2.6	25.4	11.8	6.6	11.8	16.2	11.6	43.1	14.5	20.4	19.1	27.0	46.2	6.5	7.3	43.3	9.0	15.7	8.4	9.6	13.0	8.6
C11orf53	MGC50104	ENSG00000150750	"Chromosome 11 open reading frame 53"	Q8IXP5	11	111245805-111286401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 7.6"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 51.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA056128, HPA073101"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA056128: AB_2683046, HPA073101: "	"unprognostic (3.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.84e-2)"		"unprognostic (1.94e-1)"		"unprognostic (8.07e-3)"		"unprognostic (5.60e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.50e-1)"		"unprognostic (9.95e-2)"	"unprognostic (8.66e-2)"		"unprognostic (3.52e-2)"	1.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	2.6			1.2	1.6	0.0	0.0	1.8	2.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0		0.9	0.8	0.0	0.6	1.2		0.4	2.4		4.1	0.0	3.2	0.0	3.0	0.0	0.0	0.0	4.5	7.6			0.0		0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	11.2	0.0	2.1	0.0	51.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	6.6	0.3	0.0	0.0	0.0	2.5	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	1.7	3.5
C11orf54	PTD012	ENSG00000182919	"Chromosome 11 open reading frame 54"	Q9H0W9	11	93741591-93764749	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 123.3;liver: 55.9"	"Group enriched"	"Detected in all"	5	"Cholangiocytes: 165.6;Distal tubular cells: 150.9;Hepatocytes: 260.8;Proximal tubular cells: 596.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040088, HPA040511"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		640000	"Nuclear bodies"	Nucleoplasm	"HPA040088: AB_10795518, HPA040511: AB_10795369"	"unprognostic (3.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (5.06e-6)"	"unprognostic (2.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.53e-3)"	6.0	10.2	5.0	4.3	7.6	1.8	7.2	6.7	6.0	5.9	12.0	7.7	7.8	12.2	6.4	7.3	6.8	7.5	10.6	8.5	5.3	5.0	123.3	55.9	8.0	4.6	8.4	5.1	8.5	13.9	5.6	11.6	5.7	7.3	9.7	10.0	8.9	8.3	6.5	14.2	5.2	20.0	6.7	9.3	5.2	8.4	5.1	7.8	8.9	11.3	5.3	5.3	6.9	4.9	10.6	12.4	37.6	11.7	9.3	11.9	7.2	3.8	5.5	12.7	7.8	9.9	11.4	14.8	5.3	8.8	5.4	7.5	2.1	21.6	15.7	35.4	10.2	6.0	9.0	14.6	3.9	7.5	15.8	5.0	8.6	12.8	10.1	11.3	7.2	4.6	10.6	7.5	10.0	7.2	14.6	8.7	10.9	11.3	11.0	5.5	3.0	13.1	10.0	4.6	25.6	8.8	12.5	16.5	24.8	30.9	7.4	6.5	8.3	9.7	12.2	11.7	9.9	27.1	5.7	5.7	5.5	4.4	9.6	2.8	4.9	14.3	15.5	4.2	11.9	9.4	23.7	11.7	27.3	9.0	8.5	9.3	10.6	9.3	10.2	8.9	9.5	11.5	10.1	37.6	9.3	7.4	12.4	11.9	7.2	5.0	7.6	6.7	6.0	5.3	5.0	8.4	5.1	7.3	7.8	59.6	41.2	13.2	10.0	4.8	16.3	31.1	165.6	41.5	40.9	45.4	15.7	42.4	150.9	13.7	7.6	15.8	55.5	23.3	12.2	12.2	12.6	30.6	15.0	260.8	15.3	14.3	21.4	22.7	28.8	4.7	23.9	10.6	8.5	13.6	34.5	17.1	11.1	37.0	21.5	596.3	16.8	6.5	7.2	31.1	12.4	8.7	51.8	10.2	31.6	13.7
C11orf58	SMAP	ENSG00000110696	"Chromosome 11 open reading frame 58"	O00193	11	16613132-16756881	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036591, HPA076406"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA036591: AB_10669909, HPA076406: AB_2686798"	"unprognostic (8.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.30e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-1)"	44.5	47.1	34.7	37.8	49.0	34.7	40.5	59.7	43.0	40.3	42.1	32.3	29.7	27.3	54.1	35.3	51.6	36.3	34.0	55.1	32.4	33.3	42.6	56.4	41.6	43.0	36.5	38.9	54.2	39.6	35.8	53.7	58.9	35.7	42.0	23.6	30.6	40.1	36.3	69.5	36.4	28.4	43.0	38.9	41.1	35.1	27.5	33.9	50.6	47.6	32.6	36.5	52.0	39.2	97.7	91.8	87.4	74.8	67.4	91.1	123.2	66.2	53.4	63.9	31.5	35.6	32.5	45.0	66.0	34.4	44.0	40.3	50.5	63.0	57.3	53.1	40.0	49.6	38.8	43.0	31.1	47.7	75.2	46.0	50.6	46.1	45.6	44.1	72.4	45.6	32.1	43.6	26.1	57.7	36.2	30.7	36.5	63.3	40.0	37.7	38.8	77.6	35.3	47.3	31.9	30.5	63.2	64.5	30.1	34.1	38.0	43.9	45.0	57.7	43.9	78.4	39.6	39.0	50.3	57.2	55.2	45.2	66.0	62.3	26.8	99.0	79.7	48.1	42.3	50.4	78.3	65.8	87.4	72.2	72.9	83.0	97.7	80.2	75.8	71.4	89.3	91.1	78.9	31.3	67.4	74.8	91.8	81.5	123.2	34.7	49.0	59.7	43.0	32.4	33.3	36.5	38.9	35.7	33.9	229.3	197.2	206.1	231.6	228.4	159.6	184.4	135.0	259.6	228.6	190.1	141.4	273.3	363.1	215.1	28.5	242.4	57.2	116.8	199.0	283.9	266.4	215.5	227.9	146.0	198.9	135.1	152.8	152.9	158.4	25.1	190.7	234.1	217.6	267.9	113.4	201.7	195.9	92.6	192.0	246.7	201.4	155.2	279.5	283.4	219.5	241.8	379.3	210.4	107.6	232.0
C11orf68	"BLES03, P5326"	ENSG00000175573	"Chromosome 11 open reading frame 68"	Q9H3H3	11	65916808-65919117	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045938	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA045938: AB_10961633"	"unprognostic (3.18e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.50e-3)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.18e-1)"	20.1	13.1	23.5	11.0	23.5	6.9	15.4	44.0	42.9	24.5	19.7	20.0	16.6	13.6	26.3	33.0	19.0	25.3	16.4	24.5	22.9	18.8	13.7	12.1	15.4	17.3	18.3	23.7	32.9	17.6	20.6	11.0	19.5	18.6	23.3	12.9	14.8	24.2	27.5	37.0	19.6	13.1	22.2	15.5	19.0	14.1	21.5	18.5	23.0	21.5	13.1	16.4	22.3	23.1	6.6	3.6	12.6	5.2	4.9	7.5	2.8	20.4	9.2	5.7	6.2	20.2	19.6	4.9	16.4	25.2	21.0	12.9	3.4	23.3	4.2	11.5	24.6	33.7	6.7	4.4	10.1	11.4	6.5	4.4	5.0	6.2	8.9	16.1	3.9	6.7	18.1	15.2	15.2	16.9	21.9	15.6	7.2	6.6	10.6	38.1	9.3	5.2	9.6	5.7	4.5	46.3	7.7	6.5	11.8	11.1	3.9	3.9	6.1	6.3	8.4	15.8	6.2	10.8	3.8	16.8	33.6	16.4	45.6	8.3	7.1	3.1	3.5	19.9	3.0	26.1	8.7	3.5	4.9	7.4	5.2	5.2	4.2	4.8	6.1	2.6	6.6	7.4	7.5	12.6	4.9	2.6	3.6	5.6	2.8	23.5	23.5	44.0	42.9	22.9	18.8	18.3	23.7	18.6	18.5	14.9	6.1	6.7	24.0	13.6	10.2	13.7	15.3	0.0	1.2	15.7	9.8	13.0	6.6	11.6	6.3	10.5	10.0	0.0	10.0	13.3	15.8	19.5	3.5	9.6	12.3	15.9	4.6	16.0	11.5	19.9	19.8	6.6	10.1	14.4	11.6	22.3	13.9	0.0	33.2	5.1	7.2	19.4	12.5	13.9	14.3	11.2	18.3	8.7	8.4	22.4
C11orf70	MGC13040	ENSG00000137691	"Chromosome 11 open reading frame 70"	Q9BRQ4	11	102047443-102084560	"Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.5;testis: 54.7"	"Group enriched"	"Detected in many"	9	"Ciliated cells: 186.0;Early spermatids: 270.4;Spermatocytes: 221.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.0"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038585	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA038585: AB_10795357"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-6)"	"unprognostic (1.76e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.94e-2)"	"unprognostic (6.73e-3)"	2.5	3.7	2.9	1.1	4.2	0.1	3.1	0.7	1.4	5.9	1.6	5.4	11.6	0.8	5.3	11.9	2.3	25.5	4.9	1.7	3.9	4.5	3.0	0.3	7.2	1.2	1.7	1.3	7.5	0.8	3.7	13.7	4.0	16.0	5.6	0.8	4.2	1.1	7.0	0.5	1.6	0.8	5.5	1.9	0.2	1.6	54.7	2.2	0.0	3.3	1.1	0.8	3.8	2.5	0.6	0.3	2.3	0.6	0.3	0.4	0.2	0.0	6.7	6.8	0.0	6.1	14.8	0.2	2.6	6.8	3.7	5.2	0.5	8.7	0.0	1.6	5.2	1.8	1.7	1.6	0.8	2.7	0.0	1.0	0.0	1.1	0.0	4.3	0.0	0.0	6.3	8.5	9.5	6.4	7.2	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	10.0	1.9	7.5	0.0	8.6	0.1	0.0	0.0	7.6	0.0	1.0	0.9	2.9	8.9	2.1	0.1	0.0	0.0	3.0	0.0	0.4	1.6	0.6	0.4	0.3	0.2	0.2	0.5	0.3	0.3	0.1	0.6	0.4	0.3	2.3	0.3	0.2	0.3	0.2	0.2	2.9	4.2	0.7	1.4	3.9	4.5	1.7	1.3	16.0	2.2	0.0	3.4	0.0	5.8	10.2	0.3	0.0	2.5	186.0	13.6	0.0	2.0	6.6	0.0	0.0	270.4	0.1	0.0	0.0	0.0	0.2	8.0	1.2	1.1	0.0	0.4	0.0	9.1	1.3	0.0	24.5	10.6	1.1	5.0	0.0	0.4	7.8	0.0	0.0	5.3	0.0	0.8	12.9	2.8	221.4	17.7	4.0	1.6	0.0	0.0	1.8
C11orf74	"FLJ38678, HEPIS, NWC"	ENSG00000166352	"Chromosome 11 open reading frame 74"	Q86VG3	11	36594493-36659290	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 66.1"	"Cell type enhanced"	"Detected in all"	6	"Ciliated cells: 158.0;Early spermatids: 129.9;Late spermatids: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044880	Uncertain		Approved	Aggresome,Cytosol		NA	NA			"Aggresome, Cytosol"		"HPA044880: AB_10796908"	"unprognostic (9.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.65e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.24e-1)"	10.7	13.1	16.0	4.2	18.8	8.6	11.5	15.5	20.8	10.5	15.4	8.7	8.3	5.5	11.8	18.5	9.5	25.3	10.1	28.1	14.3	15.4	17.1	13.1	8.1	4.1	17.2	16.5	17.8	10.2	12.5	23.1	7.9	19.6	13.3	8.3	9.0	8.6	8.2	26.5	3.8	7.5	13.1	15.5	5.7	9.7	33.1	14.5	3.5	66.1	10.8	4.0	12.5	7.3	0.3	18.6	7.5	12.5	8.5	8.2	5.8	5.3	9.1	20.1	15.6	16.5	28.3	8.0	11.2	12.7	11.6	20.5	0.3	8.6	0.0	8.8	11.4	15.1	2.3	13.6	15.3	23.0	0.0	22.0	8.8	5.1	9.9	13.8	12.0	2.2	17.8	11.9	7.7	10.9	19.0	19.0	7.9	11.8	0.0	12.8	9.0	2.1	9.9	12.8	3.1	13.9	8.6	24.5	5.2	16.1	1.8	0.5	23.9	11.5	3.0	18.4	18.7	18.4	6.5	12.1	15.9	11.4	21.0	9.5	3.3	6.1	0.0	13.9	14.4	8.2	7.5	12.5	0.7	1.1	9.7	3.7	0.0	3.3	2.8	13.7	0.3	8.2	2.0	0.7	8.5	9.1	18.6	0.4	5.8	16.0	18.8	15.5	20.8	14.3	15.4	17.2	16.5	19.6	14.5	8.9	9.1	2.7	12.3	7.7	14.0	55.4	12.7	158.0	33.0	22.7	3.9	16.8	58.0	26.2	129.9	15.7	4.5	23.3	23.7	15.9	19.7	14.0	15.0	16.4	23.0	9.5	5.2	17.2	16.1	113.0	14.1	11.0	20.3	5.4	8.9	16.0	20.5	10.5	14.5	48.4	10.4	6.5	21.7	91.8	26.8	10.7	6.3	4.3	12.8	9.3
C11orf80	"FLJ22531, TOPOVIBL"	ENSG00000173715	"Chromosome 11 open reading frame 80"	Q8N6T0	11	66744451-66843328	"Predicted intracellular proteins"	Meiosis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 50.6;Late spermatids: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038932, HPA038933"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA038932: AB_2676275, HPA038933: AB_10671867"	"unprognostic (2.81e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.98e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.26e-1)"	2.8	7.6	15.0	12.9	15.0	4.8	10.3	26.2	11.9	7.1	10.1	1.7	4.7	7.7	5.9	13.3	16.4	5.4	4.6	4.2	8.3	7.2	13.4	2.2	4.4	5.8	5.0	11.9	3.3	4.7	10.9	12.4	3.9	8.0	10.0	9.0	5.5	10.7	9.5	1.3	35.6	17.3	4.2	2.7	6.8	5.1	15.2	2.5	15.1	3.6	7.6	15.3	4.8	8.8	10.6	9.7	3.1	1.0	1.7	4.2	0.7	8.7	4.7	9.6	6.5	0.5	3.1	1.8	3.7	4.4	4.4	5.5	16.1	10.7	14.3	2.1	3.0	2.9	16.0	4.4	5.6	4.4	3.6	2.6	2.3	5.7	4.0	1.0	1.6	2.7	0.8	19.5	3.4	6.5	6.7	13.9	5.4	4.1	5.5	2.6	9.6	5.7	5.2	15.2	25.1	6.5	3.3	4.5	11.0	19.0	3.0	7.1	7.2	6.0	16.8	13.0	8.8	11.6	1.1	6.1	3.1	5.7	3.3	5.3	3.9	8.5	10.3	3.5	2.8	3.9	1.9	0.9	3.1	2.1	0.5	3.7	10.6	3.8	3.0	0.5	8.9	4.2	3.5	2.3	1.7	1.0	9.7	4.0	0.7	15.0	15.0	26.2	11.9	8.3	7.2	5.0	11.9	8.0	2.5	17.9	5.1	14.7	2.8	10.3	3.0	0.4	0.0	4.0	5.7	33.2	17.7	1.5	8.3	15.1	50.6	1.6	14.7	23.3	10.4	1.9	3.5	3.2	4.6	0.9	2.8	0.0	13.2	1.8	1.2	92.7	2.3	1.8	3.3	7.2	9.1	1.5	12.6	10.8	0.4	3.5	7.1	6.5	2.2	11.6	24.7	17.6	1.3	6.1	8.1	2.7
C11orf95	MGC3032	ENSG00000188070	"Chromosome 11 open reading frame 95"	C9JLR9	11	63759892-63768775	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 15.3;Leydig cells: 17.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045002			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA045002: AB_2679179"	"unprognostic (4.23e-3)"	"unprognostic (7.24e-3)"	"unprognostic (6.47e-2)"	"unprognostic (9.01e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.85e-2)"	"unprognostic (6.60e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-3)"	7.3	4.7	6.0	3.0	6.3	0.6	9.3	3.4	7.9	11.1	4.3	1.9	7.2	2.1	10.5	4.6	4.2	6.8	7.0	5.2	4.3		6.3	3.8	3.5	3.4	0.1	3.7	14.2	5.3	4.7	1.6	7.3	2.5	5.9	2.0	3.3	5.6	7.4	4.4	1.2	1.9	8.8	1.5	3.5	1.9	3.8	1.0	4.9	6.6	3.4	3.2	5.0	15.1	0.6	0.7	1.0	1.5	2.3	0.9	0.3	2.1	2.9	22.3	7.4	11.6	13.5	3.5	8.2	5.9	3.9	2.7	7.1	1.4	6.9	12.0	7.8	2.9	4.9	9.6	3.3	4.4	6.7	6.5	4.6	4.8	3.2	4.1	2.2	3.8	10.0	1.1	6.3	2.1	12.8	8.6	6.3	5.8	3.1	6.2	2.8	8.2	11.4	10.4	1.3	8.5	19.6	4.2	2.2	5.6	2.7	9.4	19.9	3.9	4.2	10.9	9.5	5.9	5.4	13.4	7.9	7.4	10.1	4.7	2.9	3.7	8.5	2.1	5.7	4.0	0.0	0.1	0.0	0.8	1.5	0.4	0.0	0.2	0.9	0.0	0.6	0.4	0.6	1.0	2.3	0.3	0.7	0.0	0.3											0.0	4.0	1.4	1.0	4.5	4.1	6.0	15.3	1.4	1.2	0.0	0.0	5.4	3.3	2.4	0.1	5.1	0.6	0.0	1.8	0.4	9.9	1.3	1.1	6.8	1.3	6.4	4.7	10.4	2.1	1.2	17.0	2.1	3.3	5.4	3.2	10.2	2.4	0.0	7.4	3.3	2.9	12.9	7.8	0.4	3.8	3.0	1.3	0.0	2.1	0.9
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"		11	43942505-43944338	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"ovary: 152.0"	"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 445.9;Sertoli cells: 297.5;Smooth muscle cells: 1129.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 65.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	NA			"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"	68.2	81.2	4.9	23.4	17.4	3.4	42.6	2.6	10.5	39.7	32.2	3.3	6.6	12.4	35.1	41.5	16.3	69.3	70.0	34.3	8.8	7.9	17.9	67.7	61.9	4.9	7.6	4.7	152.0	18.1	3.8	14.2	14.6	32.8	28.6	6.2	7.6	2.3	12.8	38.2	10.1	17.2	22.9	15.3	12.7	31.3	41.7	4.2	0.0	16.7	14.0	2.3	62.9	32.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.6	0.7	0.0	0.0	0.0	0.7	0.8	0.5	0.0	0.3	3.3	0.2	1.4	0.0	0.0	0.7	65.3	0.0	0.0	6.0	1.9	0.0	0.7	0.9	3.1	1.3	0.8	0.0	7.6	0.0	1.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	17.4	2.6	7.1	8.8	7.9	7.6	4.7	32.8	4.2	6.0	166.6	0.0	14.6	82.5	15.3	5.3	0.0	1.4	2.3	0.0	2.0	1.1	0.0	2.2	3.5	30.5	0.0	0.0	0.5	3.5	142.9	42.4	12.8	2.5	3.3	1.6	0.0	114.8	6.9	5.8	199.6	9.5	165.4	0.0	0.0	2.3	2.8	0.0	445.9	0.0	7.6	297.5	1129.9	1.6	1.4	77.3	2.6	2.5	0.0	35.8
C12orf29	DKFZp434N2030	ENSG00000133641	"Chromosome 12 open reading frame 29"	Q8N999	12	88033846-88050160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039663	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA039663: AB_10795253"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.80e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.81e-2)"	"unprognostic (6.49e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.42e-1)"	7.9	12.9	13.3	6.1	20.0	11.5	14.5	12.6	19.6	10.2	7.1	5.7	7.8	6.3	9.4	14.8	24.9	8.2	8.0	8.7	13.6	12.6	10.4	15.5	7.2	9.2	14.9	15.0	11.7	11.3	8.7	15.1	7.6	12.6	11.5	7.4	3.1	11.8	9.5	10.1	19.8	6.6	9.1	15.5	7.8	8.6	9.5	13.2	9.3	13.9	8.8	12.1	12.3	16.4	7.5	2.8	6.8	1.7	5.6	11.7	5.6	9.5	6.2	5.7	6.4	11.6	15.2	4.6	12.3	10.0	10.7	9.2	5.7	3.6	16.9	1.8	6.2	5.8	8.2	11.1	8.6	17.7	7.5	12.7	15.0	5.0	5.1	15.1	19.0	6.8	10.7	12.0	9.6	12.5	11.3	7.9	7.5	13.9	3.4	15.6	3.3	12.5	8.1	8.8	7.6	13.0	7.4	9.8	14.3	11.6	7.8	13.9	12.6	7.3	16.5	7.9	4.6	10.5	11.4	6.6	9.3	3.4	9.7	9.4	8.5	11.4	11.3	7.2	13.4	8.3	6.8	1.7	1.3	7.1	1.7	9.7	7.5	8.8	7.6	2.3	5.3	11.7	9.0	0.0	5.6	1.5	2.8	7.3	5.6	13.3	20.0	12.6	19.6	13.6	12.6	14.9	15.0	12.6	13.2	8.9	12.8	13.7	22.3	45.7	13.8	14.3	22.9	21.4	20.5	5.2	5.9	12.8	31.5	20.6	19.5	12.6	3.6	23.3	20.9	13.3	26.0	20.2	10.4	15.5	8.2	9.5	7.5	9.8	8.5	13.2	29.7	6.7	25.3	3.6	7.4	10.0	18.1	3.5	29.0	25.2	17.9	6.5	35.0	42.3	32.3	62.5	7.8	19.1	11.2	23.8
C12orf4		ENSG00000047621	"Chromosome 12 open reading frame 4"	Q9NQ89	12	4487728-4538508	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037871	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA037871: AB_10670531"	"unprognostic (5.88e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.96e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.92e-1)"	12.4	9.6	15.6	13.6	20.8	12.9	12.1	22.1	28.3	11.8	12.0	9.9	7.2	6.9	11.1	9.1	12.4	10.3	10.7	11.6	17.7	11.4	10.5	9.4	10.7	14.7	11.7	19.0	12.4	10.0	11.2	22.7	15.4	22.0	12.7	13.6	6.8	9.5	11.5	17.9	9.4	10.4	15.3	14.5	14.4	10.2	14.1	13.6	13.4	13.0	9.5	15.8	12.8	10.2	5.0	7.0	2.7	13.8	4.2	6.7	4.4	8.4	6.5	8.1	9.5	8.1	12.1	17.1	16.3	6.8	15.0	18.4	11.4	7.0	7.2	3.4	10.5	12.4	6.3	11.3	9.4	20.5	21.3	7.7	12.4	6.3	5.6	11.8	10.6	11.7	10.7	5.5	18.0	20.3	9.5	8.5	8.9	7.3	12.5	14.0	4.0	8.4	4.5	11.8	7.3	6.2	9.2	12.7	4.5	9.3	8.8	3.2	6.3	11.1	8.1	6.8	23.0	3.4	9.2	8.8	13.1	12.1	14.3	17.0	2.9	3.8	17.6	9.7	8.8	12.1	0.0	7.8	2.7	4.6	12.8	5.0	5.0	4.5	4.6	6.7	5.0	5.0	4.5	2.5	4.2	13.8	7.0	6.7	4.4	15.6	20.8	22.1	28.3	17.7	11.4	11.7	19.0	22.0	13.6	14.9	8.1	11.0	3.0	2.6	12.9	12.5	5.1	9.4	10.3	3.5	27.5	5.9	3.3	6.1	40.6	6.5	3.8	0.0	7.2	6.5	7.5	2.3	1.1	3.8	23.7	7.9	5.8	8.0	13.6	12.3	7.5	6.6	1.7	5.4	4.6	6.3	6.8	2.6	6.3	4.1	11.4	6.5	6.9	18.2	14.3	2.9	5.1	7.4	5.0	1.8
C12orf40	FLJ40126	ENSG00000180116	"Chromosome 12 open reading frame 40"	Q86WS4	12	39626167-39908300	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	28	"testis: 26.4"	"Cell type enhanced"	"Detected in some"	29	"Early spermatids: 7.1;Late spermatids: 4.1;Spermatocytes: 21.8;Spermatogonia: 4.7"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"K-562: 7.7"	"Low region specificity"	"Detected in single"							HPA039032			Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039032: AB_2676316"					"unprognostic (1.75e-1)"								"unprognostic (2.76e-6)"	"unprognostic (3.45e-1)"	"unprognostic (1.96e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.8	4.7	0.0	0.0	0.0	0.0	0.0
C12orf43	FLJ12448	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: AB_2684597"	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	10.0	8.6	12.1	7.5	12.9	7.5	8.7	15.2	19.6	7.4	10.2	8.5	3.1	5.7	11.4	5.3	7.2	11.2	5.8	8.7	8.4	8.5	7.2	12.0	7.8	9.2	8.3	11.1	14.3	8.8	9.3	6.8	8.3	13.1	7.3	6.4	8.0	10.0	8.0	7.2	6.4	5.8	10.0	7.1	7.3	7.2	7.1	6.7	7.5	7.6	4.0	8.4	9.6	6.9	16.2	10.7	5.8	13.7	11.0	19.9	13.4	9.8	22.3	11.7	9.1	10.4	8.2	12.9	12.2	12.6	20.6	13.0	16.0	9.3	18.3	12.6	11.8	10.9	11.2	13.7	18.7	12.4	21.9	15.3	14.6	9.5	11.8	12.3	19.3	11.8	9.6	9.9	18.9	12.0	13.1	11.8	19.3	17.3	4.9	10.8	16.2	21.1	15.2	20.8	7.7	16.7	19.0	13.8	13.8	12.6	14.8	16.0	10.2	16.4	7.2	13.2	10.2	19.4	9.1	11.2	11.4	13.7	9.2	12.8	8.9	12.8	14.3	15.0	11.6	16.8	3.7	10.3	5.8	16.9	13.7	15.4	16.2	16.7	16.4	10.7	13.0	19.9	16.9	1.6	11.0	11.4	8.6	15.1	13.4	12.1	12.9	15.2	19.6	8.4	8.5	8.3	11.1	13.1	6.7	23.8	17.8	18.3	14.4	7.8	17.3	5.9	7.6	22.7	7.9	17.4	19.6	19.3	19.9	13.9	4.8	14.4	4.9	0.0	15.9	18.1	10.8	10.6	13.9	10.2	14.6	15.9	2.4	11.1	11.0	8.2	12.7	8.1	13.5	25.2	7.7	15.4	13.1	8.6	12.0	12.9	13.6	19.4	14.4	12.6	12.8	6.8	11.4	16.6	9.5	10.6
C12orf45	MGC40397	ENSG00000151131	"Chromosome 12 open reading frame 45"	Q8N5I9	12	104986310-105074197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 82.3"	"Lineage enriched"	"Detected in all"	13	"dendritic cells: 82.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038722	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA038722: AB_10673118"	"unprognostic (1.27e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.58e-10)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.19e-2)"	12.1	11.4	14.1	14.4	14.4	15.9	10.8	6.5	15.4	9.0	13.6	9.4	12.4	14.9	9.6	10.0	11.1	7.3	7.1	9.2	12.3	11.5	8.0	18.8	7.7	14.6	11.4	11.0	10.2	35.3	2.7	10.8	7.9	16.0	10.3	11.7	7.5	21.6	13.8	7.7	10.6	10.6	9.7	9.6	12.3	14.1	8.1	9.7	11.0	12.1	8.5	15.4	9.0	11.1	5.9	82.3	1.2	6.2	4.7	5.5	3.5	9.4	13.5	6.5	16.6	5.5	5.6	30.2	8.5	2.1	5.2	2.9	13.5	4.8	18.1	8.6	3.8	13.1	6.3	5.4	12.9	5.8	5.1	9.7	12.0	6.9	18.5	8.1	17.9	9.5	8.3	5.5	7.8	8.5	8.7	8.4	15.2	10.0	4.7	5.0	15.8	11.8	30.7	12.7	14.2	19.6	15.9	7.9	40.8	7.0	12.4	8.4	6.1	8.2	17.7	12.7	12.4	14.7	7.3	4.0	13.1	8.5	11.1	12.9	9.9	11.2	19.1	6.1	12.6	12.3	1.2	6.2	0.1	2.6	5.2	3.2	5.9	3.5	3.2	18.7	4.4	3.6	3.4	0.7	4.7	2.9	82.3	5.5	3.5	14.1	14.4	6.5	15.4	12.3	11.5	11.4	11.0	16.0	9.7	6.0	33.1	19.3	31.8	34.7	9.6	34.4	28.1	25.4	31.8	31.4	23.6	29.8	23.2	25.1	16.4	17.7	9.1	0.0	47.4	53.7	16.7	19.3	19.7	42.3	33.7	3.2	12.0	10.4	20.2	8.5	14.1	56.0	37.1	52.3	18.7	15.6	38.0	18.4	9.6	32.1	11.1	0.0	28.3	17.2	30.2	28.5	18.4	20.8	25.3	32.5
C12orf54	MGC35033	ENSG00000177627	"Chromosome 12 open reading frame 54"	Q6X4T0	12	48482503-48496512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	38	"testis: 34.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 2100.5"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 2.8;HBEC3-KT: 9.4;hTCEpi: 2.6;hTERT-HME1: 5.6"									HPA073090			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA073090: "	"unprognostic (2.59e-3)"	"unprognostic (5.49e-2)"	"unprognostic (7.94e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.99e-2)"		"unprognostic (5.96e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.37e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.92e-1)"	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.6	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.0	34.8	0.1	0.1	0.1	0.1	0.9	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	9.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.6	0.0	22.3	4.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	444.4	0.1	0.0	0.0	0.0	0.1	0.4	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2100.5	10.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	12.4	0.2	0.0	6.5	1.4	12.9	6.4	1.9	0.0	0.0	0.0	8.4
C12orf60	MGC47869	ENSG00000182993	"Chromosome 12 open reading frame 60"	Q5U649	12	14803572-14906586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 342.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA043911			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043911: AB_10963941"	"unprognostic (3.71e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.09e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-2)"	1.7	8.9	2.6	2.3	9.9	1.7	1.8	1.9	4.7	1.5	1.3	4.8	1.6	0.7	1.1	2.9	1.3	2.9	1.8	5.4	3.7	2.0	4.8	8.7	2.0	3.2	6.3	4.7	1.5	2.1	1.7	3.8	1.6	7.2	2.1	1.2	5.1	1.9	1.4	2.5	1.3	1.4	0.8	9.2	5.5	1.9	22.5	4.9	1.7	3.3	1.0	2.0	1.5	1.7	3.9	1.1	3.6	1.4	3.3	4.5	1.2	2.5	2.8	2.8	8.1	3.1	2.2	2.5	1.9	1.0	2.0	2.4	1.2	2.8	2.2	2.3	0.6	3.0	2.9	3.1	6.2	2.7	5.0	3.1	1.7	0.8	1.9	2.5	2.6	0.9	1.1	3.8	2.0	4.2	2.7	3.8	3.6	2.8	0.5	2.7	0.8	1.0	1.5	9.6	3.8	1.6	3.1	4.8	3.3	3.6	0.8	2.0	2.5	4.1	1.0	3.6	8.6	3.2	1.2	2.9	1.8	2.0	1.4	2.1	1.4	0.9	7.3	2.2	2.4	2.5	0.3	1.3	3.6	2.3	1.4	3.7	3.9	1.9	3.3	1.1	2.6	4.5	3.8	0.3	3.3	0.8	1.0	3.6	1.2	2.6	9.9	1.9	4.7	3.7	2.0	6.3	4.7	7.2	4.9	0.0	0.0	7.5	0.4	0.2	3.3	3.3	0.0	5.3	2.3	5.2	19.6	1.4	6.6	1.3	342.1	2.3	0.0	0.0	1.0	1.7	1.2	0.4	0.0	0.8	1.0	1.6	0.0	0.0	1.2	51.4	2.8	1.1	0.0	3.6	0.1	2.5	0.6	0.0	2.5	2.9	16.1	19.4	1.0	10.5	7.9	0.9	0.2	2.5	0.3	0.3
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123232916-123257959	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"		"Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	Yes			"Nucleoplasm, Cytosol"	Mitochondria	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favorable (7.82e-5)"	7.8	15.7	13.2	11.3	15.1	9.6	9.0	21.6	18.2	14.1	10.8	12.3	11.6	13.8	14.9	16.5	10.7	11.7	11.1	17.4	13.2	15.2	12.1	15.6	10.6	18.8	11.5	13.2	21.3	12.4	8.8	24.6	9.2	15.0	15.1	9.7	13.1	21.2	10.8	14.3	17.7	12.6	10.5	14.2	14.7	11.7	17.3	12.2	80.9	15.3	7.9	15.5	14.3	13.7	23.6	10.0	22.6	4.6	17.1	28.9	10.0	14.2	9.9	11.2	21.9	5.6	6.0	6.8	11.9	7.6	12.1	8.9	10.6	8.5	17.8	10.3	3.8	12.3	10.5	12.1	6.5	11.6	13.3	10.8	21.0	9.7	9.2	12.6	9.7	10.6	6.3	15.8	8.8	18.2	18.7	7.8	25.5	22.1	7.4	8.0	6.2	23.3	18.0	8.5	12.1	15.2	17.4	13.3	16.5	11.3	8.2	23.8	10.3	13.3	6.8	12.4	8.4	10.8	11.4	8.8	13.2	15.8	11.9	12.0	12.2	14.0	16.3	8.6	12.9	17.2	22.6	3.5	14.0	15.9	3.8	19.8	23.6	22.0	21.1	6.0	20.2	28.9	24.7	3.7	17.1	4.6	10.0	18.5	10.0	13.2	15.1	21.6	18.2	13.2	15.2	11.5	13.2	15.0	12.2	38.7	45.0	27.9	34.0	40.3	32.8	41.3	15.3	17.4	20.5	24.4	13.7	36.6	51.4	17.6	17.3	20.3	14.7	23.3	9.4	19.4	29.7	17.7	14.0	27.0	12.6	42.9	9.2	16.5	7.5	5.0	35.1	13.2	23.6	37.9	16.9	33.9	12.4	13.3	39.6	23.9	34.3	12.9	33.9	63.0	26.2	31.6	9.0	44.9	20.0	7.1
C12orf66	FLJ32549	ENSG00000174206	"Chromosome 12 open reading frame 66"	Q96MD2	12	64186316-64222296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046743, HPA052855"	Uncertain		Supported	"Lysosomes,Cytokinetic bridge"		Yes	No			Lysosomes	"Cytokinetic bridge"	"HPA046743: AB_2679782, HPA052855: AB_2681973"	"unprognostic (7.44e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.07e-2)"	6.0	9.7	6.9	6.0	14.5	2.9	10.2	4.4	11.5	5.7	5.1	15.7	4.5	5.8	4.9	9.4	7.9	7.5	4.7	4.2	7.5	6.8	10.2	15.3	5.2	9.4	21.7	6.8	7.6	13.9	14.8	5.6	3.9	9.4	4.6	6.0	4.3	6.4	6.0	9.1	10.3	5.2	4.5	12.3	8.6	5.5	6.0	11.7	5.7	10.5	6.0	8.6	6.3	6.0	8.4	4.4	0.4	2.7	3.7	10.3	4.4	4.9	7.9	1.5	4.3	4.1	7.0	4.2	2.7	3.4	4.1	2.6	2.5	4.0	15.7	3.9	2.2	6.7	5.8	6.4	4.9	4.5	11.9	4.3	5.7	1.9	2.3	5.4	6.1	3.4	5.3	8.4	5.4	9.8	4.7	2.9	11.1	7.8	10.5	4.1	9.5	7.0	5.4	7.2	5.9	6.3	3.5	4.6	12.0	6.2	5.8	3.6	3.6	4.5	6.2	4.4	4.1	10.1	4.0	2.3	4.1	2.8	4.1	2.6	14.1	11.5	8.8	6.3	5.4	4.6	0.4	2.7	0.2	3.7	2.5	6.2	8.4	6.9	5.4	4.4	7.5	9.8	9.1	0.3	3.7	1.7	3.1	10.3	4.4	6.9	14.5	4.4	11.5	7.5	6.8	21.7	6.8	9.4	11.7	3.0	2.4	10.0	7.5	2.2	2.3	2.8	10.2	1.4	6.8	8.7	2.0	5.4	8.3	3.4	9.7	3.7	1.6	0.0	4.5	3.3	2.4	3.8	1.1	10.2	4.2	0.0	4.1	1.3	4.3	5.7	4.4	4.1	1.7	1.0	2.5	2.0	2.7	3.5	1.8	9.9	1.3	0.0	3.2	3.9	9.3	3.8	1.5	6.9	3.5	3.8
C12orf71	LOC728858	ENSG00000214700	"Chromosome 12 open reading frame 71"	A8MTZ7	12	27081058-27082514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 3.8;skin 1: 2.5;testis: 7.4"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 9.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	23	"NK-cell: 4.1"	"Lineage enriched"	"Detected in single"	23	"NK-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.7;JURKAT: 2.1"									"HPA038359, HPA058728"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA038359: , HPA058728: AB_2683800"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-8)"	"unprognostic (4.85e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.1	0.0	0.1	0.4	0.1	3.8	0.2	0.8	0.3	0.4	0.1			0.2	0.1	0.0	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.3	0.0		0.1	0.3	0.0	0.1	0.0		0.2	0.0		0.3	0.0	0.5	2.5	0.4	0.0	0.0	0.5	0.1	7.4			0.1		0.0	0.2	0.2	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.5	0.2	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	5.7	0.0	1.2	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.4	0.1	0.0	0.0	0.5	0.3	0.9	0.4	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.3	0.0	0.4	0.2	0.1	0.9	0.0	0.6	0.3	0.1	0.0	0.1	0.0	0.6	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1
C12orf73	"DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103950202-103965708	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.8"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Secreted - unknown location"	NA	NA			"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favorable (1.61e-4)"	6.7	11.4	14.3	8.3	14.5	4.4	9.7	15.5	17.5	7.2	7.4	11.4	7.2	7.7	9.5	13.2	7.0	8.9	5.5	11.1	13.0	14.6	9.4	8.3	5.8	10.0	13.3	13.3	11.5	9.7	9.4	21.0	7.3	13.6	10.7	9.5	8.3	8.3	11.1	43.8	9.0	7.7	7.9	14.1	7.0	9.9	10.1	13.8	11.4	11.5	12.9	10.2	6.6	6.9	11.7	11.3	8.6	5.1	12.0	14.5	3.9	5.9	11.1	16.9	10.3	4.9	6.4	11.0	6.4	3.9	7.2	5.9	11.8	5.2	7.0	8.6	3.9	6.3	9.6	10.0	8.2	5.5	10.1	20.3	10.6	16.3	14.8	7.2	15.6	9.7	5.7	9.4	3.6	6.4	17.6	6.6	20.6	13.6	4.8	6.6	6.8	17.3	23.6	8.2	5.7	19.0	10.0	6.3	6.9	9.4	8.0	27.7	9.5	6.5	11.3	14.9	7.6	19.3	8.5	3.3	8.8	4.9	6.5	6.5	13.1	20.1	14.7	10.0	8.9	7.7	7.3	5.1	8.6	10.5	4.2	10.4	11.7	9.8	10.0	7.2	10.7	14.5	13.5	1.4	12.0	3.8	11.3	13.8	3.9	14.3	14.5	15.5	17.5	13.0	14.6	13.3	13.3	13.6	13.8	6.0	5.0	6.7	8.5	5.4	16.5	14.9	7.6	13.4	5.7	8.7	0.0	9.7	23.2	20.3	59.5	6.7	9.2	0.0	10.6	10.4	7.6	8.0	9.2	11.6	14.8	7.9	10.9	6.2	8.3	25.4	8.1	7.1	1.7	11.8	10.9	12.3	16.5	3.5	8.1	17.7	13.1	6.5	7.2	23.1	21.2	4.5	7.4	4.9	11.5	7.0
C12orf74		ENSG00000214215	"Chromosome 12 open reading frame 74"	Q32Q52	12	92702843-92708549	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"memory B-cell: 3.7;naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	21	"B-cells: 3.7"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;RT4: 2.5;SK-BR-3: 2.8"									HPA062856			Approved	"Nucleoplasm,Nuclear bodies,Aggresome"		NA	NA			Nucleoplasm	"Nuclear bodies, Aggresome"	"HPA062856: "	"unprognostic (2.75e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.28e-3)"	"unprognostic (4.55e-3)"		"unprognostic (7.95e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.57e-1)"		"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.83e-4)"	"unprognostic (3.03e-1)"	"unprognostic (5.89e-2)"		"unprognostic (1.42e-2)"	0.2	0.1	0.1	12.3	0.1	0.0	0.2	0.1	0.1	2.1	0.7	0.0	3.6	0.3	0.7	6.9	1.7	4.5	0.3	0.2	0.1	0.1	1.3	0.5	6.6	1.9	0.1	0.0	1.0	1.1	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.9	0.9	0.1	0.2	1.8	0.0	0.1	2.6	2.1	0.5	0.0	0.1	0.2	0.0	10.5	2.5	1.4	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	2.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C12orf75	"AGD3, OCC-1, OCC1"	ENSG00000235162	"Chromosome 12 open reading frame 75"	Q8TAD7	12	105235290-105396097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 97.7"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 712.9;Extravillous trophoblasts: 1087.5;Proximal tubular cells: 486.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 97.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 97.7;T-cells: 26.3"	"Cell line enhanced"	"Detected in many"		"BJ: 120.7;BJ hTERT+: 67.7;fHDF/TERT166: 55.7;RPTEC TERT1: 55.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065311	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA065311: AB_2685463"	"unprognostic (5.96e-2)"	"unprognostic (3.85e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (8.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.00e-2)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.47e-3)"	7.1	3.4	5.5	17.1	5.3	4.2	14.3	3.4	3.3	22.3	10.9	4.9	57.0	4.1	12.8	9.5	5.7	9.7	48.8	3.6	3.5	6.4	37.5	1.4	8.1	6.0	5.4	2.5	7.7	26.8	15.2	2.5	15.0	4.6	19.6	10.2	1.3	3.4	54.9	16.8	5.7	7.7	3.1	4.7	5.7	22.4	28.4	3.7	13.5	2.0	6.5	8.7	4.7	18.1	2.7	97.7	4.3	0.2	9.6	26.3	11.3	5.3	8.6	2.2	1.9	8.3	16.0	3.9	120.7	67.7	25.8	14.7	17.2	0.4	1.5	48.4	55.7	4.3	9.0	4.7	6.5	28.7	29.1	8.9	5.0	2.4	3.3	1.1	3.7	5.2	6.7	1.6	8.8	9.7	15.2	3.3	9.6	0.2	8.0	25.2	1.8	15.6	33.8	5.1	2.0	19.5	2.7	5.8	1.4	55.8	0.5	9.8	2.3	4.7	1.0	1.9	6.2	3.0	0.9	5.8	26.9	10.1	10.4	15.0	4.6	7.3	7.4	6.1	1.2	7.3	4.3	0.1	0.1	25.9	0.0	12.4	2.7	11.2	26.3	3.4	1.7	3.2	16.2	0.5	9.6	0.2	97.7	20.5	11.3	5.5	5.3	3.4	3.3	3.5	6.4	5.4	2.5	4.6	3.7	3.0	3.2	69.2	50.0	89.1	3.6	0.6	236.9	100.4	25.0	177.9	3.9	20.0	712.9	456.1	123.1	11.9	114.3	0.0	196.9	1087.5	96.3	39.4	2.3	1.5	26.7	60.4	320.1	10.4	2.1	216.0	14.4	17.3	57.3	34.3	54.4	2.0	293.7	42.5	4.6	486.9	4.8	6.5	176.9	110.5	92.4	53.4	34.0	103.3	55.5	26.7
C12orf76	FLJ40142	ENSG00000174456	"Chromosome 12 open reading frame 76"	Q8N812	12	110027028-110073686	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 47.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA039713, HPA042013"	Uncertain		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Actin filaments"	"Plasma membrane"	"HPA039713: AB_2676640, HPA042013: AB_2677797"	"unprognostic (9.20e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"prognostic favorable (6.44e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (2.09e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	5.7	8.8	34.6	8.4	26.1	11.6	9.4	19.7	47.6	6.6	6.1	32.6	2.5	7.6	8.1	14.0	5.9	12.0	6.7	5.3	36.1	33.5	8.5	7.9	9.7	11.4	36.2	21.2	11.9	8.4	5.1	7.5	9.4	26.1	7.5	6.4	5.9	7.7	7.9	8.3	14.6	7.4	5.3	38.7	11.1	9.2	9.8	27.4	4.8	11.1	1.8	7.9	6.3	5.0	14.0	12.8	31.3	9.4	14.3	16.3	11.1	6.3	9.4	11.4	10.3	8.2	16.9	12.6	5.6	3.2	5.4	4.1	7.7	6.2	7.8	6.7	2.5	4.2	12.6	4.7	4.6	4.1	11.6	10.0	7.8	14.3	15.5	7.8	12.7	15.3	13.5	15.4	4.7	8.7	19.7	8.5	12.7	11.6	20.5	5.6	6.8	6.4	20.9	8.9	4.0	8.6	12.2	7.0	12.6	9.8	6.2	22.9	12.4	7.0	5.2	12.5	12.0	11.4	6.6	10.8	8.3	6.0	6.3	3.3	9.4	10.8	6.4	9.1	7.3	4.7	31.3	9.4	11.2	8.3	6.2	9.2	14.0	13.1	9.3	8.8	11.8	16.3	10.6	12.8	14.3	6.1	12.8	12.6	11.1	34.6	26.1	19.7	35.1	36.1	33.5	36.2	21.2	26.1	27.4	29.8	14.2	10.7	13.8	7.0	23.3	6.3	20.4	36.1	10.3	15.7	2.0	24.1	29.9	10.0	16.2	13.1	6.3	0.0	13.2	8.0	13.6	10.2	4.7	17.3	22.8	30.2	5.8	16.5	19.2	9.0	24.2	16.1	18.6	15.4	11.0	32.3	9.6	7.0	31.8	32.3	20.5	6.5	14.4	26.2	10.1	7.4	10.1	20.8	10.7	5.8
C14orf119	FLJ20671	ENSG00000179933	"Chromosome 14 open reading frame 119"	Q9NWQ9	14	23094765-23100462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003638	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA003638: AB_2243669"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.26e-3)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.63e-1)"	28.2	35.0	16.3	22.0	18.5	9.2	38.9	11.6	17.3	30.4	28.4	17.0	23.9	22.6	29.9	30.3	32.0	23.5	22.4	29.6	16.3	19.9	36.3	24.6	30.4	37.3	22.4	15.1	25.2	39.4	16.7	28.1	32.2	23.1	27.9	35.8	27.1	28.0	28.1	21.2	20.7	27.4	33.5	20.1	33.8	28.2	33.0	16.7	27.2	40.0	26.3	33.1	25.8	24.0	34.6	37.4	72.7	40.2	30.2	45.0	43.7	13.8	13.7	20.7	12.5	45.7	39.8	16.7	23.2	34.4	30.7	36.6	10.8	21.5	10.5	12.1	37.6	37.3	23.7	19.6	30.8	42.7	16.7	9.6	15.9	11.4	46.2	36.0	23.7	24.8	48.5	27.9	25.8	19.1	28.1	33.5	19.2	10.5	11.8	33.6	19.8	11.1	18.4	13.0	32.2	21.0	9.9	15.4	12.1	34.8	22.3	10.0	9.1	19.4	18.3	20.1	24.1	12.3	13.8	26.9	14.6	12.8	21.9	10.4	11.1	13.0	12.9	13.4	15.1	13.0	63.7	40.2	72.7	32.6	25.7	37.1	34.6	37.2	36.2	37.4	28.5	39.1	38.3	23.8	30.2	17.3	25.2	45.0	43.7	16.3	18.5	11.6	17.3	16.3	19.9	22.4	15.1	23.1	16.7	44.7	41.3	39.3	73.7	23.6	28.7	21.4	30.6	38.8	46.6	29.6	7.9	76.0	109.5	81.1	13.7	45.7	39.3	23.3	74.5	84.3	43.6	40.4	52.1	27.7	93.8	19.1	27.2	43.6	42.9	11.4	59.2	57.9	45.5	111.0	43.7	31.3	81.5	43.2	45.6	76.4	15.4	32.3	37.6	25.0	24.6	29.6	119.7	48.4	45.4	67.4
C14orf28	DRIP-1	ENSG00000179476	"Chromosome 14 open reading frame 28"	Q4W4Y0	14	44897295-44907257	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 147.4;Late spermatids: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059635			Approved	Cytosol		NA	NA			Cytosol		"HPA059635: AB_2684091"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.06e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.33e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.01e-1)"	8.8	5.3	5.0	4.1	5.6	1.6	11.8	4.0	6.2	13.3	10.3	7.2	10.7	7.3	14.4	8.4	6.5	9.2	8.9	8.5	4.8	4.1	5.1	14.4	5.1	4.4	10.6	4.3	12.4	12.4	4.4	5.0	5.7	5.6	12.8	5.8	5.9	11.4	8.7	7.4	5.9	9.0	20.4	5.4	5.9	8.5	16.1	5.4	1.7	6.6	3.2	5.0	19.0	9.2	6.8	3.4	6.9	3.5	3.9	9.7	2.1	2.4	1.7	3.3	5.6	6.6	3.5	7.4	4.9	5.4	2.4	3.8	0.1	3.1	3.2	2.9	3.3	5.4	1.3	0.8	2.3	4.2	11.7	0.6	1.5	0.8	3.3	1.9	1.4	3.7	2.8	4.0	0.7	3.9	4.6	1.3	3.9	0.8	4.5	1.8	4.7	1.3	2.7	0.6	4.6	1.9	2.3	4.0	1.3	3.3	3.1	0.7	1.0	2.0	4.0	2.1	2.7	7.1	1.4	2.0	9.1	4.4	1.5	1.0	6.3	5.1	2.1	2.6	0.7	2.8	1.8	1.7	6.9	4.3	2.6	4.9	6.8	4.4	5.6	2.0	5.1	9.7	5.5	3.8	3.9	3.5	3.4	4.8	2.1	5.0	5.6	4.0	6.2	4.8	4.1	10.6	4.3	5.6	5.4	3.0	2.4	6.2	7.6	2.7	3.2	10.3	0.0	0.0	2.3	5.2	0.0	4.6	8.3	7.7	147.4	5.6	5.4	0.0	7.5	3.8	8.0	8.6	1.1	9.6	4.1	3.2	2.9	6.2	4.3	91.1	9.8	2.8	5.0	4.6	7.5	3.1	6.1	3.5	15.2	12.8	2.9	19.4	10.8	19.2	9.4	3.9	5.5	8.7	4.9	5.8
C14orf37	UT2	ENSG00000139971	"Chromosome 14 open reading frame 37"	Q86TY3	14	57999735-58298139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 32.1;Club cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.2;AN3-CA: 7.0;fHDF/TERT166: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001580, HPA001789"	Enhanced		Approved	"Plasma membrane"		NA	NA		270000	"Plasma membrane"		"HPA001580: AB_2666366, HPA001789: AB_1078328"	"unprognostic (2.56e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.87e-8)"	"unprognostic (5.22e-6)"	"unprognostic (4.93e-2)"	"unprognostic (8.74e-4)"	"unprognostic (3.01e-4)"	2.8	5.3	11.4	1.5	11.7	1.8	2.4	10.1	14.0	4.1	2.3	3.9	1.1	1.6	6.7	4.0	1.9	4.7	3.9	6.3	8.6	4.6	16.5	2.2	1.8	1.1	5.1	7.8	9.3	2.4	9.2	5.8	1.4	21.5	4.0	2.7	3.9	2.0	3.3	1.2	2.5	1.8	5.0	3.3	1.3	3.0	5.1	5.0	0.0	3.4	0.3	0.9	2.6	3.0	0.3	0.6	0.5	0.3	0.1	0.0	0.0	0.0	0.0	11.2	7.0	5.5	2.3	0.0	2.2	1.7	0.4	0.3	0.5	0.1	0.0	0.7	12.2	1.4	0.1	3.5	0.0	0.5	0.1	1.1	0.0	0.0	0.5	0.2	0.0	5.6	2.4	0.2	0.2	0.2	3.1	0.5	0.9	0.1	0.3	1.4	0.3	0.0	0.0	5.2	0.0	2.3	1.6	0.3	2.7	4.5	0.5	1.3	0.1	0.1	0.0	0.3	3.3	0.3	0.2	0.1	1.7	4.2	0.6	2.9	0.4	0.3	0.0	3.5	0.3	1.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	11.4	11.7	10.1	14.0	8.6	4.6	5.1	7.8	21.5	5.0	3.0	6.5	0.0	7.4	1.3	3.5	0.0	0.0	32.1	20.5	0.0	0.0	0.2	0.0	0.0	1.7	3.0	0.0	0.0	0.0	0.3	4.5	1.3	4.7	2.0	0.1	0.0	0.0	3.1	2.6	0.0	9.2	1.1	3.3	0.0	2.3	9.4	0.0	0.0	9.9	0.0	2.7	0.0	1.4	2.3	2.3	1.8	0.2	1.3	0.3	5.4
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 70.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	1.0	2.7	0.0	0.6	0.2	0.0	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4	1.7	0.0	0.6	16.9	0.0	0.2	1.6	0.0	1.6	6.7	0.1	3.8	0.0	0.3	0.1	0.5	0.0	0.6	14.9	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	4.7	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.6	0.0	0.1	0.0	21.7	0.0	0.0	1.6	0.0	17.6	0.2	2.3	0.0	1.1	0.0	4.8	0.0	0.3	1.2	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.6	0.0	1.4	5.7	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	3.2	0.0	0.0	0.0	5.1	0.3	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.7	0.0	1.0	0.0	0.0	70.5	6.1	0.0	0.0	0.0	0.0	0.1
C14orf93	"FLJ12154, RTFC"	ENSG00000100802	"Chromosome 14 open reading frame 93"	Q9H972	14	22985908-23010166	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002569	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Plasma membrane"		"HPA002569: AB_1078334"	"prognostic favorable (5.05e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.11e-2)"	10.4	6.1	10.2	11.8	7.3	12.4	9.8	14.3	7.9	12.0	12.2	8.3	16.7	8.1	10.8	13.5	10.3	11.1	10.3	7.2	9.6	4.6	10.3	9.7	8.7	10.3	6.8	5.9	12.2	15.9	12.9	18.9	5.4	7.4	11.0	10.9	9.1	9.8	10.2	7.3	20.3	9.4	8.4	11.0	12.9	9.5	5.8	9.0	22.7	16.3	7.8	14.6	11.6	9.5	9.7	8.8	21.3	11.3	8.8	12.4	6.6	3.9	7.4	6.3	8.8	10.2	22.9	8.8	4.6	7.2	3.7	4.9	4.6	11.7	11.1	4.4	4.2	5.2	8.4	3.8	11.7	3.5	4.3	2.7	7.0	9.0	10.5	8.9	5.0	6.0	16.5	9.2	5.5	7.0	13.5	6.8	7.2	7.5	2.4	3.8	11.1	6.4	9.4	2.1	8.5	5.2	10.4	6.0	6.7	4.8	6.0	23.0	10.0	6.2	6.0	6.3	7.1	9.3	8.9	3.8	7.0	9.3	3.1	4.6	8.6	2.3	7.6	4.8	6.3	7.1	11.7	7.5	21.3	8.3	6.9	7.3	9.7	6.8	8.6	8.8	9.4	10.2	9.8	10.7	8.8	11.3	6.2	12.4	6.6	10.2	7.3	14.3	7.9	9.6	4.6	6.8	5.9	7.4	9.0	8.9	0.6	4.7	4.8	2.7	1.2	2.8	2.5	5.3	1.2	0.0	3.9	3.0	6.6	2.8	0.5	2.9	2.9	0.0	2.6	4.3	2.4	2.0	6.9	1.1	3.3	0.0	15.1	1.3	2.7	1.0	4.0	3.4	5.0	0.0	5.2	2.9	3.4	7.0	3.9	3.0	1.9	6.5	3.1	1.5	7.9	1.4	2.5	4.3	4.9	1.4
C15orf38-AP3S2		ENSG00000250021	"C15orf38-AP3S2 readthrough"		15	89834308-89912882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.7;Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040513, HPA047173, HPA049270, HPA052278"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA040513: AB_2677015, HPA047173: AB_2679969, HPA049270: AB_2680696, HPA052278: AB_2681783"	"unprognostic (1.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-2)"	15.1	13.5	13.3	12.0	14.4	7.1	20.3	11.4	16.4	17.4	22.2	16.7	11.4	13.3	15.3	20.1	17.0	12.3	16.4	20.7	13.1	17.1	13.9	23.5	13.1	10.0	16.5	11.5	17.9	52.9	14.8	10.9	11.6	12.9	19.9	19.7	14.5	12.5	15.4	21.1	9.7	23.7	14.4	17.5	9.8	9.7	11.7	9.1	2.5	14.3	12.0	9.9	15.4	13.5	5.2	14.8	13.9	19.8	7.5	7.1	11.1	6.8	14.7	11.7	15.6	17.4	8.0	8.4	12.0	13.9	15.4	15.5	4.9	15.9	3.6	12.7	10.2	12.9	8.7	9.6	10.6	10.6	7.6	9.0	5.3	7.0	10.7	10.4	2.6	4.2	9.6	9.0	9.1	9.8	8.7	13.7	4.7	4.9	8.8	11.8	9.6	4.0	4.2	12.3	17.3	3.7	3.0	5.1	2.8	14.8	8.0	4.0	6.2	21.5	21.4	16.4	16.0	14.0	5.3	7.0	13.8	10.3	19.3	7.7	3.3	7.9	4.1	12.0	3.7	10.2	7.1	19.8	8.4	5.5	16.3	7.1	5.2	6.7	5.9	14.8	4.9	5.0	5.0	13.9	7.5	11.9	6.2	6.7	11.1	13.3	14.4	11.4	16.4	13.1	17.1	16.5	11.5	12.9	9.1	3.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
C15orf40	MGC29937	ENSG00000169609	"Chromosome 15 open reading frame 40"	Q8WUR7	15	82988441-83011641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042980	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042980: AB_10964298"	"unprognostic (8.30e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.55e-3)"	"unprognostic (7.71e-2)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.51e-2)"	13.5	16.3	14.3	11.1	15.4	15.1	13.5	15.9	15.8	10.9	13.9	15.0	16.3	16.3	9.6	24.2	10.8	10.6	10.1	9.0	13.1	9.1	17.2	16.3	9.2	16.0	13.2	13.8	13.9	16.7	12.3	14.1	9.0	12.7	10.3	10.0	11.9	13.8	12.1	13.4	18.2	16.8	10.6	10.5	13.8	11.3	14.3	10.3	14.3	16.0	11.9	12.5	9.9	10.4	27.9	18.8	27.0	14.1	26.5	24.7	12.2	9.1	11.6	7.6	10.4	9.7	9.0	7.3	6.0	9.8	5.9	6.8	8.4	16.3	10.0	8.4	4.6	14.8	17.8	16.9	12.5	6.8	19.0	11.8	9.4	15.6	9.6	9.6	15.6	10.0	7.9	17.6	9.9	11.3	8.0	10.3	26.4	12.8	16.6	5.7	9.4	13.3	8.5	13.4	14.2	7.9	17.9	10.8	13.3	10.2	14.4	18.7	11.4	16.0	11.5	22.6	10.3	14.5	9.3	6.6	12.9	18.1	9.7	10.8	15.4	23.4	18.9	16.2	16.1	14.0	27.0	14.1	18.8	19.3	13.6	21.1	27.9	20.5	19.9	13.2	24.4	24.1	20.7	15.1	26.5	12.6	18.8	24.7	12.2	14.3	15.4	15.9	15.8	13.1	9.1	13.2	13.8	12.7	10.3	26.8	23.8	25.3	23.3	10.6	26.7	10.1	43.3	62.9	50.0	24.4	11.8	40.7	79.6	40.9	25.5	18.5	46.7	23.3	48.5	24.2	18.6	24.2	25.6	32.6	26.7	28.6	27.6	20.9	27.8	25.0	30.8	31.9	25.3	40.5	29.1	29.3	50.2	27.1	33.9	93.6	27.5	19.4	15.3	101.2	55.6	13.4	29.7	32.4	31.5	21.3
C15orf41	"FLJ22851, HH114, MGC11326"	ENSG00000186073	"Chromosome 15 open reading frame 41"	Q9Y2V0	15	36579611-36810248	"Disease related genes, Predicted intracellular proteins"			"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 79.9"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 94.8;Early spermatids: 108.6;Late spermatids: 112.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061023	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061023: AB_2684417"	"unprognostic (1.82e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-6)"	"unprognostic (1.22e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.58e-1)"	2.3	4.1	3.4	4.1	8.9	0.8	2.4	4.2	4.1	5.5	4.0	2.8	3.5	4.9	8.8	2.7	7.0	3.3	4.7	79.9	2.5	2.4	2.3	2.8	2.9	1.9	3.1	2.3	3.6	1.9	2.7	3.5	1.8	2.8	5.4	2.7	2.7	3.5	5.3	7.9	4.2	3.0	16.0	3.4	2.0	2.8	4.9	3.7	2.8	2.2	7.2	3.9	7.7	6.2	3.6	2.4	0.4	2.1	4.9	7.8	2.0	13.2	7.1	9.0	3.4	9.9	12.1	3.7	6.4	3.2	8.1	6.7	9.8	5.3	2.1	6.5	15.6	6.0	24.4	9.3	5.5	9.4	1.0	6.5	6.9	6.6	7.1	9.0	6.0	5.2	9.0	6.1	6.9	3.8	6.2	7.7	6.8	8.8	2.2	11.1	6.0	1.8	3.4	4.9	6.1	3.6	5.5	2.5	1.4	5.2	18.2	5.2	3.3	4.3	4.3	3.4	7.0	4.0	9.2	5.4	8.0	4.4	5.3	1.7	5.4	7.4	9.8	10.1	10.5	7.3	0.0	0.8	0.4	4.3	2.1	3.9	3.6	3.4	4.2	2.4	3.5	4.1	3.5	0.1	4.9	0.8	1.8	7.8	2.0	3.4	8.9	4.2	4.1	2.5	2.4	3.1	2.3	2.8	3.7	0.0	0.6	0.8	16.5	9.6	7.7	94.8	5.1	2.7	2.3	0.0	31.4	6.8	5.0	3.4	108.6	4.5	1.3	0.0	1.2	5.6	4.6	5.1	0.0	2.1	1.7	7.9	1.2	4.9	2.2	112.4	2.8	1.3	1.7	0.0	2.0	2.7	3.9	0.0	3.5	1.4	15.6	0.0	6.2	4.4	4.7	8.5	9.0	2.2	2.4	22.3
C15orf59	"INSYN1, LOC388135, MGC131524"	ENSG00000205363	"Chromosome 15 open reading frame 59"	Q2T9L4	15	73735431-73752747	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 24.1;heart muscle: 16.2"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 8.5;Cardiomyocytes: 12.5;Muller glia cells: 6.8"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.6;fHDF/TERT166: 7.7;HEK 293: 7.9;NTERA-2: 4.9;SK-BR-3: 6.9;U-2 OS: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Nucleoplasm, Cytosol"		"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	1.2	1.9	9.3	0.4	9.7	0.0	0.9	5.5	24.1	2.2	0.7			0.3	1.0	2.4	9.4	6.5	1.5	16.2	9.1	8.3	3.5	0.0	1.7	0.0	14.4		4.8	1.0	0.0	0.7	0.2		4.5	0.2		0.7	10.1	1.4	8.4	1.0	2.1	4.2	0.0	0.8	1.9			0.4		0.4	1.6	3.8	0.8	0.6	1.5	0.5	0.8	0.5	0.0	0.0	0.5	2.9	1.8	11.6	0.2	0.0	1.5	0.0	1.0	0.0	0.0	0.0	0.1	1.0	7.7	1.6	3.0	2.5	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.9	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.7	1.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.7	0.6	6.9	0.7	1.8	3.1	0.2	0.1	1.9	6.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.5	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.1	0.8	0.5	0.5	1.5	0.8	0.3	0.6	0.3	0.0											0.0	0.3	0.0	0.4	0.0	8.5	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521068-67530143	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Vesicles"	Cytosol	"HPA062820: AB_2684874"	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favorable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	9.9	10.0	10.8	4.7	18.1	11.0	17.9	14.5	17.2	5.5	6.0	2.4	5.6	7.5	6.3	5.9	5.5	5.2	5.1	21.0	8.7	7.2	8.4	6.4	7.2	7.5	6.9	10.9	7.9	20.7	8.8	10.9	5.8	7.3	7.2	6.4	5.9	7.0	6.4	45.8	8.4	5.0	7.0	5.8	5.0	6.6	25.2	5.5	3.6	7.7	16.9	3.7	4.6	8.0	7.2	7.2	10.7	6.6	5.1	9.8	5.0	4.2	4.6	1.2	5.1	5.4	7.8	3.3	1.9	3.4	3.5	2.8	3.5	3.0	3.6	4.1	2.1	4.1	5.0	4.6	1.3	2.9	2.1	10.9	3.8	3.5	4.6	3.5	4.7	3.2	8.1	3.5	1.1	4.3	2.5	1.6	11.1	4.3	8.0	1.1	2.4	3.8	7.7	1.9	3.4	5.8	5.2	2.6	13.1	2.5	3.0	6.8	5.1	3.3	3.2	5.8	2.3	2.8	7.2	1.6	4.7	7.2	5.9	4.8	7.6	11.0	8.7	2.0	9.2	2.4	8.6	6.6	10.7	7.0	5.2	8.0	7.2	9.2	6.9	6.9	5.6	9.8	7.9	0.8	5.1	4.4	7.2	5.6	5.0	10.8	18.1	14.5	17.2	8.7	7.2	6.9	10.9	7.3	5.5	20.8	9.1	25.1	28.7	59.6	71.3	69.8	20.4	6.7	7.9	15.7	35.3	35.6	68.0	21.1	136.1	26.6	30.6	0.0	25.8	25.7	33.5	30.2	33.5	33.8	26.4	12.7	26.0	17.2	20.2	22.0	38.0	16.0	35.4	7.2	47.0	62.2	24.4	38.6	24.1	54.0	68.8	32.3	28.3	136.2	21.8	53.2	17.2	31.9	43.0	15.6
C15orf65	FLJ27352	ENSG00000261652	"Chromosome 15 open reading frame 65"	H3BRN8	15	55408548-55418764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 27.6"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 50.9;Early spermatids: 140.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA067189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA067189: AB_2685800"	"unprognostic (2.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (3.18e-7)"	"unprognostic (1.59e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	3.4	3.1	6.5	0.9	7.4	0.8	5.4	2.4	6.7	7.7	5.2	3.7	5.4	2.9	3.7	11.2	3.4	13.7	5.3	7.0	6.0	7.6	11.2	1.9	3.8	2.2	5.2	6.8	4.6	11.0	6.2	17.2	1.2	12.0	5.8	6.2	2.8	27.6	5.3	8.7	2.4	2.5	3.7	3.4	1.9	7.8	11.3	4.6	1.7	7.1	0.6	1.8	3.6	1.5	2.3	0.6	6.5	1.6	0.0	0.7	0.4	0.8	1.7	2.9	1.8	4.5	6.7	0.5	1.6	2.2	1.4	2.8	0.0	1.5	1.3	4.4	5.2	3.5	1.3	0.0	2.7	0.5	2.4	2.0	1.2	10.1	0.4	8.8	2.9	1.6	2.8	14.9	4.2	1.2	7.8	2.7	0.0	2.3	4.3	6.2	2.2	0.1	9.3	0.9	5.3	3.3	0.5	0.0	11.2	7.6	0.0	7.9	4.8	2.0	3.4	12.8	1.6	6.9	2.8	1.9	2.4	0.9	2.5	0.9	1.9	5.0	1.2	6.2	7.2	1.2	6.5	1.1	3.9	0.5	1.6	0.0	1.9	0.1	0.7	0.6	2.3	0.1	0.0	2.1	0.0	0.8	0.2	0.0	0.4	6.5	7.4	2.4	6.7	6.0	7.6	5.2	6.8	12.0	4.6	3.0	0.6	0.8	3.6	1.1	0.8	7.3	2.5	50.9	4.5	5.2	0.0	1.0	14.9	7.1	140.3	3.6	2.1	0.0	9.6	1.1	3.1	4.5	4.6	1.0	2.5	3.2	3.5	3.1	1.9	6.8	4.0	0.2	3.3	1.0	16.7	3.6	7.0	11.5	5.3	16.8	7.5	6.5	2.8	5.8	2.8	1.5	0.0	0.0	4.6	1.7
C16orf45	FLJ32618	ENSG00000166780	"Chromosome 16 open reading frame 45"	Q96MC5	16	15434295-15625028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.3"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 125.3;Late spermatids: 336.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 11.1"	"Lineage enriched"	"Detected in many"	4	"T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 33.1;U-2197: 24.0;U-87 MG: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041114, HPA063757"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA041114: AB_10794542, HPA063757: "	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.28e-2)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.79e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	11.5	10.2	38.8	6.8	27.6	1.3	8.4	30.6	72.3	28.4	10.4	10.1	3.8	5.9	21.3	12.7	14.2	12.3	14.6	28.7	39.2	30.4	9.4	12.9	6.0	4.1	21.8	33.8	26.1	5.6	2.2	11.3	1.4	61.3	15.0	6.2	8.5	6.5	17.8	25.5	4.9	4.4	21.5	12.5	5.3	7.6	13.8	12.0	0.0	5.7	4.4	3.0	14.2	10.7	2.7	0.5	0.6	0.1	0.2	11.1	1.5	0.4	10.7	4.5	0.4	20.2	17.2	0.0	5.8	20.1	5.2	2.9	0.0	0.2	0.0	1.3	33.1	12.7	0.0	1.2	1.6	2.7	0.2	0.2	2.5	4.1	0.3	6.6	0.0	4.4	8.4	1.7	11.6	0.2	8.6	8.0	4.7	0.1	0.1	7.7	6.4	1.4	0.2	5.7	0.1	4.1	0.3	6.1	0.0	2.8	1.8	8.9	8.7	0.3	2.9	1.8	0.8	0.1	0.1	4.6	11.7	6.0	24.0	2.9	2.0	4.6	0.0	41.3	0.0	2.8	0.1	0.1	0.2	11.1	0.0	2.0	2.7	2.1	6.2	0.5	1.6	2.0	3.3	0.6	0.2	0.1	0.3	2.7	1.5	38.8	27.6	30.6	52.4	39.2	30.4	21.8	33.8	61.3	12.0	0.0	0.3	0.0	14.8	7.9	42.1	49.5	5.1	17.4	12.5	1.8	13.7	0.0	26.6	13.2	125.3	26.0	0.0	0.0	72.8	0.0	29.8	4.3	11.5	11.9	0.8	17.5	15.6	17.8	3.2	336.0	18.4	10.9	13.5	18.0	0.0	7.6	41.6	0.0	45.3	7.0	15.7	12.9	42.0	35.1	15.8	5.1	0.1	1.8	0.0	8.8
C16orf46	FLJ32702	ENSG00000166455	"Chromosome 16 open reading frame 46"	Q6P387	16	81053497-81077267	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 25.2"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 80.6;Late spermatids: 78.6;Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041136, HPA041379"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041136: AB_10795535, HPA041379: AB_10794666"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.53e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.72e-2)"	2.0	2.5	5.2	1.8	6.8	2.2	3.1	3.3	8.6	2.8	1.4	3.5	1.3	1.3	2.8	4.4	1.7	8.6	2.0	1.4	5.8	5.8	2.4	3.0	2.2	1.1	5.9	6.0	1.7	2.6	2.9	14.4	3.2	8.6	3.0	1.4	3.5	2.0	2.4	2.5	1.0	1.0	1.9	4.2	1.1	1.1	25.2	2.5	1.5	8.9	0.5	1.3	1.9	1.3	0.2	0.4	1.1	0.4	0.0	2.0	0.0	2.8	0.5	1.1	0.5	5.2	1.0	2.6	0.6	3.6	2.0	1.2	0.6	4.0	0.7	1.8	0.7	2.5	1.0	1.1	2.0	3.6	0.6	0.7	0.8	2.3	2.7	3.1	1.0	2.2	2.1	1.6	4.7	2.9	2.2	1.7	1.4	1.7	1.4	1.6	2.0	0.3	5.5	1.3	1.0	0.6	2.2	0.3	0.4	3.5	1.7	1.5	1.4	4.0	1.3	0.7	1.7	1.2	1.4	1.4	0.9	0.4	0.8	0.7	1.5	2.1	1.6	1.8	1.4	1.0	0.0	0.4	1.1	0.2	0.0	2.0	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	5.2	6.8	3.3	8.6	5.8	5.8	5.9	6.0	8.6	2.5	0.0	2.9	0.0	8.1	1.6	2.1	2.0	0.0	20.1	3.4	0.0	3.9	6.3	5.0	0.8	80.6	1.6	0.0	0.0	0.4	13.6	2.3	6.0	0.0	2.9	2.8	0.0	1.2	1.3	1.2	78.6	7.5	1.0	5.0	0.0	1.2	2.9	0.4	0.0	7.1	3.1	7.0	0.0	2.0	32.0	4.9	2.4	5.3	0.0	0.9	5.5
C16orf58	FLJ13868	ENSG00000140688	"Chromosome 16 open reading frame 58"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	13.5	17.7	15.9	15.3	22.3	11.0	15.7	17.9	30.8	22.6	17.5	16.6	34.2	18.6	24.2	21.4	16.8	21.0	20.0	16.7	12.9	15.3	19.1	51.0	13.9	15.7	13.8	16.4	29.5	49.1	30.7	27.6	23.1	13.1	22.0	11.6	22.9	36.9	26.7	4.8	14.1	22.2	15.6	9.1	12.9	19.7	11.9	14.3	15.1	26.4	14.2	19.3	15.9	17.4	8.9	12.0	8.8	9.8	10.8	11.3	8.4	11.6	15.4	9.7	16.8	22.5	15.0	18.0	14.0	23.9	10.9	13.0	4.6	20.5	10.0	29.7	20.6	14.1	16.3	9.6	12.9	5.1	14.5	9.6	10.1	8.8	11.6	32.7	11.9	12.2	18.2	14.1	14.3	29.5	21.5	10.5	16.1	14.9	17.3	10.6	22.0	5.5	8.0	7.5	17.1	10.1	12.7	14.5	30.2	12.4	7.3	10.6	16.3	10.5	27.7	21.8	9.6	23.9	17.6	9.1	19.1	10.7	12.2	9.1	25.2	14.7	7.5	24.4	18.4	26.2	3.8	6.9	8.8	10.3	9.8	9.6	8.9	10.7	10.2	12.0	8.5	10.8	9.3	1.2	10.8	9.6	11.0	11.3	8.4	15.9	22.3	17.9	30.8	12.9	15.3	13.8	16.4	13.1	14.3	6.0	14.2	9.0	7.9	5.5	22.6	0.8	10.2	6.7	9.1	15.7	2.0	18.1	5.0	17.5	1.5	6.3	17.7	0.0	18.6	17.9	13.1	13.9	18.4	21.9	12.9	12.7	14.3	7.4	8.4	2.5	20.1	6.4	16.9	6.4	20.7	12.4	12.0	10.5	15.2	6.8	22.3	25.8	9.2	13.4	11.7	4.1	18.7	8.3	17.8	7.9
C16orf70	"C16orf6, FLJ12076, lin-10, LIN10"	ENSG00000125149	"Chromosome 16 open reading frame 70"	Q9BSU1	16	67109958-67148539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041131, HPA041214"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA041131: AB_10795487, HPA041214: AB_10794267"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.15e-2)"	8.0	7.7	11.3	6.7	14.6	14.2	10.5	14.0	22.4	8.4	7.9	24.2	8.6	6.7	8.9	8.8	12.5	10.1	8.2	8.0	12.6	8.9	11.8	43.2	7.9	7.6	18.2	13.1	10.1	6.2	19.5	8.3	10.6	15.5	12.9	9.4	7.7	8.9	8.4	20.1	22.0	7.1	10.0	18.0	11.2	6.9	10.6	16.0	7.0	7.1	5.8	10.3	8.4	10.3	7.2	14.1	6.3	15.9	5.2	8.3	7.3	6.8	10.4	9.9	10.3	12.6	7.6	23.5	7.9	8.6	16.1	17.7	11.5	6.1	7.0	7.0	9.3	8.9	9.3	12.3	7.7	20.8	3.7	11.3	5.6	6.6	23.9	7.8	5.3	30.7	7.5	10.8	15.6	7.3	8.9	9.0	9.0	8.9	3.0	9.9	6.9	10.4	8.4	10.9	9.4	16.9	14.7	17.2	10.9	7.1	4.2	12.8	7.0	24.5	5.6	6.0	10.3	11.3	4.6	6.9	11.5	9.8	8.1	6.7	4.6	8.3	20.9	10.3	5.6	9.1	2.9	15.9	5.4	4.7	11.8	6.2	7.2	7.0	8.3	14.1	4.9	7.1	6.6	6.3	5.2	11.8	4.6	6.7	7.3	11.3	14.6	14.0	22.4	12.6	8.9	18.2	13.1	15.5	16.0	6.0	5.1	3.9	2.0	8.0	6.9	1.0	0.0	13.4	1.2	0.0	0.0	7.6	5.0	4.0	1.3	4.3	4.5	0.0	2.5	8.0	4.6	4.3	9.2	43.3	16.1	9.5	6.9	5.5	16.4	0.9	4.4	8.7	10.1	5.4	5.3	3.4	3.4	6.8	6.0	7.9	6.5	12.9	5.6	10.6	14.9	10.7	5.8	4.9	5.3	1.0
C16orf72	"FLJ41272, PRO0149"	ENSG00000182831	"Chromosome 16 open reading frame 72"	Q14CZ0	16	9091648-9121640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 187.0;Late spermatids: 474.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041568, HPA067492"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA041568: AB_10796677, HPA067492: AB_2685850"	"unprognostic (3.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.64e-3)"	"unprognostic (6.51e-2)"	20.1	16.5	15.4	15.8	22.5	80.1	17.7	15.2	25.5	20.1	19.5	18.3	17.4	13.5	17.3	16.7	24.0	14.9	22.6	24.9	13.6	14.4	17.2	23.7	19.3	20.1	14.3	19.3	17.3	16.8	31.3	14.0	20.5	19.0	16.5	14.3	17.8	16.6	16.3	34.5	19.2	17.3	16.7	14.1	19.4	16.6	20.2	12.6	20.1	17.5	20.6	21.2	17.7	21.5	4.1	3.8	14.3	4.1	3.0	5.8	1.9	9.1	10.2	16.3	14.8	19.5	15.3	8.6	18.0	15.0	10.4	10.8	8.5	11.9	16.4	10.4	20.7	8.2	10.8	15.0	15.9	22.0	10.7	8.4	11.0	14.2	17.9	25.2	13.8	12.9	23.0	25.1	17.4	25.1	16.8	18.0	17.2	16.5	25.1	18.4	13.2	12.2	12.3	19.8	9.4	9.0	21.0	20.0	17.5	13.6	16.8	10.6	11.9	21.6	15.3	18.1	15.9	17.6	14.1	20.6	20.5	13.5	26.2	11.5	28.7	24.6	23.3	18.2	12.4	16.5	5.5	3.8	4.0	5.1	4.0	5.8	3.5	4.4	3.6	2.8	4.1	5.1	4.5	14.3	3.0	4.1	3.8	3.4	1.9	15.4	22.5	15.2	25.5	13.6	14.4	14.3	19.3	19.0	12.6	44.7	39.9	33.3	37.4	68.3	43.2	33.4	22.9	9.4	20.5	21.0	82.5	23.7	16.6	24.0	187.0	26.3	30.0	0.0	25.3	28.8	34.7	42.7	17.4	52.9	28.8	41.3	46.4	38.6	79.4	474.2	22.7	35.5	30.4	19.8	35.5	37.0	32.5	38.6	25.5	29.8	48.0	32.3	42.3	35.2	21.5	56.2	47.7	31.5	34.3	57.2
C16orf74	MGC17624	ENSG00000154102	"Chromosome 16 open reading frame 74"	Q96GX8	16	85690084-85751129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.6"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 47.6;Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 69.6;Syncytiotrophoblasts: 62.1;Urothelial cells: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 26.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 34.3;hTCEpi: 29.3;T-47d: 30.5"					"Low region specificity"	"Detected in all"			HPA049367	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane"	Centrosome	"HPA049367: AB_2680730"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.15e-3)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.08e-3)"	"unprognostic (4.22e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.40e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.07e-3)"	2.7	0.7	6.3	5.6	3.9	9.3	6.8	0.6	3.3	4.7	3.0	1.4	10.8	1.5	2.1	3.7	6.8	1.5	2.4	1.8	9.2	1.7	2.0	0.8	2.0	11.7	2.0	2.1	0.9	2.1	3.9	1.0	44.6	1.6	7.1	1.3	18.8	4.5	9.5	1.5	6.3	4.2	3.9	1.5	12.9	3.0	1.4	1.5	0.4	4.7	6.2	10.3	18.9	10.0	26.3	8.8	10.3	8.2	3.3	8.3	5.4	12.2	4.1	0.1	1.7	1.9	2.1	5.1	1.5	2.0	4.8	1.3	3.1	11.5	0.1	17.4	1.2	2.0	17.7	0.7	34.3	2.7	0.0	2.7	0.0	1.8	0.3	5.2	0.3	0.0	4.5	29.3	4.6	20.1	3.6	15.6	2.1	0.0	0.0	0.1	10.3	0.0	18.7	1.1	13.2	11.8	0.5	0.0	1.0	0.0	14.0	3.9	1.0	6.2	3.2	3.1	1.4	30.5	5.2	15.9	3.1	8.0	1.3	4.4	4.3	3.1	13.5	0.0	4.4	0.6	0.0	8.2	10.3	0.6	2.7	2.2	20.4	4.5	3.6	8.8	26.3	7.6	4.7	3.2	3.3	0.8	0.1	8.3	5.4	6.3	3.9	0.6	3.3	9.2	1.7	2.0	2.1	1.6	1.5	3.0	0.6	38.4	47.6	8.2	17.9	1.2	0.0	1.4	3.4	1.8	55.0	38.4	3.3	2.8	1.3	2.1	0.0	0.0	1.0	13.5	4.8	4.1	0.0	0.0	4.3	14.3	0.0	1.3	0.8	0.0	3.1	1.6	18.6	0.0	0.0	8.8	2.2	0.0	3.2	1.7	69.6	0.0	3.4	0.9	6.4	6.0	62.1	0.9	0.0	43.2
C16orf87		ENSG00000155330	"Chromosome 16 open reading frame 87"	Q6PH81	16	46796607-46831411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 167.5;Spermatogonia: 106.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041179	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041179: AB_10795002"	"unprognostic (2.44e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (7.95e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.13e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.84e-2)"	5.4	7.7	10.9	7.7	22.1	23.3	8.2	6.3	13.9	5.8	6.7	3.9	5.9	5.1	6.9	5.2	7.2	5.0	6.4	10.3	7.4	6.2	14.2	19.7	6.1	12.7	5.5	10.6	5.3	4.2	22.0	9.6	8.7	6.5	6.2	5.0	4.3	5.5	4.4	18.2	5.6	11.8	7.6	6.5	7.8	4.6	28.5	8.0	10.6	5.0	6.1	9.0	8.7	6.4	13.6	10.9	9.1	9.8	3.8	15.4	4.8	8.7	3.8	13.8	7.5	3.8	3.5	12.9	10.1	6.2	6.9	4.2	6.0	6.3	13.2	11.4	5.4	3.8	6.8	13.0	4.7	9.2	10.8	8.8	8.1	5.9	7.4	8.5	9.4	11.7	5.4	5.6	8.8	8.6	10.1	5.9	12.9	9.0	2.5	7.3	5.1	13.6	14.1	12.8	4.4	7.1	20.6	21.3	8.9	11.2	5.5	8.4	9.5	12.6	12.2	4.7	25.4	5.2	10.9	6.7	8.2	6.7	8.4	5.1	11.5	12.2	35.6	3.8	8.2	7.7	3.0	7.8	9.1	5.5	9.8	3.0	13.6	7.8	6.8	10.9	8.1	7.4	5.3	1.1	3.8	9.0	6.0	15.4	4.8	10.9	22.1	6.3	13.9	7.4	6.2	5.5	10.6	6.5	8.0	14.9	11.5	27.0	14.9	41.9	8.2	30.5	22.9	4.0	7.9	15.7	21.6	61.1	26.6	17.6	34.8	10.8	9.8	0.0	10.6	46.5	31.9	16.3	13.9	34.4	20.5	28.6	18.3	14.1	20.8	12.1	15.8	35.1	32.1	20.8	10.8	18.6	12.2	8.6	13.4	66.8	10.7	32.3	21.2	167.5	106.7	36.6	28.7	16.0	12.0	13.2
C16orf95		ENSG00000260456	"Chromosome 16 open reading frame 95"	Q9H693	16	87083562-87317420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 47.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 56.7;Erythroid cells: 23.3;Late spermatids: 77.4;Sertoli cells: 25.8;Spermatocytes: 52.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA040850, HPA067924"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA040850: AB_10794882, HPA067924: AB_2685924"	"unprognostic (3.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.23e-1)"	1.5	1.7	1.7	1.0	2.6	2.2	0.8	1.5	2.0	0.5	1.0	1.5	1.2	1.2	0.7	1.2	0.5	0.8	1.2	1.0	1.7	1.4	1.1	2.6	0.7	0.9	1.9	0.9	0.7	2.1	1.0	0.9	0.5	1.8	0.6	0.6	0.9	1.1	1.2	3.0	0.5	1.2	1.2	1.3	0.7	1.1	47.2	1.1	1.2	0.7	0.6	0.9	0.7	0.4	3.4	6.0	1.1	6.0	1.5	5.7	3.2	3.2	9.1	3.2	3.8	3.7	2.2	5.4	3.0	1.2	3.0	2.3	4.4	5.2	8.1	8.6	0.6	3.3	2.7	2.9	2.0	1.4	3.9	5.3	7.6	3.2	5.9	3.2	0.8	1.5	3.8	0.7	3.4	1.1	1.5	2.8	6.0	6.7	4.1	3.6	8.4	2.8	6.9	2.9	2.0	5.5	6.4	1.4	4.6	1.7	1.3	4.0	3.3	7.4	0.4	2.5	1.2	4.5	3.6	3.3	5.5	2.4	3.2	2.8	12.6	10.2	15.4	7.4	7.6	3.7	0.0	4.9	1.1	4.9	4.8	3.6	3.4	4.3	4.5	4.5	2.9	3.5	5.7	0.8	1.5	6.0	6.0	5.1	3.2	1.7	2.6	1.5	2.0	1.7	1.4	1.9	0.9	1.8	1.1	0.0	1.0	2.2	0.4	1.4	2.3	2.0	2.5	1.4	0.0	0.0	2.0	1.9	1.7	2.8	56.7	0.6	4.9	23.3	3.0	2.7	1.1	0.4	0.0	4.2	2.5	1.6	0.0	2.5	1.5	77.4	3.1	1.6	0.0	3.6	2.5	2.4	3.6	2.9	4.9	2.4	2.0	25.8	0.5	52.2	4.3	0.5	0.9	1.5	5.3	0.3
C17orf100	LOC388327	ENSG00000256806	"Chromosome 17 open reading frame 100"		17	6651718-6693202	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 18.4"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 26.3;Late spermatids: 35.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.6;SH-SY5Y: 11.5"									HPA046824			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA046824: AB_2679825"	"unprognostic (9.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.65e-2)"	0.8	1.5	1.4	1.6	3.3	0.1	1.4	3.8	5.6	2.3	2.4	4.0	1.2	3.6	1.5	2.8	2.1	1.7	1.5	0.3	1.5		2.2	18.4	1.2	3.5	1.3	2.5	1.1	8.5	2.5	9.1	0.6	3.0	2.2	1.6	0.8	5.2	1.1	0.3	9.3	4.3	0.7	1.6	2.2	2.8	3.6	2.3	1.6	3.3	0.2	1.1	1.7	0.5	5.7	3.1	7.5	2.4	2.5	5.5	1.9	1.3	2.5	5.7	1.8	0.8	1.6	2.7	0.7	4.1	1.7	3.4	3.8	1.8	1.5	2.9	1.3	4.4	4.9	1.1	2.6	2.5	6.5	7.5	1.4	2.6	11.6	2.0	0.2	3.9	2.3	2.5	0.8	1.8	5.0	1.0	8.0	1.8	1.5	2.2	2.8	1.6	2.4	0.8	2.3	1.7	3.1	0.9	2.3	3.4	1.1	5.9	11.5	3.4	0.4	3.9	1.8	3.0	0.4	1.5	1.6	3.3	0.9	1.3	2.1	1.4	1.0	1.4	0.5	3.7	5.7	1.9	7.5	2.5	2.4	3.4	4.3	4.6	2.9	3.1	5.7	5.5	3.0	1.8	2.5	2.3	1.0	3.0	1.9											0.0	1.7	0.0	4.6	2.5	3.7	0.3	0.0	2.7	5.7	0.0	2.0	1.3	1.7	3.4	26.3	1.0	5.9	0.0	2.9	1.4	1.5	3.9	9.2	0.0	1.1	1.6	7.5	0.0	0.0	35.6	0.9	1.0	1.7	1.0	5.4	5.2	2.8	3.5	1.8	2.1	5.2	6.5	2.5	11.1	4.2	2.6	1.3	0.5	3.0	4.7
C17orf107		ENSG00000205710	"Chromosome 17 open reading frame 107"	Q6ZR85	17	4899418-4902932	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.7;salivary gland: 26.0"	"Group enriched"	"Detected in many"	11	"Early spermatids: 54.2;Late spermatids: 207.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 5.5;HMC-1: 7.3;hTCEpi: 6.7"	"Not detected"	"Not detected"							HPA069713	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069713: AB_2686181"	"prognostic favorable (5.06e-5)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.12e-1)"	2.4	3.7	5.0	2.3	5.1	4.2	3.0	7.7	8.7	3.9	1.4	0.2	5.9	2.1	1.9	5.9	1.3	1.8	3.3	15.3	3.8	4.3	2.2	8.8	2.9	1.0	1.6	4.2	6.4	7.7	6.2	25.7	1.5	1.7	4.5	0.9	2.1	26.0	6.4	0.6	3.3	1.6	1.2	2.2	2.1	4.6	4.7	0.6	0.1	1.9	0.6	2.7	3.3	1.9	0.0	0.0	6.7	0.2	0.0	0.9	0.1	0.7	0.8	1.0	0.3	2.2	1.7	1.5	3.9	0.5	0.2	0.6	0.7	0.7	0.4	0.6	5.5	0.0	1.4	0.1	0.5	0.3	0.1	0.8	2.1	0.6	0.8	3.1	0.0	7.3	1.8	6.7	0.1	0.4	0.2	0.2	0.2	0.1	0.1	0.1	0.7	0.1	0.6	0.3	1.9	0.8	0.3	0.2	2.9	0.3	0.3	0.1	0.5	0.6	2.3	0.3	0.5	0.7	1.1	0.5	0.3	0.7	0.6	0.5	0.6	0.6	0.1	0.5	0.1	0.3	0.0	0.2	0.8	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.8	6.7	0.0	0.1	0.0	0.0	0.1	5.0	5.1	7.7	8.7	3.8	4.3	1.6	4.2	1.7	0.6	0.0	2.2	0.9	2.5	1.5	0.5	12.3	0.0	0.0	1.2	0.0	0.0	0.3	1.7	0.3	54.2	0.7	0.0	0.0	1.1	1.6	2.2	2.2	11.5	3.4	0.9	4.8	0.0	0.6	1.5	207.3	1.4	4.3	1.7	0.0	1.6	0.0	0.8	0.0	1.1	1.6	0.6	0.0	3.1	1.0	1.1	1.1	4.3	0.7	0.2	0.9
C17orf51	"FLJ12977, FLJ31874, FLJ33618"	ENSG00000212719	"Chromosome 17 open reading frame 51"	A8MQB3	17	21524790-21574458	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.2"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 20.9;Early spermatids: 18.9;Horizontal cells: 23.8;Rod photoreceptor cells: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA052106	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA052106: AB_2681728"	"unprognostic (1.99e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.35e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.51e-3)"	"unprognostic (7.42e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.42e-5)"	"unprognostic (9.05e-3)"	6.1	7.2	8.0	4.2	8.4	0.8	3.0	41.2	20.5	5.3	4.5	5.2	3.1	3.2	8.3	10.1	3.2	6.7	3.6	6.5	8.6	7.3	4.0	3.8	3.0	3.0	5.9	8.1	5.9	6.6	7.8	8.9	2.1	5.5	6.3	3.2	3.8	5.0	7.0	7.3	3.0	2.4	6.6	5.0	3.3	4.1	9.2	5.9	1.2	2.9	2.2	3.0	4.0	4.7	4.2	4.1	1.2	3.9	2.6	6.0	1.8	2.6	6.2	2.3	8.0	7.4	7.0	2.2	7.2	3.6	5.2	6.0	12.2	0.4	3.5	4.1	3.9	6.4	0.3	9.9	3.8	8.7	11.1	15.4	0.7	5.7	5.1	13.8	0.9	3.9	6.6	3.4	10.6	11.6	1.9	3.7	9.5	1.9	0.8	4.4	0.0	7.7	0.4	4.4	3.3	5.2	7.5	4.9	0.5	1.9	0.5	5.2	0.9	6.7	0.2	5.3	8.7	0.1	0.3	6.7	6.2	6.3	14.7	8.6	2.3	2.8	13.7	7.4	1.3	7.2	0.0	3.9	0.0	4.0	1.8	3.1	2.2	1.9	1.8	1.9	4.2	6.0	5.1	1.2	2.6	1.0	4.1	1.7	1.8	8.0	8.4	41.2	14.5	8.6	7.3	5.9	8.1	5.5	5.9	0.0	0.6	1.5	4.4	4.4	20.9	3.3	0.0	4.0	2.3	1.8	15.7	0.4	5.0	1.8	18.9	2.8	0.0	0.0	3.1	1.5	6.1	2.9	0.0	2.6	1.1	23.8	1.2	1.3	0.3	11.5	5.8	1.3	5.0	0.0	1.3	5.2	1.6	0.0	7.8	2.1	28.0	0.0	7.9	13.0	6.5	1.9	0.2	0.9	0.9	1.2
C17orf53	MGC3130	ENSG00000125319	"Chromosome 17 open reading frame 53"	Q8N3J3	17	44141906-44162476	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA synthesis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1"	"Cell type enhanced"	"Detected in some"	12	"Extravillous trophoblasts: 7.0;Late spermatids: 5.5;Spermatocytes: 8.9;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA023004, HPA023393, HPA024430"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes			"Nucleoplasm, Cytosol"		"HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879"	"unprognostic (1.72e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (9.39e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.86e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.40e-2)"	2.0	0.7	0.5	3.5	0.4	13.4	2.0	2.8	1.4	1.2	1.5	0.6	0.5	1.4	1.3	1.1	4.0	0.9	1.4	1.9	0.8	0.7	0.8	0.8	1.3	2.4	0.5	0.2	1.3	1.2	0.7	0.7	2.3	1.0	1.0	1.7	0.6	1.1	1.1	1.8	2.4	2.2	1.1	0.5	1.9	1.0	32.1	0.4	8.2	0.5	1.5	4.8	0.8	1.7	1.4	3.7	0.9	1.1	0.3	2.0	0.6	7.5	9.5	7.5	6.7	0.6	2.1	8.9	5.9	5.2	11.5	12.6	9.7	4.7	8.1	5.3	5.2	12.0	6.6	9.7	9.4	10.2	9.1	12.2	5.2	8.7	6.5	0.3	5.7	6.5	1.7	1.4	14.2	7.1	1.5	4.8	8.9	11.7	10.6	5.6	5.6	13.5	8.5	5.1	3.5	9.3	8.5	12.0	10.0	2.7	6.1	4.7	2.7	3.6	3.6	2.9	8.9	7.2	6.6	2.2	11.1	8.7	7.5	8.6	6.1	10.2	7.0	5.2	4.4	6.3	0.0	1.1	0.9	1.1	0.8	0.4	0.8	0.8	0.2	0.4	1.4	0.6	0.4	0.0	0.3	0.4	3.7	2.0	0.6	0.5	0.4	2.8	1.4	0.8	0.7	0.5	0.2	1.0	0.4	0.0	0.0	0.5	0.6	1.6	0.2	0.8	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.5	2.5	0.1	0.0	0.0	0.2	7.0	0.7	0.3	0.0	0.2	2.5	0.0	0.0	0.0	0.0	5.5	0.3	0.0	0.0	0.0	0.2	0.5	0.7	0.0	1.1	0.2	0.0	0.0	0.3	8.9	13.0	1.0	1.5	0.0	0.6	0.3
C17orf58		ENSG00000186665	"Chromosome 17 open reading frame 58"	Q2M2W7	17	67991101-67996431	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 31.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.1"	HPA023036	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023036: AB_10601144"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (1.31e-10)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.01e-1)"	11.1	6.8	10.7	6.2	9.3	3.5	17.3	8.8	11.5	29.0	8.3	5.7	8.3	4.1	15.4	8.1	6.5	8.1	6.6	8.9	7.7	6.3	6.3	9.1	6.2	3.1	7.4	5.0	6.3	10.4	5.2	3.6	33.3	5.2	7.8	7.5	5.7	5.3	4.0	6.9	3.7	6.1	11.8	5.5	5.1	6.6	4.8	4.4	1.1	6.9	4.5	6.8	11.0	11.7	3.6	5.2	9.5	6.3	3.2	3.0	2.2	5.3	5.3	5.3	6.5	3.8	9.8	4.2	2.2	6.4	3.9	6.4	3.1	7.0	7.1	5.1	1.8	7.0	2.8	12.0	4.8	9.6	12.8	12.1	4.6	2.0	9.7	6.1	3.9	8.5	5.3	5.8	3.8	8.9	4.4	18.4	6.3	9.8	11.1	3.8	7.1	0.7	5.2	6.0	13.0	5.6	1.7	5.8	9.5	4.9	3.6	3.9	7.2	3.4	31.5	11.5	6.8	8.9	4.6	3.4	3.4	3.5	2.4	4.6	22.3	16.3	6.3	8.5	6.9	5.9	9.5	3.8	6.3	3.0	3.6	1.0	3.6	1.1	2.4	5.2	0.8	0.5	1.2	1.5	3.2	6.3	0.2	0.5	2.2	10.7	9.3	8.8	11.5	7.7	6.3	7.4	5.0	5.2	4.4	0.0	1.7	3.7	5.6	4.2	8.6	4.4	5.1	18.7	2.3	10.4	9.8	23.3	19.9	9.6	0.6	13.6	8.0	0.0	8.1	18.2	27.4	13.3	12.7	13.1	15.0	4.8	3.5	11.1	7.5	1.4	3.4	8.9	8.5	27.9	13.0	29.6	8.9	10.5	4.9	15.0	13.6	6.5	10.3	6.0	3.6	7.3	12.8	4.6	9.5	6.0
C17orf62	"FLJ90469, MGC4368"	ENSG00000178927	"Chromosome 17 open reading frame 62"	Q9BQA9	17	82442589-82450829	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045696	Uncertain		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA045696: AB_2679421"	"unprognostic (1.87e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.81e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.83e-11)"	"unprognostic (1.47e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.14e-3)"	19.9	17.3	16.8	35.8	25.2	16.4	20.0	8.6	20.4	16.2	16.2	20.8	10.5	12.1	16.5	13.1	17.1	16.0	22.9	12.1	15.2	12.1	17.5	29.1	20.2	48.3	26.8	12.4	17.6	21.3	12.9	15.7	14.9	20.6	19.5	13.6	12.2	14.7	12.7	6.5	13.9	21.1	20.2	19.0	53.7	16.4	8.3	20.9	26.0	13.8	8.2	42.3	29.2	13.3	30.6	33.0	74.9	44.2	24.2	25.9	34.6	14.2	20.9	11.5	19.0	18.2	19.2	11.2	12.9	15.7	19.0	22.7	7.8	14.5	36.4	11.9	18.3	23.9	14.5	7.9	9.7	13.1	25.9	6.4	9.9	6.9	9.0	18.9	11.1	29.2	22.1	14.1	16.3	9.2	18.4	24.6	28.2	8.3	27.3	16.0	15.9	46.1	9.3	8.7	19.8	11.2	35.2	6.9	27.9	14.0	18.2	9.9	18.7	23.3	27.2	16.6	21.7	28.0	44.7	8.4	14.8	14.5	24.3	13.7	49.9	16.6	26.7	19.4	18.1	13.1	43.8	34.1	44.0	25.9	44.2	20.0	30.2	23.9	25.0	31.4	30.6	20.2	19.6	74.9	24.2	39.6	33.0	24.8	34.6	16.8	25.2	8.6	20.4	15.2	12.1	26.8	12.4	20.6	20.9	29.8	24.8	93.2	8.2	9.8	16.7	0.0	17.8	9.4	13.6	0.0	9.8	23.8	0.0	0.0	1.1	17.6	29.5	23.3	0.0	27.8	22.4	13.1	32.4	21.3	69.8	25.4	24.9	19.0	53.5	1.5	24.7	43.5	18.6	0.0	20.3	22.1	0.0	28.1	17.0	0.0	12.0	0.0	11.4	10.4	7.3	7.8	23.1	58.6	15.2	7.1
C17orf64		ENSG00000141371	"Chromosome 17 open reading frame 64"	Q86WR6	17	60392429-60431421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 74.5"	"Cell type enhanced"	"Detected in some"	30	"Early spermatids: 846.4;Late spermatids: 397.1;Spermatocytes: 173.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.8;granulocytes: 2.5"	"Cell line enhanced"	"Detected in some"		"JURKAT: 2.4;MCF7: 11.0;THP-1: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044415	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044415: AB_10797148"	"unprognostic (3.00e-1)"	"unprognostic (2.60e-2)"		"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.30e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.46e-2)"	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	74.5	0.1	0.2	0.0	0.1	0.1	0.0	0.0	1.0	5.8	2.5	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.1	1.3	0.0	0.0	0.0	0.6	0.7	0.0	1.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.7	0.2	0.5	1.7	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.6	0.0	11.0	0.3	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	2.7	0.3	0.0	0.1	0.1	0.0	1.7	1.3	0.2	0.0	1.5	0.0	0.0	0.6	0.0	0.1	0.5	0.0	1.0	0.3	0.0	1.8	0.2	0.0	0.6	2.5	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	846.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	397.1	8.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	173.7	15.3	0.1	0.0	0.0	0.0	0.0
C17orf75	"NJMU-R1, SRI2"	ENSG00000108666	"Chromosome 17 open reading frame 75"	Q9HAS0	17	32324565-32350023	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004061, HPA075333"	Approved	Approved	Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA004061: AB_1078337, HPA075333: "	"unprognostic (4.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.92e-2)"	"unprognostic (7.80e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.60e-2)"	6.9	17.3	16.6	8.2	21.2	5.7	13.1	25.8	23.9	8.7	10.1	12.7	10.9	10.5	12.7	15.6	9.9	14.7	6.9	18.6	13.4	14.8	19.6	12.7	8.0	10.8	13.8	14.1	16.0	11.3	16.6	17.2	9.3	21.1	11.8	11.3	11.7	11.8	11.8	15.0	8.0	9.2	11.0	11.3	10.8	10.9	20.4	13.3	11.7	16.4	8.3	11.3	9.7	8.9	15.0	13.7	18.4	12.3	13.7	16.4	13.0	13.3	14.6	21.1	7.5	6.2	8.2	11.0	9.7	10.7	15.7	13.9	7.3	5.2	9.2	11.3	8.9	20.5	15.1	17.4	13.3	22.5	6.5	16.9	7.4	13.5	13.5	13.4	10.5	6.2	6.5	16.1	11.3	8.1	12.3	11.9	16.3	14.5	13.4	10.3	11.1	29.5	9.1	13.5	8.7	8.0	18.7	13.9	16.1	9.3	7.5	20.7	17.0	8.6	7.6	20.4	14.0	19.4	6.4	7.3	8.2	13.0	3.8	15.1	16.0	18.1	31.8	6.3	9.2	2.4	18.4	10.6	13.2	16.0	8.8	16.4	14.5	14.6	15.4	13.7	15.0	16.1	15.1	3.5	13.7	12.3	10.4	15.0	13.0	16.6	21.2	25.8	23.9	13.4	14.8	13.8	14.1	21.1	13.3	11.9	40.3	5.2	11.6	5.3	23.1	23.8	2.5	36.1	13.6	14.0	7.9	27.4	36.5	14.5	5.3	9.8	4.7	46.7	12.0	14.8	7.9	6.4	10.5	9.8	8.5	30.2	12.1	7.4	10.3	4.9	6.9	7.7	5.0	4.6	7.1	16.9	10.7	2.9	7.8	23.0	21.0	38.8	9.0	76.3	27.9	5.4	13.6	14.9	8.8	5.1
C17orf80	"FLJ20721, HLC-8, MIG3, SPEP1"	ENSG00000141219	"Chromosome 17 open reading frame 80"	Q9BSJ5	17	73232233-73248947	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 128.4;Late spermatids: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA012896	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA012896: AB_1850766"	"unprognostic (9.22e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.43e-4)"	"unprognostic (5.55e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.37e-1)"	8.0	10.5	12.8	8.5	13.2	2.4	10.6	27.8	15.4	11.3	11.7	8.4	5.3	9.1	13.1	9.0	10.8	11.2	7.8	13.5	13.8	10.0	11.5	8.6	10.2	11.0	11.8	12.7	16.0	10.1	17.2	24.9	10.9	11.8	11.6	9.0	9.4	9.0	11.2	22.2	7.5	10.4	12.4	14.4	9.9	9.7	32.5	11.3	16.1	14.6	8.3	10.3	10.3	13.3	6.5	7.1	14.6	5.0	5.2	8.7	3.9	9.9	10.5	14.6	8.9	10.7	9.2	14.2	13.1	11.4	18.6	17.7	9.9	8.2	18.9	9.3	6.7	12.7	10.0	20.2	7.5	21.8	6.8	13.7	17.4	11.0	11.6	9.4	18.3	10.3	7.2	9.4	12.3	10.2	9.3	15.9	12.8	18.7	11.3	12.3	5.7	21.1	8.7	11.5	11.0	11.3	12.8	40.2	9.6	9.7	7.5	17.9	16.1	6.9	12.8	15.2	24.1	14.0	11.5	8.7	19.5	18.0	6.3	12.4	12.9	15.3	18.3	7.8	8.3	12.3	14.6	4.0	5.7	8.5	5.0	8.7	6.5	6.3	7.5	4.6	5.8	6.0	8.6	1.9	5.2	4.7	7.1	8.6	3.9	12.8	13.2	27.8	15.4	13.8	10.0	11.8	12.7	11.8	11.3	6.0	10.8	3.4	1.6	4.4	8.2	17.9	7.6	25.4	11.4	5.2	19.6	7.3	8.3	4.8	128.4	7.1	5.1	0.0	3.4	4.8	4.1	1.7	7.0	3.9	4.1	7.9	5.2	4.3	5.3	75.5	4.9	5.4	1.7	5.4	3.0	9.8	4.2	4.0	7.1	5.3	14.7	0.0	4.7	23.5	12.3	3.9	14.1	4.1	4.4	1.3
C17orf97	"LIAT1, LOC400566"	ENSG00000187624	"Chromosome 17 open reading frame 97"	Q6ZQX7	17	410327-431062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 432.9;Late spermatids: 984.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 8.9;U-2197: 11.8"									HPA023583	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA023583: AB_1853122"	"unprognostic (6.62e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (7.73e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.19e-2)"	2.1	4.9	6.0	2.4	10.6	1.9	2.7	5.2	8.7	3.9	3.6	4.2	4.4	2.2	3.5	4.5	2.4	13.6	6.6	3.8	5.2	6.1	7.6	1.9	3.8	2.8	4.0	7.6	3.8	3.8	3.4	8.2	1.4	6.2	3.3	2.9	4.2	3.5	5.8	4.3	2.5	4.7	1.9	2.8	2.1	2.4	53.2	2.9	5.0	6.9	1.8	1.9	3.1	1.8	0.4	0.9	2.7	0.4	0.8	1.4	0.2	2.6	3.8	1.8	2.2	1.0	0.8	0.9	2.0	1.3	1.5	0.9	0.1	4.0	0.7	1.5	4.3	1.2	8.9	4.8	1.0	1.4	0.3	0.6	1.9	3.3	0.3	3.4	0.4	0.8	1.0	2.5	3.3	0.4	2.2	1.5	4.4	0.3	0.1	1.0	2.2	6.4	3.4	2.8	7.9	1.2	0.7	0.4	2.4	6.2	2.2	0.6	2.1	2.4	3.4	0.5	3.2	2.0	2.9	1.4	1.8	0.9	11.8	0.8	0.2	0.2	0.0	2.3	0.9	1.1	0.4	0.4	2.7	0.3	0.2	0.0	0.2	0.2	0.8	0.5	0.4	1.4	1.3	0.2	0.8	0.4	0.9	0.0	0.2	6.0	10.6	5.2	8.7	5.2	6.1	4.0	7.6	6.2	2.9	3.0	5.1	0.0	3.8	3.0	4.3	5.3	10.2	62.9	11.4	19.2	19.6	0.9	53.0	10.2	432.9	1.8	10.5	23.3	3.1	0.2	3.7	3.9	2.3	4.7	1.7	1.6	15.4	1.8	0.0	984.3	7.8	2.5	3.3	4.6	9.3	10.0	4.7	5.8	6.0	19.3	22.2	6.5	2.1	58.4	13.3	0.9	0.7	0.0	8.5	0.9
C17orf98	LOC388381	ENSG00000275489	"Chromosome 17 open reading frame 98"	A8MV24	17	38835088-38841455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 10.7"	"Cell type enriched"	"Detected in some"	14	"Early spermatids: 184.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 7.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051696	Uncertain		Approved	"Nucleoli,Intermediate filaments"		NA	NA			"Intermediate filaments"	Nucleoli	"HPA051696: AB_2681576"	"unprognostic (2.30e-1)"			"unprognostic (3.25e-4)"	"unprognostic (1.46e-1)"					"unprognostic (3.01e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.58e-2)"	"unprognostic (9.02e-2)"		0.1	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	10.7			0.0		0.0	0.0		1.3	0.5	0.4	0.4	0.2	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.0	7.9	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.0	1.2	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.1	0.0	1.0	0.5	0.0	1.3	0.3	0.5	0.0	0.2	0.2	0.5	0.7	0.0											0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	184.7	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.1	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.2	1.3	0.0	0.0	0.0	0.0	0.0
C18orf21	"HsT3108, PNAS-124, PNAS-131"	ENSG00000141428	"Chromosome 18 open reading frame 21"	Q32NC0	18	35972083-35979286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 94.7;Spermatocytes: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA065505, HPA067322"	Uncertain		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"		"HPA065505: AB_2685498, HPA067322: AB_2685822"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.88e-2)"	"unprognostic (8.66e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (2.53e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.97e-2)"	14.1	16.1	13.4	16.7	12.5	53.0	18.4	23.1	25.8	13.0	12.8	7.9	17.6	15.2	15.0	17.7	15.0	12.9	11.7	15.2	12.4	12.5	14.0	14.5	11.3	17.1	11.7	14.7	16.4	22.0	12.9	16.9	14.8	13.0	13.4	12.3	8.1	16.5	17.8	28.7	13.6	14.1	15.8	10.6	17.2	16.7	28.7	11.7	22.9	14.8	21.4	15.7	17.8	14.8	18.5	15.1	40.6	16.5	16.5	21.7	10.6	13.3	9.1	19.8	13.6	12.7	19.4	13.3	18.4	17.5	22.1	22.5	7.7	9.1	10.7	19.7	13.5	15.3	13.7	13.8	14.1	24.6	16.2	14.1	11.2	10.8	17.3	18.4	34.0	14.0	18.7	23.0	19.5	19.8	20.6	18.0	17.2	18.1	17.4	14.5	14.9	22.4	23.6	16.6	6.2	10.0	15.2	16.9	20.8	14.9	14.7	12.7	19.0	12.3	9.9	29.4	18.9	14.4	15.3	12.8	21.8	10.4	8.0	16.2	24.4	21.7	23.5	11.1	17.7	11.4	40.6	16.5	18.3	14.6	16.5	14.6	18.5	15.9	13.7	15.1	16.1	12.3	16.0	14.9	16.5	15.3	14.6	21.7	10.6	13.4	12.5	23.1	25.8	12.4	12.5	11.7	14.7	13.0	11.7	17.9	6.7	15.9	8.2	10.5	9.1	10.8	5.1	2.7	11.4	1.8	5.9	15.8	10.0	17.5	94.7	8.7	9.3	0.0	24.9	24.6	8.9	7.3	13.9	9.4	18.9	7.9	6.9	8.6	16.8	46.0	20.8	13.1	11.8	10.8	13.0	8.4	18.6	11.5	15.9	17.0	11.1	0.0	8.6	73.2	36.1	10.8	11.0	12.8	16.6	7.1
C18orf25	"ARKL1, MGC12909, RNF111L1"	ENSG00000152242	"Chromosome 18 open reading frame 25"	Q96B23	18	46173553-46266991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 54.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051314, HPA051899"	Approved		Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA051314: AB_2681438, HPA051899: AB_2681657"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.46e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.97e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	5.3	4.9	5.8	6.4	8.2	18.6	6.5	10.1	10.1	6.1	4.9	5.5	6.5	4.4	7.7	5.3	54.0	6.2	3.8	11.4	4.8	4.9	5.4	6.2	5.9	6.8	5.3	6.5	5.9	5.0	15.3	6.3	7.3	8.3	5.2	5.7	9.5	11.3	4.8	13.1	6.2	5.5	5.7	4.7	6.3	5.1	7.8	5.7	8.2	7.4	10.2	11.8	7.2	12.7	8.1	11.0	19.0	11.0	2.8	11.1	5.5	11.2	11.3	9.5	10.8	6.8	6.2	12.2	16.4	8.7	17.6	15.0	8.7	13.0	8.7	15.7	11.1	6.3	25.8	17.6	11.1	19.2	14.5	5.6	7.6	9.7	6.5	11.8	14.3	10.4	5.7	13.1	20.5	17.1	10.3	6.9	8.2	8.5	10.4	9.7	8.5	10.8	7.3	8.4	3.9	4.5	9.9	11.3	12.8	16.9	20.4	13.4	7.0	12.0	8.6	8.5	12.1	5.6	8.9	10.1	16.1	11.5	3.9	15.1	13.7	11.6	14.1	8.3	15.2	17.2	4.2	7.5	15.4	5.7	8.4	9.9	5.9	11.1	8.6	7.4	8.1	8.0	6.3	19.0	2.8	11.0	11.0	7.1	5.5	5.8	8.2	10.1	10.1	4.8	4.9	5.3	6.5	8.3	5.7	11.9	10.8	11.5	9.5	22.3	13.2	26.0	10.2	8.1	4.5	14.0	19.6	5.7	1.7	7.4	2.1	15.5	9.5	0.0	5.7	8.3	10.4	10.0	15.0	12.5	7.9	12.7	11.5	8.0	10.4	2.5	7.5	11.4	6.8	4.6	8.3	9.8	14.0	10.5	9.9	6.5	29.9	19.4	10.8	16.7	12.4	27.9	20.4	11.7	9.2	16.9
C18orf32	FLJ23458	ENSG00000177576	"Chromosome 18 open reading frame 32"	Q8TCD1	18	49477250-49487252	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 217.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040921	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA040921: AB_10795423"	"unprognostic (5.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.76e-2)"	"prognostic favorable (8.89e-9)"	"unprognostic (1.02e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.36e-2)"	17.1	16.5	67.0	7.1	59.0	19.1	25.5	27.4	48.4	22.2	24.2	29.5	16.1	10.7	12.7	35.0	13.6	17.2	19.4	25.1	57.5	49.8	42.2	38.6	19.6	14.8	67.8	28.3	16.5	20.1	23.8	20.5	15.7	47.0	21.3	22.4	17.0	21.6	18.9	10.8	10.2	14.2	14.9	78.5	13.6	23.4	15.5	25.2	8.3	28.8	8.0	12.7	19.4	9.6	16.1	21.4	57.2	22.1	9.8	15.4	21.0	7.7	9.0	17.0	10.5	15.4	13.7	19.5	11.8	13.1	11.5	9.8	1.7	3.5	7.0	29.8	10.0	7.6	9.1	3.9	13.3	9.9	22.5	8.0	6.3	6.0	10.8	24.6	12.4	13.6	11.9	29.7	7.7	11.5	15.7	15.4	14.3	7.2	13.5	23.8	4.8	7.8	6.4	4.7	10.9	9.0	7.4	5.9	14.1	30.7	15.3	19.6	33.7	7.7	6.1	16.0	20.8	8.7	4.5	16.4	11.9	10.1	3.4	12.7	41.3	24.5	7.6	9.4	8.4	11.1	36.3	17.1	43.2	13.9	19.3	15.4	16.1	13.7	14.3	14.1	12.8	11.7	15.4	57.2	9.8	22.1	21.4	14.6	21.0	67.0	59.0	27.4	48.4	57.5	49.8	67.8	28.3	47.0	25.2	41.7	20.3	28.9	4.1	4.8	34.9	4.3	25.5	52.2	20.5	22.7	41.2	17.0	33.2	73.7	217.6	11.1	72.2	0.0	72.4	14.3	10.6	4.9	43.9	39.5	19.7	17.5	91.7	22.1	40.2	140.1	15.8	19.2	21.9	101.8	54.1	24.7	79.0	66.6	9.6	38.9	33.0	19.4	7.6	11.7	13.0	6.8	32.4	19.1	36.5	4.6
C18orf54	"LAS2, MGC33382"	ENSG00000166845	"Chromosome 18 open reading frame 54"	Q8IYD9	18	54357917-54385218	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 21.4;testis: 25.2"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 73.3;Extravillous trophoblasts: 22.1;Late spermatids: 23.0;Spermatocytes: 34.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040704			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA040704: AB_10959454"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.60e-6)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.06e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.05e-2)"	2.9	1.3	2.8	4.8	7.7	2.0	2.1	4.5	4.3	4.1	2.4	3.8	1.0	1.3	3.6	1.1	2.0	1.9	2.1	2.0	3.3	2.2	1.6	0.9	2.5	4.0	10.0	3.4	2.5	1.1	1.9	1.0	21.4	5.7	1.8	2.3	0.7	1.4	1.6	1.0	1.8	2.0	2.7	5.8	4.3	1.5	25.2	6.7	9.3	1.9	1.2	4.0	2.1	3.2	1.4	0.6	1.9	4.1	0.8	2.1	0.6	5.8	3.4	14.6	6.9	3.6	6.3	4.9	9.7	4.2	9.8	12.6	2.2	3.1	4.3	2.7	3.2	4.3	6.3	10.1	5.3	12.8	14.4	3.2	4.2	3.7	3.7	0.8	4.8	4.6	2.1	1.1	13.3	6.2	4.2	11.7	5.7	4.4	9.4	14.0	1.8	5.2	3.0	7.2	1.1	6.7	4.0	10.8	3.0	4.8	4.0	8.1	4.6	4.0	1.7	2.2	8.7	2.5	4.1	10.5	18.2	8.0	3.0	5.3	5.7	6.4	6.4	4.8	8.2	12.8	1.9	0.7	0.3	1.3	0.8	1.2	0.9	1.1	0.9	0.6	1.4	1.0	1.2	0.0	0.8	4.1	0.3	2.1	0.6	2.8	7.7	4.5	4.3	3.3	2.2	10.0	3.4	5.7	6.7	0.0	1.1	0.0	0.6	0.3	1.6	1.2	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.1	73.3	2.6	0.1	0.0	0.2	22.1	1.5	0.3	0.0	0.0	2.1	0.0	0.0	4.9	2.8	23.0	1.4	1.7	1.7	1.8	0.6	2.3	0.3	0.0	0.7	0.2	0.7	0.0	1.4	34.4	16.0	0.4	1.7	0.7	0.8	0.7
C18orf63	DKFZP781G0119	ENSG00000206043	"Chromosome 18 open reading frame 63"	Q68DL7	18	74315813-74359187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"testis: 17.4"	"Cell type enriched"	"Detected in some"	14	"Spermatocytes: 47.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.1"					"Not detected"	"Not detected"			HPA042233			Approved	Mitochondria		NA	NA			Mitochondria		"HPA042233: AB_10960843"								"unprognostic (1.40e-1)"					"unprognostic (1.43e-4)"					0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	47.2	3.4	0.0	0.0	0.0	0.0	0.0
C19orf18	MGC41906	ENSG00000177025	"Chromosome 19 open reading frame 18"	Q8NEA5	19	57958437-57974534	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 22.6"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 83.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 4.6;HEK 293: 6.6;RT4: 4.4"									"HPA014527, HPA079195"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA014527: AB_1845612, HPA079195: "	"unprognostic (5.38e-2)"	"unprognostic (6.36e-3)"	"unprognostic (3.70e-2)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.08e-5)"	"unprognostic (1.11e-2)"	"unprognostic (8.75e-5)"	"unprognostic (1.53e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.05e-3)"	1.1	1.7	1.4	1.1	1.8	0.4	3.6	1.1	1.1	1.1	1.3	1.1	1.1	0.8	1.4	5.6	1.1	1.8	1.4	4.2	1.9	1.8	1.1	1.1	1.1	1.1	2.1	1.1	1.3	1.1	1.0	3.6	1.1	3.1	2.7	0.8	1.1	1.2	1.6	4.2	1.2	1.1	1.1	2.3	1.1	0.8	22.6	1.1	1.1	1.3	1.1	1.1	1.1	1.1	2.8	1.6	0.7	0.9	0.8	1.2	0.4	0.2	0.0	1.9	4.6	1.1	1.5	1.4	2.2	0.5	0.6	1.4	0.0	0.4	0.5	1.0	0.6	0.5	0.1	0.1	0.0	1.5	0.0	6.6	0.4	0.0	1.5	1.7	0.0	1.1	1.8	2.7	0.1	0.4	1.6	0.3	1.0	0.2	0.0	3.3	0.0	0.9	0.0	0.1	0.0	0.4	1.3	0.0	1.2	1.1	4.4	2.0	0.5	0.9	0.0	0.6	1.5	1.6	1.5	0.9	0.3	0.5	0.6	0.5	0.9	3.9	0.1	0.0	0.0	0.5	0.0	0.6	0.7	0.1	0.2	0.0	2.8	1.0	0.6	1.6	1.3	0.6	1.2	0.5	0.8	0.9	1.0	0.0	0.4	1.4	1.8	1.1	1.1	1.9	1.8	2.1	1.1	3.1	1.1	3.0	2.1	0.0	0.4	0.3	0.5	3.2	0.0	2.7	2.3	0.0	0.0	0.3	0.0	1.7	83.6	1.0	0.4	0.0	0.2	0.5	0.8	0.5	0.0	1.3	0.4	0.0	0.0	3.7	1.0	16.0	2.0	0.0	1.7	1.0	1.8	1.8	0.7	0.0	0.7	0.2	2.8	6.5	1.2	3.5	2.2	0.5	0.2	0.0	1.1	0.3
C19orf24	FLJ20640	ENSG00000228300	"Chromosome 19 open reading frame 24"	Q9BVV8	19	1275438-1279249	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA043279, HPA047026"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA043279: AB_10794656, HPA047026: AB_2679906"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.25e-2)"	20.2	25.3	13.4	20.9	14.9	17.1	65.7	11.3	15.8	11.7	15.6	9.1	17.5	21.8	13.8	22.0	18.7	13.0	26.5	14.3	13.3	10.9	22.6	48.6	17.0	55.0	13.4	7.0	16.6	41.6	5.9	16.9	18.4	9.7	17.6	6.0	11.1	29.6	22.5	6.9	16.6	19.6	10.5	10.9	22.8	16.6	16.8	10.0	23.1	25.7	19.0	15.8	15.5	21.9	40.9	44.8	9.5	27.5	19.0	33.8	21.3	25.7	24.6	2.3	20.3	4.0	9.3	9.5	12.6	6.7	13.4	11.8	28.1	14.4	7.4	17.6	4.4	9.0	13.8	4.1	13.3	1.5	27.1	21.2	8.0	22.0	16.3	16.6	17.0	17.9	11.1	17.2	10.1	4.4	3.9	9.8	23.5	15.3	43.1	5.3	25.8	20.4	25.2	11.9	12.0	24.9	15.2	4.7	46.3	7.4	13.7	16.7	10.8	8.0	19.4	29.0	1.7	14.1	28.7	6.2	24.6	7.8	29.9	29.7	28.3	36.8	9.3	26.6	21.3	22.0	9.5	26.8	9.2	31.2	27.5	30.9	40.9	33.8	32.9	26.7	36.0	31.9	32.3	4.7	19.0	23.1	44.8	31.9	21.3	13.4	14.9	11.3	15.8	13.3	10.9	13.4	7.0	9.7	10.0	11.9	22.9	82.7	40.2	67.5	16.8	7.4	45.9	10.7	5.7	38.4	11.8	75.5	51.4	88.8	46.4	40.0	109.8	0.0	100.0	114.9	38.2	84.3	42.5	125.4	107.8	4.8	59.3	39.9	79.4	237.5	39.4	64.3	65.8	66.7	84.4	22.5	100.5	97.9	28.3	142.5	12.1	19.4	34.8	26.3	98.6	73.5	80.4	49.8	87.4	59.9
C19orf25	FLJ36666	ENSG00000119559	"Chromosome 19 open reading frame 25"	Q9UFG5	19	1461143-1479556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050270, HPA067491"	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA050270: AB_2681069, HPA067491: AB_2685849"	"unprognostic (5.82e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.51e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-3)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.35e-2)"	"prognostic favorable (9.20e-8)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-3)"	12.1	17.9	25.8	14.2	22.1	10.4	11.2	26.4	22.6	12.7	15.7	19.0	17.7	23.2	17.2	12.5	12.1	17.6	12.5	17.2	24.5	21.8	17.9	16.8	13.0	19.9	23.4	15.6	16.4	27.0	10.4	18.2	15.4	15.3	15.3	8.2	16.5	27.0	13.9	11.7	13.7	22.2	14.0	23.0	16.5	16.8	17.6	17.2	17.3	24.1	7.4	14.9	12.6	18.0	28.2	28.6	34.1	20.2	17.1	31.2	23.0	13.1	10.2	6.4	10.1	6.2	5.7	12.7	13.0	9.1	14.2	13.1	14.7	6.8	7.6	10.3	7.0	6.6	16.3	9.7	8.3	3.3	23.5	14.6	9.2	6.0	17.1	13.5	14.5	18.3	5.3	18.9	5.9	9.5	10.0	7.3	16.2	23.8	18.0	8.9	7.4	13.6	12.1	20.3	8.2	16.6	22.4	8.9	19.4	9.8	9.0	10.8	14.7	9.7	12.5	15.4	3.4	18.3	17.1	8.9	10.9	12.4	22.0	12.4	25.6	13.8	12.6	11.3	14.8	19.4	26.5	20.2	34.1	27.4	19.7	22.2	22.1	25.2	23.4	14.4	28.2	26.1	20.9	32.1	17.1	15.7	28.6	31.2	23.0	25.8	22.1	26.4	22.6	24.5	21.8	23.4	15.6	15.3	17.2	14.9	8.3	41.0	27.9	17.1	58.8	8.9	20.4	8.1	9.1	48.8	60.9	37.2	41.4	32.8	3.5	20.3	69.8	0.0	40.0	27.2	22.8	28.7	11.5	16.6	31.1	92.2	48.6	25.2	22.2	5.2	24.5	24.1	23.6	59.5	25.9	47.3	39.9	52.6	20.5	23.9	70.3	45.3	22.8	28.8	32.4	17.2	44.3	48.4	26.4	30.6
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304161-38305009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 105.8;tongue: 78.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 1588.2;Exocrine glandular cells: 683.1;Mucus-secreting cells: 800.2;Pancreatic endocrine cells: 1532.5;Paneth cells: 1006.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 15.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.1"	"Cell line enhanced"	"Detected in some"		"A-431: 70.1;A549: 108.2;CAPAN-2: 66.8;HBEC3-KT: 64.8;hTCEpi: 67.9;OE19: 57.5;PC-3: 61.8"									"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	6.9	0.6	0.5	16.4	0.7	0.3	5.0	0.5	0.8	14.5	58.8	0.6	3.5	34.6	3.9	4.3	88.4	18.2	45.2	9.9	0.8	0.3	5.8	1.0	34.8	0.6	0.7	1.4	4.9	0.8	0.0	2.0	10.0	1.7	10.3	18.2	1.2	21.5	6.8	2.8	53.3	105.8	2.9	3.1	1.9	28.7	1.5	0.5	1.5	4.4	78.5	39.2	16.2	35.1	0.1	15.1	1.4	0.6	0.3	0.4	14.6	70.1	108.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	66.8	0.0	40.1	0.0	0.0	26.3	0.0	64.8	0.0	0.0	0.0	0.0	22.7	1.8	0.5	0.0	0.0	0.0	67.9	0.0	43.6	0.1	1.1	0.0	0.0	0.0	0.0	18.1	0.0	0.1	0.1	57.5	61.8	0.0	0.0	0.0	41.0	20.8	0.1	0.0	41.0	29.7	0.0	0.1	9.2	0.2	14.6	0.0	20.4	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.6	1.4	0.3	0.0	0.3	0.1	0.2	0.1	15.1	0.1	0.4	0.3	0.9	0.3	0.0	0.9	0.0	14.6	0.5	0.7	0.5	0.8	0.8	0.3	0.7	1.4	1.7	0.5	497.3	155.5	7.0	25.1	200.2	0.0	1.4	298.1	195.4	353.8	52.4	0.0	5.2	1.7	144.5	0.4	9.8	1588.2	0.0	683.1	1.0	5.6	22.7	39.1	0.0	1.3	0.0	73.3	4.9	1.6	2.8	3.7	8.2	1.7	4.6	800.2	0.0	1532.5	1006.5	0.0	21.6	0.0	0.0	5.0	1.4	1.9	304.5	2.6	0.0	506.3	112.5
C19orf44	FLJ21742	ENSG00000105072	"Chromosome 19 open reading frame 44"	Q9H6X5	19	16496311-16521352	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 37.3;Late spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041683, HPA049414"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA041683: AB_10793929, HPA049414: AB_2680754"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.19e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.02e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-1)"	5.0	4.6	8.1	3.6	8.1	6.1	5.6	11.2	8.8	9.9	7.7	7.4	10.2	3.9	12.7	5.8	5.1	11.5	7.6	5.9	6.3	5.1	6.9	4.3	4.5	3.8	4.0	3.8	13.2	8.1	14.9	19.7	4.1	5.9	11.0	2.9	11.2	10.6	9.9	6.9	7.7	3.8	8.2	5.9	3.9	5.3	19.7	5.8	4.1	9.1	3.1	4.3	6.4	6.1	3.5	1.6	5.7	1.7	1.5	2.7	1.0	5.5	6.3	5.4	7.7	3.5	8.8	7.2	4.7	4.5	5.9	8.6	3.8	6.9	4.8	8.4	3.7	4.2	3.9	4.6	4.1	4.6	2.8	11.3	2.3	9.0	4.9	6.3	2.6	2.5	4.5	4.1	7.8	5.8	10.5	3.2	6.4	6.7	1.5	3.2	7.6	4.2	6.8	3.4	6.3	8.3	3.1	2.7	6.6	6.2	2.5	6.4	3.9	4.6	6.8	4.1	5.1	5.9	2.8	6.4	8.0	3.8	5.6	6.4	4.8	3.4	2.7	5.7	2.5	6.7	5.7	1.5	0.5	1.6	0.7	0.4	3.5	1.5	0.7	0.6	3.4	1.7	2.7	3.3	1.5	1.7	1.6	0.6	1.0	8.1	8.1	11.2	8.8	6.3	5.1	4.0	3.8	5.9	5.8	0.0	6.4	0.0	0.8	0.3	3.5	3.6	5.1	6.7	7.9	7.0	11.8	1.5	0.0	1.3	37.3	1.6	0.4	0.0	1.0	1.6	1.7	0.5	0.0	1.0	0.6	0.0	6.9	1.3	0.3	52.0	2.8	1.2	0.0	1.8	0.9	2.5	1.2	0.9	4.9	2.7	7.4	0.0	2.1	7.2	2.1	0.4	0.5	0.0	1.1	0.2
C19orf48	"BC006151, MGC13170"	ENSG00000167747	"Chromosome 19 open reading frame 48"	Q6RUI8	19	50797704-50804929	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA042000	Uncertain		Approved	"Plasma membrane"		NA	Yes			"Plasma membrane"		"HPA042000: AB_10797377"	"unprognostic (2.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.39e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.80e-5)"	"unprognostic (6.59e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	5.0	9.7	6.5	11.0	6.2	20.7	9.6	7.0	8.9	7.2	9.3	7.0	4.1	6.8	7.8	6.9	13.2	13.5	9.5	4.1	4.0	3.4	7.4	12.0	8.0	22.2	6.8	8.7	13.0	40.7	3.2	4.0	7.5	5.2	32.1	5.8	6.9	8.3	5.6	6.4	15.9	6.4	6.7	5.1	8.8	7.0	19.8	5.0	23.6	17.9	9.1	12.5	5.1	7.3	29.0	20.8	2.8	8.7	12.4	21.6	9.9	21.4	34.1	16.1	10.1	3.1	9.6	14.9	19.4	13.3	28.7	28.7	41.1	20.0	36.8	9.0	7.5	11.1	15.3	26.8	27.3	9.9	11.5	64.7	24.5	14.5	23.9	8.7	25.6	12.4	15.6	28.4	29.9	32.6	7.0	15.3	36.3	26.8	18.4	13.3	18.5	34.3	31.0	12.9	26.4	43.7	25.8	26.3	34.8	9.3	35.9	26.6	12.8	19.4	25.3	26.4	6.1	14.9	25.2	7.2	13.3	24.6	8.1	26.3	10.8	12.2	30.3	8.1	23.3	17.8	1.0	6.0	2.8	9.9	8.7	14.0	29.0	14.1	11.2	11.8	27.3	21.6	16.1	0.4	12.4	6.3	20.8	14.5	9.9	6.5	6.2	7.0	8.9	4.0	3.4	6.8	8.7	5.2	5.0	3.0	6.9	49.4	35.3	51.9	8.7	4.7	12.7	1.4	6.8	17.4	5.9	84.7	28.2	25.6	6.7	15.8	10.0	23.3	94.0	106.2	23.6	54.8	8.1	11.5	36.1	0.0	23.0	6.7	8.8	12.6	16.4	21.5	16.9	39.7	66.4	9.7	47.0	14.0	7.1	15.2	7.0	6.5	21.7	27.2	39.4	60.1	51.8	15.0	100.4	27.5
C19orf53	"HSPC023, LYDG10"	ENSG00000104979	"Chromosome 19 open reading frame 53"	Q9UNZ5	19	13774168-13778462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059928, HPA061291"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA059928: AB_2684165, HPA061291: AB_2684469"	"unprognostic (3.94e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.85e-2)"	37.3	41.5	55.6	31.1	53.7	42.1	33.1	22.0	41.7	40.4	35.7	27.0	34.2	28.0	33.9	55.6	43.1	44.0	39.3	67.0	46.2	44.8	42.8	68.4	35.5	42.4	47.2	34.7	49.9	46.9	27.4	41.8	27.2	37.3	39.2	26.4	30.1	45.9	35.7	90.7	31.5	29.2	39.6	37.0	34.8	31.3	34.1	30.0	59.6	53.5	47.7	41.6	43.1	43.1	67.9	63.0	57.3	49.6	36.3	75.8	92.4	35.4	50.6	25.2	21.0	35.8	40.5	16.7	33.4	29.7	41.6	41.5	46.9	17.3	18.9	41.7	40.4	30.6	19.0	23.3	50.5	21.5	22.6	73.5	17.7	54.7	50.9	37.1	27.7	23.5	49.4	36.5	38.5	21.8	26.5	35.6	28.2	27.4	32.6	32.4	79.9	39.1	28.7	32.1	27.2	89.7	21.5	19.2	32.7	36.9	44.0	23.0	27.7	23.4	27.8	33.9	19.5	25.3	28.5	23.7	47.3	18.9	50.6	45.7	36.5	46.4	28.2	28.7	31.5	25.6	48.1	48.8	57.3	49.0	49.6	55.5	67.9	63.4	57.0	44.2	63.3	75.8	68.0	23.7	36.3	43.1	63.0	69.4	92.4	55.6	53.7	22.0	41.7	46.2	44.8	47.2	34.7	37.3	30.0	107.2	86.2	241.2	221.7	258.6	46.5	224.1	198.7	117.8	97.8	254.7	21.6	202.0	532.2	215.9	134.2	206.4	254.0	163.5	291.0	335.7	214.9	274.6	125.8	284.8	320.6	33.4	218.2	154.1	231.7	499.2	202.5	228.8	219.4	359.7	182.1	129.2	247.0	245.4	171.5	582.8	48.4	90.5	205.0	94.7	135.7	304.6	178.2	221.8	197.3	276.6
C19orf54	FLJ41131	ENSG00000188493	"Chromosome 19 open reading frame 54"	Q5BKX5	19	40740856-40751553	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059043, HPA059628"	Approved		Approved	"Intermediate filaments,Centriolar satellite"		NA	NA			"Intermediate filaments"	"Centriolar satellite"	"HPA059043: AB_2683886, HPA059628: AB_2684087"	"unprognostic (3.18e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.33e-2)"	10.1	15.7	8.6	10.6	11.8	9.2	11.2	5.0	10.6	7.6	10.1	15.6	16.7	17.9	8.7	16.6	9.2	7.6	10.1	8.4	7.5	5.9	11.8	21.3	13.4	13.3	11.1	6.9	7.0	12.9	13.7	9.6	10.2	10.9	9.5	13.3	9.2	10.1	16.4	22.5	10.1	17.2	9.2	16.8	15.0	10.4	11.4	11.0	13.4	12.2	7.8	10.6	10.3	7.2	1.6	8.2	1.8	6.5	0.7	2.9	2.4	5.1	12.7	10.0	8.6	5.4	7.9	7.8	3.6	5.3	6.3	6.6	8.6	8.3	12.2	9.7	4.9	3.5	8.8	16.4	6.9	6.2	7.5	14.7	7.8	14.4	10.5	18.1	5.3	5.8	12.2	3.5	6.5	15.3	9.2	4.3	16.5	9.5	17.4	5.3	6.6	6.9	6.1	7.6	12.6	4.1	12.1	11.2	9.1	7.6	9.7	8.3	5.2	14.3	5.8	5.4	12.7	6.0	6.7	3.7	8.7	8.8	4.2	2.7	18.8	11.5	8.7	8.9	11.4	5.7	0.1	6.0	1.8	2.0	5.1	0.7	1.6	1.6	0.9	8.2	1.4	1.6	1.4	0.9	0.7	6.5	4.3	2.9	2.4	8.6	11.8	5.0	10.6	7.5	5.9	11.1	6.9	10.9	11.0	3.0	6.2	3.7	3.1	1.4	1.4	5.8	2.5	1.4	0.0	5.2	2.0	6.3	3.3	2.5	5.9	2.8	7.8	0.0	2.2	5.8	2.1	2.4	0.0	5.5	7.4	0.0	1.2	1.3	8.0	2.0	2.3	5.3	0.0	9.0	4.2	2.0	2.6	3.4	1.1	5.1	3.6	0.0	1.1	9.8	9.1	1.5	4.7	2.5	5.3	1.6
C19orf57	MGC11271	ENSG00000132016	"Chromosome 19 open reading frame 57"	Q0VDD7	19	13882348-13906452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.9"	"Cell type enhanced"	"Detected in many"	10	"Rod photoreceptor cells: 7.7;Spermatocytes: 16.3;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"											"HPA044012, HPA054615"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044012: AB_10964782, HPA054615: AB_2682543"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (2.12e-1)"	"prognostic favorable (5.14e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.60e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-4)"	"unprognostic (1.21e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.73e-2)"	2.5	0.9	4.6	1.9	5.5	4.0	4.2	12.8	9.1	2.6	6.9	5.8	0.8	7.7	1.8	3.7	6.2	5.6	1.9	1.1	5.4	3.1	1.3	2.2	1.6	1.9	7.2	3.7	2.8	10.8	3.3	1.6	0.9	6.3	2.4	3.0	1.4	4.4	1.9	1.3	14.2	5.6	1.2	5.9	1.8	2.9	22.9	4.1	2.3	1.4	0.5	1.8	2.1	4.5	0.1	2.6	0.0	0.2	0.6	4.9	1.1	9.4	0.3	7.2	4.0	2.1	0.4	4.8	2.7	1.1	3.2	3.1	5.9	1.4	10.5	14.8	1.1	1.9	4.8	2.1	0.9	1.1	1.5	4.6	4.4	3.9	0.1	0.6	2.2	9.8	0.4	0.7	2.0	0.3	0.5	0.7	5.9	3.0	4.2	1.0	3.1	8.4	4.9	1.0	3.3	7.2	9.3	2.7	0.6	1.2	2.2	6.3	2.4	10.4	1.9	3.0	0.6	2.0	2.1	0.0	5.9	3.2	13.4	0.7	7.6	1.6	5.3	3.6	7.2	9.0	0.0	0.1	0.0	4.9	0.0	0.5	0.0	0.2	1.1	0.0	0.1	0.4	2.5	0.0	0.6	0.2	2.6	0.0	1.1	4.6	5.5	12.8	9.1	5.4	3.1	7.2	3.7	6.3	4.1	0.0	0.0	0.0	2.6	1.4	1.9	1.2	0.0	0.0	1.2	0.0	2.0	0.4	3.3	0.4	0.5	0.5	1.8	0.0	1.0	0.3	0.8	0.5	0.0	0.0	0.5	1.6	0.0	0.6	0.8	1.4	2.6	0.0	1.7	1.0	2.5	1.4	0.4	5.8	1.8	0.0	7.7	0.0	1.4	16.3	10.0	2.6	0.7	0.0	2.5	1.8
C19orf71	LOC100128569	ENSG00000183397	"Chromosome 19 open reading frame 71"	A6NCJ1	19	3539154-3544030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 88.8"	"Group enriched"	"Detected in some"	58	"Early spermatids: 515.2;Late spermatids: 237.4"	"Cancer enriched"	"Detected in all"	5	"melanoma: 23.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HeLa: 27.3;SK-MEL-30: 16.6;WM-115: 59.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048654	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Endoplasmic reticulum"	"HPA048654: AB_2680480"	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.74e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (2.02e-5)"	"unprognostic (5.52e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-3)"	1.6	2.3	1.6	4.1	2.2	5.1	1.6	9.8	2.2	1.7	1.6	2.0	1.6	4.7	2.5	1.9	1.6	2.6	1.6	1.6	1.6	1.3	3.5	1.6	2.1	4.9	1.8	1.9	2.8	4.2	0.0	4.5	1.6	1.7	2.2	0.0	1.6	7.6	1.6	1.6	7.4	3.9	1.6	1.6	5.2	3.2	88.8	1.8	1.6	6.3	1.6	1.6	1.7	1.6	0.3	0.5	0.0	0.2	0.0	0.7	0.1	5.3	4.4	1.4	2.0	0.0	0.0	2.9	3.4	0.0	0.0	0.0	2.7	1.6	0.9	2.6	0.0	7.4	4.8	0.0	0.2	0.0	5.4	2.6	0.7	27.3	0.8	0.0	0.7	3.4	0.0	0.0	0.1	0.0	1.6	0.0	2.5	3.7	4.9	0.0	3.8	1.1	1.7	1.2	0.1	1.3	1.8	2.1	5.0	0.0	2.1	3.4	3.1	5.9	3.0	16.6	0.7	3.3	1.7	4.5	2.7	3.6	8.2	3.1	3.9	1.0	1.4	8.1	3.2	59.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.2	0.5	0.0	0.1	1.6	2.2	9.8	2.2	1.6	1.3	1.8	1.9	1.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	515.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	237.4	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	6.5	0.0	2.8	1.5	0.0	0.1	0.0	0.0	0.0
C19orf73	FLJ10490	ENSG00000221916	"Chromosome 19 open reading frame 73"	Q9NVV2	19	49118397-49119140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.7"									HPA062719	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA062719: AB_2684847"	"unprognostic (3.02e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (3.05e-1)"	"unprognostic (9.00e-5)"	"unprognostic (1.19e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.13e-3)"	2.5	3.4	5.0	2.3	6.7	1.0	3.7	10.2	8.7	1.4	3.9	4.1	3.1	7.7	1.3	5.6	2.6	1.4	2.1	3.5	4.9	4.5	2.5	4.8	1.5	2.3	9.2	4.9	0.7	12.9	3.3	5.4	1.4	5.0	2.5	2.9	1.8	6.3	2.1	3.6	4.1	4.4	1.3	4.7	3.6	2.9	2.1	5.6	1.1	3.1	1.2	1.7	1.5	1.4	6.2	5.5	0.7	4.1	7.9	4.6	2.3	2.4	3.1	1.2	6.0	2.0	0.4	1.3	0.7	0.4	1.3	0.9	0.2	1.4	1.8	0.7	0.5	1.9	1.6	1.6	0.2	0.2	3.5	12.7	1.5	1.9	2.0	2.0	0.0	0.7	0.2	4.1	0.9	3.4	1.0	0.4	6.2	2.8	2.9	0.6	2.6	1.9	1.8	0.9	2.6	0.6	1.8	2.4	2.3	2.3	1.0	6.3	2.9	1.2	1.5	2.3	0.9	1.5	0.6	1.2	1.6	2.7	0.5	0.6	1.8	3.4	2.0	1.1	2.1	1.8	0.0	3.3	0.7	2.9	1.9	4.6	2.7	2.2	2.6	5.5	6.2	4.3	3.2	0.1	7.9	4.1	4.2	1.9	2.3	5.0	6.7	10.2	8.7	4.9	4.5	9.2	4.9	5.0	5.6	0.0	0.0	4.5	8.9	1.9	3.6	0.7	5.1	1.4	1.2	3.5	0.0	0.7	3.3	2.2	0.4	0.5	3.3	0.0	1.7	0.8	1.4	6.4	0.0	3.9	1.2	1.6	2.9	1.8	1.2	0.7	0.0	1.3	3.3	0.0	4.2	3.4	1.9	0.0	1.4	7.0	4.3	0.0	1.1	0.4	3.4	2.3	0.3	1.8	4.7	3.5
C19orf81		ENSG00000235034	"Chromosome 19 open reading frame 81"	C9J6K1	19	50649445-50659310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 10.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 19.2;Early spermatids: 20.8;Muller glia cells: 31.4;Rod photoreceptor cells: 22.2;Spermatocytes: 21.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.3;HMC-1: 3.4;JURKAT: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA060238	Enhanced		Approved	Vesicles,Aggresome		NA	NA			"Vesicles, Aggresome"		"HPA060238: AB_2684228"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.01e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.04e-2)"	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.6	0.2	0.0			0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.3		0.0	0.0	0.6	0.1	0.0		0.7	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.7			0.2		0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	1.1	1.4	0.0	0.0	0.0	0.7	0.0	0.0	1.2	9.3	0.9	0.0	0.0	0.5	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	2.7	2.2	1.8	0.0	0.0	0.5	1.5	0.5	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	1.1	0.5	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.6	0.0	0.1											0.0	0.0	0.0	1.2	1.9	15.4	1.2	0.0	0.0	0.0	19.2	7.9	0.0	11.6	7.6	20.8	0.2	0.0	0.0	1.1	0.2	0.5	5.4	0.0	0.0	0.9	11.1	0.0	1.8	0.0	2.5	0.6	0.0	5.0	4.6	0.0	31.4	7.2	0.0	0.7	0.0	22.2	0.0	1.2	21.5	3.2	3.8	0.0	0.0	0.0	0.1
C19orf84		ENSG00000262874	"Chromosome 19 open reading frame 84"	I3L1E1	19	51388289-51390574	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 39.0"	"Cell type enhanced"	"Detected in some"	24	"Late spermatids: 1.8;Spermatogonia: 3.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdT-cell: 1.5;plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.7;T-cells: 1.5"	"Cell line enriched"	"Detected in some"	8	"K-562: 12.3"					"Low region specificity"	"Detected in all"			HPA068082	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA068082: AB_2685949"	"unprognostic (5.94e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.13e-3)"	"unprognostic (9.28e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.99e-3)"	0.0	0.0	0.1	0.3	0.2	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.3	0.4	0.0	0.4	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.0	39.0	0.2	1.0	0.0	0.2	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.2	1.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	12.3	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.1	0.2	0.2	0.2	0.6	0.1	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0
C1GALT1	"C1GALT, T-synthase"	ENSG00000106392	"Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1"	Q9NS00	7	7156934-7248651	"Enzymes, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 171.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"LHCN-M2: 81.9"	"Low region specificity"	"Detected in all"							"HPA011294, HPA012819"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		10000	"Nuclear bodies, Cytosol"		"HPA011294: AB_1845623, HPA012819: AB_1845624"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.38e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-1)"	11.4	7.7	10.1	12.4	14.1	23.1	11.0	10.6	14.9	13.9	10.7	21.5	4.0	19.3	5.4	7.1	24.7	12.7	16.1	11.6	12.8	10.8	21.5	14.7	10.9	11.7	23.7	8.9	6.2	6.2	42.3	11.0	30.2	19.2	5.7	12.2	8.1	17.6	5.7	8.1	8.6	15.8	5.3	31.0	13.8	15.3	5.4	21.4	12.9	10.6	6.2	11.6	10.3	8.4	15.9	13.5	33.2	26.0	16.6	17.4	12.2	18.9	8.2	2.5	4.3	7.5	15.8	8.8	21.8	16.3	10.2	15.1	5.6	19.7	8.9	5.6	8.6	27.4	6.1	3.7	8.2	16.1	5.3	3.0	8.4	4.9	15.5	8.2	8.8	3.7	12.9	5.8	25.0	19.3	12.8	8.3	8.9	18.0	5.6	81.9	3.2	2.4	4.3	15.9	12.6	8.9	8.0	14.9	5.4	11.5	8.4	3.1	8.2	13.8	15.6	14.8	16.2	4.9	4.5	8.7	16.3	25.3	23.2	8.8	10.7	9.1	10.1	10.8	11.9	18.1	33.2	11.1	31.2	16.1	16.5	16.9	15.9	15.0	17.4	12.2	13.7	15.7	17.0	24.3	16.6	26.0	13.5	13.0	12.2	10.1	14.1	10.6	14.9	12.8	10.8	23.7	8.9	19.2	21.4	38.7	50.4	35.6	14.0	23.4	22.1	22.0	30.6	18.7	21.6	17.4	31.4	79.2	5.0	23.7	13.7	11.7	21.0	0.0	22.7	66.8	16.9	13.7	11.5	19.5	32.6	44.5	15.0	11.6	19.3	12.2	6.1	21.9	21.9	10.0	20.0	23.0	35.5	17.5	6.0	37.2	32.9	6.5	8.9	15.0	29.3	16.9	171.3	29.2	26.5	17.1
C1GALT1C1	"C1GALT2, COSMC"	ENSG00000171155	"C1GALT1 specific chaperone 1"	Q96EU7	X	120625793-120630150	"Disease related genes, Predicted membrane proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 83.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 73.1"	"Low region specificity"	"Detected in all"							"HPA010666, HPA015632"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA010666: , HPA015632: AB_1845625"	"prognostic unfavorable (5.66e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.26e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (3.78e-2)"	16.5	28.0	8.4	11.1	9.2	3.0	21.1	9.0	9.9	19.2	16.7	10.8	16.5	12.7	13.0	23.1	15.0	15.1	11.6	17.7	9.0	10.9	25.9	35.2	12.4	12.9	11.0	7.5	13.2	18.8	18.7	83.5	13.3	11.5	14.1	19.4	10.9	19.4	15.5	7.4	5.8	20.6	12.4	12.0	16.5	14.6	9.6	10.6	16.3	19.8	12.3	12.4	13.9	12.3	17.2	23.0	31.3	22.3	15.1	23.8	16.2	8.5	8.3	4.6	7.9	73.1	13.9	7.3	15.7	22.2	8.3	15.8	5.4	27.6	5.6	7.9	31.6	16.0	12.1	9.0	7.6	13.3	9.4	10.9	3.6	7.7	7.9	11.4	6.2	5.7	12.1	6.9	10.3	3.5	20.9	26.1	2.8	2.2	6.6	9.7	11.6	2.1	5.9	5.2	28.9	8.4	0.9	3.6	15.2	16.8	5.8	5.1	4.8	14.9	10.2	7.8	8.8	8.9	6.1	23.9	3.8	4.7	15.3	14.6	2.8	4.2	4.4	14.0	12.4	8.4	13.3	17.7	27.0	17.6	22.3	19.4	17.2	22.9	19.0	20.1	10.6	23.8	18.9	31.3	15.1	17.5	23.0	21.0	16.2	8.4	9.2	9.0	9.9	9.0	10.9	11.0	7.5	11.5	10.6	6.0	7.2	13.4	18.7	6.1	8.1	14.1	12.7	26.8	18.2	36.6	2.0	47.7	13.3	34.2	2.5	22.5	15.3	0.0	39.1	41.4	29.1	13.7	2.3	19.2	21.2	19.1	13.3	20.3	15.1	4.4	21.0	19.0	28.7	23.4	19.1	19.0	25.0	17.6	18.0	16.1	8.2	6.5	20.3	4.4	7.9	6.4	16.7	13.8	18.9	20.6
C1orf100		ENSG00000173728	"Chromosome 1 open reading frame 100"	Q5SVJ3	1	244352635-244389663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 65.3"	"Group enriched"	"Detected in some"	119	"Early spermatids: 1095.9;Late spermatids: 535.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	51	"K-562: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031179, HPA031180"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA031179: AB_10599995, HPA031180: AB_10599026"	"unprognostic (9.84e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.37e-2)"	"unprognostic (9.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-5)"	"unprognostic (1.85e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1095.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	535.2	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.9	1.6	0.0	0.0	0.0	0.0	0.0
C1orf112	FLJ10706	ENSG00000000460	"Chromosome 1 open reading frame 112"	Q9NSG2	1	169662007-169854080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 27.7;Spermatogonia: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023778, HPA024451"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023778: AB_1848665, HPA024451: AB_1848667"	"unprognostic (4.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (9.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.65e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	3.4	3.1	3.3	7.4	4.9	10.1	5.0	8.4	3.6	5.2	3.2	5.0	2.2	1.5	4.8	3.5	4.0	2.2	1.8	2.3	2.7	2.4	2.6	5.2	2.6	7.4	5.0	1.5	3.3	2.6	20.1	3.7	4.2	4.5	3.2	5.3	4.9	3.3	4.9	1.9	3.1	3.3	3.6	3.6	4.2	3.0	19.7	5.9	24.6	3.2	2.9	9.5	4.0	3.3	2.9	2.7	4.3	4.9	4.9	1.6	1.6	16.5	8.9	11.7	6.0	1.9	2.6	17.3	11.0	5.7	16.2	16.5	9.9	14.6	14.8	5.0	3.6	5.7	13.6	14.6	7.7	18.6	8.7	8.6	14.0	12.0	7.2	0.6	18.2	6.2	0.8	1.1	12.0	2.9	1.9	6.8	9.1	22.5	25.3	13.1	4.0	15.8	5.1	15.4	11.8	6.4	12.0	13.1	10.0	2.2	8.4	8.6	9.0	6.9	11.6	3.6	11.6	11.0	9.5	4.9	13.1	10.4	9.5	14.9	6.9	10.3	15.7	4.9	13.6	12.6	4.3	1.8	2.2	1.3	4.5	1.0	2.9	1.6	1.4	2.7	2.8	0.6	1.4	0.3	4.9	4.9	0.7	1.6	1.6	3.3	4.9	8.4	3.6	2.7	2.4	5.0	1.5	4.5	5.9	0.0	3.5	2.2	2.6	1.5	3.8	0.4	0.0	2.7	1.2	0.0	5.9	6.0	0.0	2.3	5.9	2.1	0.9	0.0	3.0	7.4	2.3	0.8	4.6	3.0	5.0	1.6	0.0	4.3	3.1	3.1	2.0	3.0	3.3	1.0	1.0	2.6	2.5	0.0	3.5	0.4	6.5	6.5	1.2	27.7	17.7	0.9	3.2	1.9	1.6	1.4
C1orf123	FLJ20580	ENSG00000162384	"Chromosome 1 open reading frame 123"	Q9NWV4	1	53214099-53220617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043835	Uncertain		Approved	"Vesicles,Mitotic spindle,Cytosol"		Yes	No		380000	Cytosol	"Vesicles, Mitotic spindle"	"HPA043835: AB_10796797"	"unprognostic (1.09e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.27e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (6.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-1)"	32.6	21.4	27.8	19.1	29.4	12.9	26.3	16.4	25.4	29.2	33.2	25.0	22.7	15.4	34.0	28.9	25.7	32.2	22.7	28.8	24.3	22.3	26.9	29.3	20.3	18.3	24.7	26.3	33.5	17.5	21.0	20.1	22.5	23.7	31.7	24.7	24.0	16.6	33.5	44.4	14.3	16.9	48.4	22.5	18.4	23.4	26.0	23.8	18.9	26.0	18.0	19.4	28.9	26.0	25.5	38.4	31.5	39.1	30.5	36.5	26.4	11.7	12.8	16.9	15.4	39.3	50.5	15.0	17.7	18.9	18.0	19.5	10.9	10.2	18.3	14.9	21.4	17.5	4.7	10.4	17.4	21.9	23.5	17.7	18.6	9.9	16.3	38.8	21.4	12.3	32.7	19.0	19.2	20.4	27.3	29.3	22.7	19.2	5.1	22.5	19.8	26.2	20.1	28.2	14.5	20.4	19.2	21.5	14.4	20.8	12.0	14.3	13.8	16.7	15.4	16.7	28.7	11.0	21.9	18.3	20.9	12.3	14.4	17.2	7.5	10.8	20.6	16.8	21.4	16.0	28.3	32.1	31.5	30.4	39.1	27.7	25.5	30.2	31.7	38.4	23.6	33.7	33.4	13.0	30.5	31.8	25.9	36.5	26.4	27.8	29.4	16.4	25.4	24.3	22.3	24.7	26.3	23.7	23.8	11.9	22.3	30.6	23.2	14.7	32.1	41.2	20.4	42.8	25.0	36.6	2.0	51.1	86.2	35.5	86.3	45.6	23.9	0.0	31.5	63.6	57.4	21.8	30.1	40.4	58.2	17.5	27.0	35.6	28.2	159.2	74.5	32.0	33.7	43.3	31.3	44.6	30.1	36.6	92.6	79.1	28.3	64.7	60.5	49.3	36.1	13.7	39.0	20.8	32.6	18.0
C1orf127	FLJ37118	ENSG00000175262	"Chromosome 1 open reading frame 127"		1	10946471-10982037	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pancreas: 5.1;skeletal muscle: 17.3"	"Cell type enriched"	"Detected in some"	11	"Intestinal endocrine cells: 19.5"	"Cancer enriched"	"Detected in single"	9	"pancreatic cancer: 2.8"					"Group enriched"	"Detected in some"	4	"classical monocyte: 1.7;myeloid DC: 4.2"	"Group enriched"	"Detected in many"	30	"dendritic cells: 4.2;monocytes: 1.7"	"Cell line enriched"	"Detected in some"	4	"THP-1: 7.6"									HPA027654	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA027654: AB_10611814"	"unprognostic (1.82e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.03e-1)"	0.1	0.6	0.0	0.0	0.4	0.0	0.0	3.3	0.0	0.0	0.2			0.6	0.0	0.0	0.5	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.5	0.8		0.0	5.1	0.0	0.2	0.1		0.0	0.5		0.2	0.0	17.3	0.0	0.2	0.0	0.1	0.5	2.5	0.6			0.1		0.0	0.0	0.0	0.0	4.2	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.4	0.5	0.0	0.0	7.6	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2											0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	19.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0
C1orf159	FLJ20584	ENSG00000131591	"Chromosome 1 open reading frame 159"	Q96HA4	1	1081818-1116361	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 48.9;Late spermatids: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA010019, HPA075399"	Approved		Approved	"Nucleoli rim,Mitotic chromosome,Intermediate filaments"		Yes	No			"Nucleoli rim, Mitotic chromosome, Intermediate filaments"		"HPA010019: AB_1078885, HPA075399: "	"unprognostic (2.79e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (1.34e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.62e-4)"	3.7	6.6	8.3	4.9	9.0	5.6	3.1	7.6	10.0	5.5	6.0	11.3	5.4	6.1	6.0	6.9	6.6	4.0	5.9	3.8	8.8	5.8	5.0	5.0	5.6	4.2	6.6	4.9	5.8	5.3	2.2	4.4	5.6	5.0	6.6	1.8	5.8	10.2	6.5	3.6	23.7	5.5	7.5	5.2	7.0	9.0	17.5	5.6	5.2	4.0	5.2	6.4	5.4	4.4	5.0	4.3	9.9	4.9	4.7	5.7	3.9	11.9	9.7	4.5	7.8	1.4	1.4	10.2	6.8	1.6	6.2	4.1	5.2	12.6	3.4	8.4	2.1	5.0	9.9	1.9	6.3	1.8	6.4	14.1	2.3	16.6	5.4	2.9	4.0	5.6	3.1	3.0	3.2	1.2	1.9	3.0	5.5	13.8	2.7	2.2	9.2	7.4	10.2	4.1	4.5	15.6	9.2	5.3	6.2	3.6	4.3	9.4	12.5	5.3	9.5	5.4	1.4	6.6	5.2	5.0	6.7	7.1	9.8	7.0	4.5	6.1	6.0	5.8	10.9	5.4	9.9	4.9	2.6	5.3	4.4	5.4	5.0	4.9	5.7	3.2	4.7	5.3	5.0	1.1	4.7	3.1	4.3	1.7	3.9	8.3	9.0	7.6	10.0	8.8	5.8	6.6	4.9	5.0	5.6	0.0	10.6	1.5	3.4	6.6	6.2	1.8	5.1	9.4	5.7	8.7	3.9	4.7	1.7	7.6	48.9	3.6	5.1	23.3	5.9	11.7	5.0	4.2	5.7	4.7	3.6	12.7	4.1	1.8	1.8	101.9	2.6	2.7	3.3	8.2	7.0	3.0	6.1	2.9	1.4	1.1	7.4	0.0	4.1	11.2	6.6	6.0	4.1	3.8	6.9	4.4
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.1;lymphoid tissue: 86.6"	"Cell type enhanced"	"Detected in many"	18	"granulocytes: 175.8;Hofbauer cells: 198.4;Kupffer cells: 675.1;Macrophages: 367.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HDLM-2: 45.4;HL-60: 22.1;NB-4: 12.3;THP-1: 17.5;U-937: 36.7"									HPA026988	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	39.8	9.3	9.2	25.1	17.9	37.5	20.1	4.6	9.3	5.2	6.3	4.9	0.8	2.7	5.4	7.4	4.9	10.2	11.7	14.8	13.4	4.7	17.3	14.8	40.1	86.6	17.5	1.9	5.8	4.5	1.3	9.7	5.6	15.3	5.0	6.9	5.0	5.9	2.5	7.2	3.6	8.3	13.5	31.0	78.1	5.8	6.1	13.9	10.6	6.2	1.1	20.0	7.2	6.7	24.7	83.3	98.7	119.1	40.1	27.8	74.8	0.1	0.0	0.1	0.3	0.1	0.2	0.2	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	45.4	0.1	0.1	0.1	0.0	0.2	22.1	3.7	0.0	0.9	0.3	0.3	0.3	0.6	0.2	0.2	0.1	0.1	0.1	0.1	12.3	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.1	17.5	0.0	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.1	36.7	0.5	68.4	82.5	98.7	14.2	119.1	4.1	17.5	17.7	8.2	83.3	24.7	27.8	16.8	11.4	40.1	86.3	24.9	5.0	74.8	9.2	17.9	4.6	9.3	13.4	4.7	17.5	1.9	15.3	13.9	20.8	66.7	71.8	0.5	7.0	3.7	3.1	12.7	1.4	7.9	7.0	2.0	1.1	0.0	0.2	33.3	3.7	0.6	0.0	0.2	1.2	5.8	0.7	175.8	6.4	198.4	0.0	1.7	17.8	675.1	60.1	2.6	367.2	11.8	1.0	0.0	0.3	0.2	0.0	0.7	0.6	3.9	32.3	4.2	1.8	1.7	5.6	1.4	95.6	0.6	0.3
C1orf189		ENSG00000163263	"Chromosome 1 open reading frame 189"	Q5VU69	1	154199372-154206333	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 11.9;fallopian tube: 41.8;testis: 21.0"	"Cell type enhanced"	"Detected in some"	31	"Ciliated cells: 28.1;Early spermatids: 63.9;Late spermatids: 12.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA045779	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoplasm, Golgi apparatus, Plasma membrane"		"HPA045779: AB_2679448"	"unprognostic (8.23e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.01e-3)"	"unprognostic (2.50e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.36e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.05e-2)"	0.1	0.0	0.4	0.1	0.6	0.5	0.1	0.1	0.2	2.2	0.1	0.8	0.1	0.0	0.7	11.9	0.1	41.8	0.1	0.1	0.8	1.1	0.1	0.3	5.6	0.1	0.1	0.1	4.2	0.1	0.0	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	21.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.3	3.2	1.0	0.0	1.6	0.3	0.1	0.0	1.8	0.0	1.4	0.0	1.0	0.6	0.8	2.1	0.0	3.4	0.9	1.3	0.4	0.0	0.2	0.5	1.4	2.3	0.0	1.4	2.1	0.8	2.7	2.3	2.1	0.6	0.8	2.6	1.9	0.8	0.0	0.0	0.0	1.4	1.2	0.4	1.0	3.7	0.8	0.3	3.3	1.3	3.8	0.4	1.5	0.9	0.0	0.0	0.9	0.0	0.0	0.0	2.7	0.3	2.5	0.0	1.9	0.0	2.0	1.3	1.2	2.3	2.3	0.5	0.4	0.5	0.0	0.0	0.1	1.5	0.2	1.0	0.0	0.2	0.1	0.4	0.3	0.8	0.2	1.6	3.2	0.0	0.5	0.0	0.4	0.3	0.4	0.6	0.1	0.2	0.8	1.1	0.1	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	63.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0
C1orf21	PIG13	ENSG00000116667	"Chromosome 1 open reading frame 21"	Q9H246	1	184387058-184629020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 11.4;memory CD8 T-cell: 5.9;naive CD8 T-cell: 5.9;NK-cell: 7.5"	"Group enriched"	"Detected in many"	12	"NK-cells: 7.5;T-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.3;Karpas-707: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026831	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026831: AB_1845636"	"unprognostic (8.27e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (3.35e-8)"	"unprognostic (1.81e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.60e-2)"	12.0	15.9	16.8	7.5	9.5	2.1	25.2	17.5	18.8	20.2	18.5	4.4	16.7	8.7	17.3	14.2	14.1	10.1	9.2	20.0	12.5	8.8	4.1	7.5	12.2	3.5	8.3	13.3	13.9	4.7	12.6	7.6	5.7	11.8	17.8	13.1	10.7	5.1	18.9	51.7	30.1	15.8	25.2	7.6	8.2	10.7	4.1	5.4	1.5	4.4	13.6	3.9	22.0	23.5	0.0	0.7	0.2	0.1	7.5	11.4	2.1	0.6	0.1	3.6	0.3	11.4	9.4	6.1	3.2	3.1	2.0	1.8	0.0	0.3	0.0	0.0	3.6	0.7	2.0	2.3	2.6	1.9	23.3	3.7	0.1	1.0	0.0	4.5	2.0	1.0	11.3	7.7	2.3	2.0	8.2	2.4	3.5	0.0	17.7	3.1	2.4	2.3	0.6	5.4	4.8	0.6	3.0	3.8	3.5	0.0	1.2	2.1	5.4	1.6	1.4	6.6	3.4	0.2	0.2	2.3	4.1	2.1	6.2	3.9	11.0	5.1	0.0	4.1	3.3	4.7	0.0	0.1	0.0	11.4	0.0	1.1	0.0	1.9	5.9	0.7	0.0	0.6	5.9	0.2	7.5	0.0	0.2	0.0	2.1	16.8	9.5	17.5	15.9	12.5	8.8	8.3	13.3	11.8	5.4	35.7	88.4	1.5	208.9	135.5	27.4	78.1	28.1	17.4	53.4	1.8	0.0	92.1	6.6	5.0	34.6	101.3	150.2	0.0	16.6	76.1	45.1	118.1	9.3	55.0	34.1	25.4	18.4	81.6	6.3	26.6	70.8	10.1	60.8	32.5	59.7	30.7	19.0	164.9	18.0	5.7	8.7	19.4	53.8	2.3	16.6	127.2	238.0	44.5	61.0	172.9
C1orf216	FLJ38984	ENSG00000142686	"Chromosome 1 open reading frame 216"	Q8TAB5	1	35713875-35719472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 22.3;Rod photoreceptor cells: 26.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028299, HPA031343"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028299: AB_10601122, HPA031343: AB_2673834"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (7.68e-10)"	"unprognostic (3.31e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.93e-2)"	4.3	4.4	12.5	2.1	10.5	1.1	2.4	5.0	22.1	4.7	3.5			1.0	4.1	5.0	2.1	2.5	3.0	4.0	12.1	9.7	0.7	1.8	3.1	2.4	7.0		3.5	1.2	2.0	1.8	1.6		3.1	2.0		1.1	4.4	5.1	2.9	1.2	7.0	5.2	2.2	1.2	3.4			1.4		2.5	2.4	1.4	2.5	3.2	0.1	3.7	0.8	7.3	3.0	3.4	8.0	4.4	5.7	20.1	14.8	2.9	9.8	11.5	14.5	13.9	4.7	7.3	4.3	7.1	14.3	11.9	3.3	10.9	6.4	12.5	14.0	5.2	25.7	11.7	1.3	7.6	12.7	17.0	15.1	8.2	10.4	3.3	10.7	9.4	3.2	10.2	11.6	15.5	5.6	5.1	10.9	6.4	3.7	6.8	3.4	5.8	3.5	5.0	4.0	5.9	5.9	9.3	1.9	19.0	2.7	3.6	5.7	11.2	11.8	9.4	8.8	10.1	3.5	8.7	3.2	11.8	12.3	18.4	0.0	3.2	0.1	5.9	3.7	1.9	2.5	4.7	7.3	3.2	1.4	1.1	4.4	0.1	0.8	2.7	0.7	1.6	3.0											0.0	2.1	0.0	2.9	5.4	18.4	6.4	0.0	0.0	1.2	1.8	13.7	2.0	0.0	5.5	10.2	6.0	0.0	0.0	2.4	1.2	4.7	1.8	4.6	1.7	6.9	22.3	1.7	5.5	4.0	6.8	7.8	5.4	15.1	8.2	0.0	16.2	2.2	0.0	19.4	0.7	26.6	0.0	6.9	2.8	2.2	4.0	0.9	5.0	0.3	1.4
C1orf226	FLJ13137	ENSG00000239887	"Chromosome 1 open reading frame 226"	A1L170	1	162366908-162386818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.6"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 27.5;Early spermatids: 20.6;Hepatocytes: 22.6;Late spermatids: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 13.2;HEL: 16.9"	"Low region specificity"	"Detected in all"							"HPA052251, HPA074060"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"prognostic favorable (2.60e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.71e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-3)"	"prognostic favorable (4.44e-5)"	"unprognostic (9.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.13e-4)"	1.5	8.2	1.5	3.4	1.5	1.2	7.1	4.8	2.0	3.7	18.0	1.5	1.5	4.9	1.9	1.6	4.4	2.5	3.2	1.5	1.6	2.4	5.2	15.2	3.0	1.5	1.8	1.5	2.0	3.5	1.4	6.9	18.9	1.5	3.2	8.3	2.0	8.2	7.6	1.5	3.3	28.6	2.4	2.3	2.2	5.8	2.7	1.5	1.5	1.5	7.4	5.1	2.2	1.5	0.0	0.0	0.8	0.7	0.0	0.0	0.2	13.2	0.7	10.9	8.3	0.3	0.0	0.2	1.2	1.1	0.8	0.4	1.5	6.1	0.0	9.1	0.2	4.0	9.7	3.2	0.7	0.5	0.2	4.4	16.9	0.5	7.4	0.2	0.0	0.1	1.2	0.8	0.0	0.6	3.0	3.3	1.8	1.4	0.1	0.2	4.3	0.6	0.0	6.8	11.9	6.1	0.2	1.7	0.0	9.3	5.4	4.7	3.2	4.5	1.2	2.6	4.2	4.9	0.7	2.3	0.0	1.4	0.2	3.3	6.3	0.0	0.0	1.6	0.2	0.7	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	1.5	1.5	4.8	2.0	1.6	2.4	1.8	1.5	1.5	1.5	3.0	1.6	0.0	1.4	0.7	0.7	3.3	2.5	1.4	1.2	14.0	27.5	0.0	0.0	0.8	20.6	1.1	8.0	0.0	2.0	0.1	0.6	3.7	0.0	22.6	0.1	6.4	2.4	3.7	1.0	30.4	2.0	0.0	0.0	0.0	10.3	6.5	1.7	3.5	1.8	0.0	0.3	0.0	0.2	0.7	0.7	1.3	0.1	0.0	5.6	2.0
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	10.1	12.7	14.3	15.6	17.0	12.7	12.0	23.9	15.7	12.5	11.2	11.6	16.1	12.5	13.7	10.6	17.3	14.9	8.1	8.0	13.8	10.0	10.6	10.2	11.0	12.5	17.7	13.6	19.0	21.0	12.5	10.0	12.4	15.0	13.2	6.4	10.4	19.1	16.1	14.0	24.1	11.3	13.3	9.2	12.6	13.2	8.8	13.2	14.6	12.4	6.9	12.0	12.8	13.9	20.2	26.7	21.9	18.4	17.6	21.5	10.3	9.6	10.7	6.9	4.1	3.7	3.8	16.1	7.4	3.4	6.6	4.9	9.7	9.2	9.4	16.2	2.6	4.6	10.8	6.5	7.2	2.5	10.7	34.4	5.8	7.5	9.5	6.3	13.0	7.4	3.4	8.6	6.3	6.1	3.9	7.3	10.9	14.8	5.2	4.9	11.3	17.3	16.7	13.5	12.2	25.0	12.3	10.9	15.6	5.8	7.2	12.1	11.4	7.0	11.2	9.6	2.1	13.3	12.3	6.3	5.3	7.7	13.8	15.7	9.7	5.0	8.7	6.4	7.7	8.2	6.3	16.3	21.9	16.2	18.4	20.9	20.2	18.1	17.7	20.4	16.7	21.5	18.1	2.2	17.6	17.5	26.7	18.0	10.3	14.3	17.0	23.9	15.7	13.8	10.0	17.7	13.6	15.0	13.2	20.8	19.0	30.7	27.5	59.3	48.2	15.4	12.7	17.4	11.4	36.6	17.7	65.7	38.1	35.0	3.0	27.0	34.4	23.3	34.3	47.2	35.1	28.5	24.3	19.5	36.1	44.5	25.2	28.3	24.7	2.6	47.5	35.5	30.4	27.1	35.6	37.2	33.3	33.4	43.9	30.1	49.8	64.7	30.0	35.6	47.1	70.4	23.7	36.7	41.6	21.3
C1orf53		ENSG00000203724	"Chromosome 1 open reading frame 53"	Q5VUE5	1	197902647-197907367	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 20.9"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 10.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065352			Approved	Vesicles,Aggresome		NA	NA			Vesicles	Aggresome	"HPA065352: AB_2685477"	"prognostic favorable (1.63e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.37e-1)"	3.3	10.8	6.5	1.5	3.2	1.7	2.1	1.0	6.6	3.1	5.6	2.8	4.0	4.2	1.6	6.2	3.2	1.7	4.7	7.5	4.8	4.0	8.6	20.9	5.0	2.4	2.7	2.9	2.9	8.2	0.5	6.0	2.9	3.7	2.7	3.0	4.5	4.8	1.5	6.6	1.2	4.3	2.2	1.6	2.2	3.5	4.7	3.5	0.1	4.6	2.1	1.4	1.6	1.5	0.1	2.6	0.0	10.5	0.0	0.8	1.1	4.3	5.2	0.4	2.0	2.7	8.1	3.0	6.7	4.4	5.3	2.8	4.7	3.1	7.2	10.6	7.1	1.3	1.7	1.7	1.2	0.6	2.3	13.6	4.3	3.9	7.9	1.2	9.6	6.3	4.7	3.9	1.9	0.7	3.3	2.0	1.3	1.2	1.6	3.2	6.5	0.5	8.5	4.4	4.4	7.7	1.0	2.8	2.8	8.3	6.3	16.0	12.0	8.3	1.5	2.4	2.1	3.7	3.6	4.5	6.4	7.3	8.9	3.9	3.3	2.4	1.7	4.2	2.9	6.5	0.0	3.6	0.0	0.4	10.5	0.0	0.0	0.2	0.8	2.6	0.1	0.4	0.4	0.0	0.0	5.1	0.7	0.1	1.1	6.5	3.2	1.0	6.6	4.8	4.0	2.7	2.9	3.7	3.5	8.9	8.8	1.4	3.8	2.3	1.9	10.2	28.1	10.7	9.1	21.0	0.0	16.4	16.6	8.2	12.9	1.1	7.3	0.0	12.1	8.3	6.7	6.1	1.1	53.9	8.1	3.2	7.5	2.5	4.0	1.0	13.0	3.7	8.5	1.8	11.1	4.7	9.5	11.5	9.9	19.5	3.8	0.0	1.9	6.1	2.3	2.5	9.8	0.7	15.3	4.3
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 98.9;Leydig cells: 88.1;Macrophages: 71.5;Peritubular cells: 97.9;Smooth muscle cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"myeloid DC: 36.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 36.2"	"Cell line enhanced"	"Detected in many"		"AF22: 20.9;AN3-CA: 31.6;ASC diff: 22.4;ASC TERT1: 37.5;HSkMC: 30.3;HUVEC TERT2: 29.2"	"Low region specificity"	"Detected in all"							"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA			"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: AB_2732511"	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	16.0	8.8	16.4	19.0	19.3	4.5	13.8	5.8	10.5	11.9	14.0	4.5	19.1	5.8	19.8	21.1	11.0	17.1	21.6	13.8	13.7	13.7	12.7	12.0	11.8	21.5	21.8	8.3	8.3	6.8	2.0	6.7	24.4	14.0	15.3	11.1	10.9	9.8	30.4	13.4	4.5	8.1	24.1	20.4	27.3	8.3	5.7	14.8	4.9	8.3	17.1	11.2	22.0	14.3	0.3	36.2	0.4	7.7	0.2	1.5	2.2	0.5	0.1	20.9	31.6	22.4	37.5	0.6	3.4	5.0	0.9	3.0	0.2	0.6	0.2	1.1	3.0	0.4	0.9	0.0	0.1	1.1	0.3	3.7	0.6	0.5	0.3	4.6	1.1	0.8	30.3	1.5	6.3	0.5	3.7	29.2	0.5	0.4	4.1	3.2	1.2	0.2	7.2	1.7	0.0	1.1	5.2	0.5	0.4	0.3	1.6	0.4	0.4	0.4	0.2	2.3	4.2	0.4	15.8	0.2	7.5	0.6	0.2	0.3	1.7	1.4	0.3	16.6	0.9	0.2	0.0	7.7	0.3	0.2	6.8	0.9	0.3	1.5	0.6	36.2	0.3	1.5	0.8	0.4	0.2	1.9	0.7	0.6	2.2	16.4	19.3	5.8	10.5	13.7	13.7	21.8	8.3	14.0	14.8	3.0	5.0	2.4	2.0	5.7	0.8	6.2	2.5	0.0	2.3	21.0	0.0	1.0	64.6	0.5	7.4	64.6	2.1	0.0	2.0	0.7	22.1	1.8	1.1	0.8	45.5	0.0	1.2	49.1	98.9	15.7	88.1	71.5	11.8	20.8	1.1	11.1	1.5	0.8	97.9	2.6	1.3	32.3	69.0	16.6	1.3	4.4	3.0	2.5	1.2	5.5
C1orf68	"LEP7, XP32"	ENSG00000198854	"Chromosome 1 open reading frame 68"	Q5T750	1	152719522-152720470	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 123.1"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 68.4"	"Group enriched"	"Detected in some"	13	"head and neck cancer: 2.4;melanoma: 6.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HaCaT: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057942			Approved	"Plasma membrane,Cytosol"		NA	NA		61000	"Plasma membrane"	Cytosol	"HPA057942: "		"unprognostic (1.73e-1)"				"unprognostic (7.46e-2)"			"unprognostic (9.34e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	123.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	68.4	0.0	0.0	0.0	0.0
C1orf74	"FLJ25078, URLC4"	ENSG00000162757	"Chromosome 1 open reading frame 74"	Q96LT6	1	209779208-209784559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028496	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA028496: AB_10602698"	"unprognostic (3.25e-1)"	"prognostic unfavorable (8.52e-6)"	"unprognostic (8.41e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.40e-2)"	2.5	3.9	5.7	5.5	8.5	2.3	5.8	10.4	8.9	2.7	3.8	5.8	4.0	3.3	2.3	5.2	10.4	2.8	2.3	4.1	3.7	2.9	4.9	4.1	2.2	9.8	5.1	4.6	2.5	4.5	4.5	6.5	3.4	4.8	4.6	5.2	3.9	5.1	2.7	2.3	15.0	4.1	2.4	4.9	4.9	3.9	3.9	5.0	4.9	3.2	0.0	5.7	3.9	4.7	6.3	5.5	5.9	1.9	2.8	2.9	1.9	5.6	3.0	1.9	1.1	2.6	3.0	4.4	3.2	4.2	4.0	4.1	6.0	4.4	6.0	1.9	2.1	2.4	11.5	1.2	9.4	4.7	5.9	3.9	4.0	2.2	0.5	3.6	5.5	1.8	1.8	8.3	4.9	8.1	3.3	2.3	8.2	7.8	4.4	3.4	2.9	4.6	5.7	8.0	4.0	5.1	4.9	9.1	8.4	3.4	4.9	7.7	8.2	4.4	3.4	4.9	4.6	5.3	2.9	2.2	3.4	3.9	3.5	5.2	4.0	4.1	6.6	3.0	4.6	4.7	5.9	1.6	1.4	2.9	1.9	2.1	3.8	1.4	2.3	3.2	6.3	2.4	2.8	1.1	2.8	1.0	5.5	1.2	1.9	5.7	8.5	10.4	8.9	3.7	2.9	5.1	4.6	4.8	5.0	3.0	2.1	1.4	6.1	1.9	1.4	2.0	0.0	1.4	1.2	0.0	0.0	3.1	6.6	1.7	0.0	0.6	2.0	0.0	1.8	5.7	0.6	4.8	1.1	2.0	2.3	1.6	3.5	1.3	0.3	0.2	2.3	0.8	0.0	1.8	4.4	2.3	2.7	2.6	0.0	4.8	1.2	0.0	0.4	3.7	3.6	4.3	3.3	0.0	2.9	11.4
C1orf94	MGC15882	ENSG00000142698	"Chromosome 1 open reading frame 94"	Q6P1W5	1	34166883-34219131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 24.6"	"Cell type enhanced"	"Detected in some"	29	"Early spermatids: 53.5;Late spermatids: 24.4;Spermatocytes: 12.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 11.4;U-87 MG: 33.0"	"Low region specificity"	"Detected in many"							HPA045805			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA045805: AB_10969626"					"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"				"unprognostic (9.77e-2)"	"unprognostic (4.09e-2)"			"unprognostic (1.65e-2)"	"unprognostic (2.31e-1)"			0.0	0.1	0.6	0.0	0.8	0.0	0.0	1.2	1.8	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	24.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.2	1.8	0.5	0.7	0.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	53.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	12.2	0.5	0.0	0.0	0.0	0.0	0.0
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		930000	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	24.1	51.6	34.0	51.0	31.4	36.3	42.3	25.8	46.2	22.0	48.8	21.1	22.5	33.9	25.8	25.7	51.1	27.1	33.0	47.1	34.8	35.4	48.4	69.0	26.6	81.1	35.4	25.1	25.2	51.9	32.7	31.2	26.7	36.6	23.8	52.2	24.9	25.1	28.0	55.0	27.3	30.0	29.2	27.8	43.8	26.4	21.3	17.2	55.4	28.1	71.9	46.0	25.5	25.4	59.5	68.1	9.9	35.8	39.0	55.6	65.7	49.5	77.1	27.3	44.0	20.4	25.2	36.9	38.0	31.1	88.6	54.6	73.7	16.6	106.5	37.7	28.7	32.0	44.4	87.6	51.6	82.0	24.3	150.8	49.0	40.0	85.6	32.5	59.7	39.0	27.7	47.5	48.7	70.4	21.4	45.1	63.3	58.2	27.3	34.4	34.6	84.7	43.2	61.5	56.3	46.1	67.6	38.6	58.1	51.1	37.6	21.9	41.1	31.2	40.2	53.0	28.6	25.4	30.3	26.5	28.5	26.0	32.3	82.6	14.3	21.8	46.8	27.2	57.5	43.6	9.9	34.7	8.3	40.1	35.8	52.5	59.5	45.0	39.9	68.1	49.4	55.6	46.3	2.8	39.0	26.9	56.9	34.3	65.7	34.0	31.4	25.8	46.2	34.8	35.4	35.4	25.1	36.6	17.2	26.8	23.3	138.5	155.3	215.9	60.0	72.6	68.8	16.0	27.3	78.5	25.5	269.8	265.2	184.9	64.3	105.7	64.2	23.3	178.3	380.4	101.4	99.0	62.2	125.2	179.0	57.2	76.1	74.3	73.1	64.4	110.7	119.7	148.5	174.1	146.5	91.7	174.3	77.2	92.6	338.8	60.8	84.1	121.5	45.2	160.8	223.2	149.7	85.6	301.5	214.0
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.5"	"Group enriched"	"Detected in many"	5	"Ito cells: 145.5;Sertoli cells: 103.5;Smooth muscle cells: 105.0;Syncytiotrophoblasts: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 84.6;BJ hTERT+: 19.8;HHSteC: 32.0;HSkMC: 17.0;U-87 MG: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	314000000	30000	"Nucleoplasm, Cytosol"		"CAB025429: , HPA051101: AB_2681343"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.81e-3)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (1.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.95e-2)"	62.4	18.3	1.7	7.4	4.3	0.4	60.5	1.3	5.1	14.3	10.3	5.2	30.8	2.5	11.0	14.2	10.2	14.4	19.1	77.5	2.0	4.1	9.5	19.4	9.7	16.6	4.8	2.5	25.2	7.5	10.1	4.2	34.0	7.6	13.3	3.3	19.6	13.8	51.8	11.9	8.6	6.1	6.9	2.5	14.3	6.1	8.8	2.8	1.3	26.9	13.3	5.0	14.8	27.5	0.5	0.3	1.9	0.3	1.2	0.4	0.0	0.0	8.2	0.0	0.0	84.6	7.6	0.0	4.2	19.8	1.8	3.5	0.6	4.0	0.0	0.4	1.2	5.2	0.2	0.2	0.1	1.3	0.0	0.9	0.0	3.1	0.4	32.0	0.0	0.0	17.0	0.0	3.8	0.2	2.6	2.4	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.9	8.6	0.0	5.5	0.1	0.0	0.1	0.3	1.6	2.7	0.4	7.9	0.3	0.0	0.0	0.3	9.0	0.2	1.0	1.2	0.0	0.0	0.0	20.0	0.0	0.8	1.9	0.3	0.5	0.3	0.2	0.2	0.2	0.4	0.2	0.1	0.5	0.2	0.4	0.4	1.2	0.2	0.3	0.0	0.0	1.7	4.3	1.3	4.2	2.0	4.1	4.8	2.5	7.6	2.8	0.0	1.1	0.0	0.6	5.8	0.0	9.4	10.2	0.0	0.0	1.8	0.0	17.3	0.0	13.9	0.1	10.5	1.3	0.0	5.3	1.2	14.4	1.2	0.0	1.5	2.3	0.0	4.6	145.5	10.5	0.0	9.8	0.7	3.3	19.0	6.8	0.5	3.2	2.9	3.2	0.0	0.3	103.5	105.0	0.0	0.7	4.0	39.6	0.5	4.5	0.5
C1QTNF12	"ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127"	ENSG00000184163	"C1q and TNF related 12"	Q5T7M4	1	1242446-1246722	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 11.0;skin 1: 7.8"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 10.0;Proximal tubular cells: 37.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6;NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"EFO-21: 8.3;U-2 OS: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024107	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	38200000		Vesicles		"HPA024107: AB_2101207"	"unprognostic (1.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.20e-1)"	1.0	0.0	0.5	0.2	0.0	0.0	0.5	0.2	0.2	0.1	3.4			11.0	0.1	0.0	1.2	0.2	0.1	0.2	0.0	1.0	3.1	0.2	0.1	0.0	0.1		0.0	0.0	0.0	0.1	0.3		0.0	1.2		0.4	0.0	0.1	7.8	10.4	0.1	0.2	0.0	0.3	2.4			0.2		0.1	0.0	0.4	0.3	0.6	2.6	0.3	2.2	0.4	0.2	0.3	0.0	0.0	0.6	0.4	0.1	1.6	1.1	0.0	0.1	0.0	0.6	0.4	0.1	8.3	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.3	0.1	0.9	0.6	0.1	0.3	0.0	1.3	0.0	0.0	1.2	0.3	0.0	0.0	0.7	0.0	0.6	0.1	0.0	0.0	8.2	0.1	0.0	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.6	0.3	0.4	0.0	2.6	2.2	0.3	0.0	0.0	0.2											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.2	0.0	0.0	0.0	0.0	0.7	10.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	37.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347751-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Fibroblasts: 32.3;Leydig cells: 21.6;Peritubular cells: 28.0;Smooth muscle cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 26.6;U-138 MG: 11.8;U-2 OS: 6.4;WM-115: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"	NA	NA			"Golgi apparatus, Centrosome"		"HPA061290: AB_2684468"	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	5.5	2.1	2.1	1.9	5.2	0.6	5.6	4.4	4.9	9.5	4.9	1.1	1.3	3.4	10.9	6.9	6.8	4.9	9.3	8.5	2.0	1.8	1.3	1.0	5.0	1.1	1.4	3.0	2.9	0.9	0.6	1.2	2.4	1.0	7.7	3.4	14.3	3.4	9.6	4.8	3.0	4.6	6.4	1.3	1.7	4.3	5.8	1.5	0.0	4.3	12.1	1.3	6.0	5.8	0.6	0.4	3.7	0.1	1.0	0.2	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.0	3.0	4.0	0.7	2.5	0.1	0.7	0.0	0.1	1.0	0.5	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	26.6	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.1	0.3	0.1	0.2	11.8	6.4	1.1	3.2	0.1	0.0	0.0	0.4	0.0	5.2	3.7	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.6	0.2	0.2	1.1	1.0	0.1	0.4	0.1	0.1	2.1	5.2	4.4	4.9	2.0	1.8	1.4	3.0	1.0	1.5	0.0	0.0	0.0	0.1	5.8	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	1.6	0.0	0.0	0.2	0.2	32.3	0.1	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	21.6	0.0	5.0	1.0	0.0	0.0	0.1	0.0	28.0	0.0	0.6	0.0	27.0	0.0	0.1	3.3	0.7	0.0	0.0	0.1
C1QTNF3	"2310005P21Rik, Corcs, Cors, Cors-26, CTRP3"	ENSG00000082196	"C1q and TNF related 3"	Q9BXJ4	5	34019448-34043832	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"salivary gland: 171.5"	"Group enriched"	"Detected in many"	27	"Early spermatids: 150.0;Late spermatids: 294.3;Muller glia cells: 207.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	198	"U-266/84: 132.6"									"HPA064996, HPA066011"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	44100000	27000000	"Golgi apparatus"		"HPA064996: AB_2685399, HPA066011: AB_2685597"	"unprognostic (7.71e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.83e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.35e-1)"	4.4	0.3	5.7	2.7	6.4	0.2	4.5	9.6	3.4	2.4	7.9	1.8	4.8	2.1	2.5	3.9	22.5	2.0	3.6	0.9	4.2	3.1	4.0	0.5	2.6	0.5	4.3	1.4	1.1	1.0	0.3	0.7	0.8	3.7	30.2	6.6	2.4	171.5	3.2	1.3	1.4	5.5	14.4	5.6	0.5	8.4	7.9	2.6	0.6	1.0	3.6	0.7	13.1	3.2	0.4	0.1	0.4	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.1	0.1	132.6	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.1	0.4	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.4	5.7	6.4	9.6	2.8	4.2	3.1	4.3	1.4	3.7	2.6	3.0	1.3	1.5	0.6	5.0	4.5	0.4	7.6	1.4	1.2	3.5	0.0	0.8	1.7	0.7	150.0	3.1	0.7	0.0	1.2	0.4	7.4	0.6	0.0	1.5	1.1	7.9	1.7	0.6	0.6	294.3	1.7	1.3	6.8	0.0	1.4	207.9	0.5	0.0	2.5	2.0	7.8	0.0	1.9	7.5	1.7	5.1	0.3	0.7	2.1	0.4
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180167-37199385	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 23.7;placenta: 79.5"	"Cell type enriched"	"Detected in many"	12	"Extravillous trophoblasts: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 45.0;RT4: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	No	No	354000000		Nucleoplasm		"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	3.3	4.4	1.2	4.2	1.6	0.8	2.5	1.2	1.8	7.8	2.5	1.3	1.6	1.0	23.7	7.2	1.6	5.2	6.2	3.1	1.4	0.7	3.9	7.9	9.2	3.1	1.2	1.3	5.9	2.3	1.4	1.4	79.5	1.7	4.3	2.5	4.4	2.2	3.4	1.5	3.1	3.2	5.7	1.8	4.6	1.8	3.5	1.2	1.6	2.4	1.7	1.8	5.1	2.7	2.4	1.1	1.8	0.5	4.0	3.8	1.0	6.7	8.4	4.4	1.5	0.8	8.9	13.4	1.4	2.8	1.1	0.8	1.5	9.9	0.0	5.7	2.3	0.6	14.0	0.1	3.4	0.5	1.9	1.1	1.1	3.2	1.5	3.1	0.0	0.9	12.3	1.9	0.9	0.2	3.0	10.6	0.3	0.0	3.1	0.4	45.0	0.0	0.2	2.8	1.0	0.1	0.1	0.0	1.1	10.2	20.8	0.7	5.7	0.4	8.1	1.1	2.4	2.8	0.2	3.6	0.4	2.3	0.1	0.0	6.5	0.1	0.0	0.9	0.8	1.2	1.0	0.5	1.5	0.7	0.5	0.8	0.8	1.3	1.0	0.5	2.4	2.9	2.2	1.8	4.0	0.3	1.1	3.8	1.0	1.2	1.6	1.2	1.8	1.4	0.7	1.2	1.3	1.7	1.2	0.0	0.0	3.0	1.4	1.3	0.9	1.1	2.5	4.0	2.3	1.8	0.0	4.2	1.7	1.9	1.7	1.4	2.6	0.0	1.0	349.8	8.9	0.6	1.1	5.0	8.4	0.0	0.0	11.6	1.0	6.2	0.6	0.9	5.0	1.0	2.1	4.2	2.0	3.5	0.4	1.3	0.7	0.0	3.3	7.0	4.0	0.3	28.8	2.5	3.9	1.0
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446166	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 39.6"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 15.1;Fibroblasts: 10.3;Leydig cells: 21.0;Peritubular cells: 29.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.7"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.2;ASC TERT1: 6.4;HSkMC: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	238000000		Vesicles		"CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596"	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	16.0	0.9	0.6	24.7	0.8	0.0	7.4	0.3	0.7	39.6	12.0	0.5	3.3	0.6	24.6	10.1	17.3	6.2	20.3	5.4	0.6	0.6	4.0	1.0	7.9	0.5	0.8	0.5	15.9	1.3	0.0	1.4	5.4	0.8	22.0	3.2	5.4	2.7	2.4	2.2	3.5	4.1	22.1	0.7	10.2	10.4	4.4	0.1	0.3	4.2	13.0	2.0	16.3	15.8	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	6.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.4	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.7	0.6	0.6	0.8	0.5	0.8	0.1	0.0	0.0	0.0	0.0	3.2	15.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	10.3	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	21.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	29.7	1.0	0.9	6.5	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 351.6"	"Cell type enhanced"	"Detected in many"	21	"Hepatocytes: 2464.3;Leydig cells: 1104.9;Peritubular cells: 601.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 6.2"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 99.3;ASC TERT1: 132.1;BJ hTERT+: 42.1;HSkMC: 70.1"					"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	13000000000	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	48.7	16.6	3.3	18.7	4.1	0.0	55.7	1.9	3.1	35.3	31.1	2.9	12.7	6.8	32.2	50.0	38.3	46.4	47.2	34.4	2.5	1.1	18.0	351.6	31.4	21.1	6.3	3.2	98.8	15.5	1.9	6.0	8.5	6.5	52.1	18.6	26.1	14.6	12.4	18.2	14.7	19.2	47.6	8.8	32.5	24.6	37.2	2.3	3.2	30.5	22.7	18.8	48.6	73.0	0.2	0.1	6.2	0.3	0.2	0.1	0.0	0.0	2.2	0.1	1.3	99.3	132.1	0.4	17.9	42.1	9.5	17.4	0.0	0.2	0.0	2.4	22.2	2.5	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.6	4.7	29.9	0.2	0.1	70.1	0.3	7.7	0.5	11.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	10.9	0.2	0.2	2.1	0.0	0.0	0.0	4.4	0.3	16.9	0.0	0.0	0.0	0.1	9.5	0.1	0.2	0.6	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	6.2	0.2	0.1	0.1	0.0	0.0	3.3	4.1	1.9	3.1	2.5	1.1	6.3	3.2	6.5	2.3	14.9	34.2	18.3	17.5	67.8	0.6	21.4	152.8	6.7	20.5	3.5	0.0	2.9	1.7	170.0	5.7	37.8	0.0	46.7	37.9	3.5	388.0	7.4	4.7	2464.3	7.1	4.8	0.0	105.6	49.3	8.8	1104.9	9.4	84.4	1.8	0.0	15.1	43.6	0.0	601.8	4.1	0.9	135.8	123.7	5.0	4.1	47.0	2.2	4.3	0.0	3.0
C20orf194	DKFZp434N061	ENSG00000088854	"Chromosome 20 open reading frame 194"	Q5TEA3	20	3249305-3407625	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Cone photoreceptor cells: 190.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052103, HPA067418"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Nucleoli fibrillar center, Cytosol"		"HPA052103: AB_2681727, HPA067418: AB_2685835"	"unprognostic (9.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (9.58e-3)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.52e-2)"	15.2	13.4	18.5	6.9	20.1	4.6	11.9	20.3	21.9	12.6	11.8	25.3	7.3	5.8	12.5	9.7	11.7	12.8	11.3	19.4	16.3	17.2	14.2	3.7	13.3	5.7	16.5	20.3	17.2	7.5	8.5	10.4	12.2	17.4	12.2	6.4	10.9	6.0	16.5	36.8	7.5	6.0	17.2	23.0	9.5	9.1	13.5	16.9	4.6	13.2	4.0	4.3	12.2	11.0	1.6	3.5	1.0	3.0	0.0	1.7	0.7	2.9	2.7	7.4	3.6	15.5	17.2	0.8	7.0	7.8	4.6	5.9	0.0	3.2	0.0	1.9	9.2	5.9	3.5	2.8	6.8	6.4	0.6	1.4	0.8	1.0	7.3	7.3	0.9	0.4	13.9	5.3	6.1	5.3	6.6	9.2	2.6	1.4	0.0	6.7	1.3	1.8	4.8	2.2	1.6	1.8	2.1	6.8	0.0	6.0	6.1	1.5	4.4	3.1	5.5	9.0	6.7	5.2	8.4	10.2	5.8	2.6	3.6	3.3	0.0	0.0	0.0	1.8	0.8	4.4	1.0	3.0	0.0	1.7	1.5	1.0	1.0	1.3	1.7	3.1	1.6	0.5	1.3	0.0	0.0	1.4	3.5	1.4	0.7	18.5	20.1	20.3	21.9	16.3	17.2	16.5	20.3	17.4	16.9	26.8	8.6	2.2	6.0	6.2	33.0	22.9	7.6	17.4	9.1	12.2	190.5	1.3	1.7	6.4	22.4	15.5	0.3	0.0	4.0	4.9	11.6	4.8	13.9	2.1	16.8	28.6	0.0	26.4	28.8	5.8	18.4	17.8	8.5	7.2	0.0	11.7	8.0	2.6	12.7	5.7	14.2	12.9	14.7	18.2	20.0	5.0	1.5	4.5	0.0	4.3
C20orf196	FLJ25067	ENSG00000171984	"Chromosome 20 open reading frame 196"	Q8IYI0	20	5750393-5863912	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"T-cells: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 31.0;U-698: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040749	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Endoplasmic reticulum, Golgi apparatus, Vesicles"		"HPA040749: AB_10673093"	"unprognostic (2.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (4.05e-5)"	5.4	13.9	7.1	15.5	7.3	17.8	8.1	10.6	8.7	6.8	7.9	9.2	12.6	11.9	7.7	8.7	7.4	6.7	8.0	12.3	7.0	7.0	6.9	4.1	9.3	17.6	8.9	6.7	7.7	11.1	2.8	10.6	5.1	6.9	8.7	7.4	10.9	19.1	12.9	15.1	5.6	13.7	6.7	7.1	14.2	6.2	4.2	7.8	20.4	9.6	9.4	16.8	6.4	6.6	21.7	10.9	15.6	10.8	16.2	22.7	10.2	4.8	6.1	3.1	1.4	1.9	1.6	1.3	1.4	2.4	2.0	2.8	2.8	5.5	19.1	3.7	1.4	1.5	2.3	2.0	3.6	2.2	5.7	2.3	6.9	0.9	10.3	4.2	8.3	3.3	2.4	5.2	2.9	2.0	1.8	3.9	5.5	9.7	7.7	3.5	2.1	11.7	31.0	3.6	6.4	3.3	9.6	4.1	8.6	2.9	2.4	4.9	4.6	2.9	2.8	5.6	1.6	2.2	8.8	2.3	2.2	3.1	1.9	3.0	5.3	8.8	25.3	1.0	8.7	3.7	11.2	8.7	15.6	17.0	10.4	13.2	19.7	19.5	16.7	9.2	21.7	18.8	13.4	3.9	16.2	10.8	10.9	22.7	10.2	7.1	7.3	10.6	8.7	7.0	7.0	8.9	6.7	6.9	7.8	3.0	5.5	7.5	7.2	3.3	6.3	0.0	7.6	1.4	0.0	0.0	2.0	6.1	0.0	0.0	0.1	4.2	5.8	0.0	0.0	6.0	3.2	8.1	1.1	0.8	15.0	3.2	12.1	3.7	10.3	0.5	1.7	7.3	5.0	0.0	11.4	7.7	0.0	6.8	2.1	0.0	5.0	0.0	2.5	4.8	12.2	3.8	4.9	18.7	7.3	10.1
C20orf24	"PNAS-11, RIP5"	ENSG00000101084	"Chromosome 20 open reading frame 24"	Q9BUV8	20	36605734-36612557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057387	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA057387: AB_2683425"	"unprognostic (2.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.56e-6)"	"unprognostic (4.47e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.37e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.98e-2)"	17.0	19.7	15.1	18.5	16.3	25.1	29.1	11.9	21.1	15.8	31.1	10.9	15.2	21.9	11.8	18.1	55.5	10.8	25.1	24.2	14.3	14.0	35.6	71.1	21.4	24.4	15.0	11.7	9.5	27.6	15.4	8.5	19.3	12.6	13.3	26.5	9.8	21.5	17.9	70.0	13.6	26.1	14.6	12.7	26.2	20.0	19.0	11.3	20.4	21.6	42.3	28.3	14.3	20.4	10.0	15.8	41.3	24.2	6.1	11.9	7.7	36.1	27.2	9.0	12.0	21.6	12.4	24.2	22.7	12.4	21.7	19.7	74.4	45.6	15.7	56.2	19.4	40.6	26.9	19.3	35.4	20.7	11.8	20.1	37.4	38.6	81.4	25.3	39.3	18.4	15.5	37.5	31.3	17.8	11.1	19.8	16.5	25.5	37.0	20.4	24.5	23.0	50.8	16.5	35.5	58.1	18.4	23.2	39.4	18.7	27.0	16.7	12.6	32.7	84.8	28.4	14.9	17.9	32.4	22.4	32.4	22.3	33.5	34.3	23.7	38.2	26.5	35.0	45.9	17.2	7.2	24.2	29.9	6.2	12.4	6.2	10.0	7.4	9.6	15.8	8.1	9.0	6.7	41.3	6.1	14.7	10.8	11.9	7.7	15.1	16.3	11.9	21.1	14.3	14.0	15.0	11.7	12.6	11.3	32.8	18.6	61.3	37.0	155.3	30.6	0.0	104.4	17.4	23.9	0.0	23.6	72.8	0.0	0.0	42.7	44.2	136.6	23.3	0.0	105.9	54.2	76.8	47.1	249.1	216.1	12.7	52.7	58.9	146.9	62.8	40.6	64.6	67.4	0.0	79.2	49.6	0.0	118.5	40.3	0.0	29.0	58.2	32.8	171.5	84.7	183.9	113.4	69.2	118.3	184.6
C20orf27	FLJ20550	ENSG00000101220	"Chromosome 20 open reading frame 27"	Q9GZN8	20	3753508-3768387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.7"	"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 64.7"	"Group enriched"	"Detected in many"	5	"classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 38.5;monocytes: 46.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		87000	"Nucleoplasm, Cytosol"		"HPA047483: AB_2680064"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (8.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	23.1	9.7	10.2	11.8	64.7	51.9	17.2	4.9	15.8	12.0	22.6	7.7	3.7	10.3	16.9	10.9	14.4	18.7	26.6	7.3	9.2	14.4	5.0	5.4	8.4	13.5	14.5	6.1	20.9	8.5	3.9	5.3	6.7	13.7	18.3	4.9	5.0	9.0	7.1	11.2	9.6	9.4	22.3	5.7	13.4	21.2	6.0	13.2	6.0	5.4	7.9	6.1	27.4	10.3	7.8	38.5	1.1	46.6	5.8	8.5	13.8	34.4	36.4	5.7	24.3	11.9	6.5	9.0	8.9	5.9	16.5	12.1	24.9	13.1	21.6	8.7	10.4	22.0	29.7	15.3	22.3	6.3	5.0	27.4	12.2	7.4	44.4	8.5	17.5	5.4	9.2	9.4	21.0	10.5	5.7	11.1	15.8	21.7	13.6	8.5	48.7	23.1	41.7	24.6	24.1	49.5	17.9	14.0	25.5	10.3	12.6	25.7	11.7	8.1	36.1	17.8	2.7	8.0	22.0	6.8	23.1	16.0	36.6	27.2	10.5	17.5	16.0	6.8	33.3	11.3	0.2	28.1	0.4	5.9	46.6	8.5	7.8	7.0	7.8	38.5	7.3	8.0	7.8	1.1	5.8	42.2	7.3	6.4	13.8	10.2	64.7	4.9	15.8	9.2	14.4	14.5	6.1	13.7	13.2	0.0	3.5	24.6	18.0	21.5	9.4	2.8	7.6	1.4	2.3	10.4	2.0	15.9	24.9	31.1	8.2	25.0	10.5	70.0	26.1	38.9	26.3	9.4	23.0	14.7	123.1	1.6	15.1	13.5	94.5	13.7	30.2	60.1	35.4	4.6	10.2	20.0	28.5	16.4	23.3	27.0	12.7	64.7	66.1	18.7	30.1	28.7	6.1	16.2	30.3	20.0
C20orf96	dJ1103G7.2	ENSG00000196476	"Chromosome 20 open reading frame 96"	Q9NUD7	20	270863-290778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 105.7;Early spermatids: 80.0;Spermatocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA048649	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA048649: AB_2680476"	"unprognostic (1.59e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (4.62e-2)"	"unprognostic (5.12e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"prognostic favorable (1.05e-4)"	5.6	8.6	10.4	5.5	18.4	7.1	8.2	11.2	13.6	10.5	7.8	13.5	7.7	9.7	16.9	21.8	4.4	33.9	9.1	6.5	11.7	9.9	13.2	4.7	10.3	5.2	12.5	9.1	17.7	7.3	8.3	25.1	4.0	22.0	11.2	8.8	11.8	10.2	8.6	3.4	3.8	8.1	10.8	13.8	8.0	8.2	23.4	13.4	5.9	15.1	2.0	5.2	7.4	6.7	3.5	6.4	0.0	2.8	2.5	2.9	1.6	4.2	13.4	14.1	12.4	3.7	3.6	6.3	3.0	4.0	4.5	6.2	2.6	8.3	10.7	2.0	3.7	8.0	3.7	5.2	2.3	5.3	2.6	8.1	7.1	0.1	14.5	10.4	5.8	3.1	5.1	2.1	7.8	0.9	11.6	9.1	13.8	14.4	5.4	3.9	2.1	6.8	22.6	4.6	4.2	5.9	20.9	2.5	8.7	7.1	6.6	1.5	12.7	3.6	5.3	9.0	6.8	9.1	13.0	6.1	4.6	8.0	4.0	2.5	12.3	12.4	7.3	2.5	18.2	4.2	0.0	2.8	0.0	1.6	2.2	1.0	3.5	1.0	1.3	6.4	3.4	2.2	2.9	0.0	2.5	1.6	3.0	1.4	1.6	10.4	18.4	11.2	13.6	11.7	9.9	12.5	9.1	22.0	13.4	3.0	2.2	1.5	4.6	3.3	3.0	0.7	12.7	105.7	11.4	17.4	5.9	4.0	33.2	9.4	80.0	7.5	4.2	0.0	6.0	2.6	8.0	7.9	14.9	3.0	7.9	6.4	8.1	10.4	4.4	25.9	10.0	4.6	3.3	3.6	7.1	7.2	7.9	0.0	17.0	15.1	9.4	6.5	6.7	50.9	45.4	1.4	2.3	2.2	8.8	2.1
C21orf33	"D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI"	ENSG00000160221	"Chromosome 21 open reading frame 33"	P30042	21	44133605-44210114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 29.2;Melanocytes: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.8;U-266/70: 37.2;U-266/84: 31.0"									HPA018517	Supported		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA		1800000	Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (9.61e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.57e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.61e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.60e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.30e-2)"	16.0	9.6	9.1	6.1	11.4	2.2	7.2	7.9	16.6	5.1	11.7	11.6	12.4	3.0	6.6	22.8	7.6	7.3	5.2	29.2	8.4	8.7	31.6	36.8	8.5	9.9	10.9	9.2	6.7	15.7	2.0	6.5	5.6	8.3	11.0	1.9	6.6	8.8	8.0	45.9	13.4	7.7	7.6	7.3	8.9	13.7	11.8	5.1	5.8	7.1	21.0	15.2	5.1	4.7	22.5	12.3	8.9	20.7	14.7	15.6	23.9	0.4	1.6	0.9	0.2	9.5	9.1	14.2	18.5	10.4	14.6	11.1	22.2	0.2	43.8	0.3	0.1	0.6	0.2	0.1	8.7	6.5	9.6	21.3	1.2	3.6	11.9	10.6	0.6	0.3	0.1	0.9	4.0	0.7	7.4	0.7	10.6	8.3	13.8	5.0	1.6	0.5	1.2	0.4	1.6	0.6	0.4	0.1	15.5	0.9	0.3	14.6	0.2	0.2	0.5	14.2	0.3	1.0	1.5	9.0	5.6	0.3	11.0	0.1	37.2	31.0	0.9	0.6	2.9	6.7	8.9	11.3	6.8	13.0	13.3	11.3	22.5	15.5	15.6	4.6	21.6	14.8	12.8	5.1	14.7	20.7	12.3	14.6	23.9	9.1	11.4	7.9	16.6	8.4	8.7	10.9	9.2	8.3	5.1	6.0	3.5	14.3	0.4	14.5	1.9	0.0	17.8	8.1	3.4	0.0	0.0	2.1	0.0	0.0	1.9	2.9	10.6	0.0	0.0	1.6	4.3	0.5	9.2	2.4	8.1	0.0	7.5	16.5	29.2	1.4	9.2	6.0	38.8	0.0	13.3	7.8	0.0	11.5	16.3	0.0	1.5	12.9	0.0	5.2	12.4	12.7	2.2	15.4	27.5	0.1
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 203.4;Erythroid cells: 140.2;Intestinal endocrine cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 29.3"									"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.3	1.8	2.2	4.3	5.0	11.1	5.2	3.6	3.1	3.2	3.5	4.6	3.3	4.7	2.2	9.7	3.1	27.2	3.2	2.6	2.9	2.9	1.3	1.3	9.1	5.9	2.9	1.8	8.0	3.2	1.4	25.1	2.1	5.8	2.3	2.7	1.9	2.5	1.7	1.6	5.3	4.3	1.5	1.8	2.8	3.7	5.7	2.2	22.7	1.8	2.1	4.6	1.7	2.1	2.1	1.8	8.2	0.5	0.7	1.8	0.9	12.1	5.6	14.8	9.2	1.5	2.0	8.2	7.5	2.8	5.3	5.2	2.5	9.0	8.8	1.9	2.1	6.2	9.8	3.9	3.2	1.6	9.2	8.6	14.1	14.6	1.4	0.3	4.0	8.1	0.9	0.7	3.7	0.9	1.9	3.3	22.0	8.0	23.5	4.3	5.0	19.8	5.4	6.3	3.4	2.8	29.3	6.7	7.8	1.6	2.3	12.2	7.6	5.6	4.0	1.8	3.3	9.9	8.0	2.2	3.2	9.3	3.2	4.5	9.5	4.2	4.2	5.7	17.5	8.4	8.2	0.5	1.1	0.9	0.3	0.5	0.2	1.1	1.2	0.1	2.1	1.8	1.4	0.7	0.7	0.2	1.8	1.3	0.9	2.2	5.0	3.6	3.1	2.9	2.9	2.9	1.8	5.8	2.2	3.0	1.6	3.0	1.2	0.8	17.1	3.6	0.0	203.4	22.7	1.8	25.5	3.5	0.0	1.9	13.4	1.1	2.3	140.2	0.9	5.4	3.6	1.8	2.3	1.6	3.4	4.8	66.7	3.7	1.8	25.4	4.9	2.7	0.0	1.0	3.5	4.3	1.1	3.5	2.5	0.6	28.6	0.0	2.1	52.4	42.1	1.3	1.1	2.6	5.9	0.7
C21orf91	"C21orf14, C21orf38, CSSG1, EURL, YG81"	ENSG00000154642	"Chromosome 21 open reading frame 91"	Q9NYK6	21	17788967-17819386	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018288, HPA049030"	Approved		Approved	"Microtubules,Cytokinetic bridge"		NA	NA			Microtubules	"Cytokinetic bridge"	"HPA018288: AB_1845710, HPA049030: AB_2680605"	"unprognostic (3.28e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.51e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.90e-3)"	7.2	5.6	9.6	9.3	21.7	7.4	8.3	2.9	14.1	6.9	5.2	31.7	2.0	5.1	9.7	4.6	9.4	7.0	6.1	5.4	15.7	8.8	5.5	8.8	8.8	14.3	27.3	8.0	8.6	4.0	6.9	5.3	19.1	23.6	5.6	5.4	2.0	8.1	4.2	4.6	19.0	5.9	7.7	34.2	9.4	6.2	23.9	25.8	22.2	5.8	5.2	12.8	9.9	6.5	6.0	5.8	34.2	5.0	8.8	15.1	4.9	2.9	0.5	6.8	0.0	1.7	3.3	3.0	4.4	7.9	4.4	3.9	2.5	1.5	10.4	2.2	1.7	6.1	2.3	7.2	5.7	3.8	11.3	3.8	6.9	6.0	1.7	3.9	8.4	4.0	2.3	6.2	5.7	9.3	3.0	1.2	4.3	4.8	46.8	3.1	1.9	11.6	2.5	7.1	0.7	2.4	9.1	12.9	4.2	2.9	5.1	2.7	6.2	5.0	4.3	19.8	3.1	2.6	4.7	2.0	19.4	6.1	0.1	2.8	12.4	15.1	9.0	1.5	7.9	7.3	34.2	4.8	23.4	9.6	5.0	13.7	6.0	8.9	10.2	5.8	5.1	7.0	9.2	10.7	8.8	4.9	1.4	15.1	4.9	9.6	21.7	2.9	14.1	15.7	8.8	27.3	8.0	23.6	25.8	17.9	12.0	14.2	10.0	24.7	9.5	5.5	2.5	5.3	7.9	5.2	15.7	13.1	1.7	4.0	269.6	11.7	3.1	0.0	6.0	9.5	11.3	8.1	38.2	6.4	5.0	14.3	10.3	8.6	7.9	52.3	21.9	9.1	20.3	3.6	4.7	3.4	3.6	2.9	15.9	5.3	10.9	6.5	8.0	25.6	19.2	24.1	67.1	30.6	3.8	6.4
C22orf23	"EVG1, FLJ32787, LOC84645"	ENSG00000128346	"Chromosome 22 open reading frame 23"	Q9BZE7	22	37943050-37953669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"testis: 189.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 211.4;Late spermatids: 246.7;Spermatocytes: 159.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 17.1;U-138 MG: 17.6;U-87 MG: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000650			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000650: AB_2732391"	"unprognostic (6.09e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.42e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.80e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.46e-2)"	0.9	0.9	1.3	2.0	1.8	0.7	0.8	1.7	3.3	1.2	4.1	2.8	0.8	0.8	3.7	2.8	6.1	6.0	2.5	1.8	1.7	1.7	1.2	1.1	2.7	1.0	1.9	2.0	2.2	3.4	0.1	2.2	2.0	5.5	1.8	0.0	2.0	4.1	1.4	1.8	11.3	1.2	1.2	3.2	0.8	3.8	189.0	1.2	0.8	3.4	0.9	0.9	5.2	1.6	0.7	0.3	0.9	0.2	0.1	1.4	0.2	3.5	2.8	6.2	5.7	0.1	0.2	7.6	9.8	0.3	0.3	0.4	3.3	3.2	1.8	2.9	0.2	6.4	17.1	0.2	0.1	0.3	3.5	7.3	1.0	2.3	2.3	0.2	2.8	2.5	0.2	0.1	1.1	0.1	8.6	0.0	1.4	1.2	1.1	0.0	2.2	0.1	1.7	0.9	3.5	2.5	3.3	8.8	0.7	0.1	15.6	3.1	2.3	4.6	1.7	5.5	10.4	2.1	3.9	14.9	17.6	5.9	13.7	5.2	2.5	1.1	0.9	26.5	1.3	9.9	0.9	0.1	0.0	1.3	0.2	1.4	0.7	0.3	0.1	0.0	0.7	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	1.3	1.8	1.7	1.8	1.7	1.7	1.9	2.0	5.5	1.2	0.0	3.7	0.0	0.1	0.2	0.1	0.0	0.0	50.9	2.3	0.0	0.0	0.1	1.7	0.3	211.4	0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	246.7	6.4	0.0	0.0	0.0	0.0	2.0	0.2	0.0	4.9	1.4	0.5	0.0	0.0	159.9	4.3	0.0	0.0	0.0	0.0	0.0
C22orf31	"bK747E2.1, HS747E2A"	ENSG00000100249	"Chromosome 22 open reading frame 31"	O95567	22	29058672-29061844	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 3.4;testis: 12.7"	"Group enriched"	"Detected in some"	15	"Early spermatids: 55.4;Late spermatids: 34.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.4"					"Not detected"	"Not detected"			"HPA000604, HPA068522"	Uncertain		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane"	Cytosol	"HPA000604: AB_1079086, HPA068522: "																		0.0	0.4	0.9	0.0	3.4	0.0	0.4	0.4	0.9	0.5	0.3			0.2	0.4	1.6	0.5	0.5	0.0	0.0	1.0	0.2	0.2	0.0	0.2	0.0	0.8		1.1	0.0	0.2	0.4	0.0		0.2	0.3		0.5	0.0	0.1	0.6	0.4	0.1	0.0	0.0	0.6	12.7			0.1		0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.2	0.0	0.8	0.0	0.9	0.8	0.0	0.0	0.4	0.6	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.9	0.0	1.7	0.0	0.0	3.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.7	0.6	0.0	0.0	0.0	0.0
C22orf39	MGC74441	ENSG00000242259	"Chromosome 22 open reading frame 39"	Q6P5X5	22	19351368-19448232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073701			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA073701: AB_2686627"	"unprognostic (4.97e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.45e-3)"	"unprognostic (5.34e-3)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.51e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.32e-2)"	18.2	19.5	27.0	11.9	22.6	11.4	20.1	21.9	24.4	13.1	19.6	14.0	13.9	11.3	13.8	13.9	14.4	13.6	13.1	29.9	23.7	19.6	15.6	10.3	12.5	14.1	23.5	18.3	16.4	27.3	17.4	16.5	12.6	16.2	19.6	13.5	13.7	15.4	18.5	69.5	14.6	12.0	21.3	19.2	13.6	13.1	11.7	14.1	12.9	22.1	18.4	14.7	13.7	13.7	23.5	27.6	48.8	22.4	21.3	23.7	19.9	10.6	7.1	12.3	8.7	14.9	10.4	7.8	3.8	4.0	11.0	12.3	10.4	3.4	11.3	5.1	4.3	7.3	10.5	14.8	8.0	11.3	12.4	35.5	13.2	14.1	18.1	12.8	18.5	15.3	9.9	12.8	6.7	15.0	10.1	11.0	23.5	44.8	17.2	6.9	8.3	15.3	15.3	4.5	26.1	10.4	18.9	16.8	6.9	12.4	8.8	15.9	7.0	8.5	5.8	12.6	12.1	9.7	11.6	8.0	8.4	16.3	4.3	6.2	17.4	7.5	16.1	7.1	9.5	7.8	24.3	21.6	48.8	19.3	22.4	17.7	23.5	20.9	15.6	18.5	23.2	22.3	18.4	29.4	21.3	18.9	27.6	23.7	19.9	27.0	22.6	21.9	24.4	23.7	19.6	23.5	18.3	16.2	14.1	20.8	30.2	29.0	23.3	21.6	27.3	86.7	25.5	45.5	42.1	34.9	15.7	47.2	91.2	36.1	13.9	32.2	49.1	23.3	67.6	38.3	31.6	33.0	26.5	27.0	56.0	17.5	43.4	28.3	31.9	10.2	32.5	31.1	37.1	60.5	40.1	27.8	49.4	34.5	31.8	43.3	16.4	45.3	42.2	56.4	60.9	28.4	42.1	39.5	51.9	24.7
C22orf46	"CTA-216E10.6, FLJ23584"	ENSG00000184208	"Chromosome 22 open reading frame 46"	C9J442	22	41688939-41698136	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 19.8"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 65.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			HPA052741	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"	NA	NA			Nucleoplasm	Nucleoli	"HPA052741: AB_2681933"	"unprognostic (3.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	3.9	2.0	8.1	3.1	6.8	1.0	3.9	2.2	5.7	2.7	2.4			2.3	3.1	4.5	1.7	2.4	2.7	4.8	8.7	7.5	2.7	2.3	2.2	3.1	12.8		5.2	1.4	8.3	3.5	2.1		3.3	2.8		2.8	3.0	3.3	3.3	2.6	2.9	19.8	2.8	2.4	6.2			3.5		3.1	2.2	1.5	1.1	0.4	0.1	2.6	3.5	1.2	0.7	8.8	4.5	11.1	6.8	8.2	8.7	10.1	7.5	8.1	6.4	8.6	4.5	5.8	5.5	5.5	6.2	6.3	4.1	5.7	5.8	7.7	19.7	5.4	6.1	9.4	3.8	4.8	4.5	12.0	6.9	7.8	10.7	7.6	4.9	1.6	8.6	9.9	8.2	5.6	14.6	3.5	5.5	4.5	13.4	3.5	5.1	9.2	6.1	5.4	6.1	2.7	4.2	8.7	7.9	11.3	8.5	9.0	5.5	4.3	8.4	14.4	4.4	3.9	17.5	17.8	5.1	5.0	5.5	11.4	0.1	0.5	0.0	0.7	0.4	0.9	1.1	1.1	1.1	0.2	0.5	0.9	1.2	0.1	3.5	2.6	0.4	0.7	0.7											11.9	16.5	7.1	3.9	1.9	9.4	18.9	5.1	8.1	11.4	7.0	13.7	8.3	1.7	4.2	65.6	7.1	8.4	0.0	4.2	5.8	4.9	2.0	7.0	4.0	4.2	3.2	2.9	9.2	7.3	8.2	4.9	8.3	1.7	9.0	7.2	9.7	3.7	3.7	6.0	1.3	6.2	0.0	3.5	12.0	11.5	2.3	7.1	15.8	4.0	1.4
C2CD2	"C21orf25, C21orf258, DKFZP586F0422, TMEM24L"	ENSG00000157617	"C2 calcium dependent domain containing 2"	Q9Y426	21	41885112-41953890	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 56.9"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 51.0;Cone photoreceptor cells: 78.5;Ito cells: 42.4;Rod photoreceptor cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.7;SK-BR-3: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030922, HPA030924"	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA030922: AB_2673660, HPA030924: AB_10669873"	"unprognostic (3.02e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (7.68e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.48e-1)"	23.9	56.9	5.4	6.1	8.0	1.1	21.0	2.7	7.0	5.8	5.8	7.6	10.9	3.5	6.3	6.1	5.4	4.9	7.8	3.6	5.9	5.1	5.3	4.2	9.6	9.1	12.8	4.5	11.7	10.7	19.4	3.8	4.2	10.9	8.8	4.3	11.8	8.1	9.4	2.7	10.1	4.4	5.6	11.7	20.7	5.7	2.7	9.1	5.7	4.8	3.9	5.3	7.0	23.9	1.1	1.4	0.9	1.3	1.9	2.8	0.7	6.1	2.6	1.8	4.2	38.7	10.7	7.2	4.3	6.8	2.7	2.5	4.0	7.0	0.1	2.4	8.4	6.7	0.7	6.5	4.5	3.5	0.4	2.9	1.1	3.2	3.2	5.2	0.4	0.0	6.8	4.2	14.5	5.7	6.0	12.8	0.3	3.8	0.0	7.2	0.5	0.9	1.2	10.2	2.6	8.9	0.6	2.7	3.7	4.0	13.0	3.0	1.3	4.7	21.3	3.8	3.8	5.6	2.7	4.4	6.5	0.9	2.1	3.5	2.4	3.5	0.5	19.0	3.6	1.3	0.0	1.3	0.0	1.3	0.8	0.5	0.5	1.2	0.5	1.4	1.1	2.8	1.6	0.9	1.9	0.7	0.2	1.5	0.7	5.4	8.0	2.7	7.0	5.9	5.1	12.8	4.5	10.9	9.1	3.0	13.3	6.4	6.8	3.7	51.0	2.0	5.1	4.0	5.7	3.5	78.5	9.6	0.0	5.0	0.1	12.0	2.3	0.0	7.1	3.7	6.1	12.9	0.0	4.5	3.2	1.6	4.7	42.4	7.8	0.0	3.4	2.9	1.7	0.0	7.3	3.5	7.9	6.8	2.1	2.8	35.1	12.9	15.6	0.0	2.3	2.3	7.8	1.7	7.1	12.4
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.1"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011044	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Nuclear membrane, Cytosol"	"HPA011044: AB_2668414"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	5.2	7.0	15.9	7.3	33.1	14.7	4.8	18.2	31.2	5.8	10.3	7.5	8.3	18.7	4.1	6.1	9.4	10.9	6.3	7.9	15.8	13.6	6.3	7.3	8.3	8.5	9.1	12.6	3.9	7.5	7.8	14.2	4.8	11.7	4.8	8.8	5.6	8.7	7.0	8.3	12.5	19.4	6.1	7.3	9.2	5.5	2.6	9.1	7.0	5.5	6.7	6.6	6.6	5.3	0.4	1.1	5.7	4.2	1.7	1.6	1.1	3.4	2.5	3.5	7.2	4.6	1.9	2.2	5.2	4.6	5.2	4.4	4.1	3.6	5.2	13.7	3.6	5.3	7.7	4.4	2.2	2.1	8.1	3.7	20.4	3.3	2.9	6.1	5.8	29.8	2.3	4.6	9.7	3.6	5.7	3.2	7.8	8.4	9.3	4.8	9.1	6.5	14.1	1.3	8.4	6.9	4.1	3.2	5.9	5.1	2.2	11.0	6.2	2.2	11.7	3.3	1.4	20.6	7.8	3.9	4.8	1.6	5.7	9.1	4.1	2.4	2.0	3.0	10.1	5.3	1.1	3.0	5.7	0.6	3.2	1.0	0.4	1.4	1.4	1.1	0.1	1.6	0.8	1.0	1.7	4.2	0.7	1.6	1.1	15.9	33.1	18.2	31.2	15.8	13.6	9.1	12.6	11.7	9.1	6.0	6.2	2.2	1.4	9.5	14.6	2.0	2.5	13.4	4.5	1.8	35.3	0.8	3.3	2.8	2.6	5.0	25.7	0.0	2.4	1.2	2.0	2.9	2.3	4.3	7.9	20.6	1.2	15.4	12.9	1.5	2.0	9.7	6.8	7.2	5.5	4.8	4.2	10.1	1.4	3.3	29.7	6.5	3.1	2.3	1.9	9.5	0.9	8.7	4.5	1.6
C2CD3	DKFZP586P0123	ENSG00000168014	"C2 calcium dependent domain containing 3"	Q4AC94	11	74012714-74171210	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 65.5;Alveolar cells type 2: 98.8;Ciliated cells: 88.3;Club cells: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 14.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038552, HPA038553, HPA040433"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA038552: AB_10669542, HPA038553: AB_2676080, HPA040433: AB_2676981"	"unprognostic (3.94e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.48e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.92e-1)"	7.4	11.9	10.5	13.5	11.2	17.3	8.4	14.9	11.8	8.1	6.8	14.3	4.4	6.3	10.9	10.3	7.8	12.5	6.4	8.3	9.6	6.5	8.5	8.4	9.7	8.5	12.0	8.1	10.2	6.9	17.5	15.0	13.5	11.4	8.6	9.0	10.4	8.5	7.9	6.9	9.7	7.3	7.2	11.3	10.0	7.7	19.9	13.2	16.7	13.1	4.2	12.1	8.1	9.7	5.3	2.0	14.8	3.2	3.3	2.6	0.5	5.7	11.3	8.4	10.1	4.9	4.4	3.9	8.4	6.0	11.0	9.6	15.8	4.6	5.9	6.2	5.1	10.4	10.2	9.3	4.0	13.0	9.8	4.7	8.6	12.7	6.2	5.3	9.7	13.5	3.2	3.8	11.5	6.8	3.9	6.9	7.7	8.6	11.6	9.6	5.5	10.4	5.2	5.8	10.3	5.5	8.9	39.4	6.4	3.2	9.2	10.1	6.5	15.9	5.6	12.6	7.8	9.7	5.3	7.4	7.9	12.2	8.3	7.4	9.0	6.2	18.4	2.7	5.8	8.7	14.8	1.9	2.2	2.6	2.2	2.2	2.3	1.5	2.1	1.0	5.3	2.0	1.9	13.1	3.3	3.2	2.0	1.0	0.5	10.5	11.2	14.9	11.8	9.6	6.5	12.0	8.1	11.4	13.2	65.5	98.8	2.7	3.4	4.6	8.1	4.2	2.5	88.3	61.4	8.7	3.9	3.1	0.0	3.3	25.7	5.3	4.3	0.0	2.2	2.1	3.3	4.0	33.7	2.4	4.3	11.1	7.5	6.2	7.8	19.0	4.0	7.4	6.8	3.6	4.5	6.3	3.0	2.9	6.0	1.2	13.8	6.5	4.1	9.9	6.5	4.0	1.9	9.6	5.2	2.3
C2CD4C	"FAM148C, KIAA1957, NLF3"	ENSG00000183186	"C2 calcium dependent domain containing 4C"	Q8TF44	19	405438-409170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4"	"Group enriched"	"Detected in some"	5	"Intestinal endocrine cells: 2.9;Ito cells: 3.1;Muller glia cells: 1.7;Rod photoreceptor cells: 6.6;Spermatogonia: 1.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;MCF7: 5.1;NTERA-2: 7.5;SCLC-21H: 13.4;U-2 OS: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055915	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA055915: AB_2682968"	"unprognostic (1.29e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.39e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.74e-1)"	6.9	2.1	15.8	1.7	7.4	0.8	5.4	1.0	19.4	2.2	1.3	0.7	0.0	2.0	2.4	0.9	1.2	1.6	8.6	2.2	7.1	13.5	1.6	1.0	1.5	1.2	4.7	10.8	0.9	1.1	0.9	1.7	2.0	6.5	1.1	1.0	2.2	1.1	1.0	3.1	2.4	1.8	1.3	3.0	1.2	1.6	1.9	3.0	0.0	6.7	0.0	0.9	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.8	1.5	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.1	2.4	0.0	0.7	0.0	0.9	2.8	2.8	0.2	0.1	7.4	1.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.1	5.1	0.0	0.0	7.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.4	3.9	1.2	0.0	0.0	0.7	0.2	0.0	0.0	0.1	8.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	7.4	1.0	18.2	7.1	13.5	4.7	10.8	6.5	3.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	6.6	0.0	0.0	0.7	1.9	0.3	0.0	0.0	0.0	0.0
C2orf16	DKFZp434G118	ENSG00000221843	"Chromosome 2 open reading frame 16"	Q68DN1	2	27537386-27582721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 22.3"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 68.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.3;SiHa: 4.5"					"Not detected"	"Not detected"			"HPA052136, HPA056962"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoplasm	"HPA052136: AB_2681742, HPA056962: AB_2683290"	"unprognostic (4.32e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.79e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.53e-3)"	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.2	1.0	0.5	0.1	0.4	0.5	0.2	0.2	0.2	0.9	0.2	0.2	0.2	0.2	0.4	0.4	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.6	22.3	0.2	0.2	0.7	0.2	0.2	0.4	0.2	0.0	0.3	0.3	1.0	0.0	0.6	0.1	1.6	1.6	2.3	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	2.1	0.8	2.0	0.0	1.5	0.5	0.0	0.0	0.0	1.4	0.4	3.0	1.2	1.6	0.0	1.7	1.3	0.0	0.0	0.2	0.0	1.1	0.2	0.9	1.2	2.2	0.1	0.4	0.0	0.8	0.4	0.8	0.0	1.2	1.3	0.6	0.0	1.5	6.3	1.1	4.5	1.2	0.6	0.4	1.0	1.1	2.7	1.5	2.1	1.0	1.0	0.4	0.0	1.9	0.5	0.3	2.1	0.0	1.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.3	0.0	0.8	0.2	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	68.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.0	1.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0
C2orf49	"asw, MGC5509"	ENSG00000135974	"Chromosome 2 open reading frame 49"	Q9BVC5	2	105337359-105349211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043846, HPA060814"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA043846: AB_2678698, HPA060814: AB_2684372"	"unprognostic (4.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (6.51e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.04e-2)"	15.9	14.8	17.2	15.8	20.4	24.3	17.3	25.6	22.4	19.7	15.0	21.9	19.9	13.4	22.0	13.5	18.6	19.0	14.2	21.3	20.0	16.0	13.4	15.0	14.0	16.9	25.3	19.9	30.7	19.3	13.0	12.0	19.2	18.1	17.2	15.1	12.4	15.9	17.2	28.2	14.3	14.8	18.3	22.9	15.3	19.7	19.2	22.1	26.5	18.8	13.1	18.8	18.1	21.2	16.7	18.4	17.9	13.5	8.2	11.7	6.4	13.6	9.8	12.4	12.5	13.9	17.2	22.1	13.8	14.4	12.2	16.8	21.3	13.7	16.2	17.3	11.8	33.0	13.2	16.9	11.7	15.9	21.0	12.9	17.5	8.4	16.4	17.2	14.5	14.5	12.4	20.5	17.2	15.7	17.5	10.9	12.8	24.3	13.4	17.1	10.7	17.6	16.8	16.2	9.2	11.8	11.8	18.2	18.5	13.7	13.2	14.7	11.7	12.2	11.1	16.1	14.4	10.9	16.4	17.9	13.0	18.3	9.2	11.1	17.0	13.8	17.0	13.0	14.8	12.5	10.2	13.5	11.1	9.4	7.9	9.2	14.3	10.5	9.1	8.8	16.7	11.7	9.8	17.9	8.2	10.6	18.4	11.6	6.4	17.2	20.4	25.6	22.4	20.0	16.0	25.3	19.9	18.1	22.1	14.9	11.0	27.3	12.2	25.8	36.0	25.4	12.7	46.8	22.7	24.4	27.5	18.6	21.6	19.7	30.9	16.9	14.7	0.0	15.8	23.4	13.6	10.4	16.1	19.5	14.3	22.3	10.9	14.1	13.6	30.0	25.6	16.2	6.8	13.6	15.0	37.4	19.7	15.2	27.3	14.3	42.6	19.4	15.5	29.7	29.0	21.7	30.8	18.1	13.6	14.8
C2orf54	FLJ22671	ENSG00000172478	"Chromosome 2 open reading frame 54"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 50.6;Intestinal endocrine cells: 48.2;Paneth cells: 56.1;Suprabasal keratinocytes: 22.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.4"	"Group enriched"	"Detected in some"	6	"CACO-2: 21.6;HaCaT: 16.2;SK-BR-3: 57.4"	"Not detected"	"Not detected"							HPA052722			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.3	0.0	0.3	1.5	0.3	0.0	0.9	0.3	0.3	8.9	3.9	0.3	0.3	6.3	0.7	0.4	63.8	0.3	0.3	0.3	0.3	0.0	2.8	2.8	5.5	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.7	0.3	0.5	1.1	0.3	7.6	0.3	0.3	18.6	3.6	0.3	0.3	0.3	1.0	0.3	0.3	1.0	0.3	35.5	28.6	0.8	19.1	0.8	0.1	0.7	0.2	3.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.6	1.4	0.1	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	5.3	0.1	3.2	1.0	0.0	0.0	57.4	0.0	0.0	0.4	0.2	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.3	0.5	0.0	0.1	0.8	0.1	0.2	0.1	3.4	0.2	0.0	0.2	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	50.6	1.7	0.0	0.8	2.5	0.0	0.3	0.0	1.4	10.3	1.8	0.0	1.1	5.0	1.4	0.0	0.0	2.1	0.0	3.2	0.1	0.4	1.3	0.0	3.4	0.0	0.0	48.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.5	0.0	10.5	56.1	0.0	12.6	0.0	0.0	0.2	0.0	0.0	22.7	0.2	0.0	1.2	6.3
C2orf68		ENSG00000168887	"Chromosome 2 open reading frame 68"	Q2NKX9	2	85606654-85612066	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051143	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Nucleoplasm, Nuclear membrane, Mitochondria"	Nucleoli	"HPA051143: AB_2681360"	"unprognostic (1.71e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.76e-6)"	"unprognostic (4.24e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.81e-3)"	10.7	9.8	7.0	17.4	12.3	11.5	16.5	16.6	9.9	16.5	15.2	17.2	17.7	13.1	17.1	15.0	13.6	14.3	16.2	13.7	7.7	6.6	13.5	16.8	17.5	15.6	16.1	7.2	22.2	25.4	13.3	14.6	21.8	11.4	16.5	14.1	10.8	20.6	20.6	23.3	18.6	18.5	14.8	10.9	17.5	13.4	15.1	12.3	37.1	17.2	20.4	17.6	15.2	17.0	15.4	16.5	36.1	22.7	19.2	20.1	9.5	8.6	8.1	13.3	10.0	13.7	6.8	9.0	4.0	5.3	6.7	8.9	7.3	10.6	11.8	6.1	7.3	6.2	9.6	7.3	8.0	7.2	6.2	15.3	20.2	11.9	7.6	11.3	10.8	10.7	10.4	9.3	5.0	13.3	9.7	10.9	13.2	10.2	13.3	6.4	9.9	12.3	10.6	6.4	10.6	7.0	13.8	25.4	11.6	8.6	9.2	17.1	12.3	6.2	8.3	8.0	8.2	9.4	5.5	6.4	4.8	13.3	5.4	3.8	17.2	12.0	11.0	7.1	11.0	5.8	18.0	22.7	36.1	15.4	15.0	14.5	10.9	14.7	14.5	16.5	15.4	20.1	18.7	36.1	19.2	16.9	10.6	11.9	9.5	7.0	12.3	16.6	9.9	7.7	6.6	16.1	7.2	11.4	12.3	59.6	76.5	21.4	16.8	5.3	17.5	9.3	38.2	25.4	34.2	33.2	33.4	38.5	14.9	14.0	3.3	9.0	23.5	0.0	17.1	14.2	11.3	12.3	32.5	19.2	20.3	23.8	18.5	19.0	31.3	7.0	22.5	24.2	13.5	14.4	15.8	10.8	17.3	10.5	12.7	19.2	23.7	19.4	7.6	37.2	20.6	8.5	20.8	28.0	16.8	17.6
C2orf70	LOC339778	ENSG00000173557	"Chromosome 2 open reading frame 70"	A6NJV1	2	26562582-26579532	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 11.5;testis: 44.9"	"Group enriched"	"Detected in some"	16	"Early spermatids: 140.3;Late spermatids: 288.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062453	Enhanced		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA062453: AB_2684769"	"unprognostic (5.44e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.40e-6)"		"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (4.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.08e-3)"	0.1	0.3	1.1	0.3	2.2	0.0	0.3	0.1	0.8	0.5	1.0	3.1	2.3	0.3	0.4	5.2	0.2	11.5	0.6	1.4	1.1	2.7	0.7	0.1	1.0	0.1	0.8	0.7	2.7	4.5	0.0	1.2	0.1	4.4	0.4	0.6	0.0	3.1	1.7	0.2	0.1	0.2	0.1	0.7	0.1	7.6	44.9	0.5	0.0	3.1	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	3.8	0.0	0.9	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	0.1	0.8	1.1	2.7	0.8	0.7	4.4	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	13.4	0.0	0.0	0.0	0.0	1.7	0.6	140.3	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.3	0.0	0.0	0.0	2.9	0.0	0.0	288.4	1.7	0.0	0.0	0.0	1.3	0.0	0.3	0.0	1.8	0.5	0.0	0.0	0.0	3.9	0.9	0.0	0.0	0.0	0.0	0.0
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037490-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 22.5;placenta: 23.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 33.1;Hepatocytes: 111.5;Paneth cells: 62.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;OE19: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	1.0	0.9	6.5	0.9	8.4	0.8	1.6	1.7	10.1	0.8	7.8	9.9	0.0	2.3	0.8	1.1	0.9	0.9	1.8	0.8	7.7	4.7	1.4	22.5	1.2	0.8	5.1	7.9	0.8	6.1	1.7	1.7	23.9	8.2	2.0	2.5	0.8	1.0	0.9	0.8	0.8	2.6	1.0	2.2	0.8	4.2	0.9	5.9	0.0	0.8	0.0	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	3.0	0.0	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.6	0.1	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.1	1.5	0.8	0.8	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.4	1.7	10.1	7.7	4.7	5.1	7.9	8.2	5.9	0.0	0.0	1.9	0.0	0.1	0.6	0.3	33.1	0.0	0.0	0.0	0.0	1.4	1.7	2.0	7.3	0.0	15.3	0.0	1.8	9.0	0.0	0.9	0.0	111.5	0.5	0.0	4.7	3.7	2.5	25.8	0.3	0.0	1.7	0.0	13.2	9.7	1.0	62.8	3.9	1.4	0.3	0.0	0.1	0.5	0.9	0.0	4.3	0.0	24.3	0.1
C2orf74	LOC339804	ENSG00000237651	"Chromosome 2 open reading frame 74"	A8MZ97	2	61145068-61164829	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Distal tubular cells: 162.5;Early spermatids: 469.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in single"			HPA026826	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA026826: AB_10671091"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.54e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.22e-2)"	15.8	19.4	32.2	10.7	38.5	2.4	19.1	12.6	33.7	15.4	11.5	13.6	10.0	3.6	12.7	30.2	9.6	13.6	8.6	25.3	25.8	26.1	26.0	22.7	11.4	12.3	26.9	18.4	17.1	8.9	12.5	26.0	11.2	26.0	13.0	6.0	5.8	8.7	12.5	15.0	5.4	5.7	12.7	22.3	13.5	9.9	27.4	22.5	5.7	20.5	12.5	10.1	9.9	10.0	20.1	10.8	17.0	10.4	18.4	20.6	6.8	5.8	10.1	10.5	0.0	22.6	23.1	9.5	15.3	17.6	14.6	12.1	0.0	9.9	7.3	21.3	12.4	9.7	7.9	0.0	12.5	25.2	9.2	6.3	0.0	9.6	11.6	9.1	8.7	8.2	23.6	20.6	10.9	22.3	10.5	8.1	0.1	0.0	5.5	22.3	10.6	0.0	16.7	10.0	4.4	6.4	13.2	13.0	12.2	20.1	4.6	21.9	8.4	1.9	2.0	12.7	9.7	8.0	8.8	4.2	12.4	5.4	7.4	18.5	23.4	10.6	27.6	16.4	6.3	10.9	9.9	4.9	17.0	11.4	10.4	14.5	20.1	12.5	11.6	10.8	13.0	20.6	16.3	1.1	18.4	10.1	8.9	16.1	6.8	32.2	38.5	12.6	33.7	25.8	26.1	26.9	18.4	26.0	22.5	11.9	9.7	18.6	14.5	0.0	9.8	3.2	10.2	21.4	4.5	21.0	7.9	21.1	162.5	20.1	469.7	7.4	0.0	0.0	27.3	21.6	8.2	8.3	13.9	18.7	19.9	11.1	0.0	12.9	15.3	68.5	34.2	20.7	1.7	33.3	0.0	21.8	19.4	0.0	42.5	110.7	18.2	19.4	1.4	18.0	25.6	0.0	5.4	12.5	0.0	6.5
C2orf76	"AIM29, LOC130355, MGC104437"	ENSG00000186132	"Chromosome 2 open reading frame 76"	Q3KRA6	2	119302225-119366828	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044977, HPA055362"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044977: AB_10961918, HPA055362: AB_2682794"	"unprognostic (4.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (3.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.19e-2)"	13.7	14.9	17.6	6.8	17.4	6.2	16.9	10.1	17.6	10.0	9.5	11.9	17.0	4.6	12.7	33.1	11.8	15.2	9.1	11.3	15.9	13.8	14.3	9.9	19.5	9.7	19.5	13.0	13.5	20.6	10.6	14.7	7.8	23.0	11.9	8.6	9.6	10.8	11.9	7.4	14.5	6.2	14.0	20.3	8.7	9.5	18.3	15.3	7.9	15.1	10.2	9.4	10.0	9.3	14.8	15.7	27.7	16.3	23.4	15.8	9.3	9.4	9.0	13.0	8.3	18.8	23.2	7.5	13.4	9.6	8.8	9.6	5.7	6.4	11.4	23.9	14.0	10.2	4.4	5.7	8.5	8.6	9.8	19.4	22.0	6.9	7.4	13.1	8.2	14.3	12.0	14.5	12.3	8.2	11.3	12.6	8.9	6.9	11.3	12.9	14.3	8.6	15.6	7.1	7.5	7.2	5.3	2.7	16.1	19.2	10.3	8.5	9.7	9.7	14.0	18.0	12.9	7.6	29.5	11.6	10.2	7.9	8.5	7.1	7.5	12.2	12.3	10.3	6.2	11.4	17.4	16.3	15.4	15.8	14.5	14.1	14.8	12.4	14.4	15.7	11.2	11.3	15.6	27.7	23.4	8.9	14.7	12.1	9.3	17.6	17.4	10.1	17.6	15.9	13.8	19.5	13.0	23.0	15.3	6.0	10.7	8.0	14.8	22.1	2.7	14.9	12.7	38.8	13.6	14.0	0.0	22.7	66.3	12.0	4.8	18.6	8.4	23.3	15.4	27.7	18.3	10.6	21.9	10.5	23.6	1.6	10.5	16.5	20.3	3.4	17.8	14.4	42.2	17.2	10.6	8.6	15.0	7.0	15.9	35.2	3.8	6.5	18.6	18.0	20.4	31.1	17.3	16.7	10.3	10.3
C2orf80	"GONDA1, LOC389073"	ENSG00000188674	"Chromosome 2 open reading frame 80"	Q0P641	2	208165343-208190073	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 35.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	41	"glioma: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.9"					"Low region specificity"	"Detected in all"			HPA042639			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA042639: AB_10794915"					"unprognostic (6.36e-2)"					"unprognostic (2.12e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.05e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.98e-2)"			0.9	1.0	20.8	1.3	20.8	2.4	0.9	0.4	35.3	0.7	1.1	1.1	0.0	1.0	1.0	0.9	2.2	1.0	1.4	0.9	16.3	14.2	0.9	1.1	1.0	1.1	8.0	13.1	1.0	0.7	0.8	0.4	0.9	9.6	1.1	1.1	0.5	1.4	1.4	1.2	2.0	1.3	0.9	2.1	1.0	1.2	1.7	2.4	0.0	1.1	0.0	0.8	0.9	0.0	1.5	1.7	8.4	1.2	1.0	0.7	0.2	0.4	0.5	2.7	0.9	0.0	0.0	0.2	0.6	0.6	0.0	0.0	1.0	1.2	1.5	1.0	0.3	0.6	0.4	0.0	0.0	0.0	0.4	0.3	1.0	1.3	0.4	0.0	1.2	1.8	0.4	0.5	0.3	0.3	0.3	0.0	0.5	0.6	1.5	0.0	0.8	0.0	1.6	5.9	0.4	1.8	0.4	0.3	0.4	0.0	1.2	0.8	1.3	0.3	0.9	0.2	0.4	0.5	0.0	0.8	0.5	0.3	0.4	0.5	0.8	0.3	1.1	0.0	0.6	0.9	4.3	1.2	0.9	0.7	0.7	0.5	0.9	0.7	0.7	0.3	1.5	0.6	0.7	8.4	1.0	0.5	1.7	0.3	0.2	20.8	20.8	0.4	23.1	16.3	14.2	8.0	13.1	9.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
C2orf81	"hCG40743, LOC388963"	ENSG00000284308	"Chromosome 2 open reading frame 81"		2	74414176-74421591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.9;testis: 20.0"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 17.4;Early spermatids: 35.6;Late spermatids: 23.4;Spermatocytes: 16.4"									"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 12.2;RPMI-8226: 11.6;SCLC-21H: 15.2;SH-SY5Y: 16.5"									"HPA049564, HPA054835"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA049564: , HPA054835: AB_2682620"																		0.4	0.9	2.2	1.2	5.5	0.5	0.9	1.2	3.4	1.3	0.8	2.6	8.2	0.9	2.2	4.9	1.6	17.9	2.0	0.7	2.1		1.9	0.0	2.5	3.0	0.0	2.8	3.2	1.6	4.9	13.7	1.0	1.9	1.8	0.2	3.2	1.3	3.5	0.8	0.3	1.1	0.7	0.0	2.1	1.7	20.0	0.8	5.3	2.1	0.7	1.9	1.9	0.0	6.5	13.2	0.2	1.8	3.1	3.4	1.3	3.5	6.6	2.0	7.4	2.3	1.9	0.7	0.6	2.2	0.6	0.7	0.4	4.1	8.6	1.6	1.0	1.8	1.3	0.1	1.7	0.7	4.8	0.5	0.9	0.5	0.1	1.1	1.8	1.9	1.1	4.4	0.9	0.9	2.6	0.0	4.7	0.3	1.4	1.1	12.2	2.2	4.5	4.0	2.1	1.5	1.1	0.7	11.6	2.6	1.5	15.2	16.5	2.1	3.3	0.9	0.3	3.1	1.6	0.1	0.7	3.3	2.3	1.8	3.2	5.6	2.8	4.6	1.7	1.5	0.1	1.8	0.0	0.6	1.8	0.3	5.7	0.7	0.8	6.2	6.5	3.4	1.5	0.2	3.1	1.4	13.2	0.6	1.3											0.0	3.7	0.0	1.0	0.6	0.6	1.1	2.5	17.4	4.5	3.5	0.0	0.0	5.0	2.9	35.6	1.4	0.1	0.0	1.9	0.0	2.1	0.6	0.0	0.0	0.0	3.2	6.9	2.5	2.1	23.4	3.1	3.0	3.3	9.0	1.6	4.8	2.0	0.0	7.1	4.2	3.5	6.5	3.9	16.4	1.5	0.6	0.0	0.0	1.1	0.2
C2orf91		ENSG00000205086	"Chromosome 2 open reading frame 91"	Q6ZV80	2	41935368-41954266	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.1;lung: 4.7"	"Cell type enhanced"	"Detected in single"	22	"Alveolar cells type 1: 3.0"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.8"	"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"AN3-CA: 5.2;HDLM-2: 17.9"									HPA042517	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"HPA042517: AB_10795508"	"unprognostic (9.49e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.47e-1)"	0.3	2.1	0.3	0.3	1.3	1.5	0.3	0.3	0.8	0.4	0.3	0.8	0.2	0.0	0.4	1.0	0.3	0.3	0.3	0.5	0.3	0.4	0.9	0.3	4.7	0.9	5.1	0.2	0.4	0.4	0.4	0.5	0.2	1.9	0.8	0.2	0.8	3.5	0.2	0.2	1.3	0.3	0.2	2.2	0.6	1.3	1.1	0.2	0.2	0.2	0.2	0.6	0.2	0.3	1.2	1.4	2.8	1.2	1.2	0.9	0.3	0.2	0.4	0.7	5.2	0.2	0.1	0.3	0.1	0.1	0.0	0.3	0.4	0.3	0.3	0.3	0.2	0.2	0.2	0.0	0.1	0.1	17.9	0.3	0.2	0.4	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.8	0.1	0.3	0.1	0.1	0.3	0.4	0.1	0.0	0.6	0.1	0.1	0.3	0.2	1.8	0.0	0.0	0.2	0.9	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.1	0.2	0.2	0.0	0.2	1.3	1.2	1.4	0.6	0.9	0.5	0.6	0.7	0.5	1.4	1.2	0.7	0.9	2.8	1.2	1.0	1.3	0.4	0.3	0.3	1.3	0.3	0.8	0.3	0.4	5.1	0.2	1.9	0.2	3.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
C3orf14	HT021	ENSG00000114405	"Chromosome 3 open reading frame 14"	Q9HBI5	3	62318973-62336213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 111.9;Spermatocytes: 148.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 106.9"					"Low region specificity"	"Detected in all"			HPA048286	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA048286: AB_2680340"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.69e-3)"	"unprognostic (6.91e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.76e-5)"	"unprognostic (1.57e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.33e-5)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	3.8	14.7	28.2	5.6	23.6	1.0	35.0	16.4	31.2	5.0	3.9	7.7	2.5	3.3	5.5	6.8	11.0	4.1	6.8	4.6	20.9	22.0	9.6	2.9	6.4	5.0	19.9	20.5	8.2	6.3	2.3	19.0	4.8	25.9	17.8	4.1	4.1	5.0	5.6	1.0	12.0	2.7	6.8	15.2	3.0	6.1	20.9	8.1	1.2	9.2	3.8	8.2	13.5	3.4	3.7	6.7	5.2	21.0	0.7	6.1	2.1	0.0	5.8	7.0	0.0	5.1	7.4	5.4	9.5	5.7	12.0	11.9	0.0	8.5	0.0	0.0	6.4	24.7	1.5	0.0	6.0	9.2	0.0	4.0	5.1	0.0	0.0	3.4	0.0	11.2	3.3	8.1	13.5	11.1	0.2	5.8	0.0	0.6	0.1	11.8	106.9	0.0	0.0	8.8	8.4	12.0	0.0	0.0	2.9	9.8	16.3	12.3	10.4	6.3	22.6	8.7	6.1	9.2	5.8	0.1	5.9	0.0	27.4	9.4	5.8	0.0	0.0	5.7	0.0	20.5	5.2	4.3	0.4	0.2	14.3	0.1	3.7	3.6	2.8	4.6	1.1	1.0	0.7	0.3	0.7	21.0	6.7	6.1	2.1	28.2	23.6	16.4	31.2	20.9	22.0	19.9	20.5	25.9	8.1	20.8	10.2	2.7	19.7	32.6	31.2	4.5	7.6	4.0	19.4	21.0	3.9	16.3	51.4	31.3	111.9	11.7	2.6	0.0	47.7	18.9	20.3	22.1	1.1	3.0	27.0	35.0	84.0	4.9	7.8	44.2	13.0	19.5	43.9	83.8	2.6	27.9	29.7	0.0	9.9	34.8	23.1	0.0	15.5	148.6	37.5	25.1	8.2	4.4	3.8	17.0
C3orf18	G20	ENSG00000088543	"Chromosome 3 open reading frame 18"	Q9UK00	3	50558025-50571027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 26.3;Early spermatids: 47.6;Late spermatids: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;NK-cells: 2.1;T-cells: 7.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.8"	"Group enriched"	"Detected in many"	4	"cerebellum: 31.6;olfactory region: 33.8"	"Low region specificity"	"Detected in all"			HPA012105	Approved		Approved	Cytosol		No	No			Cytosol		"HPA012105: AB_1845717"	"unprognostic (9.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (2.80e-9)"	"unprognostic (7.65e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	5.1	6.7	10.0	3.4	12.3	1.2	6.2	34.5	20.1	6.0	6.1	8.0	2.2	2.2	8.0	5.1	5.0	8.4	6.0	25.3	8.1	9.7	6.0	3.0	4.1	3.9	11.4	9.3	14.0	6.1	19.2	7.4	2.6	10.3	8.5	3.2	11.9	7.3	11.0	32.4	2.8	2.9	10.4	6.9	4.1	5.2	9.8	6.1	1.8	6.9	7.2	4.0	6.8	4.9	2.9	0.9	0.8	0.5	2.1	7.7	3.0	1.1	1.7	1.9	0.4	6.6	5.9	0.6	6.9	10.8	6.3	4.6	0.1	1.7	1.4	1.7	9.4	6.0	0.1	0.0	2.7	3.3	29.8	0.2	2.8	3.9	0.5	3.3	0.0	3.8	5.8	0.4	6.1	0.3	5.1	1.2	4.5	0.6	1.3	3.7	0.2	0.2	0.9	2.4	1.2	7.7	0.6	0.2	1.6	0.3	0.2	2.2	10.3	1.8	0.4	0.1	2.3	2.1	0.8	0.3	6.4	5.0	11.5	0.8	1.8	1.5	0.2	9.1	3.1	0.1	0.0	0.5	0.8	6.3	0.2	7.7	2.9	5.5	6.0	0.5	1.8	6.4	7.7	0.0	2.1	0.1	0.9	2.5	3.0	10.0	12.3	34.5	20.1	8.1	9.7	11.4	9.3	10.3	6.1	0.0	0.6	0.0	1.5	1.0	9.2	26.3	0.0	1.4	2.3	1.8	7.9	0.4	3.3	1.8	47.6	1.6	0.0	0.0	1.6	0.5	4.1	0.6	0.0	1.7	1.4	1.6	1.7	2.5	0.3	47.3	4.4	0.4	0.0	15.4	0.3	8.9	0.7	0.0	3.9	1.8	15.9	12.9	3.0	2.8	1.7	0.4	0.1	2.2	0.1	0.1
C3orf33	"AC3-33, FLJ31139"	ENSG00000174928	"Chromosome 3 open reading frame 33"	Q6P1S2	3	155762617-155806351	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037663	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA037663: AB_10672610"	"unprognostic (1.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (6.48e-7)"	"unprognostic (3.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.56e-1)"	4.3	16.9	6.7	3.1	7.9	2.3	6.8	9.2	9.5	5.0	3.6	6.5	5.0	4.1	6.1	9.7	2.5	5.4	3.5	9.3	7.6	7.9	9.4	4.1	5.2	2.8	5.6	11.0	6.9	19.4	11.7	8.6	2.1	7.9	7.2	3.4	5.5	4.5	6.6	5.6	1.6	2.8	11.1	5.0	2.8	4.3	6.2	6.9	1.7	13.4	2.4	1.7	4.0	6.3	2.3	3.0	3.0	1.8	6.1	7.7	3.4	6.0	8.5	4.0	5.6	0.3	5.1	1.8	2.5	4.0	2.5	6.1	2.9	7.7	1.1	6.2	2.6	3.8	0.9	4.1	0.1	4.6	2.9	6.0	3.7	1.4	7.8	7.1	5.0	1.2	4.0	4.5	2.7	5.3	3.3	4.3	6.3	5.8	2.9	4.3	4.4	5.3	4.5	5.4	5.5	1.9	5.4	2.2	5.9	14.1	2.8	3.1	4.1	5.8	7.8	5.2	2.2	10.7	6.6	2.7	2.9	2.1	6.1	6.5	4.9	4.6	0.0	2.1	4.7	2.9	3.0	1.8	0.2	6.2	1.6	7.7	2.3	4.9	5.5	3.0	2.2	6.2	6.4	0.1	6.1	1.1	2.4	3.2	3.4	6.7	7.9	9.2	9.5	7.6	7.9	5.6	11.0	7.9	6.9	3.0	7.9	0.0	5.1	1.1	7.9	9.8	2.5	5.3	7.9	0.0	5.9	3.0	5.0	3.2	5.2	2.2	1.3	0.0	2.9	2.5	4.6	4.0	6.9	3.0	2.2	6.4	3.5	1.3	0.3	4.2	5.8	1.6	1.7	0.0	3.1	15.6	1.6	3.4	7.4	5.3	7.0	0.0	3.1	11.3	17.2	1.3	3.1	2.5	4.1	2.0
C3orf36	FLJ22173	ENSG00000221972	"Chromosome 3 open reading frame 36"	Q3SXR2	3	133928145-133929812	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"lung: 8.2;seminal vesicle: 14.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 6.6;HeLa: 1.7;TIME: 5.2"									HPA046432			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA046432: AB_2679664"	"unprognostic (3.56e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-3)"	"unprognostic (4.64e-4)"	"unprognostic (5.05e-3)"	"unprognostic (8.18e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	1.1	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.2	0.7			0.2	1.3	0.0	0.6	1.1	0.8	0.7	0.0	0.0	1.9	0.0	8.2	0.1	0.0		0.0	0.7	1.6	0.2	0.1		2.3	0.3		0.4	14.7	0.0	0.1	1.4	1.0	0.0	1.5	0.8	0.0			2.7		0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C3orf38	MGC26717	ENSG00000179021	"Chromosome 3 open reading frame 38"	Q5JPI3	3	88149743-88168729	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 252.0;Late spermatids: 238.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034736, HPA034737"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034736: AB_2674307, HPA034737: AB_10671505"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (9.28e-3)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.67e-2)"	12.2	11.7	13.7	12.8	16.1	35.2	12.3	12.9	12.8	11.6	11.9	13.6	8.4	9.5	11.5	10.7	14.6	10.7	9.4	9.7	11.3	11.1	10.2	13.5	10.6	19.2	15.1	9.4	12.1	9.3	7.1	15.8	12.5	11.4	11.2	11.2	9.0	10.6	10.2	9.7	11.6	11.4	10.9	11.3	17.0	10.1	33.2	13.5	29.5	11.6	9.0	17.1	12.4	11.6	20.0	17.7	25.8	24.2	17.1	17.4	15.3	6.4	6.7	13.2	7.0	8.8	8.0	6.1	10.5	12.6	15.7	21.3	7.7	8.9	8.7	9.4	9.7	7.5	4.7	9.5	7.7	13.6	15.6	4.5	10.6	5.2	6.5	12.6	14.5	9.2	11.4	7.8	10.5	9.0	10.3	9.0	9.5	6.7	10.0	17.0	7.5	14.6	6.1	16.0	12.1	7.6	9.2	4.6	8.2	10.4	8.8	4.0	5.8	9.6	5.3	15.8	11.2	10.2	11.1	8.2	9.8	10.7	59.4	11.5	9.2	13.6	12.9	7.6	11.5	9.2	25.8	16.8	17.5	13.5	24.2	17.4	20.0	12.6	13.8	17.7	15.9	12.6	12.8	7.5	17.1	19.7	12.3	15.1	15.3	13.7	16.1	12.9	12.8	11.3	11.1	15.1	9.4	11.4	13.5	17.9	6.9	32.0	16.6	10.4	21.8	5.6	0.0	14.7	11.4	5.2	21.6	19.3	16.6	14.7	252.0	8.7	11.8	0.0	12.0	18.8	15.4	14.2	13.9	7.4	23.4	6.4	15.5	8.6	17.2	238.1	15.3	21.8	15.1	27.1	10.7	22.8	11.6	13.3	14.2	9.8	21.7	12.9	12.2	25.9	12.0	12.3	21.4	28.7	9.0	18.6
C3orf49		ENSG00000163632	"Chromosome 3 open reading frame 49"	Q96BT1	3	63819362-63848636	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Group enriched"	"Detected in some"	12	"Early spermatids: 19.9;Late spermatids: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 4.7"					"Not detected"	"Not detected"			HPA053582	Uncertain		Approved	Vesicles,Centrosome,Cytosol		NA	NA			Cytosol	"Vesicles, Centrosome"	"HPA053582: AB_2682199"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.07e-1)"	0.4	0.1	0.5	0.4	1.0	0.9	0.4	1.8	4.0	0.4	0.4	0.4	0.4	1.3	0.5	0.4	1.7	0.4	0.4	0.8	0.5	0.5	0.4	0.6	0.6	0.4	0.4	0.4	1.2	1.3	0.0	0.4	0.4	0.4	0.4	0.0	0.4	0.5	0.4	2.6	2.0	0.4	0.4	0.4	0.4	0.3	3.6	0.4	0.4	0.7	0.4	0.4	0.5	0.4	1.1	0.5	1.7	0.9	2.2	1.1	0.1	0.7	2.0	1.0	1.3	0.0	0.3	1.2	1.7	0.0	0.1	0.0	1.2	1.0	2.6	0.4	0.0	0.7	1.1	0.0	0.1	0.3	1.5	1.8	2.2	4.7	0.5	0.0	0.8	0.8	0.2	0.1	0.0	0.1	0.5	0.0	0.9	1.3	1.2	0.0	4.4	1.2	1.2	1.3	1.2	0.4	1.7	1.1	2.5	0.1	1.1	1.2	0.8	0.3	2.6	0.3	0.3	0.7	1.0	1.5	0.8	1.0	1.7	2.0	0.8	2.4	0.5	2.7	3.7	1.0	1.7	0.6	0.2	1.1	0.4	0.4	0.6	0.6	0.8	0.4	1.1	1.1	1.0	1.2	2.2	0.9	0.5	0.8	0.1	0.5	1.0	1.8	1.3	0.5	0.5	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.3	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.8	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3
C3orf52	"FLJ23186, TTMP"	ENSG00000114529	"Chromosome 3 open reading frame 52"	Q5BVD1	3	112086335-112131004	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 41.2"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 112.5;Glandular cells: 75.6;Syncytiotrophoblasts: 62.7;Urothelial cells: 119.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;U-698: 20.8"									"HPA007678, HPA008119, HPA011968"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826"	"unprognostic (8.86e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.49e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-6)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.59e-2)"	1.1	1.0	0.3	5.3	0.7	0.4	1.9	0.3	0.4	1.0	9.1	0.0	6.9	2.8	1.7	1.5	2.7	1.0	12.4	3.0	0.4	0.4	7.1	0.5	6.3	0.8	0.3	0.0	0.6	41.2	0.0	8.7	6.1	0.5	5.4	9.0	0.6	3.9	9.6	1.5	22.3	12.7	4.2	0.3	0.8	10.6	1.0	0.0	20.8	10.7	4.3	3.6	6.1	6.1	0.8	0.8	0.0	0.0	0.0	2.7	1.0	8.7	1.4	2.4	0.0	0.3	0.0	3.2	6.9	2.9	4.0	4.6	14.9	4.7	0.3	1.3	2.0	4.6	6.2	2.8	1.7	7.6	0.0	2.3	6.0	2.0	0.7	1.8	0.0	0.0	0.5	3.5	3.6	6.1	2.8	0.9	0.0	1.5	1.5	3.0	0.6	0.2	0.0	5.2	5.6	1.9	0.2	7.9	0.0	7.1	7.7	0.3	0.6	2.6	2.7	2.5	2.9	4.0	0.0	2.2	1.4	2.4	0.0	0.0	5.5	0.0	20.8	1.2	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.4	0.8	2.7	1.3	0.5	0.3	1.5	0.6	0.0	0.0	0.0	0.8	0.0	1.0	0.3	0.7	0.3	0.4	0.4	0.4	0.3	0.0	0.5	0.0	14.9	7.7	0.5	112.5	28.8	0.0	1.4	5.1	13.4	22.7	17.4	0.0	15.2	0.0	29.6	24.4	0.3	14.6	0.0	31.2	16.0	1.7	75.6	0.0	0.0	1.6	0.0	11.3	0.6	0.3	18.2	0.3	0.3	1.7	4.6	32.5	0.0	53.5	5.9	0.4	1.7	0.0	0.0	3.3	1.8	5.5	29.4	62.7	0.8	5.4	119.7
C3orf62	FLJ43654	ENSG00000188315	"Chromosome 3 open reading frame 62"	Q6ZUJ4	3	49268602-49277909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"blood: 25.0;testis: 76.9"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 25.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043328			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA043328: AB_10795613"	"prognostic favorable (3.93e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.20e-4)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.40e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (7.23e-2)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.29e-5)"	"unprognostic (2.46e-1)"	"unprognostic (4.79e-1)"	"prognostic favorable (1.62e-5)"	4.2	5.5	3.2	4.4	4.0	7.4	2.7	6.6	4.8	3.8	3.6	2.8	4.4	3.1	3.5	4.9	3.7	4.1	5.0	3.5	3.7	4.3	2.7	2.8	3.9	4.5	3.3	4.0	8.0	4.7	2.4	4.5	2.6	3.6	4.1	2.3	5.7	4.4	2.2	3.7	3.5	2.7	3.6	3.6	7.0	2.6	76.9	3.3	2.2	3.7	2.2	3.3	4.8	7.5	1.2	1.6	25.0	3.2	0.6	1.0	0.7	4.8	2.9	6.9	8.7	5.7	5.2	3.9	2.9	4.9	2.6	3.9	4.1	3.7	9.6	4.6	4.4	5.4	3.8	3.5	3.2	3.0	8.5	4.0	6.3	6.1	4.6	2.0	8.9	11.9	4.0	9.5	3.8	7.1	4.5	3.1	5.6	7.1	7.3	2.2	3.0	6.6	6.4	4.9	3.8	4.2	5.0	3.6	5.0	4.3	11.2	5.3	7.2	8.0	6.1	10.4	5.4	3.1	9.9	3.5	3.6	8.8	6.1	5.3	6.7	10.9	8.3	2.7	8.6	4.9	1.5	3.2	3.4	0.8	1.2	0.9	1.2	0.9	0.8	0.7	0.9	0.9	0.8	25.0	0.6	1.4	1.6	1.0	0.7	3.2	4.0	6.6	4.8	3.7	4.3	3.3	4.0	3.6	3.3	8.9	17.3	3.0	3.1	6.1	11.5	7.8	7.6	9.4	11.4	10.4	21.6	5.2	0.0	4.1	9.1	5.8	4.3	0.0	3.4	3.6	5.3	5.4	2.3	5.7	9.0	4.8	5.2	8.0	17.3	12.8	8.1	9.2	8.5	9.0	8.6	6.5	4.3	3.5	8.1	4.9	13.5	0.0	3.8	64.4	6.5	7.5	3.4	6.4	6.3	2.0
C3orf67	"FLJ42117, FLJ42930"	ENSG00000163689	"Chromosome 3 open reading frame 67"	Q6ZVT6	3	58717365-59050084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.4;testis: 28.4"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 80.6;Late spermatids: 61.4;Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2;T-reg: 2.2"	"Group enriched"	"Detected in many"	13	"B-cells: 2.2;T-cells: 2.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069696			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA069696: AB_2686174"	"unprognostic (4.59e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-5)"	"unprognostic (1.91e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.68e-3)"	"unprognostic (8.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.81e-2)"	0.5	1.8	1.2	1.0	4.3	0.3	0.6	0.5	2.0	1.5	0.7	0.5	0.0	0.1	0.6	1.6	10.4	3.4	0.7	0.4	0.9	0.9	0.7	1.9	0.6	1.8	0.5	0.9	0.7	0.8	1.3	8.4	1.3	1.3	1.0	0.9	1.6	2.6	0.4	0.2	0.4	0.3	0.5	0.6	0.4	0.5	28.4	0.5	0.4	0.4	2.0	3.6	0.3	2.9	2.2	0.0	0.0	0.1	0.1	2.2	0.3	10.5	1.7	3.0	0.0	1.8	5.8	0.0	5.0	1.7	2.2	1.8	0.9	3.5	11.0	1.7	1.2	0.0	1.1	4.7	2.4	4.0	1.7	0.3	0.0	1.8	0.0	1.0	0.0	0.0	1.1	2.4	4.7	3.8	2.8	4.6	7.3	8.4	0.1	3.0	1.4	0.5	0.0	3.7	3.4	7.5	10.6	0.0	4.5	2.4	0.1	7.7	3.6	1.4	1.0	3.2	5.1	3.4	0.0	0.1	0.2	3.4	5.5	2.3	4.5	9.4	2.1	2.6	0.0	7.0	0.0	0.1	0.0	0.2	0.0	0.0	1.7	0.7	0.0	0.0	2.2	0.1	0.7	0.0	0.1	0.0	0.0	2.2	0.3	1.2	4.3	0.5	2.0	0.9	0.9	0.5	0.9	1.3	0.5	0.0	0.0	0.0	1.5	0.8	0.1	0.8	0.0	13.4	2.3	1.8	0.0	0.7	1.7	3.2	80.6	0.9	0.0	0.0	0.3	1.6	1.6	0.9	0.0	1.7	0.8	0.0	2.4	0.6	0.3	61.4	2.0	0.2	1.7	0.0	0.5	0.6	4.1	0.0	1.1	0.8	0.3	0.0	1.2	27.9	15.8	0.1	0.5	0.0	1.2	1.4
C3orf70		ENSG00000187068	"Chromosome 3 open reading frame 70"	A6NLC5	3	185078050-185153014	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 26.6"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 17.4;Melanocytes: 37.1;Peritubular cells: 46.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"RH-30: 4.7;SCLC-21H: 19.5;SK-BR-3: 8.4;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041861	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA041861: AB_10804119"	"unprognostic (1.45e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.62e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.06e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	4.6	2.3	14.4	4.7	13.8	0.9	2.0	7.9	18.2	7.2	12.1	11.1	7.9	5.3	12.1	6.1	10.1	6.8	6.1	3.3	11.1	10.2	1.6	1.3	2.4	1.3	11.4	7.1	5.9	1.1	4.0	1.4	2.9	10.5	10.2	8.2	5.2	5.5	16.4	1.5	2.9	6.5	26.6	11.1	4.2	4.4	7.5	7.0	0.0	2.4	1.0	1.7	13.2	3.3	1.2	1.2	3.4	1.6	1.7	1.1	0.5	0.0	0.1	2.3	0.0	0.0	0.1	0.1	3.0	0.1	0.5	0.0	1.4	0.0	0.0	0.0	0.3	0.1	0.1	1.0	0.0	0.2	0.0	0.8	2.5	0.1	0.7	0.0	0.4	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	1.0	2.2	0.2	0.1	4.7	0.1	0.0	0.5	19.5	0.2	0.9	8.4	0.5	0.1	0.6	2.2	0.8	0.0	2.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	10.5	3.4	1.2	1.7	0.8	1.0	1.0	1.0	0.8	0.8	0.6	1.2	1.0	1.1	3.3	1.7	1.6	1.2	0.7	0.5	14.4	13.8	7.9	9.6	11.1	10.2	11.4	7.1	10.5	7.0	0.0	0.0	1.5	0.2	3.7	17.4	1.2	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.1	1.0	2.3	4.0	0.0	0.2	0.6	2.3	0.3	0.0	0.0	3.1	3.2	1.2	4.9	0.6	1.2	3.1	0.0	37.1	1.0	8.1	1.3	0.2	0.0	46.7	0.0	6.2	6.5	15.8	7.9	12.5	1.6	0.7	0.0	5.3	0.3
C4orf22		ENSG00000197826	"Chromosome 4 open reading frame 22"	Q6V702	4	80335720-80963756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;fallopian tube: 19.8;testis: 34.8"	"Cell type enhanced"	"Detected in some"	25	"Ciliated cells: 163.3;Early spermatids: 74.5;Spermatocytes: 40.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.4;pons and medulla: 22.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;BJ: 4.0;hTERT-RPE1: 6.3;LHCN-M2: 2.4;SCLC-21H: 2.7;U-251 MG: 2.6"	"Low region specificity"	"Detected in many"							HPA043383	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.1	1.4	0.1	8.4	0.1	0.3	0.6	0.2	0.9	0.1	5.1	0.1	0.3	0.4	7.8	0.2	19.8	0.3	0.1	2.8	2.5	0.4	0.1	5.9	0.3	0.1	0.1	3.5	0.1	0.1	1.2	0.1	22.0	0.2	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.1	0.1	34.8	2.4	2.9	0.7	0.0	0.2	0.1	0.0	2.1	0.5	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	1.9	0.0	4.0	0.7	0.1	0.1	0.0	0.0	1.1	0.0	1.4	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	1.0	1.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.4	8.4	0.6	0.2	2.8	2.5	0.1	0.1	22.0	2.4	0.0	1.0	0.0	0.1	0.0	0.6	0.0	0.0	163.3	23.9	0.0	0.0	0.0	0.0	0.0	74.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	40.9	2.3	0.0	0.0	0.0	0.0	0.0
C4orf3	HCVFTP1	ENSG00000164096	"Chromosome 4 open reading frame 3"	Q8WVX3	4	119296419-119304445	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Proximal tubular cells: 865.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA026907	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA026907: AB_10600760"	"unprognostic (2.97e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.85e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.04e-1)"	"unprognostic (8.85e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (8.32e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.59e-1)"	51.6	41.9	46.2	39.1	47.2	19.0	31.7	18.2	41.1	46.1	33.5	41.1	25.6	41.3	39.4	49.0	101.3	33.8	37.0	43.4	46.5	45.4	55.8	63.4	33.6	32.2	61.2	31.6	45.1	32.7	19.6	34.7	36.6	47.3	38.7	20.3	33.4	42.6	34.1	70.5	37.7	45.0	41.5	68.7	38.0	26.9	19.4	35.8	30.3	44.2	42.3	39.3	50.0	59.8	60.4	66.8	112.7	53.3	38.0	48.6	65.5	69.1	8.0	23.3	19.3	32.7	24.9	19.0	30.6	8.3	9.0	16.7	8.5	23.1	47.6	23.7	29.2	16.8	13.6	10.3	25.3	14.1	31.9	10.2	19.7	18.5	29.9	9.8	32.3	21.6	26.0	21.2	12.9	5.6	42.0	15.0	13.7	17.5	19.9	33.0	19.9	20.9	30.2	11.8	26.9	8.2	15.0	31.2	12.1	17.0	15.8	14.7	23.8	23.2	30.8	15.9	23.9	16.5	16.9	29.5	33.3	19.8	20.1	12.4	33.6	34.4	22.1	62.6	13.4	18.8	69.3	50.7	60.4	40.1	53.3	38.7	60.4	47.8	45.0	42.7	46.4	48.4	46.9	112.7	38.0	49.0	66.8	48.6	65.5	46.2	47.2	18.2	41.1	46.5	45.4	61.2	31.6	47.3	35.8	145.9	143.1	236.2	239.8	280.2	80.9	421.0	165.6	215.5	144.5	211.1	23.6	289.6	325.0	242.8	18.7	229.5	160.4	23.3	156.7	297.9	248.2	254.6	179.3	378.8	279.6	144.6	65.7	200.7	283.9	15.8	155.1	255.4	189.0	413.8	155.2	139.4	215.9	181.4	202.6	865.1	58.0	194.1	282.9	205.3	54.1	303.0	372.8	183.3	101.9	339.6
C4orf33	FLJ33703	ENSG00000151470	"Chromosome 4 open reading frame 33"	Q8N1A6	4	129093317-129116640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 23.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA061199	Uncertain		Approved	"Nuclear bodies,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nuclear bodies"	"HPA061199: AB_2684450"	"unprognostic (7.27e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (2.49e-5)"	7.5	12.2	12.7	7.4	15.9	17.7	9.4	24.2	27.9	5.8	18.1	8.2	4.7	17.7	5.8	12.0	10.7	8.9	10.8	6.7	15.8	14.8	14.5	10.7	11.4	8.3	17.0	16.5	12.8	10.8	13.1	25.8	9.9	26.7	5.5	17.4	5.8	7.2	5.2	3.0	9.0	23.9	5.9	32.4	9.4	17.7	5.6	10.7	8.8	14.0	6.7	6.5	9.7	6.7	3.5	7.5	23.5	8.1	5.2	3.3	3.4	5.5	2.6	7.8	8.6	4.7	6.1	9.8	5.3	6.2	6.7	8.0	2.4	21.8	5.3	10.2	6.0	7.7	4.0	8.6	7.3	6.2	26.4	6.3	8.9	8.4	2.1	7.3	6.2	10.5	5.1	6.5	5.9	2.4	9.5	4.6	16.7	12.4	23.6	5.8	2.1	9.7	6.1	0.4	10.6	3.5	4.0	6.5	5.3	18.1	4.7	11.2	2.2	3.4	9.4	6.3	2.0	8.2	5.5	3.2	6.0	1.9	3.9	4.4	11.6	4.5	9.1	10.3	14.6	4.7	9.5	8.1	23.5	2.3	7.8	1.9	3.5	2.0	2.7	7.5	2.0	2.0	3.3	3.8	5.2	8.1	4.2	3.2	3.4	12.7	15.9	24.2	27.9	15.8	14.8	17.0	16.5	26.7	10.7	6.0	10.2	5.6	6.8	9.3	13.7	2.8	15.3	33.5	6.8	12.2	7.9	16.4	43.1	7.2	2.6	5.8	22.5	0.0	8.3	16.0	7.8	4.3	13.9	4.7	12.5	1.6	4.7	9.8	20.0	2.8	2.0	14.7	11.8	7.2	13.9	10.5	7.8	16.4	2.1	23.7	11.4	0.0	13.1	2.8	5.1	8.2	15.8	13.1	14.3	9.0
C4orf36	MGC26744	ENSG00000163633	"Chromosome 4 open reading frame 36"	Q96KX1	4	86876205-86892422	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 14.0"	"Group enriched"	"Detected in many"	11	"Early spermatids: 140.3;Late spermatids: 253.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 1.8;cerebral cortex: 1.6;hippocampal formation: 3.3;pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.8;CAPAN-2: 4.6;hTCEpi: 3.8;hTERT-HME1: 5.5"									HPA057434	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057434: AB_2683438"	"unprognostic (2.01e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.76e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.69e-5)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.75e-2)"	0.6	0.2	0.1	0.7	1.8	0.0	2.1	0.4	1.6	1.7	0.3	0.7	0.0	0.3	1.0	0.4	1.0	0.4	0.0	1.4	3.3	0.2	0.6	0.5	0.9	0.0	0.2	0.4	1.7	0.5	0.0	2.6	0.2	1.4	1.3	0.3	0.1	0.6	0.3	0.1	4.2	0.1	0.6	0.3	0.8	0.2	14.0	0.0	0.0	0.8	0.0	0.4	0.5	0.8	0.1	0.9	0.3	0.0	0.0	0.1	0.0	5.8	0.5	0.3	0.2	0.0	0.3	1.2	2.9	0.8	0.7	0.0	0.3	4.6	0.0	0.5	0.0	0.1	2.6	0.4	2.6	0.7	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	5.5	0.1	0.0	0.2	0.4	0.1	0.0	2.7	1.8	0.2	0.8	1.2	0.0	1.4	0.0	0.0	0.9	2.4	0.7	1.8	0.8	0.4	0.0	0.5	1.1	0.0	0.0	0.6	1.0	0.3	0.4	0.2	0.9	0.3	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.4	1.6	3.3	0.2	0.2	0.4	1.4	0.0	0.0	0.0	3.4	9.5	4.4	4.8	18.1	12.7	0.0	0.0	0.0	9.8	0.9	0.0	0.0	140.3	7.1	10.2	0.0	0.0	1.6	3.8	3.9	0.0	2.4	2.8	1.6	2.9	4.3	5.4	253.3	4.9	1.5	1.7	0.0	7.4	6.3	0.3	9.3	3.2	0.0	6.8	6.5	3.1	3.7	7.0	8.9	8.1	2.2	5.2	3.9
C4orf46	"LOC201725, RCDG1"	ENSG00000205208	"Chromosome 4 open reading frame 46"	Q504U0	4	158666679-158672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047287, HPA052670"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047287: AB_2680011, HPA052670: "	"unprognostic (2.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.06e-3)"	4.5	4.6	4.2	5.4	5.6	16.7	4.3	6.4	5.5	5.4	4.5	10.7	2.4	4.2	7.2	5.1	5.5	4.2	4.0	5.1	4.5	3.7	3.9	2.7	4.8	7.7	7.3	3.5	6.4	5.8	2.2	3.1	6.3	5.3	4.1	6.1	7.2	4.1	3.4	2.8	4.1	4.4	5.7	6.6	5.4	4.3	25.5	7.3	26.3	6.1	5.8	7.2	5.3	5.0	4.0	5.1	4.9	4.9	8.6	5.8	3.4	6.9	4.2	10.4	15.3	4.6	4.8	5.2	11.9	8.2	13.8	12.1	3.7	6.3	12.5	1.9	6.0	5.1	3.9	9.0	6.1	18.1	17.0	4.6	18.8	4.8	5.0	1.6	14.3	10.4	2.8	2.2	11.2	4.9	4.6	10.0	12.6	8.2	31.5	18.9	3.7	27.2	12.9	7.1	4.5	5.6	19.8	5.9	5.5	4.2	3.5	5.7	17.3	5.2	4.8	4.3	5.4	4.0	11.5	5.3	21.5	9.8	11.9	9.8	7.2	9.1	15.7	5.4	12.8	8.2	4.9	4.7	4.5	4.9	3.9	3.7	4.0	4.0	4.8	5.1	3.9	5.5	5.8	1.6	8.6	4.9	4.4	4.1	3.4	4.2	5.6	6.4	5.5	4.5	3.7	7.3	3.5	5.3	7.3	3.0	2.6	10.0	5.2	21.4	5.6	3.6	0.0	1.4	0.0	1.8	3.9	7.4	6.6	3.2	0.9	4.5	2.6	0.0	2.6	9.4	12.3	4.9	6.9	2.1	8.0	9.5	7.5	4.3	10.8	1.5	4.4	4.4	18.6	27.1	4.0	4.2	4.0	2.9	5.6	2.1	25.5	6.5	8.2	32.0	14.2	13.7	2.7	7.7	3.6	4.1
C4orf48		ENSG00000243449	"Chromosome 4 open reading frame 48"	Q5BLP8	4	2041993-2043970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.4;brain: 37.2"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 378.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 38.6;NB-4: 27.7;PC-3: 83.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052447	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA		32000	Cytosol		"HPA052447: AB_2681837"	"unprognostic (7.96e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.17e-3)"	11.4	7.8	25.5	9.7	22.2	5.6	4.8	7.7	37.2	3.4	19.7	18.2	3.2	6.5	4.1	3.0	1.2	3.2	3.1	3.8	26.4	26.2	5.2	2.5	4.7	8.7	24.8	15.6	2.9	16.8	5.6	19.8	5.3	14.9	3.9	3.1	4.3	5.1	4.3	3.3	3.7	16.6	2.4	30.7	9.6	9.8	13.9	15.7	1.2	2.2	0.7	2.4	2.6	2.6	29.8	49.4	67.5	78.4	4.5	31.0	28.4	7.8	6.5	1.3	6.1	0.6	0.9	8.7	7.5	1.5	1.4	1.3	4.4	4.7	1.0	7.3	0.2	2.5	2.2	0.1	0.8	0.4	4.7	38.6	2.5	3.5	2.5	1.3	5.1	17.3	0.7	1.4	0.3	0.0	0.4	1.4	4.3	8.1	0.0	0.9	4.8	5.7	27.7	3.9	0.4	83.8	13.2	2.0	2.5	1.2	2.9	10.5	14.8	3.7	0.1	10.1	0.1	2.0	2.4	6.4	3.6	7.8	2.7	8.4	5.9	5.1	0.0	3.6	3.1	5.0	11.5	78.4	67.5	21.5	50.6	22.0	29.8	27.8	23.9	44.2	22.6	16.0	16.7	59.0	4.5	44.0	49.4	31.0	28.4	25.5	22.2	7.7	37.2	26.4	26.2	24.8	15.6	14.9	15.7	0.0	3.4	61.1	5.3	19.5	14.6	6.1	17.8	6.7	3.4	190.1	0.0	7.5	59.7	304.2	76.9	29.1	185.6	23.3	194.2	111.5	25.9	12.6	109.2	8.9	199.3	17.5	225.6	114.2	260.9	247.7	17.8	117.6	310.4	64.9	97.5	43.9	199.3	378.7	26.5	6.8	11.5	12.9	12.8	61.7	167.2	8.8	11.0	64.3	73.8	9.2
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.8"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 131.1;Kupffer cells: 223.6;Macrophages: 162.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 75.8"	"Group enriched"	"Detected in many"	42	"granulocytes: 75.8;monocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.0;HMC-1: 7.5;U-87 MG: 9.0;U-937: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	33.7	8.0	1.9	34.9	7.0	46.2	8.7	0.7	3.0	5.6	6.0	3.7	1.6	1.0	4.1	4.9	3.5	14.3	16.5	11.7	7.6	3.2	5.3	9.1	38.1	26.9	3.8	1.2	7.6	3.6	1.3	27.9	12.8	10.9	4.2	1.9	7.8	2.9	1.1	7.0	1.1	3.0	11.4	11.2	48.8	4.2	6.3	1.3	2.3	2.5	1.7	3.4	12.2	2.7	0.1	1.1	75.8	20.5	0.1	0.1	2.6	1.4	5.4	0.3	0.5	1.0	0.4	1.1	1.0	0.6	0.3	0.1	0.2	6.0	0.5	1.1	1.2	0.7	2.0	0.7	0.8	0.2	1.0	0.7	0.2	5.0	0.8	0.7	2.7	7.5	0.8	3.0	0.6	0.9	0.9	0.0	0.3	0.3	2.6	0.2	1.5	0.3	3.4	1.9	0.3	0.9	0.3	0.2	0.4	1.8	1.3	0.0	0.1	0.5	0.6	0.8	0.9	0.4	3.1	0.0	0.1	3.2	0.4	0.3	0.4	0.4	0.3	9.0	9.1	0.3	7.0	8.9	6.9	0.1	15.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	75.8	0.1	20.5	0.2	0.0	2.6	1.9	7.0	0.7	3.0	7.6	3.2	3.8	1.2	10.9	1.3	3.0	33.4	11.3	0.6	4.5	0.8	2.0	2.5	52.2	26.1	1.8	2.0	0.8	3.3	0.0	0.6	1.7	1.1	0.0	0.0	0.9	2.6	0.5	23.3	3.4	131.1	0.0	0.0	3.1	223.6	0.0	0.6	162.7	5.0	14.4	0.7	0.4	0.1	0.0	0.0	1.1	4.2	12.9	1.7	0.5	1.1	2.6	1.3	0.0	0.9	0.3
C5orf15	"HTGN29, KCT2"	ENSG00000113583	"Chromosome 5 open reading frame 15"	Q8NC54	5	133955502-133968787	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011951, HPA039165"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA011951: AB_2668584, HPA039165: AB_10795580"	"unprognostic (2.25e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.01e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-2)"	25.2	36.1	17.4	28.0	24.0	9.2	39.1	18.4	28.9	24.3	19.4	25.7	23.6	27.7	22.3	27.8	20.2	28.3	24.9	53.2	19.4	20.1	56.1	45.2	34.3	36.8	18.9	15.6	32.6	26.6	28.3	25.2	36.0	31.3	23.9	19.5	21.8	24.6	29.6	20.0	21.2	32.0	17.7	41.8	26.8	27.6	26.8	20.2	21.9	31.2	16.4	20.4	27.5	20.4	16.8	24.0	11.0	22.5	13.5	15.6	17.4	17.1	12.8	17.8	20.7	26.6	30.5	22.0	18.1	23.9	27.5	46.1	12.4	51.6	12.2	32.9	21.5	27.9	12.9	14.5	25.9	32.4	13.8	22.2	4.6	9.3	15.7	25.2	7.4	20.6	26.6	16.1	21.5	11.4	39.4	11.5	7.8	9.5	14.6	21.9	10.8	8.6	14.2	10.0	8.4	7.7	8.4	18.5	18.1	44.5	13.3	16.3	12.1	17.9	6.2	28.4	33.8	19.1	22.7	10.6	24.8	23.0	10.0	17.7	11.0	10.6	7.4	29.3	18.0	36.4	11.0	21.2	10.6	10.5	22.5	9.8	16.0	11.9	11.4	24.0	16.8	15.6	12.4	10.8	13.5	20.5	17.5	11.4	17.4	17.4	24.0	18.4	28.9	19.4	20.1	18.9	15.6	31.3	20.2	23.8	28.6	34.0	31.0	27.2	21.3	15.5	33.1	93.7	34.2	47.1	9.8	71.8	14.9	61.8	29.5	20.0	36.5	0.0	41.4	59.2	66.2	31.8	15.0	40.4	47.4	4.8	35.7	23.4	26.4	3.1	47.5	38.1	60.8	140.7	30.1	25.9	43.8	26.0	36.7	66.9	26.7	25.8	30.9	41.2	24.3	28.4	48.5	21.7	22.6	14.9
C5orf22	FLJ11193	ENSG00000082213	"Chromosome 5 open reading frame 22"	Q49AR2	5	31532266-31555058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 17.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043062	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA043062: AB_10795766"	"unprognostic (2.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.65e-1)"	"unprognostic (7.30e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	8.8	9.3	8.6	7.7	16.8	7.4	9.5	12.5	24.1	9.5	9.8	9.0	6.9	6.4	10.8	5.8	10.1	9.2	8.5	15.1	8.9	10.8	11.2	10.0	9.5	10.1	8.3	10.7	6.8	15.0	14.9	8.1	10.9	14.8	9.2	11.5	8.7	10.1	8.4	29.0	8.4	8.4	12.2	7.9	7.6	9.5	5.3	5.9	11.9	9.8	7.2	12.4	11.4	7.1	2.7	2.7	17.3	5.3	3.1	3.9	1.8	5.1	4.4	9.8	13.8	7.9	6.2	11.2	7.9	6.7	10.1	7.9	5.2	5.6	4.2	11.9	7.8	8.7	3.9	12.4	7.2	10.9	6.3	6.1	8.4	14.3	6.7	11.7	12.4	29.4	8.9	9.2	6.9	10.9	3.9	8.3	6.0	11.3	7.3	11.4	5.5	6.3	3.1	5.7	4.9	5.7	5.8	16.8	5.7	7.4	8.6	6.6	9.8	25.5	11.0	17.9	6.5	8.4	8.9	7.1	7.5	8.8	9.2	8.6	4.3	9.5	8.0	4.3	22.4	10.9	17.3	2.5	1.9	3.0	2.9	2.9	2.7	3.6	2.8	2.7	2.7	3.9	3.6	1.4	3.1	5.3	1.2	2.4	1.8	8.6	16.8	12.5	24.1	8.9	10.8	8.3	10.7	14.8	5.9	3.0	4.0	6.8	2.6	3.9	3.7	21.8	5.1	9.4	5.7	12.2	0.0	4.8	1.7	3.8	2.1	4.5	6.4	0.0	5.3	5.1	3.4	4.2	7.0	9.0	5.6	6.4	6.4	7.4	11.3	1.6	4.4	3.8	8.5	8.2	8.2	4.9	5.5	5.8	3.2	6.1	4.5	6.5	3.3	3.9	7.0	3.4	4.5	7.2	6.6	4.1
C5orf38	"CEI, IRX2NB"	ENSG00000186493	"Chromosome 5 open reading frame 38"	Q86SI9	5	2752131-2755397	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"salivary gland: 34.9"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 32.4;Distal tubular cells: 87.9;Melanocytes: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 38.2;HaCaT: 13.1;hTCEpi: 20.9;MCF7: 11.1;SiHa: 16.0;SK-BR-3: 15.0"									HPA073667			Approved	"Golgi apparatus,Vesicles"	"Secreted - unknown location"	NA	NA			"Golgi apparatus, Vesicles"		"HPA073667: AB_2686624"	"unprognostic (5.00e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-5)"	"unprognostic (4.08e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.67e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.84e-7)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.60e-2)"	8.3	0.5	4.5	0.6	7.6	0.5	16.3	10.4	3.0	0.6	1.1	1.5	9.8	0.7	0.7	6.8	4.1	0.6	0.6	2.4	6.0	7.0	6.6	0.5	19.4	1.1	10.5	2.0	0.5	3.8	5.0	2.6	4.3	14.8	5.9	0.7	3.4	34.9	3.9	0.9	10.6	0.5	0.5	12.2	0.7	11.2	1.5	4.7	0.0	5.0	1.6	2.4	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	6.9	0.0	3.0	2.1	38.2	4.9	3.9	3.3	2.9	1.9	0.0	0.0	0.0	0.9	0.0	13.1	0.7	3.8	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	20.9	0.8	2.7	0.0	0.0	0.0	0.0	0.0	0.8	11.1	0.0	0.1	1.0	4.3	0.0	0.0	1.4	0.0	4.3	0.0	1.0	0.0	16.0	15.0	0.0	2.3	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	7.6	10.4	0.3	6.0	7.0	10.5	2.0	14.8	4.7	11.9	8.3	0.0	13.3	21.9	0.0	0.6	0.0	1.4	6.8	12.2	0.0	32.4	87.9	0.0	0.7	0.6	0.0	0.0	0.2	12.9	3.0	11.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	0.0	0.5	37.1	0.0	1.3	0.0	0.5	0.0	0.4	0.7	0.6	0.0	17.8	0.4	0.9	18.7	12.2	0.0	1.2	2.4
C5orf42	"FLJ13231, Hug, JBTS17"	ENSG00000197603	"Chromosome 5 open reading frame 42"	Q9H799	5	37106228-37249428	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 59.6;Ciliated cells: 113.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036775, HPA036776"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA036775: AB_10669914, HPA036776: AB_2675308"	"unprognostic (3.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.09e-1)"	7.1	8.3	9.2	6.4	12.3	3.6	9.5	14.9	12.6	8.7	7.5	7.5	9.8	2.9	10.3	11.5	6.6	10.4	8.4	6.9	9.6	9.4	10.2	4.4	8.3	6.3	9.5	9.3	14.2	7.8	17.7	19.6	8.5	9.5	11.6	5.6	6.9	8.7	10.3	6.3	6.5	4.9	9.6	9.5	5.7	6.4	11.6	9.5	12.0	17.6	5.4	4.8	8.7	9.1	3.1	2.5	0.6	0.2	1.5	1.5	0.2	4.1	2.1	6.4	4.4	7.3	7.4	2.7	3.7	3.1	4.3	3.9	3.2	5.0	1.1	2.7	3.6	8.1	1.6	1.8	2.5	5.0	2.6	1.7	2.6	14.8	2.0	3.7	0.0	1.3	5.8	3.8	4.8	2.8	6.0	4.3	2.6	0.0	0.8	8.7	0.1	3.0	3.6	1.5	0.0	1.6	2.8	11.0	0.0	4.1	1.2	3.3	2.0	34.2	0.2	2.2	4.9	1.7	2.2	6.2	7.1	4.5	2.3	3.2	1.2	0.0	1.2	1.8	0.1	2.9	0.6	0.2	0.0	1.5	0.1	1.5	0.6	0.9	0.8	0.5	3.1	0.8	1.2	0.1	1.5	0.1	2.5	0.0	0.2	9.2	12.3	14.9	12.6	9.6	9.4	9.5	9.3	9.5	9.5	59.6	16.1	1.5	7.4	3.7	36.1	0.0	10.2	113.8	52.4	0.0	27.5	5.3	0.0	0.0	20.6	6.7	2.0	0.0	0.0	4.4	12.1	7.2	12.7	4.7	5.1	23.8	6.3	19.6	4.6	16.8	25.0	4.7	13.5	0.0	3.8	21.9	0.0	0.0	32.5	0.0	32.6	19.4	9.2	33.4	14.7	4.4	3.0	4.9	4.7	5.2
C5orf46	"MGC23985, SSSP1"	ENSG00000178776	"Chromosome 5 open reading frame 46"	Q6UWT4	5	147880726-147906538	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"salivary gland: 107.9;skin 1: 42.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 262.3;Late spermatids: 107.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.3"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058999, HPA079692"	Supported		Approved	"Nuclear speckles,Mitochondria"	"Secreted in other tissues"	NA	NA			"Nuclear speckles"	Mitochondria	"HPA058999: , HPA079692: "	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.26e-4)"	"unprognostic (9.75e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.75e-9)"	"unprognostic (6.48e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.79e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	5.2	2.0	0.1	0.6	0.1	0.1	0.1	0.0	0.3	0.6	0.2	0.0	0.2	3.0	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.0	0.1	4.3	0.4	0.4	0.0	0.2	107.9	0.4	0.6	42.7	0.1	1.0	0.1	0.1	0.0	6.5	0.2	0.2	0.1	1.1	0.6	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.1	5.1	0.0	0.0	0.0	4.6	25.5	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.1	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.5	0.0	8.7	25.5	0.0	0.0	1.8	0.0	0.1	0.0	12.4	262.3	0.0	0.0	0.0	2.9	0.1	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	107.1	1.7	0.0	3.3	1.0	0.0	6.7	4.3	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.8	18.1	1.1	0.0	0.0	0.1
C5orf63	"FLJ44606, YDR286C"	ENSG00000164241	"Chromosome 5 open reading frame 63"	A6NC05	5	127042558-127073492	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 32.7"									HPA043240	Approved	Approved	Approved	Mitochondria		NA	NA			Mitochondria		"HPA043240: AB_10962511"	"unprognostic (2.71e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-4)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	4.4	4.4	3.3	10.1	4.6	2.8	5.9	6.8	21.4	2.9	10.9	5.5	3.3	5.6	7.5	4.8	7.6	4.2	3.8	7.3	4.4	4.9	8.0	7.0	4.6	6.8	4.6	4.8	4.4	7.5	9.2	27.7	2.7	6.8	5.5	11.0	11.3	13.7	3.9	6.6	3.3	9.2	3.2	6.2	5.6	6.8	13.8	3.0	8.5	9.0	5.1	9.1	4.9	5.1	11.9	9.8	3.9	1.5	12.3	10.1	2.9	0.5	2.5	0.7	1.4	1.9	3.0	0.4	2.7	0.3	3.3	2.0	6.1	7.7	0.0	11.2	2.1	4.9	1.0	4.7	2.9	4.8	1.0	3.8	6.2	9.4	7.3	4.7	3.6	0.3	3.1	7.5	4.3	2.2	2.4	2.8	2.7	0.4	1.2	3.3	5.0	0.1	3.3	0.4	5.2	1.9	2.7	1.6	4.3	3.7	3.8	6.2	5.1	3.5	1.6	0.2	1.4	6.4	5.4	2.2	7.1	6.5	8.1	1.7	3.8	9.7	0.2	32.7	0.4	3.6	3.4	0.3	3.9	6.7	1.5	5.3	11.9	6.1	7.1	3.0	10.8	9.2	6.8	1.4	12.3	0.4	9.8	10.1	2.9	3.3	4.6	6.8	3.2	4.4	4.9	4.6	4.8	6.8	3.0	6.0	13.2	11.9	9.8	0.9	10.3	29.0	5.1	16.0	3.4	15.7	13.7	9.2	16.6	13.8	20.7	3.3	8.4	0.0	8.6	7.4	2.7	7.2	9.3	8.1	4.5	0.0	10.4	3.7	0.8	12.1	2.3	1.9	8.5	1.8	10.6	10.9	10.6	15.3	2.1	5.1	9.8	6.5	1.7	46.5	13.4	1.0	2.3	4.4	13.2	11.9
C5orf67		ENSG00000225940	"Chromosome 5 open reading frame 67"	F2Z3F1	5	56511567-56606232	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;kidney: 9.3;retina: 16.3"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 1.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"	"Region enriched"	"Detected in some"	5	"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9"	"Group enriched"	"Detected in some"	7	"CACO-2: 3.2;EFO-21: 9.3;U-266/70: 10.4"									HPA054214			Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoli	"Nucleoplasm, Vesicles"	"HPA054214: "	"unprognostic (7.28e-2)"	"unprognostic (1.41e-1)"		"unprognostic (2.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.69e-2)"		"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.62e-2)"		0.4	0.0	0.2	0.2	1.2	0.4	1.0	0.2	0.2	0.4	0.8	0.4	0.2	1.5	0.6	17.9	0.4	0.4	0.2	0.2	0.6	0.2	9.3	0.2	0.4	0.6	0.7	0.2	0.2	0.2	0.0	0.2	0.2	6.1	0.2	0.0	16.3	1.1	0.2	0.2	0.8	1.6	0.2	0.2	1.5	0.1	0.2	0.2	0.2	2.1	0.2	0.2	0.2	0.2	0.1	1.5	3.3	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.3	0.0	9.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.5	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	3.3	0.0	1.9	1.5	0.4	0.1	0.2	1.2	0.2	0.2	0.6	0.2	0.7	0.2	6.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C6orf10	TSBP	ENSG00000204296	"Chromosome 6 open reading frame 10"	Q5SRN2	6	32288526-32371912	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 28.6"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 313.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 1.1;U-2197: 1.3"									HPA047479			Approved	Cytosol		NA	NA			Cytosol		"HPA047479: "	"unprognostic (1.00e-1)"	"unprognostic (2.24e-1)"				"unprognostic (1.05e-1)"		"unprognostic (5.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"		"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.56e-2)"		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.1	0.0	0.0	0.0	0.0	0.0
C6orf106	"dJ391O22.4, FLJ22195"	ENSG00000196821	"Chromosome 6 open reading frame 106"	Q9H6K1	6	34587288-34696859	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 106.1;Late spermatids: 212.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034489, HPA034490"	Approved		Supported	"Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Nuclear speckles"	"Centrosome, Cytosol"	"HPA034489: AB_10669991, HPA034490: AB_2674186"	"unprognostic (3.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	16.5	10.7	12.5	13.7	12.7	7.5	15.2	22.5	18.7	9.5	22.4	6.3	6.7	9.1	9.0	15.5	13.7	8.6	15.9	60.4	11.2	10.0	23.9	35.2	16.9	10.1	14.4	6.8	11.6	12.0	14.1	7.3	11.1	9.0	9.0	9.5	10.3	12.6	16.1	66.3	10.4	14.9	12.3	7.8	9.1	10.0	20.7	8.2	5.8	15.7	26.6	13.3	13.4	11.4	8.6	4.1	18.2	7.3	5.7	9.2	4.7	28.7	13.1	13.1	19.2	31.4	17.3	15.4	19.6	23.0	23.5	29.4	25.7	13.5	33.0	14.8	19.4	32.4	28.7	38.0	16.5	29.9	46.4	14.8	27.6	15.3	24.5	30.7	23.1	30.8	11.6	34.6	23.5	21.5	16.0	18.5	13.8	31.0	14.1	13.2	17.2	16.2	16.0	12.0	46.9	11.8	12.7	16.7	17.5	18.3	28.9	15.6	12.2	29.3	14.3	28.8	28.2	18.1	19.5	18.6	19.5	14.9	20.3	19.5	20.1	45.6	25.6	7.0	20.6	22.5	18.2	3.5	7.3	9.1	6.3	4.8	6.7	6.6	7.2	4.1	8.6	3.6	5.7	4.5	5.7	7.3	2.2	9.2	4.7	12.5	12.7	22.5	18.7	11.2	10.0	14.4	6.8	9.0	8.2	26.8	40.4	23.1	14.9	22.1	17.6	73.3	25.5	33.5	25.0	7.0	19.6	11.7	11.6	14.3	106.1	21.5	21.1	0.0	18.7	6.9	9.9	26.1	25.4	53.9	13.4	12.7	24.1	9.2	17.2	212.0	18.1	18.4	15.1	29.7	17.2	9.4	28.1	19.0	20.8	26.9	18.0	6.5	18.6	9.9	14.0	28.2	18.1	17.3	12.7	30.7
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101118-42142619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 118.2;Glandular cells: 119.1;Pancreatic endocrine cells: 145.1;Urothelial cells: 193.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 20.6;CACO-2: 18.8;CAPAN-2: 15.6;OE19: 61.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	1.3	0.5	0.2	3.7	0.2	0.2	4.2	0.3	0.3	13.3	20.9	0.2	1.4	15.7	0.7	1.2	66.1	2.6	15.5	0.5	0.2	0.1	6.2	0.6	5.9	0.2	0.2	0.2	1.4	20.8	1.1	2.2	3.1	0.2	6.8	5.3	0.2	16.6	4.0	1.2	24.8	37.2	0.7	0.2	0.2	16.2	0.4	0.2	0.6	12.5	49.3	54.3	4.8	17.5	2.1	1.9	3.5	1.3	0.9	1.2	0.7	20.6	0.2	0.0	0.0	0.1	2.4	10.2	1.2	1.5	2.9	3.0	18.8	15.6	0.0	2.2	2.0	0.0	13.9	0.0	6.2	1.9	1.7	2.9	1.0	1.8	4.2	0.7	0.0	0.0	1.4	11.7	2.2	3.3	1.1	0.0	0.1	0.5	0.2	0.6	7.2	0.2	0.1	1.4	61.4	0.5	0.0	0.0	0.1	2.2	9.3	1.1	0.0	1.8	12.6	0.0	1.5	9.2	0.1	0.3	0.1	1.3	5.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.9	1.3	1.7	0.8	0.8	0.6	1.0	0.8	0.8	1.4	2.1	0.9	1.2	3.5	0.9	0.5	1.9	0.5	0.7	0.2	0.2	0.3	0.3	0.2	0.1	0.2	0.2	0.2	0.2	41.7	17.6	0.0	50.1	46.6	0.8	3.6	40.8	61.6	53.4	48.8	19.6	10.6	0.0	41.6	12.9	0.5	80.5	0.0	118.2	0.5	8.4	119.1	1.1	0.0	0.7	4.8	7.0	1.8	1.6	91.9	0.6	1.2	11.8	5.4	33.6	0.5	145.1	43.5	1.4	5.6	7.4	0.0	2.1	4.3	8.3	71.6	3.4	2.2	37.9	193.5
C6orf141	MGC46457	ENSG00000197261	"Chromosome 6 open reading frame 141"	Q5SZD1	6	49550646-49561907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.6;gallbladder: 18.9"	"Cell type enhanced"	"Detected in many"	16	"Basal keratinocytes: 36.7;Ductal cells: 32.6;Intestinal endocrine cells: 102.0;Suprabasal keratinocytes: 31.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"basal ganglia: 30.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 8.0;HaCaT: 8.8;HeLa: 7.0;hTCEpi: 6.9;PC-3: 12.0;T-47d: 7.5"									HPA036199	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA036199: AB_2675002"	"prognostic favorable (3.92e-6)"	"unprognostic (1.58e-1)"	"unprognostic (9.87e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.95e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-8)"	"unprognostic (2.33e-2)"	"unprognostic (5.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.43e-1)"	4.7	0.2	1.0	3.0	30.6	0.0	4.9	3.1	1.8	3.7	2.1	0.3	4.4	10.5	4.4	3.6	2.9	1.9	18.9	0.4	0.3	0.4	0.3	1.1	0.6	0.6	0.5	0.1	0.5	3.3	0.0	2.0	0.2	2.8	1.1	1.4	0.0	2.2	0.9	1.2	4.6	1.4	1.4	0.3	0.1	9.1	3.1	2.9	0.0	1.1	0.4	0.8	1.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	3.1	0.0	0.0	0.0	0.0	1.6	0.8	0.9	0.0	0.0	0.2	3.3	0.0	0.5	1.5	8.0	8.8	1.0	2.3	0.0	0.0	5.6	0.0	7.0	0.0	0.3	0.0	0.0	0.3	6.9	0.0	5.0	2.7	1.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.3	1.2	12.0	0.0	0.0	0.0	1.6	5.2	0.2	0.0	2.2	0.0	0.0	0.4	7.5	0.0	2.7	0.4	0.0	0.0	5.7	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	30.6	3.1	1.3	0.3	0.4	0.5	0.1	2.8	2.9	0.0	1.9	0.0	22.6	36.7	0.0	2.0	7.6	5.3	12.5	0.0	0.0	2.9	0.0	32.6	0.2	8.8	2.0	0.0	8.1	15.4	0.9	2.7	0.0	0.0	0.8	0.0	102.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	7.8	7.0	0.4	0.0	0.0	0.0	0.9	0.5	0.5	31.5	1.7	0.0	1.7	13.2
C6orf223	MGC45491	ENSG00000181577	"Chromosome 6 open reading frame 223"	Q8N319	6	44000580-44005958	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 23.6;lung: 9.4"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 2.7;Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 15.9;JURKAT: 18.7;RPTEC TERT1: 22.6;THP-1: 9.4"									"HPA035765, HPA046117"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA035765: AB_2797225, HPA046117: AB_10964082"	"unprognostic (2.94e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (7.06e-3)"	"unprognostic (2.34e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (9.38e-5)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.31e-1)"	0.1	0.4	1.1	1.3	0.9	0.5	23.6	0.2	3.0	0.7	1.4	0.0	0.0	1.8	0.8	4.7	0.1	0.2	6.9	2.9	1.1	0.8	4.9	1.4	9.4	2.8	0.1	1.2	0.1	2.4	0.1	0.8	0.2	0.9	0.2	0.7	3.4	3.1	0.1	0.3	0.5	3.1	0.2	0.0	0.7	0.2	0.3	0.0	1.0	2.1	1.1	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	1.6	0.0	0.0	0.2	0.0	0.3	0.0	18.7	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.2	0.3	0.0	0.1	1.9	3.4	1.2	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.2	3.0	1.1	0.8	0.1	1.2	0.9	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.6	0.5	1.4	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4
C6orf226	LOC441150	ENSG00000221821	"Chromosome 6 open reading frame 226"	Q5I0X4	6	42890265-42890816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA045350	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA045350: AB_10964640"	"prognostic favorable (1.93e-5)"	"unprognostic (2.21e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.17e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.13e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (4.63e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.82e-3)"	16.5	21.7	14.4	11.5	15.2	22.6	23.3	11.0	17.0	9.0	11.1	8.2	11.3	16.3	11.7	21.9	11.1	9.6	9.9	15.1	13.3	15.5	12.4	16.2	11.0	25.8	13.1	11.7	10.5	15.5	8.7	16.4	5.8	14.5	13.1	4.1	12.2	11.9	16.4	22.1	17.5	12.3	16.3	13.8	13.8	12.1	12.9	8.2	14.0	9.4	12.6	7.4	11.4	7.2	13.6	20.9	17.3	18.8	18.7	19.5	12.2	6.5	5.1	4.6	9.4	5.1	4.5	5.6	4.1	2.2	5.0	6.5	1.9	2.3	1.4	8.6	1.9	3.2	5.3	1.2	2.6	1.5	6.2	9.6	5.2	4.7	13.0	5.3	1.4	3.8	5.1	3.5	2.5	1.1	1.4	3.9	5.6	0.3	7.7	3.1	13.2	10.5	8.9	1.7	6.5	4.3	4.7	3.3	6.8	2.7	5.2	9.2	11.1	7.8	3.4	10.1	1.7	8.3	4.1	5.1	4.0	11.9	7.4	3.8	18.7	14.1	21.6	2.5	2.8	2.7	6.1	18.7	17.3	15.6	14.2	11.6	13.3	19.5	15.8	20.9	13.6	15.4	18.8	8.3	18.7	18.8	19.7	15.7	12.2	14.4	15.2	11.0	14.4	13.3	15.5	13.1	11.7	14.5	8.2	11.9	7.2	11.5	17.4	12.8	27.5	13.9	20.4	26.8	9.1	21.0	5.9	20.1	56.3	17.3	1.0	15.3	8.8	0.0	28.6	7.4	14.0	14.0	6.9	16.3	19.3	28.6	9.4	8.0	23.1	1.3	13.6	18.6	28.7	16.2	9.8	38.9	17.4	11.9	12.7	30.5	22.4	0.0	13.7	1.4	3.6	14.9	14.0	22.5	8.8	17.3
C6orf47	"D6S53E, G4"	ENSG00000204439	"Chromosome 6 open reading frame 47"	O95873	6	31658298-31660772	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;fHDF/TERT166: 6.4;HBEC3-KT: 9.0;HEK 293: 7.5;RT4: 8.7;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"							HPA045281	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA045281: AB_10961000"	"unprognostic (5.99e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.59e-3)"	7.3	9.1	5.4	7.7	7.1	3.4	14.0	7.7	10.2	8.1	11.7	8.3	9.8	2.6	10.8	18.4	14.2	8.9	13.9	13.6	5.1	4.9	10.3	9.2	14.3	16.0	6.1	4.8	11.7	18.7	2.7	8.0	8.7	6.0	9.0	10.0	9.7	9.2	10.5	11.8	23.3	14.8	15.4	6.3	13.0	10.2	4.0	5.3	11.5	11.3	10.9	11.8	11.5	8.3	3.5	1.5	1.7	2.1	0.0	3.0	1.1	0.0	5.8	0.0	4.3	7.3	1.0	0.0	0.5	0.4	1.8	0.5	0.0	0.8	1.9	4.6	6.4	0.0	0.0	0.0	9.0	0.2	0.1	7.5	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.9	5.0	8.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.8	6.4	0.0	0.0	4.2	0.2	0.7	2.0	0.0	2.5	0.0	0.8	1.6	3.0	2.1	0.1	3.5	1.1	0.5	0.5	0.0	2.1	1.9	1.7	0.0	0.0	1.5	2.1	1.1	5.4	7.1	7.7	10.2	5.1	4.9	6.1	4.8	6.0	5.3	6.0	10.4	11.6	21.5	22.2	16.6	1.2	17.8	0.0	5.7	12.2	7.9	15.4	21.6	19.9	0.0	10.8	34.2	0.0	25.4	12.5	13.0	20.0	11.5	7.8	16.4	6.4	6.4	12.9	13.5	0.0	15.0	15.3	8.5	18.0	18.2	14.3	22.8	25.9	20.5	18.2	12.3	32.3	15.2	0.9	8.3	23.5	19.9	20.0	22.3	44.3
C6orf52		ENSG00000137434	"Chromosome 6 open reading frame 52"	Q5T4I8	6	10671418-10694797	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 17.7"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 33.5;Early spermatids: 33.2;Late spermatids: 22.3;Spermatocytes: 32.4;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 8.7;NB-4: 7.7"					"Low region specificity"	"Detected in all"			HPA051142	Uncertain		Approved	"Nuclear speckles,Intermediate filaments"		No	No			"Nuclear speckles"	"Intermediate filaments"	"HPA051142: AB_2681359"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.50e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.65e-2)"	1.6	2.4	5.6	1.4	4.8	0.9	3.0	2.7	4.3	1.2	1.5	4.4	5.5	7.7	1.4	9.0	0.9	8.0	1.2	0.7	4.9	5.3	3.8	1.4	1.7	1.1	4.5	3.2	1.9	7.7	1.5	2.9	1.5	4.4	3.1	1.0	0.7	1.8	1.7	1.2	2.5	2.1	0.9	4.0	1.0	1.6	17.7	2.6	1.6	2.1	1.0	1.6	1.0	2.0	0.7	1.0	4.7	1.0	1.4	6.2	0.6	1.1	2.7	2.5	2.2	0.9	0.0	4.4	0.2	0.1	0.3	0.6	3.0	2.4	0.1	4.0	0.0	2.9	0.2	2.4	0.0	1.0	1.4	4.2	0.6	0.5	0.4	0.0	0.8	0.4	0.5	3.9	1.1	1.5	0.3	0.0	2.5	4.7	0.3	1.1	8.7	1.8	7.7	2.3	1.6	3.0	1.5	0.2	1.0	1.2	0.6	5.0	3.1	0.9	0.6	4.9	2.6	0.2	1.5	0.4	2.0	0.7	1.5	1.8	3.6	7.5	1.5	3.5	1.1	1.9	0.0	0.5	4.7	1.2	1.0	0.4	0.5	1.5	1.3	1.0	0.7	0.7	0.6	0.6	1.4	0.7	0.8	6.2	0.6	5.6	4.8	2.7	4.3	4.9	5.3	4.5	3.2	4.4	2.6	0.0	2.4	0.0	1.7	1.3	1.8	0.5	2.5	33.5	1.2	3.5	2.0	2.4	5.0	3.1	33.2	1.0	1.1	0.0	5.3	2.1	1.5	1.5	0.0	1.6	1.0	1.6	2.9	2.5	0.3	22.3	2.0	0.7	3.3	2.8	0.5	3.8	2.8	2.9	0.0	8.1	0.6	0.0	2.1	32.4	23.4	1.3	1.1	0.0	1.8	0.7
C6orf62	"DKFZP564G182, FLJ12619, XTP12"	ENSG00000112308	"Chromosome 6 open reading frame 62"	Q9GZU0	6	24704861-24720836	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 306.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030564, HPA030566"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA030564: AB_10600000, HPA030566: AB_10599425"	"unprognostic (2.07e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (4.16e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.01e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.62e-6)"	38.9	38.3	46.0	42.8	49.9	37.8	52.0	34.3	50.1	30.7	35.4	31.4	49.9	30.8	31.0	42.6	33.1	32.0	41.9	27.8	38.2	40.5	35.1	49.0	54.6	67.6	50.0	36.7	37.8	52.9	35.6	33.6	37.9	33.9	33.6	31.3	33.8	47.4	52.6	31.1	33.7	38.6	28.8	36.4	58.3	38.9	46.0	38.1	75.2	41.5	28.1	56.5	35.6	34.2	48.4	48.7	64.0	62.3	52.7	65.3	103.5	23.0	14.3	17.6	29.8	22.2	28.7	19.3	27.4	35.8	41.3	44.2	17.9	20.8	26.6	43.2	32.1	40.8	19.3	20.1	26.8	45.8	44.8	9.7	27.9	23.3	24.0	37.9	33.9	33.4	22.3	54.1	27.9	37.2	27.6	31.9	16.6	24.5	19.9	38.7	19.1	26.0	51.0	19.4	14.1	14.5	20.9	19.1	26.7	24.6	34.9	29.8	16.8	32.8	37.4	49.7	20.6	32.8	27.2	28.3	37.4	18.1	14.1	37.2	46.8	73.7	33.1	13.4	46.9	36.1	47.7	62.1	64.0	55.7	62.0	58.6	48.4	57.4	60.6	47.7	41.8	57.6	65.3	44.2	52.7	62.3	48.7	53.4	103.5	46.0	49.9	34.3	50.1	38.2	40.5	50.0	36.7	33.9	38.1	77.4	66.5	104.0	40.4	51.1	48.9	29.1	107.0	54.9	46.6	89.0	47.1	43.9	31.5	55.4	110.4	61.6	88.0	93.5	64.0	46.9	51.8	87.1	54.3	110.1	83.6	39.7	92.1	86.5	306.8	40.0	50.0	84.3	47.2	83.8	78.0	40.4	70.7	77.0	44.6	54.9	60.4	51.8	42.8	83.7	91.8	48.9	62.9	96.5	75.2	51.5
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 20.9;eosinophil: 12.3;neutrophil: 6.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 20.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: AB_2680837"	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	4.8	6.5	7.6	3.8	7.6	2.4	6.1	7.1	11.0	5.0	5.2	6.3	2.6	2.1	5.3	11.0	5.2	6.5	5.9	5.8	9.2	8.6	7.7	5.9	4.8	5.2	10.0	9.1	7.2	5.1	12.6	6.5	5.8	12.2	8.2	3.4	4.0	5.0	9.2	5.7	3.9	5.3	5.8	9.6	5.2	5.3	11.0	5.3	5.8	7.7	4.5	3.8	5.3	4.4	2.1	1.4	20.9	1.9	1.6	2.2	1.1	3.5	9.1	3.3	4.9	4.6	2.5	3.6	7.0	2.6	4.6	4.2	5.9	4.6	9.2	5.4	6.7	6.7	6.0	3.5	6.2	5.3	4.4	8.7	4.8	9.3	3.6	8.4	3.6	3.1	5.1	4.2	4.6	4.7	2.3	3.5	5.9	6.1	2.1	3.8	6.6	1.9	3.5	4.0	3.2	11.8	2.2	3.5	3.8	2.6	8.7	4.1	4.6	10.3	3.1	3.6	4.8	4.1	3.5	9.4	4.6	5.3	5.0	4.4	4.9	10.9	2.8	4.3	4.6	9.9	20.9	1.9	12.3	1.5	1.8	2.2	2.1	1.1	1.4	1.4	1.7	1.6	1.6	6.4	1.6	1.7	0.6	0.8	1.1	7.6	7.6	7.1	11.0	9.2	8.6	10.0	9.1	12.2	5.3	0.0	0.6	0.8	0.4	0.2	1.0	0.5	0.0	1.4	0.0	3.5	3.9	0.6	1.7	0.8	0.0	0.1	0.0	0.0	1.0	0.2	0.3	0.5	0.0	0.6	0.2	0.0	0.0	1.8	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.7	1.0	0.5	0.0	0.4	1.2	1.2	0.4	0.7	0.0	0.0	0.1
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590017-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: AB_2678218, HPA052175: AB_2681750"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	19.8	17.1	13.4	21.7	17.7	29.2	20.0	20.6	26.9	19.0	17.9	21.1	21.5	19.4	23.0	15.4	14.7	19.9	15.6	12.8	14.4	14.1	15.4	18.4	19.3	24.1	18.8	20.2	20.6	23.9	17.2	16.6	14.0	15.4	21.1	11.5	16.4	21.2	16.6	18.7	21.9	16.4	19.6	13.1	27.3	18.6	16.8	16.1	31.7	18.3	18.5	20.6	17.6	19.6	4.2	6.4	4.6	3.4	3.3	6.1	1.9	11.1	9.4	6.6	15.4	10.7	6.0	8.7	6.7	5.9	9.7	6.0	8.7	4.7	13.3	8.8	5.0	18.5	12.4	8.7	6.2	4.4	5.1	12.6	4.9	5.9	9.2	12.6	11.8	15.9	6.9	9.3	5.8	6.1	5.2	10.6	14.4	12.9	10.1	5.7	18.8	10.2	24.4	13.0	5.6	12.5	20.9	5.2	11.2	6.3	9.8	8.6	16.0	6.5	21.7	9.0	7.1	9.9	17.8	7.6	8.1	26.6	8.8	14.6	12.3	12.1	12.2	5.4	13.1	23.8	1.1	3.4	4.6	4.7	3.3	6.1	4.1	5.7	6.0	2.6	4.2	5.9	4.9	3.4	3.3	3.3	6.4	5.4	1.9	13.4	17.7	20.6	26.9	14.4	14.1	18.8	20.2	15.4	16.1	8.9	7.5	6.1	8.2	13.5	6.1	5.3	10.2	4.0	5.7	1.8	5.9	10.4	0.0	7.5	5.8	9.3	8.4	0.0	8.8	9.1	9.3	8.5	1.1	6.4	11.6	4.8	12.1	14.7	10.3	3.2	7.5	9.8	6.8	4.6	12.3	6.7	9.2	10.5	8.1	6.3	6.1	6.5	13.2	11.2	13.8	11.2	8.1	14.6	10.2	6.0
C7orf43	FLJ10925	ENSG00000146826	"Chromosome 7 open reading frame 43"	Q8WVR3	7	100154420-100158715	"Predicted intracellular proteins"			"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019359, HPA029463, HPA029464"	Approved		Enhanced	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			Vesicles	"Plasma membrane, Centriolar satellite"	"HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205"	"unprognostic (1.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.36e-3)"	"unprognostic (5.68e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.54e-3)"	7.0	10.4	10.6	23.0	11.3	12.2	12.2	24.8	23.2	6.7	14.0	9.4	13.6	16.2	9.6	10.8	12.1	8.4	10.5	6.4	12.8	13.9	12.3	12.9	19.0	21.4	10.8	10.6	5.7	11.6	18.7	14.5	21.6	14.6	10.2	13.5	8.8	13.5	10.8	10.1	28.1	16.4	6.9	6.0	25.8	14.9	26.8	6.9	17.6	12.2	7.4	14.0	8.5	7.8	2.1	0.7	5.2	1.7	0.5	2.6	1.0	4.8	6.3	7.5	12.6	4.7	2.5	8.4	9.1	7.2	6.4	4.6	4.9	5.8	6.2	8.4	6.9	9.9	9.5	3.5	7.3	2.5	11.6	6.8	4.6	7.9	4.3	5.6	5.8	21.8	5.1	5.0	6.2	4.8	4.6	5.5	6.4	10.1	11.3	8.3	15.2	13.1	12.4	8.3	9.1	9.2	7.9	3.4	6.9	5.5	5.6	9.5	10.1	8.2	24.0	4.8	5.2	4.8	7.0	7.6	12.7	10.8	16.8	7.0	16.9	15.9	6.3	7.1	8.0	13.4	1.7	1.0	3.5	2.0	1.6	1.4	0.9	2.6	1.8	0.7	2.1	1.5	2.2	5.2	0.5	1.7	0.6	0.2	1.0	10.6	11.3	24.8	23.2	12.8	13.9	10.8	10.6	14.6	6.9	0.0	3.2	2.9	4.0	4.9	7.5	1.4	0.0	4.0	1.2	7.0	0.0	4.8	0.0	4.6	3.5	3.1	8.8	0.0	7.3	5.9	2.3	5.6	0.0	1.5	7.0	11.1	4.1	5.5	5.6	2.5	2.0	5.4	0.0	9.0	5.1	5.0	9.1	10.1	1.1	2.1	5.1	6.5	2.3	14.0	5.9	9.5	16.2	4.4	5.3	4.8
C7orf50	"MGC11257, YCR016W"	ENSG00000146540	"Chromosome 7 open reading frame 50"	Q9BRJ6	7	996986-1138260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 250.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052281	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA052281: AB_2681784"	"unprognostic (1.64e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	22.5	14.2	37.7	14.9	29.4	9.7	14.9	16.4	32.8	17.0	17.5	15.5	19.4	12.8	20.1	18.8	14.8	21.0	20.3	28.7	28.1	21.4	21.7	14.2	16.1	21.2	22.4	23.0	21.6	79.5	12.3	39.3	13.9	17.3	21.7	7.9	25.9	25.1	28.8	68.4	8.2	13.8	34.5	19.1	19.5	25.1	19.5	9.8	6.0	20.8	18.0	16.6	17.2	10.9	32.3	41.5	76.3	27.0	8.1	20.6	22.7	41.6	26.7	8.9	27.2	4.8	6.9	18.9	18.7	9.3	16.7	14.2	18.8	17.9	12.5	12.4	12.0	21.2	26.5	10.7	22.6	3.3	11.9	21.6	11.4	18.9	25.5	19.7	14.5	7.9	9.8	18.1	15.5	14.3	7.3	11.4	10.6	20.3	12.0	7.4	60.2	6.7	38.9	21.9	18.8	39.7	19.8	3.3	20.7	7.8	11.6	20.6	29.5	15.4	18.3	25.2	6.2	43.9	26.8	13.1	9.7	43.2	28.9	24.5	10.3	13.8	11.4	19.5	24.2	30.6	3.2	27.0	76.3	20.6	26.2	14.6	23.6	16.9	17.4	41.5	32.3	13.2	15.3	3.0	8.1	25.0	12.0	19.7	22.7	37.7	29.4	16.4	32.8	28.1	21.4	22.4	23.0	17.3	9.8	32.8	64.7	92.5	33.2	20.6	74.8	64.4	40.8	56.2	30.7	62.8	17.7	65.3	250.4	73.5	7.0	40.5	17.6	23.3	74.9	70.2	42.1	41.1	54.3	32.5	140.0	54.0	87.1	33.7	63.1	3.4	34.2	61.3	67.4	120.8	45.0	82.9	55.6	17.3	41.8	101.0	58.5	25.8	67.4	18.1	41.5	21.3	38.9	48.4	57.1	30.7
C7orf55-LUC7L2		ENSG00000269955	"C7orf55-LUC7L2 readthrough"		7	139341360-139422599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 80.5;Melanocytes: 75.9;Smooth muscle cells: 39.2;Suprabasal keratinocytes: 78.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045663, HPA051631"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045663: AB_2679410, HPA051631: AB_2681558"	"unprognostic (2.54e-1)"	"unprognostic (5.27e-2)"			"unprognostic (3.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.68e-2)"		"unprognostic (4.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.42e-3)"		14.4	17.5	10.1	9.7	19.2	7.6	11.7	11.2	21.2	9.8	10.6	8.3	17.2	13.4	13.8	14.3	8.1	10.5	11.1	30.3	8.7	6.7	13.3	14.8	8.9	9.1	14.7	11.7	16.5	25.1	6.9	9.1	8.5	13.9	10.9	6.1	8.2	13.9	15.1	57.2	7.8	11.6	9.3	9.5	10.4	13.5	7.4	13.6	6.1	17.5	21.2	6.2	10.7	12.4	18.6	18.3	17.0	14.8	18.8	21.1	12.6	13.4	19.4	24.0	13.8	10.2	7.2	9.1	10.6	7.1	13.3	10.7	15.3	15.2	15.4	19.2	8.0	17.3	10.6	25.4	9.1	4.3	10.3	5.1	20.1	19.6	12.4	10.0	24.4	16.8	6.3	6.8	12.4	8.1	7.4	9.3	8.6	25.1	20.8	8.3	19.8	36.0	4.0	19.4	18.5	4.9	23.5	18.0	20.6	3.0	9.5	20.2	20.8	14.5	11.4	13.9	4.9	8.5	10.5	10.2	9.5	8.9	9.7	16.0	19.3	16.4	28.4	17.7	16.0	17.0	9.7	12.9	17.0	19.0	12.6	17.8	18.6	18.4	19.5	18.3	18.5	21.1	18.8	4.3	18.8	14.8	15.0	19.8	12.6	10.1	19.2	11.2	21.2	8.7	6.7	14.7	11.7	13.9	13.6	6.0	5.8	0.0	0.0	80.5	0.0	22.1	0.0	14.7	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	20.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	1.7	75.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.0	78.7	0.0	0.0	0.0	0.0
C7orf61	IMAGE:4839025	ENSG00000185955	"Chromosome 7 open reading frame 61"	Q8IZ16	7	100456615-100464271	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 80.4"	"Group enriched"	"Detected in many"	48	"Early spermatids: 438.3;Late spermatids: 271.6"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 22.2;NB-4: 8.1;TIME: 13.0"									HPA060395	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA060395: AB_2684274"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (7.70e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.39e-13)"	"unprognostic (9.54e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.24e-2)"	0.5	0.3	2.8	0.6	3.1	1.2	0.5	1.4	3.4	0.5	0.5	0.5	0.5	0.1	0.8	0.8	0.5	0.7	0.6	0.5	3.0	2.3	0.5	0.5	0.5	0.8	3.2	0.5	1.0	0.5	0.4	0.9	0.6	0.6	0.5	0.2	0.5	0.5	0.7	0.5	0.7	0.5	0.5	3.1	1.0	0.1	80.4	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.6	1.3	1.2	0.8	2.9	0.2	0.8	0.2	0.7	0.8	0.9	2.0	0.3	0.3	1.3	0.2	0.7	0.9	0.4	0.6	1.5	0.8	1.2	0.6	0.3	0.0	0.5	0.8	1.5	1.2	1.7	0.0	1.1	0.4	0.3	0.3	0.4	0.8	1.2	2.1	22.2	2.1	0.6	1.1	1.3	2.1	0.4	8.1	0.5	0.3	1.0	2.1	0.0	0.4	0.3	0.3	0.0	0.0	0.5	0.7	1.3	0.4	0.4	2.2	13.0	1.2	2.0	2.5	0.4	0.3	0.2	0.8	0.2	1.9	0.1	0.0	1.2	0.0	0.8	0.7	0.3	0.0	1.1	0.6	0.6	0.1	0.1	1.6	1.3	0.8	0.4	0.0	2.9	0.2	2.8	3.1	1.4	1.5	3.0	2.3	3.2	0.5	0.6	0.5	0.0	0.0	0.0	0.4	7.3	1.5	0.9	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	438.3	1.5	0.3	0.0	0.0	0.3	1.3	0.6	0.0	0.0	0.8	3.2	0.0	0.0	0.3	271.6	7.2	1.7	5.0	1.0	0.2	6.3	0.3	0.0	3.5	0.0	0.0	6.5	0.8	3.6	2.5	5.4	0.1	0.0	0.4	0.4
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330722-68819022	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;parathyroid gland: 19.9"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 16.0;Ciliated cells: 28.1;Club cells: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.5;HEK 293: 5.8;LHCN-M2: 5.1;RH-30: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: AB_2682030"	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	4.2	0.9	7.4	0.8	10.6	1.1	1.5	9.6	8.4	4.0	0.7	9.6	0.2	0.7	1.5	2.5	2.1	15.3	3.2	1.6	8.9	7.0	1.0	0.7	8.3	0.8	3.7	5.0	1.4	2.1	19.9	2.7	0.9	10.4	3.9	0.9	3.5	1.4	2.2	0.9	1.8	0.8	1.7	3.2	0.8	1.7	1.4	6.7	0.0	1.0	1.1	0.7	1.2	1.1	1.8	2.0	2.9	0.7	1.3	1.8	0.5	0.3	0.0	0.8	0.4	1.2	2.3	0.2	1.4	4.5	0.7	0.6	0.3	0.4	0.2	0.9	1.2	0.2	0.3	0.3	0.8	0.2	0.1	5.8	0.7	1.0	0.4	0.3	0.1	0.5	0.1	0.6	0.8	1.6	0.3	0.1	0.7	0.3	1.0	5.1	0.6	0.1	0.5	2.6	0.0	0.1	0.2	5.4	0.1	0.6	0.4	1.1	0.2	0.3	0.3	0.0	0.6	2.6	0.2	0.1	1.0	0.6	3.4	0.2	0.8	0.0	0.1	0.4	0.3	0.8	2.1	0.7	1.2	1.4	0.3	1.1	1.0	1.2	1.1	0.3	1.8	1.5	1.8	2.9	1.3	0.5	2.0	0.8	0.5	7.4	10.6	9.6	8.4	8.9	7.0	3.7	5.0	10.4	6.7	14.9	16.0	0.0	0.6	1.4	1.2	1.2	0.0	28.1	6.8	0.0	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.2	0.9	1.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.3	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.6	0.0	1.0	0.2	0.2	0.6	0.3	0.0	0.0	0.4
C8orf37	"BBS21, CORD16, FLJ30600, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244919-95269201	"Disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease mutation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	4.8	5.6	7.9	5.8	9.9	2.4	6.4	9.8	8.0	6.7	3.1	10.5	2.9	2.6	6.5	8.6	3.3	10.5	4.0	7.0	8.7	7.1	6.6	4.9	4.3	5.6	7.4	6.9	13.0	3.8	10.1	9.9	4.9	7.9	5.6	2.8	4.6	4.3	7.1	2.9	4.2	3.3	6.2	9.2	4.4	3.2	4.5	9.5	3.8	6.7	1.6	5.1	4.0	4.4	3.9	1.9	2.3	1.4	2.7	2.3	0.8	4.0	6.7	5.5	2.9	1.9	5.2	1.6	1.8	4.1	2.3	3.1	1.0	9.0	8.2	4.3	3.0	5.8	3.4	2.3	4.6	5.1	2.6	2.1	6.4	4.0	3.0	2.2	1.3	3.6	5.2	2.2	2.7	7.7	6.0	3.5	4.9	3.3	4.8	3.0	3.1	6.8	1.6	1.7	8.3	4.6	3.6	2.9	2.1	5.1	1.8	5.4	5.2	3.7	0.7	3.1	4.3	6.4	1.2	2.9	2.9	3.7	2.5	1.8	4.4	4.2	5.5	5.6	3.1	3.6	1.3	1.4	0.6	1.2	0.9	2.1	1.9	1.4	1.3	1.9	3.9	1.4	2.3	2.3	2.7	0.7	0.9	0.5	0.8	7.9	9.9	9.8	8.0	8.7	7.1	7.4	6.9	7.9	9.5	3.0	1.6	0.8	3.1	0.8	1.6	3.9	0.0	9.4	4.5	7.0	2.0	2.0	6.6	1.5	8.2	1.0	0.0	0.0	2.4	2.4	2.2	1.7	0.0	3.2	1.2	3.2	0.0	1.3	1.6	8.0	2.8	1.1	1.7	2.8	0.0	5.7	1.0	0.0	2.8	3.7	3.6	0.0	2.1	4.4	3.6	1.6	0.7	0.0	0.4	1.0
C8orf46	MGC33510	ENSG00000169085	"Chromosome 8 open reading frame 46"	Q8TAG6	8	66460003-66518524	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 51.7"	"Cell type enhanced"	"Detected in some"	10	"Ciliated cells: 1.4;Hepatocytes: 2.4;Leydig cells: 2.6;Peritubular cells: 1.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 6.5;LHCN-M2: 4.0;SK-MEL-30: 4.4;T-47d: 5.6;WM-115: 5.6"	"Group enriched"	"Detected in many"	8	"amygdala: 164.2;basal ganglia: 80.3;cerebral cortex: 305.1;hippocampal formation: 240.3"	"Low region specificity"	"Detected in all"			HPA075134			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA075134: AB_2686736"	"unprognostic (6.87e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-4)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.53e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.91e-2)"	1.2	1.4	14.9	1.2	16.6	1.2	1.2	1.8	51.7	1.6	1.2	16.3	0.0	1.0	1.6	1.3	1.5	1.2	1.7	2.2	39.1	8.3	1.3	1.2	1.4	1.4	13.8	19.4	1.1	1.8	1.1	0.2	1.1	10.9	2.2	1.3	0.0	1.7	5.3	3.1	1.4	1.4	2.0	17.9	1.2	1.1	1.4	10.0	0.0	1.3	0.0	1.1	1.5	0.2	0.0	0.7	0.0	0.0	0.0	0.7	0.1	3.1	0.2	0.4	2.0	0.0	0.1	0.0	0.3	0.3	0.5	0.1	0.0	3.0	0.0	0.3	3.0	6.5	0.1	0.0	0.0	2.2	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	4.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.0	1.3	0.1	0.5	0.0	0.0	0.0	4.4	0.4	5.6	0.0	0.0	0.4	0.7	0.2	2.7	0.1	1.1	0.0	1.1	0.1	5.6	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.9	16.6	1.8	26.7	39.1	8.3	13.8	19.4	10.9	10.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.4	0.1	0.0	0.0	0.6	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0
C8orf48	FLJ25402	ENSG00000164743	"Chromosome 8 open reading frame 48"	Q96LL4	8	13566843-13568287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.7;testis: 17.3"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 23.2;Late spermatids: 38.1;Spermatocytes: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.1;U-87 MG: 11.2;WM-115: 8.4"					"Low region specificity"	"Detected in all"			"HPA026107, HPA027440"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA026107: AB_10600765, HPA027440: AB_10601678"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.07e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.84e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-3)"	"unprognostic (7.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.70e-2)"	2.7	0.7	3.6	1.2	11.7	0.1	3.7	0.8	2.9	3.0	1.3	0.9	0.2	0.9	2.3	6.0	1.4	3.9	2.5	4.0	2.8	1.6	4.1	1.7	2.4	1.2	1.7	3.0	2.1	1.2	0.5	1.5	2.8	2.8	2.2	1.0	2.4	2.2	1.0	0.9	2.7	0.9	1.9	1.1	1.1	1.9	17.3	1.5	0.0	8.9	0.3	0.5	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	1.7	0.0	5.9	5.9	0.0	5.2	5.8	2.8	4.8	0.0	0.0	0.0	0.0	2.7	13.1	0.6	0.2	1.0	5.5	0.0	0.5	0.5	0.0	0.0	2.1	0.0	0.9	1.9	3.5	3.8	1.0	0.7	3.6	0.0	0.1	0.0	7.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	3.1	0.0	0.2	5.8	2.0	0.0	0.0	1.6	4.9	4.8	5.7	4.6	0.0	0.0	0.0	11.2	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	11.7	0.8	2.9	2.8	1.6	1.7	3.0	2.8	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	1.4	1.2	0.0	2.0	0.0	0.0	2.6	23.2	0.5	0.0	0.0	1.0	0.0	3.1	0.0	0.0	0.5	0.1	0.0	0.0	1.3	0.0	38.1	4.6	0.0	5.0	0.0	0.0	0.9	0.3	0.0	2.8	2.4	4.3	6.5	4.1	9.9	2.0	0.4	0.0	0.0	0.0	0.1
C8orf58	FLJ34715	ENSG00000241852	"Chromosome 8 open reading frame 58"	Q8NAV2	8	22599601-22604150	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 26.7;Sertoli cells: 25.8;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA024667, HPA028286"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA024667: AB_1845783, HPA028286: AB_1845784"	"unprognostic (8.88e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.72e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	12.3	5.4	6.0	6.3	6.2	4.4	14.5	12.9	7.1	10.3	5.9	6.5	5.8	4.0	10.9	7.6	8.6	7.3	8.9	6.7	6.3	3.6	9.4	5.7	9.2	7.4	4.2	5.9	10.5	5.5	5.8	4.4	28.5	5.3	12.3	3.9	10.2	7.1	7.1	8.2	13.0	6.2	7.3	3.3	19.7	4.9	11.6	4.2	4.0	7.9	6.5	5.7	6.3	7.6	1.8	0.5	3.7	1.6	0.1	2.3	0.6	4.6	7.0	19.5	11.2	5.4	6.2	5.3	10.5	8.9	13.2	9.5	1.3	4.0	0.9	5.1	11.5	9.1	4.6	3.5	9.9	8.5	1.4	1.6	2.7	6.8	0.7	9.5	0.9	4.3	8.9	8.5	7.9	5.0	12.0	7.6	3.7	1.7	1.4	10.4	3.3	2.0	5.0	11.9	3.8	4.7	3.4	4.9	1.0	8.0	4.3	2.0	6.3	5.2	3.7	11.8	21.2	3.5	2.2	10.5	14.4	11.7	9.9	9.6	1.7	1.0	0.9	7.4	2.0	11.7	0.0	0.9	3.7	0.7	1.6	0.4	1.7	0.4	1.0	0.5	1.8	2.3	1.8	0.0	0.1	0.0	0.5	0.0	0.6	6.0	6.2	12.9	7.1	6.3	3.6	4.2	5.9	5.3	4.2	3.0	1.3	5.0	2.9	9.2	2.5	1.6	0.0	2.7	4.5	0.0	0.0	22.8	0.0	10.1	0.9	10.5	3.0	0.0	6.0	26.7	6.2	2.7	1.1	0.6	8.1	1.6	4.1	16.5	4.4	2.2	8.1	3.6	3.3	11.8	1.9	6.3	9.7	3.1	6.0	1.6	4.1	25.8	6.6	0.7	2.4	8.4	46.7	2.5	1.9	2.4
C8orf59		ENSG00000176731	"Chromosome 8 open reading frame 59"	Q8N0T1	8	85214076-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044805, HPA071903"			Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: AB_2679095, HPA071903: AB_2686469"	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	28.1	28.2	25.3	25.3	21.9	33.0	46.1	18.9	26.5	33.0	38.4	12.6	36.3	28.1	32.0	45.5	44.8	28.7	25.8	41.5	20.6	24.1	32.3	47.1	20.8	30.7	26.3	27.2	45.1	35.1	19.5	36.0	27.7	24.4	35.5	27.7	14.7	37.8	36.2	43.9	24.8	37.1	33.7	27.0	32.2	36.9	16.7	25.7	39.1	43.5	53.6	32.0	39.1	35.2	33.3	42.7	21.3	25.3	36.5	38.0	23.9	38.9	19.9	29.6	19.2	18.4	35.7	23.2	26.0	25.0	30.4	30.0	23.2	33.8	9.7	21.5	17.2	28.5	27.2	20.5	28.5	34.3	27.4	22.4	57.6	18.8	34.2	21.8	21.6	26.1	30.2	33.9	19.6	24.8	33.1	25.8	35.0	25.8	24.0	25.2	30.7	47.7	40.6	8.5	88.2	34.8	20.4	24.8	44.2	29.5	25.0	10.0	21.5	19.7	32.4	35.7	37.3	37.3	32.3	19.7	19.4	40.7	21.5	24.6	27.9	32.7	45.8	38.7	27.7	21.5	21.3	20.5	13.4	24.7	25.3	29.5	33.3	32.7	30.1	34.8	29.9	38.0	36.3	5.1	36.5	21.5	42.7	32.1	23.9	25.3	21.9	18.9	26.5	20.6	24.1	26.3	27.2	24.4	25.7	80.4	65.2	124.2	47.1	48.2	25.9	26.3	86.6	147.2	103.5	34.9	9.8	86.5	56.3	152.0	93.6	67.1	76.6	46.7	240.4	102.1	84.3	40.2	75.1	136.0	90.6	22.3	36.9	108.6	132.2	20.6	173.2	92.3	54.0	180.3	112.7	58.4	213.9	84.2	122.0	90.6	33.5	155.2	88.6	128.1	91.8	40.0	64.3	104.7	101.8	39.3
C8orf82	MGC70857	ENSG00000213563	"Chromosome 8 open reading frame 82"	Q6P1X6	8	144525733-144529132	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034331	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB034331: AB_1565393"	"unprognostic (3.56e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.60e-2)"	"unprognostic (6.31e-3)"	"unprognostic (1.95e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.09e-2)"	"prognostic favorable (1.70e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-3)"	11.1	11.4	7.9	10.6	8.1	4.2	16.1	8.6	11.6	14.2	19.4	7.8	8.1	16.8	10.2	10.4	13.3	9.3	14.7	16.3	8.1	6.1	12.7	29.1	7.9	8.9	8.8	7.8	13.4	17.5	19.7	10.2	7.1	6.3	32.8	6.4	8.2	18.0	11.4	12.2	8.9	17.7	7.4	5.1	11.0	12.2	12.7	8.0	8.5	14.8	10.3	7.0	12.4	9.6	1.7	1.5	1.7	2.1	0.9	1.2	0.3	3.6	9.4	5.6	4.5	2.3	2.0	4.7	4.0	2.2	2.2	2.2	4.6	6.3	6.5	6.5	2.5	1.9	4.5	1.2	1.3	0.8	4.9	14.6	12.6	5.4	8.5	2.4	1.9	6.1	3.0	3.1	1.4	1.4	3.6	1.5	3.7	10.2	3.3	1.6	19.5	4.7	7.7	3.0	5.5	26.6	5.4	1.9	3.1	3.4	5.6	19.2	15.6	6.1	4.4	3.9	2.0	8.1	3.9	8.1	4.3	16.7	4.7	2.8	2.4	1.5	5.1	5.7	2.4	4.1	0.8	2.1	1.7	0.6	0.8	0.7	1.4	0.2	0.6	0.9	1.7	0.6	0.7	0.0	0.9	1.7	1.5	1.2	0.3	7.9	8.1	8.6	11.6	8.1	6.1	8.8	7.8	6.3	8.0	3.0	8.6	8.8	41.8	14.2	30.4	14.5	15.3	0.0	1.2	15.7	13.7	26.9	117.7	3.8	12.7	6.7	36.0	0.0	6.5	29.6	15.4	46.1	5.7	63.1	16.7	27.0	32.8	8.0	12.0	15.6	22.5	16.8	32.1	2.8	28.3	26.3	6.6	17.3	19.1	83.0	30.6	32.3	25.4	30.2	18.1	18.2	21.1	11.4	31.0	38.8
C9orf116	"MGC29761, PIERCE1, RbEST47"	ENSG00000160345	"Chromosome 9 open reading frame 116"	Q5BN46	9	135495181-135501734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 63.3;testis: 47.8"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 473.8;Early spermatids: 387.4;Late spermatids: 493.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 22.6;T-47d: 23.4;U-2197: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021439, HPA065287"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021439: AB_1845799, HPA065287: AB_2732732"	"unprognostic (9.02e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (3.53e-5)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	1.5	7.2	8.0	1.0	9.2	1.0	2.2	1.5	6.2	4.1	1.1	6.2	8.2	1.1	3.3	22.1	1.0	63.3	2.7	1.5	9.6	9.3	7.8	1.5	9.8	0.9	4.9	4.9	9.3	4.5	3.3	7.6	1.5	19.9	2.0	1.3	1.7	2.0	5.0	1.4	1.2	1.0	1.3	2.6	1.0	1.8	47.8	2.6	0.1	6.7	0.2	1.2	2.2	0.3	1.7	0.9	0.1	2.6	1.8	4.2	1.1	5.9	10.3	4.5	7.1	2.0	4.3	0.9	4.0	2.9	4.9	3.3	3.9	6.0	1.0	5.4	2.7	2.7	4.1	5.0	2.2	4.2	0.3	4.6	0.0	11.4	11.9	5.6	0.8	2.8	3.0	1.7	2.4	0.8	4.0	2.3	4.8	5.5	0.8	2.3	22.6	3.0	1.0	9.6	9.3	12.1	4.7	2.2	3.7	11.6	4.3	4.4	4.7	5.7	2.4	0.6	2.2	23.4	1.0	1.1	2.8	3.7	24.2	1.5	2.7	6.6	0.9	8.4	0.3	0.8	0.1	2.6	0.0	1.9	1.6	4.2	0.7	1.3	1.4	0.9	1.7	2.4	1.8	0.0	1.8	0.4	0.4	1.6	1.1	8.0	9.2	1.5	6.2	9.6	9.3	4.9	4.9	19.9	2.6	8.9	5.6	0.0	2.5	0.8	4.6	1.4	7.6	473.8	29.6	14.0	13.7	9.7	10.0	23.1	387.4	1.5	0.7	0.0	7.0	1.8	2.7	2.3	1.1	1.6	3.1	3.2	1.2	0.6	1.9	493.5	7.5	1.9	0.0	3.6	1.0	6.5	9.2	1.4	7.1	40.0	15.4	0.0	1.0	87.1	20.2	0.3	3.8	0.0	1.7	1.4
C9orf131	MGC41945	ENSG00000174038	"Chromosome 9 open reading frame 131"	Q5VYM1	9	35041095-35045991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 46.6"	"Group enriched"	"Detected in some"	32	"Early spermatids: 99.2;Late spermatids: 26.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.0;RT4: 14.0"					"Not detected"	"Not detected"			HPA022029			Approved	Mitochondria		NA	NA			Mitochondria		"HPA022029: AB_10960628"	"unprognostic (1.10e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.90e-4)"	"unprognostic (4.19e-3)"	0.2	0.1	0.2	0.2	0.3	1.3	0.3	0.6	0.3	1.0	0.2	0.2	0.2	0.0	2.2	0.8	0.2	0.2	1.4	0.2	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.3	0.7	0.2	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.8	0.5	0.2	0.2	0.2	0.2	0.2	46.6	0.2	0.2	0.3	0.2	0.2	0.3	0.2	1.0	0.1	2.7	0.5	0.9	1.4	0.0	3.4	0.1	0.3	0.8	0.7	0.0	1.0	1.0	0.0	0.0	0.0	0.9	1.8	0.7	0.3	0.0	1.2	2.2	0.0	0.0	0.4	0.3	0.5	1.2	4.0	0.9	0.0	0.4	1.2	0.0	0.5	0.0	0.0	0.0	0.5	1.4	3.4	2.4	0.0	0.5	0.7	1.8	0.6	1.0	0.0	0.0	0.3	0.0	0.3	14.0	0.3	0.0	1.2	0.0	0.5	0.6	0.8	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.9	1.3	0.3	0.5	1.5	2.7	0.5	0.0	0.5	0.0	0.0	0.5	0.4	1.4	0.0	1.0	0.5	0.8	1.3	0.9	0.0	0.1	0.1	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	99.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	26.1	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.3	0.0	0.5	0.0	0.0	0.0
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7"	"Cell type enhanced"	"Detected in many"	16	"Mucus-secreting cells: 113.3;Undifferentiated cells: 69.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	8	"OE19: 57.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA050769	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.4	0.0	0.4	1.7	0.4	0.0	6.1	0.4	0.4	5.3	16.1	0.5	10.5	9.1	1.0	0.4	2.4	1.5	7.1	0.4	0.4	0.0	0.4	0.5	3.6	0.4	0.4	0.4	0.4	3.9	0.0	0.8	0.4	0.4	11.6	20.9	0.4	34.3	17.0	0.4	3.8	7.0	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	1.6	5.2	1.3	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	57.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	3.7	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	8.9	12.3	0.0	2.5	0.2	0.0	0.2	22.9	5.3	10.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	7.7	0.0	9.9	0.0	0.2	16.2	0.0	0.9	0.1	0.0	24.9	0.0	0.0	0.0	0.0	0.2	10.1	0.0	113.3	0.0	5.3	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	69.7	4.7
C9orf153	bA507D14.1	ENSG00000187753	"Chromosome 9 open reading frame 153"	Q5TBE3	9	86220265-86259657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 24.5"	"Group enriched"	"Detected in some"	70	"Early spermatids: 170.5;Late spermatids: 185.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 4.5"									HPA079466			Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Nuclear bodies, Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA079466: "	"unprognostic (2.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.30e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-6)"	"unprognostic (9.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.10e-1)"	0.1	0.2	0.1	0.1	0.1	2.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.1	0.0	0.6	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	24.5	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.5	0.6	0.2	0.8	1.1	0.0	0.6	2.2	0.0	1.2	0.1	1.3	1.6	1.2	0.0	0.0	0.8	0.0	2.5	2.4	0.9	2.3	1.7	0.5	1.2	2.0	1.6	0.6	1.0	0.1	2.8	0.4	0.1	0.4	1.1	0.3	4.5	1.5	0.0	0.0	1.0	2.8	0.0	1.9	1.7	0.1	0.8	0.4	0.7	0.1	1.6	0.4	0.8	3.0	0.3	0.0	0.3	0.1	0.0	0.0	0.4	1.1	0.0	0.6	0.2	0.9	2.1	0.2	0.8	2.0	0.3	0.7	0.1	0.5	1.0	0.6	0.2	0.1	1.1	0.0	0.4	0.2	0.1	0.0	0.0	0.4	0.8	0.3	0.0	0.8	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	170.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.9	2.6	0.0	1.7	0.0	0.0	0.6	0.1	0.0	0.7	0.0	0.0	0.0	0.2	1.8	1.3	0.1	0.1	0.0	0.0	0.3
C9orf16	"EST00098, FLJ12823, MGC4639"	ENSG00000171159	"Chromosome 9 open reading frame 16"	Q9BUW7	9	128160260-128163928	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 98.6"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 689.6;Urothelial cells: 732.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA020725	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA020725: AB_1845816"	"unprognostic (8.85e-2)"	"prognostic favorable (7.60e-4)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (6.42e-3)"	"unprognostic (3.98e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (8.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.09e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.00e-3)"	"unprognostic (2.48e-2)"	19.6	83.4	70.6	13.9	34.4	38.7	13.1	16.9	59.7	16.3	17.0	12.1	13.3	16.9	12.3	10.3	16.8	16.9	18.7	22.7	98.6	20.3	16.0	12.2	13.5	23.9	27.4	22.1	14.2	35.0	4.2	14.7	9.5	19.1	15.6	6.9	16.1	27.0	25.4	14.0	31.4	15.4	15.1	12.1	24.3	20.1	12.1	9.1	33.2	13.3	13.7	16.6	31.0	16.4	52.3	43.6	58.3	37.1	45.5	73.7	42.0	9.2	12.4	6.4	39.4	4.8	10.9	16.5	8.8	7.4	7.4	5.9	6.1	24.4	10.4	18.2	3.7	1.5	26.2	1.9	7.1	0.3	19.7	15.9	7.3	14.8	12.3	8.7	8.0	18.9	8.2	10.6	3.8	1.9	5.7	10.5	29.5	19.4	20.8	3.9	54.3	27.2	35.2	15.4	19.0	23.5	25.9	4.2	43.3	9.3	8.0	17.7	26.3	15.8	14.1	18.4	1.7	15.8	7.5	12.5	7.6	18.4	9.6	7.5	20.4	14.8	15.6	21.5	11.3	7.6	53.4	37.1	58.3	50.1	30.4	54.0	50.7	58.0	48.8	40.7	52.3	46.6	47.1	42.3	45.5	25.6	43.6	73.7	42.0	70.6	34.4	16.9	59.7	98.6	20.3	27.4	22.1	19.1	9.1	6.0	3.7	150.4	291.1	175.2	71.1	28.3	124.9	13.4	20.5	336.8	13.7	81.7	261.9	196.7	136.2	148.4	198.7	23.3	311.7	68.6	88.9	227.8	162.3	95.5	224.6	17.5	391.5	115.4	207.4	689.6	71.1	196.6	212.6	198.4	171.2	31.1	204.1	127.0	78.1	126.0	32.1	71.1	160.2	36.3	46.0	204.0	50.5	263.3	158.6	732.8
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397832	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 47.6;fallopian tube: 76.2;testis: 23.7"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 1197.9;Early spermatids: 656.4;Late spermatids: 2140.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.5	1.2	12.7	1.0	20.0	0.8	1.0	1.5	10.8	3.3	1.6	12.2	0.0	2.1	1.3	7.2	1.1	76.2	1.0	4.8	11.2	11.0	1.9	1.0	10.3	0.9	5.3	6.4	6.2	1.5	0.8	3.1	0.9	47.6	1.5	1.3	0.0	2.0	1.1	1.6	1.2	4.3	1.2	2.0	0.9	1.4	23.7	3.0	0.0	1.2	0.1	1.0	0.9	0.0	0.6	0.4	0.1	0.1	0.9	3.6	0.5	0.8	0.0	1.6	0.6	0.3	0.0	1.3	0.6	0.6	0.3	1.4	1.4	0.0	0.3	0.6	0.0	0.7	1.2	0.5	0.2	0.0	2.3	1.3	0.0	1.6	4.1	0.0	0.1	2.0	0.3	0.2	0.4	0.0	0.5	0.6	1.0	0.0	0.6	0.2	0.0	1.3	0.9	0.6	1.2	0.9	0.6	0.1	0.1	0.5	0.1	1.6	0.6	0.0	0.4	0.1	0.1	1.1	0.0	0.0	1.3	1.0	0.5	0.9	2.5	1.4	0.4	1.4	0.2	2.5	0.0	0.0	0.0	1.1	0.1	0.0	0.6	1.3	0.4	0.4	0.0	3.6	1.1	0.1	0.9	0.0	0.0	1.7	0.5	12.7	20.0	1.5	10.8	11.2	11.0	5.3	6.4	47.6	3.0	6.0	13.7	0.0	2.6	1.9	1.0	34.3	2.5	1197.9	128.5	7.0	0.0	0.5	61.3	0.5	656.4	1.0	15.5	0.0	1.3	0.2	0.5	2.8	8.1	2.9	0.4	0.0	11.6	1.8	0.3	2140.7	9.8	2.5	0.0	0.0	9.8	1.2	0.3	6.2	6.7	5.7	0.8	32.3	0.3	10.8	3.8	0.9	0.5	0.0	16.4	1.7
C9orf3	"AOPEP, AP-O, APO, C90RF3, FLJ14675"	ENSG00000148120	"Chromosome 9 open reading frame 3"	Q8N6M6	9	94726701-95087218	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Melanocytes: 187.3;Smooth muscle cells: 202.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: AB_2686553"	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	6.2	8.5	6.8	9.1	12.7	2.4	11.3	10.5	10.3	14.0	17.8	24.6	24.1	5.1	28.8	15.0	20.2	16.0	17.9	29.9	8.9	5.9	12.7	28.1	10.9	3.1	11.3	6.1	11.7	24.7	25.0	11.1	24.4	11.3	22.1	6.8	11.4	13.1	17.6	29.8	39.1	8.1	32.2	11.6	6.8	10.8	6.4	11.4	3.3	11.6	23.7	7.8	12.9	25.1	5.4	5.8	2.1	3.6	3.4	3.6	1.8	4.6	20.6	2.2	3.9	2.3	3.0	8.8	4.4	2.0	4.7	2.8	4.4	6.0	1.4	3.8	7.4	6.6	18.2	4.1	4.2	2.3	9.6	3.2	1.3	18.7	3.9	4.8	1.2	1.0	3.1	17.6	4.1	2.7	12.6	2.6	2.2	2.1	1.9	8.5	6.7	1.7	1.5	2.9	5.5	8.6	2.7	7.2	1.7	8.1	4.1	4.6	6.9	7.5	7.0	1.6	6.3	7.7	0.9	2.0	2.0	2.0	8.3	2.3	1.7	2.2	0.7	7.0	1.1	3.6	0.3	3.6	2.1	3.6	2.5	2.3	2.4	3.0	3.3	5.8	5.4	2.3	2.7	1.3	3.4	1.7	5.2	1.9	1.8	6.8	12.7	10.5	10.3	8.9	5.9	11.3	6.1	11.3	11.4	20.8	26.6	2.0	151.6	128.8	21.9	142.0	61.1	30.8	31.8	12.2	17.7	55.1	38.1	34.9	33.0	58.5	10.1	0.0	83.2	34.0	56.4	54.9	3.5	70.1	8.0	11.1	10.9	21.5	6.2	19.5	17.5	5.9	187.3	1.8	8.5	71.9	51.7	14.4	100.0	32.7	12.4	12.9	202.8	14.3	20.0	131.6	73.8	3.5	9.5	61.6
C9orf40	FLJ10110	ENSG00000135045	"Chromosome 9 open reading frame 40"	Q8IXQ3	9	74946581-74952886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 43.7;Spermatocytes: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA042167	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		290000	"Nucleoplasm, Cytosol"	Centrosome	"HPA042167: AB_10797382"	"unprognostic (2.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.15e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	6.2	4.0	8.3	9.7	8.0	9.0	18.8	8.1	12.4	5.1	9.9	5.6	2.8	14.3	5.2	3.0	5.2	3.6	5.0	3.6	7.4	8.4	4.1	5.1	2.8	8.4	8.4	5.6	4.2	3.5	6.6	4.4	6.5	6.7	3.9	9.2	2.2	3.0	4.8	4.7	3.5	18.7	4.9	11.2	5.4	3.6	31.1	5.1	10.5	3.0	3.4	8.0	5.0	16.0	1.8	0.9	5.3	0.5	0.0	2.1	0.3	16.8	3.7	9.7	3.9	3.9	5.1	18.1	13.5	4.2	9.4	10.2	1.0	5.3	15.3	4.0	3.3	15.8	5.0	7.6	0.7	15.1	20.6	11.8	8.1	6.8	6.4	3.2	9.7	12.9	2.5	5.1	5.2	3.7	3.8	2.9	11.2	11.4	10.4	12.3	4.7	17.1	11.4	11.4	8.9	11.4	16.0	7.6	3.7	3.9	4.1	10.6	4.7	5.9	5.0	4.0	9.0	6.1	7.5	3.7	8.5	9.6	11.6	11.7	20.0	14.9	9.7	6.5	10.9	9.1	1.8	0.2	5.3	1.0	0.4	0.4	1.8	1.1	1.0	0.2	1.3	2.1	1.3	0.5	0.0	0.5	0.9	1.2	0.3	8.3	8.0	8.1	12.4	7.4	8.4	8.4	5.6	6.7	5.1	3.0	0.3	6.0	3.5	2.2	7.2	43.7	0.0	1.4	0.0	3.5	7.9	15.9	1.7	2.7	9.5	8.6	12.7	0.0	2.7	19.6	4.0	2.4	0.0	3.4	9.3	1.6	1.2	9.2	3.3	1.3	4.0	1.7	1.7	3.6	4.9	4.5	2.9	8.6	4.9	1.4	13.1	0.0	4.2	46.8	10.7	4.5	10.3	3.2	15.2	3.8
C9orf43	MGC17358	ENSG00000157653	"Chromosome 9 open reading frame 43"	Q8TAL5	9	113410054-113429684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	10	"testis: 39.4"	"Group enriched"	"Detected in some"	7	"Early spermatids: 78.7;Late spermatids: 167.1;Spermatocytes: 82.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA021310			Approved	Cytosol		NA	NA			Cytosol		"HPA021310: AB_1845825"	"unprognostic (2.91e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-1)"	0.5	1.6	1.5	0.4	2.4	1.8	1.3	2.1	2.3	0.5	0.4	1.6	0.2	0.4	0.4	1.6	0.5	0.9	0.6	0.4	1.4	0.8	1.0	1.7	0.5	0.6	0.8	1.9	1.0	3.5	1.3	3.8	0.5	1.6	0.7	0.5	1.0	0.9	0.7	0.4	0.8	0.5	0.3	1.8	0.6	0.6	39.4	1.0	0.6	1.0	0.0	0.6	0.5	0.5	1.5	1.3	2.3	1.5	1.0	2.1	0.8	1.2	1.2	0.6	1.9	1.5	0.8	0.9	0.6	1.1	1.7	1.3	1.3	1.0	3.3	1.1	0.3	3.8	2.4	0.7	1.7	0.7	2.7	0.5	2.9	2.1	0.6	1.3	0.5	0.4	1.8	2.6	2.2	2.6	1.1	1.5	3.9	1.7	3.1	0.9	2.4	1.4	0.8	0.9	1.5	3.9	0.8	0.7	1.9	1.8	0.6	3.1	0.7	3.0	1.4	1.7	1.4	4.1	0.3	0.2	2.6	0.6	1.7	2.6	2.0	3.6	5.0	1.4	1.1	0.9	0.0	0.7	0.0	1.5	1.5	0.0	1.5	0.8	2.1	0.8	0.8	1.4	2.1	2.3	1.0	0.3	1.3	0.1	0.8	1.5	2.4	2.1	2.3	1.4	0.8	0.8	1.9	1.6	1.0	0.0	0.0	0.8	0.5	0.6	1.7	0.0	0.0	10.7	2.3	0.0	0.0	0.4	1.7	0.3	78.7	0.3	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.3	167.1	2.0	0.6	0.0	1.0	0.0	2.3	1.1	0.0	1.4	0.7	2.6	0.0	0.0	82.6	16.0	0.0	0.0	0.0	0.0	0.5
C9orf64	MGC10999	ENSG00000165118	"Chromosome 9 open reading frame 64"	Q5T6V5	9	83938311-83956986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054903, HPA066190"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA054903: AB_2682636, HPA066190: AB_2685633"	"unprognostic (2.07e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.48e-3)"	12.6	17.1	8.7	8.5	10.3	2.3	14.7	8.0	9.7	12.1	13.5	12.2	10.8	24.5	13.8	12.7	8.2	12.5	8.6	9.7	7.9	9.0	14.6	25.4	9.3	9.5	9.4	6.1	12.4	15.9	18.9	13.6	9.8	9.9	12.1	9.0	11.6	9.9	10.0	10.3	6.0	22.5	11.3	8.0	8.9	10.8	11.1	8.0	16.3	26.0	6.7	8.3	11.9	10.1	4.1	12.4	10.0	12.5	13.2	7.4	4.6	12.2	10.6	0.2	0.0	5.5	7.4	13.0	8.2	2.3	7.7	8.6	9.5	11.1	0.0	6.8	8.8	3.1	7.6	0.0	0.3	10.0	13.1	7.0	5.4	13.5	18.3	12.6	0.0	16.5	8.5	10.7	7.4	0.0	1.7	4.9	0.0	13.1	0.1	9.2	12.0	2.5	0.4	10.1	7.7	5.2	0.0	16.3	0.5	6.2	2.1	10.5	10.3	14.4	3.4	10.8	0.2	4.5	10.5	1.5	0.9	11.1	17.2	2.3	3.5	0.2	0.4	7.3	0.5	5.5	7.4	11.0	10.0	7.4	12.4	7.0	2.9	5.6	7.4	12.4	4.1	6.2	7.4	4.9	13.2	12.5	8.8	5.9	4.6	8.7	10.3	8.0	9.7	7.9	9.0	9.4	6.1	9.9	8.0	11.9	9.6	0.0	4.1	1.9	4.0	4.8	5.1	8.1	2.3	3.5	3.9	10.8	10.0	9.7	4.3	3.8	8.5	0.0	7.8	16.0	5.6	3.1	9.2	22.2	10.7	3.2	4.1	6.7	15.1	2.3	7.5	6.4	1.7	13.6	5.6	12.6	8.3	4.9	10.3	12.6	6.6	0.0	6.6	8.4	5.3	1.3	3.7	4.4	8.0	2.6
C9orf72	"DENNL72, MGC23980"	ENSG00000147894	"Chromosome 9 open reading frame 72"	Q96LT7	9	27546545-27573866	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 77.6;Kupffer cells: 86.3;Macrophages: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 8.0;classical monocyte: 15.5;intermediate monocyte: 21.8;myeloid DC: 11.7;neutrophil: 15.6;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.7;granulocytes: 15.6;monocytes: 21.8"	"Cell line enhanced"	"Detected in many"		"AF22: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Secreted - unknown location"	NA	NA			"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	10.0	11.2	9.7	14.2	17.6	19.1	8.0	31.2	21.3	7.4	6.0	10.9	6.7	5.8	10.7	10.6	5.8	14.6	8.9	7.4	9.4	14.6	4.2	14.0	13.0	10.7	11.0	10.7	19.5	8.4	6.7	15.3	10.3	20.0	13.3	7.1	9.4	5.3	5.9	11.0	6.2	6.1	7.6	11.5	13.7	6.5	14.8	6.7	8.0	11.0	3.2	7.3	9.7	6.3	1.7	11.7	15.6	21.8	2.9	2.5	4.4	2.8	2.5	21.1	3.2	4.3	5.3	3.2	4.1	3.5	2.6	1.3	0.3	1.0	7.2	2.7	3.6	5.4	2.2	6.0	5.2	1.9	13.1	2.5	3.4	7.5	2.1	6.6	2.3	3.7	5.6	6.4	0.6	11.9	2.5	5.5	7.4	6.5	13.1	3.1	0.5	4.4	3.5	10.2	4.7	11.6	1.7	6.3	3.2	2.0	2.5	7.2	17.7	2.7	3.1	2.6	8.3	2.6	2.0	4.7	0.0	10.6	6.2	2.7	3.4	10.2	4.7	8.0	7.6	2.6	8.0	15.5	1.0	0.9	21.8	1.7	1.7	1.4	1.2	11.7	1.2	2.5	1.5	15.6	2.9	16.5	1.8	1.8	4.4	9.7	17.6	31.2	21.3	9.4	14.6	11.0	10.7	20.0	6.7	14.9	17.1	6.9	37.1	31.9	22.0	12.8	5.1	77.6	12.5	7.0	19.6	18.4	1.7	6.9	1.7	10.8	3.9	0.0	8.3	6.2	12.4	25.8	16.1	7.8	23.9	11.1	10.9	6.7	86.3	3.3	5.8	73.0	18.6	19.8	9.9	46.1	6.4	8.6	3.5	4.1	28.5	0.0	20.6	30.7	19.3	25.5	28.9	10.9	5.2	35.5
C9orf84	FLJ32779	ENSG00000165181	"Chromosome 9 open reading frame 84"	Q5VXU9	9	111686173-111795008	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 33.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 46.5;Spermatocytes: 81.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 4.1"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 22.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA032108			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA032108: AB_10669884"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.33e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.31e-2)"	0.1	2.9	0.1	0.5	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.0	0.3	0.6	0.2	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	1.1	33.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.2	0.2	4.1	0.0	0.1	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	4.8	1.1	0.4	0.0	0.0	0.3	0.0	0.0	22.4	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.1	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	0.1	0.0	0.6	1.2	0.0	1.4	1.2	0.0	2.0	0.0	13.3	0.0	46.5	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.6	0.0	11.5	2.8	0.0	0.0	0.0	0.0	0.2	0.9	0.0	3.5	0.0	0.3	6.5	0.0	81.0	5.5	0.0	0.0	0.0	0.0	0.7
C9orf85	MGC61599	ENSG00000155621	"Chromosome 9 open reading frame 85"	Q96MD7	9	71911510-71986054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050767, HPA076627"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA050767: AB_2681229, HPA076627: "	"unprognostic (7.81e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.18e-2)"	13.4	12.7	15.5	10.1	26.0	8.9	14.7	11.2	18.8	12.8	12.9	18.2	15.0	19.3	14.1	14.3	18.4	11.6	12.0	10.5	14.9	13.8	12.3	13.1	10.4	13.0	24.5	13.3	16.9	14.7	9.8	16.9	13.9	15.2	13.1	13.7	14.3	14.7	9.8	14.6	18.4	16.3	15.2	21.1	10.7	11.2	9.2	21.9	14.5	14.8	15.9	12.9	18.8	15.5	11.3	13.1	16.1	9.9	17.1	14.6	9.3	7.7	5.1	9.1	7.4	9.6	17.4	9.3	10.0	15.5	8.1	7.9	1.1	4.7	12.7	5.1	8.6	8.5	14.3	9.5	9.5	11.2	8.9	4.7	7.8	7.5	6.4	10.3	11.4	6.4	14.1	13.0	8.1	17.8	12.7	9.9	12.3	9.2	8.6	10.2	4.0	13.7	8.0	8.6	12.5	12.6	8.1	15.8	0.3	11.5	11.3	7.6	10.0	4.9	12.7	16.5	10.4	4.5	6.6	8.7	7.5	9.6	16.9	7.3	8.6	14.1	5.8	10.1	8.7	4.8	16.1	8.9	12.6	13.4	9.9	13.7	10.9	11.5	11.5	9.3	11.3	14.0	14.6	9.9	17.1	8.3	13.1	10.5	9.3	15.5	26.0	11.2	18.8	14.9	13.8	24.5	13.3	15.2	21.9	6.0	14.2	13.0	11.4	6.8	10.6	10.8	5.1	9.4	11.4	5.2	7.9	17.8	18.3	12.3	6.1	11.6	23.0	0.0	17.3	15.9	12.4	13.2	18.4	8.7	12.9	4.8	6.3	16.0	12.4	4.5	19.2	13.3	3.3	11.8	17.8	11.2	14.2	17.5	12.4	15.1	11.5	12.9	12.7	13.0	14.2	8.5	9.0	12.2	16.3	17.9
CA10	"CA-RPX, CARPX, HUCEP-15"	ENSG00000154975	"Carbonic anhydrase 10"	Q9NS85	17	51630313-52160017	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 59.5;cervix, uterine: 23.4"	"Cell type enhanced"	"Detected in some"	27	"Bipolar cells: 230.7;Early spermatids: 106.6;Late spermatids: 56.3"	"Cancer enhanced"	"Detected in some"		"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.2;RT4: 3.8;SCLC-21H: 11.7;SuSa: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054825, HPA057837"	Supported		Approved	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA054825: AB_2682617, HPA057837: AB_2683542"		"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.18e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"		0.5	3.8	14.4	0.5	6.3	0.5	0.5	59.5	36.7	23.4	0.8	1.7	0.0	0.8	0.7	0.5	0.6	0.7	0.6	0.5	8.0	12.4	7.8	0.5	0.5	0.5	7.0	5.0	2.5	0.8	0.5	1.8	14.2	18.3	0.5	0.7	2.9	1.5	0.5	0.5	0.5	1.1	0.6	4.2	0.5	0.6	6.0	1.3	0.0	0.5	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	2.2	3.8	11.7	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	6.3	59.5	17.9	8.0	12.4	7.0	5.0	18.3	1.3	0.0	0.0	0.0	0.0	0.0	230.7	0.3	0.0	0.0	0.0	3.5	3.9	0.0	13.3	0.0	106.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	56.3	1.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.7	0.0	9.7	0.0	0.0	0.9	1.0	0.0	0.1	0.0	0.0	0.0
CA11	"CARP2, CARPX1"	ENSG00000063180	"Carbonic anhydrase 11"	O75493	19	48637942-48646312	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;hTERT-RPE1: 24.4;SCLC-21H: 16.7;U-266/84: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041778			Approved	Vesicles,Microtubules	"Secreted in brain"	NA	NA			"Vesicles, Microtubules"		"HPA041778: AB_10794525"	"unprognostic (1.39e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (2.59e-3)"	"unprognostic (5.72e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.80e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (2.11e-5)"	"unprognostic (3.79e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.75e-1)"	2.3	9.6	60.2	2.3	58.2	1.5	4.1	54.1	87.7	3.8	2.5	4.5	1.7	5.3	17.7	16.0	3.5	10.5	3.5	2.9	44.1	12.2	4.2	1.2	3.2	3.0	18.5	31.6	24.6	3.3	16.7	5.4	1.3	8.9	4.6	2.0	2.7	4.0	8.4	5.0	6.6	4.0	10.7	11.0	2.8	3.1	2.7	17.8	0.1	4.3	0.8	3.4	2.1	1.8	3.4	4.5	0.0	1.1	2.6	3.7	1.4	1.0	6.3	11.6	23.3	1.6	0.6	0.3	0.7	7.4	0.8	1.7	1.5	8.1	3.8	0.9	0.8	2.2	2.5	4.7	2.3	0.7	0.8	6.7	1.7	3.4	0.1	1.5	0.1	5.2	2.8	4.7	0.7	1.0	24.4	0.9	10.4	2.9	10.7	0.3	2.4	2.0	0.7	5.1	3.7	2.5	1.3	0.5	7.9	5.1	0.2	16.7	9.7	0.8	0.9	1.4	3.3	3.3	0.4	0.0	2.1	7.8	0.0	0.2	10.2	17.0	0.7	2.9	2.2	1.0	0.0	0.9	0.0	3.7	1.1	3.1	2.4	2.9	2.8	1.6	3.4	3.6	3.3	0.0	2.6	0.0	4.5	3.0	1.4	60.2	58.2	54.1	63.8	44.1	12.2	18.5	31.6	8.9	17.8	3.0	7.2	9.7	6.4	6.4	72.7	5.3	20.4	8.1	9.1	29.6	15.7	0.6	21.6	6.9	10.0	7.1	7.4	0.0	8.7	0.3	5.1	4.8	5.8	34.1	5.9	27.0	12.6	8.0	21.9	4.7	20.4	8.8	8.5	4.6	4.2	24.9	4.6	3.5	25.1	19.8	25.0	6.5	8.0	0.9	3.6	9.5	0.3	8.7	4.5	5.8
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.7"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.5;OE19: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA		100000	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	2.6	2.6	2.0	1.9	3.1	0.5	2.9	2.4	2.4	3.2	18.2	0.8	0.0	14.2	1.8	1.7	6.7	1.4	25.6	5.8	1.6	1.9	10.4	17.1	9.5	2.4	2.0	0.1	2.2	1.6	9.3	6.5	1.0	5.7	2.6	3.7	1.9	7.0	1.0	1.9	7.1	56.7	1.9	5.2	2.2	7.0	0.9	0.9	0.4	10.3	3.9	5.6	2.9	5.2	0.8	2.1	3.2	2.5	0.5	0.5	1.0	0.2	0.3	0.7	0.1	0.5	0.5	0.3	0.8	0.9	0.1	2.4	5.8	4.5	0.3	0.4	1.0	5.1	1.9	1.8	2.3	0.1	1.3	0.8	12.5	1.6	5.3	1.2	0.2	0.5	1.9	0.4	0.2	1.0	1.5	1.3	0.5	3.1	2.4	2.1	0.0	0.2	0.2	0.3	24.6	0.3	0.2	1.8	0.1	6.7	0.2	0.2	0.0	0.4	0.0	1.3	0.9	0.4	0.6	1.2	2.3	3.3	0.1	1.3	1.0	0.4	1.5	4.8	1.8	2.2	3.2	2.5	1.3	0.4	0.7	0.2	0.2	0.2	0.1	2.1	0.8	0.3	0.5	0.9	0.5	0.8	0.9	0.1	1.0	2.0	3.1	2.4	2.4	1.6	1.9	2.0	0.1	5.7	0.9	3.0	7.7	1.4	2.1	1.5	1.5	5.2	5.1	10.7	12.5	12.2	31.4	0.2	8.3	3.2	9.1	2.1	16.9	0.0	1.4	0.2	3.1	2.1	0.0	4.7	0.9	0.0	4.6	9.8	3.0	10.4	0.0	2.2	5.0	0.0	3.2	2.0	3.1	4.9	0.0	16.1	5.1	0.0	1.0	1.2	2.3	2.8	0.2	1.0	3.4	1.8
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257159-150265078	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1"	"Group enriched"	"Detected in some"	16	"Cardiomyocytes: 44.5;Melanocytes: 50.6;Muller glia cells: 123.0"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 28.7;AN3-CA: 17.0;NTERA-2: 22.3;SK-MEL-30: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.1	0.3	4.6	0.2	5.2	0.9	0.3	1.4	6.8	0.1	1.7	10.8	0.1	0.3	0.1	0.5	1.6	1.3	0.7	4.4	6.4	4.1	0.3	6.3	0.2	0.2	11.3	3.2	1.4	0.3	0.8	0.1	0.3	4.4	3.2	0.7	29.4	0.6	16.5	24.1	3.7	0.6	0.5	20.9	0.3	0.8	0.5	2.7	0.1	0.9	0.1	0.1	0.2	0.1	2.8	2.2	2.1	2.0	0.2	1.6	0.2	0.2	0.0	28.7	17.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	22.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.1	57.1	4.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.1	0.1	0.1	0.0	0.0	0.9	1.3	1.6	2.0	0.6	2.0	1.0	1.2	0.2	2.8	1.2	1.3	2.1	0.2	0.5	2.2	0.0	0.2	4.6	5.2	1.4	4.7	6.4	4.1	11.3	3.2	4.4	2.7	3.0	0.3	0.0	0.2	1.9	1.4	44.5	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	50.6	0.0	0.0	123.0	1.2	0.0	3.2	0.0	4.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.4
CAAP1	"C9orf82, CAAP, FLJ13657"	ENSG00000120159	"Caspase activity and apoptosis inhibitor 1"	Q9H8G2	9	26840685-26892804	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020404, HPA024029, HPA024100"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA020404: AB_1845841, HPA024029: AB_1845842, HPA024100: AB_1845843"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (7.94e-9)"	"unprognostic (2.74e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-2)"	9.5	26.3	10.5	14.3	11.7	10.0	11.6	12.9	12.9	10.1	16.9	9.1	16.4	14.9	13.6	19.5	14.3	9.1	12.3	9.1	10.2	10.6	25.6	30.1	7.9	12.7	9.7	7.2	8.1	20.7	17.7	20.0	9.1	10.7	10.8	19.1	14.2	17.5	15.5	9.9	10.6	17.6	10.0	8.8	14.1	10.8	19.4	9.6	25.6	27.1	10.6	16.7	10.1	9.8	16.2	15.0	12.7	14.5	15.1	17.6	12.7	13.0	8.2	14.0	14.6	9.4	8.0	10.2	9.0	9.8	9.5	11.7	2.5	8.6	16.4	9.0	8.7	5.5	6.7	14.3	9.7	13.4	19.6	7.2	27.6	13.7	15.4	16.0	11.4	13.0	8.0	12.5	7.2	18.0	10.7	15.8	10.4	7.3	12.1	10.8	7.2	18.1	4.9	18.3	13.0	5.3	12.7	6.5	10.1	24.6	9.9	10.8	22.4	8.6	10.3	8.7	13.3	8.8	14.4	8.6	0.0	14.3	5.8	9.2	5.3	9.9	17.9	4.7	12.4	5.8	12.7	9.4	6.4	14.1	14.5	17.6	16.2	15.6	16.3	15.0	14.1	13.0	13.6	1.2	15.1	12.1	13.8	15.1	12.7	10.5	11.7	12.9	12.9	10.2	10.6	9.7	7.2	10.7	9.6	20.8	16.3	15.2	9.8	8.9	10.2	6.7	15.3	24.1	33.0	29.6	7.9	15.8	49.7	17.2	7.9	10.4	15.3	0.0	17.2	12.3	9.8	13.5	17.4	27.2	10.8	7.9	14.9	11.6	10.7	2.7	7.8	10.6	8.5	16.2	22.0	20.7	17.9	21.0	6.0	19.9	11.6	12.9	9.1	39.5	18.8	12.8	9.0	8.7	26.8	10.5
CAB39	"CGI-66, MO25"	ENSG00000135932	"Calcium binding protein 39"	Q9Y376	2	230712845-230821075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037112, HPA076632"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		130000	"Nucleoli fibrillar center"	Cytosol	"CAB037112: AB_1078367, HPA076632: "	"unprognostic (4.36e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (1.04e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.36e-1)"	28.8	16.7	24.5	25.8	24.0	22.1	22.2	22.4	35.0	16.5	26.1	16.8	14.0	23.4	19.3	18.3	28.3	15.5	20.8	34.2	25.4	26.0	27.4	18.9	20.9	25.8	28.4	27.6	17.0	16.3	22.3	15.2	21.0	32.8	20.9	28.4	13.9	22.4	16.7	82.2	21.8	28.8	26.3	28.0	21.5	22.6	19.6	17.8	20.9	22.0	26.6	28.1	22.9	30.8	3.6	3.6	12.4	5.1	11.6	8.4	2.6	38.1	8.9	12.1	10.3	15.0	18.9	13.8	22.0	27.6	13.9	14.6	10.8	42.1	9.9	17.4	19.1	23.5	17.7	13.5	41.4	28.4	41.4	10.6	26.5	11.5	11.5	12.8	36.6	30.9	13.3	24.2	17.8	39.6	15.9	17.2	13.8	44.2	9.2	13.2	13.3	17.0	22.7	12.1	15.7	15.7	19.8	18.1	9.7	25.9	31.1	13.2	8.1	16.5	20.7	17.5	14.3	5.1	21.3	21.7	19.7	7.5	20.7	17.9	11.9	9.0	16.1	14.0	21.4	16.1	4.5	4.5	6.9	6.0	5.1	6.2	3.6	7.5	7.7	3.6	3.1	6.0	8.4	12.4	11.6	4.7	2.7	7.1	2.6	24.5	24.0	22.4	35.0	25.4	26.0	28.4	27.6	32.8	17.8	59.6	38.6	17.5	38.6	86.8	14.7	64.8	17.8	32.1	27.3	48.8	31.4	17.2	24.9	23.5	9.2	26.8	67.3	46.7	27.9	15.6	25.8	65.5	19.7	24.9	49.6	27.0	19.5	29.4	89.4	9.5	16.1	63.1	28.7	19.0	42.5	38.5	52.1	44.6	30.1	33.9	35.6	12.9	24.5	24.6	27.0	74.4	19.3	38.8	27.6	68.0
CAB39L	"bA103J18.3, FLJ12577, MO2L"	ENSG00000102547	"Calcium binding protein 39 like"	Q9H9S4	13	49308650-49444126	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 123.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.4;RT4: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003686, HPA045954, HPA076632"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB003686: AB_426084, HPA045954: AB_2679512, HPA076632: "	"unprognostic (3.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.91e-4)"	"prognostic favorable (1.94e-13)"	"unprognostic (6.59e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.96e-2)"	"unprognostic (8.05e-3)"	19.6	32.1	18.4	5.6	18.2	2.1	32.6	17.6	22.6	12.9	33.2	13.1	19.0	5.5	11.5	14.8	25.6	12.5	13.6	14.5	22.2	16.3	12.8	5.0	12.2	3.7	29.6	19.5	17.6	10.2	17.9	10.7	10.3	26.4	35.8	10.2	7.6	13.8	20.7	4.9	10.6	8.0	21.1	23.3	3.8	18.8	24.1	24.9	2.5	8.9	9.1	4.6	21.3	13.0	3.8	3.9	9.9	3.8	2.7	5.3	3.2	1.0	1.0	6.7	1.9	6.6	6.6	9.2	6.0	12.8	3.7	3.0	24.4	3.5	8.3	0.8	4.0	4.2	1.9	3.5	4.3	7.0	2.9	3.2	2.2	1.5	1.7	3.4	1.8	1.0	4.9	3.8	3.0	4.7	5.2	4.7	1.4	0.3	2.0	5.7	1.6	1.9	1.6	5.2	3.2	1.7	1.6	0.9	1.3	5.8	25.5	0.8	2.6	3.2	7.2	7.8	7.8	11.2	3.4	4.8	1.7	1.7	3.4	4.9	1.5	1.4	9.6	1.9	1.8	4.0	9.9	3.8	7.9	4.4	3.5	3.2	3.8	5.2	5.3	3.9	2.9	4.0	3.7	8.4	2.7	2.9	0.5	5.2	3.2	18.4	18.2	17.6	22.2	22.2	16.3	29.6	19.5	26.4	24.9	14.9	11.0	0.0	11.2	2.7	5.6	13.7	5.1	24.1	11.4	10.4	5.9	22.7	10.0	8.3	123.2	2.9	1.0	0.0	9.4	10.1	12.0	23.2	4.6	1.9	5.6	1.6	2.4	5.5	2.2	17.0	14.4	4.3	11.8	7.2	2.3	11.5	7.7	0.0	11.0	3.7	5.0	6.5	11.7	8.2	3.0	3.9	24.3	1.8	1.9	20.0
CABCOCO1	"bA63A2.1, C10orf107, Em:AC022398.2, MGC44593"	ENSG00000183346	"Ciliary associated calcium binding coiled-coil 1"	Q8IVU9	10	61662961-61766766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 33.1;testis: 18.6"	"Cell type enriched"	"Detected in some"	12	"Ciliated cells: 163.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"MOLT-4: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Cytosol"	"HPA041398: AB_10794374"	"unprognostic (1.89e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.79e-4)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.52e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.33e-2)"	1.5	1.2	6.3	0.7	5.7	0.5	2.1	0.4	6.8	6.1	1.6	9.5	3.0	1.0	5.2	7.6	0.9	33.1	3.8	0.7	8.1	7.3	2.6	0.9	10.3	0.9	8.1	5.8	4.1	1.6	10.0	5.2	1.4	13.7	5.9	1.3	1.5	1.7	3.7	0.6	0.8	0.9	3.0	14.8	1.9	0.9	18.6	5.6	0.0	1.9	0.0	0.6	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.4	0.0	0.4	1.6	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.1	0.9	0.9	0.5	0.1	0.0	0.1	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	5.7	0.4	6.8	8.1	7.3	8.1	5.8	13.7	5.6	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	163.3	13.6	3.5	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	14.4	14.6	15.9	18.5	22.9	34.2	13.4	47.2	29.2	17.5	17.3	23.3	22.6	17.6	24.9	17.2	12.4	23.7	16.9	15.4	14.7	13.2	18.2	13.7	19.7	22.4	12.7	17.4	16.6	18.2	24.4	24.9	12.0	17.8	17.6	11.4	19.0	18.6	24.2	10.2	20.7	16.7	18.0	10.9	21.2	18.6	24.4	10.8	22.5	27.0	10.6	19.3	14.1	14.2	4.1	2.7	15.9	3.7	4.8	7.0	2.0	12.5	9.2	12.5	11.0	11.4	13.2	17.7	10.6	9.3	8.6	9.8	11.3	6.2	14.7	5.9	10.6	11.1	12.0	14.9	9.7	7.7	24.5	14.6	12.6	10.4	23.7	5.4	29.0	13.7	11.2	6.3	10.5	7.9	10.3	14.3	13.3	26.1	8.1	4.9	16.2	13.7	31.5	7.8	17.7	6.6	13.4	9.2	18.3	7.8	12.8	16.2	13.9	13.2	9.2	13.4	11.9	8.2	13.1	11.6	19.9	15.6	7.6	7.6	14.2	8.4	8.9	9.3	13.9	8.3	5.9	3.7	12.9	5.5	2.5	6.2	2.5	4.2	7.0	2.3	4.1	5.0	4.6	15.9	4.8	1.7	2.7	3.2	2.0	15.9	22.9	47.2	29.2	14.7	13.2	12.7	17.4	17.8	10.8	20.8	35.7	15.2	7.4	7.3	31.7	10.2	5.1	20.1	6.8	8.7	84.4	11.7	6.6	9.2	12.4	12.9	12.3	0.0	8.3	5.7	12.0	8.0	17.3	8.2	18.8	31.8	14.3	15.4	12.9	11.5	19.8	12.6	10.1	19.8	10.9	13.3	9.9	3.5	18.7	6.2	52.5	19.4	22.6	37.5	30.6	8.3	18.8	34.6	12.1	6.4
CABLES2	"C20orf150, dJ908M14.2, ik3-2"	ENSG00000149679	"Cdk5 and Abl enzyme substrate 2"	Q9BTV7	20	62388632-62407285	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.9"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 33.1;Late spermatids: 16.4;Spermatocytes: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052138			Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cell Junctions"	"HPA052138: AB_2681743"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.26e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.37e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.94e-2)"	2.3	3.3	5.9	5.6	5.6	8.3	2.8	15.1	10.2	3.4	4.4	3.6	1.3	3.6	3.7	3.6	3.7	4.7	3.0	10.5	4.3	5.5	2.6	3.6	2.9	5.7	4.9	5.3	4.3	3.7	4.1	5.8	4.3	7.2	4.1	4.1	3.1	3.6	4.2	5.4	5.2	4.9	4.3	3.5	4.1	3.8	34.9	5.4	5.1	5.7	2.6	5.2	4.1	3.2	1.4	1.1	1.0	1.1	1.5	4.1	0.5	9.3	7.0	12.2	12.4	1.9	2.7	1.7	5.3	5.3	14.9	6.9	25.4	5.4	9.4	4.6	3.4	20.4	6.0	7.4	3.5	5.8	4.2	4.1	11.0	3.7	6.1	3.4	4.4	5.7	1.7	4.0	4.3	1.6	2.6	3.4	12.3	2.8	8.3	3.3	11.5	11.6	3.5	4.0	9.4	8.1	16.1	10.3	4.1	2.2	6.2	6.6	10.2	7.8	10.4	2.1	4.8	7.0	6.8	3.5	13.8	4.2	18.1	5.5	8.0	6.5	11.2	12.4	5.1	7.2	0.0	0.9	0.2	2.7	1.1	1.5	1.4	1.9	2.1	1.1	1.1	1.0	1.2	1.0	1.5	1.1	0.9	4.1	0.5	5.9	5.6	15.1	10.2	4.3	5.5	4.9	5.3	7.2	5.4	3.0	1.7	2.2	0.5	0.8	6.4	6.7	0.0	0.0	3.4	0.0	3.9	0.9	1.7	1.7	33.1	1.5	1.5	0.0	2.0	0.5	2.1	0.9	0.0	1.5	1.7	12.7	3.4	1.8	2.4	16.4	1.7	1.5	0.0	0.0	3.3	1.6	1.9	2.9	3.2	0.7	2.9	0.0	0.9	16.7	7.3	1.8	1.9	0.0	2.5	0.5
CACFD1	"C9orf7, D9S2135, flower"	ENSG00000160325	"Calcium channel flower domain containing 1"	Q9UGQ2	9	133459965-133470848	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015280			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015280: AB_1845833"	"unprognostic (3.15e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.83e-8)"	"unprognostic (5.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.99e-3)"	2.8	7.0	7.2	7.4	6.9	3.5	11.4	8.5	9.4	5.7	14.0	9.4	5.9	18.9	6.7	16.9	8.4	7.3	15.8	9.1	6.5	5.5	19.1	33.7	9.8	8.6	12.3	6.7	7.7	16.6	10.6	12.6	5.3	8.4	8.3	8.3	6.9	9.9	10.3	5.2	3.3	17.9	6.3	8.7	5.0	22.1	13.7	8.6	4.4	13.7	3.7	3.8	8.7	12.6	4.2	1.3	7.6	1.4	2.7	1.0	1.1	0.8	3.7	8.1	5.0	1.7	0.8	5.1	2.5	3.4	2.3	0.8	8.1	6.7	1.0	8.1	3.4	3.9	1.6	2.5	2.0	0.1	1.4	3.0	0.6	5.3	5.6	4.3	0.0	1.0	1.8	5.5	1.8	1.3	6.6	3.0	1.9	1.4	2.7	2.6	9.4	1.0	1.4	4.9	8.2	3.1	2.1	2.1	7.1	4.7	3.6	10.2	11.4	3.2	13.8	2.0	3.3	15.9	1.8	1.4	5.5	5.2	1.5	0.3	4.6	5.5	3.0	2.1	0.6	1.9	3.7	1.4	7.6	0.8	1.1	0.6	3.5	0.7	1.0	1.3	4.2	0.4	0.7	0.2	2.7	0.9	0.5	0.5	1.1	7.2	6.9	8.5	9.4	6.5	5.5	12.3	6.7	8.4	8.6	17.9	15.8	1.4	4.6	2.5	4.4	7.0	28.1	1.4	6.8	19.2	11.8	1.9	3.3	17.8	10.8	2.3	46.4	0.0	28.6	3.0	5.1	9.4	4.6	38.0	2.9	3.2	27.9	6.2	5.6	6.2	7.5	1.8	5.0	4.6	36.5	6.0	22.8	42.1	7.1	14.4	9.7	0.0	4.2	12.5	6.5	1.4	2.4	1.8	12.8	5.5
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877789-138124624	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 5.9;Horizontal cells: 6.4;Late spermatids: 3.6;Spermatocytes: 5.1;Spermatogonia: 9.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 21.2"	"Low region specificity"	"Detected in all"							"HPA022919, HPA044347"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA022919: , HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.5	6.2	5.7	0.7	8.7	0.5	0.5	18.7	18.9	1.2	0.8	0.2	0.0	0.6	0.6	1.7	0.4	6.6	1.4	1.0	4.5	7.3	0.4	1.2	0.5	0.5	2.9	9.1	0.5	1.2	0.4	4.8	0.4	3.6	1.6	0.8	0.4	0.4	1.3	0.4	0.9	0.7	0.8	4.5	0.6	0.6	8.1	1.4	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	4.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	8.7	18.7	10.9	4.5	7.3	2.9	9.1	3.6	1.4	0.0	0.0	0.0	0.0	0.0	5.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.0	0.0	2.4	0.0	0.0	0.4	0.0	1.5	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.0	0.0
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 45.9;Cone photoreceptor cells: 33.4;Intestinal endocrine cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 7.2"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 14.4;RPMI-8226: 33.6;SK-BR-3: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.6	13.4	10.0	0.8	12.6	1.4	3.6	12.2	16.5	11.2	2.8	3.7	0.1	3.3	6.8	13.2	1.2	14.9	6.2	1.8	5.3	3.5	4.2	3.0	9.0	0.5	2.5	9.6	1.2	5.3	3.0	13.6	1.4	8.7	5.7	3.1	10.1	1.1	3.5	0.6	1.5	4.2	1.7	2.2	4.4	1.8	3.0	1.6	0.0	5.2	0.0	0.6	2.3	0.6	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.0	0.0	0.1	33.6	0.3	2.2	3.1	1.3	0.2	6.3	0.7	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	7.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.0	12.6	12.2	16.5	5.3	3.5	2.5	9.6	8.7	1.6	3.0	45.9	0.0	0.6	0.8	23.0	1.2	12.7	14.7	14.8	1.8	33.4	0.6	0.0	5.5	3.6	0.5	3.3	0.0	2.0	0.1	1.0	2.6	11.6	2.4	0.2	7.9	57.1	0.0	1.0	4.9	4.0	0.3	5.0	0.0	2.7	2.5	2.6	3.5	25.5	1.6	13.0	0.0	2.8	1.1	2.5	0.9	0.2	1.3	4.5	0.6
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 30.8"	"Cell type enhanced"	"Detected in single"	15	"Cardiomyocytes: 1.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.6	3.0	17.9	2.1	19.7	3.1	0.5	3.9	22.5	0.6	0.8	1.3	0.0	0.6	0.6	4.4	1.1	2.3	0.6	0.6	30.8	5.8	3.8	0.6	0.6	1.4	2.4	10.6	0.5	0.6	0.5	0.2	0.8	4.2	0.5	0.8	0.5	0.5	0.5	0.6	0.5	1.1	1.0	5.2	0.9	0.8	2.8	2.4	0.0	0.6	0.0	1.0	0.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.9	0.1	0.0	0.0	0.0	1.1	1.4	0.0	2.3	0.1	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.1	0.0	0.0	7.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	17.9	19.7	3.9	22.5	30.8	5.8	2.4	10.6	4.2	2.4	0.0	0.0	0.0	0.0	0.1	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153121-1221772	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 49.5"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 16.2;Late spermatids: 13.2;Peritubular cells: 24.4;Sertoli cells: 25.8;Smooth muscle cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.9;AN3-CA: 15.7;MCF7: 28.9;OE19: 9.6;T-47d: 8.6"	"Low region specificity"	"Detected in many"							HPA039125	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	5.0	6.8	5.1	4.2	12.0	0.3	3.3	0.3	4.3	17.5	28.1	1.6	10.2	5.4	25.7	5.9	16.3	11.7	26.0	2.2	2.5	2.1	4.7	5.5	3.5	0.7	1.0	2.8	31.8	2.1	6.6	14.8	1.9	2.0	21.0	2.2	4.2	1.7	24.9	2.9	4.8	8.5	49.5	1.1	0.5	9.7	11.7	2.1	0.0	5.2	1.4	0.5	34.6	20.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	10.9	1.9	15.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	6.5	1.9	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	1.9	2.9	0.0	0.0	28.9	0.0	0.0	5.9	9.6	2.2	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.7	8.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.0	0.3	4.3	2.5	2.1	1.0	2.8	2.0	2.1	0.0	0.0	0.0	0.0	1.3	16.2	1.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.0	1.2	0.0	0.0	0.0	0.0	0.2	3.3	4.6	8.1	0.1	0.0	10.4	0.6	0.0	13.2	7.8	0.0	0.0	0.0	0.3	0.8	0.7	0.0	24.4	0.8	1.0	25.8	16.5	1.8	4.5	3.0	0.0	0.0	0.0	0.5
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362799-50504244	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 86.1"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 71.5;Alveolar cells type 2: 145.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		1000000	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.9	1.6	1.3	11.1	1.1	1.4	14.9	6.5	1.1	1.7	0.9	0.6	1.4	1.7	1.2	0.9	1.1	0.9	7.6	1.7	9.1	1.6	0.5	86.1	1.3	3.9	3.2	2.2	4.0	3.8	6.0	1.9	6.1	3.0	2.0	6.1	1.5	1.4	1.7	2.6	1.7	1.4	1.4	1.5	4.1	5.8	2.5	0.2	2.3	0.1	0.7	0.7	0.7	1.8	0.3	0.7	0.1	2.3	3.6	1.1	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	8.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.4	66.5	0.2	0.1	0.0	2.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.2	0.0	2.7	1.8	2.6	2.0	0.0	1.3	3.6	2.2	0.0	2.3	0.1	0.3	3.2	1.1	1.6	11.1	14.9	6.5	1.7	9.1	3.9	3.2	6.1	2.5	71.5	145.9	0.0	0.3	1.3	7.2	3.0	0.0	4.0	4.5	1.8	19.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.7	19.7	0.0	0.1	0.0	1.2	0.6	0.0	2.3	0.3	0.0	0.0	0.0	3.5	4.0	0.6	0.0	1.8	0.4	10.0	12.9	0.8	1.6	11.1	0.5	0.2	1.0	0.4	0.3
CACNB3	CACNLB3	ENSG00000167535	"Calcium voltage-gated channel auxiliary subunit beta 3"	P54284	12	48813794-48828941	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"U-937: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059515			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA059515: AB_2684047"	"unprognostic (1.77e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (2.12e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	3.8	3.7	27.4	2.9	22.4	1.2	4.2	18.5	42.9	11.9	9.1	1.5	3.0	3.8	22.6	8.1	11.6	16.1	6.7	2.6	16.4	12.2	3.9	1.3	6.1	1.7	10.0	14.5	24.1	2.1	2.8	4.2	5.3	4.4	5.7	7.8	3.4	4.5	9.1	2.1	7.8	5.8	20.4	2.4	2.2	4.7	4.7	2.3	4.6	6.1	3.4	3.6	7.5	6.9	0.2	0.5	0.0	0.3	0.0	4.7	0.5	6.6	5.3	8.9	18.2	10.9	7.7	5.4	6.8	14.5	10.2	6.0	1.7	5.5	0.8	9.0	11.5	1.7	7.1	8.1	7.5	3.8	7.8	2.4	3.5	4.3	0.2	4.3	0.6	3.9	4.9	4.5	4.2	2.1	28.4	11.6	7.4	0.4	2.8	6.5	16.6	8.3	0.9	5.5	6.9	4.5	9.5	2.0	2.6	7.4	12.6	12.7	12.5	2.1	15.2	5.0	7.5	10.4	2.9	11.0	6.5	9.2	3.1	3.7	3.3	1.3	0.2	5.4	44.2	2.0	0.0	0.3	0.0	0.9	0.1	0.4	0.2	1.8	1.8	0.5	0.0	0.4	0.2	0.0	0.0	0.0	0.4	4.7	0.5	27.4	22.4	18.5	42.9	16.4	12.2	10.0	14.5	4.4	2.3	3.0	7.0	0.0	3.1	2.6	1.0	2.4	0.0	2.7	2.3	1.8	3.9	0.5	1.7	8.6	0.7	3.1	8.4	0.0	3.7	9.3	6.6	2.8	1.1	0.0	1.5	0.0	9.8	3.1	0.6	1.8	12.4	2.3	1.7	5.4	9.1	0.9	8.5	5.8	10.3	0.6	1.0	0.0	10.8	0.5	5.9	4.4	0.9	4.4	11.7	1.4
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964910-67033398	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;prostate: 16.5"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Glandular cells: 3.0;Intestinal endocrine cells: 7.5;Muller glia cells: 3.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 97.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 159.8"	"HPA005803, HPA065370"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.7	1.8	16.0	0.8	32.3	0.7	8.1	3.5	37.8	1.2	0.9	11.4	0.2	1.0	1.2	0.8	0.8	6.2	1.2	0.7	9.6	12.9	0.8	0.7	8.0	0.7	7.5	7.1	0.7	1.2	4.9	0.1	1.6	6.8	16.5	0.8	0.1	0.9	2.4	0.8	0.9	0.9	2.0	4.2	0.7	1.7	0.9	10.3	0.0	0.7	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	3.9	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	10.3	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	3.9	1.7	0.0	0.0	0.1	2.1	0.0	2.7	3.9	97.2	0.9	2.5	0.0	10.0	9.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	32.3	3.5	13.0	9.6	12.9	7.5	7.1	6.8	10.3	3.0	2.2	0.0	1.1	0.0	0.0	1.1	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	0.0	0.2	0.1	0.2	3.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53992288-54012669	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 11.4;skeletal muscle: 45.4"	"Cell type enhanced"	"Detected in some"	28	"Ciliated cells: 5.3;Horizontal cells: 1.6;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	96	"basophil: 11.4;eosinophil: 7.8"	"Lineage enriched"	"Detected in single"	114	"granulocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"A549: 12.7;EFO-21: 22.3;HHSteC: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	Cytosol	"HPA056615: AB_2683192"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"		"unprognostic (7.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.89e-2)"		"unprognostic (2.27e-1)"		"unprognostic (7.69e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.07e-8)"	"unprognostic (9.79e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.2	0.2	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	0.9	0.0		0.1	0.0		0.4	0.0	45.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	12.7	0.3	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	1.1	0.0	22.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	5.8	0.0	0.1	0.1	0.0	0.0	0.0	2.1	3.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.2	1.5	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.9	0.0	2.6	0.0	0.0	0.0	3.1	0.1	0.2	0.0	0.0	11.4	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0
CACUL1	"C10orf46, CAC1, FLJ40409, MGC33215"	ENSG00000151893	"CDK2 associated cullin domain 1"	Q86Y37	10	118674167-118755249	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 177.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050611			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050611: AB_2797238"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.75e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.54e-1)"	19.7	20.0	18.4	13.4	19.3	28.8	23.0	13.2	19.9	20.7	20.2	14.9	22.8	13.7	27.2	21.6	20.7	14.6	14.1	17.9	15.6	16.6	15.2	19.0	19.7	11.2	15.3	17.1	14.8	16.1	23.9	18.7	25.3	15.4	22.5	16.4	13.0	15.7	23.1	26.9	17.0	13.5	26.2	15.0	16.7	17.2	23.8	13.0	20.2	15.9	14.2	15.0	25.1	20.4	3.2	6.1	15.7	11.8	3.1	5.2	3.3	11.6	6.9	5.3	9.6	12.6	8.7	5.5	5.1	13.9	7.3	9.3	7.6	9.9	8.3	3.9	8.2	6.0	10.3	10.5	9.0	9.8	3.3	5.8	7.6	7.2	9.5	8.3	7.0	5.1	6.9	10.1	9.4	14.3	11.1	8.2	9.3	3.7	8.6	8.6	9.0	6.6	11.2	5.1	5.0	3.7	3.8	21.9	5.1	10.7	9.0	2.8	9.0	4.8	12.3	15.8	6.0	6.9	5.7	7.8	5.1	5.8	6.3	8.5	7.5	8.0	5.9	6.6	13.8	3.1	15.7	6.8	12.1	4.1	11.2	4.0	3.0	3.9	4.1	6.1	3.2	4.4	5.2	15.2	3.1	11.8	2.9	2.9	3.3	18.4	19.3	13.2	19.9	15.6	16.6	15.3	17.1	15.4	13.0	56.6	20.8	39.6	27.4	66.4	32.2	38.1	33.1	20.1	13.6	34.9	68.7	58.6	19.9	44.7	177.2	36.4	21.5	23.3	51.7	27.2	35.0	40.2	15.1	24.2	42.7	87.4	65.8	29.4	69.8	24.2	27.3	54.5	27.0	31.5	35.7	37.0	45.0	17.3	22.6	31.5	51.1	12.9	24.1	52.9	83.0	68.9	85.6	33.0	36.6	45.6
CADM3	"BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1"	ENSG00000162706	"Cell adhesion molecule 3"	Q8N126	1	159171609-159203313	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.5;placenta: 43.1"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 103.2;Fibroblasts: 46.4;Horizontal cells: 33.4;Melanocytes: 23.6;Muller glia cells: 35.4"	"Cancer enhanced"	"Detected in many"		"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 19.8;HSkMC: 66.3;hTERT-HME1: 35.5;U-2 OS: 9.9;WM-115: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002981, CAB025746"	Enhanced	Supported	Approved	Cytosol	"Intracellular and membrane"	NA	NA		790000	Cytosol		"CAB025746: , HPA002981: AB_1078916"	"unprognostic (1.74e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.12e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (5.52e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (5.75e-4)"	8.9	5.4	23.3	8.5	41.0	0.9	6.1	88.4	96.5	18.0	8.8	6.9	0.7	3.2	2.2	1.6	7.2	3.2	4.1	4.3	23.2	27.4	1.1	1.1	2.9	7.8	18.5	22.4	1.2	2.0	1.0	7.4	43.1	30.4	1.7	8.9	4.5	2.6	3.6	2.0	7.7	6.4	4.1	9.6	7.6	2.8	2.4	4.6	0.0	4.8	0.7	5.9	10.2	7.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.0	0.0	2.8	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	19.8	0.0	0.0	66.3	0.0	0.0	35.5	0.0	1.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.1	0.0	0.0	1.5	0.0	0.0	2.6	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	41.0	88.4	55.6	23.2	27.4	18.5	22.4	30.4	4.6	0.0	0.3	0.0	0.0	6.0	103.2	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.1	4.0	0.0	0.0	0.0	0.4	46.4	0.1	0.0	0.0	1.0	33.4	0.0	4.3	0.0	4.7	0.6	0.0	23.6	0.0	0.0	35.4	0.0	0.0	0.0	0.0	7.5	0.0	3.9	0.9	1.7	3.8	0.6	0.0	0.0	0.0
CADM4	"IGSF4C, Necl-4, SynCAM4, TSLL2"	ENSG00000105767	"Cell adhesion molecule 4"	Q8NFZ8	19	43622368-43639839	"Predicted membrane proteins"	"Cell adhesion"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.9"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 19.9;Proximal tubular cells: 22.7"	"Cancer enhanced"	"Detected in all"		"glioma: 108.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.7"	"Cell line enriched"	"Detected in many"	5	"WM-115: 112.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012612	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		5900000	"Nuclear membrane"	Nucleoplasm	"HPA012612: AB_1851530"	"unprognostic (8.80e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.81e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.39e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.93e-2)"	3.0	12.6	29.7	3.4	31.0	0.9	6.6	22.2	68.9	4.6	5.3	32.8	2.5	3.0	10.4	6.7	10.8	3.0	3.7	5.5	31.2	26.5	13.2	3.4	3.1	1.8	37.2	20.4	5.2	10.9	26.1	7.5	1.1	29.1	13.7	2.8	4.9	13.3	10.8	5.0	10.8	3.0	6.8	47.8	1.9	4.0	1.9	26.4	0.0	3.3	1.7	3.4	2.9	2.9	0.1	4.7	0.6	0.3	0.0	0.0	0.0	8.8	2.5	13.7	17.9	0.0	0.3	0.7	0.4	0.7	1.2	1.9	3.8	1.5	0.0	3.3	0.1	0.7	2.1	3.0	1.8	1.5	0.1	2.4	0.0	0.6	5.6	1.6	0.0	1.4	0.5	4.0	6.6	0.2	6.5	0.8	0.8	0.9	0.1	0.1	1.3	1.3	0.1	1.5	1.8	0.9	7.1	0.1	0.8	1.8	1.8	1.6	8.8	0.9	2.7	3.5	2.1	2.0	0.4	0.3	0.1	21.2	0.1	0.8	1.3	0.8	0.0	1.0	0.1	112.4	0.0	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	4.7	0.0	0.0	29.7	31.0	22.2	34.0	31.2	26.5	37.2	20.4	29.1	26.4	0.0	1.7	0.0	17.0	4.4	16.4	2.8	5.1	1.4	1.2	7.0	2.0	0.2	5.0	10.4	17.6	1.9	0.0	0.0	2.7	0.1	1.1	19.9	0.0	2.6	0.4	19.1	0.0	4.3	0.0	14.7	0.3	0.0	13.5	0.0	0.3	15.4	4.2	0.0	1.4	22.7	3.7	0.0	4.7	0.5	0.8	7.4	0.0	0.5	1.0	12.8
CADPS	"CAPS, CAPS1, KIAA1121, UNC-31"	ENSG00000163618	"Calcium dependent secretion activator"	Q9ULU8	3	62398346-62875389	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 784.0;Cone photoreceptor cells: 591.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"OE19: 9.2;SCLC-21H: 16.5;SK-MEL-30: 7.3;U-698: 10.5;U-87 MG: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059328	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA059328: AB_2683982"	"unprognostic (3.46e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.91e-3)"	"unprognostic (5.35e-3)"	1.2	17.2	18.2	2.8	16.0	1.0	1.6	22.4	58.0	4.0	3.5	2.4	0.0	3.9	1.5	3.4	1.1	1.1	3.2	11.6	21.9	24.7	1.1	1.1	1.6	1.4	33.7	18.4	2.8	13.5	0.9	19.6	1.1	43.6	4.5	3.3	5.3	1.3	3.8	1.0	2.2	4.0	1.7	7.1	1.4	4.1	3.2	2.7	0.0	1.1	0.0	1.6	1.2	0.6	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	9.2	0.0	0.1	0.0	0.0	0.0	0.0	16.5	1.2	0.0	0.0	7.3	0.3	0.0	0.0	0.0	1.4	0.1	2.7	0.7	0.0	1.4	10.5	17.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.2	16.0	22.4	32.0	21.9	24.7	33.7	18.4	43.6	2.7	0.0	3.4	0.0	0.2	1.1	784.0	16.5	5.1	0.0	0.0	0.0	591.0	0.1	0.0	2.1	0.9	0.1	0.3	0.0	0.3	0.0	2.6	0.3	41.5	0.0	0.0	44.5	92.0	0.0	0.0	0.9	14.1	0.0	8.5	0.0	1.9	16.8	1.2	0.2	2.5	0.0	60.9	0.0	1.2	0.2	0.2	0.1	0.0	0.0	0.4	0.3
CALB1	CALB	ENSG00000104327	"Calbindin 1"	P05937	8	90058608-90095475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	15	"brain: 73.8;kidney: 121.9"	"Cell type enhanced"	"Detected in some"	16	"Collecting duct cells: 26.2;Cone photoreceptor cells: 86.4;Distal tubular cells: 26.6;Horizontal cells: 93.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.4;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 39.3;EFO-21: 59.6;NTERA-2: 19.4;SuSa: 25.6"	"Region enhanced"	"Detected in many"		"cerebellum: 483.1"	"Group enriched"	"Detected in all"	4	"basal ganglia: 88.7;cerebellum: 312.3"	"CAB002138, HPA023099, HPA056734"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220"	"unprognostic (2.19e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.37e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-1)"	1.6	1.2	19.6	1.4	73.8	1.0	1.4	66.0	10.9	3.1	1.3	0.5	0.0	1.0	1.0	2.0	1.7	2.0	0.9	1.0	13.8	15.2	121.9	1.5	2.1	1.0	2.8	6.4	0.9	2.0	1.3	3.2	2.2	12.8	0.9	1.4	0.8	1.3	0.8	1.4	1.7	1.1	1.2	14.7	1.1	1.3	2.1	10.6	0.0	1.4	0.0	1.0	1.0	0.1	0.5	0.6	6.4	2.5	0.0	0.2	1.0	39.3	2.1	8.9	0.6	0.2	1.4	1.2	0.6	4.0	0.3	0.5	0.3	4.7	0.2	59.6	0.0	0.6	13.7	12.8	15.8	2.7	0.1	0.7	1.4	16.5	0.3	1.7	0.2	0.7	0.6	5.1	0.8	7.8	2.1	10.6	0.7	2.7	1.1	10.5	0.2	0.6	0.1	19.4	0.5	8.0	0.3	0.2	0.7	4.7	0.3	1.4	0.9	10.7	0.7	0.1	25.6	0.5	0.5	0.0	1.5	8.4	1.9	3.4	1.0	1.3	0.3	0.2	0.1	0.1	2.6	0.5	1.5	0.2	0.7	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.2	6.4	0.0	2.5	0.6	0.0	1.0	19.6	73.8	66.0	10.9	13.8	15.2	2.8	6.4	12.8	10.6	0.0	0.0	0.0	0.0	0.0	20.2	1.6	0.0	0.0	0.0	26.2	86.4	0.0	26.6	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.8	3.4	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	17.8	0.2	0.0	0.0	0.0	12.3	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0
CALCOCO1	"calphoglin, Cocoa, KIAA1536"	ENSG00000012822	"Calcium binding and coiled-coil domain 1"	Q9P1Z2	12	53708517-53727745	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.9;HSkMC: 41.0;hTERT-RPE1: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038313, HPA038314"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		11000	Cytosol	Vesicles	"HPA038313: AB_10675794, HPA038314: AB_10672587"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.63e-3)"	"unprognostic (9.88e-3)"	31.6	18.9	30.9	13.6	45.6	14.2	27.7	88.2	46.5	22.5	34.9	27.7	23.5	13.7	27.3	29.7	24.0	25.5	28.0	44.8	32.1	15.4	19.7	14.6	35.0	13.6	28.8	25.3	29.1	26.0	36.9	28.1	23.2	30.3	26.1	15.6	27.1	33.0	33.8	59.2	54.4	20.3	35.8	20.5	22.1	30.7	14.4	38.7	11.1	22.5	20.4	16.3	34.6	23.0	8.1	5.4	34.7	10.3	8.3	14.7	10.1	4.8	4.8	6.9	8.6	42.9	28.6	4.7	9.0	21.4	7.8	10.0	2.0	17.0	1.9	9.7	24.0	3.8	5.1	3.3	9.1	6.8	7.8	5.9	3.4	9.8	1.6	22.2	1.4	7.8	41.0	21.0	7.8	6.7	48.7	14.1	8.8	2.8	15.9	13.6	2.0	3.9	4.8	1.5	4.1	5.2	4.8	4.1	6.2	11.6	2.9	4.3	7.6	6.7	2.5	9.2	14.6	7.6	4.3	15.6	3.1	4.6	3.6	1.4	15.8	5.0	0.7	15.3	1.6	4.3	34.7	9.2	33.4	12.7	10.2	9.3	6.7	9.0	10.1	5.4	8.1	8.0	8.6	32.6	8.3	10.3	4.0	14.7	10.1	30.9	45.6	88.2	46.5	32.1	15.4	28.8	25.3	30.3	38.7	32.8	11.8	13.7	16.2	28.7	34.6	9.9	30.6	16.0	12.5	21.0	33.4	18.1	5.0	13.9	41.1	16.9	10.4	0.0	10.0	7.3	22.0	19.8	7.0	15.3	13.6	25.4	27.4	28.3	20.2	37.9	44.0	16.8	18.6	14.4	19.4	30.7	17.0	16.1	38.9	9.8	41.6	19.4	16.5	19.5	7.7	44.4	38.1	21.8	12.3	12.9
CALCOCO2	"MGC17318, NDP52"	ENSG00000136436	"Calcium binding and coiled-coil domain 2"	Q13137	17	48830988-48866522	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Early spermatids: 1039.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA022989, HPA023019, HPA023195"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916"	"unprognostic (3.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.65e-2)"	70.5	30.8	20.6	21.0	29.5	22.2	50.8	22.1	28.1	38.5	40.2	26.8	32.7	27.0	39.4	35.6	41.3	36.1	28.4	55.5	24.8	16.6	36.6	48.7	42.6	28.2	36.8	24.8	37.7	22.7	24.6	46.3	26.5	32.3	37.3	42.1	46.9	30.0	31.8	70.1	31.3	35.2	47.8	42.8	29.5	35.5	51.8	37.3	25.0	48.4	32.3	26.0	46.4	74.2	18.0	22.0	44.4	40.7	33.2	34.2	24.7	26.1	17.0	7.1	13.8	53.4	38.8	20.7	25.4	34.2	29.5	33.1	31.7	17.2	8.8	25.5	30.9	25.3	14.5	17.4	21.6	35.6	40.4	14.4	8.4	10.7	12.3	61.5	28.3	42.8	57.1	32.2	31.2	22.8	28.2	21.6	27.8	15.3	26.9	25.5	7.6	24.3	15.1	2.2	58.1	20.9	16.2	35.1	16.6	11.3	8.4	2.9	6.1	7.9	5.2	22.6	15.2	33.2	15.9	20.8	32.3	9.8	19.7	17.9	23.9	33.2	6.2	19.5	14.4	13.1	30.2	36.2	36.3	19.8	39.5	18.9	18.0	17.7	20.3	22.0	16.6	18.1	19.6	44.4	33.2	40.7	11.1	34.2	24.7	20.6	29.5	22.1	28.1	24.8	16.6	36.8	24.8	32.3	37.3	107.2	75.4	30.8	67.1	32.4	15.1	160.6	33.1	26.8	58.0	31.4	47.1	45.2	31.5	40.5	1039.6	77.2	83.2	46.7	36.8	36.5	44.4	46.5	96.0	48.3	25.2	7.9	48.4	86.5	94.6	158.0	65.0	55.1	25.3	5.4	41.0	41.8	31.7	46.5	69.6	36.5	63.8	71.1	51.5	110.9	26.2	40.9	68.0	44.8	56.5	57.2
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 63.7;Hofbauer cells: 47.4;Leydig cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.8;BJ: 18.8;BJ hTERT+: 19.1;fHDF/TERT166: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	24.2	10.5	3.7	10.2	3.8	1.8	28.7	1.9	7.1	34.1	9.2	3.9	8.0	5.6	36.0	18.4	13.4	19.7	18.2	17.0	3.9	2.2	5.7	3.7	11.1	15.9	4.8	5.4	32.5	4.5	1.9	4.0	23.6	4.8	18.2	4.0	10.7	7.6	10.0	8.9	8.9	9.0	19.8	5.5	24.4	7.2	14.1	3.1	3.0	11.0	9.2	10.8	19.9	24.1	7.1	36.6	11.2	47.9	14.0	21.5	17.1	5.3	3.8	0.9	1.2	14.3	23.8	4.6	18.8	19.1	5.8	8.2	1.6	2.6	1.6	2.1	21.5	0.3	2.5	1.9	0.0	1.1	0.2	10.8	3.8	1.1	0.3	6.5	0.6	0.3	8.1	0.0	1.7	0.0	10.8	6.8	4.1	0.8	10.0	3.7	12.3	1.4	1.7	2.4	1.1	3.4	4.5	1.5	3.6	0.5	0.4	2.7	1.2	0.7	3.1	1.0	0.4	0.6	1.2	12.1	1.8	2.3	6.4	1.3	1.5	3.5	1.9	15.9	11.8	0.3	11.2	22.7	0.4	21.5	42.2	17.5	7.1	14.8	17.6	36.6	1.5	2.9	11.2	0.9	14.0	47.9	4.2	18.9	17.1	3.7	3.8	1.9	7.1	3.9	2.2	4.8	5.4	4.8	3.1	3.0	1.1	3.4	2.8	4.7	0.0	2.8	2.5	0.0	0.0	3.5	0.0	2.0	0.0	3.1	0.8	20.4	0.0	0.0	0.2	63.7	23.4	0.8	8.1	0.0	47.4	0.0	1.2	28.3	27.5	0.8	42.3	14.7	8.5	1.8	0.0	0.3	0.2	0.0	15.2	0.3	0.0	19.4	29.8	0.7	0.2	3.3	16.0	17.3	0.0	1.0
CALHM3	"bA225H22.7, FAM26A"	ENSG00000183128	"Calcium homeostasis modulator 3"	Q86XJ0	10	103472804-103479240	"Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Taste, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.8;pancreas: 2.8;testis: 2.0"	"Cell type enhanced"	"Detected in some"	23	"Cardiomyocytes: 1.1;Early spermatids: 2.2;Extravillous trophoblasts: 5.4;Late spermatids: 1.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.5"					"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.8;myeloid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018205	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018205: AB_2069267"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.25e-2)"		"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.44e-1)"		"unprognostic (4.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.53e-1)"	0.2	0.1	0.5	0.0	0.6	0.0	0.0	0.2	0.7	0.3	0.1			0.8	0.3	0.9	0.0	0.3	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0		0.4	2.8	0.0	0.2	0.7		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	2.0			0.0		0.0	0.2	0.4	0.0	1.5	0.0	1.8	0.0	0.7	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.3	3.3	0.4	1.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	17.4	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0
CALHM5	"C6orf188, dJ493F7.3, FAM26E, MGC45451"	ENSG00000178033	"Calcium homeostasis modulator family member 5"	Q8N5C1	6	116511646-116524792	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	19	"Alveolar cells type 2: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 6.3;fHDF/TERT166: 6.6;HUVEC TERT2: 6.7;LHCN-M2: 7.1;TIME: 10.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034969, HPA034970"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA034969: AB_10670299, HPA034970: AB_2674390"	"unprognostic (2.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.24e-7)"	"unprognostic (1.16e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.65e-3)"	11.5	1.7	1.0	2.5	1.6	0.2	8.1	0.6	1.7	5.9	4.3	1.9	0.4	1.4	7.9	6.2	7.6	2.9	3.6	10.1	1.2	1.1	6.0	1.4	4.0	5.8	1.5	2.1	4.6	0.8	1.6	1.4	18.5	1.8	5.3	2.6	14.4	2.1	2.6	4.0	3.2	2.9	11.0	1.3	4.0	2.1	5.2	0.6	0.0	4.4	6.8	1.5	8.2	4.0	0.1	0.0	0.1	0.6	0.3	0.0	0.6	0.0	0.0	5.5	0.0	3.4	5.4	0.0	4.3	6.3	1.7	4.7	0.2	0.0	0.0	0.4	6.6	4.7	0.0	0.0	0.0	1.8	0.0	0.2	0.9	0.0	0.0	0.8	0.0	0.0	3.3	0.0	4.1	0.0	1.3	6.7	0.0	0.0	1.3	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	10.6	3.0	1.0	0.3	0.2	0.0	0.0	0.0	2.6	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	1.0	1.6	0.6	1.7	1.2	1.1	1.5	2.1	1.8	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
CALM1	"CALML2, CAMI, DD132, PHKD"	ENSG00000198668	"Calmodulin 1"	P0DP23	14	90396502-90408261	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 176.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018558, HPA044999"	Supported		Approved	Vesicles		NA	NA			Vesicles		"CAB018558: AB_2069454, HPA044999: AB_2679177"	"unprognostic (5.35e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	"prognostic favorable (5.62e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.38e-5)"	47.5	28.1	141.5	26.9	148.2	57.2	21.5	149.6	176.0	27.4	55.9	49.4	20.7	53.9	20.3	41.7	58.8	48.6	29.5	52.3	139.8	86.1	61.5	39.0	38.7	27.8	85.2	100.1	20.9	22.6	41.4	27.6	38.6	106.1	33.7	60.5	22.2	33.2	43.5	100.2	19.3	50.6	42.6	71.1	29.3	35.6	22.3	49.8	12.6	22.7	18.8	37.8	32.7	21.8	45.7	42.8	90.3	53.7	88.8	118.3	109.4	26.9	37.6	44.9	17.2	50.5	44.5	38.4	49.8	42.7	38.5	41.8	40.0	47.9	29.2	26.0	58.7	18.1	45.2	28.1	69.2	64.2	56.8	18.0	30.9	32.4	36.6	27.7	46.8	24.9	27.9	34.6	37.7	13.4	25.6	86.8	20.3	14.2	40.1	52.7	91.7	15.4	45.8	26.1	74.4	52.6	30.9	40.1	19.7	31.8	83.3	94.1	39.5	43.5	76.2	27.8	38.9	50.4	16.4	53.8	32.5	20.8	34.0	41.4	22.4	50.6	32.1	51.4	39.4	45.1	90.3	31.8	71.0	96.0	37.9	118.3	45.7	102.5	101.0	42.8	35.7	74.8	88.1	47.0	88.8	53.7	40.5	105.6	109.4	141.5	148.2	149.6	176.0	139.8	86.1	85.2	100.1	106.1	49.8	360.3	314.0	329.2	485.1	503.7	1352.9	743.7	341.4	1962.0	494.8	378.6	115.8	358.0	389.6	484.7	100.9	794.0	1033.1	23.3	391.9	774.4	358.4	298.0	468.8	297.5	680.0	570.5	576.0	585.0	268.2	58.5	195.1	732.5	595.5	1203.7	393.5	1076.8	427.8	540.1	470.2	1073.9	291.0	310.4	582.3	94.1	162.2	507.4	959.8	581.7	530.3	385.0
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206110	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 44.0;gallbladder: 28.4;intestine: 91.6"	"Cell type enriched"	"Detected in many"	5	"Ciliated cells: 174.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 39.2;non-classical monocyte: 44.0"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	No			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA051109: AB_2681346"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	2.4	2.5	1.8	12.0	1.1	0.8	2.2	2.6	1.0	3.2	40.3	2.2	7.7	34.0	1.5	7.8	5.1	7.3	28.4	1.4	2.6	0.7	12.6	12.3	3.1	2.6	0.9	1.3	2.3	5.3	0.0	3.1	2.1	8.4	4.3	21.8	3.1	1.9	6.7	1.4	1.7	91.6	2.7	1.0	5.3	5.4	2.4	0.6	1.1	1.5	1.3	1.3	1.9	2.0	0.0	4.5	1.8	44.0	0.0	0.0	2.8	2.5	7.8	5.7	3.5	0.6	1.0	4.0	1.6	1.5	2.6	2.6	14.9	16.1	2.5	2.0	1.1	2.3	10.8	12.8	2.3	1.0	2.1	12.4	4.1	13.3	5.2	2.3	3.5	5.5	1.1	3.4	1.5	2.2	2.1	2.9	5.2	3.9	2.9	0.6	7.2	5.7	7.7	4.9	12.0	2.3	8.5	5.6	5.1	0.9	4.3	2.9	3.4	2.5	2.3	6.8	1.8	1.7	3.4	2.5	3.8	3.5	6.6	6.3	10.6	6.3	7.0	2.4	6.9	1.3	0.0	6.5	0.0	0.0	39.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.0	44.0	0.2	0.0	2.8	1.8	1.1	2.6	1.0	2.6	0.7	0.9	1.3	8.4	0.6	0.0	1.0	0.9	0.6	1.3	8.8	0.3	15.3	174.0	26.1	3.5	0.0	0.4	0.0	2.0	4.8	1.9	38.6	0.0	3.9	0.4	1.0	1.2	0.0	7.2	3.1	7.9	7.5	6.7	11.9	0.0	3.4	3.4	0.0	0.0	15.0	1.7	1.8	38.6	6.3	5.8	2.2	0.0	0.3	0.0	0.5	1.8	0.1	1.8	18.3	1.1
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499555	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"salivary gland: 129.5;skin 1: 212.5"	"Cell type enriched"	"Detected in some"	6	"Suprabasal keratinocytes: 341.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"A-431: 95.2"					"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		75000000	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favorable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	8.0	0.3	0.2	6.7	0.2	0.2	0.2	0.0	1.0	0.2	4.8	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	129.5	0.2	1.8	212.5	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.1	0.2	10.9	8.2	0.2	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.2	24.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	341.5	0.0	0.0	0.0	1.4
CAMK1	CaMKI	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757342-9769992	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.5;blood: 59.4"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 76.7;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 59.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 59.4"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 94.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol		NA	NA		550000	Cytosol		"CAB031904: AB_630964, HPA051409: AB_2681473"	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	27.1	60.5	28.0	11.7	26.0	3.5	34.1	12.4	31.2	9.5	10.7	4.4	5.8	6.8	12.6	10.5	7.1	12.6	8.9	10.2	21.4	14.0	13.1	20.7	9.2	10.4	10.3	19.9	21.5	4.5	7.4	7.9	5.1	10.1	18.6	8.1	6.8	5.1	15.1	4.7	3.3	8.3	18.4	7.2	7.1	8.1	13.4	5.6	0.6	7.0	3.7	10.4	9.5	10.3	0.0	3.2	59.4	9.2	0.7	0.4	0.9	0.1	3.7	3.0	0.0	15.4	5.7	7.5	8.8	4.9	10.1	9.6	5.4	0.6	0.2	2.0	5.9	1.5	0.6	0.0	1.1	6.3	0.1	21.6	11.9	7.0	7.5	8.6	1.0	94.0	6.0	0.9	14.2	1.5	8.3	8.4	0.2	1.5	0.2	3.7	2.2	0.0	8.7	2.1	0.1	5.8	0.0	0.1	0.2	6.0	0.6	1.0	3.8	1.5	0.1	0.8	1.3	0.9	15.2	4.4	4.6	5.7	6.5	11.0	0.1	0.0	0.2	9.8	3.3	0.6	3.3	4.8	59.4	0.0	9.2	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.2	0.7	9.2	0.1	0.4	0.9	28.0	26.0	12.4	31.2	21.4	14.0	10.3	19.9	10.1	5.6	0.0	1.9	6.4	17.8	4.4	8.1	0.0	10.2	1.4	2.3	10.4	2.0	0.4	8.3	13.1	1.5	22.7	2.0	0.0	3.6	1.0	11.6	14.9	31.0	21.2	76.7	0.0	5.8	17.8	40.5	3.9	33.4	50.8	5.0	19.0	1.3	30.9	6.0	3.5	42.5	35.3	8.0	58.2	35.0	1.1	1.1	3.3	0.7	7.5	5.5	10.8
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349482-12835545	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 148.3;Cone photoreceptor cells: 369.1;Rod photoreceptor cells: 206.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 47.7;U-266/70: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	5.1	5.3	20.9	10.5	22.1	6.6	4.0	23.4	33.5	8.3	11.5	4.6	10.0	3.8	3.3	3.3	8.7	4.3	6.8	13.8	18.6	7.2	2.2	11.5	7.6	9.3	5.8	17.8	2.6	17.0	1.3	2.5	3.2	5.0	4.9	12.9	11.9	4.5	15.4	1.7	18.5	5.5	5.6	4.9	10.5	3.4	6.2	6.8	20.8	13.6	2.9	12.5	8.1	7.0	7.1	4.2	31.8	3.7	1.4	2.3	1.3	0.1	2.6	3.0	0.2	1.8	0.6	0.2	0.4	0.9	0.6	0.9	3.6	2.0	1.4	0.3	0.2	1.5	1.4	3.6	0.5	0.5	47.7	1.8	5.7	8.5	0.2	0.5	0.1	5.2	0.1	2.3	1.2	0.1	6.4	0.3	3.1	0.1	0.2	0.7	3.0	11.1	2.3	2.0	0.0	1.2	8.5	1.6	2.6	0.1	2.8	4.6	2.1	5.7	2.1	0.0	0.4	1.5	1.4	0.1	2.5	3.7	7.9	1.7	22.0	6.9	4.8	3.7	3.7	0.0	8.3	2.2	31.8	1.8	3.1	1.9	5.6	1.6	2.3	4.2	7.1	1.9	1.3	13.9	1.4	3.7	1.4	0.5	1.3	20.9	22.1	23.4	33.5	18.6	7.2	5.8	17.8	5.0	6.8	3.0	28.0	44.7	7.2	20.4	148.3	10.3	15.3	20.1	29.6	1.8	369.1	0.2	0.0	7.8	7.2	8.3	8.8	0.0	19.1	0.7	22.0	3.5	22.0	11.0	15.1	42.9	15.4	11.1	39.3	7.4	21.9	37.1	3.3	24.4	26.1	18.0	9.6	35.1	57.3	0.5	206.3	25.8	9.2	3.9	9.6	36.0	0.2	10.2	29.3	16.3
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"brain: 105.7;skeletal muscle: 50.1"	"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 3.1;Cardiomyocytes: 11.0;Fibroblasts: 2.8;Melanocytes: 3.3"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Group enriched"	"Detected in all"	6	"amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;SCLC-21H: 9.6;SuSa: 2.6;U-87 MG: 8.1"	"Group enriched"	"Detected in all"	4	"amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1"	"Low region specificity"	"Detected in all"			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		21000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0.0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0.0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0.0	1.2	0.0	1.1	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.5	1.3	0.8	0.7	0.0	0.1	0.0	0.2	0.6	0.1	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.2	1.7	0.0	1.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	9.6	0.0	0.1	0.2	0.3	2.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3	0.0	0.0	0.0	0.0	3.1	0.1	11.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.4	0.8	0.0	0.0	1.1	0.0	0.2	1.3	0.2	0.0	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell type enriched"	"Detected in many"	11	"Bipolar cells: 838.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.8	0.0	1.1	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.2	0.1	0.0	2.4	0.1	0.9	0.1	0.0	0.0	42.0	2.2	0.2	0.0	0.0	0.1	1.9	0.2	0.2	0.2	0.4	0.2	0.0	0.5	0.4	0.1	0.2	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8	0.0	0.0	0.0	27.8	1.0	838.1	74.9	2.5	0.0	0.0	0.0	43.2	0.0	8.3	0.0	0.8	0.6	0.0	0.0	0.0	0.1	0.4	2.6	4.6	4.4	0.2	57.2	39.0	0.0	1.2	2.1	1.7	0.0	1.7	0.0	0.0	14.1	0.1	0.0	0.0	0.8	46.7	0.0	0.9	0.0	1.7	0.4	0.2	0.0	0.0	0.7
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		140000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	22.8	12.9	47.7	18.3	13.0	2.8	23.5	50.2	30.6	11.0	18.2	7.4	28.6	13.6	11.6	9.4	15.6	9.6	14.8	77.1	17.9	21.4	9.6	17.6	14.7	17.5	14.0	23.8	12.9	7.4	33.7	7.0	9.3	12.5	16.3	19.0	9.9	9.4	48.3	48.5	10.8	19.2	26.2	16.0	8.4	17.6	9.4	8.5	11.2	11.6	9.8	14.5	21.5	22.6	18.5	11.2	0.6	8.8	6.4	9.7	5.2	1.0	14.5	16.1	5.4	35.2	67.4	5.7	34.1	22.8	13.4	11.6	9.8	4.1	20.9	5.0	23.7	17.0	0.5	10.0	5.3	13.7	8.0	2.5	0.0	5.3	11.2	17.9	0.0	0.0	43.0	7.3	10.4	25.8	21.3	11.9	2.6	0.8	9.3	25.3	3.9	2.1	0.8	2.3	13.9	5.4	4.0	18.9	0.1	13.7	9.9	4.3	4.4	4.6	6.9	4.6	14.0	0.1	5.6	7.1	35.5	8.4	15.1	6.7	7.3	3.6	17.9	18.3	1.3	16.7	0.0	8.8	0.0	5.1	5.1	9.7	8.0	5.0	5.6	11.2	18.5	5.8	4.9	0.6	6.4	1.7	0.0	9.3	5.2	47.7	13.0	50.2	25.6	17.9	21.4	14.0	23.8	12.5	8.5	38.7	29.9	22.6	16.0	16.4	72.0	243.3	58.6	20.1	28.4	27.9	82.5	0.4	5.0	6.4	2.9	29.8	57.0	0.0	17.5	0.4	34.7	31.3	9.3	49.4	15.8	68.3	99.5	19.6	16.8	4.5	18.7	21.0	5.0	2.8	82.1	41.3	11.4	45.6	18.7	17.7	71.5	6.5	33.3	2.9	4.4	27.9	0.9	17.5	41.1	16.3
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 94.2;Cytotrophoblasts: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 39.8"	"Cell line enhanced"	"Detected in all"		"PC-3: 46.3;SK-BR-3: 58.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		170000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	9.1	8.8	27.4	9.4	20.7	17.4	6.8	22.2	53.8	9.0	37.3	13.3	9.7	19.7	20.1	9.1	20.6	13.2	10.6	6.7	22.8	24.4	11.6	5.9	10.7	8.9	26.8	31.2	6.4	5.7	8.0	6.0	15.8	38.6	18.5	15.5	8.5	12.4	29.8	73.0	9.1	18.1	29.6	29.8	11.0	14.2	3.8	13.4	4.4	6.4	7.6	8.7	26.5	10.8	4.2	7.1	39.8	5.6	9.8	9.2	5.0	11.1	8.0	7.3	13.9	5.3	8.7	8.6	7.6	13.2	10.6	8.7	12.5	12.0	8.2	8.1	9.8	4.1	17.4	5.7	6.5	8.4	7.5	6.8	5.6	6.2	5.6	2.6	7.6	9.5	4.6	5.9	10.5	7.3	16.3	9.0	10.6	6.1	12.4	5.8	7.8	12.7	11.4	5.3	6.8	46.3	11.6	7.6	4.3	5.5	16.2	3.8	8.8	4.4	58.3	3.7	5.6	10.9	4.8	11.0	7.9	12.7	4.2	10.3	3.8	4.5	7.7	8.4	21.9	2.8	8.5	5.6	39.8	7.5	2.3	9.2	4.2	8.4	8.0	7.1	3.9	8.1	7.9	36.4	9.8	4.0	2.4	8.1	5.0	27.4	20.7	22.2	53.8	22.8	24.4	26.8	31.2	38.6	13.4	14.9	9.4	11.5	7.6	8.4	55.8	6.1	15.3	6.7	9.1	7.0	94.2	130.5	11.6	10.6	1.9	18.0	50.5	0.0	17.2	36.6	11.5	7.3	16.1	7.8	22.8	25.4	23.0	12.3	13.6	2.3	11.8	10.5	11.8	5.4	20.0	16.3	16.9	51.8	17.7	27.0	74.1	45.3	50.6	0.5	10.6	11.0	67.9	22.4	26.2	10.7
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell type enriched"	"Detected in some"	11	"Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.3	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.2	2.7	2.8	0.4	0.5	0.4	2.8	0.2	5.5	1.5	0.7	0.5	1.5	9.3	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.7	0.4	1.9	0.6	0.0	0.3	0.0	3.3	0.4	6.0	0.1	0.1	8.1	0.2	3.7	19.0	5.5	1.6	0.6	2.2	20.0	4.3	1.8	0.5	0.1	0.1	6.1	0.1	0.0	20.8	9.1	1.9	3.3	2.2	3.3	2.7	4.8	1.2	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5	0.0	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	58.8	3.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	4.8	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49870222	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"brain: 77.2"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 2.3;Cone photoreceptor cells: 2.0;Early spermatids: 4.6;Horizontal cells: 3.2;Late spermatids: 6.5"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"AF22: 5.3;HAP1: 7.0;NTERA-2: 25.2;RPMI-8226: 4.8;SCLC-21H: 8.6;SH-SY5Y: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"		NA	NA			Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	1.2	2.1	20.7	1.2	77.2	1.2	1.2	0.5	62.8	1.2	1.2	1.7	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	33.4	11.7	1.2	1.2	1.2	1.2	3.3	23.5	1.2	1.2	1.2	1.8	1.2	2.1	1.2	1.2	0.0	1.2	1.2	1.2	1.3	1.2	1.2	1.9	1.2	1.3	2.1	6.0	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	5.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.1	0.7	0.1	25.2	0.0	0.1	0.8	0.0	4.8	0.0	0.0	8.6	5.5	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	20.7	77.2	0.5	34.0	33.4	11.7	3.3	23.5	2.1	6.0	0.0	0.0	0.0	0.0	0.2	2.3	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.2	1.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.7	0.1	0.2	0.0	0.1	0.0
CAMLG	"CAML, GET2"	ENSG00000164615	"Calcium modulating ligand"	P49069	5	134738501-134752160	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 658.5;Late spermatids: 1206.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052636, HPA056472"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Vesicles	"Nucleoplasm, Nucleoli"	"HPA052636: AB_2681893, HPA056472: AB_2683143"	"unprognostic (9.23e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.16e-1)"	24.2	29.0	37.6	14.3	32.4	22.7	29.3	28.2	39.3	33.3	32.7	15.5	20.2	26.1	31.7	45.2	21.4	23.0	21.8	22.3	32.4	38.3	20.1	19.7	18.9	18.4	36.2	22.7	53.0	25.7	14.8	21.9	14.0	22.4	27.5	14.3	21.7	15.9	26.2	32.5	19.7	22.2	30.4	26.0	15.1	17.7	36.6	14.0	21.1	21.6	18.5	19.3	40.3	20.0	25.0	16.1	32.1	23.3	16.6	28.6	17.4	9.6	7.5	12.8	23.8	28.5	44.2	5.8	13.7	19.9	10.2	19.4	13.7	14.7	39.3	20.1	9.5	15.9	12.5	10.5	16.7	14.6	18.3	19.5	10.4	13.6	11.1	21.0	5.5	33.0	35.8	18.2	12.6	21.7	33.9	19.3	17.4	6.6	18.3	15.2	10.7	14.5	23.3	6.6	12.0	7.6	16.4	17.0	15.1	17.5	9.4	19.0	13.3	9.8	6.3	32.7	17.2	17.3	11.5	18.4	10.0	6.2	15.2	12.4	17.2	18.6	15.0	16.8	17.4	5.4	32.1	15.2	32.1	18.3	17.3	24.6	25.0	26.4	22.9	16.1	22.4	27.8	26.8	27.6	16.6	23.3	14.7	28.6	17.4	37.6	32.4	28.2	39.3	32.4	38.3	36.2	22.7	22.4	14.0	35.7	31.3	84.3	104.0	148.5	76.2	38.6	76.5	32.1	48.9	40.1	23.6	43.8	77.9	53.1	658.5	74.5	44.2	0.0	78.9	53.3	107.2	105.7	119.1	66.0	62.6	52.4	60.0	81.6	102.8	1206.3	155.6	92.2	91.1	124.4	64.9	79.0	61.6	59.6	124.5	149.1	63.7	97.0	161.7	114.4	74.5	176.2	61.2	108.0	83.2	90.1
CAMSAP2	"CAMSAP1L1, KIAA1078"	ENSG00000118200	"Calmodulin regulated spectrin associated protein family member 2"	Q08AD1	1	200739558-200860704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026304, HPA026511, HPA027302"	Enhanced		Supported	"Microtubule ends,Cytosol"		NA	NA			"Microtubule ends"	Cytosol	"HPA026304: AB_1852376, HPA026511: AB_1852378, HPA027302: AB_1852380"	"unprognostic (1.19e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (8.23e-3)"	"unprognostic (9.56e-2)"	11.6	11.9	12.8	4.5	15.2	0.1	7.4	16.8	29.7	11.3	5.8	16.6	5.9	2.7	14.4	7.7	8.1	6.6	8.9	7.7	13.0	11.9	8.9	5.0	10.5	2.3	10.3	11.1	14.5	3.9	20.7	6.1	13.0	17.4	8.2	4.7	8.6	5.0	10.0	5.4	9.0	2.7	11.6	10.2	5.6	5.0	10.1	7.0	1.8	13.8	5.3	4.1	13.1	7.4	0.1	0.5	0.7	0.6	0.0	1.4	0.1	11.4	7.7	10.7	9.6	8.6	11.5	12.3	11.6	10.0	9.4	7.8	5.6	6.9	0.0	6.6	12.8	8.6	10.3	11.0	17.1	11.3	6.8	5.6	0.6	11.7	2.5	9.7	0.7	2.9	8.3	26.4	15.0	58.9	10.1	14.2	1.0	1.4	3.6	15.1	6.0	0.1	0.2	10.0	3.5	11.0	4.6	11.8	5.2	8.0	8.5	5.6	10.0	17.0	10.6	9.6	13.6	10.1	0.6	16.9	15.4	9.1	9.5	14.3	7.3	12.1	6.1	11.1	1.8	11.6	0.7	0.6	0.0	0.3	0.1	0.4	0.1	1.4	0.0	0.5	0.0	1.4	0.4	0.0	0.0	0.1	0.2	0.8	0.1	12.8	15.2	16.8	16.3	13.0	11.9	10.3	11.1	17.4	7.0	56.6	33.7	0.0	26.4	71.0	45.8	78.1	5.1	5.3	47.8	14.0	13.7	14.9	1.7	13.5	26.4	49.5	1.6	0.0	7.0	14.2	39.9	20.8	4.7	5.0	8.6	47.7	11.3	33.2	11.8	27.7	26.4	18.8	18.6	2.8	2.4	58.6	14.1	2.5	42.8	4.5	15.4	25.8	43.3	21.7	16.2	43.0	33.4	1.9	3.3	28.4
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987652	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	9.8	6.4	27.0	9.2	25.2	6.4	5.4	63.6	44.9	6.2	8.0	6.4	3.8	7.3	6.2	3.1	8.4	6.8	6.1	8.0	33.8	17.4	5.5	4.2	8.8	6.2	11.7	19.1	6.7	11.7	14.8	21.3	5.1	18.5	6.8	8.0	5.5	8.7	9.1	20.1	8.6	9.0	10.5	6.5	8.7	8.0	9.0	8.8	2.7	6.5	2.9	6.5	6.5	4.7	1.3	2.2	5.7	8.1	1.1	2.7	2.1	8.0	14.4	2.7	3.8	18.1	12.6	5.6	7.8	8.7	7.4	6.6	3.6	2.2	9.5	7.6	12.2	6.3	8.2	10.2	12.2	4.2	13.3	13.2	6.0	7.8	4.0	10.4	3.5	25.8	8.7	15.3	7.0	11.0	9.0	12.3	7.4	9.7	8.7	6.9	5.3	6.2	2.2	0.4	9.6	6.0	5.4	3.0	3.7	8.4	8.5	3.7	3.2	4.9	9.0	2.4	4.8	7.9	3.5	16.3	5.9	3.5	6.2	12.7	4.4	4.7	3.4	14.4	7.0	5.7	1.0	2.2	1.8	2.7	3.0	2.1	1.3	1.2	2.5	1.4	0.9	1.8	2.0	5.7	1.1	8.1	2.2	1.1	2.1	27.0	25.2	63.6	44.9	33.8	17.4	11.7	19.1	18.5	8.8	3.0	13.7	8.3	3.5	6.2	12.1	5.9	15.3	5.3	3.4	10.4	9.8	5.2	1.7	6.8	29.0	6.9	16.3	0.0	9.8	6.8	6.8	5.5	12.7	11.9	7.7	33.4	10.9	14.1	9.2	39.5	9.5	8.0	3.3	8.2	13.1	4.3	9.1	12.4	8.9	10.5	9.6	12.9	12.3	5.2	7.6	9.2	10.4	10.2	9.5	3.4
CAND2	"KIAA0667, TIP120B, Tp120b"	ENSG00000144712	"Cullin associated and neddylation dissociated 2 (putative)"	O75155	3	12796472-12871916	"Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 76.2"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 98.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 18.4;REH: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005777	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"HPA005777: AB_2667431"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.78e-5)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-3)"	2.9	2.8	6.4	1.4	7.6	1.4	1.4	7.2	11.8	2.3	3.2	3.7	0.5	1.5	3.7	2.6	2.6	3.6	2.1	17.8	4.7	4.3	1.7	1.7	1.9	1.4	2.7	5.5	3.3	2.5	6.4	4.9	1.4	3.1	3.0	1.4	4.2	2.2	3.4	76.2	1.6	1.7	5.2	2.2	2.2	2.1	11.4	2.6	0.1	2.4	11.1	1.2	3.0	5.0	1.2	0.2	0.7	0.5	0.0	2.2	0.6	0.7	1.5	5.8	0.2	0.2	0.1	0.3	1.7	0.6	3.1	4.3	0.8	0.3	0.9	1.7	0.8	0.8	0.2	6.4	0.1	2.8	1.6	18.4	1.3	2.2	1.2	4.9	0.1	0.1	1.3	0.3	3.1	0.1	3.3	0.7	6.8	4.7	0.9	0.9	3.0	2.3	0.7	4.1	0.4	1.8	11.4	1.1	0.9	0.2	1.3	3.9	5.2	0.1	0.8	1.0	1.1	1.7	5.6	0.4	0.9	1.0	0.9	1.2	1.5	9.0	8.7	0.5	1.1	1.9	0.0	0.5	0.0	1.2	0.2	0.6	1.2	0.6	2.2	0.1	0.5	1.3	0.9	0.7	0.0	0.1	0.2	1.6	0.6	6.4	7.6	7.2	11.8	4.7	4.3	2.7	5.5	3.1	2.6	3.0	0.6	0.0	0.7	0.3	13.3	3.6	0.0	0.0	1.2	1.8	9.8	0.1	0.0	0.6	98.3	1.0	0.0	0.0	0.0	0.1	1.3	0.4	0.0	2.1	3.2	12.7	0.0	1.8	0.0	17.8	4.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	9.6	0.5	2.5	0.0	1.7	1.4	3.8	0.1	0.1	0.7	0.0	0.3
CAP1	CAP	ENSG00000131236	"Cyclase associated actin cytoskeleton regulatory protein 1"	Q01518	1	40040233-40072649	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 201.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 203.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030124	Approved		Approved	Cytosol		NA	NA		270000000	Cytosol		"HPA030124: AB_10600799"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.44e-6)"	"unprognostic (5.37e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	70.0	31.8	33.3	68.7	41.0	74.6	42.4	16.6	37.4	40.1	58.2	42.7	25.2	37.9	69.4	28.9	60.9	44.6	36.9	27.2	28.6	26.6	56.6	52.0	58.2	63.7	37.2	26.9	44.5	22.6	29.7	22.5	74.4	39.5	42.0	57.7	31.3	39.8	39.7	20.6	37.1	58.9	62.9	42.7	79.9	44.6	39.0	30.0	62.4	40.2	32.6	83.1	53.3	40.8	27.4	70.6	201.2	106.1	37.2	57.6	115.5	44.9	19.5	24.7	14.6	35.1	32.9	36.8	79.7	48.2	45.0	45.4	28.1	47.8	35.0	32.5	65.6	30.8	28.3	29.6	58.4	62.1	46.7	17.5	54.8	21.5	22.1	32.3	33.8	156.3	33.6	30.1	68.7	38.9	50.7	37.9	20.3	20.4	23.5	67.3	13.3	26.8	18.5	40.0	33.0	21.9	20.3	32.8	21.4	47.6	47.6	11.7	24.6	33.9	39.3	54.2	51.1	18.2	203.6	67.5	38.5	35.0	20.1	67.5	19.2	37.6	32.1	50.6	37.7	50.4	95.4	60.2	201.2	57.6	88.9	45.3	27.4	41.7	55.1	70.6	26.3	35.4	47.9	128.3	37.2	106.1	27.7	55.1	115.5	33.3	41.0	16.6	37.4	28.6	26.6	37.2	26.9	39.5	30.0	113.2	90.0	165.3	126.1	99.7	40.3	13.7	86.6	73.6	78.5	108.2	25.5	179.9	94.5	335.8	422.5	137.1	167.8	0.0	239.7	381.4	126.1	105.8	219.9	66.5	383.8	39.7	73.1	171.2	376.6	351.4	81.4	395.6	94.5	634.8	120.1	147.6	544.5	150.5	166.2	105.9	41.2	161.7	157.2	125.6	45.8	116.1	198.9	232.9	110.6	183.3
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393216-17557792	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 165.7"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 110.1;Ciliated cells: 48.2;Sertoli cells: 32.3;Smooth muscle cells: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"MAIT T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	5.8	4.1	13.8	3.0	20.1	0.7	3.9	7.5	26.4	5.6	7.7	1.9	2.0	1.9	9.2	5.9	7.0	5.8	3.8	31.2	19.9	8.7	3.3	2.0	2.1	1.1	5.3	17.3	2.1	1.6	3.2	1.7	6.2	8.6	8.4	3.6	2.9	2.5	10.1	165.7	0.9	2.6	13.1	2.0	1.6	3.3	1.1	1.3	0.0	2.3	14.5	1.3	4.6	6.4	0.0	0.0	0.0	0.0	0.0	2.9	0.1	5.1	8.1	15.7	18.7	0.1	0.0	3.4	18.5	13.5	15.2	13.9	2.6	2.3	0.0	17.4	19.8	21.3	2.7	6.9	6.9	22.1	0.0	2.6	0.0	5.2	8.8	1.5	0.0	0.0	1.1	3.4	7.7	3.3	24.9	0.7	0.0	0.0	0.0	32.1	8.3	0.0	0.0	5.9	0.2	4.6	1.7	20.8	0.3	8.0	2.1	2.0	3.9	6.2	20.1	10.9	30.1	22.2	3.7	0.0	12.3	11.7	0.3	16.2	0.0	0.0	0.0	4.1	0.0	16.8	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	20.1	7.5	26.4	19.9	8.7	5.3	17.3	8.6	1.3	3.0	1.0	0.0	3.5	1.6	13.5	110.1	2.5	48.2	5.7	1.8	3.9	14.9	3.3	2.4	0.1	1.0	0.0	0.0	0.6	10.7	8.2	1.4	0.0	1.8	1.9	7.9	5.8	4.9	0.0	0.0	0.6	0.0	0.0	0.0	1.1	5.0	3.6	2.0	4.6	16.1	2.0	32.3	40.1	0.1	2.1	0.6	31.4	0.0	1.5	0.7
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586716-240617705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: AB_2683037"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favorable (8.47e-5)"	"prognostic unfavorable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	9.2	11.8	16.8	12.9	15.1	10.9	6.6	20.5	15.7	8.3	13.6	12.8	10.0	20.8	11.3	8.0	9.7	9.8	10.2	11.5	15.9	10.7	14.2	9.3	8.4	15.3	11.2	18.1	10.0	13.0	8.6	13.2	7.3	11.1	10.6	12.2	12.4	14.6	10.7	6.5	19.5	16.2	8.3	8.1	21.0	15.0	10.7	13.7	15.1	9.3	5.6	13.2	8.3	7.0	1.5	2.0	7.7	1.8	5.8	2.2	0.8	5.2	7.9	7.8	6.0	3.0	2.5	13.6	6.7	2.8	4.5	4.3	5.8	12.5	4.0	2.3	2.3	6.3	8.9	2.0	4.5	2.3	15.1	13.8	7.3	13.1	10.1	4.9	4.7	10.3	2.2	3.1	4.7	1.9	4.6	3.3	11.5	8.1	5.0	1.8	4.6	10.5	18.0	11.7	6.3	5.5	10.0	5.5	8.4	7.0	6.2	19.7	15.4	4.3	6.1	8.5	2.7	3.1	5.8	5.8	7.7	6.6	6.2	8.0	12.3	2.8	7.1	7.3	8.6	7.2	1.7	1.8	3.3	2.0	1.0	0.5	1.5	1.3	2.0	0.8	1.5	1.2	1.8	7.7	5.8	1.1	2.0	2.2	0.8	16.8	15.1	20.5	15.7	15.9	10.7	11.2	18.1	11.1	13.7	3.0	5.9	3.7	6.1	4.0	12.5	8.1	12.7	4.0	3.4	8.7	13.7	4.1	6.6	11.8	1.3	5.5	7.8	0.0	7.9	4.3	3.7	7.6	23.0	3.0	5.9	46.1	10.9	4.9	3.2	2.0	8.3	7.0	1.7	9.0	4.9	11.6	11.2	3.5	8.9	5.1	16.7	0.0	6.2	12.1	8.0	4.5	4.6	5.0	6.0	6.0
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 27.1;Cholangiocytes: 50.9;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	7	"basophil: 24.5;NK-cell: 12.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.5;NK-cells: 12.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 17.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hippocampal formation: 3.6"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Nucleoplasm	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.6	0.4	0.2	4.7	0.2	0.2	0.7	0.2	0.3	4.2	4.1	0.1	5.6	1.2	1.1	1.0	1.2	3.6	21.0	0.7	1.0	0.4	7.1	21.8	2.0	1.8	0.2	0.1	0.4	5.0	0.2	0.7	0.5	2.4	2.2	0.7	0.4	34.3	3.0	0.3	4.5	1.9	0.5	0.4	4.9	1.6	0.6	0.1	0.4	0.4	1.6	5.2	1.5	1.0	1.7	0.0	24.5	0.0	12.7	2.6	0.7	0.2	1.8	0.1	0.0	0.3	0.1	2.2	0.1	0.0	0.0	0.1	3.2	0.1	0.7	0.1	0.0	0.3	1.3	0.0	0.8	0.0	0.1	0.0	0.3	0.7	0.9	0.0	0.0	17.6	0.8	2.5	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.1	0.4	0.1	0.4	0.1	1.4	0.0	0.0	0.1	0.0	0.4	0.9	0.7	0.0	0.1	0.0	0.7	24.5	0.0	1.8	2.6	0.0	2.5	1.5	0.7	1.3	0.0	1.7	0.0	0.6	0.4	12.7	0.0	0.0	0.5	0.7	0.2	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.4	0.1	11.9	27.1	15.9	8.0	8.4	1.2	0.6	50.9	5.3	5.7	5.2	0.0	1.5	0.0	9.1	0.4	1.8	4.2	0.0	6.3	8.2	1.1	2.3	4.7	12.7	0.9	0.0	3.5	1.3	1.0	0.2	0.6	2.0	3.3	0.0	18.8	1.7	4.0	3.5	0.4	16.5	0.6	0.0	1.7	0.3	2.4	8.3	2.4	25.4	16.4	4.3
CAPN13	FLJ23523	ENSG00000162949	"Calpain 13"	Q6MZZ7	2	30722771-30820542	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 67.3;pancreas: 20.4;stomach 1: 17.6"	"Cell type enhanced"	"Detected in many"	8	"Club cells: 21.6;Enterocytes: 20.8;Intestinal endocrine cells: 14.5;Undifferentiated cells: 17.1;Urothelial cells: 20.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RT4: 9.0;SK-BR-3: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029496, HPA029497, HPA030034"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281"	"unprognostic (7.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.28e-3)"	0.2	0.0	0.5	0.5	0.4	0.0	4.8	0.2	0.2	6.2	39.6	0.3	0.2	13.0	1.1	0.6	1.1	0.5	7.4	0.2	0.8	0.4	2.0	0.2	9.4	0.2	0.7	0.3	0.4	20.4	0.6	1.2	0.2	0.2	5.2	16.0	0.2	1.0	0.2	0.2	0.1	67.3	1.6	1.0	0.2	17.6	0.2	0.2	0.2	0.2	0.5	1.0	3.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	9.0	0.1	0.4	0.0	21.7	0.0	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.2	0.8	0.4	0.7	0.3	0.2	0.2	6.0	1.9	0.0	7.5	0.0	0.0	1.7	0.0	8.1	21.6	1.8	0.0	0.0	0.0	0.7	0.8	0.0	20.8	0.0	4.8	0.0	0.0	1.9	1.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	1.5	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.1	20.1
CAPN15	SOLH	ENSG00000103326	"Calpain 15"	O75808	16	527717-554636	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 15.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011960	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011960: AB_10610556"	"unprognostic (4.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.54e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.23e-3)"	9.2	7.7	7.1	13.1	6.8	12.0	12.0	20.4	10.9	5.6	15.7	5.7	8.6	26.1	7.9	5.4	10.7	7.5	13.4	5.9	9.8	2.9	9.7	14.1	8.6	8.2	5.8	4.7	8.2	20.5	4.3	9.1	6.1	5.0	7.2	4.7	3.7	11.7	6.9	11.4	14.3	24.7	7.0	3.4	16.8	21.9	10.8	4.1	9.7	6.9	6.6	11.8	6.4	11.8	2.7	0.5	15.8	1.1	1.1	0.4	0.2	8.4	11.0	1.6	4.8	0.9	1.8	24.5	9.1	2.4	2.6	1.8	14.4	6.2	12.3	8.8	1.6	2.6	11.3	1.0	3.6	0.9	12.7	19.4	10.2	11.3	8.8	3.9	11.9	14.4	2.0	2.1	2.6	1.2	1.5	2.8	7.6	18.6	3.7	0.8	13.1	13.3	13.1	14.2	4.4	10.5	23.3	4.5	12.1	1.7	5.5	10.3	9.4	6.0	8.4	5.1	1.0	6.9	12.5	13.4	8.1	11.4	8.2	11.3	9.8	5.4	10.5	3.5	7.0	5.0	3.0	1.1	0.7	0.2	0.8	0.1	0.3	0.1	0.4	0.3	2.7	0.1	0.2	15.8	1.1	1.0	0.5	0.2	0.2	7.1	6.8	20.4	10.9	9.8	2.9	5.8	4.7	5.0	4.1	3.0	9.6	6.0	3.8	7.9	11.8	2.5	10.2	1.4	3.4	7.0	15.7	3.1	1.7	6.3	15.0	7.2	31.5	0.0	13.3	3.5	6.7	8.6	6.9	15.3	6.0	19.1	4.1	8.0	13.5	5.3	6.9	4.8	1.7	2.8	24.3	7.8	10.5	24.9	4.2	4.1	11.4	0.0	3.8	4.9	6.4	6.9	2.1	7.5	19.9	11.9
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066932-77126155	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.5;intestine: 47.8"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 114.7;Mucus-secreting cells: 72.0;Paneth cells: 69.1;Undifferentiated cells: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"OE19: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	3.9	7.1	5.6	19.5	5.4	1.5	3.9	6.3	10.8	7.4	34.1	6.0	4.8	32.7	6.3	8.3	18.3	6.6	49.5	4.4	5.4	4.6	8.7	26.8	2.8	1.2	3.7	7.0	15.4	3.2	0.7	3.3	2.6	10.2	9.3	27.9	7.4	4.7	7.5	1.8	1.9	47.8	9.3	4.1	2.2	29.3	22.0	2.3	0.6	3.1	4.6	7.3	9.8	6.3	0.2	0.7	0.0	0.9	0.0	4.8	2.1	0.3	5.5	3.7	3.6	13.9	13.4	0.3	5.5	9.6	5.7	4.2	3.2	1.6	0.2	4.0	9.6	6.5	0.2	1.5	0.4	2.4	0.3	0.3	1.1	0.1	0.3	3.5	0.1	0.3	6.6	0.6	9.2	2.2	8.0	6.6	2.6	0.1	0.1	10.6	7.7	0.9	0.1	3.1	44.2	4.3	0.8	12.5	0.2	1.9	6.9	0.2	6.7	1.3	1.0	2.5	2.4	0.8	0.0	13.7	11.1	6.6	15.3	0.7	0.4	0.7	0.0	5.7	0.1	2.6	0.0	0.7	0.0	4.8	0.9	0.4	0.0	0.5	1.6	0.7	0.2	2.4	2.5	0.0	0.0	0.2	0.3	0.0	2.1	5.6	5.4	6.3	10.8	5.4	4.6	3.7	7.0	10.2	2.3	0.0	0.3	0.8	0.2	1.4	1.5	1.7	28.1	4.0	7.9	22.7	0.0	0.0	1.7	9.0	0.9	2.1	114.7	0.0	29.7	0.4	6.2	2.3	0.0	37.5	0.8	1.6	21.5	2.5	1.8	1.1	11.5	1.2	6.8	0.0	72.0	6.4	15.2	69.1	4.2	5.9	1.8	0.0	2.2	0.4	2.3	0.6	0.0	0.0	49.0	1.4
CAPN6	"CalpM, CANPX, CAPNX"	ENSG00000077274	"Calpain 6"	Q9Y6Q1	X	111245103-111270523	"Cancer-related genes, Enzymes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 62.9;placenta: 173.5"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 165.5;Syncytiotrophoblasts: 117.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 25.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.2;plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.1;NTERA-2: 15.8;SuSa: 14.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA040259			Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA040259: "	"unprognostic (1.27e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.12e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.30e-2)"	1.7	0.0	0.2	1.7	0.2	0.0	6.0	0.3	0.3	3.9	4.2	0.2	23.4	0.2	18.2	62.9	2.4	2.9	2.6	0.4	0.2	0.0	5.1	0.4	0.3	1.1	0.2	0.4	1.9	4.1	0.0	0.2	173.5	0.3	3.6	2.2	2.1	5.6	21.7	1.7	1.0	1.3	2.0	0.3	1.0	7.2	2.8	0.2	0.5	1.7	4.7	2.9	1.4	2.6	0.1	2.0	0.8	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	15.8	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.3	0.4	0.3	0.0	14.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.4	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.3	10.2	0.0	0.0	7.0	0.0	35.2	3.3	5.0	0.0	0.0	0.0	0.0	0.6	165.5	2.6	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.3	0.0	2.7	0.0	20.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	117.5	0.0	0.0	0.3
CAPN7	PalBH	ENSG00000131375	"Calpain 7"	Q9Y6W3	3	15206152-15252918	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004745, HPA046617"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA004745: , HPA046617: AB_2679721"	"unprognostic (2.70e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.85e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.05e-2)"	16.3	15.0	9.7	12.8	13.4	10.5	18.9	21.7	13.7	18.6	15.5	11.1	14.3	11.8	17.6	15.9	13.4	16.7	10.4	13.8	9.2	8.9	14.8	17.6	17.9	20.0	11.4	8.4	20.6	15.9	20.4	29.0	14.7	11.7	14.7	11.7	15.9	15.9	12.7	33.7	14.9	14.5	19.5	14.1	12.1	15.2	12.1	12.3	19.3	22.6	11.1	14.5	17.7	14.5	6.6	5.1	8.7	7.0	5.8	10.0	5.0	8.7	11.5	9.6	6.0	16.9	13.2	32.8	11.3	13.0	14.1	10.8	8.2	6.3	15.1	7.9	12.8	8.7	6.1	14.1	14.5	12.3	14.4	11.1	18.9	16.2	10.8	12.6	15.1	9.6	9.0	21.2	18.3	9.1	13.4	10.0	14.6	18.2	15.9	13.6	12.7	10.7	6.3	9.2	12.7	11.3	6.2	16.0	10.4	10.5	16.0	7.8	10.1	18.4	10.0	12.5	12.8	17.6	15.9	8.9	12.8	9.7	16.5	13.1	11.1	22.0	7.7	11.6	11.1	11.0	6.3	5.4	8.7	6.4	4.4	10.0	6.6	7.0	5.2	5.1	5.9	9.6	8.8	3.2	5.8	7.0	4.3	5.1	5.0	9.7	13.4	21.7	13.7	9.2	8.9	11.4	8.4	11.7	12.3	11.9	17.6	15.2	14.2	19.1	41.7	27.4	7.6	45.5	27.3	1.8	53.0	17.3	8.3	10.3	11.3	16.8	10.2	23.3	14.8	10.3	16.0	16.9	15.1	14.3	10.6	52.4	20.1	15.4	12.4	11.7	23.0	15.2	20.3	12.6	9.8	37.3	10.8	7.0	24.8	12.2	99.8	38.8	22.8	22.4	14.7	20.3	21.9	17.0	10.3	7.3
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665734	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 32.0;stomach 1: 85.8"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 123.4;Club cells: 94.4;Mucus-secreting cells: 49.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"OE19: 51.0;RT4: 30.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	NA			"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: AB_2686646"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.2	0.0	0.5	10.3	0.3	0.0	7.5	0.2	0.3	1.0	7.9	0.6	0.2	2.2	0.3	3.3	0.6	0.4	32.0	0.2	0.2	0.1	2.5	0.2	13.0	0.2	0.2	0.2	0.2	8.0	0.0	0.2	0.8	0.2	4.6	9.9	0.2	4.6	0.3	0.3	1.5	4.0	3.2	0.2	0.2	85.8	0.4	0.2	0.3	0.2	1.5	1.2	15.1	3.9	0.4	0.0	1.1	0.0	0.0	1.4	1.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.1	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	51.0	1.6	0.0	0.0	0.0	0.6	30.2	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.9	0.7	0.0	0.0	0.1	1.4	1.1	0.0	0.0	0.0	0.0	1.5	0.5	0.3	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2	26.8	123.4	0.0	6.0	0.1	0.0	2.2	15.3	24.1	94.4	24.4	0.0	0.1	0.0	0.4	1.4	0.0	30.0	0.0	19.7	0.0	0.0	3.3	10.4	0.0	0.5	0.0	2.9	0.0	0.0	3.5	1.7	0.4	0.0	0.0	49.6	0.0	21.9	16.9	3.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.0	13.2	15.4
CAPN9	"GC36, nCL-4"	ENSG00000135773	"Calpain 9"	O14815	1	230747384-230802003	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.6;lung: 19.8;stomach 1: 35.8"	"Group enriched"	"Detected in many"	10	"Alveolar cells type 1: 23.8;Mucus-secreting cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Group enriched"	"Detected in some"	6	"OE19: 11.9;SCLC-21H: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020398, CAB033483, HPA062050"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: "	"unprognostic (2.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.97e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.16e-1)"	0.2	0.7	0.4	7.0	0.3	0.0	0.2	0.3	0.5	0.4	10.4	0.4	0.2	3.9	0.2	0.2	0.7	1.5	12.7	0.2	0.5	0.2	0.2	0.2	19.8	0.2	0.6	0.2	0.3	0.2	0.0	0.6	0.2	0.2	0.8	13.7	0.2	8.1	0.2	1.3	0.0	17.6	0.2	1.1	0.2	35.8	0.2	0.2	0.2	0.2	1.0	7.1	3.7	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.1	0.0	0.6	11.9	0.0	0.4	0.0	0.0	0.0	0.1	17.1	0.0	0.0	0.5	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.4	0.5	0.2	0.6	0.2	0.2	0.2	23.8	4.8	0.0	0.5	0.0	0.0	3.3	0.0	4.0	3.4	0.0	0.0	0.0	0.0	0.2	4.5	0.0	3.5	0.0	0.2	0.0	0.0	0.4	2.3	0.0	0.1	0.0	2.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.4	0.2	1.1	3.5	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	1.0
CAPNS1	"30K, CANP, CANPS, CAPN4, CDPS"	ENSG00000126247	"Calpain small subunit 1"	P04632	19	36139575-36150353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006872	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		50000000	"Nucleoplasm, Cytosol"		"HPA006872: AB_1078382"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-2)"	67.8	59.4	58.7	49.6	53.1	47.1	54.4	29.9	92.0	74.8	87.8	50.8	45.3	61.3	50.1	48.8	111.9	74.9	70.6	137.2	55.7	61.0	104.0	67.5	70.7	74.0	56.6	52.0	63.0	45.1	72.3	48.6	48.1	71.5	59.8	69.6	62.8	61.4	71.8	95.7	30.9	95.6	69.2	47.4	63.6	50.4	49.2	27.8	45.4	71.4	65.9	87.3	56.7	57.9	13.4	25.7	11.3	33.2	9.6	20.3	8.1	40.6	102.1	25.6	36.5	61.8	75.7	5.2	33.3	71.2	68.0	52.8	23.1	60.5	14.6	49.4	110.9	24.2	21.7	30.6	81.6	57.8	61.6	15.0	17.0	30.8	38.9	71.8	16.8	43.0	81.0	50.9	43.9	62.5	83.0	73.8	18.0	20.5	59.0	103.3	53.5	30.1	30.6	14.7	78.2	51.8	15.9	20.7	27.1	127.6	41.0	17.3	21.8	40.1	57.0	15.8	33.7	33.2	27.7	47.7	60.4	45.9	20.1	33.4	21.1	28.0	13.1	68.5	23.1	51.6	8.8	22.5	9.3	20.3	31.4	13.0	12.9	14.3	16.2	19.8	13.4	8.8	11.8	11.3	9.6	33.2	25.7	14.0	8.1	58.7	53.1	29.9	92.0	55.7	61.0	56.6	52.0	71.5	27.8	116.1	91.8	59.6	67.7	27.2	19.1	134.0	140.1	65.6	69.4	155.3	0.0	63.2	53.0	186.3	77.2	116.2	213.8	23.3	219.3	74.8	68.1	79.4	62.3	66.0	137.4	15.9	103.5	152.2	233.3	179.9	86.3	85.5	37.1	193.8	203.5	55.8	195.6	175.4	71.5	84.9	23.3	45.3	70.7	91.6	5.5	25.2	58.6	61.8	108.1	99.3
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566672-55567687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 56.0;skin 1: 44.1;tongue: 45.6"	"Group enriched"	"Detected in some"	12	"Basal keratinocytes: 78.1;Suprabasal keratinocytes: 130.6"	"Group enriched"	"Detected in many"	15	"cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.9;intermediate monocyte: 2.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 2.1"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 71.5"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA059749: AB_2732639, HPA076768: AB_2732322"	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.1	0.0	0.1	0.1	0.4	0.2	3.4	0.1	0.1	5.8	0.1	0.1	0.1	0.0	0.4	0.1	56.0	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.0	0.2	6.7	0.1	0.6	44.1	0.1	1.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1	45.6	14.6	12.3	10.8	0.0	0.5	6.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	71.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	6.9	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	9.0	78.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	1.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	130.6	1.9	0.0	0.0	8.1
CAPRIN2	"C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140"	ENSG00000110888	"Caprin family member 2"	Q6IMN6	12	30709552-30754951	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039746	Supported		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Centrosome"	"HPA039746: AB_10672902"	"unprognostic (7.45e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (8.36e-4)"	5.5	7.8	12.5	5.3	20.6	9.3	5.0	19.9	15.7	7.3	5.3	4.4	9.5	4.0	8.6	10.5	3.6	4.9	6.1	17.4	11.8	19.0	6.5	5.3	6.5	5.4	11.2	11.6	8.3	5.5	22.4	11.0	4.2	18.2	7.4	5.7	6.1	3.1	10.0	5.6	10.6	4.6	8.4	11.5	6.7	6.5	22.3	9.4	4.3	5.7	3.9	5.0	6.1	8.1	4.1	4.2	7.5	1.5	2.6	5.4	0.9	4.5	3.2	6.0	5.1	6.0	6.3	3.6	8.5	7.1	3.7	5.0	1.7	2.9	2.7	7.5	8.8	7.4	3.6	3.2	13.8	6.7	4.0	3.5	11.1	5.2	6.4	3.3	1.7	1.1	7.3	5.5	11.8	9.5	15.4	8.3	4.9	0.7	2.7	8.7	0.9	2.2	2.9	7.1	2.4	9.7	1.0	9.1	1.3	1.6	16.4	7.5	4.6	3.1	2.2	3.6	15.0	2.0	0.5	11.2	7.1	3.9	21.6	15.5	5.2	3.6	2.4	8.6	0.5	4.6	7.5	1.5	1.2	4.4	0.6	5.4	3.7	2.8	4.6	0.6	4.1	3.1	2.8	0.3	2.6	0.7	4.2	1.8	0.9	12.5	20.6	19.9	13.7	11.8	19.0	11.2	11.6	18.2	9.4	20.8	23.0	1.4	4.6	6.4	28.8	21.4	0.0	18.7	9.1	3.5	21.6	6.4	8.3	4.4	7.4	8.5	5.1	0.0	9.6	1.5	5.4	2.6	20.9	5.9	7.7	11.1	16.0	7.4	6.1	10.7	6.4	4.6	3.3	3.6	3.0	12.2	21.7	2.6	8.1	9.5	36.8	6.5	7.7	7.5	23.0	4.0	10.3	5.2	3.2	2.4
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine		19	5911707-5915877	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 71.4;fallopian tube: 116.0"	"Cell type enriched"	"Detected in many"	8	"Ciliated cells: 1030.6"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 71.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.6;U-266/70: 10.1"					"Low region specificity"	"Detected in many"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favorable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	2.6	4.1	8.0	4.3	14.7	4.3	2.8	1.4	3.3	12.4	3.3	34.4	15.6	3.1	9.1	49.4	2.8	116.0	13.6	2.0	13.4	6.6	8.9	5.0	25.4	4.4	8.0	7.8	26.7	6.5	2.5	7.5	17.7	71.4	9.4	2.0	3.3	7.7	12.7	2.0	5.7	5.0	2.9	7.5	7.6	9.4	2.1	17.9	0.4	7.8	0.9	2.5	8.8	11.3	4.9	4.0	5.2	2.2	5.3	4.8	2.4	1.1	1.1	0.7	3.5	1.3	1.8	2.2	0.6	0.4	0.2	0.3	0.8	7.5	0.8	2.2	0.9	0.5	1.4	0.3	0.3	0.1	2.4	1.0	0.6	2.2	2.0	1.2	0.6	1.8	2.3	2.1	0.2	0.5	2.5	0.5	2.6	0.5	2.9	0.4	2.1	1.4	2.0	0.6	8.8	5.7	1.7	0.3	2.3	1.0	3.2	0.7	2.6	0.5	36.6	3.7	2.0	2.3	2.3	1.0	0.6	0.4	2.7	9.7	10.1	3.4	0.7	4.3	1.0	1.4	3.3	2.2	1.6	4.8	1.8	2.6	3.1	3.0	3.6	2.1	4.9	2.4	2.0	5.2	5.3	1.6	4.0	3.2	2.4	8.0	14.7	1.4	3.3	13.4	6.6	8.0	7.8	71.4	17.9	11.9	16.8	0.8	29.9	4.2	2.2	1.9	0.0	1030.6	124.0	115.1	3.9	21.6	29.9	26.7	4.7	3.8	3.9	0.0	5.2	16.2	21.6	27.6	5.8	0.0	4.6	6.4	18.4	0.0	0.0	4.0	4.4	4.4	10.1	1.8	19.7	7.2	24.2	2.9	4.6	3.6	3.9	6.5	4.2	0.5	0.4	3.6	17.2	0.0	7.4	100.9
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.7"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 96.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039542, HPA040004"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		Yes	No			Nucleoli	"Nucleoplasm, Vesicles, Centrosome"	"HPA039542: , HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	2.6	4.2	8.0	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5.0	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2.0	4.4	5.5	3.6	3.8	2.6	1.9	2.0	8.7	2.6	3.2	8.0	9.5	1.4	9.3	2.2	1.4	2.6	2.0	0.1	0.6	0.0	0.7	1.1	1.8	0.1	1.3	3.7	1.0	0.3	1.9	1.4	0.1	0.7	0.2	2.0	2.2	0.0	1.7	0.3	3.3	0.5	0.8	0.8	0.0	1.6	1.4	1.2	0.6	1.5	0.6	0.0	0.0	0.2	0.0	0.6	1.0	1.7	0.3	12.1	0.2	1.3	0.3	0.6	2.6	0.0	1.8	1.4	0.5	0.0	0.5	0.0	0.0	0.2	2.6	0.0	2.1	1.0	0.2	0.1	1.2	0.2	1.2	0.5	0.8	1.9	0.8	0.4	0.3	0.2	0.0	0.0	1.6	0.0	1.5	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	0.0	0.0	0.1	0.6	0.9	0.0	1.1	0.7	0.6	1.8	0.1	8.0	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5	8.9	3.2	0.0	2.5	1.5	0.7	7.1	2.5	96.4	17.0	5.2	3.9	1.0	5.0	0.8	21.6	1.7	0.0	0.0	1.5	0.5	1.7	1.5	0.0	1.5	0.5	1.6	0.0	2.5	1.8	11.5	5.8	0.9	0.0	0.0	1.7	5.8	0.4	0.0	6.7	2.5	20.8	0.0	1.4	9.1	0.9	0.5	0.2	0.0	0.6	0.5
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904295-35938779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 34.9;epididymis: 18.3;fallopian tube: 59.4"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 455.0;Early spermatids: 136.1;Late spermatids: 117.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 14.1;ovarian cancer: 3.4"	"Region enriched"	"Detected in many"	7	"pons and medulla: 34.9"	"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Group enriched"	"Detected in some"	4	"BJ hTERT+ SV40 Large T+: 7.5;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.9;REH: 7.8;U-698: 19.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules		No	No			"Nucleoplasm, Microtubules"		"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.1	0.2	3.6	0.1	4.4	0.2	0.2	0.0	0.5	2.4	0.1	4.3	0.4	0.1	1.3	18.3	0.2	59.4	0.2	0.2	5.2	5.3	0.7	0.1	11.8	0.1	0.3	0.0	6.7	0.4	0.1	17.0	0.2	34.9	0.2	0.1	0.0	0.4	0.4	0.2	0.2	0.1	0.2	0.8	0.1	0.2	5.4	0.5	0.5	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.5	6.4	0.0	0.0	2.2	0.0	0.9	0.1	0.0	0.1	0.0	4.9	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.0	1.3	2.2	0.0	0.5	0.0	0.0	19.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	4.4	0.0	0.3	5.2	5.3	0.3	0.0	34.9	0.5	3.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	455.0	51.2	1.8	0.0	0.0	1.7	0.0	136.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	117.8	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.0
CAPZA2	"CAPPA2, CAPZ"	ENSG00000198898	"Capping actin protein of muscle Z-line alpha subunit 2"	P47755	7	116811070-116922049	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007470, HPA007643"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		No	No		19000000	"Endoplasmic reticulum"	Cytosol	"HPA007470: AB_1845985, HPA007643: AB_2667886"	"unprognostic (1.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.58e-2)"	32.4	17.7	23.6	15.8	22.6	33.6	18.5	17.6	30.2	17.7	26.3	10.7	13.5	16.9	20.6	16.4	25.9	14.9	17.6	36.4	26.7	20.6	40.9	29.2	23.2	16.6	22.1	15.9	17.3	13.8	12.9	16.4	26.1	27.1	21.8	20.6	11.8	14.4	18.3	47.1	11.6	30.6	30.3	19.6	26.0	17.8	12.4	13.7	17.7	24.5	21.0	14.0	31.5	15.0	6.6	14.8	32.0	22.8	7.1	7.8	17.7	13.1	8.9	8.7	11.3	16.6	17.6	4.8	13.1	18.4	13.1	15.0	6.5	16.9	9.0	21.4	18.4	16.8	8.2	8.9	10.7	20.4	9.7	7.1	13.5	8.9	10.8	10.2	8.9	18.2	14.1	12.0	10.7	10.1	15.9	27.6	5.7	8.9	15.6	25.7	6.4	11.6	15.1	12.8	13.5	7.8	8.3	11.7	17.7	30.5	11.2	9.2	10.5	12.1	45.7	12.4	11.5	6.4	10.4	10.2	21.1	6.7	16.6	12.2	12.3	9.0	17.1	12.5	12.7	14.9	19.9	16.4	19.2	5.5	20.1	6.1	6.6	6.5	5.7	14.8	6.0	6.4	6.5	32.0	7.1	22.8	8.2	7.8	17.7	23.6	22.6	17.6	30.2	26.7	20.6	22.1	15.9	27.1	13.7	68.5	67.4	96.3	183.9	215.9	99.6	196.7	68.8	42.8	60.3	162.3	25.5	129.4	437.7	161.9	6.6	193.4	141.9	93.5	141.3	163.7	177.2	113.8	124.6	101.1	274.2	101.7	116.2	221.6	215.0	12.9	69.0	242.4	172.1	184.0	86.3	127.8	150.8	154.3	104.3	362.3	90.2	90.5	201.3	35.1	43.4	191.2	120.5	90.6	83.0	173.2
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line beta subunit"	P47756	1	19338776-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Late spermatids: 2817.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		35000000	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	29.6	24.8	57.1	38.4	47.3	27.9	28.1	23.0	39.7	34.8	84.1	34.3	19.3	29.2	40.3	28.2	41.8	29.2	29.3	80.3	53.8	40.7	29.3	37.5	29.7	50.4	53.5	33.6	38.6	24.9	23.7	18.1	36.9	29.5	42.2	43.5	30.4	23.7	35.9	160.5	27.0	43.7	49.5	72.0	42.1	32.6	70.5	22.3	51.2	34.2	35.3	54.3	56.9	32.3	39.8	55.6	155.9	96.3	27.1	57.2	78.0	48.6	29.0	52.2	37.5	71.6	92.3	36.7	82.9	86.5	73.5	75.7	36.1	68.7	33.6	36.2	103.6	44.9	41.4	44.8	57.2	82.8	52.9	31.8	65.9	38.9	56.3	73.5	43.6	108.9	85.1	47.7	62.9	59.6	63.2	66.9	39.9	23.4	48.1	73.4	34.6	48.3	50.8	39.2	64.8	31.4	43.7	36.7	44.2	92.7	28.1	31.8	24.5	48.7	40.8	54.8	49.6	44.8	38.2	68.9	49.5	40.7	81.1	39.4	29.8	35.7	42.4	65.0	57.5	53.4	53.8	54.4	155.9	49.1	79.4	41.8	39.8	51.1	52.3	55.6	29.1	43.1	46.1	87.8	27.1	96.3	30.2	57.2	78.0	57.1	47.3	23.0	39.7	53.8	40.7	53.5	33.6	29.5	22.3	92.3	61.8	162.3	259.9	138.7	89.2	77.5	127.4	100.4	63.7	96.0	39.3	284.3	252.0	312.1	989.2	166.8	227.5	23.3	225.6	329.7	194.7	191.6	142.2	80.4	668.4	73.1	135.5	131.3	269.2	2817.9	215.4	313.1	136.7	740.4	212.2	119.4	260.5	192.9	284.2	184.2	70.1	239.3	175.9	100.8	73.9	159.6	286.2	286.6	157.4	234.8
CARD10	"BIMP1, CARMA3"	ENSG00000100065	"Caspase recruitment domain family member 10"	Q9BWT7	22	37490362-37519542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.6"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 21.7;Enterocytes: 29.9;Pancreatic endocrine cells: 26.6;Paneth cells: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.1;U-2197: 36.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029359, HPA055612"	Approved		Approved	"Vesicles,Intermediate filaments,Cytosol"		No	No			"Vesicles, Intermediate filaments"	Cytosol	"HPA029359: AB_10601354, HPA055612: AB_2682861"	"unprognostic (9.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (7.73e-6)"	"unprognostic (3.66e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.31e-2)"	"unprognostic (9.69e-2)"	8.1	6.8	3.5	4.5	2.3	0.0	10.2	1.5	2.7	5.7	16.4	2.4	4.1	23.7	9.8	6.4	6.8	5.9	14.1	7.6	1.7	1.1	14.0	10.5	7.0	2.4	1.6	1.3	6.8	8.9	1.6	1.7	4.9	3.8	5.6	6.2	5.6	12.6	3.2	8.0	7.3	33.6	4.1	1.3	3.3	7.0	11.1	1.3	0.7	5.6	13.5	3.9	4.9	9.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	13.1	9.6	1.8	1.3	0.0	3.9	8.7	1.2	2.8	5.6	4.4	6.0	9.4	0.0	4.7	2.3	5.4	18.5	2.1	24.1	1.7	0.0	5.2	0.3	6.1	9.2	2.4	0.2	0.8	1.3	5.0	10.7	13.8	4.5	11.3	0.0	1.3	0.0	4.2	4.5	0.0	0.8	3.1	7.1	5.8	0.0	17.2	1.3	8.3	2.3	0.6	1.0	9.2	4.1	0.9	2.2	4.4	0.7	14.9	4.2	12.3	36.1	6.9	0.0	0.0	0.0	13.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	3.5	2.3	1.5	2.7	1.7	1.1	1.6	1.3	3.8	1.3	0.0	1.3	0.0	3.4	7.6	0.2	3.1	10.2	0.0	1.2	3.5	0.0	0.1	1.7	21.7	7.8	14.7	29.9	0.0	17.3	1.5	1.1	3.6	0.0	3.9	0.1	0.0	7.5	12.3	0.0	4.3	0.0	0.4	5.0	0.0	17.6	0.0	26.6	21.0	0.7	10.5	0.1	0.0	1.2	0.5	3.4	3.3	0.0	0.0	8.1	7.1
CARD14	"BIMP2, CARMA2, PSORS2"	ENSG00000141527	"Caspase recruitment domain family member 14"	Q9BXL6	17	80169992-80209331	"Disease related genes, Predicted intracellular proteins"	Apoptosis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.1;skin 1: 17.3;tongue: 12.3"	"Cell type enhanced"	"Detected in some"	5	"Ciliated cells: 4.0;Glandular cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 7.3;SK-BR-3: 10.0;T-47d: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023388			Supported	Aggresome,Cytosol		NA	NA			Cytosol	Aggresome	"HPA023388: AB_1846020"	"unprognostic (9.79e-3)"	"unprognostic (3.86e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.05e-5)"	"unprognostic (2.65e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.92e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-8)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-1)"	0.4	1.9	0.4	0.9	0.4	0.1	3.2	0.4	0.7	4.0	0.4	0.4	0.4	2.1	0.8	1.0	12.1	0.3	0.6	0.4	0.4	0.3	0.7	1.1	0.7	1.0	0.4	0.4	1.0	0.4	0.0	0.4	3.0	0.6	2.1	0.0	0.4	6.2	3.6	0.6	17.3	1.6	0.4	1.5	1.8	0.5	0.8	0.4	0.4	0.4	12.3	10.7	1.3	5.8	2.0	0.0	0.0	0.5	0.0	0.4	0.1	3.9	0.6	0.6	0.2	0.0	0.0	3.9	0.2	0.0	0.0	0.0	1.6	0.1	0.0	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.8	0.0	2.0	0.2	0.0	0.3	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.3	1.3	0.0	7.3	0.0	0.0	0.1	2.6	0.5	0.0	1.6	0.4	0.0	3.1	0.5	0.1	0.0	10.0	1.6	0.6	22.0	0.0	0.2	0.1	0.5	0.4	0.0	2.1	0.2	0.1	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.4	0.3	2.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.4	0.4	0.7	0.4	0.3	0.4	0.4	0.6	0.4	0.0	1.4	0.0	3.4	1.5	0.8	0.8	2.5	4.0	1.2	0.0	0.0	0.2	0.0	0.6	0.6	0.5	0.0	0.0	2.0	0.3	0.5	4.0	0.0	0.0	0.7	0.0	0.0	0.6	3.2	0.0	0.3	0.7	1.7	0.0	0.0	2.2	1.3	0.0	0.4	0.0	0.9	0.0	0.0	0.7	0.4	2.6	1.3	0.0	0.1	3.3
CARF	"ALS2CR8, CaRF, FLJ21579, NYD-SP24"	ENSG00000138380	"Calcium responsive transcription factor"	Q8N187	2	202912214-202987063	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034557, HPA043191"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA034557: AB_10601663, HPA043191: AB_2732503"	"unprognostic (4.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.58e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	8.3	8.7	9.8	7.9	15.0	7.1	11.5	10.7	18.2	9.4	8.8	18.3	9.3	6.7	15.4	15.4	8.2	11.1	8.8	7.4	12.1	8.7	10.5	6.5	7.6	11.8	18.4	14.5	13.9	8.1	12.0	18.8	7.4	19.1	10.3	9.0	10.7	8.9	11.1	7.9	11.4	9.4	10.2	15.8	10.5	8.8	27.3	16.3	16.4	15.4	3.8	11.1	12.8	9.7	4.1	2.4	1.7	2.6	11.9	6.0	1.0	2.4	2.3	6.2	5.4	4.5	8.9	4.7	3.8	4.4	3.9	3.5	3.2	6.1	3.7	1.6	4.4	4.3	4.4	3.1	2.5	4.2	2.8	1.8	6.6	2.9	1.6	3.9	3.3	3.0	8.2	5.4	3.3	8.5	9.5	2.3	13.6	2.6	15.4	5.9	4.8	6.9	5.5	2.6	1.6	3.4	4.7	4.3	3.0	6.8	2.6	4.4	4.8	4.1	2.3	1.8	8.1	3.4	6.6	2.8	7.2	1.9	4.6	2.4	13.8	7.7	4.1	6.1	3.9	4.4	1.7	1.4	1.1	3.2	2.6	3.6	2.9	3.3	2.9	1.5	4.1	4.7	3.2	0.6	11.9	1.6	2.4	6.0	1.0	9.8	15.0	10.7	18.2	12.1	8.7	18.4	14.5	19.1	16.3	8.9	20.7	4.4	2.8	2.9	33.1	6.1	10.2	20.1	19.4	14.0	17.7	3.4	10.0	3.1	13.4	3.3	4.2	0.0	2.1	7.3	4.2	1.7	19.7	3.0	3.2	25.4	1.7	7.4	7.0	9.8	10.0	5.3	1.7	1.8	4.2	8.4	2.7	3.5	8.9	3.9	30.4	6.5	3.4	42.4	7.7	2.4	1.5	7.9	5.2	1.8
CARS2	FLJ12118	ENSG00000134905	"Cysteinyl-tRNA synthetase 2, mitochondrial"	Q9HA77	13	110641412-110713603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041776	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA041776: AB_2677666"	"unprognostic (2.34e-3)"	"unprognostic (9.50e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.71e-2)"	19.6	28.1	11.9	24.8	13.0	25.6	37.1	18.2	14.5	21.8	20.2	17.6	21.2	17.8	18.5	23.0	20.2	16.8	26.9	26.0	9.9	10.3	17.0	21.4	19.9	26.7	11.3	14.1	17.6	31.7	11.5	19.7	12.5	11.7	17.5	15.0	16.6	19.0	21.3	39.7	16.1	20.1	22.1	11.7	19.7	17.9	11.2	11.4	21.8	19.2	18.5	21.9	16.9	16.7	3.4	4.0	3.1	6.8	0.6	2.2	1.7	35.4	11.8	6.8	16.5	18.1	17.0	9.2	15.8	14.5	16.0	19.7	16.6	16.0	16.6	22.2	17.2	24.4	18.9	11.6	19.8	13.1	15.1	19.3	10.3	25.0	18.9	18.5	25.2	12.6	21.2	15.8	13.9	16.8	11.4	11.4	12.6	7.1	5.2	22.5	8.2	11.2	8.2	5.7	27.2	11.7	16.6	5.0	6.8	17.1	10.4	12.1	9.2	12.7	19.7	18.2	7.6	9.5	28.1	10.2	13.4	5.0	16.9	15.8	9.4	10.7	9.6	65.5	15.1	13.2	0.0	4.7	0.7	2.0	5.1	2.2	3.4	0.6	0.8	4.0	1.4	2.0	1.0	3.1	0.6	6.8	3.4	0.7	1.7	11.9	13.0	18.2	14.5	9.9	10.3	11.3	14.1	11.7	11.4	8.9	15.7	17.6	19.1	11.4	22.3	34.3	12.7	2.7	7.9	26.2	23.6	21.5	43.1	14.9	53.5	10.8	19.0	0.0	4.1	25.5	14.3	16.8	16.1	23.1	25.1	22.3	18.0	9.8	26.7	173.5	19.0	29.2	11.8	13.6	17.0	23.0	12.9	7.0	17.0	29.6	24.7	6.5	18.6	7.2	4.7	11.8	14.1	12.9	22.3	18.2
CASC10	"bA418C1.3, C10orf114"	ENSG00000204682	"Cancer susceptibility 10"	Q5T4H9	10	21492658-21497262	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;liver: 13.6"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 5.9;Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 10.3;AF22: 10.4;AN3-CA: 14.4;BEWO: 13.9;SK-BR-3: 9.1"									HPA064131	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064131: AB_2685196"	"unprognostic (2.69e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (5.86e-4)"	1.8	2.6	8.9	0.9	6.2	0.9	0.9	2.0	8.0	2.5	0.8	6.1	0.1	1.0	1.3	1.1	1.2	2.4	1.7	3.8	11.8	3.8	6.3	13.6	1.5	1.3	3.3	4.2	2.6	1.3	3.7	3.3	7.2	2.7	1.9	0.7	2.0	1.0	1.8	5.0	3.3	0.9	1.5	2.2	0.8	0.9	2.6	5.3	0.1	5.6	0.0	0.8	2.3	1.6	0.6	0.4	2.2	0.3	1.0	0.4	0.2	1.7	10.3	10.4	14.4	1.9	1.0	13.9	0.9	0.4	0.1	0.2	1.6	3.6	0.5	1.5	0.8	1.8	2.2	1.8	0.6	0.1	0.3	1.9	0.1	1.5	2.3	0.5	0.0	0.1	1.3	1.8	0.1	0.2	1.5	0.9	0.6	0.6	0.1	0.1	1.6	0.7	0.6	1.4	0.0	0.9	0.8	0.1	0.0	2.1	1.5	1.4	5.1	4.8	9.1	0.6	3.5	1.7	7.9	2.5	0.9	8.1	0.2	1.1	0.1	0.2	0.1	4.5	0.0	4.5	1.5	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.1	0.0	0.6	0.2	0.4	2.2	1.0	0.3	0.4	0.2	0.2	8.9	6.2	2.0	8.0	11.8	3.8	3.3	4.2	2.7	5.3	0.0	0.6	0.0	0.4	1.0	2.3	2.2	0.0	2.7	0.0	1.8	0.0	2.0	5.0	0.0	0.2	3.7	0.0	0.0	0.0	2.3	1.9	0.1	0.0	5.9	0.7	4.8	0.0	3.7	0.3	0.0	4.4	0.0	1.7	0.0	0.0	2.9	0.2	0.0	1.8	10.5	0.6	0.0	0.3	0.2	0.2	0.6	3.2	0.0	0.0	0.1
CASC3	"BTZ, MLN51"	ENSG00000108349	"Cancer susceptibility 3"	O15234	17	40140318-40172183	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Stress response, Translation regulation, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024592, HPA050262"	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA024592: AB_1846034, HPA050262: AB_2681067"	"unprognostic (3.76e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.48e-2)"	27.4	21.0	37.8	20.4	34.8	22.6	26.8	30.0	36.5	30.1	27.3	40.7	19.3	16.4	35.9	26.8	22.2	35.1	21.7	17.8	36.6	32.7	21.6	14.7	23.2	21.8	39.9	27.7	42.1	22.7	31.8	32.6	21.4	29.4	27.4	23.4	25.7	22.5	36.6	50.9	23.0	19.6	35.0	40.7	23.2	22.7	59.7	31.0	19.6	29.4	18.1	25.5	34.1	29.7	6.5	7.2	26.1	11.5	6.8	9.2	5.6	13.5	13.9	17.9	20.1	14.5	15.3	11.5	13.8	12.3	19.0	16.5	15.1	11.8	25.4	22.1	17.3	15.6	24.4	21.8	14.6	26.0	17.3	19.3	18.3	17.3	15.1	13.2	22.3	12.4	15.8	13.5	18.5	29.1	14.7	23.5	14.0	19.6	19.0	15.5	7.8	32.7	12.6	14.1	11.9	8.5	20.5	23.9	26.0	9.8	11.9	28.1	16.1	20.5	74.3	18.1	29.6	24.4	17.6	15.6	16.6	17.3	15.6	21.7	18.2	16.8	25.7	15.8	12.2	17.9	5.8	5.9	8.6	9.2	8.0	8.3	6.5	6.9	8.3	7.2	6.5	7.9	7.4	26.1	6.8	11.5	3.9	6.4	5.6	37.8	34.8	30.0	36.5	36.6	32.7	39.9	27.7	29.4	31.0	17.9	30.8	20.6	20.1	17.5	38.5	23.6	17.8	29.4	45.5	22.7	21.6	17.0	18.3	15.8	11.3	31.6	14.4	0.0	20.7	17.2	23.3	22.2	15.1	19.7	14.8	28.6	30.0	17.2	20.4	18.4	33.4	25.7	33.7	16.2	19.3	20.8	18.6	14.4	28.0	14.3	40.4	12.9	35.0	52.8	63.8	17.3	22.7	21.7	18.8	22.6
CASD1	"C7orf12, FLJ21213, FLJ21879"	ENSG00000127995	"CAS1 domain containing 1"	Q96PB1	7	94509219-94557019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 54.4;Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044404	Uncertain		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA044404: AB_10964353"	"unprognostic (4.02e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.04e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.83e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.59e-3)"	8.6	21.6	16.6	7.1	24.2	4.1	13.2	20.5	24.8	10.0	13.2	10.9	7.5	5.0	11.7	12.5	5.1	9.2	8.1	13.6	25.9	22.2	10.2	7.1	9.0	9.2	13.1	16.6	14.1	7.8	12.7	22.8	9.8	20.0	11.8	15.9	8.4	22.6	8.2	11.3	3.7	6.3	9.7	13.7	8.0	6.0	10.1	11.5	7.3	13.2	2.9	8.3	9.0	6.3	1.8	1.1	0.2	0.7	1.8	4.7	0.7	3.0	5.9	20.3	7.5	6.2	7.5	3.4	4.2	7.4	4.6	6.1	3.7	7.6	7.8	11.0	5.6	8.3	1.7	5.1	1.4	9.2	12.4	4.1	6.9	5.0	6.7	5.3	11.4	0.0	6.8	5.4	4.2	6.1	9.1	7.3	9.2	3.7	17.2	11.4	4.5	15.8	6.5	10.4	4.3	4.7	10.9	16.5	6.0	9.4	8.5	7.7	26.3	6.5	12.1	4.1	15.4	3.1	7.2	3.8	11.6	9.2	9.5	6.0	16.5	15.4	16.3	6.3	2.7	7.5	0.0	0.6	0.2	1.9	0.7	4.7	1.8	2.8	2.3	1.1	1.7	2.9	2.2	0.0	1.8	0.6	1.0	1.7	0.7	16.6	24.2	20.5	24.8	25.9	22.2	13.1	16.6	20.0	11.5	26.8	22.9	6.9	5.2	4.0	54.4	17.1	17.8	18.7	17.0	19.2	17.7	9.7	3.3	4.5	2.7	13.3	12.0	0.0	4.8	4.6	9.3	11.8	10.3	10.9	7.4	63.5	6.9	17.2	11.5	4.7	10.6	5.6	23.6	2.8	27.6	25.0	6.1	8.6	9.2	8.8	28.9	19.4	7.1	6.3	11.9	4.0	14.1	7.2	14.1	3.7
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923645	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 26.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	9.1	15.9	13.9	18.8	12.7	9.8	13.2	14.2	15.7	11.1	22.1	20.0	7.1	27.1	12.2	13.7	17.2	9.9	16.0	7.0	12.1	12.8	14.6	10.8	10.3	13.6	16.3	8.5	13.9	14.2	11.1	9.8	13.4	11.9	10.7	23.8	10.4	15.9	7.7	5.8	12.8	32.9	12.1	10.1	9.6	16.2	2.9	14.3	30.9	9.3	8.1	14.0	11.8	13.1	0.6	0.3	26.3	0.8	2.4	2.3	0.3	10.9	14.0	13.4	8.0	9.1	7.4	4.3	9.6	8.0	5.6	5.2	30.1	17.9	0.1	4.9	11.9	10.2	22.0	14.7	9.8	9.4	9.7	8.2	0.0	12.6	10.6	9.4	1.7	1.5	8.4	26.9	10.7	13.7	11.3	4.6	6.4	0.8	8.5	12.2	12.8	3.1	0.7	12.3	15.8	9.1	5.1	33.0	5.2	12.7	23.8	12.3	6.5	18.0	7.2	5.5	22.6	7.7	0.3	5.3	10.5	10.7	9.0	5.3	3.3	2.1	3.7	10.3	1.2	6.7	26.3	0.8	4.8	0.5	0.7	0.5	0.4	0.6	0.8	0.2	0.6	0.7	0.7	1.1	2.4	0.4	0.3	2.3	0.3	13.9	12.7	14.2	14.2	12.1	12.8	16.3	8.5	11.9	14.3	11.9	14.8	0.9	33.3	29.0	40.5	6.5	10.2	20.1	14.8	7.0	21.6	1.6	43.1	13.2	0.8	10.8	22.7	0.0	12.7	0.7	17.5	19.6	0.0	13.0	16.2	47.7	13.3	4.9	3.5	0.2	9.2	6.8	10.1	0.0	30.6	11.9	17.9	28.1	8.9	17.0	26.0	19.4	14.4	1.6	1.9	28.4	1.4	12.5	36.5	26.9
CASKIN1	"ANKS5A, KIAA1306"	ENSG00000167971	"CASK interacting protein 1"	Q8WXD9	16	2177180-2196525	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 30.4"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 19.0;Cone photoreceptor cells: 7.9;Horizontal cells: 39.7;Muller glia cells: 18.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;HDLM-2: 17.0;HEK 293: 3.8;SCLC-21H: 7.8;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055990, HPA076882, CAB079050"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB079050: , HPA055990: AB_2682997, HPA076882: "	"unprognostic (4.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.21e-4)"	"unprognostic (2.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.39e-1)"	1.1	1.8	17.7	1.2	18.1	1.1	1.4	15.0	30.4	1.5	1.2	2.3	0.0	1.2	1.5	1.3	1.2	1.4	1.2	2.5	16.4	12.8	1.3	1.1	1.1	1.1	12.4	11.7	1.2	1.5	1.9	1.4	1.2	11.1	1.8	1.2	1.8	2.5	1.4	1.3	2.2	1.3	1.2	2.8	1.1	1.3	1.8	4.0	0.0	1.6	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	4.6	0.0	0.0	2.2	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.9	0.0	0.0	0.0	1.2	0.3	0.0	17.0	3.8	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	1.1	0.1	0.0	1.3	0.0	1.0	0.8	0.0	0.0	0.9	0.0	0.4	0.2	0.0	7.8	3.8	0.1	0.2	0.2	0.2	1.0	0.5	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	18.1	15.0	21.7	16.4	12.8	12.4	11.7	11.1	4.0	0.0	0.0	0.0	0.2	0.3	19.0	2.3	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	39.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.6	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.0	0.0
CASP10	MCH4	ENSG00000003400	"Caspase 10"	Q92851	2	201182881-201229406	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.4"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 18.0"					"Low region specificity"	"Detected in all"			"CAB003780, HPA017059"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"CAB003780: AB_289592, HPA017059: AB_1846040"	"unprognostic (4.01e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.05e-7)"	"unprognostic (3.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-2)"	16.0	3.3	3.4	10.1	3.4	14.9	7.6	1.9	3.3	7.0	17.7	4.4	4.3	18.6	8.3	8.2	10.4	4.9	7.2	4.8	3.6	3.0	10.3	7.8	14.2	10.4	4.1	1.4	3.4	6.1	1.4	2.1	8.5	4.7	5.0	11.9	4.1	6.9	6.9	3.6	5.4	42.4	4.8	5.6	26.1	8.7	2.1	2.5	17.1	6.8	8.2	17.9	9.4	6.1	7.8	6.0	4.7	15.4	7.1	7.1	5.8	2.9	2.4	0.1	0.2	0.1	0.2	5.2	0.5	3.5	0.3	1.4	3.1	6.9	0.2	5.0	1.8	1.2	2.0	0.1	1.6	0.9	1.4	3.3	8.4	2.5	10.4	1.2	5.6	9.1	0.3	1.4	3.8	0.3	0.2	18.0	3.6	10.0	12.4	0.3	0.1	10.7	5.2	0.3	4.1	1.5	5.9	0.3	12.4	6.3	4.2	0.1	0.1	2.8	0.1	1.4	2.3	0.1	5.3	7.3	0.2	0.5	2.4	0.1	13.5	8.0	0.3	3.4	4.3	0.1	4.7	9.6	0.6	6.2	13.5	5.2	7.8	5.2	3.4	5.3	5.0	7.1	6.0	1.9	7.1	15.4	6.0	1.0	5.8	3.4	3.4	1.9	3.3	3.6	3.0	4.1	1.4	4.7	2.5	17.9	7.7	16.2	2.5	5.4	0.0	1.7	7.6	14.7	5.7	8.7	0.0	0.9	1.7	11.0	0.8	24.0	35.4	23.3	9.2	0.6	3.7	3.0	7.0	5.8	8.1	0.0	2.4	20.9	21.0	0.0	0.6	16.1	6.8	11.8	18.2	0.5	8.3	24.6	0.0	6.8	0.3	0.0	2.1	0.0	0.0	4.0	0.3	13.1	11.0	7.9
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049384-15058293	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 109.4"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA		2200000	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.2	0.2	0.2	0.0	0.3	0.0	1.9	0.2	0.3	17.9	0.2	0.0	0.8	0.0	1.1	0.3	1.2	0.1	0.0	0.2	0.3	0.2	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.5	0.0	7.7	0.0	0.0	0.8	2.7	0.3	109.4	0.2	0.0	0.2	0.1	0.2	1.6	0.0	2.3	0.2	0.9	0.0	0.6	4.0	0.8	0.5	2.3	0.6	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.6	0.4	0.4	0.2	0.4	0.3	0.6	0.4	0.1	0.8	0.5	0.4	2.3	0.1	0.2	0.5	0.6	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	16.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	83.9	0.6	0.0	0.0	0.1
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012175: , HPA050678: AB_2681214"	"unprognostic (6.96e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.5	6.5	6.6	10.7	6.7	26.8	10.2	9.6	10.9	9.6	8.5	9.0	8.2	8.2	10.8	7.8	14.1	8.4	5.7	6.1	5.7	4.1	7.3	5.8	9.8	15.8	6.9	6.1	8.7	8.1	12.1	6.6	11.3	7.3	7.6	10.2	10.1	11.6	5.8	4.3	14.2	14.0	7.4	6.3	18.6	7.5	8.6	6.9	45.7	8.9	8.0	23.0	7.4	10.2	18.5	11.8	33.2	17.7	13.4	21.4	7.6	10.9	10.3	11.6	20.5	6.5	7.7	6.2	11.2	5.1	10.3	11.3	10.2	12.4	20.8	10.7	7.1	7.9	10.8	11.6	8.9	13.8	18.2	8.9	12.3	16.2	7.0	3.5	23.9	15.4	5.3	7.3	12.5	4.4	4.7	8.8	16.4	10.2	13.3	10.9	10.8	41.6	25.2	14.6	10.7	10.5	30.6	6.0	12.7	6.1	9.3	12.7	14.3	22.3	9.7	7.1	8.3	10.6	9.2	9.8	9.2	6.4	16.5	11.2	11.1	10.9	24.2	10.3	28.5	16.7	33.2	10.8	9.3	14.9	11.9	14.6	15.8	20.6	15.4	9.8	18.5	15.4	17.8	12.3	13.4	17.7	11.8	21.4	7.6	6.6	6.7	9.6	10.9	5.7	4.1	6.9	6.1	7.3	6.9	8.9	8.8	17.9	5.4	13.5	4.7	5.3	25.5	2.7	3.4	7.0	7.9	16.2	3.3	7.7	35.5	13.9	6.5	0.0	6.6	12.8	8.7	5.5	9.3	4.4	8.8	6.4	10.3	14.7	15.4	38.5	10.9	12.1	20.3	11.8	10.3	4.0	7.6	3.5	7.8	3.3	14.0	0.0	8.4	10.1	29.4	12.0	4.8	20.8	13.3	6.0
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 76.7;eosinophil: 62.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		310000	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	20.7	11.6	10.8	16.9	10.5	16.7	10.0	22.3	9.2	10.4	25.4	12.8	12.5	32.3	13.9	11.5	22.8	8.9	12.0	8.8	10.0	8.8	10.6	18.7	12.4	23.6	10.2	8.5	8.3	10.0	4.6	13.6	29.4	9.7	8.8	20.9	8.2	13.0	10.0	12.6	9.5	49.7	9.3	12.6	26.5	18.7	6.4	10.9	44.7	7.8	13.5	24.3	16.2	11.0	4.2	5.2	76.7	10.6	9.2	9.9	7.0	8.3	4.7	18.7	8.9	11.6	15.5	10.8	25.3	19.2	17.8	10.3	8.5	7.1	11.7	4.0	12.3	8.4	7.2	14.8	9.0	20.3	30.0	8.1	18.7	3.7	19.7	13.9	15.2	17.8	21.1	11.0	11.3	9.1	12.8	22.0	12.1	15.4	74.2	18.3	3.6	24.0	14.2	18.5	9.3	5.9	17.4	8.8	11.3	15.3	13.8	10.7	11.7	10.9	10.0	14.2	19.4	5.4	9.9	14.9	8.1	7.5	6.0	11.7	34.5	32.3	8.0	9.9	10.6	11.5	76.7	4.2	62.8	5.5	6.8	5.7	4.2	5.1	7.8	5.2	3.1	3.9	5.8	5.8	9.2	10.6	4.1	9.9	7.0	10.8	10.5	22.3	9.2	10.0	8.8	10.2	8.5	9.7	10.9	17.9	12.0	18.6	18.8	43.3	17.6	14.1	5.1	25.4	20.5	12.2	0.0	41.4	11.6	16.0	7.6	23.3	28.6	0.0	20.9	27.1	16.9	14.4	17.3	12.9	20.5	12.7	17.3	20.9	25.1	3.2	6.9	17.5	28.7	55.9	34.1	13.8	20.4	19.9	7.1	6.5	10.2	12.9	14.4	7.5	14.2	25.0	43.0	36.2	21.5	31.5
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969436	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 82.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	10.6	6.3	0.5	9.7	0.5	6.1	9.4	0.0	0.0	4.7	3.5			8.9	3.5	5.9	14.1	5.8	7.3	4.9	0.5	0.5	6.7	16.5	14.0	10.5	1.0		7.5	16.8	0.0	3.0	10.7		5.8	4.0		11.2	1.9	1.6	10.4	8.8	4.3	2.0	19.0	8.2	0.2			4.2		11.3	8.2	8.0	20.5	29.3	82.8	43.2	29.6	35.7	46.8	6.4	2.1	0.0	2.8	13.7	31.4	5.3	11.0	21.6	17.8	25.0	5.3	29.1	3.3	23.8	14.3	21.5	10.7	0.0	19.1	17.0	3.8	0.1	8.6	1.6	13.9	33.8	8.7	4.2	28.5	28.6	21.2	29.7	21.3	30.9	0.1	0.2	0.0	13.5	0.6	5.0	10.2	0.0	14.4	6.3	3.8	4.1	2.9	14.9	10.2	0.1	0.0	10.2	7.2	10.1	0.2	2.9	12.7	16.0	18.8	6.5	16.5	7.7	0.0	0.0	0.0	9.6	19.8	13.1	14.9	39.1	7.0	31.5	43.2	34.6	20.5	24.2	30.1	29.3	20.0	14.8	22.0	82.8	29.6	33.5	4.9	35.7	46.8											56.6	57.5	87.2	53.6	49.6	0.0	3.6	40.8	72.3	54.6	21.0	0.0	113.8	13.3	118.8	0.5	68.8	12.0	0.0	164.0	65.7	45.5	29.4	33.5	26.8	101.8	0.0	20.1	65.1	148.5	1.3	27.0	95.5	28.7	63.1	28.2	1.9	153.2	9.9	19.4	30.9	0.1	6.5	22.7	0.2	0.6	40.1	96.9	117.6	17.5	68.0
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (9.93e-4)"	8.1	6.1	3.6	6.7	4.3	5.3	14.3	2.8	3.8	6.9	25.5	2.8	4.5	23.4	5.9	4.3	8.7	5.3	11.7	4.9	4.0	2.0	11.0	14.3	5.6	8.5	5.0	1.6	7.0	13.0	2.3	6.4	4.3	4.5	8.1	19.5	3.4	8.0	10.3	3.4	6.5	42.8	14.0	6.6	9.1	9.2	2.7	4.3	14.5	11.2	3.3	8.4	8.2	12.7	4.4	8.0	8.5	7.0	5.6	21.3	8.0	12.6	4.1	8.5	7.7	6.2	6.1	12.6	7.1	4.9	6.4	6.9	6.8	26.1	1.3	8.3	7.3	8.9	5.9	10.1	11.2	5.1	20.1	6.6	11.1	3.7	6.0	5.0	11.1	7.9	6.7	8.4	6.1	1.5	8.6	12.1	15.1	14.4	39.6	10.3	7.1	28.7	7.0	6.5	8.7	7.5	10.0	5.4	6.9	21.0	12.0	9.0	6.7	7.5	13.6	4.2	10.7	5.8	4.1	10.2	7.1	7.5	3.4	8.0	5.8	10.5	1.4	9.2	13.4	3.6	8.5	5.3	6.3	4.9	4.8	5.3	4.1	17.8	9.3	6.0	4.4	21.3	11.8	1.1	5.6	7.0	8.0	16.4	8.0	3.6	4.3	2.8	3.8	4.0	2.0	5.0	1.6	4.5	4.3	14.9	13.4	8.5	9.5	9.6	5.2	3.3	30.6	25.4	20.5	19.2	5.9	16.7	8.3	35.9	2.0	9.2	52.0	0.0	40.5	34.0	12.1	6.6	9.3	17.8	17.1	0.0	56.7	6.2	8.6	1.6	11.8	8.5	1.7	25.2	48.2	12.8	42.5	56.1	9.2	26.3	1.3	6.5	6.9	1.7	8.3	10.2	4.8	12.8	64.3	7.8
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.5"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	14.1	10.6	2.0	31.6	2.6	27.1	10.2	1.4	1.8	7.9	18.5	3.9	7.0	9.6	9.6	12.0	11.7	9.1	12.1	4.4	2.1	2.3	16.4	14.8	17.1	28.3	3.9	1.1	8.2	7.6	1.8	5.9	12.3	3.2	9.8	8.7	4.4	9.6	8.4	2.7	7.4	34.7	5.1	5.0	37.7	7.4	3.8	2.7	43.7	6.7	10.7	43.4	9.6	7.3	13.8	13.7	52.5	17.0	22.2	26.4	12.0	14.5	12.4	3.6	10.1	10.1	14.8	5.6	6.4	6.3	7.6	12.6	16.6	25.4	1.6	14.1	4.9	13.7	7.4	7.9	7.6	15.1	9.4	7.2	14.2	10.1	15.8	8.2	11.0	15.4	12.8	18.8	14.4	11.3	6.4	7.2	12.3	12.7	31.6	6.9	6.0	14.3	11.6	5.9	8.0	11.1	10.8	7.5	25.9	14.3	16.2	1.1	0.5	8.3	13.8	8.2	3.5	3.6	8.6	9.0	8.2	8.6	4.3	5.0	28.7	12.8	9.9	12.3	14.8	7.7	20.7	13.0	24.9	25.0	17.0	23.1	13.8	20.5	26.4	13.7	7.8	13.3	16.9	52.5	22.2	15.6	6.1	24.0	12.0	2.0	2.6	1.4	1.8	2.1	2.3	3.9	1.1	3.2	2.7	23.8	26.1	34.1	10.1	6.6	1.5	1.6	7.6	16.0	18.2	5.2	9.8	7.5	13.3	9.0	5.6	7.1	19.8	0.0	7.3	10.3	3.8	8.1	23.2	10.4	11.2	0.0	4.1	5.5	25.6	0.7	2.3	21.7	6.8	19.8	13.0	0.1	9.6	12.7	0.7	20.0	0.4	0.0	1.4	0.7	0.4	6.8	2.9	55.4	12.1	12.7
CASP8AP2	"CED-4, FLASH, FLJ11208, KIAA1315, RIP25"	ENSG00000118412	"Caspase 8 associated protein 2"		6	89829894-89874436	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 89.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053573			Approved	"Nucleoli,Nuclear bodies"		NA	NA			"Nucleoli, Nuclear bodies"		"HPA053573: AB_2682194"	"unprognostic (7.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.75e-4)"	"unprognostic (4.58e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.53e-1)"	3.8	3.1	5.4	8.0	7.3	4.8	6.0	9.7	7.8	7.4	4.7	3.3	3.8	3.5	5.0	3.4	4.5	3.7	3.5	3.9	6.5		3.1	3.4	3.9	8.8	6.1	5.0	6.6	3.8	5.7	7.0	5.9	6.6	7.2	4.3	3.5	4.0	5.2	3.2	2.6	4.7	5.3	5.7	5.4	4.0	5.0	5.9	9.1	4.5	2.1	5.9	6.5	3.2	9.9	7.8	17.7	4.1	17.8	12.3	3.6	4.2	4.3	13.8	9.5	4.7	4.7	5.5	10.6	4.0	7.6	9.9	5.0	3.4	12.6	5.6	5.4	5.8	6.4	12.4	5.3	8.8	12.9	10.5	15.7	10.2	1.7	2.0	14.7	8.3	2.3	2.5	9.9	4.6	3.1	5.5	12.5	16.9	7.6	5.1	3.8	8.3	2.7	4.0	4.0	4.0	16.4	17.2	4.9	1.4	9.3	9.1	6.3	8.8	1.9	3.8	6.5	4.2	7.5	7.4	4.9	4.2	8.4	9.6	4.6	11.2	7.5	5.0	8.4	7.7	17.7	2.5	8.2	10.7	4.1	10.3	8.3	12.3	11.2	3.1	9.9	9.9	9.5	4.4	17.8	3.5	7.8	10.2	3.6											29.8	16.4	13.9	8.5	0.0	18.7	39.9	5.1	25.4	21.6	7.0	5.9	14.1	3.3	13.0	4.6	12.8	9.6	0.0	11.0	13.0	12.4	10.8	15.1	6.6	10.6	33.4	2.4	8.6	9.7	3.5	21.3	11.3	0.0	28.9	10.0	16.6	8.2	10.1	24.4	6.9	23.8	19.4	13.7	29.1	89.7	0.0	9.2	13.8	13.3	7.3
CASP9	"APAF-3, ICE-LAP6, MCH6, PPP1R56"	ENSG00000132906	"Caspase 9"	P55211	1	15490832-15526534	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001473, CAB004348, HPA046488"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670"	"prognostic favorable (5.91e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.90e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (1.67e-5)"	7.4	24.1	7.8	8.2	9.3	8.9	5.5	11.1	8.7	8.3	9.3	10.2	18.9	5.2	11.9	16.5	7.5	13.4	29.1	10.2	8.3	7.2	11.6	9.4	10.8	12.6	10.7	4.3	33.4	29.0	15.6	18.5	14.7	8.8	10.2	6.4	8.7	6.6	19.0	8.2	2.8	13.3	7.8	9.0	11.0	6.7	14.4	7.1	6.2	14.8	7.2	14.6	7.3	8.1	11.2	11.7	23.3	11.2	13.0	5.1	6.1	7.2	10.6	4.1	7.2	9.5	4.7	3.8	5.3	7.0	7.9	10.2	7.4	8.8	10.6	12.5	7.2	10.2	2.6	7.0	5.6	9.2	3.7	8.7	7.6	23.6	7.4	8.8	7.3	8.9	6.5	10.4	12.1	3.7	7.8	8.5	9.6	17.0	9.9	4.7	3.7	2.5	8.3	4.1	10.5	5.9	4.9	10.4	12.3	9.8	4.2	3.6	6.9	7.6	1.8	12.6	9.5	4.5	5.3	3.3	10.6	4.8	11.4	3.5	9.6	14.4	12.0	8.1	8.0	3.5	22.7	11.2	23.3	5.1	8.2	3.7	9.6	3.0	3.6	11.7	11.2	1.7	2.6	16.0	13.0	7.9	5.2	2.8	6.1	7.8	9.3	11.1	8.7	8.3	7.2	10.7	4.3	8.8	7.1	3.0	3.0	4.7	7.9	2.6	3.2	6.7	5.1	10.7	9.1	17.4	5.9	15.4	1.7	6.6	9.9	3.0	6.8	0.0	7.8	9.0	5.0	4.5	1.1	4.3	8.5	4.8	2.9	3.7	4.3	4.1	2.0	8.7	0.0	3.6	5.6	6.5	7.9	5.8	3.5	4.2	6.2	0.0	9.9	15.8	5.7	2.0	29.9	4.9	4.5	5.4
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190556-160201886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 320.9;tongue: 83.5"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 16.7;Rod photoreceptor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 10.6;HDLM-2: 20.2;RT4: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	6.1	0.1	0.5	0.0	0.3	0.1	0.2	0.3	2.0	0.1	0.1	0.0	0.1	0.0	0.1	11.9	3.9	0.2	0.1	4.0	0.4	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.5	0.0	1.3	0.0	0.2	4.5	0.4	320.9	0.1	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.0	0.9	83.5	4.7	0.4	0.1	0.9	0.0	0.9	0.7	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	20.2	0.2	0.0	0.0	0.0	0.1	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.0	36.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.9	0.7	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.9	0.1	0.1	0.9	0.2	0.1	0.0	0.3	0.0	0.5	0.3	0.3	2.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	16.7	0.0	1.4	0.0	0.0	2.0	1.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	13.0	0.0	0.8	1.4	1.0	0.0	3.8	0.0	0.0	0.3
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 573.3;Rod photoreceptor cells: 490.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 9.7;HDLM-2: 10.5;SCLC-21H: 16.3;SK-BR-3: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	3.4	0.9	0.3	2.5	1.5	2.8	6.0	0.3	0.7	6.1	20.7	0.5	14.7	8.8	11.0	2.4	9.9	3.4	13.8	9.9	0.2	0.2	4.5	1.4	7.4	0.8	0.8	0.3	1.7	4.4	0.0	4.0	1.2	0.9	12.1	2.4	19.8	17.0	17.4	29.9	25.3	27.1	8.0	0.2	1.2	9.2	1.0	0.8	0.2	1.9	14.4	6.2	7.2	7.2	0.5	3.5	1.9	2.2	1.6	1.6	0.4	9.7	0.8	1.8	1.7	0.0	0.0	0.4	0.3	0.1	0.3	0.4	2.1	2.2	0.4	2.0	0.4	0.8	8.4	1.9	1.9	0.1	10.5	3.3	0.7	1.6	2.2	0.3	1.1	3.1	0.1	7.2	0.1	0.6	0.0	0.3	1.5	0.0	0.0	0.0	5.2	0.6	7.0	0.2	5.1	0.5	0.8	1.2	0.1	1.6	4.0	16.3	1.5	2.5	15.4	0.2	0.7	8.2	1.0	0.1	0.0	1.4	0.8	0.2	0.0	0.0	1.0	0.0	3.0	0.1	1.9	0.2	1.2	1.6	0.4	0.7	0.4	0.6	1.1	0.6	0.5	0.0	0.5	0.4	1.6	2.2	3.5	0.3	0.4	0.3	1.5	0.3	0.7	0.2	0.2	0.8	0.3	0.9	0.8	26.8	20.0	0.0	17.1	29.3	11.2	21.0	10.2	14.7	7.9	14.0	573.3	0.5	3.3	12.2	0.4	11.7	41.1	0.0	7.7	0.8	2.6	37.9	4.6	4.0	1.0	130.3	39.6	6.7	0.3	0.9	0.0	1.8	1.7	10.8	33.5	24.9	13.7	29.1	6.3	1.0	490.7	0.0	7.1	1.7	2.3	53.4	0.6	3.2	22.9	24.5
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3"					"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"	NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.9	0.8	2.9	0.8	7.7	1.1	1.3	4.3	5.8	1.2	1.1	6.5	1.9	1.2	1.2	1.8	0.9	1.4	0.9	0.8	3.9	1.0	1.0	1.0	1.1	1.0	7.4	2.2	1.3	1.0	1.0	1.2	0.8	5.2	1.3	1.0	0.4	2.0	1.1	1.0	2.0	1.1	0.9	3.2	0.9	1.0	35.7	6.5	2.2	1.3	0.0	1.0	0.9	3.3	0.1	0.6	4.8	1.8	0.2	0.5	0.2	0.2	0.5	0.2	1.8	0.8	0.0	4.2	0.2	0.0	0.0	0.0	1.3	0.8	0.3	0.0	0.0	0.7	0.6	0.5	0.1	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.3	5.3	0.0	0.8	0.0	0.5	0.5	0.1	0.8	0.0	1.4	0.0	4.3	0.0	0.0	0.0	1.1	0.8	0.1	0.0	0.8	2.0	0.1	0.4	0.6	0.4	0.9	0.2	0.7	0.4	0.0	0.3	0.0	1.0	0.7	0.0	0.8	0.9	0.0	0.2	0.2	0.0	0.3	0.8	1.8	0.4	0.9	0.2	0.0	0.1	0.2	0.6	0.1	0.5	0.2	4.8	0.2	1.8	0.4	0.3	0.2	2.9	7.7	4.3	5.8	3.9	1.0	7.4	2.2	5.2	6.5	0.0	2.4	1.7	1.9	2.3	1.1	2.4	2.5	0.0	0.0	1.8	0.0	1.0	0.0	0.8	23.9	1.5	14.0	0.0	0.6	0.2	1.5	1.8	1.1	0.5	2.8	1.6	1.7	1.8	0.8	27.8	1.7	2.6	0.0	1.8	1.5	1.9	0.5	3.5	2.1	1.1	1.1	0.0	1.0	31.9	2.7	1.6	1.1	2.5	2.0	1.4
CATSPERZ	"C11orf20, DKFZP566E164, TEX40"	ENSG00000219435	"Catsper channel auxiliary subunit zeta"	Q9NTU4	11	64300391-64304770	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"testis: 139.5"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.7;CACO-2: 15.6;PC-3: 9.3;T-47d: 7.6"									HPA052822			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052822: AB_2797245"	"unprognostic (1.89e-1)"	"unprognostic (7.81e-2)"			"unprognostic (1.88e-1)"				"unprognostic (8.23e-2)"	"unprognostic (2.18e-1)"		"unprognostic (1.11e-1)"	"unprognostic (5.66e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.07e-2)"		"unprognostic (1.43e-1)"	0.1	0.0	0.5	0.0	0.4	0.0	0.8	0.1	0.9	0.2	0.1	0.1	0.2	0.0	0.1	0.7	0.1	0.0	0.2	0.0	0.5	0.2	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	139.5	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.5	0.4	0.6	0.6	0.0	0.3	0.0	0.0	4.1	0.3	0.0	0.5	1.0	5.7	0.0	0.3	0.0	0.0	15.6	3.2	0.1	0.2	0.2	0.2	3.4	3.2	0.5	0.1	0.0	0.0	1.5	0.1	1.0	0.1	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.2	0.0	1.6	0.7	0.2	0.7	0.0	0.7	1.1	4.5	9.3	1.7	0.0	2.0	4.5	1.5	0.1	0.9	1.7	0.5	0.2	0.3	7.6	0.4	0.3	0.2	0.1	2.1	0.0	0.4	0.1	0.5	0.3	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.1	0.5	0.0	0.2	0.0	0.1	0.1	0.0	0.6	0.0	0.6	0.4	0.0	0.0	0.5	0.4	0.1	0.3	0.5	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	29.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0
CAV2	CAV	ENSG00000105971	"Caveolin 2"	P51636	7	116287380-116508541	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 824.8;Basal keratinocytes: 429.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"basophil: 31.8"	"Lineage enriched"	"Detected in single"	318	"granulocytes: 31.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 48.8;HBEC3-KT: 55.8;LHCN-M2: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013488, HPA044810"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB013488: AB_2533493, HPA044810: AB_2679098"	"unprognostic (4.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.56e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.09e-3)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.81e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.84e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.34e-3)"	61.9	4.5	3.0	9.5	6.6	0.2	39.9	1.0	3.7	26.3	15.7	3.1	10.3	3.3	23.4	19.6	25.2	10.8	31.3	54.6	4.4	3.1	9.5	17.4	59.4	6.0	7.5	3.8	17.7	16.0	1.4	2.8	35.2	4.6	20.6	5.0	12.1	10.7	10.5	15.3	13.3	8.3	34.0	8.6	25.3	8.9	12.1	5.3	1.7	61.2	23.2	4.9	29.5	15.4	0.0	0.0	31.8	0.0	0.0	0.0	0.2	39.3	10.7	0.5	0.0	18.2	19.6	0.8	27.5	32.8	9.1	8.2	2.0	48.8	0.0	33.0	28.2	29.4	38.2	0.5	55.8	13.2	0.0	2.6	0.3	8.2	0.0	11.2	0.0	0.1	11.5	32.2	12.3	25.5	14.6	29.4	0.0	1.9	1.6	60.2	2.1	0.0	0.0	0.5	1.3	6.9	0.4	13.4	0.5	33.5	1.2	0.0	0.0	21.0	0.7	5.1	5.9	0.0	0.2	41.9	0.0	5.8	18.2	9.0	1.7	0.0	0.1	3.7	0.0	19.7	31.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	3.0	6.6	1.0	3.7	4.4	3.1	7.5	3.8	4.6	5.3	824.8	93.2	3.0	234.5	429.9	3.3	197.7	119.8	33.5	164.9	38.4	3.9	12.5	29.9	203.4	19.4	231.9	2.4	0.0	87.5	115.4	81.9	72.8	2.3	42.7	4.3	0.0	1.7	104.3	4.7	13.0	87.5	7.4	138.3	3.6	4.7	140.5	278.7	0.0	182.5	2.2	6.0	187.5	172.0	2.3	1.3	246.5	10.4	2.5	5.1	133.6
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733800-8841808	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 65.8;tongue: 44.6"	"Cell type enhanced"	"Detected in some"	28	"Cardiomyocytes: 18.9;Early spermatids: 4.4;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 46.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	6.3	2.3	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.7	1.3	0.1	65.8	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	44.6	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0
CAVIN1	"cavin-1, CGL4, PTRF"	ENSG00000177469	"Caveolae associated protein 1"	Q6NZI2	17	42402452-42423517	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"RNA-binding, rRNA-binding"	"Congenital generalized lipodystrophy, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 399.0;Alveolar cells type 2: 119.0;Club cells: 93.3;Cytotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 112.6;fHDF/TERT166: 80.4;TIME: 93.4;U-138 MG: 95.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049838, HPA074213"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		29000	"Plasma membrane"	Vesicles	"HPA049838: AB_2680907, HPA074213: AB_2686674"	"unprognostic (1.59e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (7.18e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.44e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (5.87e-4)"	105.6	12.7	4.7	26.4	5.4	0.7	111.2	4.5	7.6	68.6	52.0	15.3	31.9	7.1	65.6	45.6	60.3	37.1	74.0	37.3	6.4	4.6	12.1	6.6	47.0	15.6	7.7	6.1	57.8	6.8	7.5	6.9	47.7	13.6	51.8	12.4	34.0	17.4	53.8	45.4	28.6	18.6	115.4	14.7	23.9	27.0	24.3	5.2	3.3	30.4	47.9	12.6	80.6	57.9	0.9	0.6	2.7	0.5	0.7	1.2	0.2	31.2	26.8	0.5	7.1	36.3	43.8	0.7	112.6	49.0	45.0	35.7	13.5	2.0	0.0	22.6	80.4	18.5	51.8	4.8	33.7	36.9	0.1	0.9	13.7	16.4	6.5	23.0	0.0	0.1	30.0	12.5	35.4	12.1	24.1	60.7	0.0	9.3	0.1	19.2	0.5	0.7	0.1	2.6	4.8	0.1	0.0	18.0	0.0	19.2	0.1	0.0	0.2	37.8	0.6	9.0	15.8	3.1	0.2	93.4	95.7	45.0	34.2	40.8	0.0	0.0	0.1	28.4	0.0	10.7	2.7	0.5	0.3	0.5	0.4	0.3	0.3	1.2	0.3	0.2	0.9	0.6	0.3	2.3	0.7	0.4	0.6	0.3	0.2	4.7	5.4	4.5	7.6	6.4	4.6	7.7	6.1	13.6	5.2	399.0	119.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	93.3	22.7	0.0	122.7	3.3	43.9	0.0	0.0	0.0	0.0	3.9	8.9	0.0	0.0	58.1	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	65.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	0.0	0.0
CAVIN3	"cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC"	ENSG00000170955	"Caveolae associated protein 3"	Q969G5	11	6318946-6320647	"Predicted intracellular proteins"	"Biological rhythms"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 73.7"	"Cell type enhanced"	"Detected in many"	18	"Exocrine glandular cells: 224.8;Extravillous trophoblasts: 73.0;monocytes: 53.3;Pancreatic endocrine cells: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 8.1;myeloid DC: 22.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 22.4;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"A-431: 30.2;BJ: 29.1;HaCaT: 23.3;NTERA-2: 19.3;TIME: 34.5;U-87 MG: 32.7;WM-115: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055136, HPA073327"	Supported		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA055136: AB_2682711, HPA073327: AB_2686595"	"unprognostic (7.92e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (3.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.96e-2)"	30.2	5.1	0.9	14.2	1.6	0.8	12.6	0.8	2.9	38.3	16.1	1.8	14.2	5.8	31.6	32.2	20.3	13.4	15.3	16.8	0.9	1.0	8.6	2.6	9.8	6.8	2.2	3.5	14.0	5.6	1.0	1.7	22.0	2.8	20.9	2.3	11.1	5.0	11.0	12.1	6.8	7.9	34.7	1.3	9.8	11.3	73.7	0.4	0.7	5.5	14.5	4.3	26.5	16.5	0.0	22.4	0.1	8.1	0.1	3.1	2.7	30.2	2.8	0.0	0.1	1.2	5.2	0.0	29.1	9.0	4.0	4.1	0.0	0.0	0.0	9.7	4.1	0.4	23.3	0.0	1.8	0.5	7.6	0.0	0.0	3.0	0.0	3.1	0.0	0.1	3.4	2.4	1.5	1.2	0.0	7.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	19.3	0.1	0.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	10.4	0.0	6.3	0.1	0.0	0.1	34.5	0.0	0.1	11.3	0.1	0.0	0.2	0.0	32.7	0.0	34.7	0.0	8.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	22.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.1	2.7	0.9	1.6	0.8	2.9	0.9	1.0	2.2	3.5	2.8	0.4	11.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	18.7	14.8	15.7	0.0	3.0	33.2	6.0	0.0	0.0	0.0	0.0	224.8	73.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	53.3	0.0	0.0	141.7	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100587906	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 83.8;tongue: 52.4"	"Cell type enhanced"	"Detected in some"	13	"Cytotrophoblasts: 1.2;Pancreatic endocrine cells: 1.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 10.3;SCLC-21H: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	3.5	0.0	0.3	0.1	0.6	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.2	2.7	1.9	0.0	0.1	16.4	0.5	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.8	0.0	83.8	0.1	0.0	0.1	0.7	0.0	0.1	1.4	0.0	0.1	0.2	52.4	1.6	0.0	0.0	0.4	0.3	1.4	0.4	0.7	0.7	0.0	0.5	0.4	7.4	2.7	1.6	2.4	5.3	1.3	1.0	1.0	1.2	0.0	0.5	0.3	0.3	0.6	2.6	0.3	3.5	0.1	2.1	1.7	2.5	0.0	1.2	0.0	0.5	0.3	0.4	5.9	0.3	1.0	0.6	1.8	1.3	1.8	0.2	0.3	4.6	0.1	2.0	0.3	10.3	1.1	0.8	3.0	6.9	0.0	0.8	0.4	15.8	4.2	0.2	0.3	1.4	5.0	0.2	0.2	1.3	1.8	1.5	1.3	1.1	0.4	1.3	0.7	2.0	0.1	1.3	0.6	0.3	0.2	0.5	0.4	0.2	0.2	0.7	0.5	0.1	0.4	0.5	0.5	1.4	0.7	0.3	0.3	0.2	0.0	0.3	0.6	0.5	0.3	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
CBARP	"BARP, C19orf26, DOS, MGC40084"	ENSG00000099625	"CACN beta subunit associated regulatory protein"	Q8N350	19	1228287-1238027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.9;pituitary gland: 13.1"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 18.9;Early spermatids: 35.1;Late spermatids: 59.2"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 8.7"									HPA012777			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012777: AB_2067005"	"unprognostic (1.31e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-3)"	"unprognostic (3.03e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.42e-5)"	2.3	8.1	7.2	1.5	12.1	1.0	1.2	3.6	17.9	1.2	1.3	5.2	0.0	1.3	1.8	1.1	1.5	1.1	1.8	1.5	8.5	5.6	1.8	1.5	1.4	1.1	3.3	4.7	2.9	2.1	1.6	13.1	1.4	10.6	1.4	1.0	1.2	1.2	1.5	1.3	4.5	1.1	1.2	6.5	1.2	1.9	3.0	2.2	0.0	1.3	0.0	1.2	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	2.0	5.3	0.2	0.6	1.5	4.4	1.3	0.9	1.0	2.4	0.2	0.0	5.0	1.0	0.5	2.4	0.8	0.9	0.2	0.9	1.1	0.1	1.7	1.4	2.3	0.1	1.8	1.2	0.5	1.1	0.3	0.9	0.7	1.2	2.8	0.1	0.6	4.0	0.0	1.3	3.7	0.3	2.2	4.4	0.8	0.3	0.2	0.6	3.2	8.7	0.0	0.1	4.5	0.2	0.6	0.9	1.7	1.9	5.6	5.2	1.6	0.5	0.5	0.0	1.5	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	12.1	3.6	17.9	8.5	5.6	3.3	4.7	10.6	2.2	0.0	0.0	0.0	0.2	0.0	18.9	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.2	35.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.2	3.2	0.0	1.3	1.0	59.2	1.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.4	0.1	1.1	0.0	0.0	9.8	4.1	0.0	0.0	0.0	0.0	0.1
CBFA2T2	"MTGR1, ZMYND3"	ENSG00000078699	"CBFA2/RUNX1 translocation partner 2"	O43439	20	33490075-33650036	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060523, HPA072433"	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA060523: AB_2684305, HPA072433: AB_2686520"	"unprognostic (6.51e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.85e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-3)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.12e-2)"	8.7	8.5	19.2	15.6	20.8	10.2	11.6	19.2	20.3	12.3	14.7	24.6	8.1	14.8	12.8	10.0	12.7	12.8	10.1	10.5	16.4	13.2	10.9	10.1	11.3	11.6	21.2	17.0	21.0	11.0	19.5	15.9	9.7	17.5	27.9	17.3	15.2	13.9	12.7	16.2	21.7	16.9	13.4	15.9	13.3	13.7	15.4	21.2	15.8	15.6	3.9	14.2	13.4	14.9	5.6	3.1	5.9	2.4	2.7	7.3	1.4	5.2	5.3	6.4	5.2	6.0	4.7	8.3	3.2	3.4	4.6	3.7	11.4	4.5	5.8	7.3	3.9	9.6	6.7	4.3	4.9	3.8	2.5	3.2	8.1	4.5	7.4	3.8	3.2	6.3	4.0	5.8	5.0	5.7	4.6	3.5	5.7	5.3	3.8	3.2	4.4	7.4	4.6	2.2	5.7	6.1	5.8	8.1	6.1	4.1	7.5	22.4	31.9	16.3	5.5	4.6	7.2	5.6	4.3	3.9	10.9	4.7	6.5	3.9	7.9	9.1	3.6	5.4	2.8	2.9	5.9	2.4	2.8	5.3	2.3	5.0	5.3	5.2	7.3	1.0	5.6	2.9	3.9	4.8	2.7	1.4	3.1	4.2	1.4	19.2	20.8	19.2	20.3	16.4	13.2	21.2	17.0	17.5	21.2	11.9	23.7	9.7	13.6	16.9	28.7	9.6	7.6	8.1	10.3	12.2	43.2	9.6	1.7	6.8	5.7	10.6	13.4	0.0	5.5	8.2	14.1	22.5	1.1	6.6	8.2	12.7	86.8	11.6	9.9	11.0	13.0	9.9	16.9	8.2	48.4	12.3	8.8	17.3	12.0	4.2	35.5	12.9	9.8	23.1	16.7	13.4	7.4	19.3	17.8	8.9
CBFB	PEBP2B	ENSG00000067955	"Core-binding factor beta subunit"	Q13951	16	67029116-67101058	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 101.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038852	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA038852: AB_10795358"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (2.89e-8)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	15.9	10.9	15.9	26.4	25.1	20.5	15.0	9.5	14.3	15.4	10.6	23.3	11.8	8.8	15.3	10.2	20.5	14.3	16.3	21.5	16.2	13.2	12.1	14.4	16.1	32.6	23.6	12.4	17.3	13.6	40.4	18.8	13.2	17.5	14.6	11.1	13.7	19.6	10.3	33.3	14.8	12.2	11.7	22.4	18.2	17.1	7.3	24.2	42.2	17.0	14.8	31.0	15.9	18.8	6.5	9.1	20.5	9.2	14.8	7.0	5.1	15.6	10.5	9.2	14.9	6.7	8.6	14.7	18.2	10.9	17.2	15.2	21.0	18.0	34.7	17.4	15.5	7.2	15.6	16.4	10.2	23.2	11.9	9.4	24.1	9.0	16.7	9.6	31.4	51.9	8.7	7.0	19.2	14.8	9.1	13.9	17.2	25.6	12.4	17.8	11.9	32.3	16.8	9.0	8.3	14.8	65.6	39.7	29.5	12.1	14.0	13.5	12.1	46.7	7.1	18.6	11.3	6.4	22.6	19.3	26.7	18.3	15.1	24.4	17.0	30.2	101.5	20.3	21.6	24.0	20.5	7.4	7.4	6.7	9.2	7.0	6.5	6.6	7.0	9.1	6.4	6.3	5.3	4.6	14.8	6.1	3.3	7.0	5.1	15.9	25.1	9.5	14.3	16.2	13.2	23.6	12.4	17.5	24.2	8.9	19.8	29.2	37.0	49.9	4.5	15.4	15.3	13.4	17.0	38.4	11.8	12.1	23.2	14.4	4.4	17.4	7.3	0.0	24.0	26.0	32.1	38.3	26.6	14.0	33.8	9.5	18.2	27.0	43.0	5.7	22.2	46.5	49.0	10.8	12.4	12.3	47.8	5.8	19.8	9.8	14.2	12.9	24.7	13.4	16.3	55.2	14.2	54.9	11.5	52.5
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	38.4	9.0	3.7	19.5	4.9	15.5	16.3	24.4	3.8	13.7	18.7	5.9	7.7	9.3	13.8	12.2	8.3	12.5	13.4	27.5	3.8	4.8	7.4	6.7	16.3	19.1	4.4	1.9	17.7	6.8	3.4	13.5	25.4	7.9	12.9	8.0	11.6	9.1	6.3	10.3	8.5	13.8	25.6	5.7	16.4	12.4	9.2	5.2	11.6	13.5	7.0	18.0	24.9	24.1	5.1	3.1	2.8	2.1	10.3	9.9	1.6	1.6	2.3	7.7	3.8	8.9	9.0	5.0	5.8	2.9	1.7	2.7	2.9	2.0	3.6	4.0	3.0	2.7	2.9	1.0	1.0	2.1	2.8	2.9	2.0	12.0	1.9	13.1	1.4	1.5	8.6	3.1	4.5	12.3	6.4	5.6	3.7	2.1	11.7	3.6	2.1	2.0	0.9	2.7	2.0	3.3	4.2	2.3	0.6	4.1	7.4	6.0	6.5	6.8	0.8	8.9	5.6	1.7	2.9	3.1	23.9	2.0	3.2	1.4	6.6	0.6	5.7	6.4	1.2	1.5	0.7	1.5	2.8	9.9	0.9	8.8	2.2	5.1	5.6	1.3	5.1	4.4	8.0	1.0	10.3	2.1	3.1	5.6	1.6	3.7	4.9	24.4	3.8	3.8	4.8	4.4	1.9	7.9	5.2	14.9	6.7	21.6	6.8	9.6	44.8	39.9	0.0	10.7	6.8	12.2	25.5	8.9	5.0	6.0	27.4	22.6	8.7	0.0	6.9	53.5	21.6	9.6	8.1	6.7	12.2	3.2	12.1	39.3	11.3	9.0	6.9	10.4	15.1	5.4	16.2	7.4	11.7	7.0	10.3	3.1	27.4	6.5	19.9	9.8	15.8	6.0	38.0	52.3	10.7	3.0
CBLC	"CBL-3, CBL-SL, RNF57"	ENSG00000142273	"Cbl proto-oncogene C"	Q9ULV8	19	44777869-44800634	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.8"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 105.9;Pancreatic endocrine cells: 67.6;Paneth cells: 84.2;Undifferentiated cells: 54.6;Urothelial cells: 56.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 13.1;CACO-2: 12.9;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.3;OE19: 16.9;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB008087, HPA035266"	Approved		Approved	Nucleoplasm,Aggresome		NA	NA			Nucleoplasm	Aggresome	"CAB008087: AB_2228531, HPA035266: AB_2674542"	"unprognostic (1.58e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.11e-6)"	"unprognostic (3.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.21e-3)"	0.1	0.0	0.5	8.5	0.2	0.0	4.8	0.1	0.4	4.4	39.5	0.1	3.2	29.5	1.7	1.7	22.0	1.4	18.8	0.1	0.6	0.0	4.9	15.1	1.3	0.1	0.1	0.3	0.8	18.1	0.9	0.7	4.1	0.2	6.9	6.9	0.5	11.4	5.2	0.1	20.8	66.8	0.4	0.1	0.1	10.2	1.6	0.1	0.5	1.9	13.2	15.7	7.6	8.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	19.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	12.9	26.3	0.0	0.0	0.0	0.0	18.4	0.0	16.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.9	0.0	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.0	14.6	0.0	0.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.4	0.6	0.0	0.1	0.3	0.2	0.1	0.0	1.6	0.0	28.6	13.4	0.0	0.2	5.1	5.3	11.4	7.0	0.0	4.6	1.7	37.5	0.0	0.1	105.9	0.0	42.7	1.3	0.4	14.4	0.0	8.5	0.3	0.0	16.7	0.0	0.0	0.0	0.0	0.9	0.0	1.0	35.8	0.0	67.6	84.2	0.0	9.9	0.0	0.0	0.4	0.0	1.7	22.5	2.1	0.7	54.6	56.4
CBLN3		ENSG00000139899	"Cerebellin 3 precursor"	Q6UW01	14	24426532-24430954	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 105.2"	"Cell type enhanced"	"Detected in some"	8	"Fibroblasts: 2.3;Leydig cells: 2.3;monocytes: 3.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	23	"cerebellum: 105.2"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.5;naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.9;HDLM-2: 12.7;HSkMC: 18.9;Karpas-707: 14.2;U-266/70: 9.9"	"Region enriched"	"Detected in some"	25	"cerebellum: 481.8"	"Region enriched"	"Detected in some"	47	"cerebellum: 583.0"	HPA041266	Enhanced	Supported	Approved	Nucleoplasm	"Secreted in brain"	NA	NA			Nucleoplasm		"HPA041266: AB_10674430"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.39e-4)"	"unprognostic (5.39e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (6.20e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.02e-2)"	2.1	7.7	1.2	4.5	1.3	0.0	1.2	105.2	1.7	1.8	1.1	1.9	1.0	0.6	1.3	4.8	1.0	1.2	3.1	1.6	1.0	1.1	1.2	1.4	1.3	7.9	1.3	1.4	3.3	1.0	1.0	1.3	1.7	4.6	1.2	0.7	1.7	1.6	1.6	1.4	1.6	1.3	1.3	2.0	7.4	1.4	1.6	1.1	1.1	1.2	1.5	5.3	1.9	1.3	2.3	0.3	0.1	0.8	0.0	0.3	0.0	1.1	1.0	0.5	1.9	5.0	10.9	0.3	4.2	8.6	1.7	2.2	0.5	2.0	1.8	0.9	2.6	1.9	0.3	0.6	2.3	1.1	12.7	0.4	0.0	3.5	0.8	2.8	0.3	0.7	18.9	1.0	2.1	1.7	7.0	1.5	0.8	0.5	14.2	2.1	0.6	0.0	0.5	0.1	1.1	1.1	0.0	0.0	1.3	1.0	0.4	0.7	0.4	0.3	0.1	0.6	0.3	0.6	0.4	6.6	6.1	1.2	2.5	0.2	9.9	2.3	2.0	0.3	0.8	1.0	0.0	0.0	0.1	0.0	0.8	0.3	1.5	0.1	0.1	0.0	2.3	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.2	1.3	105.2	1.7	1.0	1.1	1.3	1.4	4.6	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.5	0.0	1.0	0.5	2.3	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	3.6	0.2	0.8	0.8	0.0	1.4	0.5	0.3	0.0	1.2	0.0	0.1	0.5	0.7	0.0	0.4	0.5
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 176.1"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 641.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018433, CAB034291"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		12000000	Nucleoplasm	Cytosol	"CAB034291: AB_2070856, HPA018433: AB_1846109"	"prognostic favorable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favorable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	9.6	22.9	31.7	8.4	41.6	3.7	8.5	12.0	35.8	14.6	63.4	75.9	6.5	176.1	9.3	17.1	40.2	9.6	15.1	7.8	37.7	24.7	35.2	77.2	11.7	8.5	57.3	25.2	10.4	8.0	8.9	7.9	11.7	51.6	16.7	16.8	10.4	23.1	15.0	8.7	34.4	118.1	11.6	48.1	10.0	41.4	5.7	41.9	3.6	11.3	29.8	14.3	12.4	17.1	17.0	29.9	17.1	51.4	19.1	29.2	37.0	25.3	39.1	4.8	12.3	25.1	25.4	0.2	28.5	20.5	15.6	18.7	14.4	14.9	6.4	18.8	26.5	30.1	18.7	9.8	27.9	12.0	31.5	23.1	19.1	22.8	9.8	14.4	10.6	17.6	12.4	35.2	15.1	6.6	17.9	16.6	0.0	0.0	4.7	14.3	25.1	5.3	11.1	0.0	0.0	28.6	0.0	0.1	17.7	41.4	12.7	14.0	12.5	27.5	40.0	32.4	3.9	18.9	14.8	16.7	17.5	7.4	44.3	20.6	32.0	57.9	0.1	32.1	10.6	25.3	1.8	36.6	17.1	18.1	51.4	15.3	17.0	22.7	16.9	29.9	15.6	29.2	21.4	2.5	19.1	38.6	10.4	22.7	37.0	31.7	41.6	12.0	35.8	37.7	24.7	57.3	25.2	51.6	41.9	113.2	54.7	13.0	59.4	113.9	11.9	19.9	81.5	111.1	96.7	90.7	2.0	102.1	641.6	73.2	5.9	17.8	131.2	46.7	60.9	77.8	54.3	48.6	34.6	203.8	78.0	3.2	37.1	54.6	65.5	2.9	113.6	47.2	86.0	102.8	58.6	65.5	81.3	71.8	124.5	200.8	7.4	25.8	60.8	4.2	11.3	108.0	74.6	30.9	77.6	42.0
CBS	HIP4	ENSG00000160200	Cystathionine-beta-synthase	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 55.7;pancreas: 43.0"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 3.5;Hepatocytes: 2.6;Melanocytes: 5.0;Smooth muscle cells: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	84	"neutrophil: 8.3"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 40.8;HAP1: 38.9;HHSteC: 52.7;MCF7: 45.1;RPMI-8226: 43.1"									HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	1.3	1.5	6.5	2.4	5.1	0.4	1.0	12.3	6.7	4.8	1.3	2.0	0.8	1.6	0.9	0.8	0.8	2.0	2.1	2.0	5.6	5.5	1.3	55.7	1.7	1.4	4.8	2.8	13.9	43.0	0.3	1.4	1.4	2.3	4.0	0.7	2.8	9.3	3.4	0.8	0.6	2.9	1.4	3.7	0.8	2.7	2.2	3.3	0.8	5.0	0.8	0.9	2.6	0.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.4	3.9	5.1	20.0	11.5	7.4	40.8	8.0	2.0	3.3	3.4	12.0	0.3	0.0	4.3	15.0	0.0	0.4	38.9	2.8	0.6	0.0	4.9	2.7	15.6	14.4	52.7	1.6	3.8	4.5	0.4	3.6	3.2	3.0	8.8	18.9	30.1	22.7	2.5	45.1	2.8	0.0	4.8	14.6	6.8	0.0	0.0	43.1	0.1	3.6	10.6	15.6	17.4	1.0	7.5	4.3	6.2	20.4	1.2	0.2	10.0	0.1	0.8	7.9	6.3	9.0	3.7	2.4	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	6.5	5.1	12.3	5.2	5.6	5.5	4.8	2.8	2.3	3.3	0.0	0.3	0.0	0.0	0.3	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.2	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.0	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.9	0.1	0.0	0.0	0.0
CBSL		ENSG00000274276	"Cystathionine-beta-synthase like"	P0DN79	21	6444869-6468040	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.5;liver: 21.2;pancreas: 18.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	47	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.5;NTERA-2: 67.6;SH-SY5Y: 21.6;U-266/70: 21.3"									HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA		190000	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (2.39e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.61e-1)"	0.0	0.0		0.0		0.0	0.0		11.5	1.8	0.0			0.4	0.0	0.0	0.0	0.3	0.0	1.0			0.0	21.2	0.0	0.0			1.6	18.5	0.0		0.0		1.8	0.0		0.0	3.5	0.0	0.0	0.8	0.0		0.0	0.0	0.0			5.0		0.0	0.3		0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	12.2	36.5	0.0	0.0	0.4	7.6	4.4	2.8	8.5	0.1	4.9	0.0	0.0	0.0	4.7	3.2	0.0	3.9	1.7	0.0	9.6	0.0	0.0	0.0	0.2	0.0	5.2	4.2	14.2	0.0	7.1	0.0	0.0	0.8	0.2	16.9	0.1	0.0	5.7	0.6	67.6	0.0	0.0	0.0	0.0	0.0	11.0	0.0	14.1	21.6	0.0	1.1	14.7	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.5	21.3	7.8	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CBWD1		ENSG00000172785	"COBW domain containing 1"	Q9BRT8	9	121038-179147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 54.7"									"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (3.75e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.80e-7)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.98e-3)"	6.3	14.1	5.5	5.3	6.7	3.8	7.2	5.5	4.5	4.9	5.5			4.6	4.5	8.3	10.4	5.0	3.5	7.0	4.9	6.9	16.3	10.1	5.7	4.1	5.9		5.5	10.5	7.5	7.6	8.3		7.2	5.7		8.6	4.5	7.5	7.1	4.1	4.2	4.8	5.6	6.1	6.3			10.0		7.3	6.9	5.1	8.2	28.0	7.0	28.2	4.5	7.6	15.6	12.7	4.8	7.0	3.7	9.2	8.4	15.6	6.7	4.4	9.4	7.2	7.0	4.9	11.7	8.8	2.4	5.7	2.2	3.4	6.4	10.2	20.0	11.9	0.1	11.4	21.5	10.0	33.8	5.3	7.4	3.1	2.2	18.5	6.1	10.0	6.0	3.9	25.9	7.7	15.3	7.3	54.7	7.0	11.2	10.5	14.1	10.7	22.3	12.2	36.3	12.7	7.7	13.8	5.1	5.1	18.1	10.9	32.4	10.4	5.0	7.1	6.4	5.8	3.1	4.2	13.4	12.4	18.1	5.8	1.2	25.3	7.0	4.2	28.2	6.8	8.2	7.6	6.7	28.0	5.6	6.7	7.3	3.8	4.5	21.3	7.4	6.6	15.6											50.6	47.9	33.7	27.4	42.4	48.0	46.0	25.5	38.8	59.1	33.2	102.1	83.3	29.9	60.1	37.4	22.4	21.9	0.0	103.4	31.0	20.3	19.4	30.2	16.0	28.7	36.5	30.0	18.4	26.3	13.0	16.7	36.5	30.4	85.6	35.3	24.9	55.6	28.1	12.4	58.7	53.6	32.3	38.2	33.7	19.8	44.3	104.4	16.0	55.5	21.8
CBWD2		ENSG00000136682	"COBW domain containing 2"	Q8IUF1	2	113437691-113496189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.4"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 97.9;monocytes: 81.2;Suprabasal keratinocytes: 104.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (7.69e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (7.57e-3)"	2.0	5.7	3.2	2.6	6.0	0.3	4.3	7.0	4.1	5.6	3.6			0.9	4.1	4.9	5.9	2.1	2.5	9.1	3.1	4.5	8.9	6.6	1.8	1.3	3.2		3.0	3.6	7.7	5.3	3.4		4.1	3.6		4.3	5.0	15.0	1.7	2.2	5.0	1.6	2.3	3.3	1.2			6.2		2.5	4.2	2.5	7.8	26.5	13.8	27.4	7.5	10.4	17.5	8.0	4.8	5.4	6.1	14.1	6.5	10.1	6.3	4.0	5.0	6.5	8.2	5.0	10.6	19.3	6.6	22.7	6.8	5.6	7.0	6.7	3.6	15.0	8.8	8.7	15.3	4.7	3.7	4.2	6.1	4.3	7.2	4.3	9.5	8.9	5.7	5.0	11.6	7.2	8.6	11.7	12.5	6.4	15.4	10.7	5.6	14.1	27.8	13.1	13.0	14.8	4.3	16.3	2.4	2.7	18.9	7.7	10.8	10.6	4.2	5.9	2.5	6.0	4.5	18.7	5.6	6.9	23.0	9.9	4.2	27.4	13.8	5.2	27.1	5.6	7.3	7.9	6.1	26.5	7.8	6.8	6.2	7.5	7.5	21.2	6.5	10.4	17.5											8.9	15.6	26.1	9.5	97.9	11.0	42.0	15.3	37.5	18.2	14.0	15.7	14.3	33.2	23.7	12.9	14.6	8.4	0.0	12.5	11.1	14.6	8.9	15.1	10.6	8.4	12.7	2.4	6.7	8.8	11.8	10.0	23.9	25.3	81.2	8.2	9.5	12.7	12.9	16.3	23.0	12.3	0.0	15.5	16.8	11.1	104.9	21.6	10.9	14.4	9.7
CBWD3	bA561O23.1	ENSG00000196873	"COBW domain containing 3"	Q5JTY5	9	68232003-68300015	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"blood: 34.4"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.71e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.16e-4)"	3.8	6.0	4.4	6.6	4.9	4.0	6.5	5.7	5.1	2.7	4.7			4.2	2.9	2.1	5.4	3.0	1.8	2.9	4.8	4.4	7.7	11.1	2.9	5.7	4.5		3.6	10.7	4.2	5.0	5.5		4.1	3.2		3.7	3.6	5.2	4.9	7.6	2.8	3.9	5.0	6.3	3.2			5.1		4.3	4.5	3.5	20.3	24.4	34.4	33.9	5.7	14.0	19.9	21.3	15.9	7.8	12.1	5.8	1.9	10.3	10.7	4.2	4.5	5.3	4.4	21.0	24.7	10.4	7.7	21.0	26.2	14.3	21.0	12.4	38.0	9.2	9.5	36.2	21.0	7.4	17.9	11.9	4.8	6.5	8.2	10.8	9.0	10.5	28.3	17.3	20.2	6.6	13.7	20.9	23.9	11.4	25.5	26.7	9.5	24.3	26.9	5.1	9.2	12.1	7.8	17.6	10.6	13.1	15.1	7.6	20.8	5.0	7.0	17.9	11.5	20.5	11.9	47.4	30.3	21.0	26.5	12.6	9.1	33.9	24.8	11.6	27.2	10.0	20.3	10.8	11.9	24.4	18.4	11.7	10.9	34.4	5.7	19.0	18.3	14.0	19.9											23.8	25.9	16.0	14.0	12.9	27.1	24.2	7.6	40.2	34.2	10.4	27.5	11.9	1.7	5.1	3.3	7.5	11.7	0.0	10.0	6.7	4.7	7.5	11.6	7.3	4.6	11.1	4.1	7.4	13.0	1.7	4.6	8.7	5.0	22.6	6.5	4.3	6.9	14.0	2.8	5.0	34.5	6.5	5.3	10.1	5.0	18.7	12.9	10.2	8.1	9.5
CBWD5		ENSG00000147996	"COBW domain containing 5"	Q5RIA9	9	65668805-65734041	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.23e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.02e-3)"	"unprognostic (5.32e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.87e-1)"	4.1	6.0	5.2	3.7	6.8	2.5	9.2	8.2	3.7	2.8	3.3			5.4	1.7	4.8	3.3	1.7	2.2	2.4	6.2	6.0	7.6	17.9	1.9	2.6	4.8		2.1	6.6	2.9	4.0	2.9		4.3	5.5		2.2	3.8	2.1	2.8	4.4	2.5	2.6	5.7	2.2	2.1			5.1		4.4	5.4	1.5	5.5	11.7	7.7	14.0	2.5	5.5	9.3	15.0	16.2	5.8	7.4	8.9	4.1	7.0	10.7	7.2	8.5	8.7	2.1	13.9	20.5	6.9	6.2	12.2	11.1	26.3	8.5	16.1	3.3	6.3	5.7	26.2	36.4	6.7	12.9	3.7	7.2	9.9	7.8	6.3	10.7	15.3	7.9	8.1	15.3	8.6	18.2	6.4	13.7	7.1	26.0	17.5	11.2	8.0	20.5	13.5	9.9	7.7	7.8	8.7	6.8	3.1	10.7	31.8	8.6	4.3	3.8	14.2	11.7	12.2	5.0	13.4	4.9	16.1	14.9	14.5	1.6	11.6	7.7	3.4	14.0	3.7	5.5	5.5	4.7	11.7	2.9	5.1	4.1	7.1	2.5	8.5	4.9	4.1	9.3											38.7	47.5	48.4	29.8	57.9	38.4	30.2	33.1	36.1	52.4	19.2	64.8	36.3	18.3	30.3	7.7	18.2	41.3	23.3	34.0	18.7	12.4	16.5	9.3	42.4	14.1	33.4	16.1	15.4	24.3	4.1	19.5	26.9	28.7	55.1	26.5	9.8	28.6	45.6	16.3	31.8	56.7	6.5	25.0	26.5	16.8	74.8	42.2	19.8	27.6	26.5
CBWD6	CBWD7	ENSG00000215126	"COBW domain containing 6"	Q4V339	9	41131306-41199261	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"blood: 9.3;liver: 6.1"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 34.9;Melanocytes: 13.5;Suprabasal keratinocytes: 37.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 12.5;PC-3: 19.4"									"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (9.48e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.28e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.94e-4)"	0.1	5.2	2.2	0.4	2.4	2.0	2.8	1.0	2.0	0.2	0.3			1.2	0.1	0.0	0.2	0.0	1.6	1.3	2.8	1.5	2.1	6.1	0.1	0.0	1.2		0.2	1.3	0.0	0.5	0.0		0.6	0.0		2.8	2.5	4.3	0.4	0.9	0.0	1.2	0.3	0.2	0.1			0.3		0.2	0.2	0.1	4.8	4.0	2.5	9.3	0.6	4.3	2.8	1.4	0.3	0.6	0.3	0.7	1.9	1.2	7.9	8.9	9.2	0.0	3.0	0.9	1.9	0.4	6.4	0.4	1.3	11.7	0.2	0.3	1.9	7.5	0.5	4.2	2.1	0.0	2.3	0.7	0.2	1.1	6.1	7.6	0.7	7.0	0.6	1.0	1.1	12.5	1.2	3.4	0.6	1.9	3.2	19.4	0.8	7.8	2.6	8.2	0.5	0.9	1.0	1.9	0.7	0.9	1.8	0.6	1.2	11.7	0.1	0.9	0.4	0.8	3.5	0.6	10.3	1.2	0.8	0.9	1.6	5.9	2.5	0.8	6.8	1.4	4.8	4.3	3.5	3.3	1.8	3.0	3.4	0.9	0.6	9.3	4.0	1.8	2.8											3.0	6.2	0.0	0.0	34.9	0.0	0.0	0.0	2.7	4.5	5.2	0.0	4.4	3.3	3.7	0.0	0.0	0.0	0.0	4.3	5.7	3.1	0.0	8.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	13.5	2.8	0.0	0.0	4.1	0.0	0.0	7.2	0.0	0.0	2.6	0.0	0.0	37.5	5.3	0.0	0.0	0.0
CBX6		ENSG00000183741	"Chromobox 6"	O95503	22	38861450-38872314	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048653	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA048653: AB_2680479"	"unprognostic (1.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.27e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-2)"	15.0	15.0	44.7	14.5	35.1	21.7	7.4	27.8	53.8	14.0	19.5	15.3	9.8	6.5	19.3	14.2	12.9	18.8	10.9	14.0	40.6	18.3	12.1	5.9	13.0	12.0	15.8	21.8	23.4	13.1	62.2	15.5	4.7	19.3	16.1	7.4	17.0	12.5	25.4	5.5	7.7	9.2	23.8	12.1	11.2	12.0	5.0	12.0	11.3	13.4	4.5	13.8	16.6	9.5	4.7	26.9	2.6	7.4	5.2	11.7	9.2	16.6	17.7	3.9	13.4	30.4	17.1	1.2	18.2	10.5	9.5	8.9	8.8	15.6	27.3	13.7	12.4	6.6	19.9	7.3	7.7	5.2	26.2	22.9	2.7	7.6	3.0	16.6	13.4	13.6	25.4	3.9	21.6	10.3	13.1	10.7	7.9	6.1	13.9	6.4	18.8	8.2	3.9	3.5	9.6	13.7	12.5	13.2	10.7	13.4	15.8	19.3	4.3	11.7	15.6	9.8	1.4	10.7	8.0	13.8	8.3	25.5	14.3	12.4	14.3	13.7	10.0	16.2	14.1	17.1	1.1	5.5	2.6	11.7	7.4	9.7	4.2	8.1	8.2	5.4	4.7	6.7	8.2	2.3	5.2	6.8	26.9	4.6	9.2	44.7	35.1	27.8	53.8	40.6	18.3	15.8	21.8	19.3	12.0	14.9	14.3	23.1	30.9	30.1	95.1	23.3	38.2	5.3	13.6	69.8	37.3	9.4	29.9	79.7	0.5	30.3	1.3	0.0	43.0	1.9	41.4	21.2	5.8	29.7	17.5	117.6	117.7	33.7	40.3	0.9	68.7	20.0	77.6	119.0	0.7	80.1	41.4	7.0	76.0	41.9	56.5	71.1	86.3	2.1	6.0	29.6	3.9	35.8	0.5	68.7
CBY3		ENSG00000204659	"Chibby family member 3"	A6NI87	5	179678583-179680974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 15.8"	"Group enriched"	"Detected in some"	122	"Early spermatids: 194.9;Late spermatids: 243.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.8;BEWO: 1.9;HDLM-2: 5.3;HeLa: 3.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069037	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069037: AB_2686069"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.68e-3)"	"unprognostic (7.69e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.10e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.76e-3)"	"unprognostic (7.85e-2)"	"unprognostic (5.04e-3)"	"unprognostic (4.98e-2)"	0.4	0.6	1.1	0.5	1.3	0.2	0.4	0.8	1.2	0.4	0.4	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.4	0.4	1.1	1.3	0.4	0.4	0.4	0.8	1.9	0.4	0.9	1.1	0.0	0.6	0.4	0.4	0.5	0.0	0.4	0.4	0.4	1.1	1.6	0.9	0.4	2.1	1.2	0.9	15.8	0.4	0.4	0.9	0.4	0.4	0.4	0.4	2.9	1.2	0.1	1.0	0.4	2.1	0.6	0.0	0.5	0.0	2.8	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.3	0.3	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.4	0.0	1.1	0.1	0.9	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.1	1.4	0.1	0.6	0.1	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.7	0.0	0.5	0.0	2.0	1.0	1.1	1.2	2.1	0.7	1.2	2.9	2.1	1.3	0.1	0.4	0.1	0.9	1.4	0.6	1.1	1.3	0.8	0.5	1.1	1.3	1.9	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	243.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0
CC2D1A	"FLJ20241, MRT3"	ENSG00000132024	"Coiled-coil and C2 domain containing 1A"	Q6P1N0	19	13906201-13930879	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 103.9;Rod photoreceptor cells: 91.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005436, CAB015220"	Supported		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB015220: , HPA005436: AB_1078884"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.67e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.71e-2)"	11.2	9.5	19.1	14.5	18.7	9.1	12.0	30.5	22.2	11.4	28.7	13.6	15.3	43.2	10.1	10.0	18.2	16.9	16.6	10.4	17.8	21.3	12.6	16.2	11.9	9.5	15.8	20.1	11.5	30.0	17.3	18.7	12.2	16.1	14.2	14.7	13.3	32.7	16.9	18.7	28.6	35.3	11.1	12.6	11.3	21.0	10.1	13.7	10.6	12.0	13.6	13.7	13.1	14.1	2.4	3.0	4.1	5.2	1.6	4.8	2.0	22.0	9.4	3.1	12.8	6.3	5.2	9.9	7.7	9.5	12.5	12.0	12.8	6.7	11.6	12.7	7.7	7.4	16.2	5.8	11.8	4.3	16.9	32.1	5.7	11.5	8.0	10.5	4.8	17.0	6.3	14.3	7.7	5.1	7.8	8.5	11.7	5.9	9.6	4.0	23.4	11.2	12.9	7.0	19.3	16.7	11.5	7.0	9.2	8.5	16.9	11.5	6.7	10.2	15.5	11.6	2.4	11.4	9.0	7.9	9.6	4.9	21.2	9.3	16.3	7.2	6.1	12.2	15.9	8.7	3.9	3.2	4.1	4.8	5.2	1.9	2.4	2.3	2.1	3.0	1.3	1.2	2.7	2.8	1.6	4.8	2.5	1.9	2.0	19.1	18.7	30.5	22.2	17.8	21.3	15.8	20.1	16.1	13.7	8.9	8.8	14.0	13.1	8.0	56.5	6.9	20.4	12.0	12.5	10.4	88.4	18.0	8.3	19.1	1.3	9.0	103.9	0.0	24.0	9.0	8.9	14.8	17.3	8.9	12.5	28.6	32.1	8.0	8.2	4.2	59.5	10.5	6.8	15.4	39.0	14.3	21.2	66.6	82.0	4.7	91.0	12.9	7.6	7.7	11.1	12.0	17.8	16.6	42.1	15.7
CC2D1B	KIAA1836	ENSG00000154222	"Coiled-coil and C2 domain containing 1B"	Q5T0F9	1	52345723-52366193	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027500, HPA031426"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA		140000	Nucleoplasm	Vesicles	"HPA027500: AB_10600693, HPA031426: AB_2673876"	"unprognostic (1.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (3.39e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.87e-1)"	14.6	16.0	12.6	14.5	20.0	7.4	11.5	12.9	18.8	9.6	13.0	22.5	10.8	14.3	11.1	15.2	16.5	9.6	13.6	14.9	14.3	14.9	17.7	15.5	17.9	18.7	21.0	17.2	14.1	17.2	15.3	20.0	16.2	20.6	12.7	11.0	17.3	16.1	14.0	25.6	15.6	14.9	11.3	29.2	16.9	14.4	24.3	19.2	17.9	17.1	17.1	15.7	12.8	10.8	2.9	1.7	11.2	1.8	2.7	4.0	1.9	9.3	13.3	5.9	8.7	20.5	7.6	14.5	12.4	18.8	15.0	11.9	9.2	7.3	6.7	10.6	13.0	31.9	6.7	7.3	14.6	6.3	11.0	8.6	7.4	11.2	7.1	15.2	8.4	16.4	11.9	13.6	17.1	12.2	14.0	9.4	9.2	11.3	6.7	15.0	7.1	9.2	6.8	10.9	7.8	13.0	6.2	12.0	7.8	13.9	13.7	7.1	6.1	11.5	17.1	15.6	14.3	6.2	11.1	12.7	19.2	10.7	10.2	13.7	9.8	9.2	7.3	21.4	9.7	19.3	11.2	1.8	4.0	4.0	1.0	3.0	2.9	3.2	2.9	1.7	2.2	2.5	3.4	2.6	2.7	0.8	1.7	2.3	1.9	12.6	20.0	12.9	18.8	14.3	14.9	21.0	17.2	20.6	19.2	8.9	14.9	7.4	3.3	2.9	4.4	4.9	5.1	5.3	9.1	10.4	0.0	7.8	3.3	8.9	2.9	5.8	7.8	0.0	11.0	8.6	4.1	3.9	15.1	6.7	9.9	1.6	5.8	8.6	4.8	1.3	3.1	4.2	1.7	6.4	4.8	6.3	9.9	5.8	6.0	3.7	4.0	0.0	2.1	12.7	5.1	2.8	13.2	7.0	3.6	2.7
CC2D2B	"bA248J23.4, bA690P14.3, C10orf130, C10orf131"	ENSG00000188649	"Coiled-coil and C2 domain containing 2B"	Q6DHV5	10	95907603-96032684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.6"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 8.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA044091, HPA072122"	Enhanced		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA044091: AB_2732514, HPA072122: AB_2686489"	"unprognostic (6.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.11e-3)"	"unprognostic (9.11e-4)"	"unprognostic (1.93e-2)"	"unprognostic (4.34e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-1)"	0.5	1.7	1.0	1.7	1.0	1.7	0.6	0.3	3.1	0.8	0.8			0.6	2.3	0.2	0.8	1.3	2.0	0.8	0.6	0.6	0.6	0.3	0.9	1.1	0.9		0.8	0.2	0.0	0.4	0.7		0.9	0.0		0.5	0.1	1.6	2.6	0.9	1.2	0.7	1.4	0.6	10.6			4.0		0.0	1.0	1.1	4.1	1.0	1.8	1.0	0.8	2.9	0.5	1.2	4.0	3.9	7.2	0.2	0.4	4.1	3.9	0.4	0.6	0.1	4.2	0.8	5.1	3.1	0.0	4.0	2.8	0.3	0.2	0.0	4.9	8.8	9.2	3.4	3.2	0.0	9.8	0.6	0.7	0.0	0.4	0.1	1.7	0.3	1.3	7.9	3.0	0.9	2.5	4.5	3.3	8.5	3.0	6.6	11.6	3.5	4.3	0.7	1.3	7.1	3.8	4.3	1.1	2.7	5.1	7.0	4.4	3.4	4.5	4.5	3.1	5.6	2.6	11.0	0.1	3.4	10.0	2.9	0.0	1.0	0.2	1.9	0.3	2.9	3.4	1.4	1.1	0.9	4.1	1.3	0.4	1.8	0.8	0.8	1.0	0.8	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CCDC102A	MGC10992	ENSG00000135736	"Coiled-coil domain containing 102A"	Q96A19	16	57512178-57536599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Leydig cells: 18.1;Peritubular cells: 32.5;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040598, HPA040958"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA040598: AB_10794035, HPA040958: AB_10794156"	"unprognostic (3.46e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.40e-3)"	"unprognostic (4.08e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.42e-3)"	5.0	3.7	1.9	7.4	2.1	0.8	12.1	2.0	2.4	12.1	9.7	1.8	8.1	4.5	11.1	7.2	5.5	7.9	8.4	6.4	1.6	1.5	5.6	2.2	9.9	6.2	2.0	2.8	8.2	4.6	3.6	2.4	5.0	4.2	13.5	0.9	5.5	4.6	8.6	2.6	4.3	4.3	17.2	2.9	5.8	4.7	2.9	2.2	7.7	7.2	3.9	5.2	10.6	21.2	2.4	1.0	0.3	0.0	1.6	3.5	0.7	5.7	7.0	2.7	3.9	0.9	1.4	5.7	3.8	2.1	2.2	1.1	2.8	6.8	5.3	15.2	1.2	2.9	4.3	1.4	2.0	0.8	4.3	6.2	0.7	3.2	1.2	3.5	0.4	7.1	3.3	1.3	1.8	0.4	4.9	1.7	1.9	4.0	0.0	0.7	2.3	4.7	4.6	6.6	0.6	13.3	4.2	3.1	2.1	2.8	0.9	0.5	7.2	5.9	1.9	2.7	1.1	4.1	2.6	4.7	4.0	13.6	0.3	3.4	6.4	2.3	2.0	2.3	1.9	6.7	0.0	0.0	0.0	3.1	0.0	2.6	2.4	0.8	3.5	0.0	1.3	1.4	2.4	0.3	1.6	0.0	1.0	0.1	0.7	1.9	2.1	2.0	2.4	1.6	1.5	2.0	2.8	4.2	2.2	0.0	4.0	2.2	7.9	11.4	0.0	2.4	2.5	1.4	3.4	7.0	0.0	1.4	8.3	1.4	0.5	9.0	0.4	0.0	0.8	1.0	13.9	6.2	0.0	0.9	0.3	0.0	0.0	4.3	0.0	0.9	18.1	1.2	1.7	0.0	0.7	3.3	0.9	0.0	32.5	7.9	0.0	19.4	11.2	1.7	5.9	5.0	0.2	7.5	0.8	2.6
CCDC102B	"ACY1L, AN, C18orf14, FLJ23594, HsT1731"	ENSG00000150636	"Coiled-coil domain containing 102B"	Q68D86	18	68715209-69055189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 33.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 113.6;Late spermatids: 49.0;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 11.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.8;BJ hTERT+: 20.8;fHDF/TERT166: 18.7;HSkMC: 11.5;Karpas-707: 7.4"					"Not detected"	"Not detected"			"HPA040623, HPA048194"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA040623: AB_10805715, HPA048194: AB_2680309"	"unprognostic (3.92e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.50e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.50e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (2.90e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.13e-3)"	8.7	4.2	6.4	4.7	7.1	1.3	4.4	3.2	8.0	4.2	4.8	4.9	2.9	2.3	4.0	6.4	4.7	2.9	16.9	4.7	6.0	5.4	5.9	3.3	16.4	11.5	7.0	5.0	3.3	3.1	3.2	5.0	33.7	8.7	4.0	6.1	4.0	3.2	2.2	2.1	2.9	3.9	6.4	9.3	3.3	4.7	4.3	7.0	1.7	6.8	5.0	2.9	16.9	4.0	0.9	11.5	0.4	0.3	1.3	2.6	0.3	0.0	0.0	2.9	0.2	2.7	10.8	0.2	0.6	20.8	0.2	0.3	0.1	0.3	0.1	0.4	18.7	0.3	0.2	0.1	0.2	0.3	0.9	0.3	0.6	0.0	0.9	5.3	0.1	0.3	11.5	0.4	0.3	2.6	0.4	0.1	1.4	0.0	7.4	1.7	0.0	0.4	0.2	0.6	0.1	0.3	0.9	0.2	0.3	0.1	0.0	1.3	1.1	0.1	0.0	0.0	1.2	0.2	0.9	2.9	0.4	0.2	0.1	0.2	3.2	0.2	0.5	1.5	1.2	1.8	0.0	0.1	0.4	1.4	0.3	1.3	0.6	0.8	1.1	0.3	0.9	2.6	1.6	0.0	1.3	0.2	11.5	0.3	0.3	6.4	7.1	3.2	8.0	6.0	5.4	7.0	5.0	8.7	7.0	0.0	2.1	0.5	0.6	0.6	5.6	7.4	0.0	1.4	3.4	3.5	5.9	0.7	5.0	0.6	113.6	4.5	0.0	0.0	1.5	0.5	3.6	0.5	2.3	0.6	3.0	6.4	0.0	4.3	2.2	49.0	30.0	3.1	0.0	2.8	0.2	10.8	0.3	0.3	8.5	4.5	12.2	77.6	22.5	1.6	2.7	0.5	0.2	1.0	0.4	0.5
CCDC103	"CILD17, FLJ13094, FLJ34211, PR46b"	ENSG00000167131	"Coiled-coil domain containing 103"	Q8IW40	17	44899142-44905390	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 19.6;testis: 35.5"	"Cell type enriched"	"Detected in single"	14	"Ciliated cells: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 12.8;RPTEC TERT1: 10.0;U-87 MG: 11.3"									HPA043131			Approved	Cytosol		NA	NA			Cytosol		"HPA043131: AB_10796686"	"unprognostic (9.40e-3)"	"unprognostic (1.75e-1)"			"unprognostic (5.60e-2)"	"unprognostic (1.99e-2)"		"unprognostic (4.50e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-2)"		"unprognostic (4.69e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.60e-1)"	0.6	2.3	2.6	0.9	6.3	0.6	1.2	0.5	4.7	1.4	0.9	2.9	1.6	0.5	1.7	2.8	0.4	19.6	2.8	0.4	2.5	3.0	2.7	0.7	1.9	0.3	1.5	3.9	3.5	0.8	1.9	2.1	0.5	4.3	0.9	0.7	1.6	1.2	1.5	0.3	0.7	0.4	1.2	1.0	0.4	0.9	35.5	1.0	0.2	3.5	0.1	0.5	0.7	0.4	0.8	2.5	3.0	3.7	0.7	0.4	2.4	2.2	12.8	1.9	2.4	2.8	2.3	1.6	1.0	3.8	1.8	1.3	2.4	4.2	0.3	2.1	0.9	5.5	3.9	0.8	1.8	1.0	7.9	1.4	0.6	2.7	0.0	1.8	1.6	0.3	1.6	3.0	1.9	0.7	3.7	1.3	0.9	1.7	0.3	0.1	2.4	0.0	0.7	0.4	2.1	1.9	0.3	0.7	0.5	10.0	1.3	5.1	1.0	0.5	0.4	2.3	1.1	3.4	1.7	1.0	0.8	2.0	1.0	1.9	0.4	0.5	0.4	11.3	0.8	0.3	1.2	3.7	3.0	0.3	1.9	0.4	0.0	0.0	0.4	2.5	0.8	0.4	0.3	0.5	0.7	1.7	0.8	0.1	2.4	2.6	6.3	0.5	4.7	2.5	3.0	1.5	3.9	4.3	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CCDC107	MGC31967	ENSG00000159884	"Coiled-coil domain containing 107"	Q8WV48	9	35658290-35661511	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016857, HPA050442"			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA016857: AB_10669751, HPA050442: AB_2681128"	"unprognostic (3.70e-3)"	"unprognostic (7.07e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.75e-2)"	42.1	23.4	11.1	15.4	10.3	5.4	50.3	17.2	12.9	17.5	35.2	8.5	18.1	15.0	24.9	28.6	22.4	18.2	31.5	31.3	10.2	11.0	13.0	15.0	14.0	14.1	9.7	7.9	15.3	80.2	7.6	10.5	10.8	8.4	22.8	13.7	11.5	14.6	24.5	29.3	9.6	16.0	44.8	9.7	13.5	24.2	9.2	8.8	19.3	14.0	8.8	10.9	38.9	24.1	20.7	32.5	7.6	11.0	16.4	46.9	18.3	7.9	7.2	6.0	7.5	30.2	19.4	3.5	13.4	12.2	8.6	8.1	3.3	2.4	5.2	6.0	17.6	22.3	2.6	4.4	6.5	6.4	15.3	7.1	2.4	10.9	8.1	7.1	3.7	9.5	11.4	7.7	9.2	7.2	16.1	6.0	8.8	3.2	10.0	10.8	5.1	4.2	5.6	4.4	5.7	22.2	6.1	1.4	4.1	28.6	4.3	3.9	6.5	6.9	9.7	6.6	4.7	5.1	4.7	7.5	13.9	7.7	10.0	12.2	4.5	6.6	10.3	25.6	6.0	12.1	7.6	10.6	5.1	36.1	11.0	46.9	20.7	31.7	31.4	11.8	20.1	15.5	21.3	2.1	16.4	6.4	32.5	35.2	18.3	11.1	10.3	17.2	12.9	10.2	11.0	9.7	7.9	8.4	8.8	62.5	23.5	48.4	32.4	62.4	31.1	0.6	61.1	25.4	15.9	78.5	7.9	12.3	14.9	64.0	5.7	40.2	115.3	0.0	122.5	55.2	43.7	39.9	34.5	68.4	86.5	30.2	84.6	43.0	48.7	20.1	55.0	66.1	108.0	39.7	73.5	46.8	82.6	80.7	96.2	54.7	32.0	116.4	97.8	27.9	59.2	58.5	11.6	95.8	40.0	23.7
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267188-115296831	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.4"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 227.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 50.4"	"Low region specificity"	"Detected in all"							"HPA045120, HPA050621"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: AB_2679222, HPA050621: AB_2681191"	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	5.5	4.3	9.7	5.7	13.2	7.0	7.7	12.6	12.8	6.5	9.8	7.0	4.3	8.1	6.6	7.3	6.3	4.9	3.9	6.4	11.0	9.0	3.5	1.7	6.1	4.8	9.7	7.6	2.9	13.2	6.5	12.1	3.0	12.6	7.7	10.6	1.9	6.8	8.6	4.5	5.5	6.8	7.7	14.0	5.3	7.0	40.4	11.8	3.7	4.7	3.2	4.7	7.1	4.8	5.3	11.0	11.6	5.5	3.1	3.8	2.1	5.4	2.7	5.5	8.7	3.5	6.8	1.3	4.9	2.6	3.7	4.3	1.2	3.1	6.7	4.1	3.4	5.5	3.5	5.7	2.8	7.8	5.3	4.4	4.4	4.1	1.7	4.7	5.8	2.3	3.1	3.4	4.8	6.4	4.3	5.7	6.1	1.8	5.5	4.9	4.2	8.7	5.0	6.0	5.1	4.8	9.3	6.8	50.4	3.6	2.0	8.3	10.8	5.3	3.4	14.6	3.9	5.7	8.5	5.6	4.9	3.3	9.3	6.8	6.1	5.9	1.4	3.3	4.6	2.9	0.2	5.5	11.6	3.4	4.4	3.8	3.2	2.6	2.9	5.9	5.3	3.4	2.3	3.6	3.1	5.0	11.0	0.1	2.1	9.7	13.2	12.6	12.8	11.0	9.0	9.7	7.6	12.6	11.8	14.9	12.3	12.3	4.6	12.6	28.3	14.6	2.5	12.0	9.1	5.2	9.8	0.6	5.0	24.4	6.8	8.0	11.9	0.0	22.6	1.7	8.5	6.1	9.2	2.6	28.4	9.5	38.9	6.7	23.9	13.4	3.7	28.0	13.5	42.3	28.0	10.3	27.1	14.0	3.9	2.9	24.3	12.9	13.0	227.3	60.7	19.7	0.5	5.3	31.6	3.4
CCDC115	"ccp1, FLJ30131, MGC12981"	ENSG00000136710	"Coiled-coil domain containing 115"	Q96NT0	2	130338241-130342349	"Disease related genes, Predicted intracellular proteins"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034598	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA034598: AB_10601697"	"prognostic favorable (7.59e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.16e-2)"	18.7	18.4	25.1	14.7	25.9	17.2	21.5	23.4	39.8	27.1	22.3	24.6	17.9	18.1	22.3	28.9	24.2	25.6	19.9	15.0	25.2	24.1	24.9	14.9	21.8	22.6	26.1	22.5	36.1	24.0	25.3	17.1	23.2	28.1	21.3	17.2	19.1	23.8	25.4	9.4	26.5	19.1	17.7	24.1	19.5	16.9	13.0	16.8	17.1	25.3	14.2	28.4	20.3	20.1	34.0	32.8	51.5	56.2	26.7	34.4	38.7	12.7	6.8	8.3	5.3	16.9	17.9	10.5	6.6	16.1	13.3	15.4	15.0	28.4	16.8	22.7	10.2	7.7	13.4	7.0	11.0	10.5	20.1	12.7	12.2	3.8	18.6	14.3	13.9	24.3	15.3	26.1	8.3	4.8	13.7	13.7	14.9	12.0	14.1	15.9	12.2	21.3	23.0	11.4	7.2	17.3	17.1	9.4	14.1	11.6	12.3	9.4	14.5	8.6	15.2	14.7	6.3	15.1	15.0	11.0	7.5	8.1	12.0	5.0	7.7	8.1	15.9	13.9	13.5	8.8	36.8	33.1	51.5	29.7	45.3	26.6	33.8	32.1	31.7	32.8	34.0	30.9	28.8	11.4	26.7	56.2	25.8	34.4	38.7	25.1	25.9	23.4	39.8	25.2	24.1	26.1	22.5	28.1	16.8	17.9	21.2	46.9	40.9	46.0	24.7	9.8	25.5	21.4	25.0	73.3	9.8	63.5	89.5	38.6	1.0	26.9	31.9	0.0	37.4	30.0	32.8	14.5	53.0	17.4	55.9	22.3	26.6	25.8	41.5	3.0	39.4	47.9	50.6	125.4	31.4	38.4	24.8	48.7	49.1	53.6	21.3	45.3	33.9	5.8	20.6	61.2	22.1	52.4	39.6	21.0
CCDC117	FLJ33814	ENSG00000159873	"Coiled-coil domain containing 117"	Q8IWD4	22	28772674-28789301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 75.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000826	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			Nucleoplasm	"Microtubules, Cytosol"	"HPA000826: AB_1078417"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.61e-3)"	"unprognostic (9.07e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-3)"	"unprognostic (8.25e-2)"	10.7	14.2	12.3	13.6	13.6	19.2	25.2	19.3	12.7	15.9	13.1	9.6	16.6	12.1	15.3	8.9	11.5	10.7	10.0	9.0	12.2	10.6	10.3	26.1	12.5	17.0	14.6	8.3	14.9	13.3	12.4	14.1	20.7	11.9	13.0	11.9	9.5	21.0	16.5	20.2	9.1	10.9	15.2	13.1	13.8	12.3	35.9	15.4	24.2	18.1	7.4	20.1	12.3	31.3	13.4	13.9	14.0	13.9	23.3	15.2	12.6	8.7	7.3	14.9	14.5	9.7	8.5	11.8	8.9	10.9	15.5	13.7	11.0	4.2	27.5	4.0	8.1	6.6	9.2	21.8	3.5	14.8	14.9	14.4	11.2	8.3	16.2	6.6	17.9	14.4	5.8	7.7	8.9	5.5	6.9	10.7	9.1	15.6	12.2	6.9	11.3	10.5	14.5	12.1	15.7	3.5	21.2	23.5	11.9	6.9	3.4	5.7	7.6	13.7	12.9	5.5	18.4	16.0	7.7	6.2	19.5	13.4	6.1	6.8	28.6	29.7	23.1	6.8	9.7	8.2	10.7	13.9	14.0	10.2	12.3	10.5	10.0	8.6	9.9	13.9	13.4	15.2	12.2	6.7	23.3	11.7	12.2	10.7	12.6	12.3	13.6	19.3	12.7	12.2	10.6	14.6	8.3	11.9	15.4	20.8	11.0	24.2	10.8	9.4	7.3	9.2	12.7	13.4	9.1	14.0	13.7	14.4	6.6	8.8	75.2	13.7	8.4	23.3	8.7	15.2	15.8	18.4	17.3	38.0	8.0	3.2	19.7	11.6	16.2	24.0	11.8	9.1	16.9	4.6	12.4	5.4	9.2	11.5	7.4	8.4	14.4	0.0	16.0	44.0	41.7	9.5	20.6	14.9	11.8	16.4
CCDC121	"FLJ13646, FLJ43364"	ENSG00000176714	"Coiled-coil domain containing 121"	Q6ZUS5	2	27625639-27629012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 27.5"	"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 32.1;Early spermatids: 126.1;Late spermatids: 35.6;Spermatocytes: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 12.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051791	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA051791: AB_2681611"	"unprognostic (1.52e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-3)"	"prognostic favorable (4.12e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.65e-4)"	"unprognostic (7.78e-2)"	"prognostic favorable (1.87e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.86e-2)"	"unprognostic (5.42e-2)"	4.4	3.6	7.4	2.0	12.2	1.4	5.9	7.0	10.3	5.8	3.6	5.5	6.7	2.6	5.5	5.3	5.9	8.3	3.0	6.3	9.0	5.2	6.2	3.2	4.5	2.3	13.3	6.0	11.7	3.9	8.3	7.3	3.8	9.3	7.3	3.5	3.4	5.7	8.5	3.6	3.3	3.0	4.6	10.8	4.3	3.8	27.5	11.2	1.0	8.1	1.7	2.5	4.4	3.0	3.1	1.7	12.5	4.0	2.6	3.0	1.3	3.7	4.3	5.9	6.5	10.7	4.8	7.3	1.9	1.0	1.9	0.9	3.2	3.4	1.9	3.1	1.2	5.7	3.5	4.3	1.5	2.1	2.6	4.6	1.2	2.5	4.1	2.0	1.7	3.4	1.6	5.2	1.1	2.8	3.3	3.9	0.9	5.0	2.6	2.8	3.1	1.3	1.7	6.1	4.7	2.1	6.3	14.3	3.2	4.1	2.9	7.7	8.8	1.5	7.2	2.3	5.0	5.9	4.0	2.1	1.7	6.4	1.4	5.2	1.6	1.7	2.8	4.2	2.4	2.1	2.0	2.4	12.5	0.6	3.4	1.7	3.1	1.9	0.7	1.7	2.7	3.0	2.2	5.1	2.6	4.0	0.5	0.3	1.3	7.4	12.2	7.0	10.3	9.0	5.2	13.3	6.0	9.3	11.2	6.0	1.6	0.0	1.3	0.6	4.9	2.8	5.1	32.1	2.3	0.0	19.6	2.5	6.6	2.8	126.1	4.2	1.3	0.0	1.0	1.9	1.9	1.0	0.0	1.5	1.6	3.2	1.2	4.3	0.3	35.6	8.1	2.5	1.7	1.0	1.2	11.6	1.5	0.0	6.3	2.9	10.0	12.9	0.7	33.1	10.9	1.0	1.5	1.5	1.7	0.7
CCDC122	FLJ31846	ENSG00000151773	"Coiled-coil domain containing 122"	Q5T0U0	13	43823909-43879727	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 11.4;hTERT-HME1: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034233, HPA054995, HPA061456"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB034233: AB_2228702, HPA054995: AB_2682665, HPA061456: AB_2684527"	"unprognostic (1.74e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.75e-2)"	4.3	6.7	5.0	8.5	9.5	1.8	7.5	2.4	5.6	5.5	5.5	7.2	8.8	3.3	8.0	10.7	4.5	8.6	5.9	8.3	6.1	5.0	10.4	5.7	5.5	4.6	9.8	5.8	12.2	6.9	8.4	15.6	8.2	6.0	9.8	6.9	3.6	5.7	4.8	3.3	7.8	7.3	9.8	6.4	7.7	5.8	9.7	11.0	5.2	10.9	4.5	4.7	6.2	11.8	3.6	3.0	6.4	2.6	3.6	1.9	1.0	2.2	1.8	0.8	0.0	0.7	4.5	2.3	5.9	6.5	3.0	3.4	3.2	8.0	3.6	3.3	3.5	5.2	3.5	0.8	0.9	4.3	5.8	2.8	1.5	1.0	1.8	8.6	0.9	0.4	11.4	7.2	4.5	11.8	2.6	1.5	1.5	0.0	1.1	4.2	2.7	0.5	0.6	1.0	0.5	1.9	0.8	0.0	1.9	4.7	1.3	2.1	3.1	3.9	0.1	3.5	4.8	0.7	0.6	6.9	0.2	0.8	5.3	0.0	0.0	0.0	1.6	3.0	0.1	3.1	6.4	1.6	2.4	1.3	1.4	1.6	2.4	1.9	1.4	1.2	3.6	1.3	1.4	3.9	3.6	2.6	3.0	1.7	1.0	5.0	9.5	2.4	5.6	6.1	5.0	9.8	5.8	6.0	11.0	8.9	9.4	2.7	7.8	2.7	1.5	11.2	7.6	25.4	11.4	7.0	0.0	14.2	16.6	10.3	2.0	5.8	4.4	0.0	9.0	8.0	6.1	7.9	1.1	3.9	1.8	9.5	17.3	7.4	2.2	0.4	16.4	2.5	1.7	1.0	9.1	12.3	7.2	0.0	7.4	8.7	0.6	0.0	5.1	20.5	23.7	3.3	6.6	1.3	8.1	5.9
CCDC126	FLJ23031	ENSG00000169193	"Coiled-coil domain containing 126"	Q96EE4	7	23597379-23644708	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.4"	"Group enriched"	"Detected in many"	18	"Early spermatids: 588.1;Late spermatids: 350.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 75.4"	"Lineage enriched"	"Detected in all"	18	"granulocytes: 75.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010969, HPA026883"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		31000000	"Golgi apparatus"		"HPA010969: , HPA026883: AB_1846131"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-1)"	6.7	8.1	8.7	4.4	9.2	6.9	19.5	11.6	13.2	7.4	6.5	5.6	5.8	8.7	8.0	5.3	6.6	6.7	6.2	5.7	13.8	8.9	7.6	11.7	6.5	9.3	10.5	3.9	7.4	9.8	12.2	12.6	4.6	11.1	6.0	6.5	5.8	7.5	6.5	10.0	6.6	9.4	6.7	12.9	6.1	6.8	41.3	8.1	5.4	9.9	5.0	8.6	7.0	7.7	3.8	3.0	75.4	3.6	2.9	4.1	2.9	4.8	3.4	7.5	9.5	12.6	7.1	17.3	6.1	6.0	5.3	7.7	3.6	1.6	10.4	9.7	5.1	10.1	2.8	3.2	2.9	6.9	2.2	4.3	1.8	1.4	4.6	5.1	4.7	9.3	7.5	8.5	1.7	1.6	4.4	7.0	4.4	4.1	3.0	6.3	2.2	3.2	5.7	3.5	6.4	4.3	2.2	11.9	3.1	5.5	2.2	4.6	8.6	6.3	6.1	4.5	12.2	5.1	4.4	8.4	3.1	5.6	7.1	4.8	8.4	8.3	7.4	3.5	6.9	16.9	75.4	3.6	16.4	3.0	3.3	3.7	3.8	3.3	3.5	3.0	3.2	4.1	3.2	6.9	2.9	3.1	0.6	3.6	2.9	8.7	9.2	11.6	13.2	13.8	8.9	10.5	3.9	11.1	8.1	6.0	7.2	7.1	7.0	16.9	12.6	8.3	7.6	9.4	3.4	12.2	7.9	9.0	6.6	10.1	588.1	10.5	5.8	0.0	8.0	5.6	10.4	7.1	6.9	12.7	6.2	7.9	14.5	10.4	5.1	350.6	10.6	7.9	13.5	6.4	8.6	7.2	8.1	6.2	13.4	7.2	12.6	12.9	12.2	26.8	23.8	20.7	16.9	7.5	5.6	5.9
CCDC127	FLJ25701	ENSG00000164366	"Coiled-coil domain containing 127"	Q96BQ5	5	196871-218215	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045052	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA045052: AB_10960630"	"prognostic unfavorable (7.01e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.04e-6)"	"unprognostic (2.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (2.42e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-1)"	10.3	14.3	10.3	7.3	13.0	3.8	9.7	14.0	16.2	10.7	10.0	10.6	8.2	8.7	11.6	7.7	13.4	10.5	12.7	16.3	9.8	11.8	8.1	6.8	6.9	12.4	12.0	9.8	15.3	8.6	5.0	14.9	10.2	13.9	10.5	4.1	10.5	8.1	6.1	18.4	12.4	10.1	8.1	9.5	7.2	9.4	11.1	12.2	9.6	23.5	7.4	5.2	9.9	7.9	9.0	8.1	7.2	5.3	8.6	11.0	5.3	4.0	5.3	6.0	10.9	7.3	5.6	5.9	7.8	4.0	3.5	3.5	5.6	8.5	8.5	11.4	3.6	4.6	5.4	3.7	3.0	3.4	21.6	6.6	3.0	25.0	4.9	4.3	2.4	5.5	4.6	4.9	3.3	2.3	8.4	2.9	4.7	4.9	3.0	3.7	3.2	4.2	4.8	5.1	2.4	6.9	5.0	4.4	6.9	6.6	4.1	6.7	10.5	10.8	7.5	7.1	5.0	9.8	4.5	6.6	9.0	5.3	3.6	3.2	5.0	4.2	5.8	5.8	4.2	5.6	4.6	4.5	7.2	8.1	5.3	8.7	9.0	8.3	9.6	4.5	8.8	9.8	11.0	2.9	8.6	4.7	8.1	6.2	5.3	10.3	13.0	14.0	14.7	9.8	11.8	12.0	9.8	13.9	12.2	14.9	7.2	7.0	12.0	12.6	16.5	23.8	7.6	18.7	9.1	5.2	17.7	27.5	3.3	24.3	5.1	15.1	8.1	0.0	13.3	19.7	13.2	13.4	9.2	11.9	17.2	36.5	8.1	15.4	6.9	6.5	19.2	10.3	8.5	29.7	7.7	29.9	13.9	2.9	18.7	7.5	26.8	12.9	9.5	20.9	31.3	6.9	25.2	12.8	6.8	10.6
CCDC130	MGC10471	ENSG00000104957	"Coiled-coil domain containing 130"	P13994	19	13731760-13763296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056977	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA056977: AB_2683297"	"unprognostic (6.54e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.83e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.69e-2)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.82e-4)"	17.5	20.1	17.4	23.6	22.1	28.2	20.4	22.2	24.5	18.7	17.8	32.9	23.8	21.3	27.2	18.0	17.6	20.7	18.1	22.6	16.9	14.5	20.6	17.9	19.8	28.9	24.7	19.7	30.1	19.1	24.9	26.1	21.0	19.4	20.2	11.0	23.6	24.3	21.0	26.6	22.5	21.9	16.9	17.0	26.1	20.3	22.0	24.0	22.0	25.3	11.5	19.6	17.9	21.4	19.2	16.9	23.1	17.2	17.0	20.0	13.3	8.6	6.8	13.0	13.0	8.8	7.1	7.0	9.2	9.1	9.6	8.9	5.4	6.2	7.5	7.1	8.4	7.6	8.7	5.6	5.1	3.0	11.6	16.1	5.8	17.3	9.3	17.4	6.0	15.8	9.4	11.6	12.3	8.1	10.1	11.1	14.3	6.0	14.6	5.7	6.1	14.9	11.8	8.2	4.4	12.8	13.4	6.5	9.7	6.8	9.8	7.4	9.8	6.4	5.3	15.7	7.1	5.4	13.8	8.5	15.5	6.2	18.0	12.4	22.1	8.2	5.8	13.1	14.0	10.8	22.2	17.2	23.1	17.3	14.7	20.0	18.6	18.1	18.2	16.9	19.2	16.8	19.4	17.0	17.0	16.6	12.4	14.8	13.3	17.4	22.1	22.2	24.5	16.9	14.5	24.7	19.7	19.4	24.0	8.9	13.2	23.8	16.0	11.8	28.4	14.0	5.1	24.1	12.5	27.9	25.5	14.6	6.6	14.4	25.2	17.4	27.0	23.3	13.7	16.6	15.4	12.1	23.2	9.6	15.9	25.4	18.0	11.6	19.8	18.6	17.5	19.2	23.6	27.9	13.6	27.8	16.3	21.0	15.9	12.9	40.8	25.8	21.7	27.7	19.6	13.7	29.3	25.0	15.0	9.4
CCDC136	"DKFZP434G156, KIAA1793, NAG6"	ENSG00000128596	"Coiled-coil domain containing 136"	Q96JN2	7	128790757-128822132	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.7;testis: 109.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 629.8;Late spermatids: 1449.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 18.6;U-937: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010646, HPA071015"	Enhanced	Approved	Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles"	"Plasma membrane"	"HPA010646: , HPA071015: AB_2686334"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-4)"	"unprognostic (2.58e-2)"	"unprognostic (8.44e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.18e-4)"	"unprognostic (5.27e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	2.1	4.0	11.2	2.6	11.7	1.8	2.4	34.7	28.7	2.9	6.5	8.3	2.6	2.4	3.9	2.9	2.5	2.8	2.8	4.9	12.5	20.0	1.5	1.5	1.9	3.0	15.3	16.6	2.8	1.8	1.8	3.8	2.2	11.2	9.9	3.5	13.9	2.0	11.0	3.5	1.6	2.6	17.3	9.7	1.9	2.4	109.6	7.4	0.7	1.7	0.0	2.4	6.4	2.0	0.1	0.6	1.3	0.3	2.7	1.6	0.3	0.7	0.9	7.2	4.8	3.9	3.4	1.2	2.7	3.6	2.8	2.6	1.0	0.6	3.6	0.3	3.7	11.4	1.5	4.6	0.5	2.6	10.2	4.6	6.3	1.7	0.0	1.3	0.7	13.6	3.7	0.5	3.0	0.2	2.5	1.6	6.0	2.2	3.8	1.1	1.4	4.6	1.9	10.0	0.0	2.9	11.4	1.3	1.7	0.2	1.3	4.2	12.6	1.7	2.0	2.8	2.7	0.1	1.7	1.4	4.5	2.6	2.1	2.1	2.2	0.9	3.8	18.6	27.4	1.1	0.0	0.3	1.3	1.4	0.0	1.6	0.0	1.5	1.1	0.6	0.1	0.0	1.0	0.1	2.7	0.1	0.1	0.0	0.3	11.2	11.7	34.7	28.7	12.5	20.0	15.3	16.6	11.2	7.4	0.0	0.3	0.0	0.8	0.5	255.8	6.5	2.5	2.7	1.2	0.0	92.3	0.1	0.0	0.5	629.8	1.6	0.0	0.0	1.3	0.2	0.9	1.2	0.0	0.0	5.0	38.1	0.0	0.6	0.8	1449.2	16.7	0.9	0.0	1.0	0.0	22.8	0.8	0.0	7.1	0.0	16.0	6.5	2.8	193.1	9.4	0.4	0.3	2.2	0.0	0.4
CCDC138	FLJ32745	ENSG00000163006	"Coiled-coil domain containing 138"	Q96M89	2	108786757-108885477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 57.6;Early spermatids: 83.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049899, HPA054223"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049899: AB_2680941, HPA054223: AB_2682420"	"unprognostic (2.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.24e-5)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.77e-2)"	"unprognostic (7.06e-4)"	"unprognostic (7.88e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.93e-2)"	2.6	2.5	5.7	5.0	7.0	6.1	4.8	13.5	8.2	3.1	3.9	4.9	1.6	2.1	6.0	2.8	5.5	8.6	3.8	2.3	6.8	5.0	3.6	5.5	2.8	8.1	4.3	5.1	3.7	3.5	2.3	7.4	2.8	8.0	3.1	4.8	1.9	3.3	2.1	2.1	4.8	3.4	3.3	6.4	3.2	3.7	19.4	6.5	19.5	2.3	2.9	7.2	4.3	6.1	5.4	8.1	3.1	2.1	3.2	4.8	2.4	8.3	3.8	13.2	6.8	1.1	1.2	8.4	3.6	1.1	8.7	6.3	12.4	4.9	20.0	5.4	1.1	4.3	7.1	9.5	4.9	7.8	4.6	12.3	9.2	7.2	10.3	1.3	12.6	1.4	0.8	1.5	10.2	3.0	1.3	4.5	8.7	17.5	9.3	4.4	4.6	17.9	8.6	19.6	4.5	4.0	11.9	12.5	12.2	4.8	6.6	9.3	9.1	7.9	4.3	6.3	8.5	4.6	6.1	2.8	5.5	9.7	3.5	7.6	2.9	6.7	20.9	2.3	9.8	5.4	3.1	0.9	1.3	2.1	2.1	3.9	5.1	2.8	4.0	0.9	5.4	4.1	4.8	0.5	3.2	0.8	8.1	4.1	2.4	5.7	7.0	13.5	8.2	6.8	5.0	4.3	5.1	8.0	6.5	0.0	3.5	2.9	3.2	2.2	7.3	0.8	0.0	57.6	12.5	1.8	7.9	3.8	1.7	3.0	83.9	2.2	0.5	0.0	1.2	4.4	3.0	0.9	4.6	1.8	1.9	6.4	5.2	1.3	0.6	22.1	3.4	1.3	1.7	1.0	2.1	1.5	2.7	0.0	1.8	1.7	6.9	0.0	2.3	18.5	21.2	2.5	1.1	4.3	2.6	2.4
CCDC141	"CAMDI, FLJ39502"	ENSG00000163492	"Coiled-coil domain containing 141"		2	178829757-179050086	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 47.5;lung: 17.6"	"Cell type enhanced"	"Detected in many"	22	"Alveolar cells type 2: 19.8;Cardiomyocytes: 103.0;Early spermatids: 34.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"T-reg: 12.9"	"Group enriched"	"Detected in many"	9	"B-cells: 7.6;T-cells: 12.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.4;Daudi: 4.1;HEL: 9.5;RH-30: 5.1;U-266/70: 6.1;U-698: 8.5"									HPA012718			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012718: AB_2072055"	"unprognostic (1.58e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (8.62e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.03e-3)"	"unprognostic (7.71e-8)"	"unprognostic (2.50e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-1)"	1.6	0.6	0.5	7.5	0.6	0.9	4.9	0.5	0.5	0.7	1.2	0.1	0.5	0.2	0.8	2.2	2.5	0.6	6.3	47.5	0.6	0.6	0.5	0.5	17.6	4.4	0.6	0.0	0.8	3.8	0.2	0.5	0.8	1.1	1.0	0.3	1.8	0.6	0.3	9.3	0.5	0.7	1.7	0.7	1.8	0.6	1.6	0.0	11.0	0.7	2.1	7.4	1.4	1.2	7.6	0.0	0.4	0.0	1.1	12.9	0.4	0.2	0.0	0.1	0.3	0.0	0.1	2.0	0.0	0.1	0.0	0.2	6.4	0.5	4.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	3.5	0.2	9.5	0.3	0.0	0.0	1.7	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.6	0.1	0.1	0.1	0.3	3.4	0.6	0.7	0.2	5.1	1.6	0.0	0.1	0.2	0.2	0.1	0.3	0.1	1.1	0.3	0.4	0.1	0.3	0.2	0.3	0.0	6.1	0.1	8.5	0.3	0.5	0.6	0.3	0.0	0.2	0.3	0.0	0.2	6.6	2.1	1.4	0.0	7.6	6.4	4.8	0.4	1.1	0.0	0.0	12.9	0.4	0.5	0.6	0.5	0.5	0.6	0.6	0.6	0.0	1.1	0.0	6.0	19.8	0.5	0.0	0.1	1.4	103.0	10.2	2.7	1.2	0.0	0.0	0.0	0.0	2.5	34.6	3.6	0.0	0.0	1.2	0.2	0.4	0.0	5.8	0.0	0.0	6.4	0.0	0.0	0.3	12.9	1.1	0.8	1.7	0.0	0.0	3.8	0.2	0.0	1.8	0.0	0.6	6.5	1.4	0.0	0.2	0.1	0.0	5.0	0.0	0.1
CCDC144A	"FLJ43983, KIAA0565"	ENSG00000170160	"Coiled-coil domain containing 144A"	A2RUR9	17	16689537-16777881	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 44.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 52.2;Cone photoreceptor cells: 51.1;Early spermatids: 46.7;Rod photoreceptor cells: 51.7;Spermatocytes: 128.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.1;TIME: 9.4"									"HPA022996, HPA047220, HPA047851, HPA066260"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: "	"unprognostic (8.54e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-1)"	3.7	1.9	2.5	2.7	3.5	5.5	2.7	12.0	3.6	2.1	3.1	2.8	0.4	0.9	5.4	3.9	1.3	2.6	1.7	2.5	4.7	0.8	1.0	1.5	2.8	2.3	4.3	1.8	7.3	5.4	0.2	16.7	3.7	10.3	3.0	1.4	1.7	2.2	1.5	2.4	3.7	2.0	2.5	4.2	2.4	2.2	44.4	2.8	2.4	1.8	0.4	1.5	2.8	4.9	1.0	0.8	0.8	1.3	1.0	3.8	0.0	0.6	3.9	0.9	2.4	3.5	11.1	0.4	0.2	0.0	0.2	0.2	4.9	0.1	0.5	3.4	6.8	0.3	6.0	5.0	0.3	0.3	3.5	0.3	0.5	0.5	0.4	0.2	0.7	3.2	2.0	0.1	2.3	0.2	1.1	0.1	0.2	0.5	0.3	2.2	0.2	0.1	1.2	0.8	1.0	0.4	1.5	0.2	0.1	0.1	4.7	1.3	1.4	0.7	0.2	1.4	2.0	4.0	0.2	9.4	0.8	0.5	5.3	1.5	6.7	6.9	0.2	0.4	7.0	1.8	0.7	0.6	0.3	2.2	0.5	1.4	1.0	2.1	1.4	0.4	0.5	3.8	1.9	0.8	1.0	1.3	0.8	2.1	0.0	2.5	3.5	12.0	3.6	4.7	0.8	4.3	1.8	10.3	2.8	0.0	9.3	3.0	6.4	3.5	52.2	2.5	2.5	5.3	2.3	0.0	51.1	4.2	0.0	1.6	46.7	6.5	1.3	0.0	0.0	5.8	8.2	6.7	25.4	1.7	3.5	31.8	1.2	3.7	5.1	2.9	6.6	4.9	5.0	0.0	2.0	8.3	2.2	3.4	8.5	0.5	51.7	6.5	5.7	128.1	36.1	3.1	1.6	6.9	1.6	5.1
CCDC144NL	MGC87631	ENSG00000205212	"Coiled-coil domain containing 144 family, N-terminal like"	Q6NUI1	17	20836447-20896140	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"brain: 13.1;testis: 10.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.2;Rod photoreceptor cells: 7.5;Spermatocytes: 25.8;Spermatogonia: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 26.7"									HPA023457	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA023457: AB_2671217"	"unprognostic (1.29e-1)"				"unprognostic (6.71e-2)"	"unprognostic (1.21e-1)"		"unprognostic (3.53e-1)"		"unprognostic (7.53e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.33e-2)"		"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"		"unprognostic (2.28e-1)"	0.3	0.9	0.9	0.2	13.1	0.5	1.0	2.4	6.6	0.3	0.4	1.4	0.0	0.5	1.5	0.3	0.3	0.9	0.2	0.5	1.2	1.1	0.3	0.6	0.5	0.5	1.7	1.4	1.3	0.4	0.2	1.2	0.8	4.5	1.6	0.5	0.6	0.3	1.8	0.8	0.3	0.2	1.2	4.5	0.4	0.5	10.6	0.0	0.4	0.4	0.0	0.7	0.9	0.2	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	26.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	1.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	13.1	2.4	6.6	1.2	1.1	1.7	1.4	4.5	0.0	0.0	0.3	0.0	0.6	0.2	1.7	0.4	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	7.2	0.7	0.0	0.0	0.0	1.6	0.9	0.5	0.0	0.0	0.4	1.6	1.2	0.0	0.0	1.3	2.8	0.3	1.7	0.0	0.0	1.4	0.1	0.0	1.1	0.3	7.5	0.0	0.9	25.8	7.3	0.3	0.1	0.0	0.0	0.4
CCDC146	KIAA1505	ENSG00000135205	"Coiled-coil domain containing 146"	Q8IYE0	7	77122434-77329533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;fallopian tube: 27.9"	"Cell type enhanced"	"Detected in many"	22	"Ciliated cells: 570.2;Early spermatids: 154.6;Spermatocytes: 113.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"pons and medulla: 32.7"	"Cell type enhanced"	"Detected in many"		"eosinophil: 12.5;neutrophil: 14.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 14.0;NK-cells: 5.0;T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020082, HPA020105"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA020082: AB_1852410, HPA020105: AB_2072056"	"unprognostic (3.07e-3)"	"unprognostic (9.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.02e-3)"	"unprognostic (4.05e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.70e-3)"	"unprognostic (5.58e-3)"	1.8	0.8	6.5	1.9	7.2	1.3	1.9	1.8	8.3	4.3	3.2	4.5	2.7	1.9	3.7	9.1	3.5	27.9	2.6	1.4	7.4	3.4	4.2	1.3	4.9	2.2	1.6	4.2	6.4	1.8	2.9	10.9	1.5	32.7	3.4	2.2	4.4	3.9	1.8	1.6	7.4	2.2	2.4	2.8	2.8	2.5	22.2	2.9	0.5	6.3	0.9	2.0	3.1	3.4	1.0	1.8	14.0	0.7	5.0	4.4	0.6	1.0	1.5	4.5	2.4	2.9	3.0	0.5	1.1	1.1	1.1	1.9	0.0	7.6	2.5	0.2	0.3	4.6	1.6	0.6	1.4	1.9	3.0	0.5	2.9	2.0	1.3	0.9	3.3	2.4	1.8	2.2	2.0	0.3	3.7	1.0	2.5	0.0	2.8	0.3	0.3	2.6	4.7	0.5	1.0	1.1	7.0	0.8	0.3	4.6	0.8	3.4	2.3	1.7	1.5	0.9	1.4	1.4	1.1	1.4	1.7	0.7	2.4	0.7	4.5	6.9	2.1	4.0	4.9	4.0	0.6	0.5	12.5	4.4	0.7	3.1	1.0	1.9	3.0	0.8	0.2	1.2	1.9	14.0	5.0	0.3	1.8	1.4	0.6	6.5	7.2	1.8	8.3	7.4	3.4	1.6	4.2	32.7	2.9	3.0	8.9	2.4	2.2	6.4	7.3	28.3	2.5	570.2	84.2	5.2	58.9	0.9	18.3	2.3	154.6	4.9	2.7	0.0	1.4	0.4	13.1	3.6	5.8	0.8	1.4	4.8	1.7	35.6	5.6	25.2	11.2	6.0	5.0	0.0	1.0	10.6	1.5	5.1	6.0	14.1	53.5	6.5	15.8	113.3	10.8	3.0	2.1	5.1	3.0	4.2
CCDC149	DKFZp761B107	ENSG00000181982	"Coiled-coil domain containing 149"	Q6ZUS6	4	24806117-24980204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044158, HPA047913"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA044158: AB_2678840, HPA047913: AB_2680207"	"unprognostic (1.68e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.11e-4)"	"unprognostic (9.71e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-2)"	"unprognostic (8.59e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.80e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.80e-2)"	11.7	8.3	20.1	8.2	14.7	2.8	16.7	14.8	20.6	13.2	10.8	6.9	11.1	5.3	12.9	9.2	7.9	13.9	9.9	10.9	15.9	11.5	7.5	10.3	10.0	4.4	11.5	12.7	15.9	31.7	12.8	11.2	11.6	11.3	14.3	8.6	7.5	29.8	10.1	8.6	6.9	6.4	14.5	9.9	5.8	13.8	5.4	9.4	0.9	11.9	4.6	4.3	9.6	18.3	0.0	0.8	0.8	4.5	0.2	0.0	1.2	4.1	1.6	3.3	0.5	5.2	9.6	1.0	6.0	9.1	4.8	5.6	0.0	4.6	0.0	2.9	11.4	5.4	0.7	1.0	0.7	3.1	0.0	0.0	0.0	0.3	0.3	4.4	0.0	0.0	6.6	4.3	2.7	0.0	13.5	3.8	0.0	0.0	0.8	2.9	4.4	0.0	0.1	3.8	0.4	4.6	0.0	0.0	0.2	8.6	3.0	4.6	0.0	2.5	3.8	12.3	3.7	6.4	9.2	9.3	7.0	0.8	5.2	5.1	0.1	0.0	0.0	21.5	0.9	4.8	0.0	4.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.2	1.5	0.7	0.0	1.2	20.1	14.7	14.8	20.0	15.9	11.5	11.5	12.7	11.3	9.4	0.0	7.4	0.0	6.2	5.6	11.5	5.3	5.1	4.0	3.4	7.0	9.8	4.5	0.0	5.6	0.9	13.5	1.1	0.0	8.8	1.5	5.8	10.2	0.0	6.0	9.7	4.8	1.7	6.2	11.1	1.3	10.0	3.0	8.5	0.0	10.9	9.4	7.5	3.5	11.0	2.2	11.5	6.5	11.3	1.4	1.9	2.8	8.9	0.5	4.3	5.6
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.2;testis: 19.4"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 34.8;Erythroid cells: 23.3;Spermatocytes: 93.6;Spermatogonia: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	1.9	1.3	2.2	2.5	3.9	3.2	5.2	1.2	2.4	1.6	2.2	2.2	0.3	1.3	2.2	2.9	2.4	2.1	1.5	0.9	1.9	1.2	1.2	2.4	2.6	2.0	1.6	0.8	1.7	2.3	1.7	3.8	1.6	1.6	3.0	1.6	1.5	7.7	2.2	0.8	3.7	1.8	1.2	3.3	2.5	1.5	19.4	2.3	16.2	1.3	2.6	2.9	2.6	2.2	1.5	1.1	6.7	1.7	2.3	3.9	1.3	4.7	0.9	6.4	0.0	0.5	1.8	0.0	5.2	6.4	4.9	6.1	0.1	4.0	5.6	4.6	1.8	9.8	3.8	2.7	3.5	8.9	4.7	1.1	6.9	0.8	1.5	0.2	2.0	4.0	0.4	2.5	10.2	5.1	0.9	3.7	7.2	4.6	5.8	10.3	1.0	4.2	2.3	1.5	4.1	5.9	5.3	11.7	1.8	0.7	2.0	3.6	3.2	3.0	0.3	1.3	3.2	7.3	1.8	2.6	10.1	2.3	4.4	6.4	1.4	1.5	4.9	1.4	11.3	6.7	6.7	1.3	1.7	2.4	1.7	2.5	0.8	2.2	3.9	0.4	1.5	3.1	3.4	0.8	2.3	1.7	1.1	3.7	1.3	2.2	3.9	1.2	2.4	1.9	1.2	1.6	0.8	1.6	2.3	3.0	1.4	0.9	1.3	4.4	4.7	0.6	0.0	4.0	3.4	0.0	0.0	0.4	0.0	2.0	34.8	3.0	0.0	23.3	2.9	0.2	1.7	1.4	9.2	1.0	2.8	3.2	1.2	0.6	3.3	21.2	4.0	2.6	3.3	0.0	1.2	3.4	1.3	0.0	2.1	0.7	2.5	6.5	2.0	93.6	24.9	3.3	0.1	2.2	0.6	0.3
CCDC150	FLJ39660	ENSG00000144395	"Coiled-coil domain containing 150"	Q8NCX0	2	196639554-196763490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.7;testis: 11.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 24.9;Late spermatids: 16.8;Melanocytes: 6.8;Proximal tubular cells: 9.8;Spermatocytes: 26.5;Spermatogonia: 13.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048104	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048104: AB_2680264"	"unprognostic (1.92e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.58e-4)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.91e-4)"	"unprognostic (2.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.17e-3)"	"unprognostic (5.66e-4)"	"unprognostic (7.29e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.69e-5)"	0.5	0.4	1.0	2.9	5.2	1.5	0.5	2.6	3.1	0.4	1.0	2.4	0.0	0.6	0.5	0.6	1.6	0.6	0.6	0.5	1.3	0.5	6.7	3.4	0.5	0.8	3.1	0.3	0.5	0.5	0.5	1.0	0.7	2.9	0.4	0.9	0.1	0.4	0.2	0.6	0.6	0.8	1.2	3.1	0.6	0.6	11.9	3.9	3.9	0.4	2.9	2.1	0.6	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.6	7.2	4.6	0.2	0.4	3.2	1.6	0.8	1.3	3.4	2.4	1.5	1.2	0.9	1.3	1.1	2.1	2.9	1.3	3.3	6.6	4.1	2.5	3.5	3.9	0.0	1.3	1.1	0.0	0.2	1.6	0.9	0.4	0.8	2.5	3.2	3.0	0.9	0.7	1.2	2.1	4.1	0.5	1.7	2.7	1.2	0.9	0.5	0.7	7.9	1.4	1.2	0.7	0.3	4.0	1.1	0.8	1.4	2.5	2.1	2.3	1.4	1.3	1.3	2.1	1.0	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	5.2	2.6	3.1	1.3	0.5	3.1	0.3	2.9	3.9	3.0	1.7	0.8	1.5	1.3	3.9	1.6	0.0	4.0	0.0	0.0	2.0	1.1	1.7	0.3	24.9	1.1	0.0	0.0	0.3	1.7	2.5	1.4	3.5	3.9	1.0	1.6	0.0	1.3	1.0	16.8	1.4	1.5	6.8	0.0	0.7	1.6	0.4	0.2	1.8	9.8	0.7	0.0	0.9	26.5	13.8	0.9	0.6	0.8	1.1	1.1
CCDC151	MGC20983	ENSG00000198003	"Coiled-coil domain containing 151"	A5D8V7	19	11420604-11435782	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.7;fallopian tube: 18.2"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 30.8;Distal tubular cells: 24.9;Kupffer cells: 37.0;Muller glia cells: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.3;memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 4.1;T-47d: 9.4;U-87 MG: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA044184, HPA054626"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044184: AB_10959331, HPA054626: AB_2682547"	"unprognostic (1.50e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.41e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.76e-4)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.05e-1)"	0.8	3.1	5.7	0.6	9.9	0.6	0.6	4.4	7.7	1.6	0.6	4.0	1.4	0.6	1.0	2.8	0.6	18.2	0.6	1.2	7.7	4.3	2.0	0.8	2.7	0.6	2.3	4.6	2.5	0.6	9.8	10.4	1.4	12.7	0.8	0.6	0.7	4.0	1.8	0.5	0.5	0.6	0.6	1.7	1.9	0.9	8.5	5.4	0.0	2.1	0.0	0.7	0.6	0.4	1.5	0.7	0.1	2.3	0.0	0.0	0.1	0.5	0.1	1.2	0.1	0.1	0.4	1.0	0.5	0.1	0.6	0.7	0.1	0.0	0.3	0.5	0.2	2.3	0.2	0.9	0.5	0.0	1.0	1.0	0.4	0.6	0.0	0.5	0.0	0.5	0.3	0.0	0.6	0.0	1.0	0.0	0.2	0.0	0.9	0.2	0.8	0.0	0.1	0.5	0.3	2.2	0.4	0.1	1.4	0.7	0.0	4.1	2.7	1.2	0.2	0.1	0.5	9.4	0.4	0.0	1.5	0.3	3.5	0.1	3.4	2.7	0.2	3.7	0.6	0.1	0.0	0.6	0.0	0.0	2.3	0.0	1.5	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	5.7	9.9	4.4	7.7	7.7	4.3	2.3	4.6	12.7	5.4	0.0	0.0	3.0	0.6	0.8	0.9	1.2	2.5	30.8	3.4	12.2	0.0	0.4	24.9	0.2	9.6	0.9	0.0	0.0	0.2	0.4	4.3	0.1	4.6	0.5	4.1	1.6	0.0	12.3	37.0	11.5	2.6	3.0	6.8	0.0	0.0	30.6	0.1	0.0	0.7	0.5	2.7	6.5	5.1	15.3	2.9	0.4	1.0	0.0	0.0	0.3
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756801-42802360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.8;pituitary gland: 24.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 56.6;Muller glia cells: 33.6;Spermatocytes: 65.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 10.6;JURKAT: 10.6;U-2 OS: 19.2;U-266/84: 12.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	4.0	6.0	7.5	2.5	10.2	1.6	3.0	1.0	8.4	2.1	2.3	4.1	0.5	5.0	2.7	1.9	2.0	1.6	6.1	4.6	7.1	3.2	3.6	52.8	3.2	8.6	4.9	5.5	8.2	2.1	0.0	24.3	2.8	20.9	2.1	0.3	1.9	2.1	0.3	1.5	3.1	12.4	0.6	8.8	6.9	1.9	5.7	8.5	8.5	1.7	0.5	3.0	2.9	3.1	3.6	10.0	0.3	0.7	6.2	6.1	1.3	0.3	0.1	0.8	0.1	2.7	3.5	0.0	4.6	0.1	0.0	0.3	0.0	0.2	0.0	0.3	2.0	3.4	3.6	0.0	0.0	0.4	0.0	0.3	0.2	10.6	4.4	2.7	0.1	0.0	4.4	0.0	1.9	0.0	7.0	1.4	10.6	0.5	1.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.3	5.3	0.0	0.1	0.0	4.2	0.4	0.1	0.1	0.2	19.2	4.4	0.1	0.1	12.8	0.1	5.6	0.1	0.1	0.1	0.1	0.1	4.0	0.7	4.9	2.2	3.0	5.0	0.7	3.6	4.0	6.1	0.3	6.2	0.3	10.0	1.9	1.3	7.5	10.2	1.0	8.4	7.1	3.2	4.9	5.5	20.9	8.5	56.6	31.3	4.9	0.2	3.3	13.9	8.1	0.0	6.7	13.6	1.8	0.0	1.3	0.0	0.6	5.7	3.5	2.3	0.0	1.0	1.0	10.4	0.3	9.2	4.0	2.3	31.8	1.2	4.9	10.5	5.3	6.1	2.9	3.3	1.0	2.5	33.6	2.0	2.9	7.1	0.5	2.2	0.0	6.6	65.5	22.6	3.4	1.5	10.9	1.2	0.3
CCDC154	"C16orf29, LOC645811"	ENSG00000197599	"Coiled-coil domain containing 154"	A6NI56	16	1434383-1444556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 10.8"	"Cell type enhanced"	"Detected in many"	19	"Cone photoreceptor cells: 7.9;Early spermatids: 36.6;Spermatocytes: 12.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 7.5;SCLC-21H: 26.6;U-266/70: 4.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 5.4"	"HPA041158, HPA043535, HPA048237"	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323"	"unprognostic (2.40e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.35e-2)"	"unprognostic (8.02e-6)"	"unprognostic (9.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.35e-5)"	0.6	1.5	0.6	1.5	1.1	1.6	0.5	4.5	1.4	1.0	0.7			2.6	1.3	0.4	0.0	1.5	0.7	0.2	0.7	0.9	1.2	0.4	0.4	2.5	0.5		1.3	1.1	0.0	3.9	0.6		2.9	0.0		1.2	0.8	1.2	2.9	1.2	0.2	0.7	3.4	3.7	10.8			2.8		0.6	0.2	0.6	0.7	0.0	0.8	0.1	0.0	1.1	0.0	7.5	0.3	0.2	0.5	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.2	0.6	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.3	0.3	0.1	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.9	0.4	0.0	0.5	0.0	3.8	0.2	0.0	0.1	2.2	0.1	0.1	0.0	0.1	26.6	0.4	0.1	0.1	1.1	0.1	0.8	1.9	0.0	0.4	0.1	0.3	0.0	4.8	1.2	0.0	0.0	3.8	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	0.7	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.5	0.0	3.3	0.5	2.5	1.4	0.0	3.5	7.9	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.3	0.0	0.2	0.1	1.1	0.0	0.7	6.4	0.0	0.0	0.8	4.4	1.4	0.5	1.7	0.0	0.0	3.2	0.0	0.0	0.4	0.2	3.9	0.0	1.0	12.0	1.3	0.4	0.0	0.0	0.0	0.1
CCDC159		ENSG00000183401	"Coiled-coil domain containing 159"	P0C7I6	19	11344684-11354944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 270.6;Late spermatids: 182.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.8"	"Low region specificity"	"Detected in all"							"HPA047126, HPA054655"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA047126: AB_10961722, HPA054655: AB_2682558"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (1.87e-7)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.40e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (9.46e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (8.62e-4)"	7.9	24.6	21.0	13.4	35.1	22.2	10.9	15.5	28.6	14.8	12.9	30.6	28.3	17.8	13.9	21.1	11.8	14.2	19.0	13.6	22.8	11.9	13.4	18.9	12.8	14.7	38.5	22.9	19.2	15.1	34.3	20.8	7.3	28.0	24.7	9.5	17.7	14.5	17.4	6.3	14.6	14.3	12.5	24.2	24.1	16.1	28.2	43.5	7.5	17.8	8.5	11.2	13.7	12.6	9.9	16.5	21.2	28.0	15.7	15.2	11.8	2.2	2.0	1.7	5.2	6.8	9.9	1.7	3.7	3.9	4.4	5.9	0.6	2.4	1.9	9.6	7.0	1.3	1.9	1.0	5.9	2.7	9.2	1.4	4.5	1.6	2.4	12.0	1.7	6.8	11.8	15.6	3.2	4.3	4.6	12.3	3.4	4.0	21.8	2.2	2.8	2.7	3.6	0.9	3.1	7.4	3.0	0.0	12.2	4.0	3.2	0.7	2.8	3.7	4.3	6.8	3.2	6.3	7.5	8.1	3.5	1.0	6.0	3.4	20.0	4.8	3.8	4.7	9.2	5.0	21.2	28.0	19.1	12.1	23.6	11.7	8.1	8.2	11.0	16.5	9.9	7.5	5.9	13.2	15.7	16.4	4.3	15.2	11.8	21.0	35.1	15.5	28.6	22.8	11.9	38.5	22.9	28.0	43.5	14.9	9.9	9.0	13.1	6.6	11.2	9.8	12.7	21.4	14.8	17.4	39.3	4.9	21.6	7.6	270.6	9.1	14.8	0.0	8.4	4.4	8.4	23.8	33.5	9.6	20.4	6.4	10.4	12.9	26.0	182.1	10.6	15.7	11.8	13.6	10.6	14.8	7.5	23.0	12.7	31.6	28.9	0.0	8.2	4.8	3.8	7.0	5.0	21.5	8.1	17.5
CCDC167	"C6orf129, dJ153P14.2"	ENSG00000198937	"Coiled-coil domain containing 167"	Q9P0B6	6	37482920-37499922	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.0"	"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	9	"U-698: 175.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045215	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA045215: AB_10962866"	"unprognostic (1.82e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (6.99e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.71e-7)"	"unprognostic (1.57e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.95e-1)"	6.4	10.3	16.1	11.6	18.9	12.7	10.2	11.3	15.5	12.6	10.5	12.8	11.4	6.3	8.7	25.2	13.6	11.5	6.2	17.3	13.8	12.1	10.2	29.5	7.0	23.0	18.1	9.1	4.6	14.9	6.9	8.4	9.6	15.8	12.2	13.0	5.0	16.2	7.7	10.5	6.5	8.2	16.7	22.8	15.1	7.5	18.8	16.9	32.1	11.5	11.2	35.5	8.7	8.7	24.8	9.9	23.6	6.0	8.6	70.0	26.4	3.1	7.2	16.6	11.5	4.5	8.0	6.1	3.7	3.0	5.8	6.5	7.6	4.7	17.1	8.5	6.3	11.3	2.4	10.7	8.7	5.9	14.2	19.7	8.1	3.1	19.1	4.8	7.9	3.2	3.7	18.0	6.2	5.7	4.1	18.0	18.0	5.0	14.9	9.9	10.3	14.8	6.5	0.9	9.0	4.6	9.2	5.9	12.6	7.9	6.2	11.3	13.3	5.6	5.5	8.7	15.2	6.0	8.2	4.5	3.9	7.6	2.1	3.8	11.0	10.7	175.0	3.7	17.0	10.9	4.8	6.0	23.6	26.1	5.9	31.1	24.8	43.5	32.8	9.9	17.0	20.1	19.4	1.8	8.6	4.9	6.3	70.0	26.4	16.1	18.9	11.3	15.5	13.8	12.1	18.1	9.1	15.8	16.9	6.0	10.1	32.8	22.2	12.6	8.6	42.5	33.1	16.0	7.9	14.0	7.9	52.7	26.6	58.7	80.7	18.0	15.3	140.2	43.7	96.5	31.5	33.2	15.0	109.5	77.5	14.3	24.2	29.4	18.3	242.2	12.0	25.9	52.3	29.7	18.8	29.8	51.7	14.4	17.7	66.3	8.5	6.5	20.8	95.7	92.0	13.2	24.8	54.9	25.8	27.3
CCDC168	"C13orf40, FLJ40176"	ENSG00000175820	"Coiled-coil domain containing 168"	Q8NDH2	13	102729369-102759070	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 23.7"	"Cell type enriched"	"Detected in some"	32	"Early spermatids: 828.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.6;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0"									"HPA048184, HPA058793, HPA078547"	Uncertain		Approved	Nucleoli,Centrosome,Cytosol		NA	NA			"Nucleoli, Centrosome"	Cytosol	"HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: "	"unprognostic (2.06e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.94e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.2	0.7	0.1	0.0	0.0	1.6	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.5	0.0	0.0	3.1	0.0	0.0	3.4	0.0	0.0	0.2	0.0	0.3	828.1	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.8	26.2	2.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	1.1	1.4	0.0	0.3	0.0	0.0	0.1
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494030-151621193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.4;fallopian tube: 33.0"	"Cell type enriched"	"Detected in many"	8	"Ciliated cells: 481.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.1"	"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MCF7: 14.2;T-47d: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Golgi apparatus"	"Cell Junctions"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	6.2	2.1	1.4	6.7	0.3	4.0	0.4	2.4	3.9	0.9	6.5	0.3	2.6	5.2	19.4	0.6	33.0	1.5	3.3	3.7	3.6	1.6	1.5	9.7	3.6	1.3	1.4	14.4	0.5	0.3	1.5	1.6	16.1	1.2	0.7	3.9	0.5	0.6	0.8	0.6	1.2	1.5	1.2	2.9	1.8	5.9	1.5	0.7	5.7	0.6	0.8	1.7	1.2	0.1	1.8	8.6	4.1	0.1	0.1	0.9	0.0	0.2	0.5	0.0	0.5	0.4	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.1	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.1	8.3	0.1	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	3.1	8.6	0.1	4.1	0.1	0.1	0.0	0.0	1.8	0.1	0.1	0.1	2.9	0.1	3.7	0.1	0.1	0.9	2.1	6.7	0.4	2.4	3.7	3.6	1.3	1.4	16.1	1.5	3.0	1.0	0.5	0.2	0.6	0.3	0.8	0.0	481.8	62.6	0.0	21.6	0.1	0.0	0.2	38.6	0.3	0.4	0.0	1.0	0.1	1.7	1.0	3.5	1.1	9.6	0.0	0.0	1.3	14.3	64.1	6.6	18.9	0.0	1.8	0.0	2.5	1.7	2.9	0.0	3.5	0.7	0.0	1.2	2.4	1.0	0.9	0.0	0.0	0.0	0.4
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553086-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 152.4;Late spermatids: 134.7;Rod photoreceptor cells: 44.6;Spermatocytes: 149.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.5;HEL: 14.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	2.5	2.5	5.8	5.5	7.5	4.0	3.6	8.2	7.8	4.1	2.4	1.1	6.9	1.9	11.6	5.8	2.4	4.6	3.4	2.6	4.9	4.1	2.8	1.3	2.5	2.4	3.4	7.6	6.3	3.4	4.2	7.8	7.3	6.6	3.4	2.5	2.0	1.9	7.4	2.4	4.9	2.2	7.1	6.1	1.5	3.1	20.4	3.3	20.2	4.3	1.4	2.2	2.5	2.8	1.6	0.7	5.1	0.6	0.4	1.8	0.2	1.7	0.9	2.2	2.1	1.2	2.6	1.4	1.4	1.1	1.4	1.5	0.6	0.8	9.5	0.7	0.8	2.5	0.4	0.9	1.3	1.5	2.0	0.9	14.8	1.5	1.3	1.8	2.1	1.9	1.5	2.6	1.1	2.1	1.0	0.6	5.4	0.4	2.6	1.6	0.7	4.1	1.9	1.7	0.8	2.1	4.9	1.6	0.3	1.0	1.4	3.1	1.5	2.8	1.0	3.6	1.9	1.1	1.5	1.1	2.9	1.6	0.8	0.9	1.4	1.7	6.2	1.2	1.2	2.0	5.1	0.6	0.0	0.8	0.6	1.8	0.7	0.7	0.7	0.7	1.6	0.5	0.9	0.5	0.4	0.4	0.7	0.6	0.2	5.8	7.5	8.2	7.8	4.9	4.1	3.4	7.6	6.6	3.3	0.0	6.9	0.0	5.3	2.5	24.3	7.0	0.0	17.4	9.1	3.5	15.7	4.8	5.0	2.0	152.4	2.6	2.7	0.0	3.1	3.6	1.9	0.5	1.1	0.8	1.6	9.5	1.2	2.5	0.3	134.7	5.5	1.1	0.0	1.8	2.6	11.2	2.0	0.0	5.6	1.4	44.6	12.9	2.1	149.3	27.2	2.9	4.7	0.7	3.6	2.6
CCDC175	C14orf38	ENSG00000151838	"Coiled-coil domain containing 175"	P0C221	14	59504539-59576831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 17.1;pituitary gland: 6.6;testis: 8.2"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 13.4;Cone photoreceptor cells: 7.9;Early spermatids: 7.0;Rod photoreceptor cells: 11.8;Spermatocytes: 16.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;SCLC-21H: 1.7"									HPA004200	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA004200: AB_1078743"	"unprognostic (3.64e-3)"		"unprognostic (8.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"					"unprognostic (3.83e-1)"			"unprognostic (2.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.27e-1)"			0.2	0.1	0.9	0.2	2.9	0.5	0.2	17.1	3.3	0.2	0.9	1.2	0.0	0.3	0.2	1.0	0.2	1.3	0.5	0.2	0.8	0.5	0.4	0.2	0.5	0.2	0.8	0.9	0.2	0.1	0.3	6.6	0.1	3.0	0.2	1.8	0.6	0.2	0.2	0.2	0.3	0.9	0.2	0.4	0.4	0.2	8.2	1.5	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.4	0.9	2.9	17.1	3.3	0.8	0.5	0.8	0.9	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.4	1.2	0.0	7.9	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	11.8	0.0	0.0	16.5	1.3	0.0	0.0	0.0	2.6	0.0
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 128.6;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	3.8	2.3	2.7	20.0	4.3	13.4	4.6	3.7	2.7	2.2	3.2	0.4	2.9	2.5	1.8	4.0	3.2	1.8	1.7	2.6	3.4	1.9	2.0	3.0	3.8	11.9	1.7	1.8	2.8	1.5	0.7	4.8	1.9	2.6	1.9	4.1	1.3	2.0	3.1	6.2	3.1	3.4	2.3	3.8	6.0	2.3	12.6	2.5	15.8	2.1	2.8	8.2	2.9	3.3	12.2	11.9	6.0	3.9	1.1	2.7	0.5	15.7	5.3	12.4	3.9	3.0	3.2	6.5	9.8	5.2	10.1	10.3	2.7	5.4	20.4	5.5	5.2	9.9	7.5	5.4	7.7	14.7	10.1	7.1	14.0	11.3	4.8	1.1	14.5	6.5	2.1	0.6	7.6	7.5	2.8	6.5	9.2	14.9	15.8	13.4	2.2	6.9	5.9	11.3	4.3	6.6	9.0	14.8	6.0	4.9	7.1	5.5	3.5	13.9	7.1	4.1	5.8	3.4	8.5	5.0	11.9	8.4	7.6	11.1	6.8	8.8	12.3	2.5	13.0	3.1	3.4	3.8	5.3	2.4	3.9	2.7	8.8	2.2	2.1	1.6	12.2	1.7	2.0	6.0	1.1	3.5	11.9	2.2	0.5	2.7	4.3	3.7	2.7	3.4	1.9	1.7	1.8	2.6	2.5	17.9	11.1	17.6	6.5	3.7	2.4	8.1	0.0	6.7	4.5	3.5	3.9	2.6	0.0	1.9	17.7	3.7	1.7	0.0	2.6	5.8	6.8	3.3	18.5	2.9	7.2	1.6	0.0	4.3	12.4	8.5	5.8	19.5	3.3	9.0	2.5	1.1	1.8	3.5	6.0	1.0	0.6	6.5	5.7	128.6	37.7	6.4	2.4	14.1	3.1	6.4
CCDC181	"C1orf114, FLJ25846"	ENSG00000117477	"Coiled-coil domain containing 181"	Q5TID7	1	169394870-169460669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 22.3;testis: 29.2"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 168.6;Early spermatids: 201.9;Rod photoreceptor cells: 81.8;Spermatocytes: 143.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"basophil: 3.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"AF22: 7.2;GAMG: 7.4;NTERA-2: 13.8;SCLC-21H: 8.5;SH-SY5Y: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027189, HPA027275, HPA027281, HPA027312"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349"	"unprognostic (2.45e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.89e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.41e-2)"	0.8	3.3	6.3	1.0	8.3	0.9	0.9	5.9	8.4	2.6	0.7	1.6	0.4	0.7	4.6	2.7	0.9	14.5	4.6	2.3	6.6	9.9	7.5	0.6	2.4	0.6	5.2	5.0	8.0	3.0	17.3	22.3	0.5	8.7	2.9	0.7	5.3	0.8	2.9	0.7	1.1	0.9	2.7	4.9	0.5	1.2	29.2	4.1	0.0	1.1	0.0	0.5	1.4	0.8	0.1	0.0	3.2	0.1	0.0	0.2	0.0	0.2	0.3	7.2	0.1	0.2	0.2	0.2	0.1	0.0	1.8	3.8	0.1	0.1	0.1	0.1	0.0	7.4	0.1	0.3	0.0	0.3	0.2	1.6	1.7	0.1	0.0	0.0	1.9	0.1	0.7	0.0	0.4	0.0	0.2	0.1	5.7	0.1	0.1	1.3	0.1	4.3	0.0	13.8	0.1	0.0	0.0	5.9	0.1	1.1	0.0	8.5	10.0	0.0	0.3	0.5	4.0	0.0	0.0	0.5	1.4	4.5	0.2	6.1	2.1	1.8	0.0	2.8	0.1	5.5	3.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.3	8.3	5.9	8.4	6.6	9.9	5.2	5.0	8.7	4.1	3.0	6.6	0.0	0.1	0.0	68.6	5.8	0.0	168.6	38.7	8.7	62.8	0.0	13.3	0.9	201.9	0.4	0.0	0.0	1.4	0.0	0.0	0.3	1.1	0.0	0.1	23.8	18.5	0.6	0.0	50.5	2.8	0.0	0.0	0.0	0.0	18.7	0.7	0.0	9.9	14.1	81.8	6.5	1.7	143.9	41.9	0.0	0.1	0.0	0.0	0.6
CCDC184	"C12orf68, LOC387856"	ENSG00000177875	"Coiled-coil domain containing 184"	Q52MB2	12	48183584-48185926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 51.8;Sertoli cells: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 4.2;AF22: 9.9;hTERT-RPE1: 3.8;SH-SY5Y: 6.7;U-2 OS: 4.0;U-87 MG: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039947, HPA041715"	Uncertain		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA039947: AB_2676764, HPA041715: AB_2677634"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.36e-2)"	2.0	11.4	9.0	2.3	14.4	0.8	1.3	14.9	30.5	3.0	1.8	2.2	0.1	1.1	6.1	1.3	1.7	1.3	3.3	1.9	9.3	17.6	1.3	1.3	1.5	1.0	11.5	10.6	8.8	1.3	8.7	7.3	5.1	23.7	1.6	1.5	0.8	0.9	2.3	2.2	1.5	2.1	3.6	3.6	1.4	1.5	5.1	0.4	0.0	1.2	0.5	0.8	2.1	1.8	0.0	0.3	0.6	0.2	0.0	1.2	0.3	0.0	4.2	9.9	0.4	0.8	0.8	0.0	0.3	1.8	0.5	0.8	0.5	0.1	0.0	0.2	0.3	2.6	0.1	1.0	0.2	0.1	2.3	0.2	0.0	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.1	0.0	3.8	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	6.7	0.8	0.1	0.2	0.2	0.0	0.0	0.2	1.1	4.0	0.0	0.2	0.0	0.0	0.0	5.0	0.0	1.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	1.2	0.4	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.3	9.0	14.4	14.9	30.5	9.3	17.6	11.5	10.6	23.7	0.4	0.0	0.0	0.0	0.2	0.0	2.3	0.6	0.0	9.4	1.2	0.0	0.0	0.7	0.0	0.2	51.8	1.0	0.0	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.9	4.8	5.1	8.6	0.0	10.9	0.3	0.0	0.0	0.0	0.0	2.8	0.2	0.0	2.1	0.0	6.6	45.3	2.7	5.6	0.9	0.0	1.3	0.0	0.0	0.0
CCDC186	"C10orf118, FLJ10188, FLJ35301"	ENSG00000165813	"Coiled-coil domain containing 186"	Q7Z3E2	10	114120862-114174220	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 27.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014569, HPA018019"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA014569: AB_2066352, HPA018019: AB_1845513"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (7.65e-8)"	"unprognostic (8.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	8.2	7.5	8.5	11.9	11.3	26.7	12.1	23.3	15.1	11.8	17.1	2.9	24.3	14.2	8.6	12.8	14.8	10.9	6.8	11.9	9.3	8.1	19.2	8.0	14.1	9.3	8.4	11.9	10.4	23.9	14.4	41.4	21.4	16.5	14.8	11.6	3.5	15.4	26.3	12.3	18.8	30.8	7.5	10.9	14.3	15.5	15.2	8.2	17.0	16.2	12.7	9.3	10.5	12.0	4.8	27.7	11.4	2.2	3.1	5.3	1.4	14.4	4.9	5.0	5.6	5.6	7.2	6.4	9.1	11.0	4.3	7.3	9.2	15.4	3.5	5.8	7.5	5.2	11.7	5.9	8.1	8.4	17.4	6.0	2.7	5.4	5.2	5.3	7.4	12.3	5.0	9.2	5.2	14.2	10.5	6.3	9.3	5.0	11.2	5.0	5.0	7.0	4.1	2.9	8.5	3.4	6.9	17.5	5.2	7.4	9.0	3.6	3.6	8.1	11.2	5.3	8.4	7.1	3.2	9.3	3.3	6.8	3.3	7.6	6.3	10.2	6.9	3.4	0.1	2.6	11.1	1.9	6.2	5.3	2.2	5.2	4.3	4.1	4.6	2.2	4.8	3.9	3.8	11.4	3.1	1.8	27.7	4.7	1.4	8.5	11.3	23.3	15.1	9.3	8.1	8.4	11.9	16.5	8.2	131.0	64.8	40.1	68.7	0.0	61.1	50.9	33.1	117.8	105.8	73.3	58.9	76.3	56.3	65.5	166.6	30.8	91.0	0.0	62.0	32.3	24.7	85.3	24.3	15.3	18.9	101.7	62.0	18.4	22.5	109.7	46.3	27.3	0.0	40.5	71.9	33.6	63.0	80.7	41.8	58.7	68.5	25.8	20.0	76.4	60.5	0.0	95.0	41.5	34.8	107.6
CCDC188		ENSG00000234409	"Coiled-coil domain containing 188"	H7C350	22	20148427-20151065	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 6.1;testis: 23.1"	"Group enriched"	"Detected in some"	125	"Early spermatids: 318.9;Late spermatids: 769.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	47	"plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	47	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in some"		"AF22: 5.8;SCLC-21H: 8.0;SH-SY5Y: 10.5;TIME: 4.2;U-2 OS: 4.5"					"Not detected"	"Not detected"			HPA049901			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA049901: AB_2680943"	"unprognostic (9.83e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-5)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-2)"	1.1	0.9	0.4	0.5	0.6	0.5	0.5	1.4	1.2	0.4	0.4	0.4	0.4	1.0	0.6	0.4	0.4	0.4	0.4	0.4	0.4	1.9	0.4	0.4	0.6	0.7	0.5	0.4	0.4	0.4	0.0	6.1	0.8	0.4	0.4	0.0	0.4	0.4	0.4	0.7	1.5	0.5	0.4	0.4	1.8	0.8	23.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.8	0.3	0.0	0.7	0.0	1.7	0.8	1.4	0.9	0.1	0.1	0.0	0.2	0.8	0.2	0.3	0.0	0.0	0.1	0.2	0.0	1.4	0.2	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.1	0.9	0.2	3.8	1.2	0.5	0.0	0.3	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.1	8.0	10.5	0.5	0.0	0.6	0.1	0.0	0.1	4.2	2.4	4.5	3.0	0.2	0.7	0.1	0.2	3.9	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.4	0.6	1.4	0.6	0.4	1.9	0.5	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	318.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	769.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0
CCDC189	"C16orf93, MGC104706"	ENSG00000196118	"Coiled-coil domain containing 189"	A1A4V9	16	30757423-30762710	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.7"	"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 91.0;Early spermatids: 152.5;Late spermatids: 229.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041806, HPA046289, HPA075094"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041806: AB_2677684, HPA046289: AB_2679615, HPA075094: "	"unprognostic (5.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.45e-4)"	"unprognostic (3.60e-2)"	"unprognostic (5.41e-3)"	"unprognostic (7.76e-5)"	"unprognostic (1.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.06e-7)"	"unprognostic (1.75e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.41e-2)"	1.0	4.2	4.7	3.1	5.3	11.0	4.8	0.9	6.4	3.2	2.8	2.9	5.5	2.0	2.2	15.0	1.2	15.6	4.2	0.8	5.5	6.8	4.5	0.9	5.5	1.9	7.5	3.3	3.1	3.0	4.4	10.3	1.2	7.6	3.0	3.1	2.3	3.4	5.1	0.4	1.8	1.4	1.3	1.3	1.9	2.0	23.7	2.2	2.3	6.3	1.6	3.4	1.7	0.8	1.2	13.0	6.2	3.1	1.8	1.1	0.8	7.2	5.0	1.5	5.9	1.6	1.9	0.4	2.8	1.0	3.0	2.3	0.4	5.4	0.3	4.8	2.1	1.6	9.1	0.8	4.5	1.2	0.8	11.8	1.9	10.3	3.1	0.3	3.0	2.1	0.4	0.4	5.5	4.5	4.5	2.2	2.0	2.7	1.3	2.1	3.7	3.1	6.0	2.3	2.2	2.7	3.1	1.9	5.6	6.7	0.1	5.1	1.8	3.0	8.3	1.9	1.5	8.2	3.8	1.9	1.5	1.3	2.6	2.8	3.9	2.2	2.7	8.8	7.7	0.7	1.2	1.3	6.2	0.2	1.4	1.1	1.2	0.0	0.2	1.8	0.1	0.0	0.4	0.6	1.8	3.1	13.0	0.1	0.8	4.7	5.3	0.9	6.4	5.5	6.8	7.5	3.3	7.6	2.2	0.0	1.9	0.0	3.2	0.0	0.4	0.0	0.0	91.0	6.8	7.0	3.9	2.0	5.0	3.3	152.5	1.0	0.0	46.7	2.6	0.9	1.0	5.3	1.1	0.8	4.0	0.0	2.4	0.0	1.5	229.1	6.9	2.3	0.0	4.6	2.2	3.3	1.5	0.9	4.6	6.2	11.7	0.0	0.0	45.1	9.6	0.0	2.1	1.0	1.7	3.0
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868815	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;lung: 7.2;tongue: 7.5"	"Cell type enriched"	"Detected in some"	27	"Ciliated cells: 48.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 4.1;hTERT-RPE1: 5.1;HUVEC TERT2: 5.0;LHCN-M2: 7.6;TIME: 17.3;U-2197: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.29e-1)"	"unprognostic (8.37e-2)"		"unprognostic (1.75e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.33e-3)"		"unprognostic (3.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.41e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.26e-1)"	"unprognostic (1.70e-1)"	0.2	0.1	1.1	0.2	1.7	0.0	0.2	0.2	0.9	0.3	0.2	0.2	0.2	0.0	0.2	0.8	8.3	1.1	1.3	1.0	1.2	0.7	0.2	0.2	7.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.2	0.3	0.2	0.1	0.7	0.2	0.6	0.2	7.5	2.4	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.1	2.6	5.1	5.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.4	0.0	9.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.6	1.2	0.7	0.4	0.2	0.2	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	48.2	0.0	1.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3
CCDC191	KIAA1407	ENSG00000163617	"Coiled-coil domain containing 191"	Q8NCU4	3	113964137-114056613	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 191.4;Spermatocytes: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047833	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047833: AB_10961639"	"unprognostic (2.59e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.90e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.45e-4)"	3.8	4.5	6.3	4.5	13.3	4.2	7.6	3.0	9.7	7.6	4.0	11.7	11.5	2.9	8.2	12.4	3.4	18.5	5.7	2.4	8.2	7.8	7.7	2.4	7.2	6.1	6.2	9.8	7.7	6.6	16.7	31.1	3.4	12.5	6.5	5.2	7.1	5.0	7.9	1.6	11.4	5.1	7.0	8.9	7.5	4.8	12.7	7.9	3.6	11.3	2.4	6.1	5.2	4.5	10.0	4.4	5.3	0.9	0.8	2.2	1.0	4.9	2.8	4.4	3.6	1.2	6.6	1.4	1.2	2.2	1.7	2.7	0.6	5.8	1.3	2.0	2.3	1.3	6.2	1.3	2.4	4.0	0.9	1.1	0.9	0.9	0.5	1.8	1.6	0.7	2.8	6.3	2.2	3.3	3.0	3.3	3.8	0.4	3.1	1.0	2.4	3.0	0.6	0.8	3.4	2.1	2.0	0.9	2.9	6.1	2.5	2.5	4.3	2.0	0.5	2.1	2.3	10.6	0.6	3.4	2.7	0.8	1.4	0.8	4.5	3.6	5.0	3.8	0.8	1.4	0.1	0.9	1.8	1.1	0.9	1.2	10.0	2.2	1.8	1.0	9.4	1.1	1.8	5.3	0.8	0.6	4.4	1.6	1.0	6.3	13.3	3.0	9.7	8.2	7.8	6.2	9.8	12.5	7.9	11.9	11.8	7.3	3.8	0.0	8.7	0.0	0.0	191.4	29.6	12.2	35.3	1.4	11.6	3.7	21.9	1.4	1.1	0.0	3.1	0.4	1.5	2.6	1.1	0.8	2.7	19.1	4.7	5.5	1.8	10.9	3.7	0.7	0.0	1.0	3.0	20.1	2.4	0.0	4.9	3.6	39.1	0.0	0.0	76.7	12.3	0.0	0.2	0.0	3.2	1.7
CCDC22	"CXorf37, JM1"	ENSG00000101997	"Coiled-coil domain containing 22"	O60826	X	49235467-49250526	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000229, HPA000888"	Uncertain	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000229: , HPA000888: AB_1078420"	"unprognostic (1.24e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-3)"	11.5	15.4	12.1	18.2	14.9	26.0	16.3	20.7	16.5	12.5	11.8	13.7	17.2	16.3	14.8	12.3	15.8	13.7	11.9	12.9	12.2	9.8	13.9	14.2	19.8	24.7	12.2	15.9	13.7	20.3	12.1	13.5	11.0	11.8	15.2	8.6	12.8	19.2	21.3	23.0	15.1	15.3	14.6	12.4	23.9	14.2	4.5	14.1	25.0	13.0	15.5	17.9	12.6	12.3	12.4	23.5	13.9	22.1	6.1	13.9	15.1	10.6	9.3	5.7	19.8	5.3	5.4	12.2	6.4	4.6	7.1	8.2	9.4	9.3	3.9	9.5	5.6	8.5	8.7	6.2	10.4	2.9	10.3	13.8	4.2	8.8	8.8	9.0	11.7	7.4	5.0	9.0	9.4	5.2	3.6	7.0	8.0	8.2	7.0	5.0	33.1	8.6	13.8	6.6	5.4	13.7	12.5	9.3	17.1	5.6	5.4	6.8	5.2	9.7	11.4	8.5	6.1	17.8	11.6	7.7	9.3	10.0	11.3	6.6	12.7	6.9	7.1	10.1	22.1	7.2	5.1	22.1	13.9	12.0	19.2	13.1	12.4	12.5	13.9	23.5	11.6	11.4	12.9	1.8	6.1	15.7	9.3	12.9	15.1	12.1	14.9	20.7	16.5	12.2	9.8	12.2	15.9	11.8	14.1	0.0	4.1	16.0	7.9	4.9	9.9	2.0	15.3	2.7	9.1	10.4	5.9	12.2	13.3	12.2	0.1	7.1	12.3	0.0	6.4	12.3	8.4	6.3	11.5	6.4	27.5	1.6	6.4	9.8	16.7	0.0	7.5	14.7	6.8	16.2	14.4	9.3	7.9	7.2	7.1	10.2	7.6	6.5	10.3	0.0	0.7	5.8	16.9	11.3	12.2	7.4
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 52.2;Intestinal endocrine cells: 34.9;Spermatocytes: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: AB_2684591"	"prognostic favorable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (3.18e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.8	5.5	9.3	2.6	9.8	1.1	5.1	3.0	9.8	7.2	5.0	3.2	18.9	3.7	4.9	6.6	2.6	20.3	13.1	1.5	6.4	8.0	8.9	3.0	3.2	2.6	5.5	9.6	3.4	6.0	9.6	14.5	2.4	5.2	7.2	4.1	6.5	8.4	14.7	1.5	0.9	3.3	3.4	3.3	3.0	4.9	15.4	1.7	0.6	8.8	1.0	2.5	4.7	2.1	6.8	0.8	1.4	4.0	0.5	0.6	0.5	5.1	3.1	1.4	1.6	1.4	1.0	3.1	0.2	2.2	1.6	2.8	2.0	15.0	4.2	5.9	0.6	4.6	5.3	0.8	7.4	1.5	4.4	1.8	2.1	1.9	0.6	1.6	0.7	3.7	0.3	0.7	5.2	0.5	5.0	1.3	1.6	0.9	1.6	2.2	4.5	0.3	1.6	3.1	4.7	2.6	1.3	0.0	0.8	6.2	2.0	3.4	3.0	4.6	2.6	2.9	3.1	7.8	0.1	0.4	2.4	7.0	1.8	0.7	0.6	2.0	0.9	6.3	0.6	2.0	0.0	0.7	1.4	0.6	4.0	0.3	6.8	0.2	0.2	0.8	3.0	0.0	0.0	0.6	0.5	3.1	0.6	0.0	0.5	9.3	9.8	3.0	9.8	6.4	8.0	5.5	9.6	5.2	1.7	3.0	7.4	0.5	8.2	1.0	8.8	0.8	12.7	52.2	19.4	8.7	5.9	4.7	18.3	7.1	16.4	0.7	6.3	0.0	6.4	1.7	3.3	6.8	2.3	2.1	2.9	3.2	34.9	1.8	3.2	8.5	2.0	1.8	3.3	4.6	12.1	9.5	5.4	8.6	2.8	8.0	14.2	0.0	2.4	48.8	19.5	0.6	2.1	0.0	13.0	8.4
CCDC25	FLJ10853	ENSG00000147419	"Coiled-coil domain containing 25"	Q86WR0	8	27733311-27772653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023256	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA023256: AB_2072067"	"unprognostic (1.43e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-2)"	"prognostic favorable (1.11e-7)"	"unprognostic (3.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-1)"	12.7	25.4	16.8	10.6	22.4	4.0	16.7	14.2	26.1	10.3	26.0	13.1	12.0	32.5	13.2	14.2	13.7	14.6	11.3	11.1	16.5	14.0	21.5	30.4	8.5	12.8	19.9	15.8	10.9	16.0	15.6	12.7	9.9	29.4	11.4	15.1	9.8	14.1	12.4	23.3	10.9	39.7	10.5	19.0	12.1	18.0	12.0	17.2	9.7	17.8	13.8	12.8	13.2	10.5	19.2	18.9	14.9	13.2	13.8	21.8	9.1	24.0	13.1	13.2	12.3	11.8	17.1	8.9	20.2	19.6	12.5	12.3	5.4	8.6	26.0	14.0	10.2	10.7	11.4	11.7	19.7	18.1	9.7	7.8	32.4	12.3	9.4	19.8	11.3	10.5	19.1	13.1	13.5	19.0	14.3	26.8	17.0	15.2	12.5	13.9	8.8	27.5	9.6	18.9	23.9	7.3	9.0	22.4	13.7	16.4	14.1	7.6	21.2	13.6	10.5	20.6	10.4	12.0	6.4	21.6	11.5	18.2	19.6	10.6	13.6	15.9	9.5	17.8	15.1	11.8	14.9	10.4	7.3	14.6	13.2	19.8	19.2	21.2	17.8	12.1	14.0	18.8	20.9	4.0	13.8	12.5	18.9	21.8	9.1	16.8	22.4	14.2	26.1	16.5	14.0	19.9	15.8	29.4	17.2	23.8	29.3	26.0	34.6	19.1	41.2	55.6	56.0	65.6	43.3	50.6	11.8	67.5	92.9	63.1	135.8	56.8	64.2	23.3	117.7	46.6	43.3	42.8	61.3	122.8	39.7	52.4	25.4	48.5	33.2	96.8	43.7	30.4	35.4	50.5	50.8	46.3	68.5	45.6	44.6	91.6	36.5	45.3	35.0	69.9	62.9	19.4	35.5	34.9	50.9	23.7
CCDC27	FLJ32825	ENSG00000162592	"Coiled-coil domain containing 27"	Q2M243	1	3746460-3771645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	81	"testis: 53.3"	"Group enriched"	"Detected in some"	46	"Early spermatids: 60.7;Late spermatids: 19.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"THP-1: 6.2"									HPA044395			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA044395: AB_10962987"	"unprognostic (1.36e-1)"	"unprognostic (6.67e-3)"		"unprognostic (3.23e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.28e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"	Q8IWP9	6	138773509-138793319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA055125: AB_2682705"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	12.9	30.8	25.4	19.8	28.7	20.9	17.9	22.6	27.9	15.6	17.4	13.3	18.7	18.5	11.5	24.8	12.4	22.6	16.8	11.0	31.4	32.2	36.5	40.5	17.4	19.2	22.2	21.7	14.2	22.2	25.5	19.2	19.3	28.3	16.1	15.4	16.4	31.6	20.8	17.4	11.0	21.3	13.9	16.1	18.3	16.5	15.0	13.4	18.2	33.9	9.3	19.8	19.3	12.5	30.0	29.3	73.5	27.3	30.6	44.5	24.5	3.4	6.2	4.7	8.6	8.9	12.5	9.6	5.7	10.0	7.5	12.4	5.3	6.8	14.8	11.1	5.6	10.7	6.0	7.7	7.9	12.3	17.1	17.2	12.0	7.7	10.6	14.1	20.8	12.7	8.0	10.1	5.4	16.2	15.6	12.3	21.1	12.1	20.8	8.5	7.6	17.0	27.4	4.3	13.9	6.5	10.3	4.7	13.7	9.0	5.1	5.9	9.1	7.5	6.9	16.4	9.8	3.3	23.0	9.4	5.9	6.8	11.0	8.6	27.9	24.6	10.9	6.4	12.9	5.2	33.2	27.3	33.7	26.0	27.0	23.2	30.0	27.6	28.3	29.3	29.7	32.1	29.5	73.5	30.6	22.9	25.8	44.5	24.5	25.4	28.7	22.6	27.9	31.4	32.2	22.2	21.7	28.3	13.4	29.8	34.4	36.3	23.6	11.8	15.2	9.4	15.3	60.2	20.5	34.9	17.7	69.7	104.5	12.9	140.9	19.6	31.3	0.0	27.6	36.9	20.0	38.9	41.6	41.9	35.0	9.5	23.7	28.3	38.3	64.6	15.5	34.4	30.4	35.1	32.2	20.5	17.7	32.0	14.2	100.3	12.5	12.9	12.2	40.2	30.3	13.0	91.1	37.6	22.2	27.7
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 89.3"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 44.5;Peritubular cells: 57.0;Sertoli cells: 32.3;Smooth muscle cells: 95.9;Suprabasal keratinocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.5;HAP1: 13.6;HDLM-2: 22.3;hTERT-RPE1: 10.7;U-2 OS: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			Nucleoplasm	Cytosol	"HPA062425: AB_2684759"	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	37.1	5.0	14.0	2.5	9.0	0.2	33.6	4.9	15.0	23.0	4.2	2.9	3.4	2.9	16.2	18.6	26.9	21.8	89.3	11.0	8.0	3.0	4.2	8.5	8.0	12.3	4.3	8.7	39.1	2.9	3.8	4.2	9.6	3.2	14.3	3.4	8.8	2.8	10.3	12.0	55.7	5.5	11.8	3.4	9.8	5.8	11.0	3.1	10.4	8.3	9.6	2.0	12.4	14.2	0.1	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.2	1.2	6.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.5	0.0	7.5	1.3	13.6	2.5	0.4	22.3	5.7	0.0	0.2	0.0	0.5	0.0	0.0	1.7	1.6	0.3	0.0	10.7	0.6	0.5	0.0	0.1	0.7	0.1	0.0	3.7	1.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	2.6	1.1	4.9	0.7	0.0	3.3	0.0	0.0	0.0	0.0	14.8	0.8	0.2	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	14.0	9.0	4.9	15.0	8.0	3.0	4.3	8.7	3.2	3.1	0.0	0.0	0.0	6.2	44.5	1.0	4.4	0.0	0.0	1.2	0.0	0.0	0.2	1.7	0.0	0.2	8.3	0.0	0.0	0.0	0.1	9.1	1.9	0.0	0.2	0.3	0.0	0.0	8.0	0.0	1.1	20.8	1.6	13.5	0.0	0.0	0.5	0.1	0.0	57.0	0.3	1.9	32.3	95.9	0.0	3.8	32.5	0.2	0.0	0.0	1.0
CCDC32	"C15orf57, MGC20481"	ENSG00000128891	"Coiled-coil domain containing 32"	Q9BV29	15	40528683-40565057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 75.8;Hofbauer cells: 59.5;Syncytiotrophoblasts: 68.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041688	Uncertain		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Nuclear speckles"	Vesicles	"HPA041688: AB_10796779"	"unprognostic (7.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.86e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.25e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.47e-2)"	22.7	23.5	17.9	17.2	24.3	19.0	17.9	17.6	24.0	17.1	18.4	17.6	17.4	18.4	24.5	20.0	12.6	20.3	19.4	21.4	20.7	21.9	25.9	15.3	16.6	27.8	17.6	21.0	28.2	32.6	15.8	26.5	22.6	20.8	16.5	22.0	20.5	20.7	17.4	22.4	11.5	18.5	18.5	16.7	25.2	18.9	9.2	16.1	16.2	24.4	9.4	26.8	26.9	22.2	50.6	16.3	12.7	9.6	7.7	13.8	11.6	7.9	5.7	7.6	12.3	15.5	16.3	4.5	6.4	9.6	11.4	12.0	8.6	11.2	3.0	18.0	9.5	16.4	15.0	7.5	7.2	8.2	18.0	8.7	32.6	9.8	10.7	10.6	12.2	17.2	14.1	7.7	8.9	6.0	10.7	14.2	11.7	17.8	19.9	8.6	6.9	5.5	10.7	3.0	18.2	7.4	9.8	9.6	9.9	21.0	19.3	8.4	8.6	9.5	10.0	4.7	9.4	10.5	22.7	15.7	10.6	9.3	18.6	9.2	10.8	10.6	9.6	11.2	19.4	14.9	12.7	9.4	9.3	9.8	9.6	7.9	40.9	11.0	10.6	12.2	50.6	11.2	9.5	9.9	7.7	9.4	16.3	13.8	11.6	17.9	24.3	17.6	24.0	20.7	21.9	17.6	21.0	20.8	16.1	11.9	12.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	18.2	19.2	0.0	75.8	24.9	23.7	0.0	0.0	0.0	0.0	25.7	28.6	0.0	0.0	5.8	0.0	59.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	18.0	0.0	0.0	28.2	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	68.1	0.0	0.0	0.0
CCDC34	"L15, NY-REN-41, RAMA3"	ENSG00000109881	"Coiled-coil domain containing 34"	Q96HJ3	11	27330827-27363868	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.5"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 280.3;Spermatocytes: 327.2;Spermatogonia: 197.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 37.6;U-266/70: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037574	Uncertain		Approved	"Nuclear membrane,Nucleoli fibrillar center"		NA	NA			"Nuclear membrane, Nucleoli fibrillar center"		"HPA037574: AB_10795136"	"unprognostic (8.23e-3)"	"unprognostic (1.09e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.32e-7)"	"unprognostic (9.09e-2)"	"unprognostic (1.34e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.11e-2)"	2.7	4.7	9.3	6.8	17.1	8.3	8.4	3.8	11.7	4.2	6.6	2.1	3.8	7.9	4.1	8.6	5.9	9.7	4.0	3.2	9.0	7.5	4.1	3.4	2.8	4.3	5.6	6.2	7.7	4.8	7.2	12.5	3.9	11.1	5.4	7.4	3.3	3.6	3.8	2.8	4.7	6.3	2.8	4.5	3.3	6.9	31.5	4.4	14.8	6.7	5.3	6.0	3.3	3.9	4.8	2.4	0.4	3.6	4.1	7.1	1.3	10.2	11.8	10.1	10.1	1.9	4.1	7.2	6.5	2.6	7.5	7.3	6.6	2.0	11.5	4.7	3.7	10.5	9.5	9.8	4.3	13.4	4.4	14.2	9.0	15.0	16.5	0.9	8.9	3.5	1.4	3.1	6.2	2.8	3.1	5.3	16.4	9.1	3.8	7.5	7.4	17.2	14.2	10.6	7.0	10.8	17.5	37.6	1.6	2.8	3.3	7.7	10.2	10.4	4.6	4.5	5.7	12.3	4.8	2.6	11.3	10.6	21.4	15.5	37.5	34.0	8.1	10.5	0.4	9.6	0.0	0.2	0.4	3.6	1.0	4.5	3.5	4.5	4.8	1.0	4.8	5.4	3.3	0.0	4.1	3.6	2.4	7.1	1.3	9.3	17.1	3.8	11.7	9.0	7.5	5.6	6.2	11.1	4.4	0.0	1.7	5.2	22.4	20.3	10.0	8.1	35.7	119.1	23.9	22.7	11.8	26.0	16.6	12.7	280.3	10.6	8.9	93.5	10.8	18.1	15.8	12.5	6.9	14.9	18.8	3.2	20.7	8.0	10.5	39.6	19.8	8.4	13.5	6.4	32.6	21.5	5.5	7.0	19.4	11.2	19.5	6.5	4.7	327.2	197.3	18.1	13.5	8.7	69.8	7.8
CCDC36	"CT74, FLJ25320"	ENSG00000173421	"Coiled-coil domain containing 36"	Q8IYA8	3	49198428-49258104	"Predicted intracellular proteins"	"Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 51.2;Late spermatids: 32.2;Spermatocytes: 85.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 3.9;hTEC/SVTERT24-B: 13.3;LHCN-M2: 5.5;U-2197: 7.2;WM-115: 3.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA045690, HPA069534"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045690: AB_10964634, HPA069534: AB_2686146"	"unprognostic (1.54e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.51e-4)"	"unprognostic (3.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.33e-2)"	6.5	1.7	0.8	1.8	0.8	0.4	3.6	0.8	0.7	3.7	2.2	0.7	2.1	0.4	6.3	1.2	1.1	1.3	1.4	1.9	0.9	0.4	0.5	0.4	1.4	0.5	1.1	0.1	5.0	0.4	0.2	0.4	1.4	2.0	0.6	0.4	2.6	2.0	0.8	1.6	0.8	0.6	3.9	0.4	0.7	0.6	35.4	0.3	0.0	1.3	0.3	0.6	1.2	0.9	0.9	0.6	3.6	0.3	0.8	0.5	0.2	0.0	0.2	0.1	0.2	2.8	3.1	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	3.5	0.0	0.2	2.4	0.0	13.3	0.0	0.0	1.7	0.1	0.0	0.3	5.5	0.0	0.0	0.2	3.5	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	2.5	7.2	0.1	0.1	0.1	0.1	0.0	0.2	3.6	2.1	0.3	0.6	0.4	0.2	0.3	0.8	0.4	0.3	0.1	0.9	0.4	0.5	3.6	0.8	0.2	0.6	0.3	0.2	0.8	0.8	0.8	0.7	0.9	0.4	1.1	0.1	2.0	0.3	0.0	1.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.8	5.9	0.0	0.0	0.0	51.2	2.4	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.3	0.0	0.0	0.6	0.0	32.2	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.9	0.0	0.0	85.6	6.8	0.4	0.1	0.0	0.0	0.0
CCDC40	"CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640"	ENSG00000141519	"Coiled-coil domain containing 40"	Q4G0X9	17	80036632-80100613	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 24.3;testis: 29.5"	"Cell type enhanced"	"Detected in many"	19	"Ciliated cells: 105.7;Rod photoreceptor cells: 28.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.0;SH-SY5Y: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022974	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA022974: AB_1848791"	"unprognostic (5.89e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.04e-5)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.26e-2)"	3.4	3.6	3.0	3.0	10.4	1.0	3.6	2.5	5.1	3.2	2.4	10.2	2.3	1.3	4.5	10.1	1.5	24.3	3.8	3.8	6.2	4.8	5.5	2.3	5.5	1.5	3.3	3.1	4.5	3.2	3.6	10.2	1.4	19.4	4.4	1.3	4.8	2.5	4.1	2.6	2.2	2.6	2.8	3.5	2.3	3.2	29.5	5.0	0.0	6.0	1.2	1.2	2.0	1.4	0.9	0.5	2.5	0.4	0.7	1.1	0.1	2.4	7.9	7.2	8.0	0.9	1.1	1.9	2.3	1.7	2.0	2.1	0.8	3.4	0.3	1.1	1.6	3.4	0.8	1.8	1.7	0.5	0.1	1.5	0.1	3.9	3.8	1.7	0.2	2.6	1.9	2.5	2.5	0.2	3.5	1.1	1.4	0.9	0.0	1.6	2.7	0.1	0.5	3.3	3.4	2.7	2.0	4.0	0.0	4.1	1.6	14.0	10.2	3.5	1.7	1.6	4.1	3.2	0.2	1.3	4.5	2.7	2.9	0.5	2.3	0.7	0.3	1.0	0.2	2.2	1.7	0.4	0.4	0.5	0.2	1.1	0.5	0.3	0.2	0.0	0.9	0.5	0.4	2.5	0.7	0.2	0.5	0.1	0.1	3.0	10.4	2.5	5.1	6.2	4.8	3.3	3.1	19.4	5.0	11.9	6.9	0.5	1.9	0.6	3.9	3.1	0.0	105.7	14.8	7.0	13.7	0.3	1.7	2.3	9.4	1.1	0.0	0.0	1.3	0.8	1.0	1.9	0.0	1.0	1.2	11.1	2.9	1.8	1.9	5.4	1.1	1.4	0.0	0.0	1.2	6.0	0.9	0.0	3.2	1.6	28.4	0.0	1.0	18.4	5.2	0.3	0.2	0.0	0.4	0.9
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.24e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	9.9	14.9	10.1	7.1	12.7	4.5	9.6	10.4	15.9	8.9	12.8	7.5	12.4	11.6	8.2	11.4	15.9	9.7	8.4	12.3	9.2	8.2	15.2	17.8	7.1	9.0	9.9	15.4	8.7	8.5	9.4	7.4	8.5	10.6	7.7	15.1	9.9	11.0	11.2	16.3	10.9	8.8	11.6	8.8	14.7	7.9	10.7	8.9	10.4	11.3	16.1	12.0	8.8	9.7	19.2	18.2	4.8	10.4	10.6	14.8	9.7	9.7	11.9	7.2	8.4	10.6	11.3	19.7	6.5	6.0	13.1	10.7	18.8	16.4	21.2	9.3	5.1	9.8	14.3	17.6	21.2	8.0	9.9	11.6	18.1	18.9	14.1	16.4	8.8	8.3	8.5	48.2	16.1	17.7	7.1	7.4	12.5	10.0	6.2	12.3	9.3	10.2	11.4	15.7	21.0	19.3	7.1	8.4	16.3	17.7	12.2	5.9	12.5	10.7	11.7	17.4	7.0	12.6	13.7	5.6	7.6	10.3	18.8	12.4	10.0	14.6	11.1	10.1	19.1	7.1	2.0	10.4	4.8	12.0	10.2	12.1	19.2	11.2	14.8	18.2	15.4	11.7	13.4	4.5	10.6	6.1	15.2	13.4	9.7	10.1	12.7	10.4	15.9	9.2	8.2	9.9	15.4	10.6	8.9	11.9	1.6	8.9	3.0	4.1	6.8	7.3	22.9	5.3	5.7	8.7	0.0	35.3	19.9	13.2	2.5	5.3	12.6	0.0	10.8	15.3	10.7	3.7	3.5	11.9	14.1	7.9	5.2	3.1	3.8	2.2	11.2	4.1	13.5	13.6	6.3	10.1	12.4	5.8	12.4	27.0	9.5	6.5	3.1	4.8	17.3	4.1	5.6	4.3	12.4	3.1
CCDC57	"FLJ00130, FLJ23754"	ENSG00000176155	"Coiled-coil domain containing 57"	Q2TAC2	17	82101460-82212830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 565.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.2;naive CD8 T-cell: 10.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.7"	"Low cell line specificity"	"Detected in many"											"HPA023315, HPA023326, HPA023342, HPA023344"	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			Microtubules	"Centriolar satellite, Cytosol"	"HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162"	"unprognostic (2.51e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.55e-5)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.80e-3)"	5.5	9.0	12.9	10.4	14.1	12.1	14.1	20.3	16.6	9.9	8.5	7.6	17.1	11.8	14.2	13.7	4.2	14.9	11.2	4.7	9.3	6.8	13.0	6.8	8.8	7.9	5.4	13.7	14.0	13.7	15.9	22.7	5.8	8.9	14.9	5.2	16.7	13.6	13.8	6.2	8.9	8.9	11.3	3.8	7.7	11.4	23.7	8.8	10.6	19.8	5.2	9.6	7.9	7.2	0.6	1.6	1.9	0.6	0.4	10.7	1.5	4.4	9.1	4.8	6.3	2.9	5.3	5.7	3.5	3.5	2.6	2.2	2.7	7.1	2.4	3.3	2.8	2.6	10.6	1.3	6.3	1.4	2.5	9.5	3.9	15.2	5.8	3.8	3.8	5.0	5.3	5.0	4.9	6.4	5.9	3.1	3.5	5.0	1.3	1.7	6.6	7.2	7.3	1.6	2.6	3.7	4.1	2.0	3.3	4.9	5.6	16.5	10.3	3.1	15.0	5.9	3.1	8.8	4.4	3.2	10.1	9.2	4.3	6.9	9.7	1.0	0.8	7.8	4.3	3.9	0.5	0.6	0.7	0.9	0.2	0.4	0.6	0.8	1.2	0.5	0.6	5.2	10.7	1.9	0.4	0.1	1.6	0.3	1.5	12.9	14.1	20.3	16.6	9.3	6.8	5.4	13.7	8.9	8.8	23.8	60.8	37.4	20.2	10.4	19.7	3.1	17.8	48.2	48.9	27.9	39.3	31.4	8.3	13.7	115.3	5.7	26.4	0.0	15.5	30.4	7.5	25.4	34.6	86.9	26.3	23.8	41.0	8.0	35.8	565.2	7.5	30.7	32.1	26.2	34.7	9.8	13.9	23.2	9.6	7.5	66.2	6.5	10.3	10.8	5.3	15.9	10.4	40.5	26.6	15.3
CCDC58	FLJ33273	ENSG00000160124	"Coiled-coil domain containing 58"	Q4VC31	3	122359591-122383231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047777, HPA051965"	Approved		Approved	Nucleoli,Mitochondria		No	No			Mitochondria	Nucleoli	"HPA047777: AB_2680152, HPA051965: AB_2681676"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.64e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.84e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (7.29e-4)"	9.5	13.3	8.7	6.8	8.1	7.1	9.2	6.9	12.6	8.2	13.3	7.1	12.4	10.6	7.3	12.4	14.0	5.8	7.7	12.4	7.2	7.0	21.9	23.3	5.4	10.0	8.6	5.3	8.8	9.3	3.1	7.7	6.7	8.5	8.2	14.4	6.5	7.2	6.9	35.2	6.9	10.2	6.3	7.2	8.6	9.1	8.7	9.3	5.5	8.8	24.5	9.6	8.7	7.1	13.9	18.3	1.7	10.2	11.4	16.1	4.6	34.9	11.1	21.2	13.5	7.9	11.1	27.3	13.4	14.6	32.6	32.1	31.3	17.7	25.7	23.2	10.2	25.4	24.5	34.4	23.0	39.1	8.8	12.2	30.2	7.9	37.8	13.2	44.9	10.8	9.1	11.9	20.0	21.9	13.9	15.0	22.9	34.2	11.2	17.1	17.4	28.6	32.2	40.7	38.6	21.0	19.0	25.2	31.6	22.4	18.6	21.5	10.5	15.6	16.6	37.3	18.7	16.5	29.6	8.6	18.3	23.4	7.7	26.7	8.9	11.9	55.4	20.8	21.8	16.1	0.4	5.0	1.7	10.2	10.2	12.0	13.9	13.6	13.4	10.3	13.5	16.1	14.9	0.9	11.4	8.5	18.3	10.5	4.6	8.7	8.1	6.9	12.6	7.2	7.0	8.6	5.3	8.5	9.3	3.0	17.1	19.3	16.0	13.6	9.4	23.0	25.5	32.1	20.5	12.2	9.8	19.1	46.4	27.4	0.3	11.3	13.4	0.0	25.7	38.8	10.2	10.9	19.8	46.1	15.7	0.0	5.2	11.6	7.6	0.7	11.8	12.4	8.5	26.2	14.7	6.6	31.7	14.0	7.8	78.7	8.8	12.9	8.0	13.5	23.4	16.2	12.7	7.1	22.4	21.2
CCDC59	"BR22, HSPC128, TAP26"	ENSG00000133773	"Coiled-coil domain containing 59"	Q9P031	12	82223681-82358805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038555	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA038555: AB_10669543"	"unprognostic (1.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-2)"	17.9	10.2	11.3	14.2	16.3	54.9	18.9	14.9	14.7	17.6	16.9	8.9	7.7	7.5	14.8	17.4	17.0	17.2	11.2	14.5	11.5	12.5	16.0	15.4	12.6	13.7	14.8	12.4	18.8	12.5	2.6	18.2	18.7	13.5	18.7	12.5	6.5	12.7	13.3	23.5	12.7	18.9	14.5	16.5	17.3	12.1	18.4	14.9	15.3	19.9	17.9	18.1	21.4	20.9	18.9	18.6	17.9	14.0	13.1	23.6	6.7	11.5	11.0	9.1	6.5	10.1	8.8	14.2	10.5	12.2	18.6	15.2	22.1	6.6	13.6	5.4	10.5	13.1	7.4	41.5	20.1	15.8	14.3	22.1	13.3	6.5	14.6	29.9	17.6	7.7	15.3	17.1	19.6	24.7	15.7	15.2	24.7	25.2	7.0	11.4	20.9	16.2	24.1	14.4	11.0	25.5	12.3	13.6	11.1	9.8	11.6	15.5	7.5	12.1	6.5	15.3	10.6	14.0	23.4	7.1	9.3	7.1	6.5	19.2	11.2	12.5	26.1	6.6	14.1	12.4	12.7	9.3	16.8	11.6	9.6	19.8	15.2	18.6	16.9	9.6	18.9	22.1	17.6	17.9	13.1	14.0	18.6	23.6	6.7	11.3	16.3	14.9	14.7	11.5	12.5	14.8	12.4	13.5	14.9	62.5	48.8	69.0	103.9	76.2	31.5	38.7	38.2	61.6	62.6	41.8	21.6	67.1	109.5	41.0	58.5	55.4	25.5	23.3	49.8	74.4	49.4	61.8	76.2	47.2	50.6	41.3	34.3	57.1	55.3	15.9	49.5	60.8	45.5	44.1	52.3	38.3	47.8	48.0	50.5	57.2	38.9	19.4	54.7	185.8	116.5	78.5	122.8	77.6	53.2	81.7
CCDC61		ENSG00000104983	"Coiled-coil domain containing 61"	Q9Y6R9	19	45995461-46021318	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040325, HPA061548"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040325: AB_10672970, HPA061548: AB_2684559"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.56e-1)"	"unprognostic (6.23e-3)"	"unprognostic (7.27e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.09e-1)"	9.0	10.7	7.8	16.9	8.0	6.3	8.5	10.5	9.3	9.2	12.4	13.1	9.3	9.4	15.2	9.5	9.4	18.3	10.7	7.5	6.0	5.0	10.1	10.6	8.8	11.7	6.6	12.4	12.0	10.2	11.2	12.7	7.3	6.3	11.1	6.0	11.8	10.2	11.3	5.5	15.1	10.2	14.5	6.6	12.6	10.6	22.6	10.1	17.8	13.8	7.0	13.0	11.0	9.4	1.9	0.6	7.8	1.0	0.6	2.0	0.4	8.6	6.3	3.3	5.7	6.3	4.6	5.1	6.2	3.2	3.7	6.3	3.9	7.6	5.4	3.1	4.3	5.2	7.3	3.6	8.3	2.8	10.2	3.4	5.7	5.0	6.2	7.0	5.4	8.0	5.0	11.4	3.2	6.7	6.4	7.5	10.4	6.3	11.2	4.8	2.7	12.4	35.3	1.2	9.2	2.7	8.4	1.1	8.7	6.1	7.2	3.6	3.3	6.1	8.0	4.7	3.4	3.4	7.9	6.3	2.7	1.1	1.3	6.9	6.9	3.3	5.4	6.1	6.1	4.5	7.8	0.9	0.8	2.0	0.8	1.1	1.4	1.0	1.2	0.4	1.9	1.5	1.2	2.8	0.6	1.0	0.6	1.0	0.4	7.8	8.0	10.5	9.3	6.0	5.0	6.6	12.4	6.3	10.1	0.0	4.1	1.4	6.2	5.6	4.4	4.2	2.5	1.4	4.5	10.4	0.0	10.1	8.3	1.3	2.6	4.0	8.5	0.0	1.6	7.0	4.3	3.7	0.0	4.0	6.8	3.2	3.5	3.7	4.4	0.9	4.9	2.1	3.3	0.0	8.4	4.8	1.6	5.8	5.3	6.7	1.5	6.5	4.7	13.4	6.1	4.5	6.5	4.4	8.0	3.1
CCDC62	"CT109, ERAP75, FLJ40344, TSP-NY"	ENSG00000130783	"Coiled-coil domain containing 62"	Q6P9F0	12	122774327-122827528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 44.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 148.4;Late spermatids: 50.4;Spermatocytes: 78.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 7.7"					"Low region specificity"	"Detected in all"			"HPA039021, HPA058741"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039021: AB_10673604, HPA058741: AB_2683805"	"unprognostic (3.39e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-4)"	"unprognostic (5.23e-1)"	"unprognostic (6.39e-6)"	"unprognostic (2.78e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.25e-4)"	0.2	0.2	0.3	0.1	0.3	0.1	0.1	0.3	0.7	0.2	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.7	0.2	0.1	0.3	0.1	0.6	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.3	0.2	0.1	0.1	0.2	0.3	0.0	44.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	1.1	2.4	0.6	0.8	1.9	0.4	0.4	0.5	0.3	1.0	0.1	0.7	0.9	0.2	0.3	0.8	0.3	0.3	0.7	1.6	0.2	0.0	0.4	0.3	0.5	0.2	0.4	0.7	0.7	2.6	0.3	0.2	0.0	1.7	2.1	0.3	1.0	1.1	0.4	0.2	0.1	1.8	0.9	0.8	1.1	0.3	0.2	3.4	0.4	0.1	1.9	2.0	0.8	0.3	0.6	0.3	1.5	0.0	0.3	0.9	1.2	0.6	0.1	1.7	0.4	0.9	7.7	0.4	0.4	1.0	0.7	0.7	0.0	0.7	0.5	1.5	0.6	0.4	0.5	0.3	0.9	0.3	0.3	0.4	0.2	1.0	0.8	0.7	2.4	0.8	0.3	1.1	1.9	0.4	0.3	0.3	0.3	0.7	0.7	0.2	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.5	1.2	0.8	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	148.4	0.2	0.0	0.0	0.2	0.4	0.3	0.5	0.0	0.0	0.1	1.6	0.0	0.0	0.3	50.4	2.8	0.0	1.7	0.0	0.0	0.8	0.1	0.0	2.5	0.0	1.1	12.9	0.0	78.8	3.0	0.6	0.0	0.0	0.1	0.1
CCDC63	"FLJ35843, ODA5"	ENSG00000173093	"Coiled-coil domain containing 63"	Q8NA47	12	110846769-110907535	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 26.2"	"Group enriched"	"Detected in some"	54	"Early spermatids: 233.1;Late spermatids: 164.1"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"MCF7: 9.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 10.3"	"Not detected"	"Not detected"			HPA061568			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	NA			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA061568: AB_2684561"					"unprognostic (1.98e-2)"	"unprognostic (1.05e-1)"		"unprognostic (1.17e-1)"	"unprognostic (2.65e-1)"					"unprognostic (5.59e-2)"	"unprognostic (1.09e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	164.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.7	3.4	0.0	0.1	0.0	0.0	0.0
CCDC65	"CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28"	ENSG00000139537	"Coiled-coil domain containing 65"	Q8IXS2	12	48904110-48931840	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.5;testis: 53.2"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 180.7;Early spermatids: 85.1;Spermatocytes: 50.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 13.7"	"Group enriched"	"Detected in many"	11	"gdT-cell: 8.9;MAIT T-cell: 9.5;memory CD4 T-cell: 7.6;memory CD8 T-cell: 7.1;naive CD4 T-cell: 4.7;naive CD8 T-cell: 6.3;T-reg: 4.1"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038520, HPA057573"	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			Vesicles	"Centriolar satellite"	"HPA038520: AB_10672714, HPA057573: AB_2683473"	"unprognostic (3.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.23e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.03e-4)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.16e-2)"	0.3	0.4	2.2	0.6	5.1	1.1	0.5	0.6	2.2	1.6	0.3	4.5	0.5	0.4	1.3	5.1	0.3	22.5	1.1	0.3	2.9	3.2	2.0	0.2	5.0	0.8	0.6	2.0	2.7	0.7	1.1	3.9	0.2	13.7	0.3	0.1	2.1	0.4	0.5	0.3	1.3	0.5	0.2	0.7	1.0	0.3	53.2	1.0	0.0	2.2	0.0	0.3	0.3	0.2	0.3	0.0	0.1	0.0	0.6	9.5	2.2	1.2	4.8	2.2	4.2	0.1	0.0	2.2	1.1	0.1	0.6	2.1	5.8	2.9	1.6	1.7	0.0	0.7	1.4	0.0	0.1	0.9	2.7	2.3	2.6	7.3	2.1	0.3	2.1	2.4	0.0	0.1	1.2	0.0	3.5	0.0	1.4	1.1	0.6	0.1	2.8	0.7	2.8	4.7	1.7	1.2	1.5	1.0	1.8	3.5	3.1	1.2	2.0	1.3	1.7	1.6	3.5	4.5	1.8	2.0	1.6	1.7	1.8	0.9	2.2	2.2	1.5	1.7	1.8	0.4	0.0	0.0	0.0	8.9	0.0	9.5	0.3	7.6	7.1	0.0	0.3	4.7	6.3	0.1	0.6	0.0	0.0	4.1	2.2	2.2	5.1	0.6	2.2	2.9	3.2	0.6	2.0	13.7	1.0	0.0	0.6	0.0	0.1	0.8	1.2	0.4	0.0	180.7	17.0	0.0	11.8	0.1	6.6	0.6	85.1	0.1	0.0	0.0	0.5	0.1	0.3	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	10.8	1.4	0.0	1.7	0.0	0.0	1.9	0.4	0.0	2.1	2.4	10.7	0.0	0.4	50.9	4.7	0.1	0.1	7.5	0.0	0.1
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621818	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	8.4	7.5	9.3	7.6	11.7	6.5	12.0	31.0	15.1	11.7	11.0	9.6	7.6	5.9	12.7	12.7	6.7	12.9	7.6	8.4	9.8	6.4	9.2	4.6	7.7	10.1	10.8	10.6	14.7	7.1	10.1	32.9	7.6	11.0	9.7	9.4	7.8	9.1	10.9	11.9	5.7	7.7	11.1	11.2	8.7	8.0	8.6	12.9	11.9	12.1	5.7	10.2	11.0	9.7	2.6	1.1	7.0	2.2	5.0	14.1	2.7	5.5	1.9	6.2	3.7	9.3	5.6	4.9	7.1	6.5	9.4	8.3	4.3	4.4	15.5	1.6	3.8	6.1	3.1	3.4	6.5	10.5	5.5	4.2	9.7	8.6	4.9	6.6	12.4	3.6	5.4	9.4	7.8	5.5	8.3	5.9	7.9	9.0	2.4	7.2	4.5	9.9	7.9	10.1	4.7	7.7	3.3	5.3	8.3	5.6	1.9	2.3	4.3	8.6	5.5	5.3	5.5	1.9	5.4	3.2	7.0	5.5	6.5	9.6	5.0	5.3	8.3	5.2	14.2	5.5	7.0	1.5	3.3	4.3	1.9	5.6	2.6	7.4	5.3	1.1	1.7	8.6	6.2	0.3	5.0	2.2	1.0	14.1	2.7	9.3	11.7	31.0	15.1	9.8	6.4	10.8	10.6	11.0	12.9	20.8	19.9	24.5	21.3	25.0	66.8	26.9	25.5	57.6	35.2	21.0	102.1	17.7	24.9	17.3	158.6	28.7	8.0	23.3	9.1	11.3	30.0	13.3	33.5	7.5	16.2	49.3	20.2	27.0	26.2	74.4	50.0	20.8	25.3	43.3	9.4	34.0	13.6	10.2	44.9	16.5	99.9	32.3	30.2	49.7	45.4	25.7	13.7	47.3	13.6	9.5
CCDC68	SE57-1	ENSG00000166510	"Coiled-coil domain containing 68"	Q9H2F9	18	54901509-54959508	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.1"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 73.4;Enterocytes: 61.4;Pancreatic endocrine cells: 55.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 8.1;HHSteC: 10.8;HSkMC: 11.9;RT4: 8.0;TIME: 21.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040865, HPA048197"	Supported		Approved	"Golgi apparatus,Cytosol"		No	NA			"Golgi apparatus"	Cytosol	"HPA040865: AB_2677176, HPA048197: AB_2680310"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.38e-1)"	5.6	3.0	1.2	7.7	2.4	0.3	5.8	0.6	4.7	5.5	20.7	0.8	3.1	14.8	4.5	2.5	2.1	2.6	9.1	5.7	1.7	1.7	5.6	9.9	15.2	2.3	2.0	4.7	15.4	2.8	0.5	15.7	23.9	4.4	5.2	13.9	9.3	2.2	13.0	7.7	1.0	40.1	2.1	1.6	5.8	10.5	7.4	0.1	0.0	3.5	2.1	1.0	3.0	4.2	0.8	0.6	1.1	2.2	0.5	1.0	0.5	8.1	2.5	0.0	0.0	2.4	6.7	0.0	0.2	3.2	0.5	0.5	4.4	4.8	0.0	6.0	0.0	0.0	0.1	0.6	5.2	0.4	0.0	1.2	0.6	2.9	0.9	10.8	0.0	0.0	11.9	0.0	2.5	0.1	0.0	3.8	0.0	0.0	0.1	0.3	0.6	0.0	0.1	0.0	5.8	2.8	0.2	0.0	0.2	0.9	8.0	0.0	1.9	2.5	0.8	0.1	1.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	0.7	0.7	0.4	0.8	0.6	0.6	0.6	0.5	0.4	0.8	0.9	1.0	0.7	0.5	2.2	0.6	0.5	0.5	1.2	2.4	0.6	4.7	1.7	1.7	2.0	4.7	4.4	0.1	17.9	9.3	0.5	9.7	0.2	0.0	3.2	5.1	4.0	14.8	1.8	0.0	1.7	1.7	4.7	73.4	26.3	61.4	0.0	31.6	2.2	5.8	20.5	8.1	5.7	0.3	0.0	5.8	29.4	2.7	24.0	3.1	0.2	0.0	1.8	16.2	3.4	55.0	38.6	0.7	4.3	0.0	6.5	0.7	1.2	1.5	0.0	5.0	0.0	17.1	3.6
CCDC69	"DKFZP434C171, FLJ13705"	ENSG00000198624	"Coiled-coil domain containing 69"	A6NI79	5	151181052-151224145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 99.8"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 65.4;Cardiomyocytes: 112.2;Ciliated cells: 64.3;Kupffer cells: 76.6;T-cells: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.9;Daudi: 53.9;U-266/70: 34.5;U-698: 34.8"					"Low region specificity"	"Detected in many"			"HPA043648, HPA052896"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Golgi apparatus, Actin filaments"	"HPA043648: AB_10795877, HPA052896: AB_2681983"	"prognostic favorable (3.21e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	31.6	33.7	2.1	33.4	3.2	10.9	99.8	1.7	4.7	7.3	43.4	2.5	6.6	5.7	12.2	7.3	28.1	12.7	14.0	57.6	2.2	2.5	3.8	12.6	23.7	23.2	4.3	0.9	11.4	15.3	5.3	6.1	21.4	8.4	17.2	5.8	9.0	5.5	8.7	87.1	4.5	14.9	53.0	5.1	21.7	15.6	6.7	2.2	13.3	5.1	18.8	17.7	37.2	58.4	11.4	20.4	18.0	10.7	11.9	11.7	8.3	2.1	0.2	0.1	1.8	34.9	3.7	1.2	0.4	3.4	0.6	0.5	0.4	0.2	53.9	1.9	0.1	0.9	0.1	0.8	0.6	0.2	0.0	0.7	6.8	0.0	3.3	5.7	2.5	9.9	8.9	0.0	0.2	0.0	0.6	3.4	0.2	6.5	12.1	0.0	0.0	11.5	6.3	2.0	0.0	4.4	9.8	0.2	3.3	0.1	1.5	0.0	0.2	0.6	0.9	0.4	0.9	0.5	6.3	8.4	0.2	1.7	0.1	0.4	34.5	16.1	34.8	0.4	6.1	0.0	18.0	10.7	12.3	11.7	8.6	10.2	5.9	9.1	11.0	9.3	11.4	7.3	6.7	9.2	11.9	8.2	20.4	6.6	8.3	2.1	3.2	1.7	4.7	2.2	2.5	4.3	0.9	8.4	2.2	11.9	65.4	52.4	2.4	2.3	0.6	112.2	2.5	64.3	13.6	1.8	0.0	6.2	0.0	2.4	0.4	52.5	0.0	0.0	17.5	5.9	5.8	3.7	33.5	30.4	6.9	6.4	1.7	19.0	76.6	1.3	5.2	14.3	10.1	13.6	0.0	2.5	9.5	0.0	7.4	2.4	1.2	12.9	12.8	0.2	0.5	1.1	29.6	67.1	0.2	18.4
CCDC7	"BIOT2, C10orf68, FLJ13031, FLJ32762"	ENSG00000216937	"Coiled-coil domain containing 7"	Q96M83	10	32446140-32882874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 65.5"	"Group enriched"	"Detected in many"	8	"Early spermatids: 397.3;Late spermatids: 669.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA075536			Approved	"Nucleoli,Mitotic spindle,Cytosol"		Yes	No			Nucleoli	"Mitotic spindle, Cytosol"	"HPA075536: AB_2686755"	"unprognostic (3.43e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.65e-5)"	"unprognostic (6.95e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.95e-5)"	"unprognostic (7.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	2.1	2.1	3.2	3.8	3.6	2.8	2.2	4.8	3.6	2.3	2.1	4.2	4.3	2.0	3.4	5.1	2.0	1.7	1.9	2.3	2.6	1.9	1.9	1.7	2.0	2.8	4.2	1.5	2.7	2.3	2.1	8.5	1.8	3.0	2.1	2.3	1.8	2.0	3.2	2.0	2.0	1.8	2.1	5.4	2.0	2.0	65.5	3.2	3.4	2.7	0.3	2.2	2.3	2.3	2.4	1.7	0.1	0.6	2.9	5.9	0.5	2.6	2.9	0.8	3.6	2.5	1.9	1.3	2.3	0.9	0.8	2.5	0.6	3.8	1.9	1.2	1.6	2.3	1.3	1.4	1.4	3.2	6.8	0.3	1.1	2.0	0.7	4.3	1.1	1.9	1.8	0.7	1.7	0.7	1.6	1.0	3.0	1.5	6.7	3.3	0.4	0.8	0.6	0.7	1.4	2.8	1.6	3.7	0.3	2.4	0.6	1.9	1.9	0.4	0.5	1.6	1.1	1.9	1.5	3.9	2.0	2.4	2.6	1.3	2.1	1.4	2.0	2.6	7.5	1.1	0.0	0.6	0.1	3.4	0.3	3.3	2.4	5.3	2.9	0.3	1.2	5.9	3.9	0.1	2.9	0.3	1.7	3.5	0.5	3.2	3.6	4.8	3.6	2.6	1.9	4.2	1.5	3.0	3.2	6.0	7.5	0.8	1.0	1.6	8.6	6.7	0.0	1.4	4.5	1.8	3.9	0.6	1.7	3.1	397.3	2.3	1.4	0.0	3.0	1.0	1.2	0.8	11.6	0.0	1.6	0.0	2.9	0.0	0.0	669.2	8.9	2.3	1.7	1.0	2.0	2.7	2.3	0.0	6.7	0.6	25.0	12.9	1.0	70.9	6.1	1.0	0.1	1.5	1.7	0.6
CCDC71	FLJ12800	ENSG00000177352	"Coiled-coil domain containing 71"	Q8IV32	3	49162535-49166321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047547	Uncertain		Approved	"Nuclear membrane"		No	No			"Nuclear membrane"		"HPA047547: AB_2680083"	"unprognostic (1.06e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.71e-3)"	"unprognostic (7.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (9.65e-9)"	"unprognostic (3.53e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.14e-2)"	15.5	20.2	7.9	11.2	14.4	7.9	18.0	10.8	19.2	17.6	12.3	15.7	14.7	10.1	19.9	17.3	17.4	21.3	17.5	14.8	8.9	8.5	16.2	20.3	13.7	15.2	9.6	9.9	24.1	12.3	12.2	13.1	18.7	10.6	15.3	9.6	16.3	15.8	15.7	17.2	15.8	16.3	12.8	7.3	20.4	13.2	18.1	8.8	33.2	21.5	12.1	19.4	18.3	14.9	3.2	1.9	1.9	3.5	7.8	3.2	1.3	7.9	11.0	12.9	12.3	14.8	10.9	12.4	9.9	14.4	17.4	15.4	11.3	13.0	7.1	8.7	16.9	14.0	8.5	12.7	26.5	6.2	15.8	9.2	14.5	14.3	11.3	17.6	11.6	11.0	18.3	20.9	20.6	15.9	13.0	17.0	17.5	14.5	3.1	13.8	17.1	19.9	7.1	19.9	12.0	11.9	7.3	7.1	6.6	16.4	15.5	6.6	14.2	10.1	10.8	11.8	10.9	14.3	19.4	11.1	12.3	13.1	12.1	12.8	11.7	5.0	9.8	8.9	11.0	13.6	0.0	2.0	0.8	2.0	3.5	3.2	1.2	1.7	2.5	1.9	3.2	2.7	1.7	1.9	7.8	2.6	0.7	1.9	1.3	7.9	14.4	10.8	19.2	8.9	8.5	9.6	9.9	10.6	8.8	6.0	1.0	4.4	10.6	2.4	1.2	1.1	7.6	2.7	0.0	7.0	0.0	19.5	21.6	16.8	6.7	6.3	6.3	0.0	10.3	15.3	6.0	8.9	2.3	8.7	17.4	0.0	8.1	19.0	3.7	8.2	10.9	5.6	5.0	9.0	8.3	4.5	13.7	8.6	12.7	11.9	1.3	12.9	5.2	9.1	15.6	2.4	18.8	2.9	9.7	9.9
CCDC71L	"C7orf74, FLJ36031"	ENSG00000253276	"Coiled-coil domain containing 71 like"	Q8N9Z2	7	106656765-106660996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 42.9"	"Cell type enhanced"	"Detected in many"	5	"Smooth muscle cells: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067925	Approved		Approved	"Golgi apparatus,Actin filaments,Cytosol"		NA	NA			"Golgi apparatus, Actin filaments"	Cytosol	"HPA067925: AB_2685925"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.35e-2)"	19.5	5.2	2.4	13.2	2.2	8.8	10.6	0.6	3.8	7.8	8.4	2.5	5.8	4.3	10.3	6.5	6.3	19.7	9.2	6.3	3.5	2.3	9.0	42.9	11.2	10.8	1.8	2.7	13.4	6.3	3.2	3.7	4.0	2.3	9.3	4.0	8.1	16.5	4.9	6.7	3.2	8.3	7.0	2.4	17.0	9.0	12.7	2.2	35.3	9.1	2.9	6.8	12.5	10.8	2.3	2.4	7.3	1.2	1.6	2.9	0.8	10.4	2.2	3.2	3.8	7.3	7.0	0.0	16.2	20.7	6.3	6.8	0.3	6.6	7.1	5.6	27.1	12.0	1.1	1.5	4.6	5.2	16.5	3.8	0.8	0.4	0.0	11.5	3.5	8.5	5.9	2.8	2.8	1.6	13.2	21.7	4.0	23.5	17.4	7.4	3.0	4.7	5.5	7.0	0.8	7.7	6.5	0.9	1.4	3.2	0.6	1.4	9.7	10.3	3.7	22.4	7.1	1.7	4.3	9.6	14.0	1.3	1.6	6.2	17.0	1.5	5.7	10.8	4.6	15.3	7.2	1.0	3.0	2.0	0.8	1.5	2.3	1.6	1.5	0.7	1.7	0.8	1.2	7.3	1.6	1.2	2.4	2.9	0.8	2.4	2.2	0.6	3.8	3.5	2.3	1.8	2.7	2.3	2.2	3.0	12.3	4.9	31.2	7.2	4.0	5.3	5.1	8.1	0.0	5.2	2.0	2.4	10.0	6.8	0.9	15.0	9.7	0.0	9.3	5.7	23.0	9.8	11.5	26.7	7.5	6.4	6.3	32.5	11.1	1.6	20.1	12.8	11.8	6.4	6.2	4.5	10.3	11.5	16.6	3.9	4.8	0.0	44.3	5.6	3.6	4.4	2.7	7.9	9.0	13.3
CCDC77	MGC13183	ENSG00000120647	"Coiled-coil domain containing 77"	Q9BR77	12	389273-442645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038854	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA038854: AB_10673121"	"unprognostic (3.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.26e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (8.11e-7)"	"unprognostic (2.54e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.82e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.41e-3)"	7.5	9.8	9.7	9.9	19.2	7.1	7.8	13.8	12.3	6.3	7.0	13.2	3.2	7.9	8.7	5.4	7.8	6.7	5.4	5.1	8.6	6.2	6.6	5.9	6.7	10.6	11.2	8.6	9.3	5.6	5.3	9.4	6.1	10.4	6.4	8.3	6.1	5.6	4.8	8.2	8.8	6.2	6.0	12.0	8.9	5.5	20.2	12.5	16.2	7.0	4.5	10.1	6.1	6.5	11.4	8.0	5.9	10.8	8.6	8.3	4.4	4.8	6.5	14.4	9.5	4.8	4.3	14.9	12.6	5.8	11.8	19.1	6.6	8.6	11.5	3.0	4.8	6.8	6.8	10.2	3.6	12.7	25.2	10.1	13.1	12.6	8.6	2.8	10.7	6.6	3.3	2.2	11.0	6.9	7.2	7.8	11.3	10.7	12.2	12.0	2.8	10.3	7.5	28.6	6.7	4.8	11.9	26.2	7.2	4.4	3.6	4.1	10.7	12.3	4.7	6.2	22.5	3.8	8.0	7.4	5.9	11.6	10.3	14.2	3.4	6.6	14.6	8.1	10.7	10.2	3.8	7.0	5.9	7.7	10.1	8.0	9.2	7.1	8.3	7.4	11.4	5.1	7.4	5.6	8.6	10.8	8.0	5.0	4.4	9.7	19.2	13.8	12.3	8.6	6.2	11.2	8.6	10.4	12.5	0.0	3.8	6.9	3.3	3.7	2.7	3.4	2.5	5.3	5.7	3.5	5.9	5.1	6.6	2.5	19.3	2.9	2.1	0.0	1.7	6.4	3.5	2.1	6.9	1.8	4.8	1.6	2.4	3.7	7.0	12.0	3.7	5.0	1.7	2.8	3.7	5.6	1.7	5.8	4.2	2.6	5.2	6.5	3.1	17.1	16.0	3.3	4.7	5.3	3.1	1.6
CCDC8	"3M3, DKFZp564K0322, PPP1R20"	ENSG00000169515	"Coiled-coil domain containing 8"	Q9H0W5	19	46410372-46413584	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.4"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 25.5;Distal tubular cells: 33.2;Leydig cells: 65.6;Peritubular cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"AF22: 12.0;AN3-CA: 14.3;HSkMC: 13.1;K-562: 12.5;RH-30: 16.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041993	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041993: AB_10795388"	"unprognostic (3.05e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (5.43e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.18e-3)"	2.7	13.3	3.0	2.1	3.8	0.6	7.6	0.9	2.3	18.9	2.4	5.1	6.2	0.8	15.5	17.3	2.9	19.0	9.7	18.9	3.1	2.3	7.9	0.7	7.1	0.9	2.4	2.9	39.4	19.2	8.5	9.9	5.6	4.6	12.1	1.1	10.0	8.7	7.5	3.0	2.2	1.6	6.7	2.0	1.8	1.7	9.0	2.6	4.2	11.8	2.6	1.4	4.8	5.8	0.4	0.3	3.6	0.4	0.2	0.2	0.1	1.2	0.1	12.0	14.3	3.2	4.0	5.8	6.1	0.0	1.4	0.6	0.0	0.1	0.1	8.2	4.8	0.2	0.1	0.1	9.5	0.6	0.0	6.0	0.0	0.1	0.6	10.7	0.0	0.1	13.1	0.0	3.4	10.0	0.2	0.0	0.1	12.5	0.0	4.4	0.0	0.0	0.8	8.7	0.0	0.0	0.4	16.2	0.0	10.5	0.0	1.9	0.1	0.0	0.0	0.0	9.7	0.1	2.9	1.1	0.8	3.2	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.2	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.2	3.6	0.2	0.3	0.3	0.1	0.1	3.0	3.8	0.9	2.3	3.1	2.3	2.4	2.9	4.6	2.6	0.0	0.6	0.0	5.7	0.8	0.0	25.5	10.2	2.7	6.8	10.4	0.0	5.8	33.2	11.1	0.3	0.4	0.0	0.0	0.9	7.8	9.9	0.5	1.1	0.0	1.5	0.0	0.0	1.3	0.0	1.3	65.6	0.9	1.7	0.0	0.0	13.3	5.9	0.0	54.5	0.8	0.4	12.9	7.2	0.3	4.5	0.1	1.7	0.0	0.0	0.5
CCDC82	FLJ23518	ENSG00000149231	"Coiled-coil domain containing 82"	Q8N4S0	11	96352769-96389956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 343.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038704, HPA070631"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA038704: AB_10674835, HPA070631: "	"unprognostic (3.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.94e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	19.4	12.5	22.8	14.6	32.7	12.1	15.3	34.5	29.6	13.6	12.7	18.3	6.7	9.8	18.4	12.2	9.0	14.9	13.9	10.4	23.7	9.0	13.7	17.8	15.7	17.4	31.9	20.3	16.5	13.5	11.7	22.3	14.3	25.6	12.2	11.6	8.1	11.9	13.7	10.8	10.5	15.5	14.1	26.0	16.5	13.6	19.4	35.5	7.5	15.9	6.2	15.8	15.4	16.9	14.3	12.2	28.6	10.8	22.7	19.2	11.0	5.4	8.2	25.4	9.8	16.9	14.5	9.4	21.2	13.1	13.9	20.4	13.5	19.1	11.3	20.0	11.0	23.0	12.8	9.0	7.7	20.7	19.3	5.5	23.1	17.6	11.5	12.1	18.1	15.4	8.8	4.1	28.1	10.6	13.1	16.6	11.6	13.8	12.3	18.7	0.2	15.3	17.6	5.0	9.6	5.9	10.5	21.6	10.1	10.6	14.2	4.0	10.8	11.7	1.2	10.4	17.8	1.9	9.0	19.2	24.8	13.6	20.6	11.2	4.2	12.6	16.5	7.4	14.3	17.5	28.6	8.3	15.5	16.5	10.2	17.2	14.3	17.6	16.1	8.9	12.1	19.2	18.2	11.6	22.7	10.8	12.2	18.4	11.0	22.8	32.7	34.5	29.6	23.7	9.0	31.9	20.3	25.6	35.5	17.9	35.6	25.2	24.5	27.1	51.9	30.7	12.7	84.3	29.6	29.6	94.2	15.2	23.2	29.3	343.9	53.7	8.0	0.0	15.0	15.4	39.1	12.2	38.3	31.4	21.5	30.2	19.0	33.2	26.0	42.3	40.6	33.9	25.3	42.3	7.7	32.4	24.5	11.5	40.3	27.0	45.9	32.3	28.9	80.2	51.2	17.9	6.9	39.2	8.6	18.0
CCDC84	DLNB14	ENSG00000186166	"Coiled-coil domain containing 84"	Q86UT8	11	118998142-119015791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039906, HPA071715"	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA039906: AB_2676740, HPA071715: AB_2686436"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (8.14e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	9.3	10.7	10.5	11.0	15.3	15.2	12.5	18.9	17.5	9.8	10.6	19.4	12.1	10.7	16.2	16.6	9.3	8.7	10.4	9.4	11.4	9.0	12.6	15.0	13.2	13.6	15.8	11.7	10.0	10.1	14.1	14.1	9.9	16.7	13.7	9.8	18.7	13.0	16.6	16.7	19.1	11.7	12.8	8.7	18.8	10.8	6.8	12.3	7.6	14.0	9.4	15.1	8.5	10.1	5.8	3.8	4.0	2.1	5.5	8.8	2.5	3.6	3.2	2.7	3.7	2.8	0.9	2.8	3.2	3.4	2.8	1.8	18.2	2.2	1.3	10.7	3.6	4.3	9.6	1.3	1.7	2.9	5.0	2.0	6.1	5.4	5.0	2.6	2.6	3.4	1.1	1.9	2.9	3.3	2.9	1.6	4.1	1.3	4.8	2.7	5.7	6.5	4.6	3.5	5.4	8.3	9.0	5.5	6.2	4.4	5.2	3.8	2.5	8.3	2.5	0.6	4.4	7.5	2.3	1.7	2.8	13.5	3.8	2.1	3.7	3.6	5.6	2.2	4.9	5.2	0.0	2.1	4.0	4.4	1.2	5.2	5.0	5.4	4.7	3.3	5.8	5.0	3.6	3.6	5.5	1.2	3.8	8.8	2.5	10.5	15.3	18.9	17.5	11.4	9.0	15.8	11.7	16.7	12.3	41.7	40.5	7.8	13.8	14.0	43.0	7.3	12.7	12.0	35.2	12.2	45.2	13.1	5.0	7.4	1.3	11.9	7.1	0.0	13.1	3.1	11.3	9.3	25.5	6.4	8.0	17.5	6.3	8.6	7.9	1.4	8.9	11.2	6.8	17.2	6.1	17.1	13.1	8.6	8.9	3.1	69.8	12.9	11.7	9.6	11.7	9.7	6.1	14.9	6.0	7.1
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340223-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.1;HMC-1: 40.7;Karpas-707: 10.6;THP-1: 16.2;U-937: 11.7"	"Not detected"	"Not detected"							HPA026652	Approved		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			Centrosome	"Nucleoplasm, Cytosol"	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	3.5	2.5	5.2	29.5	5.4	32.5	2.7	23.7	2.8	2.6	6.1	4.5	6.9	3.2	2.0	1.3	4.2	2.5	8.5	2.3	4.1	2.6	2.0	1.6	11.4	18.6	8.6	2.2	1.3	2.1	0.7	1.6	1.4	6.5	2.9	2.9	1.7	7.5	8.9	0.8	1.9	11.1	1.3	7.2	26.6	3.3	7.3	6.5	16.8	1.9	2.7	20.8	4.1	2.8	3.0	3.5	11.3	6.5	7.1	4.6	1.6	0.1	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	1.6	9.3	1.4	0.5	0.2	0.8	0.0	0.2	0.0	10.1	0.0	7.0	1.8	0.5	0.4	4.3	40.7	0.0	0.0	0.1	0.0	0.6	0.2	3.0	0.2	10.6	0.3	0.4	5.8	3.6	0.3	1.7	0.2	5.5	0.1	8.6	0.1	0.1	2.3	0.0	0.0	0.2	0.5	0.0	1.2	16.2	0.0	0.0	0.3	0.0	0.1	2.3	0.7	7.5	0.5	11.7	0.2	3.6	6.5	7.6	4.6	4.7	1.4	2.2	2.7	3.8	2.1	3.0	2.6	3.2	11.3	7.1	3.1	3.5	0.8	1.6	5.2	5.4	23.7	2.8	4.1	2.6	8.6	2.2	6.5	6.5	0.0	12.5	29.6	3.8	2.4	39.7	11.9	0.0	8.1	3.4	8.7	0.0	2.6	0.0	11.0	9.4	4.3	33.2	0.0	24.8	4.1	2.6	3.4	25.5	7.2	12.7	0.0	17.3	8.0	22.4	10.9	1.4	23.3	5.0	22.6	20.8	11.7	25.7	31.7	0.7	2.3	4.4	0.0	2.3	12.5	1.5	1.4	1.1	31.6	17.9	14.8
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 127.2;T-cells: 71.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 18.7"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 19.6;SCLC-21H: 23.8;U-266/70: 20.9;U-266/84: 29.4"	"Low region specificity"	"Detected in all"							HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	3.6	0.9	2.7	31.1	18.7	15.0	6.9	0.9	2.3	3.0	8.9	1.8	15.5	9.6	4.7	4.0	8.9	9.7	11.8	2.2	2.0	2.4	5.0	2.6	11.1	34.5	2.0	0.3	2.0	14.8	6.7	4.0	1.8	1.6	6.4	4.7	4.1	12.1	11.7	1.5	4.5	9.6	6.0	2.9	14.5	8.1	4.8	3.7	18.5	2.5	6.0	27.6	7.1	5.3	2.3	1.8	5.2	3.2	3.1	11.0	2.8	3.1	2.9	3.3	3.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	3.0	4.7	13.5	2.5	0.0	0.1	0.1	4.8	2.7	0.0	11.3	1.8	3.5	1.9	4.2	0.3	7.0	3.0	0.0	4.0	0.0	0.0	0.2	3.7	19.6	4.1	16.9	0.0	10.2	7.0	9.3	3.3	2.4	4.4	5.8	0.1	4.5	0.8	4.5	23.8	5.3	2.0	6.9	1.6	2.5	3.7	6.5	1.1	0.0	0.0	0.0	0.0	20.9	29.4	6.9	0.0	6.3	0.0	5.2	3.2	1.3	9.0	1.8	8.7	2.3	6.1	9.3	1.8	1.9	3.9	5.8	2.6	3.1	2.5	1.5	11.0	2.8	2.7	18.7	0.9	2.3	2.0	2.4	2.0	0.3	1.6	3.7	3.0	27.4	43.1	14.2	8.2	0.0	18.3	10.2	127.2	21.6	14.0	0.0	2.8	0.0	4.0	6.8	12.6	18.6	0.0	5.1	1.7	4.1	16.5	2.3	1.0	5.4	0.0	23.0	16.5	20.3	14.0	3.7	5.0	1.7	1.0	13.4	7.0	6.2	20.1	2.8	11.5	0.0	0.0	4.4	4.1	22.2	8.3	1.5	71.0	16.1	16.3
CCDC89	FLJ38159	ENSG00000179071	"Coiled-coil domain containing 89"	Q8N998	11	85684866-85686277	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 40.6"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 332.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.4;GAMG: 5.2;LHCN-M2: 6.2;SCLC-21H: 7.3;U-2197: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040628	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040628: AB_2677053"	"unprognostic (5.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-3)"	"unprognostic (7.75e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.52e-1)"	0.7	0.9	0.9	0.1	1.8	0.0	1.3	6.4	1.3	1.5	0.6	2.0	0.9	0.1	2.8	0.9	0.3	10.5	1.1	1.0	1.2	1.2	1.4	0.3	1.2	0.6	0.9	1.2	5.9	0.2	2.7	5.2	0.7	3.7	1.7	0.7	0.9	0.4	1.9	0.7	0.5	0.5	2.6	1.2	0.4	1.1	40.6	0.9	0.1	0.4	0.2	0.0	0.7	0.7	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.1	3.8	5.0	0.2	1.4	0.0	0.0	0.1	0.2	0.0	0.1	5.4	4.2	5.2	1.9	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.3	2.6	0.0	0.0	2.8	0.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.3	0.0	0.0	0.0	0.6	0.0	0.0	4.3	0.0	0.3	2.8	7.3	1.8	0.0	0.9	0.0	0.1	0.6	0.0	0.0	3.7	0.0	8.3	3.4	0.0	3.7	0.0	3.2	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	6.4	1.3	1.2	1.2	0.9	1.2	3.7	0.9	0.0	1.1	0.0	0.0	0.2	0.1	0.0	0.0	29.4	1.2	0.0	0.0	0.0	0.0	0.0	332.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.3	6.4	0.0	0.6	1.2	13.3	2.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.2	1.2	0.5	0.0	0.1	3.4	0.9	0.3	0.0	0.0	0.0	0.1
CCDC9	DKFZP586M1019	ENSG00000105321	"Coiled-coil domain containing 9"	Q9Y3X0	19	47255980-47273701	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 47.5;Late spermatids: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045624, HPA072007"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA045624: AB_10961402, HPA072007: AB_2686482"	"unprognostic (4.53e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.22e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (4.02e-1)"	17.4	16.9	10.1	18.4	13.5	38.3	16.0	14.9	15.0	18.0	16.1	13.0	20.6	14.8	31.2	19.6	15.0	16.2	17.4	15.6	10.6	7.1	14.3	16.0	18.0	14.3	14.7	10.4	23.4	35.1	16.2	14.9	21.8	13.2	19.3	9.8	17.9	14.7	19.8	23.2	23.5	14.0	28.2	9.3	16.8	17.3	23.3	15.6	11.1	19.0	13.1	13.3	21.8	23.2	2.3	2.9	7.8	2.7	2.0	3.6	0.8	11.6	11.9	9.4	10.4	3.0	8.2	10.7	16.3	7.2	10.0	11.0	12.6	9.2	5.3	4.4	10.7	8.3	11.0	8.6	6.9	5.5	14.1	5.3	13.7	10.9	9.5	9.6	5.5	14.3	8.7	10.3	9.5	8.9	8.5	6.6	6.8	18.6	27.3	6.6	14.0	6.4	48.6	10.4	19.3	4.7	11.4	9.0	6.0	4.5	8.5	3.6	9.3	22.1	16.0	8.6	8.1	13.3	11.4	9.0	11.6	10.4	6.9	13.7	9.1	15.7	8.0	10.8	7.5	8.9	0.8	2.5	3.8	2.9	2.7	1.5	1.4	2.3	2.4	1.9	2.3	2.4	1.7	7.8	2.0	1.7	2.9	3.6	0.8	10.1	13.5	14.9	15.0	10.6	7.1	14.7	10.4	13.2	15.6	6.0	1.7	12.0	13.6	12.5	2.0	2.2	0.0	1.4	1.2	1.8	3.9	4.4	5.0	6.6	47.5	6.7	8.1	0.0	9.8	7.2	5.1	9.2	8.1	2.9	5.1	0.0	3.5	3.1	7.5	57.5	4.0	6.3	6.8	10.0	6.5	1.5	9.3	4.3	3.5	5.4	7.0	6.5	14.4	2.6	5.9	15.6	12.8	6.9	5.8	11.9
CCDC91	"DKFZp779L1558, FLJ11088, p56"	ENSG00000123106	"Coiled-coil domain containing 91"	Q7Z6B0	12	28133249-28581511	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	52	"Early spermatids: 1874.4;Late spermatids: 6111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038169	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038169: AB_10672506"	"unprognostic (6.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.98e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-1)"	14.3	16.8	16.3	14.5	20.6	9.4	14.6	14.8	22.5	11.3	12.9	10.8	14.4	10.5	16.3	16.6	14.5	11.3	13.4	26.5	16.1	19.8	18.2	13.4	11.3	13.1	18.2	17.1	16.8	22.9	23.3	26.2	10.6	32.3	14.0	11.5	11.5	14.2	15.6	32.7	9.1	11.9	21.2	21.6	13.9	14.8	36.3	15.3	23.3	22.3	9.7	11.6	21.0	16.1	6.5	4.2	16.0	5.4	7.1	8.5	3.6	10.3	7.4	6.8	0.3	7.1	6.6	12.9	8.8	9.4	7.8	10.0	5.2	14.0	5.4	7.7	10.4	4.8	12.0	6.3	14.2	11.8	15.8	5.1	17.9	14.3	4.2	11.1	17.0	8.9	6.5	14.3	7.7	22.7	14.9	6.2	9.7	16.2	18.2	7.4	3.7	16.8	14.6	14.1	8.0	7.0	10.4	19.9	9.3	12.6	7.1	5.8	10.6	16.7	5.7	26.6	19.7	10.9	13.6	4.6	16.6	11.5	16.3	5.1	23.0	24.9	14.9	14.3	14.0	9.3	16.0	2.4	3.4	5.5	4.6	7.3	6.5	7.1	7.9	3.4	5.5	8.5	7.7	0.8	7.1	5.4	4.2	8.1	3.6	16.3	20.6	14.8	22.5	16.1	19.8	18.2	17.1	32.3	15.3	35.7	37.1	20.6	30.7	31.0	61.0	77.1	15.3	58.9	43.3	21.0	43.2	11.4	36.5	38.7	1874.4	19.1	21.3	0.0	41.1	13.3	17.8	30.2	38.3	22.2	27.2	42.9	36.9	11.6	32.1	6111.6	53.5	32.8	35.4	34.3	20.0	49.2	32.1	23.0	48.8	25.1	69.8	38.8	31.7	64.0	34.0	35.4	13.4	40.6	15.0	26.7
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 64.8;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: AB_2683476"	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	19.3	11.1	35.2	9.4	24.6	3.8	16.3	17.0	34.5	11.4	11.7	16.4	6.0	14.4	11.8	18.6	8.9	12.6	10.6	23.6	33.6	26.5	11.5	11.0	20.1	8.2	27.2	23.0	13.0	11.8	18.3	14.9	17.3	34.2	11.2	7.8	13.6	9.0	12.9	22.3	7.7	14.2	14.2	22.4	9.4	11.1	24.0	13.0	8.0	15.3	4.9	6.6	10.7	12.7	1.7	1.3	4.6	1.3	1.3	3.7	1.8	4.0	4.6	2.3	4.0	15.2	8.4	4.1	6.8	12.9	3.8	4.1	2.4	1.2	1.9	2.4	8.5	2.2	2.8	2.5	1.7	2.6	12.6	5.9	2.5	1.6	1.5	8.1	0.4	9.7	4.7	7.8	4.8	3.0	11.8	10.6	4.4	2.5	0.9	3.4	2.7	2.4	4.4	1.0	1.9	10.1	3.1	1.3	0.5	5.2	4.2	4.4	6.3	3.3	1.7	4.6	5.7	4.8	2.2	10.5	7.7	1.7	4.9	2.3	3.2	1.7	0.6	6.1	3.4	3.2	4.6	1.3	1.9	2.3	0.7	3.7	1.6	3.0	3.5	1.0	1.7	2.3	2.8	1.2	1.3	0.1	1.3	0.5	1.8	35.2	24.6	17.0	34.5	33.6	26.5	27.2	23.0	34.2	13.0	17.9	22.0	4.7	6.2	3.4	17.5	37.2	25.5	9.4	11.4	17.4	13.7	3.8	6.6	12.6	64.8	12.7	8.0	0.0	9.4	2.1	13.8	7.0	19.7	11.9	15.4	20.6	4.6	11.1	8.6	48.4	12.7	9.5	8.5	10.8	7.2	12.8	12.3	2.9	16.3	27.1	12.1	71.1	17.6	44.0	5.3	2.6	4.7	7.9	5.2	6.0
CCDC94	FLJ10374	ENSG00000105248	"Coiled-coil domain containing 94"	Q9BW85	19	4247079-4269090	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043606, HPA055675"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043606: AB_10963431, HPA055675: AB_2682880"	"unprognostic (1.75e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.32e-4)"	"prognostic favorable (8.04e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.46e-3)"	18.1	14.8	16.1	14.5	17.3	50.5	14.3	22.0	20.3	15.5	16.2	18.4	15.6	17.9	17.2	14.6	16.9	16.8	12.5	12.2	16.2	13.6	18.1	16.7	14.7	20.8	20.4	17.1	23.3	24.7	12.2	10.4	23.2	15.6	15.4	10.9	16.0	19.7	14.5	21.5	19.7	15.2	13.6	17.3	18.7	16.1	16.6	20.0	18.8	20.0	26.3	18.8	14.0	12.5	24.8	19.3	22.6	19.3	16.8	25.0	13.9	17.2	16.8	9.4	7.5	5.6	7.5	9.6	7.0	8.9	13.1	14.6	14.9	10.6	20.1	8.0	10.5	11.3	13.1	15.2	16.6	9.2	11.6	15.0	12.9	10.9	17.4	8.3	16.8	18.1	7.9	10.0	11.5	17.2	8.0	10.6	9.8	18.3	23.5	5.4	23.8	17.7	10.5	22.4	7.9	12.8	10.4	7.9	17.9	12.2	17.0	13.6	14.1	6.2	13.6	12.5	5.7	9.8	15.8	11.8	9.3	9.8	18.7	17.3	25.6	18.1	20.0	13.0	18.0	9.9	15.2	15.2	22.6	21.2	19.3	18.9	23.3	20.5	19.5	18.5	24.8	24.5	20.2	9.4	16.8	13.8	19.3	25.0	13.9	16.1	17.3	22.0	20.3	16.2	13.6	20.4	17.1	15.6	20.0	8.9	19.5	14.3	17.9	9.2	12.1	0.0	7.6	1.4	12.5	0.0	0.0	24.6	0.0	0.0	4.1	9.8	18.8	0.0	0.0	21.7	8.0	10.2	32.3	6.2	17.6	12.7	10.4	9.8	11.4	5.7	11.5	9.3	8.5	0.0	11.8	16.0	0.0	12.2	11.0	0.0	12.1	6.5	7.6	13.5	12.1	8.3	38.2	14.4	16.2	12.8
CCDC97	"FLJ40267, MGC20255"	ENSG00000142039	"Coiled-coil domain containing 97"	Q96F63	19	41310189-41324883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043320, HPA043572"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043320: AB_10964344, HPA043572: AB_10962488"	"unprognostic (9.25e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"	20.4	15.3	15.5	20.7	18.8	21.5	16.8	16.1	24.7	21.3	16.7	26.7	17.8	15.1	21.3	26.6	22.9	24.5	15.8	16.4	14.6	14.1	16.5	13.3	15.4	23.2	16.0	16.2	27.4	20.6	20.8	21.9	22.9	18.6	19.0	12.6	20.9	21.1	17.2	28.8	21.5	18.4	15.6	21.0	24.2	17.3	39.9	16.8	27.7	17.9	20.4	27.2	17.7	19.7	13.6	7.6	14.6	13.3	11.5	16.8	8.3	13.1	28.9	15.3	17.8	20.2	16.2	11.1	8.9	7.2	14.1	12.1	17.1	12.7	12.6	9.6	7.4	9.5	9.0	21.0	17.7	10.8	23.0	20.3	11.5	13.0	11.2	15.4	19.0	24.9	15.7	22.8	16.4	13.8	11.6	9.7	13.9	14.6	24.1	13.4	9.6	17.3	4.6	7.1	16.0	10.4	19.6	12.2	9.1	12.9	25.2	13.8	12.2	19.8	21.9	8.7	10.7	14.9	14.5	11.5	12.2	12.3	6.3	14.7	24.8	21.2	12.1	11.6	14.0	16.1	9.0	8.3	9.7	15.3	9.2	16.8	11.3	10.3	10.9	6.8	13.6	11.4	10.0	14.6	11.5	13.3	7.6	8.5	8.3	15.5	18.8	16.1	24.7	14.6	14.1	16.0	16.2	18.6	16.8	11.9	7.9	9.3	10.0	4.0	11.7	5.9	10.2	6.7	3.4	8.7	11.8	9.6	6.6	10.7	2.5	7.5	12.9	0.0	22.5	4.4	7.6	7.8	16.1	4.9	13.4	9.5	11.1	10.4	11.6	7.8	11.8	7.7	1.7	18.0	11.1	6.4	17.7	2.9	10.6	7.2	8.8	0.0	8.3	20.6	11.7	5.1	15.3	16.0	9.6	10.9
CCDC9B	"C15orf52, FLJ43339"	ENSG00000188549	"Coiled-coil domain containing 9B"	Q6ZUT6	15	40331452-40340967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.7;Collecting duct cells: 19.2;Ductal cells: 27.2;Pancreatic endocrine cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 37.9;hTERT-RPE1: 35.2;WM-115: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040484, HPA041834"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040484: AB_10794742, HPA041834: AB_10795643"	"unprognostic (5.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.68e-2)"	2.8	4.8	3.6	9.4	5.8	1.5	4.5	3.4	6.2	9.4	29.6	6.3	38.1	5.7	11.5	14.1	19.8	5.0	12.3	30.5	5.8	3.2	5.1	2.1	6.8	1.7	6.7	4.7	2.6	12.0	9.7	4.8	2.3	5.7	10.3	7.6	12.9	13.9	40.6	35.0	7.7	8.3	16.2	3.6	2.5	11.0	5.3	6.3	0.3	21.3	16.1	6.1	13.0	7.2	0.5	0.5	6.7	0.6	0.9	0.3	0.4	14.9	2.1	0.0	0.1	0.3	1.5	0.8	4.5	4.5	5.1	5.0	0.1	13.9	0.1	6.4	14.6	18.5	37.9	0.0	12.4	4.8	0.0	0.1	4.5	17.7	1.4	2.7	0.0	0.9	1.8	2.8	2.2	6.4	35.2	3.6	0.2	0.0	0.2	8.6	0.0	0.1	0.0	0.1	7.0	4.0	0.0	1.3	0.0	15.3	0.8	0.0	1.1	2.7	6.0	2.6	0.0	0.6	0.7	19.1	9.5	15.2	2.5	11.9	0.0	0.0	0.1	11.5	0.8	43.1	6.7	0.6	0.6	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.3	0.2	1.2	0.9	0.2	0.5	0.0	0.4	3.6	5.8	3.4	5.3	5.8	3.2	6.7	4.7	5.7	6.3	11.9	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	19.2	0.0	0.0	1.7	27.2	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36002038	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 36.4;liver: 17.9"	"Cell type enhanced"	"Detected in some"	15	"Enterocytes: 260.2;Mucus-secreting cells: 154.9;Paneth cells: 333.1;Undifferentiated cells: 126.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"Hep G2: 25.4;OE19: 14.9"									HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		7900000	"Golgi apparatus"	Vesicles	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (3.02e-4)"	0.0	0.0	0.0	6.1	0.0	0.0	0.6	0.0	0.0	0.1	18.0	0.0	0.0	11.6	0.0	0.4	0.0	1.1	7.4	0.8	0.0		6.4	17.9	2.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	15.8	0.0	0.0	0.0	0.0	0.4	36.4	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	1.0	2.2	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.7	0.4	0.2	2.2	0.9	0.1	1.0	0.3	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.7	60.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	260.2	0.0	0.6	0.0	0.0	0.0	9.2	31.0	0.1	0.0	68.9	1.8	0.6	0.0	0.0	0.0	0.0	0.0	154.9	0.0	0.6	333.1	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126.3	0.1
CCL2	"GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF"	ENSG00000108691	"C-C motif chemokine ligand 2"	P13500	17	34255218-34257203	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Ductal cells: 3138.5;Pancreatic endocrine cells: 1040.3;Smooth muscle cells: 1844.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 10.3;eosinophil: 3.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.9;monocytes: 10.3"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 163.0;HMC-1: 212.4"					"Low region specificity"	"Detected in many"			"CAB013676, HPA019163"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	323000		"Golgi apparatus"	Vesicles	"CAB013676: , HPA019163: AB_1846179"	"unprognostic (6.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.37e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	78.1	31.2	10.3	52.3	50.6	19.1	19.0	1.5	23.3	9.7	41.9	28.6	3.0	9.4	7.2	7.6	14.4	25.8	62.0	76.9	45.1	6.7	32.5	38.4	105.2	16.9	16.0	2.0	28.6	32.8	15.2	17.3	22.8	63.6	42.0	25.3	22.3	13.5	13.4	17.8	10.5	16.7	34.6	85.4	16.1	30.2	4.6	8.6	4.8	20.8	21.6	19.1	27.2	9.0	0.0	1.1	3.9	10.3	0.0	0.1	2.3	0.0	1.3	3.5	0.0	9.8	8.4	0.0	9.9	163.0	21.2	45.5	0.6	0.0	0.0	7.9	2.3	0.3	5.5	0.3	0.0	10.8	0.0	0.0	0.0	1.2	0.0	0.3	0.0	212.4	9.4	0.0	4.4	0.2	14.2	9.6	0.0	0.5	1.7	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.2	1.7	30.3	0.0	0.0	0.7	0.0	0.5	0.2	9.9	0.4	0.2	0.5	11.3	0.5	0.3	0.0	0.1	0.0	0.0	6.6	3.1	7.2	0.0	10.3	3.9	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.3	0.0	2.3	10.3	50.6	1.5	23.3	45.1	6.7	16.0	2.0	63.6	8.6	169.7	145.0	2.7	681.4	505.1	0.0	10.8	91.7	41.5	131.9	130.9	0.0	2.4	0.0	3138.5	0.0	322.6	0.0	0.0	773.5	3.2	475.0	113.8	329.6	0.0	387.1	0.0	0.0	58.3	3.5	0.0	11.2	253.5	202.4	63.1	0.0	6.0	1040.3	0.0	1.4	11.5	0.2	129.4	1844.0	0.0	0.1	194.7	3.8	4.3	0.0	39.4
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffolding protein"	Q9NUG4	20	32010450-32032180	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.0"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 22.4;Ito cells: 20.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 10.6;HUVEC TERT2: 12.5;NTERA-2: 6.8;RH-30: 4.7;SCLC-21H: 11.6;TIME: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008434: AB_1845671, HPA071063: AB_2686339"	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	7.2	1.8	2.1	1.8	2.0	0.2	15.0	2.1	2.2	4.4	1.4	1.7	2.1	1.2	7.1	2.3	1.9	2.6	2.4	5.4	2.0	1.7	3.1	1.0	15.1	1.3	2.3	1.5	1.8	1.0	1.4	1.4	6.7	2.5	1.9	1.2	4.9	1.4	2.0	3.5	1.5	1.6	3.2	1.4	53.0	1.4	1.6	1.6	0.2	3.0	5.2	1.0	2.0	4.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	12.5	1.3	0.0	0.0	0.0	3.5	0.0	0.0	6.8	0.2	0.0	0.8	4.7	0.2	0.0	0.0	11.6	1.3	0.3	0.0	0.0	1.7	3.7	0.0	6.3	0.1	2.0	0.0	0.0	0.2	0.0	0.2	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.1	2.0	2.1	2.2	2.0	1.7	2.3	1.5	2.5	1.6	0.0	0.0	0.0	0.0	0.1	0.5	3.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	20.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.5	0.3	0.0	0.0	0.0	0.0
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442882	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;parathyroid gland: 24.2;testis: 50.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 98.3;Late spermatids: 70.5;Spermatocytes: 99.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 20.7;ovarian cancer: 18.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	108	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	233	"granulocytes: 24.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 87.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.8	7.3	0.4	6.2	1.3	0.6	0.2	4.7	4.0	0.3	1.6	0.0	0.4	2.6	4.7	0.3	11.1	0.6	0.3	4.5	5.9	0.3	0.2	1.0	1.0	1.9	5.5	1.2	0.5	24.2	4.8	0.2	3.1	0.3	0.3	0.1	0.4	0.2	1.3	0.2	0.3	5.1	1.0	0.3	0.4	50.4	0.4	0.2	0.4	0.0	0.5	0.4	0.6	0.1	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	3.8	0.3	3.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.8	87.1	0.0	8.5	0.1	0.7	1.4	0.2	0.4	0.0	0.1	0.0	1.0	0.1	17.0	0.6	0.0	2.1	0.0	2.0	0.0	0.6	0.0	0.6	1.4	0.0	2.0	0.0	0.4	0.0	17.0	1.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	21.5	0.1	24.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	6.2	0.2	4.7	4.5	5.9	1.9	5.5	3.1	0.4	0.0	1.1	0.0	0.5	0.6	0.2	0.3	0.0	16.0	3.4	0.0	0.0	0.0	0.0	0.1	98.3	0.1	0.0	0.0	0.0	0.6	0.4	0.2	4.7	0.0	0.2	0.0	0.0	0.0	0.0	70.5	2.8	1.0	0.0	0.0	0.0	1.8	0.0	0.0	2.5	0.0	0.8	6.5	0.1	99.1	2.5	0.4	0.2	0.0	0.0	0.7
CCNB3		ENSG00000147082	"Cyclin B3"	Q8WWL7	X	50202713-50351910	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.1;epididymis: 11.6;pituitary gland: 3.7;testis: 14.8"	"Cell type enhanced"	"Detected in some"	20	"Sertoli cells: 12.9;Spermatocytes: 17.4;Spermatogonia: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.3;GAMG: 6.1"					"Low region specificity"	"Detected in all"			HPA000496			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA000496: AB_1078605"	"unprognostic (1.57e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.48e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.63e-2)"	0.7	0.7	0.9	0.3	3.5	0.2	0.8	0.4	1.7	0.4	0.4	5.8	0.0	0.4	0.3	11.6	0.4	0.7	0.6	0.6	1.3	1.5	0.7	1.1	0.7	0.4	2.4	2.0	0.4	0.9	0.7	3.7	0.9	4.3	0.5	0.4	0.0	0.5	0.8	1.4	1.0	0.3	0.3	6.1	0.6	1.0	14.8	1.3	0.1	0.9	1.1	0.5	0.4	0.2	0.3	0.3	0.0	0.5	0.0	2.2	0.1	0.3	1.3	0.7	0.4	0.2	0.2	0.0	0.1	0.2	0.2	0.3	1.1	4.3	1.2	0.8	0.3	6.1	0.2	0.6	0.4	0.2	1.1	1.4	0.9	0.0	0.0	1.2	0.9	0.9	0.7	0.2	0.3	0.8	0.1	0.4	3.2	0.1	3.5	1.1	0.0	0.6	0.1	0.6	0.5	0.0	0.0	1.5	0.1	0.2	0.4	0.1	0.8	0.4	0.2	0.9	0.5	3.0	0.2	0.4	1.8	3.1	0.8	0.5	0.9	0.6	1.9	0.5	0.4	0.2	0.0	0.0	0.0	2.2	0.5	0.3	0.3	0.5	0.0	0.3	0.3	0.4	1.0	0.0	0.0	0.3	0.0	0.1	0.1	0.9	3.5	0.4	1.7	1.3	1.5	2.4	2.0	4.3	1.3	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.6	0.6	0.9	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	12.9	0.0	17.4	3.8	0.1	0.0	0.0	0.0	0.0
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542380-99568973	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: AB_2686120"	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	18.0	21.1	14.5	16.8	20.4	13.7	23.8	23.2	24.3	15.6	17.3	8.7	21.8	19.8	13.5	28.1	26.5	11.7	24.7	12.0	14.9	16.9	31.5	47.4	16.2	23.4	13.6	12.6	13.5	35.6	20.8	31.8	24.4	17.6	18.2	15.9	12.4	37.0	20.9	13.1	15.4	22.6	17.3	12.1	21.1	20.2	8.6	10.0	27.3	30.7	16.8	21.9	17.5	15.5	20.1	15.0	21.5	13.9	17.7	26.6	18.8	27.3	8.1	15.7	30.6	11.8	16.1	39.4	19.9	23.9	24.1	30.9	31.3	16.1	53.6	21.4	16.4	23.9	17.9	24.0	26.9	38.2	13.5	25.8	33.2	13.6	27.3	21.2	37.1	10.9	15.9	16.4	17.0	21.4	16.7	23.9	29.8	45.0	20.0	21.1	13.9	13.5	27.4	21.0	16.7	13.5	23.3	26.4	21.3	31.2	30.9	23.6	14.4	10.0	22.6	23.2	24.4	13.2	35.5	19.1	13.3	17.7	13.9	29.2	14.2	21.8	46.0	22.4	26.5	16.3	21.5	12.9	10.7	14.2	13.9	26.6	20.1	17.9	14.5	15.0	16.0	20.1	15.7	2.5	17.7	10.4	15.0	18.0	18.8	14.5	20.4	23.2	24.3	14.9	16.9	13.6	12.6	17.6	10.0	41.7	32.8	32.0	84.7	66.6	40.4	13.7	50.9	26.8	37.5	22.7	21.6	96.3	71.3	107.0	19.5	44.4	29.0	0.0	162.8	75.7	39.3	116.5	32.3	46.4	37.2	23.8	41.9	33.7	29.7	33.8	20.8	32.2	55.6	39.7	33.7	45.2	119.1	24.6	23.7	103.7	40.3	19.4	43.4	58.1	15.7	59.0	147.5	37.4	38.8	113.6
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157151-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034684	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	18.4	8.1	11.3	13.5	15.1	25.9	26.7	53.0	17.2	15.1	12.3	8.9	9.6	8.6	16.4	10.7	45.2	8.0	10.4	6.3	9.6	5.4	23.0	3.4	12.8	21.4	7.3	10.6	12.5	7.2	8.8	7.7	20.0	7.3	26.1	11.0	12.2	18.4	10.5	7.5	12.8	9.8	13.5	7.4	14.2	7.7	8.0	7.8	25.3	17.3	7.2	22.6	20.3	18.6	4.8	2.2	16.0	2.3	1.6	4.6	0.6	10.3	1.3	23.4	12.4	15.5	19.9	15.8	8.7	25.2	6.8	12.8	1.5	15.1	20.9	14.1	8.1	6.5	7.5	6.1	28.9	13.2	14.5	4.1	1.7	6.0	3.0	8.1	3.1	21.9	16.8	14.4	3.2	7.1	22.9	10.2	12.4	1.0	12.8	12.5	4.0	14.2	6.6	2.3	5.0	1.4	8.2	22.8	1.3	43.0	28.8	6.2	19.9	10.3	16.4	6.1	14.6	12.2	4.7	9.5	9.3	9.5	6.7	1.4	9.5	7.2	14.8	6.5	4.9	4.6	11.4	1.5	16.0	0.8	2.0	1.9	2.7	1.2	0.8	1.5	4.8	0.9	0.5	6.5	1.6	2.3	2.2	4.6	0.6	11.3	15.1	53.0	17.2	9.6	5.4	7.3	10.6	7.3	7.8	11.9	10.5	50.6	33.0	33.0	67.4	4.0	5.1	4.0	4.5	52.4	21.6	23.6	72.9	23.7	0.6	35.4	27.6	0.0	17.2	86.4	68.4	86.4	38.1	1.6	26.8	23.8	16.0	31.9	38.3	0.9	25.6	27.7	54.0	67.7	29.5	17.3	37.9	17.5	25.8	40.8	46.6	64.7	34.8	5.2	10.0	23.3	13.2	22.4	13.5	38.8
CCNI	CCNI1	ENSG00000118816	"Cyclin I"	Q14094	4	77047158-77076005	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 248.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010206, HPA039853, HPA061470"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533"	"unprognostic (3.68e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.10e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	49.0	26.6	48.1	47.1	45.8	50.3	121.1	101.3	248.9	66.3	56.8	21.6	36.9	25.6	56.7	69.0	56.2	50.7	45.2	87.7	44.8	34.1	48.2	34.5	64.7	70.1	55.8	33.5	94.9	65.4	36.5	33.1	35.4	46.7	61.4	34.9	32.7	45.5	62.9	64.3	38.5	45.8	61.6	58.1	41.3	42.4	53.0	20.3	55.4	81.2	28.2	60.0	82.7	62.6	49.2	42.9	70.5	39.8	33.6	56.2	24.3	24.6	14.8	48.4	42.2	72.8	66.6	18.5	19.1	46.7	30.2	29.2	18.2	37.6	45.6	29.3	47.8	18.9	12.9	33.0	66.7	48.2	32.3	13.0	27.3	17.3	17.3	71.5	46.8	55.2	52.0	79.9	27.8	68.4	86.9	42.3	24.1	23.3	49.7	42.9	28.4	60.8	44.3	21.2	17.3	9.2	38.2	45.7	19.2	45.0	28.2	61.4	33.6	25.3	38.9	30.8	35.4	22.1	20.0	28.6	37.0	22.1	39.3	25.9	27.6	12.5	48.2	31.3	32.4	23.9	43.1	32.9	70.5	31.7	33.4	44.9	46.6	52.4	47.2	37.3	49.2	56.2	47.4	47.0	33.6	39.8	42.9	44.8	24.3	48.1	45.8	101.3	248.9	44.8	34.1	55.8	33.5	46.7	20.3	160.8	205.6	381.1	554.3	375.7	387.2	381.6	262.4	87.0	102.4	186.7	64.8	225.4	673.1	338.9	56.4	305.8	254.0	186.9	291.0	357.2	371.0	733.0	274.5	108.3	295.2	171.6	395.9	297.7	542.3	122.9	559.2	420.6	381.3	312.8	295.3	254.5	414.7	272.5	929.9	450.1	187.1	543.3	450.1	159.5	349.2	345.0	317.4	433.7	302.4	523.8
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747445-132754403	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 17.4;seminal vesicle: 15.7"	"Cell type enhanced"	"Detected in some"	6	"Distal tubular cells: 3.3;Mucus-secreting cells: 3.3;Muller glia cells: 4.2;Paneth cells: 2.9;Undifferentiated cells: 3.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"MOLT-4: 24.0"									HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA056288: AB_2683086"	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.3	0.7	3.4	5.6	3.5	0.3	0.3	8.4	4.7	1.2	5.8	3.5	17.4	7.8	0.2	0.7	0.5	0.8	5.2	0.6	3.9	2.6	3.8	0.3	0.7	1.7	3.9	0.5	0.3	7.4	0.4	0.9	0.5	4.1	1.7	6.5	1.5	8.4	15.7	0.7	0.7	8.9	0.4	7.2	0.8	5.5	1.4	3.9	7.0	0.8	0.7	2.1	2.4	0.3	0.3	0.1	0.7	0.1	0.2	2.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.4	0.0	0.6	24.0	0.1	0.4	1.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.4	1.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	3.7	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.3	0.1	2.7	0.3	2.1	2.1	0.0	0.3	1.8	0.9	0.3	0.2	0.1	0.1	2.7	0.3	3.4	3.5	8.4	2.8	3.9	2.6	3.9	0.5	4.1	3.9	0.0	0.3	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	3.3	0.4	1.7	0.0	1.7	0.0	1.4	0.1	0.0	0.9	1.1	0.0	0.1	1.6	1.2	0.0	0.0	1.5	0.3	0.0	0.0	0.0	3.3	4.2	1.2	2.9	0.0	0.3	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	3.5	0.6
CCNJ	"bA690P14.1, FLJ10895"	ENSG00000107443	"Cyclin J"	Q5T5M9	10	96043394-96060870	"Predicted intracellular proteins"		Cyclin		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 25.5;AN3-CA: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036531, HPA058151"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA036531: AB_10696656, HPA058151: AB_2683623"	"unprognostic (1.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	7.1	10.5	5.0	8.9	9.2	18.1	7.7	11.4	8.2	6.9	8.6	6.4	9.3	8.1	10.8	8.3	6.7	8.7	8.0	5.3	4.9	5.5	11.4	6.4	8.2	8.2	5.0	3.7	8.7	9.3	11.3	11.0	7.4	6.6	7.1	7.1	9.2	7.6	7.3	7.3	5.3	11.7	7.7	5.0	13.4	7.4	9.9	5.7	16.3	7.2	5.8	8.3	6.8	5.0	1.9	6.9	1.1	4.0	1.2	3.1	2.1	5.1	4.2	25.5	25.4	2.6	2.0	3.7	3.2	3.9	5.0	4.4	10.6	2.3	7.1	3.8	3.1	4.0	3.1	16.9	3.5	6.4	3.4	6.8	6.9	3.1	15.0	6.1	6.9	3.3	3.9	4.8	4.6	11.0	4.5	11.4	6.6	10.0	0.1	3.0	5.0	11.7	7.9	14.1	0.4	3.5	14.1	1.1	0.5	5.6	4.9	3.9	13.6	3.7	1.0	7.0	8.8	5.9	7.6	5.7	3.1	6.8	3.5	7.6	1.4	0.5	6.6	3.6	12.2	2.0	0.3	4.0	1.1	2.3	3.3	3.1	1.8	2.0	1.2	6.9	1.9	2.9	2.6	0.5	1.2	3.2	1.4	1.5	2.1	5.0	9.2	11.4	8.2	4.9	5.5	5.0	3.7	6.6	5.7	6.0	1.9	3.7	2.5	1.6	4.9	2.8	2.5	5.3	2.3	5.2	13.7	1.3	3.3	2.4	2.8	3.3	1.3	0.0	2.4	1.8	2.3	3.0	0.0	1.3	3.2	1.6	4.1	7.4	8.4	5.4	1.7	3.6	1.7	1.0	3.9	3.4	3.5	0.0	1.8	2.1	3.3	0.0	3.1	6.3	4.3	1.3	0.9	1.7	3.1	2.7
CCNJL	FLJ14166	ENSG00000135083	"Cyclin J like"	Q8IV13	5	160249106-160345396	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 48.9"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 25.5;Mucus-secreting cells: 27.9;Paneth cells: 20.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	19	"cerebellum: 48.9"	"Group enriched"	"Detected in some"	19	"neutrophil: 13.5;NK-cell: 4.1"	"Group enriched"	"Detected in many"	35	"granulocytes: 13.5;NK-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 26.8;WM-115: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049970	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049970: AB_2680974"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.60e-4)"	"unprognostic (1.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.10e-4)"	"prognostic favorable (8.02e-4)"	1.0	3.0	0.9	3.4	1.2	1.3	2.1	48.9	1.5	2.1	9.0	0.9	1.5	1.8	1.1	1.5	0.8	1.0	1.0	4.4	2.5	0.8	2.7	1.2	9.0	2.5	1.5	1.1	5.3	0.2	0.0	17.0	1.7	2.1	2.0	7.9	3.9	7.6	2.0	0.6	0.4	2.7	1.0	0.9	5.8	4.4	10.7	1.2	4.8	8.4	1.7	2.6	4.0	5.4	0.1	0.2	13.5	0.0	4.1	0.0	0.2	3.0	11.3	9.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.4	4.9	8.8	0.0	8.7	0.1	7.7	3.8	1.2	26.8	0.7	0.0	0.2	4.8	4.0	3.5	0.1	0.0	1.0	0.0	2.3	1.5	6.7	5.7	6.8	3.1	0.0	0.0	2.9	1.6	0.0	7.9	8.5	0.0	6.3	1.8	3.0	1.0	7.1	14.3	3.1	8.3	1.5	2.3	10.2	3.6	5.1	0.5	8.2	1.6	10.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	20.3	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	13.5	4.1	0.0	0.2	0.0	0.2	0.9	1.2	48.9	1.5	2.5	0.8	1.5	1.1	2.1	1.2	20.8	25.5	0.0	1.2	0.2	0.6	4.8	0.0	1.4	7.9	3.5	0.0	0.0	5.0	2.6	0.7	0.9	3.6	0.0	0.2	0.0	1.3	0.8	1.1	0.0	0.1	0.0	2.4	1.8	0.0	3.0	2.0	0.1	5.0	1.0	27.9	7.3	1.1	20.1	2.5	0.0	0.0	0.0	1.0	0.5	5.7	0.4	0.0	0.0	2.3	1.6
CCNQ	FAM58A	ENSG00000262919	"Cyclin Q"	Q8N1B3	X	153587919-153600045	"Disease related genes, Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 61.3;Extravillous trophoblasts: 78.8;Syncytiotrophoblasts: 101.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050137, HPA059843"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA050137: AB_2681029, HPA059843: AB_2684140"	"unprognostic (3.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.25e-2)"	3.1	5.7	4.2	6.1	12.8	4.2	9.7	3.7	11.1	4.5	5.2	6.4	4.2	6.1	3.7	10.5	5.1	5.1	4.0	14.7	7.9		6.5	6.3	5.0	10.9	9.5	6.1	4.1	9.5	3.0	6.4	6.4	7.3	5.7	6.1	3.5	8.0	6.8	10.3	4.0	5.0	4.9	6.7	7.3	5.4	2.7	7.4	3.9	4.9	4.2	8.7	5.2	4.5	7.4	1.9	6.8	2.3	1.1	4.8	1.4	19.8	15.5	6.0	21.3	11.0	5.6	9.4	12.0	10.5	11.4	11.7	14.9	7.1	16.1	23.2	12.7	17.2	12.9	19.8	11.4	11.8	9.8	20.1	3.9	9.3	11.4	9.7	13.6	9.4	7.4	10.2	7.7	8.5	5.2	9.7	8.4	4.8	7.8	9.7	23.1	9.5	16.6	7.6	21.5	26.2	10.8	9.7	8.4	8.7	8.5	7.9	10.4	6.2	9.7	14.0	6.4	3.5	12.4	6.9	10.1	14.3	22.3	18.1	11.2	10.6	20.4	9.1	21.2	7.4	0.0	2.3	6.8	4.0	2.1	1.8	7.4	3.7	2.8	1.9	6.2	4.0	2.8	1.4	1.1	1.0	1.9	4.8	1.4											3.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.7	7.0	0.0	36.5	61.3	22.4	0.0	0.0	0.0	0.0	32.2	78.8	0.0	0.0	2.3	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	39.7	0.0	0.0	27.4	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	101.1	0.0	0.0	0.0
CCNT2		ENSG00000082258	"Cyclin T2"	O60583	2	134918235-134959342	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005559	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA005559: AB_1078608"	"unprognostic (2.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.44e-4)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (3.28e-4)"	15.8	14.1	21.0	15.2	19.9	32.5	21.1	30.5	22.2	16.4	14.2	16.9	17.8	17.6	22.6	20.9	15.4	16.1	12.9	14.2	16.1	14.3	12.9	20.8	17.5	18.9	18.6	16.2	22.8	24.0	25.1	29.6	17.9	20.0	18.0	16.7	11.5	16.9	19.4	14.5	20.3	17.2	18.0	17.1	19.8	18.9	15.8	19.1	23.0	18.7	9.4	18.2	18.9	19.5	3.8	4.9	6.9	4.5	6.2	8.4	3.4	6.7	3.4	22.1	8.2	11.0	11.2	16.8	9.3	7.7	8.9	11.1	9.1	7.8	11.1	7.1	7.7	4.3	8.8	13.2	7.0	13.0	5.9	8.9	11.9	8.7	12.8	10.8	10.7	10.6	10.2	14.0	8.7	10.8	11.5	13.0	8.4	9.9	11.4	10.3	4.6	11.8	16.0	17.9	5.6	7.0	11.5	7.9	8.8	13.7	18.7	15.1	12.5	6.9	8.0	10.7	16.8	8.4	13.1	11.8	11.5	12.6	4.9	6.8	8.1	4.9	11.6	7.1	8.6	9.7	6.9	3.7	4.5	4.3	4.5	5.3	3.8	4.8	5.1	4.9	3.1	8.4	6.4	4.8	6.2	2.3	4.5	5.9	3.4	21.0	19.9	30.5	22.2	16.1	14.3	18.6	16.2	20.0	19.1	23.8	24.2	24.6	28.3	13.4	32.7	19.5	17.8	9.4	20.5	14.0	31.4	9.1	6.6	13.6	4.7	18.2	17.4	0.0	13.0	7.4	12.5	26.7	10.5	18.4	8.6	39.7	17.7	20.3	12.9	11.8	13.0	20.9	8.5	14.4	14.5	16.7	12.3	17.5	20.8	4.8	32.8	19.4	11.3	16.8	19.9	15.8	11.4	20.0	14.3	38.3
CCNYL1	FLJ40432	ENSG00000163249	"Cyclin Y like 1"	Q8N7R7	2	207711540-207761839	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Paneth cells: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 41.9"									HPA046825	Approved		Approved	"Plasma membrane"		Yes	No			"Plasma membrane"		"HPA046825: AB_10963934"	"unprognostic (2.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.12e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.96e-3)"	17.5	8.0	9.8	12.2	10.7	10.6	14.5	4.8	12.8	12.6	18.1	11.2	11.5	13.3	8.8	8.2	24.6	8.0	10.0	11.7	8.0	7.2	15.9	18.4	14.5	11.9	9.1	10.1	6.3	21.6	6.9	8.3	16.8	9.3	7.9	16.4	7.9	12.1	10.0	10.1	5.8	16.3	10.8	11.7	12.1	14.8	18.3	8.1	10.9	14.4	6.6	13.9	10.8	13.9	4.1	1.8	4.6	3.8	1.9	2.7	0.9	11.8	5.1	6.9	9.9	9.4	10.6	41.9	7.3	12.4	7.6	8.3	23.0	11.2	4.5	7.0	13.3	18.5	8.3	8.2	13.5	7.4	1.6	6.2	6.0	5.9	19.3	8.8	5.6	7.2	5.0	5.6	9.3	10.7	6.8	24.5	5.4	2.9	4.8	10.0	6.0	4.9	5.0	13.7	5.1	5.7	4.2	6.9	3.6	8.1	8.9	1.6	5.4	9.0	3.8	11.0	17.5	3.5	14.2	13.0	8.6	8.7	10.8	4.9	2.7	3.7	6.9	9.7	6.4	7.3	1.7	3.8	1.5	1.1	1.9	1.4	1.2	1.9	1.9	1.8	4.1	1.5	2.7	4.6	1.9	1.7	1.7	1.3	0.9	9.8	10.7	4.8	12.8	8.0	7.2	9.1	10.1	9.3	8.1	3.0	15.5	8.5	12.6	10.9	5.7	7.0	2.5	1.4	6.8	22.7	9.8	11.1	1.7	5.7	7.7	11.7	30.0	0.0	12.6	29.2	8.9	12.4	5.7	13.2	14.5	4.8	9.2	21.5	16.1	7.4	2.6	14.3	8.5	20.8	7.5	9.7	10.6	67.0	3.5	9.8	12.9	0.0	9.2	17.0	7.8	9.3	6.4	7.2	6.0	16.0
CCPG1	"CPR8, KIAA1254"	ENSG00000260916	"Cell cycle progression 1"	Q9ULG6	15	55340032-55408510	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 52.9;neutrophil: 59.9"	"Group enriched"	"Detected in all"	7	"granulocytes: 59.9;monocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 50.3;Karpas-707: 73.3;U-266/84: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009432, HPA026861"	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA009432: AB_2668242, HPA026861: AB_1846192"	"unprognostic (3.14e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (5.07e-4)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (1.15e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.72e-2)"	22.4	20.3	21.1	11.2	34.8	29.5	20.2	27.6	27.7	32.1	16.0	9.9	28.2	11.9	16.0	19.4	12.7	11.7	26.6	29.7	21.2	26.1	27.5	56.2	23.3	19.8	21.8	18.5	17.4	41.6	37.7	56.3	13.4	21.7	21.0	16.5	13.5	33.1	27.4	44.2	7.8	16.9	16.7	23.2	19.5	22.2	13.8	19.7	5.2	41.9	12.9	11.3	20.0	16.7	3.7	5.5	59.9	15.4	4.9	5.6	5.6	2.9	10.5	2.3	5.2	38.7	13.2	3.4	6.3	12.1	3.8	5.8	3.1	5.0	4.4	21.8	20.9	7.4	4.0	2.0	5.3	3.1	11.5	3.1	5.8	13.3	2.7	50.3	8.1	18.4	11.0	12.9	7.9	7.7	31.0	13.8	0.2	9.8	73.3	11.8	4.0	0.0	4.0	1.4	11.5	2.8	1.3	3.8	17.4	7.9	2.1	3.0	4.7	7.4	4.2	32.0	7.9	6.7	17.9	13.9	11.2	2.4	8.4	4.2	14.1	51.7	2.7	20.9	16.3	8.8	34.6	11.5	52.9	5.6	10.1	4.8	3.7	3.6	4.3	5.5	2.8	3.1	4.3	59.9	4.9	15.4	0.9	4.4	5.6	21.1	34.8	27.6	27.7	21.2	26.1	21.8	18.5	21.7	19.7	107.2	100.3	14.1	26.7	13.7	62.1	11.7	48.4	104.4	112.6	83.7	88.4	24.4	5.0	45.7	107.6	39.4	20.9	23.3	127.8	18.8	46.4	51.8	36.0	85.4	45.5	81.0	16.0	63.8	57.2	149.5	52.3	56.5	45.5	79.4	25.9	77.3	67.8	45.6	109.6	32.8	123.2	51.8	41.2	37.2	43.4	14.4	20.6	34.9	15.8	18.6
CCSER2	"FAM190B, KIAA1128"	ENSG00000107771	"Coiled-coil serine rich protein 2"	Q9H7U1	10	84328558-84518521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"Early spermatids: 1964.7;Late spermatids: 4316.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037481, HPA037482"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037481: AB_10672385, HPA037482: AB_10671501"	"unprognostic (4.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.74e-2)"	14.9	8.7	18.5	7.9	18.2	7.3	16.7	22.1	21.8	16.4	18.3	17.9	11.4	9.4	15.7	13.1	22.7	9.2	10.3	42.9	19.6	18.2	9.9	10.5	13.3	9.0	21.7	15.9	11.8	9.9	11.8	8.8	15.3	28.3	12.6	10.4	9.4	10.3	13.5	46.2	13.0	15.5	24.2	22.2	8.2	10.6	45.7	15.2	11.8	19.9	14.6	9.1	17.1	11.9	5.2	4.4	5.2	3.0	14.6	15.0	5.4	8.1	6.3	7.5	16.6	11.1	18.2	5.3	9.8	16.3	6.1	12.0	3.5	8.7	5.4	6.4	18.1	9.8	7.0	5.6	6.2	9.2	17.9	3.5	1.9	3.0	4.4	10.2	2.8	4.1	8.8	9.0	9.9	31.9	15.9	16.7	10.3	2.5	16.6	11.0	5.0	4.9	2.0	3.2	2.8	5.1	5.1	3.8	2.0	5.5	8.7	2.3	4.2	5.4	3.6	16.8	10.9	6.6	1.4	14.9	18.4	8.4	9.1	10.3	16.8	5.6	4.3	11.9	3.7	7.9	2.7	3.0	5.2	14.9	2.8	15.0	5.2	11.1	13.7	2.9	5.0	10.0	10.5	4.2	14.6	2.2	4.4	6.7	5.4	18.5	18.2	22.1	21.8	19.6	18.2	21.7	15.9	28.3	15.2	38.7	32.6	20.4	45.4	31.4	85.2	186.4	7.6	17.4	23.9	15.7	29.5	20.9	31.5	27.4	1964.7	54.3	18.1	0.0	40.4	16.4	42.3	44.4	13.9	19.5	18.3	58.8	15.6	33.2	15.6	4316.6	47.8	31.8	25.3	47.7	24.3	49.5	27.2	14.1	56.3	21.9	51.3	12.9	46.9	67.4	64.1	41.0	57.2	64.8	16.6	56.7
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		4000000	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	38.8	68.8	37.6	41.8	43.2	26.9	51.2	54.5	51.4	35.1	42.1	46.2	33.8	37.9	50.4	34.8	56.1	52.2	29.2	41.5	36.7	41.6	60.8	61.9	30.9	48.1	43.5	32.8	53.0	59.0	56.7	55.9	39.2	43.0	38.1	50.0	35.3	34.4	41.4	66.4	38.2	39.5	59.7	41.2	41.6	41.9	49.8	47.6	62.1	60.0	49.9	60.7	44.8	82.4	34.8	39.3	14.2	30.5	30.8	45.1	43.9	50.4	57.6	39.3	37.7	43.7	32.5	51.3	47.2	37.5	74.7	46.0	57.0	46.8	83.4	55.0	39.5	47.6	47.6	124.4	61.4	63.9	44.7	78.3	52.9	46.8	45.0	32.2	65.4	44.5	41.2	36.8	67.1	62.5	36.7	63.2	50.4	90.7	30.2	44.3	46.9	86.0	40.1	79.6	99.6	83.5	69.2	39.8	90.3	54.8	32.0	53.3	55.0	43.5	76.7	42.1	66.0	67.8	80.1	43.6	30.4	45.4	31.8	84.1	56.1	99.6	124.1	35.4	41.7	49.3	14.2	25.3	11.2	31.2	30.5	41.6	34.1	34.7	34.2	39.3	34.8	45.1	37.8	3.6	30.8	30.2	25.5	35.5	43.9	37.6	43.2	54.5	51.4	36.7	41.6	43.5	32.8	43.0	47.6	50.6	46.8	129.4	183.9	128.7	109.7	102.4	58.6	127.2	85.3	85.5	100.1	202.7	96.2	186.6	88.8	105.6	80.4	23.3	158.9	172.8	109.3	142.8	72.6	72.7	143.2	69.9	120.2	69.3	70.6	169.9	77.3	80.0	106.3	208.2	75.5	134.0	167.6	87.7	82.7	157.7	195.7	116.4	117.4	367.9	233.1	139.6	154.4	96.5	112.5	146.5
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868089-61888804	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		3400000	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	35.1	42.3	34.8	33.3	38.7	32.4	63.3	41.2	40.6	37.7	36.2	26.0	34.4	26.7	43.1	32.6	47.9	44.6	25.3	49.0	31.4	33.7	43.1	37.6	28.7	54.1	42.1	33.9	66.4	65.9	39.7	32.8	37.7	40.0	37.6	35.4	21.5	32.1	35.9	52.5	37.5	28.1	42.5	39.7	36.2	38.1	49.4	37.7	55.6	50.0	40.8	50.9	39.3	93.4	30.3	31.4	13.7	29.8	31.6	39.1	34.6	42.4	49.6	33.1	30.7	27.5	42.0	55.7	38.9	27.9	56.2	37.8	86.2	30.9	68.5	39.6	27.8	58.7	30.7	64.9	49.8	59.4	33.6	63.8	43.7	25.7	54.1	24.8	53.7	29.3	35.6	34.7	45.2	47.2	43.0	46.9	35.4	62.1	22.1	47.8	38.2	46.3	73.9	59.5	58.0	44.2	52.6	51.8	46.3	39.1	29.3	28.9	24.3	28.2	36.0	50.2	40.7	26.1	39.8	29.4	31.3	45.5	23.2	63.0	33.9	45.3	116.2	31.0	62.2	40.9	13.7	19.0	7.5	27.8	27.2	35.7	30.3	29.6	33.3	31.4	27.5	39.1	38.0	2.7	31.6	29.8	20.3	30.7	34.6	34.8	38.7	41.2	40.6	31.4	33.7	42.1	33.9	40.0	37.7	68.5	48.3	130.2	269.5	135.5	48.5	42.1	68.8	100.4	55.7	69.8	13.7	227.3	114.4	153.0	142.9	101.6	46.8	23.3	113.0	234.5	111.0	163.9	94.6	76.0	145.9	30.2	134.7	81.6	97.3	43.3	81.7	92.2	89.4	124.4	81.3	55.3	126.9	70.2	91.9	129.9	47.9	90.5	130.6	212.4	146.7	132.2	151.0	116.1	119.0	187.2
CCT6A	"CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20"	ENSG00000146731	"Chaperonin containing TCP1 subunit 6A"	P40227	7	56051630-56063989	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 179.4"									"HPA042996, HPA045576, HPA049949"	Supported		Approved	Cytosol		NA	NA		7400000	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (9.00e-10)"	"unprognostic (1.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.44e-3)"	32.9	36.5	35.3	35.8	36.1	32.0	62.4	43.7	40.4	26.2	29.1	19.6	28.4	29.8	31.7	23.7	39.5	29.7	22.9	49.3	34.7	39.8	43.2	45.7	22.6	42.0	36.8	26.8	33.4	42.9	48.3	33.7	33.9	34.9	30.2	35.4	16.4	27.3	32.2	72.3	32.6	28.6	35.3	35.8	36.7	32.3	27.0	26.5	41.1	38.2	41.4	44.0	37.1	83.7	24.0	35.3	11.8	34.2	26.6	29.9	25.8	179.4	41.1	24.7	37.3	17.4	21.9	28.5	33.9	19.2	33.4	27.0	46.2	22.6	55.6	26.3	21.8	60.2	38.2	50.6	38.9	46.3	31.2	38.4	34.8	39.9	40.6	18.9	49.8	28.3	18.7	22.4	33.7	33.6	26.5	32.8	25.4	76.0	14.0	37.7	22.2	38.3	43.5	52.3	40.3	54.8	35.3	25.3	32.0	37.6	34.4	33.1	33.2	30.0	51.2	29.9	39.5	37.6	38.4	27.5	23.0	44.1	76.2	69.7	17.2	35.4	68.7	23.0	44.3	76.0	6.9	25.0	11.8	22.4	31.6	29.9	24.0	23.5	24.4	35.3	17.8	24.0	25.4	3.1	26.6	34.2	19.6	24.2	25.8	35.3	36.1	43.7	40.4	34.7	39.8	36.8	26.8	34.9	26.5	83.4	81.3	76.7	149.2	96.7	57.8	100.5	58.6	236.9	216.1	45.4	25.5	172.0	74.6	212.7	12.0	112.8	57.1	0.0	237.7	208.2	81.7	105.7	127.1	61.8	133.8	36.5	97.8	66.9	79.5	15.6	65.3	122.3	55.6	225.4	84.4	73.1	209.1	73.7	85.2	112.3	50.9	58.2	92.9	81.2	184.0	95.9	167.2	86.7	111.5	124.2
CCT6B	"Cctz2, TSA303"	ENSG00000132141	"Chaperonin containing TCP1 subunit 6B"	Q92526	17	34927859-34981078	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"testis: 71.5"	"Group enriched"	"Detected in many"	21	"Early spermatids: 252.6;Late spermatids: 121.4;Spermatocytes: 273.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"unprognostic (1.56e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.99e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.56e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.82e-7)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-1)"	"unprognostic (4.23e-4)"	"unprognostic (1.49e-1)"	1.3	1.7	1.0	0.7	2.8	1.5	2.7	1.3	1.9	1.1	0.7	2.4	1.9	0.6	0.9	3.2	0.8	1.3	0.6	0.8	1.3	1.0	1.9	2.6	0.5	0.6	1.6	1.7	1.2	1.2	1.3	1.3	0.4	2.0	1.3	0.5	1.3	1.5	1.3	2.2	1.3	0.6	0.8	2.2	0.7	0.9	71.5	0.8	0.7	1.4	1.1	0.8	0.9	0.7	2.5	6.2	2.2	2.7	3.8	2.7	1.3	0.9	1.2	3.2	1.4	4.2	2.6	1.1	1.6	6.6	2.8	3.9	0.8	2.5	6.0	0.6	2.9	2.0	1.2	0.2	0.9	0.8	0.7	2.4	0.9	0.2	0.7	5.7	2.8	0.9	3.5	1.7	0.3	3.3	0.5	0.7	1.0	0.6	6.2	3.0	2.3	0.6	6.2	1.7	0.4	0.8	2.9	1.5	14.4	1.7	1.0	3.7	1.8	2.9	1.2	4.9	0.7	2.4	2.9	0.7	1.2	0.1	1.5	0.8	5.5	1.2	5.8	1.3	1.8	1.6	0.0	2.7	2.2	1.6	2.7	1.7	2.5	1.8	1.1	6.2	2.3	2.7	2.6	0.1	3.8	2.6	1.4	0.9	1.3	1.0	2.8	1.3	1.9	1.3	1.0	1.6	1.7	2.0	0.8	0.0	1.9	0.0	1.9	2.2	1.5	3.8	2.5	6.7	3.4	1.8	0.0	1.3	3.3	2.6	252.6	0.7	0.7	0.0	7.0	0.4	2.6	1.9	2.3	3.4	1.3	0.0	0.0	1.3	2.2	121.4	10.0	1.5	5.0	0.0	2.5	8.3	2.3	0.9	3.9	5.5	2.4	0.0	1.4	273.4	9.7	2.3	0.7	0.5	1.7	3.0
CCT7	"Ccth, Nip7-1"	ENSG00000135624	"Chaperonin containing TCP1 subunit 7"	Q99832	2	73233420-73253021	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008425	Approved		Approved	Cytosol		NA	NA		5900000	Cytosol		"HPA008425: AB_1078428"	"unprognostic (5.02e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.37e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.12e-2)"	35.1	55.7	33.5	34.6	46.3	27.0	54.2	52.2	46.9	34.9	36.3	32.4	29.5	28.7	46.5	42.3	43.6	47.4	32.7	56.5	36.4	36.1	38.9	48.0	29.4	47.0	35.8	37.1	51.3	56.1	45.3	34.9	34.3	36.1	41.2	43.7	27.6	33.2	41.2	82.1	32.7	28.9	51.0	33.5	36.1	36.9	80.6	28.6	49.0	44.0	52.5	51.5	37.5	61.6	53.1	49.4	29.1	45.6	42.7	54.8	62.6	46.9	78.5	45.0	48.9	33.1	27.5	57.7	40.7	38.7	72.1	45.4	127.9	33.4	89.8	27.1	44.1	66.4	40.3	100.5	65.1	79.8	49.8	89.3	59.2	50.1	91.4	37.2	68.9	46.3	42.4	37.2	70.2	86.6	38.0	64.6	54.7	76.2	32.7	60.6	75.1	80.2	96.1	63.9	65.2	56.6	73.3	110.2	64.4	52.0	45.6	64.1	39.0	35.3	51.2	48.8	43.6	29.1	40.0	39.7	49.2	58.8	30.3	80.6	37.6	38.8	83.0	40.1	81.6	53.8	29.1	31.5	17.9	48.5	42.3	53.8	53.1	50.1	48.5	48.4	49.5	54.8	51.0	9.6	42.7	45.6	49.4	43.3	62.6	33.5	46.3	52.2	46.9	36.4	36.1	35.8	37.1	36.1	28.6	53.6	40.0	72.2	131.1	61.4	74.2	94.3	63.7	78.9	58.0	55.8	17.7	167.9	92.9	145.6	274.6	80.9	50.6	0.0	121.4	180.5	69.8	91.5	72.7	60.6	117.8	77.9	72.3	48.5	53.7	195.8	97.0	56.1	70.9	128.0	80.8	110.9	124.2	49.1	100.8	99.6	59.3	71.1	100.9	234.3	136.3	64.4	139.2	70.8	109.5	98.1
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No		2700000	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	33.5	62.5	28.9	36.1	43.8	28.2	39.7	47.9	46.4	34.5	33.7	15.7	41.9	29.6	37.4	36.4	47.6	33.6	23.6	43.9	33.0	36.0	43.6	42.1	33.2	48.8	28.8	39.2	39.3	47.2	35.4	42.6	41.0	39.6	30.9	38.3	17.0	34.7	38.6	68.4	35.5	30.1	38.3	29.5	39.8	35.2	30.2	30.2	66.6	36.1	52.0	57.6	38.5	47.8	25.6	41.7	17.5	38.1	22.8	27.2	33.9	50.1	28.5	36.5	26.2	27.0	37.2	40.7	40.2	25.7	45.7	38.2	60.4	31.1	99.2	27.0	27.8	56.9	20.3	75.2	46.5	52.0	41.9	39.1	137.2	34.3	26.9	28.0	67.8	38.4	28.3	28.7	53.8	44.7	33.6	43.6	44.2	105.7	58.0	46.6	26.0	51.0	26.5	65.7	50.2	35.5	45.9	71.9	61.7	46.7	26.4	36.6	26.3	39.5	41.7	34.5	40.6	37.3	59.4	31.5	26.0	73.4	24.4	50.1	37.8	72.8	78.2	30.4	77.1	39.6	17.5	33.7	16.7	18.5	36.9	25.5	25.6	24.0	24.3	41.7	19.2	27.2	24.5	3.7	22.8	38.1	24.6	26.6	33.9	28.9	43.8	47.9	46.4	33.0	36.0	28.8	39.2	39.6	30.2	59.6	50.7	145.9	155.3	127.2	80.5	66.6	81.5	101.7	63.7	71.5	17.7	231.9	122.7	173.0	13.3	94.7	74.3	23.3	120.5	222.9	82.2	111.0	110.8	53.3	152.3	73.1	93.1	52.2	97.5	17.8	77.9	129.4	109.6	186.7	93.1	81.5	121.5	94.7	87.4	163.4	64.8	103.5	99.4	175.3	178.0	114.8	238.6	86.3	148.0	143.1
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"parathyroid gland: 203.4"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 36.9;Endothelial cells: 28.0;Hofbauer cells: 36.5;Suprabasal keratinocytes: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;BJ hTERT+: 38.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		120000000	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	27.4	1.5	1.6	1.9	2.2	1.9	6.5	0.4	1.9	15.0	7.1	3.4	2.0	1.5	22.5	8.5	22.4	3.4	2.4	8.2	1.8	1.4	3.5	1.4	14.5	1.4	1.7	1.4	2.8	1.2	203.4	0.6	5.0	3.0	7.1	2.1	0.6	4.2	2.2	4.1	12.4	2.4	12.6	4.5	1.7	1.5	3.3	2.8	6.3	1.7	16.8	4.7	8.7	8.0	0.3	2.6	1.4	0.4	0.6	0.4	0.3	9.4	8.5	0.5	0.0	12.9	62.8	0.0	8.6	38.5	2.8	6.2	0.0	5.5	0.0	5.3	17.7	6.2	26.6	0.9	17.2	3.8	2.6	1.5	3.3	6.9	1.4	2.7	0.0	0.0	17.3	13.7	5.3	21.5	9.9	20.3	1.0	0.0	0.0	12.9	0.2	0.2	0.0	0.6	0.0	5.5	0.7	2.4	11.6	1.2	1.1	0.0	0.0	19.5	0.1	8.4	0.4	0.2	1.5	18.8	26.9	3.7	4.8	7.4	0.1	5.3	0.0	10.8	0.0	23.8	0.6	0.4	0.3	0.2	0.2	0.1	0.2	0.3	0.2	2.6	0.3	0.4	0.2	1.4	0.6	0.2	1.4	0.1	0.3	1.6	2.2	0.4	1.9	1.8	1.4	1.7	1.4	3.0	2.8	3.0	1.7	0.8	6.2	36.9	0.3	11.1	0.0	2.7	12.5	0.0	0.0	0.3	1.7	0.1	18.2	28.0	0.0	0.0	0.0	0.4	7.8	5.8	2.3	0.4	36.5	0.0	0.0	19.0	2.8	17.2	0.6	15.3	21.9	4.6	0.0	0.0	0.3	0.0	0.0	15.9	0.1	0.0	14.6	0.7	3.2	38.1	1.1	2.2	0.0	6.4
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 189.4;liver: 165.8"	"Cell type enhanced"	"Detected in many"	25	"Hofbauer cells: 2162.9;Ito cells: 448.7;Kupffer cells: 633.7;Macrophages: 438.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 189.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 52.3;monocytes: 189.4"	"Cell line enhanced"	"Detected in many"		"A549: 9.1;CACO-2: 13.9;SiHa: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	15000000000	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	27.9	44.1	9.0	42.7	25.2	9.8	11.7	3.5	8.9	5.6	10.0	6.0	1.8	5.4	5.6	24.0	4.5	12.0	14.6	18.9	11.7	7.4	12.7	165.8	23.8	34.7	21.6	2.9	14.2	5.3	4.3	10.1	37.3	18.9	8.5	9.2	14.6	28.5	5.8	10.2	3.5	12.1	21.4	18.2	35.5	6.6	6.5	17.3	2.2	7.9	5.8	6.6	15.9	3.8	0.5	23.6	52.3	189.4	0.2	0.4	124.2	0.1	9.1	0.1	0.6	1.3	0.3	0.5	0.9	4.2	1.3	1.6	13.9	2.2	0.4	0.7	5.0	1.1	3.9	0.0	1.7	0.2	0.1	0.9	0.3	0.5	1.8	4.9	1.0	0.4	4.0	0.2	0.2	1.3	0.4	0.0	0.2	0.2	0.2	1.3	0.3	0.0	0.6	0.2	0.2	0.3	0.3	0.4	1.1	0.2	0.0	2.4	1.0	16.7	0.4	0.5	0.2	0.3	1.7	0.6	0.2	0.3	1.5	1.3	0.7	0.9	0.5	0.4	0.4	0.1	0.4	189.4	1.0	0.3	36.6	0.4	0.5	0.2	0.2	23.6	0.1	0.3	0.2	52.3	0.2	4.8	1.3	0.1	124.2	9.0	25.2	3.5	8.9	11.7	7.4	21.6	2.9	18.9	17.3	8.9	44.2	23.9	3.1	4.5	9.5	2.5	28.1	6.7	6.8	1.8	0.0	15.3	1.7	3.3	1.3	13.8	7.9	0.0	1.6	12.6	12.3	2.2	8.1	323.7	2162.9	31.8	6.9	448.7	633.7	3.2	4.6	438.8	8.5	0.0	4.5	36.9	2.3	8.5	4.9	5.4	3.5	32.3	9.2	0.7	0.9	3.8	38.6	5.9	5.1	3.0
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.4;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 6.9;Melanocytes: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 9.2;HDLM-2: 8.2;HUVEC TERT2: 8.9;TIME: 8.3;U-87 MG: 19.4"									HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA		170000	"Centrosome, Cytosol"	Nucleoplasm	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	5.0	1.7	1.2	19.1	1.2	0.0	2.5	0.8	1.6	1.4	9.2	0.3	1.0	5.5	1.2	8.5	1.8	1.3	2.6	3.2	1.2	1.0	1.7	1.5	2.8	14.6	1.1	0.7	1.0	1.0	0.1	1.4	6.8	3.3	1.4	15.1	2.7	2.5	1.4	1.1	1.4	18.4	1.8	1.0	31.2	2.6	4.6	0.2	9.5	1.7	6.4	12.9	4.3	1.2	0.2	0.7	0.7	0.8	0.0	0.0	0.2	0.2	0.4	0.2	0.0	1.0	0.3	0.0	0.8	1.8	0.2	0.8	0.0	1.4	0.0	0.3	0.8	9.2	0.0	0.0	1.1	1.4	8.2	0.0	0.0	0.4	1.2	0.0	0.5	0.0	0.3	0.0	0.2	3.3	0.6	8.9	0.0	0.1	4.7	5.2	0.0	0.0	6.6	0.2	0.0	0.0	1.5	1.5	1.8	0.0	0.0	1.2	5.6	4.3	6.8	0.0	0.3	0.0	5.5	8.3	3.0	2.7	0.3	0.0	0.1	0.1	0.0	19.4	0.4	5.7	0.0	0.8	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.8	1.6	1.2	1.0	1.1	0.7	3.3	0.2	0.0	0.0	0.0	0.0	1.1	2.9	0.7	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	2.2	0.7	0.0	0.0	1.2	0.3	0.5	0.1	0.0	0.4	6.9	0.0	0.0	0.0	4.1	1.1	0.0	3.3	13.5	0.0	0.0	1.0	2.0	1.1	0.0	0.0	1.7	19.4	8.0	3.4	0.7	1.1	0.2	0.0	0.0	0.1
CD164L2		ENSG00000174950	"CD164 molecule like 2"	Q6UWJ8	1	27379176-27383380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.8"	"Cell type enriched"	"Detected in some"	8	"Ciliated cells: 62.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.6;HaCaT: 3.6;HBEC3-KT: 3.9;hTCEpi: 5.4;SK-BR-3: 4.9;T-47d: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062915	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA062915: AB_2684903"	"unprognostic (8.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.64e-5)"		"unprognostic (7.81e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.91e-6)"	"unprognostic (1.33e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.71e-2)"	0.1	0.1	0.2	0.1	0.5	0.0	2.3	0.1	0.4	3.2	0.4	0.7	1.2	0.0	0.4	12.6	13.4	26.8	0.1	0.1	0.4	0.4	0.4	0.3	7.4	0.1	0.1	0.6	3.3	0.3	0.4	5.8	0.1	1.1	2.4	0.2	1.0	12.9	0.3	0.1	8.1	0.1	0.1	0.1	0.1	0.2	1.0	0.4	0.1	0.9	5.9	6.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	3.6	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.7	2.0	0.1	0.0	0.0	0.1	1.0	0.0	1.0	0.0	0.0	4.9	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.4	0.4	0.4	0.1	0.6	1.1	0.4	0.0	3.0	0.0	8.0	2.6	0.0	0.6	0.0	62.9	4.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.5	0.0	0.0	0.0	3.1
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 188.8"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"myeloid DC: 16.3"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 16.3"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 112.0"									HPA021824	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	Cytosol	"HPA021824: AB_1846262"	"unprognostic (7.72e-3)"	"unprognostic (1.55e-4)"	"unprognostic (1.66e-5)"	"unprognostic (1.04e-2)"		"unprognostic (1.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.53e-2)"	0.8	0.1	0.2	1.9	0.2	0.0	0.6	0.2	0.2	0.8	0.6	0.3	0.2	0.0	0.3	0.2	0.9	0.7	1.3	0.2	0.2	0.0	0.6	0.3	1.7	4.0	0.2	0.2	0.3	0.3	0.0	0.2	0.2	0.2	0.2	5.6	0.2	0.6	0.2	0.2	6.2	0.8	0.3	0.2	1.9	0.9	0.2	0.2	188.8	0.4	0.4	2.4	0.5	0.8	0.0	16.3	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	112.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	17.4	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314487-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 71.0"	"Cell type enhanced"	"Detected in many"	14	"Fibroblasts: 70.0;Leydig cells: 69.3;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"naive CD8 T-cell: 17.8"	"Lineage enriched"	"Detected in single"	122	"T-cells: 17.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 68.1;ASC TERT1: 67.2;BJ: 29.4;BJ hTERT+: 44.3;fHDF/TERT166: 59.3;HSkMC: 71.6;U-2197: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		27000000	"Plasma membrane"	Nucleoplasm	"HPA051856: AB_2681640"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	59.2	3.5	0.8	14.4	2.5	0.0	55.2	0.6	2.2	21.2	7.6	1.9	6.3	2.7	14.1	22.9	14.8	17.7	12.3	18.2	1.2	0.5	5.3	1.7	9.3	16.2	1.3	1.6	15.6	4.9	1.4	2.3	71.0	2.1	10.6	2.7	11.5	4.6	8.0	6.7	13.3	7.5	27.6	1.2	1.9	7.5	8.0	0.7	4.1	9.4	6.6	4.5	19.5	17.6	0.1	0.0	0.0	0.0	0.0	17.8	1.9	0.0	0.0	0.6	0.0	68.1	67.2	0.0	29.4	44.3	2.2	2.0	0.0	0.0	0.0	0.7	59.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	13.5	0.0	0.0	71.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.3	0.0	0.1	2.8	17.8	0.0	0.0	0.0	0.0	0.0	1.9	0.8	2.5	0.6	2.2	1.2	0.5	1.3	1.6	2.1	0.7	0.0	0.0	0.0	0.0	11.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.3	2.5	0.0	0.0	0.0	2.5	70.0	0.0	0.0	0.0	5.5	0.0	0.0	4.3	0.0	0.4	69.3	0.0	11.8	1.0	0.0	3.6	0.4	0.0	19.1	0.0	0.0	32.3	12.2	0.1	0.0	7.2	3.7	0.0	0.0	0.0
CD276	"B7-H3, B7H3, B7RP-2"	ENSG00000103855	"CD276 molecule"	Q5ZPR3	15	73683966-73714518	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 186.5;Hofbauer cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"HaCaT: 42.2;U-2197: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009285, HPA017139, CAB017826"	Enhanced		Approved	Vesicles		NA	NA		8900000	Vesicles		"CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246"	"unprognostic (1.05e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.57e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.50e-3)"	"prognostic unfavorable (9.81e-4)"	"unprognostic (2.57e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (1.17e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.34e-3)"	32.3	16.6	5.8	9.2	3.9	0.6	17.1	3.6	5.3	19.4	8.3	5.1	4.2	8.8	17.2	17.9	6.3	8.1	14.3	12.3	5.6	3.6	7.2	22.9	9.3	6.7	4.6	3.8	16.8	14.3	3.5	5.3	27.7	7.9	16.5	4.2	20.5	12.8	7.8	7.1	12.6	7.0	13.8	4.4	7.4	8.4	9.9	3.9	1.2	7.8	8.3	4.7	12.4	13.6	0.4	0.5	4.0	0.6	0.8	0.2	0.0	9.8	12.2	8.4	18.4	15.4	9.3	25.7	11.5	9.5	7.6	6.9	21.5	20.7	0.1	18.8	10.9	14.6	42.2	9.0	10.3	1.3	7.5	20.4	0.8	12.8	10.3	4.7	0.2	12.3	7.4	5.0	6.9	4.5	5.3	10.0	0.0	3.2	0.2	1.7	15.3	0.1	0.5	20.4	1.9	8.9	0.1	12.3	1.6	6.6	13.7	5.8	14.0	10.7	5.3	20.8	7.1	8.8	5.3	11.5	16.8	15.1	55.2	11.6	0.2	0.2	0.2	27.9	0.9	11.5	0.9	0.3	0.5	0.1	0.6	0.2	0.2	0.1	0.2	0.2	0.4	0.2	0.1	4.0	0.8	0.3	0.5	0.1	0.0	5.8	3.9	3.6	5.2	5.6	3.6	4.6	3.8	7.9	3.9	17.9	7.2	0.5	9.2	13.4	21.2	7.0	5.1	5.3	18.2	10.4	29.5	8.8	1.7	42.7	0.7	8.9	4.0	0.0	16.3	186.5	42.4	15.5	14.9	13.9	70.5	9.5	8.6	5.5	5.8	0.7	9.2	20.9	23.6	7.2	12.1	8.9	22.2	17.3	16.3	2.4	27.5	12.9	41.2	1.2	2.8	8.9	10.3	0.5	8.7	6.5
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		160000	"Plasma membrane"	"Centriolar satellite, Cytosol"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	15.2	9.9	5.3	18.0	7.6	6.6	11.9	13.6	6.1	13.2	23.5	6.2	19.0	31.0	13.2	12.9	20.1	8.0	14.7	7.3	4.9	5.3	31.3	19.2	17.3	8.0	5.8	4.0	9.9	19.3	24.0	14.4	17.2	7.3	15.0	20.9	6.6	17.5	19.4	8.7	13.0	31.9	9.5	7.7	17.0	22.3	8.7	6.4	55.1	13.3	13.3	13.8	16.9	15.5	1.3	12.2	3.7	0.7	3.8	2.4	0.7	20.6	8.2	2.6	5.3	3.6	5.2	20.5	5.1	6.2	6.9	8.8	13.5	14.7	26.8	21.4	6.6	9.0	7.8	8.5	12.7	11.3	10.7	13.7	14.8	6.9	12.0	4.8	8.2	5.7	3.7	12.0	6.6	9.6	13.4	11.1	9.0	25.9	8.6	6.2	6.5	15.7	3.1	7.6	25.1	3.0	8.4	6.6	12.2	43.5	37.0	7.8	3.0	10.2	13.7	9.9	12.2	13.0	5.3	13.2	13.9	11.7	4.4	14.3	6.5	10.9	19.2	14.9	4.5	7.1	1.9	0.7	3.7	1.5	0.5	2.4	1.2	1.4	1.5	1.5	1.3	1.3	2.0	0.1	3.8	0.4	12.2	1.1	0.7	5.3	7.6	13.6	6.1	4.9	5.3	5.8	4.0	7.3	6.4	89.3	52.6	27.4	48.2	28.6	9.7	13.7	22.9	75.0	93.3	68.0	15.7	42.2	18.3	68.4	7.7	43.2	159.3	23.3	85.1	12.7	11.4	76.4	23.1	21.5	15.6	14.3	53.6	31.3	20.7	8.4	15.5	17.8	13.5	11.8	79.7	12.1	114.0	81.8	10.3	48.5	13.3	25.8	18.6	22.2	31.1	35.9	34.2	20.0	51.8	104.3
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466416-74484796	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 81.1;brain: 28.7;lymphoid tissue: 57.8"	"Group enriched"	"Detected in some"	4	"granulocytes: 57.8;Hofbauer cells: 101.1;Kupffer cells: 71.3;Macrophages: 86.9;T-cells: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 42.2;NB-4: 17.2;RPMI-8226: 33.2"									"HPA010971, HPA011645"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2800000	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010971: , HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	8.6	4.5	9.8	16.0	17.7	11.9	4.4	2.2	11.5	2.0	4.8	3.7	0.0	6.0	1.9	1.3	2.1	2.1	7.7	3.4	7.3	4.2	3.0	7.5	10.6	19.0	20.1	0.3	1.5	2.1	0.3	3.0	6.9	12.6	2.8	4.7	2.3	3.0	1.3	1.1	2.3	7.4	6.0	28.7	57.8	2.4	1.5	17.4	4.1	1.9	0.5	6.0	5.4	2.1	2.2	19.4	81.1	45.7	52.1	29.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.5	17.2	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	81.1	20.4	57.3	29.5	45.7	6.2	2.2	6.1	8.7	19.4	0.6	2.3	7.1	71.6	52.1	44.2	18.1	0.3	19.2	9.8	17.7	2.2	11.5	7.3	4.2	20.1	0.3	12.6	17.4	0.0	11.9	15.7	0.0	0.8	0.0	0.4	2.5	0.0	1.2	0.0	0.0	0.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.0	0.5	0.1	57.8	0.8	101.1	0.0	0.0	3.1	71.3	0.0	0.0	86.9	3.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.2	0.0	0.5	0.5	1.3	25.9	0.0	0.1
CD300LB	"CLM7, TREM5"	ENSG00000178789	"CD300 molecule like family member b"	A8K4G0	17	74521174-74531474	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 20.7;blood: 30.7;bone marrow: 8.8;lymphoid tissue: 10.9"	"Group enriched"	"Detected in some"	8	"Hofbauer cells: 6.5;Kupffer cells: 10.1;Macrophages: 10.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 30.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.5;granulocytes: 30.7;monocytes: 13.0"	"Group enriched"	"Detected in some"	6	"HL-60: 4.6;NB-4: 6.0;THP-1: 4.7;U-937: 2.8"									HPA060449			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA060449: "	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.49e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.01e-2)"	20.7	0.9	0.2	10.9	0.5	8.8	2.0	0.4	0.5	0.6	0.8	0.3	0.1	0.7	0.7	1.0	1.1	1.2	2.8	1.6	1.5	0.4	1.2	1.0	4.4	6.5	1.2	0.1	2.0	2.3	0.0	0.7	1.1	1.0	0.8	1.1	1.6	1.2	0.1	0.3	0.4	2.0	2.2	0.6	6.6	0.7	0.7	0.1	0.9	0.6	0.1	2.2	2.6	0.7	0.0	10.5	30.7	13.0	0.3	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	2.8	0.0	0.6	13.0	30.7	0.0	5.6	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.1	13.8	0.3	0.7	6.6	0.0	4.2	0.2	0.5	0.4	0.5	1.5	0.4	1.2	0.1	1.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.6	10.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CD320	"8D6, 8D6A"	ENSG00000167775	"CD320 molecule"	Q9NPF0	19	8302127-8308356	"CD markers, Disease related genes, Predicted membrane proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 76.2;RPMI-8226: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014500, HPA073489"	Approved		Approved	Cytosol		NA	NA		400000	Cytosol		"HPA014500: AB_1846295, HPA073489: AB_2686609"	"unprognostic (9.97e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (4.19e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.90e-2)"	23.1	20.1	13.1	13.4	14.9	6.3	39.0	12.6	19.1	12.0	23.2	9.7	10.5	16.6	15.8	58.1	11.4	14.9	28.9	20.7	13.2	18.7	15.2	16.3	15.1	18.0	18.0	8.5	14.0	27.6	7.6	11.9	38.0	19.9	19.7	14.2	18.6	16.5	12.8	14.0	6.4	17.4	11.9	11.9	32.8	21.3	23.7	9.3	14.3	22.4	9.3	8.6	12.1	19.6	10.3	25.0	0.8	0.6	18.0	51.3	15.0	12.9	13.3	2.9	38.0	9.6	5.0	6.9	6.8	9.2	13.7	10.5	14.2	7.8	11.7	21.3	5.0	10.2	8.3	0.0	10.8	2.6	16.4	40.7	5.6	11.4	20.2	6.4	10.7	14.2	4.7	2.5	7.9	6.6	6.1	13.3	7.9	17.1	40.3	5.3	12.2	11.3	76.2	20.7	11.4	55.5	14.0	4.0	69.2	10.2	0.3	27.5	11.9	14.1	6.0	17.2	2.2	0.4	4.8	7.5	15.7	11.6	23.4	21.4	38.4	24.0	12.7	11.2	39.3	17.0	0.0	0.6	0.0	51.3	0.6	29.2	10.3	34.0	27.4	1.1	9.9	23.1	26.0	0.8	18.0	0.4	25.0	21.7	15.0	13.1	14.9	12.6	19.1	13.2	18.7	18.0	8.5	19.9	9.3	11.9	19.7	29.0	24.5	16.5	50.8	27.1	10.2	12.0	10.3	17.4	31.4	32.9	11.6	46.3	20.5	85.7	13.4	0.0	15.8	39.7	26.8	49.2	11.5	17.1	23.7	20.6	48.9	51.0	3.8	41.6	20.1	5.8	37.1	6.4	31.5	18.4	22.6	66.2	15.9	39.0	37.7	12.9	31.4	119.7	28.0	12.3	29.6	35.5	88.5	19.2
CD34		ENSG00000174059	"CD34 molecule"	P28906	1	207880972-207911402	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 214.1;Ito cells: 81.0;Leydig cells: 135.4;Peritubular cells: 115.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 32.6;MOLT-4: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000018, HPA036722, HPA036723"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		69000000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272"	"unprognostic (3.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (1.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.01e-2)"	61.9	8.8	4.6	12.8	7.6	1.9	37.5	3.1	6.7	38.3	15.9	5.2	20.5	5.0	41.4	40.3	33.8	22.3	20.6	51.2	5.4	4.9	18.8	2.2	25.0	11.9	8.1	6.7	20.7	8.6	7.8	3.6	78.9	6.3	21.0	7.4	12.8	12.4	20.5	39.7	21.2	12.1	42.3	4.7	9.2	11.3	23.1	4.7	3.5	25.8	35.9	11.0	33.6	33.1	0.6	1.7	1.6	0.3	0.6	0.5	1.5	0.0	0.0	0.1	0.0	1.6	0.1	0.1	0.2	1.2	0.3	0.9	0.0	0.0	0.0	3.2	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	32.6	0.5	0.0	0.0	0.8	0.0	32.1	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.2	1.1	0.0	4.9	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.6	0.2	0.3	0.5	0.2	0.5	0.3	0.3	0.2	0.2	0.6	0.3	0.3	1.1	0.6	0.3	1.7	0.2	1.5	4.6	7.6	3.1	6.7	5.4	4.9	8.1	6.7	6.3	4.7	3.0	8.5	0.0	0.1	14.8	0.4	12.3	2.5	0.0	0.0	3.5	2.0	0.2	0.0	0.2	10.9	214.1	0.0	0.0	0.2	0.3	22.6	0.2	1.1	0.5	0.3	0.0	0.0	81.0	0.3	4.2	135.4	2.2	16.9	0.0	0.0	0.3	0.2	0.0	115.6	0.0	0.0	6.5	4.1	0.7	0.5	11.3	0.1	0.0	0.0	0.3
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 163.4;lymphoid tissue: 109.6"	"Cell type enhanced"	"Detected in many"	18	"B-cells: 979.0;granulocytes: 262.7;Hofbauer cells: 303.3;Kupffer cells: 224.9;Macrophages: 253.6;T-cells: 359.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 67.2;HMC-1: 66.6;RPMI-8226: 23.9;THP-1: 23.9;U-698: 14.8;U-937: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"	7.3	3.1	3.4	62.9	4.8	48.7	3.7	1.0	3.1	1.9	4.2	8.5	0.0	3.2	2.0	2.2	5.9	2.9	5.2	10.4	3.8	3.8	4.3	2.7	25.3	109.6	6.9	1.7	2.5	1.6	0.5	1.9	5.4	4.7	3.5	1.7	2.7	10.7	1.4	1.1	2.0	39.3	1.7	14.5	88.1	5.1	2.9	5.0	47.9	3.4	1.7	86.8	10.2	2.4	163.4	53.7	84.4	62.8	27.9	43.5	58.8	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	11.8	0.0	0.1	0.0	2.0	66.6	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.6	3.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.6	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	14.8	0.0	17.8	0.0	42.8	58.2	71.7	34.3	53.4	34.7	137.2	41.8	36.4	41.1	163.4	43.5	36.3	84.4	27.9	62.8	53.7	40.9	58.8	3.4	4.8	1.0	3.1	3.8	3.8	6.9	1.7	4.7	5.0	8.9	20.5	979.0	1.1	10.4	12.4	1.2	2.5	1.4	4.5	1.8	5.9	1.6	0.0	0.3	98.9	4.3	0.4	0.0	0.0	1.5	5.4	0.5	262.7	2.5	303.3	0.0	1.2	14.1	224.9	158.6	2.6	253.6	27.0	43.3	0.5	1.1	0.0	5.3	0.7	2.5	5.2	0.0	0.5	1.1	0.9	10.3	2.4	359.8	0.4	0.9
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304545-118316175	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 294.2"	"Cell type enriched"	"Detected in some"	31	"T-cells: 377.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	36	"gdT-cell: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8"	"Group enriched"	"Detected in many"	29	"NK-cells: 21.8;T-cells: 62.0"	"Group enriched"	"Detected in some"	67	"JURKAT: 80.1;MOLT-4: 108.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Endoplasmic reticulum, Plasma membrane"		"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	3.9	1.0	0.5	16.7	0.7	6.8	1.9	0.5	0.7	2.1	4.7	0.9	0.7	4.4	2.0	1.4	3.3	3.0	4.0	1.4	0.5	0.5	3.3	2.6	7.3	40.9	1.3	0.6	1.5	1.3	0.0	0.9	1.2	0.9	2.6	3.9	1.9	6.4	1.1	0.8	1.3	21.1	1.1	1.9	34.5	4.6	1.2	0.5	294.2	3.4	2.1	37.8	6.3	3.0	0.2	0.9	1.4	0.2	21.8	62.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.1	0.1	0.3	0.0	0.0	108.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	1.4	0.0	0.1	0.0	1.3	0.2	0.2	59.5	0.1	50.2	0.1	50.7	55.7	0.1	0.2	61.3	62.0	1.4	21.8	0.2	0.9	46.8	32.9	0.5	0.7	0.5	0.7	0.5	0.5	1.3	0.6	0.9	0.5	0.0	11.3	4.5	0.3	4.6	0.0	0.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	6.5	0.2	0.0	0.0	0.0	0.0	1.0	0.1	7.0	0.8	0.3	0.0	0.0	12.3	7.3	0.0	0.0	2.5	11.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.5	0.0	0.0	4.6	0.2	377.3	0.2	0.3
CD3EAP	"ASE-1, CAST, PAF49"	ENSG00000117877	"CD3e molecule associated protein"	O15446	19	45406209-45410766	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 109.3;Suprabasal keratinocytes: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-251 MG: 65.8"					"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	7.3	5.9	7.7	8.4	9.7	4.0	7.1	14.9	9.0	5.6	5.5	6.5	2.9	4.9	6.4	3.0	9.9	7.1	6.4	6.7	7.1	6.4	5.2	6.8	4.5	7.2	8.1	6.0	8.7	18.3	6.6	7.3	5.1	8.0	5.2	4.9	3.1	7.2	4.6	14.2	8.4	4.3	6.6	5.6	5.8	4.3	5.2	9.3	3.6	6.1	7.8	8.5	5.5	5.8	3.5	15.9	1.3	3.7	3.2	4.1	2.1	10.4	10.8	1.7	7.9	2.6	2.1	7.0	5.0	1.7	8.9	5.2	10.6	7.5	16.3	5.3	3.7	7.2	10.1	15.6	14.3	6.3	8.0	10.1	9.0	4.1	7.8	4.4	9.1	3.2	3.2	9.2	12.9	7.1	2.2	6.4	6.0	20.5	3.3	8.6	12.3	6.9	2.6	12.7	11.6	9.1	9.4	6.9	10.7	3.5	7.8	10.8	4.0	10.7	14.3	2.3	3.8	7.2	5.5	6.2	12.7	13.3	7.3	65.8	5.9	23.4	17.3	6.3	13.0	9.1	0.9	2.8	0.3	1.7	3.7	3.4	2.8	2.2	2.4	5.0	3.5	3.1	4.1	1.3	3.2	3.3	15.9	1.2	2.1	7.7	9.7	14.9	9.0	7.1	6.4	8.1	6.0	8.0	9.3	6.0	12.8	10.0	23.3	109.3	4.5	1.2	7.6	6.7	12.5	1.8	9.8	13.7	1.7	15.9	0.2	9.0	1.7	0.0	5.8	19.4	6.6	7.7	5.7	4.2	10.0	11.1	4.6	4.9	2.6	0.5	8.9	7.0	11.8	2.8	4.3	3.5	11.0	0.0	10.6	6.1	5.8	0.0	8.9	0.5	18.9	96.7	6.4	0.0	9.5	11.5
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 187.6"	"Cell type enriched"	"Detected in some"	18	"T-cells: 153.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	30	"gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2"	"Lineage enriched"	"Detected in many"	37	"T-cells: 46.7"	"Group enriched"	"Detected in some"	53	"JURKAT: 24.1;MOLT-4: 64.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	1.1	0.6	0.4	7.1	0.4	0.5	0.8	0.3	0.3	0.7	2.3	0.4	0.4	2.0	0.9	0.6	1.5	1.1	1.9	0.6	0.4	0.4	1.2	0.9	2.4	17.2	0.5	0.2	0.7	0.7	0.0	0.5	0.4	0.3	1.0	1.6	0.9	2.9	0.3	5.9	0.6	8.1	0.2	0.8	11.5	2.4	0.5	0.2	187.6	1.4	1.7	19.2	2.5	1.1	0.1	0.2	1.2	0.2	0.2	46.7	14.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.8	0.2	0.0	0.2	64.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.2	0.2	43.5	0.1	25.6	0.1	36.1	37.1	0.1	0.1	37.6	46.7	1.2	0.2	0.1	0.2	34.2	14.1	0.4	0.4	0.3	0.3	0.4	0.4	0.5	0.2	0.3	0.2	3.0	8.6	0.8	0.0	2.1	0.1	0.4	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.8	1.3	0.1	0.0	0.0	6.2	2.8	0.4	0.0	2.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	0.2	0.0	2.0	0.2	153.8	0.0	0.0
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138870-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 888.0;Ductal cells: 858.7;Suprabasal keratinocytes: 895.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 139.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		2400000000	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	45.5	9.0	10.5	42.5	21.7	53.0	35.6	4.7	13.4	43.2	19.5	26.3	8.3	10.6	80.5	20.3	66.5	18.6	48.0	11.7	14.9	9.3	12.4	9.1	43.4	48.4	31.5	6.1	12.8	83.9	0.8	3.8	19.4	40.7	30.1	24.5	30.2	148.2	22.4	15.9	107.7	18.9	44.5	100.5	30.9	19.9	7.2	20.3	17.9	20.6	53.9	53.7	55.0	54.2	22.7	41.0	19.1	65.2	54.6	53.1	59.9	39.7	35.9	0.3	0.0	21.7	60.0	0.1	77.9	60.9	43.4	24.2	2.4	12.5	0.0	10.4	110.3	89.3	68.5	0.8	84.7	59.6	8.5	0.4	1.4	17.7	0.0	21.4	20.2	93.5	27.0	66.8	58.3	47.4	139.4	15.1	0.0	0.3	13.0	41.6	0.2	1.8	13.3	0.7	0.7	10.6	0.1	7.4	0.6	63.6	11.5	0.1	0.1	14.7	0.4	35.2	3.4	2.1	1.2	43.5	54.1	9.8	66.3	80.0	22.5	24.3	0.2	82.1	11.4	78.6	19.1	65.2	6.0	26.2	45.7	37.0	22.7	39.8	34.9	41.0	16.2	34.5	28.7	16.4	54.6	59.3	14.2	53.1	59.9	10.5	21.7	4.7	13.4	14.9	9.3	31.5	6.1	40.7	20.3	89.3	339.9	168.9	263.7	888.0	0.0	4.0	25.5	18.7	135.4	19.2	2.0	4.0	1.7	858.7	30.1	53.0	5.0	23.3	741.5	3.7	143.9	293.1	733.4	2.5	234.7	0.0	96.2	20.3	427.0	13.8	20.8	611.7	573.6	514.0	84.8	26.6	787.6	8.6	0.4	0.6	1.6	155.2	254.2	0.4	0.4	895.8	15.0	244.8	66.1	304.0
CD46	"MCP, MGC26544, MIC10, TLX, TRA2.10"	ENSG00000117335	"CD46 molecule"	P15529	1	207752057-207795513	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 41.7;eosinophil: 63.7;neutrophil: 69.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 69.8"	"Low cell line specificity"	"Detected in all"											"CAB010401, HPA016903"	Enhanced		Approved	"Plasma membrane"		NA	NA		1000000	"Plasma membrane"		"CAB010401: AB_2291289, HPA016903: AB_1846309"	"unprognostic (1.42e-2)"	"prognostic unfavorable (8.54e-5)"	"unprognostic (3.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.78e-3)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.76e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.49e-2)"	38.0	78.0	13.0	22.9	20.5	18.5	57.0	12.9	17.8	27.5	35.4	25.3	64.3	32.9	39.7	32.6	43.2	30.4	25.2	20.6	16.1	15.5	50.8	57.8	43.6	25.0	21.4	13.2	27.6	47.9	86.6	32.7	119.6	29.1	47.0	28.5	26.7	68.4	60.5	18.8	18.4	39.8	25.0	21.8	26.9	33.9	16.5	20.7	20.3	25.3	21.8	30.3	37.2	27.0	7.7	8.1	69.8	14.1	7.5	13.5	14.9	26.7	15.1	14.2	6.5	44.8	44.4	21.6	20.1	29.2	13.3	18.0	14.8	71.2	4.1	20.5	20.0	18.3	36.3	10.6	27.6	20.3	20.5	15.1	8.9	16.6	26.6	28.5	19.3	31.0	38.1	41.1	20.0	15.8	31.4	37.1	16.3	18.6	17.9	20.4	12.6	9.2	17.0	16.2	16.0	15.1	6.2	22.6	25.2	54.3	53.0	14.4	9.8	25.4	57.2	33.0	29.6	45.0	16.6	31.8	14.3	12.7	30.0	22.8	24.1	29.0	12.4	20.9	12.8	13.4	41.7	13.5	63.7	9.2	14.0	12.5	7.7	11.7	10.1	8.1	6.0	13.5	11.2	69.8	7.5	14.1	4.2	10.1	14.9	13.0	20.5	12.9	17.8	16.1	15.5	21.4	13.2	29.1	20.7	187.6	224.8	34.3	81.1	47.1	61.8	56.5	86.6	227.5	213.9	137.9	62.8	190.0	13.3	67.0	176.4	91.0	82.1	0.0	68.5	62.2	54.2	160.9	108.9	100.2	53.0	38.1	69.8	78.5	81.8	23.7	43.7	72.9	59.1	50.5	91.2	28.9	65.3	92.2	41.4	61.7	79.1	51.8	66.9	13.8	23.3	40.1	287.4	51.1	85.2	127.3
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043094-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		2000000	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (3.54e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.05e-3)"	"unprognostic (8.77e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (7.37e-2)"	"unprognostic (3.78e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (1.83e-1)"	16.2	24.3	23.0	28.8	46.5	58.0	29.0	44.0	55.5	20.5	25.7	42.5	13.4	19.8	16.2	30.4	46.7	31.7	26.0	26.7	24.1	24.4	19.1	22.1	49.6	35.1	27.4	28.8	16.2	25.7	11.5	34.8	23.3	43.6	40.2	29.0	15.7	43.8	18.9	18.1	19.3	21.2	21.0	37.7	29.0	33.4	20.6	25.0	34.4	30.1	22.0	42.5	25.1	29.1	40.1	35.6	44.1	64.4	45.1	65.3	51.7	45.7	8.2	16.6	9.4	23.8	25.6	21.9	17.3	27.1	13.5	23.1	0.4	25.9	21.0	28.1	16.6	31.0	31.4	9.2	17.5	17.6	12.4	6.3	53.5	7.7	0.7	13.8	38.1	72.3	16.4	10.7	12.9	10.4	21.0	13.3	21.8	12.6	50.0	20.0	23.5	46.3	14.3	6.9	42.7	21.0	24.6	12.2	29.7	34.2	18.3	12.6	7.8	10.3	20.5	17.5	8.8	37.1	12.5	12.8	35.0	6.4	19.6	11.7	19.4	13.1	29.5	25.5	19.1	9.6	31.7	24.7	44.1	40.2	48.1	35.0	40.1	47.0	42.0	35.6	39.2	35.4	38.3	30.1	45.1	64.4	27.7	65.3	51.7	23.0	46.5	44.0	55.5	24.1	24.4	27.4	28.8	43.6	25.0	342.4	135.6	141.2	259.6	146.8	90.6	37.8	109.5	58.9	102.4	89.0	90.3	137.8	13.3	418.5	33.5	71.3	35.8	23.3	357.7	75.9	79.2	245.6	56.6	30.2	163.7	116.0	61.4	82.9	78.2	40.6	31.7	105.3	111.3	90.2	60.0	47.2	337.0	107.2	45.6	11.9	214.8	64.7	72.9	25.2	13.2	122.5	101.4	137.1	79.7	264.1
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579467-7582113	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 179.1;lymphoid tissue: 139.1"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 1656.8;Kupffer cells: 486.8;Macrophages: 440.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 68.4;monocytes: 179.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 74.5;U-87 MG: 117.4"	"Low region specificity"	"Detected in all"							"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	118.4	28.5	12.5	46.8	21.6	46.8	40.9	2.9	11.2	27.1	38.1	15.5	2.1	57.0	9.6	24.1	26.9	17.3	33.7	39.0	10.1	6.9	20.9	43.1	84.4	102.5	21.1	4.4	15.8	7.5	2.1	8.5	34.7	15.7	12.1	18.5	12.8	22.2	4.4	16.1	9.4	58.3	15.6	26.0	139.1	17.6	9.4	16.3	13.3	8.8	12.3	21.1	31.4	19.1	3.7	68.4	11.0	179.1	0.9	0.5	125.6	35.7	7.3	0.4	0.5	74.5	28.4	0.3	11.4	31.2	15.2	17.7	1.5	10.8	0.4	13.0	33.1	27.0	1.6	0.1	7.2	10.3	0.3	1.3	5.7	1.8	8.6	6.3	2.8	32.2	9.0	1.5	31.7	23.4	25.1	3.9	0.6	2.2	3.7	14.6	0.2	0.2	2.5	0.4	9.3	5.3	0.4	0.6	21.1	3.1	1.6	0.2	0.4	9.5	4.8	11.1	0.3	0.2	21.9	12.4	19.3	1.2	19.3	14.9	0.2	0.3	0.2	117.4	7.0	9.7	10.1	155.1	0.9	0.4	179.1	0.5	3.7	0.2	0.3	40.9	2.0	0.3	0.2	11.0	0.9	170.1	68.4	0.3	125.6	12.5	21.6	2.9	11.2	10.1	6.9	21.1	4.4	15.7	16.3	0.0	22.4	23.8	26.4	14.0	0.0	0.0	7.6	9.4	13.6	5.2	0.0	7.2	5.0	60.6	0.6	16.8	36.0	0.0	137.4	51.8	33.7	27.3	40.6	16.3	1656.8	0.0	4.7	13.5	486.8	1.1	6.1	440.3	37.1	60.5	7.1	0.2	92.4	25.9	1.8	31.1	1.2	25.8	13.3	0.3	0.2	12.5	27.9	12.5	10.2	68.9
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609533-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"blood: 75.5;lymphoid tissue: 59.7"	"Cell type enriched"	"Detected in some"	4	"B-cells: 82.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 34.3;naive B-cell: 75.5"	"Lineage enriched"	"Detected in many"	22	"B-cells: 75.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.7;Karpas-707: 8.2;REH: 5.3;U-698: 28.3"	"Region enriched"	"Detected in single"	7	"basal ganglia: 3.6"	"Low region specificity"	"Detected in single"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	1.9	1.2	0.8	16.6	1.1	2.6	1.3	0.6	0.6	0.7	0.9	0.2	0.5	0.3	0.8	2.1	0.8	0.7	1.6	0.6	0.8	0.7	1.5	2.3	2.2	26.8	0.8	0.1	0.5	1.4	0.5	1.6	1.5	1.1	0.9	0.3	1.1	3.4	0.1	0.5	0.8	5.2	0.6	1.8	59.7	0.8	0.8	0.2	1.5	1.4	0.3	22.2	4.9	0.6	75.5	3.4	0.2	0.6	1.7	0.7	2.5	0.1	0.0	0.4	0.2	0.7	3.9	0.1	0.2	0.1	0.3	0.5	0.0	0.1	12.7	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.2	0.3	0.4	0.0	0.0	0.4	0.2	2.8	1.1	0.0	0.2	0.3	0.6	0.0	2.8	0.0	8.2	0.7	0.0	0.2	1.7	0.1	0.0	0.1	5.3	0.0	3.8	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	28.3	0.5	0.4	0.0	0.0	0.3	0.0	0.5	0.6	0.7	34.3	0.2	0.3	3.4	75.5	0.1	0.4	0.2	1.7	0.0	1.8	0.3	2.5	0.8	1.1	0.6	0.6	0.8	0.7	0.8	0.1	1.1	0.2	0.0	1.1	82.7	0.3	0.9	0.0	0.6	2.5	1.4	0.0	3.5	0.0	0.1	0.0	0.6	0.1	0.5	0.5	0.0	0.6	0.2	0.6	0.4	0.0	0.0	19.7	0.0	1.7	0.6	16.7	0.0	0.9	8.0	0.0	1.8	0.0	0.5	1.2	0.0	0.4	0.3	0.7	0.0	0.8	0.2	1.2	1.0	0.2	4.9	0.3	0.1
CD82	"IA4, KAI1, R2, ST6, TSPAN27"	ENSG00000085117	"CD82 molecule"	P27701	11	44564427-44620363	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"granulocytes: 269.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 80.5"	"Group enriched"	"Detected in all"	6	"B-cells: 51.1;granulocytes: 80.5;T-cells: 25.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 78.9;LHCN-M2: 46.6;U-87 MG: 55.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002508, HPA028900, HPA061418"	Supported		Approved	Vesicles		NA	NA			Vesicles		"CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510"	"unprognostic (5.31e-2)"	"unprognostic (4.62e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.30e-2)"	14.7	4.9	16.3	21.6	23.1	43.6	13.8	6.3	13.6	17.5	20.7	23.0	53.0	25.9	4.8	13.5	58.3	19.8	21.7	12.7	16.9	13.3	10.2	18.8	38.8	22.8	17.9	9.2	9.0	11.6	2.8	3.9	20.7	14.0	14.3	6.8	18.6	29.8	55.2	10.5	34.6	36.0	8.9	10.2	21.9	22.5	4.5	12.6	23.9	8.3	23.5	33.5	16.3	28.1	51.1	6.7	80.5	9.1	7.2	25.6	9.5	5.1	0.7	6.8	1.3	4.6	17.6	0.2	2.9	24.1	5.2	13.3	0.3	3.5	5.3	3.6	1.5	11.0	19.6	0.9	15.3	12.0	23.7	0.4	33.1	1.6	0.1	3.4	9.1	78.9	24.2	17.9	21.9	11.7	13.4	9.2	4.5	0.2	1.6	46.6	3.7	8.8	17.1	0.2	18.7	0.3	0.2	28.2	7.4	3.1	5.0	0.2	0.3	1.8	28.1	3.9	0.9	26.9	9.0	5.1	16.5	2.2	0.3	28.0	0.6	0.0	0.1	55.8	5.0	8.8	48.4	9.1	16.0	4.9	4.8	8.5	51.1	24.9	11.6	2.2	30.9	8.6	3.8	80.5	7.2	3.4	6.7	25.6	9.5	16.3	23.1	6.3	13.6	16.9	13.3	17.9	9.2	14.0	12.6	44.7	44.6	74.3	91.2	48.9	1.8	6.5	45.9	54.9	87.6	150.1	2.0	1.2	10.0	68.4	1.9	26.6	44.6	46.7	58.6	1.0	26.5	41.9	269.5	23.3	60.0	1.6	12.7	43.0	26.7	1.3	37.4	30.2	60.8	10.0	21.4	35.9	63.0	30.0	7.8	2.0	1.9	12.9	28.8	1.8	4.7	58.7	1.1	35.1	29.6	115.3
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.0"	"Cell type enhanced"	"Detected in many"	14	"granulocytes: 177.3;Hofbauer cells: 84.2;Kupffer cells: 123.8;Macrophages: 52.0;monocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.6;HEL: 24.3;HL-60: 6.8;HMC-1: 27.7;MOLT-4: 6.7;U-698: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	NA		36000000	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	15.9	4.8	3.8	18.5	4.5	6.7	3.7	1.3	3.4	3.3	3.2	7.9	7.7	2.5	2.5	4.3	2.7	3.1	6.4	5.0	3.8	3.0	3.1	5.1	9.2	26.0	6.0	2.2	1.8	4.3	0.9	1.9	7.1	5.3	3.7	4.7	2.4	4.3	9.8	1.6	2.7	9.6	4.1	11.1	25.6	3.5	2.8	5.9	13.8	2.9	2.3	16.3	5.8	2.7	5.1	5.4	21.0	7.3	1.0	8.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	6.8	27.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.0	0.0	6.7	5.1	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	1.5	0.0	21.0	7.3	11.0	6.9	6.3	5.2	5.1	5.9	8.2	5.4	4.7	3.5	6.3	1.0	1.0	2.4	3.2	7.9	6.1	3.8	4.5	1.3	3.4	3.8	3.0	6.0	2.2	5.3	5.9	0.0	8.3	23.1	0.7	2.2	0.2	1.2	5.1	1.4	2.3	0.0	0.0	0.4	0.0	0.0	0.6	2.6	0.0	0.0	0.2	0.3	0.8	0.6	177.3	0.9	84.2	0.0	0.0	5.5	123.8	0.5	0.6	52.0	5.0	78.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	2.0	0.8	42.4	0.0	0.7
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079349-23086340	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 232.0;Ito cells: 170.6;Kupffer cells: 149.3;Macrophages: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 14.4;neutrophil: 17.4"	"Group enriched"	"Detected in many"	40	"dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 58.4;TIME: 73.9;U-937: 98.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		440000000	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	50.5	6.1	2.4	15.0	3.4	4.7	31.4	1.0	3.0	13.6	8.1	1.7	3.9	3.2	14.3	12.5	10.0	13.6	14.2	33.3	2.4	2.2	10.8	10.9	34.8	25.3	4.1	1.2	11.6	5.9	5.1	4.3	48.9	5.3	9.7	4.3	4.9	5.9	3.9	16.2	6.8	7.7	15.4	4.3	17.5	7.5	6.9	3.3	6.9	12.3	9.3	4.5	15.6	12.2	0.0	5.5	17.4	14.4	0.0	0.3	4.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	73.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.9	0.0	0.0	14.4	0.2	0.2	10.3	0.0	0.0	0.1	0.0	5.5	0.0	0.0	0.0	17.4	0.0	4.2	0.7	0.3	4.7	2.4	3.4	1.0	3.0	2.4	2.2	4.1	1.2	5.3	3.3	3.0	11.9	3.7	0.6	13.4	0.0	7.3	10.2	5.3	6.8	0.0	0.0	0.2	0.0	0.2	0.4	232.0	0.0	0.0	0.0	0.4	6.5	2.9	4.7	1.3	16.2	0.0	0.0	170.6	149.3	0.2	1.7	59.8	8.5	0.0	0.0	0.1	0.1	0.0	26.2	0.2	0.0	19.4	15.3	0.0	0.2	8.8	0.3	2.9	0.0	0.9
CD99	MIC2	ENSG00000002586	"CD99 molecule (Xg blood group)"	P14209	X	2691133-2741309	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 359.1;breast: 433.0;heart muscle: 347.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 124.8"					"Low region specificity"	"Detected in all"			"CAB000020, HPA035304"	Supported		Approved	"Golgi apparatus"		NA	NA		34000000	"Golgi apparatus"		"CAB000020: AB_2076419, HPA035304: AB_10672861"	"unprognostic (3.71e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.97e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (2.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.61e-2)"	45.7	14.1	85.8	14.4	100.5	11.1	433.0	45.7	60.9	243.9	31.8	4.5	4.5	19.9	258.4	18.3	26.1	22.2	35.2	347.0	103.4	14.7	66.4	24.6	24.5	16.6	161.0	56.6	187.4	28.9	3.3	67.0	138.7	185.5	30.5	20.6	4.5	18.1	37.7	18.9	28.0	23.8	31.1	359.1	18.5	21.7	23.3	101.3	4.5	15.2	4.5	16.1	24.7	208.8	32.7	62.6	4.3	47.1	32.1	107.1	103.6	23.9	27.5	30.8	41.6	124.8	94.6	18.5	64.2	100.7	40.4	58.9	39.7	16.9	1.6	12.6	89.1	22.5	9.4	12.3	16.1	33.6	32.6	31.0	4.6	19.2	34.5	39.6	7.3	36.7	58.8	20.0	22.1	15.6	28.0	73.6	25.3	5.7	0.0	38.1	18.8	63.9	25.0	10.0	2.7	30.0	10.8	25.7	45.4	23.3	16.4	0.1	13.6	15.4	13.9	38.6	81.3	12.3	22.9	67.9	49.8	8.4	47.6	21.6	0.1	0.0	10.5	33.3	18.4	31.1	1.8	47.1	1.5	107.1	11.6	60.4	32.7	72.6	94.6	44.6	20.2	26.8	57.1	4.3	32.1	2.6	62.6	74.3	103.6	85.8	100.5	45.7	60.9	103.4	14.7	161.0	56.6	185.5	101.3	59.6	70.1	119.1	149.0	222.5	0.9	77.6	76.5	73.6	67.1	68.0	0.0	181.3	11.6	139.8	5.6	366.2	95.9	70.0	121.0	161.2	556.7	292.3	222.0	87.0	661.4	0.0	77.6	437.1	220.0	13.6	597.5	294.4	656.3	138.9	114.0	38.7	162.8	176.3	480.5	50.9	3.0	336.3	416.7	17.9	45.6	194.8	102.9	472.0	184.3	245.6
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20588948-20618908	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.5;bone marrow: 68.0"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 120.2;Hepatocytes: 94.4;Kupffer cells: 118.1;Pancreatic endocrine cells: 70.1;Paneth cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 126.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 126.5"	"Cell line enhanced"	"Detected in many"		"A-431: 42.9;CAPAN-2: 28.6;HeLa: 40.6;PC-3: 20.4;SiHa: 51.0;U-937: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA064202	Enhanced		Approved	Nucleoplasm		NA	NA		3700000	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	4.0	1.4	1.5	4.0	1.5	68.0	2.2	1.1	2.4	19.0	8.6	1.7	2.0	2.6	6.7	3.5	38.3	2.9	1.8	5.9	1.7	1.6	12.5	42.1	8.4	9.1	2.0	1.3	2.9	0.8	1.2	0.7	30.8	3.5	4.2	10.2	4.5	6.9	1.5	3.2	7.0	24.7	4.3	1.9	11.8	1.2	2.9	0.9	0.9	3.0	23.3	10.5	3.1	16.5	0.0	1.3	126.5	21.7	0.0	0.1	7.1	42.9	4.2	0.0	0.0	0.0	1.3	0.0	3.3	0.9	0.8	3.4	0.2	28.6	0.0	1.6	6.8	1.8	15.1	0.8	11.2	2.2	0.0	0.8	0.0	40.6	5.4	0.3	0.0	0.0	1.9	1.8	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.0	20.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	51.0	0.0	0.0	0.5	0.0	1.2	0.7	0.0	1.7	3.9	0.2	0.0	0.0	0.0	0.5	18.0	0.0	16.3	21.7	43.3	0.0	11.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	126.5	0.0	9.3	0.2	0.0	7.1	1.5	1.5	1.1	2.4	1.7	1.6	2.0	1.3	3.5	0.9	3.0	1.4	0.9	0.2	1.3	0.1	2.8	2.5	0.0	0.0	5.2	0.0	0.2	36.5	2.4	0.6	4.4	120.2	0.0	1.3	2.7	1.0	0.9	0.0	94.4	6.1	0.0	0.0	28.8	118.1	0.8	0.3	3.7	0.0	0.0	12.5	0.0	70.1	48.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	2.1	1.5	4.9	0.3
CDADC1	NYD-SP15	ENSG00000102543	"Cytidine and dCMP deaminase domain containing 1"	Q9BWV3	13	49247925-49293485	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 173.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047615, HPA058314"	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA047615: AB_2680104, HPA058314: AB_2683677"	"unprognostic (2.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (6.03e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.40e-2)"	"unprognostic (8.27e-3)"	9.3	13.8	11.6	6.5	10.4	11.0	8.6	14.1	12.9	8.4	8.6	7.1	8.4	6.3	9.7	12.5	6.7	7.6	6.7	8.5	9.5	9.7	18.6	15.4	7.0	5.7	9.8	11.2	9.5	5.6	8.8	12.5	4.3	10.7	8.2	6.7	7.6	6.8	9.5	7.9	4.7	6.0	8.4	14.2	8.7	8.0	23.5	8.8	5.5	18.5	7.2	5.2	6.5	7.4	1.0	1.3	10.3	2.7	1.8	3.3	1.4	2.6	3.2	2.8	3.4	14.0	7.7	1.4	6.2	3.9	3.1	3.3	3.2	2.1	3.5	1.3	2.7	3.1	4.4	5.7	2.8	4.0	7.6	4.6	4.0	3.1	3.3	6.1	7.5	2.2	5.3	6.9	3.0	3.8	5.6	4.6	7.0	2.5	2.6	3.9	0.9	7.1	6.2	1.0	4.3	2.8	4.8	3.0	3.5	4.6	0.8	1.6	1.4	4.2	2.7	3.5	1.9	1.9	6.6	3.4	1.7	3.1	4.4	2.8	0.8	2.8	2.2	1.4	8.7	4.6	10.3	1.9	1.5	2.4	1.5	2.6	0.7	1.8	3.3	1.3	1.0	1.6	2.3	2.0	1.8	2.7	1.3	2.5	1.4	11.6	10.4	14.1	12.9	9.5	9.7	9.8	11.2	10.7	8.8	6.0	11.3	3.9	7.2	7.1	12.0	13.6	5.1	24.1	7.9	17.4	11.8	4.0	8.3	4.8	173.6	8.9	5.3	23.3	9.3	7.7	10.8	5.9	24.3	11.5	5.4	3.2	6.4	8.6	9.4	52.5	14.7	8.5	6.8	2.8	7.6	23.8	6.1	5.8	13.4	16.7	12.1	0.0	16.9	32.9	4.1	4.6	2.1	14.4	6.0	5.0
CDC123	"C10orf7, D123"	ENSG00000151465	"Cell division cycle 123"	O75794	10	12195965-12250589	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037830, HPA057540"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA037830: AB_10671368, HPA057540: AB_2732614"	"unprognostic (5.35e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.16e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (5.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.19e-2)"	26.1	28.0	30.8	28.8	50.8	35.7	25.5	24.6	35.0	25.8	32.0	24.2	16.3	21.5	26.1	27.2	34.1	25.3	18.4	36.5	28.5	25.1	33.2	45.1	21.5	34.7	25.9	27.6	19.5	26.0	18.4	26.9	28.8	36.6	20.7	31.8	16.1	22.4	22.9	29.2	29.8	24.7	30.2	24.9	36.2	21.8	22.5	24.6	39.0	24.4	20.5	41.9	29.2	23.4	43.7	40.7	66.4	34.0	32.3	38.8	40.6	31.0	41.6	29.7	36.0	28.6	28.2	24.4	27.0	18.8	39.0	42.0	57.5	39.8	53.6	28.5	34.1	25.3	35.0	54.1	49.5	32.6	37.6	42.5	41.8	33.6	52.7	35.3	32.6	36.3	30.1	25.8	49.3	29.2	19.4	42.6	69.8	43.0	25.8	33.9	28.7	41.6	27.4	52.3	47.7	15.6	43.3	24.8	47.6	35.7	18.1	15.3	30.2	28.9	37.6	33.5	27.3	39.2	36.8	45.7	24.1	29.5	36.6	34.1	25.4	46.6	65.8	30.2	31.2	15.6	28.6	28.7	66.4	31.4	32.4	32.4	43.7	35.3	34.6	40.7	42.1	29.0	30.9	64.6	32.3	34.0	33.2	38.8	40.6	30.8	50.8	24.6	35.0	28.5	25.1	25.9	27.6	36.6	24.6	29.8	31.0	35.7	38.0	48.1	27.6	45.3	30.6	52.2	30.7	33.2	5.9	108.7	72.9	73.7	3.9	34.2	23.6	0.0	72.5	115.3	36.6	29.6	47.4	34.5	85.2	25.4	20.1	36.2	19.4	7.0	38.6	50.4	43.9	112.8	26.7	40.1	66.8	37.7	43.2	54.7	26.4	38.8	43.2	42.1	28.9	64.6	64.9	50.3	44.3	45.3
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 165.7;Late spermatids: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	6.2	2.4	5.8	6.5	5.5	13.7	12.2	1.8	6.2	7.7	11.8	4.8	2.2	7.2	15.1	4.8	3.4	13.7	3.6	4.1	8.8	3.5	6.6	2.4	12.3	15.4	3.8	5.4	5.8	6.7	9.8	8.1	7.6	4.6	10.0	6.3	8.3	7.7	3.9	4.3	5.6	22.6	5.0	3.2	9.6	6.0	38.2	4.7	12.0	6.1	3.4	11.3	5.8	8.4	4.8	6.1	11.6	3.7	3.9	13.0	4.1	2.2	1.8	5.9	6.7	2.2	1.6	4.1	2.9	1.9	2.9	2.3	6.2	1.9	1.1	2.1	1.7	2.3	1.7	4.0	1.6	2.9	2.3	9.9	4.0	1.7	2.0	0.8	5.4	7.1	1.3	0.4	3.1	1.0	1.4	5.1	2.4	30.6	3.5	4.2	1.0	4.3	6.0	3.6	1.4	2.3	4.7	7.6	1.1	2.0	5.1	1.1	1.9	3.0	2.9	4.0	3.0	1.3	7.0	2.2	1.6	3.6	2.7	1.7	1.7	0.6	1.7	1.9	5.0	0.9	11.6	3.7	8.4	7.3	3.3	13.0	4.8	11.3	8.4	3.5	3.1	11.0	5.8	5.5	3.9	2.3	6.1	5.6	4.1	5.8	5.5	1.8	6.2	8.8	3.5	3.8	5.4	4.6	4.7	3.0	5.6	2.2	4.2	3.3	0.2	5.3	0.0	28.1	5.7	1.8	3.9	1.7	0.0	2.7	165.7	9.3	12.8	0.0	1.7	0.8	4.7	6.6	14.0	1.5	2.3	0.0	4.6	6.2	4.6	161.3	4.6	4.3	5.0	5.4	4.7	9.1	2.5	8.7	0.7	1.7	3.6	0.0	2.8	1.9	3.0	2.0	1.8	10.2	2.7	2.3
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188402	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 106.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.8	1.2	1.1	5.5	1.1	13.0	0.8	0.7	1.2	1.1	3.3	0.6	1.0	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1.0	4.0	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23.0	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0.0	1.0	0.1	7.6	3.8	18.1	9.7	0.6	1.2	12.5	10.6	4.0	13.4	10.9	16.4	4.0	22.8	4.2	2.8	8.5	5.8	30.9	7.3	14.2	7.4	16.3	29.1	6.9	8.1	0.6	20.5	8.5	0.6	1.1	16.6	7.2	1.6	5.0	17.0	23.1	12.1	7.2	4.1	25.6	16.0	26.4	7.0	8.7	11.5	11.9	12.4	3.4	7.2	8.5	10.6	6.6	7.7	3.4	12.0	4.0	14.6	2.5	6.6	10.2	7.3	14.5	6.1	18.2	35.8	4.9	22.9	5.5	0.0	0.0	0.5	0.4	0.0	0.0	1.7	0.6	0.2	0.9	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2	0.0	0.0	0.0	0.4	0.3	0.0	106.0	0.0	0.0	0.0	0.0	2.0	1.9	0.0	0.5	14.7	0.1	0.3	0.0	0.8	5.7	0.5	0.4	0.0	0.2	2.5	0.0	1.2	1.3	0.3	22.9	1.4	0.0	0.0	0.0	1.5	0.5	0.9	0.0	1.8	0.2	0.4	0.0	0.4	15.8	13.7	0.0	0.2	0.0	3.2	0.3
CDC26	"ANAPC12, APC12, C9orf17"	ENSG00000176386	"Cell division cycle 26"	Q8NHZ8	9	113255835-113275589	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044130	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044130: AB_10963690"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.79e-2)"	24.2	21.8	19.1	21.0	25.3	15.8	27.4	20.8	19.8	24.2	27.4	18.0	30.9	19.7	20.1	29.4	22.2	18.6	16.6	37.5	18.1	15.9	27.6	34.9	21.7	24.7	24.9	15.2	23.2	24.2	27.4	23.3	26.7	20.7	23.4	23.2	15.6	31.7	24.6	28.1	21.7	37.1	36.3	29.1	27.7	21.8	13.3	25.7	22.7	34.5	20.1	29.7	31.5	44.6	54.8	30.1	65.2	30.3	44.9	68.5	38.2	14.2	23.4	20.5	10.3	35.2	30.4	9.4	20.9	32.9	22.4	22.2	24.6	17.4	26.7	18.7	18.7	25.3	28.3	17.3	31.9	22.4	24.2	12.6	17.5	23.6	22.8	17.2	30.7	17.7	21.0	22.4	20.7	30.4	23.4	30.0	21.4	26.1	20.1	16.9	29.4	26.0	19.8	33.8	67.2	20.9	22.9	44.0	13.1	23.5	25.1	15.8	15.1	28.1	20.3	15.6	23.6	18.6	13.3	19.7	13.5	12.5	19.9	26.9	13.5	23.3	21.1	18.9	18.2	13.1	48.1	30.0	65.2	46.7	30.3	57.2	54.8	59.4	51.5	30.1	45.3	68.5	53.1	46.0	44.9	28.0	25.5	56.7	38.2	19.1	25.3	20.8	19.8	18.1	15.9	24.9	15.2	20.7	25.7	32.8	39.2	64.1	66.0	69.1	19.1	3.6	33.1	41.5	34.2	21.0	21.6	37.2	96.2	52.8	18.0	69.7	46.7	46.7	52.2	58.4	57.1	55.8	26.5	66.9	53.1	14.3	30.6	50.3	51.1	10.0	74.2	59.9	49.0	69.5	42.9	29.4	51.6	55.4	41.1	133.8	30.6	25.8	44.3	31.4	15.8	79.4	40.0	74.6	45.5	76.1
CDC42BPA	"FLJ23347, KIAA0451, MRCK, MRCKA, PK428"	ENSG00000143776	"CDC42 binding protein kinase alpha"	Q5VT25	1	226989865-227318474	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Horizontal cells: 211.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB070414, HPA071252"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB070414: AB_11156796, HPA071252: AB_2686374"	"unprognostic (3.67e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-2)"	17.2	15.2	19.1	8.6	21.1	3.9	14.0	29.2	20.4	21.1	19.3	16.4	13.1	16.9	15.8	9.9	12.3	12.9	16.6	14.1	21.7	17.7	20.8	17.0	11.7	3.5	20.0	16.3	17.4	15.1	29.3	29.6	14.8	19.3	21.1	12.4	11.0	8.4	18.5	11.9	7.6	17.2	27.6	16.6	8.8	25.2	26.7	19.9	0.7	9.8	7.3	2.5	23.4	23.1	0.1	0.7	2.0	0.1	0.0	0.1	0.0	9.5	9.0	9.7	4.5	9.7	12.0	3.4	11.0	15.6	7.6	8.0	7.3	21.8	0.0	11.8	18.2	5.7	4.4	7.1	6.1	9.3	0.0	5.7	7.4	10.8	2.8	11.0	5.9	3.3	8.4	7.9	12.3	12.4	9.5	25.3	5.9	18.7	0.0	12.3	2.6	0.1	1.0	7.9	12.4	8.7	0.0	16.3	0.0	12.2	18.5	7.0	10.2	18.6	7.8	10.9	6.2	10.1	0.3	25.5	13.9	7.3	15.9	14.5	0.0	0.0	0.0	18.5	0.0	18.6	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	19.1	21.1	29.2	20.4	21.7	17.7	20.0	16.3	19.3	19.9	38.7	29.4	1.4	19.9	10.4	96.7	50.6	25.5	21.4	35.2	41.8	111.9	5.2	11.6	22.3	90.9	47.3	45.2	23.3	35.4	6.1	27.8	25.0	6.9	24.5	3.2	211.4	25.3	42.4	7.1	98.3	40.9	6.8	15.1	9.0	24.1	34.1	46.5	54.5	80.2	32.9	64.0	77.6	45.3	40.8	51.3	6.9	1.1	1.3	26.4	26.8
CDC42EP2	"BORG1, CEP2"	ENSG00000149798	"CDC42 effector protein 2"	O14613	11	65314818-65322429	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 52.2;Pancreatic endocrine cells: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 13.3;intermediate monocyte: 29.8;neutrophil: 46.1;non-classical monocyte: 21.7"	"Group enriched"	"Detected in many"	13	"granulocytes: 46.1;monocytes: 29.8"	"Cell line enhanced"	"Detected in many"		"PC-3: 28.8;U-2197: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038562	Approved		Supported	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA038562: AB_10671745"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.73e-3)"	"prognostic unfavorable (2.89e-5)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-2)"	47.2	5.1	7.7	11.8	37.7	2.1	32.1	3.2	15.4	15.9	11.2	39.1	4.7	12.6	13.9	6.3	11.5	12.7	20.5	11.4	10.7	6.6	9.9	6.5	15.0	8.8	31.4	8.9	10.5	7.9	2.2	4.3	16.9	19.7	8.5	4.5	2.5	4.1	8.3	7.0	4.6	10.6	11.6	24.4	15.3	12.0	2.4	24.7	0.0	17.3	7.0	3.2	18.6	16.2	0.2	2.8	46.1	29.8	0.0	0.1	3.9	5.1	6.2	2.2	3.6	8.4	13.5	0.7	5.3	19.3	5.9	7.2	10.4	9.9	0.9	13.2	11.8	2.2	6.1	2.5	14.1	1.8	1.9	3.3	1.2	8.4	7.1	22.8	0.3	0.7	6.1	1.8	16.2	14.9	3.1	14.7	1.2	2.3	3.2	5.4	8.2	0.9	0.8	3.6	11.3	28.8	1.3	1.2	1.8	11.2	2.8	0.7	2.3	11.2	9.4	1.0	1.1	1.8	0.4	16.1	4.3	4.3	31.3	2.2	1.1	1.8	1.7	6.8	0.4	3.3	0.0	13.3	0.5	0.1	29.8	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	46.1	0.0	21.7	0.2	0.0	3.9	7.7	37.7	3.2	15.4	10.7	6.6	31.4	8.9	19.7	24.7	0.0	0.0	1.9	5.3	11.3	13.9	5.5	0.0	2.7	1.2	12.2	0.0	0.3	3.3	52.2	0.2	23.9	11.6	0.0	35.2	2.8	27.9	5.9	5.7	0.9	1.2	3.2	1.7	27.0	22.4	0.9	17.3	9.0	11.8	10.8	4.4	0.8	47.9	10.5	12.7	2.2	4.1	38.8	17.8	1.4	2.5	8.8	1.4	0.7	3.8	33.6
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 88.0;Erythroid cells: 46.7;Spermatocytes: 23.9;Spermatogonia: 49.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	Yes			Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.2	11.1	13.9	10.9	0.6	1.3	5.9	16.4	7.7	18.9	18.8	8.5	7.4	14.8	5.8	4.9	7.5	12.8	14.8	10.8	17.0	18.0	25.0	19.8	12.6	9.3	0.7	28.7	10.9	0.4	0.5	14.5	6.5	1.8	9.5	15.3	87.8	18.7	11.0	17.7	23.3	13.6	4.2	25.7	8.4	19.4	23.1	6.5	4.4	12.7	18.0	9.5	8.9	9.8	2.8	6.5	6.4	12.8	3.6	14.8	23.7	11.2	14.9	6.4	11.8	17.2	7.8	14.4	19.7	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2	0.0	0.0	0.8	0.4	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.9	88.0	0.3	0.4	46.7	0.0	16.8	1.0	0.2	0.0	0.0	6.2	0.0	0.0	3.7	0.6	6.1	0.6	0.9	0.0	0.0	0.8	0.0	0.1	0.0	0.7	0.0	0.0	6.5	0.9	23.9	49.8	1.6	4.1	1.3	2.5	0.4
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287633-40304657	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 23.3;Extravillous trophoblasts: 27.7;Spermatogonia: 23.0;Syncytiotrophoblasts: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 86.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	1.8	2.9	3.1	10.8	2.6	16.8	1.5	2.3	6.0	2.7	5.8	0.8	2.7	5.3	1.9	1.6	9.0	1.3	5.4	1.6	1.9	1.4	1.8	5.1	2.8	10.6	1.0	1.5	1.5	3.6	1.1	1.2	9.4	0.8	1.4	5.6	0.2	3.2	4.1	0.9	2.3	7.9	2.4	1.6	7.7	2.7	14.8	1.2	30.0	1.3	5.0	10.1	4.1	3.0	0.7	6.2	0.2	0.3	2.2	3.4	1.2	25.4	17.6	21.3	15.1	1.1	2.3	19.5	27.8	8.3	24.4	29.5	20.0	11.4	20.6	17.4	5.9	14.1	37.1	18.4	12.6	24.3	10.9	14.5	16.7	21.0	17.9	0.7	22.8	10.3	0.6	0.9	28.2	16.9	2.6	7.3	14.2	30.5	19.3	11.8	13.3	33.1	5.5	17.5	15.1	6.5	24.4	51.9	19.4	4.0	28.7	14.6	13.1	25.3	86.7	8.6	17.4	17.6	19.8	6.1	17.6	25.2	28.8	32.9	8.1	17.5	39.7	15.2	15.1	19.2	0.1	0.3	0.0	1.3	0.0	0.9	0.7	1.2	2.1	1.4	0.7	0.9	2.1	0.2	2.2	0.0	6.2	3.4	1.2	3.1	2.6	2.3	6.0	1.9	1.4	1.0	1.5	0.8	1.2	0.0	1.3	2.2	1.1	3.8	0.0	0.6	0.0	0.0	1.2	0.0	0.0	12.0	0.0	1.2	1.4	0.5	1.1	23.3	0.6	27.7	2.4	1.1	0.0	0.9	6.8	0.0	0.0	1.8	1.3	0.2	2.6	1.3	0.0	0.0	1.7	0.3	1.2	2.9	0.7	0.2	0.3	12.9	1.0	11.4	23.0	1.4	14.0	2.5	4.6	2.0
CDCA3	"GRCC8, TOME-1"	ENSG00000111665	"Cell division cycle associated 3"	Q99618	12	6844793-6852066	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.6;lymphoid tissue: 51.0"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 53.0;Erythroid cells: 46.7;Extravillous trophoblasts: 60.9;Spermatocytes: 57.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.8"	"Cell type enhanced"	"Detected in many"		"T-reg: 7.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026587			Approved	Cytosol		NA	Yes			Cytosol		"HPA026587: AB_1846386"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.51e-5)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (3.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-3)"	"unprognostic (8.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.94e-2)"	1.6	1.9	1.0	19.2	1.8	9.9	1.9	8.8	2.2	2.0	17.3	1.2	1.2	15.5	2.3	2.0	6.9	1.0	2.9	2.2	1.1	1.6	1.3	0.9	1.9	10.8	1.3	0.7	3.7	0.6	0.3	6.9	4.7	1.2	2.2	5.3	0.7	2.4	0.4	0.7	4.3	34.6	2.0	1.4	5.2	2.4	18.2	1.1	51.0	1.3	8.5	15.1	1.6	2.8	1.6	2.3	0.5	0.6	0.8	7.7	0.9	30.1	21.8	22.3	13.5	1.3	2.0	25.9	19.9	12.2	32.8	22.9	32.3	26.0	16.7	2.5	15.0	23.8	20.8	14.3	13.7	32.6	25.1	15.9	15.0	14.6	21.0	0.2	11.1	14.3	0.9	1.1	17.6	9.6	8.0	13.9	11.8	12.4	10.9	31.2	23.6	16.2	12.9	26.1	20.3	16.9	16.4	19.4	9.4	10.9	8.5	3.4	6.7	18.0	16.8	6.2	24.9	6.6	10.8	6.1	16.0	20.7	10.4	33.4	5.6	5.6	26.1	7.5	13.9	28.1	0.0	0.6	0.0	0.5	0.3	0.8	1.6	1.3	1.9	0.7	0.8	0.6	1.2	0.5	0.8	0.5	2.3	7.7	0.9	1.0	1.8	8.8	2.2	1.1	1.6	1.3	0.7	1.2	1.1	0.0	0.3	0.8	1.2	2.6	10.5	1.0	0.0	0.0	0.0	0.0	53.0	3.3	0.0	0.9	5.9	0.4	9.5	46.7	0.3	60.9	2.6	1.0	4.6	0.8	15.7	6.4	1.2	3.1	3.5	5.4	1.7	2.7	0.0	1.8	5.7	1.4	0.3	0.8	0.4	0.7	18.0	6.5	0.4	57.5	14.9	1.6	7.1	0.8	10.9	0.6
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.3"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 133.3;Spermatogonia: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064971			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA064971: AB_2685395"	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (4.19e-4)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	4.5	2.6	1.7	11.5	2.6	38.3	4.1	8.3	3.2	8.7	3.7	2.6	4.5	4.1	5.6	4.0	16.6	4.1	4.2	2.4	1.5	1.3	2.8	3.0	5.1	9.1	2.7	1.4	5.0	6.2	1.6	1.9	12.4	3.3	4.6	2.7	3.3	5.3	2.2	1.3	21.8	4.4	3.1	2.3	6.7	3.6	12.8	2.3	24.9	5.1	11.2	15.0	3.7	8.8	7.4	4.2	8.3	4.3	10.6	14.7	5.5	15.2	15.9	18.4	13.9	3.1	5.2	24.1	22.8	7.0	17.9	15.7	19.4	19.5	20.0	12.5	8.0	13.7	24.5	12.8	26.3	10.5	21.9	10.1	12.7	13.6	16.2	3.9	22.4	10.7	3.7	8.2	13.8	13.0	6.0	12.1	17.5	13.9	20.8	12.4	37.4	20.8	15.1	13.6	13.3	36.4	20.2	26.8	7.4	6.0	17.7	10.8	13.3	21.8	8.8	17.5	8.5	17.2	15.1	18.7	15.9	20.2	21.7	30.2	7.7	9.5	20.5	13.3	11.4	26.2	0.9	3.6	8.3	10.9	3.9	13.3	7.4	11.4	14.7	3.9	5.2	6.8	8.0	1.3	10.6	4.3	4.2	8.9	5.5	1.7	2.6	8.3	3.2	1.5	1.3	2.7	1.4	3.3	2.3	0.0	2.1	10.4	19.9	57.1	3.0	0.6	0.0	8.1	3.4	1.8	0.0	53.6	3.3	12.9	6.4	9.0	1.1	23.3	6.2	133.3	12.5	7.7	28.8	2.1	21.5	12.7	2.9	7.4	6.2	4.3	7.8	10.6	16.9	10.8	4.4	3.4	9.1	3.5	5.6	1.4	2.7	6.5	10.3	31.0	64.2	58.6	21.6	17.5	6.0	48.5
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692418-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.2	1.4	0.9	12.9	1.7	19.0	1.7	0.8	1.6	1.8	6.0	1.1	0.7	5.3	1.4	1.3	9.6	0.7	2.4	0.8	0.9	0.9	1.3	1.5	2.0	12.2	1.8	1.3	0.9	1.0	0.1	0.8	3.7	1.3	1.0	7.7	0.7	2.1	1.0	0.9	4.0	5.4	1.6	1.2	5.4	3.5	44.7	1.7	51.6	0.9	6.5	14.6	1.6	2.9	2.8	1.8	4.5	5.0	6.3	8.9	2.5	28.4	12.4	23.5	17.0	1.0	2.0	15.8	21.5	10.8	38.0	27.0	19.4	21.3	34.6	8.7	13.7	15.3	16.2	27.0	14.2	40.4	23.0	12.1	31.1	13.3	15.3	0.2	29.9	16.1	0.8	1.0	21.4	19.0	4.3	16.8	24.9	26.2	37.2	27.4	12.7	27.5	18.4	27.2	16.6	17.2	26.9	32.1	19.8	8.6	11.9	20.9	9.2	23.6	11.1	14.5	21.1	16.3	11.4	10.1	18.7	19.9	10.7	33.5	25.3	32.9	47.2	8.8	27.8	21.4	0.0	1.1	1.8	2.5	2.2	4.5	2.8	5.7	3.3	1.0	2.5	1.9	3.8	4.5	6.3	5.0	1.8	8.9	2.5	0.9	1.7	0.8	1.6	0.9	0.9	1.8	1.3	1.3	1.7	0.0	0.3	9.3	0.8	3.0	1.1	0.4	5.1	8.1	0.0	0.0	0.0	2.2	0.0	1.1	0.8	0.2	4.2	0.0	0.6	20.9	0.9	0.6	0.0	1.0	9.5	1.6	3.5	1.8	3.1	2.2	1.4	4.6	1.7	2.8	5.1	0.0	1.6	4.9	1.1	0.5	0.8	19.4	0.0	82.1	41.4	2.4	2.4	3.2	6.3	0.9
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68722616	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;retina: 40.5"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 49.5;Basal keratinocytes: 54.0;Melanocytes: 57.3;Pancreatic endocrine cells: 60.0;Urothelial cells: 48.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"pons and medulla: 16.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 24.9;HaCaT: 69.1;HBEC3-KT: 33.3;hTCEpi: 26.6;hTERT-HME1: 20.3;RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	2.2	0.1	1.0	2.5	1.2	0.0	8.7	1.5	1.1	10.5	1.0	2.2	3.0	0.3	9.4	10.3	23.5	8.9	1.4	0.4	1.1	0.8	8.3	0.2	3.6	2.1	0.6	0.4	32.6	0.4	0.5	3.6	6.4	16.0	11.7	0.5	40.5	9.3	4.4	0.1	21.2	0.4	4.1	1.5	10.0	0.7	2.2	0.1	44.0	2.0	26.1	20.1	2.5	6.7	0.9	0.6	1.4	0.5	0.6	0.8	0.2	24.9	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	14.9	9.3	0.0	0.1	0.0	0.0	69.1	0.6	33.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.6	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	1.3	0.2	2.1	0.0	0.0	0.0	29.9	11.3	0.1	0.0	0.2	0.0	11.8	12.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.2	0.4	0.2	0.3	0.6	0.5	0.4	0.1	0.9	0.6	0.8	1.4	0.6	0.2	0.6	0.2	0.2	1.0	1.2	1.5	1.1	1.1	0.8	0.6	0.4	16.0	0.1	14.9	2.9	0.0	49.5	54.0	0.8	1.2	0.0	4.0	13.6	14.0	2.0	21.3	0.0	31.6	0.2	0.5	0.0	0.0	28.5	1.2	3.3	13.1	1.1	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.6	1.2	57.3	1.8	1.4	0.2	60.0	0.0	8.9	0.0	0.4	0.0	1.9	0.2	0.7	26.8	5.3	0.0	0.4	48.9
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404786	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 96.6"	"Cell type enhanced"	"Detected in many"	15	"Endothelial cells: 155.1;Ito cells: 190.9;Syncytiotrophoblasts: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 113.8;TIME: 97.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1000000000	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	48.7	5.6	4.0	6.2	5.8	0.6	28.1	2.6	4.8	11.1	6.6	3.4	5.5	3.7	18.7	11.2	8.4	7.2	12.6	21.7	4.5	4.3	7.8	12.7	43.7	9.7	6.5	2.8	7.7	3.6	5.0	3.5	96.6	7.6	9.0	4.8	8.5	5.2	4.4	19.0	7.0	6.8	12.1	5.4	10.8	5.7	6.7	3.3	1.2	16.6	15.7	4.5	11.7	11.3	0.0	0.6	0.4	0.8	0.1	0.1	1.1	0.0	0.0	0.7	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	97.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	1.1	4.0	5.8	2.6	4.8	4.5	4.3	6.5	2.8	7.6	3.3	0.0	10.4	0.0	0.0	3.7	0.0	14.6	7.6	0.0	1.2	1.8	0.0	3.3	0.0	0.1	33.0	155.1	0.0	0.0	0.0	40.7	3.1	0.1	3.5	1.5	2.1	0.0	0.0	190.9	29.5	47.7	5.8	2.3	11.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.1	13.4	0.2	2.6	67.5	0.0	0.0	0.0
CDH8		ENSG00000150394	"Cadherin 8"	P55286	16	61647242-62037035	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 29.6;seminal vesicle: 9.5"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 10.1;Ciliated cells: 4.0;Early spermatids: 3.8;Spermatogonia: 2.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"AF22: 7.0;fHDF/TERT166: 6.1;HaCaT: 13.9;LHCN-M2: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014908, HPA076441"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014908: AB_1845908, HPA076441: "	"unprognostic (1.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.91e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	0.9	0.9	13.0	0.7	20.4	0.7	1.2	0.5	29.6	1.4	0.8	5.5	0.0	1.2	0.9	1.1	1.0	0.7	1.1	1.1	10.4	7.7	0.8	0.7	0.9	0.7	9.3	12.2	3.7	0.7	0.8	0.9	1.3	12.8	1.4	0.9	0.0	1.4	9.5	1.4	0.9	1.0	1.4	7.7	0.8	0.8	1.2	5.6	0.0	1.0	0.0	0.8	1.7	0.3	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.1	0.0	13.9	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	16.8	0.0	0.0	0.0	1.3	0.0	1.3	0.0	0.0	1.0	0.0	1.8	0.1	0.1	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.0	13.0	20.4	0.5	17.8	10.4	7.7	9.3	12.2	12.8	5.6	0.0	0.3	0.0	0.7	0.1	10.1	1.1	0.0	4.0	1.2	0.0	0.0	0.9	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.4	1.2	2.6	0.1	0.2	0.0	0.0	0.6
CDHR3	"CDH28, FLJ23834, FLJ44366"	ENSG00000128536	"Cadherin related family member 3"	Q6ZTQ4	7	105876796-106033773	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 51.9;lung: 28.9;ovary: 22.3"	"Cell type enriched"	"Detected in many"	6	"Ciliated cells: 341.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 15.9"	"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 6.9;granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.9;Daudi: 10.1;WM-115: 6.8"	"Low region specificity"	"Detected in many"							HPA011218	Supported		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA011218: AB_1078886"	"unprognostic (4.38e-4)"	"unprognostic (9.18e-2)"	"unprognostic (8.16e-3)"	"unprognostic (8.08e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.51e-3)"	0.4	0.6	2.2	0.6	3.3	0.5	2.5	4.4	1.4	2.4	7.6	4.9	1.1	1.1	2.4	14.9	5.9	51.9	0.2	3.3	3.1	2.1	0.7	0.6	28.9	0.4	1.1	0.3	22.3	0.3	0.1	1.4	0.1	15.9	0.3	0.9	0.1	0.3	0.6	0.5	0.4	12.0	1.7	0.6	0.2	4.6	2.2	1.2	0.1	1.4	0.4	0.7	0.3	0.1	6.9	0.2	1.8	0.2	0.3	0.7	0.1	0.1	0.4	7.9	1.4	2.8	2.7	0.2	0.7	0.6	0.3	0.2	0.0	0.1	10.1	0.0	0.5	1.1	0.1	1.9	0.0	0.3	0.9	1.2	0.0	0.2	0.7	0.0	0.2	0.4	1.0	0.3	0.5	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.1	1.8	2.8	0.6	0.0	0.0	0.4	0.1	0.1	0.6	2.9	0.0	0.8	0.5	1.4	0.0	0.0	0.4	1.4	0.5	1.5	0.0	0.0	0.0	3.3	0.2	0.3	6.8	0.1	0.1	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	6.9	0.3	0.1	1.8	0.3	0.2	0.2	0.7	0.1	2.2	3.3	4.4	1.4	3.1	2.1	1.1	0.3	15.9	1.2	3.0	7.2	0.0	1.6	2.4	4.5	1.2	2.5	341.3	55.7	0.0	0.0	0.5	5.0	0.5	5.4	1.0	2.8	0.0	0.5	0.2	1.5	0.5	3.5	1.7	0.1	0.0	28.7	0.0	0.0	2.5	2.6	0.6	8.5	0.0	3.6	9.5	0.2	2.9	1.4	4.4	1.0	6.5	1.7	1.4	3.1	1.8	0.2	0.7	2.9	0.4
CDIPT	"PIS, PIS1"	ENSG00000103502	"CDP-diacylglycerol--inositol 3-phosphatidyltransferase"	O14735	16	29858357-29863736	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056597	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA			"Nucleoplasm, Nuclear membrane, Plasma membrane"		"HPA056597: AB_2683182"	"unprognostic (7.81e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (1.93e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.48e-1)"	40.4	40.8	24.3	20.2	28.1	15.3	42.9	50.7	39.5	37.1	37.2	21.5	33.9	24.8	33.4	23.0	39.4	30.1	34.5	44.4	23.1	27.9	34.8	66.3	27.1	22.4	24.1	26.4	52.7	40.0	47.1	24.9	43.7	21.8	36.8	16.1	29.3	42.2	38.8	21.0	29.6	32.6	31.8	21.0	25.6	29.5	20.2	16.4	30.4	47.1	19.9	17.3	41.8	42.8	4.8	6.1	20.6	6.5	8.2	8.4	2.7	12.5	27.3	7.7	15.4	42.0	29.1	22.8	22.1	24.8	15.7	15.7	15.9	24.2	8.4	41.9	25.4	13.9	19.8	12.4	14.3	7.2	21.1	25.0	6.0	20.4	23.2	29.3	8.9	15.7	49.2	25.2	21.1	9.7	24.9	19.6	16.1	9.0	21.9	14.1	40.1	12.1	17.7	18.3	13.2	20.3	23.7	9.6	24.5	20.7	12.1	31.7	17.8	11.7	24.9	17.4	14.1	18.6	24.4	17.0	23.3	7.4	18.9	11.3	16.3	18.4	6.0	25.4	14.5	14.0	7.5	6.5	20.6	6.9	4.6	4.6	4.7	6.4	7.3	3.0	4.8	6.3	5.9	16.4	8.2	5.7	6.1	8.4	2.7	24.3	28.1	50.7	39.5	23.1	27.9	24.1	26.4	21.8	16.4	23.8	21.2	20.5	35.7	36.7	46.6	49.2	30.6	18.7	10.3	43.6	43.2	92.1	34.9	59.1	22.5	43.2	44.6	46.7	62.9	107.9	45.5	34.0	13.8	36.5	56.9	55.6	35.8	33.2	37.3	11.0	71.1	25.7	21.9	47.7	34.8	54.4	41.4	37.1	58.0	30.1	42.9	45.3	43.2	8.6	14.0	44.4	61.2	40.6	37.0	35.3
CDK11B	"CDC2L1, CDK11-p110, CDK11-p46, CDK11-p58"	ENSG00000248333	"Cyclin dependent kinase 11B"		1	1635227-1659012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 147.7;Spermatogonia: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA025061, HPA073626"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA025061: AB_1846407, HPA073626: AB_2686619"	"unprognostic (7.52e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.75e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.19e-2)"	"unprognostic (6.52e-3)"	10.5	9.8	10.4	11.7	15.1	24.3	8.6	15.0	14.1	9.0	13.3	11.6	6.7	17.4	11.0	6.1	8.6	7.3	7.5	11.2	12.2	9.3	7.9	8.3	12.8	13.1	11.4	9.7	10.3	11.8	9.1	9.6	8.3	11.0	8.9	7.1	7.0	14.0	9.5	33.7	14.0	18.0	14.0	14.8	12.9	9.6	15.8	13.1	12.2	9.5	8.3	10.3	11.6	11.8	5.2	6.2	16.4	4.2	5.1	8.0	2.1	20.5	16.7	12.8	10.1	12.2	8.1	14.3	20.1	11.1	15.8	13.7	18.7	23.3	19.2	20.0	10.0	10.9	18.8	11.7	11.9	9.3	17.4	20.5	20.2	31.1	16.7	14.2	23.0	24.4	10.0	8.1	14.8	11.7	8.9	12.9	21.1	24.5	13.8	8.2	14.4	22.6	22.3	19.2	8.0	20.6	23.3	21.0	15.3	8.4	8.1	14.5	17.7	19.3	19.9	21.3	7.9	14.9	17.1	17.8	15.5	16.4	10.5	19.3	28.4	25.1	38.8	17.9	27.9	10.7	8.2	4.2	6.3	8.0	3.6	4.1	4.2	5.1	5.4	3.1	5.2	5.9	4.4	16.4	5.1	3.8	6.2	4.1	2.1	10.4	15.1	15.0	14.1	12.2	9.3	11.4	9.7	11.0	13.1	17.9	42.1	36.6	15.2	12.8	30.5	36.0	25.5	42.8	48.9	26.2	19.6	25.0	8.3	26.8	28.9	28.9	89.0	23.3	30.7	26.3	20.4	16.2	52.2	33.4	18.4	14.3	27.6	18.4	25.4	16.7	26.7	23.2	5.0	35.1	53.9	22.7	29.9	56.1	25.1	12.6	42.3	51.8	25.5	147.7	172.1	15.2	37.3	27.7	50.7	12.2
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.2;ovary: 9.8"	"Group enriched"	"Detected in some"	13	"Early spermatids: 23.2;granulocytes: 76.3;Late spermatids: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	52	"basophil: 3.5;eosinophil: 6.9"	"Lineage enriched"	"Detected in single"	69	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 14.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HBF TERT88: 18.6;HMC-1: 35.2;LHCN-M2: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	1.3	0.2	0.1	5.2	0.1	0.0	3.7	0.3	0.1	3.4	2.3	0.1	0.1	0.3	4.1	20.2	1.1	1.0	4.2	0.3	0.1	0.0	0.4	0.1	3.3	0.1	0.1	0.1	9.8	0.2	0.0	0.5	0.1	0.1	2.0	0.7	1.4	0.6	0.3	0.7	1.1	3.0	3.9	0.1	0.1	1.1	2.5	0.1	0.1	0.2	1.2	1.2	1.6	1.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1.7	0.0	3.2	14.9	5.6	12.2	0.0	1.5	0.0	0.0	1.3	0.2	0.0	0.0	0.0	18.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	35.2	2.1	0.0	1.5	0.8	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.2	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400560	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 44.5;TIME: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	16.3	9.1	20.6	13.9	47.0	31.5	14.7	17.8	35.7	11.8	12.9	23.6	3.4	9.2	20.7	7.5	11.7	10.9	12.9	9.4	25.3	17.3	9.2	12.4	15.9	15.2	23.8	21.0	12.9	8.0	9.9	7.3	24.3	14.8	11.4	9.8	5.7	7.5	9.3	7.3	9.1	9.3	23.4	19.6	15.8	7.9	19.9	28.0	29.6	9.4	6.1	16.6	11.0	10.7	9.6	5.3	29.1	4.7	16.5	14.8	8.6	4.9	4.2	11.0	2.9	5.4	14.3	7.8	11.1	15.7	9.8	9.3	2.5	2.9	7.4	7.7	8.0	5.3	4.5	6.5	6.9	13.4	7.8	5.0	10.6	2.8	3.5	11.7	5.6	6.1	10.3	7.1	14.5	26.2	17.4	44.5	6.3	7.7	6.0	22.1	3.0	5.3	8.8	4.8	2.4	7.3	9.3	5.9	6.3	11.6	4.2	5.7	3.9	6.5	6.1	8.1	8.7	4.6	5.1	53.3	8.7	3.3	4.6	6.0	8.5	6.5	7.9	3.3	2.4	6.4	29.1	3.4	8.9	12.7	4.7	13.7	9.6	10.4	14.4	5.3	8.8	14.8	12.6	12.8	16.5	4.6	3.9	8.1	8.6	20.6	47.0	17.8	24.6	25.3	17.3	23.8	21.0	14.8	28.0	14.9	6.2	24.4	8.9	23.8	10.8	8.9	5.1	9.4	10.3	8.7	15.7	10.0	0.0	4.6	2.7	42.9	6.0	0.0	3.2	25.8	15.5	10.4	17.4	8.9	10.5	4.8	14.5	35.6	15.3	3.2	9.2	9.4	16.9	7.2	7.4	20.2	5.7	3.5	8.9	6.9	9.2	6.5	27.8	6.5	7.6	22.6	11.4	27.7	5.5	11.8
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504595-205532793	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 98.7;heart muscle: 58.9"	"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 69.8;Paneth cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 20.1;HeLa: 17.7;hTERT-RPE1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.81e-5)"	2.6	4.3	13.6	2.7	31.8	1.0	2.4	4.2	25.0	7.6	6.9	38.1	20.2	17.3	3.4	4.0	2.7	5.7	6.4	58.9	22.1	16.2	13.7	4.7	6.5	1.9	47.8	16.7	7.5	10.7	3.7	4.0	9.6	22.1	3.1	6.1	5.3	16.5	23.5	3.9	1.6	15.1	4.8	98.7	3.5	9.1	0.9	36.4	0.4	4.8	1.4	2.5	3.7	4.7	0.1	1.4	0.0	2.1	0.6	0.9	0.6	11.7	0.8	0.1	0.6	0.0	0.0	12.7	0.2	2.4	0.5	3.1	5.3	8.8	7.0	1.8	0.1	1.0	10.6	2.6	20.1	0.5	1.9	2.3	1.6	17.7	5.4	2.3	0.0	0.0	1.3	1.0	0.0	0.4	17.2	0.0	10.0	0.1	8.5	0.1	9.5	0.6	0.3	10.0	3.4	0.4	0.9	0.0	8.8	1.9	7.5	4.1	1.6	3.6	1.7	7.8	14.7	7.9	3.4	0.0	0.0	4.8	0.0	0.0	2.4	1.1	1.4	0.1	5.0	2.0	0.0	0.8	0.0	0.1	2.1	0.9	0.0	0.2	0.0	1.4	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.6	13.6	31.8	4.2	19.7	22.1	16.2	47.8	16.7	22.1	36.4	0.0	0.3	0.0	6.7	3.1	4.7	25.0	7.6	0.0	1.2	69.8	0.0	4.9	6.6	15.9	1.6	1.9	20.6	0.0	5.8	1.9	4.8	1.9	0.0	3.9	5.1	0.0	5.8	1.3	1.6	2.8	0.9	3.6	3.3	7.2	12.9	19.1	6.3	98.2	1.4	15.4	1.2	6.5	12.5	1.4	10.0	1.1	1.6	0.5	11.5	5.9
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	"Cyclin dependent kinase 19"	Q9BWU1	6	110609978-110815958	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 84.5;Late spermatids: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA007053: AB_1233803"	"unprognostic (1.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (4.72e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.50e-3)"	5.3	3.3	18.1	6.1	29.4	9.7	6.0	13.8	21.3	6.6	6.3	31.1	2.4	4.8	9.6	3.7	7.8	5.3	7.8	4.1	20.8	10.1	6.3	4.6	6.2	8.0	22.1	12.9	9.7	3.1	8.0	4.1	10.5	14.4	25.8	6.1	3.4	4.5	5.9	3.2	7.9	5.9	7.1	20.8	7.0	6.5	16.4	26.3	6.1	5.8	1.3	8.4	5.9	6.4	1.3	1.8	8.5	2.2	1.3	0.8	0.6	3.6	3.9	13.7	16.5	7.4	10.7	7.1	11.9	12.7	4.5	5.9	4.9	4.1	9.3	4.3	8.3	9.0	2.1	5.2	2.5	10.3	11.5	3.0	15.8	5.8	5.7	4.5	6.4	11.9	7.3	5.6	6.1	9.5	11.3	4.4	7.9	4.8	13.0	9.6	5.9	8.6	9.6	1.3	5.2	2.7	9.2	7.0	3.5	5.2	6.7	7.0	13.0	9.0	7.4	10.6	4.8	2.5	23.6	4.9	9.4	5.0	18.9	7.2	1.4	1.9	8.0	9.9	8.7	9.7	3.3	2.2	1.5	0.8	1.2	0.8	1.1	0.7	0.7	1.8	1.3	0.5	0.7	8.5	1.3	0.7	0.9	0.8	0.6	18.1	29.4	13.8	21.3	20.8	10.1	22.1	12.9	14.4	26.3	3.0	16.2	8.1	13.2	8.8	17.3	6.2	12.7	4.0	7.9	15.7	15.7	5.4	1.7	7.5	84.5	11.7	13.8	0.0	4.1	17.1	10.8	49.2	6.9	10.5	14.4	22.3	12.1	14.7	33.3	95.4	10.0	18.4	25.3	3.6	14.2	34.3	6.0	17.5	15.2	5.6	14.1	6.5	8.5	38.1	14.1	14.2	6.6	12.8	12.9	7.4
CDK2AP2	"DOC-1R, p14"	ENSG00000167797	"Cyclin dependent kinase 2 associated protein 2"	O75956	11	67506497-67508649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047599	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047599: AB_10963069"	"unprognostic (2.44e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (8.80e-4)"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.73e-3)"	16.2	28.0	16.8	20.4	22.4	17.0	26.2	13.5	15.6	20.5	22.4	13.1	32.3	23.4	16.6	44.8	17.8	16.6	18.6	28.6	16.2	14.8	43.3	45.5	19.6	23.8	21.9	9.2	12.3	41.6	9.0	18.1	19.5	21.3	16.0	14.4	8.1	55.1	24.9	9.6	10.1	20.0	13.8	21.1	19.0	19.7	6.8	21.4	28.3	80.3	10.6	22.9	17.4	35.8	25.9	91.6	27.8	30.0	32.5	37.6	23.3	16.8	11.0	5.9	10.4	8.0	2.5	9.4	6.5	3.1	7.6	7.1	13.9	19.7	12.5	22.1	4.3	9.9	12.1	8.7	11.5	2.2	23.5	8.0	6.7	8.5	9.6	18.4	6.5	10.4	3.0	12.6	5.8	13.5	7.5	8.4	17.7	7.0	26.5	4.0	26.1	32.8	22.3	5.3	32.6	18.4	15.0	3.5	40.3	18.0	4.2	4.5	10.3	8.0	16.3	26.3	5.1	11.7	12.9	7.0	4.9	8.9	12.1	4.8	11.2	6.7	10.7	14.5	8.6	5.5	23.9	17.2	27.8	37.6	27.0	32.5	25.9	29.1	34.0	23.0	24.0	17.1	24.6	11.3	32.5	30.0	91.6	32.6	23.3	16.8	22.4	13.5	15.6	16.2	14.8	21.9	9.2	21.3	21.4	59.6	74.7	108.7	45.0	59.5	27.2	75.3	86.6	68.3	58.0	111.7	29.5	94.6	182.4	73.9	0.9	46.6	169.0	0.0	46.4	142.7	44.3	65.4	73.8	110.5	74.2	31.8	98.5	41.1	36.7	1.6	22.7	61.1	108.0	148.7	60.1	47.9	95.1	91.2	28.7	224.3	19.5	25.8	79.5	7.2	30.9	44.5	162.6	126.6	78.6	49.7
CDK3		ENSG00000250506	"Cyclin dependent kinase 3"	Q00526	17	76000906-76005999	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Basal keratinocytes: 2.4;Distal tubular cells: 1.7;Ductal cells: 1.4;Exocrine glandular cells: 2.0;Melanocytes: 3.3;Pancreatic endocrine cells: 2.0;Suprabasal keratinocytes: 2.4"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA007420	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007420: AB_1078490"	"unprognostic (6.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.80e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.75e-7)"	"unprognostic (4.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (4.47e-4)"	4.1	3.7	2.7	4.7	2.4	5.5	4.7	4.2	2.4	4.9	4.8			6.5	5.6	5.7	4.0	5.0	4.8	2.6	2.8	3.0	5.9	13.0	5.3	5.5	3.0		6.7	5.9	4.2	8.3	5.0		10.3	5.3		5.2	4.5	0.9	14.7	9.1	4.1	3.9	8.8	5.2	5.6			8.2		5.4	3.8	5.1	1.2	1.8	1.5	1.5	1.7	2.7	1.6	4.2	7.8	11.6	6.1	6.8	8.1	24.2	5.3	3.4	5.9	5.5	6.1	8.9	6.4	4.7	4.6	4.8	9.9	9.3	3.9	3.9	3.3	14.9	13.3	15.5	6.0	5.7	4.6	13.6	7.3	8.6	5.2	4.3	10.6	6.5	4.0	5.9	4.6	3.8	10.9	5.4	20.7	5.8	3.7	8.5	10.0	5.1	5.9	5.5	14.1	8.4	22.6	3.5	11.4	2.6	12.2	15.7	9.5	5.5	16.1	9.5	6.8	5.6	9.6	7.2	6.0	4.9	4.7	3.9	0.0	1.5	0.0	2.1	1.0	0.2	1.2	1.6	1.2	1.8	0.3	2.7	0.5	1.5	1.7	0.6	1.6	2.7	1.6											0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.3	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5.0	6.2	5.8	25.0	19.7	9.0	7.7	5.3	6.0	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6.0	6.3	5.7	6.5	6.2	6.0	8.6	5.2	5.7	3.1	7.7	6.8	6.0	3.6	6.9	6.7	3.1	6.6	21.5	9.0	21.7	9.5	14.9	10.6	11.7	14.1	13.2	21.5	14.6	10.7	6.6	7.8	12.8	15.3	12.6	10.0	11.0	11.6	27.9	9.6	22.8	8.4	21.2	11.8	7.0	9.1	12.6	12.7	12.4	9.9	9.6	10.2	23.9	11.6	8.9	12.6	3.9	21.4	10.3	18.2	12.9	8.5	15.3	22.7	27.6	21.0	14.5	18.9	22.3	13.5	5.4	12.9	13.3	8.9	8.4	35.9	11.2	13.8	14.7	12.6	6.4	9.0	8.7	15.1	3.9	11.3	14.5	19.7	21.5	4.5	23.7	14.8	27.0	7.8	19.0	9.0	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25.0	19.7	15.4	15.4	20.8	7.7	0.0	5.9	11.5	6.4	3.2	11.5	3.2	7.6	8.1	7.9	10.4	2.0	20.0	33.2	19.0	0.6	6.3	7.1	0.0	16.6	10.2	6.6	5.0	31.0	9.6	37.8	0.0	8.6	6.2	21.6	0.9	4.4	14.3	10.1	20.8	9.1	11.5	18.7	14.4	10.6	24.0	4.7	6.5	5.0	2.6	9.7	5.5	7.6	8.5	9.6	7.6
CDK5RAP1	"C20orf34, C42, CGI-05, HSPC167"	ENSG00000101391	"CDK5 regulatory subunit associated protein 1"	Q96SZ6	20	33358839-33401561	"Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066301			Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles"	Mitochondria	"HPA066301: AB_2685653"	"unprognostic (2.86e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.49e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.18e-2)"	"unprognostic (5.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.06e-1)"	13.9	12.8	15.1	13.0	23.0	20.8	14.8	29.2	22.4	11.1	12.2	18.3	12.3	11.3	15.4	15.4	13.2	12.8	8.3	15.0	11.2	9.5	11.8	14.6	12.5	14.7	12.2	16.2	14.0	12.4	16.6	17.9	13.1	15.5	11.5	16.2	15.5	19.7	12.0	29.2	19.0	14.5	14.1	10.1	15.8	13.0	14.8	15.9	14.4	15.8	11.2	18.7	13.4	12.5	16.0	14.2	8.5	16.3	15.6	17.4	10.8	11.0	11.5	8.0	7.2	7.6	5.9	17.7	6.7	9.6	19.5	20.5	48.5	10.0	19.6	9.0	7.2	12.6	16.4	13.6	19.0	15.1	3.6	7.2	23.6	11.9	18.4	9.0	14.9	7.5	7.7	8.2	12.9	15.7	4.9	10.7	5.6	14.9	8.2	8.4	11.1	15.2	11.2	5.9	12.4	17.0	11.3	18.2	15.0	10.6	9.8	11.0	6.1	21.3	10.2	14.1	9.6	14.8	7.2	7.9	14.4	11.8	9.8	11.2	7.1	8.0	14.5	8.6	16.1	6.8	3.3	12.7	8.5	14.7	16.3	17.4	16.0	14.5	14.0	14.2	9.8	13.1	11.3	0.7	15.6	13.0	9.9	12.4	10.8	15.1	23.0	29.2	22.4	11.2	9.5	12.2	16.2	15.5	15.9	14.9	18.3	13.4	9.5	10.8	25.5	14.2	12.7	9.4	3.4	7.0	25.5	27.3	11.6	14.6	1.5	10.7	10.1	23.3	15.9	14.6	8.0	6.7	28.9	13.4	15.2	11.1	12.1	4.3	10.5	2.5	12.0	15.9	10.1	15.4	9.4	15.1	10.4	10.5	9.9	12.4	37.2	19.4	10.8	25.0	21.5	9.2	13.4	19.2	11.9	7.8
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981774	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favorable (7.31e-5)"	15.5	19.7	20.8	30.0	38.3	21.2	22.5	35.7	31.9	21.1	21.2	27.1	39.4	24.1	26.2	45.4	20.8	26.1	22.0	14.4	23.2	16.7	23.2	31.0	18.8	22.0	31.3	25.8	28.9	51.9	29.4	41.3	15.4	27.3	24.2	25.5	25.1	44.0	26.4	10.7	16.8	25.8	18.4	18.2	32.3	28.6	40.1	29.5	32.3	29.7	16.5	24.6	20.0	18.5	22.8	26.9	27.2	33.5	22.4	22.3	21.0	21.6	35.0	19.4	34.6	16.2	16.3	34.7	15.8	19.3	16.0	14.8	27.4	21.1	26.1	32.8	16.5	10.9	21.3	12.5	17.8	17.9	38.6	16.6	12.5	41.6	37.1	18.2	14.7	13.9	18.6	15.1	14.4	28.3	19.1	15.5	52.1	14.7	24.3	16.3	41.5	40.0	23.8	11.6	26.0	15.1	21.4	32.6	29.6	15.9	27.3	13.2	31.7	12.3	11.0	15.9	20.3	25.0	19.2	12.4	13.3	11.8	16.0	20.3	31.9	30.1	16.2	16.6	20.4	16.1	9.1	33.5	27.2	20.9	32.7	22.3	22.1	20.0	18.5	26.9	22.8	18.1	19.9	15.7	22.4	32.5	24.4	19.0	21.0	20.8	38.3	35.7	31.9	23.2	16.7	31.3	25.8	27.3	29.5	23.8	60.0	43.9	57.3	29.9	50.5	21.5	53.5	68.3	54.6	38.4	29.5	59.3	43.1	46.8	30.4	31.5	56.4	0.0	58.8	47.0	41.2	53.4	67.1	47.9	55.2	54.0	59.1	22.1	38.3	29.6	37.7	41.1	43.9	48.7	49.8	44.7	36.9	56.1	28.0	39.9	50.6	32.3	28.5	71.6	40.3	22.6	51.5	51.6	47.6	51.4
CDK8	K35	ENSG00000132964	"Cyclin dependent kinase 8"	P49336	13	26254104-26405238	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 55.8;Late spermatids: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044721			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044721: AB_2679059"	"unprognostic (3.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.37e-2)"	7.6	8.8	10.1	10.4	8.5	5.2	5.6	26.9	11.3	5.9	24.0	6.0	13.8	13.8	11.2	6.5	10.0	7.0	11.2	7.6	8.3	7.3	9.4	10.4	6.7	5.2	7.8	7.9	6.1	12.7	8.4	10.2	10.6	8.2	7.8	11.2	4.6	9.0	19.2	9.7	6.1	15.0	12.7	6.0	6.4	11.7	16.3	9.9	12.8	6.4	6.9	7.2	15.5	11.0	1.9	1.7	3.4	1.6	1.0	2.1	1.3	6.9	5.7	11.6	11.8	6.2	7.6	7.2	13.4	9.2	10.0	7.2	16.6	9.7	7.4	5.9	6.9	8.0	8.6	13.3	9.0	12.6	17.1	7.4	14.1	4.6	5.7	4.3	22.0	8.1	5.5	8.7	7.5	12.7	5.5	7.3	12.1	21.8	0.0	9.0	7.4	16.8	10.3	9.2	10.5	7.1	10.6	11.5	5.1	5.8	6.5	9.9	5.8	5.7	10.9	9.8	9.6	3.9	10.1	7.4	6.4	8.2	11.7	7.3	5.7	10.1	13.6	4.0	9.3	7.6	0.4	0.9	3.4	1.1	1.6	1.9	1.0	1.5	2.1	1.7	1.9	2.1	1.7	0.0	1.0	1.2	1.0	0.6	1.3	10.1	8.5	26.9	11.3	8.3	7.3	7.8	7.9	8.2	9.9	8.9	4.1	4.5	6.7	17.5	19.1	5.0	7.6	0.0	5.7	1.8	23.6	7.2	8.3	8.5	55.8	6.8	9.7	0.0	7.2	8.3	9.3	11.0	0.0	5.4	7.1	17.5	8.1	6.2	7.5	83.1	7.2	6.6	8.5	8.2	7.8	7.1	10.6	11.5	7.8	11.5	16.6	6.5	11.3	27.8	17.5	20.8	8.1	6.9	10.5	9.1
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	26.2	27.0	22.8	18.9	22.4	33.9	17.4	31.0	26.8	23.1	21.9	22.9	24.7	16.6	22.5	20.1	22.7	29.1	21.5	22.9	26.3	23.4	18.5	48.7	23.3	26.6	23.4	18.8	43.7	29.1	15.5	28.4	19.8	20.6	20.7	10.8	18.7	20.6	21.6	14.6	26.6	21.4	21.0	17.9	29.0	17.7	22.3	16.1	29.3	25.8	18.3	24.2	17.0	17.6	6.0	8.9	5.1	6.4	18.6	9.9	2.9	9.0	16.4	10.3	11.3	11.7	9.2	13.5	9.3	13.7	9.7	8.8	12.2	10.2	15.9	10.9	10.5	13.4	18.3	6.8	15.2	3.7	14.2	8.1	14.8	17.8	10.0	17.1	14.3	23.8	16.1	18.6	10.3	11.6	12.6	20.0	14.2	12.8	21.3	8.7	23.8	15.6	21.6	22.8	13.7	17.6	45.2	8.8	22.7	14.1	10.1	10.2	12.2	14.0	14.8	8.3	8.4	18.6	13.6	22.9	11.7	13.2	10.0	9.0	38.9	29.9	14.2	10.9	9.8	10.6	3.7	3.4	4.9	9.9	4.5	9.9	3.5	5.6	7.9	4.4	6.0	6.3	7.7	5.1	18.6	6.4	8.9	3.8	2.9	22.8	22.4	31.0	26.8	26.3	23.4	23.4	18.8	20.6	16.1	11.9	14.3	20.4	20.9	21.4	13.1	12.9	15.3	18.7	7.9	10.4	2.0	18.7	13.3	26.6	3.2	26.7	12.9	0.0	32.7	18.8	16.4	18.5	24.3	23.6	20.6	23.8	18.5	31.9	17.0	4.3	18.1	18.9	15.1	64.9	11.8	16.2	30.5	11.8	29.4	12.7	7.5	0.0	22.7	7.5	24.0	19.3	42.9	23.5	13.1	23.1
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75578005-75630716	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 55.4;Ciliated cells: 28.1;Spermatocytes: 46.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HEK 293: 3.8;HHSteC: 4.4;RPTEC TERT1: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.7	2.4	7.1	1.2	11.1	0.7	1.2	7.7	13.2	1.7	2.0	6.2	0.0	1.0	1.7	2.3	2.3	4.1	1.4	1.3	5.1	6.7	11.8	0.7	9.2	1.3	7.1	7.0	3.8	1.6	5.7	8.9	0.7	12.5	2.0	2.4	3.4	1.2	2.0	0.7	0.9	0.9	1.5	7.4	0.9	1.5	27.7	6.1	0.0	6.9	0.0	2.0	1.1	0.9	0.4	0.0	0.2	0.0	0.0	1.6	0.1	5.7	0.7	0.3	0.0	0.3	0.3	0.0	0.3	1.8	2.4	2.0	0.5	1.2	0.1	0.9	0.1	2.3	0.8	0.0	0.5	2.3	0.2	3.8	0.0	0.2	0.0	4.4	0.0	0.1	1.5	2.1	0.4	0.8	1.9	0.1	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	8.2	0.3	3.1	2.5	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.4	1.6	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.2	0.1	7.1	11.1	7.7	13.2	5.1	6.7	7.1	7.0	12.5	6.1	23.8	55.4	0.0	0.4	0.1	16.6	0.8	0.0	28.1	7.9	8.7	3.9	0.0	6.6	2.0	24.5	0.0	0.0	0.0	0.2	0.5	0.2	0.3	1.1	0.0	0.1	9.5	1.7	0.6	0.0	16.4	1.7	0.5	1.7	0.0	0.2	10.4	0.1	0.0	1.1	20.7	19.5	0.0	0.0	46.8	1.7	0.3	0.2	1.0	2.6	0.1
CDKN1B	"KIP1, P27KIP1"	ENSG00000111276	"Cyclin dependent kinase inhibitor 1B"	P46527	12	12715058-12722371	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Muller glia cells: 157.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003691, CAB021888, HPA059086"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900"	"unprognostic (5.67e-2)"	"unprognostic (9.76e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.90e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	29.8	30.9	30.2	25.0	30.0	40.2	45.3	64.5	50.6	31.6	34.4	35.6	19.9	29.2	33.1	19.8	26.0	24.3	24.3	21.2	33.0	29.5	20.8	23.3	29.2	38.5	42.9	25.1	46.2	15.1	22.2	15.9	26.8	26.3	25.1	22.2	31.4	23.5	24.2	48.8	26.1	26.4	19.4	46.0	34.3	19.4	19.2	39.0	43.0	29.4	21.4	25.5	34.1	29.1	6.2	3.3	19.2	4.5	6.2	10.6	2.9	12.4	6.2	33.2	5.8	11.4	6.5	16.3	11.7	18.6	16.2	20.0	17.7	14.1	0.1	4.4	6.6	5.8	11.9	15.5	5.7	14.5	21.1	11.0	9.7	17.1	17.8	15.3	8.2	6.9	7.1	12.4	5.3	15.6	38.1	9.6	18.8	10.4	35.5	5.7	15.9	11.5	11.8	13.3	10.8	5.8	8.5	10.8	20.9	7.8	13.5	12.6	20.7	16.8	12.1	21.9	12.4	6.4	18.5	6.5	8.0	12.8	7.2	11.3	30.8	20.3	11.2	10.0	12.4	7.7	4.5	3.1	6.8	5.4	3.1	5.6	6.2	6.9	6.5	3.2	4.8	7.4	5.2	19.2	6.2	4.5	3.3	10.6	2.9	30.2	30.0	64.5	50.6	33.0	29.5	42.9	25.1	26.3	39.0	41.7	24.0	37.6	14.6	46.8	43.1	37.8	20.4	48.2	27.3	8.7	25.5	36.5	13.3	8.0	57.9	56.5	24.9	23.3	8.0	38.1	31.0	32.5	30.1	26.7	22.7	9.5	43.9	46.6	57.3	37.2	51.8	41.9	70.9	14.4	35.8	157.6	10.4	17.5	25.1	12.1	25.0	90.5	40.9	7.7	4.9	45.9	32.6	76.1	40.2	13.6
CDKN1C	"BWCR, BWS, KIP2, P57"	ENSG00000129757	"Cyclin dependent kinase inhibitor 1C"	P49918	11	2883213-2885773	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.3;placenta: 105.6"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 482.4;Extravillous trophoblasts: 1267.0;Syncytiotrophoblasts: 1874.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 26.1;non-classical monocyte: 60.3"	"Lineage enriched"	"Detected in many"	12	"monocytes: 60.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 8.4;HeLa: 8.7;RPMI-8226: 11.4;SH-SY5Y: 23.3;SiHa: 16.3;SK-MEL-30: 8.9"									HPA002924	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA002924: AB_1079548"	"unprognostic (5.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.79e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	53.6	20.7	3.3	5.4	11.9	3.4	13.0	0.9	9.2	10.6	6.9	18.4	3.9	3.3	8.3	5.2	9.9	8.5	7.7	6.9	8.5	5.4	22.7	3.0	5.1	1.8	28.7	4.9	30.9	7.9	1.5	4.0	105.6	11.5	7.2	1.9	8.3	3.1	5.9	27.6	3.0	7.9	6.3	27.9	7.1	7.4	4.3	14.5	0.3	2.0	7.6	2.1	11.2	9.8	0.0	5.0	1.4	60.3	0.0	0.3	2.5	0.1	0.0	1.1	0.0	0.3	0.3	1.2	0.2	0.4	0.2	0.0	2.2	0.2	0.0	8.4	0.1	0.1	0.3	0.2	0.2	0.1	3.8	0.8	0.1	8.7	0.0	2.3	0.0	1.0	1.7	1.1	0.0	0.1	0.1	0.2	0.0	1.8	0.6	0.3	0.0	0.0	4.0	7.5	0.3	2.7	1.5	0.0	11.4	0.5	0.0	2.5	23.3	16.3	0.2	8.9	0.6	0.1	1.9	0.3	0.0	1.6	0.0	0.0	4.9	0.0	0.0	0.0	1.3	4.6	1.4	0.2	0.2	0.1	26.1	0.3	0.0	0.1	0.1	5.0	0.0	0.2	0.0	0.3	0.0	60.3	0.0	0.1	2.5	3.3	11.9	0.9	5.6	8.5	5.4	28.7	4.9	11.5	14.5	3.0	7.2	0.8	96.5	9.5	7.1	23.0	22.9	5.3	10.3	29.6	5.9	482.4	13.3	9.2	178.7	49.1	4.0	0.0	0.5	1267.0	69.5	86.8	0.0	3.0	79.4	7.9	102.1	54.6	16.1	196.4	68.7	19.6	33.7	1.0	14.2	61.0	3.5	2.5	41.8	39.1	25.4	32.3	35.6	1.4	2.7	10.3	1874.3	3.9	5.2	72.7
CDKN2B	"CDK4I, INK4B, MTS2, P15, p15INK4b, TP15"	ENSG00000147883	"Cyclin dependent kinase inhibitor 2B"	P42772	9	22002903-22009363	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 140.1;Pancreatic endocrine cells: 107.4;Urothelial cells: 219.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 4.6;intermediate monocyte: 3.9;non-classical monocyte: 10.9"	"Lineage enriched"	"Detected in single"	16	"monocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.7;HaCaT: 16.2;HeLa: 15.3;hTERT-RPE1: 28.4;SiHa: 20.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB000349, HPA052838, HPA063327"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000349: , HPA052838: , HPA063327: AB_2684987"	"unprognostic (2.30e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.47e-6)"	"unprognostic (2.10e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (9.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.28e-2)"	22.4	1.4	1.4	7.3	1.1	0.0	25.1	0.8	1.2	6.6	35.4	1.4	1.5	14.1	2.6	0.8	27.0	1.2	1.4	1.4	1.6	0.8	0.5	0.6	9.9	2.3	2.0	0.8	0.8	1.0	3.9	7.8	3.7	3.4	3.1	13.4	0.7	5.1	3.2	6.5	8.6	47.0	3.2	1.0	4.4	3.9	3.3	1.3	1.1	0.8	9.8	12.5	2.8	16.6	0.0	0.6	0.0	10.9	0.0	0.4	1.3	0.0	0.0	0.1	0.9	13.6	18.7	0.3	0.6	0.0	2.1	5.9	1.5	4.1	0.0	1.7	1.0	0.0	16.2	0.3	3.2	2.6	1.1	5.0	0.0	15.3	0.7	6.9	0.4	2.7	3.9	0.0	2.7	12.0	28.4	2.0	0.0	0.0	7.2	3.4	1.2	0.0	0.0	0.7	0.8	9.4	0.0	0.9	0.3	4.6	0.0	2.6	0.0	20.5	5.3	14.7	12.6	1.1	0.0	5.3	0.0	0.3	0.0	0.0	6.9	3.9	0.0	0.0	0.4	0.0	0.0	4.6	0.0	0.1	3.9	0.0	0.0	0.4	0.3	0.6	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.1	1.3	1.4	1.1	0.8	1.2	1.6	0.8	2.0	0.8	3.4	1.3	62.5	7.9	0.9	16.4	4.7	1.2	2.4	2.5	4.0	3.4	5.2	0.0	0.8	0.0	50.3	4.4	2.5	140.1	0.0	34.0	0.4	7.2	41.1	0.0	0.0	1.2	0.0	7.5	2.5	14.8	1.7	0.6	4.0	3.3	1.8	21.9	3.7	107.4	49.1	1.1	0.0	6.7	0.0	6.3	13.8	3.3	21.1	2.6	0.0	11.2	219.8
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974633	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 70.0;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 53.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	42.1	12.6	5.9	10.7	7.9	14.9	31.7	4.3	5.7	13.1	13.0	8.7	7.7	6.6	17.1	13.9	11.5	8.4	13.7	20.1	5.7	3.1	7.4	3.3	7.9	11.0	13.7	5.3	22.5	9.4	23.1	5.7	3.1	3.9	10.3	5.7	6.0	5.4	12.2	9.2	8.5	7.9	15.1	7.5	8.5	5.3	5.3	8.9	54.2	8.0	4.9	9.8	17.4	21.7	3.4	7.4	12.2	2.5	6.0	14.1	3.8	14.0	5.8	1.1	19.4	20.0	2.9	0.2	13.4	13.6	22.5	19.8	0.3	4.8	27.6	12.1	11.4	8.2	1.7	13.0	1.7	11.1	16.7	17.5	20.9	44.3	3.5	1.0	14.5	9.6	1.0	0.3	6.1	2.6	8.5	5.9	22.9	9.4	0.0	13.0	3.5	18.7	7.0	0.0	5.3	14.2	22.3	18.3	0.0	7.1	5.9	9.8	23.0	18.3	12.8	4.3	0.1	6.3	49.3	4.7	25.8	10.0	15.6	0.2	28.3	26.9	22.7	0.0	53.0	22.8	12.2	2.5	11.0	5.2	1.4	6.0	3.4	7.7	6.8	6.1	1.9	4.3	4.1	0.2	6.0	0.6	7.4	14.1	3.8	5.9	7.9	4.3	5.7	5.7	3.1	13.7	5.3	3.9	8.9	0.0	4.6	5.3	2.5	9.0	4.2	12.5	2.5	2.7	2.3	3.5	15.7	1.1	14.9	3.3	3.6	5.3	3.9	70.0	3.1	11.0	20.6	2.5	16.1	6.0	22.5	4.8	8.1	17.2	19.7	5.3	36.5	11.2	6.8	24.4	4.8	27.8	4.0	4.0	44.9	26.6	9.7	84.1	18.6	5.1	6.8	9.8	1.6	33.8	3.9	1.0
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816954	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 142.1;seminal vesicle: 53.7"	"Cell type enhanced"	"Detected in many"	19	"Cytotrophoblasts: 255.3;Hepatocytes: 126.0;Syncytiotrophoblasts: 403.0"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"memory CD4 T-cell: 4.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.0;ASC diff: 28.4;ASC TERT1: 11.0;GAMG: 8.3;HAP1: 8.1;NTERA-2: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	31.9	6.2	9.3	1.7	11.2	0.8	9.9	7.6	9.4	3.4	1.5	3.7	36.4	1.0	3.1	42.6	1.8	4.9	3.7	7.6	7.3	9.0	1.7	142.1	3.9	2.3	6.5	5.5	8.7	4.7	1.0	6.5	17.7	14.5	4.0	1.3	19.2	2.8	53.7	3.5	1.1	1.1	2.6	5.3	1.8	1.2	5.0	4.3	0.0	2.8	2.5	1.6	2.4	2.1	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	23.0	0.0	28.4	11.0	0.1	0.6	0.2	2.2	2.2	0.0	0.0	0.0	0.0	0.2	8.3	0.0	8.1	0.0	3.2	0.0	4.0	0.7	0.0	0.6	0.1	0.0	0.0	4.1	0.0	0.3	0.0	0.6	2.9	0.0	0.0	0.0	2.6	0.0	0.5	0.1	8.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	2.0	0.0	2.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	9.3	11.2	7.6	9.4	7.3	9.0	6.5	5.5	14.5	4.3	0.0	2.2	0.0	0.5	0.7	16.3	1.6	0.0	0.0	0.0	1.8	5.9	255.3	0.0	6.0	5.8	3.2	0.0	0.0	0.2	7.4	16.4	1.0	0.0	126.0	20.1	1.6	1.7	21.5	4.9	8.9	84.3	0.2	1.7	1.0	0.0	31.8	0.5	0.0	35.3	0.6	2.9	12.9	3.3	1.5	0.2	1.1	403.0	0.0	0.0	0.1
CDPF1	"C22orf40, LOC150383"	ENSG00000205643	"Cysteine rich DPF motif domain containing 1"	Q6NVV7	22	46244011-46250679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018823	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018823: AB_1853018"	"unprognostic (1.98e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (3.13e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.83e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	7.3	12.7	10.4	9.4	10.9	5.3	7.8	10.6	12.4	10.1	11.4	11.4	5.3	7.0	12.4	11.8	6.0	11.9	8.3	14.1	10.4	6.8	9.4	8.5	9.4	9.0	10.7	9.5	11.2	8.5	8.0	11.1	7.9	10.9	11.0	6.0	10.3	15.5	11.8	12.3	7.7	9.4	8.2	8.7	11.6	9.9	4.0	10.9	12.9	11.2	5.2	9.6	8.1	12.2	8.9	11.6	11.0	8.5	8.3	11.6	7.3	5.5	4.1	6.6	9.6	4.2	7.3	5.5	3.0	4.4	6.1	5.7	0.7	5.7	5.6	3.2	2.2	3.5	6.4	3.0	1.0	3.7	5.3	10.5	3.0	6.2	6.2	7.6	8.1	4.5	7.9	5.9	4.5	5.5	5.0	4.5	10.5	5.8	7.1	4.3	4.0	10.0	5.8	5.1	7.9	4.0	6.4	2.7	12.1	4.6	1.8	3.3	8.0	3.7	6.6	6.3	2.7	7.1	3.4	3.5	11.5	7.3	6.4	3.7	7.0	3.3	4.4	5.3	5.9	11.2	1.5	6.5	11.0	10.1	8.0	9.5	7.3	9.9	8.9	5.5	8.9	11.6	8.4	1.7	8.3	8.5	11.6	7.4	7.3	10.4	10.9	10.6	12.4	10.4	6.8	10.7	9.5	10.9	10.9	6.0	3.8	10.4	2.2	1.5	4.5	4.7	5.1	8.1	2.3	7.0	0.0	11.4	6.6	8.3	0.8	7.1	2.0	0.0	9.8	8.3	4.9	4.0	13.9	4.3	8.2	0.0	4.1	4.3	3.7	0.2	4.6	4.0	5.0	11.8	3.3	4.4	6.3	0.0	7.4	5.4	4.8	12.9	7.3	2.4	7.0	1.8	3.8	7.2	4.9	1.8
CDR1	"CDR, CDR34, CDR62A"	ENSG00000184258	"Cerebellar degeneration related protein 1"	P51861	X	140782405-140784871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 56.2"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 139.0;Horizontal cells: 33.4;Muller glia cells: 111.9;Rod photoreceptor cells: 30.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.4;BJ: 6.6;MOLT-4: 4.2;U-87 MG: 24.4"					"Low region specificity"	"Detected in all"			HPA073147			Approved	"Nucleoplasm,Golgi apparatus,Centrosome"		NA	NA			"Nucleoplasm, Golgi apparatus, Centrosome"		"HPA073147: AB_2686574"	"unprognostic (7.10e-2)"				"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"		"unprognostic (3.49e-2)"		"unprognostic (1.44e-1)"	"unprognostic (1.03e-2)"		"unprognostic (2.41e-3)"	"unprognostic (1.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.84e-1)"		3.2	1.3	9.1	0.5	26.3	0.0	0.0	56.2	28.7	0.0	0.1			0.2	0.4	0.0	0.6	0.2	1.5	1.5	9.2	2.8	0.1	0.0	0.6	0.1	3.7		0.1	3.9	0.0	7.1	0.4		0.1	0.0		0.6	0.0	0.2	9.4	0.1	0.0	3.6	0.9	0.5	0.1			0.7		0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	3.4	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	1.4	0.0	1.2	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	1.9	139.0	0.0	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.9	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0
CDR2	"CDR62, Yo"	ENSG00000140743	"Cerebellar degeneration related protein 2"	Q01850	16	22345936-22437165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018151, HPA023870"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018151: AB_1846457, HPA023870: AB_1846459"	"unprognostic (7.89e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.38e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.67e-3)"	10.6	7.2	6.9	14.3	14.2	12.0	13.3	12.0	9.1	16.6	24.6	2.2	14.2	15.9	10.4	11.7	13.2	8.9	13.4	13.1	5.6	8.0	14.7	14.1	20.1	20.3	5.4	4.9	18.3	11.3	9.0	27.4	9.0	9.2	22.9	11.6	37.1	16.9	15.2	5.3	6.5	24.5	40.5	4.2	13.7	11.7	42.9	3.4	17.9	38.2	5.8	14.7	39.8	43.4	1.4	1.5	5.9	1.1	3.1	8.4	2.0	15.4	10.9	9.7	10.4	24.6	21.3	10.2	15.5	24.3	15.9	21.3	14.2	11.1	13.7	8.0	26.4	9.6	15.3	20.9	8.9	18.9	10.3	10.9	10.2	12.0	45.1	28.6	11.3	20.9	15.7	8.2	15.9	17.7	20.4	19.8	18.2	10.1	22.2	15.2	11.4	10.7	8.2	13.6	13.5	9.4	16.1	12.7	20.2	20.1	9.9	7.6	5.3	10.4	22.2	15.4	11.7	6.6	5.5	12.4	15.5	9.9	14.7	13.2	12.0	18.7	18.4	10.2	11.3	13.3	5.9	1.1	1.5	2.4	0.9	5.1	1.4	7.6	4.8	1.1	0.9	6.0	5.0	1.0	3.1	1.1	1.5	8.4	2.0	6.9	14.2	12.0	9.1	5.6	8.0	5.4	4.9	9.2	3.4	3.0	6.1	3.7	14.4	30.2	7.7	2.8	12.7	4.0	9.1	8.7	13.7	1.4	1.7	7.7	23.9	9.0	19.5	23.3	6.1	9.4	14.1	16.6	0.0	8.2	8.0	7.9	6.3	9.2	4.1	4.7	6.4	5.4	10.1	4.6	11.6	7.2	12.0	9.3	10.3	11.2	57.8	6.5	16.5	26.0	17.0	21.2	1.1	14.1	7.5	13.2
CDR2L	HUMPPA	ENSG00000109089	"Cerebellar degeneration related protein 2 like"	Q86X02	17	74987632-75005800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.0"	"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 21.1;Pancreatic endocrine cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 27.4;U-138 MG: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022015	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA022015: AB_1846462"	"unprognostic (4.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.36e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	9.5	6.1	7.0	4.2	18.7	0.8	20.1	40.0	14.3	6.8	9.9	19.1	4.2	31.0	14.3	2.1	4.3	6.8	12.9	8.3	11.7	8.3	6.9	2.3	8.9	1.8	22.0	6.9	2.4	6.3	4.3	4.1	10.2	21.9	5.4	2.7	2.7	10.2	8.3	3.2	3.1	15.8	8.3	25.1	2.2	17.7	5.6	14.0	0.0	3.2	1.0	1.7	7.0	10.1	0.3	0.1	0.0	0.4	0.0	0.1	1.5	6.3	18.2	4.0	8.5	7.2	6.3	1.8	9.3	4.1	5.4	6.9	10.8	5.9	0.0	9.8	16.1	4.9	17.0	4.8	2.2	3.6	0.1	8.2	0.0	11.3	6.9	4.1	0.7	0.3	3.7	3.6	12.9	1.3	3.9	11.6	1.4	2.7	0.9	5.7	5.7	0.8	0.6	5.3	15.1	9.0	2.9	6.2	2.7	14.3	4.0	7.0	23.8	11.7	27.4	0.8	2.5	7.5	1.2	8.2	28.1	6.0	17.6	5.8	0.9	0.5	0.0	7.8	2.2	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.4	0.1	0.0	1.5	7.0	18.7	40.0	14.3	11.7	8.3	22.0	6.9	21.9	14.0	14.9	0.0	0.0	1.9	5.4	2.4	3.6	15.3	2.7	2.3	5.2	0.0	2.2	13.3	10.7	5.4	10.0	0.7	0.0	6.2	0.4	7.5	5.2	0.0	0.0	1.2	0.0	4.7	4.9	0.3	21.1	2.6	1.0	1.7	1.0	3.2	0.8	19.1	0.0	2.5	1.8	2.5	0.0	7.3	2.1	1.9	2.0	1.9	0.0	0.6	11.5
CDRT1	"FBXW10B, FBXW10P1, HREP, SM25H2"	ENSG00000241322	"CMT1A duplicated region transcript 1"	O95170	17	15565483-15619512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.8;testis: 12.8"	"Cell type enhanced"	"Detected in some"	24	"Ciliated cells: 4.0;Early spermatids: 18.5;Late spermatids: 8.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"T-reg: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 15.6;HaCaT: 28.6;HeLa: 9.7;OE19: 7.1"									"HPA013332, HPA047457"			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA013332: AB_1848471, HPA047457: "	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.03e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.31e-8)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.86e-1)"	1.1	1.8	0.0	0.9	0.0	0.0	0.7	0.2	0.0	2.4	0.3			2.9	0.0	0.8	9.8	0.3	0.7	0.7	0.0	0.0	0.1	0.5	0.9	0.7	0.0		0.0	0.0	0.0	0.1	1.8		0.3	0.6		2.6	0.1	2.1	4.4	1.3	0.0	0.0	0.2	2.6	12.8			1.6		3.0	2.0	4.1	0.4	0.1	0.0	0.3	0.1	2.1	0.0	2.4	6.8	0.2	2.0	0.2	0.7	0.2	0.5	1.5	0.2	0.7	5.1	15.6	0.1	0.4	1.3	1.6	28.6	0.4	0.3	0.4	2.4	0.3	0.1	9.7	0.2	0.2	0.0	0.1	0.3	0.9	0.6	0.4	0.1	0.1	0.4	0.0	1.2	0.8	0.1	0.4	0.2	0.2	7.1	0.8	0.0	0.4	0.0	1.9	3.7	0.1	0.2	2.3	2.0	0.1	0.8	0.1	0.1	1.2	0.5	1.4	0.0	0.4	0.6	2.9	0.0	1.7	0.1	0.8	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.1	0.1	0.0	2.1	0.0											0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.2	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.5	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.4	0.0	0.0	0.0	0.0	0.3
CDRT15		ENSG00000223510	"CMT1A duplicated region transcript 15"	Q96T59	17	14235673-14236862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 5.1;testis: 19.0"	"Group enriched"	"Detected in some"	16	"Early spermatids: 60.5;Late spermatids: 42.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 6.9"									HPA055952	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA055952: AB_2682983"	"unprognostic (3.27e-2)"	"unprognostic (1.77e-2)"	"unprognostic (8.61e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.38e-2)"	0.1	0.3	0.0	1.5	0.0	0.5	0.1	0.3	0.1	0.2	0.2			0.9	0.1	0.0	0.4	0.2	0.4	0.2	0.1	0.1	0.1	0.5	0.2	3.8	0.1		0.4	0.2	0.0	0.1	0.0		0.2	0.0		0.9	0.0	0.1	5.1	1.0	0.0	0.3	1.1	0.4	19.0			0.5		0.0	0.2	0.2	0.2	0.3	0.5	0.1	0.0	2.0	0.0	1.3	2.3	1.6	3.7	0.0	0.0	0.9	1.4	0.0	0.0	0.1	4.4	0.6	3.7	0.9	0.0	0.5	1.7	0.0	0.0	0.0	3.7	6.9	2.1	3.8	3.1	0.0	1.7	2.7	0.0	0.0	0.0	0.0	1.4	0.0	1.8	1.7	0.8	0.0	0.9	1.8	2.7	1.5	2.6	2.3	1.4	0.7	1.5	0.0	1.9	1.8	3.3	0.4	1.0	0.6	5.2	0.8	0.9	2.0	6.0	0.8	1.4	1.6	1.2	1.4	1.7	0.9	2.8	4.3	0.0	0.1	0.5	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0
CDRT4	FLJ36674	ENSG00000239704	"CMT1A duplicated region transcript 4"		17	15436015-15503608	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"testis: 36.8"	"Group enriched"	"Detected in some"	19	"Early spermatids: 68.3;Late spermatids: 129.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.9;NK-cells: 1.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.2;NB-4: 10.0"					"Low region specificity"	"Detected in many"			HPA021590	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA021590: AB_1848906"	"unprognostic (5.46e-6)"	"unprognostic (9.47e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.74e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-5)"	"unprognostic (2.00e-3)"	"unprognostic (1.74e-6)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (9.27e-2)"	2.0	3.2	2.0	2.0	2.3	3.3	6.5	3.7	2.6	2.6	2.3	2.3	2.0	0.2	2.5	17.7	2.0	4.4	2.0	2.0	2.0	2.4	2.0	2.0	3.7	2.8	2.7	2.8	5.3	4.1	0.9	10.9	2.0	2.0	4.1	3.0	2.0	5.0	2.7	2.0	14.6	2.0	2.0	2.0	2.9	2.7	36.8	2.0	2.0	5.3	2.0	2.0	2.1	2.8	0.4	0.3	3.9	0.1	1.1	1.8	0.5	3.2	3.2	4.0	1.2	3.0	2.3	3.8	1.1	3.1	1.4	1.3	1.9	1.1	0.0	1.5	1.6	0.2	1.2	4.4	3.6	2.2	0.6	0.6	0.4	2.0	13.2	0.9	1.1	5.5	3.1	4.4	2.0	4.9	6.1	3.3	1.4	0.7	2.0	3.4	0.5	1.2	10.0	1.6	0.4	1.1	0.9	0.1	0.0	3.3	2.5	0.6	1.7	1.1	0.7	1.0	8.1	1.4	2.5	3.3	0.8	1.5	1.5	1.2	2.7	1.0	0.2	0.0	0.3	0.4	3.9	0.0	0.4	0.9	0.0	0.6	0.4	0.4	0.8	0.1	0.4	0.1	0.4	0.2	1.1	0.1	0.3	1.8	0.5	2.0	2.3	3.7	2.6	2.0	2.4	2.7	2.8	2.0	2.0	0.0	0.6	0.0	0.1	0.1	1.4	0.0	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.5	68.3	0.0	0.3	0.0	0.0	0.3	0.2	0.3	2.3	0.0	0.1	0.0	0.0	0.0	0.0	129.6	0.0	0.0	0.0	1.0	1.7	0.3	0.7	1.5	0.0	0.0	1.6	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.6	0.3
CDS1		ENSG00000163624	"CDP-diacylglycerol synthase 1"	Q92903	4	84582979-84651338	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.0"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.5;hTCEpi: 25.6;OE19: 19.7;SK-BR-3: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036187, HPA064546"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA036187: AB_10601797, HPA064546: AB_2732714"	"unprognostic (8.74e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (5.22e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-1)"	0.9	4.6	7.4	2.5	10.4	0.4	6.7	13.3	12.9	4.3	16.7	3.3	9.3	24.8	2.0	19.1	17.4	20.5	8.8	0.5	7.4	8.4	11.9	0.6	10.6	0.8	6.4	4.7	5.5	4.5	19.3	7.1	19.7	14.1	6.1	13.6	4.2	11.2	4.3	0.2	12.9	48.0	0.8	2.4	1.0	11.5	5.1	2.3	0.9	19.3	7.9	6.1	3.5	7.4	0.0	2.1	0.0	0.0	0.0	0.4	0.0	11.4	0.2	0.6	0.1	0.0	0.0	12.0	0.0	0.1	0.3	0.2	4.8	20.5	0.0	0.9	0.0	2.4	12.1	3.7	10.2	0.1	0.8	5.7	0.0	1.8	1.1	0.0	0.3	0.8	0.1	25.6	0.0	3.7	0.4	0.0	0.7	0.0	0.0	0.0	8.1	0.1	0.0	1.7	19.7	0.8	0.0	0.0	2.4	5.7	8.7	4.8	0.1	1.3	27.8	0.0	2.3	8.5	0.2	0.0	0.0	0.6	1.2	1.5	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	10.4	13.3	12.9	7.4	8.4	6.4	4.7	14.1	2.3	14.9	36.5	0.5	24.3	25.8	16.5	1.6	17.8	105.7	27.3	38.4	9.8	49.0	3.3	23.6	5.9	2.1	44.6	0.0	20.1	9.6	1.5	29.0	0.0	0.0	10.4	20.6	21.5	1.8	2.2	3.1	0.6	5.6	0.0	1.0	45.1	28.4	30.8	31.6	0.4	14.7	28.1	0.0	1.3	2.3	3.8	47.3	47.9	0.0	47.2	32.3
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126786-5197887	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum"		No	No		200000	"Endoplasmic reticulum"		"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.8	16.1	22.2	9.9	25.5	12.1	12.1	36.0	34.5	12.7	11.8	21.4	6.7	5.9	12.9	9.8	10.5	12.5	10.0	26.6	22.0	34.0	16.9	14.2	14.5	10.9	26.7	24.0	10.9	7.2	20.6	15.6	11.1	28.3	15.9	12.3	19.8	8.0	19.7	9.4	6.2	9.9	20.2	16.2	9.8	10.6	13.0	12.5	8.1	14.2	4.6	13.6	11.6	8.2	7.6	7.9	28.3	9.7	6.5	11.1	11.7	9.6	10.8	10.8	5.6	6.4	5.9	4.9	5.3	10.9	8.8	12.7	6.6	9.5	7.3	2.7	9.9	16.0	13.8	8.8	11.1	9.3	7.7	3.0	8.4	3.1	10.1	6.0	5.4	3.2	5.1	6.2	11.5	4.5	7.8	11.7	10.1	4.0	9.5	8.2	1.7	10.8	2.0	5.2	4.7	3.3	9.3	8.7	3.3	5.6	9.4	4.5	6.3	5.9	10.1	13.6	13.7	6.2	2.5	8.5	6.3	5.0	5.6	5.3	8.3	60.6	6.1	2.8	4.3	3.8	24.1	9.7	11.5	10.0	8.0	10.6	7.6	10.2	11.1	7.9	7.4	8.0	7.8	28.3	6.5	7.3	6.3	11.1	11.7	22.2	25.5	36.0	31.6	22.0	34.0	26.7	24.0	28.3	12.5	17.9	14.9	30.8	25.7	15.7	61.3	45.6	25.5	9.4	11.4	31.4	90.3	19.1	5.0	29.0	54.7	32.9	11.8	0.0	19.9	30.4	16.4	18.4	20.7	17.5	51.1	41.3	10.3	27.0	37.0	25.0	15.0	23.1	30.4	28.9	11.5	22.0	25.6	14.8	23.3	13.5	58.9	19.4	53.6	21.6	29.8	13.4	13.6	30.2	12.8	26.9
CDX4		ENSG00000131264	"Caudal type homeobox 4"	O14627	X	73447254-73455245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"skin 1: 5.3;testis: 3.3"	"Cell type enhanced"	"Detected in some"	22	"Spermatogonia: 1.4;Suprabasal keratinocytes: 1.0"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 2.0;SuSa: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043714, HPA056528"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA043714: , HPA056528: AB_2683166"															"unprognostic (1.97e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.4	1.0	0.0	0.0	0.0	0.0
CEACAM18		ENSG00000213822	"Carcinoembryonic antigen related cell adhesion molecule 18"	A8MTB9	19	51478622-51490952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	62	"intestine: 31.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.8;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 8.6;OE19: 7.0;RT4: 2.8"	"Not detected"	"Not detected"							HPA059487	Uncertain		Approved	Midbody		NA	NA			Midbody		"HPA059487: AB_2684036"			"unprognostic (1.12e-1)"								"unprognostic (1.87e-2)"			"unprognostic (1.00e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	16.6	0.0	0.0	14.6	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	31.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	7.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CEACAM19	CEAL1	ENSG00000186567	"Carcinoembryonic antigen related cell adhesion molecule 19"	Q7Z692	19	44662278-44684359	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA014462, HPA052865"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA014462: AB_2669006, HPA052865: AB_2681976"	"unprognostic (2.91e-1)"	"unprognostic (5.29e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.26e-9)"	"unprognostic (8.01e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-1)"	1.6	2.9	1.1	0.8	1.9	1.0	2.4	4.3	1.7	3.1	2.4			2.7	2.7	1.4	2.4	4.3	2.1	4.1	1.2	1.8	3.3	4.3	3.8	0.6	0.6		4.0	4.7	1.2	3.9	1.8		4.1	3.3		2.9	3.0	12.5	10.8	2.9	3.0	0.9	1.8	2.0	3.0			3.4		1.7	1.0	4.4	1.7	0.5	1.7	1.0	1.0	0.7	0.6	4.2	8.8	1.3	0.9	3.1	3.6	3.3	2.4	3.6	0.8	1.6	0.3	1.0	0.1	0.8	3.2	0.9	5.3	2.2	0.9	0.7	1.2	5.0	0.1	4.6	1.4	3.2	0.2	0.8	1.1	8.7	2.2	5.4	10.7	2.0	0.6	0.3	0.2	1.2	1.0	0.0	0.5	0.8	1.1	1.0	0.0	1.6	0.2	13.7	1.0	1.7	0.4	0.9	0.9	0.8	1.3	1.2	0.3	17.7	0.3	6.1	1.3	0.7	0.1	0.3	0.0	0.4	1.7	1.4	1.7	1.0	0.6	0.6	0.4	0.3	0.5	0.3	0.6	0.2	1.7	0.4	0.7	1.6	1.0	0.5	0.5	0.3	0.6											3.0	2.1	0.0	0.9	1.8	2.6	4.1	2.5	1.4	2.3	0.0	0.0	0.0	0.0	1.6	0.7	3.1	1.7	0.0	2.9	0.1	0.9	1.3	0.0	1.9	0.2	0.0	1.7	4.9	1.2	0.2	2.8	0.5	0.0	0.0	2.6	0.1	3.5	3.5	2.5	0.2	0.5	0.0	2.8	3.2	0.4	5.3	0.0	0.0	2.2	0.9
CEBPA	"C/EBP-alpha, CEBP"	ENSG00000245848	"CCAAT/enhancer binding protein alpha"	P49715	19	33299934-33302564	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 52.3;liver: 44.3"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 84.7;Hofbauer cells: 76.1;Suprabasal keratinocytes: 150.2;Syncytiotrophoblasts: 177.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.0;non-classical monocyte: 11.8"	"Group enriched"	"Detected in many"	13	"dendritic cells: 4.1;granulocytes: 11.0;monocytes: 11.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 43.5;Hep G2: 23.3;NB-4: 24.0;THP-1: 86.8;U-937: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA052734, HPA065037, HPA067937"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927"	"unprognostic (1.80e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.95e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-2)"	40.7	1.5	2.3	7.6	4.6	8.4	52.3	2.1	4.0	3.5	9.0	5.2	1.1	9.0	2.2	2.1	6.1	2.4	6.4	6.6	3.9	2.4	2.0	44.3	39.9	10.3	4.1	3.1	1.3	9.0	4.5	1.7	17.4	2.7	3.8	5.1	1.9	5.6	1.6	15.4	23.7	12.7	2.9	6.6	3.0	3.5	1.2	2.6	2.2	2.5	10.7	3.5	5.4	7.9	0.1	4.1	11.0	11.8	0.0	0.6	1.5	0.5	1.1	0.0	1.5	12.5	0.0	43.5	0.0	0.3	0.0	0.0	5.3	0.0	0.0	0.6	0.0	0.2	2.0	1.2	0.1	0.0	7.5	1.5	0.0	0.0	23.3	0.2	7.6	9.3	0.5	5.6	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	2.6	0.0	24.0	1.1	13.1	0.6	0.0	0.0	0.2	0.0	3.8	0.0	0.3	0.1	0.1	0.1	1.4	3.0	86.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	27.8	0.0	11.0	6.0	0.0	0.6	9.4	0.6	0.0	0.1	0.4	4.1	0.1	0.2	0.4	2.1	0.0	11.8	0.2	0.0	1.5	2.3	4.6	2.1	4.0	3.9	2.4	4.1	3.1	2.7	2.6	14.9	27.8	1.4	20.5	33.2	0.7	0.4	25.5	6.7	5.7	0.0	0.0	27.5	3.3	0.6	0.0	0.6	62.2	0.0	5.0	35.2	6.1	11.7	1.1	84.7	76.1	0.0	4.1	1.3	21.4	0.0	2.8	23.2	5.0	1.0	22.1	8.0	2.1	31.3	1.4	3.7	0.3	0.0	4.1	0.2	0.7	150.2	177.5	1.0	26.9	9.5
CEBPD	"C/EBP-delta, CELF, CRP3, NF-IL6-beta"	ENSG00000221869	"CCAAT/enhancer binding protein delta"	P49716	8	47736909-47739086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 1062.9;Glandular cells: 1104.9;Smooth muscle cells: 1847.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 20.9;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.5;HHSteC: 17.5;HSkMC: 17.3;NB-4: 36.7;SiHa: 15.1"					"Low region specificity"	"Detected in many"			HPA067581			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067581: AB_2685865"	"prognostic favorable (2.28e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.87e-7)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.40e-2)"	27.3	14.9	4.7	14.3	4.7	6.5	12.3	4.7	7.7	7.3	9.5	4.7	4.7	6.1	5.8	4.7	5.4	12.6	4.7	9.5	4.7	1.3	8.2	25.7	10.5	4.7	4.7	4.7	21.5	7.3	0.6	8.4	11.3	4.7	11.0	2.6	7.5	6.4	4.7	9.1	6.8	9.6	4.7	4.7	13.5	8.8	9.4	4.7	4.7	7.1	14.1	4.7	11.7	9.4	0.1	2.7	20.9	7.8	1.3	2.4	0.9	2.3	1.8	0.1	0.0	10.8	11.2	13.5	6.2	4.7	1.7	3.7	3.6	3.8	0.0	4.5	1.6	1.5	2.5	0.4	3.2	0.5	0.0	0.9	0.1	1.5	1.5	17.5	1.0	0.0	17.3	8.4	0.4	4.1	1.1	0.3	0.1	1.0	1.9	0.6	0.7	0.0	36.7	0.7	1.5	0.6	0.0	1.3	0.1	5.1	1.9	0.7	0.2	15.1	2.0	1.5	0.7	1.6	8.4	1.5	0.4	1.1	4.1	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.9	7.8	3.6	0.8	3.0	2.4	0.0	0.1	0.4	2.7	0.1	0.0	0.0	20.9	1.3	1.1	0.0	0.1	0.9	4.7	4.7	4.7	7.7	4.7	1.3	4.7	4.7	4.7	4.7	95.3	155.3	27.0	1062.9	589.5	4.9	66.7	96.8	56.2	94.4	212.9	5.9	176.8	184.1	42.0	2.5	382.1	63.9	0.0	65.1	327.7	527.3	1104.9	4.7	125.8	194.7	1.6	22.4	138.7	301.2	7.0	403.3	397.2	254.8	5.4	35.9	259.0	72.6	40.7	136.2	287.1	12.7	459.2	1847.8	2.1	3.7	714.5	294.3	115.1	47.7	772.4
CEBPE	CRP1	ENSG00000092067	"CCAAT/enhancer binding protein epsilon"	Q15744	14	23117304-23119616	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 87.1;bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 6.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	201	"eosinophil: 87.1"	"Lineage enriched"	"Detected in single"	237	"granulocytes: 87.1"	"Group enriched"	"Detected in some"	4	"HL-60: 59.4;NB-4: 30.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.3	0.0	0.1	0.8	0.2	29.4	0.1	0.1	1.3	0.1	0.1	0.1	0.1	1.4	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.1	0.2	2.7	0.2	0.3	0.1	0.1	0.1	0.0	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.9	0.1	0.3	7.7	0.4	0.1	0.1	2.6	0.1	0.1	0.8	0.2	0.1	0.0	0.1	87.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.4	10.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	30.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.3	87.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	1.3	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.6	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CEBPZ	"CBF2, CTF2"	ENSG00000115816	"CCAAT/enhancer binding protein zeta"	Q03701	2	37201612-37231713	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052065	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052065: AB_2681715"	"unprognostic (1.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.13e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.01e-2)"	21.3	23.0	13.1	23.7	14.4	20.0	21.7	17.0	16.4	22.4	17.8	8.4	17.2	12.8	17.2	16.6	18.6	17.4	12.6	19.4	12.0	12.9	30.5	22.6	15.4	16.7	13.2	12.9	24.2	17.2	18.8	27.3	18.2	16.5	20.4	15.5	8.2	15.5	17.9	88.0	14.0	19.1	19.5	15.4	23.1	15.5	27.3	14.1	19.5	22.5	18.7	17.5	30.1	41.0	20.8	17.4	17.2	14.7	17.0	23.1	9.2	19.8	15.5	16.0	8.8	15.8	17.1	13.6	19.0	13.2	16.1	17.5	24.5	15.1	36.6	17.0	11.2	22.1	17.1	41.3	19.5	20.8	23.3	18.2	34.0	16.0	19.9	12.5	34.1	15.4	13.0	19.3	21.4	21.9	10.7	14.5	9.3	37.0	16.9	16.4	10.3	19.8	26.8	52.1	26.6	14.6	15.9	26.0	27.6	15.5	18.8	17.1	27.7	15.8	19.5	21.4	24.2	14.1	15.0	11.8	15.8	18.0	14.0	26.0	19.0	19.9	29.7	14.1	31.6	17.3	17.2	11.7	10.6	17.2	14.7	21.7	20.3	18.2	16.6	11.8	20.8	23.1	19.1	4.2	17.0	14.3	17.4	14.0	9.2	13.1	14.4	17.0	16.4	12.0	12.9	13.2	12.9	16.5	14.1	80.4	74.1	56.7	60.0	95.1	42.9	29.1	56.0	68.3	106.9	47.1	41.2	45.8	91.2	46.1	195.9	50.1	23.4	46.7	53.9	30.2	41.0	51.4	70.6	63.1	30.5	41.3	42.4	44.8	35.3	23.2	56.4	35.5	20.3	47.7	48.2	52.7	48.9	24.6	47.7	55.4	87.8	51.8	44.3	132.2	95.3	88.3	37.6	59.7	48.5	54.3
CEBPZOS	CEBPZ-AS1	ENSG00000218739	"CEBPZ opposite strand"	A8MTT3	2	37196488-37216193	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA053866	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053866: AB_2682283"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (3.46e-7)"	"unprognostic (3.69e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	16.5	31.3	29.5	16.2	25.4	17.9	18.5	21.0	30.2	16.9	19.8	16.3	19.1	19.0	25.9	33.0	19.3	19.5	14.4	24.5	43.8	23.8	21.5	18.2	13.8	16.5	23.6	31.3	22.8	14.9	18.6	30.2	22.1	25.4	22.3	18.9	16.1	23.9	16.7	38.4	19.0	22.0	17.1	19.4	13.8	15.3	20.3	12.7	12.9	23.7	19.8	15.1	19.4	14.0	20.9	29.4	15.3	15.3	13.1	25.2	13.7	26.2	8.8	18.9	15.3	20.1	21.9	18.3	19.5	17.6	12.7	9.3	8.2	12.0	9.1	10.5	19.4	16.5	15.5	10.3	14.8	15.6	24.6	21.3	24.5	10.2	12.8	17.4	30.5	13.7	23.2	20.5	17.1	19.1	17.2	20.2	9.8	18.4	13.7	20.6	5.3	7.6	30.0	27.8	21.2	13.6	22.8	26.0	20.9	22.3	7.2	20.3	19.9	14.9	24.9	19.0	10.8	11.1	18.6	17.8	13.7	16.9	20.0	16.8	24.6	0.2	19.8	25.5	18.4	19.5	15.3	14.1	12.1	17.7	15.3	20.4	20.9	20.1	18.5	13.5	18.0	25.2	22.4	5.7	13.1	11.5	29.4	13.7	13.7	29.5	25.4	21.0	30.2	43.8	23.8	23.6	31.3	25.4	12.7	50.6	39.2	29.4	42.0	0.0	44.4	41.1	7.6	49.5	38.7	36.6	17.7	70.8	77.9	36.3	30.8	23.3	27.4	0.0	29.4	42.0	27.8	39.9	16.2	24.1	37.6	30.2	16.8	22.1	25.3	9.5	43.7	33.7	0.0	37.9	27.6	46.1	36.7	28.8	41.8	51.9	51.6	45.3	28.5	119.8	51.1	0.0	57.8	34.5	27.5	38.8
CECR2	KIAA1740	ENSG00000099954	"CECR2, histone acetyl-lysine reader"	Q9BXF3	22	17359949-17558149	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.1;skeletal muscle: 30.6"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 159.0;Rod photoreceptor cells: 94.7"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.8;HAP1: 11.7;K-562: 6.4;NTERA-2: 18.7;SCLC-21H: 8.4;SuSa: 7.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002943	Approved		Approved	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"HPA002943: AB_1078496"	"unprognostic (2.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.92e-3)"	"unprognostic (7.48e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.13e-6)"	"unprognostic (1.13e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.94e-2)"	1.8	1.3	4.6	1.0	8.8	1.5	2.0	25.1	8.4	1.1	1.2	10.6	0.8	1.0	4.3	1.7	1.4	2.5	1.0	4.4	6.1	2.8	1.9	6.5	4.1	0.9	8.0	4.0	5.4	5.6	0.8	8.4	4.7	5.8	2.3	1.1	4.9	1.9	1.1	30.6	1.6	1.2	2.2	5.7	1.4	1.1	6.0	8.0	0.0	2.7	2.2	0.9	2.3	2.5	0.2	0.1	0.9	0.8	0.5	0.1	0.0	0.1	0.0	12.8	4.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	11.7	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.1	0.0	0.4	18.7	0.0	0.0	1.4	0.8	0.0	0.0	4.1	8.4	0.0	0.0	0.1	0.7	7.8	1.3	2.0	0.1	0.1	2.8	0.0	0.0	4.8	1.1	1.0	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.9	0.5	0.1	0.0	0.0	0.0	4.6	8.8	25.1	5.0	6.1	2.8	8.0	4.0	5.8	8.0	6.0	8.8	0.0	0.8	0.0	21.9	10.0	0.0	1.4	1.2	1.8	159.0	7.6	0.0	0.0	3.1	1.9	0.0	0.0	0.2	2.0	0.3	1.6	0.0	9.7	0.6	4.8	0.0	3.7	0.0	3.2	1.1	0.0	0.0	0.0	0.0	22.4	0.2	0.0	1.1	1.1	94.7	6.5	1.0	1.5	15.5	0.1	27.6	0.0	0.0	3.7
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase family member 3A"	P09093	1	22001656-22012539	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2051	"pancreas: 2541.2"	"Cell type enriched"	"Detected in some"	31	"Exocrine glandular cells: 30160.2"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"MOLT-4: 21.6"									"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	2541.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	29.3	0.0	0.0	0.0	30160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.8	0.3	0.0	0.0	164.1	0.0	0.0	964.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase family member 3B"	P08861	1	21977021-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	196	"pancreas: 1614.4"	"Cell type enriched"	"Detected in some"	24	"Exocrine glandular cells: 12399.8"	"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1614.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.9	5.3	8.2	3.0	2.3	3.2	0.9	0.6	5.0	1.7	1.3	2.5	1.5	2.2	1.2	1.8	1.8	1.7	5.4	2.7	5.5	2.7	1.5	2.2	1.6	1.0	0.5	0.0	2.5	4.1	2.4	4.9	4.0	1.3	1.9	3.2	2.3	2.4	1.5	0.0	2.7	2.5	3.6	2.5	5.6	0.4	2.6	2.2	1.5	1.4	0.9	3.5	3.6	0.9	4.3	0.0	3.6	3.2	1.8	3.5	0.8	0.3	3.7	2.6	2.8	3.7	2.9	1.6	2.3	1.0	4.9	4.8	2.5	1.9	4.8	0.6	5.1	2.5	1.8	3.1	3.0	2.0	3.7	2.2	2.8	1.4	5.9	3.2	3.0	8.2	2.3	1.7	5.3	2.9	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	65.6	0.0	4.9	0.0	12399.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.0	0.9	0.0	0.0	105.6	0.0	0.0	510.5	7.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0
CELF2	"BRUNOL3, CUGBP2, Etr-3, NAPOR-2"	ENSG00000048740	"CUGBP Elav-like family member 2"	O95319	10	10798397-11336675	"Predicted intracellular proteins"	"mRNA processing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 52.8;HMC-1: 51.4;REH: 22.8"	"Low region specificity"	"Detected in all"							"CAB016395, HPA035813"	Enhanced		Supported	"Nucleoplasm,Vesicles,Midbody ring"		Yes	No			Nucleoplasm	"Vesicles, Midbody ring"	"CAB016395: AB_2086271, HPA035813: AB_2674797"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.45e-1)"	27.0	4.9	26.5	21.0	35.2	49.5	14.6	23.6	35.7	11.7	12.2	10.1	4.5	7.1	11.6	5.1	16.3	10.6	12.9	26.8	24.0	14.9	3.8	3.6	20.8	31.4	11.0	20.0	35.7	3.8	2.2	6.7	6.6	11.6	11.2	13.8	8.5	9.1	10.0	14.8	6.5	18.9	17.3	15.8	22.7	9.4	5.9	15.0	36.9	6.8	6.3	20.9	13.0	11.0	22.7	23.1	51.0	27.2	30.6	31.9	22.9	0.0	0.0	13.0	0.0	2.0	0.7	1.4	1.9	0.0	0.3	0.0	0.0	0.0	0.0	1.4	1.6	0.0	0.0	1.8	0.0	0.1	10.6	3.2	52.8	0.2	0.0	0.5	15.1	51.4	0.8	0.1	0.1	0.0	0.2	1.8	19.0	2.4	22.0	16.2	0.0	18.6	11.0	5.2	0.0	0.0	22.8	13.9	4.7	0.9	0.0	1.9	0.1	0.0	0.0	13.8	4.4	0.0	10.3	0.0	2.4	0.7	8.1	0.0	8.4	7.6	2.5	0.8	18.3	5.8	25.4	18.1	37.8	25.3	24.9	31.9	21.5	25.2	27.7	23.1	22.7	26.6	24.7	51.0	30.6	27.2	16.4	25.8	22.9	26.5	35.2	23.6	33.9	24.0	14.9	11.0	20.0	11.6	15.0	148.9	136.7	93.8	3.2	17.6	71.9	103.5	7.6	6.7	34.2	12.2	96.2	1.0	13.3	1.4	110.6	43.2	3.5	0.0	1.8	0.7	43.6	7.5	123.7	2.4	77.4	127.1	57.0	17.2	242.8	76.2	103.3	121.5	109.6	224.6	40.3	91.1	1.8	14.0	84.1	0.4	90.1	51.8	23.0	3.4	12.1	12.7	1.6	176.6	20.4	1.4
CELF3	"BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4"	ENSG00000159409	"CUGBP Elav-like family member 3"	Q5SZQ8	1	151702404-151716814	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.8;brain: 44.0;pituitary gland: 31.2"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 93.5;Cone photoreceptor cells: 37.3;Horizontal cells: 19.1;Intestinal endocrine cells: 50.7"	"Group enriched"	"Detected in many"	5	"glioma: 4.4;pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 28.6;SH-SY5Y: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006292	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006292: AB_10602250"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.05e-2)"	1.1	16.8	21.4	1.4	28.9	1.1	1.0	29.2	44.0	1.0	2.1	2.0	0.0	5.0	1.0	1.0	1.1	2.1	1.0	1.0	19.5	16.2	1.1	1.0	1.1	1.0	5.3	15.3	1.0	8.8	1.0	31.2	1.2	3.7	1.1	2.1	3.7	1.0	1.0	1.0	1.0	3.8	1.2	1.5	1.0	8.5	2.0	4.4	0.0	1.1	0.0	1.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	28.6	20.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	28.9	29.2	29.1	19.5	16.2	5.3	15.3	3.7	4.4	0.0	0.0	0.0	0.0	0.0	93.5	0.8	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	19.1	50.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.6	2.3	0.1	0.0	0.0	0.3	4.8	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537170	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 38.7;Ciliated cells: 33.5;Club cells: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 3.0;naive B-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"A549: 24.1;HaCaT: 15.2;T-47d: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA052976: AB_2682004, HPA060521: AB_2684303"	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	3.4	0.5	0.6	5.0	1.4	0.3	4.1	0.4	0.3	8.7	1.3	0.9	3.6	0.3	5.7	7.5	14.2	11.1	5.3	4.6	0.7	0.7	16.2	0.8	19.3	4.2	0.4	0.0	6.0	2.6	7.5	3.8	3.4	2.2	7.2	0.4	3.8	22.6	3.0	0.3	13.9	2.3	3.1	0.4	1.8	3.6	2.8	0.0	1.8	5.7	12.7	12.8	3.1	5.0	3.0	0.2	0.0	0.0	0.7	0.1	0.0	8.7	24.1	4.6	3.9	0.0	0.0	2.2	0.7	1.5	1.4	0.3	5.7	6.8	0.0	11.9	0.1	9.3	15.2	3.8	11.5	0.5	0.0	4.6	0.0	9.7	0.2	0.2	1.5	0.6	0.0	10.8	0.0	9.6	9.1	0.0	0.6	0.0	0.0	0.0	10.9	0.0	1.7	1.7	2.8	3.8	0.0	0.0	2.8	6.4	5.4	0.2	0.3	7.5	6.0	1.2	1.9	17.3	5.1	0.3	0.0	0.1	0.0	0.1	4.6	0.2	2.4	6.0	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.6	1.4	0.4	0.3	0.7	0.7	0.4	0.0	2.2	0.0	38.7	16.8	1.3	3.3	15.1	0.0	10.2	0.0	33.5	27.3	5.2	0.0	1.0	0.0	1.4	1.2	5.5	0.0	0.0	0.6	1.7	1.7	3.6	0.0	1.6	2.4	0.0	1.2	1.3	0.0	5.0	0.0	1.3	5.0	1.8	2.0	1.3	2.6	0.0	0.0	11.0	0.3	0.0	1.0	0.2	0.2	13.7	0.7	0.0	1.5	4.7
CELSR2	"ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3"	ENSG00000143126	"Cadherin EGF LAG seven-pass G-type receptor 2"	Q9HCU4	1	109250019-109275750	"G-protein coupled receptors, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.7;skin 1: 27.8"	"Cell type enhanced"	"Detected in many"	15	"Horizontal cells: 92.2;Muller glia cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 25.2;HaCaT: 24.9;MCF7: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013952	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA013952: AB_1846518"	"unprognostic (4.46e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.16e-2)"	1.5	2.3	12.6	1.1	16.0	0.9	5.4	9.2	31.7	6.9	1.8	13.7	3.4	1.4	3.1	4.3	10.9	18.8	1.8	5.3	17.1	8.1	5.6	1.2	1.8	1.3	10.0	15.4	1.2	4.8	7.8	2.3	1.6	8.3	3.5	1.4	5.4	6.4	10.4	9.3	27.8	1.5	2.4	14.1	1.0	2.0	11.0	8.6	0.5	10.9	2.7	3.2	2.3	6.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	7.0	6.6	25.2	4.6	0.0	0.0	6.8	0.8	0.6	1.5	0.4	1.0	0.2	1.2	5.7	0.5	1.2	24.9	6.5	4.0	0.8	0.1	2.7	0.5	6.0	1.4	0.5	0.3	3.2	0.1	9.8	0.6	0.4	5.7	0.3	4.0	4.1	0.3	0.0	28.7	0.7	0.3	8.1	0.8	1.2	6.4	2.3	0.3	5.5	2.4	10.2	4.8	3.8	8.5	5.4	6.2	8.0	1.6	0.0	0.0	4.6	0.4	6.2	1.6	0.4	0.3	1.4	0.5	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	16.0	9.2	31.7	17.1	8.1	10.0	15.4	8.3	8.6	8.9	5.3	0.0	4.8	14.0	7.2	9.4	5.1	2.7	4.5	17.4	3.9	1.9	1.7	2.2	4.9	0.8	0.5	0.0	0.4	1.0	1.0	2.1	1.1	5.9	0.9	92.2	1.7	0.0	0.0	5.3	3.1	0.5	10.1	0.0	0.3	32.3	1.7	0.0	18.0	2.7	5.2	6.5	2.0	0.9	3.4	19.9	0.5	0.0	1.2	5.7
CEMP1	CP-23	ENSG00000205923	"Cementum protein 1"	Q6PRD7	16	2530035-2531417	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	24	"Ciliated cells: 2.7;Early spermatids: 2.6;granulocytes: 1.1;Late spermatids: 6.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.7;REH: 9.3"									"HPA057658, HPA075926"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057658: AB_2683492, HPA075926: "																		0.7	4.1	5.8	1.6	3.3	0.6	0.5	3.6	3.7	1.2	0.7			1.7	1.1	0.0	3.3	0.6	2.6	3.3	4.5	2.4	3.6	2.5	1.6	5.4	3.0		2.1	0.8	0.8	0.9	1.3		1.0	0.0		5.5	0.6	1.9	8.0	4.6	0.0	2.4	3.4	0.9	1.0			2.4		0.0	4.6	0.6	0.6	1.2	4.2	0.0	0.7	1.8	0.0	1.2	0.9	1.1	6.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.9	5.3	0.0	0.7	0.0	2.3	1.9	0.0	0.0	0.0	0.7	8.7	0.7	0.0	3.0	0.0	0.7	4.2	0.0	0.0	0.0	0.0	1.3	0.0	3.6	2.1	2.0	0.0	3.6	1.0	3.0	2.4	0.5	1.8	9.3	0.6	0.1	0.0	1.8	5.0	1.8	1.4	6.5	6.4	0.3	7.4	0.8	0.4	2.3	2.0	2.9	1.3	1.0	1.7	2.1	2.8	4.3	1.2	4.2	0.0	3.5	0.3	0.0	0.6	0.6	0.6	1.1	0.0	0.4	0.2	0.9	0.0	0.7	0.0	1.2	1.8	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CEND1	"BM88, FLJ90066"	ENSG00000184524	"Cell cycle exit and neuronal differentiation 1"	Q8N111	11	787104-790123	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 85.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 89.3;Horizontal cells: 71.5"	"Cancer enriched"	"Detected in many"	13	"glioma: 24.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.6;Karpas-707: 17.0;SCLC-21H: 30.5;SH-SY5Y: 11.4;U-266/70: 11.9;U-87 MG: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042527	Enhanced	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA042527: AB_2678038"	"unprognostic (4.62e-3)"	"unprognostic (1.34e-4)"	"unprognostic (9.66e-3)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (2.20e-3)"	"unprognostic (4.11e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.24e-3)"	"unprognostic (1.94e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	1.9	8.2	28.5	2.9	34.7	1.8	1.8	46.5	85.2	1.8	2.3	8.3	1.3	2.5	1.9	2.0	2.2	1.8	1.9	2.1	34.2	25.3	2.1	1.8	1.8	2.1	32.0	30.7	1.8	1.9	1.9	5.1	1.8	42.4	3.2	1.9	2.1	1.8	3.6	1.8	1.9	2.7	2.3	10.2	1.8	1.9	1.9	5.9	0.0	1.8	0.0	2.0	2.1	0.1	3.6	0.2	0.0	0.7	0.0	1.9	0.3	0.0	0.4	0.4	0.7	0.1	0.1	0.1	0.7	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.3	7.6	0.3	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	17.0	0.3	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	30.5	11.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.5	11.9	3.2	0.7	15.9	0.1	0.2	0.0	0.0	0.0	0.9	0.7	0.3	3.6	1.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.3	28.5	34.7	46.5	65.2	34.2	25.3	32.0	30.7	42.4	5.9	0.0	0.0	0.0	0.1	0.1	89.3	0.4	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	71.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	17.6	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0
CENPBD1	MGC16385	ENSG00000177946	"CENPB DNA-binding domain containing 1"	B2RD01	16	89969773-89972832	"Predicted intracellular proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEK 293: 7.8;K-562: 4.7"									"HPA052759, HPA060522"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA052759: AB_2681938, HPA060522: AB_2684304"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.48e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (5.27e-11)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	7.2	5.9	6.6	2.6	7.3	4.5	6.3	6.1	9.5	3.3	4.0	4.9	10.5	5.9	3.6	5.0	4.0	3.6	4.6	4.2	6.6	6.1	7.6	5.6	6.7	7.1	7.9	7.0	7.6	8.9	3.9	7.1	4.4	6.2	4.9	6.0	3.8	6.0	4.8	4.2	5.1	2.9	3.8	5.6	6.6	4.7	8.2	6.3	2.5	3.5	1.8	2.5	4.8	2.7	3.7	3.6	1.4	1.6	1.4	2.7	1.3	1.2	0.0	0.2	0.4	0.5	0.9	2.1	0.8	0.3	0.0	0.0	0.6	0.0	1.3	1.2	0.9	0.3	2.0	0.0	0.0	0.3	0.0	7.8	0.0	0.3	0.5	0.4	0.4	1.3	0.0	1.4	0.0	0.0	0.2	0.0	0.6	4.7	0.9	0.0	1.1	1.4	0.6	0.7	0.4	0.5	3.2	1.6	0.0	0.0	0.0	2.7	2.0	2.9	0.3	0.1	0.3	0.7	0.0	0.0	0.2	1.9	0.3	1.2	0.8	1.3	1.0	0.5	1.2	0.5	0.6	1.6	1.4	2.4	0.7	2.1	1.2	1.9	0.8	3.6	3.7	2.7	2.3	0.5	1.4	1.4	3.1	1.1	1.3	6.6	7.3	6.1	9.5	6.6	6.1	7.9	7.0	6.2	6.3	8.9	10.7	3.7	3.1	4.1	9.6	0.4	5.1	6.7	9.1	5.2	17.7	3.7	6.6	5.6	1.5	1.6	3.4	0.0	5.1	3.6	3.5	3.4	6.9	5.8	7.4	4.8	1.2	1.3	6.3	1.3	4.4	6.9	5.0	9.0	3.2	12.6	5.2	2.9	4.9	5.0	22.5	0.0	2.8	21.8	18.8	2.8	4.2	3.2	2.6	2.1
CENPC	"CENP-C, CENPC1, hcp-4, MIF2"	ENSG00000145241	"Centromere protein C"	Q03188	4	67468748-67545606	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049740, HPA058252"			Supported	"Nucleoplasm,Nuclear bodies,Midbody"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Midbody"	"HPA049740: , HPA058252: AB_2683654"	"unprognostic (4.35e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.31e-3)"	"unprognostic (7.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (6.40e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (3.22e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.32e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-3)"	9.4	8.6	9.3	11.9	14.6	12.9	13.5	26.9	12.2	12.6	7.3	4.6	6.2	5.6	12.6	10.1	9.1	10.1	6.6	6.9	8.0	5.8	9.0	6.6	8.7	7.7	11.8	7.7	20.9	16.4	8.0	21.2	6.3	9.1	12.3	6.0	5.0	10.2	13.4	5.3	9.8	9.1	10.3	13.4	10.5	9.5	7.5	12.6	17.7	13.0	9.1	6.8	10.2	10.4	5.1	2.4	2.8	1.5	1.6	5.0	1.2	0.8	1.0	2.9	1.6	3.4	2.1	1.6	1.0	0.9	1.3	1.1	1.2	2.3	4.5	1.6	1.3	0.7	1.5	3.7	1.7	2.0	1.7	0.7	3.5	1.8	1.6	1.2	6.3	1.5	2.5	0.6	1.0	2.2	2.2	0.7	3.1	5.0	3.1	1.9	1.5	8.6	5.8	3.1	1.6	0.7	4.2	7.0	1.5	1.7	1.5	4.8	2.4	2.2	4.2	1.2	3.0	1.4	2.4	1.0	1.8	1.3	1.3	0.9	2.3	1.0	4.8	2.1	3.7	1.1	2.7	1.3	2.8	3.2	1.5	1.9	3.3	3.6	3.4	1.1	5.1	5.0	3.7	1.0	1.6	1.1	2.4	2.0	1.2	9.3	14.6	26.9	12.2	8.0	5.8	11.8	7.7	9.1	12.6	29.8	31.5	29.9	25.5	13.5	51.4	20.0	15.3	36.1	38.7	15.7	13.7	15.9	10.0	9.7	3.1	19.2	14.8	23.3	14.6	11.7	14.6	15.2	25.5	13.2	11.0	49.3	12.6	19.0	16.4	4.2	32.2	15.1	15.1	15.4	15.8	42.4	12.3	11.5	24.1	13.9	28.4	19.4	15.5	33.5	46.1	8.2	15.3	44.5	14.3	20.9
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105806-103198409	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.3;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 93.5;Spermatocytes: 69.2;Spermatogonia: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA042294	Enhanced		Approved	Nucleoplasm,Microtubules,Cytosol		NA	Yes			"Microtubules, Cytosol"	Nucleoplasm	"HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	2.7	0.9	0.6	9.4	1.5	11.3	0.7	0.2	1.3	1.0	2.1	0.5	0.0	1.9	0.7	1.9	5.9	0.5	0.8	2.5	2.0	0.8	1.3	0.6	1.4	7.3	1.9	0.6	0.7	0.5	0.1	0.4	3.1	1.4	0.7	2.7	0.2	2.2	0.8	0.4	2.2	2.4	1.4	1.3	3.3	1.6	6.6	0.6	25.1	0.6	5.9	6.4	1.5	1.9	0.6	0.5	5.7	3.0	0.8	1.4	0.2	20.9	6.0	21.9	10.6	1.5	3.4	4.3	19.1	9.6	14.3	9.5	9.5	11.4	14.2	4.9	7.0	10.0	9.4	15.7	7.7	22.6	17.7	5.8	16.7	12.6	6.9	0.2	19.8	9.7	1.0	0.6	11.4	9.6	3.2	12.0	13.0	17.3	17.0	18.3	7.6	15.6	8.9	7.0	8.5	9.4	10.5	20.5	4.7	4.0	4.2	10.1	6.0	16.9	11.8	4.6	8.8	6.7	7.0	13.0	13.8	14.5	14.3	19.5	8.3	14.2	14.8	7.7	11.1	14.6	5.7	0.1	0.7	0.2	0.6	0.0	0.6	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.8	3.0	0.5	1.4	0.2	0.6	1.5	0.2	1.3	2.0	0.8	1.9	0.6	1.4	0.6	3.0	2.1	0.0	1.0	3.2	7.1	1.4	0.0	0.0	1.2	0.0	7.9	2.4	0.0	0.4	3.4	2.8	0.5	93.5	0.0	22.1	1.5	1.3	6.9	0.8	11.2	0.0	1.2	4.3	7.3	0.7	0.9	5.5	0.0	8.2	1.4	1.4	1.3	0.6	2.5	0.0	2.5	0.0	2.5	69.2	47.7	2.5	3.0	2.5	4.7	0.6
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189548-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.8;testis: 37.3"	"Cell type enhanced"	"Detected in many"	15	"Erythroid cells: 70.0;Spermatocytes: 122.1;Spermatogonia: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036494	Approved		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.0	1.9	2.9	15.2	3.1	19.1	5.5	2.1	3.0	3.9	4.7	1.2	0.7	4.2	2.9	3.1	7.7	2.5	2.8	4.4	2.7	2.1	1.9	2.2	3.6	11.1	2.6	3.7	3.6	1.6	1.6	2.7	6.8	1.8	2.4	5.5	1.6	3.0	1.5	3.6	6.0	4.0	2.4	2.6	6.2	2.5	37.3	1.8	31.8	1.8	10.2	12.2	3.1	4.3	12.1	6.1	2.5	3.6	7.5	9.8	4.2	18.4	5.7	26.8	20.9	1.7	5.6	14.3	9.1	9.7	20.3	22.0	7.8	23.5	39.7	10.9	5.3	11.8	13.8	17.5	21.0	26.0	12.0	12.0	9.2	9.8	7.7	0.6	13.3	9.5	2.2	4.3	13.2	14.6	5.8	6.8	21.7	16.3	15.8	15.6	10.3	42.8	19.1	23.2	6.0	4.9	26.7	35.3	30.6	6.4	6.8	18.5	24.7	10.0	6.8	8.0	15.2	9.5	9.0	3.3	10.1	17.0	13.4	22.6	19.5	29.5	31.8	15.6	27.0	19.1	0.6	1.8	2.5	4.5	3.0	7.3	11.8	7.6	5.7	2.8	12.1	9.8	8.3	0.4	7.5	3.6	6.1	8.7	4.2	2.9	3.1	2.1	3.0	2.7	2.1	2.6	3.7	1.8	1.8	0.0	1.6	22.3	12.1	32.5	3.6	2.2	5.1	13.4	6.8	0.0	0.0	23.0	0.0	5.8	21.9	5.7	1.2	70.0	7.9	41.3	7.8	4.5	4.7	0.8	15.0	0.0	1.2	5.5	5.6	22.4	3.4	11.0	8.5	5.4	7.2	5.2	5.5	2.9	4.6	2.9	3.0	19.4	6.6	122.1	250.2	16.8	8.4	13.1	13.0	6.2
CENPI	"CENP-I, FSHPRH1, LRPR1, Mis6"	ENSG00000102384	"Centromere protein I"	Q92674	X	101098218-101163681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"	13	"Extravillous trophoblasts: 3.8;Hofbauer cells: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061297			Supported	"Nuclear bodies,Cytosol"		NA	Yes			"Nuclear bodies"	Cytosol	"HPA061297: AB_2684471"	"unprognostic (3.10e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.78e-6)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.62e-3)"	"unprognostic (1.20e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-13)"	"unprognostic (1.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-1)"	2.6	1.8	1.5	10.8	4.7	9.1	4.0	1.7	2.9	3.7	3.9	3.6	0.0	4.0	4.1	2.2	7.1	2.7	2.8	1.7	1.8	1.4	1.5	1.6	2.9	7.7	3.3	1.8	4.5	1.2	0.3	1.3	3.6	2.6	1.8	5.3	1.2	2.0	0.8	1.5	4.5	3.8	4.3	4.3	4.0	3.3	4.6	2.7	18.3	1.3	4.1	11.0	3.1	3.7	2.6	2.9	4.8	2.8	3.2	3.3	1.2	16.8	11.6	14.4	11.1	1.8	3.3	6.4	18.3	9.8	18.6	37.6	15.6	10.8	12.4	6.5	7.2	28.7	9.9	21.0	9.7	26.0	7.7	5.3	7.6	16.6	5.9	0.2	10.0	8.4	1.3	0.8	24.6	3.1	5.3	15.8	9.0	5.3	22.8	17.9	11.9	9.9	3.6	11.1	8.0	14.4	9.3	20.8	8.0	4.6	10.1	9.2	4.8	22.4	6.3	3.8	13.7	6.3	3.2	6.4	17.5	14.7	16.2	14.5	3.7	8.5	14.0	6.9	13.4	13.5	2.2	2.1	2.3	2.0	2.8	1.3	2.6	2.0	2.6	1.0	2.1	1.6	1.7	4.8	3.2	2.6	2.9	3.3	1.2	1.5	4.7	1.7	2.9	1.8	1.4	3.3	1.8	2.6	2.7	0.0	0.0	0.8	0.0	0.2	0.4	0.4	0.0	0.0	1.2	0.0	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.0	0.0	3.8	0.3	0.1	0.0	0.0	1.2	0.0	0.0	0.6	0.6	0.0	0.3	0.0	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.2	1.0	0.1	0.2	0.0	0.5	0.0
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325484-92620533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 56.2;Suprabasal keratinocytes: 88.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: AB_2683860"	"unprognostic (5.48e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	5.0	5.1	6.8	8.9	8.8	15.5	4.9	14.9	7.4	6.0	3.8	3.5	1.4	4.5	6.4	4.1	8.4	3.6	4.6	4.3	5.4	4.6	3.5	3.2	3.5	7.8	6.1	4.5	4.6	7.5	7.8	9.4	5.3	6.8	4.8	4.5	5.5	5.0	2.8	11.8	30.0	3.2	4.8	4.4	5.4	3.0	8.7	6.5	14.8	3.0	7.4	9.1	4.4	8.0	6.7	4.8	4.1	10.3	5.1	8.2	4.0	7.9	5.0	7.1	5.1	2.9	3.2	6.7	8.4	4.7	10.5	8.4	2.3	4.6	10.1	3.9	2.7	9.7	9.6	6.8	4.6	9.8	14.4	8.0	10.3	4.5	3.3	1.5	21.1	10.0	3.4	2.6	10.2	6.6	1.4	5.3	10.0	11.1	14.7	8.0	5.0	29.6	6.4	5.7	15.0	9.5	10.0	11.6	11.3	1.6	8.0	15.8	5.5	9.5	6.1	3.0	5.3	3.2	6.5	2.5	10.3	5.1	15.5	12.0	9.8	11.4	13.3	11.5	10.5	9.3	3.0	3.2	4.1	4.9	10.3	8.2	6.7	5.3	4.1	3.6	5.7	5.0	4.8	0.8	5.1	5.1	4.8	5.7	4.0	6.8	8.8	14.9	7.4	5.4	4.6	6.1	4.5	6.8	6.5	0.0	0.3	1.5	3.6	56.2	6.4	2.0	2.5	0.0	1.2	0.0	7.9	2.7	1.7	0.9	15.3	3.1	0.7	0.0	2.0	8.2	5.6	2.1	0.0	0.8	13.9	1.6	1.2	1.3	1.3	3.6	4.0	3.0	13.5	0.0	0.6	2.5	1.2	0.0	4.6	1.1	7.5	6.5	6.7	11.1	5.7	88.2	3.2	4.3	1.7	2.4
CENPV	"CENP-V, p30, PRR6"	ENSG00000166582	"Centromere protein V"	Q7Z7K6	17	16342534-16353656	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Paneth cells: 96.8;Spermatogonia: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.6;memory B-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 33.0;HEK 293: 27.0;JURKAT: 32.1;NTERA-2: 32.4"	"Low region specificity"	"Detected in all"							"HPA042529, HPA042616"	Enhanced		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			Nucleoplasm	"Midbody, Cytosol"	"HPA042529: AB_10793882, HPA042616: AB_10794050"	"unprognostic (7.64e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.60e-3)"	4.6	5.6	13.7	4.0	14.7	6.2	6.6	12.0	17.3	4.2	19.5	6.7	2.8	13.6	8.0	5.5	1.3	9.1	3.5	5.7	10.2	10.1	5.2	14.6	2.5	2.3	7.8	11.8	9.1	5.9	3.7	7.3	2.2	5.8	4.6	11.5	2.4	1.6	6.4	25.4	0.9	29.1	6.1	7.3	1.5	18.0	10.6	6.1	22.5	4.0	2.9	2.1	3.2	2.3	3.3	1.0	3.6	0.0	0.0	1.0	0.3	3.1	6.2	33.0	16.6	0.9	0.8	5.7	2.6	2.6	8.3	6.4	6.2	1.4	12.6	5.3	1.9	1.5	0.9	21.3	0.2	5.2	0.0	27.0	2.9	1.6	12.2	9.3	3.0	0.0	2.4	0.8	10.0	5.8	0.9	4.6	32.1	5.1	0.0	2.4	0.5	23.6	10.0	32.4	20.5	0.0	17.0	1.2	1.4	1.9	4.7	17.7	13.5	6.6	0.1	1.5	15.9	0.1	7.4	0.3	0.0	2.7	0.3	0.0	0.0	0.0	7.3	0.0	4.1	0.2	0.0	0.0	3.6	0.3	0.0	0.1	3.3	0.1	0.1	0.7	0.3	1.0	0.9	0.0	0.0	0.0	1.0	0.2	0.3	13.7	14.7	12.0	17.3	10.2	10.1	7.8	11.8	5.8	6.1	0.0	2.4	6.0	17.3	0.9	40.2	3.7	28.1	4.0	6.8	1.8	3.9	11.5	26.6	7.1	12.4	3.6	48.0	0.0	20.1	10.7	2.9	19.6	5.7	43.9	5.4	11.1	37.8	1.3	2.2	6.1	8.1	2.7	8.5	1.0	52.7	28.8	13.5	96.8	11.0	31.1	13.8	25.8	15.6	48.8	116.2	2.3	5.4	4.3	71.8	42.2
CEP112	"CCDC46, MGC33887"	ENSG00000154240	"Centrosomal protein 112"	Q8N8E3	17	65635538-66192084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 912.3;Late spermatids: 1163.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 17.0;RH-30: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024481			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA024481: AB_1846153"	"unprognostic (9.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.48e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	10.0	3.8	6.0	9.0	8.3	1.7	9.6	2.9	6.5	11.5	6.7	1.9	14.9	1.9	8.8	10.2	4.3	6.9	6.6	7.4	5.9	4.3	5.2	2.9	6.9	2.2	4.3	3.4	7.7	4.3	8.4	28.3	6.6	6.8	8.6	3.2	7.2	2.9	13.9	9.5	3.1	2.9	9.8	7.4	7.9	4.5	39.5	4.3	4.2	6.8	6.9	1.8	6.6	13.6	3.0	4.1	4.3	1.3	2.9	2.7	0.5	2.5	5.3	7.0	2.0	3.8	7.8	0.2	2.3	4.1	2.9	2.7	0.7	1.1	0.9	2.3	5.1	8.3	0.3	1.5	1.5	4.2	1.4	2.4	0.1	2.3	0.9	1.7	0.3	0.1	4.6	2.6	2.7	0.8	5.9	8.9	1.4	0.1	2.7	17.0	0.3	2.6	0.2	0.7	0.5	2.2	0.7	40.1	0.2	3.2	0.1	1.9	3.9	2.5	0.2	1.8	6.4	2.0	0.2	3.9	7.8	4.4	2.0	3.5	1.2	1.0	0.1	2.4	0.1	2.8	2.9	1.3	1.1	1.1	0.6	1.9	1.0	2.7	1.2	0.7	3.0	1.7	1.4	4.3	2.9	0.8	4.1	1.7	0.5	6.0	8.3	2.9	6.5	5.9	4.3	4.3	3.4	6.8	4.3	8.9	27.3	0.8	2.4	2.3	21.5	23.0	2.5	37.5	26.1	1.8	19.6	0.6	1.7	5.2	912.3	18.7	0.0	0.0	4.1	1.2	8.5	1.8	2.3	0.2	1.4	1.6	1.7	8.6	0.6	1163.2	23.0	4.4	13.5	0.0	0.0	14.1	4.6	0.0	18.7	2.8	150.6	12.9	7.2	22.8	13.1	1.4	0.1	0.9	1.5	1.4
CEP120	"CCDC100, FLJ36090"	ENSG00000168944	"Centrosomal protein 120"	Q8N960	5	123344885-123423592	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028823, HPA051556"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			Microtubules	Cytosol	"HPA028823: AB_10601355, HPA051556: AB_2681533"	"unprognostic (3.65e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.58e-1)"	13.3	12.9	8.6	15.2	12.8	9.2	12.1	22.9	10.8	13.1	11.1	12.5	14.4	7.9	15.7	11.3	9.3	13.5	11.6	9.5	10.0	11.6	10.7	12.7	11.4	16.1	11.2	9.8	24.3	11.0	9.8	18.1	8.9	11.4	11.7	9.6	13.9	9.8	12.0	7.3	6.9	11.8	12.0	12.0	13.9	8.6	19.4	10.9	28.4	11.7	6.0	15.6	13.0	14.2	3.6	1.6	5.5	2.4	1.6	5.4	1.7	7.7	8.7	9.6	14.2	9.6	12.3	9.8	9.2	12.0	10.3	17.2	7.3	7.0	10.9	8.5	7.1	16.2	6.2	9.4	9.9	16.6	21.8	6.0	5.4	7.2	6.3	10.1	6.9	9.4	9.3	10.5	13.8	16.4	7.7	8.7	10.0	5.5	19.5	9.9	3.6	12.1	11.6	4.6	3.2	6.5	7.1	13.3	6.8	5.7	4.5	10.5	8.7	8.1	4.3	13.4	11.0	6.3	15.3	6.4	10.8	8.8	6.0	11.6	13.0	9.9	10.7	9.3	12.6	10.5	5.5	1.2	2.6	2.0	2.4	2.7	3.6	3.4	2.7	1.5	3.1	2.9	4.9	0.8	1.6	0.8	1.6	5.4	1.7	8.6	12.8	22.9	10.8	10.0	11.6	11.2	9.8	11.4	10.9	11.9	9.3	8.1	3.5	5.3	9.1	8.4	0.0	32.1	13.6	7.0	27.5	3.4	1.7	2.4	6.8	7.1	3.2	0.0	4.1	3.7	5.3	3.6	2.3	5.8	4.8	7.9	2.4	3.1	10.7	3.9	10.9	6.0	8.5	7.2	4.2	6.8	3.7	3.5	13.1	2.9	15.8	6.5	6.4	14.4	9.1	1.6	1.9	10.2	3.3	3.0
CEP128	"C14orf145, C14orf61"	ENSG00000100629	"Centrosomal protein 128"	Q6ZU80	14	80476983-80959517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 61.2"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 22.7;monocytes: 15.4;Spermatocytes: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.6;T-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 25.8;MOLT-4: 22.1;U-266/70: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000602, HPA001116, HPA018498"	Uncertain		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	Cytosol	"HPA000602: , HPA001116: AB_1078323, HPA018498: AB_1845560"	"unprognostic (6.13e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.48e-1)"	3.8	2.0	5.2	6.5	7.6	10.5	7.5	13.6	5.4	3.4	3.6	4.2	2.7	3.2	4.0	2.2	4.4	4.8	2.0	3.1	3.8	2.5	2.4	2.0	3.8	8.1	6.9	3.1	4.4	2.1	4.2	8.6	2.3	4.5	2.9	3.3	2.3	4.5	3.2	3.1	5.1	3.0	4.0	5.5	6.3	3.1	9.0	6.8	61.2	5.7	3.1	9.1	6.0	4.4	2.2	8.6	1.7	0.8	1.1	9.6	0.8	6.0	3.2	2.9	2.3	0.7	1.1	1.5	6.9	2.0	4.0	4.0	2.1	3.5	14.0	1.2	2.0	2.6	3.2	3.1	2.0	7.7	7.9	1.9	2.7	3.9	1.1	0.3	2.7	3.6	0.2	0.5	5.7	3.1	0.7	3.0	7.1	3.3	25.8	3.7	3.8	22.1	1.4	2.2	1.6	4.0	3.9	7.0	11.0	0.8	3.1	3.7	1.7	5.5	2.2	1.2	2.9	2.5	2.1	2.8	8.8	4.8	2.4	6.7	46.5	1.8	6.2	2.5	3.7	3.0	0.0	0.8	1.7	2.9	0.3	2.3	2.2	3.2	2.2	2.5	0.9	2.8	1.3	0.1	1.1	0.5	8.6	9.6	0.8	5.2	7.6	13.6	5.4	3.8	2.5	6.9	3.1	4.5	6.8	3.0	3.2	6.7	2.4	3.5	6.7	3.9	0.0	22.7	9.1	3.5	2.0	1.0	0.0	1.2	6.1	1.7	0.0	0.0	1.0	7.0	1.9	0.6	2.3	0.0	2.2	6.4	1.2	1.3	0.0	3.1	1.4	5.5	3.3	15.4	0.6	7.1	0.8	0.0	1.4	0.4	15.0	6.5	2.0	17.7	3.4	1.5	1.9	4.1	1.2	1.3
CEP170B	"Cep170R, FAM68C, KIAA0284"	ENSG00000099814	"Centrosomal protein 170B"	Q9Y4F5	14	104865280-104896770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 216.0;Rod photoreceptor cells: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000871, HPA059017"	Enhanced		Approved	Microtubules,Centrosome,Cytosol		NA	NA			Cytosol	"Microtubules, Centrosome"	"HPA000871: AB_2666124, HPA059017: AB_2683883"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.41e-4)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-2)"	10.3	8.8	19.9	7.3	26.3	1.3	10.9	25.9	39.7	6.6	18.0	5.3	9.1	24.7	7.4	5.0	14.7	8.5	15.1	4.9	18.5	12.4	9.9	9.4	8.0	2.1	8.9	19.7	4.6	25.4	9.0	10.5	4.8	13.5	10.3	8.9	5.3	17.5	12.5	4.6	35.0	24.6	6.7	6.5	3.8	23.2	10.9	6.0	0.2	10.1	6.2	5.6	8.8	11.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	10.8	9.1	0.7	8.6	3.7	2.7	20.2	8.6	3.4	4.3	2.9	9.6	6.7	0.0	10.5	6.5	3.0	24.2	2.0	10.1	1.1	4.0	4.2	0.0	9.6	6.2	7.4	0.0	8.9	2.6	12.9	4.5	6.7	3.4	4.3	0.0	2.7	0.1	3.7	23.1	0.0	0.1	2.9	15.6	7.9	3.6	0.0	2.6	4.3	18.6	2.3	2.4	12.8	7.6	11.5	1.5	13.1	1.6	9.5	6.9	7.6	19.0	5.7	0.4	0.0	0.0	5.5	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	19.9	26.3	25.9	39.7	18.5	12.4	8.9	19.7	13.5	6.0	8.9	15.4	0.0	10.8	21.2	17.6	3.3	28.1	5.3	4.5	17.4	216.0	2.8	1.7	10.8	0.6	3.6	52.0	0.0	20.6	6.3	3.5	18.4	5.7	10.6	1.2	38.1	21.2	6.7	0.3	1.0	3.4	2.9	8.5	1.8	37.4	11.8	23.7	32.3	8.1	4.3	113.9	6.5	6.7	1.4	3.8	21.5	5.6	0.0	25.2	19.3
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039392, HPA040503"	Uncertain		Supported	Centrosome,Cytosol		Yes	No			"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	7.6	6.5	7.9	14.9	11.8	16.3	8.3	14.5	11.8	8.8	7.7	11.1	7.1	6.7	13.6	9.3	7.6	8.8	9.9	7.1	8.1	4.7	6.9	6.1	8.7	11.0	8.7	11.8	17.4	9.5	10.4	11.1	7.8	11.8	8.0	9.4	7.9	10.4	6.6	6.2	8.2	9.6	9.5	7.6	8.4	8.2	16.4	9.8	18.3	11.1	6.0	12.2	12.1	8.6	3.9	1.8	2.1	4.9	0.9	3.5	1.0	9.9	5.4	14.7	7.6	6.4	10.0	4.7	7.0	9.2	11.1	11.8	7.4	4.4	11.2	4.7	7.0	8.0	4.9	12.7	6.6	13.1	4.4	4.5	10.2	8.2	3.8	3.3	16.1	7.9	6.9	2.5	9.2	8.5	6.3	9.0	8.1	14.0	7.5	8.6	5.0	13.9	7.0	4.6	18.5	3.3	12.0	11.5	5.8	3.8	10.1	10.7	6.0	11.1	5.5	3.4	7.2	4.4	8.4	9.0	8.7	20.6	9.9	9.5	5.1	7.3	12.8	5.6	7.3	8.4	1.5	2.1	1.5	3.2	1.5	2.4	1.8	2.1	2.0	0.9	3.9	2.3	3.5	2.1	0.9	4.9	1.8	1.8	1.0	7.9	11.8	14.5	11.8	8.1	4.7	8.7	11.8	11.8	9.8	8.9	10.9	5.9	3.9	1.6	11.7	21.4	7.6	4.0	10.3	7.0	21.6	3.5	0.0	3.9	21.9	3.5	4.9	0.0	3.1	2.7	3.0	5.3	2.3	4.7	3.8	11.1	0.0	7.4	9.4	9.5	9.5	5.4	1.7	11.8	9.1	6.6	4.0	5.8	13.1	1.1	16.3	25.8	3.5	19.1	21.3	2.8	1.6	10.1	6.4	7.1
CEP295NL	"DDC8, KIAA1731NL"	ENSG00000178404	"CEP295 N-terminal like"	Q96MC4	17	78870910-78903217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 37.7"	"Group enriched"	"Detected in some"	129	"Early spermatids: 285.7;Late spermatids: 373.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.0;Karpas-707: 3.2;TIME: 3.2;U-2 OS: 5.5"									"HPA023609, HPA024619, HPA025717"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900"	"unprognostic (1.68e-3)"	"unprognostic (4.56e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.03e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.75e-3)"	0.1	0.0	0.1	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	37.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	3.5	0.4	0.1	0.1	0.0	0.7	0.1	0.0	0.9	0.2	0.6	4.0	1.7	0.1	0.6	1.1	0.2	0.6	0.0	1.1	0.6	2.5	0.1	0.0	0.2	0.6	0.0	0.0	0.0	1.3	0.3	0.4	0.2	0.1	0.4	0.0	1.2	0.0	0.2	0.4	0.1	0.0	3.2	0.1	0.0	0.3	0.0	0.3	0.0	0.6	0.8	0.5	0.1	0.2	0.0	0.1	0.9	0.5	0.4	0.7	0.9	0.1	1.1	3.2	1.4	5.5	1.7	0.7	1.2	1.6	0.0	0.0	0.1	1.7	0.0	0.4	0.7	0.0	0.4	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.0	3.5	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	285.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.3	373.8	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496632-93529092	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.9;testis: 19.3"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 15.9;Extravillous trophoblasts: 14.7;Hofbauer cells: 10.9;Spermatocytes: 35.6;Spermatogonia: 19.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023430	Approved		Supported	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	3.2	1.4	0.5	12.1	0.4	3.1	3.6	0.3	0.6	2.0	5.2	0.3	0.2	4.6	0.8	1.5	11.6	0.6	2.5	0.7	0.4	0.5	1.5	0.7	4.4	10.1	0.6	0.2	0.8	0.6	0.0	0.7	3.8	0.5	0.8	6.5	0.4	2.3	0.2	0.7	3.0	5.2	3.5	1.1	4.8	3.2	19.3	0.3	52.9	0.7	10.8	11.0	2.7	3.3	0.1	0.1	0.0	0.0	0.0	4.4	0.0	51.9	20.8	13.8	17.6	1.5	3.2	7.7	28.6	20.3	27.2	28.2	22.1	28.0	13.9	12.7	18.5	18.3	29.7	16.7	14.0	32.7	41.8	8.7	5.2	12.9	7.5	0.1	9.0	12.2	0.7	1.0	29.0	35.4	8.1	25.0	23.1	4.7	26.4	30.7	12.0	23.7	13.7	5.4	16.2	15.2	10.3	22.7	7.6	12.3	6.5	5.7	8.0	22.0	6.8	17.3	11.0	17.9	9.2	15.6	17.3	24.2	23.6	46.9	11.8	16.0	17.0	13.5	34.0	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.5	0.4	0.3	0.6	0.4	0.5	0.6	0.2	0.5	0.3	0.0	2.2	0.8	0.6	3.2	0.0	0.4	5.1	0.0	0.0	0.0	0.0	0.9	0.0	0.6	15.9	0.0	0.3	0.0	0.2	14.7	0.4	0.1	0.0	0.2	10.9	0.0	0.0	2.5	4.1	3.8	0.3	5.4	0.0	0.0	1.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	35.6	19.5	1.1	1.3	1.9	2.3	0.9
CEP57	"KIAA0092, Translokin, TSP57"	ENSG00000166037	"Centrosomal protein 57"	Q86XR8	11	95789965-95832693	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 393.9;Late spermatids: 289.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018315	Approved		Approved	Microtubules,Cytosol	"Intracellular and membrane"	NA	NA			Microtubules	Cytosol	"HPA018315: AB_1846537"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (7.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.25e-1)"	16.8	13.7	12.9	25.9	20.6	21.6	17.4	27.9	16.2	25.6	33.8	6.9	19.2	27.0	18.5	18.8	18.2	16.5	22.9	14.0	13.3	14.1	14.9	34.4	19.0	28.9	12.6	15.2	27.2	24.5	13.6	26.1	13.3	15.0	21.5	15.6	10.5	14.1	22.3	12.6	15.8	28.8	22.2	14.6	19.8	15.3	24.3	12.7	46.5	23.4	15.7	23.9	27.5	18.3	17.2	15.5	17.6	11.0	18.6	25.3	13.0	11.4	5.6	19.7	14.7	8.4	17.4	15.6	13.0	21.0	18.0	20.4	20.4	24.6	20.6	18.2	9.6	10.9	19.3	14.8	12.9	19.1	16.2	9.9	28.4	16.5	16.9	15.5	28.8	17.1	11.7	18.4	18.4	35.4	17.4	14.9	22.8	18.3	11.4	14.3	5.6	31.0	38.0	10.0	13.1	13.0	19.4	23.6	17.3	15.2	12.7	9.5	13.7	15.5	15.3	16.4	13.8	15.7	18.6	8.4	15.7	12.7	23.0	12.4	8.4	16.2	23.0	6.5	32.1	13.6	11.3	9.1	17.6	16.5	11.0	21.2	17.2	21.0	18.8	11.9	16.2	20.2	19.2	8.5	18.6	9.1	15.5	25.3	13.0	12.9	20.6	27.9	16.2	13.3	14.1	12.6	15.2	15.0	12.7	50.6	42.7	43.2	31.6	32.3	71.9	38.6	71.4	64.3	47.8	27.9	33.4	35.9	46.4	28.1	393.9	35.2	19.7	46.7	22.5	43.0	29.6	24.9	26.5	62.1	28.5	54.0	27.6	16.0	29.7	289.2	31.4	34.0	16.9	23.4	30.2	26.4	24.1	28.1	33.6	27.0	58.6	64.7	29.2	42.3	38.3	28.0	32.2	42.4	40.6	24.0
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109163932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	11.9	9.3	10.6	7.3	13.5	8.9	11.4	13.9	16.1	11.3	8.8	8.1	8.6	8.4	9.6	10.9	8.0	7.1	9.3	10.4	8.9	6.9	8.1	11.8	8.4	8.1	10.2	10.5	9.3	7.5	18.5	13.5	9.7	13.5	7.1	11.1	7.0	7.4	7.3	7.8	6.8	7.6	10.7	12.8	7.2	7.8	24.6	11.8	6.3	8.7	6.1	6.9	7.6	9.1	7.4	6.9	14.6	10.3	13.4	8.2	5.2	8.3	3.6	11.0	11.2	10.5	17.4	8.9	19.3	10.5	17.1	19.6	5.5	7.3	7.4	8.9	9.8	15.0	4.4	7.6	7.1	27.1	9.4	7.4	15.9	8.7	5.7	9.7	13.0	7.0	10.0	5.5	14.6	14.6	9.5	14.9	25.1	28.8	25.8	15.7	5.6	14.5	11.3	3.6	6.8	7.1	12.0	8.3	7.4	8.1	3.5	8.5	6.9	9.4	7.1	6.3	7.6	8.9	20.8	7.2	11.3	6.8	11.9	20.1	7.5	8.5	11.8	10.7	20.1	9.1	14.6	6.3	7.4	6.1	7.1	6.2	4.0	6.0	8.2	6.7	7.4	5.8	8.2	3.6	13.4	10.3	6.9	8.0	5.2	10.6	13.5	13.9	16.1	8.9	6.9	10.2	10.5	13.5	11.8	6.0	4.0	2.2	6.5	3.0	6.0	8.1	2.5	12.0	7.9	5.2	19.6	7.0	6.6	6.5	36.0	8.7	4.2	23.3	4.7	11.0	11.8	3.3	4.7	4.9	8.4	4.8	5.2	6.7	4.4	26.1	16.1	5.9	8.5	8.2	2.6	9.4	5.0	5.5	11.7	10.4	12.0	12.9	12.8	72.6	5.0	3.9	7.1	6.9	4.5	3.0
CEP63	FLJ13386	ENSG00000182923	"Centrosomal protein 63"	Q96MT8	3	134485743-134575017	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Mitosis"		"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 54.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058154, HPA058313"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058154: AB_2683624, HPA058313: "	"unprognostic (1.80e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	21.6	15.4	17.7	17.1	18.1	25.3	16.5	19.7	22.6	13.8	15.4	14.5	18.8	9.1	13.7	17.6	15.1	12.2	12.3	25.6	17.2	15.0	15.2	20.5	12.4	15.7	20.4	15.7	16.7	17.8	21.8	23.1	13.5	20.0	16.7	14.5	11.1	15.5	17.4	38.1	15.0	11.3	20.2	20.2	15.3	13.9	37.2	21.5	21.7	18.3	14.9	16.3	17.3	19.9	6.1	7.2	54.1	8.2	5.9	5.6	3.5	17.2	7.7	14.6	9.5	21.3	18.1	13.7	18.7	15.4	15.0	12.7	6.1	7.4	19.6	12.0	13.5	14.5	10.3	7.5	10.4	18.2	21.9	4.0	25.3	8.3	8.6	14.7	16.0	11.8	15.7	13.8	8.0	26.7	16.9	14.8	27.4	7.5	17.1	17.6	11.6	19.1	19.1	10.4	11.1	9.1	12.4	21.6	28.0	12.8	10.8	8.6	8.2	16.8	6.6	25.2	18.3	13.5	21.8	16.8	17.0	10.1	16.1	13.8	15.8	10.9	25.2	18.2	17.1	21.5	18.1	6.0	9.9	4.0	6.2	5.4	4.8	3.9	5.1	7.2	6.1	5.6	4.2	54.1	5.9	8.2	4.8	4.8	3.5	17.7	18.1	19.7	22.6	17.2	15.0	20.4	15.7	20.0	21.5	17.9	25.9	21.5	13.0	9.5	30.0	76.9	20.4	45.5	27.3	7.0	19.6	22.1	26.6	22.3	64.2	20.4	10.5	0.0	17.7	22.5	17.3	16.0	50.8	13.9	24.8	30.2	12.6	15.4	22.3	37.5	22.2	24.5	16.9	20.8	15.3	24.6	18.7	17.5	24.4	22.3	42.3	19.4	18.4	95.2	46.4	8.5	14.5	12.7	15.0	12.3
CEP68	KIAA0582	ENSG00000011523	"Centrosomal protein 68"	Q76N32	2	65056366-65087004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040493, HPA040620"	Enhanced		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA040493: AB_10673411, HPA040620: AB_10794144"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.84e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.71e-1)"	18.4	7.3	12.7	9.2	17.0	5.0	16.2	24.8	22.2	19.2	13.2	11.9	8.5	6.6	20.0	10.4	11.7	16.9	12.7	15.7	12.5	11.9	8.4	3.3	9.2	10.6	11.3	17.6	26.4	10.6	13.2	7.5	11.8	15.0	14.2	8.6	11.6	12.0	15.4	28.2	13.6	8.7	17.3	10.3	10.2	9.7	7.6	7.8	10.3	11.6	12.9	9.9	13.4	13.0	5.1	8.7	1.5	5.5	5.2	11.1	3.0	2.8	5.1	9.9	7.2	8.9	10.1	18.2	2.7	4.8	4.2	3.7	3.9	2.5	4.8	3.4	4.9	4.3	3.9	6.5	4.1	4.5	5.8	5.5	6.5	1.8	4.7	2.5	3.7	4.7	9.5	5.9	3.8	5.4	7.5	12.0	10.1	6.0	15.5	5.3	3.3	6.1	6.7	10.0	5.2	4.1	6.5	12.0	5.6	3.7	3.8	17.5	11.9	5.4	4.0	5.7	6.4	2.3	2.4	4.7	4.0	5.5	6.2	2.7	17.0	4.7	11.3	2.1	2.9	4.8	1.0	1.7	0.4	3.0	3.1	3.4	3.4	7.0	5.6	4.3	5.1	11.1	6.6	1.5	5.2	5.5	8.7	5.1	3.0	12.7	17.0	24.8	22.2	12.5	11.9	11.3	17.6	15.0	7.8	26.8	10.4	11.5	13.0	6.4	22.8	13.2	5.1	21.4	20.5	8.7	23.6	13.1	8.3	8.8	2.8	39.8	2.7	0.0	18.9	6.3	11.3	5.9	5.8	5.4	8.4	22.3	12.6	17.2	7.9	4.1	35.1	14.4	6.8	26.2	5.7	14.7	10.1	3.5	25.5	7.5	21.7	32.3	11.4	10.7	23.0	5.1	28.5	12.8	10.6	6.3
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 163.4;Late spermatids: 214.6;Spermatocytes: 140.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0"	"Group enriched"	"Detected in many"	8	"B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favorable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	5.5	8.3	11.0	5.7	15.8	3.5	9.0	14.7	15.6	20.8	12.2	7.1	22.8	35.7	14.0	14.8	10.2	20.3	8.9	11.3	10.9	15.9	17.0	18.8	11.5	4.2	12.6	10.2	14.4	17.4	16.6	27.8	2.7	14.4	14.3	12.1	12.6	6.1	28.7	10.6	4.6	11.5	14.0	19.1	3.9	8.6	41.5	15.3	24.2	26.2	6.7	4.5	13.3	9.1	2.9	0.2	0.5	0.1	3.6	6.4	2.0	21.6	4.5	10.7	13.0	6.7	7.5	10.0	4.3	8.1	6.0	8.9	6.3	11.8	5.1	10.3	8.0	22.8	9.6	9.7	8.6	13.5	9.0	6.4	14.6	10.5	8.2	10.5	0.7	5.4	40.3	5.0	4.5	11.2	16.0	8.6	16.8	10.6	17.1	9.8	8.2	15.3	0.8	6.3	5.7	10.2	16.9	13.9	13.1	11.4	9.7	13.0	8.5	22.5	5.4	25.5	12.8	27.1	7.1	5.0	4.4	8.4	9.0	5.2	15.9	8.7	17.4	9.8	1.4	15.0	0.4	0.1	0.2	4.2	0.1	5.0	2.9	3.4	3.7	0.1	2.0	5.9	6.4	0.5	3.6	0.0	0.2	2.0	2.0	11.0	15.8	14.7	15.6	10.9	15.9	12.6	10.2	14.4	15.3	29.8	54.7	0.8	31.2	8.7	15.6	23.2	17.8	48.2	38.7	19.2	33.4	5.9	61.3	18.3	163.4	7.1	4.6	0.0	15.5	3.6	6.2	27.5	19.7	12.4	2.2	20.6	15.0	4.9	0.8	214.6	9.2	3.3	10.1	1.0	9.5	19.7	13.7	7.0	12.0	17.0	29.1	6.5	11.8	140.5	9.1	7.0	8.0	4.9	22.3	24.8
CEP95	"CCDC45, DKFZp667E1824"	ENSG00000258890	"Centrosomal protein 95"	Q96GE4	17	64506588-64542461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023654, HPA052426, HPA052428, HPA061371"	Approved		Approved	"Nucleoplasm,Vesicles,Mitotic spindle,Centrosome"		Yes	No			Nucleoplasm	"Vesicles, Mitotic spindle, Centrosome"	"HPA023654: AB_2072077, HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495"	"unprognostic (1.28e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (5.78e-4)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	13.0	8.6	10.9	17.1	13.1	37.9	15.5	27.9	15.6	16.7	14.2	16.2	11.6	11.9	26.5	16.6	10.7	17.1	12.3	10.6	11.5	7.8	14.1	11.7	13.0	20.7	13.6	7.9	27.3	15.5	11.8	20.4	8.5	13.0	15.2	13.5	15.6	13.8	19.8	14.6	21.7	14.2	15.0	17.4	13.2	13.3	16.9	13.9	26.4	21.0	8.6	14.7	14.3	14.0	5.9	3.7	2.2	3.6	2.1	10.8	2.4	9.9	6.3	12.9	11.1	3.4	8.9	13.0	5.1	5.2	6.3	9.6	7.6	5.7	15.9	3.3	7.1	6.3	12.6	11.1	9.7	13.1	4.2	8.5	14.1	12.2	14.6	11.5	15.3	7.6	10.1	10.2	7.0	15.7	8.4	5.3	16.6	16.2	11.6	6.9	11.6	19.4	9.8	8.0	10.2	7.9	14.0	23.5	11.8	7.4	15.9	8.2	14.8	6.9	10.2	13.1	20.2	11.2	10.3	7.9	14.5	11.3	6.6	6.9	11.9	9.5	16.9	6.2	11.8	8.8	2.2	3.6	2.2	4.5	2.9	10.8	4.5	5.2	4.5	3.4	5.9	8.0	5.4	1.4	2.1	3.4	3.7	4.2	2.4	10.9	13.1	27.9	15.6	11.5	7.8	13.6	7.9	13.0	13.9	38.7	22.9	11.5	23.2	14.3	26.0	16.7	12.7	65.6	39.8	3.5	43.2	7.8	6.6	16.8	45.2	9.8	15.1	0.0	10.2	9.0	11.5	13.9	27.8	6.6	7.4	17.5	7.5	12.3	9.5	14.2	19.2	10.4	11.8	15.4	12.4	22.7	11.6	11.5	20.1	5.0	86.8	12.9	15.0	30.7	28.8	17.8	5.5	19.7	17.0	19.0
CEP97	"FLJ23047, LRRIQ2"	ENSG00000182504	"Centrosomal protein 97"	Q8IW35	3	101723925-101770562	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 46.8;Spermatocytes: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002980	Uncertain		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	Cytosol	"HPA002980: AB_1848820"	"unprognostic (7.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.05e-1)"	3.8	4.3	7.5	5.2	11.8	6.6	4.1	15.2	11.8	4.5	3.9	12.1	3.6	2.5	5.7	4.1	3.8	8.7	3.5	3.5	7.9	4.9	3.5	2.9	3.7	6.5	15.3	7.0	5.4	3.1	10.2	9.9	4.1	12.8	3.9	3.7	3.0	4.1	3.6	4.8	4.1	3.9	6.6	8.1	4.3	3.5	20.0	14.8	10.8	5.3	1.7	6.8	4.7	4.1	2.7	1.3	5.1	1.1	0.9	2.5	0.8	9.4	5.6	9.6	7.0	5.4	4.2	2.9	10.3	7.2	7.9	9.8	2.4	4.5	8.2	4.7	5.7	6.3	6.5	7.2	5.6	13.5	9.1	3.5	4.7	6.2	1.7	2.6	5.9	7.4	2.5	4.5	6.8	5.8	4.1	4.3	8.4	3.8	14.9	9.7	2.8	9.7	3.0	3.4	3.3	7.5	7.1	13.4	5.6	2.6	3.7	18.5	7.6	5.5	3.5	4.9	5.3	6.1	5.1	4.4	10.8	8.0	3.2	7.4	9.4	8.5	14.9	4.4	5.4	10.6	5.1	0.4	1.9	2.2	0.1	1.8	2.7	1.9	1.3	0.5	1.7	1.3	1.1	3.1	0.9	1.1	1.3	2.5	0.8	7.5	11.8	15.2	11.8	7.9	4.9	15.3	7.0	12.8	14.8	3.0	3.8	2.2	2.1	4.1	12.6	5.9	5.1	46.8	12.5	1.8	11.8	3.0	3.3	4.0	15.4	4.4	0.9	0.0	1.8	2.4	5.6	2.2	9.2	3.6	2.3	17.5	4.1	4.3	3.5	5.6	7.2	1.1	8.5	2.8	3.4	21.1	3.1	0.0	7.1	2.5	13.4	12.9	5.9	30.7	8.3	3.1	1.6	4.5	3.3	1.0
CERCAM	"CEECAM1, CerCAM, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.1"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	12.7	5.1	40.0	7.2	65.5	1.6	9.0	10.0	62.1	19.1	6.9	61.2	5.0	4.8	11.4	10.9	8.2	6.0	17.3	8.8	72.8	34.7	4.9	1.8	5.3	2.3	59.5	28.1	14.1	18.8	15.8	21.6	27.4	31.4	11.1	5.2	3.5	13.2	13.6	4.3	8.9	6.0	27.7	78.1	3.3	5.4	5.2	62.1	0.0	6.7	2.4	2.7	15.1	6.6	0.3	2.0	0.3	1.6	1.1	5.3	2.2	9.5	6.1	6.9	7.3	55.6	59.3	5.9	30.9	29.2	8.1	6.1	2.2	0.4	0.0	12.7	50.4	6.9	6.5	3.0	4.1	3.1	2.4	4.9	0.5	5.6	3.3	17.0	1.1	17.3	32.8	2.2	8.8	2.1	33.5	9.1	0.6	2.8	7.6	10.5	18.1	0.4	11.7	0.4	0.4	4.7	0.9	4.8	1.3	3.8	3.6	1.0	1.9	6.9	8.4	3.5	2.3	6.8	2.3	10.1	21.6	5.9	29.6	4.7	8.9	6.9	0.1	20.4	3.4	4.2	0.3	1.1	0.1	3.8	1.6	0.3	0.3	0.3	4.7	1.5	0.1	0.1	5.3	0.3	1.1	0.1	2.0	0.0	2.2	40.0	65.5	10.0	24.5	72.8	34.7	59.5	28.1	31.4	62.1	6.0	13.0	0.0	6.2	7.9	1.1	3.2	0.0	6.7	21.6	10.4	0.0	14.3	0.0	10.7	2.0	7.1	0.0	0.0	2.9	48.9	70.1	3.9	8.1	0.0	5.9	6.4	0.0	18.4	0.6	1.5	22.5	4.7	38.8	1.0	0.0	0.1	6.9	0.0	24.8	0.5	0.7	6.5	15.6	1.0	19.0	3.6	16.4	2.5	0.0	2.0
CERK	"dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4"	ENSG00000100422	"Ceramide kinase"	Q8TCT0	22	46684411-46738261	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064699			Approved	Vesicles		NA	NA			Vesicles		"HPA064699: AB_2685327"	"unprognostic (2.93e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.35e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.58e-4)"	10.6	15.5	10.6	16.7	10.8	14.5	12.9	29.3	21.7	10.8	14.6	9.8	15.8	24.9	14.1	7.5	10.0	15.3	18.9	36.5	11.4	16.8	15.2	12.1	10.6	19.1	21.7	13.1	22.7	23.2	7.2	33.3	7.9	23.9	8.2	12.2	12.3	11.8	11.6	12.8	11.9	25.1	12.5	10.2	14.5	14.0	6.0	6.5	39.2	16.1	8.7	19.5	10.7	17.4	2.0	4.9	3.6	6.9	2.0	16.4	3.6	9.4	5.7	27.8	8.7	16.0	12.1	2.6	16.6	13.0	9.5	6.7	8.3	3.2	13.2	7.8	17.7	5.8	6.2	11.7	7.5	9.8	4.6	12.6	5.9	14.4	10.8	11.1	18.4	1.5	10.1	9.7	10.4	3.6	15.4	28.2	14.2	4.4	17.1	17.4	0.7	12.4	9.2	12.5	3.8	6.3	23.3	31.5	15.0	5.7	0.1	25.9	23.6	8.1	3.9	17.5	6.7	4.3	14.1	25.6	19.7	10.5	14.5	24.0	17.8	21.5	8.3	21.0	10.5	16.0	0.6	2.6	3.0	9.4	6.0	16.4	1.8	9.9	9.0	4.5	2.0	5.8	5.4	3.6	2.0	6.9	4.9	8.6	3.6	10.6	10.8	29.3	21.7	11.4	16.8	21.7	13.1	23.9	6.5	8.9	20.5	11.9	5.1	3.1	21.3	35.3	5.1	0.0	15.9	1.8	5.9	1.9	13.3	11.3	5.0	14.8	26.5	0.0	10.3	1.3	7.3	1.3	9.3	19.8	9.7	25.4	13.8	28.8	27.0	9.4	8.9	13.6	3.3	5.4	2.7	19.0	8.9	15.0	14.2	13.0	10.1	0.0	12.0	0.9	1.6	3.9	1.5	20.8	15.1	0.9
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536676-181680665	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5"	"Cell type enhanced"	"Detected in some"	21	"Ciliated cells: 52.2;Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"cerebellum: 49.5;pons and medulla: 13.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 26.5;HL-60: 14.7;JURKAT: 17.0;MOLT-4: 35.5;NB-4: 31.3;SCLC-21H: 23.9;THP-1: 14.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 31.8"	"HPA035443, HPA035444, HPA043203"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.6	1.2	9.2	2.0	14.4	1.1	49.5	2.5	3.7	1.7	4.2	0.4	3.1	1.0	5.3	0.6	5.8	4.1	0.5	2.9	1.3	8.1	1.3	5.0	13.8	0.6	1.4	2.9	0.8	0.1	2.1	2.0	13.7	1.0	0.0	6.8	1.0	0.4	0.5	0.5	6.4	0.4	1.0	17.9	2.8	1.1	1.1	0.4	0.9	0.4	1.1	4.3	1.3	4.0	5.2	12.6	12.7	4.7	6.9	4.2	0.0	0.5	0.6	0.0	0.0	0.1	0.0	4.2	0.1	0.1	0.1	0.0	0.1	4.4	0.0	0.1	2.6	2.6	0.1	0.1	0.1	0.0	0.4	26.5	0.3	0.0	0.1	14.7	0.7	0.2	0.3	0.1	0.2	4.0	0.0	17.0	0.0	4.7	0.0	0.0	35.5	31.3	0.6	0.0	0.2	7.6	2.2	0.6	0.3	0.0	23.9	0.7	0.0	0.0	0.1	0.2	0.0	14.8	2.4	1.2	0.6	0.1	1.0	11.4	6.4	2.0	0.9	9.9	10.8	2.0	4.7	12.6	4.5	12.7	3.7	4.0	6.4	6.9	5.2	3.4	3.5	4.5	0.7	4.7	10.9	2.9	1.4	4.2	1.2	2.0	49.5	2.5	2.9	1.3	0.6	1.4	13.7	1.1	3.0	0.3	0.0	0.1	0.0	0.4	0.7	0.0	52.2	7.9	0.0	17.7	0.0	8.3	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	7.8	20.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
CERS1	"LAG1, LASS1, UOG1"	ENSG00000223802	"Ceramide synthase 1"	P27544	19	18868545-18896727	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 86.3"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 85.2"	"Cancer enhanced"	"Detected in many"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.7;EFO-21: 13.0;HEK 293: 18.1;NB-4: 19.4;NTERA-2: 13.3"									HPA045724	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA045724: AB_10969762"	"unprognostic (8.25e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.49e-1)"	2.4	4.7	28.9	2.3	32.9	1.7	1.7	12.5	86.3	2.2	2.1	40.5	0.0	1.6	2.0	2.1	2.5	2.1	3.9	3.4	29.5	23.2	1.6	1.6	1.9	1.6	31.9	20.5	4.3	2.4	1.7	3.2	1.9	33.8	2.0	1.8	1.8	2.3	2.1	17.8	2.0	1.9	3.0	37.8	1.7	1.8	15.7	22.2	0.0	2.4	0.0	1.6	2.6	0.4	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.1	1.8	10.9	17.7	0.6	0.2	0.3	1.2	0.1	3.1	2.2	8.7	0.6	0.0	13.0	0.8	2.5	0.1	8.0	0.3	1.2	0.0	18.1	0.1	0.4	6.5	1.4	1.8	0.2	0.6	0.1	1.0	0.3	3.5	0.7	0.1	1.1	0.1	2.1	4.5	0.1	19.4	13.3	0.0	0.3	0.0	0.3	0.3	2.4	0.0	9.3	9.3	0.4	0.0	7.9	3.7	3.0	10.8	0.3	0.0	2.5	1.7	2.5	0.3	0.2	0.0	0.0	0.6	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	28.9	32.9	12.5	35.7	29.5	23.2	31.9	20.5	33.8	22.2	0.0	0.0	0.0	0.1	0.5	2.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	18.9	0.4	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	85.2	1.1	0.0	1.7	0.0	0.0	9.2	0.0	0.0	1.1	0.0	1.2	0.0	0.3	0.9	2.7	0.4	0.2	0.0	0.0	0.0
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 63.6;Muller glia cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 21.6;NB-4: 39.0;U-937: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	6.2	6.7	17.5	10.5	22.9	2.5	21.6	14.5	19.3	13.2	6.8	24.3	7.8	4.6	9.9	41.8	26.4	11.9	7.7	9.7	16.1	10.8	16.5	32.4	12.9	12.2	26.9	13.3	13.8	56.7	11.6	10.1	2.2	16.8	22.4	3.2	26.2	34.8	12.8	2.1	20.9	6.1	8.5	20.3	8.6	9.9	8.4	29.0	6.4	38.1	9.5	15.9	9.3	13.2	13.3	2.7	16.9	4.4	13.5	5.2	3.5	0.1	0.9	0.9	10.2	0.3	0.0	0.7	1.3	3.4	1.5	0.7	7.6	0.8	15.9	11.3	0.0	4.0	5.5	6.6	0.1	0.7	14.0	5.2	3.1	0.1	21.6	13.2	0.0	8.7	5.1	8.5	3.6	7.8	4.3	0.1	7.3	2.2	0.5	0.0	0.3	1.2	39.0	10.4	0.0	3.8	19.2	0.2	1.2	2.5	0.0	3.9	5.2	1.7	0.3	5.5	7.2	7.5	3.6	0.0	1.2	3.3	7.6	0.0	10.0	8.0	12.2	0.0	24.4	1.1	5.9	4.4	16.9	5.2	2.3	3.9	13.3	3.0	3.1	2.7	12.1	2.8	2.6	14.0	13.5	1.5	2.6	3.5	3.5	17.5	22.9	14.5	19.3	16.1	10.8	26.9	13.3	16.8	29.0	6.0	12.5	16.4	11.3	16.0	23.7	3.0	12.7	16.0	15.9	1.8	17.7	2.2	6.6	15.6	1.1	6.0	0.0	0.0	26.2	0.4	11.8	36.8	12.7	63.6	12.8	11.1	23.0	6.7	9.8	4.6	13.3	5.6	25.3	29.7	0.2	146.0	15.3	0.0	15.2	35.3	25.4	6.5	10.3	0.7	1.7	22.6	2.4	17.5	0.6	9.8
CERS5	"FLJ25304, LASS5, MGC45411, Trh4"	ENSG00000139624	"Ceramide synthase 5"	Q8N5B7	12	50129306-50167533	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026589	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA026589: AB_1852727"	"unprognostic (1.59e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.49e-3)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (9.33e-11)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (3.26e-1)"	18.0	13.2	18.3	13.3	21.6	10.9	18.0	38.3	19.6	21.1	15.0	17.5	8.9	6.3	22.6	20.9	14.1	17.7	14.9	9.9	16.7	11.6	16.0	7.8	14.7	15.1	13.9	19.1	22.5	13.8	23.9	22.4	19.7	14.3	15.6	11.5	14.9	14.6	16.2	5.0	21.5	12.2	21.8	10.3	15.7	13.3	11.6	14.4	12.7	15.5	7.0	14.9	18.4	18.3	21.0	26.1	33.5	35.1	29.0	26.3	22.3	9.2	10.4	23.0	6.5	12.8	10.8	19.5	20.5	17.7	19.7	18.7	24.5	14.7	14.0	17.2	29.0	10.3	8.7	10.0	7.9	19.6	22.1	10.2	11.7	8.8	14.8	25.6	11.9	16.0	18.5	12.0	16.2	15.1	25.9	17.9	12.3	8.8	13.0	24.7	16.2	10.3	32.4	14.7	5.2	10.1	13.5	15.0	10.0	25.6	12.0	7.0	11.4	17.4	8.2	27.5	15.8	11.2	13.7	17.1	17.0	11.4	12.7	8.9	12.7	12.1	11.3	13.4	8.3	7.8	24.8	19.0	28.1	26.0	25.5	22.9	17.9	22.9	22.4	18.2	21.0	17.9	24.3	33.5	29.0	35.1	26.1	26.3	22.3	18.3	21.6	38.3	19.6	16.7	11.6	13.9	19.1	14.3	14.4	17.9	17.3	12.1	17.3	15.3	41.7	5.6	15.3	9.4	14.8	14.0	19.6	27.6	6.6	19.6	0.6	14.9	9.1	0.0	12.2	48.5	20.0	10.2	15.0	3.8	17.4	30.2	15.0	15.4	17.0	1.1	15.5	16.5	11.8	30.7	7.0	21.7	14.2	7.0	16.3	6.8	36.1	32.3	17.6	8.1	7.5	12.5	28.1	20.0	6.0	11.3
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"esophagus: 46.7;intestine: 146.9;liver: 78.6"	"Group enriched"	"Detected in many"	4	"Enterocytes: 912.6;Hepatocytes: 449.6;Paneth cells: 448.9;Undifferentiated cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA018897	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		7500000	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558"	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	5.8	15.3	8.5	8.8	11.7	2.4	5.1	13.0	15.9	9.5	42.3	12.1	11.2	146.9	7.0	11.9	46.7	6.1	14.5	15.2	7.4	6.6	22.5	78.6	6.7	4.6	8.2	10.7	8.4	12.0	10.0	6.8	7.3	10.3	9.7	42.6	13.0	12.7	7.9	11.6	8.9	117.3	10.4	5.6	7.8	10.9	8.5	8.2	9.0	11.7	14.1	12.1	7.6	11.6	6.9	8.9	5.0	10.6	7.9	10.7	5.2	6.9	9.1	9.6	12.8	9.5	8.9	7.3	7.9	12.8	9.3	11.9	9.8	11.5	8.1	7.9	10.3	7.0	18.0	7.0	19.9	7.3	7.2	9.7	7.9	5.2	18.4	13.4	10.4	14.0	12.9	37.7	13.2	22.1	11.5	6.9	5.7	11.1	6.0	15.7	4.4	9.3	8.7	5.2	7.5	9.2	11.0	9.7	9.5	26.4	12.1	6.2	8.2	25.8	6.5	6.7	3.9	11.2	12.9	8.5	12.3	6.5	7.6	5.9	12.0	14.3	9.6	18.9	8.2	9.2	4.7	10.4	4.7	10.1	7.8	9.2	6.1	7.7	10.7	8.9	6.9	9.5	8.6	5.0	7.9	10.6	7.7	6.8	5.2	8.5	11.7	13.0	15.9	7.4	6.6	8.2	10.7	10.3	8.2	29.8	24.0	25.9	13.7	17.3	28.5	25.4	137.6	42.8	12.5	50.6	19.6	13.0	31.5	21.9	1.5	9.8	912.6	0.0	29.5	5.6	12.7	14.5	27.6	449.6	16.6	27.0	23.2	25.2	27.6	1.3	17.3	13.9	10.1	5.4	141.3	17.6	37.9	448.9	17.0	124.1	22.7	32.3	11.3	42.6	10.2	17.9	11.3	18.7	459.3	15.2
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961237-66975148	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8;liver: 26.7"	"Group enriched"	"Detected in many"	5	"Enterocytes: 66.2;Hepatocytes: 40.9;Intestinal endocrine cells: 18.9;Mucus-secreting cells: 31.1;Paneth cells: 60.4;Undifferentiated cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;Daudi: 8.9;JURKAT: 14.6;U-937: 7.6"					"Not detected"	"Not detected"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.5	0.1	0.8	13.3	1.3	0.2	1.0	1.6	1.3	0.6	40.7	0.7	1.4	16.8	0.4	0.7	2.2	1.5	3.0	0.7	1.5	1.0	6.8	26.7	0.9	0.2	0.8	1.1	0.5	7.8	0.0	1.1	0.4	2.2	0.4	17.9	1.1	5.9	0.6	12.9	0.5	41.8	0.5	0.9	0.2	4.6	0.9	0.6	0.5	0.4	2.4	0.5	0.4	0.3	0.7	0.6	2.7	0.6	0.3	0.9	0.2	0.4	3.2	0.4	8.1	0.3	0.2	1.3	0.3	0.2	0.4	0.5	0.5	4.0	8.9	2.7	0.0	0.2	0.7	1.2	0.6	0.1	1.5	6.0	4.4	1.3	2.6	0.1	1.0	0.7	0.3	1.0	0.9	0.2	0.3	0.0	14.6	2.8	1.9	0.3	1.2	1.5	1.6	1.4	2.7	0.5	1.4	0.7	1.4	0.1	0.5	0.4	0.9	0.2	6.1	0.2	0.7	5.4	6.8	0.4	0.4	2.6	0.7	0.2	1.0	3.6	1.3	0.3	7.6	0.2	0.6	0.6	2.7	0.3	0.3	0.5	0.5	0.6	0.4	0.6	0.7	0.9	0.6	2.0	0.3	0.4	0.3	0.9	0.2	0.8	1.3	1.6	1.3	1.5	1.0	0.8	1.1	2.2	0.6	3.0	7.0	0.8	0.0	0.5	0.0	1.0	5.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	66.2	0.0	0.8	0.0	0.0	0.2	1.1	40.9	0.2	0.0	18.9	0.0	3.2	2.6	0.0	1.4	0.0	0.0	31.1	0.2	1.0	60.4	1.1	8.2	0.0	0.0	0.0	0.6	1.3	0.3	0.0	0.0	31.9	0.1
CES4A	"CES8, FLJ37464"	ENSG00000172824	"Carboxylesterase 4A"	Q5XG92	16	66988589-67009758	"Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 32.3"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 49.5;Spermatocytes: 27.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 19.8"	"Not detected"	"Not detected"							HPA035701	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA035701: AB_10696357"	"unprognostic (6.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-3)"	3.2	3.6	12.9	2.4	11.8	2.2	3.6	8.7	13.8	2.6	1.7	8.5	3.5	2.3	1.6	13.0	2.2	32.3	2.0	3.2	9.1	2.6	3.9	11.7	3.1	1.4	5.8	13.7	2.1	3.0	3.3	10.0	2.2	7.2	2.1	1.7	2.1	4.2	3.5	5.8	13.9	2.3	1.4	2.4	1.5	2.3	2.0	9.9	0.0	5.0	1.0	2.0	2.4	1.6	0.9	1.6	0.0	5.0	0.0	1.6	1.3	0.3	1.2	0.1	0.0	1.0	0.9	0.0	0.1	0.4	0.1	0.0	0.0	1.5	0.0	0.1	1.5	0.0	0.7	0.0	0.2	0.0	19.8	0.0	0.0	0.9	0.0	0.1	0.0	4.7	1.6	3.3	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	3.5	0.2	0.0	1.2	0.0	0.2	0.9	0.9	4.3	2.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.6	1.3	0.0	1.8	0.0	0.0	0.0	2.1	0.0	0.7	3.3	0.9	0.9	1.6	1.1	1.6	0.0	1.2	0.2	0.0	0.0	5.0	1.5	0.4	1.3	12.9	11.8	8.7	13.8	9.1	2.6	5.8	13.7	7.2	9.9	0.0	10.7	2.7	3.8	4.7	21.1	2.7	7.6	49.5	6.8	5.2	13.7	3.5	1.7	0.9	1.4	0.4	4.0	0.0	1.4	0.4	4.1	3.9	9.2	19.7	4.5	0.0	8.6	1.3	3.8	0.8	12.7	2.9	0.0	6.4	1.7	12.1	0.9	5.8	12.0	1.0	16.1	0.0	1.0	27.7	4.8	4.5	3.8	2.9	2.6	4.8
CFAP206	"C6orf165, dJ382I10.1, FLJ25974"	ENSG00000272514	"Cilia and flagella associated protein 206"	Q8IYR0	6	87407983-87464465	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 17.7;testis: 60.5"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 80.3;Early spermatids: 214.5;Spermatocytes: 42.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.5;RPTEC TERT1: 5.4;T-47d: 9.1"									"HPA044891, HPA072261"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA044891: AB_10960832, HPA072261: AB_2686501"	"unprognostic (4.31e-1)"	"unprognostic (8.75e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.51e-2)"		"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.99e-3)"	"unprognostic (9.08e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	0.2	0.5	1.3	0.3	3.0	0.2	0.5	0.3	2.2	0.9	0.3	3.0	0.2	0.3	0.7	3.4	0.2	17.7	0.4	0.3	2.1	2.0	1.5	0.3	2.4	0.2	0.7	1.4	2.7	0.3	0.8	2.6	0.4	8.1	0.5	0.2	0.3	0.3	0.5	0.2	0.3	0.2	0.3	0.5	0.2	0.2	60.5	0.6	0.0	1.4	0.0	0.2	0.4	0.1	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	2.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.2	1.0	0.0	0.0	0.0	2.1	1.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.4	1.2	1.1	0.6	0.4	0.5	0.3	0.1	9.1	0.2	0.0	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.3	3.0	0.3	2.2	2.1	2.0	0.7	1.4	8.1	0.6	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	80.3	13.6	0.0	0.0	0.1	1.7	0.1	214.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.1	0.7	0.4	0.0	0.0	42.3	2.0	0.0	0.0	0.0	0.0	0.0
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 29.5;fallopian tube: 46.9;testis: 26.8"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 149.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;MCF7: 4.8;OE19: 6.2;REH: 3.3;T-47d: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.4	0.6	3.7	0.4	8.4	0.4	0.4	0.3	2.5	2.6	0.4	8.5	0.1	0.9	1.3	6.4	0.4	46.9	0.5	0.4	5.9	6.0	0.5	0.4	3.9	0.3	0.5	0.5	4.8	0.3	0.7	5.4	0.5	29.5	0.5	0.3	0.7	1.3	0.5	0.3	0.5	0.9	0.3	1.1	0.4	0.4	26.8	3.5	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	1.6	1.9	0.0	0.7	1.3	0.9	0.9	0.0	0.1	0.0	0.0	0.1	3.9	0.0	0.4	0.0	1.4	2.2	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.4	0.1	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	4.8	0.0	0.7	0.3	6.2	0.2	3.3	0.0	0.1	0.4	0.9	0.8	0.0	0.7	1.3	0.0	0.9	2.9	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	8.4	0.3	2.5	5.9	6.0	0.5	0.5	29.5	3.5	0.0	2.9	0.0	0.2	0.0	0.4	0.3	0.0	149.9	18.2	0.0	5.9	0.5	1.7	0.0	21.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	1.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.8	0.2	2.0	0.0	0.0	25.2	0.3	0.0	0.8	0.0	0.0	0.1
CFAP53	"CCDC11, FLJ32743"	ENSG00000172361	"Cilia and flagella associated protein 53"	Q96M91	18	50227193-50266522	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Ciliopathy, Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.1;fallopian tube: 19.7;testis: 44.9"	"Group enriched"	"Detected in many"	11	"Ciliated cells: 397.5;Early spermatids: 589.3;Late spermatids: 341.5;Spermatocytes: 416.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 17.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.5"	"Low region specificity"	"Detected in some"							"HPA041069, HPA066142"	Enhanced		Approved	Midbody		Yes	No			Midbody		"HPA041069: AB_10805835, HPA066142: AB_2732739"	"unprognostic (1.73e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.85e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.61e-3)"	0.4	1.0	2.1	0.4	4.8	0.6	1.0	2.9	1.0	1.6	0.3	4.9	1.7	0.4	1.0	9.3	0.3	19.7	0.7	0.4	2.7	3.3	2.2	0.4	4.5	0.4	1.0	1.1	4.8	1.6	2.7	12.3	0.4	17.1	1.1	0.3	1.2	0.8	2.5	1.4	0.9	0.4	0.5	1.4	0.4	0.5	44.9	2.2	0.2	4.3	0.0	0.4	0.5	0.4	2.1	1.0	2.2	1.0	1.4	1.2	0.4	2.4	1.6	1.0	2.0	1.4	2.7	1.8	0.5	0.3	0.3	0.4	0.2	2.1	1.4	1.4	0.5	0.6	1.0	0.8	1.0	0.5	1.1	1.5	0.5	0.8	0.2	0.8	1.0	0.9	0.8	4.1	1.1	9.5	2.2	0.7	3.8	2.7	0.7	0.6	2.3	2.3	0.5	0.5	0.5	1.0	0.3	0.5	2.0	2.9	0.0	1.7	1.3	0.3	0.1	0.8	2.8	1.3	0.2	0.1	1.4	1.0	0.9	0.8	4.3	1.5	0.3	1.6	1.1	0.3	2.2	0.4	0.0	0.9	1.0	0.5	0.5	0.4	0.9	0.4	2.1	1.2	0.8	0.1	1.4	0.4	1.0	1.0	0.4	2.1	4.8	2.9	1.0	2.7	3.3	1.0	1.1	17.1	2.2	6.0	3.4	0.0	1.6	0.0	3.9	0.4	0.0	397.5	38.7	8.7	7.9	1.4	8.3	2.0	589.3	0.6	0.0	0.0	0.6	0.4	0.7	1.4	1.1	0.9	0.4	1.6	0.0	1.8	0.0	341.5	7.8	0.6	0.0	1.8	0.1	3.4	1.2	0.0	5.3	14.3	8.3	6.5	0.0	416.0	28.2	0.0	0.6	0.0	0.3	0.9
CFAP54	"C12orf55, C12orf63, FLJ31514, FLJ44112"	ENSG00000188596	"Cilia and flagella associated protein 54"	Q96N23	12	96489571-96875555	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;testis: 15.1"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 65.5;Alveolar cells type 2: 54.7;Ciliated cells: 195.4;Club cells: 78.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"basal ganglia: 16.5;pons and medulla: 30.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 10.8;TIME: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039897	Enhanced		Approved	Microtubules,Cytosol		NA	NA			Microtubules	Cytosol	"HPA039897: AB_10674427"	"unprognostic (1.87e-4)"	"unprognostic (3.63e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.55e-5)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.26e-2)"	"unprognostic (8.00e-2)"	1.0	0.9	3.4	1.9	16.5	4.5	1.4	1.0	3.4	2.0	1.4	9.5	1.8	2.3	3.3	8.6	1.2	8.9	1.5	0.9	5.3	3.6	1.4	1.5	8.1	1.9	1.3	3.1	3.8	0.7	1.3	11.7	0.9	30.7	1.7	1.5	0.3	1.8	1.9	1.8	2.9	1.5	1.9	1.7	1.9	1.6	15.1	5.2	0.0	2.4	0.5	1.6	1.0	1.1	2.7	1.6	3.7	1.4	1.5	1.7	0.1	1.6	0.8	1.4	1.8	0.8	1.2	1.2	1.4	0.3	0.4	0.6	0.8	2.4	1.4	2.1	0.5	1.3	1.3	0.7	0.4	0.5	2.3	1.0	1.4	3.1	0.8	0.2	2.7	1.7	0.4	0.5	2.0	0.8	2.9	10.8	1.3	0.7	5.0	1.4	0.7	1.2	2.4	2.4	0.6	1.5	1.5	1.5	1.7	3.1	1.9	2.4	1.7	1.3	0.8	1.5	1.6	2.3	0.7	12.9	2.5	3.0	2.2	2.4	5.6	2.4	1.1	1.7	1.2	1.7	3.7	1.4	1.4	1.7	0.9	1.4	1.4	1.3	1.3	0.4	2.7	1.6	1.5	3.7	1.5	1.1	1.6	1.0	0.1	3.4	16.5	1.0	3.4	5.3	3.6	1.3	3.1	30.7	5.2	65.5	54.7	0.9	0.2	0.0	3.0	0.8	0.0	195.4	78.5	0.0	21.6	0.2	0.0	0.0	22.0	1.6	0.0	0.0	0.0	0.2	0.3	0.2	34.9	0.0	0.2	0.0	1.2	0.0	0.6	12.3	0.3	0.0	0.0	0.0	0.0	10.9	0.2	0.0	0.0	0.0	7.8	0.0	0.0	11.1	6.9	0.0	0.0	0.0	0.0	0.3
CFAP57	"FLJ32000, WDR65"	ENSG00000243710	"Cilia and flagella associated protein 57"	Q96MR6	1	43172149-43254358	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.6;testis: 29.2"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 156.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 6.9;HDLM-2: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002736, HPA028623"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA002736: AB_2272982, HPA028623: AB_10603234"	"unprognostic (1.15e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.50e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.78e-2)"	0.4	0.4	1.6	0.3	6.7	0.2	0.6	0.1	1.8	1.6	0.3	4.2	0.0	0.3	1.0	9.1	0.4	25.6	0.5	0.4	3.6	2.7	1.5	2.7	4.7	0.2	0.3	1.4	7.1	0.9	0.4	5.9	0.5	12.7	0.7	0.3	0.3	0.5	0.5	0.4	0.9	0.3	0.3	0.4	0.2	0.4	29.2	0.4	0.0	1.9	0.0	0.3	0.5	0.2	3.2	2.4	0.7	4.8	1.2	1.5	1.4	2.9	1.0	0.8	0.6	0.2	0.2	0.9	1.1	1.8	1.4	1.4	0.9	1.2	0.3	1.3	2.4	0.8	6.9	0.4	0.9	2.6	4.5	0.2	0.4	0.6	0.6	0.5	0.0	0.3	0.2	1.2	1.1	0.4	1.9	2.0	0.4	0.2	0.1	0.2	0.1	0.3	0.3	1.4	0.2	0.1	0.4	1.0	0.2	3.0	0.5	1.2	0.5	1.4	0.2	1.1	0.8	1.7	0.5	3.9	0.2	1.5	0.7	0.8	0.4	0.6	0.3	0.3	0.8	0.9	0.5	1.1	0.7	1.4	2.0	1.4	2.2	1.4	1.2	2.4	3.2	1.3	1.3	0.0	1.2	4.8	1.9	1.5	1.4	1.6	6.7	0.1	1.8	3.6	2.7	0.3	1.4	12.7	0.4	6.0	0.3	0.0	0.1	0.0	0.4	0.4	0.0	156.6	10.3	0.0	5.9	0.8	0.0	0.3	22.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.1	1.6	0.0	0.6	0.0	21.6	0.9	0.0	0.0	3.6	0.0	0.5	0.2	0.0	0.7	1.4	0.8	0.0	0.0	18.7	3.3	0.0	0.0	0.0	0.0	0.1
CFAP58	"bA554P13.1, C10orf80, CCDC147, FLJ35908"	ENSG00000120051	"Cilia and flagella associated protein 58"	Q5T655	10	104353764-104455090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 10.9;testis: 17.5"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 104.4;Early spermatids: 40.7;Late spermatids: 47.0"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	55	"granulocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 5.2;U-2 OS: 10.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036555, HPA071938"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA036555: AB_10673622, HPA071938: "	"unprognostic (5.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.57e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.62e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.59e-1)"	0.3	0.5	0.8	0.6	2.0	0.4	0.3	0.7	1.0	3.0	0.3	2.9	0.3	0.1	2.3	0.3	0.3	10.9	0.3	3.0	1.4	1.5	0.3	0.3	2.1	0.3	0.3	0.3	2.0	0.3	1.5	1.9	0.4	6.8	0.4	0.0	0.6	0.3	0.4	1.4	0.2	0.3	0.8	0.3	0.3	0.1	17.5	0.7	0.3	0.8	0.3	0.4	0.3	0.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.2	0.6	0.2	1.7	5.2	1.0	2.8	0.0	0.0	4.0	0.4	0.6	3.0	0.3	0.0	0.3	3.2	0.4	0.2	0.9	1.2	0.0	0.6	0.5	0.7	0.6	2.2	0.8	2.8	2.2	1.7	0.1	1.1	1.2	1.4	0.0	0.0	1.1	0.3	0.0	0.0	0.4	0.3	0.5	0.6	0.0	0.6	0.4	0.0	0.2	0.9	1.2	0.3	0.6	3.4	1.1	10.9	0.6	3.0	0.4	0.1	0.2	1.2	1.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	2.0	0.7	1.0	1.4	1.5	0.3	0.3	6.8	0.7	0.0	0.3	0.0	0.1	0.0	0.0	6.1	0.0	104.4	17.0	0.0	0.0	0.1	0.0	0.2	40.7	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.1	0.0	47.0	0.6	0.0	0.0	0.0	0.0	0.6	0.4	0.0	1.1	0.0	0.3	0.0	0.6	14.9	1.9	0.0	0.1	0.0	0.0	0.1
CFAP65	"CCDC108, DKFZp434O0527, MGC35338"	ENSG00000181378	"Cilia and flagella associated protein 65"	Q6ZU64	2	219002846-219041527	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.3;fallopian tube: 29.2;testis: 20.4"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 53.5;Early spermatids: 163.7;Late spermatids: 138.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.1"	"Region enhanced"	"Detected in many"		"pons and medulla: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.4;SCLC-21H: 1.5;SH-SY5Y: 4.0;U-87 MG: 2.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 13.1"	"HPA055156, HPA063406"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA055156: AB_2682720, HPA063406: "	"unprognostic (3.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (6.08e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.60e-2)"	0.2	0.4	1.8	0.3	6.4	0.3	0.3	0.0	2.1	2.2	0.4	5.4	0.3	0.3	0.9	6.0	0.2	29.2	0.6	0.2	2.9	3.2	0.5	0.2	3.6	0.3	0.4	1.2	4.2	0.6	0.3	6.1	0.2	16.3	0.3	0.5	2.8	0.4	0.4	0.2	0.2	0.7	0.2	0.6	0.3	0.6	20.4	2.5	0.0	1.3	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.5	0.5	0.0	1.1	0.2	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	2.4	0.1	0.0	0.0	0.0	1.2	0.0	1.5	4.0	0.0	0.1	0.7	0.6	1.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.8	6.4	0.0	2.1	2.9	3.2	0.4	1.2	16.3	2.5	0.0	3.4	0.0	0.1	0.0	0.7	0.0	7.6	53.5	12.5	0.0	11.8	0.0	0.0	0.4	163.7	0.0	0.5	0.0	1.3	0.0	0.0	1.4	0.0	0.0	0.1	0.0	28.1	0.0	0.0	138.9	0.6	0.0	0.0	0.0	25.9	0.8	1.4	0.0	0.7	0.9	20.7	0.0	0.0	15.4	4.1	0.0	0.0	0.0	3.4	0.0
CFAP73	"CCDC42B, MIA2"	ENSG00000186710	"Cilia and flagella associated protein 73"	A6NFT4	12	113149858-113159276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;epididymis: 17.8;fallopian tube: 35.5"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 42.8;Club cells: 11.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Region enhanced"	"Detected in many"		"pons and medulla: 27.2"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.0;naive CD4 T-cell: 1.3"	"Group enriched"	"Detected in many"	9	"B-cells: 1.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.4;REH: 3.3;T-47d: 3.9;U-698: 13.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA048539	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA048539: AB_2680434"	"unprognostic (2.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.90e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.03e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.55e-2)"	0.2	0.3	4.3	0.5	16.9	2.0	0.3	0.5	0.9	3.1	0.3	15.3	1.0	0.5	1.0	17.8	0.6	35.5	0.4	0.2	5.8	6.1	0.6	0.2	5.7	0.9	0.2	0.9	6.8	0.3	0.7	0.9	0.2	27.2	0.3	0.3	0.0	2.2	0.9	0.5	4.5	0.6	0.2	1.1	0.5	3.9	1.5	4.7	0.0	0.5	0.5	1.3	0.4	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.2	0.3	0.1	0.4	0.4	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	3.1	6.4	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.5	0.3	2.2	0.2	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.4	0.0	0.0	1.1	0.3	1.1	0.4	1.2	0.2	3.3	0.0	0.5	0.9	0.7	0.6	0.1	0.0	0.9	0.0	0.3	3.9	0.0	0.2	0.1	1.1	0.3	0.2	0.6	0.2	13.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.3	16.9	0.5	0.9	5.8	6.1	0.2	0.9	27.2	4.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	42.8	11.4	3.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CFAP77	"C9orf171, FLJ46082"	ENSG00000188523	"Cilia and flagella associated protein 77"	Q6ZQR2	9	132410043-132573317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 30.9;testis: 22.0"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 66.9;Early spermatids: 92.0;Late spermatids: 37.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.8;SH-SY5Y: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021329, HPA024647, HPA061069"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657"	"unprognostic (7.28e-4)"	"unprognostic (5.68e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.74e-1)"		"unprognostic (3.01e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	0.2	0.2	1.6	0.2	4.5	0.2	0.2	1.6	0.3	1.6	0.2	8.4	0.0	0.2	0.7	8.8	0.2	30.9	0.2	4.2	2.5	2.5	0.2	0.2	5.5	0.2	0.1	0.0	9.7	0.3	0.2	1.7	0.2	8.9	0.2	0.2	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	22.0	1.6	0.0	0.3	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.4	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.8	0.0	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.2	1.8	6.6	0.0	0.0	0.0	0.5	0.3	0.0	0.6	1.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.5	1.6	0.1	2.5	2.5	0.1	0.0	8.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	5.7	0.0	0.0	0.0	0.0	0.0	92.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.5	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	2.4	0.0	0.0	10.7	2.3	0.0	0.1	0.0	0.0	0.0
CFAP97	"DKFZp434F1728, hmw, KIAA1430"	ENSG00000164323	"Cilia and flagella associated protein 97"	Q9P2B7	4	185159665-185209504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 196.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049446, HPA053335"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA049446: AB_2680770, HPA053335: AB_2682117"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.29e-1)"	23.2	12.5	11.2	17.2	13.7	4.4	19.5	11.6	15.1	18.7	15.9	8.8	17.1	7.0	19.2	13.3	18.2	15.2	14.2	13.2	11.3	10.3	18.4	24.8	15.0	19.4	12.7	12.5	25.4	13.7	23.2	20.7	12.7	13.5	19.2	10.8	10.7	15.0	23.6	11.6	13.0	9.9	21.8	17.4	19.2	12.5	32.2	14.5	14.7	25.8	11.9	14.5	27.9	14.7	17.0	16.0	3.5	9.4	10.2	19.3	5.3	12.2	7.7	10.3	17.7	12.2	21.2	6.2	16.0	14.6	12.3	9.6	4.7	15.6	31.0	5.6	18.9	9.3	6.8	11.4	14.4	16.6	27.4	7.5	12.5	4.7	11.1	15.1	16.2	9.9	14.0	20.2	13.5	29.7	15.5	10.7	14.6	21.9	29.2	17.3	5.9	8.5	8.4	5.9	3.9	6.3	13.4	5.0	19.1	15.2	6.7	7.0	18.7	12.1	11.9	22.9	6.3	7.9	10.4	15.3	11.5	7.3	4.5	12.9	11.6	5.1	9.6	14.7	14.7	23.4	3.5	3.7	1.4	16.0	6.3	19.3	17.0	16.0	15.5	4.5	16.3	16.1	11.2	0.7	10.2	9.4	16.0	10.7	5.3	11.2	13.7	11.6	15.1	11.3	10.3	12.7	12.5	13.5	14.5	59.6	32.9	20.5	43.4	0.0	54.9	23.8	40.8	66.9	42.1	43.6	49.1	23.9	59.7	46.0	196.2	42.5	3.4	23.3	44.3	27.8	20.0	39.8	25.6	55.1	17.9	65.2	11.7	37.4	23.9	108.2	75.6	16.4	0.0	50.5	14.6	57.4	41.0	3.5	82.4	68.8	62.4	71.1	35.6	177.3	98.2	0.0	13.2	20.0	17.9	32.1
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 461.5"	"Group enriched"	"Detected in many"	8	"Ductal cells: 523.0;Exocrine glandular cells: 173.6;Hepatocytes: 158.3;Pancreatic endocrine cells: 492.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.1;ASC TERT1: 6.0;CAPAN-2: 7.1;EFO-21: 5.3;fHDF/TERT166: 11.6;HSkMC: 19.1"									"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	180000000000	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	9.3	1.0	0.3	4.1	0.4	0.3	2.4	0.2	0.4	1.3	9.0	0.4	0.9	3.2	0.5	3.7	2.2	4.0	8.9	3.3	0.2	0.0	16.1	461.5	2.5	2.1	0.7	0.1	2.8	5.8	0.4	1.0	4.0	1.0	4.0	1.6	2.6	3.1	0.3	0.5	0.5	4.7	2.6	0.6	0.8	4.1	1.4	0.3	0.3	1.8	0.5	1.7	1.6	0.4	0.1	1.6	0.0	0.8	0.0	0.2	0.0	0.0	1.8	0.1	0.1	6.1	6.0	0.0	0.0	0.3	1.6	0.6	0.0	7.1	0.1	5.3	11.6	0.3	0.0	0.0	1.9	1.4	0.4	0.3	0.4	0.3	0.6	0.0	0.7	0.1	19.1	0.1	0.9	0.6	0.6	0.2	0.1	0.2	0.7	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.2	0.4	0.2	1.7	0.0	0.0	0.0	0.6	1.2	0.2	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.4	0.6	1.9	0.5	3.2	0.6	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.4	0.2	0.3	0.2	0.0	0.7	0.1	1.0	0.3	0.0	20.0	14.0	0.7	0.7	0.1	0.4	20.4	24.1	40.9	5.2	0.0	0.0	3.3	523.0	0.0	2.4	5.0	0.0	173.6	0.1	6.0	9.0	0.0	158.3	0.8	0.0	2.4	11.6	13.2	0.0	2.6	1.2	0.0	31.5	6.7	0.8	492.1	11.8	0.0	11.2	0.7	0.0	3.8	0.1	0.0	1.6	1.4	1.9	11.2	1.8
CFDP1	"BCNT, CENP-29, CP27, p97, SWC5, Yeti"	ENSG00000153774	"Craniofacial development protein 1"	Q9UEE9	16	75293698-75433485	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 441.3;Paneth cells: 557.6;Proximal tubular cells: 451.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041316, HPA048242"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA041316: AB_10794371, HPA048242: AB_2680327"	"unprognostic (1.45e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (5.81e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.25e-1)"	21.3	33.0	38.3	23.3	32.9	18.7	28.5	31.8	35.4	35.6	24.3	19.5	24.6	18.9	37.4	40.9	21.3	36.1	18.8	19.2	33.7	40.5	40.2	26.6	20.6	16.9	33.6	28.4	54.5	26.9	20.9	53.0	38.5	32.7	28.4	25.8	21.1	23.8	25.6	25.9	20.8	22.2	33.8	38.6	18.0	19.1	38.5	29.7	27.2	28.7	12.6	21.4	26.0	41.1	20.1	28.2	33.7	27.6	15.1	37.8	15.0	16.5	12.3	42.1	15.5	38.3	42.8	12.6	16.6	19.4	22.0	32.0	21.1	22.7	15.9	24.7	20.4	24.7	18.6	32.2	26.4	44.3	6.9	15.3	16.6	11.9	45.1	26.4	17.4	14.5	26.6	22.7	26.6	32.5	38.6	23.9	29.7	23.1	7.4	24.6	37.7	25.6	38.6	20.5	28.1	6.5	46.4	17.3	27.5	24.5	9.1	25.2	21.3	27.8	5.8	22.8	37.9	24.1	31.0	14.2	15.8	17.1	16.6	10.5	14.5	22.6	59.8	15.9	23.2	13.9	28.7	27.3	33.7	19.4	27.6	27.3	19.8	26.7	21.3	28.2	20.1	24.5	23.1	22.4	15.1	25.0	28.1	37.8	15.0	38.3	32.9	31.8	35.4	33.7	40.5	33.6	28.4	32.7	29.7	35.7	47.3	55.9	92.1	51.4	87.2	29.5	86.6	139.2	73.9	109.9	110.0	100.8	167.5	63.8	109.9	72.1	441.3	70.0	82.6	93.0	53.5	100.2	27.7	133.3	67.3	58.8	79.0	55.9	48.2	54.7	115.9	50.3	32.1	44.1	151.7	51.5	79.7	557.6	105.7	451.1	103.9	97.0	53.6	273.8	142.2	57.3	129.5	38.3	90.4	107.8
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196651878-196747504	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 295.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1052.9"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 16.5"	"Lineage enriched"	"Detected in single"	27	"T-cells: 16.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 26.9;HSkMC: 26.3;hTERT-RPE1: 81.0;RT4: 47.7"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	396000000000	110000000000	Vesicles		"CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113"	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	28.6	5.5	1.6	3.7	3.8	0.1	8.8	2.6	2.7	10.4	9.1	1.0	3.9	3.7	2.5	8.7	15.2	3.4	17.0	47.3	2.0	1.2	7.0	295.2	11.0	10.3	5.3	1.7	40.9	1.9	1.7	4.3	5.1	5.3	10.3	10.4	6.3	19.0	3.3	10.0	11.5	8.1	12.6	4.2	3.3	5.8	6.4	2.9	0.7	22.0	22.8	5.8	17.2	16.8	0.0	0.1	0.6	0.1	0.0	16.5	1.0	0.0	13.6	0.0	0.0	21.4	12.1	0.0	5.5	13.5	0.7	2.9	0.0	2.5	0.0	2.0	0.0	0.0	0.4	0.0	5.0	0.5	0.2	0.0	4.1	16.2	0.0	26.9	0.1	0.0	26.3	0.0	4.0	1.7	81.0	16.8	0.0	15.3	0.5	19.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.6	4.3	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	16.2	0.2	0.1	0.1	0.1	0.0	0.0	2.9	0.0	1.2	0.0	0.1	0.0	1.8	0.0	16.5	0.0	6.0	3.5	0.1	0.0	0.4	1.4	0.6	0.0	0.0	0.0	0.0	1.0	1.6	3.8	2.6	2.7	2.0	1.2	5.3	1.7	5.3	2.9	8.9	14.5	21.0	47.7	39.3	0.4	6.2	30.6	119.1	131.9	5.2	0.0	0.0	0.0	1.9	1.5	55.0	0.0	0.0	0.7	0.0	200.9	8.6	3.5	1052.9	0.9	0.0	0.0	57.1	34.9	3.6	262.9	6.0	42.2	0.0	0.0	0.3	6.4	0.0	130.4	0.0	1.4	6.5	36.8	0.7	0.6	33.4	0.1	10.2	0.0	49.2
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819757-196832189	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	174	"liver: 218.9"	"Cell type enhanced"	"Detected in some"	13	"Cholangiocytes: 7.6;Erythroid cells: 23.3;Hepatocytes: 8.9;Ito cells: 17.2;Kupffer cells: 14.9"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.7;HeLa: 3.2;HL-60: 4.8;U-266/70: 6.3"									"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		15000000000	Vesicles		"HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101"	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favorable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	218.9	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.3	0.2	2.7	1.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.7	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.6	3.2	0.2	0.2	4.8	0.8	0.2	0.0	0.0	0.0	1.0	0.1	1.0	0.3	2.4	0.8	0.0	1.5	0.0	0.9	0.0	0.0	0.8	2.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.2	0.5	0.4	0.0	1.4	0.9	0.4	0.2	0.2	6.3	0.0	1.1	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1											3.0	0.0	0.0	0.1	0.3	0.0	1.4	7.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	23.3	0.0	0.0	1.0	0.0	0.0	8.9	4.2	0.0	0.0	17.2	14.9	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.6	0.0	0.2	0.0	0.0	0.1
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34706769-34714823	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 88.5;skeletal muscle: 185.9"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 498.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		90000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	14.0	16.5	15.9	8.8	17.7	5.0	6.7	13.6	16.6	13.7	23.2	25.8	9.2	4.7	21.3	10.2	20.7	11.2	7.2	88.5	19.0	14.5	8.7	33.0	7.8	3.7	22.7	10.6	12.9	3.0	9.3	4.5	10.3	28.9	22.4	8.6	7.8	5.4	31.8	185.9	2.6	6.7	38.1	24.6	4.2	11.9	6.9	20.1	0.5	9.0	30.8	3.4	34.7	9.3	8.5	2.9	3.6	1.8	3.2	5.8	1.6	17.8	16.1	10.4	6.7	10.6	39.5	5.8	31.2	36.0	29.9	31.9	12.1	7.7	6.4	12.8	49.7	22.4	3.5	22.1	6.6	52.7	0.9	9.2	1.3	19.1	28.6	17.3	1.6	1.0	29.9	2.3	25.5	14.1	21.0	29.6	0.9	2.0	5.1	36.7	5.0	1.3	0.9	3.4	3.1	24.8	1.1	32.9	1.0	10.8	3.7	2.1	8.9	20.3	4.4	10.5	8.0	9.7	1.6	26.0	29.8	19.8	14.0	14.9	7.1	4.6	2.4	10.9	2.4	7.0	3.6	1.8	2.1	3.7	1.8	5.8	8.5	4.3	4.0	2.9	5.0	3.4	3.5	0.7	3.2	0.8	2.8	3.6	1.6	15.9	17.7	13.6	16.6	19.0	14.5	22.7	10.6	28.9	20.1	98.3	34.5	15.9	86.3	17.7	51.4	498.3	15.3	6.7	14.8	21.0	19.6	25.2	51.4	41.2	2.2	46.0	0.9	0.0	34.0	52.6	52.9	52.5	5.7	99.2	13.2	73.1	9.1	43.6	14.0	6.5	52.9	10.4	28.7	7.2	3.4	80.2	30.0	4.2	92.6	79.1	57.2	32.3	125.1	51.4	51.5	16.9	17.8	14.9	3.7	53.3
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116104-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 475.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 79.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 79.2"	"Cell line enhanced"	"Detected in all"		"U-266/70: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	Yes			"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	35.4	17.6	13.7	29.8	17.4	66.8	31.6	26.9	12.6	20.5	25.7	13.5	31.3	17.5	24.7	27.6	21.0	19.2	22.1	58.1	14.7	7.7	24.9	18.9	58.5	34.3	16.8	8.9	14.6	14.3	9.1	18.7	28.3	12.6	23.2	17.7	20.9	21.8	27.4	113.7	16.7	26.8	30.5	13.8	35.7	19.4	10.9	14.8	17.2	31.2	26.2	31.4	24.1	33.7	5.3	6.6	79.2	12.6	8.7	11.8	7.8	5.2	10.7	7.7	4.5	24.0	18.4	9.5	13.3	23.3	8.8	10.8	12.4	19.7	1.4	12.7	15.5	10.7	3.9	2.4	10.1	14.1	39.4	7.5	7.9	9.2	20.1	16.7	5.9	26.3	20.0	10.0	14.9	13.1	10.8	44.7	1.8	26.7	33.2	16.0	4.4	2.7	23.5	2.6	4.2	8.2	2.8	1.9	11.3	11.0	10.8	1.7	3.1	9.0	7.9	10.5	5.4	5.6	11.0	48.4	18.5	7.7	6.8	6.5	55.3	18.2	8.9	13.1	4.8	9.1	16.3	12.1	13.5	11.7	12.3	10.3	5.3	10.1	11.0	6.6	4.0	6.4	8.3	79.2	8.7	12.6	4.6	11.8	7.8	13.7	17.4	26.9	12.6	14.7	7.7	16.8	8.9	12.6	14.8	419.9	201.2	84.2	185.4	48.7	8.5	172.6	96.8	283.7	216.1	66.3	29.5	63.9	63.0	138.6	55.5	265.4	108.1	23.3	63.2	34.2	70.8	195.5	77.6	86.3	61.3	12.7	91.3	184.1	115.5	33.0	48.1	149.2	92.8	261.5	56.6	31.3	121.1	80.7	46.7	84.8	29.0	38.8	55.6	14.4	10.1	75.3	58.6	209.9	41.3	475.0
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 106.7;bone marrow: 39.4;lymphoid tissue: 41.3"	"Group enriched"	"Detected in many"	17	"Ito cells: 122.2;Kupffer cells: 303.6;Macrophages: 129.1;monocytes: 486.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"classical monocyte: 102.4;intermediate monocyte: 106.7;myeloid DC: 86.2;neutrophil: 64.3;non-classical monocyte: 70.6"	"Group enriched"	"Detected in many"	40	"dendritic cells: 86.2;granulocytes: 64.3;monocytes: 106.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 21.2;HEL: 4.6;HMC-1: 5.3;NB-4: 10.1;U-937: 7.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA072644			Approved	Vesicles	"Secreted to blood"	NA	NA		8500000000	Vesicles		"HPA072644: "	"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	3.3	1.0	0.7	10.3	0.9	39.4	1.6	0.7	0.6	0.6	2.0	0.2	0.6	0.5	0.7	3.1	1.8	2.5	2.1	4.3	0.6	0.6	1.3	21.6	8.7	41.3	0.4	0.0	0.7	0.4	0.0	0.7	1.6	0.3	0.8	0.4	1.2	3.1	0.6	1.4	1.0	2.1	2.6	0.4	39.3	1.1	0.8	0.0	6.0	0.9	1.3	5.6	2.1	0.9	0.4	86.2	64.3	106.7	1.1	2.1	70.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	21.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	4.6	0.1	0.0	0.1	1.1	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.0	10.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.2	0.9	0.0	0.0	0.5	0.1	0.4	0.3	0.1	0.1	7.0	0.0	9.0	102.4	3.2	0.2	106.7	0.2	0.4	1.4	0.1	86.2	0.1	2.1	0.7	64.3	1.1	70.6	2.7	1.1	70.7	0.7	0.9	0.7	0.6	0.6	0.6	0.4	0.0	0.3	0.0	0.0	14.5	8.5	0.1	3.5	3.2	0.8	2.5	4.0	4.5	0.0	0.0	0.3	0.0	0.2	0.1	1.0	0.0	0.0	0.6	0.4	1.6	0.2	1.1	1.7	15.7	1.6	0.0	122.2	303.6	0.0	0.9	129.1	5.0	486.9	0.0	0.2	0.4	0.0	1.1	0.4	1.7	0.0	0.9	0.0	0.2	2.6	0.3	3.3	0.6	0.0
CGAS	"C6orf150, cGAS, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452276	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 32.0"	"Cell type enriched"	"Detected in some"	4	"monocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.6;RH-30: 21.5;RPMI-8226: 22.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	Cytosol	"HPA031700: AB_10601693, HPA031702: AB_2673999"	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	6.5	2.0	2.9	10.5	4.5	18.5	8.1	1.2	3.9	4.7	3.7	3.4	2.1	4.1	5.5	2.8	5.3	3.9	4.3	3.2	2.8	2.9	2.5	1.9	9.6	11.8	7.2	0.6	3.4	3.8	2.3	1.8	4.8	4.4	6.6	3.1	2.2	4.2	2.9	1.9	1.8	5.2	3.6	4.7	12.8	3.5	1.7	4.3	6.2	3.9	4.2	15.5	6.6	32.0	6.3	12.5	13.3	12.9	3.0	6.0	3.9	8.9	3.0	0.1	0.1	0.6	1.3	0.0	4.5	1.9	5.9	6.5	9.9	6.8	0.1	9.8	2.1	3.2	4.6	5.0	0.0	6.3	14.9	0.0	7.8	3.8	0.0	2.1	6.0	5.5	0.9	1.6	5.8	0.0	0.0	1.8	0.0	0.0	18.6	4.3	3.7	0.0	13.6	2.9	1.1	5.5	11.6	21.5	22.6	0.0	3.7	0.1	0.0	7.9	0.2	4.7	0.1	0.0	16.2	2.1	0.0	4.3	3.9	0.1	4.0	8.8	0.1	0.0	8.6	5.9	13.3	9.2	13.2	4.6	12.9	3.6	6.3	6.0	4.6	5.4	4.8	1.4	2.6	5.8	3.0	7.8	12.5	5.8	3.9	2.9	4.5	1.2	3.9	2.8	2.9	7.2	0.6	4.4	4.3	3.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	3.5	0.6	0.0	0.0	4.7	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	47.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CGB1		ENSG00000267631	"Chorionic gonadotropin beta subunit 1"	A6NKQ9	19	49035610-49036895	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 8.4"	"Cell type enriched"	"Detected in single"	125	"Syncytiotrophoblasts: 58.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 20.5"									"HPA038925, HPA038934"	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	8.4	0.0	1.4	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.9	0.0	0.1	0.1	0.0	0.0	0.5	0.3	4.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.5	0.0	0.0	0.0
CGB2		ENSG00000104818	"Chorionic gonadotropin beta subunit 2"		19	49031912-49033238	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 2.1;testis: 4.1"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 33.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 25.4;U-266/70: 10.2;U-266/84: 12.3"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"										"unprognostic (3.05e-2)"								0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0			0.0	0.0	0.7	0.3	0.0	0.0	1.1	1.0	0.9	0.2	0.0	0.0	0.4	0.1		0.0	0.0	0.0	1.1	1.4		0.4	0.0		0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.3	4.1			0.1		0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	3.4	0.0	0.4	0.0	0.0	0.1	0.0	25.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.7	0.0	3.0	10.2	12.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	6.5	0.0	0.5	1.1	0.0	33.4	0.0	0.0	0.0
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin beta subunit 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 6.7;placenta: 15.0"	"Cell type enriched"	"Detected in some"	38	"Syncytiotrophoblasts: 724.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9;testis cancer: 4.2"					"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Cell line enriched"	"Detected in some"	20	"BEWO: 39.7"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277"									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	3.2	0.0	6.7	15.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	1.3	0.5	0.0	0.0	0.1	0.2	0.0	1.9	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	724.1	0.0	0.0	0.0
CGB5	HCG	ENSG00000189052	"Chorionic gonadotropin beta subunit 5"	P0DN86	19	49043884-49045311	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"placenta: 105.2"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 16.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"BEWO: 46.9;U-251 MG: 21.3"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (1.38e-1)"				"unprognostic (1.68e-1)"					"unprognostic (1.51e-3)"			"prognostic unfavorable (1.18e-5)"	"unprognostic (1.07e-1)"		"prognostic unfavorable (9.47e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	12.7	105.2	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.0	21.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin beta subunit 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.1"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 49.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;HaCaT: 5.7;HBEC3-KT: 4.8;hTCEpi: 6.9;U-251 MG: 10.4"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.3	0.2	0.3	0.3	0.3	0.0	0.8	0.3	1.5	1.7	0.3	0.3	3.7	0.3	1.2	0.5	4.0	1.0	2.0	2.0	0.4	0.2	1.0	0.3	0.8	0.3	0.3	0.3	0.9	2.5	0.0	2.7	3.7	1.3	4.6	0.0	0.8	1.3	3.9	6.4	8.1	0.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.9	2.2	0.3	2.4	2.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.8	0.2	1.5	0.0	0.2	7.1	0.6	0.0	1.4	1.2	1.2	2.6	0.0	0.1	1.3	2.1	5.7	0.2	4.8	0.5	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.4	6.9	0.4	0.7	1.6	0.0	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.0	0.1	0.1	1.4	0.1	0.1	1.7	1.0	0.2	0.2	2.3	2.3	0.0	10.4	0.3	0.4	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.3	1.5	0.4	0.2	0.3	0.3	1.3	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	49.1	0.0	0.0	0.0
CGB8		ENSG00000213030	"Chorionic gonadotropin beta subunit 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	85	"pituitary gland: 7.0;placenta: 22.2"	"Cell type enriched"	"Detected in some"	15	"Syncytiotrophoblasts: 37.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 61.9;U-251 MG: 21.5"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	7.0	22.2		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.3	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.3	1.4	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.9	0.0	0.2	0.0	1.2	2.6	0.2	21.5	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0
CGREF1	CGR11	ENSG00000138028	"Cell growth regulator with EF-hand domain 1"	Q99674	2	27098889-27119115	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 9.8;Peritubular cells: 8.1;Spermatogonia: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 18.7;SK-BR-3: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008241, HPA071103"	Uncertain		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA		22000	"Golgi apparatus"		"HPA008241: AB_1846605, HPA071103: "	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (8.45e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.24e-4)"	"unprognostic (1.20e-2)"	5.0	3.0	15.7	1.4	28.8	2.2	7.1	14.8	31.6	2.1	3.2	2.8	0.2	4.6	5.6	2.0	3.4	5.9	4.6	2.8	16.1	13.8	3.4	10.3	0.9	0.8	8.5	15.9	11.0	3.8	0.4	1.4	0.7	10.3	5.1	4.6	0.8	13.7	1.4	3.1	2.1	6.3	6.4	2.6	1.0	13.4	4.0	3.6	0.0	0.7	1.6	2.8	4.0	0.5	1.0	0.9	0.9	1.0	0.9	1.1	0.6	3.5	3.0	0.1	3.8	9.0	3.4	0.2	4.3	0.0	0.4	0.1	0.8	2.9	0.0	1.2	8.5	1.1	0.2	0.6	0.9	0.2	0.0	1.8	0.1	5.2	7.6	8.4	2.3	0.3	2.3	8.7	1.2	1.0	5.7	0.3	0.5	0.1	0.1	0.5	11.1	1.7	3.1	1.0	18.7	8.3	0.1	0.0	0.2	0.0	0.1	8.7	13.0	8.4	38.0	4.3	0.1	12.2	6.4	0.0	0.0	3.4	0.0	0.3	1.1	0.3	0.3	0.0	0.1	4.9	0.9	1.0	0.0	0.7	0.8	0.5	1.0	1.0	0.7	0.5	0.7	0.6	1.1	0.6	0.9	0.4	0.9	0.7	0.6	15.7	28.8	14.8	20.5	16.1	13.8	8.5	15.9	10.3	3.6	0.0	0.0	0.0	0.1	0.6	9.8	0.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.9	0.0	1.4	0.1	1.3	2.2	0.0	3.9	0.3	0.0	0.0	3.1	0.8	1.3	4.0	0.0	0.0	0.0	4.2	0.5	1.2	0.0	8.1	3.6	2.0	0.0	0.9	2.1	13.6	0.4	0.1	0.0	0.0	0.1
CHAC1	MGC4504	ENSG00000128965	"ChaC glutathione specific gamma-glutamylcyclotransferase 1"	Q9BUX1	15	40952962-40956519	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 53.0;salivary gland: 39.9;skeletal muscle: 52.4"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 29.9;Exocrine glandular cells: 24.3;Pancreatic endocrine cells: 16.5;Urothelial cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 1.8;monocytes: 1.1;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.1;HHSteC: 26.8;hTCEpi: 42.4;SK-MEL-30: 30.0;U-266/70: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042708, HPA043505"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042708: AB_2678125, HPA043505: AB_2678518"	"unprognostic (6.04e-3)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.84e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.00e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.91e-2)"	6.0	1.0	2.6	1.5	2.1	1.7	1.0	1.7	5.6	1.1	1.9	0.3	1.1	1.9	1.1	1.8	18.6	1.5	5.7	2.2	2.6	4.8	3.1	14.1	1.5	1.1	2.6	2.2	11.3	53.0	0.9	1.3	1.1	6.2	1.5	1.1	0.2	39.9	1.3	52.4	1.3	1.5	1.1	5.3	1.1	11.2	0.9	1.0	0.0	1.7	4.7	4.6	2.7	2.7	1.8	0.1	0.2	1.1	0.0	1.3	0.2	2.8	1.9	0.5	8.8	1.4	1.0	3.6	17.0	35.1	1.8	5.0	4.7	0.7	0.8	1.3	1.5	5.6	1.9	3.8	1.4	1.3	3.2	0.7	0.7	0.5	0.0	26.8	2.2	0.0	12.0	42.4	5.5	7.7	0.5	1.7	19.6	2.3	4.0	1.5	1.6	1.6	0.0	1.6	9.7	6.6	1.4	0.0	3.8	0.9	1.1	1.7	2.5	0.5	3.0	30.0	1.1	1.1	16.0	0.5	0.3	5.3	0.4	3.0	26.3	5.6	3.4	1.6	3.1	4.0	0.0	0.4	0.0	1.3	0.4	0.0	1.8	0.2	0.8	0.1	0.0	0.0	1.0	0.2	0.0	1.1	0.0	0.0	0.2	2.6	2.1	1.7	5.6	2.6	4.8	2.6	2.2	6.2	1.0	0.0	1.3	1.5	3.4	2.5	2.3	3.5	2.5	0.0	1.2	0.0	2.0	0.2	29.9	7.5	0.1	0.5	2.8	0.0	24.3	0.2	0.5	5.1	0.0	0.4	0.3	0.0	3.4	1.8	0.8	0.0	0.3	0.4	5.0	1.8	1.5	0.3	16.5	0.3	0.0	0.1	0.4	0.0	0.5	1.4	0.7	3.8	2.9	0.0	1.5	11.8
CHAC2	GCG1	ENSG00000143942	"ChaC cation transport regulator homolog 2"	Q8WUX2	2	53767792-53775196	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049235	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA049235: AB_2680686"	"unprognostic (2.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (3.80e-7)"	"unprognostic (5.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-6)"	"unprognostic (1.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	7.2	8.6	6.5	7.1	6.2	9.3	3.6	4.3	4.4	2.6	6.8	2.1	7.7	11.4	2.4	4.4	8.4	1.8	5.3	10.3	6.2	6.1	8.3	9.8	3.4	9.6	5.0	4.2	1.8	4.8	1.5	6.7	1.7	6.9	2.8	6.1	2.8	4.1	4.6	9.8	2.0	9.0	3.5	4.8	10.2	7.0	16.4	3.7	9.5	3.7	4.2	9.8	5.7	5.1	6.6	2.5	1.8	0.9	1.4	6.7	3.0	19.1	6.4	6.8	6.0	3.4	1.7	1.4	8.8	1.8	6.3	7.5	4.4	4.9	16.3	12.9	3.8	9.5	6.9	15.4	10.5	11.1	34.3	13.4	12.9	8.6	7.2	5.2	15.2	5.9	2.1	3.1	11.7	8.9	1.7	12.3	11.3	13.2	9.6	8.3	6.2	18.0	12.7	8.8	8.3	11.5	13.8	14.5	16.5	8.7	5.2	8.5	2.4	10.2	7.6	4.0	4.3	4.6	6.0	5.4	3.7	13.3	14.2	14.2	9.6	12.3	13.9	5.0	19.2	5.1	1.8	0.5	1.1	5.2	0.9	5.5	6.6	5.7	5.8	1.1	5.4	6.7	6.1	1.4	1.4	0.7	2.5	5.1	3.0	6.5	6.2	4.3	4.4	6.2	6.1	5.0	4.2	6.9	3.7	0.0	1.4	11.5	2.8	3.1	0.8	2.8	5.1	1.4	2.3	1.8	0.0	1.7	10.0	5.8	5.3	3.7	2.6	0.0	7.1	0.7	1.6	2.9	1.1	7.5	6.6	1.6	0.0	2.5	1.0	1.7	2.6	2.8	3.3	8.2	3.4	3.3	6.4	0.0	3.9	5.6	5.5	0.0	3.4	26.1	5.1	3.0	0.3	6.9	9.2	3.9
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314335-114337626	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	No			Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	13.7	16.8	11.8	12.7	18.5	16.5	13.3	25.2	19.8	12.4	13.3	15.9	10.9	13.7	16.7	11.7	12.6	16.7	10.7	10.3	11.6	12.2	12.7	20.6	12.3	19.9	12.5	12.4	17.8	20.8	12.8	9.5	13.5	16.6	14.5	14.3	12.4	13.2	14.7	16.1	12.6	16.4	14.2	11.4	16.8	16.3	11.6	11.9	35.0	15.2	9.8	23.1	14.3	11.2	7.9	14.5	7.0	6.8	3.7	5.7	2.5	15.4	6.7	24.9	10.5	8.9	13.9	10.7	16.4	13.8	15.6	17.5	9.9	9.4	31.9	6.7	12.8	9.8	9.9	18.1	13.1	23.3	12.3	22.3	20.9	9.7	8.7	10.1	30.4	12.5	13.6	8.2	12.3	12.1	5.5	7.5	11.1	13.2	8.8	19.9	6.1	20.2	8.9	18.7	19.0	8.8	20.3	11.7	11.0	11.8	9.6	12.1	14.4	9.4	21.4	15.5	18.1	12.3	25.7	8.2	8.6	13.8	9.1	10.0	11.3	11.5	34.7	17.1	18.0	16.4	7.0	4.0	5.2	4.7	4.6	5.7	6.8	4.3	4.5	4.5	7.9	3.5	3.9	1.0	3.7	6.8	14.5	2.8	2.5	11.8	18.5	25.2	19.8	11.6	12.2	12.5	12.4	16.6	11.9	8.9	8.1	18.2	6.1	3.0	10.9	5.3	15.3	9.4	1.2	12.2	3.9	11.4	11.6	10.4	0.8	8.6	9.6	0.0	9.9	14.5	8.3	14.3	9.3	18.8	18.9	14.3	10.4	10.4	17.7	1.0	10.9	12.0	11.8	14.4	12.5	8.1	10.8	8.0	10.6	14.0	9.6	6.5	6.2	8.8	20.5	3.3	6.6	8.2	10.4	3.0
CHCHD5	"C2orf9, MGC11104, MIC14, MIX14"	ENSG00000125611	"Coiled-coil-helix-coiled-coil-helix domain containing 5"	Q9BSY4	2	112584240-112589275	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038263	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038263: AB_10671525"	"unprognostic (3.56e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.36e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.18e-3)"	"unprognostic (8.04e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	12.7	17.8	15.1	11.4	15.0	15.7	15.6	9.0	13.4	10.5	12.4	11.7	19.8	17.5	11.4	17.5	16.2	20.0	16.7	20.3	12.0	12.1	20.3	36.6	12.9	17.6	16.7	11.4	10.7	36.8	10.2	20.0	11.9	10.1	13.4	6.5	11.0	12.6	37.7	33.3	12.9	16.1	11.8	12.1	11.7	15.2	50.0	12.9	20.7	20.2	23.4	8.6	13.0	12.1	27.9	40.2	32.1	35.4	28.6	37.1	28.6	13.3	22.4	10.1	0.0	4.1	8.7	9.5	5.9	7.8	12.3	8.8	24.3	16.6	10.3	23.6	8.2	10.4	9.9	3.8	13.2	1.6	11.1	18.4	13.9	7.3	19.2	18.1	11.7	9.8	11.7	11.3	16.2	10.0	5.7	6.7	0.0	14.3	15.7	7.7	33.3	10.5	18.6	11.1	10.0	11.1	0.3	8.3	20.2	16.1	12.2	12.9	14.5	7.5	11.3	13.2	2.8	14.5	10.4	9.3	12.3	17.4	7.4	8.4	28.2	26.5	11.9	17.1	3.2	14.5	11.1	35.4	32.1	26.3	31.6	22.3	24.0	25.1	24.9	31.8	27.9	26.1	26.9	19.2	28.6	28.7	40.2	37.1	28.6	15.1	15.0	9.0	13.2	12.0	12.1	16.7	11.4	10.1	12.9	8.9	15.2	54.1	60.0	38.2	19.2	30.3	101.9	40.2	23.9	78.5	9.8	114.1	185.6	95.9	138.2	39.4	145.2	46.7	153.5	94.3	60.9	61.4	24.3	180.9	108.7	6.4	88.1	50.3	119.7	199.0	28.4	59.4	50.6	95.6	80.7	31.0	111.8	144.0	26.5	166.5	20.8	12.9	43.8	100.6	34.5	50.7	77.6	55.4	82.6	66.3
CHCHD7	"COX23, MGC2217"	ENSG00000170791	"Coiled-coil-helix-coiled-coil-helix domain containing 7"	Q9BUK0	8	56211686-56218798	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050783	Approved		Approved	"Cell Junctions,Aggresome"		NA	NA			"Cell Junctions"	Aggresome	"HPA050783: AB_2681236"	"unprognostic (1.64e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (4.46e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.04e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.47e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.50e-1)"	16.6	14.8	24.1	19.6	29.4	17.6	18.9	27.1	23.3	17.6	20.7	18.3	22.8	22.5	13.1	34.3	15.7	17.6	12.3	27.0	21.0	19.5	23.4	18.0	19.4	24.4	27.0	16.0	36.3	20.0	22.5	48.3	13.3	26.7	19.2	21.3	19.2	34.5	18.0	23.2	14.6	26.2	14.8	32.0	33.0	17.7	7.6	24.8	27.4	19.8	18.3	24.9	15.5	16.4	31.0	33.6	26.2	20.6	24.2	31.1	17.3	18.7	6.0	13.5	4.4	35.9	25.5	13.9	13.4	12.7	10.7	8.0	15.4	23.0	17.8	11.9	7.9	14.8	10.6	13.9	20.7	13.3	7.7	26.8	27.1	14.3	21.2	18.2	23.1	17.4	30.4	19.1	7.6	34.1	15.2	11.1	33.4	13.2	11.7	25.3	9.4	23.1	34.3	11.8	30.0	8.7	26.5	4.1	14.8	19.8	20.3	3.5	2.3	7.0	11.0	9.9	16.9	11.5	13.0	16.1	5.7	12.1	18.3	12.6	12.3	12.6	29.6	15.9	34.4	9.7	21.5	20.6	26.2	23.2	19.0	22.5	31.0	26.0	23.6	22.8	26.4	31.1	27.8	7.9	24.2	16.6	33.6	29.7	17.3	24.1	29.4	27.1	23.3	21.0	19.5	27.0	16.0	26.7	24.8	17.9	68.8	75.2	36.1	18.4	31.3	84.5	48.4	44.2	40.9	47.1	13.7	38.6	106.1	35.3	16.9	29.6	88.5	23.3	65.0	72.3	25.3	33.7	52.0	63.7	129.2	12.7	38.1	46.6	72.1	9.6	34.2	55.9	50.6	69.5	53.7	38.5	58.7	54.7	29.0	49.6	34.8	12.9	36.3	52.6	37.9	20.8	35.2	57.5	63.2	39.1
CHD1		ENSG00000153922	"Chromodomain helicase DNA binding protein 1"	O14646	5	98853985-98928957	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022236	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA022236: AB_2670915"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (7.25e-6)"	"unprognostic (2.69e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.17e-1)"	13.0	7.4	5.5	15.8	7.5	41.7	10.2	14.9	5.5	9.4	9.3	4.7	7.9	6.6	11.3	7.5	7.6	10.8	10.6	6.8	4.9	3.1	7.3	10.1	12.1	8.8	8.8	3.2	18.1	8.3	9.3	12.0	11.1	6.4	7.7	7.4	5.6	8.1	11.5	13.2	8.2	12.3	8.3	7.2	17.2	8.6	12.0	7.4	70.1	8.1	5.5	9.3	10.4	11.3	10.1	7.1	16.7	8.2	8.1	8.4	2.2	11.0	10.2	23.9	16.2	8.1	8.4	20.9	11.5	7.5	9.3	12.2	12.6	8.6	9.4	11.2	6.6	15.2	9.2	18.7	12.6	19.5	14.7	14.1	16.6	12.1	9.6	8.9	15.9	12.9	7.2	5.2	16.2	16.4	6.3	11.2	30.8	20.0	14.5	9.3	8.9	31.6	6.9	16.0	3.5	12.4	26.9	16.7	14.0	8.2	10.6	11.2	9.6	14.7	7.7	18.6	13.0	7.5	11.0	12.7	20.1	10.8	12.5	20.2	10.1	10.6	19.9	11.0	16.0	12.0	11.4	8.2	10.7	6.5	7.5	8.2	10.1	6.1	6.1	7.1	9.4	8.4	6.6	16.7	8.1	7.1	5.2	6.3	2.2	5.5	7.5	14.9	5.5	4.9	3.1	8.8	3.2	6.4	7.4	44.7	61.6	41.0	98.1	138.2	37.4	25.7	20.4	61.6	79.6	34.9	41.2	44.3	6.6	31.7	85.6	50.1	37.2	0.0	27.6	32.9	75.7	63.5	85.6	26.0	30.8	31.8	30.5	36.2	71.6	14.8	30.0	68.0	64.1	52.3	28.7	17.0	29.9	35.1	18.0	11.0	50.1	45.3	96.8	51.7	52.7	164.7	75.5	54.3	26.9	58.2
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884806-7912760	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Approved	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Nucleoplasm, Nucleoli, Centriolar satellite"		"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	10.4	12.9	31.7	24.3	26.0	18.7	12.5	12.1	28.3	41.1	21.1	4.1	22.5	8.2	46.3	16.1	15.1	25.0	20.0	8.7	30.4	14.2	15.2	2.3	13.1	19.0	8.4	28.4	27.3	15.1	28.5	21.0	8.0	10.7	32.9	11.1	20.7	19.4	23.0	3.3	16.2	14.0	23.3	6.9	14.6	15.8	11.3	5.1	40.6	19.7	7.5	17.7	20.6	28.9	1.6	4.0	4.1	3.5	2.7	7.8	3.6	12.2	30.5	17.9	23.7	21.8	18.3	9.6	14.3	19.2	12.1	13.0	5.9	10.3	34.5	10.9	21.0	9.8	16.6	33.6	15.1	15.3	17.5	19.6	16.7	39.6	0.7	11.7	4.8	32.9	24.1	8.1	16.3	10.9	32.3	22.5	15.8	11.1	0.6	11.3	12.1	13.1	5.5	2.8	12.9	11.3	38.6	21.8	5.2	12.1	29.8	12.2	16.5	35.5	13.8	6.9	5.1	15.9	7.8	28.1	26.3	20.7	6.4	20.5	2.6	0.4	19.5	13.4	13.5	22.4	0.6	2.7	4.1	7.0	1.7	5.5	1.5	6.7	6.6	2.1	1.6	7.8	5.1	2.1	2.7	3.5	4.0	3.6	3.6	31.7	26.0	12.1	28.3	30.4	14.2	8.4	28.4	10.7	5.1	29.8	57.4	11.5	44.3	32.4	61.2	9.7	17.8	24.1	37.5	76.8	7.9	15.1	14.9	21.3	8.9	17.5	12.0	0.0	20.6	16.7	30.0	67.6	38.2	2.1	8.4	42.9	54.5	18.4	21.1	13.0	41.1	14.7	8.5	54.1	12.6	11.3	23.7	7.0	53.7	7.5	15.6	25.8	27.2	12.9	50.5	17.9	13.7	34.6	25.9	53.1
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 60.3;Early spermatids: 202.3;Horizontal cells: 212.9;Late spermatids: 67.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 17.0;U-2 OS: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	17.0	0.2	0.2	0.0	0.0	0.0	2.9	0.1	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8	0.0	0.0	0.0	0.0	0.1	60.3	1.7	0.0	0.0	0.0	3.5	11.8	0.0	0.0	0.0	202.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	212.9	0.0	0.0	0.0	67.4	0.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.4	0.0	48.3	0.0	0.9	3.4	17.0	0.4	0.0	0.0	0.0	0.0
CHD6	"CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB"	ENSG00000124177	"Chromodomain helicase DNA binding protein 6"	Q8TD26	20	41402101-41618494	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 143.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015543			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015543: "	"unprognostic (5.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.72e-3)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.12e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-2)"	12.1	12.6	16.5	12.7	16.2	18.1	19.4	34.1	24.9	17.4	11.3	16.6	15.4	6.5	20.4	19.9	11.0	16.3	11.7	12.1	15.8	13.9	11.8	10.7	11.7	12.1	14.7	16.8	26.1	12.5	31.4	30.3	12.9	24.3	19.7	10.0	14.2	14.5	17.0	9.4	14.4	10.5	14.4	17.3	12.0	12.3	11.1	18.2	21.4	21.4	6.7	15.3	16.9	15.0	12.0	11.5	15.1	9.3	10.4	10.4	2.3	6.4	7.6	16.5	7.2	9.4	9.7	11.0	5.7	11.7	10.1	12.4	10.5	5.3	7.7	10.3	9.6	11.4	9.6	10.3	9.7	11.6	2.4	5.0	10.6	7.0	10.1	5.3	8.2	5.3	9.7	9.1	7.3	8.2	10.8	8.7	10.9	8.3	8.8	7.8	17.7	13.0	9.0	5.4	4.0	12.9	10.1	19.6	5.5	6.3	15.0	14.9	10.3	17.2	4.6	11.5	12.6	7.9	6.2	9.9	16.0	7.9	8.5	4.9	8.0	6.4	10.0	7.1	4.0	5.0	15.1	6.5	7.1	8.9	6.2	8.9	8.8	7.7	7.3	5.1	12.0	10.4	8.7	0.9	10.4	9.3	11.5	5.9	2.3	16.5	16.2	34.1	24.9	15.8	13.9	14.7	16.8	24.3	18.2	44.7	25.0	32.1	38.2	16.1	123.2	51.6	22.9	45.5	34.2	21.0	88.4	26.6	18.3	19.0	12.5	32.3	4.8	0.0	13.7	22.1	28.6	28.3	20.8	18.7	14.3	143.0	58.3	23.9	21.3	14.0	46.1	23.5	16.9	32.5	27.7	76.4	14.4	14.0	42.8	10.6	137.4	19.4	29.7	22.1	59.7	15.1	27.3	31.9	20.9	22.3
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 80.0;seminal vesicle: 66.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 33.1;Extravillous trophoblasts: 31.3;Spermatogonia: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							HPA044364			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	3.0	2.5	2.5	9.0	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80.0	5.0	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2.0	1.8	9.6	3.0	1.2	3.8	4.0	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3.0	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1.0	13.0	10.6	23.9	14.5	4.9	10.5	10.4	18.3	8.8	11.7	12.6	25.9	28.8	34.0	18.8	7.2	15.6	15.7	14.6	9.6	14.5	21.3	6.7	63.1	8.9	13.2	1.5	32.2	12.0	5.4	2.0	14.8	10.5	7.0	13.9	23.2	32.0	30.0	15.4	6.7	47.8	15.8	24.2	21.3	9.6	29.1	22.3	17.9	10.8	17.4	15.1	16.0	15.0	10.4	4.4	16.9	28.0	10.5	9.3	16.9	14.4	8.1	16.8	6.7	12.0	48.5	6.2	24.3	19.8	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2.0	0.4	1.2	0.4	1.8	11.7	1.0	2.5	2.8	1.1	2.2	2.4	2.4	3.0	1.2	1.5	1.5	3.0	0.3	6.0	4.4	5.6	1.4	3.7	33.1	2.7	5.7	7.0	0.0	9.6	3.3	3.7	3.3	1.9	3.3	23.3	1.0	31.3	5.6	2.0	0.0	0.8	9.4	0.0	1.7	4.9	0.0	2.2	1.4	2.4	0.0	4.6	5.6	2.7	2.4	3.7	1.1	6.8	1.5	0.0	4.1	23.3	60.3	4.3	6.5	4.4	12.0	1.4
CHI3L1	"GP39, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186749	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 336.4"	"Cell type enriched"	"Detected in many"	7	"Hofbauer cells: 335.7"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	490	"neutrophil: 81.3"	"Lineage enriched"	"Detected in single"	490	"granulocytes: 81.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 40.7;ASC TERT1: 90.8;HSkMC: 80.6;THP-1: 128.4;U-138 MG: 38.1;U-87 MG: 37.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	14	"olfactory region: 10.7"	HPA077365			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	25100000	230000000	"Golgi apparatus"	Vesicles	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	19.0	0.8	20.3	53.4	58.0	81.6	23.9	1.2	69.4	4.3	2.1	5.0	0.0	0.9	4.3	25.5	3.5	10.2	1.9	2.6	9.1	17.8	11.9	336.4	10.0	12.4	32.3	3.6	4.5	2.5	0.8	22.9	4.7	66.4	1.5	1.6	9.1	19.3	1.1	10.5	10.0	2.2	3.3	23.5	2.9	1.7	3.4	6.5	0.9	2.0	1.7	14.6	61.5	4.0	0.0	0.0	81.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	40.7	90.8	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	80.6	0.0	0.2	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.4	0.0	38.1	0.2	0.0	0.0	0.2	4.8	0.0	37.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.3	0.0	0.1	0.0	0.0	0.1	20.3	58.0	1.2	28.9	9.1	17.8	32.3	3.6	66.4	6.5	6.0	39.7	0.0	19.4	3.8	0.0	0.8	2.5	4.0	15.9	26.2	0.0	1.2	0.0	49.4	0.0	0.4	0.0	0.0	0.0	0.9	2.2	2.2	0.0	28.7	335.7	0.0	0.0	0.0	0.3	0.0	0.9	3.9	13.5	1.8	0.0	40.4	3.1	0.0	0.0	0.1	1.8	0.0	1.7	0.0	0.0	1.0	0.7	0.0	0.0	1.6
CHIC1	BRX	ENSG00000204116	"Cysteine rich hydrophobic domain 1"	Q5VXU3	X	73563200-73687102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA052062"	Uncertain		Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Nuclear speckles, Vesicles"	Cytosol	"HPA026782: AB_1846654, HPA052062: AB_2681714"	"unprognostic (9.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.10e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (1.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.76e-2)"	5.6	13.9	11.0	7.1	16.3	1.5	7.5	14.7	17.6	14.6	8.2	8.5	7.7	4.7	11.1	7.9	5.1	8.7	9.2	10.3	11.7	13.2	12.4	3.4	5.6	7.2	11.2	13.8	11.8	4.1	13.3	18.2	4.4	16.8	9.9	8.6	6.8	5.1	13.0	4.6	6.0	5.9	10.7	15.4	7.7	4.9	3.3	12.5	3.7	12.8	2.6	6.8	7.4	10.1	1.1	0.2	1.0	0.3	1.2	3.0	0.6	4.0	4.2	2.1	2.7	6.1	8.3	0.0	4.6	6.1	3.8	4.6	2.8	5.2	1.9	6.4	4.1	7.5	1.2	3.0	2.2	8.4	4.7	3.7	2.8	3.4	0.0	3.9	0.0	5.5	5.7	2.7	7.1	3.8	4.8	5.3	1.9	0.7	18.5	7.3	0.6	1.6	0.0	6.6	0.0	4.1	1.6	5.4	1.2	4.7	2.0	1.2	1.7	5.2	2.5	5.5	3.8	2.0	1.1	6.2	4.4	4.2	8.6	2.8	5.2	13.0	0.0	6.4	3.0	3.3	1.0	0.1	0.0	1.9	0.1	3.0	1.1	1.5	1.9	0.0	1.1	1.5	2.0	0.0	1.2	0.3	0.2	1.2	0.6	11.0	16.3	14.7	17.6	11.7	13.2	11.2	13.8	16.8	12.5	3.0	7.8	2.7	4.2	2.4	10.0	9.8	7.6	2.7	4.5	3.5	5.9	0.0	0.0	3.2	3.3	6.8	1.4	0.0	2.9	0.0	5.0	5.6	4.7	1.7	1.2	12.7	0.0	5.5	1.0	1.6	2.8	1.5	5.0	1.0	6.3	5.0	2.1	5.8	8.5	8.4	6.8	0.0	3.6	2.1	1.9	4.0	0.0	5.7	2.9	3.8
CHKA	"CHK, CKI"	ENSG00000110721	"Choline kinase alpha"	P35790	11	68052859-68121444	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 282.2;Late spermatids: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024153, CAB072803"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB072803: , HPA024153: AB_1846664"	"unprognostic (5.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (2.36e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (5.00e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.73e-2)"	8.9	15.5	18.1	6.4	19.5	25.5	18.6	10.2	19.3	10.8	18.2	30.9	28.8	19.0	5.8	19.2	3.9	6.5	10.7	5.4	18.7	15.4	8.0	17.4	11.4	7.5	26.5	12.5	10.4	29.3	9.2	10.0	5.0	21.5	13.5	11.8	17.4	36.9	37.4	3.9	4.2	22.8	8.2	20.9	13.5	18.8	55.9	22.7	3.1	19.9	2.2	5.2	8.7	4.7	1.3	1.5	9.5	2.5	1.6	0.7	0.4	8.0	7.0	8.2	7.9	2.8	1.9	8.3	2.6	4.2	7.2	4.7	30.1	22.8	6.2	9.6	3.7	7.8	5.4	11.5	1.8	5.5	2.8	4.1	7.7	9.2	34.8	7.9	8.1	4.3	3.8	3.1	3.3	1.6	4.1	4.1	4.0	7.2	10.8	3.8	6.2	4.3	22.1	13.2	27.3	4.8	7.0	8.7	17.4	6.1	9.1	6.1	6.5	4.9	25.1	57.8	7.1	10.6	11.2	2.3	4.6	5.8	10.9	3.3	12.7	13.0	10.8	5.0	10.7	4.2	0.0	1.4	9.5	0.2	2.5	0.0	1.3	0.1	0.4	1.5	0.6	0.7	0.5	0.8	1.6	1.5	1.2	0.3	0.4	18.1	19.5	10.2	19.3	18.7	15.4	26.5	12.5	21.5	22.7	41.7	30.1	4.5	14.6	14.1	10.2	2.2	33.1	17.4	14.8	3.5	31.4	6.1	11.6	8.8	282.2	8.5	26.2	0.0	16.5	3.2	9.5	16.9	18.5	16.9	14.9	54.0	26.9	9.2	22.6	221.9	5.8	13.0	21.9	9.0	14.3	20.0	14.9	20.1	2.5	3.7	25.8	0.0	10.3	56.6	19.2	9.2	10.9	2.9	21.7	33.5
CHKB	"CHETK, CHKL"	ENSG00000100288	"Choline kinase beta"	Q9Y259	22	50578949-50601455	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 14.7"									HPA018797	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA018797: AB_1846666"	"unprognostic (6.03e-4)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-3)"	14.1	13.6	12.7	18.9	14.4	14.8	13.0	21.3	13.4	12.9	15.1	13.8	10.4	9.8	10.1	12.5	10.7	16.2	13.6	10.6	10.7	6.8	14.3	9.3	12.6	8.7	14.7	6.1	9.1	8.4	21.9	19.2	12.3	12.7	11.7	6.9	12.8	13.4	12.5	7.8	10.5	16.9	8.0	9.5	18.5	14.8	19.9	15.8	8.5	14.5	6.6	16.5	12.1	10.9	13.6	21.2	15.0	23.9	20.6	18.6	19.5	3.7	1.0	3.0	1.1	3.2	2.1	10.4	4.4	8.8	1.8	2.5	0.0	1.4	1.8	3.4	0.0	1.6	1.7	1.6	0.9	0.3	1.5	4.3	2.4	2.2	0.8	14.7	3.0	6.2	1.0	5.4	0.7	3.7	3.6	9.2	3.9	1.2	4.8	4.9	3.4	2.6	8.4	0.5	2.5	0.6	3.4	0.4	10.4	4.0	2.5	1.5	4.3	3.5	3.4	3.1	2.2	1.2	1.8	2.8	1.7	3.7	1.6	1.3	7.9	0.7	2.3	3.0	2.3	1.8	5.7	23.9	15.0	16.3	21.9	15.5	12.9	15.2	17.3	21.2	13.6	14.4	13.3	5.7	20.6	14.2	19.5	18.6	19.5	12.7	14.4	21.3	13.4	10.7	6.8	14.7	6.1	12.7	15.8	6.0	23.3	12.0	2.2	4.2	5.1	5.9	17.8	10.7	14.8	7.0	3.9	7.5	3.3	26.9	9.1	6.3	18.0	0.0	20.9	12.0	5.8	1.9	18.5	5.5	12.8	7.9	15.1	10.4	20.2	21.1	2.3	8.8	3.3	73.9	16.6	2.8	23.5	23.0	2.8	4.3	4.8	6.5	8.2	11.1	8.7	5.5	7.1	16.0	15.6	1.8
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851396-11854449	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 250.9"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Supported	Nucleoplasm,Midbody		Yes	No			"Nucleoplasm, Midbody"		"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favorable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	16.0	13.6	14.9	12.5	11.6	19.5	13.3	8.8	16.0	10.1	14.1	10.0	13.8	14.0	10.4	14.7	14.5	9.1	14.6	17.0	11.2	12.3	12.2	11.2	11.3	14.0	11.6	11.9	11.3	11.2	9.7	12.4	11.8	12.1	10.3	14.1	9.4	12.6	29.5	250.9	15.2	20.4	11.6	13.8	11.3	12.8	6.8	10.0	14.2	19.9	19.4	9.9	14.3	10.1	6.7	13.1	34.4	16.5	7.4	9.1	10.6	12.3	12.1	15.7	13.3	20.6	14.5	22.8	13.2	22.4	9.0	12.1	15.6	12.4	7.7	19.9	14.3	15.1	10.6	7.1	18.4	8.1	7.1	8.8	5.5	18.5	12.8	15.3	21.2	9.6	21.0	39.9	10.1	23.5	20.3	13.0	17.6	9.4	10.0	14.2	15.3	14.6	16.3	6.6	39.4	6.1	7.5	8.1	13.1	24.1	17.0	15.3	15.3	22.5	10.6	20.2	15.3	8.6	19.6	19.0	20.3	10.7	16.0	14.1	12.0	13.7	9.8	18.8	9.9	9.6	10.9	16.5	27.7	7.2	15.3	6.6	6.5	6.7	8.5	13.1	6.7	8.4	7.7	34.4	7.4	15.0	11.7	9.1	10.6	14.9	11.6	8.8	16.0	11.2	12.3	11.6	11.9	12.1	10.0	62.5	46.0	82.1	114.0	372.7	31.1	17.9	56.0	44.2	44.3	125.6	7.9	122.5	51.4	101.8	65.5	63.6	178.4	0.0	71.3	124.5	68.5	78.7	149.7	34.7	112.4	27.0	137.9	43.0	124.4	36.5	35.1	124.4	150.1	100.0	90.8	29.6	115.6	199.9	35.0	109.2	14.1	77.6	64.8	16.4	20.6	450.0	211.8	80.6	63.8	219.0
CHMP2A	"BC-2, CHMP2, VPS2, VPS2A"	ENSG00000130724	"Charged multivesicular body protein 2A"	O43633	19	58551566-58555124	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041153, HPA042031"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		49000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041153: AB_10964358, HPA042031: AB_10961727"	"unprognostic (1.80e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.71e-2)"	40.7	59.6	52.5	37.3	56.7	55.1	41.2	36.3	44.8	39.0	53.2	37.8	50.4	43.5	36.9	61.7	57.4	41.9	60.4	80.6	45.0	40.1	64.8	66.5	36.4	55.8	48.2	38.7	36.9	59.8	46.9	39.1	79.2	38.5	35.2	49.2	33.0	62.4	64.8	75.7	54.9	72.0	42.4	48.5	43.4	45.2	29.4	35.1	34.0	49.8	53.9	44.4	42.5	34.0	17.5	30.5	117.2	34.7	17.0	29.4	24.9	18.0	48.6	15.7	14.4	24.3	30.5	19.4	16.7	34.7	8.9	9.7	14.3	26.9	4.8	24.7	27.9	25.8	14.7	12.9	31.9	7.6	16.1	106.0	11.8	35.6	21.9	47.1	19.5	18.5	35.3	45.3	13.9	44.7	30.4	25.8	22.8	14.0	23.1	26.9	30.5	24.7	18.1	6.5	50.0	37.3	10.7	13.5	36.2	38.8	41.0	18.5	31.4	27.2	36.4	20.0	10.3	27.9	20.0	29.0	45.6	6.6	13.2	19.3	58.9	64.4	15.7	32.1	23.2	29.9	33.5	34.7	46.6	20.2	31.7	17.0	17.5	22.3	22.7	30.5	15.8	15.7	17.7	117.2	17.0	31.6	27.8	29.4	24.9	52.5	56.7	36.3	44.8	45.0	40.1	48.2	38.7	38.5	35.1	92.3	99.1	97.2	231.9	147.1	67.2	100.3	152.8	155.2	81.9	157.1	15.7	253.5	374.7	261.4	89.0	137.1	466.3	70.0	457.0	242.2	112.6	224.1	116.8	190.9	235.9	49.3	149.1	122.8	143.9	66.0	134.3	151.3	204.1	239.9	215.7	135.6	375.5	326.1	125.2	436.3	71.4	84.1	139.8	101.7	97.9	173.4	384.7	105.5	183.9	310.0
CHMP2B	"CHMP2.5, DKFZP564O123, VPS2B"	ENSG00000083937	"Charged multivesicular body protein 2B"	Q9UQN3	3	87227271-87255548	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 108.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035069, HPA052754"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035069: AB_10602798, HPA052754: AB_2681936"	"unprognostic (7.83e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (5.76e-2)"	"prognostic favorable (1.74e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.21e-1)"	21.8	21.5	20.1	17.6	23.5	36.5	22.1	12.5	35.9	23.6	32.4	21.4	19.2	30.1	28.2	20.5	30.9	20.1	23.4	26.2	20.8	22.0	30.9	36.1	21.5	17.7	29.5	21.0	22.9	23.5	14.7	41.7	45.1	30.7	29.2	30.5	14.7	22.7	25.4	30.1	22.9	45.8	24.8	52.6	22.3	24.3	13.3	25.6	14.5	35.5	26.3	16.4	30.7	25.3	21.2	22.4	53.4	24.8	11.4	20.0	14.3	16.8	18.3	6.2	3.9	11.4	9.2	8.0	13.3	16.9	11.0	14.2	14.3	27.6	6.0	9.4	14.3	10.1	8.6	8.1	9.2	13.3	10.6	8.5	7.4	6.6	5.8	10.0	9.9	10.3	7.0	15.6	10.9	14.8	10.6	8.4	7.4	4.4	9.1	11.8	12.1	9.6	4.1	8.1	20.3	16.4	5.1	7.7	5.8	8.3	17.3	2.4	2.5	13.0	10.6	20.2	7.5	9.5	3.0	7.6	10.2	9.4	108.6	9.0	9.2	13.6	10.3	11.2	5.7	7.3	42.8	20.8	53.4	11.9	24.8	16.0	20.0	14.9	14.6	22.4	21.2	14.1	13.7	40.3	11.4	24.7	12.8	20.0	14.3	20.1	23.5	12.5	35.9	20.8	22.0	29.5	21.0	30.7	25.6	77.4	53.5	37.2	193.5	117.3	17.0	65.5	58.6	95.0	73.9	47.1	3.9	64.1	117.7	128.3	5.1	42.3	109.6	46.7	227.8	159.4	64.8	193.3	71.7	54.0	75.6	35.0	44.9	35.6	51.1	4.0	61.2	79.5	38.8	48.7	61.4	189.8	186.7	138.6	90.5	117.0	14.1	71.1	49.5	56.6	68.8	127.2	151.3	45.3	63.1	267.1
CHN1	"ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2"	ENSG00000128656	"Chimerin 1"	P15882	2	174799363-175005369	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 145.3"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 88.1;Horizontal cells: 73.1;Muller glia cells: 49.1"	"Cancer enhanced"	"Detected in all"		"glioma: 18.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 9.0;memory CD8 T-cell: 2.9;T-reg: 10.0"	"Lineage enriched"	"Detected in single"	35	"T-cells: 10.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 60.2;BJ hTERT+ SV40 Large T+ RasG12V: 30.4"	"Low region specificity"	"Detected in all"							HPA036111			Approved	Cytosol		NA	NA			Cytosol		"HPA036111: AB_10671241"	"unprognostic (3.18e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (7.31e-3)"	"unprognostic (4.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.46e-2)"	3.8	5.2	63.4	3.4	60.8	1.0	2.4	9.1	145.3	4.7	2.5	4.4	0.2	1.7	3.9	15.1	3.2	2.9	4.7	5.2	74.0	21.4	2.1	1.4	7.1	7.4	21.4	51.7	2.8	1.9	31.7	5.2	14.4	23.0	7.2	2.6	3.1	1.4	4.6	1.2	1.9	1.8	5.5	5.1	2.7	2.1	7.5	9.1	0.0	4.0	0.0	7.2	4.5	1.2	0.2	0.2	0.0	0.0	0.1	10.0	1.1	0.0	3.3	14.9	4.2	4.6	21.2	0.1	14.4	60.2	20.7	30.4	0.1	1.9	0.1	0.4	21.7	10.4	0.5	19.0	0.4	8.3	0.2	8.3	2.6	4.9	1.4	10.2	1.4	0.3	18.8	0.5	10.0	3.2	4.6	7.6	7.1	0.1	0.6	15.2	2.8	6.8	0.6	17.6	0.5	5.1	2.2	21.0	0.1	0.2	0.1	18.4	19.9	11.4	0.1	1.7	9.7	0.7	0.3	2.3	8.8	1.3	2.8	5.2	1.7	8.0	0.2	1.9	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.7	0.2	9.0	2.9	0.0	0.0	1.3	0.3	0.0	0.1	0.0	0.2	10.0	1.1	63.4	60.8	9.1	135.3	74.0	21.4	21.4	51.7	23.0	9.1	3.0	3.4	1.9	0.3	3.9	88.1	6.1	0.0	1.4	4.5	3.5	25.5	1.1	0.0	0.2	17.1	14.0	0.0	0.0	0.5	1.0	16.0	0.7	0.0	0.6	2.4	73.1	2.4	6.2	0.0	18.2	2.8	1.0	6.8	0.0	0.0	49.1	0.6	0.0	4.9	0.0	13.5	12.9	26.9	17.0	14.5	3.1	1.7	4.4	0.0	0.3
CHN2	"ARHGAP3, RhoGAP3"	ENSG00000106069	"Chimerin 2"	P52757	7	29146569-29514328	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.2;intestine: 44.3"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 299.6;Early spermatids: 94.3;Hepatocytes: 85.0;Late spermatids: 83.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.6;HMC-1: 36.3"									"HPA018989, HPA019026"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA018989: AB_1846681, HPA019026: "	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.71e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.58e-3)"	2.7	4.4	7.9	3.3	21.8	1.4	2.1	89.2	14.7	6.6	14.1	19.2	0.3	44.3	2.7	2.1	1.9	5.0	4.8	6.9	10.5	7.0	8.2	22.0	3.7	2.0	34.7	6.9	13.4	13.9	0.5	1.9	6.4	16.5	5.3	5.9	4.6	1.6	2.9	2.7	1.5	36.3	3.0	16.5	5.1	4.2	2.3	29.2	0.8	4.7	0.0	1.7	3.5	4.0	0.3	8.5	3.9	11.2	9.3	2.5	2.6	0.1	0.4	1.6	0.0	0.0	0.0	9.7	0.0	0.0	0.4	0.0	5.1	1.5	0.5	3.1	0.1	0.6	2.7	5.1	0.0	0.0	9.1	1.7	18.6	0.8	9.9	0.1	0.0	36.3	0.0	3.4	0.0	0.7	0.0	1.9	3.0	0.7	0.2	0.1	0.2	5.0	0.2	0.6	3.4	1.8	0.4	0.0	1.0	9.4	6.3	9.7	0.7	2.2	3.3	5.9	5.5	0.3	1.0	0.2	0.5	0.1	0.0	0.2	1.8	7.1	0.0	0.1	1.1	0.7	3.9	10.5	0.1	2.5	11.2	1.8	0.3	0.4	2.2	8.5	0.2	0.5	1.0	0.6	9.3	6.4	1.0	0.0	2.6	7.9	21.8	89.2	14.7	10.5	7.0	34.7	6.9	16.5	29.2	6.0	5.1	1.4	0.6	2.4	299.6	10.6	2.5	10.7	3.4	3.5	41.2	22.2	0.0	0.2	94.3	5.5	13.6	0.0	1.8	28.5	3.4	1.2	23.1	85.0	15.9	6.4	37.7	1.8	19.1	83.5	4.6	19.6	16.9	0.0	18.9	8.5	0.3	12.9	4.6	1.6	15.0	0.0	1.1	2.3	5.9	0.5	13.7	15.2	8.6	0.6
CHODL	"C21orf68, FLJ12627, MT75, PRED12"	ENSG00000154645	Chondrolectin	Q9H9P2	21	17901263-18267373	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 59.6"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6"	"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 4.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.9"	"Cell line enhanced"	"Detected in some"		"U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4"	"Region enriched"	"Detected in all"	6	"olfactory region: 208.8"	"HPA017282, HPA057559"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA017282: AB_1846687, HPA057559: "	"unprognostic (3.91e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (6.74e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.02e-1)"	2.3	1.9	0.8	2.1	6.8	0.0	1.1	0.5	0.8	0.3	2.3	0.5	4.0	1.5	0.7	1.1	1.4	0.5	0.8	3.4	1.3	8.2	4.7	0.0	0.3	0.3	1.4	0.8	0.5	0.0	0.5	2.1	1.7	8.6	8.2	3.4	1.4	0.6	1.8	1.3	2.1	0.9	0.4	2.2	12.3	0.7	59.6	1.1	0.1	0.9	4.3	1.1	1.1	1.1	0.4	0.6	0.0	0.1	0.4	4.9	0.3	0.0	0.0	1.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.1	0.0	2.5	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.6	0.1	2.1	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.3	0.0	1.1	0.9	1.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.1	10.0	0.3	11.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	4.9	0.4	0.3	0.8	0.1	0.2	0.0	1.1	0.0	0.4	0.1	0.6	1.0	0.3	0.8	6.8	0.5	0.8	1.3	8.2	1.4	0.8	8.6	1.1	0.0	0.0	0.0	0.6	3.5	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.2	2.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	2.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.2	1.1	1.7	1.9	0.5	1.0	0.0	0.3
CHORDC1	"CHP-1, CHP1"	ENSG00000110172	"Cysteine and histidine rich domain containing 1"	Q9UHD1	11	90201160-90223364	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 100.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041040	Approved		Approved	Cytosol		NA	NA		51000	Cytosol		"HPA041040: AB_10794185"	"unprognostic (2.29e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (4.93e-7)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.27e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-1)"	13.9	17.8	24.9	18.1	31.9	17.8	22.2	29.9	30.7	12.5	10.9	9.0	10.6	10.6	13.8	17.3	13.1	13.2	12.4	17.1	23.6	24.6	11.0	16.2	12.4	21.3	37.8	12.9	19.8	9.5	14.1	47.6	21.3	33.7	14.8	13.2	6.1	9.6	13.0	12.9	12.4	9.0	12.8	39.8	15.3	12.1	13.1	40.2	14.2	16.8	8.7	23.3	14.9	100.9	12.6	11.9	7.9	12.5	14.5	15.5	9.3	9.4	27.3	9.1	6.0	8.8	4.9	13.8	11.8	3.9	11.3	10.0	38.9	7.5	16.7	19.8	5.0	22.5	12.9	26.6	6.2	14.0	14.8	13.5	16.4	15.9	18.5	6.9	11.7	11.0	1.8	7.2	10.7	12.5	6.6	8.9	10.2	24.0	7.4	13.4	4.8	10.9	16.0	10.7	32.8	22.7	16.4	5.7	9.2	9.4	4.3	8.7	3.7	13.0	10.5	4.7	11.5	17.4	5.5	8.5	8.4	18.6	12.7	13.9	3.4	26.7	13.3	2.6	17.3	7.6	6.8	7.7	7.9	12.0	12.5	12.9	12.6	13.1	12.5	11.9	10.8	14.0	13.3	2.3	14.5	8.0	9.2	15.5	9.3	24.9	31.9	29.9	30.7	23.6	24.6	37.8	12.9	33.7	40.2	17.9	24.3	33.4	113.0	62.8	44.2	28.5	2.5	52.2	37.5	10.4	127.6	34.0	10.0	19.8	71.4	32.2	10.7	0.0	14.1	67.3	45.9	65.4	86.4	13.9	34.7	62.0	65.9	11.6	17.8	51.1	30.2	35.8	27.0	28.9	14.1	20.9	20.9	17.5	29.4	18.8	54.7	12.9	42.6	80.0	39.0	71.5	42.6	45.9	12.5	68.6
CHP1	"CHP, p22, p24, Sid470p, SLC9A1BP"	ENSG00000187446	"Calcineurin like EF-hand protein 1"	Q99653	15	41230839-41281890	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Protein kinase inhibitor"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 330.0;Enterocytes: 365.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006616	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA006616: AB_1857461"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.63e-4)"	"unprognostic (7.29e-2)"	"unprognostic (3.74e-1)"	"prognostic favorable (4.07e-6)"	"unprognostic (2.20e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.79e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.04e-1)"	39.4	32.5	21.2	17.0	21.5	25.7	32.3	13.5	34.1	17.0	51.0	19.0	18.9	41.0	13.4	16.4	39.1	11.2	38.8	27.3	22.7	23.8	35.6	82.3	31.6	14.4	22.4	15.6	13.6	31.1	27.1	13.9	12.2	32.1	16.8	37.6	15.2	28.7	23.1	42.2	24.2	55.6	15.8	19.0	12.6	52.5	7.5	11.3	10.3	23.6	34.2	24.7	21.7	22.5	8.6	30.5	52.5	47.4	11.0	11.8	19.4	21.7	21.3	8.2	31.5	34.9	33.2	12.8	16.9	21.3	13.3	14.3	18.8	42.0	3.7	19.0	22.2	14.1	26.7	15.9	25.7	14.7	15.3	6.0	14.6	17.6	29.1	27.3	19.2	23.1	34.0	28.0	15.2	15.3	19.4	23.8	11.5	23.6	24.0	14.6	12.0	8.0	19.7	8.9	32.5	11.4	11.5	13.4	10.5	26.0	39.8	5.6	13.9	28.8	53.1	14.0	14.8	31.4	18.2	34.1	15.0	16.2	23.5	11.0	14.1	37.3	17.8	26.8	11.8	13.5	42.9	47.4	52.5	10.7	40.0	11.0	8.6	10.1	10.7	30.5	6.8	6.5	9.3	35.6	11.0	38.5	19.2	11.8	19.4	21.2	21.5	13.5	34.1	22.7	23.8	22.4	15.6	32.1	11.3	41.7	95.4	37.9	53.7	64.2	9.4	73.8	193.6	22.7	38.7	97.7	9.8	29.7	330.0	84.2	45.0	25.3	365.9	23.3	131.3	51.6	41.6	79.7	36.9	304.1	61.4	11.1	53.4	75.5	170.6	81.7	27.3	82.7	123.2	54.1	120.3	19.0	140.2	153.1	27.6	162.5	9.3	25.8	42.4	12.5	19.0	94.9	56.0	55.4	104.3	95.4
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538947-219543787	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 137.8;Extravillous trophoblasts: 162.1;Syncytiotrophoblasts: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.96e-4)"	8.6	14.1	9.7	8.4	11.8	1.4	6.8	8.5	19.4	22.1	8.6	11.3	23.0	18.4	17.0	24.6	7.9	9.2	17.1	36.3	12.2	10.7	11.3	52.1	11.6	5.4	9.0	10.5	38.1	60.7	16.3	36.9	62.7	10.4	19.3	3.8	27.4	31.6	19.9	4.3	9.0	13.3	9.1	8.3	4.5	15.6	34.2	7.0	3.8	17.9	7.4	10.6	11.9	8.5	1.3	11.1	6.9	0.1	2.1	3.0	0.8	18.8	3.7	2.8	23.5	10.7	16.9	32.2	19.1	16.2	5.4	5.0	10.4	16.6	5.9	41.2	18.5	18.6	24.1	1.8	11.5	0.8	9.1	6.5	2.1	5.3	45.1	15.0	1.8	12.4	22.6	20.4	5.5	5.3	19.7	0.0	2.0	13.0	14.4	5.1	29.5	0.2	4.9	11.6	6.4	14.5	0.0	8.9	11.5	6.5	8.5	6.9	10.6	9.2	9.0	26.2	5.5	3.0	6.4	0.4	20.1	11.0	24.0	9.9	17.4	5.3	2.7	18.4	1.9	20.3	2.1	0.0	6.9	2.4	0.1	3.0	1.3	1.9	1.6	0.0	0.1	2.2	0.8	0.0	2.1	0.0	11.1	1.2	0.8	9.7	11.8	8.5	19.4	12.2	10.7	9.0	10.5	10.4	7.0	0.0	14.6	4.5	19.1	12.9	13.8	27.7	25.5	2.7	6.8	71.5	9.8	137.8	8.3	48.8	3.2	3.5	16.9	0.0	70.1	162.1	52.1	34.2	10.3	49.9	16.5	41.3	41.2	6.7	1.3	5.7	23.0	2.8	64.1	2.8	36.9	62.9	60.3	26.6	59.4	16.4	11.4	25.8	16.5	11.6	5.5	9.7	259.5	7.5	11.3	28.6
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.5	29.3	13.4	19.0	12.9	22.6	19.1	13.1	20.2	15.3	14.4	11.4	20.7	14.9	19.5	16.9	13.3	14.9	17.6	18.8	13.7	12.5	14.9	20.7	17.4	23.4	11.4	17.4	14.4	23.7	16.7	41.5	18.6	11.8	18.5	10.8	12.2	25.4	19.8	7.9	14.2	17.1	17.3	9.4	28.1	20.1	12.9	11.1	16.2	17.5	7.4	13.7	18.9	12.8	2.7	9.5	9.9	5.6	2.6	5.7	3.7	9.0	7.4	5.0	14.5	17.4	17.3	7.5	19.1	29.8	10.4	12.7	4.9	15.4	2.7	33.8	30.3	14.2	11.4	2.2	13.6	4.5	10.4	6.8	2.9	8.1	6.8	16.3	5.8	24.2	26.4	7.7	9.8	3.5	21.6	16.3	4.6	2.7	8.0	16.5	14.9	5.4	22.9	6.6	3.8	8.6	5.1	2.9	9.1	10.1	7.2	5.4	9.6	10.2	10.1	4.8	3.9	3.9	9.6	22.2	11.6	1.9	15.3	16.1	14.8	2.1	4.0	42.1	7.8	15.6	1.2	5.6	7.9	5.7	5.1	5.4	2.7	3.1	5.1	6.3	2.7	2.2	2.3	9.9	2.6	5.0	9.5	3.4	3.7	13.4	12.9	13.1	20.2	13.7	12.5	11.4	17.4	11.8	11.1	8.9	10.2	11.5	4.8	4.0	9.5	1.6	12.7	4.0	4.5	10.4	3.9	9.1	1.7	10.3	0.5	4.7	10.2	23.3	14.5	12.1	9.7	9.5	5.8	8.3	11.2	23.8	8.1	13.5	11.6	0.7	15.8	8.5	6.8	7.2	10.1	4.3	14.8	15.9	14.2	3.3	6.9	19.4	6.2	3.4	1.7	3.9	8.6	12.1	8.1	8.9
CHRAC1	"CHRAC15, YCL1"	ENSG00000104472	"Chromatin accessibility complex 1"	Q9NRG0	8	140511298-140517137	"Predicted intracellular proteins"		"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059008			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059008: AB_2683878"	"unprognostic (6.34e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (4.19e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.49e-1)"	24.3	14.7	12.1	15.9	16.0	23.3	18.0	10.1	14.2	17.3	20.9	23.8	11.9	15.5	20.4	12.7	24.1	16.1	19.8	18.7	13.7	10.4	21.4	24.3	16.5	21.6	19.2	7.7	18.2	17.7	15.5	13.1	21.0	13.6	17.8	16.2	17.2	17.6	20.1	28.4	19.1	24.3	21.2	20.8	22.2	18.2	26.1	21.6	36.4	27.5	19.3	24.9	19.3	15.8	19.6	19.5	21.4	23.5	16.1	16.0	12.5	22.4	10.9	10.3	9.7	10.3	17.5	7.8	9.6	14.1	14.1	17.2	14.0	16.3	23.3	14.4	11.8	11.2	14.1	12.2	9.9	19.6	17.8	12.8	33.0	15.2	15.7	9.7	10.9	17.5	8.7	14.5	10.4	20.3	7.6	13.5	14.4	24.3	22.3	12.5	26.4	38.2	11.8	7.5	19.8	18.4	23.1	10.8	18.5	14.1	9.4	14.1	11.7	13.5	9.2	17.0	5.8	17.8	12.6	12.7	16.8	29.3	20.6	20.3	10.7	13.9	28.3	20.2	26.1	13.0	8.7	17.0	20.3	16.0	22.4	15.7	17.3	14.4	15.8	18.7	19.6	15.2	12.6	21.4	16.1	23.5	19.5	12.7	12.5	12.1	16.0	10.1	14.2	13.7	10.4	19.2	7.7	13.6	21.6	14.9	25.1	31.5	36.8	34.1	6.9	11.6	20.4	16.0	29.6	14.0	2.0	19.7	36.5	19.4	15.6	29.5	21.9	0.0	31.3	42.0	24.9	26.9	32.3	18.4	21.6	6.4	20.7	30.1	29.5	26.2	27.0	33.4	18.6	31.5	20.5	25.3	27.4	18.6	23.7	24.5	10.7	71.1	38.1	72.7	63.0	42.4	20.1	29.9	19.3	30.6
CHRDL2	BNF1	ENSG00000054938	"Chordin like 2"	Q6WN34	11	74696429-74731385	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 64.5;endometrium 1: 76.5;gallbladder: 109.2"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 22.9;Hepatocytes: 76.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 6.1;PC-3: 3.2;SiHa: 6.1;TIME: 2.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA021771, HPA076522"	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		5600000	Vesicles		"HPA021771: AB_1846689, HPA076522: "	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (9.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.58e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (6.08e-4)"	1.0	0.0	0.0	39.3	0.2	0.0	1.7	0.1	0.3	64.5	27.9	0.1	1.0	1.4	76.5	47.6	4.3	2.9	109.2	35.8	0.1	0.1	1.0	14.5	0.8	0.5	0.0	0.0	6.7	1.0	0.4	0.1	1.5	0.4	8.0	0.9	0.9	0.2	3.5	2.6	0.3	3.5	45.3	0.6	0.8	24.1	7.6	0.0	0.1	0.2	3.2	1.1	22.6	8.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	1.0	6.1	0.7	0.0	1.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.0	3.2	0.0	0.6	0.0	0.0	0.0	0.1	0.2	6.1	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.5	0.4	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.4	0.2	0.0	2.2	22.9	0.0	0.0	8.7	0.0	0.0	0.0	5.8	9.7	0.5	0.0	0.0	9.0	0.0	0.9	0.8	0.0	76.1	0.1	0.0	0.0	2.5	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.7	0.0	0.0	0.0	1.0	0.2	1.9	0.0	0.1	0.0	0.0	0.5
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.7;prostate: 28.2;salivary gland: 25.3"	"Group enriched"	"Detected in some"	6	"Glandular cells: 2.0;Melanocytes: 3.3;Mucus-secreting cells: 2.1"	"Cancer enriched"	"Detected in some"	16	"prostate cancer: 27.9"	"Group enriched"	"Detected in many"	10	"amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 4.9;OE19: 15.2"	"Group enriched"	"Detected in many"	9	"amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8"					"HPA014101, CAB022366"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB022366: , HPA014101: AB_1854210"	"unprognostic (3.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.57e-4)"	"unprognostic (4.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"		0.5	3.7	13.2	0.8	22.0	0.5	3.2	0.2	34.7	0.6	1.3	0.5	0.0	1.0	0.7	0.6	0.8	0.8	0.7	0.6	14.2	1.7	0.7	0.6	2.9	0.6	1.4	14.0	0.5	1.2	1.0	0.1	0.8	0.1	28.2	1.3	1.3	25.3	0.6	0.6	2.6	1.3	0.6	0.3	0.6	1.9	0.6	1.8	0.0	0.8	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.1	15.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.4	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	22.0	0.2	34.7	14.2	1.7	1.4	14.0	0.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1
CHRNA5		ENSG00000169684	"Cholinergic receptor nicotinic alpha 5 subunit"	P30532	15	78565520-78595269	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 33.9"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 9.6;Spermatogonia: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054381	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Plasma membrane"	"HPA054381: AB_2682468"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.20e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.03e-5)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.50e-11)"	"unprognostic (4.37e-1)"	"unprognostic (5.39e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	2.9	3.3	1.7	4.4	1.7	0.6	4.9	1.8	1.7	2.7	6.4	0.4	1.6	7.8	4.7	1.9	4.0	1.1	16.3	2.4	1.7	1.8	0.9	1.8	1.4	2.0	1.9	0.3	1.7	11.8	0.0	0.7	2.1	1.2	3.6	7.1	3.5	1.7	0.7	5.8	1.0	6.8	6.1	1.3	1.9	5.3	9.8	0.6	4.5	1.6	2.9	4.4	5.7	33.9	0.9	1.1	3.4	1.6	1.6	1.4	0.7	6.7	17.4	9.5	5.2	1.1	0.8	3.8	4.9	2.4	5.5	10.0	6.6	32.1	4.0	12.2	1.0	14.8	6.0	18.1	7.3	5.6	8.1	21.7	7.4	13.6	6.6	0.6	5.0	10.5	0.3	1.3	1.5	2.0	2.0	10.2	5.6	7.2	5.2	3.5	14.7	6.3	1.7	7.7	13.3	4.8	8.1	10.9	4.0	6.6	16.1	16.0	23.5	11.9	11.6	5.5	5.6	25.8	1.3	2.2	7.5	9.0	5.5	15.5	6.1	25.0	4.5	4.5	8.1	6.9	3.0	1.6	2.5	0.8	1.6	0.4	0.3	0.8	0.5	0.9	0.9	1.4	1.4	3.4	1.6	1.3	1.1	0.3	0.7	1.7	1.7	1.8	1.7	1.7	1.8	1.9	0.3	1.2	0.6	0.0	0.0	0.0	7.8	2.9	1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	1.0	1.0	0.0	0.0	1.8	9.6	0.4	5.2	0.0	0.0	0.9	4.8	3.4	0.0	0.0	1.2	0.3	0.8	1.7	0.0	6.3	0.2	0.7	0.0	0.4	0.2	0.5	0.0	2.1	3.2	32.1	1.4	0.8	1.3	1.5	2.7
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624119-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7"	"Group enriched"	"Detected in some"	21	"Early spermatids: 41.7;Late spermatids: 39.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"SCLC-21H: 20.7;SH-SY5Y: 26.9"	"Group enriched"	"Detected in some"	5	"olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6"	"Low region specificity"	"Detected in many"			HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"		NA	NA			"Endoplasmic reticulum"	"Cell Junctions"	"HPA059484: "	"unprognostic (4.74e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.77e-5)"	"unprognostic (8.15e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-4)"	"unprognostic (7.00e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.76e-2)"	0.2	6.6	2.7	3.9	0.8	0.7	0.2	0.5	0.4	0.6	2.3	0.2	0.0	0.2	0.8	0.7	1.4	0.1	0.1	0.8	1.0	0.3	0.5	0.1	0.1	2.9	0.2	0.0	0.3	0.2	0.0	1.6	0.0	1.3	0.2	1.1	10.6	2.2	2.4	0.6	0.3	1.0	0.9	1.0	1.0	0.8	10.7	0.1	18.5	0.4	0.3	1.1	0.5	0.5	1.5	0.4	1.4	0.8	1.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	26.9	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.3	0.5	0.2	0.6	0.9	0.5	0.6	0.2	1.5	0.8	0.8	1.4	1.0	0.4	0.4	0.3	0.0	2.7	0.8	0.5	0.4	1.0	0.3	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.1
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 49.1"	"Cell type enriched"	"Detected in single"	11	"Muller glia cells: 4.3"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	72	"RH-30: 43.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.4"	"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	49.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHST10	HNK-1ST	ENSG00000115526	"Carbohydrate sulfotransferase 10"	O43529	2	100391860-100417656	"Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.2"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 14.9;Bipolar cells: 11.4;Muller glia cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"B-cells: 2.3;dendritic cells: 3.1;T-cells: 3.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012884, HPA051545"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		290000	Cytosol		"HPA012884: AB_1846710, HPA051545: AB_2681529"	"unprognostic (5.40e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.27e-1)"	4.1	6.7	14.6	3.9	18.7	2.6	5.0	12.6	28.2	6.2	4.1	12.1	2.4	2.2	11.4	13.5	4.1	9.7	5.3	10.1	12.4	9.5	4.4	1.2	7.8	4.0	9.8	12.2	12.9	5.3	8.8	8.6	7.8	9.3	8.1	2.4	7.3	5.5	5.4	5.1	1.6	2.5	11.7	8.9	3.7	3.4	5.8	7.6	3.1	9.8	1.6	5.1	5.8	4.9	2.3	3.1	0.0	0.0	0.1	3.5	1.0	0.1	7.7	15.3	7.8	4.7	6.6	7.7	8.8	6.3	12.1	7.8	0.1	4.5	10.6	7.7	5.3	21.5	0.0	10.7	1.1	7.8	15.0	11.3	5.4	4.2	11.9	5.6	10.9	14.3	4.8	1.5	5.7	1.0	5.8	9.5	10.3	15.7	0.0	5.1	2.4	9.7	8.7	22.5	0.1	9.4	7.0	9.4	0.1	3.3	3.4	16.5	13.5	0.6	0.0	12.2	11.3	4.1	15.1	8.6	8.4	13.4	6.3	8.1	0.0	0.0	10.9	10.3	9.8	9.9	0.0	0.0	0.0	3.5	0.0	1.3	2.3	0.6	2.9	0.6	1.8	0.8	2.3	0.0	0.1	0.0	3.1	0.0	1.0	14.6	18.7	12.6	24.8	12.4	9.5	9.8	12.2	9.3	7.6	14.9	1.9	0.8	1.0	0.8	11.4	4.7	0.0	1.4	7.9	1.8	0.0	4.2	3.3	3.0	0.4	3.3	0.0	0.0	2.5	8.4	3.1	1.0	0.0	0.0	4.8	6.4	1.7	0.0	1.2	0.0	2.0	1.1	0.0	5.4	0.0	17.6	1.9	0.0	4.9	1.0	4.3	0.0	2.5	1.1	4.5	0.5	1.1	2.5	0.0	0.1
CHST11	"C4ST, C4St-1, C4ST1, HSA269537"	ENSG00000171310	"Carbohydrate sulfotransferase 11"	Q9NPF2	12	104455295-104762014	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 55.7;monocytes: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052828	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		22000	"Golgi apparatus"		"HPA052828: AB_2681966"	"unprognostic (6.35e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.28e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (7.59e-11)"	"unprognostic (1.64e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (8.42e-4)"	6.7	14.3	14.6	21.6	16.6	37.3	4.9	5.7	16.1	6.6	6.2	8.2	9.7	3.9	15.7	16.1	4.4	5.2	11.1	6.6	13.4	11.9	4.4	4.0	15.3	22.5	11.5	6.7	8.7	6.3	1.9	6.8	17.2	10.0	6.4	5.2	16.1	3.3	13.4	1.7	2.7	7.7	12.6	10.5	17.5	8.3	3.3	11.8	26.5	4.3	2.9	15.6	8.5	5.3	2.0	2.6	13.8	1.3	1.3	2.8	0.6	13.5	6.2	2.9	1.8	7.3	3.6	10.2	1.2	0.4	0.6	0.5	0.0	17.7	0.0	2.0	1.8	14.9	3.4	1.7	7.1	0.7	0.1	2.5	18.0	1.6	0.0	1.1	21.0	21.4	1.3	1.0	11.5	1.9	10.8	4.5	25.8	27.8	4.6	1.2	3.3	16.0	24.7	2.4	0.1	2.3	18.2	9.6	4.5	6.0	0.1	4.9	8.0	0.8	9.2	17.0	2.6	2.7	21.3	10.4	2.0	2.2	10.3	11.2	24.0	25.8	3.4	9.4	14.8	20.1	9.3	1.3	9.4	2.8	1.2	1.6	0.9	1.5	2.1	0.7	2.0	0.7	1.8	13.8	1.3	1.1	2.6	2.8	0.6	14.6	16.6	5.7	10.4	13.4	11.9	11.5	6.7	10.0	11.8	14.9	13.3	17.2	13.2	2.5	1.6	4.5	2.5	4.0	7.9	5.2	0.0	28.8	0.0	5.0	0.6	6.3	0.0	0.0	55.7	12.0	9.1	2.7	41.4	0.4	42.1	9.5	0.0	22.1	23.7	1.1	6.9	35.3	3.3	81.2	0.0	1.6	21.1	0.0	15.9	4.8	0.5	6.5	7.2	0.5	2.7	2.5	22.2	36.2	0.0	2.4
CHST12	"C4S-2, C4ST2"	ENSG00000136213	"Carbohydrate sulfotransferase 12"	Q9NRB3	7	2403560-2448483	"Enzymes, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ito cells: 159.0;T-cells: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 26.2;NB-4: 27.1;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041680	Approved		Approved	"Golgi apparatus"		NA	NA		430000	"Golgi apparatus"		"HPA041680: AB_10959789"	"unprognostic (4.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (9.61e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	24.2	12.0	9.4	12.1	10.5	14.5	11.2	17.8	16.5	11.9	10.1	13.2	9.0	13.5	14.4	10.6	5.9	11.7	10.9	12.0	8.8	7.7	9.3	6.8	13.6	10.3	10.4	9.2	9.6	17.5	4.9	14.4	9.6	12.7	11.8	4.2	12.3	14.1	11.6	11.9	11.5	10.1	8.1	9.5	25.0	12.4	10.2	8.6	9.0	11.2	4.4	11.8	10.6	10.3	5.7	21.0	16.4	3.5	37.4	30.2	6.7	3.9	4.0	2.5	4.5	3.7	2.7	12.7	7.2	3.4	3.1	4.3	4.5	1.5	3.5	13.6	3.2	6.8	3.2	1.6	1.9	0.9	4.6	8.5	2.4	3.5	5.0	1.7	8.0	26.2	3.7	1.2	2.8	0.3	3.2	3.2	5.9	6.2	12.7	1.4	3.6	8.4	27.1	8.5	1.2	7.3	3.1	3.3	18.3	1.5	2.1	3.0	12.5	3.5	2.6	1.8	2.5	3.3	10.2	5.4	4.6	12.0	9.0	6.3	38.6	14.9	1.6	3.7	4.1	7.9	15.5	3.5	16.4	30.2	2.8	18.9	5.2	10.7	24.5	6.6	5.7	4.5	13.5	1.0	37.4	1.2	21.0	10.2	6.7	9.4	10.5	17.8	16.5	8.8	7.7	10.4	9.2	12.7	8.6	14.9	44.5	41.3	35.2	16.1	44.3	6.7	10.2	17.4	30.7	17.4	62.8	84.2	1.7	17.6	4.4	44.9	6.7	23.3	13.5	8.5	48.9	15.3	36.9	5.9	22.1	44.5	12.2	159.0	21.8	2.7	88.6	20.1	20.3	17.2	9.4	16.0	13.1	7.0	63.6	10.3	46.4	19.4	19.6	27.6	19.4	13.4	111.7	128.5	13.1	9.1
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524283-126543291	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 46.8;liver: 42.5"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 56.2;Hepatocytes: 33.7;Spermatocytes: 29.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 46.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 46.8"	"Group enriched"	"Detected in some"	8	"CACO-2: 12.5;Hep G2: 22.4;NB-4: 14.9;THP-1: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA067960			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA067960: "	"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.5	0.2	0.2	0.5	0.3	0.9	0.0	0.2	0.6	0.1	0.9	0.1	0.0	0.8	0.0	1.1	0.1	0.1	0.2	1.1	0.2	0.1	2.6	42.5	0.6	0.6	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.6	0.5	0.1	0.3	0.0	1.8	0.0	0.3	2.9	0.6	9.7	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	7.0	46.8	10.6	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	10.6	46.8	0.0	6.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	9.8	0.0	5.2	0.0	0.0	3.6	0.2	0.3	0.2	0.6	0.2	0.1	0.3	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	12.3	0.0	1.2	1.3	7.6	3.8	1.4	3.2	0.0	0.0	0.9	0.0	0.0	2.9	1.1	7.9	0.0	0.0	0.0	29.3	2.7	0.0	0.2	0.0	1.6	0.0
CHST14	"D4ST-1, D4ST1, HD4ST"	ENSG00000169105	"Carbohydrate sulfotransferase 14"	Q8NCH0	15	40470998-40474571	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 39.3;Extravillous trophoblasts: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057697, HPA071601"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA057697: AB_2683505, HPA071601: AB_2686425"	"unprognostic (5.46e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.25e-2)"	10.3	7.9	7.1	7.5	6.9	2.3	22.7	6.5	7.4	14.9	7.9	6.0	13.8	3.6	17.5	11.1	6.5	12.3	14.1	12.6	5.5	2.9	8.1	9.6	15.9	20.9	8.1	4.5	18.8	11.6	10.2	11.4	22.4	7.1	10.7	3.8	9.8	12.7	17.2	5.5	6.8	7.1	13.3	5.9	10.5	7.3	9.2	6.3	7.5	12.4	8.3	6.1	12.1	18.2	2.1	3.4	8.0	1.9	5.5	4.0	1.1	10.6	7.0	11.3	30.4	17.7	13.7	17.6	10.5	20.0	18.6	17.7	8.5	5.4	1.7	16.1	17.8	33.0	18.3	10.0	5.9	8.8	12.7	5.8	5.4	7.5	8.1	9.6	2.3	14.2	16.7	4.9	6.5	5.0	20.6	16.3	6.3	5.3	6.4	13.8	8.0	3.8	12.2	7.2	3.2	8.2	10.7	14.3	3.0	12.4	5.5	8.2	12.5	9.2	10.4	3.4	14.4	15.1	9.8	13.3	31.6	11.7	9.9	10.4	12.9	8.9	4.9	14.2	8.0	22.7	8.0	1.9	3.6	4.0	1.9	1.1	0.5	2.0	3.4	3.4	2.1	1.8	1.4	0.3	5.5	0.9	1.2	1.3	1.1	7.1	6.9	6.5	7.4	5.5	2.9	8.1	4.5	7.1	6.3	11.9	1.4	2.4	4.3	3.1	0.4	2.5	7.6	4.0	5.7	3.5	0.0	39.3	0.0	6.5	1.4	6.3	0.1	0.0	4.3	26.3	14.6	2.6	4.6	2.6	7.9	1.6	2.4	15.4	5.1	0.9	16.4	4.3	5.0	2.8	1.7	9.3	4.6	0.0	11.0	1.0	0.6	6.5	5.6	8.0	1.6	2.3	11.3	5.4	1.5	1.0
CHST15	"BRAG, GALNAC4S-6ST, KIAA0598"	ENSG00000182022	"Carbohydrate sulfotransferase 15"	Q7LFX5	10	124007666-124093607	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 49.7;Kupffer cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 29.4;monocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.6;REH: 36.3;U-266/70: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017584	Approved		Approved	Centrosome,Cytosol		NA	NA		560000	Cytosol	Centrosome	"HPA017584: AB_1849437"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.62e-3)"	"unprognostic (7.90e-2)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (6.47e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.63e-3)"	"unprognostic (5.26e-3)"	16.4	10.0	8.7	17.0	20.6	5.7	10.7	3.4	17.9	9.8	15.4	6.6	4.0	8.8	8.6	10.8	11.3	13.1	11.7	6.4	11.3	5.3	9.0	11.9	13.9	35.4	6.5	9.6	35.0	12.6	2.9	7.7	5.9	9.2	8.5	8.3	14.4	8.2	13.4	11.0	8.3	12.5	9.5	9.0	31.5	11.4	4.8	8.7	2.8	19.3	6.1	12.6	12.5	12.0	2.1	2.0	29.4	15.4	0.0	0.1	3.2	12.8	8.7	3.2	0.7	3.2	1.7	0.0	2.6	3.5	1.4	2.0	0.2	7.0	0.0	8.5	10.7	0.9	14.7	0.6	8.5	1.2	0.0	2.4	0.0	3.9	6.4	1.0	0.0	16.6	1.0	9.8	4.0	3.4	3.5	2.8	0.0	0.0	27.6	7.0	7.1	0.0	0.0	2.8	1.9	0.0	36.3	4.4	8.5	7.1	1.2	0.3	0.7	7.0	3.9	0.0	8.4	2.9	0.0	3.3	0.3	0.1	10.1	0.4	25.1	6.0	6.9	0.1	0.0	0.0	0.0	8.8	6.2	0.0	14.0	0.0	2.0	0.0	0.0	1.8	2.1	0.1	0.0	29.4	0.0	15.4	2.0	0.1	3.2	8.7	20.6	3.4	17.9	11.3	5.3	6.5	9.6	9.2	8.7	20.8	11.1	9.7	14.5	14.9	4.4	2.2	7.6	9.4	9.1	19.2	0.0	1.5	0.0	8.2	24.2	10.8	0.0	0.0	0.6	1.9	2.7	14.0	5.7	6.4	9.4	0.0	1.7	49.7	47.8	27.7	9.5	23.2	1.7	1.8	0.0	0.1	5.9	0.0	1.8	0.3	0.3	19.4	11.3	8.4	9.2	10.2	0.8	2.2	0.0	15.2
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119331-143124014	"Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.9"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 106.5;Sertoli cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	4	"monocytes: 11.4;NK-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 20.5;ASC TERT1: 21.0;HEL: 16.2;HHSteC: 42.2;HMC-1: 19.4;HSkMC: 22.1;U-266/70: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: AB_2668861"	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	6.5	2.6	8.2	11.6	16.6	20.0	4.1	9.8	15.1	4.6	3.1	6.5	2.6	3.6	6.4	2.7	2.0	1.6	3.1	2.6	7.3	10.4	4.8	1.6	5.1	10.2	10.6	5.8	3.6	2.0	1.5	5.5	15.3	14.0	7.6	2.3	5.9	4.0	15.9	2.7	3.0	4.9	6.0	32.9	17.0	5.4	2.3	4.8	24.7	5.4	0.1	8.1	7.4	5.4	1.4	1.8	0.8	11.4	4.8	0.8	0.9	0.0	0.1	1.0	0.9	20.5	21.0	0.0	1.1	3.2	0.8	0.7	0.0	0.0	0.2	0.7	0.7	1.1	0.0	0.7	2.7	0.4	0.2	0.5	16.2	0.0	0.0	42.2	0.4	19.4	22.1	3.4	1.0	3.5	1.2	1.2	2.5	1.8	1.0	5.3	0.0	3.0	4.1	5.8	0.0	2.7	0.1	0.3	0.0	0.6	0.7	1.3	0.0	0.2	0.0	1.8	1.0	0.0	0.6	4.2	2.5	1.4	3.3	4.7	18.6	0.2	1.1	4.8	3.1	12.8	0.7	0.6	0.8	0.4	4.5	0.0	1.4	0.1	0.2	1.8	1.0	0.8	0.6	0.3	4.8	11.4	0.1	0.5	0.9	8.2	16.6	9.8	15.1	7.3	10.4	10.6	5.8	14.0	4.8	0.0	0.0	14.2	7.0	2.2	20.1	1.2	0.0	0.0	2.3	3.5	2.0	0.4	0.0	0.3	0.1	6.4	0.0	23.3	0.2	0.3	7.1	9.4	11.5	0.0	2.8	1.6	0.0	4.3	6.4	0.4	11.8	13.0	16.9	9.0	0.0	106.5	3.5	0.0	2.1	0.0	19.2	90.5	5.5	0.0	1.9	0.5	0.8	8.7	0.0	15.6
CHST3	"C6ST, C6ST1"	ENSG00000122863	"Carbohydrate sulfotransferase 3"	Q7LGC8	10	71964365-72013564	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 14.7;Leydig cells: 19.0;Peritubular cells: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 28.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047523, HPA055704"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		510000	"Golgi apparatus, Cytosol"		"HPA047523: AB_2680075, HPA055704: AB_2682891"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.54e-3)"	22.2	11.6	9.2	7.0	19.4	0.7	12.0	2.9	11.6	10.4	9.0	19.4	4.8	1.7	13.7	7.4	8.4	13.6	6.2	11.9	11.3	5.1	8.6	1.8	6.3	2.2	30.1	5.5	25.0	6.1	1.9	4.0	10.0	15.6	10.7	3.3	5.7	6.3	19.5	13.6	7.1	4.0	21.0	16.2	2.9	11.6	19.4	25.2	0.5	7.3	4.8	2.2	7.5	18.5	0.2	0.3	0.8	0.1	0.1	0.2	0.0	6.8	7.4	3.8	9.3	17.3	6.8	0.1	14.5	13.9	8.9	6.0	6.4	13.7	0.0	10.0	17.0	7.2	8.9	3.3	9.9	7.2	0.2	2.5	0.0	12.8	6.1	8.8	0.0	0.0	9.4	11.5	8.8	12.1	17.4	2.6	0.3	2.0	0.0	9.4	0.2	0.0	0.0	1.6	0.2	2.4	0.0	4.6	0.0	12.6	7.0	0.2	3.8	11.0	0.2	10.6	4.8	0.8	1.4	5.4	11.0	12.7	18.3	28.8	0.0	0.0	0.0	8.0	0.0	7.7	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.8	0.1	0.0	0.3	0.1	0.0	9.2	19.4	2.9	11.6	11.3	5.1	30.1	5.5	15.6	25.2	0.0	3.4	0.0	4.0	2.5	0.0	8.9	5.1	1.4	3.4	7.0	0.0	3.5	3.3	8.2	0.4	3.6	0.0	0.0	2.4	2.2	5.7	3.7	1.1	0.0	0.7	0.0	0.0	14.7	0.6	2.1	19.0	0.4	8.5	1.0	0.0	6.6	7.7	0.0	20.5	2.8	0.0	6.5	9.6	0.5	0.7	2.0	0.9	0.0	0.0	1.4
CHST7	"C6ST-2, C6ST2"	ENSG00000147119	"Carbohydrate sulfotransferase 7"	Q9NS84	X	46573784-46598408	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 91.0;Peritubular cells: 56.6;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 15.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 18.0;HHSteC: 13.4;NTERA-2: 16.1;PC-3: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003919, HPA030503"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA003919: AB_10601258, HPA030503: "	"unprognostic (3.16e-1)"	"prognostic favorable (7.20e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.39e-2)"	13.1	7.5	4.9	3.8	6.6	4.7	12.1	4.7	10.3	10.5	4.4	3.6	2.5	2.2	5.0	4.1	4.2	3.2	10.7	25.6	4.1	4.0	3.6	11.0	5.4	3.7	4.5	4.7	27.0	3.4	2.4	3.4	5.9	3.6	3.9	2.2	1.4	2.7	3.7	4.3	5.4	3.3	3.5	1.9	17.1	3.4	3.6	1.8	2.4	4.2	1.4	2.0	4.1	8.7	1.0	1.0	9.4	8.0	0.4	15.4	1.6	4.1	3.5	3.0	2.7	8.6	6.0	0.1	5.8	4.2	1.5	2.1	0.9	1.6	0.0	18.0	2.4	1.0	3.1	2.9	1.0	1.3	2.4	6.3	0.8	0.3	3.1	13.4	1.4	0.1	2.1	0.9	2.9	2.4	2.7	4.8	1.9	0.0	3.7	1.1	1.9	0.5	1.8	16.1	0.3	13.4	2.7	2.5	7.5	4.2	0.1	6.9	2.7	0.8	0.2	0.7	7.9	1.0	0.3	1.1	4.9	0.5	2.6	2.7	8.7	1.8	1.3	5.4	0.0	0.3	1.2	1.9	0.6	1.4	5.9	1.3	1.0	5.3	2.5	1.0	0.6	1.1	1.0	9.4	0.4	8.0	0.6	15.4	1.6	4.9	6.6	4.7	10.3	4.1	4.0	4.5	4.7	3.6	1.8	0.0	1.9	3.7	1.7	11.0	0.8	5.5	5.1	1.4	1.2	1.8	0.0	3.4	1.7	2.2	0.0	9.8	1.0	0.0	2.2	3.5	12.2	3.3	0.0	2.9	10.3	3.2	0.0	17.2	8.6	0.0	17.5	7.9	13.5	91.0	2.3	3.8	1.9	1.1	56.6	1.1	0.7	51.8	10.3	0.5	1.2	11.5	1.1	7.5	0.7	1.4
CHURC1	"C14orf52, FLJ33064, My015"	ENSG00000258289	"Churchill domain containing 1"	Q8WUH1	14	64914361-64944591	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040072	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA040072: AB_10963788"	"unprognostic (2.94e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (6.78e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	31.8	32.7	25.9	25.5	31.8	25.5	27.6	15.7	36.6	31.1	30.0	31.4	25.8	20.8	28.5	27.3	28.5	22.5	22.7	45.5	23.9	23.2	29.3	36.5	21.0	30.0	29.2	23.7	32.1	27.1	25.5	34.8	24.6	35.4	26.7	25.5	21.5	20.8	28.7	53.4	22.5	28.3	34.8	36.9	33.0	27.4	19.5	26.8	40.7	25.0	29.6	28.6	32.8	23.6	41.6	41.8	80.6	37.1	31.3	62.3	35.3	39.3	21.0	20.1	15.6	26.0	27.9	24.0	29.4	25.9	16.5	18.9	11.6	25.9	24.2	20.1	25.1	26.0	29.1	17.7	23.8	18.2	26.2	8.8	23.0	16.8	26.1	23.8	12.9	23.0	33.2	18.1	14.9	29.0	27.7	17.8	36.3	10.1	21.2	20.3	32.9	24.1	21.5	11.1	47.0	34.8	21.4	22.2	14.3	23.4	28.4	10.6	12.7	20.2	22.2	28.8	19.5	35.9	27.3	22.7	15.2	30.0	16.6	18.7	18.0	15.7	53.4	16.7	15.3	18.2	41.4	37.1	38.2	32.6	36.6	37.1	41.6	49.3	38.4	28.8	36.6	49.5	41.1	80.6	31.3	35.2	41.8	62.3	35.3	25.9	31.8	15.7	36.6	23.9	23.2	29.2	23.7	35.4	26.8	95.3	71.3	115.0	55.3	52.0	67.3	50.2	86.6	136.5	67.1	94.2	41.2	80.9	111.0	137.5	37.7	93.1	93.8	70.0	194.1	73.0	73.0	53.0	92.5	165.4	79.3	50.9	86.2	108.1	188.2	17.2	96.4	111.9	79.2	226.4	95.1	142.7	189.7	95.1	114.2	134.8	70.2	129.4	127.4	95.6	74.2	57.6	75.1	104.4	111.3	60.7
CIAO1	"CIA1, WDR39"	ENSG00000144021	"Cytosolic iron-sulfur assembly component 1"	O76071	2	96266132-96273349	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017882	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA017882: AB_1846738"	"unprognostic (2.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.15e-2)"	19.8	39.7	23.6	22.2	27.6	11.1	21.4	17.9	31.9	22.1	18.4	19.9	22.3	20.4	19.4	16.5	24.0	22.3	18.3	26.1	18.3	18.2	25.4	32.5	17.7	17.7	19.2	22.7	20.4	22.2	30.6	17.8	22.2	24.5	16.4	21.1	19.2	22.0	23.5	26.1	16.3	18.5	21.5	19.7	21.8	19.3	19.1	19.0	21.6	19.4	12.2	26.0	19.9	16.9	29.6	39.8	33.1	39.7	25.9	35.2	38.5	20.8	21.0	16.0	14.8	20.6	16.7	26.1	16.1	17.1	26.0	25.7	35.7	15.5	22.1	34.2	19.9	27.8	16.0	24.6	23.8	18.8	11.7	40.6	17.0	15.6	38.6	13.3	19.7	15.5	16.7	19.1	21.6	27.1	15.8	29.0	18.5	21.7	15.1	17.6	33.1	19.6	18.5	22.4	20.7	42.6	19.8	14.1	25.6	17.1	19.6	17.2	19.7	10.0	27.4	19.2	20.8	13.7	14.5	14.9	16.3	23.2	19.3	21.3	20.7	21.8	19.6	21.1	19.2	15.9	30.6	35.3	33.1	32.7	29.3	35.2	25.3	28.7	34.9	39.8	29.6	28.5	34.2	32.4	25.9	39.7	24.0	27.6	38.5	23.6	27.6	17.9	31.9	18.3	18.2	19.2	22.7	24.5	19.0	26.8	26.1	20.5	22.6	25.8	22.9	22.2	15.3	44.2	28.4	14.0	13.7	47.9	33.2	34.2	15.1	24.5	20.7	0.0	29.2	49.0	27.1	21.4	34.8	26.0	40.8	25.4	15.1	16.0	26.9	18.2	18.7	27.5	18.6	45.1	16.9	17.9	30.2	11.5	15.6	66.2	22.6	32.3	23.1	34.8	37.9	30.2	41.6	30.4	20.6	36.3
CIART	"BC017397, C1orf51"	ENSG00000159208	"Circadian associated repressor of transcription"	Q8N365	1	150282543-150287093	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Bipolar cells: 40.0;Cone photoreceptor cells: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.4;memory CD4 T-cell: 3.8;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	38	"T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.2;Karpas-707: 23.6;U-266/84: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027515, HPA054349"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027515: AB_10600757, HPA054349: AB_2682457"	"unprognostic (1.77e-1)"	"unprognostic (5.63e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.42e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.34e-2)"	4.8	10.0	6.9	2.9	18.4	0.6	6.7	14.2	26.5	9.1	11.8	6.3	11.1	3.0	7.4	8.2	7.3	6.2	4.0	23.5	5.4	7.1	8.3	11.5	3.0	2.1	4.9	5.8	11.5	4.4	7.5	10.6	2.6	8.4	7.2	2.8	20.5	14.2	21.1	40.2	19.7	4.9	12.9	3.1	2.4	7.3	6.3	4.2	0.8	16.1	19.6	6.5	10.3	5.2	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.1	0.6	4.8	2.2	1.8	0.8	4.1	2.9	7.1	3.8	5.0	1.1	16.2	0.0	5.0	6.2	8.6	2.8	0.1	2.8	5.7	0.0	0.4	0.1	0.2	0.0	6.5	0.9	2.4	2.5	4.3	9.6	2.0	8.9	0.6	0.1	0.1	23.6	2.1	12.5	0.0	0.5	5.3	2.8	11.9	0.6	0.0	0.1	3.8	0.6	2.5	0.9	4.8	0.4	8.6	1.2	4.1	0.4	1.2	10.8	0.1	0.4	6.3	5.0	16.8	0.1	9.7	0.0	6.4	0.0	0.0	0.0	0.5	0.0	3.4	0.0	3.8	0.0	0.0	0.0	2.4	1.2	0.0	0.0	0.0	0.0	0.3	0.3	6.9	18.4	14.2	26.5	5.4	7.1	4.9	5.8	8.4	4.2	0.0	1.0	0.0	5.3	0.0	40.0	5.6	5.1	1.4	2.3	0.0	96.2	0.2	8.3	2.5	0.2	1.1	1.3	0.0	1.3	0.1	0.0	3.5	0.0	3.0	1.0	6.4	2.4	0.6	0.0	1.1	4.9	0.3	0.0	1.8	0.3	18.4	3.1	0.3	8.9	2.6	18.0	0.0	2.9	4.3	7.9	0.0	0.0	0.0	0.6	1.0
CIB3	KIP3	ENSG00000141977	"Calcium and integrin binding family member 3"	Q96Q77	19	16161368-16173525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"blood: 5.4;bone marrow: 4.8;testis: 3.8"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 22.7;Late spermatids: 6.6"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"eosinophil: 5.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.2;MCF7: 4.4;NB-4: 2.8;THP-1: 2.6;U-937: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043553, HPA043995"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043553: AB_10964566, HPA043995: "	"unprognostic (8.43e-2)"	"unprognostic (7.26e-5)"		"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.14e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.05e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.8	0.0	4.8	0.7	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	3.8			0.0		0.7	0.1	0.0	0.1	0.6	5.4	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	9.2	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	2.8	0.4	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	4.1	0.0	1.9	0.1	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.1	0.4	0.0	0.1											0.0	0.0	1.5	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.0
CIC	KIAA0306	ENSG00000079432	"Capicua transcriptional repressor"	Q96RK0	19	42268537-42295797	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026388, HPA044341, HPA064725"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB026388: , HPA044341: AB_2678901, HPA064725: AB_2685335"	"unprognostic (2.02e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.54e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.72e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.56e-1)"	18.6	15.7	30.5	22.8	29.9	28.1	20.3	46.8	31.6	17.5	14.7	24.7	13.0	16.5	28.6	12.3	12.3	22.1	17.4	12.1	25.5	15.2	14.9	15.1	15.8	21.5	25.2	20.1	31.5	22.6	16.6	22.6	13.2	20.4	14.4	6.2	19.0	23.8	20.8	21.0	34.1	16.1	16.3	16.5	24.7	14.5	31.5	25.6	13.6	16.8	10.6	13.4	13.6	17.4	2.3	2.0	5.0	2.6	0.6	2.5	1.6	17.7	32.1	12.4	17.0	8.0	15.2	6.1	13.6	11.3	11.5	10.6	9.1	11.0	12.3	12.9	10.7	9.5	8.7	6.9	20.5	3.7	29.9	9.3	10.4	20.3	10.8	10.1	5.8	29.5	18.0	12.1	13.0	7.6	12.1	10.5	7.8	10.1	26.0	6.4	16.9	11.5	11.2	7.7	5.7	18.3	9.9	10.5	7.4	9.6	16.7	16.0	13.1	12.8	8.1	10.1	4.1	9.5	12.5	20.0	27.5	22.3	9.4	16.5	21.6	14.8	8.4	21.3	9.2	16.2	3.4	1.8	1.0	2.5	2.6	1.9	1.7	1.3	1.6	1.7	2.3	0.9	1.5	5.0	0.6	1.9	2.0	0.5	1.6	30.5	29.9	46.8	31.6	25.5	15.2	25.2	20.1	20.4	25.6	0.0	4.0	8.0	14.4	23.0	32.4	5.6	22.9	2.7	1.2	8.7	19.6	5.9	3.3	11.2	3.5	17.5	10.7	0.0	13.1	4.3	11.3	8.6	11.5	17.4	10.3	39.7	14.3	12.3	18.4	2.5	20.1	10.7	23.6	10.8	9.4	17.4	13.4	10.5	17.0	5.0	18.3	25.8	13.7	10.2	22.9	16.9	10.9	11.7	8.4	9.8
CIP2A	KIAA1524	ENSG00000163507	"Cell proliferation regulating inhibitor of protein phosphatase 2A"	Q8TCG1	3	108549869-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.5"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 8.9;Exocrine glandular cells: 6.4;Extravillous trophoblasts: 10.7;Hofbauer cells: 6.7;monocytes: 5.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes			Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	2.1	2.3	2.5	8.5	6.3	10.4	3.6	6.3	6.2	3.2	3.1	2.6	0.8	2.0	3.2	1.8	4.0	1.8	2.0	2.7	2.9	2.1	2.2	1.6	2.2	10.2	2.0	3.2	3.8	1.8	1.8	3.0	3.3	2.4	3.0	4.4	2.2	2.3	1.4	2.0	1.9	2.7	2.5	2.4	5.5	2.0	8.5	1.5	21.5	1.9	1.5	8.0	4.0	2.7	1.9	0.3	0.7	1.1	0.0	1.6	0.6	18.9	5.6	15.9	10.2	0.7	1.5	6.5	14.4	6.8	17.1	20.1	6.8	8.5	12.8	5.0	5.2	13.0	9.7	5.4	5.1	31.2	4.0	5.3	15.3	7.8	5.1	0.2	9.8	11.0	0.6	1.0	13.3	5.5	2.8	7.6	5.9	9.4	20.7	16.7	3.9	11.8	8.8	16.4	7.1	9.8	13.6	14.8	7.0	5.2	5.3	7.7	10.2	10.6	4.2	5.9	9.7	7.1	7.0	5.5	17.6	19.9	5.3	17.3	4.8	5.3	21.2	7.8	10.7	17.9	0.6	0.3	0.7	0.0	0.5	1.3	1.2	0.7	0.3	0.0	1.9	0.7	1.6	0.0	0.0	1.1	0.3	0.8	0.6	2.5	6.3	6.3	6.2	2.9	2.1	2.0	3.2	2.4	1.5	8.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.5	3.5	0.0	2.5	1.7	2.4	0.0	0.0	0.0	0.0	6.4	10.7	0.0	0.0	3.5	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0
CIPC	KIAA1737	ENSG00000198894	"CLOCK interacting pacemaker"	Q9C0C6	14	77098097-77117287	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.7"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA000644			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA000644: AB_1079206"	"unprognostic (3.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.77e-10)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-1)"	8.9	7.3	20.8	5.9	20.7	3.1	11.4	29.0	24.2	12.8	14.1	27.9	9.9	7.5	10.7	10.0	15.5	21.2	6.7	26.1	21.6	17.5	10.4	10.9	7.9	5.8	22.2	14.9	7.1	7.1	15.8	9.4	6.6	20.5	18.3	14.1	10.6	13.3	18.2	77.7	8.6	7.9	11.8	21.6	6.3	7.1	8.0	23.4	3.4	14.4	13.1	7.1	11.4	8.8	11.4	7.2	7.7	6.7	7.6	5.8	4.2	6.2	8.3	17.6	11.8	7.2	5.7	10.9	4.2	6.5	7.4	6.8	6.6	13.4	15.3	4.0	6.6	6.9	9.5	16.4	6.3	10.2	7.9	4.4	10.2	6.3	6.1	6.8	5.6	7.5	6.6	12.6	7.3	4.6	10.0	8.6	12.4	8.8	6.2	5.6	13.5	13.2	6.8	7.4	14.3	7.2	13.3	7.7	9.2	7.6	10.5	25.1	9.3	7.4	12.1	9.7	7.8	18.9	5.7	10.3	4.9	10.5	6.9	5.0	5.5	3.8	7.4	9.3	4.8	10.3	5.8	5.8	2.1	3.7	6.7	5.8	11.4	5.2	3.9	7.2	9.4	5.6	3.9	7.7	7.6	4.8	2.7	5.3	4.2	20.8	20.7	29.0	22.4	21.6	17.5	22.2	14.9	20.5	23.4	14.9	13.6	0.8	7.0	8.0	24.6	44.8	7.6	14.7	14.8	10.4	55.0	5.6	8.3	4.2	8.7	5.8	18.6	0.0	4.7	3.7	6.0	7.5	1.1	23.6	12.8	11.1	16.7	6.7	14.3	9.9	3.7	5.8	8.5	3.6	15.6	18.9	3.9	10.5	13.4	4.9	36.3	12.9	9.5	14.9	6.1	8.5	11.3	3.9	9.5	5.8
CISH	"CIS, CIS-1, G18, SOCS"	ENSG00000114737	"Cytokine inducible SH2 containing protein"	Q9NSE2	3	50606490-50611831	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 49.7;Proximal tubular cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 82.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB034039, HPA040812"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			Microtubules	"Cytokinetic bridge"	"CAB034039: AB_2080282, HPA040812: AB_2677148"	"unprognostic (2.36e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (8.54e-2)"	"unprognostic (9.38e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (6.97e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (2.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	11.8	2.8	0.8	9.7	1.9	3.7	38.0	0.6	1.1	5.2	7.5	0.7	15.6	5.9	6.8	5.9	7.4	4.5	6.4	20.8	1.3	1.0	26.1	36.2	20.5	6.4	1.2	0.2	10.6	11.3	1.9	8.6	47.6	3.8	5.6	5.3	2.8	18.4	19.6	54.0	7.0	6.3	2.8	3.5	7.6	5.5	2.5	1.4	13.8	31.3	7.1	7.0	5.9	5.4	0.4	2.8	7.3	4.0	0.8	23.3	8.1	0.6	0.2	0.7	1.5	0.1	0.9	0.6	0.1	0.1	0.1	0.1	0.6	0.1	0.0	0.5	0.2	0.3	0.7	1.2	1.0	0.0	82.0	0.2	4.9	0.4	0.6	0.5	0.6	6.0	3.9	0.4	0.1	0.3	0.0	0.1	0.5	19.3	0.1	0.1	3.7	1.0	4.4	0.7	2.2	0.7	0.4	0.3	5.0	1.6	0.7	0.4	1.2	0.2	10.0	0.1	0.2	5.6	4.0	0.1	0.2	0.6	0.7	0.3	0.1	0.1	0.0	0.1	5.9	0.1	7.3	4.0	5.3	14.3	2.4	22.2	0.4	23.3	17.8	2.8	0.1	18.3	17.5	3.5	0.8	1.5	1.8	13.9	8.1	0.8	1.9	0.6	1.1	1.3	1.0	1.2	0.2	3.8	1.4	3.0	29.7	0.0	7.1	7.1	0.5	10.9	0.0	1.4	11.4	17.4	0.0	7.6	49.7	10.0	0.8	3.0	5.8	0.0	14.1	3.8	6.1	2.7	1.1	6.0	11.2	0.0	2.4	2.5	13.2	0.2	7.8	18.8	1.7	23.4	8.4	0.0	10.1	7.0	3.5	40.0	0.1	12.9	5.1	0.5	1.4	7.9	13.3	20.1	12.3	4.2
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685790-119877291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;brain: 35.0"	"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 82.5;Early spermatids: 63.4;Late spermatids: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752"	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	1.4	4.4	14.7	3.3	14.0	15.3	1.6	12.7	35.0	1.6	4.6	2.9	0.0	4.0	1.3	1.5	3.2	0.9	1.6	1.0	9.8	5.7	5.7	1.4	3.0	3.4	3.2	21.9	0.7	0.7	1.2	2.9	2.6	7.4	1.0	5.3	0.6	1.3	1.0	1.3	5.1	3.5	2.6	5.0	5.6	3.5	8.3	9.5	5.9	1.5	0.1	4.9	1.7	1.7	0.4	0.0	0.0	0.1	0.0	1.2	0.8	15.1	13.7	12.0	11.3	1.1	3.3	7.1	11.7	9.7	12.2	9.2	8.7	6.3	11.0	6.3	9.0	6.0	9.5	8.2	6.8	16.9	7.8	6.0	13.9	8.8	5.4	0.1	7.3	12.8	0.7	0.8	14.6	9.0	4.4	9.3	12.2	8.8	9.3	11.5	7.6	13.2	11.1	6.5	5.7	9.3	12.1	21.9	3.6	2.4	6.7	8.6	4.7	19.4	3.8	9.2	6.3	13.7	5.3	7.1	15.3	14.1	10.4	12.7	6.3	7.1	7.5	10.1	8.1	23.6	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	14.7	14.0	12.7	35.0	9.8	5.7	3.2	21.9	7.4	9.5	6.0	8.8	0.8	0.6	3.0	7.4	1.6	0.0	1.4	9.1	8.7	82.5	0.9	0.0	0.2	63.4	1.1	0.4	0.0	0.7	4.0	1.1	0.3	1.1	0.8	2.9	0.0	1.7	1.3	1.9	28.5	1.1	1.0	3.3	0.0	1.1	15.4	0.1	0.0	1.1	5.7	15.0	0.0	0.4	11.5	3.5	1.1	0.8	2.5	1.6	1.0
CITED4		ENSG00000179862	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4"	Q96RK1	1	40861051-40862366	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 152.3;Cholangiocytes: 76.5;Urothelial cells: 122.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 25.8;THP-1: 74.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA056434	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA056434: AB_2683132"	"unprognostic (5.39e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.38e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.13e-2)"	17.3	10.1	2.9	2.5	5.2	21.5	22.1	3.2	9.4	18.3	12.3	8.0	13.8	3.0	11.3	14.4	14.9	7.1	15.7	10.4	2.4	5.5	12.9	27.8	8.6	4.8	5.5	2.8	12.2	39.4	4.0	2.3	12.9	6.0	11.0	1.5	26.1	15.9	19.1	37.1	22.6	3.7	8.0	2.7	33.4	7.4	12.3	2.7	1.5	8.1	16.0	11.4	8.5	10.1	0.0	1.3	2.2	1.0	0.0	1.5	0.4	8.1	1.6	0.4	9.9	0.2	0.4	10.0	0.5	0.6	0.2	0.2	0.8	11.0	0.0	1.3	0.1	0.3	12.5	0.6	6.8	0.2	0.0	0.1	0.0	0.8	1.3	1.7	0.2	0.1	1.2	2.9	0.6	2.2	0.8	0.5	0.1	0.0	0.0	0.3	0.2	0.1	5.4	3.2	0.2	1.1	0.0	0.0	0.0	25.8	4.7	1.9	0.5	0.4	10.3	0.5	1.1	5.0	74.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	3.8	0.2	0.0	1.0	0.4	0.1	0.5	0.3	0.0	0.3	0.0	1.3	0.0	1.1	1.5	2.2	0.0	0.3	0.0	0.0	0.4	2.9	5.2	3.2	9.4	2.4	5.5	5.5	2.8	6.0	2.7	8.9	0.6	0.5	152.3	16.9	3.5	9.0	76.5	4.0	4.5	21.0	0.0	0.5	36.5	11.8	34.8	3.8	0.5	0.0	37.1	0.8	3.1	48.3	0.0	28.7	1.1	1.6	7.5	3.7	7.1	46.4	4.6	2.2	18.6	1.0	3.1	41.7	27.0	3.1	5.3	65.0	1.9	19.4	3.9	0.5	0.6	21.2	0.1	0.0	2.1	122.5
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 140.2;Spermatocytes: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA008410, HPA027821"	Enhanced		Enhanced	Microtubules,Cytosol		No	Yes			Microtubules	Cytosol	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	4.6	9.2	7.1	12.1	12.2	42.3	4.4	16.4	9.9	4.3	6.7	1.9	2.3	9.0	4.2	5.2	14.7	3.0	4.1	5.3	5.8	7.8	5.0	3.2	5.0	13.5	5.9	5.8	3.5	2.4	3.4	10.9	10.2	16.1	4.6	7.4	1.4	6.7	3.6	5.8	10.4	7.0	6.5	5.5	12.4	4.2	22.1	5.2	49.2	5.0	10.3	14.8	8.1	6.6	15.2	16.1	30.4	12.8	2.5	15.7	4.2	19.5	10.6	42.5	21.0	5.5	5.5	10.7	32.3	19.1	37.7	24.3	15.2	24.8	37.6	5.2	24.0	17.6	23.0	29.2	16.4	52.6	25.4	24.1	33.9	11.9	10.8	2.3	33.6	13.8	4.0	6.8	17.6	23.2	11.2	22.8	16.1	14.2	15.6	41.5	9.2	23.1	16.6	25.1	30.5	11.2	22.2	24.4	16.4	11.5	10.7	13.0	16.9	18.2	13.4	9.9	22.5	14.7	16.2	15.0	10.9	16.8	17.0	32.3	9.2	13.5	46.3	7.6	17.6	28.7	30.4	7.2	10.4	5.4	10.4	4.8	12.2	8.2	6.4	7.5	15.2	6.5	5.5	2.2	2.5	12.8	16.1	15.7	4.2	7.1	12.2	16.4	9.9	5.8	7.8	5.9	5.8	16.1	5.2	6.0	3.2	36.9	3.9	13.4	9.9	7.3	0.0	2.7	9.1	1.8	5.9	24.3	8.3	5.2	32.6	9.8	4.5	140.2	5.2	34.8	11.3	2.6	16.1	4.3	26.4	1.6	6.9	16.5	20.7	39.9	6.9	16.4	0.0	14.4	7.9	12.3	2.8	3.5	15.9	6.7	5.8	6.5	6.2	150.2	65.4	13.4	8.4	11.7	11.3	2.4
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736607-112764677	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;lymphoid tissue: 38.3"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 8.9;Spermatocytes: 31.7;Spermatogonia: 32.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	1.5	0.7	0.6	9.2	0.6	13.4	1.3	0.7	0.6	0.6	1.8	0.0	0.3	1.5	0.5	1.4	3.8	0.7	0.1	2.3	0.6	0.5	0.7	0.7	1.2	5.3	0.6	0.2	0.6	0.6	0.0	0.5	3.2	0.2	0.6	2.4	0.0	1.0	0.0	0.6	1.5	2.4	0.9	0.6	2.2	0.9	9.0	0.1	38.3	0.6	5.9	6.0	0.9	0.7	1.0	0.8	1.8	0.7	1.6	1.8	0.4	20.1	4.0	15.9	7.2	0.9	1.5	3.2	16.7	13.9	17.4	16.6	3.8	5.9	13.8	6.9	6.5	21.7	7.8	9.1	8.8	29.3	19.2	4.0	23.0	5.6	3.2	0.0	10.8	13.8	0.4	0.8	21.8	12.4	4.5	7.9	10.1	6.1	20.2	14.1	2.9	13.1	4.1	6.8	8.6	13.2	9.5	16.7	3.6	2.9	7.9	8.8	5.5	6.8	5.6	5.8	6.2	5.5	5.0	5.6	19.3	15.0	15.3	12.2	4.3	8.4	11.8	8.3	7.8	30.2	0.8	0.5	0.7	0.5	0.7	0.4	0.9	1.2	1.1	0.5	1.0	0.5	0.7	1.8	1.6	0.7	0.8	1.8	0.4	0.6	0.6	0.7	0.6	0.6	0.5	0.6	0.2	0.2	0.1	3.0	1.1	0.8	1.6	3.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.5	1.5	0.0	0.0	0.0	0.3	8.9	0.4	0.3	0.0	0.0	5.4	0.0	0.0	1.8	2.1	0.8	0.0	1.4	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	31.7	32.2	1.5	0.8	1.5	1.0	0.9
CKLF	"C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1"	ENSG00000217555	"Chemokine like factor"	Q9UBR5	16	66552563-66566251	"Predicted membrane proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.0"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 334.0;Macrophages: 289.2;Spermatocytes: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 142.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA062779			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA062779: AB_2684867"	"unprognostic (1.64e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.06e-9)"	"unprognostic (2.36e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.07e-1)"	18.8	21.1	16.1	27.7	16.9	29.9	18.8	19.0	14.9	14.8	20.6	11.0	9.1	15.7	14.8	15.2	12.5	16.4	22.8	11.0	14.9	13.4	15.0	14.6	28.9	41.2	23.1	11.0	14.5	12.0	11.4	13.5	14.6	15.0	14.6	22.0	10.9	13.0	9.7	6.8	9.0	26.5	16.9	20.8	44.4	12.2	42.5	18.6	40.2	12.3	11.7	24.6	17.6	13.0	9.4	32.2	142.0	39.6	17.7	25.6	34.2	35.7	31.9	6.7	19.3	18.1	14.8	4.9	17.9	13.6	19.6	29.3	29.7	43.9	14.1	22.7	15.3	20.5	19.3	13.3	10.7	27.6	17.4	6.7	10.3	28.4	36.3	10.9	32.0	27.8	10.1	8.7	24.4	8.7	23.5	23.3	43.6	16.4	40.7	24.4	11.9	30.9	31.8	2.2	21.1	51.8	53.1	35.4	39.2	65.4	19.9	9.4	11.4	54.8	3.6	16.6	4.7	10.6	21.7	14.2	28.4	25.7	9.8	21.0	19.3	39.7	71.8	23.9	28.2	22.9	64.6	39.6	74.8	20.6	19.8	25.6	9.4	19.2	20.0	32.2	8.8	10.2	14.1	142.0	17.7	18.6	16.3	22.9	34.2	16.1	16.9	19.0	14.9	14.9	13.4	23.1	11.0	15.0	18.6	17.9	66.2	46.2	20.8	24.3	8.2	0.8	101.9	65.6	35.2	54.1	0.0	40.5	14.9	120.7	24.7	44.8	58.0	23.3	113.2	92.3	41.3	13.1	334.0	34.2	227.1	1.6	31.7	66.9	154.7	20.5	45.8	289.2	38.8	30.7	61.5	19.0	153.7	40.3	28.3	75.1	6.4	32.3	33.5	349.8	69.4	20.1	14.5	215.8	65.0	23.3
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979249	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 303.7;Extravillous trophoblasts: 535.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.37e-1)"	25.3	14.5	13.5	13.4	19.0	36.4	24.8	4.2	14.6	15.6	17.4	12.4	19.8	14.7	14.7	13.8	28.2	15.2	14.1	16.5	15.3	8.0	16.6	29.5	12.9	23.8	29.5	8.8	14.2	12.8	8.3	9.4	35.6	15.9	11.7	18.8	7.5	12.8	13.1	5.9	22.6	22.9	12.5	19.8	18.0	14.7	22.8	21.5	30.2	15.5	19.3	25.5	11.1	23.3	23.9	30.4	2.2	32.8	9.0	12.2	8.7	59.7	82.4	61.8	33.5	8.9	9.2	49.4	27.8	21.6	60.4	48.4	79.6	88.4	56.9	47.6	18.4	33.9	55.5	61.2	39.9	56.8	51.1	39.7	38.5	36.7	55.9	2.7	46.3	35.4	5.3	17.3	51.6	71.6	12.4	30.3	39.5	62.5	77.4	45.4	59.4	43.4	35.8	78.4	57.4	74.4	43.7	50.9	72.9	21.5	21.9	25.2	63.7	42.0	39.9	46.0	74.9	53.4	64.8	16.8	39.2	40.6	32.4	66.2	47.8	92.7	80.3	24.9	39.5	54.1	0.7	4.4	2.2	7.0	26.0	8.4	23.9	9.9	9.5	7.2	22.6	12.2	11.5	0.6	9.0	32.8	30.4	10.6	8.7	13.5	19.0	4.2	14.6	15.3	8.0	29.5	8.8	15.9	21.5	11.9	26.6	58.1	85.2	193.2	2.1	8.9	68.8	40.2	40.9	27.9	0.0	103.2	68.0	71.4	12.5	39.5	35.7	303.7	98.8	535.3	106.1	48.1	20.7	75.7	110.7	1.6	19.7	30.1	33.8	18.8	70.5	54.9	108.0	55.9	35.3	15.6	87.5	41.8	43.2	64.8	2.4	19.4	106.1	117.9	120.7	178.0	110.3	47.9	49.4	87.8
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311198-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.6;testis: 103.2"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 581.2;Spermatogonia: 464.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 54.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	4.8	22.4	4.2	22.7	6.1	38.1	10.7	4.0	7.5	3.6	10.8	3.0	16.7	10.8	4.6	4.4	20.4	2.8	4.7	3.3	6.1	3.2	11.0	10.2	9.5	24.6	5.2	4.3	3.9	2.6	7.0	2.2	12.4	5.0	4.8	10.7	3.2	4.4	7.6	3.6	6.1	9.3	4.1	5.4	12.6	6.8	103.2	3.6	41.6	4.6	13.5	20.8	8.1	16.7	18.3	54.6	12.4	7.5	11.6	17.9	6.5	84.0	72.1	44.1	29.5	13.0	11.9	32.2	50.1	27.0	55.5	44.5	29.6	41.8	63.0	29.7	18.7	98.8	59.2	52.9	38.6	63.9	49.1	42.8	31.9	52.8	78.5	5.6	65.0	36.4	4.3	8.9	39.7	35.1	21.2	51.3	51.9	38.0	55.2	71.1	63.1	51.0	114.6	64.4	99.0	66.6	44.2	48.5	37.6	43.5	19.3	37.4	22.3	41.6	40.4	40.4	43.2	48.6	37.8	29.1	24.0	45.6	58.0	72.8	44.8	90.7	50.8	35.4	37.7	34.1	10.5	5.9	12.4	7.0	7.5	7.9	18.3	9.6	6.7	6.5	13.5	5.2	6.8	4.2	11.6	4.1	54.6	17.9	6.5	4.2	6.1	4.0	7.5	6.1	3.2	5.2	4.3	5.0	3.6	35.7	93.0	97.3	70.9	248.9	4.2	55.0	5.1	12.0	17.0	14.0	0.0	149.0	19.9	15.2	25.4	26.7	39.1	350.4	9.7	329.6	72.5	59.4	147.1	19.5	152.7	0.0	117.0	28.3	40.0	59.4	23.9	84.8	133.3	33.3	56.8	24.6	23.3	46.9	15.6	148.6	6.0	45.3	99.9	581.2	464.7	261.3	166.8	40.1	104.9	59.3
CLASP2	KIAA0627	ENSG00000163539	"Cytoplasmic linker associated protein 2"	O75122	3	33496245-33718356	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.1"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 95.1;Cone photoreceptor cells: 147.3;Horizontal cells: 87.4;Rod photoreceptor cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067071			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA067071: AB_2685775"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.48e-6)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.72e-2)"	7.9	14.5	20.6	6.5	31.6	6.0	9.0	45.4	67.1	13.0	8.9	50.7	3.4	5.6	11.7	6.7	10.2	9.4	10.0	22.0	19.1	16.8	10.4	6.1	8.6	7.9	33.4	22.1	16.1	6.5	11.6	16.1	8.7	44.7	9.8	7.7	13.4	6.5	12.4	31.7	7.3	6.7	11.2	29.7	7.7	6.8	6.5	37.3	4.1	8.1	4.9	8.6	8.0	7.5	8.4	8.7	4.7	8.4	12.3	7.2	5.6	7.2	16.2	18.5	15.6	12.1	11.9	13.4	13.7	13.0	16.2	17.5	9.4	7.6	24.1	8.0	10.7	10.4	6.4	24.0	10.9	19.7	19.4	17.0	23.7	14.3	8.3	5.8	23.3	20.3	7.3	10.9	17.4	16.7	9.4	15.6	15.0	23.1	13.8	17.4	4.0	17.2	10.0	13.8	7.3	10.3	18.6	17.5	13.1	10.3	8.3	15.6	26.4	15.9	12.4	13.7	15.7	11.7	20.8	14.9	12.7	11.1	9.5	15.1	9.8	18.3	20.0	11.5	16.2	16.1	4.7	5.9	3.3	4.8	6.3	7.2	8.4	4.2	4.5	8.7	5.6	5.7	5.2	1.2	12.3	8.4	8.3	4.5	5.6	20.6	31.6	45.4	38.7	19.1	16.8	33.4	22.1	44.7	37.3	6.0	9.4	14.3	7.0	18.7	95.1	34.3	17.8	9.4	12.5	14.0	147.3	10.5	1.7	5.7	2.3	12.1	7.3	0.0	5.9	6.5	12.4	12.6	11.5	12.2	13.1	87.4	13.8	14.7	32.0	2.6	13.3	16.7	15.1	9.0	10.0	36.3	7.3	7.0	12.7	9.9	124.9	6.5	18.9	10.8	13.8	26.8	10.8	17.0	10.1	7.8
CLBA1	C14orf79	ENSG00000140104	"Clathrin binding box of aftiphilin containing 1"	Q96F83	14	104985775-105010482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 14.9;Ciliated cells: 34.8;Collecting duct cells: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042052, HPA061117"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA042052: AB_2677822, HPA061117: AB_2684434"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	2.1	5.3	5.4	2.6	12.5	2.0	6.6	3.5	13.5	7.6	3.4	5.2	11.8	2.3	6.8	15.1	5.1	18.9	6.5	2.4	6.2	6.5	8.9	6.1	7.4	1.8	3.3	5.9	6.8	11.3	13.2	15.3	2.4	5.3	7.6	3.5	7.6	6.3	8.3	1.3	9.2	2.2	4.4	2.1	2.4	5.9	23.9	1.8	1.8	17.6	1.0	2.3	4.2	3.3	1.8	2.3	2.4	1.1	1.0	1.4	0.5	4.0	7.3	2.2	6.9	2.2	3.3	3.4	3.3	3.1	4.0	1.8	0.7	7.2	0.4	7.0	3.3	2.1	8.8	0.8	4.9	2.5	3.3	2.6	0.3	6.3	0.3	7.9	1.7	1.8	2.1	11.4	4.3	8.5	6.8	2.3	3.5	2.4	1.1	2.3	13.8	0.7	5.2	2.9	4.0	7.0	2.6	1.2	2.3	8.6	2.4	14.4	7.5	4.7	2.1	3.8	1.5	15.0	2.5	2.4	5.0	2.3	10.1	2.5	1.4	0.9	0.3	6.4	0.5	3.5	1.8	1.1	0.4	1.4	1.1	0.3	1.2	1.4	0.3	0.5	1.8	0.6	1.3	2.4	1.0	1.0	2.3	0.6	0.5	5.4	12.5	3.5	13.5	6.2	6.5	3.3	5.9	5.3	1.8	14.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	34.8	4.5	15.7	0.0	1.2	3.3	6.2	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	2.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	4.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424086-86456558	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 68.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		66000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.1	0.1	27.7	0.2	0.1	0.4	0.1	1.1	0.7	105.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	1.4	0.3	0.1	5.1	0.1	0.1	36.4	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.1	42.1	33.9	6.1	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	12.6	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	68.6	0.3	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	6.0	42.1	0.0	0.3	0.0	10.7	22.7	0.0	0.0	0.2	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	47.9	0.1	0.0	0.0	35.8
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 182.1;intestine: 64.2"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 115.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	988	"RT4: 98.7"									"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	NA	NA		210000	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.2	0.1	2.2	8.8	3.0	0.1	0.6	0.0	2.0	12.3	64.2	2.0	0.0	0.1	0.3	0.1	182.1	0.1	0.1	0.1	2.2	0.6	0.1	0.1	0.1	0.1	3.2	1.6	0.1	0.0	0.1	0.0	0.1	3.0	1.8	38.4	0.0	5.9	0.1	0.1	4.5	6.1	0.8	2.4	0.1	0.1	0.1	5.0	0.0	0.1	8.6	21.5	9.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	2.0	2.2	0.6	3.2	1.6	3.0	5.0	0.0	0.0	0.0	13.3	3.0	0.0	0.2	0.0	2.7	5.7	1.8	0.0	0.0	0.0	0.0	0.3	0.0	18.6	0.0	0.0	0.0	0.0	3.9	9.2	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	0.0	0.0	4.1	115.2
CLCF1	"BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6"	ENSG00000175505	"Cardiotrophin like cytokine factor 1"	Q9UBD9	11	67364168-67374177	"Disease related genes, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Glandular cells: 55.6;Pancreatic endocrine cells: 36.3;Urothelial cells: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 26.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042444	Uncertain		Approved	"Nuclear bodies,Vesicles"	"Secreted to blood"	NA	NA			"Nuclear bodies, Vesicles"		"HPA042444: AB_10794527"	"unprognostic (2.68e-1)"	"unprognostic (7.87e-3)"	"unprognostic (6.21e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.47e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.37e-1)"	10.5	2.9	1.2	11.6	1.5	10.2	7.5	0.8	1.8	11.2	7.6	2.0	3.5	1.1	18.9	5.9	3.9	12.2	16.5	5.7	1.1	0.7	17.3	2.6	6.0	4.3	0.9	1.3	12.1	5.8	0.1	4.3	11.6	3.1	4.7	1.4	3.9	5.9	1.5	4.6	1.4	5.5	7.5	1.9	7.2	7.7	3.8	1.5	1.1	6.3	9.8	11.6	5.6	5.1	11.9	1.0	11.1	8.0	0.2	8.8	2.1	6.9	14.5	1.1	4.6	2.0	2.7	0.0	9.7	5.3	6.7	3.3	2.4	19.2	4.3	8.3	12.1	8.6	4.8	0.2	4.9	2.9	0.2	0.1	0.0	9.8	1.9	6.4	0.8	1.2	3.6	1.2	6.9	3.1	13.1	1.4	0.0	1.6	0.2	6.9	5.5	0.0	3.1	3.9	8.6	13.3	0.4	2.3	0.2	10.5	0.3	0.0	0.7	26.5	1.0	0.5	2.2	0.6	1.1	5.9	13.3	5.7	16.7	14.2	0.9	0.0	0.5	16.9	0.9	5.2	0.0	0.7	11.1	8.8	2.6	5.1	8.2	4.1	6.8	1.0	11.9	0.1	3.0	0.2	0.2	8.0	0.0	0.7	2.1	1.2	1.5	0.8	1.6	1.1	0.7	0.9	1.3	3.1	1.5	14.9	3.7	9.3	22.4	3.3	0.0	0.4	20.4	1.4	6.8	7.0	0.0	0.2	1.7	21.5	1.6	3.6	1.7	0.0	10.3	0.4	9.4	55.6	3.5	0.0	1.2	0.0	1.2	3.7	0.3	2.7	3.1	4.3	8.5	10.8	2.2	1.5	36.3	3.5	0.0	4.2	0.1	0.0	7.2	0.2	0.7	3.9	0.1	3.2	1.7	51.2
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361651	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 21.0;intestine: 20.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 10.2;Enterocytes: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.6	5.4	4.9	2.6	8.3	1.3	1.6	8.8	6.3	2.8	20.2	16.9	5.1	11.6	4.5	5.0	1.7	2.8	21.0	1.5	6.3	3.1	3.7	1.8	1.3	1.0	15.3	4.1	6.1	5.9	4.4	4.0	1.5	8.9	2.6	14.0	15.6	3.7	9.0	1.2	2.2	11.8	2.4	10.8	1.6	2.7	11.9	9.8	0.1	3.2	1.3	1.3	2.2	2.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	8.0	2.8	2.3	6.2	2.1	1.8	5.4	2.9	1.6	2.9	1.8	15.1	2.7	2.8	8.0	1.4	7.5	14.0	3.3	3.1	0.9	2.5	4.0	2.5	5.8	6.4	1.3	1.0	2.5	3.4	2.5	2.5	2.9	1.3	2.7	3.0	1.0	1.4	1.0	4.4	0.8	1.3	3.5	6.7	4.4	5.0	2.2	9.6	3.5	6.1	3.9	2.3	3.0	10.5	4.7	1.6	8.5	1.1	1.3	1.5	4.4	7.1	7.0	3.8	4.8	1.7	2.6	4.8	6.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	8.3	8.8	6.3	6.3	3.1	15.3	4.1	8.9	9.8	3.0	2.6	0.0	0.7	0.9	2.2	1.1	10.2	4.0	1.2	0.0	0.0	0.9	0.0	3.5	2.4	0.5	30.8	0.0	1.8	0.4	1.0	0.6	1.1	0.4	0.5	1.6	2.9	1.8	0.0	1.3	4.9	0.4	0.0	1.0	3.6	1.8	1.8	7.8	4.6	2.2	2.6	0.0	0.8	3.3	1.6	0.4	1.3	0.0	6.5	0.3
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156945-10237660	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 75.3;Cone photoreceptor cells: 96.2;Horizontal cells: 49.3;Rod photoreceptor cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4"	"Group enriched"	"Detected in many"	9	"B-cells: 6.8;granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 17.5;HEL: 16.2;SCLC-21H: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced	Approved	Approved	Vesicles		NA	NA			Vesicles		"HPA031313: AB_10601358, HPA063637: AB_2685069"	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favorable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	3.1	3.4	9.7	2.0	21.3	2.1	1.6	18.6	29.1	2.0	1.4	15.7	0.0	1.2	1.3	22.8	2.3	3.0	2.8	11.4	13.0	10.5	3.4	3.5	3.4	2.9	23.5	10.4	2.2	2.4	8.9	3.9	1.7	18.2	2.1	1.1	6.0	2.3	1.7	34.6	1.2	1.2	1.4	15.2	3.2	2.1	2.2	17.9	0.0	6.8	2.0	2.2	2.3	0.8	6.8	0.6	4.4	0.5	0.0	0.0	0.6	4.8	3.0	2.2	0.0	1.1	2.0	0.0	0.1	0.0	0.0	0.0	5.9	3.3	3.6	8.7	0.9	17.5	1.0	1.4	3.2	0.1	0.0	3.4	16.2	1.6	2.4	5.4	0.0	0.0	9.7	2.6	4.2	1.0	3.4	6.2	0.0	1.2	0.0	2.2	0.5	0.0	0.1	2.8	5.2	10.5	0.0	3.6	0.0	1.5	0.5	16.8	6.3	6.9	0.7	0.0	2.0	1.8	2.0	6.1	2.6	4.4	11.4	0.4	0.4	8.1	1.3	8.3	0.0	3.3	2.3	0.5	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.6	6.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.6	9.7	21.3	18.6	26.7	13.0	10.5	23.5	10.4	18.2	17.9	8.9	1.9	3.7	0.7	0.5	75.3	26.7	12.7	5.3	1.2	7.0	96.2	0.1	0.0	2.2	0.0	1.4	0.0	0.0	3.1	0.2	1.0	0.7	1.1	4.2	2.5	49.3	14.5	17.2	4.7	0.0	0.9	0.5	0.0	0.0	0.0	12.8	2.9	0.0	3.5	2.6	37.1	0.0	0.8	0.0	0.2	0.1	0.2	0.0	0.0	0.8
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11843144	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	11.2	14.6	18.9	11.5	18.7	12.2	8.6	18.0	27.9	9.2	8.7	22.4	8.6	9.6	12.8	14.2	6.3	10.7	8.1	15.7	15.0	20.6	10.0	9.1	10.6	11.1	16.4	17.8	21.4	6.6	8.4	14.8	9.6	32.4	11.3	7.8	13.1	6.7	8.7	11.2	10.0	9.1	10.8	15.9	10.6	8.5	16.1	14.5	4.3	10.7	5.0	9.5	7.7	8.2	10.1	3.2	4.2	4.6	2.0	3.2	1.1	5.6	5.3	12.0	10.1	12.9	13.4	3.7	4.7	9.2	6.6	10.3	8.1	13.8	8.1	3.9	4.4	16.4	8.4	7.9	8.8	5.9	3.6	4.2	8.4	10.5	10.7	16.7	4.7	7.9	9.2	5.2	12.4	7.0	8.0	5.9	8.4	10.6	11.7	6.7	3.1	4.8	12.7	8.0	2.7	4.2	6.1	6.6	7.4	8.7	4.7	5.2	8.3	3.2	5.1	11.0	8.8	4.5	8.4	7.1	6.2	7.0	10.5	3.3	7.0	4.3	20.8	7.6	9.4	4.5	4.2	4.6	1.5	2.6	3.7	1.5	8.0	2.1	3.2	2.7	10.1	2.3	2.1	3.9	2.0	4.6	3.2	1.4	1.1	18.9	18.7	18.0	27.9	15.0	20.6	16.4	17.8	32.4	14.5	17.9	20.5	11.3	3.3	3.1	18.5	21.8	10.2	8.1	6.8	3.5	13.7	3.2	0.0	3.6	12.5	5.6	5.4	0.0	3.9	2.2	5.2	4.1	2.3	5.5	6.5	25.4	6.3	8.0	8.2	7.4	6.9	10.1	1.7	5.4	2.9	7.8	4.2	3.5	6.7	3.0	16.0	0.0	4.2	9.7	9.4	2.8	3.4	2.5	3.0	3.5
CLDN11	"OSP, OTM"	ENSG00000013297	"Claudin 11"	O75508	3	170418865-170454733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;ovary: 47.7;testis: 86.1"	"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 37.5;Ito cells: 49.1;Leydig cells: 97.5;Peritubular cells: 63.6"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 57.6;ASC TERT1: 72.7;EFO-21: 43.2;HSkMC: 26.6;HUVEC TERT2: 62.3;TIME: 98.4"									"CAB009789, HPA013166, HPA013657"	Enhanced		Supported	"Lipid droplets,Cell Junctions"		NA	NA			"Cell Junctions"	"Lipid droplets"	"CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: "	"prognostic favorable (6.31e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (5.28e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.70e-11)"	"unprognostic (2.50e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.29e-1)"	8.2	1.9	14.1	2.0	40.6	1.7	6.3	3.5	50.3	1.9	3.4	85.9	0.5	2.2	2.7	4.6	4.6	4.2	18.9	4.0	28.7	13.0	3.2	2.8	2.8	2.1	59.5	17.1	47.7	2.1	1.8	5.5	4.2	37.3	5.1	2.5	0.6	4.7	4.2	1.7	3.6	2.6	2.8	80.6	2.6	2.5	86.1	47.9	0.0	2.0	0.9	2.0	6.3	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	57.6	72.7	0.0	0.7	3.7	4.7	7.9	0.0	9.7	0.0	43.2	5.8	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	3.3	17.8	0.0	0.0	26.6	0.0	25.9	0.0	0.2	62.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.1	40.6	3.5	25.0	28.7	13.0	59.5	17.1	37.3	47.9	0.0	1.1	0.0	12.0	12.8	0.4	1.4	0.0	0.0	0.0	1.8	0.0	1.0	0.0	0.0	6.5	21.9	0.0	0.0	0.0	1.7	37.5	1.3	0.0	0.8	0.8	0.0	0.0	49.1	0.0	16.0	97.5	1.7	13.5	0.0	0.0	0.3	0.5	0.0	63.6	0.0	0.0	0.0	5.9	7.2	2.6	8.9	0.7	0.0	0.0	1.0
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"gallbladder: 37.4;lung: 91.9;stomach 1: 126.9"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 1488.8"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.7;stomach cancer: 186.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"OE19: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	0.1	0.1	0.3	0.1	37.4	2.0	0.1	0.0	0.1	0.1	91.9	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	126.9	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.9	0.3	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.6	18.9	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	1488.8	318.5	0.0	0.0	0.0	0.8	18.9	0.0	1.4	20.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	9.9	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	257.5	0.0	0.0	0.0	1.4	0.0	0.0	6.6	3.8	0.0	0.0	0.0	0.0	0.0
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Cell type enhanced"	"Detected in some"	21	"Ductal cells: 67.3;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 28.7;Proximal tubular cells: 138.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 81.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	13.3	67.3	0.0	0.0	1.0	0.0	42.5	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	2.8	0.1	0.9	28.7	2.9	0.0	138.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0
CLDN23	CLDNL	ENSG00000253958	"Claudin 23"	Q96B33	8	8701938-8704106	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Enterocytes: 128.5;Paneth cells: 76.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.4;plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 9.8;Daudi: 7.8;RT4: 8.3;SK-BR-3: 8.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070578			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA070578: "	"unprognostic (1.86e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-2)"	"unprognostic (8.25e-3)"	"prognostic favorable (9.65e-8)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.33e-3)"	9.1	1.0	0.3	7.1	1.4	0.3	6.1	0.4	0.6	2.6	14.8	0.5	3.8	5.5	1.0	6.3	2.8	1.4	10.6	1.4	0.9	0.2	6.5	13.3	8.7	3.1	1.1	0.3	2.6	3.2	1.5	0.7	15.7	1.7	3.3	8.8	2.8	6.0	2.5	0.9	10.0	20.0	0.5	0.3	2.4	18.0	1.5	0.5	0.4	8.8	4.3	3.0	6.0	5.3	0.5	3.9	0.8	2.4	0.0	0.0	0.6	0.2	3.2	0.0	0.2	1.0	0.1	9.8	2.4	1.9	2.6	4.0	1.9	5.2	7.8	0.0	0.1	1.0	3.1	0.0	0.1	0.2	1.5	0.0	0.0	1.0	0.1	4.6	0.0	0.1	1.3	1.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.3	4.0	0.1	0.2	2.5	0.4	1.6	0.0	0.0	0.0	1.2	8.3	0.4	1.2	3.2	8.5	0.1	1.0	1.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.8	0.0	2.4	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.6	0.3	1.4	0.4	0.6	0.9	0.2	1.1	0.3	1.7	0.5	8.9	1.9	1.3	6.7	0.1	0.0	0.5	20.4	6.7	1.2	1.8	0.0	15.9	6.6	19.6	0.0	1.0	128.5	0.0	9.5	15.2	3.5	2.8	4.6	6.8	15.3	0.0	7.5	8.0	1.9	0.0	0.3	2.9	3.3	1.0	23.5	0.2	20.1	76.4	0.4	3.8	1.1	6.5	2.1	0.0	0.0	0.5	7.9	0.0	18.9	10.5
CLDN7	"CEPTRL2, CPETRL2, Hs.84359"	ENSG00000181885	"Claudin 7"	O95471	17	7259903-7263983	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 166.7"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 1175.0;Paneth cells: 985.5;Urothelial cells: 711.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 26.8;CACO-2: 27.9;CAPAN-2: 54.3;HaCaT: 114.0;MCF7: 39.7;OE19: 42.8;SK-BR-3: 47.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013063, HPA014703, HPA073662"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"CAB013063: , HPA014703: AB_1846873, HPA073662: "	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.96e-11)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (1.62e-1)"	1.6	2.0	0.4	28.0	0.4	0.0	9.5	0.4	0.4	9.9	71.4	0.4	47.6	47.2	2.4	49.3	73.4	13.4	47.2	0.7	0.4	0.3	30.0	12.1	32.3	0.8	0.4	0.4	3.4	70.9	12.3	7.3	25.0	0.4	9.8	42.5	0.7	40.9	42.2	0.9	2.9	166.7	1.8	0.5	1.4	1.2	1.8	0.4	1.5	40.5	28.3	45.6	12.2	19.3	3.8	1.6	0.0	3.0	2.2	6.7	2.3	3.2	0.3	0.0	0.0	0.0	0.2	26.8	0.0	0.1	0.0	0.0	27.9	54.3	0.0	1.0	0.1	0.1	114.0	0.0	3.5	0.0	0.0	0.6	0.0	0.7	0.0	2.1	0.0	0.2	0.5	5.4	0.0	0.2	0.0	2.5	0.0	0.3	0.1	0.0	39.7	0.0	0.3	0.2	42.8	1.0	0.0	0.0	0.7	0.0	0.0	6.5	0.1	0.3	47.5	0.0	2.2	17.3	0.4	5.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	2.2	3.0	4.8	0.5	1.5	3.3	1.6	3.8	3.7	6.7	0.0	2.2	0.1	0.2	0.9	2.3	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4	104.2	43.9	5.4	188.2	1.8	0.8	0.5	226.7	123.1	91.0	305.4	7.9	231.4	33.2	701.7	0.0	3.8	1175.0	0.0	684.7	284.5	5.1	310.2	5.7	34.7	29.8	0.0	313.6	3.7	3.1	0.0	1.1	9.1	23.6	18.0	591.9	0.4	632.6	985.5	0.0	47.8	6.8	0.0	2.1	0.2	3.0	2.3	492.5	5.9	501.5	711.9
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012456-3014505	"Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2"	"Cell type enhanced"	"Detected in some"	12	"Cholangiocytes: 10.2;Ductal cells: 8.3;Pancreatic endocrine cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.7;MCF7: 19.5;SCLC-21H: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076613			Supported	"Vesicles,Cell Junctions"		NA	NA			"Cell Junctions"	Vesicles	"HPA076613: AB_2686808"	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.4	0.4	0.5	2.1	5.2	0.3	16.5	1.4	0.6	1.0	0.3	0.3	1.8	0.3	0.9	0.3	2.3	1.1	0.4	0.8	0.8	0.6	2.6	1.5	0.3	1.4	0.3	0.3	9.6	4.8	15.9	10.2	0.5	0.3	0.1	0.3	1.7	0.3	1.5	0.4	1.2	0.3	2.2	1.0	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.3	0.1	0.0	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	5.7	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	19.5	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.1	15.3	0.1	0.8	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.1	16.5	1.4	0.8	0.8	1.4	0.3	0.5	0.3	0.0	0.0	0.0	1.8	0.1	1.4	0.3	10.2	2.7	0.0	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.7	0.0	0.0	0.1	0.0	1.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	5.9	1.1	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.4	0.9	0.0	0.2	1.7
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 75.9;brain: 227.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	14.7	12.4	61.6	10.7	76.1	11.7	14.1	11.9	77.1	14.1	10.4	100.5	3.3	10.0	16.9	12.6	22.6	10.9	14.3	15.9	85.4	52.3	11.0	14.0	12.2	13.6	133.4	28.9	19.1	5.8	7.0	6.7	20.5	72.7	14.6	13.6	4.9	6.8	15.7	9.7	17.6	9.4	18.5	227.4	11.5	7.5	28.5	95.4	4.3	11.5	4.7	14.8	14.7	11.1	19.9	19.7	28.1	18.6	49.5	75.9	28.6	17.9	7.3	22.9	14.0	27.7	21.6	12.5	14.2	19.6	20.0	27.7	14.8	18.3	9.0	19.2	13.6	38.0	24.3	17.6	10.8	35.1	21.2	7.5	18.7	5.2	13.2	22.2	16.8	18.7	25.2	58.3	15.6	16.8	21.5	21.7	17.9	9.3	27.7	28.1	9.4	12.3	11.1	19.9	7.8	15.6	8.3	30.8	11.4	18.7	8.1	8.3	22.8	19.6	6.6	28.1	32.1	6.6	14.3	20.1	26.1	24.1	17.7	18.4	36.7	15.7	14.5	43.6	16.2	33.3	28.1	18.6	19.8	21.7	10.7	40.8	19.9	40.9	39.8	19.7	16.4	16.6	16.9	13.8	49.5	10.5	12.7	75.9	28.6	61.6	76.1	11.9	38.8	85.4	52.3	133.4	28.9	72.7	95.4	32.8	39.6	30.5	103.2	128.0	19.7	48.0	12.7	16.0	23.9	26.2	23.6	44.0	24.9	18.4	58.8	63.1	19.7	46.7	14.2	132.7	70.7	85.5	35.8	18.7	31.6	14.3	27.5	54.0	25.9	62.2	47.8	38.0	108.0	43.3	18.8	28.6	24.0	11.5	43.9	18.2	31.4	51.8	126.4	168.0	50.6	171.8	80.1	103.6	17.1	110.7
CLDND2	MGC33839	ENSG00000160318	"Claudin domain containing 2"	Q8NHS1	19	51367098-51369003	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 31.4"	"Cell type enriched"	"Detected in many"	15	"Early spermatids: 230.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.7"									HPA056971	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056971: AB_2683294"	"unprognostic (2.86e-1)"	"unprognostic (4.29e-5)"	"unprognostic (2.29e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-9)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.70e-2)"	7.7	7.8	6.8	3.2	11.1	13.3	3.3	10.9	16.5	2.6	3.6	1.4	8.4	7.7	3.0	2.5	2.9	2.8	4.5	2.5	9.9	4.7	2.8	3.5	4.0	3.2	19.6	5.2	6.7	9.1	1.5	2.9	1.8	7.4	3.8	2.4	1.7	7.5	6.0	11.9	1.5	7.1	3.8	10.2	7.3	3.3	31.4	10.6	0.0	2.9	2.2	1.2	3.2	3.0	1.7	3.0	5.8	2.0	5.3	4.5	0.7	2.1	6.0	2.2	3.0	3.3	2.9	1.2	1.0	0.5	1.0	1.3	0.7	7.1	5.6	1.2	0.6	0.7	2.7	0.7	0.3	0.2	3.9	9.7	4.9	9.4	11.7	1.3	1.4	1.4	2.2	1.0	0.2	0.6	1.5	0.7	2.8	3.1	4.1	0.9	1.3	1.2	8.1	0.9	6.1	7.6	1.1	5.1	2.2	1.6	1.6	1.3	1.5	2.6	0.5	2.1	1.1	1.5	0.4	1.4	2.2	4.4	2.3	0.9	3.8	4.0	2.0	5.4	5.6	1.3	5.8	0.9	4.1	3.5	2.0	2.0	1.7	0.8	4.5	1.4	1.1	0.6	1.5	0.5	5.3	0.7	3.0	1.2	0.7	6.8	11.1	10.9	16.5	9.9	4.7	19.6	5.2	7.4	10.6	0.0	5.9	7.8	5.0	1.4	5.5	3.6	12.7	9.4	1.2	15.7	0.0	1.9	3.3	0.7	230.3	1.7	6.6	0.0	0.6	1.1	2.3	4.4	15.1	13.4	2.3	3.2	9.9	7.4	2.4	9.1	5.8	4.6	1.7	1.8	14.5	2.3	0.8	5.8	6.0	3.0	1.9	0.0	2.7	2.3	1.3	2.4	0.7	4.5	10.5	4.6
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723329-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.1"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 101.2;Fibroblasts: 98.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.0;monocytes: 17.2"	"Group enriched"	"Detected in many"	4	"HEL: 45.4;HMC-1: 84.1;NB-4: 111.7;THP-1: 90.3;U-937: 46.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	NA	NA		45000	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	5.5	5.4	3.0	5.6	3.1	77.1	4.5	4.5	3.6	33.6	6.5	1.2	6.7	3.9	26.6	27.8	6.7	13.5	10.7	5.6	2.6	3.4	7.4	5.4	7.5	3.5	2.9	1.3	16.1	2.6	2.0	7.5	6.9	4.0	18.9	2.1	8.9	2.9	10.2	3.4	5.0	5.2	8.5	3.4	4.9	3.1	4.9	0.8	4.0	3.8	4.5	2.6	8.4	10.1	0.3	12.0	1.2	17.2	3.4	3.2	6.7	0.3	0.4	0.0	0.3	4.4	6.0	10.3	17.7	4.8	2.0	2.0	0.0	0.0	0.0	0.2	8.8	0.1	0.2	0.0	0.0	1.4	0.0	2.9	45.4	0.0	0.0	2.8	0.0	84.1	4.4	0.0	0.2	0.2	0.0	2.2	2.0	0.5	0.3	3.7	0.3	0.3	111.7	0.2	0.0	0.5	3.8	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	6.8	0.0	0.1	90.3	12.7	0.1	5.5	0.0	0.1	0.2	0.2	0.0	6.4	46.9	5.8	1.0	17.2	0.2	0.6	7.2	0.0	0.3	0.2	0.1	12.0	0.3	1.5	3.2	1.2	3.4	3.3	3.2	0.1	6.7	3.0	3.1	4.5	3.6	2.6	3.4	2.9	1.3	4.0	0.8	3.0	4.8	1.4	26.8	28.4	18.8	2.8	10.2	5.3	3.4	27.9	9.8	8.6	101.2	10.9	4.6	14.5	0.7	0.0	2.6	36.0	98.6	20.9	5.7	4.4	44.2	20.6	25.4	62.6	21.5	13.3	65.6	36.7	74.2	4.6	3.4	42.6	5.0	1.4	63.3	6.3	17.5	64.7	31.1	20.5	10.0	40.1	15.3	4.3	3.4	13.1
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254103-38256369	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 63.2"	"Group enriched"	"Detected in some"	45	"Endothelial cells: 217.3;Ito cells: 286.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"myeloid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 17.4;HUVEC TERT2: 94.4;TIME: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		3600000	"Endoplasmic reticulum, Golgi apparatus"		"HPA039468: AB_2676524, HPA048119: AB_2680270"	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	32.2	3.9	3.2	6.8	4.3	0.0	47.8	2.3	3.9	14.5	9.3	3.4	5.9	5.9	18.4	13.3	9.3	9.9	13.6	23.7	3.8	3.4	6.8	11.4	63.2	7.9	4.9	2.2	7.6	3.3	5.0	2.8	15.0	4.4	11.8	4.4	10.8	5.5	6.5	36.5	6.5	7.4	12.1	3.9	9.0	5.9	6.8	2.2	1.4	14.0	21.1	3.8	9.4	14.8	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	4.3	2.3	3.9	3.8	3.4	4.9	2.2	4.4	2.2	0.0	5.6	2.9	0.3	3.1	0.0	5.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	217.3	0.0	0.0	0.2	0.1	2.7	0.2	1.1	0.8	0.3	0.0	0.0	286.7	5.6	1.0	0.6	0.7	5.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.5	0.0	4.1	0.6	0.2	2.8	0.1	0.0	0.0	0.0
CLEC16A	"Gop-1, KIAA0350"	ENSG00000038532	"C-type lectin domain containing 16A"	Q2KHT3	16	10944488-11182189	"Disease related genes, Predicted intracellular proteins"	Autophagy		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 97.8;Late spermatids: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035814, HPA035815, HPA061385"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: AB_2684498"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.92e-6)"	"unprognostic (2.69e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.03e-1)"	9.2	9.7	11.1	12.7	13.7	15.8	8.3	17.2	19.5	8.7	9.4	14.2	9.5	11.0	9.4	10.8	11.5	9.7	6.9	10.7	11.0	10.7	11.2	12.9	12.0	11.4	12.4	10.1	7.7	7.3	22.5	21.8	9.6	13.6	8.6	8.6	12.2	9.4	9.2	14.0	15.9	10.8	9.7	14.4	9.5	8.5	43.1	11.6	15.4	11.5	5.2	12.9	8.3	8.7	7.7	5.0	6.6	6.7	4.0	5.6	2.4	5.3	5.7	4.4	5.7	7.4	5.3	3.9	5.5	5.5	4.7	6.2	6.3	10.1	10.6	13.0	6.8	5.1	4.8	5.6	10.4	6.1	51.8	5.9	4.8	7.8	6.7	5.2	5.2	10.6	6.1	5.1	7.7	6.7	4.3	6.4	5.9	8.0	6.7	5.6	8.8	8.3	4.2	3.5	4.7	4.5	11.4	3.7	6.2	9.9	4.0	5.6	7.5	8.0	8.3	4.3	5.4	5.8	8.4	6.8	6.1	8.0	8.9	4.9	4.7	4.1	8.9	7.7	7.7	6.2	5.5	4.5	3.2	5.5	3.7	3.4	4.4	4.7	3.7	3.6	7.7	5.6	4.8	6.6	4.0	6.7	5.0	3.3	2.4	11.1	13.7	17.2	19.5	11.0	10.7	12.4	10.1	13.6	11.6	14.9	7.7	8.2	3.4	6.4	10.8	4.9	12.7	6.7	10.3	3.5	35.3	2.8	0.0	5.2	97.8	3.6	10.5	0.0	5.5	2.1	4.1	3.2	8.1	11.5	4.2	11.1	7.5	9.8	3.8	56.1	5.2	4.4	3.3	10.0	7.0	5.4	5.8	4.9	8.1	2.6	19.1	0.0	3.1	14.4	5.6	7.2	3.2	5.4	6.0	4.1
CLEC4F	"CLECSF13, FLJ39110, KCLR"	ENSG00000152672	"C-type lectin domain family 4 member F"	Q8N1N0	2	70808643-70820600	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	17	"Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 7.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 7.9;non-classical monocyte: 5.8"	"Lineage enriched"	"Detected in single"	11	"monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;BEWO: 2.1;HAP1: 1.7;SH-SY5Y: 1.4;T-47d: 3.1"					"Not detected"	"Not detected"			HPA056101			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA056101: "	"unprognostic (8.14e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.68e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.44e-1)"	3.1	0.0	0.5	3.2	0.5	0.0	2.1	0.7	0.7	1.8	4.2	0.5	6.8	2.5	2.9	1.4	1.5	1.5	7.0	1.5	0.5	0.1	1.2	2.4	9.0	1.8	1.2	0.5	1.3	0.5	0.0	1.4	0.5	0.5	2.9	1.3	0.8	3.3	2.7	1.4	2.3	7.6	2.0	0.5	6.8	0.7	2.0	0.5	0.9	0.6	0.5	2.0	1.5	2.5	0.0	0.7	0.0	7.9	0.0	0.0	0.6	0.0	0.1	0.1	6.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.6	0.5	0.5	0.7	0.5	0.5	0.1	1.2	0.5	0.5	0.5	0.0	0.3	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.3	0.7	0.0	1.7	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 18.6;Macrophages: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"classical monocyte: 11.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 11.5"	"Group enriched"	"Detected in some"	23	"HL-60: 15.2;U-937: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.4	3.2	1.8	7.3	2.4	35.8	0.8	0.8	2.5	1.7	0.4	1.9	0.6	0.4	0.8	0.5	1.4	1.2	2.0	3.8	7.6	3.1	2.9	2.1	13.9	0.3	2.4	0.5	2.7	2.6	1.4	1.1	2.7	8.2	0.9	0.5	0.8	2.7	0.8	0.3	2.7	0.3	1.5	4.8	2.1	0.4	0.9	4.8	1.1	1.4	4.9	1.4	1.9	1.1	0.0	0.5	1.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	1.9	1.8	2.4	0.8	2.5	7.6	3.1	2.4	0.5	8.2	4.8	0.0	7.4	0.0	0.0	1.6	0.0	0.3	2.5	5.3	9.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	2.3	0.0	18.6	0.0	0.0	0.0	3.8	0.2	0.0	57.4	1.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.0	0.0	0.0
CLHC1	"C2orf63, FLJ31438"	ENSG00000162994	"Clathrin heavy chain linker domain containing 1"	Q8NHS4	2	55174791-55232563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 44.2;Early spermatids: 38.5;Late spermatids: 28.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045418, HPA053557"	Uncertain		Approved	"Nucleoli fibrillar center,Centrosome"		NA	NA			"Nucleoli fibrillar center, Centrosome"		"HPA045418: AB_10962144, HPA053557: AB_2682188"	"unprognostic (1.60e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-4)"	"unprognostic (6.36e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.15e-4)"	4.8	5.7	10.4	3.6	8.7	3.5	6.7	15.7	11.9	6.0	5.3	12.9	9.3	3.9	8.5	9.8	5.5	9.5	6.2	4.6	8.2	5.1	5.2	3.5	5.3	6.6	6.0	8.3	7.4	5.5	8.4	23.6	6.9	8.9	9.1	6.6	8.9	5.8	8.9	3.0	9.6	5.6	7.1	12.0	7.2	4.9	23.2	8.8	10.1	8.3	1.6	5.2	6.6	6.1	1.3	2.9	4.0	2.0	3.2	2.1	1.0	4.3	3.2	8.2	4.9	3.4	4.6	7.2	5.7	5.4	2.9	2.7	6.3	4.0	6.4	3.4	2.6	3.5	6.6	3.5	4.9	6.0	5.7	4.1	9.2	9.6	5.7	3.7	5.6	4.6	6.6	4.0	3.6	8.3	8.1	2.8	5.8	4.7	3.8	3.3	3.5	4.1	6.2	3.0	1.7	1.3	5.0	4.7	4.0	4.6	5.0	9.5	5.8	3.3	5.4	5.4	6.7	4.0	3.1	8.4	7.3	4.9	3.4	4.0	7.5	1.9	3.7	5.4	5.7	1.8	1.2	0.6	4.0	0.9	2.0	0.1	1.2	1.7	0.9	1.0	1.3	2.1	1.0	0.4	3.2	1.6	2.9	1.1	1.0	10.4	8.7	15.7	11.9	8.2	5.1	6.0	8.3	8.9	8.8	0.0	2.6	2.4	4.8	1.6	11.3	3.7	0.0	44.2	10.3	3.5	15.7	2.8	5.0	3.7	38.5	2.2	1.1	0.0	1.2	1.5	2.5	4.0	0.0	0.2	2.0	9.5	7.0	6.2	4.7	28.8	3.7	2.9	1.7	1.0	2.0	8.0	1.0	0.0	5.3	2.4	20.6	0.0	1.8	20.2	2.1	1.9	2.9	1.0	3.2	3.6
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9"	"Cell type enhanced"	"Detected in many"	20	"Alveolar cells type 1: 473.4;Cardiomyocytes: 276.0;Enterocytes: 100.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.8"	"Lineage enriched"	"Detected in single"	23	"T-cells: 8.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.6;EFO-21: 9.6;HDLM-2: 5.0;REH: 11.7;U-266/70: 12.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		1000000	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	7.4	0.6	0.8	3.2	1.5	0.0	2.3	0.6	1.1	6.0	10.2	0.3	0.4	5.6	0.8	2.5	2.2	1.2	2.1	65.6	0.9	1.2	17.5	0.5	32.8	0.4	1.1	1.4	0.7	0.7	0.4	1.3	22.0	0.8	0.9	7.5	7.8	2.0	0.4	99.9	0.7	46.2	1.4	0.9	16.1	0.9	1.0	0.0	0.2	4.8	18.8	1.5	1.0	4.3	0.3	0.0	0.0	0.0	0.3	8.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.6	0.0	9.6	0.0	0.0	0.3	0.0	0.1	0.0	5.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.3	1.5	0.0	11.7	0.3	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	8.8	0.3	3.6	2.2	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	1.6	0.8	0.8	1.5	0.6	1.1	0.9	1.2	1.1	1.4	0.8	0.0	473.4	23.0	0.5	0.0	0.1	0.1	276.0	0.0	20.1	48.9	14.0	0.0	0.1	0.0	1.4	38.1	3.8	100.0	0.0	0.2	0.0	0.2	1.5	1.1	0.0	0.0	0.0	12.5	0.6	0.0	75.0	0.9	0.0	0.0	1.0	16.3	47.6	1.9	24.6	0.7	2.1	1.1	0.0	2.1	0.6	0.1	0.1	1.8	2.9	9.8	0.8
CLK4		ENSG00000113240	"CDC like kinase 4"	Q9HAZ1	5	178602664-178630615	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 288.4;Late spermatids: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043746	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA043746: AB_2678650"	"unprognostic (9.46e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.90e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-3)"	12.2	16.4	17.0	17.4	18.4	11.4	17.3	53.8	24.1	17.9	12.2	11.9	18.3	12.4	17.0	16.4	10.5	11.0	13.1	11.4	15.9	9.5	11.8	16.0	10.9	20.3	21.2	12.7	17.4	16.2	15.4	20.2	13.9	16.3	16.7	8.9	10.8	14.4	17.0	20.6	19.5	11.3	11.3	25.8	17.0	11.0	15.7	22.0	15.0	15.8	9.7	12.7	11.4	18.0	13.2	7.8	16.1	6.1	7.7	13.8	5.2	6.7	6.3	5.8	8.4	17.5	14.7	9.7	6.7	7.5	4.0	7.4	6.7	5.5	3.9	5.4	2.8	4.5	9.0	7.5	5.4	6.6	14.1	5.9	1.5	11.8	8.1	6.5	3.1	4.9	6.7	7.8	6.4	8.6	13.2	2.7	2.7	3.5	11.6	5.1	2.8	4.0	11.4	3.0	4.6	3.9	4.0	5.2	5.7	3.9	2.1	6.5	4.4	7.5	4.0	6.9	3.4	4.3	6.6	5.6	8.2	2.9	4.2	7.1	7.6	2.8	3.0	5.9	7.6	4.1	6.5	6.1	12.0	10.0	4.1	13.2	13.2	10.3	8.9	5.9	10.4	13.8	10.6	16.1	7.7	4.4	7.8	9.5	5.2	17.0	18.4	53.8	24.1	15.9	9.5	21.2	12.7	16.3	22.0	14.9	26.7	50.0	37.2	28.3	66.4	19.3	7.6	32.1	23.9	14.0	37.3	16.5	5.0	7.3	288.4	24.8	13.5	23.3	4.1	13.0	20.8	26.1	27.6	11.9	8.8	27.0	5.8	17.2	13.1	350.8	28.4	23.8	15.1	12.6	10.7	34.6	6.5	11.8	27.6	7.7	76.4	19.4	36.0	23.2	17.7	21.5	13.3	34.8	9.1	22.2
CLMN	"FLJ12383, KIAA0500, KIAA1188"	ENSG00000165959	Calmin	Q96JQ2	14	95181940-95319906	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 153.5;Late spermatids: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 11.9;SK-BR-3: 13.7;T-47d: 11.5;WM-115: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012634	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"HPA012634: AB_1846973"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.88e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.18e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (2.68e-7)"	"unprognostic (8.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.91e-3)"	14.1	2.3	11.0	5.9	36.3	2.0	13.0	3.1	20.1	7.8	15.3	31.6	5.6	4.6	5.6	11.0	4.3	8.2	8.3	3.7	13.0	5.6	18.9	18.8	5.2	2.3	38.1	8.0	3.5	18.1	4.7	3.4	9.2	17.2	8.0	17.6	7.1	9.4	7.9	4.6	3.5	6.9	4.5	14.5	3.6	10.0	33.4	34.0	0.0	6.6	1.8	2.9	7.3	7.1	3.8	3.0	7.2	8.4	0.0	0.1	2.1	5.2	7.0	1.1	0.2	4.3	1.9	0.4	0.1	0.0	0.3	0.2	0.6	8.8	0.0	0.8	0.0	11.9	4.6	0.5	3.1	0.0	3.5	1.3	0.1	0.2	4.1	0.4	0.0	0.1	2.1	3.1	1.4	5.0	1.7	3.6	1.9	0.0	1.0	2.6	4.5	0.2	0.4	0.4	6.3	1.7	3.9	3.8	2.3	3.4	8.6	1.4	1.4	1.8	13.7	7.0	1.1	11.5	0.3	1.0	0.1	3.2	0.0	0.2	1.4	0.1	4.8	2.5	2.1	13.1	6.0	8.4	0.7	0.0	3.0	0.0	3.8	0.0	0.0	1.8	2.2	0.0	0.1	7.2	0.0	1.8	3.0	0.0	2.1	11.0	36.3	3.1	20.1	13.0	5.6	38.1	8.0	17.2	34.0	14.9	4.3	9.8	28.6	5.6	59.5	42.8	43.3	50.9	12.5	55.8	13.7	1.6	23.2	46.5	153.5	5.6	41.0	0.0	41.2	1.5	4.6	50.7	4.6	61.4	7.5	36.5	22.4	1.8	17.1	245.4	20.8	7.6	3.3	6.4	64.0	3.2	40.2	35.1	10.3	17.9	25.8	103.5	91.4	4.1	16.6	2.3	2.4	2.2	48.8	39.4
CLPTM1		ENSG00000104853	"CLPTM1, transmembrane protein"	O96005	19	44954585-44993341	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068702, HPA068767"	Approved		Approved	"Nuclear membrane,Centriolar satellite"		NA	NA			"Nuclear membrane, Centriolar satellite"		"HPA068702: AB_2686020, HPA068767: "	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.59e-1)"	29.7	53.4	39.4	20.3	56.2	14.7	20.2	26.7	66.4	25.8	26.6	36.8	17.3	31.5	20.3	24.0	23.7	25.6	22.1	32.2	35.7	35.7	40.6	62.5	23.1	19.1	36.0	33.7	26.9	36.2	53.8	21.1	34.3	37.7	27.1	21.3	30.2	38.0	29.6	37.6	32.9	27.6	23.7	27.2	22.6	25.1	26.7	30.7	13.9	27.3	16.1	26.3	19.5	18.6	18.4	24.1	25.5	28.8	12.5	24.4	11.8	26.5	60.1	14.0	27.7	46.7	18.8	14.9	26.3	29.0	31.1	33.5	26.0	26.9	26.5	29.4	34.8	22.9	31.4	24.9	23.8	21.1	19.4	34.4	20.5	22.7	21.8	33.0	16.3	24.1	29.4	25.3	29.7	19.3	22.2	21.6	15.5	21.3	37.1	27.4	24.0	17.1	9.6	12.6	38.7	20.0	17.8	15.2	25.6	28.9	37.3	16.5	18.2	32.6	48.4	14.2	13.0	26.5	13.1	20.0	35.0	21.8	18.3	32.6	26.1	56.9	20.6	28.9	16.2	32.0	10.4	16.7	25.5	17.0	23.6	14.3	17.5	18.3	24.4	15.4	18.4	14.5	12.2	15.7	12.5	28.8	24.1	15.1	11.8	39.4	56.2	26.7	66.4	35.7	35.7	36.0	33.7	37.7	30.7	6.0	5.6	29.8	29.5	32.5	35.2	10.1	33.1	6.7	10.3	34.9	37.3	80.2	11.6	67.1	41.8	27.0	90.3	0.0	64.6	70.4	35.2	31.5	10.4	43.3	66.9	41.3	39.0	25.8	23.2	42.5	27.9	27.2	32.1	141.5	38.2	56.2	55.1	50.4	28.3	50.1	26.9	25.8	28.3	31.6	29.4	38.5	100.3	22.9	40.1	31.7
CLPTM1L	"CRR9, FLJ14400"	ENSG00000049656	"CLPTM1 like"	Q96KA5	5	1317744-1345099	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014791	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA014791: AB_1847250"	"unprognostic (2.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.47e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.17e-2)"	15.8	14.1	10.6	20.5	12.4	13.5	16.3	6.7	16.9	13.8	19.0	11.1	12.1	24.6	12.0	10.6	15.7	11.7	20.7	13.1	11.3	12.2	29.4	56.1	20.0	17.6	14.8	8.3	11.3	57.6	10.0	14.6	15.8	11.6	13.9	11.0	13.1	33.3	14.5	8.3	12.3	23.6	12.1	9.2	22.5	25.6	20.0	9.8	37.2	30.9	11.3	21.1	13.8	9.8	10.4	12.3	12.3	9.6	12.8	9.7	5.2	12.7	21.7	7.4	20.0	12.1	5.2	19.6	13.1	8.7	11.8	11.7	23.6	20.4	12.2	40.5	12.2	26.3	11.2	10.0	10.9	5.4	49.6	27.5	6.4	50.7	15.6	13.6	16.8	16.5	8.3	12.5	10.9	10.2	8.7	9.6	28.1	14.5	41.9	8.9	20.9	18.5	22.1	13.7	14.2	23.6	15.7	12.1	37.4	9.2	12.2	7.8	15.5	22.9	19.9	9.9	6.5	33.5	25.3	7.1	14.2	40.8	9.8	18.8	75.8	83.6	19.7	10.6	25.4	16.1	4.6	6.7	12.3	7.9	6.2	9.3	9.7	8.4	7.8	6.0	10.4	8.0	9.6	5.2	12.8	9.6	12.3	9.7	5.2	10.6	12.4	6.7	16.9	11.3	12.2	14.8	8.3	11.6	9.8	53.6	65.0	17.1	16.0	19.8	9.7	11.3	50.9	32.1	38.7	27.9	13.7	9.6	5.0	15.2	2.0	19.5	35.1	23.3	27.7	17.2	13.6	39.9	24.3	114.3	20.9	20.6	42.9	25.8	37.2	2.6	16.1	17.0	15.1	6.4	46.8	21.2	37.1	28.5	18.0	58.6	10.5	12.9	13.3	18.9	35.7	20.6	9.2	18.1	32.0	28.8
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit"	O76031	15	65148219-65185342	"Predicted intracellular proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.9"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 189.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA040262: AB_10793961, HPA048199: AB_2680312"	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	10.4	12.8	11.3	8.9	12.7	7.7	10.2	10.9	10.7	11.7	13.4	11.2	4.7	9.3	9.8	10.3	15.5	8.9	9.6	15.9	10.7	9.2	16.8	50.9	9.4	8.8	12.8	8.1	10.8	10.6	11.0	6.3	10.6	9.8	9.7	8.9	7.4	8.9	7.1	25.8	15.6	12.6	10.8	9.7	9.7	9.9	9.3	12.6	17.8	12.9	14.7	10.2	12.5	9.5	7.7	9.8	11.4	7.1	8.2	9.2	4.4	5.3	9.1	8.0	10.1	8.5	11.0	8.6	6.1	6.9	6.8	7.1	9.1	7.5	16.6	5.2	8.2	5.0	11.5	29.3	8.1	7.3	6.5	5.3	12.5	8.9	11.5	12.2	15.9	7.3	13.1	11.2	6.2	11.9	7.8	8.6	9.0	11.4	5.9	7.9	6.8	7.5	14.1	9.0	10.6	4.1	14.8	9.5	17.1	12.7	12.4	7.0	5.7	8.3	13.3	9.0	11.0	6.1	13.5	7.5	6.9	6.0	5.5	5.7	6.3	9.6	8.7	6.7	20.2	5.3	3.5	7.1	10.3	7.6	5.7	7.0	7.7	6.7	5.6	6.4	7.2	9.2	7.3	11.4	8.2	5.1	9.8	5.7	4.4	11.3	12.7	10.9	10.7	10.7	9.2	12.8	8.1	9.8	12.6	32.8	28.6	14.9	17.9	17.1	27.3	62.7	28.1	33.5	33.0	31.4	13.7	35.1	18.3	32.5	87.1	17.9	15.6	0.0	27.4	27.2	19.7	20.0	15.1	79.9	19.8	30.2	9.9	22.1	23.9	189.0	26.7	16.0	16.9	26.2	22.4	24.3	27.3	17.5	28.0	28.4	24.1	25.8	16.0	33.9	29.6	26.3	74.6	19.1	23.3	18.4
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392455-176416569	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Pancreatic endocrine cells: 1144.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 105.2;MCF7: 93.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		350000	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	20.4	24.1	29.7	18.7	26.7	13.5	16.0	27.5	47.9	27.7	34.7	14.2	11.4	35.4	15.0	15.7	94.2	12.7	28.4	65.7	26.4	26.9	20.3	15.0	15.6	12.2	25.9	22.7	24.3	19.7	17.9	19.8	61.2	28.7	16.8	18.1	19.4	22.2	19.3	93.7	81.8	41.1	27.1	15.4	14.2	39.6	9.9	10.1	14.3	17.2	55.4	31.2	26.1	45.3	4.3	9.9	28.0	9.9	7.4	11.6	3.6	33.3	16.0	4.5	19.4	10.2	7.7	37.4	43.0	16.8	27.3	19.6	20.7	15.6	7.3	25.4	19.3	11.0	31.9	7.7	105.2	10.7	49.9	14.3	4.9	23.8	12.7	16.1	7.8	13.1	8.2	36.7	14.9	17.7	5.5	12.8	5.9	9.3	18.7	15.0	93.6	12.2	11.8	3.7	28.0	23.9	13.3	8.1	24.0	14.4	13.6	19.6	6.7	20.5	22.5	14.6	5.5	9.2	15.0	27.6	9.9	14.8	17.9	24.3	14.9	10.3	9.8	7.9	16.6	11.2	2.8	9.9	28.0	7.2	7.5	3.7	3.1	6.4	7.0	9.9	4.3	5.2	5.5	18.7	7.4	9.7	8.0	11.6	3.6	29.7	26.7	27.5	47.9	26.4	26.9	25.9	22.7	28.7	10.1	53.6	23.2	58.1	196.8	563.1	275.7	186.4	73.9	9.4	29.6	78.5	60.9	109.8	114.4	340.2	7.2	90.2	537.2	23.3	397.9	474.5	139.4	165.3	48.4	90.4	99.6	317.8	145.7	58.9	80.5	11.0	113.1	120.4	209.2	73.9	265.3	88.8	1144.6	526.1	122.0	193.6	54.8	77.6	222.4	15.8	14.4	701.9	323.2	77.3	199.5	331.8
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		51000000	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	39.5	45.7	47.4	35.1	57.6	30.7	57.9	59.1	83.6	38.1	45.0	25.1	47.7	27.9	38.7	52.3	32.1	30.9	34.1	39.9	47.1	53.7	48.6	46.0	46.5	60.7	53.9	59.3	29.8	23.3	96.1	30.0	51.5	57.0	38.9	48.9	22.7	28.6	54.4	44.2	30.5	27.7	45.8	47.8	28.0	34.2	29.4	28.8	28.0	43.7	26.6	31.2	37.1	40.6	10.0	24.6	13.9	24.6	12.3	15.6	13.1	47.4	71.8	35.4	35.0	59.8	48.8	40.5	51.0	53.8	45.7	47.8	44.0	29.2	33.0	58.6	72.4	50.6	31.3	52.8	42.4	61.1	35.5	28.4	54.1	45.4	68.2	45.7	37.0	31.3	46.1	26.0	69.5	44.8	36.0	50.5	16.9	53.9	46.8	71.2	84.6	21.9	11.0	30.5	43.4	41.9	19.5	59.3	40.0	51.2	67.3	31.8	37.8	31.6	20.7	30.2	47.8	49.2	23.3	64.5	83.9	50.1	40.0	52.2	36.8	51.7	30.5	61.5	25.1	51.2	10.5	20.9	13.9	12.7	24.6	15.6	10.0	11.7	13.7	24.6	9.1	10.0	11.0	13.4	12.3	20.7	16.1	14.5	13.1	47.4	57.6	59.1	83.6	47.1	53.7	53.9	59.3	57.0	28.8	92.3	94.7	38.0	37.2	56.7	86.7	68.8	86.6	72.3	81.9	73.3	56.9	86.9	23.2	67.8	20.6	66.0	118.0	93.5	84.2	40.6	77.3	84.0	65.9	162.9	151.0	81.0	115.9	156.5	173.7	53.1	68.4	90.2	50.6	62.3	109.9	47.7	89.2	73.7	88.1	105.0	55.3	77.6	61.2	51.7	37.2	69.4	90.3	33.1	108.8	72.3
CLTCL1	"CHC22, CLH22, CLTCL, CLTD"	ENSG00000070371	"Clathrin heavy chain like 1"	P53675	22	19179473-19291716	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.0"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 11.2;Cone photoreceptor cells: 13.7;Early spermatids: 15.7;Late spermatids: 12.9;Spermatocytes: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.3;neutrophil: 8.4"	"Group enriched"	"Detected in many"	15	"granulocytes: 8.4;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 34.9;K-562: 16.3"									"HPA075327, HPA075795"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA075327: , HPA075795: AB_2686764"	"unprognostic (1.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.71e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.06e-1)"	2.9	3.3	1.1	0.9	2.0	9.7	1.6	3.4	1.8	1.3	1.0	3.7	1.2	0.4	2.3	3.1	2.2	1.4	0.9	5.6	1.3	1.7	1.0	1.7	1.2	0.6	2.7	1.4	1.4	0.9	2.1	14.9	1.1	4.1	1.8	0.8	4.2	1.5	1.1	53.0	2.1	0.9	2.4	3.6	0.9	1.0	17.2	1.2	1.3	2.7	10.4	0.7	1.2	1.3	0.2	0.3	8.4	3.3	0.0	0.3	0.6	2.3	2.4	1.6	2.6	5.9	3.2	0.7	1.6	1.7	2.3	3.4	0.8	0.7	0.9	0.2	3.6	1.7	0.8	2.5	4.6	1.9	0.1	2.4	0.1	2.2	2.7	3.0	3.3	34.9	13.9	3.7	4.2	5.9	6.7	1.4	1.3	16.3	0.9	5.3	1.8	0.4	11.6	2.0	9.4	2.0	1.2	13.3	0.0	1.8	0.9	3.8	0.6	3.5	2.2	0.2	2.0	4.7	14.1	0.4	4.1	8.7	2.3	2.7	1.8	4.2	0.4	2.4	9.0	0.8	0.0	3.3	0.3	0.1	0.7	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.0	8.4	0.0	0.0	0.1	0.0	0.6	1.1	2.0	3.4	1.8	1.3	1.7	2.7	1.4	4.1	1.2	3.0	0.3	0.0	0.5	0.6	1.6	11.2	2.5	0.0	2.3	0.0	13.7	0.3	0.0	0.7	15.7	0.4	0.0	0.0	0.0	0.1	0.9	1.4	0.0	1.5	0.3	0.0	0.0	1.3	1.5	12.9	2.3	0.0	0.0	0.0	1.2	1.7	1.0	0.0	3.9	0.6	2.1	0.0	2.1	13.4	5.3	0.6	0.9	0.0	0.9	0.0
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15665031	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 204.4"	"Cell type enriched"	"Detected in some"	15	"Proximal tubular cells: 679.1"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 5.0"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.1	0.2	0.3	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4.0	0.2	0.7	5.0	0.3	0.0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0.0	0.5	0.0	3.0	0.4	3.0	2.1	1.5	0.6	0.8	1.2	1.0	0.1	0.0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	0.2	10.6	0.9	2.5	0.0	0.4	1.4	0.3	0.0	1.0	1.6	0.0	0.0	0.2	2.4	0.4	6.1	0.7	0.0	2.4	0.7	0.6	0.3	3.5	0.2	0.4	3.5	0.9	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2.0	6.5	1.0	0.3	0.1	0.2	0.5	0.4	0.0	0.5	0.3	0.4	0.9	0.1	0.1	0.0	0.5	0.0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3.0	0.9	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	26.2	0.0	1.9	46.4	19.8	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	679.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0
CLUAP1	"CFAP22, FAP22, FLJ13297, IFT38, KIAA0643"	ENSG00000103351	"Clusterin associated protein 1"	Q96AJ1	16	3500924-3539048	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 215.5;Early spermatids: 173.4;Rod photoreceptor cells: 118.6;Spermatocytes: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA036976, HPA044191"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA036976: AB_10602209, HPA044191: AB_2678852"	"unprognostic (1.78e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.12e-2)"	8.3	10.4	12.3	6.8	22.3	3.3	12.7	13.6	18.8	19.2	11.7	12.1	15.7	4.0	23.0	14.7	10.2	27.6	9.5	9.4	11.4	12.5	16.5	6.8	10.5	6.7	11.9	17.8	22.7	10.7	30.5	22.1	9.3	15.8	15.4	8.9	12.0	10.0	18.3	8.8	6.0	6.0	17.6	11.7	5.7	8.8	34.6	10.3	8.2	19.5	6.2	5.2	12.7	9.1	4.7	4.5	2.7	2.7	5.5	19.8	4.1	8.3	10.0	11.6	15.5	17.6	18.4	6.0	10.5	14.2	17.2	12.9	2.8	17.0	4.0	9.3	17.1	10.4	8.7	7.6	12.4	14.8	3.3	7.2	3.7	5.8	5.5	20.6	6.6	4.1	11.8	13.8	16.1	16.1	18.3	9.3	9.0	10.9	0.6	12.7	9.9	6.2	7.3	12.0	3.5	5.9	13.8	8.1	8.2	25.9	2.5	12.9	11.1	6.3	4.9	7.6	9.4	10.3	15.4	6.1	11.8	7.9	9.0	8.1	7.0	5.6	1.1	4.5	3.9	8.1	2.7	2.5	0.7	4.5	2.7	8.5	4.7	13.0	7.7	4.5	4.0	19.8	13.4	1.0	5.5	1.6	4.5	6.7	4.1	12.3	22.3	13.6	18.8	11.4	12.5	11.9	17.8	15.8	10.3	20.8	15.6	4.2	12.2	4.9	38.6	10.9	7.6	215.5	35.2	14.0	102.1	17.4	36.5	18.2	173.4	8.4	4.0	0.0	7.0	6.6	15.6	7.9	4.7	8.9	9.0	36.5	16.8	17.2	3.8	47.7	29.1	4.8	3.3	26.2	7.7	41.5	8.7	3.5	31.1	27.8	118.6	6.5	14.4	118.6	62.8	3.6	7.8	10.2	9.2	4.2
CLUH	"CLU1, KIAA0664"	ENSG00000132361	"Clustered mitochondria homolog"	O75153	17	2689386-2712663	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.2"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CACO-2: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031505, HPA044346"	Uncertain		Supported	"Nuclear bodies,Vesicles"		NA	NA			Vesicles	"Nuclear bodies"	"HPA031505: AB_2673912, HPA044346: AB_10962153"	"unprognostic (3.48e-2)"	"unprognostic (3.97e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.64e-2)"	"unprognostic (5.11e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.26e-2)"	14.1	21.0	9.6	10.4	12.4	7.8	10.2	16.0	20.9	7.6	17.5	10.6	7.4	29.4	8.4	6.9	28.7	7.6	11.2	31.8	8.5	6.9	28.6	75.2	7.4	8.2	7.0	9.7	8.3	20.3	7.0	8.2	6.2	12.5	9.4	8.1	9.9	18.9	8.4	65.6	20.0	20.9	9.9	6.5	9.9	13.6	11.4	7.5	6.8	10.1	22.1	15.9	12.4	10.0	4.5	5.0	0.4	5.9	1.1	4.7	1.5	18.8	33.6	2.4	8.5	5.0	3.7	28.1	10.1	3.6	11.0	7.9	67.8	7.7	34.5	12.2	4.8	6.7	34.5	11.2	13.2	3.6	12.3	24.9	18.9	26.1	23.4	4.7	15.0	12.3	6.1	7.9	12.3	6.4	2.4	5.5	11.4	23.1	10.4	3.2	20.3	16.8	14.6	7.6	8.8	19.4	27.4	10.5	18.2	6.8	29.2	11.4	9.0	11.5	31.8	11.8	1.7	19.1	7.8	10.6	9.1	12.5	24.8	22.1	5.3	5.9	13.0	9.4	20.0	10.7	0.0	4.3	0.0	3.4	5.9	2.6	4.1	2.0	1.8	4.4	4.5	4.7	4.1	0.4	1.1	3.6	5.0	2.6	1.5	9.6	12.4	16.0	20.9	8.5	6.9	7.0	9.7	12.5	7.5	6.0	18.1	8.5	8.5	27.1	17.5	35.8	43.3	8.1	15.9	17.4	21.6	8.2	10.0	15.3	1.5	8.3	36.2	23.3	15.5	6.0	8.2	12.0	1.1	92.0	11.5	7.9	24.8	9.8	7.8	2.5	4.6	6.3	20.3	6.4	32.3	6.2	17.5	10.5	5.6	26.8	15.7	6.5	11.0	5.0	16.6	31.0	6.9	5.7	49.3	18.7
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 45.2"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 335.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 24.6"					"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: AB_2732286"	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.5	1.4	5.0	0.5	3.8	4.3	3.1	4.5	6.6	2.1	1.0	1.4	1.0	0.6	1.9	0.7	1.6	2.4	2.5	0.4	5.9	6.4	7.5	0.7	1.8	0.8	4.9	2.0	7.4	1.6	2.5	6.1	0.7	5.1	12.0	0.0	45.2	3.1	1.6	0.1	0.8	1.7	0.4	5.3	0.1	3.9	3.4	2.8	0.3	9.4	0.1	0.4	2.1	0.3	1.0	1.3	2.1	0.3	0.1	2.0	0.5	2.6	3.9	7.5	5.1	0.0	0.0	4.5	2.9	0.2	0.0	0.0	3.1	1.5	3.1	0.7	0.0	2.7	1.1	0.0	0.4	0.0	2.5	7.0	5.2	2.1	24.6	0.0	1.7	1.0	0.2	0.0	0.0	0.0	1.3	0.3	7.7	7.3	9.1	0.0	0.8	3.1	5.6	0.5	3.2	1.8	6.3	3.5	11.0	0.8	0.8	6.6	4.6	2.9	1.8	2.2	6.3	2.4	0.8	0.6	3.0	4.4	2.1	1.4	5.2	9.1	6.5	2.4	3.4	2.6	0.9	0.3	0.2	0.2	0.0	0.1	1.0	0.4	0.2	0.5	0.1	0.1	0.8	2.1	0.1	0.0	1.3	2.0	0.5	5.0	3.8	4.5	5.7	5.9	6.4	4.9	2.0	5.1	2.8	0.0	1.6	0.0	3.4	0.0	23.9	0.1	0.0	4.0	2.3	0.0	19.6	0.4	1.7	0.2	0.4	0.2	0.0	0.0	0.2	0.1	0.1	8.5	0.0	0.0	0.2	15.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	46.9	0.0	0.0	1.1	0.3	335.8	6.5	0.0	8.4	4.5	0.1	0.3	0.0	0.0	1.4
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	15	"granulocytes: 52.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;SuSa: 2.5;U-937: 3.1"	"Low region specificity"	"Detected in single"							"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	12.3	0.2	0.2	2.9	0.2	0.0	15.9	0.2	0.2	7.3	6.2	0.2	1.2	0.1	2.9	6.0	8.3	1.0	10.0	10.3	0.2	0.2	2.0	0.8	1.1	1.6	0.2	0.2	0.6	0.9	0.5	0.5	0.7	0.3	6.0	6.9	3.0	5.9	1.3	1.2	13.0	5.3	6.2	0.2	0.5	2.4	2.7	0.2	1.0	0.4	7.9	3.9	4.1	2.0	0.3	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	1.5	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.9	1.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.8	2.5	0.0	0.8	1.4	0.0	0.2	0.3	0.3	0.8	0.9	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog (yeast)"	Q9BQ75	3	99817834-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	21.4	34.1	23.7	15.1	24.5	17.7	20.6	24.1	27.4	13.4	12.9	9.4	8.2	8.3	19.6	10.7	12.0	13.3	10.5	16.6	24.0	22.2	17.1	17.5	10.8	15.8	15.3	22.3	21.1	26.4	20.7	25.9	11.7	19.2	15.1	12.4	9.3	12.4	14.5	58.2	11.5	9.3	13.8	15.7	12.9	11.0	28.1	13.5	13.6	14.9	14.4	14.7	18.8	15.7	23.5	26.1	1.6	10.9	11.2	19.0	7.9	28.9	13.1	13.0	18.7	9.2	10.9	13.4	13.5	7.3	24.3	20.3	16.3	9.7	31.4	23.7	7.2	21.5	17.5	18.0	15.3	32.2	16.2	17.2	24.7	9.3	13.2	16.6	33.8	13.6	7.4	14.9	18.1	30.3	7.7	16.8	25.4	15.2	20.4	17.6	20.0	27.0	31.5	19.0	27.6	32.9	12.2	21.0	33.6	15.0	7.1	36.7	15.4	13.5	11.0	30.7	13.0	13.3	21.2	4.8	19.3	54.8	11.2	27.4	14.6	29.0	61.0	12.5	37.4	32.2	0.3	4.7	0.8	10.0	10.9	14.2	23.2	14.8	13.5	9.9	23.5	18.7	19.0	1.6	11.2	9.7	26.1	13.7	7.9	23.7	24.5	24.1	27.4	24.0	22.2	15.3	22.3	19.2	13.5	6.0	14.2	29.8	33.2	55.3	30.0	40.3	43.3	29.4	23.9	59.3	17.7	34.3	82.9	17.0	137.8	37.9	1.1	0.0	40.8	46.0	41.2	21.8	61.1	44.9	24.7	120.8	14.5	19.0	5.8	151.1	46.9	25.2	35.4	14.4	13.3	17.6	29.9	0.0	55.2	66.2	21.4	25.8	64.6	105.9	127.7	57.7	18.3	28.7	20.7	22.0
CMTM1	"CKLFH, CKLFH1a, CKLFSF1"	ENSG00000089505	"CKLF like MARVEL transmembrane domain containing 1"	Q8IZ96	16	66566393-66579137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 80.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 60.6;Late spermatids: 113.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"REH: 16.8"									"HPA013801, HPA017136"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013801: AB_1846990, HPA017136: AB_1846992"	"unprognostic (2.37e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-1)"	0.9	0.8	0.8	1.9	1.2	0.0	0.5	2.2	1.3	0.7	0.9	0.5	0.5	1.7	1.3	1.1	0.6	0.8	1.5	0.7	0.8	1.1	0.8	0.5	0.9	1.2	0.8	0.6	1.7	0.5	0.3	1.1	0.9	0.7	0.7	0.2	0.5	0.6	0.5	0.6	0.6	1.2	0.5	0.9	2.8	0.9	80.7	0.7	0.8	0.7	0.5	0.6	0.9	0.6	0.3	1.9	8.7	2.1	1.3	1.9	1.1	4.2	6.7	1.2	5.6	2.4	2.3	1.2	5.6	2.7	4.5	4.7	1.4	2.9	2.0	3.0	1.6	1.4	3.4	1.9	0.3	2.4	7.4	1.3	0.7	3.0	1.4	1.1	3.9	4.9	1.9	0.5	4.0	0.5	6.9	2.3	4.0	3.5	2.8	1.9	1.6	7.4	3.8	1.0	0.6	2.5	16.8	14.4	4.6	4.0	2.0	3.2	4.3	7.8	0.6	2.0	0.2	2.0	2.8	5.7	8.0	12.7	4.8	2.4	2.8	6.7	7.3	3.8	5.3	9.3	8.7	2.1	7.1	1.9	0.6	1.6	0.2	0.6	0.9	1.9	0.3	0.5	0.6	8.4	1.3	1.2	0.5	0.6	1.1	0.8	1.2	2.2	1.0	0.8	1.1	0.8	0.6	0.7	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	113.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	6.5	0.0	4.8	0.4	0.3	0.1	0.0	0.0	0.0
CMTM3	"BNAS2, CKLFSF3, FLJ31762"	ENSG00000140931	"CKLF like MARVEL transmembrane domain containing 3"	Q96MX0	16	66603874-66613892	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 178.7;granulocytes: 90.0;Hofbauer cells: 108.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013870, HPA072695"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013870: AB_1847003, HPA072695: AB_2732210"	"unprognostic (1.59e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.65e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (4.42e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	24.3	8.5	5.4	11.5	6.1	8.0	29.5	1.2	4.6	19.1	7.8	10.0	7.7	3.2	18.0	19.1	10.0	12.2	16.3	15.9	5.9	4.9	8.9	6.1	21.7	34.1	6.7	2.6	25.4	6.5	22.9	5.6	30.8	8.4	16.4	6.0	15.5	9.3	8.7	7.9	11.5	9.1	14.0	8.4	19.0	6.2	61.7	6.9	35.6	8.6	10.4	14.6	13.6	21.1	1.4	19.9	7.0	11.3	6.5	12.0	4.4	1.8	9.6	27.3	19.0	20.4	12.9	16.8	4.9	22.7	10.0	10.0	5.3	6.0	0.0	13.7	13.9	17.5	2.1	18.3	16.4	8.1	9.4	6.5	6.0	1.3	14.9	27.6	17.9	22.2	25.5	1.3	10.6	2.2	41.7	22.8	17.0	9.2	0.2	12.4	2.3	14.5	30.0	13.0	0.1	9.1	45.3	19.1	0.9	4.8	0.2	2.8	9.7	2.4	0.1	15.9	18.5	0.2	16.6	15.1	14.4	17.2	3.4	5.9	1.2	0.1	6.0	9.0	13.9	15.3	6.1	11.3	7.0	7.8	10.9	10.9	1.4	8.8	8.9	9.7	0.8	6.8	8.2	6.6	6.5	6.5	19.9	12.0	4.4	5.4	6.1	1.2	4.6	5.9	4.9	6.7	2.6	8.4	6.9	0.0	10.3	18.2	25.6	13.1	0.6	1.6	5.1	2.7	7.9	5.2	0.0	7.2	0.0	20.2	1.8	33.7	0.0	0.0	5.8	178.7	48.2	33.2	90.0	0.8	108.7	0.0	12.0	41.1	71.2	6.3	36.5	64.5	27.0	11.8	0.5	10.0	25.7	0.0	23.0	2.2	0.6	6.5	19.7	3.9	9.7	7.5	7.9	69.9	0.0	19.4
CMTM4	CKLFSF4	ENSG00000183723	"CKLF like MARVEL transmembrane domain containing 4"	Q8IZR5	16	66614750-66696707	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 39.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014704, HPA023890"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles, Plasma membrane"		"HPA014704: AB_1847005, HPA023890: AB_1847007"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.43e-1)"	"unprognostic (5.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.06e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	2.7	4.8	18.9	3.3	18.2	2.9	6.6	8.3	22.1	4.8	16.1	13.5	8.7	12.6	3.2	21.8	4.5	11.5	4.8	3.3	20.0	16.2	18.3	2.5	6.5	1.3	17.0	13.0	2.5	15.1	31.7	9.4	4.3	12.5	6.8	13.4	5.2	10.7	6.9	2.7	7.2	15.8	4.2	13.3	1.8	18.5	6.3	10.3	0.0	39.3	0.5	2.1	4.3	2.6	0.2	1.3	0.1	1.2	0.2	0.9	0.2	9.6	8.3	4.8	11.9	1.6	2.4	20.2	4.1	3.5	2.2	3.6	14.6	11.0	0.4	7.1	2.4	3.0	12.3	11.8	4.6	3.3	0.8	10.8	0.9	3.0	8.8	3.5	0.8	1.9	4.0	8.2	2.5	5.2	7.5	1.2	1.3	4.9	2.7	3.2	10.6	0.1	1.9	5.7	17.1	5.4	2.1	6.4	2.9	9.5	8.7	11.5	4.4	16.6	9.2	5.7	3.6	9.8	2.0	2.5	4.0	4.7	1.1	4.1	0.9	1.9	0.5	5.0	2.0	4.9	0.0	1.2	0.0	0.3	0.3	0.0	0.0	0.1	0.9	1.3	0.2	0.1	0.2	0.1	0.2	0.7	1.3	0.7	0.2	18.9	18.2	8.3	22.1	20.0	16.2	17.0	13.0	12.5	10.3	20.8	12.0	0.0	6.0	4.6	10.9	5.9	25.5	21.4	7.9	22.7	7.9	4.2	11.6	14.5	1.6	3.0	26.2	0.0	20.6	27.7	3.1	19.1	4.6	5.0	2.0	28.6	37.5	1.3	3.0	2.1	2.3	1.5	3.3	0.0	24.3	22.6	24.1	11.5	2.8	20.3	9.2	6.5	4.7	4.7	6.8	4.8	2.4	0.0	32.7	12.7
CMTM5	"CKLFSF5, FLJ37521"	ENSG00000166091	"CKLF like MARVEL transmembrane domain containing 5"	Q96DZ9	14	23376808-23379772	"Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 19.4;brain: 67.3"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 28.7"	"Group enriched"	"Detected in some"	37	"glioma: 8.4;melanoma: 3.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 7.6;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 7.6"	"Cell line enriched"	"Detected in some"	6	"HEL: 42.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052338	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA052338: AB_2681793"	"unprognostic (2.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.40e-2)"		"unprognostic (8.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.24e-4)"	"unprognostic (3.03e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	1.7	1.8	14.1	1.3	19.4	6.6	1.3	4.8	55.4	2.6	1.9	47.0	0.0	1.3	1.6	1.6	2.1	1.7	2.5	5.8	19.6	12.1	1.1	1.0	1.7	1.1	26.9	10.3	1.7	1.1	0.9	0.1	1.5	18.4	1.9	1.6	0.6	3.1	4.2	1.4	1.5	2.0	1.7	67.3	1.9	1.1	1.1	12.7	0.0	1.0	0.0	1.0	1.3	0.7	0.1	0.7	7.6	0.4	0.0	0.3	19.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	42.7	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	7.6	0.4	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.7	0.3	19.4	14.1	19.4	4.8	24.8	19.6	12.1	26.9	10.3	18.4	12.7	0.0	0.0	0.0	0.1	0.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.2	0.0	0.0	0.0	5.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391671-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 104.7;Kupffer cells: 102.2;Macrophages: 86.9;monocytes: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 39.8;hTERT-RPE1: 41.0"	"Low region specificity"	"Detected in all"							HPA077409			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077409: AB_2686838"	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	14.5	6.5	3.3	18.9	5.7	23.8	43.1	4.5	2.2	10.0	6.2	4.3	11.0	3.1	7.7	12.3	4.8	24.5	14.6	8.3	2.8	2.8	14.8	5.9	25.1	47.5	5.9	1.0	9.3	27.6	0.9	2.8	11.4	4.7	12.8	5.9	6.1	8.7	17.6	4.0	6.4	10.9	7.0	10.3	32.4	8.2	5.8	4.6	45.9	24.5	3.3	23.1	16.5	12.4	10.0	24.8	24.4	47.0	4.9	36.2	22.1	0.1	4.5	9.8	11.9	9.2	9.1	27.9	4.4	5.3	8.0	7.4	5.0	39.8	0.0	13.8	5.3	9.9	5.0	12.1	20.5	7.1	0.0	9.6	5.3	0.0	11.6	37.6	1.3	8.5	9.6	2.7	8.2	13.1	41.0	18.0	0.0	4.4	12.0	5.9	0.1	0.0	12.3	11.8	2.0	20.9	25.6	3.7	24.4	11.3	8.8	0.5	10.2	0.6	0.7	22.8	4.4	6.2	13.8	10.3	7.6	7.6	8.3	15.4	3.4	1.2	0.0	2.7	16.7	15.9	5.5	47.0	24.4	5.3	44.1	3.2	10.0	17.9	10.9	24.8	7.0	19.5	13.5	18.0	4.9	37.2	10.5	36.2	22.1	3.3	5.7	4.5	2.2	2.8	2.8	5.9	1.0	4.7	4.6	23.8	14.7	40.7	17.6	8.8	0.2	1.5	15.3	14.7	23.9	17.4	0.0	19.8	0.0	83.6	0.1	15.7	1.3	23.3	13.6	6.7	16.0	11.2	28.9	1.0	104.7	1.6	16.6	18.4	102.2	1.0	1.4	86.9	23.6	120.0	3.4	1.3	59.3	8.6	1.1	24.0	0.2	6.5	14.5	1.2	7.2	4.8	5.7	43.6	3.0	10.2
CMTM8	CKLFSF8	ENSG00000170293	"CKLF like MARVEL transmembrane domain containing 8"	Q8IZV2	3	32238679-32370325	"Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 81.9;Syncytiotrophoblasts: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.2;memory CD4 T-cell: 2.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.2;T-cells: 2.8"	"Group enriched"	"Detected in many"	4	"BEWO: 68.3;SK-BR-3: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055077, HPA073258"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055077: AB_2682691, HPA073258: AB_2686591"	"unprognostic (9.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	9.7	9.9	4.3	4.1	3.5	0.9	27.0	1.5	3.4	4.7	6.8	1.3	10.8	5.2	3.4	13.4	4.2	6.3	5.7	8.2	3.6	3.2	8.8	40.0	19.9	12.6	3.9	3.3	2.1	79.8	2.8	3.1	12.4	2.5	8.8	5.5	4.4	13.5	19.2	4.3	6.2	8.1	2.0	3.1	1.5	10.0	1.1	1.6	5.5	20.7	6.0	11.2	4.7	5.6	0.1	0.0	4.2	0.1	0.4	2.8	0.3	3.3	3.5	0.6	4.3	3.1	4.9	68.3	0.0	0.1	0.3	0.4	4.7	4.8	0.0	7.1	0.0	0.0	1.8	5.5	1.1	0.3	0.0	10.1	2.1	0.7	7.9	0.2	0.8	1.7	9.6	3.5	0.4	3.4	1.7	2.7	3.6	0.0	0.0	3.4	2.4	2.7	0.3	1.4	5.1	3.2	3.9	0.8	0.6	4.2	3.8	1.2	1.0	0.5	19.3	1.7	0.8	5.5	0.4	2.4	0.0	5.2	0.0	1.0	0.1	0.1	0.0	0.0	1.5	1.1	0.0	0.1	4.2	0.3	0.0	0.4	0.0	2.8	0.8	0.0	0.1	1.8	0.3	0.0	0.4	0.0	0.0	0.0	0.3	4.3	3.5	1.5	3.4	3.6	3.2	3.9	3.3	2.5	1.6	35.7	27.6	0.8	29.9	10.3	0.0	1.7	12.7	6.7	19.4	0.0	0.0	81.9	10.0	16.6	7.5	35.8	13.1	23.3	32.2	59.6	6.9	51.8	0.0	67.6	8.5	0.0	21.4	46.1	6.0	1.8	2.3	4.1	5.0	1.0	41.2	30.7	28.4	10.5	1.1	21.6	1.7	0.0	4.7	3.4	2.1	5.6	97.1	15.0	21.1	38.8
CMTR2	"AFT, FLJ11171, FTSJD1, MTr2"	ENSG00000180917	"Cap methyltransferase 2"	Q8IYT2	16	71281389-71289715	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041700, HPA048265"	Uncertain		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Cell Junctions"	"Nuclear speckles"	"HPA041700: AB_2677623, HPA048265: AB_2680334"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.86e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (4.97e-5)"	"unprognostic (9.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.34e-2)"	10.4	14.9	7.1	11.7	9.0	5.4	15.9	5.3	9.1	10.6	13.4	11.5	15.6	14.1	12.5	16.4	20.4	8.8	11.0	9.0	8.5	6.9	13.5	18.2	10.7	14.7	12.4	3.4	16.2	12.2	12.7	24.3	17.4	9.0	11.9	10.5	10.6	13.6	14.1	8.4	9.9	16.1	9.4	9.5	17.5	8.9	16.0	9.3	20.9	14.3	7.6	15.4	9.6	14.2	11.2	10.3	11.0	8.0	13.1	11.2	8.6	11.5	8.1	11.6	11.5	13.1	11.4	6.5	9.4	9.2	10.7	10.3	4.8	16.0	6.2	11.4	7.4	12.0	11.4	7.1	8.5	13.1	6.5	4.8	17.2	4.7	6.0	16.3	10.2	23.7	8.2	16.2	7.8	10.6	7.8	12.1	12.3	7.5	4.7	17.7	10.3	12.3	17.2	7.2	9.6	4.8	16.6	7.4	13.5	13.2	7.8	7.7	8.6	10.6	9.3	10.4	6.7	13.9	7.4	11.6	12.1	11.2	12.3	7.3	8.7	9.0	11.1	9.1	10.4	10.4	11.0	7.2	7.1	9.8	8.0	11.2	11.2	9.2	10.3	10.3	10.2	10.5	10.3	0.4	13.1	5.2	3.6	8.0	8.6	7.1	9.0	5.3	9.1	8.5	6.9	12.4	3.4	9.0	9.3	3.0	10.2	29.3	13.2	12.6	20.9	6.7	10.2	0.0	6.8	15.7	29.5	18.6	6.6	10.2	75.3	15.7	25.5	0.0	8.3	10.6	10.4	12.0	8.1	23.6	13.9	14.3	17.9	18.4	15.4	21.7	15.5	13.0	1.7	8.2	17.2	17.1	10.3	15.2	11.7	12.9	27.8	6.5	7.4	23.0	11.7	21.2	22.1	25.4	15.5	15.2
CMYA5	"C5orf10, DKFZp451G223, myospryn, SPRYD2, TRIM76"	ENSG00000164309	"Cardiomyopathy associated 5"	Q8N3K9	5	79689877-79800240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 119.1;skeletal muscle: 329.3"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 3073.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.6;RT4: 3.1;THP-1: 10.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA074081, HPA077831"	Enhanced		Approved	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"	"Vesicles, Plasma membrane"	"HPA074081: , HPA077831: "	"unprognostic (5.53e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.01e-4)"	"unprognostic (7.00e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.69e-2)"	"unprognostic (9.74e-2)"	2.4	0.2	0.3	0.0	0.3	0.0	0.9	0.3	0.4	0.4	0.4	0.0	0.0	0.0	1.4	2.6	2.0	0.5	0.2	119.1	0.3	0.3	0.6	0.3	0.3	0.0	0.3	0.0	3.6	0.2	2.2	1.1	0.3	0.3	1.4	0.0	0.0	2.4	0.5	329.3	0.5	0.2	1.1	0.4	0.2	0.3	0.2	0.1	0.0	2.3	54.0	2.5	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	1.0	1.3	0.4	0.1	0.1	0.2	0.2	0.4	0.1	0.0	1.9	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.2	0.0	0.1	1.6	0.4	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	2.6	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	3.1	0.1	0.0	0.1	0.0	0.2	0.2	2.0	10.7	0.0	0.1	0.4	0.0	0.3	0.2	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.1	8.9	3.2	0.0	15.7	1.1	1.4	3073.8	2.5	8.1	15.9	24.4	0.0	14.8	14.9	0.5	0.1	0.7	0.0	0.0	0.4	2.5	3.7	5.2	1.1	2.0	1.8	205.0	1.7	0.6	0.3	1.1	13.8	1.1	0.0	0.0	0.0	10.8	0.4	0.0	12.7	11.5	2.6	0.0	0.9	0.2	1.1	4.6	27.5	0.5	0.0	12.0
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129169484-129183922	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Approved	Nucleoplasm,Cytosol		NA	NA		43000	Nucleoplasm	Cytosol	"HPA063097: AB_2684939"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	54.2	52.8	36.4	33.6	33.7	35.9	46.6	43.5	35.6	58.1	47.1	34.5	40.5	32.4	54.5	49.4	55.6	40.9	48.5	78.2	33.0	32.0	38.0	71.6	47.5	40.6	39.7	30.3	67.4	65.4	39.3	33.5	41.5	33.3	62.3	37.1	41.3	48.9	50.9	182.1	46.7	40.6	71.9	38.0	43.2	43.1	32.1	33.1	39.0	67.3	81.1	41.2	76.1	63.5	74.3	60.3	120.1	84.1	61.7	83.4	172.9	61.7	36.6	53.4	42.3	53.4	45.8	42.2	48.6	77.1	53.0	60.9	53.6	43.5	82.2	41.7	45.2	38.9	46.5	69.8	56.3	71.9	55.1	50.8	79.4	37.8	57.7	53.2	85.1	45.7	44.3	66.2	37.1	134.1	36.1	46.7	46.4	59.4	56.6	55.5	73.9	78.8	62.6	65.1	55.1	61.9	69.3	49.6	97.9	54.9	59.5	72.8	58.3	38.3	37.9	103.0	32.6	43.6	58.6	49.2	39.3	38.7	53.9	49.1	53.2	48.4	129.3	40.5	58.4	51.8	93.4	84.1	96.8	64.1	63.8	80.6	74.3	77.4	68.9	60.3	62.7	83.4	72.0	120.1	61.7	48.9	35.1	73.9	172.9	36.4	33.7	43.5	35.6	33.0	32.0	39.7	30.3	33.3	33.1	241.2	236.8	168.8	346.4	466.2	151.2	559.4	112.1	211.5	257.0	75.0	31.4	228.5	316.7	172.7	25.7	265.4	148.7	46.7	254.5	331.1	308.6	248.1	302.0	134.8	219.0	87.4	164.4	125.8	185.1	30.7	292.6	305.9	301.9	415.6	158.2	306.6	196.4	147.3	300.5	191.8	122.5	258.7	447.2	255.1	271.9	512.9	243.9	251.4	182.3	305.2
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390287	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 268.7;lymphoid tissue: 276.3;tongue: 323.6;vagina: 85.7"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 31.4;Enterocytes: 33.5;Intestinal endocrine cells: 31.2;Paneth cells: 38.6"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"memory B-cell: 25.1;naive B-cell: 27.5"	"Lineage enriched"	"Detected in many"	11	"B-cells: 27.5"	"Cell line enhanced"	"Detected in many"		"A549: 14.7;HEK 293: 21.0;MCF7: 10.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			Microtubules	"Cytokinetic bridge"	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favorable (4.02e-5)"	"unprognostic (2.45e-1)"	0.4	0.3	0.2	0.2	0.8	0.2	2.5	0.2	0.2	58.9	0.5	0.2	0.2	0.2	4.4	1.4	268.7	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.3	0.2	39.0	0.3	0.5	37.3	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.9	0.2	323.6	276.3	0.2	85.7	27.5	2.4	0.5	2.0	0.0	0.7	1.0	4.7	14.7	0.3	1.3	0.7	0.7	0.2	0.8	0.3	0.3	0.3	0.8	1.3	4.1	6.6	0.2	1.0	1.9	1.2	1.8	0.1	0.0	21.0	0.3	5.5	1.5	0.0	0.0	0.0	1.5	3.3	0.8	0.0	0.1	0.0	3.8	0.8	0.2	0.0	10.0	0.0	0.1	5.4	6.4	4.4	1.7	0.3	2.2	1.4	1.8	2.2	6.4	2.7	4.1	1.9	2.3	5.0	2.1	0.0	0.0	4.5	0.1	0.0	4.8	5.7	2.7	0.0	1.7	0.2	0.0	2.0	0.0	0.7	1.5	0.2	25.1	0.5	0.5	2.4	27.5	0.2	0.4	0.5	0.0	0.3	0.5	0.0	1.0	0.2	0.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	2.1	11.5	15.0	4.0	0.0	0.8	2.5	6.7	9.1	31.4	0.0	0.2	6.6	7.5	0.6	5.2	33.5	0.0	2.2	0.2	1.0	15.2	4.6	0.8	4.7	0.0	31.2	3.7	4.5	3.2	4.9	5.5	3.3	4.6	21.3	0.1	3.6	38.6	4.2	9.0	0.0	0.0	4.8	0.5	14.2	11.3	0.2	0.0	28.2	20.4
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel alpha 1"	P29973	4	47935977-48016672	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.7"	"Cell type enriched"	"Detected in many"	9	"Rod photoreceptor cells: 880.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	4.9	1.1	0.6	2.7	1.0	0.1	2.9	0.3	0.5	5.7	6.1	0.2	1.6	2.1	0.6	12.1	13.7	3.9	1.5	1.0	0.6	0.6	4.9	23.7	0.5	0.0	1.3	0.0	1.6	2.1	5.2	4.2	21.3	0.4	6.2	2.3	14.7	4.9	1.7	4.2	5.3	12.7	0.5	0.9	8.2	2.5	1.4	0.2	0.1	2.2	3.6	2.7	8.2	8.8	0.7	2.7	1.2	0.4	1.9	1.6	0.1	3.2	1.2	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	13.4	0.1	0.7	0.0	3.6	2.1	0.3	0.4	0.1	0.0	0.9	0.0	0.3	1.0	0.0	0.1	0.3	0.1	0.6	0.0	0.1	1.6	0.0	1.1	0.9	0.7	0.2	1.3	0.1	0.2	0.6	2.0	3.1	0.1	0.0	0.1	0.6	10.7	0.3	0.1	0.2	0.6	0.2	0.3	1.2	0.0	0.6	0.3	4.2	0.1	0.1	0.9	1.0	0.1	0.1	0.1	2.4	0.2	0.4	0.0	0.5	0.4	0.1	0.3	0.2	1.6	0.3	0.7	0.3	0.6	1.2	1.9	0.2	2.7	0.1	0.1	0.6	1.0	0.3	0.5	0.6	0.6	1.3	0.0	0.4	0.2	0.0	0.0	0.0	1.4	0.1	78.5	0.4	2.5	0.0	0.0	59.3	86.4	0.0	0.0	7.8	0.4	0.1	8.4	0.0	5.9	0.0	0.2	4.0	0.0	30.0	1.3	42.9	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	3.2	100.9	1.6	10.5	0.0	0.3	880.8	0.0	3.1	0.3	1.3	2.4	0.2	0.0	2.9	15.6
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel beta 1"	Q14028	16	57882340-57971116	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 79.8"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 312.2;Rod photoreceptor cells: 1014.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;RPMI-8226: 3.4;SCLC-21H: 9.6;SiHa: 5.6;SK-BR-3: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA			Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.2	7.2	13.1	3.0	3.0	0.7	0.2	0.2	6.3	0.2	1.7	0.0	0.0	0.5	0.2	0.5	0.2	0.4	0.8	0.2	7.1	11.0	0.2	0.2	0.4	0.7	1.3	4.0	0.1	1.5	0.0	0.5	1.2	4.2	0.2	1.2	79.8	0.3	0.4	0.1	0.5	1.8	0.2	0.7	0.2	0.2	1.3	0.0	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	2.6	0.3	0.3	0.4	0.0	0.6	1.2	0.0	0.2	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	3.0	0.0	1.0	0.0	0.0	2.5	0.0	0.2	0.0	0.6	1.8	1.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.6	0.1	0.2	0.0	0.2	0.1	0.0	3.4	0.0	1.2	9.6	0.1	5.6	2.8	0.0	0.2	0.1	0.1	0.7	0.3	0.5	0.4	0.1	0.2	0.6	0.1	0.1	0.3	0.1	0.6	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.4	0.2	2.6	0.3	0.3	0.3	0.0	0.0	13.1	3.0	0.2	6.3	7.1	11.0	1.3	4.0	4.2	0.0	0.0	0.0	0.0	0.5	0.0	44.0	0.8	0.0	0.0	0.0	0.0	312.2	4.7	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.4	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.3	0.0	0.0	0.0	1014.1	0.0	0.0	0.4	0.6	0.0	1.1	0.0	0.0	0.1
CNKSR1	"CNK, CNK1, KSR"	ENSG00000142675	"Connector enhancer of kinase suppressor of Ras 1"	Q969H4	1	26177403-26189886	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.1;memory CD4 T-cell: 2.4;naive CD4 T-cell: 1.4;T-reg: 2.6"	"Group enriched"	"Detected in many"	8	"B-cells: 2.1;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"A-431: 11.6;BEWO: 10.1;CAPAN-2: 18.0;HaCaT: 13.3;hTCEpi: 11.5;OE19: 10.1;SK-BR-3: 11.6;T-47d: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030847	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA030847: AB_10601100"	"unprognostic (2.73e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.91e-1)"	"prognostic favorable (5.91e-4)"	0.7	0.0	1.0	3.5	1.4	0.0	4.5	5.4	1.1	4.4	19.1	0.8	12.8	8.6	1.9	11.9	15.4	6.1	13.3	0.7	1.4	1.2	10.0	2.9	10.2	0.7	0.9	0.7	2.5	27.6	10.2	12.6	32.4	1.2	10.3	5.4	0.7	15.7	18.9	17.7	11.9	22.6	1.0	1.3	1.3	7.3	1.5	0.7	1.9	20.6	11.9	15.9	6.1	5.3	2.1	0.0	0.0	0.0	0.2	2.6	0.5	11.6	0.0	0.2	0.1	0.2	0.0	10.1	0.3	0.0	0.4	0.0	1.8	18.0	1.9	6.0	0.0	0.1	13.3	0.3	8.5	0.3	0.4	0.6	0.3	4.3	5.0	0.1	0.1	0.2	0.0	11.5	0.0	3.3	0.0	0.0	0.4	1.5	0.1	0.0	5.4	0.1	0.6	5.2	10.1	1.1	0.1	0.1	0.0	1.1	6.8	2.5	0.6	0.0	11.6	0.2	4.6	11.0	0.0	0.0	0.0	1.8	0.7	0.1	4.1	0.7	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.3	1.4	0.1	0.0	0.2	0.0	0.0	2.6	0.5	1.0	1.4	5.4	1.1	1.4	1.2	0.9	0.7	1.2	0.7	14.9	4.5	0.8	13.0	13.1	2.6	0.8	12.7	14.7	6.8	33.2	2.0	27.4	1.7	10.6	0.4	0.7	23.3	0.0	10.9	12.0	1.3	14.9	0.0	0.0	2.3	0.0	17.9	1.3	0.0	0.4	1.1	0.7	1.7	1.8	17.9	1.1	17.6	24.6	0.7	0.3	3.0	0.0	1.9	2.3	4.0	9.9	27.1	0.0	18.3	22.5
CNKSR2	"CNK2, KIAA0902, KSR2"	ENSG00000149970	"Connector enhancer of kinase suppressor of Ras 2"	Q8WXI2	X	21372801-21654695	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 38.4"	"Cell type enhanced"	"Detected in many"	21	"Cone photoreceptor cells: 19.6;Horizontal cells: 22.3;Rod photoreceptor cells: 86.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.9;naive CD4 T-cell: 3.0"	"Group enriched"	"Detected in many"	5	"B-cells: 2.9;T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 6.8;AF22: 4.8;NTERA-2: 11.1;PC-3: 5.7;RH-30: 10.3;U-251 MG: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001502			Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"		"HPA001502: AB_1078542"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.13e-2)"	2.0	5.2	23.5	1.4	29.6	1.3	2.1	31.3	38.4	1.4	1.2	1.7	0.0	1.1	1.4	1.8	1.1	2.3	1.2	1.7	26.4	4.4	1.0	2.0	2.8	2.4	3.1	20.8	1.9	4.9	1.0	1.0	1.1	1.8	2.2	1.1	3.5	1.7	1.2	7.4	1.1	1.2	1.2	1.7	1.8	1.3	1.8	5.0	0.6	1.2	0.0	2.6	1.3	0.7	2.9	0.1	0.6	0.0	0.0	3.0	0.3	0.0	6.8	4.8	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	2.0	0.1	11.1	0.0	5.7	0.0	10.3	0.0	0.0	0.0	4.7	1.9	0.0	0.1	0.2	2.9	0.0	0.6	0.0	0.1	2.2	0.0	6.8	3.6	0.0	3.6	1.0	0.0	2.7	0.1	0.0	0.6	0.1	0.0	0.4	1.1	0.6	0.0	0.0	2.9	3.0	1.0	0.0	0.0	0.0	0.1	0.8	0.3	23.5	29.6	31.3	24.4	26.4	4.4	3.1	20.8	1.8	5.0	14.9	2.2	0.5	0.5	1.1	11.3	5.6	0.0	0.0	10.3	0.0	19.6	0.0	0.0	0.4	0.2	0.0	0.4	0.0	1.9	0.0	1.4	2.1	1.1	2.4	0.1	22.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	12.8	0.8	0.0	1.4	0.0	86.9	0.0	0.8	0.9	8.7	1.6	0.0	0.0	0.1	0.0
CNKSR3	"FLJ31349, MAGI1"	ENSG00000153721	"CNKSR family member 3"	Q6P9H4	6	154387504-154510659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 67.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 17.4"									"CAB037133, HPA049651"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB037133: AB_477217, HPA049651: AB_2680841"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (4.23e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.38e-1)"	9.4	2.2	4.2	5.5	5.8	1.6	5.8	1.8	5.0	7.6	12.5	11.6	6.0	8.7	15.8	8.3	19.4	6.5	9.2	8.9	5.3	3.4	17.0	20.0	6.3	3.5	8.0	2.5	10.0	26.6	1.5	4.5	8.2	8.3	8.3	5.5	12.6	7.5	7.7	2.2	6.7	13.5	15.3	8.2	7.6	6.7	8.6	7.7	0.6	4.1	8.7	6.6	9.8	10.2	0.9	1.4	3.6	0.6	0.9	0.5	0.2	0.3	4.0	2.8	5.6	5.0	3.8	0.3	4.9	3.0	8.6	7.1	17.4	0.4	0.1	5.4	5.3	2.8	1.7	8.3	0.5	4.5	0.0	5.1	13.3	0.8	9.6	2.2	0.0	3.0	5.1	2.7	3.3	3.4	1.5	2.7	1.1	1.7	0.1	2.3	1.1	0.1	0.3	2.0	3.3	5.2	3.8	4.9	6.4	10.0	2.8	1.7	10.7	2.2	1.2	1.0	1.3	0.0	1.2	3.1	0.8	2.5	6.4	3.2	0.1	0.0	0.1	0.1	0.3	3.7	2.1	0.6	1.2	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.9	0.5	0.5	3.6	0.9	0.4	1.4	0.3	0.2	4.2	5.8	1.8	5.0	5.3	3.4	8.0	2.5	8.3	7.7	11.9	38.5	0.9	13.6	23.6	1.9	30.2	12.7	13.4	18.2	24.4	0.0	6.3	8.3	14.8	39.4	28.7	27.4	0.0	10.4	0.8	14.6	10.7	5.7	55.0	1.5	0.0	41.5	67.5	7.6	11.1	5.5	5.1	30.4	1.0	21.1	27.8	10.1	15.8	9.9	24.5	1.8	0.0	6.6	1.1	5.3	20.8	18.0	5.1	11.5	8.8
CNN1	"Sm-Calp, SMCC"	ENSG00000130176	"Calponin 1"	P51911	19	11538717-11550323	"Cancer-related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 489.2;urinary bladder: 357.9"	"Group enriched"	"Detected in many"	7	"Early spermatids: 328.5;Late spermatids: 430.5;Peritubular cells: 207.9;Smooth muscle cells: 159.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 142.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 33.7;BJ hTERT+: 12.9;BJ hTERT+ SV40 Large T+: 17.6;BJ hTERT+ SV40 Large T+ RasG12V: 24.5;HBF TERT88: 27.2;SuSa: 28.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB000007, HPA014263"	Enhanced		Approved	"Actin filaments"		No	No			"Actin filaments"		"CAB000007: AB_2082148, HPA014263: AB_1847039"	"unprognostic (4.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (5.43e-6)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.78e-3)"	"unprognostic (6.11e-3)"	9.3	4.1	0.5	34.9	0.9	0.0	7.9	0.5	1.2	90.5	193.4	1.3	78.1	9.4	182.6	50.6	140.5	52.2	105.7	22.2	0.6	0.6	6.2	1.0	9.5	2.2	0.7	1.8	36.5	1.3	0.0	0.7	4.0	2.2	120.1	26.4	8.8	9.1	125.2	4.8	4.5	37.1	489.2	1.0	1.2	66.5	16.4	0.5	0.4	3.2	4.5	3.3	357.9	26.8	0.0	0.4	0.0	0.1	0.0	0.0	5.2	0.0	0.5	2.2	0.4	0.2	0.0	1.3	33.7	12.9	17.6	24.5	9.5	0.0	0.1	1.0	9.5	1.6	0.1	0.0	0.0	27.2	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.1	1.1	0.0	10.8	0.0	0.5	0.0	0.0	12.5	0.0	0.0	0.0	0.1	1.7	1.1	0.0	0.2	0.1	0.4	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	28.8	0.0	0.0	0.1	0.1	12.7	0.5	0.4	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.5	0.9	0.5	1.2	0.6	0.6	0.7	1.8	2.2	0.5	0.0	0.0	0.0	5.1	4.2	0.0	35.3	0.0	0.0	0.0	1.8	0.0	0.4	0.0	2.8	328.5	2.4	0.0	0.0	0.3	0.9	9.3	2.2	0.0	0.0	2.0	0.0	0.0	9.2	0.0	430.5	7.8	0.0	3.3	1.0	0.0	0.2	1.4	0.0	207.9	0.0	0.0	38.8	159.5	2.5	4.9	6.1	0.6	0.0	0.0	0.9
CNN2		ENSG00000064666	"Calponin 2"	Q99439	19	1026581-1039068	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049095	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		39000000	Cytosol	"Nucleoplasm, Actin filaments"	"HPA049095: AB_2680627"	"unprognostic (2.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.54e-1)"	36.6	6.5	1.3	46.2	2.5	44.2	29.2	2.0	3.0	38.2	16.9	5.4	22.2	5.5	35.5	24.5	39.4	25.0	40.1	18.7	1.5	1.5	24.6	15.8	54.7	61.5	3.5	1.5	81.1	26.8	1.9	6.9	21.5	4.8	35.6	7.8	26.3	40.9	34.4	6.1	21.3	17.7	28.2	2.9	59.4	21.1	15.9	2.1	37.0	68.1	27.3	78.6	37.9	51.2	33.6	29.3	115.7	26.3	27.1	57.0	43.1	36.9	12.5	34.9	43.4	18.0	34.3	27.1	33.5	37.1	42.3	32.9	43.0	32.0	24.4	34.4	60.5	9.9	36.5	20.7	53.5	28.2	16.9	1.7	16.9	20.1	33.6	72.2	15.8	39.0	58.3	25.5	26.8	20.2	69.2	23.8	18.4	10.1	38.0	34.4	7.0	1.4	14.5	43.1	30.0	5.5	8.3	12.3	27.5	41.6	44.5	0.0	2.4	42.4	5.8	4.8	26.6	42.1	26.6	58.3	23.2	24.0	35.4	34.1	17.7	13.5	48.5	13.6	19.0	37.0	61.3	18.6	81.0	34.8	24.2	57.0	33.6	43.7	46.4	29.3	30.8	37.3	36.3	115.7	27.1	26.3	13.0	45.6	43.1	1.3	2.5	2.0	3.0	1.5	1.5	3.5	1.5	4.8	2.1	56.6	58.7	76.0	231.3	86.7	0.2	4.8	15.3	20.1	38.7	34.9	9.8	9.0	53.0	56.6	0.4	15.5	36.0	0.0	120.7	81.2	48.8	45.2	57.8	28.4	49.6	0.0	14.8	38.1	67.6	0.6	7.5	75.9	13.5	120.8	32.3	0.8	137.6	21.2	72.2	4.0	6.6	32.3	72.9	1.7	3.1	76.8	9.5	91.5	26.0	151.9
CNNM1	ACDP1	ENSG00000119946	"Cyclin and CBS domain divalent metal cation transport mediator 1"	Q9NRU3	10	99329099-99394330	"Predicted membrane proteins"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.5;testis: 16.8"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 30.2;Early spermatids: 76.6;Horizontal cells: 47.7;Late spermatids: 66.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"A549: 17.4;BJ hTERT+: 6.6;BJ hTERT+ SV40 Large T+: 6.1;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HAP1: 7.8;OE19: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040408	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA040408: AB_10793963"	"unprognostic (9.04e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.60e-4)"	"unprognostic (4.08e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.03e-1)"	0.6	2.5	3.4	0.7	15.5	0.5	1.3	8.1	12.7	2.0	1.0	0.3	1.1	1.2	2.1	3.7	1.4	2.4	1.0	0.5	2.8	5.0	2.4	0.8	0.6	0.5	2.1	7.1	5.4	1.7	0.4	4.2	0.5	4.8	3.6	1.2	0.7	1.0	2.1	0.5	2.5	1.2	1.5	1.0	0.5	1.6	16.8	2.3	0.0	0.5	0.2	0.6	2.2	1.2	0.1	0.1	0.2	0.0	0.1	1.3	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	2.5	6.6	6.1	10.4	0.0	4.0	0.0	0.0	1.2	0.1	1.6	7.8	0.0	4.4	0.0	0.8	1.7	2.6	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.3	2.3	0.2	0.0	0.8	6.7	0.7	0.0	0.0	0.0	0.8	0.0	2.0	5.6	1.8	0.4	0.8	0.5	0.0	0.0	0.0	0.6	0.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.3	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.4	15.5	8.1	12.4	2.8	5.0	2.1	7.1	4.8	2.3	0.0	0.0	0.0	3.4	2.1	30.2	1.1	0.0	0.0	0.0	1.8	13.7	0.0	0.0	0.4	76.6	0.7	0.0	0.0	1.3	0.0	0.5	2.4	0.0	0.0	0.0	47.7	0.0	2.5	0.0	66.1	2.0	0.0	1.7	0.0	0.0	0.8	1.8	0.0	2.5	0.5	3.3	0.0	0.3	1.1	1.4	0.9	0.0	0.0	0.0	2.2
CNNM3	ACDP3	ENSG00000168763	"Cyclin and CBS domain divalent metal cation transport mediator 3"	Q8NE01	2	96816245-96833911	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016711	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA016711: AB_1847394"	"unprognostic (1.50e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.32e-3)"	"unprognostic (3.64e-1)"	"unprognostic (5.31e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.48e-2)"	8.1	10.7	8.6	6.4	11.5	5.2	8.6	25.0	11.2	8.9	13.3	16.9	7.4	17.4	10.7	5.3	7.5	12.0	15.0	5.9	10.0	5.2	8.6	20.7	8.8	7.2	14.5	9.7	11.6	27.9	28.9	15.7	10.3	11.4	8.9	8.3	13.1	11.4	9.9	9.9	7.7	15.1	10.7	7.0	9.5	12.3	11.4	15.9	13.8	10.0	2.4	10.2	9.9	8.2	3.0	1.8	5.5	3.3	2.1	5.4	1.3	6.9	7.3	6.0	9.8	7.5	3.6	18.3	4.9	4.2	4.7	4.7	18.8	11.7	7.8	17.0	3.8	5.3	8.1	9.1	6.4	3.0	7.7	22.0	10.6	9.2	19.0	6.6	9.1	7.8	3.6	7.8	6.3	5.6	5.7	5.7	6.4	9.6	12.5	1.8	9.2	8.5	8.9	8.3	10.2	8.5	10.5	8.4	9.7	7.6	9.5	19.3	11.7	6.3	9.6	5.3	8.6	9.7	6.7	2.7	4.2	11.9	6.1	6.8	12.5	12.1	5.7	2.4	8.7	4.2	2.7	1.4	5.5	5.4	0.6	2.9	3.0	2.8	4.4	0.4	2.8	2.5	2.7	3.0	2.1	3.3	1.8	4.6	1.3	8.6	11.5	25.0	11.2	10.0	5.2	14.5	9.7	11.4	15.9	8.9	3.7	4.2	2.8	1.1	17.9	14.3	10.2	4.0	3.4	0.0	7.9	4.3	0.0	3.6	6.3	2.3	4.9	0.0	3.6	2.0	2.4	5.7	0.0	12.9	2.2	31.8	4.1	4.3	2.6	1.1	2.3	0.8	3.3	1.0	6.4	8.9	2.9	0.0	3.9	1.6	12.9	12.9	3.3	3.4	7.5	1.4	1.4	2.5	6.9	2.2
CNOT10	"FLJ12890, FLJ13165"	ENSG00000182973	"CCR4-NOT transcription complex subunit 10"	Q9H9A5	3	32685145-32773875	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 66.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035614, HPA041450"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Centrosome"	Cytosol	"HPA035614: AB_10669975, HPA041450: AB_2677487"	"unprognostic (3.75e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.43e-1)"	12.3	12.6	11.3	15.2	12.4	16.6	14.0	14.2	13.4	13.4	14.0	12.5	12.8	10.8	19.8	13.5	14.8	16.1	9.8	13.0	10.5	9.4	13.1	13.5	11.4	14.7	9.7	11.9	14.7	14.0	16.0	23.0	11.3	13.3	13.1	15.7	12.2	12.0	10.9	13.5	14.9	14.7	12.8	10.5	15.1	12.2	40.5	10.9	30.2	13.8	11.9	17.4	13.0	12.6	15.0	14.1	16.0	21.0	9.0	18.5	11.2	8.4	9.5	9.9	9.3	4.8	5.5	66.1	7.1	7.2	10.2	11.5	7.2	7.3	13.9	4.8	5.1	6.6	7.4	11.7	9.4	10.2	12.0	12.0	17.8	8.6	6.9	14.0	14.6	6.9	4.0	8.5	11.2	14.9	6.8	8.3	13.0	18.5	10.8	5.9	6.9	13.0	7.1	14.9	9.8	9.1	13.2	6.7	13.8	6.5	9.9	5.6	10.9	10.5	14.8	8.6	7.3	14.4	16.6	5.1	6.3	9.0	8.3	11.8	11.2	22.9	13.9	6.5	11.1	7.6	12.8	11.2	16.0	11.4	15.7	12.3	14.8	18.5	13.6	14.1	15.0	18.5	16.2	8.8	9.0	21.0	7.8	14.4	11.2	11.3	12.4	14.2	13.4	10.5	9.4	9.7	11.9	13.3	10.9	14.9	21.4	14.3	5.8	9.3	15.9	10.8	7.6	32.1	15.9	14.0	31.4	11.6	5.0	11.2	42.3	11.4	11.8	0.0	11.7	14.6	9.8	6.0	10.4	8.5	10.3	14.3	15.0	11.1	14.8	29.1	8.9	12.9	11.8	47.7	8.3	8.0	9.9	14.4	9.9	5.6	18.7	6.5	10.6	35.7	32.4	12.7	6.9	18.3	13.6	6.7
CNOT11	"C2orf29, C40"	ENSG00000158435	"CCR4-NOT transcription complex subunit 11"	Q9UKZ1	2	101252802-101270316	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069823, HPA074943"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069823: AB_2686209, HPA074943: "	"unprognostic (1.72e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (4.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.72e-3)"	13.2	19.0	13.9	19.7	15.1	20.9	14.4	13.3	18.6	17.0	21.5	15.0	19.7	23.0	19.2	18.2	31.9	17.7	23.7	25.6	12.5	12.5	23.9	28.9	14.9	24.1	15.0	13.8	14.3	27.9	16.8	17.6	36.7	16.9	20.6	26.0	16.9	22.5	15.8	27.3	17.5	25.5	15.3	11.1	27.2	25.0	32.5	13.2	39.8	19.4	23.6	30.7	20.7	17.0	4.0	3.6	11.1	3.9	1.6	5.9	1.7	16.2	11.2	18.5	25.6	15.5	18.8	54.9	16.9	21.3	20.9	22.2	24.7	18.8	28.7	20.0	15.0	26.6	19.8	21.9	20.1	25.4	19.5	18.9	24.0	12.2	36.8	17.2	28.7	23.8	14.8	18.5	15.0	16.0	17.3	23.4	16.4	26.7	17.5	18.8	16.8	28.0	31.2	23.0	25.7	16.0	18.0	20.1	22.0	28.6	30.9	27.9	17.7	10.2	30.4	27.1	22.0	19.2	26.6	15.6	16.5	19.0	14.1	14.0	25.2	23.5	22.6	18.1	32.5	19.0	9.1	2.8	4.9	4.5	3.9	3.1	2.9	4.7	5.5	2.2	4.0	4.4	5.9	11.1	1.6	3.6	3.6	5.7	1.7	13.9	15.1	13.3	18.6	12.5	12.5	15.0	13.8	16.9	13.2	6.0	11.2	15.3	19.2	10.4	10.7	25.0	28.1	14.7	6.8	38.4	13.7	55.7	26.6	46.1	5.4	14.6	20.0	0.0	36.3	43.7	10.7	24.8	5.8	25.4	20.2	6.4	10.4	17.2	17.1	6.3	8.9	12.6	5.0	32.5	25.1	16.9	36.3	14.4	11.3	29.3	10.7	38.8	14.7	35.6	15.1	11.2	48.2	20.8	21.3	37.9
CNOT2	"CDC36, NOT2, NOT2H"	ENSG00000111596	"CCR4-NOT transcription complex subunit 2"	Q9NZN8	12	70242994-70354993	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067711	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA067711: AB_2685893"	"unprognostic (5.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.23e-2)"	27.8	19.9	18.9	24.6	23.8	44.5	24.9	53.3	24.7	24.0	21.7	21.9	21.6	20.1	37.5	25.8	22.5	20.6	18.8	20.1	18.7	16.2	21.8	24.1	25.9	24.8	23.8	21.2	26.8	20.5	25.0	41.2	30.1	19.8	24.3	24.9	20.5	21.6	21.9	27.6	36.7	24.4	25.5	23.4	26.8	18.8	16.3	24.8	46.1	22.7	20.9	28.8	24.8	24.5	28.8	33.1	37.1	36.5	32.2	41.3	27.2	19.8	18.9	32.1	20.2	17.7	20.0	26.7	22.0	26.6	24.5	21.0	24.2	19.3	42.6	20.3	25.1	15.7	19.6	22.3	21.6	27.5	20.4	20.2	28.0	17.4	22.7	18.9	36.1	25.0	21.8	24.3	23.0	28.0	36.8	25.9	26.4	25.5	24.7	21.3	21.4	41.2	25.8	27.3	20.3	20.2	32.0	26.5	25.8	22.7	40.0	21.4	25.3	25.9	21.0	18.5	28.7	26.8	30.0	18.9	22.9	15.7	20.9	17.7	22.6	25.8	33.7	23.4	17.7	17.9	37.1	26.0	28.3	29.4	36.5	32.8	28.8	31.9	32.9	33.1	27.6	38.0	41.3	15.1	32.2	29.3	23.0	29.7	27.2	18.9	23.8	53.3	24.7	18.7	16.2	23.8	21.2	19.8	24.8	38.7	39.2	30.3	33.3	45.3	61.2	26.6	50.9	44.2	40.9	34.9	53.0	39.0	28.2	41.8	19.7	42.9	38.2	23.3	38.7	40.0	42.0	37.1	73.0	29.8	35.6	49.3	55.7	44.8	51.1	6.5	42.3	42.3	30.4	26.2	38.5	47.8	37.7	41.8	43.9	21.7	50.2	38.8	47.0	33.9	39.8	56.0	29.6	65.4	35.5	38.9
CNOT3	"KIAA0691, LENG2, NOT3, NOT3H"	ENSG00000088038	"CCR4-NOT transcription complex subunit 3"	O75175	19	54137717-54155708	"Cancer-related genes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 72.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006408	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA006408: AB_1078543"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.08e-3)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	18.1	25.2	25.5	23.6	26.4	21.4	20.2	46.8	27.9	22.1	20.7	24.5	27.7	21.3	25.0	26.5	22.1	23.6	19.7	16.2	21.9	15.6	21.3	20.2	17.9	23.9	25.5	20.8	28.0	22.7	27.6	30.2	24.2	20.3	23.3	17.5	20.7	22.4	31.4	20.2	25.2	21.4	22.0	16.7	26.3	21.9	34.4	26.9	33.6	26.3	14.3	23.3	23.8	29.9	3.2	6.7	8.4	3.1	1.6	3.6	2.9	13.8	22.3	23.2	13.3	8.6	8.8	16.2	13.0	22.5	17.4	15.6	14.3	12.0	17.1	8.3	15.0	14.3	14.6	25.7	12.6	18.1	17.6	72.5	26.5	14.5	12.7	15.0	15.1	18.6	11.0	12.2	15.5	26.3	12.6	13.8	13.0	19.5	16.0	12.8	17.1	18.7	8.9	14.1	28.5	17.9	18.7	17.8	11.1	11.7	28.1	15.0	12.6	25.1	18.1	8.2	18.0	10.3	16.2	12.3	14.8	17.1	7.9	17.6	15.1	16.4	23.6	12.9	11.6	15.6	1.4	3.1	5.2	3.6	2.2	2.5	2.9	2.4	3.2	2.8	3.2	2.7	2.6	8.4	1.6	2.6	6.7	2.5	2.9	25.5	26.4	46.8	27.9	21.9	15.6	25.5	20.8	20.3	26.9	11.9	9.0	17.1	14.7	8.9	17.3	1.7	12.7	12.0	11.4	7.0	15.7	23.7	8.3	12.8	7.4	10.5	14.4	0.0	12.6	22.9	13.5	16.1	3.5	7.6	14.1	15.9	13.8	12.9	7.9	5.4	15.8	7.2	5.0	16.2	15.2	11.3	13.1	20.1	8.9	8.1	17.8	6.5	11.2	44.2	39.9	8.7	41.9	12.5	11.9	14.8
CNOT6	"CCR4, Ccr4a, KIAA1194"	ENSG00000113300	"CCR4-NOT transcription complex subunit 6"	Q9ULM6	5	180494412-180578405	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044568	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA044568: AB_10797257"	"unprognostic (9.41e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.57e-2)"	10.2	10.1	19.2	15.4	20.2	14.4	13.3	43.9	18.7	12.0	16.4	11.7	9.7	16.2	13.1	12.4	19.6	13.3	12.7	13.0	15.9	11.1	14.1	8.6	13.0	14.3	12.3	14.0	14.8	10.3	13.4	12.7	17.6	12.9	13.9	16.2	14.3	13.4	10.9	8.3	14.4	20.6	13.4	12.3	17.0	13.7	17.6	14.9	25.1	12.6	10.0	18.4	16.9	24.5	2.2	2.5	3.4	5.8	2.1	4.5	1.7	11.1	13.4	27.6	22.0	4.6	5.3	28.5	8.1	5.5	10.9	13.0	16.3	16.4	11.8	12.5	5.3	15.1	11.7	23.0	27.2	12.8	34.5	11.5	12.8	18.1	10.5	6.8	14.9	9.4	4.4	13.2	8.0	17.0	10.2	13.2	13.9	13.6	11.4	10.0	22.9	18.9	9.0	8.1	11.2	6.4	17.5	13.9	8.4	12.0	22.1	20.2	17.1	13.8	18.5	11.8	14.1	23.1	15.1	14.3	11.6	13.4	8.4	14.4	7.4	13.3	12.5	11.0	20.5	9.5	1.5	2.6	3.4	3.8	4.1	4.0	2.0	3.3	2.3	2.4	2.2	4.5	4.4	2.2	2.1	5.8	2.5	2.3	1.7	19.2	20.2	43.9	18.7	15.9	11.1	12.3	14.0	12.9	14.9	26.8	12.0	6.7	5.5	19.3	18.0	9.6	10.2	8.1	6.8	10.4	21.6	7.9	1.7	10.2	5.2	11.9	11.1	0.0	7.8	9.9	10.4	14.0	2.3	5.7	10.6	17.5	13.9	14.7	16.7	7.5	12.0	13.1	10.1	8.2	14.3	13.1	12.9	5.8	17.7	11.8	15.3	25.8	7.3	39.4	56.2	19.4	9.6	12.9	15.1	12.9
CNOT9	"CAF40, CT129, RCD1, RCD1+, RQCD1"	ENSG00000144580	"CCR4-NOT transcription complex subunit 9"	Q92600	2	218568580-218597080	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 34.0;monocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046622	Approved		Approved	"Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA			"Cytoplasmic bodies"		"HPA046622: AB_10962694"	"unprognostic (7.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (8.41e-9)"	"unprognostic (8.08e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (4.69e-9)"	"unprognostic (1.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	24.1	24.2	18.8	26.1	25.3	36.9	18.3	27.5	27.4	23.5	20.1	30.0	17.3	18.8	26.2	22.2	24.5	21.8	17.8	21.4	19.2	19.4	16.2	26.4	20.8	30.7	20.5	12.9	23.1	19.8	22.3	41.8	25.1	20.1	21.7	25.3	24.8	19.3	22.4	23.2	21.9	19.6	22.1	22.2	27.8	17.9	33.7	16.9	45.3	18.9	20.5	37.2	21.2	20.1	20.9	24.1	20.6	21.7	23.2	30.5	22.3	17.0	13.2	22.3	29.4	13.2	12.9	28.9	19.2	20.8	25.3	24.9	22.8	14.3	19.2	12.2	22.7	22.3	20.2	31.7	22.0	30.1	27.0	19.2	37.9	25.3	28.2	18.3	41.0	22.4	11.5	17.8	26.8	27.3	11.7	19.1	26.2	23.0	43.9	20.5	13.6	40.1	25.3	34.0	13.4	21.3	33.8	31.7	19.9	13.6	25.0	28.3	23.3	18.6	17.2	18.3	22.5	13.7	23.0	14.6	27.6	20.4	20.0	23.9	21.0	21.1	45.2	19.7	25.7	19.4	20.6	18.3	19.2	30.5	21.6	26.7	20.9	25.4	25.7	20.9	19.5	24.2	26.4	7.3	23.2	21.7	24.1	20.7	22.3	18.8	25.3	27.5	27.4	19.2	19.4	20.5	12.9	20.1	16.9	20.8	26.8	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.2	12.2	0.0	24.4	23.2	19.9	0.0	0.0	0.0	0.0	17.9	34.0	0.0	0.0	15.1	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	36.1	0.0	0.0	20.4	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0
CNPY2	"Cnpy2, HP10390, TMEM4, ZSIG9"	ENSG00000257727	"Canopy FGF signaling regulator 2"	Q9Y2B0	12	56309842-56316336	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 396.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038465, HPA038466"	Supported		Supported	Cytosol	"Intracellular and membrane"	NA	NA		62000	Cytosol		"HPA038465: AB_10967609, HPA038466: AB_10672646"	"unprognostic (3.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (8.37e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.06e-2)"	17.8	31.4	19.0	16.1	23.8	14.0	27.3	17.3	24.1	29.9	23.7	23.3	40.1	23.0	21.1	46.4	19.1	26.1	19.9	16.9	19.0	20.4	26.7	53.2	17.3	14.9	21.2	21.8	25.7	59.9	19.9	39.3	39.7	21.6	23.4	24.2	18.9	46.2	33.4	10.9	12.3	26.4	16.8	22.5	20.2	23.6	13.7	20.4	13.0	38.0	15.5	16.2	19.7	17.4	33.1	35.3	22.2	36.4	30.1	38.7	33.7	16.2	29.3	21.0	19.3	57.3	22.4	42.5	18.5	36.9	34.5	24.6	39.0	29.1	15.1	32.0	39.9	18.0	23.7	26.2	20.7	20.1	18.3	24.5	14.5	30.9	34.3	28.5	27.3	22.3	26.0	31.5	28.4	32.0	49.5	27.9	21.2	23.2	39.1	23.7	26.7	16.7	32.3	21.5	33.0	41.8	19.7	17.2	32.0	26.8	12.5	22.6	13.3	27.2	27.2	27.2	28.3	25.7	60.1	15.0	15.1	11.5	16.4	22.1	19.2	25.5	11.4	28.0	26.7	24.1	22.2	36.4	18.3	33.4	26.1	38.7	33.1	37.2	35.2	35.3	27.6	37.9	34.3	5.2	30.1	15.9	34.3	31.2	33.7	19.0	23.8	17.3	24.1	19.0	20.4	21.2	21.8	21.6	20.4	44.7	80.8	67.3	61.3	48.7	74.0	8.5	150.3	68.3	56.9	96.0	60.9	216.3	44.7	170.3	31.1	66.5	86.5	23.3	146.9	396.1	82.6	106.0	90.0	177.6	129.7	55.6	136.3	84.7	56.3	11.1	96.1	63.5	116.4	114.6	123.9	72.9	148.7	108.7	94.0	116.9	81.3	25.8	72.2	66.7	41.7	47.0	197.7	84.1	139.6	60.7
CNPY4	"MGC40499, PRAT4B"	ENSG00000166997	"Canopy FGF signaling regulator 4"	Q8N129	7	100119613-100125511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014166, HPA025240"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA014166: AB_1853895, HPA025240: AB_2082630"	"unprognostic (9.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.09e-3)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.35e-2)"	12.9	18.3	10.9	13.4	9.9	5.5	11.6	16.5	13.1	22.8	13.0	14.8	8.8	6.1	23.5	15.8	6.3	16.2	20.3	13.6	9.9	9.1	11.0	6.7	9.2	15.5	9.5	9.9	26.1	7.2	17.6	17.8	20.8	10.4	14.0	10.3	18.0	6.5	17.0	4.7	8.3	9.5	21.7	11.4	14.0	8.4	9.1	13.7	16.4	11.1	9.6	9.5	13.0	16.2	2.8	5.2	8.8	9.3	8.3	15.2	4.7	3.3	5.8	14.6	26.1	34.4	16.6	7.3	12.6	13.6	6.6	12.4	3.1	3.0	7.3	14.6	22.5	4.8	3.4	5.7	6.1	6.9	6.8	5.8	3.0	9.6	4.4	9.8	5.1	5.7	15.1	1.7	6.0	2.7	14.5	22.8	3.6	2.5	4.9	9.4	9.6	10.7	6.7	7.5	2.1	8.4	3.1	11.0	3.9	6.7	0.8	3.6	7.4	12.0	9.7	6.4	9.9	4.9	2.8	18.4	21.2	12.8	8.8	5.6	4.2	6.7	6.6	12.4	7.9	8.6	8.8	3.7	5.7	11.8	8.0	15.2	2.8	12.1	14.7	5.2	2.4	9.9	14.9	1.7	8.3	9.3	3.3	9.6	4.7	10.9	9.9	16.5	13.1	9.9	9.1	9.5	9.9	10.4	13.7	6.0	1.6	0.0	2.0	3.2	6.6	3.2	5.1	4.0	4.5	12.2	2.0	29.6	1.7	5.4	0.4	11.7	2.3	23.3	2.2	8.4	26.6	0.6	9.2	0.9	11.9	7.9	2.4	19.6	1.6	0.9	32.5	3.6	15.1	5.4	1.8	25.5	2.7	2.9	29.7	2.3	13.7	12.9	12.3	1.0	3.8	3.3	15.3	6.5	1.9	0.7
CNRIP1	"C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924"	ENSG00000119865	"Cannabinoid receptor interacting protein 1"	Q96F85	2	68284171-68320051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 71.9;granulocytes: 120.1"	"Cancer enhanced"	"Detected in all"		"glioma: 14.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	79	"basophil: 11.1"	"Lineage enriched"	"Detected in single"	79	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"HEL: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035337			Approved	Cytosol		NA	NA		50000	Cytosol		"HPA035337: AB_10601359"	"unprognostic (1.23e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-3)"	26.6	8.6	26.9	7.1	21.9	6.4	11.8	28.3	42.2	15.3	7.3	7.5	2.0	4.9	15.7	8.0	6.3	9.3	10.3	8.8	26.9	22.4	5.0	3.8	10.0	5.7	16.0	22.9	24.5	2.6	2.7	7.2	14.7	12.7	10.1	6.3	10.9	3.3	11.6	7.8	3.6	7.0	11.8	10.8	10.8	5.7	4.0	6.5	0.1	4.1	3.0	4.1	9.3	13.6	0.1	0.0	11.1	0.1	0.0	0.1	0.1	0.0	0.3	3.0	0.0	11.5	8.5	0.0	11.5	8.9	10.4	7.5	0.0	0.0	0.0	0.4	11.0	7.9	0.0	0.2	0.1	11.0	0.0	2.8	53.5	0.8	0.0	12.1	0.0	7.6	7.9	0.0	6.9	4.0	6.4	16.0	0.0	0.0	0.0	7.5	0.0	0.0	0.1	5.2	0.0	5.3	0.0	4.7	0.0	0.0	0.0	15.8	16.0	0.8	0.0	8.8	0.0	0.0	0.5	17.0	7.3	4.7	6.4	16.7	0.0	0.0	0.0	5.8	0.0	5.3	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	26.9	21.9	28.3	31.9	26.9	22.4	16.0	22.9	12.7	6.5	0.0	7.0	0.0	0.4	11.4	71.9	1.9	0.0	0.0	1.2	0.0	21.6	1.3	0.0	0.3	0.6	60.8	0.0	23.3	0.2	8.9	42.3	0.7	120.1	0.5	43.9	27.0	0.0	30.1	16.8	1.5	42.0	12.4	35.4	3.6	0.0	23.6	0.9	0.0	40.0	0.0	41.8	45.3	56.7	0.4	0.2	9.4	1.7	2.2	0.0	0.9
CNTD1	"CNTD, FLJ40137"	ENSG00000176563	"Cyclin N-terminal domain containing 1"	Q8N815	17	42798792-42811587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"testis: 31.0"	"Group enriched"	"Detected in many"	12	"Ciliated cells: 80.3;Early spermatids: 53.3;Late spermatids: 75.8;Spermatocytes: 135.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 6.3;ASC diff: 4.3;SiHa: 3.3;T-47d: 2.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA023324			Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"HPA023324: AB_1848931"	"unprognostic (5.92e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.29e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.89e-7)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.81e-4)"	0.2	0.1	0.7	0.0	1.4	0.0	1.6	0.2	1.7	0.2	0.6	0.4	0.0	0.0	0.1	0.9	0.1	0.5	0.0	0.1	1.5	0.3	1.2	0.1	0.3	0.0	0.5	0.8	0.3	0.8	0.0	0.1	0.0	0.9	1.1	1.5	0.1	0.5	0.0	0.2	0.1	0.2	0.7	0.8	0.1	2.3	31.0	1.6	0.0	0.1	0.0	0.0	0.2	0.1	0.9	0.1	2.7	0.3	0.1	0.3	0.3	6.3	0.7	0.5	1.3	4.3	1.5	0.0	0.0	0.3	0.4	1.4	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.6	0.0	0.0	1.1	0.2	0.0	0.4	0.6	1.3	0.0	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.0	3.3	0.3	0.8	0.1	2.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.4	0.0	0.3	0.0	0.3	0.2	0.3	0.4	0.1	0.0	0.1	0.9	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.3	0.7	1.4	0.2	1.7	1.5	0.3	0.5	0.8	0.9	1.6	3.0	2.9	0.0	0.4	0.3	1.6	0.8	0.0	80.3	3.4	0.0	0.0	0.2	5.0	0.2	53.3	0.3	0.5	0.0	0.3	0.3	0.6	7.4	5.8	0.9	0.3	6.4	0.0	0.0	1.0	75.8	2.3	0.7	0.0	0.0	4.6	1.2	0.3	0.0	1.1	0.3	0.4	6.5	0.9	135.1	2.7	0.5	0.2	0.5	2.1	0.9
CNTF	HCNTF	ENSG00000242689	"Ciliary neurotrophic factor"	P26441	11	58622673-58625733	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 47.5"	"Cell type enriched"	"Detected in single"	5	"Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"midbrain: 47.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 12.9"	"Low region specificity"	"Detected in many"							HPA019654	Approved		Approved	Vesicles		NA	NA	69200		Vesicles		"HPA019654: AB_1859050"	"unprognostic (1.88e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-4)"	"unprognostic (5.42e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.67e-2)"	2.0	0.7	1.4	0.9	4.8	10.0	0.8	1.2	1.6	0.3	0.9	2.5	1.1	1.4	0.3	1.4	0.9	8.3	0.8	2.5	1.8	1.6	0.9	0.9	0.8	0.6	47.5	0.9	0.3	0.5	1.2	0.5	0.6	9.3	0.6	1.3	3.1	1.3	0.4	3.7	0.9	0.9	0.6	22.8	0.6	0.5	0.7	1.2	0.2	1.0	3.7	0.6	0.6	0.3	0.4	0.0	0.0	0.3	0.0	0.7	0.2	2.1	0.8	3.4	3.6	1.1	0.3	1.7	1.6	2.2	1.6	1.2	3.0	3.0	4.4	1.2	2.2	1.8	3.9	3.7	3.9	3.3	3.1	2.1	2.3	4.4	1.6	0.4	3.4	4.3	1.0	1.4	5.3	1.7	0.7	1.7	3.1	3.4	1.0	2.0	0.9	3.3	3.2	2.1	1.5	1.6	2.2	2.4	3.0	1.9	2.5	1.6	4.3	2.3	2.4	5.9	2.6	3.0	2.5	1.2	2.5	2.0	12.9	4.0	2.4	5.0	3.8	6.7	1.7	2.9	0.0	0.3	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.4	4.8	1.2	1.4	1.8	1.6	47.5	0.9	9.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CNTNAP1	"Caspr, CNTNAP, NRXN4, p190"	ENSG00000108797	"Contactin associated protein 1"	P78357	17	42682613-42699814	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.7;smooth muscle: 26.7"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 12.8;Sertoli cells: 6.5;Smooth muscle cells: 4.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"TIME: 30.0;U-138 MG: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011772	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011772: AB_1079541"	"unprognostic (4.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.16e-14)"	"unprognostic (9.52e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.37e-3)"	6.1	2.5	35.5	5.9	18.8	1.1	1.7	31.7	48.7	4.7	8.5	2.9	1.4	2.3	12.1	7.1	2.9	7.0	7.1	4.0	29.2	14.8	1.7	0.9	3.9	2.8	10.5	23.9	8.7	6.5	1.7	7.2	5.0	18.4	4.2	4.7	2.1	2.0	7.6	3.5	2.5	2.7	26.7	11.5	3.2	3.9	2.3	13.3	0.0	1.7	0.2	2.9	5.8	3.3	0.0	0.7	0.1	0.0	0.1	1.4	0.0	1.8	2.6	5.8	1.9	9.0	18.4	0.4	10.9	19.1	8.1	7.3	0.3	0.4	0.0	0.6	11.9	8.1	2.1	2.8	0.9	6.3	4.2	0.9	0.0	10.8	2.7	4.4	0.0	0.1	17.9	0.0	7.7	1.5	12.9	10.1	0.1	0.5	3.3	3.1	0.3	0.0	1.6	2.0	0.1	2.6	0.3	0.7	1.0	2.1	0.0	1.1	3.4	3.2	0.0	2.1	5.5	2.1	0.9	30.0	34.8	5.9	8.0	3.0	4.0	2.4	0.1	9.6	0.7	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	1.4	0.0	35.5	18.8	31.7	48.7	29.2	14.8	10.5	23.9	18.4	13.3	0.0	2.6	0.0	0.1	0.5	12.8	1.1	0.0	1.4	1.2	0.0	3.9	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.1	1.6	0.0	2.5	0.0	0.0	1.4	0.0	0.0	1.0	0.0	0.8	0.1	0.0	0.7	0.0	2.8	6.5	4.4	0.2	0.2	0.3	0.2	0.0	0.0	0.1
CNTNAP5	"caspr5, FLJ31966"	ENSG00000155052	"Contactin associated protein like 5"	Q8WYK1	2	124025287-124915287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 22.4"	"Cell type enhanced"	"Detected in some"	24	"Bipolar cells: 5.6;Cardiomyocytes: 1.4;Distal tubular cells: 1.7;Horizontal cells: 1.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.3;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.4"					"Low region specificity"	"Detected in all"			"HPA069095, HPA069356"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA069095: AB_2686083, HPA069356: AB_2686127"				"unprognostic (6.32e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.23e-1)"		"unprognostic (2.25e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-6)"	"unprognostic (3.65e-3)"	"unprognostic (5.32e-2)"		"unprognostic (9.58e-2)"	0.7	2.8	12.9	0.7	7.9	1.0	0.7	3.3	22.4	0.6	0.8	1.5	0.0	1.0	0.7	0.7	0.7	0.6	4.2	0.7	14.0	4.0	1.2	0.7	0.7	0.7	2.2	8.4	0.6	1.1	0.7	0.8	0.7	15.2	0.8	0.8	0.4	0.6	1.0	0.7	0.8	0.9	0.8	1.9	0.7	0.7	0.9	2.8	0.0	0.7	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	7.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.9	7.9	3.3	22.4	14.0	4.0	2.2	8.4	15.2	2.8	0.0	0.0	0.0	0.0	0.0	5.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074863-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 156.6;Spermatocytes: 334.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 35.4"	"Low region specificity"	"Detected in all"							"HPA020468, HPA020480, HPA051583"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542"	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	7.7	4.7	5.5	22.2	11.7	24.0	6.8	10.9	8.7	8.4	5.5	4.9	5.9	3.8	7.3	6.4	5.6	8.4	5.1	4.4	6.6	4.3	4.0	3.8	9.3	20.3	8.1	4.1	10.6	5.2	4.0	17.3	5.8	7.0	7.2	5.5	4.4	6.3	8.6	2.8	5.2	8.8	5.7	9.7	14.8	7.1	30.2	9.8	26.7	6.2	4.2	19.2	8.6	7.1	12.7	10.5	15.0	6.9	4.8	10.4	2.5	5.4	3.6	10.2	7.3	1.5	2.3	1.8	3.8	2.8	3.0	2.6	2.1	6.0	25.1	1.5	2.7	5.4	11.5	3.4	2.3	4.9	15.1	2.6	13.1	6.7	2.5	2.1	35.4	15.9	1.4	1.7	3.1	7.6	1.3	6.5	10.4	8.4	14.3	2.9	3.5	13.9	12.1	3.5	7.0	3.0	13.1	15.4	7.2	1.4	2.5	3.8	5.8	12.9	2.3	2.9	1.8	4.9	17.0	4.8	3.2	5.5	4.9	7.0	10.0	10.9	17.0	2.6	14.6	7.2	12.2	6.9	15.0	7.5	4.5	5.7	10.8	7.7	5.5	3.4	12.7	9.3	6.6	2.7	4.8	5.8	10.5	10.4	2.5	5.5	11.7	10.9	8.7	6.6	4.3	8.1	4.1	7.0	9.8	26.8	26.2	35.1	12.7	3.0	28.2	7.0	5.1	156.6	48.9	3.5	35.3	1.5	3.3	3.8	56.2	14.4	2.1	0.0	5.2	2.1	5.9	3.8	49.9	2.0	22.5	28.6	8.1	12.3	34.6	27.0	12.7	37.9	8.5	22.6	7.3	7.0	5.3	3.5	11.3	1.1	64.1	38.8	5.1	334.4	72.6	5.0	0.7	29.8	5.2	4.7
COA4	"CHCHD8, CMC3, E2IG2"	ENSG00000181924	"Cytochrome c oxidase assembly factor 4 homolog"	Q9NYJ1	11	73872667-73876988	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040126	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA040126: AB_10795415"	"unprognostic (7.30e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.17e-2)"	19.0	46.2	18.9	17.0	17.3	10.8	18.1	12.2	20.2	17.5	23.9	25.7	27.0	24.7	18.0	22.4	24.9	20.1	31.5	35.3	17.7	17.0	33.2	74.7	14.7	20.2	20.5	16.3	23.2	37.1	17.6	17.2	18.3	19.4	21.5	21.1	17.6	21.2	28.0	33.2	14.4	31.2	16.2	21.5	20.1	19.2	13.5	19.4	16.3	38.7	27.6	18.2	21.5	18.9	23.4	32.3	5.3	20.6	16.7	21.2	15.0	20.9	39.1	16.1	23.5	14.3	17.8	16.3	21.4	14.9	25.4	21.5	28.5	26.1	17.8	43.4	17.6	20.5	21.1	24.6	28.6	19.8	23.3	22.4	29.9	24.3	26.7	27.2	20.3	23.5	22.6	27.4	42.4	27.7	14.5	23.3	17.7	25.7	17.6	22.7	39.9	16.0	31.8	21.2	82.8	40.5	18.7	34.7	47.1	26.9	19.4	14.6	24.5	19.8	22.7	57.5	16.5	31.8	20.6	15.9	21.0	18.7	42.2	27.9	21.8	23.6	60.5	11.5	25.4	23.7	5.3	20.5	4.7	15.9	20.6	20.2	23.4	18.7	16.5	24.6	20.4	20.1	21.2	1.4	16.7	19.1	32.3	19.0	15.0	18.9	17.3	12.2	20.2	17.7	17.0	20.5	16.3	19.4	19.4	32.8	29.0	44.7	53.9	47.6	19.8	62.1	89.2	49.5	36.4	52.4	21.6	140.3	109.5	72.0	22.0	43.6	113.7	46.7	82.4	84.7	46.3	77.6	61.1	154.9	85.2	17.5	69.7	28.8	37.8	8.2	50.9	50.0	27.0	51.3	90.6	41.3	87.3	73.7	36.0	190.6	16.4	6.5	34.3	51.0	36.1	44.8	102.3	34.8	108.4	86.3
COA6	C1orf31	ENSG00000168275	"Cytochrome c oxidase assembly factor 6"	Q5JTJ3	1	234373456-234384049	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA028588	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA028588: AB_10601123"	"unprognostic (6.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.25e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.12e-4)"	11.0	17.8	26.4	14.4	33.9	9.4	16.6	14.3	27.5	9.7	17.7	5.7	12.9	26.4	8.4	20.3	15.5	9.4	14.2	19.1	19.3	15.7	21.4	21.4	13.6	16.2	16.3	16.1	9.1	16.7	7.6	9.5	8.7	13.4	13.3	15.6	6.0	13.6	11.6	52.7	8.7	19.7	10.6	11.4	12.5	14.4	5.8	13.3	13.1	13.6	20.2	12.0	11.6	14.6	27.5	33.3	19.7	31.3	18.3	36.6	20.2	17.8	22.9	8.3	9.4	8.7	17.3	26.4	13.1	8.0	13.8	13.0	17.6	23.9	17.8	24.4	7.5	25.9	22.8	12.9	16.2	11.0	22.1	55.1	8.0	26.0	46.6	33.6	19.6	15.6	11.4	21.8	18.1	14.0	12.1	17.0	19.8	38.8	16.1	14.9	9.5	18.6	38.1	20.4	40.3	10.9	11.1	10.0	35.0	17.2	16.9	14.8	10.8	12.7	22.6	40.4	5.5	20.0	33.9	12.8	16.4	13.6	21.9	39.2	19.2	37.2	21.8	12.5	31.2	29.2	19.7	31.3	9.7	18.5	28.5	18.2	27.5	29.9	23.0	33.3	18.0	31.3	23.1	8.1	18.3	23.8	22.5	36.6	20.2	26.4	33.9	14.3	27.5	19.3	15.7	16.3	16.1	13.4	13.3	8.9	20.0	38.5	39.3	50.8	13.8	71.2	22.9	53.5	26.1	45.4	3.9	44.1	87.9	47.5	2.9	23.3	63.5	23.3	59.9	71.2	34.2	56.7	21.9	46.9	75.0	11.1	21.4	22.1	35.3	3.4	24.2	49.2	28.7	43.3	52.3	20.6	56.3	40.3	26.5	86.4	13.3	19.4	24.5	17.2	25.3	51.3	36.5	30.0	65.5	64.8
COA7	"C1orf163, FLJ12439, RESA1, SELRC1"	ENSG00000162377	"Cytochrome c oxidase assembly factor 7 (putative)"	Q96BR5	1	52684451-52698366	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028154, HPA029926"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA028154: AB_10600656, HPA029926: AB_10602173"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	8.8	8.5	9.0	6.9	10.6	4.6	9.7	7.9	16.6	6.6	10.1	7.0	4.1	10.1	8.5	6.0	9.5	6.6	5.2	8.6	7.6	9.2	12.8	15.7	5.5	4.9	8.4	12.4	6.7	19.1	7.2	7.7	7.4	10.0	4.9	10.3	4.2	6.7	5.2	26.3	8.6	7.2	8.0	7.6	6.1	7.0	4.3	7.8	2.3	9.6	9.9	5.8	6.9	7.9	3.7	5.9	3.3	8.4	2.3	3.4	2.7	12.3	7.1	6.5	10.7	10.6	9.2	14.3	9.4	7.8	11.7	9.9	8.7	4.4	28.5	6.4	5.5	14.8	9.6	15.7	13.2	15.3	8.8	15.8	24.0	11.2	10.1	13.0	23.5	8.2	10.1	11.7	13.3	16.7	5.2	8.0	8.2	21.8	5.1	8.8	8.2	7.9	12.1	28.7	13.3	20.2	15.7	22.3	20.7	10.3	12.6	14.6	7.7	13.6	17.5	17.3	9.6	10.2	16.1	8.8	9.3	12.2	12.7	12.9	10.6	26.6	13.3	4.3	17.1	7.5	3.1	5.9	1.8	2.5	8.4	3.4	3.7	2.6	2.5	5.9	1.8	2.4	2.6	3.3	2.3	4.0	2.8	1.5	2.7	9.0	10.6	7.9	16.6	7.6	9.2	8.4	12.4	10.0	7.8	6.0	11.3	4.5	15.2	10.2	7.3	12.6	5.1	2.7	7.9	3.5	3.9	14.1	23.2	9.6	0.1	8.2	8.5	0.0	11.5	12.9	7.2	10.1	0.0	11.5	12.1	15.9	2.4	4.9	4.9	0.4	6.9	8.2	1.7	9.0	5.5	7.0	9.0	5.8	7.1	14.4	9.6	6.5	7.6	3.7	12.5	11.3	13.8	4.5	9.6	10.7
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.7"	"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 114.1;Rod photoreceptor cells: 71.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.1;HeLa: 27.0;OE19: 23.9;RPMI-8226: 20.7;SuSa: 16.0;U-266/84: 15.3"	"Low region specificity"	"Detected in many"							"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	1.8	1.3	27.5	1.8	26.1	0.7	9.5	12.5	23.8	3.9	11.6	27.9	2.2	11.6	2.0	4.4	9.5	12.7	5.8	32.8	27.7	14.5	8.3	12.3	8.8	0.7	23.8	13.8	2.6	11.4	24.7	5.2	3.4	10.8	9.4	7.3	2.8	26.9	3.7	68.7	10.7	20.7	2.2	25.0	0.8	7.4	2.5	16.8	0.0	5.5	12.2	3.1	1.0	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	5.5	4.1	0.0	0.1	0.0	0.0	15.1	0.0	0.0	0.0	0.0	9.9	8.9	0.0	0.4	0.0	0.6	10.4	5.7	0.0	0.0	0.0	4.4	0.0	27.0	2.1	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.8	2.8	0.1	0.0	3.5	0.0	0.0	4.0	23.9	3.4	0.0	0.2	20.7	8.1	0.0	5.4	0.1	1.9	12.1	1.7	16.0	8.7	0.0	0.0	0.0	4.9	0.1	0.4	0.0	15.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	27.5	26.1	12.5	19.0	27.7	14.5	23.8	13.8	10.8	16.8	35.7	15.8	2.2	2.5	15.9	1.6	66.3	17.8	37.5	19.4	8.7	55.0	16.7	0.0	19.8	2.6	1.4	61.6	0.0	8.3	8.0	1.8	28.8	9.3	24.7	1.8	0.0	17.9	0.6	0.6	2.7	0.6	1.8	15.1	1.8	27.0	114.1	19.3	28.1	0.4	14.7	71.8	0.0	1.0	0.5	5.5	31.1	33.6	1.3	11.7	6.4
COBLL1	KIAA0977	ENSG00000082438	"Cordon-bleu WH2 repeat protein like 1"	Q53SF7	2	164653624-164843679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 154.2"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 207.6;Cone photoreceptor cells: 235.6;Rod photoreceptor cells: 204.2;Syncytiotrophoblasts: 277.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"memory B-cell: 15.5;naive B-cell: 9.2;plasmacytoid DC: 5.5"	"Group enriched"	"Detected in many"	18	"B-cells: 15.5;dendritic cells: 5.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.3;RPTEC TERT1: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044933, HPA053344"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA044933: AB_2679148, HPA053344: AB_2682123"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.27e-13)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-1)"	14.3	35.7	3.3	4.1	4.0	1.1	9.3	1.4	4.0	8.1	7.0	3.3	17.7	4.3	5.3	11.2	16.3	2.9	9.7	3.7	4.1	3.2	35.6	43.4	10.8	4.7	4.5	2.9	7.1	23.4	4.9	8.9	154.2	5.2	11.9	3.1	8.8	8.0	22.6	2.6	8.2	5.8	9.7	3.9	4.6	12.6	3.0	2.6	1.2	7.6	9.6	6.9	13.0	11.1	15.5	5.5	0.0	0.0	0.5	0.0	0.3	4.7	1.1	3.0	0.0	3.4	0.6	5.4	16.1	6.5	2.8	2.6	3.9	2.0	0.4	3.1	1.5	2.4	17.3	12.0	10.0	2.9	1.3	4.6	4.5	4.7	16.2	4.9	0.0	0.0	0.8	9.4	0.4	13.2	2.8	10.0	0.6	0.0	29.3	3.5	5.3	0.1	0.0	1.4	11.7	5.4	0.6	11.6	4.8	29.5	16.3	6.6	2.5	7.0	6.8	2.2	5.7	5.1	0.0	4.3	5.2	4.4	2.0	3.7	11.0	4.1	1.5	2.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.5	0.0	5.5	0.0	0.3	3.3	4.0	1.4	4.0	4.1	3.2	4.5	2.9	5.2	2.6	65.5	51.4	43.3	40.0	86.4	11.5	10.1	22.9	12.0	29.6	207.6	235.6	40.1	53.0	22.3	0.0	41.7	10.7	0.0	28.9	56.5	18.0	52.9	32.4	126.9	7.6	3.2	21.4	6.2	3.7	0.4	13.6	3.0	18.6	0.0	10.3	171.4	30.8	3.5	7.4	27.0	204.2	45.3	41.9	0.5	0.9	61.5	277.1	1.9	9.2	67.1
COG2	LDLC	ENSG00000135775	"Component of oligomeric golgi complex 2"	Q14746	1	230642489-230693982	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076994			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA076994: AB_2686823"	"unprognostic (2.21e-1)"	"unprognostic (7.35e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.62e-2)"	11.6	27.5	11.4	12.7	12.5	8.0	13.2	24.9	13.7	14.1	18.5	15.4	13.4	13.3	14.3	14.6	10.9	14.5	13.9	17.7	11.4	8.6	17.3	12.7	11.0	14.7	14.5	9.6	12.7	17.0	49.1	17.6	11.1	12.3	13.0	23.0	14.0	14.6	13.6	25.5	13.5	18.0	11.9	11.1	18.5	15.8	13.9	13.4	21.6	16.8	10.7	17.2	13.7	15.9	11.6	13.8	15.0	20.2	16.2	18.1	13.4	8.1	9.6	11.6	11.2	11.6	9.1	16.9	7.1	11.0	11.8	10.4	12.9	12.6	25.2	11.1	9.6	7.6	12.4	10.8	12.7	11.3	20.3	21.5	8.8	9.5	13.6	14.3	22.8	13.9	12.2	14.1	7.4	10.8	7.6	9.7	15.7	15.2	14.3	9.4	6.5	20.5	11.4	16.6	25.0	18.0	17.8	18.6	29.7	12.2	12.2	12.0	16.4	8.3	15.3	16.0	5.4	18.3	22.4	8.3	5.7	5.3	7.0	13.7	17.5	14.5	20.1	9.5	9.4	12.0	10.9	11.8	15.0	13.1	15.0	15.2	11.6	12.5	12.5	13.8	11.0	18.1	15.7	0.5	16.2	20.2	6.9	9.9	13.4	11.4	12.5	24.9	13.7	11.4	8.6	14.5	9.6	12.3	13.4	20.8	17.9	15.6	5.5	4.6	15.6	24.8	17.8	41.5	18.2	12.2	27.5	10.7	23.2	15.3	5.4	7.7	14.3	0.0	20.3	9.8	8.2	6.6	22.0	11.3	12.0	23.8	17.9	9.8	23.4	3.3	10.6	9.9	6.8	13.6	32.6	20.0	15.1	7.0	13.8	17.9	44.0	12.9	9.2	19.0	22.0	4.3	7.7	14.6	22.2	5.2
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536630	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	12.5	17.4	8.7	17.1	14.0	10.9	17.0	19.7	14.5	16.9	17.1	13.0	22.4	13.2	16.9	20.6	14.4	14.0	12.8	12.5	8.9	9.4	16.5	46.2	12.1	11.7	9.3	10.0	17.9	29.4	10.9	22.6	32.9	11.5	20.9	20.7	12.9	28.3	25.2	12.5	14.7	18.8	13.3	10.1	14.8	15.6	9.9	11.2	17.4	18.5	8.7	18.5	14.8	14.8	5.1	7.2	7.4	4.6	4.9	8.0	3.8	5.4	4.9	9.5	8.6	12.6	14.5	9.1	9.1	13.0	10.6	8.9	7.2	10.1	7.5	4.1	10.8	7.9	12.0	7.8	9.2	16.2	5.8	6.4	8.4	6.0	12.6	15.6	12.3	8.1	10.8	13.9	7.0	25.1	12.9	10.3	7.4	5.4	4.6	12.7	8.4	6.8	11.6	7.8	27.4	6.0	8.0	5.6	7.0	9.9	8.9	4.7	8.6	5.9	11.6	12.1	9.4	7.9	12.8	9.6	5.1	4.0	9.5	5.8	6.5	3.5	7.8	9.8	6.2	9.1	7.4	4.1	7.3	7.5	4.6	8.0	5.1	5.8	6.4	3.1	4.9	6.6	6.1	3.7	4.9	2.9	7.2	6.2	3.8	8.7	14.0	19.7	14.5	8.9	9.4	9.3	10.0	11.5	11.2	8.9	31.8	15.2	12.2	14.1	9.4	16.9	20.4	9.4	23.9	12.2	13.7	12.4	13.3	9.4	12.9	12.1	27.1	23.3	32.9	15.5	10.8	25.6	16.2	73.3	9.8	9.5	21.4	20.3	20.8	7.4	13.0	14.6	10.1	6.4	43.3	5.2	18.0	34.5	12.7	11.9	10.4	6.5	9.9	11.5	6.6	14.1	27.5	17.5	21.4	19.0
COG4	"COD1, DKFZP586E1519"	ENSG00000103051	"Component of oligomeric golgi complex 4"		16	70480568-70523565	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040924, HPA042539"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA040924: AB_2677203, HPA042539: AB_2678044"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.79e-1)"	15.1	19.0	16.7	15.0	17.6	10.9	11.9	19.4	19.2	19.1	17.3	23.2	18.2	8.9	14.7	11.9	23.3	17.8	12.7	18.5	13.8	13.7	15.0	16.6	15.8	11.6	19.0	14.0	16.9	9.9	28.1	19.1	18.0	15.1	14.2	14.8	16.4	13.7	15.8	51.3	16.9	15.6	16.9	17.0	15.2	15.2	16.8	16.7	20.3	18.1	11.8	20.7	16.2	15.6	10.8	23.9	16.7	23.0	9.5	17.1	16.5	14.7	24.3	19.3	12.8	26.4	18.5	22.0	16.5	21.9	21.1	18.3	19.5	27.2	9.9	24.1	26.1	14.7	21.7	24.7	26.4	29.6	8.5	15.2	9.1	23.5	18.7	15.6	6.0	6.2	22.0	17.3	27.4	16.9	24.8	21.0	12.8	21.7	7.4	23.5	30.0	9.7	9.2	18.7	20.2	12.8	18.5	12.8	22.6	17.3	12.5	18.1	18.8	32.4	12.6	9.7	20.8	31.9	10.5	19.8	19.4	12.3	14.6	11.9	7.8	9.6	30.7	21.1	6.3	18.8	14.4	19.2	16.7	15.4	20.9	11.2	8.5	15.1	13.8	23.9	10.8	13.5	12.5	10.1	9.5	23.0	11.0	17.1	16.5	16.7	17.6	19.4	19.2	13.8	13.7	19.0	14.0	15.1	16.7	14.9	13.6	6.7	11.1	8.0	22.2	18.6	2.5	14.7	15.9	3.5	13.7	39.1	8.3	20.1	2.2	14.3	18.6	23.3	14.0	22.4	11.8	6.9	8.1	14.0	21.3	7.9	12.1	14.7	12.9	4.1	13.6	10.2	8.5	16.2	13.7	28.6	14.7	17.5	18.0	12.2	27.7	32.3	16.0	29.8	14.3	9.4	32.6	12.8	14.3	6.0
COG6	"COD2, KIAA1134"	ENSG00000133103	"Component of oligomeric golgi complex 6"	Q9Y2V7	13	39655627-39791665	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040410, HPA040441"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles, Golgi apparatus"		"HPA040410: AB_10793964, HPA040441: AB_10794030"	"unprognostic (2.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.60e-3)"	"prognostic favorable (2.81e-4)"	"unprognostic (4.87e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	11.7	16.1	16.3	9.5	18.8	2.6	13.6	23.8	18.7	17.1	12.0	11.4	9.6	13.1	12.6	8.5	13.8	13.2	13.8	19.6	13.3	12.9	13.7	11.8	8.9	9.9	13.3	17.9	19.1	23.4	18.6	37.7	19.4	17.9	17.6	11.4	8.8	16.4	15.7	10.2	13.0	13.3	14.6	15.4	9.9	15.4	24.0	14.1	10.3	18.5	7.9	10.1	14.2	11.5	7.6	6.4	5.6	7.2	10.0	10.3	5.6	7.0	4.6	8.0	5.4	15.3	19.2	14.2	11.2	16.4	10.0	12.3	5.7	11.6	12.1	6.6	17.3	12.2	9.5	8.4	8.8	11.2	13.8	10.7	11.6	5.0	8.6	9.0	11.6	12.6	8.1	10.9	6.3	7.4	13.3	9.8	11.2	4.9	4.6	16.5	7.1	8.3	11.2	7.3	21.6	6.1	8.4	20.2	5.9	7.5	9.1	4.3	5.7	10.4	8.9	8.9	11.6	10.2	7.4	13.9	5.5	6.5	11.9	5.7	3.8	3.6	9.0	16.4	6.5	16.2	4.4	4.7	5.6	6.1	7.2	10.3	7.6	7.8	8.2	6.4	6.6	6.6	8.5	1.1	10.0	4.2	3.6	8.9	5.6	16.3	18.8	23.8	18.7	13.3	12.9	13.3	17.9	17.9	14.1	17.9	5.6	10.2	5.5	8.7	13.9	19.9	0.0	6.7	5.7	12.2	9.8	13.7	5.0	6.2	18.1	6.4	7.0	0.0	8.7	26.5	9.8	5.4	9.3	8.2	7.6	4.8	8.7	11.6	5.3	8.6	12.4	5.6	1.7	1.0	19.1	14.1	7.7	8.6	12.0	9.8	11.3	6.5	10.9	32.6	27.9	11.7	13.4	8.7	9.9	4.4
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118923-116158747	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.2;retina: 32.7"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.1;Club cells: 1.2;Horizontal cells: 1.6;Muller glia cells: 2.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 51.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 30.1"	"Region enhanced"	"Detected in single"		"amygdala: 1.0"	"Low region specificity"	"Detected in single"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000	"Endoplasmic reticulum"		"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.9	0.1	0.4	0.8	0.7	0.1	0.3	0.3	1.4	1.4	0.3	0.9	0.3	0.0	0.6	0.3	0.5	0.0	12.2	0.3	0.6	0.2	0.8	0.7	3.5	0.4	0.3	0.6	5.4	4.2	0.5	0.9	0.3	3.2	2.6	0.0	32.7	6.5	0.9	0.3	0.7	0.3	0.5	0.3	2.9	0.2	0.5	0.3	0.8	1.4	0.3	2.0	0.3	0.3	0.6	0.3	2.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.2	0.3	4.6	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	30.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.9	0.1	0.3	0.4	0.0	0.0	0.1	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.3	1.4	0.6	0.2	0.3	0.6	3.2	0.3	0.0	1.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0
COL11A1	"CO11A1, COLL6, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 33.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 12.1;Melanocytes: 10.1;Muller glia cells: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 38.5;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;HBF TERT88: 16.3;HSkMC: 48.5;SuSa: 21.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		270000	"Endoplasmic reticulum"		"HPA058335: AB_2683682"	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	1.2	1.8	8.6	1.3	9.1	0.8	1.5	2.0	7.9	2.3	1.1	4.1	0.0	1.0	1.8	1.0	0.8	0.8	5.9	0.8	8.3	8.6	1.0	0.8	1.2	0.9	8.1	5.9	1.2	1.9	1.0	5.5	33.3	11.1	1.1	1.4	5.9	3.3	2.2	0.9	2.4	0.9	1.3	9.0	2.2	0.9	4.7	5.8	0.0	0.9	0.6	0.8	1.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	38.5	0.0	1.5	2.1	0.0	13.5	5.2	7.8	28.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	48.5	0.0	0.3	0.0	5.9	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.2	9.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.6	9.1	2.0	7.9	8.3	8.6	8.1	5.9	11.1	5.8	0.0	2.1	0.0	0.0	1.5	0.6	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.5	2.1	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.1	0.6	10.1	0.0	0.0	27.8	0.1	0.0	0.0	0.0	1.7	0.0	1.9	0.5	0.4	1.0	0.2	0.0	0.0	0.0
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206051	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 136.8"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 71.5;Leydig cells: 55.8;Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.5;SiHa: 97.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA009143, HPA010021"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		4300000	Vesicles	Cytosol	"HPA009143: AB_1847095, HPA010021: "	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	53.1	5.6	0.9	33.1	1.3	0.0	136.8	0.4	2.0	65.0	23.0	0.5	14.8	4.2	64.6	18.1	29.2	14.9	16.3	17.1	1.1	1.1	7.6	1.5	22.2	23.5	2.0	1.5	52.0	4.1	1.5	1.9	2.6	1.6	12.3	8.7	2.4	5.9	21.4	21.6	16.8	14.1	32.4	1.4	5.0	6.9	10.6	0.4	1.0	8.2	15.0	4.4	24.8	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	35.2	19.7	3.3	32.0	26.7	22.0	30.7	3.2	0.0	0.0	3.3	164.5	0.4	7.0	0.0	3.3	20.8	0.0	0.1	0.0	11.9	0.0	13.1	0.0	0.0	29.6	0.6	4.9	6.0	21.3	3.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.8	0.0	1.8	0.0	2.7	0.0	1.1	1.6	0.0	0.0	97.7	2.5	0.0	1.9	15.5	0.0	0.0	9.5	11.8	5.0	10.6	0.0	0.0	0.0	3.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.4	2.0	1.1	1.1	2.0	1.5	1.6	0.4	71.5	6.1	0.0	0.6	18.3	0.2	2.8	0.0	2.7	7.9	3.5	0.0	0.4	0.0	0.8	19.1	3.6	0.0	0.0	3.8	0.6	25.9	1.3	1.1	0.0	0.7	0.0	0.0	5.5	0.0	9.7	55.8	1.7	20.3	0.0	0.0	0.0	4.6	0.0	12.4	0.8	0.0	45.3	24.5	0.2	0.6	11.4	0.6	0.0	0.0	0.3
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120372036	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 87.4"	"Cell type enhanced"	"Detected in many"	21	"Cytotrophoblasts: 32.7;Fibroblasts: 157.1;Smooth muscle cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.3;hTERT-RPE1: 9.3;RH-30: 48.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		2000000	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.01e-4)"	20.0	3.3	0.8	20.8	0.9	0.0	21.6	0.7	0.9	87.4	13.9	1.0	9.6	1.3	64.6	39.2	20.0	15.6	38.6	27.8	0.8	1.0	8.3	5.0	8.8	4.5	1.1	1.1	62.1	4.4	1.1	1.8	30.8	3.0	41.7	10.5	4.2	21.8	5.8	7.6	5.4	12.2	45.2	6.5	15.4	10.1	13.3	0.4	1.1	15.7	32.5	9.9	30.4	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	18.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.6	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	5.3	0.1	0.0	4.7	0.1	1.0	0.0	9.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	48.7	0.1	2.1	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	0.9	0.8	1.0	1.1	1.1	3.0	0.4	0.0	1.4	0.0	0.2	10.1	0.0	7.8	0.0	0.0	7.9	1.8	0.0	32.7	0.0	0.0	0.8	2.9	0.0	0.0	0.0	2.9	157.1	0.4	3.5	0.0	5.4	0.0	0.0	25.8	0.0	0.4	13.6	0.8	5.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.2	0.0	54.7	3.5	2.9	8.4	21.2	0.0	0.0	0.4
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	22	"Fibroblasts: 113.2;Leydig cells: 302.6;Peritubular cells: 454.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;NK-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 13.3;BJ hTERT+: 27.8;HDLM-2: 11.8;K-562: 9.0;U-2197: 23.0;U-87 MG: 10.5;WM-115: 15.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		23000000	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	36.1	17.6	0.5	12.7	0.7	0.0	21.4	0.4	0.7	22.4	19.7	1.4	5.0	3.0	42.4	22.0	26.6	9.0	25.2	41.2	0.5	0.7	8.7	1.0	5.6	11.7	1.6	0.8	28.9	13.7	4.5	3.4	66.9	2.1	16.6	4.0	11.4	23.4	6.2	12.8	6.7	11.1	27.3	1.3	3.9	14.8	22.8	0.4	5.1	10.5	21.7	8.6	21.3	8.8	0.6	0.1	0.0	0.4	1.7	1.7	0.2	0.0	0.0	0.0	0.0	2.4	1.3	0.0	13.3	27.8	0.7	0.2	0.0	0.0	0.1	0.4	2.8	0.1	0.0	0.0	0.0	0.1	11.8	0.0	0.1	6.7	0.0	0.5	0.2	1.3	3.9	0.0	3.0	0.1	0.0	0.0	0.0	9.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	7.4	0.1	0.0	0.0	0.0	0.0	0.4	2.0	3.5	0.1	0.1	0.3	0.0	0.0	0.3	23.0	0.2	0.1	0.0	0.0	10.5	0.1	15.6	0.0	0.3	0.0	1.7	0.4	0.1	0.6	0.4	0.5	0.1	0.1	0.1	0.3	0.0	1.7	0.2	0.0	0.4	0.2	0.5	0.7	0.4	0.7	0.5	0.7	1.6	0.8	2.1	0.4	0.0	0.0	0.0	0.1	17.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.1	5.2	71.7	0.0	0.0	0.7	3.0	113.2	0.8	0.0	0.0	7.0	0.0	0.0	0.0	0.3	11.0	302.6	1.0	16.9	1.0	0.0	0.0	0.8	0.0	454.3	0.0	0.0	12.9	16.5	1.7	1.4	14.3	6.4	0.0	0.0	0.1
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 520.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.7	0.0	0.5	56.6	0.1	90.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8	0.0	100.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	5.1	3.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.6	0.0	12.4	520.3	0.6	0.8	0.0	2.7	20.5	0.0	0.0	3.5	0.0	0.7	8.5	1.0	105.8	0.0	0.8	8.3	2.1	0.6	0.0	0.0	1.2	0.0	2.4	0.0	0.0	2.6	0.3	1.0	32.1	0.0	5.9	0.4	45.8	16.1	0.7	0.0	0.4	0.0	1.7	8.3	1.1	121.8	4.7	0.0	14.5	8.0
COL18A1	"KNO, KNO1, KS"	ENSG00000182871	"Collagen type XVIII alpha 1 chain"	P39060	21	45405137-45513720	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 273.2"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 362.6;Sertoli cells: 219.9;Smooth muscle cells: 163.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.8;EFO-21: 71.6;NTERA-2: 39.8;TIME: 42.1"	"Region enriched"	"Detected in many"	6	"cerebellum: 24.8"	"Low region specificity"	"Detected in all"			"HPA030933, HPA036104"	Supported		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		250000000	"Golgi apparatus"		"HPA030933: , HPA036104: AB_2674943"	"unprognostic (4.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.23e-3)"	"unprognostic (9.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.25e-3)"	25.5	14.4	2.2	12.7	13.0	5.6	17.7	3.4	8.5	40.4	12.7	26.0	19.6	12.6	22.2	72.5	12.0	18.8	25.3	18.5	3.5	5.3	36.2	273.2	11.9	7.6	35.5	3.5	43.3	21.8	2.6	17.8	16.5	20.8	13.9	2.3	17.3	8.8	20.2	8.1	23.1	10.6	33.4	31.9	14.5	7.1	11.0	23.6	2.3	16.0	12.0	6.7	28.7	18.2	0.4	0.4	7.3	0.4	0.0	1.2	0.2	2.5	19.5	4.8	4.4	9.1	7.6	1.0	18.7	31.8	9.0	2.4	12.1	6.9	0.5	71.6	18.5	5.2	8.8	1.0	1.1	1.7	0.2	5.4	11.2	0.3	16.5	8.8	0.4	1.1	8.8	0.7	0.8	1.0	2.1	27.6	0.2	11.3	0.1	3.2	4.5	0.4	1.1	39.8	0.8	7.2	0.5	3.1	1.1	30.2	0.4	5.5	4.2	1.8	2.0	5.9	17.9	1.8	3.0	42.1	0.2	2.8	0.1	4.4	0.1	0.2	0.3	0.1	0.9	7.7	1.0	0.4	1.5	0.1	0.4	0.2	0.4	0.4	0.0	0.1	0.1	1.2	0.6	7.3	0.0	0.3	0.4	0.0	0.2	2.2	13.0	3.4	8.5	3.5	5.3	35.5	3.5	20.8	23.6	0.0	5.5	7.0	15.2	60.1	7.9	13.7	53.5	0.0	4.5	106.4	3.9	1.4	8.3	111.6	1.1	54.0	0.0	0.0	4.9	1.1	50.8	5.3	58.6	362.6	2.2	0.0	0.0	84.7	7.3	4.5	73.9	8.3	47.2	2.8	0.0	116.0	10.0	0.0	118.5	54.9	3.8	219.9	163.2	2.6	4.5	25.0	2.1	7.5	0.0	2.2
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50183289-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 415.7"	"Cell type enhanced"	"Detected in many"	22	"Fibroblasts: 2038.6;Ito cells: 615.0;Leydig cells: 514.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 91.8;BJ: 176.2;fHDF/TERT166: 266.1;HHSteC: 71.8;HSkMC: 134.8;U-138 MG: 143.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		58000000	"Endoplasmic reticulum, Vesicles"		"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	30.2	5.7	0.7	28.2	4.0	0.1	31.7	0.6	0.9	415.7	25.7	1.6	23.9	3.0	121.8	70.9	17.4	33.0	110.3	43.9	0.7	0.1	7.5	4.6	18.8	38.5	0.7	1.2	73.6	10.5	1.0	10.7	89.1	2.2	31.5	4.0	9.2	9.1	21.0	11.0	35.5	10.6	88.0	1.3	13.7	15.0	44.6	0.7	7.7	6.7	15.5	8.7	67.3	49.7	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.2	0.9	0.1	37.7	91.8	1.6	176.2	47.9	43.9	27.6	3.5	0.8	0.0	0.4	266.1	0.3	0.5	0.4	0.1	7.9	0.2	0.3	0.0	4.4	0.2	71.8	0.0	0.0	134.8	2.6	53.7	0.2	7.3	0.0	0.2	0.1	0.0	22.1	0.4	0.0	0.0	0.9	0.6	0.5	0.3	0.1	0.1	0.2	0.0	0.1	0.5	0.3	0.2	0.0	13.7	2.2	0.0	0.0	143.2	31.3	21.4	0.8	0.1	0.3	0.0	10.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.0	0.6	0.9	0.7	0.1	0.7	1.2	2.2	0.7	8.9	14.4	0.5	11.0	166.9	0.0	4.8	0.0	5.3	12.5	7.0	0.0	29.5	0.0	11.2	0.9	5.1	0.0	0.0	3.7	26.1	2038.6	12.1	2.3	1.9	59.9	0.0	2.9	615.0	0.8	4.5	514.8	7.7	178.8	0.0	2.2	2.8	25.7	0.0	252.1	0.5	0.1	77.6	273.4	4.2	1.7	142.9	93.5	0.5	1.3	7.5
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914006	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 46.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.8;Late spermatids: 25.2;Muller glia cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.9;RT4: 10.2;SCLC-21H: 6.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	12.0	0.2	1.3	1.1	0.0	0.1	6.8	1.1	1.3	0.7	1.4	10.8	0.3	2.4	1.9	0.2	0.5	0.4	0.2	0.3	0.8	2.8	0.1	0.1	0.5	0.3	0.0	0.3	0.2	1.7	46.5	0.0	1.9	4.7	0.1	1.6	0.8	5.1	0.5	0.1	0.4	2.2	1.8	0.3	3.7	0.8	0.1	1.4	0.3	0.7	1.7	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.2	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.8	0.3	0.3	0.8	0.3	0.0	1.9	0.1	0.0	0.0	0.0	2.8	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	30.8	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	26.2	2.1	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.8	0.0	0.0	0.0	0.0	1.3
COL25A1		ENSG00000188517	"Collagen type XXV alpha 1 chain"	Q9BXS0	4	108808725-109302752	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.4;retina: 22.1;testis: 23.6"	"Group enriched"	"Detected in some"	16	"Early spermatids: 89.3;Late spermatids: 22.6;Rod photoreceptor cells: 75.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HeLa: 31.5"	"Low region specificity"	"Detected in many"							HPA029107			Approved	"Endoplasmic reticulum,Vesicles,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Endoplasmic reticulum"	"HPA029107: AB_10600802"	"unprognostic (1.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.87e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.62e-3)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	9.0	0.8	6.7	0.2	4.4	0.0	5.1	0.8	3.4	1.6	0.9	0.4	0.9	4.0	2.1	3.5	0.8	1.4	3.1	2.0	4.7	2.1	2.9	3.2	0.9	0.1	0.8	0.0	1.6	0.9	3.9	17.4	0.4	2.5	0.9	0.4	22.1	6.7	1.4	1.4	1.1	3.1	1.5	0.9	1.0	0.9	23.6	1.5	0.0	3.7	0.1	0.0	1.6	3.4	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.9	0.0	0.1	0.0	2.3	4.2	31.5	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.2	4.0	0.0	0.5	0.0	1.2	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.4	0.8	3.4	4.7	2.1	0.8	0.0	2.5	1.5	0.0	0.0	0.0	0.0	0.0	1.9	0.8	0.0	0.0	1.2	1.8	3.9	0.0	0.0	0.0	89.3	0.7	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.6	0.0	1.3	0.0	22.6	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	75.2	0.0	3.4	3.2	1.5	0.1	0.0	0.0	0.0	0.0
COL26A1	"EMI6, EMID2, Emu2"	ENSG00000160963	"Collagen type XXVI alpha 1 chain"	Q96A83	7	101362820-101559024	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.4;brain: 18.3"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 5.2;Hepatocytes: 2.6;Late spermatids: 2.2;Spermatogonia: 2.2"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7"					"Cell type enriched"	"Detected in single"	63	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	63	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in some"		"AF22: 20.3;BEWO: 16.3;HAP1: 7.2;NTERA-2: 17.1;SuSa: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027059	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA027059: AB_1848142"	"unprognostic (5.94e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.48e-4)"	"unprognostic (2.83e-3)"	0.0	4.1	2.5	0.3	7.0	0.3	0.2	0.4	18.3	0.1	0.0	0.2	0.0	0.1	0.5	0.3	0.0	0.2	0.3	0.1	3.3		3.1	4.8	0.6	0.9	0.0	8.1	0.2	3.1	6.7	0.0	0.5	0.6	3.7	0.0	0.0	0.2	1.1	0.0	0.1	0.1	0.1	0.3	0.4	0.2	0.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	20.3	1.2	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.2	0.0	0.0	0.0	7.2	0.0	0.0	0.7	0.8	0.0	0.0	5.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	17.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.1	13.7	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.2	0.0	0.5	0.0	2.6	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.3	0.0	0.0	0.5
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535853	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 16.0;Cone photoreceptor cells: 17.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.3;U-266/70: 14.2;U-266/84: 3.8;WM-115: 6.9"	"Region enriched"	"Detected in single"	8	"olfactory region: 4.5"	"Not detected"	"Not detected"			"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	2.7	3.7	1.0	7.0	1.1	0.3	3.1	2.4	1.6	10.2	11.8	0.6	11.5	1.3	2.9	16.2	14.7	5.5	5.7	7.0	1.3	2.2	2.8	1.9	1.3	1.0	9.8	0.2	2.9	5.8	0.1	12.2	0.5	6.1	5.8	4.7	12.8	19.3	6.2	5.6	2.1	6.6	16.0	7.9	0.3	5.7	3.2	0.2	0.2	1.4	10.2	0.9	8.4	14.2	0.6	0.3	1.6	0.2	2.1	1.0	0.0	2.0	0.0	0.0	0.0	0.2	1.1	0.3	0.1	0.6	0.0	0.0	1.6	0.6	0.3	0.1	0.1	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.3	0.1	0.2	0.0	0.3	2.0	0.2	0.3	0.0	0.9	1.2	0.5	0.0	0.1	0.0	3.3	0.1	0.2	0.0	0.1	1.0	0.0	0.5	0.1	0.9	1.0	0.0	0.7	1.8	0.0	14.2	3.8	0.0	0.2	0.8	6.9	0.5	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.6	0.4	1.0	1.6	2.1	0.1	0.3	0.0	0.0	1.0	1.1	2.4	1.3	1.3	2.2	9.8	0.2	6.1	0.2	0.0	2.6	0.0	0.1	0.2	4.6	0.8	0.0	16.0	5.7	3.5	17.7	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.1	4.8	0.0	3.1	0.0	0.8	0.9	0.0	0.0	0.0	0.3	2.4	0.5	2.8	0.7	0.3	4.5	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.3	0.1
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972965-48004554	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 12.7;Intestinal endocrine cells: 42.2;Muller glia cells: 19.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 55.2;HAP1: 34.6;HEK 293: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002214, HPA055753"	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	No	NA			Nucleoplasm		"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (7.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	2.2	0.3	0.0	0.7	0.9	0.9	0.0	0.2	0.3	0.0	0.0	0.3	22.7	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.4	0.0	0.0	0.7	1.3	0.0	0.0	11.0	0.4	1.9	2.6	0.4	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	11.3	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	34.6	0.0	0.0	0.0	12.8	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.9	0.5	1.3	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.0	42.2	0.0	0.0	7.1	0.9	0.0	0.0	0.0	0.3	19.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.5	0.7	0.0	0.7	0.0	0.9	0.1
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974320-189012746	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 304.2;endometrium 1: 208.0"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 1855.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 81.7;ASC diff: 151.5;ASC TERT1: 263.7;fHDF/TERT166: 106.1;HHSteC: 104.2;HSkMC: 196.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		16000000	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	41.7	9.7	0.7	34.1	3.4	0.0	29.7	0.8	1.2	304.2	41.3	1.3	23.8	3.9	208.0	82.0	31.3	32.3	116.3	41.0	1.0	0.3	14.4	12.1	32.9	39.3	1.3	1.1	54.9	14.4	1.7	2.3	161.2	3.2	27.4	18.3	32.0	15.1	22.4	14.5	28.3	24.2	114.1	1.7	29.5	25.3	45.5	0.7	9.5	12.8	44.8	15.4	64.8	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.7	3.1	151.5	263.7	0.0	32.9	29.3	14.4	12.9	0.4	0.0	0.0	0.0	106.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	13.9	0.0	104.2	0.1	0.0	196.1	0.0	17.5	2.8	0.0	0.7	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.4	0.0	1.2	0.8	0.0	0.0	60.2	0.0	0.0	0.0	0.1	1.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.4	0.8	1.2	1.0	0.3	1.3	1.1	3.2	0.7	3.0	20.2	0.0	0.4	152.4	0.0	9.8	0.0	2.7	2.3	0.0	0.0	40.3	0.0	2.5	21.6	52.5	0.0	0.0	0.0	34.9	1855.8	0.5	5.8	0.9	81.7	0.0	5.8	358.5	0.8	11.8	299.1	3.8	163.6	0.0	0.0	0.0	6.1	0.0	221.7	0.0	0.0	446.3	215.4	1.1	1.0	136.1	105.6	0.0	0.0	0.3
COL4A3		ENSG00000169031	"Collagen type IV alpha 3 chain"	Q01955	2	227164565-227314792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 157.8;Cone photoreceptor cells: 375.0;Muller glia cells: 214.6"	"Group enriched"	"Detected in some"	6	"lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 3.8;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 15.4;hTERT-RPE1: 13.4;Karpas-707: 9.0;RPTEC TERT1: 10.1;U-266/70: 8.3"	"Not detected"	"Not detected"							HPA042064	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA042064: AB_10794410"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.28e-6)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (2.51e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	0.7	9.5	0.9	5.4	2.9	0.3	0.9	1.4	2.9	0.7	0.7	1.7	12.0	0.7	1.5	15.3	1.1	1.5	5.3	6.7	1.6	1.2	27.9	0.7	15.0	3.6	2.4	0.0	3.6	4.4	0.2	16.7	0.2	7.5	4.9	1.0	20.9	1.1	11.2	17.8	0.6	5.0	2.9	3.1	6.1	1.5	1.5	3.4	0.0	16.2	9.4	5.8	1.8	1.2	3.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.2	1.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	1.1	0.0	9.0	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.0	0.0	2.8	10.1	2.0	0.4	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	8.3	2.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.9	1.4	2.9	1.6	1.2	2.4	0.0	7.5	3.4	157.8	24.8	4.7	0.0	0.1	58.0	1.7	0.0	0.0	17.0	40.1	375.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.8	0.0	1.7	0.0	0.0	214.6	0.9	0.0	11.3	1.0	11.5	12.9	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0
COL4A5	"ASLN, ATS"	ENSG00000188153	"Collagen type IV alpha 5 chain"	P29400	X	108439844-108697545	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 25.8;Basal keratinocytes: 23.9;Peritubular cells: 34.6;Urothelial cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.5;HHSteC: 32.8;HUVEC TERT2: 30.8;TIME: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077177			Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	Vesicles	"HPA077177: "	"unprognostic (2.58e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.97e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.06e-1)"	3.3	2.7	13.1	1.7	27.7	0.3	5.8	1.8	16.1	16.9	3.7	47.2	9.5	2.7	31.4	18.2	6.9	19.3	12.6	5.9	13.9	6.2	5.9	1.7	5.9	0.9	46.6	15.7	11.5	2.8	22.3	10.2	9.7	19.5	18.0	4.1	5.8	3.7	23.9	4.8	17.5	3.1	32.8	20.5	2.8	17.7	2.8	40.5	0.0	5.4	0.9	0.9	23.9	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	8.8	15.8	5.0	6.2	3.6	0.1	0.9	3.9	4.8	7.9	7.9	0.6	1.3	0.0	0.6	2.9	7.1	4.4	14.9	6.1	2.1	3.8	1.1	28.5	0.9	32.8	0.0	4.5	17.0	18.1	5.9	12.7	15.4	30.8	0.0	0.0	0.0	4.6	0.6	0.0	0.1	4.7	0.0	5.3	0.0	0.0	0.0	12.0	8.8	0.0	0.0	23.0	0.7	1.9	23.3	4.3	0.0	29.1	3.2	1.0	2.1	1.3	0.6	0.0	0.0	2.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	27.7	1.8	16.1	13.9	6.2	46.6	15.7	19.5	40.5	6.0	5.3	0.0	25.8	23.9	0.3	8.9	0.0	4.0	11.4	19.2	0.0	0.6	0.0	0.2	0.1	2.9	0.0	0.0	0.8	0.3	8.5	8.2	1.1	0.4	0.4	0.0	0.0	4.9	0.3	1.2	18.7	0.8	1.7	0.0	0.0	13.0	0.5	0.0	34.6	0.0	0.4	6.5	18.6	0.3	0.7	13.9	0.6	0.0	0.0	22.6
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Predicted secreted proteins"	"Cell adhesion"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 60.9"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 19.4;Cardiomyocytes: 9.2;Muller glia cells: 7.7;Peritubular cells: 8.5;Smooth muscle cells: 8.0;Urothelial cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.4;HeLa: 16.2;HHSteC: 24.9;hTERT-HME1: 18.2;HUVEC TERT2: 16.8;TIME: 37.6"	"Low region specificity"	"Detected in single"							HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum"		"HPA065393: AB_2685483"	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	2.1	0.4	0.4	0.8	0.5	0.0	1.7	0.2	0.4	12.1	1.0	1.3	8.0	0.7	22.9	17.1	25.0	11.3	35.8	3.6	0.6	0.6	3.0	0.3	2.1	0.0	1.0	0.9	6.4	0.3	7.6	11.3	1.9	0.9	16.5	1.3	8.3	1.4	15.6	1.0	4.1	1.8	60.9	1.4	1.1	10.4	2.1	0.7	0.2	0.6	1.4	0.5	24.7	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.4	4.0	0.0	10.1	0.7	0.0	0.0	0.7	0.1	0.1	7.1	0.0	0.0	0.0	0.0	1.6	2.3	4.1	18.4	0.3	0.1	3.5	0.3	16.2	0.1	24.9	0.0	0.0	1.0	11.4	2.6	18.2	0.0	16.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.6	0.0	1.5	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.9	0.0	0.0	7.8	0.3	0.0	37.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.4	0.6	0.6	1.0	0.9	0.9	0.7	0.0	0.0	0.0	19.4	5.7	0.0	9.2	0.0	2.7	2.3	1.8	0.0	0.1	1.7	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.9	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.7	0.1	0.0	8.5	0.0	0.2	0.0	8.0	0.3	0.2	3.1	0.0	0.0	0.0	10.6
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641774-134844843	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 110.7"	"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 127.8;Leydig cells: 56.7;Peritubular cells: 36.4;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;fHDF/TERT166: 67.3;HeLa: 48.1;HHSteC: 45.8;SiHa: 47.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	No	No		12000000	Vesicles		"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	11.5	4.2	1.5	13.7	1.4	0.0	9.5	3.0	1.2	110.7	20.9	1.4	11.8	3.6	42.1	24.1	12.3	20.5	31.8	12.2	1.8	0.9	4.3	3.4	13.4	7.8	3.0	1.3	19.5	3.7	3.7	2.6	53.8	2.2	23.3	4.7	9.1	5.1	9.9	5.0	6.9	8.7	26.7	1.5	6.5	12.5	9.5	1.1	2.7	4.1	10.1	4.0	21.8	22.9	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	2.7	2.1	3.4	32.6	35.1	1.3	72.5	14.6	12.4	13.3	0.0	0.0	0.0	16.1	67.3	6.6	0.9	0.0	0.0	3.5	0.0	0.1	0.0	48.1	0.0	45.8	0.0	0.4	34.4	0.0	11.9	0.9	0.0	14.7	0.0	0.0	0.2	6.5	0.6	0.0	0.1	1.2	0.0	1.4	2.5	8.4	0.3	0.0	0.0	0.9	0.4	47.8	0.3	0.0	30.7	0.1	0.0	25.1	26.0	10.8	31.9	15.1	0.0	0.0	0.0	20.6	0.0	4.4	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	3.0	1.2	1.8	0.9	3.0	1.3	2.2	1.1	0.0	2.6	0.0	3.4	12.9	0.3	5.6	0.0	0.0	0.0	1.8	2.0	4.0	1.7	1.3	5.2	6.8	0.0	0.0	0.0	10.7	127.8	0.4	0.0	0.0	8.0	0.0	0.0	32.5	0.3	11.4	56.7	0.5	6.8	0.0	0.0	6.9	1.9	0.0	36.4	0.1	0.6	51.8	23.2	0.5	0.6	6.8	8.7	0.0	0.0	0.3
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981737-46005050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 779.8;Leydig cells: 326.8;Peritubular cells: 236.2;Smooth muscle cells: 211.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 94.0;ASC TERT1: 191.4;BJ: 71.8;HHSteC: 83.5;HSkMC: 139.9;U-138 MG: 104.8"	"Low region specificity"	"Detected in all"							"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		250000000	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (4.54e-4)"	73.4	10.8	6.8	45.5	7.1	0.1	85.4	31.9	9.1	100.7	111.6	5.1	34.7	17.1	98.8	75.0	54.5	64.7	89.7	39.7	6.0	5.6	10.2	9.9	21.6	24.7	4.8	5.4	83.0	13.5	6.2	19.8	65.7	9.2	59.6	9.9	18.6	23.1	36.4	20.0	28.2	33.8	147.8	4.7	15.9	40.9	20.2	5.5	9.4	15.9	23.4	12.8	86.9	49.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	1.5	2.4	7.8	94.0	191.4	0.3	71.8	46.4	18.5	6.5	1.2	4.9	0.0	5.9	40.4	14.6	0.3	1.0	0.1	1.5	0.0	1.1	0.0	0.2	0.4	83.5	0.0	0.1	139.9	0.0	46.0	0.6	1.6	0.4	0.0	0.0	0.0	4.7	0.1	0.0	0.2	1.7	1.0	20.2	0.0	1.5	0.3	0.1	0.8	0.0	3.1	6.6	0.0	1.3	0.8	0.3	0.3	0.0	104.8	7.0	28.7	27.4	0.0	0.0	0.0	37.4	0.5	9.1	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.3	1.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.1	31.9	9.1	6.0	5.6	4.8	5.4	9.2	5.5	0.0	8.0	0.0	9.3	108.5	14.9	33.6	2.5	1.4	7.9	8.7	0.0	9.8	3.3	23.9	4.1	30.5	0.9	0.0	2.7	15.4	779.8	4.8	1.1	11.4	20.9	14.3	1.7	138.1	4.8	7.9	326.8	5.6	140.0	3.6	0.0	22.6	7.8	0.3	236.2	11.6	2.3	181.1	211.6	2.6	4.7	78.5	17.4	2.5	0.6	2.4
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098097-46132849	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 1607.7;Leydig cells: 560.6;Peritubular cells: 443.7;Smooth muscle cells: 512.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 7.6;MAIT T-cell: 5.1;memory CD8 T-cell: 3.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 95.7;ASC TERT1: 177.1;BJ: 85.2;BJ hTERT+: 79.3;HHSteC: 93.9;HSkMC: 126.5;U-138 MG: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		8900000	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	81.2	8.7	1.5	65.0	2.7	0.2	116.7	1.8	2.7	103.5	112.6	4.7	75.0	15.3	127.2	160.3	55.5	66.5	179.8	90.6	2.1	1.3	9.6	9.1	38.7	38.3	3.2	3.8	76.1	14.8	2.7	11.8	52.6	8.8	81.0	9.8	23.5	33.4	81.4	30.6	37.8	38.1	231.3	5.8	23.6	49.0	33.2	1.8	9.8	19.9	58.5	17.2	107.2	76.1	0.0	0.0	0.0	0.0	0.5	7.6	0.7	0.7	0.9	2.8	2.5	95.7	177.1	0.8	85.2	79.3	21.6	9.9	0.1	3.3	0.0	6.4	61.1	13.9	0.0	0.6	0.0	1.7	0.0	0.9	0.0	0.0	0.0	93.9	0.0	0.3	126.5	0.0	40.8	0.8	0.0	0.0	0.0	0.0	0.0	8.6	0.4	0.0	0.1	1.5	0.0	10.4	0.0	5.4	0.1	0.0	0.0	0.0	4.4	3.3	0.0	0.0	1.6	0.1	0.5	0.0	92.4	10.8	34.0	21.0	0.0	0.0	0.0	47.2	0.0	13.1	0.0	0.0	0.0	7.6	0.0	5.1	0.0	0.7	3.8	0.0	0.0	0.8	2.1	0.0	0.5	0.0	0.0	0.1	0.7	1.5	2.7	1.8	2.7	2.1	1.3	3.2	3.8	8.8	1.8	3.0	1.1	0.0	4.5	146.1	0.1	6.7	0.0	0.0	1.2	7.0	0.0	14.3	0.0	14.0	3.2	42.2	0.0	0.0	0.3	22.5	1607.7	10.7	0.0	0.9	32.2	0.0	0.0	166.3	6.8	7.6	560.6	4.3	172.1	3.6	0.0	3.9	6.9	0.0	443.7	0.2	0.4	291.1	512.9	2.7	10.7	122.7	33.8	8.7	0.2	2.5
COL6A3		ENSG00000163359	"Collagen type VI alpha 3 chain"	P12111	2	237324003-237414375	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Congenital muscular dystrophy, Disease mutation, Dystonia, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Fibroblasts: 396.3;Leydig cells: 291.6;Peritubular cells: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 206.4;ASC TERT1: 265.7;BJ hTERT+: 77.0;HSkMC: 168.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.6"	"Not detected"	"Not detected"			"HPA010007, HPA010080"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		990000000	"Endoplasmic reticulum"	Vesicles	"HPA010007: , HPA010080: AB_1078550"	"unprognostic (8.94e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.20e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (5.57e-11)"	"unprognostic (1.54e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-3)"	95.3	2.7	0.4	22.2	1.2	0.0	48.6	0.4	0.6	104.9	29.9	1.0	27.6	3.9	101.6	70.1	31.9	33.2	47.9	33.0	0.6	0.4	6.8	3.0	24.8	32.7	0.8	0.3	61.9	12.9	2.5	1.3	35.6	1.7	47.2	9.9	1.0	17.1	16.3	31.8	10.8	17.7	73.0	0.7	17.2	16.5	25.8	0.1	4.2	18.5	22.5	8.3	74.8	39.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	206.4	265.7	3.7	48.7	77.0	10.2	11.6	0.0	0.0	0.2	0.0	48.4	4.1	0.0	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.0	41.9	0.0	0.0	168.7	0.0	36.3	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	1.1	2.7	1.6	8.3	0.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	1.2	0.4	0.6	0.6	0.4	0.8	0.3	1.7	0.1	0.0	17.5	0.0	0.5	54.3	0.8	5.8	2.5	1.4	6.8	0.0	0.0	4.8	0.0	0.9	4.6	4.7	0.0	0.0	0.0	4.6	396.3	0.8	1.1	1.5	7.1	0.0	0.0	41.7	1.0	4.0	291.6	4.3	69.2	2.8	0.0	0.5	3.9	0.0	97.2	0.0	2.5	32.3	52.3	1.2	1.0	53.8	4.8	2.9	0.0	0.8
COL7A1	"EBD1, EBDCT, EBR1"	ENSG00000114270	"Collagen type VII alpha 1 chain"	Q02388	3	48564073-48595267	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 59.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 22.7;Basal keratinocytes: 64.5;Suprabasal keratinocytes: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.8;HaCaT: 20.0;HBEC3-KT: 31.9;HDLM-2: 30.1;HeLa: 39.2;SiHa: 26.2"	"Region enhanced"	"Detected in single"		"cerebellum: 0.7"	"Not detected"	"Not detected"			"CAB016357, HPA018877, HPA042420"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum"	Vesicles	"CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990"	"unprognostic (2.69e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (6.31e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.86e-2)"	1.3	1.0	0.6	2.6	3.3	0.4	2.5	8.2	3.6	11.7	1.3	0.8	5.2	1.4	8.0	11.9	11.3	2.5	4.5	1.6	2.3	4.4	3.4	1.2	0.9	1.0	1.5	1.0	1.8	0.5	0.4	1.1	2.2	4.8	17.1	0.9	2.6	7.3	10.8	2.3	59.2	1.8	2.9	3.2	4.3	1.2	1.6	0.7	0.5	0.4	13.5	4.8	3.3	14.2	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	8.0	0.3	0.1	3.0	4.1	10.0	20.8	13.1	5.5	3.3	0.1	0.1	0.0	0.6	4.7	5.0	20.0	0.0	31.9	1.0	30.1	0.1	0.0	39.2	1.3	8.4	0.0	0.1	6.6	19.1	11.1	8.7	7.5	0.0	0.2	0.1	0.2	0.6	0.1	0.0	0.2	1.0	0.4	0.4	0.1	0.7	0.0	3.0	0.0	0.0	0.0	26.2	0.0	0.2	1.2	0.4	0.1	0.0	1.8	1.0	1.0	15.5	0.6	0.5	0.0	16.0	0.1	0.9	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	8.2	3.6	2.3	4.4	1.5	1.0	4.8	0.7	0.0	0.0	0.5	22.7	64.5	15.5	5.3	0.0	0.0	13.6	10.4	9.8	1.0	0.0	0.6	11.6	0.8	0.2	0.0	0.6	0.8	2.6	2.0	0.0	0.4	1.5	7.9	1.7	0.0	0.3	3.8	4.6	0.7	8.5	0.0	0.2	2.3	9.3	0.0	5.3	0.0	11.7	0.0	8.5	2.8	0.9	21.1	1.0	0.0	0.0	4.6
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300487-40317813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;pituitary gland: 32.1;retina: 40.8"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 280.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.4;myeloid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 6.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 35.4;HMC-1: 34.1;THP-1: 38.3"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	Nucleoplasm	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	0.7	2.3	17.2	2.6	19.5	7.6	3.1	2.3	12.1	10.0	3.6	32.0	17.4	4.6	3.9	1.5	0.7	3.7	6.5	1.0	20.8	14.5	4.3	0.6	2.8	4.2	29.8	10.5	0.6	1.7	28.3	32.1	0.9	16.3	8.8	2.6	40.8	13.7	21.3	0.3	2.0	3.3	1.3	35.3	3.2	12.8	0.8	19.7	0.2	4.3	0.9	2.5	4.0	0.5	0.7	2.7	6.4	0.7	0.4	0.3	0.1	4.3	0.1	0.7	0.3	1.0	0.5	2.9	0.0	0.0	0.2	0.5	0.1	2.5	1.2	3.8	0.1	0.0	0.7	0.0	0.0	0.1	35.4	0.5	0.7	0.3	9.9	0.6	0.3	34.1	1.8	0.0	0.0	0.0	0.2	0.0	0.5	0.0	7.4	0.0	0.9	0.4	0.7	0.8	0.0	0.4	0.8	0.0	2.4	0.0	5.2	0.5	0.8	0.0	4.4	0.4	2.6	5.6	38.3	0.0	0.0	4.5	0.0	0.1	0.5	0.0	1.2	0.3	4.5	0.2	0.0	0.2	6.4	0.0	0.5	0.0	0.5	0.2	0.0	2.7	0.7	0.1	0.0	1.1	0.4	0.7	0.3	0.3	0.1	17.2	19.5	2.3	10.8	20.8	14.5	29.8	10.5	16.3	19.7	0.0	3.5	4.5	2.6	0.9	1.8	0.8	7.6	1.4	3.4	24.4	0.0	2.3	0.0	6.3	0.0	0.0	3.3	0.0	0.7	0.4	1.4	7.8	26.4	0.0	3.3	0.0	12.2	1.3	0.3	0.8	2.0	6.5	1.7	30.7	5.5	280.3	3.6	7.0	0.0	0.1	7.8	0.0	0.9	2.6	2.6	0.5	1.1	2.2	12.2	11.1
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 120.8;Late spermatids: 311.3;Muller glia cells: 91.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 53.7;Hep G2: 21.2;SK-MEL-30: 17.6;WM-115: 21.3"	"Low region specificity"	"Detected in all"							"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	2.2	2.0	11.2	2.3	16.3	1.2	1.5	1.5	8.9	1.7	3.4	26.4	1.6	2.3	1.8	1.5	1.6	1.2	1.4	2.1	14.9	9.8	1.4	1.3	1.3	1.4	18.4	8.1	1.6	5.4	1.1	5.3	1.9	12.4	1.7	1.3	37.2	38.9	3.4	1.5	1.8	2.5	1.4	25.0	1.2	1.8	6.4	15.2	0.0	18.1	1.4	1.2	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	53.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.5	21.2	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	2.4	2.9	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	17.6	1.8	0.1	1.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	16.3	1.5	8.0	14.9	9.8	18.4	8.1	12.4	15.2	3.0	0.0	13.7	1.7	2.9	1.0	1.2	0.0	0.0	0.0	5.2	9.8	4.0	1.7	1.3	120.8	3.1	0.9	0.0	0.0	35.4	10.4	0.9	0.0	2.4	2.1	0.0	4.1	3.1	2.7	311.3	3.7	1.3	3.3	0.0	2.6	91.3	0.1	6.2	1.4	9.5	2.5	0.0	1.1	2.5	4.1	6.0	3.3	0.0	1.5	0.8
COLEC12	"CL-P1, SCARA4, SRCL"	ENSG00000158270	"Collectin subfamily member 12"	Q5KU26	18	316740-500722	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 40.8"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 109.4;Cytotrophoblasts: 115.8;Hofbauer cells: 118.9;Syncytiotrophoblasts: 93.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 17.7;BJ: 8.6;HSkMC: 14.6;U-2197: 22.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047917, HPA071056"	Enhanced		Approved	"Golgi apparatus,Vesicles,Cell Junctions"		NA	NA		550000	"Golgi apparatus, Vesicles"	"Cell Junctions"	"HPA047917: AB_2680208, HPA071056: AB_2686338"	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.01e-3)"	14.2	3.7	6.9	4.6	9.7	1.2	9.4	3.5	6.4	40.8	8.0	7.7	5.1	3.4	13.1	9.9	7.5	6.6	8.1	13.5	7.0	6.3	2.7	1.4	18.7	13.9	8.1	5.8	6.8	2.4	1.5	1.5	32.0	10.5	9.6	5.0	23.5	4.8	3.5	6.3	4.4	5.0	14.3	5.2	1.2	5.0	5.0	4.7	0.7	7.6	3.8	4.9	15.0	7.3	0.9	0.9	3.3	0.8	0.7	0.5	0.3	0.0	0.0	1.5	0.0	1.7	17.7	0.6	8.6	3.0	1.2	2.2	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.8	0.0	0.5	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.1	2.2	0.3	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.8	0.4	0.5	0.3	0.3	0.5	0.5	0.4	0.2	0.9	0.4	0.4	3.3	0.7	0.5	0.9	0.3	0.3	6.9	9.7	3.5	6.4	7.0	6.3	8.1	5.8	10.5	4.7	3.0	109.4	0.0	2.9	3.7	6.1	3.6	0.0	2.7	19.4	3.5	9.8	115.8	0.0	0.1	7.2	3.1	0.0	0.0	0.0	4.3	47.7	8.6	12.8	0.2	118.9	6.4	15.1	1.8	4.1	16.7	57.0	17.9	1.7	27.1	0.2	63.6	0.3	0.0	6.7	0.0	10.8	0.0	1.9	1.1	1.2	3.3	93.0	1.3	0.7	1.6
COLGALT1	"FLJ22329, GLT25D1"	ENSG00000130309	"Collagen beta(1-O)galactosyltransferase 1"	Q8NBJ5	19	17555594-17583162	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 66.0;Hofbauer cells: 81.3;Kupffer cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047821	Approved		Approved	Vesicles	"Intracellular and membrane"	No	No			Vesicles		"HPA047821: AB_2680168"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (2.92e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (3.83e-4)"	29.8	11.4	12.1	26.9	16.5	21.3	36.2	15.6	13.1	18.2	18.5	10.8	9.6	12.0	21.9	20.2	17.6	19.2	18.1	21.7	10.8	7.1	11.1	17.8	25.1	46.1	19.4	7.3	19.0	15.2	7.9	8.1	29.6	11.8	12.6	11.6	9.5	12.0	13.0	10.7	16.7	17.3	25.7	11.3	30.9	13.9	11.2	17.9	10.3	11.3	12.7	11.9	19.6	19.1	2.5	11.5	7.6	17.4	1.4	3.6	7.1	23.2	27.5	13.4	18.4	53.2	33.0	21.4	21.8	12.8	28.8	29.9	20.8	36.7	11.9	39.1	38.2	24.6	20.8	13.6	25.3	17.5	6.7	21.8	11.4	35.8	19.7	29.2	27.2	34.9	27.3	22.7	32.2	13.5	11.7	32.3	7.6	23.3	6.0	10.4	10.2	13.7	17.6	9.9	16.9	26.9	14.7	17.1	18.2	6.1	15.5	9.7	7.0	23.4	18.7	22.1	9.1	9.7	39.7	22.5	57.2	16.2	50.7	35.4	10.8	27.3	13.1	33.8	51.9	25.9	1.1	15.0	7.6	3.4	17.4	2.0	2.3	3.2	3.2	11.5	2.5	2.3	3.6	2.4	1.4	12.6	4.4	1.9	7.1	12.1	16.5	15.6	13.1	10.8	7.1	19.4	7.3	11.8	17.9	17.9	30.0	6.0	4.6	17.3	3.6	8.9	5.1	5.3	18.2	10.4	5.9	5.4	0.0	11.4	2.7	14.6	9.7	0.0	6.9	66.0	26.7	5.5	8.1	12.3	81.3	12.7	5.2	9.2	58.8	2.3	17.5	43.3	16.9	8.2	13.7	1.7	10.2	5.8	20.5	4.1	2.9	12.9	17.3	3.1	13.9	18.2	7.0	10.2	15.3	7.5
COLGALT2	"C1orf17, GLT25D2, KIAA0584"	ENSG00000198756	"Collagen beta(1-O)galactosyltransferase 2"	Q8IYK4	1	183929854-184037729	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 38.2;Late spermatids: 52.3;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 12.7;OE19: 10.2;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031749, HPA031750"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Nucleoplasm	Vesicles	"HPA031749: AB_10599298, HPA031750: AB_10611252"	"unprognostic (5.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-5)"	"unprognostic (2.08e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.13e-9)"	"unprognostic (1.53e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.80e-2)"	2.1	9.4	10.8	1.7	16.6	1.9	2.8	10.6	39.0	2.0	3.0	31.3	0.0	1.4	3.0	5.2	1.7	3.5	3.7	11.7	15.3	7.9	1.8	1.0	4.5	1.1	20.2	12.9	2.3	3.5	1.0	1.9	0.8	17.4	8.1	2.0	3.5	4.4	3.7	11.0	1.1	1.4	3.0	21.8	1.3	3.4	5.0	22.5	0.0	5.1	1.8	1.5	2.4	1.4	0.0	0.0	8.1	0.0	0.7	0.6	0.1	0.1	0.0	4.4	0.2	2.3	3.4	0.1	1.2	0.5	0.6	0.7	2.1	0.2	0.0	0.3	3.3	0.8	0.0	4.2	0.0	1.1	4.6	2.3	0.3	0.0	12.7	0.1	4.1	0.0	2.0	0.0	0.6	0.1	6.4	0.0	0.1	4.1	5.4	4.6	0.1	0.2	0.2	3.0	10.2	0.0	0.4	0.0	0.0	0.0	0.9	1.7	2.7	0.2	0.0	13.7	2.9	0.0	0.2	0.0	0.5	0.4	0.0	13.1	8.0	0.0	0.0	0.4	2.0	16.9	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	10.8	16.6	10.6	17.2	15.3	7.9	20.2	12.9	17.4	22.5	0.0	0.0	0.0	0.4	0.3	0.8	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	38.2	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	52.3	2.0	1.5	1.7	0.0	0.0	4.8	1.0	0.0	3.9	0.2	0.2	12.9	0.5	0.3	0.4	0.4	0.0	3.5	0.0	0.3
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Neurotransmitter degradation"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 31.8;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 6.7;Early spermatids: 4.2;Horizontal cells: 6.4;Late spermatids: 11.3;Peritubular cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 31.8"	"Lineage enriched"	"Detected in single"	35	"T-cells: 31.8"	"Group enriched"	"Detected in some"	5	"BEWO: 17.3;HDLM-2: 5.6;U-937: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA045876: AB_2679479"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.7	0.7	0.9	0.7	1.1	1.3	0.9	11.4	2.1	2.4	2.3	0.4	0.2	0.8	3.2	2.7	1.3	8.8	1.8	15.9	1.5	1.2	0.5	0.9	2.1	19.6	0.9	1.1	2.3	0.6	10.0	1.1	0.5	2.1	2.0	0.5	2.0	1.1	1.4	14.3	0.9	1.4	1.1	1.5	3.8	1.5	2.0	0.4	3.8	1.0	0.6	3.3	1.3	1.4	0.0	0.2	0.0	0.4	0.9	31.8	1.7	0.1	0.5	2.0	1.2	1.5	1.0	17.3	0.3	0.5	0.4	0.6	0.0	0.3	0.1	0.7	0.3	0.1	0.2	0.3	0.4	0.5	5.6	1.2	0.6	0.7	0.2	0.2	0.4	1.2	0.8	0.4	0.8	0.3	0.8	0.3	1.5	0.0	0.6	0.8	0.3	0.6	1.8	0.2	0.0	0.6	0.8	0.2	0.4	0.4	0.4	0.6	1.8	0.2	0.1	0.4	1.9	1.2	0.8	0.1	0.2	1.1	1.9	0.6	1.7	1.5	0.1	0.1	8.7	0.1	0.0	0.4	0.0	5.5	0.0	31.8	0.0	2.7	3.9	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.2	0.1	1.7	0.9	1.1	11.4	2.1	1.5	1.2	0.9	1.1	2.1	0.4	0.0	1.1	0.0	0.1	0.2	0.3	0.7	0.0	6.7	2.3	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.8	0.2	6.4	1.2	2.5	0.0	11.3	1.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	4.2	0.0	0.6	0.0	0.2	0.7	0.2	0.1	1.9	1.3	0.0	0.0
COMMD2	HSPC042	ENSG00000114744	"COMM domain containing 2"	Q86X83	3	149738470-149752499	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044190	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA044190: AB_10966289"	"unprognostic (2.17e-1)"	"unprognostic (8.34e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (3.69e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.86e-2)"	14.1	11.2	13.3	9.6	16.1	10.3	20.9	22.0	18.3	17.2	10.9	21.1	4.8	10.6	18.8	10.5	14.6	13.2	10.6	11.2	13.4	12.3	21.9	17.2	17.0	13.2	16.0	12.5	18.1	11.3	14.4	14.2	22.3	18.7	14.0	11.7	14.1	14.6	12.2	9.4	13.3	15.8	17.0	19.6	15.2	10.4	9.6	14.4	20.5	19.3	9.6	14.6	12.4	12.8	8.7	10.0	16.4	14.2	11.7	11.4	9.4	17.0	5.0	16.3	9.4	14.3	16.5	10.8	10.7	11.2	16.6	16.8	8.7	10.6	13.7	12.3	10.4	10.5	10.9	15.5	13.0	19.4	10.1	14.8	12.3	6.9	5.8	15.3	17.6	5.6	12.4	14.4	8.2	14.7	11.2	11.6	8.7	6.0	7.8	11.8	5.3	12.2	8.7	18.0	10.4	6.7	11.3	16.5	18.3	15.7	4.5	7.5	11.5	12.4	10.1	22.9	13.5	18.6	11.7	10.1	9.8	3.9	9.7	12.6	14.1	5.5	22.6	9.5	15.9	4.0	16.4	8.2	13.9	8.0	12.0	11.4	8.7	9.8	9.5	10.0	8.0	10.4	10.9	6.4	11.7	14.2	6.2	7.8	9.4	13.3	16.1	22.0	18.3	13.4	12.3	16.0	12.5	18.7	14.4	59.6	21.7	26.8	30.7	18.5	54.4	14.9	30.6	28.1	51.2	21.0	176.7	44.6	36.5	47.3	2.3	33.1	18.8	23.3	34.6	49.7	36.6	22.9	45.1	14.4	39.4	27.0	23.6	31.9	20.9	3.2	33.6	37.2	32.1	121.8	16.3	33.3	44.0	20.1	33.9	23.3	98.2	51.8	29.9	48.9	49.0	18.9	26.7	32.4	20.0	20.5
COMMD3-BMI1		ENSG00000269897	"COMMD3-BMI1 readthrough"		10	22316388-22329542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 20.9"									"HPA030471, HPA030472, HPA036584"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803"	"unprognostic (8.63e-2)"				"unprognostic (2.36e-2)"									"unprognostic (1.83e-2)"				8.5	12.4	4.5	6.6	9.1	2.8	6.9	5.1	8.5	9.7	11.9	4.7	8.3	4.9	4.0	5.9	9.4	8.3	4.3	14.3	4.7	4.1	5.5	6.9	8.0	5.0	6.6	4.7	4.3	11.4	5.7	8.7	4.7	5.7	5.0	2.8	4.2	8.3	14.6	22.8	4.8	7.6	7.0	7.3	7.3	7.6	23.4	6.6	12.3	3.7	7.6	6.4	12.0	5.4	25.0	30.3	25.7	25.8	18.8	21.6	26.6	3.6	13.1	4.6	0.5	5.3	3.6	0.7	3.7	4.1	2.0	5.2	7.2	1.4	1.8	5.5	12.4	9.8	1.7	4.9	8.0	0.6	14.5	1.6	5.0	2.7	3.2	16.3	0.4	2.3	6.4	4.5	7.2	3.8	8.0	5.1	20.9	1.0	5.1	0.6	3.5	14.9	0.5	0.5	8.6	4.1	4.2	5.1	4.0	2.0	4.5	0.4	1.6	7.1	1.7	1.5	1.4	3.2	3.6	6.7	1.6	5.1	0.3	1.0	11.1	13.4	5.9	2.5	11.1	1.6	25.7	25.8	17.2	15.1	23.5	16.6	25.0	16.1	14.7	30.3	21.9	11.0	12.2	3.8	18.8	17.8	29.2	21.6	26.6	4.5	9.1	5.1	8.5	4.7	4.1	6.6	4.7	5.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COMMD7	"C20orf92, dJ1085F17.3"	ENSG00000149600	"COMM domain containing 7"	Q86VX2	20	32702691-32743997	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 221.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 82.7"									HPA054119			Approved	Vesicles		NA	NA			Vesicles		"HPA054119: AB_2682388"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.31e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.52e-2)"	"prognostic favorable (3.53e-4)"	22.4	22.6	32.8	18.4	25.3	23.6	24.0	25.0	30.7	18.0	21.9	19.3	26.9	12.6	19.5	35.5	18.5	19.4	19.0	27.8	25.3	21.5	30.5	25.5	19.0	18.2	23.5	26.6	17.6	27.3	19.9	14.7	32.3	17.8	21.1	21.6	22.3	23.4	22.7	41.8	19.4	15.4	25.9	17.3	21.9	20.3	10.5	16.6	13.4	37.3	16.7	22.2	21.1	16.0	19.3	36.8	46.5	45.4	27.9	24.3	43.8	16.4	11.3	11.1	7.8	8.2	15.3	19.9	14.1	24.2	24.3	16.8	21.4	10.9	12.8	12.6	17.4	20.3	7.4	9.4	12.2	18.6	5.0	5.8	36.2	7.2	16.0	21.3	15.1	20.8	11.6	15.3	18.3	11.0	19.4	23.7	7.4	12.6	6.6	15.5	12.5	13.1	31.4	9.4	16.8	10.5	12.3	1.2	4.6	25.7	11.6	6.7	10.4	14.6	20.6	24.4	12.6	12.0	25.3	15.5	24.9	13.3	15.2	14.4	7.2	5.9	4.5	30.1	82.7	9.9	29.4	32.2	46.5	24.3	42.0	21.2	19.3	20.1	22.3	36.8	17.7	22.3	21.5	3.3	27.9	45.4	23.9	21.9	43.8	32.8	25.3	25.0	30.7	25.3	21.5	23.5	26.6	17.8	16.6	20.8	13.2	34.2	27.6	14.7	51.8	40.3	50.9	12.0	14.8	34.9	64.8	192.2	74.6	89.3	2.1	44.4	26.7	0.0	103.4	87.6	36.1	28.7	53.0	35.2	110.4	63.5	31.8	37.4	43.7	2.7	34.8	46.3	54.0	96.4	40.1	67.1	91.9	48.7	44.9	92.8	64.0	45.3	38.1	12.6	17.1	25.2	221.2	70.3	42.2	36.0
COMMD9	"FLJ31106, HSPC166"	ENSG00000110442	"COMM domain containing 9"	Q9P000	11	36269284-36289449	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009142	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA009142: AB_1847105"	"unprognostic (1.56e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.15e-2)"	"prognostic favorable (8.54e-4)"	"unprognostic (4.94e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.08e-3)"	"unprognostic (7.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.88e-1)"	26.9	25.4	28.0	15.8	25.4	32.6	18.5	18.1	36.9	14.3	15.0	26.5	9.5	16.2	12.4	20.4	18.4	16.2	15.8	23.1	25.4	25.7	34.5	28.0	20.4	24.8	27.7	23.8	15.8	23.3	19.4	18.9	18.9	22.8	12.6	19.1	16.0	16.7	11.1	43.6	19.6	16.4	17.0	28.4	26.0	14.8	14.6	17.2	24.7	19.8	21.1	23.6	16.6	12.2	22.5	66.3	28.8	66.2	14.8	18.9	46.4	10.8	13.0	14.3	15.0	22.1	15.5	7.9	13.0	16.9	29.7	28.0	10.5	9.3	12.6	13.0	25.9	23.0	16.1	25.1	17.5	28.1	15.1	29.5	6.9	24.3	18.3	20.8	26.9	20.8	19.5	19.7	16.2	10.0	15.4	24.3	17.0	17.0	13.6	23.3	14.0	17.9	18.7	15.2	21.4	27.6	19.8	32.4	14.9	30.9	10.2	17.5	19.6	18.6	18.5	16.6	12.2	40.4	10.3	16.2	18.0	13.8	42.7	19.0	9.6	19.5	14.2	20.7	25.4	17.2	12.2	66.2	28.8	16.8	59.6	15.7	21.8	16.2	16.1	66.3	22.5	18.7	15.7	7.4	14.8	47.5	25.0	18.9	46.4	28.0	25.4	18.1	36.9	25.4	25.7	27.7	23.8	22.8	17.2	20.8	21.9	17.1	14.2	13.6	18.7	25.5	10.2	6.7	7.9	17.4	9.8	36.2	66.3	59.6	7.5	21.8	19.7	0.0	40.5	47.0	19.1	4.8	18.5	15.5	95.4	4.8	24.6	15.4	46.2	23.1	16.4	57.6	23.6	52.3	18.1	27.7	40.4	17.5	11.0	51.2	20.1	12.9	11.8	28.8	29.3	18.9	20.8	27.7	23.0	8.8
COMP	"EDM1, EPD1, MED, PSACH, THBS5"	ENSG00000105664	"Cartilage oligomeric matrix protein"	P49747	19	18782773-18791314	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cell adhesion"	Heparin-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.1;skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 32.0;Fibroblasts: 20.3;Late spermatids: 53.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 138.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA077555			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		1100000000	"Golgi apparatus"		"HPA077555: "	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (9.08e-5)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (5.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (6.95e-4)"	39.1	0.2	0.0	1.0	0.0	0.0	4.1	1.8	0.2	2.7	2.0	0.1	2.5	0.0	3.0	24.2	4.7	0.4	16.2	21.6	0.2	0.0	4.5	0.4	2.9	2.7	0.0	0.6	0.9	3.3	0.1	0.1	8.2	0.2	8.7	0.0	0.1	6.0	7.4	59.6	31.8	0.3	13.0	0.2	0.1	0.9	11.5	0.0	0.3	8.9	27.6	0.9	10.8	11.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	138.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.2	0.0	0.0	0.6	0.2	0.0	3.0	0.3	0.0	0.5	10.2	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.0	0.7	0.0	0.0	0.2	0.2	20.3	0.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	53.4	0.9	0.0	10.1	0.0	0.0	1.8	0.1	0.0	0.7	0.0	0.3	6.5	6.4	3.1	1.5	6.1	0.5	0.0	0.0	0.3
COMTD1	FLJ23841	ENSG00000165644	"Catechol-O-methyltransferase domain containing 1"	Q86VU5	10	75233969-75236030	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 57.2"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 363.3;Exocrine glandular cells: 216.7;Paneth cells: 207.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.9;HEK 293: 22.9;PC-3: 31.9;RPMI-8226: 17.8;U-266/70: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042165	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA042165: AB_10794042"	"unprognostic (2.53e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.08e-3)"	"unprognostic (9.35e-2)"	"unprognostic (6.74e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.35e-1)"	2.5	5.2	1.3	5.8	1.4	2.9	5.7	3.6	2.2	4.8	14.1	0.5	9.7	17.9	2.0	5.9	20.0	1.6	6.4	8.0	1.2	1.6	12.6	14.9	4.4	4.1	1.9	1.7	2.2	57.2	3.2	5.3	7.8	2.2	3.1	2.1	3.2	21.2	9.1	19.6	7.3	22.9	1.9	1.0	3.4	16.1	1.5	0.6	2.7	7.0	14.4	6.0	2.4	7.5	6.6	15.7	3.8	9.3	7.3	12.5	7.1	4.9	0.9	0.2	0.9	0.2	0.4	14.9	1.4	0.4	0.1	0.3	1.2	4.4	14.0	2.8	0.3	0.7	7.1	0.4	1.2	0.0	2.1	22.9	0.5	1.3	2.4	0.7	2.7	2.4	0.3	1.9	0.0	1.2	0.3	0.0	1.8	5.6	2.7	0.0	3.3	3.9	8.3	0.7	3.9	31.9	7.3	0.7	17.8	1.0	0.2	5.4	1.3	1.5	11.5	3.0	0.1	6.7	0.3	1.2	0.3	4.3	0.5	1.6	15.3	3.2	6.8	0.3	2.3	0.3	0.0	8.9	3.8	12.1	9.3	12.5	6.6	11.7	12.2	10.1	4.7	3.8	6.7	1.8	7.3	8.9	15.7	9.0	7.1	1.3	1.4	3.6	1.7	1.2	1.6	1.9	1.7	2.2	0.6	17.9	14.4	22.9	33.2	26.2	5.2	26.2	48.4	2.7	4.5	50.6	9.8	24.6	122.7	126.7	1.3	10.8	363.3	0.0	216.7	64.2	12.7	34.1	12.7	75.5	32.8	1.6	38.7	19.0	24.7	2.2	8.9	19.4	35.4	37.9	104.6	5.8	134.6	207.0	6.7	96.3	26.7	32.3	19.1	2.1	2.3	33.4	25.4	25.5	104.0	43.9
COPA	HEP-COP	ENSG00000122218	"Coatomer protein complex subunit alpha"	P53621	1	160289273-160343400	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		260000	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	38.3	32.7	29.2	28.9	41.0	22.9	32.4	43.1	48.4	46.3	34.3	53.2	24.5	38.4	37.0	33.1	28.4	31.5	28.6	38.4	33.3	35.2	36.3	64.3	33.8	26.6	42.7	29.3	36.8	47.8	49.1	57.4	45.1	56.2	35.3	39.9	28.8	42.1	33.9	40.5	28.7	50.3	40.4	42.8	36.6	32.8	21.2	35.8	36.0	42.8	21.0	34.1	30.3	27.5	15.4	31.4	25.1	29.1	18.1	21.2	25.3	28.2	22.2	23.6	22.9	60.8	50.1	27.7	38.9	46.3	33.2	39.2	28.9	19.3	20.8	25.3	59.1	19.1	28.5	27.2	28.0	38.3	23.6	18.4	23.9	30.6	30.4	45.7	29.1	25.1	46.8	17.1	44.3	41.3	41.1	38.9	19.9	22.1	23.3	39.6	20.7	18.7	12.6	25.8	37.2	26.0	16.8	27.1	32.0	27.2	26.8	19.6	24.8	44.0	38.7	41.1	41.4	43.1	39.3	45.8	25.0	19.5	33.5	25.5	38.4	26.6	32.1	32.6	15.2	37.2	25.1	29.1	20.1	17.1	27.3	21.2	15.4	14.3	18.3	31.4	12.1	13.2	15.2	10.8	18.1	27.9	13.3	17.5	25.3	29.2	41.0	43.1	48.4	33.3	35.2	42.7	29.3	56.2	35.8	71.5	41.2	52.3	29.9	25.0	49.9	41.1	48.4	53.5	42.1	38.4	76.6	33.9	11.6	44.6	11.0	42.1	70.4	0.0	43.3	55.4	50.4	56.4	43.9	64.8	46.0	42.9	53.2	53.4	85.0	4.5	65.9	62.1	25.3	31.5	79.0	38.2	46.4	45.6	53.4	38.5	48.0	38.8	52.3	37.9	23.8	27.9	57.9	41.5	60.4	44.0
COPB2	"beta'-COP, betaprime-COP"	ENSG00000184432	"Coatomer protein complex subunit beta 2"	P35606	3	139355600-139389732	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036867, HPA058180"	Approved		Approved	Cytosol		NA	NA		1000000	Cytosol		"HPA036867: AB_10672271, HPA058180: AB_2683630"	"unprognostic (3.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.95e-2)"	28.7	40.8	21.9	22.3	26.2	12.1	28.7	31.7	29.0	39.5	32.4	22.6	40.3	26.1	33.0	44.7	35.9	28.9	26.2	31.4	21.6	18.9	42.1	67.5	29.1	20.1	26.0	16.6	36.0	65.5	41.2	72.2	51.7	28.7	35.5	33.8	20.5	46.5	28.6	20.6	23.5	37.1	30.0	21.1	31.3	29.9	21.1	25.7	33.1	40.4	27.4	31.2	30.0	26.5	22.6	36.4	35.9	34.4	27.4	23.5	22.6	53.5	21.5	31.6	28.5	63.6	58.6	27.7	64.2	61.0	41.5	51.3	40.2	20.4	21.7	59.4	68.0	37.6	28.5	35.9	34.3	52.1	37.4	24.6	32.6	34.1	38.4	38.1	29.0	37.4	41.0	31.2	32.6	33.8	48.2	40.0	19.6	21.3	26.3	49.1	32.4	14.5	17.8	28.7	53.3	23.7	19.6	25.6	37.3	38.1	38.8	22.4	20.6	63.1	57.2	35.4	44.7	45.6	31.3	46.6	23.3	18.8	34.4	22.5	41.1	24.5	38.3	39.0	16.5	36.0	35.9	28.4	30.1	22.9	34.4	23.2	22.6	20.4	23.5	36.4	16.3	15.9	20.0	26.9	27.4	32.3	17.0	21.9	22.6	21.9	26.2	31.7	29.0	21.6	18.9	26.0	16.6	28.7	25.7	53.6	34.0	32.0	34.0	17.4	34.8	47.2	33.1	93.7	52.4	19.2	29.5	71.4	34.9	71.2	24.9	41.9	41.4	0.0	72.1	64.7	71.0	57.8	43.9	43.3	46.9	39.7	61.3	37.4	38.0	5.8	50.6	31.5	20.3	57.7	71.8	55.4	68.4	28.8	47.0	37.2	44.9	19.4	46.7	47.7	43.0	13.0	111.3	34.9	36.6	37.8
COPG1	COPG	ENSG00000181789	"Coatomer protein complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		110000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	25.2	39.4	21.1	22.2	28.0	20.1	37.3	23.6	50.3	43.3	42.1	24.3	50.6	34.2	27.6	66.5	29.5	24.4	34.5	33.4	24.2	26.7	32.4	72.1	36.5	39.4	23.0	21.6	28.6	75.6	47.6	49.7	49.3	34.9	45.1	45.1	22.4	59.9	45.5	24.1	24.3	32.4	29.1	20.7	29.0	36.3	23.6	16.2	26.9	33.0	22.0	27.7	19.9	24.1	15.7	31.9	34.9	33.0	31.1	31.8	26.0	32.7	16.7	24.4	21.1	57.2	46.4	26.0	53.5	51.1	36.9	46.7	30.6	20.4	18.0	31.2	75.9	30.0	19.8	20.1	31.5	40.2	21.9	8.3	29.9	22.1	49.4	52.1	22.6	32.2	48.4	27.8	29.5	48.7	40.6	33.2	13.9	10.4	43.6	44.4	49.8	13.2	23.1	14.5	48.1	20.5	14.4	22.9	34.8	46.0	27.3	15.2	17.8	41.1	30.7	49.0	28.0	34.0	33.1	44.8	20.1	19.1	42.4	20.6	34.1	16.2	31.6	49.1	17.3	38.5	34.9	26.8	20.2	26.2	33.0	31.8	15.0	23.7	25.7	31.9	15.7	18.5	21.6	21.3	31.1	29.7	29.4	23.6	26.0	21.1	28.0	23.6	50.3	24.2	26.7	23.0	21.6	34.9	16.2	14.9	29.8	27.4	13.9	7.8	8.7	19.3	17.8	16.0	18.2	26.2	3.9	52.4	36.5	39.6	7.8	19.4	69.2	46.7	40.7	53.3	25.8	24.8	14.0	53.3	34.3	4.8	37.1	35.6	31.0	3.1	38.0	19.0	21.9	44.1	67.9	14.2	35.7	37.4	29.4	28.8	7.5	19.4	17.3	21.1	16.4	8.9	60.4	20.1	38.2	17.5
COPRS	"C17orf79, COPR5, HSA272196, TTP1"	ENSG00000172301	"Coordinator of PRMT5 and differentiation stimulator"	Q9NQ92	17	31851864-31859337	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 410.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA052552	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA052552: AB_2681868"	"unprognostic (1.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.11e-2)"	20.9	19.0	32.6	9.7	31.0	6.3	30.3	23.0	37.6	15.3	24.2	11.8	15.6	8.0	15.2	57.3	10.5	24.9	14.9	24.7	28.2	35.5	22.7	31.0	12.3	9.2	29.7	31.3	24.3	20.7	12.2	18.9	9.4	23.9	27.5	13.6	16.0	14.6	23.5	19.9	7.8	7.9	21.2	16.0	8.1	14.1	75.0	14.4	2.6	28.1	11.2	12.7	16.1	18.5	5.8	4.5	3.5	3.5	0.0	3.0	0.4	21.0	27.8	14.0	14.3	22.9	22.1	9.8	23.7	29.8	27.2	27.8	17.4	5.7	12.0	13.3	28.3	53.7	12.7	24.6	14.2	30.9	4.1	36.9	3.3	16.0	20.4	23.4	11.2	9.6	14.1	18.7	36.6	20.1	29.7	14.5	16.1	16.3	10.0	29.6	18.3	16.6	35.6	10.6	13.7	14.0	13.3	26.0	21.7	15.9	13.1	12.6	9.8	14.0	6.8	21.6	12.7	22.3	12.0	8.1	71.6	19.4	25.5	32.8	17.1	15.9	12.1	37.4	10.4	9.6	3.5	3.5	0.0	1.1	3.3	3.0	3.8	1.1	0.2	4.5	5.8	0.6	0.7	1.2	0.0	1.6	1.8	1.5	0.4	32.6	31.0	23.0	37.6	28.2	35.5	29.7	31.3	23.9	14.4	20.8	8.8	21.9	52.7	30.6	43.8	64.8	45.9	28.1	9.1	82.0	9.8	25.3	190.6	93.7	161.6	50.8	5.1	0.0	70.1	45.2	52.1	108.4	3.5	85.5	75.8	25.4	18.9	44.2	26.0	212.9	57.8	35.0	55.6	70.3	14.8	79.2	64.6	3.5	61.2	173.3	30.2	19.4	62.1	410.0	65.8	27.7	22.9	10.1	19.7	32.5
COPS9	"CSNAP, MYEOV2"	ENSG00000172428	"COP9 signalosome subunit 9"	Q8WXC6	2	240126563-240136807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 422.7;Exocrine glandular cells: 329.4;Hofbauer cells: 279.6;Pancreatic endocrine cells: 292.2;Proximal tubular cells: 474.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044845	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044845: AB_10962975"	"unprognostic (6.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-2)"	31.9	29.1	81.6	20.6	73.2	24.0	40.9	22.6	61.6	29.1	27.6	22.7	20.5	25.6	17.2	53.2	34.5	23.5	25.4	62.3	75.8	44.7	30.5	23.5	17.8	26.7	64.3	24.3	23.2	64.3	8.9	27.6	17.6	32.9	25.9	18.9	19.0	43.3	26.5	86.9	20.6	24.5	21.1	52.6	22.6	25.8	18.8	25.9	26.5	34.7	41.6	19.8	23.5	20.9	68.2	79.9	90.7	67.7	52.4	82.0	79.9	27.2	36.9	29.1	30.4	40.3	33.0	26.8	39.4	27.6	25.9	33.2	26.7	24.5	7.5	11.9	35.9	41.3	21.9	25.7	36.5	17.9	31.9	94.9	22.6	38.0	82.7	32.1	22.6	21.3	38.7	30.2	19.3	24.1	24.0	37.9	38.6	26.0	16.4	37.6	58.8	36.2	70.6	44.3	34.3	80.7	28.6	39.1	23.5	32.0	47.0	33.8	33.9	20.7	28.2	42.1	23.5	26.0	44.2	30.6	34.3	38.3	43.6	37.4	33.6	28.5	38.0	42.7	26.9	33.7	90.7	67.2	87.6	68.6	66.6	68.0	68.2	71.2	70.1	62.6	52.8	62.6	70.5	24.1	52.4	67.7	79.9	82.0	79.9	81.6	73.2	22.6	61.6	75.8	44.7	64.3	24.3	32.9	25.9	119.1	114.6	0.0	0.0	0.0	0.0	0.0	0.0	123.1	102.4	261.7	0.0	149.7	422.7	189.2	0.0	0.0	0.0	0.0	329.4	162.4	0.0	0.0	57.0	0.0	279.6	0.0	0.0	0.0	0.0	0.0	0.0	87.4	0.0	253.3	0.0	0.0	292.2	0.0	0.0	474.2	0.0	0.0	0.0	0.0	0.0	0.0	110.6	0.0	0.0	0.0
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266858-56270966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"HPA068931: AB_2686061"	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	2.9	12.4	5.0	2.3	6.8	2.2	3.1	7.6	7.3	3.7	2.9	4.8	5.9	1.9	3.6	7.7	4.3	5.2	3.2	43.5	4.5	5.4	7.2	12.8	3.5	3.4	5.6	3.9	4.5	5.5	6.0	9.9	1.7	4.8	4.1	2.7	14.0	6.5	5.6	103.7	2.2	2.9	3.7	3.6	3.8	2.6	2.4	3.0	4.9	5.4	46.1	6.2	2.7	3.3	11.7	6.8	8.0	1.1	5.0	8.6	3.6	2.5	10.3	10.0	6.5	5.7	5.8	4.2	3.6	8.6	12.7	12.7	8.0	3.8	14.7	8.2	9.0	3.6	2.4	11.5	2.0	7.6	2.3	12.8	6.8	9.4	8.3	7.8	5.4	4.2	6.0	3.4	9.4	3.7	8.0	6.6	10.4	4.5	6.1	11.8	3.3	7.7	19.3	8.5	1.8	6.0	16.6	10.9	9.7	7.0	1.5	14.5	15.6	12.3	2.6	3.8	7.7	4.0	6.0	4.7	2.4	7.1	6.7	3.6	12.8	13.7	7.2	7.1	5.1	1.8	8.0	1.0	0.9	7.7	1.1	7.9	11.7	7.1	8.2	1.7	6.7	8.6	8.4	0.4	5.0	0.8	6.8	4.6	3.6	5.0	6.8	7.6	7.3	4.5	5.4	5.6	3.9	4.8	3.0	3.0	7.4	6.1	12.1	11.8	17.4	115.4	7.6	12.0	4.5	10.4	15.7	5.0	44.7	2.4	0.1	9.6	2.1	0.0	4.0	5.9	8.0	4.7	4.6	14.0	4.4	30.2	15.5	2.5	1.6	1.4	7.8	2.5	11.8	1.8	2.8	21.7	2.5	3.4	15.9	11.0	30.0	38.8	18.9	1.7	17.7	9.3	2.5	13.4	4.5	4.3
COQ10B	FLJ13448	ENSG00000115520	"Coenzyme Q10B"	Q9H8M1	2	197453423-197475308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046057	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046057: AB_2679518"	"unprognostic (9.17e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.28e-3)"	"unprognostic (5.76e-3)"	"unprognostic (4.55e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-3)"	24.5	34.0	19.3	14.5	18.2	34.0	21.8	13.3	23.2	15.1	16.8	16.6	13.0	13.9	19.2	14.6	16.7	14.9	23.2	28.7	18.7	18.8	30.1	34.3	17.3	15.3	18.3	14.1	15.2	25.0	20.4	23.0	33.1	20.6	16.1	18.2	17.6	17.4	16.3	16.0	13.3	22.3	25.5	17.3	17.7	17.8	9.1	12.6	11.5	18.7	16.2	16.4	21.1	14.1	14.8	11.7	40.6	17.8	13.9	24.1	16.0	6.9	6.7	4.9	8.6	23.5	16.8	11.4	18.2	26.3	19.6	21.9	13.4	8.4	6.5	15.6	14.6	24.5	6.4	7.0	9.7	22.4	12.8	6.0	9.3	9.6	15.7	19.7	7.5	21.7	18.7	15.1	18.6	13.3	10.7	10.6	9.5	7.8	17.5	18.7	9.1	8.1	11.7	7.5	8.2	13.7	6.2	7.2	8.5	21.1	18.9	3.1	6.1	8.3	11.0	22.6	18.1	7.8	10.6	11.1	19.4	6.7	21.6	13.0	16.7	23.6	7.3	24.2	7.3	14.9	27.3	13.6	24.4	20.7	15.6	23.3	14.8	20.0	20.5	11.7	11.5	21.1	21.4	40.6	13.9	17.8	7.4	24.1	16.0	19.3	18.2	13.3	23.2	18.7	18.8	18.3	14.1	20.6	12.6	17.9	14.5	31.9	92.5	93.8	29.4	27.1	22.9	29.4	15.9	38.4	39.3	28.2	109.5	35.0	38.1	42.3	36.8	46.7	40.9	38.0	47.3	53.4	59.9	32.1	27.7	60.4	25.8	20.9	18.3	14.4	19.0	38.3	67.4	32.5	31.3	50.9	41.3	28.1	28.7	58.7	32.0	45.3	69.0	19.3	34.7	93.2	145.4	45.8	12.3	83.8
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease mutation, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 45.2;Kupffer cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.6	25.5	4.9	8.4	7.0	8.9	9.9	1.9	6.0	7.4	12.1	5.8	8.4	7.8	8.0	10.2	13.1	5.4	7.4	17.5	4.3	4.1	8.0	14.9	9.8	9.0	6.5	3.4	8.0	5.9	6.7	12.3	7.2	5.0	6.6	12.5	5.2	12.7	8.5	21.8	13.8	8.2	5.8	6.7	14.1	4.8	6.6	6.7	2.9	10.1	23.9	9.2	6.2	7.4	3.6	11.8	6.0	17.4	3.7	2.0	6.8	11.7	6.9	6.8	12.9	5.3	5.4	4.8	7.6	12.6	14.5	17.0	4.8	17.0	7.9	5.6	13.5	11.5	9.1	11.5	12.4	18.3	8.1	7.3	7.1	9.0	6.7	5.8	14.4	34.2	8.0	7.9	7.0	12.1	4.3	14.4	4.5	4.6	9.5	13.4	12.1	3.8	9.7	5.0	13.9	9.7	6.6	5.3	10.2	21.1	5.7	4.8	3.1	8.7	11.1	3.9	3.2	7.1	7.9	10.0	6.8	7.1	5.1	10.6	2.8	2.3	4.7	13.3	16.9	9.3	1.1	16.3	2.3	1.6	14.4	1.2	3.6	1.8	1.5	11.8	3.5	1.3	2.0	6.0	3.7	17.4	6.2	2.0	6.8	4.9	7.0	1.9	6.0	4.3	4.1	6.5	3.4	5.0	6.7	0.0	3.4	11.8	9.6	6.0	5.2	17.1	5.1	2.7	6.8	8.7	0.0	20.5	26.6	5.8	0.6	3.6	9.6	0.0	9.5	25.6	5.4	9.8	0.0	11.4	45.2	1.6	4.6	12.9	48.6	0.6	3.4	26.3	6.8	1.0	15.2	12.9	4.7	14.0	4.6	8.2	4.2	0.0	4.7	4.3	14.5	11.0	10.4	10.0	23.9	8.9
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369400-99394204	"Enzymes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 37.1;Distal tubular cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	5.2	7.8	8.6	4.2	10.8	3.2	7.5	13.6	16.3	4.5	8.9	4.5	4.3	6.9	4.3	6.8	8.2	4.5	3.0	21.7	8.2	7.5	10.2	12.4	2.9	7.1	6.9	12.0	6.0	5.7	11.6	7.4	2.5	9.8	6.8	11.0	7.3	11.7	7.6	28.0	5.8	6.3	6.6	4.6	4.8	5.2	2.3	6.0	4.1	4.3	16.8	7.0	7.5	4.6	6.6	8.0	9.4	7.4	9.7	12.5	5.3	12.0	6.9	8.4	11.9	5.5	6.2	11.6	10.4	6.5	15.8	18.3	9.6	5.2	11.8	7.0	7.8	10.2	11.2	14.0	16.3	19.3	12.5	17.9	14.4	9.5	10.3	7.2	20.8	5.7	3.9	10.0	9.3	9.4	3.5	9.6	14.6	21.9	9.0	8.4	11.9	9.1	17.4	10.2	11.9	13.4	4.5	8.6	15.7	12.4	10.5	13.2	7.0	7.2	11.2	13.6	5.9	13.7	13.7	3.4	6.9	10.1	10.6	15.8	3.2	5.9	18.6	8.8	20.2	10.1	9.4	3.3	2.4	6.0	7.4	6.8	6.6	7.6	9.5	8.0	3.1	12.5	9.5	0.5	9.7	6.3	5.2	5.5	5.3	8.6	10.8	13.6	16.3	8.2	7.5	6.9	12.0	9.8	6.0	3.0	3.0	6.1	8.0	3.9	7.1	37.1	7.6	0.0	5.7	3.5	0.0	13.0	28.2	10.0	0.4	4.5	3.2	0.0	9.3	11.0	4.1	2.0	1.1	7.8	5.7	6.4	0.0	3.7	0.6	0.0	7.5	3.3	5.0	1.8	6.5	10.4	7.0	6.0	5.6	8.8	7.8	6.5	8.2	3.4	12.4	3.8	5.3	4.4	9.0	3.1
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067599-19080095	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubiquinone biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 45.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 45.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA067252: AB_2685813, HPA071922: AB_2686473"	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	9.1	14.2	13.5	7.8	12.9	4.0	12.6	11.3	18.5	11.2	12.8	12.8	15.2	11.4	14.7	17.4	11.9	15.0	13.9	21.1	12.1	13.0	13.5	11.4	14.6	11.1	12.2	12.0	19.4	12.2	23.7	15.1	9.4	12.9	17.1	12.5	16.5	11.3	14.7	37.3	7.5	12.1	11.1	12.4	8.7	11.8	34.7	10.7	9.4	15.3	24.7	7.6	12.1	10.0	5.1	5.3	45.2	4.0	4.1	4.4	1.8	12.6	13.6	11.8	6.9	6.7	7.1	9.9	7.4	6.1	10.2	10.5	8.6	10.6	9.6	36.1	5.7	11.0	13.4	16.4	9.3	7.4	8.2	16.6	5.1	12.5	26.4	8.3	12.2	11.3	5.9	8.2	9.4	6.9	8.4	8.2	11.6	14.0	9.0	7.1	22.7	12.7	9.9	9.0	4.9	7.3	15.6	13.1	12.3	8.8	8.5	17.2	9.8	6.9	15.3	8.6	6.0	14.1	16.6	8.9	10.8	6.3	7.9	10.6	8.4	13.6	10.5	11.6	7.1	6.9	10.8	4.0	5.8	3.5	3.5	3.3	5.1	3.2	3.1	4.3	5.0	4.4	3.9	45.2	4.1	3.9	5.3	2.0	1.8	13.5	12.9	11.3	18.5	12.1	13.0	12.2	12.0	12.9	10.7	14.9	9.3	38.9	25.6	9.7	30.8	19.0	22.9	21.4	9.1	15.7	37.3	18.0	38.1	20.5	10.9	11.3	47.3	0.0	15.9	14.6	13.0	14.3	25.3	8.9	20.1	19.1	23.1	13.5	18.7	6.2	17.3	15.3	10.1	9.0	30.7	39.8	11.7	24.3	13.1	19.5	53.8	19.4	15.1	77.6	54.5	10.8	26.9	33.1	29.9	22.2
COQ9	"C16orf49, DKFZP434K046"	ENSG00000088682	"Coenzyme Q9"	O75208	16	57447425-57461275	"Disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.0"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 184.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040918	Supported		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA040918: AB_10794154"	"unprognostic (9.18e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.03e-11)"	"unprognostic (7.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-2)"	8.8	19.3	11.5	7.8	12.4	3.7	9.3	11.2	13.8	7.9	17.9	9.4	14.7	17.6	7.2	9.9	16.6	9.5	11.3	46.1	9.5	8.8	28.8	29.1	5.8	6.4	9.7	8.6	6.9	12.6	23.6	8.9	8.1	8.8	10.4	14.5	12.2	17.7	14.5	86.0	9.4	23.7	22.1	6.9	5.3	13.6	8.9	8.5	5.4	11.8	31.1	9.4	16.3	8.4	13.6	23.3	14.7	24.1	15.2	18.7	14.1	11.9	24.4	6.6	16.6	13.3	10.3	7.9	11.6	9.1	16.4	9.2	14.8	15.6	14.5	22.4	10.1	12.6	25.6	19.1	20.3	10.3	7.8	16.5	10.0	16.7	22.7	14.7	12.7	16.4	17.1	26.6	13.0	25.4	10.9	18.2	12.8	19.2	6.6	9.8	17.0	10.5	9.2	10.9	25.9	32.2	21.4	21.8	37.3	25.5	13.3	20.9	21.1	39.3	37.9	19.2	6.1	21.8	14.2	12.5	11.9	14.7	12.9	14.6	16.1	9.9	17.3	16.6	18.3	13.5	11.5	19.3	14.7	13.9	24.1	14.4	13.6	12.0	12.2	23.3	12.0	13.0	18.7	6.0	15.2	23.5	14.5	16.8	14.1	11.5	12.4	11.2	13.8	9.5	8.8	9.7	8.6	8.8	8.5	11.9	17.6	19.3	15.0	7.4	15.8	75.0	50.9	26.8	17.0	24.4	15.7	61.9	184.1	42.5	28.2	16.5	72.4	0.0	25.5	19.3	14.4	15.7	6.9	45.9	33.9	19.1	26.5	16.5	14.0	20.8	19.5	12.8	27.0	30.7	42.6	24.6	24.1	37.4	19.1	80.1	22.7	12.9	16.7	66.0	31.1	9.8	65.8	15.2	58.3	17.0
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593998-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 11.6;heart muscle: 39.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 50.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 32.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Low region specificity"	"Detected in single"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No			"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0.0	3.4	11.6	0.7	1.2	4.5	39.5	0.0	0.2	2.0	0.0	1.3	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.6	1.6	1.7	0.0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0.0	3.5	0.3	3.7	0.0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0.0	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	7.5	32.6	0.0	1.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.6	0.0	0.0	6.9	0.0	0.2	3.4	0.8	50.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	9.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.8	4.4	0.0	5.0	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.1	0.0	4.2	3.0	4.6	2.4	0.0	0.0	0.0	0.2
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 204.4;bone marrow: 94.9;lymphoid tissue: 99.8"	"Group enriched"	"Detected in many"	5	"B-cells: 445.3;Hofbauer cells: 429.4;Kupffer cells: 429.2;Macrophages: 313.3;monocytes: 310.2;T-cells: 809.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 86.3;HL-60: 60.2;HMC-1: 104.2;JURKAT: 54.9;MOLT-4: 58.2;NB-4: 68.9;RPMI-8226: 90.9;U-698: 56.3;U-937: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		NA	NA		130000000	Cytosol		"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	6.4	4.9	12.7	58.9	10.8	94.9	4.4	7.8	13.6	2.9	5.0	6.0	0.2	8.3	3.0	3.0	4.7	5.9	8.6	4.8	10.4	7.8	4.9	3.8	13.7	99.8	9.6	8.2	2.2	2.7	0.6	3.0	4.8	7.3	3.3	2.9	2.2	12.3	1.6	1.3	3.4	28.7	4.1	9.0	92.0	8.5	1.1	7.5	86.0	3.6	3.2	64.8	15.8	3.1	41.6	67.7	204.4	67.5	39.1	66.4	101.2	0.2	0.3	1.0	2.1	0.0	0.0	0.5	0.2	0.0	0.5	0.2	0.0	0.6	86.3	0.5	0.0	0.1	0.4	0.4	1.0	0.1	27.6	0.2	9.1	0.0	1.3	0.1	60.2	104.2	0.3	0.0	0.4	0.0	0.0	0.1	54.9	0.1	44.4	0.3	7.3	58.2	68.9	0.4	0.2	0.6	31.7	1.6	90.9	0.1	0.4	1.6	1.2	0.2	10.4	0.2	0.0	0.1	35.0	0.1	0.4	0.8	0.2	0.2	34.5	45.5	56.3	0.3	76.3	0.6	52.5	58.3	204.4	53.7	67.5	50.5	41.6	48.4	52.2	67.7	41.6	46.6	48.1	105.8	39.1	66.3	38.2	66.4	101.2	12.7	10.8	7.8	13.6	10.4	7.8	9.6	8.2	7.3	7.5	20.8	52.4	445.3	1.0	10.1	1.2	1.2	17.8	5.3	7.9	1.8	0.0	4.1	0.0	3.5	0.4	3.6	1.1	0.0	0.8	13.9	9.4	0.7	83.0	2.1	429.4	0.0	5.8	20.9	429.2	0.4	0.6	313.3	30.4	310.2	1.7	0.8	6.6	28.8	0.0	3.7	0.7	6.5	7.2	0.0	0.9	8.0	4.1	809.5	1.3	1.0
CORO2A	"IR10, WDR2"	ENSG00000106789	"Coronin 2A"	Q92828	9	98120975-98192640	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 36.1"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 38.2;Enterocytes: 69.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 32.3;OE19: 26.3;SK-BR-3: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041161, HPA041302"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041161: AB_10795537, HPA041302: AB_10794195"	"unprognostic (4.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.40e-3)"	1.6	0.8	1.2	6.9	1.8	8.1	2.9	9.3	2.4	3.9	22.0	0.7	1.3	20.8	2.0	2.2	13.6	2.7	27.7	1.5	1.3	3.0	1.4	2.9	7.5	1.6	2.6	1.3	1.5	1.4	2.8	5.2	3.5	3.3	9.0	7.9	1.2	5.4	1.9	0.9	6.3	36.1	1.9	0.6	3.8	6.6	11.4	0.6	5.6	1.1	3.6	6.6	7.7	6.2	0.6	0.7	10.9	7.0	1.5	11.1	1.4	3.9	1.4	0.3	0.9	0.6	0.6	32.3	0.3	0.3	1.0	1.6	8.9	0.6	0.0	4.5	0.6	1.5	11.0	3.7	6.0	0.6	3.2	0.8	0.1	5.6	7.9	1.3	3.6	0.3	0.2	7.4	0.5	9.1	0.3	0.3	4.7	3.1	1.8	0.1	2.9	0.7	3.6	4.1	26.3	1.0	2.8	0.0	0.1	0.6	11.1	0.8	1.1	2.0	21.8	0.7	7.6	2.5	6.0	0.3	0.1	4.8	0.1	1.1	0.3	1.8	0.3	0.2	1.2	1.3	7.7	1.5	10.9	2.4	3.0	5.5	0.6	4.1	3.8	0.5	0.6	2.7	3.5	1.1	1.5	7.0	0.7	11.1	1.4	1.2	1.8	9.3	2.4	1.3	3.0	2.6	1.3	3.3	0.6	11.9	23.8	0.9	17.5	6.0	1.5	1.2	38.2	20.1	35.2	0.0	3.9	8.5	0.0	3.0	2.2	1.9	69.1	0.0	4.5	31.7	3.1	14.5	0.0	3.2	5.8	1.6	6.9	1.3	11.0	3.0	0.0	4.9	0.0	0.0	14.0	0.5	13.8	17.3	0.4	1.4	1.5	0.0	1.9	0.5	3.2	8.7	13.3	8.7	25.7	26.0
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578969-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.5;fallopian tube: 27.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 32.6;Ciliated cells: 14.7;Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 20.9"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.2;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	21	"B-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.9;ASC TERT1: 27.8;HSkMC: 20.0;hTEC/SVTERT24-B: 16.3;U-87 MG: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced	Supported	Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	4.4	15.7	3.2	30.1	1.9	4.8	33.7	53.5	6.5	3.4	27.3	0.8	2.4	7.5	3.9	2.7	27.4	6.3	7.2	23.0	15.1	5.5	2.0	5.8	3.5	20.9	18.8	18.4	2.9	1.6	1.5	4.7	23.6	3.2	2.9	11.8	3.4	6.9	3.8	5.6	3.3	8.4	35.0	3.6	2.0	2.2	17.5	0.0	4.6	0.6	1.9	3.0	1.6	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	12.3	1.0	12.9	27.8	0.0	6.2	6.9	1.1	1.5	0.1	1.4	1.5	0.7	1.0	1.7	0.0	0.4	0.1	4.5	0.0	0.5	0.0	0.0	0.6	4.7	0.0	0.1	20.0	0.1	16.3	1.0	9.7	0.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.5	1.7	0.0	7.1	0.1	0.1	0.0	3.6	2.4	0.0	1.4	0.1	3.7	4.1	0.7	8.2	0.0	0.0	1.5	27.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	30.1	33.7	29.3	23.0	15.1	20.9	18.8	23.6	17.5	0.0	0.0	0.0	0.3	0.9	32.6	1.1	0.0	14.7	0.0	7.0	35.3	0.0	0.0	3.8	0.2	1.5	0.0	0.0	0.5	0.0	2.6	0.1	0.0	0.0	0.2	0.0	3.5	5.5	0.3	0.0	7.2	0.0	6.8	0.0	0.0	9.5	0.4	0.0	0.4	0.0	20.9	6.5	2.3	0.2	0.4	0.6	0.0	0.0	0.0	0.1
CORO6	FLJ14871	ENSG00000167549	"Coronin 6"	Q6QEF8	17	29614756-29622907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 130.9"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 30.8;Extravillous trophoblasts: 17.0;Horizontal cells: 28.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"basophil: 3.9;eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"REH: 12.5;RH-30: 14.1;SH-SY5Y: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021556			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA021556: "	"unprognostic (7.12e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-4)"	"unprognostic (9.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.00e-4)"	"unprognostic (6.70e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.61e-7)"	"unprognostic (8.48e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.13e-2)"	2.7	1.6	5.7	1.2	17.7	0.9	2.2	4.5	12.4	1.4	4.4	0.7	1.6	1.3	3.3	3.4	6.9	3.5	2.4	28.4	5.2	3.3	0.9	0.8	2.1	1.0	1.8	8.7	1.2	1.0	11.7	1.0	25.7	8.1	4.0	1.7	1.2	3.8	2.7	130.9	2.0	2.4	5.6	1.3	1.1	2.1	1.0	3.6	0.0	21.3	18.3	1.1	4.9	1.9	0.0	0.0	3.9	0.0	0.0	0.1	0.1	7.7	3.4	3.0	0.0	4.7	2.6	4.7	2.6	0.9	1.6	0.7	0.2	0.0	0.1	0.6	4.1	0.2	8.2	2.3	0.5	0.8	0.1	3.9	0.0	6.4	1.0	7.6	0.0	0.4	9.3	0.7	0.8	0.0	4.3	1.7	0.0	0.5	0.1	5.5	0.0	5.1	0.2	1.0	0.0	0.1	12.5	14.1	0.3	0.4	0.0	0.0	17.5	0.7	2.3	0.0	2.3	0.0	1.1	0.5	1.1	0.0	1.4	1.1	6.6	3.4	0.9	2.4	0.0	0.0	3.9	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	17.7	4.5	12.4	5.2	3.3	1.8	8.7	8.1	3.6	0.0	0.0	0.0	2.8	1.3	0.5	30.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.0	17.0	1.9	0.8	0.0	0.0	1.2	28.6	0.0	3.1	2.2	0.0	6.6	0.4	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.9	6.5	3.4	0.2	0.7	0.4	2.1	0.7	0.0	0.1
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354814	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 66.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 22.6;SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.3	0.0	0.4	0.6	0.6	0.7	0.5	0.3	0.6	0.2	3.3	0.2	0.2	0.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.5	0.5	0.2	0.2	0.6	0.4	0.2	0.4	0.2	0.0	0.4	0.2	0.6	0.2	3.5	0.7	0.6	0.2	0.2	1.8	0.2	0.2	0.7	0.2	0.0	66.5	0.3	0.2	0.2	0.2	1.2	0.2	0.4	1.3	1.4	5.7	1.0	1.6	0.9	0.8	2.7	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.1	22.6	0.1	0.2	0.2	0.3	1.8	0.7	0.2	0.2	0.8	0.7	0.0	1.7	0.1	0.3	0.2	1.8	0.2	2.5	0.4	0.5	1.7	0.0	0.1	0.4	0.2	0.0	0.5	0.1	0.2	0.6	2.3	0.5	0.1	0.0	0.2	0.0	0.4	9.7	0.3	0.3	0.1	0.0	0.6	0.4	0.0	0.4	0.3	0.5	0.1	0.2	1.5	1.2	0.1	0.1	0.3	0.2	1.9	1.0	1.0	0.8	0.5	0.5	0.7	0.7	0.6	0.3	1.3	0.7	0.9	5.7	1.6	0.7	1.4	0.6	0.8	0.4	0.6	0.3	0.6	0.2	0.5	0.4	0.2	0.6	0.3	0.0	0.3	0.0	0.6	0.5	2.1	0.4	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.6	23.6	0.0	3.2	0.0	0.6	0.2	0.4	0.2	0.0	0.0	0.1	3.2	1.2	0.0	0.0	19.1	0.6	0.0	0.0	0.0	1.3	0.9	5.6	3.5	0.0	0.0	4.1	0.0	0.0	77.8	1.3	0.4	0.3	0.0	4.4	2.5
COX7A2L	"COX7AR, COX7RP, EB1, SIG81"	ENSG00000115944	"Cytochrome c oxidase subunit 7A2 like"	O14548	2	42333546-42425088	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059124, CAB073545"			Enhanced	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB073545: , HPA059124: AB_2683912"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.02e-1)"	25.1	73.3	47.3	24.4	63.3	47.7	45.4	35.2	58.2	33.4	33.8	21.0	28.8	31.7	30.2	37.9	20.9	31.2	27.1	49.8	40.4	45.3	50.9	48.9	24.0	28.1	42.6	35.6	49.8	49.3	24.9	42.7	24.0	34.9	29.5	36.2	32.3	37.0	30.3	24.4	21.5	32.1	28.4	33.1	23.1	29.4	24.8	20.5	28.0	35.8	35.8	30.9	24.5	31.1	45.1	59.7	57.2	48.7	40.5	53.7	100.9	38.3	24.6	27.3	29.6	46.9	66.9	32.7	31.8	46.5	29.1	37.2	26.9	27.8	34.0	31.9	36.4	37.3	17.2	32.5	33.7	42.6	52.2	25.0	23.0	17.6	47.7	55.3	34.5	25.6	65.6	67.9	28.4	68.8	42.2	40.9	26.7	33.4	58.4	45.0	31.2	41.1	57.4	26.8	45.4	25.6	22.5	47.4	28.8	41.6	31.1	32.5	37.1	13.3	33.6	91.2	31.7	24.1	40.3	30.8	26.4	34.6	31.9	31.0	48.0	53.6	25.5	37.4	37.5	22.4	57.2	48.7	27.2	39.0	42.0	50.0	45.1	47.9	45.3	53.1	37.6	53.7	46.1	21.6	40.5	46.3	59.7	52.8	100.9	47.3	63.3	35.2	58.2	40.4	45.3	42.6	35.6	34.9	20.5	29.8	61.2	171.1	166.3	235.9	115.5	140.5	132.5	96.4	51.2	141.3	35.3	190.2	547.2	206.3	15.8	157.6	103.8	23.3	199.6	263.9	167.1	184.8	86.4	193.0	204.8	123.9	277.2	113.5	243.6	17.7	149.8	177.9	209.2	287.7	202.3	182.8	197.6	161.4	149.2	386.1	95.5	109.9	206.0	195.8	267.6	214.7	275.6	186.4	235.2	168.4
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266827-130289798	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	529	"pancreas: 1357.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 4303.0"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;CACO-2: 7.5;RH-30: 6.2;SCLC-21H: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	NA	NA		1500000	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1357.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.5	0.0	0.1	0.0	0.0	0.0	0.7	0.0	7.5	0.0	0.0	1.0	0.0	0.6	0.0	1.4	0.0	0.1	1.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	6.2	0.1	0.1	0.7	3.4	0.0	0.2	0.0	2.1	0.3	0.0	0.2	0.0	0.0	1.1	0.8	0.6	0.0	0.7	0.2	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	6.6	3.8	0.0	0.8	0.0	4303.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	24.4	0.0	2.8	764.8	8.6	0.0	0.0	0.3	0.0	0.0	0.3	1.5	0.1	0.2	0.0	0.2	0.1
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell type enriched"	"Detected in some"	15	"granulocytes: 4120.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 81.5"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	81.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4	29.8	269.3	0.0	0.2	1.4	0.0	0.2	0.0	16.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.1	4120.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.3
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell type enhanced"	"Detected in some"	18	"Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0"	"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	19.4	1.0	0.0	0.0	0.1	0.3	0.0	15.6	29.6	15.9	3.9	0.1	1.7	0.0	3.0	6.6	16.1	1.1	0.0	8.6	16.5	0.0	0.0	0.0	6.3	0.4	0.4	0.0	0.0	0.2	13.9	1.4	2.0	55.9	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.1	0.1	2.3	0.0	16.1	0.0	7.5	0.8	0.0	0.0	10.3	4.9	0.1	6.3	0.1	0.0	11.9	3.9	32.8	1.3	1.5	0.0	0.0	0.0	59.0	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1	3.0	0.3	0.0	0.5	15.8	0.0	0.3	0.0	2.7	2.3	0.0	0.0	3.7	0.0	0.5	0.3	0.1	0.0	0.0	45.1	1.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	27.0	7.9	0.0	0.0	0.9
CPA5		ENSG00000158525	"Carboxypeptidase A5"	Q8WXQ8	7	130344816-130368730	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"blood: 25.2;testis: 30.4"	"Group enriched"	"Detected in some"	20	"Early spermatids: 46.3;Late spermatids: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2"	"Lineage enriched"	"Detected in single"	114	"T-cells: 25.2"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.2;RT4: 5.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020322			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA020322: AB_10960562"	"unprognostic (2.44e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.88e-13)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.4	0.0	1.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.4	0.1	0.1	1.6	0.0	30.4	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.0	0.0	0.2	0.0	0.0	25.2	3.1	0.8	0.0	0.1	0.6	0.0	0.0	0.0	0.4	3.3	0.2	0.4	2.4	0.0	0.0	0.0	0.0	1.1	0.1	0.4	0.7	0.0	0.0	1.9	0.7	0.7	1.2	0.5	0.0	0.0	0.0	1.1	0.0	1.2	1.4	0.0	0.9	0.0	1.6	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	11.2	0.4	1.5	5.1	1.4	0.2	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	8.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	8.0	4.1	0.0	0.0	2.1	20.3	0.0	0.0	0.0	0.0	25.2	3.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	2.8	0.0	0.0	46.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	106.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	1.9	0.0	3.9	0.0	0.0	0.0
CPD	GP180	ENSG00000108582	"Carboxypeptidase D"	O75976	17	30378905-30469989	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 178.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052796, HPA055465"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear speckles"		NA	NA		930000	"Nucleoplasm, Nuclear speckles"	"Nuclear membrane"	"HPA052796: AB_2681953, HPA055465: AB_2682823"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.25e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.08e-1)"	16.4	8.0	9.8	12.3	12.4	18.1	17.9	9.1	13.3	28.6	16.2	18.5	10.1	12.9	12.6	10.1	10.0	15.2	33.6	10.5	12.8	10.4	13.4	26.8	20.0	14.2	22.1	11.4	7.8	14.7	21.2	14.9	22.3	13.9	11.4	13.3	7.5	59.7	7.9	10.0	7.8	22.0	15.1	25.9	7.9	24.6	25.0	13.5	5.8	37.2	7.7	10.0	11.5	11.6	0.4	3.4	19.3	5.5	2.1	3.8	2.5	12.2	18.7	16.2	16.7	16.9	32.2	5.8	16.9	24.8	11.7	14.5	21.9	7.9	1.5	21.6	19.4	14.9	8.8	10.5	21.4	19.9	5.8	15.0	3.5	11.5	13.5	20.6	22.7	9.2	57.4	9.6	15.0	14.6	19.6	23.8	5.3	6.7	18.1	9.4	2.4	7.3	6.2	4.5	28.2	4.3	7.0	18.8	4.7	22.0	14.0	4.1	10.3	20.2	17.5	8.8	19.8	16.5	15.8	28.3	11.7	7.7	18.2	16.1	7.3	15.2	5.2	15.0	14.9	9.9	2.8	5.5	6.4	3.4	2.8	3.8	0.2	1.7	2.8	3.4	0.4	1.4	1.7	19.3	2.1	2.3	0.4	1.1	2.5	9.8	12.4	9.1	13.3	12.8	10.4	22.1	11.4	13.9	13.5	29.8	19.2	7.5	28.1	19.6	23.1	10.4	178.3	18.7	27.3	27.9	43.2	20.5	1.7	21.2	75.9	48.4	31.6	0.0	21.4	9.1	26.2	58.6	24.2	67.2	14.9	44.5	31.0	51.0	34.9	41.5	15.5	20.5	28.7	10.0	69.1	11.1	30.2	20.1	15.2	17.7	35.0	0.0	22.6	15.6	24.2	16.3	20.1	20.8	31.5	38.6
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498320	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 203.7"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 533.2;Cone photoreceptor cells: 585.1;Glandular cells: 402.2;Intestinal endocrine cells: 564.2;Leydig cells: 463.7;Muller glia cells: 511.1;Peritubular cells: 583.8;Rod photoreceptor cells: 443.0;Sertoli cells: 840.8;Smooth muscle cells: 614.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 49.0;SCLC-21H: 69.0;SiHa: 101.3;SuSa: 59.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		470000	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	27.7	33.8	123.1	4.4	135.5	0.9	21.5	82.9	203.7	10.7	9.6	31.6	5.3	5.0	13.3	94.3	16.4	15.7	14.0	19.6	116.9	56.3	12.0	6.3	11.0	7.6	56.9	70.7	23.4	35.5	33.9	40.0	2.2	53.0	66.5	8.8	13.2	12.0	20.1	11.0	5.5	6.2	18.5	40.5	2.8	19.2	30.4	53.3	0.9	40.7	4.3	7.7	6.3	9.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	8.9	1.7	7.1	0.7	0.4	0.0	3.6	1.3	2.9	0.0	0.0	0.0	2.6	0.0	0.3	0.2	3.4	0.7	0.7	0.0	13.0	0.0	3.6	49.0	0.5	0.0	0.0	17.3	3.6	0.0	0.0	17.2	0.0	0.0	0.0	0.3	1.8	2.4	0.0	0.4	5.6	0.0	2.0	0.0	0.0	0.1	0.1	0.5	69.0	22.8	101.3	12.7	0.0	59.1	7.6	0.3	0.0	2.7	7.0	0.2	0.2	3.9	0.0	0.3	2.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	123.1	135.5	82.9	82.2	116.9	56.3	56.9	70.7	53.0	53.3	0.0	9.3	0.0	67.8	23.2	533.2	32.3	40.8	0.0	3.4	21.0	585.1	0.4	0.0	15.1	5.5	57.1	1.6	0.0	1.5	0.1	129.4	402.2	0.0	7.9	0.8	66.7	564.2	115.4	9.2	11.5	463.7	12.5	82.7	1.8	12.7	511.1	19.3	2.9	583.8	9.6	443.0	840.8	614.9	17.7	9.6	18.2	0.7	1.9	3.7	11.3
CPEB2		ENSG00000137449	"Cytoplasmic polyadenylation element binding protein 2"	Q7Z5Q1	4	15002674-15070153	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 76.2;Suprabasal keratinocytes: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072513			Approved	Cytosol		Yes	No			Cytosol		"HPA072513: AB_2686529"	"unprognostic (6.59e-2)"	"unprognostic (4.21e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	10.0	7.5	18.5	6.0	21.5	23.0	13.6	11.5	21.0	8.8	11.5	28.7	13.2	9.6	8.2	9.4	13.6	7.1	10.7	7.8	17.4	16.2	13.5	18.9	9.5	6.4	27.2	17.4	7.9	5.4	23.8	6.4	7.4	16.4	10.2	10.7	20.7	8.9	21.9	7.1	23.0	9.5	10.8	21.7	6.6	10.8	37.4	27.6	3.6	6.1	7.8	7.2	8.3	12.6	0.4	0.7	2.4	0.4	1.3	1.6	0.3	1.3	8.3	0.8	0.3	6.2	11.4	1.4	4.6	3.1	2.9	2.1	0.2	1.6	0.8	0.9	4.2	5.4	1.5	1.8	1.0	1.8	2.3	0.6	0.2	6.4	1.4	2.9	0.3	1.1	5.6	5.5	7.0	6.8	3.6	2.6	0.1	0.1	6.0	11.8	0.6	0.1	1.8	0.8	2.4	1.2	0.1	0.6	0.3	25.2	1.1	0.7	4.6	1.5	1.0	4.7	3.9	0.6	5.3	5.1	10.4	0.9	6.5	2.5	3.9	0.5	0.4	8.5	4.7	3.8	0.0	0.4	1.7	0.5	0.4	1.6	0.1	0.8	0.5	0.7	0.4	0.9	0.3	2.4	1.3	0.2	0.3	0.2	0.3	18.5	21.5	11.5	21.0	17.4	16.2	27.2	17.4	16.4	27.6	29.8	13.9	5.8	9.4	76.2	7.6	18.3	15.3	1.4	6.8	29.6	25.5	1.1	1.7	3.5	47.6	11.4	23.2	0.0	4.2	1.2	11.0	8.7	10.4	21.2	9.1	14.3	9.8	12.9	15.4	15.5	5.8	12.2	50.6	2.8	10.9	6.1	5.9	11.9	7.8	10.3	19.0	0.0	13.4	14.7	3.1	113.2	1.1	6.4	6.6	14.4
CPEB3	KIAA0940	ENSG00000107864	"Cytoplasmic polyadenylation element binding protein 3"	Q8NE35	10	92046692-92291087	"Predicted intracellular proteins"	"Translation regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.4;liver: 39.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 216.8;Late spermatids: 321.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.1;U-266/70: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070942			Approved	"Nucleoplasm,Plasma membrane,Midbody,Cytosol"		NA	No			Cytosol	"Nucleoplasm, Plasma membrane, Midbody"	"HPA070942: "	"unprognostic (4.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.95e-5)"	"prognostic favorable (5.06e-5)"	"unprognostic (4.09e-4)"	"unprognostic (2.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.84e-9)"	"unprognostic (3.33e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.40e-1)"	3.1	6.1	11.9	3.0	10.9	2.9	5.0	33.4	24.6	4.0	3.8	4.4	5.5	4.8	3.3	6.8	6.0	3.3	3.4	7.0	10.7	11.5	7.0	39.5	3.6	3.0	10.3	15.1	5.8	5.4	6.6	8.6	2.8	16.4	6.5	4.2	3.0	10.2	8.0	23.4	5.3	4.6	3.4	4.6	4.1	4.5	20.5	7.0	0.3	9.3	5.4	3.4	3.3	4.5	1.8	0.9	6.5	1.5	0.5	0.7	0.5	1.2	0.3	0.4	2.7	0.7	0.7	1.1	1.2	0.9	1.7	1.4	0.9	2.7	1.4	1.3	0.5	0.8	3.4	1.1	0.9	0.9	1.6	1.4	1.9	1.8	1.0	2.0	0.9	2.0	0.7	2.1	1.0	3.1	1.5	1.5	1.9	1.3	16.1	0.7	0.9	1.2	1.1	0.2	1.8	1.3	1.6	2.3	2.8	1.6	0.5	2.0	0.7	1.1	3.1	2.0	1.4	3.9	2.0	1.2	0.8	0.9	0.6	1.0	9.0	2.4	1.5	0.4	3.0	0.2	6.5	1.1	2.2	0.7	1.4	0.5	1.8	0.4	0.7	0.9	0.5	0.4	0.4	1.3	0.5	1.5	0.6	0.3	0.5	11.9	10.9	33.4	24.6	10.7	11.5	10.3	15.1	16.4	7.0	6.0	6.5	0.8	3.2	7.8	25.2	21.8	5.1	2.7	3.4	12.2	47.1	1.8	5.0	2.1	216.8	6.0	7.5	0.0	2.3	1.3	3.9	15.1	3.5	66.1	4.2	28.6	19.0	11.6	22.6	321.1	5.5	7.7	5.0	6.4	9.1	2.5	3.1	3.5	7.4	2.5	21.8	0.0	3.1	11.2	6.8	12.2	1.0	2.5	5.2	5.3
CPEB4	KIAA1673	ENSG00000113742	"Cytoplasmic polyadenylation element binding protein 4"	Q17RY0	5	173888280-173961976	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.1"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 9.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 39.1;U-266/84: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038394			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA038394: AB_10671226"	"unprognostic (2.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (4.99e-8)"	"unprognostic (2.66e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	11.9	42.2	25.9	10.3	21.0	39.7	11.5	29.7	30.9	11.3	7.5	10.5	9.8	8.1	8.6	6.0	18.6	6.4	12.1	26.4	22.3	14.7	30.3	44.6	12.5	6.9	15.1	20.7	6.6	21.1	45.7	20.5	17.8	33.3	7.7	8.0	14.4	17.3	13.5	106.1	10.8	8.8	12.5	38.4	9.7	11.3	8.4	18.9	1.5	20.0	16.9	9.3	11.6	15.8	1.6	0.8	9.6	2.3	0.8	1.3	0.6	4.0	5.5	2.7	1.5	5.0	2.9	5.5	7.2	6.7	2.5	3.0	5.2	2.7	5.0	5.2	4.0	8.0	0.3	2.4	3.8	4.1	10.0	2.8	3.3	13.3	3.0	10.7	1.1	6.6	4.5	8.7	6.5	10.0	11.3	2.4	1.8	10.9	12.3	5.7	2.9	0.9	1.0	1.5	1.7	5.5	0.9	2.2	16.6	3.6	7.3	3.1	3.5	0.8	10.1	13.0	4.9	7.0	2.3	7.1	4.1	2.0	2.0	4.6	39.1	56.1	2.6	10.1	2.3	5.2	0.5	1.8	2.0	1.0	1.7	1.0	1.6	1.1	0.8	0.6	1.2	1.3	0.7	9.6	0.8	2.3	0.8	1.0	0.6	25.9	21.0	29.7	30.9	22.3	14.7	15.1	20.7	33.3	18.9	71.5	29.3	27.4	12.7	37.7	148.4	204.8	101.9	49.5	43.3	50.6	127.6	9.5	19.9	29.9	46.6	42.1	41.8	303.7	22.7	4.8	24.4	44.9	87.8	135.7	55.5	138.2	60.1	69.3	106.0	36.0	8.1	47.3	70.9	28.9	21.7	91.5	33.7	35.1	20.1	36.6	121.5	0.0	63.5	43.8	7.5	44.8	51.8	22.9	14.9	35.9
CPED1	"C7orf58, FLJ21986"	ENSG00000106034	"Cadherin like and PC-esterase domain containing 1"	A4D0V7	7	120988677-121297444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Fibroblasts: 35.2;Ito cells: 30.7;Peritubular cells: 76.7;Smooth muscle cells: 39.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 7.6;intermediate monocyte: 7.8;myeloid DC: 17.2;non-classical monocyte: 4.8;plasmacytoid DC: 10.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 17.2;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 28.7;Hep G2: 16.5;K-562: 55.7;LHCN-M2: 19.7;U-138 MG: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA012058	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012058: AB_1845761"	"unprognostic (7.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.52e-3)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.28e-3)"	"unprognostic (5.05e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.54e-4)"	21.6	8.3	3.2	8.0	3.7	0.1	7.8	1.1	2.7	19.4	16.3	4.1	15.0	3.7	21.8	15.7	10.5	12.2	14.4	10.3	2.9	1.7	3.9	19.4	9.0	1.5	5.1	1.9	36.8	2.0	0.4	4.5	10.6	3.1	20.7	6.7	18.5	2.8	17.1	24.4	2.9	10.6	48.9	8.7	9.9	8.6	7.1	3.8	0.2	4.9	15.9	1.4	34.3	14.6	1.0	17.2	1.4	7.8	0.0	0.1	2.1	1.9	0.0	0.1	0.0	4.7	13.8	0.1	8.1	28.7	2.8	7.7	0.2	0.1	0.3	0.1	4.3	3.2	0.1	0.1	0.0	7.4	0.1	0.3	2.2	0.1	16.5	8.2	0.0	0.0	5.6	0.0	6.6	0.1	2.2	1.4	0.0	55.7	4.2	19.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	11.3	5.5	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.2	0.8	16.8	0.4	14.0	7.7	1.8	0.0	0.2	1.9	0.0	0.8	1.4	7.6	0.0	0.0	7.8	0.1	1.0	0.0	0.0	17.2	0.3	0.0	0.0	0.3	0.0	4.8	10.3	0.0	2.1	3.2	3.7	1.1	2.7	2.9	1.7	5.1	1.9	3.1	3.8	17.9	0.3	1.3	0.5	2.7	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	1.5	35.2	0.8	0.0	20.2	3.9	3.2	0.0	30.7	11.5	0.0	19.5	25.2	3.3	1.0	0.0	21.5	0.0	0.0	76.7	0.0	0.2	0.0	39.2	0.3	0.4	1.8	0.3	0.0	0.0	1.3
CPNE2	CPN2	ENSG00000140848	"Copine 2"	Q96FN4	16	57092537-57148367	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041132	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA041132: AB_2677316"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	14.1	3.9	8.4	4.6	15.1	22.8	11.4	7.9	15.4	16.4	12.0	40.6	1.1	2.0	8.8	3.1	6.4	12.0	5.6	5.9	10.6	11.6	4.8	4.3	15.5	8.2	20.8	9.8	5.1	3.3	3.7	4.9	11.5	12.9	5.1	11.9	4.6	3.7	7.4	4.9	4.0	6.6	10.5	13.5	6.0	3.7	15.3	20.1	0.2	5.8	2.2	3.2	6.4	8.3	0.0	2.1	4.0	4.2	0.5	1.2	0.9	8.4	16.3	25.2	13.9	4.5	4.4	4.2	9.2	14.6	21.1	14.8	4.5	9.8	5.0	8.5	13.9	11.7	13.3	9.9	5.5	11.5	6.2	5.8	2.1	6.5	3.8	8.2	1.7	0.2	4.2	6.2	8.2	4.0	15.8	31.0	2.8	5.6	0.1	5.3	3.9	2.5	24.7	5.7	4.1	3.5	31.5	7.9	4.2	14.0	3.2	0.5	10.2	11.7	2.5	7.0	11.9	2.7	33.7	21.8	19.3	10.5	4.8	11.9	1.2	1.0	11.3	12.5	7.4	13.5	0.0	4.2	1.9	0.7	1.2	0.7	0.0	0.4	1.2	2.1	0.0	0.3	0.6	4.0	0.5	0.4	0.1	0.5	0.9	8.4	15.1	7.9	15.4	10.6	11.6	20.8	9.8	12.9	20.1	17.9	6.1	2.9	13.5	2.1	0.0	2.2	2.5	1.4	2.3	5.2	0.0	0.6	5.0	3.9	14.0	20.4	28.0	0.0	3.4	2.1	10.4	9.0	0.0	1.6	20.0	0.0	3.5	72.4	21.2	4.7	6.4	6.9	6.8	3.6	15.7	3.3	5.9	21.0	7.1	1.6	0.0	32.3	14.4	0.5	1.7	3.8	0.7	4.4	15.9	9.9
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514427-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 66.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA		52000	"Nucleoplasm, Cytosol"	"Nucleoli, Mitochondria"	"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	26.5	16.6	21.3	9.8	18.0	35.1	20.6	18.8	13.5	26.0	16.4	20.9	13.2	15.1	28.6	12.6	40.5	15.9	14.6	24.4	17.6	19.7	29.8	25.5	16.9	22.6	19.7	10.5	26.7	24.1	25.4	28.9	16.1	17.0	22.4	16.5	21.0	20.6	15.3	10.4	18.7	19.5	20.9	18.7	18.3	16.9	9.7	14.1	30.5	33.6	21.8	29.7	25.4	20.0	14.6	31.4	28.2	24.3	15.0	18.3	14.4	34.6	12.3	8.5	11.0	32.7	25.5	6.9	16.7	24.9	14.0	15.8	7.9	11.9	9.5	11.1	20.3	8.5	26.8	18.2	17.7	25.2	10.1	14.3	1.5	9.0	9.4	11.3	0.8	0.8	17.3	19.2	15.5	20.6	22.6	17.1	4.9	8.5	18.3	17.2	13.4	16.6	0.5	3.2	28.7	17.8	7.9	7.7	44.4	18.1	24.9	18.0	14.1	14.6	66.7	10.5	10.2	25.4	2.6	18.2	12.5	12.2	16.6	12.9	13.2	15.8	2.6	18.0	3.6	11.5	10.8	16.7	26.4	18.3	19.1	14.2	14.6	14.8	12.8	30.8	14.1	13.3	14.3	28.2	15.0	24.3	31.4	10.5	14.4	21.3	18.0	18.8	13.5	17.6	19.7	19.7	10.5	17.0	14.1	128.1	76.8	40.4	87.4	72.7	16.8	108.0	79.0	77.6	69.4	66.3	13.7	59.5	84.6	63.4	1.1	55.4	37.1	23.3	72.9	45.8	62.4	110.2	8.1	86.6	42.9	42.9	48.1	57.7	74.2	2.2	79.4	49.0	50.6	32.5	53.7	70.1	62.4	52.6	82.4	99.4	16.5	58.2	55.6	3.0	10.0	79.5	65.2	47.5	69.8	73.5
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;prostate: 35.7"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 17.1;Glandular cells: 18.5;Intestinal endocrine cells: 4.7"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A549: 9.9;AF22: 9.3;Karpas-707: 2.8;RT4: 3.1"	"Low region specificity"	"Detected in many"							"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA032036: AB_10600898, HPA078300: AB_2732377"	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	1.4	1.4	7.0	0.8	11.6	0.8	0.7	0.4	27.2	1.0	1.1	2.5	0.7	1.6	0.9	1.6	1.1	1.2	0.7	1.9	17.5	5.3	2.1	0.8	1.2	0.7	1.3	11.8	0.7	0.8	3.8	9.5	0.7	3.1	35.7	1.0	0.1	1.1	6.0	0.6	1.0	1.4	1.2	4.6	1.8	1.4	2.3	3.6	0.0	1.1	0.0	0.7	0.7	1.1	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	9.9	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	2.8	1.3	0.6	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.6	3.1	1.4	0.6	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.2	2.3	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	7.0	11.6	0.4	27.2	17.5	5.3	1.3	11.8	3.1	3.6	0.0	0.0	0.0	0.4	0.2	0.8	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.5	18.5	0.0	0.0	0.1	1.6	4.7	0.0	0.0	3.6	0.3	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	1.2	0.5	0.0	0.8	1.2	1.1	0.1	0.0	0.0	0.0	0.8
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36840002	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;brain: 50.3;heart muscle: 28.6"	"Cell type enhanced"	"Detected in many"	16	"B-cells: 43.6;Cardiomyocytes: 20.4;granulocytes: 11.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.3"	"Group enriched"	"Detected in some"	82	"memory B-cell: 27.1;naive B-cell: 12.9"	"Lineage enriched"	"Detected in single"	111	"B-cells: 27.1"	"Group enriched"	"Detected in some"	4	"Daudi: 33.0;HUVEC TERT2: 13.6;U-266/70: 11.4;U-266/84: 9.1;U-698: 15.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 100.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 166.9"	HPA031369	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	1.8	1.1	8.1	12.5	50.3	1.1	1.7	1.9	49.4	1.8	4.2	1.3	0.0	3.9	3.7	1.0	1.8	11.3	1.7	28.6	3.7	4.9	1.3	0.5	1.5	14.3	3.6	12.8	2.3	1.0	0.8	3.6	1.3	3.3	2.9	3.6	4.1	2.0	2.2	0.5	1.0	2.9	3.6	3.0	7.1	3.4	11.8	6.2	0.1	1.4	0.0	20.3	5.5	1.9	27.1	0.1	0.2	0.1	0.0	0.1	2.2	0.5	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.1	33.0	0.3	0.4	1.6	0.3	0.1	0.2	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	2.4	13.6	0.1	0.1	0.9	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.6	0.1	0.0	0.5	3.1	0.2	0.4	0.0	1.3	11.4	9.1	15.5	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.1	0.1	0.0	0.0	12.9	0.0	0.0	0.2	0.0	0.1	0.1	0.0	2.2	8.1	50.3	1.9	20.4	3.7	4.9	3.6	12.8	3.3	6.2	0.0	5.1	43.6	0.1	0.6	9.8	20.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.9	2.8	5.1	0.0	0.2	0.0	0.6	0.2	11.6	0.4	0.4	0.0	4.1	3.7	1.5	3.5	0.0	0.2	3.3	0.0	0.8	1.0	0.2	10.5	0.4	0.0	1.1	0.0	0.3	0.6	1.4	0.1	0.0	0.5	1.5	0.1
CPSF2	"CPSF100, KIAA1367"	ENSG00000165934	"Cleavage and polyadenylation specific factor 2"	Q9P2I0	14	92121937-92172145	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024238	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA024238: AB_1847200"	"unprognostic (2.31e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.78e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.90e-2)"	20.5	24.0	14.6	24.1	16.3	10.6	16.7	14.5	16.5	18.3	16.4	19.3	21.5	15.1	19.3	16.5	25.7	15.4	15.9	16.3	14.9	13.6	16.8	22.2	17.3	20.1	20.8	11.8	21.5	16.5	24.9	28.9	19.6	16.0	17.1	18.1	14.7	18.5	25.3	36.6	14.9	19.0	18.8	19.7	23.8	17.8	25.7	18.1	44.0	22.6	19.4	25.0	19.7	17.7	9.3	13.0	15.0	14.4	12.8	13.4	9.7	18.5	18.6	19.0	19.6	9.9	8.8	28.3	24.1	23.7	22.5	22.3	16.1	25.9	20.0	15.9	25.7	15.2	27.6	26.1	21.9	32.5	32.3	9.0	29.2	19.2	15.4	29.3	29.4	24.8	14.4	18.8	21.3	38.5	14.9	20.9	21.8	26.3	25.4	24.9	27.2	33.8	10.4	21.5	30.1	17.0	33.4	29.5	17.9	15.3	26.5	21.0	14.2	28.4	16.1	20.5	17.9	33.4	18.5	22.3	18.0	11.4	13.5	20.5	15.3	24.9	40.8	21.8	23.2	27.9	15.0	14.4	10.4	9.6	13.6	12.9	9.3	8.6	10.2	13.0	5.3	7.8	10.5	5.2	12.8	10.7	8.4	13.4	9.7	14.6	16.3	14.5	16.5	14.9	13.6	20.8	11.8	16.0	18.1	26.8	25.6	13.7	10.9	9.2	12.2	21.8	15.3	41.5	31.8	7.0	27.5	21.2	11.6	16.5	18.7	17.9	10.7	0.0	20.6	19.5	15.2	23.6	29.0	24.5	21.6	11.1	13.3	22.1	36.9	8.4	17.5	27.0	3.3	28.9	17.0	14.1	18.7	15.2	21.5	14.4	22.2	32.3	18.6	50.6	43.6	11.2	21.2	16.6	14.4	19.7
CPT1C	"CPT1P, CPTIC, FLJ23809"	ENSG00000169169	"Carnitine palmitoyltransferase 1C"	Q8TCG5	19	49690898-49713731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 39.6;Horizontal cells: 30.2;Late spermatids: 17.8;Rod photoreceptor cells: 18.1"	"Cancer enhanced"	"Detected in many"		"glioma: 9.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.8;AN3-CA: 15.8;SCLC-21H: 13.1;SH-SY5Y: 33.9;U-87 MG: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014529, HPA063621"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA014529: AB_1847206, HPA063621: AB_2732706"	"unprognostic (1.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.36e-1)"	"unprognostic (1.92e-10)"	"unprognostic (9.44e-4)"	"unprognostic (3.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (4.72e-3)"	3.4	9.3	11.2	3.1	18.9	0.8	1.1	16.3	34.0	4.1	1.9	8.9	0.2	2.7	6.4	5.3	1.8	4.1	7.6	2.8	11.9	12.8	1.6	1.6	2.5	2.6	8.0	13.4	3.8	1.2	0.7	15.6	1.9	11.4	2.8	1.7	7.4	1.5	4.8	1.7	1.5	2.4	7.8	6.6	4.2	1.4	4.1	6.3	0.0	1.7	0.2	1.7	4.4	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	18.8	15.8	6.8	5.4	0.0	6.0	11.9	7.7	10.8	0.3	0.0	0.3	0.0	5.9	0.9	1.4	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	11.1	0.0	0.0	6.2	0.0	6.2	0.0	2.0	10.6	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.8	1.2	3.9	0.0	0.0	0.0	0.4	0.0	13.1	33.9	0.0	0.0	0.0	0.3	0.0	0.0	8.6	0.4	0.1	3.6	3.0	0.1	1.4	0.1	14.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	11.2	18.9	16.3	23.4	11.9	12.8	8.0	13.4	11.4	6.3	0.0	0.0	0.0	3.3	1.9	39.6	1.2	2.5	0.0	0.0	0.0	15.7	0.8	0.0	0.0	7.9	4.5	0.0	0.0	0.0	3.6	3.1	1.5	0.0	0.0	0.3	30.2	0.0	3.1	1.2	17.8	3.1	0.0	0.0	0.0	0.0	14.9	0.5	0.0	12.4	0.0	18.1	0.0	5.3	2.7	6.9	1.6	0.9	0.0	0.0	0.9
CPTP	"GLTPD1, MGC10334"	ENSG00000224051	"Ceramide-1-phosphate transfer protein"	Q5TA50	1	1324756-1328897	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056832	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA056832: AB_2683251"	"unprognostic (9.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.27e-2)"	9.8	8.7	8.0	9.2	7.6	3.7	8.1	7.2	13.8	10.7	14.9	6.0	12.0	21.4	7.0	21.9	20.5	6.1	9.6	43.1	9.3	5.8	19.1	38.9	6.8	9.0	8.1	7.2	6.4	14.5	9.0	3.7	10.4	9.2	8.4	6.2	5.3	46.4	15.0	51.7	13.9	21.1	4.3	5.7	13.4	15.7	28.2	4.8	12.0	8.8	18.4	13.7	6.6	10.2	4.9	1.8	8.6	1.9	1.8	7.6	1.9	18.8	6.8	3.3	6.0	3.2	2.7	5.4	10.0	5.3	9.4	6.2	9.2	10.6	7.5	11.6	4.5	6.2	14.1	2.6	5.8	3.5	8.9	9.1	5.6	7.3	9.2	8.1	5.3	5.7	5.2	4.6	9.9	2.8	4.7	5.0	4.9	8.2	4.5	3.1	6.9	5.9	6.3	3.0	4.9	30.3	7.4	5.5	21.6	7.6	5.0	7.8	8.2	8.0	25.3	17.0	1.8	9.0	3.7	8.4	10.1	7.1	11.0	8.1	10.0	7.6	7.8	9.7	8.0	3.0	2.9	1.9	8.6	2.6	1.0	1.5	4.9	3.2	2.5	1.3	1.9	1.9	1.5	2.7	1.8	1.8	1.8	7.6	1.9	8.0	7.6	7.2	13.8	9.3	5.8	8.1	7.2	9.2	4.8	0.0	2.7	4.5	8.0	0.0	9.0	20.5	5.1	0.0	2.3	7.0	0.0	16.1	33.2	22.4	50.8	7.5	50.3	0.0	21.2	17.4	2.9	9.5	0.0	25.1	14.5	22.3	5.8	12.3	5.7	124.6	11.2	3.0	0.0	19.8	18.5	16.0	34.5	10.5	9.2	13.5	6.2	12.9	2.0	9.4	5.3	0.0	16.4	6.9	21.5	7.5
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 63.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 29.5;BJ: 17.0;BJ hTERT+: 22.9;hTERT-RPE1: 13.7;RH-30: 25.1;U-2197: 18.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"		"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	4.3	0.9	0.3	2.8	1.1	0.0	5.4	1.1	1.6	15.7	1.8	1.5	27.1	0.1	7.9	24.1	3.0	7.4	12.9	2.4	0.4	0.3	1.5	0.8	2.9	0.7	1.5	0.4	63.2	1.1	0.3	2.3	18.9	2.3	4.1	0.5	4.4	0.8	20.6	0.3	5.5	1.2	10.3	1.3	0.7	1.7	4.4	0.1	1.6	3.5	0.1	2.2	9.8	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.0	0.7	2.2	0.2	29.5	17.0	22.9	6.4	2.6	0.7	0.3	0.0	1.6	9.3	0.1	0.0	0.0	0.0	2.4	0.0	1.2	0.0	0.1	0.3	2.0	0.0	0.0	4.2	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.4	2.5	0.0	0.0	3.9	0.1	9.3	0.0	25.1	0.0	0.0	0.5	0.0	0.0	0.6	0.2	0.0	3.8	0.1	0.0	0.0	0.9	1.2	18.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	1.1	1.6	0.4	0.3	1.5	0.4	2.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CRADD	RAIDD	ENSG00000169372	"CASP2 and RIPK1 domain containing adaptor with death domain"	P78560	12	93677375-93894840	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005337	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB005337: AB_2085481"	"unprognostic (1.07e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (9.65e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.10e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.18e-2)"	"prognostic favorable (4.04e-9)"	"unprognostic (2.57e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	7.8	15.9	11.0	4.4	14.2	7.1	10.4	12.5	10.4	8.8	9.3	11.5	16.7	14.8	10.6	11.9	9.9	8.3	9.6	35.7	12.3	8.9	14.8	31.4	7.5	7.1	9.8	9.7	8.5	9.7	18.7	21.2	6.5	13.3	9.4	7.5	11.3	10.3	8.8	22.1	8.0	15.4	12.2	11.5	8.3	9.5	15.0	13.2	9.7	8.6	15.5	5.5	10.2	8.4	8.6	7.6	25.3	12.2	10.8	15.0	6.8	6.1	14.0	6.9	7.9	10.1	18.3	8.8	7.1	8.8	6.3	7.4	13.1	2.5	11.1	4.4	8.2	4.8	6.4	7.5	9.4	8.1	11.6	10.1	5.8	6.0	9.6	10.4	5.3	5.7	16.6	14.3	10.1	7.9	6.6	7.5	12.4	16.6	5.3	7.4	9.9	7.8	9.6	8.9	7.0	10.8	13.2	3.6	15.3	6.1	4.6	10.8	10.3	9.6	9.5	17.0	7.0	16.8	10.5	8.0	14.6	7.2	6.9	7.1	12.4	6.7	10.2	6.8	7.9	6.9	24.9	6.9	25.3	14.7	8.3	13.0	8.6	10.3	15.0	5.6	7.2	11.1	8.2	19.4	10.8	12.2	7.6	11.5	6.8	11.0	14.2	12.5	10.4	12.3	8.9	9.8	9.7	13.3	13.2	8.9	4.6	9.0	8.0	6.5	5.7	37.0	5.1	13.4	9.1	7.0	7.9	12.5	19.9	14.5	112.7	14.5	24.0	23.3	19.6	10.0	9.7	13.0	4.6	34.4	9.8	22.3	7.5	9.8	10.0	23.6	16.4	8.8	3.3	9.0	11.8	14.3	16.5	17.6	22.3	46.2	14.1	6.5	17.8	29.5	10.6	7.0	9.0	12.5	12.9	7.4
CRAMP1	"CRAMP1L, KIAA1426"	ENSG00000007545	"Cramped chromatin regulator homolog 1"	Q96RY5	16	1612325-1677908	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041752	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA041752: AB_10796459"	"unprognostic (3.67e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.78e-4)"	"unprognostic (4.17e-2)"	"unprognostic (8.53e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.86e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	8.5	6.4	9.2	10.5	9.3	13.9	11.6	24.2	11.0	8.4	8.8	11.1	5.1	7.2	11.4	8.3	8.6	9.9	6.5	7.2	8.6	5.4	6.5	4.7	9.2	8.0	9.7	10.5	12.3	9.2	10.2	10.9	8.4	9.4	9.8	7.1	9.8	8.4	9.5	8.9	13.7	8.4	8.8	7.9	9.4	8.5	21.9	9.8	18.1	11.8	4.4	7.5	10.6	11.7	0.8	2.1	0.5	0.6	2.5	1.9	0.5	5.3	8.7	11.0	10.4	7.4	7.4	12.8	6.2	5.5	8.5	6.1	8.0	9.1	5.3	6.0	7.1	5.1	9.0	13.2	6.4	7.8	6.4	13.7	8.4	10.0	4.9	5.4	11.8	13.6	6.4	8.7	10.1	8.2	8.1	8.4	12.0	11.2	4.2	4.6	8.8	7.8	7.3	8.8	3.5	5.4	30.3	5.2	9.3	5.6	5.4	11.5	8.2	9.3	7.7	4.9	8.2	6.2	16.4	9.5	8.1	7.9	6.9	7.9	7.1	10.2	13.6	2.8	7.9	7.2	0.4	0.6	0.0	1.9	0.6	0.9	0.8	0.6	0.6	0.3	0.8	0.9	0.9	0.5	2.5	0.2	2.1	0.3	0.5	9.2	9.3	24.2	11.0	8.6	5.4	9.7	10.5	9.4	9.8	14.9	13.4	0.0	4.3	0.0	7.3	0.0	7.6	5.3	15.9	8.7	17.7	3.5	1.7	4.1	21.2	4.3	3.9	0.0	1.6	2.5	3.3	6.1	4.7	3.4	4.4	3.2	2.4	8.6	6.5	7.6	4.0	2.8	0.0	1.8	8.7	4.5	5.3	3.5	6.3	1.4	17.5	6.5	0.0	13.5	19.0	0.0	4.5	6.4	6.4	4.2
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094810-129111189	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6;testis: 71.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 149.6;Late spermatids: 410.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		13000	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	11.6	13.4	8.4	4.6	9.2	5.9	10.7	7.5	15.9	8.3	15.4	8.6	6.2	24.3	6.5	9.5	9.4	5.4	10.0	17.3	7.7	7.9	12.9	50.0	4.2	3.1	8.3	9.1	7.3	33.1	16.8	3.2	7.9	9.3	10.5	4.4	8.1	14.7	7.9	98.6	7.0	22.8	8.3	5.2	4.6	8.1	71.7	4.4	2.4	8.0	20.2	4.4	9.3	6.8	2.6	11.3	6.0	11.3	6.0	10.0	8.1	0.1	18.3	6.4	13.1	12.0	16.1	9.3	7.8	8.7	9.5	6.0	3.8	7.4	0.7	4.7	13.1	12.7	3.3	1.7	2.8	3.4	11.8	0.4	3.6	9.2	14.7	17.1	0.1	14.0	14.7	0.0	8.0	0.2	12.1	12.4	3.5	1.6	3.8	9.7	3.6	0.3	8.1	1.5	19.8	8.2	9.1	12.3	6.0	9.2	0.3	2.1	6.6	0.0	4.1	2.7	2.1	26.6	4.0	11.1	14.3	1.0	17.9	7.7	13.0	11.0	0.0	16.9	2.2	9.1	2.5	11.3	6.0	5.0	7.4	10.0	2.4	6.9	6.6	11.3	2.6	4.3	4.7	2.9	6.0	7.3	5.3	6.4	8.1	8.4	9.2	7.5	15.9	7.7	7.9	8.3	9.1	9.3	4.4	6.0	3.0	5.4	4.5	2.9	1.4	52.0	20.4	1.4	3.4	3.5	2.0	38.4	14.9	16.6	149.6	12.6	94.4	0.0	19.6	46.4	21.8	14.9	6.9	58.6	18.0	1.6	14.9	14.1	8.1	410.0	20.4	8.8	5.0	9.0	16.9	13.4	12.1	38.6	23.0	41.0	1.4	6.5	14.6	94.3	6.9	4.0	42.1	10.7	22.1	9.9
CRCP	"CGRP-RCP, RCP, RCP9"	ENSG00000241258	"CGRP receptor component"	O75575	7	66114604-66154568	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007216	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA007216: AB_1856160"	"unprognostic (2.36e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.67e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.49e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.87e-2)"	"unprognostic (4.81e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.06e-1)"	19.0	19.8	18.5	13.1	21.5	32.5	18.7	26.1	23.3	18.2	18.8	17.0	19.6	16.5	20.9	16.1	21.4	19.4	15.8	18.1	15.4	18.9	17.7	22.3	17.0	15.5	16.0	19.5	19.8	33.9	23.7	22.3	14.2	16.7	18.9	21.3	17.6	31.6	17.9	19.5	20.5	14.6	21.8	18.8	16.5	17.8	19.1	15.6	15.0	21.3	13.3	17.1	22.2	20.0	14.5	11.3	20.2	14.6	9.2	17.7	10.5	17.7	11.7	7.9	10.8	11.8	15.0	8.0	12.0	14.0	19.2	14.9	17.6	14.7	15.6	15.2	11.4	15.8	13.1	11.0	15.2	20.0	10.7	10.8	8.9	7.6	7.5	7.7	18.8	13.5	11.8	13.7	16.5	31.5	12.0	10.3	9.3	20.0	12.2	12.8	13.5	14.0	13.3	16.2	24.2	14.1	14.9	12.8	15.6	11.1	16.4	19.6	26.0	14.2	39.5	12.0	9.9	31.8	9.1	11.5	26.7	14.2	14.9	22.6	15.1	27.8	22.1	15.3	14.7	21.4	18.9	11.7	18.5	17.7	10.1	17.3	14.2	15.3	14.4	8.5	14.5	14.7	17.1	20.2	9.2	14.6	11.3	14.7	10.5	18.5	21.5	26.1	23.3	15.4	18.9	16.0	19.5	16.7	15.6	26.8	23.8	16.4	18.7	11.8	29.5	21.6	10.2	50.9	29.6	15.7	21.6	10.9	29.9	17.3	3.3	12.4	9.8	0.0	21.5	10.0	11.6	21.9	32.4	22.5	10.8	28.6	15.4	10.4	9.9	3.0	17.3	13.5	15.1	20.8	13.3	19.3	22.0	12.7	20.8	13.7	22.8	6.5	11.3	21.6	16.8	12.9	9.6	25.5	12.0	27.4
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002067	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.6"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 120.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	14.9	19.8	4.7	17.1	9.8	10.8	15.7	1.9	6.0	25.4	16.7	11.4	18.7	11.6	28.2	25.5	12.8	16.2	16.2	20.4	5.6	4.3	17.0	11.7	14.6	15.2	11.8	3.7	25.9	16.0	38.4	28.8	81.6	9.8	15.9	9.5	24.9	26.5	23.3	5.0	6.9	17.5	17.7	6.2	12.1	14.1	9.8	9.1	7.0	35.8	10.9	18.1	21.3	15.7	4.6	12.4	7.4	5.6	6.5	11.8	3.2	4.0	6.3	12.0	0.2	20.5	20.4	9.0	20.4	33.0	14.3	14.5	8.6	3.7	0.8	5.5	22.1	7.8	2.2	7.0	14.9	28.0	5.9	3.5	25.7	8.6	20.5	13.6	7.7	36.9	8.4	9.5	18.0	21.1	14.7	18.8	2.1	13.2	12.0	16.7	7.3	2.4	9.5	4.3	5.6	4.5	5.4	6.5	6.8	11.2	4.2	3.1	7.2	6.6	17.1	9.1	7.3	2.5	5.8	20.0	19.2	2.9	23.1	7.4	14.2	4.9	5.3	23.0	21.8	42.5	7.4	5.6	5.9	8.2	2.9	10.6	4.0	6.0	8.6	5.8	4.6	2.2	3.8	2.1	6.5	1.5	12.4	11.8	3.2	4.7	9.8	1.9	6.0	5.6	4.3	11.8	3.7	9.8	9.1	6.0	20.4	20.6	8.1	10.9	7.2	14.1	20.4	10.7	18.2	22.7	9.8	50.6	11.6	9.3	48.0	20.2	32.0	0.0	15.3	76.5	40.4	27.0	48.5	24.5	49.4	14.3	15.1	30.1	33.2	14.1	57.2	25.1	25.3	10.0	17.0	6.7	15.1	17.3	96.9	9.1	12.4	38.8	42.4	1.1	4.3	6.1	120.8	27.3	14.9	17.2
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974363	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 49.9"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 54.0;Mucus-secreting cells: 48.0"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 24.9;OE19: 25.3;SK-BR-3: 55.0;T-47d: 44.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Nucleoplasm, Nuclear membrane"	Mitochondria	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	4.3	5.0	3.2	5.4	4.0	2.9	22.6	5.7	3.5	14.6	5.1	4.3	18.3	5.0	8.5	12.1	5.1	8.8	7.9	3.2	2.5	1.4	4.5	8.4	4.7	5.5	3.2	3.0	9.3	7.9	3.7	3.4	6.6	4.0	49.9	6.9	4.7	24.7	11.4	6.1	5.9	5.3	3.4	3.3	4.5	13.2	4.3	3.0	12.9	12.5	6.6	8.3	4.5	15.1	6.6	7.3	2.6	3.5	10.9	6.0	3.1	2.3	3.3	3.1	3.4	2.2	3.3	7.8	1.9	2.2	2.6	2.3	1.5	9.7	4.2	10.1	0.8	2.0	3.7	4.6	3.0	1.4	3.4	1.8	3.1	3.6	2.7	1.8	1.4	2.7	3.5	2.9	2.5	5.7	2.4	2.3	5.1	2.4	5.3	1.2	24.9	2.7	1.1	2.1	25.3	4.0	6.2	3.2	7.8	2.8	1.6	5.9	6.3	2.0	55.0	5.2	4.2	44.1	4.5	1.4	0.8	2.4	1.6	1.5	10.0	5.1	3.1	1.7	2.6	2.5	2.2	3.5	2.6	4.5	1.5	6.0	6.3	2.6	3.3	6.4	6.6	2.5	4.8	0.1	10.9	2.1	7.3	2.1	3.1	3.2	4.0	5.7	3.5	2.5	1.4	3.2	3.0	4.0	3.0	6.0	12.5	2.0	15.5	2.6	4.7	1.7	10.2	18.7	12.5	1.8	2.0	11.1	8.3	11.1	0.0	4.9	3.2	0.0	11.8	13.3	3.3	54.0	5.7	12.3	4.8	0.0	8.6	3.1	7.9	0.0	6.6	2.2	5.0	1.8	48.0	6.0	7.4	3.5	2.1	3.6	7.5	19.4	3.3	3.6	8.7	2.6	3.5	4.4	11.8	3.5
CREB5	"CRE-BPA, H_GS165L15.1"	ENSG00000146592	"CAMP responsive element binding protein 5"	Q02930	7	28299321-28825894	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.3;brain: 38.0"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 116.6;Macrophages: 74.2;monocytes: 74.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 53.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 53.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 32.2;Karpas-707: 13.5;U-2 OS: 14.2;U-2197: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050020, HPA061622"			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA050020: AB_2680993, HPA061622: AB_2684569"	"unprognostic (3.59e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	20.0	3.6	12.1	15.4	19.5	11.5	9.0	10.4	17.8	4.6	5.6	38.0	0.9	2.8	16.3	6.9	7.7	4.7	23.1	10.4	16.7	8.7	6.6	4.6	9.5	6.1	17.9	12.1	2.4	7.0	1.5	2.8	19.5	18.3	3.1	4.3	1.1	6.5	3.0	6.2	5.5	4.2	9.8	14.6	12.6	3.2	2.3	22.7	0.0	3.8	7.0	2.5	5.5	5.0	0.3	4.8	53.3	7.8	0.0	0.0	1.5	0.0	0.3	3.9	0.2	0.2	5.7	0.1	0.3	0.8	2.4	3.6	2.2	1.4	9.9	0.7	0.9	2.4	0.4	0.1	3.4	7.6	0.0	2.7	10.7	2.1	0.2	0.2	32.2	0.4	0.7	0.7	10.2	11.0	0.5	1.6	0.0	1.2	13.5	0.8	0.0	0.0	0.0	4.9	0.0	3.9	0.2	3.7	0.2	4.9	1.0	0.4	2.8	0.1	0.2	1.1	5.7	0.1	0.7	0.4	4.7	14.2	15.5	4.5	0.8	2.2	0.1	5.2	0.2	8.0	0.0	7.8	0.0	0.0	2.7	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	53.3	0.0	0.8	0.0	0.0	1.5	12.1	19.5	10.4	15.6	16.7	8.7	17.9	12.1	18.3	22.7	6.0	11.1	4.5	116.6	19.5	0.0	14.1	22.9	5.3	6.8	12.2	0.0	2.5	1.7	61.9	0.4	14.9	0.0	0.0	23.7	9.2	31.3	32.4	13.9	0.5	8.1	4.8	0.0	7.4	46.4	1.1	5.5	74.2	28.7	74.9	0.0	16.6	30.3	0.0	0.4	18.3	0.6	19.4	10.7	12.5	3.3	11.5	20.7	1.3	0.0	28.7
CREBL2		ENSG00000111269	"CAMP responsive element binding protein like 2"	O60519	12	12611827-12645108	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043738	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA043738: AB_10795041"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.53e-1)"	21.9	77.6	24.3	16.5	31.9	3.0	18.9	21.4	24.6	16.4	13.4	14.6	13.5	13.2	11.4	17.5	10.4	14.9	16.4	14.3	19.8	23.0	28.7	28.2	18.5	18.8	20.2	19.8	22.6	14.2	31.7	31.5	13.8	19.7	17.1	14.2	20.5	15.4	14.4	6.6	14.1	13.3	12.0	20.0	20.2	14.1	17.1	18.3	8.6	25.9	6.7	16.6	17.7	14.0	2.0	4.2	3.6	8.7	1.6	8.1	2.2	5.5	7.2	6.3	7.1	22.3	22.6	12.2	10.9	18.4	8.0	11.1	5.2	8.1	4.8	4.2	13.2	12.2	4.7	9.5	8.3	13.7	26.8	5.7	3.8	7.2	6.3	14.6	5.3	7.1	14.6	15.0	9.4	15.5	27.5	11.7	3.8	3.8	7.6	13.5	8.9	2.8	4.4	18.9	5.3	6.6	3.8	10.9	3.0	15.4	16.1	7.4	8.5	11.0	5.4	19.0	28.5	3.0	6.1	9.4	11.1	7.1	10.9	10.7	6.4	8.5	1.2	13.2	4.6	11.4	1.7	3.8	3.6	2.8	8.7	5.0	1.5	5.5	4.4	4.2	2.0	5.5	4.5	0.7	1.6	3.6	2.1	8.1	2.2	24.3	31.9	21.4	24.6	19.8	23.0	20.2	19.8	19.7	18.3	23.8	21.6	14.3	16.0	19.7	16.9	12.3	22.9	16.0	12.5	31.4	2.0	14.7	34.9	16.6	23.6	20.4	18.6	0.0	19.2	14.9	18.4	35.5	10.3	38.9	36.4	35.0	28.8	22.7	83.1	5.0	33.4	54.7	32.1	45.9	18.1	28.7	18.7	10.5	33.2	48.0	11.0	38.8	9.1	30.0	17.4	25.5	23.0	15.3	15.1	19.2
CREBZF	ZF	ENSG00000137504	"CREB/ATF bZIP transcription factor"	Q9NS37	11	85659708-85682908	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021526, HPA063652"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA021526: AB_2670738, HPA063652: AB_2685075"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.38e-3)"	15.4	18.7	16.6	19.5	23.3	13.2	19.8	31.4	21.7	23.1	18.1	23.7	18.5	22.0	29.0	19.9	15.0	22.3	18.2	13.3	16.9	10.5	14.9	16.2	17.5	25.0	34.0	18.7	31.5	27.2	30.0	23.8	18.3	20.2	21.2	20.6	20.0	19.3	17.0	13.1	18.2	24.4	20.0	21.3	26.1	20.2	12.7	24.8	21.6	27.1	11.7	21.3	19.1	21.3	3.1	2.4	2.3	2.8	1.9	3.8	0.8	3.6	11.1	9.3	3.1	3.9	4.3	11.4	5.8	3.4	5.0	6.6	11.1	17.8	9.3	5.9	3.2	20.7	13.4	7.5	3.9	7.5	7.5	9.3	9.6	32.1	3.4	3.1	9.6	5.6	4.5	9.3	5.5	8.2	4.7	2.8	6.8	8.3	15.8	4.5	5.9	8.6	13.8	3.7	11.0	5.8	17.5	10.7	6.7	4.4	7.0	9.8	9.3	9.2	13.1	2.3	4.9	15.6	15.7	4.3	10.7	8.7	17.2	8.0	5.9	5.2	12.9	2.9	6.9	8.6	1.9	1.6	1.4	2.3	1.4	3.8	3.1	1.5	1.9	2.0	2.9	2.5	2.3	2.3	1.9	2.8	2.4	1.1	0.8	16.6	23.3	31.4	21.7	16.9	10.5	34.0	18.7	20.2	24.8	17.9	19.2	20.4	20.2	36.7	100.5	11.3	12.7	14.7	14.8	21.0	86.4	13.0	8.3	10.5	19.0	26.4	25.1	23.3	7.4	12.3	29.2	26.1	21.9	26.0	8.7	85.8	37.8	22.1	18.6	13.7	28.4	14.6	32.1	9.0	23.6	57.0	8.3	20.9	31.5	5.3	112.5	12.9	28.9	20.0	5.9	36.1	12.0	25.8	19.9	21.0
CREG1	CREG	ENSG00000143162	"Cellular repressor of E1A stimulated genes 1"	O75629	1	167529677-167553767	"Predicted secreted proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Hofbauer cells: 442.0;Kupffer cells: 417.0;monocytes: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 15.1;classical monocyte: 36.8;eosinophil: 21.7;intermediate monocyte: 21.5;myeloid DC: 26.9;neutrophil: 13.0;non-classical monocyte: 19.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 26.9;granulocytes: 21.7;monocytes: 36.8"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 158.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056390			Approved	Vesicles,Microtubules	"Secreted to blood"	NA	NA		550000	Microtubules	Vesicles	"HPA056390: AB_2683113"	"unprognostic (3.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.54e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.99e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.16e-1)"	50.9	52.6	15.7	21.0	17.9	29.6	56.7	11.8	15.0	23.0	32.8	21.7	21.3	16.5	22.0	46.8	41.9	25.0	40.8	48.9	15.5	13.6	39.8	81.3	68.5	83.8	16.4	9.6	43.3	41.6	19.1	36.2	46.8	14.7	41.4	23.7	28.7	39.0	22.6	33.0	37.1	30.4	40.9	21.0	98.2	22.7	27.6	15.1	12.6	53.1	32.7	23.7	50.8	40.9	1.3	26.9	21.7	36.8	3.3	5.3	13.9	12.0	5.4	2.8	5.8	44.8	12.5	7.2	5.2	2.3	4.1	5.4	8.8	13.9	13.3	15.2	5.7	7.7	19.1	3.2	11.2	2.8	18.0	11.0	5.4	4.5	4.9	15.4	12.0	40.1	13.0	33.8	4.8	5.3	5.8	1.3	4.7	27.9	54.6	5.7	5.0	2.4	12.4	3.0	27.8	8.5	4.2	7.9	158.5	7.4	8.5	1.9	3.5	13.0	17.8	14.4	9.9	23.6	32.9	2.5	1.1	5.4	17.0	3.3	10.7	21.3	8.7	18.0	12.5	2.1	15.1	36.8	21.7	1.6	21.5	2.5	1.3	2.4	2.0	26.9	0.6	5.3	2.6	13.0	3.3	19.9	1.8	1.1	13.9	15.7	17.9	11.8	15.0	15.5	13.6	16.4	9.6	14.7	15.1	32.8	78.6	17.9	43.5	39.2	16.0	45.9	63.7	22.7	31.8	52.4	84.4	79.1	19.9	26.7	18.6	34.9	20.0	116.8	34.5	36.0	45.2	30.0	29.9	79.5	442.0	14.3	28.2	43.0	417.0	20.2	40.3	100.2	23.6	450.0	40.4	25.3	26.6	24.6	26.9	45.2	30.1	12.9	41.5	32.9	43.2	44.7	106.0	14.6	47.5	37.3
CRELD1	AVSD2	ENSG00000163703	"Cysteine rich with EGF like domains 1"	Q96HD1	3	9933822-9945413	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026964	Uncertain		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA		16000000	Cytosol	Nucleoli	"HPA026964: AB_10602210"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.78e-2)"	21.8	22.9	31.6	15.3	32.4	7.3	27.3	52.2	45.1	9.9	22.4	12.0	17.1	12.5	15.1	17.8	13.1	20.1	15.8	50.2	25.6	24.9	16.6	23.5	15.8	11.0	17.2	30.7	19.7	15.2	21.9	32.4	15.1	27.2	25.4	11.4	10.0	19.4	32.2	24.4	11.6	13.1	19.5	19.4	11.9	14.8	11.1	22.3	5.9	45.7	7.4	8.2	17.8	15.6	10.5	13.7	11.5	12.5	13.4	14.3	10.4	2.8	5.2	8.5	4.4	14.4	9.4	47.1	10.4	3.1	2.6	4.9	5.0	8.5	3.4	22.9	7.2	12.1	1.8	4.1	7.5	1.8	6.7	3.9	3.1	6.7	11.8	28.8	1.1	12.0	9.6	13.9	6.4	5.9	31.4	11.8	5.2	3.7	4.1	2.5	6.8	2.0	8.4	2.3	11.6	3.5	2.1	1.2	8.1	11.0	4.9	3.4	11.0	4.8	4.5	9.3	11.7	11.5	6.8	8.2	5.0	8.1	6.6	2.5	4.7	6.0	6.3	11.1	3.5	5.3	11.5	11.4	9.4	14.2	11.6	14.3	8.9	10.5	13.7	8.2	10.5	14.2	12.7	1.8	13.4	12.5	13.7	8.0	10.4	31.6	32.4	52.2	45.1	25.6	24.9	17.2	30.7	27.2	22.3	17.9	13.7	10.7	19.5	8.7	20.8	34.7	33.1	8.1	7.9	15.7	15.7	20.0	6.6	17.7	5.8	15.0	14.7	0.0	3.9	9.2	21.7	31.7	20.7	11.5	18.5	30.2	25.9	16.0	7.8	7.9	29.7	10.2	11.8	19.0	14.9	21.0	8.8	15.0	24.8	8.2	15.0	25.8	14.1	49.7	11.9	10.8	18.5	12.1	14.1	16.3
CREM	hCREM-2	ENSG00000095794	"CAMP responsive element modulator"	Q03060	10	35126791-35212958	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 1553.0;Late spermatids: 579.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001818, CAB018352"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB018352: AB_673599, HPA001818: AB_1078566"	"unprognostic (1.78e-1)"	"unprognostic (6.26e-3)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (9.27e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (4.44e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.52e-1)"	21.9	61.4	14.3	21.3	15.1	8.1	15.4	6.2	13.8	10.6	8.0	8.4	10.2	4.1	13.3	10.8	8.2	9.9	19.7	19.5	14.5	15.2	15.4	26.1	19.6	7.1	12.7	8.3	21.4	8.2	8.3	24.2	42.0	20.1	12.2	6.4	9.6	5.7	19.2	10.0	3.2	7.0	11.0	15.5	21.8	7.5	74.9	7.7	8.1	10.8	6.8	7.3	18.1	11.7	6.4	11.2	10.1	4.9	8.6	14.6	8.2	9.1	14.8	12.5	12.8	8.8	9.2	12.5	12.1	9.5	7.6	10.6	1.7	3.9	15.7	11.8	7.0	8.3	2.1	10.7	7.9	11.2	38.5	7.9	5.6	10.2	6.9	10.5	1.3	5.9	8.1	10.0	14.9	4.6	6.7	21.2	11.9	16.2	6.5	11.7	7.4	9.5	4.0	3.7	3.4	34.1	5.9	6.5	2.9	13.4	3.6	2.9	8.0	5.7	5.0	32.0	14.9	2.8	4.1	28.1	5.8	7.5	16.0	7.9	2.9	3.9	5.4	13.9	12.4	5.0	4.7	3.3	10.1	11.5	4.9	14.2	6.4	12.7	10.1	3.8	5.5	9.0	10.4	9.0	8.6	3.6	11.2	14.6	8.2	14.3	15.1	6.2	13.8	14.5	15.2	12.7	8.3	20.1	7.7	17.9	64.8	33.0	45.1	127.4	16.5	58.9	20.4	53.5	31.8	157.1	5.9	87.7	82.9	30.2	1553.0	61.6	13.0	0.0	38.6	102.1	73.7	43.8	344.6	37.7	100.7	9.5	66.1	14.1	50.2	579.8	24.2	113.1	234.5	315.6	10.3	26.0	26.6	17.5	30.8	49.4	18.2	45.3	183.3	211.4	136.9	94.7	192.3	100.1	11.0	45.0
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 1: 911.2;Ciliated cells: 2667.4;Club cells: 874.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 110.7;CAPAN-2: 61.7;HaCaT: 66.8;HDLM-2: 47.3;HeLa: 54.3;OE19: 188.5;T-47d: 86.8"	"Low region specificity"	"Detected in all"							HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	44.3	3.3	3.8	37.5	4.9	5.5	97.2	3.2	4.0	37.7	44.0	4.5	65.3	25.7	20.0	83.0	28.4	23.7	33.8	45.5	4.5	4.7	20.4	2.6	56.7	53.0	4.7	4.5	11.2	4.2	1.1	7.3	38.5	4.8	11.7	13.2	9.9	21.8	71.0	12.9	48.8	106.3	25.9	5.1	16.6	20.3	7.5	1.9	24.2	32.0	83.4	58.3	18.4	18.9	111.4	79.3	56.3	49.4	56.9	121.1	75.8	0.0	110.7	0.7	0.1	1.9	1.4	10.3	0.2	0.0	1.5	0.0	3.4	61.7	33.4	0.6	29.5	0.4	66.8	0.0	0.0	0.1	47.3	0.0	2.6	54.3	18.6	0.4	0.0	0.0	0.6	0.0	3.6	0.0	0.1	0.0	10.8	0.0	0.0	0.0	0.9	1.7	0.3	1.0	188.5	5.7	26.2	0.0	6.9	0.0	0.0	2.9	0.2	0.4	0.1	0.0	0.1	86.8	15.9	0.2	0.0	0.1	0.8	0.0	0.0	0.0	2.8	0.0	0.0	0.1	19.4	43.3	56.3	47.7	38.5	32.7	111.4	92.1	51.4	79.3	43.6	21.9	25.7	2.9	56.9	49.4	62.1	121.1	75.8	3.8	4.9	3.2	4.0	4.5	4.7	4.7	4.5	4.8	1.9	911.2	276.7	125.9	1.0	165.7	0.0	0.8	2.5	2667.4	874.7	48.8	0.0	0.5	1.7	9.2	2.8	10.9	494.0	0.0	2.8	3.1	16.3	0.4	486.4	0.8	53.8	0.0	73.6	27.0	188.7	20.7	23.3	296.9	350.9	697.9	172.6	0.2	20.6	407.1	8.9	2.2	0.0	219.9	30.1	0.1	10.4	219.9	1.3	239.7	156.7	2.6
CRIP2	"CRP2, ESP1"	ENSG00000182809	"Cysteine rich protein 2"	P52943	14	105472962-105480170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"heart muscle: 180.3"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 702.6;Endothelial cells: 478.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 24.0;T-reg: 29.2"	"Group enriched"	"Detected in many"	19	"B-cells: 17.9;T-cells: 29.2"	"Cell line enhanced"	"Detected in many"		"A549: 38.5;EFO-21: 39.4;HUVEC TERT2: 36.8;MCF7: 56.5;SK-BR-3: 44.3;T-47d: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042664	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA		490000	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA042664: AB_10797017"	"unprognostic (2.68e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.68e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.26e-3)"	22.8	11.5	27.5	9.1	24.6	1.6	16.9	3.6	30.3	20.2	10.1	9.4	33.7	7.9	15.3	30.6	25.6	29.5	24.5	180.3	22.6	18.7	20.0	6.9	28.5	9.3	13.5	16.9	12.5	12.6	4.3	20.4	29.1	10.4	14.6	3.8	8.8	18.4	28.0	10.7	28.4	9.1	24.9	10.3	13.0	11.3	10.9	7.8	1.0	17.8	23.8	13.3	23.8	17.5	17.9	0.9	0.2	0.5	1.2	29.2	3.4	0.4	38.5	5.6	15.3	0.9	4.0	1.6	1.7	0.4	0.5	0.1	1.2	7.1	0.0	39.4	12.6	0.8	22.0	0.7	9.3	0.0	0.2	0.2	0.0	24.2	14.6	4.1	0.0	3.3	1.9	0.8	0.9	5.3	7.2	36.8	0.0	0.0	0.3	5.5	56.5	0.1	0.1	1.5	7.8	23.1	0.0	0.7	1.6	25.9	0.1	8.5	21.4	2.5	44.3	0.3	0.9	37.9	0.0	14.3	12.8	6.0	0.3	7.1	0.1	0.1	0.1	3.7	0.0	25.7	0.0	0.5	0.0	2.4	0.2	2.3	14.4	24.0	5.3	0.9	17.9	5.9	1.6	0.2	1.2	0.1	0.1	29.2	3.4	27.5	24.6	3.6	30.3	22.6	18.7	13.5	16.9	10.4	7.8	145.9	41.3	6.5	66.0	136.0	2.2	702.6	96.8	105.7	131.9	179.7	3.9	0.9	131.0	90.2	30.6	478.7	0.0	0.0	80.2	15.4	145.8	41.0	7.0	27.0	2.6	89.0	24.2	229.6	13.7	62.0	25.9	11.3	148.5	2.8	0.0	55.2	33.3	0.0	13.8	9.8	3.7	271.7	208.1	5.9	44.5	172.0	26.8	6.4	0.0	77.0
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308797	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;heart muscle: 24.8;liver: 29.0"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 5.1;Distal tubular cells: 8.3;Late spermatids: 6.8;Spermatocytes: 5.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	14	"myeloid DC: 25.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 25.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.1;HEK 293: 4.9;HeLa: 5.1;Hep G2: 9.2;NTERA-2: 8.4;RPMI-8226: 6.8;THP-1: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036198	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.4	0.5	4.2	5.6	5.8	2.5	2.1	9.4	3.0	0.8	0.8	0.6	3.1	2.2	0.8	2.7	0.9	1.0	4.6	24.8	3.5	3.5	10.4	29.0	0.6	5.3	2.3	2.2	1.0	2.4	0.8	1.1	0.7	2.1	4.1	0.5	1.0	0.7	9.5	0.5	1.8	4.5	1.0	1.7	4.4	0.3	13.5	0.4	0.6	1.1	0.4	6.1	1.8	0.5	1.7	25.5	0.5	1.5	0.2	0.0	0.9	0.0	1.2	0.3	0.1	0.4	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.4	0.0	0.2	0.9	4.1	0.1	0.0	0.0	4.9	0.0	5.1	9.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	6.8	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.6	0.9	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	1.5	0.5	0.0	1.0	0.0	1.4	0.0	0.0	25.5	1.7	0.0	0.0	0.4	0.2	1.3	0.2	0.0	0.9	4.2	5.8	9.4	3.0	3.5	3.5	2.3	2.2	2.1	0.4	0.0	0.0	2.2	0.2	0.6	0.4	1.8	5.1	0.0	0.0	0.0	0.0	0.0	8.3	0.8	3.1	0.0	0.3	0.0	0.2	0.0	0.2	0.1	0.0	2.9	0.2	0.0	0.0	0.0	0.8	6.8	1.1	0.0	0.0	1.0	0.0	0.3	0.4	0.0	0.0	2.4	0.7	0.0	0.0	5.9	0.9	0.0	0.0	0.0	0.1	0.1
CRIPT	HSPC139	ENSG00000119878	"CXXC repeat containing interactor of PDZ3 domain"	Q9P021	2	46616416-46625742	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046080, HPA056765"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA046080: AB_2679529, HPA056765: AB_2683230"	"unprognostic (3.38e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.42e-2)"	13.8	17.1	29.3	9.4	26.2	10.0	18.9	24.3	23.9	12.2	11.4	28.7	10.8	15.5	18.2	17.5	12.6	14.6	10.5	22.1	26.5	23.1	19.8	18.8	9.3	11.9	27.6	18.1	17.5	9.8	12.7	21.9	14.3	23.2	14.9	13.4	13.6	16.8	12.5	18.4	13.6	14.2	12.1	36.6	10.1	11.3	12.3	26.2	13.4	14.0	8.8	13.2	14.4	10.8	13.3	14.0	20.9	9.4	11.5	15.5	9.0	15.7	9.3	9.9	8.6	12.2	13.1	12.6	11.0	8.3	9.6	10.0	12.0	12.0	8.5	30.1	12.3	14.0	8.4	10.0	10.7	14.8	18.3	11.8	9.0	11.8	15.4	14.0	8.7	8.6	10.1	14.2	12.3	8.8	20.0	14.3	7.5	13.0	12.8	11.2	8.4	9.0	17.4	10.2	18.6	12.9	8.2	19.0	16.5	13.4	10.2	14.2	20.6	11.5	9.6	15.8	11.2	7.2	8.1	9.9	13.7	11.9	11.1	14.6	9.9	10.6	10.9	17.9	10.3	12.3	20.9	9.4	17.8	8.8	8.4	8.6	13.3	9.8	8.5	9.9	11.2	9.9	9.0	19.1	11.5	6.8	14.0	15.5	9.0	29.3	26.2	24.3	23.3	26.5	23.1	27.6	18.1	23.2	26.2	17.9	10.7	43.3	56.4	38.2	28.4	54.3	40.8	29.4	30.7	29.6	23.6	49.5	58.0	55.6	24.5	30.2	49.6	46.7	34.7	69.1	37.1	49.4	27.7	49.7	42.7	15.9	62.5	25.8	42.4	10.5	33.6	28.6	28.7	45.1	34.8	31.4	60.2	59.6	24.1	73.3	48.6	19.4	42.0	55.7	45.0	46.3	80.0	35.5	29.3	51.5
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819984-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	19	"Leydig cells: 251.5;Peritubular cells: 250.0;Smooth muscle cells: 678.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 36.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 36.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.3;BEWO: 23.8;HHSteC: 56.8;HSkMC: 23.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	No	219000000000		"Nucleoplasm, Nucleoli"		"HPA030054: AB_2732452, HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	29.2	11.6	2.2	41.1	5.0	3.0	57.2	2.1	3.6	44.1	26.0	2.5	10.6	4.2	38.5	58.7	21.1	43.6	107.4	19.1	2.1	2.0	10.1	6.7	31.0	21.4	5.5	1.6	37.1	9.1	1.0	6.4	50.2	7.1	31.6	7.3	21.9	6.8	23.6	15.9	12.0	17.5	48.0	8.6	10.0	22.5	16.8	3.1	0.4	15.9	11.4	3.3	40.3	32.7	0.0	0.5	36.0	7.9	0.0	0.1	1.3	0.3	0.7	0.2	2.0	15.3	5.7	23.8	11.6	10.3	9.3	6.6	1.5	0.9	0.0	1.0	10.1	2.7	0.3	0.0	0.0	9.4	0.0	0.0	0.1	0.2	0.0	56.8	0.0	0.1	23.8	0.0	2.7	0.0	3.1	0.0	0.0	0.1	0.1	1.0	0.4	0.1	0.5	0.6	1.5	0.6	0.0	0.1	0.1	0.1	1.8	2.3	0.1	2.7	1.2	0.2	3.4	4.7	0.3	1.3	0.1	0.6	9.7	0.3	0.1	0.0	1.9	0.0	0.2	1.4	4.4	7.9	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	1.3	2.2	5.0	2.1	3.6	2.1	2.0	5.5	1.6	7.1	3.1	3.0	2.9	0.8	7.9	41.0	0.6	7.6	0.0	1.4	2.3	0.0	0.0	6.0	0.0	1.1	10.8	12.0	0.4	0.0	0.4	24.6	126.1	19.2	6.9	0.0	4.4	1.6	2.9	60.2	40.4	10.7	251.5	12.2	45.5	0.0	4.2	5.0	0.8	0.0	250.0	0.0	0.5	90.5	678.7	0.9	0.9	37.4	7.6	4.8	1.3	5.2
CRK		ENSG00000167193	"CRK proto-oncogene, adaptor protein"	P46108	17	1420689-1463162	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010485, HPA068087"	Approved		Approved	"Plasma membrane"		NA	NA		390000	"Plasma membrane"		"CAB010485: AB_2085043, HPA068087: AB_2685950"	"unprognostic (6.82e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.70e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.93e-2)"	37.1	22.1	23.3	15.9	23.7	4.2	40.0	25.1	23.4	23.3	27.2	21.2	31.5	21.4	26.0	27.5	25.9	19.0	27.5	22.0	23.0	21.6	26.0	40.5	25.6	14.6	25.3	18.4	21.4	22.1	22.6	11.8	33.6	24.2	22.4	28.6	18.0	21.2	27.3	27.8	18.1	26.9	29.3	24.0	17.6	21.6	17.9	26.4	13.6	32.5	20.2	15.8	28.8	40.7	5.5	4.7	16.3	4.6	3.0	4.2	1.7	15.1	23.7	17.7	18.8	29.9	25.2	16.5	26.3	22.2	20.8	19.4	30.5	9.0	7.4	13.2	30.1	14.5	23.5	23.4	19.0	30.7	3.7	16.0	8.2	15.5	16.7	27.8	3.5	7.3	24.4	22.5	21.5	27.2	16.0	25.5	7.0	13.7	7.0	29.0	15.3	3.7	4.0	16.0	16.9	11.9	8.0	8.9	6.7	27.3	16.4	6.5	17.2	25.0	15.6	17.9	17.4	15.3	5.9	27.1	21.0	12.0	22.1	25.8	3.3	5.1	4.6	17.7	6.9	22.8	5.4	4.4	5.4	3.6	4.6	3.6	4.1	3.8	3.1	4.7	5.5	2.9	4.2	16.3	3.0	4.6	4.4	2.6	1.7	23.3	23.7	25.1	22.3	23.0	21.6	25.3	18.4	24.2	26.4	62.5	51.7	22.8	58.7	132.8	40.3	28.2	50.9	33.5	30.7	31.4	25.5	52.9	34.9	58.9	3.3	65.0	75.5	0.0	56.8	51.0	50.5	60.3	7.0	58.9	38.4	50.9	47.8	90.2	42.1	4.2	40.6	35.6	50.6	43.3	51.7	40.4	59.0	54.7	41.4	30.5	36.0	45.3	60.8	22.7	53.5	146.7	71.1	17.3	46.2	81.9
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917426-20953749	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 89.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		1500000	Nucleoplasm	Cytosol	"HPA000532: AB_2666019, HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.4	15.2	25.0	18.1	24.1	41.9	18.4	34.0	31.7	17.8	19.9	26.4	12.3	20.2	18.9	12.8	25.2	19.9	13.6	22.6	22.6	23.8	16.4	24.9	19.0	21.3	24.6	26.1	26.9	21.7	22.2	17.9	25.1	20.7	18.8	18.7	16.7	14.5	19.1	48.1	22.7	19.1	18.6	23.6	19.6	14.3	12.6	19.8	35.7	16.6	17.8	24.7	17.7	24.6	11.7	14.8	19.2	21.5	11.0	19.7	16.8	11.5	6.9	15.6	12.2	10.5	6.8	16.8	7.8	9.6	12.1	13.7	11.4	5.2	14.8	6.3	8.2	8.3	14.8	18.2	12.5	14.4	12.5	17.8	20.5	7.5	12.5	10.5	21.8	10.5	6.8	16.6	10.5	18.0	9.9	10.6	12.0	89.5	12.2	9.7	10.8	12.7	10.2	12.2	12.0	7.5	16.5	24.7	3.5	8.0	10.1	10.1	12.9	13.1	11.6	9.5	19.5	9.9	12.2	8.5	19.2	21.9	7.2	9.8	11.8	11.3	17.3	14.2	9.3	11.7	13.4	13.0	19.2	17.5	12.5	18.9	11.6	15.8	17.5	14.8	11.7	19.7	18.4	14.1	11.0	21.5	7.4	12.8	16.8	25.0	24.1	34.0	31.7	22.6	23.8	24.6	26.1	20.7	19.8	8.9	16.2	15.6	11.6	48.1	16.8	20.3	10.2	10.7	10.3	5.2	13.7	17.3	1.7	6.8	20.7	14.3	12.4	23.3	7.3	32.0	16.2	13.4	1.1	21.2	15.0	17.5	19.5	18.4	13.7	43.2	14.1	11.1	23.6	10.8	21.5	16.0	9.1	8.6	14.5	8.4	12.7	12.9	11.1	11.6	11.3	52.8	22.8	10.0	14.5	17.4
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972979	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 135.2"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	5.0	3.8	3.2	3.2	7.0	2.1	2.5	12.9	3.0	3.9	2.8	5.4	2.2	2.4	5.1	2.4	3.2	9.9	2.3	2.1	4.6	3.5	2.4	1.8	3.9	3.2	2.1	2.5	5.0	4.2	3.0	3.6	2.2	11.3	3.3	0.6	30.6	135.2	2.9	8.2	14.4	3.1	1.8	2.3	6.4	3.5	1.9	4.3	2.1	2.5	2.3	1.8	2.9	3.8	1.1	0.6	1.7	0.8	1.3	2.8	0.6	4.1	1.7	3.2	3.2	2.3	2.1	1.3	3.0	1.0	1.0	1.1	0.2	1.9	10.9	2.8	1.2	0.3	5.0	0.8	2.2	0.1	0.9	5.8	5.0	5.3	0.8	3.9	0.3	5.1	1.8	5.2	0.9	0.9	1.7	1.6	7.9	0.7	2.8	0.3	3.5	3.3	1.2	11.6	0.9	2.7	3.1	4.2	3.7	0.7	1.2	9.9	10.6	3.2	2.1	9.7	1.0	4.2	1.4	4.4	2.8	3.7	7.0	2.3	5.0	3.6	2.2	2.8	0.7	3.3	0.0	0.4	1.7	1.6	0.8	2.8	0.7	1.3	1.3	0.2	1.1	1.1	0.9	0.1	1.3	0.3	0.6	1.3	0.6	3.2	7.0	12.9	3.0	4.6	3.5	2.1	2.5	11.3	4.3	0.0	5.8	0.5	4.2	5.6	20.9	3.2	2.5	14.7	3.4	5.2	25.5	1.1	0.0	4.8	3.5	6.8	0.7	0.0	2.0	5.8	4.5	2.1	1.1	2.4	2.0	3.2	3.5	6.7	2.2	1.9	17.8	2.2	5.0	2.8	3.7	11.9	3.2	2.3	12.0	1.3	111.2	0.0	9.2	1.4	13.2	4.4	0.9	3.8	2.5	1.4
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345681-87399795	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 116.1;Rod photoreceptor cells: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 35.3;RT4: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	4.6	10.1	9.3	5.1	9.6	1.6	10.5	7.4	8.4	9.0	9.4	5.5	24.1	19.6	10.0	12.6	17.0	6.8	8.7	5.9	5.2	5.4	12.3	21.5	4.2	3.4	5.4	6.6	7.2	4.6	15.5	9.1	13.7	5.8	14.8	7.0	9.8	8.3	32.3	7.2	15.0	19.1	8.8	6.8	4.8	4.9	3.8	4.7	7.4	27.1	8.4	8.0	22.4	15.3	2.2	2.3	3.4	5.5	13.0	9.5	3.0	7.2	5.4	6.6	2.3	6.3	5.8	4.9	7.7	7.2	4.7	5.1	2.8	3.8	3.0	6.8	6.5	9.4	9.1	1.1	10.2	6.7	4.3	4.6	6.6	3.8	3.6	4.1	4.1	4.1	4.7	35.3	3.8	3.0	6.0	6.6	5.0	0.3	4.4	12.3	7.1	5.1	4.1	1.4	2.6	8.0	2.3	9.1	0.5	6.0	34.6	1.1	5.2	9.4	10.9	4.9	4.7	6.9	1.5	3.5	10.9	4.7	14.7	7.2	6.7	9.6	4.2	7.3	0.0	6.4	2.0	1.4	3.4	7.4	1.7	9.5	2.2	7.5	6.0	2.0	2.2	6.1	6.6	0.9	13.0	5.5	2.3	6.3	3.0	9.3	9.6	7.4	8.4	5.2	5.4	5.4	6.6	5.8	4.7	20.8	7.7	4.4	49.0	14.9	16.1	13.2	7.6	32.1	36.4	50.6	43.2	116.1	8.3	6.6	18.7	6.5	24.7	0.0	7.6	5.2	7.3	20.4	7.0	28.8	12.0	14.3	7.0	5.5	7.5	33.1	14.7	7.4	18.6	6.4	13.1	24.1	8.0	7.4	13.1	15.3	76.5	6.5	8.3	2.5	3.6	13.4	41.0	7.0	10.9	43.1
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"liver: 1139.7"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 2991.5"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5400000000	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	17.2	0.1	0.1	0.0	0.1	1139.7	0.1	0.1	0.1	0.1	0.1	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	7.8	0.0	0.3	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.9	0.0	13.1	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	55.9	0.0	0.0	0.0	0.0	109.5	0.0	0.0	0.0	0.0	0.0	0.0	220.4	1.2	0.0	0.0	23.3	52.3	0.0	0.0	0.0	0.0	2991.5	0.1	0.0	0.0	82.9	72.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	97.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRTAP	"CASP, LEPREL3, P3H5"	ENSG00000170275	"Cartilage associated protein"	O75718	3	33113979-33147773	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 172.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 67.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 55.8;monocytes: 67.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 122.6;ASC TERT1: 80.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043598, HPA044150"	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"	"Secreted to blood"	NA	NA			"Intermediate filaments, Actin filaments, Cytosol"		"HPA043598: AB_10960991, HPA044150: AB_10959594"	"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.85e-3)"	"unprognostic (7.36e-2)"	"unprognostic (4.73e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.28e-3)"	59.2	33.4	16.3	13.4	22.2	13.6	63.2	5.4	14.1	57.5	39.4	23.3	32.7	12.8	54.2	41.1	42.8	35.1	43.5	37.0	16.8	13.1	25.7	16.8	35.9	37.8	24.2	13.0	48.5	13.3	14.6	7.6	25.4	13.8	54.5	19.7	35.4	16.4	42.2	23.9	24.6	18.8	66.1	22.8	17.6	25.2	26.1	19.0	5.1	34.1	25.8	18.3	62.4	59.7	7.6	55.8	5.5	67.8	6.9	12.9	30.8	9.1	18.1	5.7	17.8	122.6	80.3	33.0	20.0	43.7	24.3	23.2	6.1	5.2	6.4	22.4	38.0	19.6	11.8	10.1	15.3	17.6	15.8	15.7	10.0	14.2	6.3	36.7	6.4	8.2	64.0	31.4	21.9	27.9	47.3	25.5	4.0	8.5	12.3	24.5	7.8	2.3	6.6	6.8	9.8	24.7	8.5	16.7	12.3	19.0	6.1	1.2	9.2	13.5	11.9	28.8	13.8	12.8	15.9	16.6	31.9	13.6	17.3	21.1	8.9	30.1	0.9	25.0	13.0	17.4	2.1	67.8	4.9	6.9	26.3	10.0	7.6	10.1	7.7	55.8	6.8	5.8	5.4	5.5	6.9	7.8	15.0	12.9	30.8	16.3	22.2	5.4	14.1	16.8	13.1	24.2	13.0	13.8	19.0	8.9	42.6	18.6	27.6	53.7	18.7	29.5	25.5	4.0	19.4	36.6	7.9	42.5	10.0	19.9	1.0	55.3	18.1	0.0	27.7	59.7	94.1	20.8	46.2	44.4	93.2	33.4	5.8	103.2	172.9	2.2	132.3	73.7	75.9	27.9	22.6	17.7	20.2	10.5	136.2	43.7	10.5	109.9	117.1	1.4	7.9	40.8	23.5	20.8	33.1	22.1
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683677-18782333	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.7"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022035, HPA063619"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255, HPA063619: "	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favorable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.6	7.7	26.0	7.4	38.8	3.2	3.8	40.7	30.1	5.0	4.4	6.5	4.3	6.5	6.8	5.6	3.1	10.5	5.5	5.6	17.7	7.8	6.6	4.5	5.7	6.3	6.4	18.1	6.7	10.0	8.4	11.3	6.4	6.0	7.0	2.6	5.1	8.8	9.4	12.4	5.5	6.2	4.3	4.8	8.1	8.0	7.5	10.2	1.9	7.4	1.1	3.7	4.6	3.5	4.1	3.8	1.8	3.4	1.1	3.0	1.3	4.4	8.1	5.9	9.4	5.5	4.6	16.7	4.9	3.3	4.7	4.5	5.4	5.8	6.2	10.4	4.6	3.3	4.8	1.8	3.0	1.1	2.7	14.1	5.2	7.2	8.9	5.3	7.1	14.6	7.5	2.9	4.0	1.2	6.2	2.6	6.4	4.1	5.7	2.6	16.1	4.6	8.1	7.6	2.3	11.9	7.3	2.6	6.8	2.9	7.9	10.8	9.7	5.5	5.2	5.8	2.0	5.8	4.3	4.7	5.3	8.2	9.7	5.6	3.8	3.0	4.1	6.2	7.7	4.0	1.5	3.4	1.8	1.7	1.3	1.8	2.3	2.7	3.0	3.0	4.1	2.3	1.8	1.7	1.1	1.9	3.8	1.8	1.3	26.0	38.8	40.7	30.1	17.7	7.8	6.4	18.1	6.0	10.2	0.0	4.0	4.2	9.5	2.4	24.9	14.0	5.1	2.7	2.3	17.4	25.5	8.5	10.0	3.6	0.7	4.5	5.1	0.0	5.3	2.1	5.4	3.0	2.3	3.4	7.8	41.3	18.4	1.3	5.4	1.7	8.6	3.7	3.3	1.8	6.9	8.9	2.6	8.6	4.6	4.3	14.1	0.0	8.2	2.9	7.2	1.8	8.7	5.1	4.8	2.5
CRY1	PHLL1	ENSG00000008405	"Cryptochrome circadian regulator 1"	Q16526	12	106991364-107093829	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 107.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018762	Approved		Supported	"Nucleoplasm,Nuclear membrane,Microtubules"		NA	NA			"Nucleoplasm, Nuclear membrane, Microtubules"		"CAB018762: AB_2083970"	"unprognostic (1.21e-3)"	"unprognostic (4.74e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	12.2	12.2	8.7	8.5	12.6	9.5	18.3	29.2	10.3	12.4	14.3	12.4	5.0	10.7	14.3	12.9	10.7	15.8	16.3	12.2	10.5	8.7	16.0	13.7	18.0	5.0	17.4	7.3	10.7	12.9	8.6	10.0	13.4	13.1	11.2	8.3	8.7	9.4	11.8	10.8	8.7	17.6	15.9	15.4	10.1	14.6	37.6	15.1	26.5	20.1	6.2	7.5	9.5	18.4	1.7	3.5	6.8	6.4	4.7	13.9	4.7	8.6	8.9	10.9	12.0	7.8	4.9	19.5	9.3	9.9	19.1	12.9	10.1	5.3	0.0	5.9	8.6	12.2	6.0	14.0	4.7	20.9	8.7	8.7	8.5	7.9	7.1	10.1	8.7	7.5	4.6	5.0	14.0	13.3	9.5	15.8	16.3	9.6	7.7	11.7	6.1	19.5	9.9	13.3	8.4	13.0	17.5	27.6	3.1	13.3	10.2	19.8	10.2	17.6	11.5	5.5	11.2	8.1	4.9	7.0	11.2	12.0	7.6	8.3	14.2	13.2	4.0	5.4	8.3	9.1	6.8	2.5	4.4	11.2	3.8	13.9	1.6	8.5	7.0	3.5	1.7	8.0	7.8	1.1	4.7	6.4	2.3	11.0	4.7	8.7	12.6	29.2	10.3	10.5	8.7	17.4	7.3	13.1	15.1	14.9	14.4	5.1	37.9	61.5	15.5	9.3	10.2	17.4	5.7	10.4	19.6	7.7	14.9	9.5	8.6	13.1	8.8	0.0	14.4	10.4	26.7	29.3	4.7	18.5	5.5	25.4	18.8	12.3	5.4	2.7	10.6	7.7	15.1	21.6	6.8	21.9	15.1	3.6	16.3	13.9	11.9	6.5	11.3	107.6	21.1	51.9	12.6	12.9	5.2	23.3
CRYAA2		ENSG00000276076	"Crystallin alpha A2"		21	6560714-6564489	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	6	"kidney: 34.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	200	"Hep G2: 28.9"									"HPA037737, HPA038430"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			34.4	5.3	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYBB2	"CCA2, CRYB2, CRYB2A"	ENSG00000244752	"Crystallin beta B2"	P43320	22	25219522-25231869	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 26.9"	"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 23.2;Melanocytes: 11.8;Peritubular cells: 7.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.2;THP-1: 1.7;U-138 MG: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043749	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043749: AB_2678652"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.57e-3)"	"unprognostic (9.51e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-3)"	0.8	0.7	2.0	0.5	3.7	0.1	1.7	0.5	1.8	1.0	1.3	0.5	0.5	0.8	0.5	1.8	1.1	0.4	0.5	0.6	2.9	1.5	0.5	0.5	1.4	0.5	0.8	0.5	0.5	0.5	0.0	2.6	0.5	0.9	0.9	1.5	26.9	1.2	0.5	0.6	0.4	1.0	1.0	0.5	0.5	0.2	4.0	0.5	0.5	1.7	0.5	0.5	0.5	0.5	1.4	1.3	0.5	1.1	1.7	1.4	0.7	0.2	0.5	0.1	0.7	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.0	0.6	0.0	1.2	0.8	0.0	0.0	0.2	0.0	1.1	0.6	5.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.3	1.2	0.3	0.6	0.0	0.2	0.1	0.6	0.0	0.2	0.0	0.0	0.9	1.7	0.0	3.0	0.7	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.5	0.8	0.4	1.4	0.6	0.6	1.4	1.2	0.7	1.1	1.0	1.1	1.2	0.1	1.7	1.1	1.3	0.4	0.7	2.0	3.7	0.5	1.8	2.9	1.5	0.8	0.5	0.9	0.5	0.0	0.0	0.0	0.4	4.7	0.1	0.8	0.0	0.0	0.0	1.8	0.0	0.1	23.2	0.0	2.5	2.4	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.0	0.0	0.6	0.3	4.0	2.3	0.7	11.8	0.0	0.1	0.7	0.4	0.0	7.8	0.7	0.0	0.0	4.2	2.1	2.6	3.3	0.1	0.0	0.0	0.6
CRYBB3	CRYB3	ENSG00000100053	"Crystallin beta B3"	P26998	22	25199850-25207363	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"granulocytes: 4.6;Muller glia cells: 3.5;Proximal tubular cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.7;HEK 293: 3.7;HeLa: 4.5;hTERT-HME1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055840	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA055840: AB_2682939"	"unprognostic (1.36e-2)"	"unprognostic (6.27e-4)"	"unprognostic (6.30e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-3)"	0.6	1.2	0.6	0.6	0.6	0.0	1.5	0.6	0.6	0.9	1.3	0.6	0.6	0.6	0.6	0.6	1.4	0.8	0.7	0.8	0.6	0.2	4.5	4.7	0.6	0.6	0.6	0.6	0.6	0.6	0.0	0.7	0.6	0.6	1.8	0.9	4.1	2.4	0.8	1.4	1.9	1.5	0.6	0.6	0.6	1.1	0.6	0.6	0.6	3.1	0.6	0.6	0.6	1.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.7	0.6	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.2	0.4	0.0	1.0	0.0	0.5	3.7	2.3	1.6	0.0	0.0	3.7	0.0	4.5	2.6	0.2	0.0	0.2	0.0	1.9	1.1	3.2	0.7	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.4	2.8	0.1	0.2	0.1	0.3	0.5	0.6	0.4	0.4	0.5	0.0	0.9	0.2	0.0	0.5	0.0	1.8	1.5	0.3	0.0	0.7	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.2	0.6	0.6	0.6	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	0.2	4.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	9.8	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"	Q9Y4K1	6	106360808-106571978	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.7;placenta: 96.6"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"pons and medulla: 10.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.1"	"Low region specificity"	"Detected in single"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	4.6	0.8	0.6	6.8	0.7	6.5	11.3	0.6	0.9	7.4	7.4	1.6	2.5	7.6	1.5	10.8	61.7	2.0	2.0	0.9	1.1	0.6	9.8	3.6	4.0	5.6	0.7	0.7	2.0	5.5	5.0	0.9	96.6	10.3	12.6	5.9	16.0	10.2	4.3	0.8	16.6	7.6	4.4	0.8	6.5	2.5	1.8	0.5	2.3	1.8	24.6	35.8	11.5	13.1	6.8	8.7	3.1	4.4	5.7	10.9	3.9	10.6	0.0	0.0	0.0	9.0	32.1	3.3	1.5	11.8	3.4	3.2	0.7	3.8	16.7	0.7	7.3	4.8	17.2	0.1	40.2	1.7	22.7	0.7	0.0	0.5	5.2	4.2	10.1	0.0	16.0	23.5	6.5	31.1	0.0	14.7	13.2	0.5	2.4	9.2	1.2	2.9	4.0	0.1	0.0	7.1	5.0	0.1	0.1	5.4	25.3	0.7	0.0	6.5	11.1	0.1	1.0	5.5	7.7	4.2	3.9	0.5	0.0	10.6	1.8	1.4	18.2	18.4	12.8	8.3	0.3	3.8	0.4	8.1	4.4	10.9	6.8	10.5	8.9	8.7	3.8	6.7	6.3	3.1	5.7	4.4	1.0	9.9	3.9	0.6	0.7	0.6	0.9	1.1	0.6	0.7	0.7	10.3	0.5	11.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	23.9	31.4	0.0	184.0	3.3	8.8	0.0	0.0	0.0	0.0	10.8	7.2	0.0	0.0	1.1	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	16.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	501.8	0.0	0.0	0.0
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.9;placenta: 55.0"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 40.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	8.0	4.4	0.0	0.0	4.9	0.9	0.6	43.9	0.2	2.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	55.0	0.0	0.8	1.4	0.1	5.1	0.0	0.0	13.8	10.4	0.0	0.0	0.0	0.9	1.2	0.0	0.1	0.0	22.0	19.8	4.9	16.1	0.7	0.0	2.4	0.1	0.2	1.7	0.3	7.1	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.1	25.1	16.9	0.1	5.1	0.0	0.1	6.3	0.0	4.5	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.2	4.0	0.0	0.0	0.0	0.1	0.3	1.6	0.3	0.0	0.0	3.0	0.0	1.2	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.5	0.7	1.7	0.7	0.0	0.6	0.5	0.5	2.4	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	4.9	1.7	1.8	0.0	0.0	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0
CRYBG3	DKFZp667G2110	ENSG00000080200	"Crystallin beta-gamma domain containing 3"	Q68DQ2	3	97822040-97944963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 113.3;Early spermatids: 95.6;Late spermatids: 103.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 1.9;classical monocyte: 3.0;intermediate monocyte: 1.8;myeloid DC: 2.6;non-classical monocyte: 1.9;plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 7.1;granulocytes: 1.9;monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.3"					"Low region specificity"	"Detected in many"			HPA075635			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA075635: "	"unprognostic (1.88e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.10e-2)"	"unprognostic (3.41e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.86e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (1.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.38e-3)"	19.9	5.1	6.4	13.4	20.9	1.9	13.1	1.6	13.0	14.6	19.2	8.2	12.1	6.0	10.4	7.4	13.9	9.0	8.6	14.9	9.1	5.3	8.2	5.3	11.3	6.5	28.4	5.1	8.7	8.5	10.2	7.4	15.8	15.0	12.9	11.9	4.7	10.6	9.0	21.5	19.5	8.4	10.1	20.3	7.8	11.1	19.2	20.5	2.0	39.7	12.3	7.0	11.2	16.9	0.5	7.1	1.9	3.0	0.1	0.6	0.5	11.4	4.3	2.5	3.0	8.0	8.6	4.5	4.1	3.6	3.0	4.5	0.3	3.8	0.1	1.4	6.9	4.6	7.4	4.9	3.4	5.7	14.0	2.7	2.8	1.9	1.4	4.2	4.2	0.7	5.6	3.5	3.7	4.2	4.8	5.7	0.9	0.2	2.2	5.1	0.1	1.5	0.4	2.2	3.3	4.0	0.0	8.8	1.4	4.3	7.6	28.3	2.0	8.6	3.3	2.8	1.7	3.0	4.6	7.7	6.5	5.0	3.7	4.9	3.6	0.1	2.6	6.8	2.5	4.1	1.9	3.0	0.1	0.3	1.8	0.5	0.2	0.6	0.4	2.6	0.5	0.2	0.4	0.0	0.1	1.9	7.1	0.1	0.5	6.4	20.9	1.6	13.0	9.1	5.3	28.4	5.1	15.0	20.5	29.8	18.7	0.0	5.9	4.5	113.3	36.3	2.5	36.1	27.3	17.4	5.9	2.9	1.7	7.7	95.6	22.6	3.2	0.0	11.4	8.6	6.2	6.7	0.0	5.0	6.0	12.7	12.2	15.4	14.3	103.5	7.8	11.0	8.5	13.6	8.9	36.4	13.1	10.4	4.2	1.7	7.3	38.8	8.2	40.4	6.8	5.4	1.9	0.0	4.4	6.4
CRYGB	CRYG2	ENSG00000182187	"Crystallin gamma B"	P07316	2	208142573-208146168	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ovarian cancer: 1.1;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.1;NTERA-2: 2.8;SuSa: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (6.73e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.5	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYGC	CRYG3	ENSG00000163254	"Crystallin gamma C"	P07315	2	208128137-208129830	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 5.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1.6;Late spermatids: 2.9;Spermatocytes: 1.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8;ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;CACO-2: 1.0;EFO-21: 2.0;U-2 OS: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (1.89e-1)"					"unprognostic (2.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0
CRYGD	CRYG4	ENSG00000118231	"Crystallin gamma D"	P07320	2	208121607-208124501	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"ovary: 17.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 10.1;Muller glia cells: 30.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"HEL: 15.4"					"Not detected"	"Not detected"			"HPA041269, HPA043386"	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA041269: AB_2732491, HPA043386: "					"unprognostic (4.49e-2)"						"unprognostic (2.64e-1)"				"unprognostic (3.62e-1)"			0.2	0.2	4.2	0.2	2.0	2.3	0.2	0.0	2.5	0.2	0.2	0.3	0.0	0.4	0.2	0.2	0.3	0.3	0.2	0.6	2.1	4.3	0.2	0.2	0.2	0.2	4.0	1.6	17.7	0.2	0.2	0.4	0.5	1.9	2.0	0.2	2.1	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.2	0.5	1.4	0.5	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.2	2.0	0.0	2.5	2.1	4.3	4.0	1.6	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 104.0;liver: 80.8"	"Cell type enhanced"	"Detected in many"	15	"Distal tubular cells: 411.1;Hepatocytes: 272.9;Proximal tubular cells: 848.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040403	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		210000	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	9.8	8.9	21.5	8.8	22.9	3.5	7.0	10.4	17.4	11.8	35.1	26.7	18.9	61.0	9.2	18.0	7.4	9.3	16.1	9.3	18.8	19.8	104.0	80.8	6.8	5.9	24.5	12.3	7.3	15.4	5.3	10.4	5.6	16.8	11.2	16.5	17.2	13.1	20.1	5.4	4.1	45.7	8.0	32.0	6.5	12.0	2.7	16.4	3.2	11.9	5.6	5.5	8.6	5.9	9.3	25.7	1.8	24.3	6.0	15.6	17.5	3.3	2.9	2.5	18.4	14.1	16.3	2.5	4.7	8.5	2.1	1.7	1.1	3.1	0.0	9.1	6.5	4.8	0.8	2.5	4.2	2.1	8.1	2.0	5.9	0.3	23.0	8.1	1.9	5.4	9.6	2.7	1.5	9.7	7.6	22.3	8.7	0.4	2.3	5.5	12.1	5.1	3.0	0.1	28.9	4.5	2.6	1.6	0.4	17.8	7.1	1.8	2.2	2.8	1.3	21.2	1.3	9.1	7.6	21.3	2.6	1.2	6.3	2.9	3.3	0.6	0.0	4.9	3.3	10.5	1.8	21.8	1.4	10.5	24.3	8.5	9.3	14.0	10.0	25.7	9.1	11.0	10.2	0.7	6.0	20.1	2.8	15.6	17.5	21.5	22.9	10.4	17.4	18.8	19.8	24.5	12.3	16.8	16.4	6.0	6.4	19.9	13.2	9.2	5.0	9.8	48.4	10.7	6.8	73.3	11.8	18.1	411.1	21.5	2.6	23.7	181.3	0.0	27.8	9.4	16.4	23.5	24.3	272.9	59.4	1.6	8.7	49.1	76.7	2.9	24.2	36.1	35.4	11.8	69.9	93.7	32.1	152.6	22.6	848.9	10.8	19.4	12.3	0.9	0.2	8.2	17.4	15.3	78.8	12.2
CRYZL1	"4P11, QOH-1"	ENSG00000205758	"Crystallin zeta like 1"	O95825	21	33589341-33643926	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019120, HPA029399, CAB034129"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.28e-3)"	18.9	17.6	32.6	14.1	27.6	18.4	19.4	36.6	32.4	20.5	21.5	24.8	13.2	13.4	26.9	18.0	17.6	17.2	15.1	17.9	26.4	23.0	21.6	16.0	14.5	14.7	30.8	19.4	20.4	13.6	18.5	27.7	19.3	25.2	17.3	18.8	17.2	15.2	21.7	15.5	20.9	13.3	19.8	29.9	13.2	15.6	28.9	27.0	18.2	22.6	9.7	13.4	20.8	15.6	27.5	30.7	24.8	26.1	31.5	33.8	18.2	20.9	9.3	26.6	19.6	14.4	20.9	13.5	15.0	21.6	19.2	17.3	13.6	16.7	14.8	13.6	18.3	14.9	11.7	14.0	15.4	17.6	13.7	14.7	27.2	19.9	12.3	22.7	17.1	17.4	19.6	13.6	20.3	15.9	25.4	24.1	24.4	20.1	15.4	17.9	10.7	16.5	17.7	18.6	21.7	12.6	15.9	21.3	20.4	27.1	18.9	11.6	18.3	19.7	9.9	21.4	23.3	19.7	12.7	25.4	15.6	14.9	12.8	11.6	25.3	34.8	16.1	20.3	12.8	17.3	21.7	25.2	24.8	24.2	26.1	25.9	26.5	25.9	22.5	30.7	27.5	33.8	27.4	14.4	31.5	23.7	24.2	20.3	18.2	32.6	27.6	36.6	32.4	26.4	23.0	30.8	19.4	25.2	27.0	29.8	15.9	13.6	40.2	20.9	45.3	22.7	35.7	21.4	19.4	29.6	29.5	59.3	41.4	31.7	56.7	31.7	21.2	0.0	25.5	34.3	29.6	18.4	62.5	10.9	28.8	44.5	20.2	20.3	22.2	20.6	40.9	28.3	35.4	34.3	18.6	41.5	22.8	28.1	38.5	36.3	49.0	19.4	44.3	79.9	15.5	18.7	37.3	25.5	29.9	33.3
CSDC2	PIPPin	ENSG00000172346	"Cold shock domain containing C2"	Q9Y534	22	41560763-41577741	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 84.8;ovary: 48.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 64.6;Muller glia cells: 39.5;Proximal tubular cells: 29.3;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HeLa: 8.1;U-2 OS: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003073, HPA076549"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003073: AB_1078578, HPA076549: AB_2686807"	"unprognostic (9.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (6.42e-4)"	"unprognostic (8.86e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.09e-3)"	2.5	39.0	4.7	2.1	9.6	1.1	1.2	30.5	15.3	16.8	2.6	2.7	5.5	1.6	18.4	2.0	2.2	4.1	2.6	84.8	6.0	8.5	9.9	1.2	2.8	1.1	9.0	6.0	48.5	25.5	1.1	4.1	1.3	17.7	5.3	1.4	5.6	1.4	11.7	1.5	1.1	1.5	9.1	10.5	1.2	1.6	11.1	3.4	0.0	1.1	0.3	1.0	5.8	6.2	1.0	1.0	1.7	1.1	0.4	1.6	0.7	0.0	0.1	1.0	0.1	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	3.1	0.3	0.1	0.0	0.0	0.0	0.0	2.1	0.0	8.1	0.9	2.4	0.0	0.0	1.3	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.7	0.1	0.0	0.0	0.1	0.7	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.1	29.6	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	1.0	1.0	1.7	1.3	1.1	0.5	1.0	0.8	0.7	1.0	1.0	1.5	0.7	1.0	0.4	0.9	0.2	1.6	0.7	4.7	9.6	30.5	14.7	6.0	8.5	9.0	6.0	17.7	3.4	0.0	0.0	0.0	0.2	0.2	8.1	64.6	0.0	1.4	0.0	7.0	2.0	0.1	16.6	0.3	1.1	0.1	0.0	0.0	9.2	0.1	1.9	0.1	0.0	0.0	0.2	6.4	0.0	0.6	0.0	3.6	4.9	0.0	1.7	0.0	0.0	39.5	2.3	0.0	2.5	29.3	3.1	71.1	22.6	0.2	0.2	0.1	0.2	0.0	0.0	0.0
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.5;lymphoid tissue: 82.6"	"Group enriched"	"Detected in many"	8	"Extravillous trophoblasts: 97.9;Hofbauer cells: 277.3;Kupffer cells: 200.7;Macrophages: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 60.7;non-classical monocyte: 82.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 82.5"	"Group enriched"	"Detected in some"	5	"BEWO: 51.8;SK-BR-3: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1500000000	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	20.9	12.4	18.2	28.1	18.9	1.8	7.7	2.8	13.5	9.3	8.3	25.4	1.1	9.2	5.9	13.1	8.4	7.9	16.1	8.7	16.4	13.7	7.8	15.1	13.7	25.4	21.3	6.0	5.3	5.2	5.9	6.4	52.1	17.1	8.5	8.4	16.8	8.0	8.7	3.0	5.8	14.5	16.2	25.8	82.6	9.0	4.9	23.0	3.1	4.2	2.9	8.2	16.4	4.7	0.0	19.1	2.9	82.5	0.0	0.1	13.9	1.7	0.0	0.0	0.0	0.8	0.2	51.8	0.1	0.0	0.0	0.0	1.5	0.0	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.8	0.0	7.4	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.0	2.6	0.9	0.0	0.4	18.1	0.5	0.1	60.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	2.9	0.0	82.5	1.4	0.0	13.9	18.2	18.9	2.8	13.4	16.4	13.7	21.3	6.0	17.1	23.0	0.0	6.7	0.5	0.0	2.5	0.0	2.8	5.1	1.4	0.0	0.0	0.0	2.9	0.0	0.0	3.7	2.2	0.0	0.0	0.0	97.9	3.3	0.0	2.3	0.8	277.3	0.0	0.0	4.9	200.7	3.5	1.7	125.7	3.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	12.9	1.3	0.5	0.2	1.1	22.1	2.2	0.0	0.0
CSF2RB	"betaGMR, CD131, IL3RB, IL5RB"	ENSG00000100368	"Colony stimulating factor 2 receptor beta common subunit"	P32927	22	36913628-36940449	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.1;placenta: 73.6"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 32.6;granulocytes: 87.9;Macrophages: 41.6;monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.1;neutrophil: 20.1"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 53.1"	"Group enriched"	"Detected in some"	6	"HEL: 27.0;HMC-1: 84.6"					"Low region specificity"	"Detected in all"			HPA078677			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA078677: AB_2732389"	"unprognostic (1.67e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.47e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (5.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.52e-2)"	8.5	1.8	1.5	28.9	1.5	21.7	6.0	0.6	1.0	3.0	5.9	2.0	0.4	4.5	2.2	2.8	4.0	3.6	5.5	4.2	1.4	1.4	2.4	3.5	12.6	34.1	2.9	0.2	2.5	1.9	0.3	1.2	73.6	2.4	3.5	3.8	2.8	9.7	1.0	2.6	3.8	10.2	3.0	2.9	25.2	3.9	2.1	1.9	8.2	3.4	4.8	30.5	8.2	4.3	0.4	3.8	53.1	2.1	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	27.0	0.0	0.0	0.0	0.4	84.6	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	3.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.7	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.4	0.1	0.2	0.0	0.0	0.0	0.4	0.2	1.7	0.0	3.9	0.0	53.1	1.9	5.8	0.0	2.1	0.0	0.4	0.0	0.0	1.2	0.3	0.0	0.0	20.1	0.0	1.7	3.8	0.6	1.8	1.5	1.5	0.6	1.0	1.4	1.4	2.9	0.2	2.4	1.9	0.0	14.5	8.2	0.0	6.4	0.0	0.8	5.1	5.3	3.4	0.0	0.0	2.2	0.0	0.0	11.1	9.0	0.0	0.0	0.2	32.6	4.1	0.0	87.9	0.0	16.8	0.0	0.0	4.3	26.0	26.5	0.0	41.6	11.8	29.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	5.5	13.8	1.3	0.0	0.0
CSGALNACT1	"ChGn, CSGalNAcT-1, FLJ11264"	ENSG00000147408	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1"	Q8TDX6	8	19404161-19758029	"Enzymes, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 57.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 41.5;Endothelial cells: 33.7;Glandular cells: 33.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 22.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 20.1;granulocytes: 10.3;T-cells: 25.5"	"Cell line enhanced"	"Detected in some"		"A549: 29.0;BJ hTERT+: 16.3;GAMG: 11.7;RPTEC TERT1: 20.3;U-2197: 18.5;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068462			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"		"HPA068462: "	"unprognostic (8.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.17e-3)"	"unprognostic (9.78e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.02e-2)"	13.8	8.7	22.7	6.0	15.4	6.8	7.2	3.8	21.4	13.0	3.8	9.2	4.0	2.8	7.1	5.9	21.2	8.7	10.8	23.8	17.7	8.2	5.3	2.3	7.9	10.5	9.1	18.7	38.6	10.9	4.2	5.9	25.1	7.0	21.7	2.1	2.6	5.8	7.3	3.9	4.2	4.2	17.2	8.6	6.3	5.4	2.7	10.3	4.0	57.7	4.5	6.1	18.9	9.7	20.1	1.7	10.3	1.2	3.2	25.5	4.8	0.7	29.0	0.2	0.0	4.8	1.1	3.7	0.6	16.3	0.1	0.1	1.4	0.3	0.0	0.0	0.0	11.7	0.3	0.0	0.0	0.1	3.6	0.2	0.0	8.3	0.7	2.1	0.0	0.0	0.4	0.7	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	1.2	1.1	0.1	0.0	3.6	0.9	0.1	0.0	0.0	20.3	0.7	0.1	0.1	8.5	3.4	1.1	0.6	0.0	0.0	0.3	0.4	0.4	18.5	0.2	0.1	0.0	0.0	13.4	1.6	5.6	0.0	1.2	10.3	2.5	0.0	0.3	20.1	11.5	3.9	1.1	6.2	20.6	5.2	7.1	3.2	0.1	1.7	25.5	4.8	22.7	15.4	3.8	21.4	17.7	8.2	9.1	18.7	7.0	10.3	3.0	1.4	8.2	8.2	3.9	0.4	41.5	0.0	2.7	1.2	12.2	9.8	1.4	1.7	3.7	5.5	33.7	0.0	0.0	1.5	13.5	20.0	33.6	0.0	0.0	12.0	17.5	2.9	20.3	21.2	5.9	4.9	5.1	11.8	0.0	0.0	0.9	3.0	0.0	11.3	0.0	1.0	6.5	7.2	0.1	0.0	2.8	7.0	2.2	0.0	2.1
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138486-43185308	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 62.0;Macrophages: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	18.3	8.2	9.0	16.4	13.0	80.6	11.5	10.0	10.9	11.4	12.5	17.6	4.8	6.8	14.7	7.5	9.8	12.8	18.4	11.5	10.0	9.0	8.2	11.3	24.0	25.7	11.0	6.2	16.2	6.3	7.8	15.0	18.3	11.5	10.4	8.9	19.8	7.9	8.6	12.5	8.1	9.6	15.7	14.4	21.1	8.7	6.7	9.6	24.3	9.2	6.6	12.2	17.8	11.0	2.5	11.6	15.2	16.3	8.7	6.3	5.1	4.9	3.3	6.2	5.9	9.7	16.4	1.5	18.1	24.4	8.0	12.5	1.1	5.1	8.2	4.5	16.3	3.8	4.6	5.1	6.8	13.1	9.8	3.8	4.3	3.1	3.4	21.2	9.9	9.0	16.3	7.5	17.8	37.3	10.1	10.2	12.5	1.8	24.7	16.3	2.6	7.5	5.9	2.7	1.7	4.3	4.7	6.2	3.4	7.1	2.6	5.6	11.1	4.7	4.8	11.3	5.6	6.4	8.2	15.0	6.9	10.9	21.5	12.1	6.4	8.9	4.4	14.6	24.3	3.2	10.7	9.8	15.2	6.3	11.4	5.5	2.5	4.9	4.9	11.6	2.2	5.8	4.8	9.0	8.7	16.3	3.4	5.6	5.1	9.0	13.0	10.0	10.9	10.0	9.0	11.0	6.2	11.5	9.6	14.9	16.0	7.2	10.1	15.8	11.9	9.2	2.5	6.7	14.8	10.4	9.8	1.9	0.0	5.4	2.1	14.0	1.4	0.0	6.0	5.6	26.7	10.2	46.2	10.4	15.8	7.9	8.6	14.1	62.0	0.4	15.8	59.7	8.5	7.2	2.1	4.4	9.8	1.7	11.7	3.4	8.3	25.8	25.1	11.7	17.2	10.7	1.3	32.8	1.6	6.0
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 91.8;Kupffer cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		1500000	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	9.3	8.0	9.5	39.3	11.0	19.9	12.6	18.7	13.4	12.1	13.5	11.8	7.3	16.1	13.9	6.4	33.3	10.6	11.2	14.0	9.8	8.5	8.0	20.9	15.6	67.2	11.1	7.4	10.5	6.7	6.6	10.4	8.8	12.2	9.8	8.9	9.8	13.2	7.0	8.7	14.9	26.2	8.5	10.9	62.7	13.1	8.1	10.6	62.7	8.1	9.5	47.4	17.4	13.2	35.6	22.8	49.6	46.8	16.3	30.7	19.9	12.9	18.3	9.0	14.7	8.6	6.6	7.7	8.7	8.4	16.6	11.8	16.7	12.0	58.0	11.5	7.8	15.4	13.5	18.8	17.5	4.7	28.1	23.2	49.1	6.7	16.7	11.9	25.6	62.6	9.3	8.7	11.8	10.6	8.3	12.5	27.4	14.1	20.2	9.8	21.9	18.4	15.1	11.1	11.7	13.1	20.5	7.7	42.3	7.6	28.8	14.9	10.3	11.3	23.7	15.1	6.0	16.3	37.8	10.8	20.1	10.6	15.7	15.0	10.8	21.8	59.2	10.4	49.0	13.6	20.7	19.7	49.6	23.4	42.4	20.0	29.4	20.3	23.1	22.8	35.6	15.7	18.4	39.1	16.3	46.8	13.2	30.7	19.9	9.5	11.0	18.7	13.4	9.8	8.5	11.1	7.4	12.2	10.6	3.0	11.6	91.8	7.2	8.2	16.5	8.1	12.7	5.3	6.8	8.7	5.9	6.3	1.7	8.5	10.0	11.5	27.7	0.0	12.0	11.0	7.6	9.3	25.5	25.0	46.4	27.0	9.1	12.3	77.9	2.1	8.3	44.5	8.5	36.9	25.3	6.5	15.2	17.3	7.8	6.8	4.1	6.5	8.5	3.8	11.3	8.0	4.7	60.9	22.8	10.5
CSMD1	"KIAA1890, PPP1R24"	ENSG00000183117	"CUB and Sushi multiple domains 1"		8	2935353-4994972	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"brain: 29.5;testis: 9.0"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 8.4;Ciliated cells: 17.4;Early spermatids: 38.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"K-562: 9.0;U-2 OS: 4.4;U-266/70: 4.3;U-266/84: 3.9;U-698: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074707			Approved	Vesicles		NA	NA			Vesicles		"HPA074707: AB_2686707"	"unprognostic (6.32e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.67e-3)"	"unprognostic (5.72e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.11e-1)"	1.0	1.1	20.4	0.8	21.1	0.8	1.4	6.3	29.5	2.5	0.8	1.7	0.0	1.0	1.2	0.9	0.8	3.2	0.8	0.7	12.9	4.5	2.7	0.7	1.4	0.9	3.9	18.2	0.9	0.9	0.7	0.7	2.8	3.4	1.1	0.8	0.0	0.7	1.5	1.1	1.0	1.0	1.7	2.4	2.8	0.8	9.0	2.4	0.0	1.1	0.0	0.9	1.1	0.5	0.0	0.9	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	4.4	0.0	0.0	4.3	3.9	3.7	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	20.4	21.1	6.3	29.5	12.9	4.5	3.9	18.2	3.4	2.4	0.0	0.3	0.0	0.0	0.2	8.4	1.6	0.0	17.4	1.2	1.8	0.0	2.4	0.0	0.0	38.6	0.4	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.6	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.7	0.5	0.0	0.0	7.1	5.4	0.1	3.0	0.0	0.0	0.0
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492197-149551552	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 741.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB016680: AB_1614518, HPA051334: AB_2681446"	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	33.5	35.8	26.0	26.9	35.2	71.0	40.2	32.0	39.3	33.8	38.2	28.2	40.5	23.2	41.0	29.4	66.1	31.8	36.0	45.7	24.4	26.1	24.0	30.1	37.5	27.3	28.0	29.8	31.7	23.9	46.9	30.9	28.7	38.0	38.1	31.4	25.5	38.5	39.3	51.4	48.4	31.8	45.8	33.9	23.6	34.2	28.6	24.1	38.6	32.0	53.1	41.1	45.0	40.0	28.6	40.6	47.4	39.6	34.2	41.9	40.8	36.9	24.7	41.6	39.4	43.0	52.7	44.5	52.8	50.2	41.2	43.4	48.1	50.1	19.7	58.5	56.1	44.2	37.8	29.3	71.1	63.0	28.5	17.7	26.7	28.6	22.1	38.7	41.8	43.0	43.1	73.8	46.2	74.5	45.6	47.4	35.6	22.5	29.7	46.4	23.2	38.3	16.9	21.8	40.9	60.2	28.7	33.0	22.4	28.7	64.4	32.1	28.9	39.2	52.6	64.3	38.5	49.3	36.4	47.0	48.5	25.5	32.1	50.3	27.6	35.4	30.4	45.3	30.4	58.6	47.4	36.6	35.4	29.0	38.7	33.1	28.6	36.7	32.9	40.6	23.4	39.9	34.0	31.1	34.2	39.6	24.2	41.9	40.8	26.0	35.2	32.0	39.3	24.4	26.1	28.0	29.8	38.0	24.1	137.0	158.5	75.9	513.8	608.0	132.0	46.4	73.9	278.4	290.0	109.9	60.9	146.8	77.9	135.8	55.7	139.6	98.3	23.3	160.7	185.9	198.0	381.5	112.3	94.7	120.9	143.0	124.9	225.9	143.6	66.9	96.4	139.7	145.1	118.2	136.8	145.0	155.3	98.2	105.0	78.9	100.0	155.2	201.9	125.6	93.5	741.0	293.5	102.2	111.1	404.2
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 287.2;Late spermatids: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	30.1	36.3	30.8	25.9	30.8	21.0	26.3	36.3	42.8	30.9	33.0	27.7	32.9	32.6	37.9	29.8	31.3	38.0	34.9	28.5	26.2	26.9	32.0	33.5	30.1	25.8	27.2	27.8	31.4	42.8	34.2	35.9	32.8	30.3	35.3	19.3	28.4	38.0	37.7	52.3	26.7	42.3	34.1	21.4	36.4	32.5	48.3	24.6	29.2	33.0	31.8	33.7	31.4	26.1	6.4	11.4	29.6	12.1	8.7	7.6	7.1	21.6	25.8	14.7	20.3	19.4	20.8	29.6	31.9	20.1	22.9	21.5	21.2	18.7	19.8	25.3	22.7	24.3	21.0	13.8	32.3	18.5	16.8	33.4	24.6	20.5	22.6	56.4	20.2	18.9	31.4	23.0	15.5	23.2	28.6	33.3	14.7	27.7	10.5	21.6	25.3	26.0	21.2	15.8	25.7	40.7	22.4	18.2	17.6	24.1	34.0	18.2	32.9	38.1	31.8	35.7	21.4	22.8	26.6	35.1	32.9	29.6	28.6	24.2	23.1	11.1	21.2	26.4	17.3	23.8	4.7	11.0	14.6	7.6	12.1	7.4	6.4	5.9	7.3	11.4	5.6	5.0	5.3	29.6	8.7	11.1	5.5	5.2	7.1	30.8	30.8	36.3	42.8	26.2	26.9	27.2	27.8	30.3	24.6	44.7	51.2	45.8	92.5	50.4	45.6	14.1	25.5	64.3	62.6	40.1	25.5	56.2	28.2	62.7	287.2	39.4	93.0	0.0	60.1	78.4	37.7	85.7	57.8	25.6	57.5	90.6	44.4	40.5	51.6	600.1	27.9	56.2	27.0	73.1	56.1	34.9	72.9	48.0	37.8	40.4	47.4	38.8	58.6	35.2	26.6	42.2	105.8	64.7	38.3	96.3
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 208.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (2.32e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.95e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (2.08e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.16e-3)"	"prognostic unfavorable (4.67e-6)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.25e-3)"	28.5	22.9	30.7	18.3	32.5	21.4	28.6	40.1	42.6	26.4	21.5	32.3	15.7	19.0	37.3	27.3	23.4	28.0	22.1	28.8	31.7	22.3	17.3	11.8	28.4	17.3	28.6	30.1	38.1	25.4	56.2	29.2	33.1	28.7	26.2	17.4	30.5	23.9	23.1	26.3	35.3	17.1	24.0	23.2	20.9	21.8	13.0	33.9	13.3	21.4	14.2	17.4	25.5	28.8	3.7	15.7	4.8	1.8	5.9	4.0	1.2	23.6	11.5	31.3	30.0	15.7	24.1	23.6	30.9	39.5	28.1	27.3	14.8	18.5	17.8	13.5	29.1	18.9	20.2	23.7	42.7	20.4	28.4	51.7	5.7	38.1	11.3	32.3	12.4	15.2	23.0	36.2	42.8	58.0	36.9	29.8	15.6	12.6	36.8	27.1	15.8	17.3	15.3	22.9	17.2	16.7	32.4	22.4	27.9	25.8	19.9	46.4	18.2	26.3	27.3	30.8	19.4	13.9	18.1	33.9	25.5	27.8	14.7	24.6	16.5	23.6	25.1	37.8	14.0	42.6	3.8	1.8	3.4	3.4	0.8	4.0	2.5	3.8	3.4	1.8	3.7	2.1	3.1	4.8	5.9	0.6	15.7	1.7	1.2	30.7	32.5	40.1	38.8	31.7	22.3	28.6	30.1	28.7	33.9	35.7	17.1	22.2	117.4	69.8	122.3	44.0	38.2	16.0	23.9	22.7	56.9	29.6	6.6	26.6	42.8	62.1	10.7	0.0	35.7	33.5	53.2	138.6	3.5	18.6	19.2	68.3	60.3	44.8	14.9	42.7	79.1	18.5	57.3	11.8	40.8	105.4	42.3	29.6	62.2	4.1	58.4	71.1	106.1	6.0	9.6	91.6	104.9	13.4	31.9	208.0
CSNK1G2	CK1g2	ENSG00000133275	"Casein kinase 1 gamma 2"	P78368	19	1941149-1981338	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 218.1;Late spermatids: 503.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034868, HPA056572"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034868: AB_10671235, HPA056572: AB_2683178"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.51e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.83e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-2)"	18.7	22.2	24.8	34.9	19.5	38.1	16.7	30.8	28.9	14.1	19.0	18.2	18.9	27.0	16.5	19.0	22.1	16.9	20.4	16.0	23.3	18.3	19.3	17.9	21.8	35.1	17.3	21.2	18.6	27.0	11.4	24.4	16.7	18.7	18.7	8.7	19.7	26.6	16.0	29.0	23.3	22.1	15.1	12.7	39.1	24.1	58.5	17.4	20.6	16.5	18.1	32.2	17.1	17.1	4.0	5.9	11.2	14.1	3.5	4.9	2.3	23.3	12.6	17.5	27.5	6.2	11.6	14.7	14.5	9.6	11.1	13.6	10.3	12.8	14.7	12.2	9.2	6.1	16.9	9.4	17.7	4.9	13.3	20.4	10.4	20.5	17.4	9.9	16.5	26.4	11.5	11.7	11.5	7.4	8.5	13.1	18.4	21.7	50.6	7.3	13.6	32.8	21.8	31.8	6.5	14.2	28.6	11.1	23.8	8.3	24.6	28.3	23.2	11.0	18.1	16.0	6.9	11.5	27.3	15.6	14.0	11.0	29.3	16.8	32.7	17.3	18.0	14.2	15.7	14.6	2.8	4.0	5.0	4.9	6.2	3.5	3.9	3.6	4.2	3.9	4.0	2.9	4.1	11.2	3.5	14.1	5.9	2.5	2.3	24.8	19.5	30.8	28.9	23.3	18.3	17.3	21.2	18.7	17.4	14.9	17.0	12.0	15.7	19.5	44.1	10.1	7.6	13.4	14.8	10.4	39.3	9.9	8.3	15.1	218.1	19.9	22.5	0.0	25.3	17.2	15.8	22.1	29.9	14.0	12.9	23.8	29.2	14.1	17.0	503.0	19.0	20.5	13.5	5.4	20.2	21.3	24.4	16.5	17.7	12.6	37.2	12.9	14.4	15.6	13.1	22.1	15.2	27.3	18.0	28.5
CSNK2A3	CSNK2A1P	ENSG00000254598	"Casein kinase 2 alpha 3"	Q8NEV1	11	11351942-11353357	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 11.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 5.6"									"HPA059206, HPA061698"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.25e-4)"	"unprognostic (4.36e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.38e-2)"	4.6	1.6	1.3	2.8	1.3	0.6	1.9	1.6	5.5	2.8	3.8	0.5	2.1	3.4	1.8	3.8	3.4	1.1	1.6	2.3	1.5	1.2	5.4	3.0	3.7	1.0	1.1	0.7	2.0	1.4	0.6	1.7	2.9	2.0	2.2	0.7	2.1	1.7	3.6	5.3	1.9	2.9	2.9	1.2	0.9	1.3	3.5	0.3	3.6	1.6	1.8	2.7	1.8	1.3	0.7	0.9	1.1	0.6	0.8	1.0	1.2	5.6	1.2	0.2	2.1	0.0	0.0	0.7	0.5	0.3	0.3	0.3	0.0	0.3	0.0	0.4	0.0	1.6	1.9	1.0	0.8	0.0	0.2	0.3	0.0	0.2	0.5	0.0	0.2	0.4	0.6	0.4	0.0	0.6	0.1	0.0	0.8	0.4	0.8	0.7	0.6	1.3	0.7	1.7	0.4	3.0	0.9	0.2	1.0	0.6	1.0	0.5	1.2	1.6	3.2	0.6	0.2	1.2	0.4	0.7	0.9	1.2	0.4	0.6	0.5	0.9	0.8	2.6	0.2	2.6	0.7	0.5	1.1	0.6	0.6	0.9	0.7	0.4	0.7	0.9	0.7	1.0	0.3	0.1	0.8	0.6	0.7	0.7	1.2	1.3	1.3	1.6	5.5	1.5	1.2	1.1	0.7	2.0	0.3	3.0	0.3	0.0	0.8	1.5	1.0	11.1	0.0	1.4	1.2	3.5	0.0	0.6	0.0	0.7	1.7	1.6	0.4	0.0	0.7	0.4	0.5	1.0	1.1	0.0	0.2	3.2	1.2	0.6	1.0	1.4	0.6	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.0	0.6	0.5	0.0	0.7	0.6	0.9	0.9	0.8	0.8	0.4	0.5
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562239-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 81.1"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 28.1;Muller glia cells: 86.9;Rod photoreceptor cells: 19.5;Spermatocytes: 17.2"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.8;HEK 293: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	1.8	1.8	30.6	1.3	25.8	1.1	1.6	7.2	81.1	1.3	1.4	6.7	0.0	1.1	1.3	1.2	1.3	1.4	1.2	1.3	20.2	17.1	1.2	1.2	1.7	1.3	12.9	12.6	1.1	1.4	1.1	0.2	1.8	5.6	1.5	1.3	8.0	1.1	1.1	1.5	1.6	1.3	1.4	6.2	1.1	1.2	2.2	4.1	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	26.8	4.7	0.5	0.0	0.7	0.5	0.1	1.0	0.3	0.2	1.6	0.1	2.1	0.0	2.0	0.4	2.2	0.2	0.2	0.0	7.4	0.4	1.1	0.0	0.0	0.3	1.2	0.0	0.9	0.1	0.0	0.7	0.0	0.9	5.2	0.2	0.1	1.2	0.2	0.3	2.6	1.9	2.7	0.4	0.2	0.6	1.1	0.9	2.8	1.3	1.7	3.4	0.1	0.7	1.3	2.4	0.2	0.0	5.6	0.1	1.5	0.6	0.6	0.0	0.4	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	25.8	7.2	22.4	20.2	17.1	12.9	12.6	5.6	4.1	3.0	1.3	0.0	0.1	0.7	28.1	1.2	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.5	0.2	6.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	86.9	0.2	0.0	0.0	0.0	19.5	0.0	0.2	17.2	1.0	0.5	0.1	0.0	0.2	0.1
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: AB_2683726"	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.07e-4)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	33.5	24.9	5.9	16.4	11.5	70.1	20.4	4.9	8.6	16.2	14.4	11.4	13.9	5.1	12.9	9.6	25.9	35.8	28.7	19.7	5.4	5.3	9.6	33.3	35.7	7.9	8.8	3.3	24.9	16.3	11.7	17.6	30.9	15.3	15.8	6.8	9.7	10.9	50.1	22.4	19.9	21.0	26.9	11.9	9.2	20.3	11.4	7.5	8.9	14.5	14.6	7.8	21.4	16.9	3.6	3.9	15.9	9.2	2.2	2.5	1.9	2.3	5.3	1.4	2.7	2.7	2.8	4.4	8.7	12.3	7.3	6.0	7.5	2.2	7.8	1.9	6.6	5.3	2.7	1.6	11.6	3.6	11.6	2.2	8.9	4.3	5.6	3.3	2.2	8.9	1.3	6.3	11.5	1.8	6.6	9.9	2.1	6.7	13.9	6.0	7.5	0.4	3.6	6.4	4.0	4.5	3.6	5.8	12.7	5.8	8.7	3.9	0.6	4.8	36.2	2.9	8.6	4.0	4.1	4.9	3.7	16.0	3.1	6.4	3.6	3.0	3.6	8.2	2.8	4.6	0.1	2.7	3.2	1.7	5.6	2.1	3.6	1.6	1.9	3.0	3.6	2.0	1.3	15.9	2.2	9.2	3.9	2.5	1.9	5.9	11.5	4.9	8.6	5.4	5.3	8.8	3.3	15.3	7.5	44.7	66.0	21.2	65.0	91.8	1.4	12.9	17.8	9.4	17.0	10.4	0.0	13.0	8.3	30.2	47.7	63.8	51.3	23.3	34.0	40.3	70.9	58.0	96.7	34.8	35.2	0.0	56.9	49.7	35.1	34.1	1.4	49.4	65.8	20.8	34.8	4.3	37.1	28.1	3.9	4.8	1.6	12.9	150.2	0.2	3.2	69.5	75.9	27.7	25.5	32.3
CSRNP2	"C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12"	ENSG00000110925	"Cysteine and serine rich nuclear protein 2"	Q9H175	12	51061205-51083664	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018503, HPA019914"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA018503: AB_1845535, HPA019914: AB_2670315"	"unprognostic (8.67e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.74e-2)"	"prognostic favorable (2.78e-4)"	13.7	12.3	14.7	8.0	16.5	3.5	22.2	23.3	26.4	13.3	9.2	11.4	6.0	7.6	16.1	14.2	9.0	9.6	13.3	11.8	14.0	16.2	10.4	7.9	9.7	9.3	12.7	13.5	14.7	10.4	11.2	15.7	12.8	13.3	11.3	8.2	11.7	8.6	12.8	15.8	8.9	7.1	16.7	11.4	9.6	8.3	32.1	12.8	12.1	13.0	8.3	7.7	11.2	9.0	1.2	0.9	2.6	0.9	5.9	2.7	0.4	5.5	6.2	19.0	16.9	14.6	10.4	20.2	10.9	12.3	15.0	10.4	11.9	4.0	4.6	10.8	11.4	10.3	6.7	9.2	5.9	12.0	10.0	7.0	5.4	7.1	3.7	16.0	3.7	8.3	12.6	16.7	17.4	10.0	16.5	14.7	21.1	7.7	8.2	17.3	9.4	12.9	5.2	15.7	2.5	9.8	7.8	12.3	3.6	8.6	7.1	13.5	16.0	15.9	12.5	15.9	14.0	7.9	10.4	13.3	15.0	8.0	10.0	7.4	9.0	9.9	4.3	9.2	5.0	4.8	0.0	0.9	2.3	1.9	0.1	0.7	1.2	2.0	1.1	0.9	0.7	2.0	2.7	2.6	5.9	0.6	0.4	1.3	0.4	14.7	16.5	23.3	23.2	14.0	16.2	12.7	13.5	13.3	12.8	3.0	5.0	4.2	10.0	15.9	6.6	14.6	2.5	4.0	2.3	5.2	23.6	5.5	3.3	6.2	18.8	15.5	9.5	0.0	4.4	6.7	12.2	9.1	11.5	2.4	5.5	6.4	7.9	11.1	5.3	11.7	5.8	5.2	15.1	3.6	5.9	5.8	6.1	5.8	7.4	3.3	7.5	0.0	24.7	30.4	15.1	14.1	12.6	5.0	5.0	4.8
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66011841-66013505	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 124.5"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 86.4;Ciliated cells: 56.2;Collecting duct cells: 55.8;Pancreatic endocrine cells: 216.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 171.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"A-431: 26.8;CAPAN-2: 74.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		110000000	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: AB_2679158"	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	0.6	0.2	0.1	1.5	0.1	0.2	8.7	0.4	0.2	5.5	0.2	0.0	1.4	0.1	0.3	0.8	11.3	4.3	0.7	2.4	0.1	0.2	1.0	0.1	27.2	1.2	0.1	0.0	1.3	0.2	0.5	0.4	26.5	0.2	0.9	0.1	1.1	1.3	26.5	0.7	124.5	0.2	0.2	0.2	0.2	0.2	1.0	0.0	2.8	14.6	13.6	4.4	0.5	3.7	0.4	0.9	0.0	1.6	0.0	0.2	0.7	26.8	0.0	0.0	0.1	0.0	0.0	8.0	0.2	0.0	0.0	0.0	0.1	74.8	0.0	0.4	0.9	0.0	0.9	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	7.5	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.7	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.2	0.0	86.4	6.7	0.0	1.2	1.0	0.0	1.0	0.0	56.2	26.1	55.8	0.0	5.9	0.0	14.5	0.1	0.1	0.0	0.0	19.3	11.2	1.9	1.4	21.8	0.0	43.3	0.0	0.0	0.0	0.3	0.5	0.0	6.5	5.0	1.8	0.0	0.8	216.2	0.0	0.4	0.2	0.0	0.0	0.4	1.4	16.7	24.1	53.7	0.0	0.0	5.4
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325244-122341972	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 312.4;tongue: 421.9"	"Cell type enhanced"	"Detected in many"	16	"Kupffer cells: 712.6;monocytes: 1063.2;Syncytiotrophoblasts: 279.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 405.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	20	"classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6"	"Group enriched"	"Detected in many"	193	"dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 33.8;hTCEpi: 149.9;THP-1: 93.6;U-698: 59.6;U-937: 29.8"									"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		39000000	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favorable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	2.0	0.2	0.3	4.4	0.8	19.8	4.5	0.2	0.5	55.4	0.4	0.2	1.1	0.0	4.7	1.7	312.4	0.2	0.7	1.0	0.3	0.0	0.4	3.4	6.8	4.8	1.1	0.2	1.8	0.2	0.0	0.3	1.3	0.5	1.3	0.1	0.3	57.4	0.7	0.7	28.2	0.3	0.4	0.7	2.0	2.2	0.3	0.6	2.2	0.3	421.9	99.0	1.5	93.5	0.1	54.6	36.0	74.6	0.2	0.2	32.0	1.7	0.1	0.0	0.4	3.9	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.7	0.0	10.5	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.8	0.8	13.6	0.2	3.8	149.9	0.3	14.7	0.0	0.0	0.1	0.1	3.6	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.8	0.0	0.0	1.6	0.9	1.2	0.0	0.1	93.6	0.0	0.2	2.4	0.0	0.1	0.0	0.2	59.6	3.2	29.8	0.0	0.7	74.6	2.2	0.0	37.5	0.2	0.1	0.1	0.1	54.6	0.0	0.0	0.1	36.0	0.2	21.6	1.0	0.1	32.0	0.3	0.8	0.2	0.5	0.3	0.0	1.1	0.2	0.5	0.6	6.0	27.0	9.0	93.6	74.1	0.0	0.0	2.5	30.8	34.2	0.0	0.0	203.1	0.0	2.0	0.2	3.5	1.3	0.0	19.8	10.9	5.6	14.2	12.8	90.0	136.3	0.0	0.0	8.0	712.6	0.6	9.5	248.7	8.5	1063.2	0.5	0.0	27.6	1.1	3.5	0.5	0.0	32.3	4.2	0.1	0.1	179.2	279.5	4.3	0.8	83.6
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell type enhanced"	"Detected in all"	7	"Hofbauer cells: 2667.6;Urothelial cells: 2153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 68.7;RT4: 87.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA		6100000	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	55.9	16.9	5.6	7.1	29.8	24.5	13.9	12.1	14.1	7.7	7.6	13.0	31.4	4.5	9.4	18.8	68.7	10.0	12.9	13.5	4.8	18.8	15.3	12.6	13.0	15.0	26.7	3.1	10.6	26.0	14.1	21.0	10.5	14.4	10.6	4.3	9.3	25.0	11.2	14.1	3.9	9.7	13.5	37.6	29.2	6.5	3.1	51.3	22.0	87.3	5.3	4.8	15.9	8.5	34.0	2.8	7.9	7.8	16.3	12.7	6.6	11.9	7.6	6.1	10.8	8.4	55.4	14.7	8.9	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1	163.8	245.7	187.7	333.5	342.3	67.2	88.0	305.8	447.0	218.4	394.3	33.4	255.6	455.9	484.2	8.1	312.8	471.8	23.3	431.0	773.3	255.1	459.8	223.9	313.1	2667.6	63.5	229.7	229.6	443.8	23.5	353.0	857.1	447.1	1223.7	177.1	98.3	684.5	378.7	310.4	313.1	54.5	116.4	179.2	37.0	105.4	520.9	336.5	191.8	261.7	2153.8
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	17	"testis: 12.5"	"Cell type enriched"	"Detected in some"	5	"Spermatogonia: 5.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 70.1;Karpas-707: 32.4"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	32.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.6	0.0	0.0	0.5	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	5.5	0.0	0.0	0.0	0.0	0.0
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 14.1"	"Cell type enriched"	"Detected in some"	16	"Spermatogonia: 57.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 33.3;K-562: 9.9;Karpas-707: 36.9;U-266/84: 31.0"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0		0.0		0.0	0.0		0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	14.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	7.3	31.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	57.9	0.0	0.0	0.0	0.0	0.0
CT45A2	"CT45-2, CT45.2"	ENSG00000271449	"Cancer/testis antigen family 45 member A2"	Q5DJT8	X	135811668-135820012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	42	"testis: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 32.7"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A3	"CT45-3, CT45-4, CT45.3, CT45.4, CT45A4"	ENSG00000269096	"Cancer/testis antigen family 45 member A3"	Q8NHU0	X	135759846-135768191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"testis: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 29.9;T-47d: 17.5;U-266/84: 90.4"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	1.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	15.6			0.0		0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.1	0.0	0.0	0.6	0.0	0.0	0.1	90.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0
CT45A5	"CT45-5, CT45.5"	ENSG00000228836	"Cancer/testis antigen family 45 member A5"	P0DMU8	X	135777130-135785298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"testis: 10.5"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 2: 2.2;Spermatogonia: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 18.3;Karpas-707: 12.8;RPMI-8226: 6.8;U-266/84: 66.2"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	2.5	0.0	0.0	0.9	66.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0
CT45A6	"CT45-6, CT45.6"	ENSG00000278289	"Cancer/testis antigen family 45 member A6"	P0DMU7	X	135794706-135802656	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"testis: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"U-266/84: 47.3"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A7		ENSG00000273696	"Cancer/testis antigen family 45 member A7"	P0DMV0	X	135829247-135837268	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	5	"testis: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.4	0.0		0.0		0.0	0.0		0.8	0.0	0.0			0.1	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	4.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.4	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A8		ENSG00000278085	"Cancer/testis antigen family 45 member A8"	P0DMV1	X	135846499-135854538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	16	"testis: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 14.2;HMC-1: 30.1"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A9		ENSG00000270946	"Cancer/testis antigen family 45 member A9"	P0DMV2	X	135863776-135871812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	17	"testis: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HMC-1: 55.7"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT55	"CXorf48, FLJ20527"	ENSG00000169551	"Cancer/testis antigen 55"	Q8WUE5	X	135156536-135171398	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 9.2"	"Group enriched"	"Detected in some"	35	"Spermatocytes: 8.1;Spermatogonia: 23.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"K-562: 12.8"									HPA059575			Approved	Vesicles	"Secreted in male reproductive system"	NA	NA			Vesicles		"HPA059575: "	"unprognostic (6.20e-2)"				"unprognostic (1.39e-1)"			"unprognostic (8.36e-2)"		"unprognostic (5.86e-3)"			"unprognostic (3.47e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.49e-1)"		0.1	0.2	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0			0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.2		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.2			0.2		0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	0.2	0.6	0.8	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.1	23.4	0.0	0.0	0.0	0.0	0.0
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 72.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 22.0;K-562: 27.8;OE19: 41.0;RPMI-8226: 61.9;SK-BR-3: 40.5;U-266/84: 70.1"									"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA071467: AB_2686402, HPA076586: "							"prognostic unfavorable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.2	1.0	0.4	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.2			0.0	0.0	0.0	1.0	2.9	0.0	8.5	0.0	0.0	0.1	0.8	0.2	0.0	0.2		0.8	3.6	0.0	0.4	4.4		0.2	0.0		0.1	0.0	5.7	0.2	0.0	0.0	0.0	0.3	0.6	11.9			0.0		0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.6	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	40.5	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.5	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.3	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.8	72.0	0.0	0.9	0.0	0.0	0.0
CTBP2	ribeye	ENSG00000175029	"C-terminal binding protein 2"	P56545	10	124984317-125161170	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA023559, HPA023564, CAB031916, HPA044971, CAB079018"	Approved	Approved	Approved	Cytosol		NA	NA			Cytosol		"CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: AB_2679161"	"unprognostic (8.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.99e-3)"	"prognostic favorable (1.70e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.62e-1)"	13.9	13.1	14.5	9.6	16.3	9.0	29.8	23.5	11.8	31.1	20.9	22.5	17.8	19.8	29.0	21.2	16.3	23.3	17.4	10.9	16.1	12.3	15.4	3.1	17.3	6.5	19.2	11.8	24.1	24.5	12.9	13.6	14.9	15.6	22.9	17.9	28.6	19.9	18.5	11.4	8.6	19.4	23.7	15.1	12.1	19.9	14.5	16.8	3.1	43.3	11.6	6.1	16.7	23.8	0.3	6.5	15.4	11.6	19.7	5.3	2.6	25.2	28.7	25.4	21.1	13.6	13.5	14.0	19.8	23.1	18.7	21.3	17.8	29.9	0.0	10.2	19.8	11.8	20.0	25.2	31.7	14.1	0.1	19.1	18.6	18.9	0.4	28.6	7.8	14.9	11.5	25.2	19.3	38.6	24.8	23.7	1.5	0.7	0.1	11.6	28.1	0.8	8.0	19.1	26.4	18.4	22.5	10.6	0.2	22.0	11.5	7.8	22.3	19.2	16.9	25.4	20.6	11.9	13.0	19.1	11.3	14.3	16.1	16.9	0.4	1.5	0.0	14.1	0.1	11.1	15.4	5.1	9.2	5.3	5.0	0.6	0.3	0.2	1.4	6.5	0.2	0.3	2.3	8.5	19.7	11.6	5.5	0.1	2.6	14.5	16.3	23.5	11.8	16.1	12.3	19.2	11.8	15.6	16.8	29.8	25.6	10.4	75.3	41.9	161.2	28.5	48.4	85.6	56.9	36.6	149.2	17.7	58.0	61.2	23.4	58.3	50.5	0.0	53.0	54.5	41.8	75.6	16.3	1.0	26.4	101.7	52.8	64.4	53.8	28.9	55.8	44.0	55.6	46.9	71.1	60.5	66.1	43.2	73.2	31.8	100.9	58.2	65.1	9.1	33.4	34.8	16.1	21.8	82.1	78.5
CTCFL	"BORIS, CT27, dJ579F20.2"	ENSG00000124092	"CCCTC-binding factor like"	Q8NI51	20	57495966-57525652	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 35.4"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 114.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"HMC-1: 33.3;K-562: 45.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001472	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001472: AB_1078583"	"unprognostic (2.50e-1)"	"unprognostic (4.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.85e-5)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.00e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.75e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.84e-2)"		0.2	0.1	0.1	0.1	0.4	1.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.3	0.1	0.1	0.1	0.4	0.0	0.5	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.1	35.4	0.1	0.1	0.4	0.1	0.1	0.1	0.1	2.1	1.0	4.3	0.8	0.8	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.3	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	1.2	0.1	0.1	0.2	1.8	0.7	1.2	0.6	0.7	0.5	1.3	0.4	0.5	0.3	2.1	0.7	0.8	4.3	0.8	0.8	1.0	0.5	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.5	0.4	18.5	114.6	0.0	0.0	0.0	0.0	0.1
CTDNEP1	"DULLARD, HSA011916, NET56"	ENSG00000175826	"CTD nuclear envelope phosphatase 1"	O95476	17	7243591-7252491	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 140.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037439, HPA066466"	Uncertain		Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA037439: AB_10601264, HPA066466: AB_2732745"	"unprognostic (7.11e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (6.45e-4)"	"unprognostic (3.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.90e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.37e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.02e-2)"	27.1	23.1	21.4	22.4	21.0	24.2	38.8	21.8	26.6	25.3	24.8	26.6	16.7	20.8	31.2	22.8	26.6	27.3	18.8	29.0	21.5	12.9	23.8	20.6	26.5	39.4	24.7	17.1	31.1	27.9	30.7	26.1	30.4	20.5	25.2	27.9	20.4	23.0	23.8	140.1	35.5	30.9	26.7	25.6	38.3	24.3	26.6	24.3	43.8	26.0	31.5	34.1	22.4	26.7	13.0	17.3	18.3	11.8	7.2	11.2	3.8	38.9	58.3	32.8	35.2	51.4	63.3	24.9	29.2	48.9	47.1	40.6	27.8	27.3	36.1	31.1	52.1	32.9	32.7	43.0	45.0	52.7	53.6	36.5	25.2	39.2	47.9	47.7	28.6	47.7	51.0	54.8	53.9	57.6	48.5	50.1	35.8	22.5	26.8	44.2	24.6	31.9	30.7	22.8	34.9	24.8	38.9	29.2	28.8	37.4	20.5	12.6	36.2	23.2	23.3	31.1	33.9	22.0	23.6	28.5	34.4	29.6	27.4	54.8	23.2	20.2	18.5	44.2	39.6	35.5	6.3	11.8	18.3	10.5	11.7	8.5	13.0	10.1	11.0	8.4	12.4	7.8	11.2	15.6	7.2	7.7	17.3	9.6	3.8	21.4	21.0	21.8	26.6	21.5	12.9	24.7	17.1	20.5	24.3	23.8	21.0	48.6	41.4	41.9	42.6	10.8	30.6	9.4	25.0	38.4	21.6	54.3	10.0	54.2	3.7	44.4	63.2	0.0	73.6	98.0	42.3	51.3	19.7	33.8	80.8	28.6	70.8	40.5	83.4	5.0	53.5	53.1	27.0	36.9	73.9	45.9	67.9	46.0	44.2	29.3	28.2	25.8	33.0	14.6	35.6	58.6	69.6	36.2	58.8	56.2
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679801-79756623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cataract, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 89.2;Late spermatids: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	10.6	8.2	6.2	12.8	9.5	21.8	9.5	7.5	12.2	7.9	12.0	14.4	5.3	13.4	11.9	9.3	11.4	9.8	10.0	6.6	6.8	5.7	8.9	13.4	10.2	14.4	12.3	5.1	7.7	13.4	4.6	7.9	10.6	9.1	9.1	6.2	8.4	10.6	8.3	12.1	20.9	13.8	8.2	6.8	15.3	12.2	27.2	10.6	26.2	9.4	8.8	14.8	11.4	8.9	0.7	1.5	6.4	1.0	2.4	2.0	0.5	8.1	9.1	5.1	7.2	4.1	3.4	16.9	5.5	4.0	5.0	5.0	6.0	5.2	10.4	2.6	3.6	6.1	10.0	4.3	5.7	2.1	9.6	7.8	5.4	4.5	8.1	5.9	23.7	13.3	5.7	5.5	5.4	2.5	3.1	6.0	7.9	6.5	5.3	1.9	7.3	15.8	18.7	7.9	2.7	12.2	12.3	6.7	12.5	3.7	8.5	7.9	8.1	6.5	6.5	8.7	4.0	5.2	13.9	8.2	8.7	12.6	3.4	5.9	4.5	16.6	10.3	7.4	12.0	6.1	0.0	1.0	6.4	1.3	0.9	1.1	0.7	1.0	2.0	1.5	0.4	1.3	0.7	2.7	2.4	0.9	0.2	0.3	0.5	6.2	9.5	7.5	12.2	6.8	5.7	12.3	5.1	9.1	10.6	0.0	2.6	3.7	4.2	7.6	9.8	3.1	5.1	6.7	3.4	3.5	13.7	7.8	1.7	4.4	89.2	5.2	11.7	23.3	6.2	6.5	4.2	8.1	6.9	5.5	7.7	22.3	5.8	7.4	7.3	97.9	7.2	9.5	6.8	0.0	15.1	7.8	8.0	14.4	9.9	5.7	14.3	0.0	5.1	5.9	6.8	8.8	15.9	13.3	10.6	11.5
CTDSP2	"OS4, PSR2, SCP2"	ENSG00000175215	"CTD small phosphatase 2"	O14595	12	57819927-57846739	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"RH-30: 169.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052607	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA052607: AB_2681883"	"unprognostic (7.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.38e-3)"	"unprognostic (5.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	44.5	43.6	28.2	31.6	34.8	17.6	39.6	57.1	33.4	49.0	48.4	36.7	47.7	24.4	50.4	32.9	38.0	41.9	37.7	34.6	31.2	16.5	32.8	32.6	51.3	31.3	37.1	19.9	52.5	53.9	33.7	25.4	42.9	31.0	40.5	38.6	29.3	45.8	60.9	48.8	39.9	36.1	44.1	25.7	38.1	43.1	21.0	40.9	62.9	40.1	32.8	33.9	46.1	63.0	7.3	9.3	18.7	9.7	8.2	11.5	7.1	11.0	4.8	23.1	14.7	20.8	35.9	7.7	12.0	22.8	11.9	10.7	6.1	18.1	13.6	13.8	25.5	4.6	8.9	9.6	11.7	12.5	4.5	4.1	18.8	7.4	4.9	19.4	8.5	11.0	34.3	12.4	10.8	9.2	25.6	18.6	8.3	9.8	24.1	5.9	5.1	9.1	5.1	11.7	7.0	6.1	12.2	169.3	17.8	9.3	16.1	4.3	9.6	16.7	9.6	14.4	14.7	17.4	14.9	14.9	10.6	11.6	11.9	4.2	7.2	7.7	16.4	11.9	7.9	8.2	11.5	9.7	14.7	6.9	9.0	8.2	7.3	9.9	8.0	9.3	6.5	11.5	8.7	18.7	8.2	7.7	7.7	6.4	7.1	28.2	34.8	57.1	33.4	31.2	16.5	37.1	19.9	31.0	40.9	68.5	36.0	33.5	41.6	60.0	18.7	31.1	79.0	13.4	23.9	45.4	15.7	36.7	13.3	64.0	44.2	58.1	55.7	0.0	117.0	34.7	57.1	49.1	24.3	49.7	36.0	19.1	46.8	80.4	63.9	111.0	48.1	36.8	40.5	66.7	42.3	41.1	88.4	51.8	45.6	23.9	10.8	71.1	55.2	5.8	25.8	66.6	47.0	40.6	35.4	58.0
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861960-37984469	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		10000	Vesicles	Nucleoplasm	"HPA048325: AB_2680359"	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	12.8	6.3	11.1	7.8	12.4	5.6	22.0	30.2	14.1	15.5	19.9	8.0	25.7	9.3	14.5	18.3	16.8	12.2	37.2	18.9	13.1	5.9	26.7	13.3	19.0	4.9	7.8	9.9	13.7	10.2	8.3	9.4	20.6	6.9	17.5	20.3	15.6	45.5	22.4	12.5	34.8	11.2	21.3	8.1	11.3	19.7	8.1	8.3	2.9	10.0	13.9	6.9	19.6	21.7	0.0	0.2	1.1	0.5	0.0	0.5	5.6	15.8	6.9	2.9	9.0	11.3	16.2	21.4	10.9	13.8	7.6	8.9	10.0	13.0	0.0	6.7	13.5	3.1	13.3	7.0	20.7	6.1	0.0	5.5	9.7	7.4	22.6	10.3	0.0	2.4	8.3	50.9	8.0	9.6	8.6	10.6	4.4	3.1	0.0	12.5	5.0	3.9	0.0	11.8	6.5	1.0	4.4	5.5	0.1	24.3	10.6	2.4	7.5	6.0	10.8	12.2	12.1	10.4	2.6	8.4	5.5	7.7	10.2	6.8	0.2	0.0	0.0	6.1	5.4	10.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.0	0.0	0.0	5.6	11.1	12.4	30.2	14.1	13.1	5.9	7.8	9.9	6.9	8.3	62.5	19.3	0.0	13.3	26.8	9.6	33.8	71.4	14.7	31.8	22.7	0.0	27.6	19.9	10.8	21.9	17.5	10.3	0.0	4.2	7.7	21.7	12.0	1.1	13.9	6.3	9.5	43.5	19.0	9.5	32.3	66.4	5.5	8.5	0.0	17.7	7.1	10.0	5.8	92.3	14.9	1.6	25.8	22.7	2.8	15.8	25.1	7.9	2.2	29.9	14.2
CTDSPL2	"FLJ10523, HSPC129"	ENSG00000137770	"CTD small phosphatase like 2"	Q05D32	15	44427234-44529038	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 155.1;Late spermatids: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040763, HPA062198"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040763: AB_10960989, HPA062198: AB_2684708"	"unprognostic (6.64e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (8.36e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.16e-1)"	17.4	11.1	13.0	15.9	16.3	19.8	17.0	33.2	18.4	17.7	14.2	11.6	15.7	11.2	21.3	13.3	14.6	15.4	13.3	11.8	11.5	9.3	12.8	11.5	14.3	20.1	13.4	10.7	22.7	13.0	13.4	21.1	17.6	11.6	14.7	12.8	12.2	15.6	12.7	17.9	16.0	14.9	16.0	11.6	16.5	11.8	21.7	13.8	35.5	17.4	9.7	20.9	18.4	15.8	12.3	16.0	10.3	13.1	17.0	16.5	11.2	11.0	5.5	23.3	11.7	3.6	8.3	12.9	11.4	9.9	14.9	19.0	11.2	10.4	11.7	11.0	8.1	8.4	15.7	13.4	7.8	17.6	11.6	6.3	14.6	14.5	6.9	5.2	25.1	13.0	6.6	5.9	10.4	13.8	6.5	11.5	15.2	16.9	13.2	10.8	4.7	29.8	8.7	12.3	11.9	7.9	33.4	32.1	10.8	7.9	14.8	10.6	15.7	14.1	11.6	6.5	9.0	15.6	22.8	9.8	18.5	20.1	17.7	19.3	7.8	29.5	36.0	8.7	19.9	14.2	6.0	12.8	10.3	12.7	13.1	11.9	12.3	12.4	11.5	16.0	12.1	13.4	15.0	9.0	17.0	9.9	10.2	16.5	11.2	13.0	16.3	33.2	18.4	11.5	9.3	13.4	10.7	11.6	13.8	17.9	29.4	18.2	12.4	21.9	22.2	21.8	12.7	22.7	43.3	12.2	9.8	15.1	14.9	10.2	155.1	21.2	12.0	0.0	12.6	16.2	20.7	15.1	33.7	11.5	11.8	28.6	8.6	17.8	21.6	125.2	18.7	17.5	15.1	18.0	12.7	18.4	13.2	8.6	12.4	9.8	28.3	25.8	14.1	18.1	34.2	19.2	12.2	22.4	13.8	12.9
CTGF	"CCN2, IGFBP8"	ENSG00000118523	"Connective tissue growth factor"	P29279	6	131948176-131951373	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 425.8;Ito cells: 621.2;Peritubular cells: 453.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"naive B-cell: 11.6"	"Lineage enriched"	"Detected in single"	117	"B-cells: 11.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 131.2;HUVEC TERT2: 110.3;TIME: 227.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	No	No	1010000	5200000	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	51.9	15.5	3.5	48.2	7.6	0.0	39.2	1.6	7.1	84.0	26.9	7.2	27.5	5.8	84.9	50.1	38.9	56.3	82.5	73.6	8.8	3.6	83.5	18.8	45.8	53.3	4.7	9.4	30.7	26.3	4.7	9.7	44.0	13.8	54.5	19.7	55.0	28.2	45.3	29.4	30.1	28.7	123.4	12.0	169.8	41.6	24.4	2.3	5.9	66.9	46.9	9.8	48.5	23.3	11.6	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	10.2	0.3	23.2	13.2	0.1	29.6	14.3	18.4	9.8	0.0	0.9	0.0	131.2	38.0	15.1	0.4	0.3	2.1	17.3	0.1	0.2	0.0	4.2	10.6	9.1	0.0	0.0	19.2	0.4	13.3	3.3	27.8	110.3	0.0	0.0	0.0	52.2	0.2	0.0	0.0	4.9	3.2	1.7	2.5	0.4	0.0	6.7	0.0	0.0	0.0	3.0	5.0	1.4	26.2	0.5	0.2	227.6	25.5	20.0	32.1	54.7	0.9	0.1	0.2	3.4	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.5	7.6	1.6	7.1	8.8	3.6	4.7	9.4	13.8	2.3	425.8	55.6	2.9	247.2	86.5	0.0	34.4	73.9	103.1	38.7	12.2	0.0	11.5	0.0	245.6	0.9	205.6	11.7	0.0	212.2	18.8	248.5	11.6	13.9	23.6	12.0	0.0	13.3	621.2	7.2	2.7	46.6	12.6	62.4	27.1	7.9	2.8	177.6	6.6	453.3	0.7	0.2	103.5	206.0	1.2	4.4	52.6	13.6	1.8	7.5	6.5
CTHRC1		ENSG00000164932	"Collagen triple helix repeat containing 1"	Q96CG8	8	103371515-103382997	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Endothelial cells: 36.6;Fibroblasts: 168.4;Melanocytes: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.3;NK-cell: 5.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;NK-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 56.2;fHDF/TERT166: 24.7;HHSteC: 37.4;HSkMC: 77.1;WM-115: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059806, HPA061896"	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		320000	Nucleoplasm		"HPA059806: AB_2684130, HPA061896: AB_2684633"	"unprognostic (2.04e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.22e-14)"	"unprognostic (2.33e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.37e-3)"	35.1	1.4	1.1	5.2	1.1	0.0	32.3	0.8	2.3	5.3	3.8	0.5	3.0	2.0	6.9	11.2	3.5	3.0	33.0	4.2	1.1	1.6	2.0	0.7	4.5	7.6	1.6	1.3	3.7	2.1	0.3	2.1	32.2	1.9	4.0	2.1	2.6	23.0	4.2	9.2	17.4	2.1	8.4	2.6	1.4	1.8	8.4	0.8	2.2	4.8	3.7	5.4	31.3	3.6	0.2	0.7	2.3	0.0	5.2	0.4	0.3	2.1	0.1	0.6	0.1	16.9	56.2	0.0	6.3	1.7	0.6	0.9	0.2	1.5	0.2	6.7	24.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	3.4	37.4	0.1	0.1	77.1	0.1	5.7	0.0	0.2	11.0	0.4	0.0	17.0	3.4	0.3	3.0	7.3	2.0	0.0	10.6	6.4	5.7	0.2	0.5	0.0	1.0	0.8	0.0	0.0	18.9	2.4	0.0	0.0	8.9	0.8	0.3	0.9	0.0	0.5	0.1	0.1	0.4	0.0	70.8	0.0	0.0	2.3	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.2	0.3	0.1	5.2	0.0	0.7	0.0	0.3	1.1	1.1	0.8	2.3	1.1	1.6	1.6	1.3	1.9	0.8	3.0	2.9	0.0	0.1	28.4	0.3	0.6	2.5	0.0	0.0	3.5	0.0	5.6	0.0	4.4	0.3	36.6	0.0	0.0	0.6	8.9	168.4	0.6	0.0	0.0	7.0	0.0	1.2	26.4	0.3	0.2	11.5	1.7	47.2	1.0	0.0	5.5	2.4	0.0	0.4	0.3	1.0	0.0	24.7	1.6	15.6	23.8	13.8	0.0	0.0	0.4
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 116.5"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 254.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042617, HPA067089"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Plasma membrane, Cell Junctions, Mitochondria"		"HPA042617: AB_2678081, HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	12.6	4.0	10.1	4.3	8.1	7.7	18.3	21.4	14.8	16.6	5.8	10.1	10.9	7.4	4.8	31.3	49.0	5.2	4.8	13.7	10.1	9.5	5.6	4.8	15.2	4.0	8.4	11.3	5.5	14.1	4.0	6.6	11.0	13.7	9.9	4.2	13.3	15.5	16.5	13.1	116.5	5.8	4.5	9.2	3.3	8.8	11.8	6.5	4.8	7.9	33.9	13.5	5.6	21.7	1.9	6.8	12.9	5.4	8.8	2.9	2.3	26.2	3.9	24.2	18.4	3.6	6.1	7.7	5.2	9.2	7.7	4.9	1.9	33.5	8.1	15.1	6.7	7.9	13.4	2.8	30.9	3.5	20.4	4.3	5.2	1.2	24.4	7.6	3.9	3.1	6.8	30.6	9.8	10.0	6.6	20.7	15.3	9.2	3.8	4.7	16.1	8.7	14.6	12.8	21.2	6.8	10.0	7.1	5.2	3.9	9.0	26.6	16.8	11.8	10.8	15.7	8.6	13.2	9.7	13.5	5.0	6.1	7.5	11.4	8.4	10.9	9.5	1.8	20.0	19.7	2.7	5.4	12.9	2.9	1.9	1.7	1.9	1.5	2.4	6.8	1.6	1.4	1.4	4.0	8.8	1.2	2.1	1.2	2.3	10.1	8.1	21.4	14.8	10.1	9.5	8.4	11.3	13.7	6.5	26.8	11.5	11.8	34.8	91.7	8.4	11.6	22.9	1.4	7.9	17.4	7.9	61.2	28.2	16.0	101.0	18.1	20.6	23.3	16.2	34.6	26.7	52.4	0.0	22.9	49.6	15.9	47.1	16.0	32.6	19.5	13.8	30.5	45.5	5.4	34.9	106.1	27.9	25.8	21.5	23.0	12.2	45.3	22.1	72.3	36.2	254.8	40.5	18.1	24.3	54.7
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 296.8;granulocytes: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol		No	No			Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	21.0	14.7	19.6	25.8	21.4	27.3	18.9	20.9	21.3	20.3	23.5	18.4	31.7	16.1	25.4	25.2	18.9	21.0	17.7	25.6	17.5	15.8	19.3	35.3	19.3	26.9	17.9	14.7	21.7	14.6	14.5	22.6	22.4	17.5	19.4	18.1	16.1	15.5	34.3	27.3	20.1	19.7	23.8	16.6	49.5	25.9	35.5	20.6	31.0	15.9	15.5	29.7	22.2	29.3	24.9	31.4	60.3	29.1	21.7	18.2	18.4	15.6	14.4	13.8	10.8	10.0	8.3	21.9	10.0	10.5	24.1	21.3	53.9	12.7	17.4	14.7	10.1	23.3	16.8	18.6	23.7	26.0	8.4	9.2	57.1	7.9	26.3	10.4	18.0	76.0	8.7	14.1	13.6	13.6	8.4	14.3	25.0	15.4	7.2	12.8	12.9	29.2	24.0	12.5	17.6	21.0	20.6	26.8	13.1	10.5	13.1	11.1	13.3	17.4	24.9	17.6	13.4	12.3	14.5	10.6	24.1	14.4	15.8	16.2	8.4	10.6	20.3	17.0	11.3	12.7	60.3	22.3	27.9	15.8	29.1	15.0	24.9	15.4	16.2	31.4	23.4	15.5	16.6	4.9	21.7	28.7	24.7	18.2	18.4	19.6	21.4	20.9	21.3	17.5	15.8	17.9	14.7	17.5	20.6	26.8	26.6	37.0	27.7	20.3	25.3	35.5	20.4	21.4	31.8	17.4	17.7	122.6	31.5	25.9	296.8	26.1	24.4	0.0	30.3	56.0	26.8	18.9	250.2	39.2	44.0	17.5	20.1	31.3	29.7	86.0	31.7	43.3	25.3	129.0	23.0	28.3	25.6	19.8	31.5	32.3	21.0	19.4	40.1	76.5	43.0	19.6	44.3	32.4	19.5	18.6
CTNND2	"GT24, NPRAP"	ENSG00000169862	"Catenin delta 2"	Q9UQB3	5	10971840-11904043	"Disease related genes, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 74.3"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 18.0;Cholangiocytes: 38.2;Early spermatids: 21.0;Late spermatids: 23.3;Muller glia cells: 39.5"	"Cancer enriched"	"Detected in many"	16	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.1;MCF7: 8.2;SK-BR-3: 5.4;U-266/84: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015077, CAB037339, HPA071124"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"CAB037339: , HPA015077: AB_2669150, HPA071124: "	"unprognostic (7.32e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.23e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.55e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.76e-2)"	1.7	2.4	30.9	1.8	26.3	1.4	2.8	21.6	74.3	1.7	1.8	16.6	0.0	1.7	1.6	1.9	1.6	1.7	4.8	6.0	26.0	17.7	1.5	1.7	2.4	1.6	22.8	20.2	2.1	12.5	1.5	5.7	1.9	11.0	2.6	1.9	2.6	1.7	1.7	1.6	1.5	2.0	1.6	13.3	5.7	1.9	4.2	14.7	0.0	1.7	0.0	1.5	1.6	0.1	0.0	0.0	0.8	0.4	0.0	0.3	0.6	0.0	0.1	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	15.4	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.6	30.9	26.3	21.6	29.1	26.0	17.7	22.8	20.2	11.0	14.7	0.0	0.0	0.0	0.0	0.0	18.0	8.4	38.2	0.0	0.0	1.8	0.0	0.0	3.3	5.4	21.0	0.3	0.0	0.0	5.4	0.0	0.0	3.6	0.0	0.0	0.1	7.9	4.7	0.0	0.0	23.3	1.4	0.0	0.0	0.0	0.0	39.5	3.5	0.0	0.0	0.3	2.6	0.0	0.0	1.4	3.1	0.0	0.0	0.0	0.0	0.1
CTNS	"CTNS-LSB, PQLC4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636468-3661542	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"		NA	NA			"Vesicles, Intermediate filaments"		"HPA046947: AB_2679872"	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	9.6	19.0	8.5	8.2	11.9	8.3	12.1	5.0	9.9	18.8	8.2	16.1	34.8	10.8	10.3	7.2	7.3	8.3	10.6	9.3	7.7	5.9	23.9	16.4	11.4	9.1	12.1	5.6	12.6	32.7	11.3	14.5	13.2	8.5	10.2	6.4	11.4	10.5	46.2	22.6	18.0	9.2	7.9	10.2	12.2	12.9	27.0	13.0	11.7	9.0	6.5	9.0	10.1	9.1	3.5	19.6	13.7	5.6	2.5	3.3	3.7	6.2	14.0	8.2	7.0	13.3	6.8	5.1	6.0	10.2	7.0	8.8	7.8	6.1	3.7	6.4	4.1	19.2	16.0	7.2	4.1	5.4	46.5	12.7	4.2	10.5	6.3	18.0	2.8	29.1	8.4	5.3	7.3	6.0	10.9	7.7	6.0	4.3	5.9	6.5	5.7	2.8	2.7	3.6	4.3	6.1	6.2	3.3	8.8	6.2	6.3	1.6	6.0	7.1	9.5	7.1	7.3	6.7	2.8	9.0	6.9	4.3	15.5	4.9	4.7	6.1	1.8	10.6	3.1	4.7	13.7	5.6	12.1	1.9	3.7	2.7	3.5	2.3	3.3	5.4	3.1	2.9	3.1	2.0	2.5	3.8	19.6	2.6	3.7	8.5	11.9	5.0	9.9	7.7	5.9	12.1	5.6	8.5	13.0	3.0	2.1	0.0	3.2	1.4	1.4	3.6	7.6	2.7	1.2	12.2	9.8	5.1	0.0	5.4	33.5	6.0	2.8	0.0	5.5	5.9	4.8	5.5	8.1	5.8	20.7	4.8	2.4	13.5	7.1	23.4	8.9	8.3	5.0	12.6	2.5	6.6	5.8	2.0	12.0	7.9	3.6	6.5	2.8	11.4	8.5	2.0	7.1	4.3	1.8	2.6
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979335-41012565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	Yes			Cytosol	"Actin filaments"	"CAB017111: , HPA051322: AB_2681441"	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	7.1	10.0	4.5	10.8	7.8	9.7	5.1	5.9	9.8	14.4	23.6	5.8	16.3	4.3	25.9	8.4	11.3	21.9	13.4	6.7	4.7	5.1	8.6	26.4	7.0	9.4	7.9	4.7	10.1	6.3	16.8	5.4	7.7	6.2	14.4	9.8	9.1	56.5	19.6	13.2	5.8	13.5	35.8	5.1	7.5	9.0	11.8	6.7	14.6	4.5	11.3	13.2	21.3	9.5	6.0	12.8	0.0	7.3	6.6	7.0	3.8	21.2	19.5	27.6	22.2	7.6	9.5	43.4	37.4	16.1	41.1	27.7	38.3	18.9	39.9	17.0	17.1	11.3	15.0	29.5	27.9	41.1	16.7	22.4	24.4	26.0	12.1	25.0	32.5	19.2	10.4	15.1	42.5	30.6	7.2	18.6	29.3	24.5	17.6	28.7	11.9	35.1	12.1	37.7	17.8	23.2	27.1	33.5	25.8	20.7	19.4	37.1	18.1	23.3	25.1	9.3	28.3	8.7	45.0	15.2	27.2	35.6	18.3	46.4	11.4	13.3	35.5	17.8	25.9	28.3	0.0	4.0	0.0	4.6	7.3	6.6	6.0	5.3	4.8	12.0	3.9	4.4	7.0	0.0	6.6	6.1	12.8	6.6	3.8	4.5	7.8	5.9	9.8	4.7	5.1	7.9	4.7	6.2	6.7	6.0	20.2	17.3	10.5	7.1	9.9	4.2	20.4	2.7	5.7	5.2	5.9	14.6	1.7	15.2	22.6	7.3	2.8	0.0	15.1	21.5	6.6	4.3	1.1	24.5	9.6	11.1	2.9	2.5	2.4	21.2	10.0	6.0	1.7	12.6	2.6	5.2	14.2	0.0	23.3	9.6	4.2	38.8	14.4	9.3	42.5	6.5	4.7	5.7	5.2	5.8
CTPS2		ENSG00000047230	"CTP synthase 2"	Q9NRF8	X	16588003-16712936	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017437, HPA075930"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA		14000	"Mitochondria, Cytosol"		"HPA017437: AB_1847326, HPA075930: "	"unprognostic (1.40e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (6.57e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.56e-4)"	10.0	12.0	7.8	11.5	11.9	7.8	13.5	14.3	9.9	17.5	13.3	14.8	10.8	15.6	22.0	10.2	9.6	12.1	11.9	7.2	8.6	7.1	8.1	13.4	8.3	7.9	9.1	6.1	17.9	14.9	22.9	8.5	8.3	9.3	12.8	12.6	14.1	11.8	9.7	5.5	9.2	12.8	14.0	12.3	7.1	11.3	4.4	10.8	11.5	11.8	8.4	10.6	11.8	11.2	1.6	3.3	1.1	6.1	3.8	2.4	1.4	7.6	7.0	11.4	9.5	5.8	4.4	0.1	4.2	3.5	6.8	6.3	7.0	8.0	0.2	13.5	4.3	6.2	6.2	16.0	7.7	8.2	0.0	10.6	4.3	9.8	10.2	3.0	3.1	0.1	4.8	2.6	6.4	5.4	7.7	9.1	0.1	6.1	0.3	6.2	10.1	0.1	2.4	19.6	2.8	8.2	0.1	6.6	2.4	7.3	8.5	7.1	13.1	13.3	1.0	7.6	12.9	18.5	8.9	5.8	3.6	1.9	9.4	3.6	0.2	0.1	25.3	2.8	2.7	3.9	0.4	1.5	1.1	1.3	0.8	2.4	1.6	2.2	1.4	3.3	1.4	1.7	1.7	0.1	3.8	6.1	2.2	2.0	1.4	7.8	11.9	14.3	9.9	8.6	7.1	9.1	6.1	9.3	10.8	8.9	7.0	3.7	5.0	2.9	4.9	5.2	10.2	4.0	9.1	5.2	0.0	2.9	3.3	8.7	2.8	4.9	6.0	0.0	8.4	6.2	3.9	4.8	5.8	7.5	4.5	6.4	10.9	6.7	4.9	5.8	8.3	2.6	8.5	9.0	7.4	3.4	10.3	11.0	3.9	2.2	4.4	6.5	4.1	0.0	0.2	3.3	1.3	3.8	8.1	4.8
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell type enhanced"	"Detected in all"	11	"Hofbauer cells: 2617.6;Kupffer cells: 1392.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 239.8;fHDF/TERT166: 139.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		130000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.5	3.8	16.2	66.6	74.9	11.8	122.8	239.8	43.0	51.0	14.0	38.4	0.1	17.8	139.3	57.7	35.8	5.2	33.9	27.2	3.2	5.0	9.5	3.4	34.5	67.8	2.1	7.1	82.1	46.2	38.9	34.8	74.9	84.1	2.8	7.9	21.7	35.7	5.2	0.8	3.5	3.2	75.8	9.9	3.4	3.8	16.6	13.1	10.2	1.6	9.6	14.2	7.7	64.0	11.7	12.5	6.4	116.4	73.1	24.8	23.4	22.8	21.6	15.7	0.6	83.9	8.2	34.2	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4	101.3	205.9	73.7	364.9	48.5	44.4	251.7	175.8	137.9	227.5	108.2	39.3	224.9	23.2	276.8	13.3	119.6	152.5	210.2	211.7	280.5	149.9	239.1	169.3	203.7	2617.6	55.6	148.7	214.9	1392.4	12.2	70.8	859.7	153.5	399.5	80.9	115.8	264.9	108.7	87.4	331.7	35.7	38.8	121.0	4.8	18.5	35.4	543.3	50.7	114.7	284.4
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 82.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 1152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 42.8"	"Group enriched"	"Detected in all"	5	"B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.1;HaCaT: 31.5;OE19: 31.0;RT4: 119.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		10000000	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	16.7	10.6	9.5	24.2	7.0	5.4	23.9	4.5	9.8	25.1	11.4	17.7	14.7	10.6	10.3	17.1	7.8	13.1	29.2	16.5	14.8	6.7	66.7	18.7	82.6	65.4	12.1	11.6	14.6	25.8	12.3	6.5	7.7	9.4	18.6	6.6	6.7	15.4	15.9	7.0	13.5	16.6	9.8	10.8	20.3	15.6	6.7	15.7	6.6	8.5	4.8	34.8	39.6	13.5	20.6	41.2	1.4	42.8	1.3	7.6	27.3	16.2	1.1	0.4	4.8	1.1	0.0	5.3	1.6	0.6	2.8	1.5	7.1	43.1	5.7	1.8	0.1	3.1	31.5	2.0	7.8	2.3	24.0	0.1	0.1	0.2	16.5	1.7	0.0	1.1	0.8	2.2	0.0	0.0	11.8	0.2	0.7	11.6	0.0	3.9	1.7	3.7	10.0	1.2	31.0	0.3	0.0	0.3	0.9	9.9	119.7	0.5	1.2	7.0	3.9	9.7	2.3	1.6	5.4	2.2	0.0	1.0	0.0	0.7	0.1	12.4	3.1	0.0	10.5	1.7	0.0	42.8	0.4	1.4	28.3	7.6	20.6	4.1	2.1	41.2	12.0	0.4	0.7	1.4	1.3	17.0	4.2	3.1	27.3	9.5	7.0	4.5	9.8	14.8	6.7	12.1	11.6	9.4	15.7	220.3	1152.3	144.6	210.0	21.5	0.8	25.2	351.6	270.4	197.9	349.0	3.9	16.6	71.3	153.3	17.1	109.7	15.8	0.0	128.8	33.6	30.0	89.1	30.2	82.9	261.0	0.0	8.7	15.4	160.1	15.9	67.6	392.5	75.9	476.1	19.5	21.1	69.6	11.5	5.6	352.9	5.6	19.4	17.8	5.0	52.9	16.3	19.6	25.4	37.0	308.4
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87725519-87731393	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 237.0"	"Cell type enhanced"	"Detected in all"	8	"Cytotrophoblasts: 935.7;Extravillous trophoblasts: 843.2;Hofbauer cells: 1004.8;Ito cells: 672.8;Syncytiotrophoblasts: 1290.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 31.0;non-classical monocyte: 44.3"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 201.6;HSkMC: 93.2"									"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		17000000	"Golgi apparatus, Vesicles"		"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	60.3	21.5	10.4	27.2	24.6	18.4	23.3	6.9	12.3	14.8	23.2	14.1	13.7	9.0	24.1	22.3	11.4	25.7	20.7	37.7	10.7	11.4	65.4	98.0	53.1	80.5	18.9	7.7	25.0	14.3	18.8	18.0	237.0	18.4	19.4	13.0	23.2	22.0	23.5	29.3	9.1	12.0	36.6	16.1	108.1	17.5	14.1	15.7	6.8	19.2	9.4	10.1	41.3	26.5	0.0	1.7	0.1	44.3	0.0	4.3	2.4	6.4	37.4	2.6	4.4	47.1	201.6	15.7	20.8	60.7	17.9	22.4	3.6	5.9	0.0	9.8	26.9	56.7	5.5	3.4	6.8	14.8	0.1	3.3	1.1	10.6	8.7	30.5	0.0	4.5	93.2	11.4	29.2	11.4	15.6	14.1	0.0	12.1	0.0	25.7	10.8	0.0	0.7	4.9	10.1	7.1	1.5	1.5	0.0	12.5	3.4	3.7	4.6	4.3	9.8	23.9	15.6	1.1	7.4	22.0	16.0	8.7	58.4	8.8	1.6	6.0	0.0	58.7	0.0	5.2	0.1	3.5	0.1	0.0	31.0	0.0	0.0	1.8	0.0	1.7	0.0	4.3	0.3	0.1	0.0	44.3	0.1	0.3	2.4	10.4	24.6	6.9	11.7	10.7	11.4	18.9	7.7	18.4	15.7	38.7	60.6	38.5	79.1	33.5	37.4	87.3	84.1	56.2	38.7	71.5	17.7	935.7	23.2	77.5	3.5	75.9	8.6	46.7	82.1	843.2	226.1	43.7	27.8	100.7	1004.8	12.7	11.1	672.8	182.1	10.4	145.3	481.4	60.8	19.8	7.7	78.6	55.2	2.9	176.0	107.8	35.6	90.5	103.2	144.4	46.2	29.6	1290.9	15.3	8.8	43.0
CTSS		ENSG00000163131	"Cathepsin S"	P25774	1	150730196-150765957	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 171.4;lymphoid tissue: 111.4"	"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 672.3;Kupffer cells: 1992.4;Macrophages: 1161.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 171.4;intermediate monocyte: 151.2;myeloid DC: 43.5;neutrophil: 94.5;non-classical monocyte: 138.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 43.5;granulocytes: 94.5;monocytes: 171.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.6;HMC-1: 51.4;U-698: 109.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000460, HPA002988"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		19000000	Vesicles		"CAB000460: , HPA002988: AB_1078409"	"unprognostic (7.81e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-3)"	41.6	9.3	6.8	32.3	10.3	30.3	9.7	1.9	6.2	4.7	32.9	6.6	5.6	19.6	3.7	12.9	8.8	10.7	15.9	17.3	6.4	5.1	9.6	21.5	55.8	99.5	12.6	2.3	7.6	6.4	0.4	3.4	14.4	9.3	7.5	33.4	6.5	12.9	3.3	3.5	3.8	38.0	6.8	17.1	111.4	13.8	3.8	9.5	12.9	7.6	4.6	22.8	21.5	5.3	11.1	43.5	94.5	171.4	3.3	5.6	145.4	1.0	3.3	0.0	0.0	0.4	0.3	0.3	0.0	3.3	0.2	0.6	0.0	21.6	14.9	1.6	0.1	6.1	0.4	0.0	0.1	0.0	8.3	0.0	6.5	0.1	0.0	0.0	8.9	51.4	0.6	0.0	1.9	0.1	0.1	1.2	0.0	0.6	13.0	0.4	0.0	0.0	6.3	0.0	0.0	0.0	3.7	1.2	18.2	4.0	3.2	0.0	0.1	0.2	0.9	0.3	0.0	0.0	18.2	1.8	1.3	0.2	0.0	0.3	9.0	0.8	109.3	7.6	9.6	0.8	1.2	171.4	16.5	3.2	151.2	3.9	11.1	3.9	3.8	43.5	10.2	3.9	3.6	94.5	3.3	138.5	9.4	5.6	145.4	6.8	10.3	1.9	6.2	6.4	5.1	12.6	2.3	9.3	9.5	101.3	167.2	252.8	20.8	15.0	2.0	3.0	84.1	518.0	134.2	40.1	11.8	3.1	0.0	145.4	5.3	35.1	277.5	0.0	157.6	3.9	26.3	16.7	100.8	19.5	672.3	0.0	40.9	64.4	1992.4	1.7	4.9	1161.7	54.0	251.5	198.9	0.3	150.7	378.7	2.1	4.2	4.1	19.4	7.6	0.2	0.4	13.6	5.1	117.4	149.8	109.8
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 114.1;Extravillous trophoblasts: 136.0;Syncytiotrophoblasts: 56.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Group enriched"	"Detected in many"	9	"BEWO: 92.0;SuSa: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	5.9	1.8	2.0	5.3	0.1	0.0	92.0	0.0	0.0	1.3	1.0	12.1	5.9	0.0	0.5	0.0	8.8	11.4	9.8	7.2	1.9	0.0	1.3	0.2	0.6	1.8	0.0	0.0	0.8	0.0	2.4	0.3	0.3	0.1	0.4	1.7	0.2	0.0	2.3	2.2	0.1	0.0	12.2	12.0	1.7	0.0	4.4	0.1	1.8	0.7	0.5	0.9	6.0	2.1	2.1	118.9	3.8	0.7	0.0	0.3	6.0	0.0	0.6	1.2	3.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0	0.0	0.6	1.5	13.2	27.0	4.4	0.8	0.0	0.0	3.4	1.8	9.8	114.1	1.7	1.2	1.5	1.5	1.2	0.0	0.7	136.0	2.6	7.1	0.0	0.0	11.8	0.0	1.7	0.6	0.0	9.6	3.7	1.6	0.0	0.0	0.9	4.5	0.6	1.7	1.1	11.1	26.0	6.5	0.8	34.6	32.6	10.5	56.3	0.0	3.7	6.4
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"A-431: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA		34000000	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: AB_2683379"	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (2.19e-6)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	37.5	53.6	33.0	19.7	36.7	5.7	32.0	33.3	41.1	41.3	35.3	42.3	33.7	37.1	48.8	40.2	49.4	35.5	56.2	37.3	28.5	23.5	47.2	24.9	30.5	13.7	45.0	32.0	46.3	40.0	28.9	38.3	32.3	37.2	38.9	32.4	24.4	38.0	38.5	31.5	52.9	39.2	43.1	36.0	21.4	51.3	30.2	38.6	7.7	36.0	44.5	26.7	33.2	38.2	0.1	0.8	4.6	0.2	0.0	0.4	13.9	129.8	28.6	9.7	11.1	16.4	25.6	15.9	27.8	27.8	24.5	19.4	37.8	32.8	5.1	27.6	35.5	26.3	28.9	11.5	29.2	18.0	10.2	11.7	0.5	21.3	17.6	35.3	0.1	6.9	36.1	20.6	27.1	15.3	25.7	20.5	0.1	14.6	1.0	24.1	35.5	0.2	1.8	10.5	47.6	17.5	0.0	11.9	4.1	27.4	42.3	8.0	13.6	20.3	27.9	46.2	18.1	22.8	0.5	25.6	21.7	13.8	33.6	18.5	2.2	1.5	0.3	43.1	0.1	29.5	1.4	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	4.6	0.0	0.2	0.8	0.0	13.9	33.0	36.7	33.3	41.1	28.5	23.5	45.0	32.0	37.2	38.6	41.7	43.8	5.9	84.2	135.0	34.6	57.8	68.8	50.9	53.4	127.4	17.7	73.0	54.7	124.2	9.3	75.2	104.4	23.3	191.8	75.9	68.3	111.3	5.8	37.6	9.6	36.5	71.5	68.7	5.4	16.3	95.5	8.6	116.4	9.0	107.2	38.3	199.6	136.8	93.0	111.0	30.1	58.2	106.6	31.2	52.1	152.9	88.9	6.9	79.7	167.3
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 53.0;granulocytes: 134.2;Horizontal cells: 69.9;Muller glia cells: 122.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"non-classical monocyte: 9.6"	"Lineage enriched"	"Detected in single"	22	"monocytes: 9.6"	"Group enriched"	"Detected in some"	6	"HEL: 27.5;HMC-1: 36.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"		Yes	No			"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: AB_2679037"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	11.2	3.9	10.7	1.8	17.6	0.7	4.7	8.3	15.5	10.7	3.9	22.1	2.0	3.3	11.4	9.4	14.0	7.2	6.6	2.4	13.5	9.1	11.5	3.8	3.2	1.0	16.2	9.9	5.4	13.1	21.9	5.8	3.4	15.5	6.6	5.0	5.0	5.2	4.0	1.1	2.5	3.3	9.5	14.3	4.2	1.8	2.2	16.8	0.0	9.8	1.7	2.1	4.8	4.9	0.0	0.4	0.0	9.6	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.0	27.5	0.2	0.0	0.1	0.0	36.6	0.1	0.2	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.1	5.2	0.0	3.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.5	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	10.7	17.6	8.3	15.3	13.5	9.1	16.2	9.9	15.5	16.8	3.0	4.5	0.0	3.0	1.6	26.3	2.9	10.2	1.4	6.8	7.0	53.0	2.5	1.7	4.0	1.1	8.7	0.5	0.0	3.8	1.2	2.3	1.4	134.2	1.0	7.0	69.9	1.7	26.4	7.5	2.7	0.9	6.4	6.8	1.8	0.5	122.7	0.8	2.6	1.1	14.3	3.3	0.0	3.5	0.4	0.4	0.3	0.9	0.7	6.0	1.1
CTTNBP2NL	DKFZp547A023	ENSG00000143079	"CTTNBP2 N-terminal like"	Q9P2B4	1	112396181-112463456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007301	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"		"HPA007301: AB_1847693"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.21e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (8.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (5.12e-2)"	18.8	5.3	10.0	9.8	13.0	0.5	15.0	10.6	12.4	12.9	15.3	14.4	5.0	7.5	18.3	7.6	20.0	8.8	17.0	8.9	10.1	7.9	10.3	5.5	16.5	5.7	10.8	7.8	10.1	4.7	9.6	9.3	20.1	10.2	9.5	15.2	9.7	10.8	10.0	4.4	20.0	12.3	13.9	18.7	10.1	8.5	5.8	11.0	2.6	8.9	7.2	9.5	13.6	15.6	0.5	10.6	0.1	3.3	0.0	2.3	0.5	9.6	3.6	11.9	5.6	8.0	10.6	4.0	15.2	14.3	9.9	9.8	2.7	4.9	1.5	6.1	11.4	4.9	7.9	7.7	10.5	11.6	3.1	3.7	2.0	6.2	2.1	9.3	0.7	3.6	12.5	6.4	12.2	10.7	11.4	24.0	2.6	1.8	1.4	13.6	2.8	1.3	0.2	7.6	2.7	5.6	2.3	11.1	0.0	15.0	7.2	5.8	6.1	11.8	2.4	6.1	11.9	1.9	0.8	30.9	9.9	11.7	10.1	7.1	0.1	1.3	0.0	10.3	0.9	26.0	0.0	3.3	0.0	0.0	2.6	0.0	0.1	0.0	0.0	10.6	0.5	0.0	0.0	0.1	0.0	0.5	4.6	2.3	0.5	10.0	13.0	10.6	12.4	10.1	7.9	10.8	7.8	10.2	11.0	53.6	19.0	8.2	19.2	34.5	10.1	7.5	5.1	14.7	44.3	21.0	5.9	13.6	3.3	29.9	2.4	60.8	30.5	23.3	18.9	10.6	17.4	23.0	18.5	1.0	12.3	4.8	7.9	35.0	23.6	2.1	9.8	40.9	15.1	45.1	23.1	11.4	36.6	31.6	10.6	16.6	8.8	19.4	14.6	14.2	15.0	53.1	21.3	1.0	17.2	51.7
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924485-7926166	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 91.1"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 14.7;Late spermatids: 13.4;Spermatogonia: 10.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.9;HEK 293: 23.6;NTERA-2: 25.7;REH: 19.5;SCLC-21H: 20.0;SH-SY5Y: 33.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	2.1	4.8	47.7	2.5	91.1	1.6	2.1	0.0	74.2	5.2	6.1	5.0	3.6	2.6	17.5	5.1	2.4	16.4	1.8	1.6	49.4	16.8	3.1	1.5	3.0	1.6	15.7	20.1	2.7	2.1	2.3	6.5	2.0	4.0	5.5	2.1	0.0	2.1	16.5	1.6	2.8	2.1	7.1	1.5	2.0	2.2	6.1	8.3	0.0	1.8	0.0	1.6	2.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	2.8	7.3	33.9	0.0	0.1	1.7	2.9	0.8	1.4	0.8	0.8	1.7	0.0	5.8	0.7	0.8	12.3	1.6	0.3	0.0	1.0	23.6	0.2	1.9	0.5	0.3	0.6	0.6	0.0	0.9	0.5	0.3	3.5	1.9	3.2	7.1	0.1	0.1	13.7	6.2	4.6	25.7	0.8	11.9	19.5	0.0	2.2	5.2	0.5	20.0	33.6	1.8	0.9	3.1	0.6	7.4	0.2	2.8	0.7	11.9	1.3	1.6	0.2	0.3	1.6	2.8	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.7	91.1	0.0	63.8	49.4	16.8	15.7	20.1	4.0	8.3	0.0	0.0	0.0	3.6	1.0	0.2	0.2	0.0	0.0	0.0	8.7	3.9	0.1	3.3	5.0	7.3	0.5	0.0	0.0	0.3	0.4	0.9	14.7	0.0	0.0	0.2	0.0	8.7	0.6	0.0	13.4	1.1	0.1	1.7	0.0	0.0	0.1	2.0	0.2	1.8	7.2	0.4	0.0	4.2	3.6	10.4	1.8	0.2	0.0	0.0	5.9
CUEDC1		ENSG00000180891	"CUE domain containing 1"	Q9NWM3	17	57861243-57955323	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 17.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 17.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023050, HPA024836"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Centrosome	"HPA023050: AB_1847332, HPA024836: AB_1847333"	"unprognostic (4.46e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.77e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.04e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-2)"	9.8	10.6	11.7	8.6	19.3	5.2	9.3	8.5	16.6	22.3	18.5	39.1	11.8	5.0	13.4	13.9	21.2	21.6	12.9	24.2	12.6	12.1	12.0	3.7	13.7	4.4	30.0	8.0	6.4	11.6	7.1	11.5	7.8	18.5	13.0	7.2	19.3	19.1	18.4	48.9	5.5	7.3	19.2	18.7	6.6	12.2	2.9	28.3	2.5	11.2	15.8	4.7	15.4	10.4	0.0	17.6	1.8	1.3	0.1	0.0	0.1	8.3	25.9	27.1	4.8	4.4	8.1	0.9	5.9	12.0	12.5	9.0	4.7	32.2	0.1	24.2	11.4	10.6	6.7	2.9	12.7	4.4	16.3	5.0	0.3	16.8	3.9	10.7	0.1	2.0	8.3	7.7	7.2	6.1	11.0	6.0	0.1	0.3	0.1	11.4	4.7	0.4	0.2	0.9	9.6	7.1	0.8	7.0	1.2	8.5	5.5	11.2	6.1	2.5	2.7	10.2	4.8	37.5	0.9	7.6	33.4	21.1	9.1	13.1	0.0	0.1	0.1	14.5	1.1	26.6	0.6	0.4	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	1.3	17.6	0.0	0.1	11.7	19.3	8.5	15.4	12.6	12.1	30.0	8.0	18.5	28.3	17.9	5.1	1.3	13.8	3.7	32.2	15.6	10.2	12.0	10.3	21.0	60.9	0.6	6.6	20.2	0.3	8.4	4.5	0.0	22.5	0.2	10.6	18.5	0.0	2.9	14.5	9.5	3.4	2.5	9.7	2.3	6.4	6.8	5.0	3.6	4.6	25.1	20.7	0.0	4.9	7.1	59.5	6.5	10.4	0.0	0.4	2.0	0.6	0.0	5.5	15.4
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 377.8;Late spermatids: 391.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		190000	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	26.0	20.9	21.2	20.4	22.4	22.3	27.5	27.5	26.2	23.9	25.8	19.5	22.5	16.7	30.2	23.7	22.7	21.2	18.7	25.7	21.1	21.8	16.9	35.2	20.5	26.5	21.7	16.7	25.0	17.9	24.9	30.7	32.0	21.0	23.9	18.8	22.7	19.6	25.0	58.9	20.5	21.2	37.7	26.3	21.9	22.4	65.6	23.7	16.9	24.5	24.6	24.5	26.1	28.8	16.8	24.1	13.4	17.1	22.1	20.8	16.1	30.8	24.0	23.6	36.5	18.6	20.9	30.0	25.5	30.2	25.8	24.7	25.5	21.6	42.4	20.5	25.2	41.8	20.9	33.7	23.8	30.5	27.7	28.6	25.0	17.0	24.8	21.8	28.4	23.8	17.1	23.4	18.9	19.2	23.4	28.1	21.4	38.6	32.7	28.1	29.5	24.6	32.5	44.2	26.3	23.0	29.9	20.8	40.8	21.2	22.6	34.0	24.9	29.8	35.5	20.1	29.0	11.6	22.6	21.6	18.5	6.4	37.4	29.3	30.7	21.3	42.0	37.6	31.7	27.2	13.4	15.2	12.0	16.1	17.1	18.6	16.8	16.7	18.6	24.1	14.4	20.8	16.7	2.1	22.1	14.5	5.5	15.9	16.1	21.2	22.4	27.5	26.2	21.1	21.8	21.7	16.7	21.0	23.7	32.8	29.7	24.2	26.3	24.7	29.4	23.2	10.2	42.8	42.1	8.7	27.5	57.0	14.9	24.9	377.8	21.8	9.5	23.3	22.9	69.2	23.6	16.6	22.0	37.5	26.1	20.6	15.0	19.0	15.2	391.5	20.1	22.4	27.0	64.1	19.5	32.1	23.7	14.4	28.7	9.3	42.8	32.3	27.8	53.2	33.0	22.2	61.2	20.8	16.5	17.9
CUL4A		ENSG00000139842	"Cullin 4A"	Q13619	13	113208193-113267108	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058979			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058979: AB_2683868"	"unprognostic (3.01e-1)"	"unprognostic (5.93e-3)"	"unprognostic (6.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.41e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.57e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.48e-1)"	14.6	13.5	9.7	13.9	12.0	20.7	16.5	13.2	10.0	12.0	13.6	12.6	16.1	10.5	13.5	14.4	14.7	11.9	15.0	36.8	8.6	8.4	14.1	23.6	13.3	15.8	10.1	7.0	12.6	23.8	11.2	13.4	13.3	10.6	13.7	11.8	11.2	15.8	15.6	70.5	16.8	12.8	21.7	10.7	13.8	14.0	18.0	9.7	12.8	13.3	25.7	17.4	14.3	15.7	11.7	11.9	11.8	19.3	10.8	22.8	15.4	35.1	18.1	16.7	14.9	20.3	22.8	22.4	36.1	26.0	30.2	23.2	31.2	28.8	42.9	15.7	30.1	29.6	22.5	25.5	19.1	27.4	19.1	25.7	29.0	37.9	23.7	24.3	44.2	19.6	16.4	23.1	17.7	27.3	19.8	19.8	15.8	28.6	8.4	29.2	16.3	22.7	38.7	15.9	47.5	18.2	23.5	18.0	19.9	20.2	16.0	25.5	14.9	18.3	39.1	17.0	15.0	28.7	45.8	28.3	14.9	31.3	16.4	19.8	22.4	16.8	37.8	32.8	35.9	23.1	8.4	13.2	11.8	20.1	19.1	18.6	11.7	20.3	22.8	11.9	10.6	17.1	20.4	4.8	10.8	19.3	9.1	13.2	15.4	9.7	12.0	13.2	10.0	8.6	8.4	10.1	7.0	10.6	9.7	26.8	35.5	13.4	24.4	41.2	13.9	122.7	30.6	18.7	15.9	33.2	9.8	28.7	21.6	25.7	51.2	27.4	20.6	0.0	32.1	30.6	27.2	43.5	10.5	51.3	26.9	27.0	23.0	20.9	47.0	92.3	33.1	25.6	37.1	20.8	33.3	12.5	32.0	17.5	29.7	22.8	17.7	32.3	31.5	57.1	24.5	52.4	33.2	20.6	29.3	36.0
CUL5	VACM-1	ENSG00000166266	"Cullin 5"	Q93034	11	108008733-108107776	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002185, CAB017787"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"CAB017787: , HPA002185: AB_1078587"	"unprognostic (5.66e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (3.83e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	11.6	13.2	10.8	9.0	14.8	25.0	13.4	17.1	19.3	13.1	10.8	12.7	11.0	9.0	13.6	10.7	11.2	10.9	8.7	14.8	11.3	10.6	16.7	15.3	9.7	10.2	12.5	12.3	13.2	11.2	17.8	14.6	12.6	19.5	12.9	9.5	11.2	11.4	10.9	41.6	11.5	11.2	11.8	13.1	12.5	10.3	6.5	12.7	23.1	14.6	15.1	10.0	10.8	13.6	6.4	5.9	4.1	6.7	4.0	6.2	3.6	9.9	4.6	14.1	10.8	9.2	14.9	7.0	10.5	11.6	9.7	10.9	14.9	11.7	14.0	19.7	13.2	10.2	12.8	13.1	8.8	14.2	9.0	8.0	13.1	4.5	11.1	16.0	14.8	10.7	11.7	12.0	10.1	13.5	12.8	13.3	11.6	16.9	5.2	15.2	5.5	14.2	12.9	7.3	12.8	8.3	10.3	10.5	15.2	12.2	15.1	10.2	14.5	14.3	15.3	8.5	9.1	22.2	12.2	13.8	18.0	8.4	12.6	11.3	5.3	4.1	18.3	7.0	16.9	11.4	1.9	6.7	4.1	5.4	5.2	4.9	4.4	5.6	5.3	5.9	6.4	6.1	6.2	1.2	4.0	6.0	5.9	4.0	3.6	10.8	14.8	17.1	19.3	11.3	10.6	12.5	12.3	19.5	12.7	53.6	34.4	27.0	23.9	26.6	50.6	88.7	33.1	37.5	45.5	29.6	62.8	30.3	43.1	26.2	4.6	34.6	14.7	0.0	20.3	17.7	27.7	25.8	41.6	48.1	23.5	52.4	16.9	35.6	42.9	4.5	28.4	34.3	13.5	32.5	24.0	34.1	23.7	24.6	35.7	61.7	57.0	19.4	25.4	26.9	46.3	26.5	30.0	28.7	26.5	28.6
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182175-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	68	"Early spermatids: 532.1;Late spermatids: 1222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	6.2	9.2	11.7	9.5	13.9	12.8	6.9	12.5	13.8	7.4	8.5	12.9	7.3	8.2	11.2	6.5	11.5	10.7	8.5	5.5	10.0	6.4	7.7	5.6	7.5	11.7	10.0	9.8	9.5	8.6	13.2	15.9	5.0	9.2	8.3	5.1	11.2	8.7	9.3	6.0	16.1	10.2	7.7	6.9	10.1	8.7	12.5	10.4	10.8	10.9	4.9	10.8	12.0	7.0	1.1	1.1	0.5	0.9	0.3	2.6	1.0	7.5	5.6	3.1	7.4	8.8	5.2	4.2	3.0	5.4	4.9	4.6	1.8	3.2	6.3	5.9	4.8	4.4	5.5	2.6	6.4	2.3	7.6	2.4	6.9	6.0	2.8	5.7	4.3	11.4	7.1	13.5	4.0	3.6	4.3	7.1	11.1	3.6	8.4	4.3	7.0	8.7	6.3	0.5	14.7	3.6	12.9	2.1	6.2	3.7	7.9	5.3	7.6	4.0	4.9	6.8	2.8	8.3	9.8	6.5	12.3	8.5	3.6	5.7	8.0	7.5	5.1	3.1	7.7	5.5	0.0	0.9	0.3	1.2	0.5	1.3	1.1	0.7	2.6	1.1	0.8	0.6	1.4	0.5	0.3	0.4	0.9	2.5	1.0	11.7	13.9	12.5	13.8	10.0	6.4	10.0	9.8	9.2	10.4	0.0	8.0	4.4	2.2	5.7	9.5	4.4	12.7	4.0	4.5	3.5	11.8	2.7	3.3	3.1	532.1	5.8	7.4	0.0	5.4	1.5	2.8	1.9	2.3	5.5	10.6	11.1	5.8	9.2	5.7	1222.3	10.3	4.6	3.3	4.6	6.5	9.5	4.8	0.0	7.8	4.6	10.0	12.9	3.9	9.3	9.7	4.8	2.2	4.9	6.2	2.4
CUTA	"ACHAP, C6orf82"	ENSG00000112514	"CutA divalent cation tolerance homolog"	O60888	6	33416442-33418317	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016787, HPA064369"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA		35000000	"Plasma membrane, Focal adhesion sites"		"CAB016787: , HPA064369: AB_2685248"	"unprognostic (7.03e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.98e-2)"	"prognostic favorable (8.50e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.55e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.74e-1)"	26.6	65.6	47.9	28.3	60.1	33.5	47.6	37.7	73.7	47.7	37.9	36.8	53.9	42.1	40.1	78.5	30.5	46.0	48.8	49.6	45.2	44.9	46.3	61.6	39.0	77.4	46.5	37.8	57.7	66.6	43.8	86.1	45.7	39.8	38.8	28.9	34.2	74.3	69.7	34.6	32.7	37.2	32.4	47.0	36.0	38.7	27.3	31.6	52.2	69.7	30.3	31.3	42.6	28.9	56.5	31.4	27.1	32.0	49.9	69.8	60.8	43.8	26.3	42.1	53.3	31.7	31.2	20.4	40.1	75.1	77.6	82.7	26.2	27.4	31.0	31.2	45.9	56.4	26.8	27.3	40.8	43.8	26.2	60.5	32.3	43.6	68.6	41.3	25.1	24.6	41.3	34.5	37.3	31.5	54.0	20.8	32.9	39.6	63.1	56.7	34.1	38.0	53.5	37.7	38.0	34.7	41.8	25.1	81.9	53.4	19.1	82.4	42.0	24.0	41.8	72.8	25.2	30.7	52.8	22.9	42.0	35.7	29.8	41.8	62.0	61.6	33.9	36.3	55.6	34.1	27.1	32.0	16.5	45.7	22.9	63.2	56.5	67.6	52.7	31.4	44.2	68.5	53.2	4.6	49.9	16.8	27.1	69.8	60.8	47.9	60.1	37.7	73.7	45.2	44.9	46.5	37.8	39.8	31.6	122.1	105.5	178.5	242.5	204.8	84.5	113.4	239.5	131.2	121.7	300.1	64.8	309.8	240.4	162.1	64.8	93.9	157.7	23.3	122.9	203.5	204.8	237.5	167.3	299.7	277.3	73.1	280.4	131.3	162.9	285.6	185.2	150.2	300.3	80.2	266.0	150.8	114.3	196.4	180.0	440.5	69.0	90.5	220.1	100.6	65.6	201.4	203.1	245.2	291.8	203.9
CUZD1	"ERG-1, UO-44"	ENSG00000138161	"CUB and zona pellucida like domains 1"	Q86UP6	10	122832149-122850793	"Predicted membrane proteins"	"Cell adhesion, Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	200	"pancreas: 650.6"	"Group enriched"	"Detected in some"	23	"Exocrine glandular cells: 224.1;Pancreatic endocrine cells: 71.0"	"Cancer enriched"	"Detected in some"	54	"pancreatic cancer: 32.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	6	"B-cells: 1.1;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.2;LHCN-M2: 8.0"	"Low region specificity"	"Detected in single"							"HPA068479, HPA068660, HPA074117"	Enhanced		Approved	Nucleoli,Vesicles		No	No			Nucleoli	Vesicles	"HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663"	"unprognostic (4.68e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.52e-5)"	"unprognostic (8.08e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.15e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.75e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.83e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	650.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	3.2	0.2	1.6	1.7	1.7	0.0	0.5	0.8	1.0	2.5	0.7	0.3	1.7	1.8	3.7	0.9	0.7	1.1	0.0	1.7	0.0	1.5	2.6	2.3	2.2	3.6	4.7	0.8	0.3	0.0	3.8	1.2	0.3	1.5	7.2	0.2	1.8	1.5	1.3	1.5	8.0	0.4	2.0	2.7	1.7	0.9	1.3	0.0	4.0	0.6	1.4	1.3	1.9	0.7	0.9	0.4	1.1	2.0	1.3	1.9	3.6	0.0	2.4	0.9	0.0	1.9	1.4	3.2	1.3	5.9	0.0	0.0	0.1	0.3	0.8	0.1	1.3	0.6	0.9	1.1	0.1	1.1	1.4	0.7	0.0	0.0	0.2	0.2	3.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.1	0.0	0.0	0.0	224.1	0.0	0.1	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	4.5	0.3	0.0	0.0	6.4	0.0	0.0	71.0	0.0	0.4	0.0	0.5	0.0	0.0	0.5	0.2	0.1	0.0	0.5	0.0	0.0
CWC15	"AD002, C11orf5, Cwf15, HSPC148"	ENSG00000150316	"CWC15 spliceosome associated protein homolog"	Q9P013	11	94962622-94973612	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 683.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039878	Supported		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles, Mitochondria"		"HPA039878: AB_2676722"	"unprognostic (1.97e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.81e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.84e-3)"	"prognostic favorable (9.75e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (5.23e-2)"	9.5	9.6	9.9	7.9	12.0	10.6	13.5	12.4	11.9	10.1	9.2	7.2	7.7	5.8	8.6	14.9	10.0	9.2	5.5	14.1	9.8	9.6	14.0	15.6	8.8	8.7	10.3	10.1	11.8	8.6	7.5	12.1	11.1	12.6	9.5	8.1	6.4	10.2	9.1	24.4	9.0	10.1	7.3	11.7	10.7	9.5	17.2	12.4	11.2	11.2	14.7	9.6	9.8	10.6	31.8	31.3	36.8	33.0	26.1	35.8	25.7	10.8	8.8	26.3	12.5	25.0	22.8	13.7	16.3	23.0	27.4	22.7	39.3	24.8	16.8	33.1	23.1	20.3	11.4	15.9	20.6	29.4	21.3	14.0	21.1	10.5	17.7	21.5	26.3	13.1	22.6	23.7	18.3	24.5	22.8	26.6	20.5	24.8	14.6	24.6	14.3	25.3	35.6	12.6	30.5	22.2	17.2	16.0	17.7	27.2	13.1	14.9	11.6	18.0	17.8	14.1	25.5	28.6	21.3	14.6	18.0	14.4	25.0	16.2	6.9	17.6	23.2	10.1	30.4	17.5	36.8	25.1	34.5	26.8	27.3	35.8	31.8	34.6	32.8	31.3	27.6	34.4	34.7	29.5	26.1	33.0	29.7	35.4	25.7	9.9	12.0	12.4	11.9	9.8	9.6	10.3	10.1	12.6	12.4	68.5	52.8	80.4	76.4	52.7	51.9	156.1	96.8	103.1	97.8	48.8	13.7	121.9	187.3	96.3	683.1	78.7	55.1	140.2	125.1	102.3	82.2	67.4	99.6	99.5	111.8	38.1	27.3	83.4	57.4	99.0	104.4	88.5	67.4	94.6	54.4	99.4	104.3	80.6	87.4	170.4	46.4	135.8	50.5	192.5	186.1	55.8	99.8	69.1	59.8	59.2
CWF19L1	"FLJ10998, hDrn1"	ENSG00000095485	"CWF19 like 1, cell cycle control (S. pombe)"	Q69YN2	10	100232298-100267680	"Disease related genes, Predicted intracellular proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036889, HPA036890"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA036889: AB_10670928, HPA036890: AB_10696789"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.61e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	13.8	9.8	8.6	13.6	12.5	20.5	15.8	18.3	18.6	11.8	9.9	15.4	6.1	7.9	13.8	9.0	11.0	12.9	8.7	10.6	9.0	10.3	11.2	14.8	11.6	19.1	11.5	8.6	14.3	14.1	12.4	12.4	12.2	12.4	10.5	11.5	12.3	11.0	10.6	14.1	14.7	11.8	14.4	11.2	19.1	10.1	19.7	10.8	22.3	13.8	11.2	22.6	12.5	10.1	12.2	12.2	18.6	13.9	13.9	15.4	11.1	14.4	10.9	9.8	14.2	4.8	6.5	10.2	9.5	14.2	22.4	19.2	10.8	11.2	16.7	9.9	8.5	8.3	13.4	22.8	13.0	23.9	11.6	9.2	9.5	9.7	8.8	8.1	23.5	9.1	8.1	5.4	16.3	15.3	7.0	14.8	14.7	11.0	13.9	11.9	8.5	18.3	7.8	7.0	6.7	9.7	6.2	18.6	9.8	6.9	7.9	4.5	8.5	12.4	4.8	12.3	7.1	19.4	6.5	11.8	7.9	10.4	8.8	15.7	11.4	15.2	10.1	10.4	18.5	5.1	9.8	13.9	18.6	12.1	13.2	15.4	12.2	12.7	13.0	12.2	12.0	14.1	13.8	7.2	13.9	11.7	4.8	15.2	11.1	8.6	12.5	18.3	18.6	9.0	10.3	11.5	8.6	12.4	10.8	17.9	9.6	6.6	6.0	3.9	8.4	7.0	5.1	14.7	13.6	5.2	3.9	8.8	6.6	4.5	13.3	7.1	3.6	0.0	6.6	8.9	6.1	4.6	17.3	5.8	8.2	9.5	4.1	3.7	17.3	4.5	6.4	6.0	8.5	13.6	3.4	5.1	5.9	4.8	3.9	5.4	11.9	0.0	7.1	11.4	11.3	6.8	9.2	10.9	4.3	3.8
CWF19L2	FLJ32343	ENSG00000152404	"CWF19 like 2, cell cycle control (S. pombe)"	Q2TBE0	11	107326345-107457844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038166	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA038166: AB_10669518"	"unprognostic (1.38e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.76e-2)"	16.5	9.9	19.0	18.2	24.4	11.5	18.4	43.7	25.1	23.0	13.6	5.6	14.9	8.0	17.7	13.9	11.5	13.2	9.8	11.3	16.2	10.7	18.2	13.3	11.4	14.8	16.3	16.9	23.8	9.6	17.7	27.9	13.2	17.9	16.6	10.3	5.1	11.4	14.6	29.1	13.0	11.3	14.9	23.5	18.0	11.1	9.0	21.7	15.8	15.8	9.2	16.8	21.0	47.4	19.4	12.5	22.2	6.8	11.2	13.9	2.8	6.2	5.1	11.1	5.3	9.2	10.4	8.3	8.2	7.7	6.5	8.7	11.9	14.8	10.9	15.8	5.8	8.3	15.3	12.2	6.3	11.4	12.1	6.8	12.1	5.9	7.7	6.0	14.2	10.2	5.3	11.1	7.5	11.3	7.5	8.7	6.6	18.2	6.3	9.4	4.6	10.9	12.9	10.4	10.4	7.3	9.6	10.6	14.6	7.6	7.8	6.4	5.3	12.0	9.0	4.5	9.7	12.1	6.8	7.9	10.8	8.7	5.6	7.3	3.4	6.2	10.8	3.2	14.0	9.9	22.2	6.8	11.8	9.8	6.0	10.8	17.6	11.4	9.7	2.9	19.4	13.9	10.6	13.0	11.2	6.3	12.5	9.7	2.8	19.0	24.4	43.7	25.1	16.2	10.7	16.3	16.9	17.9	21.7	35.7	53.5	49.4	17.3	15.9	90.9	22.6	50.9	24.1	46.6	78.5	90.3	21.2	28.2	18.3	2.6	43.6	16.9	0.0	16.0	18.5	22.2	6.0	44.0	50.5	13.8	65.2	12.6	47.9	27.5	6.2	50.3	29.7	13.5	26.2	20.7	53.3	13.8	22.9	60.1	37.1	129.6	38.8	23.1	49.8	46.9	11.7	14.2	43.6	20.3	6.7
CX3CR1	"CCRL1, CMKBRL1, CMKDR1, GPR13, V28"	ENSG00000168329	"C-X3-C motif chemokine receptor 1"	P49238	3	39263494-39281735	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"	"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 69.2;brain: 51.6"	"Cell type enhanced"	"Detected in some"	17	"Kupffer cells: 14.4;Macrophages: 26.4;Sertoli cells: 6.5;T-cells: 15.2"	"Cancer enhanced"	"Detected in many"		"glioma: 21.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 69.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	20	"RPMI-8226: 114.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032478, HPA046587"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB032478: AB_638830, HPA046587: AB_2679708"	"unprognostic (2.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.12e-1)"	2.3	3.8	14.9	6.0	17.3	0.9	4.8	2.5	34.1	2.7	1.2	51.6	0.0	1.2	2.7	4.2	1.4	5.9	2.5	2.2	12.4	11.9	2.5	1.9	9.0	1.8	21.8	7.4	1.8	1.8	5.2	2.5	4.3	21.8	3.7	1.2	3.5	6.4	7.0	5.2	2.4	1.2	3.3	33.5	10.3	1.5	1.8	16.3	0.8	2.4	0.7	4.7	2.8	1.3	0.1	15.7	3.5	69.2	6.5	46.5	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	114.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	1.2	15.9	0.2	46.5	43.3	0.5	0.1	10.4	25.2	15.7	0.1	3.7	22.7	3.5	6.5	69.2	1.1	0.2	29.8	14.9	17.3	2.5	19.9	12.4	11.9	21.8	7.4	21.8	16.3	0.0	0.3	0.0	0.0	0.5	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.7	0.0	3.5	0.0	0.0	0.6	14.4	0.0	0.3	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.5	0.0	0.7	0.2	0.5	0.0	15.2	0.0	0.0
CXCL16	"CXCLG16, SR-PSOX, SRPSOX"	ENSG00000161921	"C-X-C motif chemokine ligand 16"	Q9H2A7	17	4733526-4739922	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 715.4;Late spermatids: 3190.9;monocytes: 938.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7"	"Cell line enhanced"	"Detected in many"		"A-431: 35.0;CACO-2: 24.1;CAPAN-2: 19.0;HaCaT: 39.2;T-47d: 18.9"									"HPA053253, HPA066315"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1100000	4000000	"Golgi apparatus"	Vesicles	"HPA053253: AB_2682091, HPA066315: AB_2685657"	"unprognostic (4.64e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-1)"	32.5	9.5	8.2	18.7	9.7	16.3	9.7	2.0	6.6	8.0	17.2	15.8	3.4	19.1	4.8	10.5	13.1	9.5	23.0	5.2	9.9	6.9	12.5	34.8	41.9	28.8	13.3	5.1	10.6	11.0	34.6	8.6	9.7	10.0	9.8	8.3	12.7	26.6	5.9	3.3	11.3	29.5	5.2	16.5	34.1	18.7	51.9	10.0	4.5	8.1	8.5	10.1	9.7	7.4	3.4	10.7	25.9	37.7	0.0	0.3	6.9	35.0	4.8	0.0	11.3	0.1	0.9	4.5	0.4	3.4	3.4	4.6	24.1	19.0	0.0	4.2	0.2	2.1	39.2	5.6	4.0	1.2	3.6	6.4	0.0	0.5	10.6	2.4	0.0	5.2	0.2	6.7	1.8	0.2	1.3	0.9	0.1	0.0	0.2	0.3	7.4	0.1	0.6	0.0	10.1	3.0	0.4	0.0	5.2	7.2	5.8	0.0	0.4	7.1	2.9	1.8	0.4	18.9	0.4	0.1	0.5	2.5	0.8	2.0	1.2	1.6	0.0	0.1	0.1	0.9	0.0	18.3	4.0	0.1	29.3	0.1	2.9	0.3	0.2	10.7	3.4	0.1	0.3	25.9	0.0	37.7	4.6	0.0	6.9	8.2	9.7	2.0	6.6	9.9	6.9	13.3	5.1	10.0	10.0	68.5	50.1	21.2	107.8	62.3	2.0	0.7	40.8	14.7	37.5	38.4	2.0	2.4	3.3	146.2	715.4	13.4	32.3	0.0	129.6	1.8	13.6	179.9	71.7	5.9	190.7	3.2	29.6	160.8	160.8	3190.9	22.7	246.0	25.3	938.6	23.4	6.8	134.1	45.6	28.3	6.8	0.8	19.4	18.9	20.7	11.8	66.9	2.4	10.0	19.3	257.2
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137253	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 216.1"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 17.5;Club cells: 3.4;granulocytes: 5.8;Kupffer cells: 5.0;Macrophages: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	59	"neutrophil: 216.1"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 216.1"	"Group enriched"	"Detected in some"	11	"BEWO: 12.4;HL-60: 6.9;HMC-1: 14.4;THP-1: 13.1;U-937: 12.9"	"Low region specificity"	"Detected in single"							"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		NA	NA			"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	9.3	0.9	1.3	25.6	1.5	4.0	0.6	1.2	1.3	5.2	0.6	0.5	2.5	0.0	0.8	1.1	18.1	3.3	5.2	4.3	1.5	0.6	0.7	4.6	16.7	40.5	6.6	0.0	1.2	1.7	0.0	0.7	4.5	1.7	1.9	0.3	1.8	3.3	2.6	0.6	3.0	0.7	1.4	4.1	30.6	1.0	1.1	0.7	0.6	0.6	4.8	10.1	5.4	6.4	0.0	1.6	216.1	1.9	0.4	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.1	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	13.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.9	0.0	3.6	1.9	3.2	1.9	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.7	216.1	0.4	0.2	1.6	0.0	1.0	1.3	1.5	1.2	1.3	1.5	0.6	6.6	0.0	1.7	0.7	0.0	17.5	0.0	0.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.2	5.8	0.0	1.6	0.0	0.0	0.0	5.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.0	1.8
CXorf21	FLJ11577	ENSG00000120280	"Chromosome X open reading frame 21"	Q9HAI6	X	30558824-30577844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7"	"Cell type enhanced"	"Detected in some"	13	"B-cells: 25.2;granulocytes: 15.0;Hofbauer cells: 20.5;Kupffer cells: 21.1;Macrophages: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 59.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001185	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	6.5	2.1	4.6	9.8	4.0	16.0	2.0	0.8	4.4	1.4	3.0	2.3	0.2	4.3	1.2	2.4	1.4	1.5	3.6	1.5	5.0	2.1	1.9	2.8	6.1	12.9	6.3	0.0	1.0	2.0	0.7	1.5	2.7	5.1	1.5	3.1	1.1	3.3	0.5	0.8	1.1	5.3	1.8	9.9	16.7	3.1	0.8	5.2	9.1	1.4	1.2	9.3	4.8	1.4	11.1	21.9	14.9	18.9	3.2	1.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	7.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.0	0.0	0.0	5.6	0.5	2.7	0.0	8.5	0.0	3.4	10.3	11.4	0.8	9.6	0.1	11.1	1.0	0.5	12.0	10.8	1.0	0.7	14.9	3.2	18.9	21.9	1.6	3.5	4.6	4.0	0.8	4.4	5.0	2.1	6.3	0.0	5.1	5.2	0.0	2.2	25.2	0.2	0.5	0.0	0.2	0.0	2.7	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	15.0	0.0	20.5	0.0	0.0	0.6	21.1	0.0	0.0	39.3	8.5	5.4	0.0	2.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.2	1.3	0.0	0.1
CXorf38	MGC39350	ENSG00000185753	"Chromosome X open reading frame 38"	Q8TB03	X	40626921-40647554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050120	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA050120: AB_2681024"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.73e-2)"	"prognostic favorable (1.44e-8)"	12.5	12.5	6.5	14.2	9.6	11.7	11.7	8.2	7.2	11.6	14.3	9.7	13.9	10.1	12.5	13.9	9.4	13.0	8.8	11.2	7.7	6.1	11.1	11.2	14.4	25.3	8.5	7.2	12.4	9.6	16.5	9.4	12.5	8.8	8.5	9.7	7.8	11.0	19.3	7.1	9.1	14.6	8.9	10.9	18.3	8.2	4.8	9.0	17.3	16.5	7.5	16.4	12.2	9.9	9.0	13.7	21.3	21.9	6.7	9.8	9.4	9.5	5.0	5.1	4.0	5.7	9.8	3.0	6.6	9.1	8.2	8.6	6.7	13.5	16.7	6.2	9.8	14.1	6.5	6.2	11.0	7.6	23.2	10.3	10.6	5.7	3.5	9.8	18.9	17.0	8.3	7.2	11.6	10.8	7.3	9.9	13.5	4.7	12.0	14.9	9.4	12.4	12.0	4.7	6.5	11.7	10.4	11.1	11.9	9.5	15.2	6.1	8.2	13.0	6.2	7.2	10.5	10.6	7.9	11.4	10.2	6.4	7.7	5.4	13.7	5.0	7.2	13.2	8.9	6.9	9.5	16.1	21.3	9.6	15.0	9.6	6.8	8.8	7.0	13.7	9.0	7.9	7.4	20.4	6.7	21.9	5.9	9.8	9.4	6.5	9.6	8.2	7.2	7.7	6.1	8.5	7.2	8.8	9.0	8.9	7.8	31.3	8.0	3.2	12.9	5.3	17.8	4.0	5.7	15.7	17.7	7.6	6.6	21.5	0.7	9.9	12.4	0.0	26.3	7.9	7.4	10.5	16.2	8.5	32.3	14.3	7.0	8.6	31.7	0.4	8.9	29.9	3.3	45.9	14.1	12.3	28.2	17.5	4.9	11.2	7.7	6.5	5.6	3.7	6.5	4.6	6.9	24.2	12.1	25.2
CXorf56	FLJ22965	ENSG00000018610	"Chromosome X open reading frame 56"	Q9H5V9	X	119538149-119565408	"Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038245, HPA038617, HPA064831"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: AB_2685364"	"prognostic unfavorable (3.45e-4)"	"unprognostic (3.88e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.92e-2)"	"unprognostic (7.74e-3)"	"unprognostic (6.38e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.68e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-1)"	15.9	14.5	18.7	12.7	29.1	19.1	21.1	21.0	24.2	15.0	15.6	18.3	15.1	12.3	17.6	14.5	13.6	17.6	12.4	16.3	16.0	20.5	18.2	14.3	14.6	15.7	18.0	21.3	24.0	16.3	20.5	12.6	29.0	20.2	15.3	15.0	18.6	14.6	16.1	16.4	17.4	12.5	16.2	17.8	15.0	13.0	12.7	17.6	12.8	20.2	13.2	19.0	14.4	13.1	19.4	12.0	16.8	15.4	7.7	12.9	10.9	16.5	19.4	11.7	13.3	13.4	9.8	15.0	11.4	11.8	17.9	16.2	16.8	16.8	26.1	28.7	13.3	37.4	11.0	29.5	15.1	25.2	15.7	22.3	9.3	17.7	11.2	10.7	25.8	15.0	10.8	13.1	21.9	18.8	10.4	12.5	16.5	20.9	16.7	8.7	29.0	16.2	13.6	17.5	21.9	20.1	15.8	12.1	19.7	10.7	13.0	8.1	14.1	22.1	12.3	15.3	13.4	10.2	11.3	12.0	10.8	7.5	20.0	24.1	14.5	25.6	26.6	9.8	25.3	13.8	5.7	12.8	16.8	12.4	15.4	11.4	13.5	10.8	12.9	12.0	19.4	11.1	10.5	6.5	7.7	14.1	11.3	12.4	10.9	18.7	29.1	21.0	24.2	16.0	20.5	18.0	21.3	20.2	17.6	3.0	11.5	11.1	7.2	5.6	15.6	10.6	5.1	8.1	4.5	3.5	5.9	16.9	18.3	7.7	1.2	6.8	8.1	0.0	5.8	16.9	6.7	4.9	17.3	3.9	8.9	7.9	8.2	4.9	10.5	1.0	8.9	7.4	11.8	19.8	5.6	17.0	5.8	8.5	10.6	10.5	10.2	12.9	9.1	3.4	7.8	5.1	29.7	5.7	8.4	7.3
CXorf58	FLJ25444	ENSG00000165182	"Chromosome X open reading frame 58"	Q96LI9	X	23907801-23939507	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 8.4"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 18.3;Spermatocytes: 20.0;Spermatogonia: 5.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"monocytes: 1.0;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"GAMG: 4.4;PC-3: 2.0;U-266/70: 1.9"									"HPA031542, HPA031543, HPA031544"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031542: AB_2673927, HPA031543: AB_10603789, HPA031544: AB_2673929"	"unprognostic (9.74e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.06e-3)"	0.1	0.4	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.1	0.2	0.0	0.9	0.0	0.2	0.2	0.3	0.6	0.2	0.1	0.0	0.2		0.0	0.4	0.2	0.3	0.0		0.0	0.0		0.3	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	8.4			0.6		0.0	0.2	0.0	0.1	0.2	0.1	1.0	0.0	1.8	0.1	0.7	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.3	0.1	0.1	0.0	0.8	1.0	0.2	0.0	4.4	0.5	0.1	0.7	0.0	0.4	0.5	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.7	0.6	0.5	0.0	0.0	1.6	0.3	0.2	0.1	0.1	0.1	0.8	0.0	0.1	2.0	0.4	0.0	0.1	1.0	0.0	0.9	0.1	0.5	0.1	0.4	0.1	1.1	0.1	0.4	0.0	0.0	0.2	0.3	1.9	0.9	0.2	0.2	0.1	0.3	0.0	0.0	0.1	0.3	1.0	1.4	0.1	1.3	1.0	0.0	0.1	1.0	0.7	0.0	0.0	0.2	0.2	1.8	0.1											0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	4.0	0.0	0.0	0.0	0.1	1.7	0.0	18.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.0	0.0	0.5	0.1	0.0	0.0	0.0	2.3	0.0	0.0	20.0	5.2	0.0	0.1	0.0	0.0	0.0
CXXC5	"HSPC195, RINF, WID"	ENSG00000171604	"CXXC finger protein 5"	Q7LFL8	5	139647299-139683882	"Predicted intracellular proteins"	Transcription	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 68.2"	"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 594.9;Horizontal cells: 511.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036508, HPA058148"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036508: AB_10673620, HPA058148: AB_2683621"	"unprognostic (3.08e-2)"	"unprognostic (9.03e-2)"	"prognostic favorable (2.40e-4)"	"prognostic unfavorable (4.10e-7)"	"unprognostic (2.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.57e-1)"	12.3	9.5	22.4	9.3	19.9	22.2	9.2	68.2	38.8	17.5	10.2	39.3	5.1	6.0	9.9	18.0	10.1	18.1	11.4	15.8	23.9	16.7	25.6	33.8	9.0	15.5	30.9	21.7	5.4	24.9	18.2	18.6	10.4	25.4	8.1	7.9	14.2	30.0	11.7	39.7	9.8	9.1	8.4	36.7	18.1	11.4	19.0	27.5	20.5	12.5	7.7	13.5	9.6	9.9	29.3	19.1	0.7	2.1	21.8	10.2	3.4	9.4	8.0	8.8	3.3	12.4	17.0	3.4	6.2	9.5	2.7	5.4	17.6	9.6	12.5	27.6	16.5	16.3	10.9	1.8	4.8	1.3	1.3	3.1	18.6	7.1	12.3	5.3	4.1	0.6	6.1	1.1	4.5	1.3	26.2	0.7	0.4	17.4	2.0	19.5	24.7	4.4	13.2	10.7	10.3	2.2	8.0	18.1	19.1	20.3	6.9	28.2	29.1	2.2	57.1	4.6	20.4	31.2	19.5	3.9	22.2	4.4	10.5	5.5	7.5	15.6	23.6	33.4	1.4	12.2	0.3	2.1	0.1	3.2	0.4	10.2	27.7	0.3	2.3	1.8	29.3	0.2	0.9	0.7	21.8	0.1	19.1	0.4	3.4	22.4	19.9	68.2	38.8	23.9	16.7	30.9	21.7	25.4	27.5	44.7	16.8	79.0	14.3	23.4	189.2	39.2	91.7	25.4	18.2	139.6	23.6	2.7	268.5	104.4	594.9	41.3	10.1	23.3	127.1	18.5	63.9	34.4	20.8	98.7	39.4	511.7	17.9	26.4	25.4	156.4	36.2	34.8	57.3	50.5	49.6	220.2	83.9	5.8	28.7	146.6	42.7	12.9	77.3	5.4	7.8	18.2	31.5	24.5	24.3	15.8
CYB561A3	CYBASC3	ENSG00000162144	"Cytochrome b561 family member A3"	Q8NBI2	11	61348745-61362299	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.7;blood: 98.8"	"Cell type enhanced"	"Detected in many"	10	"Melanocytes: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8"	"Group enriched"	"Detected in all"	10	"B-cells: 50.1;dendritic cells: 98.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045674, HPA052548"	Approved		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA045674: , HPA052548: AB_2681866"	"unprognostic (2.61e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.41e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.80e-3)"	10.0	113.7	4.0	22.5	6.4	7.1	7.5	4.7	6.9	6.6	10.9	10.9	14.4	6.1	10.9	9.9	8.8	11.0	11.0	5.7	5.1	4.1	9.7	30.6	12.4	21.7	8.3	3.5	14.5	17.9	9.0	6.6	21.0	6.8	9.2	9.6	10.7	10.9	8.1	10.2	24.8	15.8	7.6	5.6	24.0	8.5	8.0	7.0	16.8	10.0	8.4	33.3	10.7	7.3	50.1	98.8	3.8	7.4	3.3	3.8	8.7	18.2	30.8	4.9	14.2	23.4	15.5	4.2	9.2	14.0	11.1	11.1	8.3	20.4	35.5	16.6	16.2	9.0	25.5	4.7	25.6	6.8	23.7	10.5	6.1	20.8	5.6	11.0	8.4	15.9	21.8	36.2	24.1	11.1	9.2	16.5	16.1	20.0	21.3	18.6	19.6	15.8	3.6	9.2	16.3	17.7	19.2	4.8	26.5	12.8	18.1	6.1	10.1	18.8	27.1	21.2	3.4	22.0	9.8	10.9	13.1	6.8	12.7	13.2	13.3	17.6	19.9	18.0	14.7	16.4	1.6	7.4	3.8	3.8	6.0	3.4	40.5	2.7	3.4	7.4	50.1	2.8	3.0	2.5	3.3	6.4	98.8	2.6	8.7	4.0	6.4	4.7	6.9	5.1	4.1	8.3	3.5	6.8	7.0	6.0	28.1	119.0	16.1	25.1	15.4	1.4	7.6	29.4	25.0	12.2	29.5	43.5	10.0	22.6	55.7	11.9	46.6	0.0	34.2	35.0	17.5	17.4	8.1	18.7	49.1	17.5	18.5	11.6	20.3	10.6	19.2	29.8	303.7	77.5	27.1	16.9	21.9	38.6	19.4	12.9	51.6	12.9	12.3	5.4	11.1	21.0	33.1	21.8	26.6	12.9
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424525-69466266	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 130.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"		NA	NA		1600000	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	21.3	130.7	29.6	15.4	33.1	5.9	17.1	12.0	37.9	16.6	29.0	22.8	12.6	21.9	20.5	24.6	21.4	19.2	14.7	18.0	23.1	22.0	26.9	26.5	18.3	20.1	21.6	24.4	19.9	12.8	26.3	16.2	24.6	34.3	17.1	38.2	20.2	14.8	16.7	19.9	16.0	31.2	19.9	20.8	20.7	15.4	14.0	16.0	26.0	19.9	17.6	23.5	24.3	16.0	24.8	44.2	35.8	28.3	32.3	46.0	32.4	29.6	94.4	38.9	24.0	18.0	24.0	16.6	26.6	37.1	44.6	42.2	65.8	36.4	27.1	26.8	25.7	36.3	35.3	37.0	38.5	50.8	14.4	14.1	13.0	17.0	76.7	26.6	26.8	29.0	20.6	19.4	52.8	25.3	18.9	42.0	31.3	21.0	13.1	27.3	38.6	43.9	32.6	28.8	27.6	12.9	41.6	21.5	29.7	59.5	34.0	22.8	11.7	70.8	13.6	22.5	20.9	26.3	21.5	18.9	25.7	21.2	17.0	23.4	15.9	35.1	82.9	26.5	22.3	29.7	35.8	20.3	24.3	39.3	28.3	32.2	24.8	29.6	30.8	24.8	22.6	24.6	29.2	6.1	32.3	20.1	44.2	46.0	32.4	29.6	33.1	12.0	37.9	23.1	22.0	21.6	24.4	34.3	16.0	41.7	38.5	39.4	44.1	44.3	21.6	21.7	25.5	52.2	42.1	59.3	5.9	140.9	66.3	51.1	13.9	49.6	69.8	23.3	62.0	75.3	41.2	33.1	58.9	43.3	55.7	28.6	22.5	36.2	27.6	17.2	41.1	44.4	59.1	64.9	68.4	45.7	54.3	63.1	41.8	46.7	30.4	45.3	42.2	31.1	48.5	36.9	50.0	71.0	55.0	45.3
CYB5D1	FLJ32499	ENSG00000182224	"Cytochrome b5 domain containing 1"	Q6P9G0	17	7857746-7862282	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 56.2;Early spermatids: 65.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA021632	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Nucleoli, Golgi apparatus"		"HPA021632: AB_1847368"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-2)"	14.0	13.0	13.2	5.5	22.5	7.2	13.1	14.1	16.8	10.5	7.9	14.0	12.8	6.5	10.9	17.0	7.9	28.2	9.4	13.9	14.4	12.0	19.2	13.0	8.8	4.7	9.4	13.5	14.6	13.1	9.7	18.1	7.0	16.5	11.0	7.8	11.7	10.5	13.2	9.9	10.1	6.0	9.4	6.5	5.9	8.4	14.5	11.7	6.9	22.8	8.6	5.6	7.4	7.5	3.4	3.1	2.7	2.3	1.6	5.9	1.8	16.1	12.0	5.8	15.4	10.4	9.3	3.5	8.3	8.3	9.0	8.6	7.6	3.1	7.0	5.9	6.7	5.3	14.5	12.8	10.9	13.5	4.6	14.7	4.6	15.7	10.8	4.7	8.1	3.3	7.8	13.8	15.6	14.1	5.5	9.5	17.1	3.3	4.8	4.9	7.0	12.6	3.3	7.3	10.5	12.5	8.7	2.7	7.0	14.1	3.1	7.9	5.3	13.2	7.4	7.6	6.2	8.7	3.3	6.6	7.0	6.1	12.2	10.5	2.5	6.1	3.9	14.5	4.5	4.4	0.5	2.3	0.1	2.7	1.9	3.3	3.4	2.4	1.4	3.1	1.5	5.9	3.1	2.7	1.6	1.1	1.4	2.2	1.8	13.2	22.5	14.1	16.8	14.4	12.0	9.4	13.5	16.5	11.7	11.9	24.5	1.9	4.1	4.5	4.2	0.2	10.2	56.2	15.9	5.2	19.6	3.6	11.6	3.6	65.5	6.8	5.1	0.0	2.7	2.1	5.3	8.0	10.4	7.6	3.4	1.6	5.8	6.2	1.0	34.0	4.4	4.0	5.0	0.0	7.5	6.8	5.2	3.5	3.5	9.6	18.0	6.5	3.8	2.8	2.5	5.4	2.2	1.3	7.6	1.6
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011032, HPA042299"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum, Plasma membrane"		"HPA011032: , HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favorable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favorable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.9	10.7	6.2	6.5	40.1	11.8	2.6	7.7	16.7	5.7	5.8	3.1	5.3	2.6	7.0	8.9	4.8	11.3	2.6	3.6	2.3	8.5	12.9	2.4	6.7	5.3	7.3	1.0	4.9	15.4	8.6	3.1	6.2	11.9	10.2	5.8	2.5	15.8	4.3	9.8	3.7	1.6	2.2	6.8	5.8	4.5	5.5	6.3	13.1	4.2	5.0	4.2	8.7	5.1	11.4	7.2	13.5	1.6	13.7	8.3	2.1	7.6	4.0	3.0	2.3	2.0	10.2	2.2	3.2	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1	11.9	9.3	19.5	18.9	47.7	26.3	8.5	56.0	45.5	11.4	29.6	55.0	44.7	44.7	26.6	19.7	31.6	18.6	0.0	23.9	24.3	20.3	8.4	10.5	31.1	17.8	38.1	13.3	29.4	21.3	23.3	26.7	17.5	13.5	14.4	13.8	34.2	24.3	17.3	26.9	34.9	30.0	0.0	21.2	83.1	23.6	37.5	32.3	15.2	15.8	7.8
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961869-202967280	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 119.2"	"Cell type enhanced"	"Detected in all"	6	"Basal keratinocytes: 166.3;Syncytiotrophoblasts: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		860000	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	9.6	14.5	7.8	5.0	8.4	3.9	16.9	6.2	11.0	11.6	7.5	8.7	10.6	4.4	10.1	32.3	13.7	16.4	9.2	33.9	7.3	9.2	15.5	18.4	10.1	11.7	10.0	9.1	10.8	11.1	16.3	11.1	63.8	11.9	10.5	5.0	15.7	14.4	10.1	119.2	28.5	6.9	10.6	7.4	10.8	18.6	20.1	6.7	11.7	13.5	26.4	10.0	13.6	10.1	20.2	21.9	25.7	33.3	17.2	26.5	28.8	8.5	5.3	4.7	9.6	43.9	10.1	46.1	17.1	16.2	11.2	10.0	4.4	10.1	5.3	14.6	17.1	6.2	47.3	3.8	14.7	7.4	7.6	9.7	3.0	6.5	5.0	15.8	2.6	7.6	16.2	48.7	12.3	6.7	9.5	7.3	6.6	8.9	9.6	40.2	10.0	3.2	2.3	3.1	7.7	10.3	5.4	22.7	11.3	10.6	10.2	4.0	5.0	9.6	32.0	13.9	10.7	14.8	5.8	7.1	12.8	5.4	4.8	9.5	9.0	10.6	2.5	14.1	4.0	9.5	11.6	33.3	25.6	16.7	24.2	22.2	13.6	19.3	17.8	21.9	20.2	26.5	18.8	25.7	17.2	15.7	15.1	19.1	28.8	7.8	8.4	6.2	11.0	7.3	9.2	10.0	9.1	11.9	6.7	20.8	24.3	13.0	30.5	166.3	19.6	98.7	33.1	58.9	20.5	27.9	27.5	100.3	6.6	35.7	4.3	29.5	11.9	23.3	41.7	159.6	29.6	19.2	27.7	36.0	54.2	9.5	18.4	23.4	39.9	5.4	27.6	33.5	60.8	9.0	10.9	56.4	53.6	10.5	29.4	32.1	25.9	12.9	34.0	24.6	2.7	137.6	245.4	17.5	14.2	47.8
CYB5R2		ENSG00000166394	"Cytochrome b5 reductase 2"	Q6BCY4	11	7665100-7677222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 58.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 205.4;Late spermatids: 439.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 5.9;memory B-cell: 12.2"	"Group enriched"	"Detected in many"	9	"B-cells: 12.2;granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.5;BJ hTERT+ SV40 Large T+: 22.7;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 18.2;NTERA-2: 23.9;WM-115: 32.7"	"Low region specificity"	"Detected in many"							"HPA038962, HPA061707"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038962: AB_10675954, HPA061707: AB_2732668"	"unprognostic (1.47e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.41e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.01e-2)"	3.3	1.9	9.3	2.8	12.1	1.9	7.7	3.1	12.3	6.6	2.3	26.1	4.2	1.3	10.0	13.1	8.0	5.2	3.4	2.0	11.2	5.3	2.4	2.5	4.6	3.8	22.3	7.3	14.9	2.2	23.1	0.6	6.7	11.6	7.8	2.7	12.2	12.8	11.6	0.8	23.4	1.7	6.8	12.4	2.0	2.2	58.8	14.5	0.2	2.6	6.7	4.9	5.9	7.1	12.2	0.0	5.9	1.0	0.0	0.2	0.7	2.3	1.2	0.5	0.0	0.1	0.6	7.9	14.8	42.5	22.7	20.7	0.2	3.2	0.0	3.5	7.6	7.0	0.2	0.0	0.1	18.2	0.0	0.0	0.0	1.3	0.3	12.3	0.1	2.3	6.2	0.5	0.1	1.2	0.0	1.9	0.0	2.2	0.0	0.1	0.0	0.0	0.0	23.9	2.4	1.1	11.2	0.0	0.0	0.0	1.5	0.0	0.2	0.1	9.5	0.6	4.0	1.6	3.1	0.0	2.1	0.0	0.1	1.1	0.0	0.0	3.5	0.1	0.0	32.7	0.0	1.0	5.9	0.0	0.5	0.0	12.2	0.2	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.7	9.3	12.1	3.1	12.3	11.2	5.3	22.3	7.3	11.6	14.5	20.8	3.2	0.0	7.4	6.3	0.8	1.9	0.0	8.1	2.3	3.5	19.6	4.6	0.0	1.4	205.4	1.0	0.0	0.0	4.2	16.5	7.1	4.8	2.3	1.1	2.3	0.0	0.0	0.0	0.0	439.8	4.4	1.4	5.0	0.0	1.4	0.8	4.6	0.9	5.6	0.0	37.7	12.9	12.6	63.0	5.9	8.8	3.8	0.0	1.4	10.5
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095027-144097525	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.2"	"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 693.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 151.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA		110000	Mitochondria	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	16.0	31.3	16.2	13.2	20.1	19.5	12.1	19.1	32.1	13.0	33.3	13.4	14.4	38.1	13.9	10.1	36.2	15.5	13.1	92.1	16.6	14.1	44.8	55.9	11.2	16.5	18.0	18.6	15.0	21.4	17.9	10.6	16.0	17.7	16.5	25.3	13.3	23.3	17.2	145.2	17.7	42.6	16.3	11.8	18.3	22.4	13.9	11.5	21.5	21.7	43.8	18.5	19.9	14.4	34.9	76.7	22.1	60.0	30.2	26.1	58.5	22.2	50.5	13.4	28.0	11.1	12.4	25.9	12.8	15.7	32.7	21.5	35.3	27.9	31.6	29.0	17.1	15.9	33.0	29.3	25.4	12.3	19.3	38.8	33.9	42.7	32.3	20.0	20.0	22.1	18.0	31.9	20.8	41.4	11.0	19.0	21.9	30.8	28.2	17.1	80.0	37.4	18.5	15.6	62.7	151.5	33.0	18.0	55.3	26.9	35.9	36.1	15.9	35.8	49.5	26.3	7.7	40.7	30.7	14.4	20.9	44.6	23.0	39.0	31.4	22.8	23.4	26.6	34.1	26.6	22.1	59.7	15.9	24.1	60.0	25.4	34.9	20.1	25.8	76.7	29.4	19.7	25.4	5.8	30.2	44.8	42.9	26.1	58.5	16.2	20.1	19.1	32.1	16.6	14.1	18.0	18.6	17.7	11.5	17.9	24.8	104.2	137.8	138.6	109.2	340.1	175.8	33.5	25.0	75.0	76.6	235.5	693.0	191.2	55.0	98.8	477.2	70.0	250.0	197.5	112.8	124.7	59.9	203.6	217.6	82.6	140.6	55.3	91.9	71.2	82.3	127.4	170.4	267.9	288.6	98.9	227.1	319.6	85.2	391.4	75.4	71.1	158.3	73.6	93.6	143.2	198.1	79.6	481.1	207.2
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.8;brain: 44.2;kidney: 69.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 150.1;Distal tubular cells: 147.6;Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 52.0;JURKAT: 35.9;MOLT-4: 49.3;U-266/70: 38.4;U-698: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favorable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	1.9	6.6	28.6	13.4	31.7	22.8	1.7	39.1	44.2	1.8	4.3	7.7	1.6	3.1	3.5	12.3	2.1	4.9	4.7	5.1	28.7	20.4	69.7	8.2	5.9	25.9	16.2	27.2	2.7	3.6	30.6	13.2	4.4	15.8	3.2	5.0	4.7	2.2	3.5	3.1	1.8	6.4	2.9	7.9	15.8	9.5	2.6	8.9	28.5	5.4	0.0	25.7	6.0	1.7	13.7	15.6	30.1	42.8	17.4	32.1	22.9	0.0	8.1	12.5	7.0	0.2	0.3	20.0	1.4	2.5	0.6	1.8	1.5	0.1	52.0	3.6	0.8	1.8	0.1	9.9	6.7	1.5	11.8	15.6	6.6	10.6	6.0	1.0	6.9	18.4	1.4	2.7	2.0	0.1	4.9	2.1	35.9	0.1	20.9	1.7	1.9	49.3	1.3	5.5	0.1	2.1	12.2	0.3	24.8	6.6	7.4	18.1	7.2	0.1	7.1	1.1	12.7	4.8	0.2	2.9	0.4	5.3	1.7	1.3	38.4	9.6	36.6	5.5	8.3	2.9	17.4	4.3	30.1	32.1	20.0	22.9	13.7	23.3	27.7	6.2	13.4	24.7	28.1	14.4	17.4	42.8	15.6	18.4	22.9	28.6	31.7	39.1	38.3	28.7	20.4	16.2	27.2	15.8	8.9	3.0	24.0	31.6	2.0	1.0	56.1	15.1	10.2	6.7	11.4	150.1	15.7	28.2	147.6	8.4	15.2	2.7	5.3	0.0	1.4	38.9	2.1	1.2	2.3	30.8	4.7	85.8	13.8	7.4	5.4	14.9	1.7	6.2	6.8	13.6	5.6	10.9	2.5	9.9	6.3	46.6	33.3	0.0	7.1	2.3	11.5	1.3	17.6	48.4	8.8	1.4
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 88.6;Melanocytes: 74.2;Sertoli cells: 90.5;Smooth muscle cells: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 25.0;Hep G2: 19.1;HHSteC: 38.0;HSkMC: 31.0;SH-SY5Y: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: AB_2684573"	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favorable (2.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	48.1	16.1	6.2	9.5	8.3	1.1	34.4	10.9	11.6	13.3	19.0	1.5	8.4	15.2	8.8	8.4	12.5	8.8	24.1	43.4	4.2	11.2	6.9	13.6	17.8	9.5	6.3	5.5	11.2	7.6	8.5	5.0	10.0	17.7	22.8	7.0	23.7	10.4	9.4	17.1	8.2	17.8	17.6	3.5	8.0	13.1	9.3	2.2	1.1	22.0	11.4	3.4	35.1	41.5	4.4	0.4	2.4	0.3	2.5	1.3	0.5	0.0	0.3	0.6	0.1	25.0	7.4	8.4	0.2	0.6	0.1	0.3	0.0	0.1	0.0	8.1	0.7	0.1	0.2	0.0	10.7	0.0	0.0	0.0	0.1	0.1	19.1	38.0	0.0	0.0	31.0	2.3	0.8	0.8	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.2	41.5	0.0	0.0	0.8	1.9	0.0	0.2	0.0	1.0	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.1	3.2	0.0	0.3	0.4	0.5	0.2	0.3	3.4	0.4	0.2	0.4	4.4	0.7	1.3	2.4	2.5	0.2	0.0	0.5	0.5	6.2	8.3	10.9	11.6	4.2	11.2	6.3	5.5	17.7	2.2	3.0	1.3	0.0	1.2	9.6	24.0	3.4	0.0	25.4	10.3	0.0	0.0	0.9	0.0	0.8	0.7	16.2	0.0	0.0	0.2	0.5	13.7	0.7	0.0	0.9	0.4	7.9	0.0	3.7	0.0	1.1	88.6	3.5	74.2	0.0	0.0	17.5	0.2	0.0	21.9	0.0	10.0	90.5	44.5	1.0	1.2	5.8	2.4	0.5	0.0	0.6
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	9.3	16.2	13.9	22.9	26.4	51.1	9.1	14.2	20.9	9.2	10.3	18.8	12.8	10.2	16.1	8.1	15.3	8.5	13.3	12.7	15.7	17.0	9.4	13.2	15.6	30.7	16.3	14.3	11.5	12.2	20.3	27.8	9.8	20.0	11.0	12.7	13.3	12.6	10.9	31.7	12.4	14.2	12.5	16.3	23.4	12.4	22.6	13.7	16.9	16.2	8.0	29.3	14.1	12.6	9.2	10.2	31.4	9.8	13.6	19.1	10.2	9.3	2.9	3.4	3.8	5.4	7.8	3.1	13.8	20.2	14.4	8.5	2.4	4.4	10.7	5.0	13.5	15.7	3.6	4.0	8.4	21.5	47.2	6.1	5.3	5.2	2.0	10.7	5.3	25.3	8.5	6.8	17.4	18.2	13.7	5.8	7.6	2.2	9.4	20.1	1.4	5.2	7.7	3.6	2.9	4.9	4.7	6.9	10.3	4.7	3.2	4.4	3.3	11.7	4.0	3.4	5.4	4.0	6.7	6.5	24.7	5.6	8.6	5.6	24.8	23.5	12.0	18.1	6.0	5.2	31.4	8.6	20.8	10.7	9.8	12.9	9.2	15.8	14.4	10.2	6.2	14.7	11.4	19.4	13.6	9.5	6.2	19.1	10.2	13.9	26.4	14.2	20.9	15.7	17.0	16.3	14.3	20.0	13.7	41.7	25.6	39.6	48.8	106.7	75.4	32.7	25.5	12.0	19.4	17.4	88.4	5.4	5.0	18.3	32.8	37.9	13.4	46.7	16.5	3.8	37.2	52.3	78.5	22.1	19.0	63.5	29.9	21.5	32.3	24.7	23.6	47.1	70.9	34.3	10.3	22.6	15.2	18.7	19.8	10.3	49.3	6.5	34.4	52.6	13.8	135.9	3.4	73.4	12.0	56.3
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153449-54173973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Group enriched"	"Detected in some"	16	"A549: 95.1;Hep G2: 27.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022261, HPA063771"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.1	0.1	0.4	0.2	0.7	0.0	2.5	0.1	0.4	2.5	0.1	0.0	0.3	0.0	11.2	0.4	4.4	0.3	0.0	0.1	0.4	0.8	38.8	0.3	1.6	0.1	0.2	0.0	0.1	0.1	0.0	0.7	7.0	0.3	7.0	0.0	0.1	0.3	1.5	0.1	1.0	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.4	1.4	5.9	25.8	31.2	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	95.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.7	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	1.6	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.4	0.4	0.8	0.2	0.0	0.3	0.0	0.0	0.0	1.5	21.1	20.3	0.0	0.3	0.0	8.1	29.6	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.0	39.9
CYP26B1	P450RAI-2	ENSG00000003137	"Cytochrome P450 family 26 subfamily B member 1"	Q9NR63	2	72129238-72148038	"Disease related genes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Group enriched"	"Detected in many"	8	"Leydig cells: 70.2;Peritubular cells: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 8.2;HaCaT: 12.1;RH-30: 15.6;U-2 OS: 17.3;U-2197: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012567	Uncertain		Approved	Cytosol	"Intracellular and membrane"	No	No			Cytosol		"HPA012567: AB_1847429"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.19e-4)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.17e-4)"	"unprognostic (8.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.04e-2)"	16.6	2.6	8.3	2.1	7.8	0.1	7.7	25.0	23.9	5.8	2.4	1.2	1.6	3.6	1.5	1.6	3.4	2.7	1.2	6.0	2.5	1.5	4.2	0.7	2.7	4.4	3.4	10.0	4.9	0.2	0.9	5.2	3.2	35.4	1.3	1.2	1.2	5.1	7.5	7.6	20.5	2.4	1.5	0.6	1.9	0.5	13.8	1.1	4.9	9.2	2.2	2.8	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.9	0.0	0.1	8.2	3.1	4.9	0.7	0.1	0.2	0.2	1.5	0.4	0.0	0.4	0.6	2.4	12.1	6.9	0.0	0.1	0.0	2.2	0.0	4.9	0.6	0.1	0.0	0.2	0.0	0.4	0.0	0.2	2.5	0.9	3.3	0.4	0.1	0.7	2.3	0.0	0.1	0.0	0.1	0.8	0.0	15.6	0.0	0.0	1.2	0.5	0.1	2.7	0.0	2.9	1.0	0.2	0.7	0.0	1.3	17.3	7.6	2.6	0.0	0.9	0.0	5.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.8	25.0	23.9	2.5	1.5	3.4	10.0	35.4	1.1	0.0	0.0	2.9	1.1	13.1	0.1	1.1	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	1.6	0.0	0.0	0.0	0.7	3.7	0.3	0.0	0.2	0.1	0.0	1.7	17.2	4.5	4.9	70.2	0.0	6.8	0.0	0.0	5.4	0.2	0.0	216.0	0.0	0.0	0.0	5.6	1.4	3.0	8.4	0.1	0.0	0.0	0.1
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 149.0"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 367.9;Hofbauer cells: 155.3;monocytes: 143.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 176.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 38.2;neutrophil: 30.6"	"Group enriched"	"Detected in many"	20	"granulocytes: 30.6;monocytes: 38.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 74.3;HSkMC: 14.2;RPTEC TERT1: 18.9;SK-MEL-30: 30.5;WM-115: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	14.4	12.3	6.3	4.7	13.4	0.7	5.5	2.4	7.5	6.5	21.9	16.9	24.9	21.0	5.0	5.4	3.5	9.2	5.1	6.9	8.3	6.2	12.6	149.0	22.4	5.6	19.9	5.7	9.5	2.4	6.3	7.1	2.0	12.1	11.6	6.0	15.1	10.0	21.5	10.0	3.9	36.8	5.0	18.8	3.1	3.5	3.7	15.7	3.7	3.1	4.0	7.6	5.5	5.7	0.1	1.7	30.6	38.2	0.0	0.1	10.0	0.0	0.0	0.7	0.0	1.3	0.9	0.1	0.8	3.0	1.0	2.1	3.7	0.1	0.0	1.5	2.1	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.0	0.1	74.3	4.3	0.1	0.0	14.2	0.1	0.0	0.0	3.5	1.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.7	0.1	18.9	0.0	0.0	0.0	0.0	0.0	30.5	0.7	0.5	0.7	1.7	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.9	0.0	38.2	0.1	0.0	4.3	0.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	30.6	0.0	0.3	0.2	0.0	10.0	6.3	13.4	2.4	7.5	8.3	6.2	19.9	5.7	12.1	15.7	3.0	28.2	0.9	44.4	4.6	13.8	5.0	17.8	14.7	12.5	3.5	25.5	0.9	8.3	9.2	0.9	7.1	46.1	0.0	10.8	0.5	20.2	45.1	2.3	367.9	155.3	9.5	23.5	19.6	15.9	0.6	44.0	31.1	47.2	143.3	9.0	29.6	6.6	19.3	25.1	66.2	13.7	0.0	8.5	0.3	0.0	2.8	1.0	2.5	18.7	20.0
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991250-41018398	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 137.3"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 326.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 7.0;OE19: 4.9"					"Not detected"	"Not detected"			"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	3.0	137.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	1.8	3.1	0.8	0.7	0.9	0.1	0.4	0.4	0.5	0.4	0.1	0.0	0.4	0.2	0.3	0.0	0.1	1.5	0.0	0.3	0.3	0.2	0.1	7.0	0.4	0.1	0.1	0.3	0.6	0.4	0.7	0.4	0.4	0.4	0.4	0.0	0.4	0.3	0.1	0.3	0.5	0.7	0.4	0.1	0.2	0.1	0.8	1.8	0.6	4.9	0.4	0.2	0.5	0.4	1.7	0.1	0.9	0.2	0.3	0.1	0.5	0.3	0.7	1.1	0.8	0.6	0.3	0.7	0.5	0.3	0.7	0.9	0.2	1.1	0.3	3.1	0.8	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.1	1.9	0.5	0.8	2.7	0.7	0.3	1.8	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.2	2.5	1.4	1.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.9	46.7	0.2	0.0	0.0	0.1	0.0	326.3	0.0	0.0	0.0	10.4	11.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	7.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.2	0.6
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 78.0"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 435.9"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3"									HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	3.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	78.0	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	11.2	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.3	0.2	0.0	0.6	0.0	0.2	3.6	0.0	1.1	0.0	0.0	0.1	0.3	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.3	4.3	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.5	0.5	6.5	0.3	2.5	1.4	0.0	1.8	2.0	0.1	1.7	0.6	2.9	0.3	3.9	0.0	0.5	0.1	0.2	0.5	0.0	435.9	0.1	11.1	1.2	6.7	6.2	11.4	0.0	0.0	0.0	0.0	1.0	0.9	0.5	2.9	1.4	0.5	2.0	0.0	0.2	0.7	0.3	1.0	0.3	0.5	0.8	0.2
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell type enriched"	"Detected in many"	65	"Hepatocytes: 5979.1"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.7	1.4	4.0	0.0	0.3	0.0	2.4	1.3	0.2	0.4	0.0	9.8	0.0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0.0	0.6	1.7	0.0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0.0	1.8	0.0	0.0	0.0	3.7	0.0	0.6	0.1	0.2	0.8	0.0	1.3	0.4	2.0	0.9	2.0	0.8	2.8	1.3	6.4	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.6	21.0	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0.0	2.0	0.0	0.0	0.3	1.3	0.4	0.0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0.0	7.9	0.0	68.2	91.8	1.9	1.4	0.0	0.0	0.0	0.0	1.0	2.6	0.0	2.5	0.0	5.2	0.0	0.5	3.6	2.2	6.6	0.1	8.7	0.0	0.0
CYP2U1	SPG49	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931369-107953457	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 122.7"	"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 18.6;Peritubular cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.6	7.9	7.7	4.4	9.1	0.4	7.3	11.3	9.2	7.8	7.3	7.0	4.1	4.0	9.5	4.6	6.3	9.8	6.6	8.8	7.1	7.9	6.4	6.8	6.6	6.7	8.3	5.2	12.0	2.6	10.3	8.1	2.7	7.8	12.4	4.7	8.6	4.5	11.0	4.3	3.1	6.0	12.3	7.0	8.5	4.6	3.9	7.4	122.7	4.7	3.5	5.4	7.3	5.3	2.6	2.7	0.7	5.9	1.6	1.7	0.4	2.5	1.2	3.4	6.3	18.8	9.0	0.5	10.8	16.3	6.6	10.5	0.0	1.7	6.9	0.8	6.4	5.2	0.1	5.3	4.0	10.4	1.9	1.6	1.4	2.4	0.3	7.5	2.0	0.0	10.1	3.4	3.1	2.1	13.5	2.5	7.8	0.1	3.3	5.5	1.8	7.4	0.0	3.5	0.2	3.0	4.2	4.1	0.0	2.1	4.3	6.7	5.0	2.7	4.7	11.5	3.0	2.3	1.0	6.8	4.3	0.5	6.1	4.3	14.0	13.2	2.2	3.5	0.0	4.8	0.0	0.3	0.7	1.2	1.1	0.9	2.0	0.9	1.0	2.2	2.6	1.7	1.3	0.0	1.6	5.9	2.7	0.0	0.4	7.7	9.1	11.3	6.9	7.1	7.9	8.3	5.2	7.8	7.4	3.0	3.8	3.2	3.2	1.0	4.3	3.4	2.5	13.4	3.4	8.7	3.9	0.4	0.0	0.9	9.6	5.8	2.6	0.0	1.7	0.3	5.1	1.7	4.6	6.8	1.9	1.6	2.9	6.7	6.1	6.1	16.4	4.6	18.6	3.6	1.1	9.9	0.4	0.0	16.6	2.4	3.3	0.0	5.2	0.9	4.3	1.3	0.2	1.3	1.6	0.7
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell type enriched"	"Detected in some"	45	"Hepatocytes: 2276.5"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0"									"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.1	4.5	0.3	0.0	0.0	0.0	2.2	6.7	0.0	0.5	2.6	5.0	0.5	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.4	0.0	0.7	0.1	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.3	1.0	0.3	0.0	0.3	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.6	46.7	0.8	0.0	0.0	0.5	0.0	2276.5	0.0	0.0	0.0	39.3	50.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.4	0.9
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"liver: 32.5"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.2	32.5	0.1	0.1	0.1	0.1	0.1	8.0	0.0	2.2	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.5	1.6	0.6	0.3	0.6	0.2	0.1	0.0	0.9	0.3	1.1	0.2	0.2	0.0	0.2	0.2	0.2	1.2	0.7	1.5	0.3	0.3	0.1	1.3	0.2	0.0	0.7	0.2	0.5	0.9	1.5	1.3	0.3	0.9	1.3	0.0	0.7	0.0	0.0	0.6	0.5	0.1	1.0	1.0	0.0	0.0	0.0	0.6	0.4	0.3	0.0	0.9	0.0	0.2	0.8	1.6	0.5	0.4	0.6	1.7	0.0	0.7	0.5	0.0	1.6	0.5	0.2	1.1	0.7	1.1	1.2	0.1	0.8	0.4	0.2	1.5	0.6	0.4	0.6	0.2	0.3	0.3	0.3	0.2	0.1	0.6	0.5	0.5	1.6	0.3	0.2	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.3	6.8	0.1	1.6	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.2	0.3	0.0	0.0	0.0	0.0
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99680026	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 72.9;liver: 73.4;stomach 1: 21.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	1.0	3.3	0.4	2.0	0.5	0.0	1.3	0.6	0.6	1.9	32.6	0.6	1.0	30.3	0.7	0.5	5.2	0.5	8.2	0.4	0.4	0.0	6.8	73.4	2.4	0.8	0.4	0.4	0.6	12.1	0.0	1.8	0.6	0.8	4.9	5.1	0.4	0.6	1.3	0.4	4.3	72.9	0.6	0.5	0.4	21.3	0.7	0.4	0.5	0.4	2.2	4.0	3.0	2.7	0.0	0.2	0.1	0.6	0.0	0.7	0.2	0.0	2.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	8.3	5.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.3	0.2	23.6	0.0	0.1	0.0	0.6	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.5	0.6	0.6	0.4	0.0	0.4	0.4	0.8	0.4	11.9	11.3	11.2	107.3	41.0	13.1	1.0	346.5	14.7	12.5	3.5	11.8	1.3	0.0	58.0	1.7	2.5	640.5	46.7	44.6	1.0	3.8	166.5	9.3	330.1	0.6	7.9	52.5	9.8	8.3	0.0	2.3	4.6	3.3	7.2	117.1	6.0	69.5	210.5	2.5	4.2	20.2	0.0	3.5	6.8	4.2	51.6	1.3	12.9	85.2	352.8
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99684957-99735196	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 82.6"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 135.0"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.1	0.4	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.7	0.0	0.0	0.1	0.3	0.1	0.2	0.0	3.9	0.0	0.1	0.0	2.8	82.6	0.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.4	3.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	135.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	18.4	0.1	0.0	0.0	4.9	3.7	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
CYP3A7-CYP3A51P		ENSG00000282301	"CYP3A7-CYP3A51P readthrough"	P24462	7	99685226-99735093	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 73.9"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 7.6"									"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.3;U-87 MG: 2.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "																		0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0		1.1	73.9	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.0	0.0	0.5	0.0	0.3	0.5	1.6	0.5	0.2	4.3	0.0	0.6	0.2	0.0	0.0	0.0	1.3	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.9	1.4	1.9	0.0	0.0	0.5	0.3	0.4	0.4	0.0	0.4	0.5	0.0	0.8	0.5	1.1	0.1	0.2	1.2	0.5	0.2	0.5	0.2	0.1	0.4	1.5	0.0	0.0	0.4	0.2	0.0	0.5	0.6	0.6	0.0	0.1	0.4	0.3	0.5	0.5	0.6	0.9	0.7	0.1	2.6	0.7	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191520-186213456	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Monooxygenase, Oxidoreductase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 92.7;Muller glia cells: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.1;SK-MEL-30: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	6.6	16.6	7.8	5.0	12.4	1.6	5.5	8.9	7.5	6.7	8.0	8.9	4.9	11.4	5.7	4.2	5.2	6.2	13.7	7.4	7.7	4.6	21.6	64.7	7.3	4.1	7.7	9.0	6.3	12.1	30.8	16.1	3.0	6.7	5.6	8.2	19.1	6.2	9.1	3.3	2.8	14.7	6.4	7.0	7.5	5.2	3.2	7.4	4.4	11.9	2.1	3.8	8.0	5.1	2.3	2.5	0.0	6.2	1.3	4.0	1.5	2.6	1.8	0.6	0.0	11.3	4.6	0.1	3.8	8.1	1.4	2.0	0.0	10.9	1.0	0.5	2.5	5.7	1.3	1.3	1.2	0.4	6.5	1.3	4.1	0.4	0.5	3.4	2.2	2.0	4.2	0.5	1.4	0.7	4.7	0.1	4.2	1.6	13.1	4.7	2.3	2.5	0.6	1.4	1.1	0.0	2.1	0.5	1.1	4.6	5.2	2.8	4.1	0.9	0.0	19.4	0.2	1.9	3.5	4.2	3.0	0.7	3.3	1.6	0.0	0.0	0.5	9.0	8.3	3.6	0.0	1.2	0.0	4.0	4.1	2.5	1.0	2.5	3.4	1.5	2.3	2.7	2.3	0.0	1.3	6.2	2.5	2.1	1.5	7.8	12.4	8.9	7.5	7.7	4.6	7.7	9.0	6.7	7.4	6.0	7.8	8.3	3.1	2.3	31.1	15.3	45.9	12.0	10.3	14.0	29.5	1.8	8.3	16.1	2.4	5.5	19.2	0.0	19.5	1.7	8.4	5.5	6.9	92.7	11.5	4.8	16.3	9.2	11.2	1.7	4.6	7.1	3.3	0.0	19.1	64.2	11.0	10.5	6.0	31.8	27.1	0.0	10.2	8.1	5.4	2.8	0.8	10.7	8.9	5.0
CYSRT1	"C9orf169, MGC59937"	ENSG00000197191	"Cysteine rich tail 1"		9	137224635-137226311	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	4	"esophagus: 33.4"	"Cell type enriched"	"Detected in some"	6	"Pancreatic endocrine cells: 33.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 10.0;CAPAN-2: 12.7;HaCaT: 14.1;HeLa: 12.5;MCF7: 19.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021883, HPA021886"	Approved		Approved	"Nuclear speckles,Vesicles,Midbody"		Yes	No			"Nuclear speckles"	"Vesicles, Midbody"	"HPA021883: AB_1853190, HPA021886: AB_1853192"	"unprognostic (1.35e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.31e-3)"	"unprognostic (6.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.11e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	0.7	0.4	1.0	0.7	0.9	0.2	0.8	0.7	1.7	1.4	0.7	0.7	0.7	0.3	0.7	0.7	33.4	1.0	0.7	0.7	1.4	1.3	1.4	0.7	0.7	0.7	0.8	0.7	0.7	0.7	0.3	3.5	0.7	0.7	1.1	0.0	0.7	2.2	0.7	0.7	8.1	0.7	0.7	0.7	0.7	0.8	2.2	0.7	0.7	1.3	0.7	5.3	0.7	2.1	0.9	0.6	0.9	3.0	0.9	0.3	0.1	10.0	1.2	1.0	2.1	0.0	0.1	2.8	0.3	0.3	0.4	0.2	0.7	12.7	0.7	0.8	0.2	0.4	14.1	0.3	3.2	0.0	1.3	1.0	0.2	12.5	6.6	0.7	0.1	0.6	0.3	1.5	0.4	0.1	0.7	0.1	1.0	0.4	2.2	0.8	19.6	0.4	0.7	0.5	2.0	1.5	1.5	1.3	1.7	0.5	0.7	0.3	1.0	2.1	1.8	0.5	0.7	4.0	0.2	0.5	0.8	0.5	1.8	0.3	1.2	0.9	0.7	0.8	0.6	0.8	0.9	0.2	0.2	0.3	1.7	0.1	0.9	0.3	0.2	0.6	0.8	0.2	0.3	0.7	0.9	3.0	0.4	0.2	0.1	1.0	0.9	0.7	1.7	1.4	1.3	0.8	0.7	0.7	0.7	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	4.5	5.2	0.0	0.4	0.0	1.1	0.5	0.0	0.4	0.0	5.1	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	33.8	0.0	0.4	0.5	0.5	0.0	0.2	1.9	0.3	0.0	0.0	0.0	0.2	1.1
CYTH2	"ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like"	ENSG00000105443	"Cytohesin 2"	Q99418	19	48469032-48482314	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 195.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB014872, HPA060662"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Golgi apparatus, Plasma membrane"	"CAB014872: , HPA060662: AB_2732652"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.33e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.21e-4)"	13.5	14.2	12.7	14.1	13.6	8.0	19.5	11.4	24.4	21.9	11.7	12.9	14.8	23.2	15.4	15.9	18.8	15.0	25.5	8.3	12.4	7.4	19.2	8.9	15.2	10.0	13.2	18.9	14.4	17.3	35.1	21.0	21.1	12.4	18.0	9.7	13.5	24.2	14.4	7.4	19.9	23.0	12.2	8.7	13.0	19.2	42.0	13.5	18.4	46.2	15.1	10.6	15.6	15.9	4.1	5.6	11.1	4.0	1.8	6.1	3.2	9.0	13.7	41.7	9.4	6.3	5.5	7.6	7.1	6.5	7.6	7.2	7.5	12.3	5.9	7.5	6.2	6.3	11.4	8.0	8.7	4.9	9.0	10.9	8.4	17.2	8.0	5.7	5.1	11.5	7.0	14.9	9.5	6.1	35.0	9.8	8.8	8.3	20.9	10.1	7.3	8.5	37.3	4.5	8.1	5.7	10.9	6.3	4.1	13.0	19.7	12.2	12.0	7.8	21.9	6.0	13.5	10.3	6.9	10.6	16.5	8.4	3.9	10.1	20.8	11.0	3.9	6.0	10.2	11.5	4.1	4.0	3.3	4.1	3.0	2.7	4.1	5.3	6.1	3.3	2.7	4.9	3.4	11.1	1.8	3.9	5.6	5.3	3.2	12.7	13.6	11.4	24.4	12.4	7.4	13.2	18.9	12.4	13.5	26.8	33.9	13.7	98.2	40.8	35.5	10.1	58.6	50.9	33.0	38.4	23.6	40.9	29.9	73.0	195.8	42.1	25.3	0.0	81.0	38.9	34.0	62.5	16.3	7.8	38.3	20.6	25.0	36.8	22.1	127.7	34.5	34.4	33.7	73.1	30.9	37.8	102.2	41.6	34.6	39.6	55.8	51.8	45.9	70.2	46.4	41.5	119.3	32.0	31.1	126.1
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.4;lymphoid tissue: 92.9"	"Cell type enriched"	"Detected in many"	4	"monocytes: 788.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.6;HDLM-2: 11.7;Karpas-707: 39.9;RPMI-8226: 12.2;U-266/70: 68.0;U-266/84: 25.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.4"	"Not detected"	"Not detected"			HPA007191	Approved		Approved	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"	9.4	1.4	1.4	33.3	1.6	32.3	3.9	0.8	1.0	4.4	9.7	1.6	0.8	9.3	3.1	4.2	6.6	2.8	5.8	3.8	1.5	1.5	4.1	3.9	26.8	92.9	3.1	0.6	2.9	3.1	0.0	1.5	1.3	2.0	2.4	5.0	3.1	11.5	3.1	1.4	2.1	17.4	2.1	4.3	48.3	14.4	3.3	1.3	40.5	3.2	3.8	61.8	24.1	3.2	21.9	13.0	48.5	53.3	19.9	53.4	31.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	39.9	0.2	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	12.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	68.0	25.5	6.6	0.6	1.8	0.0	48.5	8.4	24.5	30.6	27.8	30.9	21.9	32.4	28.9	13.0	21.1	53.4	40.7	48.2	19.9	53.3	6.7	31.3	31.6	1.4	1.6	0.8	1.0	1.5	1.5	3.1	0.6	2.0	1.3	3.0	16.4	102.3	1.0	18.5	0.0	2.0	5.1	0.0	2.3	1.8	0.0	0.5	13.3	0.2	1.2	1.2	0.5	23.3	1.7	9.8	8.5	0.5	6.9	1.0	24.4	0.0	1.7	4.9	80.4	1.7	0.0	153.9	79.2	788.1	1.9	0.0	0.2	0.0	0.0	0.8	0.0	0.0	3.2	0.0	0.2	15.6	2.5	190.7	1.5	0.1
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.2"	"Cell type enhanced"	"Detected in some"	12	"Endothelial cells: 8.3;Fibroblasts: 15.8;granulocytes: 9.2;Hofbauer cells: 12.7;Macrophages: 5.9;Melanocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 18.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 18.8"	"Cell line enhanced"	"Detected in some"		"HEL: 42.6;HUVEC TERT2: 34.2;NB-4: 83.4;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: AB_2732760"	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (7.43e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.25e-4)"	5.2	2.3	6.5	2.0	6.0	10.8	6.4	0.7	4.2	11.0	4.9	9.2	4.9	1.0	10.1	2.8	5.3	7.3	4.6	4.4	5.4	4.4	1.2	0.8	17.1	9.4	6.2	2.1	2.5	1.1	1.7	1.6	42.2	4.7	10.5	1.8	4.5	4.0	14.2	0.8	3.3	2.1	4.2	11.0	1.1	4.9	2.2	8.4	0.5	5.7	3.6	4.8	13.2	7.4	0.0	0.3	1.9	1.0	18.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	0.0	34.2	0.0	0.0	1.7	0.0	0.0	0.0	83.4	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	5.2	0.0	0.0	0.0	11.7	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	20.2	1.9	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.1	18.8	0.0	0.3	0.0	0.6	6.5	6.0	0.7	4.2	5.4	4.4	6.2	2.1	4.7	8.4	0.0	0.3	0.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	8.3	0.0	0.0	0.0	0.1	15.8	0.5	9.2	0.0	12.7	0.0	0.0	1.3	0.0	0.0	0.0	5.9	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.5	0.0	0.0	0.6
CYYR1	C21orf95	ENSG00000166265	"Cysteine and tyrosine rich 1"	Q96J86	21	26466209-26573284	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"breast: 59.8"	"Group enriched"	"Detected in many"	6	"Endothelial cells: 113.7;Ito cells: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	38	"plasmacytoid DC: 21.1"	"Lineage enriched"	"Detected in single"	73	"dendritic cells: 21.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.0;NTERA-2: 25.2;PC-3: 6.9;RH-30: 10.7;SCLC-21H: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034921, HPA067685"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB034921: AB_2089315, HPA067685: AB_2685887"	"unprognostic (5.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-3)"	"unprognostic (9.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	30.9	28.9	3.8	7.7	4.4	4.0	59.8	2.1	4.3	19.0	8.4	2.7	13.4	3.5	15.1	14.7	13.1	8.6	10.8	29.1	4.7	3.9	10.6	7.1	23.8	13.4	5.6	2.5	9.8	4.5	5.1	3.5	21.7	3.9	11.7	4.0	11.6	5.4	10.5	14.5	4.8	6.8	14.6	5.0	34.1	5.9	9.2	2.5	3.6	11.2	9.1	2.7	11.2	23.9	0.0	21.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.2	0.0	3.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	25.2	0.0	6.9	0.0	10.7	0.0	1.0	0.0	21.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	21.1	0.0	0.0	3.8	4.4	2.1	4.3	4.7	3.9	5.6	2.5	3.9	2.5	0.0	1.1	0.9	1.1	10.4	0.0	5.6	0.0	1.4	2.3	14.0	0.0	0.1	3.3	0.0	0.6	113.7	0.0	0.0	0.0	0.2	6.1	0.4	0.0	0.0	0.3	0.0	0.0	60.8	2.7	0.9	2.0	1.2	6.8	1.0	0.0	0.5	0.1	0.0	0.0	2.6	0.0	0.0	3.3	0.2	1.1	4.6	0.2	0.0	0.0	0.7
DAAM1	KIAA0666	ENSG00000100592	"Dishevelled associated activator of morphogenesis 1"	Q9Y4D1	14	59188646-59371405	"Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Basal keratinocytes: 415.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 18.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026605, HPA064789"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA		450000	"Plasma membrane, Cytosol"		"HPA026605: AB_1847464, HPA064789: AB_2685352"	"unprognostic (2.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	13.8	8.0	13.8	9.4	9.3	3.7	9.3	17.3	13.3	14.6	11.4	6.3	7.4	4.5	16.9	7.0	19.2	8.4	6.0	17.3	10.2	6.7	6.0	10.7	9.7	8.8	5.6	13.6	8.6	8.2	25.6	9.6	12.4	8.7	10.9	7.8	16.9	12.0	10.5	6.0	25.6	7.7	19.5	10.0	10.2	9.1	5.8	7.2	4.1	7.1	14.1	13.8	15.3	13.1	10.7	18.3	4.9	3.1	6.9	3.8	1.9	13.1	1.3	9.1	2.3	6.0	4.2	11.8	1.7	1.7	3.5	3.7	6.8	10.9	13.6	3.5	4.1	7.2	27.2	8.5	6.6	2.9	6.0	3.0	5.1	3.4	8.1	3.7	5.7	2.7	2.8	6.7	3.0	2.9	7.0	7.7	6.7	8.3	6.7	2.1	11.3	4.8	2.8	4.9	8.1	3.9	4.5	7.7	1.3	4.5	10.3	14.1	3.1	11.5	16.8	10.2	6.1	22.3	1.2	7.7	2.7	5.3	6.1	1.5	1.5	1.7	15.9	3.6	1.0	6.5	4.9	2.1	2.5	2.6	2.4	3.1	10.7	3.3	2.4	2.4	4.7	2.7	2.7	2.6	6.9	3.1	18.3	3.8	1.9	13.8	9.3	17.3	13.3	10.2	6.7	5.6	13.6	8.7	7.2	32.8	24.8	21.7	108.9	415.1	111.0	118.9	30.6	65.6	52.4	27.9	290.6	30.5	19.9	42.3	28.7	59.1	37.1	186.9	81.9	21.8	46.3	89.2	25.4	41.2	26.6	184.3	84.3	111.7	17.1	11.1	55.8	14.9	86.0	24.4	50.3	117.4	130.6	38.6	69.6	11.3	180.1	32.3	49.5	32.1	44.8	290.2	28.6	20.2	36.8	75.2
DAAM2	KIAA0381	ENSG00000146122	"Dishevelled associated activator of morphogenesis 2"	Q86T65	6	39792298-39904877	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 83.3"	"Cell type enriched"	"Detected in many"	5	"Sertoli cells: 148.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	29	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"HSkMC: 25.8;JURKAT: 13.8;LHCN-M2: 25.3;SK-MEL-30: 31.3;WM-115: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051300, HPA054630"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA051300: AB_2681430, HPA054630: AB_2682549"	"unprognostic (7.53e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.93e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.54e-2)"	"unprognostic (7.94e-2)"	"unprognostic (8.54e-4)"	21.5	17.8	34.8	6.7	43.0	1.7	7.8	4.4	52.2	9.3	6.4	83.3	8.0	7.6	7.5	8.5	28.3	8.9	5.9	6.1	40.4	25.2	5.9	4.0	8.4	2.8	42.8	24.8	7.3	5.2	3.5	2.1	9.4	41.3	8.7	7.1	5.1	4.3	17.6	23.8	4.4	8.9	13.7	48.8	15.5	7.0	8.7	51.9	0.0	5.0	2.1	2.2	4.6	4.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.7	0.1	0.1	4.4	5.9	1.0	0.5	0.4	0.0	0.0	0.2	6.6	2.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	4.1	0.0	0.0	25.8	0.0	0.1	0.0	7.2	0.0	13.8	0.0	0.0	25.3	0.0	0.6	0.0	0.7	1.3	0.0	0.0	4.6	3.5	0.0	0.0	0.9	1.0	0.0	0.3	31.3	5.6	0.0	0.0	0.2	9.6	2.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	34.8	43.0	4.4	28.9	40.4	25.2	42.8	24.8	41.3	51.9	8.9	9.8	0.0	0.8	1.5	1.7	2.1	0.0	2.7	6.8	0.0	0.0	0.4	0.0	0.4	3.6	2.0	0.0	0.0	3.0	0.4	11.3	0.8	0.0	1.0	0.2	0.0	0.0	3.1	15.2	4.2	21.9	3.1	8.5	0.0	0.0	8.2	0.4	0.0	20.8	0.0	1.5	148.8	28.3	0.7	1.1	1.0	0.2	0.0	0.0	1.0
DAB2	DOC-2	ENSG00000153071	"DAB2, clathrin adaptor protein"	P98082	5	39371675-39462300	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 194.4"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 1338.9;Proximal tubular cells: 964.6;Syncytiotrophoblasts: 1107.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 52.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"plasmacytoid DC: 26.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 26.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.0;ASC TERT1: 46.3;fHDF/TERT166: 67.0;TIME: 40.3;U-138 MG: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009314, HPA028888"	Enhanced		Enhanced	"Nucleoli fibrillar center,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoli fibrillar center"	"CAB009314: AB_638976, HPA028888: AB_2672814"	"unprognostic (1.24e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.37e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.38e-6)"	"unprognostic (3.11e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	51.6	44.2	2.6	12.2	3.5	0.6	21.8	6.1	2.6	16.6	14.0	4.1	4.5	3.3	16.6	34.8	10.8	9.6	13.3	25.1	2.9	3.0	75.2	6.9	22.4	31.8	4.0	2.1	12.7	11.3	3.2	3.9	194.4	4.7	11.6	14.6	14.6	12.9	5.3	12.7	9.3	10.4	16.0	5.2	21.1	7.2	8.7	2.5	7.3	10.9	8.4	7.4	17.8	14.7	0.1	26.6	2.2	2.5	0.9	1.3	7.0	0.0	1.6	2.5	5.4	43.0	46.3	3.1	27.8	28.4	11.0	18.1	20.3	0.1	0.0	1.7	67.0	10.8	0.0	0.3	1.0	15.4	0.0	0.8	3.7	36.9	6.6	10.4	0.0	4.8	28.8	0.0	17.8	3.2	17.0	32.9	1.9	0.0	0.9	18.1	0.1	0.3	0.0	1.7	0.7	3.0	1.0	6.3	0.0	7.3	0.6	0.0	0.0	3.3	1.8	15.5	4.1	0.1	0.9	40.3	46.9	5.2	5.4	2.2	0.0	0.0	0.0	16.3	3.4	6.1	2.2	1.2	0.2	1.3	2.5	0.0	0.1	0.2	0.7	3.4	0.1	0.1	1.0	1.8	0.9	0.6	26.6	0.2	7.0	2.6	3.5	6.1	2.6	2.9	3.0	4.0	2.1	4.7	2.5	35.7	35.6	25.8	1.3	12.9	0.7	50.4	61.1	9.4	7.9	90.7	66.8	112.4	167.5	58.4	0.6	97.7	30.4	23.3	1.6	14.9	120.5	7.2	24.3	2.1	1338.9	7.9	9.4	214.9	131.6	1.1	113.4	176.8	11.8	7.2	5.6	72.3	7.0	12.7	60.5	964.6	2.1	6.5	26.7	0.5	4.7	11.7	1107.7	10.8	19.2	0.7
DACH1	DACH	ENSG00000276644	"Dachshund family transcription factor 1"	Q9UI36	13	71437966-71867192	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 70.5;Horizontal cells: 82.6;Late spermatids: 80.3;Muller glia cells: 155.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	15	"basophil: 4.7;eosinophil: 9.2;NK-cell: 4.9;plasmacytoid DC: 7.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 9.2;NK-cells: 4.9"	"Cell line enhanced"	"Detected in some"		"AF22: 8.2;HAP1: 12.8;HEK 293: 9.6;HL-60: 20.7;NB-4: 9.2;SCLC-21H: 21.3;SH-SY5Y: 17.1;THP-1: 15.0"	"Region enriched"	"Detected in many"	5	"basal ganglia: 34.7"	"Region enriched"	"Detected in all"	5	"basal ganglia: 34.0"	"HPA012672, HPA012938"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA012672: AB_1847466, HPA012938: "	"unprognostic (3.16e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.17e-2)"	4.9	12.2	0.6	3.8	15.5	5.7	9.2	1.8	2.9	11.4	5.4	0.0	3.5	5.4	6.3	4.1	0.9	2.9	15.8	3.0	0.2		10.2	1.9	10.2	0.3	0.0	1.5	0.9	1.8	7.3	24.4	7.3	4.9	7.9	3.5	19.6	1.9	6.9	3.6	0.6	9.6	2.1	2.9	7.8	1.8	6.1	6.6	6.1	0.0	1.2	0.2	2.1	10.2	0.0	7.5	9.2	0.2	4.9	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.8	0.0	0.0	0.0	9.6	0.1	0.0	0.0	0.2	20.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.5	9.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.3	17.1	0.0	0.0	0.0	0.0	0.5	15.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	4.7	0.2	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	4.9	0.0	7.5	0.0	0.1											0.0	1.1	0.0	2.9	1.4	10.4	1.6	0.0	1.4	0.0	7.0	3.9	0.0	5.0	0.5	70.5	17.3	1.1	0.0	0.0	0.0	0.8	9.2	4.7	0.0	0.2	82.6	32.7	1.8	1.6	80.3	3.1	1.1	0.0	0.0	13.3	155.3	0.5	0.0	1.8	3.5	4.8	12.9	1.4	21.1	7.0	1.1	0.0	0.0	3.7	1.8
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148458-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 29.5;epididymis: 9.3;fallopian tube: 8.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 1.3;Horizontal cells: 3.2;Muller glia cells: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HAP1: 11.5"	"Low region specificity"	"Detected in some"							"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.9	0.9	7.9	0.6	29.5	0.6	0.6	0.2	17.8	1.0	0.8	0.3	0.0	1.2	1.2	9.3	0.7	8.0	0.6	0.6	13.5	10.8	2.4	0.6	0.9	0.6	3.4	10.4	1.4	1.1	0.7	1.3	0.6	11.8	1.5	0.7	1.6	0.7	0.8	0.6	0.7	1.3	0.8	0.7	0.6	1.4	0.7	1.7	0.0	0.7	0.0	0.6	1.4	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	29.5	0.2	16.8	13.5	10.8	3.4	10.4	11.8	1.7	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DACT3	"DAPPER3, MGC15476, RRR1"	ENSG00000197380	"Dishevelled binding antagonist of beta catenin 3"	Q96B18	19	46647612-46661138	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 15.7;Early spermatids: 18.3;Smooth muscle cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 9.4;SH-SY5Y: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA043053: AB_10794769"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.30e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.59e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.66e-4)"	5.2	3.8	21.0	5.8	15.9	1.7	1.6	3.7	32.3	10.7	17.3	24.6	3.5	4.2	21.6	14.8	7.8	10.9	7.4	10.5	21.7	13.9	3.9	2.2	5.6	1.5	17.4	13.6	8.8	1.5	1.4	1.2	2.1	14.1	11.7	7.2	13.7	1.7	25.1	1.7	2.8	4.7	30.3	17.0	4.8	7.4	5.7	9.4	0.0	1.6	1.5	1.3	13.2	6.0	1.6	1.2	5.9	0.9	2.0	0.7	0.3	0.2	0.3	5.2	4.9	1.8	1.4	0.5	2.9	4.7	0.9	1.4	0.3	0.3	0.4	1.9	9.4	1.0	0.3	3.2	0.1	1.0	0.4	1.7	1.3	0.7	0.2	2.6	0.2	2.2	4.7	0.1	1.2	0.0	0.6	0.4	0.8	1.6	1.7	0.8	0.4	0.2	1.2	2.0	0.2	0.7	4.2	1.4	0.3	0.3	0.4	2.0	23.0	0.5	0.2	0.4	5.6	0.4	0.4	0.5	2.4	3.0	2.5	0.5	1.5	0.5	0.7	0.6	0.8	1.8	5.9	0.9	1.0	0.7	0.5	0.5	0.7	0.7	0.5	0.2	1.6	0.7	0.7	4.6	2.0	0.7	1.2	0.5	0.3	21.0	15.9	3.7	32.3	21.7	13.9	17.4	13.6	14.1	9.4	6.0	8.5	0.0	1.1	2.1	13.7	15.7	0.0	0.0	1.2	0.0	2.0	4.3	0.0	0.0	18.3	2.2	0.0	0.0	0.0	2.5	7.3	0.8	5.8	0.0	0.9	1.6	1.7	2.5	1.5	6.1	7.2	1.9	3.3	1.0	0.0	5.8	0.1	0.0	13.8	0.3	4.9	6.5	27.6	2.1	1.7	2.9	8.2	0.0	0.2	0.9
DAD1	OST2	ENSG00000129562	"Defender against cell death 1"	P61803	14	22564905-22589269	"Cancer-related genes, Predicted membrane proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028882	Uncertain		Approved	Cytosol		NA	NA		14000	Cytosol		"HPA028882: AB_10602214"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (9.43e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.37e-3)"	48.1	64.7	47.9	36.4	49.4	26.4	61.2	19.3	39.5	59.0	46.7	55.9	93.6	39.7	49.8	118.7	61.2	56.5	54.9	55.2	45.9	43.1	85.1	123.6	48.4	54.6	51.5	25.1	55.4	114.1	35.6	57.0	54.6	51.9	48.3	51.5	43.5	81.9	100.1	39.7	35.6	73.4	49.6	65.3	57.4	48.0	56.7	33.6	84.6	107.0	50.7	52.2	49.3	43.4	80.2	121.1	75.3	65.9	61.5	95.6	122.5	47.9	45.1	37.1	50.3	101.4	72.9	32.1	51.4	62.3	45.6	64.6	28.3	69.1	30.3	33.0	59.0	51.9	44.0	38.4	49.3	73.2	41.1	35.1	29.6	26.4	112.8	70.7	41.3	43.0	54.1	66.3	47.7	61.5	52.1	66.5	29.4	22.3	71.7	67.1	58.8	19.6	50.5	22.8	106.4	73.8	27.5	31.4	39.5	67.1	39.7	28.5	35.7	39.0	55.9	56.6	46.6	33.7	42.2	50.3	39.8	31.9	48.3	32.3	53.7	62.2	39.1	36.0	29.0	57.4	66.0	65.9	68.1	86.7	56.2	85.1	80.2	90.9	81.7	62.0	71.2	95.6	83.8	75.3	61.5	47.8	121.1	83.5	122.5	47.9	49.4	19.3	39.5	45.9	43.1	51.5	25.1	51.9	33.6	148.9	165.4	142.8	161.3	176.2	21.8	136.5	170.7	219.5	109.2	242.5	25.5	222.0	182.4	458.8	135.7	237.6	168.9	23.3	362.6	309.7	253.7	161.4	292.5	226.5	313.4	20.6	130.4	183.0	140.5	70.6	198.5	173.2	313.8	230.0	162.7	174.4	363.0	131.9	187.0	354.4	32.8	148.8	195.7	167.4	132.2	188.6	241.7	163.9	144.2	147.6
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	20.1	28.2	12.6	12.7	20.3	25.8	29.8	18.4	26.1	19.1	18.0	11.4	19.4	15.1	14.3	17.5	16.2	12.5	26.6	18.9	12.4	13.8	24.0	88.0	18.4	25.2	11.6	5.8	22.5	47.0	14.2	19.0	45.7	7.5	14.6	10.6	14.6	34.1	22.3	22.0	22.1	31.3	16.0	13.2	15.1	14.0	27.1	7.9	7.2	23.1	15.1	16.8	15.6	20.8	5.6	18.9	13.6	14.7	2.4	8.4	7.5	10.9	12.5	5.4	7.0	8.2	6.4	4.3	15.4	10.5	13.3	14.4	6.6	12.0	5.9	6.7	7.4	32.5	16.2	8.8	8.1	7.6	2.7	6.1	3.1	14.3	4.5	8.8	8.9	5.0	5.7	13.5	8.9	8.8	5.3	5.7	7.6	8.9	2.9	7.8	7.7	3.1	12.6	19.7	5.4	9.5	27.4	6.2	12.7	8.4	4.0	7.0	4.2	8.7	13.4	2.5	9.0	9.3	16.7	7.0	11.5	21.9	14.4	7.1	3.1	5.6	5.0	5.7	14.0	13.9	6.2	14.7	13.6	4.4	13.9	3.9	5.6	3.5	2.9	18.9	3.6	8.4	4.8	7.3	2.4	12.2	3.2	2.9	7.5	12.6	20.3	18.4	23.4	12.4	13.8	11.6	5.8	7.5	7.9	8.9	13.0	3.9	2.8	14.9	4.2	2.4	2.5	2.7	3.4	5.2	2.0	4.4	0.0	6.2	0.4	6.7	10.9	0.0	5.3	7.7	4.6	4.6	3.5	6.2	14.7	0.0	2.4	8.0	15.4	0.9	5.8	15.3	5.0	11.8	4.7	0.9	9.2	5.8	2.1	1.8	4.5	0.0	5.7	7.2	6.8	11.7	10.4	5.3	6.3	3.2
DALRD3	FLJ10496	ENSG00000178149	"DALR anticodon binding domain containing 3"	Q5D0E6	3	49015488-49022293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 129.7;Late spermatids: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036862	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA036862: AB_10673507"	"unprognostic (2.76e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.56e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.33e-2)"	"unprognostic (9.52e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	9.4	14.1	9.3	13.9	9.0	4.4	21.6	10.2	11.9	11.3	9.5	7.7	14.9	7.2	7.7	14.7	13.1	34.3	14.2	8.6	8.6	7.3	16.0	9.3	10.8	9.1	7.2	9.4	13.5	29.3	12.6	11.1	8.7	6.3	8.4	7.5	8.4	13.2	18.5	7.5	13.0	10.2	6.5	5.1	8.5	9.9	32.0	6.8	21.1	21.1	13.5	12.7	9.5	14.1	17.7	8.2	7.3	9.3	14.5	19.2	9.3	6.2	8.5	5.3	10.5	15.4	20.5	6.6	5.3	14.3	8.8	8.4	6.0	7.8	2.5	7.5	14.0	7.6	4.1	7.0	13.5	6.1	3.8	4.7	2.7	7.9	11.2	10.0	7.5	5.4	13.8	14.0	11.0	24.6	22.3	13.5	5.8	2.1	6.2	8.5	10.6	3.4	5.1	8.9	12.9	8.1	1.7	0.7	17.9	23.3	9.8	3.4	11.4	5.7	15.8	11.9	9.3	11.2	8.3	8.4	3.4	5.4	12.1	4.7	19.9	10.9	1.3	13.0	3.5	6.7	7.1	7.7	3.7	10.2	9.3	18.8	17.7	17.0	12.7	8.2	15.5	14.4	9.3	7.3	14.5	8.6	5.6	19.2	9.3	9.3	9.0	10.2	11.9	8.6	7.3	7.2	9.4	6.3	6.8	14.9	9.8	15.9	21.0	22.8	29.2	1.2	15.3	65.6	19.4	26.2	17.7	23.7	31.5	33.6	129.7	14.3	30.3	0.0	34.6	30.0	20.5	9.2	24.3	5.8	17.2	38.1	18.3	15.4	10.8	227.2	22.5	15.9	20.3	29.7	19.2	23.2	22.0	17.5	17.3	36.2	53.2	45.3	15.5	91.9	33.3	29.7	15.3	17.5	25.0	13.2
DAND5	"CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3"	ENSG00000179284	"DAN domain BMP antagonist family member 5"	Q8N907	19	12965159-12974762	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.3;heart muscle: 13.7"	"Cell type enriched"	"Detected in single"	29	"Cardiomyocytes: 13.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	15	"SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"							"HPA043493, HPA049472"	Uncertain		Approved	Mitochondria	"Secreted in other tissues"	NA	NA			Mitochondria		"HPA043493: AB_2732505, HPA049472: AB_2680781"	"unprognostic (1.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (7.27e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-10)"	"unprognostic (4.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.37e-1)"	0.2	2.0	0.9	0.9	2.5	3.0	0.4	1.4	1.4	0.2	3.6	2.1	0.0	0.4	0.4	0.4	0.3	0.1	0.7	13.7	0.4	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.4	0.4	0.4	0.2	0.0	3.8	0.2	0.5	3.6	2.6	0.0	0.2	0.7	2.5	0.4	1.6	0.1	0.7	0.8	0.3	0.0	0.5	0.0	0.0	0.3	0.2	1.6	1.4	5.3	0.6	1.4	1.2	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.4	0.0	0.7	0.3	0.0	0.1	0.2	0.2	0.0	0.3	0.0	0.2	0.1	0.8	0.4	1.3	0.0	0.5	0.3	0.1	0.2	0.1	0.3	0.2	0.0	0.3	0.2	0.1	1.1	21.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.2	0.5	0.1	0.1	0.0	0.3	0.1	2.7	0.6	1.3	0.7	0.4	0.6	0.9	0.4	0.4	0.2	1.6	0.7	1.2	5.3	1.4	0.3	1.4	0.2	0.3	0.9	2.5	1.4	0.8	0.4	0.3	0.5	0.0	3.8	0.3	0.0	0.0	0.0	0.2	0.1	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1
DAP		ENSG00000112977	"Death associated protein"	P51397	5	10679230-10761272	"Predicted intracellular proteins"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA029456	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"	Nucleoplasm	"HPA029456: AB_10601262"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (4.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (2.04e-2)"	17.4	36.6	13.7	17.9	12.7	10.6	23.1	3.9	11.6	23.5	25.4	11.4	63.4	26.5	21.1	34.7	14.3	18.6	44.0	22.9	13.4	9.1	40.1	78.2	21.6	22.6	10.2	10.1	26.1	178.8	30.0	28.4	26.4	21.8	24.8	20.2	22.7	71.1	76.0	5.9	15.2	42.6	18.3	10.8	23.8	31.6	23.2	9.8	15.5	31.2	12.8	18.6	25.9	16.9	18.1	32.8	27.3	33.2	13.1	17.6	22.5	19.2	14.1	17.5	16.1	32.8	39.7	19.4	47.4	73.7	35.9	41.7	10.0	16.5	8.4	31.2	58.5	22.7	3.8	10.8	28.1	40.0	44.3	7.9	11.3	27.3	24.6	31.0	21.1	8.4	20.4	9.8	23.5	42.7	20.8	66.9	9.5	13.1	28.6	35.1	15.3	11.3	13.5	6.3	26.2	32.3	15.5	7.7	13.9	47.3	35.9	11.9	16.0	48.3	19.7	12.6	14.0	15.6	31.0	32.7	22.3	24.2	14.7	25.1	16.1	20.8	12.4	22.0	41.2	33.4	14.9	33.2	18.6	14.8	29.4	17.6	18.1	15.3	13.0	32.8	12.0	11.3	11.2	27.3	13.1	28.5	26.9	16.1	22.5	13.7	12.7	3.9	11.6	13.4	9.1	10.2	10.1	21.8	9.8	14.9	40.1	32.0	53.6	17.1	8.1	11.0	56.0	12.0	30.7	50.6	5.9	59.1	112.7	83.0	10.9	31.6	98.3	0.0	168.9	84.1	36.6	77.8	35.6	106.2	46.0	4.8	42.5	36.2	35.6	22.8	27.6	32.0	27.0	38.7	87.4	19.0	105.6	63.3	32.2	50.2	7.2	0.0	21.7	33.1	6.1	15.8	84.4	24.1	65.2	69.2
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	27.8	36.5	22.9	26.3	25.9	28.9	34.2	19.5	23.6	23.5	33.4	19.5	22.8	29.4	28.7	28.1	31.3	21.8	23.2	56.3	27.0	26.4	32.8	52.2	23.9	49.0	24.9	23.0	23.3	38.5	20.7	27.1	20.5	23.0	27.9	32.1	24.5	28.0	27.1	64.0	30.9	26.5	36.0	23.2	30.8	30.3	31.6	21.1	44.4	27.6	28.4	38.0	38.0	24.1	39.0	41.1	15.9	35.2	34.0	56.5	39.6	32.4	21.1	17.2	27.3	25.5	32.3	42.5	27.4	29.0	28.2	24.7	38.9	40.0	46.3	55.9	22.3	18.1	33.2	25.6	23.9	30.8	29.0	18.7	28.2	18.8	35.2	34.9	38.6	25.2	27.0	34.3	35.9	47.6	22.1	27.7	43.0	60.9	33.0	29.3	43.2	33.9	45.2	30.5	51.1	34.5	28.0	21.6	49.2	33.5	31.2	20.1	35.6	26.3	77.6	47.2	33.4	48.2	63.5	23.6	24.0	25.3	29.6	45.9	36.1	53.9	53.4	23.9	34.6	30.8	13.9	30.1	15.9	31.3	35.2	51.4	39.0	45.1	38.0	41.1	32.2	56.5	48.4	13.0	34.0	31.9	26.8	45.0	39.6	22.9	25.9	19.5	23.6	27.0	26.4	24.9	23.0	23.0	21.1	41.7	35.8	49.1	58.4	48.8	26.0	99.7	45.9	68.3	58.0	15.7	19.6	67.1	56.3	62.2	13.1	35.0	35.4	93.5	68.2	87.5	44.8	51.6	61.1	48.1	67.9	12.7	24.6	34.4	47.0	10.6	30.0	61.0	33.7	88.4	35.3	13.3	67.0	31.6	23.7	57.4	46.0	12.9	47.2	38.7	26.6	55.2	118.4	64.7	54.9	62.6
DAPK1	"DAPK, ROCO3"	ENSG00000196730	"Death associated protein kinase 1"	P53355	9	87497228-87708633	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 94.7"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 65.3;Ito cells: 79.2;Kupffer cells: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	55	"dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 38.8;HUVEC TERT2: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390"	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (8.31e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-3)"	14.6	4.9	10.4	8.8	25.5	3.8	4.1	2.9	17.6	8.1	16.6	6.5	8.1	7.8	8.7	16.1	4.5	12.2	21.6	4.1	12.4	8.1	14.7	21.3	28.6	8.5	4.6	10.4	32.7	21.2	4.8	16.6	94.7	6.6	5.1	7.5	5.9	9.3	7.3	1.5	3.7	11.0	8.1	4.8	16.4	15.0	6.3	7.3	34.5	7.2	1.5	5.2	13.2	10.5	0.1	5.3	6.9	11.9	0.1	0.1	2.1	0.0	18.3	8.8	6.2	0.2	0.1	14.0	1.2	1.7	7.2	8.2	2.6	0.1	0.1	1.8	0.3	0.1	17.1	5.4	0.4	3.1	0.1	4.4	8.8	2.5	8.9	7.9	0.0	38.8	0.5	2.9	1.3	0.5	11.3	22.0	2.5	6.6	3.7	6.0	0.5	2.6	0.0	10.0	16.9	0.0	0.7	7.8	0.0	20.1	18.3	4.0	4.5	0.0	1.8	7.7	13.5	0.0	5.8	0.1	0.0	0.1	0.0	0.0	14.6	3.0	0.0	0.1	2.4	1.2	1.3	5.3	6.9	0.0	11.9	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	1.6	0.1	11.7	5.3	0.0	2.1	10.4	25.5	2.9	17.6	12.4	8.1	4.6	10.4	6.6	7.3	47.6	65.3	5.9	0.6	3.2	19.8	1.9	40.8	16.0	40.9	21.0	2.0	5.6	1.7	27.2	1.2	13.0	2.1	0.0	20.1	14.4	11.4	3.9	23.1	16.3	21.3	17.5	0.0	79.2	64.1	2.2	13.8	42.1	11.8	30.7	7.7	14.5	31.5	1.7	12.7	5.9	2.9	0.0	2.3	3.9	4.1	2.8	11.9	0.7	2.8	9.3
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;skeletal muscle: 46.1"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 80.4;Enterocytes: 44.6;Late spermatids: 59.2"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4"	"Lineage enriched"	"Detected in many"	23	"granulocytes: 51.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.1;HaCaT: 8.4;HMC-1: 17.2;MCF7: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	8.2	1.6	2.6	6.8	5.0	10.3	5.2	1.4	3.9	3.6	16.6	12.0	8.3	14.2	1.7	1.5	2.1	1.2	1.7	17.6	3.6	2.0	2.2	1.4	14.0	2.5	6.8	3.0	0.7	1.7	1.1	1.1	0.3	4.7	3.1	4.7	1.9	4.8	4.8	46.1	4.6	25.8	1.2	3.4	4.7	6.9	2.0	6.5	1.1	22.3	8.7	3.3	2.1	9.6	0.3	2.2	51.8	0.0	0.7	0.6	0.3	2.8	2.0	5.7	1.4	10.1	0.4	0.1	1.9	6.1	1.0	1.1	0.9	1.4	0.2	0.6	6.1	3.4	8.4	3.5	0.1	0.6	0.2	0.1	1.1	3.9	0.1	0.1	0.1	17.2	1.1	7.3	0.4	0.2	6.6	0.6	0.1	0.4	0.1	0.7	8.7	0.0	0.3	0.6	2.8	2.0	2.6	0.0	0.3	0.0	2.8	0.4	0.3	0.4	1.1	0.0	1.4	4.8	0.4	0.4	0.8	1.0	1.3	1.6	0.6	0.2	0.0	0.0	2.7	0.2	19.1	0.0	51.8	0.6	0.0	0.2	0.3	0.1	0.5	0.0	0.1	0.0	0.4	16.4	0.7	0.0	2.2	0.0	0.3	2.6	5.0	1.4	3.9	3.6	2.0	6.8	3.0	4.7	6.5	80.4	21.1	2.7	6.6	10.3	0.0	34.6	2.5	2.7	19.4	0.0	0.0	0.1	1.7	7.8	19.1	2.8	44.6	0.0	30.2	0.1	3.1	14.5	15.0	0.8	0.4	4.8	8.1	8.6	1.2	59.2	2.8	1.4	0.0	0.0	13.0	1.6	13.0	28.8	5.3	0.3	0.1	12.9	2.1	0.9	3.4	3.6	0.1	14.9	16.9	10.7
DAPL1		ENSG00000163331	"Death associated protein like 1"	A0PJW8	2	158795317-158862781	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 522.1"	"Group enriched"	"Detected in all"	7	"cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.7;hTCEpi: 22.1;SCLC-21H: 5.7;U-87 MG: 8.1"	"Not detected"	"Not detected"							"HPA046937, HPA058635"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Microtubules"		NA	NA			"Nucleoplasm, Nuclear bodies, Microtubules"		"HPA046937: AB_2679870, HPA058635: AB_2732625"	"unprognostic (3.95e-5)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.63e-2)"		"unprognostic (8.59e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-3)"	0.3	14.7	1.4	0.4	1.3	0.0	7.4	0.4	1.0	11.7	1.0	0.8	1.6	0.0	2.1	53.5	75.6	21.1	0.6	0.2	1.5	3.6	1.3	0.2	0.8	0.4	2.8	0.3	3.8	5.7	0.0	5.6	0.2	1.5	2.3	0.0	63.9	6.8	0.4	0.2	61.3	0.5	1.1	0.4	0.2	0.2	2.1	0.8	0.8	21.5	37.3	16.9	2.0	21.1	1.4	4.0	2.9	2.6	2.8	1.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.2	22.1	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.3	5.7	0.0	0.0	0.0	0.6	0.0	0.6	1.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	8.1	0.0	0.0	2.9	2.6	1.6	0.5	1.9	1.0	1.2	0.8	0.4	1.0	1.4	0.4	0.5	2.2	2.8	0.6	4.0	1.3	0.5	1.4	1.3	0.4	1.0	1.5	3.6	2.8	0.3	1.5	0.8	0.0	0.0	14.6	31.4	94.9	6.8	0.0	5.1	1.4	17.0	8.7	5.9	5.5	3.3	8.0	10.6	0.5	2.5	0.0	5.1	10.7	4.1	10.8	4.6	12.1	12.9	3.2	2.9	0.6	7.9	43.8	3.7	5.5	11.8	2.8	1.6	522.1	5.7	3.5	2.1	5.8	16.3	0.0	5.1	9.8	4.1	110.7	3.8	1.9	2.5	25.5
DARS2	FLJ10514	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824503-173858546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	17.0	22.2	6.3	10.1	8.1	5.4	9.0	7.5	8.6	7.8	15.1	6.7	8.3	11.7	10.4	6.1	13.4	6.4	5.9	11.2	5.5	6.0	21.9	14.8	8.2	11.0	6.4	4.2	9.5	14.9	18.1	15.3	10.9	10.0	8.5	16.6	10.2	10.2	6.2	10.6	6.0	16.1	6.2	9.0	11.4	11.3	8.4	6.9	26.1	12.2	6.3	12.5	9.7	8.1	9.3	9.0	4.8	10.7	5.0	9.3	5.2	29.0	19.4	12.1	7.5	9.2	13.1	15.5	12.8	10.6	18.5	14.2	18.2	26.1	15.7	17.5	10.2	12.2	29.8	33.4	21.6	25.3	17.9	16.4	13.6	9.7	12.6	9.0	11.5	12.4	9.5	9.9	18.7	19.1	5.9	18.4	11.9	27.5	12.4	15.4	8.0	14.6	6.5	23.4	32.5	17.4	17.2	15.4	28.9	16.8	9.7	15.9	14.5	14.0	31.3	20.2	19.0	32.8	15.2	8.1	9.5	15.0	13.1	20.4	9.7	24.5	18.2	5.5	12.7	20.5	4.4	7.0	4.8	6.6	10.7	9.3	9.3	7.2	5.8	9.0	7.3	7.7	4.8	0.7	5.0	7.4	3.7	5.1	5.2	6.3	8.1	7.5	8.6	5.5	6.0	6.4	4.2	10.0	6.9	3.0	1.9	4.3	3.6	1.5	2.2	10.5	7.6	1.4	3.4	5.2	0.0	7.3	6.6	3.9	1.9	3.2	4.5	23.3	2.3	13.0	3.4	2.3	5.7	4.3	8.9	3.2	4.1	1.3	3.5	1.0	2.8	5.0	1.7	6.4	5.0	2.4	3.6	0.0	1.4	6.4	2.7	0.0	2.3	5.7	6.4	1.4	3.5	2.9	6.0	2.5
DAW1	"FLJ25955, ODA16, WDR69"	ENSG00000123977	"Dynein assembly factor with WD repeats 1"	Q8N136	2	227871054-227924344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 14.9;fallopian tube: 24.4;testis: 49.9"	"Group enriched"	"Detected in some"	12	"Ciliated cells: 69.6;Early spermatids: 83.7;Late spermatids: 157.9;Spermatocytes: 115.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 6.2;HUVEC TERT2: 15.2;U-2197: 28.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 25.4"	HPA046118	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			Nucleoplasm	"Nuclear bodies, Plasma membrane"	"HPA046118: AB_10961428"		"unprognostic (1.23e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.37e-1)"		"unprognostic (1.23e-1)"	"unprognostic (5.63e-3)"	"unprognostic (2.90e-2)"	"unprognostic (9.92e-3)"		"unprognostic (1.54e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-1)"	0.4	0.1	2.5	0.3	14.9	0.4	0.5	0.0	1.8	0.7	0.3	3.1	0.0	0.1	0.3	3.1	0.6	24.4	0.4	0.4	3.9	3.0	0.3	0.5	2.4	0.3	0.3	2.7	1.3	0.1	0.7	0.2	0.8	14.3	0.2	0.2	0.0	0.3	0.2	2.6	0.3	0.2	0.2	0.3	0.3	0.2	49.9	1.1	0.0	0.2	0.0	0.3	0.3	0.0	0.5	0.5	1.2	0.5	0.2	0.8	0.0	0.6	0.0	0.1	0.0	0.2	0.9	0.4	0.6	0.3	0.6	0.4	3.7	0.3	0.2	0.0	0.1	6.2	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.1	1.3	0.0	0.7	0.5	4.1	15.2	0.0	0.1	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.2	0.1	0.3	1.5	0.1	1.4	28.5	0.0	0.0	0.1	0.2	2.7	0.0	0.2	1.2	0.0	0.2	0.2	0.5	0.8	0.3	0.4	0.4	0.0	0.5	0.6	0.3	0.0	0.2	0.5	0.5	0.6	0.0	2.5	14.9	0.0	1.8	3.9	3.0	0.3	2.7	14.3	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	69.6	9.1	0.0	3.9	0.0	0.0	0.0	83.7	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	157.9	3.1	0.0	0.0	0.0	0.0	0.2	1.7	0.0	2.5	0.0	0.2	0.0	0.0	115.4	1.4	0.1	0.2	0.0	0.0	0.0
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell type enriched"	"Detected in single"	43	"Ito cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 206.1"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	38	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.2	206.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DBN1	D0S117E	ENSG00000113758	"Drebrin 1"	Q16643	5	177456608-177474401	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 78.5;Pancreatic endocrine cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.0;T-cells: 12.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051452, HPA056940"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA		17000000	"Plasma membrane, Actin filaments"		"HPA051452: AB_2681489, HPA056940: AB_2683279"	"unprognostic (3.81e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.57e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (8.28e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-3)"	21.4	9.0	21.7	15.0	42.4	5.4	13.5	12.0	46.0	25.7	21.7	8.8	8.7	8.6	37.4	15.0	19.2	16.2	21.5	13.9	24.2	20.9	15.1	2.7	12.1	7.3	11.9	22.1	20.2	13.2	9.1	17.1	6.7	20.3	14.9	5.8	9.3	24.8	23.0	21.3	12.7	10.0	29.5	8.6	7.8	17.0	14.4	9.4	19.8	20.0	11.0	4.4	20.6	12.0	0.2	5.1	6.0	0.9	0.1	12.7	1.5	3.0	10.3	34.3	59.8	8.2	12.9	10.6	36.6	9.4	21.5	18.0	35.4	10.8	0.0	26.2	28.4	7.3	4.8	15.1	26.6	10.2	0.8	13.1	19.9	13.4	14.7	28.9	7.5	3.7	16.8	7.0	24.0	7.2	21.6	35.4	24.5	9.1	4.8	15.7	4.3	20.4	11.4	49.6	1.0	23.1	61.2	37.1	6.0	16.1	4.3	40.4	54.9	12.0	5.3	20.4	11.6	14.6	7.7	54.7	24.1	32.7	5.3	17.0	1.1	0.5	32.0	10.1	7.0	14.7	6.0	0.9	0.7	9.2	0.5	12.7	0.1	0.2	6.6	1.4	0.2	0.3	4.5	2.5	0.1	0.4	5.1	0.0	1.5	21.7	42.4	12.0	40.8	24.2	20.9	11.9	22.1	20.3	9.4	3.0	1.0	0.5	10.4	9.2	7.6	3.4	5.1	6.7	3.4	8.7	3.9	0.8	1.7	78.5	15.9	26.1	0.8	0.0	37.0	2.4	27.1	6.4	10.4	0.0	1.4	39.7	39.0	20.3	3.2	27.6	46.3	4.1	8.5	2.8	1.6	12.7	52.8	0.0	38.5	2.6	3.7	19.4	17.6	6.1	15.6	6.4	0.7	7.5	3.6	7.2
DBNDD1	"FLJ12582, MGC3101"	ENSG00000003249	"Dysbindin domain containing 1"	Q9H9R9	16	90004865-90020128	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6;skeletal muscle: 39.7"	"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 13.8;Exocrine glandular cells: 16.0;Horizontal cells: 28.6;Pancreatic endocrine cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 14.4"	"Lineage enriched"	"Detected in many"	6	"B-cells: 14.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 47.7"									HPA043018	Uncertain		Approved	"Nuclear speckles,Cytosol"		No	No			"Nuclear speckles"	Cytosol	"HPA043018: AB_10794921"	"unprognostic (1.07e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (2.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (5.67e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.00e-2)"	2.1	6.9	21.5	2.3	13.7	0.8	4.7	16.1	31.6	2.6	2.0	6.5	1.9	1.9	1.4	9.6	13.9	3.9	3.9	3.4	15.7	14.6	6.9	6.2	3.0	3.9	17.6	9.4	3.1	14.1	6.3	3.0	0.6	19.2	3.7	1.8	3.9	11.9	3.8	39.7	3.9	1.2	1.6	6.8	1.6	4.3	1.1	4.5	0.0	3.6	2.3	4.7	2.0	2.3	14.4	0.1	0.6	0.0	0.0	2.5	0.8	7.8	12.0	1.1	14.5	0.3	0.1	8.6	1.7	2.2	3.5	1.7	11.7	6.4	0.0	1.0	0.3	3.3	8.2	12.7	0.3	3.4	0.0	23.1	0.0	1.7	19.1	0.5	0.1	1.3	0.3	1.0	6.1	0.0	8.1	15.2	0.2	2.2	0.1	1.2	47.7	0.0	9.9	20.3	5.7	5.1	4.8	11.0	0.2	19.8	1.5	17.5	18.7	1.9	1.7	14.9	3.3	11.3	1.3	12.2	2.8	5.5	0.1	7.8	0.0	0.1	0.0	1.2	0.9	6.9	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.6	0.4	0.0	14.4	2.5	0.4	0.0	0.0	0.0	0.1	0.0	0.8	21.5	13.7	16.1	31.6	15.7	14.6	17.6	9.4	19.2	4.5	3.0	1.3	0.8	0.5	0.3	1.3	2.2	7.6	1.4	2.3	8.7	0.0	0.1	8.3	13.8	0.0	0.6	0.3	0.0	16.0	0.2	0.2	4.5	0.0	2.0	0.3	28.6	5.8	1.8	0.0	0.0	1.1	0.0	3.3	0.0	2.1	5.1	15.0	2.9	0.4	7.3	1.2	0.0	0.7	0.0	1.9	0.9	0.0	0.0	0.6	1.0
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 160.5;skeletal muscle: 84.2"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.0;Ciliated cells: 9.4;Club cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	12.2	7.8	56.5	9.9	64.9	2.1	15.3	21.3	88.8	11.0	26.4	132.3	5.0	16.6	14.9	13.6	18.3	17.7	10.2	68.4	85.1	47.3	5.9	2.5	13.9	5.8	98.2	31.5	6.5	6.7	18.4	5.0	13.2	51.8	14.2	28.4	3.1	9.0	29.1	84.2	10.4	19.4	31.0	160.5	5.0	13.3	3.0	70.7	2.7	4.8	10.5	8.2	16.8	8.2	0.3	15.0	0.3	9.3	0.6	7.9	3.5	21.7	3.9	3.1	22.0	2.0	0.9	4.4	12.8	13.9	10.7	7.3	10.5	29.8	0.3	2.2	12.6	4.0	32.2	21.5	1.1	6.6	0.1	12.6	18.1	16.8	9.5	12.9	0.9	27.6	0.3	3.7	4.0	3.8	18.7	7.3	18.6	1.3	0.4	0.8	27.6	1.5	1.3	4.1	14.3	23.2	0.0	0.3	0.2	30.6	0.4	7.2	3.7	4.4	2.4	27.5	2.3	30.1	5.6	11.7	0.4	21.3	14.2	13.9	0.3	0.4	0.1	1.5	0.1	3.1	0.0	8.4	0.0	7.9	9.3	2.9	0.1	6.9	5.8	6.0	0.3	6.4	6.0	0.3	0.6	5.0	15.0	5.8	3.5	56.5	64.9	21.3	62.5	85.1	47.3	98.2	31.5	51.8	70.7	3.0	0.3	0.0	0.1	0.0	0.0	1.0	0.0	9.4	4.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1
DCAF10	"FLJ23201, MGC10765, WDR32"	ENSG00000122741	"DDB1 and CUL4 associated factor 10"	Q5QP82	9	37800502-37867666	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 134.0;Late spermatids: 237.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024160	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA024160: AB_1858802"	"unprognostic (2.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (1.01e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.05e-2)"	12.4	21.1	8.8	8.1	12.0	9.9	12.1	14.8	14.9	14.2	13.3	8.8	13.0	10.0	14.2	12.1	16.9	11.7	10.4	15.3	7.9	7.9	14.5	19.1	10.6	9.3	8.4	9.9	15.6	14.8	25.8	13.7	10.5	10.3	16.0	10.9	10.9	12.9	15.7	16.9	12.6	15.2	13.3	7.6	9.4	11.7	29.7	8.6	19.0	16.2	8.0	8.6	17.3	20.4	3.4	1.2	4.2	3.7	3.0	3.5	0.6	12.2	5.7	6.2	5.9	10.3	14.1	8.1	9.9	9.1	5.6	8.0	2.0	4.5	12.4	4.6	11.4	7.1	4.7	6.2	6.9	6.8	10.5	6.2	5.6	9.3	3.7	18.6	7.2	4.2	12.7	14.0	6.6	23.5	10.7	9.0	7.0	19.6	5.7	8.7	4.4	6.8	3.3	6.8	15.4	5.0	6.8	3.2	6.4	9.0	5.7	7.2	9.9	9.1	10.2	8.0	7.4	8.2	13.6	11.3	6.3	4.9	8.8	6.9	5.5	9.4	7.1	10.0	7.3	8.7	0.9	1.4	4.2	2.3	1.2	1.5	2.6	1.9	2.6	1.2	3.4	3.5	2.0	3.9	3.0	3.7	1.1	1.1	0.6	8.8	12.0	14.8	14.9	7.9	7.9	8.4	9.9	10.3	8.6	14.9	23.7	17.9	23.3	36.2	26.6	15.5	7.6	10.7	23.9	12.2	23.6	14.6	8.3	20.0	134.0	21.2	17.7	0.0	19.0	14.1	22.3	28.9	4.7	38.0	13.4	23.8	18.5	23.4	12.6	237.0	25.9	15.7	25.3	10.0	22.3	22.8	20.1	10.5	36.0	23.8	24.8	38.8	23.8	58.5	7.7	45.8	19.1	15.2	25.1	23.7
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	25.3	22.8	21.3	21.7	15.5	18.0	16.0	18.9	14.5	18.0	18.5	22.4	24.8	35.3	32.4	19.8	17.8	19.1	28.8	24.2	34.9	33.6	20.5	48.7	13.7	25.4	17.7	19.9	21.0	14.6	16.7	26.5	44.1	11.3	24.9	24.3	32.7	15.5	27.3	20.6	37.8	21.0	32.6	71.8	35.6	24.6	25.9	36.3	26.2	21.2	27.2	25.8	11.8	18.5	21.4	19.6	28.6	13.7	16.4	18.3	29.5	23.6	25.3	17.1	29.8	49.9	24.7	43.6	23.4	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0	14.9	14.2	31.8	57.7	70.6	19.2	17.3	7.6	14.7	31.8	31.4	23.6	50.1	33.2	41.0	33.6	28.9	16.1	0.0	42.0	61.5	36.1	25.3	40.3	14.7	39.5	15.9	13.9	17.2	15.4	10.8	22.5	25.0	25.3	30.7	16.0	25.8	34.4	10.5	16.6	66.3	19.8	12.9	36.3	85.0	87.9	67.2	28.4	26.3	25.4	52.2
DCAF15	"C19orf72, MGC99481"	ENSG00000132017	"DDB1 and CUL4 associated factor 15"	Q66K64	19	13952492-13961449	"Predicted intracellular proteins"	"Immunity, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068351			Approved	Vesicles,Mitochondria		NA	NA			Mitochondria	Vesicles	"HPA068351: AB_2685977"	"unprognostic (6.91e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.72e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.97e-4)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (7.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	10.3	6.5	10.4	15.1	8.5	27.5	11.1	20.1	13.3	13.9	12.7	8.7	8.9	10.7	11.4	8.4	14.7	11.3	10.0	11.0	12.1	7.0	11.1	13.1	14.8	19.4	9.0	8.5	10.3	8.4	11.0	10.7	18.6	8.8	10.4	8.4	9.8	10.0	9.1	13.3	21.0	13.8	8.2	7.4	21.4	9.9	41.0	6.5	29.2	10.7	16.5	23.4	9.9	12.8	2.2	2.8	5.1	2.2	0.8	3.6	1.3	15.6	9.7	25.6	14.0	2.7	4.0	11.7	10.8	7.6	22.7	22.7	17.2	6.7	14.5	12.6	10.4	13.4	14.3	16.2	10.2	8.1	17.4	28.9	17.8	16.2	17.8	5.8	14.7	26.3	5.3	9.6	16.7	7.6	8.2	11.3	23.5	18.7	21.4	9.9	23.8	26.2	27.3	30.4	10.6	15.3	24.2	9.0	9.9	12.1	12.1	16.4	16.9	9.7	7.0	8.8	11.0	9.0	19.0	7.8	15.6	11.6	24.5	20.1	15.1	16.6	15.1	10.0	21.5	13.4	1.2	2.0	5.1	2.1	2.2	1.6	2.1	1.7	2.4	1.2	2.2	0.9	2.4	4.1	0.8	1.4	2.8	3.6	1.3	10.4	8.5	20.1	13.3	12.1	7.0	9.0	8.5	8.8	6.5	0.0	0.0	16.4	8.1	4.2	15.5	0.9	5.1	0.0	2.3	8.7	7.9	10.8	1.7	9.7	4.0	8.3	6.3	0.0	9.1	12.7	6.4	4.9	1.1	3.2	13.4	14.3	7.5	9.2	6.0	7.8	17.0	8.8	1.7	14.4	6.1	8.4	7.9	7.0	11.3	3.3	13.2	6.5	4.7	25.1	23.7	8.5	11.6	12.2	6.8	9.2
DCAF16	"C4orf30, FLJ20280"	ENSG00000163257	"DDB1 and CUL4 associated factor 16"	Q9NXF7	4	17800655-17810758	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042487	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042487: AB_10795505"	"unprognostic (2.23e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.40e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-3)"	"prognostic favorable (7.67e-4)"	13.0	13.1	12.7	12.1	20.5	23.3	19.8	19.4	19.7	18.5	13.1	22.5	9.9	12.0	26.9	16.5	11.5	16.1	11.3	11.8	13.9	15.7	11.3	6.8	12.6	16.7	14.4	16.2	29.6	16.0	17.8	25.8	14.8	19.0	16.9	14.8	17.1	15.2	13.0	16.2	22.4	14.0	17.2	16.0	13.3	13.6	19.2	16.3	30.6	15.7	7.0	18.3	16.3	14.6	4.8	3.0	9.7	2.8	3.6	6.3	2.2	12.2	2.6	14.3	15.0	4.1	7.2	7.9	8.0	9.5	9.6	11.4	7.5	10.0	13.9	6.4	7.4	7.8	6.2	8.4	8.5	14.3	4.7	7.7	19.4	8.8	12.2	9.9	17.0	7.9	9.4	7.0	12.2	12.1	6.5	6.6	13.7	20.8	23.1	5.5	4.6	18.7	16.4	11.8	3.6	7.7	19.8	16.4	8.9	4.1	9.7	21.4	17.2	8.5	2.3	9.2	7.6	8.4	4.7	8.3	11.2	8.8	12.3	10.1	10.3	4.1	17.3	9.2	11.9	7.5	9.7	2.4	3.4	4.5	2.8	5.9	3.7	5.0	4.9	1.5	4.8	6.3	5.9	1.8	3.6	1.9	3.0	3.4	2.2	12.7	20.5	19.4	19.7	13.9	15.7	14.4	16.2	19.0	16.3	17.9	19.0	9.0	15.5	22.6	11.8	14.8	15.3	21.4	17.0	8.7	5.9	14.1	11.6	8.6	14.8	12.1	7.1	23.3	6.7	7.7	16.1	12.3	16.2	5.7	6.4	14.3	16.8	11.6	9.7	9.1	19.5	9.6	10.1	5.4	16.5	23.4	8.7	5.8	20.8	5.0	13.6	12.9	13.2	24.2	17.2	18.4	10.3	15.2	13.0	14.3
DCAF4	"DKFZp434K114, WDR21, WDR21A"	ENSG00000119599	"DDB1 and CUL4 associated factor 4"	Q8WV16	14	72926332-72959703	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047276	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047276: AB_10959615"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.96e-3)"	"unprognostic (2.11e-2)"	9.0	10.4	6.7	10.2	11.4	7.3	10.8	6.1	19.2	8.4	10.5	12.0	7.5	6.7	14.5	9.8	10.0	8.9	9.9	6.6	7.4	9.2	12.3	9.6	6.3	9.4	9.4	10.9	15.0	17.9	9.4	6.5	14.5	15.4	9.3	10.6	9.0	13.4	8.6	18.2	18.5	8.8	9.6	6.6	9.2	10.7	14.5	6.6	7.9	17.7	7.5	12.1	9.9	9.6	12.0	3.5	1.0	4.5	9.0	7.1	3.1	12.6	6.1	1.5	6.6	6.5	8.6	12.1	7.3	7.4	9.5	11.0	6.8	5.6	16.3	5.5	13.8	8.8	9.6	10.5	11.2	16.8	8.1	5.8	6.8	2.7	8.9	9.4	4.6	11.1	15.2	11.4	10.2	19.2	6.4	3.3	16.0	9.8	10.6	7.6	20.9	7.9	11.6	3.8	12.9	12.7	5.6	8.0	9.3	14.2	7.5	7.8	3.1	4.4	23.1	9.1	6.9	7.8	6.2	5.0	5.1	12.2	14.1	3.6	14.8	14.1	10.9	7.3	3.9	3.2	0.3	1.7	0.3	4.5	2.7	6.7	12.0	5.5	5.1	3.5	10.3	6.4	6.7	1.0	9.0	4.5	2.7	7.1	3.1	6.7	11.4	6.1	19.2	7.4	9.2	9.4	10.9	15.4	6.6	6.0	4.0	9.0	6.0	5.5	2.7	3.6	2.5	2.7	11.4	3.5	3.9	16.9	3.3	5.6	2.9	4.0	1.7	0.0	4.9	16.1	6.1	2.7	0.0	4.0	5.2	0.0	4.1	0.0	2.2	1.9	3.4	1.9	1.7	3.6	3.3	1.6	4.5	6.2	5.3	5.0	3.4	0.0	5.4	6.7	19.4	5.8	4.7	3.2	6.3	3.1
DCAF5	"BCRG2, BCRP2, D14S1461E, KIAA1824, WDR22"	ENSG00000139990	"DDB1 and CUL4 associated factor 5"	Q96JK2	14	69050881-69153150	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 118.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041575, HPA048098"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041575: AB_2677558, HPA048098: AB_2680263"	"unprognostic (8.12e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-1)"	23.5	18.1	18.5	18.1	21.7	19.0	21.7	23.5	24.0	23.1	24.4	21.4	20.2	15.6	26.9	17.2	24.5	22.0	19.9	22.2	17.9	11.7	19.3	23.8	23.8	18.4	13.6	13.5	24.5	17.8	32.6	30.1	20.6	15.5	23.7	16.0	23.4	20.6	24.9	47.7	23.4	20.5	24.5	20.1	22.3	20.6	41.8	17.5	38.7	25.0	14.0	27.9	24.2	24.6	5.3	3.5	9.6	2.5	17.5	19.4	7.2	26.0	8.3	19.6	18.2	21.9	19.2	12.9	12.3	18.0	14.2	17.9	10.7	16.7	14.4	11.3	19.1	10.7	12.8	13.8	18.4	13.3	19.5	7.6	15.5	8.4	7.6	16.6	5.9	18.9	21.6	19.3	12.6	17.8	24.6	21.1	17.3	11.9	12.2	14.0	15.5	18.5	10.3	8.8	12.3	13.3	12.4	18.6	5.7	18.8	20.4	14.0	15.8	16.5	17.3	11.0	17.7	21.1	12.0	19.0	24.2	22.9	11.1	7.2	16.1	5.2	13.3	16.1	7.1	7.3	9.6	2.5	9.0	19.4	2.4	16.4	5.0	10.5	14.2	3.3	5.3	10.1	12.5	3.2	17.5	1.6	3.5	4.7	7.2	18.5	21.7	23.5	24.0	17.9	11.7	13.6	13.5	15.5	17.5	41.7	52.6	15.9	17.8	23.4	17.5	53.4	35.7	48.2	46.6	14.0	25.5	16.4	1.7	19.9	118.8	28.9	18.0	0.0	21.6	14.7	21.8	18.2	34.8	28.0	16.9	17.5	22.4	26.4	20.9	68.0	28.7	19.0	10.1	17.2	21.1	20.8	25.0	17.5	32.2	10.8	23.8	45.3	28.3	45.2	16.4	17.3	12.8	27.7	18.3	18.7
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.9"	"Group enriched"	"Detected in all"	4	"Cardiomyocytes: 200.2;Early spermatids: 375.8;Late spermatids: 573.8;monocytes: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Nucleoplasm, Focal adhesion sites"		"HPA054305: AB_2682444"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	10.6	17.0	10.9	7.8	12.2	6.2	8.8	10.5	17.8	10.2	11.5	3.9	8.4	6.2	9.5	11.4	9.3	7.7	8.2	43.8	7.6	5.5	9.5	26.2	7.3	4.8	5.2	11.5	8.3	6.1	10.8	11.3	7.8	6.5	10.5	8.7	5.7	10.3	11.9	155.9	6.4	7.8	10.2	4.8	5.9	9.8	21.5	4.8	7.8	8.2	27.3	7.3	9.1	7.3	6.2	7.7	12.5	13.9	4.4	7.2	5.0	23.0	11.0	6.1	9.9	20.3	28.9	21.6	23.6	35.4	16.8	25.1	18.3	19.5	19.1	13.8	30.5	8.0	17.4	9.6	17.7	23.8	10.8	10.2	20.3	16.8	13.1	16.4	9.1	9.7	20.5	17.9	15.9	13.3	25.6	18.3	6.1	22.9	15.8	24.7	5.3	10.1	8.3	3.9	12.9	12.3	7.8	12.7	14.8	41.9	11.3	9.0	7.2	18.9	17.4	12.9	13.4	29.7	11.2	25.8	16.8	10.5	16.2	9.7	17.0	13.8	14.9	22.4	7.8	6.8	6.0	7.0	12.5	6.7	9.6	7.2	6.2	5.4	5.8	7.7	4.5	5.0	6.4	7.2	4.4	13.9	4.6	6.1	5.0	10.9	12.2	10.5	17.8	7.6	5.5	5.2	11.5	6.5	4.8	53.6	33.4	19.8	24.8	51.4	13.4	200.2	45.9	60.2	53.4	24.4	21.6	61.0	14.9	25.7	375.8	29.8	24.8	46.7	16.9	26.6	39.2	32.0	18.5	81.0	17.8	4.8	20.3	25.8	28.6	573.8	53.2	22.6	35.4	176.7	27.3	14.6	18.0	28.1	45.6	26.9	16.7	32.3	37.1	78.4	58.9	34.8	68.0	20.8	28.8	23.7
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262531	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	26.6	28.7	26.3	21.6	29.5	21.2	26.4	37.6	38.3	22.2	28.0	39.6	31.6	25.0	28.7	38.2	24.6	27.6	29.0	35.8	25.9	20.0	25.6	42.2	23.0	25.5	30.1	29.2	29.8	34.6	45.3	33.1	21.5	31.7	23.8	19.0	29.3	29.0	44.9	86.4	28.8	26.1	26.8	23.8	28.6	28.6	20.8	32.5	25.7	36.9	27.2	22.7	28.0	21.6	26.6	17.8	22.4	21.6	24.9	26.6	14.4	17.1	21.5	24.4	22.0	30.7	23.3	21.3	20.4	28.9	17.1	15.3	22.6	29.8	19.0	38.3	23.1	12.6	21.3	11.8	19.2	10.8	43.5	23.2	21.1	30.1	17.7	25.0	17.6	27.0	27.6	20.3	15.2	22.1	19.0	26.4	24.6	19.0	35.0	15.8	16.3	22.7	17.6	17.5	22.6	21.4	22.3	14.4	37.1	19.6	30.6	16.6	16.0	34.2	38.3	22.9	24.7	35.9	26.7	31.7	21.1	10.9	12.9	18.8	57.5	39.2	30.9	23.5	16.6	17.2	22.4	17.5	18.1	26.6	16.9	26.1	23.7	23.6	25.0	14.8	26.6	26.2	23.8	19.9	24.9	21.6	17.8	24.3	14.4	26.3	29.5	37.6	38.3	25.9	20.0	30.1	29.2	31.7	32.5	53.6	45.7	13.9	17.0	16.4	43.6	50.1	22.9	48.2	38.7	24.4	60.9	25.4	53.0	18.8	1.7	23.6	23.7	0.0	18.8	17.5	22.0	14.7	31.4	60.2	20.7	38.1	24.1	17.2	29.6	1.9	25.9	19.5	13.5	30.7	19.1	36.1	17.3	10.5	30.8	27.6	56.3	12.9	25.5	27.5	17.9	21.1	37.1	28.0	19.0	8.2
DCAKD	FLJ22955	ENSG00000172992	"Dephospho-CoA kinase domain containing"	Q8WVC6	17	45023340-45061109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060997			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060997: AB_2797262"	"unprognostic (1.32e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.71e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.13e-1)"	"unprognostic (8.24e-3)"	"unprognostic (7.57e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.82e-2)"	14.6	26.9	25.1	10.3	28.1	6.5	14.9	20.3	32.6	18.8	11.8	31.2	17.8	10.0	18.7	23.7	19.6	28.2	13.6	29.0	28.0	30.0	13.6	15.9	9.9	11.3	28.7	22.9	26.5	16.5	21.1	25.0	11.8	28.6	21.3	10.5	23.7	38.1	22.5	12.7	21.5	10.2	15.6	24.6	11.2	9.8	11.6	23.6	21.8	27.0	8.7	14.8	17.9	15.6	5.7	13.2	2.2	6.5	4.7	9.4	3.9	7.7	14.8	14.3	21.8	12.3	13.0	7.9	6.9	4.7	8.8	8.9	3.5	8.3	13.9	15.0	6.7	7.7	9.9	9.9	6.7	7.6	43.6	19.0	14.3	7.1	17.5	14.9	6.0	8.3	16.1	15.7	9.8	2.9	8.2	7.5	21.4	13.3	9.7	10.3	17.3	18.7	6.7	7.6	14.0	12.7	11.3	11.7	11.4	7.9	10.2	17.8	22.7	4.7	3.7	8.2	12.9	11.1	8.8	11.3	11.5	7.8	16.4	7.2	12.2	5.8	6.3	20.1	6.2	13.4	1.0	4.5	2.2	7.5	6.5	9.4	5.7	7.6	6.6	7.0	5.1	7.0	7.3	0.8	4.7	4.6	13.2	6.9	3.9	25.1	28.1	20.3	28.1	28.0	30.0	28.7	22.9	28.6	23.6	6.0	8.6	5.4	11.2	6.8	11.1	14.5	10.2	6.7	4.5	19.2	3.9	15.9	19.9	4.0	1.6	4.5	3.4	0.0	4.2	9.1	9.1	8.4	0.0	9.5	6.5	15.9	11.6	6.7	4.6	2.7	8.6	4.6	15.1	25.2	9.2	20.7	3.3	9.0	10.3	12.1	10.5	12.9	7.2	4.6	4.3	6.9	9.4	5.7	12.9	7.9
DCANP1	"C5orf20, DCNP1"	ENSG00000251380	"Dendritic cell associated nuclear protein"	Q8TF63	5	135444214-135447348	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.0;lymphoid tissue: 3.0;skin 1: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"THP-1: 6.7"									HPA048308	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA048308: AB_2680349"																		0.2	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.6			0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.5	3.0	0.2		0.0	0.3	0.0	0.0	0.0		0.1	0.4		0.2	0.1	0.1	2.2	2.0	0.0	0.2	2.7	0.1	0.0			0.2		1.6	0.1	0.2	0.0	1.0	0.1	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.5	0.0	1.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCBLD1	"dJ94G16.1, MGC46341"	ENSG00000164465	"Discoidin, CUB and LCCL domain containing 1"	Q8N8Z6	6	117453817-117569858	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA059667	Approved		Approved	Cytosol		NA	NA		11000000	Cytosol		"HPA059667: AB_2684099"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.44e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.74e-2)"	"unprognostic (8.99e-2)"	"unprognostic (5.69e-3)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (8.57e-8)"	"unprognostic (6.99e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.36e-1)"	15.5	5.2	6.6	7.9	5.6	0.7	12.2	5.1	8.9	12.9	10.6	4.2	10.4	9.0	7.9	6.2	7.9	3.9	12.8	8.2	4.8	3.7	6.1	13.2	15.6	6.3	4.7	3.2	3.2	13.1	12.2	12.6	12.1	7.0	7.6	8.7	4.5	7.1	9.6	17.8	4.3	12.7	7.1	10.2	5.8	10.5	7.6	3.2	1.2	8.8	7.0	5.1	10.5	12.2	0.0	1.2	0.0	0.7	1.0	3.5	1.2	3.1	7.3	2.6	2.9	4.6	5.8	7.4	18.2	24.0	15.5	11.8	15.3	6.9	0.0	9.1	7.8	19.3	7.3	5.0	8.1	16.4	1.4	3.8	2.7	7.6	24.9	20.0	3.9	2.3	6.6	19.0	14.0	13.3	17.9	21.5	2.7	5.8	2.8	20.2	2.5	0.0	2.6	1.9	8.6	3.0	0.0	0.5	1.8	3.4	3.8	7.9	0.1	13.4	1.5	2.1	3.9	1.9	5.2	15.9	0.0	18.8	5.2	7.9	7.8	2.1	2.1	7.8	3.9	6.8	0.0	0.5	0.0	1.7	0.7	0.3	0.0	2.4	3.5	0.6	0.0	3.0	3.5	0.0	1.0	0.3	1.2	2.2	1.2	6.6	5.6	5.1	8.9	4.8	3.7	4.7	3.2	7.0	3.2	14.9	13.1	5.2	2.9	4.6	5.6	3.2	12.7	5.3	15.9	5.2	5.9	23.0	1.7	5.2	22.6	7.8	9.7	0.0	4.2	4.8	5.1	3.1	1.1	7.9	5.0	4.8	4.1	13.5	5.1	7.0	0.9	6.3	8.5	1.0	7.1	1.2	7.9	7.8	0.4	2.1	3.0	12.9	17.6	1.5	13.6	5.3	15.2	6.1	9.3	5.3
DCBLD2	"CLCP1, ESDN"	ENSG00000057019	"Discoidin, CUB and LCCL domain containing 2"	Q96PD2	3	98795941-98901689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 66.0;Cone photoreceptor cells: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 59.8;hTERT-RPE1: 84.9;LHCN-M2: 99.6;RPTEC TERT1: 62.4;U-87 MG: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016909	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		1800000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA016909: AB_1847510"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-3)"	"unprognostic (9.29e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.32e-5)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.59e-3)"	13.1	14.6	4.5	6.4	7.2	1.1	19.3	9.7	9.6	12.0	13.1	5.1	8.1	2.7	16.8	9.2	8.8	13.9	11.7	24.2	4.5	6.2	11.3	9.2	13.1	3.2	6.7	3.5	19.0	6.4	17.6	12.7	9.9	6.5	11.2	6.8	19.3	11.1	14.7	6.6	7.7	5.2	16.7	7.1	2.1	8.6	33.8	7.3	8.1	18.7	6.3	3.6	15.1	6.8	0.6	1.2	1.7	0.5	0.1	1.1	0.2	6.8	50.2	6.7	5.3	9.0	21.4	2.9	15.5	7.4	10.6	12.0	4.2	21.9	0.0	48.8	26.6	32.5	6.4	3.0	25.2	24.4	0.1	1.0	2.4	1.6	6.4	5.5	1.1	1.1	8.4	3.9	30.4	59.8	84.9	6.9	0.9	0.4	0.6	99.6	1.8	0.9	0.6	4.7	0.0	17.4	1.0	12.7	0.6	62.4	1.8	1.8	3.1	4.2	0.8	18.1	4.8	3.4	0.9	11.4	27.3	21.9	6.9	54.2	0.8	1.1	0.9	76.2	0.4	11.8	1.2	0.5	1.7	0.0	0.1	0.0	0.6	0.1	0.1	0.5	0.2	1.1	0.1	0.9	0.1	0.3	1.2	0.0	0.2	4.5	7.2	9.7	9.6	4.5	6.2	6.7	3.5	6.5	7.3	29.8	44.4	4.5	12.4	20.3	11.2	66.0	12.7	18.7	20.5	17.4	72.6	9.6	0.0	20.3	2.5	7.1	0.9	0.0	7.0	8.2	18.1	10.1	36.9	18.7	3.5	12.7	3.5	4.9	1.6	3.6	20.4	2.6	8.5	1.8	7.3	44.0	17.8	3.5	47.4	6.9	49.1	0.0	19.1	15.8	23.3	13.7	3.3	0.0	10.7	5.9
DCC	"IGDCC1, NTN1R1"	ENSG00000187323	"DCC netrin 1 receptor"	P43146	18	52340172-53535903	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.0;testis: 16.5"	"Group enriched"	"Detected in some"	27	"Early spermatids: 183.2;Late spermatids: 131.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 15.4;U-266/70: 47.9;U-266/84: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055376, HPA069552"	Enhanced		Approved	"Golgi apparatus"		NA	NA		25000	"Golgi apparatus"		"HPA055376: AB_2682798, HPA069552: AB_2686151"	"unprognostic (1.96e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.22e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-3)"	0.5	1.9	6.3	0.8	22.0	0.4	0.6	0.7	10.1	0.8	0.9	1.3	0.0	0.5	0.4	1.0	0.7	0.7	0.5	0.5	18.4	2.0	0.9	0.5	3.8	0.4	1.5	9.9	0.7	1.2	0.6	1.1	0.4	5.3	1.3	0.8	0.0	0.8	3.5	0.4	0.8	0.7	0.5	2.4	0.8	0.8	16.5	6.5	0.7	0.5	0.0	1.1	0.8	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	47.9	22.5	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	22.0	0.7	10.1	18.4	2.0	1.5	9.9	5.3	6.5	0.0	5.9	0.0	0.1	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	183.2	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	131.3	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.4	0.0	0.0	1.4	1.9	0.0	0.1	0.0	0.0	0.0
DCHS1	"CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16"	ENSG00000166341	"Dachsous cadherin-related 1"	Q96JQ0	11	6621323-6655854	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	22	"Endothelial cells: 12.7;Fibroblasts: 17.1;Ito cells: 63.3;Melanocytes: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 19.2;HUVEC TERT2: 26.7;REH: 12.9;SH-SY5Y: 18.7;TIME: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017970, HPA050246"	Approved		Approved	"Plasma membrane"		NA	NA		75000	"Plasma membrane"		"HPA017970: AB_2669718, HPA050246: AB_2681062"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.52e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (5.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-3)"	9.0	2.0	4.1	7.7	4.7	0.5	6.8	5.2	4.4	26.1	12.9	4.4	9.0	3.8	23.9	4.7	5.0	10.4	9.1	8.0	4.0	4.5	3.4	5.6	7.7	3.9	2.5	3.4	13.7	3.3	1.6	2.7	9.7	3.3	12.0	3.4	9.7	3.3	12.0	3.5	3.4	6.0	16.0	1.6	10.2	6.8	2.6	2.5	5.8	3.3	2.6	2.6	10.9	11.9	0.0	1.4	0.1	0.0	0.0	0.9	0.4	0.0	0.0	19.2	0.1	0.0	0.0	0.1	0.6	4.9	3.1	3.5	0.1	0.0	0.1	2.9	5.5	0.2	0.0	1.5	0.0	2.1	0.0	0.5	0.4	0.0	0.0	0.2	0.1	0.0	0.6	0.1	1.4	0.0	0.0	26.7	0.0	0.1	0.0	1.1	0.0	0.6	0.3	2.8	0.0	0.0	12.9	0.0	0.0	0.0	0.0	1.4	18.7	0.0	0.1	0.1	2.1	0.0	0.7	11.4	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.8	0.9	0.1	0.0	0.0	1.4	0.0	0.4	4.1	4.7	5.2	4.4	4.0	4.5	2.5	3.4	3.3	2.5	0.0	0.3	0.0	0.2	2.6	0.4	2.8	5.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	2.2	12.7	0.0	0.0	0.3	0.3	17.1	0.2	0.0	0.0	1.8	0.0	0.0	63.3	6.0	2.9	1.1	0.4	15.1	0.0	0.7	0.5	0.2	0.0	1.8	0.0	0.3	0.0	2.2	2.7	0.5	1.5	0.2	0.0	1.0	0.0
DCHS2	"CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ"	ENSG00000197410	"Dachsous cadherin-related 2"		4	154231742-154495570	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"endometrium 1: 8.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 20.6;Horizontal cells: 23.8;Intestinal endocrine cells: 6.4;Late spermatids: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"U-2 OS: 8.0"					"Low region specificity"	"Detected in many"			HPA064159	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA064159: AB_2685201"	"unprognostic (1.38e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-3)"	0.9	1.6	3.4	1.3	7.0	1.1	1.0	0.6	4.8	2.6	4.0	1.9	1.1	1.3	8.6	1.5	1.0	2.0	1.6	0.8	3.5	2.6	0.9	0.7	1.1	0.8	3.0	2.3	1.9	0.6	1.1	1.7	0.8	4.6	1.6	1.5	2.7	0.8	3.6	1.0	2.1	1.0	3.0	7.0	0.8	4.9	2.6	2.9	0.0	1.0	0.0	0.9	2.3	1.2	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.4	7.0	0.6	4.8	3.5	2.6	3.0	2.3	4.6	2.9	0.0	0.0	0.0	0.2	0.3	0.0	1.7	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	23.8	6.4	0.0	0.0	14.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.3	0.0	0.0	0.0	0.0
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131306	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 76.5"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 84.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.7;ASC TERT1: 15.8;fHDF/TERT166: 12.9;GAMG: 19.8;HAP1: 10.0;HSkMC: 14.6;NTERA-2: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		11000	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265"	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	13.9	3.3	14.3	4.2	25.0	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2.0	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3.0	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17.0	10.4	4.6	2.5	2.2	8.5	0.0	2.1	1.4	2.9	5.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	16.7	15.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	12.9	19.8	0.0	10.0	0.2	0.0	0.0	0.6	0.0	0.4	0.0	0.6	0.0	0.0	14.6	7.3	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	1.1	0.0	0.5	0.0	4.1	2.5	0.0	0.0	1.2	6.1	0.0	0.0	0.0	0.0	3.4	4.3	0.7	0.1	0.0	0.0	1.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	25.0	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5	8.9	1.1	0.0	1.0	13.5	2.2	5.1	0.0	4.0	4.5	3.5	3.9	0.0	0.0	0.0	1.3	2.9	0.0	0.0	0.0	0.0	9.3	0.5	0.0	0.0	0.1	9.5	0.0	0.6	0.3	0.9	19.2	0.0	13.5	0.0	0.0	84.2	0.3	0.0	3.9	0.2	2.1	6.5	16.8	1.6	0.7	8.4	0.0	0.0	0.0	1.3
DCLRE1A	"hSNM1, KIAA0086, PSO2, SNM1"	ENSG00000198924	"DNA cross-link repair 1A"	Q6PJP8	10	113834725-113854383	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036907	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA036907: AB_10673626"	"unprognostic (1.22e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.34e-2)"	3.4	7.1	7.0	4.1	8.1	4.5	6.1	10.2	9.9	5.0	5.3	3.7	4.5	4.7	5.9	6.9	6.5	5.0	4.0	4.8	6.0	6.4	7.3	15.6	7.0	7.5	6.0	2.6	6.5	9.4	10.7	16.9	4.8	8.4	7.4	6.3	5.6	5.4	5.0	6.8	4.2	5.2	4.8	5.5	6.8	5.9	5.2	5.2	8.2	6.1	2.8	6.0	5.1	3.4	1.4	2.1	1.8	0.8	1.9	6.0	2.5	10.8	9.0	13.9	14.0	1.8	3.1	7.9	6.6	6.7	9.0	10.4	7.1	14.9	8.4	7.5	3.3	7.0	9.1	13.2	5.8	11.7	16.5	11.3	14.2	6.0	9.0	6.1	14.9	13.5	2.0	7.0	7.5	13.4	6.0	5.4	11.5	16.3	9.2	5.0	6.4	7.1	6.0	6.7	8.6	4.9	4.2	16.5	5.5	5.9	5.1	6.1	10.0	3.8	6.6	9.7	9.9	7.8	7.3	4.7	5.2	10.3	7.0	10.8	10.7	12.2	13.0	7.8	21.9	7.4	1.8	0.6	1.4	5.8	0.4	3.8	1.4	2.6	3.9	2.1	0.7	1.9	3.2	0.3	1.9	0.8	0.9	6.0	2.5	7.0	8.1	10.2	9.9	6.0	6.4	6.0	2.6	8.4	5.2	6.0	2.6	0.0	0.7	0.6	5.0	6.2	7.6	6.7	3.4	1.8	0.0	2.6	6.6	1.6	0.4	1.4	1.4	0.0	1.0	1.5	1.1	0.9	1.1	6.0	2.6	6.4	3.4	1.8	4.9	0.4	1.4	1.1	0.0	4.6	2.5	3.4	1.3	2.9	1.4	3.1	3.3	0.0	0.7	3.4	4.5	0.5	0.6	2.2	2.5	0.5
DCLRE1C	"A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C"	ENSG00000152457	"DNA cross-link repair 1C"	Q96SD1	10	14897359-14954432	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069295			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA069295: AB_2686112"	"unprognostic (8.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.30e-4)"	"unprognostic (8.02e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.91e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (9.03e-8)"	"unprognostic (2.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.45e-3)"	7.0	5.1	4.8	13.8	9.9	15.2	6.9	6.8	5.9	6.2	6.0	6.0	6.2	6.0	5.7	4.8	9.5	5.8	4.6	4.8	5.4	3.5	5.9	3.3	5.9	14.8	6.9	3.4	6.1	4.4	5.3	7.2	5.0	6.3	7.0	6.2	5.0	6.8	9.2	3.7	7.8	7.8	8.2	8.2	13.3	6.9	2.8	8.3	23.3	7.1	5.6	16.5	9.7	8.0	23.5	17.2	19.3	14.5	8.0	12.2	6.7	12.0	5.9	4.9	10.6	5.1	6.6	5.2	7.5	4.0	10.3	10.4	6.5	10.1	16.2	3.0	5.8	7.2	10.1	5.6	3.9	8.5	9.5	5.9	12.1	5.3	4.3	4.0	7.5	14.2	5.3	3.7	9.9	4.1	6.3	5.6	10.6	7.8	13.7	6.2	5.5	11.0	7.3	3.5	10.6	2.7	12.5	6.9	9.1	5.3	4.7	2.7	5.2	8.0	8.4	20.9	4.4	9.8	13.8	4.7	6.3	9.3	13.0	7.9	7.8	13.7	16.6	6.4	8.0	8.8	19.3	11.1	14.9	10.1	14.5	12.1	19.3	11.7	12.2	16.2	23.5	10.2	11.3	10.7	8.0	12.7	17.2	9.0	6.7	4.8	9.9	6.8	5.9	5.4	3.5	6.9	3.4	6.3	8.3	3.0	5.8	22.9	17.0	15.3	24.2	4.1	12.7	8.1	6.8	14.0	58.9	12.5	3.3	7.6	20.7	9.5	9.5	0.0	9.7	17.7	11.3	16.9	5.8	1.0	9.0	30.2	6.4	6.7	17.4	1.5	11.5	16.7	18.6	11.8	5.4	7.2	10.6	11.8	10.6	2.2	42.0	19.4	13.9	10.0	18.4	18.4	4.2	20.2	5.6	35.5
DCP1B	FLJ31638	ENSG00000151065	"Decapping mRNA 1B"	Q8IZD4	12	1946054-2004535	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 19.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA039709	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA039709: AB_10672901"	"unprognostic (9.60e-2)"	"unprognostic (7.19e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.84e-2)"	"unprognostic (7.42e-2)"	7.3	14.3	8.6	7.1	9.9	2.4	7.4	10.7	8.4	11.0	17.9	6.7	5.6	4.8	18.1	9.8	6.1	11.5	9.2	3.2	10.3	4.9	6.5	7.2	6.4	7.0	7.6	8.2	12.9	8.5	8.5	19.8	6.0	6.1	11.7	8.4	7.5	7.2	11.6	8.7	6.2	7.7	29.1	8.5	7.5	9.9	15.8	7.5	10.0	8.0	1.7	7.1	14.4	8.2	3.8	3.9	2.6	3.4	4.0	19.1	3.8	0.1	3.3	6.0	4.6	7.7	9.7	10.1	4.0	8.0	5.1	6.4	0.2	5.2	8.0	1.5	5.9	4.4	0.0	4.1	4.2	4.5	13.5	4.4	3.4	2.5	4.8	10.3	4.7	3.9	7.3	7.1	4.6	4.0	10.7	8.4	6.3	2.0	3.3	6.2	4.1	6.5	3.9	13.2	2.9	1.4	3.8	2.9	1.4	6.0	0.0	0.9	4.4	3.5	2.9	3.0	14.0	2.9	4.4	4.9	2.5	9.0	5.7	4.1	2.8	2.1	5.5	5.9	3.1	6.2	2.6	2.1	0.2	7.9	3.1	9.7	3.8	8.0	7.6	3.9	3.8	6.3	8.0	0.4	4.0	3.4	2.0	19.1	3.8	8.6	9.9	10.7	8.4	10.3	4.9	7.6	8.2	6.1	7.5	6.0	2.9	0.0	3.7	0.8	6.1	2.0	2.5	4.0	4.5	7.0	9.8	4.7	11.6	6.0	42.8	3.6	4.2	0.0	3.7	4.0	4.7	2.7	5.7	5.5	5.1	6.4	2.4	2.5	3.4	13.7	5.2	2.7	1.7	6.4	5.3	4.7	4.6	5.9	8.9	6.3	6.2	0.0	3.3	19.5	8.2	2.0	2.4	7.5	6.3	3.4
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113020970	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 52.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	8.0	7.5	8.1	16.3	9.5	22.9	15.0	16.8	10.9	9.1	6.6	6.4	6.6	6.3	10.5	6.8	7.4	8.0	6.5	6.1	8.1	8.9	8.1	8.1	13.2	19.8	6.9	6.1	12.8	6.2	7.0	12.2	40.2	8.3	8.1	7.3	6.5	9.6	8.6	8.3	9.8	8.7	7.3	7.4	19.9	6.7	6.8	6.5	52.9	7.0	4.1	20.0	8.7	9.1	5.1	6.5	16.3	8.3	3.9	5.9	3.2	3.6	3.1	14.1	11.3	2.8	3.1	22.8	3.3	2.7	4.2	6.1	14.6	7.8	19.1	5.3	1.9	3.4	4.5	16.2	4.5	5.1	5.1	7.0	17.9	2.7	5.8	3.2	10.9	9.3	2.9	3.1	5.1	5.1	4.0	7.1	14.7	13.2	7.5	3.8	4.6	16.0	11.6	12.2	2.2	1.9	15.7	13.4	7.1	6.5	9.3	3.3	7.0	4.6	5.2	6.7	15.3	15.4	14.6	4.6	4.7	8.4	2.4	5.0	5.1	11.2	14.6	2.7	15.3	3.6	12.2	7.2	5.5	4.0	7.1	5.5	5.1	4.9	4.2	6.5	3.6	4.6	4.7	16.3	3.9	8.3	3.5	5.9	3.2	8.1	9.5	16.8	10.9	8.1	8.9	6.9	6.1	8.3	6.5	17.9	15.6	38.9	16.7	24.6	21.6	11.4	5.1	18.7	22.7	19.2	74.6	53.4	16.6	8.9	23.5	21.8	10.0	0.0	10.3	41.1	27.2	25.6	18.5	5.9	27.7	27.0	15.5	27.6	71.2	42.2	17.5	46.5	25.3	36.9	9.1	34.4	12.8	10.5	10.3	11.2	35.2	6.5	17.9	29.3	19.0	23.2	53.9	38.8	11.3	37.6
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		13000	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	24.8	46.2	24.7	19.9	23.8	12.9	27.3	11.6	28.3	27.1	20.4	17.3	22.6	16.4	26.0	20.1	30.9	25.9	40.9	25.8	22.5	22.2	25.7	47.6	25.8	29.4	21.1	20.3	35.9	51.7	28.3	25.3	18.9	21.3	23.7	21.5	30.0	26.4	22.8	24.8	19.4	19.1	27.4	25.6	24.9	27.2	11.8	16.7	15.0	52.9	21.3	26.0	24.5	25.1	31.9	24.8	23.7	25.7	30.8	36.8	22.7	22.7	21.0	21.4	19.8	32.4	44.3	28.1	43.9	39.2	31.5	19.5	21.3	44.2	7.9	10.9	42.7	21.5	11.3	15.6	27.4	29.0	38.3	11.8	36.5	12.2	25.3	34.8	35.5	22.9	36.8	29.2	27.6	28.8	31.9	26.9	17.5	36.2	79.2	41.8	16.6	23.0	21.7	17.0	9.2	18.3	25.1	15.3	15.3	25.4	27.3	21.2	13.1	20.7	17.9	20.5	20.8	13.7	18.6	31.3	26.2	20.2	12.6	33.4	30.4	16.4	10.1	28.9	23.3	30.8	23.7	22.0	19.7	29.2	25.7	36.8	31.9	25.6	29.7	24.8	21.7	25.5	26.7	1.6	30.8	24.9	19.1	21.9	22.7	24.7	23.8	11.6	28.3	22.5	22.2	21.1	20.3	21.3	16.7	11.9	15.0	31.7	28.8	22.6	4.3	20.6	38.2	18.7	11.4	31.4	3.9	16.6	31.5	61.9	6.3	32.1	15.5	23.3	47.4	19.9	41.7	29.4	22.0	38.0	48.4	3.2	13.9	25.2	29.6	13.2	40.9	29.6	25.3	38.7	28.6	31.5	60.2	10.5	33.2	34.1	6.3	32.3	28.2	9.3	15.4	20.1	6.1	27.4	29.9	34.5
DCTN3	DCTN-22	ENSG00000137100	"Dynactin subunit 3"	O75935	9	34613545-34620523	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044905	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA044905: AB_10960996"	"unprognostic (3.38e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.47e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.88e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.26e-3)"	"unprognostic (4.24e-3)"	"prognostic favorable (5.76e-11)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.43e-2)"	26.4	32.5	42.4	16.2	49.1	46.5	30.4	33.7	58.3	25.7	23.3	20.7	22.2	21.4	24.6	25.5	33.7	31.7	23.1	42.8	36.3	37.4	32.8	32.4	21.1	21.9	35.8	48.4	32.6	33.7	29.8	36.3	23.0	37.4	27.4	20.6	27.5	32.4	28.6	69.1	37.9	18.3	28.0	26.2	19.4	23.7	16.2	22.0	42.6	32.4	37.1	29.2	22.5	24.9	28.5	44.6	62.3	45.9	29.9	56.0	46.8	34.2	28.8	26.8	28.0	23.8	33.3	11.0	29.3	27.4	40.9	32.2	18.4	12.9	15.8	18.4	38.5	14.3	13.7	24.3	30.7	26.2	49.5	30.5	10.5	51.0	15.8	25.8	27.6	32.1	29.3	26.6	28.2	18.5	20.0	26.9	29.8	12.5	32.8	35.6	28.2	34.7	74.5	8.1	14.4	46.5	17.5	14.5	21.7	19.7	12.2	8.9	22.9	21.7	20.0	11.2	8.2	26.8	31.7	24.4	25.8	20.9	29.2	28.4	22.2	28.7	10.5	40.5	16.1	52.4	62.3	44.0	59.3	35.2	44.2	32.0	28.5	37.8	37.2	44.0	28.3	29.9	35.7	38.4	29.9	45.9	44.6	56.0	46.8	42.4	49.1	33.7	58.3	36.3	37.4	35.8	48.4	37.4	22.0	29.8	31.8	49.9	82.5	90.2	76.0	72.8	63.7	57.6	43.3	76.8	23.6	100.4	175.8	103.7	8.3	78.7	68.5	210.2	135.3	93.0	101.4	62.7	86.5	74.9	115.9	69.9	71.7	73.1	79.5	15.7	95.8	80.9	141.7	86.6	53.8	145.8	101.0	66.0	115.2	170.3	63.4	58.2	101.0	73.5	71.3	124.6	83.4	96.6	55.1	72.9
DCTN4		ENSG00000132912	"Dynactin subunit 4"	Q9UJW0	5	150708440-150759109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017532, HPA038026"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"CAB017532: AB_1122152, HPA038026: AB_2675792"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.87e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.83e-1)"	26.1	27.9	27.9	13.3	27.3	41.0	25.7	30.3	36.5	19.8	15.9	32.4	17.7	15.9	20.6	27.6	20.0	18.4	16.5	20.6	27.3	29.0	20.0	22.0	17.8	13.3	30.8	24.0	26.3	32.5	23.9	27.7	25.9	33.2	24.1	18.6	21.3	15.7	22.4	42.0	19.0	15.4	21.3	34.7	13.9	18.0	22.9	25.4	18.8	24.8	15.3	14.5	23.3	16.2	5.0	10.9	16.4	10.7	3.0	6.9	5.2	9.5	11.5	20.9	34.8	25.5	24.7	17.1	17.0	17.1	20.5	20.8	21.5	12.1	9.4	23.8	20.1	18.0	11.7	25.6	19.9	25.2	18.8	20.1	12.1	13.3	13.4	23.3	14.6	17.3	24.9	17.8	18.3	32.3	21.0	14.5	11.7	18.4	12.1	26.6	10.0	8.9	7.8	10.5	11.3	18.1	7.9	12.6	10.4	15.2	16.5	47.4	19.9	18.0	24.6	25.2	15.1	23.8	19.5	16.1	23.0	12.9	15.0	17.9	10.7	13.8	5.6	26.4	19.6	18.7	3.2	10.7	10.5	5.5	7.8	5.6	5.0	6.2	5.4	10.9	4.4	5.9	6.9	16.4	3.0	6.4	5.1	4.3	5.2	27.9	27.3	30.3	33.3	27.3	29.0	30.8	24.0	33.2	25.4	44.7	29.8	14.5	12.5	15.8	19.1	31.7	33.1	13.4	11.4	15.7	19.6	18.8	10.0	10.6	1.9	15.7	15.7	0.0	14.1	14.7	17.4	17.4	11.6	33.6	26.2	28.6	36.1	22.1	41.2	3.3	20.4	19.3	11.8	10.0	26.4	26.6	16.5	17.3	18.0	17.3	31.0	12.9	14.3	18.6	16.7	17.9	24.8	12.9	16.2	14.4
DCTN5	"MGC3248, p25"	ENSG00000166847	"Dynactin subunit 5"	Q9BTE1	16	23641392-23677455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042003, HPA063710"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA042003: AB_10796468, HPA063710: AB_2685101"	"unprognostic (5.90e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.36e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.55e-2)"	16.9	16.4	26.6	17.5	38.8	36.9	15.9	19.0	47.1	15.3	19.3	26.9	13.3	20.9	19.2	13.1	30.4	14.6	14.7	17.3	19.4	17.2	22.0	15.4	17.4	20.7	19.1	23.8	14.7	18.6	23.2	17.6	21.1	29.0	18.4	26.1	17.4	19.7	15.5	21.0	23.8	22.2	22.3	19.7	21.5	19.4	20.1	19.9	16.2	19.6	10.5	31.6	20.9	18.7	14.5	17.0	19.0	19.3	20.2	17.9	16.0	12.0	24.0	23.5	19.5	16.8	12.5	16.5	21.4	13.3	13.8	16.7	26.8	16.7	16.9	17.4	22.3	14.5	12.6	38.7	20.6	17.2	19.3	15.3	20.9	28.8	37.8	11.4	25.4	16.2	10.4	14.9	17.0	18.2	15.4	21.8	21.3	39.8	13.1	22.1	33.3	19.5	7.3	27.7	17.5	10.6	23.9	20.3	18.4	11.2	25.5	19.7	20.5	18.7	15.3	12.7	21.6	21.3	21.6	29.4	18.7	8.5	14.6	14.9	17.9	26.8	27.2	17.8	12.7	20.2	11.2	16.1	19.0	16.2	13.5	17.9	14.5	15.0	17.5	17.0	11.2	12.8	15.1	7.0	20.2	19.3	11.8	17.3	16.0	26.6	38.8	19.0	47.1	19.4	17.2	19.1	23.8	29.0	19.9	14.9	25.8	16.2	11.1	13.1	49.6	23.4	15.3	13.4	15.9	19.2	86.4	26.9	10.0	21.9	17.5	19.4	27.4	23.3	22.1	30.2	15.6	13.0	26.6	12.1	24.5	49.3	21.2	18.4	18.6	20.3	12.0	15.7	6.8	34.3	20.1	24.4	33.6	14.0	17.0	18.9	42.0	12.9	10.5	64.6	15.5	12.4	40.3	18.1	20.8	15.3
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423619-30430075	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002832	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes		270000	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	15.3	15.8	14.8	25.0	13.2	12.5	20.7	15.5	19.2	12.1	37.4	10.3	11.3	20.7	14.1	14.4	19.7	18.9	28.1	23.3	12.1	12.6	27.0	25.3	11.2	27.6	13.3	16.6	16.6	25.2	16.4	7.7	16.3	11.4	15.4	40.3	10.6	20.5	21.1	28.3	16.1	22.9	13.9	11.3	22.5	16.4	9.9	7.8	21.3	22.6	26.0	25.0	13.2	13.0	47.3	30.9	19.0	24.5	23.1	26.2	25.3	26.6	32.7	14.9	19.2	4.2	5.7	13.8	12.8	7.7	19.4	19.8	24.6	22.8	36.1	27.0	8.0	12.4	21.0	30.9	25.1	24.3	19.0	48.8	21.0	15.0	32.0	5.5	37.5	32.8	6.6	14.3	21.6	12.5	5.9	19.9	19.4	26.4	12.7	13.7	46.5	44.5	42.1	19.7	27.0	26.4	63.2	16.6	47.0	22.4	17.3	31.8	18.0	8.5	30.5	12.0	10.2	26.3	16.1	10.0	15.0	13.4	19.3	23.0	8.4	25.0	46.0	9.9	31.2	17.5	19.0	12.4	11.7	18.8	22.1	26.2	47.3	24.2	21.3	28.7	40.2	21.8	21.0	1.5	23.1	24.5	30.9	24.1	25.3	14.8	13.2	15.5	19.2	12.1	12.6	13.3	16.6	11.4	7.8	17.9	14.6	32.0	37.1	80.1	23.9	33.1	61.1	20.1	19.4	41.8	7.9	81.7	107.8	107.5	10.2	47.2	79.9	0.0	108.6	68.9	31.5	41.3	31.1	18.1	68.6	14.3	37.0	25.2	16.6	36.0	18.1	35.6	45.5	108.2	103.3	19.7	78.9	105.2	18.7	54.0	16.3	19.4	35.0	2.8	33.6	70.1	23.2	25.9	124.8	43.2
DCUN1D1	"DCUN1L1, RP42, SCCRO, SCRO, Tes3"	ENSG00000043093	"Defective in cullin neddylation 1 domain containing 1"	Q96GG9	3	182938074-182985953	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 95.0"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 9862.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		70000	Nucleoplasm	Cytosol	"HPA035911: AB_10673489"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.98e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.52e-1)"	5.0	5.2	7.9	5.0	7.1	6.9	4.8	9.3	8.3	4.5	4.9	4.1	2.7	4.9	5.4	4.9	6.7	4.3	4.6	5.5	7.4	5.0	7.2	11.2	4.3	5.0	9.3	6.8	4.7	3.6	4.6	14.6	4.5	8.0	6.1	4.8	2.8	4.9	5.4	14.7	5.2	6.5	8.1	9.2	5.2	4.2	95.0	7.6	7.2	6.7	5.2	6.0	8.4	4.9	7.4	10.7	17.3	9.8	11.2	8.0	5.7	23.3	10.4	13.9	6.0	14.7	14.5	11.8	15.0	16.9	16.9	16.6	15.3	17.4	27.4	33.0	14.0	25.5	13.1	11.6	12.0	22.5	22.4	6.3	26.4	8.1	6.4	9.3	15.5	19.9	10.3	14.7	9.4	8.9	12.5	11.6	16.8	8.8	14.4	12.3	12.5	15.2	8.3	11.3	17.6	9.5	12.0	14.7	18.1	12.2	16.5	10.1	10.1	26.3	18.9	14.1	15.3	38.7	12.6	11.2	10.5	10.1	14.3	17.6	11.9	22.0	27.8	13.2	14.7	15.1	9.4	9.1	17.3	7.8	9.8	7.5	7.4	6.4	7.7	10.7	4.7	7.5	7.9	15.0	11.2	6.3	8.2	8.0	5.7	7.9	7.1	9.3	8.3	7.4	5.0	9.3	6.8	8.0	7.6	20.8	25.6	17.1	21.7	38.5	14.2	28.2	17.8	20.1	27.3	45.4	9.8	16.2	31.5	26.1	2225.5	18.8	26.6	46.7	26.5	15.7	27.7	32.3	28.9	42.3	24.9	17.5	25.8	17.8	32.1	9862.3	80.3	36.4	11.8	45.1	19.9	16.6	27.2	23.4	60.5	33.6	20.5	77.6	25.5	86.4	52.0	37.1	16.7	25.3	19.6	34.8
DCUN1D2	"C13orf17, FLJ10704, FLJ20092"	ENSG00000150401	"Defective in cullin neddylation 1 domain containing 2"	Q6PH85	13	113455819-113490952	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039349	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039349: AB_10673240"	"unprognostic (3.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.43e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.21e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.25e-2)"	4.9	4.5	6.2	6.0	7.0	7.8	4.6	24.0	13.3	4.1	4.3	6.5	3.4	3.1	6.2	6.6	4.7	4.0	4.9	59.1	5.9	7.2	4.3	4.0	3.8	4.6	7.2	5.9	5.5	4.5	3.5	7.1	5.2	9.7	3.9	4.5	6.2	4.5	4.5	65.6	9.1	5.4	5.2	8.5	4.9	4.3	5.6	6.1	5.3	3.3	7.5	4.9	3.8	3.7	3.5	2.7	10.9	2.2	2.8	4.1	1.8	6.9	4.3	7.2	5.5	5.3	4.7	5.6	5.4	6.6	5.1	5.8	15.3	4.2	5.0	1.7	6.2	8.0	10.0	7.8	4.1	7.3	3.2	13.1	8.4	19.6	4.1	2.8	12.9	6.3	6.9	6.8	5.7	4.6	3.5	4.3	6.9	4.7	4.8	4.9	4.9	8.7	21.2	4.6	5.0	6.8	9.2	12.0	6.6	3.8	4.5	32.2	7.2	4.1	14.5	4.0	5.3	8.3	6.1	7.1	6.7	9.1	5.1	7.7	14.2	6.0	10.0	15.3	5.7	4.5	10.9	1.9	3.6	3.1	1.7	4.1	3.5	2.8	1.9	2.7	1.9	3.0	1.6	1.5	2.8	2.2	0.3	2.9	1.8	6.2	7.0	24.0	13.3	5.9	7.2	7.2	5.9	9.7	6.1	14.9	17.0	2.7	1.7	5.3	7.7	67.8	0.0	5.3	13.6	3.5	15.7	2.0	1.7	1.6	5.2	4.6	3.6	0.0	1.2	1.1	4.5	2.6	4.7	3.9	1.2	17.5	6.3	6.2	4.0	4.5	6.6	3.5	5.0	0.0	4.3	4.4	1.8	0.0	5.3	2.1	9.9	0.0	3.3	3.4	4.8	6.5	2.2	2.6	3.7	2.5
DCUN1D3	"DKFZp686O0290, FLJ41725, MGC48972, SCCRO3"	ENSG00000188215	"Defective in cullin neddylation 1 domain containing 3"	Q8IWE4	16	20854925-20900384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 38.4"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 30.6;ASC TERT1: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041983, HPA043511"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041983: , HPA043511: AB_2678521"	"unprognostic (9.34e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.42e-1)"	19.2	9.9	4.3	6.0	4.6	2.7	17.2	7.9	5.6	7.5	6.0	5.5	3.2	3.4	7.7	5.9	8.5	6.6	9.6	8.9	2.5	2.8	10.0	17.4	9.7	3.1	5.2	3.0	5.3	6.6	6.4	9.5	9.4	6.7	6.6	4.1	6.3	3.9	4.5	38.4	7.1	4.9	11.9	3.9	4.5	6.4	7.9	3.8	1.5	4.8	11.5	4.5	6.7	15.8	1.4	1.6	4.8	2.5	2.6	2.7	1.0	2.7	4.8	2.4	5.2	30.6	23.1	3.3	9.1	7.9	4.6	6.3	6.0	5.2	1.7	7.4	8.9	2.8	3.7	2.8	3.8	6.2	2.3	1.9	1.4	3.8	8.7	8.0	2.2	13.9	15.2	5.2	8.7	4.9	4.9	12.6	1.7	1.6	4.7	9.3	3.7	2.0	3.2	5.7	2.3	1.6	3.4	2.7	1.7	4.0	2.8	2.2	3.0	3.5	3.9	2.1	3.0	2.6	1.0	6.2	9.8	3.4	4.1	2.4	4.0	2.3	1.2	10.4	2.3	5.0	4.8	1.4	1.2	1.7	2.5	1.7	1.0	1.2	2.7	1.6	1.4	1.5	2.7	1.9	2.6	2.2	1.2	1.0	1.0	4.3	4.6	7.9	5.6	2.5	2.8	5.2	3.0	6.7	3.8	11.9	17.1	0.0	12.6	27.8	12.1	4.0	5.1	0.0	6.8	8.7	33.4	3.0	0.0	3.5	50.8	14.3	4.3	0.0	4.4	1.7	12.7	8.1	0.0	12.9	2.1	12.7	19.4	10.4	7.1	34.5	10.0	8.0	11.8	0.0	4.7	5.2	3.9	0.0	9.2	4.0	23.2	6.5	12.2	4.6	3.5	19.7	4.2	4.3	3.8	16.9
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	16.9	22.9	15.9	9.9	26.1	3.5	13.5	15.4	24.8	15.9	14.3	12.8	15.5	7.6	17.8	17.3	13.4	13.6	14.2	14.9	29.8	22.3	19.4	36.5	10.4	10.7	17.7	22.0	20.8	9.8	9.9	19.8	9.3	24.6	16.6	12.0	9.4	15.9	22.9	14.3	10.2	9.8	31.4	24.0	11.4	14.6	20.4	13.4	3.9	16.8	8.6	8.2	20.3	13.7	4.6	2.9	10.2	4.2	4.4	10.7	5.3	5.7	10.3	13.9	20.1	14.3	14.3	5.3	17.9	13.3	10.2	9.2	6.6	6.2	4.3	11.6	20.1	13.5	5.8	17.7	11.2	14.1	2.7	5.2	7.6	8.0	15.9	30.2	10.5	10.3	14.8	13.2	11.7	10.2	13.6	10.2	4.1	8.4	3.2	17.6	8.4	12.9	7.4	8.2	11.6	8.5	6.2	7.2	2.4	13.3	6.8	8.2	8.9	7.7	9.6	14.8	8.2	9.8	6.7	16.6	13.6	11.1	10.9	14.2	5.8	8.3	4.0	9.5	10.1	7.7	5.5	4.2	10.2	7.2	3.7	10.7	4.6	8.1	8.0	2.9	3.3	7.8	8.5	1.7	4.4	2.6	1.9	3.7	5.3	15.9	26.1	15.4	24.8	29.8	22.3	17.7	22.0	24.6	13.4	6.0	13.1	10.4	16.2	33.1	22.1	33.1	20.4	16.0	12.5	15.7	15.7	4.6	11.6	9.4	58.2	21.5	8.7	0.0	10.5	7.4	21.0	13.4	12.7	32.7	7.2	28.6	6.4	18.4	6.3	89.6	13.8	10.8	30.4	3.6	6.9	14.1	10.8	10.5	24.4	19.5	15.9	0.0	18.6	22.8	27.9	29.1	2.9	10.1	8.1	13.7
DCUN1D5	"FLJ32431, MGC2714"	ENSG00000137692	"Defective in cullin neddylation 1 domain containing 5"	Q9BTE7	11	103062076-103092215	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050863	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA050863: AB_2681259"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.62e-4)"	"prognostic unfavorable (2.01e-7)"	"unprognostic (1.92e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (9.52e-5)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (2.64e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.43e-3)"	20.9	18.3	18.9	17.2	24.5	13.4	19.1	22.5	28.8	12.9	13.5	15.9	11.5	11.4	15.9	13.7	26.5	12.9	10.6	24.2	20.3	16.6	14.4	19.0	13.9	21.5	15.6	21.0	12.2	17.7	14.5	17.0	17.3	23.6	15.4	13.9	9.9	15.6	13.5	38.7	14.0	11.3	18.4	17.5	15.7	16.0	24.0	21.0	19.4	13.2	24.2	21.3	14.4	14.7	14.4	17.3	11.8	13.1	20.5	17.0	13.4	22.3	12.4	13.7	21.0	11.2	14.2	15.2	22.2	12.1	18.3	18.9	47.5	26.2	10.8	39.3	15.8	19.0	21.3	28.8	28.1	18.9	19.0	19.4	28.9	10.7	18.4	19.0	41.4	15.0	12.4	25.0	24.5	25.4	9.6	22.7	26.4	47.2	0.0	17.3	20.2	27.3	32.4	26.7	19.5	31.7	11.6	21.9	27.4	13.9	23.0	18.6	19.7	20.7	21.2	18.4	14.7	24.8	17.4	18.4	14.9	18.1	26.4	19.8	9.1	14.4	36.0	10.6	40.7	15.4	11.8	11.1	10.2	13.8	13.1	16.3	14.4	16.3	14.2	13.7	14.1	14.0	16.3	4.0	20.5	10.0	17.3	17.0	13.4	18.9	24.5	22.5	28.8	20.3	16.6	15.6	21.0	23.6	21.0	14.9	8.3	25.2	44.6	70.6	11.0	26.6	15.3	14.7	14.8	8.7	7.9	51.2	41.4	60.4	3.0	19.7	6.9	23.3	48.3	76.2	37.5	35.6	15.1	21.3	40.1	6.4	13.8	20.9	29.7	5.9	13.3	22.6	28.7	25.2	16.1	14.8	51.7	14.0	18.4	31.1	12.3	25.8	31.1	118.2	114.7	73.1	36.6	24.5	23.4	57.0
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.1;testis: 6.4"	"Cell type enriched"	"Detected in some"	12	"Rod photoreceptor cells: 22.7"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 34.6;SH-SY5Y: 14.2"	"Region enriched"	"Detected in many"	9	"olfactory region: 90.9"	"Region enriched"	"Detected in all"	5	"olfactory region: 130.1"	HPA036121	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"HPA036121: AB_2674950"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"	0.8	1.1	7.0	0.7	9.2	0.7	3.2	0.7	17.1	0.7	0.6	0.9	0.0	0.7	4.1	3.6	0.6	0.6	0.8	0.7	4.2	5.4	0.5	0.5	0.6	0.7	2.5	6.7	0.6	0.8	0.5	1.0	0.6	3.7	0.5	0.8	0.0	2.2	0.6	0.5	0.7	0.7	0.6	3.0	0.6	1.2	6.4	2.3	0.0	0.6	0.0	0.5	0.6	0.3	0.3	0.4	0.6	0.2	0.7	0.4	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	34.6	14.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.1	0.4	0.3	0.3	0.2	0.1	0.3	0.3	0.3	0.6	0.7	0.0	0.4	0.1	0.0	7.0	9.2	0.7	10.8	4.2	5.4	2.5	6.7	3.7	2.3	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.2	0.0	1.4	0.0	22.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DDA1	"C19orf58, MGC2594, PCIA1"	ENSG00000130311	"DET1 and DDB1 associated 1"	Q9BW61	19	17309518-17323301	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 364.2;Syncytiotrophoblasts: 212.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042134, HPA055272"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA042134: AB_10794169, HPA055272: AB_2682767"	"unprognostic (1.30e-1)"	"unprognostic (6.35e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	11.6	15.5	24.5	12.7	26.6	16.1	9.9	14.6	36.2	10.8	14.6	13.5	9.6	15.4	11.6	9.9	13.4	13.5	11.8	16.4	18.9	19.8	12.9	17.9	14.6	14.7	19.0	24.4	12.9	13.4	10.9	10.9	26.4	23.0	12.9	13.1	10.8	13.6	15.9	17.8	20.8	16.9	11.5	13.2	13.4	17.4	29.6	12.0	15.9	10.5	10.9	13.7	12.4	9.9	7.1	12.7	11.5	8.0	6.5	8.8	5.7	12.5	11.2	8.5	6.7	8.9	6.4	13.2	8.5	10.9	13.1	12.1	9.9	11.1	5.0	11.9	8.7	6.3	10.7	6.2	12.4	6.4	8.2	16.5	6.1	8.8	9.3	10.8	6.8	11.9	9.7	14.3	7.8	7.3	8.0	7.6	11.6	7.2	8.7	6.8	6.3	13.7	10.2	9.7	12.6	19.2	8.7	6.7	8.3	10.3	9.4	8.7	13.0	6.2	14.4	7.4	5.3	7.3	9.1	11.4	8.8	7.4	22.6	11.8	10.7	14.5	6.9	19.3	11.8	8.6	5.0	7.3	11.5	8.6	8.0	7.4	7.1	7.2	8.5	5.9	6.6	8.3	8.0	8.2	6.5	6.9	12.7	8.8	5.7	24.5	26.6	14.6	36.2	18.9	19.8	19.0	24.4	23.0	12.0	26.8	13.1	28.4	28.3	48.4	17.7	14.5	2.5	16.0	18.2	26.2	11.8	121.6	33.2	69.0	364.2	20.2	49.3	0.0	40.5	112.0	27.8	33.7	38.1	21.7	56.2	12.7	19.4	14.7	21.1	84.5	20.8	27.9	28.7	77.5	38.9	25.1	96.6	38.6	25.5	44.5	14.3	19.4	29.8	67.3	35.1	54.1	212.0	34.6	23.5	76.5
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.6"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 36.9;SH-SY5Y: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		140000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	4.3	14.3	43.9	5.8	44.9	0.7	6.6	14.4	37.2	7.7	22.1	20.7	4.3	21.1	6.0	33.8	4.9	18.4	12.2	6.4	29.5	24.1	61.6	39.9	11.8	1.1	24.9	37.0	3.4	13.8	13.0	7.2	3.1	13.8	13.1	21.4	4.1	8.5	6.2	13.8	2.8	19.9	7.4	8.1	4.1	15.6	9.3	11.0	0.0	14.1	1.0	1.2	6.0	3.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	18.3	2.3	6.5	1.2	10.9	9.2	0.8	21.7	13.2	7.7	8.2	26.1	4.9	0.0	9.1	24.6	7.6	5.3	23.5	4.5	9.9	0.0	9.0	0.0	6.2	9.1	3.9	16.7	1.0	7.7	0.4	6.5	4.1	9.8	12.3	0.0	0.0	1.8	19.8	1.5	0.8	0.0	7.8	36.9	6.8	0.0	15.2	0.2	33.0	13.7	18.3	35.6	2.8	16.5	2.6	9.7	8.9	1.2	24.0	6.8	5.5	1.6	15.1	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	43.9	44.9	14.4	37.2	29.5	24.1	24.9	37.0	13.8	11.0	32.8	31.3	4.2	4.0	12.2	2.7	11.4	68.8	30.8	13.6	66.3	3.9	1.7	106.1	15.6	17.1	4.5	78.7	0.0	26.7	0.8	23.5	37.8	0.0	94.3	0.9	0.0	32.8	9.2	2.2	18.4	14.7	1.5	11.8	1.0	77.8	59.7	34.2	73.6	70.4	219.6	8.0	12.9	18.9	5.0	5.6	12.5	0.7	3.3	85.4	6.5
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"monocytes: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: AB_2683708"	"prognostic favorable (7.29e-4)"	"prognostic favorable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	12.2	22.2	5.3	13.3	8.6	8.1	11.3	11.0	8.2	16.8	13.5	7.3	13.4	6.0	18.2	14.1	25.4	14.3	13.0	6.1	4.7	2.9	6.6	20.8	11.3	16.1	15.0	5.0	9.8	15.6	6.1	8.6	5.5	6.3	20.9	12.3	8.1	17.6	14.8	6.3	36.9	11.0	19.0	17.6	15.1	9.1	7.6	7.6	23.3	6.6	16.7	26.0	17.3	15.2	11.4	6.1	11.5	11.0	7.4	27.0	9.0	8.4	22.7	9.5	7.1	6.1	12.4	11.2	9.2	21.7	11.9	14.0	3.7	4.9	20.3	1.9	8.4	8.9	14.8	5.4	18.8	5.9	5.0	10.2	4.7	21.7	16.8	6.0	5.5	12.7	16.6	21.4	5.9	13.2	3.8	34.6	5.3	1.2	9.9	19.4	15.9	21.1	2.6	3.0	11.1	8.2	10.6	2.4	10.9	5.0	8.3	5.0	6.2	11.3	3.3	3.0	11.9	20.8	1.8	14.9	36.4	16.6	7.9	4.3	10.4	7.9	4.5	13.7	7.0	13.0	5.9	8.1	11.5	12.1	11.0	11.7	11.4	12.7	11.7	6.1	7.4	9.4	10.1	2.2	7.4	9.2	0.1	27.0	9.0	5.3	8.6	11.0	8.2	4.7	2.9	15.0	5.0	6.3	7.6	14.9	20.3	19.2	35.4	34.6	4.6	7.2	12.7	10.7	13.6	5.2	9.8	2.1	8.3	9.6	1.1	17.8	7.9	0.0	12.0	7.7	14.1	9.5	22.0	12.4	15.9	1.6	7.5	14.1	16.5	1.6	17.5	16.5	18.6	221.8	13.6	14.2	15.3	7.0	9.9	6.2	11.6	0.0	15.5	0.7	9.9	26.5	1.3	38.8	14.0	21.3
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565457	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 90.1;kidney: 68.1"	"Group enriched"	"Detected in many"	5	"Intestinal endocrine cells: 394.4;Proximal tubular cells: 366.2;Rod photoreceptor cells: 456.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 7.9;pons and medulla: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 17.2;Hep G2: 15.1;OE19: 26.4;SCLC-21H: 43.6;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"midbrain: 90.4;pons and medulla: 40.7"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		380000	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.3	10.9	0.3	3.0	0.7	0.0	0.3	0.3	0.4	0.3	36.7	0.4	0.3	33.5	0.3	1.8	0.3	0.0	0.7	0.3	0.3	1.3	68.1	11.7	0.7	0.3	7.9	0.3	0.4	9.8	0.0	0.3	0.3	3.4	0.4	8.1	0.4	0.3	0.3	0.3	0.1	90.1	0.3	0.3	0.3	4.3	0.6	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.4	0.0	0.0	0.0	0.2	0.4	0.0	43.6	45.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.3	0.4	0.3	1.3	7.9	0.3	3.4	0.5	0.0	9.8	0.8	0.0	0.0	81.1	0.4	5.1	0.0	1.2	3.5	39.3	0.0	21.6	0.0	3.6	0.0	72.8	0.0	0.7	0.1	0.0	0.4	0.0	58.7	0.1	3.2	394.4	1.3	1.3	4.3	0.0	0.0	0.0	0.0	30.4	24.1	0.2	26.6	0.0	366.2	456.4	0.0	0.0	3.6	0.4	0.0	0.1	0.0	46.0	0.0
DDHD2	"KIAA0725, SAMWD1, SPG54"	ENSG00000085788	"DDHD domain containing 2"	O94830	8	38225218-38275558	"Disease related genes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015202, HPA023143, HPA023147"	Supported		Supported	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535"	"unprognostic (1.49e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.49e-1)"	20.1	14.3	24.5	13.5	27.1	9.4	14.9	34.4	48.1	18.9	13.5	23.2	10.6	15.3	16.6	18.7	16.9	15.5	13.9	21.3	26.6	25.1	17.4	9.1	13.0	13.8	28.6	24.9	24.3	16.4	17.3	15.4	11.8	27.5	18.6	13.4	20.0	13.6	23.8	21.4	12.5	17.1	16.7	37.3	12.5	11.0	16.8	17.9	8.8	15.0	9.3	16.4	14.9	13.3	13.3	5.5	3.7	4.0	13.2	12.3	5.9	25.3	11.5	26.3	12.8	10.6	14.2	8.5	8.0	14.4	19.2	17.2	13.8	10.0	10.1	11.2	13.8	11.9	9.8	14.8	14.8	29.3	8.6	10.1	36.1	15.9	13.2	9.1	4.2	5.7	7.3	11.9	11.9	12.4	12.3	22.6	13.6	25.5	11.0	12.0	5.4	28.5	6.3	5.9	4.1	6.9	15.2	22.7	6.9	10.4	15.2	9.5	14.8	19.5	10.3	9.8	8.6	11.9	11.4	20.6	11.0	14.6	10.9	12.7	11.8	10.5	23.0	17.9	8.2	15.5	2.1	3.1	3.7	9.6	4.0	10.7	8.3	8.6	10.6	5.5	13.3	9.5	6.7	0.3	13.2	2.8	3.0	12.3	5.9	24.5	27.1	34.4	48.1	26.6	25.1	28.6	24.9	27.5	17.9	20.8	6.5	6.9	8.7	12.2	24.1	21.0	5.1	2.7	9.1	19.2	17.7	10.4	19.9	10.2	3.8	11.7	9.0	0.0	9.6	9.6	9.7	8.5	20.7	4.7	6.4	50.9	15.1	12.3	7.6	7.6	18.7	8.5	18.6	18.0	8.3	15.8	12.0	7.0	19.4	7.8	5.0	6.5	8.3	13.0	30.2	9.4	5.4	17.3	7.8	6.2
DDIAS	"C11orf82, FLJ25416, FLJ38838, noxin"	ENSG00000165490	"DNA damage induced apoptosis suppressor"	Q8IXT1	11	82899975-82958277	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.6;testis: 16.3"	"Cell type enhanced"	"Detected in some"	12	"Kupffer cells: 5.3;Spermatocytes: 12.0;Spermatogonia: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA038540, HPA038541"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA038540: AB_10672648, HPA038541: AB_2676071"	"unprognostic (2.53e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.86e-6)"	"unprognostic (4.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.04e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.11e-16)"	"unprognostic (7.17e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.13e-2)"	1.3	1.0	0.8	6.1	0.8	7.0	1.7	0.8	1.2	1.9	2.3	1.2	0.2	1.3	1.5	2.6	5.5	1.0	0.4	2.6	0.9	0.7	1.0	2.3	3.1	5.0	0.8	0.6	1.3	0.9	0.0	0.5	2.5	1.0	0.9	2.0	0.2	2.1	0.2	10.1	2.3	1.9	1.5	0.9	5.5	1.1	16.3	0.9	17.6	0.8	9.5	5.9	1.8	1.8	2.0	4.5	5.8	10.7	1.9	0.7	3.2	6.0	9.6	9.9	7.2	1.0	1.5	7.3	11.5	4.9	12.8	14.9	9.4	7.6	7.4	17.3	2.6	10.1	11.6	16.7	7.2	17.7	13.4	9.0	10.5	4.9	4.2	0.1	12.9	9.3	0.3	0.7	16.1	7.4	1.1	6.0	9.2	10.6	12.8	11.3	8.8	12.1	10.5	11.8	16.7	11.0	9.0	19.2	9.5	2.7	10.1	7.4	10.0	7.1	7.2	2.7	10.1	7.8	5.4	2.8	12.8	17.4	33.7	14.0	7.3	19.1	25.7	4.0	9.3	12.1	0.6	10.7	3.9	0.5	8.3	0.3	1.1	0.3	0.7	4.5	2.0	0.7	0.4	5.8	1.9	7.8	1.4	0.5	3.2	0.8	0.8	0.8	1.2	0.9	0.7	0.8	0.6	1.0	0.9	0.0	0.0	4.6	0.8	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	1.4	0.0	0.5	2.7	0.0	0.0	0.0	0.5	4.3	0.0	0.3	0.0	0.5	2.2	0.0	0.0	1.3	5.3	1.6	0.3	1.6	0.0	0.0	0.2	0.0	0.3	0.0	0.7	0.2	0.0	0.0	0.3	12.0	15.1	0.0	0.2	0.0	0.6	0.9
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 145.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.8;HBEC3-KT: 24.5;RT4: 32.5;T-47d: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		2100000	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	6.7	11.3	23.5	7.9	36.2	2.2	12.5	6.8	42.2	9.7	25.2	57.4	17.6	16.8	7.7	10.5	30.5	31.7	18.9	8.7	27.8	20.8	19.8	3.5	13.2	3.1	55.7	19.8	11.3	20.9	28.2	14.6	13.3	34.7	17.7	14.9	4.0	28.3	20.5	9.1	41.3	32.1	3.1	43.2	5.1	52.2	5.1	37.0	8.7	20.9	10.5	7.6	16.3	16.6	1.8	0.4	0.0	0.2	0.0	1.8	0.9	19.7	6.5	9.2	1.9	0.6	0.9	5.7	0.5	0.1	0.3	0.0	8.7	10.5	0.1	11.0	1.7	9.6	31.8	2.0	24.5	0.1	10.9	3.5	0.0	6.0	2.3	1.8	0.0	0.4	1.2	12.7	0.1	0.2	5.8	0.7	0.5	5.7	0.2	1.4	12.5	0.7	0.0	1.6	10.9	1.3	1.3	6.9	0.7	4.7	32.5	1.6	0.9	1.8	14.7	7.1	3.2	36.5	0.2	1.5	4.6	4.3	0.4	4.6	0.2	0.0	0.8	3.0	0.0	4.0	0.0	0.2	0.0	1.1	0.0	0.8	0.4	0.2	0.7	0.4	1.8	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.9	23.5	36.2	6.8	25.0	27.8	20.8	55.7	19.8	34.7	37.0	32.8	24.0	2.2	62.3	47.2	5.2	19.9	38.2	33.5	31.8	85.5	0.0	53.4	5.0	115.9	10.8	4.9	88.3	23.3	66.9	19.7	6.5	54.7	1.1	0.4	5.4	6.4	44.4	1.8	0.8	16.6	7.8	2.2	15.1	22.6	55.1	145.4	62.4	74.8	4.9	5.6	7.4	6.5	8.9	0.7	4.5	45.4	38.9	0.0	54.4	76.8
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787400	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 84.7;Leydig cells: 58.4;Peritubular cells: 83.1;Smooth muscle cells: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 61.7;ASC TERT1: 61.0;BJ hTERT+: 45.1;fHDF/TERT166: 32.3;HSkMC: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Supported	"Plasma membrane,Actin filaments"		Yes	No		850000	"Plasma membrane, Actin filaments"		"HPA070112: AB_2686229"	"unprognostic (4.12e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (1.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.10e-3)"	42.1	43.5	4.7	10.9	6.9	0.2	15.6	7.9	7.1	30.3	30.4	9.0	18.6	3.3	24.2	17.7	25.0	13.4	16.6	15.4	7.9	4.7	4.0	3.3	8.9	5.1	12.9	3.4	26.4	2.2	2.1	4.0	6.6	12.7	21.8	9.1	30.7	6.4	19.3	5.2	6.1	10.1	34.3	19.7	3.4	14.1	8.3	7.5	0.0	8.6	12.8	4.1	29.0	18.3	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	16.3	61.7	61.0	0.2	24.0	45.1	10.5	15.1	0.0	0.0	0.0	0.0	32.3	2.1	0.0	0.0	0.1	14.4	12.9	0.1	0.0	0.1	0.0	26.8	0.0	0.0	43.3	0.1	18.5	0.5	17.0	12.1	0.1	0.1	5.1	9.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	6.9	0.1	0.0	0.0	0.0	9.9	0.0	0.0	0.8	0.9	0.0	0.0	0.6	16.8	3.7	8.5	3.3	0.7	1.3	0.0	15.2	0.0	17.0	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	4.7	6.9	7.9	7.1	7.9	4.7	12.9	3.4	12.7	7.5	3.0	2.9	0.0	2.4	11.2	3.1	23.3	2.5	4.0	1.2	0.0	0.0	0.5	0.0	0.5	6.9	21.3	2.0	0.0	1.5	0.4	84.7	4.1	1.1	3.0	1.1	0.0	1.2	24.5	2.1	4.0	58.4	1.5	21.9	0.0	0.7	19.0	1.5	1.7	83.1	0.9	2.9	38.8	68.4	0.9	0.9	7.5	0.8	1.3	0.6	3.3
DDT	DDCT	ENSG00000099977	"D-dopachrome tautomerase"	P30046	22	23971365-23980469	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Melanin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.8;liver: 58.4"	"Cell type enriched"	"Detected in all"	5	"Hepatocytes: 4710.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 68.5"									"HPA049871, HPA074115"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA049871: AB_2680926, HPA074115: "	"unprognostic (1.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.61e-3)"	9.7	6.6	5.4	3.4	4.8	8.8	4.5	2.1	4.4	3.0	9.8			11.8	2.7	4.3	5.8	2.8	1.4	7.7	4.2	4.0	11.3	58.4	3.2	2.9	5.4		4.1	14.4	1.3	1.8	2.5		5.8	6.4		7.1	4.4	10.4	3.7	11.6	2.0	4.6	3.2	8.2	1.2			3.7		2.7	4.3	3.2	30.4	52.8	27.8	38.0	23.8	29.0	28.6	27.1	11.6	4.0	9.4	7.7	6.8	24.5	7.9	5.3	6.9	7.2	10.2	7.9	26.0	7.4	4.1	10.2	22.5	10.0	9.8	4.5	11.0	68.5	15.6	15.8	22.2	7.8	34.2	15.7	6.8	7.5	6.9	6.1	8.0	7.4	4.1	14.1	10.5	6.9	13.3	7.5	31.0	12.1	24.0	35.0	16.5	7.5	37.1	12.3	10.0	13.7	13.2	16.3	30.9	23.2	5.7	7.8	10.8	8.5	7.2	16.0	7.3	8.2	32.4	10.7	16.3	14.1	12.7	13.8	20.7	38.0	27.8	19.9	32.4	20.3	30.4	24.1	21.1	35.7	28.4	21.9	21.3	24.2	23.8	29.6	52.8	29.0	28.6											77.4	62.3	170.5	177.4	123.4	46.7	20.4	580.9	78.9	76.2	230.3	84.4	209.3	608.5	198.5	156.1	122.0	650.8	116.8	322.3	247.0	92.9	222.4	128.0	4710.9	242.3	41.3	249.4	161.4	217.6	261.8	108.4	147.1	150.1	220.0	322.2	63.3	238.6	309.5	104.0	969.7	70.4	77.6	140.0	72.1	40.3	164.4	250.7	154.1	488.9	247.4
DDX10	"Dbp4, HRH-J8"	ENSG00000178105	"DEAD-box helicase 10"	Q13206	11	108665025-108940930	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004691	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA004691: AB_1078629"	"unprognostic (9.49e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (2.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.43e-3)"	14.0	11.9	17.3	15.0	20.3	10.4	15.5	20.5	18.3	14.3	12.2	8.1	11.7	8.8	18.4	12.8	12.6	16.8	8.8	12.1	13.5	11.5	19.6	12.5	10.6	13.1	12.2	16.3	18.6	18.0	16.7	22.2	12.9	13.1	12.4	13.3	7.9	10.6	14.7	13.6	14.8	9.1	16.8	13.3	15.0	11.3	25.1	12.6	13.8	13.4	8.8	14.2	14.3	18.8	11.6	8.4	1.4	6.7	9.4	11.3	4.3	7.4	7.3	6.9	9.7	6.9	5.6	7.2	8.0	4.3	9.7	9.6	20.8	10.9	25.3	15.1	6.1	10.5	8.3	19.8	9.7	14.0	9.6	8.9	17.1	4.3	7.7	12.3	17.4	8.2	5.0	7.6	11.0	13.8	5.8	8.8	6.6	24.0	2.8	9.5	4.8	14.6	14.7	9.0	14.0	11.1	12.5	11.3	23.6	6.0	6.4	12.9	6.8	11.2	9.9	4.2	9.7	12.0	6.1	9.2	10.2	10.4	9.7	10.8	4.3	7.5	58.4	3.5	21.1	10.3	1.4	5.0	1.0	8.6	6.7	11.3	10.4	7.5	10.1	8.4	11.6	8.1	7.8	0.7	9.4	6.4	8.2	6.3	4.3	17.3	20.3	20.5	18.3	13.5	11.5	12.2	16.3	13.1	12.6	14.9	30.3	22.6	17.3	25.2	21.1	18.2	7.6	18.7	22.7	3.5	90.3	21.4	16.6	13.2	28.6	19.8	2.9	0.0	18.3	17.8	17.6	12.7	13.9	10.2	13.1	17.5	14.5	9.2	9.2	5.9	27.3	18.2	6.8	18.0	7.8	8.9	15.1	3.5	20.1	46.2	25.2	12.9	15.6	64.4	44.6	25.3	21.6	14.4	13.6	12.2
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048291-94081245	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 103.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (3.06e-9)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	18.0	45.5	19.7	13.7	41.3	53.3	18.5	31.4	40.8	17.4	20.9	21.9	14.3	13.6	23.2	103.0	20.1	18.9	21.3	28.6	25.0	31.3	36.3	30.1	16.4	27.4	22.0	29.0	21.4	12.5	8.3	32.0	11.2	38.7	16.0	14.6	17.4	15.9	17.7	28.5	23.4	12.6	17.9	21.8	18.1	15.0	38.5	17.4	14.3	25.3	11.8	25.8	21.7	14.9	4.1	3.1	10.6	3.3	6.2	5.3	5.0	3.8	1.1	7.2	4.6	4.3	5.7	1.7	10.8	9.1	14.1	12.7	1.4	2.5	17.9	4.1	2.4	4.2	2.5	7.4	0.6	15.4	7.8	0.4	9.5	2.1	5.8	3.6	13.7	4.2	0.9	4.1	2.6	2.5	4.7	2.3	3.4	4.9	5.3	6.0	10.8	4.1	11.7	4.8	1.2	0.1	5.5	16.7	2.1	10.2	1.4	5.7	5.3	10.6	2.6	5.0	1.3	4.2	4.9	6.9	4.0	2.7	5.1	3.3	2.1	13.8	19.3	5.8	7.5	3.1	10.6	3.3	2.5	5.0	2.6	1.4	2.9	2.9	3.0	2.0	4.1	5.3	5.3	2.6	6.2	2.5	3.1	3.3	5.0	19.7	41.3	31.4	40.8	25.0	31.3	22.0	29.0	38.7	17.4	157.8	151.6	175.7	121.2	162.3	169.0	198.2	58.6	192.7	154.7	139.6	123.7	76.5	230.5	124.3	63.9	107.4	65.5	116.8	86.3	59.9	133.4	81.0	147.1	96.2	75.0	219.3	93.7	105.0	83.4	46.7	214.3	119.2	94.5	181.3	57.7	131.2	82.3	69.1	230.2	135.3	189.8	161.7	156.5	383.4	396.2	127.2	131.4	217.1	54.9	94.1
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 17.3;testis: 64.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 250.3;Spermatocytes: 190.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.8;NTERA-2: 11.4;SCLC-21H: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.7	2.8	8.7	0.8	13.2	0.9	0.8	7.9	17.3	0.8	0.8	2.0	0.0	1.0	0.9	0.9	0.8	0.9	0.8	0.7	8.4	7.1	2.7	0.8	0.8	0.8	4.8	8.9	1.2	1.8	2.6	7.1	0.9	5.9	0.9	0.8	2.3	0.8	1.0	0.8	1.6	0.8	0.7	3.4	0.9	1.0	64.2	3.0	0.0	4.3	0.0	0.8	0.7	0.2	0.6	0.5	3.3	0.3	1.3	0.5	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.2	1.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.8	0.0	0.3	0.0	0.5	1.6	0.0	11.4	0.5	0.0	0.4	0.0	0.0	0.0	0.1	9.2	2.1	0.1	0.0	1.6	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	2.1	0.3	0.6	0.3	0.2	0.2	0.4	0.5	0.2	0.1	0.6	0.4	0.3	3.3	1.3	0.2	0.5	0.1	0.1	8.7	13.2	7.9	12.5	8.4	7.1	4.8	8.9	5.9	3.0	0.0	0.3	0.0	0.7	0.1	18.2	0.8	0.0	0.0	0.0	0.0	15.7	0.0	3.3	0.1	250.3	0.9	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.5	0.1	15.9	0.0	0.6	0.0	41.7	3.4	0.1	0.0	0.0	0.0	16.0	0.1	0.0	4.6	1.8	16.0	0.0	0.1	190.6	24.5	0.0	0.0	0.0	0.0	0.1
DDX27	"dJ686N3.1, DRS1"	ENSG00000124228	"DEAD-box helicase 27"	Q96GQ7	20	49219295-49244077	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047087	Uncertain		Approved	Nucleoli		Yes	No			Nucleoli		"HPA047087: AB_10964059"	"unprognostic (4.47e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (2.82e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (6.70e-7)"	"unprognostic (2.28e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.84e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	22.0	22.5	21.9	33.0	23.2	40.9	23.6	34.8	26.3	24.3	26.4	16.3	20.4	23.2	26.2	19.1	26.5	23.9	27.1	19.2	22.6	17.3	25.9	21.0	20.1	32.3	19.9	18.8	37.4	27.3	25.9	25.6	23.9	21.2	22.0	22.1	14.4	22.9	24.3	32.9	27.8	33.6	20.0	20.7	34.1	22.9	25.0	24.0	30.6	23.5	19.4	35.3	24.0	27.2	30.4	28.0	22.2	24.2	18.2	26.7	18.6	20.2	19.3	9.9	7.6	11.0	10.2	28.2	13.5	11.1	42.6	19.8	62.7	22.7	24.1	25.2	10.9	37.0	28.8	22.0	21.6	31.7	8.5	12.9	18.3	16.2	30.4	16.2	23.1	21.5	10.8	25.4	24.8	19.1	9.7	7.0	19.0	24.9	13.4	13.8	13.6	24.3	30.6	18.7	24.8	25.1	21.0	24.6	22.2	15.4	15.7	12.9	15.3	37.6	54.4	22.6	14.3	28.8	26.9	8.8	27.4	24.1	22.9	28.0	15.3	16.5	31.6	17.5	18.5	17.6	11.1	19.8	22.2	21.7	21.2	22.8	29.4	20.6	19.7	23.3	30.4	26.7	20.3	8.1	18.2	24.2	28.0	26.3	18.6	21.9	23.2	34.8	26.3	22.6	17.3	19.9	18.8	21.2	24.0	26.8	43.1	49.7	41.1	31.7	24.0	22.7	20.4	40.2	45.5	31.4	13.7	49.9	16.6	46.3	131.4	24.2	38.6	0.0	38.0	41.7	28.8	24.4	110.8	20.3	29.9	27.0	29.7	12.3	16.4	107.1	36.8	41.8	18.6	43.3	30.5	32.3	46.2	37.4	31.8	34.2	27.6	25.8	29.7	67.4	60.0	28.1	62.4	50.1	43.2	37.1
DDX31	"FLJ13633, FLJ14578, FLJ23349, PPP1R25"	ENSG00000125485	"DEAD-box helicase 31"	Q9H8H2	9	132592997-132670401	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020891			Supported	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			Nucleoli	"Golgi apparatus, Vesicles"	"HPA020891: "	"unprognostic (5.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	6.8	6.9	8.2	15.3	11.2	6.0	12.3	18.4	8.5	7.5	6.6	9.4	12.6	5.0	8.9	8.8	9.8	8.8	7.5	5.4	6.3	6.3	8.4	9.2	12.0	15.1	9.1	5.7	16.9	17.3	10.0	8.8	5.8	9.8	9.2	8.0	7.4	12.7	12.6	12.9	14.0	7.2	12.7	12.9	8.7	6.8	15.2	8.3	6.8	22.7	10.8	13.8	7.2	12.6	5.0	4.5	1.9	2.7	3.1	6.9	3.0	7.0	13.2	6.4	8.8	7.9	7.1	12.6	7.6	7.5	12.0	9.2	14.6	14.6	17.7	6.9	7.1	12.5	19.8	20.2	8.9	9.7	10.8	7.5	9.6	11.7	7.6	9.5	17.0	7.8	6.3	12.2	12.3	17.3	4.6	7.8	13.2	17.6	6.9	9.9	15.2	11.8	9.3	15.9	21.0	13.5	12.5	11.4	20.3	10.9	6.8	11.6	8.3	13.9	12.4	10.5	7.8	25.9	5.0	6.6	20.4	9.2	11.5	11.7	3.4	10.7	13.8	7.3	10.8	15.3	0.0	1.9	1.9	5.7	2.7	4.7	4.2	5.5	4.4	4.5	5.0	6.9	5.1	0.3	3.1	1.9	2.8	3.6	3.0	8.2	11.2	18.4	8.5	6.3	6.3	9.1	5.7	9.8	8.3	6.0	5.9	3.4	3.1	4.9	3.4	3.1	0.0	6.7	15.9	7.0	3.9	4.6	1.7	4.1	2.1	3.9	0.7	0.0	4.6	5.8	2.6	4.1	1.1	3.2	4.6	1.6	23.6	3.1	2.4	2.4	16.7	2.8	1.7	4.6	3.7	1.5	4.7	0.0	12.4	4.3	3.1	0.0	2.1	11.2	15.7	5.5	2.5	4.1	5.7	2.6
DDX39A	"BAT1L, DDX39, DDXL, URH49"	ENSG00000123136	"DExD-box helicase 39A"	O00148	19	14408819-14419383	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 238.8;Late spermatids: 232.5;Spermatocytes: 336.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055334	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055334: AB_2682787"	"unprognostic (1.31e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.50e-10)"	"unprognostic (1.55e-3)"	"unprognostic (8.57e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.38e-3)"	10.9	8.5	7.2	20.6	11.4	41.4	10.5	9.1	7.9	8.2	10.9	11.0	4.4	13.0	9.4	7.2	15.9	7.0	8.1	7.8	6.6	6.1	9.7	12.1	10.3	31.2	12.6	5.0	7.4	8.8	3.0	7.4	10.5	10.0	7.3	8.9	5.2	7.9	4.4	7.9	10.6	12.8	6.8	9.4	23.4	10.4	60.7	10.3	39.9	8.4	16.3	26.1	10.3	8.8	36.7	36.6	7.7	28.5	21.5	39.7	33.6	32.9	27.1	13.9	26.9	5.7	4.2	13.6	14.7	8.1	30.6	18.9	27.5	17.9	63.7	15.6	12.1	16.4	20.4	34.2	23.8	12.5	22.3	17.9	68.4	31.6	19.7	10.1	37.2	30.6	5.8	5.4	19.8	8.1	4.5	16.0	23.4	42.0	28.1	17.0	39.9	63.7	55.2	26.6	32.2	41.5	44.2	24.6	37.3	10.9	27.1	32.4	17.9	10.9	22.8	16.5	9.5	25.2	36.3	14.9	27.1	16.9	44.5	32.8	29.2	51.2	65.6	30.4	40.6	27.0	6.8	25.9	7.7	35.6	28.5	30.5	36.7	28.4	28.2	36.6	33.2	24.9	26.7	7.7	21.5	23.4	22.6	39.7	33.6	7.2	11.4	9.1	7.9	6.6	6.1	12.6	5.0	10.0	10.3	14.9	27.9	70.7	37.1	67.5	10.3	9.4	17.8	21.4	18.2	5.2	0.0	37.6	31.5	37.9	238.8	33.8	44.6	23.3	57.3	97.5	36.2	30.0	89.1	10.6	78.7	11.1	24.6	27.6	51.6	232.5	24.5	64.4	47.2	70.3	24.3	13.8	42.5	28.1	17.7	22.6	3.9	19.4	54.6	336.3	94.8	62.0	50.1	65.4	35.5	32.5
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3, X-linked"	O00571	X	41333284-41364472	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 631.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		110000	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	80.9	49.3	26.1	40.0	34.5	49.3	46.5	31.1	36.2	52.4	43.3	35.1	21.3	29.5	56.4	25.9	53.5	56.3	42.6	47.6	30.8	24.5	55.6	77.9	45.3	40.4	41.4	29.0	60.1	30.9	68.7	60.2	79.9	37.9	30.0	29.2	30.8	37.4	26.5	63.4	42.2	54.0	57.2	53.9	46.1	43.0	27.0	39.0	49.2	45.6	44.0	42.6	55.8	50.2	13.1	20.5	32.0	21.6	17.3	21.5	17.9	45.8	51.1	47.7	26.2	56.2	47.7	29.1	33.5	47.1	34.4	27.6	52.5	30.9	0.5	23.9	37.4	41.4	31.0	58.3	47.1	57.3	27.2	45.4	29.2	50.8	31.5	29.2	54.7	52.5	34.5	33.4	57.9	56.0	38.5	53.9	25.7	53.6	28.9	31.9	34.7	34.4	17.1	45.9	24.4	20.6	40.4	50.8	37.4	32.4	61.9	32.6	49.4	75.8	38.9	40.1	50.2	35.0	37.2	48.6	35.5	37.9	37.9	39.7	33.7	40.0	45.3	35.7	33.2	33.6	22.5	20.2	17.5	14.8	21.1	21.5	13.1	14.5	16.3	20.5	9.0	16.3	15.1	32.0	17.3	21.6	6.9	14.3	17.9	26.1	34.5	31.1	36.2	30.8	24.5	41.4	29.0	37.9	39.0	80.4	161.8	98.4	138.2	234.8	74.1	130.3	81.5	65.6	85.3	55.8	123.7	79.4	36.5	59.8	317.8	170.8	178.1	116.8	73.8	80.3	155.2	122.4	162.7	142.1	107.7	57.2	176.3	120.3	200.6	631.6	61.5	160.4	121.4	72.1	136.1	88.8	86.2	143.8	59.1	71.7	117.4	71.1	155.5	15.7	55.7	291.5	144.6	132.3	100.9	182.7
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177517469	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	17.9	22.7	27.0	25.1	30.7	17.2	16.5	22.8	39.2	19.1	21.2	16.9	18.5	25.5	19.5	16.5	23.0	22.1	17.1	15.3	29.3	20.1	23.7	29.3	16.8	19.9	22.1	24.8	21.2	18.0	22.2	15.1	22.1	27.4	16.3	15.4	19.0	19.0	17.5	36.6	21.7	26.8	16.7	14.8	21.9	19.7	16.8	15.4	24.9	22.9	18.2	23.5	19.6	18.4	15.9	22.5	16.4	22.8	18.6	20.6	18.0	21.2	24.3	13.3	15.7	13.7	16.3	44.9	19.1	11.6	14.1	10.4	39.6	19.8	23.9	29.1	18.0	24.7	17.4	17.4	43.7	9.6	57.0	21.8	30.3	24.7	23.5	18.2	31.3	32.2	15.9	15.4	13.3	17.9	12.0	17.9	23.9	26.2	17.0	16.5	45.8	26.1	15.4	23.5	19.9	19.7	28.4	16.2	28.1	15.7	24.8	15.8	17.3	20.3	27.0	22.8	8.1	18.9	45.8	19.1	25.7	15.2	16.4	29.7	20.5	24.0	40.7	28.2	34.6	16.9	10.6	22.8	16.4	16.1	21.5	20.6	15.9	16.0	15.3	22.5	14.1	14.8	15.5	7.7	18.6	21.4	10.2	15.6	18.0	27.0	30.7	22.8	39.2	29.3	20.1	22.1	24.8	27.4	15.4	23.8	19.1	26.4	18.3	18.7	17.4	7.1	25.5	14.7	15.9	8.7	2.0	40.7	34.9	39.1	8.4	20.3	22.6	23.3	34.4	49.6	19.5	16.0	28.9	16.3	43.7	7.9	10.9	12.3	22.2	16.2	13.8	21.8	11.8	41.5	23.7	15.8	29.9	20.1	19.8	28.9	9.4	12.9	20.6	24.2	23.2	17.8	31.4	22.3	26.3	16.3
DDX46	"FLJ25329, KIAA0801, Prp5, PRPF5"	ENSG00000145833	"DEAD-box helicase 46"	Q7L014	5	134758771-134855133	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036554, HPA057501"	Supported		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA036554: AB_10673621, HPA057501: AB_2683449"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.01e-6)"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.50e-2)"	22.2	21.8	18.8	29.4	23.8	22.7	22.7	39.0	24.8	25.1	21.4	17.5	18.6	19.0	26.8	19.8	23.7	21.0	15.8	18.3	17.7	13.0	22.9	22.7	21.6	26.6	22.9	15.1	25.8	24.2	27.2	37.5	22.1	21.7	19.0	24.2	12.8	23.9	23.3	46.6	26.3	23.0	24.6	27.8	30.0	22.2	17.8	25.9	40.4	22.1	21.0	29.1	23.1	28.9	27.0	23.5	34.6	19.9	19.4	20.4	9.7	26.0	23.9	17.1	22.2	6.7	7.5	23.6	17.5	13.6	18.5	20.9	36.2	19.1	32.9	15.1	11.7	19.7	16.2	25.1	16.7	21.9	22.1	22.8	39.6	26.2	14.6	5.8	35.9	21.4	6.7	9.1	19.5	11.0	7.9	14.6	26.6	33.6	14.2	13.7	12.4	30.9	14.0	23.5	15.2	10.8	27.0	44.7	16.6	10.1	22.6	20.3	19.4	24.5	11.6	12.6	20.8	18.2	20.6	18.1	19.7	13.7	15.0	34.6	11.2	30.3	43.7	13.6	34.2	12.4	25.7	19.9	27.6	20.0	17.5	18.0	22.0	19.6	19.8	15.2	27.0	20.4	20.3	34.6	19.4	15.7	23.5	17.1	9.7	18.8	23.8	39.0	24.8	17.7	13.0	22.9	15.1	21.7	25.9	71.5	105.7	105.4	97.5	101.1	127.7	65.7	58.6	77.6	91.0	97.7	78.5	115.9	48.0	74.4	33.8	94.6	63.5	46.7	93.1	132.3	81.3	98.0	97.2	105.0	85.5	114.4	88.5	70.0	102.8	19.1	103.6	110.8	54.0	131.7	71.2	91.8	98.0	56.1	106.4	70.1	171.0	97.0	97.9	194.9	273.4	119.7	131.5	115.4	84.3	132.0
DDX49	"Dbp8, FLJ10432"	ENSG00000105671	"DEAD-box helicase 49"	Q9Y6V7	19	18919675-18928633	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041870, HPA048093"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041870: AB_2677717, HPA048093: AB_2680262"	"unprognostic (3.51e-1)"	"prognostic favorable (2.01e-6)"	"unprognostic (2.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.67e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (7.44e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.24e-1)"	14.8	16.8	17.6	17.3	16.9	28.3	18.0	17.0	30.7	15.3	15.8	19.0	14.8	19.5	15.6	13.2	23.4	16.5	12.2	18.2	19.2	12.9	15.5	25.6	13.0	19.3	15.7	14.8	15.7	26.8	13.0	11.1	23.3	16.2	15.5	10.3	13.5	24.3	15.8	27.2	23.6	18.7	12.7	16.8	16.7	15.7	19.7	16.3	23.4	18.8	16.6	18.7	16.4	15.6	8.2	25.0	13.5	19.5	14.1	14.0	9.7	15.8	16.5	6.7	21.0	9.8	7.9	25.2	10.1	6.8	17.9	14.5	18.8	16.1	20.8	30.9	10.0	5.7	13.6	14.9	13.8	5.1	6.3	39.6	10.2	17.9	16.3	23.3	26.1	14.2	15.7	13.3	14.2	15.0	5.0	8.1	16.6	19.2	14.9	6.3	35.5	18.9	12.2	21.8	17.2	40.3	21.0	11.2	22.5	9.6	10.0	23.6	24.3	13.3	13.2	16.1	3.7	13.5	12.6	10.4	8.7	9.8	31.5	16.5	19.6	23.4	19.0	11.0	30.2	13.6	10.5	17.7	13.5	12.8	19.5	10.6	8.1	9.7	9.6	25.0	8.2	9.7	10.2	7.9	14.1	12.6	11.2	14.0	9.7	17.6	16.9	17.0	30.7	19.2	12.9	15.7	14.8	16.2	16.3	3.0	7.7	21.6	16.0	20.0	17.5	12.5	15.3	8.1	12.5	17.4	3.9	39.6	31.5	25.8	28.0	10.8	42.3	0.0	45.8	41.7	17.9	16.3	18.4	13.9	29.8	9.5	24.8	8.0	19.8	81.0	19.8	18.3	25.3	26.2	20.9	16.0	25.6	30.6	18.7	21.4	20.9	19.4	20.2	29.7	36.4	24.7	35.2	15.8	30.7	17.3
DDX51		ENSG00000185163	"DEAD-box helicase 51"	Q8N8A6	12	132136594-132144335	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039503	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA039503: AB_10796328"	"unprognostic (2.84e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.65e-3)"	10.5	8.5	12.7	12.7	17.1	17.2	10.3	23.5	18.9	8.8	8.4	11.8	10.6	7.8	11.5	12.2	8.5	12.4	10.0	8.1	11.6	9.9	9.5	7.2	8.9	11.1	10.5	16.9	19.6	14.8	10.1	9.8	7.2	11.8	9.3	7.3	8.9	10.7	12.4	13.8	18.0	8.2	10.4	10.5	10.6	9.3	6.7	12.0	9.5	9.9	7.1	10.4	9.3	8.6	2.5	2.3	2.6	2.1	1.6	2.0	1.0	6.2	10.1	4.2	5.3	4.0	3.9	8.0	4.8	2.9	7.2	3.0	6.2	3.1	10.9	4.2	2.9	1.7	6.6	10.5	7.7	3.5	2.6	10.1	12.9	5.4	2.0	4.9	9.0	7.5	3.4	5.7	4.0	3.6	8.1	3.8	12.2	9.5	3.6	2.1	6.2	11.0	18.5	7.4	5.3	17.4	13.1	5.8	12.1	4.9	5.0	10.3	5.4	5.3	7.5	5.3	3.7	6.6	8.3	6.7	2.7	8.3	6.6	11.1	10.2	5.9	12.8	5.6	6.9	6.3	1.1	2.1	1.2	2.0	1.0	0.7	1.5	1.3	0.9	0.6	2.5	1.2	1.6	2.6	1.6	1.0	2.3	0.6	1.0	12.7	17.1	23.5	18.9	11.6	9.9	10.5	16.9	11.8	12.0	3.0	15.9	3.0	6.8	11.1	27.9	4.0	10.2	4.0	13.6	3.5	23.6	6.0	1.7	4.0	0.9	7.7	3.5	0.0	4.5	4.9	6.5	7.3	5.8	6.4	4.9	31.8	8.1	7.4	6.2	0.7	7.8	5.7	10.1	3.6	8.3	11.1	5.4	7.0	7.8	2.9	27.4	0.0	6.4	5.7	9.4	12.3	3.4	6.9	12.1	5.8
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643464	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 210.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	6.4	4.5	4.3	5.3	5.5	9.1	4.6	8.1	6.5	6.9	6.1	4.8	5.0	5.9	7.8	10.7	6.7	3.5	5.0	3.0	4.5		9.4	7.1	4.2	5.1	5.4	3.1	6.3	4.4	6.2	8.8	5.8	6.5	6.1	6.0	4.0	4.1	4.8	6.7	6.0	10.6	4.8	6.2	5.7	4.8	4.8	4.9	8.7	5.7	5.8	6.1	6.0	6.9	4.0	5.7	3.5	4.2	3.5	4.7	1.5	4.8	9.9	1.0	9.8	5.5	4.9	4.2	6.5	5.8	8.6	8.3	5.0	1.8	2.7	4.5	4.3	1.8	4.4	10.9	7.1	11.5	6.5	12.3	6.1	6.2	4.0	5.4	7.8	3.2	5.1	7.3	5.6	6.9	4.1	9.8	2.7	0.8	1.9	5.0	1.5	11.7	4.0	5.6	2.7	0.4	7.6	8.6	5.0	9.7	5.4	7.2	5.8	7.8	1.8	4.8	5.7	3.4	6.0	6.6	7.0	4.4	3.6	7.4	2.4	3.9	5.5	5.7	4.9	5.5	3.4	3.2	3.5	4.2	4.2	3.3	3.6	4.0	3.5	2.3	4.0	3.4	4.7	2.8	3.5	2.4	5.7	3.1	1.5											38.7	19.5	26.1	27.2	30.7	28.6	28.7	28.1	28.1	38.7	26.2	31.4	30.7	29.9	64.6	210.7	26.3	24.7	0.0	45.3	25.7	21.9	24.4	26.5	32.8	22.8	44.5	25.2	29.4	23.8	70.2	22.7	23.7	16.9	47.7	26.7	23.2	47.9	21.0	22.6	32.3	32.6	25.8	12.6	28.9	57.6	29.1	20.9	34.4	36.5	43.1
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999961-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 11.5"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 47.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.6;K-562: 6.3;RPMI-8226: 3.3;U-2197: 2.1;U-266/84: 14.1"					"Low region specificity"	"Detected in many"			HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.4	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.0	8.8	0.0	0.0	0.0	0.0	0.0
DDX54	"APR-5, DP97, MGC2835"	ENSG00000123064	"DEAD-box helicase 54"	Q8TDD1	12	113157174-113185479	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028244, HPA070786"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA028244: AB_10603885, HPA070786: AB_2686311"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	17.2	17.6	9.2	20.7	12.8	25.4	17.2	9.9	13.6	17.9	16.4	12.4	18.1	20.3	18.0	19.4	19.5	17.2	17.9	20.1	8.8	7.9	22.3	28.6	14.0	19.9	8.1	9.4	22.4	27.0	18.3	7.4	22.6	10.0	16.6	9.0	13.4	17.4	13.9	45.4	18.7	19.4	14.8	8.1	22.2	16.1	11.4	8.6	26.6	23.1	21.6	22.2	16.7	17.5	12.1	13.3	8.0	15.2	11.9	13.0	10.0	26.8	28.1	10.5	19.3	7.0	8.5	27.1	14.6	13.6	20.0	11.0	28.9	13.1	34.9	17.2	12.2	14.9	20.0	18.6	19.0	7.6	20.0	22.8	20.9	15.1	19.7	12.4	34.9	24.8	13.9	15.1	19.3	11.9	16.4	16.3	21.2	30.3	12.5	10.2	24.8	30.0	49.8	24.5	18.9	20.0	22.3	15.5	35.6	10.9	28.1	13.6	12.4	20.7	31.8	13.2	9.0	27.3	27.3	12.1	17.0	19.0	20.1	30.4	18.3	20.8	39.2	15.0	19.5	17.8	8.0	10.0	2.3	12.4	15.2	13.0	11.6	11.4	12.2	13.3	12.1	11.8	12.5	0.6	11.9	9.8	10.0	9.4	10.0	9.2	12.8	9.9	13.6	8.8	7.9	8.1	9.4	10.0	8.6	29.8	28.0	32.1	27.0	15.3	20.2	12.4	20.4	10.7	21.6	12.2	2.0	51.4	21.6	35.0	0.9	19.7	30.2	23.3	43.1	46.0	18.7	23.5	24.3	35.5	34.5	25.4	27.1	15.4	31.7	2.1	27.3	23.0	11.8	23.4	28.6	23.8	38.0	38.2	22.6	34.9	18.1	6.5	18.9	15.4	18.9	17.1	60.5	37.3	38.2	32.3
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565417-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		NA	NA			Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.8	12.0	10.3	12.4	11.9	12.4	9.2	13.6	18.9	11.9	10.0	12.2	8.6	11.9	12.8	10.3	13.1	12.6	12.5	9.3	10.6	9.9	17.7	29.2	8.9	13.2	10.4	9.3	15.0	22.5	13.1	11.9	12.3	12.2	14.1	9.0	11.0	16.9	11.5	16.9	16.3	11.4	8.4	8.8	12.1	10.6	14.6	10.9	14.5	13.8	16.7	15.1	9.2	10.3	12.8	16.0	6.9	16.5	15.7	12.3	12.7	7.6	20.5	1.6	4.4	2.0	2.0	6.8	7.3	3.7	8.3	7.3	13.2	7.6	13.5	9.5	2.7	11.4	13.1	3.3	7.3	1.5	5.0	20.8	8.9	13.0	10.1	3.6	9.3	5.0	2.9	5.3	7.4	4.6	1.5	4.2	5.0	18.3	3.8	5.3	10.1	4.7	8.6	11.1	6.6	19.3	3.8	7.2	5.3	4.7	8.2	5.2	8.4	9.6	15.0	5.5	1.3	10.9	9.6	8.9	6.8	9.9	4.6	18.3	12.4	19.0	19.4	7.5	11.4	9.5	6.9	11.8	4.3	9.9	15.3	12.3	11.5	10.7	11.1	16.0	12.8	12.3	10.3	0.4	15.7	16.5	7.7	10.1	12.7	10.3	11.9	13.6	18.9	10.6	9.9	10.4	9.3	12.2	10.9	14.9	25.3	16.0	20.1	15.1	25.2	10.8	12.7	24.1	34.2	21.0	13.7	48.6	23.2	34.9	39.1	23.8	26.9	0.0	28.4	38.8	18.4	15.9	27.7	27.7	31.4	6.4	17.7	18.4	10.1	30.0	19.5	17.4	13.5	32.5	19.6	20.6	31.1	20.1	18.7	40.8	23.2	12.9	20.6	30.2	29.0	17.3	39.5	18.7	27.0	18.1
DDX58	"DKFZp434J1111, FLJ13599, RIG-I"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455705-32526324	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 47.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012643, HPA047193"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane"	Cytosol	"CAB012643: , HPA047193: AB_2679978"	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	27.7	8.2	5.7	14.5	7.9	5.6	11.3	4.2	5.7	9.9	9.5	5.2	9.1	7.2	12.7	11.7	10.8	7.6	10.3	7.1	6.0	5.1	14.7	8.5	13.7	14.3	6.3	4.5	9.2	7.7	6.6	10.2	14.8	7.5	12.1	8.1	5.5	12.4	5.8	8.3	10.7	16.1	10.8	7.7	13.8	8.0	4.5	6.4	35.4	13.0	7.4	9.7	9.9	9.4	4.9	2.0	24.8	5.7	6.1	6.5	3.0	2.9	1.1	1.6	0.9	3.9	4.1	2.5	1.8	8.9	45.5	47.6	1.2	2.6	0.8	3.2	1.6	14.7	2.4	1.8	2.0	6.4	7.3	0.6	2.8	2.5	2.0	3.2	1.8	2.2	2.8	0.7	5.2	1.6	3.5	8.3	2.2	0.6	0.6	6.0	0.4	2.6	4.7	1.3	0.6	1.3	2.4	1.2	0.3	6.9	1.6	1.2	0.8	2.6	1.1	5.0	1.1	1.9	1.6	9.4	1.4	1.3	1.1	0.9	0.1	0.5	0.6	2.0	0.8	0.9	8.5	3.8	10.3	6.2	5.7	5.5	4.8	5.6	5.6	2.0	4.9	5.1	5.6	24.8	6.1	3.9	0.1	6.5	3.0	5.7	7.9	4.2	5.7	6.0	5.1	6.3	4.5	7.5	6.4	20.8	9.1	5.4	4.4	3.8	3.7	4.4	2.5	8.1	6.8	1.8	2.0	4.5	0.0	17.2	2.0	14.5	14.6	0.0	10.6	6.7	5.1	4.6	4.7	6.4	5.0	6.4	2.9	8.6	6.9	0.0	6.1	6.7	0.0	2.8	2.9	9.4	12.8	5.8	5.6	6.5	2.7	6.5	6.6	0.5	1.5	4.6	2.1	9.2	1.9	4.3
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669969	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	14.0	14.4	12.1	16.4	14.8	23.7	22.7	16.7	11.2	14.5	11.6	10.8	12.6	8.1	15.8	17.6	12.0	13.8	11.4	18.0	12.0	9.9	13.6	15.1	11.8	15.1	15.1	6.7	17.1	21.6	13.9	10.7	46.5	12.8	14.1	12.5	15.0	19.4	12.9	28.6	21.5	12.4	14.0	17.2	20.9	10.4	9.9	14.5	18.5	15.1	10.1	13.2	12.8	12.7	12.2	9.5	23.1	16.2	12.4	15.6	7.9	9.4	10.9	12.7	10.6	5.7	10.0	28.3	10.6	9.5	11.4	9.3	3.4	11.1	9.6	5.4	8.4	9.3	9.0	7.1	10.8	8.1	30.3	7.3	7.3	14.0	10.1	11.5	10.5	13.6	10.7	16.4	8.6	23.5	9.5	8.7	13.8	9.2	14.3	11.0	10.9	6.3	15.8	13.4	5.7	8.9	5.3	8.8	18.5	12.2	11.0	7.7	20.0	16.8	17.5	18.6	17.2	15.1	14.8	7.8	9.6	5.4	9.5	10.9	10.9	14.2	12.7	9.2	6.6	16.4	23.1	10.3	19.0	13.0	8.9	10.6	12.2	10.9	11.7	8.5	11.5	11.3	10.3	18.2	12.4	16.2	9.5	15.6	7.9	12.1	14.8	16.7	11.2	12.0	9.9	15.1	6.7	12.8	14.5	17.9	19.0	14.5	11.1	14.3	3.3	15.9	5.1	10.7	7.9	7.0	2.0	18.5	13.3	7.5	2.0	15.9	7.4	0.0	7.3	22.7	10.8	10.1	19.7	6.4	11.5	6.4	1.2	10.4	8.6	0.2	7.5	11.7	5.0	17.2	10.7	8.5	7.9	8.0	12.7	8.4	6.0	0.0	12.3	12.1	19.0	13.7	36.6	13.1	8.8	8.6
DDX6	"HLR2, RCK"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747766-118791149	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	29.8	23.0	25.0	24.1	41.0	43.3	25.1	41.9	39.2	26.9	23.2	29.4	14.5	17.1	30.1	22.9	31.8	23.4	17.5	26.8	25.5	25.1	22.8	24.6	23.4	32.2	21.9	27.1	38.2	27.9	30.9	43.2	26.1	29.6	24.9	20.8	25.4	26.8	22.9	43.8	23.9	24.1	27.8	30.4	30.6	21.2	19.9	24.0	46.0	27.9	19.4	42.8	33.0	25.7	12.2	6.5	17.8	10.3	7.2	12.6	5.7	11.9	16.3	26.3	25.9	23.1	23.7	17.2	16.2	21.3	15.1	14.4	23.7	18.4	27.4	17.1	26.5	15.1	19.1	30.6	23.7	24.4	20.6	6.1	52.9	10.5	19.3	15.3	37.9	20.4	25.0	17.5	22.4	36.4	19.9	24.0	18.5	24.3	39.8	21.3	32.6	27.5	17.6	18.7	16.9	12.0	30.3	21.3	21.9	17.7	31.0	17.4	24.0	30.6	24.6	9.7	20.6	28.7	14.9	27.4	25.1	13.8	14.3	16.3	12.4	16.1	32.7	10.0	18.2	21.4	10.5	4.1	11.6	10.1	5.7	12.6	11.4	9.9	10.4	4.7	12.2	12.4	10.8	17.8	7.2	10.3	6.5	8.9	5.7	25.0	41.0	41.9	39.2	25.5	25.1	21.9	27.1	29.6	24.0	56.6	60.1	71.3	62.3	26.9	78.4	105.7	35.7	40.2	43.3	41.8	47.1	31.3	26.6	28.5	3.7	65.3	48.0	46.7	30.5	30.1	37.5	44.5	49.8	37.6	33.8	58.8	82.4	58.9	51.1	8.2	50.0	42.0	32.1	73.1	55.4	81.3	38.8	65.4	42.5	35.6	75.0	38.8	41.9	66.1	72.8	26.7	64.0	103.8	45.4	65.9
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216293-168318807	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 22.8;BJ hTERT+ SV40 Large T+ RasG12V: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	18.0	8.3	4.1	18.5	5.0	4.4	9.0	1.3	3.8	11.4	14.8	4.3	5.1	8.8	10.8	15.2	10.7	8.1	11.5	8.5	3.7	3.5	10.0	8.8	21.6	18.7	4.2	3.2	20.3	5.5	8.8	6.7	25.5	5.6	11.6	14.3	9.0	15.6	6.2	5.6	7.9	16.7	11.2	6.1	18.9	29.2	5.7	3.9	23.2	14.5	6.0	9.3	8.2	7.2	4.1	2.5	3.2	6.3	7.6	10.0	3.5	5.6	1.2	2.8	1.1	2.1	7.8	3.2	1.9	13.7	22.8	22.1	0.0	12.4	0.0	1.1	3.0	10.5	4.7	0.3	4.5	6.6	4.3	0.6	8.8	4.8	0.0	10.3	3.3	2.2	7.0	2.0	5.8	1.3	5.5	8.5	4.2	0.0	1.7	2.8	0.3	5.0	2.4	0.5	0.8	1.6	3.4	1.5	0.1	6.7	3.4	0.6	0.6	3.6	1.0	13.7	0.2	0.9	4.2	5.6	1.4	1.5	0.5	1.4	1.0	0.2	0.0	4.3	3.8	4.0	3.2	2.8	2.6	8.5	5.1	10.0	4.1	6.7	8.0	2.5	3.3	6.8	8.5	2.8	7.6	6.3	0.2	5.5	3.5	4.1	5.0	1.3	3.8	3.7	3.5	4.2	3.2	5.6	3.9	32.8	6.2	5.0	4.0	3.8	0.7	7.1	10.2	14.7	12.5	12.2	0.0	6.4	5.0	7.0	1.7	10.3	10.7	0.0	5.9	8.5	5.0	3.8	26.5	3.8	5.8	0.0	2.9	15.4	4.1	1.4	7.5	8.8	3.3	0.0	13.6	8.0	8.7	7.2	8.9	3.3	3.0	6.5	3.8	0.9	0.7	2.4	2.4	10.1	5.8	3.1
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 22.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 23.3"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	12.7	5.0	2.8	13.1	3.1	33.0	9.9	1.4	3.2	7.2	8.4	3.2	2.7	6.0	9.2	7.9	3.8	6.9	6.7	6.0	2.4	2.4	4.5	6.0	25.8	17.7	3.8	1.4	7.3	5.1	4.4	5.2	32.6	3.4	5.0	6.5	6.8	7.0	5.7	3.3	4.3	14.0	5.3	4.2	11.9	9.5	2.7	3.1	25.3	5.8	3.5	8.1	4.9	6.8	1.6	2.4	22.5	7.8	1.7	3.7	1.6	6.1	3.6	1.4	0.6	3.7	10.8	7.0	6.2	13.1	23.3	16.2	0.0	14.5	0.1	0.3	6.3	12.7	2.4	0.6	3.7	6.8	3.5	0.5	13.6	4.0	0.3	4.5	5.5	3.4	3.0	1.1	8.4	0.7	4.9	16.4	3.1	0.2	0.1	14.9	0.1	4.9	3.5	0.3	0.6	3.1	2.7	3.2	0.0	2.2	3.6	0.2	1.9	11.0	1.3	6.2	0.2	1.0	7.8	17.5	1.2	8.2	2.9	2.1	5.9	0.9	0.0	4.1	16.5	1.8	1.6	4.0	3.5	2.7	6.3	3.7	0.9	2.7	2.7	2.4	1.6	2.2	2.3	22.5	1.7	7.8	0.0	3.6	1.6	2.8	3.1	1.4	3.2	2.4	2.4	3.8	1.4	3.4	3.1	8.9	7.9	0.0	2.1	0.9	1.3	8.1	5.1	12.0	3.4	3.5	21.6	4.5	0.0	6.8	10.7	13.1	11.6	0.0	8.7	29.4	7.0	2.6	8.1	5.4	22.5	0.0	0.0	9.2	23.2	3.6	3.1	29.7	0.0	26.2	13.2	3.2	17.0	14.0	3.9	3.3	16.8	6.5	3.3	0.5	1.3	2.0	5.9	8.7	3.8	1.4
DEAF1	"NUDR, SPN, ZMYND5"	ENSG00000177030	"DEAF1, transcription factor"	O75398	11	644233-706715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030302	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA030302: AB_2673421"	"unprognostic (1.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.15e-2)"	4.8	5.9	36.1	6.5	19.9	4.5	16.9	19.4	26.2	5.4	4.3	5.3	5.2	4.8	7.5	6.3	6.8	9.8	6.0	8.3	30.2	15.7	4.5	2.8	5.3	4.4	18.3	3.4	6.0	13.2	5.9	14.5	5.2	9.7	6.7	2.2	3.6	11.8	4.7	7.8	6.6	4.0	7.2	8.1	4.0	7.2	5.7	9.8	15.2	12.0	2.7	5.3	7.0	20.3	1.2	4.4	3.3	3.0	3.5	5.9	1.6	7.5	4.6	7.4	3.9	7.3	9.5	5.8	5.6	7.2	11.9	8.7	4.9	6.5	2.1	6.1	5.5	3.2	5.0	7.1	5.1	1.7	9.1	42.1	5.0	2.6	3.7	13.2	11.0	8.2	8.0	7.0	2.1	6.0	7.6	9.4	5.8	11.1	8.8	4.4	3.8	4.1	10.1	17.4	7.8	9.7	10.1	2.6	8.2	8.4	0.9	10.6	11.1	4.0	6.0	4.0	1.9	3.7	3.2	10.8	3.9	2.2	1.6	4.8	9.8	3.6	3.9	4.4	7.3	7.7	0.0	3.0	3.3	2.4	1.7	2.6	1.2	4.7	2.7	4.4	0.8	5.9	3.2	1.8	3.5	1.9	0.5	1.7	1.6	36.1	19.9	19.4	26.2	30.2	15.7	18.3	3.4	9.7	9.8	0.0	3.8	9.0	22.8	11.7	18.3	6.1	10.2	5.3	4.5	33.2	9.8	11.6	44.7	17.9	3.0	13.5	11.1	0.0	9.7	5.1	14.9	30.4	0.0	10.4	8.8	57.2	10.5	4.9	7.0	5.1	18.4	9.0	16.9	12.6	8.6	20.4	12.8	10.7	28.3	22.3	17.1	12.9	15.5	6.7	11.7	13.6	12.9	8.7	8.9	26.8
DECR2	"PDCR, SDR17C1"	ENSG00000242612	"2,4-dienoyl-CoA reductase 2"	Q9NUI1	16	401826-412487	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 68.2"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 103.3;Proximal tubular cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047631			Approved	Peroxisomes,Microtubules		NA	NA			Peroxisomes	Microtubules	"HPA047631: "	"unprognostic (2.74e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.22e-3)"	5.7	10.8	3.2	4.3	4.0	3.5	4.0	3.8	5.0	2.9	10.2	2.7	5.0	14.2	4.0	7.3	4.1	2.5	7.8	4.4	2.8	2.3	16.9	68.2	4.3	3.9	2.0	3.0	2.6	9.7	1.8	2.6	2.3	2.0	4.1	2.4	3.0	6.2	5.6	15.9	2.9	14.4	5.1	1.9	1.9	5.9	4.1	1.8	1.2	1.7	4.3	2.9	2.7	2.2	3.3	9.5	0.4	6.1	2.7	5.1	3.9	1.1	11.1	1.4	6.6	1.3	3.0	4.2	3.4	2.5	2.9	3.0	7.0	7.6	3.8	7.3	4.2	1.7	2.5	1.1	2.8	0.4	8.4	3.6	0.9	5.4	16.6	8.7	3.4	5.4	4.3	2.1	1.9	2.4	3.3	3.6	4.4	2.3	3.5	2.4	11.6	1.9	4.7	4.1	4.2	5.8	4.5	0.5	6.9	2.9	2.9	2.9	4.5	6.4	7.2	3.7	0.5	10.3	4.2	7.5	2.5	2.7	3.5	2.6	5.0	3.9	1.6	3.4	5.1	8.1	0.0	6.1	0.4	3.6	5.6	2.5	2.8	2.2	2.4	6.5	3.3	5.1	3.0	0.3	2.7	4.5	9.5	1.7	3.9	3.2	4.0	3.8	5.0	2.8	2.3	2.0	3.0	2.0	1.8	11.9	14.4	4.2	8.0	3.4	2.0	7.0	17.8	12.0	9.1	19.2	0.0	28.2	33.2	28.8	1.8	5.8	56.4	46.7	34.2	4.7	8.9	4.3	12.7	103.3	11.0	3.2	12.0	6.7	6.7	5.5	6.1	5.3	5.0	15.4	26.4	5.8	28.8	35.1	6.3	98.2	2.7	0.0	6.2	1.8	5.7	5.3	10.5	2.2	34.3	2.7
DEDD	"CASP8IP1, DEDD1, DEFT, FLDED1, KE05"	ENSG00000158796	"Death effector domain containing"	O75618	1	161120974-161132688	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030681, HPA073628"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030681: AB_2797220, HPA073628: AB_2732230"	"unprognostic (2.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.20e-3)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.43e-2)"	24.4	15.7	15.8	17.3	16.4	24.2	20.8	19.3	24.0	16.6	20.4	19.3	16.4	19.4	19.6	14.8	24.0	18.4	20.1	18.5	14.3	12.8	16.5	26.3	20.3	17.8	12.9	11.8	22.1	18.7	14.5	14.0	36.7	18.2	17.2	13.1	17.5	18.1	16.0	39.0	21.5	17.9	20.0	13.8	21.2	16.6	35.8	14.7	19.2	18.7	24.2	19.5	20.1	18.5	16.3	21.3	33.6	23.8	16.5	24.0	18.7	13.2	13.1	15.6	13.5	12.0	12.2	10.7	11.4	16.3	13.3	14.8	9.1	23.0	14.2	11.5	17.1	9.8	12.1	11.8	17.8	8.6	14.1	12.8	13.2	15.7	12.2	21.3	9.2	20.1	15.3	19.1	14.2	22.7	17.7	21.3	19.7	11.2	21.3	15.4	20.8	22.3	10.1	25.9	26.6	13.6	18.4	10.7	18.9	13.2	16.2	16.5	25.0	11.6	30.8	19.8	17.8	18.4	18.9	14.9	14.5	15.5	16.8	16.5	29.5	18.6	25.1	17.3	10.0	10.3	33.6	23.8	32.1	19.0	21.9	16.2	16.3	19.0	18.9	21.3	15.4	21.5	17.5	26.6	16.5	22.5	18.8	24.0	18.7	15.8	16.4	19.3	24.0	14.3	12.8	12.9	11.8	18.2	14.7	23.8	9.4	6.8	11.7	22.3	6.0	8.7	12.7	5.3	7.9	8.7	5.9	16.8	19.9	11.5	30.8	18.0	10.6	0.0	16.8	16.5	15.0	8.8	16.1	9.2	13.3	12.7	10.9	14.1	18.6	37.1	10.9	15.9	13.5	17.2	8.7	5.0	11.9	11.5	9.2	11.3	9.2	6.5	18.6	15.7	14.7	21.8	22.5	8.3	9.9	13.7
DEDD2	FLAME-3	ENSG00000160570	"Death effector domain containing 2"	Q8WXF8	19	42198598-42220140	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 58.6"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 22.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043419			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043419: AB_10960747"	"unprognostic (1.59e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (3.26e-6)"	8.7	12.5	9.9	13.5	13.1	22.2	12.3	17.6	14.9	7.8	13.8	6.0	11.5	14.5	7.2	7.9	11.6	9.6	6.4	6.3	9.4	15.4	11.5	11.1	12.9	12.7	14.5	5.7	9.7	11.6	7.1	17.0	10.5	10.4	13.8	5.7	6.3	11.6	8.2	13.6	11.4	13.2	5.8	8.2	17.8	19.7	9.6	10.5	17.2	24.1	6.3	13.2	10.4	58.6	16.9	19.0	49.2	29.1	14.3	21.9	24.2	10.1	22.9	1.5	1.8	3.5	0.8	6.8	4.1	3.6	3.3	2.3	6.4	6.6	6.6	8.0	1.2	3.6	4.0	6.9	1.5	1.5	5.5	18.3	3.2	5.4	9.8	4.3	3.7	6.8	0.5	3.8	2.5	3.5	6.0	1.9	2.8	15.9	7.4	0.9	4.4	3.9	11.8	3.6	9.4	13.8	4.6	2.9	5.7	2.6	3.7	11.8	4.6	3.7	10.9	2.1	2.2	2.0	4.3	3.3	2.5	7.9	1.0	7.4	13.9	6.3	2.1	3.8	5.8	2.6	27.5	21.5	34.5	20.1	27.0	21.9	16.9	18.6	19.2	13.5	16.4	16.8	17.3	49.2	14.3	29.1	19.0	17.4	24.2	9.9	13.1	17.6	14.9	9.4	15.4	14.5	5.7	10.4	10.5	6.0	6.9	42.9	43.3	41.2	27.1	5.5	5.1	21.4	3.4	14.0	11.8	24.7	10.0	21.5	27.8	12.7	56.1	0.0	21.3	35.2	14.6	62.6	72.3	7.4	33.6	14.3	88.4	6.2	27.4	2.8	12.4	48.4	37.1	35.1	33.2	17.2	32.9	38.6	12.0	13.6	18.4	6.5	24.7	15.9	12.6	46.9	135.5	55.4	23.8	77.9
DEF8	FLJ20186	ENSG00000140995	"Differentially expressed in FDCP 8 homolog"	Q6ZN54	16	89947925-89968060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041745, HPA049434"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041745: AB_2677650, HPA049434: "	"unprognostic (4.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (9.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.09e-1)"	18.0	15.9	25.4	22.4	23.0	25.3	15.6	42.4	30.6	12.6	16.4	15.4	19.4	12.0	17.1	14.1	22.5	14.3	16.3	23.7	23.7	24.8	14.9	12.2	15.4	42.8	28.0	29.0	18.2	22.5	19.0	18.0	11.5	20.5	14.5	9.2	13.9	21.4	18.9	19.5	27.4	13.6	17.6	23.6	16.6	15.2	8.8	15.0	4.8	14.5	13.6	32.4	15.5	23.8	23.0	27.4	32.0	16.7	5.3	11.5	11.1	15.2	31.2	14.2	19.2	14.6	15.5	16.2	23.7	20.2	35.1	16.4	33.0	18.5	18.5	17.9	16.1	14.3	10.1	16.7	28.1	15.6	4.5	47.6	8.3	16.6	47.2	15.8	6.0	13.2	17.4	23.3	25.1	14.8	15.5	26.2	17.1	27.2	6.3	20.8	55.7	11.7	18.2	17.9	7.1	31.9	24.4	10.4	15.8	18.8	14.7	21.0	21.6	38.2	14.3	13.3	7.8	13.3	19.5	26.2	20.3	22.2	10.8	25.1	12.3	8.7	23.2	21.7	15.5	23.7	2.3	16.7	32.0	11.5	13.4	10.5	19.6	9.6	8.4	10.7	23.0	6.6	6.4	22.5	5.3	7.6	27.4	11.4	11.1	25.4	23.0	42.4	30.6	23.7	24.8	28.0	29.0	20.5	15.0	0.0	11.3	33.5	18.0	39.8	22.8	26.6	25.5	8.1	10.3	14.0	25.5	26.2	24.9	43.1	5.6	26.4	18.2	0.0	79.2	44.9	34.3	30.7	9.3	20.2	55.6	28.6	20.7	25.8	24.7	16.0	19.5	29.4	43.9	64.1	14.3	13.8	83.0	14.4	31.5	36.3	23.3	19.4	41.1	5.6	9.0	47.8	27.1	16.2	13.2	19.7
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056734	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	231	"intestine: 574.2"	"Group enriched"	"Detected in some"	4	"Enterocytes: 16.2;granulocytes: 4.6;Intestinal endocrine cells: 13.6;Mucus-secreting cells: 13.7;Paneth cells: 11.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 19.9;NB-4: 16.4;RPMI-8226: 17.2;SH-SY5Y: 14.0;U-2197: 6.0"									"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"	NA	NA			Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favorable (9.44e-5)"											"unprognostic (3.91e-2)"				0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	408.9	0.0	0.0	249.9	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	574.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	1.8	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	2.8	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.0
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100160163	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;skin 1: 30.6"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 22.9"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.9;granulocytes: 6.4"	"Group enriched"	"Detected in some"	16	"OE19: 29.1;T-47d: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046644			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.66e-4)"	0.4	0.3	2.0	2.3	4.6	0.5	5.8	22.9	6.4	5.3	20.2	1.8	0.6	20.8	3.4	4.6	20.9	1.9	13.3	0.3	2.0	1.5	8.7	17.2	2.6	0.8	2.4	1.4	0.8	13.0	0.3	1.6	0.6	2.7	2.5	4.2	0.8	4.5	2.3	0.5	30.6	44.5	0.7	1.9	0.5	17.9	0.7	0.7	0.0	2.4	7.3	11.1	7.1	5.2	11.9	0.7	6.4	0.5	0.2	1.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.7	0.1	0.1	0.0	29.1	0.0	0.1	0.0	1.5	0.0	0.7	2.2	0.0	0.0	1.3	0.0	0.0	45.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.5	6.4	1.8	0.0	0.0	11.9	0.1	0.8	0.7	5.9	0.0	1.2	0.2	0.2	0.0	0.1	0.0	0.8	2.0	4.6	22.9	6.4	2.0	1.5	2.4	1.4	2.7	0.7	3.0	5.3	0.0	2.8	1.5	4.4	0.4	38.2	77.6	11.4	78.5	0.0	5.9	1.7	13.4	1.0	0.9	31.3	0.0	1.3	1.5	0.3	1.1	9.2	0.2	1.6	0.0	53.2	0.6	1.9	1.5	0.3	1.0	0.0	0.0	43.3	1.2	2.8	43.8	0.0	0.1	24.4	0.0	0.2	0.9	1.9	13.4	31.2	1.3	46.7	17.4
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favorable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	11.4	12.2	17.4	13.9	19.8	32.5	10.0	18.6	21.2	10.9	14.8	12.8	10.3	15.8	13.3	9.0	11.3	13.0	10.5	10.3	15.9	12.8	16.4	14.5	9.4	11.6	11.8	14.9	12.0	8.9	20.1	19.0	23.9	13.9	11.0	14.1	14.5	8.5	11.8	11.0	9.3	17.2	14.4	10.1	20.2	9.9	12.1	13.2	10.6	15.5	5.6	9.5	10.6	17.4	1.5	8.4	11.2	15.2	0.5	1.3	3.2	14.8	8.8	7.9	14.9	5.4	8.5	36.8	14.4	21.8	12.3	10.7	12.0	6.6	11.9	3.0	11.6	16.3	8.4	6.7	10.5	12.0	5.0	5.1	5.6	21.3	8.8	7.2	6.7	3.8	7.8	9.5	10.2	17.5	4.3	10.9	11.6	15.4	9.2	9.9	8.5	8.0	9.7	15.7	17.2	13.4	12.5	7.7	10.1	6.1	5.3	16.8	13.7	11.6	7.7	9.0	5.4	10.5	17.0	5.1	13.3	5.1	15.5	7.5	14.0	10.9	8.2	11.2	13.4	8.8	11.2	15.2	2.8	1.3	10.1	0.7	1.1	0.9	0.6	8.4	1.5	0.6	0.7	9.3	0.5	8.2	1.3	0.4	3.2	17.4	19.8	18.6	21.2	15.9	12.8	11.8	14.9	13.9	13.2	0.0	1.0	7.3	2.3	4.5	15.9	7.7	7.6	1.4	1.2	15.7	15.7	8.6	5.0	4.0	28.4	10.1	17.6	0.0	4.4	27.4	5.2	4.7	4.6	12.1	14.5	30.2	11.5	7.4	15.9	67.9	13.6	10.8	3.3	2.8	6.6	13.5	5.2	10.7	10.6	11.5	12.3	0.0	5.2	3.4	1.1	2.5	7.3	3.8	6.7	3.1
DENND1B	"C1orf218, FAM31B, FLJ20054, MGC27044"	ENSG00000213047	"DENN domain containing 1B"	Q6P3S1	1	197504748-197775696	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042586	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"HPA042586: AB_2678064"	"unprognostic (8.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.54e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-2)"	5.9	3.9	6.2	12.7	8.3	6.4	8.7	3.9	5.6	5.7	13.0	1.4	8.8	7.5	3.6	6.4	9.0	3.1	5.4	7.3	4.9	4.9	7.9	6.6	7.3	7.8	4.0	2.7	5.6	8.7	9.9	15.9	3.6	3.7	7.5	7.8	6.4	9.9	15.8	6.5	3.8	21.6	4.1	3.5	7.7	6.1	4.4	2.6	17.9	8.2	6.5	11.7	6.9	6.8	2.3	2.0	5.0	0.6	5.8	3.6	0.7	6.0	1.5	1.7	2.9	0.8	4.5	2.7	4.6	3.2	2.9	1.7	1.6	3.9	11.0	2.4	7.1	1.7	3.1	2.7	3.4	2.5	8.3	3.0	4.0	3.0	0.8	2.4	12.9	4.9	1.5	4.6	1.1	3.2	8.8	1.2	6.4	3.0	17.1	2.8	1.1	6.9	6.6	0.6	1.5	1.5	4.3	1.5	8.6	7.1	5.7	3.0	4.7	7.1	4.8	1.2	2.9	2.0	11.3	3.4	0.3	2.8	0.1	2.7	8.7	0.0	5.6	3.0	5.3	5.3	5.0	0.3	2.3	2.1	0.6	1.1	2.3	1.4	3.3	1.5	0.7	0.8	1.5	1.0	5.8	0.6	2.0	3.6	0.7	6.2	8.3	3.9	5.6	4.9	4.9	4.0	2.7	3.7	2.6	38.7	11.5	19.6	20.9	7.4	19.3	24.6	12.7	4.0	12.5	14.0	23.6	8.1	14.9	8.1	25.6	4.8	51.6	0.0	19.9	7.7	8.9	21.4	63.5	14.3	17.9	4.8	13.8	8.0	21.7	19.7	22.2	29.4	15.1	13.6	24.1	7.1	17.6	42.1	12.4	13.2	13.8	0.0	2.9	8.0	13.3	10.7	6.2	33.8	22.4	47.8
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.7;lymphoid tissue: 32.9"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 28.3;Erythroid cells: 23.3;granulocytes: 16.1;T-cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 13.2;HEL: 8.8;HMC-1: 27.4;MOLT-4: 8.4;THP-1: 8.1;U-937: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"	2.1	1.3	1.5	22.0	2.5	14.1	2.0	0.5	1.6	1.0	2.8	2.5	0.0	3.4	1.0	1.5	1.7	1.7	3.4	1.0	1.3	1.3	2.2	2.0	5.2	30.1	3.1	0.6	0.8	1.0	0.0	1.1	1.3	2.2	1.7	0.8	1.4	5.4	0.8	0.6	1.0	12.1	0.8	2.7	31.3	3.5	0.5	2.7	32.9	1.8	1.2	25.2	3.0	1.5	16.3	12.2	19.0	20.6	14.1	26.7	20.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	13.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	8.8	0.0	0.9	0.0	4.3	27.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	5.7	0.1	0.0	8.4	6.7	0.0	0.3	0.0	1.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.1	0.0	18.3	0.0	10.4	11.6	19.0	26.7	20.6	23.4	16.3	19.1	22.9	12.2	13.7	24.8	21.6	17.6	14.1	20.0	7.1	21.9	20.2	1.5	2.5	0.5	1.6	1.3	1.3	3.1	0.6	2.2	2.7	3.0	4.8	28.3	0.0	0.3	0.0	0.9	2.5	2.7	0.0	1.8	0.0	0.1	1.7	0.4	0.6	0.0	1.1	23.3	0.0	0.2	0.2	0.0	16.1	0.0	12.9	0.0	0.0	1.8	9.9	0.4	0.0	9.2	3.3	3.6	0.6	0.0	0.4	0.0	0.0	3.4	0.0	0.0	0.3	0.2	0.7	0.1	0.2	32.3	0.8	0.1
DENND3	KIAA0870	ENSG00000105339	"DENN domain containing 3"	A2RUS2	8	141117278-141195808	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.9"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 145.9;Kupffer cells: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.0;neutrophil: 22.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HeLa: 33.9;U-937: 24.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024491, HPA041668"		Approved	Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA024491: AB_2671581, HPA041668: "	"unprognostic (2.27e-1)"	"unprognostic (9.62e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.42e-2)"	21.8	6.2	12.2	21.7	15.2	75.9	17.6	1.7	12.3	10.4	17.0	11.5	2.3	5.5	10.3	6.1	6.8	8.3	12.0	8.8	12.1	8.5	12.2	3.9	30.1	27.8	15.9	7.7	8.9	4.7	4.5	5.8	13.0	13.7	9.0	7.4	7.1	10.2	8.3	12.9	8.3	12.7	7.8	21.9	24.7	9.1	4.6	11.8	3.4	11.4	3.5	20.6	9.5	9.8	2.4	2.2	22.2	5.4	1.4	0.4	1.6	6.9	6.3	0.4	1.3	1.9	2.9	1.1	4.0	11.7	1.6	1.3	1.9	6.6	1.8	10.4	7.4	3.3	3.5	1.8	4.3	1.2	27.4	1.6	7.2	33.9	0.6	1.7	7.2	1.1	0.2	2.2	1.8	2.3	4.0	9.2	3.4	0.0	17.7	1.2	2.1	1.0	10.0	0.4	1.3	8.3	1.2	0.3	6.9	6.6	2.4	2.0	1.3	0.8	0.5	0.5	3.3	2.9	11.6	7.3	0.3	3.2	4.6	0.1	3.6	15.7	0.5	1.1	24.9	0.4	9.3	2.9	18.0	0.4	4.5	0.4	2.4	0.3	0.1	2.2	2.3	0.0	0.1	22.2	1.4	5.4	0.0	0.1	1.6	12.2	15.2	1.7	12.3	12.1	8.5	15.9	7.7	13.7	11.8	145.9	32.8	17.6	6.5	14.0	4.7	7.8	12.7	9.4	19.4	21.0	3.9	0.6	1.7	2.8	4.9	20.2	7.4	0.0	3.1	0.5	4.2	8.9	10.4	0.0	19.6	1.6	4.6	19.6	50.4	1.5	1.4	26.4	8.5	21.6	7.6	0.6	7.1	3.1	0.7	2.1	0.3	38.8	16.5	7.0	7.2	8.0	0.5	10.2	3.6	4.9
DENND4A	"IRLB, MYCPBP"	ENSG00000174485	"DENN domain containing 4A"	Q7Z401	15	65658046-65792293	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 93.5;Horizontal cells: 104.9;Rod photoreceptor cells: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065343	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA065343: AB_2685476"	"unprognostic (1.10e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.83e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.48e-1)"	13.7	15.7	9.5	13.9	11.3	32.9	9.5	26.7	12.6	10.0	9.6	12.2	6.8	6.9	11.5	6.6	8.0	9.3	13.2	8.2	10.7	8.5	9.8	19.1	12.8	20.8	12.1	9.7	16.3	19.9	17.9	21.2	9.9	11.6	8.1	8.2	14.6	9.5	7.2	15.3	7.6	10.2	12.5	16.6	13.6	10.2	9.0	11.9	16.9	12.7	5.6	20.1	13.4	10.1	9.3	3.1	6.8	3.6	4.4	8.0	1.9	4.8	4.6	2.4	2.5	7.3	8.1	3.0	5.1	6.8	3.4	5.0	2.6	3.9	25.2	3.5	7.4	4.2	9.2	4.7	4.5	6.0	27.9	5.5	23.9	6.0	5.0	4.2	8.1	8.5	5.4	5.1	4.7	10.0	6.0	9.1	5.7	7.2	15.6	3.9	2.6	3.7	4.3	0.7	14.6	3.5	1.8	8.6	21.7	4.0	9.4	3.9	3.7	4.9	3.4	4.4	3.0	3.3	20.7	9.8	4.7	5.3	8.5	7.0	8.5	9.5	9.5	6.7	17.7	3.8	3.1	3.6	6.8	5.3	1.5	8.0	7.8	4.6	6.7	3.1	9.3	4.9	4.7	1.9	4.4	1.2	1.2	4.2	1.9	9.5	11.3	26.7	12.6	10.7	8.5	12.1	9.7	11.6	11.9	14.9	23.9	21.9	25.1	24.7	75.6	10.9	15.3	21.4	21.6	8.7	56.9	4.2	0.0	7.8	1.5	23.3	5.1	93.5	11.3	5.7	14.1	17.9	47.4	23.2	16.5	104.9	16.7	17.8	20.8	2.9	12.0	24.7	23.6	7.2	10.1	24.1	12.2	10.4	11.7	8.7	124.0	6.5	16.4	10.7	9.6	14.9	10.5	29.9	8.9	14.1
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946696	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: AB_2732173"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	14.5	9.6	14.4	21.5	13.6	30.7	9.9	23.5	19.7	8.6	8.3	11.9	3.1	9.2	10.3	7.9	7.7	8.8	9.9	12.4	10.5	9.8	8.6	7.9	14.2	25.8	12.5	8.5	12.4	11.0	8.5	8.3	10.1	12.6	7.9	6.3	8.0	10.2	7.6	40.6	8.6	12.7	8.8	9.3	25.9	9.2	5.5	12.9	15.7	9.4	5.9	21.1	10.7	7.7	3.0	4.8	3.9	6.2	2.0	3.9	3.0	5.9	11.5	8.9	8.9	5.3	5.2	9.3	5.8	6.4	9.3	8.8	6.9	6.9	15.0	10.0	3.9	7.1	10.6	8.0	5.4	4.2	13.7	7.2	13.2	12.0	6.6	7.4	13.8	26.9	4.7	9.5	8.7	9.4	7.8	6.6	16.5	14.0	8.5	5.3	12.3	16.7	12.8	12.3	7.1	11.2	18.0	6.0	8.5	4.5	8.9	10.6	13.0	6.2	14.7	8.3	9.3	10.6	34.2	6.8	10.1	9.8	8.3	9.3	25.7	18.0	19.8	6.9	10.9	12.0	2.5	3.8	1.1	3.3	6.2	3.9	2.9	2.6	1.9	3.7	3.0	1.3	2.8	3.9	2.0	4.9	4.8	1.7	3.0	14.4	13.6	23.5	19.7	10.5	9.8	12.5	8.5	12.6	12.9	8.9	13.0	8.3	3.2	4.1	20.5	18.1	12.7	4.0	5.7	7.0	5.9	3.8	5.0	4.4	1.2	10.9	4.3	23.3	5.5	4.0	4.9	4.5	17.3	8.3	15.5	33.4	4.7	11.1	26.6	0.4	6.9	22.4	5.0	6.4	4.8	6.1	5.6	3.5	7.4	2.3	16.9	6.5	5.0	5.4	8.9	3.0	2.9	14.9	6.3	4.3
DENND5A	"FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1"	ENSG00000184014	"DENN domain containing 5A"	Q6IQ26	11	9138825-9265390	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052923, HPA055009"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA052923: AB_2681989, HPA055009: AB_2682669"	"unprognostic (5.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (1.14e-6)"	"unprognostic (9.86e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.40e-2)"	26.7	13.0	36.6	18.6	37.2	22.9	15.8	23.7	43.8	20.0	16.8	56.8	9.3	4.4	23.2	16.7	13.8	18.1	19.8	35.2	36.3	31.6	13.1	11.4	22.8	13.4	44.4	20.4	18.2	17.5	18.1	9.2	22.1	35.3	14.5	10.2	13.6	9.0	26.6	12.1	7.3	8.0	32.8	51.0	21.9	10.5	10.4	34.9	7.3	11.5	5.9	12.4	17.9	20.3	1.8	5.1	14.7	9.9	1.7	5.5	2.0	6.5	8.9	24.3	21.7	35.4	32.5	24.3	21.3	31.3	29.4	34.6	8.3	4.9	0.0	9.2	39.1	25.9	5.4	21.7	7.1	36.2	22.4	11.8	2.3	13.5	12.0	20.1	11.2	4.8	25.2	4.9	17.5	25.2	20.5	26.3	7.3	10.7	0.2	30.7	5.0	6.2	7.6	6.9	1.0	9.5	10.6	14.5	0.1	14.0	5.0	5.5	11.4	19.9	9.5	10.6	25.1	5.2	7.3	18.6	23.2	13.8	27.8	15.6	0.5	0.1	5.5	22.6	5.8	17.5	5.3	5.2	6.1	0.3	7.8	0.8	1.8	1.9	1.6	5.1	0.5	5.5	2.6	14.7	1.7	9.9	1.6	0.0	2.0	36.6	37.2	23.7	33.9	36.3	31.6	44.4	20.4	35.3	34.9	17.9	16.4	6.4	16.3	19.3	8.2	29.5	15.3	2.7	7.9	14.0	56.9	13.4	0.0	6.6	0.8	27.9	0.0	0.0	5.8	14.1	32.8	23.5	2.3	9.6	19.2	12.7	6.3	20.9	36.7	1.4	19.8	42.5	18.6	26.2	1.6	10.6	9.4	0.6	19.4	7.7	9.2	25.8	38.1	5.6	10.4	7.2	9.4	4.3	0.6	12.1
DENND5B	MGC24039	ENSG00000170456	"DENN domain containing 5B"	Q6ZUT9	12	31382223-31591097	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 41.3;Cardiomyocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.0;naive B-cell: 4.1;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	5	"B-cells: 4.1;dendritic cells: 2.2"	"Cell line enhanced"	"Detected in many"		"SuSa: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038865	Approved		Approved	Nucleoli,Microtubules		NA	NA			Microtubules	Nucleoli	"HPA038865: AB_2676245"	"unprognostic (5.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.60e-2)"	6.0	9.5	9.9	9.3	16.6	3.1	5.9	24.5	17.8	6.5	8.1	7.9	2.7	12.4	9.7	3.4	3.9	6.0	6.2	14.4	9.3	12.4	10.7	17.0	4.6	9.3	8.7	10.9	30.5	7.9	6.0	12.8	6.9	16.0	4.7	6.3	7.7	3.2	5.0	10.9	2.8	14.6	10.2	6.4	8.9	6.8	20.3	8.4	0.4	4.6	3.2	11.1	6.6	7.3	4.1	2.2	0.6	0.3	0.4	0.2	0.2	1.5	15.2	11.2	4.3	4.1	5.1	1.7	3.7	4.1	9.5	6.9	10.2	6.1	5.6	6.2	8.0	10.4	0.4	2.2	1.0	9.5	0.0	4.7	0.1	12.0	6.1	3.8	5.1	0.1	3.1	3.3	6.3	10.5	8.7	8.7	3.2	2.1	11.5	5.9	1.4	3.0	5.3	11.4	3.5	2.7	2.9	15.5	0.1	8.0	2.0	3.6	5.4	9.3	1.0	8.1	33.8	1.6	2.8	9.0	3.6	9.1	6.4	7.8	6.1	6.8	5.7	6.1	0.6	6.0	0.3	0.3	0.3	0.2	0.1	0.1	4.0	0.1	0.1	0.6	4.1	0.1	0.1	0.6	0.4	0.2	2.2	0.0	0.2	9.9	16.6	24.5	17.8	9.3	12.4	8.7	10.9	16.0	8.4	3.0	0.3	20.1	2.6	2.6	41.3	39.9	20.4	2.7	3.4	7.0	29.5	0.5	3.3	1.4	15.1	5.8	9.9	0.0	8.0	2.5	8.9	2.1	0.0	29.2	3.6	27.0	8.1	23.4	4.3	6.4	7.8	2.5	21.9	3.6	2.3	12.5	6.9	3.4	9.9	11.1	23.4	6.5	8.0	29.0	14.3	1.3	0.6	0.5	2.3	0.9
DENR	"DRP, DRP1, SMAP-3"	ENSG00000139726	"Density regulated re-initiation and release factor"	O43583	12	122752774-122771064	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021783	Approved		Approved	Cytosol		NA	NA		120000	Cytosol		"HPA021783: AB_2670820"	"unprognostic (3.65e-2)"	"unprognostic (7.00e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (2.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (8.57e-6)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-1)"	19.5	23.2	23.3	28.3	23.8	19.3	27.1	21.7	36.8	19.1	20.8	12.0	24.8	20.9	20.8	23.6	33.6	17.8	23.1	20.1	22.5	26.1	22.4	26.2	16.8	28.6	24.9	30.3	19.2	21.6	56.5	23.7	27.9	23.2	23.6	21.2	13.2	24.5	24.9	42.5	23.1	21.8	30.4	16.4	24.5	19.0	11.7	14.8	35.5	24.0	28.4	26.9	22.6	22.2	15.5	15.5	57.7	20.8	14.8	17.7	13.7	34.6	19.6	25.0	25.3	15.7	23.4	21.6	31.6	17.5	27.7	19.3	27.1	12.9	31.0	33.6	22.2	21.5	26.6	29.2	27.6	37.6	28.0	21.0	37.9	11.6	19.3	20.5	42.5	31.5	20.3	27.5	25.5	34.3	26.2	26.8	34.7	39.4	11.5	29.6	22.8	41.8	40.5	50.5	20.7	40.2	37.3	29.3	19.7	26.9	30.7	28.6	20.6	43.9	13.0	32.1	26.2	41.3	23.8	26.0	26.2	31.3	29.5	31.5	18.9	43.7	50.1	24.9	30.9	28.9	57.7	11.7	18.5	13.8	17.2	16.0	15.5	15.0	13.8	15.5	14.0	17.7	15.5	13.9	14.8	20.8	13.8	15.7	13.7	23.3	23.8	21.7	36.8	22.5	26.1	24.9	30.3	23.2	14.8	65.5	34.4	63.8	54.7	63.8	36.1	60.9	28.1	57.6	48.9	45.4	39.3	61.7	54.7	64.0	15.8	42.7	36.0	0.0	53.2	110.1	42.8	48.2	41.6	44.5	50.4	52.4	81.4	37.4	44.5	7.7	46.6	50.8	25.3	55.1	49.0	36.6	67.8	45.6	43.2	53.7	34.1	19.4	47.3	51.6	143.1	56.8	50.7	52.4	54.2	44.1
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6;placenta: 71.5"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 17.8;Extravillous trophoblasts: 18.7;Spermatocytes: 32.0;Syncytiotrophoblasts: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA038255: AB_10669521, HPA072558: AB_2686534"	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.42e-4)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (3.08e-4)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.6	0.6	0.6	3.7	1.5	7.9	0.6	0.8	1.4	1.2	3.3	0.6	0.1	4.8	0.9	0.5	5.2	0.4	19.0	0.4	0.8	0.8	3.3	0.9	1.0	6.9	2.3	0.7	0.6	0.5	0.0	0.3	71.5	1.4	0.5	4.6	0.4	1.3	0.1	0.2	2.1	5.1	0.5	3.2	3.3	2.0	17.0	1.2	21.6	1.5	2.3	7.6	0.9	2.2	1.0	0.6	3.3	0.3	1.4	6.4	0.9	24.0	8.2	25.0	15.2	0.5	0.8	27.4	6.5	4.4	11.5	15.0	13.6	15.3	13.7	16.1	2.0	14.9	8.0	20.0	14.6	15.5	19.5	14.5	17.1	9.4	16.9	0.4	14.4	16.7	0.5	1.5	3.7	5.4	2.2	10.6	14.7	12.2	18.8	10.1	15.1	23.2	12.6	18.4	5.2	13.3	25.8	20.3	11.7	9.3	12.0	13.9	6.4	15.3	5.5	7.2	11.7	10.2	11.5	4.9	4.9	14.4	3.9	16.5	9.5	16.6	27.1	6.1	21.2	13.6	3.3	0.3	1.7	0.5	0.0	0.4	1.0	2.2	1.5	0.6	0.1	0.3	0.3	0.0	1.4	0.0	0.1	6.4	0.9	0.6	1.5	0.8	1.4	0.8	0.8	2.3	0.7	1.4	1.2	0.0	2.6	0.8	0.8	4.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	1.9	0.0	0.3	1.4	0.1	1.7	0.0	0.2	18.7	0.4	0.5	3.5	0.0	5.2	0.0	0.0	0.0	1.2	1.8	0.3	2.2	0.0	0.0	1.0	0.2	0.7	2.0	0.0	0.5	0.0	6.5	0.4	32.0	8.7	1.8	39.2	0.0	6.3	0.3
DEPDC4	"DEP.4, FLJ33505"	ENSG00000166153	"DEP domain containing 4"	Q8N2C3	12	100203669-100267079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 7.5"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 9.9;Late spermatids: 14.1"	"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	7	"naive B-cell: 2.8;naive CD4 T-cell: 2.1;naive CD8 T-cell: 1.8"	"Group enriched"	"Detected in many"	8	"B-cells: 2.8;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA039323	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA039323: AB_10674283"	"unprognostic (8.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.09e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-2)"	0.2	0.6	1.3	0.2	1.0	0.7	1.4	0.2	1.3	0.4	1.0			2.1	0.5	0.7	1.1	0.6	0.6	0.6	1.0	1.2	3.3	2.2	0.3	0.3	1.1		1.3	1.8	1.0	1.2	1.1		1.3	1.4		0.9	1.9	0.3	0.6	0.6	0.2	1.6	0.1	0.9	7.5			0.8		0.2	1.0	0.5	2.8	0.0	0.0	0.3	0.0	2.1	0.0	2.1	3.1	5.7	1.6	0.3	0.7	3.6	2.9	2.1	6.3	3.7	4.8	1.2	2.2	1.9	1.6	1.8	3.3	4.9	2.5	6.9	2.5	5.4	7.9	1.5	5.4	0.7	2.6	3.2	0.6	1.5	2.2	0.5	1.3	1.6	4.1	4.7	1.0	2.8	2.2	1.6	4.7	2.7	2.7	3.2	3.3	5.8	5.3	2.9	1.3	1.6	3.5	1.7	2.3	1.8	3.5	4.7	2.8	0.3	4.3	1.7	1.7	2.3	2.6	2.6	5.0	1.3	2.0	3.5	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	2.8	2.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0											0.0	4.1	0.0	1.0	0.8	1.8	0.8	0.0	2.7	3.4	5.2	3.9	2.9	5.0	0.4	9.9	0.6	0.5	0.0	1.1	1.7	0.9	0.6	0.0	0.4	0.9	0.0	0.0	0.0	0.3	14.1	1.1	0.0	1.7	0.0	0.6	1.0	0.4	0.0	0.0	3.4	3.9	0.0	0.5	4.7	6.6	0.3	1.0	0.0	1.6	0.9
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015864-33033582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 51.8;liver: 42.2"	"Cell type enhanced"	"Detected in many"	17	"Basal keratinocytes: 30.9;Early spermatids: 98.0;Extravillous trophoblasts: 40.1;Spermatocytes: 27.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 27.2;RH-30: 20.6;SiHa: 18.8;U-2197: 17.5"	"Low region specificity"	"Detected in many"							HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol		Yes	No			Nucleoli	"Nucleoplasm, Cytosol"	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.5	2.0	1.4	4.1	0.9	2.0	0.5	2.6	1.7	15.3	4.3	1.2	14.1	1.2	1.4	3.1	0.8	3.1	0.9	2.6	1.4	10.9	42.2	0.7	0.4	4.0	1.5	1.3	2.7	3.5	0.8	1.2	2.8	1.4	3.1	1.2	1.7	1.0	3.3	3.4	51.8	1.0	3.2	0.5	2.2	15.6	3.3	1.8	0.6	2.0	0.9	0.9	2.4	0.0	4.4	9.0	0.7	3.0	3.1	0.6	4.5	2.5	3.7	1.6	2.0	1.9	2.5	8.2	2.7	5.0	6.8	6.7	0.4	0.0	1.9	8.1	2.3	4.7	5.4	1.9	6.0	0.0	7.5	1.3	7.9	9.4	1.6	4.4	5.6	2.4	2.9	2.9	2.1	2.7	0.0	0.0	3.0	0.0	27.2	0.5	0.0	7.1	2.4	3.8	0.0	0.0	20.6	0.0	1.6	0.6	0.8	2.1	18.8	3.3	16.3	2.7	0.8	2.3	0.0	3.2	5.4	17.5	5.2	0.0	0.0	0.0	1.2	0.0	15.9	4.0	0.7	9.0	0.3	0.2	0.0	0.0	0.6	0.3	4.4	0.0	2.9	3.1	0.0	3.0	0.0	1.8	0.0	0.6	2.0	4.1	0.5	2.6	2.6	1.4	4.0	1.5	2.8	3.3	0.0	0.0	0.0	8.3	30.9	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.3	3.3	0.4	98.0	0.1	8.6	0.0	0.5	40.1	1.6	0.8	2.3	19.4	2.7	0.0	3.4	2.5	0.3	6.3	1.4	2.4	1.7	1.8	1.0	0.0	1.0	0.0	1.1	11.2	0.0	0.0	1.4	27.7	7.6	6.5	1.3	0.0	2.1	0.7
DESI1	"D15Wsu75e, FAM152B, PPPDE2"	ENSG00000100418	"Desumoylating isopeptidase 1"	Q6ICB0	22	41598028-41621096	"Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 685.0;Late spermatids: 303.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053415	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Cytokinetic bridge"	"HPA053415: AB_2682141"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.16e-3)"	"unprognostic (8.75e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	12.9	14.5	24.6	12.6	25.4	8.4	13.4	17.0	33.3	11.7	11.9	22.8	9.5	14.5	10.4	15.1	19.7	11.3	11.5	30.3	24.3	19.7	19.5	69.2	14.0	13.2	23.5	16.3	12.7	13.2	15.7	10.0	11.8	18.3	13.4	14.0	9.7	13.2	14.4	14.6	15.9	16.1	14.5	22.4	11.3	12.6	29.2	19.0	9.7	9.7	14.6	16.8	10.8	9.2	6.2	7.4	10.6	12.5	2.8	7.3	5.5	7.0	7.6	7.6	10.4	10.7	12.9	4.3	14.4	9.3	13.4	9.9	10.0	4.5	27.2	10.0	16.6	7.1	10.4	20.1	16.1	14.1	12.2	15.3	6.1	14.1	8.4	13.2	23.9	8.3	11.0	18.8	16.4	15.4	11.0	20.2	9.5	17.7	30.9	10.6	9.0	5.4	7.3	7.5	26.7	11.5	7.4	3.2	27.8	16.8	4.6	5.4	2.8	13.9	15.3	9.8	9.0	5.0	7.8	20.4	9.9	7.2	10.4	7.0	11.4	8.8	13.0	24.6	10.6	13.1	9.5	9.3	10.6	5.0	12.5	6.4	6.2	6.2	5.9	7.4	5.4	5.6	6.5	5.5	2.8	8.2	4.4	7.3	5.5	24.6	25.4	17.0	33.3	24.3	19.7	23.5	16.3	18.3	19.0	8.9	13.9	25.3	26.2	7.7	21.3	44.5	10.2	6.7	9.1	8.7	5.9	24.8	33.2	44.8	685.0	20.4	35.5	0.0	26.0	35.1	19.1	35.6	10.4	60.6	45.6	20.6	18.9	16.0	22.9	303.8	17.5	21.6	13.5	65.9	16.1	16.2	45.9	21.8	9.9	43.5	8.8	25.8	18.2	109.0	21.3	11.5	69.9	20.8	23.8	53.6
DESI2	"C1orf121, CGI-146, FAM152A, FLJ21998, PNAS-4, PPPDE1"	ENSG00000121644	"Desumoylating isopeptidase 2"	Q9BSY9	1	244652935-244709033	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 160.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049950			Approved	Vesicles		NA	NA			Vesicles		"HPA049950: AB_2680969"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (4.52e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.49e-2)"	16.4	13.3	6.4	16.1	12.9	10.5	19.9	17.4	6.5	18.5	19.4	7.6	14.6	10.9	27.7	12.8	14.7	12.4	12.7	27.6	6.5	5.8	9.6	13.5	28.4	11.5	7.7	3.2	16.3	10.0	14.8	11.8	20.4	6.9	14.9	13.1	17.8	12.1	14.8	16.2	11.6	17.5	23.2	6.6	14.3	14.9	49.2	7.4	16.8	25.8	14.5	14.7	16.8	14.4	8.0	4.8	9.1	4.0	3.9	5.6	1.2	24.5	9.2	18.1	15.6	20.8	21.8	22.7	14.3	25.0	14.3	13.2	16.3	11.7	43.8	19.6	17.8	8.3	10.8	22.1	16.2	19.7	14.9	16.2	11.1	6.9	12.2	18.2	19.0	13.4	15.1	22.1	19.0	24.0	13.8	20.0	19.9	16.7	24.4	21.4	4.3	17.4	10.2	41.0	23.3	22.4	12.4	27.4	16.6	10.9	10.3	16.0	21.5	20.3	10.1	17.8	15.2	10.5	14.5	21.7	16.3	17.0	22.0	24.8	24.8	31.9	25.8	13.1	20.6	29.6	4.6	3.0	9.1	4.0	3.9	4.2	8.0	4.2	5.6	4.8	4.7	5.5	5.4	2.5	3.9	4.0	4.2	5.2	1.2	6.4	12.9	17.4	6.5	6.5	5.8	7.7	3.2	6.9	7.4	80.4	41.8	24.3	26.4	49.1	34.2	21.2	28.1	13.4	25.0	17.4	19.6	25.5	18.3	18.2	124.1	27.0	18.6	0.0	29.2	33.3	29.2	39.4	6.9	20.2	21.2	38.1	15.0	23.4	25.4	74.9	32.2	17.4	15.1	26.2	17.8	21.8	26.3	25.9	48.8	13.5	25.0	38.8	32.4	160.4	90.2	36.1	36.2	20.2	25.5	51.9
DET1	FLJ10103	ENSG00000140543	"DET1, COP1 ubiquitin ligase partner"	Q7L5Y6	15	88494440-88546675	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Nucleoplasm, Microtubules"	"Cytokinetic bridge, Cytosol"	"HPA048873: AB_2680541"	"unprognostic (9.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.67e-2)"	6.0	9.3	5.5	4.3	7.0	1.9	6.4	5.5	6.8	9.5	6.3	8.2	7.0	5.5	15.9	9.1	3.8	9.6	7.8	8.8	4.3	4.2	5.4	4.5	4.3	4.2	5.0	6.1	17.9	10.1	7.1	6.4	5.6	5.9	8.5	5.6	12.6	6.7	7.4	13.8	4.4	5.9	11.4	5.1	4.4	5.5	3.6	4.6	10.7	6.8	4.1	6.4	7.7	6.0	5.3	7.6	2.9	7.4	3.4	6.6	3.8	2.0	6.8	9.7	7.1	4.8	7.3	1.9	6.6	7.1	5.8	6.1	1.4	6.5	4.0	5.1	8.4	5.7	3.2	11.0	2.0	5.0	0.3	7.0	7.6	3.8	2.4	7.6	2.9	1.6	6.2	7.3	2.7	7.9	4.9	4.5	4.1	9.5	4.8	7.3	3.2	4.1	3.2	4.4	3.2	2.1	4.8	8.0	4.9	3.0	6.0	3.7	5.9	7.4	2.6	16.6	7.1	3.7	6.0	3.6	5.9	4.6	6.0	6.1	2.8	2.0	2.6	6.6	4.9	5.2	0.0	4.8	2.9	5.3	7.4	3.9	4.8	4.6	4.7	7.6	5.3	6.6	5.4	0.7	3.4	4.6	4.1	5.1	3.8	5.5	7.0	5.5	6.8	4.3	4.2	5.0	6.1	5.9	4.6	3.0	2.4	1.7	2.1	0.6	11.9	1.6	0.0	4.0	1.2	3.5	9.8	5.5	1.7	2.6	0.4	2.1	2.6	0.0	3.3	5.7	3.9	1.2	0.0	2.8	3.7	6.4	2.9	1.3	1.2	0.4	4.0	2.3	3.3	4.6	2.5	6.5	2.5	0.0	3.5	1.9	7.2	0.0	3.1	4.8	8.5	1.1	3.4	0.5	2.9	1.3
DEXI	MYLE	ENSG00000182108	"Dexi homolog"	O95424	16	10928891-10942460	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041511	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA041511: AB_10796675"	"unprognostic (4.14e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.47e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.83e-2)"	15.0	25.2	15.7	8.0	20.8	4.1	10.7	14.0	27.5	12.2	13.9	9.8	12.7	11.1	11.7	18.5	12.9	14.5	11.6	32.2	13.1	13.6	13.3	26.3	9.5	9.9	18.8	12.3	15.9	18.0	22.1	12.9	13.3	21.3	13.6	6.6	13.7	15.4	16.6	81.6	10.3	11.1	12.1	9.4	12.7	10.6	8.9	11.9	13.7	18.4	10.6	8.1	10.9	10.5	4.0	2.4	8.2	0.7	3.9	7.0	1.2	9.5	13.9	7.5	13.2	30.6	16.9	6.9	14.7	15.4	9.7	9.2	6.5	10.0	11.3	22.2	16.6	10.5	12.4	8.8	15.8	8.3	26.6	19.8	5.6	9.1	27.5	17.6	9.6	10.7	17.1	18.3	9.4	11.0	15.7	13.9	16.2	12.8	11.4	10.7	16.8	11.9	10.5	10.5	11.8	14.5	11.1	9.9	17.3	11.9	7.1	15.5	13.6	14.0	15.5	11.7	6.6	12.3	16.8	15.2	9.8	10.5	23.0	9.6	15.1	11.6	3.3	8.6	20.7	11.0	1.7	0.6	8.2	6.0	0.7	5.6	0.6	5.2	7.0	0.4	4.0	6.4	6.0	0.7	3.9	0.3	2.4	3.9	1.2	15.7	20.8	14.0	27.5	13.1	13.6	18.8	12.3	21.3	11.9	6.0	8.9	13.4	27.4	29.7	18.1	0.0	48.4	8.1	2.3	26.2	11.8	20.0	64.6	22.3	6.3	18.5	9.7	0.0	31.5	17.9	28.6	35.2	1.1	87.3	33.0	22.3	14.3	38.1	12.3	11.5	69.6	8.7	15.1	16.2	13.5	38.1	25.7	13.9	80.6	56.2	12.9	19.4	35.5	2.4	2.7	28.4	9.7	18.1	16.8	37.0
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472526	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	17.8	19.9	22.9	15.6	23.0	7.9	20.9	20.4	20.7	16.6	15.1	22.5	19.1	16.5	18.4	14.4	24.2	18.6	15.3	17.2	20.7	19.9	23.7	18.9	15.5	15.6	26.4	18.9	22.5	19.8	25.7	17.2	27.2	26.1	17.0	17.3	15.0	16.3	18.4	16.8	14.8	14.7	22.4	24.1	14.8	16.8	13.4	21.9	16.7	18.0	13.0	21.4	18.7	26.1	14.1	10.7	7.2	9.9	14.1	14.4	8.9	14.6	14.6	12.6	14.3	10.7	10.2	6.1	20.9	13.5	21.8	16.3	34.9	19.4	31.3	13.5	17.6	12.2	12.1	24.3	24.8	22.1	12.4	16.8	15.6	15.2	13.9	17.5	19.0	10.4	12.7	12.5	34.4	27.8	12.0	16.6	15.7	27.8	7.1	15.4	18.6	18.7	8.6	11.0	11.1	17.1	16.1	15.1	15.8	19.6	11.3	14.9	14.5	19.5	17.0	23.0	11.4	10.9	6.6	17.3	10.3	14.0	18.8	13.8	8.8	12.3	45.6	10.9	18.1	15.5	1.3	9.9	7.2	14.4	8.0	10.9	14.1	9.7	12.4	9.2	13.7	10.2	12.3	1.5	14.1	9.7	10.7	13.5	8.9	22.9	23.0	20.4	20.7	20.7	19.9	26.4	18.9	26.1	21.9	41.7	29.3	39.4	29.8	30.6	18.3	22.1	28.1	32.1	35.2	17.4	102.1	83.5	31.5	40.0	25.0	27.1	15.1	0.0	33.8	52.0	19.4	20.0	24.3	27.7	36.5	19.1	32.8	30.7	19.8	58.1	27.9	18.5	10.1	44.1	12.4	21.1	39.9	7.0	30.4	45.1	30.9	19.4	20.0	31.2	30.4	35.5	55.5	24.9	25.7	31.2
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 291.1;Paneth cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.2	2.0	3.6	3.2	1.3	2.3	2.8	2.7	2.6	1.8	9.7	2.6	1.5	10.7	1.7	1.3	3.3	1.6	3.8	0.6	2.8	4.0	2.8	3.4	15.8	2.3	0.7	2.9	1.8	2.9	1.7	1.9	1.8	2.0	4.9	2.2	3.6	1.7	3.2	4.8	3.1	0.9	9.2	17.6	6.3	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	0.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.1	0.4	0.6	1.5	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2	14.9	21.3	6.5	9.8	7.1	24.2	17.9	15.3	4.0	7.9	17.4	27.5	10.2	1.7	6.8	13.4	13.5	291.1	0.0	10.4	8.3	7.1	8.8	6.9	49.5	16.5	17.5	22.4	10.4	25.4	16.4	6.4	15.0	5.0	1.0	70.1	18.1	11.4	112.2	6.3	6.8	21.9	0.0	10.5	25.1	15.9	8.2	13.7	8.5	84.8	18.4
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.3;blood: 68.9;liver: 81.3"	"Cell type enhanced"	"Detected in many"	19	"Early spermatids: 192.0;Hepatocytes: 104.6;Late spermatids: 49.3;Spermatocytes: 45.4;Spermatogonia: 49.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"eosinophil: 26.3;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 68.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.3;HDLM-2: 22.0;Hep G2: 22.9;OE19: 44.2"	"Low region specificity"	"Detected in all"							HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	104.3	1.3	1.9	12.5	6.8	1.7	30.4	0.1	4.2	1.0	11.8	0.6	0.4	3.6	0.5	0.6	6.3	0.7	6.3	6.0	1.0	1.2	1.0	81.3	1.8	16.1	0.6	1.2	0.6	1.3	0.4	0.6	0.5	1.0	1.0	1.4	1.2	9.9	0.6	1.3	34.1	8.1	0.9	0.6	3.7	3.3	13.6	0.5	1.0	2.4	3.9	4.5	4.0	2.7	1.5	1.1	68.9	4.2	0.0	0.0	0.9	4.6	2.3	0.1	4.0	30.3	2.4	0.3	0.4	0.5	0.6	0.3	16.7	4.9	7.4	6.2	0.1	4.4	0.1	0.6	2.3	1.6	22.0	0.4	0.5	1.6	22.9	0.3	2.6	2.6	10.1	12.4	2.7	3.9	1.6	0.4	7.5	0.4	10.1	0.2	3.0	1.7	5.7	1.3	44.2	10.9	0.0	0.0	8.7	0.4	12.9	8.3	0.5	4.2	0.7	1.0	1.0	1.6	9.3	0.5	5.3	2.6	0.1	3.2	5.9	13.2	9.9	3.8	8.4	9.0	3.0	4.2	26.3	0.0	0.8	0.0	1.5	0.0	0.0	1.1	1.2	0.0	0.0	68.9	0.0	0.8	0.3	0.0	0.9	1.9	6.8	0.1	4.2	1.0	1.2	0.6	1.2	1.0	0.5	6.0	4.8	3.4	0.8	1.0	0.6	3.4	0.0	1.4	1.2	0.0	2.0	0.5	0.0	1.4	192.0	0.3	0.4	0.0	0.4	0.1	0.8	2.0	0.0	104.6	2.3	1.6	1.2	1.3	5.6	49.3	2.0	1.7	1.7	0.0	5.0	0.5	2.1	2.6	0.7	1.7	0.0	6.5	0.3	45.4	49.4	6.9	0.7	0.0	3.4	4.2
DGKA	"DAGK, DAGK1, DGK-alpha"	ENSG00000065357	"Diacylglycerol kinase alpha"	P23743	12	55927319-55954027	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.1"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 42.2;hTERT-HME1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041645, HPA045462"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Vesicles	"Nucleoplasm, Mitochondria"	"HPA041645: AB_2677595, HPA045462: AB_2679335"	"unprognostic (1.12e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.02e-2)"	4.9	4.7	7.1	31.8	8.2	9.7	4.8	6.0	10.8	8.4	13.4	3.6	3.1	20.5	6.9	4.1	42.0	4.9	7.9	3.8	4.6	2.4	3.9	1.5	7.6	28.6	2.1	4.1	4.9	6.4	6.2	3.1	10.2	3.3	10.6	11.0	4.1	16.2	5.3	1.0	33.0	27.2	5.7	3.7	23.1	4.8	4.4	2.6	117.1	4.5	9.6	57.0	13.0	15.1	7.6	4.0	5.4	2.8	5.2	30.2	10.9	6.7	4.3	3.0	4.0	7.5	9.8	0.9	15.2	15.6	6.0	4.4	2.0	11.5	3.8	3.6	10.1	2.0	12.4	3.2	42.2	7.2	3.2	0.7	6.1	9.1	1.1	6.5	1.9	6.0	8.4	22.8	8.3	44.8	20.0	12.2	22.7	0.7	5.9	16.1	0.7	12.5	2.4	0.6	5.6	5.1	5.8	1.0	0.6	14.2	19.5	0.5	1.7	5.0	0.2	0.5	8.2	2.7	2.0	10.9	3.9	2.8	0.8	0.5	0.7	0.3	9.2	4.7	5.2	1.1	5.2	2.8	5.4	6.5	2.0	11.7	7.6	24.3	11.7	4.0	6.4	30.2	18.1	5.2	5.2	1.2	4.0	26.7	10.9	7.1	8.2	6.0	10.8	4.6	2.4	2.1	4.1	3.3	2.6	3.0	6.2	15.6	8.5	13.4	0.8	2.0	0.0	0.0	11.4	5.2	0.0	13.4	0.0	4.1	6.5	3.3	38.4	0.0	8.4	4.0	3.8	8.2	6.9	0.0	3.7	0.0	2.4	4.9	4.1	4.7	3.4	10.2	0.0	16.2	7.5	4.9	15.8	6.2	2.8	0.1	0.4	6.5	3.1	3.8	2.7	12.2	22.1	20.6	5.2	18.0
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362237	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.4"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 16.2;Ito cells: 27.6;Muller glia cells: 7.5;Sertoli cells: 12.9;Smooth muscle cells: 16.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.2;HL-60: 6.4;U-266/84: 7.7;U-87 MG: 12.8;U-937: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	3.1	6.9	13.4	3.1	7.1	14.5	1.9	53.4	23.1	2.7	3.5	6.2	1.1	3.0	1.9	14.6	8.5	7.7	2.2	15.0	15.3	7.4	3.1	2.1	4.3	2.1	7.4	11.3	2.0	1.6	4.7	7.5	13.5	25.2	3.1	2.1	7.8	1.9	4.0	2.4	1.4	2.7	5.3	5.6	2.0	3.3	1.2	7.1	0.0	2.5	0.0	2.1	4.8	2.4	0.6	2.9	5.3	4.2	0.0	0.0	1.3	2.7	4.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.4	0.0	2.9	0.2	0.0	0.0	0.0	20.2	0.0	2.7	0.0	2.9	0.0	6.4	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.1	0.1	2.2	0.4	0.0	1.2	1.4	0.0	2.3	0.0	0.0	0.5	0.0	0.8	0.0	1.7	0.0	0.1	4.2	0.0	0.0	0.7	2.1	2.4	0.0	7.7	0.0	12.8	6.0	2.3	0.0	4.2	2.4	0.0	2.4	0.0	0.6	0.0	0.0	2.9	0.3	0.0	0.0	5.3	0.0	2.8	0.5	0.0	1.3	13.4	7.1	53.4	14.7	15.3	7.4	7.4	11.3	25.2	7.1	0.0	1.7	1.5	0.1	0.3	0.0	16.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.2	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	0.0	1.9	1.6	0.0	27.6	2.7	2.0	1.7	2.3	0.0	1.0	0.0	7.5	0.7	0.0	0.4	0.8	0.0	12.9	16.7	0.0	0.0	0.4	0.1	0.0	0.0	0.4
DGKH	DGKeta	ENSG00000102780	"Diacylglycerol kinase eta"	Q86XP1	13	42040036-42256578	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 105.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039533, HPA040355, HPA061538"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: "	"unprognostic (2.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.55e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.43e-2)"	4.9	2.8	3.3	4.9	12.7	2.3	8.3	9.6	6.2	5.2	6.4	3.4	7.9	3.1	9.4	14.0	5.2	5.9	6.8	10.2	9.0	2.7	6.0	6.8	9.5	4.0	3.5	4.0	4.3	4.2	1.4	3.5	8.9	3.6	4.6	6.9	5.5	7.7	4.8	5.8	6.2	5.1	8.3	3.5	6.1	4.0	7.0	4.3	2.2	4.3	2.0	2.9	8.1	6.0	1.4	1.5	4.3	1.3	0.7	1.7	0.2	4.9	5.8	4.8	3.7	1.8	4.1	0.5	3.2	2.5	2.1	2.6	0.5	4.3	3.9	3.9	3.3	7.4	11.0	4.1	7.1	3.2	3.3	11.5	7.0	3.1	0.4	2.3	2.9	2.0	1.5	7.2	4.0	16.4	3.1	9.4	5.1	2.8	2.7	3.6	4.7	3.0	1.6	1.9	4.8	4.0	4.7	3.9	2.7	7.0	15.0	2.7	2.5	2.9	3.7	2.7	1.9	3.4	8.2	9.1	4.0	3.6	4.3	4.3	1.4	1.3	4.5	2.2	2.7	2.8	2.4	1.3	0.6	1.1	0.9	1.2	0.8	1.7	1.7	0.3	1.4	1.0	1.6	4.3	0.7	0.7	1.5	1.1	0.2	3.3	12.7	9.6	6.2	9.0	2.7	3.5	4.0	3.6	4.3	20.8	28.6	1.9	54.1	54.8	48.5	7.1	25.5	69.6	39.8	10.4	3.9	3.3	1.7	10.6	21.9	28.0	13.6	0.0	6.3	1.8	13.3	64.9	7.0	2.6	5.8	1.6	45.5	27.0	7.5	14.9	3.1	16.5	8.5	9.0	22.6	15.5	17.7	14.4	8.5	7.3	2.2	25.8	35.8	2.3	2.6	29.0	2.4	5.1	18.0	105.9
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933682-48944969	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 32.4;kidney: 18.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.8;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	31	"granulocytes: 5.8;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"JURKAT: 6.3;U-266/70: 6.4;U-266/84: 5.0"					"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.3	0.5	1.5	0.1	2.1	0.1	0.2	1.8	1.5	0.1	8.2	0.2	0.1	10.6	0.2	0.4	0.8	0.3	0.8	0.1	2.7	2.0	18.0	0.7	1.9	0.2	0.4	0.4	0.5	0.4	0.2	2.1	1.3	0.6	3.5	0.1	1.2	0.8	0.2	0.3	0.2	32.4	0.1	0.9	1.8	0.7	2.8	0.1	0.4	0.1	0.5	0.7	1.1	0.3	0.1	0.0	5.8	0.0	0.0	4.8	0.5	2.8	0.0	0.2	1.4	0.8	0.6	1.1	0.0	0.4	0.5	1.4	2.7	2.2	0.0	0.5	0.0	1.8	0.8	0.9	2.0	0.9	1.0	2.2	3.9	0.9	1.0	0.0	0.0	0.9	0.5	0.2	1.1	0.0	0.7	0.0	6.3	1.2	0.4	0.0	0.6	0.0	0.2	0.6	4.0	1.8	1.4	0.2	1.9	0.3	0.9	4.2	2.3	0.5	0.3	0.9	0.3	1.9	0.1	0.0	0.0	1.7	0.6	0.1	6.4	5.0	1.6	1.3	0.0	0.4	5.8	0.0	0.9	1.6	0.0	0.8	0.0	1.6	0.7	0.0	0.1	4.8	3.1	0.1	0.0	0.0	0.0	1.2	0.5	1.5	2.1	1.8	1.5	2.7	2.0	0.4	0.4	0.6	0.1	3.0	5.4	0.0	2.6	0.7	1.3	0.4	0.0	0.0	4.5	3.5	0.0	0.1	8.3	1.3	0.5	0.6	1.7	0.0	0.3	0.1	0.5	5.2	1.1	0.0	10.9	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.7	1.5	1.2	2.9	0.0	56.2	4.3	0.0	0.1	0.0	0.6	0.1	0.1	0.0	0.6	2.6
DHFR		ENSG00000228716	"Dihydrofolate reductase"	P00374	5	80626228-80654983	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Methotrexate resistance, One-carbon metabolism"	"Oxidoreductase, RNA-binding"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 163.5;Spermatocytes: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB037129, HPA051465"	Uncertain		Approved	Mitochondria		NA	Yes			Mitochondria		"CAB037129: AB_439683, HPA051465: AB_2681494"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.91e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	17.7	6.1	16.0	11.6	13.9	28.3	10.9	10.2	14.0	7.5	12.6	18.1	11.7	14.5	5.9	9.0	9.8	4.7	6.9	9.7	17.3	14.4	13.1	35.5	8.6	23.2	18.9	9.4	7.5	4.9	9.6	7.2	8.5	13.0	5.9	15.5	8.6	8.0	8.4	10.4	5.9	14.5	7.3	25.3	9.1	7.4	10.5	11.5	13.4	9.2	2.3	22.8	7.9	6.1	2.4	3.3	3.5	2.6	2.1	4.0	2.1	19.8	13.8	35.1	25.9	6.6	7.0	12.9	15.9	12.2	27.8	32.1	13.1	24.0	40.4	7.0	9.2	22.7	14.0	45.1	20.5	45.0	17.9	27.8	19.3	23.0	12.1	1.4	22.5	8.6	4.8	2.1	24.9	2.8	4.7	13.4	29.7	21.7	31.1	28.1	19.9	55.4	9.1	17.7	9.9	8.1	36.0	68.9	40.0	16.0	12.7	28.7	20.0	22.5	10.5	11.4	18.6	20.8	22.3	8.0	8.8	13.4	24.6	30.4	14.6	29.2	43.7	19.7	45.8	22.6	0.8	1.2	1.1	2.3	2.6	1.1	2.1	2.7	3.2	1.9	2.4	2.1	2.7	3.5	2.1	1.7	3.3	4.0	2.1	16.0	13.9	10.2	14.0	17.3	14.4	18.9	9.4	13.0	11.5	6.0	9.4	21.6	5.3	6.2	3.7	13.2	7.6	8.1	6.8	14.0	2.0	13.0	8.3	6.6	4.3	3.6	20.0	163.5	3.3	35.4	9.5	2.1	2.3	41.2	36.1	3.2	4.7	9.2	13.2	4.6	13.0	8.3	0.0	2.8	11.1	10.0	4.3	5.8	15.2	33.5	3.4	12.9	9.0	92.4	48.0	4.8	11.1	10.1	21.0	3.7
DHFR2	"DHFRL1, DHFRP4, FLJ16119"	ENSG00000178700	"Dihydrofolate reductase 2"	Q86XF0	3	94047836-94063389	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 11.9;Ciliated cells: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	13	"hTERT-RPE1: 61.0"									HPA051465	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA051465: AB_2681494"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.30e-6)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-2)"	6.6	8.0	9.7	5.2	10.9	2.2	7.7	5.2	13.2	9.8	6.3	15.2	2.8	5.8	11.7	9.9	5.3	9.4	7.6	5.1	9.8	8.1	10.6	9.3	7.1	7.3	10.2	6.9	15.3	10.8	15.4	13.1	4.5	12.2	9.5	6.7	6.2	6.6	8.9	2.8	5.8	10.1	9.0	12.6	9.4	6.6	8.2	8.6	16.9	10.3	4.8	6.4	7.3	6.2	5.0	4.1	3.8	3.3	2.8	7.3	2.5	1.3	2.1	1.6	1.6	2.3	2.9	0.6	2.1	2.3	1.1	1.2	0.4	2.2	0.9	1.4	1.1	1.4	1.9	1.2	1.5	1.7	3.0	0.7	1.1	1.0	1.2	2.3	0.7	1.3	2.9	2.0	1.2	1.6	61.0	1.1	4.6	0.5	2.1	1.4	1.7	3.9	0.4	1.3	3.9	2.6	1.0	2.1	1.5	1.5	0.7	2.0	2.1	3.1	0.8	3.5	1.3	2.1	1.1	1.7	1.7	2.9	0.7	0.8	1.6	1.5	1.3	1.7	2.0	2.3	3.6	2.2	3.8	3.8	3.2	7.3	3.8	5.1	6.1	1.4	5.0	6.9	6.2	3.5	2.8	3.3	4.1	6.1	2.5	9.7	10.9	5.2	13.2	9.8	8.1	10.2	6.9	12.2	8.6	11.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	16.0	3.4	3.5	0.0	2.0	3.3	4.8	0.0	0.0	0.0	0.0	4.8	1.5	0.0	0.0	2.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.6	0.0	0.0	4.6	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 72.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	5.9	4.2	4.7	8.8	5.1	2.9	5.0	2.7	5.0	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3.0	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4.0	2.6	5.2	3.9	4.8	5.9	6.0	4.4	11.7	4.0	3.0	7.5	4.0	3.5	3.4	4.3	5.4	4.0	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.4	15.5	4.5	7.5	2.4	3.2	8.6	6.4	2.6	9.7	7.5	12.2	6.8	16.8	8.7	3.5	5.4	7.9	8.9	6.9	11.5	3.8	8.4	9.2	7.5	12.0	6.8	12.7	6.8	3.1	7.1	11.7	12.3	3.1	7.0	11.4	14.0	3.1	5.9	19.8	12.0	12.2	10.2	12.7	6.1	15.2	5.9	17.7	5.8	4.9	5.4	6.3	8.6	9.2	4.2	5.8	8.2	6.4	3.0	8.9	5.5	8.4	9.3	5.9	10.9	28.4	4.6	14.0	8.1	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9.0	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5.0	4.3	3.0	4.8	2.7	5.2	5.4	3.0	9.6	9.5	6.4	4.9	5.7	12.1	7.6	9.4	1.2	7.0	3.9	12.0	5.0	6.6	2.1	6.7	0.7	0.0	4.4	9.6	6.0	5.0	8.1	106.1	6.9	3.2	1.2	2.5	5.3	2.3	2.6	3.4	11.8	3.6	4.4	4.8	5.2	2.9	2.1	20.1	4.2	0.0	9.9	7.9	8.0	3.3	2.4	5.0	6.2	4.1
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681902	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	16.4	30.3	26.9	18.6	31.2	17.0	24.8	43.3	38.8	20.7	25.7	27.5	25.3	23.1	20.9	16.9	21.3	32.3	18.2	26.0	26.3	28.0	23.4	30.3	18.9	24.2	27.5	28.0	34.8	32.0	28.8	32.6	23.2	22.4	24.1	24.5	20.2	24.8	24.6	65.1	25.6	21.5	24.5	29.1	19.5	24.2	13.3	26.3	31.9	24.9	22.9	26.9	23.5	19.2	39.6	29.5	35.8	30.5	27.8	38.1	29.7	20.6	15.3	24.8	13.1	11.1	18.5	5.8	13.3	19.5	25.4	25.6	10.9	10.1	21.4	15.1	14.5	23.4	12.6	17.0	18.8	17.6	18.8	12.0	14.3	16.7	14.2	13.7	17.1	22.9	14.8	23.2	15.3	26.5	25.8	17.8	42.8	13.0	15.3	18.5	41.1	30.4	24.8	19.4	27.0	26.0	20.2	9.3	30.9	19.5	11.1	32.4	43.9	13.4	19.5	22.6	15.7	18.0	28.6	8.9	29.9	12.1	29.2	20.2	48.8	52.5	14.5	18.4	21.0	28.2	14.5	27.0	35.8	24.7	24.2	25.9	39.6	28.9	25.6	29.0	36.9	38.1	28.1	9.7	27.8	30.5	29.5	34.3	29.7	26.9	31.2	43.3	38.8	26.3	28.0	27.5	28.0	22.4	26.3	38.7	21.2	44.9	67.5	49.3	77.6	7.7	22.9	34.8	9.1	31.4	43.2	43.4	72.9	48.6	15.6	35.9	36.2	0.0	32.3	43.6	36.5	53.0	23.1	29.4	38.0	39.7	39.6	18.4	36.3	21.8	41.7	38.3	47.2	71.3	54.9	114.9	45.5	63.3	32.5	75.5	92.9	45.3	55.6	29.6	70.0	44.5	60.1	50.3	52.4	59.7
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299833	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000599, HPA076886"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655, HPA076886: "	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.18e-5)"	"prognostic favorable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	6.5	8.9	3.0	6.1	5.0	3.3	7.4	6.3	6.0	8.6	12.0	9.8	8.4	16.1	6.7	8.9	35.7	5.4	10.2	3.7	2.7	3.1	8.5	47.1	6.7	4.8	3.6	5.3	4.2	10.7	11.5	5.2	4.1	6.0	5.5	5.4	7.1	14.0	15.6	1.8	20.8	25.7	4.8	4.4	6.3	6.1	2.8	3.7	5.6	6.6	25.6	16.5	6.0	13.0	10.4	10.7	17.3	9.5	4.2	11.7	4.7	11.1	2.7	2.9	1.1	6.8	7.2	0.7	4.0	8.8	9.5	10.3	1.0	10.9	5.2	1.7	6.2	1.5	9.1	2.2	18.5	4.6	3.5	2.3	1.6	6.5	17.6	3.2	3.1	1.2	6.5	10.9	2.3	1.7	7.7	7.1	4.3	3.2	5.0	7.7	4.5	1.2	1.1	0.5	8.9	4.0	4.0	2.0	7.2	7.3	4.2	2.5	1.9	5.7	7.7	1.9	2.1	3.9	0.9	2.7	0.7	1.8	1.1	1.3	2.8	2.2	2.5	3.4	2.7	0.9	10.0	8.7	17.3	6.9	9.5	7.5	10.4	7.5	6.3	10.7	7.0	7.6	4.2	5.7	4.2	5.9	6.4	11.7	4.7	3.0	5.0	6.3	6.0	2.7	3.1	3.6	5.3	6.0	3.7	20.8	17.9	18.2	23.9	29.2	10.8	13.9	45.9	16.0	18.2	33.2	17.7	40.2	33.2	24.7	15.1	15.7	74.2	0.0	26.8	7.7	17.9	21.4	5.8	70.1	24.0	14.3	18.5	14.1	11.6	27.0	18.7	16.2	43.9	11.8	37.9	14.1	42.2	46.0	19.4	44.2	44.1	25.8	21.7	26.2	9.3	40.0	21.9	26.1	38.6	36.3
DHRS11	"MGC4172, SDR24C1"	ENSG00000278535	"Dehydrogenase/reductase 11"	Q6UWP2	17	36591798-36600806	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"intestine: 88.0"	"Cell type enhanced"	"Detected in many"	16	"Cone photoreceptor cells: 121.7;Enterocytes: 380.9;Paneth cells: 114.5;Undifferentiated cells: 112.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041226, HPA048236, HPA053623"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		11000	Cytosol	"Golgi apparatus"	"HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209"	"unprognostic (2.00e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	1.3	0.6	1.2	4.1	2.4	0.4	0.7	0.5	5.7	0.4	38.7	0.4	0.4	42.7	0.4	0.1	1.2	1.1	1.4	2.0	0.5		2.5	1.7	0.1	0.0	0.0	2.4	0.1	2.8	1.5	0.2	0.0	1.6	0.5	12.4	2.8	2.1	0.8	2.0	0.8	88.0	0.9	0.1	0.0	1.1	2.2	0.3	0.0	1.3	1.3	1.0	0.4	0.0	0.9	0.2	0.9	0.7	0.1	2.7	0.1	6.7	6.0	2.9	7.6	0.6	1.8	5.6	2.0	1.4	6.5	5.9	9.8	5.4	0.7	1.4	2.0	2.7	7.0	6.1	4.2	6.6	3.5	11.6	1.7	5.8	18.9	3.1	2.0	0.6	0.9	3.9	4.5	3.3	1.4	5.0	6.9	15.8	5.9	3.5	5.9	6.5	3.6	2.2	7.9	2.3	8.1	7.1	11.2	6.6	5.7	6.1	2.6	7.2	7.4	16.6	4.7	10.2	1.8	1.8	0.9	9.3	4.9	5.1	9.7	8.1	2.3	3.3	4.8	2.9	0.4	0.5	0.9	1.0	0.7	0.1	0.4	1.0	0.6	0.1	0.9	1.3	0.9	0.5	0.1	0.1	0.2	2.7	0.1											0.0	1.0	1.9	6.8	3.8	17.5	8.4	0.0	1.4	0.0	7.0	121.7	6.4	49.7	8.1	18.9	4.8	380.9	23.3	9.9	3.7	2.7	10.9	0.0	11.5	3.0	15.9	11.6	3.1	2.2	23.8	3.7	2.3	18.6	4.6	59.2	11.6	6.1	114.5	4.9	26.7	62.6	0.0	3.5	26.3	5.2	5.3	5.8	1.3	112.5	13.2
DHRS12	"FLJ13639, SDR40C1"	ENSG00000102796	"Dehydrogenase/reductase 12"	A0PJE2	13	51767993-51804157	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.6"					"Low region specificity"	"Detected in all"			"CAB034238, HPA057028, HPA058315"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678"	"prognostic favorable (1.41e-4)"	"unprognostic (1.98e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.22e-16)"	"unprognostic (2.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.44e-1)"	15.6	6.4	6.9	4.1	7.1	3.9	11.1	5.2	10.9	9.5	7.6	13.8	7.1	5.5	8.4	16.0	7.7	7.5	7.4	8.3	6.0	6.0	14.2	15.8	8.7	4.8	5.8	6.2	10.4	37.6	11.1	10.0	7.3	8.0	7.7	4.7	14.0	11.5	13.0	10.4	10.1	12.2	8.3	7.2	8.3	7.3	3.9	6.5	4.4	10.2	6.9	9.2	6.4	5.7	6.0	4.5	36.3	7.3	1.6	11.6	5.7	0.9	3.1	5.6	7.6	2.5	5.4	5.2	1.7	3.9	2.2	1.2	3.5	15.6	3.9	1.2	3.2	3.5	1.9	0.1	0.8	0.3	3.6	2.7	1.2	1.0	3.2	6.7	0.7	1.1	3.4	6.0	0.7	3.2	7.1	5.2	3.6	1.6	4.4	2.5	4.5	1.5	3.2	6.7	7.0	0.5	0.5	0.7	6.4	8.8	2.6	3.4	7.1	2.6	5.7	6.8	8.3	5.9	3.9	9.1	1.3	1.9	0.3	1.8	2.1	1.5	1.9	4.0	2.1	4.9	2.9	7.3	0.2	6.4	6.2	11.6	6.0	9.9	8.0	4.0	5.6	8.8	6.2	36.3	1.6	7.0	4.5	8.6	5.7	6.9	7.1	5.2	10.9	6.0	6.0	5.8	6.2	8.0	6.5	11.9	15.0	11.1	11.1	10.1	10.7	13.2	17.8	16.0	7.9	15.7	7.9	20.5	44.7	8.8	21.4	11.2	6.8	0.0	14.6	15.3	9.1	9.3	11.5	27.6	14.7	3.2	9.9	8.6	10.7	43.5	10.3	9.4	13.5	9.0	12.3	24.0	14.0	13.1	9.2	51.9	18.3	0.0	12.3	1.6	6.3	13.0	19.9	13.3	11.5	9.2
DHRS13	"MGC23280, SDR7C5"	ENSG00000167536	"Dehydrogenase/reductase 13"	Q6UX07	17	28897781-28903071	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 29.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022991	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA022991: AB_1853865"	"unprognostic (8.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.55e-1)"	2.3	6.0	5.9	5.1	7.9	31.7	5.9	24.9	5.7	6.4	4.5	6.4	9.0	4.1	2.6	6.5	6.7	4.0	3.0	2.7	5.3	10.9	6.9	27.0	4.1	8.6	6.7	5.4	3.6	9.5	8.5	5.3	9.5	9.9	14.9	3.5	5.0	11.8	10.9	1.1	6.8	3.0	3.2	5.6	8.0	5.5	2.8	3.6	4.4	5.5	1.2	8.1	9.2	5.1	4.0	3.1	29.7	3.5	4.6	6.3	3.1	5.6	3.6	8.5	10.8	1.3	1.9	8.3	3.1	4.0	5.7	8.8	11.2	3.4	15.6	5.3	0.6	6.6	5.1	12.0	3.4	2.4	15.7	11.6	8.8	6.7	6.1	3.2	4.4	1.0	1.4	3.1	3.6	3.8	4.0	1.7	11.0	19.7	5.4	1.1	10.2	9.7	7.4	5.2	14.9	0.5	15.5	8.1	12.0	10.5	9.6	12.3	10.3	4.9	34.0	6.6	4.7	22.6	7.2	0.5	1.8	5.6	4.4	4.2	12.6	11.8	9.7	5.4	5.6	4.5	0.4	2.3	1.6	4.8	3.5	5.9	3.6	6.1	6.0	3.1	4.0	6.3	4.6	29.7	4.6	3.3	1.7	5.7	3.1	5.9	7.9	24.9	5.7	5.3	10.9	6.7	5.4	9.9	3.6	3.0	3.4	3.0	11.5	1.3	5.4	0.4	2.5	0.0	3.4	7.0	2.0	21.6	8.3	7.8	10.7	2.9	2.4	46.7	2.4	18.2	1.9	9.4	1.1	3.8	5.2	4.8	2.9	6.7	0.8	3.8	1.1	2.7	5.0	24.4	2.7	6.9	3.2	2.9	0.4	2.9	5.0	6.5	1.4	1.5	12.6	1.5	11.3	5.3	5.7	4.3
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12617731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5"	"Cell line enhanced"	"Detected in many"		"A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	22.7	4.4	6.3	6.2	8.6	2.5	30.6	4.0	7.9	16.7	16.3	3.4	9.2	13.6	7.6	15.5	19.0	12.2	11.2	16.1	6.8	8.6	12.3	45.6	11.6	8.3	9.0	4.5	11.8	20.3	0.5	8.9	11.5	9.8	16.3	5.6	20.3	11.8	14.3	10.2	5.6	18.9	11.1	9.8	4.2	12.3	5.2	4.2	3.1	40.5	5.4	5.2	21.0	9.4	0.2	8.6	2.1	0.3	13.8	33.5	15.6	4.8	27.6	0.0	12.2	16.0	1.3	3.2	1.6	0.0	0.0	0.1	3.3	56.6	0.0	1.3	16.2	4.9	22.3	6.0	3.1	0.0	0.0	9.9	4.3	2.8	15.4	2.4	0.0	0.0	8.1	3.7	0.0	0.1	55.9	5.2	0.1	6.5	0.0	0.1	0.8	1.1	0.2	1.8	5.2	11.2	0.1	0.0	5.6	0.0	9.5	0.3	0.5	9.3	30.4	1.7	3.9	2.9	1.2	3.8	0.1	0.6	8.5	0.1	0.8	0.0	0.0	6.4	0.3	52.5	2.1	0.2	0.0	33.5	0.1	24.2	0.2	18.3	15.7	8.6	0.2	31.6	19.7	1.7	13.8	0.3	1.0	0.5	15.6	6.3	8.6	4.0	7.9	6.8	8.6	9.0	4.5	9.8	4.2	89.3	49.3	3.7	141.7	22.8	0.8	31.9	38.2	58.9	55.7	19.2	17.7	22.8	19.9	81.6	86.2	36.5	70.9	23.3	142.3	39.4	26.7	66.3	15.1	157.8	60.3	0.0	24.1	62.0	40.2	235.9	21.0	19.3	6.8	17.2	30.8	13.7	112.0	49.1	9.2	39.4	2.0	0.0	30.1	1.4	1.4	23.6	22.0	22.3	29.9	124.6
DHRS4	"FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2"	ENSG00000157326	"Dehydrogenase/reductase 4"	Q9BTZ2	14	23953586-23969279	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.21e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.55e-6)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.68e-2)"	15.8	18.5	8.3	10.3	13.7	5.9	15.4	4.4	9.6	11.0	22.2	10.2	12.1	30.3	13.7	11.7	17.2	8.3	16.3	16.3	9.0	6.6	65.8	40.3	12.6	13.6	14.0	7.7	12.6	20.6	7.3	9.7	8.9	9.3	17.0	12.4	12.0	17.5	14.4	25.3	16.6	35.2	14.4	9.6	12.4	12.9	13.5	12.6	6.9	17.1	16.1	11.1	10.0	14.8	9.7	22.0	2.6	25.5	7.9	10.6	14.9	7.7	15.7	5.4	8.8	8.6	9.6	0.1	14.6	7.7	5.8	4.6	3.3	8.3	6.6	7.8	7.2	4.0	9.2	4.3	6.0	5.2	17.8	8.9	4.0	13.2	18.3	5.2	5.7	24.6	9.5	7.5	4.8	10.6	6.6	7.2	9.9	5.9	15.8	7.9	26.3	10.4	5.4	5.3	9.0	15.8	16.9	9.5	21.8	6.0	9.0	10.5	8.8	14.0	9.1	6.9	3.6	8.4	7.7	13.4	7.2	7.6	7.4	4.7	12.1	11.2	1.8	6.3	6.5	7.2	2.4	25.5	2.6	8.9	21.0	10.6	9.7	10.1	8.9	22.0	8.3	10.3	9.9	1.1	7.9	11.1	18.5	8.6	14.9	8.3	13.7	4.4	9.6	9.0	6.6	14.0	7.7	9.3	12.6	14.9	26.2	4.7	9.5	11.1	4.7	30.1	7.6	32.1	31.8	14.0	0.0	8.3	66.3	5.2	39.4	10.8	35.9	0.0	8.6	4.2	11.6	9.3	12.8	64.8	26.6	6.4	18.5	16.0	34.4	43.6	10.3	34.4	5.0	3.6	41.8	12.8	6.6	7.0	16.3	63.7	1.6	6.5	11.3	27.0	2.0	11.7	3.2	14.1	63.5	9.0
DHRS4L2	SDR25C3	ENSG00000187630	"Dehydrogenase/reductase 4 like 2"	Q6PKH6	14	23969874-24006408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 186.0;Proximal tubular cells: 502.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.41e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-3)"	"unprognostic (7.34e-2)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.65e-2)"	6.3	11.2	6.9	12.8	7.9	3.0	11.4	14.6	9.6	7.2	9.9	3.4	2.6	12.1	5.6	10.4	25.5	5.4	4.3	8.9	5.0	4.1	42.0	33.0	16.7	7.2	4.6	2.4	7.1	28.4	6.0	5.2	3.1	7.6	8.3	9.5	5.4	14.2	10.9	18.7	9.8	14.9	6.4	5.6	8.1	7.1	28.2	4.5	13.8	5.9	32.8	14.5	5.3	7.1	10.4	22.3	3.2	27.2	7.9	11.5	14.7	8.5	12.9	2.2	11.0	21.4	22.4	0.2	7.7	15.3	11.3	8.4	3.7	10.1	5.6	5.3	15.5	7.3	9.3	9.9	12.9	9.4	18.2	6.0	1.3	11.2	23.0	15.8	7.1	22.2	23.1	16.4	7.3	10.8	7.8	13.2	17.3	4.3	19.9	12.1	26.9	17.7	7.4	4.4	20.1	14.3	28.0	9.1	17.4	16.2	11.3	12.0	7.2	10.6	9.8	6.4	4.9	11.8	10.7	9.3	6.0	6.2	7.0	3.9	11.6	9.2	1.6	5.2	10.3	8.5	2.3	27.2	3.2	10.1	22.5	10.4	10.4	10.8	11.5	22.3	8.2	11.1	10.1	1.3	7.9	13.2	18.3	10.3	14.7	6.9	7.9	14.6	9.6	5.0	4.1	4.6	2.4	7.6	4.5	14.9	23.5	21.4	38.6	24.6	9.7	15.1	17.8	32.1	23.9	24.4	2.0	16.3	107.8	33.6	16.0	33.7	49.1	23.3	48.9	6.2	41.2	29.1	17.3	186.0	120.7	11.1	35.8	45.4	59.2	31.0	40.6	42.6	49.0	45.9	56.0	58.7	33.6	63.1	35.0	502.2	6.9	32.3	38.1	8.9	1.4	35.1	10.9	27.3	69.8	32.0
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144120-60169856	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 123.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031121, HPA078401"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No		63000	"Nucleoplasm, Mitochondria"		"HPA031121: AB_10600803, HPA078401: "	"prognostic favorable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	15.0	24.6	12.3	10.1	10.9	10.5	17.9	10.6	12.4	11.1	30.6	10.7	57.3	20.7	11.7	19.4	12.3	9.9	15.3	17.4	11.0	11.4	22.6	27.9	13.1	13.9	14.1	8.8	13.4	17.2	40.2	17.2	6.1	17.8	83.4	13.4	9.1	113.7	93.0	123.5	9.8	48.7	9.6	15.5	11.1	32.6	4.9	11.0	6.4	24.8	16.7	10.1	12.4	15.6	26.0	56.6	121.4	32.2	37.3	50.8	54.0	52.6	15.9	9.2	20.2	47.7	18.7	11.7	17.0	43.8	6.2	13.8	8.8	35.7	5.5	10.2	15.9	15.8	22.7	12.0	23.9	9.1	38.3	11.2	13.6	7.8	14.4	25.1	16.1	0.4	13.9	28.8	9.8	33.3	11.1	11.9	14.0	4.1	11.9	15.5	15.9	9.3	15.3	4.3	31.1	16.1	9.7	12.4	6.4	27.7	18.0	19.8	24.8	17.2	26.1	37.7	11.8	18.3	7.1	8.3	30.9	10.5	8.4	9.7	4.2	1.9	9.8	16.8	15.6	21.2	80.1	32.2	71.6	50.8	22.6	49.9	26.0	36.0	43.9	27.1	21.8	20.2	38.9	121.4	37.3	29.0	56.6	29.0	54.0	12.3	10.9	10.6	12.4	11.0	11.4	14.1	8.8	17.8	11.0	50.6	96.5	40.4	57.0	30.2	23.6	16.5	147.7	46.8	59.1	82.0	78.5	22.0	16.6	184.7	1.5	65.9	155.6	0.0	145.2	76.8	60.2	242.6	172.3	147.5	88.2	39.7	44.6	30.1	58.9	2.0	76.2	101.1	102.9	178.5	77.9	88.0	174.5	89.2	79.2	41.6	54.4	84.1	70.6	1.1	3.1	22.2	17.4	135.7	66.0	41.6
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	15.9	17.8	14.0	10.3	14.5	2.5	16.2	11.1	15.2	17.6	14.2	11.9	16.7	14.4	13.5	25.3	12.8	15.4	16.3	17.9	11.8	13.2	23.1	18.4	13.9	14.0	14.5	14.8	11.8	18.9	31.2	11.4	14.2	12.9	14.8	15.2	16.5	17.5	10.5	23.7	15.7	18.3	12.7	11.1	11.5	14.7	30.5	9.1	8.0	19.7	15.8	10.9	10.7	12.8	4.2	11.7	15.0	20.4	4.1	5.7	7.5	8.6	10.2	3.7	8.1	10.0	6.8	6.5	8.2	4.6	6.0	11.0	12.8	9.1	3.6	12.6	7.0	4.7	12.2	5.4	13.5	8.5	6.9	17.6	5.0	7.5	11.0	5.5	2.7	3.7	5.3	9.0	7.7	11.7	3.0	5.8	6.4	3.0	4.5	7.0	17.7	3.0	10.8	5.2	28.1	4.4	5.0	9.9	6.3	20.0	10.5	2.0	4.4	10.2	9.1	8.8	31.4	6.1	5.7	2.9	5.0	3.5	15.1	9.3	2.5	3.8	6.7	7.9	10.3	7.5	9.7	18.9	15.0	3.8	17.9	3.4	4.2	3.8	2.5	11.7	3.6	4.1	3.6	13.5	4.1	20.4	5.0	5.7	7.5	14.0	14.5	11.1	15.2	11.8	13.2	14.5	14.8	12.9	9.1	14.9	14.9	16.4	24.6	14.4	20.5	12.2	25.5	28.1	14.8	27.9	29.5	44.8	14.9	40.1	48.5	21.9	30.7	23.3	34.3	26.4	19.3	22.8	8.1	16.3	25.9	17.5	6.9	28.8	12.3	16.2	20.8	11.7	18.6	19.8	19.0	29.9	27.5	22.4	32.9	21.4	35.7	6.5	16.9	44.2	20.3	16.3	43.1	16.6	21.2	17.9
DHX29	DDX29	ENSG00000067248	"DExH-box helicase 29"	Q7Z478	5	55256245-55307722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038317, HPA038318"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA038317: AB_10673169, HPA038318: AB_10672589"	"unprognostic (3.43e-2)"	"unprognostic (5.09e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.01e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.78e-3)"	"unprognostic (9.40e-2)"	14.6	16.2	15.1	12.2	16.6	9.8	16.3	22.0	16.9	17.3	18.4	9.2	20.2	11.3	17.4	12.8	18.5	13.6	11.7	22.1	12.8	9.6	22.4	20.6	15.2	11.8	13.7	11.9	13.8	15.3	30.3	30.7	17.7	16.3	18.9	13.3	7.8	15.2	24.3	31.8	15.9	14.7	18.5	13.1	14.3	14.8	10.2	16.6	15.6	20.9	12.0	11.9	19.9	14.4	18.5	25.9	32.4	19.6	16.0	18.8	6.3	22.1	15.6	13.0	17.2	21.5	18.0	16.0	23.7	18.7	17.4	18.1	12.7	14.5	13.0	21.6	26.5	22.8	16.4	20.5	23.0	25.0	5.2	11.6	11.9	14.5	8.9	12.3	7.9	12.7	15.8	14.2	18.6	11.2	12.2	22.9	10.6	14.5	9.9	20.8	15.3	13.9	8.0	11.1	6.4	17.5	6.8	20.5	21.4	15.1	15.3	12.1	8.3	23.4	12.9	11.7	13.7	18.3	14.7	20.0	16.0	13.5	14.3	17.2	9.5	14.3	17.6	19.7	13.8	18.0	32.4	16.3	15.9	13.5	16.4	15.1	18.5	16.9	15.0	12.1	17.6	18.8	15.8	15.2	16.0	19.6	25.9	13.9	6.3	15.1	16.6	22.0	16.9	12.8	9.6	13.7	11.9	16.3	16.6	65.5	35.2	25.3	32.1	33.4	77.9	67.4	48.4	33.5	66.0	61.1	39.3	58.7	46.4	45.2	32.2	35.9	31.5	93.5	53.9	43.6	42.1	40.8	30.1	40.5	36.0	39.7	36.9	21.5	25.0	13.6	43.1	37.1	27.0	36.1	33.2	34.7	50.0	25.9	49.8	84.5	77.5	51.8	44.2	87.3	127.3	41.5	68.0	27.7	35.1	33.6
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	10.4	7.3	9.7	6.9	14.6	13.9	9.8	9.7	14.3	12.2	23.2	14.8	10.7	9.9	19.7	13.9	13.9	12.5	9.2	16.9	9.0	5.8	10.4	7.5	8.7	12.6	8.2	6.7	13.9	6.5	12.1	13.5	8.4	10.9	13.3	14.3	12.4	10.4	12.6	12.5	11.1	12.4	14.7	9.9	8.4	13.4	12.5	9.4	12.1	8.5	7.6	11.2	15.9	11.8	4.6	6.7	2.0	4.9	5.8	8.2	4.4	7.3	4.5	12.0	4.9	4.6	6.0	8.5	4.4	7.9	10.2	7.8	21.2	7.2	8.5	7.9	8.4	7.9	11.7	8.3	13.0	10.1	2.1	4.1	11.3	10.1	12.0	5.5	13.1	5.9	7.0	8.4	9.0	8.4	6.3	4.5	14.5	11.4	4.9	5.4	6.0	21.4	10.1	6.9	13.4	9.9	10.5	17.5	6.8	3.7	8.5	10.6	8.3	12.1	7.3	11.2	7.8	10.0	10.8	4.4	14.7	8.1	5.8	9.2	4.9	6.4	8.8	8.6	6.0	7.6	0.0	4.9	2.0	5.3	4.5	5.2	4.6	4.5	5.6	6.7	4.3	8.2	4.3	1.0	5.8	3.8	2.4	2.8	4.4	9.7	14.6	9.7	14.3	9.0	5.8	8.2	6.7	10.9	9.4	0.0	3.0	0.8	1.2	0.5	5.8	4.8	5.1	4.0	4.5	1.8	3.9	3.1	1.7	2.5	2.9	2.4	3.3	0.0	1.0	2.0	2.4	2.1	8.1	5.5	4.3	4.8	5.2	5.5	3.7	0.4	5.8	3.1	3.3	2.8	6.2	2.6	1.7	2.9	6.0	1.7	4.6	0.0	2.3	1.7	10.0	1.8	2.5	1.7	4.4	1.0
DHX37	"DDX37, Dhr1, KIAA1517, MGC2695, MGC4322"	ENSG00000150990	"DEAH-box helicase 37"	Q8IY37	12	124946825-124989122	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047607	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA047607: AB_2680101"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.54e-10)"	"unprognostic (2.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.73e-1)"	9.5	9.2	8.6	12.7	12.1	29.6	9.3	5.7	12.1	8.9	7.9	11.8	6.0	10.2	11.6	6.5	11.2	9.8	10.7	12.4	7.3	5.4	7.4	10.7	8.2	13.3	11.6	7.4	12.7	14.4	4.7	5.7	6.7	10.5	8.7	5.7	5.6	9.1	7.3	22.7	15.8	9.5	7.7	7.5	12.2	9.1	6.8	11.1	7.8	8.9	9.7	11.5	9.7	13.6	4.3	1.6	0.2	2.5	1.4	2.5	1.4	7.4	21.5	3.8	11.8	3.8	4.3	9.7	2.6	3.9	8.6	6.9	27.1	5.2	18.3	10.0	3.1	11.5	10.4	9.9	5.8	3.1	15.8	18.4	9.0	12.2	10.7	5.4	11.8	16.3	4.0	6.6	14.9	2.4	3.4	5.0	9.3	18.9	5.1	5.1	11.0	16.7	12.4	13.8	8.0	13.0	12.3	3.7	9.1	3.7	17.0	6.7	3.3	7.0	7.6	5.7	2.7	8.5	10.5	5.9	10.0	7.5	14.2	17.3	11.7	14.7	18.1	6.6	6.9	12.5	0.0	0.6	0.0	1.5	2.0	2.2	4.3	1.8	2.5	1.6	0.2	0.9	0.8	0.2	1.4	2.5	1.2	0.9	1.4	8.6	12.1	5.7	12.1	7.3	5.4	11.6	7.4	10.5	11.1	3.0	6.9	8.2	2.2	3.8	2.6	3.2	0.0	2.7	4.5	0.0	0.0	3.7	3.3	4.3	1.5	3.6	3.3	0.0	5.3	4.8	3.5	3.1	5.8	6.0	4.6	12.7	8.6	1.8	6.9	1.5	4.9	4.5	0.0	6.4	6.7	2.0	7.2	0.0	2.5	3.9	1.8	6.5	2.7	1.4	5.6	3.4	2.4	4.4	7.3	2.8
DHX57	DDX57	ENSG00000163214	"DExH-box helicase 57"	Q6P158	2	38797729-38875934	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 120.8;Late spermatids: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036160	Uncertain		Approved	"Nucleoli,Intermediate filaments,Microtubules,Cytosol"		NA	NA			"Intermediate filaments, Microtubules"	"Nucleoli, Cytosol"	"HPA036160: AB_10670711"	"unprognostic (6.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.77e-1)"	9.6	11.2	9.7	8.5	16.7	7.0	10.4	11.9	16.4	14.1	9.4	9.9	9.8	4.2	13.9	17.1	8.4	11.2	9.5	9.3	9.6	11.0	11.2	7.2	7.9	9.2	8.9	9.5	13.2	9.5	18.9	17.9	11.2	13.1	10.5	9.2	11.6	7.8	14.2	11.5	11.1	6.9	11.8	7.7	9.9	7.9	27.7	8.3	13.9	11.8	8.1	11.1	10.5	8.3	7.1	5.2	1.7	10.1	3.3	6.0	4.2	16.9	13.6	15.3	11.5	10.1	12.4	12.5	11.8	11.7	11.2	11.1	10.9	5.2	5.0	11.9	12.0	12.7	8.8	17.2	13.1	18.5	20.5	12.7	9.7	9.2	14.9	9.1	10.2	5.6	11.8	7.9	14.5	9.1	7.9	14.9	3.7	12.4	7.1	12.1	12.4	10.2	9.4	19.0	7.3	8.1	5.1	20.2	9.8	10.3	6.5	12.6	18.6	11.8	12.2	13.8	11.2	8.6	5.6	11.5	11.2	13.0	8.5	12.7	7.4	8.3	2.1	8.7	7.1	7.4	1.7	10.1	1.7	4.5	6.9	6.0	5.7	4.0	3.5	5.2	7.1	4.8	3.0	0.5	3.3	8.0	1.7	3.3	4.2	9.7	16.7	11.9	16.4	9.6	11.0	8.9	9.5	13.1	8.3	3.0	7.5	8.2	2.2	2.4	23.0	5.9	5.1	28.1	13.6	22.7	53.0	6.0	0.0	6.9	120.8	4.3	1.6	23.3	6.4	5.8	5.6	1.6	10.4	5.7	6.1	17.5	11.3	9.2	13.6	273.7	14.7	9.5	1.7	5.4	5.5	11.2	6.9	3.5	13.1	4.9	28.3	0.0	3.9	15.2	6.4	2.3	2.4	6.9	5.1	1.3
DHX58	"D11LGP2, LGP2"	ENSG00000108771	"DExH-box helicase 58"	Q96C10	17	42101404-42112733	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"monocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;SK-MEL-30: 14.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018670, HPA019570"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA018670: AB_1847665, HPA019570: AB_1847666"	"prognostic favorable (3.45e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-3)"	12.7	16.3	6.7	15.3	7.8	11.1	9.8	2.8	8.4	7.9	9.8	9.6	15.0	8.2	9.6	16.2	8.7	12.0	12.6	5.3	6.5	5.3	11.0	20.9	21.7	14.4	5.9	9.0	12.9	7.4	4.3	9.6	7.0	8.2	10.6	5.0	13.4	18.0	17.1	6.9	7.8	10.5	9.2	7.9	17.1	9.1	10.7	5.1	17.2	7.5	5.6	12.9	10.9	7.6	6.4	7.6	8.6	12.0	7.6	7.1	5.9	1.2	0.0	0.0	0.7	6.2	5.4	0.2	1.7	11.9	24.6	28.8	0.1	7.7	0.1	1.8	2.8	5.6	1.0	0.1	1.9	0.9	4.8	0.1	2.0	1.1	0.4	7.0	1.8	4.6	8.7	3.2	2.1	2.1	4.3	2.9	12.5	0.0	6.8	1.3	0.0	11.0	2.3	0.2	0.3	0.0	4.0	0.0	0.5	2.7	4.5	0.2	0.0	0.8	3.1	14.0	0.0	4.2	1.9	1.2	1.2	0.0	0.4	0.6	2.3	1.9	0.1	2.5	1.7	1.3	3.1	9.9	8.6	4.5	12.0	6.5	6.4	6.4	4.0	7.6	4.9	7.1	5.3	4.0	7.6	10.5	2.5	5.5	5.9	6.7	7.8	2.8	8.4	6.5	5.3	5.9	9.0	8.2	5.1	8.9	4.3	2.7	4.8	1.3	0.6	0.8	5.1	8.1	6.8	7.0	0.0	2.8	1.7	4.9	5.4	4.5	2.4	0.0	6.0	2.8	2.8	5.0	1.1	10.5	8.8	0.0	0.0	5.5	6.0	8.3	8.1	5.0	3.3	65.9	2.8	2.0	5.1	4.9	8.5	3.8	0.6	0.0	2.3	9.6	0.7	1.4	0.7	7.7	1.6	1.8
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43544463	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA049285: AB_2680698"	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	21.9	18.6	17.5	17.0	22.9	47.8	22.3	21.6	29.8	20.3	21.0	25.3	17.2	17.1	26.1	28.4	26.6	17.9	16.7	18.5	18.1	18.7	18.5	20.1	19.8	21.0	20.8	19.7	19.5	17.4	35.4	23.0	21.7	22.7	22.1	24.6	20.1	21.7	21.7	25.2	32.9	22.0	24.6	19.2	27.3	19.5	34.6	20.6	40.8	20.5	17.8	28.9	19.4	22.6	11.5	16.3	23.3	20.4	9.5	14.9	9.8	12.5	35.7	19.4	24.1	19.4	19.8	10.7	13.2	27.9	29.2	28.1	16.2	12.8	17.4	12.3	25.9	21.0	17.0	29.1	23.2	34.3	18.2	23.0	14.7	27.2	25.1	16.6	25.5	22.4	9.9	19.7	24.0	26.4	14.1	25.9	22.9	16.3	17.2	22.6	13.7	32.3	22.7	15.8	15.3	13.7	19.7	37.0	17.9	19.8	26.4	16.8	25.3	14.8	8.5	11.8	24.4	19.8	25.2	17.6	22.8	12.4	16.4	19.7	12.9	15.3	19.7	18.9	15.9	18.2	23.3	15.2	17.2	13.7	20.4	13.6	11.5	11.4	14.9	16.3	10.6	11.2	10.9	19.2	9.5	19.6	8.4	11.7	9.8	17.5	22.9	21.6	29.8	18.1	18.7	20.8	19.7	22.7	20.6	6.0	12.9	15.2	5.8	10.5	15.7	11.9	12.7	12.0	22.7	21.0	17.7	7.9	11.6	14.1	16.1	13.5	8.9	0.0	15.3	7.0	11.1	7.5	13.9	13.1	9.6	6.4	25.6	12.9	13.3	8.1	11.5	12.0	16.9	17.2	13.1	10.1	15.6	11.5	10.3	10.1	18.6	19.4	11.1	24.9	14.5	11.7	17.7	16.0	10.2	14.4
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000284934	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207662-122227534	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 17.0"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 21.4"									HPA001825	Uncertain		Approved	Mitochondria		NA	NA		21000	Mitochondria		"HPA001825: AB_1857247"																		0.1	8.7	0.0	3.8	0.0	0.0	0.0	0.0	0.5	0.2	5.3	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0		0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.9	2.4	0.0	1.2	0.6	1.1	0.6	0.6	2.3	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.5	0.4	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.7	0.0	0.4	1.9	21.4	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.7	0.5	0.3	1.4	0.6	1.0	0.3	1.0	2.3	0.6	1.2	0.3	1.3	1.1	0.6	0.2	0.4	2.2	0.5											0.0	1.1	2.9	4.0	4.4	7.1	0.0	10.2	0.0	1.2	0.0	3.9	0.0	0.0	0.2	4.3	1.9	8.8	0.0	0.0	0.0	2.4	3.1	4.6	2.8	0.0	3.2	7.0	4.3	1.9	3.9	5.2	0.8	3.3	0.0	7.8	7.2	0.2	9.7	3.2	0.0	9.1	6.5	4.1	17.0	15.2	4.3	0.0	5.0	9.3	3.3
DIAPH1	"DFNA1, hDIA1, LFHL1"	ENSG00000131504	"Diaphanous related formin 1"	O60610	5	141515016-141619055	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	Actin-binding	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 106.8"	"Low region specificity"	"Detected in all"							"HPA004916, HPA076913"	Approved		Approved	"Plasma membrane"		NA	NA		10000000	"Plasma membrane"		"HPA004916: AB_1847668, HPA076913: "	"unprognostic (6.79e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.65e-1)"	14.5	10.0	5.2	22.3	10.4	27.9	10.6	8.8	7.8	11.6	17.1	3.9	11.4	14.2	9.9	16.8	26.5	9.1	15.7	21.3	5.1	6.3	30.1	48.7	22.4	21.7	3.8	4.3	9.7	20.2	17.6	22.1	28.2	7.2	7.8	11.0	8.8	18.0	13.8	79.8	19.1	24.1	9.6	3.4	20.2	15.5	12.1	2.9	44.2	14.9	23.8	34.1	12.3	13.3	5.9	8.6	19.2	9.3	8.2	22.7	9.3	25.7	16.7	9.7	12.8	7.8	10.5	13.4	10.6	11.3	12.4	13.0	57.1	24.7	28.8	16.3	15.6	19.7	28.8	21.6	36.1	15.7	15.5	12.0	49.8	22.1	18.6	7.4	34.6	106.8	6.7	19.2	17.8	18.0	5.7	16.2	44.1	17.5	20.3	12.2	25.2	38.4	45.2	9.6	13.6	11.1	43.2	16.0	15.9	23.8	28.5	12.9	6.9	26.3	35.0	10.5	9.1	14.6	16.8	9.4	17.5	9.3	9.6	21.5	10.2	16.2	20.0	9.5	27.8	10.8	12.7	8.6	19.2	22.7	9.2	15.2	5.9	14.4	17.6	8.6	5.0	10.5	17.3	9.4	8.2	9.3	6.6	11.9	9.3	5.2	10.4	8.8	7.8	5.1	6.3	3.8	4.3	7.2	2.9	44.7	41.4	32.0	39.1	46.8	17.7	17.9	22.9	24.1	60.3	41.8	51.1	15.3	5.0	57.1	16.9	35.0	40.0	0.0	84.2	26.5	20.2	67.6	45.1	77.8	16.2	6.4	5.2	9.2	34.1	6.8	10.9	53.5	18.6	17.2	18.0	10.9	93.8	28.1	10.3	13.0	72.6	12.9	19.6	15.4	23.7	52.1	43.6	55.8	23.9	92.4
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 117.7;Syncytiotrophoblasts: 99.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	25.3	5.7	8.2	16.5	13.6	19.9	12.0	1.6	4.6	17.8	18.5	2.9	15.1	5.5	10.7	9.1	16.3	10.4	12.6	13.0	6.6	3.0	6.1	15.7	16.8	6.9	4.1	4.4	14.2	6.6	8.7	5.5	37.2	7.1	16.0	11.4	4.7	9.4	17.2	19.9	9.3	12.0	18.5	7.3	9.8	9.9	12.3	5.1	9.4	7.5	12.0	4.9	19.8	26.9	2.7	4.3	5.7	5.8	1.4	2.8	1.0	0.0	4.0	1.9	3.9	11.1	18.5	0.0	7.0	7.4	3.8	8.0	3.3	7.6	11.3	5.6	6.0	7.2	0.0	10.4	1.1	4.9	0.3	5.9	0.0	4.9	3.6	9.3	14.6	5.2	9.3	3.7	5.0	15.8	5.1	7.3	8.5	0.0	9.4	7.0	3.2	5.5	6.0	15.4	0.0	5.9	0.0	10.5	0.0	2.1	6.0	0.0	4.0	0.0	2.0	5.6	12.5	1.7	8.0	9.1	8.1	3.7	6.7	4.5	0.1	0.0	9.5	6.8	14.9	4.7	0.0	5.8	5.7	2.3	5.4	1.8	2.7	2.4	2.8	4.3	2.4	1.6	1.5	0.6	1.4	4.5	4.1	1.3	1.0	8.2	13.6	1.6	4.6	6.6	3.0	4.1	4.4	7.1	5.1	29.8	42.7	10.6	4.8	9.6	5.7	19.0	7.6	42.8	18.2	19.2	0.0	41.5	6.6	16.9	60.0	25.2	23.6	0.0	20.1	14.6	25.5	6.7	7.0	23.1	17.8	0.0	23.6	8.0	30.6	117.7	41.7	21.4	8.5	6.4	27.6	12.5	26.4	35.1	19.1	6.1	14.0	25.8	18.6	4.9	12.2	15.9	99.0	12.5	28.1	4.8
DIDO1	"BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333"	ENSG00000101191	"Death inducer-obliterator 1"	Q9BTC0	20	62877738-62937952	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004374, HPA049904"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			Nucleoplasm	"Vesicles, Cytosol"	"CAB004374: AB_2093108, HPA049904: AB_2680944"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (9.92e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.82e-2)"	25.1	15.9	19.7	21.5	21.3	22.8	26.9	38.1	23.2	29.7	24.0	27.0	26.7	18.4	33.2	26.9	20.7	29.2	27.0	23.2	17.9	14.7	18.2	18.3	22.9	27.5	22.9	18.8	37.4	21.4	28.0	25.1	30.6	17.6	24.3	19.2	27.0	26.3	25.5	27.6	34.0	25.2	27.5	17.5	25.8	21.2	24.1	23.1	35.1	25.1	20.5	29.6	26.1	35.6	9.7	8.6	20.9	7.6	10.1	15.3	7.1	11.7	9.1	15.3	8.7	7.9	9.7	8.2	8.9	7.6	33.3	9.7	39.0	12.3	11.7	12.4	10.9	19.3	18.5	13.9	17.3	21.6	6.4	9.4	16.8	15.0	27.8	10.0	15.0	17.4	10.0	23.8	11.5	6.5	7.6	9.1	22.5	16.4	10.7	8.4	11.4	30.3	13.2	12.2	14.4	13.3	21.5	19.6	7.4	5.5	10.5	18.9	11.2	17.9	17.4	11.7	9.6	17.3	17.2	11.3	27.2	19.0	9.0	12.6	7.1	4.6	15.6	12.4	7.6	9.8	20.9	5.6	15.1	12.9	7.6	13.3	9.7	11.3	12.3	4.1	8.2	15.3	14.1	8.6	10.1	5.8	8.6	9.0	7.1	19.7	21.3	38.1	23.2	17.9	14.7	22.9	18.8	17.6	23.1	23.8	26.7	14.9	30.5	21.5	23.5	22.9	17.8	49.5	23.9	24.4	31.4	23.6	19.9	15.5	30.5	21.1	20.9	0.0	12.0	13.2	18.7	23.2	22.0	17.4	12.1	36.5	18.5	19.6	13.2	7.9	32.5	16.3	20.3	17.2	22.7	15.8	17.0	21.0	31.8	9.2	22.1	6.5	17.6	18.9	31.8	22.3	16.5	26.1	20.8	28.8
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197527-80387757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 67.7;thyroid gland: 128.7"	"Group enriched"	"Detected in many"	14	"Extravillous trophoblasts: 495.6;Muller glia cells: 220.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 26.7;fHDF/TERT166: 14.7;HeLa: 30.6;HHSteC: 15.2;SiHa: 55.9;SK-BR-3: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048002			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA048002: AB_2680230"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.67e-4)"	"prognostic favorable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.3	1.8	13.0	0.9	12.3	0.7	6.1	1.0	19.7	67.7	1.2	1.6	1.9	1.2	15.6	1.1	36.1	0.9	2.5	4.7	14.2	2.7	2.4	0.7	1.2	1.0	4.1	7.6	0.7	1.3	0.9	35.9	5.9	13.2	5.0	1.3	13.1	17.7	12.4	3.0	3.3	1.2	2.4	1.2	0.9	2.5	2.5	1.4	0.0	128.7	15.8	12.0	2.6	13.7	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.4	0.0	26.7	5.7	2.4	0.3	0.0	0.1	0.0	0.1	14.7	0.1	0.5	0.9	0.0	1.9	0.0	0.0	0.0	30.6	0.0	15.2	0.0	0.0	1.7	0.0	0.5	0.0	1.3	0.5	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.5	0.0	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.0	55.9	11.7	0.1	2.5	0.0	0.0	0.3	0.1	2.4	5.6	6.7	0.9	0.0	0.0	2.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	13.0	12.3	1.0	19.7	14.2	2.7	4.1	7.6	13.2	1.4	0.0	0.3	0.0	0.1	2.6	2.9	1.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	18.5	1.4	0.0	0.0	0.0	495.6	26.0	0.2	0.0	0.0	8.2	1.6	0.0	0.6	1.0	9.6	3.1	0.3	5.0	0.0	0.0	220.7	0.6	0.0	3.9	0.0	6.2	0.0	8.2	3.3	0.6	2.6	23.6	0.0	0.0	0.0
DIP2A	"C21orf106, Dip2, KIAA0184"	ENSG00000160305	"Disco interacting protein 2 homolog A"	Q14689	21	46458899-46569852	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 110.0;Rod photoreceptor cells: 214.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052516	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052516: AB_2681859"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.35e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-3)"	10.8	12.6	9.8	18.1	15.0	16.7	13.1	17.1	14.6	10.5	10.3	20.6	8.6	12.5	11.8	7.6	14.3	11.7	9.0	15.4	11.0	7.5	7.5	5.9	10.5	12.5	14.1	10.7	12.1	13.0	10.8	12.6	10.9	14.7	13.7	7.8	15.1	14.1	9.1	18.3	12.9	13.6	9.5	11.4	15.8	13.8	16.9	13.3	16.0	10.2	7.4	11.3	14.9	11.4	4.0	10.4	11.5	6.5	9.3	15.7	4.0	12.5	8.2	16.0	7.5	7.6	7.0	9.9	8.7	6.9	8.7	7.2	14.4	9.7	5.3	8.3	9.1	8.8	6.6	7.0	11.7	5.1	20.5	10.1	18.0	13.4	8.8	5.0	6.5	9.4	6.2	8.0	9.1	9.8	6.6	12.6	10.3	11.6	12.2	7.2	11.3	10.0	9.9	8.7	11.0	8.7	10.2	6.6	10.6	5.3	11.4	8.6	5.5	13.4	8.8	7.7	4.4	9.4	6.4	17.1	7.1	5.1	10.1	6.5	12.6	6.3	5.0	7.7	11.0	11.9	8.1	5.4	11.5	15.7	6.3	9.9	3.2	6.9	10.4	2.9	4.0	5.0	9.7	10.4	9.3	6.5	10.4	5.6	4.0	9.8	15.0	17.1	14.6	11.0	7.5	14.1	10.7	14.7	13.3	38.7	19.2	13.7	8.6	13.1	54.6	23.8	12.7	6.7	20.5	14.0	110.0	8.3	8.3	9.1	14.6	29.2	18.8	0.0	9.4	6.6	14.1	16.4	12.7	9.5	15.0	17.5	23.1	31.9	37.8	18.2	22.2	16.5	6.8	11.8	21.1	15.4	14.7	14.4	20.8	6.8	214.6	25.8	9.0	36.4	28.8	15.4	9.4	23.6	20.0	12.9
DIP2B	"FLJ34278, KIAA1463"	ENSG00000066084	"Disco interacting protein 2 homolog B"	Q9P265	12	50504985-50748667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038472, HPA046133, HPA056045"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA038472: AB_2676033, HPA046133: AB_2679551, HPA056045: AB_2683019"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-3)"	8.6	12.2	20.3	11.2	33.0	14.3	14.2	37.7	25.6	10.0	12.4	35.9	5.3	8.3	8.6	5.1	17.1	6.3	9.5	7.6	24.5	17.2	8.4	14.7	9.0	11.9	35.2	17.4	13.2	10.2	21.4	8.9	13.9	24.8	9.3	14.6	9.0	11.1	6.2	6.7	22.6	8.3	9.7	35.6	18.4	9.3	9.9	34.4	11.4	11.2	6.4	15.1	9.0	10.4	3.9	2.5	7.7	5.6	0.9	3.1	1.2	13.7	8.6	13.0	9.1	7.5	7.3	18.0	7.9	9.4	7.8	5.9	15.3	7.8	9.3	9.6	8.8	8.0	14.5	20.8	15.2	9.2	10.7	7.4	14.7	7.3	19.4	11.7	17.6	9.0	8.2	13.2	8.7	12.7	13.6	14.7	8.6	20.3	9.0	6.8	11.0	13.6	8.9	7.4	8.0	15.0	15.9	12.7	4.5	8.8	11.0	12.2	8.5	19.8	11.8	12.2	15.8	16.6	12.4	14.8	6.3	7.4	5.7	6.5	6.5	10.7	11.0	8.8	8.2	8.6	1.7	2.0	4.3	0.7	2.3	1.2	2.5	1.8	0.7	2.5	3.9	3.1	2.5	7.7	0.9	5.6	0.7	1.6	1.2	20.3	33.0	37.7	23.2	24.5	17.2	35.2	17.4	24.8	34.4	6.0	8.0	14.5	21.8	48.8	26.2	8.5	15.3	4.0	4.5	8.7	60.9	11.0	0.0	8.9	1.4	14.6	15.5	0.0	14.9	15.4	8.7	29.0	10.4	16.6	16.5	11.1	30.1	14.7	25.2	2.2	9.5	12.8	15.1	7.2	20.1	15.6	16.0	14.4	9.6	4.5	31.3	0.0	6.8	11.2	18.4	58.5	31.8	6.9	10.2	19.5
DIP2C	KIAA0934	ENSG00000151240	"Disco interacting protein 2 homolog C"	Q9Y2E4	10	274190-689668	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.8;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030264, HPA059325"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA030264: AB_10600903, HPA059325: AB_2683979"	"unprognostic (1.72e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.10e-3)"	15.4	8.1	19.9	5.0	25.0	0.9	9.9	23.0	24.7	12.6	20.8	21.2	6.4	6.2	14.1	7.8	12.2	9.1	11.3	17.3	16.3	10.1	19.2	11.5	6.7	3.4	21.7	14.4	18.1	10.4	10.4	7.4	6.3	16.5	11.5	6.3	13.0	5.6	12.7	38.2	5.5	7.3	16.1	14.9	4.5	8.3	9.4	23.1	0.0	7.3	2.9	2.5	11.6	13.0	3.8	0.5	0.1	0.3	0.3	1.3	0.4	0.4	4.0	7.5	4.0	12.7	13.9	6.2	8.9	5.6	6.8	5.6	1.1	1.2	0.3	2.4	14.3	1.8	0.1	4.6	0.7	4.2	0.2	4.1	0.1	2.7	1.2	6.2	0.0	5.6	11.3	3.6	4.3	0.0	10.8	1.5	0.1	0.0	0.8	5.1	10.9	0.4	0.0	1.9	3.4	1.6	6.2	3.1	1.2	4.9	4.6	3.8	5.4	1.5	3.2	12.8	4.1	4.3	0.0	0.1	7.3	1.9	21.7	2.9	0.5	8.6	4.6	9.2	0.2	4.1	0.0	0.3	0.0	0.4	0.0	0.4	2.6	0.8	1.0	0.0	3.8	1.2	1.3	0.1	0.3	0.0	0.5	0.5	0.4	19.9	25.0	23.0	24.7	16.3	10.1	21.7	14.4	16.5	23.1	8.9	4.3	3.7	4.5	7.0	18.1	25.0	22.9	8.1	6.8	3.5	21.6	4.4	0.0	6.9	11.0	6.0	2.8	0.0	3.5	3.4	12.1	4.9	19.7	21.7	4.7	1.6	10.4	8.0	3.5	3.8	10.6	2.0	21.9	1.0	4.1	20.4	6.5	0.0	18.4	14.7	18.0	6.5	17.8	21.3	16.5	3.3	3.2	1.0	6.1	8.1
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045896-68051631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 49.9;ovary: 33.2;pituitary gland: 35.2"	"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 16.7;Distal tubular cells: 54.7;Exocrine glandular cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 49.9"	"Group enriched"	"Detected in some"	18	"plasmacytoid DC: 2.1;T-reg: 1.8"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.5;HSkMC: 15.7;TIME: 9.7;U-251 MG: 7.9;U-87 MG: 15.2"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favorable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.0	10.2	2.0	0.2	49.9	0.0	2.4	0.9	2.9	2.3	1.6	1.0	0.0	3.4	1.2	5.4	1.3	1.3	5.9	5.7	1.3	8.7	3.2	4.5	2.3	0.0	1.3	1.1	33.2	9.9	8.8	35.2	0.0	17.3	2.3	0.1	2.4	1.3	1.1	1.0	1.1	1.2	0.3	1.7	1.2	1.9	2.4	0.5	0.0	1.6	0.3	0.1	1.2	1.9	0.0	2.1	0.0	0.0	0.0	1.8	0.0	0.0	1.3	1.4	0.0	4.8	3.6	0.5	4.0	1.4	0.3	1.1	0.0	0.7	0.0	0.2	4.2	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.6	0.0	7.5	0.0	0.0	15.7	0.1	0.6	0.0	0.0	0.9	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.1	0.5	0.1	0.0	9.7	0.0	0.4	0.2	7.9	2.5	0.0	0.0	15.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	0.0	2.0	49.9	0.9	2.9	1.3	8.7	1.3	1.1	17.3	0.5	0.0	2.6	0.0	16.7	2.9	0.6	4.8	10.2	1.4	3.4	3.5	9.8	0.7	54.7	2.0	0.0	0.6	0.0	0.0	17.0	0.1	10.6	3.2	0.0	2.6	0.1	0.0	15.5	1.8	0.0	0.0	6.4	0.2	5.0	0.0	0.3	0.7	3.6	0.0	1.4	5.0	5.6	0.0	2.6	0.0	0.2	2.5	0.3	0.0	0.6	2.1
DIRC1		ENSG00000174325	"Disrupted in renal carcinoma 1"	Q969H9	2	188734155-188790104	"Disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 5.9;gallbladder: 2.1"	"Group enriched"	"Detected in some"	7	"Early spermatids: 1.8;Late spermatids: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 24.7;HSkMC: 9.0"									HPA068508			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068508: AB_2732783"	"unprognostic (3.11e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.80e-2)"			"unprognostic (2.77e-1)"		"unprognostic (2.28e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"			"unprognostic (7.39e-4)"			"unprognostic (6.95e-2)"	1.4	0.0	0.0	0.4	0.0	0.0	5.9	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.7	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	24.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
DIS3L	"DIS3L1, FLJ38088, KIAA1955, MGC4562"	ENSG00000166938	"DIS3 like exosome 3'-5' exoribonuclease"	Q8TF46	15	66293217-66333898	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041805	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Centrosome	"HPA041805: AB_10796783"	"unprognostic (2.57e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.40e-1)"	13.7	15.4	18.7	14.7	16.6	11.8	14.5	15.7	16.4	13.7	11.8	20.7	19.1	9.0	14.7	15.5	10.6	15.5	10.0	20.1	17.3	17.0	14.2	15.2	10.8	14.0	19.4	10.8	16.2	24.4	24.9	18.9	9.0	17.7	14.7	10.3	15.4	14.4	16.3	29.4	9.4	9.0	15.2	19.6	11.1	10.5	15.4	14.0	19.3	18.0	9.4	12.8	12.5	9.7	9.1	10.5	7.8	13.1	14.1	13.2	8.0	8.6	19.6	5.9	7.8	7.4	10.1	8.3	6.4	7.0	9.5	8.0	9.6	5.8	30.6	7.0	7.7	8.4	14.6	14.6	5.1	7.0	8.0	13.4	18.0	12.7	10.9	5.6	17.4	6.3	4.1	5.8	2.6	8.5	5.5	7.3	9.9	10.4	7.4	8.5	6.3	7.8	10.2	9.3	6.9	10.8	11.7	25.5	17.9	3.1	9.8	10.1	9.8	13.0	4.3	7.2	5.9	6.4	11.6	9.5	11.0	10.4	4.5	11.0	6.5	20.3	14.7	3.7	23.0	4.4	7.8	5.9	5.1	9.9	7.1	12.8	8.5	9.5	13.2	10.5	9.1	11.6	9.6	0.7	14.1	13.1	7.5	8.8	8.0	18.7	16.6	15.7	16.4	17.3	17.0	19.4	10.8	17.7	14.0	6.0	14.4	12.9	4.8	3.8	15.3	28.6	17.8	10.7	9.1	3.5	3.9	14.6	5.0	4.9	5.0	7.1	4.3	0.0	3.1	3.8	8.8	4.7	16.1	15.7	8.3	9.5	2.9	3.7	8.2	7.9	18.4	10.3	1.7	10.0	8.9	16.6	3.3	5.8	19.1	8.4	19.5	19.4	8.5	27.9	15.2	4.6	3.1	10.4	13.5	2.7
DISC1		ENSG00000162946	"Disrupted in schizophrenia 1"	Q9NRI5	1	231626815-232041272	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 105.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 12.4;TIME: 9.7;WM-115: 9.9"					"Low region specificity"	"Detected in all"			HPA048911			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA048911: AB_2732549"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	5.3	3.3	9.1	6.4	10.6	5.3	7.6	2.5	7.6	4.9	3.1	11.6	0.0	2.6	4.2	1.6	3.1	2.9	5.6	19.2	9.2	5.9	2.7	3.1	3.9	11.3	10.5	4.8	9.6	2.1	2.7	2.8	14.3	9.2	3.9	2.9	13.1	4.0	2.4	3.2	2.9	3.1	3.4	10.2	6.1	2.4	2.2	9.3	4.2	4.1	2.5	3.9	4.5	7.2	0.5	3.3	2.6	2.9	0.7	1.6	0.7	0.0	0.5	4.5	0.1	0.1	0.4	3.3	1.7	4.1	4.8	4.0	1.6	1.0	0.1	5.4	1.5	1.1	0.0	0.4	0.1	4.2	2.8	1.9	2.4	0.4	4.4	0.6	4.0	6.0	2.5	0.8	1.5	1.3	3.2	4.2	3.1	0.0	1.8	5.2	0.4	1.1	6.1	2.3	0.0	1.7	3.0	1.3	0.5	0.2	0.0	0.8	2.5	1.6	0.0	2.7	1.2	0.0	12.4	9.7	2.5	2.6	1.2	1.0	1.1	0.8	0.0	1.9	6.2	9.9	0.3	2.7	0.1	0.9	2.9	0.5	0.1	1.4	0.3	3.3	0.5	1.6	0.5	2.6	0.7	1.2	1.9	0.5	0.7	9.1	10.6	2.5	6.3	9.2	5.9	10.5	4.8	9.2	9.3	0.0	1.4	0.0	0.5	0.8	10.7	4.6	0.0	1.4	1.2	3.5	7.9	6.0	0.0	0.6	12.9	5.3	0.0	0.0	1.0	0.6	3.3	0.4	6.9	0.0	9.3	0.0	0.0	9.8	13.5	17.3	0.9	8.9	3.3	0.0	0.0	2.5	1.4	0.0	1.4	0.0	105.2	0.0	1.3	0.4	1.1	1.0	2.1	3.1	0.2	0.5
DISP1	"DISPA, DKFZP434I0428, MGC13130, MGC16796"	ENSG00000154309	"Dispatched RND transporter family member 1"	Q96F81	1	222872271-223005995	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 12.7;Collecting duct cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 15.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051411	Uncertain		Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"HPA051411: AB_2681475"	"unprognostic (2.10e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-1)"	"prognostic favorable (5.00e-4)"	"unprognostic (4.13e-1)"	"prognostic favorable (3.86e-5)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (4.16e-4)"	"unprognostic (9.69e-3)"	8.3	7.7	2.7	3.8	8.5	0.1	3.9	2.5	2.9	3.8	10.3	4.2	6.7	3.3	5.9	11.5	6.9	3.1	24.0	4.9	3.3	3.1	7.9	8.1	33.3	1.5	2.6	2.1	6.5	3.2	6.9	3.9	6.9	6.6	14.2	2.9	9.2	2.5	4.0	4.7	4.2	4.8	18.8	2.1	4.9	6.9	28.1	2.7	0.7	7.5	5.1	2.5	12.3	3.3	3.1	1.4	0.1	1.2	2.5	4.4	1.1	0.6	2.2	5.8	3.8	11.5	7.9	2.6	3.9	2.7	1.6	2.3	2.6	1.8	0.3	4.3	1.7	2.7	0.5	1.7	1.0	1.8	7.2	2.8	1.0	8.4	1.2	5.2	0.8	0.9	5.3	3.4	2.7	1.4	7.0	2.4	1.4	0.1	0.1	3.8	1.3	1.1	1.1	3.5	7.3	1.3	1.8	15.9	0.2	8.7	1.0	1.5	2.6	1.7	0.9	2.1	3.0	3.4	1.9	2.2	2.3	1.6	4.1	4.2	1.1	0.6	0.4	3.7	0.7	5.3	0.0	0.7	0.1	2.6	1.2	4.4	3.1	1.5	2.9	1.4	2.4	2.0	1.3	0.0	2.5	0.9	0.7	0.7	1.1	2.7	8.5	2.5	2.9	3.3	3.1	2.6	2.1	6.6	2.7	6.0	1.7	0.9	0.5	0.5	2.8	3.3	12.7	4.0	4.5	10.4	0.0	1.2	0.0	1.6	1.7	1.4	1.7	0.0	2.3	1.5	4.9	0.5	0.0	3.4	4.8	0.0	0.0	8.0	1.0	3.1	1.4	3.5	0.0	1.0	1.7	1.2	1.3	1.7	3.2	4.6	2.0	0.0	1.4	1.9	1.5	1.0	0.7	1.3	1.1	0.1
DISP2	"C15orf36, DISPB, HsT16908, KIAA1742, LINC00594"	ENSG00000140323	"Dispatched RND transporter family member 2"	A7MBM2	15	40358235-40378639	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 37.2"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 15.6;Enterocytes: 12.9;Horizontal cells: 17.5;Mucus-secreting cells: 14.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.2;HaCaT: 8.1;SCLC-21H: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059903	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059903: AB_2684156"	"unprognostic (3.43e-4)"	"unprognostic (7.65e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.47e-8)"	"unprognostic (1.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	0.8	2.5	9.0	1.5	7.6	1.3	0.6	37.2	14.5	0.7	4.0	1.0	0.0	3.4	0.9	0.9	0.7	1.1	1.1	0.8	9.0	7.0	0.5	0.7	0.9	1.5	2.9	14.0	1.3	1.4	0.6	2.8	1.0	11.4	0.8	3.9	0.3	1.2	1.8	0.8	1.3	3.0	1.4	2.0	1.1	3.9	2.4	1.8	0.0	3.4	0.0	0.6	1.2	0.4	0.9	1.1	2.9	0.4	1.1	0.6	0.2	1.5	0.6	0.4	2.5	0.1	0.1	0.9	0.2	0.1	1.0	1.5	2.3	0.7	0.2	1.7	0.9	5.2	8.1	0.3	1.3	0.6	0.2	0.5	0.4	0.5	0.1	0.0	0.5	1.5	1.8	0.0	0.3	0.2	0.3	0.5	0.9	0.6	1.0	1.3	0.3	0.2	0.4	0.4	2.0	1.1	0.2	0.4	0.5	0.3	2.1	16.7	2.4	0.3	0.2	0.2	0.5	0.4	0.2	0.5	1.2	0.9	0.2	0.2	0.3	0.2	0.3	0.4	0.7	2.3	2.1	0.4	0.5	0.6	0.3	0.4	0.5	0.4	0.4	0.2	0.9	0.5	0.6	2.9	1.1	0.4	1.1	0.4	0.2	9.0	7.6	37.2	14.5	9.0	7.0	2.9	14.0	11.4	1.8	3.0	5.1	0.0	2.0	0.0	15.6	1.4	2.5	4.0	7.9	3.5	9.8	0.2	0.0	0.3	0.9	1.0	12.9	0.0	0.3	0.2	0.8	1.1	8.1	0.0	0.8	17.5	9.2	0.6	0.0	1.5	1.1	0.9	0.0	0.0	14.1	1.7	0.2	2.9	0.0	0.0	7.2	0.0	0.4	4.2	6.6	0.0	0.2	0.0	4.8	1.0
DKKL1	"CT34, SGY-1"	ENSG00000104901	"Dickkopf like acrosomal protein 1"	Q9UK85	19	49361783-49375116	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 91.5"	"Group enriched"	"Detected in some"	39	"Early spermatids: 1802.9;Late spermatids: 1817.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 4.1"	"Lineage enriched"	"Detected in single"	42	"B-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"AF22: 7.3;AN3-CA: 13.8"	"Group enriched"	"Detected in many"	17	"amygdala: 27.1;basal ganglia: 15.6;cerebral cortex: 50.1;hippocampal formation: 25.1;olfactory region: 20.8"	"Low region specificity"	"Detected in all"			"CAB025410, HPA047194"	Enhanced		Approved	Vesicles	"Secreted in male reproductive system"	NA	NA			Vesicles		"CAB025410: , HPA047194: AB_2679979"	"unprognostic (1.64e-1)"	"unprognostic (5.30e-1)"	"unprognostic (5.39e-4)"	"unprognostic (1.85e-4)"	"unprognostic (3.79e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.52e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.57e-2)"	0.2	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.4	0.5	0.3	0.4	0.2	0.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.2	0.1	0.3	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.0	91.5	0.0	0.0	0.0	0.2	0.1	0.3	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.3	13.8	0.1	0.5	0.6	1.4	0.0	0.2	0.4	0.0	0.6	0.0	1.0	0.3	0.5	0.1	0.2	0.0	0.0	0.0	2.6	0.0	3.5	0.3	0.0	0.0	1.2	1.0	0.4	0.2	0.5	1.3	1.2	0.0	1.4	0.6	0.1	0.6	0.0	0.1	2.9	0.7	1.5	0.1	0.1	0.1	0.0	0.0	0.0	3.0	1.2	0.0	0.7	1.5	1.4	2.7	1.7	1.6	0.9	1.0	0.0	0.6	0.8	0.3	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	1802.9	1.0	0.0	0.0	0.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1817.6	15.5	0.0	1.7	0.0	0.1	2.2	0.4	0.0	11.3	0.0	0.1	6.5	0.3	46.8	10.9	0.0	0.0	0.0	0.0	0.1
DLC1	"ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12"	ENSG00000164741	"DLC1 Rho GTPase activating protein"	Q96QB1	8	13083361-13604610	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 232.3;Alveolar cells type 2: 178.8;Ito cells: 219.1;Sertoli cells: 219.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 6.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.5"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 19.1;hTERT-HME1: 14.0;HUVEC TERT2: 19.2;U-138 MG: 13.7;U-2197: 18.9;WM-115: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017753	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA017753: AB_10600805"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.79e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.67e-1)"	33.9	8.0	8.5	8.8	15.4	4.9	31.9	3.1	11.4	13.6	13.1	16.0	2.0	6.1	12.4	7.4	8.6	10.4	13.1	15.1	10.0	7.3	9.2	24.1	32.4	5.6	18.0	6.8	8.0	6.3	6.3	4.4	22.3	16.2	5.7	4.5	13.6	4.9	4.1	7.6	5.4	8.5	18.7	15.0	16.6	11.1	5.5	16.5	0.0	12.0	6.1	2.9	17.1	17.2	0.0	0.2	6.5	1.3	0.0	0.1	0.0	0.0	0.1	1.7	0.0	12.5	7.1	6.0	0.6	0.1	0.3	0.6	3.9	2.4	0.0	0.2	11.9	5.5	2.0	1.0	1.7	1.1	0.0	0.9	0.3	0.0	4.2	6.5	0.0	3.6	5.5	0.1	19.1	14.0	0.5	19.2	0.0	1.0	0.0	5.7	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	6.0	0.0	0.8	0.0	0.2	6.3	6.5	0.0	0.0	1.9	13.7	7.5	18.9	4.5	0.0	0.0	0.0	10.6	0.0	13.9	6.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	8.5	15.4	3.1	11.0	10.0	7.3	18.0	6.8	16.2	16.5	232.3	178.8	4.3	2.6	13.2	0.5	31.1	22.9	5.3	35.2	3.5	0.0	6.3	1.7	3.0	6.6	118.2	1.0	0.0	3.9	1.5	53.2	1.2	63.8	21.3	3.0	12.7	1.2	219.1	20.0	2.5	67.0	4.3	23.6	0.0	0.1	1.0	3.9	0.2	33.9	1.3	1.6	219.9	63.1	4.9	11.7	8.2	2.3	0.7	0.4	1.8
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		16000000	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	40.1	32.6	18.1	31.1	26.0	23.0	20.5	23.1	19.5	26.9	20.9	38.0	22.6	39.3	39.9	24.5	44.0	26.7	36.3	32.6	40.7	26.2	21.6	27.6	43.2	27.1	20.0	45.4	28.5	26.2	23.7	28.6	15.6	17.1	32.3	33.0	68.9	29.3	29.2	45.1	37.1	32.9	21.5	48.5	23.7	26.8	29.0	53.3	36.8	60.0	22.5	23.8	37.8	64.0	34.0	37.6	24.4	38.9	20.4	29.8	24.4	57.9	35.1	22.2	42.3	26.4	28.0	48.5	30.7	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7	26.8	16.5	23.1	30.6	27.8	45.9	284.8	61.1	37.5	18.2	75.0	21.6	94.8	192.3	59.5	3.8	30.0	47.9	46.7	49.3	49.9	26.3	23.6	26.5	77.8	61.0	20.6	29.4	27.6	36.8	5.6	21.6	34.1	35.4	65.9	39.3	31.3	37.7	56.1	39.6	134.4	33.4	25.8	43.4	41.2	52.4	28.2	90.6	27.7	64.6	28.5
DLG2	"chapsyn-110, PPP1R58, PSD-93, PSD93"	ENSG00000150672	"Discs large MAGUK scaffold protein 2"	Q15700	11	83455012-85627922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.7"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 223.8;Cone photoreceptor cells: 259.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;CACO-2: 4.7;NTERA-2: 5.2;SCLC-21H: 5.2;SH-SY5Y: 7.8;SK-BR-3: 4.7;SuSa: 6.6;T-47d: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021307, HPA023896, CAB072341"	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353"	"unprognostic (2.61e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.44e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.61e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.84e-1)"	"unprognostic (7.66e-6)"	"unprognostic (2.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.89e-2)"	1.4	11.0	20.0	1.4	30.7	0.7	2.5	9.3	44.7	2.4	1.7	39.5	0.6	1.5	3.3	4.4	7.8	6.0	2.3	2.8	19.9	9.9	3.7	2.8	1.9	1.3	28.7	21.2	6.2	3.3	14.6	7.9	2.7	25.7	4.3	1.5	2.9	3.1	5.4	1.2	19.5	1.5	2.6	19.7	2.6	1.5	6.6	37.3	0.0	15.6	0.0	2.9	1.5	2.1	1.3	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.1	0.0	0.1	0.2	1.4	0.0	0.0	0.0	0.1	0.0	4.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.1	5.2	0.0	0.0	0.0	0.7	0.4	0.0	0.0	5.2	7.8	0.0	4.7	0.0	6.6	19.3	0.0	0.0	0.3	0.9	0.2	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.2	20.0	30.7	9.3	34.9	19.9	9.9	28.7	21.2	25.7	37.3	3.0	7.2	0.0	3.1	3.0	223.8	7.2	0.0	1.4	3.4	7.0	259.2	6.2	8.3	0.7	16.5	2.8	0.9	0.0	0.4	0.4	3.3	2.5	0.0	3.8	3.0	22.3	4.1	0.6	0.3	12.1	7.2	0.0	1.7	1.0	0.1	17.1	0.3	0.0	6.0	2.3	52.8	6.5	1.9	8.1	3.3	7.4	1.7	1.0	0.4	0.9
DLG3	"KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102"	ENSG00000082458	"Discs large MAGUK scaffold protein 3"	Q92796	X	70444861-70505490	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"OE19: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001733, HPA078130"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001733: AB_1078675, HPA078130: AB_2686879"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	"prognostic favorable (1.72e-10)"	"unprognostic (3.36e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-3)"	2.7	3.3	12.5	6.5	17.6	0.7	10.8	16.4	25.2	9.2	16.0	4.3	14.7	11.7	7.6	23.7	14.5	17.4	16.3	6.0	15.2	10.0	10.8	1.4	7.8	3.1	6.5	10.2	11.2	27.1	21.2	8.9	5.5	8.0	9.6	17.1	10.2	21.0	10.4	1.1	8.4	20.8	11.3	3.4	14.6	13.8	1.9	3.5	3.2	13.8	2.6	8.0	11.2	9.9	0.4	0.0	0.0	0.0	1.7	2.4	0.3	3.4	1.6	9.9	4.2	2.6	3.1	6.9	2.0	2.3	1.1	1.1	9.8	8.1	0.0	4.8	2.0	0.8	7.5	19.2	4.5	0.7	4.0	5.8	0.0	8.8	5.3	5.0	0.1	1.3	3.2	3.0	1.4	3.2	10.2	0.4	6.6	1.8	13.8	1.1	12.1	7.8	0.0	16.7	28.0	11.6	7.3	4.9	1.4	6.7	10.6	4.7	0.3	1.6	19.2	3.7	8.6	10.1	0.0	0.7	1.3	1.3	1.2	1.5	9.1	6.8	4.3	1.9	0.0	1.9	0.0	0.0	0.0	2.1	0.0	1.8	0.4	1.7	2.4	0.0	0.0	1.1	1.8	0.0	1.7	0.0	0.0	2.4	0.3	12.5	17.6	16.4	25.2	15.2	10.0	6.5	10.2	8.0	3.5	17.9	16.1	3.2	4.8	0.7	15.6	16.7	25.5	32.1	12.5	8.7	0.0	5.5	10.0	11.9	0.0	0.3	27.4	0.0	21.3	2.0	5.0	15.9	1.1	0.0	0.6	4.8	24.6	1.8	0.3	0.0	1.4	1.3	1.7	2.8	22.3	10.3	21.5	17.3	6.0	3.7	5.8	6.5	5.1	0.4	1.7	1.8	1.4	3.8	17.2	9.0
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 28.7"	"Cell type enhanced"	"Detected in some"	11	"Early spermatids: 11.5;Hofbauer cells: 7.8;Horizontal cells: 20.6;Late spermatids: 13.7"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 1.0;glioma: 1.5;ovarian cancer: 1.9;testis cancer: 5.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 9.6;NTERA-2: 5.2;SCLC-21H: 15.5;SH-SY5Y: 3.0"	"Group enriched"	"Detected in all"	4	"amygdala: 128.4;basal ganglia: 124.0;cerebral cortex: 122.6;hippocampal formation: 84.0;thalamus: 55.9"	"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		NA	NA			"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	1.3	1.5	17.4	1.8	20.0	2.8	1.1	14.6	28.7	0.9	1.2	3.3	0.0	1.4	1.0	1.0	0.9	1.0	1.1	1.0	17.7	5.5	1.3	1.0	1.1	1.4	5.4	9.6	1.0	2.2	1.0	1.9	1.0	2.3	1.0	1.0	0.7	1.1	1.5	1.0	1.1	1.3	1.0	1.1	2.5	1.3	6.7	5.0	0.0	1.0	0.0	1.2	1.0	0.0	0.3	3.2	0.4	2.3	0.1	0.8	0.9	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	9.6	0.2	0.0	1.2	0.0	1.6	0.0	0.0	0.2	0.2	0.7	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.6	0.0	0.0	5.2	0.0	0.0	0.5	0.0	0.2	0.0	0.5	15.5	3.0	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.1	1.7	0.0	0.0	0.2	0.3	1.9	0.1	0.1	0.1	0.4	2.3	0.0	0.2	1.4	0.8	0.3	0.5	0.5	3.2	0.3	0.2	0.8	0.0	0.1	0.1	0.9	0.7	0.9	17.4	20.0	14.6	22.4	17.7	5.5	5.4	9.6	2.3	5.0	0.0	0.0	0.0	0.6	0.2	4.0	1.1	0.0	0.0	0.0	1.8	3.9	0.1	3.3	0.4	11.5	0.1	0.8	0.0	0.5	0.2	0.2	0.2	0.0	0.0	7.8	20.6	1.2	0.0	7.3	13.7	0.9	1.0	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.7	2.2	0.0	0.1	2.7	3.4	0.3	0.0	0.8	0.7	0.1
DLGAP4	"DAP4, KIAA0964, SAPAP4"	ENSG00000080845	"DLG associated protein 4"	Q9Y2H0	20	36306336-36528637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054105, HPA056378"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA054105: AB_2682381, HPA056378: "	"unprognostic (1.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-2)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (1.23e-1)"	"prognostic favorable (9.88e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	18.8	16.6	25.7	14.3	32.9	4.5	18.0	16.2	31.9	19.0	20.1	9.0	14.9	13.5	23.1	13.1	16.8	18.5	17.0	25.9	23.7	12.7	10.2	11.0	21.6	9.8	9.5	20.7	18.9	30.2	7.7	10.2	16.9	8.8	15.7	10.1	15.4	19.3	21.2	58.0	27.1	13.6	27.2	6.8	14.5	12.2	12.6	10.9	8.3	13.8	16.8	10.8	29.0	15.0	16.1	13.5	19.5	13.1	6.9	12.5	9.1	14.1	12.9	15.8	13.0	15.0	24.6	15.9	21.4	19.6	21.0	14.6	19.4	9.1	4.0	11.6	30.0	18.6	13.7	4.2	21.9	15.7	6.4	1.5	9.1	6.6	13.1	21.7	3.6	7.9	16.2	17.0	24.8	17.4	16.3	20.6	5.7	6.3	11.0	15.8	10.6	7.4	13.9	6.8	10.4	27.6	7.4	4.2	5.5	9.8	7.0	10.4	14.3	14.0	28.5	17.6	16.8	16.3	6.4	20.7	64.1	19.5	27.5	11.7	3.8	2.7	4.3	25.6	4.6	25.1	2.1	12.8	19.5	12.5	13.1	9.8	16.1	11.3	8.7	11.3	14.9	8.8	7.0	18.5	6.9	12.6	13.5	8.7	9.1	25.7	32.9	16.2	31.9	23.7	12.7	9.5	20.7	8.8	10.9	14.9	18.6	15.9	41.2	59.0	31.9	25.0	25.5	17.4	13.6	12.2	7.9	19.6	6.6	45.3	63.3	34.3	19.2	0.0	47.9	41.6	32.7	58.9	11.6	16.3	24.9	69.9	60.7	24.5	18.1	119.1	27.6	21.1	10.1	63.1	29.8	36.4	66.0	24.6	24.8	16.3	27.9	71.1	41.0	13.6	16.2	62.7	46.1	15.0	16.9	46.3
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191678	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.1"	"Cell type enhanced"	"Detected in many"	22	"Erythroid cells: 140.2;Spermatocytes: 61.2;Spermatogonia: 32.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 8.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	1.4	0.9	0.3	11.4	0.4	16.2	0.5	0.3	0.5	1.3	3.3	0.2	0.2	2.9	0.9	1.0	8.7	0.3	1.3	0.7	0.2	0.3	1.1	0.8	2.1	10.6	0.3	0.2	0.7	0.4	0.0	0.3	3.3	0.3	0.5	4.1	0.3	1.5	0.2	0.5	1.9	4.1	1.3	0.3	6.6	2.2	13.0	0.2	65.1	0.4	6.4	11.4	1.7	2.4	1.1	0.4	0.4	0.0	1.3	8.3	1.2	37.6	15.0	39.4	17.7	0.9	3.9	12.2	21.9	14.5	32.4	30.9	12.2	20.8	21.9	12.1	12.7	13.0	23.4	25.2	17.5	42.6	26.4	12.4	22.5	14.1	10.5	0.1	22.0	13.8	0.8	0.6	15.2	7.3	5.2	35.6	22.5	18.2	22.0	30.1	18.1	27.7	11.2	20.3	16.8	15.6	21.7	38.1	10.1	10.6	12.2	20.1	11.3	23.3	8.8	8.6	17.5	19.6	8.2	13.8	14.5	38.0	14.0	25.1	5.4	11.7	29.1	10.1	15.7	23.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.1	2.3	0.4	0.1	0.5	0.2	0.4	1.3	0.0	0.0	8.3	1.2	0.3	0.4	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.2	0.0	0.3	8.5	0.2	1.0	0.0	0.3	0.0	1.4	1.2	0.0	0.0	1.3	0.0	0.4	10.7	0.0	0.2	140.2	0.0	19.8	1.0	0.2	0.0	0.8	8.6	0.0	0.0	1.8	4.5	4.6	0.9	2.2	0.0	0.0	1.3	0.0	0.1	0.0	1.1	0.0	0.0	6.5	0.0	61.2	32.3	0.4	1.6	1.5	2.5	1.1
DLK1	"Delta1, FA1, pG2, Pref-1, ZOG"	ENSG00000185559	"Delta like non-canonical Notch ligand 1"	P80370	14	100725705-100738224	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 157.6;pituitary gland: 143.1;placenta: 244.9"	"Group enriched"	"Detected in many"	5	"Exocrine glandular cells: 527.9;Leydig cells: 1256.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.1"	"Group enriched"	"Detected in some"	5	"hypothalamus: 2.6;pons and medulla: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 23.1;Hep G2: 77.0;SH-SY5Y: 91.7"	"Region enhanced"	"Detected in some"		"hypothalamus: 65.4"	"Region enhanced"	"Detected in many"		"midbrain: 159.6"	"CAB005872, HPA062262"	Enhanced		Approved	"Golgi apparatus"		NA	NA		160000	"Golgi apparatus"		"CAB005872: AB_731965, HPA062262: AB_2684729"	"unprognostic (2.16e-2)"			"prognostic unfavorable (2.31e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.89e-3)"	"unprognostic (5.75e-2)"		"unprognostic (1.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.24e-1)"		"unprognostic (3.11e-2)"	"unprognostic (6.57e-2)"			0.3	157.6	0.2	0.7	0.8	0.0	0.9	0.0	0.1	0.5	0.0	1.8	0.2	0.2	0.2	4.4	0.3	0.3	0.8	2.7	0.1	2.6	0.1	0.1	0.1	0.1	0.8	0.0	34.9	4.6	0.0	143.1	244.9	6.0	0.2	0.0	0.2	8.2	0.0	2.0	0.1	0.2	0.2	0.3	0.2	0.2	14.2	0.0	0.5	0.0	10.0	1.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	77.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.1	6.5	91.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.8	0.0	0.0	0.1	2.6	0.8	0.0	6.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	3.2	0.0	0.0	0.0	0.0	0.0	52.1	0.0	2.9	4.0	0.0	0.0	0.0	527.9	35.4	1.3	0.5	0.0	0.0	73.1	0.0	0.0	0.0	0.0	11.5	1256.4	0.0	0.0	0.0	0.0	0.0	6.5	0.0	162.3	0.0	0.0	58.2	0.0	6.5	56.6	0.4	88.4	0.0	0.0	0.1
DLK2	"EGFL9, MGC2487"	ENSG00000171462	"Delta like non-canonical Notch ligand 2"	Q6UY11	6	43450352-43456632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 19.3"	"Cell type enriched"	"Detected in some"	7	"Basal glandular cells: 79.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA061223, HPA068672, HPA070955"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		No	No			Nucleoplasm	"Nucleoli, Vesicles"	"HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: "	"unprognostic (4.65e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.68e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.80e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.27e-12)"	"unprognostic (7.71e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.43e-2)"	1.0	1.1	4.5	1.4	7.9	1.7	4.3	12.2	8.2	2.2	0.7	0.9	6.4	1.1	1.4	3.8	10.5	1.1	0.9	1.8	4.1	4.6	0.7	0.7	1.1	1.7	1.5	4.8	1.7	1.5	0.4	0.5	1.3	0.9	10.4	0.5	0.3	12.4	13.0	0.7	19.3	1.0	0.6	1.5	1.5	1.1	1.1	1.2	1.3	0.8	4.7	3.9	2.2	5.3	0.8	1.8	1.0	0.5	2.5	3.2	0.3	5.2	1.9	0.5	7.9	0.0	0.4	1.8	1.9	2.1	2.2	1.0	1.8	0.2	1.0	1.2	0.4	2.7	16.5	5.6	9.0	0.5	1.0	2.1	0.4	0.9	2.8	0.6	0.3	1.1	0.9	27.2	0.6	5.1	0.7	0.0	3.1	0.4	0.8	0.8	2.0	0.4	0.4	0.7	2.0	2.0	1.1	1.0	0.5	0.3	1.8	5.9	0.6	0.6	0.2	0.3	0.4	0.5	1.6	0.5	0.8	2.5	0.6	3.8	1.2	0.3	1.7	0.1	0.7	0.5	0.9	0.4	0.4	0.7	0.3	3.2	0.6	2.2	2.2	0.1	0.8	0.9	0.4	1.0	2.5	0.5	1.8	0.3	0.3	4.5	7.9	12.2	8.2	4.1	4.6	1.5	4.8	0.9	1.2	0.0	0.3	0.0	79.5	9.0	0.6	0.5	0.0	0.0	7.9	0.0	0.0	0.8	0.0	0.1	0.2	0.3	0.0	0.0	0.0	2.1	0.2	4.3	0.0	0.0	0.1	11.1	1.2	0.0	0.0	0.2	0.3	0.0	1.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.9	0.0	0.3	1.2	5.5	2.3	0.2	0.0	0.0	3.9
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.5"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 37.2"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4;naive CD8 T-cell: 3.3"	"Group enriched"	"Detected in many"	13	"B-cells: 5.4;T-cells: 3.3"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 42.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA056533			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.6	0.6	8.9	0.7	10.1	0.6	0.6	1.4	38.5	0.5	0.6	10.3	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.6	6.5	6.8	0.5	0.6	0.6	0.7	4.5	1.9	0.6	0.5	0.6	3.2	0.5	4.3	0.6	0.5	0.0	0.6	0.5	0.5	0.6	0.6	0.5	3.6	0.6	0.6	1.2	2.3	0.0	0.7	0.0	0.6	0.6	0.0	5.4	0.3	0.0	0.0	0.0	3.3	0.4	0.0	2.0	0.4	1.0	0.0	0.0	0.3	0.5	0.0	0.3	0.1	0.3	0.4	0.0	2.0	0.0	0.8	0.0	1.2	0.5	0.1	0.6	3.1	0.1	0.0	0.2	0.1	0.5	2.4	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.0	3.2	0.3	0.1	0.1	0.1	0.1	7.4	7.6	1.5	0.0	42.1	0.1	0.0	0.1	0.0	0.0	1.4	0.1	0.5	0.7	0.0	0.4	0.0	0.2	1.2	0.0	0.0	0.0	0.9	0.0	0.4	5.4	0.2	1.3	0.3	1.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.4	8.9	10.1	1.4	4.8	6.5	6.8	4.5	1.9	4.3	2.3	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5	0.0	0.0	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	2.9	0.0	0.0	1.6	1.1	0.0	1.7	0.0	0.0	0.5	0.2	0.0	1.4	0.0	0.6	6.5	0.0	5.4	37.2	0.1	0.2	0.0	0.0	0.0
DLST	DLTS	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903745	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		800000	"Nucleoplasm, Mitochondria"		"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	32.2	38.6	12.0	22.7	19.9	28.5	31.3	19.1	25.6	31.2	36.0	18.5	15.9	24.7	26.3	28.3	31.4	19.2	29.7	47.6	10.8	11.8	43.7	45.1	20.8	26.7	13.5	13.7	21.5	27.1	25.8	16.2	25.2	19.7	20.9	26.8	19.2	22.3	20.1	59.2	26.9	43.2	32.9	11.4	20.8	24.3	21.0	10.4	23.5	27.2	49.8	28.4	26.9	21.1	3.8	6.3	8.4	4.3	7.7	5.3	3.2	25.8	27.0	20.7	14.6	32.5	36.9	31.7	33.8	34.4	34.6	32.4	26.5	28.1	26.3	14.4	38.8	15.6	29.2	34.8	33.4	36.6	19.0	14.6	21.5	22.6	23.2	33.6	15.2	14.8	37.7	29.3	33.5	41.4	31.2	35.6	11.9	16.4	17.9	37.5	34.7	18.0	21.6	17.7	45.7	25.4	23.1	30.4	14.5	42.9	31.8	24.6	20.9	31.9	42.6	22.0	19.3	39.0	22.0	31.5	21.1	27.6	25.7	23.1	12.7	13.2	23.1	30.8	15.8	22.0	8.4	3.0	5.0	5.0	4.3	4.5	3.8	4.5	3.9	4.7	2.7	4.0	5.3	3.0	7.7	3.9	6.3	4.4	3.2	12.0	19.9	19.1	25.6	10.8	11.8	13.5	13.7	19.7	10.4	6.0	4.5	20.7	19.3	23.5	17.5	23.4	20.4	2.7	3.4	19.2	29.5	33.7	48.0	32.5	6.2	14.6	39.3	0.0	22.3	30.6	23.8	21.8	20.7	37.3	28.4	12.7	14.3	24.5	16.2	3.4	16.7	16.5	21.9	36.1	28.3	8.5	35.0	25.9	19.4	51.5	20.0	25.8	17.9	9.3	11.7	24.8	66.5	20.3	36.1	20.8
DLX2	TES-1	ENSG00000115844	"Distal-less homeobox 2"	Q07687	2	172099439-172102900	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.9"	"Cell type enhanced"	"Detected in some"	16	"Basal keratinocytes: 1.5;Early spermatids: 4.3;Melanocytes: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AN3-CA: 39.6;HEK 293: 25.2"	"Group enriched"	"Detected in many"	4	"basal ganglia: 13.8;olfactory region: 36.1"	"Region enriched"	"Detected in many"	5	"olfactory region: 43.5"	HPA056965			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA056965: AB_2683291"	"unprognostic (8.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.60e-3)"	"unprognostic (3.03e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.69e-10)"	"unprognostic (9.38e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.95e-3)"	0.7	3.2	4.5	0.7	5.4	1.2	1.2	0.1	10.9	0.4	0.7	1.1	0.0	0.6	0.5	0.4	0.4	0.5	0.7	0.7	4.3	7.5	0.5	0.6	0.5	0.4	0.4	4.1	0.4	0.4	0.4	0.2	0.6	0.0	1.0	0.6	0.0	1.7	0.7	0.4	1.9	1.2	0.5	0.1	0.4	0.5	2.5	3.4	1.4	1.5	1.5	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.6	0.2	0.2	1.1	2.1	0.5	0.3	0.1	0.2	0.1	0.0	1.2	0.9	1.9	2.0	1.3	0.1	0.1	0.0	25.2	0.6	4.1	0.9	0.1	0.2	0.1	0.0	1.8	0.0	0.2	0.1	0.0	1.0	0.2	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.0	0.6	2.3	0.6	0.3	0.1	0.1	2.8	0.0	1.5	0.2	0.0	0.0	0.2	2.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	5.4	0.1	10.9	4.3	7.5	0.4	4.1	0.0	3.4	0.0	0.0	0.0	0.1	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.7	0.0	0.3	0.0	0.2	0.0
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020392-97024950	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6"	"Cell type enhanced"	"Detected in some"	19	"Cytotrophoblasts: 128.5;Extravillous trophoblasts: 203.8;Sertoli cells: 58.2;Syncytiotrophoblasts: 263.3"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 32.9;HAP1: 16.5;SuSa: 8.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory region: 36.5"	"Region enhanced"	"Detected in many"		"olfactory region: 24.3"	HPA005670	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.5	0.6	2.7	0.5	11.5	0.3	1.5	0.1	3.9	10.0	0.6	0.3	1.4	0.7	17.7	1.7	5.8	2.0	0.8	1.2	2.2	4.5	0.4	0.2	0.4	1.9	0.5	2.5	2.1	0.2	0.4	1.9	44.5	0.0	1.8	0.3	0.1	3.6	3.9	0.6	20.6	0.3	1.4	0.2	0.3	0.3	1.2	3.1	2.5	1.6	6.5	2.7	1.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.7	16.5	0.0	0.0	0.0	2.8	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	2.1	0.9	1.3	0.1	0.0	0.0	8.6	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.0	2.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.5	0.1	3.9	2.2	4.5	0.5	2.5	0.0	3.1	0.0	0.0	0.0	0.7	8.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	128.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	203.8	2.2	1.1	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	58.2	7.1	1.8	6.0	18.1	263.3	0.0	0.0	1.4
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005548-97011039	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.2;placenta: 11.3;testis: 10.4"	"Cell type enhanced"	"Detected in some"	20	"Cytotrophoblasts: 24.7;Extravillous trophoblasts: 48.9;Sertoli cells: 12.9;Syncytiotrophoblasts: 14.5"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 23.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.3;BEWO: 24.3;HAP1: 10.9;SH-SY5Y: 8.0;SuSa: 14.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory region: 44.2"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: AB_2684529"	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.9	0.4	1.8	0.3	23.2	0.9	0.4	0.3	6.1	5.7	0.6	0.5	0.0	0.4	7.0	2.4	0.3	1.5	0.3	0.5	3.9	2.6	0.4	0.3	0.3	1.0	0.5	2.8	0.9	0.3	0.4	0.4	11.3	0.0	0.7	0.3	0.0	1.7	2.5	0.5	1.6	0.3	0.9	0.3	0.5	0.4	10.4	4.2	0.1	0.7	0.0	0.8	0.9	0.6	0.4	0.6	1.5	0.7	0.5	0.7	0.3	0.0	0.0	0.0	7.3	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.4	0.0	0.0	1.3	10.9	0.0	0.0	0.0	2.8	0.0	4.1	4.9	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.8	1.1	0.0	0.0	0.0	0.0	1.5	5.3	8.0	0.7	0.0	0.2	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.8	0.6	1.1	0.5	0.6	0.2	0.3	0.5	0.4	0.4	0.3	0.3	0.4	0.7	0.6	1.5	0.5	0.7	0.6	0.5	0.3	1.8	23.2	0.3	6.1	3.9	2.6	0.5	2.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	9.5	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	12.9	0.0	1.7	7.1	0.0	14.5	0.0	0.0	0.1
DMAC2	"ATP5SL, FLJ10241"	ENSG00000105341	"Distal membrane arm assembly complex 2"	Q9NW81	19	41431318-41440717	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 41.9;Ductal cells: 37.6;Extravillous trophoblasts: 58.6;monocytes: 55.1;Syncytiotrophoblasts: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041427	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041427: AB_2677473"	"unprognostic (1.42e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (4.37e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.10e-1)"	"prognostic favorable (4.07e-5)"	"unprognostic (5.20e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.29e-3)"	12.9	16.2	12.3	9.9	13.5	10.3	18.3	10.9	21.9	12.1	21.4	14.1	11.1	28.9	15.8	7.2	15.8	13.1	13.5	48.1	12.5	11.1	18.6	20.0	15.2	15.7	12.9	13.7	12.3	18.3	14.2	11.3	12.2	15.4	14.9	11.9	13.6	16.3	14.4	38.7	14.0	31.4	16.2	11.6	12.9	17.3	10.6	10.9	17.9	22.3	22.0	14.1	16.8	12.1	14.3	29.4	17.0	20.3	15.0	17.8	15.1	15.6	55.6	20.3	13.5	14.5	13.3	12.1	13.2	15.3	23.3	21.1	39.5	18.0	16.4	20.2	19.2	12.2	11.8	15.4	24.0	12.0	14.9	19.6	15.3	16.0	28.6	21.5	25.7	15.5	22.4	22.3	19.0	13.4	16.0	27.7	22.6	20.7	16.4	15.8	19.4	23.5	10.7	25.2	22.3	17.0	19.5	15.6	14.4	22.5	21.9	14.5	24.1	21.1	17.5	14.2	16.8	16.4	29.3	20.6	20.3	22.2	12.2	22.5	17.3	16.3	14.7	18.1	18.7	14.5	9.7	20.3	17.0	17.2	18.8	17.8	13.1	13.1	17.1	29.4	14.3	14.2	13.4	6.7	15.0	15.4	19.1	15.3	15.1	12.3	13.5	10.9	21.9	12.5	11.1	12.9	13.7	15.4	10.9	26.8	16.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	10.3	12.2	0.0	41.9	33.2	37.6	0.0	0.0	0.0	0.0	35.0	58.6	0.0	0.0	7.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	55.1	0.0	0.0	28.2	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0
DMBT1	"Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin"	ENSG00000187908	"Deleted in malignant brain tumors 1"	Q9UGM3	10	122560665-122643736	"Disease related genes, Predicted secreted proteins"	"Antiviral defense, Differentiation, Host-virus interaction, Protein transport, Transport"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 122.3;salivary gland: 130.0"	"Group enriched"	"Detected in many"	12	"Alveolar cells type 2: 221.3;Paneth cells: 136.4"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 47.6;lung cancer: 18.0;pancreatic cancer: 33.3;stomach cancer: 76.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.6;LHCN-M2: 9.2;RH-30: 21.4"									HPA040778	Enhanced		Approved	"Centriolar satellite"	"Secreted in other tissues"	NA	NA		7500000	"Centriolar satellite"		"HPA040778: AB_2677132"	"unprognostic (3.32e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.08e-9)"	"unprognostic (2.26e-1)"	"unprognostic (2.92e-4)"	"unprognostic (2.00e-3)"	"unprognostic (2.22e-1)"	0.1	0.1	0.2	2.4	0.2	0.0	0.1	0.1	0.2	1.1	34.8	0.1	0.1	122.3	0.2	0.1	0.3	0.3	2.7	0.1	0.3	0.2	0.1	0.1	13.1	0.1	0.6	0.1	0.2	1.2	0.0	0.1	0.1	0.1	0.5	1.5	0.1	130.0	0.1	0.2	0.2	68.3	0.9	1.1	0.1	0.2	0.3	0.1	0.1	0.1	19.7	14.7	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.3	0.2	4.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	21.4	2.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.6	2.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.1	0.1	0.1	6.0	221.3	0.0	3.3	0.0	0.0	0.4	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.4	2.3	0.0	14.7	0.0	13.8	0.0	0.0	0.8	9.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.4	0.0	1.0	136.4	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.0	0.0	0.0	4.5	12.8
DMC1	LIM15	ENSG00000100206	"DNA meiotic recombinase 1"	Q14565	22	38518949-38570286	"Predicted intracellular proteins"	"Cell cycle, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.1"	"Cell type enhanced"	"Detected in many"	21	"Erythroid cells: 23.3;Sertoli cells: 12.9;Spermatocytes: 61.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.7;hTEC/SVTERT24-B: 12.6;U-266/84: 14.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA001232, CAB015397"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015397: AB_629406, HPA001232: AB_1078683"	"unprognostic (1.29e-2)"	"unprognostic (3.11e-3)"	"unprognostic (4.48e-3)"	"unprognostic (5.71e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.16e-4)"	"unprognostic (3.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.99e-1)"	1.7	0.6	1.6	4.7	2.0	3.1	4.4	2.2	2.0	2.5	1.3	0.7	1.2	0.4	3.7	2.6	1.5	1.6	1.8	3.3	2.5	1.1	1.0	0.5	1.1	3.9	2.8	1.5	1.8	0.8	0.8	1.1	1.0	3.2	2.9	1.6	2.7	1.0	1.3	1.8	2.5	1.1	3.4	4.4	0.9	1.0	24.1	2.3	8.2	0.8	3.2	4.5	2.0	3.8	1.2	0.8	3.3	1.0	2.5	1.5	0.4	4.9	1.9	3.7	0.1	0.3	1.5	0.2	5.3	0.7	8.5	5.9	0.2	0.6	2.5	0.2	1.4	0.0	0.9	1.4	0.2	9.7	17.7	0.3	9.5	1.4	0.1	0.1	0.8	2.1	0.4	0.0	12.6	0.0	0.0	0.7	8.0	7.1	2.6	3.0	2.8	1.9	7.2	6.5	2.4	0.1	4.2	0.0	3.6	1.1	0.7	7.2	0.4	8.9	0.8	0.1	0.9	1.6	2.1	0.2	0.1	0.5	0.1	0.1	7.1	14.7	4.5	1.5	2.0	0.7	2.2	1.0	0.5	1.5	0.3	0.3	0.5	1.3	0.6	0.8	1.2	1.2	0.5	3.3	2.5	0.6	0.7	0.7	0.4	1.6	2.0	2.2	2.0	2.5	1.1	2.8	1.5	3.2	2.3	0.0	2.9	0.0	0.7	2.1	0.6	2.0	0.0	1.4	4.5	3.5	0.0	0.8	1.7	0.2	1.9	0.6	0.0	23.3	0.0	1.3	1.2	0.2	1.1	0.0	0.8	0.0	0.0	0.6	0.0	1.6	1.4	0.8	0.0	0.0	0.8	2.3	0.1	0.0	1.4	0.0	0.3	12.9	0.8	61.6	8.3	0.5	0.7	1.0	2.1	0.0
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 365.3"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 7442.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Cell type enhanced"	"Detected in many"		"NK-cell: 11.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.1;T-cells: 7.0"	"Cell line enhanced"	"Detected in many"		"A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3"									HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		29000000	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	0.6	0.5	4.7	0.6	23.9	0.7	2.0	54.8	1.2	1.1	2.5	1.0	5.6	9.2	25.3	8.7	0.6	1.4	0.7	1.1	11.3	0.8	8.8	0.5	0.9	0.6	11.7	29.5	4.7	13.3	1.7	9.5	5.0	1.0	9.5	8.2	9.1	2.4	365.3	1.2	0.9	0.9	0.6	1.8	0.8	2.3	3.1	25.9	62.9	16.9	3.5	27.5	1.7	0.2	0.0	0.0	11.1	7.0	1.2	32.0	5.2	0.0	0.0	1.3	2.0	9.0	0.1	4.3	0.2	0.3	39.6	34.0	0.0	13.0	0.3	1.6	18.0	9.8	51.9	0.4	0.1	9.5	0.0	0.0	8.8	1.5	0.0	0.1	17.8	14.0	0.9	30.2	3.0	0.0	0.0	0.1	0.0	0.1	28.0	0.0	0.0	28.8	23.3	2.1	0.0	0.0	1.3	51.3	21.2	0.1	0.0	7.8	0.0	3.1	8.6	13.0	0.0	0.0	5.0	15.2	0.1	0.1	0.2	0.0	0.2	4.2	0.0	0.3	0.0	0.0	0.0	7.0	0.0	6.1	1.7	0.6	3.4	0.0	0.2	0.1	2.4	0.0	11.1	0.0	0.2	0.0	1.2	0.6	4.7	0.7	2.0	0.7	1.1	0.9	0.6	9.5	2.3	98.3	94.2	3.7	121.7	1442.2	1.4	15.2	94.3	261.0	92.1	193.7	0.0	0.7	195.6	125.9	15.0	6.0	1.3	0.0	120.1	1.1	57.3	55.5	7.0	2.0	1.0	0.0	47.4	5.5	0.8	67.8	12.0	5.1	290.1	4.6	4.2	9.3	137.6	5.8	14.9	4.4	0.7	0.0	14.2	7.1	16.4	7442.2	1.9	5.3	11.0	72.7
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769717-45782552	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.6"	"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	9.0	18.7	5.1	9.7	6.3	1.7	4.9	8.8	6.2	16.5	23.4	4.4	15.6	8.7	21.2	15.0	31.2	13.7	20.3	56.7	5.0	5.3	4.9	2.2	6.5	4.1	4.8	6.5	8.4	33.3	3.1	10.7	6.8	5.6	16.3	3.8	22.0	6.1	19.7	79.6	5.1	11.3	65.1	4.2	5.3	12.0	5.9	4.0	1.1	6.1	36.6	5.0	44.9	8.2	1.5	0.0	0.0	0.8	0.3	2.2	0.0	7.2	10.2	12.1	7.5	8.2	11.5	7.3	16.4	12.1	6.6	6.4	1.2	3.9	2.3	2.5	18.7	5.3	10.7	3.5	1.6	2.5	11.4	10.7	0.9	12.7	1.7	8.0	0.1	4.1	16.6	5.7	5.7	2.8	16.3	3.0	1.2	7.2	5.9	9.5	8.1	1.1	2.8	7.2	3.2	2.2	3.7	44.7	3.8	3.5	8.4	6.5	10.5	8.9	18.8	5.3	6.9	15.4	3.6	9.2	7.7	7.6	7.2	12.0	11.4	9.7	2.3	7.0	1.0	10.7	0.0	0.0	0.0	2.2	0.8	0.5	0.3	0.7	0.2	0.0	1.5	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.1	6.3	8.8	6.2	5.0	5.3	4.8	6.5	5.6	4.0	0.0	2.1	0.9	7.0	7.1	4.9	3.1	2.5	0.0	2.3	3.5	7.9	2.3	1.7	2.4	1.4	6.0	3.6	0.0	15.0	1.5	12.7	3.3	0.0	0.9	0.7	4.8	9.7	10.4	1.2	1.4	6.6	0.5	6.8	0.0	5.5	2.2	5.0	3.5	21.9	22.0	7.6	58.2	23.7	6.3	6.0	5.9	1.4	5.0	3.6	3.7
DMRTA1		ENSG00000176399	"DMRT like family A1"	Q5VZB9	9	22446841-22455740	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.2;salivary gland: 16.3"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 13.3;Hepatocytes: 25.3;Proximal tubular cells: 21.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.0;hTERT-RPE1: 11.0;LHCN-M2: 4.2;RPTEC TERT1: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 2.5"	"HPA044764, HPA062253"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA044764: AB_10959788, HPA062253: AB_2684726"	"unprognostic (1.47e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.74e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.67e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.92e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.53e-3)"	2.1	0.2	0.7	1.4	0.7	0.0	5.6	0.8	0.7	2.4	1.0	0.7	1.1	0.7	1.2	1.8	5.5	0.3	1.2	0.6	0.6	0.5	5.5	12.2	1.1	1.4	0.8	0.4	0.6	2.7	6.1	2.9	0.0	0.9	2.4	0.4	1.9	16.3	0.5	0.9	0.5	0.8	0.7	0.7	0.4	2.8	0.6	0.0	1.1	5.0	0.6	2.0	0.9	1.7	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.5	0.1	0.0	0.4	0.1	0.2	0.0	9.0	0.3	0.3	0.1	0.1	0.0	2.0	0.0	0.2	0.3	1.8	2.4	0.3	0.0	0.6	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.7	11.0	0.6	0.0	0.0	3.3	4.2	0.9	0.0	0.0	1.8	0.4	3.0	0.0	0.2	1.2	4.3	0.0	0.1	0.0	1.1	0.7	2.0	2.2	0.0	0.0	3.1	0.0	3.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.8	0.7	0.6	0.5	0.8	0.4	0.9	0.0	0.0	2.4	0.0	4.7	0.0	0.5	1.1	2.5	4.0	4.5	5.2	0.0	0.0	13.3	5.4	0.0	0.0	2.6	0.0	6.0	0.0	1.3	5.6	0.0	25.3	0.3	0.0	2.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	4.8	5.6	0.0	0.0	21.4	0.0	0.0	0.4	0.0	0.6	0.4	0.1	0.0	1.9	6.2
DMRTA2		ENSG00000142700	"DMRT like family A2"	Q96SC8	1	50417550-50423500	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 3.7;Intestinal endocrine cells: 1.2"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HBEC3-KT: 4.3;RH-30: 15.6;SH-SY5Y: 3.3;SiHa: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043098, HPA062958"	Uncertain		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA043098: AB_10796684, HPA062958: AB_2684911"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.75e-2)"		"unprognostic (1.15e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.08e-3)"	"unprognostic (4.16e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.68e-3)"	0.2	0.1	0.4	0.1	1.5	0.2	0.2	0.4	2.1	0.3	0.3	8.5	0.0	0.4	0.2	0.1	3.8	0.2	0.1	0.1	1.2	0.7	0.2	0.2	0.2	0.2	1.2	0.0	0.2	0.1	0.4	5.4	0.2	2.1	0.2	0.3	0.0	0.5	0.2	0.3	0.1	0.2	0.1	2.0	0.3	0.2	4.0	3.7	0.3	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	1.9	0.0	1.3	4.3	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	3.3	3.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.4	1.8	1.2	0.7	1.2	0.0	2.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
DMRTC1		ENSG00000269502	"DMRT like family C1"	Q5HYR2	X	72872025-72943814	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Group enriched"	"Detected in many"	17	"B-cells: 2.2;T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;Daudi: 3.6;JURKAT: 2.6;NTERA-2: 1.2;U-266/70: 1.2;U-266/84: 1.4;U-698: 2.0"									"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (1.83e-1)"													0.0	1.3		0.0		0.0	0.0		4.0	0.6	0.1			0.0	1.1	0.0	0.1	2.1	0.2	0.0			0.0	0.0	0.0	0.6			1.3	0.0	0.0		0.0		0.0	0.3		0.0	0.2	0.0	0.0	0.1	0.6		0.7	0.0	1.1			2.0		0.8	0.0		2.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.0	2.2	0.7	1.2	0.0	0.0	0.0	0.0	0.4	0.1											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.1;ovary: 12.1;pituitary gland: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	12	"B-cells: 2.1;T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;SK-BR-3: 1.0;SuSa: 2.2;U-266/70: 1.5"									"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.3	4.6	11.0	1.7	15.1	0.1	0.7	4.5	14.3	1.7	0.6	2.2	1.4	0.5	2.2	9.6	0.3	3.3	0.6	0.2	8.6	14.2	1.6	0.2	1.1	1.4	4.9	9.1	12.1	5.2	1.5	12.1	0.2	2.2	3.8	0.8	2.4	1.0	1.9	0.2	0.5	0.5	0.6	2.2	1.3	1.2	7.1	2.9	0.7	3.9	0.2	2.1	0.3	0.2	2.1	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.4	0.0	2.1	2.1	2.8	0.0	0.2	0.0	0.0	0.0	0.2	11.0	15.1	4.5	11.4	8.6	14.2	4.9	9.1	2.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMWD	"D19S593E, DMR-N9, gene59"	ENSG00000185800	"DM1 locus, WD repeat containing"	Q09019	19	45782947-45792802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068172, HPA069843"	Approved		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA068172: AB_2685964, HPA069843: AB_2686212"	"unprognostic (6.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (5.11e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.59e-2)"	20.1	15.5	24.2	12.9	29.4	7.3	11.0	17.1	34.2	12.1	17.7	19.2	6.6	10.8	21.7	9.0	13.2	14.5	16.6	29.0	20.2	16.2	9.6	5.8	13.6	11.5	17.8	19.1	17.0	13.4	13.7	20.3	16.7	18.8	14.7	8.7	14.8	13.6	14.9	31.8	13.1	10.4	16.9	9.9	15.0	13.1	17.8	16.7	11.2	11.8	6.7	8.5	14.6	11.8	4.3	0.7	1.8	1.9	4.8	3.8	0.9	17.0	19.1	17.3	12.0	10.6	13.5	13.3	15.1	10.6	13.4	12.2	11.3	9.6	7.2	8.8	16.9	16.4	13.0	9.0	7.4	7.0	21.2	16.9	6.2	19.0	9.8	13.2	0.7	10.1	12.6	9.2	12.5	17.9	15.4	11.5	4.6	15.1	16.4	10.5	14.1	8.6	4.9	7.8	11.3	12.5	8.9	6.2	7.9	8.3	16.4	17.3	19.3	16.1	12.6	10.7	8.0	10.9	4.2	24.1	15.5	15.4	10.3	22.3	23.6	14.5	8.2	16.2	1.1	18.0	1.3	0.7	0.5	3.8	1.6	3.0	1.7	3.2	3.0	0.7	4.3	1.2	2.4	1.8	4.8	1.9	0.6	1.9	0.9	24.2	29.4	17.1	34.2	20.2	16.2	17.8	19.1	18.8	16.7	6.0	6.6	1.5	12.2	7.4	31.0	23.8	10.2	4.0	3.4	8.7	56.9	6.0	5.0	6.2	15.1	13.0	8.6	23.3	9.1	8.1	11.8	9.7	11.5	5.4	1.6	49.3	25.2	17.8	4.3	46.1	15.8	1.5	5.0	0.0	8.7	25.5	10.8	5.8	15.9	6.2	37.8	12.9	12.3	8.6	12.3	6.0	4.6	5.0	6.9	9.5
DMXL1		ENSG00000172869	"Dmx like 1"	Q9Y485	5	119037772-119249138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036431, HPA036432"	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA036431: AB_10669791, HPA036432: AB_2675120"	"unprognostic (2.47e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.18e-2)"	17.8	10.4	9.3	14.0	14.1	29.3	16.1	14.2	15.4	12.0	11.6	15.4	9.6	8.3	15.7	8.5	13.0	12.0	10.3	10.2	8.9	5.6	18.8	9.6	13.9	12.5	11.5	11.4	17.4	20.1	21.3	14.1	9.5	18.9	35.9	9.8	13.3	13.6	10.9	10.9	21.4	13.1	13.0	10.9	11.5	12.4	9.2	13.1	18.1	17.9	6.8	13.8	14.3	12.4	11.2	9.5	4.6	9.0	1.5	3.8	2.6	9.5	7.4	8.5	8.6	9.1	12.1	9.0	7.9	7.9	8.0	9.4	8.9	5.9	18.6	8.2	10.1	12.4	5.8	9.3	9.4	10.4	14.3	9.3	13.1	12.9	3.1	7.6	8.5	11.4	9.6	5.3	9.2	7.7	8.2	10.4	11.7	11.0	12.6	6.4	6.0	11.4	4.9	4.6	3.3	4.5	9.0	15.6	7.2	6.2	11.1	7.9	8.0	13.6	5.0	12.2	9.4	8.2	9.9	10.0	9.5	8.0	9.5	8.3	11.9	8.4	16.2	11.8	8.4	7.6	4.6	5.5	3.9	2.9	4.9	3.6	9.7	2.3	2.4	3.8	11.2	3.8	2.1	4.5	1.5	9.0	9.5	2.8	2.6	9.3	14.1	14.2	15.4	8.9	5.6	11.5	11.4	18.9	13.1	26.8	15.3	22.9	15.7	12.0	36.2	22.4	2.5	12.0	14.8	15.7	23.6	9.9	14.9	9.5	6.0	13.4	14.6	0.0	17.5	7.5	11.6	51.6	13.9	13.4	14.8	20.6	5.8	9.2	20.5	7.4	14.1	17.3	32.1	27.1	11.4	17.3	12.1	11.9	14.5	27.0	22.4	12.9	15.0	15.6	19.2	16.4	13.6	14.9	10.1	10.7
DNAAF1	"CILD13, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.3;testis: 49.6"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 520.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.1"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.5;Karpas-707: 8.8;PC-3: 2.7;SK-BR-3: 2.5;U-266/70: 7.4;U-266/84: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA041166: AB_10794190, HPA074239: AB_2732250"	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.8	1.2	3.5	0.6	9.4	1.5	0.5	0.1	1.5	2.1	0.6	5.3	1.5	0.4	1.0	13.3	0.9	21.3	0.5	0.4	4.6	6.5	0.7	2.0	3.7	0.9	0.5	1.5	4.2	0.4	0.7	6.1	1.5	11.1	0.4	0.4	0.9	0.5	0.6	0.6	0.5	0.6	0.4	1.0	7.2	0.5	49.6	1.2	0.0	1.2	0.0	0.4	0.8	0.0	0.5	1.0	5.5	0.8	0.9	2.1	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.1	1.3	0.2	0.0	0.0	2.5	0.1	0.1	0.9	0.0	0.0	0.4	0.0	0.0	0.0	7.4	4.8	0.7	0.2	0.4	0.0	3.6	0.8	0.4	0.4	0.6	0.1	0.0	0.2	0.1	0.4	0.5	0.8	0.8	5.5	0.9	0.4	1.0	2.1	0.9	3.5	9.4	0.1	1.5	4.6	6.5	0.5	1.5	11.1	1.2	0.0	17.2	2.2	1.6	0.6	1.4	0.6	2.5	520.6	108.1	3.5	51.1	0.2	0.0	1.0	67.6	1.4	0.0	0.0	0.3	0.4	0.9	0.8	3.5	0.4	1.9	0.0	0.0	3.1	2.7	16.2	1.1	4.8	82.7	1.0	0.0	2.1	1.3	0.0	0.4	0.7	53.5	0.0	0.4	118.6	19.6	0.3	0.3	0.0	0.0	0.7
DNAAF3	"C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22"	ENSG00000167646	"Dynein axonemal assembly factor 3"		19	55158661-55166722	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	12	"fallopian tube: 29.7;testis: 60.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 336.2;Late spermatids: 540.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 17.3;HEL: 20.1;K-562: 15.7;U-937: 11.4"									HPA056220			Approved	"Nuclear bodies,Mitochondria"		No	No			Mitochondria	"Nuclear bodies"	"HPA056220: AB_2683071"	"unprognostic (1.71e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.03e-2)"	0.2	1.0	0.7	0.1	1.7	0.0	0.4	0.1	0.5	1.9	0.3	2.5	1.8	0.0	0.9	3.8	0.3	29.7	0.6	2.9	1.2	1.5	2.5	1.7	3.3	0.1	0.5	0.1	3.1	0.8	1.0	0.3	0.1	2.7	0.2	0.0	0.4	0.8	0.6	0.2	0.3	0.1	0.1	0.2	0.2	0.2	60.1	0.8	0.2	1.5	0.1	0.4	0.1	0.1	0.0	0.9	0.5	0.4	0.0	0.0	1.6	5.5	4.6	0.4	4.5	0.0	0.0	0.5	0.1	0.0	0.6	0.5	0.2	2.6	6.7	1.7	0.2	1.3	6.7	0.9	1.9	0.2	0.0	17.3	20.1	0.2	0.3	0.1	8.5	2.0	0.1	2.8	1.1	1.5	0.6	0.3	3.0	15.7	9.1	0.2	3.6	0.2	0.2	0.3	6.0	10.0	10.4	0.6	2.0	3.5	0.1	0.6	1.8	0.7	0.7	1.0	0.1	5.6	0.3	0.7	0.5	2.6	2.6	0.1	0.2	1.5	0.3	3.2	11.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.7	1.7	0.1	0.5	1.2	1.5	0.5	0.1	2.7	0.8	0.0	0.3	0.0	0.0	2.9	0.0	3.3	2.5	49.5	6.8	7.0	0.0	0.0	6.6	2.0	336.2	0.3	0.0	0.0	0.9	0.1	1.1	0.2	0.0	0.2	0.2	0.0	0.0	0.6	0.0	540.3	4.0	0.2	0.0	0.0	0.0	1.9	0.2	0.0	2.8	4.3	0.0	0.0	0.0	70.4	14.7	1.1	0.0	0.0	0.0	0.1
DNAAF4	"CILD25, DYX1C1, EKN1, FLJ37882"	ENSG00000256061	"Dynein axonemal assembly factor 4"	Q8WXU2	15	55410525-55508234	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 26.6"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 187.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.1"					"Low region specificity"	"Detected in all"			HPA051048	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA051048: AB_2681325"	"unprognostic (5.97e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.30e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	1.8	3.0	11.4	1.8	14.7	1.6	4.9	1.8	8.0	4.3	2.1	3.2	5.9	1.1	7.0	15.3	1.8	15.7	3.4	1.6	9.2	7.8	7.2	1.0	6.2	1.5	4.2	8.9	4.8	3.5	13.6	26.6	1.2	9.1	3.2	1.5	6.9	2.4	3.2	1.3	2.4	1.3	3.1	3.7	2.0	1.7	14.6	4.5	0.1	14.3	0.9	1.3	2.8	2.0	2.9	4.2	4.3	1.8	0.7	1.1	0.4	6.5	4.4	4.7	10.1	1.9	3.3	1.5	0.9	2.4	3.1	3.6	0.9	2.6	0.5	4.2	2.0	5.0	1.8	1.8	2.6	3.7	2.0	2.1	2.3	2.8	1.5	1.8	5.0	4.1	2.0	5.5	7.5	2.8	4.9	7.0	2.1	0.7	0.3	4.6	2.3	0.9	4.3	2.6	10.1	3.6	0.8	2.3	0.8	17.1	2.3	4.8	10.5	4.3	1.1	5.8	4.4	6.0	1.2	2.3	5.0	2.5	4.1	4.8	1.8	4.8	1.4	8.2	1.0	1.1	0.0	1.8	1.3	0.6	1.2	0.4	2.9	0.9	0.7	1.2	2.6	1.1	0.8	4.3	0.7	1.2	4.2	0.9	0.4	11.4	14.7	1.8	8.0	9.2	7.8	4.2	8.9	9.1	4.5	11.9	15.9	0.0	0.0	0.0	0.0	0.0	0.0	187.4	28.4	12.2	0.0	1.6	5.0	11.3	0.0	0.0	0.0	0.0	4.4	1.1	0.0	0.0	2.3	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726701-786475	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavorable (8.42e-4)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	11.5	13.0	9.3	13.5	11.4	10.7	12.3	17.4	14.2	15.5	16.3	14.7	10.3	12.0	18.4	13.9	16.7	23.4	15.4	18.8	11.6	8.6	15.0	18.2	9.9	11.8	9.5	7.6	20.6	22.5	14.4	21.1	12.1	10.4	16.1	9.9	14.0	17.6	14.3	33.9	12.0	13.6	13.9	9.2	12.5	13.0	14.8	9.4	20.7	15.9	11.2	14.2	15.6	12.4	3.3	4.6	1.4	2.8	3.0	4.7	1.9	30.7	24.4	7.3	16.9	4.8	5.3	18.4	6.4	6.2	8.0	7.6	24.3	16.4	18.9	9.3	6.7	19.1	18.7	13.4	16.1	6.2	3.2	22.8	4.6	14.5	17.5	6.6	14.0	8.4	6.4	6.9	10.0	7.4	5.3	10.8	9.6	29.3	3.9	5.8	30.3	8.3	12.6	26.8	10.2	19.4	15.4	2.3	13.0	9.3	13.0	15.3	25.4	10.5	25.9	7.4	8.7	22.8	11.8	9.0	4.5	16.0	15.3	14.3	7.7	9.2	10.9	9.8	14.8	23.3	0.0	1.9	1.4	2.2	2.8	3.3	1.6	3.5	4.7	2.7	3.3	3.3	2.5	0.0	3.0	2.0	4.6	0.8	1.9	9.3	11.4	17.4	14.2	11.6	8.6	9.5	7.6	10.4	9.4	17.9	7.8	0.0	5.2	0.0	5.8	12.5	5.1	14.7	7.9	8.7	25.5	6.8	13.3	6.0	0.5	5.6	3.8	0.0	3.6	11.2	5.1	3.9	0.0	8.2	5.0	9.5	3.5	5.5	8.2	1.3	6.6	2.7	0.0	0.0	10.5	9.1	8.6	0.0	8.1	8.6	16.1	0.0	3.9	6.7	20.0	0.0	3.8	2.2	11.2	3.5
DNAH17	"DNAHL1, DNEL2, FLJ40457"	ENSG00000187775	"Dynein axonemal heavy chain 17"	Q9UFH2	17	78423697-78577394	"Predicted intracellular proteins"		"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 39.4"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 44.2;Cone photoreceptor cells: 82.5;Early spermatids: 36.7;Late spermatids: 24.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 10.0;MOLT-4: 4.8"	"Not detected"	"Not detected"							"HPA024354, HPA076261"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"HPA024354: AB_1847911, HPA076261: AB_2732305"	"unprognostic (4.98e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.70e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.35e-3)"	"unprognostic (1.58e-10)"	"unprognostic (5.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.12e-1)"	"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.1	0.0	39.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.0	0.0	10.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	6.0	0.3	0.5	0.2	0.6	44.2	2.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0	36.7	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	24.9	0.6	1.3	0.0	0.0	0.0	0.8	0.1	0.0	0.4	0.0	7.2	0.0	0.2	16.2	0.5	0.1	0.0	0.0	0.0	0.1
DNAH2	"DNHD3, FLJ46675, KIAA1503"	ENSG00000183914	"Dynein axonemal heavy chain 2"	Q9P225	17	7717354-7833744	"Predicted intracellular proteins, Predicted membrane proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 14.3;parathyroid gland: 20.0;testis: 21.0"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 33.5;Rod photoreceptor cells: 127.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 4.8;CACO-2: 7.5;CAPAN-2: 4.8;OE19: 3.5;SCLC-21H: 4.6;SiHa: 4.5"	"Low region specificity"	"Detected in many"							HPA067103	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA067103: AB_2685778"	"unprognostic (2.03e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.50e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.60e-2)"	0.2	0.1	1.5	0.2	4.8	0.5	0.5	1.8	0.9	1.3	0.2	7.9	1.1	0.2	0.7	5.7	0.2	14.3	0.4	0.2	2.1	1.9	0.2	0.3	5.5	0.2	0.2	0.6	3.0	0.5	20.0	1.2	1.8	7.0	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	21.0	0.7	0.2	0.3	0.2	0.2	0.2	0.2	1.2	0.6	3.2	0.7	0.6	0.7	0.1	4.8	0.2	0.3	0.3	0.1	0.0	0.8	0.2	0.1	0.0	0.1	7.5	4.8	0.2	2.3	0.1	0.1	0.4	0.0	1.1	0.1	0.1	0.2	0.1	0.5	0.2	1.2	0.3	0.2	0.4	0.0	0.8	0.1	0.7	0.0	0.3	0.2	0.4	0.0	0.9	0.1	0.4	0.4	3.5	1.6	0.2	0.5	0.1	0.0	1.4	4.6	0.3	4.5	0.1	2.3	0.4	0.4	0.3	0.2	0.4	0.9	0.1	0.0	0.4	0.1	0.2	0.1	0.1	0.8	0.7	0.7	0.4	0.7	0.3	0.5	0.5	0.4	0.6	0.2	1.2	0.5	0.7	3.2	0.6	0.3	0.6	0.3	0.1	1.5	4.8	1.8	0.9	2.1	1.9	0.2	0.6	7.0	0.7	0.0	1.4	0.0	0.8	0.2	2.1	1.7	0.0	33.5	4.5	0.0	2.0	0.0	0.0	0.1	5.0	0.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	1.6	6.4	0.6	0.3	1.7	0.3	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	127.6	0.0	0.4	11.6	2.3	0.1	0.0	0.0	0.0	0.7
DNAH3	"DKFZp434N074, DLP3, Dnahc3b, Hsadhc3"	ENSG00000158486	"Dynein axonemal heavy chain 3"	Q8TD57	16	20933111-21159441	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 10.4;testis: 6.2"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 87.0;Early spermatids: 28.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.2;hTEC/SVTERT24-B: 1.4;U-698: 1.2"									HPA062493			Approved	"Nuclear membrane,Intermediate filaments"		NA	NA			"Nuclear membrane"	"Intermediate filaments"	"HPA062493: "	"unprognostic (1.68e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.57e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.2			0.0	0.2	0.0	0.0	10.4	0.0	0.0	0.5	0.7	0.0	0.0	1.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.3		0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	6.2			0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	1.0	1.2	0.1	0.4	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.9	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.6	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.7	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.5	0.2	0.0	1.6	0.0	87.0	9.1	0.0	0.0	0.2	0.0	0.0	28.8	0.3	0.9	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	5.3	0.5	0.0	0.0	1.9	0.1
DNAJA2	"CPR3, DNAJ, DNJ3, HIRIP4"	ENSG00000069345	"DnaJ heat shock protein family (Hsp40) member A2"	O60884	16	46955362-46973788	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049789, HPA060538"	Approved		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA		31000	"Nucleoli, Cytosol"	"Intermediate filaments"	"HPA049789: AB_2680883, HPA060538: AB_2684315"	"unprognostic (7.68e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.67e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.19e-9)"	"unprognostic (9.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.69e-2)"	25.0	29.2	32.3	18.0	36.5	23.6	22.8	29.8	44.2	21.7	21.1	17.1	20.3	22.3	25.6	33.6	23.4	20.3	18.9	37.9	30.5	27.1	31.2	39.0	17.7	21.4	25.5	27.6	26.1	18.9	29.0	18.9	22.1	31.5	25.6	21.9	18.4	19.1	24.9	43.7	22.3	23.8	26.9	21.2	24.1	20.3	33.0	18.7	20.8	25.4	31.8	23.2	24.5	23.5	13.6	10.5	14.5	14.0	14.3	18.9	10.2	11.0	13.1	13.2	11.2	18.1	17.5	20.2	14.4	17.3	21.6	10.3	11.4	11.5	17.7	11.6	15.4	9.3	17.2	21.1	14.8	25.2	4.2	17.6	13.0	6.4	24.1	21.8	19.7	18.2	18.6	17.2	12.5	11.9	19.0	14.9	7.2	14.9	6.0	18.2	12.0	14.1	27.5	20.1	10.1	19.5	16.4	24.3	21.0	26.0	11.7	18.1	11.6	17.0	25.9	15.6	13.6	10.0	15.4	15.3	12.9	8.1	9.2	12.0	14.8	10.1	23.8	13.5	17.1	10.7	13.0	11.5	14.5	11.9	14.0	15.4	13.6	16.1	13.3	10.5	10.4	16.0	15.7	12.1	14.3	12.0	7.4	18.9	10.2	32.3	36.5	29.8	44.2	30.5	27.1	25.5	27.6	31.5	18.7	47.6	31.0	65.5	60.6	112.8	37.1	86.5	28.1	80.3	42.1	38.4	17.7	68.7	76.3	62.0	53.0	41.0	64.6	0.0	54.2	58.1	44.1	43.1	53.1	50.8	51.1	35.0	49.8	31.3	41.3	44.4	46.3	47.7	69.2	64.1	46.0	56.2	58.4	56.1	55.5	78.9	37.8	51.8	68.0	155.1	97.9	105.3	144.2	46.5	47.8	68.8
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 63.2;skeletal muscle: 69.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 661.6;Late spermatids: 1220.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.7;HeLa: 18.6;RT4: 34.6;SCLC-21H: 22.3;SiHa: 17.4;THP-1: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB004646: AB_426011, HPA041790: AB_2677674"	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	7.3	10.1	29.6	7.6	33.7	28.6	7.6	20.1	25.8	8.6	8.7	10.5	10.4	7.8	5.1	25.3	9.1	21.7	6.6	63.2	22.3	33.8	7.7	1.9	7.0	6.0	26.0	28.1	3.6	3.2	9.5	11.9	5.5	29.2	15.4	10.6	7.2	6.8	9.6	69.0	15.5	9.0	10.7	16.0	5.1	10.8	26.8	14.9	2.0	6.3	15.2	6.9	12.6	62.3	1.9	1.1	2.7	1.0	0.4	4.7	1.6	13.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.2	0.0	17.7	0.0	0.1	1.3	0.0	12.8	0.0	0.0	0.0	0.0	0.0	7.9	18.6	0.0	4.0	0.0	8.6	1.5	1.7	1.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	13.4	0.0	0.0	0.0	5.8	0.1	0.0	0.0	0.0	0.0	34.6	22.3	0.0	17.4	3.5	1.5	1.0	13.4	16.0	0.2	0.0	3.7	1.6	0.1	0.2	0.9	0.0	0.0	1.7	0.0	0.0	0.8	2.7	1.8	0.9	2.6	1.9	2.5	2.5	1.1	0.4	4.7	3.9	0.0	0.4	1.0	0.6	1.4	1.6	29.6	33.7	20.1	25.8	22.3	33.8	26.0	28.1	29.2	14.9	6.0	4.5	10.8	119.2	25.5	16.8	36.3	2.5	131.2	36.4	7.0	76.6	1.2	1.7	1.2	661.6	9.0	34.2	93.5	2.1	3.7	10.3	173.0	37.9	0.2	13.8	6.4	96.0	7.4	7.3	1220.8	9.5	17.6	49.0	1.8	23.3	9.8	3.7	22.8	10.6	5.0	21.2	6.5	7.7	27.5	21.6	40.8	5.7	8.5	16.9	141.9
DNAJB13	"RSPH16A, TSARG6"	ENSG00000187726	"DnaJ heat shock protein family (Hsp40) member B13"	P59910	11	73950319-73970366	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Chaperone	"Ciliopathy, Disease mutation, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 30.4;testis: 10.8"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 66.9;Early spermatids: 65.2;Late spermatids: 44.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 8.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA052465, HPA061330"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA052465: AB_2681842, HPA061330: AB_2732659"	"unprognostic (1.07e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.72e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.40e-2)"	0.0	0.0	1.2	0.4	1.4	2.1	0.0	0.0	0.1	4.7	0.0			0.1	1.0	3.2	0.0	30.4	1.1	0.0	1.6	1.5	0.6	0.0	1.9	1.0	0.0		0.0	0.3	0.0	0.5	0.1		0.3	0.0		0.4	1.6	0.0	0.2	1.4	0.0	0.2	0.5	0.0	10.8			0.1		0.0	0.0	0.0	1.6	3.4	3.1	0.8	0.6	1.7	0.4	0.4	0.9	1.4	1.7	0.1	0.4	0.8	0.3	0.0	0.4	0.1	1.8	0.7	1.8	4.0	0.7	0.8	1.3	0.3	0.0	0.1	5.1	0.8	2.1	1.9	0.7	0.0	1.1	1.6	0.0	0.8	0.4	0.0	1.1	0.0	2.6	0.7	5.2	1.0	0.8	1.3	1.8	0.6	0.5	2.9	0.8	2.8	1.8	8.3	1.6	0.8	2.1	1.0	4.3	0.4	0.9	0.8	1.5	0.3	0.6	1.3	1.9	0.7	4.3	3.5	3.5	0.6	0.5	0.5	3.1	0.8	1.1	1.2	0.2	0.4	1.6	1.2	0.7	0.7	1.5	1.0	1.7	1.4	0.6	0.3	3.4	1.1	0.4											3.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	66.9	3.4	1.8	0.0	0.0	0.0	1.1	65.2	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.5	1.1	0.0	1.7	0.0	0.0	0.2	0.1	0.0	1.1	0.1	0.5	0.0	0.0	9.7	0.9	0.0	0.0	0.0	0.0	0.6
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 99.4"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 37.5;Smooth muscle cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"myeloid DC: 7.7;neutrophil: 7.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 7.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023818: AB_1847793, HPA050794: AB_2681241"	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	7.2	6.3	5.9	5.1	7.2	0.9	2.6	8.6	13.0	6.5	19.1	6.2	9.2	3.8	18.5	9.7	15.7	9.6	8.7	29.3	6.6	6.3	3.7	2.0	3.7	2.2	4.7	3.4	6.5	3.1	2.2	8.6	1.4	6.0	13.8	6.2	5.7	3.7	26.2	99.4	1.5	6.1	29.9	4.5	5.6	11.3	8.1	3.5	1.6	4.4	38.0	2.9	23.0	3.6	0.7	7.7	7.6	1.5	0.5	1.3	0.7	2.5	2.1	13.4	7.1	7.9	6.1	1.5	11.2	8.2	17.3	15.4	1.5	0.6	2.4	2.8	12.3	18.2	0.3	5.1	8.8	14.7	3.5	1.6	0.9	3.1	0.7	9.1	0.3	8.1	8.9	0.6	10.2	5.1	7.7	11.0	4.6	0.2	5.2	13.9	1.8	4.2	3.6	6.3	1.1	4.5	3.2	13.9	1.3	2.4	0.2	5.7	9.3	6.0	0.3	1.3	12.1	2.2	0.8	4.9	8.3	18.2	4.3	3.4	1.9	1.3	1.7	9.5	1.0	8.9	0.1	1.5	0.0	0.4	0.4	1.3	0.7	0.3	0.1	7.7	0.3	0.5	1.1	7.6	0.5	0.1	0.2	1.3	0.7	5.9	7.2	8.6	8.5	6.6	6.3	4.7	3.4	6.0	3.5	6.0	1.0	0.9	1.9	1.8	4.1	37.5	2.5	1.4	1.2	0.0	5.9	0.1	0.0	2.1	5.3	5.2	0.7	0.0	3.0	0.5	3.1	1.5	0.0	1.1	4.7	1.6	0.0	2.5	1.5	5.1	1.4	2.8	5.0	1.0	0.0	12.0	4.2	0.0	7.4	3.7	2.5	6.5	19.4	8.0	0.9	2.6	0.7	0.8	0.0	0.6
DNAJB9	MDG1	ENSG00000128590	"DnaJ heat shock protein family (Hsp40) member B9"	Q9UBS3	7	108569568-108574850	"Predicted intracellular proteins"	"Unfolded protein response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Melanocytes: 322.2;Syncytiotrophoblasts: 476.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 34.1;Karpas-707: 31.1;U-266/70: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040967, HPA041553"	Supported		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA040967: AB_10794430, HPA041553: AB_10794300"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.75e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.76e-2)"	13.7	28.9	11.6	9.7	14.1	16.7	14.6	8.6	15.4	18.2	11.1	10.0	33.7	11.1	12.6	31.4	8.7	12.8	10.8	24.2	11.6	18.7	29.2	54.3	16.1	13.3	14.0	11.4	14.6	47.9	6.9	31.0	51.2	15.7	14.2	9.6	10.1	32.2	29.5	29.4	7.6	10.8	10.7	14.7	10.8	11.9	18.5	10.6	5.4	37.4	7.2	14.2	18.1	13.5	10.0	30.1	25.8	7.7	9.9	24.0	11.4	2.5	2.9	4.0	4.6	11.2	8.1	8.9	9.4	11.4	5.2	6.3	2.9	4.9	3.4	10.5	2.9	16.4	3.1	4.5	2.3	5.4	3.6	2.4	1.8	2.1	9.0	34.1	2.7	3.6	5.7	18.0	3.0	16.9	11.8	5.4	2.0	2.6	31.1	8.1	3.7	2.5	3.1	4.0	3.0	1.6	1.6	4.1	17.7	4.3	1.6	2.8	5.9	3.5	15.8	17.3	11.8	2.9	3.7	6.2	5.5	2.6	6.8	3.3	54.8	17.5	3.9	4.8	3.5	5.0	25.8	7.7	3.5	14.1	5.8	24.0	10.0	15.4	14.1	5.7	8.1	8.9	10.2	2.1	9.9	6.2	30.1	8.9	11.4	11.6	14.1	8.6	15.4	11.6	18.7	14.0	11.4	15.7	10.6	3.0	24.5	55.9	74.7	164.9	35.2	49.9	33.1	12.0	26.1	50.6	7.9	92.1	41.4	36.7	250.3	25.6	26.9	46.7	40.0	74.4	81.3	107.9	93.2	138.2	37.2	19.1	63.8	27.0	30.2	167.7	35.4	38.7	322.2	17.2	22.8	79.9	42.7	35.1	43.5	139.7	27.0	38.8	75.0	129.5	59.0	138.6	476.2	51.1	13.6	74.9
DNAJC1	"DNAJL1, ERdj1, MTJ1"	ENSG00000136770	"DnaJ heat shock protein family (Hsp40) member C1"	Q96KC8	10	21756537-22003769	"Predicted membrane proteins, Transcription factors"		"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013432	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013432: AB_1847797"	"unprognostic (7.00e-2)"	"unprognostic (9.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (4.44e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.22e-2)"	14.8	16.0	8.6	13.5	13.4	11.1	14.6	8.3	11.2	14.5	17.8	9.6	16.2	19.9	15.5	14.0	14.1	10.9	16.4	14.2	10.2	7.2	22.1	41.3	20.5	9.5	13.5	6.8	13.4	33.7	27.1	34.3	16.6	13.8	29.2	13.6	12.6	28.5	14.3	10.6	11.6	18.5	22.8	15.0	13.7	19.9	7.7	13.9	12.2	21.8	11.6	11.5	25.9	28.8	6.5	21.5	5.4	15.2	17.9	21.1	7.7	12.7	8.3	18.7	6.9	17.6	12.5	8.1	17.4	7.6	7.3	11.5	11.4	11.3	5.6	7.7	10.6	10.9	12.3	4.2	8.7	4.0	29.4	14.1	13.4	6.8	6.8	42.7	1.0	5.7	12.7	16.2	8.6	9.9	10.7	9.5	5.6	14.0	32.4	8.1	13.0	3.1	4.3	2.4	11.1	7.0	4.6	6.5	20.6	10.0	3.0	3.9	6.0	12.8	21.5	12.6	21.5	6.8	14.4	14.5	7.1	15.6	11.9	9.8	10.4	3.2	3.9	10.6	42.7	4.2	5.4	9.2	3.6	20.9	8.7	21.1	4.9	12.0	16.6	8.3	6.5	7.8	9.9	5.2	17.9	15.2	21.5	8.4	7.7	8.6	13.4	8.3	11.2	10.2	7.2	13.5	6.8	13.8	13.9	32.8	26.9	21.2	53.6	34.5	28.0	12.9	56.0	21.4	22.7	29.6	43.2	13.3	23.2	67.3	35.8	46.6	45.3	23.3	64.6	86.2	53.4	72.0	40.5	79.1	47.8	36.5	36.8	46.6	37.7	15.6	87.8	31.8	64.1	40.5	54.8	41.6	73.1	46.5	62.9	69.2	144.0	58.2	37.3	70.7	72.9	38.6	29.5	94.8	50.0	63.1
DNAJC13	"KIAA0678, RME8"	ENSG00000138246	"DnaJ heat shock protein family (Hsp40) member C13"	O75165	3	132417526-132539032	"Predicted membrane proteins"	"Protein transport, Transport"	Chaperone	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036923, HPA036924"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA036923: AB_10672480, HPA036924: AB_2675386"	"unprognostic (3.35e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (3.68e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (8.36e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.81e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	23.3	17.8	20.4	15.1	14.4	20.5	16.2	18.0	19.9	20.8	23.1	8.1	23.3	14.5	25.0	18.7	22.3	16.8	13.1	20.5	19.9	11.0	23.6	12.1	17.7	14.9	11.5	17.8	20.1	12.2	21.1	12.3	22.9	17.3	17.8	18.8	10.2	16.1	24.6	20.0	13.7	20.1	26.3	12.5	19.4	16.0	10.3	16.4	13.0	20.6	13.8	13.6	24.5	32.4	2.2	5.7	3.4	7.0	1.7	2.1	1.6	14.8	8.5	11.7	5.9	27.2	24.2	7.1	16.2	30.3	15.7	17.4	9.5	9.5	7.8	10.3	21.9	21.1	12.2	10.8	11.7	22.0	8.9	3.0	9.6	8.6	6.3	14.4	9.6	9.5	17.6	8.6	14.2	17.7	12.0	22.0	12.8	5.4	13.0	22.2	11.4	7.9	4.6	6.8	12.9	7.7	7.7	8.3	6.2	14.2	15.7	4.2	6.9	15.4	8.1	17.5	10.4	12.7	9.1	20.4	17.8	9.2	17.3	6.9	7.4	7.2	10.6	18.6	6.8	13.0	3.4	5.2	0.7	1.9	4.3	1.8	2.2	2.0	1.7	5.7	1.4	1.5	2.1	1.2	1.7	7.0	2.7	1.1	1.6	20.4	14.4	18.0	19.9	19.9	11.0	11.5	17.8	17.3	16.4	11.9	18.7	7.5	6.2	6.0	10.4	41.1	10.2	14.7	11.4	12.2	31.4	6.7	1.7	7.9	1.3	15.5	16.5	0.0	7.9	6.5	10.3	11.3	11.5	7.8	17.4	63.5	13.8	16.5	39.6	1.9	14.1	18.3	27.0	9.0	13.3	13.4	10.9	11.5	20.1	15.8	11.0	6.5	10.3	3.4	12.3	6.6	4.2	6.1	12.1	10.5
DNAJC16	KIAA0962	ENSG00000116138	"DnaJ heat shock protein family (Hsp40) member C16"	Q9Y2G8	1	15526813-15592379	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043643	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA043643: AB_10796794"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (4.52e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.74e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.70e-2)"	9.6	11.5	9.8	9.5	18.7	3.9	12.3	13.2	24.3	10.2	10.9	18.4	14.2	12.0	12.9	14.7	11.5	13.0	11.2	9.1	11.0	10.8	22.1	20.0	8.9	10.5	11.1	10.8	13.1	13.4	20.1	20.3	13.9	17.2	10.8	11.2	12.0	12.1	10.8	19.2	10.2	11.2	11.9	10.7	11.3	9.9	11.1	11.0	11.4	13.9	8.9	12.5	10.3	9.4	6.9	4.1	3.8	4.1	3.2	8.0	3.6	7.5	7.2	6.0	10.9	16.4	13.3	5.6	9.0	9.2	9.1	9.8	6.2	11.1	6.5	6.1	9.0	11.9	9.4	7.3	8.0	12.9	7.7	3.4	6.7	8.3	10.7	16.3	10.3	7.8	9.6	9.5	14.7	8.2	11.4	10.1	5.5	14.1	6.0	10.4	3.0	5.2	5.3	5.7	6.8	5.1	6.2	7.7	7.3	11.2	5.2	6.7	6.3	9.3	8.9	7.6	9.0	5.6	4.2	13.7	16.1	5.8	14.8	4.9	8.2	11.5	5.9	10.0	6.0	7.6	3.8	4.1	3.0	5.6	4.0	8.0	6.8	5.8	5.0	4.1	6.9	7.4	6.3	2.3	3.2	2.9	3.7	5.3	3.6	9.8	18.7	13.2	24.3	11.0	10.8	11.1	10.8	17.2	11.0	0.0	8.3	11.2	4.1	4.5	13.4	12.0	20.4	21.4	11.4	24.4	21.6	10.5	1.7	8.1	7.1	8.7	8.6	0.0	6.0	6.3	8.6	10.7	8.1	15.3	9.4	17.5	11.1	16.5	19.9	5.4	11.5	5.8	6.8	5.4	11.3	12.4	8.2	7.0	10.6	13.8	15.0	6.5	4.6	22.7	14.5	5.1	18.4	4.3	11.5	5.2
DNAJC17	FLJ10634	ENSG00000104129	"DnaJ heat shock protein family (Hsp40) member C17"	Q9NVM6	15	40765155-40807478	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040914, HPA041187"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040914: AB_10794072, HPA041187: AB_10794192"	"unprognostic (9.79e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.58e-2)"	17.0	15.7	19.5	13.0	18.5	7.5	19.8	38.0	22.1	18.3	17.8	20.5	12.7	11.0	20.1	15.4	19.7	19.7	15.2	12.6	14.0	10.3	16.7	23.6	14.7	16.6	16.0	17.3	23.7	16.2	19.4	12.6	18.4	17.2	15.9	15.6	16.2	19.1	16.0	13.6	18.2	15.1	17.2	13.9	19.1	14.1	7.7	19.0	12.1	17.3	11.8	21.2	13.7	17.9	14.8	17.1	19.5	20.0	8.5	26.1	9.2	5.9	5.5	13.9	13.4	6.3	15.8	5.9	11.4	11.3	19.2	15.8	4.4	8.7	9.4	12.6	13.6	8.8	12.7	14.1	18.6	17.0	17.2	8.8	15.8	11.1	4.2	17.8	8.1	14.1	15.6	12.0	15.1	27.3	10.7	17.6	16.1	11.0	5.0	14.6	7.7	11.9	11.0	5.0	14.2	8.1	8.8	11.5	4.8	19.3	11.1	8.8	5.6	8.3	7.7	6.0	10.3	9.8	16.5	17.2	10.9	9.4	12.3	9.6	5.6	16.5	20.5	7.0	21.2	9.2	17.6	15.8	19.5	18.6	20.0	13.1	14.0	15.9	17.3	17.1	14.8	17.3	16.5	5.7	8.5	11.3	13.9	26.1	9.2	19.5	18.5	38.0	22.1	14.0	10.3	16.0	17.3	17.2	19.0	11.9	16.0	10.0	17.1	4.9	14.0	4.7	15.3	18.7	23.9	24.4	11.8	20.3	16.6	15.7	2.0	10.5	21.4	0.0	15.5	13.7	11.3	11.6	20.9	12.5	20.2	12.7	7.5	20.9	9.5	1.4	14.1	15.4	6.8	13.6	12.5	6.6	14.8	20.7	15.2	17.7	9.8	0.0	10.3	4.7	3.9	4.5	14.4	17.8	15.1	19.5
DNAJC18	MGC29463	ENSG00000170464	"DnaJ heat shock protein family (Hsp40) member C18"	Q9H819	5	139408588-139444491	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 51.4"	"Group enriched"	"Detected in many"	20	"Early spermatids: 425.4;Late spermatids: 1065.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036538, HPA060154"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"HPA036538: AB_10670802, HPA060154: AB_2684212"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.73e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.97e-2)"	4.1	4.0	8.2	2.9	15.7	1.9	4.3	10.7	19.5	4.7	3.3	12.4	0.7	1.8	7.6	4.9	3.9	4.9	4.2	6.3	8.7	8.7	4.5	1.2	4.5	3.3	8.8	11.7	10.7	2.3	6.5	7.1	4.1	16.2	4.9	3.0	3.4	2.1	5.9	8.4	2.2	2.4	6.8	9.0	2.9	2.4	51.4	7.5	1.2	5.1	1.7	2.6	3.4	3.3	3.5	2.0	2.1	2.0	6.0	6.7	1.4	1.6	1.8	11.3	10.4	6.3	6.7	1.2	3.4	7.5	6.0	11.0	4.0	1.3	7.5	9.3	5.3	13.3	2.9	6.3	10.2	6.3	17.0	8.4	5.1	3.8	1.9	5.0	0.6	2.5	9.0	1.3	10.0	6.1	10.2	8.2	2.9	2.2	7.3	8.9	0.9	2.2	2.4	7.8	0.6	2.5	6.2	12.3	1.2	3.6	1.8	10.5	11.0	3.5	1.4	7.7	15.2	1.6	3.8	10.5	8.0	0.0	2.4	7.2	8.7	11.4	4.0	4.3	3.8	3.4	1.9	2.0	2.1	2.2	1.3	3.2	3.5	3.2	4.1	1.5	3.5	3.2	2.0	0.6	6.0	0.7	2.0	6.7	1.4	8.2	15.7	10.7	19.5	8.7	8.7	8.8	11.7	16.2	7.5	3.0	4.6	2.2	8.0	1.3	29.0	8.8	0.0	2.7	7.9	1.8	9.8	3.8	1.7	4.8	425.4	11.3	0.5	0.0	0.9	3.3	5.4	2.7	9.2	0.0	2.4	15.9	12.1	12.9	3.1	1065.4	13.0	2.6	5.0	4.6	2.5	14.5	2.5	1.4	17.7	2.9	18.4	19.4	8.5	37.2	4.9	1.0	3.9	3.2	1.2	2.6
DNAJC22	"FLJ13236, wus"	ENSG00000178401	"DnaJ heat shock protein family (Hsp40) member C22"	Q8N4W6	12	49346917-49357546	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 10.0;intestine: 10.0;liver: 18.9"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 40.8;Enterocytes: 38.0;Exocrine glandular cells: 37.8;Hepatocytes: 39.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.7;EFO-21: 16.9;MCF7: 13.8;OE19: 28.8;T-47d: 12.5"	"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Not detected"	"Not detected"			HPA039953			Approved	Vesicles		NA	NA			Vesicles		"HPA039953: AB_2676770"	"unprognostic (5.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.01e-2)"	"prognostic favorable (4.56e-5)"	"unprognostic (4.77e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (7.54e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-2)"	1.1	0.3	0.5	0.4	1.0	0.0	0.4	0.4	2.2	1.5	5.4	0.8	0.4	10.0	2.2	1.3	0.4	0.8	10.0	0.4	0.7	0.5	5.2	18.9	0.4	0.4	1.0	1.2	0.4	5.2	2.7	0.4	0.9	4.6	0.4	5.2	0.8	1.2	0.4	0.4	0.2	8.3	0.4	0.8	0.4	4.4	0.6	0.4	0.4	6.6	0.4	0.4	0.4	0.7	0.7	0.8	2.7	0.5	0.5	0.5	0.4	1.4	9.4	0.0	10.0	0.0	0.0	3.3	0.3	3.0	1.0	2.2	15.7	9.9	0.0	16.9	0.3	0.9	0.1	1.4	0.0	1.7	0.1	2.3	0.3	0.2	7.8	2.4	0.0	1.7	0.1	0.0	1.5	0.3	4.0	1.4	0.0	0.1	0.3	0.7	13.8	0.0	0.0	0.0	28.8	4.8	0.0	4.8	0.0	0.2	0.0	1.6	0.8	0.3	0.5	3.1	0.2	12.5	0.2	0.2	1.0	3.1	0.1	1.3	0.0	0.0	0.0	2.3	0.0	2.0	2.3	0.5	0.5	0.5	0.3	0.3	0.4	0.4	0.3	0.1	0.7	0.3	0.3	2.7	0.5	0.4	0.8	0.2	0.4	0.5	1.0	0.4	2.2	0.7	0.5	1.0	1.2	4.6	0.4	0.0	0.6	0.0	1.8	0.6	0.1	0.3	40.8	8.1	1.2	1.8	0.0	0.1	0.0	13.9	3.9	0.3	38.0	0.0	37.8	0.2	1.3	0.5	1.1	39.4	0.1	3.2	20.2	1.3	0.3	1.3	0.0	0.0	3.3	1.0	24.6	0.6	20.2	23.0	0.7	18.0	0.3	0.0	0.3	0.0	0.4	0.3	0.3	0.0	23.4	0.1
DNAJC24	"DPH4, JJJ3, ZCSL3"	ENSG00000170946	"DnaJ heat shock protein family (Hsp40) member C24"		11	31369840-31431849	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 159.5;Late spermatids: 169.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020025, HPA025237"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA020025: AB_1847801, HPA025237: AB_1847802"	"unprognostic (2.07e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.67e-1)"	10.4	10.7	13.0	8.8	21.6	3.7	10.2	16.4	17.4	9.1	8.9	9.4	7.4	7.2	10.7	9.9	10.7	6.8	9.2	20.2	12.7	13.4	10.5	9.8	7.6	10.6	12.3	11.1	8.4	13.3	9.7	21.8	8.4	14.7	9.9	7.7	8.9	9.0	10.1	25.6	14.1	8.1	11.9	13.5	9.0	8.7	8.2	12.8	7.1	11.8	9.5	9.5	11.2	7.0	5.1	4.3	7.5	4.5	3.5	8.1	3.2	4.2	5.5	9.8	7.0	7.3	9.7	4.8	11.0	6.9	6.3	6.0	4.4	4.5	5.3	5.9	7.3	9.5	5.3	6.1	7.2	10.3	13.6	10.6	6.3	9.5	4.3	9.0	11.9	9.4	8.8	8.5	3.9	12.1	8.5	8.4	9.3	12.0	9.8	12.0	4.7	8.9	5.7	4.6	6.0	6.4	5.8	18.2	5.5	7.5	4.3	4.5	6.5	10.6	7.1	7.9	5.4	9.8	7.2	9.9	12.1	8.3	14.0	13.4	11.4	9.8	7.3	17.9	6.0	12.8	7.5	2.9	2.1	6.1	4.5	8.1	4.2	5.6	5.2	2.1	5.1	7.3	7.4	2.3	3.5	2.6	4.3	3.9	3.2	13.0	21.6	16.4	17.4	12.7	13.4	12.3	11.1	14.7	12.8	3.0	6.1	11.7	6.2	10.8	10.4	16.5	2.5	2.7	9.1	3.5	9.8	7.7	3.3	7.3	159.5	6.3	4.4	0.0	7.9	8.5	8.6	7.0	4.7	9.7	7.1	22.3	6.9	7.4	6.5	169.1	8.3	9.6	11.8	4.6	3.4	30.3	8.5	7.0	8.9	7.8	13.6	0.0	8.5	14.4	18.1	7.2	5.3	15.0	4.9	7.1
DNAJC25	bA16L21.2.1	ENSG00000059769	"DnaJ heat shock protein family (Hsp40) member C25"	Q9H1X3	9	111631352-111654351	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 41.9"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019122	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019122: AB_1853155"	"unprognostic (3.07e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.94e-3)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (9.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.19e-2)"	5.1	10.2	3.3	3.9	4.6	1.9	5.8	4.5	4.2	3.4	5.1	2.5	5.7	4.6	4.1	7.7	3.4	3.8	3.6	6.7	4.3	3.8	7.8	41.9	3.5	4.1	2.7	2.3	5.7	7.0	7.4	9.0	4.4	3.3	5.9	3.0	3.6	9.7	4.0	3.6	2.4	6.9	5.0	2.9	2.9	3.7	4.2	1.9	1.4	4.3	2.4	2.2	6.4	4.5	0.6	1.1	1.2	1.9	0.4	0.8	0.3	2.6	2.0	1.4	2.4	14.7	6.6	5.4	10.2	4.9	4.0	4.0	3.9	1.7	2.3	4.0	7.0	6.3	8.6	1.5	2.9	3.9	1.9	2.0	2.3	0.0	7.9	4.8	4.3	3.4	5.7	8.3	3.1	5.9	3.2	3.3	1.3	4.6	2.0	5.1	2.9	1.3	0.2	2.5	5.1	4.8	2.2	7.5	2.1	8.4	2.9	2.4	1.3	5.7	8.0	3.6	2.6	4.2	1.1	6.4	4.9	2.2	13.1	5.8	3.7	5.6	1.3	8.4	2.1	4.3	0.0	0.1	1.2	0.6	1.9	0.2	0.3	0.5	0.0	0.5	0.6	0.5	0.2	0.8	0.4	1.0	1.1	0.8	0.3	3.3	4.6	4.5	4.2	4.3	3.8	2.7	2.3	3.3	1.9	6.0	11.0	14.5	13.2	9.4	7.7	9.0	7.6	13.4	12.5	10.4	19.6	11.8	11.6	13.6	7.8	4.9	17.6	0.0	14.1	18.7	13.1	26.6	1.1	75.4	10.9	12.7	16.6	6.7	5.0	1.4	9.5	7.9	11.8	4.6	14.9	3.9	11.0	7.4	9.6	10.7	20.2	12.9	11.3	29.8	11.9	8.2	11.6	7.9	10.9	17.1
DNAJC27	"RabJS, RBJ"	ENSG00000115137	"DnaJ heat shock protein family (Hsp40) member C27"	Q9NZQ0	2	24943636-24972094	"Predicted intracellular proteins"			Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 30.4"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 74.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036815, HPA036816"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036815: , HPA036816: AB_10673506"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.44e-4)"	"unprognostic (8.84e-2)"	"prognostic favorable (8.48e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.78e-3)"	6.0	5.6	6.7	3.4	13.8	5.3	5.9	9.4	15.7	5.6	4.1	6.8	1.9	3.2	6.6	8.1	3.7	5.7	4.8	7.3	6.7	8.0	6.1	3.1	4.4	4.1	9.5	6.5	10.9	3.6	7.6	10.2	4.6	19.0	5.5	4.6	4.9	3.2	5.2	6.5	4.5	3.3	5.0	8.3	4.1	3.7	30.4	8.2	3.6	5.3	2.4	3.9	4.1	6.1	1.4	0.8	2.9	1.2	4.5	1.9	0.9	4.6	2.0	4.3	4.4	6.2	5.2	3.3	3.6	5.3	3.8	3.3	2.1	2.1	4.3	0.8	2.5	3.2	3.7	3.3	2.2	3.9	1.9	2.6	2.7	2.4	1.9	3.9	2.4	3.8	3.9	3.8	3.0	5.9	4.3	1.5	5.2	1.8	4.0	4.1	1.7	4.3	4.2	2.8	1.6	1.8	2.7	8.7	2.4	3.6	2.5	1.6	5.6	3.3	2.6	4.9	4.8	2.3	1.8	1.4	5.0	3.6	2.6	3.2	10.4	3.7	5.2	2.5	4.0	2.1	0.0	0.8	2.9	1.0	0.5	1.9	1.4	1.2	0.8	0.8	1.1	1.6	1.8	0.2	4.5	1.2	0.4	1.1	0.9	6.7	13.8	9.4	15.7	6.7	8.0	9.5	6.5	19.0	8.2	8.9	7.7	4.2	5.9	1.8	22.7	19.8	5.1	22.7	2.3	7.0	35.3	3.3	3.3	2.4	37.0	4.1	3.2	0.0	2.2	1.6	4.0	4.1	10.4	2.5	2.9	35.0	14.9	5.5	2.4	25.8	8.1	4.3	1.7	3.6	4.6	11.7	1.3	0.0	6.0	2.2	22.5	0.0	12.8	74.8	19.0	2.9	3.5	5.7	4.3	3.0
DNAJC3	"ERdj6, HP58, P58, P58IPK, PRKRI"	ENSG00000102580	"DnaJ heat shock protein family (Hsp40) member C3"	Q13217	13	95677139-95794989	"Disease related genes, Predicted intracellular proteins"	"Antiviral defense, Stress response, Translation regulation, Unfolded protein response"	"Chaperone, Repressor"	"Deafness, Diabetes mellitus, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039336, HPA041326"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		2900000	"Endoplasmic reticulum"		"HPA039336: AB_2676451, HPA041326: AB_2677412"	"unprognostic (1.44e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.12e-2)"	"prognostic favorable (3.47e-5)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.30e-3)"	"unprognostic (8.18e-2)"	19.1	16.1	11.2	13.5	14.5	24.5	25.4	8.5	12.3	24.4	15.5	10.0	35.5	14.7	18.5	25.9	13.9	15.8	14.0	16.6	9.8	9.8	22.1	61.9	18.7	19.0	12.8	9.0	15.0	44.8	14.8	33.9	31.6	13.8	22.8	17.1	10.8	43.3	34.0	10.3	11.6	22.0	14.2	17.5	17.2	17.9	8.6	12.9	8.9	40.7	10.4	12.8	19.1	19.2	4.5	18.0	32.5	13.0	8.9	10.6	5.6	12.2	7.0	5.6	16.1	23.4	11.7	16.9	17.4	15.8	8.0	7.4	8.7	26.0	11.3	16.6	17.4	11.4	12.6	7.3	13.2	12.4	10.9	3.3	15.5	10.0	13.9	32.3	18.8	20.6	13.9	14.2	11.8	27.4	14.8	17.4	5.1	5.2	0.1	13.5	5.0	6.3	6.8	4.2	28.8	5.5	6.5	9.8	8.6	17.8	15.3	3.2	6.2	12.3	29.6	8.5	13.5	14.7	20.9	19.7	15.7	5.4	10.4	8.9	24.2	10.5	5.2	26.4	11.4	21.5	21.9	10.6	32.5	10.2	12.5	10.6	4.5	8.5	8.5	6.8	3.8	6.1	8.2	30.6	8.9	13.0	18.0	5.1	5.6	11.2	14.5	8.5	12.3	9.8	9.8	12.8	9.0	13.8	12.9	74.5	58.8	47.9	69.5	83.6	21.8	45.1	71.4	64.3	56.9	45.4	25.5	47.0	18.3	87.5	152.1	55.4	52.5	23.3	103.7	111.5	93.0	145.2	65.8	125.0	73.0	23.8	40.2	63.3	61.2	22.1	66.4	81.8	113.1	51.3	45.2	44.2	87.6	42.4	71.1	57.9	16.8	90.5	89.1	33.5	81.0	81.2	158.7	51.7	36.6	100.0
DNAJC5	"CLN4, DNAJC5A, FLJ00118, FLJ13070"	ENSG00000101152	"DnaJ heat shock protein family (Hsp40) member C5"	Q9H3Z4	20	63895182-63936031	"Disease related genes, Predicted membrane proteins"		Chaperone	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012139, HPA012737, HPA013154"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Vesicles	"HPA012139: , HPA012737: AB_1847293, HPA013154: AB_1847292"	"unprognostic (9.96e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (3.04e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (2.24e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.08e-2)"	13.0	14.2	30.5	12.1	36.6	16.4	8.5	38.0	48.6	7.3	12.3	11.2	9.6	14.2	7.2	7.8	29.9	10.8	8.7	22.6	28.1	31.6	9.3	9.6	12.3	14.5	23.8	26.7	5.9	23.7	20.7	15.1	10.7	23.4	11.2	8.9	12.8	14.9	14.3	10.2	16.5	14.7	9.9	12.8	11.7	11.4	8.2	9.2	8.1	14.7	8.4	10.1	11.8	8.2	3.2	9.0	7.5	7.6	2.6	6.7	4.5	11.9	11.3	9.6	9.2	9.7	7.6	7.0	13.3	12.7	23.4	11.3	26.3	14.3	4.8	14.7	13.0	11.3	16.9	7.7	25.1	8.8	3.6	6.1	9.1	8.5	14.6	9.0	8.9	20.7	8.8	19.2	10.8	5.8	9.5	11.7	8.0	8.9	4.2	10.7	8.6	9.5	15.1	3.5	10.4	13.6	9.5	5.4	4.9	8.6	11.6	10.5	6.7	14.4	24.3	8.2	6.3	11.4	36.1	20.5	20.9	6.8	9.8	10.1	4.9	2.4	6.5	20.9	12.0	12.4	2.2	7.5	4.8	6.7	7.6	4.4	3.2	4.4	6.1	5.2	2.9	5.2	5.6	7.5	2.6	5.7	9.0	5.9	4.5	30.5	36.6	38.0	43.5	28.1	31.6	23.8	26.7	23.4	9.2	6.0	16.2	5.3	10.4	18.4	55.1	25.2	15.3	6.7	14.8	22.7	58.9	15.2	11.6	18.8	39.2	18.0	53.6	23.3	32.2	14.9	9.5	25.8	1.1	24.1	37.2	74.7	31.2	26.4	43.4	86.4	6.6	20.5	13.5	20.8	27.7	20.9	42.5	35.1	11.7	19.2	43.4	12.9	10.8	12.0	13.8	19.9	25.3	10.2	23.4	59.6
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 29.6;Cardiomyocytes: 26.1;Erythroid cells: 23.3;Horizontal cells: 49.3;Rod photoreceptor cells: 21.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.2;HEL: 56.7;K-562: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	2.1	12.1	18.6	2.2	28.5	5.0	2.0	24.2	91.4	2.2	2.8	26.9	0.0	2.3	1.9	1.8	1.7	2.4	2.3	9.0	25.0	26.7	8.5	1.6	2.7	1.6	28.8	23.8	1.9	3.4	2.1	7.5	8.0	40.5	2.5	3.0	2.2	1.7	2.1	1.6	2.1	2.3	2.2	28.7	3.2	2.9	3.2	21.1	0.0	3.0	0.0	1.7	1.8	0.6	0.5	0.5	0.0	0.0	0.6	1.5	0.3	3.5	1.0	0.0	1.6	0.8	0.2	8.4	7.1	11.6	11.7	11.5	0.9	0.1	3.4	0.6	2.9	2.9	0.9	5.1	1.1	9.2	21.2	2.4	56.7	1.9	0.2	0.0	1.9	1.4	1.0	0.8	1.1	5.0	2.2	0.2	2.8	22.0	0.4	2.4	0.6	0.7	0.0	2.3	0.0	0.8	0.0	1.7	0.1	8.9	0.0	14.2	9.7	4.1	5.6	1.9	14.1	2.7	0.1	2.2	1.7	1.2	0.2	2.0	2.1	1.4	1.0	4.8	1.4	2.9	0.0	0.0	0.0	1.5	0.0	0.1	0.5	0.5	0.9	0.0	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.3	18.6	28.5	24.2	37.4	25.0	26.7	28.8	23.8	40.5	21.1	0.0	0.3	0.0	0.2	1.1	29.6	26.1	0.0	0.0	0.0	0.0	13.7	4.8	1.7	0.8	1.8	0.7	0.0	23.3	0.6	1.9	1.7	1.3	0.0	0.0	1.1	49.3	6.9	0.0	0.0	1.4	0.0	0.8	6.8	1.8	1.3	3.1	0.4	0.0	0.0	5.9	21.6	0.0	2.3	1.0	2.3	0.3	6.2	0.0	0.5	0.1
DNAL1	"1700010H15RiK, C14orf168, CILD16, MGC12435"	ENSG00000119661	"Dynein axonemal light chain 1"	Q4LDG9	14	73644875-73703732	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 42.4"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 129.8;Early spermatids: 234.2;Spermatocytes: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053129, HPA060974"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA053129: AB_2682051, HPA060974: "	"unprognostic (1.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.17e-8)"	"unprognostic (9.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	6.2	6.3	9.9	5.2	15.0	5.2	4.7	9.2	15.6	5.6	4.7	10.6	7.2	2.4	9.8	11.2	4.1	20.2	8.6	7.6	16.0	9.6	9.9	3.9	6.7	4.3	7.3	14.2	7.1	5.7	11.8	15.0	4.2	18.8	5.5	5.0	7.6	5.5	7.7	4.4	2.9	3.1	8.2	8.5	4.1	5.0	42.4	7.6	3.5	14.2	2.9	3.9	4.8	4.4	6.8	10.9	6.3	4.7	3.8	7.5	2.4	9.2	6.8	8.4	7.6	6.0	7.6	6.9	9.3	7.2	12.3	12.7	7.1	14.7	3.7	7.0	9.8	11.6	5.6	7.9	7.2	17.7	5.5	3.3	3.0	10.1	2.5	6.2	3.5	3.8	5.7	5.8	13.3	9.6	9.3	7.8	5.9	3.4	8.5	14.7	15.1	9.0	4.3	3.9	7.7	6.8	6.5	12.7	1.5	10.1	9.8	13.1	6.1	15.5	3.0	7.2	6.9	16.6	2.4	7.4	15.3	27.6	11.4	8.6	5.0	10.4	7.9	12.5	1.8	10.6	6.3	4.3	4.5	5.2	4.7	7.5	4.9	5.1	5.3	3.9	6.8	4.8	5.2	4.1	3.8	3.7	10.9	4.3	2.4	9.9	15.0	9.2	15.6	16.0	9.6	7.3	14.2	18.8	7.6	17.9	12.2	5.6	6.2	2.9	13.9	11.5	20.4	129.8	26.1	17.4	56.9	4.4	8.3	13.8	234.2	10.5	2.6	0.0	12.4	7.6	10.5	6.3	9.3	5.5	7.5	14.3	9.8	8.0	7.5	33.5	16.1	6.3	11.8	8.2	6.0	18.8	9.5	5.1	15.6	18.2	38.1	12.9	8.2	109.4	22.6	1.8	2.1	5.7	5.4	4.1
DNAL4	"dJ327J16, PIG27"	ENSG00000100246	"Dynein axonemal light chain 4"	O96015	22	38778508-38794198	"Disease related genes, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 73.8;Late spermatids: 143.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003647	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Nucleoli, Cytosol"	"HPA003647: AB_1078712"	"unprognostic (8.45e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.83e-2)"	8.2	11.4	24.1	9.6	21.9	3.9	13.7	8.6	19.8	17.8	10.1	8.5	19.7	7.3	9.8	15.0	12.3	33.5	12.7	9.9	17.7	15.2	16.0	7.1	12.8	7.5	9.5	15.7	15.8	14.9	19.2	19.3	11.9	7.9	13.2	9.2	13.1	16.4	16.3	4.4	11.4	8.0	7.7	6.4	7.5	11.1	36.5	9.7	13.2	26.1	6.6	8.6	8.4	9.1	12.6	14.8	17.5	11.2	15.7	16.6	8.1	8.9	4.5	9.1	8.2	11.7	11.8	0.0	3.8	7.4	5.9	6.5	2.8	10.5	2.2	8.3	5.5	6.8	4.3	5.7	10.1	4.2	5.5	7.5	1.3	1.3	3.1	18.6	7.1	1.9	9.5	33.2	7.8	14.2	15.5	8.4	10.9	2.6	4.5	7.3	11.1	6.6	7.1	3.6	13.3	3.7	6.5	3.9	2.9	12.4	5.3	12.9	6.9	7.9	6.1	15.4	6.9	11.0	6.9	5.1	5.4	5.5	8.1	3.8	2.8	0.8	1.0	16.1	2.4	5.2	15.6	9.6	12.8	13.5	9.5	16.6	8.7	11.2	12.1	9.8	12.6	13.3	11.0	17.5	15.7	11.2	14.8	10.2	8.1	24.1	21.9	8.6	19.8	17.7	15.2	9.5	15.7	7.9	9.7	6.0	8.0	3.7	11.7	4.9	13.6	3.6	15.3	28.1	12.5	3.5	2.0	23.5	26.6	24.0	73.8	4.5	8.0	0.0	13.8	16.6	7.6	8.9	15.0	2.9	12.2	11.1	12.1	9.8	3.8	143.7	10.9	4.9	8.5	6.4	13.8	10.1	16.3	8.6	7.1	15.7	13.1	6.5	4.4	52.4	14.3	9.3	16.6	6.5	13.4	10.8
DNHD1	"C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184"	ENSG00000179532	"Dynein heavy chain domain 1"	Q96M86	11	6497260-6593758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 58.7"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 46.7;Spermatocytes: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA039698, HPA040267, HPA057639"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Nucleoplasm, Cytokinetic bridge"		"HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.45e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-4)"	"unprognostic (8.15e-2)"	1.9	2.1	3.6	1.9	5.9	6.8	2.1	6.8	3.4	2.6	2.9	1.6	2.2	2.2	2.8	3.5	1.3	2.0	3.1	1.8	2.3	1.9	1.5	3.1	3.1	3.4	1.5	1.6	3.3	1.6	1.3	2.0	1.3	2.0	2.3	2.0	2.0	2.3	3.2	1.9	3.4	3.6	6.4	2.2	3.5	1.8	58.7	1.3	1.3	2.5	1.3	2.8	2.2	11.0	1.8	1.5	3.0	0.4	0.1	2.2	0.5	4.3	4.6	4.3	4.0	3.5	5.1	4.3	2.0	2.0	2.3	1.5	3.5	3.9	3.7	0.9	1.6	3.2	7.4	2.1	1.7	2.7	2.3	3.9	3.1	6.0	2.7	2.2	4.3	1.9	3.5	2.9	4.2	6.2	2.2	1.0	5.2	3.7	4.4	1.6	0.9	1.4	4.8	4.3	1.2	3.4	2.2	1.8	2.8	2.4	2.5	2.3	4.4	1.3	4.2	3.1	3.4	2.2	4.6	1.9	2.3	2.5	5.1	2.9	10.7	8.4	5.7	2.2	4.8	2.7	0.0	0.4	3.0	1.3	0.0	1.4	0.3	1.3	0.5	0.6	1.8	1.9	2.2	1.3	0.1	0.3	1.5	1.3	0.5	3.6	5.9	6.8	3.4	2.3	1.9	1.5	1.6	2.0	1.3	0.0	4.3	3.0	1.1	0.8	9.3	3.6	0.0	4.0	5.7	0.0	3.9	0.3	0.0	0.2	8.7	2.2	2.0	46.7	0.3	0.2	1.1	1.8	1.1	4.9	0.7	9.5	0.0	3.1	1.5	9.6	0.9	1.2	0.0	1.0	1.7	5.6	0.3	1.5	1.1	0.3	9.1	0.0	1.2	17.5	1.7	3.3	0.6	0.5	1.7	1.6
DNLZ	"bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17"	ENSG00000213221	"DNL-type zinc finger"	Q5SXM8	9	136359480-136363789	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 7.4;Collecting duct cells: 5.2;Spermatogonia: 4.8;Suprabasal keratinocytes: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.2;MCF7: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062738			Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA062738: AB_2684857"	"unprognostic (2.81e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.6	11.3	13.8	13.0	11.9	13.4	10.4	8.1	13.9	9.7	8.9	9.2	4.0	12.8	10.0	6.2	13.4	7.4	7.1	29.9	11.2	9.1	13.7	14.0	8.0	14.9	11.4	3.5	13.6	25.3	5.0	6.5	7.1	8.5	11.2	2.8	6.2	9.2	7.0	29.6	7.0	7.2	9.9	8.0	13.7	8.3	6.3	6.8	11.6	11.2	7.4	8.9	8.0	9.2	8.6	4.2	8.0	3.1	0.9	6.9	1.2	4.1	7.6	2.6	7.7	1.3	2.8	6.8	6.9	3.8	5.6	2.5	9.1	4.5	9.9	25.3	5.0	4.1	9.2	1.6	4.0	0.6	40.2	10.0	3.5	3.8	3.8	5.2	8.0	6.7	3.5	4.1	4.1	2.5	1.4	2.9	4.3	5.7	7.1	3.6	31.6	9.4	13.1	11.5	6.1	20.1	28.7	3.8	11.4	6.8	4.4	11.7	16.9	7.0	6.5	6.2	1.1	8.1	7.3	6.4	9.4	8.5	6.5	10.5	6.2	8.9	8.7	6.9	3.9	8.6	8.0	1.8	0.3	3.8	3.1	4.8	8.6	5.3	5.6	2.4	5.7	5.4	4.5	1.4	0.9	1.7	4.2	6.9	1.2	13.8	11.9	8.1	11.7	11.2	9.1	11.4	3.5	8.5	6.8	0.0	0.0	1.7	0.9	7.4	0.4	0.8	0.0	0.0	1.2	5.2	0.0	0.8	1.7	0.4	0.1	0.5	0.8	0.0	1.0	0.8	1.0	0.5	0.0	0.9	0.9	0.0	0.0	0.6	0.3	0.0	1.1	1.0	1.7	0.0	1.1	0.5	0.5	0.0	1.1	2.4	0.4	0.0	3.3	0.9	4.8	8.0	0.9	0.0	1.1	1.0
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		500000	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	23.8	32.6	18.5	29.3	31.2	53.4	20.4	25.7	29.7	20.1	51.4	57.5	46.0	32.1	20.4	16.8	29.9	19.7	27.0	35.0	20.8	18.0	38.5	25.1	39.2	28.2	48.3	18.0	17.9	32.2	19.5	20.0	32.3	32.2	24.0	42.5	24.5	24.7	37.7	46.6	40.6	50.8	18.6	43.1	37.6	48.2	23.3	36.4	39.1	23.5	21.1	41.5	35.7	31.5	3.4	11.1	8.6	9.8	10.1	5.8	4.6	35.0	29.0	21.3	16.9	22.0	21.5	27.3	23.5	22.3	34.8	29.6	28.9	23.2	25.5	42.3	25.3	16.6	30.8	29.0	25.5	29.2	31.2	23.0	48.9	25.9	32.3	27.1	26.8	46.4	22.1	19.7	26.6	25.1	21.2	33.8	26.3	39.3	43.9	21.4	42.5	37.3	25.6	24.2	41.6	35.2	37.9	23.1	28.7	22.9	52.9	30.7	20.1	26.8	23.0	16.8	24.8	18.4	32.0	30.6	38.3	13.0	53.7	31.0	36.4	37.1	23.5	28.6	41.1	18.9	3.0	4.5	8.6	5.6	8.2	5.1	3.4	4.2	5.8	5.3	3.1	2.4	4.1	8.5	10.1	9.8	11.1	4.8	4.6	18.5	31.2	25.7	29.7	20.8	18.0	48.3	18.0	32.2	36.4	29.8	21.1	33.5	15.2	20.6	26.5	23.8	15.3	5.3	18.2	48.8	21.6	21.9	43.1	30.7	37.5	27.5	130.4	0.0	27.6	96.1	18.2	17.4	18.5	18.7	42.3	41.3	20.7	20.3	22.9	75.8	15.5	40.5	18.6	50.5	92.3	16.0	35.8	87.7	26.2	31.5	27.7	25.8	19.8	8.0	13.3	27.6	26.5	39.9	56.9	19.7
DNM3	KIAA0820	ENSG00000197959	"Dynamin 3"	Q9UQ16	1	171841498-172418466	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 19.5;Cone photoreceptor cells: 27.5;Endothelial cells: 14.6;Rod photoreceptor cells: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.2;HMC-1: 8.5;RPTEC TERT1: 15.7;U-251 MG: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064121			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA064121: AB_2685193"	"unprognostic (8.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.70e-3)"	5.0	19.3	14.1	2.3	28.3	2.6	3.4	41.4	39.7	6.8	2.7	26.8	0.0	1.9	5.9	3.1	3.0	6.0	5.1	3.0	14.3	16.3	5.8	1.4	7.5	2.5	19.6	17.7	4.6	2.6	3.5	10.3	1.6	47.3	3.6	2.7	2.9	3.7	3.6	2.5	4.0	2.4	5.7	16.4	3.6	5.3	5.4	22.1	0.0	3.4	0.0	2.2	4.3	3.6	0.7	0.7	1.1	0.4	1.0	4.0	3.8	0.6	2.0	1.6	0.3	1.2	0.8	0.0	0.4	1.0	0.8	1.0	0.0	3.0	0.0	6.3	0.9	1.0	0.2	1.2	2.3	0.7	0.8	2.4	18.2	3.0	0.0	0.1	0.3	8.5	0.6	0.4	1.0	0.5	0.9	0.4	1.6	0.0	0.3	0.3	0.0	1.1	0.1	4.7	7.5	1.4	1.2	8.2	0.0	15.7	0.1	3.2	0.6	2.2	0.6	0.2	0.6	0.0	0.7	0.2	2.3	3.2	1.9	11.3	3.1	0.5	0.1	2.2	0.9	0.8	0.0	0.4	0.0	0.7	0.0	0.9	0.7	1.0	0.5	0.7	0.0	1.2	1.5	1.1	1.0	0.3	0.0	4.0	3.8	14.1	28.3	41.4	31.6	14.3	16.3	19.6	17.7	47.3	22.1	0.0	5.0	0.0	1.2	2.2	19.5	2.1	0.0	1.4	0.0	0.0	27.5	0.0	3.3	0.3	6.5	14.6	0.0	0.0	0.3	0.1	3.3	0.4	1.1	0.0	0.7	7.9	0.0	4.3	0.0	2.3	1.7	1.3	0.0	0.0	0.4	3.1	1.6	0.0	2.5	0.5	28.5	0.0	1.4	5.0	0.3	1.5	0.2	0.0	0.5	0.9
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009919	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"		Yes	No			"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: AB_2683640"	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.15e-4)"	11.0	4.8	3.7	8.3	3.6	5.8	8.4	9.2	4.4	13.0	24.9	3.2	23.0	14.5	15.6	11.1	8.2	9.2	10.2	6.0	3.1	2.6	11.1	8.6	6.6	4.5	2.3	3.0	13.8	22.3	24.6	5.0	8.5	3.5	11.6	13.8	8.5	7.2	23.3	10.2	20.0	38.3	15.9	3.1	6.2	15.3	8.6	2.3	30.4	7.1	8.8	7.7	17.4	16.8	4.3	0.8	1.6	2.7	5.3	1.7	1.2	10.4	8.6	7.8	12.3	14.3	12.1	1.9	18.9	18.3	9.2	8.9	5.8	15.9	10.9	8.1	14.4	5.0	8.3	9.1	10.8	12.9	0.5	2.8	1.5	9.7	4.0	7.4	1.0	0.7	5.6	2.4	11.3	10.0	32.4	21.9	3.5	1.4	0.0	18.5	1.3	1.8	2.0	7.5	7.3	5.2	2.2	8.0	0.5	15.6	9.1	1.3	1.8	3.1	0.8	2.3	11.3	0.6	1.0	26.3	6.9	6.6	5.5	12.3	0.9	0.6	15.3	6.5	3.4	5.1	0.0	1.8	0.4	1.7	2.7	1.6	3.0	0.4	1.2	0.8	4.3	0.4	0.8	1.6	5.3	2.7	0.6	0.0	1.2	3.7	3.6	9.2	4.4	3.1	2.6	2.3	3.0	3.5	2.3	8.9	8.3	4.9	7.1	31.1	6.5	5.2	12.7	26.8	14.8	12.2	33.4	6.4	3.3	6.0	1.0	10.8	34.6	0.0	12.4	1.0	11.3	5.5	2.3	13.1	4.1	12.7	3.5	9.2	12.7	2.5	12.7	7.5	3.3	0.0	25.4	3.3	13.5	23.0	8.5	2.9	24.9	0.0	8.2	2.1	8.5	39.9	3.1	1.5	22.8	17.8
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"kidney: 7.8;liver: 20.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 17.3;Proximal tubular cells: 13.5"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Group enriched"	"Detected in some"	16	"memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.2;dendritic cells: 1.1"	"Cell line enriched"	"Detected in some"	7	"BEWO: 31.2"									"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.1	0.0	0.1	0.2	0.1	0.3	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	7.8	20.5	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	4.6	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229484	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 381.3;Proximal tubular cells: 791.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 93.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		370000	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	17.4	25.5	24.1	16.2	27.5	10.1	8.4	7.0	18.7	11.9	39.3	15.0	10.2	53.1	12.3	13.2	19.3	19.5	18.5	12.0	17.3	16.7	48.7	34.7	10.0	14.8	17.2	14.0	13.7	38.8	17.2	9.3	7.3	13.4	13.1	9.7	16.9	22.4	11.8	40.8	10.7	51.0	10.4	10.4	18.8	22.2	5.4	10.8	14.6	14.2	19.2	19.3	12.2	8.9	44.1	36.2	0.9	46.7	7.5	52.6	19.5	32.0	23.5	3.6	15.2	2.6	8.1	11.4	7.8	2.8	5.3	7.0	9.6	11.7	23.1	12.4	2.6	0.2	16.4	2.8	6.2	1.5	12.3	55.9	10.8	21.5	27.2	6.2	9.1	7.1	5.1	7.9	1.6	4.8	2.1	6.9	16.9	24.6	41.0	4.2	53.1	8.7	22.9	7.3	93.7	14.3	14.8	4.9	58.5	9.1	11.0	14.2	17.1	7.2	19.1	15.7	1.2	26.3	30.5	8.6	4.0	7.0	9.1	15.3	28.7	13.1	18.0	2.5	12.3	6.3	0.1	23.3	0.9	9.2	46.7	16.7	44.1	30.4	16.2	36.2	38.2	27.2	18.3	0.8	7.5	33.2	27.4	52.6	19.5	24.1	27.5	7.0	18.7	17.3	16.7	17.2	14.0	13.4	10.8	26.8	33.9	82.4	72.2	54.5	10.6	78.7	186.0	178.0	37.5	109.9	2.0	50.2	381.3	174.9	0.5	25.1	264.9	0.0	92.9	48.7	52.6	77.9	34.5	174.5	265.7	6.4	62.2	33.2	57.1	2.2	62.2	60.3	104.6	40.5	164.0	37.3	143.5	157.8	56.3	791.8	15.3	0.0	47.4	5.4	42.8	64.4	27.0	27.7	262.6	70.6
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791937-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Group enriched"	"Detected in all"	7	"dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6"	"Cell line enhanced"	"Detected in all"		"PC-3: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	15.2	16.3	15.8	19.0	18.0	31.6	16.0	15.5	19.9	16.4	24.2	15.4	20.5	14.0	23.3	21.3	18.8	20.6	18.6	20.6	14.6	15.3	15.6	18.7	18.2	17.7	14.5	17.6	20.1	24.1	18.2	17.8	18.3	15.1	23.5	32.0	16.1	21.0	21.6	45.0	21.8	19.6	32.6	13.8	21.2	20.7	36.9	11.8	25.2	21.1	19.4	21.7	30.1	16.1	3.2	14.2	41.0	16.6	1.0	3.4	4.5	20.4	10.9	11.3	10.7	8.7	9.4	11.8	7.7	12.5	25.0	22.7	34.5	33.6	8.5	25.3	11.2	39.9	15.5	9.9	16.5	16.6	4.6	12.4	9.2	11.5	22.0	17.7	18.0	15.4	9.4	15.6	16.3	15.8	11.5	14.6	12.4	8.5	8.7	14.8	27.2	14.7	27.9	7.6	11.6	74.6	11.9	14.0	8.8	12.5	9.8	10.6	9.6	15.7	12.8	16.1	9.2	12.7	28.9	8.5	15.0	11.2	14.5	18.4	9.5	6.1	10.5	32.8	11.6	12.8	4.8	16.6	21.6	1.4	6.9	1.4	3.2	1.9	2.4	14.2	2.7	3.4	1.6	41.0	1.0	4.2	5.5	2.7	4.5	15.8	18.0	15.5	19.9	14.6	15.3	14.5	17.6	15.1	11.8	14.9	18.5	22.9	37.2	22.7	18.5	17.9	12.7	24.1	21.6	24.4	3.9	56.0	43.1	57.6	31.1	21.1	32.8	0.0	66.5	35.6	23.6	31.5	5.8	16.8	62.7	19.1	21.4	22.7	26.5	10.6	26.2	33.7	15.1	86.6	70.1	42.1	70.4	51.8	25.5	33.4	24.1	0.0	24.5	77.5	33.7	24.1	48.3	18.1	31.6	54.5
DOCK11	"ACG, FLJ32122, FLJ43653, ZIZ2"	ENSG00000147251	"Dedicator of cytokinesis 11"	Q5JSL3	X	118495898-118686163	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 43.8;Kupffer cells: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.8;HMC-1: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059695	Uncertain		Approved	"Nuclear membrane,Nucleoli"		NA	NA			Nucleoli	"Nuclear membrane"	"HPA059695: AB_2684104"	"unprognostic (4.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.16e-3)"	27.3	6.9	5.0	15.9	15.0	23.5	30.6	1.4	3.1	7.6	11.6	1.5	4.2	2.5	7.9	8.2	7.8	7.0	7.3	6.7	4.4	3.3	7.4	2.6	11.7	27.5	5.4	2.0	3.5	1.7	2.4	15.9	10.0	3.9	6.0	4.8	1.4	4.4	4.1	2.5	4.4	9.7	9.6	7.8	13.8	7.3	3.7	5.3	19.7	9.4	3.6	13.8	9.3	13.3	5.2	4.6	13.1	7.3	7.6	11.3	2.1	0.0	2.4	2.0	1.9	27.8	11.9	5.4	2.8	6.1	2.3	6.2	0.3	0.0	7.5	0.2	10.2	2.8	0.1	3.6	0.0	2.1	9.3	3.1	16.5	2.7	0.0	9.0	9.9	39.9	8.3	0.1	2.5	2.8	1.6	0.1	6.6	5.0	13.7	1.4	1.6	5.9	13.2	2.1	2.2	3.9	4.0	5.3	0.2	0.0	0.5	0.7	4.9	8.5	7.9	2.7	1.6	0.9	8.4	0.1	1.9	0.6	10.9	1.2	4.2	6.3	7.0	4.1	15.9	1.0	6.3	4.2	7.5	8.8	6.1	5.5	4.9	7.4	7.0	4.6	5.2	6.7	8.3	13.1	7.6	7.3	3.7	11.3	2.1	5.0	15.0	1.4	3.1	4.4	3.3	5.4	2.0	3.9	5.3	26.8	3.0	16.0	0.1	2.6	0.4	1.1	0.0	1.4	13.6	7.0	0.0	3.2	0.0	0.1	0.3	2.1	0.7	0.0	0.0	2.6	8.0	0.4	43.8	0.8	17.4	0.0	4.1	3.7	50.0	0.2	11.2	27.1	8.5	10.8	3.7	0.2	0.5	0.8	4.6	4.8	0.3	25.8	9.1	0.7	3.0	1.6	5.7	23.8	0.8	0.1
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206411	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 44.7;Horizontal cells: 89.0;Ito cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 19.2;HUVEC TERT2: 36.4;TIME: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	10.7	6.5	16.5	10.0	28.2	2.3	6.8	11.7	28.2	9.1	4.4	21.0	2.0	2.8	7.9	4.4	4.4	8.7	7.9	6.9	22.2	10.1	7.3	13.9	25.5	3.7	18.2	12.4	14.2	5.0	4.7	4.0	10.8	12.2	6.5	4.9	1.7	4.4	3.9	6.7	3.5	3.2	10.7	20.3	3.2	3.1	3.5	21.8	0.0	5.8	2.7	3.6	5.7	5.2	0.2	0.3	6.4	1.2	0.1	0.1	0.2	0.0	1.7	4.1	3.3	3.4	5.0	2.3	0.4	4.5	0.8	1.3	0.0	0.0	0.3	3.4	1.0	0.9	0.2	0.6	3.9	3.5	1.2	6.7	0.1	2.8	5.7	2.4	0.5	0.2	2.6	0.4	19.2	9.9	1.2	36.4	1.6	0.0	10.3	1.7	0.4	0.8	0.2	2.2	0.5	7.0	0.2	3.0	1.6	2.8	0.1	0.9	3.2	2.5	2.1	2.5	3.8	0.3	0.1	31.4	3.2	1.5	6.1	1.3	0.4	0.1	0.3	0.3	0.8	7.1	0.2	0.7	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	6.4	0.1	0.2	0.3	0.0	0.2	16.5	28.2	11.7	18.2	22.2	10.1	18.2	12.4	12.2	21.8	44.7	5.0	0.5	3.6	4.6	26.2	11.6	2.5	12.0	21.6	3.5	21.6	0.2	0.0	1.4	2.4	32.2	0.7	0.0	0.3	0.2	6.0	9.4	2.3	14.9	13.6	89.0	10.5	40.5	15.6	1.1	5.2	17.3	8.5	8.2	0.7	4.4	1.0	9.9	7.8	1.1	10.3	12.9	3.3	0.7	1.7	2.4	0.0	0.0	0.8	1.6
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 40.5;lymphoid tissue: 61.0"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 83.1;Cone photoreceptor cells: 72.6;Kupffer cells: 113.9;Macrophages: 79.1;monocytes: 79.4;T-cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 17.3;HL-60: 17.2;MOLT-4: 16.1;NB-4: 27.2;REH: 20.2;RT4: 17.9;THP-1: 51.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003218, HPA073349"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695, HPA073349: "	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favorable (6.89e-6)"	6.7	12.9	5.6	27.4	8.4	20.8	6.1	1.2	4.1	3.1	3.9	9.2	0.9	3.9	3.0	4.3	6.0	4.1	8.2	2.9	6.3	3.3	7.5	3.9	16.8	35.3	10.2	2.3	2.5	6.4	7.6	3.5	10.4	8.1	4.9	4.1	4.4	10.5	2.4	1.7	3.3	15.0	3.4	13.6	43.5	4.9	7.2	8.9	61.0	5.1	3.0	27.1	10.5	4.0	7.3	15.4	40.5	21.5	6.6	5.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.5	0.4	17.3	1.2	0.0	0.0	0.7	0.2	0.1	0.0	5.9	0.6	0.0	0.0	0.0	0.0	17.2	2.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	3.7	8.7	0.0	1.0	16.1	27.2	0.1	0.0	0.2	20.2	0.0	6.7	0.0	17.9	0.0	0.0	0.0	0.2	1.2	0.3	0.4	51.7	3.4	0.0	0.1	0.2	0.0	3.5	0.0	0.0	0.0	10.9	0.3	14.2	14.7	16.7	4.6	15.1	3.8	7.3	5.5	4.8	15.4	6.8	4.4	4.2	40.5	6.6	21.5	4.4	5.3	6.4	5.6	8.4	1.2	4.1	6.3	3.3	10.2	2.3	8.1	8.9	8.9	31.0	83.1	1.5	5.7	0.2	2.0	22.9	1.4	3.4	7.0	72.6	44.4	1.7	0.8	24.2	4.8	0.5	0.0	5.9	3.1	2.9	1.1	23.2	2.5	50.8	0.0	8.1	3.1	113.9	11.5	2.8	79.1	8.5	79.4	8.9	1.0	1.4	17.5	0.4	8.7	3.8	12.9	14.4	15.4	4.1	3.3	35.7	76.2	1.0	3.0
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490822-3500940	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	8.1	6.5	10.5	6.6	13.0	9.3	3.4	5.5	13.0	3.9	5.5	6.9	2.6	18.9	3.7	4.1	4.1	3.1	4.9	5.1	14.9	9.1	6.0	6.4	4.0	4.5	18.2	6.2	3.8	7.6	3.8	3.9	3.8	8.4	5.1	2.0	3.2	6.0	4.0	23.1	7.0	12.3	2.4	25.5	5.9	7.3	4.2	6.1	4.7	2.9	7.8	4.5	3.1	4.7	11.6	11.0	1.8	6.6	6.9	12.3	4.4	9.2	11.0	1.7	3.6	0.9	1.1	7.4	8.8	1.8	4.3	3.4	15.3	3.8	7.2	6.9	1.3	3.9	9.6	2.7	3.0	0.9	10.6	12.4	7.5	6.2	18.2	3.5	10.0	10.5	1.2	3.0	4.2	1.8	1.5	2.2	8.0	16.3	8.5	1.7	10.5	10.8	11.4	9.8	3.7	14.9	12.3	4.0	10.4	2.6	5.2	10.5	7.7	6.2	5.5	8.8	0.8	7.5	5.5	5.0	5.4	7.4	14.3	16.1	11.3	8.2	9.6	6.4	22.8	6.4	1.1	5.3	1.8	6.2	6.2	8.1	8.1	8.5	12.3	8.7	11.6	12.3	10.4	0.3	6.9	6.6	11.0	9.6	4.4	10.5	13.0	5.5	13.0	14.9	9.1	18.2	6.2	8.4	6.1	6.0	2.1	18.5	14.9	20.9	17.4	7.1	10.2	1.4	2.3	5.2	9.8	25.8	18.3	21.7	7.1	12.1	9.7	0.0	18.5	26.0	13.9	16.8	13.8	8.2	19.0	23.8	12.6	11.1	7.2	17.2	13.0	8.6	18.6	24.4	11.0	13.1	19.1	14.4	14.2	23.9	11.8	0.0	13.7	11.1	12.3	24.1	29.1	12.8	16.1	15.3
DOK2	"Dok-2, p56dok-2"	ENSG00000147443	"Docking protein 2"	O60496	8	21908873-21913860	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 138.5"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 113.3;Kupffer cells: 141.8;Macrophages: 166.3;T-cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 138.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.1;HEL: 21.6;HMC-1: 46.4;JURKAT: 8.4;THP-1: 16.7;U-937: 16.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004379, HPA005507, HPA066571"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		1200000	Cytosol	"Nucleoplasm, Nuclear bodies, Golgi apparatus"	"CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749"	"unprognostic (5.39e-2)"	"unprognostic (8.84e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.22e-2)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.22e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.80e-1)"	13.6	3.3	0.6	14.2	0.6	8.4	3.5	0.5	0.6	2.4	4.4	0.4	2.1	3.5	2.0	5.9	3.8	2.8	4.8	3.8	0.6	0.7	2.7	4.6	14.0	12.3	1.5	0.2	2.4	2.3	0.0	1.5	5.3	1.4	3.9	1.6	2.6	2.9	0.6	1.4	1.8	5.9	3.4	2.2	28.6	3.2	1.9	0.7	17.9	1.8	2.7	13.5	4.4	9.8	1.4	38.9	138.5	55.9	27.1	52.8	60.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	21.6	0.0	0.0	0.0	0.1	46.4	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	1.9	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	16.2	0.0	44.9	45.1	138.5	39.0	55.9	18.0	1.4	27.4	29.5	38.9	0.6	15.4	19.1	3.4	27.1	49.3	0.7	52.8	60.8	0.6	0.6	0.5	0.6	0.6	0.7	1.5	0.2	1.4	0.7	3.0	27.3	13.0	0.5	10.2	0.0	1.7	0.0	2.7	2.3	3.5	0.0	0.6	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.9	5.1	0.2	36.8	0.9	113.3	0.0	0.0	4.3	141.8	0.0	0.3	166.3	18.6	8.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.1	0.3	1.7	7.4	0.8	159.2	0.0	0.9
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501907-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.5;bone marrow: 51.8;lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in some"	14	"granulocytes: 17.4;Hofbauer cells: 49.3;Kupffer cells: 45.9;Macrophages: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.5"	"Group enriched"	"Detected in many"	6	"B-cells: 12.7;granulocytes: 47.5;monocytes: 23.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 41.4;HMC-1: 33.7;REH: 51.0;U-698: 40.9;U-937: 29.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		NA	NA		750000	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	6.9	2.4	2.7	22.6	7.1	51.8	4.7	2.7	3.3	1.4	2.4	1.5	0.4	3.6	1.4	2.5	2.4	3.3	2.4	2.2	3.6	2.2	2.3	4.0	10.9	26.3	6.1	0.7	2.0	1.8	0.4	1.4	4.0	4.1	2.1	1.8	2.3	4.1	1.0	1.3	1.0	10.8	2.4	7.6	50.0	2.9	3.1	2.9	1.9	1.7	0.6	21.7	4.8	1.5	12.7	4.8	47.5	23.2	0.1	0.1	7.8	1.4	2.2	1.5	1.8	0.9	0.1	4.0	1.2	0.2	4.0	3.7	3.3	0.6	41.4	0.9	1.0	2.0	2.5	3.4	2.1	1.9	7.5	4.5	6.7	5.2	0.6	0.3	15.6	33.7	0.5	1.3	4.5	0.4	0.4	0.7	3.3	4.6	18.2	1.4	3.8	0.7	19.7	3.8	0.4	3.9	51.0	3.1	0.3	1.2	1.5	2.2	1.4	0.5	0.6	1.8	1.4	3.5	22.1	0.9	3.8	3.6	1.9	1.4	3.7	4.0	40.9	0.8	29.5	0.7	4.7	20.6	19.9	0.1	20.4	0.1	12.7	0.0	0.1	4.8	6.7	0.0	0.0	47.5	0.1	23.2	0.3	0.0	7.8	2.7	7.1	2.7	3.3	3.6	2.2	6.1	0.7	4.1	2.9	0.0	9.3	13.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.5	0.4	0.1	17.4	0.0	49.3	0.0	0.0	8.0	45.9	0.0	0.6	19.8	1.7	1.0	0.1	0.5	0.0	0.0	1.1	0.0	0.6	0.0	0.4	3.0	1.9	0.3	0.8	0.0	0.6	0.1
DOK4	FLJ10488	ENSG00000125170	"Docking protein 4"	Q8TEW6	16	57471922-57487327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 96.4;Paneth cells: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 1.4;neutrophil: 4.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.3;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"A549: 26.0;CACO-2: 29.5;SH-SY5Y: 67.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008348, HPA055849"	Supported		Approved	Cytosol		NA	No			Cytosol		"HPA008348: , HPA055849: AB_2682942"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.18e-3)"	5.0	4.6	7.8	9.5	4.5	0.7	13.6	15.6	6.9	14.2	29.2	2.0	17.7	24.4	9.9	11.8	15.5	8.1	21.0	7.3	5.0	6.9	27.1	25.8	12.3	1.9	3.4	4.7	12.8	14.8	7.2	10.1	6.6	5.2	12.9	16.9	8.4	7.5	15.0	3.1	22.7	51.5	9.6	2.1	5.1	19.9	8.4	2.9	1.9	8.6	12.9	6.3	8.8	14.1	0.5	0.1	4.3	0.0	0.1	1.4	0.2	2.7	26.0	4.2	7.5	5.9	6.5	4.7	4.9	6.5	3.5	1.0	29.5	14.7	0.2	21.4	10.2	2.0	5.8	2.5	1.3	1.5	0.7	1.9	6.0	7.6	17.0	8.4	0.0	0.6	4.5	4.0	4.6	0.5	7.8	5.3	1.0	1.9	1.2	4.1	2.6	0.3	1.1	2.6	12.5	1.1	2.4	2.2	0.3	18.2	1.0	20.8	67.9	4.0	1.7	1.2	19.6	1.5	1.1	5.6	0.6	4.4	1.7	0.2	0.8	1.0	0.2	1.9	1.3	2.6	0.0	0.0	0.0	1.4	0.0	0.6	0.1	0.3	0.2	0.1	0.5	0.4	0.3	4.3	0.1	0.0	0.0	0.1	0.2	7.8	4.5	15.6	6.9	5.0	6.9	3.4	4.7	5.2	2.9	11.9	12.3	0.5	6.3	7.0	16.3	2.7	28.1	0.0	2.3	14.0	0.0	0.6	5.0	12.9	1.1	5.7	96.4	0.0	20.6	6.2	7.5	4.9	0.0	16.1	0.8	7.9	3.5	5.5	0.6	1.1	12.4	0.7	3.3	1.0	23.3	2.5	22.2	60.2	11.3	38.2	0.8	6.5	4.7	0.2	2.3	15.7	0.5	1.0	23.3	5.2
DOK5	"C20orf180, dJ805C22.1"	ENSG00000101134	"Docking protein 5"	Q9P104	20	54475597-54651171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 41.3"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 33.2;Horizontal cells: 36.5;monocytes: 25.2;Muller glia cells: 60.0"	"Group enriched"	"Detected in many"	6	"glioma: 18.0;ovarian cancer: 29.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.7;ASC diff: 8.0;ASC TERT1: 6.8;hTEC/SVTERT24-B: 8.2;U-138 MG: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054460, HPA065235"	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA054460: AB_2682495, HPA065235: AB_2685441"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (8.99e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.49e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.99e-2)"	3.5	2.7	15.5	2.3	11.0	0.6	2.0	1.4	14.8	1.8	1.3	6.6	0.4	1.0	2.1	1.0	2.4	13.6	10.6	18.1	11.0	12.5	3.6	3.2	1.0	1.2	8.4	6.2	2.4	1.9	0.9	1.2	2.4	7.3	1.6	1.4	7.6	1.7	1.5	41.3	0.6	1.1	3.5	5.4	0.9	0.9	2.2	6.4	0.0	5.9	6.4	1.0	3.6	3.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	19.7	0.0	8.0	6.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	2.6	0.0	8.2	0.0	0.3	1.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	2.0	4.2	0.0	5.2	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	31.2	2.0	0.9	0.0	0.0	0.0	0.1	1.4	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	11.0	1.4	12.6	11.0	12.5	8.4	6.2	7.3	6.4	0.0	0.0	0.0	1.0	0.2	9.7	5.9	17.8	0.0	0.0	10.4	5.9	0.2	33.2	16.2	1.9	2.3	0.0	0.0	1.0	0.5	11.2	0.9	0.0	0.0	21.8	36.5	0.0	9.8	0.3	3.1	2.3	1.1	0.0	25.2	0.0	60.0	3.5	0.0	1.1	0.0	7.4	0.0	2.0	0.6	0.4	0.4	0.7	0.0	0.0	0.4
DOK6	"DOK5L, HsT3226, MGC20785"	ENSG00000206052	"Docking protein 6"	Q6PKX4	18	69401055-69849087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 239.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.4;Hep G2: 10.9;RPMI-8226: 10.5;SCLC-21H: 4.8;SH-SY5Y: 10.9;SuSa: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041099, HPA063534"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"		"HPA041099: AB_2677299, HPA063534: AB_2685032"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.62e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.13e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.09e-3)"	2.1	1.6	21.3	1.6	11.3	0.6	1.3	6.8	22.1	3.8	1.5	0.9	0.3	1.0	3.0	1.4	1.7	1.7	5.8	10.2	19.2	9.2	8.7	4.4	4.2	1.2	13.7	13.1	4.2	0.7	3.4	1.1	9.9	14.0	3.5	1.3	5.5	1.7	4.2	0.6	1.2	1.3	6.6	2.7	1.8	1.3	2.8	2.7	0.0	4.1	0.0	1.2	5.2	6.6	0.0	0.0	0.0	0.0	0.9	0.9	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	10.9	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.5	0.0	0.0	4.8	10.9	0.0	0.0	0.0	8.1	0.0	0.0	0.0	4.1	0.6	0.0	1.5	0.3	0.0	0.0	3.1	0.0	3.2	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.0	0.9	0.0	0.0	0.3	0.4	21.3	11.3	6.8	17.1	19.2	9.2	13.7	13.1	14.0	2.7	0.0	0.0	0.0	0.1	0.2	239.6	6.5	0.0	0.0	2.3	0.0	13.7	0.0	1.7	0.0	32.5	0.7	0.0	0.0	0.0	0.0	5.3	0.1	0.0	1.0	0.0	9.5	0.0	0.0	0.3	23.0	1.4	0.3	0.0	0.0	0.0	4.1	0.0	0.0	6.3	7.8	12.7	0.0	2.7	0.7	0.1	0.5	0.0	0.0	0.0	0.1
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947619	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	11.0	20.2	7.9	7.8	13.8	1.4	9.5	7.0	18.6	9.8	8.6	14.9	7.1	8.8	12.4	16.8	10.9	10.8	10.8	12.0	7.6	9.9	17.5	22.0	10.6	10.6	8.1	6.7	13.2	16.9	19.2	8.0	19.5	16.3	12.3	8.0	14.2	15.5	12.8	7.9	11.4	10.9	11.1	5.9	11.6	12.4	22.4	6.0	12.5	11.0	11.9	12.1	10.4	7.3	9.4	14.2	5.6	16.4	9.8	13.7	9.0	5.1	19.3	6.8	10.1	20.2	10.7	9.3	10.8	17.5	13.3	9.9	15.1	8.2	2.8	5.7	15.6	18.8	36.7	9.3	13.5	6.9	4.7	8.1	3.5	13.3	10.9	20.5	3.8	6.3	14.8	12.5	14.3	7.9	7.8	12.9	4.1	8.6	4.6	14.3	25.4	3.1	3.2	8.8	14.8	12.0	3.2	9.0	11.2	11.9	7.8	6.3	7.0	14.3	11.8	6.3	6.7	20.6	5.1	10.7	12.0	4.3	15.1	8.8	4.4	10.8	2.9	11.3	3.5	9.1	2.3	13.5	5.6	10.2	13.3	9.1	9.4	9.2	11.2	14.2	9.2	12.1	12.3	2.1	9.8	16.4	8.1	13.7	9.0	7.9	13.8	7.0	18.6	7.6	9.9	8.1	6.7	16.3	6.0	6.0	2.6	1.5	3.2	1.5	9.0	3.0	7.6	6.7	3.4	7.0	7.9	21.7	0.0	14.1	10.7	8.3	6.2	0.0	12.3	14.0	5.6	3.1	1.1	8.3	11.4	4.8	1.2	17.2	6.9	2.8	11.2	2.7	3.3	1.8	3.8	11.2	10.4	5.8	5.6	7.2	6.5	0.0	4.1	24.0	14.9	1.1	15.2	1.9	5.5	1.7
DOLPP1	LSFR2	ENSG00000167130	"Dolichyldiphosphatase 1"	Q86YN1	9	129081100-129090438	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019179	Approved		Approved	"Vesicles,Intermediate filaments"		NA	NA			Vesicles	"Intermediate filaments"	"HPA019179: AB_1847827"	"unprognostic (1.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	6.4	12.8	10.0	6.8	10.6	7.7	6.8	11.7	19.3	8.3	17.1	17.7	8.6	28.6	6.0	7.4	18.8	6.6	9.2	4.1	10.1	10.7	9.4	21.8	6.7	6.6	13.2	10.6	7.7	10.5	10.4	6.9	11.6	12.5	10.0	14.2	6.1	10.3	5.8	5.2	10.3	27.7	6.3	15.2	8.5	11.8	12.2	11.0	9.4	6.3	8.5	9.1	7.8	8.0	8.8	12.5	9.8	8.3	7.9	21.7	7.2	4.1	16.0	15.7	14.4	5.3	4.5	18.2	10.3	6.0	19.6	11.0	20.6	13.9	8.1	9.1	6.4	15.0	30.3	16.1	8.6	8.3	9.4	9.9	10.6	10.8	15.7	9.4	11.0	13.2	4.9	12.1	12.8	10.2	4.5	8.7	15.1	17.5	8.1	5.5	21.0	12.5	11.4	13.5	30.9	13.0	14.8	12.7	14.5	7.1	6.7	18.0	11.8	13.0	11.8	4.3	9.6	21.7	7.3	7.1	16.9	8.1	15.9	13.9	10.1	19.4	12.3	7.5	2.2	11.1	4.4	6.8	9.8	8.9	8.1	21.7	8.8	10.9	10.8	8.5	6.0	11.1	10.5	1.4	7.9	8.3	12.5	10.1	7.2	10.0	10.6	11.7	19.3	10.1	10.7	13.2	10.6	12.5	11.0	6.0	4.6	3.7	2.9	2.1	3.2	1.6	5.1	0.0	2.3	1.8	5.9	16.9	1.7	5.9	0.5	2.4	26.6	0.0	8.4	11.4	3.3	2.7	5.7	17.0	6.5	3.2	3.5	6.2	3.8	0.4	2.0	2.3	5.0	4.6	9.0	9.1	5.4	13.3	3.9	3.8	3.4	0.0	3.1	4.5	8.7	3.4	13.7	3.8	12.2	3.4
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"Downstream neighbor of SON"	Q9NYP3	21	33559542-33588708	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 44.4;Spermatocytes: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: AB_2676570, HPA049033: AB_2680608"	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	6.4	3.5	4.1	9.2	8.0	9.4	10.2	7.8	5.6	6.8	7.1	3.3	3.5	6.1	6.7	5.8	8.3	6.3	5.9	7.5	5.5	4.4	5.6	16.2	5.2	11.1	4.7	4.0	13.5	5.7	11.7	6.9	12.2	8.1	5.7	7.4	4.4	4.8	4.3	5.9	9.1	9.3	5.4	5.2	8.2	5.8	24.0	3.0	26.4	5.0	8.1	10.7	4.5	9.7	0.7	0.5	0.1	0.9	0.4	1.4	0.3	27.4	6.4	13.5	11.8	4.2	7.8	10.5	21.9	9.5	16.8	19.1	18.0	7.5	14.9	5.7	10.9	12.7	8.2	18.2	7.8	18.5	14.9	15.7	27.9	14.1	16.3	3.1	14.8	6.8	5.5	2.5	19.0	4.6	5.0	10.7	7.8	26.6	26.0	14.4	5.6	13.5	5.3	14.0	13.1	7.9	12.1	27.9	15.9	7.5	7.4	14.7	6.1	32.9	10.5	9.6	7.0	13.8	7.5	6.2	16.0	11.2	11.7	15.4	23.6	23.2	24.5	8.9	19.8	18.0	0.0	0.3	0.1	1.4	0.9	0.7	0.2	1.4	0.6	0.2	0.7	0.8	0.1	0.0	0.4	0.0	0.5	0.6	0.3	4.1	8.0	7.8	5.6	5.5	4.4	4.7	4.0	8.1	3.0	3.0	3.4	0.8	7.7	7.2	3.5	3.4	7.6	0.0	1.2	3.5	9.8	8.0	1.7	3.0	44.4	4.5	2.7	0.0	4.0	22.1	6.4	4.6	8.1	5.5	7.6	6.4	1.2	8.6	2.7	16.6	9.5	5.1	6.8	3.6	3.8	2.4	3.7	2.9	13.1	4.2	2.7	0.0	8.1	53.1	21.1	8.5	13.8	5.7	5.1	8.1
DOPEY1	"dJ202D23.2, KIAA1117"	ENSG00000083097	"Dopey family member 1"	Q5JWR5	6	83067666-83171350	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 37.3;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027902, HPA027904"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA027902: AB_10600003, HPA027904: AB_10600877"	"unprognostic (7.18e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	9.7	8.7	15.7	11.3	19.5	5.5	13.3	25.2	21.2	11.9	9.5	10.1	10.1	9.5	13.9	9.5	9.5	12.0	8.9	10.6	15.2	7.0	8.9	7.5	9.1	8.3	10.9	12.9	17.7	12.1	20.3	21.7	7.3	17.3	12.4	11.0	9.0	13.8	14.9	12.7	16.6	11.7	9.5	13.1	9.5	9.5	14.9	12.8	10.7	16.9	8.5	8.9	12.2	10.7	2.3	2.8	1.4	1.4	1.2	4.1	1.3	3.7	2.7	9.1	8.2	8.2	8.7	4.3	6.4	5.3	4.4	6.4	5.8	0.9	7.3	4.6	6.9	5.5	5.0	9.1	6.9	5.5	6.3	10.3	6.1	3.7	2.1	4.5	8.9	6.4	6.9	9.7	6.1	15.9	5.8	6.4	11.4	12.6	5.4	4.7	3.5	2.6	4.0	1.9	2.7	5.5	7.3	6.9	2.6	5.8	10.5	16.4	3.0	4.8	3.0	1.2	6.8	4.8	5.1	10.7	5.5	2.0	5.6	4.9	6.8	4.8	4.2	3.0	4.1	4.3	0.1	1.3	1.4	1.9	1.4	1.6	2.3	1.6	4.1	2.8	1.9	3.0	1.4	0.2	1.2	1.2	1.2	1.5	1.3	15.7	19.5	25.2	21.2	15.2	7.0	10.9	12.9	17.3	12.8	17.9	7.8	3.2	6.1	10.2	24.8	8.1	2.5	14.7	15.9	3.5	37.3	3.7	1.7	5.4	4.0	6.2	10.2	0.0	7.6	0.9	3.7	2.9	15.1	4.3	3.5	11.1	9.8	8.6	6.9	2.7	9.8	6.4	1.7	1.0	8.3	6.3	4.5	11.8	8.9	4.1	42.6	6.5	4.2	23.8	16.0	8.5	2.9	6.9	8.1	5.9
DOPEY2	"C21orf5, KIAA0933"	ENSG00000142197	"Dopey family member 2"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 43.1"	"Cell type enhanced"	"Detected in many"	7	"Mucus-secreting cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072065	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Nucleoplasm	Mitochondria	"HPA072065: AB_2686486"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	4.6	2.3	5.5	7.5	9.5	17.1	4.9	28.7	11.6	5.1	11.8	3.8	6.8	9.7	2.8	3.3	13.5	3.6	6.5	4.3	4.6	4.0	3.5	7.2	7.2	5.8	3.1	5.8	2.3	3.8	43.1	3.1	4.7	9.5	9.8	12.0	2.8	15.2	9.1	11.1	7.4	13.9	3.8	3.7	5.2	15.8	3.3	3.3	9.3	3.6	7.5	10.6	5.4	6.5	12.0	6.4	6.3	3.2	1.1	3.1	1.3	14.9	3.2	2.4	4.0	2.7	5.2	23.2	7.1	8.5	10.1	6.3	2.2	1.2	2.8	1.1	5.3	7.7	3.1	4.6	1.6	8.2	5.1	4.2	6.4	0.7	0.8	2.4	6.2	3.3	1.8	3.3	6.6	1.7	6.1	4.2	6.7	2.0	4.6	2.9	16.8	4.9	6.4	2.0	17.7	3.3	8.9	1.4	13.6	5.4	6.0	6.5	3.7	4.7	21.5	6.1	3.4	7.8	7.7	7.2	3.9	1.1	5.1	5.7	3.4	8.4	1.3	5.6	13.5	2.2	1.0	3.2	6.3	3.1	3.1	1.7	8.6	2.0	1.8	2.1	12.0	1.3	1.1	5.5	1.1	2.6	6.4	1.5	1.3	5.5	9.5	28.7	11.6	4.6	4.0	3.1	5.8	9.5	3.3	0.0	5.8	31.4	6.9	2.7	5.3	4.0	10.2	6.7	3.4	8.7	3.9	1.5	3.3	8.1	0.7	3.3	17.3	0.0	2.8	9.8	2.8	21.2	8.1	8.5	15.7	0.0	28.2	6.2	15.4	0.0	2.3	12.0	5.0	7.2	56.5	1.5	7.5	24.6	2.8	1.3	3.0	0.0	2.5	4.4	13.0	4.5	6.8	7.5	19.5	10.1
DPCD	"DKFZP566F084, RP11-529I10.4"	ENSG00000166171	"Deleted in primary ciliary dyskinesia homolog (mouse)"	Q9BVM2	10	101570560-101609668	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 56.2"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 438.7;Late spermatids: 828.3;Spermatocytes: 210.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 11.9;intermediate monocyte: 13.2;myeloid DC: 17.4;non-classical monocyte: 5.3"	"Group enriched"	"Detected in many"	13	"dendritic cells: 17.4;monocytes: 13.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036603, HPA036604"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036603: AB_2675212, HPA036604: AB_10673503"	"unprognostic (1.22e-2)"	"unprognostic (1.73e-3)"	"unprognostic (4.66e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.90e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.83e-2)"	"unprognostic (7.54e-2)"	4.6	8.1	21.9	4.0	19.9	4.4	9.3	3.4	14.0	10.7	7.1	6.0	4.6	3.1	8.4	20.6	8.3	35.0	7.2	13.0	15.6	16.6	14.7	4.9	6.7	3.8	16.1	18.6	10.8	9.0	17.9	23.6	4.8	16.0	7.9	6.5	9.6	10.0	10.2	9.5	5.8	2.8	8.5	8.1	1.7	6.1	56.2	7.5	1.1	15.5	5.1	3.6	5.2	5.5	0.8	17.4	0.6	13.2	0.9	1.2	4.6	29.4	16.4	11.9	24.4	11.2	18.8	5.1	14.0	15.8	17.7	16.9	11.6	16.0	2.7	23.5	12.5	7.3	16.8	16.5	19.5	18.9	6.9	16.3	3.4	16.1	17.3	6.0	18.0	2.6	13.4	16.8	21.7	17.4	46.7	15.2	3.8	9.2	3.8	13.4	36.7	0.0	14.2	8.8	7.9	12.6	0.0	16.3	6.2	28.6	8.0	11.8	20.3	11.3	7.5	9.3	11.0	22.6	7.2	11.0	8.6	8.1	17.6	18.5	11.0	12.7	5.0	30.5	4.1	3.7	0.0	11.9	0.5	1.1	13.2	1.0	0.8	0.9	0.9	17.4	0.5	1.0	1.2	0.6	0.9	5.3	2.4	0.3	4.6	21.9	19.9	3.4	14.0	15.6	16.6	16.1	18.6	16.0	7.5	32.8	7.7	2.2	25.6	8.7	11.8	24.6	35.7	158.0	35.2	47.1	17.7	19.9	81.2	52.5	438.7	13.1	5.2	0.0	23.9	15.9	26.0	24.1	1.1	10.2	20.8	11.1	23.0	11.6	6.2	828.3	21.9	11.0	15.1	4.6	10.7	17.5	29.9	10.5	26.2	91.2	37.4	0.0	27.0	210.7	59.6	12.4	8.9	2.2	21.5	16.5
DPF1	"BAF45b, NEUD4, neuro-d4"	ENSG00000011332	"Double PHD fingers 1"	Q92782	19	38211006-38229714	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 31.6"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 18.4;Early spermatids: 23.8;Horizontal cells: 42.9;Late spermatids: 17.6"	"Cancer enhanced"	"Detected in some"		"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 15.7;SCLC-21H: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049148	Enhanced	Approved	Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA049148: AB_2680653"	"unprognostic (7.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-16)"	"unprognostic (2.56e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.96e-2)"	"unprognostic (8.20e-4)"	1.1	1.5	11.8	1.5	15.7	1.0	0.9	6.4	31.6	0.8	1.0	0.9	0.0	0.9	1.0	0.8	0.8	1.0	1.0	1.0	12.4	7.7	0.8	0.8	1.0	1.1	4.5	11.3	0.9	0.9	0.9	1.3	1.1	2.0	0.9	0.9	0.0	1.2	0.8	1.1	1.2	1.0	1.3	2.1	1.1	0.8	2.5	1.2	0.0	0.8	0.0	1.1	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.5	3.0	12.8	9.3	0.9	0.6	1.3	3.8	2.2	6.5	5.5	2.1	0.3	5.8	2.6	2.9	2.6	2.3	15.7	2.1	2.9	5.5	3.0	1.9	1.4	0.8	0.3	1.4	1.6	0.7	0.0	3.8	1.2	0.8	1.2	4.4	4.3	0.3	6.1	4.9	3.1	0.3	2.3	1.0	3.5	5.8	6.5	1.2	0.6	1.1	18.5	6.4	4.2	0.4	0.8	1.6	1.9	0.3	1.4	9.4	3.0	2.2	3.4	2.3	7.7	7.7	4.9	2.0	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	11.8	15.7	6.4	19.6	12.4	7.7	4.5	11.3	2.0	1.2	0.0	0.0	0.0	0.0	2.1	18.4	1.1	0.0	1.4	0.0	0.0	7.9	0.1	0.0	0.0	23.8	0.3	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.0	0.2	42.9	0.0	0.0	0.0	17.6	0.6	0.0	0.0	0.0	0.0	2.6	0.1	0.0	2.5	0.0	2.9	0.0	1.3	4.9	6.8	1.0	0.1	0.0	0.0	0.0
DPH2	DPH2L2	ENSG00000132768	"DPH2 homolog"	Q9BQC3	1	43970000-43973369	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045796	Uncertain		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA045796: AB_2679456"	"unprognostic (2.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.17e-8)"	"unprognostic (1.38e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.37e-2)"	9.6	12.7	13.5	12.4	14.1	7.5	9.8	7.9	18.8	8.3	12.0	12.4	5.9	8.9	9.4	7.5	15.2	10.8	11.5	11.6	11.6	6.3	11.5	21.7	8.5	14.1	13.6	9.3	9.1	21.1	10.4	10.6	8.3	9.7	9.8	11.9	5.8	11.6	9.2	33.4	13.1	9.9	11.2	7.6	13.7	10.6	14.7	12.3	10.8	8.9	14.6	13.5	10.3	7.8	9.0	10.2	0.5	9.2	9.8	10.1	5.8	9.9	11.5	5.2	11.0	3.9	4.1	17.5	5.3	5.8	13.9	11.4	14.6	9.8	16.8	9.1	5.5	7.2	11.5	17.4	15.1	7.5	11.5	15.2	17.3	14.4	15.1	10.3	19.9	9.8	6.3	16.9	16.4	9.1	4.2	9.6	13.4	21.8	9.5	6.9	11.6	17.6	11.0	35.9	16.7	13.2	15.2	11.9	27.2	8.7	8.0	17.9	20.7	7.0	17.8	12.9	7.3	7.5	13.8	6.2	6.7	15.4	11.8	21.1	23.3	38.5	17.2	6.0	22.2	9.8	0.0	6.6	0.3	6.7	9.2	9.9	9.0	6.8	6.9	10.2	8.8	7.0	10.1	0.5	9.8	4.7	8.5	6.6	5.8	13.5	14.1	7.9	18.8	11.6	6.3	13.6	9.3	9.7	12.3	0.0	3.7	17.1	9.7	20.4	6.3	8.5	10.2	6.7	3.4	1.8	9.8	12.3	5.0	14.8	0.3	6.0	2.5	0.0	16.3	12.3	7.0	9.4	4.6	4.2	7.7	3.2	11.5	3.1	1.8	0.9	7.8	5.0	5.0	10.8	6.5	4.5	11.7	0.0	3.5	7.3	5.5	0.0	11.2	8.6	27.1	23.7	7.2	6.9	11.8	8.0
DPH5	CGI-30	ENSG00000117543	"Diphthamide biosynthesis 5"	Q9H2P9	1	100989623-101026088	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046439, HPA076234"	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA046439: AB_2679667, HPA076234: AB_2797274"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.00e-2)"	12.6	21.5	11.2	9.1	19.0	7.9	21.4	10.4	11.9	17.3	12.8	11.5	13.2	6.8	20.6	19.0	16.1	19.3	10.0	19.2	11.2	11.9	14.1	18.1	8.5	15.2	11.9	11.4	39.0	28.4	15.5	31.7	9.3	12.3	15.3	13.7	10.8	16.1	12.7	16.8	11.5	9.2	15.4	16.7	13.6	11.5	9.2	11.3	22.2	18.4	15.5	17.7	14.4	14.7	12.1	8.4	3.3	6.2	14.9	16.2	6.7	9.6	8.8	13.1	12.8	16.2	46.2	11.3	8.5	14.0	12.5	10.6	10.5	2.4	17.0	11.4	7.2	7.8	6.3	14.6	13.0	18.4	7.1	10.7	8.9	8.5	19.9	25.3	10.8	4.7	31.0	18.9	11.7	38.0	24.1	18.6	11.8	19.9	5.4	18.8	8.3	13.2	10.6	10.6	5.2	13.8	12.2	19.1	9.8	14.1	7.4	15.2	7.4	4.7	13.1	37.7	10.4	8.5	6.4	9.4	7.4	10.4	10.7	11.2	6.4	7.4	10.4	10.1	10.2	2.7	3.3	5.1	2.6	11.1	5.5	15.1	12.1	12.3	12.1	8.4	9.6	16.2	14.8	1.9	14.9	6.2	6.2	8.2	6.7	11.2	19.0	10.4	11.9	11.2	11.9	11.9	11.4	12.3	11.3	6.0	10.5	39.8	17.8	14.1	5.0	21.8	17.8	20.1	7.9	7.0	0.0	22.0	19.9	12.0	1.2	11.3	3.4	0.0	15.9	23.6	15.8	9.8	25.3	25.4	17.0	1.6	9.8	13.5	29.4	1.5	25.0	11.3	11.8	26.2	11.4	15.8	10.5	17.5	13.1	22.8	6.2	6.5	10.3	16.4	16.4	15.7	10.9	20.0	23.2	6.3
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554904-137578935	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.7	12.1	14.0	16.4	8.2	10.7	15.9	17.8	13.3	12.7	21.5	14.3	5.9	14.2	17.8	9.4	18.2	10.3	12.6	14.0	7.6	11.1	11.0	10.4	13.0	19.1	11.5	17.3	20.8	14.1	14.9	10.5	12.8	15.6	11.9	10.8	16.1	15.4	9.6	13.5	12.2	14.6	9.0	16.0	11.8	10.1	18.6	11.2	13.8	5.8	13.9	10.9	11.7	10.8	14.2	15.6	9.2	9.3	13.5	8.8	7.1	7.5	12.2	10.9	8.8	6.7	14.1	7.1	6.9	12.0	10.2	14.9	7.1	14.0	12.8	7.4	8.9	17.1	14.1	12.1	9.6	11.2	16.5	5.9	10.1	5.4	10.0	13.2	12.7	6.9	10.8	8.0	15.2	9.8	15.9	11.1	11.8	7.5	8.3	20.2	10.0	14.4	14.0	25.8	15.9	17.9	6.4	11.4	9.9	6.7	13.9	12.6	10.9	9.3	7.9	7.7	13.4	13.1	7.5	9.5	7.7	10.9	13.6	6.2	11.9	15.6	4.9	9.1	8.9	15.6	8.9	9.7	10.9	9.2	11.6	10.8	13.5	12.7	10.4	9.5	11.5	11.7	2.3	9.3	6.4	14.2	9.3	8.8	12.1	16.4	15.9	17.8	14.0	7.6	19.1	11.5	12.8	18.6	6.0	14.0	13.7	10.0	14.8	19.0	12.6	5.1	9.4	7.9	1.8	47.1	18.3	3.3	8.7	1.3	11.7	5.1	0.0	8.1	11.4	11.8	10.7	10.4	5.8	10.5	15.9	6.4	8.6	5.7	4.5	15.3	6.9	8.5	10.8	10.6	17.1	10.1	8.0	14.9	4.2	57.2	19.4	13.0	20.5	25.6	16.6	10.2	16.2	13.9	9.1
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110542-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 751.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 57.2;THP-1: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1300000	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	28.1	45.2	23.7	23.4	35.3	31.8	20.8	23.5	27.5	21.5	22.0	24.9	40.7	23.2	17.5	35.8	19.1	27.0	30.2	44.7	24.6	29.2	21.0	29.9	25.6	34.8	29.7	25.9	14.3	55.4	23.3	42.5	21.9	24.2	28.8	6.9	32.8	73.1	41.6	25.3	26.9	17.8	22.8	21.7	29.1	24.4	30.9	26.8	18.9	41.2	17.5	24.7	21.3	16.6	20.0	60.8	12.2	43.1	19.2	36.8	38.2	6.9	11.0	0.9	0.9	13.6	10.9	1.4	10.5	17.2	7.0	4.6	10.4	5.7	13.7	11.5	6.9	0.3	15.0	8.0	2.1	0.3	13.4	0.5	6.3	15.2	0.3	30.5	16.9	35.2	13.4	8.3	3.0	6.3	10.2	9.1	17.0	13.8	10.7	4.6	19.2	8.5	16.2	3.7	25.2	10.8	12.5	0.1	57.2	11.1	7.7	17.6	12.2	12.1	31.9	29.7	0.2	11.4	54.9	11.0	17.9	6.1	11.3	7.2	13.2	7.5	3.7	21.4	10.3	8.0	6.8	43.1	12.2	34.4	37.6	35.5	19.7	31.1	29.6	41.7	20.0	28.1	25.1	2.6	19.2	22.6	60.8	36.8	38.2	23.7	35.3	23.5	27.5	24.6	29.2	29.7	25.9	24.2	26.8	50.6	79.4	78.5	85.1	59.5	68.6	52.7	58.6	42.8	46.6	50.6	33.4	44.8	31.5	93.8	230.4	57.3	44.4	23.3	59.4	85.7	82.6	106.0	74.8	62.7	275.2	114.4	84.6	55.3	148.6	751.7	143.8	125.9	158.6	165.1	27.0	123.1	65.3	48.9	159.1	69.0	73.5	51.8	56.5	57.7	46.0	56.8	43.0	127.1	37.4	74.0
DPPA2	"CT100, PESCRG1"	ENSG00000163530	"Developmental pluripotency associated 2"	Q7Z7J5	3	109293788-109316517	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.9;testis: 9.0"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 2.7;Extravillous trophoblasts: 9.2"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 35.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Group enriched"	"Detected in some"	5	"BEWO: 7.6;EFO-21: 14.5;SuSa: 8.7"									HPA036134	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036134: AB_10601547"				"unprognostic (2.23e-1)"						"unprognostic (2.79e-1)"				"unprognostic (1.81e-2)"	"unprognostic (3.50e-2)"			0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.5	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	8.7	0.5	0.1	0.1	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.3;lymphoid tissue: 35.8"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 18.3;Extravillous trophoblasts: 16.9;Syncytiotrophoblasts: 5.1"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 10.3"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 10.3"	"Group enriched"	"Detected in some"	4	"HAP1: 22.5;NTERA-2: 83.0;SuSa: 32.3"									"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.1	0.1	0.2	0.3	1.0	8.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.1	0.2	1.3	0.6	0.8	0.3	0.0	0.0	0.0	0.0	2.2	4.2	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	8.1	0.0	35.8	0.1	0.0	1.0	0.4	0.1	0.9	10.3	0.0	0.0	0.7	0.2	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.7	0.0	10.3	0.0	0.1	0.2	1.0	0.1	0.3	0.6	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.4	1.2	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.3	0.2	1.1	1.0	1.4	0.0	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	2.1	0.0	5.1	0.7	0.0	0.3
DPPA5	Esg1	ENSG00000203909	"Developmental pluripotency associated 5"	A6NC42	6	73353062-73354295	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lung: 2.0;testis: 6.8"	"Cell type enhanced"	"Detected in single"	35	"Spermatocytes: 1.4"	"Cancer enriched"	"Detected in single"	2209	"testis cancer: 347.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"SuSa: 12.7"					"Not detected"	"Not detected"			"HPA055016, HPA064505"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055016: , HPA064505: AB_2685275"															"unprognostic (1.85e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	6.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0
DPT		ENSG00000143196	Dermatopontin	Q07507	1	168695459-168729264	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.1"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 155.7;Leydig cells: 214.6;Peritubular cells: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 55.3;fHDF/TERT166: 21.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065548			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		25000	Vesicles		"HPA065548: AB_2685511"	"unprognostic (1.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.12e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.98e-3)"	128.1	6.1	0.8	22.6	0.8	0.0	99.3	0.8	2.4	51.0	81.7	0.9	19.8	2.4	20.4	38.8	33.1	23.0	52.3	48.8	0.8	0.3	2.4	6.0	9.6	7.7	0.8	0.8	12.8	13.4	0.0	0.9	7.8	0.9	24.0	9.4	1.8	14.4	10.2	13.0	8.6	23.1	76.1	0.8	1.0	23.6	8.7	0.8	2.3	16.3	55.7	22.8	48.7	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.2	0.0	0.0	2.4	2.7	2.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	2.4	0.8	0.3	0.8	0.8	0.9	0.8	3.0	1.7	0.0	0.1	28.3	0.0	5.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.6	0.4	0.0	0.0	0.2	0.3	155.7	0.2	0.0	0.0	0.6	0.0	0.0	12.9	0.0	0.7	214.6	0.0	37.1	0.0	0.0	0.0	0.3	0.0	116.3	0.0	0.0	0.0	15.0	0.3	0.3	28.0	0.3	0.0	0.0	0.5
DPY19L1	KIAA0877	ENSG00000173852	"Dpy-19 like C-mannosyltransferase 1"	Q2PZI1	7	34928876-35038271	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 183.8;Late spermatids: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059139	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA059139: AB_2683921"	"unprognostic (4.66e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.53e-3)"	"unprognostic (2.47e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.12e-2)"	9.7	12.2	11.0	10.2	13.0	9.0	13.7	16.9	27.0	15.6	9.3	13.5	4.5	4.8	17.7	4.3	7.1	10.3	13.8	18.1	11.8	13.4	7.2	25.2	13.0	9.9	16.3	12.0	8.6	6.7	5.0	11.2	19.0	23.6	8.6	11.3	10.3	6.4	8.4	4.0	4.5	6.8	17.5	38.1	14.1	9.0	31.7	5.8	2.3	10.4	3.6	8.4	11.5	11.3	1.6	1.6	2.8	2.3	1.6	4.1	1.0	5.3	21.0	12.0	15.2	23.7	18.9	2.5	11.9	10.8	7.4	10.6	5.0	14.0	7.7	17.5	12.3	30.8	9.5	9.1	6.5	16.8	4.0	7.3	11.3	13.3	8.2	8.6	10.5	10.5	9.7	5.4	10.1	6.7	21.3	30.6	3.8	8.4	31.6	26.0	3.0	0.1	10.5	7.7	12.5	9.5	7.8	15.8	11.0	28.2	18.5	5.5	14.5	10.6	1.5	6.1	19.7	10.7	12.7	35.3	14.9	18.0	10.2	16.0	14.3	30.8	8.7	18.4	9.8	41.3	2.8	1.7	0.1	3.9	2.3	4.1	1.3	1.7	3.1	1.5	1.6	0.6	1.8	0.3	1.6	0.8	1.6	1.0	1.0	11.0	13.0	16.9	27.0	11.8	13.4	16.3	12.0	23.6	5.8	26.8	16.0	1.9	5.0	6.4	7.2	12.0	5.1	10.7	14.8	7.0	17.7	10.8	0.0	6.4	183.8	10.5	4.5	0.0	14.0	3.5	8.7	7.7	26.5	13.9	7.4	11.1	14.3	21.5	8.2	52.5	8.6	4.0	5.0	0.0	5.0	7.2	16.9	5.8	9.6	1.5	13.3	0.0	6.6	8.3	3.4	4.3	17.7	5.3	6.3	9.5
DPY19L2	"FLJ32949, SPATA34"	ENSG00000177990	"Dpy-19 like 2"	Q6NUT2	12	63558913-63668939	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.0"	"Group enriched"	"Detected in many"	6	"Early spermatids: 300.2;Late spermatids: 304.6;Spermatocytes: 171.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.4;naive CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"U-266/84: 10.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA071264, HPA078305"	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA071264: AB_2686375, HPA078305: "	"unprognostic (1.97e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (4.22e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.79e-1)"	5.7	4.3	2.6	1.6	5.2	2.1	2.4	5.2	4.5	5.6	2.6	1.4	3.1	0.7	7.8	3.4	1.3	3.7	2.4	12.9	1.8	2.4	6.0	0.3	1.1	0.8	1.7	3.1	7.3	2.3	7.4	10.9	1.2	3.0	5.7	1.2	5.1	2.3	6.3	0.5	1.4	0.9	4.3	0.7	1.1	1.5	44.0	0.9	0.5	8.4	1.4	0.7	2.7	3.1	0.1	0.0	0.1	0.0	0.1	3.4	0.4	1.2	3.1	2.8	6.6	0.7	0.0	0.3	2.1	2.2	2.9	3.8	0.4	1.0	3.4	2.2	0.9	3.6	0.5	3.3	0.3	4.4	1.7	2.0	5.4	1.4	2.0	0.6	3.9	1.7	1.5	0.1	1.4	0.0	7.4	0.8	2.6	2.2	3.4	4.7	2.1	0.2	1.6	2.5	0.5	2.5	0.1	2.3	0.0	5.6	0.5	8.5	0.9	0.8	0.3	1.2	1.2	2.4	1.1	0.6	4.0	5.2	0.6	5.4	9.1	10.4	0.0	4.3	1.9	3.6	0.1	0.0	0.0	0.6	0.0	3.4	0.0	0.1	0.6	0.0	0.1	1.0	2.7	0.0	0.1	0.0	0.0	0.0	0.4	2.6	5.2	5.2	4.5	1.8	2.4	1.7	3.1	3.0	0.9	3.0	0.0	0.0	2.9	0.5	41.9	24.2	2.5	16.0	6.8	12.2	13.7	1.1	5.0	0.4	300.2	2.3	0.0	0.0	0.0	1.1	1.0	3.0	2.3	0.0	0.3	3.2	0.0	0.0	0.0	304.6	6.6	0.0	6.8	0.0	0.0	11.1	0.2	0.0	8.1	5.6	6.2	25.8	15.6	171.9	4.1	0.4	1.1	0.0	0.0	0.9
DPY19L3		ENSG00000178904	"Dpy-19 like C-mannosyltransferase 3"	Q6ZPD9	19	32405543-32485895	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008325	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA008325: AB_1847853"	"unprognostic (9.58e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.55e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	8.4	10.9	20.7	8.1	23.0	11.5	10.1	11.2	18.5	12.8	6.2	15.2	9.9	4.2	10.7	9.3	6.1	8.9	9.7	6.4	17.9	14.1	8.6	7.4	7.6	7.1	15.3	11.0	19.3	11.3	15.0	13.3	11.7	14.5	16.1	6.7	9.8	10.2	8.7	3.6	4.9	5.9	7.6	15.7	10.8	9.8	12.3	10.2	6.8	15.3	4.5	6.9	8.3	7.5	2.9	2.2	9.0	2.7	1.3	2.2	0.8	3.0	5.8	22.0	9.7	22.6	11.7	11.0	9.4	6.7	3.9	7.0	6.8	3.4	11.9	6.0	6.7	2.8	1.6	8.9	4.1	7.4	6.0	5.8	15.9	5.9	6.2	14.9	8.2	9.2	12.1	2.3	4.8	4.6	7.5	9.2	5.7	11.4	3.8	10.1	5.1	2.1	4.1	9.2	5.8	2.3	5.8	8.8	3.5	7.4	7.5	4.9	13.2	4.6	4.5	5.0	12.8	3.4	9.7	10.1	8.0	5.7	4.8	9.9	5.9	12.0	8.0	11.2	10.0	12.8	6.0	2.5	7.4	1.8	1.9	1.0	2.0	1.7	1.7	2.2	2.9	1.4	1.6	9.0	1.3	2.7	1.6	2.2	0.8	20.7	23.0	11.2	15.0	17.9	14.1	15.3	11.0	14.5	10.2	6.0	10.0	3.2	3.5	1.8	11.0	3.1	0.0	6.7	5.7	14.0	9.8	5.5	1.7	1.9	1.7	6.5	3.9	0.0	3.5	4.5	7.7	14.9	1.1	4.9	4.7	74.7	3.5	26.4	14.8	2.2	10.0	2.1	1.7	0.0	8.7	25.9	3.2	4.3	11.0	3.3	12.0	0.0	3.1	10.4	21.2	2.6	12.5	2.1	3.6	3.1
DPYSL2	"CRMP2, DHPRP2, DRP-2, DRP2"	ENSG00000092964	"Dihydropyrimidinase like 2"	Q16555	8	26514022-26658178	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.0"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 240.0"	"Cancer enhanced"	"Detected in all"		"glioma: 89.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 25.5;monocytes: 26.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 61.4;Karpas-707: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002381, CAB018719"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		3900000	Cytosol	"Plasma membrane"	"CAB018719: AB_2085366, HPA002381: AB_1847244"	"unprognostic (2.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (5.41e-5)"	31.6	21.7	53.5	13.4	48.1	3.0	21.3	51.8	137.0	14.6	12.2	54.7	3.9	7.1	14.2	8.1	12.0	14.7	18.0	27.2	52.9	48.6	12.1	11.2	45.3	9.9	56.5	45.4	25.8	7.5	5.1	7.2	25.6	46.9	9.8	12.4	8.2	6.5	10.3	10.9	10.2	9.7	19.9	70.1	19.0	8.5	7.5	44.9	5.8	7.7	5.2	12.3	14.0	13.1	3.2	25.5	0.6	26.7	4.0	4.6	8.8	4.7	23.1	22.8	12.1	61.4	28.3	2.2	9.3	21.8	8.9	11.6	9.0	6.9	7.1	6.8	29.2	18.0	4.6	23.9	9.3	8.5	16.1	2.0	8.1	8.8	12.6	39.4	1.7	3.3	35.1	13.5	24.4	14.2	28.8	17.9	5.6	0.2	63.2	8.9	3.0	13.7	1.7	17.8	15.3	4.5	18.3	9.1	4.7	15.0	5.5	10.4	21.9	11.3	0.1	6.1	15.7	1.7	3.2	32.2	20.3	8.2	16.8	4.0	8.9	9.1	5.6	29.4	10.6	10.3	0.4	24.0	0.2	3.5	26.7	1.2	3.2	3.1	2.3	25.5	1.7	1.6	2.1	0.6	4.0	16.2	15.1	4.6	8.8	53.5	48.1	51.8	68.4	52.9	48.6	56.5	45.4	46.9	44.9	122.1	67.9	17.3	0.8	35.8	104.6	86.8	104.4	17.4	31.8	21.0	29.5	12.9	3.3	17.3	2.6	134.9	3.1	0.0	1.6	9.2	59.6	1.1	19.7	13.4	46.2	133.5	58.3	240.0	207.1	6.4	100.9	92.1	114.7	101.8	73.9	141.1	9.7	3.6	84.1	17.3	36.8	135.8	60.8	3.1	8.5	29.5	3.8	8.7	6.6	1.1
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390811-147510056	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 91.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 312.2;Peritubular cells: 193.4;Rod photoreceptor cells: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 119.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Approved	Cytosol		NA	NA		170000	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.23e-4)"	21.7	7.2	22.9	18.9	20.4	0.5	14.1	6.7	31.0	26.8	39.7	20.9	31.4	6.8	38.8	28.0	28.8	20.1	33.9	18.5	23.7	24.7	2.5	1.8	16.2	6.1	16.7	15.2	33.0	2.2	1.0	4.2	7.1	27.0	40.0	14.3	32.3	7.1	61.4	22.1	7.3	12.9	91.4	24.7	9.1	15.0	12.1	15.9	0.3	7.2	15.5	9.6	45.6	18.9	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	6.1	11.0	0.0	0.4	11.3	0.2	5.8	27.8	12.4	16.5	19.1	0.5	0.0	1.6	16.8	6.5	0.6	2.2	0.2	13.8	2.6	5.0	0.0	5.3	0.0	11.2	0.0	0.0	2.1	0.1	26.6	10.5	31.2	35.3	0.0	0.0	0.2	7.0	0.0	0.0	0.1	23.4	0.0	9.1	0.0	23.4	0.0	10.9	2.4	8.2	119.4	0.0	0.0	1.9	15.9	0.1	0.1	15.4	9.0	6.8	22.0	21.3	19.8	3.5	0.0	8.3	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	22.9	20.4	6.7	12.5	23.7	24.7	16.7	15.2	27.0	15.9	0.0	3.2	0.0	2.8	8.4	12.5	5.2	2.5	4.0	5.7	0.0	312.2	0.1	0.0	3.6	14.1	50.5	0.0	0.0	7.4	0.2	38.0	9.9	1.1	0.2	1.5	4.8	6.3	29.4	0.6	13.2	39.7	1.1	18.6	0.0	0.0	22.9	10.7	0.0	193.4	0.0	109.3	0.0	35.1	1.4	2.6	7.2	0.3	0.0	0.0	3.4
DPYSL4	"DRP-4, ULIP4"	ENSG00000151640	"Dihydropyrimidinase like 4"	O14531	10	132186900-132205776	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;heart muscle: 19.0"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 33.5;Cone photoreceptor cells: 55.0;Horizontal cells: 31.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 23.7;AN3-CA: 31.1;SH-SY5Y: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049066	Approved		Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA049066: AB_2680619"	"unprognostic (6.27e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (8.36e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.47e-6)"	"unprognostic (3.04e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.11e-4)"	1.5	4.4	11.8	2.0	12.3	1.1	1.5	8.9	32.0	1.7	1.4	6.5	0.2	1.1	6.4	2.2	1.4	1.4	2.1	19.0	13.6	9.6	1.0	1.0	1.5	1.4	9.0	9.1	3.0	1.9	1.0	5.0	1.3	6.0	4.8	1.0	4.6	1.5	4.2	2.5	1.6	1.2	2.7	8.1	2.5	1.8	6.7	4.8	0.0	1.0	0.0	1.3	1.4	0.4	0.7	0.0	0.0	0.6	1.1	2.5	0.8	0.0	6.7	23.7	31.1	0.0	0.2	0.0	2.0	0.2	1.3	0.3	0.0	0.2	0.0	0.8	1.0	2.3	0.0	4.6	4.5	0.1	0.0	0.9	0.0	0.0	2.4	4.2	0.0	4.7	2.1	2.2	0.7	0.1	0.4	2.4	0.0	0.0	0.2	3.4	1.9	0.0	0.0	4.1	0.3	2.3	0.0	0.0	3.7	0.0	0.4	3.7	32.3	0.7	0.0	4.1	1.4	0.1	0.0	3.9	5.9	9.9	0.0	5.6	0.0	1.6	0.0	9.9	0.0	0.6	0.0	0.1	0.0	1.4	0.6	0.0	0.0	1.1	0.1	0.0	0.7	2.5	0.7	0.0	1.1	0.5	0.0	0.0	0.8	11.8	12.3	8.9	18.7	13.6	9.6	9.0	9.1	6.0	4.8	0.0	0.0	0.0	0.2	0.5	33.5	14.2	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.2	4.3	0.9	0.0	0.0	0.0	0.1	2.4	0.4	0.0	0.0	0.2	31.8	1.7	0.0	0.0	7.1	3.7	0.0	1.7	0.0	0.0	7.5	0.8	0.0	4.2	0.0	12.3	0.0	4.7	4.4	2.7	0.1	0.0	0.0	0.0	0.0
DPYSL5	"CRAM, CRMP-5, CRMP5, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 47.1"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 80.5;Early spermatids: 30.8;Late spermatids: 97.8"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 41.9;HAP1: 34.9;SCLC-21H: 50.0;SH-SY5Y: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: AB_2686516"	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	1.2	4.7	6.1	1.6	18.4	1.1	1.1	7.8	36.6	1.4	1.6	43.5	0.0	1.7	1.2	1.1	1.3	1.2	1.1	1.1	10.3	11.3	1.2	1.1	1.1	1.1	24.3	8.8	1.1	1.1	1.1	2.8	1.2	21.9	1.3	1.5	1.6	1.1	1.1	1.2	1.2	1.7	1.6	47.1	1.1	1.1	10.3	19.7	0.0	1.1	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	41.9	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	1.1	0.0	34.9	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.0	29.6	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	18.4	7.8	11.8	10.3	11.3	24.3	8.8	21.9	19.7	0.0	0.0	0.0	0.3	0.0	9.2	5.3	0.0	0.0	0.0	0.0	80.5	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.3	0.0	0.1	7.9	0.0	0.0	0.0	97.8	1.4	0.2	1.7	0.0	0.0	15.6	0.0	0.0	1.1	0.0	12.4	0.0	0.0	3.2	2.3	0.3	0.0	0.0	0.0	0.1
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526336	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 41.0"	"Cell type enhanced"	"Detected in some"	15	"Enterocytes: 21.9;Mucus-secreting cells: 12.7;Paneth cells: 11.8;Undifferentiated cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.9;Hep G2: 16.6;hTCEpi: 6.1;OE19: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039158	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039158: AB_10960125"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.1	0.0	0.1	2.1	0.2	0.0	0.1	0.1	0.1	0.8	13.3	0.2	0.1	14.7	0.1	0.1	3.7	0.2	3.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.0	0.1	0.2	5.1	0.1	0.6	0.1	0.1	1.5	41.0	0.3	0.1	0.2	2.9	0.1	0.1	0.2	0.1	0.7	1.5	1.1	1.4	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.6	0.1	5.9	0.0	0.0	0.3	0.4	0.1	16.6	0.0	0.2	0.3	0.0	6.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.3	14.1	0.0	0.1	0.1	0.1	0.0	1.1	0.0	0.1	0.0	2.3	0.0	1.1	0.6	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	5.3	1.2	0.0	2.0	1.2	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.5	0.1	11.8	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.9	0.0	10.6	0.2
DRAP1	NC2-alpha	ENSG00000175550	"DR1 associated protein 1"	Q14919	11	65919257-65921561	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Basal keratinocytes: 722.4;Suprabasal keratinocytes: 887.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006790	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006790: AB_1078702"	"unprognostic (1.69e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.58e-2)"	"unprognostic (8.47e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.96e-5)"	"unprognostic (1.62e-1)"	39.1	41.0	45.9	39.7	43.2	41.8	22.4	43.1	53.5	22.0	27.2	28.4	17.1	30.2	27.2	19.4	32.3	20.2	27.2	41.0	40.5	36.6	23.9	27.7	24.7	34.0	37.1	40.6	24.3	39.1	21.6	25.2	24.6	33.3	25.9	12.7	18.9	27.7	28.4	84.4	31.2	26.6	28.4	32.7	38.5	25.1	46.9	30.8	40.2	40.3	42.0	25.8	25.2	23.8	21.6	30.9	45.7	84.6	31.2	24.6	16.7	59.3	23.1	13.1	25.6	12.9	25.3	7.8	69.1	34.6	43.4	28.6	8.5	34.5	15.3	31.4	53.1	51.3	25.5	5.1	34.3	18.9	22.2	7.6	18.6	9.4	8.2	23.1	15.4	25.2	15.7	14.2	46.6	31.6	25.9	16.2	16.1	7.9	29.2	47.6	29.7	27.8	26.8	19.1	9.1	63.2	25.1	11.2	32.9	14.0	7.5	14.2	15.5	16.4	17.7	35.3	6.8	22.2	12.9	46.9	56.3	51.9	108.4	63.7	24.0	20.1	15.9	55.5	9.9	77.5	21.5	20.6	45.7	23.5	50.3	21.5	21.6	21.5	24.6	30.9	19.8	21.3	22.9	27.3	31.2	84.6	22.6	24.4	16.7	45.9	43.2	43.1	51.1	40.5	36.6	37.1	40.6	33.3	30.8	6.0	32.8	129.7	134.1	722.4	51.3	29.0	56.0	14.7	29.6	123.9	33.4	120.9	240.4	172.6	96.4	114.7	101.6	140.2	148.1	133.9	210.1	153.2	236.3	90.4	270.5	60.4	145.8	80.4	126.4	50.8	166.0	269.4	234.5	261.5	87.1	51.3	208.3	108.7	162.6	190.4	38.5	90.5	180.3	150.9	179.1	887.9	145.9	174.4	99.6	356.0
DRD1		ENSG00000184845	"Dopamine receptor D1"	P21728	5	175440039-175444208	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"brain: 34.5"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 40.8;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 24.2"	"Region enriched"	"Detected in many"	9	"basal ganglia: 147.4"	"Region enriched"	"Detected in many"	13	"basal ganglia: 95.6"	"HPA013393, HPA017304"		Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA013393: AB_1847833, HPA017304: "	"unprognostic (2.74e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.15e-6)"	"unprognostic (6.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.60e-4)"	"unprognostic (5.86e-2)"	"unprognostic (5.43e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	0.7	1.5	1.9	0.2	34.5	0.0	0.1	0.1	12.0	0.7	0.7	0.4	0.0	0.5	0.4	0.7	0.7	0.6	1.1	0.3	1.0	0.6	0.7	2.6	1.8	0.1	0.5	1.6	0.3	0.0	0.0	0.1	2.5	0.3	2.7	0.9	2.1	0.1	1.2	0.1	0.1	0.3	0.4	0.1	0.4	0.4	0.1	6.8	0.1	0.1	0.0	0.4	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	24.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	34.5	0.1	5.3	1.0	0.6	0.5	1.6	0.3	6.8	0.0	0.0	0.0	0.0	0.1	40.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	31.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRG2		ENSG00000108591	"Developmentally regulated GTP binding protein 2"	P55039	17	18087886-18107971	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007716	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Vesicles, Cytosol"	Nucleoplasm	"HPA007716: AB_1078705"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (1.26e-3)"	"unprognostic (7.86e-2)"	"unprognostic (8.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	19.9	19.9	16.1	17.5	21.8	17.4	19.3	14.7	30.8	19.3	19.3	22.9	16.6	19.2	23.5	22.8	21.6	25.2	18.2	22.4	15.7	17.0	19.1	31.9	15.7	21.2	17.6	16.1	27.6	23.9	20.6	18.8	22.4	17.9	21.1	13.4	18.4	21.7	21.7	33.3	19.4	17.9	18.3	17.1	20.7	17.6	14.6	17.2	21.6	23.6	21.2	25.6	20.5	18.0	12.6	18.4	17.0	20.9	20.0	19.8	14.0	14.9	21.4	7.3	7.2	13.6	14.5	13.9	10.6	10.5	17.2	16.0	22.7	9.0	14.5	13.8	12.2	9.2	15.9	12.0	14.6	11.6	12.8	32.9	6.3	11.4	12.6	14.8	5.8	10.1	16.1	13.0	17.2	14.5	10.0	16.3	19.5	11.1	5.7	10.0	16.9	15.4	9.7	5.4	21.2	15.8	16.6	17.7	26.9	10.2	8.8	4.1	11.8	10.5	6.2	12.9	45.9	12.4	8.8	12.2	8.3	7.9	9.7	17.4	6.5	7.9	8.1	12.0	10.6	15.2	11.6	15.9	17.0	19.8	17.2	16.4	12.2	14.7	15.8	18.4	12.6	14.0	15.3	2.1	20.0	20.9	10.3	18.3	14.0	16.1	21.8	14.7	30.8	15.7	17.0	17.6	16.1	17.9	17.2	0.0	7.7	15.6	18.9	14.8	10.8	3.2	15.3	4.0	6.8	7.0	2.0	32.2	24.9	23.5	5.9	15.7	22.3	0.0	23.6	33.6	16.4	17.5	11.5	14.5	28.1	6.4	20.7	15.4	16.4	10.0	19.8	15.6	11.8	24.4	16.3	18.8	21.1	14.0	23.0	22.6	13.8	6.5	19.6	11.2	10.4	10.2	32.8	24.2	20.9	12.6
DRGX	"DRG11, PRRXL1"	ENSG00000165606	"Dorsal root ganglia homeobox"	A6NNA5	10	49364181-49396016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"adrenal gland: 13.9;brain: 8.0"	"Cell type enriched"	"Detected in single"	4	"Melanocytes: 1.7"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5"	"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low region specificity"	"Detected in all"			HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA043978: AB_10961154"		"unprognostic (1.42e-2)"	"unprognostic (5.68e-2)"		"unprognostic (3.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.58e-1)"		"unprognostic (4.54e-2)"	"unprognostic (3.74e-2)"			"unprognostic (8.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"		0.2	13.9	0.0	0.4	0.2	0.3	0.1	0.4	3.3	0.0	0.4	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.1	2.0	0.6	0.0	0.0	0.0	0.9	0.0	4.8	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.3	0.0	8.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.3	0.2	0.3	2.0	0.6	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRICH1	C22orf43	ENSG00000189269	"Aspartate rich 1"	Q6PGQ1	22	23608452-23632321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 68.5"	"Group enriched"	"Detected in some"	100	"Early spermatids: 369.6;Late spermatids: 442.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 15.6"									HPA020446			Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA020446: AB_1853151"	"unprognostic (7.48e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.22e-4)"	"unprognostic (6.46e-2)"	"unprognostic (8.35e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.73e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.08e-3)"	0.5	0.5	0.5	0.5	0.5	1.3	0.8	1.0	0.5	0.5	0.5	0.5	0.5	0.1	1.3	9.7	0.5	0.6	0.5	0.5	0.5	0.3	1.2	0.5	0.5	0.7	0.5	0.5	1.3	0.9	8.3	0.8	0.5	0.5	0.7	0.2	0.5	0.5	0.6	0.5	1.3	0.6	0.5	0.5	0.8	0.4	68.5	0.5	0.5	1.0	0.5	0.5	0.5	0.5	0.0	0.0	0.4	0.6	0.0	1.0	0.0	0.7	0.9	2.2	0.6	2.7	0.6	2.0	0.0	0.0	0.1	0.1	15.6	0.6	1.0	0.1	0.6	0.5	1.5	3.0	0.1	0.4	0.2	1.5	0.5	1.2	0.7	1.0	0.4	2.4	1.2	1.3	0.5	0.0	0.9	0.4	0.4	1.2	0.3	0.2	0.8	0.3	0.7	0.2	0.7	0.8	1.6	0.1	0.0	0.4	1.7	1.0	0.7	0.0	1.3	1.1	0.5	0.3	0.1	0.4	0.0	2.8	2.5	0.2	1.0	1.4	0.1	2.6	0.6	0.2	0.0	0.3	0.0	1.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.0	0.5	0.5	0.3	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	369.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	442.6	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.4	0.3	0.0	0.0	0.0	4.1	1.5	0.0	0.1	0.0	0.0	0.0
DRP2		ENSG00000102385	"Dystrophin related protein 2"	Q13474	X	101219769-101264497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 20.3"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 2.3;Intestinal endocrine cells: 1.7;Peritubular cells: 2.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 11.3;TIME: 19.0;U-87 MG: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002949			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles, Plasma membrane"		"HPA002949: AB_1078706"	"unprognostic (8.47e-4)"	"unprognostic (3.56e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.58e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.27e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.44e-16)"	"unprognostic (3.71e-4)"	"unprognostic (4.22e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.25e-1)"	1.1	1.5	9.3	1.2	17.2	1.1	0.8	0.4	20.3	1.7	2.8	1.2	0.0	1.1	2.5	2.7	1.3	1.0	1.3	0.9	5.8	4.2	0.7	0.6	0.8	0.8	4.6	10.1	4.4	0.6	0.6	2.4	0.7	2.6	4.1	1.8	0.5	0.7	3.1	0.7	0.8	1.2	2.2	3.1	0.7	0.7	1.6	2.2	0.9	0.6	0.0	0.8	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.7	2.4	0.1	0.1	0.2	0.1	0.5	0.1	0.4	1.0	0.0	0.4	0.3	0.3	0.1	0.7	0.0	0.3	0.0	0.8	0.1	0.2	0.2	0.5	0.0	0.2	0.1	0.5	1.5	0.0	0.8	0.0	0.1	1.4	0.5	0.0	1.0	1.6	0.0	1.3	0.5	0.1	0.1	0.1	0.3	11.3	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.5	0.0	0.1	19.0	0.2	0.7	0.2	0.4	0.0	0.1	0.0	4.6	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	9.3	17.2	0.4	20.3	5.8	4.2	4.6	10.1	2.6	2.2	0.0	0.0	0.0	0.0	0.1	2.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847139	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 22.2;pituitary gland: 9.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 15.0;Horizontal cells: 15.9"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.6;MCF7: 12.3;NTERA-2: 3.4;SCLC-21H: 5.1;T-47d: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019324, HPA057493"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA019324: AB_2670118, HPA057493: "	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.9	1.1	12.7	0.9	10.3	0.9	1.2	3.0	22.2	0.9	1.0	8.2	0.0	1.0	0.9	2.8	0.9	1.1	1.0	0.9	10.1	8.6	0.9	1.4	1.0	0.9	6.8	10.1	0.9	1.2	0.9	9.1	2.9	9.5	1.0	1.0	0.7	0.9	1.0	0.9	0.9	1.0	0.9	3.7	2.9	0.9	2.0	6.9	0.0	0.9	0.0	0.9	1.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.5	3.4	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.7	10.3	3.0	14.7	10.1	8.6	6.8	10.1	9.5	6.9	0.0	0.0	0.0	0.0	0.0	15.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	15.9	0.0	0.6	1.0	3.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.8	1.5	0.0	0.7	0.0	0.0	0.0
DSCC1	"DCC1, hDCC1, MGC5528"	ENSG00000136982	"DNA replication and sister chromatid cohesion 1"	Q9BVC3	8	119833976-119856010	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 34.2"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 15.8;Spermatogonia: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA023780, HPA024401"	Uncertain		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA023780: AB_2671311, HPA024401: AB_2671557"	"unprognostic (7.36e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.91e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.92e-6)"	"prognostic unfavorable (3.93e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.12e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.32e-9)"	"unprognostic (2.75e-2)"	"unprognostic (5.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (8.18e-2)"	4.3	4.7	3.6	8.5	3.9	9.2	5.4	9.4	5.0	5.1	4.6	3.3	3.5	4.1	6.2	2.4	5.8	3.0	4.7	3.4	3.9	2.6	2.1	2.5	3.3	11.5	4.0	2.0	4.1	7.0	1.3	1.6	4.0	5.3	4.1	6.4	2.1	11.4	4.3	3.9	4.5	4.0	4.9	4.2	4.1	4.0	4.8	5.1	34.2	2.4	5.7	9.5	3.4	5.1	1.4	0.8	0.2	0.2	2.4	3.3	0.9	11.9	5.9	11.7	10.6	1.7	3.1	5.0	8.2	1.7	5.9	6.2	5.3	7.3	21.6	7.2	2.4	3.7	8.8	13.2	5.1	6.4	14.6	11.9	27.5	6.0	6.2	0.5	10.7	9.7	1.4	0.8	7.3	3.5	1.4	1.7	14.5	9.3	9.7	7.1	11.7	28.2	6.7	17.1	31.7	14.6	10.1	11.1	10.3	4.6	7.5	10.5	6.4	4.4	35.1	5.5	9.5	6.5	5.9	1.1	6.5	17.7	6.2	11.9	13.3	19.8	22.9	3.3	17.3	9.4	0.0	0.2	0.2	3.3	0.0	2.5	1.4	0.7	1.6	0.2	0.6	0.4	1.4	0.0	2.4	0.0	0.8	1.1	0.9	3.6	3.9	9.4	5.0	3.9	2.6	4.0	2.0	5.3	5.1	0.0	0.3	0.0	1.9	3.1	0.4	0.7	0.0	2.7	0.0	0.0	0.0	1.8	0.0	1.6	0.1	2.4	0.1	0.0	2.1	15.8	3.5	1.4	4.6	0.0	4.1	0.0	0.0	6.2	1.3	0.0	1.1	0.0	3.3	0.0	0.4	1.3	0.5	0.0	2.5	1.1	0.2	0.0	2.8	1.1	22.6	2.9	1.1	1.3	1.5	0.9
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: AB_2681746"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.5	2.3	7.9	7.4	21.5	14.2	9.0	12.5	29.4	15.7	23.1	0.0	3.0	0.3	1.1	21.8	15.8	20.3	1.1	29.4	20.6	10.9	4.8	0.7	3.4	0.1	24.0	0.5	0.5	30.1	12.7	17.4	17.1	8.2	9.2	2.7	0.2	4.8	7.5	0.3	1.4	0.6	4.2	0.0	0.6	1.8	7.3	5.0	10.4	0.7	2.6	2.0	12.1	0.0	0.3	5.7	0.1	1.2	3.4	15.9	4.6	3.9	10.0	1.0	0.3	0.5	8.4	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0	14.9	2.6	18.6	20.6	46.1	4.1	7.0	5.1	18.7	18.2	3.5	0.0	2.0	6.6	4.0	39.9	11.9	0.0	0.0	7.5	3.7	35.5	14.2	22.0	3.8	39.5	1.6	1.2	57.7	85.3	19.2	50.9	81.1	10.1	97.4	0.7	3.9	9.5	0.0	28.3	6.1	3.0	32.3	29.2	2.6	5.1	34.9	4.1	6.5	1.0	42.4
DSEL	"C18orf4, DE-epi2, FLJ11477, NCAG1"	ENSG00000171451	"Dermatan sulfate epimerase-like"	Q8IZU8	18	67506582-67516980	"Predicted membrane proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 43.3;Extravillous trophoblasts: 69.4;Fibroblasts: 40.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ: 19.9;BJ hTERT+: 11.5;LHCN-M2: 24.9;U-138 MG: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060942			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA060942: AB_2684392"	"unprognostic (2.49e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.91e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.16e-4)"	10.2	3.4	8.8	3.2	15.5	1.6	9.4	7.9	12.8	10.9	4.5	15.7	2.5	2.2	5.7	4.0	3.1	7.1	8.3	5.1	8.6	8.4	9.0	7.1	6.0	1.9	13.2	4.5	7.6	3.6	3.6	1.3	11.5	9.7	4.8	3.5	2.4	2.3	4.9	1.9	3.2	2.7	7.4	11.1	4.5	3.1	3.4	10.9	0.0	2.8	1.1	1.6	3.6	8.4	0.2	0.1	0.6	0.1	0.3	3.2	0.3	0.0	0.0	2.4	0.0	4.7	7.0	0.3	19.9	11.5	5.1	2.2	0.0	0.0	0.0	0.0	10.1	1.3	0.1	0.4	0.9	4.9	0.0	0.0	0.0	2.2	0.0	4.0	0.0	0.0	7.0	1.3	3.1	7.4	1.9	1.0	0.0	0.0	0.2	24.9	0.0	0.0	0.0	0.3	0.0	2.1	0.2	5.3	0.0	2.3	0.0	0.9	1.1	1.8	0.0	0.0	1.1	0.0	0.0	1.7	25.9	0.8	1.8	2.2	0.1	0.0	0.0	5.4	0.0	2.2	0.6	0.1	0.2	0.2	0.0	1.7	0.1	0.8	1.2	0.0	0.2	0.5	3.2	0.5	0.3	0.1	0.1	0.2	0.3	8.8	15.5	7.9	9.9	8.6	8.4	13.2	4.5	9.7	10.9	6.0	14.4	2.0	8.0	10.3	9.4	14.3	43.3	0.0	2.3	10.4	3.9	2.4	0.0	7.9	1.1	11.3	0.5	0.0	2.0	69.4	40.8	6.6	4.6	12.9	2.2	3.2	6.3	16.0	2.1	1.4	22.7	2.9	6.8	0.0	0.1	14.3	5.4	0.0	34.6	18.8	4.2	12.9	12.3	13.1	11.7	11.5	7.4	2.5	0.6	5.4
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954628	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Basal glandular cells: 1024.4;Basal keratinocytes: 2104.0;Cone photoreceptor cells: 1319.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 94.5;hTERT-HME1: 70.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	26.5	29.2	43.4	11.7	57.1	2.5	59.2	43.6	52.4	53.8	31.5	32.1	11.5	15.1	53.6	21.7	37.1	19.4	16.8	28.1	41.2	36.2	18.0	26.6	29.4	5.4	56.5	28.9	30.3	14.0	32.1	28.2	15.1	53.9	22.6	17.4	8.4	23.6	25.3	57.5	81.8	16.9	53.6	54.9	12.8	14.8	11.7	66.5	6.1	7.6	33.6	7.7	19.7	23.7	0.6	5.3	0.3	1.7	2.1	0.4	0.3	12.2	5.9	7.9	4.4	13.1	20.7	4.5	16.5	15.8	6.8	7.6	3.4	3.2	1.9	6.8	37.2	6.8	8.6	6.7	29.0	13.5	11.6	9.9	3.4	10.6	6.2	11.8	3.3	0.0	9.1	94.5	16.6	70.1	11.9	12.9	1.9	2.8	8.1	17.7	3.4	1.0	1.3	6.0	6.8	4.3	0.0	6.1	2.8	20.6	15.8	10.5	7.9	7.0	2.4	11.2	14.1	3.7	5.3	34.5	15.1	12.7	7.2	13.6	9.1	6.4	1.0	10.7	1.8	7.2	0.3	1.7	0.0	0.3	1.3	0.1	0.2	0.4	0.0	3.2	0.6	0.1	0.2	0.1	2.1	1.0	5.3	0.0	0.3	43.4	57.1	43.6	52.4	41.2	36.2	56.5	28.9	53.9	66.5	312.7	10.2	2.2	1024.4	2104.0	540.0	729.3	79.0	49.5	257.0	52.4	1319.4	36.7	6.6	171.1	26.9	93.9	163.1	23.3	56.2	11.1	132.5	139.6	16.2	67.6	21.5	290.8	43.1	50.3	48.7	7.9	123.4	67.7	204.1	62.3	71.1	216.1	150.7	84.2	143.2	6.7	103.8	64.7	142.4	7.1	9.1	749.3	22.2	6.1	19.2	121.2
DTD2	"C14orf126, MGC9912"	ENSG00000129480	"D-tyrosyl-tRNA deacylase 2 (putative)"	Q96FN9	14	31446036-31457510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001117	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA001117: AB_2666204"	"unprognostic (2.56e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.28e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (5.74e-6)"	11.9	11.0	12.4	6.8	16.0	2.9	13.1	9.1	19.6	6.7	6.8	15.2	3.8	5.6	8.0	7.7	9.9	7.5	6.9	6.0	13.2	11.0	8.6	11.6	10.0	8.0	13.6	8.9	8.6	9.9	8.3	9.6	6.2	13.3	8.8	8.2	7.1	10.3	6.1	2.3	8.2	5.3	8.3	10.9	6.7	5.7	14.6	9.9	12.3	9.4	2.8	7.8	7.5	6.5	6.4	6.6	3.5	4.8	6.9	9.1	4.8	8.4	7.2	6.3	8.2	11.6	9.9	4.3	7.8	7.7	6.2	5.5	3.9	8.2	16.2	5.4	8.9	6.7	8.2	9.9	8.8	10.7	8.7	4.4	4.6	5.2	21.7	12.5	9.3	5.7	11.1	10.0	5.5	12.5	5.2	9.1	9.8	9.0	7.8	8.2	10.2	13.4	8.4	8.5	14.7	7.5	9.1	4.6	8.4	11.6	7.4	9.4	6.2	12.8	16.7	9.0	5.6	15.3	4.9	6.5	6.9	6.0	5.5	6.7	9.6	17.9	15.8	3.0	8.6	11.0	3.5	4.8	1.7	4.0	4.1	5.6	4.9	5.9	4.3	6.6	6.4	9.1	6.0	3.0	6.9	2.0	4.0	2.9	4.8	12.4	16.0	9.1	19.6	13.2	11.0	13.6	8.9	13.3	9.9	8.9	7.0	5.2	5.4	4.6	4.3	3.6	7.6	5.3	4.5	3.5	7.9	7.4	3.3	4.8	3.3	3.5	2.7	0.0	5.4	5.3	5.8	4.4	1.1	11.1	4.5	4.8	2.9	1.3	6.4	5.1	6.9	2.9	3.3	2.8	5.9	9.5	4.9	3.5	7.8	6.8	8.3	0.0	6.7	8.1	2.5	4.6	2.3	2.9	7.5	3.8
DTNB		ENSG00000138101	"Dystrobrevin beta"	O60941	2	25377198-25673647	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 49.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA061357	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA061357: AB_2684489"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.78e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.98e-2)"	"unprognostic (9.45e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.49e-2)"	3.6	3.5	19.1	5.2	21.3	4.7	13.9	14.5	24.6	7.7	2.7	9.5	13.6	2.2	4.7	14.0	4.6	7.3	5.9	3.4	20.6	12.6	6.3	5.1	6.6	4.6	12.4	11.7	7.2	10.3	12.2	9.6	5.4	13.2	10.5	2.4	4.2	49.4	13.9	2.7	4.6	2.3	3.1	13.1	4.4	7.7	9.0	7.3	6.3	15.7	1.0	5.4	5.2	4.3	7.4	1.1	7.2	2.2	5.1	7.4	2.8	8.9	7.6	6.2	6.9	3.6	4.6	0.2	2.7	3.7	3.4	4.9	2.9	2.3	4.7	1.1	2.2	4.4	3.2	4.3	11.7	1.9	7.2	10.0	3.7	2.3	8.9	2.6	4.7	3.7	3.7	10.1	3.6	6.3	4.3	4.7	9.7	0.3	7.2	2.6	9.0	7.7	3.9	7.1	2.4	5.2	6.2	10.1	8.9	6.4	8.4	8.2	11.9	8.9	15.8	10.9	3.4	8.3	2.8	1.9	1.4	6.4	2.0	4.8	12.7	5.6	8.5	4.0	8.6	5.1	0.5	2.2	7.2	5.8	1.1	6.6	5.7	7.4	5.2	0.7	7.4	7.3	5.0	4.3	5.1	0.6	1.1	6.4	2.8	19.1	21.3	14.5	24.6	20.6	12.6	12.4	11.7	13.2	7.3	8.9	10.9	3.7	21.9	7.1	8.6	2.2	12.7	0.0	5.7	14.0	5.9	3.1	10.0	3.9	2.3	3.8	0.0	0.0	10.2	1.2	2.1	14.7	1.1	5.0	26.1	20.6	2.9	2.5	4.7	4.5	1.4	3.1	11.8	2.8	2.3	15.1	6.9	0.3	2.5	7.1	7.8	6.5	1.4	9.4	12.4	1.8	1.7	8.6	1.0	16.0
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522801-15663058	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.0"	"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	7.2	5.0	22.8	10.5	91.0	9.3	7.7	6.7	18.4	6.8	10.5	7.8	4.5	7.2	8.0	12.5	7.2	6.9	7.9	12.0	15.0	18.0	11.3	5.0	8.4	16.9	18.5	10.3	7.3	6.7	13.1	8.5	9.3	13.7	8.1	10.9	13.4	6.7	10.1	15.4	7.1	7.6	11.9	9.4	10.2	7.6	5.5	17.2	9.3	7.8	2.7	19.4	8.6	8.1	17.8	17.9	8.1	7.1	26.9	12.1	6.6	15.8	6.9	5.9	12.7	8.7	9.9	9.1	8.2	10.7	19.7	17.9	9.1	7.4	22.5	22.1	11.6	16.3	5.5	11.6	8.7	18.0	14.4	15.5	15.8	9.0	13.5	15.2	15.9	13.5	9.4	13.4	10.0	14.9	9.0	17.3	15.5	14.9	5.6	11.8	18.6	16.5	25.3	4.1	13.5	10.0	19.6	11.6	17.5	18.4	16.6	12.1	5.1	6.4	15.4	19.3	14.3	11.1	10.2	7.9	11.2	7.3	11.5	15.0	15.1	28.9	15.8	5.2	14.1	21.1	5.9	5.9	8.1	12.1	7.1	8.0	13.7	10.3	10.4	6.4	17.8	9.8	7.9	6.8	26.9	4.9	17.9	6.9	6.6	22.8	91.0	6.7	18.4	15.0	18.0	18.5	10.3	13.7	17.2	11.9	9.9	44.3	12.8	25.8	42.2	26.6	17.8	9.4	6.8	14.0	55.0	37.3	31.5	32.0	38.0	30.8	18.0	0.0	31.0	15.5	19.0	10.2	54.2	4.5	46.0	23.8	13.3	16.0	15.1	14.5	9.5	25.1	35.4	33.3	15.2	31.7	24.9	8.6	14.5	53.8	136.7	6.5	24.2	17.4	12.7	19.3	14.0	27.9	17.5	9.3
DTWD1	"MDS009, MGC111207"	ENSG00000104047	"DTW domain containing 1"	Q8N5C7	15	49620980-49656232	"Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042214	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles"		Yes	No			"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"HPA042214: AB_2677903"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.70e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.35e-1)"	19.1	12.6	15.7	11.3	27.5	4.2	17.5	16.7	16.0	24.5	20.1	10.9	9.4	6.9	25.2	15.8	11.7	17.0	19.9	12.0	11.5	9.3	10.3	9.9	11.6	10.4	12.9	12.2	21.6	28.5	8.7	22.1	11.2	11.9	19.2	11.2	11.6	18.0	14.2	10.7	10.8	8.9	22.4	11.7	9.4	15.6	8.2	13.1	12.1	15.5	11.8	8.7	21.5	17.2	8.6	21.6	5.4	11.9	11.1	11.5	5.2	4.5	5.3	9.8	5.2	19.6	38.2	7.8	13.1	13.2	17.6	13.0	1.7	3.7	7.2	9.9	16.4	8.1	8.2	6.9	6.9	17.1	4.8	4.9	6.2	10.8	6.4	13.1	8.1	5.4	18.4	9.3	10.9	13.4	15.6	7.2	8.9	11.5	7.7	18.4	9.1	5.4	6.6	6.1	10.1	7.2	7.8	20.2	28.2	5.7	3.2	8.8	6.6	16.0	5.5	12.3	10.6	5.4	11.8	4.7	20.8	8.3	11.7	14.7	6.1	9.3	4.3	18.3	23.2	12.9	5.4	8.6	4.2	6.5	9.8	8.9	8.6	9.6	10.4	10.8	8.6	11.5	10.6	2.1	11.1	11.9	21.6	7.5	5.2	15.7	27.5	16.7	16.0	11.5	9.3	12.9	12.2	11.9	13.1	17.9	12.9	19.8	15.0	17.1	43.1	13.9	17.8	45.5	19.4	33.2	29.5	19.7	26.6	17.7	7.3	16.6	5.6	0.0	18.1	23.0	40.2	17.4	6.9	13.2	17.8	17.5	14.9	23.9	19.3	10.4	35.1	18.5	15.1	4.6	15.4	18.8	20.0	10.5	26.5	15.4	41.6	6.5	46.7	42.3	43.9	16.7	8.1	15.2	18.7	11.1
DTWD2	FLJ33977	ENSG00000169570	"DTW domain containing 2"	Q8NBA8	5	118837322-118988545	"Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053173, HPA054864"	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA053173: AB_2682068, HPA054864: AB_2682629"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.15e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.59e-1)"	5.9	8.2	8.5	4.5	8.6	1.9	6.9	10.9	8.9	9.9	6.7	8.7	7.3	6.0	5.5	4.8	8.3	4.9	6.9	14.3	7.1	6.0	14.7	9.8	4.7	3.8	6.0	7.4	4.0	8.5	14.1	6.2	3.5	6.6	7.0	6.7	7.5	7.4	10.0	18.4	5.7	6.6	6.4	8.0	5.9	5.2	5.7	7.2	5.3	17.7	8.2	6.7	7.0	5.2	3.9	2.7	2.8	2.2	3.1	3.3	1.7	6.1	3.9	4.8	6.8	2.9	1.3	5.7	6.2	3.9	8.3	9.7	2.4	4.3	5.2	11.9	4.2	4.2	6.4	7.9	6.2	9.8	2.1	7.4	6.5	6.9	3.4	2.4	7.7	9.2	2.3	9.7	3.5	3.7	4.4	2.6	9.0	6.1	7.6	4.4	6.5	6.4	3.8	5.3	3.8	3.1	2.4	4.8	2.5	9.4	9.1	2.6	4.3	6.4	5.4	7.3	4.3	13.5	4.8	3.0	9.0	7.6	3.3	8.4	5.6	10.1	4.1	5.3	4.4	4.7	2.8	1.9	0.9	1.4	1.5	1.5	2.6	1.5	2.1	2.3	3.9	3.0	3.3	2.4	3.1	2.2	2.7	0.7	1.7	8.5	8.6	10.9	8.9	7.1	6.0	6.0	7.4	6.6	7.2	8.9	2.2	0.0	2.5	2.5	11.5	8.7	10.2	2.7	2.3	7.0	15.7	2.3	8.3	2.6	10.5	1.5	3.6	0.0	7.4	0.9	1.3	2.8	0.0	5.0	3.4	19.1	4.1	1.3	1.6	15.0	2.3	3.0	6.8	5.4	2.2	7.2	2.1	4.3	2.1	8.9	8.3	0.0	2.0	10.8	16.4	3.1	0.6	1.3	3.3	2.0
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 66.7"	"Cancer enhanced"	"Detected in all"		"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 2.0;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: AB_2684097"	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	7.2	18.8	22.7	9.0	35.2	3.5	9.4	47.8	53.6	17.6	22.8	23.7	11.0	6.7	29.7	30.6	9.7	31.8	14.1	20.5	23.8	19.8	11.4	2.4	12.2	11.0	18.3	28.4	36.3	12.0	23.9	32.7	16.0	22.5	21.1	10.1	20.4	13.2	29.5	10.9	7.9	9.4	28.7	16.9	11.2	11.2	7.8	21.6	6.8	16.8	5.1	8.8	11.8	13.5	0.3	0.6	0.0	0.0	2.0	5.5	1.8	3.1	8.2	24.4	0.0	0.0	0.0	0.1	5.0	12.9	11.0	11.2	4.2	13.2	4.4	7.6	10.8	0.1	5.1	0.0	0.6	7.8	11.0	1.5	2.5	12.6	4.4	18.8	0.0	0.0	9.3	6.1	8.4	0.1	31.5	12.3	0.0	0.0	15.0	8.4	6.8	13.4	0.1	19.2	2.5	0.7	0.0	20.3	0.2	1.0	8.2	17.7	28.1	3.9	1.1	2.4	6.1	14.1	6.7	0.0	14.4	5.8	6.6	7.1	24.6	18.4	0.0	9.2	0.0	7.5	0.0	0.0	0.0	5.5	0.0	1.3	0.3	2.1	2.5	0.2	0.3	1.9	3.5	0.0	2.0	0.0	0.6	4.2	1.8	22.7	35.2	47.8	53.6	23.8	19.8	18.3	28.4	22.5	21.6	14.9	14.1	2.2	9.6	5.6	45.2	9.4	5.1	32.1	15.9	12.2	47.1	0.3	11.6	7.6	1.0	4.5	0.0	0.0	1.7	0.2	9.3	8.6	5.7	0.8	0.6	66.7	15.0	14.1	1.6	1.6	31.7	0.5	3.3	1.0	1.1	25.9	3.3	0.0	29.7	2.9	41.2	45.3	29.3	3.5	4.1	2.5	1.0	10.1	0.3	2.5
DTX4	"KIAA0937, RNF155"	ENSG00000110042	"Deltex E3 ubiquitin ligase 4"	Q9Y2E6	11	59171430-59208587	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.8"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 33.1;Muller glia cells: 28.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 63.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 27.3;CACO-2: 14.8;CAPAN-2: 15.7;OE19: 15.1;RT4: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056760, HPA059294"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA056760: AB_2683228, HPA059294: AB_2683969"	"unprognostic (3.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.03e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (5.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.57e-3)"	7.0	2.2	8.9	7.6	12.8	8.2	7.9	14.0	16.5	8.9	17.7	29.8	1.4	16.7	4.3	2.3	3.7	6.5	9.5	2.1	10.7	10.9	6.5	23.9	17.7	5.2	15.3	8.8	16.3	5.9	1.7	3.3	15.3	24.8	5.6	18.4	7.7	16.0	3.7	1.5	4.2	14.3	3.6	42.8	5.0	12.2	1.9	9.1	0.8	12.4	2.3	6.7	19.8	14.7	3.3	6.1	3.1	1.0	0.1	0.1	0.2	2.0	2.3	13.5	0.2	3.8	0.2	27.3	0.2	1.1	0.1	0.1	14.8	15.7	4.8	0.9	0.3	0.5	7.0	4.1	5.1	0.0	0.3	0.2	0.0	2.7	4.7	1.0	0.4	0.9	0.6	8.5	0.0	0.2	0.9	0.0	0.9	0.0	0.5	0.6	1.1	0.2	0.0	6.9	15.1	0.6	1.6	11.9	0.5	1.1	41.0	0.0	0.0	10.4	2.7	0.3	3.6	2.0	0.2	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.5	0.1	1.2	1.1	1.5	1.0	0.7	0.1	1.0	0.0	2.2	0.1	0.0	1.4	3.3	0.0	0.0	3.1	0.1	0.5	6.1	0.0	0.2	8.9	12.8	14.0	16.5	10.7	10.9	15.3	8.8	24.8	9.1	17.9	15.6	2.4	2.4	1.4	1.4	1.1	33.1	12.0	18.2	7.0	0.0	12.2	0.0	6.5	0.3	2.0	19.7	0.0	4.4	16.4	5.2	2.1	1.1	17.4	3.2	0.0	4.7	3.7	2.6	0.0	3.7	1.6	5.0	1.0	10.0	28.1	8.4	17.3	3.2	9.1	1.1	0.0	0.4	0.2	1.5	1.1	4.6	0.8	13.7	22.1
DTYMK	"CDC8, TMPK, TYMK"	ENSG00000168393	"Deoxythymidylate kinase"	P23919	2	241675742-241686991	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042593, HPA042719"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042593: AB_10959590, HPA042719: AB_10960633"	"unprognostic (1.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (7.13e-2)"	"unprognostic (6.81e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.19e-2)"	12.4	17.6	11.6	17.3	15.0	29.1	14.4	14.5	12.4	10.0	13.8	16.5	9.3	12.0	12.4	9.7	20.0	9.7	10.2	9.4	9.0	6.5	15.5	19.5	10.5	21.0	14.0	9.5	9.5	13.6	5.0	8.8	10.4	11.8	11.5	11.7	10.8	9.6	10.0	6.7	17.9	13.0	13.0	9.5	18.8	13.5	11.1	15.1	20.7	9.4	16.1	17.9	11.7	11.9	19.8	21.1	12.0	24.7	15.7	21.8	15.7	25.1	27.8	24.2	30.7	8.0	8.7	25.6	20.6	15.5	27.5	32.4	12.7	30.5	12.2	6.4	16.6	32.8	21.2	22.2	25.1	14.8	28.7	26.4	26.1	23.3	24.1	6.6	16.5	21.7	6.1	6.8	26.5	10.8	8.4	26.4	17.7	29.4	10.3	29.1	26.2	30.5	28.7	23.8	28.2	23.4	26.1	35.6	17.0	15.9	14.6	29.2	18.3	13.4	20.6	16.5	7.7	18.7	29.6	17.1	40.1	28.8	25.5	38.0	11.6	12.2	34.2	32.1	26.5	46.6	12.0	14.9	9.5	17.4	24.7	16.8	19.2	16.1	18.2	10.5	19.8	16.0	14.7	2.5	15.7	18.8	21.1	21.8	15.7	11.6	15.0	14.5	12.4	9.0	6.5	14.0	9.5	11.8	15.1	8.9	4.3	11.9	17.5	13.5	18.2	9.2	25.5	8.1	11.4	24.4	2.0	48.5	18.3	37.3	1.8	17.5	9.3	46.7	29.4	118.6	22.0	17.5	15.0	16.6	74.0	4.8	13.8	20.9	13.1	2.0	15.3	23.4	21.9	57.7	19.9	16.3	27.3	14.0	18.0	27.5	14.2	25.8	16.1	27.6	57.7	10.5	23.0	15.8	34.8	12.0
DUS1L	"DUS1, PP3111"	ENSG00000169718	"Dihydrouridine synthase 1 like"	Q6P1R4	17	82057506-82065887	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023384	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA023384: AB_1847879"	"unprognostic (4.42e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (4.17e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.70e-3)"	21.4	17.5	12.4	29.1	16.5	37.1	20.2	21.4	20.3	17.7	29.5	14.1	26.8	30.8	18.1	23.4	26.0	18.5	27.9	23.8	13.0	10.9	19.8	54.6	21.5	31.2	18.9	16.0	20.1	59.6	15.2	23.5	16.5	12.9	26.9	14.8	16.0	45.4	18.9	44.1	40.8	28.0	19.6	10.5	30.9	28.9	23.7	12.4	28.0	22.8	26.2	30.4	17.0	18.5	5.0	10.6	6.3	6.0	7.9	9.8	2.9	36.1	23.4	8.1	9.6	6.4	6.5	26.1	12.8	5.8	12.5	8.9	21.3	16.3	29.7	15.0	7.1	8.5	24.4	10.0	13.1	5.0	11.7	61.0	18.8	32.5	36.9	14.4	29.1	23.4	9.7	16.6	8.2	10.4	5.9	14.0	26.8	32.4	15.0	6.3	56.7	40.3	25.1	9.8	17.9	34.1	30.9	9.6	31.9	9.2	23.9	43.4	27.3	9.8	41.1	26.2	8.1	24.0	28.0	10.6	20.3	20.6	17.3	32.2	37.6	10.4	24.0	12.8	21.8	13.9	4.2	5.0	6.3	6.0	5.1	8.7	5.0	6.1	7.0	4.8	5.0	9.8	8.1	1.7	7.9	6.0	10.6	9.8	2.9	12.4	16.5	21.4	20.3	13.0	10.9	18.9	16.0	12.9	12.4	26.8	15.5	15.7	16.5	19.6	29.0	16.2	30.6	10.7	11.4	10.4	27.5	14.3	6.6	10.9	65.7	16.2	40.4	0.0	32.9	16.0	11.3	33.5	3.5	72.7	18.4	17.5	41.5	12.9	19.6	101.1	13.3	17.2	10.1	13.6	53.1	17.1	30.1	25.9	12.7	20.2	46.0	12.9	13.7	20.7	9.8	24.8	13.0	12.8	54.9	32.6
DUS3L	"DUS3, FLJ13896"	ENSG00000141994	"Dihydrouridine synthase 3 like"	Q96G46	19	5784832-5791238	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA041854, HPA041944, HPA062846"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879"	"unprognostic (1.25e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.64e-3)"	"unprognostic (6.08e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (7.35e-3)"	"unprognostic (4.25e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	9.1	9.4	7.4	11.4	9.4	25.4	9.5	7.1	13.2	8.9	12.4	13.7	8.7	16.6	13.1	7.7	12.3	11.1	11.1	7.8	6.0	5.0	9.9	17.5	7.9	12.6	8.3	6.7	11.8	17.6	4.7	8.6	11.1	7.8	11.8	4.6	12.4	12.4	10.1	14.3	17.5	14.4	7.6	7.5	12.5	12.3	42.5	8.1	15.6	11.7	10.3	11.1	8.8	9.7	13.5	19.2	4.3	18.6	15.8	16.6	9.9	11.0	10.9	3.2	11.0	0.9	1.4	10.3	3.7	2.1	3.9	2.9	16.9	5.1	11.2	14.0	1.5	4.4	7.1	2.6	3.6	0.6	8.2	24.9	7.3	5.6	6.3	5.5	16.4	21.6	3.4	3.8	4.3	3.1	0.5	2.6	7.4	19.6	0.0	2.0	14.3	13.7	16.7	11.2	4.0	29.5	7.1	6.5	13.7	1.6	7.9	10.9	11.0	3.8	6.4	7.2	0.7	4.5	13.4	3.4	5.5	9.7	16.3	15.7	32.2	23.7	10.7	5.3	17.0	6.2	4.3	13.2	3.4	14.8	18.6	16.6	10.2	11.0	13.5	18.7	13.5	15.1	14.4	1.5	15.8	14.4	19.2	12.5	9.9	7.4	9.4	7.1	13.2	6.0	5.0	8.3	6.7	7.8	8.1	8.9	10.6	15.2	16.4	13.1	6.5	2.6	5.1	5.3	6.8	1.8	11.8	16.8	6.6	8.9	27.8	8.0	10.1	0.0	19.1	14.3	10.1	6.1	35.7	6.8	13.3	11.1	7.5	3.7	5.6	6.6	11.8	9.4	5.0	3.6	9.4	4.5	10.0	6.6	6.0	5.6	10.1	19.4	10.8	36.1	10.8	11.2	18.2	10.0	13.6	13.2
DUS4L	"DUS4, PP35"	ENSG00000105865	"Dihydrouridine synthase 4 like"	O95620	7	107563484-107578464	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044301	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA044301: AB_10967460"	"unprognostic (7.95e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-3)"	"unprognostic (7.74e-3)"	"unprognostic (6.72e-3)"	4.5	6.2	9.4	7.0	10.4	2.9	7.8	5.0	8.2	5.5	5.7	7.5	6.2	4.8	5.7	10.4	5.5	6.0	4.7	10.1	8.0	7.7	9.9	9.0	3.9	5.0	10.3	6.2	7.8	5.4	8.0	5.1	4.8	7.6	7.8	5.7	5.7	5.1	4.8	7.1	7.1	5.2	5.3	11.0	4.3	5.4	7.7	6.6	6.6	8.5	5.9	5.7	6.2	4.5	1.5	1.3	0.5	1.3	1.2	2.4	0.7	6.5	3.0	3.0	1.8	1.2	2.0	3.9	1.9	2.6	2.8	2.7	3.4	5.4	7.0	3.6	1.5	7.4	2.0	3.1	4.0	4.3	2.1	2.6	2.5	1.6	3.7	3.0	4.8	0.4	2.0	5.4	2.7	9.2	3.2	4.1	6.6	8.7	2.6	4.3	4.8	6.6	8.4	4.3	5.2	5.4	3.6	2.7	7.9	5.4	3.4	2.7	6.8	3.1	6.4	5.4	3.9	3.1	3.8	2.9	4.0	3.2	3.0	4.4	4.9	6.0	7.9	4.3	6.8	4.8	0.0	1.2	0.1	1.4	1.3	1.6	1.5	2.3	1.2	1.3	0.7	1.9	2.4	0.5	1.2	0.7	1.1	1.7	0.7	9.4	10.4	5.0	8.2	8.0	7.7	10.3	6.2	7.6	6.6	6.0	4.6	5.6	7.5	4.5	8.8	8.0	2.5	22.7	6.8	10.4	3.9	7.9	6.6	8.7	20.0	2.7	3.8	0.0	13.9	7.4	4.2	5.5	13.8	8.9	6.1	3.2	9.2	4.9	4.6	17.7	4.0	4.9	3.3	5.4	4.5	13.0	11.5	5.3	3.5	13.2	9.1	12.9	4.2	11.2	10.9	3.4	3.1	3.8	5.5	6.4
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768090-172771195	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 326.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 326.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 43.7;hTCEpi: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	158.4	78.0	12.4	68.5	14.0	89.7	91.8	17.4	14.9	81.4	37.1	32.4	48.5	9.4	55.4	71.6	82.7	94.8	138.8	49.2	12.5	11.4	29.8	115.4	135.0	43.5	30.6	9.7	69.4	34.4	26.6	40.8	93.7	29.3	67.1	34.2	61.0	38.1	192.8	54.8	116.1	27.6	65.0	29.5	36.1	53.6	45.9	18.7	10.8	90.4	104.1	46.9	69.0	109.7	2.4	11.5	326.0	31.8	4.5	9.8	14.0	2.1	5.5	1.7	2.4	38.1	22.3	2.9	35.4	10.3	23.8	9.6	6.0	2.6	0.7	10.3	24.8	27.4	0.9	1.7	8.7	11.2	19.4	4.7	0.4	12.0	2.5	43.7	0.2	0.8	21.3	76.4	10.8	17.6	12.4	7.4	1.5	1.8	13.9	15.3	2.5	1.1	1.0	1.5	1.6	1.6	41.1	3.2	6.4	16.9	1.1	7.5	3.1	9.6	16.3	1.2	7.6	1.4	0.4	19.5	16.9	8.4	16.4	2.7	2.9	1.6	0.6	15.1	0.3	0.6	33.3	24.6	69.8	3.9	25.0	9.8	2.4	3.5	4.0	11.5	2.1	1.7	1.9	326.0	4.5	31.8	0.6	2.8	14.0	12.4	14.0	17.4	14.9	12.5	11.4	30.6	9.7	29.3	18.7	381.2	398.8	474.0	769.9	1136.9	64.0	181.6	236.9	45.5	126.3	200.7	25.5	239.6	48.0	361.0	67.1	510.4	567.7	46.7	76.6	355.3	824.5	763.6	295.5	297.9	967.3	46.1	687.8	403.9	1172.3	21.1	356.4	1745.4	514.5	55.9	830.1	603.1	188.6	648.8	292.4	25.4	177.1	756.7	886.8	11.8	23.0	1710.3	486.7	546.6	309.1	534.2
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.4"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;HaCaT: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	7.4	4.7	6.0	7.1	11.2	23.2	8.2	5.9	11.1	5.7	10.8	21.1	0.3	2.1	4.9	2.7	7.0	8.5	7.6	3.8	7.2	4.0	2.8	35.4	8.0	9.0	14.0	5.6	2.8	18.3	1.8	2.5	4.5	8.4	3.6	4.9	8.5	9.5	1.7	21.0	8.0	6.2	9.7	10.1	6.4	4.5	3.9	14.1	5.6	5.3	10.6	8.6	8.5	4.1	0.8	5.4	4.6	4.2	15.1	12.7	1.6	6.1	2.6	0.2	0.2	19.2	9.9	0.2	4.1	10.8	6.9	5.3	0.1	1.7	4.8	1.4	10.7	5.0	42.3	0.9	4.0	6.0	12.3	0.5	8.2	1.2	0.7	4.5	3.6	5.6	13.8	2.9	7.4	7.5	3.2	0.2	1.2	0.8	1.7	6.5	0.1	0.7	2.8	0.6	1.3	0.3	0.4	11.7	0.3	2.3	3.7	15.8	1.2	0.5	0.5	17.5	2.5	0.9	2.1	1.5	3.5	0.9	5.3	5.1	2.9	2.0	2.6	5.4	1.6	3.6	4.6	4.2	0.2	3.6	3.7	3.3	0.7	2.5	2.5	5.4	0.8	0.8	1.5	0.3	15.1	1.4	0.2	12.7	1.6	6.0	11.2	5.9	11.1	7.2	4.0	14.0	5.6	8.4	14.1	0.0	1.7	1.9	12.6	45.2	4.5	3.3	10.2	8.1	6.8	3.5	19.6	2.2	0.0	27.3	29.1	6.3	1.0	0.0	7.8	2.7	8.3	10.9	135.7	50.4	22.0	1.6	42.1	1.8	11.0	2.7	23.0	23.9	21.9	13.6	9.9	13.5	21.9	0.0	12.0	0.7	32.3	0.0	5.1	3.8	2.0	36.1	2.9	29.9	2.2	14.4
DUSP11	PIR1	ENSG00000144048	"Dual specificity phosphatase 11"	O75319	2	73762184-73780157	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021052			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge"		Yes	Yes			"Nucleoplasm, Nucleoli fibrillar center"	"Cytokinetic bridge"	"HPA021052: AB_2670577"	"unprognostic (2.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.28e-3)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (7.20e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.84e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.46e-1)"	19.6	16.1	15.1	15.1	17.9	29.5	21.4	31.8	21.5	23.1	16.8	16.4	16.2	16.3	29.9	19.8	38.7	37.4	15.2	15.2	17.2	13.9	19.3	16.5	17.2	21.5	12.7	15.8	26.4	14.9	11.6	28.2	19.1	14.0	18.2	16.8	16.5	22.3	20.3	16.2	27.9	19.7	18.9	13.4	21.5	15.4	19.7	13.8	28.7	16.8	16.2	29.3	20.4	27.3	29.9	20.9	42.6	19.1	28.0	37.6	29.2	19.4	8.4	9.1	9.6	16.5	20.7	16.3	14.3	18.7	18.6	19.1	12.1	14.8	25.3	9.2	15.4	16.7	13.6	11.2	28.8	18.0	17.4	11.7	15.5	6.4	18.5	17.3	17.4	14.6	16.7	35.0	16.6	23.1	16.2	20.6	12.4	16.4	14.9	20.6	10.8	16.7	18.6	14.6	18.3	11.7	6.7	24.5	22.7	15.0	16.2	13.5	7.3	13.2	15.8	16.8	11.4	8.4	9.3	11.7	13.3	16.4	15.2	16.8	15.9	12.6	33.4	12.3	17.7	12.9	24.7	19.1	42.6	26.8	16.9	34.6	29.9	31.7	31.6	20.9	28.1	33.9	31.8	29.1	28.0	16.9	15.9	37.6	29.2	15.1	17.9	31.8	21.5	17.2	13.9	12.7	15.8	14.0	13.8	8.9	11.8	34.3	47.9	73.8	9.4	6.9	33.1	26.8	22.7	12.2	3.9	27.8	43.1	24.2	5.9	29.2	13.5	23.3	24.2	35.1	26.6	23.0	41.4	12.9	27.5	4.8	11.5	29.4	22.3	5.6	26.7	20.5	21.9	42.3	19.0	9.3	22.5	17.8	24.1	38.5	13.9	6.5	22.8	23.6	31.8	72.5	32.3	32.4	17.2	54.2
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489831-37513501	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 152.9;Basal keratinocytes: 159.6;Cytotrophoblasts: 141.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 10.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.7;HBF TERT88: 18.3;U-138 MG: 8.7;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		44000	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	4.7	3.7	3.3	2.1	6.6	1.1	3.9	1.8	8.0	3.3	1.0	1.5	0.1	0.7	2.7	1.2	7.2	11.7	5.1	2.6	2.3		2.1	6.5	2.4	1.0	1.9	2.5	3.0	2.9	1.7	3.3	11.6	2.6	1.4	1.4	1.6	2.8	1.1	1.7	8.4	0.9	3.5	2.7	1.7	1.0	3.5	0.8	2.3	8.3	6.1	4.3	1.9	1.0	0.5	0.0	3.2	0.0	0.4	0.4	0.5	1.7	0.1	0.4	0.8	0.0	0.5	1.5	8.2	6.2	10.9	12.7	0.9	1.9	0.1	0.7	5.9	0.1	1.4	0.1	4.8	18.3	0.1	0.6	0.0	1.1	2.0	0.8	0.4	1.3	4.8	2.9	3.8	2.0	0.6	0.2	0.2	0.4	0.0	8.0	0.3	0.8	0.2	0.2	0.0	0.0	0.7	0.5	0.2	2.7	0.7	1.3	0.1	0.4	0.7	1.2	3.2	0.6	1.0	0.8	8.7	2.0	0.1	4.1	0.0	0.2	0.1	0.0	0.0	10.5	0.0	0.0	0.9	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.3	0.2	3.2	0.4	0.0	0.0	0.0	0.5											6.0	4.8	5.9	152.9	159.6	6.2	14.2	5.1	52.2	26.1	7.0	7.9	141.3	24.9	33.6	35.0	22.7	0.0	0.0	13.2	71.8	47.7	52.8	87.4	10.2	17.0	14.3	2.4	14.7	2.8	40.7	12.7	10.4	59.1	43.3	1.0	9.0	46.1	1.1	5.6	11.8	18.7	0.0	52.6	28.9	29.2	80.9	56.8	6.4	0.8	72.6
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 75.1"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 232.1;Early spermatids: 237.5;Late spermatids: 743.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.4;REH: 17.7;SH-SY5Y: 5.1;SK-MEL-30: 4.4;U-2 OS: 4.3"					"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA076649: AB_2686811"	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favorable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.1	2.1	2.8	0.6	4.0	0.5	1.3	1.2	3.7	1.6	0.8	4.2	6.9	0.9	1.4	10.4	0.6	0.7	1.1	2.7	2.8	3.1	15.4	0.6	0.8	1.0	4.9	2.3	2.1	1.8	10.6	2.7	1.1	5.9	1.9	0.5	5.3	2.1	9.3	2.4	0.7	1.0	2.3	5.2	1.0	1.1	75.1	1.4	0.0	3.5	0.1	0.6	0.7	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	5.4	0.1	1.1	2.2	0.3	3.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	3.8	0.7	0.0	0.0	17.7	2.1	0.1	0.0	0.0	2.5	5.1	2.9	0.0	4.4	0.2	1.3	1.1	0.0	0.0	4.3	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.0	1.2	3.7	2.8	3.1	4.9	2.3	5.9	1.4	0.0	0.0	0.0	1.0	0.6	0.5	2.0	2.5	0.0	0.0	17.4	3.9	0.0	232.1	1.7	237.5	0.7	0.0	0.0	0.9	0.1	2.4	0.7	0.0	0.0	0.5	6.4	1.7	3.1	0.0	743.6	8.1	0.8	6.8	1.0	0.0	2.7	0.9	0.0	10.3	33.5	0.2	0.0	1.0	85.0	5.2	0.1	0.1	0.0	0.0	0.1
DUSP19	"DUSP17, SKRP1"	ENSG00000162999	"Dual specificity phosphatase 19"	Q8WTR2	2	183078559-183100005	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 20.1;Early spermatids: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021501	Approved		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA021501: AB_1847892"	"unprognostic (1.24e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.80e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.75e-2)"	2.8	4.6	9.2	2.0	16.3	1.0	3.0	2.9	9.6	3.4	4.7	2.2	3.8	3.5	6.8	9.2	4.2	8.4	3.5	7.4	17.4	3.4	4.7	3.0	3.4	2.3	3.3	6.8	4.4	4.3	7.7	10.6	2.7	3.7	4.2	3.0	3.0	2.8	5.4	3.8	3.4	3.0	8.6	2.9	4.0	9.1	10.4	4.7	6.2	4.6	1.1	1.9	4.0	2.7	4.1	1.5	2.0	0.8	2.2	3.2	1.3	0.1	2.4	2.9	1.4	3.9	2.2	0.0	1.1	1.8	4.6	1.6	2.3	3.0	1.0	6.0	1.2	3.3	0.3	5.7	0.8	3.5	5.8	3.2	10.6	1.8	1.6	1.7	2.6	6.5	1.7	0.5	2.3	1.1	2.9	2.6	0.0	3.1	1.6	2.7	1.0	5.0	2.5	2.4	1.0	2.0	4.9	4.5	0.3	1.0	1.1	3.6	1.5	4.0	1.7	2.9	0.2	0.8	1.0	2.0	2.5	2.1	1.7	0.9	2.0	2.4	0.1	3.1	0.4	3.7	2.0	0.5	1.9	2.3	0.8	2.3	4.1	2.1	3.1	0.6	2.2	2.7	2.7	1.3	2.2	0.4	1.5	3.2	1.3	9.2	16.3	2.9	9.6	17.4	3.4	3.3	6.8	3.7	4.7	0.0	2.7	1.7	1.2	0.9	1.7	6.5	2.5	20.1	2.3	1.8	2.0	2.0	5.0	0.6	10.4	1.0	1.6	0.0	0.6	1.2	1.3	0.9	1.1	1.0	0.6	1.6	2.4	1.8	0.6	4.6	1.7	0.1	0.0	1.8	2.0	4.5	0.5	2.5	2.5	2.3	1.0	0.0	1.4	4.7	3.1	1.4	0.6	0.0	2.1	1.3
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 71.9;U-266/70: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	24.8	13.1	22.0	24.6	31.3	19.4	28.7	12.1	27.5	18.1	29.0	29.8	18.8	21.2	20.6	25.2	29.8	15.0	20.4	31.0	22.6	17.4	16.0	20.3	24.6	27.4	33.5	16.1	13.9	27.9	10.8	14.8	25.9	25.5	16.1	15.9	16.9	20.9	15.5	32.0	30.6	21.8	23.4	29.2	30.0	21.4	41.3	30.0	9.2	19.9	19.0	27.9	22.8	27.4	21.6	18.0	16.3	17.5	2.9	8.2	9.8	3.6	2.2	4.8	7.2	5.6	6.2	6.4	2.7	2.2	2.4	2.9	2.4	4.1	7.7	6.6	2.8	5.1	2.5	6.0	5.0	1.7	18.4	6.9	5.2	1.8	6.6	2.8	1.8	6.8	4.6	15.2	1.7	3.2	4.0	6.8	6.6	4.8	25.7	2.0	2.1	2.7	6.7	2.9	2.7	5.2	5.4	3.3	71.9	4.5	1.6	8.3	3.2	2.3	0.9	7.9	11.0	4.9	2.4	9.3	2.2	2.9	2.2	1.6	36.6	25.8	10.7	0.8	5.1	4.9	16.3	17.5	6.9	5.0	14.0	3.5	21.6	3.9	5.1	18.0	17.5	3.6	5.1	12.0	2.9	12.6	15.4	8.2	9.8	22.0	31.3	12.1	27.5	22.6	17.4	33.5	16.1	25.5	30.0	14.9	17.6	38.7	19.8	23.6	5.2	35.3	10.2	26.8	25.0	5.2	0.0	9.1	18.3	21.3	11.0	33.7	13.8	0.0	45.0	6.9	17.8	14.6	32.3	22.1	25.5	0.0	9.1	22.7	40.0	14.8	14.4	35.8	43.9	83.8	13.0	9.8	28.3	14.0	8.9	14.6	2.6	25.8	27.2	30.7	73.7	32.4	5.5	15.0	14.5	23.5
DUSP27		ENSG00000198842	"Dual specificity phosphatase 27, atypical"	Q5VZP5	1	167094045-167129165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 131.1"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RH-30: 18.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA012912			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	2.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	46.8	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.0	0.9	0.0	64.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	18.2	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	131.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766121-43778988	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	17.1	17.8	23.1	10.2	20.8	4.6	22.0	14.3	28.6	12.8	28.4	11.1	16.7	13.4	17.5	18.7	23.6	10.6	19.3	64.0	21.5	18.1	27.1	39.9	17.2	9.0	17.6	19.1	9.1	19.2	27.5	11.4	15.0	17.1	22.6	13.1	14.3	11.1	36.6	106.9	8.9	15.2	31.1	12.7	14.5	19.6	8.0	10.8	1.2	13.9	22.8	6.5	20.7	24.1	1.7	19.5	5.2	17.0	0.9	1.7	5.8	10.5	19.2	7.4	7.9	21.6	11.6	6.3	8.0	19.2	18.8	22.8	18.4	7.1	1.6	12.7	15.0	39.0	9.2	11.4	9.8	19.9	3.6	8.7	5.3	8.8	15.0	26.4	0.6	5.6	10.7	17.8	14.5	12.6	20.6	13.1	5.4	4.8	1.8	21.9	7.6	2.7	2.7	3.4	15.1	14.0	3.4	22.3	4.0	26.1	11.2	4.1	7.5	9.4	6.3	23.6	21.3	28.1	14.9	13.6	21.3	14.5	30.2	13.2	9.8	13.0	0.4	25.3	7.5	7.1	5.2	17.0	3.5	1.0	8.9	1.7	1.7	1.5	1.2	19.5	1.6	1.2	1.1	4.1	0.9	10.8	8.2	0.9	5.8	23.1	20.8	14.3	28.6	21.5	18.1	17.6	19.1	17.1	10.8	23.8	16.8	7.2	42.9	19.9	16.3	242.3	48.4	14.7	9.1	40.1	23.6	14.4	34.9	42.9	73.8	32.1	42.0	0.0	50.5	17.5	18.4	41.2	38.1	99.4	73.0	19.1	34.9	27.6	34.5	128.1	13.6	40.3	10.1	32.5	17.6	14.8	50.2	28.1	24.8	69.4	16.6	32.3	35.5	2.4	2.9	25.2	37.6	6.4	14.6	32.8
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 270.1;granulocytes: 438.5;Kupffer cells: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 82.0;NB-4: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.4	82.0	21.1	18.0	0.0	8.8	11.2	1.8	1.3	7.2	1.3	0.0	2.1	3.7	3.4	9.4	0.1	22.0	2.5	0.1	0.1	3.6	0.2	11.4	15.0	15.7	40.2	3.5	7.7	15.5	14.5	18.4	40.7	0.4	0.0	3.8	5.6	0.5	0.5	58.8	14.8	28.0	20.0	40.0	3.0	1.5	25.2	23.7	0.4	17.4	0.2	0.1	46.7	8.7	1.2	8.8	10.9	6.0	0.1	1.1	4.2	0.6	3.2	0.1	24.9	11.1	38.0	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4	95.3	270.1	20.5	66.1	80.7	1.2	8.1	53.5	22.7	111.5	171.0	31.4	63.9	14.9	10.9	1.1	97.2	31.9	0.0	11.9	2.9	29.6	20.6	438.5	128.2	43.3	1.6	18.4	173.1	216.2	1.4	1.4	140.4	11.8	1.8	11.0	9.0	12.3	7.4	3.2	23.5	2.0	25.8	8.5	1.2	1.1	21.7	41.2	18.5	12.8	23.4
DUSP8	"C11orf81, FLJ42958, HB5, HVH-5"	ENSG00000184545	"Dual specificity phosphatase 8"	Q13202	11	1554044-1571920	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 101.5;Cone photoreceptor cells: 45.2;Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;MCF7: 6.2;SH-SY5Y: 5.5;U-251 MG: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020071	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA020071: AB_1847903"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.75e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.30e-2)"	6.3	2.2	18.8	3.2	18.8	7.5	3.5	20.0	30.2	1.9	4.3	4.2	1.4	1.7	5.9	4.8	3.5	4.0	5.4	5.7	16.6	9.3	2.6	3.7	3.6	3.5	5.5	11.2	2.2	12.7	1.7	10.8	2.8	5.1	3.0	4.1	2.7	5.1	2.7	6.1	3.2	6.3	9.3	3.6	6.3	4.3	2.4	5.1	0.0	2.6	2.2	2.3	2.7	1.6	0.1	0.1	0.0	0.0	0.0	0.7	0.0	1.8	0.8	1.0	0.1	0.0	0.1	2.2	0.1	1.2	0.4	1.2	0.0	0.0	0.1	0.0	0.3	0.0	1.2	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.4	0.0	0.1	0.1	0.0	1.8	0.0	6.2	0.0	0.4	0.0	0.0	1.9	0.1	0.1	0.7	0.0	0.2	0.0	5.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.0	2.3	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	18.8	18.8	20.0	30.2	16.6	9.3	5.5	11.2	5.1	5.1	3.0	0.6	0.0	5.6	8.8	101.5	5.2	5.1	0.0	0.0	12.2	45.2	0.1	1.7	6.9	0.2	2.2	22.7	0.0	9.6	0.4	4.5	12.8	0.0	0.4	0.4	85.8	40.5	1.3	0.0	0.0	0.6	0.3	5.0	1.8	20.2	16.0	9.8	17.5	0.4	1.1	36.7	6.5	5.1	0.2	0.4	4.3	4.9	1.3	16.8	9.8
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 90.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	0.0	4.0	0.0	0.3	1.8	10.1	0.2	0.0	0.2	1.8	0.0	0.7	90.8	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.2	0.2	0.4	3.7	0.0	0.0	0.0	0.0	2.3	0.1	0.3	0.6	0.7	0.3	0.2	0.1	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8	0.0	0.0	0.0	0.6	0.6	0.0	1.8	0.0	0.0	0.0	10.4	0.0	876.9	616.8	0.1	0.0	0.0	0.0	0.0	0.0	57.4	0.2	0.3	0.0	0.8	72.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.0	0.0	0.0	0.7	8.3	0.0	1451.1	0.0	0.0	0.9
DVL3	KIAA0208	ENSG00000161202	"Dishevelled segment polarity protein 3"	Q92997	3	184155388-184173610	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046486, HPA058265"	Approved		Approved	"Intermediate filaments,Midbody ring,Centrosome"		Yes	No			"Midbody ring, Centrosome"	"Intermediate filaments"	"CAB046486: AB_10610845, HPA058265: AB_2683658"	"unprognostic (2.20e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (8.61e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.77e-5)"	"prognostic unfavorable (1.53e-8)"	"unprognostic (1.87e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.95e-1)"	22.8	18.5	18.0	16.8	19.4	15.3	25.1	18.3	23.2	22.6	27.6	24.7	23.9	16.2	32.1	16.4	20.0	22.2	22.2	27.9	19.9	12.3	16.8	13.1	20.6	12.1	21.4	16.0	30.0	22.7	17.2	17.8	56.0	17.4	19.7	15.8	31.1	18.7	26.2	26.3	27.6	19.1	30.3	16.4	17.8	19.4	15.6	20.1	7.3	20.9	13.3	14.6	24.5	26.3	2.5	2.7	4.1	4.0	1.5	3.1	1.2	20.1	6.6	16.0	18.1	16.6	16.7	41.3	11.9	12.3	14.5	12.1	19.3	8.1	14.1	32.1	15.6	15.7	17.2	13.1	9.5	10.1	22.2	13.7	15.8	9.9	11.7	24.9	8.8	12.3	16.8	17.1	10.5	12.1	24.4	10.6	9.5	15.7	19.6	15.2	19.2	12.9	10.4	14.1	14.8	9.5	20.6	18.6	12.3	13.5	16.6	17.4	22.0	15.0	17.3	29.2	16.3	43.1	11.2	10.4	13.2	12.8	13.8	18.6	21.0	15.5	15.8	13.1	9.4	10.1	0.2	2.4	4.1	2.3	4.0	3.1	2.5	1.5	2.4	2.3	2.0	2.0	1.3	3.6	1.5	2.8	2.7	1.1	1.2	18.0	19.4	18.3	23.2	19.9	12.3	21.4	16.0	17.4	20.1	23.8	16.0	9.3	11.7	16.7	18.7	25.7	5.1	8.1	17.0	21.0	25.5	27.9	19.9	11.6	10.5	12.8	27.8	0.0	14.3	16.8	18.6	17.6	16.2	17.8	17.3	58.8	33.0	22.1	17.5	35.6	31.1	13.3	11.8	4.6	20.2	18.5	17.1	17.3	35.0	14.9	17.2	19.4	22.1	8.8	10.2	19.1	43.6	9.6	19.0	22.2
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972292	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 374.6;Late spermatids: 209.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	4.3	18.4	8.3	8.0	11.0	4.2	7.0	15.5	12.4	7.1	5.0	6.5	8.6	7.8	6.4	6.4	4.0	7.9	6.0	8.4	7.7	6.5	8.5	8.7	5.1	4.3	9.0	6.5	10.5	12.3	9.4	12.4	4.7	7.4	7.6	4.2	5.8	5.5	6.8	5.6	3.4	4.1	6.3	4.9	7.2	7.6	32.8	7.3	3.4	8.8	4.7	4.3	6.4	5.5	2.2	3.2	1.5	1.9	3.0	3.3	1.5	3.0	1.3	0.5	14.3	1.7	1.0	1.5	1.7	2.7	4.5	3.7	2.2	2.9	1.0	3.2	5.8	0.8	4.1	1.5	3.2	1.6	1.9	4.4	2.0	2.9	2.9	3.9	0.0	2.7	2.2	2.9	1.8	3.0	2.2	6.6	1.1	2.5	3.2	1.8	4.4	0.1	2.4	0.7	1.9	0.1	0.1	2.0	1.8	5.3	0.8	7.4	5.6	3.3	1.4	3.7	0.5	0.0	4.5	0.9	0.8	4.9	2.8	3.7	1.9	3.4	2.4	2.6	4.6	2.2	0.0	1.0	1.5	1.1	1.9	3.3	1.4	1.4	1.8	3.2	2.2	1.3	1.6	0.6	3.0	1.2	1.2	0.6	1.5	8.3	11.0	15.5	9.4	7.7	6.5	9.0	6.5	7.4	7.3	6.0	11.1	11.2	13.5	7.6	12.9	6.5	7.6	8.1	6.8	3.5	15.7	12.3	16.6	7.5	374.6	6.3	6.1	0.0	10.8	7.9	10.8	9.4	5.8	9.7	5.9	4.8	15.5	6.7	4.9	209.7	16.4	6.7	11.8	4.6	7.0	16.2	6.4	8.6	11.7	11.7	14.7	12.9	10.8	58.1	11.8	4.8	16.8	13.1	6.8	7.3
DYNC1I2	"DIC74, DNCI2"	ENSG00000077380	"Dynein cytoplasmic 1 intermediate chain 2"	Q13409	2	171687409-171748420	"Predicted intracellular proteins"	"Host-virus interaction, Transport"	"Motor protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033836, HPA040619, HPA053987"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		33000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Microtubules"	"CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.19e-1)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.42e-2)"	33.4	32.9	39.6	22.5	53.2	10.8	35.5	30.1	50.0	36.1	33.0	50.0	20.1	28.8	43.1	29.3	37.5	26.5	32.0	34.3	45.2	38.3	43.5	21.8	27.3	18.5	59.3	37.9	40.6	23.3	35.8	29.9	40.2	58.7	33.7	35.8	15.1	28.3	34.7	41.3	27.9	27.7	43.7	92.7	25.8	26.5	28.6	49.2	27.9	31.2	23.5	24.3	36.7	31.8	23.5	35.3	51.7	30.8	18.9	19.9	11.5	20.0	12.9	40.1	14.7	37.2	35.9	22.7	35.2	27.5	29.7	32.4	22.4	20.0	18.4	31.0	41.8	40.7	20.4	31.5	33.8	39.0	6.9	14.2	16.1	16.6	25.3	18.6	18.3	17.3	27.8	32.2	36.7	23.7	41.6	52.0	18.0	25.3	5.1	58.6	12.6	15.6	14.9	18.5	29.5	13.2	15.8	36.1	13.3	39.5	32.3	25.1	28.3	19.5	15.7	20.9	31.9	15.3	17.9	56.3	45.3	22.5	18.0	21.0	6.3	12.0	14.9	30.8	14.9	33.1	51.7	30.8	14.7	16.9	30.1	18.0	23.1	19.5	19.6	21.4	23.5	17.6	16.7	1.8	18.9	29.4	35.3	19.9	11.5	39.6	53.2	30.1	45.7	45.2	38.3	59.3	37.9	58.7	49.2	184.6	55.8	68.6	52.1	45.0	68.0	67.4	196.1	111.1	96.7	160.5	60.9	85.6	111.0	177.4	58.5	118.7	140.2	70.0	139.8	89.1	77.0	39.2	96.2	130.7	90.2	76.3	80.9	188.4	142.1	30.8	119.0	94.7	33.7	151.5	111.3	91.1	161.5	106.7	129.7	165.2	120.2	109.9	79.3	209.8	92.5	52.4	96.7	52.4	94.0	47.0
DYNC1LI2	DNCLI2	ENSG00000135720	"Dynein cytoplasmic 1 light intermediate chain 2"	O43237	16	66720893-66751798	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057201			Approved	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA057201: AB_2683366"	"unprognostic (6.03e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.34e-1)"	26.5	21.4	63.8	16.8	63.5	16.7	19.0	28.8	43.3	23.0	24.4	61.2	17.6	19.5	23.9	19.5	23.7	17.9	22.5	26.6	68.3	48.3	20.3	13.0	20.8	11.0	75.0	28.9	22.1	20.2	44.7	19.3	21.1	51.1	25.3	28.7	13.6	20.8	24.5	17.2	23.1	19.8	30.1	89.5	15.5	22.6	14.9	55.0	6.7	28.8	7.9	12.6	20.4	20.0	9.0	12.1	16.3	17.1	8.2	14.9	7.9	15.1	16.0	23.8	21.3	30.8	30.5	21.6	24.9	20.0	20.4	26.6	21.6	15.0	6.3	19.9	24.4	14.8	22.1	18.2	17.8	30.0	4.3	13.1	7.8	18.5	20.4	17.1	8.2	11.6	19.9	24.5	23.5	16.3	28.7	28.6	6.6	12.7	8.4	26.4	10.8	5.1	10.8	14.3	16.9	27.8	11.3	50.3	7.6	20.3	21.4	23.9	16.7	45.0	9.8	28.9	17.9	11.8	8.3	36.3	26.5	13.2	12.9	16.9	10.7	7.8	12.6	22.8	8.0	16.6	10.1	17.1	16.1	13.4	9.8	14.9	5.2	11.3	10.7	12.1	9.0	9.6	9.1	16.3	8.2	13.1	7.6	10.9	7.9	63.8	63.5	28.8	43.3	68.3	48.3	75.0	28.9	51.1	55.0	95.3	106.1	25.9	55.1	58.7	77.3	44.2	50.9	123.1	95.5	26.2	31.4	49.4	6.6	70.7	85.1	86.2	65.1	0.0	50.4	50.0	55.7	71.0	34.8	29.3	26.9	101.7	101.8	51.5	44.8	54.2	58.7	48.5	65.8	19.0	68.1	106.0	84.7	57.5	75.7	38.3	61.1	116.4	75.0	66.6	52.2	61.1	70.9	23.5	54.7	68.6
DYNC2H1	"DHC1b, DHC2, DNCH2, DYH1B, hdhc11"	ENSG00000187240	"Dynein cytoplasmic 2 heavy chain 1"	Q8NCM8	11	103109431-103479863	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 35.7"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 167.3;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 86.1;Spermatocytes: 64.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.9;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.0"	"Low region specificity"	"Detected in all"							"HPA039015, HPA039016"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA039015: AB_2676309, HPA039016: AB_10673410"	"unprognostic (3.11e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (8.49e-5)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.11e-3)"	7.3	5.7	6.3	3.8	8.9	1.4	8.4	13.2	9.3	11.5	4.8	5.5	11.0	4.1	11.3	9.6	3.9	14.6	7.8	3.7	7.1	7.1	8.5	2.6	10.2	2.6	4.8	7.9	11.4	5.1	24.2	35.7	3.9	11.2	7.6	2.6	6.2	4.5	10.7	1.6	5.7	3.4	7.8	5.1	4.8	4.2	14.3	5.2	1.1	10.7	3.0	2.4	6.1	6.6	0.5	0.4	0.4	0.2	2.9	2.2	0.0	1.0	2.2	5.7	2.8	8.0	18.0	0.3	3.2	5.2	5.4	5.8	1.2	1.1	0.0	4.5	6.2	2.5	4.3	4.4	6.0	4.3	0.0	4.1	0.8	3.7	0.1	7.7	1.7	1.0	11.2	2.3	12.1	13.9	8.4	2.1	1.1	0.1	0.0	6.9	4.1	0.5	0.4	1.5	0.0	6.1	0.0	4.7	0.1	5.8	0.7	4.1	2.9	5.1	1.4	2.4	1.4	5.3	1.1	5.1	6.5	2.6	6.1	2.1	0.0	0.0	0.0	1.9	5.2	1.9	0.4	0.2	0.0	0.9	0.1	2.2	0.5	0.7	1.1	0.4	0.3	0.8	1.1	0.0	2.9	0.1	0.2	0.0	0.0	6.3	8.9	13.2	9.3	7.1	7.1	4.8	7.9	11.2	5.2	0.0	12.5	0.0	11.5	6.0	22.2	9.4	2.5	167.3	23.9	26.2	106.0	0.3	1.7	5.6	13.4	9.0	0.0	0.0	3.1	0.4	14.8	5.9	3.5	0.8	2.0	30.2	16.6	6.7	1.5	6.5	19.2	3.8	8.5	0.0	0.8	17.7	6.8	1.1	17.3	14.8	86.1	19.4	11.3	64.2	10.4	4.8	0.5	2.5	0.9	5.7
DYNC2LI1	"CGI-60, D2LIC, DKFZP564A033, LIC3"	ENSG00000138036	"Dynein cytoplasmic 2 light intermediate chain 1"	Q8TCX1	2	43774039-43810010	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 111.1;Early spermatids: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062905	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA062905: AB_2684899"	"unprognostic (3.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.73e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.60e-2)"	11.2	18.2	16.9	8.9	32.2	4.4	23.3	8.1	25.3	24.2	10.7	9.8	22.7	13.1	25.1	34.0	8.5	38.1	14.7	11.5	17.2	18.0	35.2	9.3	16.4	6.5	13.9	24.8	29.2	11.8	25.5	39.8	9.6	28.7	15.3	13.0	13.2	11.5	22.4	12.0	11.0	11.2	14.3	19.0	7.5	11.9	29.0	13.0	5.9	24.3	9.0	6.8	11.4	10.4	5.1	4.0	13.3	5.1	3.2	3.9	2.2	8.7	4.9	8.8	5.6	14.4	28.9	7.6	4.9	10.6	5.8	5.4	1.7	6.1	5.0	10.8	6.4	7.4	5.8	4.2	7.0	6.7	6.4	9.0	3.9	2.4	6.3	13.9	7.4	6.4	17.0	10.1	11.5	5.3	17.7	7.9	6.0	11.8	2.4	8.0	4.5	3.7	8.5	4.0	11.4	5.1	5.1	8.2	1.5	47.7	7.6	6.1	10.9	5.5	3.0	6.1	8.8	8.5	7.0	5.5	5.1	4.6	6.2	4.0	9.1	5.0	1.2	11.3	1.9	5.4	13.3	3.0	2.8	2.5	5.1	2.6	5.1	3.1	3.4	4.0	3.2	3.9	3.4	1.3	3.2	3.8	2.5	1.9	2.2	16.9	32.2	8.1	25.3	17.2	18.0	13.9	24.8	28.7	13.0	17.9	12.6	6.4	15.0	8.7	18.8	11.9	17.8	111.1	18.2	50.6	27.5	16.5	76.3	18.8	99.7	8.3	10.3	0.0	19.5	7.9	24.6	13.1	17.3	6.4	10.7	15.9	12.2	14.7	3.9	21.2	30.8	6.0	21.9	1.0	18.6	27.4	13.8	21.2	31.8	69.2	36.0	19.4	7.1	86.9	14.7	8.0	7.8	2.5	13.0	12.4
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 2849.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	Yes		650000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	45.5	48.5	128.5	34.4	97.8	21.9	54.3	48.4	120.5	50.6	61.8	61.9	31.1	31.6	47.2	64.9	113.7	107.1	46.7	44.2	124.1	105.2	49.7	40.7	40.3	41.2	92.9	90.7	49.0	45.7	30.4	46.4	49.8	67.4	39.9	64.5	24.8	34.0	54.9	15.0	117.3	38.9	75.2	93.6	30.4	45.1	59.4	56.8	35.4	37.1	84.3	65.6	59.0	63.0	55.0	80.6	73.6	55.0	46.7	63.4	50.8	78.6	89.9	89.2	68.4	78.4	83.2	28.7	108.9	50.3	88.9	53.4	84.7	53.1	44.1	58.8	104.0	87.0	71.0	106.0	91.0	88.9	58.4	69.4	43.1	64.5	114.6	79.2	45.0	71.7	50.5	97.5	66.6	54.7	98.8	92.3	47.8	54.0	50.9	117.3	104.1	58.6	97.8	73.2	101.0	104.9	59.9	46.2	54.7	127.0	72.9	61.3	45.3	88.7	77.1	98.8	97.4	76.4	65.8	71.0	68.5	58.5	60.4	93.7	30.6	58.8	43.8	75.9	70.3	87.6	73.6	49.5	63.6	37.7	51.4	28.7	55.0	39.0	39.0	49.1	36.5	25.2	31.5	9.1	46.7	55.0	80.6	63.4	50.8	128.5	97.8	48.4	120.5	124.1	105.2	92.9	90.7	67.4	56.8	181.7	88.8	250.9	293.4	819.1	137.3	144.1	321.0	1203.2	211.5	378.6	78.5	490.2	943.3	628.7	1147.1	421.8	466.9	116.8	472.1	694.2	640.5	264.0	307.3	460.6	658.6	81.0	461.6	421.7	304.4	2849.5	478.4	414.2	565.2	861.2	700.1	95.2	648.6	662.9	659.7	842.5	153.7	362.2	584.0	638.3	583.5	1407.5	841.8	195.6	373.7	348.8
DYNLT1	TCTEL1	ENSG00000146425	"Dynein light chain Tctex-type 1"	P63172	6	158636474-158644739	"Predicted intracellular proteins"	"Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046559			Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA046559: AB_2679698"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-2)"	20.2	34.2	20.2	16.6	23.6	8.2	29.6	16.0	22.0	29.3	33.5	17.4	31.1	27.0	30.8	38.5	44.2	42.7	28.7	36.0	18.4	15.1	45.6	25.5	32.3	23.9	26.5	16.9	24.7	19.5	14.2	27.6	25.6	32.5	28.8	33.6	16.0	37.8	31.0	44.9	14.1	55.5	42.4	29.3	27.2	26.7	52.5	22.8	15.7	32.8	30.8	28.9	32.1	27.7	10.8	27.7	99.5	56.5	12.0	20.3	30.9	31.9	22.8	37.7	36.8	39.1	39.9	15.6	33.3	26.9	41.2	48.8	27.0	29.0	7.7	13.9	69.1	31.0	29.5	23.6	35.9	50.1	11.0	32.9	12.2	22.3	31.0	41.3	5.6	8.6	34.3	38.9	33.9	34.1	35.8	52.0	10.9	23.3	9.3	60.4	28.5	2.5	14.7	20.6	57.8	18.7	5.0	20.3	7.0	57.3	22.0	75.6	37.8	46.9	38.4	13.5	33.5	26.1	12.7	45.1	20.5	25.8	21.9	29.8	5.6	7.0	12.9	29.1	23.6	22.1	17.9	56.5	5.4	16.4	52.5	18.1	10.8	17.6	18.5	27.7	6.6	14.6	15.2	99.5	12.0	38.9	13.6	20.3	30.9	20.2	23.6	16.0	22.0	18.4	15.1	26.5	16.9	32.5	22.8	89.3	87.3	54.4	206.4	48.0	16.8	146.9	173.3	546.0	134.2	200.7	11.8	189.7	353.1	366.9	70.1	71.6	286.6	0.0	241.4	159.7	112.4	234.5	58.9	73.1	140.1	22.3	165.8	125.2	101.8	42.1	99.8	99.9	108.0	154.1	199.8	78.6	342.5	284.0	120.2	447.2	40.3	135.8	134.9	320.2	181.7	53.3	179.9	79.1	152.2	375.2
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	20.0	18.5	19.2	23.4	20.0	49.7	19.9	31.6	24.6	23.7	23.0	16.3	17.6	15.4	24.4	18.7	16.8	19.4	19.0	23.2	18.8	17.9	16.9	16.1	24.8	27.3	15.5	17.8	25.7	17.8	31.0	25.1	25.0	14.0	17.6	18.1	18.5	18.7	22.7	39.8	20.1	18.7	22.7	13.8	24.1	18.5	23.5	16.3	60.9	22.7	17.4	22.1	22.7	29.3	3.0	3.3	6.0	2.5	1.3	3.8	0.8	10.4	8.1	16.6	11.6	7.9	8.6	14.7	9.3	11.8	9.4	9.9	11.5	9.2	14.0	6.3	16.2	12.4	7.1	12.1	9.0	11.1	21.4	5.2	41.4	13.5	7.0	11.8	16.3	15.2	8.7	10.8	12.2	18.7	10.8	9.7	19.8	15.6	32.5	9.8	10.4	21.4	11.2	17.5	10.3	4.8	27.8	9.1	12.9	9.8	13.6	17.1	9.6	21.1	14.5	14.5	5.8	13.5	15.2	12.4	12.9	3.9	8.0	7.7	22.1	17.1	20.0	10.2	18.4	14.0	5.5	1.5	2.0	3.4	2.1	2.1	2.8	3.6	2.6	1.8	3.0	3.8	3.7	6.0	1.3	2.5	3.3	3.1	0.8	19.2	20.0	31.6	24.6	18.8	17.9	15.5	17.8	14.0	16.3	17.9	21.0	14.9	21.8	33.3	28.8	68.6	17.8	18.7	21.6	10.4	25.5	8.2	0.0	11.5	21.3	24.8	20.2	23.3	12.6	9.6	20.6	24.7	24.3	15.3	13.8	44.5	20.5	28.3	24.3	15.3	15.0	20.8	23.6	6.4	16.5	15.6	16.7	20.4	18.4	8.1	19.4	12.9	24.5	15.8	14.0	27.7	12.8	30.6	13.6	28.3
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.1"	"Group enriched"	"Detected in many"	14	"Early spermatids: 145.5;Late spermatids: 469.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	4.8	7.9	7.4	3.7	10.2	5.0	4.0	10.1	13.1	4.5	4.2	7.4	6.1	6.2	6.4	12.3	6.7	8.0	4.6	9.0	6.6	6.1	6.1	3.2	5.4	5.1	4.4	6.7	6.1	5.2	7.1	12.3	3.8	6.4	5.5	3.4	6.7	5.5	5.8	89.1	6.3	5.1	3.9	3.4	5.9	5.2	28.8	4.6	11.2	6.4	25.3	5.3	5.6	4.1	4.7	8.3	4.8	3.2	6.2	7.0	2.6	0.4	8.6	8.4	5.9	4.8	4.5	0.7	2.7	1.7	2.5	2.3	0.8	3.3	1.3	10.6	3.2	0.1	2.9	1.2	1.9	2.2	4.9	7.3	0.6	5.4	0.8	4.0	0.3	1.8	6.1	1.2	0.8	2.8	8.2	0.6	3.3	1.4	1.9	0.4	4.3	1.9	0.8	2.0	2.5	2.0	0.9	0.1	0.6	5.4	2.1	12.2	13.8	4.2	4.2	0.2	4.7	4.1	0.5	4.2	1.1	1.9	0.9	0.8	3.1	1.0	0.9	7.1	0.8	0.4	1.2	3.1	3.2	5.9	3.2	7.0	4.7	4.0	5.9	3.5	3.5	2.2	3.5	4.8	6.2	2.9	8.3	4.2	2.6	7.4	10.2	10.1	13.1	6.6	6.1	4.4	6.7	6.4	4.6	0.0	1.1	13.7	3.6	3.1	14.9	5.3	5.1	1.4	0.0	15.7	19.6	1.8	8.3	11.7	145.5	5.7	9.1	0.0	3.7	1.5	4.0	5.4	1.1	3.0	4.9	9.5	19.5	6.2	9.2	469.8	6.6	2.7	5.0	3.6	9.4	8.1	8.6	8.6	4.9	11.2	13.0	0.0	2.3	22.4	14.0	2.5	1.1	6.9	8.5	3.2
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 39.9;skeletal muscle: 53.3"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 20.1;Endothelial cells: 22.1;Ito cells: 34.4;Kupffer cells: 20.6;Syncytiotrophoblasts: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 19.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 19.9"	"Group enriched"	"Detected in some"	5	"hTERT-RPE1: 12.8;HUVEC TERT2: 32.9;LHCN-M2: 29.9;RH-30: 31.6;TIME: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	6.6	2.1	1.1	7.2	1.3	18.6	7.9	1.2	2.0	1.9	6.4	0.0	3.9	1.6	4.2	4.9	5.1	3.6	3.3	20.8	1.2	2.0	4.7	13.4	9.1	17.8	2.1	0.7	4.1	1.4	2.0	2.1	39.9	7.0	4.8	1.9	3.3	1.9	3.6	53.3	1.7	3.3	12.1	1.4	26.5	3.2	1.5	0.3	0.8	4.9	8.3	1.0	8.7	11.9	0.0	0.0	19.9	2.6	0.3	0.3	0.7	0.4	0.0	1.3	1.1	0.0	0.0	2.4	0.0	0.3	0.9	0.6	0.1	0.3	0.0	4.9	0.0	1.3	1.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.9	4.2	12.8	32.9	0.0	3.1	0.0	29.9	0.0	0.0	2.2	3.2	0.0	0.3	0.0	31.6	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	3.3	0.1	0.3	21.5	0.1	1.5	0.1	0.4	0.0	0.0	0.0	0.0	5.2	0.0	0.0	2.6	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	19.9	0.3	0.1	0.0	0.0	0.7	1.1	1.3	1.2	2.0	1.2	2.0	2.1	0.7	7.0	0.3	3.0	13.8	0.5	0.0	2.2	0.8	20.1	0.0	1.4	2.3	0.0	0.0	5.4	0.0	0.4	4.4	22.1	0.0	0.0	0.2	2.8	1.4	0.2	2.3	9.9	11.0	0.0	0.0	34.4	20.6	4.1	0.6	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.7	0.1	6.5	3.1	0.5	0.0	1.4	55.4	0.9	0.0	0.0
DZANK1	"ANKRD64, bA189K21.8, C20orf12, C20orf84, dJ568F9.2, FLJ10600, FLJ30892"	ENSG00000089091	"Double zinc ribbon and ankyrin repeat domains 1"	Q9NVP4	20	18383367-18467281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 50.9;Early spermatids: 19.6;Rod photoreceptor cells: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"THP-1: 20.1;U-266/84: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059478, HPA064255"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA059478: AB_2684033, HPA064255: AB_2685228"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.78e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.81e-3)"	3.2	1.9	4.4	2.4	7.5	8.1	7.4	5.1	8.1	3.4	1.7	3.4	2.8	1.4	3.3	4.0	1.5	9.0	1.4	1.2	4.0	5.9	3.9	1.7	3.4	2.7	3.0	4.9	2.8	2.0	1.1	10.5	1.6	5.3	3.3	1.8	3.2	3.8	1.5	1.8	4.3	1.4	1.9	2.7	2.4	2.4	5.2	2.4	0.5	5.3	1.1	2.3	2.6	2.5	2.9	1.1	6.3	2.1	1.7	1.2	0.6	0.3	1.4	1.4	1.2	1.4	0.8	0.2	0.7	0.3	2.0	1.2	5.1	0.7	2.6	0.3	0.6	0.9	0.5	4.4	0.5	1.5	0.3	0.8	1.3	0.7	0.6	1.0	2.0	0.9	0.5	0.8	3.6	0.6	0.5	0.6	0.9	0.1	1.0	0.5	2.1	0.1	0.9	2.9	1.0	0.2	0.7	0.6	0.1	2.7	1.3	1.4	1.7	2.1	1.0	2.4	1.2	0.8	20.1	0.0	1.7	0.4	1.4	1.0	3.0	21.2	3.0	0.6	2.5	0.6	6.3	1.0	1.3	0.5	2.1	0.5	2.9	0.6	1.2	0.9	1.2	0.8	0.6	2.8	1.7	1.7	1.1	1.0	0.6	4.4	7.5	5.1	8.1	4.0	5.9	3.0	4.9	5.3	2.4	0.0	5.1	0.9	1.0	1.3	4.1	1.2	0.0	50.9	13.6	3.5	15.7	0.4	1.7	1.7	19.6	0.8	0.9	0.0	1.0	0.6	1.0	1.1	3.5	0.0	1.9	6.4	0.0	0.6	2.2	11.3	0.3	1.1	5.0	1.0	1.3	3.9	2.0	0.0	1.8	3.2	18.4	0.0	0.7	10.3	12.2	1.3	0.2	1.0	1.5	0.6
DZIP1	"DZIP, KIAA0996"	ENSG00000134874	"DAZ interacting zinc finger protein 1"	Q86YF9	13	95578202-95644703	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Early spermatids: 313.9;Late spermatids: 570.8;Spermatocytes: 228.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054891, HPA057272, HPA070194"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Centriolar satellite"	"HPA054891: AB_2682631, HPA057272: AB_2683390, HPA070194: AB_2686233"	"unprognostic (6.74e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.89e-3)"	5.0	6.3	17.2	4.4	17.4	0.4	3.7	13.9	16.1	11.5	6.7	4.1	3.8	2.2	16.2	10.7	6.2	10.7	8.5	3.8	13.1	18.1	16.2	1.7	4.0	3.6	8.7	13.5	24.2	9.6	0.9	8.9	4.6	8.8	7.7	3.7	5.8	3.2	13.3	1.7	1.1	2.6	12.3	5.6	2.8	3.6	27.3	4.5	0.6	1.7	1.8	3.5	5.0	5.2	0.4	0.2	1.2	0.2	0.3	0.3	0.0	1.3	5.0	16.9	17.2	13.1	16.3	3.4	12.2	14.2	13.7	16.5	0.1	0.0	0.0	2.8	9.7	6.2	0.0	11.2	4.5	15.5	0.9	10.0	15.6	3.8	10.6	9.1	0.0	0.1	11.5	0.3	4.2	5.6	22.2	9.2	1.1	0.0	0.0	10.0	0.0	0.0	0.0	7.7	0.0	0.4	0.0	11.6	0.0	13.1	1.8	4.2	11.0	9.3	0.0	0.5	20.8	0.0	5.8	0.7	13.6	6.6	1.8	10.0	0.0	0.0	0.0	3.5	0.0	2.4	1.2	0.2	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.0	0.4	0.1	0.3	1.1	0.3	0.1	0.2	0.1	0.0	17.2	17.4	13.9	16.1	13.1	18.1	8.7	13.5	8.8	4.5	0.0	0.0	0.0	1.1	0.6	17.7	2.9	0.0	17.4	5.7	1.8	3.9	3.9	6.6	13.1	313.9	2.7	0.0	0.0	0.2	1.8	10.6	0.5	0.0	0.0	0.5	6.4	0.0	3.1	0.0	570.8	35.9	1.2	3.3	3.6	0.0	6.2	0.8	0.0	41.1	19.5	1.2	19.4	13.2	228.9	7.0	0.9	1.5	0.0	0.0	0.3
DZIP3	"hRUL138, PPP1R66"	ENSG00000198919	"DAZ interacting zinc finger protein 3"	Q86Y13	3	108589682-108694846	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 57.4"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 183.4;Cone photoreceptor cells: 308.3;Spermatocytes: 314.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035066, HPA049232"	Approved		Approved	Vesicles		No	No			Vesicles		"HPA035066: AB_10601549, HPA049232: AB_2680684"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.51e-3)"	"unprognostic (3.81e-2)"	4.6	9.3	14.1	4.5	25.7	3.1	5.0	14.5	23.7	5.2	4.4	5.8	2.1	2.8	7.4	9.7	3.8	17.4	5.4	10.8	13.2	18.5	10.5	3.9	6.0	8.4	10.3	16.0	10.3	4.9	10.3	57.4	4.5	20.3	9.2	4.5	4.0	3.3	7.0	10.1	3.4	3.6	7.9	9.2	7.0	6.0	29.9	8.0	10.4	12.0	2.8	7.0	5.0	3.5	6.8	1.8	5.2	1.6	11.7	6.5	1.8	6.5	6.0	17.0	10.2	7.6	7.9	5.8	4.1	8.2	6.9	9.4	8.3	4.5	11.8	8.9	4.4	14.9	2.4	9.7	3.5	14.7	4.3	4.1	5.4	2.2	5.7	4.5	2.1	3.1	8.2	1.9	6.4	8.0	7.1	4.3	7.6	5.1	5.8	13.1	5.9	5.3	2.3	10.4	3.4	4.3	6.8	14.0	1.1	5.8	3.2	11.5	11.0	6.9	0.7	7.4	16.0	10.2	1.8	4.9	6.2	9.5	1.2	3.6	6.7	3.8	23.0	4.7	1.7	7.5	5.2	0.7	1.4	5.0	1.0	6.0	6.8	5.1	6.1	0.6	6.0	4.5	6.0	0.1	11.7	1.6	1.8	6.5	1.8	14.1	25.7	14.5	23.7	13.2	18.5	10.3	16.0	20.3	8.0	11.9	13.8	8.3	8.5	6.6	67.2	33.6	2.5	183.4	29.6	31.4	308.3	19.8	11.6	8.1	23.6	8.2	3.9	0.0	8.1	7.3	13.9	8.8	8.1	3.6	7.8	73.1	50.7	6.7	7.3	46.6	16.1	6.2	6.8	14.4	6.1	33.9	8.4	3.5	16.6	15.3	32.1	19.4	9.2	314.4	93.7	6.5	12.4	18.5	6.3	4.3
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401906-20493715	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: AB_2732448, HPA065012: AB_2685403"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	9.5	8.4	7.6	12.2	13.4	22.1	10.8	1.7	10.1	4.8	7.1	2.9	3.2	6.8	6.3	6.9	8.0	4.9	9.9	11.1	8.3	6.8	14.6	6.1	7.8	19.7	5.8	7.3	4.0	3.6	2.9	3.2	7.4	7.9	5.0	8.6	5.1	4.7	4.5	15.1	4.3	8.0	7.9	5.0	16.9	5.0	8.9	3.1	17.7	11.4	10.2	12.0	9.2	4.8	0.7	3.7	10.3	3.1	4.8	3.6	1.5	6.8	5.6	16.1	17.3	5.4	6.0	11.2	9.3	8.1	8.9	9.9	6.9	4.3	15.4	18.0	8.6	8.3	7.2	18.4	8.3	15.0	6.0	13.0	27.9	9.3	7.7	5.8	18.3	16.8	4.8	6.2	8.7	10.7	9.2	6.1	14.7	30.9	9.5	10.1	7.1	20.7	20.5	12.1	5.3	5.8	22.6	14.2	17.7	10.6	11.9	11.6	21.3	8.6	11.9	12.2	10.3	6.1	11.1	8.2	14.4	9.0	7.1	14.7	6.0	19.0	19.3	3.5	11.3	20.4	6.9	3.1	1.4	2.3	2.3	3.1	0.7	1.5	3.6	3.7	0.7	1.3	2.8	10.3	4.8	1.5	1.6	2.2	1.5	7.6	13.4	1.7	10.1	8.3	6.8	5.8	7.3	7.9	3.1	0.0	1.6	8.2	10.8	8.1	35.1	8.9	7.6	0.0	12.5	7.0	21.6	6.3	8.3	7.0	10.2	5.2	7.9	0.0	5.9	11.3	10.4	18.4	19.7	5.0	14.5	30.2	11.5	19.0	49.7	5.0	2.6	18.9	5.0	8.2	11.3	2.1	11.2	11.6	2.8	20.5	9.2	0.0	8.2	2.7	3.2	7.9	2.6	9.6	12.7	14.2
E2F5		ENSG00000133740	"E2F transcription factor 5"	Q15329	8	85177225-85217158	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"B-cells: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 13.3;naive B-cell: 7.6"	"Lineage enriched"	"Detected in many"	9	"B-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"AF22: 27.5;Daudi: 54.2;U-698: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055723, HPA065441"			Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA055723: AB_2682897, HPA065441: "	"unprognostic (8.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (2.88e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.95e-3)"	3.0	9.0	6.4	22.2	8.1	1.5	5.9	2.6	5.3	5.0	5.9	4.0	3.4	4.6	5.4	7.4	4.7	7.2	6.6	3.2	5.6	5.6	9.0	4.5	5.1	22.4	4.6	2.7	8.3	14.6	12.7	10.6	4.3	3.8	5.1	7.2	3.4	5.7	5.9	1.1	1.7	7.3	3.8	4.5	9.9	5.1	10.5	3.2	13.6	10.2	3.0	26.0	6.0	7.6	13.3	1.4	0.0	0.0	1.1	0.6	0.6	4.9	5.3	27.5	10.2	0.5	0.7	8.8	1.0	2.2	0.8	2.4	3.2	5.8	54.2	3.8	1.1	9.9	1.0	16.0	1.3	1.0	5.6	7.3	5.5	3.0	7.4	4.4	1.6	0.0	1.0	2.2	1.1	3.9	5.4	0.8	5.7	11.5	0.4	1.5	3.2	5.5	3.6	8.8	9.2	4.7	4.4	1.1	5.8	8.9	3.5	3.4	10.6	0.6	1.9	8.1	11.5	11.6	1.7	0.0	1.3	1.0	1.6	3.6	10.2	6.8	25.9	1.5	1.4	2.7	0.0	0.0	0.0	0.1	0.0	0.0	13.3	0.0	0.0	0.1	7.6	0.2	0.4	0.0	1.1	0.0	1.4	0.6	0.6	6.4	8.1	2.6	4.5	5.6	5.6	4.6	2.7	3.8	3.2	0.0	6.2	16.3	2.8	2.1	0.4	1.0	2.5	9.4	3.4	5.2	9.8	2.7	0.0	2.9	5.2	1.5	1.3	0.0	2.1	0.6	3.0	2.7	1.1	2.4	0.4	0.0	7.5	0.6	1.0	2.9	1.4	0.4	3.3	0.0	3.4	4.3	2.8	0.0	1.8	4.9	1.1	0.0	1.7	11.1	3.4	2.5	0.9	1.9	3.7	1.6
EAPP	"BM036, C14orf11, FLJ20578"	ENSG00000129518	"E2F associated phosphoprotein"	Q56P03	14	34515929-34539711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002916	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA002916: AB_1078715"	"unprognostic (8.76e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.81e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.64e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (3.24e-2)"	30.1	32.8	24.4	23.1	23.5	53.4	36.5	32.4	30.1	30.0	35.0	20.6	25.3	24.7	27.9	33.0	26.3	28.5	19.9	19.9	22.8	26.4	30.1	34.4	20.5	23.2	21.8	25.3	37.3	22.5	31.1	28.1	33.8	27.8	29.4	36.8	21.6	27.3	27.8	41.3	39.1	43.2	23.8	20.9	26.5	23.5	21.6	24.2	34.8	34.1	22.6	24.8	27.7	31.2	36.8	19.3	50.2	26.2	33.6	42.3	24.8	15.1	18.6	17.4	10.2	20.7	21.2	27.1	14.0	21.5	17.5	18.4	8.8	20.2	15.9	19.9	17.0	10.5	14.3	12.8	18.6	20.7	19.8	11.3	11.6	14.6	37.1	28.2	20.6	12.9	24.3	24.0	10.0	26.0	23.2	17.4	22.5	11.5	17.7	16.3	35.5	28.5	16.7	10.2	28.3	20.9	18.1	20.9	15.9	21.1	20.7	14.0	15.5	19.8	19.2	29.8	17.5	33.4	13.2	18.8	9.2	7.8	11.8	9.0	22.4	25.0	16.9	8.6	11.4	11.5	40.7	22.0	45.2	24.8	20.1	29.7	36.8	31.1	28.0	19.3	33.7	31.8	28.8	50.2	33.6	26.2	16.9	42.3	24.8	24.4	23.5	32.4	30.1	22.8	26.4	21.8	25.3	27.8	24.2	20.8	44.0	56.1	67.2	41.2	75.1	29.7	53.5	104.4	45.5	78.5	29.5	102.7	147.6	71.8	11.9	52.6	81.1	23.3	74.0	64.7	52.1	52.3	71.6	87.3	51.6	23.8	63.4	45.4	51.6	7.4	82.8	55.7	86.0	63.1	99.8	110.6	51.5	112.6	88.8	94.6	66.9	71.1	50.1	103.2	38.4	58.2	158.4	91.3	92.5	44.8
EARS2	"KIAA1970, MSE1"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23522014-23557731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	8.4	19.0	11.0	8.5	19.0	2.7	13.6	13.4	16.8	11.1	10.0	10.8	12.7	6.4	11.4	10.2	10.5	13.1	7.8	14.9	10.9	11.9	14.5	18.3	7.3	8.1	9.9	14.0	12.0	18.9	32.7	10.9	12.4	10.3	11.3	11.0	8.8	16.4	11.7	17.3	11.1	6.9	8.3	9.3	7.6	9.2	12.6	10.4	6.3	14.5	9.0	11.0	8.6	16.9	3.0	6.2	0.5	5.5	10.6	7.9	3.3	8.2	16.8	7.9	12.7	5.5	7.9	9.6	9.2	7.0	11.4	9.5	12.2	8.4	11.5	9.5	8.5	7.1	9.3	29.7	16.9	10.9	4.6	14.4	6.7	10.3	20.6	8.9	7.4	8.4	8.5	10.1	10.2	14.4	8.6	5.1	11.6	20.7	6.1	8.1	17.5	7.3	5.3	20.8	11.8	5.9	13.2	9.1	22.1	14.4	7.2	14.1	10.4	7.2	13.6	7.3	13.3	18.4	8.3	4.0	9.0	8.0	9.9	11.6	11.2	10.6	9.3	9.1	10.3	13.3	0.0	2.8	0.3	4.2	3.6	7.9	3.0	4.7	4.3	6.2	3.0	4.6	4.5	0.5	10.6	5.5	4.5	3.4	3.3	11.0	19.0	13.4	16.8	10.9	11.9	9.9	14.0	10.3	10.4	8.9	5.1	3.0	3.5	1.9	3.8	9.8	2.5	6.7	2.3	3.5	2.0	12.9	5.0	6.5	2.1	3.5	1.3	23.3	3.1	9.9	3.3	3.5	5.7	10.5	6.3	7.9	5.2	4.3	1.8	1.9	2.3	3.1	5.0	6.4	5.5	2.8	4.1	0.0	1.8	6.8	3.7	0.0	1.9	4.3	10.4	2.6	9.5	2.5	5.5	2.7
EBF1	"EBF, OLF1"	ENSG00000164330	"Early B cell factor 1"	Q9UH73	5	158695916-159099761	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Leydig cells: 264.3;Peritubular cells: 114.2;Sertoli cells: 97.0;Smooth muscle cells: 110.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 23.6"	"Group enriched"	"Detected in some"	62	"memory B-cell: 11.8;naive B-cell: 10.4"	"Lineage enriched"	"Detected in single"	66	"B-cells: 11.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.4;HSkMC: 15.1;REH: 40.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (7.86e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (9.62e-7)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (5.75e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.37e-3)"	33.7	3.3	1.9	9.7	2.5	3.1	25.0	23.6	2.0	15.9	5.8	1.1	9.0	1.2	19.7	13.0	5.0	8.5	9.4	15.5	2.0	2.4	3.3	0.9	5.2	12.7	3.2	1.2	7.4	3.7	1.8	2.6	10.7	4.7	8.5	3.4	10.4	4.7	10.8	15.5	4.8	4.5	25.7	6.6	5.4	3.4	8.4	1.0	0.1	6.8	13.2	9.1	11.7	12.5	11.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	6.2	0.0	19.4	8.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	5.6	0.0	2.3	1.2	0.0	0.2	0.0	0.1	1.3	0.0	0.0	1.6	0.0	0.3	0.0	0.0	15.1	0.0	6.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	40.6	0.2	0.0	0.0	0.0	3.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.8	8.5	0.1	0.0	0.0	5.6	4.9	0.4	6.7	0.1	0.0	0.1	0.0	0.0	0.0	11.8	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	2.5	23.6	1.6	2.0	2.4	3.2	1.2	4.7	1.0	0.0	0.3	44.7	0.4	10.9	4.1	4.3	0.0	1.4	1.2	1.8	0.0	0.1	0.0	2.4	15.8	55.5	0.0	0.0	0.0	0.3	40.4	0.6	0.0	1.0	0.7	0.0	0.0	2.5	0.8	15.5	264.3	1.0	13.5	16.2	0.0	1.7	0.2	0.0	114.2	0.0	2.0	97.0	110.4	2.2	0.4	6.0	0.3	1.3	0.0	0.5
EBF2	"COE2, FLJ11500"	ENSG00000221818	"Early B cell factor 2"	Q9HAK2	8	25841730-26045397	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.8"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;ASC TERT1: 25.5;HSkMC: 25.9;hTEC/SVTERT24-B: 14.4;U-138 MG: 9.3;U-2197: 12.2;U-87 MG: 10.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.9;cerebellum: 3.4;hypothalamus: 2.4;midbrain: 5.3;pons and medulla: 2.9"	"Low region specificity"	"Detected in some"			"HPA003954, HPA055101"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003954: , HPA055101: "	"unprognostic (3.70e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (7.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.82e-2)"	25.8	1.1	0.2	3.2	0.9	0.1	14.5	0.2	0.2	3.0	4.2	0.0	2.9	0.2	3.0	14.1	5.2	5.1	3.8	16.4	0.2	0.5	0.9	0.2	1.3	4.4	0.9	0.0	3.9	4.0	3.1	0.6	0.8	2.8	3.7	0.7	0.1	1.7	0.8	11.1	1.8	1.0	5.4	10.1	0.2	1.2	4.2	0.0	0.4	7.4	11.6	0.5	6.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.5	25.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	14.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.3	0.1	12.2	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.2	0.2	0.5	0.9	0.0	2.8	0.0	0.0	0.3	0.0	0.1	0.1	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.2	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	38.8	9.5	0.2	0.2	0.3	0.0	0.0	0.0	0.0
EBF3	"COE3, DKFZp667B0210"	ENSG00000108001	"Early B cell factor 3"	Q9H4W6	10	129835283-129963841	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 25.8;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in some"	24	"Cardiomyocytes: 2.4;Endothelial cells: 3.5;Smooth muscle cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.1;HAP1: 11.8;LHCN-M2: 18.9;NB-4: 23.8;RH-30: 10.3;SCLC-21H: 24.4;THP-1: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (2.96e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.50e-3)"	"unprognostic (8.53e-6)"	"unprognostic (2.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.58e-2)"	20.0	0.9	0.3	3.4	0.4	0.1	25.8	0.7	0.5	7.3	3.6	0.2	2.5	0.2	5.4	4.9	4.3	3.8	4.3	10.5	0.3	2.5	0.6	0.4	1.0	29.9	5.0	0.3	1.0	1.2	3.6	0.9	3.8	4.8	4.6	0.8	2.0	3.6	2.2	10.9	2.8	1.0	6.3	9.3	0.2	1.6	4.6	0.1	0.5	6.7	6.3	2.4	4.7	16.9	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	10.1	7.8	0.1	0.7	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	11.8	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.0	0.7	0.0	0.0	18.9	0.1	0.0	23.8	0.1	0.0	0.0	0.3	10.3	0.0	0.0	0.1	24.4	0.3	0.0	0.0	0.0	0.2	0.0	10.0	0.0	0.0	1.2	6.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.5	0.3	2.5	5.0	0.3	4.8	0.1	0.0	0.0	0.0	0.0	1.6	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.6	0.0	11.8	0.0	0.9	0.6	0.0	0.0	0.0	0.0
EBLN2		ENSG00000255423	"Endogenous Bornavirus like nucleoprotein 2"	Q6P2I7	3	73061659-73063337	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA062510, HPA068795"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA062510: AB_2684787, HPA068795: AB_2686038"	"unprognostic (1.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.38e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.12e-1)"	2.2	1.2	0.0	2.1	0.0	15.3	2.6	0.5	0.3	2.4	1.5			1.0	2.6	2.5	1.8	3.1	1.1	2.1	0.1	0.0	0.8	1.8	3.1	1.7	0.1		5.1	2.6	1.2	1.2	1.9		1.6	2.4		3.1	0.5	1.3	2.2	2.1	1.4	1.0	2.1	1.8	0.9			2.4		1.5	2.4	2.9	2.6	2.2	6.3	1.5	1.1	3.8	0.2	1.3	0.9	5.3	4.7	1.4	3.0	4.0	2.1	0.4	1.3	1.0	2.6	4.3	3.3	0.8	2.8	1.3	1.8	2.0	2.2	2.7	1.3	1.2	2.2	5.0	2.3	0.8	4.2	4.9	2.9	1.6	2.7	2.6	2.6	1.8	2.9	1.6	5.1	1.5	2.8	2.0	5.9	3.3	1.1	1.4	5.3	1.3	2.0	1.4	5.5	1.2	2.6	1.3	2.3	0.7	3.9	3.5	1.6	3.4	1.5	2.9	4.0	3.2	5.1	2.4	2.6	1.5	4.6	2.6	0.3	1.5	6.3	3.6	0.5	3.0	1.5	3.2	3.1	0.5	2.6	2.7	3.8	3.3	1.1	0.6	2.2	3.7	0.2											0.0	2.1	5.0	11.6	5.0	4.7	0.8	15.3	2.7	2.3	3.5	7.9	7.1	0.0	3.1	1.5	4.5	4.5	23.3	1.4	5.4	6.2	7.7	1.1	4.4	2.5	3.2	4.1	7.4	3.3	0.2	7.8	3.9	1.7	1.8	3.3	2.8	3.5	3.5	3.5	0.1	5.0	6.5	3.1	3.7	4.8	5.5	12.2	7.5	3.3	11.2
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487828	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;ovary: 57.1"	"Group enriched"	"Detected in some"	19	"Muller glia cells: 76.3;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 30.1;HeLa: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	0.9	2.6	0.5	0.9	4.0	0.2	0.4	0.7	1.2	0.3	0.4	0.5	0.1	0.3	0.6	4.9	0.3	1.7	1.0	1.1	0.1	28.6	1.0	0.7	0.2	1.2	0.3	0.1	57.1	0.6	0.3	8.9	0.4	5.5	0.3	0.2	11.5	0.3	1.2	1.8	0.3	0.3	1.1	4.5	2.0	0.3	0.8	1.6	0.1	0.5	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.7	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.0	0.7	1.2	0.1	28.6	0.3	0.1	5.5	1.6	0.0	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	76.3	0.2	0.0	19.8	0.0	1.7	0.0	2.1	0.2	1.7	0.0	0.0	0.0	0.0	0.0
ECHDC1	dJ351K20.2	ENSG00000093144	"Ethylmalonyl-CoA decarboxylase 1"	Q9NTX5	6	127288710-127343609	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035445, HPA035446"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA035445: AB_10669860, HPA035446: AB_2732468"	"unprognostic (9.57e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.89e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.99e-1)"	"unprognostic (9.97e-2)"	"unprognostic (8.21e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	40.1	16.8	20.8	16.5	23.1	6.8	21.9	16.6	21.4	18.6	27.2	12.0	12.8	21.9	13.7	15.5	20.6	11.4	16.1	20.0	19.4	18.0	44.4	44.3	26.8	17.8	27.3	16.5	11.9	14.2	14.5	16.1	17.0	23.1	19.8	26.3	15.1	22.2	14.5	22.0	13.3	25.8	30.1	27.3	14.1	18.1	8.3	20.9	20.7	42.4	14.2	19.4	24.2	22.6	13.2	29.6	13.4	31.2	6.4	11.6	16.9	15.9	12.8	18.4	16.9	27.3	26.0	15.6	26.2	31.8	22.6	28.8	22.2	12.2	24.3	22.5	24.8	25.6	13.2	0.0	19.6	28.6	14.4	12.3	32.3	17.2	35.2	24.3	43.1	18.2	29.3	23.7	21.0	17.9	20.5	20.4	17.9	40.0	14.7	30.0	15.1	28.5	20.0	15.1	8.0	15.9	13.4	22.6	19.9	41.1	19.8	21.1	20.6	14.7	0.5	35.9	14.6	0.5	50.5	21.1	13.9	22.3	35.0	29.1	19.0	38.0	31.9	25.4	37.8	32.6	6.2	31.2	10.0	11.0	25.6	11.6	12.8	9.5	10.8	29.6	13.2	11.6	11.6	13.4	6.4	17.9	22.6	9.6	16.9	20.8	23.1	16.6	21.4	19.4	18.0	27.3	16.5	23.1	20.9	89.3	91.1	32.9	31.3	23.2	25.4	53.7	25.5	48.2	87.6	29.6	29.5	92.5	107.8	66.8	54.2	29.5	50.2	0.0	69.9	70.0	41.4	25.3	42.7	52.3	76.6	27.0	13.3	22.1	48.0	20.2	30.5	56.1	33.7	19.0	31.2	28.6	47.4	28.1	29.4	160.1	37.1	25.8	25.6	26.9	22.6	19.9	54.8	31.9	50.3	46.0
ECHDC2	FLJ10948	ENSG00000121310	"Enoyl-CoA hydratase domain containing 2"	Q86YB7	1	52895910-52927212	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.9"	"Cell type enhanced"	"Detected in all"	8	"Hepatocytes: 663.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.4;HHSteC: 11.1;THP-1: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026731, HPA026768"	Enhanced		Approved	Mitochondria		NA	NA		410000	Mitochondria		"HPA026731: AB_1847969, HPA026768: AB_1847970"	"unprognostic (2.73e-3)"	"unprognostic (1.52e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.67e-2)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.11e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.62e-1)"	"prognostic favorable (2.70e-4)"	10.2	13.3	4.8	9.3	7.4	3.1	10.3	12.3	2.9	10.0	11.2	2.6	20.3	14.5	10.4	20.5	10.2	9.1	20.7	11.1	4.8	2.6	21.3	74.9	9.2	2.5	2.9	3.6	11.8	9.9	8.4	18.1	4.4	5.3	10.9	3.8	15.9	11.2	25.6	22.2	6.0	13.3	16.2	4.6	3.8	10.2	3.8	4.2	1.8	16.4	11.1	8.1	8.0	10.7	5.2	8.2	1.7	1.8	4.8	11.0	3.8	0.0	1.5	0.0	0.0	1.1	0.5	15.4	1.2	7.1	1.5	2.4	0.0	1.1	0.0	7.1	1.2	0.0	0.8	0.0	1.2	0.3	0.0	7.2	0.0	2.6	3.2	11.1	0.0	2.1	1.6	3.2	1.0	1.1	2.1	4.4	0.0	1.1	0.2	0.0	3.8	0.0	0.8	0.1	6.2	1.6	0.0	0.1	0.6	4.9	6.0	0.7	0.3	2.1	5.6	0.1	0.8	1.1	9.3	1.7	0.0	0.0	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.3	0.0	1.8	1.7	11.0	1.4	8.2	5.2	9.0	10.3	8.2	2.6	10.2	6.2	0.4	4.8	0.7	2.0	10.8	3.8	4.8	7.4	12.3	2.9	4.8	2.6	2.9	3.6	5.3	4.2	50.6	72.4	17.1	77.5	27.2	30.8	55.4	119.8	60.2	70.5	82.0	308.3	162.8	150.9	46.2	111.4	19.6	107.0	46.7	52.0	12.3	46.8	90.9	28.9	663.7	26.8	39.7	50.1	25.8	25.9	134.0	142.6	17.0	38.8	10.0	59.3	58.0	41.0	123.8	105.7	257.8	155.8	19.4	46.6	14.2	12.8	25.7	103.7	39.2	56.8	67.7
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		12000000000	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.2	0.6	2.3	0.0	14.0	77.4	2.1	22.7	53.9	14.2	18.6	0.3	3.5	0.1	0.2	50.8	1.6	13.1	0.0	2.7	14.9	0.1	0.1	0.9	0.8	0.1	3.9	0.0	23.5	6.8	0.1	36.5	1.3	20.9	3.9	0.1	4.8	0.1	39.5	0.0	0.0	0.7	0.2	26.5	0.7	0.3	17.0	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.4	1.1	0.0	6.0	1.0	30.1	4.5	3.4	4.9	0.1	0.2	0.2	15.8	2.1	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0	0.0	0.6	1.4	1.8	13.1	0.7	1.1	12.7	0.0	2.3	3.5	0.0	1.3	0.0	4.8	0.2	4.4	0.2	0.0	3.7	26.0	80.6	1.0	10.3	0.6	16.0	1.6	0.0	56.4	2.1	0.0	9.2	4.8	70.9	0.0	0.3	0.8	42.0	0.0	20.8	0.0	1.1	12.9	16.1	0.5	0.4	16.7	9.2	0.0	0.2	5.8
ECPAS	"ECM29, FLJ22036, KIAA0368"	ENSG00000136813	"Ecm29 proteasome adaptor and scaffold"	Q5VYK3	9	111360692-111484745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 92.6"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 53.6;Alveolar cells type 2: 52.8;Ciliated cells: 44.2;Club cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021646, HPA059795"	Uncertain		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA021646: AB_2670788, HPA059795: AB_2684127"	"unprognostic (1.64e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.05e-1)"	21.0	17.2	16.4	12.9	29.0	13.2	19.4	18.4	18.1	16.6	16.6	14.1	20.8	17.1	18.9	17.2	13.6	14.3	13.2	19.9	27.4	13.7	16.0	16.6	12.7	13.8	15.1	12.8	17.9	19.2	28.5	20.8	12.8	15.7	19.2	16.4	13.7	14.9	23.3	92.6	15.3	17.8	19.5	11.5	13.9	15.7	18.3	11.5	8.7	17.7	23.7	14.5	17.8	18.5	5.6	11.6	4.0	8.6	6.6	8.2	3.6	20.7	19.2	12.9	13.8	30.8	30.9	21.2	25.6	22.0	21.1	14.6	17.8	12.9	21.0	12.1	22.4	17.3	30.3	16.4	17.1	19.7	23.1	10.3	12.9	23.2	25.5	22.9	24.1	14.2	28.0	18.0	21.1	31.5	24.0	21.4	5.3	29.7	29.8	17.2	17.6	0.1	14.1	25.2	26.6	16.1	11.8	39.6	12.6	17.9	18.7	24.7	11.8	21.9	23.6	16.0	14.6	18.5	12.9	23.3	14.2	16.3	21.2	23.4	26.4	49.2	25.8	20.8	10.0	13.1	4.0	8.2	2.7	6.9	8.6	8.2	5.6	7.4	8.0	11.6	5.3	4.5	7.6	2.6	6.6	6.2	5.3	5.8	3.6	16.4	29.0	18.4	18.1	27.4	13.7	15.1	12.8	15.7	11.5	53.6	52.8	0.0	0.0	0.0	0.0	0.0	0.0	44.2	60.3	12.2	0.0	13.8	8.3	18.8	0.0	0.0	0.0	0.0	18.6	9.6	0.0	0.0	22.1	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	19.0	0.0	0.0	20.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0
ECSCR	"ARIA, ECSM2"	ENSG00000249751	"Endothelial cell surface expressed chemotaxis and apoptosis regulator"	Q19T08	5	139448556-139462743	"Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	20	"Endothelial cells: 271.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.7"	"Group enriched"	"Detected in some"	121	"EFO-21: 49.7;HUVEC TERT2: 125.6;TIME: 92.7"									HPA063337			Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA063337: AB_2732701"	"unprognostic (5.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.91e-1)"	14.8	1.9	0.8	5.7	1.6	0.0	17.5	0.4	0.7	13.7	6.1	1.0	5.1	1.9	14.3	14.4	11.0	7.9	8.6	26.9	0.8		5.6	4.3	23.4	26.9	1.4	0.7	7.9	1.0	1.3	0.4	19.6	2.9	9.3	4.3	6.8	3.6	5.5	13.4	2.9	3.4	14.3	4.3	12.1	1.1	6.8	1.1	0.1	11.5	14.5	4.6	13.2	13.1	0.6	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	49.7	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	125.6	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	92.7	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.6	1.1	1.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.6	0.0											0.0	4.6	0.0	0.2	13.3	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.5	0.0	271.3	0.0	0.0	1.0	0.1	2.6	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	5.8	10.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	12.2	0.2	0.0	0.0	0.7
EDA	"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED"	ENSG00000158813	"Ectodysplasin A"	Q92838	X	69616067-70039469	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 11.2;Early spermatids: 15.7;Ito cells: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Group enriched"	"Detected in many"	6	"monocytes: 3.0;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 5.7;Hep G2: 18.4;OE19: 5.3;RPMI-8226: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037972, HPA037973"			Supported	"Vesicles,Lipid droplets"	"Intracellular and membrane"	NA	NA			Vesicles	"Lipid droplets"	"HPA037972: AB_2675761, HPA037973: AB_2675762"	"unprognostic (3.76e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.25e-4)"	"unprognostic (4.33e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.04e-9)"	"unprognostic (8.63e-4)"	"unprognostic (7.64e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.79e-1)"	6.8	11.7	2.2	3.1	3.0	0.3	3.9	0.9	2.4	10.3	3.4	3.9	7.4	0.9	6.3	5.7	5.0	4.4	7.0	13.3	2.6	2.1	6.9	3.1	4.3	5.8	4.3	2.0	7.9	6.3	18.4	1.9	2.7	2.9	8.3	1.7	5.0	5.4	10.4	3.3	5.4	1.6	5.4	4.6	2.0	4.7	2.7	2.3	0.8	8.9	5.0	1.2	4.4	8.1	0.0	0.0	0.0	3.0	0.6	4.0	0.3	0.0	0.6	0.3	3.0	0.6	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.3	5.7	0.2	0.2	0.4	4.1	1.5	0.0	0.0	4.7	0.0	0.1	18.4	1.1	0.0	1.2	2.4	1.5	0.0	1.0	0.0	0.5	3.7	0.0	5.2	0.0	1.2	0.0	0.0	3.0	5.3	0.4	0.0	1.3	6.2	0.1	0.0	1.6	0.0	0.1	0.4	0.1	2.3	0.3	0.1	0.5	1.9	2.5	2.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	3.0	4.0	0.0	1.8	0.9	0.0	0.0	1.1	0.2	0.0	0.6	2.0	0.0	0.0	0.3	2.2	3.0	0.9	2.4	2.6	2.1	4.3	2.0	2.9	2.3	3.0	0.3	0.0	2.3	3.4	0.2	11.2	0.0	1.4	0.0	5.2	0.0	0.1	0.0	1.2	15.7	1.4	0.4	0.0	1.2	0.1	2.0	2.2	0.0	0.9	3.1	0.0	1.7	14.7	5.4	5.3	4.4	1.5	1.7	0.0	0.3	1.5	1.0	0.0	2.1	2.7	0.0	6.5	3.8	0.7	2.7	3.6	0.0	0.0	0.2	1.0
EDA2R	"EDA-A2R, EDAA2R, TNFRSF27, XEDAR"	ENSG00000131080	"Ectodysplasin A2 receptor"	Q9HAV5	X	66595637-66639298	"Predicted membrane proteins"	Differentiation	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Muller glia cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;naive B-cell: 1.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.0;HSkMC: 19.1;LHCN-M2: 17.6;SuSa: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054522			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA054522: AB_2682516"	"unprognostic (1.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (4.15e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.08e-1)"	4.7	9.4	2.3	1.9	3.2	0.0	5.6	1.2	3.0	9.7	3.7	5.7	4.6	0.4	13.5	6.3	3.6	6.5	4.8	2.8	2.9	1.2	3.0	1.2	3.7	0.6	5.7	1.1	12.9	4.9	7.4	16.0	4.8	4.5	14.5	7.6	5.5	6.1	8.3	11.0	2.5	1.8	7.5	8.2	2.0	1.6	2.7	4.0	1.5	8.2	1.9	1.2	6.3	7.4	1.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	9.0	8.3	0.0	12.0	14.0	0.1	12.3	13.4	1.2	1.8	0.0	0.0	4.4	0.0	8.0	0.0	0.0	0.0	4.7	4.1	0.0	4.3	0.0	0.2	5.9	2.1	0.0	0.0	19.1	11.2	9.3	8.5	11.4	0.3	0.2	0.4	4.6	17.6	1.0	0.2	0.0	3.1	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	1.5	0.0	0.0	0.0	14.8	0.2	0.1	9.4	0.0	6.8	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.3	1.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	2.3	3.2	1.2	2.6	2.9	1.2	5.7	1.1	4.5	4.0	3.0	0.0	0.0	1.0	0.2	0.0	0.5	2.5	0.0	0.0	1.8	0.0	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	1.1	1.0	0.8	0.0	0.0	0.2	0.0	1.2	0.6	0.0	0.0	1.7	0.0	1.7	0.0	0.3	2.3	0.7	0.0	0.4	0.2	0.0	0.0	1.9	0.0	0.1	0.5	0.6	0.0	0.4	0.6
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.6"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 22.7;granulocytes: 20.9;Syncytiotrophoblasts: 18.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	6	"basophil: 24.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 24.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 37.6;RT4: 30.4"	"Group enriched"	"Detected in some"	5	"olfactory region: 0.7;thalamus: 0.8"	"Low region specificity"	"Detected in many"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.9	0.4	0.5	2.4	0.5	0.2	5.8	0.3	0.4	1.1	1.1	0.1	13.7	0.2	0.9	13.0	7.2	1.0	1.3	2.2	0.4	0.4	2.5	0.6	1.7	1.2	0.5	0.0	0.7	5.5	0.0	0.4	6.4	0.1	11.3	0.2	1.7	3.6	16.6	0.3	5.7	0.7	3.6	0.4	2.9	6.4	4.0	0.2	4.5	6.4	5.3	6.8	15.6	9.9	0.1	0.3	24.6	0.2	2.9	4.0	1.1	0.0	1.8	0.1	0.0	0.0	0.0	7.7	0.0	0.0	0.7	0.4	0.4	0.0	0.0	0.0	0.1	2.0	4.2	3.0	4.5	0.7	6.0	3.6	0.0	0.0	0.6	0.0	0.1	37.6	0.0	1.3	0.5	0.4	0.0	0.0	0.9	0.2	0.0	0.0	0.3	0.1	0.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	30.4	0.2	0.1	0.0	0.6	0.1	0.2	7.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.6	0.2	0.0	2.1	0.2	2.7	0.1	3.2	4.0	0.3	0.1	0.3	2.1	0.2	2.9	0.1	0.0	2.9	1.1	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.0	0.1	0.2	0.0	2.2	0.8	6.8	6.2	0.0	2.8	5.1	1.4	6.8	0.0	0.0	22.7	3.3	1.2	4.8	1.8	0.0	0.0	0.8	12.0	2.0	3.1	20.9	0.0	3.1	0.0	0.0	4.3	2.7	5.8	0.3	0.7	11.8	6.4	0.0	0.4	1.0	0.0	0.4	0.2	0.0	0.0	1.7	3.1	3.4	4.5	18.9	5.0	0.0	5.8
EDEM3	C1orf22	ENSG00000116406	"ER degradation enhancing alpha-mannosidase like protein 3"	Q9BZQ6	1	184690231-184754913	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025754, HPA025755, HPA027297"	Approved		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA025754: AB_1845638, HPA025755: AB_1845639, HPA027297: AB_2672205"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.63e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.01e-1)"	12.5	12.6	10.8	11.3	13.8	6.4	11.1	15.2	11.8	13.2	17.6	7.5	10.8	16.0	11.7	7.7	10.9	10.2	10.4	10.4	9.1	8.2	9.6	27.8	13.3	8.9	13.5	8.4	8.8	27.3	18.4	26.4	17.9	10.6	12.3	21.3	7.6	18.3	14.3	20.8	7.1	14.4	10.6	13.3	9.5	31.3	6.2	11.5	15.8	11.5	6.3	10.6	11.6	16.1	2.7	5.9	7.4	6.8	4.0	6.3	3.4	6.6	5.0	7.0	6.1	25.4	26.2	11.3	13.5	9.4	5.2	5.4	2.6	19.3	4.6	14.8	10.2	5.2	9.1	6.6	7.0	7.6	4.5	5.4	6.1	5.3	3.7	9.8	15.9	9.0	14.9	8.7	12.5	11.2	9.7	13.8	12.5	16.0	21.7	9.8	5.5	12.7	8.3	9.7	15.1	4.7	5.6	5.3	15.8	7.5	4.7	7.8	11.1	6.6	11.5	9.3	12.1	10.8	25.0	16.2	7.4	3.4	15.7	11.3	33.3	12.8	6.2	9.9	18.2	16.2	7.4	6.8	4.1	2.9	6.7	5.1	2.7	4.5	3.5	5.9	2.0	6.3	3.3	6.9	4.0	6.3	3.0	3.0	3.4	10.8	13.8	15.2	11.8	9.1	8.2	13.5	8.4	10.6	11.5	17.9	13.4	12.2	6.8	14.8	27.8	13.7	10.2	22.7	23.9	14.0	23.6	10.6	0.0	11.1	14.7	22.4	27.1	0.0	30.7	9.0	21.5	26.1	20.7	38.0	11.5	20.6	29.4	20.9	41.6	5.6	19.0	19.1	18.6	4.6	60.6	8.0	21.3	21.0	17.0	8.1	14.2	19.4	14.1	14.3	8.1	17.9	16.2	13.1	29.1	15.2
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290363-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 804.7;Ductal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 109.7;HUVEC TERT2: 72.7;T-47d: 22.4;TIME: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	NA	Yes	9740		"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	35.7	1.5	8.4	6.2	30.8	3.6	19.2	3.2	22.0	8.2	9.2	4.2	1.1	9.0	7.2	15.3	10.8	8.6	11.9	5.2	19.0	6.2	5.7	2.8	25.1	6.7	10.9	5.5	4.3	8.2	1.6	1.0	16.0	25.1	5.4	12.9	6.9	9.7	8.5	25.6	8.2	6.7	9.7	13.5	10.2	6.8	4.8	5.6	0.2	2.9	3.8	2.1	5.3	4.1	0.2	0.2	1.2	7.9	0.0	0.2	0.0	1.6	9.2	0.1	0.0	0.0	0.0	0.0	2.9	2.6	2.4	2.0	11.9	1.4	0.0	109.7	1.1	1.5	0.8	0.0	1.7	1.8	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	1.0	0.4	0.3	0.7	72.7	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.1	1.6	0.1	0.0	0.8	0.0	5.8	1.5	0.1	0.0	0.3	8.7	0.0	20.3	22.4	0.1	53.8	6.2	4.9	0.1	3.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	7.9	0.1	0.0	0.0	8.4	30.8	3.2	22.0	19.0	6.2	10.9	5.5	25.1	5.6	160.8	31.6	0.8	804.7	168.7	0.0	2.0	5.1	0.0	46.6	36.6	0.0	1.4	3.3	273.4	11.4	170.8	145.3	0.0	195.7	0.6	8.2	167.4	1.1	0.8	1.7	1.6	15.0	109.2	6.3	10.0	5.2	3.6	8.5	19.0	12.9	0.2	217.0	147.3	0.4	5.7	0.0	6.5	6.2	1.1	0.4	56.3	0.7	5.7	34.9	116.8
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484673	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.8"	"Cell type enhanced"	"Detected in many"	18	"Basal glandular cells: 145.6;Collecting duct cells: 66.3;Glandular cells: 63.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Region enriched"	"Detected in single"	12	"pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.6;EFO-21: 21.7;HeLa: 7.3;SCLC-21H: 10.4;SK-BR-3: 25.8;U-2 OS: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.5	0.2	0.0	0.9	0.2	0.3	2.2	0.0	0.1	15.1	13.6	0.4	1.4	4.5	1.8	6.3	17.4	2.3	0.4	1.9	0.0	0.0	4.0	0.8	18.4	0.1	0.0	0.0	0.8	3.2	0.1	1.1	0.4	2.6	9.7	1.3	1.4	4.3	1.0	0.9	8.9	27.8	0.2	0.0	0.1	0.9	0.7	0.1	0.0	1.3	4.0	13.7	1.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	8.6	0.0	21.7	0.0	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.8	5.1	5.8	0.4	10.4	0.0	0.2	25.8	0.0	0.5	0.5	0.0	0.0	0.0	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.1	6.0	1.0	0.0	145.6	27.0	0.0	0.4	5.1	1.4	0.0	66.3	0.0	0.0	0.0	6.2	0.0	0.0	10.9	0.0	0.9	0.0	0.5	63.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	6.7	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.5	0.0	0.0	3.3	23.3
EDRF1	"C10orf137, DKFZp586F1019, FLJ21617"	ENSG00000107938	"Erythroid differentiation regulatory factor 1"	Q3B7T1	10	125719515-125764143	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031820			Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA031820: AB_10600753"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.84e-4)"	"unprognostic (4.76e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.63e-3)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (3.44e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.68e-3)"	9.2	6.7	6.3	16.6	9.7	27.9	9.0	20.3	10.0	10.5	8.1	7.7	6.8	7.1	12.2	8.3	7.5	9.8	6.4	7.5	7.4	5.4	5.9	5.0	7.2	12.5	8.8	7.3	13.4	14.0	6.3	18.1	8.2	8.0	10.0	7.3	5.2	19.7	12.7	12.7	8.3	9.0	9.5	7.8	9.3	8.4	21.2	9.0	20.2	7.7	4.5	10.7	10.1	8.7	9.6	9.9	9.1	7.0	6.9	9.7	3.5	9.0	8.8	11.1	12.1	5.2	8.6	5.8	11.4	11.1	13.2	15.0	11.2	7.7	12.2	5.7	7.2	7.3	11.5	17.5	2.7	15.0	8.0	13.9	8.5	7.5	6.5	8.8	12.8	8.8	5.3	4.4	12.6	5.7	11.5	6.2	6.2	8.0	9.4	7.4	3.6	12.7	8.8	16.4	5.6	8.0	10.1	10.6	7.9	4.6	4.2	6.0	11.8	8.5	4.3	7.7	10.7	7.8	4.8	3.9	7.0	7.2	9.2	12.9	12.2	8.1	19.2	7.5	6.3	3.9	9.1	7.0	6.5	7.8	5.8	9.7	9.6	6.9	7.1	6.8	8.1	7.3	7.5	8.4	6.9	4.2	9.9	7.4	3.5	6.3	9.7	20.3	10.0	7.4	5.4	8.8	7.3	8.0	9.0	11.9	8.9	5.6	5.1	5.3	21.0	11.4	10.2	6.7	10.3	10.4	31.4	5.9	0.0	3.9	140.9	7.1	4.7	0.0	6.2	4.9	6.6	5.1	19.7	7.4	3.6	19.1	4.1	6.7	5.3	46.0	19.5	5.8	6.8	4.6	5.7	12.8	7.6	6.5	18.7	2.6	23.7	6.5	6.1	26.7	19.4	7.2	3.8	12.5	6.5	4.2
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488012-63499322	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 298.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 100.4;Cardiomyocytes: 108.0;Horizontal cells: 254.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HAP1: 56.2;HBF TERT88: 28.3;MCF7: 46.5;SCLC-21H: 29.6;T-47d: 24.1;U-2 OS: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Approved	Nucleoli,Cytosol		NA	NA		55000000	Cytosol	Nucleoli	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	2.2	8.0	21.3	2.3	23.5	1.9	2.2	41.1	51.3	1.9	2.3	2.3	0.1	2.2	2.0	2.3	4.1	2.1	2.6	51.9	23.0	21.0	2.0	2.0	2.0	2.1	13.9	31.0	2.0	3.5	6.1	16.6	2.0	23.1	3.7	2.1	1.8	3.4	2.2	298.6	2.2	2.3	2.1	4.8	2.0	3.6	2.3	3.6	0.0	2.0	23.9	2.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.3	0.1	10.8	0.2	2.6	0.0	0.1	1.3	2.1	0.3	10.7	3.6	1.4	7.1	0.0	18.9	0.1	2.9	5.1	56.2	0.1	28.3	0.1	2.6	0.0	4.0	0.4	0.6	0.0	2.5	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	46.5	0.1	0.1	1.9	19.3	18.1	1.3	0.0	1.7	0.4	0.5	29.6	18.0	17.1	1.9	0.1	0.5	24.1	0.6	0.0	0.0	32.9	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	21.3	23.5	41.1	51.3	23.0	21.0	13.9	31.0	23.1	3.6	0.0	0.0	0.0	0.5	0.3	100.4	108.0	0.0	0.0	1.2	0.0	11.8	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.2	0.1	0.2	2.9	5.7	0.0	0.0	254.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.8	0.3	0.0	0.0	0.3	33.6	0.0	0.3	0.0	0.1	1.6	0.0	0.0	0.0	0.9
EEF1AKMT1	N6AMT2	ENSG00000150456	"EEF1A lysine methyltransferase 1"	Q8WVE0	13	20728731-20773958	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 20.8;Cytotrophoblasts: 17.3;Distal tubular cells: 23.2;Proximal tubular cells: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040417, HPA042543"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA040417: AB_2676973, HPA042543: AB_2678045"	"unprognostic (4.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.31e-2)"	12.1	14.1	15.2	8.9	13.8	3.9	13.4	20.9	14.1	12.2	9.4	9.5	8.6	5.9	14.8	19.9	8.0	15.2	8.4	12.4	12.2	14.7	11.5	17.3	7.8	8.1	14.3	14.7	14.5	10.3	9.1	19.1	8.5	11.7	14.1	8.1	10.6	12.8	12.7	15.5	7.2	5.9	12.5	16.2	8.1	8.1	8.2	14.0	11.3	12.9	8.2	8.6	8.9	8.6	10.7	8.8	0.7	4.4	13.1	11.2	5.7	5.8	4.5	3.8	6.2	16.0	16.6	9.3	7.8	5.9	6.8	3.6	6.3	6.6	9.5	5.8	8.4	3.1	4.8	5.1	6.6	7.1	6.1	4.5	12.2	2.1	12.0	8.8	24.1	2.5	11.3	5.9	5.1	11.4	7.7	12.2	8.3	7.1	1.3	19.3	16.2	8.0	21.5	6.5	10.7	3.4	10.1	4.1	1.8	9.7	6.8	8.7	5.2	6.6	3.3	8.6	3.3	3.5	22.3	7.1	4.7	0.0	10.5	3.4	1.8	3.4	10.3	4.0	16.7	3.3	0.0	4.4	0.7	7.7	3.3	8.1	10.7	9.0	7.6	7.2	4.9	11.2	9.8	0.6	13.1	3.4	8.8	9.5	5.7	15.2	13.8	20.9	14.1	12.2	14.7	14.3	14.7	11.7	14.0	20.8	8.6	0.0	0.0	0.0	0.0	0.0	0.0	13.4	14.8	7.0	0.0	17.3	23.2	10.0	0.0	0.0	0.0	0.0	9.0	11.0	0.0	0.0	3.5	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.4	0.0	0.0	7.5	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0
EEF1AKMT2	"C10orf138, Efm4, METTL10"	ENSG00000203791	"EEF1A lysine methyltransferase 2"	Q5JPI9	10	124748149-124791870	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 24.1;Distal tubular cells: 56.3;Extravillous trophoblasts: 24.1;Proximal tubular cells: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA050138	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles, Cytosol"	"HPA050138: AB_2681030"	"unprognostic (1.64e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.75e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.04e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.09e-2)"	11.5	11.8	17.6	13.2	19.0	13.0	17.3	25.2	18.0	11.1	12.0	12.5	17.3	6.2	11.8	18.3	10.1	11.7	10.7	14.0	13.8	12.6	16.5	17.8	9.0	9.8	12.3	14.2	16.4	11.3	15.7	15.4	10.2	12.1	12.5	13.3	9.6	15.0	12.2	28.4	10.5	11.2	13.0	14.8	9.6	12.5	28.6	13.3	8.3	17.7	12.1	12.0	9.3	12.5	9.8	6.7	6.0	5.2	10.4	10.8	5.7	19.0	5.0	8.0	10.6	5.0	12.3	6.1	8.9	15.3	12.5	11.6	5.6	13.8	11.5	5.1	7.9	6.4	6.4	7.2	5.8	18.3	11.9	3.8	7.5	5.9	5.9	10.6	11.6	5.5	6.8	7.4	6.2	14.5	9.5	8.4	9.7	11.5	14.5	15.0	6.9	7.3	11.6	8.0	6.7	7.9	3.3	7.8	4.4	5.9	3.8	2.1	7.9	4.8	6.2	14.7	5.6	8.1	12.6	8.5	5.2	6.6	5.8	14.2	6.8	6.0	11.9	7.2	5.4	6.4	6.0	5.0	3.5	8.1	5.0	10.5	9.8	8.8	8.5	6.2	6.6	10.8	8.5	1.5	10.4	5.2	6.7	9.9	5.7	17.6	19.0	25.2	18.0	13.8	12.6	12.3	14.2	12.1	13.3	3.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.5	10.4	0.0	24.1	56.3	16.7	0.0	0.0	0.0	0.0	17.6	24.1	0.0	0.0	2.3	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	19.8	0.0	0.0	16.1	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0
EEF1B2		ENSG00000114942	"Eukaryotic translation elongation factor 1 beta 2"	P24534	2	206159585-206162928	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012477, HPA035029"	Supported		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		640000	"Nucleoli fibrillar center, Cytosol"		"CAB012477: AB_732078, HPA035029: AB_2674422"	"prognostic favorable (2.60e-4)"	"unprognostic (3.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (9.95e-4)"	"unprognostic (2.70e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.62e-6)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-2)"	42.9	33.9	37.6	72.1	32.6	93.8	78.8	18.8	37.1	46.7	80.3	23.3	37.8	55.8	41.4	43.9	71.7	42.1	54.1	40.7	30.2	26.4	36.9	72.4	41.9	171.3	35.9	20.7	73.2	252.4	9.1	19.4	34.6	35.3	41.6	49.1	19.3	93.2	60.0	122.3	59.4	58.3	59.7	36.1	58.7	40.4	27.3	22.4	58.3	44.2	101.5	69.2	63.1	79.0	88.9	55.0	6.2	29.4	46.5	95.3	121.3	27.8	34.6	40.7	38.0	58.1	98.5	86.6	56.0	57.5	59.3	39.4	76.3	47.7	79.7	37.7	66.1	33.3	36.1	53.9	66.7	54.0	24.6	49.6	56.6	48.9	102.9	77.6	112.1	50.6	99.4	79.2	44.0	100.0	58.6	62.2	65.8	77.9	66.5	65.6	58.0	99.4	93.1	56.5	64.7	59.0	74.4	79.4	101.0	64.1	54.7	41.0	42.0	22.4	48.8	54.5	49.6	29.8	138.8	43.9	31.3	41.7	40.7	53.1	71.8	58.8	90.9	36.4	76.2	23.7	6.2	28.2	3.5	37.2	29.4	68.4	88.9	66.4	49.4	55.0	69.7	95.3	76.8	4.1	46.5	23.1	53.5	35.1	121.3	37.6	32.6	18.8	37.1	30.2	26.4	35.9	20.7	35.3	22.4	184.6	288.1	1590.3	1462.2	1014.9	112.3	142.8	496.8	258.3	467.5	155.3	25.5	807.3	583.6	557.5	144.9	476.3	640.1	490.6	1616.2	1370.7	453.3	520.7	530.4	500.5	730.4	49.3	427.5	372.0	671.4	335.2	802.5	760.7	506.2	719.6	1295.6	92.1	954.4	764.5	454.7	995.5	89.9	265.1	669.9	134.7	214.8	1101.0	794.9	1001.9	1557.8	1242.4
EEF1G	EF1G	ENSG00000254772	"Eukaryotic translation elongation factor 1 gamma"	P26641	11	62559601-62574086	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 334.5"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 310.9;Ciliated cells: 275.7;Club cells: 547.1;granulocytes: 349.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040688, HPA055316"	Enhanced		Approved	Mitochondria		NA	NA		4600000	Mitochondria		"HPA040688: AB_10961632, HPA055316: AB_2732593"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.22e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.04e-2)"	46.5	38.1	33.0	41.3	40.0	60.6	84.9	30.4	56.5	53.8	45.4	30.6	29.7	40.9	48.6	43.0	71.1	61.0	35.1	62.2	34.6	24.7	49.4	64.5	41.7	98.8	29.1	31.8	105.3	103.9	29.9	31.7	41.4	51.4	50.4	49.2	29.0	58.9	35.5	207.2	88.5	45.0	38.2	39.6	48.4	45.8	236.9	28.8	43.9	41.1	118.6	70.9	47.7	66.1	203.5	136.9	27.4	83.9	114.5	251.4	334.5	88.9	94.8	99.1	140.2	149.4	193.7	99.4	77.9	141.5	97.8	75.0	105.3	113.3	264.8	124.4	123.9	56.2	105.5	117.1	114.8	89.6	85.1	108.9	69.0	106.6	107.7	162.6	139.0	81.5	221.3	208.1	96.7	237.9	162.2	134.5	93.4	138.1	127.9	115.1	183.7	151.0	248.8	119.4	79.5	83.0	126.5	127.4	251.8	130.4	117.8	85.9	107.0	46.9	159.4	211.8	66.0	182.6	155.2	90.6	56.9	79.8	109.8	67.3	89.6	86.7	132.4	64.6	103.1	79.6	27.4	83.9	21.0	87.3	78.5	173.5	203.5	167.7	112.9	136.9	187.5	251.4	169.1	12.3	114.5	64.0	108.5	119.2	334.5	33.0	40.0	30.4	56.5	34.6	24.7	29.1	31.8	51.4	28.8	140.0	310.9	21.7	1.8	7.0	0.2	0.0	15.3	275.7	547.1	1.8	2.0	15.0	3.3	107.6	3.5	4.3	75.4	0.0	165.8	22.5	5.1	2.5	349.5	4.3	11.2	0.0	142.8	8.6	9.7	16.1	2.8	8.0	1.7	204.6	135.2	0.7	121.7	69.1	2.1	8.2	0.3	0.0	5.1	1.4	0.5	5.4	17.6	20.3	189.4	2.0
EEF2K	eEF-2K	ENSG00000103319	"Eukaryotic elongation factor 2 kinase"	O00418	16	22206282-22288732	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 4.0;HMC-1: 4.8;NB-4: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007818, HPA056061"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB007818: AB_598150, HPA056061: AB_2683021"	"unprognostic (4.79e-2)"	"unprognostic (6.10e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	16.8	5.5	5.3	8.6	3.7	7.6	12.4	17.5	4.8	14.3	10.7	1.3	9.4	5.6	13.2	8.3	6.1	8.2	12.5	9.0	3.2	3.3	3.7	5.5	9.2	6.7	2.4	4.9	6.4	8.1	3.3	3.0	6.4	4.9	12.5	4.6	4.4	12.4	20.5	16.2	37.5	5.1	15.5	1.6	6.1	6.4	4.6	3.1	4.0	4.4	11.5	6.7	13.3	14.2	0.7	2.3	2.2	0.9	1.3	1.6	0.1	0.1	0.0	0.0	0.0	1.1	1.3	1.0	0.0	0.0	0.2	0.0	0.7	0.0	1.0	0.4	0.0	0.0	4.0	0.6	0.0	0.0	0.4	0.0	1.6	0.7	2.7	0.0	3.8	4.8	0.0	1.0	0.3	0.3	0.9	0.2	0.2	0.5	3.4	0.0	0.0	0.2	4.1	0.4	1.1	0.0	1.0	2.6	0.7	1.2	0.0	1.0	1.6	0.0	0.0	0.4	0.3	0.6	1.2	1.3	2.4	0.9	3.7	0.1	0.8	0.4	1.1	2.8	2.8	0.4	1.5	0.8	0.6	0.5	0.9	0.7	0.4	0.3	0.2	0.2	0.7	0.7	0.3	2.2	1.3	0.5	2.3	1.6	0.1	5.3	3.7	17.5	4.8	3.2	3.3	2.4	4.9	4.9	3.1	20.8	14.1	9.5	7.8	11.2	47.9	16.2	15.3	18.7	12.5	8.7	13.7	15.1	0.0	4.0	41.4	9.5	8.5	0.0	11.6	10.1	9.3	6.6	28.8	14.5	16.0	1.6	2.9	16.0	11.5	60.9	13.3	8.1	8.5	7.2	10.9	7.7	9.6	25.9	14.9	3.0	19.6	6.5	10.3	0.9	3.6	20.1	6.5	7.5	6.8	3.9
EEFSEC	"eEFSec, EFSEC, SELB"	ENSG00000132394	"Eukaryotic elongation factor, selenocysteine-tRNA specific"	P57772	3	128153454-128408646	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;GAMG: 10.3;SH-SY5Y: 8.8;SK-BR-3: 14.7;SK-MEL-30: 12.7;T-47d: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035795	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA035795: AB_10696512"	"unprognostic (1.01e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-3)"	"unprognostic (6.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	8.2	6.8	5.6	7.9	7.9	3.1	7.9	8.4	9.8	11.6	8.6	9.3	7.3	2.5	10.8	5.4	8.0	9.4	7.1	18.7	7.6	6.4	9.4	18.1	7.1	15.5	5.4	4.2	11.5	8.4	23.9	9.2	9.7	6.9	9.0	4.9	7.2	10.7	11.2	20.3	15.9	15.7	10.0	5.0	9.2	6.9	11.5	6.2	17.2	8.4	6.7	10.5	7.7	7.9	7.1	10.9	7.3	7.8	9.7	7.0	3.8	0.4	0.1	3.4	1.4	0.1	0.2	0.4	0.0	0.2	0.2	0.2	0.3	5.7	12.4	0.1	3.1	10.3	0.9	0.3	0.1	0.1	0.3	0.2	0.0	0.1	0.1	4.9	0.2	0.3	0.1	0.1	3.4	0.1	0.1	0.2	0.0	0.0	0.2	2.9	0.1	6.2	0.3	0.4	0.0	0.1	0.2	0.2	0.8	0.0	0.0	0.3	8.8	0.0	14.7	12.7	0.3	7.9	0.5	0.0	0.1	0.0	0.1	0.2	0.4	0.6	0.3	0.1	0.4	0.2	0.5	7.5	7.3	6.7	7.8	5.6	7.1	5.9	5.8	10.9	5.8	5.6	6.5	0.0	9.7	6.2	4.6	7.0	3.8	5.6	7.9	8.4	9.8	7.6	6.4	5.4	4.2	6.9	6.2	0.0	5.9	11.8	7.7	5.7	8.7	9.4	0.0	2.7	1.2	15.7	2.0	19.4	13.3	5.9	21.8	7.1	5.5	0.0	6.2	14.9	10.0	7.4	27.7	11.9	13.0	12.7	10.9	6.2	6.0	63.4	12.0	8.6	11.8	3.6	8.7	8.3	5.4	0.0	8.1	21.4	6.6	25.8	7.5	26.5	16.0	8.7	24.8	10.2	8.7	5.6
EEPD1	KIAA1706	ENSG00000122547	"Endonuclease/exonuclease/phosphatase family domain containing 1"	Q7L9B9	7	36153149-36301543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 28.1;Hofbauer cells: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.2;neutrophil: 21.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 23.2;T-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 13.4;HDLM-2: 13.9;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053668			Approved	"Nuclear speckles,Vesicles"		NA	NA			"Nuclear speckles"	Vesicles	"HPA053668: AB_2682223"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.89e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.59e-2)"	20.3	5.1	4.9	6.4	8.6	8.1	22.5	3.3	19.3	9.6	15.2	11.8	6.5	11.0	12.5	5.6	6.5	5.4	18.4	6.2	6.4	5.4	3.7	15.2	8.7	4.6	13.3	3.5	6.9	8.1	2.4	3.3	4.6	5.6	8.2	4.5	5.7	3.8	4.3	39.7	10.2	23.6	9.1	10.2	7.5	10.5	3.4	7.7	11.5	2.2	4.4	3.6	6.1	10.9	0.1	1.5	23.2	2.8	1.7	11.5	2.0	1.6	4.6	1.4	4.4	13.1	2.8	0.1	1.1	5.6	0.9	1.6	0.9	3.5	4.5	1.4	1.7	13.4	1.9	1.9	2.2	0.8	13.9	3.1	0.6	0.4	8.4	1.2	0.7	4.4	5.9	1.4	0.5	0.3	3.6	0.1	3.4	5.4	0.5	1.0	1.8	4.5	11.1	6.4	5.7	17.6	1.2	1.6	0.9	2.8	3.6	3.5	2.4	0.4	0.6	1.7	2.7	1.4	5.4	0.4	1.7	5.2	1.2	1.3	3.5	3.7	0.0	4.3	2.9	1.1	10.0	2.8	23.2	1.5	1.7	2.6	0.1	11.5	3.3	1.5	0.0	2.6	0.7	21.9	1.7	0.7	1.3	5.1	2.0	4.9	8.6	3.3	7.5	6.4	5.4	13.3	3.5	5.6	7.7	0.0	0.3	0.5	11.6	2.4	2.1	3.4	28.1	2.7	0.0	0.0	19.6	0.1	5.0	17.7	15.1	12.6	10.1	0.0	6.5	0.2	2.3	7.2	9.2	16.0	25.1	6.4	9.2	0.6	5.2	3.6	4.6	6.2	3.3	1.8	5.8	1.9	11.6	6.8	15.6	1.9	0.8	6.5	5.9	0.5	4.1	3.4	0.5	1.5	5.9	8.1
EFCAB1	FLJ11767	ENSG00000034239	"EF-hand calcium binding domain 1"	Q9HAE3	8	48710789-48735311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 61.9"	"Group enriched"	"Detected in many"	21	"Ciliated cells: 342.6;Early spermatids: 456.6;Late spermatids: 332.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 9.1;ASC diff: 4.0;ASC TERT1: 9.3;CAPAN-2: 4.5;hTEC/SVTERT24-B: 3.8;SCLC-21H: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023527, HPA069955"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA023527: AB_2231065, HPA069955: AB_2686220"	"unprognostic (5.29e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.94e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.47e-3)"	0.6	1.5	5.4	0.5	9.5	0.9	2.5	0.2	4.1	8.1	0.8	14.0	10.3	0.9	8.6	19.0	0.9	61.9	0.9	0.6	9.1	8.4	0.6	0.9	16.5	0.5	2.7	3.9	13.7	1.8	0.4	2.0	0.8	23.9	4.2	0.7	1.9	1.8	4.6	0.5	3.5	1.1	2.7	1.4	0.6	0.8	19.7	3.0	0.0	0.5	0.3	0.6	1.4	2.1	1.0	0.0	4.1	0.0	1.1	1.1	0.3	9.1	0.0	1.2	0.0	4.0	9.3	0.0	0.1	0.9	0.0	0.3	0.0	4.5	0.0	0.0	0.2	0.0	2.5	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.1	3.3	0.3	3.8	1.6	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.3	0.1	0.0	0.0	0.0	2.1	7.2	0.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.5	0.0	1.1	1.0	0.7	0.8	0.0	0.8	0.5	0.3	4.1	1.1	0.0	0.0	0.7	0.3	5.4	9.5	0.2	4.1	9.1	8.4	2.7	3.9	23.9	3.0	0.0	5.1	0.0	6.6	6.1	0.0	0.4	0.0	342.6	18.2	0.0	0.0	0.3	0.0	0.1	456.6	0.1	0.0	0.0	1.3	0.1	1.9	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	332.2	4.4	1.2	1.7	0.0	0.0	0.0	2.0	0.0	5.3	0.0	0.0	0.0	0.8	5.7	4.4	1.6	0.2	0.0	0.0	1.8
EFCAB11	C14orf143	ENSG00000140025	"EF-hand calcium binding domain 11"	Q9BUY7	14	89794669-89954777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.9"	"Group enriched"	"Detected in many"	7	"Early spermatids: 451.2;Late spermatids: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051209			Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA051209: AB_2681389"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.84e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.45e-2)"	4.7	5.8	10.2	6.2	8.1	5.3	9.3	5.7	7.6	5.6	5.2	10.4	6.7	5.1	4.9	6.9	6.2	11.0	4.9	3.7	7.8	6.6	7.6	5.8	3.2	3.3	8.6	5.7	5.2	4.8	8.3	8.2	8.4	7.7	5.4	5.6	6.1	5.6	5.4	2.4	3.7	3.6	6.3	8.4	6.7	4.4	36.9	6.2	2.5	7.9	3.3	6.3	5.2	4.1	2.6	2.1	12.8	5.3	3.3	1.6	0.8	4.8	7.5	6.5	8.2	4.0	4.4	18.5	7.2	6.5	9.8	6.9	8.8	17.4	7.6	13.7	4.8	7.0	10.7	5.6	14.3	14.2	8.6	3.6	5.5	6.4	14.3	0.9	7.0	13.3	3.0	3.5	6.4	7.3	5.6	8.1	8.2	5.7	7.6	11.6	25.3	5.2	9.4	2.8	19.9	13.6	6.0	10.4	5.5	9.0	13.6	2.8	4.6	9.1	16.9	8.4	14.2	13.7	5.0	6.9	5.3	7.4	5.6	7.0	4.5	13.0	13.2	7.7	3.3	9.7	12.8	1.3	3.4	0.6	3.0	0.3	2.6	1.0	1.0	2.1	2.6	1.6	1.4	4.0	3.3	5.3	1.8	1.3	0.8	10.2	8.1	5.7	7.6	7.8	6.6	8.6	5.7	7.7	6.2	0.0	0.6	12.8	5.3	4.5	8.4	3.5	17.8	49.5	6.8	17.4	2.0	13.9	8.3	10.8	451.2	6.0	2.7	0.0	14.8	23.8	8.0	3.2	4.7	5.8	10.3	3.2	0.0	4.3	3.7	287.7	5.2	6.4	3.3	12.6	3.3	4.2	5.4	6.2	7.1	13.3	10.8	0.0	3.1	26.2	12.8	2.9	6.4	2.9	9.5	4.6
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 24.4;fallopian tube: 29.9;testis: 24.8"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 58.9;Early spermatids: 23.2;Late spermatids: 14.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"basal ganglia: 14.9;pons and medulla: 24.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.7;RPTEC TERT1: 3.8;SCLC-21H: 2.9"					"Region enhanced"	"Detected in many"		"midbrain: 14.2"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		NA	NA			Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.7	0.6	2.2	0.7	14.9	1.5	0.9	1.7	3.0	2.0	0.6	7.8	0.0	0.5	1.8	10.1	0.6	29.9	1.5	0.7	4.2	4.3	1.2	2.1	3.6	0.8	0.5	3.5	6.1	1.0	3.1	15.2	0.7	24.4	4.1	0.6	1.5	0.6	0.9	0.5	0.5	0.5	0.6	1.0	0.7	1.0	24.8	1.6	0.0	2.4	0.0	0.9	0.5	0.1	1.4	0.0	1.3	0.4	0.3	0.6	0.0	0.4	2.2	0.7	2.2	0.4	0.1	0.4	0.0	0.2	0.3	0.1	0.8	1.2	0.5	0.4	0.0	0.0	0.3	0.0	0.4	0.3	0.6	0.5	0.6	0.6	4.7	0.3	0.3	0.9	0.5	0.0	0.5	0.0	0.4	0.0	1.3	1.4	0.9	0.0	0.3	0.1	1.7	0.3	0.2	0.1	0.8	0.0	0.5	3.8	0.0	2.9	0.1	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.0	0.5	1.1	0.2	1.4	1.8	2.2	0.5	0.8	0.2	0.0	0.4	0.8	0.1	0.0	0.3	0.3	0.0	0.6	0.0	1.4	0.3	0.2	1.3	0.3	0.0	0.0	0.2	0.0	2.2	14.9	1.7	3.0	4.2	4.3	0.5	3.5	24.4	1.6	3.0	1.7	0.0	0.1	0.5	0.2	1.1	2.5	58.9	2.3	0.0	2.0	0.0	0.0	0.1	23.2	0.3	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.8	0.1	4.8	0.0	0.0	0.0	14.5	0.3	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	5.2	0.0	0.0	8.2	2.5	0.3	0.0	0.0	0.0	0.1
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 29.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 161.3;Late spermatids: 143.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	4.1	2.8	2.9	12.2	3.4	3.4	6.5	2.8	3.8	6.5	4.7	2.3	3.5	4.8	8.9	4.4	2.4	4.2	4.1	3.5	2.3	1.5	7.5	4.0	3.1	4.3	3.6	0.4	5.5	2.8	8.4	7.6	5.4	3.2	9.3	3.4	2.6	5.4	2.0	1.3	2.2	6.3	9.9	3.5	4.6	3.5	20.0	2.7	2.4	14.9	0.7	4.3	5.5	29.9	5.6	1.0	5.3	2.1	0.8	2.6	0.8	0.9	4.0	1.7	0.2	2.1	7.3	3.1	2.2	0.5	0.7	1.2	1.7	5.6	0.3	6.6	0.8	0.0	1.1	0.0	0.4	4.0	0.2	0.6	5.2	3.3	0.5	2.1	4.0	0.6	1.3	1.9	2.7	0.0	5.0	4.5	4.1	1.5	9.9	2.4	0.1	1.7	2.3	0.9	2.8	3.2	4.7	1.3	1.8	9.2	3.2	1.2	0.6	1.2	0.1	2.6	1.3	6.6	4.7	1.6	0.3	1.3	0.4	1.1	10.2	7.0	0.9	6.3	7.8	4.3	5.3	2.1	0.6	1.1	1.2	0.9	4.3	0.9	0.6	1.0	5.6	2.6	1.2	0.0	0.8	0.7	0.4	0.1	0.8	2.9	3.4	2.8	3.8	2.3	1.5	3.6	0.4	3.2	2.7	8.9	2.1	2.0	1.7	0.7	2.3	3.8	0.0	5.3	1.2	0.0	0.0	0.2	0.0	0.7	161.3	6.3	0.5	0.0	0.7	0.2	1.3	1.0	5.8	0.8	1.7	3.2	2.9	3.7	2.1	143.2	1.7	1.3	0.0	1.8	0.2	1.1	1.2	0.0	3.5	0.8	2.6	0.0	2.3	34.1	7.9	0.5	0.0	0.0	0.6	1.0
EFCAB14	KIAA0494	ENSG00000159658	"EF-hand calcium binding domain 14"	O75071	1	46675159-46719064	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011224, HPA011938"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA		58000	Cytosol	"Nucleoli, Golgi apparatus"	"HPA011224: AB_1852314, HPA011938: AB_1852317"	"unprognostic (2.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-1)"	29.4	17.4	29.4	14.3	29.5	6.7	22.5	16.2	24.8	25.3	26.0	40.6	15.6	17.2	23.7	27.3	30.0	22.0	19.7	20.2	27.2	20.5	27.8	24.9	24.0	16.4	31.0	15.2	25.2	16.0	107.1	17.2	25.2	27.3	24.4	24.0	23.0	19.9	24.9	24.7	20.4	26.9	22.5	36.1	24.0	36.4	21.9	30.6	28.7	30.1	13.2	20.2	25.7	20.0	16.6	16.0	30.3	21.1	17.1	28.5	18.3	14.5	8.3	7.1	11.2	34.0	21.4	16.3	15.8	23.3	17.5	18.1	9.9	9.9	11.7	16.5	21.4	23.7	17.6	12.1	17.4	23.8	22.2	7.8	14.6	9.2	4.0	11.7	18.8	28.8	18.9	29.2	13.9	11.6	16.8	21.3	11.4	9.0	16.7	18.0	5.7	12.4	8.5	10.1	17.2	9.4	9.5	19.9	10.2	18.5	29.6	3.7	5.1	19.5	27.6	14.8	20.1	12.3	16.5	19.6	15.0	7.3	17.4	16.0	17.2	23.8	9.4	19.2	16.2	11.0	15.6	18.6	30.3	23.6	21.1	28.5	16.6	20.6	20.2	16.0	16.2	18.0	19.5	12.5	17.1	18.3	12.9	17.8	18.3	29.4	29.5	16.2	24.8	27.2	20.5	31.0	15.2	27.3	30.6	68.5	69.2	34.6	40.1	28.2	30.1	33.2	45.9	45.5	45.5	108.2	29.5	31.8	26.6	31.3	50.1	52.8	51.8	0.0	33.7	27.6	35.0	57.4	96.2	51.2	37.0	44.5	36.2	46.1	67.7	14.4	43.7	41.1	25.3	34.3	62.6	50.2	37.9	57.5	46.7	30.6	17.7	25.8	28.8	37.2	23.3	38.0	49.3	41.5	41.9	98.2
EFCAB2	"CFAP200, DRC8, MGC12458"	ENSG00000203666	"EF-hand calcium binding domain 2"	Q5VUJ9	1	244969705-245127164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 161.9;Early spermatids: 83.3;Late spermatids: 104.3;Spermatocytes: 117.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 34.8;THP-1: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031206, HPA031207"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA031206: AB_10599710, HPA031207: AB_10599946"	"unprognostic (1.36e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (4.88e-2)"	11.0	12.5	16.7	5.6	18.6	10.8	14.7	20.1	15.5	11.6	7.3	23.6	13.9	3.0	18.7	19.5	9.6	32.1	13.1	13.7	18.0	14.3	12.5	6.5	11.2	7.8	22.3	12.3	10.6	12.1	14.6	20.6	14.7	16.3	9.2	11.3	11.8	7.4	16.0	15.5	6.1	6.5	13.2	20.9	6.4	10.5	24.4	21.9	5.4	23.7	13.5	9.1	11.5	16.0	3.6	10.8	4.9	1.8	2.9	0.8	1.2	3.1	4.0	9.1	2.3	3.3	7.8	11.1	4.0	4.3	5.2	4.8	10.2	8.6	11.0	8.7	5.0	5.5	2.5	3.6	2.3	3.2	1.1	2.2	5.3	15.9	4.5	7.0	5.4	34.8	6.7	4.9	7.0	6.6	6.2	7.9	0.3	20.3	9.0	4.4	3.3	1.1	14.9	11.6	4.5	3.0	20.8	1.4	2.9	13.2	5.4	7.2	9.7	7.0	2.7	5.8	10.7	2.6	30.7	1.2	6.4	2.4	3.5	14.5	3.1	5.1	7.3	5.1	15.6	5.1	1.2	1.7	2.8	0.5	1.8	0.8	3.6	0.7	0.4	5.5	3.3	0.6	0.6	4.9	2.9	1.3	10.8	0.8	1.2	16.7	18.6	20.1	15.5	18.0	14.3	22.3	12.3	16.3	21.9	3.0	12.6	4.7	9.1	4.5	12.5	54.7	0.0	161.9	21.6	22.7	13.7	12.8	43.1	5.7	83.3	11.4	2.6	0.0	9.5	40.1	10.4	6.8	0.0	6.8	9.8	4.8	18.1	8.0	14.2	104.3	8.3	9.8	6.8	6.4	6.3	12.5	5.9	5.8	6.0	14.4	20.0	6.5	11.8	117.5	31.9	2.6	28.6	6.2	6.0	8.8
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 25.4;Sertoli cells: 25.8;Spermatocytes: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	4.3	8.4	12.7	3.5	16.7	3.1	9.3	24.5	19.5	9.4	5.1	3.7	6.4	3.2	9.6	9.8	5.7	12.6	7.2	9.7	11.4	11.8	8.8	2.8	6.2	5.2	8.1	10.8	12.8	4.9	16.3	31.6	5.1	13.7	8.7	5.0	3.5	5.3	8.2	10.8	4.9	3.4	7.5	9.4	4.2	5.0	20.0	10.2	11.5	9.1	2.4	5.2	7.3	12.9	3.3	1.7	9.8	3.3	1.8	2.9	1.1	6.0	5.1	6.7	4.3	7.1	10.6	3.4	3.9	4.3	6.8	8.4	1.6	4.8	4.3	9.4	2.2	13.9	5.6	5.7	3.7	8.2	7.9	4.0	3.4	9.5	3.5	4.5	4.7	3.1	5.7	9.2	8.0	5.4	10.8	5.7	7.9	4.3	7.0	4.4	1.3	9.0	3.2	2.9	4.2	5.1	5.8	10.1	4.2	10.4	3.2	14.4	5.5	7.5	4.2	9.6	9.4	4.3	3.4	1.5	3.8	3.4	11.4	3.7	4.7	8.1	4.9	7.0	3.4	5.6	9.8	0.7	0.2	2.1	0.4	2.9	3.3	2.4	2.5	1.3	2.8	2.5	2.4	0.1	1.8	3.3	1.7	2.7	1.1	12.7	16.7	24.5	19.5	11.4	11.8	8.1	10.8	13.7	10.2	11.9	2.6	2.9	5.2	2.7	8.3	6.2	0.0	25.4	4.5	5.2	3.9	2.9	6.6	2.9	17.3	2.1	0.5	0.0	0.6	1.6	3.0	1.5	2.3	0.8	2.1	0.0	1.7	2.5	2.4	3.2	10.0	1.1	1.7	1.8	1.4	5.8	1.1	0.0	12.7	4.6	10.5	25.8	2.3	58.1	17.7	1.9	1.0	1.3	1.7	0.7
EFHB	"CFAP21, FLJ25200"	ENSG00000163576	"EF-hand domain family member B"	Q8N7U6	3	19879472-19947025	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.3;testis: 19.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 129.8;Early spermatids: 43.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	33	"RPTEC TERT1: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078067			Approved	Nucleoli		NA	NA			Nucleoli		"HPA078067: AB_2732370"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.51e-5)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	1.1	1.5	3.9	0.7	6.0	0.7	1.8	0.7	4.3	2.0	0.7	6.5	0.0	0.6	2.0	7.8	1.0	23.3	1.3	0.8	6.3	4.7	1.8	0.7	3.9	0.7	4.4	2.2	5.5	0.5	0.5	1.6	1.0	9.5	1.0	1.0	2.3	0.6	1.3	0.7	1.1	0.6	1.6	3.1	1.2	0.6	19.2	6.0	0.0	1.2	0.0	0.8	0.7	0.6	1.3	0.6	1.1	0.8	0.4	2.2	0.4	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	21.5	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	2.2	0.1	0.1	0.8	0.3	0.4	0.0	1.3	0.5	0.3	1.1	0.4	0.3	0.6	0.0	0.4	3.9	6.0	0.7	3.8	6.3	4.7	4.4	2.2	9.5	6.0	0.0	0.6	0.0	0.4	0.1	0.5	0.3	7.6	129.8	20.5	3.5	2.0	0.8	5.0	0.3	43.0	0.2	0.5	0.0	0.2	0.4	1.1	0.3	3.5	0.4	0.4	1.6	1.2	0.6	1.3	16.0	2.3	0.7	0.0	0.0	0.0	3.6	0.4	0.0	2.1	4.5	0.7	0.0	0.3	18.4	3.3	0.1	0.7	0.0	0.3	0.1
EFHC2	"FLJ22843, MRX74"	ENSG00000183690	"EF-hand domain containing 2"	Q5JST6	X	44147882-44343672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6;fallopian tube: 20.8"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 64.3;Early spermatids: 62.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 20.6"	"Group enriched"	"Detected in some"	5	"basophil: 14.1;NK-cell: 6.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 14.1;NK-cells: 6.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;HEL: 5.4;HMC-1: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034492	Approved	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Plasma membrane"	"HPA034492: AB_10671227"	"unprognostic (1.93e-1)"	"unprognostic (7.80e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.07e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.13e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.97e-2)"	0.7	0.6	4.0	0.8	6.2	1.9	1.2	1.6	3.1	4.6	1.6	6.5	3.7	0.6	5.4	12.6	2.9	20.8	3.0	6.0	4.8	3.9	2.0	0.1	4.5	0.5	1.5	2.0	5.2	0.3	0.9	6.9	1.3	20.6	2.9	0.6	0.6	9.6	5.8	0.1	4.7	0.8	2.6	1.4	0.6	1.6	10.1	3.1	0.4	3.7	1.4	0.9	1.7	1.4	0.1	0.4	14.1	0.0	6.6	2.1	1.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	5.2	0.0	0.1	0.0	1.7	0.0	0.4	0.0	0.1	0.0	0.1	5.4	0.0	0.0	0.0	0.0	18.0	0.3	0.3	0.3	0.0	0.2	0.0	0.8	1.5	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.1	0.3	0.0	0.0	1.5	0.0	0.3	0.6	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	14.1	0.0	0.0	2.1	0.0	0.8	0.1	0.8	0.1	0.4	0.1	0.7	1.0	1.9	6.6	0.0	0.0	0.0	1.4	4.0	6.2	1.6	3.1	4.8	3.9	1.5	2.0	20.6	3.1	0.0	4.6	0.0	5.2	2.7	0.1	12.2	5.1	64.3	2.3	0.0	2.0	0.0	1.7	0.5	62.9	0.0	1.3	0.0	5.3	0.0	1.0	0.7	15.1	0.0	0.2	0.0	0.0	0.0	0.0	12.0	6.4	0.2	0.0	0.0	1.3	4.9	0.7	0.0	6.7	0.0	0.0	6.5	2.1	8.6	10.4	2.5	0.2	0.5	3.5	6.5
EFHD1	FLJ13612	ENSG00000115468	"EF-hand domain family member D1"	Q9BUP0	2	232606057-232682781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.0;breast: 83.4;kidney: 75.9"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 333.2;Sertoli cells: 194.1;Smooth muscle cells: 137.2;Syncytiotrophoblasts: 220.7"	"Cancer enhanced"	"Detected in all"		"breast cancer: 100.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.1;T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 30.4;RPTEC TERT1: 16.4;SK-BR-3: 72.5;T-47d: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049331, HPA056959"	Enhanced		Supported	"Nucleoli fibrillar center,Golgi apparatus"		No	NA			"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA049331: AB_2680716, HPA056959: AB_2683288"	"unprognostic (9.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.57e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-3)"	16.1	4.0	32.0	2.3	71.3	1.1	83.4	4.1	39.1	37.2	3.9	85.0	0.8	2.7	22.2	16.5	5.1	16.7	6.0	13.5	42.0	24.5	75.9	24.2	4.0	2.3	85.0	25.2	32.1	39.3	4.8	3.5	55.2	43.2	8.0	3.4	12.9	10.1	13.8	13.5	5.9	3.8	10.3	66.0	20.7	3.7	7.3	80.1	0.0	6.8	3.6	1.8	5.0	9.3	0.8	0.7	6.1	0.7	0.3	1.6	0.3	0.0	0.8	1.4	0.3	0.5	0.0	30.4	6.3	0.5	0.5	0.4	0.2	0.1	0.0	0.4	2.7	0.7	0.0	4.5	0.0	0.0	0.1	2.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.3	0.9	0.1	0.1	0.5	0.1	0.0	1.9	0.0	0.0	0.1	1.7	0.1	16.4	0.1	0.0	0.7	2.1	72.5	4.2	10.7	56.7	0.6	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.2	1.9	0.7	0.4	0.7	0.3	1.2	0.8	1.0	1.0	0.3	0.3	1.6	1.6	6.1	0.3	0.2	0.7	0.3	0.3	32.0	71.3	4.1	35.5	42.0	24.5	85.0	25.2	43.2	80.1	0.0	0.0	0.9	2.3	3.2	0.2	5.5	2.5	1.4	1.2	33.2	0.0	88.3	333.2	0.0	5.5	3.6	0.0	0.0	0.0	19.0	12.5	5.1	0.0	67.8	7.6	0.0	0.0	4.9	1.0	4.7	41.1	1.8	8.5	0.0	0.0	41.8	0.0	0.0	53.7	77.7	1.1	194.1	137.2	1.4	9.8	2.8	220.7	0.0	0.1	1.8
EFHD2	MGC4342	ENSG00000142634	"EF-hand domain family member D2"	Q96C19	1	15409895-15430343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Pancreatic endocrine cells: 329.7;Urothelial cells: 408.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 45.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 79.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048961	Enhanced		Approved	Cytosol		No	No		35000	Cytosol		"HPA048961: AB_2680572"	"unprognostic (1.37e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (9.11e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (6.31e-9)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (2.70e-4)"	"prognostic favorable (3.60e-5)"	12.9	21.8	16.1	35.4	15.4	69.3	8.7	13.3	41.2	9.3	24.8	7.0	7.5	39.5	11.8	6.2	18.4	10.3	21.2	7.2	19.6	15.3	7.4	10.4	19.2	31.8	14.2	22.0	9.2	26.8	4.0	10.1	16.4	56.5	14.6	14.8	6.8	11.1	10.3	3.3	10.8	45.0	8.7	8.2	48.9	42.8	28.5	7.1	17.1	14.7	7.5	27.2	20.6	12.9	1.4	9.7	45.0	11.9	9.4	15.6	4.9	79.3	20.2	2.0	5.3	3.2	7.0	10.6	10.1	9.7	9.6	9.2	7.8	21.9	17.3	32.2	7.0	12.4	19.4	5.4	17.9	6.2	21.5	10.6	4.1	4.7	12.3	5.2	21.0	36.2	5.5	6.1	19.6	5.0	4.5	12.4	7.9	9.8	8.4	5.9	7.9	10.8	40.6	2.6	10.9	25.2	14.5	18.5	13.7	5.6	16.7	4.5	3.5	8.9	7.7	16.5	1.6	3.3	22.8	23.2	14.3	15.2	44.3	16.3	5.7	13.4	7.4	19.9	41.9	19.3	4.7	11.9	16.3	15.6	11.1	4.5	1.3	3.6	7.2	9.7	1.4	1.7	6.7	45.0	9.4	9.3	3.4	2.3	4.9	16.1	15.4	13.3	41.2	19.6	15.3	14.2	22.0	56.5	7.1	3.0	16.4	40.3	77.9	58.7	1.0	5.9	28.1	9.4	11.4	21.0	9.8	17.6	16.6	55.1	72.9	39.4	263.4	0.0	225.6	181.1	21.9	96.0	44.9	17.8	193.0	0.0	59.2	29.4	182.4	177.9	9.2	155.3	21.9	97.4	131.4	3.2	329.7	122.8	6.3	27.0	4.2	45.3	23.7	5.9	4.9	59.8	44.6	86.3	90.1	408.3
EFL1	"EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1"	ENSG00000140598	"Elongation factor like GTPase 1"	Q7Z2Z2	15	82130230-82262763	"Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Elongation factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 13.4;Club cells: 7.9;Pancreatic endocrine cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039654, HPA047110, HPA052345"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.92e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.56e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (8.58e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.05e-2)"	16.3	14.0	7.0	17.3	9.9	8.9	11.8	10.2	9.4	9.5	17.2	11.0	6.8	13.2	9.2	12.2	14.1	9.1	8.0	10.7	8.8	7.9	11.9	15.4	9.0	10.0	9.5	4.5	9.8	12.5	17.9	15.0	12.8	13.3	12.7	19.6	7.4	12.1	8.5	18.5	14.6	25.7	10.8	10.1	10.1	9.7	13.9	9.9	26.9	9.8	11.3	14.9	10.8	11.7	10.7	6.8	15.8	9.0	5.8	9.0	4.5	4.9	12.3	9.2	7.9	6.2	8.5	5.9	14.4	17.0	10.4	14.0	6.1	8.7	12.1	5.9	10.7	13.1	12.9	24.4	9.5	16.6	10.7	11.9	13.3	11.8	4.6	9.8	8.5	9.5	4.2	14.9	10.5	24.2	12.3	13.7	15.6	9.9	5.5	12.0	6.9	11.1	7.7	8.3	8.8	6.4	11.9	13.7	6.5	7.3	14.9	8.4	9.0	9.0	10.6	11.0	16.7	7.9	7.6	11.5	14.8	10.0	36.9	14.2	7.1	26.3	10.2	13.5	16.0	5.4	15.8	5.6	13.7	9.0	8.1	7.2	8.9	8.4	7.6	6.8	10.7	7.3	6.3	1.0	5.8	9.0	3.3	7.6	4.5	7.0	9.9	10.2	9.4	8.8	7.9	9.5	4.5	13.3	9.9	3.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	13.4	7.9	0.0	0.0	6.1	3.3	6.0	0.0	0.0	0.0	0.0	5.3	3.1	0.0	0.0	4.7	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.6	0.0	0.0	7.4	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1286154-1300237	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"gallbladder: 10.0;intestine: 30.3;liver: 14.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 1.3;Cardiomyocytes: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.9;BEWO: 5.1;Hep G2: 9.5;NTERA-2: 5.5;REH: 7.3;SH-SY5Y: 17.2;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.2	0.1	1.5	3.4	2.2	0.2	0.1	1.5	2.0	0.1	10.7	2.0	0.0	12.0	0.2	0.1	0.4	0.1	10.0	0.1	1.0	1.6	0.3	14.2	0.1	0.1	1.2	0.5	0.1	0.1	0.1	0.3	0.2	1.1	0.1	2.3	1.9	0.1	0.2	0.2	0.1	30.3	0.2	0.9	0.2	0.6	0.6	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	1.7	0.0	0.0	5.1	0.2	0.0	0.0	0.0	3.6	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.1	2.2	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	5.5	2.4	0.0	7.3	0.6	0.1	0.0	0.1	0.0	17.2	0.2	0.0	0.1	0.7	0.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.2	1.5	2.0	1.0	1.6	1.2	0.5	1.1	0.7	0.0	0.0	0.0	0.0	1.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
EFNA5	"AF1, EPLG7, LERK7"	ENSG00000184349	"Ephrin A5"	P52803	5	107376889-107670895	"Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5;memory CD8 T-cell: 3.0"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.5;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"AF22: 19.6;RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013282, HPA054047"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB013282: AB_2533353, HPA054047: AB_2682355"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.98e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (9.46e-3)"	"unprognostic (4.92e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.92e-7)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.27e-1)"	5.3	1.9	1.9	2.3	6.0	0.0	7.3	10.1	22.2	15.0	4.2	0.9	2.5	1.2	1.6	2.8	9.1	3.9	3.6	8.3	2.5	5.3	5.3	0.6	7.0	3.2	2.1	8.9	5.5	0.7	6.9	18.5	3.1	4.8	6.2	3.6	3.3	11.2	6.8	1.1	13.3	2.3	2.8	3.5	6.3	3.1	1.8	1.1	0.1	2.5	6.0	3.3	4.0	8.1	0.0	0.0	0.4	0.1	2.5	3.5	0.4	6.3	11.3	19.6	0.0	9.4	8.2	1.8	0.2	3.4	2.5	6.1	0.1	7.1	0.0	10.7	1.2	3.7	6.6	10.8	9.3	2.3	0.0	6.6	0.0	6.2	0.0	1.8	0.3	0.0	8.8	8.9	0.0	7.9	2.3	7.8	0.0	0.0	0.0	4.7	6.1	0.0	0.0	2.4	0.0	0.9	0.0	8.8	0.2	29.9	8.2	3.0	7.8	3.0	4.6	1.9	7.1	2.0	1.2	0.1	14.9	2.6	9.0	3.5	0.6	0.0	4.1	6.5	0.5	16.0	0.2	0.0	0.1	3.5	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.3	1.4	0.4	2.5	0.1	0.0	0.1	0.4	1.9	6.0	10.1	22.2	2.5	5.3	2.1	8.9	4.8	1.1	8.9	19.5	0.0	20.5	14.2	0.2	27.7	12.7	16.0	27.3	14.0	0.0	12.5	19.9	1.9	1.5	1.6	0.0	0.0	1.2	3.9	23.9	10.3	0.0	0.0	1.5	6.4	11.5	3.7	0.3	2.7	17.0	0.6	8.5	6.4	10.3	3.7	9.3	0.0	20.5	0.0	1.0	0.0	3.9	0.1	1.9	21.1	3.2	0.0	7.0	19.2
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849943-44899662	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	22.5	26.5	16.0	23.1	27.0	25.0	17.7	13.4	34.9	14.8	20.3	22.0	10.4	16.6	22.1	15.4	27.0	20.2	12.7	22.6	16.6	16.7	21.5	27.7	17.3	25.2	15.8	19.8	15.3	20.0	21.2	15.3	27.5	22.6	14.9	23.2	19.1	27.2	15.7	49.6	22.0	20.3	18.5	15.7	25.9	18.5	30.2	13.1	36.9	18.6	17.9	34.9	18.6	16.0	12.8	31.8	31.6	31.5	15.6	16.9	23.3	22.7	45.6	22.3	36.0	17.1	16.9	26.2	18.1	24.3	45.8	39.8	35.1	19.6	39.4	21.4	22.8	35.3	26.1	48.3	31.7	53.6	39.6	40.1	39.1	28.5	37.3	18.9	46.0	29.1	18.3	18.2	42.4	23.1	17.7	39.6	35.7	48.1	15.4	26.1	22.7	46.1	30.4	22.9	53.8	38.2	32.5	45.3	34.2	26.1	25.6	36.7	21.9	17.8	13.2	18.8	34.1	35.0	29.1	24.0	34.5	26.6	20.8	45.6	16.3	20.4	39.6	27.7	25.7	35.1	12.3	31.5	31.6	15.2	31.0	16.9	12.8	13.5	14.6	31.8	12.5	12.0	13.3	5.1	15.6	29.7	13.7	13.2	23.3	16.0	27.0	13.4	34.9	16.6	16.7	15.8	19.8	22.6	13.1	0.0	12.3	16.4	10.8	10.4	13.9	15.9	28.1	14.7	12.5	17.4	31.4	30.5	3.3	25.5	9.7	16.3	14.6	0.0	23.3	26.0	12.2	9.3	19.6	18.4	34.2	25.4	10.4	17.2	31.7	4.9	11.8	22.3	5.0	49.5	12.0	14.3	21.4	10.5	8.5	10.1	16.1	19.4	9.2	24.7	36.5	12.8	22.8	13.1	20.5	10.3
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164583-32168281	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear speckles"	"HPA061173: AB_2684443"	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	4.5	6.3	7.3	2.6	7.6	4.5	5.0	6.3	9.4	7.1	6.7	8.4	8.7	4.7	6.4	5.5	4.3	4.8	8.4	4.8	8.2	4.4	4.3	1.8	4.3	2.0	25.7	3.9	14.4	2.9	1.3	2.9	9.2	14.1	6.0	2.7	14.7	3.9	5.3	3.8	12.9	5.8	3.0	11.9	3.5	3.9	2.3	7.0	0.2	3.1	8.3	2.0	5.2	6.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.3	1.3	3.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.2	0.0	0.0	2.0	1.3	0.4	0.0	0.0	1.9	0.0	1.0	3.6	1.1	0.0	0.7	0.0	0.3	0.3	0.0	0.1	0.7	2.2	0.3	0.0	0.0	1.7	1.0	3.0	0.0	0.3	0.0	1.1	0.1	0.0	0.2	0.6	0.5	1.2	0.0	0.1	3.7	0.0	1.4	2.2	0.0	0.8	1.7	0.0	0.1	0.0	0.1	0.1	0.1	1.1	1.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	7.6	6.3	9.4	8.2	4.4	25.7	3.9	14.1	7.0	6.0	5.5	0.0	0.6	1.3	1.4	0.1	0.0	2.7	2.3	1.8	2.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.2	0.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	2.5	0.3	0.0	3.4	0.0	0.0	0.0	1.0	1.1	0.2	0.0	1.1	0.0	1.1	0.0	1.2	0.4	0.4	1.9	0.7	0.0	1.2	0.4
EHD3	PAST3	ENSG00000013016	"EH domain containing 3"	Q9NZN3	2	31234337-31269447	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.4;esophagus: 29.1"	"Cell type enriched"	"Detected in many"	5	"Ito cells: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 17.8;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	9	"B-cells: 17.8"	"Cell line enhanced"	"Detected in many"		"BJ: 25.6;BJ hTERT+: 63.5;HEL: 24.6;U-266/70: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		41000000	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (3.44e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.88e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (4.92e-3)"	2.7	7.1	15.0	5.6	16.3	2.0	3.3	10.6	37.4	5.6	2.2	7.3	0.0	1.9	3.9	3.4	29.1	4.9	3.6	14.8	16.7	8.9	15.0	10.8	4.8	6.3	9.6	21.6	2.9	1.4	8.7	6.0	11.3	13.3	5.7	2.1	2.8	4.8	4.9	2.3	3.0	2.9	4.8	9.4	5.8	1.9	1.6	6.6	1.2	2.5	1.5	10.4	7.8	4.2	17.8	0.4	1.0	1.9	0.6	1.7	7.8	0.5	2.7	1.5	1.3	2.5	3.9	0.2	25.6	63.5	2.5	2.3	0.0	0.3	0.2	0.9	8.4	2.2	0.2	0.0	1.7	1.8	1.0	2.3	24.6	0.1	0.0	8.8	0.0	0.0	6.2	0.7	2.4	1.0	6.7	0.0	0.0	0.0	0.1	1.8	4.0	0.3	0.0	5.8	0.0	1.3	0.8	0.1	0.5	1.9	2.9	0.7	3.9	0.2	0.4	0.0	4.9	0.3	0.0	0.0	1.9	1.8	0.1	2.0	15.9	2.0	0.0	4.9	0.0	4.0	0.4	0.4	0.3	1.7	0.8	0.9	17.8	0.9	1.1	0.4	4.4	0.8	0.4	1.0	0.6	1.9	0.0	0.4	7.8	15.0	16.3	10.6	32.7	16.7	8.9	9.6	21.6	13.3	6.6	0.0	0.0	23.6	1.4	0.7	9.2	18.9	2.5	0.0	1.2	0.0	0.0	3.5	0.0	0.3	0.0	5.2	0.0	0.0	0.2	7.3	2.3	0.8	0.0	0.8	1.4	0.0	1.7	172.5	21.8	0.0	1.1	0.2	0.0	1.0	0.0	8.1	0.2	0.0	2.8	0.2	5.4	19.4	3.3	0.2	2.1	0.6	36.7	2.5	0.0	3.2
EHD4	PAST4	ENSG00000103966	"EH domain containing 4"	Q9H223	15	41895939-41972578	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 159.2;Urothelial cells: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 34.2;TIME: 56.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA052729, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		410000	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.72e-1)"	26.1	5.0	3.3	12.9	5.0	8.0	17.9	1.9	5.6	11.4	11.4	4.7	11.3	4.7	20.8	16.4	18.1	10.5	17.4	35.4	4.3	2.6	14.5	22.8	19.9	24.3	7.2	2.0	14.1	14.1	13.9	6.5	14.4	7.5	14.1	9.3	17.4	11.1	12.0	10.5	16.1	16.0	11.6	7.1	11.1	10.0	7.5	4.3	5.3	19.1	9.0	13.7	14.4	10.1	2.6	13.3	7.7	12.7	3.6	6.8	6.2	9.0	3.1	3.1	3.1	1.5	2.2	2.7	4.8	10.3	8.6	12.2	13.3	5.2	1.9	13.1	6.1	17.2	9.2	4.5	10.6	6.4	11.3	3.8	2.7	4.7	2.2	3.8	1.2	8.1	1.8	4.2	8.7	9.7	3.3	34.2	2.8	2.9	2.1	6.9	3.8	1.3	1.4	2.3	8.9	11.0	0.0	8.1	2.9	7.8	18.5	5.1	2.1	3.5	7.7	5.5	3.1	7.5	1.8	56.2	2.7	5.3	10.1	23.5	6.0	9.6	3.9	3.4	3.0	23.5	0.9	12.7	7.7	3.8	11.2	5.8	2.0	6.0	4.8	13.3	2.6	2.6	3.7	2.1	3.6	4.4	2.2	6.8	6.2	3.3	5.0	1.9	5.6	4.3	2.6	7.2	2.0	7.5	4.3	6.0	46.5	24.5	159.2	72.5	5.0	32.5	17.8	40.2	56.9	41.8	29.5	8.6	6.6	63.9	12.4	61.2	81.9	0.0	54.9	17.5	15.6	38.0	61.1	7.7	74.1	1.6	21.7	51.5	26.4	26.1	6.9	48.1	18.6	75.7	16.5	47.6	58.7	45.6	4.6	3.1	21.5	12.9	18.4	4.2	8.8	69.8	14.5	13.8	23.0	196.5
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34661057	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 340.0;Ciliated cells: 235.5;Club cells: 254.8;Urothelial cells: 370.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 34.8;HaCaT: 23.9;HBEC3-KT: 26.3;OE19: 29.4;RT4: 53.2;T-47d: 53.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	No	NA			Nucleoplasm	"Golgi apparatus"	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.8	1.0	0.8	9.3	0.9	0.0	32.1	0.7	0.7	19.3	16.0	0.5	152.4	6.9	4.5	21.4	69.0	23.0	22.1	0.7	0.9	0.9	11.6	1.6	9.9	0.1	1.5	0.3	4.7	10.5	0.2	0.9	0.5	1.4	20.7	22.3	0.2	118.0	161.8	0.7	12.8	10.1	1.7	3.3	0.7	10.1	1.4	0.5	0.4	1.2	50.3	59.7	13.7	30.3	0.0	4.9	0.0	0.4	0.0	0.0	0.2	11.4	6.7	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	34.8	0.0	4.4	0.0	0.0	23.9	0.0	26.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	29.4	0.2	0.0	0.0	0.2	4.7	53.2	0.0	0.0	0.1	3.6	0.0	0.0	53.9	0.1	0.0	0.0	0.3	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.7	0.7	0.9	0.9	1.5	0.3	1.4	0.5	44.7	66.1	0.0	340.0	97.3	0.0	0.4	43.3	235.5	254.8	52.4	0.0	0.0	13.3	55.4	8.4	0.2	36.0	0.0	76.2	0.0	1.9	138.5	1.1	0.6	0.1	0.0	22.3	0.0	0.0	0.0	0.0	5.3	11.8	9.0	45.3	3.9	68.8	28.8	0.0	0.1	0.0	0.0	2.3	0.1	0.0	148.7	1.1	0.0	33.6	370.0
EIF1AX	"eIF-1A, eIF-4C, EIF1A, EIF4C"	ENSG00000173674	"Eukaryotic translation initiation factor 1A, X-linked"	P47813	X	20124518-20141844	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA002561	Uncertain	Supported	Approved	Cytosol		NA	NA			Cytosol		"HPA002561: AB_1078724"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.26e-3)"	"unprognostic (7.13e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.23e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	30.9	23.2	22.0	23.7	28.8	28.3	53.4	35.4	57.3	26.1	23.6	14.5	23.9	22.7	33.8	18.7	32.6	24.7	18.4	29.2	21.4	19.5	31.0	32.0	22.1	20.9	23.5	23.5	37.0	33.0	28.7	19.8	24.7	29.0	19.5	16.9	12.0	25.2	25.0	61.5	22.5	18.9	32.5	34.1	16.5	22.7	18.0	23.7	14.8	25.7	24.6	17.2	29.3	33.9	31.1	30.2	12.6	19.9	27.2	30.9	23.8	46.2	26.2	20.2	26.8	19.7	26.9	16.4	41.4	15.2	22.7	17.9	37.6	22.2	43.4	27.8	27.3	21.2	19.9	35.5	35.9	35.4	17.7	58.7	19.2	32.9	32.0	13.8	51.0	27.1	12.6	22.1	34.9	54.9	15.0	31.5	14.1	49.6	24.4	22.2	22.6	31.4	32.0	52.4	19.6	43.5	25.9	46.4	46.3	17.8	25.9	23.4	26.2	43.9	34.3	27.2	30.4	27.9	21.7	18.0	27.6	17.1	89.8	30.9	16.7	31.5	51.4	18.8	23.4	20.8	12.6	19.1	11.5	23.1	19.9	30.2	31.1	26.5	27.1	18.3	27.7	30.9	25.8	4.7	27.2	19.2	30.2	20.3	23.8	22.0	28.8	35.4	57.3	21.4	19.5	23.5	23.5	29.0	23.7	98.3	94.3	135.4	291.6	421.9	162.4	89.0	132.5	107.1	166.1	109.9	88.4	168.6	159.2	183.9	401.5	152.7	92.4	46.7	198.9	430.4	186.0	298.0	159.4	317.5	176.9	96.9	160.6	121.5	132.4	74.9	133.5	136.3	146.8	92.0	191.7	167.0	198.1	98.2	136.5	205.2	118.8	142.3	222.6	52.6	114.6	498.3	189.8	92.0	263.5	304.6
EIF1AY		ENSG00000198692	"Eukaryotic translation initiation factor 1A, Y-linked"	O14602	Y	20575725-20593154	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 78.3;skeletal muscle: 124.6"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 345.1;Erythroid cells: 467.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.9;HEL: 46.5;U-266/84: 32.9;U-698: 74.6"									HPA002561	Uncertain	Supported	Approved	Cytosol		NA	NA			Cytosol		"HPA002561: AB_1078724"			"unprognostic (4.31e-2)"		"unprognostic (3.74e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.89e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.89e-1)"		"unprognostic (6.03e-2)"	5.9	8.3	7.0	18.6	8.3	29.2	5.0	4.5	10.9	0.0	12.6	10.0	22.2	9.0	0.1	20.2	9.9	0.0	10.5	78.3	6.5	10.4	9.1	23.0	13.3	22.8	8.2	0.0	0.1	15.0	0.2	11.4	10.3	13.4	17.4	16.1	8.8	13.1	22.9	124.6	4.2	17.9	28.2	9.2	45.8	6.5	13.1	0.0	28.7	6.2	48.9	15.9	8.9	0.0	22.1	23.0	44.5	8.0	7.8	11.9	5.0	0.1	5.5	0.0	0.0	0.0	0.0	11.6	12.3	8.3	8.6	8.5	0.0	0.0	37.9	0.0	6.5	0.0	0.0	0.0	0.0	11.8	20.4	0.0	46.5	0.0	13.8	8.5	0.0	0.0	4.6	9.4	0.0	0.0	0.0	0.0	12.8	0.0	0.0	13.7	0.0	30.0	0.0	8.2	0.0	0.0	0.0	15.5	15.1	12.0	14.4	11.0	0.0	0.0	0.0	8.4	16.5	0.0	6.5	12.2	6.6	0.1	0.0	13.3	22.9	32.9	74.6	2.5	0.0	0.0	10.0	6.7	9.3	5.2	7.7	7.3	19.2	9.5	6.1	5.7	22.1	11.9	9.0	44.5	7.8	8.0	23.0	10.9	5.0	7.0	8.3	4.5	10.9	6.5	10.4	8.2	0.0	13.4	0.0	29.8	47.1	119.4	60.3	48.5	15.1	345.1	22.9	49.5	51.2	50.6	9.8	109.0	74.6	30.4	26.6	37.2	2.6	467.2	0.3	42.0	36.5	59.3	86.9	0.9	30.7	6.4	17.0	39.3	60.3	8.8	39.7	51.5	64.1	79.4	12.1	66.9	34.6	8.6	41.1	80.0	20.6	38.8	56.6	53.4	88.1	44.3	77.6	62.3	1.0	56.7
EIF2A	EIF-2A	ENSG00000144895	"Eukaryotic translation initiation factor 2A"	Q9BY44	3	150546678-150584242	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036256	Approved		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA036256: AB_10611961"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.05e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (6.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-1)"	33.5	23.7	12.6	21.4	22.8	27.2	34.3	38.3	23.8	35.1	29.4	12.6	17.3	23.1	31.5	19.9	37.2	20.6	19.0	24.9	11.3	11.9	27.0	44.5	24.7	32.8	16.5	11.7	35.6	39.4	22.6	36.4	26.2	22.7	32.9	23.8	15.4	29.8	23.9	53.3	26.8	33.1	25.0	16.9	28.9	26.5	16.3	17.9	38.5	41.8	33.8	25.8	44.0	26.1	17.0	27.7	7.9	24.6	20.5	26.9	19.0	38.5	14.0	19.7	20.7	25.3	50.4	27.2	23.8	33.0	30.5	33.0	38.8	42.6	50.9	36.5	28.3	39.0	31.3	32.6	33.0	43.5	19.2	21.9	29.8	16.9	30.0	24.3	37.2	28.5	33.6	37.6	22.4	50.1	44.5	37.8	26.3	24.5	30.3	24.6	27.1	27.0	19.7	27.9	38.8	22.2	23.8	25.8	59.0	31.9	24.0	25.0	26.8	14.3	22.9	37.2	23.2	33.6	34.6	22.1	19.3	18.4	27.3	45.7	52.6	27.6	46.8	24.5	32.6	9.6	7.9	22.6	4.7	14.9	23.5	23.3	17.0	21.2	18.2	27.7	14.9	26.9	21.0	1.8	20.5	24.6	13.1	17.3	19.0	12.6	22.8	38.3	23.8	11.3	11.9	16.5	11.7	22.7	17.9	32.8	55.5	71.7	137.7	124.4	27.0	97.7	48.4	41.5	48.9	33.2	25.5	72.1	116.0	60.9	13.8	61.2	56.4	0.0	94.1	85.0	60.9	65.4	74.9	27.6	57.0	22.3	54.5	46.1	95.5	5.0	57.0	72.0	65.8	64.9	76.1	26.1	62.8	40.3	53.0	90.1	30.8	77.6	69.4	29.9	39.0	107.4	100.6	76.1	82.2	109.1
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	"Eukaryotic translation initiation factor 2 alpha kinase 4"	Q9P2K8	15	39934146-40035591	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.9;monocytes: 9.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011811	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA011811: AB_2668543"	"unprognostic (3.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.97e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.11e-3)"	20.7	16.5	20.2	19.4	27.3	20.2	36.0	22.4	27.3	16.8	16.3	13.6	17.1	12.2	35.7	17.9	17.8	18.1	19.4	18.2	19.5	20.5	15.4	22.7	22.5	16.6	18.6	14.2	20.1	21.5	20.3	34.7	20.5	17.6	22.0	14.6	17.9	16.7	20.3	20.4	20.7	12.2	24.3	14.6	16.1	16.4	11.5	15.1	17.7	24.1	10.6	15.9	27.0	14.4	5.0	32.9	4.2	9.3	3.8	4.5	2.4	14.0	6.8	12.1	18.2	19.9	33.6	11.5	19.8	22.8	16.3	16.1	9.6	6.1	7.5	10.4	26.9	21.8	15.0	16.1	24.0	22.7	35.3	8.1	15.9	12.5	11.6	17.1	9.6	11.0	26.5	16.5	15.5	27.9	23.0	22.6	15.8	11.7	7.1	32.0	4.7	8.0	13.2	7.4	12.5	15.1	9.7	16.8	12.3	20.2	9.6	6.3	9.7	14.2	8.6	12.3	12.3	12.1	16.6	24.0	21.7	16.5	10.8	12.8	9.8	17.7	2.3	15.2	13.2	30.3	4.2	5.8	4.0	3.6	6.7	3.1	3.5	4.0	4.1	8.4	5.0	4.5	4.2	1.7	3.8	9.3	32.9	2.7	2.4	20.2	27.3	22.4	27.3	19.5	20.5	18.6	14.2	17.6	15.1	14.9	23.6	17.2	22.6	10.6	28.5	28.8	22.9	13.4	26.1	15.7	11.8	29.7	11.6	22.9	1.0	27.0	7.3	0.0	22.0	29.4	26.2	25.6	23.1	20.8	27.4	27.0	13.8	23.4	28.6	2.4	39.1	46.9	30.4	32.5	20.8	31.3	33.9	10.5	37.4	15.1	22.8	45.3	18.6	9.8	29.6	12.7	12.7	15.8	27.6	17.2
EIF2B1	"EIF-2B, EIF-2Balpha, EIF2B, EIF2BA"	ENSG00000111361	"Eukaryotic translation initiation factor 2B subunit alpha"	Q14232	12	123620406-123633766	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034258, HPA049509"	Approved		Approved	Cytosol		NA	NA		8500	Cytosol		"CAB034258: AB_2095995, HPA049509: AB_2680797"	"unprognostic (2.14e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.65e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.78e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.40e-2)"	27.9	29.5	24.0	27.8	29.0	27.5	27.6	35.6	33.4	24.1	26.4	25.7	24.6	24.3	32.3	27.3	30.2	27.3	27.2	21.1	22.6	20.3	22.8	30.2	21.3	32.7	29.9	28.0	32.7	29.2	22.0	29.0	29.8	26.8	25.8	28.0	21.7	25.6	28.0	34.9	44.3	27.6	33.8	24.3	30.1	24.9	29.1	26.9	33.3	25.2	30.5	36.6	28.0	27.3	23.2	35.6	42.3	38.2	22.6	26.6	32.6	19.0	16.8	17.9	18.8	16.5	16.6	18.7	23.5	13.2	22.8	16.5	21.2	12.0	36.1	28.1	17.3	10.2	19.2	27.5	17.9	23.9	29.4	30.0	25.9	23.9	18.8	15.5	36.4	32.6	15.0	22.2	19.5	13.8	19.3	20.8	23.4	46.1	12.1	20.8	16.9	29.2	37.6	29.4	20.5	22.0	30.8	21.8	27.3	15.0	16.0	22.3	25.3	17.3	17.4	21.6	17.4	31.5	21.9	19.9	15.8	19.2	22.6	21.8	32.9	34.5	53.3	23.1	24.7	22.6	32.5	32.7	42.3	22.5	38.2	20.4	23.2	22.9	23.1	35.6	20.3	23.7	21.8	3.6	22.6	34.5	22.4	26.6	32.6	24.0	29.0	35.6	33.4	22.6	20.3	29.9	28.0	26.8	26.9	14.9	18.7	29.4	15.7	18.1	18.6	17.5	30.6	17.4	15.9	17.4	7.9	60.3	24.9	22.5	6.1	24.3	18.4	0.0	35.1	48.7	19.2	11.7	40.4	10.4	33.0	15.9	20.8	18.4	17.5	3.6	23.3	21.9	18.6	28.9	13.7	33.2	25.6	18.7	15.6	17.7	20.4	32.3	23.7	42.2	41.1	17.9	43.1	21.0	20.2	14.3
EIF2B2	"EIF-2Bbeta, EIF2B"	ENSG00000119718	"Eukaryotic translation initiation factor 2B subunit beta"	P49770	14	75002911-75012366	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005841, CAB037105, HPA048028"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	11.8	20.1	11.6	9.2	12.3	9.1	11.6	11.0	16.4	13.2	13.9	13.2	9.2	9.8	11.6	15.8	14.3	10.4	12.6	15.0	11.5	12.0	19.6	18.8	10.3	11.6	13.6	11.4	12.3	12.9	32.3	11.9	20.4	15.7	13.6	12.2	11.7	11.1	14.8	29.0	12.5	13.1	11.0	14.8	12.1	10.9	20.1	11.0	17.7	33.4	11.2	12.7	14.9	9.7	4.2	5.1	7.7	3.9	6.5	8.1	4.8	5.1	6.3	5.1	5.8	5.9	4.9	6.8	3.3	5.5	6.5	7.6	7.9	5.3	4.6	2.1	5.2	4.1	3.9	7.9	7.7	9.8	2.8	5.9	4.0	5.5	5.4	7.7	3.0	4.8	4.5	7.4	8.3	8.6	5.6	22.3	4.0	3.6	4.5	13.9	15.2	4.7	3.7	3.6	6.4	9.3	3.0	6.0	3.8	9.2	6.2	5.5	4.4	3.5	5.0	7.4	6.6	8.1	2.8	5.7	5.0	4.9	2.2	4.2	7.7	6.3	5.4	5.5	3.7	3.8	7.7	3.9	2.8	6.7	3.9	5.6	4.2	5.9	5.4	5.1	4.1	4.4	4.6	2.2	6.5	3.7	4.2	8.1	4.8	11.6	12.3	11.0	16.4	11.5	12.0	13.6	11.4	15.7	11.0	17.9	8.6	15.1	16.5	15.8	25.7	16.1	28.1	10.7	14.8	24.4	43.2	42.7	34.9	31.8	7.6	18.8	14.3	0.0	28.8	47.0	15.5	14.3	20.8	10.5	29.7	27.0	15.0	12.9	16.5	7.8	14.7	14.0	13.5	34.3	9.1	24.2	26.4	12.4	15.2	35.2	27.5	25.8	21.2	39.0	22.8	19.2	138.4	13.8	17.8	15.9
EIF2B4	"DKFZP586J0119, EIF-2B, EIF2B, EIF2Bdelta"	ENSG00000115211	"Eukaryotic translation initiation factor 2B subunit delta"	Q9UI10	2	27364352-27370486	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 158.7;Late spermatids: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032234, HPA039993"	Uncertain		Approved	"Nuclear membrane,Actin filaments"		NA	NA			"Nuclear membrane"	"Actin filaments"	"CAB032234: AB_668909, HPA039993: AB_2676790"	"unprognostic (2.26e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (3.64e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (5.46e-8)"	"unprognostic (1.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-2)"	18.5	20.6	22.0	18.0	21.6	9.1	18.8	21.8	20.6	19.7	23.8	17.4	20.0	13.6	20.3	16.4	25.5	17.6	14.0	29.2	20.4	14.4	20.3	24.1	15.0	14.2	19.0	17.8	17.5	27.4	21.1	21.0	18.1	19.3	23.3	17.9	16.3	25.8	22.1	52.7	27.1	14.6	22.5	19.6	15.7	20.1	28.5	19.9	14.0	15.8	13.7	21.2	20.6	24.1	17.7	28.3	22.7	29.7	15.1	25.4	21.1	15.7	24.0	18.7	14.1	25.8	19.2	20.5	17.3	18.7	24.1	16.4	36.8	6.5	20.0	16.0	20.6	20.5	10.0	26.8	21.5	16.1	15.4	17.4	25.6	15.4	40.3	22.4	23.7	9.3	18.0	22.3	30.1	22.6	17.4	22.8	15.7	23.4	9.5	22.9	13.9	11.2	21.9	19.6	24.8	16.6	20.4	29.8	17.0	21.5	12.4	14.2	15.3	13.6	20.1	16.6	17.7	12.2	8.6	21.3	16.6	20.1	14.3	18.9	20.8	25.8	30.2	13.9	19.5	15.3	22.7	29.7	20.4	18.2	25.7	25.4	17.7	18.3	18.4	28.3	14.5	17.5	19.3	4.4	15.1	25.4	20.9	22.4	21.1	22.0	21.6	21.8	20.6	20.4	14.4	19.0	17.8	19.3	19.9	11.9	15.0	22.0	15.8	31.9	21.9	29.1	17.8	26.8	18.2	21.0	62.8	36.2	16.6	27.0	158.7	20.7	20.0	0.0	29.1	20.9	23.9	17.2	30.1	30.7	21.5	9.5	23.1	22.7	22.4	199.6	21.6	20.4	21.9	33.3	19.7	23.3	24.3	17.8	23.3	22.6	56.8	19.4	34.4	51.6	36.2	30.5	38.6	25.5	16.9	12.9
EIF2S2	"EIF2, EIF2beta, PPP1R67"	ENSG00000125977	"Eukaryotic translation initiation factor 2 subunit beta"	P20042	20	34088298-34112332	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034415, HPA041262, HPA041332"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB034415: AB_2095998, HPA041262: AB_2677381, HPA041332: AB_2677417"	"unprognostic (5.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (9.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (9.64e-10)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"	25.9	30.1	32.8	23.3	40.7	21.4	38.1	20.2	37.7	21.1	24.3	10.9	27.1	21.2	21.2	22.4	36.3	17.0	18.3	36.3	30.1	20.4	22.0	40.1	27.2	37.7	40.0	26.2	19.9	45.4	18.7	22.4	29.9	35.8	20.4	24.7	7.4	26.3	25.5	101.8	21.2	20.4	37.0	50.2	23.0	28.1	19.6	35.6	18.2	24.1	32.7	30.1	25.0	30.7	38.8	48.5	28.1	39.3	32.4	42.4	27.3	39.3	26.5	20.1	24.2	19.7	30.0	38.4	36.1	34.6	36.0	36.4	93.1	27.8	35.4	26.6	32.6	40.1	37.3	32.6	59.3	43.8	11.3	17.8	70.1	21.8	47.5	51.0	44.8	22.9	30.6	50.7	35.6	53.3	24.7	37.6	52.5	41.1	33.9	29.6	25.3	41.5	37.5	19.5	45.8	48.5	23.9	34.3	32.7	28.4	33.0	20.5	14.0	40.0	24.3	74.0	24.4	36.7	53.1	25.3	41.2	25.4	25.8	33.8	31.8	28.0	36.9	38.7	34.9	29.8	21.2	37.0	28.1	26.9	39.3	32.9	38.8	38.2	37.6	34.7	31.8	36.4	36.5	21.9	32.4	35.6	48.5	42.4	27.3	32.8	40.7	20.2	37.7	30.1	20.4	40.0	26.2	35.8	35.6	157.8	148.8	160.1	252.4	160.3	53.2	134.4	252.3	164.6	154.7	132.6	29.5	312.1	260.2	306.9	265.0	180.9	122.1	397.1	456.4	341.9	160.2	180.5	139.9	436.7	212.4	39.7	121.7	263.9	224.1	127.6	117.1	190.4	113.1	327.4	153.0	65.4	448.4	141.1	121.6	191.6	90.0	109.9	93.7	435.4	188.7	152.4	536.6	139.5	166.4	296.5
EIF3A	"EIF3, eIF3-p170, eIF3-theta, eIF3a, EIF3S10, KIAA0139, TIF32"	ENSG00000107581	"Eukaryotic translation initiation factor 3 subunit A"	Q14152	10	119033670-119080823	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038315, HPA038316"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA038315: AB_10672588, HPA038316: AB_10673168"	"unprognostic (8.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.07e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.89e-2)"	36.7	27.4	19.6	29.4	20.2	41.4	42.4	22.4	22.3	27.8	29.2	21.7	32.3	26.0	33.4	26.0	35.7	22.7	25.0	36.7	19.9	18.6	28.2	41.5	24.6	39.0	24.2	20.1	29.2	61.9	35.8	33.2	33.7	25.5	26.9	26.4	14.4	31.4	31.6	92.3	36.0	29.2	49.3	29.8	29.8	34.1	18.6	22.6	45.8	28.6	33.6	28.7	40.5	38.9	15.0	20.2	21.6	29.7	14.2	27.6	13.9	50.9	38.6	31.8	43.5	34.6	50.2	24.7	46.4	48.3	29.9	30.1	36.3	33.7	59.8	17.3	38.3	23.6	51.3	41.4	35.6	42.7	32.8	34.0	51.4	29.8	40.3	39.6	75.1	38.2	43.4	40.1	44.1	76.0	50.3	33.9	24.4	52.6	39.5	38.6	30.2	31.1	35.5	30.5	19.8	19.7	32.1	68.8	28.5	28.7	43.1	14.9	31.5	36.5	34.4	48.1	28.7	22.0	48.1	49.7	29.1	26.9	30.3	67.1	34.2	37.5	58.9	30.8	74.2	19.9	21.6	21.2	12.6	16.5	23.9	19.1	15.0	19.9	14.9	20.2	13.3	13.9	15.0	5.7	14.2	29.7	11.6	27.6	13.9	19.6	20.2	22.4	22.3	19.9	18.6	24.2	20.1	25.5	22.6	217.4	278.3	92.9	185.7	270.3	56.3	294.1	114.7	196.7	246.9	61.1	58.9	145.7	23.2	129.2	164.6	122.4	96.0	93.5	158.7	131.5	136.7	213.5	137.9	165.4	112.9	41.3	135.5	80.4	187.8	87.8	100.7	140.0	140.0	160.5	137.9	70.1	165.5	84.2	110.7	43.0	50.4	58.2	140.5	137.2	105.1	318.1	211.0	121.1	152.2	227.0
EIF3B	"eIF3b, EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		22000	Cytosol	Nucleoplasm	"CAB017562: AB_2246341, HPA048983: AB_2680588"	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	27.5	27.3	16.5	28.9	21.8	38.7	28.8	20.0	26.2	23.5	33.3	22.4	25.7	20.3	29.6	24.1	38.8	28.6	26.2	32.1	15.8	16.5	24.3	51.4	21.7	29.6	22.2	19.4	31.2	66.6	24.2	20.3	34.6	21.1	26.0	24.0	18.0	34.1	24.2	72.3	39.8	23.9	33.0	16.5	31.6	29.7	45.2	19.0	44.9	23.1	34.3	35.9	32.9	29.7	6.5	8.0	3.7	7.3	16.5	9.5	4.4	85.9	44.0	18.2	49.4	20.6	18.7	45.1	30.3	22.7	34.5	32.4	57.4	33.7	50.2	25.0	32.1	48.8	46.9	50.1	39.8	38.1	15.0	58.8	38.2	42.7	38.7	29.1	46.5	28.4	23.2	26.3	37.3	39.3	18.2	27.7	23.4	97.1	23.4	31.5	61.0	22.4	52.3	56.8	30.1	39.6	27.7	36.9	51.7	22.1	39.4	41.6	31.1	32.0	71.3	17.3	33.2	47.4	51.6	29.2	26.7	58.9	40.9	54.5	25.9	34.7	50.9	30.3	52.2	65.1	1.8	7.3	3.7	7.6	6.8	9.5	6.3	7.4	8.4	7.8	6.5	8.8	8.9	0.6	16.5	5.8	8.0	8.7	4.4	16.5	21.8	20.0	26.2	15.8	16.5	22.2	19.4	21.1	19.0	23.8	61.0	27.4	38.7	57.1	36.2	30.7	28.1	24.1	48.9	26.2	60.9	54.0	3.3	33.5	9.1	45.4	29.7	0.0	52.8	53.4	38.1	43.4	16.2	53.9	42.2	49.3	45.8	70.6	38.4	13.9	40.6	33.2	15.1	16.2	54.8	41.2	58.1	20.1	35.0	25.4	44.8	25.8	40.6	29.9	34.0	68.4	69.1	28.9	53.9	38.6
EIF3CL		ENSG00000205609	"Eukaryotic translation initiation factor 3 subunit C like"	B5ME19	16	28379579-28403879	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 32.4;Cardiomyocytes: 31.6;Ciliated cells: 69.6;Club cells: 69.4"	"Group enriched"	"Detected in some"	5	"glioma: 0.8;ovarian cancer: 0.5;stomach cancer: 0.7"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 33.0;REH: 26.1"									"HPA047097, HPA049495, HPA050112"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.75e-5)"	"unprognostic (6.56e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.58e-2)"	6.9	4.6	5.2	2.5	5.5	5.5	6.0	3.0	4.9	4.7	8.9			8.9	4.1	10.2	5.8	7.9	2.5	5.5	5.0	4.6	5.9	5.5	3.6	3.7	4.6		7.3	10.4	4.3	4.2	3.6		4.1	1.2		9.3	13.7	13.2	18.0	9.1	4.0	3.3	4.0	7.3	3.4			5.5		10.6	4.2	4.1	7.7	10.5	4.6	15.9	10.8	11.5	5.1	2.5	4.4	5.5	3.4	2.3	3.4	3.1	3.1	7.5	9.3	11.7	4.9	1.8	1.5	10.5	2.9	6.2	3.1	3.9	7.5	6.0	1.1	2.1	2.1	5.7	7.1	2.5	4.0	7.4	2.8	6.1	2.7	2.2	3.9	6.0	3.8	2.9	2.7	2.1	5.5	9.4	33.0	6.2	4.8	2.2	26.1	5.6	5.9	7.3	3.0	8.2	10.4	1.6	8.2	12.6	0.7	4.2	7.0	2.7	2.7	8.7	2.9	3.2	7.9	2.1	4.9	3.0	6.4	1.8	4.6	6.9	4.3	6.5	15.9	5.5	6.2	11.3	8.1	10.5	7.7	10.2	11.5	0.6	10.8	9.6	6.2	7.7	5.1											20.8	32.4	0.0	1.0	1.1	0.0	31.6	0.0	69.6	69.4	0.0	0.0	0.7	0.0	0.6	0.0	1.1	0.7	0.0	1.1	0.4	0.6	0.8	9.3	0.0	0.4	0.0	0.0	2.5	1.0	0.7	0.3	1.8	0.0	0.0	0.7	0.0	1.0	1.1	0.4	1.4	0.0	0.0	0.9	0.3	0.4	1.4	0.7	1.3	1.0	0.7
EIF3H	"eIF3-gamma, eIF3-p40, eIF3h, EIF3S3"	ENSG00000147677	"Eukaryotic translation initiation factor 3 subunit H"	O15372	8	116642130-116766925	"Cancer-related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 200.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023117, HPA023553"	Approved		Approved	Cytosol		NA	NA		3300000	Cytosol		"HPA023117: AB_1848076, HPA023553: AB_1848077"	"prognostic unfavorable (5.26e-4)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.11e-1)"	63.1	41.3	39.4	41.3	47.6	65.8	56.8	39.5	39.9	69.2	52.8	35.1	30.8	38.8	53.1	43.6	80.9	49.7	36.4	52.9	33.2	33.0	53.4	55.6	44.2	58.0	38.6	26.7	96.0	65.4	37.6	52.6	52.0	40.1	77.1	47.0	34.9	51.5	38.5	94.6	44.8	56.2	68.3	45.4	56.0	46.3	44.9	31.6	90.0	72.3	59.3	74.7	83.7	57.6	69.1	73.6	21.6	55.3	47.1	88.5	76.7	48.2	27.9	33.7	29.3	44.6	78.2	33.6	32.0	41.3	35.4	34.6	28.8	57.3	77.3	32.5	33.3	25.8	31.1	36.9	48.6	44.7	50.0	30.0	68.2	25.0	42.8	55.8	29.4	36.5	71.9	67.8	32.0	74.4	60.4	38.4	61.0	57.6	41.0	39.8	35.8	81.8	41.3	34.3	107.1	44.6	47.4	22.5	54.8	53.2	35.6	38.3	46.3	16.7	200.9	53.2	34.6	59.6	59.4	35.1	22.8	42.4	33.6	41.7	66.2	59.7	63.8	31.6	52.1	31.0	21.6	55.3	19.8	36.7	54.8	60.3	69.1	66.5	53.1	73.6	59.1	88.5	71.9	12.0	47.1	53.3	41.1	73.2	76.7	39.4	47.6	39.5	39.9	33.2	33.0	38.6	26.7	40.1	31.6	169.7	173.8	354.3	365.2	299.8	59.1	142.4	173.3	99.0	193.3	89.0	11.8	379.0	379.7	249.7	301.7	214.9	114.6	116.8	331.0	435.7	226.0	279.9	187.3	94.3	292.1	25.4	193.0	149.8	325.6	209.1	306.9	322.8	199.1	375.1	270.1	77.5	285.4	199.9	206.8	338.0	52.1	194.1	271.9	179.4	126.9	311.5	482.6	284.1	291.2	372.2
EIF3I	"eIF3-beta, eIF3-p36, eIF3i, EIF3S2, TRIP-1"	ENSG00000084623	"Eukaryotic translation initiation factor 3 subunit I"	Q13347	1	32221928-32231604	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029939, HPA029940"	Enhanced		Approved	Cytosol		NA	NA		16000	Cytosol		"HPA029939: AB_10611109, HPA029940: AB_10600878"	"unprognostic (4.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.82e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (9.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (4.81e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.47e-2)"	46.3	45.9	26.1	28.9	27.6	32.2	44.8	21.2	28.7	36.6	39.1	25.3	41.0	24.5	33.5	50.4	61.0	37.9	42.7	44.4	25.2	25.0	47.6	89.7	33.9	42.7	27.1	21.9	50.5	72.0	27.0	25.0	45.4	22.8	38.7	45.5	26.5	59.6	40.6	79.1	35.0	39.5	38.5	25.9	36.1	34.8	31.3	17.0	55.8	67.9	75.4	46.6	43.3	34.5	44.4	56.6	23.8	50.3	42.4	52.9	61.6	49.6	39.2	31.8	59.0	48.2	60.7	30.5	39.5	73.8	76.2	60.4	45.7	55.0	75.5	40.1	70.0	52.8	35.0	68.2	77.6	93.5	27.8	64.6	45.9	35.1	50.7	54.8	75.9	39.0	58.4	69.7	73.6	83.2	59.1	66.2	52.6	88.2	30.3	68.9	39.0	56.7	59.4	83.3	68.9	61.6	41.3	53.0	64.0	75.2	34.9	42.8	47.6	43.1	46.5	77.0	63.1	35.7	38.3	40.7	44.0	46.4	67.4	82.8	51.1	55.1	63.8	49.6	61.8	57.4	23.8	47.3	21.7	42.1	50.3	47.7	44.4	45.1	41.9	56.6	39.7	40.2	38.3	6.1	42.4	36.8	43.5	52.9	61.6	26.1	27.6	21.2	28.7	25.2	25.0	27.1	21.9	22.8	17.0	47.6	67.3	128.8	178.4	121.3	38.5	37.7	81.5	91.0	78.5	48.8	9.8	263.3	112.7	251.4	51.4	121.5	96.3	0.0	237.9	288.5	128.5	125.4	112.0	70.0	199.5	12.7	132.9	70.0	89.1	20.4	159.6	124.5	136.7	223.6	124.0	53.3	233.6	105.2	130.8	144.9	32.3	90.5	209.4	67.7	73.9	123.6	286.3	137.0	158.7	187.7
EIF3J	"eIF3-alpha, eIF3-p35, eIF3j, EIF3S1"	ENSG00000104131	"Eukaryotic translation initiation factor 3 subunit J"	O75822	15	44537057-44563029	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050977	Approved		Approved	Cytosol		NA	NA		8600	Cytosol		"HPA050977: AB_2681297"	"unprognostic (4.47e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.76e-1)"	"prognostic unfavorable (4.96e-5)"	23.7	17.8	24.7	21.0	21.9	16.4	22.8	16.6	23.1	15.6	18.4	13.2	20.5	17.7	15.8	17.2	28.0	11.9	14.8	36.8	22.8	23.7	23.3	46.3	14.7	18.3	26.3	19.2	15.0	35.1	17.3	22.9	22.9	31.6	17.1	20.0	6.9	27.0	25.4	134.3	18.9	16.6	18.6	29.0	20.9	18.4	14.7	20.9	17.0	19.2	27.3	24.9	23.0	20.6	26.7	33.2	22.6	19.2	28.2	23.9	6.4	22.5	12.0	19.7	12.3	14.1	14.2	24.2	35.8	10.6	24.9	17.0	38.1	13.8	20.9	42.2	15.0	23.7	42.8	31.6	22.8	30.6	23.4	16.0	47.6	29.7	24.1	26.4	51.0	21.2	12.6	30.6	17.2	33.7	15.3	26.8	23.7	61.8	27.5	22.3	15.9	25.6	34.8	12.0	42.9	19.7	29.9	33.9	31.1	28.4	27.0	26.7	16.4	33.0	31.4	19.8	17.3	26.3	42.3	31.6	27.1	32.2	29.1	48.0	32.8	61.7	52.8	18.9	55.7	25.6	22.6	19.2	16.8	17.4	18.3	21.0	26.7	23.2	22.3	22.2	24.7	22.8	23.9	7.7	28.2	16.3	33.2	23.6	6.4	24.7	21.9	16.6	23.1	22.8	23.7	26.3	19.2	31.6	20.9	56.6	49.9	94.2	75.5	155.6	53.4	84.7	117.2	50.9	87.6	137.9	19.6	122.2	164.2	124.7	123.5	94.8	95.5	23.3	127.9	138.5	81.8	61.2	124.7	370.0	99.0	41.3	112.5	102.5	88.2	85.7	84.3	75.4	57.3	96.4	107.9	41.1	136.6	97.1	66.8	158.9	63.2	45.3	85.9	219.1	126.3	150.4	206.6	73.5	113.9	75.3
EIF3L	"EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025"	ENSG00000100129	"Eukaryotic translation initiation factor 3 subunit L"	Q9Y262	22	37848868-37889407	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003028	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		22000000	Nucleoli	Nucleoplasm	"HPA003028: AB_1078726"	"unprognostic (2.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.03e-3)"	30.9	18.4	17.4	17.5	19.8	26.4	55.1	34.4	19.3	40.7	29.1	16.1	16.7	20.8	36.1	18.9	33.4	24.2	14.0	15.5	15.0	15.6	23.7	36.1	18.4	31.3	14.0	13.4	63.4	78.8	20.2	26.8	27.9	17.7	38.7	23.8	21.5	39.6	31.0	40.3	30.6	25.2	35.8	15.6	24.7	22.7	19.6	11.4	44.0	54.8	32.3	31.0	38.6	22.0	33.6	58.1	9.8	35.9	25.0	42.5	55.2	16.8	9.6	27.1	19.6	26.3	58.8	19.5	16.2	39.0	26.2	35.8	16.0	12.5	58.2	4.5	18.9	9.1	10.9	29.8	22.4	30.9	7.6	49.8	20.5	14.0	7.5	16.4	54.4	17.7	31.6	25.7	19.3	29.2	45.4	32.5	19.3	17.0	15.9	30.2	6.6	14.5	25.2	15.4	20.6	25.3	16.6	37.2	17.0	19.9	10.2	19.8	30.6	16.0	18.8	21.9	31.8	14.3	22.0	15.7	16.3	19.9	9.9	12.9	9.5	15.5	23.7	15.3	24.1	13.3	9.8	35.9	9.6	20.7	35.4	34.6	33.6	30.0	25.0	58.1	27.5	42.5	31.8	4.8	25.0	29.1	28.4	29.1	55.2	17.4	19.8	34.4	19.3	15.0	15.6	14.0	13.4	17.7	11.4	110.2	191.5	294.7	357.3	352.7	56.1	1.4	165.6	77.6	174.0	62.8	27.5	578.0	353.1	204.0	111.9	215.8	81.1	116.8	400.6	517.3	230.5	236.6	216.1	101.7	227.0	23.8	189.5	125.8	250.1	286.2	206.0	267.8	215.9	373.3	211.0	74.0	242.7	189.4	199.4	249.7	32.9	161.7	287.4	90.7	87.1	375.5	588.1	261.5	327.6	377.5
EIF3M	"eIF3m, FLJ29030, GA17, hfl-B5, PCID1, TANGO7"	ENSG00000149100	"Eukaryotic translation initiation factor 3 subunit M"	Q7L2H7	11	32583798-32606262	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031063	Approved		Approved	Cytosol		NA	NA		48000	Cytosol		"HPA031063: AB_10602128"	"unprognostic (4.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.28e-9)"	"unprognostic (5.79e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.42e-2)"	44.3	46.1	25.4	36.8	30.9	41.0	47.1	19.3	32.2	49.0	35.1	17.3	26.5	26.2	40.2	38.9	48.7	52.0	29.1	34.3	23.3	23.0	50.0	54.5	30.8	47.7	23.4	21.9	80.9	60.6	34.0	33.1	44.7	28.3	44.3	35.0	18.8	32.5	30.3	48.8	35.1	37.8	39.2	26.4	45.0	37.1	43.5	19.6	84.1	55.1	54.7	48.1	59.8	34.6	36.5	64.0	15.4	53.2	33.3	38.5	39.4	29.0	37.6	30.0	38.1	40.1	57.8	44.3	30.3	42.1	46.7	45.5	48.4	21.5	75.5	20.9	34.5	40.1	37.1	52.2	55.0	58.5	25.4	64.7	34.0	30.6	51.1	58.1	78.9	48.9	51.7	62.5	31.4	77.3	39.3	52.3	40.6	67.0	26.4	51.1	34.2	39.3	83.0	32.9	39.1	58.2	32.3	75.8	35.2	50.9	55.0	23.2	35.9	21.5	40.8	46.4	34.5	45.2	47.3	24.4	29.3	33.4	62.0	91.1	32.4	40.7	55.1	26.3	48.1	28.7	14.3	53.2	15.4	26.5	45.8	36.3	36.5	36.6	33.4	64.0	29.2	38.5	34.8	6.3	33.3	33.3	38.4	37.9	39.4	25.4	30.9	19.3	32.2	23.3	23.0	23.4	21.9	28.3	19.6	77.4	57.3	141.1	205.6	189.1	44.1	38.3	56.0	54.9	75.1	57.6	19.6	216.5	111.0	149.6	121.1	121.7	46.7	46.7	216.8	238.7	136.9	115.7	153.7	66.1	176.7	9.5	69.5	81.6	264.9	43.2	124.0	180.6	104.6	164.1	128.3	52.2	174.4	87.7	113.1	160.4	36.8	71.1	155.2	89.9	83.3	196.7	203.2	160.3	148.5	209.0
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572706-7579005	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 1192.5;Suprabasal keratinocytes: 1078.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		2300000	Cytosol		"CAB011689: AB_732122, HPA068286: AB_2685968"	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	56.5	49.0	19.3	41.4	19.8	51.4	80.2	13.6	26.6	40.4	45.6	28.5	26.4	28.7	45.9	30.2	76.4	43.4	39.2	33.5	18.5	17.1	34.2	58.0	46.3	135.7	27.7	12.9	55.2	77.0	19.8	28.8	45.2	21.8	36.2	44.0	33.0	65.8	30.7	36.5	48.4	30.9	46.5	33.4	46.8	42.2	31.6	21.8	91.5	34.7	73.8	67.7	42.5	40.8	35.1	143.6	29.1	115.7	47.1	60.3	170.1	85.9	117.9	79.1	71.6	71.2	83.3	73.8	83.0	94.4	154.0	119.1	119.0	39.0	117.7	64.0	87.0	67.6	77.2	167.7	127.8	166.0	38.1	124.3	66.3	76.7	132.2	109.0	67.7	67.1	110.3	66.1	129.3	132.3	92.1	115.5	66.8	67.6	24.4	110.8	90.4	70.3	58.2	67.8	89.0	81.7	66.4	59.7	56.5	107.6	79.1	41.8	81.2	74.8	50.4	104.0	61.8	55.9	52.1	82.5	81.4	56.8	52.0	166.9	24.0	33.4	77.1	87.5	83.4	89.2	19.6	115.7	29.1	37.0	102.6	60.3	35.1	40.0	39.5	143.6	28.9	39.4	39.6	12.1	47.1	75.7	54.8	49.2	170.1	19.3	19.8	13.6	26.6	18.5	17.1	27.7	12.9	21.8	21.8	107.2	246.6	70.7	485.7	1192.5	106.4	4.8	71.4	168.6	257.0	69.8	110.0	292.0	129.3	287.6	27.4	250.8	114.3	0.0	199.9	314.2	406.1	269.6	140.3	57.2	188.0	100.1	111.9	143.1	130.1	33.1	149.0	241.8	688.4	127.2	116.0	108.1	249.6	126.3	102.6	131.4	109.7	148.8	550.1	57.5	86.6	1078.3	532.6	174.8	147.8	417.5
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789900	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB011690, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		1000000	Cytosol		"CAB011690: AB_732123, HPA068286: AB_2685968"	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	34.6	66.1	61.2	27.7	79.9	1.9	53.5	121.1	111.5	65.1	52.1	26.5	30.1	30.3	73.1	45.5	44.5	73.9	45.1	83.7	58.4	71.9	63.9	43.5	33.7	36.1	48.9	61.7	142.0	59.0	30.9	84.1	47.3	69.6	57.9	40.1	31.8	43.7	62.8	126.7	19.8	35.6	57.1	41.9	32.5	39.0	32.9	39.5	23.9	67.8	36.4	35.4	61.1	51.7	55.1	19.3	39.4	24.8	33.0	63.4	51.3	10.1	5.1	21.4	3.5	82.7	78.0	6.6	18.3	16.5	19.4	25.6	18.9	3.7	22.7	102.5	26.2	35.9	17.1	31.5	7.7	34.3	21.2	16.6	36.6	6.8	25.3	32.4	7.7	25.7	52.2	37.0	5.6	46.7	98.7	34.4	19.2	12.3	38.3	63.1	1.7	12.2	3.8	21.3	41.0	24.6	15.7	15.2	13.8	38.5	12.4	42.2	8.5	29.7	20.5	38.9	56.7	32.0	28.2	25.1	15.4	7.7	14.8	11.2	30.5	43.2	10.4	10.6	8.1	7.2	39.4	16.0	18.5	28.5	18.2	45.3	55.1	41.9	34.8	19.3	46.1	63.4	50.2	11.0	33.0	24.8	17.4	38.6	51.3	61.2	79.9	121.1	111.5	58.4	71.9	48.9	61.7	69.6	39.5	110.2	187.7	337.3	695.6	613.2	269.9	244.1	206.4	220.8	192.2	247.7	60.9	410.2	560.3	199.1	25.8	233.7	293.3	23.3	81.4	227.6	351.3	637.4	309.0	119.2	199.9	368.7	391.5	183.0	192.6	37.8	357.2	230.1	327.3	376.9	296.7	294.3	160.6	364.6	444.5	452.5	161.0	232.8	455.3	100.9	174.0	540.1	514.8	331.3	287.0	611.0
EIF4E2	"4EHP, EIF4EL3, IF4e"	ENSG00000135930	"Eukaryotic translation initiation factor 4E family member 2"	O60573	2	232550052-232583644	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019253, HPA077074"			Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA019253: AB_1848092, HPA077074: "	"unprognostic (3.44e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.42e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.38e-2)"	19.0	22.9	27.9	24.0	24.4	25.4	19.4	27.1	38.1	17.6	30.7	18.4	17.0	24.4	26.2	18.2	32.1	18.5	20.0	21.3	25.8	14.8	29.8	43.2	20.4	21.0	18.6	27.2	22.0	26.2	16.3	25.0	26.8	26.3	19.9	35.7	16.1	27.3	15.9	77.6	23.8	25.2	25.3	27.0	25.4	26.7	25.2	21.5	18.1	19.1	24.8	27.1	20.0	21.2	13.5	38.9	49.6	46.8	14.1	24.1	29.7	27.9	23.2	28.4	21.0	20.9	28.6	43.9	37.7	20.4	26.0	26.6	25.6	26.5	27.4	10.7	36.7	30.7	23.9	32.0	32.8	32.7	24.5	26.4	37.5	25.1	33.9	25.4	52.4	35.5	24.5	24.6	27.3	19.7	26.5	42.2	13.4	35.2	9.3	29.3	45.1	21.3	44.5	45.3	31.0	19.4	18.4	63.2	17.9	52.1	33.4	27.7	37.9	20.1	23.3	24.0	32.0	22.2	36.8	38.5	24.4	32.1	25.4	27.8	17.5	16.6	36.1	27.3	28.9	21.1	49.6	45.1	40.7	14.8	46.8	11.8	13.5	15.1	15.4	38.9	12.2	12.9	13.1	29.5	14.1	41.7	15.2	24.1	29.7	27.9	24.4	27.1	38.1	25.8	14.8	18.6	27.2	26.3	21.5	38.7	52.3	42.4	59.6	33.8	19.5	33.6	71.4	34.8	31.8	33.2	17.7	120.6	63.0	146.2	103.8	31.0	104.8	0.0	131.7	170.6	55.5	66.8	42.7	102.9	110.3	19.1	63.4	46.1	84.3	214.1	35.4	81.8	28.7	140.7	94.2	22.7	139.4	87.7	36.4	98.2	18.3	25.8	36.6	47.9	59.9	44.7	152.5	45.7	76.5	86.7
EIF4E3	MGC39820	ENSG00000163412	"Eukaryotic translation initiation factor 4E family member 3"	Q8N5X7	3	71675416-71754773	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.8;monocytes: 4.2;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 20.0;U-937: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058649, HPA076465"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA058649: AB_2683785, HPA076465: "	"unprognostic (3.16e-3)"	"unprognostic (7.60e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.31e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (3.10e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.16e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (6.99e-5)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.83e-2)"	18.8	9.4	17.2	11.8	22.6	17.7	25.6	13.9	19.4	9.6	16.3	11.5	3.7	10.4	11.0	8.5	16.0	12.2	11.9	30.3	18.6	14.6	10.5	8.8	13.7	11.7	15.2	12.4	17.9	19.4	26.7	14.6	4.7	12.8	14.8	13.0	10.8	12.9	14.5	40.4	7.2	17.6	25.6	19.4	15.3	9.9	5.9	6.7	7.8	19.7	14.5	7.8	17.6	21.8	0.2	0.9	14.8	4.2	1.0	5.4	1.6	0.3	1.3	1.3	4.3	1.3	3.4	1.7	1.1	1.2	1.1	0.6	0.7	0.6	0.0	2.9	1.1	7.4	1.6	4.7	6.5	0.9	14.9	1.4	0.0	0.1	0.1	4.6	2.3	2.6	3.0	4.2	0.3	3.6	0.6	3.6	2.7	0.5	20.0	0.2	5.0	2.0	0.5	10.5	0.5	2.3	1.1	5.2	0.6	14.3	7.2	2.7	7.2	7.8	1.7	0.2	4.3	7.5	0.1	0.9	0.6	3.4	9.2	1.0	14.1	13.1	0.0	0.5	27.1	2.6	1.2	4.2	5.9	2.2	1.8	3.4	0.2	3.1	3.6	0.9	0.1	2.3	2.7	14.8	1.0	2.3	0.0	5.4	1.6	17.2	22.6	13.9	19.4	18.6	14.6	15.2	12.4	12.8	6.7	26.8	12.6	0.0	8.5	9.0	10.3	35.1	7.6	2.7	10.3	10.4	0.0	3.3	3.3	4.9	0.9	9.3	27.6	0.0	4.9	2.3	8.4	10.8	6.9	4.9	4.0	1.6	8.7	14.7	15.7	1.1	11.8	5.8	3.3	1.0	11.1	13.5	8.0	14.4	8.9	11.4	0.5	0.0	17.5	0.2	0.4	11.8	1.3	13.8	6.4	7.6
EIF4EBP2		ENSG00000148730	"Eukaryotic translation initiation factor 4E binding protein 2"	Q13542	10	70404379-70428618	"Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019415, HPA037410, HPA061665"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB019415: AB_10699019, HPA037410: AB_2675461, HPA061665: AB_2684580"	"unprognostic (9.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.61e-2)"	57.3	27.2	22.1	28.2	21.8	20.2	77.1	22.7	23.0	28.7	47.9	16.7	25.9	30.8	24.8	18.3	28.3	22.7	37.9	52.4	18.0	15.8	44.4	40.1	31.8	21.6	19.0	14.7	33.4	28.4	23.2	13.3	36.2	18.6	33.2	31.6	34.8	25.5	50.2	54.5	27.6	51.2	32.4	17.8	30.5	28.7	17.9	16.2	34.8	23.5	29.2	22.1	39.8	64.3	7.0	14.0	20.6	17.5	9.3	14.2	14.2	17.1	5.6	30.7	29.9	59.4	22.6	16.6	10.5	13.1	7.9	8.5	24.5	15.4	17.9	6.4	15.5	4.9	11.1	14.9	9.7	8.9	19.0	7.7	12.9	6.8	9.6	13.9	22.9	9.1	25.1	10.1	9.6	8.7	16.0	11.9	14.8	21.0	16.4	12.1	9.8	19.5	23.6	25.8	17.1	10.2	20.1	12.3	11.5	10.0	17.9	16.6	25.1	14.5	33.5	13.9	21.9	15.2	20.5	12.9	5.1	6.4	8.3	9.3	11.0	21.5	21.1	5.9	34.3	5.2	13.8	15.5	20.6	14.2	13.8	11.6	7.0	11.5	11.7	14.0	6.1	9.8	10.1	17.0	9.3	17.5	4.7	12.5	14.2	22.1	21.8	22.7	23.0	18.0	15.8	19.0	14.7	18.6	16.2	23.8	32.8	41.3	43.1	47.1	42.0	128.1	66.2	17.4	25.0	34.9	19.6	37.6	36.5	37.0	19.7	34.3	154.3	23.3	51.0	104.3	50.6	50.3	11.5	142.1	41.5	22.3	25.4	65.7	88.3	40.0	60.9	37.0	20.3	45.9	79.3	63.3	50.7	84.0	57.7	108.0	15.4	77.6	30.7	32.9	41.7	61.2	47.9	42.4	61.8	85.2
EIF4G3	eIF4GII	ENSG00000075151	"Eukaryotic translation initiation factor 4 gamma 3"	O43432	1	20806292-21176888	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025031, HPA025039, HPA025041"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104"	"unprognostic (1.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.60e-7)"	"unprognostic (1.02e-1)"	"unprognostic (6.95e-3)"	"unprognostic (8.36e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	17.8	19.2	24.8	19.0	28.6	24.1	14.3	24.8	33.8	17.2	17.9	24.5	18.6	12.2	19.7	17.5	16.8	17.1	17.0	16.6	25.9	24.8	14.8	13.6	12.9	14.8	23.1	24.8	15.7	10.6	44.5	30.3	13.8	36.3	16.1	21.0	17.4	11.3	18.5	29.1	17.7	14.0	23.8	25.0	16.1	14.2	67.1	23.1	13.9	30.5	9.7	16.1	18.0	15.7	3.6	5.6	4.2	2.6	1.4	3.7	1.5	11.2	9.2	30.5	12.1	31.9	31.7	6.3	24.5	26.5	17.2	17.8	10.0	12.4	22.7	15.9	26.6	16.2	12.7	18.8	19.9	24.4	19.7	17.7	11.3	18.2	7.0	16.1	18.6	21.0	33.1	16.2	18.1	23.5	27.5	22.2	8.6	8.5	15.9	25.5	10.0	5.8	9.7	8.6	14.1	8.3	11.2	11.2	7.5	19.0	6.1	17.3	13.4	25.5	11.1	14.9	18.6	8.0	21.6	22.6	19.5	7.3	27.7	11.1	7.3	7.8	0.1	25.0	29.7	18.1	2.0	2.6	3.0	3.7	0.5	1.6	2.6	1.5	1.8	3.4	3.6	1.0	2.8	4.2	1.4	1.0	5.6	1.7	1.5	24.8	28.6	24.8	33.8	25.9	24.8	23.1	24.8	36.3	23.1	17.9	26.2	21.5	15.0	18.3	47.5	39.2	10.2	58.9	35.2	15.7	62.8	4.2	0.0	18.6	138.6	31.0	42.3	0.0	16.8	7.4	18.3	16.8	25.5	12.7	20.1	47.7	15.6	39.3	33.2	92.8	41.4	24.3	13.5	2.8	21.4	20.0	22.0	28.8	42.1	8.8	39.4	32.3	21.7	100.5	49.8	23.1	2.9	13.8	23.3	23.7
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174245-74197101	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1039.9;Late spermatids: 2062.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		520000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	46.8	42.7	47.6	37.6	52.8	82.3	42.8	56.0	89.5	39.8	44.5	46.6	36.2	43.1	48.1	37.9	58.6	44.4	40.7	47.4	45.6	41.4	34.5	50.7	37.4	42.8	45.4	54.6	54.2	74.3	54.3	30.1	72.2	47.6	44.8	35.1	35.6	60.3	45.4	89.6	53.0	41.5	43.4	59.9	34.6	45.4	52.5	32.1	46.8	43.5	57.9	44.2	43.4	41.4	38.4	57.6	60.2	64.2	46.7	52.0	80.6	87.4	58.3	44.5	53.9	39.7	42.3	50.6	62.6	47.6	51.9	51.1	71.4	67.5	75.2	17.1	57.8	75.1	46.5	49.0	83.2	49.1	50.5	57.4	41.9	54.8	57.3	45.5	70.6	42.3	49.5	52.9	57.6	82.0	61.0	56.8	45.0	73.6	32.7	53.1	74.7	55.7	83.8	59.4	72.7	57.8	65.4	59.7	67.9	43.1	56.0	45.3	57.2	58.4	73.8	49.6	61.4	83.4	45.8	59.0	74.4	50.6	62.2	78.7	38.9	46.4	128.4	58.1	74.2	76.3	45.7	58.4	60.2	43.5	64.2	44.9	38.4	44.7	43.0	57.6	35.3	52.0	42.4	39.0	46.7	63.6	24.4	47.6	80.6	47.6	52.8	56.0	89.5	45.6	41.4	45.4	54.6	47.6	32.1	77.4	68.6	90.9	132.2	105.9	91.7	38.9	66.2	53.5	59.1	41.8	23.6	170.5	91.2	122.8	1039.9	93.3	74.9	46.7	138.2	310.9	112.7	87.9	121.1	74.9	110.6	92.2	86.8	73.6	90.7	2062.3	96.1	91.0	69.2	181.3	80.6	92.2	119.2	69.1	104.0	54.1	63.7	84.1	131.0	55.4	62.9	101.5	330.6	89.7	87.9	119.5
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337353-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: AB_2676843"	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	24.5	16.0	25.2	22.4	32.6	11.5	22.6	27.7	26.0	23.7	25.1	10.5	19.9	14.8	19.4	28.7	30.8	14.5	15.0	61.7	26.0	22.3	28.8	32.1	17.9	19.2	26.9	23.0	22.3	24.6	26.8	27.5	26.4	28.5	26.0	20.3	7.1	22.3	29.1	105.8	25.3	19.3	31.5	37.6	27.0	20.7	22.6	33.8	17.8	18.2	29.2	22.8	40.1	31.9	15.9	20.2	11.6	12.1	14.1	14.9	4.5	34.1	17.1	19.5	25.4	23.7	28.1	32.4	30.2	19.0	20.1	20.1	39.3	24.4	39.2	26.2	22.4	23.9	19.6	34.1	29.2	35.6	23.6	20.4	47.1	17.5	51.7	18.8	46.0	29.1	18.9	20.6	27.9	28.6	17.3	29.2	24.1	51.9	19.6	28.9	27.7	29.1	42.7	30.4	22.5	25.2	25.5	29.1	31.9	41.2	28.7	16.6	15.7	16.4	37.8	24.3	38.8	15.3	30.4	32.0	31.3	30.7	16.3	26.8	14.6	20.6	32.0	22.7	51.1	23.0	11.6	8.8	9.8	12.7	9.5	14.9	15.3	13.4	12.5	6.4	15.9	13.2	14.0	2.3	14.1	12.1	20.2	9.0	4.5	25.2	32.6	27.7	26.0	26.0	22.3	26.9	23.0	28.5	33.8	101.3	209.4	134.1	138.3	285.5	99.2	532.6	145.2	179.3	205.9	326.2	47.1	126.1	122.7	191.6	558.1	145.8	91.2	116.8	202.2	178.1	139.3	179.5	165.5	428.2	118.4	73.1	151.6	136.2	112.7	88.6	115.3	122.6	135.0	171.3	133.7	81.8	227.8	86.3	165.2	160.8	108.6	271.7	161.7	293.6	551.3	283.8	151.7	127.0	125.6	200.5
EIPR1	"EIPR-1, TSSC1"	ENSG00000032389	"EARP complex and GARP complex interacting protein 1"	Q53HC9	2	3188925-3377882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 43.9;Distal tubular cells: 43.1;Extravillous trophoblasts: 29.7;Hofbauer cells: 29.7;monocytes: 28.9;Proximal tubular cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031231, HPA031232, HPA031233, HPA031234"	Approved		Supported	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli"	"Intermediate filaments"	"HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (3.67e-7)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.83e-2)"	7.3	12.3	20.1	17.3	24.4	14.2	9.0	26.0	22.9	8.3	11.9	12.1	10.0	10.7	7.7	18.4	14.5	12.0	7.9	10.3	17.7	19.3	12.4	11.4	7.9	15.2	15.1	14.5	5.8	11.6	14.2	20.8	8.0	13.6	7.7	10.9	10.5	9.9	7.4	10.9	9.2	9.3	9.4	12.4	12.0	9.3	9.9	11.5	14.5	20.4	15.5	15.3	11.1	7.7	15.7	23.4	13.9	13.3	16.3	16.9	14.0	10.6	20.1	10.7	12.1	6.8	9.2	24.3	11.2	11.7	13.5	10.3	13.4	13.5	18.7	19.9	11.4	12.8	11.0	8.4	16.2	7.5	14.5	15.9	16.5	12.5	30.9	13.0	16.1	20.6	8.4	14.7	13.7	17.8	7.5	17.1	33.4	18.4	13.0	12.4	19.9	14.9	23.5	12.4	25.2	16.1	17.5	11.4	25.1	16.8	14.8	23.4	27.2	7.9	13.3	12.2	6.0	12.3	15.1	12.0	10.9	5.6	8.9	15.0	14.9	36.0	15.5	12.9	16.8	10.0	13.9	11.8	9.4	16.1	13.3	16.3	13.9	13.4	16.8	21.3	15.7	14.7	15.8	5.0	16.3	11.9	23.4	16.9	14.0	20.1	24.4	26.0	22.9	17.7	19.3	15.1	14.5	13.6	11.5	3.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	8.1	11.4	19.2	0.0	43.9	43.1	25.6	0.0	0.0	0.0	0.0	13.9	29.7	0.0	0.0	3.5	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	28.9	0.0	0.0	17.8	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0
ELAVL2	"HEL-N1, HuB"	ENSG00000107105	"ELAV like RNA binding protein 2"	Q12926	9	23690104-23826337	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 30.7;testis: 45.3"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 154.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 10.1;AF22: 15.6;SCLC-21H: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022222, HPA063001"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB022222: , HPA063001: AB_2684918"	"unprognostic (3.51e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.74e-4)"	"unprognostic (3.98e-1)"	"unprognostic (9.08e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.65e-1)"	1.0	2.4	8.7	1.0	13.4	1.4	1.1	18.3	27.5	1.0	1.3	0.7	0.0	1.0	1.5	1.4	1.1	1.0	1.1	1.0	8.1	19.2	1.4	0.8	1.1	1.0	16.3	18.9	2.1	0.8	1.2	2.5	0.9	30.7	1.2	1.5	0.5	1.0	1.0	1.0	1.5	1.1	1.1	5.0	1.0	1.0	45.3	1.1	0.0	1.2	0.0	1.0	1.6	0.3	1.8	1.1	5.1	0.9	1.4	1.3	0.1	10.1	0.1	15.6	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.2	6.5	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	4.0	0.0	4.7	0.0	0.1	0.0	0.3	0.5	2.2	0.0	0.0	0.0	4.1	0.0	4.9	0.0	5.6	0.1	0.0	0.0	52.1	4.9	0.1	0.1	0.1	4.2	0.2	0.7	0.0	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	2.7	0.9	1.6	0.5	0.6	0.6	1.0	0.5	0.4	0.4	1.8	1.1	1.3	5.1	1.4	0.5	1.1	0.6	0.1	8.7	13.4	18.3	27.5	8.1	19.2	16.3	18.9	30.7	1.1	0.0	0.0	0.0	0.3	0.9	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	34.9	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	15.9	4.1	0.0	0.0	30.7	2.8	0.0	0.0	0.0	0.7	2.7	0.0	0.0	1.4	0.0	9.6	0.0	0.3	12.2	154.0	0.6	0.0	0.0	0.8	0.8
ELAVL4	"HUD, PNEM"	ENSG00000162374	"ELAV like RNA binding protein 4"	P26378	1	50048014-50203786	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.1"	"Group enriched"	"Detected in some"	11	"Early spermatids: 111.8;Intestinal endocrine cells: 31.6;Late spermatids: 117.9"	"Group enriched"	"Detected in some"	10	"glioma: 2.6;pancreatic cancer: 0.6;testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.4;non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.1"	"Cell line enriched"	"Detected in some"	19	"SH-SY5Y: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004442, HPA043047"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB004442: AB_627765, HPA043047: AB_2732502"	"unprognostic (1.25e-1)"	"unprognostic (6.63e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.83e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.43e-2)"	0.9	11.4	11.5	3.3	12.8	0.8	1.0	11.6	43.1	0.9	3.0	0.9	0.0	2.3	0.9	0.8	1.1	0.9	1.0	1.0	12.3	16.5	0.9	1.0	1.0	0.9	10.6	30.7	0.8	2.8	0.8	7.1	0.9	37.0	1.0	3.8	0.0	0.9	0.9	0.8	1.2	3.1	2.0	8.5	1.0	1.9	7.8	1.4	0.1	0.8	0.0	1.0	0.9	0.5	0.0	0.6	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.6	0.0	0.0	11.5	12.8	11.6	40.4	12.3	16.5	10.6	30.7	37.0	1.4	0.0	0.0	0.0	0.0	0.7	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	31.6	0.0	4.5	117.9	1.4	2.3	1.7	0.0	0.0	1.0	0.5	0.0	0.4	0.0	3.0	0.0	0.0	7.5	7.9	0.6	0.1	0.0	0.0	0.0
ELF4	"ELFR, MEF"	ENSG00000102034	"E74 like ETS transcription factor 4"	Q99607	X	130064874-130110716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058595, HPA060277"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA058595: AB_2683768, HPA060277: AB_2684239"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.43e-3)"	"unprognostic (7.86e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.42e-4)"	16.9	3.6	2.0	18.1	2.5	27.6	16.9	0.5	3.0	7.7	10.8	3.1	7.0	8.4	10.5	8.1	10.5	9.5	11.0	7.3	3.1	1.2	5.9	2.5	21.9	33.3	3.8	0.9	12.7	4.5	3.8	4.2	23.5	3.0	6.6	10.9	3.6	5.4	7.9	5.7	9.1	16.3	6.4	4.2	18.9	12.3	3.5	2.9	18.1	3.9	7.4	11.5	11.7	14.4	3.9	6.1	9.4	10.3	8.4	10.3	5.1	22.8	8.5	1.5	0.1	3.9	8.5	22.3	10.7	13.6	13.0	14.4	11.8	16.3	11.7	21.4	14.4	18.0	14.9	8.5	12.5	12.7	12.5	7.0	23.0	11.4	5.4	8.8	20.0	29.5	8.8	14.1	20.8	20.6	8.1	12.5	2.6	8.8	3.2	7.0	13.2	3.2	11.4	1.0	11.6	8.4	7.1	2.7	5.0	7.9	26.4	5.9	2.5	9.5	9.3	2.9	8.4	4.6	19.3	11.6	9.1	7.2	16.9	19.6	1.8	0.7	9.4	10.7	18.5	2.1	1.6	5.4	7.8	10.3	10.3	8.3	3.9	6.2	8.8	6.1	3.5	6.2	7.2	9.4	8.4	7.0	3.7	6.3	5.1	2.0	2.5	0.5	3.0	3.1	1.2	3.8	0.9	3.0	2.9	8.9	4.1	0.5	8.0	12.0	0.0	0.6	0.0	6.7	5.7	0.0	0.0	9.1	0.0	2.2	0.1	4.5	15.6	0.0	3.6	31.1	5.6	5.4	1.1	0.4	8.7	0.0	8.6	6.7	10.2	0.4	1.7	8.9	3.3	7.2	6.6	0.0	5.7	14.0	1.1	0.3	0.0	6.5	3.8	0.0	3.8	9.2	9.4	5.3	5.9	15.5
ELF5		ENSG00000135374	"E74 like ETS transcription factor 5"	Q9UKW6	11	34478793-34513805	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	11	"breast: 48.8;ductus deferens: 72.2;salivary gland: 85.1;seminal vesicle: 86.9"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 2: 29.3;Collecting duct cells: 96.0;Cytotrophoblasts: 17.5;Melanocytes: 16.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"RT4: 17.8;T-47d: 34.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062706			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062706: AB_2684841"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.41e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.93e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	48.8	0.0	0.0	0.5	0.0	0.0	72.2	0.6	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.0	6.5	0.0	2.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.8	0.0	1.4	0.0	0.0	85.1	86.9	0.0	3.5	0.0	1.0	0.0	0.3	0.1	0.1	0.0	0.2	0.0	3.5	1.0	5.8	1.2	0.5	0.5	2.0	1.8	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	17.8	0.0	0.0	0.0	3.1	0.0	0.1	34.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.0	0.3	0.2	0.5	1.8	0.3	0.2	0.3	0.4	0.3	0.5	0.4	0.4	0.9	0.7	1.8	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	29.3	0.0	2.5	0.2	0.0	0.3	0.0	5.3	9.1	96.0	0.0	17.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	1.9	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	9.6	0.0	0.0	5.8
ELFN1	PPP1R28	ENSG00000225968	"Extracellular leucine rich repeat and fibronectin type III domain containing 1"	P0C7U0	7	1688119-1747954	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 13.3"	"Cell type enhanced"	"Detected in some"	10	"Cone photoreceptor cells: 5.9;Hepatocytes: 7.8;Ito cells: 9.8;Rod photoreceptor cells: 6.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 19.5;U-138 MG: 12.3;U-2 OS: 18.0;U-2197: 20.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066382			Approved	"Nucleoplasm,Cell Junctions"		NA	NA		11000	"Nucleoplasm, Cell Junctions"		"HPA066382: AB_2732744"	"unprognostic (8.45e-2)"	"unprognostic (3.39e-3)"	"unprognostic (6.54e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.68e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.63e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-1)"	1.8	0.8	2.2	0.6	1.4	0.0	0.6	0.0	4.2	3.2	0.3			0.2	2.2	0.3	0.3	0.8	0.8	3.3	1.8	2.2	2.8	13.3	0.3	0.1	2.7		0.0	0.2	0.2	0.2	0.7		0.6	0.0		0.5	0.2	1.2	0.6	0.3	0.5	1.7	1.7	0.2	0.7			0.2		0.0	0.5	0.9	0.5	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	3.0	6.3	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.1	0.3	0.0	3.0	1.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	2.9	1.2	0.0	0.7	19.5	0.0	1.9	0.0	0.0	2.8	1.3	0.1	0.1	0.0	0.3	0.0	0.2	0.0	12.3	18.0	20.9	0.0	0.0	0.2	5.3	0.0	0.0	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.0											0.0	1.1	0.0	0.4	0.1	1.0	1.6	0.0	0.0	0.0	0.0	5.9	0.0	3.3	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.8	0.1	0.0	0.0	9.8	0.6	0.0	0.9	0.0	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.7	0.0	0.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0
ELFN2	"dJ63G5.3, KIAA1904, LRRC62, PPP1R29"	ENSG00000166897	"Extracellular leucine rich repeat and fibronectin type III domain containing 2"	Q5R3F8	22	37367960-37427470	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 30.0"	"Cell type enriched"	"Detected in some"	11	"Bipolar cells: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.7;CAPAN-2: 8.4;GAMG: 9.4;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000781	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA000781: AB_1079280"	"unprognostic (2.74e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.28e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-1)"	1.0	2.1	26.8	0.9	10.9	0.9	0.9	0.7	30.0	0.9	0.9	1.9	0.0	0.9	0.9	0.9	0.9	1.0	1.9	0.8	16.2	8.7	1.2	0.8	2.0	1.0	6.7	15.0	0.8	1.1	0.8	0.1	0.8	5.8	2.2	0.9	0.9	0.9	0.9	0.9	1.5	0.9	0.8	3.8	0.9	1.1	4.2	3.9	0.1	0.8	0.0	0.9	0.9	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.7	3.7	0.0	0.0	0.0	0.7	0.0	4.0	2.1	0.9	0.0	1.4	8.4	0.2	5.2	2.8	9.4	6.1	0.4	0.8	0.1	0.2	0.0	0.0	3.9	0.0	0.2	0.0	0.1	0.7	0.1	0.3	1.2	3.5	0.3	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.2	5.2	8.0	0.1	0.0	8.4	16.4	0.0	0.7	0.0	3.6	4.6	0.0	0.0	0.0	0.1	0.4	0.0	18.7	0.1	2.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	10.9	0.7	16.8	16.2	8.7	6.7	15.0	5.8	3.9	0.0	3.2	0.0	0.0	0.1	43.2	0.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.3	1.6	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ELK3, ETS transcription factor"	P41970	12	96194382-96269835	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 91.0;Endothelial cells: 133.8;Ito cells: 151.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	36.9	9.3	5.0	20.9	6.7	8.3	23.5	12.9	4.5	29.2	12.6	7.3	12.0	4.6	45.2	15.6	25.7	15.0	16.3	15.5	4.8	5.1	13.3	8.2	17.1	20.6	6.1	2.8	13.3	5.8	6.6	6.0	15.9	8.9	18.1	7.5	15.7	14.1	8.6	10.5	8.7	11.1	20.8	13.1	32.7	9.1	8.6	6.3	17.4	19.7	25.1	32.1	15.9	20.9	11.3	9.4	4.1	12.8	10.5	24.1	6.3	12.9	7.8	8.0	4.2	20.4	38.4	2.0	16.5	31.7	13.2	10.2	0.4	9.7	2.1	5.7	18.5	9.9	4.6	0.9	26.5	23.3	5.6	3.0	0.6	3.3	2.9	6.2	6.3	1.5	22.5	5.0	27.2	20.6	26.9	31.5	1.6	1.5	8.7	44.5	2.0	1.2	4.2	9.8	1.8	10.4	10.3	13.5	2.3	11.3	3.4	0.4	8.5	5.4	2.4	8.2	12.7	1.3	3.4	19.3	36.3	14.2	22.3	14.3	16.7	13.9	0.5	12.8	7.4	25.1	3.3	12.8	0.3	6.2	6.9	24.1	11.3	14.7	8.4	9.4	9.9	8.9	6.5	4.1	10.5	5.9	3.8	23.4	6.3	5.0	6.7	12.9	4.5	4.8	5.1	6.1	2.8	8.9	6.3	6.0	30.6	17.6	31.5	29.0	0.5	4.8	5.1	91.0	54.6	5.2	3.9	0.9	5.0	18.1	0.6	133.8	0.7	0.0	13.5	3.1	34.2	29.1	16.2	3.6	20.8	0.0	1.2	151.0	36.0	1.3	10.6	22.2	11.8	3.6	3.0	4.7	36.9	2.9	9.9	0.0	0.4	12.9	24.3	0.0	14.7	23.6	0.9	15.9	2.9	67.8
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772600-43777543	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.3;lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 5.3;Early spermatids: 1.5;Enterocytes: 1.7;Late spermatids: 1.8;Mucus-secreting cells: 2.0;Undifferentiated cells: 2.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.3;naive B-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.9;U-698: 19.2"	"Region enriched"	"Detected in single"	11	"olfactory region: 2.4"	"Not detected"	"Not detected"			"HPA028938, HPA073494"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		NA	NA			"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA028938: AB_10795352, HPA073494: "	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.7	1.1	1.0	24.2	0.6	0.4	2.5	4.7	0.6	2.3	10.6	0.5	1.6	4.8	1.0	1.0	5.5	1.3	0.9	0.6	1.0	0.6	1.8	0.5	0.9	7.5	1.3	0.0	1.3	0.7	0.6	1.2	0.8	2.6	2.1	1.8	0.8	2.0	0.7	1.0	7.0	13.3	0.9	0.6	1.5	1.1	12.3	0.5	0.8	1.1	2.8	16.7	1.3	1.7	8.5	1.0	0.1	0.1	0.1	1.2	0.6	0.6	0.1	0.6	0.2	1.6	0.1	0.1	0.2	0.5	0.8	1.3	0.1	0.5	7.9	0.1	0.7	0.1	2.9	0.3	0.0	0.5	0.7	3.4	0.3	2.6	0.8	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.3	0.2	0.3	0.0	0.1	1.2	0.3	0.9	0.0	1.1	0.8	0.8	0.1	0.1	0.2	0.0	3.6	0.2	0.3	1.5	0.3	0.1	3.6	0.2	0.1	0.2	0.0	0.3	0.2	0.0	0.0	19.2	0.2	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.2	5.3	0.5	0.2	0.0	8.5	1.2	0.3	0.1	0.1	0.0	1.0	0.3	0.6	1.0	0.6	4.7	0.6	1.0	0.6	1.3	0.0	2.6	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.7	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.0	2.0	0.1
ELMO3	"CED-12, CED12, ELMO-3, FLJ13824"	ENSG00000102890	"Engulfment and cell motility 3"	Q96BJ8	16	67199111-67204029	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 67.1;Paneth cells: 44.1;Undifferentiated cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 6.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;CAPAN-2: 24.9;HaCaT: 23.6;T-47d: 23.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA021484	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA021484: AB_1848129"	"unprognostic (4.49e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.14e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (6.95e-3)"	"prognostic favorable (2.77e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-2)"	1.1	0.8	0.6	7.8	1.8	2.5	4.6	6.7	1.4	2.8	30.3	0.5	32.0	18.9	2.6	9.8	13.1	4.8	16.0	0.9	0.7	0.8	13.3	3.9	6.9	1.4	0.5	0.5	1.2	26.6	6.5	28.7	13.7	1.0	13.2	5.1	0.9	25.1	28.8	0.5	19.1	37.7	1.7	0.5	2.8	12.8	8.7	0.6	1.1	18.2	9.7	9.2	6.8	6.0	1.2	0.8	2.1	0.4	0.4	1.0	0.1	10.8	1.2	1.2	1.5	0.2	0.3	17.0	0.6	0.3	0.8	0.7	7.1	24.9	1.5	0.8	0.3	0.3	23.6	1.1	10.9	0.2	0.7	1.4	1.5	2.0	2.3	0.5	0.9	3.9	0.2	8.0	0.6	0.6	0.8	0.8	1.3	1.5	0.8	0.4	9.0	0.9	4.5	1.6	10.2	1.0	2.2	1.2	2.4	1.0	1.5	8.3	1.9	1.6	7.4	0.7	0.7	23.3	1.7	1.4	1.9	2.3	1.2	1.1	2.5	0.8	2.8	1.0	2.1	0.9	0.0	0.4	1.0	1.0	0.0	0.1	1.2	0.8	0.1	0.5	1.1	0.6	0.2	2.1	0.4	0.1	0.8	0.5	0.1	0.6	1.8	6.7	1.4	0.7	0.8	0.5	0.5	1.0	0.6	0.0	12.5	2.4	11.4	7.8	0.8	1.1	12.7	1.4	2.3	19.2	0.0	26.3	14.9	16.5	19.0	1.4	67.1	0.0	20.8	12.4	1.0	6.3	4.6	3.9	3.1	0.0	12.6	1.3	1.3	26.2	0.9	1.4	3.3	2.8	31.8	0.4	23.9	44.1	0.7	23.7	1.3	0.0	0.4	7.9	2.5	11.8	14.1	0.0	45.7	8.1
ELMOD1	DKFZp547C176	ENSG00000110675	"ELMO domain containing 1"	Q8N336	11	107591091-107666779	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 51.1;pituitary gland: 20.8;skin 1: 34.7"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 30.4;Cone photoreceptor cells: 15.7;Horizontal cells: 35.0;Late spermatids: 14.0;Rod photoreceptor cells: 17.8"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 11.9;RH-30: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038435, HPA066479"			Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038435: AB_10795575, HPA066479: "	"unprognostic (2.74e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.13e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	1.5	4.2	10.7	1.5	41.1	1.3	4.1	12.8	51.1	1.5	1.4	1.7	0.0	1.4	1.6	1.3	1.2	3.6	1.2	4.8	13.8	14.3	4.7	1.3	1.6	1.3	8.7	15.2	1.2	1.2	1.2	20.8	1.2	14.8	2.1	1.3	1.4	1.3	1.2	2.8	34.7	1.3	1.4	6.6	1.2	1.2	2.9	3.9	0.0	1.3	0.0	1.2	1.1	0.1	0.9	0.7	2.4	0.9	1.8	0.5	0.2	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.2	3.5	0.4	2.2	0.3	0.4	0.0	1.8	0.1	0.0	0.1	1.2	0.1	0.0	0.4	0.1	0.0	0.0	0.1	11.9	1.5	0.0	0.1	0.8	0.1	0.0	0.1	0.5	0.0	1.8	0.0	27.1	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.3	0.0	0.7	0.1	0.0	0.0	3.6	0.0	2.1	1.6	0.9	0.6	0.4	0.6	0.4	0.5	0.5	0.2	0.2	0.9	0.4	0.5	2.4	1.8	0.6	0.7	0.4	0.2	10.7	41.1	12.8	26.9	13.8	14.3	8.7	15.2	14.8	3.9	0.0	3.8	0.0	0.4	0.0	30.4	3.6	0.0	8.1	2.3	0.0	15.7	0.1	0.0	0.0	8.5	0.7	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.8	0.1	35.0	0.0	0.6	0.3	14.0	0.3	1.4	0.0	0.0	0.0	6.5	0.0	0.0	0.4	3.6	17.8	0.0	0.5	0.9	0.4	2.8	0.0	0.0	0.0	0.3
ELMOD2	MGC10084	ENSG00000179387	"ELMO domain containing 2"	Q8IZ81	4	140524158-140553770	"Predicted intracellular proteins"	"Antiviral defense"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047600	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"	Nucleoplasm	"HPA047600: AB_2680098"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.17e-8)"	"unprognostic (3.17e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (1.82e-2)"	11.6	20.8	9.2	11.9	14.0	8.5	16.7	14.0	10.6	13.8	17.9	10.4	24.7	14.4	15.4	15.8	13.9	13.9	10.9	18.0	10.4	11.2	20.6	19.3	14.5	13.9	13.6	9.2	13.0	17.2	20.2	24.1	17.3	13.6	15.5	15.2	12.1	13.5	21.2	8.4	10.5	31.0	12.4	14.4	11.6	12.1	9.1	12.3	18.2	19.6	10.5	11.2	12.1	11.6	6.0	10.6	17.0	7.8	7.8	8.6	4.8	6.6	7.4	15.2	11.6	15.9	18.4	9.8	15.8	15.0	8.8	10.6	7.3	14.2	10.9	7.0	9.8	10.7	6.1	14.4	10.0	10.9	10.5	8.5	8.9	5.8	9.4	14.5	13.6	8.0	12.6	16.7	7.4	7.7	13.9	9.6	13.3	11.4	18.0	15.0	4.8	14.8	4.7	8.0	9.7	6.1	17.4	11.7	7.0	12.7	10.6	7.2	26.8	10.3	10.6	11.3	17.8	10.4	5.7	9.6	20.3	7.3	9.4	16.2	18.9	26.8	13.8	14.8	10.8	15.2	2.6	7.2	8.7	7.5	7.8	8.6	3.8	6.9	8.3	6.1	6.0	7.1	7.0	17.0	7.8	5.9	10.6	8.0	4.8	9.2	14.0	14.0	10.6	10.4	11.2	13.6	9.2	13.6	12.3	26.8	15.3	5.2	9.6	8.1	19.0	12.3	5.1	25.4	5.7	17.4	17.7	19.0	1.7	20.2	2.0	11.7	15.3	0.0	22.7	7.3	13.3	8.8	19.6	24.6	17.2	14.3	8.7	11.1	17.4	1.0	12.0	13.4	16.9	11.8	12.5	18.5	21.7	12.2	10.3	15.1	22.8	6.5	6.1	25.6	19.4	10.2	16.8	10.7	10.8	4.8
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 53.4;Ito cells: 49.1;Leydig cells: 102.4;Peritubular cells: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.9;BJ: 23.4;fHDF/TERT166: 33.6;U-2197: 133.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2900000	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280"	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.62e-3)"	35.0	8.8	4.3	14.9	3.6	0.0	24.8	27.8	5.8	23.3	12.1	12.9	9.1	3.2	22.3	26.0	30.1	17.1	30.8	41.5	5.4	3.0	8.3	3.7	49.7	7.5	4.4	9.2	10.6	35.3	0.7	6.1	22.5	13.7	25.1	4.6	34.3	16.8	14.5	6.0	23.6	9.2	34.7	9.9	10.7	16.0	8.1	6.4	0.9	11.9	10.3	4.4	34.0	21.7	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.3	0.1	0.0	16.9	0.1	0.1	23.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.1	0.1	0.0	9.0	0.1	0.0	0.0	4.6	11.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	133.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.3	3.6	27.8	5.8	5.4	3.0	4.4	9.2	13.7	6.4	0.0	8.3	0.0	13.2	9.7	0.9	8.9	2.5	4.0	5.7	7.0	2.0	0.1	0.0	0.2	2.5	26.4	0.0	0.0	3.5	0.2	53.4	1.2	0.0	2.1	0.4	6.4	1.7	49.1	0.3	4.2	102.4	1.0	13.5	0.0	1.3	17.8	1.5	0.0	139.3	0.0	0.7	0.0	31.5	0.9	1.1	9.5	0.1	0.0	0.0	0.8
ELOA2	"HsT832, TCEB3B, TCEB3L"	ENSG00000206181	"Elongin A2"	Q8IYF1	18	47032572-47035621	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	30	"testis: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.8;WM-115: 1.2"									"HPA041009, HPA043501, HPA048971, HPA049178, HPA050086, HPA053158"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041009: AB_10959881, HPA043501: AB_10960403, HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "	"unprognostic (2.38e-1)"	"unprognostic (4.47e-1)"		"unprognostic (2.54e-4)"	"unprognostic (2.39e-1)"			"unprognostic (8.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.64e-1)"			"unprognostic (5.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.97e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELOA3	"ELOA3A, HsT829, TCEB3C, TCEB3L2"	ENSG00000183791	"Elongin A3"	Q8NG57	18	47028202-47030078	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.7"									"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.1	0.1	0.3	0.1	0.8	0.1	0.1	0.6	0.3	0.4	0.1			0.1	0.6	0.1	0.1	0.6	0.1	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.2		0.1	0.1	0.1	0.1	0.1		0.2	0.1		0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.6	0.9			0.6		0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELOA3B	"HsT828, TCEB3CL"	ENSG00000278674	"Elongin A3 family member B"	Q3SY89	18	47022287-47023927	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"									"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0		0.0		0.6	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3	0.4	0.0	0.0		0.0	0.0	0.2			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELOA3D	TCEB3CL2	ENSG00000274744	"Elongin A3 family member D"	A6NLF2	18	46962768-46964408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;U-2 OS: 1.6"									"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.0		0.0	0.1	0.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELOC	"SIII, TCEB1"	ENSG00000154582	"Elongin C"	Q15369	8	73939169-73972287	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 271.8;Hofbauer cells: 287.3;Pancreatic endocrine cells: 255.4;Proximal tubular cells: 236.7;Syncytiotrophoblasts: 278.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078113			Approved	"Nucleoli,Vesicles,Cell Junctions"		NA	NA		250000	Vesicles	"Nucleoli, Cell Junctions"	"HPA078113: AB_2686877"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.02e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.99e-3)"	"unprognostic (4.02e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.95e-2)"	27.0	29.5	39.1	19.2	37.6	35.4	24.2	25.6	43.3	17.5	19.6	12.2	21.0	13.4	18.2	31.7	24.5	17.2	17.9	50.1	33.9	29.5	28.2	36.1	21.2	35.2	32.5	28.4	17.9	25.5	17.6	20.0	25.7	27.3	19.2	20.6	12.1	16.3	21.0	62.5	16.6	14.5	24.4	33.9	18.7	18.5	51.0	18.8	19.7	19.6	31.9	27.9	19.3	16.7	38.9	55.3	51.7	35.4	32.5	44.9	26.4	43.9	36.0	33.0	23.9	25.3	33.1	23.7	43.7	35.7	42.9	44.1	32.0	38.4	22.4	35.4	38.7	58.0	31.5	36.4	43.6	56.8	25.8	30.2	39.0	38.5	50.6	33.0	25.0	29.3	33.4	35.0	38.8	50.2	31.9	39.8	38.8	34.4	30.1	56.3	32.5	64.3	44.9	30.0	72.1	58.4	23.5	20.8	21.3	46.8	38.6	31.2	29.6	18.3	99.9	40.8	35.8	36.8	27.0	30.4	31.2	35.3	34.1	43.7	34.2	41.8	41.3	37.5	27.4	37.8	51.7	32.2	38.2	31.2	35.4	34.0	38.9	37.5	34.8	34.2	34.0	34.3	34.4	37.7	32.5	33.8	55.3	44.9	26.4	39.1	37.6	25.6	43.3	33.9	29.5	32.5	28.4	27.3	18.8	62.5	90.6	0.0	0.0	0.0	0.0	0.0	0.0	116.4	91.0	113.4	0.0	190.4	225.5	210.9	0.0	0.0	0.0	0.0	197.5	271.8	0.0	0.0	64.0	0.0	287.3	0.0	0.0	0.0	0.0	0.0	0.0	68.7	0.0	196.6	0.0	0.0	255.4	0.0	0.0	236.7	0.0	0.0	0.0	0.0	0.0	0.0	278.0	0.0	0.0	0.0
ELOF1	"ELF1, MGC4549"	ENSG00000130165	"Elongation factor 1 homolog"	P60002	19	11551147-11559236	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 392.9;Late spermatids: 1089.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045606	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA045606: AB_10965133"	"unprognostic (4.32e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (4.38e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.12e-2)"	19.0	23.4	25.5	20.4	23.9	33.0	20.9	32.8	29.0	24.5	19.8	19.8	19.5	19.2	27.4	28.6	21.2	29.2	20.6	21.2	25.1	27.6	24.8	45.2	18.9	24.9	25.0	22.4	28.1	39.3	19.7	29.6	19.4	21.2	25.4	15.9	21.0	34.2	30.6	24.9	22.7	20.8	22.1	20.5	22.5	23.2	69.0	20.8	33.1	29.3	24.3	23.2	22.5	22.6	63.1	60.4	44.2	43.2	32.4	47.1	41.4	39.7	27.8	19.2	26.3	24.0	24.4	9.9	25.7	21.8	35.4	35.9	27.6	11.0	25.6	25.4	23.2	23.2	18.8	23.3	35.8	24.8	20.2	23.8	32.0	18.2	26.0	27.1	20.7	22.1	23.6	26.6	31.2	22.8	25.5	17.2	24.6	44.4	33.6	21.1	51.4	30.7	24.3	49.8	20.3	51.4	22.9	16.4	26.9	29.1	18.6	24.2	30.7	20.7	25.0	24.1	18.4	21.0	16.7	11.9	36.7	13.9	38.4	38.6	39.1	52.4	21.7	34.2	29.3	18.4	25.0	42.4	44.2	34.3	40.1	31.7	63.1	36.0	31.8	36.8	46.9	32.6	29.1	28.8	32.4	43.2	60.4	47.1	41.4	25.5	23.9	32.8	29.0	25.1	27.6	25.0	22.4	21.2	20.8	14.9	19.2	58.8	46.7	75.4	23.1	27.8	48.4	37.5	17.0	31.4	7.9	72.7	89.5	71.8	392.9	30.6	56.1	70.0	89.2	67.4	55.4	39.7	21.9	32.1	67.5	14.3	57.8	36.8	48.9	1089.7	68.4	55.3	65.8	68.5	40.1	38.1	80.9	45.2	67.1	73.2	12.4	25.8	57.7	100.8	69.2	71.0	60.8	54.3	43.4	34.6
ELOVL3	CIG-30	ENSG00000119915	"ELOVL fatty acid elongase 3"	Q9HB03	10	102226328-102229589	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 24.6"	"Cell type enhanced"	"Detected in some"	11	"Ito cells: 1.3;Kupffer cells: 2.4;Smooth muscle cells: 2.0;Spermatogonia: 2.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	11	"classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.6;monocytes: 9.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.3;ASC TERT1: 8.3;HSkMC: 12.2;NB-4: 9.4;SiHa: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036236	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA036236: AB_10601550"	"unprognostic (1.52e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (6.25e-5)"	"unprognostic (8.23e-3)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-4)"	"unprognostic (4.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.66e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.79e-1)"	6.3	1.1	1.2	2.1	2.4	3.6	7.3	0.4	0.9	0.2	0.2	0.0	0.0	0.0	0.9	0.3	0.3	0.3	2.5	2.5	0.6	0.2	0.5	0.2	1.8	0.1	0.7	0.0	0.2	0.2	0.0	1.8	2.4	1.1	0.3	0.2	1.6	3.4	1.7	1.7	24.6	0.3	0.0	0.2	0.8	0.2	6.8	0.0	0.0	0.2	2.8	0.0	0.6	2.6	0.0	2.6	0.5	9.4	0.0	0.0	1.9	2.6	0.2	0.1	6.6	8.3	8.3	2.4	0.1	0.2	0.3	0.4	0.4	2.5	0.0	0.3	0.0	0.0	0.0	5.0	0.1	0.4	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.1	12.2	1.4	3.0	0.0	0.0	0.0	0.8	0.1	3.0	0.7	0.0	0.0	9.4	0.1	0.9	0.9	0.0	4.3	0.0	1.7	0.0	0.0	0.3	18.9	0.8	0.6	0.5	6.9	2.2	0.0	1.3	0.0	0.3	0.2	0.4	5.8	0.0	3.0	5.4	0.0	0.0	9.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.0	6.6	0.0	0.0	1.9	1.2	2.4	0.4	0.9	0.6	0.2	0.7	0.0	1.1	0.0	0.0	0.6	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.0	0.0	1.3	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.7	0.1	0.2	0.0	0.0	0.0
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513761	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: AB_2685282"	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	10.8	25.9	15.6	16.3	18.5	8.8	15.3	23.2	24.6	12.8	13.3	22.7	19.0	13.3	17.5	22.1	14.2	16.0	13.3	17.0	16.3	15.7	16.4	18.7	11.6	17.5	16.7	21.8	20.8	18.8	16.6	18.8	12.9	19.9	18.1	13.0	18.5	14.8	17.5	23.6	14.7	11.7	16.4	18.6	14.9	13.9	24.9	13.6	23.7	17.8	13.7	17.8	15.5	11.9	20.4	19.5	10.4	12.0	18.4	21.3	14.2	16.9	16.0	21.5	21.7	17.3	16.0	12.2	20.5	14.2	26.2	23.8	15.6	18.0	32.0	12.8	17.7	24.8	10.5	20.8	29.9	16.1	17.8	16.1	28.9	24.8	17.4	19.0	21.8	18.0	17.2	16.2	29.9	19.1	15.3	22.6	27.6	30.2	10.0	26.1	18.7	26.0	24.8	25.7	16.4	27.5	13.1	10.4	19.5	18.4	15.0	19.2	18.7	17.5	14.1	10.6	18.2	19.2	17.6	14.7	26.9	19.2	13.9	25.6	21.1	27.7	29.3	13.9	26.7	27.4	10.4	12.0	8.4	19.5	11.0	15.1	18.7	18.3	19.5	15.0	20.4	17.3	17.4	1.7	18.4	7.6	19.5	21.3	14.2	15.6	18.5	23.2	24.6	16.3	15.7	16.7	21.8	19.9	13.6	6.0	10.5	27.4	16.0	7.4	23.6	21.6	25.5	14.7	13.6	31.4	13.7	38.8	51.4	24.8	6.1	18.9	16.3	0.0	20.7	32.8	14.8	8.1	21.9	25.2	24.9	36.5	16.7	25.8	14.9	10.7	21.3	12.1	15.1	23.4	12.0	39.0	16.7	14.7	28.7	36.1	25.6	6.5	19.3	55.3	23.8	7.3	22.4	26.2	20.4	7.3
EMC3	TMEM111	ENSG00000125037	"ER membrane protein complex subunit 3"	Q9P0I2	3	9962537-10011116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 287.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042372	Approved		Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA042372: AB_10795609"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.81e-6)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.58e-2)"	41.8	31.5	19.8	17.2	27.1	35.4	24.7	17.2	28.0	17.6	25.0	18.6	23.5	23.2	19.4	19.6	31.3	18.8	17.7	28.3	18.6	21.5	33.0	47.2	22.3	12.7	23.6	20.6	16.3	27.2	25.5	15.9	19.6	27.9	20.8	23.2	16.3	26.0	21.9	54.7	25.4	24.8	20.2	21.9	17.1	23.1	52.6	19.2	15.0	37.7	22.4	20.3	27.3	25.4	25.0	35.1	41.6	46.1	28.1	40.2	51.4	13.5	28.8	10.8	6.5	69.2	27.2	36.4	27.9	24.2	17.5	19.0	19.7	21.7	10.8	20.4	31.6	33.7	19.1	18.4	16.5	18.1	29.3	18.5	17.7	21.9	12.8	29.9	19.9	20.0	31.9	29.8	30.5	17.6	22.4	21.7	11.9	22.5	31.7	25.8	33.4	10.5	9.9	12.0	28.9	19.7	13.7	15.2	32.1	21.2	24.6	7.7	15.5	19.9	29.9	17.9	11.9	25.3	16.3	24.8	17.5	14.7	18.9	28.3	17.1	44.3	21.9	37.0	14.7	21.9	38.4	46.1	41.3	27.4	36.2	28.3	24.9	27.2	31.2	35.1	25.0	19.9	26.8	41.6	28.1	34.7	31.5	40.2	51.4	19.8	27.1	17.2	27.9	18.6	21.5	23.6	20.6	27.9	19.2	50.6	63.5	44.0	48.5	45.0	39.0	97.2	56.0	62.9	61.4	43.6	37.3	43.1	39.7	83.4	287.9	55.4	60.4	256.9	103.9	42.9	46.8	56.5	32.4	82.2	88.7	22.3	20.3	42.4	51.0	67.2	46.6	55.9	55.6	120.8	32.8	60.4	90.0	70.2	35.3	57.8	53.0	58.2	48.9	135.1	54.3	53.1	71.7	50.4	50.0	70.1
EMC6	"MGC2963, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668815-3669668	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA062681: AB_2684831"	"unprognostic (2.21e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	14.6	18.5	15.5	12.2	15.5	21.4	12.5	9.9	21.2	8.9	15.9	14.9	10.0	16.9	9.8	10.8	15.6	9.5	12.1	26.2	14.5	12.3	19.8	42.1	10.2	10.7	14.2	11.0	8.7	24.5	7.6	9.3	16.6	12.2	12.9	9.7	14.6	17.8	10.5	100.1	10.6	16.8	10.1	13.6	12.5	18.8	27.4	11.1	14.3	14.9	31.5	14.3	9.7	9.1	34.5	56.1	40.7	42.0	25.2	43.4	38.5	31.2	30.8	13.5	14.1	9.7	7.8	26.0	22.5	11.0	18.5	17.1	18.6	11.8	19.7	32.8	10.5	16.3	30.2	15.6	15.8	13.4	19.0	58.3	14.3	21.6	25.8	14.1	9.9	14.7	9.8	18.0	17.0	11.9	14.6	14.0	23.7	17.9	14.3	13.5	19.0	20.2	29.2	19.4	19.1	34.8	18.9	12.6	18.6	25.9	8.9	11.1	20.2	18.4	14.5	23.9	14.1	16.9	10.7	15.3	15.5	19.2	23.3	32.8	14.0	15.4	12.9	24.3	13.0	18.6	34.5	42.0	40.7	34.9	39.7	32.0	34.5	39.0	38.3	35.8	32.3	40.6	36.7	31.6	25.2	27.9	56.1	43.4	38.5	15.5	15.5	9.9	21.2	14.5	12.3	14.2	11.0	12.2	11.1	14.9	23.4	62.6	99.3	79.0	40.5	0.3	94.3	53.5	23.9	55.8	33.4	102.2	140.9	117.4	202.1	52.2	55.0	23.3	123.7	126.4	43.1	113.2	54.3	108.8	90.3	31.8	49.3	39.3	53.3	121.5	35.6	54.6	64.1	101.0	61.0	85.4	129.4	63.1	32.2	149.9	38.8	38.8	51.5	146.4	87.0	89.1	107.9	52.2	68.0	156.9
EMC7	"C11orf3, C15orf24"	ENSG00000134153	"ER membrane protein complex subunit 7"	Q9NPA0	15	34084017-34101948	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010029, HPA047572"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA010029: AB_1078335, HPA047572: AB_2680090"	"unprognostic (2.16e-1)"	"unprognostic (8.16e-3)"	"unprognostic (5.28e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (9.25e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.47e-3)"	31.2	45.1	36.8	22.4	41.6	31.8	29.7	22.5	36.8	25.1	30.1	30.9	38.2	25.1	27.1	53.1	25.0	23.0	24.5	36.5	34.0	45.3	52.5	62.3	26.5	24.4	44.0	38.7	24.1	46.7	35.5	33.5	57.6	35.2	31.8	32.3	29.8	29.6	46.0	44.8	28.2	28.1	29.0	42.2	28.5	28.5	39.3	30.8	18.8	35.3	26.7	21.8	26.3	26.2	37.8	68.8	66.6	54.7	32.6	53.7	49.1	14.3	39.6	14.4	18.3	56.4	32.3	15.1	41.2	43.0	38.6	40.1	36.0	17.3	8.5	42.8	40.2	40.1	28.0	20.9	20.7	28.9	20.9	20.7	21.1	59.2	30.7	51.6	21.1	30.1	35.7	39.5	27.6	40.1	26.3	24.2	16.4	20.5	57.0	37.2	16.6	11.7	24.1	12.8	33.8	26.3	14.8	16.7	29.4	40.6	25.5	23.6	17.5	24.5	33.2	20.4	17.9	24.0	34.2	20.3	41.4	16.0	27.3	30.7	38.6	46.6	19.0	41.8	32.4	33.5	66.6	47.3	49.0	42.7	51.0	41.6	37.8	42.9	43.4	43.1	28.9	31.6	39.0	41.3	32.6	54.7	68.8	53.7	49.1	36.8	41.6	22.5	36.8	34.0	45.3	44.0	38.7	35.2	30.8	26.8	26.0	38.7	50.2	77.2	49.7	83.2	45.9	48.2	40.9	97.7	43.2	105.5	33.2	106.2	83.3	62.5	52.0	0.0	149.7	127.4	78.3	46.4	44.9	78.4	102.1	28.6	43.8	56.4	57.1	65.1	83.4	60.8	97.8	64.1	51.6	111.7	112.9	52.6	97.9	61.9	46.3	116.4	76.2	178.6	21.7	75.5	133.9	64.0	55.9	50.3
EMC9	"C14orf122, CGI-112, FAM158A"	ENSG00000100908	"ER membrane protein complex subunit 9"	Q9Y3B6	14	24138959-24141588	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054715, HPA078254"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA054715: AB_2682582, HPA078254: "	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.99e-1)"	5.0	15.4	10.6	5.2	11.7	10.0	8.5	18.4	16.0	6.1	11.4	5.7	13.1	17.8	5.9	9.8	7.9	6.7	7.3	9.6	9.9	11.1	9.9	17.1	5.1	7.4	8.6	9.7	6.8	15.1	8.8	17.0	6.1	12.8	9.8	6.9	16.8	15.5	12.7	35.6	9.0	11.4	6.3	5.2	8.4	6.5	10.3	4.2	11.8	10.1	12.9	9.3	7.5	5.5	5.3	12.3	4.0	5.2	3.8	8.9	4.3	7.6	18.1	5.1	14.2	2.7	1.4	4.7	4.9	4.0	7.1	7.2	7.8	5.9	6.4	4.3	3.9	5.5	7.0	4.2	7.7	4.2	5.0	10.1	1.5	7.0	34.4	3.4	5.5	3.3	2.0	3.2	3.8	6.8	5.8	8.0	9.2	1.4	8.4	5.6	18.0	5.5	4.8	5.9	7.8	13.4	3.5	12.7	6.6	5.5	9.2	9.0	7.2	9.1	16.4	4.2	2.6	9.1	2.9	4.0	3.1	8.8	4.6	8.0	10.7	9.3	7.2	4.8	2.4	4.9	1.0	5.2	4.0	5.0	2.6	5.5	5.3	6.8	6.5	5.3	4.9	3.4	4.5	0.5	3.8	2.5	12.3	8.9	4.3	10.6	11.7	18.4	16.0	9.9	11.1	8.6	9.7	12.8	4.2	0.0	6.5	18.6	8.4	16.1	47.5	16.3	22.9	10.7	10.3	22.7	17.7	24.4	48.0	15.0	62.5	9.3	25.7	23.3	10.3	21.5	21.2	14.4	4.7	22.2	25.9	11.1	20.2	6.7	12.7	115.8	10.6	13.2	15.1	19.0	14.6	13.8	10.4	10.5	20.5	44.8	44.0	12.9	21.2	9.7	5.5	20.8	20.5	17.0	26.2	7.2
EME1	"FLJ31364, MMS4L, SLX2A"	ENSG00000154920	"Essential meiotic structure-specific endonuclease 1"	Q96AY2	17	50373220-50381483	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 15.3;epididymis: 10.6;testis: 21.9"	"Cell type enhanced"	"Detected in some"	13	"Extravillous trophoblasts: 4.0;Spermatocytes: 10.5;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	29	"basophil: 15.3"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 15.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016127, HPA052188"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"CAB016127: AB_2278026, HPA052188: "	"unprognostic (3.81e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.94e-5)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.83e-3)"	"unprognostic (0.00e+0)"	"unprognostic (9.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-1)"	1.0	0.9	1.6	2.5	2.0	6.0	0.8	0.8	1.8	1.3	1.9	3.0	0.0	1.1	0.9	10.6	2.6	0.7	1.6	0.7	0.9	0.6	0.7	0.8	1.1	3.3	1.4	0.9	1.3	0.6	0.2	0.5	2.4	1.5	0.7	2.0	1.0	1.6	0.1	1.4	1.5	2.1	0.8	1.9	2.2	1.1	21.9	2.8	5.7	0.5	0.9	3.9	1.0	1.2	0.1	0.5	15.3	0.0	0.0	0.1	0.2	7.4	11.0	14.7	7.7	0.7	1.5	10.6	7.8	3.0	10.9	10.1	17.3	6.1	6.0	10.4	3.1	6.8	5.9	13.6	6.2	15.6	11.7	10.7	14.3	12.7	8.0	0.0	5.8	4.7	0.3	0.4	12.6	5.2	1.4	2.5	17.3	8.6	14.4	6.4	8.2	13.3	7.5	8.5	7.7	7.6	13.8	28.5	8.3	2.4	3.0	5.7	11.4	4.8	2.6	4.5	12.3	9.4	6.7	1.7	14.2	8.5	9.3	10.7	9.0	9.1	5.8	4.5	6.6	8.7	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.6	2.0	0.8	1.8	0.9	0.6	1.4	0.9	1.5	2.8	0.0	1.4	0.0	0.2	0.1	1.5	0.4	0.0	1.4	1.2	0.0	0.0	1.9	0.0	0.2	0.4	0.0	0.0	0.0	0.0	4.0	0.5	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.6	0.7	0.0	1.8	0.4	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.4	10.5	8.0	0.1	0.9	0.0	0.6	0.1
EMG1		ENSG00000126749	"EMG1, N1-specific pseudouridine methyltransferase"	Q92979	12	6970893-6979941	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA039304, HPA039666"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA039304: AB_2676432, HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	8.1	10.1	4.9	12.4	6.6	7.3	8.8	3.6	6.3	5.8	7.5	4.8	11.5	7.5	6.9	9.9	8.1	5.8	7.4	11.6	5.0		7.2	8.3	6.4	8.8	6.4	4.2	8.9	9.4	2.7	5.6	12.6	6.2	7.2	6.8	5.1	8.6	11.4	14.9	5.6	6.7	6.3	5.5	7.7	6.0	4.8	6.1	9.0	8.7	9.5	10.8	7.5	8.7	33.3	20.5	7.7	29.6	20.8	30.1	28.5	17.1	17.1	6.6	8.1	5.2	3.8	27.5	12.8	5.7	10.2	7.0	33.6	18.4	17.3	4.8	7.9	18.6	12.6	6.0	14.6	11.5	12.5	9.8	24.0	16.9	30.9	6.7	24.3	15.6	6.1	8.8	14.8	16.9	5.3	4.4	12.3	11.8	3.9	9.5	20.3	12.6	15.0	54.8	14.2	9.0	17.5	13.4	13.8	6.4	21.8	3.9	11.6	13.5	14.2	12.3	19.7	3.9	18.1	9.2	10.6	13.9	8.7	29.0	4.7	5.3	30.1	11.4	10.6	16.9	4.4	16.6	7.7	24.0	23.8	24.8	30.7	25.5	26.3	18.8	33.3	30.1	27.7	2.3	20.8	29.6	20.5	24.1	28.5											14.9	42.4	35.6	63.8	32.4	13.1	0.0	20.4	42.8	40.9	40.1	7.9	97.4	41.4	64.5	5.3	31.5	18.7	23.3	58.0	98.9	31.9	43.5	60.0	31.0	57.4	15.9	9.2	21.5	24.6	11.1	35.1	40.5	27.0	54.1	22.4	15.6	60.5	17.5	24.4	66.2	13.8	38.8	20.2	28.2	53.8	34.9	62.1	32.8	31.6	55.2
EMILIN3	"C20orf130, dJ620E11.4, EMILIN5"	ENSG00000183798	"Elastin microfibril interfacer 3"	Q9NT22	20	41359966-41366827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 49.9"	"Cell type enhanced"	"Detected in some"	25	"Leydig cells: 1.7;Peritubular cells: 4.6"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;HAP1: 12.1;NTERA-2: 7.7;SCLC-21H: 14.4"	"Region enriched"	"Detected in single"	29	"cerebellum: 3.7"	"Low region specificity"	"Detected in single"			"HPA044034, HPA059912, HPA078559"	Enhanced		Approved	"Golgi apparatus,Microtubules,Cytokinetic bridge"	"Secreted to extracellular matrix"	NA	NA		650000	"Golgi apparatus"	"Microtubules, Cytokinetic bridge"	"HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: "	"unprognostic (1.66e-4)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.13e-7)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.62e-2)"	0.9	1.9	2.9	1.6	2.0	0.5	3.5	0.7	8.2	7.1	4.1	1.9	8.5	1.1	2.7	49.9	1.1	3.2	0.9	6.0	3.0	2.9	0.8	0.6	0.7	0.6	3.8	0.7	9.2	0.6	0.5	1.6	0.6	2.7	8.1	0.8	5.8	1.5	10.0	1.3	3.4	1.4	1.6	2.2	0.6	1.9	4.3	2.3	0.3	0.7	2.9	0.8	2.4	5.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	12.1	0.0	0.3	0.0	1.4	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.4	1.4	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.9	2.0	0.7	8.2	3.0	2.9	3.8	0.7	2.7	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0
EML2	"ELP70, EMAP-2, EMAP2"	ENSG00000125746	"Echinoderm microtubule associated protein like 2"	O95834	19	45606994-45645629	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012757	Approved		Approved	Vesicles		NA	NA		140000	Vesicles		"HPA012757: AB_1848145"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.05e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.48e-2)"	"unprognostic (7.03e-2)"	7.7	23.0	13.0	9.4	25.3	9.5	10.0	11.3	20.7	12.6	15.5	32.8	13.5	8.6	5.9	6.4	26.8	9.3	9.9	14.7	15.8	18.9	11.0	5.4	9.6	9.3	32.4	12.0	3.6	15.6	47.9	9.7	16.9	26.6	11.2	11.1	12.4	21.2	17.5	4.1	22.0	7.9	8.9	24.1	8.6	13.5	2.9	25.5	9.9	15.7	6.2	10.6	15.6	14.3	7.8	8.8	10.6	7.0	3.7	9.7	4.9	17.6	6.0	1.2	0.4	9.8	5.4	6.7	11.1	14.4	5.0	5.7	2.3	14.8	4.5	6.6	5.9	1.5	14.9	2.2	22.1	1.7	20.0	5.5	2.3	6.6	4.1	18.6	6.7	4.9	8.3	29.1	5.8	28.5	4.0	3.6	10.5	6.8	13.3	3.8	17.5	3.7	1.3	0.7	28.2	5.4	0.7	2.1	6.6	12.9	21.7	6.5	1.2	6.1	12.1	8.2	6.7	7.1	7.3	5.7	0.0	2.1	1.8	0.1	25.1	15.4	2.8	7.9	7.5	14.5	10.6	4.9	7.1	9.6	6.2	7.0	7.8	6.5	9.7	5.9	3.4	4.2	5.7	1.3	3.7	7.0	8.8	7.7	4.9	13.0	25.3	11.3	20.7	15.8	18.9	32.4	12.0	26.6	25.5	3.0	12.5	10.2	36.5	16.6	27.3	8.1	17.8	13.4	9.1	33.2	13.7	59.6	31.5	13.9	55.8	11.6	22.7	0.0	18.1	16.7	6.9	20.3	19.5	5.9	14.0	27.0	16.8	14.1	6.7	19.4	3.7	7.6	18.6	18.0	32.1	12.5	16.5	26.0	6.7	5.9	151.2	0.0	13.3	2.6	5.9	12.5	84.4	24.5	25.5	40.6
EML4	"C2orf2, ELP120, ROPP120"	ENSG00000143924	"Echinoderm microtubule associated protein like 4"	Q9HC35	2	42169350-42332548	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 60.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036687, HPA036688, HPA065337"	Enhanced		Supported	"Intermediate filaments,Microtubules,Cytosol"		NA	NA		41000	Microtubules	"Intermediate filaments, Cytosol"	"HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	11.3	17.3	5.8	29.3	6.8	19.2	10.5	4.6	5.2	9.4	21.6	6.7	6.8	20.3	13.6	11.6	10.7	8.7	20.3	6.5	5.1	3.9	11.7	26.4	19.3	27.7	4.6	4.0	12.5	37.8	10.8	11.6	26.9	6.5	8.5	12.8	12.1	17.7	8.9	4.3	17.9	33.5	9.2	5.0	30.9	11.7	14.2	5.3	17.4	13.2	6.9	30.0	14.0	9.0	11.5	4.2	10.0	11.0	9.4	17.5	5.9	14.6	25.5	14.9	11.8	5.4	8.9	16.3	9.1	7.2	10.1	9.8	26.6	18.5	13.4	6.3	8.9	15.6	7.6	12.7	8.8	17.7	26.2	10.7	12.3	7.9	60.9	6.9	9.3	12.7	9.7	3.3	13.4	9.1	4.9	7.0	4.6	12.1	13.6	10.9	8.6	8.7	2.5	15.2	18.9	7.4	9.0	23.6	7.9	8.3	21.3	14.7	29.6	9.0	9.4	6.9	14.1	4.9	3.7	8.2	10.4	13.9	8.3	8.2	15.3	10.6	11.6	9.0	8.9	7.2	4.4	3.9	7.7	7.8	10.9	16.3	11.5	13.0	12.7	3.3	7.9	11.4	8.3	10.0	9.4	11.0	4.2	17.5	5.9	5.8	6.8	4.6	5.2	5.1	3.9	4.6	4.0	6.5	5.3	56.6	103.1	87.1	59.5	59.8	36.4	5.7	40.8	32.1	69.4	38.4	45.2	112.3	14.9	30.5	25.2	34.6	46.7	0.0	65.3	37.0	71.8	58.2	46.2	54.6	62.4	15.9	98.2	48.5	34.8	23.1	22.2	58.2	15.1	24.4	56.5	34.1	37.0	58.3	21.5	31.5	48.1	6.5	46.2	40.3	39.2	69.6	99.4	95.6	60.7	86.1
EML6	FLJ42562	ENSG00000214595	"Echinoderm microtubule associated protein like 6"	Q6ZMW3	2	54723499-54972025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2;lymphoid tissue: 11.9"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 25.5;Cone photoreceptor cells: 53.0;Horizontal cells: 36.5;Rod photoreceptor cells: 32.8"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.5"	"Lineage enriched"	"Detected in single"	26	"B-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.3;SCLC-21H: 20.5;U-698: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062808, HPA068759"	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			Mitochondria	Vesicles	"HPA062808: AB_2684872, HPA068759: AB_2686027"	"unprognostic (1.06e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (9.96e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.26e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.85e-6)"	"unprognostic (5.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.13e-3)"	0.1	3.3	1.8	4.0	2.8	0.0	0.2	7.2	4.2	0.0	0.6			0.6	0.0	1.3	0.3	0.4	0.1	0.0	1.9	2.1	1.3	0.2	0.1	7.9	1.5		0.0	0.5	3.0	3.4	1.4		0.4	0.8		0.1	0.4	0.6	0.8	1.8	0.3	0.5	2.7	0.4	1.5			3.1		11.9	0.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.1	0.7	0.2	1.5	0.1	0.2	0.2	0.2	0.6	0.2	7.3	0.1	0.4	0.3	0.2	1.0	0.3	0.3	0.7	0.3	0.4	0.6	2.8	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.1	4.0	0.0	1.2	0.0	0.7	1.4	0.2	0.3	0.1	1.2	0.6	0.5	0.6	0.0	0.7	20.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.6	0.4	0.4	5.0	1.3	23.3	1.3	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.4	5.2	1.6	3.3	25.5	1.4	0.0	5.3	5.7	3.5	53.0	0.4	0.0	0.1	12.7	1.7	0.4	0.0	0.4	0.4	0.7	1.5	0.0	0.8	1.0	36.5	2.4	1.8	1.3	9.6	0.6	1.0	0.0	0.0	1.7	19.3	0.1	0.0	0.7	0.5	32.8	0.0	2.1	3.9	1.9	3.9	0.1	0.0	0.2	2.3
EMP1	"CL-20, TMP"	ENSG00000134531	"Epithelial membrane protein 1"	P54849	12	13196716-13219939	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 240.9;lymphoid tissue: 129.3"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 616.6;Fibroblasts: 489.5;Melanocytes: 448.7;Suprabasal keratinocytes: 601.1;Urothelial cells: 926.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 28.6"	"Cell type enriched"	"Detected in some"	7	"myeloid DC: 7.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 132.0;fHDF/TERT166: 91.8;HaCaT: 82.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051931, HPA056250"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051931: , HPA056250: "	"unprognostic (1.40e-2)"	"unprognostic (7.30e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (2.98e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (9.69e-8)"	63.3	5.0	2.7	8.0	10.4	2.1	20.8	0.8	3.9	51.3	11.6	5.5	4.0	4.6	14.0	10.4	240.9	9.9	25.2	16.1	7.3	2.8	8.9	4.4	18.1	5.9	5.3	0.9	5.7	10.2	2.9	2.8	10.6	28.6	6.3	6.9	17.8	45.4	2.8	12.0	16.8	10.7	17.6	9.7	8.5	6.0	5.2	3.0	0.6	22.5	99.1	129.3	14.1	80.6	0.0	7.0	0.0	0.5	0.1	0.1	0.0	38.9	2.0	1.0	0.2	63.1	132.0	0.1	28.8	52.9	14.9	19.0	0.2	66.0	0.2	20.6	91.8	6.5	82.1	1.1	3.8	20.2	0.7	0.0	0.1	6.9	0.0	15.2	0.2	0.2	41.4	5.6	47.3	13.9	11.8	34.0	0.0	0.2	0.6	35.0	0.1	0.0	0.8	0.7	7.3	6.7	0.1	4.0	0.3	43.5	0.4	0.0	0.0	12.9	1.9	21.5	7.7	0.3	0.2	37.2	33.5	11.8	31.4	15.5	0.1	0.4	0.2	48.8	0.2	39.3	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	2.7	10.4	0.8	3.9	7.3	2.8	5.3	0.9	28.6	3.0	190.6	90.0	2.7	198.6	616.6	0.0	9.5	2.5	87.0	247.9	17.4	0.0	0.8	13.3	17.9	0.7	293.7	59.6	0.0	3.9	1.5	489.5	352.1	46.5	2.0	41.5	0.0	45.6	127.7	32.1	0.5	64.5	93.9	448.7	7.2	4.0	2.5	37.6	27.1	102.9	0.2	0.0	6.5	173.1	0.7	0.5	601.1	0.9	5.1	5.6	926.6
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580698	"Disease related genes, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 118.7"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 3868.0;Suprabasal keratinocytes: 1026.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 59.5;RT4: 40.9;SK-BR-3: 58.8;T-47d: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	16.5	2.0	5.0	7.9	5.1	0.0	26.2	3.4	4.7	14.8	10.4	3.4	6.1	4.2	7.3	13.8	35.7	7.4	7.3	14.0	5.5	3.0	3.1	47.5	118.7	5.7	5.4	2.5	14.0	3.2	19.9	3.2	23.5	5.3	11.1	10.0	10.8	9.9	5.8	7.7	40.2	6.6	12.8	3.4	5.3	9.3	5.6	4.1	2.2	7.5	26.4	18.4	10.6	16.3	1.3	1.1	4.1	1.1	1.4	1.0	0.4	6.3	8.8	3.6	4.3	8.2	7.1	7.2	9.1	8.4	5.5	8.3	28.8	22.3	0.0	2.9	10.9	4.0	28.3	9.3	11.2	7.3	0.0	5.9	0.0	18.5	15.7	1.4	0.0	0.1	4.3	3.0	7.3	0.7	1.2	2.3	0.0	2.1	0.6	15.2	59.5	0.1	0.1	4.2	10.3	2.1	1.6	4.2	13.8	1.2	40.9	5.1	5.8	11.2	58.8	3.3	11.0	35.9	1.4	1.2	17.6	7.6	5.9	5.0	0.1	0.2	0.0	7.7	0.1	17.2	3.4	1.0	1.0	0.8	0.8	1.0	1.0	0.8	0.7	0.5	1.3	0.9	0.9	4.1	1.4	1.1	1.1	0.8	0.4	5.0	5.1	3.4	4.7	5.5	3.0	5.4	2.5	5.3	4.1	3868.0	343.3	4.5	123.1	317.0	1.8	48.0	109.5	153.9	326.4	40.1	0.0	59.0	0.0	2.5	4.2	191.2	51.9	0.0	60.2	16.3	121.0	91.1	34.8	181.1	8.8	0.0	100.6	112.3	14.0	5.0	176.6	42.0	82.7	58.7	141.3	5.2	27.3	172.1	259.6	0.0	1.1	51.8	141.5	2.3	13.2	1026.6	40.2	4.3	139.9	220.6
EMP3	YMP	ENSG00000142227	"Epithelial membrane protein 3"	P54852	19	48321509-48330553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 165.9"	"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 530.6;Hofbauer cells: 548.3;Kupffer cells: 540.8;Macrophages: 782.1;Melanocytes: 1059.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 195.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 116.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062030			Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA062030: "	"unprognostic (5.06e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.31e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.31e-7)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-3)"	27.6	23.4	10.4	26.5	12.6	66.2	28.7	7.2	8.4	50.6	40.3	9.2	14.6	8.4	45.9	22.6	26.9	26.1	21.1	37.9	10.8	6.9	15.6	7.0	36.1	48.0	15.2	6.7	41.4	6.4	2.2	6.1	29.9	12.7	30.7	15.4	24.7	11.3	23.1	13.2	16.3	20.8	46.7	19.1	27.8	19.2	18.2	8.2	16.2	11.6	13.4	25.6	36.8	30.6	44.9	54.8	165.9	91.0	59.7	119.1	124.8	5.6	63.2	3.5	10.1	56.2	87.8	0.1	39.0	71.1	51.7	45.8	6.1	20.4	0.7	8.8	86.6	26.7	1.0	3.7	4.2	31.8	18.6	1.6	27.0	16.6	3.7	47.2	13.3	28.3	47.6	0.8	53.0	36.6	38.4	22.1	6.1	17.8	46.4	79.0	0.9	2.0	116.0	4.7	1.2	16.0	1.6	12.2	27.4	44.3	0.0	0.1	0.2	17.7	0.1	10.1	6.8	0.2	20.4	36.4	46.8	20.3	36.9	30.6	24.5	30.4	1.7	27.7	17.6	31.7	165.9	77.2	105.6	109.2	91.0	90.4	44.9	114.8	106.6	54.8	35.4	65.7	78.2	85.7	59.7	86.6	40.8	119.1	124.8	10.4	12.6	7.2	8.4	10.8	6.9	15.2	6.7	12.7	8.2	0.0	5.0	254.5	67.7	246.9	2.2	3.9	15.3	5.3	11.4	31.4	0.0	10.5	5.0	62.4	5.0	137.6	1.3	0.0	9.8	19.7	530.6	38.3	254.8	4.7	548.3	0.0	5.8	114.8	540.8	9.1	310.7	782.1	1059.5	206.4	2.9	65.0	72.6	17.3	204.0	6.5	3.3	103.5	237.6	9.8	4.5	166.0	16.9	200.3	2.6	22.6
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8;kidney: 27.4"	"Group enriched"	"Detected in some"	8	"Collecting duct cells: 52.4;Proximal tubular cells: 31.6"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;CACO-2: 5.7;HEK 293: 12.8;HMC-1: 2.5;RPTEC TERT1: 2.2;U-2 OS: 2.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6"	"HPA006230, HPA006421"	Approved		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.3	5.2	0.2	3.1	0.1	0.1	0.1	14.8	0.1	0.5	0.0	0.8	1.4	0.1	6.0	0.2	0.1	0.1	0.2	5.0	0.4	27.4	0.2	0.1	0.2	0.4	1.5	0.2	0.4	4.8	0.2	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.2	0.2	1.1	0.1	0.1	0.1	0.3	2.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.8	0.0	0.0	1.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.1	0.1	14.8	5.0	0.4	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	52.4	0.0	0.0	5.0	0.0	0.8	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542444-117549546	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.8;epididymis: 53.9;seminal vesicle: 76.3"	"Cell type enhanced"	"Detected in many"	17	"Collecting duct cells: 226.8;Distal tubular cells: 76.3;Leydig cells: 55.8;Proximal tubular cells: 156.2"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 17.2;fHDF/TERT166: 19.0;RPTEC TERT1: 19.2;RT4: 6.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favorable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	4.6	0.5	11.5	0.6	10.3	0.5	1.4	0.5	12.5	23.5	0.7	7.3	46.8	0.5	40.5	53.9	0.7	25.4	1.2	0.6	14.7	2.1	25.5	0.5	0.5	0.7	1.8	10.4	5.7	0.5	0.6	1.1	0.6	2.5	1.9	0.5	3.4	1.3	76.3	5.1	4.7	0.5	22.6	0.6	0.5	0.5	3.6	6.2	0.0	0.5	1.2	0.7	4.2	2.4	0.7	0.5	2.4	0.9	1.0	0.7	0.1	0.0	0.0	0.0	1.9	0.0	0.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	17.2	19.0	0.0	0.1	0.4	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.1	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.1	19.2	6.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.6	0.5	0.6	0.7	0.4	0.4	0.4	0.4	0.7	0.6	0.5	1.1	1.0	0.9	0.5	0.6	0.1	11.5	10.3	0.5	12.5	14.7	2.1	1.8	10.4	2.5	6.2	0.0	0.0	0.0	1.9	9.5	0.0	1.1	0.0	0.0	0.0	226.8	0.0	0.0	76.3	0.0	1.2	0.8	0.0	0.0	0.0	0.3	13.4	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	55.8	1.8	20.3	0.0	0.0	0.0	0.0	0.0	38.5	156.2	0.0	51.8	12.2	0.1	0.2	6.6	0.1	0.0	0.0	1.1
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847678	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 11.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Group enriched"	"Detected in some"	10	"midbrain: 11.4;pons and medulla: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.4;ASC TERT1: 6.5;fHDF/TERT166: 11.3;HSkMC: 12.1;PC-3: 6.8;U-138 MG: 8.8;U-2197: 9.8"	"Region enriched"	"Detected in single"	5	"midbrain: 5.9"	"Region enriched"	"Detected in some"	5	"midbrain: 23.9"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	5.6	0.1	0.0	0.1	0.4	0.0	2.7	0.9	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	11.4	0.0	0.1	0.0	0.1	0.0	0.0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10.0	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.5	0.2	14.4	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	4.2	0.4	0.5	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.1	0.0	0.0	0.0	8.8	0.9	9.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	0.2	0.1	11.4	0.0	8.8	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	2.3	0.0	0.0	0.0	0.0
ENDOD1	KIAA0830	ENSG00000149218	"Endonuclease domain containing 1"	O94919	11	95089810-95132645	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008932, HPA010517"	Enhanced		Approved	"Nuclear membrane"	"Secreted - unknown location"	NA	NA		19000000	"Nuclear membrane"		"HPA008932: AB_2262252, HPA010517: AB_1852351"	"unprognostic (8.81e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.64e-7)"	"unprognostic (5.92e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (3.27e-4)"	14.9	13.8	20.3	7.9	27.9	4.1	15.0	14.3	31.0	17.6	25.4	52.6	9.7	8.4	13.7	12.2	19.0	13.1	12.2	14.4	24.0	22.3	18.9	4.9	10.6	7.3	33.5	20.1	12.0	4.7	48.8	11.8	12.1	40.6	36.5	29.4	15.5	12.5	22.9	34.4	20.6	14.5	16.2	40.4	22.9	8.3	9.3	25.5	0.5	12.6	12.3	6.7	9.0	16.5	7.3	2.9	1.3	5.4	3.1	5.9	6.1	1.1	1.7	2.2	1.3	62.5	20.0	9.2	8.3	1.8	2.2	2.3	8.6	15.1	8.0	10.3	6.6	5.0	11.1	2.1	11.4	0.8	6.3	1.6	17.3	0.8	3.6	6.8	3.1	22.4	18.1	14.9	1.3	4.2	15.3	7.7	7.7	3.5	5.2	8.3	2.9	1.3	0.1	0.5	12.4	5.6	5.8	0.0	3.3	6.6	9.3	1.1	0.9	3.5	3.5	6.2	3.1	3.6	0.9	5.5	12.2	3.6	8.1	3.5	4.3	3.2	0.6	3.7	1.7	27.2	1.3	1.3	0.9	5.9	3.2	5.5	7.2	3.9	5.0	2.9	7.3	3.2	3.8	0.6	3.1	5.4	1.3	2.2	6.1	20.3	27.9	14.3	31.0	24.0	22.3	33.5	20.1	40.6	25.5	8.9	14.2	11.5	14.8	7.1	2.1	4.4	17.8	1.4	11.4	10.4	0.0	4.6	1.7	4.5	2.5	22.4	35.5	23.3	7.7	6.5	8.6	20.7	13.9	2.9	2.9	0.0	15.5	38.1	4.3	2.6	9.5	5.5	27.0	1.0	22.5	1.9	6.1	40.2	14.2	9.3	0.6	38.8	19.1	0.3	3.6	10.9	10.4	5.1	18.4	8.6
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815012-127854756	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Endothelial cells: 336.5;Ito cells: 724.3;Leydig cells: 451.1;Peritubular cells: 1336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 36.6;HUVEC TERT2: 68.4;TIME: 139.4;U-138 MG: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"		NA	NA		260000000	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (6.61e-4)"	"prognostic favorable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	40.3	19.3	6.4	26.6	10.5	5.5	52.7	3.9	8.6	26.3	14.0	7.6	18.5	11.2	27.0	25.2	17.2	23.2	28.3	105.4	8.0	5.0	40.8	26.8	66.7	44.1	10.6	7.0	66.4	9.6	8.6	12.5	60.2	10.1	23.1	6.4	35.5	9.9	51.7	24.1	10.1	14.5	23.1	8.7	52.4	11.6	37.2	7.7	6.7	35.4	19.3	11.0	20.3	44.8	1.1	6.4	0.3	17.7	4.6	2.3	4.6	0.1	0.1	1.0	0.0	17.2	11.8	30.3	19.9	14.3	10.6	6.2	0.0	0.1	0.1	9.7	36.6	8.0	0.3	0.0	3.2	3.5	0.0	0.0	5.6	11.3	0.6	13.3	2.6	0.0	20.1	0.7	13.8	5.0	0.1	68.4	0.1	0.0	0.1	12.4	0.1	0.0	0.2	0.2	0.0	0.5	8.8	1.7	0.1	0.0	0.0	0.1	0.2	10.5	9.2	2.7	0.7	1.8	4.0	139.4	34.9	1.9	22.7	0.0	0.7	0.1	0.1	9.4	7.0	11.4	0.0	12.2	0.3	1.3	17.7	0.4	0.4	2.1	2.3	6.4	1.1	1.3	2.0	0.3	4.6	13.0	2.4	0.8	4.6	6.4	10.5	3.9	8.6	8.0	5.0	10.6	7.0	10.1	7.7	3.0	23.1	25.1	2.3	10.6	2.5	16.5	22.9	8.1	3.4	3.5	3.9	24.4	0.0	8.3	7.0	336.5	0.0	23.3	1.0	249.8	36.6	1.4	15.0	5.1	119.5	0.0	2.4	724.3	66.8	29.3	451.1	50.7	23.6	46.9	1.1	3.1	2.0	0.0	1336.5	0.0	4.1	71.1	20.8	3.7	4.9	7.3	314.8	5.7	0.2	1.1
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074939-79088599	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 51.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Enhanced		Approved	Centrosome,Cytosol		No	No			Cytosol	Centrosome	"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.73e-5)"	10.0	10.1	9.5	20.7	18.4	8.9	11.4	7.0	13.9	10.9	15.1	12.4	8.8	20.3	11.4	6.8	6.5	10.6	8.6	10.3	9.3	5.8	9.2	10.2	10.1	10.7	16.8	8.5	16.3	9.3	11.3	9.8	8.1	13.6	12.3	12.5	10.7	12.1	9.6	35.4	11.9	17.3	7.3	11.9	24.9	11.4	3.9	14.0	8.1	13.6	7.0	9.1	17.5	51.4	0.2	0.7	0.0	1.1	0.0	2.1	0.6	4.5	9.8	3.4	6.3	3.6	1.5	6.6	3.5	1.8	2.9	2.0	5.2	5.0	0.0	4.2	3.5	4.8	6.8	5.4	3.8	1.6	2.7	7.3	4.1	10.0	3.1	2.7	4.7	7.8	4.1	5.3	2.5	2.8	5.6	3.0	8.9	5.9	2.9	1.8	3.9	0.4	4.5	1.5	9.5	8.8	8.6	11.7	3.0	1.5	12.9	2.9	5.7	5.6	25.9	2.6	5.3	9.1	4.4	3.9	5.6	4.2	4.8	3.4	6.9	1.2	2.0	2.3	8.7	4.0	0.0	0.7	0.0	0.0	1.1	0.9	0.0	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.6	2.1	0.6	9.5	18.4	7.0	13.9	9.3	5.8	16.8	8.5	13.6	14.0	0.0	13.6	6.4	3.8	3.9	10.7	4.8	7.6	0.0	6.8	10.4	33.4	4.2	0.0	3.5	1.5	6.5	16.4	0.0	3.6	3.8	4.8	7.4	4.7	10.6	7.5	7.9	25.1	9.8	10.8	1.0	3.1	8.2	0.0	5.4	15.9	5.6	2.5	11.5	1.8	1.7	24.7	12.9	6.0	2.2	1.4	5.1	5.6	5.7	18.8	4.1
ENKD1	"C16orf48, DKFZP434A1319"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"		Yes	No			"Plasma membrane"	"Centrosome, Cytosol"	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favorable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	8.5	7.7	4.9	5.9	7.0	3.8	6.6	5.0	6.9	10.4	11.7	6.1	18.6	4.7	11.2	14.2	8.2	14.5	11.0	6.1	5.4	5.2	10.9	4.7	8.9	2.9	4.5	4.4	10.9	38.8	23.7	12.0	4.8	8.3	12.7	3.6	7.9	11.7	12.6	6.0	7.2	5.1	12.9	4.3	6.1	7.3	19.6	6.4	7.1	20.4	5.2	4.9	12.9	6.4	0.6	4.2	3.0	1.3	0.7	1.5	0.5	6.9	4.8	11.4	5.3	3.8	3.9	5.6	5.5	3.4	4.4	5.4	3.5	10.7	2.6	9.4	3.4	0.0	8.2	2.9	6.6	5.5	4.0	6.6	2.6	14.5	8.2	6.1	4.6	3.6	3.4	4.7	6.0	5.5	10.3	3.5	8.7	4.3	1.7	2.2	3.5	5.0	19.3	5.4	7.3	1.9	17.9	1.2	19.3	4.6	0.7	11.5	12.5	11.7	1.1	6.0	2.7	10.3	6.6	9.3	5.4	7.6	10.1	0.1	12.6	5.6	2.8	8.1	6.9	1.6	0.0	1.3	0.0	0.3	0.5	1.5	0.6	1.2	0.7	0.5	0.0	0.8	1.1	3.0	0.7	0.7	4.2	0.0	0.5	4.9	7.0	5.0	6.9	5.4	5.2	4.5	4.4	8.3	6.4	20.8	15.6	0.8	6.2	6.2	3.6	5.0	17.8	36.1	2.3	8.7	3.9	2.8	1.7	11.9	28.8	9.0	2.0	0.0	9.2	2.1	7.0	5.2	1.1	14.7	4.2	3.2	12.7	11.1	3.8	14.5	12.0	2.9	5.0	2.8	5.9	9.5	8.2	0.0	13.4	5.9	10.8	6.5	6.6	20.2	7.3	4.5	2.9	1.9	4.4	2.4
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase family member 4"	A6NNW6	10	116849512-116911788	"Enzymes, Predicted intracellular proteins"	Glycolysis	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1;epididymis: 12.6;fallopian tube: 13.6"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 36.1;Cone photoreceptor cells: 21.6;Early spermatids: 11.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;MCF7: 8.3;T-47d: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA037937: AB_10697089, HPA037938: AB_2675746"	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.7	2.1	4.3	0.6	4.3	0.2	2.2	2.6	3.6	1.7	1.0	8.0	0.9	0.3	4.3	12.6	1.4	13.6	1.3	0.5	6.4	4.7	2.3	2.7	3.9	1.2	4.1	4.8	4.2	3.2	3.7	3.4	0.5	12.1	2.1	0.8	3.0	1.6	1.2	0.2	1.1	0.5	0.9	4.4	0.5	0.8	8.8	1.9	0.2	4.2	0.0	0.6	1.8	0.5	1.8	1.0	0.0	0.6	0.0	1.2	0.1	1.5	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.3	1.1	0.0	0.9	2.1	0.2	2.7	0.0	0.7	0.8	0.0	1.5	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.9	0.1	1.1	0.1	0.0	0.7	8.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	1.2	0.6	0.9	0.0	2.2	0.1	0.0	1.8	5.2	0.0	0.5	0.0	0.8	0.4	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	1.6	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.0	0.2	1.0	1.2	0.1	4.3	4.3	2.6	3.6	6.4	4.7	4.1	4.8	12.1	1.9	0.0	0.0	0.0	0.2	0.1	4.4	0.2	0.0	36.1	0.0	0.0	21.6	0.2	0.0	0.3	11.9	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	4.8	1.7	0.0	0.0	8.8	1.1	0.1	0.0	1.0	0.0	1.3	0.2	0.0	0.7	0.6	9.0	0.0	0.2	7.6	2.7	0.0	0.1	0.0	0.1	0.0
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430562-82461091	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		140000	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	10.2	15.4	43.4	12.1	37.1	14.3	16.3	22.9	38.8	13.8	12.7	34.7	5.1	12.2	10.5	23.3	13.5	10.4	9.0	11.1	44.2	34.9	20.8	13.3	11.1	16.0	47.5	26.4	12.9	14.6	17.8	11.7	17.7	31.0	17.2	15.3	8.9	11.4	11.9	9.8	13.1	11.0	11.1	66.2	12.8	13.2	6.1	29.4	14.2	18.0	8.2	18.6	10.7	9.5	13.0	14.1	4.3	10.4	14.4	20.2	12.2	18.5	12.3	22.1	13.7	13.5	13.3	24.2	21.6	14.5	19.8	17.7	22.4	20.8	37.0	22.7	16.4	21.7	10.0	29.2	27.4	35.9	22.2	13.6	22.4	12.0	29.8	21.9	37.0	19.4	12.8	29.1	20.7	24.6	14.3	20.0	23.5	28.9	20.4	25.8	23.9	40.8	22.0	20.3	47.0	10.0	29.1	33.9	20.1	32.3	18.4	31.3	19.1	12.3	37.3	27.5	20.7	16.8	17.9	14.7	24.6	18.3	24.3	28.5	23.5	20.1	46.1	15.9	23.1	33.0	3.4	8.7	4.3	14.4	10.4	18.0	13.0	17.3	16.5	12.7	11.0	20.2	16.2	0.7	14.4	8.8	14.1	18.4	12.2	43.4	37.1	22.9	38.4	44.2	34.9	47.5	26.4	31.0	29.4	14.9	8.0	28.1	32.4	60.9	36.5	11.3	12.7	12.0	15.9	12.2	15.7	71.0	74.6	41.8	4.1	24.5	12.6	0.0	22.6	47.0	29.3	32.2	38.0	10.2	49.6	27.0	28.2	13.5	22.1	4.1	24.5	27.7	37.1	45.1	21.1	46.8	34.7	8.6	22.6	42.5	27.7	12.9	30.9	6.8	22.6	56.0	39.0	34.8	25.8	31.0
ENOX2	"APK1, COVA1, tNOX"	ENSG00000165675	"Ecto-NOX disulfide-thiol exchanger 2"	Q16206	X	130623369-130903317	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Growth regulation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000514, HPA003027"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"HPA000514: AB_1078558, HPA003027: "	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.27e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (6.42e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.38e-1)"	13.1	14.6	13.5	14.8	17.6	4.7	11.4	7.6	11.0	13.2	11.6	13.9	10.7	8.0	15.6	12.9	13.3	13.2	11.2	18.9	14.6	13.1	10.4	23.6	8.8	16.0	14.7	8.8	14.6	7.4	12.5	12.3	11.7	12.2	12.9	9.3	8.5	10.3	15.1	11.2	8.6	11.1	14.5	13.4	17.7	9.2	9.7	17.7	17.4	11.0	11.7	15.9	14.2	9.7	12.8	11.9	15.0	16.7	11.3	13.3	9.7	12.3	9.1	14.0	5.8	12.0	11.4	5.6	10.5	12.1	7.1	4.4	4.3	10.7	8.7	25.4	8.8	9.5	8.7	9.1	9.7	8.8	11.5	10.0	20.2	6.2	5.7	9.3	14.7	14.3	9.0	16.6	7.7	9.6	3.0	10.6	7.8	12.4	7.1	5.5	17.2	9.2	3.2	7.3	17.3	12.7	6.6	8.7	9.6	8.2	8.7	4.2	8.5	9.1	6.0	14.7	5.2	3.9	8.1	8.6	6.8	4.1	10.9	21.3	7.4	3.6	5.7	19.9	15.4	11.5	8.0	12.0	15.0	10.4	16.7	11.1	12.8	12.2	10.8	11.9	11.6	13.3	11.7	2.1	11.3	7.8	5.7	13.2	9.7	13.5	17.6	7.6	11.0	14.6	13.1	14.7	8.8	12.2	17.7	3.0	6.1	1.5	5.8	3.8	4.3	10.1	5.1	20.1	10.3	3.5	0.0	4.9	6.6	7.0	0.8	7.1	4.0	0.0	8.2	4.4	5.6	5.8	5.8	10.6	6.0	3.2	4.6	6.2	17.7	0.9	5.2	14.4	8.5	19.0	4.2	4.9	8.9	3.5	6.0	6.7	6.4	6.5	8.4	6.5	10.6	4.3	6.1	8.2	5.0	4.7
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 103.7;placenta: 79.0"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 38.2;Fibroblasts: 51.0;Hofbauer cells: 50.0;Intestinal endocrine cells: 51.9;Melanocytes: 43.9;Proximal tubular cells: 45.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 26.8"	"Cell line enhanced"	"Detected in some"		"AF22: 25.2;ASC diff: 34.5;ASC TERT1: 73.7;BJ hTERT+: 42.4;fHDF/TERT166: 27.3;HSkMC: 33.8;U-2197: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Intracellular and membrane"	NA	NA		1100000000	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: AB_2682218"	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	29.9	15.4	24.0	18.2	42.0	0.7	26.2	4.4	33.3	19.6	8.1	103.7	1.7	20.8	44.8	6.4	2.9	18.7	12.7	3.6	39.8	21.5	24.9	8.9	13.5	31.0	71.5	20.9	5.3	5.2	0.9	4.1	79.0	59.7	8.5	10.6	67.6	3.4	9.2	3.0	5.4	12.1	28.9	102.4	17.3	8.3	9.7	63.9	3.6	3.7	0.8	26.1	13.4	5.7	0.2	3.8	26.8	0.1	0.2	1.8	0.3	0.0	0.0	25.2	0.0	34.5	73.7	0.0	23.2	42.4	10.0	9.6	0.0	0.0	0.0	0.3	27.3	0.0	0.0	0.5	0.0	7.1	1.8	0.7	0.0	0.0	0.6	15.4	0.0	0.1	33.8	0.2	20.4	1.0	0.1	0.1	0.0	0.0	4.1	0.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	20.3	0.4	24.4	0.1	0.2	0.0	0.0	17.1	0.1	0.5	26.8	0.1	5.2	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	1.8	0.6	0.3	0.2	0.0	3.8	0.0	0.3	24.0	42.0	4.4	33.3	39.8	21.5	71.5	20.9	59.7	63.9	11.9	5.1	3.2	0.5	9.4	1.1	1.2	38.2	6.7	1.2	1.8	0.0	3.4	1.7	0.0	34.3	16.3	0.9	0.0	0.0	1.5	51.0	0.1	5.8	0.4	50.0	0.0	51.9	19.0	12.5	3.6	2.8	8.9	43.9	0.0	0.6	3.3	1.2	0.3	3.2	45.6	1.2	0.0	5.1	1.1	0.4	4.5	5.4	0.5	0.6	0.9
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)"	Q9UJA9	6	46159187-46170971	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 116.5"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 68.3;Muller glia cells: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 13.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 13.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.7;HSkMC: 7.8;SuSa: 6.9;T-47d: 9.2;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		300000	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.5	4.8	6.5	1.3	10.3	0.8	7.1	9.2	16.1	6.9	2.0	3.3	28.7	1.5	1.6	116.5	1.6	7.9	3.9	3.9	6.6	9.4	12.1	1.0	4.7	1.2	14.2	10.5	5.4	6.2	21.8	23.3	1.5	14.4	14.6	2.3	11.8	6.9	27.5	6.9	1.3	1.6	5.1	5.5	3.2	3.5	16.2	3.5	1.0	24.3	0.9	1.4	5.7	1.7	0.4	0.0	1.0	0.1	2.2	13.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.6	0.1	0.3	11.7	1.9	3.9	0.2	4.0	0.0	0.6	1.6	0.1	0.0	2.6	0.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	1.9	0.0	0.5	2.5	5.5	0.0	0.0	0.3	0.2	4.9	0.6	5.1	0.2	0.0	4.9	0.0	6.9	9.2	0.0	0.0	0.0	1.3	0.0	0.1	5.8	7.9	0.0	3.1	0.0	0.1	0.0	0.0	0.0	13.4	0.1	7.2	0.4	2.7	8.6	0.0	0.4	0.8	8.2	1.0	2.2	0.0	0.0	0.0	2.6	6.5	10.3	9.2	16.1	6.6	9.4	14.2	10.5	14.4	3.5	11.9	9.8	0.0	4.7	0.8	11.0	8.1	7.6	68.3	9.1	22.7	3.9	4.2	1.7	6.9	0.8	0.1	1.4	0.0	6.5	2.4	3.3	16.0	4.6	0.0	0.3	9.5	7.9	0.6	0.0	1.5	2.6	0.7	0.0	1.0	3.4	94.1	2.7	2.9	11.3	16.2	2.9	6.5	0.7	0.2	2.3	0.5	0.2	3.8	2.5	2.6
ENPP6	MGC33971	ENSG00000164303	"Ectonucleotide pyrophosphatase/phosphodiesterase 6"	Q6UWR7	4	184088706-184221230	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;kidney: 30.8"	"Group enriched"	"Detected in some"	5	"Peritubular cells: 33.2;Proximal tubular cells: 21.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HDLM-2: 1.9;Karpas-707: 6.4;SH-SY5Y: 7.3;U-266/70: 6.0;U-266/84: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042740, HPA069197"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		68000	"Golgi apparatus"		"HPA042740: AB_10793984, HPA069197: "	"unprognostic (4.81e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.60e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.01e-1)"	0.5	0.6	2.0	1.1	8.0	1.1	1.0	1.7	6.7	0.5	1.3	35.2	0.4	2.0	0.5	6.9	1.3	0.5	0.8	0.5	5.4	3.5	30.8	0.4	0.6	1.1	26.1	3.3	13.7	0.3	0.3	4.1	0.4	19.5	2.7	1.3	7.7	0.9	6.9	0.4	0.5	2.5	0.4	28.2	1.2	1.5	2.7	14.0	0.0	0.5	0.0	3.1	0.9	0.7	0.9	0.8	2.2	0.9	1.5	0.6	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	0.7	0.3	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.2	7.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.1	0.0	0.1	6.0	3.2	0.1	0.1	0.1	0.0	2.2	0.9	0.6	0.5	0.5	0.6	0.7	0.4	0.3	0.1	0.9	0.4	0.5	1.7	1.5	0.3	0.8	0.5	0.1	2.0	8.0	1.7	6.7	5.4	3.5	26.1	3.3	19.5	14.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	3.3	0.9	0.8	0.2	0.0	0.0	0.2	0.0	0.2	0.1	5.7	0.0	0.2	0.0	0.0	0.0	0.6	0.0	3.7	0.0	1.7	1.8	0.0	0.0	0.0	0.0	33.2	21.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 625.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	13	"U-698: 429.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol		NA	NA		22000	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: AB_2681425"	"unprognostic (6.27e-2)"	"prognostic favorable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	30.3	26.4	48.9	26.9	48.9	46.8	33.0	33.8	69.3	31.7	31.8	28.0	26.8	34.4	29.7	45.4	66.3	26.3	28.5	30.0	42.4	37.9	31.7	32.3	28.6	30.0	42.0	39.0	27.7	30.5	33.0	25.2	37.5	34.6	23.9	30.4	28.5	29.4	22.8	67.7	49.8	34.0	27.3	38.3	23.8	28.7	12.8	27.3	25.8	35.2	42.9	35.5	31.7	36.3	34.4	39.5	49.5	33.6	33.0	33.2	38.4	14.7	7.7	10.8	10.4	6.9	5.7	11.7	6.6	6.7	9.9	8.4	8.7	11.1	13.2	11.0	5.3	6.2	11.9	8.7	14.7	7.3	22.8	12.1	18.9	10.9	6.6	4.6	15.2	24.4	4.5	9.1	10.3	13.2	5.5	9.3	10.5	14.4	27.8	6.6	31.8	15.0	12.4	21.6	17.4	9.6	14.6	9.0	16.4	13.0	13.0	16.2	10.2	9.4	19.8	10.3	9.5	27.1	22.4	9.8	7.4	13.7	8.8	17.1	15.6	22.7	429.6	10.2	17.7	9.7	28.7	30.7	49.5	32.2	33.6	28.9	34.4	27.0	33.2	39.5	31.8	22.3	32.9	29.0	33.0	31.9	30.2	29.8	38.4	48.9	48.9	33.8	69.3	42.4	37.9	42.0	39.0	34.6	27.3	38.7	144.0	138.7	185.4	169.1	60.1	89.1	79.0	109.7	114.9	78.5	43.2	247.9	215.5	139.6	6.0	100.3	151.4	46.7	132.7	150.0	85.0	114.8	218.3	71.0	175.6	63.5	125.5	52.8	77.7	11.1	79.7	128.3	97.8	625.8	119.8	57.9	90.7	136.8	97.9	148.1	46.3	71.1	92.7	22.2	27.4	250.8	320.0	133.9	128.5	226.6
ENTPD4	"KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase"	ENSG00000197217	"Ectonucleoside triphosphate diphosphohydrolase 4"	Q9Y227	8	23385783-23457695	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA017655	Supported		Approved	Vesicles		NA	NA		28000	Vesicles		"HPA017655: AB_1848181"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.72e-2)"	16.3	11.5	15.0	21.9	19.8	25.7	15.3	20.3	27.4	15.2	18.5	14.7	15.7	17.0	18.8	17.9	13.3	12.7	14.4	21.0	14.5	12.8	13.0	14.4	19.9	26.0	16.2	12.2	14.7	26.5	30.4	25.2	19.3	20.6	17.6	20.2	18.0	19.5	13.7	14.9	12.2	26.1	16.1	14.5	26.9	19.1	18.7	15.8	17.0	15.8	9.3	30.7	16.7	16.7	9.7	8.0	15.9	9.5	4.4	10.7	6.8	9.3	12.9	16.3	11.2	14.2	18.1	16.6	15.0	14.3	10.2	16.0	18.5	12.5	15.9	10.9	15.1	15.7	11.4	7.3	13.6	19.6	3.8	5.1	8.4	8.0	6.4	11.6	4.4	16.7	11.1	16.6	13.5	14.5	24.9	14.6	12.4	5.8	14.6	17.2	4.2	6.4	5.4	9.5	12.0	4.7	6.4	16.3	4.8	13.0	11.1	13.0	12.4	5.6	8.2	11.0	33.9	6.0	6.3	18.0	18.6	18.4	20.8	11.0	11.7	4.9	20.7	24.9	5.3	18.6	14.9	6.0	13.7	8.5	9.5	10.0	9.7	8.3	9.1	8.0	6.7	10.7	8.3	15.9	4.4	6.9	7.3	6.5	6.8	15.0	19.8	20.3	27.4	14.5	12.8	16.2	12.2	20.6	15.8	17.9	34.6	17.1	9.5	5.8	30.2	20.4	7.6	14.7	28.4	14.0	13.7	12.6	0.0	13.8	6.9	13.7	17.8	23.3	14.7	13.0	12.7	14.2	16.3	10.5	10.5	44.5	16.6	11.1	11.0	15.7	6.6	15.2	11.8	12.6	15.2	18.9	18.1	11.9	8.1	3.7	34.2	12.9	12.3	20.7	21.1	4.8	16.9	15.0	10.5	13.9
ENTPD7	"FLJ30978, LALP1"	ENSG00000198018	"Ectonucleoside triphosphate diphosphohydrolase 7"	Q9NQZ7	10	99659506-99706240	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 46.1"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 14.1;Urothelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014351	Uncertain		Approved	Nucleoplasm		NA	NA		24000	Nucleoplasm		"HPA014351: AB_1848183"	"unprognostic (1.82e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.01e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.39e-1)"	3.1	5.6	2.2	5.1	2.1	6.4	2.7	2.4	3.3	4.4	15.7	1.3	11.3	18.6	3.9	5.7	9.1	3.1	9.1	3.2	2.0	1.7	6.0	14.5	4.2	7.1	1.4	1.9	3.2	23.9	3.6	8.6	8.5	1.5	5.6	4.9	3.4	9.0	13.2	1.6	4.4	46.1	5.6	1.4	5.4	5.1	3.5	0.5	2.5	3.5	6.0	6.3	11.4	5.0	0.9	7.7	3.7	2.2	2.7	2.2	1.3	5.2	6.0	8.0	14.8	4.0	4.0	9.7	9.9	20.6	12.9	10.8	11.0	5.9	4.5	5.8	13.3	3.9	13.9	6.7	4.0	10.6	1.9	5.3	3.4	4.7	10.1	6.0	12.0	7.8	3.7	6.9	16.2	15.4	15.0	13.0	4.8	6.4	4.4	5.1	4.7	2.4	2.5	4.7	6.5	2.6	0.0	6.2	2.4	14.1	17.0	3.3	6.4	6.9	2.6	8.6	5.7	7.2	6.1	8.2	11.2	7.2	7.2	8.3	4.5	7.5	4.1	10.9	3.7	3.0	0.3	2.2	3.7	2.2	2.2	2.0	0.9	0.8	1.8	5.0	0.3	1.4	0.9	2.0	2.7	1.2	7.7	0.6	1.3	2.2	2.1	2.4	3.3	2.0	1.7	1.4	1.9	1.5	0.5	0.0	0.0	0.0	14.1	7.2	0.4	0.6	0.0	4.0	2.3	5.2	2.0	4.5	0.0	1.9	1.4	1.0	6.5	0.0	4.3	4.4	1.5	1.8	0.0	3.4	1.7	0.0	5.2	0.6	1.2	2.2	0.9	1.3	0.0	6.4	2.7	0.7	3.4	2.9	0.7	1.3	1.8	0.0	1.4	1.4	0.7	6.5	4.2	0.0	1.4	22.1
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 48.1"	"Group enriched"	"Detected in some"	6	"Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.4	0.0	0.4	2.6	0.4	0.0	0.4	0.4	0.4	0.4	19.2	0.4	0.4	18.5	0.4	0.4	0.4	0.3	2.2	0.4	0.5	0.0	2.1	9.8	0.8	0.4	0.4	0.4	0.4	1.8	0.0	4.2	0.5	0.4	0.4	7.5	0.8	4.1	0.4	0.4	0.0	48.1	0.4	0.4	0.4	6.1	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.0	9.1	0.0	0.6	0.0	0.7	0.1	0.0	0.0	0.0	1.5	0.2	0.0	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	1.6	0.0	0.2	0.1	3.0	0.4	0.0	0.0	8.8	1.4	0.0	0.3	0.9	0.2	0.0	0.1	0.7	4.8	0.2	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.5	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	12.7	0.0	0.0	19.2	0.0	0.0	0.0	0.8	0.0	0.0	107.0	0.0	6.8	0.1	0.0	1.0	0.0	8.2	0.1	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	160.6	0.0	0.5	49.1	0.0	4.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	12.7	0.6
ENY2	"DC6, FLJ20480, Sus1"	ENSG00000120533	"ENY2, transcription and export complex 2 subunit"	Q9NPA8	8	109334324-109345953	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024648	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA024648: AB_2100208"	"unprognostic (2.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.66e-1)"	31.9	35.0	28.7	28.1	34.3	44.4	34.8	20.6	31.4	28.2	34.5	18.7	28.3	31.8	24.6	33.8	30.1	22.9	19.1	34.0	31.8	26.2	44.1	58.8	24.7	26.6	27.6	28.3	19.6	27.8	16.5	35.8	30.6	29.1	24.0	33.7	19.9	27.2	25.9	66.7	20.3	31.6	28.4	31.9	30.6	29.0	21.3	24.3	26.1	24.3	29.5	30.3	29.6	23.3	14.0	32.1	30.3	38.9	13.0	14.6	22.6	42.3	35.5	52.8	23.7	20.1	25.8	15.2	33.9	21.9	34.8	44.0	26.2	26.4	27.6	31.9	26.3	15.8	21.7	23.6	24.0	42.5	43.7	27.9	53.0	26.7	53.9	21.5	18.2	33.0	19.5	16.4	22.9	21.7	25.5	52.3	27.3	50.4	15.6	39.5	69.1	55.0	41.4	38.3	49.6	34.6	35.1	23.0	34.2	47.0	32.6	31.9	34.4	21.2	26.7	28.9	30.4	33.9	31.6	35.5	23.4	39.5	24.2	34.3	26.7	28.5	52.2	23.6	30.8	27.2	16.3	35.6	30.3	10.7	37.1	13.2	14.0	14.6	13.0	32.1	9.6	12.1	13.3	19.4	13.0	38.9	26.5	14.2	22.6	28.7	34.3	20.6	31.4	31.8	26.2	27.6	28.3	29.1	24.3	65.5	81.6	148.3	163.4	164.9	66.1	154.2	137.6	89.7	112.6	137.9	115.8	224.8	323.3	190.8	103.7	229.2	183.6	46.7	173.6	235.2	173.8	163.6	89.0	317.8	241.4	42.9	147.9	137.5	200.9	78.7	137.2	217.4	150.1	225.4	166.7	92.6	220.3	192.9	105.7	416.4	119.0	77.6	185.8	187.5	108.4	152.6	139.9	126.9	175.3	175.2
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975214-69013961	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	14.9	5.8	3.4	10.1	4.4	3.0	11.9	2.5	4.8	16.8	12.1	4.4	10.2	4.8	23.3	10.4	15.1	11.4	18.1	18.2	3.9	3.6	6.6	5.5	15.8	9.6	4.2	5.0	12.7	7.8	3.9	5.5	15.2	5.1	18.9	5.8	8.7	14.0	24.0	28.0	6.1	7.7	29.4	4.9	10.2	10.1	7.4	2.4	8.3	5.4	14.2	7.3	27.0	9.8	1.7	3.4	5.5	2.2	3.3	9.2	1.8	8.2	2.8	5.4	6.6	7.7	15.2	4.0	11.2	13.7	7.1	9.4	3.7	4.7	0.4	1.7	12.1	6.1	2.7	3.7	14.6	9.0	26.7	2.6	8.6	6.3	5.3	8.6	4.8	3.6	12.6	12.4	9.2	11.7	8.7	39.1	0.3	2.3	5.1	23.8	2.1	0.7	1.5	6.3	2.7	1.3	0.3	5.7	3.5	6.1	19.0	0.5	3.0	12.9	1.0	10.1	6.0	2.8	6.6	20.7	20.1	6.1	2.3	10.8	2.6	8.4	4.0	8.0	7.5	11.2	5.5	2.2	0.0	3.0	1.9	3.5	1.7	4.8	6.4	3.4	1.2	4.1	4.1	0.3	3.3	0.7	0.6	9.2	1.8	3.4	4.4	2.5	4.8	3.9	3.6	4.2	5.0	5.1	2.4	11.9	10.1	1.5	10.1	6.4	2.2	13.7	7.6	8.1	14.8	1.8	15.7	0.8	0.0	4.0	13.9	15.0	2.5	0.0	7.0	3.8	7.5	7.5	0.0	3.8	5.9	0.0	5.8	21.5	5.1	12.0	2.8	7.7	8.5	9.0	3.4	1.3	9.0	2.9	38.2	1.5	4.8	0.0	23.8	1.1	2.4	4.0	0.7	4.4	2.5	5.8
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.9;brain: 22.6;lymphoid tissue: 21.4"	"Group enriched"	"Detected in some"	8	"Erythroid cells: 23.3;T-cells: 32.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in some"	20	"cerebellum: 22.6"	"Group enriched"	"Detected in many"	7	"gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9"	"Group enriched"	"Detected in many"	102	"NK-cells: 17.9;T-cells: 16.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.2;JURKAT: 12.3;SCLC-21H: 5.7"	"Region enriched"	"Detected in some"	8	"olfactory region: 95.2"	"Group enriched"	"Detected in many"	13	"cerebellum: 44.2;olfactory region: 21.9"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.4	0.7	0.5	6.8	0.4	1.6	1.6	22.6	0.4	1.8	0.8	0.0	0.0	0.3	3.2	0.9	1.4	0.6	5.0	0.7	0.4	0.7	1.0	4.9	10.1	15.6	0.5	0.3	1.3	0.9	0.0	0.6	1.6	1.1	2.1	0.9	3.3	2.2	0.1	0.4	0.4	1.8	0.7	0.9	21.4	1.4	0.5	0.0	1.8	1.1	0.9	11.2	3.3	0.8	0.0	0.0	0.1	0.0	17.9	16.5	1.4	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	2.6	2.0	0.0	10.2	1.5	0.0	0.1	0.8	0.0	1.2	0.0	0.1	1.2	0.0	1.4	0.5	0.0	12.3	0.3	0.0	0.0	3.0	2.7	0.0	0.3	0.2	1.2	1.9	0.0	0.0	1.0	0.0	5.7	0.0	0.0	0.0	1.2	0.5	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	10.0	0.0	16.5	0.0	1.9	12.0	0.0	0.0	0.1	7.5	0.1	17.9	0.0	0.0	0.0	1.4	0.5	0.4	22.6	0.4	0.4	0.7	0.5	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	3.7	3.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.6	0.1	0.0	32.6	0.0	0.0
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386703	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 200.8"	"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 341.0;Ito cells: 438.9;Smooth muscle cells: 281.4;Syncytiotrophoblasts: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 14.9;eosinophil: 7.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 14.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 46.9;BJ hTERT+: 46.2;HHSteC: 58.7;RT4: 58.1;TIME: 58.0;U-138 MG: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	71.2	14.2	12.5	17.1	15.7	0.8	101.7	5.3	13.9	24.9	20.9	8.9	11.3	12.0	28.8	13.0	21.6	24.8	35.2	40.0	12.8	11.0	35.2	31.2	200.8	27.2	14.3	11.1	20.2	15.5	18.1	9.4	119.6	18.4	20.7	11.5	41.2	13.3	18.7	25.2	13.0	15.6	19.2	12.5	20.5	12.8	13.8	8.0	1.1	43.8	15.2	10.3	32.2	39.3	0.0	0.0	14.9	0.1	0.7	0.1	0.1	5.3	5.7	0.3	0.4	27.6	17.8	46.9	16.9	46.2	9.7	10.6	1.0	0.9	0.0	4.2	32.2	9.7	2.6	0.1	13.5	7.3	0.1	0.2	0.0	1.8	12.0	58.7	0.0	3.4	26.0	18.7	19.0	13.4	7.2	33.4	0.1	0.5	0.0	5.9	4.6	0.1	0.1	0.2	3.7	3.2	0.1	0.6	1.7	6.0	58.1	0.2	12.0	13.3	30.6	3.6	12.5	2.0	2.3	58.0	50.4	1.4	6.7	1.4	0.0	0.0	0.0	36.7	0.9	1.2	14.9	0.1	7.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	12.5	15.7	5.3	12.6	12.8	11.0	14.3	11.1	18.4	8.0	71.5	137.9	8.1	61.5	42.7	3.5	58.5	50.9	30.8	96.7	3.5	9.8	93.6	1.7	15.5	12.6	341.0	66.4	0.0	45.9	256.0	104.5	46.7	40.4	77.4	47.9	0.0	4.1	438.9	58.4	41.8	11.5	23.9	27.0	0.0	13.6	89.1	25.9	40.4	6.0	24.0	57.7	278.1	281.4	1.2	1.7	29.1	292.5	9.6	11.6	58.0
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	11	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.4	1.8	18.6	8.8	1.5	0.2	6.2	1.9	2.8	2.3	2.9	4.9	9.0	13.8	5.0	2.5	3.8	3.4	23.2	1.8	2.5	24.8	7.1	39.5	5.6	8.0	2.9	13.4	26.4	0.5	5.4	2.2	4.0	5.7	4.1	22.1	37.2	11.0	0.0	2.5	21.7	8.8	19.5	12.3	2.9	33.4	8.2	19.8	2.2	9.5	25.1	18.6	5.8	5.5	12.6	6.6	4.2	5.2	0.4	0.1	3.9	3.6	3.8	16.5	21.4	24.7	3.5	13.8	2.1	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9	17.9	64.9	30.6	6.3	9.3	105.3	20.1	30.6	22.7	21.6	15.7	129.6	2.3	14.9	15.8	13.9	14.5	25.2	116.8	16.1	3.2	3.3	11.2	23.1	28.8	6.5	20.6	40.0	20.3	22.1	13.3	2.0	11.5	0.0	11.8	25.9	13.2	25.6	22.4	2.1	10.5	166.4	12.9	4.7	8.6	53.0	14.6	3.4	42.8	28.3	11.5
EPB41L4A	NBL4	ENSG00000129595	"Erythrocyte membrane protein band 4.1 like 4A"	Q9HCS5	5	112142441-112419316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 68.8;Ciliated cells: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 20.0;HeLa: 22.6;RT4: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036580	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036580: AB_10669908"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.40e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.65e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-1)"	21.4	3.7	3.5	5.0	4.0	2.1	19.0	2.1	6.1	7.3	3.0	1.7	22.1	1.9	6.1	11.3	13.6	6.2	11.7	9.3	4.0	3.1	10.0	4.8	21.9	6.9	3.7	2.0	4.9	4.2	14.3	4.3	8.9	3.7	5.3	3.8	10.5	7.7	22.0	6.8	7.2	3.2	5.9	4.3	6.7	4.3	4.8	1.9	2.1	15.7	8.2	6.9	5.5	12.2	3.6	0.5	1.3	1.2	0.4	4.8	0.9	0.5	3.5	9.2	0.9	0.0	0.0	1.9	1.3	0.0	0.0	0.0	1.9	7.8	3.8	20.0	0.0	0.5	4.7	0.6	4.3	0.0	0.6	3.2	6.1	22.6	1.2	0.1	1.6	2.0	0.0	1.9	0.0	0.0	1.0	5.8	1.1	1.2	3.6	0.0	1.1	2.8	2.1	1.7	0.7	0.7	1.4	7.0	0.8	5.4	13.6	7.7	4.0	6.8	3.4	2.7	6.7	10.2	0.8	10.0	0.4	1.6	1.2	2.7	3.6	0.7	2.9	0.9	3.2	0.5	1.3	0.4	0.2	4.8	0.6	2.7	3.6	1.5	1.4	0.5	3.3	2.4	4.7	0.5	0.4	1.2	0.3	1.4	0.9	3.5	4.0	2.1	3.9	4.0	3.1	3.7	2.0	3.7	1.9	26.8	7.7	4.2	14.0	5.4	4.0	7.6	68.8	42.8	27.3	14.0	3.9	6.0	10.0	12.3	16.7	18.0	2.6	0.0	6.8	0.9	6.7	12.1	8.1	1.7	2.1	1.6	1.2	30.1	5.6	14.1	1.7	1.3	3.3	4.6	6.3	7.7	10.4	10.5	1.8	20.3	31.5	0.0	4.7	1.6	6.1	7.0	2.1	1.7	4.5	16.3
EPB41L4B	EHM2	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171975-109320964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.1;pancreas: 59.8"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 67.5;Hepatocytes: 107.1;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 52.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.0;hTCEpi: 25.1;OE19: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavorable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	6.5	4.2	7.3	1.2	14.6	0.0	4.8	4.9	11.4	1.1	18.4	1.5	7.1	15.1	0.7	5.9	0.7	3.2	1.8	3.5	2.9	3.5	1.9	28.1	1.7	0.2	1.6	6.8	4.7	59.8	3.3	0.9	1.1	2.7	2.2	18.7	2.4	8.0	3.5	2.2	5.6	16.1	0.3	2.2	0.2	9.4	2.7	1.3	0.4	14.6	1.3	1.2	1.2	1.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	4.2	5.3	0.3	0.4	0.4	0.0	16.0	0.5	0.2	1.8	0.9	9.0	4.2	0.0	1.1	0.5	4.5	6.9	10.6	5.6	2.0	4.4	2.5	0.0	1.7	12.8	1.1	0.2	0.0	0.1	25.1	0.7	8.6	0.5	0.1	3.9	0.1	0.0	2.6	10.7	0.1	0.1	6.9	30.4	7.8	0.0	0.0	0.2	6.4	6.4	6.6	0.7	1.7	11.1	0.0	3.3	2.6	0.0	0.2	3.8	3.9	1.2	1.5	0.0	0.0	0.0	2.8	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.6	4.9	11.4	2.9	3.5	1.6	6.8	2.7	1.3	6.0	3.2	0.8	4.6	10.2	8.3	14.9	22.9	16.0	5.7	7.0	0.0	3.3	0.0	3.2	8.7	0.7	67.5	0.0	18.0	1.6	2.2	9.9	0.0	107.1	0.5	36.5	49.7	4.3	1.6	1.5	12.4	0.2	1.7	0.0	52.8	1.8	12.8	37.4	2.5	0.6	1.0	0.0	0.4	1.4	14.8	21.0	1.6	0.0	34.5	5.7
EPC2	DKFZP566F2124	ENSG00000135999	"Enhancer of polycomb homolog 2"	Q52LR7	2	148644440-148787568	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036759	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036759: AB_10672365"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.91e-2)"	19.5	16.3	16.1	16.2	15.6	41.0	18.6	32.9	18.3	23.9	17.2	13.6	19.3	9.7	26.0	15.2	13.2	17.1	15.8	16.2	14.1	14.0	13.6	12.8	14.7	16.4	14.5	16.6	33.4	12.0	15.4	30.6	22.7	13.7	20.1	14.6	13.1	14.8	19.0	19.1	14.6	16.5	19.8	14.8	18.1	12.0	13.8	15.8	27.7	20.0	12.9	15.6	18.8	22.7	1.9	2.0	8.6	3.7	0.8	3.3	1.0	5.9	4.7	16.4	10.1	11.0	13.9	12.3	10.7	14.6	17.4	14.8	9.4	8.2	13.2	5.4	12.5	7.6	8.2	14.1	8.6	21.6	11.4	10.4	25.4	7.5	13.1	11.2	19.1	15.6	14.5	15.4	17.7	17.5	10.9	10.8	10.7	13.4	22.6	10.9	9.7	13.1	13.1	16.5	5.8	9.3	13.5	15.0	11.9	8.8	17.2	22.6	16.3	13.2	8.2	19.8	11.9	5.3	17.2	12.8	13.9	12.3	9.4	8.9	13.8	10.7	16.8	11.0	11.5	14.9	0.3	1.9	2.2	2.1	1.4	2.7	1.9	3.0	1.8	1.8	1.9	3.3	2.3	8.6	0.8	3.7	2.0	2.6	1.0	16.1	15.6	32.9	18.3	14.1	14.0	14.5	16.6	13.7	15.8	23.8	9.9	2.9	22.8	12.5	17.3	18.1	7.6	13.4	23.9	8.7	5.9	9.1	3.3	8.2	15.4	11.5	7.3	23.3	7.8	9.1	16.7	17.7	5.8	3.8	7.4	7.9	17.3	7.4	12.6	2.7	22.2	12.8	11.8	9.0	8.1	13.3	7.4	7.0	21.5	5.8	14.8	12.9	17.6	14.1	14.7	13.7	16.8	12.1	6.8	23.6
EPG5	"hEPG5, KIAA1632"	ENSG00000152223	"Ectopic P-granules autophagy protein 5 homolog"	Q9HCE0	18	45847609-45967274	"Disease related genes, Predicted intracellular proteins"	Autophagy		"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031689	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA031689: AB_10609997"	"unprognostic (3.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.11e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.66e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (4.04e-5)"	"unprognostic (5.71e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.18e-1)"	11.1	12.5	15.4	11.3	16.1	26.8	16.3	20.1	21.1	10.3	9.3	11.2	11.6	7.8	13.1	14.5	12.2	10.4	8.1	14.5	14.1	10.1	13.5	10.0	14.7	14.0	11.5	12.3	16.7	11.1	18.6	18.1	14.8	12.7	10.4	10.1	13.0	10.7	10.1	23.8	22.7	10.2	10.2	15.6	16.9	9.5	8.6	12.4	20.2	17.0	8.7	13.8	9.1	14.4	1.7	1.9	2.4	2.2	1.1	4.8	0.9	2.8	2.2	2.3	1.6	7.9	9.6	2.3	18.2	7.6	10.5	11.0	0.6	2.1	2.9	1.1	13.6	12.7	2.7	3.0	3.6	13.5	2.3	1.3	2.2	2.6	2.2	7.5	3.8	5.9	6.4	3.4	11.6	8.0	9.3	5.2	2.6	1.9	1.6	30.9	2.0	1.6	3.7	1.1	1.0	1.4	1.6	2.8	2.0	4.9	4.0	2.4	1.9	3.2	1.3	3.7	3.4	1.9	2.7	12.5	13.1	2.7	1.9	5.0	3.2	2.2	1.6	5.6	3.4	4.3	1.2	2.2	2.0	4.8	2.1	4.6	1.2	2.9	2.8	1.6	1.7	2.6	3.1	2.4	1.1	2.0	1.9	1.6	0.9	15.4	16.1	20.1	21.1	14.1	10.1	11.5	12.3	12.7	12.4	17.9	8.0	10.9	4.0	9.2	15.3	13.9	7.6	5.3	3.4	10.4	23.6	5.9	1.7	6.2	2.0	8.7	5.4	0.0	3.2	3.4	6.8	6.6	6.9	8.5	10.6	12.7	7.9	13.5	12.6	1.8	11.5	6.5	13.5	6.4	7.0	8.7	6.0	5.8	11.0	7.3	18.6	12.9	6.8	7.5	6.6	11.5	7.6	8.9	6.4	5.9
EPGN	"ALGV3072, EPG, epigen, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308473-74315307	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 14.3;esophagus: 39.6;tongue: 25.7"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"hTCEpi: 62.6;U-2197: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA014420: AB_10601551"	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavorable (2.40e-4)"	1.1	0.0	0.0	1.3	0.0	0.1	1.0	0.0	0.0	7.9	0.3	0.0	1.0	0.0	0.0	14.3	39.6	1.2	0.3	0.6	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.0	1.0	0.0	1.7	0.0	0.3	0.0	0.0	2.5	2.8	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	25.7	5.4	0.6	6.5	0.4	0.1	0.0	0.6	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.1	1.2	0.0	1.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.1	0.0	62.6	1.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	28.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.2	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	2.2
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.2"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	115	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6"					"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	6.7	3.4	1.3	3.1	2.6	0.0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31.0	2.8	3.4	12.7	13.1	2.7	3.0	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	15.6	31.7	8.8	4.2	0.6	0.7	5.2	9.5	13.4	17.2	10.9	13.2	42.4	0.0	40.9	5.4	21.3	6.4	2.1	21.9	6.0	0.0	1.4	0.0	9.2	8.4	11.3	0.0	0.0	1.0	8.2	9.3	20.7	27.0	18.3	0.0	0.0	0.0	10.9	5.0	0.0	0.0	4.2	11.8	48.6	0.0	8.0	0.0	18.2	8.1	0.0	1.3	18.4	4.5	1.2	4.8	0.6	0.1	22.6	6.1	16.5	0.4	49.8	0.0	0.1	0.1	4.7	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2	50.6	28.9	0.5	100.5	179.7	0.6	5.8	40.8	37.5	33.0	8.7	3.9	8.1	0.0	31.3	5.4	17.5	57.1	0.0	12.5	0.9	7.0	56.8	5.7	19.8	1.6	0.0	2.9	32.5	2.8	0.0	3.1	4.6	25.3	1.8	19.6	5.8	62.9	20.1	0.0	1.4	2.0	32.3	17.6	0.0	0.7	217.2	6.3	0.0	17.7	155.0
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 66.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.8	0.0	0.0	4.1	0.0	0.0	0.6	0.7	0.0	1.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.8	0.0	0.0	0.0	0.6	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0	0.0	0.0	0.0	0.3	0.5	1.5	2.1	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.1	12.2	0.1	0.0	0.0	0.1	19.1	0.0	0.6	0.0	1.3	2.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	7.8	0.0	16.9	6.5	20.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 74.7"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 74.7"	"Group enriched"	"Detected in some"	33	"neutrophil: 15.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 15.4;granulocytes: 15.9"	"Group enriched"	"Detected in some"	4	"HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	2.0	1.5	9.0	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2.0	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1.0	3.3	2.8	7.0	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6.0	1.7	1.7	6.0	3.4	1.3	16.7	6.0	0.0	11.6	2.9	3.3	4.5	2.6	0.0	15.4	15.9	0.0	0.0	0.4	0.1	0.0	0.0	4.8	0.0	0.1	0.0	0.1	3.6	0.0	0.2	0.0	0.0	0.0	0.6	1.0	1.9	0.3	0.0	3.2	0.0	0.7	34.7	0.4	2.6	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	2.6	0.1	0.1	0.1	1.4	0.6	0.0	0.0	0.5	0.1	9.4	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.1	0.4	0.2	0.6	2.0	0.3	4.3	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	15.4	0.0	0.1	9.0	16.6	74.7	19.0	9.4	5.3	2.8	7.0	7.1	6.0	0.0	0.0	0.9	0.0	3.3	1.2	1.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.8	30.2	0.6	0.0	0.0	0.3	0.0	0.2	0.1	0.0	5.8	0.4	0.0	0.0	0.0	0.0	26.8	0.6	0.0	1.7	0.0	0.0	16.2	0.6	0.0	0.0	0.0	0.9	0.0	0.8	0.4	0.9	5.1	0.0	0.0	0.0	0.1
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		290000	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	15.9	6.7	6.5	10.4	0.6	0.6	0.0	3.7	0.2	11.3	2.4	2.3	6.4	0.2	8.0	1.6	34.4	15.1	4.4	21.7	3.0	0.0	1.6	0.0	0.7	0.0	6.8	0.0	1.6	2.2	7.0	20.2	0.1	10.0	29.7	0.9	0.6	0.0	2.2	2.3	0.3	0.1	1.5	17.8	4.4	1.9	6.7	0.3	5.5	1.5	7.1	7.4	6.5	0.2	0.0	0.6	0.4	0.2	29.4	4.5	11.8	11.4	25.5	0.0	0.1	0.0	8.4	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3	3.0	0.0	0.0	1.5	0.7	11.6	1.2	12.7	1.4	3.4	0.0	0.0	0.4	0.0	42.3	2.3	0.5	6.8	0.0	6.8	2.2	1.5	1.4	0.0	0.5	9.1	6.4	46.8	0.6	7.5	0.4	0.9	3.7	0.0	0.0	53.6	20.9	38.4	3.5	0.7	0.0	1.7	0.0	1.7	0.5	2.6	0.4	0.9	0.0	82.9	1.0
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6"	"Group enriched"	"Detected in many"	4	"Suprabasal keratinocytes: 37.9;Urothelial cells: 18.6"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 2.8;monocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.0;NTERA-2: 3.7;OE19: 12.9;SuSa: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.2	0.1	0.1	0.2	0.3	0.1	1.0	0.1	0.3	12.5	0.2	0.2	0.4	0.1	0.9	0.3	34.8	1.1	1.7	0.1	0.5	0.1	1.6	0.2	1.6	0.0	0.2	0.0	0.6	0.0	2.2	2.4	0.2	0.4	1.5	0.1	0.6	3.4	0.6	0.2	33.1	0.2	0.2	0.2	1.2	0.5	2.7	0.2	2.4	0.2	39.6	29.6	2.8	13.6	0.0	2.8	0.2	4.9	0.0	0.0	0.5	0.1	0.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.5	0.3	4.0	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.6	0.0	0.5	3.7	12.9	0.5	0.0	0.0	0.0	0.1	0.8	1.6	0.2	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.0	1.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	4.9	2.8	0.0	0.5	0.1	0.3	0.1	0.3	0.5	0.1	0.2	0.0	0.4	0.2	0.0	0.6	0.0	1.5	6.3	0.2	0.3	2.5	1.4	0.0	5.2	0.0	1.5	1.7	0.5	0.3	0.1	0.0	0.0	0.0	2.5	0.7	2.0	0.0	0.0	0.6	0.0	0.0	1.3	1.3	0.0	0.0	1.4	0.0	1.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	2.1	2.1	37.9	2.2	0.0	0.0	18.6
EPHX4	"ABHD7, EPHXRP, FLJ90341"	ENSG00000172031	"Epoxide hydrolase 4"	Q8IUS5	1	92029982-92063536	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 13.3;brain: 20.7"	"Cell type enhanced"	"Detected in some"	11	"Endothelial cells: 2.9;Melanocytes: 3.3;Muller glia cells: 8.1;Pancreatic endocrine cells: 3.0;Spermatocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 13.3"	"Lineage enriched"	"Detected in single"	24	"T-cells: 13.3"	"Cell line enhanced"	"Detected in some"		"A-431: 10.0;CAPAN-2: 8.8;EFO-21: 17.9;RPTEC TERT1: 24.8;U-251 MG: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035067	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA035067: AB_10601465"	"unprognostic (1.27e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (6.10e-8)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (5.36e-3)"	"unprognostic (2.72e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.44e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.36e-6)"	"unprognostic (6.93e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	1.0	1.3	5.8	1.3	14.1	0.3	3.2	1.7	20.7	2.4	1.0	0.3	0.1	1.6	1.7	1.3	2.1	1.3	1.2	1.2	3.3	2.4	0.9	0.4	1.5	0.7	3.1	9.8	0.6	0.3	0.5	1.3	1.9	4.4	2.2	1.4	1.5	0.4	4.1	0.4	0.6	0.9	2.5	1.1	0.4	0.5	2.6	2.1	0.0	3.9	0.0	0.7	1.9	0.4	0.1	0.0	0.0	0.0	0.5	13.3	1.4	10.0	0.3	2.0	0.0	0.0	0.0	0.5	0.2	3.7	0.3	0.2	0.0	8.8	0.0	17.9	0.0	2.7	0.1	0.3	0.8	0.3	0.0	5.4	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.4	0.0	0.0	6.5	3.1	0.0	0.0	0.0	0.3	0.6	1.4	0.3	1.9	0.0	3.5	0.3	0.2	0.0	24.8	2.0	1.2	1.5	6.1	0.0	1.8	0.1	0.0	1.4	0.1	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	2.3	0.1	1.7	3.3	0.0	0.0	0.4	3.4	0.0	0.5	0.0	0.0	0.0	1.4	5.8	14.1	1.7	20.7	3.3	2.4	3.1	9.8	4.4	2.1	0.0	0.0	0.0	0.1	0.1	0.8	1.2	0.0	0.0	1.2	0.0	2.0	0.4	0.0	0.3	1.3	2.9	0.0	0.0	0.7	0.6	0.5	0.2	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	8.1	3.0	0.0	0.0	0.0	1.8	0.0	0.8	3.8	0.7	0.4	0.0	0.0	0.0	0.3
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 71.6"	"Low region specificity"	"Detected in all"							"CAB009729, HPA061136, HPA071503"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	26.7	23.4	34.2	20.6	31.4	15.7	31.4	26.3	47.1	13.5	32.7	17.2	18.1	67.7	13.7	19.8	21.3	15.4	28.2	56.0	28.0	18.6	23.1	36.0	16.5	25.5	17.5	25.9	23.2	54.5	12.1	14.3	15.0	15.8	19.3	13.8	13.5	24.8	22.7	84.7	22.2	59.7	12.2	14.3	26.9	55.1	20.2	13.1	11.2	15.3	26.3	14.6	13.1	16.2	2.2	3.6	4.6	6.9	0.7	2.0	2.4	25.0	34.6	8.6	17.7	10.0	9.6	17.8	18.7	10.7	13.3	13.4	14.4	15.9	15.4	12.8	14.9	11.8	19.2	7.5	14.3	4.8	5.3	71.6	11.3	18.5	17.1	13.8	7.2	10.8	12.4	12.6	11.5	8.3	9.6	12.7	11.1	16.8	13.1	8.7	14.1	11.5	11.9	19.8	18.9	49.0	7.8	11.8	27.0	10.1	14.8	12.5	30.4	17.3	18.8	12.3	6.3	14.1	25.4	21.1	37.1	17.9	13.3	26.9	14.4	13.1	11.0	27.3	14.6	18.3	2.4	3.5	4.4	1.4	4.5	1.0	2.2	1.4	1.3	2.4	2.0	1.4	1.3	4.6	0.7	6.9	3.6	2.0	2.4	34.2	31.4	26.3	47.1	28.0	18.6	17.5	25.9	15.8	13.1	3.0	27.3	32.6	23.9	27.8	31.1	12.9	50.9	10.7	7.9	41.8	62.8	40.3	101.2	45.0	50.6	29.6	273.7	0.0	77.2	65.9	30.7	31.5	10.4	95.7	53.6	27.0	43.3	78.0	103.2	121.6	44.0	36.6	21.9	23.4	108.9	27.8	78.4	136.8	49.8	53.1	37.3	12.9	21.7	45.0	57.1	24.0	43.7	21.8	112.6	32.8
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532543-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 17.4;Cytotrophoblasts: 52.4;Mucus-secreting cells: 17.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 6.8;pons and medulla: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HBEC3-KT: 16.6;MCF7: 26.7;OE19: 25.1;RT4: 20.9;SK-BR-3: 10.8;T-47d: 24.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2"	"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA055546: AB_2682844, HPA063224: AB_2684964"	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.4	7.7	0.5	1.9	0.7	0.4	1.9	1.1	6.8	5.3	7.8	1.5	24.0	5.1	0.7	3.8	26.2	6.0	12.6	6.6	0.5	0.7	10.9	0.4	0.7	0.0	2.0	1.4	10.3	18.3	9.6	0.9	8.4	17.8	9.3	3.4	0.3	16.7	18.7	0.4	19.7	5.1	0.5	0.6	0.3	23.8	2.2	0.0	3.4	1.2	15.9	21.9	8.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	6.1	5.2	0.0	0.1	0.0	0.0	12.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	9.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.1	0.0	0.0	25.1	0.2	0.0	0.0	0.0	0.1	20.9	0.2	0.0	0.0	10.8	0.0	0.1	24.1	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.1	6.8	0.5	0.7	2.0	1.4	17.8	0.0	0.0	0.0	0.0	3.4	2.1	0.3	4.8	7.6	0.0	0.0	17.4	0.0	52.4	5.0	5.6	0.4	0.1	9.3	0.0	10.0	5.6	0.3	4.4	0.0	0.0	5.1	0.0	3.5	0.0	0.0	1.8	2.6	0.0	0.0	1.0	17.7	0.5	5.2	10.5	0.0	0.0	0.3	0.0	0.3	0.0	0.4	4.8	8.9	0.0	16.6	5.8
EPOP	"C17orf96, LOC100170841, PRR28"	ENSG00000273604	"Elongin BC and polycomb repressive complex 2 associated protein"	A6NHQ4	17	38671703-38675421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.5"	"Cell type enhanced"	"Detected in some"	17	"Ductal cells: 3.3;Exocrine glandular cells: 3.4;monocytes: 4.6;Pancreatic endocrine cells: 3.5;Syncytiotrophoblasts: 11.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.1;Hep G2: 18.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055190, HPA056555"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA055190: AB_2682731, HPA056555: AB_2683172"	"unprognostic (9.08e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.78e-10)"	"unprognostic (8.97e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	1.2	2.0	2.5	1.5	5.1	0.4	1.1	0.0	13.5	0.3	0.2	0.0	2.5	0.2	0.7	0.7	0.7	0.4	0.8	0.4	1.1		0.3	3.4	0.4	2.4	0.3	3.2	0.1	3.6	3.0	0.0	1.2	0.4	0.7	0.3	0.2	0.5	1.2	0.1	1.0	0.2	0.5	0.8	0.6	0.5	5.8	0.8	1.7	0.1	1.1	3.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	2.9	3.5	2.3	16.1	0.5	0.1	3.9	0.6	0.2	0.7	1.1	3.5	1.1	5.6	3.9	0.4	2.0	2.4	7.5	1.5	1.2	5.8	5.7	1.2	0.6	18.4	1.0	0.6	3.0	0.3	2.6	0.7	1.5	1.5	0.5	6.3	3.8	8.7	0.4	4.7	5.0	1.6	0.5	1.9	3.2	12.0	1.3	12.2	0.4	0.7	3.5	5.4	1.9	2.6	0.6	3.9	3.8	2.3	0.8	0.6	0.7	0.7	0.6	4.6	5.0	7.1	1.3	8.3	2.3	0.0	0.0	0.0	0.4	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.8	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.0	3.4	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	3.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0
EPS15L1	eps15R	ENSG00000127527	"Epidermal growth factor receptor pathway substrate 15 like 1"	Q9UBC2	19	16355239-16472085	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019237, HPA055309"	Uncertain		Approved	Vesicles		NA	NA		8900	Vesicles		"HPA019237: AB_1848223, HPA055309: AB_2682780"	"unprognostic (3.06e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.54e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.47e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.32e-1)"	14.1	12.2	16.4	12.4	22.9	22.7	10.2	34.2	31.6	15.3	10.8	19.9	11.4	8.7	14.1	7.4	18.5	15.4	11.0	26.4	16.8	15.5	13.0	11.5	10.8	14.1	15.4	17.2	16.1	12.8	19.8	18.2	15.6	20.5	13.9	11.1	16.4	14.4	16.0	44.0	20.6	11.2	16.7	11.8	14.3	11.9	14.7	15.2	14.2	12.9	13.9	16.5	11.6	14.4	11.1	4.4	26.4	6.2	8.7	5.9	4.2	13.6	6.5	14.2	9.3	15.3	11.9	21.0	9.1	8.0	15.9	13.9	7.1	9.8	14.8	16.6	13.9	12.6	13.8	19.9	11.1	13.9	7.3	18.7	12.6	9.0	15.1	15.5	11.0	13.7	9.7	11.4	17.5	12.2	15.9	12.8	13.3	9.8	16.3	13.3	27.7	12.5	16.3	8.9	19.1	22.5	16.2	6.0	12.6	10.9	14.8	12.6	7.8	9.9	8.8	9.4	11.1	30.4	10.8	13.2	9.7	6.2	31.0	15.3	4.5	9.2	14.2	10.3	16.4	13.3	23.5	5.8	16.1	5.8	5.7	5.5	11.1	5.0	5.9	4.4	9.7	5.6	4.1	26.4	8.7	6.2	4.2	4.9	4.2	16.4	22.9	34.2	31.6	16.8	15.5	15.4	17.2	20.5	15.2	8.9	9.8	16.8	11.5	14.7	27.1	15.9	5.1	12.0	5.7	8.7	47.1	17.3	8.3	9.8	71.6	9.0	7.9	0.0	5.0	17.2	17.2	12.1	11.5	7.3	16.6	11.1	10.9	10.4	11.0	13.6	17.3	12.0	3.3	8.2	10.3	11.5	7.1	9.3	19.1	11.0	24.7	19.4	12.3	18.6	16.9	21.3	9.2	15.3	8.5	19.3
EPS8		ENSG00000151491	"Epidermal growth factor receptor pathway substrate 8"	Q12929	12	15620158-15882329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Sertoli cells: 394.5;Smooth muscle cells: 265.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 16.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 56.9;HHSteC: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003897	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA003897: AB_1848224"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (2.68e-1)"	"prognostic favorable (1.45e-7)"	"unprognostic (7.47e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.79e-2)"	52.6	5.9	7.9	7.4	10.7	0.1	37.3	7.9	7.6	28.7	24.9	9.5	13.5	16.6	39.1	28.5	12.2	16.9	25.4	16.3	8.4	6.8	25.4	16.3	12.7	7.0	12.6	6.6	23.4	6.6	6.4	4.4	23.4	10.9	24.4	24.2	23.3	12.0	19.0	12.7	9.8	26.2	36.0	13.5	11.1	14.2	12.1	11.8	0.1	15.9	9.5	2.8	33.5	40.1	1.0	4.4	3.6	16.7	0.7	0.9	1.2	13.6	8.3	8.3	0.3	56.9	40.5	11.7	15.9	13.0	7.6	10.2	7.1	21.0	0.0	0.5	29.9	25.3	3.5	2.4	2.0	11.5	0.0	2.7	1.2	2.6	7.3	49.2	0.9	0.0	35.7	9.2	20.1	25.7	9.9	3.8	0.0	0.0	0.0	36.6	3.7	0.0	0.6	1.1	10.6	6.7	0.0	24.1	0.1	21.7	19.7	0.6	1.0	4.6	2.6	19.6	1.4	7.5	0.9	6.1	12.2	3.2	7.0	6.5	0.7	0.0	0.0	7.1	2.2	34.7	0.0	2.2	0.2	0.2	8.7	0.1	1.0	0.8	0.3	4.4	0.3	0.9	0.4	3.6	0.7	16.7	0.3	0.1	1.2	7.9	10.7	7.9	7.6	8.4	6.8	12.6	6.6	10.9	11.8	11.9	128.1	6.4	32.5	15.0	9.0	26.6	45.9	123.1	67.1	22.7	62.8	28.6	51.4	61.2	44.8	38.3	132.6	0.0	60.3	5.2	39.1	23.0	5.8	29.8	50.7	6.4	36.8	43.0	42.7	39.2	124.8	32.7	33.7	10.0	53.1	11.3	68.7	76.3	41.1	88.2	140.5	394.5	265.9	10.8	3.1	11.4	17.6	5.7	61.9	92.1
EPS8L3	"FLJ21522, MGC16817"	ENSG00000198758	"EPS8 like 3"	Q8TE67	1	109750080-109764027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 30.0;intestine: 115.1"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 255.7;Late spermatids: 82.4;Mucus-secreting cells: 88.8;Paneth cells: 126.3;Undifferentiated cells: 82.1"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	22	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"NK-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.6;CAPAN-2: 8.2;Hep G2: 19.4;OE19: 36.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030998	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA030998: AB_2673691"	"unprognostic (1.73e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (5.55e-3)"		"unprognostic (3.71e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.87e-3)"	"unprognostic (3.89e-1)"		"prognostic favorable (1.82e-4)"	0.2	0.1	0.2	11.0	0.2	0.0	0.2	0.2	0.2	0.5	88.2	0.2	0.2	41.3	0.2	0.2	0.3	0.2	30.0	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.3	22.1	0.2	0.2	0.3	0.2	0.1	115.1	0.5	0.2	0.2	15.1	1.2	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	8.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	36.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	28.5	0.0	255.7	0.0	21.7	0.0	0.0	0.0	4.6	0.0	0.0	0.0	49.3	0.0	0.0	82.4	0.6	0.0	0.0	0.0	88.8	0.0	26.8	126.3	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	82.1	0.5
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		27000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: AB_2677946"	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	23.8	13.6	9.3	22.7	11.9	11.6	23.3	14.2	14.6	14.5	23.8	10.1	11.2	30.8	14.7	13.4	12.3	14.3	19.9	16.1	9.7	6.8	13.3	23.7	17.8	16.4	13.5	7.6	15.5	16.5	11.1	39.4	28.2	11.4	13.4	21.9	8.5	13.9	15.2	23.1	17.7	39.7	10.6	17.1	19.5	16.5	5.4	13.8	55.5	13.5	9.8	17.8	15.9	14.1	14.9	15.2	19.8	17.5	19.8	21.8	10.7	7.4	4.7	6.4	6.0	35.4	34.7	18.6	5.5	17.7	13.3	23.3	5.9	27.0	22.3	11.5	10.6	18.7	7.6	5.3	11.2	8.3	40.2	2.2	7.2	3.2	4.0	40.6	3.4	13.4	14.4	4.9	15.2	4.7	19.6	18.2	14.5	3.7	21.6	7.9	3.5	32.0	3.6	3.2	0.9	3.1	23.8	8.7	11.1	9.9	11.5	2.4	1.6	8.7	5.9	8.5	4.6	5.1	16.6	14.5	11.4	3.9	1.9	9.0	8.1	15.1	17.3	12.2	11.8	6.7	19.8	13.2	15.6	21.2	11.4	19.7	13.0	18.5	18.2	9.5	14.9	21.8	17.4	14.4	19.8	17.5	15.2	12.3	10.7	9.3	11.9	14.2	14.6	9.7	6.8	13.5	7.6	11.4	13.8	8.9	12.3	13.7	12.1	22.1	11.6	8.5	10.2	22.7	14.8	8.7	2.0	8.0	0.0	10.8	20.0	11.3	25.8	0.0	13.4	9.1	16.1	9.2	14.0	27.0	16.2	3.2	9.9	18.4	31.2	5.2	9.2	18.5	6.8	21.6	25.9	9.7	11.2	17.5	15.2	5.0	7.2	0.0	9.5	1.2	0.7	9.7	7.7	20.0	19.1	12.2
ERAP2	"L-RAP, LRAP"	ENSG00000164308	"Endoplasmic reticulum aminopeptidase 2"	Q6P179	5	96875939-96919716	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 63.4;T-cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.1;GAMG: 30.0;hTEC/SVTERT24-B: 23.7;MOLT-4: 26.2;TIME: 51.5"					"Low region specificity"	"Detected in all"			"CAB025618, HPA034498, HPA064360"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		7400000	"Golgi apparatus"		"CAB025618: , HPA034498: AB_2674191, HPA064360: "	"unprognostic (4.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.01e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.48e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-1)"	9.0	6.0	3.1	21.6	3.8	3.5	7.4	2.2	3.5	9.6	37.0	3.1	6.2	17.0	8.3	10.3	12.4	5.7	5.6	5.8	3.3	2.6	8.6	10.8	16.8	30.8	4.2	0.5	18.2	5.9	1.4	11.1	13.6	3.6	9.4	3.1	7.0	9.3	3.5	4.1	4.9	22.4	5.1	8.7	37.6	9.2	2.6	3.1	32.5	11.3	9.6	24.4	11.8	8.7	16.4	10.7	10.9	15.3	24.0	22.4	14.1	0.5	0.6	0.4	0.2	0.5	1.0	0.1	2.1	3.7	2.0	3.3	2.1	49.1	2.9	9.7	3.1	30.0	0.7	0.2	17.8	1.6	1.0	2.1	0.1	0.7	2.0	0.7	10.8	5.2	7.3	3.3	23.7	0.1	0.3	1.3	7.3	0.0	7.3	5.6	0.3	26.2	5.4	0.0	0.0	1.0	11.7	4.2	7.7	14.2	4.1	0.9	0.0	0.3	0.2	4.1	0.1	1.7	0.4	51.5	1.0	0.3	2.7	6.3	7.1	6.1	1.0	14.3	1.4	0.2	10.9	6.5	7.8	14.2	15.3	18.1	16.4	20.2	17.6	10.7	9.6	22.4	17.0	2.2	24.0	14.4	3.5	18.2	14.1	3.1	3.8	2.2	3.5	3.3	2.6	4.2	0.5	3.6	3.1	29.8	18.3	63.4	8.3	5.0	1.4	3.5	7.6	9.4	15.9	41.8	0.0	10.0	0.0	5.0	0.2	29.2	40.8	0.0	21.9	14.9	15.1	3.1	6.9	14.3	12.0	0.0	1.7	20.3	17.4	0.0	9.8	22.3	6.8	7.2	21.5	7.5	14.1	24.6	7.4	5.7	2.0	0.0	8.2	0.9	0.7	2.6	5.6	53.6	20.6	8.1
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	7.4	15.6	11.4	10.6	17.7	6.7	7.1	9.5	23.8	9.4	8.1	11.7	7.8	7.9	11.7	6.0	6.7	10.0	10.1	7.9	9.4	9.1	8.7	13.2	6.5	9.9	8.2	10.5	9.5	13.1	12.9	10.9	7.2	14.0	8.2	6.4	12.5	9.5	11.8	15.9	10.7	7.1	11.2	5.3	9.7	8.3	17.2	7.8	10.8	10.2	5.1	8.3	9.3	6.6	7.8	17.2	5.0	13.9	11.3	9.8	8.7	12.6	6.2	12.9	18.1	7.7	9.1	6.8	18.0	12.4	23.3	17.9	14.3	8.7	4.5	10.3	17.5	8.5	6.5	9.0	15.1	8.9	10.9	14.8	7.7	11.7	15.1	16.3	12.2	13.6	10.5	2.4	26.6	15.1	13.0	13.5	13.0	18.6	5.1	16.0	6.1	7.1	8.1	5.9	11.6	10.9	13.8	9.2	3.8	6.7	11.2	7.5	8.2	16.0	11.3	6.4	10.2	10.7	16.2	17.5	22.3	12.2	9.4	40.0	11.9	6.8	6.5	6.6	7.4	9.8	0.0	13.3	5.0	7.7	13.9	9.8	7.8	7.4	7.4	17.2	5.8	7.1	7.4	0.4	11.3	10.9	8.3	7.4	8.7	11.4	17.7	9.5	23.8	9.4	9.1	8.2	10.5	14.0	7.8	6.0	4.3	3.6	3.9	5.6	0.0	6.0	10.2	6.7	5.7	5.2	0.0	9.4	11.6	7.6	4.1	3.8	2.9	0.0	7.0	10.0	6.8	3.5	0.0	11.5	9.8	0.0	6.9	9.2	7.3	2.2	6.1	4.6	3.3	1.8	7.8	0.0	6.2	3.5	7.4	11.3	0.0	0.0	5.2	33.8	11.0	5.0	4.0	2.9	7.7	3.3
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"Q03468, P0DP91, Q8N328"	10	49455368-49539538	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 25.1;hTERT-RPE1: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	7.9	6.9	11.5	6.0	12.3	13.9	11.1	21.0	13.9	9.8	7.0	8.9	10.6	6.4	9.3	8.6	13.5	8.1	7.7	9.1	12.7	6.5	10.1	10.0	8.0	7.9	9.2	11.4	12.5	13.1	20.3	14.2	9.7	10.1	10.5	8.8	9.2	10.5	13.7	9.6	14.4	9.1	7.9	11.8	9.2	7.6	7.8	12.4	7.8	13.6	8.2	9.6	9.9	11.6	7.9	5.1	10.9	8.1	1.6	5.3	2.1	4.8	2.5	1.9	1.2	3.3	5.5	1.5	8.7	12.1	6.0	4.2	2.6	3.0	2.1	1.6	7.8	2.9	4.6	2.7	6.9	6.1	3.4	1.7	1.6	9.6	1.4	1.9	2.2	1.7	1.9	9.4	5.8	25.1	57.2	8.7	1.5	3.2	0.6	7.7	3.5	1.5	1.3	1.7	1.9	4.5	1.4	2.8	1.2	2.0	3.5	2.5	2.7	6.4	2.3	3.9	4.4	4.2	1.2	16.7	3.3	2.7	4.0	2.2	2.3	2.2	2.0	4.1	2.4	2.4	10.9	4.1	9.7	5.3	3.7	4.2	7.9	3.1	2.9	5.1	6.3	3.8	1.8	9.8	1.6	8.1	2.8	4.0	2.1	11.5	12.3	21.0	13.9	12.7	6.5	9.2	11.4	10.1	12.4	14.9	10.4	2.4	1.3	3.2	0.0	4.9	7.6	13.4	12.5	8.7	0.0	1.9	5.0	4.6	8.2	2.0	3.8	0.0	5.3	1.5	3.5	2.3	7.0	4.0	2.3	0.0	1.2	3.7	3.8	10.6	2.6	3.9	1.7	14.4	4.5	0.0	4.8	3.5	2.1	2.8	0.0	6.5	1.9	5.4	4.2	3.6	1.5	5.0	2.4	1.6
ERCC6L2	"C9orf102, FLJ37706, RAD26L"	ENSG00000182150	"ERCC excision repair 6 like 2"	Q5T890	9	95875701-96014571	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021260, HPA022422"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021260: AB_1859544, HPA022422: "	"unprognostic (6.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (8.70e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.39e-2)"	13.5	13.9	14.6	12.7	17.4	7.6	13.6	21.8	19.3	17.7	12.9	13.2	13.9	10.4	18.7	11.8	11.6	11.4	11.8	13.3	14.0	9.7	12.4	11.7	12.7	15.0	15.3	12.2	21.7	10.6	26.2	22.0	11.7	16.1	15.5	11.5	11.0	11.2	12.7	13.9	10.1	13.5	16.1	12.1	15.8	13.4	12.5	15.4	29.7	20.3	7.1	12.4	17.4	13.8	7.3	12.7	4.3	5.3	5.1	12.9	4.0	11.4	14.6	17.3	12.4	6.8	11.6	8.3	10.2	10.4	10.4	11.9	11.2	5.1	13.0	5.7	14.6	14.9	14.3	16.6	7.1	15.4	9.3	8.0	11.7	11.1	7.2	6.6	14.9	11.6	10.3	7.3	12.8	10.2	9.6	9.7	13.4	15.1	7.3	10.7	9.2	12.4	5.6	12.9	12.3	8.8	11.6	22.5	4.6	8.8	10.5	16.2	12.4	7.2	7.6	7.3	9.4	7.1	7.7	10.2	11.7	14.9	14.4	12.0	4.9	7.4	6.2	11.3	7.1	16.9	3.2	4.4	4.3	8.7	5.3	8.4	5.7	8.3	9.3	4.8	7.3	12.9	9.4	2.7	5.1	4.2	12.7	9.9	4.0	14.6	17.4	21.8	19.3	14.0	9.7	15.3	12.2	16.1	15.4	14.9	15.2	4.7	11.1	4.4	0.0	15.9	7.6	21.4	18.2	0.0	0.0	4.5	0.0	7.6	6.2	7.2	5.9	23.3	7.0	2.8	7.5	8.6	15.0	6.0	5.5	0.0	4.7	8.0	9.1	3.0	24.7	10.6	3.3	8.2	7.1	0.0	6.3	3.5	26.2	2.8	0.0	19.4	10.3	15.2	9.6	3.9	4.0	12.8	5.6	7.5
ERCC8	"CKN1, CSA"	ENSG00000049167	"ERCC excision repair 8, CSA ubiquitin ligase complex subunit"	Q13216	5	60873831-60945073	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cockayne syndrome, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029328			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA029328: AB_2673000"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.68e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (7.19e-2)"	13.6	10.4	11.5	7.1	12.4	4.2	13.9	10.2	16.5	9.8	9.9	11.8	8.6	8.5	9.8	10.0	10.0	8.4	8.0	11.6	10.3	10.6	13.2	10.6	8.0	9.2	11.4	8.9	9.1	8.5	6.6	18.7	12.6	14.7	7.7	12.2	10.6	8.4	10.3	8.7	7.2	7.7	12.9	12.5	11.5	7.6	14.1	11.7	14.0	10.2	8.9	11.6	11.2	7.8	4.3	12.1	1.4	6.5	3.6	6.3	3.9	6.0	8.8	12.2	13.3	7.6	10.2	7.0	8.9	10.4	12.7	14.9	10.1	9.5	8.1	13.2	10.5	13.1	6.0	9.9	13.3	16.2	13.4	5.9	5.7	3.6	12.6	10.4	6.3	5.3	9.1	12.0	10.8	6.1	5.6	11.7	10.4	7.7	4.6	12.3	9.2	9.0	6.8	6.5	2.6	5.4	14.9	13.4	8.0	6.4	7.8	8.4	11.3	9.5	5.6	9.4	9.6	10.0	7.6	7.0	5.1	7.8	8.4	14.3	6.2	12.3	9.9	7.3	12.4	13.6	0.0	6.5	1.4	5.1	5.9	5.6	4.3	4.3	6.2	12.1	2.4	5.9	5.9	0.2	3.6	1.7	5.5	6.3	3.9	11.5	12.4	10.2	16.5	10.3	10.6	11.4	8.9	14.7	11.7	3.0	2.9	3.0	2.5	2.6	0.0	3.4	2.5	8.1	2.3	15.7	0.0	7.1	13.3	5.2	35.4	2.5	1.3	0.0	4.5	8.4	3.9	3.2	5.7	4.3	5.6	0.0	0.0	3.7	4.7	6.2	4.4	3.7	6.8	7.2	3.7	0.0	4.2	2.6	2.8	5.4	0.0	0.0	3.1	14.4	9.1	3.8	2.9	5.1	4.3	2.8
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365143-74388751	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;tongue: 44.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 44.2;Kupffer cells: 56.9;Macrophages: 122.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 60.3;CAPAN-2: 17.1;hTEC/SVTERT24-B: 19.0;U-2197: 41.1;U-87 MG: 70.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054373			Approved	Vesicles	"Secreted to blood"	NA	NA	46000		Vesicles		"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	2.2	0.0	0.1	4.6	0.3	52.1	1.2	0.0	0.1	5.0	1.2	0.1	0.0	0.0	0.1	0.5	15.3	1.2	7.3	0.8	0.0	0.0	0.4	0.2	6.7	1.1	0.0	0.2	0.5	0.1	0.0	0.0	2.0	0.3	0.2	1.6	0.1	1.6	0.0	0.5	10.7	1.0	1.3	0.1	1.9	0.3	0.3	0.0	0.2	0.0	44.0	7.2	4.1	4.6	0.6	1.3	2.6	1.2	0.4	0.3	0.3	0.3	9.1	0.0	0.0	0.9	1.5	0.0	2.0	60.3	0.6	0.3	7.1	17.1	0.0	10.1	0.0	4.6	0.5	0.0	13.1	0.6	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.9	4.6	19.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	41.1	0.0	0.0	0.0	0.0	70.5	0.0	0.0	1.9	1.2	2.6	0.3	1.0	0.2	0.2	0.2	0.2	1.3	0.6	0.3	0.2	1.0	0.4	0.2	0.4	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	6.0	11.1	1.9	4.9	4.7	0.0	15.7	2.5	4.0	29.6	0.0	0.0	0.5	0.0	0.0	3.1	2.2	44.2	0.0	0.2	0.7	6.1	2.0	6.9	0.0	28.2	0.0	3.5	0.6	56.9	0.4	0.3	122.8	6.8	29.7	24.7	0.0	0.4	17.5	0.0	0.1	0.0	0.0	2.2	0.5	0.2	8.2	0.6	1.0	27.7	6.7
ERG	"erg-3, p55"	ENSG00000157554	"ERG, ETS transcription factor"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 84.3;granulocytes: 22.1;Ito cells: 63.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.7;NK-cell: 1.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 1.0"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 43.7;MOLT-4: 14.3;REH: 46.4;TIME: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018377, HPA046598"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: AB_2679715"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"	39.1	4.2	5.7	6.5	8.5	6.6	20.5	3.6	7.0	17.9	5.2	2.3	5.6	3.3	16.9	9.0	6.2	9.2	11.6	10.1	6.2	3.6	10.8	6.0	19.9	7.4	8.0	1.8	7.7	4.8	2.3	3.9	23.2	8.0	8.1	3.6	7.8	4.2	5.6	13.5	5.3	6.2	11.8	4.7	32.5	5.0	4.8	5.0	2.4	10.8	9.1	3.6	9.6	15.8	0.0	1.7	0.0	0.2	1.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.3	14.3	0.0	0.1	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	35.4	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	5.7	8.5	3.6	7.0	6.2	3.6	8.0	1.8	8.0	5.0	0.0	4.6	1.9	1.5	3.1	0.0	2.5	7.6	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.5	84.3	0.0	0.0	0.0	0.0	2.1	0.4	22.1	0.8	0.2	0.0	0.0	63.3	9.8	1.5	0.9	1.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.9	3.0	0.0	0.0	0.0	0.6
ERG28	"C14orf1, NET51"	ENSG00000133935	"Ergosterol biosynthesis 28 homolog"	Q9UKR5	14	75649791-75661189	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 130.3;Ductal cells: 84.3;Exocrine glandular cells: 97.0;Extravillous trophoblasts: 121.7;Syncytiotrophoblasts: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043172, HPA063568"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043172: AB_10793942, HPA063568: AB_2685043"	"unprognostic (2.68e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.66e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (4.30e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.20e-1)"	6.4	20.0	14.2	6.3	16.3	8.1	12.6	9.2	25.5	11.8	11.7	16.3	10.5	14.9	11.3	29.6	23.7	12.4	11.8	9.4	13.6	15.5	17.6	48.3	19.3	9.4	11.9	10.4	15.0	12.4	16.5	13.2	15.6	17.9	15.5	11.2	26.2	15.4	10.6	6.6	15.6	16.9	10.5	18.2	7.1	9.5	52.2	9.6	7.5	24.3	21.3	15.6	9.2	13.5	18.1	18.2	11.8	6.0	14.2	22.0	13.9	14.2	8.0	16.3	12.6	11.0	20.6	10.1	5.8	18.0	11.3	19.5	12.3	34.1	6.0	8.5	7.2	22.7	15.8	14.3	24.8	13.0	11.3	9.5	6.5	8.2	17.4	16.1	7.1	9.8	25.7	21.4	16.2	9.1	9.1	13.1	16.7	5.8	14.8	7.8	28.0	10.8	7.9	15.8	22.8	13.0	8.7	11.0	12.0	37.1	18.5	14.0	7.8	14.7	12.6	8.7	15.0	21.0	10.6	9.4	6.2	12.5	5.9	5.8	9.7	11.3	13.1	9.9	10.5	10.4	11.8	6.0	8.9	20.1	5.9	19.8	18.1	22.0	20.9	14.2	15.3	20.2	20.1	3.2	14.2	5.9	18.2	19.4	13.9	14.2	16.3	9.2	25.5	13.6	15.5	11.9	10.4	17.9	9.6	20.8	41.5	0.0	0.0	0.0	0.0	0.0	0.0	33.5	20.5	57.6	0.0	130.3	41.4	84.3	0.0	0.0	0.0	0.0	97.0	121.7	0.0	0.0	4.7	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	65.9	0.0	0.0	61.2	0.0	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	97.3	0.0	0.0	0.0
ERH	DROER	ENSG00000100632	"ERH, mRNA splicing and mitosis factor"	P84090	14	69380123-69398627	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002567	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA002567: AB_1078749"	"unprognostic (2.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (8.61e-3)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.39e-1)"	42.6	45.4	54.9	43.9	46.7	47.0	51.3	45.1	48.4	46.6	43.5	31.1	39.4	42.1	53.3	63.3	44.8	46.4	35.9	40.6	47.6	51.1	56.1	62.2	34.5	52.5	43.5	48.5	47.8	38.7	23.9	45.5	55.2	45.4	40.4	50.3	41.3	58.5	40.3	43.3	31.0	47.3	46.9	43.6	55.2	35.6	54.6	28.4	72.2	55.2	37.5	64.4	47.7	36.8	38.7	37.3	24.2	32.4	34.1	35.3	38.8	90.9	59.0	59.1	39.4	29.7	21.9	35.8	47.7	27.5	43.1	40.4	60.1	37.8	86.3	21.0	31.9	32.9	26.7	59.8	39.6	51.3	45.0	36.5	43.3	39.2	67.1	45.8	37.6	31.5	24.9	21.3	38.5	34.6	24.5	35.2	56.0	41.7	29.0	35.2	104.0	56.8	53.6	46.1	48.2	56.0	46.1	58.6	29.5	43.4	62.2	45.5	42.4	45.5	41.7	26.1	35.0	51.3	52.7	37.6	42.2	62.5	28.0	47.4	32.6	30.9	96.5	31.3	40.0	40.7	15.3	32.4	24.2	26.1	30.1	25.7	38.7	32.5	28.6	34.0	30.6	30.7	27.2	15.4	34.1	27.1	37.3	35.3	38.8	54.9	46.7	45.1	48.4	47.6	51.1	43.5	48.5	45.4	28.4	56.6	48.3	181.6	193.1	242.6	132.5	105.5	158.0	116.4	66.0	240.8	35.3	400.5	570.3	308.1	69.0	200.3	146.7	93.5	240.5	449.3	263.5	196.9	126.7	237.4	297.7	69.9	181.0	155.9	148.1	29.8	250.8	172.7	291.8	355.3	176.1	207.1	246.0	166.8	243.6	389.2	92.5	187.5	273.0	273.2	229.3	278.7	234.1	150.3	215.6	194.6
ERI1	"3'HEXO, THEX1"	ENSG00000104626	"Exoribonuclease 1"	Q8IV48	8	9002147-9116746	"Predicted intracellular proteins"	"RNA-mediated gene silencing, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033838, HPA055548, HPA056074"	Uncertain		Approved	Vesicles,Microtubules		NA	NA			Microtubules	Vesicles	"CAB033838: AB_2098575, HPA055548: AB_2682845, HPA056074: AB_2683029"	"unprognostic (2.49e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (8.05e-5)"	"unprognostic (1.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.36e-2)"	11.9	6.9	6.6	12.2	8.6	20.0	15.4	10.8	8.0	8.8	9.3	7.9	6.6	8.8	15.3	7.1	10.0	10.0	7.5	6.9	6.4	6.3	10.1	9.9	10.9	12.6	8.4	4.9	9.1	7.4	9.1	11.9	32.2	6.3	8.5	9.2	9.2	9.0	7.4	6.8	6.4	8.8	9.7	9.0	13.0	7.9	18.7	8.0	17.8	7.6	4.6	13.2	11.4	15.6	7.5	5.4	7.6	7.3	8.3	13.5	5.0	17.2	11.1	10.0	7.5	7.9	12.9	13.4	14.9	8.2	11.4	14.2	8.2	8.3	19.1	3.8	8.9	18.8	6.2	8.7	10.3	16.0	7.9	5.3	10.8	9.4	6.4	8.0	8.4	16.3	7.5	3.5	9.3	8.5	6.4	14.9	11.7	12.0	13.2	13.0	5.7	24.7	10.4	11.0	13.4	7.0	10.8	14.1	7.2	14.5	25.9	1.4	10.6	8.8	7.1	7.4	7.3	5.4	7.6	12.8	12.0	12.0	23.0	11.7	2.6	9.4	17.3	8.9	12.1	9.5	7.6	6.5	4.7	6.2	7.3	6.4	7.5	7.5	6.6	5.4	5.8	6.1	5.6	4.9	8.3	4.6	4.1	13.5	5.0	6.6	8.6	10.8	8.0	6.4	6.3	8.4	4.9	6.3	8.0	3.0	7.2	9.3	8.7	16.3	11.9	4.1	2.5	9.4	9.1	3.5	13.7	22.0	3.3	6.7	35.1	6.7	4.5	23.3	10.4	22.2	10.8	5.7	8.1	4.0	12.0	4.8	3.5	11.6	7.5	12.8	6.1	13.1	10.1	14.4	4.8	6.3	9.5	5.8	8.5	7.1	18.9	12.9	8.0	37.4	34.5	8.8	17.4	8.7	4.6	3.0
ERI3	"FLJ22943, PINT1, PRNPIP"	ENSG00000117419	"ERI1 exoribonuclease family member 3"	O43414	1	44221070-44355260	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 823.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027147, HPA029895"	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA027147: AB_1855725, HPA029895: AB_2673239"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (5.94e-2)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.70e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-3)"	12.6	15.4	30.7	8.3	32.0	12.4	15.2	19.7	43.7	15.1	13.4	23.2	10.8	12.3	14.7	22.2	13.4	23.4	12.7	21.1	28.9	25.1	25.3	15.5	11.7	10.0	23.9	26.8	18.6	15.7	24.0	17.2	13.5	22.9	16.7	14.1	14.8	14.7	16.9	35.7	13.3	8.6	17.7	17.9	9.5	10.6	24.4	21.9	9.7	17.6	11.9	11.0	12.5	12.1	18.8	25.3	9.6	22.2	14.8	18.2	15.2	28.6	22.2	28.2	31.2	18.5	23.3	17.7	18.8	25.0	33.4	31.2	14.3	30.7	20.5	31.8	23.1	17.1	16.6	25.2	32.0	23.6	22.9	48.6	22.9	37.5	20.2	27.1	23.1	13.2	23.7	30.1	25.3	34.8	24.8	22.9	22.9	22.3	16.7	21.9	19.3	25.6	21.6	33.4	25.5	35.2	24.7	25.9	30.0	25.9	15.1	48.1	22.7	20.5	28.1	33.2	23.3	18.4	19.1	13.9	22.1	23.1	24.0	28.4	15.9	18.5	22.0	27.4	20.1	27.8	9.4	16.3	9.6	16.7	22.2	18.2	18.8	14.0	16.2	25.3	18.3	16.7	17.2	1.5	14.8	21.3	18.9	18.1	15.2	30.7	32.0	19.7	43.7	28.9	25.1	23.9	26.8	22.9	21.9	23.8	16.8	23.4	29.6	28.0	20.9	13.7	10.2	10.7	9.1	27.9	2.0	80.0	82.9	48.6	192.5	20.2	20.0	0.0	54.5	67.1	42.9	35.8	15.0	21.3	39.5	23.8	113.7	19.6	24.3	823.2	33.6	22.4	45.5	35.1	48.9	30.3	33.0	25.9	34.3	131.8	13.5	6.5	31.1	46.2	48.7	30.2	51.5	15.4	35.1	23.5
ERICH1		ENSG00000104714	"Glutamate rich 1"	Q86X53	8	614746-738106	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003725	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA003725: AB_1853023"	"unprognostic (7.19e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.42e-1)"	20.2	11.7	12.3	35.7	16.9	30.5	18.1	9.0	15.6	13.6	16.0	13.9	13.7	13.1	21.7	25.6	15.3	13.7	17.1	14.7	15.1	11.4	17.6	15.3	19.4	29.3	14.5	14.0	16.9	12.2	13.8	16.1	16.9	16.9	15.4	11.7	14.0	13.5	19.4	17.2	17.0	15.8	16.2	17.0	22.2	14.9	11.8	14.0	21.8	18.2	13.3	25.0	17.1	15.3	11.7	10.2	18.5	20.9	7.2	6.2	6.0	9.1	13.3	7.1	8.5	7.7	9.4	14.8	8.8	4.7	8.1	8.9	8.4	5.9	21.0	4.2	7.4	15.4	15.5	13.0	13.6	5.8	9.1	16.9	14.7	8.6	12.0	8.6	8.9	13.8	10.8	8.9	6.1	7.9	8.4	8.8	18.6	15.0	12.2	8.1	7.6	17.2	15.9	11.2	10.3	5.9	15.6	4.6	14.4	8.9	17.0	3.3	9.2	6.4	8.3	11.7	12.2	3.5	10.7	14.0	6.0	2.8	0.3	9.4	7.9	20.7	22.7	12.2	14.4	6.2	11.4	20.9	7.2	5.4	19.0	4.8	9.7	6.2	5.3	10.2	11.7	5.3	4.7	18.5	7.2	16.8	7.8	4.4	6.0	12.3	16.9	9.0	15.6	15.1	11.4	14.5	14.0	16.9	14.0	41.7	35.5	50.9	39.7	32.4	21.9	18.6	22.9	28.1	23.9	31.4	11.8	51.9	92.9	32.4	12.1	68.4	34.3	23.3	31.9	51.8	34.0	36.4	39.4	27.6	37.0	46.1	18.9	63.8	70.8	7.5	55.8	69.4	33.7	101.0	32.1	18.6	42.9	38.6	38.2	35.4	20.8	38.8	32.3	46.1	50.7	35.8	45.2	57.3	28.7	29.2
ERICH2		ENSG00000204334	"Glutamate rich 2"	A1L162	2	170783786-170798971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 61.2"	"Cell type enriched"	"Detected in many"	8	"Early spermatids: 1704.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Cell line enriched"	"Detected in many"	4	"hTCEpi: 36.9"					"Low region specificity"	"Detected in all"			HPA061010			Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli fibrillar center"	Vesicles	"HPA061010: "	"unprognostic (1.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (9.49e-4)"	"unprognostic (7.57e-3)"	"unprognostic (6.61e-2)"	"unprognostic (9.62e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (8.98e-7)"	"unprognostic (1.03e-1)"	"unprognostic (5.28e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.76e-1)"	0.6	0.3	1.4	0.6	1.1	0.0	1.3	0.6	0.8	2.1	0.6	0.6	0.6	0.0	1.5	1.0	0.6	3.3	0.6	0.9	1.0	1.5	0.9	1.6	4.2	0.6	1.1	0.6	0.6	0.7	0.8	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.1	0.6	0.6	0.6	0.6	1.0	61.2	0.6	0.6	6.7	0.6	0.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	5.4	0.0	0.0	4.6	0.0	0.0	0.2	0.0	0.0	0.9	1.9	4.6	1.1	0.0	0.2	0.0	2.0	0.1	1.1	0.4	0.0	0.7	1.2	2.3	0.0	0.1	4.8	0.2	0.3	0.7	36.9	0.0	8.5	0.1	0.0	0.9	5.1	0.0	0.0	1.9	0.0	0.4	5.7	6.5	0.9	0.0	0.9	0.0	2.6	0.1	0.6	1.2	3.3	0.0	1.3	1.1	0.8	0.7	0.0	1.2	1.0	0.0	0.5	0.0	0.0	0.0	4.6	2.2	3.5	0.0	0.0	0.0	2.7	0.0	0.9	0.0	0.5	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.6	0.8	1.0	1.5	1.1	0.6	0.6	0.6	6.0	19.5	0.0	0.6	0.2	1.3	1.7	5.1	20.1	2.3	1.8	0.0	0.0	11.6	0.7	1704.8	0.0	0.0	0.0	1.5	0.2	1.0	0.2	0.0	2.1	0.0	0.0	7.5	0.0	0.0	202.2	8.9	0.0	0.0	0.0	0.6	1.1	1.9	0.0	7.1	0.3	0.2	6.5	0.3	12.1	9.1	0.1	0.0	0.0	0.1	0.0
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443158-41444765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 78.1"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 73.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"CACO-2: 4.8;Hep G2: 11.1;THP-1: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.2	0.2	0.3	0.0	0.6	0.2	0.3	0.4	21.0	0.2	0.2	27.1	0.4	0.4	0.2	0.4	0.5	1.3	0.2	0.0	10.0	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.9	0.0	78.1	0.2	0.3	0.2	0.1	0.8	0.2	0.2	0.3	0.2	0.2	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	11.6	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	73.4	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064311-98093610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 27.9;retina: 26.7"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 84.1;Ciliated cells: 72.3;Ductal cells: 42.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 5.3"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.3"	"Cell line enhanced"	"Detected in some"		"A549: 6.5;HAP1: 6.0;HEK 293: 8.8;JURKAT: 11.6;RPTEC TERT1: 5.8;RT4: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (9.38e-4)"	0.5	0.2	2.3	0.2	6.7	0.0	0.8	0.4	2.2	2.0	3.3	0.1	3.6	4.3	1.1	0.6	0.7	8.8	13.1	5.4	0.7	2.6	8.7	8.1	1.7	0.7	1.0	2.2	1.6	27.9	0.6	1.7	4.1	1.9	2.2	3.0	26.7	1.3	1.9	0.1	0.6	1.3	0.4	1.0	0.2	9.5	3.4	0.5	0.3	0.6	0.0	0.5	3.1	0.5	0.0	5.3	0.0	0.0	0.0	0.5	0.0	0.0	6.5	0.0	0.0	0.1	0.0	3.8	3.4	1.3	1.8	1.4	0.1	2.0	0.0	5.0	0.9	2.8	0.3	6.0	0.1	2.2	0.0	8.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	11.6	0.0	0.0	0.1	0.1	0.0	0.7	1.4	0.1	2.6	0.0	0.0	0.1	5.8	15.3	3.5	0.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	6.7	0.4	2.2	0.7	2.6	1.0	2.2	1.9	0.5	3.0	0.0	0.0	1.1	0.0	0.0	5.9	84.1	72.3	5.7	7.0	0.0	0.3	0.0	42.6	0.3	0.0	0.7	0.0	16.3	1.5	0.0	3.1	0.0	3.9	0.1	0.0	17.2	0.0	0.0	0.0	0.3	0.8	0.0	0.0	2.3	5.8	17.1	0.0	0.0	19.3	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	3.3	1.3
ERMAP	"BTN5, RD, SC"	ENSG00000164010	"Erythroblast membrane associated protein (Scianna blood group)"	Q96PL5	1	42817088-42844993	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 21.6;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 24.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA042573, HPA054672"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA042573: AB_10794282, HPA054672: "	"unprognostic (9.46e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.48e-2)"	10.0	14.1	9.3	6.7	10.4	25.7	8.4	2.5	9.3	9.3	7.9	12.4	12.2	6.4	9.4	16.7	8.3	10.2	7.4	4.7	9.3	6.3	7.8	13.1	9.8	4.4	10.4	8.3	6.2	11.7	9.8	12.3	12.0	10.8	9.4	8.3	11.8	10.2	8.0	4.0	9.2	9.4	6.5	14.6	8.6	7.8	4.2	11.9	4.8	13.1	3.2	8.1	9.7	8.0	2.4	8.1	3.0	7.1	3.5	5.0	2.9	3.5	4.7	1.5	4.7	5.3	15.5	1.3	7.0	11.7	6.2	6.2	1.9	6.4	3.1	2.5	7.3	2.9	4.4	1.6	2.1	5.7	5.1	5.6	24.9	3.4	1.5	6.6	3.6	12.9	9.4	7.9	2.9	6.8	11.4	4.0	3.8	16.9	3.1	5.7	2.3	1.7	1.3	3.6	2.2	2.6	1.7	2.1	2.9	5.3	5.4	3.3	2.4	6.0	2.2	2.6	2.6	4.4	13.3	6.3	4.7	2.8	3.9	3.2	1.4	2.7	1.3	3.8	3.8	3.0	0.5	6.8	3.0	2.1	7.1	1.2	2.4	2.3	2.2	8.1	1.3	2.0	2.3	2.1	3.5	4.5	2.3	5.0	2.9	9.3	10.4	2.5	9.3	9.3	6.3	10.4	8.3	10.8	11.9	11.9	10.4	0.8	3.1	3.4	1.2	1.7	7.6	6.7	7.9	3.5	21.6	2.5	1.7	3.0	3.2	3.5	2.6	23.3	6.2	1.1	3.6	2.6	2.3	11.6	7.0	11.1	5.2	2.5	11.9	18.9	2.6	6.6	5.0	1.8	5.6	5.0	4.1	3.5	3.9	2.9	3.8	0.0	1.9	0.0	0.9	3.3	2.4	0.9	6.6	0.9
ERMARD	"C6orf70, dJ266L20.3, FLJ11152"	ENSG00000130023	"ER membrane associated RNA degradation"	Q5T6L9	6	169751622-169781584	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 35.6;Late spermatids: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041741	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041741: AB_10804116"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.31e-2)"	12.6	14.4	11.9	16.6	15.6	10.6	13.2	12.4	16.0	10.9	10.1	17.5	18.6	8.6	21.8	25.0	10.1	13.3	11.0	7.2	10.0	9.3	12.1	16.4	9.9	16.6	10.9	14.6	18.7	13.3	14.1	17.7	13.6	12.1	12.0	11.1	16.1	15.4	15.6	13.0	21.8	12.4	12.8	11.7	16.7	10.1	27.4	11.8	15.5	14.8	12.1	15.8	11.2	9.9	7.1	7.0	2.2	13.4	7.3	9.8	6.3	4.0	5.0	9.3	14.2	10.7	12.3	3.7	5.3	10.5	6.4	6.8	3.3	9.4	7.7	5.4	7.7	7.9	11.7	4.3	11.8	6.7	8.1	4.7	10.2	7.4	3.3	15.0	12.6	6.8	12.9	13.0	6.5	18.1	10.8	7.2	13.1	9.6	10.3	10.5	7.4	5.9	11.3	3.1	9.0	4.0	7.4	6.3	11.9	10.0	4.6	3.3	6.2	8.3	10.1	4.1	8.1	6.4	14.1	5.5	5.1	3.0	8.0	5.7	11.0	12.5	6.8	7.8	10.4	8.1	2.2	5.7	1.9	6.9	11.1	6.9	6.2	7.2	7.5	7.0	7.1	8.1	7.5	0.9	7.3	13.4	5.3	9.8	6.3	11.9	15.6	12.4	16.0	10.0	9.3	10.9	14.6	12.1	11.8	3.0	12.0	3.0	3.8	3.7	11.1	2.0	0.0	18.7	5.7	5.2	9.8	10.7	10.0	8.2	35.6	3.6	3.3	0.0	7.4	7.0	5.6	2.3	2.3	7.4	5.2	4.8	5.8	7.4	7.1	38.1	4.0	4.0	3.3	4.6	2.8	12.8	4.6	2.9	4.2	6.8	10.5	6.5	5.2	27.7	15.3	2.8	5.9	3.8	3.9	3.1
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318625-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 106.7"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 2.2;Early spermatids: 1.2;Kupffer cells: 1.2;Macrophages: 1.1;T-cells: 1.9"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 2.2;glioma: 9.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"HAP1: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	1.6	1.4	29.1	2.9	50.5	9.7	1.6	2.7	106.7	1.4	1.8	52.4	0.0	1.8	1.6	1.5	1.7	1.4	1.9	1.6	40.9	21.4	1.5	1.5	2.0	3.1	75.1	18.4	1.5	1.6	1.4	0.1	1.4	54.5	1.5	1.9	4.3	2.4	1.5	1.7	1.9	1.9	1.6	100.9	2.5	2.2	1.7	69.5	0.0	1.6	0.0	2.7	1.7	0.1	1.7	1.3	3.9	1.6	2.4	2.1	0.7	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.2	0.0	2.0	0.0	0.3	21.3	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	0.4	0.2	0.8	2.3	0.3	0.1	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.6	0.0	0.1	0.0	0.3	0.7	1.3	0.0	0.2	0.1	0.2	0.6	3.5	2.0	0.6	1.8	1.0	1.0	2.6	1.6	1.1	2.1	1.2	1.0	0.7	0.8	0.6	0.6	1.7	1.5	1.6	3.9	2.4	1.0	1.3	0.9	0.7	29.1	50.5	2.7	27.9	40.9	21.4	75.1	18.4	54.5	69.5	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0
ERV3-1	"envR, ERV-R, ERV3, H-PLK, HERV-R"	ENSG00000213462	"Endogenous retrovirus group 3 member 1, envelope"	Q14264	7	64990809-65006743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.1;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.5"									"HPA017209, HPA046508"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA017209: AB_2732419, HPA046508: AB_2732525"	"unprognostic (2.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.88e-2)"	27.2	41.3	9.9	9.0	11.7	8.6	18.3	13.8	11.6	9.4	7.1	8.7	5.6	3.9	11.2	31.9	18.9	9.0	17.9	8.4	10.1	7.2	7.3	4.0	10.7	5.6	11.2	9.2	10.6	7.6	9.6	19.3	21.2	11.7	8.1	6.5	9.3	14.9	13.1	5.1	14.2	5.8	8.5	13.2	7.0	6.9	9.4	12.7	12.6	10.2	6.2	10.2	10.5	13.8	0.9	1.2	10.1	2.5	1.4	1.5	1.1	2.1	0.7	12.7	19.5	8.0	3.3	8.6	4.0	4.5	1.4	3.3	0.7	14.2	3.5	3.7	1.5	2.7	2.5	1.7	0.9	2.2	2.6	0.9	1.9	0.6	6.8	0.6	5.2	2.5	3.9	1.1	1.3	0.3	7.5	8.1	4.1	8.4	7.0	5.3	5.3	3.3	3.2	3.6	6.8	0.8	7.7	0.5	2.5	2.2	4.4	2.4	12.3	4.3	1.2	0.4	14.1	3.2	11.5	6.6	4.9	0.6	3.6	2.0	2.2	5.1	1.1	3.9	15.1	2.9	0.1	1.5	3.4	0.9	2.5	0.8	0.7	0.2	0.7	1.2	0.9	0.6	0.6	10.1	1.4	0.8	0.7	1.5	1.1	9.9	11.7	13.8	11.6	10.1	7.2	11.2	9.2	11.7	12.7	3.0	9.6	34.1	15.5	3.8	26.4	1.8	15.3	10.7	11.4	15.7	27.5	14.5	8.3	12.4	5.5	11.3	6.7	23.3	15.3	9.4	6.9	10.3	8.1	2.1	8.2	17.5	13.3	15.4	15.4	4.1	10.6	15.5	10.1	13.6	7.2	14.0	14.3	7.0	9.2	2.2	18.2	6.5	7.1	9.8	9.5	5.0	33.6	25.8	6.0	22.2
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751640	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 32.0;placenta: 26.9"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		5000000	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.3	1.3	1.2	0.4	0.7	0.2	2.8	0.5	3.0	1.3	0.5	0.0	1.4	0.5	0.9	1.3	3.7	0.7	0.4	6.2	0.8	1.0	4.4	0.3	1.8	1.9	0.6	0.2	3.9	1.7	32.0	0.2	26.9	0.8	0.7	0.7	0.8	1.3	3.0	0.2	1.0	0.5	0.4	1.5	1.9	1.1	1.7	0.3	0.0	2.5	3.7	1.2	1.0	1.8	0.6	0.4	1.2	0.1	0.4	0.3	0.0	4.5	0.2	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	28.2	6.0	0.0	0.6	0.1	0.4	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	1.3	20.3	0.0	3.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	1.9	1.8	0.8	0.0	0.0	0.0	15.1	0.4	1.2	0.3	1.9	0.8	0.0	3.0	2.5	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.1	0.5	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.3	0.2	1.1	0.4	0.1	0.4	0.2	0.0	1.2	0.7	0.5	3.0	0.8	1.0	0.6	0.2	0.8	0.3	0.0	0.0	0.0	1.1	0.5	0.0	2.4	0.0	0.0	0.0	7.0	0.0	66.3	0.0	2.3	3.2	0.1	0.0	0.0	0.7	80.6	1.3	1.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.3	0.2	0.4	0.1	14.5	0.0	0.4	1.1
ERVV-1	"ENVV1, FLJ32214, HERV-V1"	ENSG00000269526	"Endogenous retrovirus group V member 1, envelope"	B6SEH8	19	53013921-53016122	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"placenta: 19.7"	"Cell type enriched"	"Detected in some"	31	"Syncytiotrophoblasts: 218.2"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 11.7;SuSa: 9.8"									HPA076115			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA076115: "	"unprognostic (1.04e-3)"			"unprognostic (7.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"		"unprognostic (1.67e-2)"		"unprognostic (9.92e-2)"		"unprognostic (6.75e-2)"	"unprognostic (4.34e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.9	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	19.7		0.8	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.2	0.0	0.0	0.0
ERVV-2	ENVV2	ENSG00000268964	"Endogenous retrovirus group V member 2, envelope"	B6SEH9	19	53044738-53051076	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	105	"placenta: 85.9"	"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 3.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 19.1;SuSa: 12.9;T-47d: 5.4"									HPA076115			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA076115: "				"unprognostic (3.14e-3)"		"unprognostic (2.06e-1)"				"unprognostic (1.31e-1)"			"unprognostic (4.33e-9)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.60e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0
ESAM	W117m	ENSG00000149564	"Endothelial cell adhesion molecule"	Q96AP7	11	124752583-124762290	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 93.0"	"Cell type enhanced"	"Detected in many"	12	"Endothelial cells: 198.2;Ito cells: 127.7;Sertoli cells: 148.8;Smooth muscle cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.7;neutrophil: 5.5"	"Group enriched"	"Detected in many"	9	"B-cells: 6.7;granulocytes: 5.5;T-cells: 1.8"	"Group enriched"	"Detected in some"	10	"HEL: 53.4;HUVEC TERT2: 69.5;TIME: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051043, HPA056293"	Uncertain		Approved	Microtubules		NA	NA		64000000	Microtubules		"HPA051043: AB_2681323, HPA056293: AB_2683089"	"unprognostic (1.52e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.06e-2)"	37.1	6.0	6.6	5.3	9.6	1.3	44.6	3.8	8.2	11.8	6.1	5.4	3.7	4.3	14.5	9.5	10.7	10.3	11.5	20.1	7.5	6.6	15.5	10.2	38.4	6.9	9.1	3.9	8.4	6.4	5.4	5.5	93.0	9.0	10.9	5.0	12.4	5.1	9.8	14.6	5.9	6.4	17.2	7.2	8.2	7.6	5.4	5.9	0.9	44.9	10.9	5.0	11.4	25.4	6.7	0.3	5.5	0.5	0.0	1.8	19.4	0.2	0.4	0.1	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	3.5	0.2	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.3	53.4	0.0	1.9	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	69.5	0.0	0.0	1.5	0.1	0.4	0.0	0.0	0.1	5.0	0.5	0.0	0.2	0.2	0.0	0.5	0.0	0.2	0.0	4.0	0.0	2.0	0.8	0.2	34.8	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.5	0.0	0.1	0.2	0.0	1.4	1.3	0.1	0.3	6.7	1.8	0.6	5.5	0.0	0.0	0.3	0.4	19.4	6.6	9.6	3.8	8.2	7.5	6.6	9.1	3.9	9.0	5.9	35.7	59.6	0.8	0.6	13.5	1.3	10.6	0.0	2.7	4.5	14.0	3.9	0.9	5.0	3.3	4.0	198.2	0.0	0.0	2.1	13.5	8.5	1.1	3.5	0.8	0.9	0.0	0.0	127.7	5.6	13.6	0.9	2.6	11.8	1.0	0.2	0.8	27.0	2.6	0.4	0.0	1.0	148.8	94.7	0.0	0.3	9.5	31.0	0.0	1.7	1.7
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3"	"Group enriched"	"Detected in many"	9	"Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	1.0	1.7	0.5	7.1	0.5	5.5	1.0	0.4	0.6	1.2	9.6	0.1	0.5	11.9	0.6	1.0	5.0	0.3	1.8	1.1	0.7	0.5	1.6	1.4	1.1	4.2	0.5	0.6	0.6	1.0	0.3	0.3	1.5	0.5	0.5	4.5	0.1	1.4	1.4	0.4	1.1	23.2	0.4	0.8	4.7	2.4	10.3	0.2	39.8	0.5	5.3	5.7	1.0	1.8	1.3	1.9	0.8	1.5	0.9	4.6	0.8	25.1	19.1	8.6	10.4	1.1	1.8	4.8	15.1	6.4	14.1	16.1	6.7	5.0	9.3	8.0	3.9	11.8	13.9	10.4	4.1	21.4	7.2	4.4	11.0	8.6	7.1	0.1	5.6	10.3	0.3	0.4	8.2	2.1	1.4	5.2	7.2	8.8	14.2	8.1	4.9	22.6	2.5	5.8	13.8	6.4	10.0	25.7	6.8	4.6	15.2	3.7	5.5	7.6	9.2	3.8	3.3	6.3	6.2	2.3	8.7	18.0	17.5	11.8	1.9	5.0	11.5	4.8	9.4	12.0	0.1	0.7	0.4	0.3	1.5	0.1	1.3	0.7	1.0	1.9	0.1	0.5	0.4	0.8	0.9	0.4	0.2	4.6	0.8	0.5	0.5	0.4	0.6	0.7	0.5	0.5	0.6	0.5	0.2	0.0	6.6	2.2	0.7	2.1	1.5	1.1	0.0	2.7	5.7	0.0	3.9	1.0	0.0	0.3	3.9	0.1	5.3	70.0	0.0	5.5	0.9	0.2	1.1	1.1	4.5	0.0	1.2	0.6	4.1	0.4	1.7	3.5	0.0	0.0	2.3	0.0	0.1	0.8	0.0	0.0	1.8	6.5	0.3	30.1	77.3	0.5	0.8	2.9	4.0	0.9
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797232	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		16000000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	58.5	30.9	32.0	28.6	29.8	24.2	44.5	23.7	32.0	54.4	37.3	29.0	34.2	31.8	53.2	50.4	54.1	40.6	30.3	45.6	30.7	29.3	58.8	82.2	28.2	31.4	31.7	32.1	61.3	24.9	27.5	47.5	26.4	28.6	55.2	41.7	32.5	31.5	45.2	47.4	29.7	38.4	50.8	37.4	31.1	32.1	32.4	26.7	65.5	78.9	50.9	31.7	62.5	36.9	30.1	48.7	15.1	37.1	29.8	35.7	26.4	22.1	12.9	39.1	26.9	45.9	75.9	10.5	31.9	46.3	44.5	34.7	21.8	27.2	25.2	9.6	38.2	33.3	22.7	43.0	37.7	57.0	28.8	44.7	32.6	13.0	33.5	37.6	63.6	14.0	51.8	35.0	28.7	38.7	53.7	41.7	43.5	31.8	6.8	73.6	21.7	56.4	42.3	10.1	28.7	24.5	44.9	23.0	17.0	63.1	9.0	19.4	22.0	14.2	12.1	25.6	28.1	23.2	36.5	27.8	16.4	19.4	31.5	29.4	4.6	9.9	21.8	35.4	36.5	21.9	7.7	37.1	15.1	15.0	31.5	24.6	30.1	30.0	23.0	40.8	25.3	35.7	27.9	4.3	29.8	28.0	48.7	24.9	26.4	32.0	29.8	23.7	32.0	30.7	29.3	31.7	32.1	28.6	26.7	50.6	42.5	68.7	203.4	119.1	47.0	89.2	124.9	77.6	61.4	146.5	39.3	134.7	305.1	153.5	36.2	95.8	72.1	46.7	90.4	115.2	195.1	96.4	94.6	148.9	197.0	20.6	104.5	112.3	138.2	18.5	247.9	128.5	156.9	100.0	108.9	147.8	82.8	115.8	198.7	400.9	62.5	148.8	210.1	67.4	44.1	113.0	62.2	82.2	173.0	130.7
ESF1	"bA526K24.1, C20orf6"	ENSG00000089048	"ESF1 nucleolar pre-rRNA processing protein homolog"	Q9H501	20	13714322-13784886	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047083, HPA050396"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047083: AB_2679924, HPA050396: AB_2681111"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (7.81e-9)"	"unprognostic (2.52e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.91e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.57e-1)"	12.4	10.5	13.5	9.7	19.7	7.1	11.9	17.0	17.4	10.8	8.8	6.9	9.2	7.7	11.2	11.5	11.9	9.2	9.1	9.7	17.2	11.6	10.8	14.6	7.0	10.3	16.8	17.5	14.1	8.7	12.9	20.0	11.9	17.2	12.2	10.7	4.2	8.9	8.6	29.9	11.3	7.5	12.9	28.9	10.7	8.1	14.3	17.9	9.2	11.5	12.1	10.1	11.2	9.2	13.8	14.6	2.0	10.6	11.5	12.4	3.7	13.4	12.8	11.9	6.0	9.1	11.0	6.6	14.4	8.8	10.5	9.0	13.6	12.7	17.7	7.3	6.8	19.6	20.7	17.7	14.4	18.7	4.7	8.4	23.3	5.2	31.9	12.7	28.0	6.4	8.8	10.3	17.2	14.0	7.8	7.9	9.2	32.3	8.1	11.9	11.9	21.2	16.8	11.4	12.5	7.7	13.8	29.5	12.9	7.4	11.9	11.7	7.2	11.6	18.3	17.9	11.6	9.2	12.3	10.7	16.2	11.2	11.8	26.6	8.2	19.7	21.7	6.8	12.3	14.7	1.8	6.9	2.0	8.7	8.6	10.0	13.6	10.0	9.3	6.9	13.8	12.4	11.3	0.4	11.5	10.6	14.6	7.5	3.7	13.5	19.7	17.0	17.4	17.2	11.6	16.8	17.5	17.2	17.9	20.8	32.3	50.2	39.5	55.0	83.6	53.4	40.8	40.2	51.2	31.4	43.2	41.7	28.2	45.6	67.2	39.8	42.3	0.0	36.5	34.4	44.1	25.1	25.4	49.7	38.2	90.6	46.6	38.1	29.7	20.6	60.4	41.3	25.3	49.5	47.3	45.9	48.7	42.1	69.3	31.9	67.2	32.3	50.5	168.4	174.8	46.9	34.7	29.9	52.5	31.5
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Predicted intracellular proteins"	Hearing	Actin-binding	"Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.4;liver: 54.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 302.8;Late spermatids: 360.4;Muller glia cells: 292.0;Paneth cells: 221.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 6.0"	"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.6;memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	37	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.0;Hep G2: 27.1;SK-BR-3: 55.6;T-47d: 18.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA028674, HPA060220"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	1.4	0.6	2.5	0.8	6.7	2.9	6.0	0.7	13.3	44.8	0.6	9.2	27.1	1.2	19.7	9.9	6.3	1.2	0.6	1.0	0.1	14.3	54.9	1.6	0.6	0.6	0.6	2.4	0.6	12.9	12.1	1.3	0.6	2.6	1.7	19.5	2.9	4.7	0.6	27.1	70.4	1.0	0.6	0.6	0.4	37.7	0.6	1.2	0.7	2.4	3.2	0.8	5.9	0.0	0.0	0.0	0.0	0.0	3.6	0.3	4.6	0.2	0.2	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	10.1	0.5	0.1	2.3	0.0	0.0	11.1	0.8	0.0	0.0	0.6	0.2	0.1	0.2	27.1	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.3	5.7	0.0	0.0	9.4	0.0	0.3	0.2	1.2	4.2	0.0	0.1	3.6	0.0	0.0	7.3	0.3	1.3	55.6	1.7	0.1	18.5	2.4	5.3	0.0	0.2	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.6	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.6	0.8	6.0	0.7	1.0	0.1	0.6	0.6	0.6	0.6	0.0	1.1	1.4	1.7	6.9	5.5	1.1	5.1	1.4	1.2	8.7	64.8	2.2	11.6	0.3	114.4	0.6	302.8	23.3	2.9	0.4	0.4	1.4	0.0	99.9	0.2	0.0	5.8	3.1	2.9	360.4	3.4	0.3	0.0	0.0	16.1	292.0	0.1	221.0	2.1	91.6	68.8	0.0	0.0	2.6	2.5	19.8	5.5	0.8	19.0	3.2
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 64.5;endometrium 1: 68.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 36.0;Hepatocytes: 48.4;Horizontal cells: 58.8"	"Group enriched"	"Detected in many"	9	"breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"MCF7: 24.9;T-47d: 32.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	3.0	0.9	0.5	1.6	0.5	0.2	16.2	0.8	0.4	64.5	1.5	0.2	2.2	0.1	68.9	27.7	1.1	26.7	1.9	1.1	0.5	0.8	1.5	6.6	3.6	1.6	0.4	0.1	14.2	0.4	0.0	9.3	0.9	0.6	3.6	0.1	2.6	1.6	4.1	2.0	0.6	0.5	20.8	0.4	1.6	0.3	1.9	0.4	1.9	1.3	2.2	2.5	3.8	23.7	0.6	1.0	0.0	0.8	0.3	2.5	1.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.0	0.0	0.0	0.6	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.1	32.2	0.0	0.0	0.1	0.1	0.3	0.0	3.0	0.5	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.3	0.2	1.0	0.6	1.3	0.4	1.0	0.4	2.5	0.9	0.0	0.3	0.0	0.0	0.3	1.0	0.5	0.5	0.8	0.4	0.5	0.8	0.4	0.1	0.6	0.4	0.0	0.6	0.0	1.4	0.9	3.8	4.5	0.0	1.4	1.2	0.0	7.9	0.1	1.7	0.0	36.0	0.6	0.0	0.0	0.2	0.1	4.7	0.6	2.3	48.4	0.9	58.8	1.7	6.7	4.7	6.9	3.7	2.4	1.7	0.0	0.0	2.7	0.2	0.0	2.1	3.3	4.0	0.0	1.4	1.6	1.2	1.5	0.1	0.0	0.0	8.4
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305572-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053785, HPA077297"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"		Yes	No			"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: AB_2682260, HPA077297: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	8.2	9.6	6.0	8.9	7.7	7.9	17.8	9.8	9.4	4.3	32.4	4.9	18.3	43.1	4.6	6.2	17.1	4.1	15.7	45.2	6.8	5.0	21.4	26.9	8.7	9.2	10.4	5.2	2.5	20.5	10.1	4.6	11.0	8.0	7.5	12.6	6.0	28.7	14.9	78.3	10.5	46.4	7.1	7.4	9.3	14.1	2.2	6.0	6.0	8.2	27.1	10.0	8.5	12.0	4.1	4.2	8.5	8.4	2.6	5.4	2.4	9.8	15.8	3.9	9.5	5.3	5.2	21.5	9.7	4.7	3.6	3.6	14.5	12.0	13.5	18.2	5.1	9.6	25.4	6.6	13.1	1.4	9.1	8.5	8.7	18.7	11.4	7.4	14.8	22.0	7.2	20.0	8.2	10.8	5.1	5.1	7.2	14.7	7.5	6.0	22.2	7.2	21.0	10.9	11.9	30.1	7.7	7.7	30.3	12.1	20.8	8.3	10.2	4.9	33.0	31.2	2.3	10.2	14.7	11.0	6.7	8.0	18.7	9.8	11.6	9.5	8.9	10.9	14.5	5.2	0.3	4.7	7.1	4.4	8.4	4.4	2.9	3.8	3.1	4.2	4.1	4.1	5.4	8.5	2.6	7.5	3.2	5.1	2.4	6.0	7.7	9.8	9.4	6.8	5.0	10.4	5.2	8.0	6.0	8.9	27.2	29.9	28.0	16.6	29.0	7.9	132.5	5.3	12.5	19.2	31.4	79.6	46.4	50.0	2.6	9.0	143.7	46.7	68.6	49.1	11.9	19.0	7.0	154.8	29.6	31.8	36.4	44.2	93.5	0.2	6.1	20.2	16.9	19.8	71.8	17.3	67.0	94.7	11.3	48.1	19.0	12.9	10.3	2.8	8.0	16.2	112.2	15.3	83.1	49.8
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 14.5;retina: 50.2"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 14.7;Horizontal cells: 52.4;Late spermatids: 27.9;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.8;K-562: 9.7;U-266/70: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074772			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA074772: "	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.2	0.1	0.3	0.0	1.0	0.0	0.6	0.3	0.6	0.1	0.0	0.8	0.3	0.0	0.1	0.4	0.1	0.1	0.0	7.8	0.3	0.4	14.5	0.1	0.1	0.9	0.5	0.4	0.0	0.2	0.0	0.3	0.1	1.3	0.2	0.0	50.2	0.1	0.4	9.5	0.0	0.1	0.0	0.5	1.2	5.1	2.0	0.2	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	1.5	0.5	0.0	0.1	0.0	0.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	9.7	0.4	0.0	1.3	0.0	0.4	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	1.0	0.1	0.5	4.9	1.4	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.0	0.3	0.6	0.3	0.4	0.5	0.4	1.3	0.2	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.0	0.0	0.0	0.0	2.0	0.0	11.6	0.0	14.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	52.4	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.3	40.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
ESRRG	NR3B3	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5;parathyroid gland: 37.2;placenta: 40.8"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 55.0;Syncytiotrophoblasts: 179.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"pons and medulla: 49.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 15.4;SH-SY5Y: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.5	5.1	2.8	0.4	3.3	0.2	2.9	6.9	10.3	1.4	0.7	0.7	2.2	4.0	0.5	1.5	1.4	2.1	0.8	8.3	3.2	2.6	22.0	0.8	0.7	0.4	6.8	1.7	0.8	4.4	37.2	9.9	40.8	49.5	2.6	0.4	10.7	11.0	2.4	6.3	1.5	3.7	0.9	2.6	1.0	22.2	1.0	1.5	0.0	4.6	7.2	0.4	1.0	0.7	0.4	0.2	1.5	0.0	0.2	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	15.4	2.4	1.7	5.5	29.5	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.1	0.1	1.5	0.2	0.0	0.2	0.0	0.0	2.8	3.3	6.9	10.3	3.2	2.6	6.8	1.7	49.5	1.5	0.0	2.6	0.0	3.3	0.2	26.3	45.0	7.6	18.7	1.2	22.7	55.0	29.1	46.4	3.1	4.5	0.3	0.0	0.0	2.1	3.1	1.5	8.3	0.0	0.8	3.8	46.1	7.9	0.6	0.8	4.6	0.3	0.0	8.5	0.0	0.7	12.3	0.6	0.2	0.7	23.0	34.7	0.0	1.0	1.4	0.1	0.3	179.8	0.0	0.2	1.4
ESS2	"bis1, DGCR13, DGCR14, DGS-H, DGSI, ES2, Es2el, ESS-2"	ENSG00000100056	"Ess-2 splicing factor homolog"	Q96DF8	22	19130279-19144684	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 13.0;monocytes: 18.0;Pancreatic endocrine cells: 12.5;Syncytiotrophoblasts: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 11.7;RH-30: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001221, HPA001222"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001221: AB_1078645, HPA001222: AB_1078647"	"unprognostic (8.31e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.71e-3)"	4.5	4.0	6.3	5.1	7.2	2.5	4.2	18.9	11.8	5.2	7.9	6.3	3.8	3.6	6.8	4.4	6.4	7.3	4.1	5.9	6.0	6.1	3.9	2.9	4.7	4.9	5.7	6.8	9.4	3.7	5.4	5.2	4.9	5.6	6.4	4.2	5.0	4.4	9.6	6.3	9.3	4.1	6.9	5.0	5.6	5.0	7.2	5.8	6.1	5.0	5.5	6.0	7.2	5.5	1.2	1.5	1.7	1.1	1.8	1.4	1.1	2.1	3.9	2.2	2.6	3.6	0.6	1.0	2.0	1.2	3.4	2.8	3.0	0.7	2.7	0.7	0.9	0.8	3.7	6.6	1.1	1.7	4.3	7.5	0.8	3.3	0.5	0.9	3.4	2.6	0.5	3.9	2.4	0.7	0.9	0.6	2.1	11.7	0.3	1.5	2.1	2.1	2.0	1.9	2.3	3.1	3.2	11.0	0.0	0.9	1.6	5.5	1.2	0.9	1.7	2.4	1.5	1.1	1.3	0.5	3.0	4.4	2.9	1.5	1.5	3.2	1.1	1.0	2.1	2.0	0.3	1.1	1.7	0.9	0.4	0.4	0.4	1.2	0.6	0.7	1.2	1.3	1.4	0.9	1.8	0.5	1.5	0.6	1.1	6.3	7.2	18.9	11.8	6.0	6.1	5.7	6.8	5.6	5.8	6.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	8.1	3.4	8.7	0.0	13.0	11.6	11.7	0.0	0.0	0.0	0.0	9.1	10.4	0.0	0.0	4.7	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.0	0.0	0.0	12.5	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
ETNK1	"EKI, EKI1"	ENSG00000139163	"Ethanolamine kinase 1"	Q9HBU6	12	22625075-22690665	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 201.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010712, HPA029407"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA010712: AB_2668349, HPA029407: AB_2673026"	"unprognostic (2.06e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.98e-3)"	"unprognostic (8.30e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.53e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.75e-4)"	15.7	17.7	15.2	41.1	19.4	13.7	16.9	19.7	22.2	12.9	33.2	16.4	14.6	27.2	16.6	24.1	14.7	13.1	27.3	10.4	15.6	23.9	22.0	30.2	19.6	18.5	17.2	15.8	17.2	14.9	15.8	30.6	13.4	18.9	13.8	19.5	15.9	16.7	14.7	8.2	17.8	24.5	10.0	17.1	18.3	53.7	22.3	17.5	33.4	17.6	8.2	16.5	14.2	18.6	16.2	10.7	28.1	17.6	14.0	15.7	13.4	6.7	14.0	15.6	14.4	11.3	11.4	11.6	8.0	6.0	8.3	8.6	10.8	17.1	20.1	7.2	5.2	8.7	5.1	13.7	3.8	15.0	16.7	11.1	16.6	6.2	9.3	10.8	15.9	15.3	7.4	3.7	11.2	9.5	13.3	10.3	7.9	19.9	8.5	11.0	4.6	17.3	32.4	30.2	8.7	9.2	15.6	13.8	16.1	13.8	9.2	5.0	8.8	8.7	7.6	12.5	22.4	11.8	15.4	8.8	6.6	10.6	8.9	12.0	6.2	7.7	21.6	8.4	10.4	11.0	28.1	11.7	12.1	12.9	17.5	12.7	16.2	14.1	11.9	10.7	13.0	15.7	15.5	11.5	14.0	17.6	9.7	15.3	13.4	15.2	19.4	19.7	22.2	15.6	23.9	17.2	15.8	18.9	17.5	44.7	25.1	40.9	63.3	128.1	40.4	11.0	53.5	72.3	35.2	41.8	47.1	27.9	23.2	26.3	201.9	28.7	55.0	0.0	39.6	20.3	28.6	70.5	33.5	38.4	37.5	25.4	103.9	27.6	78.9	26.1	22.5	44.7	64.1	22.6	52.6	21.4	29.0	46.1	20.1	26.4	35.5	38.8	44.3	47.7	15.1	148.8	63.0	39.2	36.0	60.2
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742040-108763054	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.5;liver: 111.0"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 9.4;Hepatocytes: 22.6;Muller glia cells: 6.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.0;Hep G2: 4.3;NTERA-2: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Approved		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	1.2	1.9	50.8	1.3	51.3	1.2	1.3	7.9	53.5	1.3	1.2	13.4	0.0	1.3	1.4	1.2	1.3	1.2	1.4	3.2	37.5	20.1	6.2	111.0	1.2	1.2	26.0	28.7	1.3	1.2	1.4	0.1	1.2	15.7	1.2	1.2	0.5	19.9	1.3	1.6	1.2	1.2	1.2	7.3	1.6	10.4	1.5	18.7	0.0	1.9	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.1	11.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	2.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.9	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	51.3	7.9	24.9	37.5	20.1	26.0	28.7	15.7	18.7	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.6	1.0	1.3	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ETV1	ER81	ENSG00000006468	"ETS variant 1"	P50549	7	13891228-13991425	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 90.0;salivary gland: 45.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 2: 112.4;Cardiomyocytes: 72.8;Intestinal endocrine cells: 190.4"	"Cancer enhanced"	"Detected in all"		"glioma: 22.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 90.0"	"Cell type enriched"	"Detected in single"	5	"T-reg: 3.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.2;hTERT-RPE1: 25.6;SCLC-21H: 26.3;U-87 MG: 51.8;WM-115: 25.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 418.9"	"HPA068389, HPA077249"		Supported	Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA068389: , HPA077249: AB_2686829"	"unprognostic (2.45e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.64e-7)"	"unprognostic (7.08e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	2.5	12.4	8.1	1.1	11.7	0.2	4.4	90.0	35.2	1.4	2.4	3.1	0.1	1.2	2.4	1.3	1.5	1.1	9.2	18.0	7.0	4.5	2.1	2.0	14.9	0.7	4.5	6.9	1.0	1.6	11.4	7.4	1.9	8.3	3.1	2.4	0.9	45.8	7.1	0.9	1.5	1.9	2.0	3.5	4.5	1.7	4.5	2.9	0.3	6.5	0.9	4.7	1.8	1.3	0.0	0.0	0.0	0.6	0.0	3.1	0.2	0.0	1.6	11.6	22.2	4.1	12.2	0.0	1.0	3.9	0.6	2.6	0.0	5.3	0.0	1.2	1.8	3.2	0.1	0.4	1.2	1.4	0.3	0.5	0.6	1.0	0.0	2.4	3.8	1.5	3.6	0.0	7.6	0.6	25.6	5.0	0.3	3.4	0.1	4.7	0.0	0.0	0.0	17.5	0.6	11.8	0.0	7.1	0.9	7.9	0.1	26.3	5.1	0.0	0.4	6.3	4.2	0.4	0.1	2.7	2.3	0.7	4.5	4.3	4.0	1.2	0.0	51.8	0.2	25.6	0.0	0.2	0.0	0.1	0.6	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	8.1	11.7	90.0	10.9	7.0	4.5	4.5	6.9	8.3	2.9	17.9	112.4	0.0	2.5	0.9	4.2	72.8	38.2	1.4	1.2	3.5	0.0	0.4	5.0	2.7	18.7	5.2	0.0	0.0	0.8	0.3	4.2	0.2	2.3	11.0	2.6	4.8	190.4	1.8	6.0	6.6	1.4	0.8	11.8	0.0	0.7	12.2	0.9	0.0	32.5	2.7	0.4	19.4	8.2	0.5	1.0	1.1	0.2	0.7	1.1	0.3
ETV3	PE-1	ENSG00000117036	"ETS variant 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 155.1;Suprabasal keratinocytes: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004794, HPA073211"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA004794: AB_1078761, HPA073211: "	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	15.2	7.0	8.9	9.2	10.1	17.8	10.9	9.0	9.3	14.2	12.7	10.2	13.1	13.0	13.1	10.6	20.8	10.8	11.3	9.4	8.6	7.7	6.4	7.4	13.0	8.1	8.9	5.7	11.8	7.2	25.9	7.5	19.5	9.9	12.7	8.6	9.7	11.0	8.1	9.9	37.2	15.1	13.2	7.1	10.7	10.4	8.9	11.0	14.4	8.4	13.6	17.0	14.0	14.3	4.4	7.4	8.9	8.1	6.6	10.8	3.8	6.9	6.9	7.2	6.1	10.8	7.2	6.1	6.5	6.9	6.6	6.2	7.3	6.9	8.4	8.4	8.0	3.5	10.8	7.9	10.1	8.5	18.3	5.0	7.0	7.1	3.9	6.5	11.0	11.1	8.0	11.9	9.8	8.2	5.2	6.6	5.5	8.1	6.2	7.3	9.2	3.3	6.2	23.4	10.1	5.3	5.1	8.5	9.6	4.9	26.2	6.0	11.7	7.1	17.0	17.3	13.2	8.6	12.2	11.2	8.3	7.4	8.0	8.2	15.2	7.8	10.2	9.6	6.4	27.3	8.3	8.1	5.4	7.9	6.7	10.8	3.8	6.9	7.8	7.4	4.4	7.2	6.3	8.9	6.6	6.2	2.2	5.2	3.8	8.9	10.1	9.0	9.3	8.6	7.7	8.9	5.7	9.9	11.0	32.8	15.2	9.0	15.3	62.5	2.5	7.3	10.2	24.1	20.5	12.2	9.8	6.4	0.0	5.2	7.3	14.6	16.6	0.0	5.5	6.6	20.6	12.8	21.9	6.8	8.3	1.6	10.3	16.5	13.7	4.7	3.7	27.5	15.1	155.1	11.3	3.8	8.0	11.8	4.2	2.2	5.4	12.9	11.2	6.4	9.0	68.8	12.5	22.4	11.3	42.4
ETV4	"E1A-F, E1AF, PEA3"	ENSG00000175832	"ETS variant 4"	P43268	17	43527844-43579620	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 38.4"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 10.2;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.2;Intestinal endocrine cells: 14.3;Syncytiotrophoblasts: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 45.2;Hep G2: 42.4;SK-MEL-30: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005768	Approved		Supported	"Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli rim"	"Mitotic chromosome"	"HPA005768: AB_1848294"	"unprognostic (2.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.58e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.08e-2)"	"prognostic favorable (7.60e-4)"	"unprognostic (1.69e-1)"	0.6	2.4	1.4	0.9	1.4	0.0	6.8	1.6	8.3	3.6	3.3	0.4	1.3	5.7	3.4	2.2	9.9	2.4	38.4	2.6	1.8	1.3	7.8	1.4	2.5	0.4	2.3	1.1	1.2	23.8	19.3	19.7	11.6	2.7	4.7	1.6	1.7	4.9	4.5	1.3	6.7	3.8	1.2	1.8	0.5	3.6	1.3	0.5	0.3	6.6	15.0	12.1	3.1	5.3	0.2	0.0	1.3	0.2	0.0	0.6	0.1	5.9	16.8	20.6	45.2	0.8	5.3	4.6	1.9	5.3	3.8	3.9	9.4	8.6	0.0	1.1	1.0	9.4	10.9	0.7	10.1	3.4	0.2	0.1	0.5	2.7	42.4	1.1	11.4	5.4	0.9	0.3	14.6	9.1	4.3	8.1	0.0	11.8	0.0	7.8	2.4	0.0	20.3	29.8	30.4	28.2	24.5	2.5	14.4	8.5	4.3	0.0	18.4	0.5	1.1	48.9	11.8	0.2	3.4	3.7	2.7	13.5	4.0	5.4	1.8	11.3	0.0	4.9	2.2	15.9	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.6	1.3	0.0	0.0	0.0	0.0	0.1	1.4	1.4	1.6	3.6	1.8	1.3	2.3	1.1	2.7	0.5	0.0	0.0	0.0	2.1	1.6	1.1	0.6	10.2	1.4	3.4	0.0	0.0	2.2	14.9	6.8	2.8	0.6	0.9	0.0	0.9	11.2	1.7	0.4	0.0	0.0	0.7	0.0	14.3	0.6	0.0	3.9	0.3	0.0	3.3	0.0	0.8	7.7	2.7	2.3	0.4	0.0	0.3	0.0	0.8	0.0	0.0	1.0	12.5	0.0	2.5	3.1
ETV6	TEL	ENSG00000139083	"ETS variant 6"	P41212	12	11649854-11895402	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.7;NB-4: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA000264	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA000264: AB_611466"	"unprognostic (4.03e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (9.38e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.66e-8)"	"unprognostic (1.33e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.54e-5)"	17.2	8.9	5.1	20.0	7.6	32.8	20.4	1.6	9.1	10.5	14.5	6.0	9.8	7.2	10.8	14.2	11.3	8.9	15.3	6.7	5.6	3.8	9.2	9.6	16.0	13.4	6.0	3.1	10.5	10.4	8.4	8.7	7.7	7.4	14.9	11.0	8.0	41.9	12.4	6.9	23.9	14.6	25.0	9.4	17.8	9.7	4.7	5.7	30.6	10.0	10.0	19.9	19.0	15.8	2.9	6.2	11.4	7.1	2.4	2.2	1.3	2.6	3.5	3.2	5.6	2.5	2.3	3.9	1.9	3.3	2.5	3.0	0.2	12.4	2.2	1.9	3.3	3.0	3.4	1.4	5.9	3.1	39.7	0.7	14.0	1.9	1.3	3.1	14.7	15.3	4.6	3.7	2.5	5.2	4.9	7.6	10.2	1.0	7.4	2.3	1.7	8.3	21.1	5.3	2.7	0.9	2.3	3.1	5.7	5.8	16.5	0.6	3.3	3.8	3.7	3.6	5.4	1.2	9.3	8.6	5.7	4.9	1.9	4.1	3.3	2.5	1.2	3.7	0.1	6.5	5.6	5.7	6.6	1.5	6.6	2.0	2.9	2.2	1.4	4.1	2.3	1.3	0.8	11.4	2.4	7.1	6.2	1.4	1.3	5.1	7.6	1.6	9.1	5.6	3.8	6.0	3.1	7.4	5.7	6.0	8.1	21.4	28.1	13.3	1.9	7.5	17.8	28.1	22.7	14.0	5.9	11.8	1.7	15.2	4.5	23.5	22.5	0.0	30.8	3.6	10.8	33.7	10.4	9.3	17.1	0.0	31.2	38.6	48.1	3.6	7.2	48.8	27.0	40.5	26.8	4.8	31.2	24.9	10.3	7.9	4.0	19.4	28.8	0.6	7.0	19.6	7.2	14.6	20.4	60.6
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.4;pancreas: 32.3"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 71.0;Proximal tubular cells: 53.7;Syncytiotrophoblasts: 104.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.2;U-138 MG: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	0.6	0.3	0.3	0.7	0.5	0.0	1.2	0.3	0.2	3.7	0.6	0.1	11.4	0.5	1.6	5.1	0.5	1.3	0.4	0.6	0.3	0.3	23.6	69.4	15.2	0.1	0.8	0.0	0.8	32.3	0.8	0.8	26.6	0.5	0.6	0.2	5.7	14.3	13.5	0.9	1.5	1.1	0.7	0.4	5.9	0.4	2.2	0.3	3.3	1.2	0.8	0.8	0.3	0.6	0.8	0.0	0.0	0.0	0.0	1.1	0.7	0.3	4.6	0.5	0.1	1.0	7.1	0.5	21.7	14.6	19.4	9.9	0.1	0.4	0.0	2.0	27.2	17.8	3.0	0.5	4.6	12.2	0.0	0.3	0.0	0.8	14.4	0.7	0.0	0.0	5.0	2.7	23.9	11.0	19.5	12.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	1.0	0.0	7.5	2.4	0.0	0.0	10.7	0.1	0.3	0.5	2.0	0.1	16.6	0.7	0.0	0.1	9.8	36.5	15.3	0.6	22.6	0.2	0.0	0.0	20.7	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.3	0.3	0.8	0.0	0.5	0.3	38.7	30.7	2.7	9.2	2.5	0.8	0.2	0.0	1.4	36.4	10.4	0.0	33.7	23.2	27.0	11.0	1.3	0.0	0.0	14.2	17.5	2.1	5.2	0.0	71.0	3.2	0.0	1.7	3.7	0.6	8.2	0.3	0.8	27.0	0.0	0.0	0.0	15.1	0.0	0.7	53.7	0.0	0.0	1.0	1.7	0.4	0.6	104.4	0.0	0.0	10.0
EVA1B	"C1orf78, FAM176B, FLJ10647"	ENSG00000142694	"Eva-1 homolog B"	Q9NVM1	1	36322031-36324154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 229.9;Ito cells: 91.4;Syncytiotrophoblasts: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 20.0;NB-4: 24.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041928, HPA043537"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041928: AB_2677752, HPA043537: AB_2678538"	"prognostic favorable (4.58e-4)"	"unprognostic (5.66e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.79e-5)"	"unprognostic (1.87e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	7.2	5.9	3.3	5.0	2.6	3.1	10.6	1.7	3.7	9.4	4.4	2.5	4.1	8.9	9.8	3.8	4.1	5.1	4.2	7.7	2.4	1.1	10.5	2.8	6.3	8.1	3.4	1.7	8.9	1.9	1.3	2.0	23.3	3.2	7.4	0.5	2.9	7.8	4.3	3.6	6.9	8.1	6.4	3.4	10.4	3.9	5.1	2.9	2.6	9.2	1.7	2.5	5.4	8.3	0.0	1.1	5.8	2.1	3.5	2.2	0.3	2.8	1.7	1.4	2.6	5.2	14.7	7.6	20.0	13.6	3.4	3.8	2.9	2.0	0.4	6.6	5.8	0.7	4.4	0.1	0.7	0.7	2.3	4.9	2.6	1.8	2.3	11.1	0.1	1.5	13.1	0.0	4.2	0.4	5.3	5.2	0.7	0.9	1.0	2.2	3.3	0.1	24.7	1.6	0.2	7.7	1.6	0.3	4.2	2.7	0.6	1.1	3.4	2.0	2.2	7.9	2.2	0.3	1.8	8.8	5.4	0.6	7.9	2.2	1.1	0.3	0.6	3.2	1.6	4.4	5.8	2.1	0.0	0.4	0.8	1.4	0.0	0.8	1.2	1.1	0.0	0.0	0.1	3.7	3.5	0.3	0.0	2.2	0.3	3.3	2.6	1.7	3.7	2.4	1.1	3.4	1.7	3.2	2.9	0.0	0.0	6.9	16.7	14.3	0.0	1.6	2.5	0.0	1.2	7.0	0.0	44.7	1.7	17.7	5.6	44.2	0.2	0.0	12.8	229.9	52.8	37.6	4.6	0.4	40.9	0.0	0.0	91.4	28.8	20.1	46.9	15.6	11.8	6.4	0.0	10.9	23.2	0.0	45.6	6.3	0.5	25.8	41.1	9.3	2.4	10.8	134.9	9.5	0.2	17.8
EVC	DWF-1	ENSG00000072840	"EvC ciliary complex subunit 1"	P57679	4	5711197-5814305	"Disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 8.0;Melanocytes: 5.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.4;hTERT-HME1: 26.4;hTERT-RPE1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008703, HPA016046"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008703: AB_1078765, HPA016046: AB_1848299"	"unprognostic (1.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (5.60e-9)"	"unprognostic (3.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (9.47e-5)"	5.0	2.9	2.5	4.6	2.7	0.0	4.1	1.9	2.3	13.2	4.3	1.8	8.4	0.6	17.2	10.1	6.0	8.1	16.0	3.8	2.2	2.2	26.5	3.7	6.4	1.0	2.3	1.4	20.2	9.2	14.9	2.3	1.8	2.9	10.2	1.6	12.0	9.1	5.7	2.4	4.2	2.8	15.8	2.4	2.1	3.6	5.3	1.0	1.0	6.9	3.9	3.8	7.5	9.0	0.1	0.3	1.2	0.1	0.1	0.5	0.0	3.0	3.9	2.2	5.7	14.3	20.7	0.8	6.9	26.4	8.0	10.4	0.0	0.0	0.0	2.2	10.9	13.4	3.7	2.3	5.7	6.6	5.1	1.5	0.0	2.2	1.0	10.6	0.0	0.6	10.2	8.4	10.7	26.4	22.9	5.5	0.0	0.0	0.0	18.5	0.0	0.0	0.0	2.4	0.0	3.6	4.7	6.0	0.0	2.8	0.5	1.2	3.7	0.0	0.0	2.8	2.2	1.4	0.2	9.6	6.8	1.3	4.8	6.0	4.2	3.4	0.3	19.6	0.0	6.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.3	0.5	0.0	2.5	2.7	1.9	2.3	2.2	2.2	2.3	1.4	2.9	1.0	3.0	2.9	0.0	1.6	3.1	0.0	1.6	2.5	1.4	1.2	3.5	0.0	0.0	1.7	0.4	0.4	0.0	0.0	0.0	0.0	0.0	8.0	0.7	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.9	0.0	5.0	0.0	0.0	2.1	0.2	0.0	0.7	1.1	0.0	0.0	1.7	0.0	0.0	2.5	0.1	0.0	0.0	1.1
EVC2	LBN	ENSG00000173040	"EvC ciliary complex subunit 2"	Q86UK5	4	5542772-5709548	"Disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 5.5;Fibroblasts: 5.3;Leydig cells: 10.6;Peritubular cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.0;BJ hTERT+: 8.9;HHSteC: 12.4;hTERT-HME1: 9.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040910, HPA048122"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA040910: AB_2677195, HPA048122: AB_2680272"	"unprognostic (6.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.57e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (1.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.61e-2)"	"unprognostic (6.29e-5)"	6.9	1.2	1.2	7.6	1.6	0.3	15.7	1.6	1.0	13.2	5.2	1.1	3.4	1.3	14.1	8.5	5.1	6.3	8.2	4.7	1.9	0.7	8.0	1.4	4.1	3.7	1.6	0.5	14.4	5.0	8.1	2.5	2.6	1.3	8.6	1.3	7.7	5.0	4.2	2.8	5.6	2.9	14.2	1.7	3.6	3.5	4.5	0.6	1.1	12.4	3.7	7.9	7.2	24.6	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.0	2.5	0.0	6.1	8.0	9.0	0.0	3.7	8.9	3.3	5.6	0.0	0.0	4.6	0.0	2.9	1.9	2.6	0.0	1.5	3.2	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	5.6	4.2	4.3	9.9	0.0	3.5	0.0	0.0	0.2	4.8	0.0	0.0	0.0	3.6	0.0	0.0	7.6	7.6	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	1.5	0.0	0.5	6.0	0.0	0.0	2.2	0.0	3.8	4.1	1.1	2.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.6	0.8	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.2	1.6	1.6	1.0	1.9	0.7	1.6	0.5	1.3	0.6	0.0	0.3	0.0	3.9	1.9	0.0	0.9	2.5	0.0	1.2	0.0	0.0	5.5	0.0	1.3	1.4	1.0	0.0	0.0	0.4	0.2	5.3	2.2	2.3	0.0	0.5	0.0	0.0	1.8	0.0	0.4	10.6	0.0	0.0	0.0	0.0	1.7	0.8	0.0	7.4	0.6	0.0	0.0	1.9	1.6	2.0	0.6	1.1	0.0	0.0	1.2
EVI2A	"EVDA, EVI2"	ENSG00000126860	"Ecotropic viral integration site 2A"	P22794	17	31317560-31321884	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.7;brain: 74.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 75.5;Hofbauer cells: 100.8;Kupffer cells: 231.8;Macrophages: 127.6;T-cells: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 20.2;Karpas-707: 33.4;RPMI-8226: 51.6"									"HPA045033, HPA057051"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA045033: AB_2679191, HPA057051: AB_2683321"	"unprognostic (7.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (7.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.90e-2)"	6.4	4.7	26.8	25.8	36.0	15.1	4.7	3.8	30.0	5.2	6.2	16.5	0.0	6.3	2.2	1.6	3.5	2.1	10.6	2.6	42.5	21.8	2.2	5.3	12.5	27.4	64.7	13.9	1.6	1.6	1.0	1.6	11.6	33.7	2.4	8.2	0.0	3.0	2.0	1.2	1.5	6.8	4.1	74.0	20.4	6.9	1.2	59.7	32.1	2.0	0.6	22.6	14.2	2.2	8.6	17.9	51.7	26.5	8.9	19.2	23.9	0.0	0.0	0.0	0.0	1.7	10.6	0.0	1.3	2.2	1.7	6.1	0.0	0.5	9.0	0.0	1.7	9.9	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	20.2	10.4	11.4	13.1	0.0	2.4	7.0	2.6	0.6	8.3	0.3	33.4	13.2	0.1	7.4	11.4	0.0	0.0	0.0	7.8	1.3	51.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.4	4.3	7.3	0.2	0.3	4.8	15.0	0.0	10.1	5.9	7.6	6.0	1.3	26.5	1.0	11.3	12.7	13.7	8.6	16.1	13.1	17.9	4.2	19.2	16.8	51.7	8.9	9.6	5.9	17.1	23.9	26.8	36.0	3.8	24.0	42.5	21.8	64.7	13.9	33.7	59.7	0.0	6.4	31.5	0.3	3.5	0.2	0.3	0.0	2.7	2.3	0.0	0.0	0.6	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.5	2.6	0.2	75.5	0.8	100.8	0.0	0.0	7.4	231.8	0.0	0.3	127.6	13.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.7	0.0	1.6	0.1	0.2	2.8	1.1	130.3	0.0	0.3
EVI2B	"CD361, D17S376, EVDB"	ENSG00000185862	"Ecotropic viral integration site 2B"	P34910	17	31303766-31314112	"CD markers, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 133.6;lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"	16	"B-cells: 217.4;Kupffer cells: 447.5;Macrophages: 274.7;T-cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 133.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 133.6;monocytes: 34.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.2;HHSteC: 19.9;HL-60: 27.3;HMC-1: 38.5;Karpas-707: 27.3;NB-4: 21.6;RPMI-8226: 39.9;THP-1: 34.4"					"Low region specificity"	"Detected in all"			HPA007436	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"HPA007436: AB_1848307"	"unprognostic (1.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.73e-2)"	15.0	3.6	4.4	37.7	5.8	44.0	4.2	1.7	4.4	3.7	10.7	6.5	0.3	6.0	2.8	4.8	7.1	4.7	8.1	6.7	6.4	4.4	7.8	7.1	38.5	37.5	10.2	2.6	3.8	2.7	0.4	2.1	4.8	7.8	5.3	8.1	2.5	6.6	1.5	2.3	2.4	23.3	4.2	22.0	72.8	8.0	3.7	6.7	26.1	4.0	3.0	43.0	13.0	7.6	18.6	14.6	133.6	34.3	4.1	16.4	19.8	0.1	0.1	0.0	0.0	1.9	2.5	0.0	0.2	1.7	2.0	3.7	0.0	0.9	24.2	0.0	1.5	7.5	0.1	0.0	0.3	2.2	0.0	0.0	0.5	0.0	0.0	19.9	27.3	38.5	4.6	0.0	1.1	1.5	0.6	1.9	2.0	0.3	27.3	5.7	0.0	7.9	21.6	0.0	0.0	0.0	13.9	0.1	39.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	34.4	2.1	0.5	0.0	0.2	1.9	5.3	0.2	5.3	2.5	9.4	0.6	78.9	30.5	74.5	8.2	23.2	7.9	18.6	12.6	10.6	14.6	14.3	9.7	9.1	133.6	4.1	34.3	8.4	16.4	19.8	4.4	5.8	1.7	4.4	6.4	4.4	10.2	2.6	7.8	6.7	0.0	17.9	217.4	0.6	4.7	0.2	0.4	2.5	4.0	11.4	1.8	0.0	0.5	0.0	0.0	5.3	2.7	0.2	0.0	0.0	0.5	2.8	0.3	78.7	1.7	88.8	0.0	0.0	9.8	447.5	4.7	0.0	274.7	35.4	10.8	0.0	0.0	0.7	0.0	0.4	0.7	0.8	19.4	4.1	0.3	0.5	3.1	0.2	178.5	0.0	1.1
EVI5	NB4S	ENSG00000067208	"Ecotropic viral integration site 5"	O60447	1	92508696-92792404	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027339	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA027339: AB_1848308"	"unprognostic (1.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.04e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.35e-2)"	4.5	8.5	27.5	3.4	13.4	1.6	3.6	5.1	35.7	5.4	4.1	2.3	1.7	3.4	5.6	3.9	3.2	4.4	5.0	6.0	12.5	5.5	4.2	14.5	5.9	2.1	5.6	23.1	3.5	4.4	8.8	4.5	10.4	3.7	4.6	4.6	1.7	4.2	5.0	3.1	4.0	3.3	6.1	5.7	3.3	5.3	8.0	2.4	1.7	5.6	1.7	2.4	4.2	3.9	2.3	2.2	6.0	4.8	0.2	0.2	0.7	3.7	4.1	6.5	6.3	10.7	13.5	6.2	8.6	13.1	5.9	6.8	7.2	1.0	1.6	12.2	9.8	11.0	4.3	6.1	6.3	10.6	0.1	2.4	3.0	4.2	4.3	10.5	2.1	3.5	8.4	5.2	10.2	6.2	17.3	12.7	0.1	5.2	2.7	9.8	1.8	0.2	2.5	1.9	2.4	3.4	1.5	15.6	2.1	4.5	10.8	2.4	5.1	10.1	5.3	11.5	7.4	2.6	4.9	8.3	6.6	4.9	8.7	5.6	3.9	2.3	2.7	4.3	3.5	5.4	1.3	4.8	4.4	0.2	3.3	0.1	2.0	0.2	0.0	2.2	2.3	0.1	0.1	6.0	0.2	4.7	1.5	0.1	0.7	27.5	13.4	5.1	35.7	12.5	5.5	5.6	23.1	3.7	2.4	56.6	25.1	12.7	21.7	38.6	23.4	46.0	22.9	36.1	35.2	15.7	23.6	42.6	14.9	25.8	2.6	27.4	18.8	23.3	25.8	20.4	35.1	27.0	12.7	46.1	26.8	28.6	21.2	46.1	51.1	3.1	26.2	36.2	25.3	13.6	24.7	27.6	47.1	17.3	50.9	15.5	24.8	12.9	30.0	35.6	42.8	43.7	54.8	3.2	18.7	31.6
EVI5L		ENSG00000142459	"Ecotropic viral integration site 5 like"	Q96CN4	19	7830233-7864976	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 30.8;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043099, HPA043563"	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA043099: AB_10796685, HPA043563: AB_2678556"	"unprognostic (3.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.97e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.04e-2)"	7.7	7.8	22.8	6.0	20.0	3.7	4.2	18.7	31.6	7.6	6.6	23.5	5.3	6.2	6.8	6.2	11.6	6.0	6.6	13.3	25.7	20.5	9.0	4.9	6.9	5.0	21.4	17.3	6.6	7.8	11.9	9.6	9.7	18.3	9.9	5.5	5.4	8.9	12.1	21.8	12.3	5.3	10.7	20.3	7.2	7.1	24.0	18.5	5.3	7.3	4.0	5.5	8.6	4.8	0.4	0.5	0.8	3.9	0.3	1.2	0.2	7.2	1.5	5.9	8.7	10.9	9.2	16.7	10.9	11.5	7.9	8.4	0.6	2.8	1.9	13.2	14.8	4.1	5.0	2.1	7.4	7.2	10.6	7.1	1.4	3.4	1.2	13.8	1.6	3.8	8.5	9.0	3.8	18.3	6.5	9.4	9.8	1.7	10.0	8.0	7.5	5.8	3.7	2.2	5.4	15.9	7.0	4.9	5.3	4.7	6.2	2.5	5.9	10.1	4.5	3.2	4.1	3.8	5.4	9.2	5.4	2.5	30.2	4.0	14.6	3.2	2.4	9.1	4.1	4.6	0.0	0.4	0.3	0.8	0.8	1.0	0.2	0.5	0.5	0.3	0.4	1.0	1.2	0.8	0.3	3.9	0.5	0.8	0.2	22.8	20.0	18.7	25.8	25.7	20.5	21.4	17.3	18.3	18.5	0.0	6.1	0.0	1.7	3.4	30.8	3.7	5.1	0.0	0.0	8.7	17.7	2.8	0.0	2.1	12.0	2.1	4.1	0.0	2.1	15.1	2.5	2.4	0.0	1.5	3.2	31.8	5.2	5.5	1.5	22.2	3.7	1.8	3.3	0.0	3.4	7.5	2.4	3.2	4.2	2.4	19.4	6.5	3.5	17.9	4.2	3.6	2.9	1.0	2.4	3.8
EVL	RNB6	ENSG00000196405	Enah/Vasp-like	Q9UI08	14	99971449-100144236	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 98.2"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 421.2;T-cells: 371.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018849, HPA019536, CAB033987"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180"	"unprognostic (1.12e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.43e-1)"	14.5	15.0	50.9	37.0	57.8	19.9	28.5	57.4	66.2	11.8	12.4	20.7	10.7	12.7	23.6	25.1	11.2	18.0	20.1	19.7	42.4	43.3	12.4	24.4	28.4	63.5	34.8	31.4	23.3	17.1	9.8	28.6	13.5	26.2	16.4	12.0	24.2	20.0	16.5	12.8	15.6	18.7	29.4	23.1	44.2	15.2	13.2	20.3	98.2	11.0	7.5	55.8	18.3	9.3	7.8	2.5	14.2	8.7	9.3	20.6	5.4	4.1	3.6	27.6	8.3	5.6	16.0	16.0	5.4	6.9	3.5	4.9	0.2	2.8	7.8	7.2	4.9	3.0	0.1	13.0	9.4	4.4	8.4	8.2	12.8	2.9	2.2	4.6	3.8	30.4	8.5	4.8	2.4	9.4	7.8	9.6	29.8	6.4	0.5	3.9	5.6	71.4	20.5	5.8	3.6	5.4	17.2	14.3	1.3	4.5	0.1	33.5	19.7	3.8	5.9	1.6	6.8	4.6	11.3	5.9	2.9	4.6	18.0	3.0	14.6	11.0	21.9	3.9	6.5	4.7	1.5	1.5	14.2	11.6	7.6	8.9	6.2	13.6	11.0	2.5	7.8	16.5	14.6	0.3	9.3	8.7	0.4	20.6	5.4	50.9	57.8	57.4	66.2	42.4	43.3	34.8	31.4	26.2	20.3	26.8	48.9	156.1	17.2	18.4	110.7	4.1	20.4	32.1	12.5	12.2	379.0	17.5	26.6	12.5	2.9	40.5	1.7	0.0	11.9	10.1	19.8	14.8	16.2	95.1	134.9	73.1	8.1	33.2	56.1	8.6	23.0	74.9	25.3	0.0	0.9	52.0	14.3	1.1	46.7	11.5	421.2	6.5	20.8	13.4	26.7	27.5	12.2	371.9	1.5	13.9
EVPLL		ENSG00000214860	"Envoplakin like"	A8MZ36	17	18377662-18389647	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.2;lymphoid tissue: 10.4"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 1.9;Basal glandular cells: 1.7;Club cells: 2.3;Collecting duct cells: 1.8;Spermatogonia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.9;HaCaT: 1.9;HeLa: 3.3;hTCEpi: 11.5;RT4: 4.0;SiHa: 2.1;T-47d: 3.5"									HPA045728	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA045728: AB_10960394"	"unprognostic (1.34e-1)"	"unprognostic (4.88e-2)"				"unprognostic (2.06e-5)"	"unprognostic (1.58e-1)"	"unprognostic (2.08e-2)"		"unprognostic (1.64e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.60e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.06e-2)"	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	3.3	0.5	0.0	0.7	0.4	0.8	0.9	22.2	0.4	0.8	0.0	0.0	0.0	0.9	2.0	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.7	0.2	0.0	2.1	3.1	0.1	7.8	0.4	1.4	0.0	0.1	1.7	2.5	0.0	0.1	2.2	9.5	10.4	3.5	7.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.5	0.0	2.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.7	0.5	0.0	0.0	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	3.4	1.1	0.0	0.0	0.0	1.0
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9"	"Group enriched"	"Detected in some"	29	"Early spermatids: 49.8;Late spermatids: 47.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	26	"pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"OE19: 21.4;RT4: 13.3"	"Group enriched"	"Detected in some"	15	"midbrain: 1.0;pons and medulla: 1.0"	"Not detected"	"Not detected"			HPA055132			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055132: AB_2682707"	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.1	6.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.2	0.6	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	3.0	6.4	0.7	0.1	0.1	6.7	0.1	0.0	0.1	1.9	0.1	0.1	0.0	1.7	0.1	0.1	0.1	0.1	0.1	8.9	5.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.2	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	3.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	47.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7
EXD3	"FLJ20433, LOC54932, mut-7"	ENSG00000187609	"Exonuclease 3'-5' domain containing 3"	Q8N9H8	9	137306896-137423262	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"granulocytes: 63.2;Late spermatids: 57.2;Paneth cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 21.6"					"Low region specificity"	"Detected in all"			HPA047395	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Actin filaments"	"HPA047395: AB_10962864"	"unprognostic (2.91e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.75e-3)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.05e-2)"	9.7	10.9	8.0	10.1	11.1	8.4	10.4	11.9	12.4	11.2	15.5	16.5	14.9	22.8	10.2	17.5	11.1	11.5	14.1	10.5	8.7	7.9	11.8	7.3	12.3	8.0	9.5	11.2	11.1	13.3	8.3	13.8	8.3	11.0	14.0	8.9	13.9	17.5	11.4	15.9	17.4	20.6	15.8	7.4	16.3	14.3	5.1	9.1	1.7	11.4	6.8	7.8	10.0	10.8	4.0	5.3	10.8	6.0	5.3	8.5	3.6	5.7	4.9	2.4	6.8	2.0	3.0	5.7	2.9	3.3	2.5	3.9	3.3	12.4	2.5	7.9	2.1	6.3	10.7	0.7	3.1	0.8	5.8	5.9	2.0	8.7	5.1	6.2	1.4	21.6	3.4	4.3	2.2	1.9	7.3	8.6	0.0	4.7	4.6	2.1	15.4	0.1	4.9	2.8	12.6	3.4	4.4	2.0	17.2	5.1	3.3	3.3	6.0	2.8	6.0	2.7	2.9	9.7	6.4	10.7	3.5	3.4	5.5	4.3	6.1	2.7	2.1	6.7	4.5	6.6	10.8	5.0	10.6	3.5	6.0	4.0	3.9	6.0	3.3	5.3	4.0	4.8	3.7	1.2	5.3	5.8	3.4	8.5	3.6	8.0	11.1	11.9	12.4	8.7	7.9	9.5	11.2	11.0	9.1	0.0	4.6	0.5	9.4	5.3	13.3	4.5	5.1	5.3	6.8	7.0	13.7	8.3	8.3	6.2	13.5	11.3	39.9	0.0	9.8	2.8	5.3	8.7	63.2	5.5	7.6	20.6	7.0	16.5	4.9	57.2	5.5	5.1	3.3	2.8	22.2	8.6	6.3	178.5	7.4	10.3	10.3	12.9	7.1	2.8	9.4	7.9	3.3	6.9	28.5	7.4
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853616-55905034	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: AB_2679125"	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (5.50e-5)"	21.2	19.7	20.7	21.0	24.0	12.9	25.3	22.8	40.7	18.4	20.2	18.2	14.6	18.9	20.8	24.6	32.7	18.3	17.9	19.8	26.9	23.6	18.7	11.4	26.2	29.2	24.7	22.8	18.2	14.9	29.7	20.0	23.4	30.7	16.8	22.4	12.9	20.3	19.2	14.6	31.6	20.5	18.4	29.1	23.7	17.5	18.5	21.5	19.1	19.0	15.8	21.9	18.8	21.4	7.3	11.7	16.4	18.1	10.1	9.2	6.3	11.5	6.7	12.1	13.9	20.9	26.2	8.1	16.3	16.5	13.4	14.1	4.6	20.2	11.2	11.5	17.5	16.2	13.9	9.8	13.0	19.3	5.9	6.8	10.3	8.4	5.4	19.7	11.2	14.7	21.1	17.8	13.9	15.4	17.4	21.8	8.7	14.8	11.0	29.0	7.3	8.1	11.4	7.6	16.6	12.8	9.5	9.0	9.0	14.9	12.7	9.0	16.0	9.8	16.1	13.5	10.8	10.2	12.1	26.2	16.6	13.6	14.2	14.0	13.3	6.6	9.9	21.6	12.5	15.7	15.2	12.1	10.4	5.8	15.7	7.5	7.3	8.2	8.2	11.7	6.7	7.4	5.4	16.4	10.1	18.1	5.3	9.2	6.3	20.7	24.0	22.8	40.7	26.9	23.6	24.7	22.8	30.7	21.5	38.7	29.4	13.7	12.5	30.9	45.5	26.4	20.4	44.2	26.1	21.0	29.5	53.7	16.6	18.4	31.3	32.2	30.4	0.0	17.4	27.7	28.1	16.9	34.8	9.7	35.9	27.0	21.4	41.7	40.5	10.6	19.8	36.1	38.8	19.8	26.7	45.2	26.5	28.1	22.3	14.0	30.3	32.3	21.4	27.7	34.1	34.9	42.8	18.8	25.1	19.6
EXOC2	"FLJ11026, SEC5L1, Sec5p"	ENSG00000112685	"Exocyst complex component 2"	Q96KP1	6	485133-693111	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032093			Approved	Vesicles		NA	NA		5300	Vesicles		"HPA032093: AB_10611964"	"unprognostic (1.61e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.20e-1)"	15.9	13.8	16.6	18.2	19.9	8.8	16.7	17.0	20.8	16.4	13.5	22.2	9.3	12.8	14.3	12.5	18.7	10.5	13.6	16.7	17.0	19.0	14.5	15.3	16.8	18.2	19.7	11.6	12.6	11.0	22.8	22.0	26.4	22.4	12.5	15.5	24.4	13.4	12.9	15.7	17.5	14.5	14.1	22.2	18.4	13.4	25.7	17.1	24.8	21.5	12.2	20.2	16.5	14.5	12.5	12.1	8.9	13.6	12.2	18.8	11.4	10.3	8.0	13.4	14.6	12.3	11.1	8.2	9.4	11.0	11.3	13.5	10.2	5.6	7.7	23.2	11.2	17.0	9.1	15.0	16.4	13.5	24.1	16.0	9.8	9.7	10.1	15.4	10.4	9.9	9.6	13.4	8.0	9.4	11.2	18.9	15.3	19.2	5.7	14.0	9.0	13.9	10.2	13.6	9.3	7.7	13.2	11.6	15.5	10.1	11.3	13.2	7.7	7.5	4.6	14.8	26.3	11.9	6.4	27.4	10.2	7.6	12.7	8.7	14.1	28.1	8.2	10.4	8.7	31.3	8.9	7.8	8.6	15.7	9.5	18.8	12.5	15.9	16.4	12.1	12.0	15.2	14.5	2.5	12.2	13.6	9.9	17.2	11.4	16.6	19.9	17.0	20.8	17.0	19.0	19.7	11.6	22.4	17.1	3.0	16.4	4.4	3.0	4.2	8.1	7.6	0.0	6.7	5.7	5.2	7.9	11.8	6.6	5.8	8.8	8.4	4.0	0.0	4.4	5.8	4.5	4.9	4.7	8.3	8.7	7.9	2.4	9.8	9.8	2.7	6.4	5.6	5.0	8.2	5.9	4.8	6.2	4.9	8.5	6.9	9.0	0.0	6.2	17.2	17.9	6.8	10.8	15.2	5.1	6.0
EXOC3	"SEC6L1, Sec6p"	ENSG00000180104	"Exocyst complex component 3"	O60645	5	443158-471937	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037880			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA037880: AB_2675716"	"unprognostic (2.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.82e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.70e-1)"	18.7	15.6	22.0	20.7	22.4	19.1	16.5	20.1	28.6	18.1	22.4	22.5	22.3	18.3	22.2	14.9	26.3	19.0	20.9	20.8	22.5	17.3	15.9	14.1	15.6	18.8	23.3	29.5	21.6	23.5	20.8	18.0	17.9	22.7	17.6	13.3	14.5	23.9	20.2	47.5	24.9	17.1	26.7	16.2	18.2	20.8	40.7	21.0	13.3	19.8	20.7	17.4	20.8	17.6	3.6	3.5	31.0	6.2	9.8	6.4	4.4	12.7	21.5	7.3	16.2	12.5	10.8	18.1	11.3	11.8	11.5	13.9	10.8	18.9	10.9	17.7	14.2	14.1	14.6	5.8	9.8	8.4	40.0	10.1	11.7	45.1	8.1	11.7	17.5	29.6	11.0	7.3	12.8	11.3	12.1	12.8	7.2	8.9	7.1	8.9	15.1	12.5	20.8	6.0	7.8	12.9	10.3	8.3	13.9	9.7	16.1	7.3	9.3	28.3	16.1	11.0	7.4	21.7	20.2	9.5	11.4	14.1	8.7	9.1	12.1	8.7	7.7	12.0	21.2	10.3	5.4	5.7	31.0	6.4	6.2	5.4	3.3	5.0	5.1	3.5	3.6	6.4	5.9	7.9	9.8	4.4	2.6	6.4	4.4	22.0	22.4	20.1	28.6	22.5	17.3	23.3	29.5	22.7	21.0	20.8	26.1	14.5	14.7	38.0	13.8	26.6	12.7	33.5	20.5	14.0	33.4	20.2	23.2	23.4	22.8	15.3	23.8	0.0	25.9	19.0	15.8	14.7	23.0	15.7	20.9	60.4	5.2	13.5	24.4	44.8	18.7	21.7	25.3	21.6	18.6	16.9	24.4	20.1	15.9	20.3	19.2	19.4	22.3	30.9	16.2	47.0	28.5	19.1	20.7	20.4
EXOC3L1	"EXOC3L, FLJ35539, FLJ35587"	ENSG00000179044	"Exocyst complex component 3 like 1"	Q86VI1	16	67184366-67190204	"Predicted intracellular proteins"	Exocytosis			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.6"	"Cell type enhanced"	"Detected in many"	13	"Endothelial cells: 11.7;Ito cells: 32.5;Leydig cells: 14.4;Peritubular cells: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.1;SuSa: 3.8;TIME: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA029574	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA029574: AB_10602495"	"unprognostic (1.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.64e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.35e-1)"	4.5	2.4	0.3	1.8	0.9	0.0	2.4	0.4	1.2	1.4	0.6	0.3	0.3	0.8	3.6	0.8	1.2	0.9	1.5	4.5	1.3	0.2	3.3	1.4	8.7	1.8	0.3	0.8	2.0	1.0	0.4	1.1	6.0	1.0	1.6	0.3	2.4	1.1	0.5	1.8	0.7	1.0	0.8	1.0	26.6	0.7	1.0	0.3	0.3	4.1	1.0	0.5	1.0	0.5	0.0	0.7	1.8	2.0	0.0	0.0	0.3	0.2	0.1	1.2	0.4	0.0	0.1	3.1	0.4	0.0	0.0	0.0	1.4	0.3	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.3	0.8	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	5.8	0.6	0.5	0.0	0.1	0.2	0.3	0.1	0.5	0.1	0.6	1.3	1.2	0.2	0.0	0.2	11.1	1.3	1.5	0.3	0.1	3.8	1.0	0.1	4.0	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.8	0.0	0.3	0.0	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.3	0.3	0.9	0.4	1.2	1.3	0.2	0.3	0.8	1.0	0.3	0.0	0.0	0.0	1.6	0.8	1.7	0.8	0.0	0.0	0.0	3.5	0.0	0.4	6.6	0.7	1.6	11.7	4.2	0.0	3.3	2.5	0.2	0.3	0.0	0.8	0.8	3.2	1.2	32.5	1.5	3.1	14.4	0.3	0.0	1.0	3.3	0.2	0.5	1.7	17.3	0.1	0.8	0.0	0.1	0.4	0.9	1.8	0.7	0.0	2.3	1.3
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"	Q2M3D2	19	45212621-45245431	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"Ito cells: 57.1"									"Group enriched"	"Detected in some"	4	"basophil: 1.6;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	7	"HEL: 18.2;K-562: 16.8"									"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA			Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: AB_2684431"																		3.2	4.3	0.0	2.0	0.0	0.9	3.0	0.0	0.3	3.6	2.1	0.1	2.4	2.3	14.5	1.2	2.3	0.6	6.9	1.9	0.0		12.7	9.4	3.4	6.3	0.0	0.0	3.4	2.8	2.4	3.5	0.4	0.0	3.7	0.2	13.7	3.3	3.6	1.0	2.4	3.9	1.6	0.0	12.6	2.4	2.1	0.0	0.0	4.6	1.5	3.2	1.6	3.3	0.5	0.3	2.5	0.4	0.2	0.4	0.2	0.1	0.3	2.3	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.1	2.2	0.0	0.2	1.2	0.0	0.1	0.0	0.1	0.0	18.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.8	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.5	1.3	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.7	0.1	0.3	0.4	0.8	1.6	0.3	0.1	0.2	0.1	0.0	0.1	0.2	0.1	1.6	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	2.5	0.2	0.3	0.3	0.1	0.2											0.0	2.2	0.0	0.3	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	57.1	1.5	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.2	3.4	0.6	0.0	0.0	0.0	0.1
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Rod photoreceptor cells: 229.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	21.2	23.7	18.5	17.7	22.3	10.5	19.4	25.7	24.4	20.8	17.0	19.7	22.2	11.2	25.8	20.6	21.5	24.2	16.8	16.5	14.7	15.4	15.6	15.2	16.5	12.6	14.2	19.3	27.7	26.5	28.5	31.2	16.4	22.0	16.9	18.8	19.3	20.5	18.8	50.7	24.4	13.7	20.8	18.7	17.9	16.3	17.2	17.3	34.7	22.9	18.3	22.1	26.3	20.6	8.3	16.3	8.1	12.7	18.4	12.4	10.4	17.8	14.7	20.4	20.1	23.9	25.0	7.1	13.1	21.9	11.9	15.7	8.5	25.2	13.4	9.5	24.6	17.5	11.4	10.9	17.9	19.8	20.4	13.1	10.8	15.5	8.9	26.3	14.2	11.8	24.3	22.4	17.0	31.5	26.4	20.3	17.8	15.5	13.4	22.1	11.7	25.8	15.7	15.3	21.5	13.8	11.5	18.1	24.1	19.2	16.0	15.9	25.1	19.7	18.2	21.1	24.0	12.0	13.4	22.0	13.3	7.0	14.0	14.3	21.3	13.0	13.0	39.3	16.7	20.2	8.1	12.0	6.9	11.8	12.7	10.5	8.3	12.3	12.4	16.3	8.0	10.1	10.4	4.0	18.4	10.5	7.3	12.4	10.4	18.5	22.3	25.7	24.4	14.7	15.4	14.2	19.3	22.0	17.3	20.8	21.1	11.9	14.2	16.8	35.3	24.9	7.6	18.7	15.9	14.0	88.4	13.6	3.3	12.9	23.1	21.5	15.8	0.0	15.7	13.8	11.9	17.0	8.1	14.4	15.6	47.7	16.7	24.5	30.4	20.6	16.1	18.0	13.5	12.6	21.4	20.6	13.9	17.5	17.7	13.3	229.7	12.9	10.8	18.1	12.6	14.9	9.4	20.8	18.4	16.9
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92834713-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Rod photoreceptor cells: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 46.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: AB_2683907"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	9.7	19.4	15.3	8.5	16.9	11.6	9.4	18.9	16.2	7.4	9.6	4.5	5.1	8.3	7.3	7.5	4.9	6.3	10.3	7.0	15.5	8.6	7.0	10.8	12.0	16.7	6.1	12.8	5.4	12.5	8.2	17.8	34.6	8.1	9.4	10.8	3.5	7.2	5.0	29.3	6.2	9.8	12.8	6.7	12.6	7.6	10.0	8.1	13.5	29.1	10.2	8.2	9.5	8.2	4.9	7.6	21.2	3.4	1.8	2.5	1.7	8.5	10.7	11.4	7.5	0.6	0.7	4.1	3.9	10.9	3.6	4.4	4.0	7.3	9.7	8.3	1.9	2.9	5.4	9.2	2.5	4.6	8.6	9.3	14.1	3.8	5.0	4.4	15.2	12.6	1.0	1.3	3.2	2.2	6.6	46.7	6.4	11.9	6.5	1.7	4.6	6.4	9.9	1.5	17.4	3.1	9.7	4.9	5.0	7.8	5.8	3.8	5.4	4.1	4.1	5.1	3.0	8.1	8.0	9.5	0.2	3.7	3.4	6.4	4.9	5.2	7.9	1.2	17.2	4.0	3.7	3.4	10.1	2.2	2.7	2.2	4.7	2.5	2.1	3.4	4.9	2.1	2.4	21.2	1.8	2.6	7.6	2.3	1.7	15.3	16.9	18.9	16.2	15.5	8.6	6.1	12.8	8.1	8.1	14.9	14.7	15.9	8.5	3.0	36.3	10.8	22.9	12.0	13.6	15.7	37.3	18.0	5.0	22.6	4.1	34.6	10.2	70.0	13.2	6.2	3.6	13.6	10.4	13.4	17.9	22.3	24.5	55.9	20.6	10.9	4.0	14.9	5.0	4.6	14.7	20.2	13.2	8.5	13.8	7.1	133.9	12.9	3.3	15.7	22.4	4.3	17.2	12.8	10.0	15.7
EXOC6B	"KIAA0919, SEC15B, SEC15L2"	ENSG00000144036	"Exocyst complex component 6B"	Q9Y2D4	2	72175984-72826041	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 51.7"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034546, HPA063991"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034546: AB_2674218, HPA063991: AB_2685168"	"unprognostic (5.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.29e-2)"	12.1	14.2	17.9	5.7	23.0	1.9	9.5	19.8	23.3	10.2	7.2	18.0	6.0	8.4	11.8	7.5	16.5	8.7	7.8	51.7	18.3	14.4	8.8	4.8	7.9	3.8	18.5	17.0	17.4	6.0	18.6	11.2	34.7	19.8	9.7	7.0	7.3	7.6	10.9	11.2	27.5	10.7	11.6	15.0	6.0	8.0	7.7	20.4	3.1	11.7	7.8	7.3	9.5	12.6	3.0	1.7	3.2	2.0	1.6	3.4	1.2	11.0	8.4	7.8	9.4	22.4	9.3	13.5	8.1	11.5	7.0	4.6	11.4	1.7	2.9	5.1	13.5	10.5	18.5	6.5	13.4	10.2	2.1	5.3	8.5	5.9	6.5	12.1	1.2	2.9	7.9	19.5	7.9	12.4	11.1	11.4	4.5	0.9	0.0	9.2	3.8	3.2	1.5	8.1	7.6	4.7	1.7	14.0	1.1	6.8	26.0	3.9	3.4	13.9	4.3	5.6	9.0	3.0	1.1	12.6	8.2	7.0	6.9	4.9	2.9	2.9	0.0	9.5	0.6	6.5	3.2	1.9	0.2	2.7	1.7	2.1	2.4	2.1	1.7	1.7	3.0	2.4	3.4	0.0	1.6	2.0	0.6	2.6	1.2	17.9	23.0	19.8	22.8	18.3	14.4	18.5	17.0	19.8	20.4	0.0	5.5	0.0	9.0	23.2	16.7	77.2	15.3	8.1	2.3	8.7	23.6	12.0	5.0	7.6	41.6	13.1	12.8	0.0	10.1	10.9	6.2	6.3	8.1	4.9	4.0	15.9	2.9	9.2	9.1	4.0	7.8	4.5	5.0	1.0	4.1	9.1	8.3	8.6	7.1	4.1	9.9	0.0	8.9	8.7	4.8	32.6	20.6	2.5	3.8	7.8
EXOC7	"BLOM4, EXO70, Exo70p, KIAA1067, YJL085W"	ENSG00000182473	"Exocyst complex component 7"	Q9UPT5	17	76081017-76121576	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022840, HPA022842"	Supported		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA022840: AB_1848316, HPA022842: AB_1848317"	"unprognostic (5.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-1)"	23.2	22.2	30.5	18.2	37.1	27.5	20.4	27.8	46.2	23.8	24.4	33.0	20.8	19.1	28.7	20.8	31.8	32.6	21.3	27.5	29.2	23.5	21.0	22.6	21.2	17.6	20.9	28.2	31.5	24.1	40.5	29.3	24.0	34.6	30.0	17.0	27.0	29.2	27.9	24.0	21.8	21.6	31.1	21.7	21.4	19.6	14.5	23.0	23.7	29.5	14.1	26.4	30.2	20.5	12.8	13.7	29.6	34.4	15.5	17.9	19.0	21.6	27.0	24.9	20.2	23.7	16.8	25.9	19.9	26.7	36.2	26.2	22.7	14.7	11.3	14.7	34.8	22.9	17.9	15.0	19.4	24.3	9.7	20.3	18.6	21.2	23.9	16.5	20.7	19.4	23.5	15.4	28.0	13.7	25.7	40.0	20.5	12.4	11.5	22.5	20.0	33.3	9.2	13.1	16.3	28.8	18.0	42.7	11.4	20.8	45.1	13.6	31.8	22.6	16.8	15.5	25.0	27.5	17.1	26.1	38.8	23.4	25.6	21.9	15.9	5.8	10.4	23.2	9.4	20.0	21.1	19.2	29.6	17.9	26.6	12.3	12.4	13.7	15.3	13.7	12.8	14.5	12.2	22.2	15.5	34.4	5.9	14.8	19.0	30.5	37.1	27.8	46.2	29.2	23.5	20.9	28.2	34.6	23.0	17.9	34.9	47.7	30.5	17.5	78.7	6.4	35.7	32.1	27.3	38.4	135.5	45.1	28.2	34.4	17.9	25.1	47.9	23.3	32.5	23.9	29.3	37.9	39.4	22.8	32.8	63.5	46.8	27.6	25.9	31.6	34.5	25.7	23.6	33.3	34.6	62.0	34.4	38.6	36.0	28.6	102.9	45.3	31.0	26.8	16.6	17.3	59.5	38.9	27.8	37.5
EXOC8	"EXO84, Exo84p, SEC84"	ENSG00000116903	"Exocyst complex component 8"	Q8IYI6	1	231332753-231337852	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027438	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA027438: AB_1848318"	"unprognostic (3.85e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	12.1	9.3	10.4	11.2	9.6	22.1	10.3	14.8	12.8	8.6	8.6	9.9	9.5	8.8	9.3	7.6	11.1	8.5	7.7	9.0	9.2	10.3	9.2	11.2	9.5	12.6	9.1	9.9	11.2	11.2	17.1	11.9	14.4	11.9	8.7	7.3	6.7	9.5	9.9	26.7	12.2	11.4	6.8	9.0	13.0	10.1	6.7	9.3	16.9	12.9	9.2	13.3	7.7	9.9	1.8	2.1	6.0	3.8	2.0	3.5	1.2	7.4	8.2	5.0	5.1	13.1	10.7	12.2	9.1	7.7	6.9	6.5	7.7	7.5	8.4	8.1	9.0	6.2	12.2	7.2	9.8	7.6	10.9	17.6	5.1	10.4	4.9	7.4	8.9	14.2	10.7	10.8	10.1	9.7	8.1	8.4	8.8	9.3	20.2	10.9	3.8	8.3	5.5	7.6	9.3	7.0	5.5	7.8	10.8	8.6	8.6	6.7	7.2	9.2	12.1	8.9	4.1	11.6	13.0	11.4	9.3	6.6	12.4	15.9	15.2	8.7	9.2	10.7	8.1	11.7	4.5	1.8	3.3	1.3	2.3	1.6	1.2	1.7	1.5	1.3	1.8	2.0	3.5	6.0	2.0	3.8	2.1	1.5	1.2	10.4	9.6	14.8	12.8	9.2	10.3	9.1	9.9	11.9	9.3	8.9	9.8	9.0	4.6	16.5	3.9	6.7	12.7	2.7	9.1	8.7	5.9	3.6	1.7	2.9	0.8	9.2	6.3	23.3	3.1	2.5	5.3	4.9	2.3	8.2	4.8	3.2	4.6	8.6	12.3	0.4	3.7	6.4	3.3	2.8	4.5	5.7	4.0	0.0	5.3	4.1	11.6	0.0	3.8	4.9	4.7	12.9	7.8	7.7	3.8	6.5
EXOSC1	"CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p"	ENSG00000171311	"Exosome component 1"	Q9Y3B2	10	97436142-97446017	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038370	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038370: AB_10672515"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.88e-9)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.41e-2)"	18.2	23.3	22.3	28.8	26.2	24.8	23.4	22.8	26.6	19.9	21.9	21.4	23.4	21.9	22.9	45.6	25.1	20.2	19.2	19.4	21.6	23.2	20.5	24.6	18.3	30.1	24.2	19.8	22.3	35.0	21.0	33.6	22.8	21.8	21.5	26.2	20.6	32.5	27.7	23.6	22.1	20.7	24.2	22.4	27.4	26.2	15.6	20.8	36.6	23.4	21.1	34.1	23.5	19.9	37.3	32.2	30.9	43.0	18.5	47.2	28.4	19.0	19.3	12.3	20.4	17.1	18.3	16.1	17.0	29.4	23.1	26.9	31.1	21.1	21.4	17.0	19.0	16.0	21.4	19.4	22.9	22.6	22.7	24.0	13.2	16.7	23.5	30.0	29.4	14.5	18.9	30.2	26.1	39.7	26.2	26.8	31.8	15.9	35.6	17.9	24.3	27.9	48.8	19.1	24.7	16.7	20.3	14.4	37.0	15.4	11.0	7.0	12.3	12.0	10.1	25.3	17.0	23.7	33.4	13.2	11.5	13.1	17.4	35.5	22.4	27.4	37.3	18.7	37.3	8.7	24.3	31.6	30.9	28.1	43.0	35.3	37.3	35.5	31.9	32.2	29.4	34.2	29.6	13.0	18.5	39.0	28.1	47.2	28.4	22.3	26.2	22.8	26.6	21.6	23.2	24.2	19.8	21.8	20.8	23.8	21.1	55.1	30.1	16.9	30.3	19.1	28.1	30.8	14.8	41.8	25.5	42.5	33.2	32.2	10.1	26.3	18.7	23.3	36.2	48.1	24.7	20.3	24.3	20.4	45.2	28.6	13.7	32.5	31.3	14.7	30.2	29.3	28.7	64.9	24.4	21.5	34.0	17.3	22.6	35.2	46.4	25.8	28.1	26.2	37.3	21.3	34.4	35.9	26.4	31.4
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397479	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA053150: AB_2682058, HPA055677: AB_2682882"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	9.1	14.3	12.6	12.3	16.6	13.1	11.1	7.6	21.3	8.8	12.1	10.8	9.0	10.0	8.1	6.0	14.6	13.6	6.4	11.6	12.0	10.3	7.9	25.1	5.7	17.0	13.4	9.9	13.2	46.9	3.2	4.9	6.5	10.3	9.5	6.6	6.3	14.0	8.1	30.9	18.5	9.5	6.6	14.0	12.7	9.8	7.5	11.8	16.8	15.1	15.7	12.2	11.3	8.6	22.9	36.8	3.3	23.7	17.1	21.1	13.5	17.9	33.5	4.7	13.8	3.0	3.8	11.0	7.6	3.6	12.5	10.3	19.5	13.3	28.0	19.8	3.7	6.4	6.8	9.3	8.5	3.9	17.8	32.1	12.5	12.7	14.9	9.6	22.4	12.4	4.7	19.1	10.0	9.6	3.4	5.8	16.0	16.6	20.1	4.1	23.4	19.3	15.8	16.6	25.4	16.6	18.3	12.9	25.2	5.0	12.8	18.2	13.6	11.0	18.3	18.6	3.2	8.5	27.7	4.6	13.1	11.0	8.3	23.3	31.7	40.5	30.4	10.2	32.4	11.1	3.3	21.7	0.6	13.2	23.7	15.8	21.1	14.4	13.3	34.1	22.9	21.1	18.5	1.5	17.1	14.0	36.8	11.1	13.5	12.6	16.6	7.6	21.3	12.0	10.3	13.4	9.9	10.3	11.8	3.0	3.7	19.5	26.4	27.1	5.6	8.1	17.8	18.7	11.4	17.4	3.9	24.0	31.5	14.5	7.3	9.0	5.1	23.3	18.3	115.4	11.0	15.5	4.7	17.9	26.6	6.4	8.2	4.3	13.8	5.6	15.5	19.8	13.5	14.4	16.8	4.8	20.0	5.8	11.7	19.5	2.1	6.5	18.4	11.9	27.2	29.1	17.7	11.7	30.9	22.0
EXOSC8	"bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p"	ENSG00000120699	"Exosome component 8"	Q96B26	13	36998816-37009613	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034240, HPA039702, HPA043942, HPA075230"	Uncertain		Supported	"Nucleoli fibrillar center,Mitotic chromosome,Vesicles"		NA	NA			"Nucleoli fibrillar center, Mitotic chromosome, Vesicles"		"CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: AB_2678742, HPA075230: "	"unprognostic (8.67e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (8.39e-7)"	"unprognostic (9.58e-3)"	"unprognostic (7.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.51e-1)"	15.1	14.5	16.0	18.0	15.7	24.5	20.1	15.4	16.3	17.3	17.1	16.7	13.5	13.0	15.6	15.2	18.8	16.3	10.1	16.8	14.9	12.7	16.5	22.9	15.5	22.8	19.8	15.5	19.4	14.5	6.9	15.3	21.6	15.2	18.3	19.8	12.6	13.1	14.4	22.5	16.2	20.0	19.3	18.5	20.0	14.9	30.4	19.6	31.5	18.9	21.1	24.6	20.4	14.5	27.6	23.5	9.3	16.0	18.0	30.7	21.3	12.9	9.9	28.1	19.0	8.7	9.1	21.6	20.2	14.2	27.9	22.7	21.4	26.5	18.8	8.8	11.2	26.4	18.2	27.4	19.7	32.8	27.3	23.1	51.2	10.9	26.0	11.2	41.2	17.6	5.4	15.0	18.9	30.5	6.6	21.1	26.5	24.2	11.8	19.5	16.8	20.9	33.6	29.4	31.7	13.0	13.6	28.7	15.2	15.5	9.2	7.2	13.9	11.0	12.5	17.9	15.2	9.7	32.9	10.5	10.2	14.6	12.4	26.6	6.9	8.3	40.1	16.1	29.4	18.7	9.3	13.0	9.2	19.2	16.0	19.9	27.6	24.6	22.7	14.3	22.9	30.7	28.5	2.8	18.0	15.7	23.5	22.2	21.3	16.0	15.7	15.4	16.3	14.9	12.7	19.8	15.5	15.2	19.6	29.8	38.8	35.8	43.7	32.1	20.1	44.3	17.8	60.2	51.2	10.4	7.9	66.5	48.0	37.9	87.3	35.8	10.3	0.0	45.5	72.3	37.6	27.3	97.4	16.3	40.4	27.0	12.7	14.7	12.9	45.1	37.7	32.4	25.3	39.7	17.8	24.1	31.9	21.0	34.3	19.5	29.7	25.8	41.2	120.0	82.0	31.7	56.1	39.6	24.5	30.2
EXTL1	"EXTL, MGC70794"	ENSG00000158008	"Exostosin like glycosyltransferase 1"	Q92935	1	26019884-26036464	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 6.2;Cardiomyocytes: 2.9;Horizontal cells: 9.5;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	13	"melanoma: 21.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 58.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010726, HPA037749"	Approved		Approved	Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		68000	Centrosome	Vesicles	"HPA010726: , HPA037749: AB_10805350"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-2)"	0.6	2.1	15.3	0.6	9.5	0.5	2.0	1.1	21.1	1.3	0.6	1.4	0.0	0.7	2.5	0.7	1.5	1.7	1.2	6.0	12.7	3.7	0.7	0.5	0.7	0.8	3.7	7.9	2.3	1.0	0.5	0.5	1.0	2.9	1.2	0.6	2.7	0.8	0.9	20.5	1.6	0.7	2.9	2.7	2.2	0.6	1.0	0.8	0.0	0.9	3.2	0.6	0.9	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	58.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	15.3	9.5	1.1	21.1	12.7	3.7	3.7	7.9	2.9	0.8	0.0	0.0	0.0	0.0	0.1	6.2	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.4	1.4	0.0	6.8	0.0	0.0	0.6	0.0	0.0	2.5	0.0	1.4	0.0	0.3	0.2	0.2	0.0	0.8	0.0	0.0	0.0
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895998	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 175.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		83000000	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	7.5	23.0	9.8	4.1	19.9	1.7	10.4	14.7	22.8	13.4	8.7	8.1	9.9	4.5	16.7	13.1	6.0	10.1	10.3	8.2	9.5	13.3	11.2	10.0	7.6	3.4	14.0	12.0	18.8	7.7	17.5	18.7	21.8	20.1	12.3	7.1	8.6	6.0	11.4	5.3	5.9	4.6	15.4	11.4	5.4	6.2	9.7	16.3	6.4	9.3	5.0	3.4	9.0	6.2	2.1	7.4	3.3	1.1	5.3	5.6	1.9	5.2	2.7	20.1	21.0	22.3	16.5	12.8	9.0	14.9	7.1	15.9	2.6	4.0	5.8	8.8	8.3	5.6	5.1	7.3	7.7	14.4	11.8	5.1	7.1	9.7	7.2	7.3	11.0	3.8	19.5	2.7	14.2	2.8	15.0	25.9	7.4	8.9	0.7	17.9	2.7	5.8	6.1	25.3	4.7	6.1	4.2	20.7	4.7	7.6	4.0	8.3	23.6	6.9	1.8	16.2	15.3	4.3	5.0	10.8	17.8	10.5	11.4	9.5	6.2	5.5	3.6	28.3	11.4	5.8	3.3	0.8	0.0	5.6	1.1	2.8	1.9	1.9	3.7	2.5	2.1	2.1	4.8	0.2	5.3	0.9	7.4	0.0	1.9	9.8	19.9	14.7	22.8	9.5	13.3	14.0	12.0	20.1	16.3	11.9	5.9	2.2	11.4	7.6	20.3	9.7	10.2	29.4	14.8	14.0	33.4	175.5	10.0	5.2	19.7	10.8	2.0	0.0	1.8	25.1	33.5	5.4	17.3	14.7	21.3	3.2	9.1	15.4	7.0	27.2	23.3	3.6	21.9	10.0	3.9	18.6	2.5	2.9	32.5	10.8	17.8	12.9	16.5	29.8	8.1	7.0	62.1	6.9	6.3	3.0
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 65.6"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 11.9;Cardiomyocytes: 13.7;Collecting duct cells: 43.6;monocytes: 12.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 12.7;GAMG: 13.2;HeLa: 35.6;RH-30: 12.1;U-87 MG: 12.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.6	3.0	1.2	0.2	1.3	0.1	2.4	0.4	1.2	9.7	0.6	2.5	11.1	0.4	2.6	1.9	0.7	8.3	0.7	6.2	1.5	1.2	6.1	0.4	2.0	0.2	2.1	0.8	1.6	0.4	0.2	7.2	0.2	3.5	6.6	0.4	2.7	0.8	13.9	65.6	0.4	0.5	1.9	3.5	0.6	0.7	7.4	1.4	1.8	2.5	5.5	0.7	2.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	1.2	0.0	0.0	0.0	0.0	0.0	10.2	0.2	1.5	0.0	0.0	0.0	10.0	0.0	13.2	0.0	7.7	3.3	0.0	0.0	10.0	1.3	35.6	0.0	0.3	0.0	3.5	2.6	0.0	7.3	2.3	1.7	0.0	0.0	0.0	5.4	4.1	0.0	0.0	0.0	0.0	0.1	0.7	0.1	12.1	0.0	0.0	1.9	1.9	2.0	0.1	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	3.7	1.6	0.0	12.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.4	1.2	1.5	1.2	2.1	0.8	3.5	1.4	11.9	2.6	0.0	0.1	0.1	0.0	13.7	0.0	0.0	3.4	43.6	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.7	0.6	1.3	2.0	0.6	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.6	6.6	0.0	0.0	0.0	0.0	0.1
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186265945-186288806	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 88.9"	"Cell type enhanced"	"Detected in some"	27	"Alveolar cells type 2: 19.3;Distal tubular cells: 10.0;Hepatocytes: 59.9"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 14.0"	"Not detected"	"Not detected"							HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	2.7	0.1	0.1	5.5	0.2	0.3	0.1	0.1	4.8	0.1	0.1	0.1	10.2	88.9	2.8	0.1	0.1	0.1	0.1	19.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.1	6.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	19.3	0.0	0.0	0.0	0.0	0.3	2.5	0.0	4.5	1.8	0.0	0.0	10.0	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	59.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021348	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 235.2;Urothelial cells: 227.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 44.5;neutrophil: 32.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 44.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 45.8;OE19: 44.1;SuSa: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"		NA	NA		41000000	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589"	"unprognostic (1.60e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.72e-3)"	"unprognostic (5.01e-2)"	20.7	13.3	3.0	9.6	3.6	6.4	11.8	2.0	3.5	14.5	36.3	3.9	21.4	20.5	8.6	11.2	41.5	12.3	30.5	10.0	3.4	3.2	35.9	69.8	55.0	10.4	3.6	1.8	10.9	37.9	18.5	16.3	61.8	5.3	17.8	19.5	5.7	59.3	23.7	9.0	22.0	59.8	4.9	4.0	27.0	18.8	11.0	3.3	8.1	52.2	25.8	29.9	16.8	19.7	1.3	7.0	44.5	8.9	2.2	3.8	6.6	26.4	3.4	1.0	0.3	0.7	0.0	21.5	0.1	0.0	0.9	0.9	24.5	35.0	1.9	18.0	0.0	5.2	45.8	5.4	22.7	1.4	1.5	4.0	5.5	1.4	11.1	1.1	5.1	16.5	0.3	28.7	0.1	7.6	5.5	21.5	4.2	7.5	0.5	0.1	11.4	1.6	2.9	18.2	44.1	4.9	2.4	0.0	8.5	15.4	20.1	7.6	2.0	6.4	27.5	5.7	54.5	29.9	9.2	12.9	0.0	0.6	0.1	0.2	6.4	12.6	0.6	4.1	5.1	1.7	7.6	8.9	44.5	3.8	4.5	2.0	1.3	3.5	2.3	7.0	0.9	3.4	2.7	32.2	2.2	3.4	5.3	1.5	6.6	3.0	3.6	2.0	3.5	3.4	3.2	3.6	1.8	5.3	3.3	235.2	115.8	3.7	97.8	31.3	0.8	3.0	61.1	163.3	161.5	73.3	2.0	64.9	6.6	66.4	6.8	40.7	78.8	0.0	61.9	148.6	11.0	102.0	17.4	55.2	27.9	0.0	59.7	24.5	14.6	1.5	2.0	22.4	8.5	63.1	64.1	1.4	68.6	75.0	0.7	11.9	2.5	0.0	3.1	12.9	1.2	44.3	52.7	8.7	42.7	227.3
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.1"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 97.5;Enterocytes: 75.9;Suprabasal keratinocytes: 147.0;Urothelial cells: 93.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.8"	"Cell type enriched"	"Detected in many"	4	"neutrophil: 24.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 34.7;RPTEC TERT1: 57.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	0.6	1.1	1.0	7.2	1.4	0.1	2.9	0.4	0.8	2.4	34.0	1.1	25.3	17.4	1.0	2.2	6.4	2.9	13.6	3.6	1.1	0.9	28.9	7.4	2.8	3.7	0.8	0.4	1.2	16.6	1.3	3.2	2.8	7.8	6.0	21.4	1.1	7.1	23.7	0.3	24.8	64.1	0.7	1.5	3.5	16.8	0.8	0.5	0.6	9.6	5.8	3.1	5.3	3.9	0.3	2.7	24.9	5.7	0.3	2.3	2.0	8.7	14.4	1.2	0.0	0.4	1.1	9.3	0.4	4.8	0.2	0.7	12.4	22.6	0.0	19.5	1.0	22.3	15.0	7.6	6.7	0.4	0.0	7.1	0.2	0.3	8.8	3.1	0.0	0.0	1.6	19.2	2.2	14.4	2.3	23.9	2.2	0.1	0.0	0.0	4.7	1.0	0.0	1.6	4.9	34.7	0.0	0.0	0.2	57.6	16.2	0.6	0.1	3.4	3.5	0.0	14.5	1.5	0.0	15.7	0.0	9.1	0.0	0.0	1.3	0.2	0.0	5.1	0.0	0.4	4.6	5.7	1.0	0.3	1.9	1.2	0.3	2.3	1.2	2.7	0.1	2.2	1.3	24.9	0.3	0.3	0.3	0.6	2.0	1.0	1.4	0.4	0.8	1.1	0.9	0.8	0.4	7.8	0.5	8.9	3.0	2.0	18.2	97.5	0.0	0.3	35.7	18.7	11.4	29.6	0.0	4.8	1.7	20.1	0.0	0.6	75.9	0.0	13.1	6.2	3.7	19.6	2.3	8.5	0.7	0.0	12.6	1.8	2.4	0.0	0.0	1.1	1.7	0.0	43.8	0.0	29.3	35.1	0.0	20.2	1.6	0.0	1.0	0.0	1.4	147.0	1.7	0.0	39.6	93.4
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529225-94541800	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 636.0;Exocrine glandular cells: 410.4;Muller glia cells: 389.7;Pancreatic endocrine cells: 1078.7;Peritubular cells: 498.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 117.4;HaCaT: 55.6;HBEC3-KT: 144.4;U-2197: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	45.5	9.8	27.0	14.1	42.9	2.1	55.1	3.4	27.9	14.8	18.7	20.9	18.7	18.3	30.5	23.7	21.3	25.4	30.9	18.8	26.9	14.5	6.6	2.8	31.4	5.8	14.1	20.3	41.6	35.0	6.1	28.8	65.4	39.2	29.7	22.2	49.9	29.2	33.0	2.4	17.7	19.2	5.9	46.3	2.9	18.2	16.4	16.0	0.0	21.8	17.3	11.9	24.7	22.3	0.5	0.9	2.8	0.8	0.7	0.4	0.2	117.4	0.2	0.2	0.0	12.8	6.3	6.6	16.7	10.0	18.1	19.7	2.1	25.2	0.0	8.6	20.7	3.9	55.6	1.5	144.4	29.9	0.1	0.1	0.0	3.6	0.3	4.2	0.0	0.0	10.9	3.2	8.5	41.9	34.4	0.1	0.1	0.1	0.1	12.6	0.2	0.1	2.4	1.1	0.7	0.2	0.1	1.2	0.0	2.2	0.3	0.1	0.3	13.3	5.5	0.4	3.6	0.1	1.6	0.0	11.0	0.3	54.8	5.0	0.1	0.1	0.1	8.4	0.6	0.4	1.7	0.8	0.1	0.3	0.3	0.4	0.2	0.3	0.2	0.2	0.5	0.3	0.3	2.8	0.7	0.2	0.9	0.2	0.2	27.0	42.9	3.4	27.1	26.9	14.5	14.1	20.3	39.2	16.0	122.1	188.9	0.5	636.0	14.4	1.5	21.1	7.6	72.3	238.8	14.0	0.0	13.6	0.0	120.9	5.6	10.5	10.3	0.0	410.4	4.8	48.3	85.3	2.3	0.6	5.4	3.2	12.6	12.3	4.0	9.8	260.4	4.9	3.3	3.6	40.9	389.7	1078.7	11.0	498.9	0.3	13.3	6.5	7.2	1.1	3.4	6.6	6.4	0.8	9.5	358.5
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169514166-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;liver: 88.8;placenta: 32.2"	"Cell type enhanced"	"Detected in many"	22	"Cholangiocytes: 79.0;Cytotrophoblasts: 65.0;Hepatocytes: 221.3;Syncytiotrophoblasts: 49.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Region enriched"	"Detected in many"	11	"pons and medulla: 27.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 8.7;neutrophil: 8.0"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0"	"Group enriched"	"Detected in some"	23	"Hep G2: 13.8;OE19: 52.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8"	"Group enriched"	"Detected in many"	7	"amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.4	0.4	1.4	0.5	1.5	0.8	1.0	0.4	0.4	0.4	6.7	0.0	0.5	0.4	2.2	0.4	1.6	14.1	13.9	2.5	0.5	1.2	88.8	1.1	1.1	1.4	0.1	0.4	1.3	0.1	2.0	32.2	27.9	1.0	0.4	17.8	4.4	0.1	0.4	1.3	0.5	0.5	2.6	1.9	2.2	0.7	1.1	0.0	0.7	0.2	2.6	1.5	0.4	0.0	0.5	8.7	4.2	0.0	7.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2	8.7	0.0	0.2	0.0	0.0	1.7	0.2	0.5	0.0	0.3	0.0	8.0	0.0	0.0	0.0	7.0	1.1	0.4	0.5	1.0	0.4	2.5	0.5	1.4	0.1	27.9	1.1	3.0	1.1	0.0	4.4	0.1	0.1	8.6	79.0	5.3	3.4	0.0	2.0	65.0	0.0	1.6	0.7	1.0	0.0	0.0	0.2	1.6	7.7	0.3	0.0	221.3	4.7	0.0	24.2	3.1	18.7	0.0	0.0	0.2	3.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	49.8	1.3	0.0	9.0
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"liver: 68.0"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 131.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Group enriched"	"Detected in some"	9	"CACO-2: 16.6;Hep G2: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1500000000	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	68.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.6	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.2	0.0	0.5	0.0	0.0	131.2	0.1	0.0	0.0	3.7	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.5	0.0	0.0
FAAH	FAAH-1	ENSG00000117480	"Fatty acid amide hydrolase"	O00519	1	46394265-46413848	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 68.0;Late spermatids: 88.3;Spermatocytes: 73.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 19.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.2;OE19: 10.7;RT4: 23.9;SK-BR-3: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007425	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA007425: AB_1078820"	"unprognostic (6.12e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.39e-3)"	"unprognostic (9.86e-2)"	"prognostic favorable (4.25e-5)"	"prognostic favorable (3.63e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.00e-3)"	6.1	7.7	11.2	2.5	22.0	7.9	7.9	20.4	21.9	6.9	15.0	40.7	10.1	18.0	3.1	8.2	4.9	10.6	4.6	2.9	14.7	11.7	12.0	18.3	6.7	2.1	19.1	19.3	2.7	18.2	15.1	10.6	3.5	17.6	33.3	12.8	7.4	12.8	8.6	7.1	10.1	17.8	2.3	23.6	2.0	14.3	30.9	18.8	5.6	24.9	3.5	3.5	5.7	4.2	0.1	6.0	19.1	4.7	0.3	0.4	0.9	2.8	0.7	0.4	0.5	0.7	0.5	22.2	0.6	0.3	0.3	0.5	4.1	6.6	0.2	2.3	0.4	0.2	9.4	0.4	1.3	0.1	1.2	3.1	0.0	0.1	1.9	0.5	0.8	1.6	0.4	6.4	0.2	0.8	0.2	0.0	0.5	0.1	0.5	0.0	5.9	0.4	1.2	1.8	10.7	0.2	0.5	0.2	0.1	5.2	23.9	2.8	2.1	3.2	12.4	0.1	0.6	8.5	8.2	0.0	0.0	0.3	0.6	0.4	1.2	0.5	0.3	0.1	7.6	0.2	0.0	4.7	19.1	0.3	1.2	0.1	0.0	0.3	0.1	5.7	0.1	0.4	0.4	0.2	0.3	0.6	6.0	0.1	0.9	11.2	22.0	20.4	21.9	14.7	11.7	19.1	19.3	17.6	18.8	20.8	10.4	4.2	27.1	4.6	12.6	2.2	25.5	4.0	10.3	21.0	41.2	14.4	0.0	12.8	35.5	1.8	68.0	0.0	5.6	6.3	2.4	27.0	0.0	29.2	2.6	1.6	14.9	0.6	3.2	88.3	6.9	2.9	5.0	0.0	33.1	6.3	5.0	40.4	4.2	19.5	11.4	0.0	2.7	73.1	7.7	5.3	10.4	0.0	48.5	12.3
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322390	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"intestine: 358.6"	"Group enriched"	"Detected in some"	5	"Enterocytes: 422.5;Mucus-secreting cells: 344.1;Paneth cells: 175.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Hep G2: 2.5;NB-4: 3.9;RPMI-8226: 3.3;SH-SY5Y: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		46000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.1	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	47.0	0.0	0.0	50.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.9	0.1	0.1	0.0	0.1	0.1	358.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.5	7.6	0.7	0.9	0.5	0.0	0.2	0.3	0.2	0.4	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.4	0.4	0.4	0.1	0.0	0.3	0.3	0.0	0.2	0.1	0.1	0.3	0.1	0.5	2.5	0.0	0.5	0.4	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.3	0.5	0.0	0.1	0.4	3.9	0.2	0.2	0.5	0.3	0.3	3.3	0.0	0.5	1.0	2.6	0.1	0.4	0.0	0.2	0.3	0.1	0.9	0.4	0.4	1.5	0.2	0.7	0.3	0.6	0.3	0.3	0.1	2.1	0.7	0.7	0.4	0.3	0.4	0.2	0.4	0.3	0.2	0.5	0.5	0.5	7.6	0.9	0.2	0.5	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	422.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	344.1	0.0	0.0	175.6	0.0	18.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	64.7	0.0
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365625-31376850	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 420.9;skeletal muscle: 129.4"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2447.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"ASC TERT1: 120.7"	"Low region specificity"	"Detected in all"							"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		NA	NA	1640000	4400000	"Focal adhesion sites"	"Golgi apparatus, Plasma membrane"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	2.3	5.2	8.1	0.7	6.0	0.5	22.7	1.4	14.6	3.9	1.3	0.8	3.4	0.7	6.8	5.3	3.1	2.8	1.1	420.9	11.0	5.3	21.3	1.9	4.3	1.3	9.8	6.0	2.2	0.4	0.3	0.7	1.1	13.7	5.0	1.5	3.0	4.4	14.0	129.4	0.9	0.6	13.0	3.4	3.9	3.6	2.0	1.3	0.1	1.7	31.6	2.2	2.5	2.5	1.4	0.5	0.0	0.9	0.2	0.9	0.6	0.1	0.0	3.3	0.2	23.1	120.7	1.1	0.9	8.9	0.1	3.2	0.2	0.9	0.2	12.8	2.5	0.0	0.3	0.9	0.0	0.1	0.1	0.5	0.4	1.1	2.4	1.5	0.2	0.0	10.7	0.0	2.4	0.0	0.3	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.2	6.1	0.0	0.4	0.1	1.2	0.0	2.9	0.0	0.3	0.0	0.5	0.0	13.9	7.1	0.1	1.4	0.3	0.2	0.1	2.1	0.2	0.1	0.4	0.1	0.5	0.1	0.3	0.0	0.4	0.0	0.9	0.9	0.6	0.2	0.5	0.5	0.5	1.4	0.0	0.9	0.0	0.2	0.1	0.4	0.6	0.6	8.1	6.0	1.4	13.3	11.0	5.3	9.8	6.0	13.7	1.3	0.0	1.7	0.8	1.0	3.2	3.1	2447.6	5.1	2.7	2.3	26.2	2.0	2.1	383.0	0.3	2.1	0.8	0.0	0.0	0.3	1.3	14.9	3.8	1.1	0.0	96.1	7.9	0.0	3.7	20.0	4.2	6.4	17.6	8.5	0.0	0.0	2.7	0.5	3.6	7.4	399.5	8.1	0.0	32.3	0.3	0.1	2.6	1.4	1.0	0.1	5.2
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 1256.0;Hofbauer cells: 2357.3;monocytes: 1172.2"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 93.8;MOLT-4: 91.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		28000000	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.8	16.7	10.2	0.0	48.8	4.6	0.0	11.9	0.6	9.3	11.8	0.2	8.0	93.8	6.8	2.9	0.1	5.4	24.8	19.1	8.0	47.6	53.9	33.8	11.9	25.2	4.3	32.3	8.8	3.5	39.3	11.5	23.7	9.4	53.4	24.9	9.7	10.2	5.6	5.6	91.6	16.5	13.5	57.9	64.9	40.9	0.0	9.9	15.0	72.5	42.4	16.1	5.8	1.9	4.4	18.5	0.1	16.6	7.6	0.0	26.5	0.1	0.1	12.6	4.9	66.8	4.3	31.0	14.9	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6	268.0	1256.0	87.2	58.7	107.4	21.2	2.8	2.5	100.4	708.6	21.0	43.2	16.9	3.3	27.1	23.0	313.1	94.4	0.0	20.3	209.8	84.3	44.5	54.3	0.8	2357.3	20.6	189.4	31.9	161.8	37.2	5.8	624.3	195.7	1172.2	116.5	252.2	31.0	459.1	4.9	0.8	41.8	355.7	66.0	131.8	169.3	147.4	22.5	71.0	321.9	172.7
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779475-122784074	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 62.7;breast: 26.8"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 827.1"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1"	"Group enriched"	"Detected in some"	8	"AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3"	"Region enriched"	"Detected in all"	6	"olfactory region: 1471.1"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	2.1	1.3	34.8	1.1	15.5	1.3	26.8	51.6	62.7	1.1	1.5	13.0	0.0	1.2	1.2	1.3	1.6	1.2	1.2	1.2	32.0	16.4	1.6	1.4	1.1	1.1	11.4	30.3	1.1	1.1	1.0	2.1	1.3	11.2	1.3	1.2	5.7	7.0	3.7	6.7	10.5	1.1	1.1	8.1	1.1	1.3	1.2	6.9	0.0	1.1	0.0	1.1	1.4	0.0	0.4	0.2	3.1	0.3	1.1	0.4	0.0	0.0	0.0	38.7	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.4	0.0	23.3	3.1	0.3	0.1	0.3	0.1	0.3	0.2	0.3	0.4	0.1	0.4	0.3	0.3	0.5	1.1	0.2	0.2	0.1	0.0	34.8	15.5	51.6	27.3	32.0	16.4	11.4	30.3	11.2	6.9	0.0	0.0	0.0	0.1	10.9	6.8	0.4	0.0	0.0	0.0	0.0	11.8	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	162.7	1.1	0.0	0.0	0.0	2.5	4.8	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	827.1	0.0	0.0	0.0	0.2	37.4	0.0	0.8	0.0	0.0	16.6	5.9	0.0	0.0	0.0
FADS3	"CYB5RP, LLCDL3"	ENSG00000221968	"Fatty acid desaturase 3"	Q9Y5Q0	11	61873519-61892051	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 63.1"	"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 109.7;Rod photoreceptor cells: 109.4;Smooth muscle cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.9;naive B-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 63.4;HHSteC: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045224	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA045224: AB_10967570"	"unprognostic (4.69e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (1.76e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.50e-9)"	"unprognostic (1.14e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-1)"	63.1	25.9	15.7	17.5	17.9	4.1	23.5	8.7	16.5	9.3	8.3	13.8	5.9	4.3	9.8	25.4	7.4	9.0	9.9	22.7	14.4	11.6	16.6	8.5	16.3	15.4	16.9	10.0	12.7	12.1	12.4	5.0	48.2	15.1	7.1	4.4	16.8	5.5	11.3	15.7	4.2	9.0	14.9	13.3	9.7	8.3	6.0	15.6	1.1	6.1	7.3	15.7	10.4	9.9	10.6	0.7	5.7	1.2	0.6	2.4	0.7	7.7	2.4	0.7	4.9	63.4	12.8	15.8	15.8	38.6	16.9	16.4	3.4	2.8	5.8	10.3	31.4	13.2	4.3	2.9	42.9	9.0	1.6	1.6	4.8	10.3	6.9	54.9	0.4	0.9	14.0	18.7	20.3	38.8	10.3	19.5	3.1	4.6	11.0	28.7	9.0	1.7	2.4	2.3	0.8	6.4	9.7	31.3	16.1	18.9	2.7	1.2	1.6	18.0	2.4	16.0	6.8	3.5	1.0	13.2	16.5	11.5	4.8	6.9	3.4	1.6	7.0	13.8	2.3	11.9	0.0	0.7	5.7	1.8	1.2	1.6	8.9	1.6	2.4	0.7	10.6	0.1	0.6	0.3	0.6	0.8	0.0	0.4	0.7	15.7	17.9	8.7	15.4	14.4	11.6	16.9	10.0	15.1	15.6	29.8	6.9	31.8	7.1	6.1	10.3	18.6	7.6	2.7	1.2	5.2	7.9	34.9	1.7	39.5	16.2	27.8	7.0	23.3	17.7	109.7	19.7	8.5	6.9	8.5	17.2	1.6	6.4	18.4	3.7	8.3	26.4	14.0	33.7	12.6	3.6	57.1	21.1	3.5	16.6	9.1	109.4	19.4	106.1	2.1	3.8	4.8	56.9	4.3	4.8	3.3
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 250.1;Hofbauer cells: 63.7;Proximal tubular cells: 236.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 76.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		230000000	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	32.1	17.8	4.6	6.1	3.6	4.7	22.8	2.3	3.3	4.7	8.6	3.1	8.3	4.1	5.1	14.8	4.4	6.8	7.1	6.8	4.1	2.8	18.9	109.4	7.9	6.2	4.0	2.1	7.2	6.5	4.8	4.4	2.3	3.5	4.9	3.4	2.4	5.3	5.4	7.7	2.4	7.6	4.4	5.9	6.0	3.3	9.7	3.0	2.3	4.2	4.9	3.9	4.1	6.1	0.1	16.0	16.9	11.7	3.6	5.8	6.1	4.5	7.6	3.1	3.9	14.7	15.1	7.8	5.8	13.3	6.2	5.3	4.6	8.4	0.0	9.6	12.2	8.6	6.7	11.2	13.9	6.0	2.9	6.3	38.8	4.5	23.8	76.6	18.3	21.5	26.1	8.6	5.3	9.6	20.3	8.6	8.9	16.2	8.3	11.5	6.9	5.0	9.1	2.2	3.5	8.7	2.8	4.5	29.1	17.8	5.5	0.1	1.9	6.5	18.0	18.2	5.3	13.7	12.5	29.9	11.3	7.1	6.0	9.8	7.6	15.5	3.1	23.5	42.9	6.3	16.9	11.7	1.9	5.8	4.9	1.5	0.1	1.6	3.9	16.0	0.0	2.0	1.8	0.7	3.6	4.8	1.2	1.5	6.1	4.6	3.6	2.3	3.3	4.1	2.8	4.0	2.1	3.5	3.0	3.0	14.4	5.2	13.1	6.1	0.4	12.0	10.2	5.3	4.5	31.4	0.0	32.5	44.7	8.5	6.3	2.5	15.8	23.3	3.1	9.0	17.2	8.6	42.5	250.1	63.7	0.0	4.1	11.1	20.0	10.6	9.2	23.1	18.6	3.6	11.8	3.5	4.6	14.4	7.4	236.8	0.3	0.0	8.1	1.5	2.1	5.0	18.4	8.7	22.4	12.8
FAIM	"FAIM1, FLJ10582"	ENSG00000158234	"Fas apoptotic inhibitory molecule"	Q9NVQ4	3	138608606-138633376	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 61.9"	"Cell type enhanced"	"Detected in many"	8	"Rod photoreceptor cells: 189.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 45.4"					"Low region specificity"	"Detected in all"			"HPA042440, HPA052209"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042440: AB_2677999, HPA052209: AB_2681761"	"unprognostic (6.45e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (3.96e-5)"	"unprognostic (4.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.63e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.98e-2)"	13.7	6.6	12.3	6.7	11.6	2.6	19.0	7.8	9.9	24.5	6.8	10.2	38.5	4.7	9.6	15.1	8.8	28.5	9.0	4.7	12.2	12.5	15.4	6.0	7.6	7.2	13.9	7.1	8.4	27.5	7.2	15.4	6.1	10.7	11.4	6.0	9.1	7.2	61.9	6.1	6.2	4.2	7.2	19.6	3.7	6.7	5.4	9.1	13.2	15.2	9.3	9.6	10.3	13.2	13.9	5.0	11.1	2.6	13.9	9.1	3.4	26.9	5.3	0.5	4.8	5.2	9.8	19.4	8.3	5.0	8.8	7.6	9.1	7.9	0.0	7.4	10.9	10.2	7.1	23.1	4.7	10.0	22.1	24.1	5.1	14.6	13.1	5.8	0.0	1.6	13.7	9.3	3.3	5.1	5.4	9.5	1.9	3.3	6.9	5.4	10.2	0.1	22.8	10.5	0.8	5.3	27.2	6.3	0.7	14.0	13.4	9.1	7.7	14.8	8.2	20.8	6.0	13.9	6.7	5.8	1.8	4.2	9.0	4.0	0.0	0.1	45.4	7.3	0.0	7.2	11.1	2.4	1.7	9.1	2.6	8.5	13.9	5.0	7.2	5.0	7.9	3.4	8.5	0.3	13.9	1.7	3.5	5.4	3.4	12.3	11.6	7.8	8.2	12.2	12.5	13.9	7.1	10.7	9.1	17.9	15.6	9.3	23.8	9.6	27.4	4.5	63.7	87.0	36.4	24.4	62.8	37.0	26.6	49.3	9.6	10.8	2.0	0.0	43.5	25.4	17.6	19.1	40.4	10.2	24.6	14.3	20.3	8.6	3.5	11.1	16.1	5.5	15.1	23.4	8.3	34.0	31.2	0.0	18.7	19.0	189.9	0.0	19.6	16.8	2.2	11.4	12.2	9.6	11.5	23.3
FAIM2	"KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2"	ENSG00000135472	"Fas apoptotic inhibitory molecule 2"	Q9BWQ8	12	49866896-49904217	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 138.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 136.4;Early spermatids: 135.6;Horizontal cells: 219.3"	"Cancer enriched"	"Detected in many"	8	"glioma: 21.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 1.7;T-reg: 6.2"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"HHSteC: 9.1;OE19: 11.7;SH-SY5Y: 4.9;U-87 MG: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018790, HPA048800"	Enhanced		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA018790: AB_1852822, HPA048800: AB_2680526"	"unprognostic (1.74e-1)"	"unprognostic (5.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.61e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-6)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.78e-4)"	3.9	27.2	35.6	4.1	57.5	1.4	2.5	42.4	138.5	3.2	4.7	29.1	0.2	2.7	4.2	6.4	3.9	5.8	7.5	7.4	38.8	51.0	2.0	1.5	2.5	3.5	35.9	33.7	2.6	2.8	14.7	7.8	1.5	65.6	8.8	3.5	3.9	3.0	7.1	2.0	1.8	4.0	8.7	36.9	2.5	2.6	12.1	20.5	0.0	1.7	0.0	3.1	4.7	2.0	0.0	0.0	0.0	0.4	0.6	6.2	0.2	0.0	0.3	0.4	0.5	2.0	1.3	0.1	0.5	2.6	0.5	0.3	0.3	0.0	0.0	0.1	3.6	0.2	0.2	1.2	0.0	0.3	0.0	0.0	2.0	0.0	0.0	9.1	0.1	0.0	0.8	0.2	1.9	0.0	0.0	0.0	0.2	1.1	0.3	0.5	0.0	0.1	0.0	0.0	11.7	0.0	0.0	0.1	0.0	0.0	0.0	3.2	4.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	28.4	0.0	0.2	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	6.2	0.2	35.6	57.5	42.4	99.5	38.8	51.0	35.9	33.7	65.6	20.5	0.0	0.0	0.0	0.1	0.2	136.4	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	135.6	0.0	0.0	0.0	0.2	0.0	1.4	0.6	26.4	0.0	0.4	219.3	0.0	0.0	0.0	31.4	4.6	0.0	0.0	0.0	2.0	34.2	0.1	0.0	4.9	0.1	14.5	0.0	0.9	1.2	2.1	0.3	0.1	0.0	0.2	0.1
FAM102A	"bA203J24.7, C9orf132, Eeig1, SYM-3A"	ENSG00000167106	"Family with sequence similarity 102 member A"	Q5T9C2	9	127940579-127980513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036030			Approved	Cytosol		NA	NA			Cytosol		"HPA036030: AB_10670675"	"unprognostic (3.27e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.98e-2)"	5.3	18.3	28.2	19.9	39.1	7.6	12.1	10.5	31.8	22.4	35.8	65.9	8.7	33.3	15.7	12.6	27.4	29.8	28.5	6.7	29.4	17.3	15.1	23.9	8.5	34.4	41.5	22.9	19.7	21.6	12.9	22.9	5.7	28.0	10.6	11.2	12.5	19.1	13.5	1.9	18.7	39.3	16.7	39.0	12.9	61.8	15.4	53.0	32.0	12.1	13.7	26.3	17.8	18.6	4.7	0.1	2.2	0.1	0.5	11.8	3.0	10.1	22.5	4.8	3.8	10.2	12.3	18.3	3.9	10.9	2.7	1.6	12.9	18.1	11.6	2.6	7.5	5.7	11.2	2.5	2.0	1.0	5.5	2.5	3.4	5.7	11.5	6.4	1.6	26.9	5.0	10.4	7.5	3.2	5.3	3.6	7.1	2.8	14.6	3.0	26.2	6.7	3.6	5.8	20.0	10.9	3.5	3.5	4.2	7.6	17.5	7.5	3.7	6.5	14.7	9.3	5.4	27.6	2.2	3.8	4.2	4.5	22.1	5.9	19.8	26.9	8.0	18.1	2.2	9.9	0.6	0.1	2.2	1.9	0.0	6.1	4.7	9.4	5.6	0.1	1.2	9.1	6.0	0.1	0.5	0.0	0.0	11.8	3.0	28.2	39.1	10.5	31.8	29.4	17.3	41.5	22.9	28.0	53.0	6.0	7.0	18.2	26.3	19.5	14.0	10.9	45.9	13.4	6.8	61.1	9.8	5.0	6.6	45.0	4.6	5.8	107.7	0.0	86.2	4.9	13.2	53.6	18.4	40.9	2.9	25.4	26.9	69.3	7.9	4.3	31.7	2.3	21.9	4.6	34.2	62.4	54.3	31.6	40.7	10.5	15.5	0.0	7.8	5.9	9.3	41.9	4.5	20.3	20.4	65.9
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	11.6	5.2	11.8	10.4	11.4	19.0	11.3	23.3	20.0	8.5	13.8	3.8	6.6	11.4	7.5	8.2	6.5	6.7	15.7	9.2	15.6	14.3	4.6	5.1	8.1	8.8	12.6	19.0	10.5	5.8	12.1	7.3	6.0	11.4	8.5	15.7	5.5	13.5	9.6	2.3	4.2	11.5	11.4	10.2	8.6	7.9	8.8	5.0	9.4	6.7	4.3	8.4	16.4	18.0	0.9	2.7	5.7	2.3	0.7	1.4	0.5	3.6	2.6	5.4	2.8	9.7	5.9	3.5	2.2	2.9	3.4	5.8	0.9	3.7	4.0	2.0	5.6	3.5	7.2	18.2	0.7	4.4	2.6	2.6	5.7	20.5	0.4	2.5	7.3	11.0	3.1	0.8	5.0	0.3	6.9	2.2	6.8	13.8	22.8	7.9	15.1	4.7	5.3	4.2	8.7	13.4	10.8	13.6	0.8	0.9	4.3	17.5	5.1	8.7	15.2	4.5	4.0	3.2	12.1	0.4	5.5	10.4	4.7	8.2	4.1	1.0	3.8	8.1	5.8	2.9	5.7	1.1	1.0	1.0	2.3	0.6	0.9	1.0	1.4	2.7	0.9	0.7	0.5	1.0	0.7	0.9	0.5	0.8	0.5	11.8	11.4	23.3	20.0	15.6	14.3	12.6	19.0	11.4	5.0	0.0	2.1	0.0	2.1	5.5	4.6	1.2	10.2	2.7	2.3	1.8	0.0	2.1	1.7	1.7	9.2	5.8	7.1	0.0	5.3	2.1	7.3	2.6	7.0	0.8	8.9	0.0	6.9	6.7	22.2	4.5	13.3	16.8	5.0	10.0	10.0	1.2	4.3	10.5	19.4	0.4	0.9	0.0	3.9	1.7	6.0	3.1	2.9	5.0	13.0	4.6
FAM104A	FLJ14775	ENSG00000133193	"Family with sequence similarity 104 member A"	Q969W3	17	73207353-73236753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1144.0;Late spermatids: 1283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021459, HPA079514"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021459: AB_1848361, HPA079514: "	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	9.3	7.2	8.7	9.1	9.0	23.2	12.4	10.8	7.9	9.9	9.1	6.9	7.4	7.8	8.4	8.4	10.4	6.6	8.5	11.6	8.1	7.0	6.4	10.0	8.2	10.1	6.9	8.3	8.2	11.4	8.4	11.2	14.2	6.4	9.3	8.1	8.4	8.3	8.0	11.9	11.7	10.1	7.3	7.1	11.8	13.3	74.8	6.5	14.6	9.2	7.1	11.2	9.9	11.6	21.3	19.7	34.3	20.3	26.7	49.5	29.9	23.0	19.0	9.5	17.7	14.7	13.8	31.4	18.9	19.9	20.9	21.6	15.9	14.9	13.5	15.6	18.1	20.3	14.7	12.3	13.8	22.7	15.8	16.5	19.6	16.3	24.0	19.5	17.1	33.8	14.6	18.3	18.5	13.6	13.7	24.4	16.4	15.2	22.6	25.0	15.7	30.4	11.8	13.2	17.0	24.3	16.7	26.7	13.0	15.9	19.0	15.8	21.0	11.0	16.1	20.2	18.7	22.6	17.7	16.9	24.7	28.6	16.8	22.0	22.4	22.1	16.4	22.1	18.8	18.2	24.5	20.3	34.3	24.7	17.6	23.7	21.3	30.3	28.1	19.7	20.2	22.2	26.7	33.3	26.7	18.6	12.8	49.5	29.9	8.7	9.0	10.8	7.9	8.1	7.0	6.9	8.3	6.4	6.5	8.9	12.2	25.3	20.2	50.6	15.0	5.0	20.4	16.0	12.5	21.0	5.9	95.7	26.6	29.8	1144.0	18.8	18.8	23.3	22.0	52.3	27.1	25.6	28.8	17.8	31.7	25.4	19.0	11.1	20.2	1283.3	32.5	21.6	23.6	33.3	24.5	18.6	28.1	24.3	22.6	15.4	19.4	6.5	17.5	121.4	59.8	57.5	271.7	30.5	18.4	48.7
FAM105A	"FLJ11127, NET20"	ENSG00000145569	"Family with sequence similarity 105 member A"	Q9NUU6	5	14581775-14615007	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 89.3;Hofbauer cells: 83.6;Intestinal endocrine cells: 59.1;Kupffer cells: 69.4;Spermatogonia: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.0;HMC-1: 44.0;OE19: 12.3;THP-1: 12.2;U-937: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	5.1	3.5	4.0	7.9	4.9	35.4	5.2	3.1	5.1	6.3	15.4	9.0	4.5	8.3	3.0	5.6	2.9	3.1	4.1	3.0	3.9	4.3	5.2	1.9	28.8	16.7	6.1	3.8	4.0	13.3	1.9	8.7	6.7	7.9	12.6	17.3	10.3	3.1	13.5	1.3	2.6	13.7	3.3	10.8	13.2	5.4	4.4	4.1	3.5	27.2	3.0	6.2	7.1	5.8	0.1	26.7	6.9	26.2	14.1	9.6	16.2	0.0	0.6	1.2	0.0	0.2	0.0	5.3	1.5	1.4	0.4	0.7	1.9	1.4	0.0	0.8	0.7	2.2	0.1	2.6	1.2	0.6	0.8	3.6	3.4	14.0	0.3	1.3	0.0	44.0	0.1	0.3	0.2	0.0	0.0	0.0	2.2	0.0	5.5	0.1	1.1	0.0	1.2	1.9	12.3	9.4	0.4	0.5	1.6	0.0	10.5	4.6	5.1	0.7	0.5	0.0	1.3	0.5	12.2	0.0	0.6	3.4	0.2	1.1	0.0	0.0	0.0	0.8	20.8	0.2	0.0	26.2	0.1	4.5	12.4	6.0	0.1	5.7	6.1	26.7	0.1	7.8	7.5	6.9	14.1	9.4	19.7	9.6	16.2	4.0	4.9	3.1	5.1	3.9	4.3	6.1	3.8	7.9	4.1	89.3	8.2	0.9	4.4	7.4	0.7	0.0	2.5	0.0	3.4	0.0	0.0	0.7	0.0	0.0	1.1	6.3	22.2	0.0	0.0	1.5	5.9	7.8	49.6	0.2	83.6	0.0	59.1	4.3	69.4	2.0	4.0	37.7	11.8	0.0	39.6	2.5	0.0	37.1	3.2	0.0	0.9	0.0	3.8	20.5	57.7	5.9	1.1	30.5	41.5	2.7
FAM107B	"C10orf45, FLJ45505, HITS, MGC11034"	ENSG00000065809	"Family with sequence similarity 107 member B"	Q9H098	10	14518557-14774897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"granulocytes: 17.3;NK-cells: 14.5;T-cells: 32.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 65.1;HDLM-2: 77.8;Karpas-707: 55.8;THP-1: 51.6"									"HPA039661, HPA058814, HPA073195"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.82e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.53e-2)"	15.0	15.2	30.0	27.5	44.7	48.7	19.3	13.1	21.7	15.0	20.2	56.3	85.8	10.4	15.7	7.0	8.3	7.0	21.8	5.9	44.1	23.8	40.1	47.4	20.8	45.7	49.7	14.6	3.5	40.7	16.4	10.7	17.2	38.5	10.0	14.0	3.9	27.7	85.7	2.1	8.4	17.8	10.5	66.3	15.4	37.9	11.6	44.7	7.5	6.2	4.1	41.9	15.5	9.8	3.5	1.4	17.3	3.7	14.5	32.4	19.2	10.5	22.8	9.1	0.6	1.4	0.3	3.8	10.6	15.3	6.5	4.7	14.0	8.9	65.1	9.6	4.8	2.4	3.3	2.8	6.4	11.6	77.8	2.5	1.8	10.3	16.5	4.9	23.4	4.2	0.7	5.0	2.7	1.3	7.7	27.6	12.9	0.1	55.8	5.0	2.7	5.7	6.8	2.2	12.7	5.0	41.7	7.0	23.9	14.9	6.8	3.4	9.7	4.2	2.2	6.9	8.5	8.2	51.6	9.0	6.8	5.7	21.4	3.5	24.7	22.0	42.1	1.2	20.6	1.8	11.5	1.7	17.3	29.8	2.0	29.1	3.5	24.0	25.1	1.4	3.1	32.4	32.0	7.2	14.5	3.7	1.0	21.1	19.2	30.0	44.7	13.1	21.7	44.1	23.8	49.7	14.6	38.5	44.7	98.3	44.3	102.5	106.0	79.7	4.0	3.9	127.4	91.0	58.0	272.2	2.0	13.9	189.0	38.0	23.9	29.6	36.4	0.0	92.2	29.2	52.6	147.0	117.6	155.2	36.2	190.7	13.7	63.3	52.4	41.5	2.3	57.8	49.0	43.3	91.1	13.5	84.5	17.3	4.6	157.5	13.2	0.0	41.2	55.4	35.6	72.0	52.3	117.6	22.4	208.7
FAM111A	"FLJ22794, KIAA1895"	ENSG00000166801	"Family with sequence similarity 111 member A"	Q96PZ2	11	59142748-59155039	"Disease related genes, Predicted intracellular proteins"	"Antiviral defense, DNA replication, Host-virus interaction"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 73.4"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039529, HPA040176"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"		"HPA039529: AB_10795149, HPA040176: AB_10793958"	"unprognostic (4.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (4.39e-4)"	16.3	13.7	4.8	28.1	6.7	9.9	14.5	3.3	4.8	14.7	14.2	8.3	13.2	12.8	18.1	16.8	10.2	11.3	15.9	6.7	5.5	3.9	14.5	11.7	17.5	19.6	7.4	3.8	11.2	10.7	17.8	17.4	10.8	8.1	22.5	11.7	13.2	13.4	13.0	5.6	11.0	19.3	14.0	12.3	29.5	12.9	5.9	6.5	73.4	19.5	12.9	21.3	10.9	13.2	4.6	6.5	7.7	6.3	6.9	8.6	2.4	21.2	5.5	2.7	2.6	6.1	7.4	1.8	30.4	16.6	13.1	19.3	8.3	20.0	31.2	12.8	9.8	17.9	7.4	9.0	13.3	16.6	27.7	0.4	11.7	7.0	2.5	6.3	18.6	15.9	5.1	3.4	12.2	3.9	7.6	12.1	19.3	1.4	25.8	14.1	6.0	28.1	12.5	1.2	6.6	6.0	19.4	9.8	7.3	8.8	19.0	0.0	0.7	15.6	13.1	5.9	1.5	26.9	8.4	11.7	21.4	19.3	14.6	14.2	13.2	13.7	5.1	11.7	13.3	25.7	6.2	6.3	6.7	6.6	5.4	8.6	4.2	4.5	4.8	6.5	4.6	4.4	3.7	7.7	6.9	2.6	1.8	4.6	2.4	4.8	6.7	3.3	4.8	5.5	3.9	7.4	3.8	8.1	6.5	59.6	39.5	24.4	9.7	7.6	2.2	3.9	12.7	46.8	26.1	15.7	0.0	8.9	8.3	10.1	0.0	17.5	12.9	0.0	6.6	1.2	14.9	15.7	26.6	7.9	24.4	0.0	5.8	27.6	31.6	1.1	12.0	25.0	6.8	12.6	19.1	29.9	8.0	15.8	6.3	7.6	6.5	0.0	10.7	0.4	1.9	7.8	3.7	21.8	15.3	10.9
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127410	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 43.9"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 4.8;Basal keratinocytes: 3.8;Hofbauer cells: 3.4;Undifferentiated cells: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.7;naive B-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	1.3	1.3	0.4	8.9	0.8	3.5	1.9	0.3	1.1	1.8	4.7	0.4	0.3	2.5	0.8	2.0	9.3	0.7	1.8	1.0	0.4	0.4	1.8	2.6	2.1	9.9	0.5	0.3	1.0	0.8	1.4	0.9	2.8	0.8	1.2	5.0	0.3	2.6	0.3	0.5	3.5	4.1	1.3	0.6	5.4	2.8	1.0	0.6	43.9	0.7	9.2	11.1	1.5	2.6	5.7	0.3	3.1	0.2	0.1	1.4	0.3	24.4	6.3	9.4	0.1	1.0	1.8	0.1	18.6	9.3	11.1	16.5	13.3	9.7	30.5	12.6	5.4	9.3	19.0	13.7	12.6	19.8	15.8	3.3	3.3	12.0	5.8	0.0	0.1	3.9	0.4	0.4	10.7	0.8	2.1	5.9	8.3	0.9	28.8	13.0	9.2	19.2	0.2	0.1	14.8	7.4	20.3	14.0	11.9	5.9	21.1	1.8	6.0	15.4	17.8	3.0	3.6	19.7	1.7	3.2	8.6	18.8	26.0	16.9	22.2	16.0	0.2	12.5	0.1	12.3	0.5	0.2	0.2	0.3	0.1	0.2	5.7	0.4	0.7	0.3	5.7	0.2	0.2	3.1	0.1	0.2	0.3	1.4	0.3	0.4	0.8	0.3	1.1	0.4	0.4	0.5	0.3	0.8	0.6	0.0	0.0	4.8	2.0	3.8	0.0	0.3	0.0	2.7	1.2	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.3	0.3	0.8	0.0	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	2.4	0.1	0.5	6.3	0.9
FAM114A2	"133K02, C5orf3"	ENSG00000055147	"Family with sequence similarity 114 member A2"	Q9NRY5	5	153990128-154038936	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035869, HPA035870"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA035869: AB_10669534, HPA035870: AB_10673222"	"unprognostic (1.81e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.37e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.17e-2)"	"unprognostic (5.90e-3)"	"unprognostic (2.85e-2)"	15.7	16.1	10.3	11.1	10.4	6.9	13.6	7.2	10.5	10.5	10.6	8.5	15.9	10.3	12.8	15.1	14.0	10.9	9.7	16.5	12.7	9.5	13.7	18.3	12.0	16.7	10.1	9.8	14.0	26.4	22.3	18.9	11.4	11.5	13.0	9.7	12.5	16.0	12.5	20.7	10.2	13.4	17.4	8.9	14.3	13.0	30.7	9.9	16.6	14.6	11.5	14.3	13.1	11.1	12.4	10.9	25.9	15.8	12.1	14.5	8.7	8.4	11.2	12.0	18.8	17.0	15.9	10.9	20.4	14.3	15.2	21.2	8.2	12.5	10.7	19.6	15.0	10.6	7.2	10.4	19.9	18.5	11.9	11.6	13.6	6.8	5.9	20.0	11.9	14.1	14.2	12.4	13.6	24.7	11.2	21.2	14.1	8.5	16.8	19.6	8.1	13.5	4.9	5.2	9.0	5.5	11.7	16.6	16.2	11.6	5.9	2.8	10.1	14.8	16.0	20.7	13.3	21.5	8.7	19.6	14.1	10.1	12.9	12.2	25.6	20.6	15.1	16.8	16.5	15.1	20.0	10.9	25.9	12.4	13.8	14.2	12.4	10.4	14.5	10.9	11.7	13.0	12.7	5.5	12.1	15.8	9.9	11.6	8.7	10.3	10.4	7.2	10.5	12.7	9.5	10.1	9.8	11.5	9.9	8.9	8.6	14.3	5.5	5.6	8.9	24.0	2.5	13.4	5.7	10.4	3.9	19.1	6.6	10.8	31.5	17.9	5.4	0.0	10.8	13.2	13.0	4.3	17.3	16.8	15.3	9.5	5.2	6.7	17.0	9.8	10.3	12.3	13.5	10.8	6.9	23.6	8.9	3.5	9.2	12.3	16.2	6.5	10.3	100.0	36.0	5.9	15.3	10.7	5.2	2.7
FAM117A		ENSG00000121104	"Family with sequence similarity 117 member A"	Q9C073	17	49710332-49789180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 24.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 35.4;U-266/84: 24.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA022531	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022531: AB_2101087"	"prognostic favorable (5.30e-5)"	"unprognostic (8.06e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.25e-7)"	"unprognostic (4.05e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.66e-2)"	9.9	5.7	7.6	15.5	9.4	42.9	9.6	12.4	5.7	17.4	15.8	5.6	12.2	7.2	21.2	9.6	11.3	12.4	13.3	12.5	5.6	3.7	8.3	10.0	9.0	14.2	2.8	5.4	16.0	17.6	8.6	11.9	4.4	10.8	16.4	6.0	24.3	11.9	21.3	4.0	13.6	13.7	20.7	2.1	26.7	10.3	18.4	3.6	30.0	14.2	6.5	24.1	21.8	8.5	13.9	2.1	24.3	0.9	6.7	5.5	1.8	3.0	0.7	4.9	0.0	2.2	0.4	8.8	1.0	1.7	1.8	3.1	21.7	5.0	14.3	5.4	0.6	8.3	1.7	3.8	3.6	1.4	1.0	6.2	15.8	0.0	6.9	2.4	2.4	12.6	2.1	3.0	3.1	1.7	1.9	3.3	12.4	19.2	12.2	1.7	8.1	15.2	12.7	7.3	4.1	2.4	4.8	4.1	7.5	2.8	2.7	4.9	3.2	1.0	0.4	3.5	5.0	7.2	9.1	0.3	1.8	1.5	1.9	0.8	35.4	24.3	9.5	1.6	3.5	1.5	24.3	0.9	4.9	5.0	0.6	5.5	13.9	3.3	4.2	0.7	9.3	2.7	3.7	1.9	6.7	0.1	2.1	3.2	1.8	7.6	9.4	12.4	5.7	5.6	3.7	2.8	5.4	10.8	3.6	6.0	5.7	11.0	1.2	8.0	12.6	16.1	2.5	1.4	5.7	7.0	13.7	0.9	5.0	1.3	2.3	6.5	0.9	93.5	3.1	1.6	6.1	2.6	2.3	5.0	1.1	4.8	10.3	6.7	3.2	4.5	13.3	3.4	6.8	11.8	4.4	3.9	3.2	0.0	14.5	2.8	3.1	0.0	7.2	17.2	12.4	12.3	0.7	13.1	2.6	0.9
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202635188-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome		Yes	No			Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: AB_2672760"	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	5.8	12.5	10.1	11.1	10.3	4.3	10.0	20.8	18.1	5.5	7.9	3.2	7.1	7.0	5.0	7.5	9.6	6.6	6.2	4.3	8.6	10.8	8.3	3.6	6.2	13.0	5.9	9.1	8.8	11.6	24.7	7.5	11.0	4.7	8.6	7.9	3.7	8.6	9.3	5.8	9.0	6.0	7.3	5.7	8.2	6.6	12.6	5.8	22.4	5.5	4.8	11.7	7.2	12.7	9.0	4.8	2.3	8.9	4.5	9.9	3.3	1.6	2.0	8.9	6.1	3.0	1.7	8.6	0.5	0.8	0.5	1.0	2.5	3.5	6.7	5.5	1.0	1.3	1.6	7.5	3.8	1.5	0.1	6.1	5.6	3.8	9.4	2.4	4.7	2.5	2.3	5.3	1.1	1.7	4.0	2.4	8.9	8.0	1.4	0.5	3.2	12.7	9.9	9.0	4.7	3.8	10.1	1.8	7.8	4.7	4.3	15.1	13.1	6.6	4.4	3.2	7.8	1.9	6.6	1.4	1.1	2.1	1.5	0.9	4.9	2.8	8.9	2.0	3.7	1.1	0.3	4.5	1.6	1.6	8.9	4.0	9.0	3.6	3.1	4.8	8.5	9.9	6.8	2.3	4.5	8.8	1.7	1.3	3.3	10.1	10.3	20.8	18.1	8.6	10.8	5.9	9.1	4.7	5.8	3.0	6.9	14.1	1.9	15.2	4.7	3.9	10.2	2.7	2.3	17.4	3.9	6.1	0.0	6.7	1.7	3.3	5.2	0.0	5.5	4.9	8.4	7.0	5.7	1.7	2.5	6.4	24.8	5.5	22.9	0.9	12.0	9.9	3.3	1.0	12.9	1.9	5.7	7.0	22.3	4.9	2.7	6.5	3.1	4.4	16.3	17.3	2.3	6.4	11.9	5.4
FAM118A	"bK268H5.C22.4, C22orf8, FLJ20635"	ENSG00000100376	"Family with sequence similarity 118 member A"	Q9NWS6	22	45308968-45341955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 117.8;Syncytiotrophoblasts: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003902	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA003902: AB_1848368"	"unprognostic (6.22e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (9.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.16e-3)"	8.4	7.9	9.8	14.3	17.3	11.7	14.7	14.6	12.0	10.5	13.9	9.6	10.3	12.2	15.5	41.7	10.8	6.5	15.3	13.9	12.1	7.7	8.4	8.8	10.0	29.0	10.2	5.0	13.8	8.2	32.9	22.7	11.4	11.7	23.7	7.6	12.1	14.6	18.6	20.0	23.9	16.0	14.5	8.1	14.5	12.5	22.1	10.7	14.0	14.4	6.6	17.9	17.3	13.3	8.3	15.7	6.5	8.6	5.9	13.9	4.7	5.5	4.0	4.6	5.9	4.0	4.2	12.9	4.1	6.1	5.9	5.2	11.6	5.2	24.7	3.2	3.7	3.1	19.4	6.2	5.4	5.6	5.5	16.2	13.3	5.9	7.8	5.9	12.0	3.5	4.7	5.5	7.9	5.2	3.4	3.5	7.1	19.8	26.2	2.5	12.3	7.5	23.1	3.9	21.4	5.9	9.2	3.4	8.6	2.9	13.8	10.4	13.1	4.7	8.8	11.0	7.9	4.3	6.1	4.0	4.4	14.9	5.4	5.2	14.4	2.8	12.7	5.4	8.0	8.1	4.5	8.6	2.5	7.0	7.1	5.6	5.3	8.6	8.6	10.9	8.3	13.9	10.0	6.5	5.9	5.6	15.7	11.4	4.7	9.8	17.3	14.6	12.0	12.1	7.7	10.2	5.0	11.7	10.7	8.9	14.2	13.7	31.5	20.0	18.7	9.3	2.5	6.7	15.9	7.0	17.7	58.0	0.0	6.5	117.8	21.5	14.0	0.0	5.5	5.9	27.7	19.4	1.1	13.4	11.6	6.4	31.6	28.8	12.1	47.6	33.1	23.9	1.7	55.9	15.3	12.1	4.4	16.7	22.3	2.8	15.5	0.0	18.4	65.8	35.3	8.7	101.1	25.4	14.6	32.2
FAM120B	"CCPG, KIAA1838, PGCC1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407065	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	32	"Early spermatids: 546.2;Late spermatids: 1520.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (1.60e-4)"	"prognostic favorable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	18.4	20.6	18.5	21.1	28.7	10.7	20.5	28.4	27.7	20.5	16.6	28.5	16.3	15.8	28.3	24.1	16.5	26.8	18.1	18.4	18.1	22.8	17.3	15.6	18.3	16.7	20.6	19.5	23.4	17.0	24.7	32.0	19.5	26.1	22.4	18.6	19.1	21.4	21.2	25.7	18.4	16.2	20.1	21.1	16.9	16.9	20.7	20.4	24.7	22.3	15.3	22.0	19.8	16.3	7.4	9.2	14.7	13.6	15.9	10.2	8.5	5.9	6.1	9.3	11.1	13.4	13.0	5.5	10.0	11.7	8.9	8.9	5.4	4.6	8.4	6.0	14.3	10.4	7.1	9.6	11.5	11.7	12.1	5.9	8.9	5.7	7.1	12.0	8.8	7.2	15.7	12.3	8.2	10.9	15.6	13.7	9.4	9.8	6.9	14.9	12.2	6.4	7.9	4.6	12.3	4.2	5.5	8.7	8.7	9.2	5.3	6.6	10.1	8.6	7.7	3.0	12.0	7.6	17.6	11.6	3.8	6.3	10.0	6.9	8.5	7.1	8.9	10.4	7.3	13.9	14.7	8.1	10.0	8.3	9.0	9.5	6.6	7.9	8.9	9.2	7.4	10.2	8.1	13.9	15.9	13.6	5.3	8.4	8.5	18.5	28.7	28.4	27.7	18.1	22.8	20.6	19.5	26.1	20.4	20.8	14.5	2.7	4.7	3.2	15.0	15.7	15.3	14.7	13.6	14.0	31.4	8.9	0.0	8.3	546.2	15.3	8.6	0.0	8.0	6.4	6.5	11.1	9.3	7.6	9.5	6.4	9.2	11.1	8.2	1520.1	17.8	8.7	18.6	1.8	13.9	6.6	7.9	8.5	13.4	4.9	11.5	32.3	5.3	16.1	11.5	5.1	11.2	5.1	7.4	5.5
FAM120C	"CXorf17, FLJ20506, ORF34"	ENSG00000184083	"Family with sequence similarity 120C"	Q9NX05	X	54068324-54183281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047677	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA047677: AB_2680118"	"unprognostic (4.70e-2)"	"unprognostic (2.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.86e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.28e-2)"	8.7	10.5	15.3	8.1	15.8	9.4	9.3	15.5	18.3	11.9	6.2	16.9	6.2	4.6	10.5	16.3	8.1	9.9	6.9	6.8	14.0	11.6	9.9	8.3	6.2	8.4	16.8	11.5	14.9	9.0	16.0	15.8	7.1	12.5	9.0	5.9	7.9	7.3	10.6	12.4	8.3	5.6	9.2	12.1	8.6	5.6	8.3	16.2	10.9	10.8	5.5	9.4	7.8	7.8	4.9	6.0	0.3	2.7	1.7	3.1	1.6	4.0	7.2	3.8	8.5	8.7	6.3	6.9	3.8	6.4	5.9	6.3	3.4	4.3	5.6	2.6	3.3	8.8	10.8	10.7	2.8	5.2	4.3	11.7	2.9	10.5	5.5	4.0	2.7	3.2	4.4	3.6	5.2	6.1	6.9	3.6	5.9	3.1	4.6	4.6	10.8	4.3	10.7	7.0	2.3	16.2	5.2	6.0	5.8	4.8	2.2	5.1	5.1	10.0	7.7	2.6	9.6	9.0	2.4	6.5	5.3	6.8	6.9	3.1	5.7	5.4	4.2	5.9	8.2	6.3	0.0	2.7	0.3	2.6	1.4	2.3	4.4	2.5	2.1	4.8	4.9	2.9	3.1	0.0	1.7	0.6	6.0	0.9	1.6	15.3	15.8	15.5	13.6	14.0	11.6	16.8	11.5	12.5	16.2	3.0	1.6	4.2	4.9	5.3	9.9	5.6	5.1	1.4	0.0	0.0	3.9	7.6	8.3	2.4	0.1	5.7	0.7	0.0	2.4	4.3	4.1	3.6	2.3	3.2	3.6	6.4	4.6	3.7	1.3	0.4	6.1	4.4	1.7	1.8	0.2	4.8	1.6	0.9	4.6	5.3	8.6	0.0	4.2	1.4	9.1	4.1	2.1	2.2	2.2	2.6
FAM122A	"C9orf42, MGC17347"	ENSG00000187866	"Family with sequence similarity 122A"	Q96E09	9	68780034-68784608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056646	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoplasm	"HPA056646: AB_2683202"	"unprognostic (1.88e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.18e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.58e-3)"	"prognostic favorable (1.34e-5)"	"unprognostic (9.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.89e-2)"	21.0	21.3	13.9	12.0	20.2	9.8	21.4	22.5	24.6	23.1	15.5	17.0	12.4	10.0	20.3	15.6	17.6	19.7	14.4	24.2	13.8	14.3	21.5	21.2	14.1	14.7	16.8	14.2	24.2	17.9	25.3	20.8	21.8	18.0	20.6	14.9	22.4	17.0	19.8	20.0	15.1	15.0	17.6	13.9	17.7	15.0	16.2	14.6	18.1	19.1	14.8	15.4	15.7	16.5	5.8	6.7	4.3	5.1	4.5	9.8	2.5	5.4	3.7	5.1	4.4	17.6	11.5	7.0	7.7	7.3	6.9	5.5	1.3	2.7	11.4	3.9	8.2	5.0	10.2	5.7	5.2	8.6	12.3	6.0	6.3	6.1	4.5	10.9	11.4	4.5	9.3	12.0	6.3	4.9	7.8	6.8	8.3	6.7	13.0	7.3	2.9	6.3	3.0	6.5	12.9	6.6	7.8	7.1	3.5	6.2	4.5	8.2	3.7	5.7	4.8	3.9	7.5	2.9	5.0	8.4	6.4	4.6	11.9	5.7	15.3	6.2	4.7	6.9	7.3	7.1	4.3	5.1	3.7	4.5	4.9	4.0	3.6	4.5	4.9	5.7	5.8	9.8	5.5	2.9	4.5	4.8	6.7	4.9	2.5	13.9	20.2	22.5	24.6	13.8	14.3	16.8	14.2	18.0	14.6	3.0	6.0	19.1	16.1	20.9	17.5	13.9	7.6	25.4	6.8	5.2	15.7	24.6	56.3	13.9	23.4	14.8	11.2	46.7	11.9	13.7	16.9	11.3	17.3	15.3	19.0	7.9	17.2	13.5	19.4	11.4	14.1	17.4	13.5	8.2	15.4	31.5	13.0	13.3	15.9	20.3	18.4	45.3	45.6	36.3	17.7	20.7	25.6	17.5	12.5	15.3
FAM122B	"DKFZp686L20116, RP11-308B5.5"	ENSG00000156504	"Family with sequence similarity 122B"	Q7Z309	X	134769566-134797232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000266	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000266: AB_1078801"	"unprognostic (2.10e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.19e-3)"	13.4	18.5	24.5	18.4	41.5	27.1	14.8	20.9	29.6	15.7	15.4	22.3	13.4	15.5	23.0	27.7	16.2	20.3	13.6	13.9	22.5	21.8	15.2	9.8	15.5	27.2	22.9	24.7	29.3	15.9	29.0	27.8	17.4	21.3	17.3	23.6	13.3	18.8	17.4	10.3	19.4	19.5	20.3	21.8	26.1	18.5	34.5	20.5	21.4	20.7	11.1	26.5	16.3	16.3	1.6	3.8	5.9	1.2	2.7	3.3	1.1	17.8	16.5	13.3	9.4	6.8	8.9	9.3	14.2	12.5	16.1	15.3	14.6	16.0	17.5	28.2	10.3	22.6	12.0	19.5	11.7	29.4	21.6	13.5	17.6	33.0	4.7	4.2	32.3	22.5	5.8	11.6	17.7	7.8	10.5	9.3	18.0	11.4	22.6	16.9	24.1	20.0	28.1	7.2	20.6	17.8	20.4	14.4	15.3	9.8	18.6	12.1	8.6	7.6	10.3	5.1	11.9	5.5	16.7	6.6	13.5	8.8	34.1	30.8	12.5	14.4	22.7	14.4	37.6	16.7	0.1	1.2	5.9	2.1	0.5	2.8	1.6	2.0	2.8	1.2	1.5	2.4	3.3	1.3	2.7	1.1	3.8	2.0	1.1	24.5	41.5	20.9	29.6	22.5	21.8	22.9	24.7	21.3	20.5	11.9	7.2	13.9	12.1	11.9	4.2	9.0	5.1	2.7	11.4	15.7	11.8	7.4	14.9	6.3	1.2	11.9	10.4	23.3	11.9	8.9	11.3	12.7	24.1	6.8	12.5	12.7	5.8	8.0	18.8	3.3	9.8	11.4	16.9	8.2	13.7	3.9	9.6	17.5	6.0	5.9	5.4	0.0	8.2	2.3	3.6	9.8	7.3	24.9	13.2	16.3
FAM124A	FLJ30707	ENSG00000150510	"Family with sequence similarity 124 member A"	Q86V42	13	51222334-51284241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.3"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HAP1: 13.3;HUVEC TERT2: 7.9;NTERA-2: 26.1;SH-SY5Y: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048182	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA048182: AB_2680301"	"unprognostic (3.94e-3)"	"unprognostic (8.76e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.38e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.05e-2)"	5.3	3.5	7.7	4.7	19.6	0.7	2.6	2.6	15.0	3.3	7.2	40.3	0.3	1.4	3.8	8.4	2.4	3.6	4.3	7.1	13.5	7.4	6.7	1.5	3.3	1.5	29.1	7.7	1.3	2.7	1.2	1.5	6.2	18.8	6.5	2.6	3.8	12.4	8.1	1.8	1.9	2.1	8.9	25.3	13.2	4.1	2.3	26.7	0.3	2.8	0.6	1.1	4.1	1.8	0.8	1.0	2.7	0.9	1.2	0.8	0.3	0.0	1.2	0.9	0.8	0.2	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.4	0.0	0.0	1.6	0.1	13.3	0.1	0.1	0.0	2.0	0.0	0.3	0.0	1.0	0.6	0.8	0.3	0.1	0.4	0.0	0.0	7.9	3.5	0.1	0.0	0.0	0.2	3.2	0.2	26.1	0.2	2.0	0.7	0.0	1.9	0.0	0.1	1.9	10.0	0.4	1.6	1.5	2.0	0.2	0.7	0.1	0.0	0.9	0.7	0.9	0.2	0.0	0.0	1.2	2.3	1.1	2.7	0.8	0.8	0.8	0.6	0.8	0.6	0.5	0.6	0.4	0.8	0.7	0.7	2.4	1.2	0.9	1.0	0.6	0.3	7.7	19.6	2.6	11.8	13.5	7.4	29.1	7.7	18.8	26.7	0.0	0.0	0.0	2.1	0.7	7.7	8.9	0.0	2.7	0.0	1.8	47.1	0.0	3.3	1.9	3.5	6.8	0.0	0.0	0.7	0.0	0.9	1.6	1.1	0.0	0.2	6.4	0.0	6.7	0.3	3.3	0.6	0.5	3.3	0.0	0.0	3.4	0.8	0.0	0.4	8.4	43.8	0.0	2.1	0.0	1.4	0.1	0.0	0.0	0.0	0.4
FAM126B	"HYCC2, MGC39518"	ENSG00000155744	"Family with sequence similarity 126 member B"	Q8IXS8	2	200973718-201071671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 155.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in all"		"U-266/84: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036166, HPA036167, HPA067307"	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821"	"unprognostic (7.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.52e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	10.5	6.9	9.8	8.7	17.2	22.1	7.3	28.7	21.1	5.9	10.3	6.5	5.9	9.8	6.8	6.3	12.1	5.8	6.4	6.5	9.3	9.2	12.0	10.9	9.4	7.9	7.3	11.6	7.8	7.1	9.8	16.6	7.2	15.1	5.8	9.6	8.8	7.0	4.9	5.6	10.2	9.3	5.8	8.1	10.6	11.0	6.3	6.4	8.3	10.3	2.9	8.7	5.5	8.1	2.1	1.2	20.3	1.9	2.3	3.4	1.5	3.3	1.8	2.5	2.7	2.7	3.6	5.5	3.2	1.9	2.5	2.5	4.5	4.0	3.1	3.1	3.2	2.4	4.1	5.1	2.0	4.0	4.4	3.2	8.9	4.7	4.1	2.2	10.7	7.8	1.5	2.5	3.5	2.1	2.0	2.5	3.3	8.2	11.4	2.6	2.0	6.4	7.1	1.7	2.2	3.0	3.8	3.8	2.7	2.4	3.7	5.0	2.5	3.4	3.9	2.8	3.4	2.7	4.7	4.9	4.8	3.5	2.4	2.9	8.5	35.4	6.6	2.8	4.2	3.3	1.7	1.4	5.1	3.1	1.8	3.4	2.1	2.6	2.4	1.2	2.0	2.6	3.1	20.3	2.3	1.9	0.9	1.7	1.5	9.8	17.2	28.7	21.1	9.3	9.2	7.3	11.6	15.1	6.4	26.8	19.2	18.5	8.9	46.8	48.4	13.4	20.4	14.7	14.8	19.2	155.1	13.2	14.9	8.8	4.8	18.0	46.6	23.3	9.3	7.9	12.8	13.1	24.3	17.7	10.4	25.4	35.6	34.4	29.2	2.5	29.4	26.5	28.7	13.6	19.0	21.4	15.0	26.6	24.1	13.5	38.9	19.4	17.6	30.8	20.3	64.7	14.5	30.5	16.5	16.1
FAM129A	"C1orf24, GIG39, NIBAN"	ENSG00000135842	"Family with sequence similarity 129 member A"	Q9BZQ8	1	184790724-184974550	"Cancer-related genes, Predicted intracellular proteins"	"Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 129.1;urinary bladder: 90.3"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 641.6;monocytes: 234.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 32.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		40000	"Plasma membrane, Cytosol"		"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.52e-4)"	10.1	3.5	1.1	16.9	1.8	2.3	7.8	0.8	1.3	13.0	39.3	1.0	14.9	2.5	14.6	11.0	32.3	10.7	30.4	52.2	1.1	1.1	1.8	1.2	6.1	10.7	3.0	0.5	8.0	27.3	0.8	1.9	2.9	1.7	34.6	5.1	13.8	59.3	14.7	21.4	4.1	8.3	129.1	2.1	6.5	30.0	4.1	1.3	4.9	4.7	14.7	8.7	90.3	20.3	0.5	2.3	32.7	1.5	2.6	5.3	0.8	13.8	0.1	0.0	0.0	9.9	15.1	0.5	7.1	14.7	6.2	7.8	0.0	5.9	0.0	4.7	18.3	1.6	15.7	0.8	0.5	10.0	27.6	1.1	5.8	2.9	0.0	23.2	18.8	6.6	13.8	22.7	18.0	21.9	4.4	0.0	2.1	1.3	29.4	0.2	0.0	0.6	3.3	3.8	0.0	1.5	4.4	3.4	0.2	8.5	0.2	0.8	0.7	0.1	0.0	10.2	2.5	3.1	6.0	1.1	12.3	0.0	2.2	14.6	24.7	9.7	2.9	24.1	7.9	12.0	7.1	1.5	4.7	2.5	0.9	2.1	0.5	2.2	2.3	2.3	0.1	0.2	0.9	32.7	2.6	0.3	0.2	5.3	0.8	1.1	1.8	0.8	1.3	1.1	1.1	3.0	0.5	1.7	1.3	8.9	24.2	6.6	12.3	11.2	0.1	641.6	7.6	9.4	48.9	1.8	0.0	0.2	0.0	2.5	0.0	17.7	0.0	0.0	61.8	0.9	15.1	45.2	2.3	0.0	13.2	4.8	1.7	11.6	31.3	0.2	10.0	78.8	13.5	234.4	0.1	0.0	33.4	0.0	6.7	0.3	0.0	84.1	72.3	0.0	0.1	7.3	0.3	29.8	0.6	15.6
FAM129C	"BCNP1, FLJ39802"	ENSG00000167483	"Family with sequence similarity 129 member C"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9"	"Cell type enriched"	"Detected in some"	37	"B-cells: 63.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	226	"memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2"	"Group enriched"	"Detected in many"	284	"B-cells: 19.5;dendritic cells: 37.2"	"Group enriched"	"Detected in some"	22	"Daudi: 29.8;REH: 15.0;U-698: 18.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.5	0.2	0.2	37.9	0.2	12.1	0.2	0.3	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.6	0.2	0.2	0.5	0.3	0.9	17.4	0.2	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.4	9.9	0.2	0.1	0.2	12.3	0.0	0.3	28.5	0.4	0.5	0.0	2.5	0.5	0.4	35.4	3.0	0.4	19.5	37.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.7	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	1.1	63.2	0.7	0.1	0.1	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.1	0.0	0.1	0.0	0.0	1.3	0.3	0.4	0.0	0.4	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.9	0.3	0.1	0.0	0.0	0.3
FAM131A	"C3orf40, MGC21688"	ENSG00000175182	"Family with sequence similarity 131 member A"	Q6UXB0	3	184335926-184348421	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5"	HPA042800	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"	"Secreted - unknown location"	Yes	No			"Nucleoli rim"	"Mitotic chromosome"	"HPA042800: AB_10797023"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.28e-2)"	8.1	14.9	18.8	4.6	26.4	2.5	5.0	21.9	54.7	5.4	6.4	8.0	4.8	6.3	7.5	4.9	7.5	7.7	8.4	11.9	28.1	13.0	4.1	3.0	6.0	3.4	9.1	25.9	8.8	11.3	9.2	16.4	5.0	7.8	6.7	3.5	3.3	7.1	11.7	9.3	10.5	5.8	8.7	5.9	5.3	5.5	7.0	7.0	0.8	3.5	3.9	2.7	5.5	4.1	2.1	5.5	11.1	6.5	1.6	2.2	2.5	8.2	3.4	5.5	9.7	7.5	6.2	5.2	3.7	8.4	5.9	4.6	2.6	2.9	1.2	15.5	3.6	12.6	7.8	0.0	6.7	3.8	8.8	9.3	0.0	5.2	5.6	7.6	0.1	6.5	4.6	1.1	5.0	11.6	5.5	11.8	5.7	1.8	1.3	2.2	6.4	3.2	0.2	9.4	5.1	6.9	5.8	2.2	7.9	5.9	0.2	16.9	17.6	2.3	6.5	8.6	3.7	19.1	2.1	11.9	7.2	5.6	5.8	11.6	14.0	8.4	0.8	23.2	1.2	5.1	2.0	4.8	6.0	1.5	6.5	1.6	2.0	1.2	1.6	5.5	2.1	1.2	1.5	11.1	1.6	3.4	2.3	2.2	2.5	18.8	26.4	21.9	54.7	28.1	13.0	9.1	25.9	7.8	7.0	6.0	5.3	6.7	16.9	9.8	21.2	5.1	10.2	16.0	1.2	14.0	13.7	8.2	1.7	5.6	3.9	8.8	13.1	23.3	2.9	2.7	5.4	12.7	6.9	1.5	6.8	22.3	9.2	15.4	5.4	0.7	17.3	8.3	1.7	9.0	6.4	14.1	7.4	8.6	19.4	3.0	16.3	6.5	10.3	11.6	6.8	12.8	27.8	4.4	8.1	13.1
FAM131C	"C1orf117, FLJ36766"	ENSG00000185519	"Family with sequence similarity 131 member C"	Q96AQ9	1	16057769-16073632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 41.1"	"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 16.6;Horizontal cells: 36.5;Muller glia cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 10.8;HEK 293: 7.0;PC-3: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031046	Uncertain		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Intermediate filaments, Cytosol"		"HPA031046: AB_2673711"	"unprognostic (4.69e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (9.33e-6)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.44e-1)"	0.7	7.8	5.6	0.6	4.0	0.5	1.1	41.1	9.1	1.1	1.0	7.7	0.0	0.7	1.0	1.4	1.2	1.1	1.4	5.2	5.0	6.5	10.4	2.2	0.6	0.5	10.7	3.8	1.2	7.1	2.0	5.6	0.7	8.7	0.8	0.6	0.8	6.3	1.6	0.6	3.2	0.8	0.9	17.7	0.6	1.6	1.3	4.9	0.0	1.7	0.0	1.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.3	10.8	0.4	0.6	0.0	0.0	0.0	1.0	0.9	1.2	2.7	0.2	2.4	0.0	0.4	0.5	2.7	1.2	1.4	0.3	0.4	0.0	7.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.9	3.8	0.7	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.5	2.2	8.0	0.0	0.0	4.6	0.8	0.0	1.5	3.1	0.4	1.3	0.3	0.0	0.3	0.0	1.7	0.2	3.8	0.0	0.0	1.7	0.1	0.0	3.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	4.0	41.1	7.1	5.0	6.5	10.7	3.8	8.7	4.9	0.0	0.0	0.0	0.3	0.2	3.5	1.6	2.5	0.0	0.0	8.7	3.9	0.0	16.6	2.6	1.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	36.5	3.4	0.6	0.0	1.3	0.0	0.0	0.0	4.6	0.0	32.7	0.4	0.0	0.0	0.3	2.0	0.0	0.3	0.6	1.9	1.0	0.0	0.0	0.0	0.4
FAM135A	"FLJ20176, KIAA1411"	ENSG00000082269	"Family with sequence similarity 135 member A"	Q9P2D6	6	70412941-70561174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031743, HPA031744"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031743: AB_10600767, HPA031744: AB_10601101"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (8.00e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.69e-4)"	"unprognostic (4.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (3.99e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.65e-2)"	5.8	4.3	6.4	9.2	6.8	1.7	5.3	14.0	10.7	9.6	13.3	4.0	5.3	14.9	7.7	4.9	33.8	5.4	8.8	5.2	5.4	5.2	9.6	5.5	5.5	4.1	6.1	7.1	8.0	6.9	16.4	13.8	22.7	8.5	18.9	13.0	4.2	10.4	6.7	5.7	14.2	27.9	4.8	8.9	4.5	12.3	11.0	6.0	4.1	4.8	13.1	10.6	7.6	14.4	3.9	6.3	3.3	5.3	5.4	2.2	1.5	5.9	3.4	7.7	4.8	3.6	2.6	6.9	1.9	3.8	2.1	3.5	6.7	4.8	10.6	13.9	1.4	10.1	5.8	7.6	4.8	3.6	5.1	6.3	4.8	3.7	5.9	4.4	8.9	5.0	2.3	11.1	4.0	11.1	2.6	5.5	3.4	7.6	5.5	2.4	0.7	1.6	4.2	5.0	7.1	2.8	5.2	24.2	5.0	7.9	3.2	8.1	2.4	2.3	2.1	2.3	5.1	1.4	4.0	2.7	1.8	4.6	1.7	4.4	6.6	7.5	4.3	1.3	8.1	3.2	3.3	4.3	0.2	1.5	3.5	1.9	3.0	1.4	0.6	6.3	3.9	2.2	1.3	1.2	5.4	5.3	1.0	1.7	1.5	6.4	6.8	14.0	10.7	5.4	5.2	6.1	7.1	8.5	6.0	26.8	12.2	1.4	9.5	14.2	18.2	9.4	15.3	8.1	5.7	19.2	27.5	2.2	5.0	5.8	24.9	10.0	28.4	0.0	10.7	1.2	5.9	32.9	8.1	5.7	5.1	225.6	22.4	9.2	14.2	17.3	14.4	13.1	5.0	9.0	26.1	12.8	13.3	30.0	12.4	6.8	27.5	6.5	6.6	25.1	8.2	29.4	6.9	3.9	19.4	11.2
FAM135B	C8ORFK32	ENSG00000147724	"Family with sequence similarity 135 member B"	Q49AJ0	8	138130023-138496822	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.1;brain: 14.3;testis: 10.3"	"Cell type enhanced"	"Detected in some"	27	"Bipolar cells: 27.7;Cone photoreceptor cells: 27.5;Early spermatids: 96.5;Late spermatids: 22.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"RH-30: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023911, HPA023950, HPA024815"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376"	"unprognostic (3.78e-1)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.36e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.85e-4)"	"unprognostic (9.92e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.47e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.30e-1)"	0.6	8.1	12.1	0.9	6.8	0.6	0.7	13.9	14.3	0.7	2.7	1.3	0.0	1.4	0.6	0.9	0.7	0.7	0.7	0.8	9.3	4.5	1.4	0.8	0.7	0.6	4.6	5.6	0.6	1.9	0.6	3.6	0.6	5.2	1.3	2.3	0.7	0.7	1.4	0.6	0.6	1.4	0.8	2.5	0.6	2.5	10.3	3.5	0.0	0.6	0.0	0.6	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	14.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	6.8	13.9	12.3	9.3	4.5	4.6	5.6	5.2	3.5	0.0	0.0	0.0	0.0	0.0	27.7	1.1	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	96.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	22.0	1.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0
FAM136A	FLJ14668	ENSG00000035141	"Family with sequence similarity 136 member A"	Q96C01	2	70295975-70302090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030103, HPA030104"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030103: AB_10600194, HPA030104: AB_10600534"	"unprognostic (2.81e-1)"	"unprognostic (5.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (4.95e-3)"	"unprognostic (3.03e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.00e-3)"	8.9	12.2	16.4	12.9	17.7	13.2	13.0	18.0	16.5	12.4	19.4	6.4	18.4	19.9	13.4	11.8	18.1	11.2	13.7	18.0	13.3	17.5	18.7	26.3	9.1	12.0	15.3	10.3	9.0	53.1	14.0	11.4	15.9	17.6	13.4	21.4	8.8	38.3	17.7	16.6	11.0	23.0	14.9	9.0	17.1	16.7	9.6	7.6	13.6	16.1	14.0	15.7	13.3	11.9	21.8	22.2	17.1	22.9	29.1	19.8	16.0	25.0	22.7	14.2	19.9	7.5	11.2	22.0	13.6	13.0	18.9	13.1	59.7	14.5	17.5	12.4	11.7	16.4	11.8	29.2	10.8	19.4	17.8	33.5	26.6	17.0	37.0	10.8	43.8	17.6	7.6	7.6	17.7	15.1	10.1	20.2	25.4	42.4	14.1	14.0	37.0	28.2	38.3	35.9	34.1	24.7	19.1	26.7	28.6	29.0	17.7	33.5	14.6	10.2	25.0	20.0	13.7	10.3	12.8	12.1	8.1	23.9	12.4	25.8	11.8	18.1	20.2	20.2	25.0	13.7	17.1	16.7	12.1	13.7	22.9	19.8	21.8	15.1	16.1	22.2	18.4	17.6	17.9	1.5	29.1	15.3	14.7	11.8	16.0	16.4	17.7	18.0	16.5	13.3	17.5	15.3	10.3	17.6	7.6	38.7	24.0	49.8	25.7	24.8	22.9	48.4	10.2	34.8	27.3	31.4	23.6	78.4	59.7	64.0	1.0	16.7	50.0	0.0	86.0	86.9	33.9	45.3	27.6	50.4	62.1	7.9	31.6	12.9	19.3	2.3	12.4	29.2	27.0	45.9	49.3	16.1	76.3	56.1	17.3	54.2	18.5	12.9	21.7	9.1	52.8	36.6	24.7	34.1	58.8	40.2
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 111.2;Syncytiotrophoblasts: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.6"	"Low region specificity"	"Detected in all"							"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	58.6	10.8	9.1	11.0	9.3	6.5	19.0	17.9	18.5	15.5	41.0	3.7	7.4	30.5	10.9	12.0	9.3	14.8	10.7	8.8	9.6	5.7	14.0	22.9	13.3	5.3	10.0	6.8	17.8	23.5	45.5	11.2	20.7	11.4	15.9	9.3	11.5	13.3	8.0	8.4	17.5	30.5	15.6	19.4	4.9	13.4	11.1	12.9	3.2	20.4	16.1	4.0	30.4	23.8	0.1	5.7	1.4	6.5	0.7	5.2	2.6	2.4	3.7	5.6	7.3	32.6	13.5	9.2	5.8	7.0	2.3	2.1	3.1	5.8	0.1	2.3	4.1	3.6	1.5	8.2	4.1	5.2	0.3	5.7	4.1	5.2	0.4	9.6	3.4	0.5	12.9	3.4	5.8	2.1	10.1	3.9	1.4	10.6	0.4	4.9	0.1	0.3	1.5	6.9	0.4	3.9	5.6	9.5	2.2	4.2	12.2	14.2	3.8	1.4	4.5	5.4	5.8	3.1	0.1	1.4	6.5	3.6	3.1	3.3	2.0	1.1	0.0	9.6	0.3	3.3	0.1	6.5	0.1	1.8	3.2	1.3	0.1	4.7	0.6	5.7	0.1	5.2	1.3	1.4	0.7	1.0	1.9	2.5	2.6	9.1	9.3	17.9	18.5	9.6	5.7	10.0	6.8	11.4	12.9	11.9	27.5	3.7	19.8	9.0	19.2	22.7	22.9	81.7	46.6	10.4	33.4	57.4	24.9	8.6	2.3	12.5	34.9	0.0	14.6	29.6	23.6	13.3	1.1	111.2	17.5	0.0	4.7	8.0	29.1	2.4	41.7	12.6	18.6	4.6	37.9	26.9	31.2	63.3	31.5	34.7	10.7	0.0	24.2	4.8	6.1	6.8	233.8	6.4	14.6	16.6
FAM13B	"ARHGAP49, C5orf5, FAM13B1, KHCHP, N61"	ENSG00000031003	"Family with sequence similarity 13 member B"	Q9NYF5	5	137937960-138051961	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036525, HPA041819, HPA071936"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036525: AB_10696655, HPA041819: AB_2677690, HPA071936: AB_2686474"	"unprognostic (8.09e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.02e-3)"	"unprognostic (6.51e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (3.55e-5)"	"unprognostic (9.56e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.06e-2)"	12.8	27.1	19.7	18.3	22.0	19.1	14.6	29.4	22.6	15.2	16.4	15.8	18.4	8.9	21.1	13.7	13.3	14.6	13.8	18.3	17.0	21.9	13.1	7.9	13.5	17.8	18.5	15.5	23.7	9.3	14.9	17.7	14.6	26.3	23.4	11.6	14.2	12.3	34.4	5.8	10.1	13.5	29.6	13.4	15.3	12.4	29.4	21.5	13.5	14.1	5.7	20.5	21.2	15.2	7.9	3.7	11.9	6.6	7.6	6.2	1.8	9.3	4.7	14.2	11.6	19.0	6.0	11.1	20.8	17.0	15.9	18.6	12.6	8.5	21.2	7.0	18.1	20.4	7.3	8.7	6.5	20.9	16.0	9.4	9.5	11.5	3.9	6.4	15.5	13.2	7.6	3.9	12.1	7.1	8.4	5.4	7.8	5.4	10.9	14.6	6.9	15.5	8.6	5.6	7.3	5.7	11.2	14.1	4.2	9.6	16.8	16.1	14.2	16.2	5.0	20.4	21.4	13.6	15.8	7.1	17.1	7.5	12.6	15.6	8.9	21.0	20.3	9.7	12.7	14.6	11.9	2.9	10.5	6.2	3.9	5.2	6.5	4.4	5.4	2.1	7.9	4.6	5.9	9.1	7.6	6.6	3.7	4.1	1.8	19.7	22.0	29.4	22.6	17.0	21.9	18.5	15.5	26.3	21.5	20.8	13.7	26.1	14.6	13.7	20.6	41.1	12.7	12.0	19.4	5.2	19.6	10.0	3.3	5.4	31.0	13.8	6.7	0.0	2.9	3.6	16.9	10.5	29.0	5.0	12.1	11.1	9.9	18.4	22.1	22.6	15.0	22.6	11.8	3.6	9.8	7.8	5.3	5.5	24.1	3.3	16.2	25.8	24.0	31.0	22.2	12.0	4.3	30.0	7.9	10.7
FAM13C	FAM13C1	ENSG00000148541	"Family with sequence similarity 13 member C"	Q8NE31	10	59246129-59363181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 36.1;Early spermatids: 31.6;Sertoli cells: 38.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.3;HSkMC: 6.9;hTERT-RPE1: 4.6;NTERA-2: 5.7;SCLC-21H: 11.4;SH-SY5Y: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037888	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037888: AB_10962981"	"unprognostic (3.68e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.69e-5)"	"unprognostic (8.54e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-6)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.66e-3)"	11.8	17.0	16.1	3.8	22.3	0.3	7.7	12.4	24.9	9.4	6.4	36.6	3.2	4.5	9.0	8.7	14.4	15.3	11.6	7.8	18.9	15.9	3.8	2.3	10.0	4.5	23.8	18.8	22.2	2.5	4.0	8.3	2.9	21.2	17.9	6.7	16.5	4.9	8.7	15.3	7.3	5.0	12.5	33.2	5.0	3.9	5.2	28.9	0.0	6.0	7.6	2.5	7.4	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	1.7	0.3	0.1	0.0	1.6	0.0	5.3	2.4	0.2	0.0	0.0	6.9	0.8	0.3	0.0	4.6	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	5.7	0.0	0.5	0.0	1.1	0.0	0.0	1.7	11.4	6.7	0.0	0.3	0.0	0.5	1.0	0.0	0.0	3.3	3.1	0.1	2.6	0.0	0.0	0.1	4.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	22.3	12.4	23.4	18.9	15.9	23.8	18.8	21.2	28.9	0.0	0.0	0.0	9.5	4.2	10.0	2.8	0.0	36.1	1.2	0.0	5.9	0.0	6.6	0.0	31.6	12.6	0.0	0.0	0.0	0.0	3.0	4.5	0.0	0.6	0.0	3.2	0.0	2.5	0.0	17.2	21.3	0.5	3.3	0.0	0.0	8.8	0.0	0.0	19.8	0.4	13.1	38.8	18.6	0.9	0.7	5.5	0.0	0.0	0.0	0.5
FAM149A	"DKFZP564J102, MST119, MSTP119"	ENSG00000109794	"Family with sequence similarity 149 member A"	A5PLN7	4	186104419-186172667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.7"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 34.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 11.3;JURKAT: 8.1;MOLT-4: 8.0;RT4: 9.3;SCLC-21H: 14.2"					"Low region specificity"	"Detected in all"			"HPA044019, HPA055004"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA044019: AB_2732513, HPA055004: AB_2682667"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.64e-2)"	"prognostic favorable (2.67e-6)"	"unprognostic (7.08e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.36e-1)"	8.7	4.3	17.6	3.7	22.7	0.3	8.6	5.1	12.4	6.1	7.3	8.2	4.7	4.6	6.0	9.8	9.1	11.1	12.8	7.3	15.4	10.0	27.3	37.7	4.3	1.1	8.9	5.8	6.2	19.6	8.8	3.7	1.9	7.4	7.5	6.2	12.2	12.2	13.3	7.0	1.7	3.9	13.8	12.4	1.9	8.4	3.6	5.7	1.0	2.7	3.2	1.5	8.4	4.9	1.0	0.7	0.2	0.0	0.0	4.0	0.0	0.0	3.2	2.9	0.1	11.3	4.6	0.1	0.0	0.0	0.3	0.3	0.0	1.9	0.0	1.6	1.5	2.9	0.0	5.1	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.7	0.1	0.2	2.1	0.3	0.2	0.0	1.1	0.0	8.1	0.0	2.5	1.3	1.6	8.0	0.3	5.1	0.0	0.0	0.3	0.0	2.0	1.7	9.3	14.2	3.9	0.1	0.0	4.4	0.9	1.0	0.0	0.8	0.2	1.7	0.0	1.6	0.0	0.0	0.0	0.8	0.0	1.3	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.1	1.1	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.7	4.0	0.0	17.6	22.7	5.1	12.4	15.4	10.0	8.9	5.8	7.4	5.7	0.0	1.0	0.0	2.3	0.5	11.0	6.9	17.8	10.7	6.8	5.2	43.2	0.6	5.0	8.6	10.0	0.3	0.8	0.0	4.8	0.7	2.0	2.4	0.0	11.4	0.2	1.6	9.1	1.3	1.5	3.2	3.1	1.6	3.3	0.0	2.7	20.8	4.0	3.5	3.9	7.7	34.6	6.5	2.2	1.0	2.8	0.3	0.7	0.0	3.0	1.8
FAM149B1	KIAA0974	ENSG00000138286	"Family with sequence similarity 149 member B1"	Q96BN6	10	73168166-73244504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039189, HPA039859"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039189: AB_10805355, HPA039859: AB_2676712"	"unprognostic (2.23e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.24e-2)"	9.3	8.9	21.3	7.3	17.0	5.4	10.1	7.7	15.1	12.2	13.4	14.9	10.3	5.4	9.1	10.6	10.5	11.4	12.8	15.7	19.2	14.2	17.5	15.2	7.9	6.3	20.8	9.8	12.6	9.3	12.9	10.8	10.3	13.6	10.5	8.0	8.1	9.0	9.1	9.4	5.8	9.5	9.3	22.8	5.9	7.2	16.6	13.2	6.2	9.8	13.4	7.3	8.3	7.3	2.7	2.7	5.0	1.8	4.6	3.4	1.3	6.9	5.3	11.9	10.9	26.1	16.3	7.7	8.0	15.7	5.4	9.6	3.3	12.2	5.2	3.1	13.9	6.2	6.7	6.9	10.0	6.5	6.3	3.5	6.6	4.1	5.6	13.6	9.1	4.4	13.9	7.4	7.0	27.3	24.0	13.6	8.3	5.9	9.7	9.8	6.3	6.0	8.6	5.1	15.0	13.9	4.0	7.5	5.3	14.6	7.0	2.6	11.3	6.2	16.7	9.6	11.1	9.6	5.8	7.2	5.3	5.4	5.3	10.0	10.7	4.8	4.6	9.1	9.1	4.2	5.0	0.7	2.5	2.2	1.8	2.8	2.7	2.2	2.1	1.5	2.2	3.4	3.1	1.5	4.6	1.0	2.7	2.5	1.3	21.3	17.0	7.7	15.1	19.2	14.2	20.8	9.8	13.6	13.2	3.0	1.9	3.7	3.0	1.8	6.6	10.2	5.1	10.7	5.7	1.8	5.9	5.8	1.7	3.8	17.7	5.8	4.7	0.0	3.1	4.8	4.3	4.0	2.3	3.4	4.8	3.2	7.5	5.5	4.5	19.6	7.8	2.5	1.7	1.8	5.8	4.2	4.0	0.0	4.2	6.8	12.1	12.9	5.2	10.9	3.8	3.1	6.9	2.1	5.2	3.7
FAM151B	UNQ9217	ENSG00000152380	"Family with sequence similarity 151 member B"	Q6UXP7	5	80487969-80542563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 6.7;Kupffer cells: 6.8;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.0;eosinophil: 2.2;intermediate monocyte: 1.1;myeloid DC: 3.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.5;granulocytes: 2.2;monocytes: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043805	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA043805: AB_10794287"	"unprognostic (1.29e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.28e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.46e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.44e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.63e-1)"	2.8	4.6	5.2	2.4	7.7	13.1	2.5	4.5	7.2	3.1	1.8	2.2	0.2	1.7	3.3	4.8	2.5	4.4	3.2	3.0	8.5	3.6	5.5	3.7	2.9	2.9	3.1	4.8	2.5	6.8	3.0	6.9	5.6	3.2	3.0	2.3	2.5	3.4	2.1	2.6	1.7	1.4	3.1	2.9	3.0	2.0	3.2	2.0	0.0	2.8	0.3	1.6	2.7	2.4	0.0	3.5	2.2	2.0	0.1	0.2	0.5	0.1	2.8	1.2	5.1	4.3	6.4	2.0	2.2	3.2	1.7	4.0	0.2	2.2	0.0	0.5	5.7	5.8	1.4	1.8	0.5	1.5	0.5	1.0	0.7	1.0	0.8	1.9	0.7	2.8	2.9	2.0	2.2	0.1	3.5	2.8	0.6	0.1	0.8	3.0	2.2	0.4	0.5	0.1	0.5	1.0	0.6	4.2	0.7	2.0	1.0	0.5	1.4	0.8	2.1	2.2	0.4	3.1	2.3	1.3	0.3	0.3	0.0	0.8	0.2	1.3	0.0	3.0	2.3	1.9	0.0	2.0	2.2	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.5	5.2	7.7	4.5	7.2	8.5	3.6	3.1	4.8	3.2	2.0	0.0	0.0	0.0	0.6	0.2	0.7	1.6	5.1	4.0	1.2	3.5	0.0	6.7	0.0	1.2	2.7	0.5	0.1	0.0	1.8	5.3	2.3	0.8	1.1	0.0	4.5	1.6	0.0	0.6	6.8	1.5	1.1	2.5	0.0	0.0	0.7	0.8	0.4	0.0	0.4	3.4	0.4	0.0	0.7	2.8	1.0	0.9	6.6	0.0	0.2	0.5
FAM155A		ENSG00000204442	"Family with sequence similarity 155 member A"	B1AL88	13	107163510-107866735	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0;pituitary gland: 10.3"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 18.2;Bipolar cells: 15.9;Early spermatids: 42.2;Horizontal cells: 35.0;Late spermatids: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 5.4;RPTEC TERT1: 11.7;SCLC-21H: 7.2;SH-SY5Y: 16.3;U-87 MG: 10.4"	"Low region specificity"	"Detected in all"							"HPA039453, HPA058768"	Enhanced		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Nucleoplasm, Vesicles"	Centrosome	"HPA039453: AB_10795290, HPA058768: AB_2683813"	"unprognostic (8.40e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.26e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.02e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.69e-3)"	0.9	2.7	10.7	0.6	4.3	0.4	0.6	6.9	19.0	1.5	0.7	0.6	0.0	0.5	1.7	4.0	0.7	0.7	1.3	0.7	8.8	10.8	0.7	0.4	1.2	0.5	6.4	4.9	0.7	0.5	0.4	10.3	1.2	2.0	2.7	0.7	0.7	0.3	3.8	0.4	0.5	0.7	1.2	2.7	0.6	0.7	2.3	0.5	0.0	1.3	0.0	0.9	1.4	0.2	0.2	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.7	0.0	2.5	0.1	5.4	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	4.4	0.0	0.0	0.2	0.0	11.7	1.9	7.2	16.3	0.0	0.0	0.0	0.2	4.1	0.0	0.2	5.0	2.0	1.7	0.2	0.0	0.0	0.0	10.4	0.0	3.5	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.4	0.8	0.0	0.0	0.0	0.0	10.7	4.3	6.9	12.3	8.8	10.8	6.4	4.9	2.0	0.5	3.0	18.2	0.0	0.4	0.1	15.9	0.7	0.0	0.0	3.4	3.5	0.0	0.0	0.0	1.4	42.2	2.9	0.0	0.0	0.0	0.1	1.8	0.8	0.0	0.0	0.2	35.0	0.0	1.8	0.0	14.6	1.7	0.0	0.0	0.0	0.0	7.0	0.3	0.0	1.1	0.0	1.5	6.5	0.2	1.1	0.9	0.0	0.0	0.0	0.0	0.1
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409216-151663632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.6"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 10.5;Horizontal cells: 7.9;Suprabasal keratinocytes: 12.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 5.8"	"Cell line enhanced"	"Detected in many"		"A-431: 8.3;HeLa: 10.1;hTERT-HME1: 9.5;SiHa: 9.0;SK-BR-3: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046348	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	1.4	1.2	3.0	3.4	0.8	1.5	3.8	7.5	0.9	6.3	5.2	0.6	10.4	1.7	6.1	5.9	13.1	2.8	4.9	6.5	0.7	0.7	7.0	1.6	5.4	0.1	0.6	0.0	3.7	23.7	11.1	9.4	1.8	4.8	4.5	3.3	10.0	11.1	12.5	33.6	12.6	9.0	1.8	0.7	0.7	2.3	3.5	0.0	0.9	11.4	22.0	10.0	6.2	5.0	0.0	5.8	0.4	0.0	0.1	0.1	0.0	8.3	0.7	0.0	0.2	0.0	0.0	3.1	0.4	2.0	0.8	0.2	3.6	3.1	0.0	0.9	0.1	2.8	7.6	2.2	6.3	1.3	0.0	3.6	0.0	10.1	0.8	0.0	0.0	0.1	0.1	6.3	0.0	9.5	1.9	0.1	0.7	0.0	0.0	0.5	1.2	0.0	0.0	2.9	2.6	0.8	0.0	2.1	0.3	4.4	5.7	1.4	0.4	9.0	7.9	0.0	2.5	3.4	0.0	0.0	0.6	3.7	0.2	1.4	0.0	0.0	0.0	2.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	3.0	0.8	7.5	0.9	0.7	0.7	0.6	0.0	4.8	0.0	3.0	1.3	0.0	6.2	10.5	0.0	1.6	0.0	0.0	6.8	0.0	0.0	0.3	0.0	1.3	1.8	0.3	3.4	0.0	1.5	0.5	0.3	5.9	1.1	0.5	0.2	7.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.0	3.7	1.2	0.0	0.0	0.3	4.5	0.0	0.3	2.1	4.1	12.7	1.4	0.0	1.4	6.8
FAM160A2	"C11orf56, DKFZP566M1046, FHIP, FLJ22665, KIAA1759"	ENSG00000051009	"Family with sequence similarity 160 member A2"	Q8N612	11	6211335-6234711	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055994, HPA063987"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055994: AB_2682999, HPA063987: AB_2685166"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.04e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.85e-1)"	13.6	12.9	11.5	10.5	21.6	29.8	15.6	23.0	23.8	16.6	20.7	15.7	20.5	26.6	19.8	11.7	11.7	18.4	18.6	10.7	9.9	6.0	12.6	17.4	14.1	12.5	12.5	12.3	20.2	21.0	19.6	15.8	10.7	12.0	14.0	22.4	16.1	15.9	15.0	11.3	18.2	25.9	12.9	9.7	12.2	15.9	26.5	9.8	10.5	20.3	9.0	12.8	14.2	14.5	2.8	3.7	6.1	6.0	1.9	6.0	3.1	10.7	10.7	7.5	11.1	10.2	11.1	16.3	6.2	7.5	9.3	8.9	9.1	20.1	8.5	6.9	7.2	15.3	14.3	7.6	11.2	5.7	9.2	10.9	2.8	17.6	4.8	8.4	7.0	9.8	10.0	14.2	8.4	14.9	12.2	9.4	13.3	9.0	10.6	5.8	8.5	6.7	13.6	11.2	14.0	10.1	7.5	3.9	6.8	8.7	7.8	10.1	6.6	8.9	10.6	5.5	8.1	7.2	10.0	8.0	11.5	8.9	17.0	6.5	14.2	12.1	6.4	12.7	5.7	10.1	1.7	6.0	5.9	6.0	2.5	3.7	2.5	2.4	4.4	3.7	2.8	1.9	3.3	6.1	1.9	1.9	1.1	0.4	3.1	11.5	21.6	23.0	23.8	9.9	6.0	12.5	12.3	12.0	9.8	17.9	14.4	13.7	10.9	11.1	13.3	4.1	7.6	12.0	7.9	12.2	15.7	10.6	6.6	9.5	12.0	12.7	61.0	0.0	9.9	8.5	8.9	10.5	6.9	20.2	8.7	6.4	24.0	11.1	16.5	4.5	9.2	9.4	13.5	5.4	31.6	6.8	12.6	40.3	7.1	6.9	22.2	12.9	8.9	27.8	20.7	13.0	9.6	15.0	30.3	7.4
FAM160B1	"bA106M7.3, KIAA1600"	ENSG00000151553	"Family with sequence similarity 160 member B1"	Q5W0V3	10	114821744-114899832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043624	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA043624: AB_10797145"	"unprognostic (2.61e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.45e-3)"	"unprognostic (6.43e-2)"	"unprognostic (9.87e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (3.41e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.25e-2)"	15.9	13.3	9.9	12.1	13.1	40.9	31.0	10.2	15.7	11.7	10.8	6.1	11.8	11.2	18.4	10.6	9.8	13.4	11.0	18.1	7.7	5.9	7.4	16.8	13.4	18.7	5.9	8.5	15.1	10.8	13.6	11.4	14.4	7.0	10.0	7.6	8.5	9.6	11.0	42.6	9.4	13.4	18.7	6.7	12.1	10.9	16.0	5.2	17.7	12.9	7.2	8.8	13.6	19.7	3.4	3.2	15.0	2.7	3.9	8.7	2.0	9.0	5.1	5.6	8.3	13.7	15.7	6.4	16.5	16.6	9.9	8.0	1.8	3.6	5.5	4.9	15.5	2.5	6.2	2.7	6.8	11.7	18.5	5.2	2.2	8.9	4.0	10.0	5.8	7.5	12.2	6.6	7.4	12.0	21.3	13.2	11.5	2.9	14.2	18.4	4.3	10.0	5.8	3.6	2.7	3.5	8.7	9.2	3.7	6.7	5.6	1.2	5.0	7.3	7.9	8.5	6.9	3.1	3.4	13.2	6.1	3.9	17.8	5.8	5.4	1.5	6.4	7.9	14.8	5.7	15.0	2.7	3.9	5.0	2.1	3.7	3.4	6.8	8.5	3.1	3.2	3.8	5.0	13.6	3.9	2.3	3.2	8.7	2.0	9.9	13.1	10.2	15.7	7.7	5.9	5.9	8.5	7.0	5.2	14.9	7.2	2.9	5.4	6.3	13.1	13.7	5.1	5.3	5.7	3.5	11.8	9.9	1.7	8.9	20.4	15.8	12.8	0.0	8.4	8.6	13.4	13.2	2.3	25.6	5.4	9.5	7.5	22.7	17.0	26.1	26.4	6.1	3.3	4.6	8.1	10.1	11.9	4.2	20.8	5.7	16.3	6.5	8.5	10.4	4.8	4.3	10.5	10.7	5.2	8.8
FAM160B2	"FLJ21801, RAI16"	ENSG00000158863	"Family with sequence similarity 160 member B2"	Q86V87	8	22089159-22104898	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025040	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA025040: AB_1856049"	"unprognostic (3.45e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.67e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.75e-3)"	15.8	11.8	9.6	13.1	10.0	6.6	14.3	14.3	14.8	12.9	13.2	12.9	20.8	12.0	13.2	16.9	13.7	14.1	14.5	26.0	8.5	6.9	12.3	9.8	11.0	11.2	12.5	10.5	11.4	22.1	15.3	14.1	22.4	10.9	14.4	6.0	13.4	18.8	25.1	15.1	24.4	13.4	25.3	10.4	12.3	16.1	6.4	10.3	6.5	16.0	11.6	13.2	19.9	11.2	2.7	0.9	0.5	1.4	1.7	3.2	2.1	3.7	9.3	4.5	6.9	9.1	8.4	6.9	5.8	12.6	8.6	6.0	3.8	4.6	3.9	6.4	18.2	7.8	5.3	3.3	10.4	1.8	3.4	3.5	5.8	2.5	2.6	12.3	1.5	5.3	14.1	7.1	6.3	4.2	8.9	8.8	8.9	3.9	3.3	8.1	7.8	4.2	2.2	1.8	7.9	3.3	4.4	3.3	2.2	7.3	9.2	1.6	4.8	3.5	7.5	4.8	4.7	4.5	3.4	8.4	8.7	6.7	7.8	4.0	2.6	0.8	0.7	9.2	2.8	9.4	0.0	1.2	0.5	3.2	0.7	1.9	2.7	2.1	2.6	0.8	2.3	1.9	2.7	0.3	1.7	1.4	0.9	0.3	2.1	9.6	10.0	14.3	14.8	8.5	6.9	12.5	10.5	10.9	10.3	11.9	15.0	9.0	8.7	5.3	22.4	21.8	20.4	2.7	4.5	12.2	25.5	7.0	0.0	8.0	3.6	12.2	13.8	0.0	12.8	11.4	8.0	10.8	6.9	12.2	6.4	22.3	12.7	17.8	11.8	1.9	10.0	5.4	1.7	4.6	9.7	12.7	13.7	12.5	5.3	3.8	24.2	0.0	7.3	1.7	5.9	6.6	12.5	8.6	8.6	8.1
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133578415-133586197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 41.7"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 15.1"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"SH-SY5Y: 40.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067336	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: AB_2685825"	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	8.2	10.0	0.0	2.7	0.0	0.0	3.2	41.7	0.0	0.4			0.0	0.0	0.3	0.0	0.0	0.4	1.2	6.1	3.9	0.1	2.7	0.0	1.3	3.3		0.0	0.1	0.0	0.0	0.6		0.0	0.4		0.4	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.8	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM167A	C8orf13	ENSG00000154319	"Family with sequence similarity 167 member A"	Q96KS9	8	11421463-11474715	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.0;thyroid gland: 51.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 14.9;Distal tubular cells: 11.6;Early spermatids: 17.1;Intestinal endocrine cells: 18.3;Late spermatids: 27.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.6;RPMI-8226: 26.0;SH-SY5Y: 19.7;U-698: 19.7;U-87 MG: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023915, HPA030426"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023915: AB_1845768, HPA030426: AB_10601318"	"unprognostic (8.51e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (3.08e-2)"	"unprognostic (4.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-2)"	0.8	1.6	13.8	1.8	11.2	1.3	2.0	7.1	20.0	1.1	1.4	12.6	0.0	1.1	0.9	1.3	1.4	2.0	1.8	0.9	13.8	7.6	6.6	0.8	10.5	2.8	8.6	11.8	0.8	2.8	0.8	12.3	2.5	12.2	2.1	1.4	0.5	3.3	5.7	0.8	11.8	1.3	0.8	7.0	1.9	2.7	3.2	7.6	0.8	51.1	0.3	3.5	1.3	1.0	4.0	1.3	0.1	1.8	0.9	0.1	0.1	2.0	1.3	2.7	0.2	0.2	1.1	0.0	7.4	7.0	4.5	1.9	0.0	0.6	24.6	0.4	7.9	2.1	0.7	0.0	1.7	5.3	10.6	0.3	0.0	0.0	0.0	9.3	0.0	0.0	1.3	1.1	2.3	14.5	14.5	0.0	0.0	0.1	1.0	2.6	0.7	0.0	0.0	0.7	0.0	0.0	0.1	0.0	26.0	2.3	0.2	11.7	19.7	0.3	2.1	0.9	0.3	0.8	0.0	12.5	0.4	0.7	11.4	0.1	7.9	5.7	19.7	16.3	0.0	0.7	0.1	0.2	0.0	0.0	1.8	0.1	4.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.9	1.7	1.3	0.0	0.1	13.8	11.2	7.1	12.5	13.8	7.6	8.6	11.8	12.2	7.6	14.9	2.6	0.0	0.4	5.3	0.0	0.6	2.5	1.4	0.0	5.2	9.8	0.0	11.6	1.8	17.1	0.0	0.0	0.0	1.7	0.0	0.5	1.1	0.0	0.0	0.1	0.0	18.3	0.0	0.3	27.3	0.3	0.0	0.0	0.0	1.3	1.8	0.9	2.9	0.4	0.0	1.7	0.0	0.0	1.2	2.5	3.0	0.0	0.0	0.0	0.1
FAM167B	"C1orf90, MGC10820"	ENSG00000183615	"Family with sequence similarity 167 member B"	Q9BTA0	1	32247233-32248856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"vagina: 91.1"	"Cell type enriched"	"Detected in some"	10	"Ito cells: 188.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 46.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 7.0;EFO-21: 8.9;SK-MEL-30: 21.5;U-2197: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029398, HPA062074"	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA029398: AB_10602807, HPA062074: AB_2684677"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.03e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-3)"	"unprognostic (7.44e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.04e-2)"	"unprognostic (5.08e-2)"	17.2	10.5	1.4	5.0	1.7	0.1	20.1	1.7	1.9	6.1	3.1	1.1	7.4	3.6	7.8	2.2	4.5	3.4	5.5	11.3	1.8	1.7	20.3	18.4	22.4	6.2	3.2	0.6	3.8	6.6	5.2	8.5	5.8	3.3	9.2	2.7	5.2	2.6	8.2	3.3	1.1	4.1	7.5	2.6	1.4	4.0	1.8	2.7	1.2	11.8	1.5	1.9	7.2	91.1	1.0	0.0	0.8	0.0	0.3	4.5	0.7	0.6	1.3	0.4	0.0	0.9	0.8	0.0	3.1	7.0	1.4	1.9	0.0	0.6	0.1	8.9	5.2	1.6	1.0	0.2	0.0	0.4	0.1	0.0	0.0	2.8	0.4	0.3	0.0	0.1	0.8	0.5	1.0	0.3	1.8	2.6	0.4	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.1	3.0	0.6	0.0	0.8	0.9	0.3	1.3	0.3	2.0	0.1	21.5	0.5	0.3	0.0	2.3	0.6	0.7	22.0	0.0	0.1	0.2	0.5	0.2	0.1	0.3	0.0	0.0	0.8	2.6	0.0	0.7	0.5	0.8	0.8	0.0	1.0	0.5	1.6	0.0	0.3	0.0	0.0	4.5	0.7	1.4	1.7	1.7	1.9	1.8	1.7	3.2	0.6	3.3	2.7	0.0	1.4	3.9	0.4	0.2	0.2	0.4	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.4	0.0	19.1	0.0	0.0	0.7	0.3	0.9	0.6	0.0	1.0	0.5	0.0	0.0	188.4	11.9	0.0	2.6	0.4	1.7	0.0	1.0	0.0	0.2	0.2	1.1	0.0	0.6	0.0	1.2	0.0	0.2	0.9	0.2	3.3	0.4	0.3
FAM168A	"KIAA0280, TCRP1"	ENSG00000054965	"Family with sequence similarity 168 member A"	Q92567	11	73400487-73598189	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037580	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037580: AB_10672906"	"unprognostic (2.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (4.60e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.41e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.70e-4)"	12.4	10.3	32.0	9.7	28.5	9.9	12.3	29.1	54.7	15.3	10.1	28.2	7.9	7.9	14.6	16.3	9.3	14.0	13.6	11.8	30.3	22.5	11.8	7.9	9.9	7.8	30.1	29.2	16.9	10.3	34.0	9.2	9.5	34.3	12.7	9.4	9.6	11.3	16.2	16.1	8.0	9.8	17.4	35.3	8.5	8.2	6.4	22.4	5.5	14.5	4.3	7.6	9.9	8.5	1.1	2.6	7.5	4.1	0.9	1.5	0.6	8.3	9.3	20.1	11.5	14.3	16.5	3.2	12.0	14.0	14.1	13.3	9.9	10.4	8.9	11.0	22.1	12.6	7.2	12.5	12.5	16.6	7.0	8.4	10.3	9.6	4.9	5.6	5.7	19.4	16.0	7.9	14.7	7.5	17.2	8.5	14.3	2.7	7.0	13.1	11.7	13.4	4.8	7.1	14.9	12.0	18.4	33.5	4.7	7.3	7.2	13.9	20.7	14.2	10.2	21.3	7.4	17.3	6.3	10.9	15.8	13.5	19.7	9.6	15.6	11.0	16.0	7.8	6.6	14.1	7.5	2.7	1.5	1.5	4.1	0.8	1.0	0.8	1.3	2.1	1.1	1.1	1.3	6.3	0.9	2.9	2.6	1.2	0.6	32.0	28.5	29.1	42.4	30.3	22.5	30.1	29.2	34.3	22.4	3.0	10.9	4.5	1.7	3.4	21.0	18.2	20.4	5.3	11.4	7.0	43.2	1.8	0.0	3.1	18.3	6.3	4.9	0.0	2.3	3.2	6.1	2.6	23.0	15.5	8.6	3.2	12.2	9.8	15.1	18.1	6.9	6.9	5.0	2.8	7.8	24.9	3.6	3.5	12.0	3.1	22.1	6.5	13.3	3.7	4.1	3.3	2.3	2.5	6.6	1.4
FAM171A1	"C10orf38, FLJ12884"	ENSG00000148468	"Family with sequence similarity 171 member A1"	Q5VUB5	10	15211643-15371062	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.9"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 104.4;Ito cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	23	"T-cells: 7.4"	"Cell line enhanced"	"Detected in many"		"TIME: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051345	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		96000	"Plasma membrane"	Nucleoplasm	"HPA051345: AB_2681449"	"unprognostic (3.60e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.71e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (4.90e-6)"	"unprognostic (3.28e-2)"	6.9	3.7	22.1	5.5	37.9	0.2	4.6	11.1	31.8	8.8	16.1	25.3	6.5	13.7	9.7	4.8	4.7	11.8	9.3	7.0	24.1	17.5	17.8	6.2	5.3	3.7	25.1	14.3	10.9	13.8	8.9	1.9	2.9	21.5	8.4	12.9	2.5	10.0	9.4	5.1	2.4	8.9	9.0	43.9	8.5	10.3	2.4	21.9	0.6	4.3	1.1	4.6	6.0	6.2	0.0	0.0	0.0	0.0	0.3	7.4	1.3	0.0	6.3	13.0	5.0	5.3	10.1	0.1	7.9	1.5	4.0	3.5	1.1	7.4	0.0	9.6	20.5	9.1	0.6	9.3	0.1	4.5	2.6	14.6	18.4	2.0	18.2	5.8	0.0	14.9	7.9	1.9	10.9	1.6	14.6	20.0	2.7	7.2	0.0	12.7	0.5	3.1	0.0	12.5	3.5	3.5	12.4	6.9	1.9	5.0	0.0	9.0	11.5	4.4	0.1	0.0	14.5	0.0	0.2	42.6	5.5	23.2	19.9	8.3	2.7	0.7	0.0	12.2	0.0	4.2	0.0	0.0	0.0	2.6	0.0	6.8	0.0	3.8	3.3	0.0	0.0	7.4	3.7	0.0	0.3	0.0	0.0	0.7	1.3	22.1	37.9	11.1	23.1	24.1	17.5	25.1	14.3	21.5	21.9	0.0	0.0	0.0	3.3	1.1	3.8	5.1	104.4	2.7	2.3	14.0	0.0	0.1	3.3	17.1	0.6	18.9	12.0	0.0	10.5	0.1	8.9	13.8	1.1	18.3	0.3	6.4	20.2	41.1	4.4	1.0	4.9	0.0	1.7	1.0	25.9	1.5	15.9	8.6	5.3	4.1	1.1	0.0	6.2	2.3	3.5	1.6	0.1	1.3	31.1	2.1
FAM171B	"FLJ34104, KIAA1946"	ENSG00000144369	"Family with sequence similarity 171 member B"	Q6P995	2	186693971-186765965	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.0"	"Cell type enriched"	"Detected in many"	6	"Bipolar cells: 137.0"	"Cancer enriched"	"Detected in many"	5	"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 25.4;U-138 MG: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010639, HPA013434"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA010639: AB_1852447, HPA013434: AB_2262499"	"unprognostic (2.52e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (9.51e-7)"	"unprognostic (4.63e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.03e-4)"	3.1	13.1	32.0	2.0	32.6	1.1	3.7	12.7	62.0	6.7	2.1	5.8	0.1	1.6	7.1	2.6	2.4	3.2	4.9	1.9	25.5	13.1	1.8	1.1	2.0	1.6	9.1	23.0	9.7	1.6	11.4	13.4	3.5	9.7	3.2	2.5	1.4	17.8	2.8	1.3	3.8	1.9	4.5	8.4	2.0	2.4	1.6	10.4	0.0	2.7	0.0	1.7	2.9	1.8	0.3	1.3	1.1	1.7	2.4	1.1	0.5	2.3	2.8	4.2	13.1	12.5	9.5	0.1	2.6	4.6	3.2	4.6	7.7	12.6	0.0	0.9	7.3	5.5	0.3	5.7	2.5	4.6	0.0	3.3	2.8	1.3	0.0	1.0	0.8	1.0	12.1	1.0	2.5	2.0	4.2	7.0	2.2	0.0	25.4	6.1	1.6	1.6	0.0	5.6	0.0	2.8	0.0	8.1	0.6	5.0	9.0	13.2	7.2	1.3	0.8	3.5	2.6	1.0	0.6	4.1	17.6	2.3	0.3	1.6	6.8	6.5	0.0	5.4	0.0	2.4	1.1	0.7	0.3	0.8	1.7	0.7	0.3	1.0	0.9	0.6	0.2	0.6	1.1	0.4	2.4	1.6	1.3	0.1	0.5	32.0	32.6	12.7	30.4	25.5	13.1	9.1	23.0	9.7	10.4	0.0	0.0	0.0	2.1	7.9	137.0	0.8	10.2	0.0	2.3	0.0	13.7	7.9	0.0	0.7	1.4	10.5	0.0	0.0	0.3	0.8	6.6	1.2	0.0	0.0	1.7	22.3	4.6	8.0	0.3	2.5	7.2	1.1	3.3	1.0	0.0	16.5	0.5	0.0	13.1	0.1	15.5	0.0	4.1	0.1	1.4	4.5	6.9	0.0	0.0	0.5
FAM173A	"C16orf24, MGC2494"	ENSG00000103254	"Family with sequence similarity 173 member A"	Q9BQD7	16	720581-722601	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 314.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046262	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046262: AB_10963070"	"unprognostic (3.94e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.88e-4)"	"unprognostic (2.11e-1)"	"unprognostic (4.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.24e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.28e-2)"	"unprognostic (3.60e-3)"	16.0	10.4	15.6	10.3	9.1	7.3	9.6	8.9	21.5	4.8	15.5	8.2	9.3	19.1	6.5	8.3	6.1	5.2	10.6	11.1	13.6	11.5	18.6	15.8	7.5	7.5	11.3	12.2	4.3	10.2	8.5	13.4	5.8	9.2	8.4	3.5	6.5	15.1	8.6	37.3	6.2	14.5	5.6	9.5	15.0	19.3	21.8	7.9	8.6	7.8	11.1	7.1	5.9	8.9	9.0	6.0	5.3	6.8	6.3	18.0	4.2	6.4	4.3	0.8	2.3	0.1	0.3	10.3	5.6	1.4	1.3	1.6	4.3	5.4	8.3	10.1	0.6	2.4	10.1	0.8	2.8	0.4	18.3	11.4	3.5	4.5	4.5	2.0	5.8	4.8	0.7	2.1	0.6	1.7	2.9	0.5	5.8	7.3	3.8	1.2	10.5	0.9	14.0	3.3	3.6	14.1	3.5	2.1	15.5	3.6	2.3	3.7	9.7	2.9	4.8	9.3	0.5	5.3	5.2	4.7	1.2	10.0	3.6	3.9	33.6	15.0	8.9	2.5	4.3	3.2	0.0	6.8	5.3	7.3	3.9	16.5	9.0	5.8	12.9	4.4	9.0	5.9	18.0	0.8	6.3	4.8	6.0	12.5	4.2	15.6	9.1	8.9	21.5	13.6	11.5	11.3	12.2	9.2	7.9	6.0	5.4	49.9	28.1	9.0	86.9	11.2	50.9	1.4	0.0	61.1	33.4	40.1	99.5	47.3	182.0	14.5	140.4	0.0	56.0	31.2	20.0	36.4	28.7	74.6	77.3	50.9	50.1	27.6	51.9	314.4	23.6	43.6	45.5	55.1	53.9	57.8	49.3	73.7	17.7	139.1	71.7	25.8	27.8	65.4	88.0	8.3	21.4	60.6	62.2	31.4
FAM173B	JS-2	ENSG00000150756	"Family with sequence similarity 173 member B"	Q6P4H8	5	10226330-10249897	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 40.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074513			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA074513: AB_2686698"	"prognostic unfavorable (1.32e-6)"	"unprognostic (8.87e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.03e-1)"	10.1	14.6	17.7	10.4	16.2	3.3	9.0	20.1	18.6	7.9	9.7	12.2	8.8	7.7	9.3	12.6	7.9	9.2	9.9	8.8	14.9	18.1	12.1	13.1	7.5	8.9	18.8	9.9	8.6	6.8	19.2	22.8	5.3	18.6	12.2	12.4	10.3	8.8	12.3	7.3	7.4	7.1	10.1	13.2	5.6	7.8	6.5	18.9	8.4	12.7	6.2	8.7	11.6	13.9	5.7	8.9	11.6	9.7	5.1	8.6	4.5	7.3	8.1	8.0	7.6	8.8	6.7	2.8	11.4	5.7	6.1	4.8	8.5	12.2	9.5	20.5	8.1	15.4	5.5	12.2	10.4	9.9	15.8	7.5	7.9	27.6	6.3	5.9	12.2	9.5	6.1	11.6	10.1	3.4	6.9	11.8	9.4	11.0	9.7	17.2	6.9	6.0	10.8	4.9	17.1	9.8	8.3	5.5	8.4	15.6	9.7	6.4	6.4	40.2	14.2	6.4	6.3	14.5	12.7	6.5	13.0	7.7	7.9	8.3	6.6	7.2	10.6	8.2	14.0	5.3	5.0	9.3	11.6	7.0	9.7	8.4	5.7	6.7	8.5	8.9	4.2	6.8	8.6	3.4	5.1	7.7	3.1	7.8	4.5	17.7	16.2	20.1	18.6	14.9	18.1	18.8	9.9	18.6	18.9	3.0	1.4	3.0	5.1	1.3	8.4	5.9	5.1	14.7	3.4	10.4	2.0	5.0	5.0	6.0	4.1	4.9	3.6	0.0	3.7	3.9	6.3	5.8	9.2	7.4	6.9	9.5	2.4	1.8	4.5	2.5	3.4	2.3	3.3	5.4	3.9	7.8	3.4	6.0	6.3	6.3	12.2	6.5	2.5	10.0	15.8	1.6	2.2	5.0	5.3	3.4
FAM174A	"NS5ATP6, TMEM157, UNQ1912"	ENSG00000174132	"Family with sequence similarity 174 member A"	Q8TBP5	5	100535305-100586741	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	8	"neutrophil: 28.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 28.0"	"Cell line enhanced"	"Detected in many"		"U-266/84: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019539	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA019539: AB_2293743"	"unprognostic (2.34e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (5.55e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	15.6	24.6	18.8	8.3	21.0	3.0	15.3	14.2	26.8	11.1	12.0	16.5	14.0	11.8	11.3	15.2	18.0	35.9	9.5	17.3	22.0	25.0	18.3	15.2	17.6	5.5	19.3	18.2	9.1	26.8	23.6	21.9	15.6	24.1	19.5	9.1	16.6	16.5	13.7	38.8	20.4	10.7	9.6	19.4	10.1	15.5	37.3	12.2	4.4	14.3	17.0	9.6	9.9	11.7	1.5	2.2	28.0	2.7	2.5	2.7	1.6	5.0	5.3	2.2	6.9	5.3	4.3	7.7	11.6	6.5	4.8	6.5	1.1	6.6	0.9	23.6	5.0	8.3	4.3	1.8	7.5	3.4	6.1	5.5	0.6	9.2	3.1	7.2	2.6	6.4	5.6	18.0	3.6	2.8	10.8	7.1	2.7	1.8	6.9	7.8	10.1	0.7	5.4	1.1	0.6	14.5	1.7	8.3	8.7	8.3	6.1	4.4	11.7	8.1	7.3	6.4	2.6	7.1	5.7	8.1	6.0	3.8	9.6	9.1	22.0	28.7	1.1	7.5	3.5	5.2	3.6	2.5	3.4	1.8	2.7	2.7	1.4	1.8	2.2	2.2	1.5	1.6	2.1	28.0	2.5	2.7	2.2	2.2	1.6	18.8	21.0	14.2	26.8	22.0	25.0	19.3	18.2	24.1	12.2	29.8	25.6	12.6	27.4	78.3	24.0	14.9	20.4	211.5	31.8	27.9	3.9	33.9	36.5	26.0	16.2	23.7	14.7	0.0	26.4	32.0	28.2	31.9	12.7	27.2	20.9	28.6	33.5	31.9	14.3	4.0	16.7	17.1	47.2	19.0	31.7	63.9	27.0	20.1	23.0	32.2	36.9	12.9	22.6	86.9	16.8	100.6	42.1	13.1	19.9	34.6
FAM174B	"LOC400451, MGC102891"	ENSG00000185442	"Family with sequence similarity 174 member B"	Q3ZCQ3	15	92617443-92809884	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 57.6"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 98.3;Mucus-secreting cells: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;MCF7: 25.6;OE19: 21.5;RPMI-8226: 30.0;RT4: 63.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015306	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA015306: AB_2669182"	"unprognostic (3.00e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (9.03e-5)"	"unprognostic (4.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.23e-3)"	"unprognostic (7.67e-3)"	"unprognostic (5.05e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-2)"	6.1	3.5	5.9	3.3	6.3	0.7	17.9	3.9	8.6	10.9	6.2	2.9	21.5	3.6	5.1	4.9	5.2	14.6	6.4	4.2	7.4	8.3	3.3	4.0	16.3	5.5	6.5	6.2	10.2	57.6	2.5	15.9	4.6	6.7	19.4	9.2	7.7	47.7	10.8	16.3	4.9	5.0	4.6	4.9	3.2	17.3	9.7	3.6	4.2	28.9	3.9	4.8	24.4	15.3	0.4	4.5	3.7	0.9	0.7	10.9	0.7	0.0	3.6	2.3	0.7	0.0	0.0	0.3	1.3	6.3	0.0	0.0	21.3	2.4	0.3	6.1	0.1	1.7	0.1	4.0	0.1	0.0	0.1	1.8	0.2	0.4	0.2	0.4	0.3	0.9	0.3	0.1	0.0	0.0	0.1	3.0	2.0	0.3	15.8	3.5	25.6	0.7	0.0	11.5	21.5	0.0	2.4	6.6	30.0	1.5	63.4	1.4	1.1	1.8	12.2	3.9	7.0	9.8	2.2	0.0	0.0	0.5	0.1	2.9	0.5	4.7	0.7	0.0	0.2	1.5	1.1	0.8	0.9	0.2	0.9	0.4	0.4	2.5	0.0	0.6	0.3	2.8	3.3	3.7	0.7	0.0	4.5	10.9	0.7	5.9	6.3	3.9	8.6	7.4	8.3	6.5	6.2	6.7	3.6	98.3	20.3	0.0	14.7	2.1	5.3	4.1	10.2	14.7	18.2	7.0	7.9	1.1	6.6	4.4	19.8	5.8	2.3	0.0	12.4	15.9	4.1	29.2	18.4	5.8	4.2	11.1	40.5	30.7	4.3	39.0	5.5	1.8	11.8	0.0	61.2	3.5	17.4	0.0	1.8	1.1	2.7	0.0	5.3	1.0	3.4	2.6	0.6	2.1	4.7	23.7
FAM177A1	C14orf24	ENSG00000151327	"Family with sequence similarity 177 member A1"	Q8N128	14	35044907-35113130	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA053222, HPA055440"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		180000	Vesicles	Nucleoplasm	"HPA053222: AB_2682083, HPA055440: AB_2682817"	"unprognostic (6.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (4.64e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.91e-1)"	20.8	25.6	29.5	17.5	29.2	24.9	20.6	14.1	25.9	27.2	45.8	29.2	19.6	32.6	16.3	17.9	22.2	12.7	22.0	44.2	31.6	35.3	35.5	49.1	36.0	10.4	41.1	24.2	14.4	21.5	14.2	43.8	17.7	39.6	37.9	41.6	13.6	19.5	22.3	33.8	17.4	34.0	25.5	45.4	15.7	24.1	42.6	22.2	13.3	31.0	19.0	12.8	27.6	18.2	14.1	16.8	56.7	15.1	9.4	18.5	9.7	20.3	16.5	12.6	10.1	21.8	21.9	17.0	33.3	18.1	17.3	19.0	16.8	27.0	8.5	23.8	31.6	23.6	21.4	15.2	18.8	22.2	23.8	11.6	6.5	20.9	56.8	26.9	9.9	15.1	19.6	24.8	20.9	16.5	25.5	19.8	15.4	15.4	26.2	33.3	29.2	12.2	9.2	10.3	32.1	23.5	7.0	17.8	11.8	31.3	22.1	17.6	15.8	39.3	30.9	25.6	26.0	28.6	7.6	23.2	22.7	20.1	25.2	17.0	20.4	24.4	10.0	14.0	6.6	22.1	20.9	15.1	24.9	10.7	11.4	12.6	14.1	14.2	12.2	10.9	11.3	11.3	11.0	56.7	9.4	9.7	16.8	18.5	9.7	29.5	29.2	14.1	25.9	31.6	35.3	41.1	24.2	39.6	22.2	223.4	156.1	82.9	157.1	142.8	34.3	125.5	66.2	148.5	129.7	99.5	25.5	63.2	101.2	106.7	472.3	134.1	241.2	46.7	217.0	95.5	80.8	234.3	79.8	184.5	67.0	22.3	128.5	82.9	53.3	400.3	50.0	70.6	141.7	179.5	172.8	36.1	275.5	227.7	49.8	271.4	43.2	45.3	134.8	116.8	87.3	149.8	103.1	90.6	196.2	201.3
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748846	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.0"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 6.6;Cardiomyocytes: 5.2;Fibroblasts: 5.8;Ito cells: 8.0;Leydig cells: 2.6;Melanocytes: 6.8;Peritubular cells: 3.9;Smooth muscle cells: 2.8;Suprabasal keratinocytes: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"U-2197: 74.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	9.3	2.6	0.1	1.7	0.5	0.0	5.6	0.1	1.0	7.8	5.7	0.3	0.5	0.7	9.4	2.0	5.1	3.0	21.2	14.7	0.1	0.1	8.7	23.0	4.6	0.0	0.1	0.0	8.1	1.1	0.0	0.3	1.4	0.5	6.1	1.8	1.9	2.2	0.1	3.5	5.5	3.2	8.1	0.4	0.9	1.6	3.9	0.1	0.0	4.6	4.8	0.9	6.6	8.3	0.6	0.2	2.0	0.3	0.4	0.5	0.1	0.0	0.0	0.0	0.0	8.1	8.4	0.0	4.2	16.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	10.3	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	16.7	0.0	74.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.1	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.6	0.4	0.5	0.8	0.4	0.3	0.2	0.2	0.1	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	6.6	0.0	5.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	2.6	0.0	6.8	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	2.8	0.0	0.0	4.3	0.6	0.0	0.0	0.0
FAM181B	"LOC220382, MGC33846"	ENSG00000182103	"Family with sequence similarity 181 member B"	A6NEQ2	11	82729941-82733864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 29.6"	"Cell type enhanced"	"Detected in some"	24	"Collecting duct cells: 5.2;Distal tubular cells: 3.3;Muller glia cells: 18.0;Smooth muscle cells: 3.1"	"Cancer enriched"	"Detected in many"	19	"glioma: 29.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 6.7;SH-SY5Y: 3.6;U-2 OS: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066861	Enhanced		Approved	"Nuclear membrane,Mitochondria"		NA	NA			Mitochondria	"Nuclear membrane"	"HPA066861: AB_2685738"	"unprognostic (2.84e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (6.71e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.27e-4)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.20e-3)"	"unprognostic (7.20e-2)"	1.9	2.9	18.3	1.8	13.3	1.5	1.6	16.9	29.6	2.0	1.7	18.6	0.0	1.9	2.2	1.8	1.5	2.6	1.4	2.0	19.6	11.3	2.0	1.3	1.3	1.4	17.1	13.0	2.7	1.5	1.5	1.1	1.4	17.2	1.9	1.5	0.7	3.2	2.7	1.7	1.7	2.3	1.6	16.9	1.3	1.8	1.7	16.7	0.0	2.1	0.0	1.7	2.2	0.5	0.2	0.0	0.6	0.3	0.3	0.4	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.1	0.3	0.1	0.4	0.0	0.1	0.1	0.5	0.4	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.1	0.1	1.2	0.0	0.2	0.1	0.0	0.0	0.2	6.7	1.0	3.6	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.1	3.5	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.6	0.3	0.3	0.0	0.1	0.0	18.3	13.3	16.9	11.4	19.6	11.3	17.1	13.0	17.2	16.7	0.0	0.0	0.0	0.2	0.2	0.2	2.7	0.0	0.0	0.0	5.2	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	18.0	0.0	0.0	0.4	0.0	0.8	0.0	3.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1
FAM182B		ENSG00000175170	"Family with sequence similarity 182 member B"	Q5T319	20	25763466-25868225	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 7.6;testis: 9.9"	"Group enriched"	"Detected in some"	37	"Early spermatids: 201.1;Late spermatids: 281.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"SCLC-21H: 17.4"									HPA050100	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050100: AB_2681014"	"unprognostic (8.05e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.47e-9)"	"unprognostic (2.36e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.54e-2)"	"unprognostic (3.18e-1)"	0.4	0.9	2.9	0.2	3.8	0.0	0.8	7.6	5.9	0.6	0.2			0.1	1.2	0.3	0.6	6.4	0.2	0.3	3.0	3.7	0.4	0.0	1.2	0.2	2.0		1.7	0.8	0.5	2.7	4.4		1.7	0.1		0.8	0.5	1.2	5.2	0.7	0.4	1.2	0.8	0.6	9.9			1.4		0.0	0.0	0.4	0.2	0.2	2.1	0.1	0.7	1.2	0.4	2.2	1.0	1.2	1.2	0.6	0.1	0.5	0.3	0.0	0.1	0.4	0.0	3.0	0.2	1.3	1.5	1.0	4.1	0.0	0.4	0.0	0.0	0.4	0.0	0.7	0.0	0.3	0.2	1.1	0.9	0.1	0.0	1.1	0.0	0.1	1.4	1.0	2.8	0.0	0.1	1.4	0.7	0.1	1.7	1.6	0.1	0.1	0.6	0.4	0.0	17.4	1.1	0.7	0.2	1.2	1.2	0.5	0.6	0.3	0.2	3.7	0.8	0.5	1.8	0.3	0.8	0.2	0.5	1.5	0.0	0.1	1.7	0.6	0.0	0.6	0.1	1.0	0.3	0.2	0.2	0.9	1.2	2.1	0.7	0.0	0.1	0.0	0.4											0.0	0.0	0.0	0.1	3.0	0.6	0.4	0.0	0.0	0.0	1.8	5.9	0.5	1.7	0.0	201.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	281.2	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.5	6.5	1.4	5.1	1.3	2.5	0.0	0.0	0.0	0.0
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.4"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 90.2;Spermatocytes: 64.6;Syncytiotrophoblasts: 222.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 15.9;HEK 293: 9.4;JURKAT: 13.4;K-562: 13.0;SCLC-21H: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	4.0	2.8	14.2	3.7	13.7	0.6	6.1	13.9	16.0	2.8	3.0	4.6	0.4	3.8	3.9	3.6	2.6	3.9	2.3	2.4	11.3	10.5	6.7	6.4	15.3	4.9	9.1	10.0	7.1	5.1	14.2	15.4	31.4	11.9	4.0	1.9	2.7	2.9	4.1	1.2	2.3	2.6	3.1	4.6	1.0	1.7	23.2	7.1	0.1	8.5	1.1	5.8	2.1	2.0	0.5	0.0	0.0	0.2	0.3	1.9	0.0	0.1	0.2	15.9	1.6	0.2	0.2	0.0	0.5	0.3	0.5	0.8	2.1	1.2	1.1	0.0	0.2	6.0	0.0	4.9	0.0	0.2	1.2	9.4	0.5	1.4	7.0	0.1	0.0	1.5	0.3	0.2	0.1	0.0	0.3	0.0	13.4	13.0	0.5	0.2	0.3	0.3	0.0	5.3	0.6	1.2	0.0	0.0	0.0	0.1	0.1	10.4	7.7	0.5	0.5	1.5	3.0	2.1	1.8	0.2	0.8	0.4	0.1	4.0	4.0	4.3	0.3	1.2	0.0	2.0	0.0	0.0	0.0	0.2	0.2	0.6	0.5	0.2	0.0	0.0	0.1	1.5	1.2	0.0	0.3	0.0	0.0	1.9	0.0	14.2	13.7	13.9	12.9	11.3	10.5	9.1	10.0	11.9	7.1	44.7	90.2	0.0	6.1	2.2	36.7	3.9	5.1	60.2	31.8	3.5	27.5	45.2	14.9	0.8	12.9	1.9	0.1	0.0	1.0	13.5	5.0	0.9	5.8	3.4	4.9	12.7	5.8	3.1	0.3	5.4	3.4	0.8	0.0	0.0	0.0	12.5	0.5	0.0	6.7	1.3	27.8	6.5	2.3	64.6	15.4	3.0	222.8	4.1	0.4	1.0
FAM185A	MGC35361	ENSG00000222011	"Family with sequence similarity 185 member A"	Q8N0U4	7	102748971-102809225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020470, HPA029883"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA020470: AB_1853890, HPA029883: AB_10601903"	"unprognostic (8.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.36e-5)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.25e-2)"	3.7	4.6	6.6	3.0	4.9	3.6	3.8	9.3	6.3	5.6	4.3	4.4	4.1	2.3	3.8	3.1	4.4	3.1	3.4	4.2	4.2	2.3	4.0	9.4	4.8	2.3	5.1	6.0	4.7	3.7	8.7	4.8	2.8	4.0	5.2	4.3	6.1	5.1	8.4	9.5	4.6	3.1	3.7	4.5	3.0	5.9	2.2	5.1	3.0	3.8	2.4	2.7	4.4	4.0	3.3	2.6	7.5	3.0	1.2	2.2	0.9	1.4	3.5	1.6	4.1	0.6	1.7	4.2	0.9	1.7	1.6	0.5	3.4	2.9	0.0	2.2	1.2	4.3	3.6	2.3	2.4	1.6	1.8	2.0	0.2	0.4	4.2	1.0	2.9	0.4	0.0	2.7	1.0	1.2	3.3	2.0	1.1	2.1	1.5	1.7	2.7	1.4	0.3	1.8	2.7	0.0	0.3	0.1	10.2	0.8	2.5	1.4	3.0	3.4	5.4	0.4	0.9	3.3	0.0	3.6	0.4	1.7	2.5	0.5	4.9	1.6	0.6	0.7	0.9	0.0	0.0	3.0	3.3	2.1	2.2	0.9	3.3	1.4	2.2	2.6	1.9	1.3	1.5	7.5	1.2	1.0	2.4	1.6	0.9	6.6	4.9	9.3	6.3	4.2	2.3	5.1	6.0	4.0	5.1	3.0	1.0	2.4	5.9	3.8	7.7	4.4	10.2	2.7	6.8	0.0	9.8	11.6	16.6	3.7	3.1	4.5	2.3	0.0	2.0	4.9	3.3	3.1	0.0	5.9	4.0	4.8	1.2	4.3	1.3	1.9	6.6	1.9	6.8	1.8	2.2	3.5	2.2	0.0	4.9	9.1	21.2	12.9	2.8	5.2	3.6	4.0	6.8	4.9	3.5	5.1
FAM187A		ENSG00000214447	"Family with sequence similarity 187 member A"	A6NFU0	17	44899712-44905390	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.2;testis: 37.0"	"Cell type enriched"	"Detected in single"	67	"Ciliated cells: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 12.4;U-87 MG: 14.1"									HPA043131			Approved	Cytosol		NA	NA			Cytosol		"HPA043131: AB_10796686"																		0.7	1.3	5.8	0.6	8.9	0.7	1.4	1.0	5.0	2.5	0.9	3.1	1.7	0.3	1.9	2.7	0.5	21.2	3.0	0.6	5.4	6.7	3.7	0.5	2.0	0.7	5.3	4.1	3.7	1.6	2.2	2.2	0.3	4.5	1.1	1.0	1.7	1.3	1.9	0.4	0.6	0.6	1.1	4.2	0.4	0.6	37.0	1.1	0.3	4.5	0.2	0.6	0.9	0.3	0.8	1.8	1.9	2.9	0.2	0.8	2.0	1.7	8.8	2.2	1.8	2.7	3.1	1.4	0.5	4.3	2.5	3.1	2.6	4.7	0.2	1.4	1.6	5.9	5.2	0.5	2.3	1.1	5.2	2.1	0.7	3.7	0.7	1.1	1.0	0.7	0.4	3.0	4.7	1.0	4.2	1.1	1.1	1.6	0.1	0.9	1.2	0.1	1.3	0.7	3.0	1.2	0.8	0.3	0.4	12.4	0.8	5.9	1.4	0.5	0.1	0.7	1.7	6.3	1.0	0.6	1.0	2.2	1.2	1.0	0.2	0.2	0.4	14.1	0.8	1.1	0.0	2.9	1.9	0.2	0.8	0.0	0.0	0.0	0.8	1.8	0.8	0.0	0.1	0.0	0.2	0.3	0.0	0.6	2.0	5.8	8.9	1.0	5.0	5.4	6.7	5.3	4.1	4.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM189A1	"KIAA0574, TMEM228"	ENSG00000104059	"Family with sequence similarity 189 member A1"	O60320	15	29120254-29570723	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.3;parathyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"	7	"Cardiomyocytes: 3.1;Ductal cells: 3.7;Enterocytes: 2.3;Intestinal endocrine cells: 2.9;Paneth cells: 3.5;Undifferentiated cells: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;HDLM-2: 15.6;Karpas-707: 2.0;REH: 3.7"	"Low region specificity"	"Detected in many"							"HPA009410, HPA010637"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009410: AB_1852332, HPA010637: AB_1852333"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.12e-1)"	0.8	1.5	12.8	0.6	7.9	0.4	0.6	4.2	9.5	0.4	4.0	1.5	0.0	1.0	1.1	0.8	0.6	1.5	0.5	0.7	15.3	4.7	1.7	0.5	1.5	0.5	3.5	3.4	0.4	3.3	6.5	0.0	0.7	4.0	0.8	3.0	0.0	1.1	0.5	0.4	0.8	3.2	1.0	0.7	1.3	0.6	2.3	0.3	0.0	1.9	0.0	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.3	0.0	0.0	0.0	0.2	15.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	2.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.8	7.9	4.2	9.5	15.3	4.7	3.5	3.4	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.7	0.0	2.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.5	0.9	0.0	0.0	0.0	1.7	0.1	0.2	3.5	1.4	0.8	0.3	0.0	0.2	0.5	1.2	0.0	0.0	0.0	2.9	0.5
FAM193A	"C4orf8, RES4-22"	ENSG00000125386	"Family with sequence similarity 193 member A"	P78312	4	2536631-2732565	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043116	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043116: AB_10795767"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.84e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.96e-3)"	17.1	14.1	17.8	25.5	17.7	22.4	19.7	33.0	23.2	17.4	14.5	18.2	21.3	15.3	23.5	16.0	12.1	16.4	17.2	11.9	16.7	14.3	12.4	13.7	20.2	17.3	18.0	11.8	23.7	17.4	20.4	21.5	15.3	16.1	16.4	11.9	18.8	16.4	19.3	18.1	16.6	15.8	16.0	13.9	17.0	14.7	29.1	17.2	26.3	15.4	13.7	16.0	14.6	30.7	2.5	3.9	5.7	6.3	3.2	2.9	1.0	7.1	9.0	16.7	9.5	10.2	10.5	9.1	11.0	9.4	10.8	9.1	9.1	11.7	14.0	6.8	11.9	13.3	6.2	11.6	7.8	8.9	8.7	7.6	21.0	11.1	9.4	12.4	12.6	14.8	11.5	8.3	10.6	10.8	9.8	10.6	8.4	14.7	15.5	8.8	7.5	20.5	20.5	13.7	7.1	10.2	20.3	8.8	6.9	7.2	9.4	14.7	12.6	9.3	6.5	9.5	9.4	12.0	13.0	14.3	16.5	9.8	8.9	14.2	15.7	11.5	13.6	9.3	10.6	11.7	5.7	2.2	1.8	2.2	1.5	1.5	1.5	1.9	2.9	1.4	2.5	1.9	2.7	4.2	3.2	6.3	3.9	1.4	1.0	17.8	17.7	33.0	23.2	16.7	14.3	18.0	11.8	16.1	17.2	11.9	15.6	2.7	6.0	8.4	24.2	13.1	0.0	4.0	21.6	1.8	45.2	5.9	1.7	7.9	6.7	12.6	11.6	0.0	6.5	5.7	10.8	9.1	8.1	4.9	7.5	14.3	13.8	10.4	8.2	11.0	15.8	11.3	13.5	8.2	9.0	15.4	8.7	9.0	13.8	2.2	24.7	6.5	10.0	29.8	28.5	8.7	4.7	6.4	8.9	6.4
FAM198B	"C4orf18, DKFZp434L142, ENED, FLJ38155"	ENSG00000164125	"Family with sequence similarity 198 member B"	Q6UWH4	4	158124474-158173318	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 83.8"	"Cell type enhanced"	"Detected in many"	13	"Endothelial cells: 51.3;Hofbauer cells: 56.1;Ito cells: 49.7;Kupffer cells: 140.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8"	"Group enriched"	"Detected in many"	37	"dendritic cells: 7.6;monocytes: 23.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.5;ASC TERT1: 40.6;HSkMC: 46.6;HUVEC TERT2: 52.0;WM-115: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007227	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA007227: AB_1847689"	"unprognostic (4.87e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (9.42e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.74e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-2)"	24.1	83.8	13.9	12.9	12.6	0.9	15.9	22.9	16.0	16.7	8.9	12.1	6.2	4.5	27.5	13.2	6.0	10.6	12.6	25.8	24.2	9.0	4.2	2.9	6.9	7.1	18.6	20.2	50.1	4.8	4.4	2.7	9.5	12.4	8.3	8.1	4.2	7.9	10.8	3.8	3.5	6.3	23.9	25.9	15.7	7.5	7.0	17.5	0.0	8.2	3.1	2.3	14.2	7.3	0.0	7.6	0.4	23.8	0.0	0.0	7.3	3.2	2.6	1.6	0.3	21.5	40.6	3.1	0.8	0.6	0.1	1.0	3.5	1.3	0.0	0.1	1.3	1.4	0.0	19.0	5.0	0.5	0.0	0.0	0.2	0.0	9.7	14.4	0.1	0.0	46.6	1.2	6.6	0.7	2.2	52.0	0.0	3.3	0.0	9.6	0.2	0.0	0.0	0.1	11.3	0.0	0.0	0.1	0.0	0.0	7.3	0.1	0.0	0.0	7.5	2.1	9.6	1.4	0.0	2.5	4.4	4.8	2.6	1.6	0.0	0.0	11.8	0.6	0.0	20.0	0.0	23.8	0.0	0.0	14.8	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.4	0.0	6.8	0.3	0.0	7.3	13.9	12.6	22.9	16.0	24.2	9.0	18.6	20.2	12.4	17.5	8.9	3.8	1.7	1.7	8.1	0.0	30.3	0.0	2.7	2.3	3.5	0.0	3.6	0.0	0.5	2.4	51.3	2.6	0.0	5.0	0.9	14.8	2.4	1.1	0.8	56.1	6.4	1.7	49.7	140.4	4.3	32.5	27.2	8.5	0.0	6.5	0.0	3.2	1.9	39.6	0.0	0.0	6.5	10.3	4.4	0.5	6.5	4.9	2.2	2.9	1.0
FAM199X	CXorf39	ENSG00000123575	"Family with sequence similarity 199, X-linked"	Q6PEV8	X	104166620-104195902	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003093	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA003093: AB_1078597"	"unprognostic (2.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.08e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-2)"	19.5	13.4	19.6	7.5	24.4	13.0	13.1	17.1	25.9	11.1	9.3	14.2	21.0	8.7	13.0	39.2	9.0	10.5	7.8	8.0	17.4	19.2	17.1	8.6	9.0	8.7	19.3	17.9	13.9	13.1	24.9	11.8	9.9	22.6	11.8	9.7	8.7	10.8	16.6	10.7	10.4	8.2	9.9	16.9	9.2	8.9	10.9	12.9	6.5	19.4	5.6	8.5	9.5	12.8	3.8	2.3	2.6	2.0	1.5	3.9	1.3	16.8	10.8	9.8	10.7	7.3	8.8	9.9	9.0	8.5	11.8	11.1	8.3	14.2	9.4	11.2	8.3	9.3	12.9	17.6	13.3	19.4	4.5	9.8	7.4	13.8	9.4	10.4	14.0	10.5	6.8	17.0	11.6	11.7	18.4	11.9	6.1	8.0	21.2	13.0	12.1	7.5	10.0	9.7	15.0	12.6	8.0	6.4	11.7	20.1	11.4	5.3	6.5	21.7	14.6	15.5	10.1	7.3	7.0	14.5	13.2	4.8	10.2	9.6	10.0	8.3	10.5	14.9	15.2	9.6	2.2	2.0	1.1	2.8	1.5	3.2	1.6	2.6	3.4	2.3	3.8	3.9	2.3	2.6	1.5	2.0	1.2	2.9	1.3	19.6	24.4	17.1	23.3	17.4	19.2	19.3	17.9	22.6	12.9	14.9	12.6	15.2	9.5	21.3	22.7	11.8	17.8	6.7	9.1	59.3	13.7	9.6	19.9	10.2	0.5	13.2	14.0	0.0	16.4	9.6	11.0	12.5	9.2	15.7	14.7	31.8	16.1	14.1	16.6	2.7	10.9	14.1	10.1	6.4	20.2	19.1	13.4	15.9	13.8	20.7	14.6	25.8	10.5	2.6	10.9	23.1	12.2	8.5	14.3	12.7
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297930-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038182, HPA062025"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: AB_2684663"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	31.2	17.5	30.0	18.5	31.6	40.3	28.1	18.9	37.8	24.9	26.8	20.0	19.6	17.9	27.4	29.5	26.1	19.2	19.2	29.5	25.4	21.7	25.0	24.8	21.4	22.4	23.4	25.9	26.2	21.4	19.1	31.3	19.1	30.4	21.1	21.6	19.4	21.9	20.7	36.3	17.1	18.5	34.0	31.2	24.1	20.8	39.9	20.9	19.8	26.0	21.9	23.0	32.8	18.4	27.4	32.4	36.6	35.1	17.5	27.2	28.7	21.6	9.8	16.1	22.4	16.1	17.6	9.2	17.1	32.3	24.9	22.6	11.5	20.3	15.4	10.7	18.4	11.2	18.7	13.4	17.9	22.7	24.1	16.7	12.7	10.0	10.1	24.1	33.1	18.2	12.1	22.0	18.2	38.4	20.9	21.1	19.9	13.3	18.2	20.5	12.0	20.3	30.8	11.4	9.5	8.7	17.4	31.2	11.2	22.5	11.0	10.4	16.4	11.7	11.0	25.2	8.3	17.5	24.0	14.7	13.1	12.2	11.5	26.0	13.1	11.6	22.1	25.5	35.9	13.2	29.8	31.7	36.6	21.7	34.4	22.7	27.4	24.6	19.8	32.4	20.2	21.3	24.7	17.6	17.5	35.1	23.5	27.2	28.7	30.0	31.6	18.9	37.8	25.4	21.7	23.4	25.9	30.4	20.9	56.6	51.4	57.2	54.8	49.3	36.8	71.2	50.9	53.5	47.8	41.8	68.7	32.9	114.4	58.3	206.7	61.6	25.0	46.7	98.7	40.6	62.0	51.0	65.9	40.6	54.1	31.8	40.3	59.5	64.6	82.8	70.8	79.5	57.3	48.7	48.6	54.4	77.4	58.3	65.7	92.5	54.8	25.8	71.2	217.2	170.6	44.3	25.6	57.4	45.3	52.2
FAM206A	"C9orf6, CG-8, FLJ20457, Simiate"	ENSG00000119328	"Family with sequence similarity 206 member A"	Q9NX38	9	108934181-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035917, HPA035918"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Cytokinetic bridge"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	12.0	11.4	16.8	9.0	28.8	12.9	17.8	12.3	19.2	11.6	13.3	12.8	10.3	13.8	12.6	22.9	16.0	18.9	9.9	13.3	16.2	16.0	14.1	12.6	12.0	9.9	16.7	20.0	13.7	13.7	23.3	28.5	10.6	16.0	11.9	15.1	7.6	16.9	13.5	12.2	22.9	15.1	14.4	16.6	7.5	13.0	16.7	14.8	8.4	20.9	10.2	10.6	10.5	11.7	10.6	23.6	24.4	20.7	12.4	16.1	11.9	8.7	9.4	10.3	11.3	18.3	25.5	13.8	8.9	9.6	8.3	6.9	13.9	4.8	8.5	4.9	7.9	11.4	21.2	8.2	8.7	8.3	5.2	8.6	5.2	12.8	13.1	15.3	18.6	7.3	13.4	16.4	10.1	23.3	10.7	11.3	12.6	18.2	8.9	9.8	24.5	13.3	7.5	11.6	26.4	13.8	6.6	16.7	8.9	10.8	9.7	13.2	7.2	12.8	11.2	14.0	10.2	15.2	10.1	7.4	4.6	8.5	20.6	10.5	7.2	18.7	6.3	14.9	7.4	6.8	19.9	20.6	19.0	9.9	20.6	15.2	10.6	15.8	13.1	22.6	6.9	16.1	12.1	24.4	12.4	20.7	23.6	13.0	11.9	16.8	28.8	12.3	19.2	16.2	16.0	16.7	20.0	16.0	14.8	3.0	11.8	0.0	6.0	13.5	3.6	17.7	15.3	56.2	18.2	0.0	9.8	4.9	8.3	4.9	5.5	7.1	6.5	0.0	7.9	8.4	9.1	3.9	2.3	2.9	6.9	6.4	4.1	3.7	2.7	5.5	15.8	5.9	10.1	1.8	7.2	6.0	6.4	8.4	17.3	6.5	6.9	19.4	8.5	29.5	8.8	12.2	6.1	2.2	6.3	4.8
FAM207A	"C21orf70, PRED56"	ENSG00000160256	"Family with sequence similarity 207 member A"	Q9NSI2	21	44940010-44976989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034178, HPA036354"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"CAB034178: AB_1564323, HPA036354: AB_10672242"	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (3.23e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.77e-2)"	15.5	12.4	9.3	15.3	13.1	15.6	10.0	13.1	15.3	7.6	12.3	7.7	9.2	15.8	9.3	8.4	10.2	8.3	13.9	33.0	8.2	8.0	11.0	19.5	8.2	12.1	9.9	12.4	8.1	15.9	6.4	5.8	8.1	9.5	8.8	6.0	7.2	16.5	10.5	35.5	11.4	11.8	7.5	6.7	18.3	13.3	25.2	8.0	15.3	10.0	15.3	10.7	10.9	13.1	9.7	12.3	5.5	6.2	6.0	6.5	3.0	15.1	16.5	5.7	7.2	2.9	3.9	13.6	10.5	2.9	8.0	6.5	28.0	4.8	15.6	22.9	3.7	11.9	10.2	7.8	11.5	3.4	11.3	23.6	46.3	11.3	23.5	11.3	14.9	6.0	6.7	6.8	7.3	6.8	3.6	8.6	13.6	26.1	11.1	6.3	26.8	14.1	23.6	19.2	11.6	23.7	13.9	6.0	26.9	7.7	6.0	27.8	11.8	13.9	16.7	15.8	4.6	11.6	10.8	11.4	6.8	14.1	9.1	22.5	23.3	20.1	15.2	5.4	25.8	9.4	4.3	5.6	5.5	2.8	5.8	2.6	9.7	4.8	6.5	5.4	6.2	5.1	5.2	3.7	6.0	6.2	12.3	5.1	3.0	9.3	13.1	13.1	15.3	8.2	8.0	9.9	12.4	9.5	8.0	0.0	6.9	21.6	29.4	17.1	23.3	22.6	25.5	8.1	7.9	17.4	3.9	32.0	39.7	62.9	11.9	15.5	66.7	0.0	54.6	58.5	15.5	30.5	10.3	49.9	60.6	6.4	25.3	28.8	31.1	29.3	13.6	20.3	23.6	61.3	28.2	18.8	52.7	31.7	12.0	73.8	13.3	32.3	34.0	50.5	37.3	18.3	25.7	20.0	35.4	31.1
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.3	6.5	0.2	9.3	11.9	19.7	0.0	11.9	20.2	6.5	5.2	0.7	8.2	0.0	6.6	17.8	8.8	11.6	1.0	0.5	1.6	2.8	0.6	0.0	3.1	3.5	9.0	0.0	0.9	50.3	1.5	0.2	0.7	39.1	4.5	0.0	0.0	0.1	1.7	1.8	0.0	0.7	6.3	0.1	0.4	1.5	0.3	0.0	4.8	0.0	3.1	0.1	12.4	0.0	1.8	1.2	8.8	6.1	12.5	8.1	4.0	6.9	3.6	0.0	0.0	0.0	31.0	0.8	23.1	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8	6.0	3.2	2.4	1.9	9.0	20.6	8.1	33.1	5.3	0.0	52.4	0.0	0.5	5.0	1.3	0.0	2.4	3.5	0.0	4.1	0.6	13.5	6.8	3.5	80.0	49.0	1.6	11.3	9.8	15.6	1.1	15.0	14.7	1.7	11.8	4.2	16.6	6.5	3.5	53.0	46.8	8.0	12.9	15.3	0.2	0.7	7.0	0.5	0.0	7.3	1.4
FAM210A	"C18orf19, HsT2329, MGC24180"	ENSG00000177150	"Family with sequence similarity 210 member A"	Q96ND0	18	13663347-13726663	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014324, HPA051564"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		NA	NA			"Nucleoplasm, Golgi apparatus, Mitochondria"		"HPA014324: AB_2668972, HPA051564: AB_2681536"	"unprognostic (1.32e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.18e-3)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.23e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.79e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.27e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.82e-2)"	10.5	8.1	7.5	8.9	7.1	4.0	9.4	8.3	8.8	5.8	9.9	7.2	5.8	11.5	6.6	4.4	13.5	5.7	5.4	27.5	6.4	7.8	12.0	17.6	5.6	7.4	7.4	6.4	8.7	5.6	7.8	7.5	9.3	8.2	7.1	8.5	6.5	7.0	7.6	27.9	5.6	10.9	8.2	9.1	6.4	6.1	10.2	7.3	5.9	8.4	16.3	8.9	14.7	7.9	9.2	8.6	4.3	10.7	7.6	9.7	5.0	12.2	7.0	4.9	4.6	5.8	6.1	7.2	8.5	7.9	9.6	11.2	9.4	6.0	12.7	10.7	6.0	17.8	6.0	9.4	10.6	15.7	8.7	4.4	8.9	5.1	6.8	6.9	15.1	8.4	5.2	8.4	9.2	32.6	6.7	6.1	7.7	12.0	7.0	11.1	8.4	9.3	9.8	5.5	24.1	7.0	7.6	11.7	14.7	7.9	7.8	3.2	5.5	7.4	11.0	20.3	7.4	5.8	7.2	6.7	24.7	24.2	15.2	10.4	7.9	9.8	14.7	13.1	7.9	9.8	3.4	7.0	4.3	8.9	10.7	9.7	8.1	7.6	7.7	8.6	9.2	9.6	9.0	1.2	7.6	5.3	5.6	7.2	5.0	7.5	7.1	8.3	8.8	6.4	7.8	7.4	6.4	8.2	7.3	8.9	8.8	20.4	10.4	49.1	53.0	60.1	5.1	1.4	11.4	7.0	19.6	19.1	18.3	16.3	6.1	15.8	11.7	0.0	7.8	31.2	17.4	9.1	6.9	19.0	18.1	28.6	10.9	5.5	8.4	3.1	8.6	16.6	8.5	11.8	8.4	17.4	10.7	0.0	9.6	21.9	29.7	6.5	16.0	27.0	29.8	50.1	21.5	11.4	17.7	10.4
FAM210B	"C20orf108, dJ1167H4.1, DKFZP434A1114"	ENSG00000124098	"Family with sequence similarity 210 member B"	Q96KR6	20	56358915-56368663	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 233.6;Peritubular cells: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042652	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA042652: AB_2678098"	"unprognostic (3.29e-1)"	"prognostic favorable (5.44e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.34e-2)"	"unprognostic (9.45e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (1.44e-10)"	"unprognostic (1.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.00e-1)"	19.8	47.7	13.2	9.3	22.8	30.5	29.0	13.4	12.3	23.4	18.1	10.9	24.0	10.7	22.3	24.7	24.4	18.5	29.5	48.1	13.0	12.9	15.2	43.2	16.3	11.8	15.2	9.3	50.5	21.8	13.1	15.1	17.6	13.7	30.9	13.8	21.4	29.0	33.5	54.2	17.5	15.0	19.9	11.1	12.2	16.3	11.1	9.7	5.9	19.8	25.7	12.3	22.8	30.9	1.9	2.8	10.3	5.6	2.2	4.0	1.5	4.8	1.9	7.5	18.2	21.7	24.6	14.6	6.0	13.4	10.9	12.6	3.4	2.4	0.4	3.1	10.2	6.3	14.1	4.0	17.2	18.4	0.7	6.3	3.0	4.4	32.5	14.3	0.3	1.9	21.0	19.3	6.2	8.8	12.7	17.5	2.6	22.5	3.2	13.3	5.0	2.5	1.3	6.3	7.1	11.8	0.0	15.5	3.8	5.6	5.7	10.4	18.7	14.5	31.7	73.1	16.7	14.0	2.7	12.1	9.8	6.5	15.6	3.6	2.5	2.6	0.1	7.8	1.9	6.3	3.3	3.8	10.3	2.9	5.6	2.2	1.9	3.4	4.0	2.8	1.8	3.6	3.4	1.7	2.2	2.4	2.4	3.7	1.5	13.2	22.8	13.4	12.3	13.0	12.9	15.2	9.3	13.7	9.7	14.9	21.1	2.2	74.0	22.0	7.6	52.5	68.8	1.4	14.8	15.7	37.3	61.4	54.7	24.7	0.6	24.8	25.3	233.6	16.9	19.6	25.7	58.3	19.5	106.8	25.0	1.6	48.9	44.2	41.8	2.6	61.9	18.3	35.4	32.5	26.7	25.1	32.5	7.0	146.3	38.9	16.9	19.4	28.4	1.2	10.4	28.4	35.0	13.1	32.1	44.8
FAM212A	"C3orf54, INKA1"	ENSG00000185614	"Family with sequence similarity 212 member A"	Q96EL1	3	49803254-49805030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 25.8;skin 1: 30.0"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 22.2;granulocytes: 19.8;Hofbauer cells: 41.3;Ito cells: 39.3;Suprabasal keratinocytes: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 19.0;memory B-cell: 25.8;naive B-cell: 23.4"	"Group enriched"	"Detected in many"	6	"B-cells: 25.8;granulocytes: 19.0"	"Cell line enhanced"	"Detected in many"		"HEL: 31.9;HMC-1: 21.9;NB-4: 17.7;THP-1: 19.7;U-937: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041879	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA041879: AB_10797269"	"unprognostic (1.36e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.96e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.40e-2)"	6.0	4.1	5.8	3.2	4.7	5.0	3.5	8.0	6.3	6.8	2.6	4.9	1.4	1.7	5.5	2.8	16.3	2.9	4.8	7.6	4.4	4.3	3.4	1.2	7.3	5.9	6.3	4.8	3.6	2.3	0.8	2.0	5.2	5.6	5.4	1.4	3.2	4.5	3.9	15.3	30.0	3.5	5.3	8.3	6.9	2.2	2.4	4.3	1.8	1.9	10.4	8.4	4.8	8.5	25.8	3.6	19.0	2.9	0.0	1.5	2.8	0.6	0.5	0.7	0.5	0.9	2.0	0.0	1.4	0.9	0.7	0.8	0.0	0.0	6.9	0.2	1.0	0.7	4.1	0.2	4.9	0.0	1.2	0.0	31.9	0.3	0.1	1.3	4.8	21.9	2.7	7.0	1.4	1.3	0.4	2.9	0.5	2.1	0.6	0.6	0.3	0.4	17.7	0.5	0.0	2.8	6.5	0.4	1.5	0.0	7.9	0.3	2.5	1.3	0.2	0.7	0.2	0.1	19.7	1.8	3.6	0.4	1.6	0.6	0.8	0.7	0.5	1.5	16.4	0.8	19.0	0.9	4.3	0.6	2.2	0.1	25.8	0.6	0.7	0.2	23.4	0.9	1.5	0.5	0.0	2.9	3.6	0.6	2.8	5.8	4.7	8.0	6.3	4.4	4.3	6.3	4.8	5.6	4.3	3.0	1.1	0.0	11.6	22.2	1.0	0.0	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.0	1.6	7.5	0.0	0.0	0.0	0.4	7.5	1.1	19.8	0.0	41.3	0.0	0.0	39.3	2.2	7.4	1.7	0.0	11.8	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.4	12.9	0.5	1.7	3.2	24.1	0.9	0.0	0.0	4.7
FAM212B	"C1orf183, FLJ31105, INKA2"	ENSG00000197852	"Family with sequence similarity 212 member B"	Q9NTI7	1	111680630-111739424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"Hofbauer cells: 3.6"	"Cancer enhanced"	"Detected in many"		"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	13	"neutrophil: 19.2"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.2;U-87 MG: 37.5;WM-115: 14.2"									"HPA027809, HPA027810, HPA027811"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872"	"unprognostic (1.92e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.81e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (9.96e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.50e-3)"	"unprognostic (9.92e-5)"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.07e-2)"	12.1	1.4	14.9	4.6	11.5	4.0	8.6	5.5	22.4	2.6	3.7	2.9	1.5	1.8	4.9	1.8	11.1	7.9	4.7	12.9	13.1	3.5	3.9	1.4	6.9	2.4	4.8	13.4	3.2	1.7	4.5	0.9	9.4	3.9	4.6	3.3	1.8	2.7	6.3	8.3	8.8	2.9	8.1	3.9	6.3	4.9	4.3	3.7	0.5	3.8	3.5	2.9	3.1	3.9	0.4	0.8	19.2	1.4	0.0	0.0	0.4	1.2	1.1	2.1	1.6	10.7	3.8	0.9	0.9	2.0	1.7	4.0	2.1	0.0	0.9	0.4	0.8	0.8	1.1	1.1	2.4	1.5	2.3	1.1	7.4	0.7	1.9	3.6	0.3	1.2	2.6	10.7	18.2	0.8	0.4	4.5	1.1	0.0	1.7	2.0	1.1	0.4	0.3	0.3	0.9	1.0	1.1	9.9	0.3	0.5	1.7	5.6	1.6	0.5	0.0	4.9	2.3	1.4	1.2	1.7	3.8	6.0	2.0	0.7	10.8	1.9	0.9	37.5	1.8	14.2	0.0	1.3	1.0	0.0	1.1	0.0	0.2	0.0	0.0	0.8	0.4	0.0	0.0	19.2	0.0	1.4	0.3	0.0	0.4	14.9	11.5	5.5	22.4	13.1	3.5	4.8	13.4	3.9	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
FAM213B	"C1orf93, MGC26818"	ENSG00000157870	"Family with sequence similarity 213 member B"	Q8TBF2	1	2586491-2591469	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 26.7;U-2197: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006403	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA006403: AB_1853870"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.76e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (5.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.20e-2)"	6.0	9.1	14.7	5.7	14.9	3.8	4.6	7.4	20.0	7.9	15.4	6.2	5.2	22.0	4.5	6.7	5.7	10.5	23.7	3.2	15.0	15.5	7.4	3.5	6.0	5.8	11.7	11.0	7.1	4.6	4.4	4.3	8.4	10.7	5.7	7.4	9.0	5.3	7.7	1.8	6.1	20.2	4.8	6.5	7.4	11.7	3.3	4.7	5.4	5.2	0.9	5.2	6.3	3.5	2.1	2.2	1.5	2.3	7.5	6.3	3.2	7.7	4.3	4.4	4.8	2.1	2.4	0.6	7.0	2.9	6.6	2.9	3.1	9.1	2.0	7.1	4.5	2.7	6.5	3.9	4.9	2.2	5.8	2.0	4.8	3.3	4.9	5.1	2.7	1.4	3.5	2.5	4.6	1.7	3.1	9.3	3.6	6.5	3.1	6.6	5.6	6.3	1.2	5.3	9.0	16.6	6.9	6.5	5.1	6.9	3.9	5.9	9.8	6.0	26.7	8.0	1.1	4.6	1.0	13.5	5.8	6.7	22.9	2.6	2.9	4.3	1.4	5.4	9.2	1.1	1.5	2.0	1.1	3.8	2.3	6.3	2.1	4.2	4.1	2.2	1.5	3.5	5.4	1.5	7.5	2.0	1.0	5.6	3.2	14.7	14.9	7.4	20.0	15.0	15.5	11.7	11.0	10.7	4.7	3.0	1.7	3.9	4.5	3.7	11.0	4.5	12.7	10.7	6.8	33.2	0.0	0.4	6.6	24.6	0.6	11.6	37.6	0.0	8.8	0.4	4.0	3.7	0.0	2.6	8.0	22.3	15.1	12.3	4.9	1.1	4.9	7.6	6.8	8.2	25.7	6.0	31.4	38.2	3.9	11.8	5.2	19.4	8.1	0.9	11.1	4.5	0.6	6.9	32.8	7.0
FAM214A	"FLJ10980, KIAA1370"	ENSG00000047346	"Family with sequence similarity 214 member A"	Q32MH5	15	52581317-52709817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 27.1;U-698: 30.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039369, HPA040180"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039369: AB_10795250, HPA040180: AB_10794736"	"unprognostic (1.75e-1)"	"unprognostic (6.40e-2)"	"unprognostic (4.54e-1)"	"prognostic favorable (7.27e-6)"	"unprognostic (1.08e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.32e-3)"	"prognostic favorable (8.68e-4)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.94e-3)"	21.7	17.1	11.6	15.3	16.2	12.1	18.8	41.3	18.5	11.9	12.0	8.7	32.0	8.8	12.7	6.7	21.1	10.9	8.8	10.5	11.6	5.6	7.7	24.5	9.9	14.5	14.0	14.1	10.4	16.8	24.4	26.0	6.5	11.9	10.1	10.9	9.4	17.3	27.9	47.7	11.9	14.2	13.9	7.1	11.9	12.9	14.9	16.1	12.1	16.4	13.4	18.9	16.4	17.7	7.7	10.0	6.1	0.7	5.4	5.3	1.4	2.4	3.2	3.4	5.8	10.4	6.3	3.9	6.0	10.5	3.2	4.2	1.8	2.6	16.6	7.3	5.6	1.5	4.9	2.4	5.5	2.9	13.3	3.4	4.2	7.2	1.5	3.6	2.0	2.2	14.8	8.9	3.2	3.5	6.1	10.6	5.2	2.4	17.6	4.5	9.5	3.1	5.1	0.6	4.1	3.9	7.6	3.5	12.6	5.3	11.3	3.8	6.7	6.0	11.4	4.5	10.8	17.8	4.4	7.8	3.3	1.0	3.6	1.3	27.1	16.2	30.5	5.6	2.7	1.1	0.8	0.7	6.1	4.7	0.2	5.0	7.7	3.4	3.1	0.9	6.9	3.9	3.6	4.5	5.4	0.3	10.0	5.3	1.4	11.6	16.2	41.3	18.5	11.6	5.6	14.0	14.1	11.9	16.1	41.7	21.9	37.7	12.6	14.4	19.7	22.9	28.1	41.5	25.0	3.5	58.9	2.5	3.3	8.4	2.0	16.5	14.4	0.0	12.8	2.2	16.0	25.3	3.5	34.2	6.1	25.4	27.9	26.4	12.6	2.1	26.2	9.4	25.3	2.8	23.5	29.0	13.2	14.1	30.1	5.6	26.4	12.9	14.1	26.0	8.5	12.5	16.9	27.7	11.5	22.8
FAM214B	"bA182N22.6, FLJ11560, KIAA1539"	ENSG00000005238	"Family with sequence similarity 214 member B"	Q7L5A3	9	35104112-35116341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.4;granulocytes: 14.6;monocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"TIME: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048831, HPA055751"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA048831: AB_2680535, HPA055751: AB_2682906"	"unprognostic (2.91e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.15e-2)"	13.0	10.3	14.1	12.4	14.9	35.0	6.7	10.4	18.9	7.3	12.0	25.9	10.7	10.9	7.7	7.9	22.4	6.1	12.5	16.5	15.4	14.4	12.5	7.7	13.6	7.4	17.0	11.4	7.5	5.6	10.4	10.9	26.3	20.8	8.6	11.5	9.3	8.6	11.1	8.9	10.9	10.6	11.8	20.5	19.1	10.7	5.8	8.4	3.7	9.1	12.2	12.0	10.4	8.8	0.5	4.4	14.6	8.5	1.7	2.1	2.5	2.9	2.4	6.7	4.8	5.3	8.2	1.4	14.4	13.0	8.0	5.2	1.6	2.0	0.7	4.3	23.2	21.1	1.3	1.1	4.6	5.2	3.7	0.3	3.7	5.2	1.5	5.4	0.9	15.9	5.8	8.3	9.4	6.0	18.7	15.4	3.7	1.9	2.9	16.7	0.8	1.4	4.4	1.2	2.1	3.6	1.6	1.1	0.8	10.5	0.6	0.4	4.4	2.3	1.6	7.7	7.4	2.1	2.4	26.2	11.3	5.5	5.4	5.2	1.9	1.8	0.3	17.8	1.8	12.5	4.7	5.2	4.7	2.1	6.9	0.7	0.5	1.3	1.4	4.4	0.2	0.5	0.9	14.6	1.7	8.5	1.1	0.7	2.5	14.1	14.9	10.4	18.9	15.4	14.4	17.0	11.4	20.8	8.4	0.0	4.6	1.4	4.6	7.4	3.1	6.5	0.0	0.0	3.4	15.7	13.7	2.3	3.3	9.4	9.8	8.6	21.3	0.0	11.1	7.9	7.4	8.1	8.1	5.4	14.1	0.0	5.2	20.3	27.6	49.2	3.1	21.0	15.1	16.2	9.0	8.4	25.8	14.2	7.4	9.0	3.3	6.5	7.2	3.1	5.4	12.7	3.5	4.8	7.6	6.0
FAM216A	"C12orf24, HSU79274"	ENSG00000204856	"Family with sequence similarity 216 member A"	Q8WUB2	12	110468364-110490385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.9"	"Cell type enriched"	"Detected in many"	6	"Spermatocytes: 244.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038286	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA038286: AB_2675931"	"unprognostic (7.91e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (4.18e-10)"	"unprognostic (7.60e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.05e-1)"	3.3	6.6	8.6	6.1	11.7	3.7	3.9	15.8	19.7	4.6	2.5	3.8	0.7	1.8	4.9	1.5	2.6	3.9	4.2	7.0	11.6	13.0	3.0	3.2	2.1	6.3	8.3	11.9	6.5	2.3	4.4	4.0	3.7	12.5	4.1	2.5	1.2	2.2	5.1	6.0	1.9	2.3	5.6	6.6	4.3	2.2	43.9	6.2	5.0	3.0	1.4	4.4	3.8	2.5	9.9	5.5	3.2	4.9	2.5	12.3	5.4	8.0	7.0	5.1	6.6	3.8	7.0	1.3	14.3	3.9	16.5	7.6	6.9	2.3	29.2	3.8	6.6	4.3	5.9	9.5	8.6	18.8	9.3	23.0	15.0	4.4	5.0	5.6	17.8	11.8	6.4	2.2	8.4	18.5	9.9	5.5	12.6	16.0	7.6	10.9	2.7	14.3	22.9	17.6	3.2	13.0	7.2	7.7	20.5	5.8	0.1	25.3	8.3	7.0	4.4	3.5	1.6	11.6	10.4	4.8	5.5	2.4	4.8	13.8	14.1	10.2	22.8	9.0	16.6	10.1	1.4	4.9	1.9	3.1	3.3	4.4	9.2	4.8	5.0	5.5	9.9	12.3	7.3	3.2	2.5	3.1	2.9	3.3	5.4	8.6	11.7	15.8	19.7	11.6	13.0	8.3	11.9	12.5	6.2	0.0	1.0	8.5	4.7	1.4	10.2	15.3	0.0	5.3	4.5	3.5	2.0	0.6	0.0	3.2	29.5	5.8	0.0	0.0	0.8	1.9	5.1	1.6	10.3	3.9	6.7	12.7	1.2	4.9	4.5	44.3	8.9	2.1	3.3	1.8	0.0	4.6	2.5	0.0	5.3	2.9	4.1	12.9	5.1	244.4	20.0	1.8	0.5	3.2	0.2	1.3
FAM219A	"bA573M23.5, C9orf25, FLJ39031"	ENSG00000164970	"Family with sequence similarity 219 member A"	Q8IW50	9	34398184-34458570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.9"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019338, HPA052909"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA019338: AB_1845819, HPA052909: AB_2681986"	"unprognostic (9.96e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (3.46e-3)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.76e-1)"	13.6	10.3	27.8	10.9	27.0	4.9	7.1	26.3	56.9	7.5	6.3	23.3	3.7	7.2	13.2	8.6	6.3	6.5	7.6	17.5	25.4	27.6	6.1	5.0	11.0	7.8	30.8	31.0	10.7	8.4	9.4	10.6	16.3	34.0	9.2	6.6	5.4	7.1	9.7	28.6	12.3	6.7	15.0	25.2	9.8	7.2	6.9	25.6	2.9	7.2	4.0	6.6	6.5	6.4	0.5	0.6	3.8	0.7	0.7	1.5	0.3	12.6	4.9	11.6	6.6	10.8	4.1	11.3	7.7	5.8	6.7	8.5	3.4	2.9	2.8	8.0	7.4	13.3	5.3	9.2	4.9	6.7	43.6	5.2	1.1	6.3	3.6	6.1	2.7	6.5	4.3	5.0	10.0	5.6	8.3	11.0	5.0	2.7	14.0	5.2	2.5	4.2	3.8	7.5	1.7	7.3	5.5	1.9	2.4	4.8	2.7	3.7	11.8	6.6	4.8	3.8	11.1	2.4	2.8	13.0	7.4	5.8	15.3	10.6	3.7	5.3	2.4	21.2	6.4	13.0	2.3	0.6	3.8	1.5	0.4	0.8	0.5	0.8	0.4	0.5	0.4	0.6	0.8	2.0	0.7	0.7	0.6	1.4	0.3	27.8	27.0	26.3	40.8	25.4	27.6	30.8	31.0	34.0	25.6	6.0	3.5	2.2	2.9	5.6	18.4	10.5	0.0	1.4	1.2	3.5	3.9	8.2	0.0	5.2	12.0	14.3	0.9	0.0	4.2	12.1	5.6	5.6	2.3	2.4	5.2	50.9	10.4	5.5	4.6	25.8	3.4	2.3	8.5	3.6	1.6	8.5	5.6	1.4	5.3	2.1	10.5	6.5	8.2	10.3	2.4	5.6	17.3	4.4	0.8	2.6
FAM219B	"C15orf17, FLJ00005"	ENSG00000178761	"Family with sequence similarity 219 member B"	Q5XKK7	15	74899987-74907121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048929, HPA058064"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA048929: AB_2680561, HPA058064: AB_2683592"	"unprognostic (1.12e-1)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.11e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.91e-3)"	16.5	14.4	12.5	10.0	16.5	5.9	28.7	18.5	20.0	11.3	11.6	10.1	10.3	11.2	11.1	22.9	16.6	14.6	12.1	22.7	13.0	13.6	11.7	4.7	13.4	10.6	13.8	12.5	13.0	11.0	22.3	21.5	9.1	15.1	18.6	9.8	13.8	15.9	13.7	12.0	18.1	10.1	12.8	10.2	18.2	11.2	5.2	11.0	4.4	13.7	8.1	11.8	16.8	11.2	3.7	1.4	6.9	1.5	2.1	3.7	1.1	2.5	5.7	11.1	5.4	15.9	9.9	5.8	8.1	4.1	6.8	5.2	2.3	6.4	7.2	5.3	5.2	4.5	9.1	12.1	4.9	3.7	13.8	12.3	2.9	9.8	1.3	5.9	4.2	7.7	5.6	16.6	2.6	6.4	11.6	5.5	5.3	4.4	5.7	6.5	0.6	3.9	5.3	6.5	6.5	10.0	9.5	3.6	4.0	13.0	5.6	9.7	5.1	7.2	6.3	10.9	6.9	10.0	2.8	10.9	4.6	4.1	3.8	6.4	6.6	4.8	3.5	6.9	10.5	5.2	3.8	1.0	6.9	2.2	1.4	3.7	3.7	2.8	0.9	1.4	2.9	2.3	1.8	2.4	2.1	1.5	0.3	0.3	1.1	12.5	16.5	18.5	20.0	13.0	13.6	13.8	12.5	15.1	11.0	17.9	12.7	13.7	18.7	5.7	40.0	4.0	15.3	14.7	13.6	26.2	55.0	13.3	11.6	12.9	0.7	15.5	16.7	0.0	9.1	9.6	14.2	19.3	24.3	4.7	15.0	22.3	20.1	16.0	10.7	3.2	21.6	14.3	13.5	19.8	16.8	24.9	12.7	14.4	26.9	9.8	65.3	25.8	18.1	7.9	18.5	6.8	7.0	16.6	15.2	19.0
FAM220A	"ACPIN1, C7orf70, MGC12966, SIPAR"	ENSG00000178397	"Family with sequence similarity 220 member A"	Q7Z4H9	7	6329409-6348981	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.7;testis: 40.9"	"Group enriched"	"Detected in many"	14	"Early spermatids: 230.4;Late spermatids: 278.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055050			Approved	Vesicles		NA	NA			Vesicles		"HPA055050: AB_2682684"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (3.71e-2)"	5.8	6.9	10.5	5.1	9.3	2.3	7.7	14.0	16.6	7.5	6.1	6.8	3.8	4.3	8.1	6.1	8.9	6.2	5.9	12.6	10.3	9.7	6.5	5.1	4.9	6.8	8.3	11.6	8.7	10.5	15.3	7.2	6.0	7.9	6.6	4.4	5.6	7.2	6.9	56.7	7.7	4.6	7.3	7.9	5.8	5.3	40.9	5.4	9.7	9.1	11.8	7.7	7.5	6.3	11.1	9.6	9.5	5.5	16.2	10.2	3.8	15.9	10.1	7.4	17.3	17.2	14.6	8.2	8.2	10.2	9.9	11.7	6.7	8.9	13.3	9.5	9.7	19.9	11.8	11.2	6.9	13.0	9.2	7.2	4.4	8.1	7.5	18.7	8.0	6.7	8.1	23.4	7.4	18.0	9.6	9.2	10.1	8.6	12.8	8.5	12.5	4.9	14.7	17.3	8.4	13.2	12.8	11.1	11.1	9.1	5.8	7.6	13.1	11.5	14.2	17.1	15.6	13.6	21.0	6.9	7.9	18.1	15.3	10.4	13.8	21.3	14.5	9.2	14.5	24.1	6.7	5.5	9.5	5.5	4.5	5.7	11.1	6.6	8.5	9.6	10.6	10.2	8.4	2.4	16.2	4.7	7.7	8.3	3.8	10.5	9.3	14.0	16.6	10.3	9.7	8.3	11.6	7.9	5.4	3.0	1.4	4.4	4.7	6.9	2.7	8.5	0.0	1.4	9.1	1.8	5.9	5.4	1.7	4.8	230.4	3.3	2.5	0.0	4.1	6.2	5.2	3.7	1.1	3.4	5.7	0.0	5.8	5.5	5.9	278.7	7.8	5.7	3.3	6.4	4.0	3.7	5.0	2.3	12.4	2.2	1.8	0.0	4.2	17.9	10.4	8.8	6.9	3.3	3.2	5.9
FAM221A	"C7orf46, DKFZp686F0810, FLJ45875, MGC72075"	ENSG00000188732	"Family with sequence similarity 221 member A"	A4D161	7	23680130-23703249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 46.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.6;GAMG: 15.8;MOLT-4: 15.0;SCLC-21H: 14.1;SH-SY5Y: 24.0"	"Low region specificity"	"Detected in many"							"HPA019719, HPA026748, HPA026752"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.42e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.81e-2)"	3.9	4.8	12.8	3.8	19.7	2.1	5.7	12.9	12.3	5.0	8.2	25.1	2.9	12.0	3.5	5.1	8.7	12.1	6.8	4.0	15.9	13.4	8.4	10.0	5.5	4.3	30.0	10.3	4.5	25.2	3.8	4.5	2.3	17.2	4.7	11.0	27.8	8.7	9.2	2.1	4.7	8.9	3.2	24.6	2.3	14.6	22.9	24.3	2.1	7.7	1.4	6.2	4.2	3.1	6.9	5.3	3.8	5.2	6.8	11.4	3.7	0.0	0.3	6.7	5.5	0.2	0.0	3.1	0.2	0.5	0.8	1.0	6.8	3.0	0.7	11.6	0.1	15.8	1.3	0.0	0.0	1.3	0.0	9.0	1.8	0.6	0.0	1.8	0.0	10.0	0.4	0.4	0.1	0.0	1.4	2.1	6.8	0.0	0.0	0.2	3.1	15.0	0.0	0.0	0.0	3.3	6.2	0.6	0.0	3.7	3.0	14.1	24.0	1.0	0.0	0.0	1.6	3.0	4.3	0.3	0.0	2.4	1.3	0.6	0.0	0.0	0.0	0.6	0.0	1.1	0.0	3.0	3.8	5.4	1.9	11.0	6.9	9.0	6.5	5.3	6.0	10.6	5.7	0.1	6.8	5.2	4.3	11.4	3.7	12.8	19.7	12.9	12.3	15.9	13.4	30.0	10.3	17.2	24.3	14.9	7.4	3.9	8.6	14.3	7.0	4.4	12.7	46.8	20.5	7.0	2.0	3.0	8.3	11.6	6.8	7.1	7.7	0.0	9.3	0.2	5.0	10.3	4.7	13.1	5.7	6.4	14.3	3.7	3.7	8.2	4.4	7.7	8.5	0.0	21.7	7.3	11.7	18.7	3.5	10.3	8.0	19.4	6.1	26.5	25.7	16.6	0.7	4.4	17.1	9.5
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109714228-109770507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.9"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 31.4;Early spermatids: 23.4;Horizontal cells: 73.1;Rod photoreceptor cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA058774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites, Mitochondria"	"HPA040181: AB_10796448, HPA058774: "	"unprognostic (8.59e-3)"	"prognostic favorable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	1.8	16.0	7.3	2.3	17.4	2.0	3.0	15.1	25.5	1.6	3.3	37.9	0.0	10.0	1.5	2.7	2.1	1.4	2.6	4.4	11.7	9.6	7.7	2.7	1.8	1.7	23.2	7.9	7.8	6.9	1.5	13.1	1.3	15.1	2.3	3.0	10.3	7.3	2.1	2.8	4.7	5.1	1.8	27.8	6.3	8.0	17.4	23.0	0.0	1.4	0.0	2.1	1.4	2.4	0.2	0.6	0.9	0.2	0.0	0.2	0.0	0.9	1.3	0.7	1.6	0.4	0.0	0.5	0.2	0.1	0.7	0.1	12.0	0.2	0.1	1.0	0.3	0.7	0.5	0.8	0.0	0.2	7.7	1.8	1.5	0.4	2.7	0.1	1.1	1.6	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.5	0.2	0.1	4.8	0.3	1.5	1.3	1.4	2.4	1.0	3.5	0.5	1.5	0.6	8.5	51.4	1.1	1.6	3.4	0.2	1.9	1.3	0.1	0.2	1.4	0.6	1.0	1.3	1.7	1.0	0.1	0.8	1.7	0.0	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	7.3	17.4	15.1	13.7	11.7	9.6	23.2	7.9	15.1	23.0	0.0	0.0	0.5	0.6	1.9	21.6	6.1	2.5	0.0	0.0	1.8	31.4	0.1	6.6	1.4	23.4	0.8	0.6	0.0	0.7	0.1	1.7	1.4	0.0	1.3	0.3	73.1	7.5	0.0	0.0	11.0	1.1	0.3	6.8	0.0	4.1	10.0	0.8	0.0	0.4	0.6	48.4	0.0	1.4	0.7	2.6	1.6	0.7	0.0	0.8	0.2
FAM227B	"C15orf33, FLJ32800"	ENSG00000166262	"Family with sequence similarity 227 member B"	Q96M60	15	49326962-49620931	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 25.4;Early spermatids: 25.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA049774, HPA061695"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049774: AB_2680873, HPA061695: AB_2684588"	"unprognostic (1.19e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.57e-3)"	"unprognostic (6.32e-3)"	"unprognostic (6.41e-2)"	"unprognostic (7.48e-5)"	"unprognostic (2.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.76e-1)"	1.9	7.6	8.0	6.4	8.4	1.8	9.1	2.4	6.7	10.5	6.5	11.6	10.6	3.8	9.0	10.5	4.8	11.0	5.3	11.5	7.8	7.2	10.9	9.7	4.9	7.6	9.8	7.1	13.9	8.6	9.0	28.4	1.8	6.6	8.1	3.9	6.7	7.2	8.7	10.8	5.2	4.0	11.3	9.5	3.7	4.5	19.0	8.1	12.1	10.1	5.2	5.6	8.6	4.0	5.5	4.7	7.8	0.9	3.3	8.2	2.6	0.9	0.9	5.9	3.2	1.8	3.5	0.7	2.4	3.4	3.7	6.0	0.8	2.8	1.7	5.7	3.9	4.3	0.9	2.1	3.5	4.4	3.9	1.7	3.7	1.5	1.8	5.0	1.6	1.6	3.7	4.7	2.2	2.3	7.2	3.4	8.6	5.8	2.7	8.1	3.8	3.4	1.4	2.6	1.3	1.5	3.0	5.0	8.8	5.5	1.1	4.5	6.1	2.2	2.9	6.7	4.9	3.5	1.3	2.4	2.5	2.1	3.4	1.4	14.0	11.4	5.3	2.9	4.4	2.7	7.8	0.3	2.4	4.9	0.7	6.4	4.0	4.9	6.4	0.5	5.5	8.2	7.8	0.6	3.3	0.9	4.7	4.2	2.6	8.0	8.4	2.4	6.7	7.8	7.2	9.8	7.1	6.6	8.1	8.9	4.5	2.0	4.7	2.5	4.5	9.1	2.5	25.4	13.6	3.5	0.0	1.6	21.6	3.2	25.3	1.6	1.2	0.0	2.9	1.1	3.2	4.0	3.5	4.3	0.5	4.8	8.1	0.6	0.3	19.0	3.7	1.1	3.3	0.0	2.2	10.5	2.7	0.9	2.8	9.1	5.9	0.0	1.9	18.5	12.9	3.8	0.3	4.3	2.3	2.0
FAM228B		ENSG00000219626	"Family with sequence similarity 228 member B"		2	24076526-24169640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 82.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 15.8"									"HPA052598, HPA063357"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA052598: AB_2681880, HPA063357: AB_2684994"	"unprognostic (2.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.39e-5)"	"unprognostic (5.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.15e-1)"	"unprognostic (6.93e-2)"	7.0	6.8	6.7	2.2	7.5	3.6	6.0	6.7	6.8	4.3	2.1	10.1	4.2	0.4	6.4	12.4	3.1	6.7	5.3	8.3	6.9		3.8	1.9	3.7	2.3	9.2	6.8	9.4	1.6	7.0	9.0	3.5	7.0	6.4	2.2	5.8	4.1	7.9	7.0	1.3	1.2	6.1	6.0	4.2	2.2	11.5	8.5	0.7	3.8	2.0	2.5	3.0	2.0	9.3	12.4	11.8	6.4	5.2	7.9	4.3	2.1	1.5	3.1	11.7	8.2	10.7	0.3	5.1	4.9	1.9	1.3	0.1	1.3	2.6	2.6	3.9	3.8	0.1	0.7	0.6	1.8	3.9	5.0	3.2	0.4	0.6	15.8	1.5	0.8	9.9	5.5	0.9	7.8	12.9	4.0	2.4	0.3	3.4	2.5	3.3	0.5	7.5	1.0	0.2	4.4	2.5	1.3	1.1	5.6	2.1	1.1	8.3	1.6	0.0	8.9	5.1	3.0	7.5	4.2	3.5	0.3	0.7	1.6	5.6	1.6	3.0	7.7	5.7	2.4	10.0	6.4	11.8	7.1	4.3	3.7	9.3	5.0	5.6	7.6	5.9	7.4	7.9	5.3	5.2	4.1	12.4	4.8	4.3											47.6	33.6	5.9	9.8	5.7	26.6	19.0	7.6	58.9	56.9	14.0	7.9	8.7	26.6	4.3	76.0	15.5	1.6	23.3	4.8	3.1	22.1	4.8	24.4	2.4	9.2	35.0	9.2	18.4	10.5	82.4	39.1	20.7	10.1	14.4	2.2	32.4	3.3	0.0	36.0	9.1	25.0	51.8	28.1	36.1	8.2	6.5	2.7	8.3	3.2	3.9
FAM229B	"C6orf225, DKFZp586F0922, LOC619208"	ENSG00000203778	"Family with sequence similarity 229 member B"	Q4G0N7	6	112087599-112102790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 118.9"	"Group enriched"	"Detected in many"	10	"Early spermatids: 2880.3;Late spermatids: 5153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036068			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA036068: AB_10673495"	"unprognostic (1.65e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (3.74e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	4.7	7.4	18.4	2.1	16.8	2.0	7.7	5.8	14.8	8.2	4.2	17.3	4.3	2.2	9.6	17.0	3.8	23.7	8.8	16.8	15.7	16.2	11.6	11.0	5.2	2.0	20.7	11.2	10.7	4.3	10.0	15.4	5.2	15.3	7.3	3.1	8.6	3.9	11.0	5.9	1.9	2.3	8.6	21.7	2.3	4.3	118.9	13.6	1.6	9.7	2.6	2.0	4.6	2.6	4.0	3.4	2.7	0.3	5.4	8.1	2.8	1.6	4.2	17.4	8.5	15.4	15.3	0.8	6.4	24.5	9.2	19.5	0.7	4.1	1.3	19.0	11.8	9.6	1.0	3.6	9.3	14.8	0.4	12.0	1.5	1.9	6.5	9.6	3.3	0.8	9.3	6.3	15.2	2.6	21.5	9.0	15.2	2.0	3.4	11.2	0.4	6.2	5.4	4.5	1.2	10.1	9.7	4.3	1.3	13.5	0.2	16.2	6.8	5.1	0.6	9.9	9.8	8.3	3.1	5.1	7.7	3.3	29.4	8.5	2.5	0.1	11.7	12.3	2.8	10.2	0.1	0.1	2.7	4.2	0.0	5.3	2.5	3.7	3.3	0.5	4.0	8.1	7.2	0.4	5.4	0.3	3.4	0.4	2.8	18.4	16.8	5.8	14.0	15.7	16.2	20.7	11.2	15.3	13.6	3.0	10.7	4.7	14.7	7.4	29.1	81.9	22.9	313.2	31.8	48.8	11.8	1.2	112.7	25.4	2880.3	27.2	0.0	0.0	9.2	4.2	30.9	16.9	1.1	39.9	2.7	15.9	2.9	34.4	1.9	5153.7	67.3	6.2	23.6	2.8	0.3	63.3	6.5	0.0	85.2	62.8	30.9	58.2	24.7	416.7	35.0	7.5	0.5	4.4	0.6	7.9
FAM231C		ENSG00000268674	"Family with sequence similarity 231 member C"	"P0DMU3, P0DMU4, P0DMU5"	Unmapped	35407-35916	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 1.6;brain: 5.6;parathyroid gland: 3.2;testis: 1.4"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.1;U-698: 1.3"									"HPA043267, HPA043292, HPA077864"	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA043267: , HPA043292: , HPA077864: AB_2686862"																		0.0	0.3	0.1	0.0	0.1	0.1	0.0	5.6	0.3	0.1	0.3			0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0		0.2	0.1	3.2	0.0	0.1		0.1	0.0		0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.4			0.0		0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM234B	KIAA1467	ENSG00000084444	"Family with sequence similarity 234 member B"	A2RU67	12	13044284-13142521	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 17.4;Erythroid cells: 23.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010803, HPA010850"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010803: AB_1079200, HPA010850: AB_2732402"	"unprognostic (1.85e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.03e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (7.62e-2)"	4.4	3.6	9.6	2.3	17.5	3.5	21.2	21.3	28.5	3.4	1.6	4.4	4.2	2.6	3.6	4.4	2.8	4.0	2.4	1.9	10.8	12.4	7.3	3.0	3.6	2.1	9.1	16.7	3.5	3.4	4.8	5.2	7.1	13.6	8.1	1.9	3.4	3.4	5.0	2.8	15.5	2.5	3.2	5.1	2.9	1.7	6.8	5.0	0.5	10.9	0.1	2.2	3.6	2.8	6.8	4.3	1.9	6.9	2.7	4.5	1.4	2.9	3.0	9.2	6.5	7.3	7.1	7.2	2.0	2.3	4.5	8.9	3.1	4.4	12.0	2.5	2.4	7.9	4.5	11.5	2.2	9.5	1.4	6.4	7.1	3.3	2.5	3.9	6.2	4.1	5.4	4.7	6.5	5.0	6.8	5.9	8.4	1.8	4.4	4.9	9.8	5.2	4.0	12.1	2.3	1.7	6.8	12.0	1.3	2.8	7.2	12.9	4.2	4.4	2.9	3.5	16.5	3.7	3.5	3.0	3.0	5.1	5.5	2.1	2.4	3.1	7.8	9.6	2.8	3.7	0.3	2.7	1.9	2.6	4.5	3.4	4.6	2.9	2.5	2.3	6.8	4.3	4.5	0.7	2.7	6.9	4.3	2.3	1.4	9.6	17.5	21.3	28.5	10.8	12.4	9.1	16.7	13.6	5.0	3.0	3.5	0.9	1.7	0.0	11.3	0.0	2.5	0.0	0.0	17.4	2.0	5.6	1.7	1.9	7.0	0.0	0.0	23.3	1.2	2.7	1.0	3.8	0.0	2.0	3.1	3.2	11.7	4.9	1.3	2.7	5.2	0.5	0.0	2.8	0.1	3.8	1.2	0.0	4.9	1.0	2.9	0.0	0.0	8.8	10.9	0.0	3.0	0.0	0.0	1.1
FAM241B	C10orf35	ENSG00000171224	"Family with sequence similarity 241 member B"	Q96D05	10	69630251-69633599	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 15.7;Distal tubular cells: 10.0;Ductal cells: 23.4;Exocrine glandular cells: 15.9;Pancreatic endocrine cells: 15.7;Proximal tubular cells: 10.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.2"	"Lineage enriched"	"Detected in single"	25	"T-cells: 14.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034591	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Centrosome"	Cytosol	"HPA034591: AB_10670572"	"unprognostic (1.12e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.17e-3)"	"prognostic unfavorable (8.64e-4)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (9.72e-4)"	1.4	3.3	13.1	2.0	13.5	1.1	5.3	34.5	23.9	1.3	3.0	3.2	0.6	3.0	2.7	13.0	4.0	4.8	2.1	6.9	15.0	17.8	4.7	2.3	4.1	2.7	10.8	14.4	2.0	7.9	5.6	5.3	1.3	8.3	7.8	2.6	5.1	5.6	5.6	1.6	2.4	2.2	4.5	4.6	0.8	4.2	11.4	2.4	0.7	6.0	0.1	2.4	2.6	1.6	0.3	0.0	0.5	0.0	0.2	14.2	2.8	13.3	14.5	1.8	14.9	0.0	0.0	6.5	1.3	0.3	2.4	2.6	10.5	11.0	0.0	20.4	0.3	8.6	5.5	7.8	4.5	3.4	13.2	10.7	0.0	3.2	4.0	3.9	0.0	4.8	0.0	4.4	0.1	2.3	1.8	0.0	20.1	4.9	0.0	0.2	17.9	0.1	0.0	9.0	5.4	26.9	0.0	0.0	0.1	5.1	7.6	7.6	10.4	5.5	14.0	8.5	3.9	9.6	2.3	0.6	0.3	9.3	0.0	3.9	2.4	6.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	3.4	0.0	8.9	0.1	8.5	5.6	0.0	0.3	14.2	4.9	0.5	0.2	0.0	0.0	5.3	2.8	13.1	13.5	34.5	23.9	15.0	17.8	10.8	14.4	8.3	2.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	8.1	5.7	15.7	0.0	5.6	10.0	23.4	0.0	0.0	0.0	0.0	15.9	4.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	15.7	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0
FAM35A	"bA163M19.1, FAM35A1, MGC5560"	ENSG00000122376	"Family with sequence similarity 35 member A"	Q86V20	10	87094161-87191468	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036582	Uncertain		Approved	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA036582: AB_10670233"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.44e-3)"	"unprognostic (3.61e-2)"	17.3	16.9	5.4	14.4	7.2	5.4	15.4	6.4	4.9	12.6	20.2	4.7	9.1	15.0	10.8	10.6	12.6	9.3	7.4	11.5	6.0	6.1	31.2	35.3	12.5	16.4	9.0	3.5	12.7	10.2	3.6	19.4	7.4	6.8	14.0	11.6	7.4	11.4	14.0	9.3	9.1	33.1	14.8	6.9	15.6	8.7	7.1	7.9	12.0	30.7	12.6	9.4	12.3	13.6	9.0	10.7	4.9	11.1	11.2	13.7	8.5	16.1	13.1	7.5	17.2	8.5	8.2	11.0	10.9	15.4	14.7	16.2	15.0	12.5	11.9	6.1	14.8	8.6	10.8	18.5	8.3	15.2	16.9	12.2	16.4	12.5	14.1	13.1	25.6	14.4	7.5	15.4	13.4	23.2	13.0	9.8	13.0	20.8	21.5	13.6	9.3	20.7	18.3	8.6	11.8	9.2	12.9	14.9	13.1	13.5	13.6	3.7	15.5	8.4	10.0	14.5	7.3	22.0	14.5	9.5	8.4	7.7	12.5	21.7	12.1	26.4	28.8	14.2	32.0	4.5	4.9	7.0	2.3	6.8	11.1	13.7	9.0	10.3	10.0	10.7	7.2	10.5	10.5	0.1	11.2	8.4	3.7	9.7	8.5	5.4	7.2	6.4	4.9	6.0	6.1	9.0	3.5	6.8	7.9	17.9	16.3	7.2	11.3	9.3	7.7	0.0	15.3	14.7	21.6	0.0	13.7	5.6	0.0	0.0	16.8	8.6	14.8	0.0	0.0	13.2	13.9	20.1	9.2	58.0	13.0	6.4	6.9	16.0	18.4	17.8	19.0	20.0	16.9	0.0	16.0	14.3	0.0	12.9	18.7	0.0	21.1	12.9	5.3	15.7	6.8	9.8	1.8	13.1	15.7	14.6
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"Family with sequence similarity 3 member A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"	"Secreted - unknown location"	Yes	No			"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"CAB025016: , HPA035268: , HPA056991: AB_2683303"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	18.9	18.9	18.9	14.7	20.9	13.7	17.3	13.4	25.7	22.3	21.2	31.1	16.3	37.0	18.2	16.2	19.3	19.1	25.3	31.4	21.3	18.7	19.8	28.5	16.1	16.7	23.0	16.4	29.1	35.5	18.2	22.1	21.0	18.5	20.6	9.9	17.3	29.4	34.7	33.4	15.3	33.7	14.4	25.4	18.4	23.6	10.7	16.8	13.5	28.8	16.1	12.2	16.9	16.9	8.0	13.3	21.2	11.5	8.5	13.3	8.9	16.6	16.0	4.0	13.5	12.2	6.2	11.4	8.5	5.9	5.9	7.0	7.3	10.1	10.8	43.4	14.2	11.5	12.1	6.3	7.5	1.4	8.8	8.6	4.2	14.0	5.1	19.1	2.8	6.8	7.7	6.8	12.1	8.5	7.0	4.1	7.0	8.0	8.0	6.7	17.4	5.2	12.3	1.7	18.1	20.1	6.5	4.0	29.7	6.4	6.9	8.0	6.1	3.9	9.5	14.0	3.1	7.2	4.4	4.5	7.9	4.8	21.4	11.5	30.8	16.8	13.2	14.6	7.4	8.1	21.2	9.9	12.5	13.3	11.5	12.9	6.2	8.2	9.3	9.9	8.0	10.2	11.9	5.0	8.5	9.5	13.3	8.5	8.9	18.9	20.9	13.4	25.7	21.3	18.7	23.0	16.4	18.5	16.8	11.9	14.7	8.0	19.3	14.4	23.0	20.5	25.5	8.1	6.8	21.0	13.7	39.7	23.2	22.8	0.6	17.7	66.7	23.3	37.0	40.6	24.2	23.6	5.7	27.2	26.3	20.6	16.8	20.3	14.9	1.6	31.1	13.9	32.1	19.0	45.1	25.5	24.3	49.1	27.6	26.2	15.2	6.5	16.0	3.7	8.6	18.4	59.6	19.3	33.2	20.3
FAM3B	"2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44"	ENSG00000183844	"Family with sequence similarity 3 member B"	P58499	21	41304212-41357431	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.8;pancreas: 120.3;salivary gland: 67.9"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 242.6;Exocrine glandular cells: 349.6;Pancreatic endocrine cells: 184.9;Syncytiotrophoblasts: 134.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 40.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;CAPAN-2: 6.0;Hep G2: 15.3;OE19: 13.2;RPMI-8226: 42.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015885, HPA029777, CAB034131"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2080000	57000	Vesicles		"CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194"	"unprognostic (2.88e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.79e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-3)"	0.6	0.2	0.2	4.5	0.4	0.0	4.3	0.2	0.3	1.8	38.5	0.4	29.9	38.2	0.2	8.8	17.4	4.5	6.9	0.4	0.2	0.2	5.2	0.6	2.0	0.7	0.3	0.2	0.7	120.3	0.0	1.9	7.9	0.4	10.0	0.0	0.2	67.9	36.0	0.2	0.9	83.8	2.0	0.3	0.5	30.8	2.0	0.2	2.3	3.9	7.4	17.6	17.5	4.7	0.2	1.3	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	13.2	0.0	0.0	0.0	42.4	0.0	2.8	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	6.9	0.0	0.6	1.3	0.0	0.0	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.2	20.8	18.8	0.0	11.2	1.1	0.0	0.1	81.5	22.7	50.0	62.8	0.0	242.6	21.6	113.7	19.2	1.0	0.0	0.0	349.6	6.2	5.7	99.4	1.1	0.0	23.0	0.0	0.0	0.0	2.5	7.0	0.6	8.1	5.0	3.6	0.9	0.0	184.9	0.0	0.4	0.4	0.0	0.0	0.9	26.7	7.2	1.1	134.9	0.0	0.0	104.8
FAM43A	FLJ90022	ENSG00000185112	"Family with sequence similarity 43 member A"	Q8N2R8	3	194686544-194689037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 61.8;Extravillous trophoblasts: 69.8;Ito cells: 78.5;Syncytiotrophoblasts: 135.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 47.9;NB-4: 28.5;PC-3: 22.6;TIME: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048345	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA048345: AB_2680367"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.71e-3)"	"unprognostic (5.13e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-3)"	"prognostic unfavorable (9.96e-4)"	10.7	1.8	1.6	3.5	1.6	2.4	10.4	2.7	4.2	5.2	4.2	2.1	1.6	0.8	4.8	2.7	5.3	6.0	4.2	7.0	2.7	1.6	4.6	23.5	5.6	8.0	2.5	3.6	3.5	7.0	0.5	2.7	9.3	4.1	7.9	1.7	3.3	6.7	2.1	5.5	8.6	3.8	2.9	1.6	20.6	2.7	6.1	2.3	2.6	2.6	5.8	5.2	5.7	8.9	5.0	8.7	3.6	1.3	2.8	1.4	0.4	0.1	0.7	0.6	0.4	9.7	4.7	3.9	1.2	3.3	0.0	0.0	0.2	0.1	0.5	13.7	4.5	3.1	1.4	0.8	0.3	0.0	0.3	2.5	1.7	3.8	0.5	0.8	0.4	5.0	1.2	2.0	0.2	0.0	0.2	47.9	0.0	1.0	0.9	0.1	0.7	0.0	28.5	2.2	4.8	22.6	2.1	0.1	0.2	0.0	0.0	13.3	1.1	0.9	0.9	2.8	1.0	0.5	5.9	24.0	0.5	0.7	0.6	0.3	0.0	0.5	1.2	0.2	13.0	9.0	3.6	1.3	1.5	1.0	1.1	1.4	2.3	0.6	0.9	1.3	5.0	0.1	0.3	1.6	2.8	0.7	8.7	0.4	0.4	1.6	1.6	2.7	4.2	2.7	1.6	2.5	3.6	4.1	2.3	0.0	4.5	27.4	20.1	3.5	14.8	31.3	0.0	0.0	0.0	1.8	7.9	18.7	6.6	4.5	0.1	61.8	15.4	0.0	1.5	69.8	14.0	21.7	15.0	0.5	5.1	0.0	6.3	78.5	9.7	0.8	15.3	3.1	11.8	0.0	2.5	2.1	4.4	17.5	9.2	0.5	1.7	25.8	17.6	0.5	5.9	3.4	135.8	15.2	7.3	11.2
FAM43B	FLJ44952	ENSG00000183114	"Family with sequence similarity 43 member B"	Q6ZT52	1	20552439-20555010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"adrenal gland: 21.9;brain: 14.9;epididymis: 8.7"	"Cell type enhanced"	"Detected in some"	19	"Cardiomyocytes: 1.2;Distal tubular cells: 3.3"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;BJ hTERT+: 3.3;fHDF/TERT166: 6.7;Hep G2: 4.9;SCLC-21H: 6.0;SiHa: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050813	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA050813: AB_2681244"	"unprognostic (1.51e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.78e-4)"	"unprognostic (1.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.12e-2)"	3.2	21.9	5.6	1.5	14.9	0.9	1.5	8.8	14.4	1.6	1.3	2.4	0.0	1.1	1.4	8.7	1.3	1.6	1.5	3.3	5.3	12.1	2.6	1.4	1.2	1.0	10.1	6.0	1.0	1.2	0.9	0.7	2.5	11.2	1.4	1.1	0.5	1.2	1.3	2.8	1.0	1.2	2.9	4.0	1.4	0.9	1.3	2.8	0.0	1.3	1.7	0.9	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	4.6	0.2	0.1	0.0	0.5	3.3	0.6	0.0	0.1	0.0	0.0	0.2	6.7	1.2	0.0	0.7	0.0	0.1	0.0	1.0	0.2	0.3	4.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.0	0.7	11.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	14.9	8.8	14.4	5.3	12.1	10.1	6.0	11.2	2.8	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.3	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0
FAM45A		ENSG00000119979	"Family with sequence similarity 45 member A"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	12.2	13.2	16.2	8.5	20.0	17.0	9.5	10.2	17.6	11.6	12.5	10.2	6.5	7.6	9.4	10.7	16.0	9.0	8.5	10.8	13.5	10.4	16.6	18.9	8.6	6.8	10.6	17.6	17.3	8.8	11.6	5.4	10.8	18.4	8.9	11.0	7.7	10.7	8.3	14.0	12.0	9.7	9.8	13.5	8.4	9.7	7.1	11.5	10.1	14.8	10.8	9.9	13.1	14.7	2.3	9.9	30.2	19.2	3.8	10.0	6.0	8.3	9.8	12.5	14.5	21.4	21.4	5.5	11.9	29.8	10.7	10.3	9.5	11.2	5.9	4.5	14.6	11.2	12.7	10.6	10.5	9.3	10.0	6.0	1.3	3.4	8.3	24.4	3.5	2.8	22.3	9.0	7.8	11.0	22.2	14.4	5.1	2.8	6.7	13.4	6.7	4.4	6.0	7.5	6.3	4.0	4.8	15.7	4.3	10.3	8.9	2.1	8.3	8.5	9.0	17.4	12.2	8.6	12.3	14.6	7.6	3.9	7.9	6.0	7.3	2.7	6.5	12.3	15.3	3.4	23.0	15.1	30.2	4.2	18.3	3.4	2.3	6.3	5.5	9.9	1.9	3.1	4.1	20.1	3.8	19.2	2.5	10.0	6.0	16.2	20.0	10.2	17.6	13.5	10.4	10.6	17.6	18.4	11.5	8.9	21.6	15.2	23.3	15.8	17.0	32.3	28.1	20.1	17.0	24.4	0.0	45.9	94.5	28.0	2.0	15.3	46.3	0.0	43.7	21.6	29.9	20.6	19.7	52.9	46.9	7.9	24.2	51.0	96.9	4.7	23.9	34.6	28.7	36.1	27.9	29.4	40.7	45.6	25.8	78.7	16.9	19.4	11.8	18.5	23.2	22.2	37.9	28.7	34.5	24.3
FAM46A	"C6orf37, FLJ20037"	ENSG00000112773	"Family with sequence similarity 46 member A"	Q96IP4	6	81491439-81752774	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 106.4"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 311.3;Horizontal cells: 276.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 22.1;fHDF/TERT166: 25.4;HeLa: 25.1;HL-60: 28.8;THP-1: 49.6;U-937: 22.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051067: , HPA067140: AB_2685788"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	10.0	7.1	1.4	4.9	1.4	64.7	5.6	2.8	0.9	14.4	17.7	1.3	24.2	5.1	12.8	20.0	4.2	8.8	17.1	19.4	1.2	4.4	3.2	11.8	5.8	2.3	1.4	0.9	20.1	3.5	6.5	20.4	106.4	3.5	16.2	5.6	4.9	49.8	45.6	4.5	7.0	32.6	15.3	2.5	5.8	13.2	6.8	1.4	1.2	7.7	6.7	3.7	13.4	31.1	12.0	12.4	22.4	22.2	8.3	6.2	6.1	1.0	1.5	1.0	0.0	22.1	9.8	1.9	8.4	6.0	5.0	7.6	15.7	0.8	0.1	0.3	25.4	3.2	0.9	0.7	1.3	3.7	0.0	1.9	0.0	25.1	2.4	6.9	28.8	2.2	4.3	0.7	3.9	0.7	16.4	0.6	0.2	0.4	0.0	3.3	4.4	0.0	20.4	0.2	8.9	1.2	0.0	9.1	0.0	0.6	1.9	1.0	1.4	3.7	1.6	2.5	3.3	0.3	49.6	1.4	5.7	1.2	2.4	2.3	0.1	0.1	0.1	8.1	22.3	2.4	16.1	14.9	22.4	6.2	15.1	3.7	8.0	2.4	3.0	12.4	12.0	4.7	4.4	7.3	8.3	22.2	4.3	2.7	6.1	1.4	1.4	2.8	0.9	1.2	4.4	1.4	0.9	3.5	1.4	59.6	92.4	0.9	134.5	49.9	25.9	0.0	45.9	21.4	102.4	0.0	70.7	30.7	0.0	0.0	0.4	20.4	311.3	23.3	0.0	89.3	98.1	34.0	210.9	34.5	26.7	276.5	183.7	6.7	35.9	0.5	95.3	46.7	62.4	0.0	64.6	75.7	0.0	105.2	37.1	0.0	45.1	25.8	43.8	0.9	5.4	31.7	135.5	20.3	33.3	105.6
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283780	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ciliated cells: 75.0;Early spermatids: 25.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 3.1;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	5	"B-cells: 3.1;dendritic cells: 2.3"	"Cell line enriched"	"Detected in many"	5	"OE19: 24.0"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	5.5	6.8	12.5	0.8	8.5	1.2	8.9	2.4	14.8	3.7	3.2	9.2	4.4	4.3	2.4	15.5	1.6	23.5	5.1	3.2	10.1	13.7	9.1	11.2	4.8	0.9	10.7	15.5	1.2	9.7	9.9	10.3	10.0	12.1	5.2	3.8	2.7	5.4	4.0	9.5	2.0	4.2	3.0	13.3	1.8	6.0	9.2	6.2	0.0	13.2	1.5	0.9	2.6	1.1	3.1	2.3	0.1	0.4	0.1	0.5	0.1	0.4	2.0	1.8	0.5	1.4	0.2	0.4	0.2	1.3	0.3	0.4	2.3	1.7	0.1	0.5	0.7	4.1	0.6	0.8	0.4	0.7	1.8	0.1	0.1	1.1	3.3	0.8	0.4	0.3	0.8	0.5	0.5	0.5	0.7	0.2	0.2	0.2	1.1	0.6	2.8	0.1	0.2	0.4	24.0	0.9	0.3	0.5	0.3	2.5	1.6	3.1	2.2	0.8	1.0	0.3	0.5	1.0	0.2	0.5	0.4	0.4	1.1	0.3	4.4	1.0	0.1	1.3	0.2	0.6	0.0	0.4	0.1	0.2	0.0	0.5	0.2	0.2	0.1	0.2	3.1	0.4	0.1	0.1	0.1	0.4	2.3	0.0	0.1	12.5	8.5	2.4	14.8	10.1	13.7	10.7	15.5	12.1	6.2	8.9	1.6	0.5	2.2	0.6	11.4	6.2	5.1	75.0	7.9	0.0	11.8	2.2	8.3	5.8	25.0	1.5	5.4	0.0	6.9	0.9	1.5	4.2	0.0	3.0	0.7	1.6	7.5	2.5	0.0	3.1	0.6	0.0	1.7	0.0	4.9	4.3	5.1	2.9	0.4	7.8	6.9	0.0	1.2	10.9	3.9	0.3	2.9	0.0	2.7	1.6
FAM49A	"DKFZP566A1524, FLJ11080"	ENSG00000197872	"Family with sequence similarity 49 member A"	Q9H0Q0	2	16549459-16666331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.8;brain: 39.5"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 90.0;Kupffer cells: 96.6;monocytes: 191.2;Syncytiotrophoblasts: 125.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 23.3;HUVEC TERT2: 18.6;RH-30: 41.7;SK-BR-3: 12.2;TIME: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017847, HPA060398"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB017847: , HPA060398: AB_2684275"	"unprognostic (3.45e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.78e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (4.46e-4)"	10.8	9.1	22.7	15.6	28.0	15.3	7.0	6.6	39.5	13.7	5.3	7.0	1.2	2.9	8.2	2.1	4.3	6.2	8.7	3.3	17.2	14.1	1.9	6.1	9.6	13.4	10.2	25.2	10.0	2.4	1.1	4.8	15.3	9.9	6.9	5.3	2.9	3.2	7.3	6.0	2.9	4.6	8.6	6.0	20.1	3.4	1.8	6.3	1.9	31.8	1.1	13.6	7.7	7.4	8.9	15.5	45.8	34.4	13.4	5.3	8.5	0.2	0.0	2.6	0.1	2.8	0.8	7.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	1.8	1.6	0.6	1.0	0.0	2.8	0.1	1.6	0.0	0.0	1.4	0.0	23.3	1.3	1.0	0.2	0.0	2.1	18.6	0.0	0.1	2.0	1.6	0.1	0.0	5.4	1.1	0.1	0.0	0.9	41.7	0.1	2.2	10.3	0.4	1.5	0.0	12.2	0.0	3.4	0.4	0.7	14.5	0.2	2.4	0.0	0.0	1.2	0.0	1.4	6.1	1.2	0.8	0.0	23.6	31.4	5.3	29.8	0.6	8.9	0.2	2.7	15.5	6.1	0.2	2.1	45.8	13.4	34.4	7.7	0.1	8.5	22.7	28.0	6.6	33.3	17.2	14.1	10.2	25.2	9.9	6.3	3.0	17.3	26.5	17.4	10.0	3.2	1.4	0.0	1.4	9.1	0.0	2.0	40.6	0.0	2.9	0.8	6.0	0.0	23.3	0.8	90.0	12.5	8.1	11.5	1.0	31.7	0.0	0.0	29.4	96.6	0.0	2.0	70.2	28.7	191.2	0.0	22.8	0.2	0.0	1.8	0.0	2.4	12.9	14.1	0.0	2.1	7.3	125.4	11.7	0.0	24.3
FAM49B	BM-009	ENSG00000153310	"Family with sequence similarity 49 member B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.5;bone marrow: 80.1"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 468.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA009076	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		990000	Nucleoplasm	Cytosol	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	19.2	14.5	23.2	42.8	33.1	80.1	20.6	28.0	36.9	7.2	14.3	18.2	5.5	14.2	8.0	10.6	17.9	7.9	14.9	9.8	25.5	25.2	11.8	12.3	19.1	49.6	28.5	19.6	6.4	10.0	7.5	16.1	19.4	21.2	7.6	17.4	7.3	12.0	7.9	16.8	9.0	19.3	13.5	38.8	41.3	12.9	13.6	21.2	28.2	13.8	9.7	46.4	20.6	8.4	21.0	47.3	93.5	42.2	30.8	29.3	43.4	32.2	17.3	18.9	10.6	1.7	2.5	25.2	9.8	9.5	13.6	14.6	9.9	22.3	32.3	21.6	6.4	10.8	16.1	15.6	25.9	20.5	67.5	10.9	32.3	9.7	11.2	6.6	20.9	27.9	4.0	12.1	9.2	19.2	11.2	12.0	26.3	23.1	37.5	14.9	14.4	71.0	15.5	16.0	25.4	24.0	31.0	12.8	54.1	27.9	13.3	12.6	16.5	19.6	12.4	29.0	17.9	14.5	27.2	7.4	5.0	32.4	10.6	20.8	12.5	36.7	53.5	7.9	45.6	13.0	45.5	35.3	65.6	29.3	42.2	22.4	21.0	16.7	23.9	47.3	15.1	15.0	24.6	93.5	30.8	36.5	30.4	22.5	43.4	23.2	33.1	28.0	36.9	25.5	25.2	28.5	19.6	21.2	21.2	29.8	31.5	95.1	103.3	116.3	33.0	23.3	35.7	13.4	33.0	73.3	39.3	108.2	44.7	52.9	13.3	30.0	27.9	0.0	43.3	127.2	26.9	56.3	64.6	16.1	225.8	23.8	26.6	22.7	194.9	6.5	5.8	254.2	45.5	468.9	24.3	12.1	64.0	38.6	4.2	23.5	17.1	19.4	15.5	29.9	40.7	72.6	50.6	182.7	28.1	113.6
FAM53A	DNTNP	ENSG00000174137	"Family with sequence similarity 53 member A"	Q6NSI3	4	1617915-1684302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 3.6;Early spermatids: 11.4;Spermatocytes: 14.4;Spermatogonia: 11.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.9"	"Low region specificity"	"Detected in all"							"HPA036452, HPA058138"	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA036452: AB_10671841, HPA058138: AB_2683619"	"unprognostic (8.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.33e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.15e-3)"	1.3	0.8	0.8	0.6	0.7	0.9	1.2	1.6	1.1	0.9	1.0			0.0	1.6	6.0	0.8	2.1	1.5	0.5	1.1	0.7	0.7	1.2	0.7	0.9	1.5		1.5	4.0	1.3	6.8	0.1		1.1	0.2		1.7	0.8	1.5	3.3	0.4	1.0	2.7	0.8	0.9	12.7			5.7		0.2	0.9	0.6	2.4	4.9	0.6	3.8	0.9	4.4	1.0	1.2	0.8	2.0	4.0	1.4	3.5	0.8	6.6	3.6	6.4	4.3	1.6	2.9	3.2	3.3	1.8	2.5	0.2	0.0	1.3	1.7	0.8	0.9	0.8	0.3	0.7	5.6	0.0	1.2	2.7	3.8	3.2	6.4	1.3	1.0	6.8	2.4	0.9	2.8	0.8	1.9	2.0	2.5	0.6	9.1	0.9	0.5	0.1	1.7	1.9	9.9	4.2	2.5	0.5	4.7	1.5	3.1	2.1	1.6	0.3	0.4	1.2	0.8	0.4	1.6	0.8	0.1	1.2	7.8	0.0	1.1	0.6	0.5	3.8	1.2	2.4	0.7	0.8	2.5	1.6	4.4	0.2	0.0	0.9	1.5	4.9	1.0	1.0											0.0	0.0	0.0	0.4	1.1	0.8	3.6	2.5	0.0	0.0	1.8	0.0	0.0	1.7	0.3	11.4	0.5	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.8	0.2	0.0	0.0	1.3	0.0	1.3	0.6	0.3	0.0	1.0	0.0	0.3	0.4	0.0	0.4	0.3	0.4	0.0	0.9	14.4	11.8	0.4	0.0	0.0	0.4	0.1
FAM53B	"bA12J10.2, KIAA0140, smp"	ENSG00000189319	"Family with sequence similarity 53 member B"	Q14153	10	124619292-124744269	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037751, HPA037752"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA037751: AB_2675645, HPA037752: AB_10672285"	"unprognostic (7.88e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.91e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (7.00e-6)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.81e-7)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.41e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.45e-2)"	12.1	14.2	13.8	20.0	20.1	20.9	8.2	15.4	20.2	9.9	10.9	32.4	11.5	14.9	17.8	5.1	11.3	11.5	8.5	11.9	17.6	10.9	8.0	3.1	11.8	28.6	21.5	12.0	17.6	5.7	14.6	9.6	7.3	12.8	6.4	7.0	12.2	14.3	8.2	36.9	11.9	14.1	12.5	19.7	16.5	8.2	10.4	30.2	37.7	14.4	7.9	23.7	8.1	5.8	9.5	2.8	4.5	3.6	1.0	10.7	4.0	5.8	6.7	5.1	14.6	6.1	3.2	14.9	2.8	3.5	3.0	2.6	3.4	3.5	21.7	5.9	3.3	2.9	11.6	6.8	8.2	1.3	25.9	7.5	9.9	3.2	8.5	4.1	8.7	6.7	3.1	8.6	2.7	4.4	3.7	4.8	11.2	7.7	9.0	2.9	10.5	10.2	11.6	3.4	4.9	6.1	18.5	1.9	9.6	2.4	10.2	7.0	6.7	2.4	9.6	31.6	2.1	3.8	11.2	2.5	3.6	3.2	3.7	5.6	1.4	2.9	13.2	2.7	7.1	1.9	1.2	3.1	2.9	10.7	3.0	5.1	4.8	4.6	5.5	2.0	9.5	1.8	3.2	4.5	1.0	3.6	2.8	5.0	4.0	13.8	20.1	15.4	20.2	17.6	10.9	21.5	12.0	12.8	30.2	8.9	13.0	7.5	5.1	3.2	4.8	13.4	2.5	8.1	5.7	3.5	9.8	3.7	1.7	2.4	13.7	6.3	18.0	0.0	3.5	4.2	4.5	2.6	4.7	3.2	11.2	1.6	14.5	21.5	23.1	4.1	5.2	5.2	8.5	7.2	15.1	2.8	2.8	13.3	9.9	3.7	22.3	0.0	2.5	7.1	6.8	5.0	0.7	13.4	12.4	4.4
FAM69A	FLJ23493	ENSG00000154511	"Family with sequence similarity 69 member A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 25.6;Syncytiotrophoblasts: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favorable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	13.3	3.4	20.7	10.4	22.5	7.0	7.8	19.4	22.2	7.3	13.2	15.9	4.2	8.8	15.7	3.8	9.3	8.3	11.1	5.3	22.6	18.0	6.1	24.7	4.5	10.1	25.0	12.2	6.0	3.5	20.5	4.1	12.8	17.7	9.5	12.4	5.4	5.5	11.3	7.5	5.6	8.2	19.4	24.7	7.6	8.8	6.4	24.4	9.6	6.2	3.6	8.8	12.2	6.0	22.5	7.1	0.2	0.9	11.8	14.2	6.7	4.3	4.8	2.0	4.8	7.5	14.1	2.4	13.6	28.1	7.7	15.7	2.7	0.9	14.8	2.5	25.0	15.4	5.6	0.3	10.2	12.8	5.9	4.8	0.5	3.8	6.9	2.7	1.3	0.9	8.4	8.2	17.0	3.9	13.1	0.1	9.1	5.2	15.7	9.7	1.6	4.9	1.2	3.5	7.3	1.9	4.4	14.5	4.5	1.1	4.5	4.9	3.8	3.8	3.8	5.0	4.6	1.8	0.4	0.5	9.1	7.0	17.7	4.8	23.8	22.7	17.3	4.3	0.9	0.8	0.0	0.9	0.0	10.5	0.4	8.1	22.5	12.1	8.2	4.3	13.6	14.2	12.1	0.2	11.8	0.2	7.1	10.7	6.7	20.7	22.5	19.4	22.0	22.6	18.0	25.0	12.2	17.7	24.4	0.0	2.4	9.3	3.5	10.1	1.3	3.6	7.6	10.7	1.2	5.2	2.0	25.6	3.3	1.6	1.5	3.0	1.3	0.0	2.1	4.9	9.9	3.7	0.0	13.2	3.7	7.9	0.0	4.9	3.7	2.3	0.9	2.2	6.8	16.2	3.2	0.7	2.8	0.0	7.1	4.4	1.3	0.0	9.2	0.7	1.6	8.2	21.2	5.7	2.5	1.8
FAM69B	"C9orf136, MGC20262"	ENSG00000165716	"Family with sequence similarity 69 member B"	Q5VUD6	9	136712570-136724050	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 15.8;Horizontal cells: 25.4;Ito cells: 20.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"naive B-cell: 7.3;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	34	"B-cells: 7.3;dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 28.7;HEK 293: 25.7;HUVEC TERT2: 31.9;REH: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054443			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA054443: AB_2682489"	"unprognostic (2.78e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (6.67e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.78e-1)"	8.0	3.8	12.3	3.6	14.2	8.2	5.6	19.8	21.4	6.1	4.6	4.9	2.3	4.7	9.6	5.0	4.7	11.0	5.9	18.8	12.3	14.6	6.6	5.5	11.0	4.5	12.4	15.9	5.4	11.9	7.9	11.4	24.5	14.2	6.5	1.3	17.5	11.2	4.5	9.9	13.0	4.4	4.1	5.3	7.9	3.5	7.5	3.2	1.6	7.6	4.1	2.1	3.2	3.1	7.3	1.9	0.0	0.1	0.0	0.0	0.7	0.5	3.4	9.6	9.4	0.0	0.0	8.6	0.3	0.0	0.4	0.4	9.7	1.6	0.8	28.7	0.0	3.1	2.9	4.9	0.1	0.0	1.3	25.7	5.4	0.4	0.3	0.1	0.8	2.9	0.1	0.0	0.1	0.0	1.4	31.9	6.9	6.4	0.9	0.0	4.2	3.7	8.6	14.8	2.1	2.1	20.5	0.2	9.6	0.5	1.0	16.4	17.7	0.4	1.9	7.1	3.1	5.3	5.0	16.3	0.8	7.1	1.3	0.6	5.7	0.5	2.5	0.6	0.8	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.7	12.3	14.2	19.8	21.4	12.3	14.6	12.4	15.9	14.2	3.2	0.0	5.3	1.4	1.3	0.9	10.5	4.4	0.0	0.0	1.2	0.0	9.8	0.5	3.3	0.6	1.2	15.8	0.0	0.0	0.0	5.3	2.1	1.3	1.1	3.9	0.4	25.4	0.0	20.3	0.6	3.7	4.4	0.2	11.8	0.0	0.0	9.7	0.2	0.0	2.5	1.1	8.3	0.0	0.8	1.2	5.5	0.3	0.2	0.0	0.0	0.0
FAM71A	FLJ32796	ENSG00000162771	"Family with sequence similarity 71 member A"	Q8IYT1	1	212624474-212626778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	149	"testis: 57.1"	"Group enriched"	"Detected in many"	135	"Early spermatids: 1249.7;Late spermatids: 344.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.2;SK-BR-3: 1.6;U-266/70: 1.0"					"Not detected"	"Not detected"			"HPA028462, HPA060344"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA028462: AB_10601904, HPA060344: "																		0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.8	0.5	0.0	0.0	2.5	0.0	3.4	0.0	0.0	2.0	0.0	0.4	1249.7	0.1	0.5	0.0	1.1	1.5	0.4	2.9	1.1	0.0	1.2	0.0	1.2	3.1	0.0	344.8	4.9	1.0	0.0	0.0	2.6	0.3	1.0	0.9	2.5	0.0	0.0	0.0	0.9	3.6	1.8	0.1	2.4	0.0	1.7	0.6
FAM71E1		ENSG00000142530	"Family with sequence similarity 71 member E1"	Q6IPT2	19	50466785-50476753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 36.0"	"Group enriched"	"Detected in many"	54	"Early spermatids: 1823.2;Late spermatids: 2935.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 17.3"					"Low region specificity"	"Detected in many"			HPA048111			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA048111: "	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.35e-7)"	"unprognostic (7.26e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-2)"	0.5	1.3	4.3	0.9	5.4	0.5	1.3	3.6	4.3	2.0	1.3	0.0	7.1	2.2	0.9	3.6	1.2	2.7	2.1	1.6	3.1	5.0	2.3	3.6	3.5	0.5	5.5	2.8	2.6	5.6	1.4	10.9	1.1	1.5	1.9	0.8	0.6	7.4	4.7	4.6	1.3	1.8	0.5	2.1	0.7	1.9	36.0	0.5	1.5	3.6	4.6	0.7	0.8	0.3	2.4	2.3	1.6	0.9	3.6	3.5	0.8	2.4	1.6	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.3	0.4	0.0	0.1	0.6	3.7	0.0	0.9	0.0	0.2	17.3	0.0	0.9	0.0	2.9	0.1	2.2	0.8	1.9	0.2	0.4	0.2	0.0	1.2	0.6	1.2	0.0	3.3	0.6	0.0	0.0	4.3	2.6	1.8	0.3	1.0	1.1	3.2	4.0	1.0	1.2	4.2	0.5	1.1	3.2	1.2	0.0	0.0	1.1	0.2	0.3	0.9	1.8	0.1	0.0	0.0	0.2	0.8	0.9	1.6	2.3	0.1	3.5	1.4	2.2	1.3	0.2	2.4	2.3	3.0	0.7	3.6	0.5	2.3	0.2	0.8	4.3	5.4	3.6	4.3	3.1	5.0	5.5	2.8	1.5	0.5	0.0	0.3	0.0	2.8	0.6	4.7	1.7	0.0	2.7	0.0	3.5	0.0	5.6	10.0	3.2	1823.2	0.6	1.3	0.0	4.8	3.2	0.9	3.6	0.0	1.5	1.6	4.8	2.9	1.8	0.0	2935.1	15.8	0.6	0.0	2.8	4.6	7.4	2.6	2.3	14.2	11.9	5.8	19.4	0.4	44.4	24.9	2.0	11.7	0.0	3.3	3.5
FAM71F2	FAM137B	ENSG00000205085	"Family with sequence similarity 71 member F2"	Q6NXP2	7	128672288-128687872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"testis: 28.1"	"Group enriched"	"Detected in many"	7	"Early spermatids: 138.1;Late spermatids: 512.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA020513, HPA024248"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020513: AB_1853077, HPA024248: AB_2671497"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.29e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.65e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.40e-4)"	"unprognostic (2.47e-2)"	1.4	1.1	0.7	0.7	1.2	1.3	0.7	1.8	1.1	0.7	0.7	0.7	0.7	0.4	0.7	1.6	0.7	0.5	0.8	0.9	0.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.9	0.7	0.2	2.5	0.7	0.7	0.9	0.5	0.7	1.6	0.7	1.6	1.3	0.7	1.0	0.7	1.2	1.0	28.1	0.7	0.7	0.9	0.7	0.7	0.7	0.7	1.4	1.3	4.2	0.8	1.2	0.9	0.2	0.8	1.3	1.5	2.9	2.6	2.0	0.7	1.7	0.4	0.4	1.0	0.3	1.4	0.9	0.8	2.8	1.0	2.0	0.2	0.7	0.7	0.9	1.3	0.5	2.7	0.2	0.7	0.7	1.9	1.7	0.7	3.0	0.5	2.0	0.4	0.9	0.4	1.4	1.2	1.3	0.4	1.4	0.9	0.3	1.9	1.1	0.3	0.4	1.0	3.5	1.2	0.8	0.7	0.8	2.2	1.9	1.1	0.4	4.3	1.9	0.7	3.9	1.6	2.9	2.5	0.9	1.0	1.2	1.3	3.9	0.8	0.6	0.5	0.4	0.5	0.8	0.6	0.5	0.3	1.4	0.6	0.6	4.2	1.2	0.5	1.3	0.9	0.2	0.7	1.2	1.8	1.1	0.7	0.7	0.7	0.7	0.7	0.7	3.0	2.1	0.0	1.4	0.0	12.1	1.1	0.0	0.0	0.0	3.5	49.1	0.4	0.0	1.3	138.1	0.7	0.3	0.0	0.6	0.7	0.8	1.6	2.3	0.6	0.8	0.0	1.2	1.8	2.2	512.3	3.7	0.2	0.0	1.0	1.3	2.9	1.0	1.5	2.8	0.0	17.9	0.0	0.9	10.2	2.7	0.1	2.1	0.0	1.4	0.8
FAM72A	"LMPIP, MGC57827, RP11-312O7.1, UGENE"	ENSG00000196550	"Family with sequence similarity 72 member A"	Q5TYM5	1	206186179-206204414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 14.9;Kupffer cells: 15.6;Late spermatids: 22.6;monocytes: 10.8;Spermatocytes: 13.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (3.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.20e-5)"	"unprognostic (3.61e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.01e-5)"	"unprognostic (7.70e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-16)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.89e-1)"	3.4	2.5	1.9	4.7	1.6	6.3	3.2	8.0	1.3	0.8	1.5			2.4	0.6	0.0	2.5	1.8	2.2	0.9	2.4	1.8	1.0	1.3	2.4	8.9	2.6		0.8	0.7	2.3	0.4	2.8		0.5	1.7		0.7	0.2	0.2	5.0	2.2	1.3	3.1	6.3	0.8	6.3			0.5		6.2	1.1	1.2	2.1	5.6	1.2	9.2	0.6	3.6	2.4	9.7	8.0	8.4	3.6	1.2	1.5	10.1	7.0	3.0	8.1	6.1	4.7	14.6	25.1	6.0	1.8	9.1	11.7	9.7	3.8	9.7	13.8	8.0	11.3	7.3	6.3	0.8	19.5	12.8	2.1	0.7	7.2	12.8	2.4	5.0	21.9	22.5	17.3	5.0	5.7	12.1	17.5	15.3	6.9	10.7	13.5	14.6	18.9	4.6	1.5	8.4	4.9	5.0	4.6	4.1	10.0	9.7	10.6	2.6	6.5	7.5	8.4	11.5	14.0	20.5	22.5	5.3	16.1	8.9	0.0	7.5	0.0	0.9	9.2	0.2	2.1	1.8	1.8	5.6	0.8	0.2	0.4	1.2	0.6	5.4	2.3	3.6	2.4											0.0	1.0	0.9	0.1	1.5	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.4	0.0	0.8	14.9	5.2	0.9	0.0	0.7	2.8	2.4	0.4	0.0	0.0	7.8	0.0	0.0	6.7	15.6	22.6	0.0	6.0	3.3	10.8	0.4	0.5	0.3	0.0	0.0	0.1	0.1	0.0	1.7	13.5	4.5	0.9	0.6	0.9	0.4	0.5
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 6.5;lymphoid tissue: 9.3"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 4.7;Spermatocytes: 14.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	1.0	0.8	1.3	4.1	1.0	6.5	0.6	5.1	1.0	0.5	1.0			1.3	0.4	0.2	3.0	0.5	1.0	0.2	1.6	0.9	0.3	0.4	0.8	9.3	1.4		0.4	0.1	1.5	0.1	1.4		0.2	1.3		0.5	0.0	0.0	2.1	1.3	0.7	1.4	3.2	0.9	3.6			0.2		7.9	0.9	0.9	0.8	3.3	0.1	2.4	0.8	1.4	1.1	12.0	4.4	7.4	3.6	0.7	1.1	5.8	6.4	2.7	7.5	6.3	0.1	6.3	26.6	8.9	1.2	7.4	7.5	10.1	3.6	11.6	17.6	7.5	11.5	4.9	5.3	0.4	20.0	10.3	0.6	0.4	5.9	12.0	1.9	4.5	22.2	15.0	16.4	5.4	5.0	10.0	16.5	13.9	6.5	9.1	15.0	15.9	12.2	2.9	1.4	8.0	4.6	4.8	3.8	3.7	7.9	5.0	15.6	1.5	6.2	10.5	12.0	11.3	14.6	18.2	26.3	5.5	21.7	14.3	0.0	2.4	0.0	0.0	0.9	0.0	0.8	0.4	0.5	3.3	0.3	0.0	0.1	0.1	0.8	1.1	0.4	1.4	1.1											0.0	0.0	3.7	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.7	1.0	1.7	0.0	0.2	1.9	0.5	0.0	0.0	0.0	0.9	0.0	0.0	3.1	0.6	1.2	0.6	0.7	0.0	3.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	14.9	3.4	0.9	0.1	1.0	0.4	0.0
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6;lymphoid tissue: 6.4"	"Cell type enhanced"	"Detected in some"	16	"Extravillous trophoblasts: 3.6;Sertoli cells: 6.5;Spermatocytes: 10.0;Spermatogonia: 3.2"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 29.2"									"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.1	0.0		1.6		3.6	0.0		0.0	0.0	0.2			0.5	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.0	6.1			0.0	0.0	0.0		0.3		0.0	0.6		0.0	0.0	0.0	1.5	0.0	0.1		0.5	0.1	1.9			0.0		6.4	0.4		1.1	0.4	0.0	1.0	1.7	2.2	0.6	8.6	5.0	6.1	2.7	0.3	0.8	5.9	4.3	1.4	5.8	4.5	0.8	10.4	20.6	5.7	0.5	5.5	8.3	8.1	2.6	6.3	7.1	4.8	8.9	4.4	1.5	0.3	18.1	8.1	0.2	0.0	4.5	11.9	1.3	2.5	16.6	15.5	9.7	0.3	0.6	10.7	14.0	4.9	9.7	3.3	13.6	4.4	14.6	1.0	1.1	3.1	5.6	4.2	2.4	2.3	6.6	6.0	15.6	1.7	4.6	7.6	6.0	9.4	20.3	29.2	12.2	2.5	11.3	2.9	0.0	1.0	0.0	0.1	0.3	0.0	1.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	1.7	0.6	0.1	2.2	0.6											0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	1.0	0.0	0.0	0.2	3.6	0.3	0.0	0.0	0.0	1.3	0.0	0.0	1.8	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	10.0	3.2	0.3	0.2	0.0	0.0	0.0
FAM72D		ENSG00000215784	"Family with sequence similarity 72 member D"	Q6L9T8	1	145096000-145112696	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7"	"Cell type enhanced"	"Detected in some"	22	"Extravillous trophoblasts: 4.6;Spermatocytes: 17.9;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.70e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-3)"	"unprognostic (5.88e-5)"	"unprognostic (7.65e-4)"	"unprognostic (6.72e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (6.63e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.74e-2)"	"unprognostic (6.50e-2)"	1.1	0.7	0.8	7.2	0.8	5.5	0.7	4.0	0.9	0.6	1.1	0.6	0.4	1.4	0.8	0.4	4.4	0.2	0.5	0.4	1.0	0.7	0.5	0.4	1.3	7.6	1.0	0.4	0.4	0.4	0.3	0.4	1.5	0.8	0.4	1.6	0.4	0.6	0.4	0.4	2.9	2.0	0.5	1.1	3.3	0.8	6.7	0.4	17.7	0.4	2.7	7.4	1.1	2.5	0.1	0.7	0.1	1.7	0.0	1.0	0.5	8.4	5.1	6.0	2.4	0.2	0.5	6.6	4.8	1.4	6.1	3.8	3.4	7.6	13.8	4.9	0.7	5.5	8.9	7.3	1.4	7.2	11.0	7.3	6.9	2.5	5.0	0.1	12.2	7.7	0.3	0.5	4.8	9.3	1.0	2.7	16.7	13.6	19.2	4.0	6.3	8.3	11.9	11.5	10.5	7.1	7.3	7.6	16.2	2.1	1.1	5.9	5.0	3.7	3.3	2.2	7.9	9.3	7.9	1.2	4.5	5.0	3.8	8.6	14.6	22.8	21.4	0.0	9.8	5.1	0.0	1.2	0.0	0.0	1.7	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.0	0.5	0.8	0.8	4.0	0.9	1.0	0.7	1.0	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.5	0.0	0.0	0.0	4.6	1.0	0.1	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.0	0.0	1.2	1.7	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	17.9	4.1	0.9	0.2	0.5	0.1	0.0
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725979-27763122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 122.7;Late spermatids: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: AB_2686867"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	22.1	8.6	10.6	12.2	17.2	14.3	14.1	17.9	18.3	14.7	12.8	17.4	8.4	10.2	15.9	16.6	13.9	13.8	15.3	13.8	11.3	11.4	13.7	13.8	13.1	11.3	9.5	16.1	14.6	14.4	11.7	19.5	12.8	14.3	12.9	16.2	15.7	12.4	16.8	39.7	15.4	12.1	17.8	11.9	12.1	13.8	28.5	10.9	13.6	18.7	17.8	13.8	14.0	14.1	13.6	14.6	13.7	12.2	12.0	16.0	6.4	8.8	7.1	8.1	8.4	10.3	9.0	14.7	8.3	8.7	12.3	12.1	8.1	11.9	16.1	5.4	9.2	11.6	11.7	10.2	9.1	9.6	8.3	7.7	5.0	10.0	9.5	8.3	7.9	7.8	9.1	9.9	13.4	13.6	6.2	6.1	8.7	9.4	15.2	8.8	8.5	18.7	7.3	12.8	8.5	7.1	11.4	9.7	9.1	9.7	12.7	11.8	5.3	9.5	10.3	9.9	10.4	7.4	3.1	6.5	14.6	6.3	16.8	5.7	13.9	15.1	13.2	9.0	10.4	6.2	10.0	12.2	13.7	14.7	12.1	15.6	12.2	15.3	14.0	10.4	13.6	14.5	16.0	8.3	12.0	12.1	14.6	11.3	6.4	10.6	17.2	17.9	18.3	11.3	11.4	9.5	16.1	14.3	10.9	26.8	17.1	25.3	8.5	16.9	27.1	13.2	7.6	26.8	9.1	22.7	25.5	23.1	18.3	9.7	122.7	11.3	8.6	23.3	8.5	9.5	13.4	4.4	10.5	15.3	10.5	27.0	4.1	20.9	15.6	84.8	15.5	14.5	37.1	7.2	9.5	20.5	8.4	8.5	35.0	12.4	35.8	19.4	17.9	20.0	49.8	23.6	38.0	17.8	8.5	3.9
FAM76B	MGC33371	ENSG00000077458	"Family with sequence similarity 76 member B"	Q5HYJ3	11	95768942-95790409	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 212.1;Late spermatids: 286.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036608	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA036608: AB_2675215"	"unprognostic (8.17e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-3)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.72e-4)"	10.1	6.2	5.3	12.1	9.3	35.7	9.3	12.3	9.7	8.5	10.8	6.2	6.1	9.5	8.2	7.5	7.8	7.3	10.1	4.9	6.1	4.4	5.2	13.6	8.2	16.8	10.5	5.6	8.3	6.7	6.3	9.5	8.2	7.1	9.0	5.7	6.3	9.1	8.2	5.6	8.7	9.0	9.8	8.9	8.8	6.6	28.2	10.1	12.0	8.4	4.1	17.8	8.6	7.9	3.0	7.3	8.7	3.0	4.5	7.6	2.8	4.4	3.5	13.1	7.1	2.2	2.2	10.9	7.7	3.8	5.7	6.6	13.0	8.9	17.1	9.9	3.8	7.4	8.7	7.6	2.6	6.1	9.1	5.6	20.0	6.3	6.8	5.5	14.0	11.5	2.8	4.4	6.6	5.9	3.8	5.4	10.2	11.8	9.5	3.2	3.3	15.7	16.5	7.3	4.9	3.2	17.1	9.8	10.0	4.3	5.1	5.5	15.8	9.5	5.4	5.8	4.6	7.2	6.1	5.5	8.0	8.6	9.3	7.0	5.2	11.0	26.3	1.9	13.7	11.2	0.1	2.9	5.2	5.4	3.0	4.4	3.0	4.9	5.4	2.0	2.6	4.5	6.7	8.7	4.5	2.8	7.3	7.6	2.8	5.3	9.3	12.3	9.7	6.1	4.4	10.5	5.6	7.1	10.1	6.0	13.9	22.8	11.5	12.2	15.0	6.9	7.6	10.7	18.2	5.2	25.5	7.4	0.0	6.2	212.1	15.5	9.1	46.7	6.5	8.4	10.6	12.1	10.4	14.7	7.2	11.1	19.5	16.5	14.8	286.0	15.8	16.0	15.1	9.0	12.1	15.6	7.1	11.5	14.5	2.1	13.2	25.8	15.5	20.5	19.2	14.1	6.4	19.2	9.9	9.0
FAM78B		ENSG00000188859	"Family with sequence similarity 78 member B"	Q5VT40	1	166057426-166166969	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 82.5;Horizontal cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.4;SK-MEL-30: 11.2;U-2 OS: 3.0;WM-115: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052789, HPA073246"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA052789: AB_2681949, HPA073246: AB_2686588"	"unprognostic (7.38e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.87e-11)"	"unprognostic (7.41e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.69e-2)"	3.3	1.5	5.1	2.7	6.4	1.4	3.1	8.6	10.5	3.6	2.8	1.0	0.3	3.5	3.6	1.1	1.6	1.1	2.3	3.2	2.4	1.1	2.7	2.8	1.6	1.8	1.1	3.1	2.1	5.2	1.1	3.5	1.4	2.1	1.8	1.1	5.7	2.2	1.3	3.1	2.0	1.6	1.1	1.2	2.2	3.6	3.7	1.5	0.0	1.7	1.7	1.3	2.7	2.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.3	0.1	0.6	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.8	0.5	0.0	0.2	11.2	0.0	0.3	0.4	0.2	0.7	3.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.4	8.6	10.5	2.4	1.1	1.1	3.1	2.1	1.5	0.0	1.7	0.0	0.4	0.5	11.9	9.8	2.5	0.0	0.0	0.0	82.5	0.0	1.7	0.6	1.4	0.7	0.0	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.0	77.9	0.0	0.6	0.3	1.8	1.1	0.0	1.7	1.0	0.4	2.0	0.3	0.0	0.7	1.2	13.4	0.0	0.3	0.5	2.1	0.1	0.0	0.0	0.9	0.1
FAM81A	MGC26690	ENSG00000157470	"Family with sequence similarity 81 member A"	Q8TBF8	15	59372693-59523549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.2"	"Cell type enhanced"	"Detected in many"	16	"Collecting duct cells: 29.6;Horizontal cells: 9.5;Melanocytes: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.5;plasmacytoid DC: 12.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.5"	"Cell line enriched"	"Detected in many"	4	"Daudi: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001847, HPA065797"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001847: AB_2666462, HPA065797: AB_2685560"	"unprognostic (3.43e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.80e-2)"	1.0	0.8	13.7	3.1	14.0	0.4	1.8	1.2	32.2	8.4	5.2	3.2	0.7	3.0	3.3	5.7	1.0	7.8	2.1	1.9	16.1	8.7	8.7	0.8	1.1	5.7	5.6	17.7	1.1	2.5	0.6	3.3	1.1	3.7	3.1	6.6	1.2	3.3	2.2	0.9	1.5	1.8	1.7	4.3	1.8	3.1	2.2	1.9	0.0	2.7	0.0	6.6	0.9	1.1	2.6	12.5	0.4	0.6	0.1	0.0	0.3	5.8	8.5	0.6	0.1	0.2	0.1	3.5	0.3	0.0	0.6	1.7	1.0	1.0	37.3	0.2	0.1	8.2	4.5	4.8	1.4	1.1	0.4	2.5	0.0	5.7	0.3	0.0	3.1	0.8	0.0	0.9	0.2	0.4	0.4	0.0	1.5	0.1	0.0	0.5	2.0	0.0	0.1	0.5	1.5	3.1	0.8	8.6	0.9	1.9	2.1	1.8	0.5	3.4	0.1	5.5	0.4	1.5	1.9	0.2	1.4	4.4	1.7	6.3	0.0	0.0	0.4	1.4	1.2	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.5	2.6	0.0	0.0	0.4	0.1	0.0	12.5	0.0	0.3	13.7	14.0	1.2	32.2	16.1	8.7	5.6	17.7	3.7	1.9	0.0	2.2	1.9	0.9	0.5	0.0	6.2	0.0	6.7	1.2	29.6	0.0	0.1	5.0	0.4	0.4	0.6	0.7	0.0	0.2	1.1	0.4	2.1	1.1	0.0	1.1	9.5	1.2	0.0	0.3	0.4	0.3	0.7	8.5	0.0	0.9	1.0	0.3	1.9	0.0	0.1	0.1	0.0	0.9	0.1	1.3	0.4	0.0	0.0	3.7	0.9
FAM83A	"BJ-TSA-9, MGC14128"	ENSG00000147689	"Family with sequence similarity 83 member A"	Q86UY5	8	123178960-123210079	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.8;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"	14	"Pancreatic endocrine cells: 16.6;Suprabasal keratinocytes: 13.2;Urothelial cells: 19.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 52.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 24.3;HBEC3-KT: 37.9;hTCEpi: 20.3;K-562: 59.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA052615			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052615: AB_2797244"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.98e-9)"	"unprognostic (2.62e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.07e-2)"	0.1	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.6	0.4	0.0	8.3	0.6	0.8	2.0	44.8	2.8	1.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	2.7	0.0	1.3	0.0	0.0	3.1	13.6	0.1	4.4	2.5	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.3	13.4	28.6	3.1	18.4	0.4	0.3	0.7	0.2	0.3	0.4	0.0	24.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	3.2	0.0	0.0	7.8	0.0	37.9	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.0	20.3	0.0	5.2	0.0	0.0	0.0	59.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	4.3	2.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.4	0.1	0.3	0.1	0.2	0.1	0.0	0.4	0.1	0.2	0.7	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.4	0.0	0.6	0.0	4.0	4.5	1.8	0.0	0.0	0.0	0.3	0.6	0.0	0.5	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	1.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	13.2	0.0	0.0	0.4	19.7
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;smooth muscle: 69.8"	"Cell type enhanced"	"Detected in many"	22	"Erythroid cells: 23.3;Extravillous trophoblasts: 36.2;Syncytiotrophoblasts: 127.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Mitotic spindle"	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA049333: AB_2680717, HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.44e-6)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	0.5	0.5	0.5	4.9	0.8	7.9	0.7	0.4	1.2	1.7	29.6	0.4	0.7	3.4	0.8	1.5	39.0	0.2	5.6	1.5	0.5	0.1	2.2	1.4	2.6	1.5	0.3	0.5	0.7	0.2	0.0	0.3	2.2	0.7	7.6	3.6	1.2	3.1	1.0	0.4	4.1	16.2	69.8	0.4	1.0	22.8	3.8	0.2	9.2	0.5	8.6	17.9	24.5	6.4	1.6	0.1	0.0	0.4	2.4	4.6	1.2	31.5	19.5	15.4	12.9	1.7	2.0	27.7	14.2	8.9	28.2	17.3	29.8	14.5	8.0	14.1	9.3	21.9	27.2	21.1	24.4	26.5	2.6	8.3	9.3	15.0	21.4	1.4	4.1	4.9	1.0	1.2	16.2	9.4	3.4	15.4	3.6	8.2	11.6	16.0	17.0	6.3	6.0	12.8	18.4	24.9	6.1	28.5	4.4	8.1	8.1	7.1	11.9	41.5	34.7	6.1	15.0	21.7	4.2	7.3	18.7	23.0	21.2	31.3	3.5	5.4	8.3	8.4	6.1	13.7	0.0	0.0	0.0	0.7	0.4	2.3	1.6	2.4	2.7	0.1	1.6	2.7	3.4	0.0	2.4	0.1	0.0	4.6	1.2	0.5	0.8	0.4	1.2	0.5	0.1	0.3	0.5	0.7	0.2	0.0	2.2	0.0	5.2	2.1	0.0	0.8	0.0	1.4	1.2	0.0	0.0	2.6	0.0	0.0	0.4	0.5	2.6	23.3	0.0	36.2	0.9	0.7	0.0	5.4	4.0	0.0	1.7	1.8	2.1	0.6	0.3	0.4	0.0	0.0	2.2	0.0	0.1	3.7	0.0	4.3	0.0	19.4	2.1	11.1	14.5	1.6	127.6	2.2	2.5	4.3
FAM83F		ENSG00000133477	"Family with sequence similarity 83 member F"	Q8NEG4	22	39994949-40043529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.4;seminal vesicle: 33.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 31.6;Late spermatids: 52.5;Suprabasal keratinocytes: 30.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.1;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 23.0;hTERT-HME1: 7.2;OE19: 10.3;RT4: 11.0;SCLC-21H: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051207, HPA064657"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA051207: AB_2681388, HPA064657: AB_2685313"	"unprognostic (2.78e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.36e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.79e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-7)"	"unprognostic (2.93e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.32e-2)"	1.1	0.2	0.1	2.8	0.2	0.8	4.7	0.2	0.3	2.6	6.9	0.1	29.4	3.0	0.2	7.5	15.4	1.1	4.0	1.5	0.2	0.1	4.8	2.1	1.0	0.1	0.2	0.1	0.5	14.4	2.6	2.6	0.5	0.1	6.3	3.1	0.4	7.8	33.3	0.1	13.8	12.5	0.8	0.2	0.1	5.9	24.9	0.1	1.3	12.6	12.8	8.1	3.0	4.1	0.7	0.5	2.7	0.4	0.6	0.3	0.1	4.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	7.1	1.4	0.0	0.0	0.0	0.0	7.6	0.0	9.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	23.0	0.0	7.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	10.3	0.0	0.0	0.0	0.0	0.1	11.0	24.3	0.0	0.2	2.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.3	2.2	0.6	0.3	0.5	0.1	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	11.8	25.4	0.5	5.1	2.5	2.7	1.2	22.7	0.0	0.1	3.3	8.6	20.7	0.8	31.6	0.0	13.2	0.1	1.6	13.1	1.1	1.0	0.2	0.0	12.6	0.0	0.8	52.5	1.7	0.9	1.7	0.0	18.3	1.0	11.4	20.1	2.1	5.0	0.7	0.0	0.8	7.2	2.2	30.2	1.1	0.0	12.7	15.2
FAM83H	FLJ46072	ENSG00000180921	"Family with sequence similarity 83 member H"	Q6ZRV2	8	143723933-143733801	"Disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.2;lymphoid tissue: 30.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 19.7;MCF7: 27.0;RT4: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024505, HPA024604"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA024505: AB_1848417, HPA024604: AB_1848418"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (9.69e-3)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	0.8	1.9	1.2	4.1	1.0	0.2	2.9	0.2	1.6	8.8	12.5	0.9	6.1	6.3	1.1	3.0	42.2	3.0	17.7	0.3	1.1	0.4	5.0	10.4	3.9	0.5	0.3	0.6	1.3	6.7	5.9	2.8	8.9	0.9	5.6	2.7	2.6	8.3	2.9	0.1	17.7	17.9	1.8	0.7	0.7	9.1	1.3	0.2	1.1	6.9	27.9	30.7	5.1	9.5	0.3	0.2	0.5	0.3	0.1	0.2	0.0	13.8	6.5	0.0	0.0	0.0	0.0	12.2	0.9	0.0	0.4	0.1	5.9	12.5	0.0	10.1	0.2	0.0	19.7	0.8	12.1	0.2	1.0	2.2	0.3	13.0	4.1	1.0	0.3	0.9	0.7	14.3	0.0	3.6	0.2	0.0	0.9	7.3	0.0	0.0	27.0	0.2	0.0	2.5	14.3	6.0	0.0	0.0	1.3	3.9	16.2	3.8	0.0	10.9	12.7	2.1	1.8	13.7	1.8	0.0	0.0	3.9	0.9	0.0	1.9	2.0	0.0	0.0	0.0	0.6	0.3	0.3	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	1.2	1.0	0.2	1.6	1.1	0.4	0.3	0.6	0.9	0.2	29.8	16.8	0.0	12.2	20.3	1.2	3.6	22.9	9.4	12.5	27.9	2.0	10.1	3.3	18.5	1.1	1.2	29.9	0.0	22.0	15.5	1.8	19.5	0.0	21.2	4.0	9.5	13.8	0.6	1.9	0.0	0.0	1.1	1.7	3.6	23.7	6.0	31.6	21.5	0.4	6.5	2.1	0.0	1.2	1.2	1.0	23.5	12.2	0.8	22.5	29.2
FAM84A	"FLJ35392, NSE1"	ENSG00000162981	"Family with sequence similarity 84 member A"	Q96KN4	2	14632686-14650814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.0"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 143.9;Mucus-secreting cells: 133.7;Syncytiotrophoblasts: 173.8;Undifferentiated cells: 210.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.1;hTCEpi: 12.0;RT4: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047703	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047703: AB_2680123"	"unprognostic (1.05e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.36e-1)"	0.9	1.8	22.0	9.1	14.8	0.6	2.7	3.1	31.8	9.9	34.0	1.7	0.9	22.4	3.0	29.0	22.6	2.8	5.6	2.1	7.7	7.7	3.3	1.8	5.6	0.8	3.6	11.2	7.9	3.3	2.0	3.0	5.9	2.4	11.1	31.9	1.6	15.9	2.5	1.3	14.4	21.3	3.0	2.5	0.8	3.0	20.0	3.9	0.6	2.2	10.4	3.8	9.5	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	1.6	0.4	0.3	0.0	0.2	0.0	0.0	0.2	0.0	6.1	0.6	2.7	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	12.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.8	4.9	0.0	0.1	0.5	0.0	2.6	0.0	0.0	0.1	4.6	31.9	2.8	1.3	0.0	1.2	0.0	0.2	0.0	0.0	1.9	5.5	0.4	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	14.8	3.1	31.8	7.7	7.7	3.6	11.2	2.4	3.9	0.0	1.4	2.4	19.6	10.0	1.7	1.5	2.5	8.1	5.7	29.6	0.0	143.9	10.0	2.2	8.0	14.9	93.2	0.0	6.4	16.6	4.4	47.3	10.3	0.9	10.6	0.0	47.6	30.7	3.8	9.6	4.6	1.1	6.8	1.0	133.7	13.7	5.4	57.5	2.8	0.8	1.1	0.0	11.3	0.5	0.9	23.1	173.8	1.7	210.4	69.9
FAM84B	"BCMP101, NSE2"	ENSG00000168672	"Family with sequence similarity 84 member B"	Q96KN1	8	126552442-126558393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 21.6;AN3-CA: 31.3;MCF7: 31.6;PC-3: 21.5;SuSa: 50.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050782, HPA062115"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050782: AB_2681235, HPA062115: AB_2684686"	"unprognostic (2.46e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (2.75e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.07e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (2.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.75e-5)"	8.1	3.0	6.0	6.5	8.2	2.2	20.0	8.7	6.8	10.0	8.0	10.8	11.4	10.7	10.5	11.2	20.9	7.2	16.4	4.8	7.7	5.1	23.5	10.2	10.7	4.7	13.9	3.8	3.7	13.8	9.0	5.6	7.8	11.0	7.3	7.0	18.6	33.3	13.2	2.0	7.5	6.3	4.0	6.2	2.8	14.1	2.7	10.3	1.9	8.3	5.4	8.1	6.3	11.2	1.6	0.1	2.7	0.1	1.9	5.3	1.6	21.6	2.8	1.7	31.3	0.0	0.0	2.1	0.3	0.8	0.2	0.3	0.8	13.0	0.0	14.4	0.0	2.4	9.8	0.9	4.2	0.4	0.0	18.7	0.0	0.0	0.1	0.4	0.0	0.4	0.1	6.0	0.0	2.6	5.2	1.8	5.6	0.0	0.0	0.1	31.6	0.7	0.0	1.6	18.4	21.5	0.0	0.7	0.2	12.8	9.4	8.6	0.0	0.7	10.3	9.3	50.8	15.5	0.2	0.0	0.1	2.9	0.0	0.6	0.4	0.0	0.0	0.2	1.4	5.8	2.5	0.1	2.7	2.7	0.0	2.5	0.6	3.6	5.3	0.0	1.6	3.9	4.0	0.3	1.9	0.0	0.1	4.7	1.6	6.0	8.2	8.7	5.3	7.7	5.1	13.9	3.8	11.0	10.3	11.9	29.5	3.2	9.0	14.9	1.9	5.3	15.3	4.0	13.6	40.1	62.8	4.4	6.6	23.9	0.6	22.7	7.9	0.0	11.6	1.6	8.5	16.8	0.0	20.3	1.3	52.4	26.5	22.7	4.1	1.0	0.6	2.9	33.7	0.0	16.0	31.4	26.7	10.5	0.4	32.9	6.5	0.0	3.9	0.7	0.7	15.3	2.4	5.7	17.5	22.1
FAM89A	"C1orf153, MGC15887"	ENSG00000182118	"Family with sequence similarity 89 member A"	Q96GI7	1	231018958-231040246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 39.6;placenta: 48.3"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 143.5;Extravillous trophoblasts: 248.1;Rod photoreceptor cells: 96.4;Syncytiotrophoblasts: 232.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 52.2;SK-MEL-30: 27.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA059052, HPA059578"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA059052: AB_2683890, HPA059578: AB_2684070"	"unprognostic (7.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.05e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.26e-2)"	39.6	12.9	8.0	3.7	8.5	3.9	32.8	3.9	5.4	5.1	3.6	4.9	2.0	1.6	5.7	2.1	3.4	2.7	4.6	4.7	7.9	11.2	8.7	5.7	10.5	6.7	14.0	2.3	4.7	15.0	4.0	4.2	48.3	13.1	4.7	2.4	12.0	3.5	3.9	4.2	14.1	1.8	3.5	10.9	9.6	3.1	2.8	8.3	0.8	3.9	5.0	3.6	4.3	9.7	1.2	0.0	4.3	0.7	0.3	3.0	0.8	0.3	4.8	2.2	4.7	5.5	1.1	52.2	2.7	2.0	1.0	1.8	7.3	4.3	0.0	0.6	1.7	6.0	2.9	4.2	0.6	0.8	14.5	10.2	2.3	0.1	0.3	21.2	1.7	12.6	18.4	9.5	0.0	4.8	0.0	2.6	5.3	18.0	3.0	0.9	1.7	1.1	3.0	3.3	4.3	1.5	5.7	7.3	5.5	3.6	5.1	2.0	5.8	0.9	0.4	27.3	5.2	0.2	10.1	0.4	8.2	0.0	0.1	5.0	6.6	7.9	4.0	2.4	3.4	16.1	4.3	0.7	0.0	0.6	0.1	1.1	1.2	0.8	1.5	0.0	0.6	1.3	3.0	0.0	0.3	0.2	0.0	0.0	0.8	8.0	8.5	3.9	5.4	7.9	11.2	14.0	2.3	13.1	8.3	0.0	1.6	2.7	15.8	26.8	32.0	3.0	2.5	0.0	1.2	0.0	72.6	143.5	3.3	2.1	1.1	20.1	0.0	0.0	2.9	248.1	6.4	12.7	4.6	10.6	41.7	7.9	0.0	5.5	13.1	1.8	2.6	3.0	20.3	0.0	0.4	22.8	4.3	0.0	1.4	4.4	96.4	0.0	2.1	3.8	8.9	28.7	232.7	2.2	0.9	13.3
FAM8A1	AHCP	ENSG00000137414	"Family with sequence similarity 8 member A1"	Q9UBU6	6	17600355-17611719	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 685.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044698, HPA073675"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA044698: AB_2679051, HPA073675: AB_2732236"	"unprognostic (4.06e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.17e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.98e-1)"	14.7	13.0	19.8	8.3	21.1	21.1	15.2	23.7	22.6	17.2	16.2	10.8	23.8	12.9	21.4	15.4	11.1	16.7	16.4	11.8	17.7	17.8	18.8	58.7	14.5	14.6	17.3	16.5	22.6	17.8	19.0	16.2	11.5	17.5	16.9	18.1	8.7	16.3	31.4	17.5	13.1	15.9	19.7	17.9	10.5	12.0	28.4	16.4	15.1	18.3	10.5	6.4	15.0	16.2	0.2	0.4	9.0	0.6	2.6	2.0	0.5	4.8	1.9	7.2	17.1	25.0	23.6	5.9	7.9	10.8	4.0	7.1	11.1	1.6	4.2	19.0	13.3	4.4	4.0	10.8	6.8	5.4	3.5	15.4	5.0	6.8	23.7	11.1	3.1	5.2	12.4	11.1	4.6	3.3	13.1	9.0	4.7	10.1	8.6	6.4	5.9	2.3	9.8	3.0	6.0	3.0	6.2	7.0	12.6	13.8	3.9	2.2	11.5	6.1	13.3	12.0	13.0	15.4	4.9	6.9	5.2	1.8	8.0	2.8	7.2	6.0	4.1	4.7	3.7	7.1	4.2	0.5	1.5	1.9	0.6	2.0	0.0	0.9	1.6	0.3	0.2	1.2	1.9	9.0	2.6	0.4	0.4	0.6	0.5	19.8	21.1	23.7	22.6	17.7	17.8	17.3	16.5	17.5	16.4	17.9	19.0	3.0	8.6	11.8	26.8	12.2	15.3	12.0	14.8	27.9	13.7	8.4	5.0	7.4	685.5	9.3	26.4	0.0	6.8	10.4	12.6	10.7	1.1	67.4	5.4	14.3	11.5	23.9	20.0	149.2	33.9	6.5	5.0	1.0	11.3	17.4	7.3	17.5	29.0	11.4	15.3	32.3	17.5	30.6	16.8	13.9	10.2	10.2	13.4	7.0
FAM90A1	FLJ10408	ENSG00000171847	"Family with sequence similarity 90 member A1"	Q86YD7	12	8221260-8227618	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.8"	"Cell type enhanced"	"Detected in some"	15	"Cholangiocytes: 2.5;Early spermatids: 1.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"classical monocyte: 1.1;myeloid DC: 2.8;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.8;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;HDLM-2: 7.9;NTERA-2: 19.1"									HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (2.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.69e-3)"	"unprognostic (1.94e-4)"	"unprognostic (4.37e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.30e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.06e-2)"	0.2	2.5	2.1	1.2	4.1	0.1	0.3	4.1	9.8	0.3	0.2			0.6	1.9	1.4	1.0	1.6	2.9	2.0	2.3	2.7	0.5	0.0	1.4	0.8	2.2		5.8	2.5	0.0	3.3	0.4		1.7	0.0		2.8	0.6	0.4	2.3	0.3	0.2	1.8	0.7	0.4	2.1			3.1		0.1	0.6	0.5	0.1	2.8	0.0	1.1	0.1	0.2	0.2	0.0	0.0	0.7	1.3	0.2	0.0	5.3	0.4	0.4	0.1	0.0	0.0	2.2	0.3	0.9	0.1	0.3	0.0	3.4	0.0	0.0	7.9	0.4	0.5	0.0	0.1	0.0	0.1	0.0	0.5	1.3	0.3	0.2	2.5	0.2	0.8	2.9	0.4	0.0	1.1	0.1	2.9	19.1	0.0	0.0	0.2	0.1	0.0	1.3	0.4	0.2	0.4	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.8	0.0	0.2	0.1	0.4	2.9	0.0	2.0	2.5	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.1	0.2	2.0	0.0	0.2											0.0	0.0	0.0	0.0	0.1	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.3	0.5	0.7	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.0
FAM90A26	FAM90A26P	ENSG00000229924	"Family with sequence similarity 90 member A26"		4	9170409-9176730	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 1.1"									HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (1.80e-2)"				"unprognostic (3.76e-1)"			"unprognostic (1.56e-1)"		"unprognostic (1.37e-2)"			"unprognostic (2.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.41e-1)"		0.0	0.6	0.1	0.0	0.3	0.1	0.1	0.2	1.6	0.0	0.0			0.0	0.1	0.1	0.0	0.3	0.4	0.3	0.1	0.1	0.0	0.1	0.2	0.0	0.0		0.7	0.3	0.0	0.2	0.0		0.2	0.0		0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM91A1	FLJ23790	ENSG00000176853	"Family with sequence similarity 91 member A1"	Q658Y4	8	123768456-123815452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027978	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Nucleoplasm, Microtubules"		"HPA027978: AB_10600004"	"unprognostic (2.21e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	21.9	15.3	12.2	16.1	14.3	39.1	17.3	17.2	15.2	17.3	18.7	11.8	26.7	15.3	16.4	15.5	20.0	13.6	17.3	14.6	12.6	14.4	20.0	30.6	18.4	17.9	15.4	11.6	18.8	15.4	25.2	20.3	26.9	15.6	14.0	16.3	16.1	18.0	24.2	9.2	17.1	23.0	12.8	18.4	31.3	14.4	11.9	14.0	24.4	19.8	12.0	20.0	15.3	16.2	5.7	8.9	12.0	10.4	6.6	4.3	4.2	25.6	17.3	5.5	9.4	10.4	11.3	8.7	14.9	16.2	14.2	18.1	8.5	10.6	12.1	16.7	12.2	11.4	12.6	12.7	16.1	25.3	23.0	12.3	19.0	9.1	10.2	16.3	8.7	24.7	10.6	13.0	18.4	23.1	9.7	12.7	7.7	6.7	17.2	12.7	30.2	14.9	5.7	5.3	21.2	15.6	8.1	8.9	8.9	11.9	26.4	6.5	9.1	19.7	42.6	19.8	8.3	13.1	9.2	12.8	13.5	24.4	14.9	21.6	13.5	25.8	11.7	21.2	15.7	16.4	6.9	8.3	12.0	3.8	10.4	3.4	5.7	3.8	3.2	8.9	5.0	3.3	4.3	11.4	6.6	9.1	3.5	3.3	4.2	12.2	14.3	17.2	15.2	12.6	14.4	15.4	11.6	15.6	14.0	23.8	10.4	19.1	15.9	35.1	12.6	5.6	35.7	4.0	14.8	24.4	21.6	9.7	5.0	10.6	18.5	22.5	17.3	23.3	13.5	10.2	17.4	24.8	8.1	50.5	23.8	22.3	26.4	21.5	65.1	17.5	13.0	29.0	20.3	10.0	18.8	17.4	25.8	17.5	13.8	14.7	19.9	12.9	20.8	11.2	10.5	40.8	16.0	17.5	13.3	39.9
FAM92A	"FAM92A1, FLJ38979"	ENSG00000188343	"Family with sequence similarity 92 member A"	A1XBS5	8	93698561-93731527	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.0"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 46.8;Distal tubular cells: 34.9;Proximal tubular cells: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA034760, HPA058942"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA034760: AB_10599947, HPA058942: AB_2732628"	"unprognostic (2.65e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.48e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.07e-2)"	11.2	13.3	15.9	4.2	14.7	2.8	8.4	13.6	19.1	9.4	7.0	2.9	5.5	2.8	12.0	19.9	5.5	10.1	10.5	16.3	12.9	11.2	15.3	11.4	7.1	4.2	8.4	15.9	13.8	15.1	15.2	21.6	7.5	9.7	9.8	4.8	5.2	3.3	9.2	6.9	5.1	4.1	11.1	6.2	3.7	5.4	71.0	6.4	1.8	9.4	3.1	2.7	11.6	10.6	0.9	6.2	0.3	3.8	2.8	1.6	1.0	13.6	7.3	19.7	20.3	21.3	30.6	5.3	12.5	18.3	17.0	16.4	1.3	3.1	1.1	16.3	18.4	19.5	9.8	19.9	11.9	15.4	0.4	11.0	8.0	7.3	6.7	24.5	0.3	2.0	19.3	5.3	16.6	13.6	24.5	18.1	6.7	4.7	0.6	13.3	5.1	8.4	1.4	8.3	0.3	0.4	0.8	14.8	0.2	13.3	3.1	5.7	7.3	9.0	0.1	15.1	9.3	3.0	4.2	10.0	16.7	6.7	17.3	10.1	0.9	0.9	0.4	14.6	1.1	5.8	0.3	3.8	0.0	0.4	2.2	0.5	0.9	1.1	0.4	6.2	0.2	0.2	0.7	0.1	2.8	0.3	0.8	1.6	1.0	15.9	14.7	13.6	19.1	12.9	11.2	8.4	15.9	9.7	6.4	8.9	6.5	0.0	0.0	0.0	0.0	0.0	0.0	46.8	15.9	7.0	0.0	10.8	34.9	16.9	0.0	0.0	0.0	0.0	14.8	11.6	0.0	0.0	3.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.8	0.0	0.0	14.6	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0
FAM98A	DKFZP564F0522	ENSG00000119812	"Family with sequence similarity 98 member A"	Q8NCA5	2	33583658-33599382	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036250, HPA036251"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA036250: AB_2675020, HPA036251: AB_10673124"	"unprognostic (7.25e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (4.86e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (6.01e-2)"	19.5	18.5	17.6	13.5	19.7	4.5	11.6	15.0	27.1	16.4	13.8	23.5	9.3	9.6	16.1	14.0	16.4	9.6	11.7	26.6	22.5	16.3	19.2	19.1	9.6	11.6	20.9	17.9	13.8	11.8	57.7	26.4	26.6	26.0	16.8	12.3	8.4	24.8	12.4	38.4	11.5	9.9	24.8	23.4	11.5	13.5	36.3	16.5	8.2	14.8	17.7	14.8	12.6	10.1	12.0	6.8	3.0	8.9	4.4	10.0	4.6	25.6	12.8	7.4	12.4	29.3	32.0	11.7	63.8	22.9	17.5	23.0	13.4	5.3	39.5	11.8	27.8	16.1	11.6	23.4	17.5	23.9	18.2	15.8	32.8	13.7	18.7	14.1	26.1	12.7	16.9	11.9	23.7	15.3	18.4	23.0	4.3	22.4	12.2	30.7	12.5	14.4	7.6	18.3	23.3	17.1	11.4	23.9	14.1	18.3	19.7	13.1	7.4	16.6	25.8	7.5	12.3	10.7	4.2	38.5	11.2	19.2	23.8	25.0	23.3	28.0	39.2	26.7	19.0	15.8	1.3	4.9	3.0	8.0	8.9	8.3	12.0	6.6	6.8	6.8	7.2	8.8	6.9	0.1	4.4	4.8	4.2	10.0	4.6	17.6	19.7	15.0	27.1	22.5	16.3	20.9	17.9	26.0	16.5	20.8	7.8	18.6	10.5	18.1	16.4	65.5	15.3	17.4	22.7	7.0	2.0	22.5	21.6	19.1	11.3	17.8	6.0	0.0	25.2	27.8	19.2	13.5	2.3	20.3	14.5	44.5	5.2	20.3	8.9	11.4	20.8	10.3	8.5	2.8	11.1	17.0	21.8	10.4	20.5	32.6	14.2	0.0	19.8	31.5	44.9	17.9	33.4	8.7	9.1	21.7
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	15.6	15.6	20.4	16.9	21.0	10.8	17.0	27.3	24.4	13.7	19.3	12.7	8.7	12.5	17.9	12.9	14.9	14.5	11.0	15.8	20.1	19.6	17.7	10.1	10.6	16.3	18.6	20.3	15.6	10.6	27.5	18.3	20.1	17.7	16.5	15.7	9.3	11.2	14.2	16.2	11.5	12.8	17.4	21.0	13.8	12.0	13.0	14.0	27.4	15.7	12.3	16.8	14.8	13.4	3.5	2.5	3.7	1.1	3.8	6.6	0.7	13.8	7.4	36.5	18.6	6.8	12.5	17.8	17.8	13.0	17.6	17.8	16.3	6.7	9.5	19.7	14.7	17.9	14.7	22.0	18.2	24.8	9.8	11.9	28.2	17.0	12.5	9.8	26.7	16.3	11.5	11.4	15.7	18.3	13.0	18.0	21.2	20.2	12.0	16.8	6.2	22.5	14.3	19.6	15.8	10.3	24.0	19.7	8.0	15.2	18.3	22.5	23.1	19.6	12.6	8.5	17.1	15.4	16.5	15.0	20.1	24.5	13.3	19.9	22.5	20.1	34.8	11.0	17.7	20.8	3.7	0.9	2.5	5.3	0.8	4.6	2.8	5.4	4.4	1.1	3.5	6.6	5.1	0.8	3.8	1.1	2.5	3.3	0.7	20.4	21.0	27.3	24.4	20.1	19.6	18.6	20.3	17.7	14.0	14.9	18.4	13.2	9.5	13.1	35.6	45.7	15.3	22.7	21.6	15.7	15.7	27.3	6.6	14.9	2.3	13.7	9.3	0.0	17.1	17.8	11.1	9.8	12.7	9.4	10.9	19.1	12.1	14.7	14.2	1.7	11.5	11.9	5.0	22.6	19.3	14.8	12.6	5.8	15.9	11.3	27.6	6.5	10.0	28.6	14.6	12.9	18.0	14.9	17.3	12.3
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (5.53e-4)"	10.8	8.9	18.3	9.3	16.9	11.0	9.8	17.0	19.9	8.7	14.2	12.8	9.0	19.6	9.9	7.2	14.3	13.8	9.1	11.6	16.0	13.1	9.1	13.4	8.7	9.5	12.3	16.9	10.2	22.4	10.6	8.1	7.6	13.0	12.5	7.0	8.2	17.7	9.5	2.5	17.0	22.2	6.8	12.7	10.1	19.2	5.4	9.7	5.3	11.8	7.7	11.2	9.4	9.5	6.0	3.2	12.6	3.4	3.3	5.6	1.6	10.9	11.9	1.4	6.9	1.5	5.2	6.1	6.4	5.4	6.3	6.7	2.0	8.0	10.0	7.2	3.7	2.2	5.3	2.7	4.6	1.0	16.1	5.6	3.2	2.0	4.6	6.8	2.8	6.0	5.0	9.6	3.2	5.8	3.5	3.7	16.4	9.0	11.0	3.7	12.1	4.0	2.1	1.0	18.2	12.8	8.3	2.9	5.9	7.7	5.8	2.4	7.1	6.4	11.4	3.8	0.7	8.6	8.7	4.8	2.8	7.8	8.8	7.6	11.9	6.0	4.2	7.4	6.5	4.5	0.0	2.3	12.6	3.1	3.3	4.2	2.6	5.6	4.6	3.2	6.0	4.3	3.4	2.0	3.3	3.4	1.2	4.4	1.6	18.3	16.9	17.0	19.9	16.0	13.1	12.3	16.9	13.0	9.7	8.9	9.9	17.1	21.7	19.2	13.2	4.3	10.2	6.7	5.7	22.7	11.8	10.3	18.3	17.4	5.0	9.3	43.8	0.0	28.7	9.4	10.0	14.8	15.0	11.9	9.9	11.1	24.6	10.4	10.5	2.1	17.3	14.7	21.9	12.6	32.7	11.1	19.7	34.5	17.3	15.9	11.6	12.9	11.4	27.3	41.1	26.1	5.1	20.3	33.5	22.0
FANCD2OS	"C3orf24, MGC40179"	ENSG00000163705	"FANCD2 opposite strand"	Q96PS1	3	10081317-10108231	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 53.0"	"Group enriched"	"Detected in some"	88	"Early spermatids: 499.8;Late spermatids: 668.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.8;Daudi: 1.5;HEL: 2.5;MCF7: 2.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA076166			Approved	Vesicles		NA	NA			Vesicles		"HPA076166: "	"unprognostic (5.99e-2)"	"unprognostic (4.33e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.63e-2)"		"unprognostic (4.78e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.11e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	8.4	1.6	0.4	0.4	0.1	0.3	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	0.6	1.5	0.7	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	2.3	1.3	0.0	0.1	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.8	0.2	0.1	0.0	1.2	0.6	0.3	0.9	0.6	0.4	0.5	0.3	0.3	0.4	0.2	0.4	0.2	0.1	0.8	0.3	0.3	8.4	0.4	1.6	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	499.8	0.0	0.0	0.0	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	668.2	6.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.0	5.1	2.4	0.0	0.0	0.0	0.0	0.0
FANCG	"FAG, XRCC9"	ENSG00000221829	"Fanconi anemia complementation group G"	O15287	9	35073835-35080016	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 17.3;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008105, HPA045335"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"	Nucleoli	"CAB008105: AB_2231542, HPA045335: AB_2679292"	"unprognostic (9.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	5.8	5.0	4.4	7.1	6.5	14.9	7.5	13.9	8.5	6.2	5.9	5.3	8.4	6.7	6.8	3.2	9.2	8.6	4.7	5.9	7.6	4.0	5.2	4.5	5.1	9.9	8.7	4.4	9.2	17.0	6.7	4.8	7.6	6.6	7.0	5.5	3.5	8.7	9.7	2.9	8.9	6.5	6.4	4.2	8.6	5.8	8.9	7.6	25.6	9.3	4.8	9.2	6.8	6.9	6.8	4.8	8.9	2.5	8.8	9.2	3.4	15.7	19.6	14.4	13.3	3.2	5.1	12.1	11.1	8.0	21.8	21.0	9.3	9.9	15.6	7.7	3.5	15.6	9.7	11.9	10.2	8.4	18.3	7.2	11.2	21.0	5.7	0.9	11.3	12.9	4.2	2.0	19.0	8.6	3.8	11.1	19.2	7.3	21.0	11.0	14.0	19.1	15.6	14.9	11.8	15.1	19.9	16.9	11.0	5.1	6.7	7.0	12.7	7.3	10.4	4.1	6.5	13.5	8.2	6.7	10.4	20.7	13.3	14.9	5.7	10.8	9.4	9.2	8.4	14.2	8.9	0.8	7.7	7.4	2.5	6.5	6.8	6.1	5.7	2.2	6.5	4.8	5.0	1.3	8.8	2.3	4.8	9.2	3.4	4.4	6.5	13.9	8.5	7.6	4.0	8.7	4.4	6.6	7.6	3.0	5.8	5.2	3.6	3.9	4.3	1.0	0.0	0.0	2.3	3.5	3.9	8.2	3.3	3.7	0.3	2.8	1.6	0.0	2.0	17.3	3.8	3.5	13.9	1.0	6.5	4.8	1.7	3.7	0.3	0.4	3.1	2.0	3.3	3.6	3.9	3.5	2.3	3.2	3.9	1.7	3.0	0.0	2.7	10.9	23.7	2.3	5.5	5.3	5.0	3.3
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"Fanconi anemia complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 62.5"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"		NA	Yes			"Nuclear bodies"	Vesicles	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (7.80e-5)"	6.3	29.2	16.0	11.2	22.9	10.6	16.2	7.1	18.1	11.6	9.6	30.7	7.9	9.2	16.6	15.7	8.6	11.7	9.8	10.2	17.0	23.5	7.1	16.7	7.7	10.9	25.0	15.2	21.3	10.8	16.8	62.5	10.0	33.5	11.6	12.4	13.7	14.8	9.1	6.5	14.4	10.1	11.3	23.4	12.0	10.5	14.7	28.2	8.6	14.2	6.9	12.0	10.1	12.7	10.8	7.1	5.6	6.9	8.8	5.5	2.7	18.5	13.5	27.6	13.5	4.9	6.5	14.7	13.6	8.5	13.5	17.6	11.9	23.3	12.8	17.7	4.4	18.6	10.8	15.3	10.3	22.6	30.1	24.2	21.0	19.0	16.1	5.3	20.2	11.6	4.8	4.9	9.9	3.9	12.0	10.6	9.2	19.5	11.7	9.2	9.4	7.1	25.1	29.8	29.7	2.8	13.5	21.0	10.0	11.8	18.3	31.3	15.7	19.4	8.0	12.7	15.5	7.4	13.6	6.2	12.1	18.2	8.8	15.0	12.1	7.6	7.5	25.7	13.7	18.3	2.7	3.7	5.6	4.9	6.9	3.8	10.8	4.1	5.4	7.1	10.0	1.4	3.1	1.1	8.8	4.9	6.5	5.5	2.7	16.0	22.9	7.1	18.1	17.0	23.5	25.0	15.2	33.5	28.2	17.9	18.3	5.8	13.7	9.2	12.4	13.2	5.1	20.1	10.3	8.7	3.9	25.0	10.0	6.9	1.7	10.5	7.3	0.0	3.6	12.2	8.9	6.8	10.4	10.4	9.4	7.9	8.6	10.4	8.5	1.7	10.0	6.9	25.3	9.0	16.3	20.3	4.6	13.1	13.4	4.1	18.8	12.9	8.1	47.7	30.4	5.9	6.2	5.0	13.6	5.9
FAR2	"FLJ10462, MLSTD1, SDR10E2"	ENSG00000064763	"Fatty acyl-CoA reductase 2"	Q96K12	12	29149103-29340980	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 162.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 26.3;HUVEC TERT2: 30.8;NB-4: 26.4;SK-BR-3: 32.5;TIME: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015884	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA015884: AB_1853998"	"unprognostic (6.32e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.13e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-3)"	9.4	7.2	9.8	6.9	17.4	12.0	7.6	5.1	18.2	4.6	25.7	3.2	6.1	13.3	6.2	29.4	6.0	3.7	4.2	5.4	12.8	10.9	4.0	3.1	8.6	6.7	9.4	10.4	2.1	2.6	1.0	2.9	19.2	6.6	2.8	22.3	4.1	4.8	1.7	4.5	8.7	14.0	6.0	5.1	12.3	3.7	8.4	5.9	7.2	3.5	4.5	2.3	6.6	4.3	0.9	4.0	23.7	11.5	1.8	7.6	4.4	0.9	1.8	1.8	0.4	2.6	10.1	0.8	7.6	9.0	2.1	2.0	3.0	10.3	1.3	2.0	1.0	1.5	0.5	4.7	0.0	0.5	0.6	11.8	26.3	4.2	0.9	5.4	10.5	8.8	2.8	0.0	3.2	4.1	5.4	30.8	1.0	2.3	1.0	0.3	0.3	6.7	26.4	7.1	0.5	20.1	5.6	2.9	1.1	9.5	2.6	3.1	2.8	1.7	32.5	12.9	3.8	1.5	9.9	25.0	5.7	1.7	2.0	3.3	1.6	1.7	0.6	9.1	13.8	4.9	1.3	11.5	23.7	2.7	6.9	1.8	0.9	4.5	3.2	4.0	0.7	1.5	1.7	20.7	1.8	3.7	1.5	7.6	4.4	9.8	17.4	5.1	18.2	12.8	10.9	9.4	10.4	6.6	5.9	0.0	3.5	0.0	0.1	1.1	1.9	8.7	0.0	4.0	2.3	0.0	0.0	14.0	0.0	0.0	16.3	11.1	22.3	0.0	0.2	16.9	4.3	0.4	10.4	0.0	16.4	4.8	6.9	3.7	19.8	4.2	1.1	7.2	15.1	1.0	19.9	0.4	1.9	31.9	0.4	0.3	1.1	0.0	3.3	0.2	0.9	0.3	162.1	4.4	19.4	0.1
FARP1	"CDEP, MGC87400, PLEKHC2, PPP1R75"	ENSG00000152767	"FERM, ARH/RhoGEF and pleckstrin domain protein 1"	Q9Y4F1	13	98142562-98455176	"Predicted intracellular proteins"		"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 146.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.0;Hep G2: 38.9;SuSa: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000760			Approved	Cytosol		NA	NA			Cytosol		"HPA000760: AB_1078816"	"unprognostic (4.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.18e-2)"	10.4	16.5	21.3	9.1	14.6	1.4	28.3	4.6	19.0	18.3	22.9	11.2	16.0	6.5	16.5	26.2	5.9	15.4	15.1	10.7	16.0	13.1	43.4	38.4	29.3	9.2	11.7	20.0	11.0	32.7	14.1	17.5	22.2	17.2	23.9	10.6	16.8	27.2	21.9	14.0	8.0	8.0	18.8	19.7	9.5	17.2	8.1	10.6	1.5	28.7	3.9	3.6	17.7	18.7	2.2	0.1	0.3	0.2	0.0	0.8	0.2	0.2	3.2	14.6	20.6	4.2	8.3	7.1	22.0	14.4	12.4	11.0	25.3	9.8	0.0	8.5	38.0	3.0	0.4	6.1	6.0	21.0	0.3	6.3	0.1	11.4	38.9	11.3	0.0	0.1	9.7	2.7	3.6	0.8	7.2	8.1	0.3	0.0	0.2	8.5	5.5	0.8	0.1	6.9	12.2	3.8	7.6	5.7	0.4	27.5	14.2	6.2	13.6	2.7	5.8	15.6	36.2	8.3	0.0	7.8	13.5	5.2	9.1	11.1	0.2	0.2	0.1	6.2	0.4	9.3	0.3	0.1	0.0	0.3	0.2	0.0	2.2	0.8	0.6	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	21.3	14.6	4.6	19.0	16.0	13.1	11.7	20.0	17.2	10.6	41.7	19.0	0.0	50.6	6.2	10.5	7.3	86.6	34.8	33.0	54.1	43.2	5.7	68.0	39.8	146.6	12.9	5.1	0.0	30.5	4.8	23.7	58.1	12.7	60.4	41.7	28.6	29.9	24.5	15.8	95.9	17.5	9.1	27.0	29.7	8.4	34.6	40.5	2.9	27.6	120.7	16.8	19.4	27.7	5.4	7.7	2.5	3.8	2.9	13.2	39.6
FARP2	"FIR, FRG, KIAA0793, PLEKHC3"	ENSG00000006607	"FERM, ARH/RhoGEF and pleckstrin domain protein 2"	O94887	2	241356243-241494841	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031226, HPA055592"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA031226: AB_10602808, HPA055592: AB_2682856"	"unprognostic (3.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-1)"	10.2	11.2	11.2	17.6	15.3	5.5	10.1	28.4	16.5	9.9	24.5	24.0	17.3	22.2	16.4	9.3	16.0	10.8	14.4	8.4	12.3	11.5	11.4	16.1	11.1	12.2	18.3	9.7	12.8	12.9	16.0	10.2	10.1	19.5	10.9	24.4	19.7	10.1	20.1	10.5	22.6	26.1	13.3	15.7	12.1	22.6	27.0	15.2	6.1	7.8	8.2	18.2	13.9	10.6	7.1	8.2	9.2	6.7	2.0	2.5	1.9	10.2	7.4	13.8	9.3	11.9	15.9	12.3	10.2	8.5	10.6	11.1	7.8	12.3	4.3	2.8	20.0	7.5	11.7	18.2	10.7	16.3	6.8	9.5	9.6	13.3	10.3	8.7	8.6	7.5	15.9	8.0	15.5	12.7	5.0	9.6	8.4	10.8	4.0	8.5	8.6	9.2	6.3	6.8	18.1	5.9	10.3	30.9	13.0	13.8	21.1	16.3	10.9	11.5	8.2	31.2	8.3	4.3	8.7	14.4	10.2	7.8	12.6	8.3	6.9	4.9	9.7	9.2	6.0	20.5	5.4	2.6	9.2	1.8	6.7	1.6	6.1	1.9	2.1	3.9	7.1	1.3	1.4	1.6	2.0	3.5	8.2	2.5	1.9	11.2	15.3	28.4	16.5	12.3	11.5	18.3	9.7	19.5	15.2	26.8	5.1	5.7	7.5	13.7	11.8	27.7	10.2	17.4	12.5	17.4	17.7	4.8	3.3	7.2	34.8	7.1	20.1	0.0	10.6	4.7	8.7	9.2	5.8	9.4	3.8	19.1	26.9	11.6	6.5	17.0	13.8	9.1	37.1	9.0	35.1	6.7	11.4	22.9	9.9	6.1	15.2	19.4	12.0	39.2	17.2	13.2	9.3	5.3	23.7	22.7
FARSA	"CML33, FARSL, FARSLA"	ENSG00000179115	"Phenylalanyl-tRNA synthetase alpha subunit"	Q9Y285	19	12922479-12934037	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001911	Enhanced		Approved	Cytosol		NA	NA		11000	Cytosol		"HPA001911: AB_1848427"	"unprognostic (1.52e-1)"	"prognostic favorable (8.23e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.22e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (8.32e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.84e-2)"	18.0	20.7	24.8	23.6	29.5	23.5	15.4	24.6	49.2	17.7	24.0	18.3	14.9	22.1	16.1	13.1	26.6	21.2	16.3	24.9	23.9	30.1	23.0	39.6	13.4	27.6	25.6	28.1	19.1	26.7	17.8	21.0	22.9	29.1	18.5	15.0	14.8	25.1	20.4	33.3	27.8	18.8	15.3	17.2	21.2	18.9	17.1	18.6	32.7	24.4	15.2	22.0	19.5	15.2	34.7	42.2	28.9	41.2	38.3	40.2	39.7	29.1	27.6	11.1	23.9	7.7	7.3	20.0	21.0	13.6	30.1	23.7	33.8	12.4	32.3	33.8	11.8	12.2	22.4	27.0	24.0	11.0	18.9	40.7	25.3	24.3	26.7	25.0	48.8	33.4	10.0	17.7	23.2	18.7	9.9	16.3	32.9	38.2	6.8	12.6	39.2	57.9	60.7	34.6	18.1	46.9	30.0	11.5	41.4	15.8	17.2	34.8	31.9	14.1	24.4	14.9	5.4	19.2	29.7	15.6	24.5	10.8	37.2	39.0	45.2	38.5	33.6	22.2	44.1	25.3	17.3	39.2	28.9	32.5	41.2	40.2	31.9	32.0	30.2	42.2	34.7	32.9	31.2	2.5	38.3	30.4	34.1	29.4	39.7	24.8	29.5	24.6	49.2	23.9	30.1	25.6	28.1	29.1	18.6	8.9	21.3	25.9	20.3	22.6	23.5	22.1	2.5	13.4	13.6	22.7	9.8	74.5	49.7	50.2	3.9	18.0	20.6	23.3	40.4	65.4	18.4	19.3	23.1	22.9	56.1	17.5	21.9	17.2	26.9	7.5	17.5	19.2	32.1	52.3	22.0	19.4	40.6	24.6	12.4	43.4	13.0	6.5	20.6	14.6	41.5	25.7	80.9	27.7	31.6	19.5
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990582-89015785	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 40.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 40.1;T-cells: 30.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.0;Karpas-707: 44.7"					"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	11900000	450000	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	13.5	26.3	6.1	17.3	7.7	12.4	10.6	2.1	7.2	15.6	14.2	6.1	7.0	5.9	15.7	16.6	14.1	14.2	14.5	8.9	8.2	2.7	11.7	21.9	28.6	15.6	6.0	3.9	24.7	4.1	4.5	4.6	9.0	7.5	22.3	21.3	4.4	7.1	8.5	4.3	9.6	16.3	12.5	10.2	15.3	5.0	7.3	5.1	12.5	10.0	15.8	14.4	14.8	21.4	3.0	4.0	40.1	6.8	1.2	30.9	3.9	8.7	3.4	1.8	5.6	14.5	21.4	0.0	19.2	19.5	0.7	3.8	0.0	9.5	1.7	7.4	18.0	3.2	1.4	0.3	16.2	1.3	28.0	2.8	0.1	1.8	5.7	13.9	0.9	0.4	26.5	14.5	12.0	26.0	9.4	1.7	6.4	0.0	44.7	19.6	0.8	2.8	1.4	0.2	0.0	0.9	0.2	0.1	1.8	27.1	2.8	0.1	0.1	2.8	0.0	0.3	2.8	6.1	0.3	4.2	6.2	3.4	5.7	4.4	17.5	1.8	0.1	5.1	3.5	1.8	11.3	3.2	9.4	3.3	3.9	4.8	3.0	10.4	7.2	4.0	0.7	1.2	3.4	40.1	1.2	6.8	0.0	30.9	3.9	6.1	7.7	2.1	7.2	8.2	2.7	6.0	3.9	7.5	5.1	53.6	14.4	3.7	100.3	40.8	0.0	1.2	15.3	21.4	21.6	8.7	0.0	0.4	0.0	6.7	5.4	8.4	12.0	0.0	3.8	0.2	34.9	22.7	3.5	15.3	5.0	1.6	8.1	2.5	6.9	3.5	17.5	12.7	11.8	20.8	15.0	17.1	4.3	0.0	13.1	11.5	0.7	6.5	33.4	4.8	1.3	38.3	0.3	37.9	23.2	22.7
FASTKD3	"FLJ23274, MGC5297"	ENSG00000124279	"FAST kinase domains 3"	Q14CZ7	5	7859159-7869037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068525, HPA074462"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA068525: AB_2685999, HPA074462: AB_2686692"	"unprognostic (5.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (6.66e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.53e-4)"	7.1	15.5	8.6	9.7	13.3	7.6	12.3	9.1	15.0	8.3	10.7	8.6	7.9	10.4	8.8	10.2	8.9	7.5	6.5	7.2	8.7	7.3	17.8	14.5	8.3	10.0	9.2	13.7	9.3	8.4	13.0	10.8	6.4	8.0	8.6	13.5	8.1	11.1	15.8	10.2	9.0	12.1	7.8	8.8	12.0	9.1	6.0	7.4	12.2	8.9	7.4	12.2	9.1	7.0	9.6	6.7	7.4	7.3	4.8	10.3	4.7	7.1	6.3	6.2	8.0	3.9	4.9	12.1	6.0	5.2	9.5	7.3	9.4	7.7	24.9	12.2	6.3	12.1	7.6	15.1	8.4	13.5	6.8	7.8	8.6	20.6	7.4	5.3	14.2	7.2	5.6	3.6	8.8	5.5	4.3	5.2	10.2	11.8	4.4	7.1	5.1	9.5	8.3	5.6	7.5	9.0	11.1	7.6	5.7	7.7	7.7	4.3	4.1	18.1	8.0	8.8	5.8	7.2	6.6	3.5	9.4	9.6	9.7	9.9	5.1	4.8	15.9	6.2	13.2	7.6	3.8	5.4	7.4	6.1	7.3	8.2	9.6	9.4	6.5	6.7	6.8	10.3	9.7	0.2	4.8	5.7	3.8	10.2	4.7	8.6	13.3	9.1	15.0	8.7	7.3	9.2	13.7	8.0	7.4	14.9	5.1	5.2	1.9	2.3	2.9	3.6	7.6	5.3	0.0	0.0	0.0	6.3	5.0	7.2	0.4	4.3	8.0	0.0	10.3	7.0	4.6	2.3	3.5	9.9	7.3	4.8	6.9	4.9	7.0	0.4	4.9	5.8	1.7	14.4	6.2	3.5	9.3	3.5	4.2	14.9	5.1	0.0	5.1	3.4	5.4	4.8	3.5	6.9	6.6	1.6
FAT4	"CDHF14, CDHR11, FAT-J"	ENSG00000196159	"FAT atypical cadherin 4"	Q6V0I7	4	125316399-125492932	"Cancer-related genes, Disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Endothelial cells: 11.1;Fibroblasts: 9.3;Ito cells: 30.7"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.3;ASC TERT1: 9.1;fHDF/TERT166: 8.9;HSkMC: 10.5;HUVEC TERT2: 11.1;TIME: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052819	Approved		Approved	Cytosol		NA	NA		7900000	Cytosol		"HPA052819: AB_2681963"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.81e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-3)"	3.8	0.5	0.9	0.8	0.7	0.0	3.2	0.0	0.5	4.4	7.1			0.3	2.7	0.6	1.9	2.1	4.1	5.0	1.0	0.4	2.6	2.0	5.3	0.1	0.9		5.3	0.5	6.7	0.4	2.5		3.6	1.9		1.0	2.3	1.1	1.4	2.4	3.3	0.6	2.1	2.4	0.1			3.9		0.2	3.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	6.0	0.6	12.3	9.1	0.0	2.0	2.4	1.0	1.0	0.0	0.3	0.0	2.5	8.9	1.2	0.0	2.2	2.5	0.6	0.0	1.0	1.3	2.5	0.0	4.0	0.8	0.0	10.5	1.4	0.5	5.5	7.2	11.1	0.0	0.0	1.6	5.0	0.1	0.4	0.0	0.4	0.0	0.2	0.7	1.2	0.0	0.1	0.0	0.1	1.2	0.3	0.0	0.0	0.3	0.0	0.0	17.3	6.1	1.7	2.1	0.9	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0											6.0	0.0	0.0	0.1	1.4	1.3	5.3	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.7	0.8	11.1	0.0	0.0	0.2	0.0	9.3	0.1	0.0	6.8	0.2	0.0	0.0	30.7	2.4	0.0	5.5	0.0	3.3	0.0	0.0	1.2	0.2	0.0	4.6	0.6	0.1	0.0	3.9	0.0	0.6	0.5	0.0	0.0	0.0	0.0
FAXC	"C6orf168, dJ273F20, MGC2817"	ENSG00000146267	"Failed axon connections homolog"	Q5TGI0	6	99271169-99350062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 17.5;Bipolar cells: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.2;HAP1: 14.5;SCLC-21H: 21.3;SH-SY5Y: 14.8;SK-MEL-30: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039106	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039106: AB_10697546"	"unprognostic (8.03e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (2.47e-3)"	"unprognostic (6.70e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.49e-3)"	0.7	3.3	9.4	2.1	12.2	0.4	4.6	11.0	19.7	1.8	13.3	1.8	5.1	2.3	4.5	15.3	8.6	2.4	3.5	1.3	7.7	10.3	2.5	0.3	2.3	0.4	9.1	9.9	3.4	2.2	9.3	10.4	1.4	7.5	10.1	4.3	1.4	5.8	15.1	0.9	0.4	2.1	19.1	4.8	0.8	5.2	2.8	1.6	0.0	2.0	0.2	0.5	13.6	1.7	1.2	0.6	1.4	0.6	0.8	0.4	0.0	2.3	1.9	6.4	8.8	0.0	0.0	2.3	3.0	1.9	5.0	4.4	1.1	0.7	0.0	0.3	0.6	16.2	0.1	14.5	2.8	4.4	0.0	7.2	0.0	1.2	0.4	0.4	0.0	0.0	0.3	4.6	0.1	2.3	3.7	0.0	1.2	0.3	0.0	1.6	4.1	0.0	0.0	7.5	0.0	2.9	0.0	0.6	0.0	2.7	0.1	21.3	14.8	2.7	2.0	13.0	2.7	6.1	0.0	0.6	1.6	2.9	0.0	9.2	0.0	0.0	0.0	0.1	0.0	11.9	0.8	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.2	1.2	0.3	0.4	1.4	0.8	0.3	0.6	0.2	0.0	9.4	12.2	11.0	17.4	7.7	10.3	9.1	9.9	7.5	1.6	23.8	17.5	0.0	3.4	0.3	12.6	0.8	0.0	2.7	10.3	1.8	9.8	0.8	8.3	1.7	2.1	0.6	0.0	0.0	0.6	0.1	0.4	4.1	3.5	0.0	0.2	3.2	0.0	1.3	0.8	3.6	0.0	0.4	1.7	0.0	0.2	3.1	1.3	0.0	1.8	0.8	11.6	0.0	0.7	0.9	9.0	0.3	0.2	0.0	0.2	1.0
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 180.0;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 54.1;TIME: 84.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"		NA	NA			"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: AB_2686554"	"unprognostic (4.10e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	11.6	6.0	1.7	12.8	1.4	0.0	10.1	0.8	1.3	21.5	36.6	1.4	26.8	24.6	30.3	15.8	17.8	16.5	60.2	21.7	1.2	1.0	18.2	3.0	14.7	16.1	1.8	1.6	36.0	13.0	13.9	3.8	21.5	2.3	26.7	15.7	9.0	13.0	26.5	4.1	6.2	62.8	18.7	1.3	22.7	18.9	22.3	0.9	1.3	10.3	7.4	6.3	24.7	16.9	1.8	1.3	4.6	1.2	1.6	1.2	0.3	6.5	3.7	3.3	0.1	0.8	1.7	4.5	11.2	17.9	8.3	6.7	1.2	9.9	0.0	24.3	18.0	14.4	12.7	2.4	25.7	4.1	0.0	1.2	0.0	0.9	6.3	21.6	0.0	0.1	8.5	17.2	6.9	16.5	17.2	54.1	0.4	0.2	1.6	2.8	0.1	0.1	0.1	3.4	10.3	4.8	0.0	0.0	0.2	10.4	4.5	0.0	8.0	5.9	0.7	1.3	7.2	1.4	0.1	84.4	11.0	1.5	0.1	5.1	0.1	0.2	0.1	1.6	0.0	0.1	4.6	1.2	1.0	0.7	0.5	0.6	1.0	0.7	0.7	0.4	1.8	1.1	1.2	3.5	1.6	0.7	1.3	0.4	0.3	1.7	1.4	0.8	1.3	1.2	1.0	1.8	1.6	2.3	0.9	11.9	21.5	5.2	54.8	76.6	3.5	30.9	45.9	12.0	29.6	15.7	5.9	5.8	0.0	80.2	2.4	18.4	138.3	0.0	46.9	102.1	26.9	24.2	17.4	1.8	5.3	1.6	44.1	38.1	0.6	1.8	74.2	10.4	13.5	3.6	47.1	10.0	88.8	84.2	180.0	1.2	5.1	142.3	66.2	2.3	1.8	54.8	16.2	6.1	40.4	47.2
FBLL1	LOC345630	ENSG00000188573	"Fibrillarin like 1"	A6NHQ2	5	168529116-168530634	"Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 8.1;Cone photoreceptor cells: 5.9;Horizontal cells: 6.4;Intestinal endocrine cells: 6.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 19.4;SH-SY5Y: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049546, HPA077724"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA049546: AB_2680811, HPA077724: "	"unprognostic (2.75e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.18e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.8	6.2	10.3	0.9	12.1	0.7	1.1	10.6	24.9	1.0	0.9	0.9	0.0	1.4	0.8	0.8	0.8	1.4	1.1	1.3	11.0	18.4	1.1	0.9	0.9	0.7	9.7	8.5	1.2	2.1	1.8	7.4	1.0	7.9	1.4	0.9	0.5	1.4	1.3	0.9	1.5	1.6	1.1	3.0	0.8	1.4	5.1	1.7	0.0	0.8	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.4	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.4	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	16.1	1.6	0.0	0.9	0.0	0.0	1.2	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.1	10.6	16.9	11.0	18.4	9.7	8.5	7.9	1.7	0.0	0.0	0.0	0.0	0.1	8.1	1.2	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.0	0.1	6.4	6.4	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.1	0.5	0.3	0.0	0.0	0.0	2.6	6.5	0.0	2.3	0.2	0.1	0.0	0.0	0.2	0.0
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 287.9;vagina: 228.2"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 571.3;Extravillous trophoblasts: 448.0;Fibroblasts: 795.3;Syncytiotrophoblasts: 1016.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 29.1"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 157.8;ASC TERT1: 70.0;BJ: 84.6;BJ hTERT+: 134.5;HSkMC: 115.4;RT4: 121.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		34000000000	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	42.3	14.9	2.6	16.9	3.7	0.0	101.2	2.9	6.0	141.6	20.5	11.6	30.3	8.6	62.4	69.7	48.3	47.1	123.7	86.4	6.6	1.3	8.1	2.9	42.5	9.2	3.8	4.2	46.6	12.3	30.0	10.0	287.9	29.1	99.0	10.0	35.3	12.8	21.8	11.5	33.1	16.9	136.1	6.1	2.7	30.3	20.7	2.8	1.1	21.6	18.9	5.3	67.1	228.2	0.4	2.9	0.9	5.7	0.1	0.3	0.2	1.4	3.4	10.2	21.4	157.8	70.0	46.9	84.6	134.5	7.5	2.8	14.5	0.4	0.0	3.6	3.1	0.2	7.4	6.4	0.2	0.9	0.0	1.7	0.0	18.4	9.7	20.9	0.0	0.0	115.4	1.3	7.5	2.7	0.1	0.0	0.1	0.0	0.1	5.2	0.2	0.0	0.2	14.4	0.3	1.2	0.1	0.0	0.1	3.4	121.1	0.7	13.6	10.4	49.3	0.0	30.3	0.3	0.4	0.6	1.4	9.4	38.9	0.0	0.1	0.0	0.1	0.1	0.0	3.6	0.9	0.1	0.0	0.2	0.7	0.2	0.1	0.2	0.1	1.2	0.4	0.3	0.2	0.6	0.1	5.7	2.9	0.2	0.2	2.6	3.7	2.9	6.0	6.6	1.3	3.8	4.2	29.1	2.8	6.0	2.2	0.0	92.6	151.8	0.0	8.6	12.7	1.4	13.6	1.8	0.0	571.3	0.0	0.5	8.4	22.5	0.0	0.0	0.2	448.0	795.3	17.7	1.1	0.4	73.2	0.0	0.0	36.2	0.0	18.3	85.4	3.3	161.9	0.0	0.0	0.0	0.7	0.0	28.7	0.3	0.5	116.4	93.7	18.7	76.7	113.9	1016.7	0.0	0.2	69.1
FBLN7	"FLJ37440, TM14"	ENSG00000144152	"Fibulin 7"	Q53RD9	2	112138385-112188216	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Melanocytes: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4"	"Lineage enriched"	"Detected in single"	36	"T-cells: 18.5"	"Cell line enhanced"	"Detected in some"		"AF22: 17.5;BJ hTERT+: 12.5;hTERT-RPE1: 9.2;SCLC-21H: 11.3;SH-SY5Y: 9.0;U-2197: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034992			Approved	"Plasma membrane,Cell Junctions"	"Secreted to extracellular matrix"	NA	NA		27000	"Plasma membrane"	"Cell Junctions"	"HPA034992: AB_10601469"	"unprognostic (1.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.33e-2)"	7.5	5.8	2.9	9.0	3.4	1.1	10.4	10.3	16.4	12.4	2.3	1.6	4.1	1.7	6.5	8.2	2.9	10.5	7.1	3.3	4.0	3.8	2.5	6.6	3.7	11.8	6.9	4.2	2.8	3.4	16.7	27.4	13.6	10.5	4.7	2.0	14.7	3.9	9.0	1.9	7.1	3.8	3.2	2.2	7.3	4.1	2.0	1.1	8.7	14.9	5.5	9.5	3.6	10.4	0.0	0.5	0.0	0.0	0.0	18.5	3.5	0.0	0.1	17.5	0.0	1.9	1.4	0.0	3.8	12.5	4.2	6.6	0.0	0.1	0.0	0.1	5.7	0.7	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.8	0.9	0.0	0.0	1.3	0.1	7.0	0.0	9.2	1.0	0.2	0.0	0.0	1.4	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	4.4	0.2	0.0	11.3	9.0	0.0	0.0	0.5	0.1	0.5	0.1	3.6	0.6	0.5	18.1	0.5	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	18.5	0.2	0.0	0.0	16.2	0.5	0.0	0.0	0.0	0.5	17.4	3.5	2.9	3.4	10.3	16.4	4.0	3.8	6.9	4.2	10.5	1.1	3.0	0.3	0.0	0.7	3.9	3.7	0.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	1.9	2.1	0.0	0.0	0.2	5.9	4.7	0.4	1.1	1.0	0.4	3.2	0.0	0.6	0.0	1.7	0.3	0.0	16.9	0.0	0.0	2.2	0.4	0.0	4.9	0.5	7.2	6.5	4.7	0.1	0.2	3.3	1.3	4.4	0.0	0.3
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408306-48645849	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.8"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 91.8;Fibroblasts: 78.5;Leydig cells: 218.7;Peritubular cells: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 36.9;ASC TERT1: 79.9;fHDF/TERT166: 68.5;HSkMC: 43.2;hTERT-RPE1: 35.7;U-138 MG: 35.1;U-2197: 51.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		540000000	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	34.2	5.4	2.1	7.8	2.7	1.8	10.9	1.0	2.8	24.6	11.1	3.5	10.7	2.2	18.4	25.6	22.1	12.1	15.5	24.3	2.5	2.3	2.9	1.9	10.7	5.8	2.8	2.6	20.4	2.5	2.6	3.3	69.8	3.1	11.8	6.9	13.4	5.7	7.8	15.4	6.6	6.9	21.5	3.8	11.3	7.2	13.6	1.6	1.9	17.9	16.3	4.9	22.8	11.2	0.8	0.8	1.8	0.6	1.1	0.6	0.2	0.0	0.8	3.3	3.7	36.9	79.9	0.0	28.8	10.4	8.6	5.5	0.0	0.0	0.0	1.3	68.5	0.0	0.1	0.6	0.1	7.8	3.3	0.2	0.3	14.7	0.0	20.8	0.1	0.0	43.2	0.0	22.7	2.6	35.7	9.2	0.2	0.0	0.0	9.2	0.0	0.2	0.0	0.6	0.0	1.1	0.0	2.8	0.0	1.0	0.0	0.0	2.1	0.0	0.3	0.0	2.7	0.0	0.2	17.4	35.1	1.0	51.0	6.0	0.2	0.1	0.0	23.5	0.0	2.3	1.1	0.5	0.7	0.5	0.3	0.4	0.5	0.4	0.4	0.2	0.8	0.5	0.6	1.8	1.1	0.6	0.8	0.3	0.2	2.1	2.7	1.0	2.8	2.5	2.3	2.8	2.6	3.1	1.6	0.0	2.2	0.0	1.1	22.8	4.5	9.3	0.0	5.3	10.3	12.2	0.0	91.8	0.0	0.2	6.3	21.7	0.0	0.0	0.5	16.3	78.5	0.5	1.1	0.6	13.5	0.0	0.0	38.1	1.0	15.7	218.7	4.4	40.5	3.6	0.0	0.5	2.0	0.0	213.6	0.6	0.1	25.8	44.7	3.0	2.1	18.1	55.0	0.0	0.0	0.1
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"placenta: 175.9"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 251.0;Syncytiotrophoblasts: 136.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;non-classical monocyte: 5.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 38.0;HSkMC: 27.1;hTERT-HME1: 59.9;HUVEC TERT2: 33.7"	"Region enhanced"	"Detected in single"		"olfactory region: 2.6"	"Low region specificity"	"Detected in some"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		4600000	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (7.41e-5)"	0.3	7.9	0.3	1.0	0.3	1.6	0.1	0.2	0.3	1.5	0.7	0.4	1.0	0.2	2.9	0.6	1.1	0.6	0.2	6.7	0.2	0.5	0.2	0.2	0.2	1.3	0.2	0.4	0.9	0.1	0.0	1.3	175.9	0.4	1.0	0.8	6.2	0.4	0.9	0.2	0.3	0.5	0.8	0.4	0.6	0.5	4.6	0.2	0.3	0.9	0.4	0.7	0.4	1.2	0.0	1.1	0.6	5.0	0.0	0.0	0.4	0.0	4.5	16.4	0.0	2.7	4.7	3.4	17.9	0.0	15.9	11.9	0.0	0.0	0.0	0.0	23.9	0.0	2.7	10.6	2.7	14.9	0.0	4.2	0.0	7.5	0.0	38.0	2.3	0.0	27.1	1.4	6.7	59.9	5.1	33.7	0.0	0.0	0.0	9.8	0.0	0.0	0.9	7.1	0.0	5.4	5.1	5.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	14.0	0.0	5.0	0.0	6.4	12.2	18.3	0.0	0.0	0.0	0.0	1.9	0.0	6.7	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	5.0	0.0	0.0	0.4	0.3	0.3	0.2	0.3	0.2	0.5	0.2	0.4	0.4	0.2	0.0	0.3	0.0	0.1	0.0	0.0	11.3	0.0	0.0	2.3	0.0	0.0	251.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	27.7	3.3	1.5	0.0	0.0	29.6	0.0	0.0	0.0	12.9	5.3	1.1	1.8	1.7	0.0	0.0	3.1	0.1	0.0	2.1	0.0	0.0	6.5	0.2	12.7	3.8	0.4	136.7	0.0	0.0	0.1
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 248.1;lung: 87.8"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 322.6;Proximal tubular cells: 631.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 73.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 20.5;MCF7: 64.2;RT4: 42.1;SK-BR-3: 12.3;U-698: 30.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		23000000	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	19.3	5.8	0.6	2.3	0.9	1.1	7.0	0.4	0.8	2.2	48.8	0.7	17.6	40.7	0.6	2.5	0.7	0.9	9.7	1.3	0.8	0.5	34.6	248.1	87.8	8.9	0.9	0.7	1.0	8.1	17.1	1.9	1.0	1.0	6.4	3.0	1.5	9.1	17.7	0.5	1.7	60.4	3.1	1.2	2.8	10.4	1.0	0.8	0.5	4.3	1.0	1.1	22.4	9.6	0.6	17.1	73.5	30.7	2.8	3.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	64.2	0.0	1.1	0.2	10.4	2.3	0.0	0.2	0.4	0.0	42.1	0.2	1.2	0.1	12.3	0.0	0.2	7.3	1.8	0.0	0.0	0.2	0.2	0.0	0.0	0.2	30.5	0.0	0.3	0.0	10.6	13.0	73.5	1.5	30.7	2.3	0.6	0.9	0.9	17.1	0.6	3.3	1.6	2.3	2.8	16.3	6.1	0.4	5.2	0.6	0.9	0.4	0.8	0.8	0.5	0.9	0.7	1.0	0.8	71.5	142.5	10.2	6.5	0.7	0.0	0.6	107.0	13.4	68.2	59.3	0.0	9.7	94.5	14.4	0.0	1.8	32.6	23.3	56.4	1.6	1.7	17.4	45.2	322.6	187.5	0.0	30.7	11.1	49.8	0.8	1.4	103.2	11.8	0.0	49.9	2.1	23.8	68.4	3.9	631.0	0.0	6.5	1.2	0.6	0.1	0.9	8.5	13.1	59.5	51.2
FBRS	"FBS, FBS1, FLJ11618"	ENSG00000156860	Fibrosin	Q9HAH7	16	30658431-30670814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044117	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044117: AB_10794394"	"unprognostic (1.87e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.01e-3)"	"unprognostic (6.32e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	13.4	13.0	14.2	19.8	15.4	41.0	9.9	22.6	16.4	12.1	13.6	18.5	12.2	18.3	15.5	8.7	21.5	14.7	10.8	9.4	16.7	8.2	13.1	12.9	13.6	17.1	20.0	10.5	14.3	14.6	16.5	23.8	23.6	13.8	14.6	6.0	13.1	17.5	18.5	16.8	21.3	19.0	10.0	13.0	21.7	13.6	52.9	19.3	22.7	14.8	8.1	19.7	13.8	12.3	2.3	2.9	5.6	2.9	1.2	2.8	2.5	12.4	13.3	7.0	5.8	7.1	7.2	17.9	9.3	7.6	8.0	6.0	7.8	11.5	11.7	15.5	7.5	7.2	10.4	7.4	8.8	3.8	31.4	18.6	15.7	12.4	14.2	17.4	11.4	23.8	10.7	12.0	15.5	7.6	9.0	9.8	10.9	13.6	22.6	5.8	25.6	14.4	22.3	2.0	5.6	8.5	21.0	5.3	12.7	8.4	9.3	9.9	11.1	7.3	14.0	9.8	3.2	31.6	15.1	15.2	18.3	11.2	11.3	12.1	26.6	12.8	11.2	17.6	11.2	10.7	0.0	2.9	2.3	2.4	1.2	2.3	1.9	2.0	2.3	1.5	2.3	0.6	2.8	5.6	1.2	1.7	2.9	0.2	2.5	14.2	15.4	22.6	16.4	16.7	8.2	20.0	10.5	13.8	19.3	14.9	27.4	15.9	13.0	16.7	19.3	7.5	10.2	12.0	4.5	7.0	31.4	7.8	5.0	9.2	62.2	11.7	30.0	0.0	12.8	7.8	12.1	15.9	18.5	7.3	12.3	41.3	16.1	22.1	14.8	79.8	15.8	15.8	10.1	18.0	19.3	13.0	15.7	24.5	15.2	7.2	24.1	0.0	10.3	63.0	21.5	21.2	27.6	17.5	15.3	20.7
FBRSL1	KIAA1545	ENSG00000112787	"Fibrosin like 1"	Q9HCM7	12	132489551-132585188	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 34.7"	"Low region specificity"	"Detected in all"							HPA049880	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA049880: AB_2680930"	"unprognostic (2.02e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (9.82e-4)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (7.21e-4)"	7.6	4.7	4.3	4.9	6.6	5.2	3.2	13.0	9.9	3.4	4.9	2.9	2.9	7.0	4.8	4.6	4.5	4.7	9.6	4.4	4.8	3.1	4.3	5.2	4.2	4.5	9.8	5.5	5.1	12.7	3.9	7.9	4.5	4.5	5.4	1.8	5.0	9.7	4.4	17.9	4.7	7.3	2.9	2.9	10.9	6.1	6.1	4.5	8.0	4.0	2.9	8.6	4.5	3.2	2.8	3.6	4.1	2.0	0.7	1.9	0.9	4.6	7.5	3.4	6.0	1.4	1.8	26.1	4.4	1.1	2.8	1.7	13.6	2.7	7.0	7.7	1.3	2.5	8.7	3.6	2.2	0.9	6.1	18.5	9.0	4.3	10.3	3.0	9.4	9.8	1.6	4.2	2.8	1.9	2.5	2.7	6.0	19.5	1.6	1.2	11.9	12.2	34.7	9.4	3.1	13.2	19.3	3.9	4.9	2.3	4.3	13.9	10.7	4.2	6.6	5.3	1.5	7.2	9.7	4.3	3.1	8.0	5.8	5.5	9.5	4.9	4.6	3.5	9.5	3.9	2.3	1.5	4.1	1.2	1.3	1.3	2.8	1.2	1.2	1.2	2.6	1.1	1.6	1.7	0.7	2.0	3.6	1.9	0.9	4.3	6.6	13.0	9.9	4.8	3.1	9.8	5.5	4.5	4.5	3.0	6.9	0.8	5.2	8.1	22.6	11.3	5.1	5.3	3.4	10.4	39.3	5.8	6.6	5.3	1.3	6.2	15.4	23.3	6.5	4.7	5.2	12.1	1.1	16.3	5.8	11.1	29.7	8.6	12.1	0.4	15.0	8.0	5.0	4.6	19.2	8.6	8.3	15.9	14.5	4.9	22.2	6.5	5.1	6.3	6.1	9.2	9.6	5.7	17.7	7.6
FBXL12	"Fbl12, FLJ20188"	ENSG00000127452	"F-box and leucine rich repeat protein 12"	Q9NXK8	19	9810267-9827816	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002843			Approved	Mitochondria		NA	NA			Mitochondria		"HPA002843: AB_2666679"	"unprognostic (7.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (3.21e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (1.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (4.07e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.77e-3)"	14.3	10.4	6.6	12.4	9.8	25.1	16.3	12.2	12.6	14.7	16.8	10.5	8.6	16.2	18.6	18.7	13.2	17.0	15.6	12.1	6.9	7.1	12.0	15.3	14.8	14.1	8.8	8.7	19.3	12.4	8.2	13.4	16.3	10.5	16.5	11.7	10.0	9.9	17.8	17.3	11.3	18.6	14.5	6.7	13.9	12.9	11.8	7.6	87.9	13.5	9.2	12.7	17.8	13.4	19.0	17.1	27.3	14.7	22.5	18.4	11.6	9.5	4.8	11.3	10.7	12.8	11.4	12.7	10.3	10.7	11.3	13.5	14.7	6.4	9.0	16.7	10.4	8.8	9.1	8.4	9.1	9.0	8.9	16.2	17.2	9.6	14.6	16.6	12.4	10.7	16.3	6.2	10.9	9.7	8.3	8.1	23.4	13.0	18.7	5.9	7.6	18.4	38.6	12.8	5.8	9.1	10.8	8.3	16.2	8.0	13.0	6.9	9.5	7.6	5.7	11.8	10.8	7.8	14.8	9.2	15.6	7.5	20.8	10.1	25.3	9.8	13.9	6.6	11.3	7.3	20.8	14.7	27.3	15.9	12.1	18.2	13.6	15.6	18.3	16.6	19.0	18.4	14.5	10.9	22.5	11.3	17.1	16.5	11.6	6.6	9.8	12.2	12.6	6.9	7.1	8.8	8.7	10.5	7.6	6.0	8.6	10.9	13.9	6.5	7.3	20.7	7.6	6.7	7.9	12.2	3.9	36.4	5.0	9.9	1.1	18.8	27.5	0.0	8.5	25.3	20.3	11.5	3.5	6.6	14.9	7.9	12.1	14.7	8.9	2.1	24.5	10.8	10.1	22.6	15.0	8.6	8.0	18.1	20.5	7.9	10.5	12.9	20.4	20.4	18.1	9.7	53.0	17.5	16.9	18.7
FBXL14	"Fbl14, MGC40195"	ENSG00000171823	"F-box and leucine rich repeat protein 14"	Q8N1E6	12	1565993-1594165	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Early spermatids: 38.0;Late spermatids: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053889	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA053889: AB_2682293"	"unprognostic (8.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.90e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (9.04e-6)"	"unprognostic (5.60e-3)"	"unprognostic (1.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.12e-3)"	6.0	6.0	12.5	8.1	13.0	7.4	4.9	10.2	15.8	5.9	11.7	9.3	4.2	7.3	5.1	3.4	7.2	9.2	7.5	5.7	11.4	9.3	5.4	4.8	6.2	10.4	9.7	7.2	6.8	17.4	9.9	11.3	6.2	7.9	5.2	5.3	6.2	8.2	6.8	3.4	3.6	8.0	3.7	10.5	8.9	14.1	20.1	9.9	21.2	9.4	1.8	6.2	6.3	19.4	3.8	0.6	2.2	0.5	2.4	4.6	0.5	7.8	11.5	3.4	6.0	3.0	3.1	10.1	1.8	3.3	1.7	1.9	12.1	10.4	10.8	2.1	2.0	2.9	5.5	2.8	4.2	0.3	17.8	13.1	13.3	3.3	3.8	3.9	10.0	9.8	4.8	2.0	3.2	2.7	3.1	3.0	9.4	5.4	30.9	2.1	8.6	10.0	5.0	14.3	4.5	4.8	8.8	5.5	6.8	2.8	7.3	6.5	6.4	4.3	6.8	6.7	3.7	5.2	8.4	4.2	3.9	11.9	4.8	6.3	3.6	3.9	13.4	8.2	6.0	5.8	2.2	0.5	0.0	0.4	0.4	0.4	0.9	1.4	1.5	0.6	3.8	1.5	0.7	1.1	2.4	0.5	0.6	4.6	0.5	12.5	13.0	10.2	15.8	11.4	9.3	9.7	7.2	7.9	9.9	0.0	0.0	0.0	0.4	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	38.0	1.0	0.7	0.0	0.5	0.1	0.3	0.6	0.0	0.9	0.6	9.5	0.0	3.1	0.3	69.2	0.3	0.4	0.0	1.0	0.7	2.7	0.2	0.0	1.4	0.6	2.9	0.0	0.0	1.2	0.2	0.0	0.1	0.0	1.1	0.2
FBXL18	"Fbl18, FLJ11467"	ENSG00000155034	"F-box and leucine rich repeat protein 18"	Q96ME1	7	5431335-5513798	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036049			Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA036049: AB_2674918"	"unprognostic (2.86e-3)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.98e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.28e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.30e-4)"	"unprognostic (1.73e-3)"	6.4	6.2	11.0	7.2	15.0	8.5	3.7	10.8	17.7	3.0	4.6	8.1	4.3	5.6	5.1	3.4	6.1	4.4	3.3	5.0	10.2	8.0	4.3	3.6	4.4	5.7	6.6	12.3	4.3	8.0	6.2	4.8	4.2	7.6	5.0	3.2	5.6	5.3	3.8	10.8	10.2	5.0	4.3	5.4	5.4	4.6	5.7	7.7	4.3	4.8	2.8	5.6	4.8	3.2	3.4	2.5	8.9	4.0	3.9	2.7	1.8	9.3	12.3	3.5	7.5	3.2	3.4	6.1	5.6	2.9	3.5	3.7	9.3	6.0	4.3	6.8	2.7	6.6	14.8	4.1	9.8	2.6	3.3	5.1	2.2	9.3	3.0	2.4	4.8	3.6	2.8	5.3	5.4	2.6	2.6	4.1	2.7	6.8	3.8	2.4	9.8	2.5	3.0	11.3	3.3	10.2	6.3	6.8	2.3	2.2	4.9	7.6	10.6	8.7	14.8	2.9	4.5	14.5	2.9	9.5	11.5	16.5	8.4	8.5	5.1	6.3	3.3	5.9	5.9	13.6	7.9	3.5	1.3	2.7	3.2	2.7	2.1	1.7	2.5	2.5	3.4	1.9	2.4	8.9	3.9	4.0	2.5	2.0	1.8	11.0	15.0	10.8	17.7	10.2	8.0	6.6	12.3	7.6	7.7	6.0	4.5	0.8	1.7	2.3	8.8	3.9	2.5	2.7	7.9	0.0	3.9	3.2	0.0	1.8	1.1	1.6	2.6	0.0	2.1	2.5	2.3	1.3	2.3	1.7	1.3	1.6	4.6	1.8	3.2	0.0	1.4	2.2	0.0	2.8	1.9	4.8	1.7	2.6	0.7	1.0	6.4	0.0	1.4	2.6	5.1	2.9	1.8	2.9	3.8	1.6
FBXL19	"CXXC11, DKFZp434K0410, Fbl19, JHDM1C"	ENSG00000099364	"F-box and leucine rich repeat protein 19"	Q6PCT2	16	30923055-30948783	"Predicted intracellular proteins"	"Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074250			Approved	Nucleoplasm		NA	No			Nucleoplasm		"HPA074250: "	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.37e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.38e-2)"	5.5	6.7	17.4	9.8	15.3	8.3	3.8	13.2	23.5	6.8	9.6	3.4	9.5	11.2	7.5	4.4	10.5	6.0	9.4	4.9	17.6	10.5	6.1	3.1	5.8	9.8	9.6	11.6	6.9	6.6	11.0	8.3	11.2	9.5	6.9	4.1	5.2	8.4	7.1	4.5	12.7	9.8	6.2	4.8	9.9	9.3	19.6	8.4	7.3	5.8	4.7	6.7	9.7	7.0	2.1	2.8	1.9	1.7	3.6	1.5	0.4	6.3	17.6	16.8	14.1	3.0	3.1	15.4	8.9	4.8	7.2	6.8	9.2	9.6	10.2	10.6	5.2	5.3	9.3	13.4	9.5	5.3	27.6	41.8	10.9	27.5	13.2	3.8	12.0	27.5	3.2	7.6	8.5	6.1	6.0	11.1	14.2	29.4	9.9	3.8	17.2	13.1	16.6	17.3	4.7	5.8	27.4	5.3	10.0	6.6	8.7	11.9	22.3	3.2	20.4	5.0	9.9	12.5	12.8	11.0	8.4	10.3	5.1	6.3	8.8	7.0	6.0	9.8	18.3	11.7	0.0	1.7	1.9	1.5	0.8	1.2	2.1	0.4	0.6	0.9	0.8	0.2	1.2	1.8	3.6	0.2	2.8	0.7	0.4	17.4	15.3	13.2	23.5	17.6	10.5	9.6	11.6	9.5	8.4	0.0	1.4	0.0	2.0	7.3	5.2	1.4	5.1	0.0	2.3	3.5	11.8	4.8	0.0	4.8	3.5	3.8	5.1	0.0	6.1	4.6	3.0	4.7	0.0	2.1	4.4	1.6	2.4	3.1	2.8	4.5	1.4	2.7	0.0	2.8	5.2	2.6	6.4	3.5	2.5	3.4	5.3	6.5	1.9	4.1	2.5	7.9	7.8	0.9	4.7	6.5
FBXL2	"FBL2, FBL3"	ENSG00000153558	"F-box and leucine rich repeat protein 2"	Q9UKC9	3	33277025-33403662	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 23.6;Early spermatids: 41.5;Late spermatids: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 8.9;LHCN-M2: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061783			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA061783: AB_2684605"	"unprognostic (5.73e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.72e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.90e-2)"	3.2	5.2	8.0	2.2	15.0	1.9	4.1	7.2	18.1	3.7	2.9	4.1	1.8	3.2	5.2	8.2	2.3	6.0	3.0	2.7	8.7	11.3	5.5	1.4	4.6	1.8	6.6	13.4	4.5	3.5	7.7	16.1	5.5	13.1	4.3	1.5	6.4	3.1	6.5	1.5	2.9	2.0	3.5	4.5	2.3	2.5	4.3	2.8	0.0	8.6	0.6	1.5	2.6	2.5	1.3	0.9	2.8	1.0	0.9	1.1	0.1	3.9	1.1	1.6	1.8	2.3	3.8	0.6	3.1	2.5	2.8	4.1	0.8	4.7	0.2	0.9	2.0	1.3	1.0	1.4	3.4	1.9	0.4	1.9	0.7	3.2	0.8	2.8	0.3	0.7	1.5	2.5	1.8	1.3	8.9	5.0	2.8	0.9	0.3	9.4	0.4	0.8	0.7	1.2	0.5	0.9	0.1	1.0	0.1	7.1	1.1	2.0	2.0	1.3	0.8	2.3	2.7	2.2	1.2	3.9	1.4	1.3	1.1	1.7	0.4	0.2	0.2	1.3	0.3	0.9	1.5	1.0	0.7	0.9	0.5	0.7	0.5	0.7	0.9	0.3	1.3	1.1	1.1	2.8	0.9	0.7	0.9	0.4	0.1	8.0	15.0	7.2	18.1	8.7	11.3	6.6	13.4	13.1	2.8	3.0	8.2	0.0	5.1	1.0	16.5	2.0	2.5	13.4	4.5	5.2	23.6	0.4	3.3	3.5	41.5	2.2	0.0	0.0	0.3	1.0	3.6	2.9	0.0	0.0	0.4	17.5	0.0	3.1	0.3	37.9	1.4	1.2	1.7	0.0	0.1	6.7	3.4	0.0	3.9	2.1	14.2	6.5	2.9	11.7	7.9	1.0	0.6	1.3	0.0	3.3
FBXL20	"Fbl2, Fbl20, MGC15482"	ENSG00000108306	"F-box and leucine rich repeat protein 20"	Q96IG2	17	39252644-39402523	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044748, HPA050397"	Uncertain		Supported	Microtubules		NA	NA			Microtubules		"HPA044748: AB_2679072, HPA050397: AB_2681112"	"unprognostic (7.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	9.1	12.9	12.7	11.0	13.3	15.4	9.9	23.6	13.9	10.3	10.4	11.1	9.3	7.6	9.6	8.0	9.8	9.2	8.1	8.0	12.7	11.7	9.4	9.9	8.7	7.4	10.1	10.2	11.0	9.4	12.2	12.3	11.6	10.1	8.5	9.2	8.7	8.2	10.2	10.8	11.7	8.0	11.0	10.7	9.1	8.2	25.1	11.3	15.2	8.7	4.2	8.5	9.4	9.8	4.2	3.6	18.7	4.2	5.4	5.3	1.5	2.3	4.9	4.9	5.1	6.3	4.5	2.8	3.2	4.5	3.8	4.7	1.6	5.6	3.7	7.4	4.3	7.7	5.6	5.6	3.9	5.6	7.0	7.5	3.9	4.3	4.6	4.6	5.5	5.0	3.8	4.6	3.8	4.4	5.5	4.6	4.7	7.7	2.7	3.7	3.4	5.4	3.9	1.3	4.8	2.0	2.7	9.7	2.5	2.0	3.7	3.1	2.4	6.3	40.1	4.2	6.7	6.2	5.3	3.5	4.3	4.3	3.2	3.1	4.8	5.0	3.1	5.4	2.5	3.3	15.4	3.8	11.8	3.0	3.1	2.7	2.5	2.9	2.7	2.8	4.2	2.6	2.6	18.7	5.4	4.2	3.6	5.3	1.5	12.7	13.3	23.6	13.9	12.7	11.7	10.1	10.2	10.1	11.3	17.9	17.8	11.1	6.4	3.5	27.1	5.6	10.2	12.0	9.1	12.2	55.0	11.6	1.7	8.3	11.9	9.0	16.2	0.0	5.3	6.8	7.1	11.2	8.1	9.0	9.6	19.1	9.2	17.2	13.0	10.6	16.7	12.0	1.7	14.4	12.4	15.1	12.8	10.5	10.6	4.5	36.7	6.5	7.6	34.4	25.6	4.8	20.3	10.2	9.0	6.2
FBXL6	FBL6	ENSG00000182325	"F-box and leucine rich repeat protein 6"	Q8N531	8	144355431-144359376	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA008867			Approved	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA008867: AB_2668161"	"unprognostic (2.97e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (4.49e-10)"	"unprognostic (3.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	6.1	5.8	3.1	7.7	3.6	6.0	8.2	8.1	5.6	6.9	13.4	3.7	9.9	14.3	4.4	7.5	8.3	4.4	12.0	2.7	2.9	3.1	5.7	15.5	11.6	9.9	3.8	2.6	2.7	13.8	5.1	4.6	6.1	3.2	4.9	6.3	3.6	9.6	9.4	4.6	7.5	19.1	3.1	2.9	8.3	6.2	5.6	3.5	6.0	3.9	6.8	6.5	5.1	4.7	0.7	2.4	1.9	4.3	0.8	1.2	0.2	8.1	2.5	1.8	11.9	2.5	0.6	3.7	4.2	4.6	4.1	2.8	2.7	3.5	3.9	5.2	1.9	2.0	5.4	2.2	5.4	0.9	7.1	3.2	7.9	1.5	6.8	3.8	1.9	7.9	1.1	4.9	2.3	6.1	1.0	3.4	6.0	3.7	6.0	1.5	14.1	5.2	1.9	2.6	8.6	8.0	6.3	2.2	12.5	5.3	2.6	3.0	2.9	4.7	7.2	7.0	1.1	11.9	3.3	2.9	2.0	7.8	9.8	4.9	2.4	1.8	2.7	3.1	4.7	2.6	0.0	0.6	1.9	1.2	1.3	1.1	0.7	0.9	0.8	0.5	0.5	0.1	0.4	0.2	0.8	4.3	2.4	0.1	0.2	3.1	3.6	8.1	5.6	2.9	3.1	3.8	2.6	3.2	3.5	6.0	1.3	10.8	5.1	5.0	9.1	1.2	5.1	1.4	5.7	0.0	13.7	7.4	5.0	3.8	1.7	3.8	31.6	0.0	5.3	8.6	4.5	5.9	1.1	5.9	6.2	1.6	2.4	6.7	4.1	1.0	4.9	7.3	5.0	1.0	13.3	7.3	6.4	9.5	1.8	6.3	8.1	0.0	4.2	2.3	8.0	5.8	3.2	5.9	13.5	5.1
FBXL8	Fbl8	ENSG00000135722	"F-box and leucine rich repeat protein 8"	Q96CD0	16	67159931-67164570	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 26.6"									"HPA035587, HPA035588"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035587: AB_2674690, HPA035588: AB_10670023"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (3.79e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.94e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.68e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.17e-3)"	6.6	12.6	5.0	7.8	11.6	3.8	10.3	6.6	9.6	9.1	11.6	6.8	13.0	11.0	9.4	9.1	9.3	10.1	13.1	5.4	6.1	1.3	7.6	8.3	8.4	4.8	14.6	3.4	9.0	27.6	9.2	20.7	8.5	8.8	21.1	7.5	4.6	28.3	10.7	10.5	21.5	8.1	7.5	8.1	7.1	23.6	2.6	10.4	3.2	10.8	5.6	8.5	6.8	11.4	2.2	5.1	8.0	5.7	6.6	13.5	3.7	3.5	4.4	0.8	5.8	3.3	5.8	15.4	3.1	2.3	2.3	2.5	3.8	9.8	2.7	4.6	2.7	2.5	12.1	1.7	2.8	0.7	6.8	7.1	2.7	8.6	4.3	2.3	1.5	11.6	4.4	3.2	2.6	2.0	7.3	1.7	7.5	5.4	6.3	1.8	9.9	2.2	6.0	0.4	3.1	10.7	7.4	2.0	13.0	3.8	5.0	6.2	5.9	7.2	4.0	2.0	2.0	19.5	3.6	3.5	6.3	7.1	14.4	2.6	26.6	5.8	3.7	7.1	5.2	3.6	4.5	5.7	5.3	4.8	2.5	4.3	2.2	13.5	6.3	2.8	2.0	3.1	3.1	8.0	6.6	2.4	5.1	4.6	3.7	5.0	11.6	6.6	9.6	6.1	1.3	14.6	3.4	8.8	10.4	0.0	1.9	2.2	4.0	2.9	1.7	0.7	10.2	0.0	4.5	5.2	7.9	2.2	1.7	6.1	0.0	2.3	9.2	0.0	7.0	2.1	3.5	5.6	0.0	3.4	2.5	4.8	6.4	1.8	2.2	0.0	8.6	1.8	10.1	9.0	10.0	1.9	7.5	3.5	5.3	4.9	4.3	6.5	3.5	0.1	0.7	3.9	1.3	1.7	8.0	4.2
FBXO10	FBX10	ENSG00000147912	"F-box protein 10"	Q9UK96	9	37510892-37576349	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 30.0;Late spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"AF22: 18.0;HHSteC: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002863, HPA072721"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002863: AB_10965996, HPA072721: "	"unprognostic (2.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.93e-5)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-1)"	3.8	7.5	4.8	7.5	8.3	1.2	3.4	4.4	12.1	3.6	6.7	4.9	6.3	2.8	5.0	16.9	4.7	2.8	4.5	4.3	6.3	5.9	3.9	4.0	3.5	7.7	4.0	6.7	3.1	7.4	6.4	20.8	3.1	3.9	4.0	2.9	5.3	15.0	5.2	27.0	2.9	4.8	5.0	3.1	10.1	3.6	12.2	3.3	2.9	11.7	6.0	7.7	4.5	2.9	5.9	0.8	0.0	0.2	0.2	1.1	0.5	1.6	4.1	18.0	4.6	8.4	3.0	1.4	3.2	5.6	3.9	5.9	2.3	1.1	10.5	1.1	3.3	1.6	0.1	6.5	1.5	2.9	5.8	5.2	2.1	3.8	2.0	25.8	5.5	0.7	6.9	1.2	3.5	2.3	2.6	5.5	1.0	7.2	2.9	6.9	1.4	2.1	1.8	8.3	2.4	1.5	4.1	7.9	1.3	2.2	1.1	3.8	9.6	2.0	2.5	2.2	5.5	1.0	5.7	4.3	2.8	4.9	2.5	2.2	3.6	2.8	1.7	2.4	2.2	2.6	0.0	0.1	0.0	0.7	0.2	0.7	5.9	1.1	0.7	0.0	3.2	0.1	0.1	0.0	0.2	0.2	0.8	0.2	0.5	4.8	8.3	4.4	12.1	6.3	5.9	4.0	6.7	3.9	3.3	0.0	0.6	6.1	0.1	0.2	3.3	1.4	0.0	1.4	0.0	1.8	3.9	0.3	0.0	1.2	30.0	0.6	0.0	0.0	1.3	0.7	0.6	0.6	0.0	0.9	3.2	3.2	5.2	6.7	0.3	29.3	0.9	0.0	1.7	1.0	0.5	1.5	1.4	0.0	1.4	1.3	0.9	0.0	0.9	3.1	1.9	0.5	0.2	0.0	0.3	0.3
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 26.8;Cone photoreceptor cells: 33.4;Rod photoreceptor cells: 42.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Cell line enhanced"	"Detected in many"		"AF22: 15.7;Karpas-707: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: AB_2683795, HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favorable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.3	2.6	15.7	6.1	0.4	0.0	0.4	0.1	0.6	2.4	4.6	2.4	3.6	4.7	5.7	0.1	6.5	4.1	1.7	2.5	2.4	1.9	2.9	2.2	0.2	1.3	0.3	2.7	1.6	0.2	8.4	0.6	2.6	1.1	0.0	4.0	0.8	18.1	1.0	4.1	0.3	3.7	3.4	1.6	3.6	0.1	3.7	7.2	3.3	2.1	10.2	4.3	0.4	2.5	6.8	2.9	10.9	4.6	0.5	1.3	4.8	2.8	2.2	4.0	3.5	3.9	5.3	0.6	2.8	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4	3.0	2.6	0.0	2.3	0.1	7.9	2.0	5.1	26.8	6.8	3.5	33.4	0.5	6.6	4.5	8.6	0.0	0.0	0.0	3.9	0.2	0.9	2.7	0.0	2.4	2.0	4.8	9.8	0.6	1.0	8.4	1.1	0.0	0.0	0.0	1.9	7.8	2.9	0.0	0.7	4.0	42.0	0.0	1.2	7.4	3.4	0.0	0.0	0.0	0.8	1.0
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.7;pancreas: 52.5"	"Cell type enriched"	"Detected in many"	5	"Exocrine glandular cells: 606.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 1.4;T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 21.1;HBEC3-KT: 18.5;Hep G2: 44.2;SiHa: 83.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA005472: AB_2667332"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	1.7	21.8	49.7	2.6	39.2	1.2	7.9	21.1	48.3	2.1	1.8	13.2	2.1	13.7	1.5	6.4	3.6	3.6	2.9	2.6	33.1	32.6	6.9	11.0	3.0	2.5	40.0	23.0	2.2	52.5	17.7	20.2	1.3	25.7	5.1	1.3	2.7	21.7	7.6	1.3	6.6	4.9	1.7	31.4	2.2	3.8	4.4	24.3	1.1	3.7	0.0	3.8	2.6	2.9	1.4	0.1	0.0	0.0	0.0	3.1	0.6	6.9	2.1	0.0	6.8	0.1	0.0	1.0	0.3	0.6	0.1	0.0	21.1	2.0	0.0	8.7	0.0	1.8	0.0	0.7	18.5	0.0	0.1	0.2	0.0	0.2	44.2	0.9	0.0	0.0	0.6	3.4	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.0	1.6	0.5	0.7	0.9	83.5	0.0	0.8	0.7	4.1	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	3.1	1.4	1.2	2.9	0.1	1.1	1.8	2.6	0.0	0.0	0.0	0.0	0.8	0.6	49.7	39.2	21.1	30.3	33.1	32.6	40.0	23.0	25.7	24.3	0.0	1.0	6.6	52.3	17.4	10.7	2.4	17.8	5.3	5.7	45.4	2.0	0.6	72.9	20.7	1.7	0.6	0.0	0.0	606.0	3.5	2.4	21.4	4.6	87.3	0.4	27.0	1.2	2.5	1.6	1.8	32.2	1.2	42.2	5.4	0.0	65.1	127.3	0.0	38.2	5.8	10.3	0.0	1.9	11.4	10.4	8.7	0.8	12.9	0.0	22.5
FBXO21	"FBX21, KIAA0875"	ENSG00000135108	"F-box protein 21"	O94952	12	117141988-117190531	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 78.4"	"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 208.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062411, HPA071452"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062411: AB_2684755, HPA071452: AB_2686398"	"unprognostic (6.38e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (1.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.29e-2)"	8.1	29.4	17.8	8.8	21.6	5.2	11.4	27.0	28.0	12.6	10.5	18.8	25.5	10.6	16.1	70.1	10.2	78.4	14.2	18.9	17.9	18.4	33.3	17.0	11.2	8.2	13.5	21.4	38.8	19.0	17.3	18.8	12.3	17.5	17.4	9.8	14.0	10.7	19.8	16.3	11.8	9.5	12.8	17.0	11.6	11.8	27.8	14.2	9.9	19.1	6.9	9.3	12.7	10.2	12.8	8.5	3.7	10.5	9.2	13.0	7.1	9.5	22.8	14.4	7.9	11.9	12.4	16.5	12.8	14.0	12.1	9.9	14.7	6.8	12.6	12.7	13.1	9.0	13.1	16.9	12.8	14.6	7.1	15.1	0.6	12.6	11.8	10.8	4.1	4.5	12.2	12.4	9.6	15.5	19.8	16.8	11.2	5.0	4.2	10.3	15.6	11.6	2.9	21.5	14.7	14.9	13.8	20.9	13.2	12.1	22.9	28.6	17.3	32.1	8.5	6.9	12.1	19.9	1.6	12.9	8.1	10.4	9.4	8.3	7.4	7.6	16.5	11.7	6.4	11.2	1.1	5.8	3.7	10.7	10.5	11.2	9.8	11.3	11.1	8.5	12.8	13.0	11.7	0.5	9.2	10.1	5.8	11.4	7.1	17.8	21.6	27.0	28.0	17.9	18.4	13.5	21.4	17.5	14.2	29.8	27.8	27.2	40.8	33.1	41.6	47.8	30.6	36.1	45.5	48.8	39.3	49.4	38.1	52.1	35.4	34.8	15.1	0.0	44.6	30.7	30.8	42.7	3.5	35.9	13.3	69.9	37.5	41.1	21.5	46.7	92.3	14.7	21.9	16.2	24.9	57.0	28.8	17.5	208.9	69.6	32.7	103.5	45.3	20.0	40.5	39.5	54.8	27.7	25.9	40.4
FBXO27	"Fbg5, Fbx27"	ENSG00000161243	"F-box protein 27"	Q8NI29	19	38990714-39032785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 19.6;Cytotrophoblasts: 20.2;Syncytiotrophoblasts: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 16.6"	"Low region specificity"	"Detected in all"							"HPA046800, HPA062242"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046800: AB_2679813, HPA062242: AB_2684723"	"prognostic favorable (2.15e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (1.48e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.80e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.04e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.21e-2)"	8.9	3.1	11.8	2.0	7.9	2.3	21.3	18.5	14.1	4.5	5.2	4.7	5.2	2.0	3.9	2.3	11.6	4.4	4.4	14.1	8.8	8.8	5.1	5.8	3.9	3.5	7.3	10.5	8.1	3.8	1.4	3.3	3.1	6.4	7.2	6.7	5.1	5.5	6.4	1.5	26.7	3.9	5.8	6.7	2.5	2.8	3.6	4.1	2.9	3.7	6.0	5.6	9.3	7.1	1.6	1.1	4.0	0.7	2.7	0.9	0.3	4.2	5.4	0.2	3.5	7.6	0.4	1.6	0.6	3.3	2.6	2.4	1.8	1.6	0.6	8.6	4.8	4.4	7.4	0.3	3.1	1.7	0.4	0.2	0.2	1.4	0.2	1.3	0.4	1.3	2.7	5.0	2.6	0.2	4.1	1.5	0.2	2.4	0.6	3.6	3.8	0.3	0.6	3.9	1.4	9.9	0.1	0.0	0.6	1.6	16.6	0.3	5.3	8.4	1.1	0.0	2.5	4.4	0.8	1.9	0.3	0.2	0.2	0.4	1.7	3.9	0.9	4.4	0.1	0.1	1.8	0.7	0.4	0.8	0.6	0.5	0.8	0.5	0.6	0.5	1.6	0.9	0.7	4.0	2.7	0.4	1.1	0.5	0.3	11.8	7.9	18.5	14.1	8.8	8.8	7.3	10.5	6.4	4.1	3.0	19.6	0.0	4.6	5.3	7.4	8.3	2.5	6.7	10.3	1.8	0.0	20.2	1.7	1.4	2.5	0.7	0.0	0.0	0.7	3.1	2.1	2.6	7.0	2.5	3.9	7.9	0.0	0.6	0.0	1.7	2.6	1.0	0.0	1.8	0.0	4.0	0.5	0.0	3.9	5.3	2.9	0.0	1.4	5.7	1.3	15.6	22.5	1.3	0.1	4.2
FBXO3	"FBA, FBX3"	ENSG00000110429	"F-box protein 3"	Q9UK99	11	33740939-33774543	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002467			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA002467: AB_2666602"	"unprognostic (1.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.36e-2)"	"prognostic favorable (2.46e-9)"	"unprognostic (6.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-2)"	18.2	16.0	18.4	8.7	33.9	14.1	17.4	27.7	30.3	16.1	13.3	17.1	11.5	11.2	16.4	15.8	21.1	15.0	13.5	28.1	17.3	19.3	29.3	25.3	12.2	10.3	15.2	15.4	18.8	16.5	35.9	21.8	15.3	27.8	16.6	15.0	16.7	17.0	16.9	67.6	18.4	16.3	19.0	12.4	12.6	14.6	15.1	15.2	18.6	21.6	24.2	16.6	15.9	16.6	11.1	8.4	13.0	9.2	15.7	22.8	10.4	11.5	10.4	14.1	15.0	17.1	13.5	8.5	13.8	13.9	11.3	14.1	11.8	11.7	7.7	9.8	15.0	13.9	20.1	18.8	18.3	18.9	7.7	26.1	3.9	16.3	9.6	10.9	9.1	9.3	13.6	18.6	7.7	12.4	16.5	14.8	5.7	13.4	15.5	12.6	7.8	6.7	5.3	7.1	26.2	16.0	5.2	31.6	10.9	16.3	14.7	20.0	11.0	19.6	13.5	10.1	14.2	19.5	7.0	13.5	14.0	12.3	19.7	11.6	8.7	11.3	13.1	12.5	7.1	13.7	13.0	7.8	11.1	15.1	7.5	16.6	10.9	17.9	17.0	8.4	11.1	22.8	15.9	8.4	15.7	9.2	4.3	21.4	10.4	18.4	33.9	27.7	30.3	17.3	19.3	15.2	15.4	27.8	15.2	32.8	15.0	18.2	54.0	43.4	58.2	36.0	12.7	33.5	18.2	24.4	25.5	19.9	48.0	41.8	83.0	29.3	20.5	0.0	22.0	24.3	25.4	28.3	16.1	34.2	10.5	54.0	23.0	30.1	12.0	42.2	27.6	14.1	27.0	9.0	18.0	50.1	28.5	19.9	25.5	47.3	42.8	58.2	31.1	51.9	29.8	59.0	30.6	33.2	16.2	46.2
FBXO30	"Fbx30, MGC21674"	ENSG00000118496	"F-box protein 30"	Q8TB52	6	145793502-145814753	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 10.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012583			Approved	Microtubules		NA	NA			Microtubules		"HPA012583: AB_2668686"	"unprognostic (8.69e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.36e-2)"	"unprognostic (7.61e-7)"	"unprognostic (5.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.78e-1)"	6.9	6.9	7.4	5.9	11.2	8.8	6.0	7.3	9.0	7.6	17.9	5.6	6.4	5.8	10.8	4.8	14.7	7.0	8.5	11.5	10.6	6.3	6.1	4.9	6.1	5.6	10.8	6.3	9.1	9.7	7.6	5.7	6.9	11.3	10.8	7.1	5.1	7.0	10.9	22.9	4.7	8.5	20.9	7.8	5.6	8.6	9.0	10.8	4.8	15.4	4.5	5.8	19.7	8.9	1.4	2.4	10.5	1.9	0.7	1.2	0.8	3.1	5.9	8.5	11.5	8.9	8.0	8.7	8.9	8.3	6.1	6.1	7.4	2.9	14.4	6.9	10.1	11.2	4.9	7.3	6.5	9.3	8.3	5.0	9.1	7.7	7.4	16.1	11.8	9.5	13.1	7.3	7.5	10.1	8.0	8.8	3.6	10.5	10.4	11.8	2.4	5.2	6.3	9.8	2.0	4.4	6.9	19.0	4.9	6.3	3.2	3.8	6.1	10.9	5.7	5.2	8.9	2.6	11.7	11.5	6.3	5.3	8.0	8.8	7.7	5.9	5.8	10.1	5.1	6.7	10.5	1.9	2.3	0.7	1.6	0.5	0.9	0.7	1.2	2.4	1.4	1.0	1.0	1.8	0.7	1.3	0.7	0.5	0.8	7.4	11.2	7.3	9.0	10.6	6.3	10.8	6.3	11.3	10.8	3.0	5.1	1.4	5.0	12.7	9.3	19.1	12.7	1.4	4.5	3.5	3.9	4.5	10.0	4.6	7.8	13.5	3.5	70.0	2.8	2.8	14.7	5.6	11.5	6.7	6.6	25.4	5.8	9.2	13.5	3.1	10.3	8.1	6.8	5.4	5.5	9.5	4.4	3.5	9.6	6.5	7.6	0.0	14.4	18.5	8.9	15.2	4.7	7.9	5.0	4.3
FBXO31	"FBX14, Fbx31, FBXO14, MGC15419"	ENSG00000103264	"F-box protein 31"	Q5XUX0	16	87326987-87392142	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA030150	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA030150: AB_10670559"	"unprognostic (4.85e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.16e-5)"	"unprognostic (3.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.26e-3)"	25.7	11.5	10.5	6.1	12.1	5.4	22.3	39.7	18.7	10.4	14.1	5.9	9.3	9.0	13.3	7.4	10.8	11.1	6.7	17.2	8.3	8.2	5.3	11.3	5.6	6.3	6.9	10.4	13.9	13.5	8.8	16.6	5.4	8.5	9.4	6.4	7.9	10.3	12.0	50.4	8.9	11.4	14.8	4.6	5.3	8.3	9.1	5.6	4.5	6.0	7.0	5.4	12.2	22.6	2.4	0.9	1.4	0.7	0.2	3.7	1.4	4.9	9.4	3.1	8.5	16.2	9.8	9.2	8.6	8.6	8.6	4.5	8.5	4.2	11.5	9.5	9.1	4.3	7.6	6.0	7.2	5.8	5.3	11.1	3.9	5.7	23.9	9.1	3.7	3.3	11.6	6.1	11.2	10.6	5.6	5.2	6.0	11.0	4.5	4.5	7.1	8.7	5.0	6.1	5.1	8.4	11.3	3.7	4.9	3.8	3.5	14.6	7.1	19.2	3.9	5.9	2.4	6.1	3.2	7.2	8.3	6.3	7.8	6.7	10.5	8.1	14.3	6.6	6.9	5.1	1.4	0.6	0.2	1.0	0.6	1.8	2.4	1.7	2.4	0.4	1.6	1.8	1.9	0.9	0.2	0.7	0.9	3.7	1.4	10.5	12.1	39.7	18.7	8.3	8.2	6.9	10.4	8.5	5.6	0.0	2.9	3.7	4.3	13.1	12.3	19.4	0.0	4.0	1.2	5.2	31.4	8.8	0.0	3.1	6.9	8.4	17.0	0.0	4.3	2.7	7.1	3.8	0.0	23.7	3.5	0.0	8.6	3.7	5.1	22.2	7.5	1.9	3.3	4.6	10.4	3.9	3.7	11.5	10.6	4.4	11.8	19.4	9.0	13.5	5.1	11.3	6.1	5.0	13.6	3.5
FBXO33	Fbx33	ENSG00000165355	"F-box protein 33"	Q7Z6M2	14	39397669-39432500	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046657	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046657: AB_10960398"	"unprognostic (8.84e-3)"	"unprognostic (6.72e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (9.61e-2)"	"unprognostic (4.54e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.58e-3)"	8.9	13.3	8.9	8.9	12.1	49.1	8.4	12.3	19.7	10.1	7.0	7.1	10.0	8.2	8.5	12.0	7.5	8.8	8.6	6.1	10.4	11.7	8.5	8.8	9.0	12.8	9.1	11.0	9.4	7.8	18.4	19.0	8.8	9.3	9.1	6.9	9.4	10.8	12.0	4.4	6.7	8.0	7.7	7.2	10.4	8.2	12.8	7.5	16.6	14.9	5.7	10.6	8.6	8.7	2.5	1.6	7.8	2.2	5.5	4.8	1.3	9.7	6.1	5.6	8.6	20.2	9.5	9.3	9.8	13.3	5.5	6.5	3.6	8.7	11.0	12.2	15.3	5.5	5.0	14.4	9.7	10.0	10.5	9.3	4.3	8.9	9.3	5.7	16.4	16.7	8.8	10.5	9.4	3.0	9.6	4.6	11.0	3.8	10.0	10.8	10.4	14.6	10.3	5.7	8.8	9.2	12.7	9.1	9.9	10.5	12.5	9.7	4.4	8.9	9.4	10.7	8.7	6.9	10.6	5.8	9.4	8.4	13.9	7.8	13.6	16.0	17.3	7.2	7.8	6.9	1.6	1.7	3.7	3.4	2.1	3.2	2.5	3.4	3.7	1.6	2.3	4.8	4.5	7.8	5.5	2.2	1.5	3.4	1.3	8.9	12.1	12.3	19.7	10.4	11.7	9.1	11.0	9.3	7.5	8.9	19.0	17.1	12.7	30.7	22.6	5.9	2.5	1.4	5.7	8.7	41.2	7.0	6.6	7.2	32.0	14.3	14.7	0.0	8.2	7.7	16.9	17.3	10.3	9.0	9.3	27.0	23.0	9.8	19.6	8.0	7.8	14.0	18.6	6.4	12.6	12.4	11.0	7.0	4.9	2.7	16.1	0.0	17.9	19.6	10.2	49.3	17.7	17.5	12.4	20.9
FBXO34	"Fbx34, FLJ20725"	ENSG00000178974	"F-box protein 34"	Q9NWN3	14	55271303-55361918	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 134.7;Late spermatids: 158.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052592	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA052592: AB_2681877"	"unprognostic (6.19e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.87e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	9.7	8.2	17.7	15.0	21.1	12.6	20.1	13.5	29.3	11.6	23.9	5.6	9.5	12.6	10.0	14.5	31.3	13.9	11.6	11.4	25.9	10.6	16.4	10.5	15.6	11.3	8.8	18.5	11.9	16.0	10.8	7.9	8.7	9.4	11.9	24.9	10.8	19.5	11.3	36.3	12.7	13.6	11.2	9.1	11.6	15.5	24.1	6.4	12.4	30.6	12.0	13.5	13.6	17.1	8.2	11.8	10.5	13.5	13.6	14.9	9.7	18.7	11.4	8.7	8.1	11.4	9.5	9.5	9.5	16.6	14.7	17.1	9.7	24.4	15.1	8.0	8.5	9.7	18.7	11.3	10.0	19.1	9.5	7.5	16.2	7.0	6.0	8.7	18.5	15.8	8.0	14.5	10.3	10.6	11.2	11.2	16.7	12.3	12.4	9.6	12.3	14.8	12.9	5.1	16.4	9.1	15.9	21.6	8.3	13.2	21.9	10.1	10.5	11.5	11.4	9.0	11.4	13.8	12.0	8.1	12.6	16.8	6.7	7.3	5.7	5.0	17.2	9.1	10.2	7.1	10.5	12.0	2.8	13.1	7.6	14.9	8.2	12.6	12.9	11.8	8.2	11.3	10.7	6.9	13.6	13.5	5.3	7.8	9.7	17.7	21.1	13.5	29.3	25.9	10.6	8.8	18.5	9.4	6.4	20.8	24.0	7.8	28.6	18.7	30.5	20.4	2.5	38.8	30.7	17.4	21.6	10.6	14.9	19.3	134.7	24.8	42.0	0.0	27.0	3.8	13.4	29.3	17.3	6.8	8.6	35.0	25.3	7.4	12.9	158.7	21.3	16.7	11.8	6.4	25.4	14.1	15.5	31.6	15.6	14.3	31.4	6.5	17.0	39.4	14.6	21.2	22.5	27.4	24.8	54.5
FBXO36	"Fbx36, FLJ37592"	ENSG00000153832	"F-box protein 36"	Q8NEA4	2	229922302-230013109	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 54.9;Cone photoreceptor cells: 33.4;Early spermatids: 33.5;Spermatocytes: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053865			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053865: AB_2682282"	"unprognostic (4.39e-3)"	"unprognostic (6.51e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.68e-1)"	4.0	7.8	8.9	1.9	12.6	1.9	7.3	4.1	12.2	6.7	2.8	11.9	4.7	3.2	5.4	8.9	3.8	21.7	3.9	2.9	8.3	9.1	10.3	3.7	4.9	2.1	8.1	6.9	6.8	3.7	11.7	11.7	3.6	10.1	6.4	3.0	9.3	5.0	5.8	2.0	6.1	3.2	3.9	8.9	2.1	3.7	14.0	5.2	2.7	14.8	2.8	2.7	2.9	3.3	2.8	3.6	0.8	1.7	2.7	4.5	1.2	1.3	2.6	3.1	1.2	1.5	9.4	6.1	1.6	4.3	2.3	4.0	0.8	4.1	0.1	0.9	2.8	2.8	1.0	1.4	0.8	4.0	0.3	0.9	0.5	0.9	1.6	6.0	1.0	0.4	9.9	7.0	4.4	3.4	3.0	2.4	4.5	1.8	0.8	2.7	5.2	2.2	2.4	8.1	2.8	2.9	2.6	0.9	0.6	4.1	1.0	2.9	3.7	2.6	2.1	1.1	3.6	4.5	1.8	1.8	3.8	1.4	6.1	0.6	2.8	2.3	0.9	4.7	0.5	2.8	0.1	1.7	0.1	2.5	1.3	2.1	2.8	1.9	1.7	3.6	2.0	4.5	2.5	0.8	2.7	0.9	1.7	3.5	1.2	8.9	12.6	4.1	12.2	8.3	9.1	8.1	6.9	10.1	5.2	8.9	1.4	0.0	2.9	3.4	7.0	3.1	0.0	54.9	10.3	10.4	33.4	1.6	13.3	4.9	33.5	2.4	1.8	0.0	5.8	1.5	3.1	2.8	0.0	2.4	0.9	9.5	0.0	1.8	1.0	5.4	3.1	1.2	3.3	4.6	1.4	6.6	4.5	0.0	3.9	7.5	27.5	6.5	2.7	34.9	10.3	4.0	1.8	0.5	1.5	1.1
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	No			"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: AB_2677484"	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	23.2	19.3	13.8	17.7	21.2	12.6	20.6	20.8	21.1	22.3	18.4	20.0	20.4	13.8	25.2	18.2	17.6	16.7	16.9	24.1	18.8	13.8	19.2	25.7	20.7	19.0	16.3	18.8	19.2	16.9	29.2	34.1	19.7	24.6	22.2	19.3	16.4	19.4	18.7	28.5	19.3	18.4	18.2	17.8	24.8	18.8	20.0	18.9	26.9	18.1	17.1	21.7	21.7	18.0	5.5	8.1	13.7	14.8	8.0	7.9	4.9	8.6	9.2	14.3	10.4	16.1	18.2	7.5	11.3	21.6	16.1	22.1	13.5	10.6	12.5	11.1	18.2	17.0	12.1	14.9	14.2	19.4	13.7	9.6	7.4	13.5	9.1	16.1	20.0	12.2	17.5	12.2	15.4	15.2	17.2	21.6	11.7	8.2	13.6	15.7	3.5	12.6	9.5	6.7	9.6	14.0	11.3	20.9	12.5	15.6	10.1	12.8	12.5	15.0	10.1	14.5	12.8	10.6	14.6	14.0	14.7	5.3	7.7	12.5	16.7	16.8	10.7	14.6	11.5	11.1	13.7	6.3	9.0	5.9	8.6	6.3	5.5	5.5	5.7	8.1	4.8	5.7	7.2	12.0	8.0	14.8	3.9	7.9	4.9	13.8	21.2	20.8	21.1	18.8	13.8	16.3	18.8	24.6	18.9	14.9	40.8	7.0	5.2	3.0	9.8	16.2	7.6	16.0	10.3	10.4	9.8	6.2	5.0	7.4	7.9	6.7	8.0	0.0	5.8	5.5	6.0	8.8	15.1	17.3	11.1	12.7	9.2	13.5	25.7	2.1	8.3	15.0	3.3	4.6	9.8	5.6	8.7	8.6	17.3	7.5	9.2	0.0	4.7	22.1	7.5	3.3	10.3	6.9	9.1	7.1
FBXO4	FBX4	ENSG00000151876	"F-box protein 4"	Q9UKT5	5	41925254-41941743	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003362			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003362: AB_2666918"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (8.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.39e-2)"	"unprognostic (8.27e-2)"	15.5	13.3	6.6	9.4	9.8	8.5	14.9	7.1	10.3	11.1	9.2	7.8	14.4	9.2	10.0	19.6	10.0	10.5	12.3	8.6	6.3	6.5	9.2	19.9	10.2	12.9	8.9	7.3	12.1	19.3	9.7	9.4	8.6	8.7	11.2	9.7	10.8	11.7	11.7	7.6	11.2	9.9	10.6	7.8	14.8	9.2	11.0	8.2	11.1	16.2	9.9	15.1	11.0	8.9	11.5	9.6	2.6	15.9	8.0	9.9	6.7	5.6	4.1	0.7	10.6	5.7	9.4	6.4	4.8	9.0	8.1	11.1	2.0	15.4	14.5	6.5	6.6	1.8	1.4	2.5	1.6	6.8	5.0	1.0	7.6	15.0	5.3	11.1	12.3	4.9	5.6	3.6	4.1	15.5	3.0	6.1	6.6	7.0	4.6	9.3	2.3	7.8	2.5	0.3	8.1	3.6	1.4	1.6	3.7	5.5	5.5	1.7	3.2	19.0	1.4	7.0	0.4	9.5	13.9	4.3	9.1	2.6	6.1	3.8	7.2	6.2	0.9	9.2	13.7	4.7	2.6	5.1	1.1	8.5	7.4	9.9	11.5	9.5	8.9	9.6	11.1	9.7	8.9	0.3	8.0	15.9	8.5	7.4	6.7	6.6	9.8	7.1	10.3	6.3	6.5	8.9	7.3	8.7	8.2	8.9	11.0	9.3	9.0	11.2	5.8	3.0	15.3	13.4	4.5	10.4	0.0	22.5	10.0	11.5	0.6	7.0	3.6	0.0	14.4	23.5	15.5	4.4	4.7	16.4	14.6	3.2	1.7	8.6	4.0	0.9	9.8	11.5	18.6	4.6	8.4	8.3	9.2	7.0	9.9	17.3	7.1	6.5	9.2	21.8	17.9	12.4	10.4	17.0	10.1	5.4
FBXO41	"Fbx41, KIAA1940"	ENSG00000163013	"F-box protein 41"	Q8TF61	2	73254682-73284431	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 10.8;Horizontal cells: 6.4;Intestinal endocrine cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055246, HPA058386"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA055246: AB_2682758, HPA058386: AB_2683701"	"unprognostic (1.15e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.74e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (7.97e-3)"	"unprognostic (7.55e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-2)"	1.5	3.6	21.9	5.9	19.3	4.2	2.1	21.7	33.3	1.2	2.1	1.7	0.9	2.2	1.9	3.6	1.6	2.0	2.7	1.1	18.8	10.6	0.8	1.1	2.2	9.4	5.9	17.8	2.5	4.1	9.8	7.3	1.1	6.8	3.0	2.4	0.8	3.7	3.3	0.6	3.4	2.7	2.1	2.1	7.5	2.5	2.4	3.5	2.1	1.5	0.0	9.0	2.8	0.8	0.5	0.9	0.0	2.6	1.1	0.7	0.4	3.6	1.8	0.6	0.0	0.1	0.1	0.8	0.7	0.6	1.2	1.5	4.1	2.1	27.0	0.1	0.1	2.7	3.0	3.8	2.4	1.2	11.2	0.3	8.2	4.1	1.7	0.9	12.4	6.3	1.5	0.9	0.0	0.9	3.3	0.2	7.4	1.6	4.4	1.2	0.9	4.3	11.6	2.7	1.3	1.6	15.2	7.0	13.1	0.8	1.3	9.4	3.5	4.6	2.0	2.9	0.2	2.6	5.2	0.2	4.2	3.7	3.8	0.7	5.3	2.2	12.8	1.1	13.7	1.7	0.0	0.5	0.0	0.6	2.6	0.7	0.5	0.4	0.0	0.9	0.2	0.4	0.4	0.0	1.1	0.1	0.7	0.2	0.4	21.9	19.3	21.7	33.3	18.8	10.6	5.9	17.8	6.8	3.5	0.0	1.1	1.7	0.3	0.2	10.8	1.7	2.5	1.4	0.0	1.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.2	0.1	0.6	0.7	2.3	0.0	1.7	6.4	11.5	1.3	2.6	0.9	0.3	0.9	1.7	1.8	0.0	0.6	1.0	0.0	0.7	0.0	2.2	0.0	0.5	0.5	1.7	0.3	0.0	1.3	0.4	0.1
FBXO42	"Fbx42, KIAA1332"	ENSG00000037637	"F-box protein 42"	Q6P3S6	1	16246839-16352454	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025071	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025071: AB_1848461"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (3.22e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.78e-3)"	"unprognostic (3.91e-2)"	18.2	15.0	18.2	13.0	18.7	11.3	16.1	37.3	23.9	19.1	15.8	17.1	16.1	10.4	24.3	18.5	23.0	18.5	16.3	19.7	16.2	15.9	13.4	15.7	15.2	15.3	16.1	13.4	22.2	22.6	21.2	19.6	16.2	19.5	21.6	15.0	19.0	18.2	22.0	24.3	33.6	12.5	24.9	13.1	15.9	14.3	16.5	17.7	20.1	18.2	10.4	18.9	19.9	22.1	12.2	14.4	18.5	16.8	12.4	12.9	7.9	10.6	5.8	14.2	14.3	17.3	11.2	6.2	11.1	16.9	16.1	15.8	5.4	9.9	11.4	10.0	15.4	11.1	9.8	14.3	10.6	13.3	13.1	6.7	10.6	8.8	6.1	20.6	12.5	13.9	12.0	24.4	14.1	20.5	14.7	16.1	14.4	11.3	16.0	11.4	7.3	12.0	11.0	6.1	14.3	6.6	13.7	8.7	10.1	10.6	3.1	13.4	8.8	12.6	10.6	13.1	13.6	8.6	9.9	10.0	8.2	7.2	13.4	8.6	7.9	8.0	11.6	10.8	16.5	11.2	7.1	12.3	18.5	12.9	16.8	9.7	8.2	9.8	8.2	14.4	12.2	11.3	9.6	10.9	12.4	12.5	6.4	12.2	7.9	18.2	18.7	37.3	23.9	16.2	15.9	16.1	13.4	19.5	17.7	11.9	10.2	12.2	5.3	23.0	20.2	17.1	10.2	2.7	4.5	12.2	43.2	9.2	0.0	6.7	7.2	9.2	7.1	0.0	6.6	11.9	12.2	9.8	2.3	8.6	11.8	27.0	10.3	10.4	12.7	7.2	13.8	14.6	1.7	8.2	5.8	12.5	7.7	7.0	10.6	2.8	21.7	12.9	10.5	13.6	8.8	30.4	22.0	14.4	8.2	4.4
FBXO44	"FBG3, FBX30, Fbx44, Fbxo6a, MGC14140"	ENSG00000132879	"F-box protein 44"	Q9H4M3	1	11654375-11663327	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.7"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003363	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003363: AB_1078831"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (2.63e-4)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.29e-5)"	"unprognostic (1.34e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.02e-3)"	6.6	21.1	26.6	8.3	39.0	5.3	7.0	61.7	45.0	6.5	5.0	12.3	8.9	14.2	8.5	10.3	7.7	12.1	10.5	13.7	28.7	26.4	12.2	7.7	8.1	16.3	20.7	27.4	11.3	17.8	21.7	19.5	2.4	23.1	13.7	3.4	9.9	25.5	15.4	6.4	22.1	7.8	6.2	14.2	13.4	8.1	8.5	15.3	3.2	13.0	3.3	9.9	7.4	7.5	10.9	5.1	1.5	2.5	1.5	11.7	6.1	7.5	12.2	4.5	17.2	6.7	7.0	6.1	6.1	7.4	6.7	5.8	8.9	14.3	0.2	13.6	6.7	11.2	1.9	9.0	20.3	2.8	8.6	11.0	0.2	6.6	14.8	9.3	0.2	1.1	9.0	13.5	6.3	4.8	13.9	5.2	14.1	4.6	1.9	1.7	4.7	12.6	1.4	4.7	6.8	8.7	5.1	0.2	2.5	10.8	2.7	13.7	11.3	16.0	6.2	27.0	5.8	11.1	6.9	6.4	4.9	11.9	6.5	4.8	12.7	7.1	4.6	11.3	3.2	11.6	1.1	2.1	0.6	11.7	2.4	9.0	10.0	8.0	8.9	3.3	10.9	10.9	7.5	1.5	1.5	2.5	5.1	7.1	6.1	26.6	39.0	61.7	45.0	28.7	26.4	20.7	27.4	23.1	15.3	0.0	9.0	9.1	10.8	16.4	20.1	3.6	5.1	2.7	5.7	15.7	13.7	1.3	26.6	8.0	3.6	3.8	0.8	0.0	5.7	2.4	10.1	9.3	3.5	3.9	5.1	38.1	4.1	5.5	6.2	9.9	21.3	5.0	10.1	5.4	2.0	14.8	6.5	1.1	27.3	9.1	6.8	0.0	6.6	11.1	7.2	14.9	0.7	20.0	2.1	4.7
FBXO45	Fbx45	ENSG00000174013	"F-box protein 45"	P0C2W1	3	196568611-196589059	"Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040730	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA040730: AB_10959311"	"unprognostic (7.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.61e-5)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.16e-5)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (5.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.65e-1)"	6.3	5.6	15.6	7.2	15.0	14.6	9.4	19.0	19.4	6.2	8.4	12.5	4.0	6.6	6.2	4.0	11.5	4.8	5.7	4.5	15.5	12.0	4.9	8.4	5.6	7.7	13.5	11.1	6.7	6.7	13.7	7.8	6.7	11.8	6.6	9.1	3.5	5.9	5.8	15.3	15.8	6.2	6.3	14.9	6.0	6.8	14.4	13.3	6.7	4.7	7.7	12.0	7.3	11.4	2.0	4.4	3.8	3.3	1.6	4.8	1.2	19.9	3.8	8.1	10.2	5.4	5.4	9.6	8.9	4.1	7.0	7.3	10.6	6.8	8.4	15.4	5.7	10.5	8.6	15.4	10.1	13.1	12.2	6.9	15.4	7.0	6.6	5.2	20.5	7.9	2.7	11.5	8.0	14.8	3.7	7.7	13.8	18.4	18.0	7.8	20.0	11.9	9.6	12.6	17.9	14.8	10.2	10.6	20.4	5.9	8.2	16.5	11.3	9.6	16.8	10.2	7.4	28.9	13.8	7.6	8.2	8.9	11.8	23.9	17.7	29.5	23.7	7.1	26.6	7.8	3.8	3.1	3.1	2.8	2.9	4.6	1.8	2.8	1.6	3.7	2.0	2.6	3.0	1.2	1.6	3.3	4.4	4.8	1.2	15.6	15.0	19.0	19.4	15.5	12.0	13.5	11.1	11.8	13.3	11.9	2.6	9.3	5.6	8.8	18.5	9.0	2.5	6.7	2.3	3.5	13.7	2.2	0.0	4.2	11.6	5.2	4.6	0.0	6.4	3.8	3.8	11.6	1.1	7.9	5.0	12.7	16.7	6.2	11.1	12.9	5.2	6.5	5.0	2.8	7.9	7.7	6.2	3.5	6.0	2.7	9.8	0.0	5.6	26.8	24.3	11.8	1.6	4.5	7.4	15.6
FBXO46	"20D7-FC4, Fbx46, FBXO34L"	ENSG00000177051	"F-box protein 46"	Q6PJ61	19	45710629-45730904	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049390	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA049390: AB_2680742"	"unprognostic (9.02e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (9.33e-2)"	"prognostic favorable (5.44e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.13e-2)"	"prognostic favorable (8.11e-4)"	"unprognostic (9.77e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (5.09e-6)"	7.4	7.4	13.8	12.9	13.1	10.4	9.8	10.4	15.7	11.2	10.3	8.6	10.6	9.6	15.7	10.0	20.7	10.7	7.3	8.7	13.3	4.8	7.6	10.5	7.7	17.2	13.9	10.1	17.1	12.6	8.4	10.4	12.3	10.2	10.1	9.7	8.6	11.0	9.0	12.8	12.8	11.4	10.9	9.7	15.8	13.3	11.5	13.0	13.6	12.8	9.2	17.1	10.0	12.4	5.9	2.6	7.1	2.3	1.1	3.7	1.2	7.0	11.0	8.5	9.9	2.2	4.0	9.7	3.7	2.1	2.9	3.4	9.1	9.3	12.3	5.0	2.0	4.2	10.3	6.3	4.7	2.2	15.1	13.3	10.0	37.1	4.9	3.3	4.4	12.9	3.3	4.3	5.0	3.1	7.5	4.4	15.3	7.8	15.0	2.4	6.7	10.2	5.1	5.4	6.6	3.8	13.8	4.7	11.4	3.5	8.5	8.5	7.5	5.9	12.5	4.9	8.5	10.6	5.5	4.9	6.3	5.7	3.4	6.0	14.4	19.9	8.2	7.0	6.2	5.1	7.1	2.3	2.3	3.7	1.8	2.5	4.0	2.8	2.5	1.5	5.9	2.6	3.0	6.7	1.1	2.1	2.6	2.6	1.2	13.8	13.1	10.4	15.7	13.3	4.8	13.9	10.1	10.2	13.0	8.9	4.5	6.0	9.3	23.1	2.8	4.5	7.6	5.3	4.5	7.0	2.0	7.1	1.7	5.5	2.3	4.5	10.4	0.0	4.2	13.6	3.8	7.1	3.5	16.3	3.1	11.1	7.0	4.9	4.3	2.2	5.2	3.6	5.0	3.6	11.7	4.0	5.8	11.8	1.8	1.7	2.7	0.0	3.9	6.0	3.8	31.2	10.4	4.8	8.6	9.6
FBXO48		ENSG00000204923	"F-box protein 48"	Q5FWF7	2	68459419-68467258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 29.8;Alveolar cells type 2: 64.5;Club cells: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049775, HPA054782"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA049775: AB_2680874, HPA054782: AB_2682599"	"unprognostic (2.90e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.89e-2)"	6.3	3.9	4.2	4.1	5.4	2.1	5.8	5.5	5.9	3.8	5.0	5.1	4.2	5.5	5.8	3.7	4.8	2.3	2.6	3.2	3.9	3.6	4.5	6.1	5.2	4.9	6.5	6.4	5.7	4.7	4.9	7.2	3.7	6.2	4.8	3.9	2.0	4.8	2.6	8.2	7.6	4.8	4.1	5.1	6.4	4.2	3.2	4.0	5.3	3.6	4.8	5.4	5.4	6.8	3.2	2.5	5.6	3.1	2.7	5.5	1.7	3.6	1.3	2.5	1.7	3.0	3.4	1.7	2.7	3.2	2.7	3.0	1.9	1.8	4.6	1.9	1.3	3.7	2.0	2.2	2.2	5.0	6.1	2.5	2.5	1.2	1.0	1.3	1.1	2.8	1.6	3.9	3.8	3.3	1.4	1.2	7.8	1.1	8.9	2.1	0.7	2.6	3.3	1.4	2.6	1.9	2.4	4.3	3.0	1.9	1.1	2.4	1.7	1.3	0.7	3.0	2.2	0.8	1.1	1.2	3.2	2.8	3.7	2.9	7.0	4.3	2.1	1.9	2.0	2.3	5.6	2.1	2.4	3.0	1.8	2.8	2.3	4.8	2.9	1.1	3.2	3.7	3.7	4.4	2.7	3.1	2.5	5.5	1.7	4.2	5.4	5.5	5.9	3.9	3.6	6.5	6.4	6.2	4.0	29.8	64.5	6.7	3.8	6.4	3.6	9.8	10.2	21.4	27.3	5.2	2.0	3.7	10.0	2.5	1.1	4.5	5.8	0.0	2.7	3.0	3.5	3.2	11.6	5.9	3.7	3.2	2.9	3.7	3.1	0.0	3.7	7.0	1.7	2.8	4.9	1.9	2.9	2.9	1.4	4.9	5.8	0.0	4.1	10.3	7.9	6.9	1.4	4.5	3.1	3.0
FBXO8	"FBS, FBX8"	ENSG00000164117	"F-box protein 8"	Q9NRD0	4	174236658-174284264	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002885	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA002885: AB_1078835"	"unprognostic (8.17e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (1.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-1)"	16.8	18.5	13.5	9.2	14.1	7.3	16.4	19.4	14.0	15.6	17.3	14.0	10.7	13.4	13.1	19.5	16.4	15.1	13.1	19.1	13.3	12.0	20.2	43.5	11.8	9.5	14.6	10.1	15.7	22.6	16.5	26.9	27.1	14.3	16.8	15.3	14.7	13.3	13.1	7.4	16.0	18.9	18.8	14.7	13.9	14.7	10.0	14.0	18.2	19.9	6.5	12.4	20.6	18.2	12.6	8.6	19.2	8.9	9.8	15.5	7.8	4.8	3.2	6.6	2.2	14.9	16.3	5.2	9.9	9.1	6.6	6.7	2.5	8.6	3.7	9.4	6.4	5.6	3.1	4.4	5.7	7.0	11.1	10.0	3.2	5.5	4.0	11.4	4.4	3.6	9.3	14.2	6.0	8.0	11.8	6.5	4.1	6.8	19.1	8.6	4.8	4.5	4.6	1.8	7.8	3.4	2.7	4.3	5.8	10.2	2.0	6.2	40.1	4.4	7.8	11.0	6.7	4.4	4.8	7.4	3.8	3.7	11.0	5.5	9.9	4.7	3.1	13.0	3.2	5.3	19.2	6.2	12.7	12.3	7.8	15.5	12.6	14.2	12.1	8.5	10.7	13.5	11.8	6.2	9.8	8.9	8.6	15.0	7.8	13.5	14.1	19.4	14.0	13.3	12.0	14.6	10.1	14.3	14.0	3.0	11.4	16.0	15.8	18.3	11.9	9.0	12.7	18.7	13.6	21.0	5.9	29.9	43.1	14.8	14.7	16.8	18.2	23.3	9.7	44.8	19.0	18.2	2.3	50.0	18.5	17.5	11.6	19.0	16.9	4.1	16.1	8.5	10.1	19.8	20.1	20.7	11.1	19.3	24.8	32.6	16.1	12.9	14.7	33.3	17.4	27.5	74.9	17.5	13.4	20.6
FBXO9	"FBX9, NY-REN-57"	ENSG00000112146	"F-box protein 9"	Q9UK97	6	53051991-53100873	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064246			Approved	Centrosome		NA	NA			Centrosome		"HPA064246: AB_2685225"	"unprognostic (6.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.89e-3)"	"prognostic favorable (1.51e-4)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.64e-3)"	22.6	77.8	19.0	25.2	22.3	47.2	22.8	33.5	42.6	19.4	22.3	15.2	37.2	17.4	21.3	26.6	25.1	20.6	22.6	28.7	20.0	23.8	27.3	38.0	40.5	28.9	22.7	30.5	20.6	32.9	32.7	22.5	28.9	30.4	21.3	18.0	21.8	35.3	43.7	32.0	20.9	19.9	26.9	13.8	22.2	27.0	18.2	17.1	13.8	24.8	29.9	18.3	20.7	18.6	16.0	15.6	14.6	24.2	14.8	14.6	8.4	28.0	11.5	10.8	32.0	22.2	18.0	24.9	27.2	27.7	25.1	25.1	22.3	12.2	14.4	18.6	26.8	15.8	17.2	23.3	21.7	32.3	17.8	23.3	34.4	21.2	31.6	18.6	32.6	21.8	23.3	24.0	17.3	17.9	25.4	21.2	14.9	34.0	22.5	26.3	18.5	14.1	21.4	9.5	27.1	16.7	16.4	29.0	17.4	27.5	21.1	38.8	14.8	27.3	20.0	35.8	22.7	30.8	31.9	17.2	36.1	24.8	39.3	30.8	23.8	29.9	22.2	17.4	22.6	19.8	14.6	24.2	13.4	12.8	12.6	14.4	14.4	13.1	12.6	15.6	16.0	14.6	11.1	14.4	14.8	12.2	12.3	13.5	8.4	19.0	22.3	33.5	42.6	20.0	23.8	22.7	30.5	30.4	17.1	71.5	78.7	19.3	17.6	12.6	77.5	35.4	38.2	46.8	60.3	19.2	62.8	34.4	33.2	58.3	113.4	26.9	23.7	116.8	66.7	35.9	19.3	26.9	30.2	57.2	22.4	73.1	28.7	25.2	35.1	96.7	35.6	31.6	18.6	22.6	22.4	61.2	54.3	17.8	30.4	47.7	75.8	19.4	25.5	24.7	22.2	14.2	63.0	28.0	21.1	14.8
FBXW10	"C17orf1, C17orf1A, Fbw10, HREP, SM2SH2"	ENSG00000171931	"F-box and WD repeat domain containing 10"	Q5XX13	17	18744024-18779349	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 15.9"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 8.1;Early spermatids: 30.2;Late spermatids: 8.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.8;ASC diff: 2.1;CAPAN-2: 3.1;HaCaT: 4.3;HeLa: 3.4"									HPA047457			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047457: "	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.20e-7)"	"unprognostic (3.16e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.05e-1)"	0.1	0.7	0.1	0.1	0.7	0.0	0.1	1.9	0.6	0.6	0.1	0.1	0.1	0.4	0.1	2.1	0.2	0.8	0.4	0.1	0.6	0.3	0.2	1.1	0.3	0.1	0.1	0.8	0.1	0.1	0.1	0.4	0.1	1.6	0.1	0.0	0.4	0.3	0.2	0.8	0.1	0.4	0.1	0.1	0.1	0.3	15.9	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	5.8	0.0	0.1	2.1	1.3	0.1	0.0	0.2	0.0	0.3	0.1	3.1	0.1	0.1	0.4	0.2	4.3	0.0	0.0	0.2	0.1	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.4	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.9	0.6	0.6	0.3	0.1	0.8	1.6	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.4	0.1	0.0	0.0	0.0	0.1
FBXW11	"BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696"	ENSG00000072803	"F-box and WD repeat domain containing 11"	Q9UKB1	5	171861549-172006873	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072204	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA072204: AB_2686493"	"unprognostic (4.04e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.76e-1)"	15.0	17.1	28.1	11.5	29.4	7.9	17.2	29.7	34.4	17.5	11.2	24.7	9.4	10.2	19.2	10.7	20.0	22.7	14.5	30.3	28.9	26.3	19.5	16.5	14.0	14.0	28.8	20.1	21.8	24.1	37.8	15.8	11.2	23.3	16.2	13.3	12.4	11.6	18.1	24.5	11.0	10.3	21.6	30.6	13.6	15.8	11.3	21.2	12.0	17.5	7.0	17.0	12.9	16.0	9.0	8.2	19.1	7.0	12.9	6.2	5.5	15.8	16.3	24.3	21.2	19.1	19.5	12.4	17.1	24.6	21.5	26.9	16.7	10.8	14.6	21.1	21.9	34.2	10.5	17.4	25.8	35.8	19.3	17.3	11.8	17.0	12.8	17.4	13.1	16.9	14.0	18.0	17.2	28.3	23.0	17.8	12.8	7.3	14.7	26.0	11.9	9.1	6.9	9.3	9.4	18.2	13.4	20.5	9.9	16.5	13.5	10.2	17.9	15.1	12.8	31.5	19.1	16.0	14.1	15.5	21.3	10.6	12.8	16.8	15.1	17.0	10.2	14.9	12.6	16.1	19.1	7.0	6.5	5.7	4.7	6.2	8.7	4.9	5.7	6.9	9.0	4.7	5.8	6.7	12.9	5.1	8.2	5.3	5.5	28.1	29.4	29.7	29.9	28.9	26.3	28.8	20.1	23.3	21.2	23.8	16.8	19.4	11.2	16.9	36.7	51.5	45.9	10.7	20.5	26.2	7.9	7.3	36.5	28.4	22.6	21.7	20.1	23.3	31.8	6.4	15.5	19.1	19.7	38.4	11.3	33.4	27.6	25.2	23.9	30.0	27.3	14.9	11.8	18.0	18.3	56.5	43.0	15.8	26.9	26.9	29.9	45.3	18.9	29.7	15.2	20.7	10.1	17.1	15.1	32.6
FBXW2	"FBW2, Fwd2, Md6"	ENSG00000119402	"F-box and WD repeat domain containing 2"	Q9UKT8	9	120751978-120793412	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067878	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067878: AB_2685913"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (1.38e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.83e-2)"	26.4	31.7	17.4	22.9	25.8	35.6	29.7	27.0	30.3	26.0	22.6	22.6	17.4	18.1	28.8	25.2	25.5	22.7	24.2	25.3	18.1	16.1	20.4	25.5	27.4	25.0	15.1	19.8	20.9	27.3	30.7	23.4	18.8	18.8	22.8	22.3	23.8	25.6	23.2	20.2	27.2	20.9	29.7	16.8	30.1	24.5	23.0	16.7	32.9	22.8	15.7	26.6	25.2	23.8	10.6	11.7	17.7	13.2	15.4	19.3	9.6	14.1	18.0	13.5	22.8	25.6	21.1	12.5	19.1	21.9	21.1	20.7	14.2	17.2	21.3	10.1	24.8	21.4	31.3	19.4	19.0	26.4	28.5	8.4	13.8	30.4	20.6	14.5	30.7	19.1	15.3	23.8	23.3	25.0	19.9	24.7	22.2	18.3	23.3	18.3	22.7	22.0	9.2	20.1	24.2	17.2	17.0	21.6	21.3	14.6	16.1	10.8	16.4	26.8	19.9	13.8	16.7	32.5	8.9	18.3	18.1	14.5	29.1	23.5	16.9	33.9	18.6	19.2	13.7	18.5	13.3	12.6	17.7	19.3	12.0	14.7	10.6	14.1	18.1	11.7	6.9	11.7	15.8	13.4	15.4	13.2	10.3	13.4	9.6	17.4	25.8	27.0	30.3	18.1	16.1	15.1	19.8	18.8	16.7	23.8	49.9	14.5	22.8	20.1	19.5	19.1	17.8	17.4	29.6	10.4	11.8	15.7	18.3	22.8	36.2	31.5	18.9	0.0	29.7	24.2	25.1	28.8	15.1	28.7	22.4	31.8	26.6	34.4	30.8	127.2	24.5	23.2	45.5	33.3	21.9	14.7	25.6	22.9	33.6	21.1	23.1	6.5	25.0	40.3	58.2	28.0	14.9	30.5	21.3	22.6
FBXW4	"dactylin, Fbw4, SHFM3"	ENSG00000107829	"F-box and WD repeat domain containing 4"	P57775	10	101610664-101695295	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043496	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA043496: AB_2678514"	"unprognostic (4.31e-2)"	"unprognostic (5.43e-3)"	"unprognostic (8.40e-3)"	"prognostic favorable (4.91e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (4.67e-4)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (2.94e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.85e-2)"	15.3	11.8	26.4	10.9	27.2	9.5	22.5	16.3	22.1	13.5	22.1	15.9	16.4	11.0	9.4	21.3	17.0	15.1	16.8	40.3	28.1	22.3	14.1	13.3	17.1	10.9	34.6	20.0	14.0	28.5	38.1	16.9	17.2	19.1	17.6	11.5	10.0	27.9	19.9	41.4	19.6	12.0	32.8	36.1	10.5	15.5	7.9	24.2	5.2	15.5	14.8	11.9	18.6	37.1	7.1	5.6	2.8	2.1	5.4	6.7	1.7	10.8	12.9	2.0	14.7	10.6	8.7	9.8	5.7	15.9	6.6	5.2	6.0	11.5	12.4	9.1	11.7	6.8	6.7	5.5	8.4	2.2	13.2	7.7	2.9	4.4	12.8	18.8	4.9	3.9	8.0	26.8	3.5	22.3	15.4	5.6	8.9	3.0	7.8	7.2	22.6	5.5	7.0	5.8	5.6	6.3	4.6	15.3	5.2	12.9	7.3	6.4	11.1	11.0	4.1	10.1	3.2	17.1	8.8	5.9	7.2	0.9	2.9	5.7	16.5	7.4	5.6	5.8	6.2	4.1	1.7	2.1	2.8	6.5	1.1	3.7	4.9	6.2	6.1	1.5	7.1	6.7	5.4	0.3	5.4	1.8	5.6	1.8	1.7	26.4	27.2	16.3	22.1	28.1	22.3	34.6	20.0	19.1	24.2	3.0	41.2	10.7	14.1	10.0	28.3	30.5	12.7	5.3	10.3	10.4	17.7	12.8	3.3	12.6	47.9	7.7	21.6	23.3	22.8	7.7	9.3	18.8	4.7	22.1	7.9	35.0	19.5	6.7	7.6	20.2	13.3	6.6	13.5	10.8	24.6	25.1	16.8	17.5	15.9	10.2	20.7	12.9	17.5	4.4	6.3	10.9	13.0	10.2	19.6	14.9
FBXW5	"DKFZP434B205, Fbw5, MGC20962"	ENSG00000159069	"F-box and WD repeat domain containing 5"	Q969U6	9	136940435-136944696	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 460.8;Late spermatids: 1531.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046615	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA046615: AB_10965648"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.56e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (4.74e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	17.6	13.9	13.3	12.4	14.4	14.7	11.8	11.2	24.3	9.8	17.0	9.6	12.7	23.7	11.1	11.8	19.5	8.5	15.9	30.7	15.3	9.6	13.4	31.0	9.0	10.8	11.8	10.9	8.4	25.9	8.8	10.5	12.8	12.0	13.7	7.5	9.3	25.7	16.1	68.2	11.5	23.4	18.2	6.5	12.7	16.4	67.8	9.6	16.2	12.8	17.3	16.0	14.4	11.6	16.3	38.7	33.0	28.4	20.1	41.2	26.0	15.1	26.3	6.0	14.7	14.7	9.6	35.8	15.9	10.9	11.1	6.1	17.5	19.8	10.4	18.4	16.2	8.7	20.0	5.4	13.8	1.8	13.9	18.3	9.0	35.9	18.0	16.3	13.1	23.3	11.0	12.4	10.1	8.4	8.9	11.3	8.1	17.5	17.2	8.3	40.1	10.2	15.7	11.1	18.4	28.8	11.5	9.2	18.9	9.6	15.5	12.7	12.8	19.6	21.2	21.1	2.4	24.4	20.7	21.9	16.6	15.0	30.9	13.7	14.4	17.1	6.9	22.6	11.7	12.5	19.6	24.8	33.0	41.2	28.4	31.3	16.3	31.3	34.5	23.3	12.9	14.0	23.2	13.1	20.1	21.9	38.7	36.3	26.0	13.3	14.4	11.2	24.3	15.3	9.6	11.8	10.9	12.0	9.6	17.9	47.9	36.0	34.0	25.4	26.7	73.4	48.4	13.4	19.4	22.7	15.7	58.4	63.0	97.4	460.8	47.6	329.2	0.0	129.2	114.9	40.1	69.0	28.8	95.6	79.2	57.2	64.6	41.1	51.5	1531.1	47.8	44.4	65.8	159.7	119.4	39.5	113.5	143.8	66.8	98.2	31.7	58.2	56.1	189.9	37.9	31.5	84.8	55.4	85.6	54.2
FBXW9	"Fbw9, MGC10870"	ENSG00000132004	"F-box and WD repeat domain containing 9"	Q5XUX1	19	12688053-12696643	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042087	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA042087: AB_10794168"	"unprognostic (4.46e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (4.69e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.42e-3)"	4.0	8.3	5.6	5.1	7.7	6.2	6.8	6.3	10.8	7.1	5.7	4.2	6.5	7.6	5.4	11.0	10.3	22.6	8.6	3.4	6.0	6.6	8.3	5.4	9.4	4.8	3.7	7.2	6.3	7.4	4.6	7.0	4.5	7.0	6.8	3.3	5.4	12.0	6.7	2.5	10.2	5.3	3.2	2.5	3.8	6.1	30.4	4.9	7.3	9.0	10.6	5.9	4.8	5.6	3.3	12.0	0.4	8.2	4.6	6.1	5.3	11.2	7.7	5.1	7.4	2.2	3.8	6.2	3.7	3.8	7.9	6.5	4.2	7.0	2.8	9.7	3.3	1.9	10.3	4.9	7.0	1.4	2.0	13.0	3.3	8.7	7.0	5.1	8.4	2.0	5.1	11.3	5.5	2.7	4.8	6.2	6.6	8.0	1.9	1.8	23.5	9.0	10.9	8.6	6.0	7.3	4.8	3.5	15.8	7.0	3.4	11.8	14.0	5.5	11.7	5.1	1.7	11.6	6.3	3.0	4.7	4.4	5.7	5.8	11.7	4.9	3.0	5.8	3.1	3.0	0.0	8.2	0.0	3.2	7.8	5.3	3.3	3.5	2.4	12.0	3.2	3.3	2.3	0.4	4.6	5.1	3.4	6.1	5.3	5.6	7.7	6.3	10.8	6.0	6.6	3.7	7.2	7.0	4.9	3.0	4.8	0.0	4.5	5.4	2.2	0.8	5.1	50.9	10.3	1.8	5.9	12.6	5.0	12.5	3.9	3.6	3.6	0.0	13.9	6.5	4.7	2.7	0.0	3.2	6.1	0.0	4.6	6.7	5.0	7.4	2.3	3.3	3.3	3.6	8.1	4.7	8.9	3.5	4.2	12.4	5.7	6.5	2.2	25.0	15.7	7.2	5.4	3.5	11.1	4.3
FCF1	"Bka, C14orf111, CGI-35, UTP24"	ENSG00000119616	"FCF1, rRNA-processing protein"	Q9Y324	14	74713144-74738620	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046681	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046681: AB_10960541"	"unprognostic (1.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (5.54e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (7.79e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.47e-1)"	23.9	26.0	19.5	18.4	23.0	18.3	27.1	15.7	21.6	25.6	21.6	24.6	25.9	14.4	29.5	18.5	30.4	30.6	17.8	21.9	17.7	18.2	24.6	25.1	21.1	24.2	25.2	17.5	32.7	18.3	23.1	34.5	24.4	23.8	22.8	23.2	20.8	22.7	25.4	26.3	20.3	19.3	23.8	34.9	21.4	19.8	19.4	21.6	28.3	37.8	23.3	30.5	26.6	24.0	19.0	25.2	15.8	14.5	12.1	18.1	6.8	36.1	26.7	19.3	21.8	30.8	27.3	25.5	31.8	24.5	31.8	28.5	29.6	29.9	32.4	20.8	27.7	15.4	26.7	32.2	30.0	56.4	30.0	14.0	22.4	16.8	19.3	22.3	27.3	20.7	21.3	26.6	33.7	35.5	25.3	29.6	28.2	26.8	19.6	28.5	25.8	31.7	9.8	25.9	21.1	31.1	24.2	38.0	15.4	16.2	29.7	13.6	19.8	40.8	21.7	18.1	22.4	27.7	19.1	26.9	25.5	27.3	24.0	36.3	17.3	45.3	50.4	24.2	26.1	28.2	10.0	14.5	15.8	16.6	12.3	18.1	19.0	16.0	14.2	11.2	18.7	17.4	17.8	12.1	12.1	14.2	25.2	15.4	6.8	19.5	23.0	15.7	21.6	17.7	18.2	25.2	17.5	23.8	21.6	6.0	19.4	22.2	6.5	2.7	6.9	18.9	43.3	62.9	18.2	12.2	5.9	10.3	13.3	15.2	17.6	13.6	14.2	46.7	16.3	12.5	7.3	6.1	25.4	87.3	11.2	11.1	9.8	34.4	35.1	8.8	14.4	12.0	0.0	8.2	14.0	14.5	15.2	8.6	15.9	10.7	6.3	12.9	5.2	10.6	11.9	4.3	7.3	13.8	14.2	5.5
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	5	"cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9"	"Cell type enriched"	"Detected in many"	10	"Mucus-secreting cells: 4433.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 9.8;JURKAT: 3.3;RH-30: 11.0;RPMI-8226: 3.8;U-266/70: 3.6"					"Not detected"	"Not detected"			"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytokinetic bridge"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.28e-5)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.08e-1)"	1.7	0.6	1.7	5.9	1.8	0.0	2.7	0.2	1.6	13.9	43.3	0.8	0.7	15.2	0.2	0.4	0.2	0.0	46.6	0.7	0.6		0.6	0.2	0.6	0.2	0.9	0.6	0.6	0.2	0.0	1.2	1.5	1.1	0.4	16.7	0.3	1.3	1.2	0.2	2.8	16.9	0.2	2.1	0.2	17.0	0.4	0.9	0.5	20.9	0.2	0.5	0.2	0.2	0.6	2.3	0.0	0.9	1.3	3.2	0.6	0.0	9.8	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.3	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.4	0.0	0.4	2.8	1.2	0.3	3.2	0.7	0.2	11.0	3.8	0.2	1.3	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.6	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.9	0.3	0.0	0.7	1.4	2.3	0.6	0.9	3.2	0.0	1.3	0.5	0.0	0.2	0.6											3.0	3.2	2.7	0.7	3.3	1.2	3.1	114.7	5.3	21.6	24.4	0.0	0.6	0.0	3.5	6.2	0.7	445.8	0.0	0.8	0.2	1.1	18.9	16.1	0.8	33.7	0.0	77.9	0.6	21.7	7.1	0.9	10.0	8.5	0.0	4433.7	0.0	2.4	241.9	0.0	1.3	1.0	58.2	0.4	0.7	2.4	5.9	0.3	2.9	169.3	4.7
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 182.8"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 145.9;Kupffer cells: 155.0;Macrophages: 311.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 182.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 182.8"	"Cell line enhanced"	"Detected in some"		"HEL: 14.3;HMC-1: 28.9;K-562: 8.4;NB-4: 8.1;THP-1: 30.7;U-937: 13.2"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		55000000	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	36.8	12.6	13.2	44.6	19.2	18.6	8.2	2.2	10.1	9.1	7.1	10.0	0.0	3.8	4.7	6.6	5.5	11.6	17.0	11.3	17.0	8.9	11.5	7.1	44.1	50.0	25.9	1.7	8.0	5.8	2.8	6.1	47.5	19.6	7.0	9.9	10.8	8.3	4.8	7.3	3.0	7.3	17.6	30.9	43.4	5.9	4.8	19.2	3.2	6.3	2.5	4.4	19.3	4.5	0.2	7.0	182.8	27.2	0.0	0.0	10.6	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.2	0.0	0.3	4.1	28.9	0.3	0.0	0.0	0.0	0.4	0.0	0.0	8.4	0.2	0.0	0.0	0.2	8.1	0.0	0.0	0.6	0.1	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	30.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	13.2	3.6	0.1	27.2	31.6	0.0	20.7	0.0	0.2	0.0	0.0	7.0	0.1	0.0	0.0	182.8	0.0	16.7	0.2	0.0	10.6	13.2	19.2	2.2	10.1	17.0	8.9	25.9	1.7	19.6	19.2	20.8	63.3	13.7	0.4	7.7	0.0	1.2	5.1	6.7	21.6	0.0	0.0	0.8	8.3	0.2	37.5	2.6	0.0	0.0	0.5	1.1	5.8	0.3	29.0	0.8	145.9	0.0	0.0	4.3	155.0	35.2	1.4	311.2	16.9	1.8	0.0	0.3	0.7	0.0	0.0	7.9	0.1	6.5	5.8	0.3	0.4	6.8	1.4	4.1	0.0	0.3
FCHO2		ENSG00000157107	"FCH domain only 2"	Q0JRZ9	5	72955981-73090522	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 15.9;monocytes: 4.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037685, HPA037686, HPA077850"	Enhanced		Approved	Vesicles,Centrosome,Cytosol		NA	NA			Centrosome	"Vesicles, Cytosol"	"HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: AB_2686860"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.00e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-1)"	32.2	9.6	10.7	10.0	12.2	8.3	18.0	23.1	18.3	16.2	18.3	8.9	15.3	15.5	23.7	13.0	30.2	14.6	15.7	12.5	11.2	7.0	18.6	16.0	22.8	18.5	10.8	9.5	16.1	11.1	17.5	11.4	19.2	10.9	12.6	16.1	9.9	17.1	12.6	17.7	15.2	20.8	16.6	11.9	18.9	12.2	10.5	12.4	3.2	22.4	11.7	11.8	14.6	22.5	0.7	1.1	15.9	4.5	0.7	1.3	0.5	9.0	7.4	7.1	6.2	10.0	13.3	20.9	8.0	11.9	6.1	9.6	3.7	15.9	2.2	11.2	11.1	11.4	6.9	6.0	14.1	8.3	2.3	7.0	4.4	6.1	4.6	5.0	0.9	4.6	8.9	7.3	8.1	13.1	13.9	13.8	2.2	5.0	3.9	12.5	4.2	0.0	4.4	2.2	1.8	3.7	2.0	6.9	2.6	14.8	12.9	2.8	4.5	11.0	7.8	5.0	10.5	9.5	6.3	14.3	8.0	3.8	8.8	5.6	1.4	2.5	0.4	5.2	0.6	9.7	11.5	2.6	6.4	1.3	3.5	0.8	0.3	0.4	0.5	1.1	0.7	0.2	0.4	15.9	0.7	4.5	0.4	0.3	0.5	10.7	12.2	23.1	18.3	11.2	7.0	10.8	9.5	10.9	12.4	53.6	34.0	1.5	11.1	9.3	10.4	13.3	17.8	24.1	25.0	33.2	3.9	12.1	11.6	13.9	1.6	27.0	19.3	0.0	15.2	6.9	12.1	18.9	17.4	9.6	18.4	11.1	14.3	62.0	68.1	1.4	12.4	21.1	15.1	10.0	13.0	16.7	22.5	21.6	13.1	17.0	8.9	25.8	11.4	11.6	13.8	13.4	11.4	4.3	12.4	29.3
FCHSD1	FLJ00007	ENSG00000197948	"FCH and double SH3 domains 1"	Q86WN1	5	141639302-141651419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043795	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043795: AB_10963435"	"prognostic favorable (8.62e-4)"	"unprognostic (4.08e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.50e-3)"	"unprognostic (8.56e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (6.19e-6)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (4.12e-3)"	"prognostic favorable (1.21e-4)"	7.5	6.6	9.2	16.1	14.1	15.2	8.6	3.0	12.5	11.7	9.9	11.1	4.9	9.7	12.5	8.6	8.6	8.5	13.7	5.4	8.8	6.6	6.8	2.9	9.6	18.6	18.8	4.3	17.7	7.5	23.8	12.6	7.9	14.5	10.0	4.8	5.6	10.3	6.1	2.6	18.5	15.3	8.8	14.5	18.4	10.5	7.4	15.4	7.4	10.6	8.8	23.2	12.1	13.8	5.3	1.9	9.8	3.0	2.3	7.2	2.9	7.3	4.6	6.3	13.1	5.3	6.8	11.0	16.0	8.2	14.4	22.7	8.7	15.8	3.1	8.0	12.3	2.3	4.2	2.0	8.8	6.5	13.0	3.4	6.4	6.2	3.1	4.1	2.0	21.9	8.3	7.1	11.3	3.7	12.2	8.2	0.2	4.0	5.8	1.6	6.5	1.6	3.9	1.8	2.6	4.3	0.0	0.0	2.9	4.9	11.0	0.7	7.1	0.3	6.0	9.1	5.0	7.3	6.1	16.6	0.2	4.0	5.8	6.6	7.0	2.3	1.6	12.6	7.3	6.9	6.3	1.7	5.6	7.0	2.0	5.2	5.3	3.8	7.2	1.9	3.0	3.6	4.9	9.8	2.3	3.0	1.7	5.0	2.9	9.2	14.1	3.0	12.5	8.8	6.6	18.8	4.3	14.5	15.4	0.0	2.1	9.0	3.2	2.4	4.3	0.4	5.1	1.4	2.3	3.5	11.8	0.8	0.0	4.0	6.4	2.9	4.1	0.0	5.7	3.8	3.5	3.0	9.2	0.8	4.7	50.9	4.1	2.5	2.2	4.3	3.7	3.3	3.3	1.8	4.4	1.9	5.6	3.4	3.5	0.3	1.1	6.5	3.1	1.8	3.9	2.5	1.1	10.5	2.4	2.0
FCHSD2	"KIAA0769, SH3MD3"	ENSG00000137478	"FCH and double SH3 domains 2"	O94868	11	72836745-73142261	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Ito cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 54.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038545, HPA038546"	Uncertain		Supported	"Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites"		Yes	No			"Plasma membrane"	"Nuclear speckles, Actin filaments, Focal adhesion sites"	"HPA038545: AB_2676074, HPA038546: AB_10673013"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	18.5	15.1	28.4	41.5	27.8	19.0	26.5	16.9	25.2	13.2	11.4	17.0	6.8	7.0	12.7	10.2	9.7	11.5	18.1	19.2	24.8	21.4	10.6	13.3	26.2	31.7	19.7	12.1	26.3	9.2	10.2	7.6	24.1	17.6	11.2	11.2	12.5	11.1	11.7	7.4	7.0	14.4	16.4	15.6	30.8	10.1	17.4	26.3	19.2	11.9	4.8	33.0	17.9	11.3	16.8	19.0	11.6	4.8	1.1	2.4	2.0	5.2	4.5	9.3	12.2	3.8	9.5	8.7	9.3	19.9	5.7	4.8	3.5	7.7	28.5	11.5	11.9	5.5	7.5	5.4	5.4	7.6	9.8	2.8	22.9	5.1	11.5	9.8	11.2	2.9	5.7	6.0	5.6	6.8	12.5	13.6	9.9	5.0	18.5	7.3	5.6	13.5	19.3	2.0	5.6	5.5	20.7	14.5	54.2	9.0	7.0	4.7	6.6	3.4	6.4	12.1	4.4	4.6	8.2	17.6	18.3	7.1	12.7	2.9	17.8	9.9	25.3	3.1	18.7	5.3	11.0	4.8	10.5	1.7	3.1	1.2	13.0	1.8	2.0	4.8	16.8	2.1	2.4	11.6	1.1	1.6	19.0	1.8	2.0	28.4	27.8	16.9	20.2	24.8	21.4	19.7	12.1	17.6	26.3	8.9	12.3	31.6	4.7	7.6	11.3	15.3	10.2	2.7	5.7	3.5	23.6	9.4	1.7	4.1	5.8	26.5	1.1	23.3	5.3	7.7	6.1	3.0	2.3	10.0	15.9	9.5	4.6	45.4	25.4	8.2	10.0	19.2	5.0	15.4	6.2	8.3	4.0	5.1	15.6	3.3	16.1	6.5	21.5	7.5	10.9	5.1	10.1	7.5	4.2	3.8
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206904386-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9"	"Group enriched"	"Detected in many"	11	"B-cells: 125.3;T-cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 99.6;T-cells: 60.0"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 53.0;U-266/70: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA		2400000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA003910: AB_1078798"	"prognostic favorable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	15.5	0.6	0.5	42.9	0.5	2.9	1.5	0.4	0.4	0.8	2.5	0.4	0.3	1.2	1.2	0.8	3.4	1.3	2.6	1.0	0.5	0.5	2.4	1.5	3.9	77.2	0.5	0.0	1.3	0.7	0.0	0.9	0.8	0.2	1.4	2.3	1.3	10.1	0.3	1.9	0.6	30.1	0.4	0.6	78.8	2.8	0.5	0.0	51.8	1.8	1.2	84.9	8.5	1.2	99.6	1.4	5.3	0.4	18.4	60.0	28.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.1	0.0	0.0	3.4	0.0	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	2.7	0.0	7.4	0.0	0.1	1.0	0.1	0.0	0.0	0.0	1.7	0.2	53.0	0.0	0.1	0.0	0.0	1.0	0.2	5.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	26.7	1.9	7.4	0.3	0.0	0.2	0.5	0.2	0.2	20.3	0.4	26.4	80.3	28.1	26.2	0.2	99.6	49.5	33.3	5.3	18.4	0.3	1.4	60.0	28.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.2	0.0	0.0	4.6	125.3	3.9	0.0	0.0	3.0	7.6	1.4	2.3	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	2.6	0.1	0.6	2.6	0.0	1.1	3.8	0.0	0.0	5.5	5.1	0.0	0.3	1.2	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.3	0.1	1.0	0.0	0.0	41.7	1.2	7.1
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	21.0	57.8	19.3	17.6	26.5	16.5	19.8	12.8	32.2	19.0	25.0	22.6	14.5	45.9	18.0	21.7	41.4	16.7	18.8	19.6	18.6	23.4	23.7	100.8	25.7	19.2	19.5	24.3	15.2	27.5	15.6	12.3	20.2	47.3	16.5	29.7	20.5	29.2	12.9	15.7	29.3	32.3	18.9	23.0	17.7	23.4	15.1	16.5	25.1	19.5	41.7	27.3	13.7	20.8	41.1	39.7	49.4	37.1	45.3	45.5	48.3	36.0	19.6	72.1	26.0	16.9	62.0	25.7	17.2	34.1	27.5	44.8	31.7	85.9	27.5	41.9	15.0	65.7	40.3	42.9	149.6	25.8	15.0	30.7	15.9	35.0	38.3	27.8	25.8	18.3	44.1	23.7	43.7	22.0	12.5	47.9	40.8	28.5	74.2	28.6	38.7	33.0	25.1	43.3	26.8	28.7	28.5	31.3	76.3	72.5	24.1	28.1	24.0	17.7	32.3	29.7	42.9	23.3	70.2	34.8	15.4	18.9	9.5	31.4	31.5	24.2	49.1	15.0	27.6	24.2	30.5	36.0	49.4	39.4	37.1	35.0	41.1	34.8	39.8	39.7	34.2	31.5	39.3	16.5	45.3	27.2	31.4	45.5	48.3	19.3	26.5	12.8	32.2	18.6	23.4	19.5	24.3	47.3	16.5	68.5	144.0	64.8	78.5	32.6	65.5	1.4	107.0	85.6	83.0	50.6	58.9	177.4	116.0	154.2	171.3	113.0	197.2	93.5	286.2	162.6	57.3	89.5	62.2	111.9	95.6	52.4	68.5	133.8	57.6	52.3	56.4	56.4	91.1	217.4	74.5	75.0	194.9	143.8	66.1	113.5	78.0	71.1	63.8	41.9	15.5	52.2	120.0	77.8	106.3	110.3
FEM1A		ENSG00000141965	"Fem-1 homolog A"	Q9BSK4	19	4791681-4801273	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 103.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016565, HPA063622"			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA016565: AB_1848489, HPA063622: AB_2685063"	"unprognostic (4.62e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (6.18e-5)"	"unprognostic (3.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.70e-2)"	3.0	2.4	3.3	2.2	4.4	3.3	4.0	4.1	5.0	2.0	2.7	3.0	0.9	2.2	2.7	4.0	4.2	2.1	1.9	8.6	3.3	2.6	2.2	4.4	2.3	3.8	3.2	2.5	2.1	4.2	4.4	2.3	4.5	3.1	2.8	2.0	2.7	3.1	2.1	103.9	6.9	2.3	2.3	2.2	2.7	2.2	2.2	3.2	4.2	2.1	18.6	3.0	2.5	2.3	7.2	6.8	9.1	8.2	6.8	6.9	4.2	7.2	5.0	4.7	10.1	5.2	3.1	6.8	4.3	3.6	7.0	4.9	7.8	3.3	8.2	4.4	5.3	3.8	7.5	8.2	7.2	4.6	9.7	9.4	8.0	4.0	5.8	7.9	13.2	10.3	4.5	11.1	5.4	7.8	3.3	5.0	11.3	11.7	15.8	4.8	7.3	11.0	4.8	14.4	4.5	12.1	10.3	6.1	8.6	6.3	9.3	15.2	10.8	5.7	10.8	8.1	3.8	8.3	11.5	7.0	6.4	4.6	10.0	11.4	18.4	15.2	7.1	6.6	9.5	9.0	9.1	7.3	7.1	6.9	8.2	6.0	5.3	5.5	6.3	6.8	7.2	5.0	5.7	6.6	6.8	7.3	6.6	3.9	4.2	3.3	4.4	4.1	5.0	3.3	2.6	3.2	2.5	3.1	3.2	23.8	42.3	20.9	12.5	17.9	16.3	5.6	7.6	16.0	21.6	1.8	15.7	18.1	11.6	9.6	4.0	8.8	10.0	23.3	10.1	12.1	7.1	11.5	22.0	13.9	11.0	11.1	12.6	14.1	17.0	2.7	8.3	8.1	3.3	15.4	14.8	11.4	9.9	7.0	7.8	7.9	17.0	6.5	10.3	12.1	5.7	25.7	22.7	12.1	11.9	15.0
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223886	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.4;bone marrow: 57.6;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 94.6;Hofbauer cells: 174.8;Kupffer cells: 81.3;Macrophages: 95.8;monocytes: 155.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 62.7;HL-60: 27.4;HMC-1: 67.1;Karpas-707: 27.0;NB-4: 35.3;U-937: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065231			Approved	Vesicles		NA	NA		450000000	Vesicles		"HPA065231: AB_2685439"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	20.0	5.6	3.1	29.4	5.5	57.6	5.6	0.9	3.2	3.4	8.8	3.4	0.7	8.1	3.4	6.0	3.6	5.8	6.5	7.2	2.2	2.4	5.3	5.5	17.8	39.1	6.3	0.8	4.9	2.8	0.2	2.6	7.5	3.7	4.2	3.0	5.6	8.9	2.9	3.2	2.8	12.4	3.3	4.8	52.7	10.6	2.5	4.3	51.2	4.0	2.4	29.6	6.2	2.9	13.7	47.3	54.7	49.5	22.6	30.6	59.4	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.4	6.6	0.6	1.3	0.1	0.5	0.2	0.1	0.1	17.0	0.1	62.7	0.2	0.0	2.3	27.4	67.1	0.2	0.2	1.1	0.0	0.1	17.0	16.0	1.4	27.0	1.8	0.7	24.4	35.3	0.2	0.2	0.4	14.7	1.8	0.1	0.0	0.1	0.4	0.1	0.1	0.9	0.3	0.1	0.4	19.1	1.6	0.2	0.5	0.4	0.1	0.3	0.6	12.0	4.1	28.4	18.1	40.6	49.5	54.7	30.6	46.3	29.4	13.7	24.4	28.4	39.0	13.4	16.1	21.1	45.0	22.6	33.5	47.3	28.3	59.4	3.1	5.5	0.9	3.2	2.2	2.4	6.3	0.8	3.7	4.3	8.9	17.1	42.2	0.6	4.1	0.6	2.0	5.1	1.4	6.8	0.0	0.0	0.9	0.0	0.6	0.1	3.6	5.9	23.3	2.2	1.1	5.3	0.9	94.6	1.7	174.8	0.0	0.0	17.2	81.3	0.8	0.9	95.8	16.9	155.9	22.4	0.1	2.8	10.5	2.5	0.2	0.2	6.5	6.1	1.1	0.7	4.0	2.2	69.2	13.9	0.7
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.8;lymphoid tissue: 49.7"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 40.6;Kupffer cells: 93.1;Macrophages: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5"	"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HL-60: 19.0;HMC-1: 40.7;NB-4: 24.9;THP-1: 37.4;U-937: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	14.9	3.4	4.8	9.7	4.1	38.3	12.7	2.4	5.7	6.8	5.4	3.2	4.7	3.0	7.4	5.6	4.9	7.6	7.3	7.9	4.2	2.2	5.2	11.8	12.7	23.3	3.7	0.9	6.4	3.7	1.8	2.7	8.1	7.2	7.7	2.4	5.3	33.8	6.3	3.4	3.5	5.2	5.4	6.9	49.7	4.3	3.2	4.7	3.1	7.2	4.1	4.5	7.2	9.4	1.1	32.6	60.8	30.5	9.3	0.1	13.8	0.1	0.2	0.3	3.6	1.0	3.1	6.1	0.9	0.0	1.8	1.0	0.9	0.0	2.3	0.1	2.0	0.0	0.5	0.6	0.1	0.5	1.2	0.3	21.3	0.0	3.8	2.1	19.0	40.7	3.1	0.0	2.6	0.0	0.0	10.8	3.2	0.6	0.0	0.0	6.9	0.6	24.9	1.0	0.8	0.0	2.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.9	1.1	0.0	37.4	8.4	0.0	3.7	0.1	0.0	0.0	2.7	0.8	0.1	16.1	0.8	10.4	30.5	60.8	0.1	17.6	0.0	1.1	0.0	0.0	32.6	0.9	0.0	0.0	20.0	9.3	7.3	12.9	0.0	13.8	4.8	4.1	2.4	5.7	4.2	2.2	3.7	0.9	7.2	4.7	3.0	8.0	6.4	4.7	3.4	0.0	2.5	5.1	0.0	0.0	1.8	0.0	4.5	3.3	4.8	1.1	24.5	0.4	0.0	3.9	3.8	6.2	4.0	28.8	8.2	40.6	0.0	2.9	22.7	93.1	4.7	8.3	37.3	6.8	27.1	2.1	2.3	2.0	0.0	9.6	1.3	1.9	12.9	7.2	3.5	9.1	2.5	3.8	10.2	2.6	5.2
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 76.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 37.1"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.5;Hep G2: 4.5;HSkMC: 1.0;NTERA-2: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035132, HPA035133"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	47500000000	4500000000	Vesicles		"HPA035132: AB_10601650, HPA035133: "		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	2.6	11.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.5	0.0	1.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.7	0.4	0.2	0.0	0.4	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	1.3	2.4	4.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
FEZ1	UNC-76	ENSG00000149557	"Fasciculation and elongation protein zeta 1"	Q99689	11	125445745-125496317	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 123.4"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 101.7;Horizontal cells: 157.3;Melanocytes: 74.2"	"Cancer enriched"	"Detected in all"	10	"glioma: 68.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 30.8;MAIT T-cell: 18.0;memory CD8 T-cell: 8.9;naive CD8 T-cell: 7.7"	"Lineage enriched"	"Detected in many"	14	"T-cells: 30.8"	"Cell line enhanced"	"Detected in many"		"AF22: 40.5;HBEC3-KT: 39.3;NTERA-2: 37.2;SCLC-21H: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038490, HPA076844"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA038490: AB_10672647, HPA076844: "	"unprognostic (5.68e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	6.6	5.6	48.3	4.4	50.1	1.3	4.3	28.2	121.4	6.4	5.1	58.8	0.2	2.9	6.9	4.0	5.9	4.1	9.4	12.4	54.2	38.2	2.7	7.4	10.0	3.5	68.2	29.8	6.0	1.4	5.0	2.3	6.0	43.4	6.6	5.3	1.4	2.4	12.9	1.7	3.5	3.5	13.0	123.4	3.9	2.5	7.2	51.4	0.0	2.2	0.0	2.9	16.8	2.1	0.0	0.4	2.1	0.5	1.0	30.8	5.0	0.0	0.0	40.5	0.0	26.7	24.4	0.0	6.3	8.2	1.6	0.3	0.0	0.0	0.0	7.4	11.9	3.9	0.1	18.4	39.3	0.9	3.2	0.3	18.6	0.0	0.0	22.6	0.0	0.1	19.9	9.1	7.3	19.4	0.1	17.9	0.0	2.5	0.2	1.9	1.0	0.1	0.0	37.2	0.2	0.4	0.0	0.0	0.0	0.0	14.2	39.7	4.1	0.1	0.0	0.6	15.2	3.0	18.2	16.0	0.1	1.0	0.0	5.3	0.4	0.1	0.0	4.4	0.0	17.1	2.1	0.5	0.0	30.8	0.1	18.0	0.0	1.1	8.9	0.4	0.0	0.4	7.7	0.6	1.0	0.0	0.0	0.0	5.0	48.3	50.1	28.2	97.4	54.2	38.2	68.2	29.8	43.4	51.4	0.0	6.9	1.7	4.4	7.1	15.1	101.7	0.0	1.4	3.4	0.0	2.0	5.7	23.2	2.7	52.4	14.0	0.0	0.0	0.3	1.2	36.9	3.0	0.0	0.6	68.8	157.3	5.2	53.4	15.9	52.7	23.6	1.6	74.2	1.0	0.0	65.9	0.5	0.0	33.2	1.1	13.4	19.4	30.1	11.8	7.0	4.8	3.5	9.6	0.0	1.6
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	31.7	23.4	28.7	12.0	25.3	8.1	18.6	20.1	31.2	18.3	17.2	28.0	6.0	13.1	20.4	13.1	20.4	13.1	14.6	28.5	26.1	22.6	21.4	18.4	16.5	13.1	27.6	21.6	18.3	6.8	14.2	8.5	29.6	29.3	15.6	18.4	19.0	9.7	22.1	51.0	9.1	18.7	26.9	33.8	17.8	12.2	12.6	25.4	9.4	14.8	12.2	12.1	15.5	13.5	1.7	13.6	4.7	3.5	3.1	1.5	0.7	15.6	9.4	12.8	5.4	25.4	33.6	10.1	39.8	20.4	24.4	15.5	6.5	5.1	9.7	24.5	51.5	10.7	6.2	10.8	13.7	26.7	2.2	5.9	7.9	3.3	10.8	12.2	7.9	2.0	32.2	11.8	15.0	18.1	16.7	34.9	2.3	8.5	3.0	45.1	5.5	4.8	6.8	6.7	9.0	14.8	3.2	11.6	3.3	19.4	15.3	0.3	11.7	9.8	8.1	9.5	15.0	2.8	9.8	40.5	15.3	8.1	8.4	23.1	2.3	2.7	6.6	15.2	5.5	21.5	2.4	3.5	4.7	1.5	3.3	1.0	1.7	1.1	0.8	3.6	1.0	1.3	0.5	4.0	3.1	1.9	13.6	1.3	0.7	28.7	25.3	20.1	28.8	26.1	22.6	27.6	21.6	29.3	25.4	50.6	29.1	13.8	81.0	27.8	33.3	36.3	12.7	30.8	70.5	55.8	43.2	85.1	48.0	58.2	4.3	78.7	55.8	0.0	26.7	74.7	58.7	87.3	23.1	32.1	80.7	20.6	23.1	93.3	74.8	4.9	50.3	60.5	54.0	36.9	29.6	75.8	51.7	37.4	62.2	31.6	34.6	58.2	52.3	13.0	27.6	28.1	150.6	28.0	32.6	117.0
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301394-122310691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.7;testis: 11.0"	"Cell type enriched"	"Detected in single"	5	"Spermatocytes: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 58.8;SCLC-21H: 25.7"	"Region enriched"	"Detected in single"	11	"hypothalamus: 13.7"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.9"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.6	0.2	6.4	0.2	4.9	0.2	0.2	0.0	2.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	1.0	16.7	0.2	0.2	0.2	0.2	2.0	0.0	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	1.4	0.6	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	11.0	3.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	58.8	1.4	1.0	0.0	0.0	0.0	0.0	0.1	25.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.9	0.0	2.0	1.0	16.7	2.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590766	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	740	"liver: 2009.3"	"Cell type enriched"	"Detected in many"	40	"Hepatocytes: 16694.6"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 96.9"	"Not detected"	"Not detected"							"CAB016776, HPA051370, HPA064755"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	170000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.7	2009.3	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	96.9	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.4	83.9	0.0	0.0	0.0	0.4	420.4	17.4	5.7	0.0	0.0	0.0	1.7	5.5	23.9	0.0	0.0	256.9	1.5	0.0	0.0	0.0	0.0	16694.6	0.1	0.0	0.0	255.3	257.1	29.3	0.6	0.0	0.0	0.0	0.0	0.0	31.5	0.0	1.1	1.0	0.0	0.0	0.0	14.4	0.6	0.0	0.1	4.3	0.0	0.0
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496166	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Melanocytes: 6.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000911	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA000911: AB_1078853"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	5.9	7.7	15.6	5.9	10.9	1.6	7.1	16.3	15.6	12.3	7.2	3.7	3.4	4.5	12.4	4.4	9.3	7.6	7.8	9.2	9.6	7.1	5.1	1.9	4.6	4.0	4.8	11.2	13.7	6.9	6.9	5.4	9.4	5.7	6.5	3.8	6.8	7.7	7.9	3.3	11.8	5.5	11.9	3.7	5.8	5.2	4.6	4.8	0.0	5.6	7.3	4.3	7.6	7.8	1.6	0.6	0.5	2.6	1.2	3.2	1.1	13.6	5.8	11.2	14.6	5.2	9.3	5.4	8.1	8.2	6.9	5.6	1.7	1.2	0.8	6.7	12.6	8.7	5.3	9.4	5.8	3.8	1.4	8.2	0.4	4.5	2.0	5.6	0.7	0.5	7.5	3.7	10.5	5.0	8.7	6.2	3.3	2.2	0.5	5.4	2.9	1.6	1.5	11.0	1.6	9.2	7.8	6.4	0.5	5.9	0.8	10.5	9.8	8.9	0.8	13.4	18.6	9.8	1.2	6.0	8.6	7.7	18.9	7.5	1.0	2.0	1.5	9.6	1.6	4.7	0.0	0.6	0.5	2.0	1.3	2.0	1.5	1.6	2.2	0.6	1.6	3.2	1.8	0.0	1.2	2.6	0.2	1.4	1.1	15.6	10.9	16.3	15.6	9.6	7.1	4.8	11.2	5.7	4.8	0.0	0.0	0.0	1.1	2.6	2.5	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.4	3.5	0.0	0.0	0.9	1.0	4.7	0.7	0.0	0.0	0.3	1.6	1.2	3.1	0.0	0.0	2.6	0.0	6.8	0.0	0.8	2.3	0.6	0.0	3.9	1.4	3.3	0.0	2.1	0.2	1.5	3.6	0.2	0.0	2.6	0.8
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947451-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.2;lymphoid tissue: 48.1"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 52.4;Late spermatids: 74.6;T-cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 21.0;Karpas-707: 29.2;RT4: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	3.1	1.5	2.3	20.5	2.5	23.4	3.5	0.5	1.6	1.8	3.1	3.1	1.6	1.9	2.8	2.5	2.8	2.5	3.1	1.5	2.2	2.0	4.6	2.1	7.5	30.5	3.3	1.0	1.1	5.7	0.1	1.0	2.6	2.6	3.2	1.4	2.2	6.6	1.0	0.7	3.1	10.1	1.5	6.3	28.1	2.6	3.9	2.5	48.1	3.5	2.1	25.8	7.7	3.2	11.3	10.3	49.2	24.7	10.5	15.7	17.1	6.4	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.0	4.4	5.2	0.3	0.0	0.0	4.2	0.3	0.0	0.0	9.0	0.0	8.2	0.0	0.3	0.0	2.2	21.0	0.0	0.1	0.0	0.0	0.0	0.0	8.8	0.3	29.2	0.0	10.7	9.6	9.2	0.2	2.1	0.5	9.5	0.0	7.4	0.0	16.5	0.6	0.2	0.0	7.1	0.2	0.2	2.8	9.7	0.0	0.0	0.3	0.0	0.0	2.9	2.9	2.4	1.5	4.6	0.0	34.0	13.4	36.7	15.1	17.3	15.5	8.5	15.6	14.1	10.3	11.3	15.7	13.3	49.2	10.5	24.7	4.7	13.5	17.1	2.3	2.5	0.5	1.6	2.2	2.0	3.3	1.0	2.6	2.5	20.8	11.6	2.7	0.7	0.7	0.0	2.2	2.5	0.0	3.4	8.7	0.0	2.1	0.0	5.5	52.4	1.4	0.0	0.0	0.2	2.9	0.8	0.0	18.5	0.6	12.6	0.0	1.7	2.5	17.8	74.6	0.3	12.6	1.7	2.8	0.3	0.3	0.4	0.0	0.4	0.6	4.2	0.0	0.9	1.6	1.9	0.9	3.8	38.3	0.1	0.4
FGD4	"CMT4H, frabin, FRABP, ZFYVE6"	ENSG00000139132	"FYVE, RhoGEF and PH domain containing 4"	Q96M96	12	32399529-32646050	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 150.3;Late spermatids: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039235	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA039235: AB_10673420"	"unprognostic (6.73e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.16e-5)"	"unprognostic (9.50e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.41e-3)"	28.9	6.1	12.4	7.7	13.8	16.0	13.2	3.8	12.4	8.8	23.6	13.2	11.8	11.6	5.3	7.4	11.4	8.3	13.7	8.5	12.8	6.8	14.8	21.5	14.7	5.3	15.1	6.8	31.1	12.2	21.8	8.5	13.6	13.0	6.7	13.3	14.3	11.8	15.0	17.3	12.4	27.4	5.1	21.2	11.0	33.6	15.3	17.3	0.4	8.5	6.3	4.6	8.3	9.7	1.8	4.1	9.6	6.5	0.8	0.5	1.3	4.1	2.0	4.6	1.4	17.3	10.7	6.8	3.1	15.5	0.8	0.3	5.6	5.9	0.6	2.0	0.2	1.9	3.8	3.7	5.4	0.5	0.7	2.0	3.2	2.0	1.6	3.2	0.8	0.0	6.3	7.9	4.2	9.3	2.4	8.2	0.9	0.4	3.7	10.8	1.3	0.0	1.2	14.3	4.0	0.1	0.3	5.0	10.9	5.9	3.7	5.3	6.1	3.4	3.1	4.5	9.1	5.2	0.2	10.1	0.1	1.3	13.1	0.5	1.3	3.1	2.0	0.0	1.9	3.8	3.1	4.6	9.6	0.4	6.5	0.4	0.7	0.4	0.3	4.1	1.8	0.4	0.5	7.8	0.8	5.9	0.4	0.3	1.3	12.4	13.8	3.8	12.4	12.8	6.8	15.1	6.8	13.0	17.3	44.7	22.3	1.4	10.1	7.4	19.8	15.3	56.0	12.0	15.9	21.0	111.9	0.7	11.6	14.7	150.3	19.8	45.6	0.0	18.2	14.6	10.8	12.0	2.3	35.8	11.2	66.7	18.4	4.3	69.8	183.7	4.4	37.6	13.5	6.4	29.4	83.6	26.1	30.0	1.4	12.9	99.3	51.8	19.6	10.3	6.4	11.0	1.1	0.7	25.9	17.9
FGD6	"FLJ11183, ZFYVE24"	ENSG00000180263	"FYVE, RhoGEF and PH domain containing 6"	Q6ZV73	12	95076749-95217482	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Group enriched"	"Detected in many"	6	"B-cells: 2.0;dendritic cells: 1.9;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.8;hTERT-HME1: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007974	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA007974: AB_1848520"	"unprognostic (1.28e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.62e-5)"	"prognostic unfavorable (9.83e-4)"	"prognostic unfavorable (5.46e-6)"	"unprognostic (1.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.92e-1)"	4.6	8.6	7.8	31.4	9.1	2.6	6.4	5.3	8.5	7.2	10.0	3.9	14.5	2.7	6.6	2.6	9.2	5.1	9.3	8.2	7.4	3.4	6.5	6.0	9.9	9.5	3.7	5.2	9.0	10.2	4.2	3.8	13.1	4.3	7.4	8.1	6.2	4.8	17.2	4.2	14.3	8.7	9.8	6.3	5.9	5.2	5.6	5.4	5.0	9.9	5.1	17.1	7.2	11.1	2.0	1.9	0.5	5.5	0.3	0.2	0.9	14.8	13.6	12.6	1.4	1.3	1.2	6.6	2.1	3.0	0.8	1.2	5.2	10.3	15.8	3.6	1.3	0.9	6.0	2.2	12.7	1.8	1.6	1.4	0.7	2.2	2.5	1.8	1.6	0.1	5.3	5.8	1.5	15.6	5.1	8.1	2.2	3.3	0.3	0.4	0.8	1.3	0.3	5.2	1.9	4.7	3.6	2.5	1.2	9.0	4.8	2.1	3.4	6.1	3.2	0.3	6.6	1.4	0.1	11.1	0.5	1.4	0.6	1.6	1.5	3.4	4.5	0.6	1.0	1.0	0.5	3.3	0.0	0.1	5.5	0.0	1.3	0.0	0.0	1.9	2.0	0.2	0.0	0.2	0.3	3.8	0.0	0.0	0.9	7.8	9.1	5.3	8.5	7.4	3.4	3.7	5.2	4.3	5.4	14.9	13.4	0.9	19.4	43.0	4.5	20.5	5.1	9.4	12.5	8.7	3.9	3.7	0.0	20.4	1.1	15.7	13.1	0.0	19.3	7.2	3.3	17.0	1.1	5.0	9.9	1.6	12.0	15.4	13.4	1.5	11.5	7.8	1.7	5.4	9.4	2.0	51.0	10.5	9.9	4.4	8.1	0.0	3.4	1.5	16.8	21.8	36.6	0.0	4.6	26.3
FGF11	"FHF3, FLJ16061, MGC102953, MGC45269"	ENSG00000161958	"Fibroblast growth factor 11"	Q92914	17	7438273-7444937	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.5"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 17.5;Muller glia cells: 12.7;Suprabasal keratinocytes: 8.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 9.4;HaCaT: 17.3;LHCN-M2: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066605, HPA075188"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA066605: AB_2685693, HPA075188: AB_2732283"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-4)"	"unprognostic (9.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.00e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.90e-3)"	"unprognostic (4.97e-3)"	3.3	23.5	10.5	3.0	13.8	2.1	2.9	4.5	11.6	6.4	1.6	4.6	0.1	1.8	3.1	1.9	13.0	1.7	3.2	11.6	11.7	4.6	3.4	1.1	1.3	6.2	8.1	5.2	1.6	1.3	1.5	1.0	2.0	10.6	1.4	1.4	6.8	3.7	1.7	8.8	19.7	1.3	2.9	4.1	2.4	1.6	2.8	9.9	2.5	7.2	7.1	9.0	2.9	8.7	0.0	0.0	1.6	0.6	0.0	0.3	0.0	9.4	0.6	5.3	0.0	3.1	0.1	2.7	0.2	3.3	0.3	0.6	0.2	1.0	2.8	0.7	0.1	0.1	17.3	2.0	5.4	1.2	5.9	4.2	5.2	0.5	1.3	0.5	0.2	5.8	0.6	1.5	0.4	0.2	0.5	0.2	2.2	2.0	0.2	11.4	2.1	1.7	2.3	1.9	0.4	0.2	4.5	4.8	1.2	0.7	0.8	1.1	5.4	0.6	0.6	0.4	3.1	0.3	0.4	0.2	0.3	5.7	0.0	0.2	0.4	1.3	0.9	1.3	3.2	0.6	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.3	0.0	10.5	13.8	4.5	11.6	11.7	4.6	8.1	5.2	10.6	9.9	0.0	0.0	0.0	0.3	4.8	2.8	0.4	2.5	0.0	0.0	1.8	5.9	0.3	3.3	0.5	1.3	0.8	0.4	0.0	0.2	0.4	0.4	0.5	0.0	0.0	0.3	17.5	0.0	0.6	0.3	3.4	1.7	0.3	1.7	0.0	0.3	12.7	1.0	0.0	2.1	0.1	2.5	0.0	0.9	1.2	1.3	8.4	0.6	0.0	0.6	0.9
FGF12	"FGF12B, FHF1"	ENSG00000114279	"Fibroblast growth factor 12"	P61328	3	192139395-192767764	"Disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 381.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 11.8;NTERA-2: 8.1;SCLC-21H: 18.9;U-251 MG: 11.3;WM-115: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071557			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA071557: AB_2686417"	"unprognostic (1.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.75e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.87e-7)"	"unprognostic (2.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.99e-2)"	1.2	21.5	8.8	0.7	15.8	0.6	1.0	17.7	31.9	0.9	0.9	1.9	0.0	1.0	1.2	0.7	1.5	1.5	0.9	75.7	6.8	4.1	2.0	0.9	1.2	0.7	5.1	15.8	1.1	4.9	0.7	2.9	0.8	22.3	1.3	0.8	1.1	3.6	4.2	1.1	0.7	0.7	1.0	2.7	6.8	0.9	1.7	2.8	0.0	1.4	0.0	0.7	0.8	0.8	1.1	0.3	1.2	0.4	0.5	0.4	0.1	0.0	0.8	11.8	0.0	0.0	0.0	0.1	0.0	0.1	1.1	1.4	0.0	0.1	0.6	5.7	0.2	0.2	0.1	0.0	0.0	1.3	0.1	0.1	2.4	5.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.0	3.3	0.0	0.0	8.1	5.4	0.2	0.0	0.1	0.0	3.7	1.4	18.9	0.0	0.0	0.4	0.0	1.4	0.9	0.2	0.3	4.9	2.5	0.0	11.3	0.1	1.8	0.0	1.0	0.0	13.7	1.2	0.2	0.5	0.2	0.3	0.4	1.1	0.2	0.2	0.1	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.3	0.1	8.8	15.8	17.7	31.9	6.8	4.1	5.1	15.8	22.3	2.8	0.0	0.0	0.0	4.3	0.6	77.1	381.1	0.0	1.4	3.4	5.2	3.9	0.1	6.6	0.7	15.9	4.9	0.0	0.0	11.4	0.2	0.8	1.0	0.0	0.0	0.1	31.8	0.0	8.6	0.3	21.4	6.4	0.0	1.7	0.0	0.0	2.9	4.0	0.2	1.1	0.2	13.0	0.0	0.5	2.1	6.1	0.1	0.0	0.0	0.0	1.4
FGF14	"FHF4, SCA27"	ENSG00000102466	"Fibroblast growth factor 14"	Q92915	13	101710804-102402457	"Disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 46.4;cervix, uterine: 23.2;fallopian tube: 15.7"	"Cell type enhanced"	"Detected in many"	18	"Bipolar cells: 37.1;Ciliated cells: 96.4;Horizontal cells: 30.2;Late spermatids: 22.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Region enhanced"	"Detected in all"		"cerebellum: 46.4"	"Group enriched"	"Detected in some"	11	"memory CD4 T-cell: 1.0;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049828			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA049828: AB_2680901"	"unprognostic (2.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.80e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.86e-2)"	"unprognostic (8.48e-2)"	1.6	4.4	6.0	0.8	12.1	0.4	0.8	46.4	13.6	23.2	0.9	1.0	0.1	1.2	0.8	1.5	2.4	15.7	1.1	3.5	4.5	10.4	1.3	2.1	3.0	0.6	2.3	4.5	0.5	1.5	0.5	4.6	0.6	6.5	0.7	1.1	0.0	1.2	1.4	0.7	1.2	0.8	0.8	1.8	0.6	3.2	3.5	3.6	0.0	0.7	0.0	0.5	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	4.9	20.9	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.3	0.3	0.0	0.3	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	6.0	12.1	46.4	11.4	4.5	10.4	2.3	4.5	6.5	3.6	3.0	1.0	0.0	0.5	0.5	37.1	5.6	5.1	96.4	14.8	0.0	0.0	0.0	0.0	0.1	15.2	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	2.4	0.1	30.2	18.4	0.0	0.0	22.8	2.3	0.0	1.7	0.0	0.1	5.7	0.2	0.0	0.0	0.3	2.9	0.0	0.5	3.0	7.0	0.5	0.0	0.0	0.0	0.0
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell type enhanced"	"Detected in some"	16	"Club cells: 1.2;Distal tubular cells: 1.7;Proximal tubular cells: 2.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 20.2;BJ hTERT+: 38.1;fHDF/TERT166: 27.5;HBF TERT88: 28.7;LHCN-M2: 25.7;U-138 MG: 35.6;U-251 MG: 17.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"	NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: AB_2678001"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.1	0.1	0.1	1.7	0.1	0.5	0.1	38.2	1.3	0.1	3.1	0.0	0.0	0.4	0.4	0.1	1.3	0.1	9.2	0.3	1.6	0.2	2.3	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.3	0.1	4.1	0.2	0.1	0.0	0.1	0.0	0.5	0.4	2.8	2.4	0.3	0.1	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.7	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	7.2	0.0	20.2	38.1	5.3	3.9	0.0	0.0	0.0	0.0	27.5	0.4	0.0	0.0	7.0	28.7	0.0	0.3	0.0	0.0	0.0	0.5	0.2	0.0	2.0	0.0	15.6	7.5	9.0	1.8	0.0	0.0	0.1	25.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	6.5	35.6	1.4	1.7	17.0	0.0	0.0	0.0	2.0	0.0	0.7	1.7	0.3	0.3	0.4	0.2	0.5	0.2	0.3	0.4	0.2	0.7	0.5	0.5	0.9	0.2	0.2	0.7	0.2	0.0	0.1	0.1	38.2	1.3	1.6	0.2	0.2	0.2	4.1	0.1	0.0	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF7	KGF	ENSG00000140285	"Fibroblast growth factor 7"	P21781	15	49423096-49488775	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 101.2;Fibroblasts: 91.0;Leydig cells: 77.1;Smooth muscle cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 24.2;ASC TERT1: 22.3;fHDF/TERT166: 10.0;HSkMC: 22.6;RH-30: 18.0;U-138 MG: 12.2"	"Region enriched"	"Detected in single"	9	"cerebellum: 9.7"					HPA043605	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA043605: AB_10960215"	"unprognostic (4.65e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.63e-3)"	39.7	2.7	0.6	9.9	0.6	0.0	16.5	0.6	2.4	73.3	22.2	0.0	10.1	1.1	13.1	16.1	25.2	14.1	25.4	19.1	0.6	0.6	5.9	1.2	44.8	5.5	2.1	0.0	43.7	2.5	2.9	2.8	9.1	0.8	42.5	4.5	2.7	6.4	8.1	25.6	3.6	4.2	38.3	1.4	1.0	6.6	12.7	0.0	0.0	23.2	24.7	2.9	72.2	32.4	0.2	0.1	1.6	0.2	0.3	0.5	0.0	0.1	0.0	0.1	0.1	24.2	22.3	0.0	7.3	4.5	0.0	0.0	0.0	0.1	0.0	0.1	10.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.1	0.0	22.6	0.4	1.9	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	18.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.1	12.2	0.2	0.4	0.0	0.2	0.1	0.0	3.3	0.0	0.2	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.5	0.2	0.0	0.3	0.2	0.1	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.6	2.1	0.0	0.8	0.0	11.9	13.4	0.9	13.5	12.8	7.9	40.0	5.1	0.0	0.0	8.7	2.0	4.7	101.2	1.1	2.8	5.3	0.0	0.0	0.6	3.8	91.0	9.0	1.1	2.5	1.8	3.2	0.0	0.0	1.0	3.1	77.1	3.1	6.8	0.0	0.0	7.3	0.6	0.0	4.6	24.5	6.0	6.5	82.4	0.3	0.1	11.0	2.4	1.0	0.0	7.1
FGFR1OP2	DKFZp564O1863	ENSG00000111790	"FGFR1 oncogene partner 2"	Q9NVK5	12	26938383-26966650	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038308, HPA038696"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038308: AB_10672524, HPA038696: AB_10675948"	"unprognostic (1.68e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.36e-2)"	22.4	32.2	25.5	21.4	30.5	38.5	19.9	20.8	40.1	20.4	18.1	18.2	13.8	16.9	24.0	23.0	17.5	17.9	21.9	23.5	26.9	21.0	23.4	20.5	20.1	28.5	24.7	28.5	46.6	11.6	16.4	30.7	19.8	25.6	17.0	15.4	12.1	14.5	14.9	18.7	17.4	16.9	20.4	32.5	23.3	14.8	16.7	25.7	30.4	18.3	16.3	22.1	20.3	21.6	12.5	13.4	34.0	17.3	13.3	31.8	12.7	11.5	14.1	12.2	16.4	21.1	15.4	17.6	20.3	23.6	15.6	17.1	22.1	13.5	17.0	10.0	17.7	15.0	12.3	8.4	15.1	22.3	12.7	12.1	28.8	15.8	14.7	25.0	16.4	22.1	11.1	9.9	19.0	24.8	21.5	22.3	15.5	17.0	13.1	18.2	13.7	21.8	40.7	20.1	15.0	23.6	13.2	33.7	14.2	13.8	14.2	3.7	7.4	23.0	8.6	19.7	29.4	15.3	25.5	24.2	21.0	21.0	38.2	18.7	9.2	9.3	36.1	17.5	19.4	16.9	34.0	17.3	20.9	18.2	16.2	16.4	12.5	19.2	17.5	13.4	10.4	17.9	19.3	17.5	13.3	15.3	11.2	31.8	12.7	25.5	30.5	20.8	40.1	26.9	21.0	24.7	28.5	25.6	25.7	35.7	30.4	58.0	54.3	124.7	52.2	41.1	12.7	21.4	51.2	26.2	72.6	36.4	61.3	26.5	13.6	75.5	17.5	116.8	20.3	31.3	77.3	39.0	57.8	25.1	53.4	55.6	25.8	59.5	52.7	12.7	97.5	56.4	84.4	35.1	20.1	59.9	24.4	25.9	160.5	49.5	44.4	45.3	78.4	32.9	69.0	104.6	49.8	105.0	18.4	59.2
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 191.1;Club cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.2	58.9	0.0	0.0	19.8	0.1	0.0	0.0	0.0	15.4	0.3	0.0	4.2	0.9	0.0	17.8	19.1	4.0	0.0	0.0	4.1	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.9	2.7	0.0	0.0	0.0	2.3	5.7	5.0	0.1	0.1	0.1	10.8	0.0	11.5	15.8	0.0	0.0	0.1	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1	17.9	31.8	0.0	29.5	35.6	0.0	2.7	191.1	18.7	52.4	34.9	0.0	12.6	0.0	4.0	2.9	0.5	2.6	0.0	0.2	2.7	17.5	9.8	0.0	4.3	2.0	0.0	2.4	3.1	0.3	6.5	1.1	1.3	5.0	1.0	32.0	1.6	0.6	1.4	5.6	11.5	0.1	0.0	2.1	0.9	7.7	24.2	3.3	1.5	3.0	27.7
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	495	"liver: 2225.7"	"Cell type enriched"	"Detected in many"	15	"Hepatocytes: 7797.1"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"Hep G2: 128.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	68000000000	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	2.7	2225.7	4.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	128.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	17.9	218.6	146.9	0.0	0.0	0.0	0.2	507.0	2.7	4.5	0.0	0.0	0.0	0.0	3.8	2.8	0.0	0.0	327.1	40.0	0.1	0.0	0.0	10.5	7797.1	0.2	0.0	0.0	232.7	240.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	266.1	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.3	20.1	0.0	0.0
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.4"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 181.0;Cholangiocytes: 349.1;Hepatocytes: 122.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.8;RH-30: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054971			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		110000	"Nucleoplasm, Nuclear bodies"		"HPA054971: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.5	10.3	5.4	6.5	5.7	1.4	4.6	23.2	5.5	4.9	5.1	4.4	10.1	4.9	9.6	26.1	4.5	7.0	8.6	7.6	3.7	5.0	13.0	45.4	7.8	5.2	6.2	3.3	3.8	8.4	9.9	7.4	2.7	4.4	5.7	4.7	6.8	7.6	8.8	26.0	3.7	7.6	6.3	3.0	3.4	3.8	2.9	3.4	4.5	5.4	4.3	6.9	6.2	3.7	8.2	3.6	3.9	4.8	4.7	8.0	3.0	2.8	0.9	6.1	2.5	3.0	10.8	0.5	2.5	4.3	1.5	2.2	0.0	2.2	3.4	8.3	6.8	2.7	1.2	1.0	7.6	3.1	26.8	0.7	2.3	2.0	5.4	8.0	1.3	1.5	15.2	6.4	3.1	5.0	6.4	2.9	3.9	1.6	2.1	9.7	3.3	1.8	2.0	3.8	8.3	3.3	4.0	18.6	1.3	8.1	5.5	4.7	2.0	3.5	2.1	7.3	5.4	1.7	1.4	2.8	2.5	1.9	2.9	1.7	4.9	1.7	2.9	8.3	5.6	2.3	2.6	2.2	2.2	5.4	2.3	5.0	8.2	2.6	6.6	3.6	6.8	4.8	8.0	3.9	4.7	4.8	1.8	4.5	3.0	5.4	5.7	23.2	5.5	3.7	5.0	6.2	3.3	4.4	3.4	50.6	181.0	3.7	19.6	18.5	9.2	20.3	349.1	56.2	27.3	12.2	11.8	7.6	14.9	35.1	12.9	6.3	8.8	0.0	38.7	3.8	4.5	19.5	9.3	122.9	10.8	7.9	2.4	6.7	8.0	8.9	1.7	8.5	33.7	16.2	9.9	11.7	15.0	7.8	2.8	34.0	15.5	0.0	4.4	3.9	7.9	27.6	3.8	2.9	16.3	26.4
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"	19	"Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 30.1;U-266/70: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	55.9	0.7	2.3	0.0	6.8	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1	6.0	30.7	12.5	0.5	2.5	0.0	1.6	2.5	2.7	10.3	1.8	0.0	0.4	0.0	0.0	0.2	11.5	0.0	0.0	0.2	0.5	1.4	0.3	12.7	0.9	58.9	0.0	0.0	4.3	187.9	0.4	0.3	86.1	1.7	7.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.2	0.5	1.0	0.8	45.8	0.0	0.9
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad"	P49789	3	59749310-61251459	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 138.8;Proximal tubular cells: 112.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"naive CD4 T-cell: 38.3"	"Lineage enriched"	"Detected in all"	14	"T-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.1;U-266/70: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	6.4	24.0	13.7	8.0	17.5	9.0	12.1	4.7	13.3	7.9	8.0	21.0	12.4	8.2	6.2	9.5	5.1	9.2	13.0	14.9	15.3	13.8	30.9	10.7	5.2	9.3	19.5	9.3	8.9	11.8	16.3	15.2	4.1	14.4	5.8	7.8	14.0	11.4	9.9	11.6	7.0	7.6	9.1	17.1	6.0	8.1	10.5	18.2	3.7	15.6	5.7	6.9	7.3	6.1	1.6	2.4	1.8	1.8	2.6	38.3	4.7	0.0	0.0	1.0	0.0	0.6	0.0	1.7	0.1	0.1	0.0	0.0	1.8	3.1	2.6	0.5	0.1	1.9	0.0	10.1	2.1	0.0	1.4	3.5	2.2	1.3	4.2	2.7	5.7	0.1	6.9	4.2	0.1	5.1	0.2	0.0	2.8	1.7	8.4	0.1	2.5	10.2	4.6	0.8	8.7	0.6	7.6	0.0	12.1	11.3	1.4	2.1	2.9	1.0	7.0	6.6	4.1	0.4	0.1	0.0	1.2	0.4	0.1	1.6	24.7	7.5	0.0	2.7	0.0	1.5	1.8	1.8	0.2	0.9	1.2	0.5	1.6	6.9	0.7	2.2	1.4	38.3	6.7	0.3	2.6	0.4	2.4	7.4	4.7	13.7	17.5	4.7	13.3	15.3	13.8	19.5	9.3	14.4	18.2	6.0	8.8	14.1	16.1	6.8	12.4	9.2	33.1	2.7	3.4	26.2	55.0	33.8	66.3	17.3	41.1	6.2	12.3	0.0	4.1	6.5	4.3	10.2	5.7	20.8	17.6	28.6	7.5	11.6	6.7	138.8	17.8	9.6	11.8	6.4	11.4	17.8	11.6	14.0	9.2	112.3	19.5	0.0	3.1	18.1	6.4	9.8	27.3	7.5	17.2	19.0
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 557.6;tongue: 239.4"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 1067.5;Early spermatids: 313.2;Late spermatids: 886.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 20.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 58.7;fHDF/TERT166: 53.1"	"Low region specificity"	"Detected in all"							"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		18000000	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavorable (2.11e-4)"	61.9	4.1	7.6	11.0	9.5	0.7	30.6	6.3	7.2	31.5	30.6	3.9	10.0	5.0	25.5	27.7	43.2	14.2	11.7	79.0	6.1	8.1	3.3	2.5	13.7	2.5	5.5	8.1	6.7	2.4	13.4	5.0	13.5	4.4	23.4	10.0	13.5	16.5	30.1	557.6	4.9	11.4	77.7	4.3	2.5	22.1	5.7	3.0	0.6	18.2	239.4	22.1	47.0	14.3	3.4	12.5	0.7	0.4	20.6	11.4	6.2	0.0	9.6	13.3	12.5	29.0	11.7	0.2	37.3	58.7	7.5	18.1	0.0	2.7	0.1	13.0	53.1	21.0	0.1	25.8	31.8	6.3	0.1	29.7	0.1	7.9	0.0	27.2	0.0	6.2	21.7	5.2	9.0	28.6	3.1	7.8	7.3	0.0	5.6	17.5	0.4	5.2	0.3	4.1	0.0	11.3	14.6	0.5	7.9	0.2	0.0	9.4	14.1	1.4	0.0	2.7	5.6	0.0	0.5	22.0	34.7	16.1	1.3	9.3	1.5	3.2	0.2	2.6	0.3	3.8	0.0	0.4	0.0	3.2	0.0	8.6	3.4	11.4	4.5	1.8	2.3	7.6	2.3	0.7	20.6	0.0	12.5	1.2	6.2	7.6	9.5	6.3	7.2	6.1	8.1	5.5	8.1	4.4	3.0	44.7	16.0	6.4	17.4	50.3	30.5	1067.5	0.0	5.3	7.9	10.4	7.9	0.7	1.7	3.3	313.2	63.3	0.0	0.0	0.2	1.0	98.8	2.5	15.1	4.7	3.8	93.8	13.2	131.3	5.9	886.8	114.8	9.8	30.4	10.8	0.5	182.0	0.6	0.2	143.2	4.8	16.9	103.5	304.9	6.0	79.0	39.1	2.3	13.4	0.6	1.8
FHL3	SLIM2	ENSG00000183386	"Four and a half LIM domains 3"	Q13643	1	37996770-38005606	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"blood: 67.9;skeletal muscle: 247.1;tongue: 100.1"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 67.9"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 67.9"	"Cell line enhanced"	"Detected in many"		"HEL: 29.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA045723			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045723: AB_10966278"	"prognostic favorable (5.62e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (4.20e-11)"	"unprognostic (8.88e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.77e-2)"	7.0	2.0	1.2	3.3	2.1	3.9	4.5	0.6	1.4	5.5	6.4	1.3	2.4	1.1	7.5	8.1	6.9	4.4	3.6	2.3	1.6	1.1	1.7	1.3	2.9	5.0	2.4	0.9	7.6	2.0	1.4	1.1	2.1	2.1	4.8	1.6	2.2	5.5	3.6	247.1	2.6	1.9	12.0	2.2	2.5	2.7	1.7	1.0	0.3	1.8	100.1	4.0	15.5	5.7	0.1	3.8	67.9	5.7	3.0	3.4	2.3	6.2	2.3	6.2	6.3	5.8	23.6	3.9	5.0	9.8	9.4	7.0	5.2	5.0	0.0	8.4	11.2	4.5	2.4	4.0	6.0	4.7	2.3	7.2	29.5	5.1	5.9	22.8	2.3	21.7	20.8	6.9	10.8	6.1	20.1	13.2	3.1	24.8	0.1	17.6	3.3	0.8	10.0	8.1	0.4	1.6	4.0	5.2	0.4	6.2	1.1	0.7	3.2	4.5	0.4	7.2	12.1	1.9	2.0	9.3	4.2	9.5	1.1	4.5	1.6	5.7	0.7	1.9	13.8	4.3	1.3	5.7	67.9	3.2	3.7	3.4	0.0	0.7	1.6	3.8	0.1	0.5	0.7	7.4	3.0	2.4	0.1	1.6	2.3	1.2	2.1	0.6	1.3	1.6	1.1	2.4	0.9	2.1	1.0	0.0	4.0	0.5	16.0	18.5	0.3	3.9	5.1	0.0	4.5	7.0	0.0	7.1	1.7	16.8	0.6	9.3	0.0	0.0	24.2	26.2	19.0	5.1	73.7	0.9	25.9	0.0	0.0	15.4	14.3	0.9	20.8	24.2	5.0	8.2	0.0	2.4	24.2	0.0	30.1	2.5	0.3	25.8	30.6	1.1	14.7	14.2	8.1	12.2	0.0	8.4
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;parathyroid gland: 10.7;testis: 9.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 14.5;Exocrine glandular cells: 27.4;Late spermatids: 25.9;Mucus-secreting cells: 12.2;Pancreatic endocrine cells: 16.7;Spermatogonia: 15.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	11	"hippocampal formation: 19.2"	"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 5.7"	"Lineage enriched"	"Detected in single"	11	"monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.4;MCF7: 21.2;OE19: 15.0;RPTEC TERT1: 16.5;THP-1: 8.2;U-2 OS: 11.3;U-251 MG: 9.2"	"Group enriched"	"Detected in many"	4	"basal ganglia: 18.2;hippocampal formation: 75.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 81.5"	HPA055353	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.0	8.5	1.7	0.1	1.1	0.0	1.1	0.1	3.0	0.0	1.8	0.3	0.0	0.5	0.0	1.4	0.4	0.0	5.0	2.0	19.2	1.2	0.0	0.0	5.3	0.0	0.6	0.0	0.4	0.0	10.7	0.0	1.7	1.5	1.0	1.4	1.1	1.6	0.0	0.0	0.0	1.6	2.1	0.0	0.8	0.1	9.5	0.8	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.2	0.2	2.3	0.8	0.0	0.0	0.0	0.0	5.0	5.9	0.3	0.8	0.0	2.5	0.0	1.8	0.2	4.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	0.2	0.0	0.1	2.7	0.0	9.4	0.0	0.0	0.6	0.0	0.0	21.2	0.0	2.2	1.5	15.0	0.5	0.0	4.4	0.3	16.5	0.0	0.1	0.0	0.7	0.0	0.5	0.7	1.3	8.2	0.0	0.9	11.3	0.1	9.2	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	1.7	1.1	0.1	1.0	19.2	1.2	0.6	0.0	1.5	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	7.7	0.0	0.3	14.5	0.1	4.7	0.0	27.4	0.4	1.8	0.7	0.0	0.0	0.9	3.2	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	12.2	0.8	16.7	3.5	3.2	0.0	0.1	0.0	0.3	1.1	15.1	0.0	3.3	0.0	4.7	1.7
FICD	"HIP13, HYPE"	ENSG00000198855	"FIC domain containing"	Q9BVA6	12	108515185-108525837	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	"Hydrolase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 65.6;Late spermatids: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021390, HPA071134"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA021390: AB_1851340, HPA071134: AB_2686347"	"unprognostic (1.00e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (4.61e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.22e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.65e-2)"	4.2	9.6	5.6	6.1	8.2	3.0	4.5	4.0	6.7	8.5	3.8	7.3	10.5	3.9	4.6	15.8	2.3	4.1	4.1	3.5	5.4	5.9	5.2	16.4	5.0	4.9	8.9	5.1	4.8	27.9	4.8	15.3	7.9	6.0	6.1	3.6	10.2	19.7	7.9	2.6	3.4	3.3	4.6	7.5	4.8	5.1	8.5	6.6	5.4	13.6	1.0	6.2	4.1	4.5	5.0	15.2	10.9	5.4	3.1	8.0	1.8	1.9	4.8	2.0	3.9	4.7	3.3	5.4	12.7	6.7	6.0	4.2	3.0	1.9	2.7	4.8	6.0	7.1	2.5	2.1	1.4	5.3	4.5	3.1	1.5	3.7	4.2	18.5	2.2	5.7	1.5	3.0	8.4	12.1	7.4	4.3	2.5	1.0	9.1	5.3	4.4	2.9	2.3	2.1	2.0	8.0	1.7	2.6	6.5	2.8	3.8	1.9	1.3	5.7	2.7	6.2	3.0	4.2	2.2	4.8	6.2	2.2	10.8	4.8	18.2	2.9	0.9	8.5	2.0	4.3	10.9	2.8	4.2	6.8	4.8	8.0	5.0	5.0	6.2	2.7	3.3	2.9	5.6	5.5	3.1	5.4	15.2	3.1	1.8	5.6	8.2	4.0	6.7	5.4	5.9	8.9	5.1	6.0	6.6	0.0	3.0	1.5	2.9	0.7	5.2	1.7	5.1	2.7	0.0	7.0	2.0	4.9	5.0	3.7	65.6	3.7	1.6	0.0	8.1	3.9	4.7	7.7	13.8	4.9	5.7	12.7	1.7	4.9	1.8	37.2	3.1	4.7	6.8	3.6	2.5	14.7	7.6	0.8	9.2	1.8	8.3	12.9	2.7	7.2	6.8	2.9	26.0	4.5	1.6	4.2
FIG4	"ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3"	ENSG00000112367	"FIG4 phosphoinositide 5-phosphatase"	Q92562	6	109691312-109825428	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017823, HPA068859"	Approved		Supported	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"CAB017823: , HPA068859: AB_2686049"	"prognostic unfavorable (5.91e-4)"	"unprognostic (4.12e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.44e-3)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.00e-2)"	11.0	13.5	14.5	12.2	30.3	14.0	14.4	13.5	35.3	12.4	13.2	11.0	5.0	8.3	11.3	17.0	11.7	10.5	13.4	10.1	14.5	18.5	13.2	8.7	19.2	16.6	17.6	17.7	12.2	9.9	25.4	15.4	12.6	19.0	11.6	14.6	9.7	17.0	12.0	12.1	9.2	10.7	14.7	16.0	17.3	11.4	12.6	12.9	18.1	12.6	8.5	15.0	12.5	10.5	15.5	15.9	12.8	20.0	8.0	7.7	9.8	6.2	6.5	9.8	11.7	10.4	14.4	6.2	8.1	11.7	6.7	18.0	4.8	6.6	16.8	5.2	13.1	12.4	4.7	9.6	6.4	15.6	10.2	11.7	9.4	6.5	4.8	9.6	8.8	8.4	7.4	8.4	11.4	7.9	17.2	13.6	11.1	5.5	7.2	9.4	5.8	9.0	7.6	5.1	9.3	3.2	6.3	4.5	5.8	11.3	15.5	10.9	10.2	5.3	7.8	16.4	12.5	5.6	14.7	9.5	4.2	3.6	6.1	6.9	3.4	2.4	8.1	22.3	6.3	3.8	11.5	20.0	12.8	7.7	19.7	6.0	14.6	5.7	7.3	15.9	15.5	7.0	6.8	8.7	8.0	13.5	6.9	6.6	9.8	14.5	30.3	13.5	35.3	14.5	18.5	17.6	17.7	19.0	12.9	14.9	7.0	5.9	6.5	4.0	6.1	5.1	5.1	9.4	4.5	8.7	2.0	11.5	5.0	8.9	13.3	5.0	5.3	0.0	9.9	5.8	4.4	4.5	8.1	3.8	20.0	1.6	9.8	6.2	20.5	13.8	3.1	13.5	8.5	9.0	8.8	7.5	6.8	6.8	6.3	6.3	6.0	0.0	6.6	4.9	11.7	3.9	10.3	10.7	6.1	7.6
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 48.1;Peritubular cells: 32.2;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	54	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 17.2;SuSa: 10.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	8.5	7.6	9.6	2.9	13.7	2.8	5.2	5.1	11.9	6.8	5.9	5.5	3.7	2.1	3.3	5.0	2.9	4.5	4.4	10.1	8.8	4.3	7.2	7.9	4.3	2.5	8.7	4.7	14.3	7.2	1.8	12.1	4.4	7.7	4.8	3.4	4.3	8.4	9.9	3.6	3.2	3.6	5.6	9.1	8.7	4.5	4.4	10.5	0.0	3.1	3.0	1.6	4.1	6.3	0.0	0.0	5.4	0.0	0.0	0.0	0.0	5.6	2.0	17.2	0.0	0.0	0.0	6.3	2.2	1.5	1.6	3.0	0.0	2.0	0.0	6.2	2.4	3.2	0.8	5.7	2.4	1.3	0.0	4.2	0.0	3.9	4.1	1.4	0.0	0.0	0.8	2.1	3.1	8.4	2.5	3.7	0.0	0.0	0.0	4.7	1.4	0.0	0.0	7.3	0.4	2.7	0.0	5.8	0.0	4.0	1.9	2.7	2.3	0.0	1.6	1.5	10.1	1.8	0.0	0.3	7.1	6.5	0.0	4.6	1.0	0.0	0.0	2.1	0.0	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	13.7	5.1	11.9	8.8	4.3	8.7	4.7	7.7	10.5	6.0	5.3	1.4	0.1	1.6	15.3	16.8	10.2	6.7	3.4	12.2	0.0	18.1	1.7	2.5	2.7	0.7	0.0	0.0	1.3	5.9	6.3	0.9	0.0	11.3	1.2	6.4	0.0	7.4	0.0	4.2	48.1	0.2	16.9	0.0	0.0	6.5	1.7	0.0	32.2	6.3	1.9	71.1	13.9	0.2	0.6	0.4	14.1	0.0	0.0	0.0
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.6;smooth muscle: 44.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 542.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 10.7;HUVEC TERT2: 2.7;RPTEC TERT1: 3.0;U-266/70: 10.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"		No	NA			"Plasma membrane, Actin filaments"		"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	11.0	1.3	2.0	6.3	3.0	0.2	2.5	0.6	2.5	8.2	10.9	0.0	4.1	1.3	8.8	4.1	10.5	4.5	5.9	37.6	3.7	1.2	2.7	2.4	7.5	1.2	1.1	0.7	4.4	1.4	5.4	5.1	3.7	0.8	14.9	2.6	4.3	1.5	2.8	29.4	0.9	4.1	44.7	1.4	0.6	3.9	2.8	0.0	0.0	2.3	10.8	0.7	30.7	6.0	1.4	0.9	1.8	0.8	0.6	0.9	0.0	0.1	1.9	0.3	0.1	0.1	0.3	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.2	10.7	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.2	0.1	0.0	0.3	0.2	1.4	0.1	0.2	0.1	0.1	2.7	0.4	0.1	0.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	3.0	0.6	0.2	0.2	0.0	0.1	0.1	2.5	0.1	0.4	0.0	0.1	0.0	0.1	0.1	10.7	1.0	0.1	0.1	0.5	0.1	1.2	0.6	0.6	0.6	0.6	0.5	0.6	0.5	0.4	0.2	1.4	0.9	0.6	1.8	0.6	0.8	0.9	0.3	0.0	2.0	3.0	0.6	1.9	3.7	1.2	1.1	0.7	0.8	0.0	119.1	78.3	0.0	0.6	0.6	3.3	542.5	0.0	83.0	14.8	0.0	0.0	0.7	1.7	0.0	36.1	36.8	0.0	0.0	0.3	0.3	26.7	0.6	1.1	0.6	1.2	0.0	0.0	58.3	1.9	16.2	2.3	2.0	1.7	0.0	0.0	4.5	0.0	0.0	4.2	0.0	3.8	90.5	88.2	4.5	6.4	0.6	0.7	0.0	0.0	0.4
FILIP1L	"DOC-1, GIP130"	ENSG00000168386	"Filamin A interacting protein 1 like"	Q4L180	3	99830141-100114513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 302.8;Sertoli cells: 252.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.3;HDLM-2: 25.5;TIME: 47.6"	"Region enriched"	"Detected in some"	7	"olfactory region: 22.1"	"Low region specificity"	"Detected in all"			HPA043133	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA043133: AB_10793991"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (2.46e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.82e-3)"	29.0	7.5	11.7	22.1	2.4	0.0	15.2	1.3	7.4	36.2	28.3	0.9	27.2	6.9	52.5	50.0	25.3	17.8	24.3	23.8	4.0	2.1	12.5	6.7	15.9	10.9	2.9	6.5	65.6	10.3	7.7	3.1	14.6	9.4	36.7	7.7	5.5	6.1	36.8	44.8	9.5	19.2	86.3	2.2	27.1	25.1	19.9	1.3	2.5	11.7	53.4	5.8	49.8	16.2	1.5	4.4	0.5	5.9	1.0	0.4	0.5	18.7	0.0	7.4	0.0	12.2	10.4	0.6	9.6	19.3	16.8	19.1	5.7	0.0	0.0	1.7	27.3	4.4	2.3	0.0	4.7	20.0	25.5	0.2	1.5	0.0	7.5	6.1	0.4	0.0	8.2	1.7	1.9	0.0	10.8	7.5	0.0	1.2	0.1	2.5	0.1	1.6	0.3	0.4	1.0	0.0	0.0	8.7	0.2	11.3	0.3	0.6	1.2	0.1	0.1	0.0	4.1	0.0	3.4	47.6	2.9	0.0	0.6	5.0	1.4	0.0	0.1	2.2	0.1	0.0	0.3	1.0	0.2	0.3	2.2	0.1	1.4	0.4	0.3	4.4	1.5	0.2	0.2	0.5	1.0	5.9	0.8	0.3	0.5	11.7	2.4	1.3	7.4	4.0	2.1	2.9	6.5	9.4	1.3	14.9	17.2	0.0	37.5	24.6	4.0	115.5	33.1	2.7	2.3	5.2	7.9	0.6	1.7	158.4	302.8	69.7	2.9	0.0	97.5	0.6	90.1	2.5	33.5	0.5	3.0	100.1	2.9	44.2	29.2	157.4	76.8	76.0	16.9	28.9	3.0	1.0	44.0	0.0	97.9	0.3	5.9	252.2	159.4	7.1	1.9	19.8	2.6	0.5	0.3	3.7
FIZ1	"FLJ14768, ZNF798"	ENSG00000179943	"FLT3 interacting zinc finger 1"	Q96SL8	19	55591371-55601970	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074026			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074026: AB_2686653"	"unprognostic (1.97e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.43e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.51e-3)"	"unprognostic (8.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (8.42e-4)"	"unprognostic (7.02e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (2.02e-4)"	10.9	8.6	13.9	9.3	16.6	5.8	12.4	17.0	17.8	10.2	10.9	13.6	10.4	10.4	14.5	13.0	8.0	10.9	11.1	10.0	13.7	11.2	11.5	8.1	9.7	8.0	14.2	9.1	12.1	15.4	21.1	13.9	8.6	9.2	11.7	8.7	14.7	14.3	15.5	18.2	10.6	10.7	16.0	12.3	10.5	13.7	9.4	10.8	9.5	14.4	8.6	9.4	9.4	17.6	2.5	3.4	1.9	3.0	2.1	2.6	0.9	7.2	15.5	10.7	7.6	6.2	4.3	12.2	6.1	4.2	7.0	5.3	8.6	8.2	12.7	5.7	3.8	3.8	7.3	7.4	7.7	6.9	10.0	19.4	9.8	10.5	7.5	6.3	8.3	9.3	5.0	12.6	6.0	7.2	6.7	3.5	8.0	12.0	5.9	5.1	6.4	14.7	6.2	11.7	8.8	11.1	15.4	10.0	6.9	7.0	13.4	14.3	16.3	9.6	7.0	6.4	6.6	7.2	9.9	5.5	6.6	10.8	2.4	7.4	15.5	22.8	8.3	9.4	7.9	7.2	0.1	1.7	0.2	1.0	3.0	1.0	2.5	2.6	1.5	1.2	1.5	1.3	1.9	1.9	2.1	1.1	3.4	1.0	0.9	13.9	16.6	17.0	17.8	13.7	11.2	14.2	9.1	9.2	10.8	8.9	0.6	1.4	3.0	3.0	13.9	4.8	10.2	8.1	3.4	5.2	3.9	3.4	0.0	3.4	0.5	3.2	4.8	0.0	3.4	3.0	2.8	3.1	0.0	5.1	4.0	12.7	9.7	3.7	3.0	0.6	2.8	3.4	0.0	1.8	4.2	8.8	4.7	3.5	3.2	4.1	13.7	0.0	2.3	2.6	2.2	1.9	2.9	2.2	5.1	2.7
FJX1	"FLJ22416, FLJ25593"	ENSG00000179431	"Four jointed box 1"	Q86VR8	11	35618419-35620868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 15.5;Cytotrophoblasts: 18.7;Extravillous trophoblasts: 14.0;Ito cells: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059220	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA059220: AB_2683950"	"unprognostic (8.99e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.56e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.39e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (9.24e-9)"	"unprognostic (1.64e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.35e-2)"	"prognostic unfavorable (6.56e-4)"	6.0	3.5	7.8	3.5	10.3	0.7	3.6	6.6	25.4	8.8	1.4	7.9	0.0	1.1	10.1	3.4	3.1	6.1	4.5	2.4	8.0	4.9	3.8	4.9	2.2	2.3	5.7	5.7	12.2	17.0	1.7	1.8	6.6	7.7	4.1	1.1	2.7	2.6	4.7	1.1	10.3	1.1	3.4	5.1	7.8	1.7	1.2	3.3	1.7	2.2	3.0	3.4	3.7	2.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	9.8	4.9	5.2	1.6	1.8	5.8	1.6	11.1	7.5	10.6	7.7	6.2	3.1	0.0	2.5	4.3	22.0	10.5	1.8	18.3	9.1	0.1	14.5	0.9	1.9	0.2	4.4	1.1	0.0	2.1	14.0	5.5	16.9	1.7	4.8	0.5	5.2	0.0	10.2	2.3	0.3	0.0	7.2	0.0	14.7	0.6	11.7	2.2	8.1	12.2	5.0	2.8	1.2	0.9	3.1	4.0	21.1	0.2	9.4	8.5	15.7	1.6	26.1	0.0	0.0	0.0	15.2	0.4	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	10.3	6.6	12.3	8.0	4.9	5.7	5.7	7.7	3.3	0.0	0.0	0.0	9.3	15.5	0.4	1.0	0.0	4.0	3.4	0.0	11.8	18.7	1.7	7.9	0.0	5.6	0.0	0.0	0.2	14.0	4.5	1.5	0.0	0.0	3.1	0.0	0.0	16.0	0.6	0.0	0.6	1.5	0.0	0.0	0.0	10.3	1.1	0.0	0.7	6.7	0.3	0.0	5.3	0.4	1.1	8.3	10.0	0.0	0.0	2.6
FKBP10	"FKBP6, FLJ20683, FLJ22041, FLJ23833, hFKBP65"	ENSG00000141756	"FK506 binding protein 10"	Q96AY3	17	41812680-41823217	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 83.0;Leydig cells: 43.4;Peritubular cells: 42.1;Sertoli cells: 58.2;Smooth muscle cells: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 72.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051171, HPA057021"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		5500	Mitochondria		"HPA051171: AB_2681371, HPA057021: AB_2683312"	"unprognostic (8.30e-2)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.34e-2)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (3.43e-5)"	"prognostic unfavorable (4.99e-4)"	16.9	16.5	6.6	13.2	7.2	0.2	14.9	3.4	8.4	43.0	11.5	6.0	15.8	3.8	42.7	39.0	14.0	21.4	28.6	19.2	5.6	3.6	10.3	3.2	16.2	17.1	5.3	6.7	35.5	13.5	24.7	22.7	33.8	5.2	21.3	5.7	17.1	6.5	17.0	9.6	8.8	7.6	27.9	5.5	7.9	8.5	15.1	5.7	1.2	16.9	9.5	8.1	24.4	19.2	0.3	0.0	0.0	0.0	2.0	0.9	0.1	0.0	16.2	15.0	49.1	52.8	61.7	13.2	66.9	67.0	25.2	21.8	8.4	0.6	0.0	0.9	72.6	6.4	0.1	8.9	17.8	10.7	4.4	13.5	6.4	18.3	24.0	57.7	0.0	0.0	66.2	0.0	20.6	15.8	48.4	21.4	0.0	0.2	2.3	21.0	21.1	0.0	0.0	11.7	34.3	5.5	1.3	17.7	2.1	4.3	0.0	3.7	13.1	0.1	48.1	22.4	19.8	7.5	0.4	24.2	30.4	15.8	20.2	10.2	0.1	0.0	0.0	41.7	0.0	29.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	6.6	7.2	3.4	5.8	5.6	3.6	5.3	6.7	5.2	5.7	0.0	7.4	0.0	10.9	7.6	0.8	1.6	2.5	0.0	2.3	0.0	0.0	6.3	0.0	8.8	0.5	23.9	0.0	0.0	4.2	23.1	83.0	4.1	0.0	0.0	4.2	14.3	0.0	34.4	0.0	1.9	43.4	2.2	15.1	0.0	1.4	29.2	3.0	0.0	42.1	0.0	1.0	58.2	43.4	0.5	8.3	4.4	10.0	0.0	0.6	1.7
FKBP11	FKBP19	ENSG00000134285	"FK506 binding protein 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 175.6;salivary gland: 62.0"	"Cell type enhanced"	"Detected in all"	7	"Exocrine glandular cells: 145.3;Melanocytes: 258.1;T-cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 37.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 44.0;Karpas-707: 40.1;OE19: 56.1;RPMI-8226: 40.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041709	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	5.6	4.6	1.1	8.2	1.4	3.7	3.7	0.9	2.2	7.5	6.9	0.9	21.6	9.2	4.4	12.9	4.4	4.8	8.1	3.4	1.3	2.4	4.8	38.4	5.8	16.6	1.0	1.3	3.7	175.6	0.2	12.3	3.3	1.6	4.8	6.3	1.9	62.0	20.9	1.4	1.7	7.6	2.9	1.0	18.7	10.0	1.9	0.9	2.2	4.7	4.9	14.5	8.2	4.3	11.1	8.3	1.1	0.3	5.1	37.6	7.3	2.0	2.7	0.5	0.7	12.0	18.2	1.0	15.9	22.8	17.6	20.8	10.2	11.4	30.9	0.5	25.9	0.2	8.5	5.5	7.0	9.1	6.5	1.1	1.1	2.9	0.1	44.0	0.6	0.8	20.3	13.5	13.5	25.1	7.5	9.9	10.5	0.4	40.1	6.4	5.8	4.6	1.1	1.4	56.1	5.1	12.7	0.7	40.1	2.2	0.4	6.5	1.9	5.3	7.9	3.5	0.6	0.4	0.9	7.9	3.4	0.6	0.3	0.3	23.5	19.4	15.7	2.1	0.7	5.6	0.9	0.2	0.6	22.5	0.3	37.6	11.1	15.6	17.7	0.3	4.8	9.4	14.4	1.1	5.1	0.1	8.3	6.4	7.3	1.1	1.4	0.9	2.2	1.3	2.4	1.0	1.3	1.6	0.9	14.9	18.4	30.6	44.0	25.1	4.9	1.7	35.7	28.1	19.4	8.7	37.3	19.0	6.6	17.0	15.1	19.7	11.7	46.7	145.3	59.9	74.1	89.1	12.7	90.3	9.7	1.6	24.1	49.1	14.2	13.2	25.6	9.7	258.1	5.4	84.9	1.5	80.1	7.0	13.1	12.2	15.0	6.5	22.1	8.0	6.8	18.6	35.4	152.0	40.1	37.6
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FK506 binding protein 14"	Q9NWM8	7	30010587-30026684	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (4.25e-4)"	8.8	7.4	8.7	9.2	7.3	5.1	8.8	17.6	7.7	14.9	7.8	4.1	6.9	4.2	12.1	14.2	8.0	8.1	8.5	9.8	7.1	5.2	5.4	9.2	7.6	8.1	9.2	5.2	13.0	9.8	8.6	27.8	10.7	7.1	9.8	6.9	8.4	7.6	10.9	3.3	6.4	5.3	18.8	8.1	6.7	7.2	4.2	7.1	2.6	5.6	5.9	7.7	13.4	8.7	1.6	3.3	2.7	1.2	1.0	1.6	0.6	3.4	2.6	7.4	17.2	19.3	24.8	3.4	17.7	16.6	6.2	12.1	2.2	2.2	1.2	8.4	15.5	7.6	7.6	4.1	6.4	12.4	0.6	5.9	2.8	5.0	6.5	9.8	2.0	4.9	15.5	6.7	10.8	12.8	14.6	13.7	1.8	4.5	2.6	11.1	1.4	1.0	2.4	3.9	3.8	4.8	0.0	5.0	4.0	6.1	3.1	1.9	6.5	6.2	14.2	4.3	9.2	3.2	2.6	11.0	6.6	7.7	11.3	7.0	3.9	4.0	2.1	9.4	1.9	20.6	1.9	1.2	1.2	1.3	0.8	1.0	1.1	1.6	1.1	2.2	1.6	1.5	1.3	2.7	1.0	0.5	3.3	1.4	0.6	8.7	7.3	17.6	7.7	7.1	5.2	9.2	5.2	7.1	7.1	17.9	16.5	3.7	19.2	24.4	15.5	13.5	7.6	2.7	10.3	17.4	25.5	9.5	1.7	6.7	0.3	7.4	3.3	0.0	3.2	24.1	26.4	15.0	2.3	6.6	5.3	14.3	1.2	8.6	2.8	0.0	12.0	5.8	10.1	2.8	7.9	31.5	5.3	14.4	19.4	2.9	19.8	6.5	10.5	0.7	3.3	15.9	13.2	4.3	4.8	24.8
FKBP15	"FKBP133, KIAA0674, PPP1R76, WAFL"	ENSG00000119321	"FK506 binding protein 15"	Q5T1M5	9	113161006-113221361	"Predicted intracellular proteins"	"Endocytosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 53.0;Kupffer cells: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007979	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA007979: AB_1848615"	"unprognostic (2.81e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (3.44e-2)"	"unprognostic (5.62e-3)"	19.8	17.8	16.7	25.3	21.9	19.2	19.4	18.6	21.6	16.9	15.3	25.4	14.2	15.1	18.1	17.0	18.8	16.7	14.4	16.4	16.2	13.1	15.7	17.2	26.7	30.9	22.6	15.4	18.6	17.5	34.7	22.1	24.4	19.2	17.2	18.7	17.6	20.0	22.3	19.2	22.3	18.2	20.5	23.5	36.5	15.9	6.8	20.9	25.1	18.7	13.4	23.3	18.6	18.3	2.8	8.5	5.7	20.5	3.7	3.4	4.5	11.7	12.1	8.1	7.9	17.7	15.6	11.0	14.7	22.3	16.6	14.9	7.6	12.3	19.7	7.2	18.7	32.9	25.8	9.9	14.4	15.3	15.0	6.6	7.6	13.2	7.3	14.4	16.1	19.9	15.7	14.7	18.2	19.0	17.1	16.1	11.4	9.3	12.1	16.9	18.0	12.0	8.5	8.5	16.9	9.7	10.9	17.2	7.1	12.0	10.9	7.2	7.2	17.9	13.7	8.6	11.2	16.4	6.0	18.7	17.9	6.7	17.6	15.2	10.4	11.3	9.1	18.7	9.3	14.6	1.8	11.6	1.6	3.4	14.6	2.8	2.0	2.1	2.1	8.5	2.8	2.5	1.9	5.7	3.7	20.5	3.5	2.2	4.5	16.7	21.9	18.6	21.6	16.2	13.1	22.6	15.4	19.2	20.9	14.9	29.0	13.4	5.8	5.0	12.3	12.0	10.2	14.7	14.8	14.0	25.5	11.9	1.7	10.8	0.9	11.3	8.1	0.0	11.8	10.2	12.4	6.3	10.5	7.8	53.0	11.1	4.6	17.8	50.5	1.1	15.5	49.5	6.8	1.0	7.4	8.3	13.5	8.6	14.9	4.3	16.1	19.4	6.1	3.9	11.5	3.6	10.2	11.8	8.0	9.2
FKBP1B	"FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase"	ENSG00000119782	"FK506 binding protein 1B"	P68106	2	24049701-24063681	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1;intestine: 24.9"	"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 21.9;NTERA-2: 21.3;SH-SY5Y: 15.5;SuSa: 23.9;TIME: 18.6"	"Low region specificity"	"Detected in all"							"HPA045572, HPA051798"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA045572: AB_2732521, HPA051798: AB_2681615"	"unprognostic (3.01e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	2.9	5.9	25.0	2.8	30.7	1.9	5.9	15.7	23.1	5.1	7.2	1.6	7.4	24.9	3.6	4.2	4.5	4.5	7.1	3.4	31.1	14.0	4.4	4.6	9.0	2.2	13.0	19.7	4.6	4.9	6.4	2.8	5.6	7.9	5.1	4.6	2.4	3.3	9.2	1.1	3.6	6.7	4.0	5.2	1.8	13.3	1.6	4.4	0.6	5.0	1.1	3.2	7.1	3.5	1.5	2.2	4.4	0.8	0.3	5.4	1.1	0.1	0.9	8.5	0.0	5.4	2.1	3.0	2.8	2.9	1.2	1.8	0.5	1.0	0.0	2.1	5.0	7.7	3.3	12.5	9.8	0.8	1.4	8.0	2.9	0.1	21.9	2.0	0.0	7.0	2.0	2.3	2.9	0.6	7.3	7.9	3.3	0.7	0.0	2.8	0.0	0.9	0.0	21.3	0.7	1.5	1.5	0.7	0.0	0.9	0.5	2.1	15.5	0.1	0.0	2.7	23.9	0.5	1.0	18.6	0.0	2.6	0.1	0.6	0.5	0.2	0.0	3.1	0.0	0.6	1.3	0.8	4.4	0.3	0.7	0.0	0.3	0.6	0.5	2.2	1.5	0.0	0.2	0.1	0.3	0.0	0.4	5.4	1.1	25.0	30.7	15.7	23.1	31.1	14.0	13.0	19.7	7.9	4.4	0.0	5.0	0.0	11.5	8.1	1.2	0.4	28.1	1.4	0.0	7.0	0.0	4.5	11.6	24.5	0.4	9.3	9.3	0.0	33.8	22.1	7.8	15.8	1.1	9.8	6.2	1.6	9.1	11.1	3.4	1.8	2.6	9.4	27.0	19.8	7.9	12.1	37.4	28.1	3.9	4.1	2.5	25.8	11.2	1.4	3.0	6.5	4.3	0.0	3.4	14.5
FKBP2	"FKBP-13, PPIase"	ENSG00000173486	"FK506 binding protein 2"	P26885	11	64241003-64244132	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 119.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025561, HPA049405"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	No	No		400000	"Plasma membrane"		"CAB025561: , HPA049405: AB_2680749"	"unprognostic (4.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.66e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.57e-2)"	18.2	35.8	28.9	20.2	35.5	12.1	20.2	18.8	27.1	31.3	28.0	20.3	87.8	39.0	24.4	102.7	20.8	25.5	30.3	28.0	29.7	35.7	40.3	89.6	18.8	17.0	39.3	24.8	22.1	107.2	34.0	57.2	59.2	29.0	26.1	21.9	19.4	59.3	116.6	11.8	18.5	30.2	19.7	28.5	20.9	31.1	19.8	20.6	12.4	63.2	18.6	18.8	21.3	23.9	21.3	119.6	29.0	25.4	20.0	30.7	15.5	24.2	32.0	17.3	35.0	37.5	21.4	24.6	29.4	29.9	22.3	20.7	31.5	54.7	18.0	46.9	36.1	30.5	31.8	13.7	24.4	10.6	22.3	11.9	19.9	42.6	32.1	49.3	16.5	28.0	24.9	36.4	29.5	32.6	32.2	17.7	16.3	14.9	53.9	26.4	40.1	18.0	26.1	20.2	41.7	28.9	16.1	17.1	65.5	40.3	24.4	24.2	21.1	20.2	57.2	32.4	12.7	22.0	14.3	16.7	26.8	23.9	42.6	15.7	32.8	10.2	14.6	35.9	17.4	30.3	29.0	24.5	3.4	24.1	25.4	30.7	21.3	19.2	23.3	23.2	20.5	13.0	18.1	9.1	20.0	20.8	119.6	7.1	15.5	28.9	35.5	18.8	27.1	29.7	35.7	39.3	24.8	29.0	20.6	137.0	150.2	102.0	207.7	146.1	76.1	98.2	310.8	108.4	116.0	369.9	21.6	256.2	349.8	239.2	83.7	136.1	585.6	23.3	222.4	308.7	201.1	281.8	142.9	635.0	211.8	30.2	328.9	152.9	95.0	70.2	213.2	169.2	285.1	186.7	264.4	122.7	276.9	273.5	239.7	629.6	65.3	181.1	142.1	273.8	237.0	146.9	518.9	105.4	226.6	265.6
FKBP7	FKBP23	ENSG00000079150	"FK506 binding protein 7"	Q9Y680	2	178463664-178478600	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 116.0;Fibroblasts: 67.2;Leydig cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.8;ASC TERT1: 32.8;HSkMC: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.6	4.6	1.5	4.3	4.1	0.7	11.1	3.5	2.3	20.5	6.9	1.0	10.0	1.8	21.4	21.9	8.4	12.4	12.8	12.1	1.5	1.5	5.5	7.4	6.8	5.2	4.0	1.8	34.6	4.3	1.5	11.1	8.2	2.9	19.5	4.2	7.1	4.9	9.7	4.4	4.0	3.9	19.9	3.9	3.0	5.3	8.3	2.2	2.2	8.7	8.0	2.3	15.5	9.9	2.8	5.8	0.2	1.6	1.2	2.8	0.8	0.0	0.6	6.1	9.0	52.8	32.8	0.5	10.9	18.1	2.0	6.4	0.1	0.6	1.7	2.4	19.9	1.8	0.1	2.3	0.9	3.5	1.4	1.3	1.7	2.5	1.7	8.1	1.1	1.3	22.0	0.5	8.0	1.1	14.7	6.5	2.1	0.8	1.1	8.4	0.1	1.9	1.9	1.2	1.1	0.9	2.5	10.7	2.3	2.7	0.2	3.2	10.6	2.3	0.0	1.8	4.5	0.1	2.1	6.0	3.7	2.3	4.3	1.0	2.1	2.2	0.8	6.8	2.7	8.0	0.0	1.1	0.1	2.3	1.6	2.8	2.8	2.0	1.6	5.8	1.7	2.2	2.4	0.2	1.2	0.0	4.5	2.2	0.8	1.5	4.1	3.5	2.3	1.5	1.5	4.0	1.8	2.9	2.2	6.0	2.6	2.2	6.7	6.3	4.6	12.6	2.5	2.7	3.4	7.0	0.0	6.2	1.7	9.1	116.0	18.6	0.1	0.0	7.4	18.5	67.2	3.6	13.9	9.8	5.3	4.8	1.2	13.5	4.3	22.0	59.2	4.8	16.9	1.8	4.8	3.7	4.0	0.0	45.6	3.5	3.3	6.5	39.2	3.7	5.5	5.1	4.2	5.0	2.6	3.4
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FK506 binding protein 9"	O95302	7	32957404-33006931	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.4;fHDF/TERT166: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"	No	No			"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: AB_2682761"	"unprognostic (1.23e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (5.80e-4)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavorable (7.02e-6)"	35.4	21.1	9.7	12.5	13.6	0.9	43.7	4.5	16.3	33.6	18.3	9.3	16.8	8.8	31.3	30.9	23.7	24.1	28.8	44.4	9.7	11.9	18.2	10.1	30.6	17.5	10.8	9.7	25.9	26.0	12.9	16.0	35.2	13.2	23.7	21.2	30.4	16.0	25.6	17.1	28.0	13.4	37.0	12.8	10.7	17.4	16.3	6.4	2.9	18.9	19.4	11.1	23.7	23.6	0.4	1.4	7.4	4.1	0.3	0.1	0.9	7.1	13.6	5.3	21.9	50.4	58.4	7.1	38.7	40.3	12.8	20.4	5.9	17.0	0.0	15.8	71.8	20.5	14.0	7.8	18.9	14.7	0.0	2.3	1.2	14.6	5.8	21.0	0.0	2.1	37.9	11.5	11.4	11.1	30.5	16.1	0.0	2.7	1.4	26.0	6.9	0.0	3.6	1.1	14.3	7.2	0.0	14.3	0.0	14.3	2.4	5.0	12.1	22.1	11.3	13.7	14.1	7.9	3.5	21.5	21.0	20.2	13.0	8.8	4.6	8.9	0.0	20.5	0.0	41.7	1.5	4.1	0.9	0.1	2.6	0.1	0.4	0.1	0.0	1.4	0.3	0.1	0.1	7.4	0.3	0.7	0.3	0.0	0.9	9.7	13.6	4.5	16.3	9.7	11.9	10.8	9.7	13.2	6.4	11.9	20.0	0.0	12.5	30.5	7.7	38.3	15.3	6.7	7.9	17.4	9.8	17.1	5.0	16.3	0.5	65.3	16.9	0.0	36.7	25.2	46.6	8.5	5.7	10.5	6.7	11.1	11.7	58.9	6.2	0.7	33.9	4.5	57.3	3.6	27.2	34.3	30.2	17.5	51.9	7.4	4.5	45.3	51.9	0.9	0.9	25.0	11.0	1.3	21.4	8.6
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FK506 binding protein like"	Q9UIM3	6	32128707-32130291	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.6	5.6	4.1	2.7	4.7	4.6	7.1	12.1	6.2	4.4	4.5	3.9	8.9	6.0	4.1	8.7	12.7	7.0	4.5	6.0	4.1	3.5	5.9	6.7	4.5	7.7	7.1	2.4	7.0	13.2	6.2	5.0	6.9	5.8	3.8	4.9	3.7	8.0	3.6	5.1	11.5	4.4	5.1	3.6	7.8	6.6	7.6	6.8	10.5	11.6	2.8	6.8	4.7	6.3	3.4	3.7	8.3	4.8	3.3	4.6	1.5	0.0	2.0	4.4	11.9	6.6	4.7	3.8	2.9	3.3	5.5	5.3	9.5	4.0	3.3	3.4	5.1	7.4	2.2	6.2	5.7	3.8	5.9	7.6	0.0	6.6	5.3	3.7	0.0	3.6	4.6	5.8	10.7	6.7	4.1	5.8	8.7	11.1	8.3	5.6	3.2	3.6	4.1	3.3	8.6	1.7	3.0	5.8	7.3	5.7	0.7	8.5	2.0	2.9	5.3	6.4	2.3	9.2	6.4	2.5	8.0	6.6	4.1	7.0	4.4	7.7	3.0	3.1	5.4	4.9	4.9	3.4	2.3	4.6	4.8	4.4	2.8	2.6	3.3	3.7	3.4	3.0	2.9	8.3	3.3	2.5	2.9	1.1	1.5	4.1	4.7	12.1	6.2	4.1	3.5	7.1	2.4	5.8	6.8	6.0	5.1	4.7	3.2	10.0	2.9	2.0	5.1	0.0	4.5	1.8	0.0	8.3	5.0	6.7	2.2	4.5	8.1	0.0	5.9	10.6	7.4	3.3	2.3	2.8	4.5	9.5	5.8	3.7	3.2	4.0	2.6	4.4	6.8	4.6	4.9	6.4	5.4	3.7	3.2	7.7	4.0	0.0	6.2	8.9	8.3	8.9	11.8	6.5	5.0	4.1
FKRP	"LGMD2I, MDC1C"	ENSG00000181027	"Fukutin related protein"	Q9H9S5	19	46746046-46776988	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043115, HPA060454"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA043115: AB_2678324, HPA060454: AB_2684281"	"unprognostic (4.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.59e-3)"	"prognostic favorable (8.98e-4)"	"unprognostic (3.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-2)"	13.7	10.7	12.4	12.5	17.5	12.6	9.6	7.4	25.2	10.5	11.5	12.8	13.7	7.8	15.7	8.7	8.3	12.7	10.1	13.1	9.8	12.2	10.7	10.8	11.6	11.0	11.5	11.1	13.3	13.2	12.9	16.9	16.5	14.1	13.6	7.3	13.0	17.8	13.2	23.6	9.6	9.7	13.4	9.1	14.7	10.3	13.0	11.1	8.8	13.5	7.8	7.9	12.3	10.2	6.9	5.0	5.4	4.2	5.6	4.5	2.4	8.4	18.1	12.4	8.7	11.0	12.2	11.1	21.6	14.6	8.9	14.0	11.5	14.7	7.6	12.1	12.4	14.7	9.0	4.6	10.1	8.2	14.9	15.4	8.0	8.7	7.2	9.7	6.2	13.8	13.5	8.7	10.9	10.7	10.4	11.6	4.2	8.0	7.7	8.9	3.8	4.5	15.2	12.1	5.3	4.5	12.3	7.7	2.8	5.6	18.1	8.5	16.2	10.8	5.3	7.1	8.6	6.4	4.9	11.9	13.2	14.0	4.8	17.3	8.2	9.8	7.2	10.7	5.0	17.6	3.4	4.2	2.5	4.1	2.5	2.8	4.6	3.0	4.5	2.6	6.9	3.7	4.5	5.4	5.6	2.6	5.0	1.6	2.4	12.4	17.5	7.4	25.2	9.8	12.2	11.5	11.1	14.1	11.1	8.9	6.1	0.8	4.3	0.7	9.7	13.7	7.6	10.7	6.8	5.2	5.9	7.9	5.0	4.3	7.3	3.9	3.5	23.3	2.1	4.7	4.1	3.6	1.1	13.4	6.3	3.2	7.5	9.2	11.4	9.9	5.2	1.8	5.0	4.6	4.6	6.8	4.9	3.1	3.9	5.8	10.7	6.5	4.7	9.1	4.3	1.4	15.7	5.0	3.6	3.4
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	16.5	16.5	20.3	15.5	18.9	12.1	17.4	15.9	20.8	14.1	16.4	19.3	14.7	19.6	15.9	21.2	19.8	16.7	11.8	16.1	18.2	10.4	19.0	36.5	13.5	20.0	20.8	15.6	14.5	19.0	13.6	12.0	18.5	15.9	18.7	19.0	16.1	16.2	16.3	26.3	23.3	23.9	17.6	12.4	22.9	16.1	19.1	18.9	15.7	20.8	18.4	22.0	15.5	15.4	25.1	24.5	15.2	24.1	14.9	26.4	22.7	13.0	20.9	13.3	22.7	11.6	8.6	25.4	9.9	8.2	14.4	12.4	18.6	16.1	15.2	20.0	9.1	7.5	17.1	25.6	20.5	9.4	15.8	19.2	12.3	16.6	13.1	15.9	17.8	16.1	12.3	26.9	16.4	17.6	7.0	16.7	16.3	19.8	12.4	12.2	28.1	12.2	12.5	29.1	28.4	21.7	20.7	6.6	34.9	13.7	18.2	22.5	30.9	15.5	35.1	19.5	27.0	30.0	27.1	10.5	9.1	12.5	11.6	15.5	19.4	24.0	26.2	10.9	14.5	14.5	15.2	23.0	14.8	24.0	20.9	26.4	25.1	22.1	22.7	24.1	20.5	20.5	20.2	5.2	14.9	24.1	24.5	23.3	22.7	20.3	18.9	15.9	20.8	18.2	10.4	20.8	15.6	15.9	18.9	8.9	8.8	15.9	13.2	23.6	15.2	34.3	20.4	16.0	11.4	24.4	5.9	36.7	26.6	22.3	20.5	11.2	23.6	23.3	24.5	35.2	12.7	16.8	8.1	24.5	24.6	14.3	11.5	9.8	14.6	61.7	9.5	14.0	13.5	41.5	18.3	19.0	20.5	17.5	9.2	27.4	14.7	6.5	13.3	20.0	17.9	24.1	30.1	16.0	19.9	17.0
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 215.6;Extravillous trophoblasts: 184.6;Pancreatic endocrine cells: 247.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 71.8;TIME: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		37000000	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	24.7	17.8	7.8	25.3	10.6	2.2	30.0	12.6	7.4	21.3	33.5	17.2	49.6	19.4	36.1	47.4	18.6	17.3	16.0	7.7	10.6	8.5	20.6	29.2	14.1	9.4	16.1	5.3	22.9	22.4	25.6	7.8	36.0	13.2	35.8	28.5	20.1	25.5	44.0	7.7	28.9	50.2	39.7	24.3	12.1	21.2	11.7	13.5	49.3	28.2	12.0	13.0	32.8	34.7	3.8	15.9	7.4	1.2	5.9	4.9	1.2	20.2	34.7	3.5	5.1	2.4	4.1	61.2	7.5	6.1	16.9	17.3	34.7	34.8	3.3	2.8	26.6	27.5	33.4	6.5	48.2	16.5	18.3	3.2	2.8	29.5	16.8	17.5	2.4	10.0	6.5	20.9	23.4	71.8	20.0	57.0	14.8	4.6	1.0	10.5	4.4	7.3	5.8	5.4	22.4	30.1	3.2	0.9	2.8	22.5	34.6	3.9	3.6	38.3	21.0	4.2	26.8	17.3	6.7	80.8	4.4	13.8	52.7	26.9	0.7	0.2	2.6	16.4	4.4	4.6	7.4	0.3	4.2	0.5	0.8	2.6	3.8	1.6	0.7	1.2	1.6	4.9	3.5	0.1	5.9	1.2	15.9	1.7	1.2	7.8	10.6	12.6	7.4	10.6	8.5	16.1	5.3	13.2	13.5	47.6	33.3	5.1	35.9	45.0	2.7	10.5	58.6	54.9	44.3	45.4	37.3	23.5	0.0	81.2	15.8	61.2	215.6	0.0	57.7	184.6	26.7	99.5	24.3	46.4	13.6	1.6	47.3	130.8	11.4	17.1	15.0	10.9	5.0	17.2	70.6	10.0	247.2	108.7	26.2	6.8	10.9	0.0	12.0	1.9	5.1	45.2	41.6	7.5	60.6	62.1
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742733	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 54.3;hTERT-RPE1: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		1500000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	25.7	43.8	32.1	22.6	26.1	22.4	45.9	27.8	37.4	32.9	23.3	14.3	18.8	16.7	19.3	16.7	15.8	27.6	18.8	46.4	29.5	25.7	26.6	26.0	22.9	34.1	29.2	31.9	16.5	24.7	28.7	17.9	25.9	27.2	23.1	18.4	13.0	25.5	32.9	46.1	8.2	16.7	29.0	30.4	22.8	16.7	11.7	18.7	7.8	28.7	13.8	17.1	21.3	36.9	2.9	6.0	29.1	7.3	7.2	3.5	4.7	5.1	2.1	5.0	5.8	5.1	7.9	2.6	5.2	7.2	9.3	8.3	2.7	2.5	3.5	5.7	11.9	54.3	3.8	4.9	2.0	5.7	10.7	4.7	4.5	2.0	2.7	12.2	0.8	5.9	8.5	3.0	5.5	10.7	33.1	6.4	2.8	3.2	5.6	9.7	1.7	2.9	1.2	1.6	3.3	5.9	3.8	5.6	4.8	3.6	1.5	4.7	4.5	3.9	2.8	19.7	5.7	4.5	0.9	4.3	17.8	5.8	3.1	14.7	3.8	3.7	3.5	2.4	3.7	11.2	12.8	7.3	12.2	3.5	3.4	2.3	2.9	2.2	2.9	5.5	2.2	2.5	2.9	29.1	7.2	2.2	6.0	0.3	4.7	32.1	26.1	27.8	37.4	29.5	25.7	29.2	31.9	27.2	18.7	83.4	85.1	32.7	93.5	25.4	14.4	80.8	56.0	88.3	63.7	80.3	5.9	67.0	104.5	62.0	46.3	117.8	81.2	23.3	74.8	57.5	67.5	53.3	140.8	42.9	116.2	19.1	66.0	127.7	63.0	109.6	57.2	92.7	67.4	121.8	59.2	44.6	72.3	101.7	35.7	125.1	17.0	51.8	58.7	108.0	26.7	23.5	51.5	43.6	72.5	97.7
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322988-14337616	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.1"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 116.8;Basal glandular cells: 129.3;Club cells: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.6;hTCEpi: 29.4;RPTEC TERT1: 9.9;WM-115: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		240000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	7.3	4.3	3.4	2.2	7.4	0.1	2.7	27.5	18.9	3.8	5.0	0.7	3.2	12.4	2.6	5.5	2.5	2.7	5.6	1.6	9.3	4.1	43.1	28.9	26.2	0.2	2.3	5.3	11.9	2.3	4.6	2.1	2.0	2.9	12.7	1.0	1.9	1.5	16.4	2.1	6.9	6.0	3.9	2.3	0.8	9.7	1.7	0.7	4.8	8.5	1.8	0.4	12.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	15.6	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	8.5	3.1	0.0	0.5	0.3	0.0	4.4	0.0	4.6	0.1	0.0	1.0	0.0	0.2	0.1	1.3	0.0	0.0	2.7	29.4	0.0	5.5	0.0	0.0	0.1	0.0	0.1	3.0	0.2	1.9	0.0	5.1	3.4	0.0	0.0	0.1	0.0	9.9	1.9	0.3	3.2	0.0	0.0	4.9	9.2	0.2	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	7.4	27.5	18.9	9.3	4.1	2.3	5.3	2.9	0.7	202.5	116.8	0.0	129.3	7.7	13.3	0.9	17.8	22.7	126.3	21.0	5.9	0.3	11.6	18.8	0.0	1.6	2.0	0.0	13.0	0.0	5.4	11.3	4.7	7.8	0.2	6.4	10.9	1.8	0.0	0.2	3.4	0.9	5.0	2.8	1.0	0.5	9.4	2.9	0.4	41.7	2.9	0.0	0.1	0.0	0.0	14.4	0.0	0.5	1.5	9.0
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;brain: 19.3;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"	25	"Kupffer cells: 29.6;Macrophages: 12.4;monocytes: 55.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.3"	"Group enriched"	"Detected in some"	11	"myeloid DC: 29.9;plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 29.9"	"Group enriched"	"Detected in some"	11	"REH: 28.5;THP-1: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		180000	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.9	0.6	0.6	7.2	1.1	7.5	2.6	19.3	3.5	0.9	1.2	0.1	0.1	0.4	0.8	0.8	1.0	1.2	4.6	0.5	0.9	1.7	2.8	0.7	2.7	15.0	1.8	1.1	0.5	5.7	0.0	0.4	0.0	7.4	0.6	1.4	0.1	2.3	0.6	0.4	1.2	3.0	1.3	4.4	8.8	0.9	1.2	0.0	8.2	0.6	0.0	5.8	2.4	0.7	0.1	29.9	1.4	1.8	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.5	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	1.4	0.0	0.3	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.8	0.0	12.1	0.0	1.2	0.6	1.1	19.3	3.5	0.9	1.7	1.8	1.1	7.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	29.6	1.6	0.0	12.4	1.7	55.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA"	ENSG00000162769	"Feline leukemia virus subgroup C cellular receptor 1"	Q9Y5Y0	1	212858255-212899363	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	3.2	3.8	4.6	4.5	7.2	7.8	4.8	11.3	5.9	4.4	12.9	4.7	3.3	13.5	4.0	7.5	3.2	3.6	3.6	2.5	5.0	7.5	3.5	3.1	3.7	4.1	5.3	5.9	4.0	5.1	7.0	16.8	3.5	7.2	5.3	4.4	4.0	2.9	4.3	1.6	4.3	40.6	3.8	4.8	4.2	7.1	4.0	5.5	5.4	3.6	2.1	3.3	4.0	5.0	1.2	1.6	4.7	0.8	0.7	1.4	0.2	4.8	6.4	10.0	3.0	1.7	2.1	18.9	1.4	1.1	2.9	1.8	9.4	9.0	5.3	2.7	1.0	6.2	7.4	10.8	3.2	2.9	3.1	4.7	3.1	6.3	8.5	2.0	8.3	5.1	1.6	2.1	3.1	4.0	1.5	2.2	3.7	8.3	4.4	1.9	1.8	2.3	4.1	33.1	6.4	4.6	5.2	9.2	6.1	3.6	4.7	10.9	7.7	6.6	6.6	6.0	8.7	10.8	3.9	1.3	1.4	3.4	4.6	6.5	2.7	5.5	6.3	2.1	4.8	1.7	1.6	0.8	4.7	0.8	0.6	0.9	0.9	1.2	1.0	0.5	1.2	1.2	1.1	2.6	0.7	0.8	1.6	1.4	0.2	4.6	7.2	11.3	5.9	5.0	7.5	5.3	5.9	7.2	5.5	11.9	13.6	12.6	8.8	12.7	22.7	3.3	7.6	9.4	15.9	19.2	33.4	3.0	1.7	3.8	3.2	7.7	17.9	0.0	11.7	5.3	7.8	10.1	6.9	4.9	5.5	15.9	31.2	10.4	10.3	5.3	5.8	9.0	5.0	8.2	8.6	6.3	7.3	10.5	2.5	4.1	31.2	6.5	7.2	10.1	5.9	8.2	2.1	8.9	6.5	3.7
FLYWCH1	DKFZp761A132	ENSG00000059122	"FLYWCH-type zinc finger 1"	Q4VC44	16	2911937-2951208	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040753, HPA041001"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA040753: AB_10794880, HPA041001: AB_10794259"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-2)"	15.6	16.6	13.1	12.6	17.2	12.5	10.2	24.4	27.4	13.6	12.2	17.7	9.5	14.7	14.3	13.4	11.8	11.9	15.0	16.7	12.1	15.9	10.1	5.9	10.7	11.6	15.8	18.5	21.4	12.2	22.6	12.2	9.5	18.8	13.9	4.7	25.3	14.4	15.6	28.1	22.8	14.4	14.1	16.2	19.9	11.0	5.1	10.9	8.5	11.5	8.4	10.3	17.1	15.7	4.6	1.6	2.3	1.6	0.9	5.5	2.1	5.1	18.1	4.1	12.3	6.7	6.9	12.6	9.5	7.5	4.8	4.9	3.0	16.7	12.5	25.4	7.2	7.9	10.7	3.4	6.4	1.0	20.8	10.3	4.2	15.2	10.0	15.1	5.5	14.6	6.1	20.2	10.1	7.4	8.9	6.8	8.4	9.3	13.3	3.7	12.2	12.6	6.7	6.7	3.8	12.4	22.2	6.2	22.4	5.6	3.5	8.9	8.3	10.0	10.9	12.7	2.4	8.5	10.1	12.7	8.1	7.4	15.6	6.3	19.7	16.9	11.2	8.8	9.1	9.4	2.3	1.6	0.6	3.0	0.7	4.9	2.0	4.5	5.5	1.6	4.6	3.9	3.4	0.2	0.9	0.8	1.0	2.2	2.1	13.1	17.2	24.4	27.4	12.1	15.9	15.8	18.5	18.8	10.9	0.0	3.4	2.2	9.5	11.0	41.7	10.2	10.2	4.0	2.3	21.0	33.4	15.4	1.7	6.0	0.4	11.3	5.9	0.0	5.7	6.9	10.4	4.2	0.0	5.5	7.4	31.8	2.4	11.1	13.3	0.9	10.3	5.3	8.5	9.0	4.4	16.6	5.4	3.5	13.4	4.8	36.2	0.0	15.1	0.7	3.2	12.2	7.3	7.2	6.2	5.9
FLYWCH2		ENSG00000162076	"FLYWCH family member 2"	Q96CP2	16	2883186-2899382	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041354	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041354: AB_10795007"	"unprognostic (3.57e-2)"	"prognostic favorable (9.38e-4)"	"unprognostic (7.33e-2)"	"unprognostic (8.53e-3)"	"unprognostic (4.40e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (5.50e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	19.7	33.9	20.8	13.0	24.6	9.3	14.9	28.5	29.5	15.7	15.0	14.7	19.4	20.8	16.8	13.7	20.8	18.3	22.0	23.8	19.8	27.1	20.2	8.3	15.7	12.6	22.8	16.4	19.5	13.9	17.6	21.7	10.3	22.9	22.4	7.4	22.9	25.4	19.6	34.6	15.9	14.6	13.2	18.2	31.4	17.6	22.3	10.4	19.8	27.0	18.6	17.0	14.2	12.6	15.3	25.3	10.1	18.4	9.8	19.3	12.7	8.7	17.6	7.4	17.3	7.4	10.5	10.7	6.8	5.2	7.4	5.0	8.0	11.0	8.6	26.2	6.3	7.1	5.6	4.0	9.5	1.3	14.4	11.0	9.0	17.2	6.3	20.8	5.4	9.2	14.6	7.3	5.9	3.0	9.2	5.7	15.5	6.5	9.5	5.1	40.9	13.9	23.7	8.0	8.3	18.1	27.1	7.8	18.6	5.2	2.6	11.4	14.8	19.0	20.6	13.7	2.9	24.4	18.0	7.8	12.7	10.3	19.7	6.9	15.6	13.6	11.8	7.4	8.0	9.2	5.6	13.0	10.1	15.1	18.4	16.5	15.3	17.5	14.5	18.4	14.3	19.3	16.5	5.6	9.8	17.8	25.3	16.3	12.7	20.8	24.6	28.5	29.5	19.8	27.1	22.8	16.4	22.9	10.4	11.9	12.8	16.0	36.2	18.1	19.5	13.3	12.7	13.4	7.9	41.8	7.9	17.9	71.3	38.9	8.4	30.8	27.6	0.0	48.7	37.6	34.7	40.7	13.9	5.5	30.2	14.3	32.3	13.5	6.5	8.7	19.5	22.5	40.5	23.4	36.2	46.1	36.0	31.6	23.7	43.4	14.1	32.3	33.0	47.7	38.1	24.8	10.1	21.7	32.4	26.3
FMC1	"C7orf55, HSPC268"	ENSG00000164898	"Formation of mitochondrial complex V assembly factor 1 homolog"	Q96HJ9	7	139339457-139346319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 68.3;Collecting duct cells: 80.3;Distal tubular cells: 169.1;Proximal tubular cells: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045663, HPA050553"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045663: AB_2679410, HPA050553: AB_2681173"	"unprognostic (3.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.19e-1)"	"prognostic favorable (5.63e-6)"	"unprognostic (1.04e-3)"	"unprognostic (2.39e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (1.50e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.02e-2)"	9.2	9.7	11.2	6.0	16.9	7.0	10.2	6.2	18.6	8.4	8.8	7.2	15.1	8.4	7.1	13.6	6.5	11.5	9.7	26.7	10.3	10.0	12.2	17.5	7.2	7.9	12.8	10.2	10.6	22.1	5.5	10.7	4.4	12.2	12.9	6.2	7.1	14.2	13.2	28.3	5.2	6.0	8.1	9.2	6.0	8.7	6.4	11.9	5.3	15.4	18.7	4.0	7.9	10.9	15.9	15.0	7.4	7.7	10.4	12.1	5.3	2.4	9.1	5.4	5.6	2.9	2.5	2.2	0.8	2.3	6.3	4.6	3.0	3.3	5.9	5.5	2.7	5.8	2.0	5.1	2.2	1.4	2.9	30.8	3.0	9.3	12.7	6.1	2.4	4.0	6.3	4.4	2.0	1.7	2.4	4.8	3.9	5.6	8.6	3.5	17.6	5.8	14.6	5.1	4.2	13.1	3.5	2.7	7.6	4.9	2.3	10.2	6.8	2.8	2.3	3.8	0.9	1.1	1.8	2.3	2.2	2.1	2.7	2.3	3.0	2.9	6.5	5.4	5.3	3.6	7.4	7.7	7.4	8.3	4.6	7.4	15.9	10.3	8.3	8.4	14.6	12.1	8.7	3.5	10.4	5.0	15.0	11.3	5.3	11.2	16.9	6.2	18.6	10.3	10.0	12.8	10.2	12.2	11.9	41.7	34.6	0.0	0.0	0.0	0.0	0.0	0.0	68.3	36.4	80.3	0.0	54.8	169.1	29.3	0.0	0.0	0.0	0.0	30.9	18.2	0.0	0.0	11.6	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	22.6	0.0	0.0	24.3	0.0	0.0	98.7	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0
FMN2		ENSG00000155816	"Formin 2"	Q9NZ56	1	240014348-240475189	"Disease related genes, Predicted intracellular proteins"	"DNA damage, Protein transport, Stress response, Transport"	"Actin-binding, Developmental protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 41.0;parathyroid gland: 26.6"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 28.2;Cone photoreceptor cells: 47.1;Horizontal cells: 117.6"	"Group enriched"	"Detected in some"	8	"glioma: 5.9;testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 27.0;BJ hTERT+: 14.3;fHDF/TERT166: 26.6;LHCN-M2: 29.3;U-138 MG: 19.4;WM-115: 30.2"	"Low region specificity"	"Detected in all"							HPA050649			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA050649: AB_2681202"	"unprognostic (1.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.11e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.40e-3)"	1.2	7.3	17.1	1.3	14.5	0.9	1.3	17.2	41.0	1.1	3.2	9.4	0.0	1.4	2.5	2.1	2.1	3.7	2.0	0.9	16.2	11.8	2.9	0.9	1.4	0.9	9.9	15.5	3.9	2.1	26.6	5.6	1.2	12.2	2.9	3.0	1.4	1.3	3.6	0.9	1.0	1.3	2.7	12.3	1.2	1.2	3.4	12.3	0.0	1.3	0.0	1.0	1.2	0.4	0.5	0.4	0.6	0.3	0.4	2.3	0.0	0.0	0.8	2.9	0.0	7.4	5.6	0.0	27.0	14.3	10.7	5.8	0.0	0.0	0.0	0.0	26.6	0.5	0.0	0.4	0.0	10.5	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	3.5	0.7	6.8	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.1	0.0	0.0	0.0	4.5	4.0	0.0	0.1	0.1	0.1	1.1	0.0	0.1	19.4	0.1	7.3	7.0	0.0	0.0	0.0	3.8	0.0	30.2	0.6	0.3	0.1	0.3	0.2	0.2	0.1	0.9	0.1	0.1	0.5	2.3	1.4	0.5	0.4	0.1	0.4	0.3	0.0	17.1	14.5	17.2	19.3	16.2	11.8	9.9	15.5	12.2	12.3	0.0	0.0	0.0	0.0	0.1	28.2	1.2	0.0	0.0	0.0	1.8	47.1	0.0	0.0	0.0	9.1	0.3	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	117.6	11.6	0.6	1.2	2.4	0.3	0.2	1.7	0.0	0.2	1.8	0.0	0.0	0.0	0.0	2.4	0.0	0.3	1.6	4.4	0.0	0.5	0.0	0.0	0.0
FMNL1	"C17orf1, C17orf1B, FMNL"	ENSG00000184922	"Formin like 1"	O95466	17	45221444-45247320	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.4;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 52.5;Kupffer cells: 54.4;Macrophages: 116.9;monocytes: 95.6;T-cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 50.4;MOLT-4: 34.6;U-266/70: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008129, HPA028288"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA008129: AB_1848963, HPA028288: AB_10612110"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"prognostic unfavorable (4.23e-8)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.16e-1)"	8.6	3.8	10.7	29.7	9.6	107.4	7.5	8.1	16.1	4.6	5.2	4.2	0.8	5.8	2.6	5.8	4.5	6.1	9.1	5.8	13.4	6.0	4.2	3.6	22.2	38.1	6.1	6.4	3.1	3.6	3.6	7.4	7.4	7.2	4.3	4.1	3.3	8.4	2.3	2.5	4.2	14.9	4.3	6.2	45.9	6.6	2.7	3.3	56.6	3.9	4.1	22.8	11.3	4.6	3.5	4.3	22.3	5.6	5.4	7.6	3.5	4.2	8.3	0.0	0.4	0.0	1.9	0.4	0.5	1.1	3.1	2.3	0.4	1.9	13.1	4.3	0.1	3.3	0.7	0.0	0.1	1.0	22.9	1.1	7.6	12.3	0.6	8.9	19.7	26.8	1.4	0.3	4.1	1.8	4.3	0.0	14.6	0.6	50.4	2.3	2.7	34.6	20.4	0.4	0.5	0.2	21.9	2.9	23.4	0.8	0.5	2.6	1.2	2.5	0.4	1.0	0.7	2.4	16.1	1.0	0.2	3.0	0.5	18.5	42.1	18.5	13.4	0.3	16.1	0.6	6.8	5.1	8.2	7.0	5.6	4.7	3.5	5.5	7.6	4.3	3.3	3.6	4.8	22.3	5.4	4.2	2.5	6.0	3.5	10.7	9.6	8.1	16.1	13.4	6.0	6.1	6.4	7.2	3.3	3.0	4.8	52.5	2.8	5.5	4.0	1.9	2.5	1.4	1.2	1.8	0.0	0.4	0.0	1.1	2.0	2.9	0.0	0.0	0.8	1.0	10.7	1.9	23.0	0.5	43.3	3.2	1.2	8.6	54.4	0.7	4.9	116.9	42.2	95.6	0.1	0.9	0.4	0.0	0.0	0.6	1.2	6.5	3.8	0.5	1.7	5.4	2.1	97.0	0.2	1.4
FMNL2	"FHOD2, KIAA1902"	ENSG00000157827	"Formin like 2"	Q96PY5	2	152335237-152649834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7;non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 57.7;hTERT-HME1: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005464	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA005464: AB_1848965"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.58e-1)"	15.1	13.6	26.2	7.0	44.6	0.8	9.4	18.3	55.0	8.5	6.6	55.0	1.4	5.8	13.6	10.2	4.6	6.7	11.1	4.8	32.0	20.6	9.7	5.3	17.9	8.2	63.4	27.9	35.9	7.4	17.8	10.2	35.9	39.2	8.9	8.4	5.4	20.1	8.2	31.0	4.0	5.5	10.7	74.1	12.0	8.2	5.8	56.7	1.3	14.5	3.2	5.4	9.1	11.6	0.0	0.9	0.0	4.2	0.0	0.1	0.0	4.1	4.4	13.8	7.6	16.7	18.1	57.7	4.2	8.7	7.5	10.6	4.7	0.2	0.0	9.0	3.6	16.2	4.7	6.6	13.5	12.0	0.0	7.0	0.0	2.8	20.2	4.8	1.1	0.2	11.8	8.4	14.5	37.5	14.6	13.2	1.9	0.1	0.1	4.1	1.1	0.2	1.3	8.8	3.6	8.9	7.4	2.9	6.0	21.9	2.9	14.1	11.5	3.6	1.3	14.6	12.2	0.3	0.4	14.7	11.4	0.3	3.8	7.2	0.4	0.1	0.0	10.5	0.9	23.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.9	0.1	0.0	26.2	44.6	18.3	36.7	32.0	20.6	63.4	27.9	39.2	56.7	23.8	23.4	0.8	14.1	23.5	20.5	2.8	2.5	10.7	23.9	10.4	0.0	30.2	11.6	15.8	18.3	19.7	1.4	0.0	5.9	11.6	29.6	14.2	1.1	1.3	36.8	0.0	7.9	16.0	47.8	6.5	32.5	31.0	6.8	4.6	3.0	3.6	8.9	0.0	38.9	6.3	1.3	6.5	9.0	6.2	6.9	14.8	22.5	1.9	6.6	10.1
FMNL3	"DKFZp762B245, MGC45819, WBP3"	ENSG00000161791	"Formin like 3"	Q8IVF7	12	49636499-49708165	"Predicted intracellular proteins"	Angiogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 37.3;granulocytes: 26.6;monocytes: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002552, HPA023201"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Vesicles, Plasma membrane"	Cytosol	"HPA002552: AB_1078862, HPA023201: AB_1848575"	"unprognostic (2.97e-1)"	"unprognostic (2.77e-3)"	"unprognostic (4.97e-3)"	"unprognostic (7.19e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.37e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	18.3	6.4	10.1	19.9	10.7	5.0	13.8	8.5	11.2	9.3	8.0	23.2	6.3	6.0	13.5	20.8	5.1	7.5	13.0	12.6	10.6	9.0	10.1	3.1	18.0	22.5	14.0	7.7	18.9	3.8	3.7	5.0	14.4	12.9	7.5	6.2	9.8	5.0	5.1	6.3	4.8	10.7	12.3	14.2	13.0	6.7	10.5	11.3	16.2	15.0	5.1	27.9	9.6	7.7	1.7	8.6	3.6	0.7	1.1	1.5	0.7	4.4	1.3	9.8	3.2	2.7	11.1	0.1	5.4	11.1	7.4	6.6	5.0	1.2	9.4	10.5	6.4	8.2	0.2	5.0	2.3	6.8	8.3	1.9	10.3	1.4	0.2	4.8	2.0	13.5	6.9	0.3	11.6	4.9	22.2	19.6	4.7	2.3	6.9	10.8	3.2	8.3	3.0	3.2	0.4	2.9	4.1	12.3	1.4	7.0	0.6	1.6	4.6	3.1	0.4	6.4	5.2	0.8	3.0	24.7	18.5	6.4	0.3	9.3	3.6	0.2	5.1	11.5	6.4	7.7	3.6	0.3	1.2	1.5	0.7	0.7	0.4	0.5	0.9	0.4	1.7	0.8	0.9	0.0	1.1	0.6	8.6	0.3	0.7	10.1	10.7	8.5	11.2	10.6	9.0	14.0	7.7	12.9	11.3	3.0	4.3	11.5	0.6	1.4	6.2	2.0	0.0	0.0	2.3	1.8	37.3	1.5	0.0	0.2	1.1	14.8	0.0	0.0	0.6	1.0	2.9	0.3	26.6	0.4	10.5	3.2	0.0	14.1	4.1	3.9	3.4	10.4	5.0	36.9	0.6	0.5	0.6	0.0	6.0	0.0	1.9	12.9	7.5	3.4	7.2	1.3	2.1	6.9	0.0	0.4
FMO4	FMO2	ENSG00000076258	"Flavin containing monooxygenase 4"	P31512	1	171314208-171342084	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 33.8;liver: 42.2"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 24.9;Hepatocytes: 19.8;Proximal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 7.9;HSkMC: 9.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favorable (1.09e-4)"	"prognostic favorable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	5.3	3.6	1.4	5.1	4.8	0.9	4.5	0.6	2.7	4.5	6.0	4.8	3.1	4.2	3.0	10.0	4.6	3.8	4.6	6.3	2.3	1.5	33.8	42.2	3.4	2.8	7.5	2.8	4.1	3.2	5.5	5.0	2.3	3.7	3.9	3.7	6.7	2.7	2.0	1.6	2.9	16.1	2.0	7.0	3.8	3.9	2.0	6.2	2.7	4.5	3.3	3.4	2.9	3.7	5.3	2.9	0.9	4.0	3.9	4.9	2.0	0.1	0.0	0.4	0.6	5.5	5.0	0.2	1.1	5.0	1.6	1.7	0.8	7.2	4.4	7.9	0.0	2.6	0.3	0.8	1.3	2.2	2.1	1.1	0.0	0.0	0.1	0.8	0.9	1.0	9.3	3.2	0.6	1.3	0.6	0.3	2.2	0.2	3.3	0.7	1.0	2.1	1.9	0.5	1.3	1.6	0.4	0.5	2.5	3.5	0.0	0.2	0.0	1.5	1.5	3.0	5.7	3.1	1.3	0.1	1.3	0.4	1.4	1.0	4.0	1.3	2.7	2.4	1.5	1.1	0.6	2.6	0.9	2.5	4.0	1.8	3.1	2.4	3.3	2.2	5.3	3.3	2.5	0.5	3.9	2.7	2.9	4.9	2.0	1.4	4.8	0.6	2.7	2.3	1.5	7.5	2.8	3.7	6.2	0.0	1.6	0.5	3.8	2.5	0.0	3.5	2.5	6.7	0.0	8.7	0.0	2.1	24.9	1.6	4.0	0.9	8.6	0.0	1.2	1.2	3.1	1.1	1.1	19.8	3.2	0.0	1.2	1.8	5.7	0.4	1.4	2.3	5.0	1.8	1.9	1.5	0.9	0.0	0.4	33.2	0.0	0.0	1.2	0.2	0.2	1.4	1.6	0.5	1.4	1.7
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 117.2;Hepatocytes: 260.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 29.0;HMC-1: 6.6;THP-1: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.1	1.9	0.5	0.7	0.4	0.4	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.1	0.3	0.0	0.0	0.0	1.0	0.1	1.2	0.0	29.0	0.6	1.0	6.6	0.9	0.1	0.3	0.0	0.3	0.4	0.2	0.1	0.1	1.1	1.0	0.2	0.5	2.1	3.6	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	2.0	0.9	1.0	1.4	7.4	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0	8.9	48.6	8.5	3.5	1.4	2.0	1.4	117.2	21.4	13.6	14.0	0.0	1.2	6.6	4.3	5.9	2.7	52.0	0.0	5.1	0.9	1.3	4.1	5.7	260.8	3.2	3.2	6.4	3.1	10.1	4.1	2.6	2.6	27.0	0.0	25.3	0.3	5.7	28.1	1.4	41.5	1.3	0.0	0.8	1.8	0.7	1.4	1.1	4.3	16.4	6.2
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735575-82751197	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 45.2;Distal tubular cells: 76.3;Rod photoreceptor cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;Hep G2: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		1400000	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	12.0	29.4	25.7	3.1	32.7	8.9	5.0	24.8	48.1	10.0	11.0	44.8	6.4	19.4	7.8	7.0	4.7	11.9	6.6	38.1	24.7	22.8	41.7	34.7	7.4	2.6	28.9	25.3	14.0	14.9	17.9	11.9	5.2	34.2	10.4	8.8	11.4	24.6	11.9	14.8	5.0	12.4	6.6	30.8	4.4	10.7	4.6	25.3	0.0	8.2	3.5	2.7	5.6	4.5	0.2	0.0	0.0	0.0	0.9	0.4	0.2	0.6	8.2	2.3	12.1	3.7	3.1	1.5	1.5	1.1	2.8	1.4	10.7	1.7	0.1	2.1	1.3	2.4	0.3	17.8	1.3	1.0	0.5	1.2	6.3	6.8	33.0	10.1	0.1	5.3	2.6	4.7	1.1	0.0	3.0	5.5	0.5	11.1	0.3	0.5	0.9	0.1	0.1	1.5	3.8	6.8	1.0	0.2	0.0	6.0	2.3	3.7	11.9	2.7	0.6	7.7	2.1	8.0	2.3	1.2	0.2	0.8	2.9	2.2	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.2	25.7	32.7	24.8	48.1	24.7	22.8	28.9	25.3	34.2	25.3	3.0	1.3	1.4	2.7	1.3	35.7	5.1	2.5	1.4	2.3	29.6	45.2	9.7	76.3	3.2	0.0	2.1	9.2	0.0	1.0	1.9	4.3	3.2	1.1	4.7	6.5	30.2	5.2	4.9	1.2	0.0	4.9	2.0	11.8	1.0	10.1	26.8	2.2	7.0	2.8	38.4	70.5	0.0	5.1	0.3	3.6	1.6	7.0	1.3	8.6	3.0
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716683-82730328	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm		NA	NA		14000	Nucleoplasm		"HPA056172: AB_2683055, HPA065831: AB_2685565"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	17.6	18.3	27.9	10.8	26.3	12.3	15.7	19.5	27.3	15.3	17.4	27.4	10.0	11.8	18.4	16.7	16.4	16.6	13.0	12.7	26.1	20.8	18.8	23.1	12.8	12.9	25.7	23.0	21.9	15.3	10.8	11.4	17.1	22.2	17.1	14.4	13.2	17.2	20.0	7.3	16.1	13.6	20.3	30.7	13.7	12.6	8.8	21.6	8.2	15.1	9.8	17.5	12.1	12.9	16.5	23.2	18.5	15.5	18.5	23.0	17.1	10.9	44.3	12.1	16.0	5.9	11.3	10.0	20.6	11.5	19.9	16.3	23.4	7.7	9.0	13.8	16.6	18.4	12.6	11.0	15.6	18.0	6.0	19.5	15.1	24.8	26.9	10.5	10.5	8.5	10.4	18.5	18.9	10.4	12.2	14.3	12.8	14.5	5.7	25.4	20.8	20.5	15.6	5.5	24.1	19.3	15.4	30.8	14.0	14.1	21.1	10.1	21.5	34.0	15.4	16.6	21.9	25.7	15.3	12.6	38.7	13.3	27.3	30.3	11.7	12.8	22.4	18.0	13.4	17.8	17.0	14.2	18.5	20.4	15.5	20.0	15.7	19.9	19.5	11.7	16.5	23.0	16.7	2.1	18.5	8.4	23.2	18.6	17.1	27.9	26.3	19.5	27.3	26.1	20.8	25.7	23.0	22.2	21.6	11.9	12.0	13.7	25.9	13.4	17.8	5.2	20.4	10.7	12.5	10.4	7.9	80.4	19.9	17.2	1.3	11.7	9.5	23.3	9.9	35.3	15.1	14.6	12.7	9.0	28.7	3.2	7.5	11.6	9.4	2.3	26.2	11.8	21.9	28.9	13.3	29.2	14.9	17.3	29.7	15.8	14.3	12.9	17.6	9.7	22.6	13.4	52.3	14.9	16.9	21.3
FNBP1	"FBP17, KIAA0554"	ENSG00000187239	"Formin binding protein 1"	Q96RU3	9	129887187-130043194	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 605.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.6;JURKAT: 45.5;MOLT-4: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019635, HPA019691, HPA022119, HPA067742"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: "	"unprognostic (2.86e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.30e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	11.5	6.5	20.7	30.5	27.3	20.0	10.1	56.0	21.3	16.9	42.5	30.1	12.2	8.5	23.6	10.2	23.0	15.6	15.9	8.7	22.3	18.6	7.8	10.4	14.1	39.8	25.1	14.5	13.4	5.5	6.2	8.6	9.2	22.8	20.8	17.4	11.4	7.7	26.7	12.2	13.4	15.7	64.7	29.9	32.1	15.3	9.1	27.3	52.1	15.7	5.7	40.4	34.6	12.4	13.5	8.2	12.3	6.9	6.5	13.4	4.9	13.1	6.1	11.3	13.1	6.9	8.6	9.5	7.5	6.4	5.7	4.8	6.3	5.1	25.8	6.6	14.0	6.7	6.6	10.5	6.8	5.7	42.6	3.1	7.1	7.4	4.2	11.9	19.1	24.5	6.2	3.0	10.5	6.4	8.3	8.3	45.5	1.6	0.3	5.2	10.5	42.8	18.8	8.8	1.7	10.4	9.9	9.1	7.4	7.1	7.2	1.8	5.7	13.7	13.8	5.2	11.3	9.6	8.8	10.0	5.4	6.8	9.8	4.6	5.3	19.5	1.2	6.5	13.2	8.0	12.3	6.0	10.5	13.4	6.6	11.7	13.5	12.2	12.7	6.8	9.0	11.3	10.9	11.4	6.5	6.9	8.2	12.3	4.9	20.7	27.3	56.0	21.3	22.3	18.6	25.1	14.5	22.8	27.3	32.8	31.8	93.1	17.5	29.5	17.2	13.2	7.6	44.2	37.5	21.0	49.1	14.3	16.6	18.3	1.3	38.0	14.7	0.0	15.0	20.9	49.4	46.8	77.5	14.7	40.2	27.0	17.4	46.1	165.2	3.6	43.1	119.6	72.6	605.1	8.3	55.6	16.4	17.3	48.4	11.3	28.0	58.2	45.6	12.6	39.8	35.9	53.4	178.7	14.4	26.8
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169397-159272109	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell type enriched"	"Detected in some"	5	"Fibroblasts: 15.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Region enriched"	"Detected in single"	6	"hippocampal formation: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;fHDF/TERT166: 6.6;SuSa: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA			"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favorable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.2	0.6	0.5	7.6	0.7	0.0	2.5	0.3	0.7	9.7	12.9	3.2	0.0	2.1	4.8	2.2	2.2	0.9	13.1	3.5	4.8	0.5	1.0	1.5	1.2	2.1	0.7	0.0	4.8	1.2	0.0	0.4	0.7	0.5	0.7	1.6	1.0	2.5	0.6	6.2	1.2	7.0	10.2	1.5	0.7	0.7	2.1	0.1	1.0	36.6	11.8	3.6	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	2.4	6.6	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	7.4	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.7	4.8	0.5	0.7	0.0	0.5	0.1	0.0	1.1	0.0	0.0	2.9	0.0	1.4	0.0	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	15.5	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.4	0.3	1.3	0.1	0.0	0.0	0.0
FNDC11	"C20orf195, MGC5356"	ENSG00000125531	"Fibronectin type III domain containing 11"	Q9BVV2	20	63547891-63556708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 52.5"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 12.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 3.2;naive B-cell: 6.6"	"Lineage enriched"	"Detected in many"	6	"B-cells: 6.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.5;EFO-21: 4.9;HaCaT: 2.7;OE19: 3.2;SH-SY5Y: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041341			Approved	Nucleoplasm,Vesicles,Aggresome		NA	NA			"Nucleoplasm, Vesicles"	Aggresome	"HPA041341: AB_10794991"	"unprognostic (2.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.94e-2)"	"unprognostic (8.30e-4)"	"unprognostic (3.68e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.81e-2)"	0.1	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	2.2	0.2	1.1	0.2	0.1	0.1	0.3	0.2	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.3	52.5	0.2	0.1	0.1	0.1	0.3	0.2	0.2	6.6	0.0	1.0	0.0	0.0	0.8	0.2	0.3	0.0	1.8	0.0	0.1	0.1	0.0	0.3	0.6	0.0	0.0	0.1	9.5	0.6	4.9	0.1	0.2	2.7	0.2	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.0	1.2	0.0	0.2	0.7	0.0	0.0	0.9	0.0	0.7	0.0	0.0	1.0	0.0	0.1	0.2	3.2	0.8	0.0	0.0	0.1	1.7	0.0	0.4	6.0	0.0	0.0	0.3	0.4	0.1	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.3	0.0	0.0	1.0	0.1	0.0	0.0	3.2	0.2	0.6	0.0	6.6	0.4	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	2.3	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
FNDC3A	"bA203I16.5, FNDC3, KIAA0970"	ENSG00000102531	"Fibronectin type III domain containing 3A"	Q9Y2H6	13	48975912-49209779	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008927, HPA012555, HPA012825"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Centrosome"	Cytosol	"HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.14e-2)"	13.9	27.2	16.9	14.8	24.9	10.0	17.4	19.4	15.0	25.3	22.3	14.6	32.0	17.8	22.4	32.2	10.6	18.2	17.9	14.0	15.0	23.1	20.4	43.0	18.1	12.0	14.6	14.8	25.0	37.4	14.1	59.0	79.8	15.7	15.6	16.2	15.1	22.5	31.6	9.1	9.2	24.7	17.5	14.8	16.2	18.5	18.8	16.6	13.2	34.2	11.6	12.7	17.8	15.4	6.6	7.6	8.7	6.9	3.9	7.9	3.2	4.5	5.2	19.2	5.0	24.3	30.8	3.7	21.3	28.5	20.6	15.0	7.1	11.1	3.4	4.0	16.0	8.9	4.9	11.4	7.2	30.0	8.6	8.8	5.6	15.0	13.0	14.8	5.2	0.9	15.7	10.1	18.2	21.2	19.3	21.2	4.8	6.9	8.5	22.3	1.8	5.1	10.4	9.4	9.8	4.4	4.9	7.6	6.3	17.3	8.4	7.3	12.0	8.0	7.2	15.2	12.7	3.8	10.2	16.6	10.7	7.4	9.9	15.0	10.4	5.4	3.2	8.1	6.7	11.0	3.4	5.7	3.6	5.2	4.0	7.5	6.6	6.1	4.4	3.6	4.9	7.9	6.7	8.7	3.9	6.9	7.6	4.7	3.2	16.9	24.9	19.4	14.5	15.0	23.1	14.6	14.8	15.7	16.6	50.6	43.5	17.9	23.8	16.4	46.2	21.6	25.5	32.1	30.7	34.9	35.3	10.1	11.6	24.5	39.5	33.8	23.2	0.0	31.5	29.4	31.7	42.8	30.1	63.7	22.7	33.4	41.8	27.6	26.5	7.9	31.4	34.7	35.4	25.2	35.7	64.1	29.0	25.4	37.1	38.9	46.7	6.5	26.9	73.8	28.1	10.5	27.0	19.3	22.5	24.4
FNDC3B	"DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421"	ENSG00000075420	"Fibronectin type III domain containing 3B"	Q53EP0	3	172039628-172401665	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007859	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007859: AB_1078900"	"unprognostic (7.18e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (2.17e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (5.65e-7)"	"unprognostic (4.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-2)"	39.6	22.1	4.0	16.5	5.7	18.2	27.3	2.9	5.1	20.8	18.4	4.2	20.9	7.5	28.9	21.7	13.2	12.3	18.3	18.9	4.9	4.2	17.6	35.6	23.1	10.9	6.7	2.3	26.4	30.7	12.3	21.4	64.1	5.9	15.1	11.5	13.4	27.7	19.8	22.0	8.1	13.1	17.8	6.6	17.5	15.0	10.5	5.0	4.8	21.2	10.5	12.8	25.4	25.8	0.6	2.7	22.7	5.0	2.4	2.6	1.8	12.2	14.2	9.9	12.0	31.0	21.4	24.0	17.6	19.9	11.9	16.3	7.8	27.1	1.2	47.2	26.5	23.7	7.3	3.4	14.3	21.0	7.0	2.5	1.7	9.1	21.4	31.2	15.7	27.6	21.6	7.3	22.2	21.2	28.6	31.7	2.2	2.8	8.9	12.5	3.8	0.6	6.9	5.7	4.7	5.8	1.4	10.2	5.9	13.1	10.9	0.6	3.0	16.8	8.7	14.6	14.3	8.2	8.1	45.8	16.8	7.8	21.2	13.8	18.7	20.7	2.4	17.7	9.1	16.5	7.8	5.0	11.4	2.6	3.0	1.1	0.6	0.8	1.4	2.7	0.0	0.9	1.6	22.7	2.4	1.5	0.4	0.7	1.8	4.0	5.7	2.9	5.1	4.9	4.2	6.7	2.3	5.9	5.0	80.4	43.5	12.0	47.6	56.7	7.5	43.1	50.9	13.4	35.2	43.6	11.8	35.6	13.3	62.0	7.7	56.2	22.4	0.0	39.5	90.0	84.5	54.9	15.0	60.6	44.9	0.0	16.1	62.0	65.2	5.3	53.2	61.1	65.8	50.5	28.4	16.6	73.1	40.8	51.2	30.5	12.2	51.8	50.5	2.4	2.7	29.4	29.1	19.2	20.0	74.5
FNDC4	"FLJ22362, FRCP1"	ENSG00000115226	"Fibronectin type III domain containing 4"	Q9H6D8	2	27491883-27495245	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.9;liver: 57.6"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 165.4;Hepatocytes: 113.4;Late spermatids: 388.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.0;ASC diff: 17.4;HUVEC TERT2: 20.9;SH-SY5Y: 16.3;TIME: 19.0;U-87 MG: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051804, HPA063581"	Uncertain		Approved	Nucleoplasm,Aggresome,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Aggresome, Cytosol"	"HPA051804: AB_2681617, HPA063581: AB_2685048"	"unprognostic (2.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (6.11e-4)"	18.5	45.9	13.4	2.7	13.7	0.7	9.1	10.8	29.5	3.8	2.0	4.0	0.5	1.5	2.8	2.8	11.8	1.5	10.0	3.1	15.6	8.5	2.3	57.6	2.0	1.4	12.0	8.6	16.5	4.6	18.6	2.8	2.5	22.2	6.3	2.1	1.9	2.1	3.3	1.3	2.4	1.4	4.7	5.4	3.5	3.2	10.2	3.8	0.0	1.8	0.7	2.7	4.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	17.0	17.4	10.7	0.1	3.9	7.8	2.8	2.5	0.7	0.2	0.0	0.4	12.3	3.7	0.0	6.5	2.3	2.5	0.0	1.0	0.8	0.0	8.7	6.5	0.0	0.1	9.1	1.1	4.9	1.0	12.9	20.9	0.0	0.9	0.0	10.3	0.0	0.0	0.0	6.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.1	16.3	0.1	0.0	0.1	1.3	0.0	0.0	19.0	2.7	1.2	1.0	3.0	0.0	0.0	0.0	14.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.7	10.8	29.5	15.6	8.5	12.0	8.6	22.2	3.8	0.0	0.3	0.0	2.8	3.1	8.2	2.5	10.2	0.0	0.0	0.0	3.9	0.1	3.3	68.5	165.4	5.8	0.0	0.0	41.6	0.1	8.1	14.7	5.7	113.4	0.5	0.0	0.0	6.2	1.3	388.8	14.4	0.6	3.3	1.8	0.0	12.3	60.5	0.0	11.0	0.2	11.8	0.0	11.3	4.9	3.6	2.0	0.0	0.0	0.0	1.0
FNDC7	FLJ35838	ENSG00000143107	"Fibronectin type III domain containing 7"	Q5VTL7	1	108712657-108742740	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.0;testis: 5.2"	"Cell type enhanced"	"Detected in some"	24	"Bipolar cells: 1.1;Early spermatids: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.1;Karpas-707: 1.2;U-87 MG: 1.8"	"Not detected"	"Not detected"							"HPA028079, HPA054297"	Enhanced		Approved	"Nucleoplasm,Actin filaments"	"Secreted in male reproductive system"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA028079: AB_10602501, HPA054297: AB_2682441"	"unprognostic (2.35e-2)"	"unprognostic (2.65e-2)"			"unprognostic (3.74e-1)"			"unprognostic (8.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-4)"		"unprognostic (1.90e-10)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-1)"		"unprognostic (1.31e-1)"	0.1	0.1	0.6	0.1	0.8	0.6	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.7	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.8	0.1	3.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.5	0.6	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.1	0.9	0.5	0.0	0.9	0.0	0.0	0.1	0.2	0.1	0.6	0.2	0.3	0.1	0.0	1.1	0.0	1.2	0.5	0.0	0.1	0.0	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.5	0.3	0.3	0.1	0.4	0.2	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.4	1.1	1.7	0.7	0.1	0.1	3.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FNTA	"FPTA, PGGT1A, PTAR2"	ENSG00000168522	"Farnesyltransferase, CAAX box, alpha"	P49354	8	43034194-43085788	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010149, HPA018830"	Approved		Approved	Cytosol		NA	NA		220000	Cytosol		"CAB010149: AB_2106299, HPA018830: AB_1848992"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (2.94e-12)"	"unprognostic (3.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-3)"	32.5	21.5	25.3	20.9	31.9	15.3	29.8	21.2	28.8	26.7	25.7	36.9	25.0	23.7	23.7	29.4	28.0	22.9	18.1	32.6	25.6	23.1	24.0	30.5	22.7	27.4	43.3	23.8	21.5	26.0	17.9	24.7	32.6	33.4	25.1	22.5	14.1	23.6	25.9	45.2	29.7	20.4	23.9	75.9	22.9	20.9	18.3	36.8	26.0	25.4	26.8	28.1	27.1	29.8	11.7	11.7	11.1	8.9	13.9	11.9	5.3	24.0	11.9	16.5	5.3	29.0	37.8	13.7	14.0	16.4	16.4	15.1	19.3	18.6	28.3	10.8	17.6	21.8	13.2	20.3	23.3	19.3	7.4	13.4	22.1	8.1	16.6	37.8	9.0	11.9	29.2	38.1	11.8	33.8	23.7	28.1	15.3	26.8	16.6	18.0	2.8	21.6	13.8	28.5	20.4	8.7	18.9	26.2	15.2	22.5	17.9	9.8	15.2	18.2	15.1	24.0	19.5	19.2	17.1	22.6	5.5	7.2	22.3	14.9	15.6	13.1	27.6	14.5	17.5	12.9	3.0	6.6	11.1	8.7	8.9	10.3	11.7	9.1	11.7	11.7	11.6	11.9	11.9	1.6	13.9	6.7	11.0	11.5	5.3	25.3	31.9	21.2	28.8	25.6	23.1	43.3	23.8	33.4	36.8	53.6	16.9	34.6	70.9	78.0	21.6	35.9	28.1	41.5	27.3	31.4	35.3	121.1	59.7	61.9	33.1	51.7	30.3	23.3	61.0	105.3	62.9	62.6	32.3	25.4	71.6	19.1	30.9	49.1	38.3	40.9	44.5	50.7	89.4	75.7	36.2	36.3	57.6	42.1	56.6	40.2	53.7	51.8	48.7	59.3	32.4	83.6	173.5	55.4	39.1	62.6
FNTB	FPTB	ENSG00000257365	"Farnesyltransferase, CAAX box, beta"	P49356	14	64986720-65062652	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 75.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062743	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA062743: AB_2684861"	"unprognostic (2.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (6.21e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-3)"	7.4	9.0	6.3	4.9	21.9	2.3	7.8	11.4	13.7	8.0	6.3	24.3	6.2	5.6	6.4	6.6	13.5	9.0	5.1	12.0	8.1	7.9	8.0	5.6	7.0	5.1	34.0	7.2	7.4	5.9	13.6	7.9	8.2	25.4	8.9	7.9	4.4	8.0	9.6	14.3	10.3	5.1	11.6	75.0	4.6	5.7	9.0	22.2	4.7	5.6	5.8	7.3	7.4	7.8	2.4	6.4	12.3	10.3	2.8	8.8	5.3	18.7	13.6	10.6	6.0	6.8	6.0	7.8	10.8	8.0	12.3	12.7	7.2	7.7	3.2	6.2	11.4	6.8	12.5	25.5	8.4	10.1	4.5	7.2	12.7	3.7	10.5	4.4	4.3	17.6	5.1	7.3	5.3	2.9	11.5	10.2	5.9	6.8	4.6	7.1	12.4	6.5	7.2	4.6	11.6	13.9	6.4	9.9	4.0	8.4	6.9	6.8	6.7	6.7	13.3	14.7	8.8	12.2	7.5	8.0	8.9	18.4	4.0	6.9	2.4	2.7	3.2	10.3	5.6	20.5	12.3	10.3	9.2	3.6	8.6	8.8	2.4	5.5	4.3	6.4	1.9	4.5	3.3	2.7	2.8	4.3	4.9	5.1	5.3	6.3	21.9	11.4	13.7	8.1	7.9	34.0	7.2	25.4	22.2	11.9	2.1	0.0	2.9	2.2	4.4	6.1	2.5	1.4	6.8	3.5	2.0	13.7	0.0	5.9	5.2	2.9	3.3	0.0	4.2	12.8	5.8	5.0	0.0	7.3	7.0	4.8	7.5	5.5	9.5	4.5	5.2	3.4	5.0	7.2	5.5	7.0	4.0	0.0	8.1	4.6	4.0	19.4	2.7	2.1	3.2	3.1	6.9	2.5	5.0	2.6
FO393400.1		ENSG00000285382			20	32632183-32743567	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	31	"HEL: 13.2"									HPA054119			Approved	Vesicles		NA	NA			Vesicles		"HPA054119: AB_2682388"																		3.3	2.9	2.8	2.4	3.0	3.1	3.3	3.8	5.1	2.2	2.2	2.6	4.2	1.9	3.3	4.4	2.4	3.6	2.5	4.4	2.2		3.7	4.6	3.2	2.1	1.4	4.2	3.5	4.3	2.6	1.6	5.4	2.3	3.0	2.0	3.2	3.5	3.1	3.1	3.9	2.6	4.0	0.8	2.5	3.0	3.3	2.0	1.3	6.5	2.0	2.9	3.9	1.7	1.0	0.8	1.6	0.3	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.3	0.8	0.4	0.2	0.3	0.4	0.3	0.3	0.1	1.0	0.3	0.6	0.5	0.6	0.2	0.8	0.5	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FO681492.1		ENSG00000277758			10	47750864-47763592	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 5.2;brain: 6.7;lung: 10.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 37.0"									"HPA036971, HPA036972, HPA064559"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286"	"unprognostic (2.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-5)"	"unprognostic (4.52e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.11e-2)"	0.5	0.0		0.1		0.0	0.0		6.7	0.3	0.0			0.0	0.1	0.0	2.4	1.1	0.4	0.4			0.0	0.0	10.6	2.3			0.3	1.4	0.0		1.1		0.0	0.0		1.4	0.4	0.0	3.4	0.0	0.0		0.2	0.0	0.0			0.0		0.5	0.9		0.7	2.5	0.4	5.2	0.9	1.1	0.4	0.5	4.2	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.1	0.0	2.7	3.0	0.0	0.2	1.2	0.8	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.2	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	3.3	37.0	0.1	0.2	3.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.3	2.3	0.3	0.7	2.8	1.1	0.7	1.1	0.8	2.5	0.3	0.5	0.7	0.4	0.9	5.2	1.0	0.7	0.4											3.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOLR1	FOLR	ENSG00000110195	"Folate receptor 1"	P15328	11	72189558-72196323	"Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 157.6;salivary gland: 101.2"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Region enriched"	"Detected in many"	20	"pons and medulla: 157.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 83.6;RPTEC TERT1: 88.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0"	"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA		81000	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.0	0.7	1.3	0.2	1.7	0.0	6.6	0.6	3.5	31.4	0.1	21.4	2.8	0.0	1.0	3.5	1.6	46.7	1.0	0.2	7.9	1.8	38.8	0.2	47.0	0.0	0.8	0.4	8.9	1.8	0.4	3.5	24.5	157.6	1.5	0.0	17.0	101.2	4.0	0.1	0.9	0.1	0.0	0.7	0.0	7.4	0.4	0.2	0.0	12.7	2.6	3.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	7.8	7.9	0.0	8.1	0.1	0.0	0.1	0.4	0.3	0.0	0.0	0.2	0.1	83.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.0	88.8	0.0	0.0	0.5	0.2	1.2	0.0	7.3	11.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3	1.7	0.6	3.5	7.9	1.8	0.8	0.4	157.6	0.2	461.6	156.4	0.0	7.8	0.8	0.0	0.3	35.7	178.0	316.2	301.8	0.0	307.8	112.7	15.6	0.0	0.0	0.0	0.0	1.2	101.0	3.8	4.7	4.7	0.0	26.1	0.0	1.7	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.4	4.1	0.0	0.0	286.0	0.0	0.0	0.1	0.0	0.1	0.1	216.6	0.0	0.0	8.6
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22581005-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.4;pancreas: 47.9;stomach 1: 20.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 89.3;Alveolar cells type 2: 60.1;Cholangiocytes: 48.4;Hepatocytes: 51.3;Mucus-secreting cells: 82.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;OE19: 13.2;PC-3: 15.1;SCLC-21H: 26.2"	"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	7	"midbrain: 4.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.2	0.0	0.2	1.3	0.2	0.0	0.2	0.2	0.3	9.7	4.5	0.2	0.2	2.2	1.8	0.2	0.2	3.8	13.1	0.2	0.2	0.1	0.2	44.4	15.9	0.2	1.4	0.2	3.4	47.9	0.0	0.4	0.3	0.4	0.5	6.0	0.2	0.2	0.2	0.2	0.0	1.8	0.2	0.2	0.2	20.7	0.3	0.2	0.2	2.2	0.2	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.7	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.3	0.0	7.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.2	15.1	0.0	0.0	0.0	0.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	1.4	0.2	0.4	0.2	89.3	60.1	0.0	1.0	0.0	0.0	0.3	48.4	17.4	22.7	0.0	0.0	0.0	0.0	21.4	0.0	0.0	4.9	0.0	31.8	0.0	0.0	0.6	4.6	51.3	0.0	0.0	27.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	82.6	0.0	24.8	2.9	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	33.6	0.0
FOXA3	HNF3G	ENSG00000170608	"Forkhead box A3"	P55318	19	45863989-45873797	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 36.7;pancreas: 63.3"	"Cell type enhanced"	"Detected in many"	19	"Intestinal endocrine cells: 79.9;Mucus-secreting cells: 184.0;Paneth cells: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.5;Hep G2: 12.9;K-562: 10.3;OE19: 45.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB015154, HPA054034"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015154: AB_647545, HPA054034: AB_2682349"	"unprognostic (2.88e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.11e-1)"	0.3	0.0	0.2	5.9	0.2	0.0	0.1	0.1	0.3	0.5	9.7	0.3	0.7	4.7	0.2	0.1	0.2	0.1	13.7	0.5	0.1	0.0	0.9	36.7	0.6	0.1	0.1	0.1	0.1	63.3	0.7	0.1	0.1	0.2	0.3	8.0	0.1	1.0	0.8	0.1	0.1	9.0	0.1	0.1	0.1	17.1	0.7	0.3	0.2	0.1	0.5	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.7	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.5	0.5	0.1	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	10.3	0.0	0.0	0.1	0.0	0.0	5.2	45.3	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.0	0.0	0.7	3.2	0.0	0.3	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.3	0.0	4.5	1.4	0.5	0.2	0.0	0.4	10.2	0.0	0.0	1.8	0.0	0.0	0.0	9.7	0.1	0.6	22.2	0.0	21.3	0.0	0.1	6.3	4.6	31.7	0.0	0.0	79.9	0.6	2.1	0.0	0.0	0.0	1.7	0.0	184.0	0.0	26.3	49.1	0.0	0.2	0.0	0.0	0.5	2.3	6.4	0.3	0.0	0.0	36.6	0.9
FOXB1	"FKH5, HFKH-5"	ENSG00000171956	"Forkhead box B1"	Q99853	15	60004222-60061730	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 16.7"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 18.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Region enhanced"	"Detected in many"		"pons and medulla: 16.7"	"Cell type enriched"	"Detected in single"	4	"T-reg: 3.8"	"Lineage enriched"	"Detected in single"	38	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;HDLM-2: 15.3;HEK 293: 11.7;JURKAT: 6.1"	"Region enhanced"	"Detected in some"		"hypothalamus: 7.7"	"Low region specificity"	"Detected in many"			HPA073369			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA073369: AB_2686597"	"unprognostic (1.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-2)"		"unprognostic (1.47e-2)"	"unprognostic (5.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.12e-9)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"		"unprognostic (9.38e-2)"	0.0	0.0	0.3	0.5	4.1	0.2	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.2	0.9	0.1	0.2	0.1	6.2	0.0	0.1	0.1	1.8	6.5	0.0	0.0	0.4	0.0	0.0	1.9	16.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	8.4	0.1	1.8	2.6	3.7	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	2.6	0.0	7.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.3	11.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.3	4.1	0.6	0.0	0.1	6.2	6.5	0.0	16.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0
FOXD4	"FKHL9, FOXD4a, FREAC5"	ENSG00000170122	"Forkhead box D4"	Q12950	9	116231-118204	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.7;testis: 3.1"	"Cell type enriched"	"Detected in single"	7	"monocytes: 4.6"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"THP-1: 8.9"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (8.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.46e-2)"	"unprognostic (2.52e-4)"	"unprognostic (3.66e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-3)"	0.6	0.6	1.2	0.5	1.4	0.1	0.1	5.7	1.5	0.4	0.2			0.4	0.7	0.1	0.1	0.3	0.1	0.2	1.3	1.5	1.6	0.2	0.6	0.7	0.8		0.3	0.5	0.2	0.7	0.6		0.7	0.3		0.3	0.5	1.4	0.3	0.6	0.4	0.4	1.0	0.6	3.1			0.2		0.2	0.2	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.4	0.8	0.4	3.7	0.2	0.4	0.0	0.3	1.0	0.2	3.7	0.6	0.0	0.1	0.0	0.9	0.2	0.3	3.6	3.0	0.0	0.5	0.3	0.2	2.6	1.9	0.5	0.0	0.0	0.1	0.6	0.0	0.2	1.2	1.6	0.1	1.4	0.3	2.1	0.1	0.5	1.8	0.3	0.8	0.5	0.9	1.9	1.8	1.4	1.0	0.6	0.0	0.3	0.9	8.9	0.5	1.1	1.1	0.7	1.3	0.1	0.4	0.8	0.8	2.0	1.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 2.2;bone marrow: 3.0;brain: 3.3;lymphoid tissue: 1.2;testis: 3.1"	"Cell type enriched"	"Detected in single"	134	"monocytes: 54.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	22	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	22	"B-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"RH-30: 5.3;THP-1: 3.7"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.2	0.5	0.4	1.2	1.2	3.0	0.1	3.3	0.8	0.0	0.0			0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.6	0.6	0.4	0.1	0.4	0.4	0.3		0.0	0.2	0.0	0.4	0.1		0.2	0.1		0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.2	3.1			0.2		0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.6	0.7	1.1	0.0	1.5	0.0	0.6	0.0	0.1	0.3	0.0	2.0	0.9	0.1	0.2	0.1	0.6	0.0	0.1	1.9	1.4	0.8	1.0	1.0	0.0	2.1	1.6	0.0	0.7	0.2	0.0	0.8	0.0	0.9	1.2	1.7	0.3	0.1	0.3	0.9	0.0	0.2	0.7	0.6	5.3	0.7	0.1	0.6	0.7	0.4	0.5	0.1	0.3	0.0	0.4	3.7	0.4	1.7	1.5	0.6	1.3	1.4	1.4	0.7	0.3	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FOXD4L3	FOXD6	ENSG00000187559	"Forkhead box D4 like 3"	Q6VB84	9	68302867-68304905	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.6;fallopian tube: 2.4;lymphoid tissue: 2.0"	"Cell type enriched"	"Detected in single"	12	"monocytes: 1.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.7;NB-4: 1.2;THP-1: 1.9"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"		"unprognostic (7.93e-4)"			"unprognostic (8.71e-2)"					"unprognostic (7.04e-2)"				"unprognostic (4.75e-2)"				0.0	0.1	0.7	1.4	1.3	0.0	0.0	2.1	2.3	0.3	0.1			0.0	0.0	0.0	0.0	2.4	0.4	0.0	2.6	0.7	0.0	0.0	0.0	1.6	0.5		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.3	0.0	0.0	0.4	0.0	0.0	0.1	2.0	0.0	0.9			0.0		0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.3	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.4	0.0	0.9	0.1	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.6	0.1	0.8	0.5	0.4	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXD4L4	"bA460E7.2, FOXD4L2"	ENSG00000184659	"Forkhead box D4 like 4"	Q8WXT5	9	65736555-65738784	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (6.92e-2)"	"unprognostic (5.48e-2)"			"unprognostic (5.19e-2)"						"unprognostic (7.78e-2)"		"unprognostic (7.93e-3)"	"unprognostic (7.14e-2)"				0.4	0.6	0.3	1.0	1.2	0.0	0.2	1.5	1.3	0.7	0.2			0.0	0.2	0.0	0.2	0.2	0.1	0.4	1.0	0.7	0.2	0.1	0.0	0.1	0.6		0.2	0.0	0.0	0.2	0.2		0.2	0.1		0.4	0.1	0.4	0.0	0.4	0.1	0.2	0.5	0.1	0.5			0.0		0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.7	0.5	1.4	0.0	0.2	0.3	0.7	0.0	0.0	0.2	1.0	0.0	0.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.2	0.5	0.0	0.2	0.2	0.7	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.5	0.2	0.7	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.8	1.0	0.4	0.0	0.1	0.2	0.7	0.0	0.1	0.5	0.0	0.4	1.0	0.5	0.7	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXD4L5	bA15J10.2	ENSG00000204779	"Forkhead box D4 like 5"	Q5VV16	9	65282101-65285209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (8.26e-2)"	"unprognostic (6.95e-3)"									"unprognostic (1.58e-1)"			"unprognostic (5.76e-2)"	"unprognostic (2.57e-1)"			0.7	1.1	0.3	0.1	0.5	0.0	0.7	0.6	2.2	0.3	0.1			0.1	0.1	1.1	0.4	0.7	0.1	0.2	1.0	0.5	0.5	0.2	0.3	0.2	0.3		0.2	0.2	0.0	0.2	0.5		0.3	0.0		1.2	0.1	0.5	2.0	0.3	0.0	0.2	0.2	0.4	1.0			0.8		0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.2	1.1	0.7	2.8	0.5	0.3	3.5	0.6	0.2	0.0	0.0	0.7	0.3	2.0	0.4	0.2	0.3	0.0	1.5	0.2	0.2	2.8	1.7	1.8	0.8	0.9	0.0	1.5	2.7	0.2	0.8	0.2	0.6	1.0	0.0	0.2	2.7	1.1	0.3	0.6	0.3	1.0	0.8	0.3	0.9	0.6	2.2	0.7	0.7	1.4	1.4	2.6	0.6	0.3	0.2	1.8	0.9	3.5	0.4	0.4	2.1	1.2	1.1	0.8	1.7	0.5	0.3	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXD4L6		ENSG00000273514	"Forkhead box D4 like 6"	Q3SYB3	9	41126430-41128463	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 1.8;lymphoid tissue: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"		"unprognostic (2.41e-1)"			"unprognostic (3.41e-1)"									"unprognostic (3.61e-1)"				0.0	0.0		1.5		0.0	0.0		1.8	0.0	0.0			0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.2	0.1	0.3			0.0	0.2	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.8	0.2	0.3			0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.7	0.2	0.0	0.5	1.0	0.0	0.1	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.1	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.7	0.3	0.0	0.8	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXF1	"FKHL5, FREAC1"	ENSG00000103241	"Forkhead box F1"	Q12946	16	86510527-86515418	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 54.7;urinary bladder: 48.5"	"Cell type enhanced"	"Detected in some"	22	"Endothelial cells: 4.7;Fibroblasts: 7.2;Ito cells: 4.9;Smooth muscle cells: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ: 9.4;BJ hTERT+: 20.7;HHSteC: 20.3;U-2197: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028886			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028886: AB_10601652"	"unprognostic (7.91e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.44e-1)"	2.2	0.3	2.5	15.4	2.9	0.0	0.8	2.3	4.2	7.9	34.6	1.3	1.6	7.2	2.1	0.9	17.9	1.2	39.7	0.6	3.4	1.9	1.2	2.4	33.1	2.4	3.5	1.0	0.6	0.9	1.1	0.4	18.5	3.5	35.7	9.2	0.5	0.9	4.8	0.3	0.4	18.4	54.7	3.0	0.5	18.4	0.6	3.7	0.0	3.6	2.6	3.3	48.5	25.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	20.7	2.9	1.0	0.0	0.1	0.0	0.0	0.8	2.0	0.0	1.6	0.0	2.5	0.0	1.1	0.0	1.5	0.0	20.3	0.0	1.7	2.1	0.0	3.3	0.4	0.3	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	3.1	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	8.9	0.0	0.0	0.0	0.0	1.9	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.5	2.9	2.3	4.2	3.4	1.9	3.5	1.0	3.5	3.7	0.0	1.1	0.0	0.2	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.3	7.2	0.7	0.0	0.0	0.3	0.0	0.0	4.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	19.6	0.0	0.4	0.3	1.0	0.0	0.0	0.2
FOXJ3	KIAA1041	ENSG00000198815	"Forkhead box J3"	Q9UPW0	1	42176539-42335877	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067284			Approved	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA067284: AB_2685817"	"unprognostic (5.60e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.24e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (3.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (4.51e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (5.43e-2)"	24.8	15.1	21.2	20.1	31.3	31.6	25.6	38.2	30.9	22.3	18.4	22.9	15.4	18.8	24.9	18.9	17.4	19.8	16.2	23.5	21.5	20.2	16.8	17.6	20.4	19.6	22.9	19.2	29.5	22.6	31.6	28.7	33.5	21.2	21.7	22.5	18.4	19.0	23.7	44.3	24.3	20.0	22.0	20.7	19.6	20.8	19.0	22.6	29.0	23.7	15.2	22.2	22.8	21.4	12.3	9.7	10.9	9.4	11.6	13.1	4.3	13.8	11.7	12.9	13.4	14.0	17.2	18.6	10.5	15.6	14.2	15.9	10.8	16.7	21.3	11.3	14.7	12.2	13.3	18.0	17.3	24.2	16.0	10.1	23.5	14.9	9.1	12.1	21.5	16.2	12.8	17.2	21.2	26.4	15.2	15.4	17.1	14.1	15.5	16.9	7.9	21.7	12.3	20.1	11.1	10.7	20.4	33.9	14.5	12.1	20.2	18.0	16.9	19.0	22.0	19.1	19.3	11.0	32.1	14.3	14.9	20.0	15.0	17.4	15.4	18.9	17.4	13.5	18.0	11.9	6.0	5.7	6.1	9.0	4.8	10.9	8.0	11.0	9.5	4.6	12.3	11.8	13.1	10.9	11.6	9.4	9.7	7.0	4.3	21.2	31.3	38.2	30.9	21.5	20.2	22.9	19.2	21.2	22.6	11.9	17.6	20.1	9.7	31.5	18.4	37.6	7.6	12.0	15.9	15.7	17.7	11.1	14.9	9.7	14.9	23.2	22.8	46.7	12.6	26.0	14.6	16.6	12.7	14.9	10.3	20.6	25.9	14.1	19.0	14.2	20.8	12.7	10.1	6.4	26.0	14.1	13.7	17.3	18.7	11.0	32.9	6.5	12.3	22.8	22.7	29.2	23.3	12.5	17.9	19.2
FOXK1	IMAGE:5164497	ENSG00000164916	"Forkhead box K1"	P85037	7	4682309-4771443	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017998, HPA018864"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA017998: AB_1849077, HPA018864: AB_1849079"	"unprognostic (3.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-1)"	13.0	16.7	15.5	12.7	16.0	24.7	10.3	18.1	23.8	14.1	15.4	18.4	9.5	10.1	16.9	8.3	12.4	14.4	11.7	13.6	14.4	13.7	10.7	8.4	14.3	11.9	19.3	13.9	15.5	17.6	10.6	22.2	9.9	14.2	11.7	9.3	13.8	12.6	14.0	27.4	21.0	11.3	15.5	12.1	15.6	11.9	14.7	19.9	12.5	9.2	9.5	11.0	14.9	19.0	3.2	2.8	1.9	4.0	3.7	6.5	2.9	8.7	11.3	7.3	14.5	7.2	5.5	9.1	4.0	3.6	2.9	3.3	11.2	10.0	15.0	4.8	6.5	9.4	14.5	7.9	9.9	3.0	4.3	4.9	7.0	11.7	6.3	7.1	8.7	8.1	10.4	5.6	7.0	9.7	4.7	5.6	5.8	15.1	3.3	3.5	10.1	3.3	15.6	11.0	3.6	5.7	12.5	7.3	9.5	4.2	13.1	6.6	8.3	6.1	13.4	4.8	6.0	7.4	11.6	17.1	5.1	16.1	7.8	8.6	9.3	7.6	9.9	6.8	10.2	8.0	1.9	2.4	1.0	4.6	4.0	6.5	3.2	4.5	4.3	2.8	3.2	5.1	4.7	1.4	3.7	3.7	2.3	2.2	2.9	15.5	16.0	18.1	21.4	14.4	13.7	19.3	13.9	14.2	19.9	29.8	13.7	14.4	10.4	29.8	16.7	11.1	10.2	10.7	9.1	14.0	21.6	11.0	5.0	8.8	33.5	14.3	7.8	0.0	13.2	3.8	16.7	21.0	7.0	10.6	9.5	22.3	12.6	11.6	19.4	86.3	17.8	8.8	15.1	10.8	9.2	9.8	16.4	8.6	26.9	14.7	14.2	19.4	34.0	14.0	15.7	43.7	3.3	14.4	15.6	18.8
FOXN3	"C14orf116, CHES1"	ENSG00000053254	"Forkhead box N3"	O00409	14	89124871-89619149	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059209	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA059209: AB_2683949"	"unprognostic (1.69e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.58e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.11e-1)"	26.8	14.5	12.6	23.2	11.3	33.9	35.2	46.9	10.7	17.2	28.4	15.3	12.2	18.2	19.3	11.2	21.0	17.4	11.9	20.2	12.8	7.8	7.5	15.4	14.1	20.1	11.3	7.4	28.8	15.1	35.0	10.1	11.3	13.2	15.7	11.1	17.8	13.4	12.6	44.3	29.5	31.1	25.1	14.0	13.2	15.9	12.6	13.2	34.0	8.8	18.4	19.9	25.7	31.7	9.6	19.3	21.4	14.2	17.3	24.3	15.2	0.1	2.7	7.3	4.3	29.7	9.6	5.0	5.5	5.9	5.1	8.5	2.6	2.1	8.6	2.9	8.8	3.6	1.9	12.5	8.1	7.6	37.2	2.4	2.8	5.4	9.0	9.6	5.6	5.1	22.5	4.7	0.4	3.6	6.3	10.9	12.1	3.3	24.6	8.6	3.3	11.1	5.6	7.6	5.0	4.9	17.5	24.8	8.0	0.6	8.9	3.8	13.0	8.1	8.1	2.3	24.7	4.5	16.2	19.2	8.9	11.9	8.6	8.3	22.0	37.3	15.5	3.0	10.0	5.2	21.4	13.0	18.8	24.3	14.2	19.5	7.8	16.4	20.8	19.3	9.6	21.5	20.5	5.4	17.3	8.7	4.3	19.2	15.2	12.6	11.3	46.9	10.7	12.8	7.8	11.3	7.4	13.2	13.2	29.8	33.4	42.2	20.1	79.3	120.0	94.3	45.9	13.4	46.6	8.7	0.0	28.4	18.3	8.5	51.6	50.4	42.4	23.3	18.2	16.8	35.5	24.5	12.7	73.7	37.8	74.7	57.0	52.2	76.4	26.5	89.2	69.9	30.4	26.2	40.3	32.4	15.4	24.6	80.2	10.5	9.3	38.8	52.6	2.3	10.0	129.0	24.7	76.1	43.5	22.0
FOXN4		ENSG00000139445	"Forkhead box N4"	Q96NZ1	12	109277979-109309220	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 13.1"	"Cell type enhanced"	"Detected in some"	21	"Spermatocytes: 1.8;Spermatogonia: 2.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Region enriched"	"Detected in single"	11	"basal ganglia: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.4;SCLC-21H: 6.4;SH-SY5Y: 6.6;U-266/70: 9.1"	"Not detected"	"Not detected"							HPA050018	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA050018: AB_2680992"	"unprognostic (1.09e-3)"	"unprognostic (9.63e-2)"		"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"		"unprognostic (1.08e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"		"unprognostic (6.00e-2)"	0.2	0.0	0.1	0.1	2.7	0.0	0.1	0.2	0.1	1.4	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.9	2.3	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.4	0.1	0.4	0.1	0.1	0.0	13.1	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	6.6	0.0	0.1	0.0	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	9.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.6	0.0	0.0	0.0	0.0	0.0
FOXP4	FLJ40908	ENSG00000137166	"Forkhead box P4"	Q8IVH2	6	41546426-41602384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 38.6;Mucus-secreting cells: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CACO-2: 39.3;OE19: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007176	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007176: AB_1078911"	"unprognostic (8.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.17e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.13e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-2)"	12.1	7.8	6.3	13.7	12.6	4.4	15.5	12.3	10.0	28.2	15.8	14.0	16.4	18.7	20.7	8.4	10.5	10.1	29.5	12.9	6.6	7.3	16.4	18.9	14.4	9.1	12.9	4.9	17.1	24.8	5.9	12.6	5.5	9.4	21.7	7.2	21.2	30.1	13.0	7.9	7.1	19.3	11.7	7.9	5.8	37.0	15.4	10.9	12.0	23.9	6.3	14.0	11.7	27.6	2.0	1.0	0.3	0.9	0.6	1.5	0.4	9.1	12.6	15.9	17.0	3.0	1.0	16.3	5.0	2.7	4.5	3.1	39.3	2.9	10.6	9.5	3.0	13.5	7.0	4.6	4.8	1.9	8.4	7.3	8.4	7.0	26.3	5.8	5.3	6.9	2.5	5.9	4.0	2.4	6.6	4.4	6.6	10.4	4.3	2.1	24.8	6.2	9.2	4.0	48.5	4.4	6.8	5.1	7.1	3.9	7.6	4.5	6.4	5.4	12.9	9.0	5.1	7.3	13.0	6.1	5.7	14.2	8.9	8.5	3.4	2.1	14.7	4.7	9.0	5.3	0.3	0.7	0.3	0.7	0.9	1.2	1.0	0.6	1.5	0.6	2.0	0.1	0.3	0.3	0.6	0.3	1.0	1.1	0.4	6.3	12.6	12.3	9.2	6.6	7.3	12.9	4.9	9.4	10.9	0.0	9.4	0.5	4.9	8.1	4.7	14.6	10.2	1.4	3.4	5.2	2.0	2.1	0.0	6.9	22.9	2.8	18.6	0.0	14.0	2.7	5.7	13.8	3.5	15.5	3.6	0.0	38.6	7.4	3.2	16.3	3.7	2.6	1.7	7.2	37.4	0.8	16.6	20.1	8.1	6.9	2.6	12.9	8.9	2.1	7.2	6.8	3.7	3.2	15.0	8.4
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844301-31845619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	28	"Peritubular cells: 53.4;Sertoli cells: 129.4;Smooth muscle cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;hTERT-RPE1: 13.3;RH-30: 11.1;U-2 OS: 14.8;U-251 MG: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	5.9	3.1	2.7	3.0	4.7	0.3	11.7	2.7	4.9	9.7	2.6	4.8	1.8	0.9	15.5	6.2	2.8	3.6	11.7	14.0	3.2	2.6	5.5	0.9	6.5	4.6	4.1	4.8	4.0	1.1	0.8	3.2	14.4	5.2	5.0	1.6	7.0	2.0	7.0	4.5	1.8	1.8	3.7	2.6	5.5	1.6	9.7	0.6	3.0	4.9	7.0	3.1	4.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	14.8	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.7	2.7	4.9	3.2	2.6	4.1	4.8	5.2	0.6	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.4	0.0	3.4	0.1	0.0	0.0	0.4	0.0	0.0	1.3	0.0	4.0	4.6	0.0	1.7	0.0	0.0	0.0	3.3	0.0	53.4	0.0	0.0	129.4	31.6	0.5	0.5	0.3	0.2	0.0	0.0	0.0
FP565260.1		ENSG00000275464			21	5130871-5154734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 17.2"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 10.8;Ductal cells: 8.0;Exocrine glandular cells: 6.9;Hofbauer cells: 5.1;monocytes: 5.4;Pancreatic endocrine cells: 7.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 38.1"									HPA024573	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	3.0	3.0	1.1	3.0	2.2	3.3	1.4	1.1	6.8	1.7	1.9	7.2	1.1	2.8	1.6	2.6	1.9	2.4	4.8	2.9	3.2		1.8	1.1	1.8	4.2	2.4	1.1	1.9	2.0	2.5	1.1	2.3	2.9	1.8	2.7	1.1	1.7	1.1	6.8	1.8	2.2	3.4	1.1	2.8	1.4	1.4	1.1	1.1	1.7	1.1	2.3	2.4	1.1	8.9	6.6	5.0	12.9	7.4	17.2	7.5	11.8	8.9	6.0	9.3	2.6	2.0	3.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	5.5	4.0	8.0	7.9	16.7	7.3	0.0	2.5	5.4	38.1	4.6	4.5	4.2	17.4	11.3	7.2	8.9	10.2	8.0	1.9	7.8	5.9	21.2	4.2	2.5	10.4	12.8	12.0	23.7	13.7	11.1	20.1	5.6	10.5	5.3	9.5	5.7	10.4	9.8	14.8	5.6	1.6	12.3	9.4	3.8	4.5	11.6	0.1	12.3	4.9	5.3	23.9	8.1	23.1	6.3	2.6	5.5	5.0	15.0	9.7	17.2	8.7	9.1	11.0	6.6	8.9	9.2	12.6	3.3	7.4	12.9	4.4	6.0	7.5											0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.5	0.0	0.0	2.3	0.0	8.0	0.0	0.0	0.0	0.0	6.9	1.6	0.0	0.0	4.7	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	7.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
FP565260.3		ENSG00000277117			21	5022493-5040666	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Cell type enriched"	"Detected in single"	22	"monocytes: 8.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.3;REH: 12.7;SiHa: 10.9"									HPA029179			Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA			"Plasma membrane, Cytoplasmic bodies"		"HPA029179: AB_2732445"	"unprognostic (3.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.58e-4)"	"unprognostic (6.66e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-1)"	1.5	0.2	0.6	3.4	4.5	2.4	1.9	0.4	7.0	2.6	2.0	9.2	0.6	4.3	0.8	1.7	1.4	2.1	2.6	2.9	2.2		2.5	2.3	1.2	4.5	4.2	3.1	0.2	1.8	0.0	0.0	1.9	4.3	1.3	1.6	0.1	1.3	1.0	0.7	3.1	2.8	0.7	2.6	2.3	4.1	0.5	3.6	0.0	1.0	1.9	5.7	1.6	1.2	5.3	0.9	0.0	3.0	0.0	1.1	0.8	0.2	0.6	0.0	1.1	0.3	0.7	16.3	1.3	1.0	0.2	0.0	3.9	0.7	8.7	2.6	0.0	2.1	3.1	1.0	1.2	0.2	0.2	0.8	0.0	0.5	2.1	0.2	6.7	6.4	0.1	1.7	0.9	0.8	0.0	0.9	0.0	1.0	0.3	0.1	2.2	0.0	4.0	0.6	10.8	5.3	12.7	0.4	8.9	0.4	5.5	0.7	0.0	10.9	9.6	0.1	0.6	2.9	9.0	0.3	0.0	2.5	0.0	0.2	6.0	6.1	5.7	6.9	3.8	1.5	0.0	0.6	0.0	0.0	3.0	0.3	2.9	0.5	0.2	0.7	5.3	0.1	0.5	0.0	0.0	0.6	0.9	1.1	0.8											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
FP565260.6		ENSG00000280071			21	5079294-5128425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 47.1"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 3.4;Collecting duct cells: 3.5;Hofbauer cells: 7.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA018517	Uncertain		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (4.87e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.67e-4)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.25e-1)"	"unprognostic (2.84e-2)"	3.9	6.7	2.8	2.0	6.6	1.3	3.4	8.2	7.0	3.0	5.7	5.2	2.5	5.7	2.2	5.0	3.9	3.3	2.8	15.5	3.2		12.9	14.4	4.8	10.5	6.7	4.7	5.6	2.7	4.0	0.9	6.4	4.2	3.0	4.7	4.4	4.9	2.3	17.1	1.3	3.6	2.4	3.0	2.6	2.2	1.4	3.9	1.1	4.2	11.1	2.4	3.9	2.0	47.1	43.8	19.9	46.4	37.1	41.4	46.1	13.2	12.5	13.9	24.4	13.3	12.7	6.8	0.0	2.6	0.8	1.2	2.0	13.6	1.2	15.4	16.3	13.8	9.5	20.0	10.4	1.2	9.1	8.9	51.5	13.3	12.7	12.1	22.1	9.8	20.3	17.6	8.0	14.7	11.9	16.1	17.5	20.2	15.3	9.6	27.8	22.0	24.2	27.2	37.2	20.4	45.2	10.5	48.2	18.2	12.3	14.1	23.7	18.4	34.7	12.9	7.5	35.7	31.1	5.7	8.0	9.9	0.8	8.0	20.7	21.1	8.7	16.4	45.8	6.7	19.9	33.6	16.9	31.6	36.0	31.6	43.9	41.4	32.9	43.8	47.1	39.7	30.2	6.8	37.1	46.4	28.9	40.0	46.1											0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	3.5	0.0	2.8	0.0	1.4	0.0	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
FPGT-TNNI3K		ENSG00000259030	"FPGT-TNNI3K readthrough"		1	74198235-74543982	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"heart muscle: 28.0"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 7.9;Cone photoreceptor cells: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 5.0;CAPAN-2: 4.6;SiHa: 6.5"									HPA072331			Approved	Vesicles		NA	NA			Vesicles		"HPA072331: "	"unprognostic (6.29e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.87e-3)"	8.5	5.5	5.4	3.1	6.3	2.7	6.1	16.1	8.2	6.4	6.3	6.6	3.4	2.5	9.3	4.2	6.0	5.7	4.2	28.0	5.4	4.9	6.3	3.7	6.1	3.5	8.0	5.2	5.6	3.1	4.7	15.0	3.8	7.4	5.5	3.7	5.2	5.4	6.0	11.2	8.0	5.1	6.3	8.5	5.9	4.9	4.1	7.1	2.9	5.1	3.0	3.5	5.5	4.9	2.4	2.4	4.9	4.7	0.8	4.9	3.5	0.0	1.1	0.7	1.5	0.8	5.0	0.1	2.1	1.0	0.2	0.4	1.1	4.6	0.1	3.3	0.2	0.0	0.0	0.3	3.1	0.4	0.1	0.2	1.7	0.1	0.1	0.8	0.4	0.3	2.1	2.1	0.2	0.2	0.6	0.2	0.2	0.0	1.7	1.0	0.0	0.1	0.2	0.1	1.7	0.9	2.3	3.9	0.0	0.4	0.0	1.1	3.4	6.5	0.3	0.3	0.0	0.0	2.3	0.1	0.7	0.2	0.2	0.8	0.2	0.1	1.7	1.0	1.0	1.1	3.6	4.1	3.5	1.1	4.7	3.5	2.1	3.9	2.2	2.4	2.4	4.9	2.5	4.9	0.8	1.2	2.1	3.8	3.5	5.4	6.3	16.1	8.2	5.4	4.9	8.0	5.2	7.4	7.1	3.0	0.6	0.0	0.4	0.1	4.9	7.9	2.5	1.4	1.2	0.0	9.8	0.1	0.0	0.1	0.9	0.5	0.0	0.0	0.9	0.1	0.5	0.3	2.3	0.4	0.2	4.8	2.9	2.5	1.9	0.2	2.6	0.1	1.7	0.0	0.0	1.2	0.9	1.4	0.7	0.5	2.7	0.0	0.5	1.8	1.4	0.1	0.0	0.0	0.2	0.2
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.3;lymphoid tissue: 64.4"	"Cell type enhanced"	"Detected in many"	21	"Hofbauer cells: 97.2;Kupffer cells: 262.0;Macrophages: 111.7"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 213.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 213.3"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 35.0"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	22.6	3.7	5.2	52.2	12.4	54.5	2.9	1.1	6.3	2.6	2.4	5.9	0.0	1.1	2.3	2.3	3.3	8.4	9.6	11.2	15.7	4.3	6.0	7.5	28.8	58.4	15.5	0.8	1.9	3.5	0.8	2.3	13.0	9.7	1.8	1.2	2.4	2.4	0.9	3.2	1.1	2.2	12.8	14.3	64.4	3.2	2.9	10.1	0.9	2.7	0.7	3.2	7.9	4.6	0.0	8.9	213.3	36.3	0.0	0.0	16.9	0.3	0.5	0.2	0.3	0.4	1.1	0.3	0.2	0.0	0.3	1.0	0.2	0.3	0.6	0.3	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	2.8	0.2	0.4	2.4	0.1	0.9	0.8	4.2	0.0	0.2	0.1	0.4	7.1	0.5	0.1	0.2	0.2	0.2	0.4	0.2	0.4	0.0	0.6	0.3	0.1	0.2	0.4	0.1	0.3	0.1	0.6	0.6	0.5	1.2	0.3	0.0	1.7	0.1	0.0	0.3	35.0	0.9	0.1	13.0	36.3	10.0	0.0	15.9	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	213.3	0.0	9.5	0.3	0.0	16.9	5.2	12.4	1.1	6.3	15.7	4.3	15.5	0.8	9.7	10.1	14.9	40.8	6.2	0.2	0.6	0.4	0.2	0.0	16.0	28.4	0.0	0.0	0.9	0.0	0.0	1.2	0.4	0.0	0.0	0.0	1.2	0.9	0.2	24.4	1.7	97.2	0.0	0.0	4.3	262.0	1.3	0.3	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	6.5	1.0	0.5	0.6	0.0	2.5	0.0	0.0	0.0
FRAT1		ENSG00000165879	"FRAT1, WNT signaling pathway regulator"	Q92837	10	97319267-97321915	"Predicted intracellular proteins"	"Wnt signaling pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 24.7;Early spermatids: 30.0;Late spermatids: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 9.0;neutrophil: 11.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.2"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB046472, HPA055258"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB046472: AB_1849131, HPA055258: AB_2682763"	"unprognostic (1.48e-2)"	"prognostic favorable (5.92e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (6.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (5.27e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.43e-2)"	5.2	3.7	3.0	8.0	4.0	14.9	3.9	5.8	5.8	3.9	6.9	3.4	5.0	7.4	3.6	2.0	3.8	4.0	6.8	3.5	3.3	4.5	2.9	12.6	6.6	18.7	4.4	3.1	3.4	6.7	4.1	2.8	6.5	4.9	4.9	3.3	2.8	6.1	5.9	5.7	4.9	9.9	2.6	2.7	16.2	8.2	21.6	3.3	9.7	2.7	3.3	4.3	3.5	4.7	0.6	1.1	11.2	2.2	0.2	0.8	0.5	0.9	1.5	1.7	8.1	2.3	1.1	1.8	0.9	3.5	0.7	0.7	0.2	1.0	5.2	1.8	0.6	1.2	2.4	1.3	1.7	0.1	4.6	2.5	4.5	0.8	2.1	0.8	1.7	4.9	1.0	2.5	0.3	1.1	3.3	1.4	7.4	1.9	3.8	0.5	4.9	4.6	9.2	2.3	5.6	6.6	3.8	0.4	3.4	0.6	1.1	0.9	2.7	1.2	2.5	1.7	1.8	9.4	6.4	1.3	0.4	0.5	1.3	0.4	3.5	2.0	1.8	0.6	8.3	0.0	1.0	2.2	9.0	0.6	1.4	0.4	0.5	0.5	0.8	1.1	0.6	0.8	0.6	11.2	0.2	1.6	0.7	0.3	0.5	3.0	4.0	5.8	5.8	3.3	4.5	4.4	3.1	4.9	3.3	3.0	4.3	6.7	0.8	1.0	24.7	3.1	7.6	4.0	0.0	1.8	0.0	0.4	0.0	1.2	30.0	3.6	2.8	0.0	1.6	1.2	0.7	2.6	0.0	14.3	3.4	3.2	4.1	2.5	15.1	51.1	1.1	5.9	3.3	0.0	4.5	4.4	1.2	2.9	1.8	0.8	8.4	0.0	0.8	1.2	0.6	1.4	1.9	4.9	2.2	1.8
FRAT2		ENSG00000181274	"FRAT2, WNT signaling pathway regulator"	O75474	10	97332497-97334709	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 46.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 29.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 29.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.0	3.8	5.7	8.7	7.5	23.8	9.7	8.6	9.4	5.7	18.8	4.8	10.2	21.9	6.0	5.9	13.2	6.4	7.2	7.7	6.1	4.9	5.8	15.6	12.0	22.4	5.6	2.0	3.0	16.5	4.8	3.2	9.6	7.7	8.8	14.0	5.4	22.4	4.9	8.7	17.8	20.3	3.7	5.9	28.0	11.5	14.9	7.3	9.0	8.1	8.3	11.1	7.9	13.2	1.2	1.9	29.3	3.7	0.6	1.1	1.1	5.3	2.1	3.5	15.7	2.5	2.1	13.0	1.2	4.4	1.9	1.9	3.3	6.2	6.5	4.3	1.2	1.1	10.1	9.1	4.7	1.5	9.7	14.0	8.7	4.5	7.2	1.5	13.9	10.5	1.6	10.1	1.8	5.8	4.0	4.6	5.8	7.5	2.1	0.9	8.7	6.0	17.6	21.7	17.7	8.8	6.2	1.4	9.2	4.5	4.8	6.3	5.2	1.5	9.6	6.0	14.9	14.5	22.0	2.1	1.1	1.4	0.8	3.1	5.8	5.9	3.2	1.3	24.1	0.4	3.3	3.7	7.1	0.6	2.3	0.3	0.5	0.7	0.9	1.9	1.2	1.1	0.7	29.3	0.6	3.5	0.4	0.3	1.1	5.7	7.5	8.6	9.4	6.1	4.9	5.6	2.0	7.7	7.3	0.0	4.6	7.7	21.9	28.2	16.8	5.6	7.6	4.0	2.3	14.0	3.9	4.1	10.0	2.1	31.9	4.7	16.0	0.0	4.5	15.6	4.8	26.8	1.1	8.2	7.7	11.1	13.3	3.1	18.0	31.4	2.0	6.4	10.1	1.0	28.5	4.3	4.1	17.3	2.5	2.2	16.9	0.0	7.6	1.2	3.9	46.0	6.5	5.7	27.3	25.6
FREM2	DKFZp686J0811	ENSG00000150893	"FRAS1 related extracellular matrix protein 2"	Q5SZK8	13	38687129-38887131	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 13.9;lung: 11.2;thyroid gland: 12.2"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 2: 19.8;Cholangiocytes: 7.6;Proximal tubular cells: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.2;HAP1: 8.2;MCF7: 5.9;RT4: 5.5;SK-BR-3: 5.0;SuSa: 24.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA028831	Uncertain		Approved	Cytosol		NA	NA		170000	Cytosol		"HPA028831: AB_10603668"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (7.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.14e-1)"	0.6	0.4	1.3	0.1	1.7	0.1	0.5	1.5	6.4	0.7	1.3	1.2	1.1	0.4	1.1	0.5	0.2	0.9	1.5	0.2	2.8	0.4	13.9	3.4	11.2	0.1	0.4	0.8	1.8	5.2	0.1	1.1	2.6	0.8	3.5	0.4	2.9	0.4	1.5	6.3	0.6	0.7	0.7	0.4	0.3	2.2	1.8	1.5	0.1	12.2	4.1	0.1	1.5	0.3	0.3	0.3	0.9	0.2	0.2	0.2	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	8.2	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	1.8	0.0	0.1	0.0	1.1	0.1	1.8	5.5	0.1	0.1	0.0	5.0	0.2	24.6	0.9	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.6	0.9	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.2	0.7	0.2	0.2	0.3	0.1	0.0	1.3	1.7	1.5	6.4	2.8	0.4	0.4	0.8	0.8	1.5	0.0	19.8	0.0	0.1	0.6	0.1	2.0	7.6	5.3	2.3	1.8	0.0	5.1	5.0	1.7	0.6	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.3	0.0	0.0	22.4	0.2	0.0	0.0	0.1	0.4	0.1	1.6	0.0	0.0	0.0
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 73.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 19.0;RT4: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	1.5	2.2	0.8	3.0	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9.0	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2.0	41.4	2.5	2.4	1.0	5.5	1.8	0.5	1.2	1.0	5.2	7.4	5.0	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	2.5	4.2	0.7	1.0	0.3	0.3	0.8	0.6	0.2	0.0	0.1	3.3	4.1	1.1	3.9	0.6	0.6	6.1	0.3	1.2	0.1	3.5	0.4	1.4	3.6	2.8	0.2	1.0	0.9	0.3	1.7	0.4	0.4	0.5	0.2	0.7	0.7	2.6	1.0	1.4	0.8	0.6	1.1	19.0	0.7	1.2	3.7	1.3	5.2	8.0	0.9	1.0	0.9	5.4	0.5	1.1	1.6	0.8	1.0	1.2	1.2	0.9	0.6	4.0	2.8	1.8	1.2	0.7	0.8	3.2	1.0	1.0	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1.0	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5	0.0	10.1	0.0	15.3	2.4	0.7	8.4	12.7	22.7	15.9	22.7	0.0	4.3	10.0	16.5	73.1	0.3	35.5	0.0	14.3	3.8	3.5	20.3	3.5	19.2	0.8	6.4	19.0	1.8	0.6	17.7	0.6	0.5	0.0	1.8	13.0	0.3	19.1	20.1	1.1	22.5	0.0	12.9	7.5	1.4	0.7	2.8	0.7	0.5	16.1	34.6
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 10.8;lymphoid tissue: 29.4"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 26.3;Paneth cells: 59.6;Proximal tubular cells: 14.4"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 4.7;RPMI-8226: 7.5"					"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"			6.4	0.1	0.0	6.0	0.2	0.0	10.8	0.2	0.1	0.2	9.8	0.0	0.0	2.3	0.2	0.2	0.3	0.2	0.5	0.1	0.0	0.0	5.6	0.2	0.1	0.0	1.5	0.2	0.2	0.2	0.0	0.1	0.3	0.6	0.1	6.8	1.1	1.7	0.0	2.6	0.2	4.5	0.1	1.0	2.9	7.5	8.1	0.0	29.4	0.1	1.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	12.7	0.0	26.3	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.5	0.0	0.0	10.1	0.6	0.0	0.0	0.0	14.0	0.0	0.0	59.6	1.4	14.4	0.0	0.0	0.0	13.7	4.3	0.0	0.1	0.0	13.7	0.1
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 48.5;skeletal muscle: 42.1"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 102.0;Cardiomyocytes: 66.5;Cone photoreceptor cells: 74.6;Early spermatids: 112.3;Horizontal cells: 95.3;Late spermatids: 100.0;Sertoli cells: 71.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.8;monocytes: 4.7"	"Cell line enhanced"	"Detected in some"		"HEL: 11.2;OE19: 23.5;RPMI-8226: 37.7;SCLC-21H: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.68e-3)"	12.7	4.6	3.5	2.8	2.3	3.0	16.8	2.0	3.0	4.6	7.1	1.7	14.3	1.9	5.5	9.8	4.1	1.9	2.9	48.5	3.2	4.5	11.7	0.7	2.9	0.9	3.6	1.7	1.4	1.4	8.9	6.1	8.7	2.9	5.1	4.1	5.3	2.1	35.3	42.1	1.6	10.9	3.5	2.8	4.3	2.2	6.1	0.8	0.0	8.8	11.1	0.7	3.8	5.0	0.6	0.6	3.8	4.7	0.4	0.6	9.2	0.0	2.1	1.8	0.1	0.3	0.1	0.1	2.0	0.1	0.0	0.0	0.2	2.5	0.4	2.3	0.9	0.4	0.1	0.1	0.0	0.0	0.1	0.1	11.2	2.4	1.3	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.2	23.5	3.5	0.0	1.5	37.7	3.1	4.9	13.9	6.7	0.7	0.1	0.4	0.3	0.8	0.4	2.1	0.1	0.3	0.0	1.4	0.2	0.1	0.0	0.5	3.6	1.4	0.0	2.8	0.0	0.4	4.7	0.6	0.5	0.2	0.1	0.4	0.6	0.1	0.0	3.8	0.4	2.1	0.6	0.0	9.2	3.5	2.3	2.0	3.0	3.2	4.5	3.6	1.7	2.9	0.8	20.8	0.6	0.0	1.0	0.9	102.0	66.5	10.2	0.0	2.3	1.8	74.6	0.3	14.9	2.5	112.3	13.1	26.2	0.0	1.7	0.9	2.1	1.0	0.0	0.2	0.8	95.3	1.2	3.1	4.6	100.0	2.0	1.5	0.0	0.0	19.4	2.0	2.0	7.0	4.6	8.7	4.7	71.1	28.9	1.6	1.4	1.1	0.1	0.0	1.6	1.3
FRMD4A	"bA295P9.4, FLJ10210, FRMD4, KIAA1294"	ENSG00000151474	"FERM domain containing 4A"	Q9P2Q2	10	13643706-14462142	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 28.2;TIME: 34.4;WM-115: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038449	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038449: AB_10669539"	"unprognostic (6.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.51e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.84e-1)"	20.5	2.9	8.2	4.6	13.6	2.6	5.6	4.2	22.4	5.3	3.6	2.0	5.9	2.5	4.3	3.4	4.6	4.4	4.9	5.8	10.3	9.5	5.6	6.0	6.1	5.0	7.3	10.3	3.8	8.5	1.1	9.3	12.3	4.3	5.4	2.9	7.8	7.5	9.6	3.8	18.5	3.4	3.3	5.0	17.1	3.3	7.6	1.5	2.6	3.7	2.0	4.5	4.1	3.6	1.9	2.1	2.0	0.9	1.4	2.0	0.2	1.9	1.2	21.3	0.1	1.9	5.4	5.3	5.5	11.4	8.0	13.1	3.7	0.6	0.0	6.3	5.5	6.0	4.1	0.1	1.0	6.9	0.1	3.1	0.4	0.2	0.0	2.6	0.1	0.3	3.7	1.0	28.2	4.0	22.9	22.6	0.9	4.0	0.1	15.7	2.6	1.3	0.2	3.7	0.1	0.8	0.1	4.7	0.0	5.3	1.7	0.7	3.7	0.0	10.3	17.1	3.6	5.8	0.7	34.4	13.0	3.0	8.4	8.1	0.1	0.0	0.0	10.1	0.3	48.8	0.4	0.5	0.5	0.4	0.9	0.7	1.9	1.8	0.6	0.4	0.8	0.8	0.5	2.0	1.4	0.6	2.1	2.0	0.2	8.2	13.6	4.2	22.4	10.3	9.5	7.3	10.3	4.3	1.5	29.8	1.6	0.0	11.4	31.1	60.0	9.7	25.5	4.0	5.7	31.4	17.7	56.1	10.0	10.6	32.6	27.0	0.2	23.3	3.4	30.6	9.3	7.0	15.0	4.7	31.7	76.3	4.6	46.1	57.5	64.5	2.0	21.7	15.1	4.6	2.5	54.5	2.4	0.0	1.8	1.9	9.9	12.9	25.9	1.0	0.7	28.5	24.0	1.5	5.3	3.6
FRMD6	"C14orf31, EX1, MGC17921, willin"	ENSG00000139926	"FERM domain containing 6"	Q96NE9	14	51489100-51730727	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 119.7;Early spermatids: 184.0;Late spermatids: 333.9;Suprabasal keratinocytes: 120.2;Urothelial cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.3;naive CD4 T-cell: 2.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.3;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"BJ: 58.1;fHDF/TERT166: 121.7;U-138 MG: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001297	Uncertain	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA001297: AB_1078913"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.05e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.28e-4)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.20e-2)"	7.8	6.4	2.7	7.6	5.3	0.2	12.9	14.3	4.6	44.6	9.8	4.8	14.1	2.2	52.3	11.6	32.8	8.8	16.0	9.0	4.3	2.1	2.7	4.7	5.4	4.1	3.8	2.8	12.0	2.8	1.0	2.7	10.7	4.4	21.5	5.0	13.2	10.7	23.0	3.8	20.4	4.8	27.5	3.6	8.3	5.4	14.0	2.1	5.2	4.8	20.9	23.3	20.3	18.5	0.1	0.0	3.3	0.6	0.3	2.5	0.7	12.2	2.1	3.5	6.7	7.3	11.2	1.4	58.1	30.2	32.4	29.2	7.6	2.8	0.2	1.8	121.7	10.1	12.7	1.0	18.6	39.0	0.1	1.3	0.1	1.1	0.3	9.3	0.0	0.6	9.6	7.5	26.9	33.4	14.2	9.8	0.6	0.1	3.9	33.7	1.8	1.0	0.0	0.8	0.0	4.2	0.1	13.6	0.1	6.0	18.4	0.6	7.8	4.1	0.8	5.7	7.3	0.5	0.1	36.4	49.8	19.0	12.5	12.4	3.0	2.4	0.0	3.2	0.0	19.7	3.3	0.3	0.0	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	2.5	1.9	0.2	0.3	0.6	0.0	0.0	0.7	2.7	5.3	14.3	4.6	4.3	2.1	3.8	2.8	4.4	2.1	3.0	1.0	0.0	119.7	99.0	0.4	2.2	10.2	0.0	5.7	0.0	0.0	32.7	0.0	13.0	184.0	10.3	0.0	0.0	2.5	3.7	47.2	36.8	1.1	3.4	3.3	0.0	0.0	9.8	0.3	333.9	16.4	3.3	30.4	1.0	0.0	10.1	37.9	0.0	20.8	0.3	0.2	6.5	24.7	4.4	6.4	120.2	32.6	0.0	0.0	134.9
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076993-132128020	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5"	"Cell type enriched"	"Detected in single"	30	"Distal tubular cells: 8.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5"	"Region enriched"	"Detected in single"	29	"olfactory region: 80.8"	"Region enriched"	"Detected in single"	103	"olfactory region: 45.5"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0			0.0	7.4	1.1	0.0	1.1	0.0	0.1	0.0	0.1	6.6	1.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.5	0.0		0.0	1.1	0.0	0.5	0.0	5.5	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRS2	"FRS2A, FRS2alpha, SNT-1, SNT1"	ENSG00000166225	"Fibroblast growth factor receptor substrate 2"	Q8WU20	12	69470349-69579789	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038323			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA038323: "	"unprognostic (9.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.50e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.70e-3)"	"unprognostic (3.80e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.66e-2)"	13.4	11.9	18.4	6.9	21.9	23.1	16.3	23.4	19.5	16.3	10.3	20.7	10.0	7.8	16.4	15.8	10.5	13.0	15.6	10.2	19.3	12.0	10.3	14.3	10.2	7.2	18.3	16.8	20.2	8.7	18.4	16.0	14.2	15.4	10.9	10.0	10.7	10.4	9.9	11.0	10.0	9.6	14.7	21.2	8.1	9.4	10.0	22.7	6.9	16.4	7.0	8.7	11.2	10.2	8.8	4.1	6.8	10.3	3.6	7.4	2.9	10.4	8.2	13.9	6.7	8.6	10.6	27.8	11.2	13.1	10.8	9.3	16.4	4.3	5.0	7.7	15.0	5.1	8.8	7.1	11.8	12.4	7.2	7.4	7.5	7.0	6.2	9.0	7.3	5.9	10.0	14.9	12.1	10.5	13.4	4.8	4.7	5.4	9.4	9.7	12.6	5.6	3.7	17.1	5.5	7.8	4.7	12.0	4.0	8.1	21.9	7.7	14.5	19.3	7.7	10.9	17.5	21.8	4.3	8.2	8.5	8.6	11.4	8.5	8.3	13.2	3.9	7.0	3.8	7.7	1.2	5.6	3.0	4.1	5.6	4.4	4.2	4.3	3.3	4.1	8.8	7.4	4.7	6.8	3.6	10.3	3.9	2.2	2.9	18.4	21.9	23.4	19.5	19.3	12.0	18.3	16.8	15.4	22.7	6.0	10.1	3.0	8.4	18.0	11.2	19.7	2.5	10.7	19.4	10.4	15.7	6.2	3.3	7.3	4.3	9.5	5.6	0.0	6.2	9.0	17.0	10.2	13.8	13.9	6.0	6.4	9.8	6.7	14.0	6.7	17.5	6.5	6.8	10.8	11.5	18.6	9.9	3.5	12.4	5.5	9.5	6.5	12.3	9.8	11.9	11.0	5.3	2.5	8.1	10.1
FRYL	"AF4p12, DKFZp686E205, KIAA0826, MOR2"	ENSG00000075539	"FRY like transcription coactivator"	O94915	4	48497361-48780322	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Mucus-secreting cells: 166.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 12.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031106, HPA031107"	Supported		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA031106: AB_10600660, HPA031107: AB_10600536"	"unprognostic (7.50e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.22e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	9.6	7.5	13.4	13.1	27.4	12.4	8.3	10.1	20.2	7.3	30.5	23.4	7.1	8.6	8.5	3.7	6.3	6.5	7.1	7.7	13.8	8.6	7.6	4.8	9.0	10.6	30.2	7.9	7.1	5.8	28.4	12.5	9.0	17.6	5.9	30.8	5.5	6.1	6.2	9.1	8.8	13.4	8.1	25.8	8.8	9.1	5.2	30.1	11.8	6.9	3.9	10.9	8.8	6.0	2.1	2.2	12.6	2.0	3.3	2.8	0.9	10.3	6.3	14.9	9.5	6.2	8.8	8.1	9.4	9.7	10.1	12.0	4.9	8.3	13.0	8.0	10.2	18.4	6.6	9.7	16.1	21.4	7.4	3.3	24.3	6.4	2.3	4.2	16.7	9.7	6.7	6.2	13.8	14.4	9.2	14.5	11.9	7.5	5.2	12.6	5.3	17.0	5.9	2.5	4.7	5.8	13.6	18.9	2.6	9.2	11.3	13.2	5.9	9.8	2.6	5.3	7.6	3.9	10.9	21.6	10.9	14.6	5.8	19.0	7.1	9.2	11.8	9.1	11.1	10.8	12.6	1.2	2.3	2.8	2.0	2.2	2.1	2.5	2.2	1.1	1.8	2.8	2.7	3.7	3.3	1.2	2.2	1.8	0.9	13.4	27.4	10.1	20.2	13.8	8.6	30.2	7.9	17.6	30.1	35.7	34.5	32.0	20.8	42.0	41.5	31.3	17.8	5.3	21.6	15.7	127.6	19.2	3.3	11.5	8.8	48.5	86.6	23.3	10.2	16.6	20.2	32.9	45.1	11.1	16.4	44.5	76.3	41.7	29.4	2.6	15.8	27.0	25.3	21.6	166.5	39.2	21.6	80.1	17.3	6.5	111.4	19.4	27.8	9.0	6.9	43.2	9.0	24.5	66.0	48.0
FSD2	"RP11-127F21, SPRYD1"	ENSG00000186628	"Fibronectin type III and SPRY domain containing 2"	A1L4K1	15	82755362-82806070	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 70.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 8.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA046263			Approved	Cytosol		NA	NA			Cytosol		"HPA046263: AB_2679604"	"unprognostic (2.80e-1)"	"unprognostic (3.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.59e-2)"	1.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.6	0.7	0.1	0.0	20.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.4	1.0	0.0	54.0	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	18.1	1.4	0.0	0.1	1.4	0.8	2.3	0.9	0.8	2.2	0.5	1.3	1.3	2.0	2.4	0.0	0.0	1.2	1.3	0.0	0.0	0.0	1.1	2.1	4.1	0.9	0.0	1.1	5.0	0.0	0.0	0.4	0.7	5.4	2.3	5.7	1.8	0.0	1.4	0.9	0.1	0.2	0.0	0.6	1.4	0.0	1.7	2.0	3.7	0.0	1.2	0.7	2.4	1.9	0.8	1.1	1.3	1.5	1.0	0.2	2.3	1.9	1.7	1.0	1.0	1.5	1.0	1.7	1.8	0.8	3.0	1.6	1.1	1.8	8.5	3.6	1.4	1.8	4.9	0.7	2.3	0.8	0.8	1.0	0.7	0.8	1.4	1.1	0.9	0.8	1.1	2.2	1.1	1.1	0.8	0.9	0.8	1.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.0	1.0	0.3	2.6	70.6	2.5	0.0	1.2	0.0	5.9	0.0	0.0	0.0	1.6	0.6	0.0	0.0	0.3	0.1	0.2	0.3	1.1	0.0	0.2	11.1	1.2	0.0	0.8	1.8	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	3.6	0.0	0.3	0.7	0.2	0.5	0.2	0.0	0.0	0.3
FSIP2	FLJ34780	ENSG00000188738	"Fibrous sheath interacting protein 2"	Q5CZC0	2	185738895-185833290	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 27.6"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 128.1;Alveolar cells type 2: 68.3;Ciliated cells: 83.0;Early spermatids: 179.5;Spermatocytes: 69.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.7;HeLa: 2.2;Karpas-707: 2.8;OE19: 2.0;RT4: 4.7;SuSa: 2.1;U-266/70: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036139			Approved	Microtubules,Mitochondria		NA	NA			Microtubules	Mitochondria	"HPA036139: AB_10602134"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.64e-5)"	0.4	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.3	0.3	2.7	0.1	0.1	0.0	0.6	0.5	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.4	0.6	0.5	0.5	0.3	1.4	0.3	0.2	0.1	0.1	0.3	0.6	0.6	0.1	0.5	3.6	27.6	0.1	0.1	0.4	0.1	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.1	0.0	0.0	0.0	0.7	2.0	0.7	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.5	0.1	128.1	68.3	0.8	0.2	0.5	14.6	3.2	0.0	83.0	56.9	0.0	9.8	0.2	0.0	0.5	179.5	0.6	2.6	0.0	0.2	0.1	0.6	0.3	37.2	0.0	0.3	17.5	7.5	1.8	0.0	20.4	2.0	1.4	1.7	0.0	13.3	5.8	3.2	0.0	3.5	0.0	8.0	0.0	0.5	69.0	2.7	0.3	0.2	0.0	0.6	0.1
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480409-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.7"	"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 85.9;Hepatocytes: 22.9;Urothelial cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.0;naive CD4 T-cell: 2.0;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	5	"monocytes: 1.0;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.4;HaCaT: 50.3;HBEC3-KT: 32.1;HMC-1: 36.1;PC-3: 97.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA016612, CAB026025"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1800000	Vesicles		"CAB026025: , HPA016612: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	12.4	3.2	2.0	3.1	0.8	0.1	7.1	0.2	0.7	3.5	5.2	0.3	1.1	0.9	2.3	9.5	3.6	4.9	4.1	5.6	1.0	1.0	1.7	42.7	4.3	0.8	0.4	0.6	20.7	19.4	0.0	2.9	13.5	1.0	9.3	1.7	5.7	5.5	6.5	12.6	9.0	4.3	3.7	0.4	0.2	4.8	4.9	0.5	1.2	2.0	6.7	7.1	6.2	13.8	0.1	0.2	0.0	1.0	0.0	2.0	0.1	3.3	0.3	5.9	0.0	6.7	2.3	9.8	13.0	59.4	8.0	7.8	0.0	0.0	0.0	0.1	3.4	0.4	50.3	0.0	32.1	5.7	0.1	0.0	0.6	0.2	5.3	3.6	0.0	36.1	5.5	0.0	14.7	9.6	5.5	6.8	0.0	0.0	0.1	5.0	0.0	0.0	0.2	9.0	0.0	97.2	0.6	7.5	0.0	0.0	5.5	0.0	0.0	0.5	0.0	0.3	15.8	0.0	0.0	0.0	22.0	6.3	2.2	1.9	0.0	0.0	0.0	2.5	0.7	20.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.1	2.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.8	0.2	0.7	1.0	1.0	0.4	0.6	1.0	0.5	0.0	1.4	0.0	12.8	17.7	0.0	7.3	0.0	0.0	12.5	0.0	0.0	0.6	0.0	0.6	0.3	1.6	0.0	0.0	3.8	7.6	85.9	5.3	0.0	22.9	1.6	0.0	0.0	1.3	0.3	0.9	2.8	0.4	5.0	0.0	0.0	0.0	10.0	0.0	10.6	0.0	0.0	12.9	12.5	0.3	0.7	4.1	5.0	0.0	0.0	26.0
FSTL1	"FRP, FSL1, OCC-1, OCC1, tsc36"	ENSG00000163430	"Follistatin like 1"	Q12841	3	120392293-120451253	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 309.5;Fibroblasts: 318.9;Leydig cells: 303.2;Peritubular cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 10.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 129.7;BJ: 150.5;fHDF/TERT166: 185.7;HBF TERT88: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035251, HPA040815"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		32000000	"Vesicles, Cytosol"		"HPA035251: AB_10601906, HPA040815: AB_2732489"	"unprognostic (2.60e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.84e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.47e-3)"	72.3	28.6	4.8	23.1	5.8	0.0	104.0	2.5	6.7	52.1	39.1	7.3	28.7	5.8	41.6	58.1	39.2	42.6	45.6	69.4	5.9	3.2	15.1	5.5	33.6	44.4	4.3	4.3	26.9	8.7	5.5	7.9	110.0	13.2	36.3	15.4	26.2	17.5	32.5	23.6	18.4	18.6	90.2	9.4	16.7	22.1	19.8	4.9	4.7	23.8	29.1	11.1	67.1	65.8	0.1	1.2	10.2	0.1	0.0	0.0	3.6	5.4	1.4	15.7	6.5	94.2	129.7	0.0	150.5	84.5	97.5	86.5	0.0	12.5	0.0	12.8	185.7	7.9	1.4	4.8	18.7	124.2	0.0	2.2	0.0	11.9	0.0	20.7	0.0	0.0	98.5	0.6	62.9	13.7	43.5	56.4	0.7	0.0	0.0	15.8	0.0	1.5	0.1	12.9	0.0	12.6	0.0	6.5	0.0	10.4	0.1	2.8	6.6	53.4	0.9	5.4	34.2	1.6	0.4	68.9	36.7	35.2	19.1	22.3	0.0	0.0	0.1	12.8	0.0	4.7	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	3.6	4.8	5.8	2.5	6.7	5.9	3.2	4.3	4.3	13.2	4.9	59.6	13.1	0.0	32.3	56.9	1.8	102.1	7.6	37.5	35.2	22.7	0.0	90.3	0.0	52.7	1.9	103.4	0.0	0.0	5.1	309.5	318.9	79.3	1.1	12.2	18.0	1.6	2.9	169.4	14.3	3.6	303.2	5.6	104.6	17.2	0.0	128.4	76.1	0.0	254.5	2.4	2.8	58.2	135.9	0.9	1.3	42.0	45.8	0.5	0.6	31.6
FSTL4	KIAA1061	ENSG00000053108	"Follistatin like 4"	Q6MZW2	5	133196455-133612564	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.5"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 13.7;Early spermatids: 31.1;Late spermatids: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 33.1;U-266/70: 11.9;U-266/84: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045920	Uncertain		Approved	"Nuclear membrane,Mitochondria"	"Secreted to blood"	NA	NA			Mitochondria	"Nuclear membrane"	"HPA045920: AB_10965844"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.02e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.25e-2)"	0.7	2.2	8.4	1.0	14.6	3.0	1.1	18.5	18.0	1.0	1.6	1.7	0.0	1.1	0.5	2.8	3.1	1.6	0.7	0.6	1.5	3.2	4.8	0.5	2.0	0.4	1.9	10.1	0.8	2.9	7.1	4.0	6.4	2.6	2.9	1.9	1.4	1.4	0.1	1.5	5.3	1.2	0.3	1.0	0.5	2.3	2.8	4.7	0.0	1.3	0.0	1.7	10.2	1.6	2.8	1.2	3.4	1.1	0.8	2.3	1.2	4.4	7.6	0.8	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	6.8	0.9	0.3	6.2	0.0	0.8	0.1	0.9	0.2	0.0	0.4	0.3	0.3	7.4	0.6	0.0	0.0	0.4	0.1	1.1	0.0	0.0	0.2	0.0	0.3	3.4	4.0	0.0	7.2	0.8	0.3	8.2	7.8	0.8	0.3	0.7	7.7	0.0	8.4	33.1	0.7	1.7	1.4	0.1	7.8	2.8	0.3	0.2	0.3	1.4	0.4	0.2	11.9	11.8	0.3	0.1	0.0	0.2	3.4	1.1	0.6	1.2	0.4	2.3	2.8	1.7	1.2	0.6	2.6	2.1	1.3	2.4	0.8	0.7	1.2	1.6	1.2	8.4	14.6	18.5	18.0	1.5	3.2	1.9	10.1	2.6	4.7	0.0	1.9	0.0	1.7	1.4	10.3	7.3	0.0	6.7	7.9	0.0	13.7	0.3	0.0	0.2	31.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	8.6	0.0	0.0	13.9	0.3	0.0	10.1	0.0	0.0	3.3	0.8	0.0	0.7	2.3	2.4	6.5	0.0	0.4	0.6	1.4	0.0	0.0	0.0	2.6
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 126.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 338.0;Late spermatids: 92.6;Proximal tubular cells: 322.0"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.5"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 45.4"									"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		580000	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.2	0.0	0.6	0.2	1.6	0.0	0.2	0.2	0.7	0.2	0.3	0.2	0.2	0.3	0.2	2.0	0.2	0.0	0.2	0.2	0.5	0.4	25.9	126.8	0.2	0.2	0.4	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.1	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	45.4	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	2.5	0.1	0.6	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.2	0.2	0.0	0.0	24.9	0.0	0.1	1.0	1.0	68.8	0.0	0.0	8.7	0.0	0.0	39.7	0.0	75.4	0.6	0.0	0.0	0.0	0.0	0.8	0.5	0.0	338.0	0.1	3.2	0.0	22.7	22.3	92.6	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	322.0	0.4	0.0	0.1	10.7	12.2	0.4	0.0	6.9	0.0	0.0
FTCDNL1	FONG	ENSG00000226124	"Formiminotransferase cyclodeaminase N-terminal like"	E5RQL4	2	199760544-199851173	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA065748			Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA065748: "	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (3.92e-2)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.21e-2)"	4.5	9.4	5.5	1.8	19.0	4.0	4.2	1.6	12.0	1.7	2.3	9.7	2.6	2.1	1.2	3.9	2.9	3.9	2.0	5.3	5.8	4.8	8.0	17.9	2.8	3.5	7.6	7.5	2.4	4.3	1.9	2.0	1.5	7.9	2.8	2.5	2.7	4.8	1.7	13.1	2.4	1.8	3.4	9.1	8.0	2.1	2.8	4.0	0.1	11.0	2.4	1.8	1.6	1.9	3.8	10.6	2.0	6.2	1.2	2.4	1.9	0.7	2.4	0.1	0.1	2.5	1.5	1.8	0.9	0.9	1.2	0.5	0.0	4.3	2.4	0.3	1.0	7.2	0.0	1.1	6.4	1.5	2.9	0.8	1.8	1.0	2.0	0.9	6.4	8.1	1.1	0.2	0.5	0.1	0.9	0.0	6.1	3.4	0.1	0.9	7.4	2.4	2.6	2.0	0.6	5.1	0.4	0.2	0.1	0.5	0.0	2.9	0.0	4.2	3.9	4.0	1.8	6.0	8.5	0.7	3.5	0.0	2.2	1.5	6.5	3.5	1.4	6.5	3.3	1.7	0.0	5.3	2.0	0.6	6.2	2.3	3.8	2.2	0.8	6.9	2.1	1.5	2.4	0.0	1.2	5.6	10.6	0.0	1.9	5.5	19.0	1.6	12.0	5.8	4.8	7.6	7.5	7.9	4.0	0.0	0.0	0.5	2.3	2.4	3.3	4.5	5.1	0.0	2.3	3.5	3.9	1.1	1.7	0.2	1.6	1.1	0.0	0.0	0.6	1.2	1.4	1.8	0.0	5.8	7.0	1.6	0.0	2.5	6.2	0.8	0.3	4.3	6.8	1.0	0.6	0.9	0.5	0.0	0.4	8.7	5.4	0.0	3.6	0.5	0.7	1.9	0.2	0.0	0.9	0.7
FTH1	"FHC, FTH, FTHL6, PIG15, PLIF"	ENSG00000167996	"Ferritin heavy chain 1"	P02794	11	61959718-61967660	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 756.2"	"Cell type enhanced"	"Detected in all"	9	"monocytes: 52379.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 756.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 555.5;HHSteC: 578.8"	"Low region specificity"	"Detected in all"							CAB008623	Approved		Approved	Microtubules		NA	NA		9000000	Microtubules		"CAB008623: "	"unprognostic (7.15e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (2.99e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.83e-2)"	155.1	118.0	177.6	138.9	92.6	162.0	302.9	38.5	163.7	104.2	142.4	97.8	72.0	72.2	81.6	102.4	88.8	70.6	83.5	236.1	124.7	91.2	113.5	128.2	297.3	394.0	118.5	110.6	81.7	150.8	49.7	46.7	70.1	77.5	60.9	138.5	79.5	180.5	65.1	124.1	42.5	110.0	140.0	182.1	84.4	81.0	67.8	88.2	58.5	100.3	64.1	48.9	106.7	94.0	69.5	163.3	756.2	424.5	30.7	69.2	284.2	65.4	183.8	28.0	74.1	555.5	269.1	154.7	60.1	258.0	61.3	61.9	22.2	90.9	7.6	381.6	172.8	234.7	112.1	25.0	49.7	39.8	31.2	12.3	38.1	254.7	145.1	578.8	17.8	59.9	364.4	244.0	122.3	230.1	194.4	76.7	44.1	56.7	87.4	214.0	88.5	20.0	29.2	47.9	229.9	310.8	19.9	34.6	54.5	313.4	178.2	23.8	30.2	206.4	22.7	97.7	96.5	40.4	24.1	85.4	191.7	45.9	84.8	37.7	15.1	52.0	23.4	261.3	8.0	45.6	401.9	297.7	247.4	40.8	367.6	40.2	68.6	58.3	40.4	163.3	69.5	49.3	38.2	756.2	30.7	424.5	121.2	69.2	284.2	177.6	92.6	38.5	163.7	124.7	91.2	118.5	110.6	77.5	88.2	1223.8	3688.2	1741.3	6882.7	4581.6	811.0	10.8	4076.4	2049.0	1899.5	1819.7	540.0	3704.8	9226.3	8116.7	214.1	3238.4	10084.1	4345.2	9486.9	4714.1	4023.6	8092.3	6278.5	3801.3	17699.0	697.6	2425.9	2794.1	10131.9	335.0	4320.5	19898.9	6750.0	52379.0	4287.5	3515.6	10476.1	8248.3	3589.2	14886.0	2120.1	2050.2	6618.7	591.9	960.7	3108.0	3865.9	1625.8	5251.4	8218.4
FTL	"MGC71996, NBIA3"	ENSG00000087086	"Ferritin light chain"	P02792	19	48965301-48966878	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Iron storage"		"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 1149.4"	"Cell type enhanced"	"Detected in all"	10	"Hofbauer cells: 67925.7;Kupffer cells: 48067.7;Proximal tubular cells: 39652.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"granulocytes: 1149.4;monocytes: 890.5"	"Cell line enhanced"	"Detected in all"		"HHSteC: 575.7;HSkMC: 481.6"									"CAB020769, HPA041602"	Enhanced		Approved	Cytosol		NA	NA		240000000	Cytosol		"CAB020769: , HPA041602: AB_2677575"	"unprognostic (2.95e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	326.0	111.3	147.1	113.6	130.9	179.8	321.8	25.8	101.3	105.7	107.5	134.7	58.2	120.5	54.9	85.4	85.0	71.3	214.6	140.8	111.7	88.2	295.2	526.9	391.6	444.6	139.4	49.6	126.8	108.0	27.0	63.6	166.3	89.0	108.0	92.3	114.4	59.4	75.4	75.6	48.3	159.4	149.2	194.5	317.9	105.2	53.9	74.5	45.1	130.0	57.5	67.5	159.8	172.1	147.8	231.2	1149.4	890.5	41.5	86.1	674.1	18.7	285.4	21.4	32.7	370.5	384.5	38.3	48.6	286.4	70.1	158.0	62.5	76.1	14.3	93.6	290.5	153.7	11.2	17.5	28.8	63.3	192.3	11.3	37.8	74.5	408.6	575.7	88.8	127.3	481.6	39.1	119.3	52.5	104.8	101.5	17.2	69.9	29.9	138.3	4.5	24.5	51.9	38.8	330.4	29.2	20.5	14.5	147.1	44.5	11.9	27.4	15.9	127.8	7.0	26.6	121.4	4.1	185.8	75.9	76.8	40.4	98.5	66.5	129.3	285.0	13.3	81.5	93.7	134.3	488.0	642.5	675.8	63.9	890.5	72.6	147.8	71.3	68.3	231.2	132.2	86.1	74.8	1149.4	41.5	768.3	97.2	83.8	674.1	147.1	130.9	25.8	101.3	111.7	88.2	139.4	49.6	89.0	74.5	1045.2	3325.0	4263.9	4805.4	2481.8	468.5	679.4	4145.2	769.6	1043.0	1917.5	166.9	816.1	9070.4	3524.4	247.8	2245.5	2735.4	2149.2	5208.6	1016.5	4146.4	6478.0	2236.8	16333.4	67925.7	503.7	1551.5	4087.4	48067.7	879.3	3866.6	17106.8	4823.4	23991.6	2116.7	1184.6	7872.5	3673.3	1890.2	39652.4	496.5	1319.4	4074.7	56.3	327.7	1946.3	1256.7	2296.9	2288.6	7488.3
FTSJ1	"CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7"	ENSG00000068438	"FtsJ RNA methyltransferase homolog 1"	Q9UET6	X	48476021-48486364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002718	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA002718: AB_1078914"	"unprognostic (2.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.96e-3)"	"unprognostic (2.06e-3)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.24e-10)"	"unprognostic (2.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	17.6	19.4	12.3	18.2	21.6	18.4	17.1	18.7	21.2	23.3	11.7	13.6	20.8	10.7	18.5	12.6	19.0	15.9	12.8	15.0	9.9	10.3	15.9	21.3	16.9	22.9	13.6	9.2	17.4	36.6	13.9	16.2	11.3	14.9	13.3	10.6	12.4	20.8	18.6	17.3	18.0	12.0	16.6	11.0	19.6	17.8	14.6	15.2	17.2	20.0	24.8	18.6	17.3	17.2	17.1	16.8	10.7	16.1	15.9	26.9	15.1	25.8	17.9	6.9	27.3	9.9	10.4	11.3	12.7	12.3	18.7	14.8	10.7	36.4	15.1	9.6	19.4	11.8	17.6	13.7	44.9	8.4	11.5	12.9	9.6	22.7	12.0	28.1	13.2	24.4	9.6	22.8	23.4	23.1	10.4	13.0	17.4	8.1	12.6	24.1	14.7	17.0	9.4	15.5	11.1	30.8	13.9	22.6	31.3	17.5	8.8	9.3	9.2	20.2	11.2	9.3	8.4	12.8	7.6	12.7	14.8	20.1	30.7	15.5	17.1	13.3	10.9	32.7	24.8	15.4	9.2	14.1	10.7	21.9	16.1	26.9	17.1	18.9	22.1	16.8	16.9	17.3	21.9	2.0	15.9	15.1	11.6	17.5	15.1	12.3	21.6	18.7	21.2	9.9	10.3	13.6	9.2	14.9	15.2	6.0	11.2	14.1	9.5	11.3	4.5	5.6	7.6	17.4	14.8	7.0	2.0	4.8	14.9	20.1	37.9	9.9	5.4	0.0	16.0	22.0	10.8	7.7	8.1	4.4	15.8	3.2	5.2	6.2	10.2	56.9	10.0	11.0	5.0	8.2	8.9	5.2	41.1	0.0	8.1	7.3	5.5	12.9	13.5	6.8	10.1	9.5	4.8	10.0	8.1	16.2
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA methyltransferase homolog 3"	Q8IY81	17	63819433-63830012	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA055544: AB_2682843, HPA062628: AB_2684813"	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.1	19.9	14.2	15.8	18.2	12.5	16.4	13.6	15.2	17.5	17.4	22.4	25.0	12.9	22.7	19.4	17.6	17.3	16.8	19.2	14.8	9.2	24.4	24.9	13.9	17.5	18.9	9.5	22.3	14.6	30.6	13.3	15.4	16.2	19.3	17.1	17.4	16.5	18.1	25.1	21.2	16.2	21.5	17.7	19.8	16.5	13.0	17.8	31.1	22.4	19.7	26.0	18.0	16.8	9.8	13.3	6.5	12.8	12.3	15.1	9.0	20.6	32.6	12.6	17.9	20.4	17.6	19.6	20.7	15.2	23.7	18.9	27.1	13.9	27.6	8.5	12.1	12.5	14.3	23.5	19.7	30.6	4.7	23.5	24.8	23.2	25.2	14.9	31.3	18.1	12.4	15.6	36.8	17.8	12.1	19.7	17.0	24.6	11.3	15.8	34.8	27.5	10.2	34.0	23.3	33.3	24.6	34.7	19.4	15.5	18.9	11.7	45.9	24.4	20.8	14.1	26.3	19.8	10.5	17.7	17.7	24.9	19.7	38.2	27.4	38.5	27.5	15.8	20.9	17.1	4.5	10.8	6.5	11.4	12.8	15.1	9.8	12.2	14.9	13.3	9.8	9.8	12.0	2.4	12.3	9.2	10.1	14.2	9.0	14.2	18.2	13.6	15.2	14.8	9.2	18.9	9.5	16.2	17.8	29.8	23.8	10.4	12.4	12.2	6.9	26.9	20.4	29.4	30.7	14.0	9.8	13.8	11.6	21.2	6.1	18.5	13.1	0.0	29.2	13.7	11.6	9.0	24.2	17.1	12.5	3.2	12.2	9.2	15.2	11.9	22.5	14.0	8.5	20.8	11.2	13.8	23.1	13.6	18.0	21.6	8.6	45.3	17.9	10.4	12.8	11.2	13.6	10.0	16.4	9.1
FUBP3	FBP3	ENSG00000107164	"Far upstream element binding protein 3"	Q96I24	9	130578965-130638352	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047658, HPA058392"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		6200	Nucleoplasm	Cytosol	"HPA047658: AB_2680114, HPA058392: AB_2683703"	"unprognostic (1.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (3.12e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.23e-2)"	26.6	24.1	24.3	18.5	24.3	10.5	21.8	23.9	30.3	22.8	24.0	37.7	22.9	19.9	32.7	20.7	24.2	22.1	25.4	24.3	24.6	20.0	22.4	37.6	19.9	18.7	27.4	22.8	25.2	27.7	36.6	23.8	33.8	23.9	26.1	20.4	21.9	26.1	25.3	15.2	22.0	20.5	26.9	30.0	20.2	22.0	30.0	27.5	26.4	39.9	18.1	20.1	23.2	22.9	4.5	5.6	2.1	4.5	7.3	6.9	3.0	20.8	19.2	28.1	23.1	20.3	23.1	35.6	29.9	26.8	24.2	18.8	27.7	19.3	20.2	15.8	28.3	21.4	36.4	23.6	25.4	28.8	22.3	20.2	22.4	30.6	20.3	27.8	33.6	25.3	22.3	20.5	25.4	24.0	20.3	19.7	16.9	35.5	12.6	25.0	28.0	25.9	17.1	36.1	32.9	24.6	23.2	35.0	27.1	21.2	22.1	18.7	30.9	31.8	23.6	19.5	22.1	32.4	25.6	25.0	43.9	20.9	29.5	34.6	11.6	19.1	26.3	24.5	14.6	31.2	0.0	3.7	2.1	4.7	4.5	6.9	4.5	5.1	5.6	5.6	3.3	5.9	5.1	1.0	7.3	3.5	4.9	4.0	3.0	24.3	24.3	23.9	23.7	24.6	20.0	27.4	22.8	23.9	27.5	17.9	19.4	18.0	17.5	29.8	22.5	16.5	25.5	21.4	12.5	15.7	13.7	24.3	24.9	18.3	3.2	20.4	13.2	0.0	16.5	25.4	24.2	24.1	7.0	48.6	22.9	30.2	20.8	30.1	22.9	7.2	19.0	17.2	35.4	16.2	18.9	52.7	20.0	17.3	26.2	29.5	27.4	12.9	30.9	14.3	10.4	35.8	38.3	15.4	15.5	22.6
FUK	FLJ39408	ENSG00000157353	Fucokinase	Q8N0W3	16	70454421-70480274	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041971	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041971: AB_10795648"	"unprognostic (4.55e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.91e-4)"	"unprognostic (2.49e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.89e-2)"	"prognostic favorable (8.38e-4)"	6.7	11.3	11.5	9.8	13.2	8.5	7.3	13.9	13.5	7.5	12.1	15.5	15.1	18.5	8.3	11.5	8.2	10.8	9.4	7.2	9.4	7.4	13.1	11.9	8.1	9.1	12.5	12.4	10.5	12.2	17.1	16.4	11.0	9.8	9.1	7.7	12.9	10.8	9.4	9.0	13.0	13.1	6.3	9.3	9.7	12.2	6.1	12.5	7.2	12.0	4.2	11.1	7.6	6.8	4.3	3.2	3.9	4.4	2.9	6.7	2.5	3.1	4.4	2.6	5.7	1.5	1.8	9.9	1.8	2.9	2.4	3.1	3.9	10.3	2.2	8.8	1.7	0.7	4.5	1.8	4.5	1.5	4.2	6.3	2.9	8.0	4.5	3.8	3.7	2.2	3.0	5.3	1.8	4.5	3.6	4.5	4.3	5.4	2.7	1.8	9.8	4.4	8.5	1.6	5.1	2.5	6.5	0.6	9.7	6.1	5.5	4.2	5.1	10.2	3.5	5.2	2.1	15.0	7.2	4.7	1.9	2.5	4.1	2.1	9.6	4.5	4.5	3.4	3.5	4.2	0.6	4.4	1.8	4.8	2.5	4.1	1.9	4.8	4.8	2.7	4.3	6.7	3.1	3.9	2.9	2.8	3.2	3.2	2.5	11.5	13.2	13.9	13.5	9.4	7.4	12.5	12.4	9.8	12.5	3.0	8.1	1.5	1.7	1.0	5.0	4.5	2.5	0.0	3.4	15.7	3.9	4.7	1.7	4.5	0.8	3.6	15.4	0.0	6.3	2.2	2.5	2.6	0.0	5.8	4.2	9.5	4.1	7.4	3.8	1.1	2.8	2.1	1.7	3.6	10.7	4.5	4.5	11.5	6.0	5.5	7.3	0.0	1.7	4.2	2.0	2.4	4.3	2.9	13.6	1.3
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868592-90883458	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"liver: 118.4;placenta: 158.9;salivary gland: 337.9"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 102.2;Hepatocytes: 114.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009499, HPA067869"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		41000	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095, HPA067869: "	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	8.3	3.3	3.0	7.5	3.6	16.6	5.9	5.0	4.4	4.1	6.6	2.8	3.5	5.7	4.9	10.8	4.7	4.4	3.9	6.9	3.1	1.8	6.4	118.4	9.5	3.1	2.8	2.7	4.2	22.5	3.8	7.2	158.9	3.5	9.3	2.2	3.0	337.9	4.7	8.7	9.0	5.9	3.1	3.0	8.2	6.0	5.3	2.9	4.8	8.9	5.5	4.1	4.4	4.3	1.5	3.3	10.3	3.3	3.1	1.9	2.0	14.4	8.8	2.0	8.9	14.5	9.4	22.7	18.2	13.9	7.5	5.3	12.9	15.8	0.5	46.8	13.2	13.5	26.0	4.0	9.4	1.6	41.6	10.3	25.3	15.8	16.8	7.7	3.5	41.7	10.6	10.6	8.5	3.9	18.3	24.0	4.2	19.3	2.5	5.0	9.9	1.3	11.4	6.3	12.2	2.6	2.2	7.7	3.3	11.7	11.0	4.0	2.7	15.4	8.4	12.8	9.9	3.0	9.2	35.4	8.5	18.2	13.0	26.6	4.5	25.6	1.2	16.2	11.4	17.2	7.5	3.3	10.3	1.9	1.1	1.4	1.5	1.2	1.2	2.1	1.0	0.6	0.8	7.4	3.1	0.7	3.3	0.9	2.0	3.0	3.6	5.0	4.4	3.1	1.8	2.8	2.7	3.5	2.9	3.0	30.9	6.7	7.5	17.2	11.9	15.0	10.2	1.4	5.7	21.0	23.6	16.5	0.0	44.3	0.4	25.5	23.8	23.3	102.2	11.4	12.3	26.5	15.1	114.9	22.3	7.9	36.4	23.4	26.1	0.2	10.3	24.1	15.1	7.2	27.3	11.7	83.4	21.8	10.3	5.6	25.2	25.8	12.5	2.3	3.4	20.1	70.5	11.7	16.1	13.9
FUT10		ENSG00000172728	"Fucosyltransferase 10"	Q6P4F1	8	33370824-33473422	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 187.5;Late spermatids: 217.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053970, HPA058655"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Endoplasmic reticulum, Golgi apparatus"		"HPA053970: AB_2682327, HPA058655: AB_2683789"	"unprognostic (6.02e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.76e-4)"	"unprognostic (3.06e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.01e-3)"	5.6	7.2	7.9	3.9	10.9	2.0	8.9	18.8	8.6	10.9	6.3	6.9	5.0	6.4	10.5	5.3	5.8	8.4	4.8	5.4	7.4	4.5	8.3	5.2	6.0	4.1	5.8	7.2	13.6	10.9	14.5	11.7	8.2	6.8	6.0	6.9	12.4	6.7	5.9	2.4	9.7	6.1	7.3	5.1	3.8	5.7	4.1	4.6	5.8	6.9	2.2	6.0	6.6	7.2	2.4	3.5	1.9	1.5	3.8	4.1	2.1	2.2	4.4	7.1	8.4	11.1	11.3	3.7	4.5	7.3	4.4	5.9	6.7	3.9	2.5	5.5	5.6	3.7	6.1	10.2	4.1	4.4	5.7	3.9	8.4	3.7	7.3	5.1	1.8	3.0	7.9	7.4	1.1	5.4	9.4	8.7	4.6	7.6	3.4	4.1	1.3	6.5	2.8	10.0	6.3	2.9	4.9	5.5	1.4	6.2	5.5	2.4	2.3	2.5	3.8	4.9	7.8	3.8	1.9	7.1	3.3	1.5	8.5	3.5	1.4	2.2	1.7	2.0	5.4	3.4	1.1	1.5	1.9	3.7	0.7	4.0	2.4	2.2	3.5	3.5	1.0	2.5	2.4	1.1	3.8	0.5	2.0	4.1	2.1	7.9	10.9	18.8	8.6	7.4	4.5	5.8	7.2	6.8	4.6	3.0	1.3	0.0	2.6	2.4	3.1	2.2	5.1	1.4	3.4	3.5	9.8	9.6	1.7	4.1	187.5	3.0	2.6	0.0	3.5	5.8	4.1	1.1	5.7	3.9	3.0	3.2	3.5	4.3	1.8	217.3	6.4	1.9	1.7	2.8	2.9	31.7	3.1	0.0	4.6	2.8	10.8	0.0	2.8	1.6	2.4	1.5	5.0	0.5	2.9	1.3
FUT11	MGC33202	ENSG00000196968	"Fucosyltransferase 11"	Q495W5	10	73772291-73780251	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 147.9;Late spermatids: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014033	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		840000	"Nuclear membrane"	"Golgi apparatus"	"HPA014033: AB_1849192"	"prognostic unfavorable (6.78e-4)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.66e-2)"	16.2	9.5	8.9	9.0	9.2	7.8	13.9	7.9	11.8	13.8	7.0	8.2	9.8	4.4	12.5	7.8	14.6	9.0	12.8	14.5	7.3	6.3	9.2	7.4	16.1	18.2	10.4	7.2	13.4	7.9	8.9	7.7	24.0	9.7	9.7	5.6	9.7	9.1	9.8	7.5	6.9	7.9	11.9	8.7	14.2	6.9	18.8	7.4	4.5	10.0	6.8	8.6	10.8	11.1	1.7	2.6	3.9	1.3	7.8	16.0	4.4	13.6	7.5	5.4	11.1	10.7	12.4	1.6	7.0	16.9	8.9	17.5	2.5	7.4	3.1	5.1	11.4	3.0	5.8	2.8	7.0	9.9	7.5	5.8	4.2	6.1	3.9	4.2	5.9	13.4	8.2	1.6	8.5	8.7	27.6	16.2	1.5	4.1	5.7	8.8	1.6	1.0	3.1	2.5	1.3	18.9	1.4	3.3	3.7	3.2	2.5	1.6	5.2	6.1	6.5	3.9	4.8	4.4	2.6	16.5	11.6	5.0	5.7	8.6	7.5	2.6	0.7	16.3	5.3	3.8	3.9	1.0	1.0	16.0	1.2	11.4	1.7	4.8	11.2	1.3	1.5	3.5	7.4	0.2	7.8	1.3	2.6	1.9	4.4	8.9	9.2	7.9	11.8	7.3	6.3	10.4	7.2	9.7	7.4	14.9	13.3	5.6	4.8	12.0	14.0	10.7	10.2	8.1	5.7	10.4	13.7	9.0	0.0	10.7	147.9	29.2	2.6	0.0	5.9	14.6	15.3	6.2	13.9	5.0	10.8	19.1	4.6	40.5	17.8	165.7	15.0	9.5	16.9	6.4	4.2	10.8	8.2	4.8	13.8	3.3	13.8	6.5	12.1	22.8	15.3	10.0	8.1	15.2	3.1	4.8
FUT4	"CD15, ELFT, FCT3A, FUC-TIV"	ENSG00000196371	"Fucosyltransferase 4"	P22083	11	94543840-94549898	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 71.3"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 20.4;Mucus-secreting cells: 20.8;Pancreatic endocrine cells: 18.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 20.8;NB-4: 13.5;THP-1: 26.3;U-937: 18.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000014, CAB016129"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB000014: , CAB016129: AB_626918"	"unprognostic (6.36e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (7.26e-2)"	"unprognostic (4.14e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.10e-3)"	5.5	2.4	5.5	6.1	6.2	71.3	6.3	3.0	6.0	4.4	8.3	6.7	4.7	10.9	5.9	2.5	3.0	4.6	7.5	3.7	6.2	2.2	4.1	3.0	6.0	5.4	8.1	2.5	4.9	11.4	1.4	2.9	3.4	4.8	3.4	8.3	3.8	6.3	2.9	1.7	1.9	10.1	5.8	5.7	6.5	9.7	2.9	4.5	10.4	2.9	1.9	3.1	4.4	3.0	0.7	1.9	2.5	3.9	0.8	1.9	0.8	1.6	0.8	1.0	0.0	3.2	2.9	5.3	1.5	0.7	1.3	1.5	7.1	2.3	0.0	3.6	2.5	0.7	0.8	1.7	0.1	1.3	10.7	1.7	5.3	1.2	0.1	1.6	20.8	4.7	2.5	0.0	1.7	0.0	0.3	2.1	4.8	5.3	0.0	1.6	0.8	4.3	13.5	2.0	6.5	2.0	3.9	0.0	0.0	1.4	1.1	1.4	0.5	0.9	2.1	0.8	3.1	1.2	26.3	1.9	1.1	2.9	0.0	0.5	0.6	0.3	0.0	0.9	18.7	0.6	2.0	3.1	2.5	1.1	1.5	0.7	0.6	1.0	1.3	1.8	0.7	1.1	0.7	1.7	0.8	3.9	1.9	1.9	0.8	5.5	6.2	3.0	6.0	6.2	2.2	8.1	2.5	4.8	4.5	0.0	0.0	0.0	2.3	1.4	0.6	0.8	20.4	2.7	2.3	1.8	3.9	12.9	0.0	12.8	0.2	1.3	12.1	0.0	15.5	2.0	4.6	1.6	0.0	0.8	7.7	0.0	9.8	2.5	10.6	0.2	4.0	3.3	3.3	10.0	20.8	0.5	18.4	3.5	1.1	1.9	8.8	0.0	1.4	0.9	3.2	0.5	1.8	2.5	14.4	1.2
FUT7		ENSG00000180549	"Fucosyltransferase 7"	Q11130	9	137030174-137033010	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 40.4;lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in some"	24	"Kupffer cells: 7.0;monocytes: 19.8;T-cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 40.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"NB-4: 14.4;THP-1: 18.5;U-937: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042780			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA042780: AB_2678162"	"unprognostic (1.33e-2)"	"unprognostic (4.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (2.50e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.75e-4)"	"unprognostic (4.68e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.69e-6)"	"unprognostic (3.99e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.75e-2)"	0.4	0.1	0.2	2.5	0.2	5.9	0.2	3.2	0.3	0.2	0.2	0.2	0.2	0.0	1.4	0.2	0.4	0.5	4.4	0.2	0.3	0.3	0.2	0.2	1.5	6.2	1.7	0.2	0.2	0.2	0.0	0.4	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.6	0.2	0.4	10.5	0.3	0.2	0.2	0.2	0.3	0.2	4.6	0.5	0.2	4.2	40.4	18.3	1.5	22.1	16.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.4	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.3	1.5	0.3	2.1	0.3	10.5	4.2	10.3	5.7	4.4	1.2	0.2	0.8	18.3	22.1	0.0	40.4	16.3	3.4	0.2	0.2	3.2	0.3	0.3	0.3	1.7	0.2	0.9	0.2	0.0	0.0	3.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	7.0	0.0	0.0	2.9	0.0	19.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.7	0.2	0.0
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA043410"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA043410: AB_2678467"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	7.2	7.6	16.2	12.0	21.1	3.3	9.4	24.1	18.1	6.7	9.8	29.1	16.1	15.4	8.7	5.0	6.5	14.0	10.1	5.2	19.8	12.9	6.2	2.9	7.0	11.2	20.5	11.2	7.2	10.5	6.2	5.2	18.8	17.3	5.4	10.4	7.1	33.7	13.7	3.5	4.9	15.1	9.5	39.8	8.5	27.6	13.1	23.6	8.4	7.5	2.4	15.2	14.4	5.6	13.5	2.2	0.5	1.7	12.0	8.2	2.5	34.4	6.8	3.3	30.3	14.6	11.0	20.5	11.1	17.0	7.7	8.6	5.3	12.7	9.2	9.5	10.9	21.2	2.6	7.8	3.0	11.8	34.0	3.4	9.2	2.5	6.9	7.5	2.0	7.6	27.7	2.0	10.6	5.0	33.8	19.5	4.5	3.4	7.8	5.5	17.7	9.8	5.1	4.4	16.0	23.9	6.7	2.9	5.3	13.8	9.7	7.0	5.3	5.9	2.8	2.4	20.7	2.8	3.3	42.5	10.1	10.9	4.5	8.9	15.7	6.0	21.9	20.5	3.6	3.2	0.5	1.7	0.5	3.5	0.6	3.5	13.5	5.6	5.1	2.2	6.8	6.1	6.0	0.2	12.0	1.1	2.2	8.2	2.5	16.2	21.1	24.1	17.3	19.8	12.9	20.5	11.2	17.3	23.6	11.9	33.3	42.9	6.7	10.8	10.6	5.6	10.2	16.0	22.7	12.2	3.9	38.8	0.0	7.7	28.3	11.3	6.8	0.0	28.1	24.2	15.8	5.7	7.0	3.2	11.0	7.9	5.2	15.4	12.1	10.9	11.8	7.0	1.7	1.8	17.5	35.8	36.1	8.5	12.7	7.8	8.0	0.0	10.3	31.6	26.2	8.5	11.8	13.8	9.4	4.6
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015984-96215612	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 37.7;stomach 1: 35.4"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 2.9;Exocrine glandular cells: 1.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	1.1	1.7	18.5	1.1	22.5	1.1	1.9	37.7	28.6	1.1	1.1	10.7	0.0	4.1	1.4	1.2	1.1	1.4	1.1	1.1	20.0	6.2	1.2	1.1	1.1	1.1	10.2	24.0	1.1	8.0	1.1	0.9	1.7	13.8	1.5	1.2	0.0	1.1	1.5	1.2	1.1	1.1	1.1	10.2	1.1	35.4	1.1	16.5	0.0	1.2	0.0	1.1	2.2	0.4	0.3	0.2	1.5	0.1	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	2.1	4.1	0.0	0.0	0.0	0.0	0.0	9.5	9.7	0.2	0.0	5.5	0.0	0.2	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.8	0.2	0.0	0.2	0.0	0.0	18.5	22.5	37.7	28.6	20.0	6.2	10.2	24.0	13.8	16.5	0.0	0.0	0.0	0.6	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1
FUZ	"FLJ22688, Fy"	ENSG00000010361	"Fuzzy planar cell polarity protein"	Q9BT04	19	49806869-49817376	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 116.2"	"Group enriched"	"Detected in many"	24	"Early spermatids: 1102.3;Late spermatids: 1611.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041779, HPA042196"	Approved		Approved	Cytosol		No	NA			Cytosol		"HPA041779: AB_10793974, HPA042196: AB_10797383"	"unprognostic (2.40e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.70e-1)"	5.6	7.8	7.4	2.1	8.4	4.7	4.1	5.4	9.0	6.5	3.8	11.3	3.5	3.7	6.1	6.6	3.4	17.8	4.7	4.5	7.7	5.8	9.0	3.0	4.4	4.1	7.8	5.6	9.8	7.0	5.6	5.2	3.6	6.8	4.5	1.7	4.8	6.2	7.1	15.1	2.0	3.2	3.8	7.9	3.6	4.6	116.2	8.1	5.4	6.8	3.4	3.2	3.5	3.0	5.7	12.3	14.9	4.0	3.0	4.6	2.4	0.0	6.6	6.1	8.0	5.4	6.3	1.7	3.0	3.4	5.3	7.1	0.5	10.8	1.9	6.4	2.9	1.5	2.8	1.5	5.8	2.3	6.2	12.6	7.5	4.4	0.0	6.6	4.5	4.3	6.6	3.9	10.2	2.4	4.0	4.4	11.7	1.8	5.4	2.5	0.4	8.9	9.6	10.3	4.7	3.5	15.4	4.5	4.3	5.9	1.4	17.4	20.1	0.6	6.6	10.7	2.5	3.8	2.9	2.3	4.4	3.9	1.1	1.1	15.5	15.4	4.9	4.9	0.1	5.4	5.4	4.0	14.9	4.6	1.9	3.6	4.6	2.8	3.7	3.2	5.7	3.5	4.0	8.9	3.0	1.3	12.3	3.2	2.4	7.4	8.4	5.4	9.0	7.7	5.8	7.8	5.6	6.8	8.1	0.0	3.2	10.4	15.2	3.4	7.2	3.4	10.2	10.7	2.3	7.0	3.9	13.8	56.3	10.8	1102.3	4.4	2.0	0.0	4.5	9.6	10.8	10.5	10.3	5.1	11.5	9.5	2.4	9.2	6.0	1611.7	25.6	6.7	0.0	11.8	3.2	23.6	4.8	3.1	16.6	53.1	10.1	0.0	7.1	46.0	10.9	3.6	10.1	7.2	3.9	13.1
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138808-35143109	"Predicted membrane proteins"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 170.5;Hepatocytes: 393.6;Leydig cells: 398.4;Muller glia cells: 148.5;Peritubular cells: 120.6;Sertoli cells: 116.4;Smooth muscle cells: 231.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.7"	"Group enriched"	"Detected in many"	5	"B-cells: 11.7;T-cells: 7.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 31.0;ASC TERT1: 9.0;HSkMC: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	28.2	8.1	35.7	5.2	40.7	2.0	21.8	16.8	34.7	46.5	16.9	25.5	7.1	5.0	26.3	17.9	18.8	31.1	14.8	134.1	23.8	19.9	4.5	137.1	14.1	3.0	36.1	23.7	34.0	6.2	2.1	4.3	8.6	21.5	21.6	7.9	14.1	6.4	20.7	299.8	5.8	7.5	27.7	19.0	6.2	8.4	7.5	14.8	0.0	3.9	29.0	3.5	12.7	23.7	11.7	0.7	1.2	0.7	2.0	7.1	0.7	0.7	0.0	0.0	0.1	31.0	9.0	0.8	3.7	0.1	0.0	0.0	0.0	0.2	2.4	1.0	0.0	0.1	0.6	0.7	0.4	0.0	2.2	0.9	0.4	0.0	1.2	3.5	0.2	0.2	12.8	0.0	0.1	0.3	0.3	0.1	0.1	0.6	2.5	0.1	0.0	0.0	0.5	0.1	1.8	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.1	0.4	0.1	1.0	0.2	0.1	4.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.6	0.4	5.1	1.2	0.3	0.0	1.4	0.7	0.9	11.7	4.1	1.7	0.3	6.6	0.8	1.0	0.6	2.0	0.7	0.7	7.1	0.7	35.7	40.7	16.8	34.7	23.8	19.9	36.1	23.7	21.5	14.8	0.0	0.0	3.7	5.1	26.2	1.4	0.3	2.5	5.3	0.0	24.4	3.9	1.3	0.0	0.1	1.2	6.0	1.3	0.0	4.2	1.5	170.5	2.1	0.0	393.6	4.2	0.0	0.0	49.1	11.0	5.1	398.4	4.1	50.6	0.0	0.4	148.5	1.6	2.5	120.6	0.0	7.0	116.4	231.4	3.8	11.7	23.8	2.4	4.9	0.6	2.3
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease mutation, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 258.1;pancreas: 68.9;salivary gland: 91.7"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1434.4;Distal tubular cells: 2501.8;Proximal tubular cells: 3101.2"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	25	"MOLT-4: 141.0;RPTEC TERT1: 323.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA		26000	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	0.3	0.2	0.2	0.2	0.1	0.0	0.7	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.3	2.8	0.3	0.3	54.7	0.2	0.1	0.2	258.1	2.2	0.2	0.6	0.1	0.0	0.4	68.9	0.0	0.3	0.6	0.1	0.3	0.0	0.1	91.7	0.1	0.1	0.2	0.3	0.1	0.1	0.4	0.2	0.2	0.0	9.5	0.2	0.3	0.4	0.2	0.6	0.4	3.2	0.0	1.1	8.4	14.1	2.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.2	0.0	0.0	0.0	0.0	141.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	323.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	1.1	0.2	1.8	14.1	0.2	0.4	5.1	4.1	0.0	8.4	0.0	3.2	1.6	2.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.1	0.8	1434.4	0.0	0.0	413.5	0.0	0.1	2501.8	465.3	14.4	1.3	0.0	0.0	8.3	0.1	1.1	0.1	0.0	2.4	2.9	0.0	14.6	5.5	4.3	15.4	8.6	2.6	0.0	14.4	0.0	0.5	33.3	0.0	7.1	3101.2	3.5	6.5	3.9	0.4	0.2	0.6	0.2	0.0	0.0	0.0
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 160.2;salivary gland: 141.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 1850.8;Mucus-secreting cells: 1977.6;Paneth cells: 3546.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 70.3;hTCEpi: 128.0;OE19: 239.6;RT4: 66.8;SK-BR-3: 65.8;WM-115: 47.1"									HPA010856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	0.4	0.1	1.6	29.5	2.3	0.0	20.4	1.7	2.1	30.0	133.2	1.1	2.3	8.6	3.9	2.9	82.1	9.0	56.6	0.8	1.4	0.3	2.1	0.5	35.8	0.3	2.1	0.8	1.9	28.9	0.0	3.7	41.9	2.2	58.4	160.2	15.8	141.7	3.5	0.5	64.2	36.4	7.5	1.8	0.4	50.6	0.7	1.0	2.5	0.5	93.2	49.8	48.7	42.5	0.3	3.2	0.6	0.1	0.0	0.2	0.5	12.6	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.4	18.5	0.0	0.0	0.0	0.1	70.3	0.0	26.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	128.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.1	0.0	239.6	0.1	0.0	0.0	0.0	0.0	66.8	15.7	0.1	0.0	65.8	4.8	0.1	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.6	0.0	0.0	3.2	0.0	0.5	1.6	2.3	1.7	2.1	1.4	0.3	2.1	0.8	2.2	1.0	708.7	211.8	0.0	720.0	512.4	2.3	1.3	239.5	860.6	417.5	127.4	0.0	696.6	1.7	18.8	0.1	3.8	1850.8	0.0	640.2	148.4	41.3	1079.2	23.0	0.6	70.8	1.6	937.0	0.0	0.0	0.0	0.0	12.2	391.4	2.8	1977.6	233.2	377.2	3546.9	0.0	0.6	8.5	0.0	25.8	0.2	0.2	756.6	1264.5	0.7	1253.7	1183.0
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169883	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 407.2;Kupffer cells: 403.3;Macrophages: 433.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	58.8	10.6	6.0	47.4	9.0	72.4	66.9	2.7	7.1	44.3	15.6	14.4	10.4	8.8	33.6	25.9	31.3	26.0	28.6	29.1	7.0	7.9	13.7	13.2	39.5	110.7	12.0	7.6	18.9	8.0	3.4	11.7	56.9	11.8	27.3	14.0	19.8	19.7	16.7	17.0	22.7	27.0	18.7	18.2	80.3	20.8	10.8	9.3	33.9	16.0	26.9	97.4	36.6	59.8	73.3	91.4	66.5	76.9	99.6	109.0	94.6	98.9	23.7	0.0	0.1	35.4	44.9	23.8	56.9	75.9	40.7	30.4	6.7	29.1	22.8	15.6	68.7	14.6	23.3	14.6	35.1	26.3	28.1	9.6	42.6	13.1	0.0	27.9	24.2	42.5	26.6	15.7	29.5	51.1	24.0	38.3	6.3	39.9	110.3	25.3	0.1	2.8	10.1	7.3	92.0	13.8	13.6	5.0	28.8	14.9	0.5	4.3	0.0	31.4	16.5	33.2	13.5	8.6	19.5	54.0	50.3	19.1	54.5	4.3	0.1	1.6	5.8	76.6	56.4	76.7	66.5	73.5	13.4	60.3	76.9	56.8	73.3	102.5	62.8	91.4	66.7	68.0	55.0	18.1	99.6	74.5	41.9	109.0	94.6	6.0	9.0	2.7	7.1	7.0	7.9	12.0	7.6	11.8	9.3	3.0	14.9	263.7	53.6	95.1	0.3	2.4	22.9	1.4	7.9	94.2	0.0	9.5	0.0	153.7	1.1	336.6	0.8	0.0	176.3	377.4	156.4	26.1	356.4	4.3	407.2	0.0	10.3	249.2	403.3	2.7	6.1	433.0	199.1	27.9	5.1	0.0	365.9	7.0	0.7	2.5	0.2	64.7	75.9	1.1	7.0	60.5	42.6	318.2	5.2	88.0
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 142.8"	"Group enriched"	"Detected in many"	4	"Ito cells: 132.6;Leydig cells: 220.4;Peritubular cells: 341.9;Sertoli cells: 349.3"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"classical monocyte: 21.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 21.9"	"Cell line enhanced"	"Detected in some"		"AF22: 37.9;HAP1: 25.0;RH-30: 15.7;SCLC-21H: 57.4;SH-SY5Y: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	12.9	38.7	41.2	9.5	46.2	3.1	8.1	49.1	142.8	24.3	52.0	30.2	9.2	7.6	54.8	19.0	9.8	26.7	29.0	25.6	35.4	51.6	12.3	10.4	21.5	8.5	18.4	59.5	82.8	9.5	3.5	28.5	5.6	20.2	35.6	11.7	11.9	9.8	22.9	11.0	3.9	16.3	58.5	12.8	42.8	17.6	23.2	18.5	2.9	15.9	6.4	5.9	38.1	13.9	0.0	3.6	0.5	21.9	0.0	0.3	5.1	0.0	0.2	37.9	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.4	0.1	25.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.4	1.6	0.1	7.6	0.0	0.0	0.0	15.7	0.2	0.9	0.0	57.4	32.7	0.0	0.1	1.3	10.9	0.6	0.6	0.0	0.0	9.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	21.9	0.0	0.0	5.3	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	5.1	41.2	46.2	49.1	78.8	35.4	51.6	18.4	59.5	20.2	18.5	6.0	2.1	0.0	2.7	6.0	2.1	4.8	2.5	2.7	1.2	0.0	2.0	0.8	1.7	5.2	2.2	57.8	0.0	0.0	0.3	1.1	30.7	2.3	0.0	0.4	57.8	1.6	12.0	132.6	22.4	8.6	220.4	9.7	15.1	3.6	0.0	51.6	0.6	0.0	341.9	0.0	3.0	349.3	63.8	1.4	3.2	3.3	1.1	0.0	0.0	1.4
FXYD6-FXYD2		ENSG00000255245	"FXYD6-FXYD2 readthrough"		11	117820163-117876667	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"Distal tubular cells: 82.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"MOLT-4: 9.8;RPTEC TERT1: 11.2"									"HPA068838, HPA075209"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA068838: AB_2686047, HPA075209: AB_2732285"																		2.8	2.7	7.4	1.8	12.4	1.8	2.7	4.2	22.2	6.0	4.5	7.9	1.4	1.8	11.4	5.2	2.5	3.9	6.6	3.0	4.8	2.9	23.0	2.8	3.1	2.1	2.5	16.5	10.2	9.6	2.4	4.2	2.5	4.6	9.4	2.0	2.2	19.5	2.2	2.9	2.5	3.0	13.7	2.5	4.2	2.9	3.6	4.3	0.0	2.9	0.5	2.3	10.1	2.8	0.0	0.5	0.0	1.1	0.8	1.3	0.7	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	9.8	0.0	0.7	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.6	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.3	0.0	0.4	0.3	0.0	0.8	0.0	0.5	0.0	0.7	7.4	12.4	4.2	22.2	4.8	2.9	2.5	16.5	4.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	10.4	0.0	0.0	82.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	9.0	0.0	6.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FYB1	"ADAP, FYB, FYB-120/130, SLAP-130"	ENSG00000082074	"FYN binding protein 1"	O15117	5	39105255-39274528	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 153.7;lymphoid tissue: 63.5"	"Cell type enhanced"	"Detected in some"	17	"Extravillous trophoblasts: 65.7;Hofbauer cells: 145.5;Macrophages: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEL: 16.3;JURKAT: 58.0;MOLT-4: 55.5;REH: 16.2;U-937: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025336, HPA026796, HPA067427"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6600000	"Plasma membrane"	Nucleoplasm	"CAB025336: , HPA026796: AB_10964126, HPA067427: "	"unprognostic (5.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-1)"	7.0	3.5	6.3	36.0	18.3	22.1	3.9	1.8	10.1	3.5	4.4	8.3	0.3	4.1	2.7	6.5	4.9	4.2	7.9	3.5	6.8	6.6	5.7	6.2	13.8	35.5	15.5	2.7	2.6	2.5	1.3	3.5	8.7	11.7	3.8	5.3	3.0	5.4	1.5	1.9	2.4	11.7	5.6	29.4	41.5	5.2	3.5	12.2	63.5	4.1	1.8	28.0	10.1	3.6	0.1	11.9	153.7	41.3	8.6	28.7	30.8	0.0	1.1	0.0	0.0	0.1	0.0	6.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.2	4.5	0.0	0.1	0.0	0.0	0.0	16.3	0.0	0.0	0.0	6.1	5.2	0.0	0.1	0.0	0.1	0.0	0.0	58.0	0.0	0.0	0.0	0.0	55.5	3.5	0.0	0.0	0.0	16.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.1	1.6	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	21.5	0.0	11.9	33.8	32.3	7.9	38.6	5.5	0.1	22.5	13.8	11.9	0.1	28.7	17.3	153.7	8.6	41.3	3.0	21.7	30.8	6.3	18.3	1.8	10.1	6.8	6.6	15.5	2.7	11.7	12.2	14.9	34.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	10.3	14.0	0.0	25.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	65.7	0.0	0.0	14.0	0.0	145.5	0.0	0.0	0.0	0.0	0.0	0.0	50.3	0.0	10.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0
FZD2		ENSG00000180340	"Frizzled class receptor 2"	Q14332	17	44557459-44559570	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 17.9;Kupffer cells: 11.1;Leydig cells: 21.6;Peritubular cells: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.5;myeloid DC: 5.6;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.6;monocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"A549: 25.9;BJ hTERT+ SV40 Large T+: 25.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057667	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"HPA057667: AB_2683497"	"unprognostic (6.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	2.3	2.8	2.3	3.9	5.8	0.9	3.2	0.7	3.1	16.1	2.9	2.1	3.0	2.9	10.8	7.6	2.4	6.6	7.7	5.8	3.2	1.5	5.0	0.5	6.9	3.1	2.1	2.9	12.1	2.7	1.6	1.9	8.4	4.9	4.2	0.8	14.3	2.9	7.9	1.8	1.1	3.6	3.3	2.0	3.7	2.1	6.5	1.8	1.1	5.3	2.4	3.1	3.8	4.3	0.2	5.6	0.0	3.5	0.0	0.8	0.6	7.6	25.9	14.9	8.5	3.3	2.9	0.3	21.5	13.1	25.8	18.6	20.0	4.4	0.0	6.8	5.3	7.8	3.6	1.7	1.8	6.2	1.9	5.0	0.8	4.2	0.1	4.3	0.1	4.4	5.5	1.4	6.2	4.2	15.2	1.1	2.7	1.6	0.2	6.5	4.0	3.4	2.0	16.3	0.0	4.8	9.9	4.5	1.3	3.3	0.3	1.9	6.4	2.7	0.7	1.6	9.7	8.3	3.6	0.4	13.9	12.4	2.6	12.6	0.6	0.4	1.9	2.6	1.4	6.3	0.0	3.5	0.0	0.1	0.2	0.0	0.0	0.0	0.8	5.6	0.2	0.0	0.2	0.0	0.0	0.2	2.6	0.0	0.6	2.3	5.8	0.7	2.1	3.2	1.5	2.1	2.9	4.9	1.8	17.9	0.0	0.0	0.2	0.6	0.0	1.7	0.0	0.0	0.0	1.8	0.0	1.4	0.0	0.3	0.4	0.6	0.0	0.0	1.6	0.4	5.1	0.1	0.0	0.0	4.5	0.0	1.2	1.3	11.1	0.0	21.6	4.2	0.0	2.8	0.0	6.4	0.5	0.0	17.0	0.1	0.2	0.0	1.0	0.3	0.9	0.4	1.9	0.0	0.0	0.0
FZD3		ENSG00000104290	"Frizzled class receptor 3"	Q9NPG1	8	28494205-28574268	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 92.3;Rod photoreceptor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.8;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"AF22: 31.1;Karpas-707: 16.0;SCLC-21H: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024995, HPA042320"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB024995: , HPA042320: AB_2677948"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.69e-2)"	"unprognostic (4.26e-4)"	"unprognostic (2.11e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.09e-3)"	2.2	6.4	13.3	3.4	21.1	3.2	5.4	14.4	20.9	5.3	4.4	5.2	8.7	3.2	7.5	15.6	4.4	7.8	3.2	3.0	9.1	7.8	5.7	1.9	2.6	4.3	4.4	14.4	15.0	7.1	8.2	12.5	3.1	9.6	9.6	3.1	4.3	7.0	12.4	2.7	3.3	2.5	5.8	5.4	1.8	5.1	9.9	4.3	1.3	7.4	0.3	3.3	5.2	3.7	1.6	11.8	0.9	0.3	1.1	3.1	0.9	8.2	1.7	31.1	5.8	0.0	0.4	4.8	0.3	0.6	1.7	0.8	1.7	1.7	4.1	1.5	0.2	3.8	2.9	4.7	4.9	1.2	5.1	3.6	2.6	0.6	1.1	0.0	1.4	4.6	0.3	2.6	0.1	1.3	0.3	0.3	4.1	1.9	16.0	0.1	2.0	0.1	3.2	7.8	3.5	2.6	1.8	4.6	3.7	2.4	2.4	22.9	6.2	1.6	4.3	4.8	4.2	4.2	2.2	0.0	0.0	8.4	1.1	2.1	2.9	3.3	3.7	2.4	0.0	1.5	0.9	0.3	0.0	2.2	0.2	2.8	1.6	1.6	3.1	1.2	0.9	2.2	2.3	0.2	1.1	0.0	11.8	0.0	0.9	13.3	21.1	14.4	20.9	9.1	7.8	4.4	14.4	9.6	4.3	8.9	8.1	7.8	6.9	6.0	26.0	5.2	2.5	12.0	15.9	8.7	92.3	9.6	1.7	10.9	12.8	3.0	1.0	0.0	12.8	7.4	7.3	12.2	5.7	2.4	3.3	20.6	27.5	11.6	1.8	11.0	44.5	2.9	32.1	0.0	4.2	15.3	14.2	3.5	48.1	10.2	82.4	25.8	13.9	23.2	29.3	4.1	4.0	2.5	5.5	6.4
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955391	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 75.7"	"Cell type enhanced"	"Detected in many"	18	"Collecting duct cells: 34.9;Endothelial cells: 26.3;Ito cells: 108.6;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;Hep G2: 32.6;HSkMC: 18.8;HUVEC TERT2: 36.8;TIME: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042328, HPA074833"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA042328: AB_10962494, HPA074833: AB_2686716"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.97e-1)"	75.7	5.3	3.4	6.0	4.8	0.5	57.8	1.5	4.3	11.5	9.0	1.4	32.6	2.0	13.1	13.5	6.3	9.6	8.7	12.5	3.1	2.2	17.0	8.9	19.0	4.7	2.9	3.2	12.8	6.0	4.4	10.1	7.3	5.5	9.3	4.3	20.0	7.1	56.0	17.9	3.7	5.4	8.6	2.8	8.6	8.2	5.5	1.6	0.5	11.4	11.1	3.0	8.3	20.7	0.4	0.2	0.8	0.4	1.4	0.3	0.0	0.5	0.4	1.1	2.0	25.9	6.8	1.5	3.2	2.9	1.2	1.3	2.7	0.3	0.0	0.7	1.0	1.7	1.1	1.2	0.5	1.0	0.1	0.8	1.0	0.8	32.6	7.7	0.0	0.0	18.8	0.2	1.1	0.2	3.0	36.8	0.0	1.4	0.1	0.8	0.8	0.0	0.0	1.5	2.8	7.4	0.0	1.9	0.0	3.6	5.3	0.2	0.3	1.3	0.4	0.5	2.3	4.7	0.0	18.0	3.1	2.1	3.6	0.6	0.1	0.5	0.0	0.4	0.0	0.8	0.7	0.3	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.8	1.4	0.4	0.2	0.0	0.0	3.4	4.8	1.5	4.3	3.1	2.2	2.9	3.2	5.5	1.6	0.0	2.2	1.9	0.4	1.3	0.7	7.8	7.6	1.4	1.2	34.9	9.8	0.1	3.3	0.6	0.4	26.3	0.8	0.0	1.4	0.1	4.3	0.8	0.0	10.4	0.2	0.0	0.0	108.6	11.2	1.7	8.6	0.9	0.0	0.0	1.1	0.3	1.0	0.0	6.3	6.9	0.1	32.3	5.1	0.2	3.0	0.5	0.2	0.0	0.6	0.1
FZD8		ENSG00000177283	"Frizzled class receptor 8"	Q9H461	10	35638249-35642278	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 17.9;Muller glia cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.8;PC-3: 27.5;U-138 MG: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045025, HPA071142"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045025: AB_10795888, HPA071142: AB_2686349"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.19e-1)"	8.9	2.6	7.4	2.7	5.1	0.7	4.9	0.5	8.5	5.2	10.4	4.9	0.6	1.8	3.4	2.2	2.1	7.9	3.9	12.5	12.0	1.7	13.1	5.0	9.5	4.3	2.7	3.8	4.9	9.5	6.0	4.0	1.8	7.1	3.4	4.6	14.2	4.5	3.5	5.8	4.6	2.6	3.6	1.4	21.3	10.4	4.1	5.5	3.3	14.7	2.4	3.0	2.8	5.4	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.9	0.5	0.0	1.2	0.0	1.8	3.2	0.1	0.1	0.1	0.3	0.5	0.0	0.5	1.4	3.3	1.0	0.3	1.0	0.0	0.0	8.4	0.0	0.3	0.1	0.6	0.0	0.2	1.0	4.1	6.7	2.6	10.8	2.3	0.0	0.1	0.0	0.9	1.2	0.0	0.0	2.7	0.2	27.5	2.7	1.7	0.0	5.2	0.2	8.3	0.2	0.6	0.2	0.0	4.0	0.0	0.4	5.5	10.3	1.6	5.0	8.8	0.0	0.0	0.0	5.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	5.1	0.5	8.5	12.0	1.7	2.7	3.8	7.1	5.5	17.9	3.5	0.0	0.6	0.2	0.2	8.9	2.5	1.4	0.0	0.0	2.0	0.1	0.0	2.2	0.0	4.4	5.3	0.0	2.7	0.1	1.1	0.8	0.0	3.4	0.5	0.0	1.2	9.2	0.6	0.0	1.1	0.8	0.0	0.0	2.9	31.4	2.6	0.0	2.1	3.1	1.0	6.5	2.3	0.1	1.1	1.0	0.1	0.0	3.5	0.1
G2E3	"FLJ20333, KIAA1333, PHF7B"	ENSG00000092140	"G2/M-phase specific E3 ubiquitin protein ligase"	Q7L622	14	30559123-30620063	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.6"	"Group enriched"	"Detected in all"	7	"Early spermatids: 712.5;Late spermatids: 198.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001601	Uncertain		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Vesicles"	"HPA001601: AB_1079198"	"unprognostic (4.75e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.44e-6)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	7.6	5.1	5.6	7.6	14.2	8.5	6.6	10.8	10.4	8.1	5.8	5.8	4.2	5.9	8.5	4.8	7.0	5.4	4.5	4.9	6.7	5.2	5.4	5.5	5.4	8.6	7.3	4.9	7.1	5.7	6.0	10.9	6.9	7.6	6.0	6.1	5.3	5.9	7.1	5.2	6.1	5.8	6.7	7.1	7.9	5.4	39.6	8.8	20.9	7.3	4.8	9.5	6.0	8.3	11.5	8.1	16.5	12.5	7.9	12.4	5.0	21.2	9.7	21.8	10.0	7.1	8.7	18.4	20.0	7.2	12.1	13.7	9.4	12.9	17.9	6.4	10.9	9.9	17.9	20.8	11.4	24.7	14.7	8.5	9.8	10.6	17.2	6.3	18.9	12.5	5.4	4.6	9.7	22.1	11.4	14.3	13.4	12.1	14.9	17.0	12.4	12.6	4.7	18.2	16.8	17.1	11.7	0.0	4.9	7.1	13.2	18.5	12.5	16.1	10.9	4.6	13.1	12.5	6.4	10.7	13.0	13.8	9.5	13.0	8.6	25.1	21.4	3.9	9.5	19.2	16.5	7.5	14.1	9.6	9.7	12.4	10.8	9.4	7.7	6.4	11.5	12.0	10.1	6.8	7.9	12.5	8.1	7.3	5.0	5.6	14.2	10.8	10.4	6.7	5.2	7.3	4.9	7.6	8.8	17.9	7.0	27.4	17.9	19.5	31.8	8.7	10.2	9.4	14.8	5.2	23.6	12.4	8.3	8.6	712.5	15.2	6.3	46.7	6.1	19.3	15.0	16.9	16.2	6.4	12.2	33.4	13.3	17.8	14.5	198.8	15.3	11.7	8.5	7.2	12.7	14.1	9.7	10.2	13.4	11.1	31.9	51.8	15.6	69.3	43.2	22.2	8.4	15.0	10.4	19.7
GAA		ENSG00000171298	"Glucosidase alpha, acid"	P10253	17	80101556-80119879	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.8;eosinophil: 8.4;intermediate monocyte: 20.0;myeloid DC: 15.6;neutrophil: 10.8;non-classical monocyte: 24.7"	"Group enriched"	"Detected in all"	9	"dendritic cells: 15.6;granulocytes: 10.8;monocytes: 24.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026970, HPA029126"	Enhanced		Approved	Vesicles		NA	NA		3000000	Vesicles		"HPA026970: AB_2672065, HPA029126: AB_2672918"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.18e-1)"	27.5	19.6	13.8	17.0	14.8	11.3	18.6	14.3	23.0	14.9	16.5	23.4	21.7	19.4	20.1	50.9	13.9	18.2	23.5	21.4	13.5	17.6	27.9	44.2	34.0	30.2	18.1	16.1	14.6	29.4	28.8	24.7	84.1	14.9	22.3	7.2	21.9	27.5	22.1	26.3	18.3	15.4	17.2	16.6	35.8	17.4	30.7	14.6	13.9	21.9	14.9	13.5	24.0	13.4	1.4	15.6	10.8	24.7	1.1	1.8	9.8	11.4	22.4	4.4	14.5	13.9	14.0	28.9	7.2	13.3	5.5	4.5	6.6	18.7	4.1	19.2	5.6	4.7	4.9	1.4	8.3	1.3	5.3	16.7	0.0	3.8	23.7	24.2	0.5	13.7	30.1	12.0	10.3	3.6	11.2	9.7	11.2	4.1	17.3	4.1	26.5	1.9	2.7	9.2	2.8	15.7	10.0	15.2	7.0	4.4	12.0	5.1	14.7	9.4	10.5	12.9	2.8	30.0	16.4	6.2	20.4	11.0	14.7	2.6	41.4	11.5	1.2	6.5	10.7	12.8	0.1	23.8	8.4	1.5	20.0	1.8	1.3	1.2	1.6	15.6	1.4	1.4	0.9	10.8	1.1	24.7	3.8	0.8	9.8	13.8	14.8	14.3	23.0	13.5	17.6	18.1	16.1	14.9	14.6	17.9	45.3	3.9	14.4	10.0	15.6	14.3	30.6	5.3	17.0	14.0	7.9	106.8	5.0	23.0	42.5	17.4	18.6	0.0	13.8	125.7	30.3	19.9	8.1	23.1	92.2	11.1	5.8	29.4	107.0	25.5	22.2	64.5	23.6	31.5	14.3	28.7	9.4	17.5	18.0	18.2	16.5	6.5	10.3	18.4	26.8	7.3	139.0	7.7	15.5	10.8
GAB1		ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 38.0;U-266/70: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	9.2	8.4	15.0	7.3	33.3	8.8	9.7	5.8	22.0	10.1	17.0	64.0	10.2	10.4	17.7	13.1	18.2	8.6	11.1	26.2	19.5	11.4	12.9	7.9	15.6	5.0	35.7	19.0	18.1	7.0	17.2	6.3	18.0	30.5	7.8	20.3	15.4	11.7	13.9	11.2	11.1	10.4	15.9	32.3	6.2	11.0	7.9	41.7	1.0	7.8	6.0	7.3	9.9	11.9	3.1	3.4	5.9	2.3	7.4	0.4	0.4	3.4	0.7	8.9	6.4	4.5	4.3	11.6	2.4	8.0	2.9	5.1	6.6	5.9	0.1	0.7	3.3	2.0	1.9	8.5	2.8	3.3	0.5	2.0	6.2	1.9	3.1	3.1	0.8	1.2	5.3	5.0	3.5	2.3	6.2	3.8	0.1	2.0	11.5	2.0	4.9	0.5	0.0	2.5	1.8	2.8	38.0	4.3	4.4	4.5	4.2	2.1	6.3	1.6	7.0	3.0	6.2	4.5	0.8	2.8	3.7	2.9	1.7	1.8	18.5	9.0	13.7	2.5	2.5	3.0	5.9	0.6	0.7	0.0	0.8	0.4	1.3	0.1	0.0	0.8	3.1	0.0	0.0	4.0	7.4	2.3	3.4	0.0	0.4	15.0	33.3	5.8	22.0	19.5	11.4	35.7	19.0	30.5	41.7	26.8	14.7	6.7	7.6	18.0	1.9	27.8	7.6	2.7	5.7	12.2	0.0	18.0	0.0	5.0	0.9	16.5	11.2	0.0	2.2	8.5	11.5	6.2	2.3	5.8	5.3	3.2	21.4	11.6	9.7	2.1	19.2	5.7	15.1	2.8	25.0	14.1	4.1	8.6	17.7	5.0	0.7	12.9	16.5	1.8	5.2	21.8	8.7	1.3	13.5	11.1
GABARAP	"ATG8A, MM46"	ENSG00000170296	"GABA type A receptor-associated protein"	O95166	17	7240014-7242770	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 381.1;monocytes: 547.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065883			Approved	Vesicles		NA	NA			Vesicles		"HPA065883: AB_2685574"	"unprognostic (2.58e-1)"	"unprognostic (4.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.52e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.58e-1)"	104.5	120.3	103.9	69.9	94.9	90.9	108.6	54.9	127.8	105.0	89.0	125.1	77.0	63.3	84.0	136.8	103.0	94.1	86.2	94.1	91.8	97.8	113.0	191.6	99.8	87.9	112.1	68.9	139.6	109.2	82.0	118.8	112.4	85.7	108.8	86.6	98.2	126.9	96.9	152.5	85.6	114.5	80.8	119.8	116.5	83.7	142.8	61.4	109.4	148.8	100.7	90.7	98.9	88.7	54.9	138.6	314.7	174.9	30.4	47.9	162.9	25.1	39.7	67.6	46.0	109.6	126.8	26.7	41.3	79.8	41.4	62.0	16.4	22.7	26.5	26.4	77.4	49.3	22.9	49.2	38.4	54.9	46.3	53.6	20.2	36.0	41.4	104.1	12.8	41.7	125.0	54.1	49.4	45.2	107.4	75.0	39.3	15.7	29.3	70.4	18.1	30.5	29.6	26.9	47.0	37.6	42.4	31.6	35.2	79.7	26.9	30.3	80.0	32.2	29.7	42.3	53.4	38.2	25.4	63.1	42.6	24.2	41.0	34.3	31.4	30.4	16.5	67.9	33.4	43.6	107.9	174.9	157.5	35.9	155.4	37.2	54.9	42.8	37.6	138.6	50.7	38.9	36.5	314.7	30.4	130.2	105.9	47.9	162.9	103.9	94.9	54.9	127.8	91.8	97.8	112.1	68.9	85.7	61.4	83.4	111.1	36.6	3.4	18.4	2.4	0.3	43.3	279.7	127.4	26.2	0.0	20.6	36.5	370.8	18.5	15.3	263.7	0.0	269.7	25.6	28.6	6.9	143.5	38.2	69.9	1.6	381.1	46.1	163.5	56.9	19.5	71.9	32.1	547.4	268.5	7.7	357.3	340.1	13.1	66.3	2.5	6.5	18.4	18.5	5.3	20.3	44.3	34.6	223.3	2.3
GABARAPL1	"APG8L, ATG8B, ATG8L, gec1"	ENSG00000139112	"GABA type A receptor associated protein like 1"	Q9H0R8	12	10212458-10223130	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Distal tubular cells: 366.4;Syncytiotrophoblasts: 776.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 27.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 27.1;NK-cells: 9.1;T-cells: 12.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 44.0;SiHa: 40.4;SuSa: 113.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051386, HPA065883"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA051386: AB_2681463, HPA065883: AB_2685574"	"unprognostic (9.58e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.85e-3)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.90e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (8.19e-8)"	"unprognostic (5.42e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.77e-1)"	41.7	34.7	35.9	11.3	61.8	48.5	24.8	39.9	95.5	16.5	15.9	18.6	17.7	13.9	23.1	46.3	13.2	13.0	26.8	78.5	35.5	42.3	88.0	68.7	25.5	5.2	35.8	48.3	27.9	31.9	42.0	41.1	65.7	52.6	24.9	14.7	27.5	35.6	27.3	63.0	12.0	12.2	24.1	19.8	10.3	22.4	10.1	20.3	2.2	21.6	14.0	5.5	23.7	24.0	0.1	1.2	27.1	2.7	9.1	12.1	2.5	1.4	2.9	6.3	5.6	38.1	10.2	4.9	33.7	15.6	5.8	7.7	12.6	4.8	0.3	2.7	38.5	14.7	9.1	5.9	4.0	5.3	0.9	5.1	1.9	18.4	3.4	44.0	2.3	2.2	17.8	8.9	4.5	4.0	18.3	14.0	4.0	2.3	0.1	2.4	0.1	1.9	2.3	14.7	0.3	2.9	0.1	11.6	0.1	25.3	3.5	0.6	1.2	40.4	6.2	11.4	113.2	2.8	1.4	18.9	1.9	6.2	2.9	1.5	5.9	9.4	9.5	6.4	1.1	2.6	17.0	1.9	17.2	12.1	1.1	3.9	0.1	1.6	7.2	1.2	0.0	1.6	6.6	27.1	9.1	2.7	0.5	2.4	2.5	35.9	61.8	39.9	74.7	35.5	42.3	35.8	48.3	52.6	20.3	56.6	39.0	18.2	194.1	55.8	119.9	178.4	53.5	9.4	21.6	55.8	145.3	239.1	366.4	47.0	234.0	94.1	36.0	23.3	50.1	25.6	92.0	152.5	16.3	86.4	67.4	84.2	68.1	43.0	59.4	49.7	23.9	59.4	70.9	27.9	31.8	94.0	50.5	28.1	23.0	147.8	196.5	19.4	42.1	7.5	6.3	36.9	776.9	64.8	8.0	135.8
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.8"	"Cell type enhanced"	"Detected in many"	4	"Ito cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;HEL: 7.9;U-2 OS: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050483, HPA058459"	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA			Centrosome		"HPA050483: AB_2681140, HPA058459: "	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.93e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (3.77e-10)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.55e-2)"	14.0	7.4	33.6	7.0	47.2	8.2	4.2	29.1	53.8	6.9	5.6	17.3	3.0	2.3	18.1	1.9	2.9	7.9	4.1	4.6	24.8	21.4	2.9	2.0	6.9	6.6	15.6	33.7	7.8	5.1	1.8	5.8	5.0	22.3	12.8	3.2	4.4	13.0	13.3	8.5	18.3	6.1	5.5	14.9	24.2	6.1	4.3	15.4	0.0	3.9	0.1	5.2	4.0	5.9	1.8	1.7	0.0	0.5	0.0	0.4	0.3	3.0	0.0	1.9	8.1	0.9	2.1	2.1	2.0	0.9	1.8	0.5	2.4	0.1	1.4	2.0	0.0	0.5	2.5	0.9	0.0	0.0	7.3	3.4	7.9	3.5	0.0	1.2	0.3	4.0	0.0	0.0	1.6	0.0	2.3	1.0	4.3	6.7	0.0	0.3	2.0	0.8	0.1	0.6	0.0	1.1	3.5	0.7	0.1	0.3	0.0	0.5	1.3	0.5	0.0	3.3	0.6	1.5	1.2	4.6	3.3	8.4	0.3	3.8	7.1	0.8	0.0	1.8	3.6	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.3	33.6	47.2	29.1	53.8	24.8	21.4	15.6	33.7	22.3	15.4	11.9	19.8	5.2	6.1	10.5	22.1	8.9	2.5	1.4	18.2	3.5	0.0	0.4	0.0	1.2	2.4	11.9	0.0	0.0	0.7	0.2	9.6	5.4	7.0	0.0	1.1	22.3	6.9	28.8	7.2	1.7	14.1	10.5	0.0	5.4	3.8	9.7	2.2	1.5	24.1	0.7	13.8	12.9	15.5	1.1	1.5	9.7	0.5	1.0	1.2	1.8
GABPB2	MGC29891	ENSG00000143458	"GA binding protein transcription factor beta subunit 2"	Q8TAK5	1	151070578-151125542	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 26.5"	"Low region specificity"	"Detected in all"							"HPA028471, HPA058483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028471: AB_10602319, HPA058483: AB_2683730"	"unprognostic (1.21e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.76e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.65e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.98e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-3)"	9.9	8.3	9.5	9.3	13.3	12.2	10.9	12.3	12.2	10.0	8.5	14.8	10.7	7.0	10.1	8.0	8.7	10.2	10.7	11.0	11.6	5.8	7.9	6.4	7.7	9.9	14.4	9.7	17.6	7.8	15.1	12.8	6.5	11.4	9.4	9.8	11.0	7.6	12.6	10.0	13.9	8.1	12.0	10.2	10.1	9.8	20.2	15.2	15.7	10.0	11.6	9.8	9.9	16.6	4.7	5.0	4.7	5.1	2.6	4.8	2.6	6.9	2.4	1.7	2.1	6.1	9.0	2.2	6.4	4.0	3.7	2.6	0.7	5.2	7.2	2.4	6.1	2.0	6.1	3.7	3.3	5.5	2.7	1.4	2.0	3.8	0.1	4.1	7.8	4.1	4.9	3.8	5.1	7.7	2.9	1.4	7.7	4.8	5.1	4.4	9.8	10.8	1.4	0.8	4.0	2.7	3.2	2.8	3.4	3.1	1.9	3.0	1.2	8.2	2.9	2.4	1.7	7.2	8.6	4.1	1.0	3.2	6.6	5.1	2.8	1.3	26.5	3.0	5.9	4.4	3.6	2.8	1.6	4.4	3.3	2.7	3.1	4.8	3.9	2.5	4.7	4.3	4.7	4.7	2.6	5.1	5.0	1.7	2.6	9.5	13.3	12.3	12.2	11.6	5.8	14.4	9.7	11.4	15.2	8.9	12.6	13.8	9.2	10.2	26.2	21.4	25.5	24.1	18.2	12.2	23.6	4.9	8.3	5.6	28.3	9.0	9.8	0.0	5.1	4.2	10.8	6.2	6.9	5.9	7.3	31.8	9.2	16.0	14.8	13.9	20.8	8.0	8.5	9.0	15.4	15.4	4.6	10.5	20.1	3.3	39.9	6.5	16.0	54.6	51.3	8.8	3.8	14.4	14.9	6.7
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor alpha1 subunit"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 58.6"	"Cell type enriched"	"Detected in some"	24	"Bipolar cells: 209.5"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA029363, HPA055746"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB022502: , HPA029363: , HPA055746: AB_2682904"					"unprognostic (2.58e-2)"						"unprognostic (4.78e-3)"	"unprognostic (1.84e-1)"		"unprognostic (3.31e-1)"		"unprognostic (2.43e-1)"		1.0	2.6	8.5	1.0	21.9	1.0	1.0	35.2	58.6	1.0	1.0	1.8	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	10.5	8.8	1.0	1.0	1.0	1.0	6.7	22.0	1.0	1.0	1.0	0.1	1.0	7.4	1.2	1.0	0.2	1.0	1.1	1.0	1.0	1.0	1.0	1.3	1.1	1.5	1.1	0.0	0.0	1.0	0.0	1.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	21.9	35.2	49.8	10.5	8.8	6.7	22.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	209.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA5		ENSG00000186297	"Gamma-aminobutyric acid type A receptor alpha5 subunit"	P31644	15	26866363-26949207	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 52.6"	"Cell type enhanced"	"Detected in single"	18	"Spermatogonia: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A549: 26.4;HAP1: 9.1;NTERA-2: 10.9;U-2 OS: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029363, HPA077031, CAB079022"		Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB079022: , HPA029363: , HPA077031: AB_2686825"	"unprognostic (6.33e-2)"			"unprognostic (8.94e-3)"	"unprognostic (1.04e-1)"			"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.57e-1)"		"unprognostic (7.63e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.44e-2)"		0.8	0.8	12.0	0.8	48.2	0.8	0.8	0.1	52.6	0.8	0.8	0.8	0.0	0.8	0.8	0.7	2.5	0.8	1.5	0.9	20.9	6.0	0.9	0.8	0.8	0.8	2.3	15.2	0.7	0.7	0.7	0.1	0.8	1.0	1.0	0.7	0.0	0.7	0.9	0.7	0.8	0.7	1.4	0.3	0.8	1.1	1.4	2.0	1.3	0.9	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	9.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	48.2	0.1	26.0	20.9	6.0	2.3	15.2	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 53.9"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 9.8;Distal tubular cells: 6.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.8;HEL: 34.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"olfactory region: 888.9"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	1.2	2.0	14.5	0.9	28.1	3.7	1.0	10.6	53.9	1.8	1.0	3.1	0.0	1.0	2.6	5.5	1.2	1.1	1.0	1.0	10.8	24.4	6.0	1.0	1.1	1.1	8.6	17.5	1.1	1.1	9.5	2.8	1.4	6.0	1.8	1.0	1.3	1.0	1.3	0.9	1.0	1.1	1.0	2.6	1.0	1.0	4.0	3.4	0.0	1.1	0.0	1.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.4	0.0	3.8	0.0	0.0	0.0	0.2	0.0	1.4	0.9	2.5	3.6	0.0	0.5	0.2	1.7	10.8	1.2	0.3	0.8	1.4	7.4	34.9	3.0	0.1	0.0	0.1	0.6	0.0	3.1	0.0	1.2	0.3	0.0	0.3	9.0	0.1	0.4	0.8	0.0	0.0	4.3	5.2	3.8	0.5	2.6	0.2	4.7	5.0	3.7	1.2	6.6	0.0	1.8	0.3	0.1	0.0	0.0	6.5	0.9	1.3	3.8	0.0	0.0	0.0	6.3	1.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	28.1	10.6	36.7	10.8	24.4	8.6	17.5	6.0	3.4	0.0	0.0	0.0	1.4	0.2	3.8	1.1	0.0	0.0	0.0	0.0	9.8	0.0	6.6	4.2	4.3	0.3	0.0	0.0	4.7	0.1	0.2	0.8	0.0	0.0	3.0	4.8	2.9	0.0	0.3	3.6	0.6	0.2	0.0	0.0	0.0	3.9	4.2	0.0	0.0	0.0	5.4	0.0	0.8	3.2	4.7	0.1	0.5	0.0	0.0	0.3
GADD45B	"DKFZP566B133, GADD45BETA, MYD118"	ENSG00000099860	"Growth arrest and DNA damage inducible beta"	O75293	19	2476122-2478259	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Smooth muscle cells: 2211.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029816: AB_10601325"	"unprognostic (1.32e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.90e-2)"	"unprognostic (8.27e-3)"	"unprognostic (6.00e-2)"	50.5	37.3	10.3	24.6	33.8	142.2	34.2	6.7	26.4	20.0	29.2	17.9	4.1	9.7	14.2	10.7	17.6	34.3	44.6	59.0	22.5	15.6	26.2	143.6	49.8	14.7	17.1	3.9	36.3	45.5	16.7	27.5	22.6	32.4	27.2	6.6	26.6	28.1	36.9	38.4	22.1	12.3	14.5	32.8	14.7	27.1	12.4	13.1	6.7	53.9	29.5	13.7	35.0	15.0	12.2	13.5	45.1	14.9	14.9	22.6	10.1	21.4	4.3	0.5	2.9	16.3	12.6	1.3	21.9	6.4	17.3	8.9	6.0	8.3	10.2	14.9	10.8	6.2	11.9	1.1	7.3	4.2	7.8	3.9	1.1	4.7	2.3	27.7	2.3	7.1	20.4	4.7	5.2	25.8	18.7	6.8	1.1	0.5	27.8	17.8	6.9	2.6	11.4	2.6	2.1	9.2	9.9	7.9	16.0	7.8	3.9	0.2	0.2	24.4	18.3	7.0	10.0	9.7	17.2	27.9	17.3	15.9	12.3	27.3	12.5	9.2	4.2	4.2	6.9	5.6	11.7	11.8	45.1	22.6	14.9	20.4	7.4	15.8	17.3	11.9	12.2	14.1	18.5	34.5	14.9	11.6	13.5	19.1	10.1	10.3	33.8	6.7	26.4	22.5	15.6	17.1	3.9	32.4	13.1	393.1	604.5	105.2	327.2	303.6	9.8	755.2	165.6	246.3	216.1	48.8	5.9	91.9	162.5	250.0	1.5	410.0	221.1	0.0	188.1	49.6	617.1	761.5	748.2	106.8	373.8	12.7	81.8	133.2	143.4	1.7	68.4	643.2	490.9	244.3	77.7	120.7	209.6	203.4	27.6	91.0	27.0	174.6	2211.4	1.6	5.7	269.9	120.6	154.5	59.8	284.3
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 21.6"	"Cell type enhanced"	"Detected in some"	18	"Club cells: 2.3;Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 9.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.5	0.3	0.2	0.2	0.3	1.0	0.4	0.5	0.7	0.4	0.2	0.0	0.0	0.1	0.2	1.6	1.4	0.2	2.0	2.3	0.2	0.3	0.7	0.2	1.6	0.3	0.3	0.8	0.5	0.3	0.1	0.6	0.5	2.1	0.5	0.1	0.3	0.3	0.0	21.6	0.8	0.2	2.5	0.7	0.5	0.2	1.1	0.0	0.0	1.2	3.3	0.7	0.5	0.3	1.7	0.5	1.9	0.8	0.5	1.3	0.3	1.3	0.3	0.8	1.1	0.9	0.5	1.6	0.6	0.3	0.3	0.2	1.3	1.2	1.1	0.5	0.2	0.7	0.9	9.9	0.3	0.4	1.7	0.5	1.6	1.6	0.5	0.4	0.9	3.4	0.4	0.6	0.7	0.3	1.0	0.6	1.0	1.2	4.1	0.9	1.1	0.7	1.3	1.9	0.7	0.5	1.9	2.1	1.0	1.0	1.5	1.2	1.0	1.2	0.7	2.9	1.2	1.2	0.8	5.1	1.5	1.4	1.9	0.7	1.6	0.8	0.7	0.6	0.9	1.9	1.9	0.7	0.8	1.0	0.6	0.8	1.2	0.9	0.6	0.4	1.7	1.1	1.0	1.7	0.5	0.8	0.5	1.3	0.3	0.2	0.3	0.5	0.7	0.2	0.3	0.3	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GAGE1	CT4.1	ENSG00000205777	"G antigen 1"	Q13068	X	49589496-49608536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	37	"testis: 36.8"	"Cell type enriched"	"Detected in some"	11	"Spermatogonia: 107.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 249.2"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8			0.0		0.0	0.0	0.0	0.6	1.0	0.7	0.8	0.1	0.7	0.0	0.0	0.0	0.0	249.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.8	0.1	0.3	0.3	0.7	0.0	0.2	0.3	0.3	0.0	0.0	0.6	0.1	0.3	0.7	0.1	0.8	1.0	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	9.7	107.0	0.0	0.0	0.0	0.0	0.0
GAGE12C		ENSG00000237671	"G antigen 12C"	A1L429	X	49532211-49539538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 23.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"U-2 OS: 7.8;U-266/84: 27.7"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12D		ENSG00000227488	"G antigen 12D"	A1L429	X	49541767-49549094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 23.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"U-2 OS: 7.8;U-266/84: 27.7"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
GAGE12F		ENSG00000236362	"G antigen 12F"	"P0CL80, O76087, P0CL82"	X	49551278-49568218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"blood: 16.2;testis: 58.6"	"Cell type enriched"	"Detected in single"	5	"Spermatogonia: 1.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"AN3-CA: 136.7;K-562: 133.6"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	58.6			0.0		0.0	0.0	0.0	7.0	8.5	3.1	9.1	9.6	14.7	16.2	1.1	0.0	0.0	136.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.5	6.9	0.9	0.0	0.1	0.0	7.9	0.0	0.0	0.0	17.0	0.9	9.1	3.1	3.9	7.5	2.5	7.0	10.3	7.2	0.0	6.2	8.5	7.5	0.9	9.6	6.3	8.5	14.7	16.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0
GAGE12G		ENSG00000215269	"G antigen 12G"	"P0CL81, O76087, P0CL82"	X	49570434-49577754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	33	"blood: 7.4;stomach 1: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"AN3-CA: 149.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0			0.0		0.0	0.0	0.0	2.6	1.4	1.3	2.5	0.4	7.4	6.2	0.0	0.0	0.0	149.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.4	2.5	1.3	0.8	2.2	1.3	1.5	3.6	0.5	0.0	2.6	0.6	3.2	0.0	0.4	1.8	1.4	7.4	6.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12H		ENSG00000224902	"G antigen 12H"	A6NDE8	X	49579983-49587301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	223	"testis: 22.3"	"Cell type enriched"	"Detected in single"	12	"Spermatogonia: 4.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	52	"A-431: 19.6;U-266/84: 58.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	58.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.7	0.0	0.0	0.0	0.0	0.0
GAGE12J	GAGE11	ENSG00000224659	"G antigen 12J"	A6NER3	X	49322057-49329384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 20.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"AN3-CA: 48.3;K-562: 48.4"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.2			0.0		0.0	0.0	0.0	0.8	0.6	0.4	0.7	0.8	1.6	0.0	0.0	0.0	0.0	48.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	9.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.2	0.4	0.8	0.7	0.9	0.0	0.7	1.6	0.4	0.4	0.8	0.5	0.6	1.4	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
GAGE13	GAGE12A	ENSG00000274274	"G antigen 13"		X	49331616-49338952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	17	"testis: 26.8"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 13.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AN3-CA: 129.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	26.8			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	129.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	13.9	0.0	0.0	0.0	0.0	0.0
GAGE2A	"CT4.2, GAGE2"	ENSG00000189064	"G antigen 2A"	Q6NT46	X	49589529-49596827	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	34	"testis: 46.7"	"Cell type enriched"	"Detected in some"	13	"Spermatogonia: 363.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Karpas-707: 19.6;T-47d: 67.6;WM-115: 74.4"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"															"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7			0.0		0.0	0.0	0.0	1.0	0.7	0.4	0.7	0.5	0.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	19.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	67.6	0.0	0.0	11.0	2.4	0.0	0.0	0.2	2.9	0.0	0.6	0.0	74.4	0.4	0.6	0.1	0.1	0.7	0.0	1.0	0.5	0.6	0.0	0.4	0.5	0.2	0.0	0.5	0.6	0.7	0.6	1.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	12.9	0.0	27.8	363.5	0.0	0.0	0.0	0.0	0.0
GAGE2E	GAGE8	ENSG00000275113	"G antigen 2E"		X	49341192-49345922	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	52	"blood: 5.8;stomach 1: 18.4;testis: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 144.6;K-562: 69.2;T-47d: 35.0"									HPA043232	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0		0.0	18.4	4.9			0.0		0.0	0.0		2.5	2.6	0.7	1.2	0.7	5.8	0.2	0.0	0.0	0.0	144.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.2	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	35.0	0.0	0.4	8.9	0.3	0.0	0.0	0.1	2.6	0.0	0.1	0.0	15.2	0.7	1.2	0.3	1.0	0.0	0.0	1.5	0.4	2.2	0.0	2.5	4.9	0.0	0.7	0.7	0.0	2.6	5.8	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAK	DNAJC26	ENSG00000178950	"Cyclin G associated kinase"	O14976	4	849276-932373	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.70e-6)"	"unprognostic (1.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (7.41e-4)"	16.5	18.9	16.8	42.2	22.7	29.9	16.7	32.4	27.7	18.0	32.5	19.7	18.6	48.2	22.4	18.6	23.7	20.5	26.8	11.4	16.2	13.9	25.0	22.1	22.2	22.4	17.6	19.4	21.1	33.0	19.5	18.9	16.6	17.9	20.3	15.2	16.9	70.8	20.6	26.2	25.6	41.1	15.2	14.3	30.9	39.2	28.6	18.5	23.6	19.7	19.2	22.3	18.9	18.9	4.7	7.1	10.8	19.3	4.0	8.5	6.9	15.9	12.8	7.8	13.3	7.9	6.8	20.2	15.1	9.1	10.4	8.7	16.2	22.8	13.6	10.3	9.1	18.8	13.9	8.1	12.5	4.9	13.8	14.2	15.7	12.9	12.1	14.8	16.0	24.8	9.8	10.8	10.5	5.1	6.6	11.4	16.2	16.9	17.3	7.0	15.4	27.0	41.3	14.0	17.0	23.5	22.4	9.1	12.1	8.4	13.0	13.5	14.7	8.8	11.2	10.5	6.9	18.0	13.8	18.6	14.5	8.5	14.7	20.1	28.0	18.7	15.1	16.4	19.6	13.3	2.6	9.0	10.8	8.5	8.9	7.4	4.7	5.6	5.7	6.0	4.0	3.2	4.7	6.7	4.0	19.3	7.1	5.0	6.9	16.8	22.7	32.4	27.7	16.2	13.9	17.6	19.4	17.9	18.5	23.8	28.6	15.3	12.6	15.0	27.8	9.5	15.3	16.0	22.7	24.4	60.9	16.1	8.3	16.1	102.1	20.4	83.6	0.0	24.3	13.5	15.3	23.7	17.4	25.9	31.3	11.1	28.3	21.5	37.8	102.9	23.3	25.0	15.1	16.2	53.5	15.6	29.1	45.8	17.7	26.4	25.2	19.4	15.3	30.2	26.3	19.4	26.0	27.3	45.3	36.3
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168750	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.8"	"Cell type enriched"	"Detected in some"	6	"Hofbauer cells: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 4.3;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	3.9	5.4	8.4	4.2	9.4	1.0	4.1	1.5	10.9	7.8	6.5	18.6	0.4	4.1	9.0	3.7	8.4	6.3	5.9	4.9	8.0	3.8	1.8	1.0	5.3	2.9	11.9	4.7	7.6	1.5	1.6	4.6	9.8	8.1	6.5	7.0	4.2	24.9	4.3	1.9	27.8	8.9	10.6	14.9	2.7	2.8	4.4	10.2	37.8	2.0	2.4	3.9	7.3	10.6	0.1	4.3	0.3	0.1	0.2	15.0	2.2	0.0	0.6	4.0	1.8	3.6	7.1	7.6	2.2	2.2	1.3	1.8	0.4	0.2	0.7	0.5	7.4	2.3	8.6	0.2	1.3	0.4	0.0	0.4	0.2	0.1	0.2	2.4	0.4	2.4	8.7	3.4	3.9	0.4	2.8	2.5	3.1	1.1	0.1	2.4	0.3	2.7	0.1	1.3	8.2	0.9	2.2	1.8	0.1	0.0	0.3	0.2	1.7	0.6	0.0	4.6	0.7	0.0	0.2	2.2	0.2	1.2	0.3	0.1	0.1	0.1	1.7	1.4	0.4	29.6	0.0	0.1	0.0	0.5	0.0	0.0	0.0	4.4	0.3	0.0	0.1	15.0	4.5	0.3	0.2	0.1	4.3	1.1	2.2	8.4	9.4	1.5	10.9	8.0	3.8	11.9	4.7	8.1	10.2	0.0	0.3	0.0	2.0	3.8	0.0	0.8	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.5	0.1	0.5	0.0	0.0	0.0	0.2	6.0	0.3	0.0	0.0	38.9	0.0	0.0	1.8	0.3	0.0	4.4	0.7	5.0	1.0	0.6	0.5	0.5	2.9	4.9	0.0	0.0	0.0	2.2	0.4	0.2	7.0	0.7	0.0	6.0	0.9
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.3	19.7	7.9	12.5	2.9	4.2	7.7	11.2	15.2	19.9	14.9	18.0	55.1	3.9	15.8	6.5	26.7	18.2	7.0	28.7	15.1	8.3	4.5	11.0	10.0	19.5	30.1	4.7	3.3	8.9	15.1	18.3	46.0	20.1	17.0	8.5	12.2	1.0	14.1	17.5	7.8	5.1	2.2	23.0	19.2	9.3	7.7	4.9	32.2	11.0	3.1	7.0	20.3	18.4	19.9	9.4	13.5	3.9	9.3	14.5	21.7	14.9	13.7	5.1	12.2	5.1	15.4	20.2	7.8	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6	11.9	33.5	8.2	17.9	6.8	14.3	3.1	40.8	12.0	19.4	38.4	15.7	47.8	29.9	42.8	20.5	9.8	92.2	0.0	103.0	85.9	6.3	18.2	10.4	31.8	81.7	7.9	11.6	9.2	3.7	5.1	4.4	12.2	23.6	29.7	119.4	20.6	62.8	84.5	3.2	64.1	13.1	0.0	5.3	14.6	9.7	4.3	80.6	7.5	58.2	38.3
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765711	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 36.7"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		8600	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.62e-5)"	6.4	3.3	3.8	6.2	4.4	3.6	14.2	4.6	5.1	4.7	9.3	3.7	3.5	15.9	4.7	5.0	9.0	4.8	3.8	7.2	3.6	3.6	12.3	31.6	4.7	11.7	4.3	3.8	5.2	16.0	1.9	2.6	4.6	3.2	4.7	1.3	3.6	14.9	4.7	5.4	6.2	17.3	3.7	4.0	7.2	5.3	5.7	3.3	7.6	3.3	5.1	4.8	3.6	5.0	10.6	36.7	20.7	30.2	5.7	9.4	14.6	8.1	30.7	1.9	8.6	2.7	6.8	7.2	6.6	5.5	6.8	6.4	17.0	1.6	12.7	8.3	3.5	5.0	4.8	2.0	1.9	0.7	5.5	19.2	7.9	11.6	28.5	9.3	5.3	17.6	6.1	2.7	3.4	1.5	3.4	15.8	7.2	6.2	7.8	4.1	34.9	14.6	19.9	2.1	3.8	15.9	17.5	21.4	21.1	3.8	3.3	4.2	11.6	5.6	14.5	14.4	1.5	11.8	8.7	13.9	10.1	9.7	9.6	5.8	19.7	4.8	3.2	11.3	12.4	7.8	2.6	30.2	8.3	9.4	25.5	8.5	10.6	7.8	8.6	27.2	6.8	4.2	6.2	20.7	5.7	20.2	36.7	8.7	14.6	3.8	4.4	4.6	5.1	3.6	3.6	4.3	3.8	3.2	3.3	14.9	11.7	15.8	8.2	7.7	6.8	17.6	20.4	0.0	3.4	12.2	0.0	41.6	58.0	23.3	0.6	17.9	12.3	0.0	47.9	88.4	28.2	7.0	27.6	107.1	49.1	3.2	8.1	30.7	45.2	3.6	28.7	28.4	37.1	27.9	13.6	15.8	25.0	25.1	22.6	75.3	6.2	6.5	12.3	1.2	22.0	10.9	35.4	15.0	24.0	7.6
GALK2	GK2	ENSG00000156958	"Galactokinase 2"	Q01415	15	49155656-49367869	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043564, HPA048267"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043564: AB_2678557, HPA048267: AB_2680335"	"unprognostic (2.27e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.88e-5)"	"unprognostic (2.33e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.93e-1)"	12.7	24.9	10.2	9.2	15.3	6.5	12.4	15.7	15.3	14.7	16.3	15.3	25.6	21.5	16.0	9.9	11.5	13.5	9.9	14.2	11.3	10.3	32.3	28.4	12.7	8.0	16.2	9.4	11.5	18.5	19.4	34.2	10.8	15.3	11.1	17.9	13.2	12.2	16.3	12.5	11.6	17.9	11.8	13.9	12.8	13.9	9.2	14.8	14.6	16.7	10.9	11.5	10.3	11.6	9.6	10.4	24.2	11.3	12.8	23.1	8.7	6.3	7.4	3.4	4.5	8.8	13.7	10.0	6.6	8.8	6.6	7.8	9.4	6.7	2.0	5.3	6.9	8.2	9.3	13.5	9.4	9.3	11.4	4.0	11.8	7.0	7.9	9.6	8.1	3.7	7.1	17.3	7.0	17.5	7.6	13.3	4.9	11.8	11.5	7.1	6.8	5.9	6.5	1.4	19.3	7.1	7.2	4.2	30.6	12.2	6.0	4.1	2.7	7.3	15.2	12.4	7.1	7.5	7.9	7.2	6.4	4.4	26.3	6.2	9.5	32.7	3.9	10.0	31.1	8.8	24.2	10.6	18.6	12.8	11.3	13.6	9.6	13.1	12.6	10.4	6.7	10.5	10.7	5.4	12.8	10.8	9.2	23.1	8.7	10.2	15.3	15.7	15.3	11.3	10.3	16.2	9.4	15.3	14.8	3.0	9.3	11.5	12.7	4.9	12.6	1.1	30.6	30.8	9.1	5.2	35.3	12.4	24.9	15.8	5.0	7.1	15.5	23.3	11.4	23.6	8.9	10.4	2.3	24.2	17.8	14.3	8.6	22.7	14.6	3.1	10.6	11.0	13.5	13.6	22.6	10.3	11.8	17.0	10.6	37.9	24.8	0.0	7.5	19.1	5.4	5.5	21.5	10.8	15.8	9.5
GALM		ENSG00000143891	"Galactose mutarotase"	Q96C23	2	38665910-38741237	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 54.2"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 102.0;Proximal tubular cells: 198.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.2;T-cells: 29.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.8;U-266/70: 31.3"	"Low region specificity"	"Detected in all"							"HPA035472, HPA035473, HPA064835"	Enhanced		Approved	Nucleoplasm		NA	NA		570000	Nucleoplasm		"HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723"	"unprognostic (5.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"prognostic favorable (1.32e-4)"	11.2	54.2	3.1	10.4	2.5	0.7	4.6	1.9	2.7	5.9	28.4	2.5	44.3	22.7	6.8	11.8	3.4	11.6	13.3	7.7	2.5	1.8	39.1	28.8	5.8	6.4	2.4	1.9	6.4	7.9	10.4	2.4	3.1	2.9	8.1	10.7	15.3	7.9	29.1	4.6	2.2	39.8	5.4	3.3	4.1	5.0	4.7	2.1	6.4	7.4	3.3	9.3	6.5	5.2	2.8	4.5	13.2	2.1	2.3	29.7	5.3	0.0	10.6	3.3	0.0	11.1	6.5	5.9	1.3	4.0	3.0	4.9	11.9	5.6	4.1	7.9	5.9	6.0	1.7	4.6	0.3	6.0	18.7	7.7	2.2	2.9	23.7	4.0	0.9	0.1	4.5	0.1	6.8	0.0	4.2	3.4	0.0	6.3	27.8	5.5	0.3	9.1	14.8	5.0	22.6	3.5	5.7	0.2	8.0	3.9	18.4	0.6	4.7	0.0	7.6	5.4	4.4	3.6	2.1	1.3	1.0	0.2	7.3	0.4	31.3	21.1	0.1	6.9	2.6	0.1	13.2	2.1	1.8	10.2	1.5	15.0	2.8	16.0	14.8	4.5	2.5	5.8	5.0	5.1	2.3	0.2	0.4	29.7	5.3	3.1	2.5	1.9	2.7	2.5	1.8	2.4	1.9	2.9	2.1	26.8	11.2	12.5	6.5	6.0	2.9	17.3	22.9	24.1	9.1	66.3	0.0	17.0	21.6	9.1	0.8	9.3	102.0	0.0	13.3	25.1	14.3	6.4	6.9	40.4	91.8	3.2	12.7	6.2	12.3	0.5	18.7	36.1	16.9	12.6	36.5	34.6	10.1	63.0	91.9	198.6	7.1	6.5	9.6	1.0	2.1	5.3	5.3	24.5	72.8	4.7
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433, HPA074225"	Supported		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2400000	Cytosol		"CAB026404: , HPA042433: AB_2732499, HPA074225: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	11.9	14.9	9.3	11.2	11.1	25.0	14.8	12.9	15.4	11.1	15.5	11.5	8.8	13.3	9.0	19.9	10.2	14.8	12.7	12.5	11.2	13.9	13.7	17.8	14.7	10.6	11.8	5.2	11.9	7.3	9.9	13.2	15.6	11.6	10.5	8.3	7.1	10.6	9.0	7.1	10.0	17.2	9.4	9.4	10.4	9.5	27.4	8.8	7.9	14.5	6.1	9.0	11.1	13.0	2.1	7.1	19.3	11.2	2.4	3.1	4.7	2.5	19.6	2.8	20.1	22.7	10.9	19.7	8.2	12.8	9.0	7.0	10.2	17.0	3.2	17.4	13.4	13.6	15.1	4.1	6.5	5.5	2.1	6.5	2.0	8.0	5.8	15.3	1.5	13.3	15.2	12.7	10.1	2.8	12.9	7.7	3.5	4.4	1.9	5.3	15.0	4.1	6.5	6.6	6.5	9.1	8.7	2.5	5.4	5.6	6.0	7.4	5.7	19.5	1.8	9.7	7.2	12.7	14.4	14.4	19.8	15.1	20.2	4.5	2.0	1.9	5.5	21.5	13.3	11.7	0.9	11.2	19.3	3.1	8.0	2.6	2.1	1.8	2.7	7.1	0.9	1.7	2.1	14.2	2.4	5.6	3.0	3.0	4.7	9.3	11.1	12.9	15.4	11.2	13.9	11.8	5.2	11.6	8.8	14.9	4.5	1.9	6.4	5.8	3.9	6.7	2.5	26.8	7.9	3.5	5.9	7.9	3.3	5.3	14.3	4.9	12.3	0.0	3.0	11.4	10.2	5.7	1.1	5.7	17.8	23.8	11.5	7.4	13.9	28.0	6.6	8.0	6.8	20.8	6.9	8.5	5.4	12.4	6.3	4.5	9.7	6.5	9.2	49.5	33.7	5.0	13.3	5.7	8.6	5.1
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.7"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 74.0;TIME: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		830000	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	9.5	13.5	8.4	15.4	9.1	10.1	8.7	3.2	6.2	15.9	10.6	14.4	1.0	8.8	4.9	11.5	5.9	9.2	17.8	7.7	6.9	7.5	6.8	3.4	10.1	11.5	7.2	5.2	43.7	9.2	14.1	9.7	5.2	10.1	8.3	9.4	31.6	11.6	2.4	5.6	4.0	12.4	14.1	7.7	16.7	13.8	4.3	9.2	5.6	10.6	4.2	9.3	7.5	10.0	4.7	3.1	5.7	3.8	3.9	7.5	2.1	6.2	21.4	5.2	4.5	11.1	9.9	4.0	18.1	10.1	7.2	6.9	3.0	14.4	4.1	12.8	30.4	12.9	1.1	2.4	14.1	6.6	10.6	1.7	11.2	4.1	4.0	8.5	2.4	10.9	12.3	3.3	5.8	8.6	74.0	13.8	3.1	2.5	13.0	12.3	6.5	0.2	1.6	2.0	17.6	4.4	1.2	2.7	4.1	10.0	4.3	0.7	1.7	8.0	30.0	2.3	8.0	11.6	1.8	40.5	17.6	4.2	4.3	19.2	3.7	3.6	2.2	11.5	4.8	5.3	3.4	2.7	5.3	7.5	3.6	6.6	4.5	4.3	4.8	3.1	4.7	1.9	5.3	5.7	3.9	3.8	2.7	3.5	2.1	8.4	9.1	3.2	6.2	6.9	7.5	7.2	5.2	10.1	9.2	8.9	36.1	12.3	3.5	4.2	3.5	4.1	5.1	0.0	12.5	14.0	3.9	0.6	8.3	9.3	10.6	13.4	15.5	23.3	26.2	1.2	9.1	9.9	10.3	4.7	7.2	0.0	2.9	19.0	15.4	16.0	35.4	9.7	0.0	6.4	16.1	20.8	26.5	11.5	47.0	2.9	11.4	6.5	7.3	1.7	3.1	3.1	0.7	13.8	9.3	2.8
GALNT14	"FLJ12691, GalNac-T10, GalNac-T14"	ENSG00000158089	"Polypeptide N-acetylgalactosaminyltransferase 14"	Q96FL9	2	30910467-31155202	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 42.7"	"Cell type enhanced"	"Detected in some"	18	"Distal tubular cells: 11.6;Ito cells: 11.1;Proximal tubular cells: 39.7"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 45.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"A549: 13.1;RPMI-8226: 15.2;RPTEC TERT1: 22.4;RT4: 16.6;SCLC-21H: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030138			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		9400	"Golgi apparatus"	Nucleoplasm	"HPA030138: AB_2673332"	"unprognostic (5.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.51e-3)"	1.2	1.5	1.5	0.9	3.7	4.3	1.1	1.8	9.6	1.4	0.6	1.8	0.3	0.6	0.6	1.0	10.2	1.1	3.7	0.4	1.6	1.5	42.7	1.2	0.6	2.6	1.2	2.3	0.9	2.7	7.6	5.7	0.2	0.9	1.7	0.2	2.1	1.7	0.2	0.4	1.9	3.1	0.7	0.8	1.8	0.6	1.6	0.3	0.1	1.1	1.0	4.2	2.0	1.4	1.4	0.0	10.6	0.0	0.0	0.0	0.1	11.1	13.1	0.0	0.0	0.0	0.0	0.0	3.7	2.0	2.5	0.3	0.0	0.0	10.4	3.8	0.2	0.0	0.0	0.4	0.5	0.4	0.3	1.3	5.8	0.0	0.0	0.0	8.4	0.0	0.1	2.3	0.0	8.6	0.1	0.0	0.3	0.0	9.3	0.0	5.1	0.0	0.0	6.2	0.0	0.0	7.3	0.0	15.2	22.4	16.6	12.3	8.9	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	9.8	0.0	0.2	0.9	2.8	0.0	0.0	5.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.1	1.5	3.7	1.8	9.6	1.6	1.5	1.2	2.3	0.9	0.3	0.0	0.0	0.8	3.8	2.5	0.2	0.4	0.0	0.0	1.2	8.7	0.0	0.0	11.6	2.5	5.3	0.6	0.4	0.0	0.3	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	11.1	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	39.7	0.3	6.5	0.8	0.4	3.4	0.6	0.0	0.0	0.0	1.0
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174649-16231992	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 66.7;brain: 52.3"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 19.5;Endothelial cells: 15.2;Ito cells: 39.9;Muller glia cells: 48.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 44.9;ASC TERT1: 44.3;HSkMC: 33.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 10.7;pons and medulla: 6.7"	"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		25000	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	66.7	5.3	7.6	2.6	17.4	1.1	22.8	2.3	31.5	3.9	8.6	28.1	1.1	2.8	3.5	3.3	11.4	5.3	5.2	7.3	14.8	6.6	8.3	2.8	3.1	3.4	38.9	8.4	8.4	3.2	1.6	1.0	35.5	24.8	4.9	3.8	1.3	8.0	4.1	17.3	11.6	5.3	10.5	52.3	12.8	4.6	8.1	19.9	0.0	6.3	1.6	1.5	16.6	23.5	0.6	0.9	0.9	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.0	44.9	44.3	0.0	1.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	33.7	0.0	0.4	0.5	0.3	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.2	7.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.0	0.6	0.4	0.2	0.9	0.3	0.3	0.9	0.3	0.3	7.6	17.4	2.3	13.6	14.8	6.6	38.9	8.4	24.8	19.9	0.0	1.7	0.0	0.5	0.5	0.8	1.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	19.5	15.2	0.0	0.0	0.0	0.0	2.9	1.2	1.1	0.2	0.1	0.0	0.0	39.9	0.6	10.6	1.7	0.2	0.0	0.0	0.0	48.3	0.2	0.0	0.7	0.0	3.1	0.0	1.2	10.2	0.5	0.6	0.0	0.0	0.0	0.1
GALNT16	"GalNAc-T16, GALNTL1, KIAA1130"	ENSG00000100626	"Polypeptide N-acetylgalactosaminyltransferase 16"	Q8N428	14	69259277-69357033	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 7.4;ASC diff: 9.8;hTEC/SVTERT24-B: 13.9;hTERT-RPE1: 14.2;SCLC-21H: 7.3;U-2 OS: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059136, HPA075325"	Approved		Approved	Vesicles,Cytosol		NA	NA		250000	"Vesicles, Cytosol"		"HPA059136: AB_2683919, HPA075325: "	"unprognostic (9.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.62e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (5.23e-6)"	"unprognostic (5.38e-3)"	"unprognostic (3.34e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.96e-5)"	13.6	15.5	20.0	2.9	17.9	0.8	14.5	16.1	21.7	7.8	4.1	5.0	4.0	3.2	6.4	6.0	5.1	6.5	4.8	27.6	18.3	27.2	5.6	3.0	4.2	4.2	6.6	25.2	2.8	5.6	4.0	4.1	1.2	13.0	4.6	3.4	1.7	28.9	6.6	5.3	7.0	5.0	11.3	8.7	14.3	2.4	3.3	3.3	0.0	3.5	6.3	2.2	5.0	3.8	0.5	0.2	1.3	0.5	0.3	0.3	0.2	0.0	0.6	7.4	0.2	9.8	4.5	0.0	1.0	0.0	1.3	1.9	0.4	0.0	0.0	0.2	1.2	0.6	0.0	2.4	0.0	0.2	0.1	5.1	0.0	0.1	0.3	0.1	0.0	0.5	0.4	0.0	13.9	0.0	14.2	0.8	0.0	0.0	0.0	2.3	0.3	0.0	0.0	1.4	0.0	0.1	0.0	3.9	0.0	0.5	0.0	7.3	2.4	1.6	0.3	0.0	0.3	0.2	0.0	0.1	1.5	16.7	1.9	1.5	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.5	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	0.5	0.3	0.2	1.3	0.3	0.1	0.2	0.1	0.2	20.0	17.9	16.1	16.2	18.3	27.2	6.6	25.2	13.0	3.3	0.0	0.0	0.0	0.5	3.7	1.9	38.2	0.0	0.0	0.0	0.0	2.0	0.1	3.3	0.0	6.4	0.1	0.0	0.0	0.0	0.0	5.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.4	0.9	0.0	3.3	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.6	6.5	9.2	0.7	1.9	2.9	0.0	0.0	0.0	0.4
GALNT18	"GalNAc-T18, GALNT15, GALNTL4, MGC71806"	ENSG00000110328	"Polypeptide N-acetylgalactosaminyltransferase 18"	Q6P9A2	11	11270876-11622005	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 41.7;Cytotrophoblasts: 37.3;Endothelial cells: 34.9;Muller glia cells: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"gdT-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"A-431: 18.9;HaCaT: 24.2;HBEC3-KT: 16.9;PC-3: 17.0;RPMI-8226: 17.7;SK-BR-3: 22.1;U-87 MG: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012955, HPA070681"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		200000	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA012955: AB_1849460, HPA070681: "	"unprognostic (1.26e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.81e-2)"	18.6	6.0	15.5	4.9	13.5	0.8	9.1	21.3	16.2	7.0	13.3	5.8	8.3	3.9	15.0	6.4	7.8	7.6	12.6	21.9	13.1	7.0	19.7	6.6	31.2	5.8	10.0	12.1	3.8	9.5	9.1	4.3	26.6	12.8	8.2	4.3	7.1	10.4	11.5	6.1	7.6	4.9	15.0	6.5	4.0	4.1	13.3	8.4	0.7	39.2	5.6	4.2	10.3	9.1	0.0	0.0	0.0	0.0	0.0	1.7	0.3	18.9	6.9	0.9	4.2	0.0	0.0	0.1	2.1	5.2	0.2	0.0	0.7	2.5	0.0	1.5	0.0	2.6	24.2	4.6	16.9	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	7.0	0.0	6.4	0.0	0.0	8.6	0.0	0.0	0.9	4.6	0.2	0.0	0.7	0.0	17.0	0.0	0.0	17.7	13.1	2.3	0.3	1.9	3.5	22.1	0.1	0.6	4.6	0.0	0.0	0.3	3.8	0.1	0.1	0.0	0.0	0.0	16.0	0.0	4.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	15.5	13.5	21.3	16.2	13.1	7.0	10.0	12.1	12.8	8.4	41.7	5.8	0.0	5.8	4.9	0.8	7.3	22.9	12.0	14.8	19.2	2.0	37.3	13.3	18.3	2.1	34.9	0.0	0.0	3.4	2.2	2.8	9.8	1.1	2.6	2.3	0.0	0.0	22.1	1.5	0.7	1.4	0.5	1.7	0.0	0.0	44.1	5.8	0.0	2.8	28.1	1.8	12.9	5.2	0.5	1.0	4.6	12.9	0.0	0.8	1.0
GALNT4	GalNAc-T4	ENSG00000257594	"Polypeptide N-acetylgalactosaminyltransferase 4"	Q8N4A0	12	89519408-89524806	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 1.1;Ciliated cells: 5.3;Club cells: 3.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 18.8"									HPA076116			Approved	"Golgi apparatus"		NA	NA		270000	"Golgi apparatus"		"HPA076116: AB_2686778"	"unprognostic (2.96e-2)"	"unprognostic (7.65e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.94e-5)"	"unprognostic (3.50e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.81e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.52e-1)"	5.0	2.4	4.0	5.8	3.2	3.9	2.6	1.4	3.4	11.1	14.3	3.7	2.7	11.1	9.5	1.9	3.7	7.7	15.8	2.9	1.9	1.7	8.3	5.6	3.2	1.7	4.4	1.1	4.3	8.6	1.1	5.9	2.9	3.7	2.9	11.4	3.3	22.6	1.2	1.1	1.8	20.8	2.0	2.6	7.5	21.0	1.4	3.7	0.2	2.7	2.0	8.2	4.1	2.8	2.8	3.4	5.9	7.5	7.3	5.8	2.7	2.5	7.8	2.7	15.1	5.6	8.1	1.9	6.3	2.9	2.6	2.7	3.0	4.9	0.0	1.5	4.7	0.9	4.0	0.8	4.1	4.4	6.6	1.7	3.2	1.4	2.4	2.6	2.9	7.1	3.6	1.8	5.3	2.3	5.8	8.2	0.4	1.9	1.4	4.0	2.0	0.2	5.6	1.8	5.6	18.8	0.6	0.5	1.2	7.7	8.1	0.1	1.2	0.8	4.3	5.7	2.7	8.4	2.8	7.6	5.4	1.9	3.3	2.0	1.3	2.3	1.2	2.7	1.4	3.1	5.9	5.2	2.4	3.2	7.4	5.8	1.9	1.8	2.4	3.4	2.8	2.6	2.3	5.0	7.3	7.5	1.2	1.9	2.7	4.0	3.2	1.4	3.4	1.9	1.7	4.4	1.1	3.7	3.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257598-157314211	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 145.9;Mucus-secreting cells: 66.8;Urothelial cells: 121.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 28.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 23.6;BJ: 15.5;BJ hTERT+: 27.8;CAPAN-2: 13.6;fHDF/TERT166: 32.4;HaCaT: 27.7;K-562: 16.0;LHCN-M2: 27.7;U-138 MG: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA		630000	"Golgi apparatus, Cytosol"	"Nucleoli, Vesicles"	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.4	0.2	0.2	1.5	0.2	0.5	1.1	28.2	0.2	7.5	12.0	0.7	0.0	2.3	0.5	0.5	9.0	0.2	17.1	0.9	0.4	0.2	0.3	0.2	15.5	0.0	0.2	0.0	0.3	1.5	0.0	6.8	0.1	4.4	1.6	16.1	0.3	18.9	0.2	0.2	0.5	8.4	0.8	0.3	0.3	15.2	0.5	0.0	0.1	0.3	12.2	11.7	2.3	6.6	0.2	0.1	0.2	0.1	0.1	0.5	0.0	23.6	2.6	0.0	0.0	1.0	8.3	0.0	15.5	27.8	0.2	0.6	1.1	13.6	0.0	0.0	32.4	0.0	27.7	0.5	5.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.5	0.0	0.0	0.0	16.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.2	28.2	0.2	0.4	0.2	0.2	0.0	4.4	0.0	145.9	29.7	0.0	10.3	0.7	0.0	0.4	2.5	5.3	36.4	0.0	0.0	0.0	0.0	0.8	5.1	0.0	18.6	23.3	2.9	0.0	2.1	7.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.6	3.3	2.8	66.8	0.0	31.4	31.7	0.0	0.0	0.0	0.0	0.1	2.6	0.2	0.1	0.0	0.0	20.7	121.3
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 35.4"	"Cell type enriched"	"Detected in many"	4	"granulocytes: 164.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 33.6;CACO-2: 33.2;OE19: 28.5;SK-BR-3: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		2900000	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	3.1	1.8	4.0	4.1	9.5	4.4	10.6	1.0	5.1	19.5	13.4	15.4	0.5	11.8	0.9	14.4	2.8	3.7	6.8	0.8	7.1	3.6	2.5	0.8	4.1	4.0	14.4	3.6	1.4	6.3	0.4	1.6	9.9	5.8	1.3	3.9	0.9	23.8	6.3	0.6	5.5	16.9	0.8	8.3	5.5	35.4	0.8	9.7	6.6	1.8	2.3	6.6	2.2	2.2	2.9	3.7	23.8	6.5	10.8	3.4	2.8	11.5	1.2	0.2	0.0	0.0	0.1	18.5	19.3	33.6	8.3	5.6	33.2	6.1	0.1	1.8	10.9	0.0	11.1	0.6	8.4	5.2	2.6	1.2	7.3	0.2	0.2	0.3	3.9	26.1	0.7	7.8	7.4	7.1	0.0	20.3	4.2	1.6	0.3	0.0	22.6	12.4	2.9	1.6	28.5	20.9	0.0	0.0	3.3	6.5	0.8	0.1	7.4	0.1	33.8	0.0	3.9	18.8	1.7	23.9	0.0	4.2	0.0	0.0	0.6	0.1	1.0	2.3	8.7	0.1	4.5	4.4	23.8	3.4	3.7	1.4	0.8	1.7	2.6	3.7	2.9	2.7	2.3	0.8	10.8	6.5	3.1	1.1	2.8	4.0	9.5	1.0	5.1	7.1	3.6	14.4	3.6	5.8	9.7	3.0	3.7	15.2	2.7	2.6	0.4	0.8	2.5	10.7	14.8	1.8	0.0	11.3	3.3	2.7	1.6	1.4	20.4	0.0	9.8	40.7	1.7	5.0	164.7	0.0	13.2	0.0	0.0	2.5	12.0	1.0	0.0	11.8	1.7	1.0	14.2	0.0	15.6	26.2	0.4	1.8	0.0	0.0	0.9	0.2	1.2	8.2	4.0	8.7	9.2	5.4
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168753-173323967	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.4"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 70.2;Glandular cells: 85.7;Mucus-secreting cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		5000000	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	3.7	4.4	8.4	7.4	8.4	5.0	12.0	27.6	8.0	13.4	23.3	9.4	2.8	14.1	9.3	5.5	12.0	4.9	9.5	3.5	6.5	5.2	4.9	1.2	4.5	5.2	10.8	7.0	7.2	14.9	5.3	5.6	6.3	11.2	20.3	26.7	6.2	20.1	4.2	1.4	3.1	16.2	8.4	16.3	5.7	32.8	6.4	8.8	67.4	6.6	4.4	9.6	9.4	4.8	5.0	9.8	16.8	11.4	5.5	6.8	4.7	20.4	10.7	10.6	3.3	5.7	8.4	15.2	5.4	6.1	5.1	7.0	3.3	32.5	11.4	4.0	4.8	13.7	17.5	4.4	9.5	6.9	44.2	8.7	13.9	22.3	0.1	3.8	20.4	9.9	5.4	8.6	11.3	5.7	19.3	33.5	8.3	9.2	17.8	25.7	6.7	15.0	11.3	10.4	20.4	7.1	15.0	9.8	2.9	37.2	9.6	8.5	6.5	2.5	15.0	7.4	14.4	6.0	6.1	40.0	3.6	16.2	0.1	11.6	5.2	0.0	6.1	14.8	12.3	13.0	9.6	11.4	14.6	4.3	6.0	6.2	5.0	4.9	4.6	9.8	3.1	3.9	3.0	16.8	5.5	6.1	4.1	6.8	4.7	8.4	8.4	27.6	8.0	6.5	5.2	10.8	7.0	11.2	8.8	6.0	29.4	4.7	7.8	1.5	36.4	5.9	12.7	14.7	30.7	19.2	2.0	0.9	0.0	12.2	1.8	6.9	70.2	0.0	43.4	2.9	6.6	85.7	23.1	0.0	9.6	9.5	21.9	8.0	21.3	3.1	8.6	8.8	8.5	8.2	125.7	7.5	33.8	50.7	4.9	8.6	23.6	12.9	6.8	2.3	4.4	1.0	0.7	4.4	37.4	15.7
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	"Q9NY28, P17658"	12	4720341-4851927	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 12.7;intestine: 33.2;testis: 18.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 74.9;Late spermatids: 88.4;Mucus-secreting cells: 32.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.1;NTERA-2: 9.3;SuSa: 11.2;U-266/84: 7.5"					"Not detected"	"Not detected"			"HPA012638, HPA073461"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	Yes	No			"Golgi apparatus, Vesicles"		"HPA012638: AB_2294503, HPA073461: AB_2686604"	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	1.1	2.2	5.3	2.2	6.5	0.5	3.1	1.4	12.7	1.0	15.5	9.4	0.0	7.2	0.9	0.4	0.7	1.2	1.1	3.7	8.0	1.7	1.2	0.8	0.9	1.0	5.7	9.6	1.6	0.9	0.2	3.7	0.5	6.0	1.1	33.2	0.1	1.0	0.9	0.7	0.9	14.7	2.1	3.5	1.2	1.3	18.5	11.5	0.0	0.8	0.5	0.9	1.2	0.9	1.0	0.7	0.1	0.1	0.9	3.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	26.1	0.0	0.0	0.2	0.1	9.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	11.2	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.3	7.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.3	0.7	1.2	0.0	1.0	0.0	0.1	0.1	0.9	0.0	0.7	3.0	0.0	5.3	6.5	1.4	12.7	8.0	1.7	5.7	9.6	6.0	11.5	6.0	0.3	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.3	0.0	0.0	88.4	1.4	0.0	0.0	0.0	32.6	0.1	0.3	0.0	2.5	1.0	0.3	6.5	0.0	11.6	3.6	0.0	0.0	0.0	1.8	0.0
GALNT9	GALNAC-T9	ENSG00000182870	"Polypeptide N-acetylgalactosaminyltransferase 9"	Q9HCQ5	12	132196372-132329349	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"brain: 52.4"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 7.3;Collecting duct cells: 26.2;Proximal tubular cells: 5.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.6;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.6"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075016			Approved	Vesicles		NA	NA			Vesicles		"HPA075016: AB_2686729"	"unprognostic (1.13e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.69e-2)"	2.6	2.2	9.3	1.0	6.7	0.6	0.5	52.4	27.9	1.1	0.8	0.8	0.0	1.1	1.8	7.7	0.5	1.9	0.7	0.6	12.9	6.8	3.2	0.5	0.9	1.3	4.3	10.8	1.3	0.4	1.9	2.7	0.5	6.9	1.0	0.6	0.3	1.2	1.7	0.5	0.9	1.0	0.6	1.7	1.2	0.7	0.9	1.1	0.0	6.1	0.0	0.4	0.7	0.1	2.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.7	0.0	6.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	26.6	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	2.6	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.3	6.7	52.4	20.2	12.9	6.8	4.3	10.8	6.9	1.1	0.0	1.1	0.0	0.4	0.0	7.3	0.8	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.1	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.8	5.0	2.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.8
GALR1	"GALNR, GALNR1"	ENSG00000166573	"Galanin receptor 1"	P47211	18	77250549-77277896	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.3;brain: 3.5;pituitary gland: 4.9"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 21.4;Early spermatids: 46.5;Intestinal endocrine cells: 16.9"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.0"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"hypothalamus: 6.1"	"Low region specificity"	"Detected in many"			HPA074584			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA074584: "	"unprognostic (1.65e-1)"				"unprognostic (1.56e-2)"	"unprognostic (2.85e-1)"			"unprognostic (3.00e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.34e-3)"	"unprognostic (7.33e-3)"	"unprognostic (9.49e-2)"	"unprognostic (2.18e-1)"		1.1	5.3	1.2	0.3	0.8	0.7	0.5	0.0	3.5	0.0	0.3			0.4	0.2	0.5	0.0	0.3	0.1	0.1	0.7	2.0	0.1	0.5	0.0	0.1	0.8		0.1	0.5	0.0	4.9	0.0		0.8	0.5		0.5	0.7	0.1	0.4	0.5	0.1	0.9	0.0	0.3	0.4			0.3		0.0	0.0	0.1	0.4	0.4	1.6	0.2	0.5	0.3	0.0	0.3	0.4	0.6	0.8	0.5	1.2	0.6	0.2	0.5	0.1	0.1	0.8	1.1	0.8	0.2	0.4	0.2	0.4	0.4	0.3	0.1	1.1	0.6	1.1	0.8	0.5	0.3	0.5	0.8	0.8	0.4	0.3	0.3	0.5	0.3	0.5	0.4	1.6	0.1	0.9	0.4	0.9	0.6	0.1	0.5	0.5	0.4	0.4	0.2	0.6	1.5	0.5	0.2	0.4	0.4	0.9	0.5	0.4	0.6	0.6	0.7	1.1	0.1	0.6	0.3	0.4	0.8	0.3	0.4	1.0	0.2	0.3	0.3	0.2	0.3	0.3	0.3	0.2	0.1	0.4	0.2	0.2	1.6	0.5	0.2	0.4	0.1	0.0											0.0	5.1	0.0	0.7	0.0	1.8	0.4	0.0	21.4	1.2	1.8	0.0	0.0	0.0	0.0	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.1	0.0	16.9	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		NA	NA		120000	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favorable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.3	16.1	8.0	13.8	12.5	7.4	6.6	9.3	7.3	8.5	19.4	5.8	12.4	18.1	7.2	8.4	7.7	6.5	10.5	10.9	6.7	8.6	11.8	47.0	6.8	10.8	9.0	6.0	8.7	7.6	12.1	10.3	21.7	7.5	7.2	6.8	11.0	12.5	13.4	9.5	14.4	26.1	5.9	5.0	9.4	8.1	2.6	7.1	11.3	8.5	7.2	10.6	7.0	6.5	16.3	15.9	10.9	17.5	20.5	21.1	13.1	5.0	6.7	6.1	2.5	8.4	8.5	7.1	3.7	10.7	3.9	4.5	8.3	4.7	5.6	3.9	4.5	1.5	2.7	1.1	10.4	0.7	8.4	4.5	2.3	13.4	8.4	8.2	1.3	3.0	12.3	6.6	2.5	3.1	8.3	9.5	7.4	1.9	6.2	6.3	4.4	4.8	9.5	2.1	5.8	1.2	7.4	5.6	3.0	10.8	7.0	1.4	5.4	4.7	9.4	5.1	4.6	8.4	7.3	1.4	1.8	3.3	3.3	0.0	3.5	2.0	1.2	4.1	4.0	9.9	10.9	17.5	8.3	12.1	15.0	16.7	16.3	19.8	16.3	15.9	9.3	12.2	12.0	3.3	20.5	14.1	13.3	21.1	13.1	8.0	12.5	9.3	7.3	6.7	8.6	9.0	6.0	7.5	7.1	6.0	23.4	12.3	13.7	19.3	40.6	20.7	15.3	6.7	10.3	15.7	45.2	59.8	24.9	16.7	6.9	12.0	18.0	0.0	6.5	29.6	13.1	4.5	19.7	52.9	21.0	44.5	15.6	20.3	11.9	31.3	17.0	13.3	20.3	14.4	15.1	18.9	8.5	21.8	13.1	29.4	37.0	6.5	10.1	4.2	4.7	17.7	49.4	23.3	19.8	7.8
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		37000000	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	33.6	34.6	16.2	23.3	20.7	17.9	30.1	19.9	31.0	38.9	31.5	29.8	43.4	26.0	44.0	38.6	29.2	34.2	33.8	32.6	17.2	16.5	35.9	91.5	31.4	30.2	21.7	19.5	49.0	51.4	56.6	27.3	61.1	20.0	29.4	32.6	33.7	43.5	40.7	28.2	24.5	39.8	37.4	19.5	37.4	31.2	27.7	20.2	41.8	45.6	25.2	34.0	36.0	29.4	14.6	17.5	16.5	18.8	22.5	20.0	17.6	42.5	37.3	46.7	84.6	72.1	63.1	50.6	48.0	72.1	66.5	57.5	31.1	79.2	29.2	97.1	84.8	52.9	58.2	56.3	53.9	68.9	23.5	24.3	28.8	51.2	12.9	53.3	44.6	36.3	61.2	35.0	66.1	69.4	84.2	61.6	30.0	40.8	52.7	59.7	37.4	23.2	14.5	39.5	35.0	30.3	31.0	56.0	73.3	32.6	34.8	24.7	33.5	68.6	44.5	51.1	52.5	58.3	38.1	46.3	66.6	42.6	52.2	44.6	52.9	61.2	22.3	73.1	24.0	64.7	16.5	15.0	14.4	20.0	18.8	20.0	14.6	13.8	15.9	17.5	13.1	17.9	16.3	7.0	22.5	16.4	11.6	13.0	17.6	16.2	20.7	19.9	31.0	17.2	16.5	21.7	19.5	20.0	20.2	11.9	26.8	19.7	22.3	25.1	29.5	6.5	61.1	10.7	7.9	64.6	56.9	71.8	5.0	43.0	15.3	31.5	35.1	0.0	36.9	114.6	43.7	31.3	10.5	80.2	51.7	33.4	30.6	51.5	41.2	11.0	54.1	24.9	33.7	36.9	50.5	40.2	38.3	25.9	64.0	24.2	33.9	32.3	26.7	18.4	48.6	27.4	67.1	24.2	55.2	26.0
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	13.3	14.0	12.5	17.3	20.7	17.6	14.4	16.6	14.2	15.8	14.3	25.6	15.4	11.7	17.9	26.0	20.7	12.9	13.0	12.4	13.4	10.4	13.5	18.0	30.5	13.8	25.0	13.7	18.8	13.1	17.4	20.5	10.8	19.8	13.1	17.8	18.3	20.4	13.7	23.9	13.9	15.4	15.9	25.1	15.5	13.1	24.5	22.6	17.4	16.8	12.3	18.3	16.2	16.3	17.6	12.2	9.3	10.1	4.0	7.4	4.7	6.2	3.2	7.9	8.6	9.6	13.6	5.0	13.7	14.8	15.1	12.7	4.7	4.4	3.4	7.5	13.8	10.5	13.0	9.5	14.6	10.5	8.5	4.4	8.5	8.6	9.2	8.1	8.2	7.4	9.2	8.7	6.1	10.5	8.5	10.2	8.7	8.8	9.6	11.9	1.3	5.5	9.1	4.9	2.7	4.2	10.6	9.3	11.8	11.4	5.8	6.0	8.5	7.7	6.7	4.8	4.5	2.5	19.4	9.2	15.9	4.2	13.1	8.2	10.4	13.7	6.9	7.5	15.1	8.7	9.3	9.3	7.4	3.7	10.1	5.0	16.2	5.7	6.9	12.2	17.6	7.4	4.4	5.0	4.0	8.1	9.6	5.5	4.7	12.5	20.7	16.6	14.2	13.4	10.4	25.0	13.7	19.8	22.6	17.9	36.3	8.3	15.1	9.3	5.1	6.9	2.5	12.0	10.3	1.8	9.8	4.4	5.0	4.3	9.0	4.0	8.4	0.0	3.3	4.2	4.5	6.5	10.4	9.0	6.0	3.2	4.1	7.4	11.6	3.0	6.6	10.3	13.5	11.8	5.5	10.4	5.0	16.5	6.0	6.3	6.5	12.9	5.2	14.2	14.4	4.5	2.4	5.0	7.5	21.3
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		2200000000	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	188.4	332.6	95.9	149.5	93.6	154.4	209.1	143.2	204.0	209.6	218.8	234.7	129.4	220.4	28.3	168.8	159.1	107.3	89.1	332.2	145.5	193.2	96.8	121.9	208.7	199.3	126.2	197.0	98.1	129.1	108.5	206.0	232.8	501.3	230.7	161.2	65.4	46.4	238.1	376.0	224.4	103.7	354.5	226.1	110.8	182.6	170.9	104.9	238.5	230.6	68.0	109.1	126.4	329.8	190.3	285.1	51.5	139.2	143.9	163.6	197.8	84.4	247.4	105.5	76.7	284.0	346.8	124.9	256.0	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9	220.3	245.0	821.1	1485.4	1615.7	992.1	33.2	1355.4	275.7	444.7	970.1	392.7	4082.4	2934.5	4447.1	583.7	1564.4	2836.9	443.9	3299.5	7140.5	1484.6	1124.2	551.6	1346.2	3470.6	2218.3	1273.2	1144.2	2599.6	1556.8	823.5	2367.4	4003.5	3613.2	2061.2	5234.8	4742.6	2687.7	965.3	5345.0	1026.0	1131.8	2133.1	429.6	390.5	1399.2	3925.6	1271.1	3009.6	2464.1
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533412-35545316	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 154.6"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 6946.0"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0.0	0.3	0.3	0.3	0.3	0.0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1.0	1.2	0.8	1.4	2.0	0.8	4.5	16.5	4.6	6.9	0.0	0.0	3.9	1.3	0.0	0.0	0.0	10.0	7.6	7.5	2.2	0.0	1.9	5.5	0.0	0.0	0.0	7.3	8.0	5.0	10.5	5.1	0.1	4.5	6.0	0.0	0.0	0.0	0.0	2.9	0.0	7.3	12.0	4.4	0.0	14.1	1.7	2.1	6.2	2.9	2.2	5.3	3.2	5.8	0.0	4.5	8.3	3.7	1.7	4.2	4.9	3.3	3.4	1.9	1.5	5.3	6.0	1.3	1.9	12.3	3.3	4.4	2.9	8.1	1.9	0.0	0.8	1.2	1.1	0.6	2.0	1.1	0.4	1.9	1.0	2.1	1.1	1.2	0.0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1712.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	6946.0	23.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	25.8	0.2	30.4	13.5	0.1	0.0	0.0	0.0	0.0
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: AB_2683904"	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	16.6	18.9	15.2	19.5	19.9	34.7	22.4	11.0	16.5	14.6	20.9	12.4	15.5	17.0	24.3	14.8	26.6	17.2	17.8	11.6	14.2	13.3	15.6	20.0	13.7	17.2	15.5	17.1	20.2	24.1	15.7	19.1	24.8	13.8	17.3	21.0	14.5	23.3	17.5	13.8	25.4	16.3	19.0	18.1	18.8	15.1	27.7	16.3	29.5	17.3	27.6	22.4	15.5	15.5	11.3	9.3	7.4	9.3	9.5	10.7	4.3	15.9	18.5	12.7	17.2	6.8	9.7	11.0	16.6	9.0	13.7	11.1	28.8	20.2	38.8	10.9	12.5	14.6	7.6	23.3	16.5	22.8	11.5	22.9	23.2	16.7	31.5	16.5	49.5	12.2	8.8	17.3	16.9	12.1	9.6	16.6	17.9	55.2	11.9	16.8	34.0	30.6	34.2	20.7	25.2	22.4	20.7	20.8	14.4	18.0	22.4	18.7	19.2	10.4	27.2	14.7	10.1	9.6	14.8	14.4	13.7	19.2	10.1	21.1	15.1	24.5	48.0	9.8	24.3	14.8	7.4	5.9	3.3	9.7	9.3	10.3	11.3	9.2	9.8	9.3	10.0	10.7	9.9	1.0	9.5	8.0	9.2	9.6	4.3	15.2	19.9	11.0	16.5	14.2	13.3	15.5	17.1	13.8	16.3	3.0	13.4	29.0	25.3	51.4	11.1	12.3	15.3	34.8	30.7	15.7	13.7	56.9	21.6	40.4	1.1	23.2	12.3	46.7	46.3	54.6	20.3	18.3	18.5	18.7	31.5	4.8	17.9	17.8	12.3	3.6	20.4	16.5	16.9	10.8	34.7	25.7	41.7	24.6	17.7	33.6	8.6	6.5	18.6	42.1	37.3	52.4	73.5	17.0	40.4	30.3
GAREM1	"C18orf11, FAM59A, FLJ21610, GAREM"	ENSG00000141441	"GRB2 associated regulator of MAPK1 subtype 1"	Q9H706	18	32124877-32470484	"Predicted intracellular proteins"		Mitogen		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.5"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 48.3;Urothelial cells: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 12.2;hTERT-HME1: 21.2;RT4: 18.0;SH-SY5Y: 14.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040709, HPA042046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040709: AB_2677090, HPA042046: AB_2677818"	"unprognostic (9.52e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.49e-6)"	"unprognostic (2.36e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	11.1	8.7	9.7	2.9	10.9	8.0	6.0	17.6	11.1	6.0	7.2	19.5	0.3	6.5	4.2	3.4	11.0	4.8	4.9	8.9	11.8	5.8	15.3	12.5	5.2	1.3	16.3	10.1	4.4	43.5	1.9	5.1	4.8	13.2	4.3	6.3	3.0	11.2	5.1	7.7	13.9	7.8	4.6	12.9	3.1	12.7	6.7	16.4	0.0	3.5	3.1	2.9	9.3	9.1	1.9	5.0	2.6	1.0	3.1	1.4	0.0	1.0	1.6	1.7	0.3	4.7	3.3	4.8	0.3	0.0	0.0	0.0	0.3	2.6	3.0	2.5	0.2	2.0	3.4	2.6	5.0	0.0	1.0	1.6	0.0	3.0	1.0	2.4	0.3	0.2	3.9	12.2	0.2	21.2	0.2	0.2	1.8	0.1	0.6	1.8	2.5	0.8	0.1	1.9	7.9	0.9	1.2	6.9	5.3	6.1	18.0	5.7	14.9	3.9	5.1	0.2	2.2	1.0	2.6	0.2	1.2	1.4	0.0	0.5	2.1	0.2	0.7	1.9	0.0	1.4	0.0	1.0	0.2	0.5	0.1	0.2	0.3	0.8	0.5	0.1	1.9	1.0	1.4	2.6	3.1	0.1	5.0	0.1	0.0	9.7	10.9	17.6	11.1	11.8	5.8	16.3	10.1	13.2	16.4	8.9	35.2	0.0	30.5	0.0	31.8	0.0	7.6	8.1	15.9	24.4	3.9	15.6	1.7	9.4	10.1	0.0	6.3	0.0	11.4	2.0	0.3	48.3	3.5	7.7	1.6	39.7	3.5	0.6	3.7	2.5	1.7	0.9	0.0	1.0	10.2	41.9	10.3	7.0	4.9	20.9	7.0	0.0	0.0	1.4	2.5	0.0	28.0	0.0	8.3	68.5
GAREM2	"FAM59B, FLJ00375, GAREML, KIAA2038"	ENSG00000157833	"GRB2 associated regulator of MAPK1 subtype 2"	Q75VX8	2	26173091-26189663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 21.2;parathyroid gland: 17.0"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 39.7;Muller glia cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 15.4;SH-SY5Y: 9.5;U-2 OS: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071575			Approved	Cytosol		NA	NA			Cytosol		"HPA071575: AB_2686420"	"unprognostic (1.70e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.04e-1)"	3.2	1.6	19.9	1.8	13.9	0.9	1.5	8.2	21.2	2.5	3.0	11.7	0.7	1.2	3.0	1.7	2.6	2.4	2.8	2.0	17.9	11.0	1.8	0.5	1.1	2.2	13.1	8.9	4.1	4.4	17.0	1.4	1.5	16.5	1.7	2.9	0.9	1.8	3.5	3.7	2.4	1.1	3.6	15.9	1.6	1.5	2.6	13.9	0.0	2.6	0.0	2.0	2.1	1.2	0.8	2.5	1.6	0.6	0.4	1.9	0.3	2.6	4.0	4.9	0.4	0.8	1.8	0.4	1.5	0.0	0.4	0.4	7.7	0.9	0.0	2.0	3.1	4.9	0.1	15.4	0.0	0.7	1.7	5.7	1.3	1.3	0.5	6.0	0.1	0.3	2.3	0.7	2.3	0.2	0.3	1.8	3.8	7.1	0.2	2.8	0.0	0.4	0.5	5.2	0.4	1.1	1.6	0.0	0.0	2.5	0.9	1.0	9.5	3.4	0.3	2.9	1.5	0.2	8.0	0.8	2.1	13.1	3.8	0.1	0.3	0.0	1.6	0.1	0.0	2.8	0.4	0.6	0.2	1.2	0.2	0.5	0.5	1.9	1.4	0.5	0.8	1.5	0.5	1.6	0.4	0.5	2.5	0.4	0.3	19.9	13.9	8.2	14.1	17.9	11.0	13.1	8.9	16.5	13.9	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	3.5	2.0	0.3	39.7	1.7	3.4	0.4	0.0	0.0	1.3	2.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.6	0.3	5.2	2.0	0.0	0.0	1.0	0.5	20.6	1.5	0.0	3.2	2.0	1.2	6.5	0.0	1.4	5.4	0.0	0.2	0.0	0.6	0.3
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 7.8;RPMI-8226: 5.6;SH-SY5Y: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	4.2	8.4	11.4	2.5	13.5	0.4	6.4	33.3	19.6	9.1	3.6	12.9	3.8	3.0	10.6	6.6	7.0	8.5	5.8	16.3	7.5	9.6	3.4	3.0	3.8	2.0	7.8	10.7	6.6	3.5	15.7	3.1	2.3	12.9	9.0	3.1	4.3	7.0	6.4	2.2	4.3	2.7	10.1	7.2	2.4	2.9	4.0	9.4	0.0	8.6	1.5	2.1	7.9	4.8	0.5	3.8	0.0	0.5	0.0	1.3	0.2	0.8	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.5	0.3	1.7	1.8	0.6	0.0	1.6	0.1	0.6	0.9	3.2	0.0	0.3	0.0	1.3	0.0	2.7	1.8	0.8	0.7	0.3	0.1	2.5	0.0	0.0	2.3	1.2	2.8	1.3	1.0	0.1	0.9	0.0	0.6	0.7	7.8	2.6	0.1	1.9	5.6	3.0	3.9	2.0	6.1	1.3	4.4	0.5	1.0	1.5	0.0	0.0	0.3	1.8	0.0	0.6	3.9	3.7	1.9	0.8	0.9	0.8	0.0	0.5	0.0	1.2	0.1	0.3	0.2	0.1	1.3	0.5	0.5	0.8	0.0	0.0	0.0	0.0	3.8	0.6	0.2	11.4	13.5	33.3	19.6	7.5	9.6	7.8	10.7	12.9	9.4	0.0	0.0	0.0	1.8	2.4	11.8	6.2	5.1	0.0	3.4	3.5	0.0	0.5	1.7	0.3	1.4	1.0	0.5	0.0	0.6	0.1	3.7	3.3	0.0	1.8	0.7	1.6	1.2	1.3	1.8	0.4	6.9	0.6	1.7	0.0	0.9	5.7	0.6	0.9	3.2	1.1	0.9	0.0	1.7	1.4	3.9	1.8	0.2	0.0	0.8	0.8
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol		NA	NA		1300000	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (5.05e-5)"	"prognostic unfavorable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.9	24.7	16.0	20.0	22.3	14.2	22.2	14.5	20.3	16.2	20.1	20.5	13.3	18.9	21.7	15.9	28.1	19.9	14.3	19.3	16.4	14.9	19.2	33.6	18.3	24.4	21.9	14.6	21.0	30.6	21.6	22.9	23.1	21.0	16.4	26.9	19.5	18.6	16.1	33.2	17.6	19.1	23.5	17.9	21.4	21.9	47.0	21.7	40.8	20.0	19.4	32.8	21.6	17.6	18.7	19.5	9.7	20.9	27.1	21.1	13.3	30.2	14.4	21.3	23.6	15.7	16.2	24.0	19.6	16.7	23.0	24.4	27.3	25.7	40.3	11.7	13.1	30.1	16.0	44.7	30.8	33.6	21.1	26.6	60.8	17.2	17.8	21.5	33.7	16.0	14.3	21.6	27.1	39.9	11.7	21.7	32.6	70.6	25.9	20.7	14.5	35.6	22.6	46.6	44.2	17.0	29.7	39.8	57.0	18.4	16.2	22.7	20.5	27.2	21.4	25.4	20.6	27.2	21.7	15.9	15.6	18.7	13.5	21.0	25.8	35.6	44.0	16.4	39.7	23.1	5.3	15.2	9.7	17.3	20.9	21.1	18.7	16.9	17.9	19.5	14.4	17.7	17.4	7.0	27.1	17.7	14.7	20.6	13.3	16.0	22.3	14.5	20.3	16.4	14.9	21.9	14.6	21.0	21.7	17.9	17.5	28.9	32.0	40.9	17.7	16.9	2.5	14.7	26.1	14.0	33.4	35.3	19.9	22.6	9.1	20.1	11.8	0.0	20.8	29.3	16.6	18.9	7.0	17.1	21.0	4.8	12.6	16.5	18.7	2.2	16.1	16.9	11.8	17.2	15.1	12.9	24.5	10.5	17.0	11.3	25.4	12.9	25.0	50.8	27.2	40.1	21.4	17.5	20.8	38.9
GAS1		ENSG00000180447	"Growth arrest specific 1"	P54826	9	86944363-86947189	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 61.8"	"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 57.5;Muller glia cells: 106.0;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.7;ASC diff: 13.5;BJ hTERT+: 26.7;HSkMC: 19.1;RH-30: 40.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB024164, HPA036085, HPA066902"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.97e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (1.96e-5)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (3.59e-2)"	26.5	2.9	0.9	8.3	1.1	0.0	14.0	1.3	1.3	26.4	9.1	2.1	15.0	0.9	61.8	37.1	10.0	20.9	11.8	9.9	1.0	0.5	4.5	0.8	4.1	5.7	1.8	0.8	31.5	4.3	0.8	3.2	50.1	2.0	18.1	1.0	8.7	4.8	8.9	8.1	10.1	3.4	24.5	0.9	1.2	6.3	18.9	0.5	3.6	6.0	3.8	1.6	11.3	15.6	0.0	0.8	0.0	0.0	0.1	0.6	0.0	0.0	0.0	3.3	19.7	13.5	5.1	0.3	3.7	26.7	1.3	1.1	0.0	0.0	0.0	0.2	6.9	0.1	0.2	0.0	0.1	0.5	2.2	7.6	0.0	11.1	0.0	6.9	0.0	0.3	19.1	2.9	0.4	2.4	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.1	4.1	0.1	0.0	3.9	40.7	0.0	0.2	0.0	0.4	1.7	5.5	0.0	5.8	2.3	0.0	0.1	0.0	5.8	1.6	0.4	1.3	0.0	0.0	0.0	0.2	0.2	1.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.9	1.1	1.3	1.2	1.0	0.5	1.8	0.8	2.0	0.5	0.0	1.1	0.0	8.0	23.0	6.5	5.8	0.0	0.0	1.2	14.0	9.8	17.4	8.3	0.6	0.0	6.1	0.0	0.0	0.3	3.8	57.5	1.9	0.0	0.0	5.2	4.8	0.0	23.4	0.6	0.0	30.0	1.0	16.9	0.0	0.0	106.0	0.3	0.0	11.7	2.2	2.8	38.8	10.3	0.1	0.7	10.9	3.8	0.0	0.0	0.3
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625642-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 10.9;Cholangiocytes: 10.2;Ciliated cells: 6.7;Hepatocytes: 20.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"Hep G2: 19.9;JURKAT: 11.3;Karpas-707: 40.7;SCLC-21H: 11.9;U-266/84: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		Yes	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favorable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.7	1.1	2.1	1.1	3.6	0.4	0.9	0.9	2.2	1.2	0.7	1.4	1.2	2.0	1.1	1.3	1.0	1.5	2.7	3.6	2.1	2.5	5.3	37.2	1.3	1.1	4.3	1.2	2.3	22.7	0.5	4.8	0.7	4.5	1.3	0.7	0.5	2.2	0.9	4.8	1.0	1.8	0.6	8.6	1.5	2.6	1.1	3.2	19.6	1.1	3.0	1.0	1.8	0.7	1.0	0.6	0.3	0.0	0.1	1.7	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.0	19.9	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	11.3	0.7	40.7	0.0	0.1	0.1	0.0	0.1	1.1	0.0	0.4	0.2	2.0	0.0	0.5	11.9	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.2	0.5	0.0	0.5	13.5	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	1.7	1.0	0.4	0.0	0.0	0.9	1.6	0.4	0.0	0.1	0.0	0.6	0.3	0.1	2.1	3.6	0.9	2.2	2.1	2.5	4.3	1.2	4.5	3.2	0.0	0.0	0.0	0.2	0.1	2.7	10.9	10.2	6.7	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.0	0.0	0.0	2.9	0.0	0.3	0.1	0.0	20.2	0.0	0.0	0.0	0.6	0.0	3.7	0.6	0.0	0.0	0.0	0.0	0.3	2.6	0.3	0.0	2.1	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.3
GAS2L1	GAR22	ENSG00000185340	"Growth arrest specific 2 like 1"	Q99501	22	29306582-29312785	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.5"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 77.3;Late spermatids: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.0;eosinophil: 3.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019858	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA019858: AB_1849486"	"unprognostic (3.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (4.23e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-2)"	15.1	10.7	15.2	5.3	13.4	5.4	7.6	10.5	19.8	4.5	5.6	6.8	40.5	17.9	5.1	8.4	8.6	4.6	4.3	7.0	12.9	8.1	6.0	6.6	7.5	2.2	11.3	10.2	2.9	10.0	4.6	6.8	4.3	9.5	7.1	2.2	3.2	12.7	22.9	4.9	22.4	13.0	4.5	10.0	11.5	8.3	16.6	8.8	0.0	4.5	9.2	3.5	3.9	4.7	0.0	1.1	3.1	2.0	0.0	0.2	1.2	8.3	9.8	1.5	6.2	2.4	2.3	9.8	12.6	3.8	5.4	2.8	4.4	6.0	0.0	5.7	6.7	5.6	25.6	2.6	7.1	1.0	11.4	1.2	11.0	7.8	3.1	3.1	0.1	7.7	2.5	4.9	5.1	2.0	3.9	7.1	11.2	5.2	1.7	3.8	7.1	0.2	6.1	2.2	5.6	22.1	0.2	4.4	0.7	3.2	5.4	0.5	8.3	9.7	13.0	7.0	2.0	13.0	1.7	15.0	33.7	23.2	15.0	12.6	0.1	0.1	0.1	14.9	0.4	8.2	0.0	2.0	3.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.5	0.0	1.4	0.0	0.0	1.2	15.2	13.4	10.5	19.8	12.9	8.1	11.3	10.2	9.5	8.8	6.0	1.7	0.8	5.7	25.0	2.6	3.5	7.6	1.4	9.1	1.8	5.9	19.1	6.6	10.8	26.3	19.3	19.0	23.3	6.0	10.4	10.8	6.1	1.1	10.5	13.1	12.7	1.7	77.3	12.6	73.5	8.9	10.7	11.8	4.6	5.4	4.5	8.3	9.3	11.0	7.0	19.2	38.8	14.1	2.3	10.8	28.2	5.6	0.7	9.0	2.2
GAS6	"AXLLG, AXSF, DKFZp666G247, FLJ34709"	ENSG00000183087	"Growth arrest specific 6"	Q14393	13	113820549-113864067	"Predicted secreted proteins"	"Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 328.9;Sertoli cells: 316.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in single"	51	"dendritic cells: 31.7"	"Cell line enhanced"	"Detected in many"		"BJ: 56.3;BJ hTERT+: 81.4;HSkMC: 47.7;RPMI-8226: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008275, HPA056080"	Approved		Approved	"Centriolar satellite,Cytosol"	"Secreted to blood"	NA	NA	8900000	920000	Cytosol	"Centriolar satellite"	"HPA008275: AB_1849497, HPA056080: AB_2683032"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"prognostic unfavorable (8.93e-6)"	25.6	12.6	10.6	6.8	10.7	1.0	35.3	8.0	13.2	52.9	17.1	7.9	35.7	17.9	48.6	20.1	27.0	45.8	24.3	45.9	10.6	8.3	14.7	13.9	27.9	14.4	9.2	9.5	33.0	18.4	7.3	15.8	19.1	13.9	34.2	9.5	20.3	26.8	35.9	27.1	27.9	17.0	53.4	8.8	7.7	16.5	25.2	9.5	10.0	29.2	13.1	6.5	31.8	44.7	0.0	31.7	0.0	0.6	0.0	0.1	0.5	23.8	1.0	0.7	0.6	28.7	16.0	3.0	56.3	81.4	23.5	28.2	1.5	11.5	0.2	1.8	25.3	4.1	22.5	0.3	12.6	6.0	0.0	3.2	0.1	1.7	0.1	20.5	0.1	0.2	47.7	7.4	6.5	6.5	40.6	0.8	0.3	0.4	13.1	37.9	1.1	0.1	0.2	1.5	3.8	1.6	0.7	0.0	77.2	8.5	0.3	3.9	3.5	6.2	0.2	0.0	4.1	7.5	19.1	13.2	6.1	7.6	0.7	15.9	0.0	1.2	0.2	7.0	0.5	0.9	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	31.7	0.0	0.5	10.6	10.7	8.0	13.2	10.6	8.3	9.2	9.5	13.9	9.5	184.6	30.0	11.5	77.9	75.0	18.8	75.9	35.7	10.7	31.8	29.6	0.0	2.0	23.2	27.3	4.3	59.4	72.1	0.0	6.0	1.3	59.2	12.7	8.1	19.5	77.3	328.9	9.9	109.2	19.1	6.6	85.4	18.7	116.4	11.8	57.5	28.3	16.4	31.6	55.9	0.3	8.5	316.9	124.6	3.9	17.6	62.9	2.4	3.8	132.1	33.9
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910609-10198551	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 49.9;Kupffer cells: 62.0;Late spermatids: 52.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"WM-115: 110.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: AB_2685319"	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (6.89e-4)"	19.1	6.5	22.1	15.4	40.3	18.7	10.8	86.2	64.7	22.6	9.3	33.4	1.7	5.2	9.7	4.4	17.0	12.6	11.5	23.1	25.8	15.0	1.5	2.1	9.9	5.9	28.1	25.0	5.9	2.8	1.4	1.7	11.0	14.2	3.7	8.7	7.7	4.0	8.2	3.9	21.2	7.4	16.3	33.8	10.0	4.2	11.8	22.2	2.7	2.5	2.7	7.2	11.7	7.8	0.4	3.6	11.0	17.6	2.8	2.1	4.4	0.0	0.1	0.1	0.2	3.4	4.9	0.0	0.1	0.0	0.5	0.2	0.0	0.0	1.3	0.4	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.3	0.1	1.1	0.3	10.1	0.9	0.0	1.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.0	10.7	3.2	0.5	0.4	0.0	2.8	0.0	9.8	0.0	0.0	0.0	0.6	0.0	0.0	12.7	4.7	0.5	5.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	7.1	110.2	0.4	17.6	10.8	2.1	4.7	0.7	0.3	0.2	1.0	3.6	0.4	0.2	1.0	11.0	2.8	3.1	0.6	0.0	4.4	22.1	40.3	86.2	38.8	25.8	15.0	28.1	25.0	14.2	22.2	0.0	6.2	3.2	3.8	7.3	34.5	11.3	0.0	26.8	1.2	5.2	25.5	1.1	0.0	0.6	49.9	7.0	0.0	0.0	0.0	1.1	43.4	1.6	17.3	0.5	34.5	0.0	0.0	7.4	62.0	52.5	9.5	29.6	32.1	1.0	0.0	8.0	0.3	0.0	1.8	0.0	30.3	0.0	5.2	1.1	6.1	14.4	1.6	7.5	0.0	4.3
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 84.3;Early spermatids: 174.5;Late spermatids: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA041311: AB_2677402, HPA048238: AB_2680324"	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favorable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favorable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	7.1	11.1	8.5	6.5	13.2	2.3	7.6	13.5	12.2	11.7	6.8	10.0	10.8	4.1	12.7	16.2	7.8	26.5	11.6	21.0	8.7	9.8	12.4	6.3	9.9	4.0	8.9	8.9	12.8	12.9	23.2	22.0	3.5	10.1	8.9	4.6	11.0	16.2	12.6	18.8	4.2	4.2	8.4	7.5	4.2	7.6	16.1	6.4	1.7	15.5	5.5	5.2	6.6	5.1	2.5	4.8	4.3	5.0	0.0	3.7	2.3	10.8	8.8	1.1	5.5	5.1	4.0	9.4	2.2	5.5	8.9	2.6	8.8	8.3	0.6	6.0	4.5	5.4	10.8	3.6	6.4	2.0	0.0	6.5	2.3	5.6	10.0	5.8	1.3	1.8	5.2	3.7	6.7	3.1	3.8	5.3	3.8	8.7	1.2	3.8	26.1	1.5	5.5	7.3	6.9	4.6	0.4	10.2	0.6	11.2	5.3	9.3	6.7	11.5	6.2	13.1	1.0	11.7	5.1	3.7	5.5	6.4	3.0	5.1	2.0	3.3	0.0	14.0	1.7	9.6	4.3	3.1	3.7	1.8	5.0	1.8	1.2	2.8	3.7	4.4	2.5	2.3	2.0	4.0	0.0	3.1	4.8	3.5	2.3	8.5	13.2	13.5	12.2	8.7	9.8	8.9	8.9	10.1	6.4	20.8	9.9	0.5	4.2	1.0	8.8	6.4	28.1	84.3	15.9	21.0	19.6	2.6	11.6	14.7	174.5	4.5	4.3	0.0	9.6	3.0	3.3	6.4	2.3	3.6	3.3	25.4	5.8	4.9	0.0	126.7	13.0	3.3	5.0	1.8	5.4	11.4	10.1	3.5	7.1	23.0	25.1	6.5	3.7	18.9	13.6	2.3	1.4	0.0	5.0	4.8
GATA5	"bB379O24.1, GATAS"	ENSG00000130700	"GATA binding protein 5"	Q9BWX5	20	62463497-62475970	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 22.1;intestine: 23.6"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 4.1;Fibroblasts: 1.8;Ito cells: 4.3;Late spermatids: 1.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HEL: 5.0;K-562: 7.9;SiHa: 3.5;T-47d: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067583			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA067583: AB_2685867"	"unprognostic (2.21e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.34e-2)"		"unprognostic (1.69e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	1.9	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	4.4	15.9	0.0	5.2	14.8	3.8	1.7	0.3	9.1	22.1	6.8	0.0	0.0	3.3	0.7	1.6	0.0	0.0	0.0	3.1	0.0	0.3	0.6	0.6	0.0	11.3	0.0	1.0	0.4	0.8	0.1	0.3	23.6	18.3	0.2	0.1	10.3	16.8	0.0	0.0	1.2	0.0	0.0	14.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.6	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.3	5.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.6	3.5	0.0	0.0	1.6	8.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	1.8	0.0	0.0	0.0	0.3	0.0	0.0	4.3	0.0	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.0	0.0
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	15.6	19.3	28.9	17.0	23.3	11.0	24.3	42.3	41.6	14.8	35.1	17.0	28.4	41.5	19.0	22.3	16.6	16.8	21.4	34.6	22.4	21.0	34.8	25.0	20.9	17.3	23.7	19.5	16.4	20.9	27.9	27.1	19.3	36.6	23.9	32.8	28.4	27.7	25.5	46.1	23.5	51.1	23.3	21.0	23.4	26.9	11.6	19.5	10.9	25.4	15.5	16.4	18.2	16.9	5.6	6.8	12.2	6.1	3.1	7.3	3.1	7.9	13.2	18.2	17.6	8.9	5.4	18.5	10.8	8.5	11.0	11.7	14.6	6.4	8.5	7.9	6.6	23.8	8.3	17.4	7.3	5.6	12.1	11.9	9.2	34.4	15.6	9.8	13.6	22.8	9.3	13.7	9.3	9.8	26.9	28.8	8.6	8.9	16.4	10.2	7.9	3.7	14.1	18.8	16.2	20.9	6.8	7.3	7.2	15.3	18.8	14.9	19.9	6.1	15.2	10.7	23.3	10.4	12.4	20.1	12.0	14.5	10.2	13.1	11.2	7.1	7.1	15.0	5.0	9.3	12.2	4.4	2.9	6.0	6.1	4.1	5.0	5.8	7.3	4.2	5.6	3.7	3.2	4.9	3.1	3.7	6.8	4.0	3.1	28.9	23.3	42.3	41.6	22.4	21.0	23.7	19.5	36.6	19.5	11.9	10.1	8.0	16.1	6.5	73.4	10.9	20.4	21.4	14.8	26.2	108.0	8.7	18.3	9.9	12.7	13.7	68.4	0.0	10.4	7.6	7.4	14.9	13.9	16.3	7.9	49.3	34.3	26.4	15.4	17.0	11.5	10.1	11.8	7.2	32.8	15.5	12.6	56.1	9.2	16.5	95.2	12.9	9.9	8.6	4.9	8.7	18.5	12.5	30.3	22.5
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489699-81762161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Cytosol		NA	NA		5900000	Cytosol		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	23.1	22.4	2.2	7.8	4.2	5.6	19.2	4.2	4.6	6.4	7.7	5.2	5.2	4.1	8.4	4.9	7.5	4.9	11.5	19.7	3.6	4.3	14.0	36.3	11.3	7.5	7.9	3.4	8.2	5.7	8.2	11.6	11.4	8.4	5.7	4.5	9.9	8.0	10.1	56.9	5.9	6.3	7.2	6.1	8.0	4.5	4.6	4.1	5.4	6.5	11.2	4.5	9.6	10.0	11.6	13.6	14.5	11.4	13.0	7.2	6.1	12.1	7.3	2.4	34.9	61.4	46.7	4.4	20.2	28.8	12.1	20.6	1.4	3.2	13.6	8.9	24.8	7.2	1.4	2.0	9.3	28.6	6.4	1.1	4.2	15.2	4.5	42.3	14.3	3.7	34.4	6.9	19.5	20.1	30.5	26.9	1.6	3.3	7.9	39.4	3.5	2.4	17.0	2.4	3.4	11.2	4.5	11.1	16.0	8.6	4.1	1.2	1.6	13.2	3.8	4.1	3.7	2.7	11.8	37.3	25.1	5.9	17.6	18.6	36.1	4.1	5.0	40.9	9.6	10.2	6.3	11.4	14.5	5.6	10.4	5.4	11.0	6.0	5.9	13.6	11.6	7.0	7.2	11.0	13.0	10.8	4.5	5.0	6.1	2.2	4.2	4.2	4.6	3.6	4.3	7.9	3.4	8.4	4.1	14.9	11.3	7.2	17.9	27.2	15.9	51.9	15.3	13.4	10.3	29.6	0.0	25.8	34.9	29.0	29.2	28.5	9.6	0.0	21.8	58.4	22.2	15.3	42.7	67.1	23.2	28.6	21.2	14.1	14.5	11.6	16.1	15.1	23.6	12.6	6.9	9.6	34.4	6.8	12.4	46.6	16.8	32.3	41.6	6.5	5.1	18.6	45.9	10.0	7.3	12.4
GBX2		ENSG00000168505	"Gastrulation brain homeobox 2"	P52951	2	236165236-236168369	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 11.9"	"Cell type enhanced"	"Detected in single"	26	"Early spermatids: 1.8"	"Group enriched"	"Detected in some"	6	"glioma: 1.7;testis cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 32.5;BEWO: 5.6;PC-3: 9.6;TIME: 5.1"	"Group enriched"	"Detected in some"	6	"basal ganglia: 0.7;thalamus: 1.4"	"Region enhanced"	"Detected in many"		"thalamus: 6.3"	HPA067809			Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA067809: AB_2685900"	"unprognostic (5.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.55e-4)"	"unprognostic (8.69e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.39e-4)"	0.1	0.1	0.3	0.4	5.8	0.1	0.1	11.9	3.6	0.1	0.2	4.2	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.4	0.6	3.8	0.2	0.3	0.1	0.1	1.2	0.3	0.1	0.1	0.1	0.2	1.4	6.3	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.2	0.3	4.6	0.1	0.1	1.3	2.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	32.5	1.2	0.0	0.0	5.6	0.4	0.0	0.9	0.0	0.7	0.0	0.0	0.6	0.0	1.0	0.0	0.2	0.1	0.2	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	2.1	0.0	0.4	0.8	0.0	0.2	0.8	0.0	9.6	0.0	3.5	0.0	0.3	0.0	0.4	0.2	1.1	0.0	0.3	1.0	0.0	0.0	5.1	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.8	11.9	0.0	0.6	3.8	1.2	0.3	6.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8"	"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 188.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 41.1;neutrophil: 112.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 112.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		890000	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	13.1	6.8	13.4	24.8	21.3	116.0	7.8	6.9	15.8	6.0	7.7	15.3	3.2	8.2	4.6	11.0	5.0	7.2	9.7	11.2	15.9	13.0	8.5	7.6	15.6	51.8	26.0	9.7	4.4	11.5	4.8	8.1	10.6	24.6	5.7	8.6	3.7	6.9	4.9	2.2	3.7	7.8	7.7	30.2	50.0	10.3	10.7	20.8	5.8	7.4	2.5	10.3	10.0	6.3	3.1	8.9	112.7	18.2	0.3	1.3	8.4	1.4	2.1	5.9	0.0	1.4	1.3	0.2	2.1	6.2	3.4	6.2	4.8	16.4	1.9	15.2	0.1	7.8	0.8	2.2	6.9	4.2	9.2	9.3	17.3	1.5	9.2	1.7	21.5	5.0	1.5	2.4	3.1	0.7	9.0	0.4	14.1	0.3	6.7	0.3	16.9	0.5	12.5	3.7	12.0	8.4	7.5	1.4	9.7	18.1	9.6	3.8	6.5	2.8	12.7	10.7	7.2	8.6	9.7	0.4	0.8	6.3	9.8	3.2	6.3	11.8	0.3	5.4	8.4	4.0	4.4	18.2	41.1	0.4	10.7	0.5	3.0	0.6	0.6	8.9	3.1	1.1	0.7	112.7	0.3	8.0	2.2	1.3	8.4	13.4	21.3	6.9	15.8	15.9	13.0	26.0	9.7	24.6	20.8	14.9	44.6	45.9	25.1	13.7	9.0	2.8	50.9	26.8	12.5	31.4	2.0	46.0	64.6	39.8	106.9	25.9	14.7	0.0	53.4	16.4	13.6	27.8	42.8	11.6	91.1	11.1	37.8	39.3	188.7	17.6	10.0	119.8	15.1	66.7	26.1	17.3	34.6	28.1	6.0	52.8	4.6	6.5	18.9	62.9	11.5	15.8	39.2	10.7	26.4	20.4
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580618-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 108.4;Late spermatids: 98.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	11.5	14.1	13.4	11.0	13.7	17.7	14.2	13.9	12.8	11.6	10.2	12.8	8.6	9.6	13.2	10.3	14.1	10.7	12.2	9.0	10.2	7.9	9.8	17.8	10.4	12.3	19.8	7.6	13.6	12.7	14.8	14.5	13.6	13.0	11.5	9.6	8.4	13.8	11.0	12.5	14.5	12.9	8.4	12.1	15.5	12.7	20.7	17.9	15.7	11.8	9.5	14.4	10.3	29.2	8.4	7.9	15.6	9.1	10.2	11.6	8.8	8.4	11.4	5.0	10.8	11.3	7.8	7.0	7.4	8.6	7.4	9.4	9.5	5.8	7.8	4.5	6.8	16.8	9.3	7.3	8.1	8.0	10.8	6.6	5.7	6.2	4.9	16.8	9.8	9.5	7.3	22.3	7.9	15.7	7.0	7.0	7.8	9.3	8.9	8.3	8.4	9.5	8.5	10.5	9.3	8.9	6.8	5.4	8.8	6.4	6.5	8.0	11.6	7.9	37.8	14.7	9.5	6.4	7.1	9.0	11.0	3.5	9.5	8.4	24.5	10.7	5.0	10.9	10.1	11.2	5.8	8.1	15.0	9.1	8.2	11.6	8.4	8.2	8.9	7.9	8.0	6.8	6.7	15.6	10.2	9.1	4.6	7.6	8.8	13.4	13.7	13.9	12.8	10.2	7.9	19.8	7.6	13.0	17.9	11.9	7.7	0.9	5.0	9.4	3.7	3.7	5.1	0.0	3.4	3.5	3.9	5.4	5.0	4.5	108.4	5.6	6.6	0.0	5.5	3.9	4.3	5.3	1.1	6.8	4.5	11.1	6.9	4.9	7.9	98.5	4.9	5.4	11.8	5.4	7.5	4.4	5.5	5.5	3.5	3.3	5.3	6.5	6.1	5.6	4.5	9.2	8.7	5.7	4.5	5.1
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142873-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"pancreas: 202.8"	"Cell type enriched"	"Detected in some"	14	"Intestinal endocrine cells: 5260.0"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 38.0;U-2 OS: 54.1"	"Region enriched"	"Detected in single"	10	"pons and medulla: 3.7"	"Region enhanced"	"Detected in single"		"midbrain: 2.0"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	127000		"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				1.0	0.1	0.2	0.6	0.2	1.1	0.2	0.2	1.8	0.2	6.6	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	3.4	0.2	0.2	0.2	0.2	0.2	0.2	202.8	0.0	0.2	0.2	0.5	0.2	12.6	0.2	0.2	0.2	0.2	2.5	11.0	0.2	0.2	0.2	2.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	2.9	0.0	1.4	9.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5260.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	8.5	0.0	378.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44144271-44198170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 46.8"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 5.5;Cardiomyocytes: 3.1;Fibroblasts: 3.9;Horizontal cells: 4.8;Muller glia cells: 3.0;Smooth muscle cells: 4.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	17	"B-cells: 4.4;T-cells: 4.8"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 12.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	1.1	0.5	3.2	0.7	2.8	0.0	0.7	9.5	3.7	1.4	1.4	1.3	0.7	0.3	1.5	1.5	0.7	2.3	0.9	7.1	2.1	7.5	0.7	8.7	0.7	0.7	2.9	1.2	2.2	2.9	0.0	46.8	3.3	1.6	0.8	0.5	0.8	0.7	1.6	0.7	1.2	0.7	0.7	1.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.9	4.4	0.2	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.6	0.9	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.3	2.2	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.6	4.4	1.6	0.4	0.2	0.7	4.8	0.9	0.0	0.0	0.0	0.0	0.0	0.7	3.2	2.8	9.5	2.4	2.1	7.5	2.9	1.2	1.6	0.7	0.0	0.0	0.0	0.7	1.0	5.5	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	3.9	0.3	0.0	0.6	0.6	4.8	2.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.0	0.1	0.0	2.1	0.0	0.8	0.0	4.3	0.2	0.9	0.1	0.7	0.0	0.0	0.1
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496842-27523684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	16	"liver: 60.9"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 76.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 12.7;Hep G2: 19.4;HUVEC TERT2: 6.2;TIME: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA052227"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB034098: AB_2247323, HPA052227: "	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.2	2.0	0.1	0.1	0.3	0.2	0.1	0.2	0.2	0.1	0.4	0.1	0.1	0.2	0.1	0.3	0.4	0.0	3.9	0.5	0.1	0.0	0.2	60.9	0.1	0.1	0.1	0.1	2.0	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.2	1.3	0.1	0.1	0.5	3.1	0.9	0.2	0.1	0.1	0.1	0.2	0.1	0.1	2.4	0.8	2.6	1.2	1.7	0.9	0.7	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	12.7	0.5	19.4	0.8	0.1	0.4	0.3	1.0	0.5	0.1	2.2	6.2	0.0	0.0	0.2	0.2	0.1	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.5	0.1	3.8	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	2.6	1.2	0.3	0.6	1.0	0.6	0.8	0.4	0.4	0.1	2.4	0.9	0.8	2.1	1.7	0.3	0.8	0.1	0.7	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.3	0.4	0.0	0.0	9.0	0.0	0.0	0.3	0.0	76.9	0.1	0.0	0.0	1.3	1.9	2.8	0.3	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 102.4;Intestinal endocrine cells: 212.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3600000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	15.8	11.1	12.9	9.0	16.0	14.4	13.0	5.4	15.1	6.8	16.2	21.6	8.2	18.9	9.2	5.3	20.0	29.1	14.9	7.4	13.1	10.6	15.4	69.2	12.9	10.1	21.6	12.2	6.2	12.4	6.6	5.4	6.2	13.0	13.0	12.2	5.2	11.2	10.1	7.0	8.6	14.8	11.9	13.6	16.8	14.8	5.2	17.5	3.1	14.1	32.4	10.6	34.4	12.3	1.6	4.2	2.2	1.9	8.0	2.3	0.6	7.3	49.2	4.0	9.5	4.8	2.2	5.4	3.7	6.0	2.8	3.3	7.2	17.1	14.0	7.1	3.3	21.5	10.5	12.3	27.1	3.8	11.0	7.6	9.3	9.5	42.0	5.5	12.3	5.8	3.4	11.5	3.1	14.1	3.7	4.2	12.3	5.1	4.4	1.3	7.7	10.5	4.9	7.5	68.1	4.6	3.5	2.5	12.3	9.1	45.4	11.7	5.7	6.2	10.0	6.5	6.1	6.8	5.8	5.9	2.5	8.8	6.4	5.5	5.9	9.1	8.1	6.3	8.8	4.2	2.2	1.1	0.6	1.2	1.9	0.8	1.6	1.0	2.3	4.2	1.0	0.6	1.3	0.5	8.0	1.8	3.0	1.6	0.6	12.9	16.0	5.4	11.9	13.1	10.6	21.6	12.2	13.0	17.5	0.0	3.7	7.8	42.9	30.9	12.8	17.8	25.5	48.2	47.8	0.0	23.6	5.2	10.0	12.8	1.4	13.5	19.9	46.7	11.0	6.5	8.7	44.8	2.3	102.4	19.8	7.9	212.1	9.2	60.1	1.0	6.1	16.4	8.5	6.4	16.3	13.8	17.1	8.5	8.9	19.8	4.0	12.9	10.3	3.3	8.1	21.8	6.5	10.7	13.8	89.1
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885205-93909456	"Cancer-related genes, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 210.2;Glandular cells: 272.8;Urothelial cells: 201.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	10.3	17.5	7.0	6.0	7.7	11.3	23.9	5.7	8.9	4.5	22.8	4.2	11.5	16.6	3.5	6.5	8.8	12.8	12.5	7.7	6.8	8.9	17.8	41.7	8.4	10.4	9.2	5.7	4.6	6.9	6.3	5.1	10.3	8.7	5.3	5.2	6.4	6.7	6.4	19.2	3.4	20.0	3.4	7.7	6.9	6.1	3.2	2.8	5.6	15.0	23.0	8.6	8.9	8.0	3.2	1.9	3.3	0.7	4.6	6.7	1.2	13.1	20.9	2.3	4.5	7.8	4.9	8.9	15.8	9.8	12.0	9.0	3.5	7.8	5.0	31.6	10.2	39.2	13.3	3.4	6.4	9.7	13.5	4.6	34.9	14.2	15.0	14.6	12.8	5.6	6.0	2.4	24.4	3.9	4.8	13.1	5.7	13.8	7.4	8.6	2.5	9.2	3.0	7.9	12.6	10.0	4.3	7.0	7.3	8.5	15.4	5.4	2.2	14.8	11.7	5.5	27.5	2.6	8.0	13.7	12.6	7.4	23.6	23.6	6.7	8.5	5.2	10.4	7.2	4.4	3.3	0.7	1.3	5.3	0.4	3.1	2.6	5.0	6.7	0.6	3.2	3.2	3.2	2.9	4.6	0.5	1.9	1.3	1.2	7.0	7.7	5.7	8.9	6.8	8.9	9.2	5.7	8.7	2.8	38.7	18.4	13.3	119.7	10.2	23.7	13.5	53.5	49.5	19.4	27.9	5.9	60.1	21.6	24.6	3.0	14.5	25.6	210.2	10.7	16.4	25.0	272.8	19.6	71.6	16.8	31.8	50.4	41.7	17.7	1.9	19.8	15.4	8.5	10.8	9.3	19.3	22.5	7.0	11.7	45.8	12.6	0.0	44.3	22.8	40.4	8.2	37.6	34.6	13.2	201.0
GCM1	"GCMA, hGCMa"	ENSG00000137270	"Glial cells missing homolog 1"	Q9NP62	6	53126964-53148829	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"placenta: 102.4"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 166.4;Syncytiotrophoblasts: 222.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.5"	"Group enriched"	"Detected in many"	8	"B-cells: 1.8;granulocytes: 4.5"	"Cell line enriched"	"Detected in some"	5	"BEWO: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011343, HPA073469"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA011343: AB_2668489, HPA073469: "	"unprognostic (2.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.42e-2)"		"unprognostic (2.96e-2)"	0.3	0.3	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	1.5	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.2	102.4	0.1	0.2	0.0	0.1	0.1	0.1	3.1	0.0	0.4	0.1	0.1	2.2	0.0	2.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.8	0.2	4.5	0.3	0.4	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.0	30.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.0	6.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.6	0.3	2.2	0.2	0.1	0.2	0.7	0.1	0.1	0.2	1.8	0.2	0.2	4.5	0.4	0.3	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.3	1.9	0.0	0.0	0.0	0.2	166.4	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.0	222.5	0.0	0.0	0.0
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 71.5;Melanocytes: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.4;Hep G2: 11.0;SuSa: 10.2"	"Region enriched"	"Detected in many"	4	"basal ganglia: 54.8"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		560000	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	2.0	0.9	2.5	7.9	2.8	0.7	12.7	7.6	1.9	6.0	13.0	2.0	0.9	7.8	5.6	1.3	3.7	1.7	2.8	11.8	2.2	2.4	19.6	14.3	10.4	3.3	2.4	0.4	0.9	5.5	1.0	6.2	3.1	4.0	21.9	3.7	8.1	7.4	0.9	2.3	2.5	25.1	2.6	2.2	4.2	8.3	9.0	2.9	0.9	2.4	1.2	7.2	2.0	3.0	2.1	2.5	4.2	3.1	0.5	0.4	0.7	4.2	3.5	1.2	2.9	0.0	0.0	3.5	0.0	3.1	0.8	0.2	6.2	3.2	2.4	26.4	0.0	1.8	0.1	0.3	3.2	1.8	1.6	0.9	0.5	1.9	11.0	0.0	1.1	3.0	0.0	0.0	0.3	0.0	1.7	7.0	0.0	0.3	0.0	0.3	0.0	0.0	2.3	4.0	0.0	2.4	0.1	2.4	3.8	9.4	2.3	2.6	1.8	0.0	9.2	8.9	10.2	0.1	0.4	5.9	0.5	0.4	0.0	3.4	0.0	0.0	1.7	0.6	0.2	1.4	4.2	3.1	1.3	0.3	2.3	0.1	2.1	0.3	0.4	2.5	1.3	0.4	0.4	0.2	0.5	0.8	0.6	0.2	0.7	2.5	2.8	7.6	1.9	2.2	2.4	2.4	0.4	4.0	2.9	71.5	26.7	12.3	5.5	4.0	4.3	14.9	2.5	30.8	28.4	7.0	0.0	22.4	10.0	2.4	3.3	5.8	28.4	23.3	22.4	1.0	1.1	21.1	2.3	31.1	12.9	3.2	2.4	8.6	6.3	6.0	0.3	6.9	47.2	9.0	2.8	2.9	9.0	1.7	0.0	8.8	0.5	0.0	0.4	1.9	20.4	1.5	9.2	0.0	7.2	7.0
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 99.5;Ductal cells: 59.9;Enterocytes: 119.9;Pancreatic endocrine cells: 45.2;Paneth cells: 59.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 29.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 54.4;EFO-21: 9.4;Hep G2: 10.9;OE19: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.3	0.5	0.3	8.8	0.4	0.0	0.3	0.3	0.3	5.3	37.6	0.3	0.3	25.4	1.3	0.4	8.7	0.7	29.6	0.3	0.3	0.2	9.9	0.4	0.7	0.3	0.3	0.3	1.1	1.7	0.0	0.4	1.0	0.5	1.0	33.4	0.3	27.4	0.3	0.3	0.2	103.3	0.9	0.3	0.3	6.5	1.7	0.3	0.5	0.7	5.2	15.5	0.7	14.0	1.2	1.4	3.4	0.8	1.1	0.7	0.1	0.0	54.4	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	2.3	2.2	0.2	9.4	0.0	3.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	10.9	0.0	0.1	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	27.6	0.1	0.1	0.0	0.2	3.8	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.1	0.1	0.2	3.4	0.1	0.0	2.6	0.8	0.6	0.7	0.4	0.4	0.6	0.5	0.3	0.2	1.2	0.4	0.6	3.4	1.1	0.4	1.4	0.5	0.1	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.0	2.1	0.0	6.7	0.0	0.0	0.5	12.7	0.0	0.0	99.5	0.0	0.0	0.0	59.9	7.6	0.0	119.9	0.0	13.4	0.0	0.0	4.7	0.0	0.0	0.1	0.0	7.5	0.0	0.3	13.3	0.0	0.0	0.0	1.8	18.6	0.0	45.2	59.6	0.0	3.3	0.0	6.5	0.0	0.9	0.1	0.0	0.0	0.0	30.8	43.7
GCNT4	C2GNT3	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4, core 2"	Q9P109	5	75025346-75030899	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.6;intestine: 13.1;stomach 1: 10.4"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 35.7;Cytotrophoblasts: 27.4;Syncytiotrophoblasts: 20.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Group enriched"	"Detected in many"	54	"granulocytes: 13.6;T-cells: 11.6"	"Cell line enriched"	"Detected in some"	5	"RT4: 26.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.6	0.6	0.3	1.0	0.7	0.0	0.9	0.0	2.3	1.1	1.1			13.1	1.4	0.6	1.3	1.1	2.5	0.3	0.3	0.1	1.8	0.4	1.0	1.7	0.1		0.9	3.0	8.4	0.1	3.0		1.0	0.2		0.5	2.4	1.0	1.5	10.8	0.7	0.0	0.6	10.4	1.0			0.5		1.1	6.4	2.0	0.0	0.0	13.6	0.1	0.2	11.6	1.6	0.2	0.1	1.0	1.6	1.8	0.6	0.1	2.0	5.2	1.0	0.9	2.5	0.1	0.0	0.2	1.5	0.6	0.7	1.0	1.8	0.2	0.0	0.0	0.8	0.2	0.2	0.8	0.0	0.0	0.3	2.9	0.1	0.4	0.0	0.0	1.5	0.0	0.3	0.1	0.0	1.4	0.0	0.4	5.7	0.0	0.0	0.0	2.6	0.2	26.6	0.0	0.0	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.5	0.1	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	13.6	0.0	0.0	0.9	0.0	3.5	0.0	8.1	2.6	0.0	0.0	8.1	5.9	0.1	0.2	0.1	0.0	11.6	1.6											3.0	5.3	0.0	5.5	0.6	0.0	0.4	35.7	0.0	4.5	12.2	0.0	27.4	8.3	6.1	0.1	1.0	6.7	0.0	3.7	0.7	1.1	1.5	7.0	0.8	2.1	0.0	0.0	4.9	0.8	0.0	3.7	0.0	0.0	1.0	0.5	0.0	4.9	1.7	2.5	0.6	0.0	6.5	0.9	0.0	0.2	0.1	20.4	0.0	0.6	4.1
GCNT7	"C20orf105, dJ1153D9.2"	ENSG00000124091	"Glucosaminyl (N-acetyl) transferase family member 7"	Q6ZNI0	20	56491492-56525925	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 3.9;bone marrow: 9.6"	"Cell type enhanced"	"Detected in single"	33	"Early spermatids: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA052617, HPA059403"	Uncertain		Approved	"Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Nuclear bodies, Vesicles"	Cytosol	"HPA052617: AB_2681886, HPA059403: "	"unprognostic (3.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.96e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.69e-2)"	0.2	0.2	0.0	0.7	0.0	9.6	0.3	0.6	0.3	0.0	0.2			0.3	0.2	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.1	0.3	0.4	0.4	0.0		0.5	0.5	0.0	0.6	0.1		0.3	0.0		0.4	0.0	0.3	1.0	0.4	0.0	0.1	0.5	0.3	1.6			0.3		0.0	0.6	0.3	1.0	0.9	3.9	0.7	0.3	1.1	0.1	0.6	1.0	0.8	0.5	0.0	0.0	1.1	1.0	0.0	0.0	0.0	2.1	0.5	0.1	0.4	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.1	1.2	1.7	0.5	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	1.0	1.5	0.0	1.3	0.7	1.4	0.5	0.1	0.7	0.1	0.4	0.5	0.0	1.9	1.0	0.5	1.2	1.0	0.2	0.5	0.8	0.2	0.0	2.2	0.4	0.5	0.6	1.6	0.1	0.5	0.3	0.6	0.5	1.1	0.7	0.9	0.8	0.5	0.8	0.7	0.7	0.5	0.4	1.0	1.1	0.4	3.9	0.3	0.7	0.9	0.9	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GCOM1	"FLJ30973, GRINL1A, MYZAP-POLR2M"	ENSG00000137878	"GRINL1A complex locus 1"		15	57591908-57714745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 107.1;smooth muscle: 42.3"	"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 3.0;Cardiomyocytes: 2.8;Paneth cells: 3.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.4;pons and medulla: 3.9"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6;naive CD4 T-cell: 4.0"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;monocytes: 1.5;T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"HEL: 25.3;RH-30: 7.1;RT4: 8.0;TIME: 10.9"									"HPA039827, HPA068141"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039827: AB_10673364, HPA068141: AB_2685962"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.69e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.78e-2)"	6.7	4.6	1.2	1.9	1.4	2.9	10.3	10.4	1.3	4.1	3.6	0.1	2.3	3.6	5.2	1.2	9.9	1.3	2.3	107.1	1.2	1.6	1.2	0.9	7.6	1.7	1.2	0.0	2.3	5.6	0.4	1.0	9.1	3.9	10.2	1.3	0.0	4.6	2.7	7.3	2.6	5.8	42.3	1.0	2.6	3.3	2.5	0.0	0.0	1.1	5.0	4.8	25.3	9.5	3.6	0.5	0.4	1.5	0.0	4.0	4.5	3.3	0.6	0.0	3.3	0.0	0.0	0.8	0.6	2.3	1.1	1.0	2.4	3.3	0.0	0.5	0.0	2.9	2.1	0.0	2.0	0.9	0.0	0.1	25.3	0.7	0.1	0.0	0.1	0.1	0.1	0.1	0.3	5.0	0.1	1.0	0.1	1.3	0.0	0.2	0.4	0.0	0.0	0.1	4.6	0.1	0.0	7.1	0.0	0.0	8.0	0.0	0.8	0.7	0.7	0.0	0.5	3.2	0.0	10.9	0.3	2.1	0.3	0.2	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	1.2	0.7	0.0	0.5	3.6	4.0	0.0	0.4	0.0	1.5	0.0	0.3	4.5	1.2	1.4	10.4	1.3	1.2	1.6	1.2	0.0	3.9	0.0	3.0	0.3	0.0	0.2	0.0	0.0	2.8	0.0	1.4	1.2	0.0	0.0	0.1	0.0	1.4	0.0	0.3	1.3	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	1.3	3.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.3
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 48.3;brain: 17.6"	"Cell type enriched"	"Detected in some"	27	"granulocytes: 214.1"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	10	"cerebellum: 17.6"	"Cell type enriched"	"Detected in single"	439	"basophil: 48.3"	"Lineage enriched"	"Detected in single"	439	"granulocytes: 48.3"	"Group enriched"	"Detected in some"	73	"HEL: 28.5;HMC-1: 113.3"					"Low region specificity"	"Detected in single"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA027507: AB_10600756, HPA027510: AB_2672309"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	3.7	0.3	0.4	1.1	0.4	2.4	1.6	17.6	0.4	3.8	2.1	0.2	0.0	2.2	2.4	2.2	1.9	0.6	2.7	1.3	0.4	0.5	0.5	0.4	5.6	1.1	0.5	0.0	0.3	0.5	0.1	0.4	0.3	1.7	9.5	2.4	0.4	1.0	0.9	0.5	1.2	2.5	6.6	0.9	0.5	1.4	5.3	0.0	1.4	0.4	2.4	1.5	3.4	9.4	0.1	0.0	48.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	113.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	48.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	17.6	0.4	0.4	0.5	0.5	0.0	1.7	0.0	0.0	7.9	0.0	0.0	0.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	6.7	0.1	0.0	0.0	0.0	0.0	0.3	1.3	214.1	0.0	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	6.9	1.6	0.5	0.0	0.0	0.0	0.0
GCSH		ENSG00000140905	"Glycine cleavage system protein H"	P23434	16	81081938-81096425	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.9"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 501.6;Extravillous trophoblasts: 1237.6;Proximal tubular cells: 489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041368, HPA057079"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA041368: AB_10804001, HPA057079: "	"unprognostic (4.09e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.55e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (6.26e-6)"	"unprognostic (1.12e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.47e-2)"	10.9	10.0	28.9	3.7	26.8	3.0	11.4	8.1	21.8	9.9	6.4	15.0	14.2	3.8	9.4	35.9	6.0	10.4	6.3	11.7	23.5	20.6	37.3	55.9	4.0	5.8	30.8	15.8	8.9	10.2	19.4	7.2	12.9	18.7	9.9	7.0	10.4	9.4	9.3	18.1	4.3	3.1	6.9	27.6	2.6	5.2	3.5	17.9	6.7	48.7	5.9	4.8	6.6	4.9	4.4	12.2	2.8	2.6	7.9	7.3	2.9	18.1	8.0	25.3	11.0	12.4	9.6	51.7	10.6	7.9	12.9	6.3	10.7	17.0	4.8	9.6	4.6	9.8	9.3	19.3	10.7	21.6	1.3	25.2	6.2	10.7	33.0	14.1	20.0	7.2	9.8	14.4	8.0	16.5	4.0	6.5	13.5	24.0	1.0	12.8	19.2	13.0	40.6	33.4	14.6	16.8	20.4	13.3	7.2	29.2	16.7	13.1	13.6	15.2	9.9	20.0	20.4	14.5	9.6	5.7	8.4	14.7	13.3	10.9	4.1	8.7	29.0	5.6	12.0	6.7	2.8	1.7	1.7	3.4	2.6	5.7	4.4	3.3	4.9	4.5	3.3	5.8	7.3	2.2	7.9	2.0	12.2	2.6	2.9	28.9	26.8	8.1	21.8	23.5	20.6	30.8	15.8	18.7	17.9	3.0	5.1	31.8	74.7	25.8	44.4	11.8	33.1	20.1	13.6	76.8	35.3	501.6	250.4	57.2	25.7	29.8	9.8	0.0	37.0	1237.6	66.3	92.3	36.8	317.5	102.2	36.5	25.3	31.3	17.6	15.2	130.3	25.7	81.0	24.4	29.9	130.3	38.6	14.0	132.6	489.6	42.3	32.3	58.7	20.0	68.6	23.7	191.3	21.0	48.6	56.2
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;intestine: 54.5;liver: 27.6"	"Group enriched"	"Detected in many"	7	"Enterocytes: 113.2;Hepatocytes: 49.7;Paneth cells: 91.2;Proximal tubular cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 11.1;EFO-21: 44.1;HeLa: 15.4;hTCEpi: 20.6;OE19: 50.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1300000	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.5	1.7	26.7	1.8	27.7	0.5	0.5	0.4	33.8	1.0	20.6	0.9	7.7	47.4	2.4	0.6	0.5	4.7	13.1	0.5	25.7	15.0	21.4	27.6	0.5	0.5	2.9	27.4	0.4	1.7	10.8	1.7	10.3	0.8	0.4	5.5	0.0	0.4	4.1	1.1	1.6	54.5	0.5	0.6	0.5	2.0	1.0	0.2	0.0	0.4	1.0	2.6	3.4	0.5	1.4	0.5	3.0	0.7	1.0	1.0	0.1	11.1	1.4	0.0	0.0	0.0	0.0	0.2	0.0	8.1	0.0	0.0	1.0	6.3	0.0	44.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	50.0	0.0	0.0	0.0	0.3	0.3	2.5	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.0	0.7	0.3	1.0	0.6	0.3	0.6	0.5	0.4	0.3	1.4	0.7	0.7	1.9	1.0	0.4	0.5	0.5	0.1	26.7	27.7	0.4	33.8	25.7	15.0	2.9	27.4	0.8	0.2	0.0	0.3	1.7	0.5	0.0	0.0	0.6	12.7	0.0	0.0	0.0	0.0	0.1	3.3	9.2	1.0	0.0	113.2	0.0	9.7	1.0	0.4	0.6	0.0	49.7	0.2	0.0	4.6	1.3	1.0	0.0	0.3	0.0	0.0	1.0	11.2	0.0	4.4	91.2	0.0	84.2	0.0	0.0	0.3	0.4	4.2	0.1	1.6	0.0	7.8	0.8
GDAP1	"CMT2K, CMT4, CMT4A"	ENSG00000104381	"Ganglioside induced differentiation associated protein 1"	Q8TB36	8	74321130-74488872	"Disease related genes, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.3"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 42.1;Cone photoreceptor cells: 45.2;Horizontal cells: 44.5;Rod photoreceptor cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014266, HPA024334"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA014266: AB_1849581, HPA024334: AB_1849583"	"unprognostic (3.19e-2)"	"unprognostic (1.52e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (2.68e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.17e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.73e-1)"	2.8	11.2	19.2	3.8	25.9	2.1	5.6	24.9	48.3	3.2	2.9	7.6	1.1	3.2	5.4	5.7	5.3	3.7	3.4	2.8	17.6	21.4	5.3	2.0	3.2	3.7	16.5	19.2	8.2	10.8	12.3	16.4	2.3	23.3	5.6	3.6	3.7	2.9	5.4	2.6	2.1	3.0	3.9	14.6	2.9	3.2	5.4	9.6	0.7	7.5	0.5	3.4	3.8	1.8	2.7	1.7	2.8	7.2	1.9	4.6	1.4	2.3	7.7	12.0	2.7	1.0	0.9	1.2	1.0	5.7	6.1	7.0	4.1	2.7	9.2	1.4	1.3	6.4	4.0	6.4	3.9	11.9	7.9	2.0	4.8	4.3	7.9	1.3	3.9	9.9	2.9	1.3	2.9	6.2	0.7	0.7	3.9	2.3	0.1	3.6	2.9	8.0	0.6	13.9	12.5	10.6	4.1	5.7	1.7	2.0	7.2	11.8	28.9	7.1	2.7	6.0	3.6	11.9	1.3	0.1	8.9	4.1	2.0	2.8	6.1	5.7	4.5	4.0	0.2	9.3	0.0	1.7	2.8	1.5	4.3	1.8	2.7	1.6	1.9	1.7	1.9	1.3	1.6	0.0	1.9	7.2	0.0	4.6	1.4	19.2	25.9	24.9	25.8	17.6	21.4	16.5	19.2	23.3	9.6	6.0	3.2	3.5	6.4	1.5	42.1	4.8	5.1	4.0	3.4	3.5	45.2	0.4	8.3	4.1	4.4	6.4	2.4	0.0	5.2	0.3	2.9	3.7	17.3	1.6	4.1	44.5	19.5	5.5	4.0	0.5	3.7	4.9	1.7	1.0	2.0	18.0	3.6	0.3	5.3	5.0	45.4	0.0	6.6	14.2	11.7	1.1	0.0	1.5	1.4	3.3
GDAP1L1		ENSG00000124194	"Ganglioside induced differentiation associated protein 1 like 1"	Q96MZ0	20	44247099-44280917	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.4"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 8.8;Early spermatids: 7.1;Horizontal cells: 14.3;Late spermatids: 21.0"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 9.8;SCLC-21H: 24.2;SH-SY5Y: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054182, HPA063265"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA054182: , HPA063265: AB_2684972"	"unprognostic (6.58e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-4)"	"unprognostic (3.69e-1)"	"unprognostic (5.15e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.07e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.81e-5)"	"unprognostic (8.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-1)"	1.1	3.9	18.9	1.3	14.9	1.2	1.1	17.8	47.4	1.2	1.2	1.4	0.0	1.0	1.5	1.1	1.1	1.2	1.1	1.3	13.1	14.3	1.1	1.0	1.0	1.0	9.1	12.2	3.0	1.8	2.4	7.1	1.0	10.6	1.1	1.1	0.9	1.0	1.1	1.1	1.5	1.3	1.2	2.6	1.0	1.9	2.8	1.6	0.0	1.1	0.0	1.0	1.1	0.0	0.1	0.0	0.7	0.1	0.5	0.8	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	11.8	0.0	0.1	1.0	0.2	0.0	3.1	0.1	0.9	0.5	0.2	0.0	0.0	0.1	0.6	0.8	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.5	0.1	0.0	0.0	0.0	18.9	14.9	17.8	25.7	13.1	14.3	9.1	12.2	10.6	1.6	0.0	0.0	0.0	0.0	0.0	8.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.0	0.0	21.0	0.6	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.0	4.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
GDAP2	"dJ776P7.1, FLJ20142, MACROD3"	ENSG00000196505	"Ganglioside induced differentiation associated protein 2"	Q9NXN4	1	117863485-117929630	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046185	Approved		Approved	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA046185: AB_10960897"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.68e-1)"	12.1	9.7	9.3	10.2	10.8	18.9	11.3	12.9	12.7	10.7	10.5	10.7	13.1	11.1	10.4	12.9	12.7	7.6	9.2	9.5	8.6	7.3	13.5	14.5	15.3	13.9	11.7	8.8	10.6	15.2	17.1	12.3	11.8	11.5	10.3	12.6	9.7	12.8	10.5	7.8	11.0	13.3	12.0	8.8	12.7	11.8	12.6	10.7	13.0	13.1	6.2	11.9	12.3	12.9	2.7	7.0	13.1	7.8	4.2	4.4	3.3	8.6	4.9	6.0	5.0	6.5	3.1	8.9	5.1	6.6	10.2	9.9	5.2	6.0	3.4	6.2	6.8	7.8	5.2	7.9	6.6	12.6	6.8	4.6	5.1	6.8	5.6	7.9	6.3	6.6	2.5	8.4	12.8	9.9	4.6	6.7	7.8	5.3	7.5	8.4	9.0	5.6	5.2	10.4	6.6	8.6	3.0	16.5	5.0	5.8	8.8	4.5	5.0	6.1	10.5	8.0	19.0	3.6	6.5	4.1	7.3	8.6	8.4	6.8	7.8	5.6	4.8	9.4	4.6	8.9	9.6	7.4	13.1	2.8	7.8	4.4	2.7	3.1	3.3	7.0	2.7	2.9	2.8	7.1	4.2	7.6	1.6	4.0	3.3	9.3	10.8	12.9	12.7	8.6	7.3	11.7	8.8	11.5	10.7	8.9	7.5	8.2	5.5	11.9	13.4	6.3	5.1	6.7	9.1	3.5	17.7	10.7	6.6	9.4	13.4	7.3	13.1	0.0	5.5	9.5	6.2	9.8	0.0	7.8	11.8	14.3	4.1	6.2	16.1	2.2	5.5	13.5	10.1	5.4	9.9	9.7	9.0	7.2	6.7	8.8	13.2	0.0	8.3	30.5	10.4	12.0	17.6	6.9	7.0	8.2
GDE1	MIR16	ENSG00000006007	"Glycerophosphodiester phosphodiesterase 1"	Q9NZC3	16	19501689-19522145	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 226.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077420			Approved	Vesicles		NA	NA			Vesicles		"HPA077420: "	"unprognostic (1.69e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (7.52e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.60e-3)"	"unprognostic (9.92e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (8.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	20.3	18.5	30.6	11.7	34.3	17.5	23.9	13.5	32.2	18.1	31.0	24.5	23.0	22.7	15.0	22.6	19.0	13.4	17.5	40.7	31.1	17.5	21.1	21.3	22.1	13.1	29.2	20.6	9.9	28.3	35.3	13.9	15.5	20.8	21.4	32.5	12.5	20.4	24.9	42.4	18.5	20.8	27.2	25.3	10.1	22.8	14.8	23.8	9.6	17.9	21.7	12.7	22.8	12.4	4.6	7.4	23.9	12.4	3.7	7.4	4.6	14.8	17.9	9.8	11.7	47.6	17.6	14.2	15.4	26.4	12.0	14.9	10.2	26.6	11.1	19.8	22.3	13.2	12.9	13.7	18.1	14.6	12.1	21.2	9.3	17.6	21.9	28.9	12.2	8.7	18.5	29.4	12.8	15.0	22.3	16.1	14.5	5.1	11.6	13.0	26.8	10.7	11.3	11.5	23.3	13.9	15.4	18.1	16.1	29.7	22.8	11.5	10.5	14.9	17.9	14.2	15.9	18.3	14.7	16.9	10.2	9.1	13.4	9.4	10.9	10.2	7.8	15.6	18.2	9.0	23.9	11.8	6.4	5.7	10.5	7.3	4.6	6.8	6.6	7.4	3.7	3.6	5.7	19.8	3.7	12.4	4.6	7.4	4.6	30.6	34.3	13.5	32.2	31.1	17.5	29.2	20.6	20.8	23.8	35.7	72.1	27.9	29.4	20.8	14.8	63.5	35.7	26.8	26.1	8.7	25.5	63.8	19.9	79.5	27.6	16.8	94.2	23.3	143.1	66.0	28.2	77.4	3.5	20.0	53.4	30.2	32.1	17.8	30.7	51.5	26.4	32.5	23.6	22.6	50.6	19.8	66.9	87.7	35.7	39.2	21.5	12.9	25.5	71.0	39.2	25.7	226.1	21.8	61.0	49.4
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300386-47313547	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.8;tongue: 14.8"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 17.8;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 34.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"AF22: 17.7;MOLT-4: 3.8;SH-SY5Y: 7.2"	"Region enriched"	"Detected in many"	8	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	6.8	4.4	1.4	0.3	2.8	0.0	10.8	7.6	5.2	1.9	0.4	1.7	0.0	0.0	2.3	2.4	5.4	0.5	2.9	2.1	3.0		0.0	0.0	15.8	0.9	0.0	5.0	0.1	11.6	0.2	0.0	0.0	0.9	2.8	0.3	6.8	3.0	0.3	2.5	0.3	0.1	0.6	0.8	0.1	0.1	10.5	0.8	0.0	3.7	14.8	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1											0.0	1.1	0.0	0.0	0.3	17.8	0.6	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	4.7	0.0	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.2	0.9	0.0	1.7	0.0	0.0	4.3	0.0	0.0	0.0	0.0	34.3	0.0	0.1	0.2	0.5	0.6	0.0	0.0	0.0	0.0
GDF11	BMP-11	ENSG00000135414	"Growth differentiation factor 11"	O95390	12	55743280-55757278	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 35.4"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 71.9;Cone photoreceptor cells: 72.6;Horizontal cells: 54.0;Rod photoreceptor cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 54.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060985, HPA069609"	Approved		Approved	Vesicles	"Secreted to blood"	No	No	46400	270000	Vesicles		"HPA060985: AB_2684403, HPA069609: AB_2686159"	"unprognostic (5.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.48e-2)"	4.6	4.9	15.9	5.6	13.9	2.6	1.9	10.7	13.3	10.3	4.5	9.2	6.6	2.7	10.0	3.5	4.0	6.9	7.4	11.4	13.3	12.9	3.2	1.6	3.1	4.1	13.9	7.3	7.5	4.7	4.6	4.6	3.3	9.3	7.7	2.8	35.4	7.0	16.0	1.9	2.1	3.6	7.3	13.1	5.7	3.5	1.7	9.5	5.7	4.6	1.6	2.9	7.5	2.9	2.4	2.3	1.4	1.2	0.8	3.9	0.5	1.9	3.1	13.8	7.7	10.5	7.7	3.5	4.1	3.9	5.3	4.5	10.6	0.9	3.8	5.5	4.3	2.5	1.9	10.4	7.4	1.8	7.3	9.4	4.7	5.2	1.6	2.1	3.9	54.1	7.4	0.4	7.7	2.2	5.9	6.8	5.2	5.2	12.6	6.7	3.7	6.3	3.4	11.1	0.1	7.8	10.1	3.8	2.4	3.2	2.7	9.4	5.7	2.5	1.2	1.1	5.9	4.4	4.3	4.1	6.4	9.9	5.0	3.0	3.4	1.0	1.9	3.4	3.9	4.4	0.7	0.7	1.4	3.9	0.5	3.6	2.3	2.4	2.5	0.6	2.4	2.2	3.0	1.2	0.8	1.2	2.3	1.7	0.5	15.9	13.9	10.7	10.0	13.3	12.9	13.9	7.3	9.3	9.5	0.0	0.6	5.4	8.5	0.5	71.9	23.4	0.0	0.0	1.2	0.0	72.6	2.9	0.0	4.3	0.4	4.5	1.3	0.0	1.2	3.9	5.8	4.5	5.7	0.0	1.4	54.0	10.3	3.7	0.6	0.4	8.3	0.3	3.3	2.8	1.3	28.4	3.1	2.9	5.3	0.4	49.9	12.9	5.7	1.2	3.5	0.6	3.9	17.3	2.0	5.3
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142330-96160792	"Disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.8;placenta: 16.9"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 2.0;Distal tubular cells: 1.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA			Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	2.5	0.2	1.4	1.5	0.9	0.0	0.8	0.1	1.7	0.3	1.4	0.3	1.5	0.6	3.0	0.7	0.8	1.0	6.6	11.8	0.9	1.0	0.4	0.7	0.4	1.9	0.9	0.1	2.2	1.3	0.1	0.3	16.9	1.1	0.6	0.5	2.9	0.1	2.7	0.8	0.0	1.6	1.8	0.2	0.1	1.4	1.1	1.1	0.1	1.4	0.1	0.1	3.2	2.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.4	2.9	1.9	0.0	1.7	1.5	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.2	0.0	15.4	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.9	0.1	1.7	0.9	1.0	0.9	0.1	1.1	1.1	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0
GDI1	"FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4"	ENSG00000203879	"GDP dissociation inhibitor 1"	P31150	X	154436913-154443467	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 122.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012979, HPA049290, HPA057668"	Enhanced		Approved	Vesicles		NA	NA		70000000	Vesicles		"CAB012979: AB_2533970, HPA049290: AB_2680700, HPA057668: AB_2683498"	"prognostic unfavorable (6.84e-4)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.72e-1)"	19.8	27.1	51.7	16.2	65.3	10.5	12.0	61.3	122.3	16.7	13.6	46.2	6.5	11.5	20.1	15.7	14.4	23.0	15.2	25.7	53.7	54.3	13.7	10.3	16.9	15.1	45.1	49.6	27.7	16.2	18.8	26.9	19.0	65.3	19.6	13.9	13.8	13.6	24.0	14.3	17.2	13.1	25.6	46.4	17.1	13.5	12.9	31.3	6.8	12.7	6.2	15.7	13.9	11.8	7.6	8.3	20.6	13.4	5.6	13.0	4.9	20.3	18.9	42.6	35.2	17.5	20.7	13.4	29.5	19.8	31.1	32.5	10.9	10.8	16.3	30.9	29.9	47.4	16.1	37.4	18.0	21.6	29.4	18.4	5.1	27.7	7.3	25.7	4.9	18.6	21.2	22.3	36.0	22.1	34.0	20.0	20.6	6.2	25.9	36.9	20.6	15.6	12.3	11.3	22.7	34.4	15.6	11.1	9.3	21.7	9.5	59.0	45.7	14.2	18.5	22.3	34.6	11.0	8.9	22.5	28.7	24.9	29.6	43.1	36.7	38.8	25.9	31.1	11.1	35.2	14.9	5.7	17.2	8.9	8.6	13.0	7.3	9.6	8.6	4.7	7.6	7.6	7.5	20.6	5.6	13.4	8.3	10.8	4.9	51.7	65.3	61.3	96.6	53.7	54.3	45.1	49.6	65.3	31.3	14.9	33.8	24.4	21.0	24.2	64.9	56.8	22.9	44.2	18.2	26.2	23.6	18.6	26.6	37.0	2.2	31.8	21.6	0.0	27.5	30.2	32.7	23.2	33.4	12.1	31.9	57.2	87.1	27.6	30.7	4.0	34.8	27.8	16.9	88.4	21.4	35.7	37.8	21.0	37.4	22.4	28.6	51.8	45.7	19.7	64.1	26.5	41.4	39.9	13.3	20.3
GDNF	"ATF1, ATF2, HFB1-GDNF"	ENSG00000168621	"Glial cell derived neurotrophic factor"	P39905	5	37812677-37839686	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes, Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1;skeletal muscle: 12.4"	"Cell type enhanced"	"Detected in single"	9	"Fibroblasts: 1.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 25.0;SuSa: 7.8;U-87 MG: 7.6;WM-115: 27.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Low region specificity"	"Detected in many"			"CAB005210, HPA070283"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"CAB005210: AB_2247684, HPA070283: AB_2686246"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.42e-2)"	1.9	0.3	0.6	1.9	2.3	0.0	0.4	14.1	1.3	0.8	9.4	0.4	0.4	1.6	1.7	3.4	1.0	0.9	0.9	0.9	0.6	0.4	1.0	0.7	0.4	0.4	0.6	1.2	4.5	0.4	0.0	0.4	6.3	1.4	1.6	3.1	1.1	0.4	6.3	12.4	1.4	2.5	2.5	0.5	0.4	1.9	3.9	2.4	0.4	0.4	1.5	0.4	0.6	1.1	0.8	0.4	1.2	0.3	0.9	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	3.4	2.1	0.6	0.9	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.0	1.0	0.1	25.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	1.7	7.8	0.0	0.0	0.0	3.4	0.0	0.8	3.9	2.3	0.0	0.0	7.6	0.0	27.5	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.8	0.2	0.4	1.2	0.9	0.2	0.4	0.1	0.0	0.6	2.3	14.1	1.3	0.6	0.4	0.6	1.2	1.4	2.4	0.0	0.0	0.0	0.0	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.0	0.6	0.0	0.8	0.3	0.1	0.0	0.0	0.5
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113856	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 50.9;Extravillous trophoblasts: 52.5;Late spermatids: 201.8;Proximal tubular cells: 62.4"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"eosinophil: 1.6;neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.1"	"Group enriched"	"Detected in many"	5	"MCF7: 13.7;OE19: 16.9;SK-BR-3: 48.5"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	"Low region specificity"	"Detected in many"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		NA	NA			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	3.0	0.9	1.2	10.5	1.2	0.5	2.5	5.7	1.3	9.4	11.3	1.2	1.2	4.0	2.8	3.4	30.8	2.1	3.6	1.7	1.2	0.7	5.9	1.2	3.7	2.3	1.2	1.2	3.3	1.2	0.4	2.3	12.9	2.5	2.4	7.4	1.2	4.9	1.2	1.3	5.3	8.6	2.4	1.2	4.1	8.3	1.2	1.2	1.9	2.3	36.6	40.8	2.7	9.2	0.1	0.0	5.1	0.2	0.0	0.2	0.0	5.3	0.0	1.9	0.5	0.5	2.8	1.6	0.5	0.4	0.5	0.6	0.6	3.7	0.6	0.7	0.3	0.1	0.5	0.5	0.2	0.5	1.0	1.5	0.1	0.8	2.5	0.5	0.2	0.4	0.1	0.7	1.5	0.1	1.5	2.1	2.0	0.4	0.9	0.7	13.7	0.4	0.9	1.1	16.9	0.2	2.5	0.6	2.9	1.1	2.4	0.5	0.9	0.0	48.5	0.3	0.5	0.9	1.0	1.5	0.5	0.5	1.1	0.5	1.6	0.3	0.6	1.4	0.8	0.3	0.1	0.0	1.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	5.1	0.0	0.1	0.0	0.1	0.0	1.2	1.2	5.7	1.3	1.2	0.7	1.2	1.2	2.5	1.2	6.0	0.6	0.0	0.6	1.1	1.1	0.9	0.0	1.4	1.2	5.2	0.0	20.4	5.0	1.0	50.9	4.0	43.6	0.0	1.2	52.5	2.1	1.4	0.0	0.0	2.8	1.6	3.4	3.7	3.0	201.8	3.1	0.7	1.7	1.0	28.5	0.2	11.2	12.9	2.8	62.4	1.7	6.5	1.4	1.2	1.2	1.8	7.8	1.5	4.7	3.9
GDPD5	"GDE2, PP1665"	ENSG00000158555	"Glycerophosphodiester phosphodiesterase domain containing 5"	Q8WTR4	11	75434640-75525903	"Predicted membrane proteins"	Neurogenesis	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.2;placenta: 41.7"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 64.5;Cone photoreceptor cells: 139.4;Late spermatids: 125.5;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.3;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 17.4;fHDF/TERT166: 16.6;HDLM-2: 34.0;U-2 OS: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065257, HPA066762, HPA069281"	Uncertain		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.12e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.59e-9)"	"unprognostic (8.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.65e-1)"	16.5	6.0	3.3	3.3	4.6	7.8	8.0	23.2	7.9	3.3	3.0	3.3	1.6	2.0	6.4	3.1	1.6	3.2	3.6	2.8	3.0	1.8	2.3	2.7	5.4	4.3	3.0	2.6	2.9	13.4	0.4	7.0	41.7	4.2	3.1	1.3	18.8	15.5	4.1	5.9	2.3	3.2	4.9	3.4	37.2	1.4	11.9	5.5	2.0	2.6	1.4	3.4	3.5	11.5	1.1	1.1	9.3	1.2	0.0	3.1	0.7	1.0	3.8	1.7	1.9	1.1	0.6	5.8	1.2	1.6	0.6	0.4	5.1	2.3	7.3	17.4	16.6	4.3	2.4	2.1	1.9	0.3	34.0	1.6	1.3	5.9	10.6	1.7	0.8	5.7	1.3	1.0	0.4	0.8	1.7	13.9	6.6	2.3	3.3	0.7	2.2	1.9	3.6	3.0	1.8	5.5	2.2	0.5	1.9	0.4	1.8	0.9	0.6	2.5	9.6	4.6	2.3	1.4	3.2	4.1	3.9	16.2	3.1	1.3	0.8	0.1	1.3	0.9	4.3	0.4	9.3	1.2	0.7	2.0	0.6	2.9	1.1	2.3	1.6	0.3	0.4	1.2	1.5	0.1	0.0	0.0	1.1	3.1	0.7	3.3	4.6	23.2	7.9	3.0	1.8	3.0	2.6	4.2	5.5	6.0	0.0	0.0	0.2	0.9	64.5	2.8	0.0	1.4	1.2	0.0	139.4	2.3	0.0	3.7	37.5	1.8	0.3	0.0	8.0	0.9	3.3	0.9	4.6	1.9	1.8	4.8	0.0	21.5	4.1	125.5	5.5	3.4	5.0	1.8	0.5	5.6	5.4	0.0	2.5	0.0	81.6	0.0	1.3	4.7	7.7	1.0	38.4	2.2	0.2	0.4
GDPGP1	C15orf58	ENSG00000183208	"GDP-D-glucose phosphorylase 1"	Q6ZNW5	15	90233808-90245811	"Enzymes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA048189, HPA059841"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA048189: AB_2680307, HPA059841: AB_2684138"	"prognostic favorable (6.32e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-3)"	3.9	9.2	9.8	5.7	9.8	5.1	4.8	9.9	12.4	4.4	10.7	8.0	7.2	10.1	5.0	7.5	6.2	9.4	6.0	10.8	12.9	7.1	7.7	12.2	5.8	6.1	5.9	11.6	6.1	9.1	11.9	10.2	2.1	8.8	7.5	14.8	7.2	9.9	10.0	12.5	4.5	9.4	5.8	5.1	8.2	6.9	9.5	8.4	8.5	7.6	3.1	7.8	7.2	3.9	8.3	4.6	7.4	5.2	6.7	7.8	2.9	3.3	13.0	1.6	4.8	5.0	1.0	4.4	3.0	1.9	4.0	3.8	3.8	12.9	8.1	5.9	2.3	2.9	5.5	5.1	3.4	1.6	7.2	8.7	7.2	7.5	5.5	5.3	3.9	4.8	1.3	2.4	2.8	1.5	4.5	4.6	4.8	2.6	3.2	2.3	7.4	2.9	1.9	2.0	9.9	5.4	5.1	1.2	4.1	4.6	6.4	5.1	2.3	4.8	7.4	5.0	3.1	8.5	4.0	4.6	2.1	2.3	3.0	2.9	6.6	7.6	3.6	4.6	3.3	3.8	6.8	4.6	2.2	6.6	5.2	5.6	4.8	6.2	7.8	4.1	8.3	6.7	6.2	7.4	6.7	4.1	4.6	7.5	2.9	9.8	9.8	9.9	12.4	12.9	7.1	5.9	11.6	8.8	8.4	0.0	2.7	1.4	1.9	0.0	3.8	6.0	12.7	4.0	1.2	7.0	5.9	2.1	3.3	3.5	1.8	0.7	4.0	0.0	5.3	1.0	1.0	1.9	3.5	4.4	3.7	1.6	5.2	1.8	2.8	1.9	2.6	3.4	0.0	1.8	3.8	3.3	3.8	5.7	2.1	4.4	3.5	0.0	0.5	2.7	2.7	0.3	0.3	2.2	3.7	1.6
GEMIN2	SIP1	ENSG00000092208	"Gem nuclear organelle associated protein 2"	O14893	14	39114223-39136973	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015426, HPA046570, HPA057114"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340"	"unprognostic (4.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (8.62e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.78e-2)"	10.0	8.2	13.2	8.1	16.9	15.2	13.3	15.7	15.2	10.1	9.5	10.9	5.2	11.4	9.3	12.5	10.2	9.9	7.2	12.4	13.8	10.1	8.2	9.2	9.1	14.1	11.0	13.8	11.3	8.5	4.3	16.1	9.0	13.4	8.4	10.9	8.9	7.7	7.7	18.9	10.4	8.0	12.6	12.4	9.5	8.4	13.2	12.8	11.9	9.8	9.9	13.3	11.3	9.6	17.1	15.8	8.9	12.6	11.6	15.5	8.7	11.6	16.7	16.5	12.0	5.8	6.7	8.5	5.5	4.4	14.9	14.8	14.6	13.7	17.2	11.6	4.7	5.3	8.9	22.1	9.4	15.7	8.8	12.9	10.0	10.2	36.2	11.8	15.2	6.6	3.6	9.0	9.4	13.5	4.4	13.0	15.2	11.9	12.6	8.3	23.1	16.6	14.6	11.5	14.1	18.8	15.5	18.0	10.8	8.3	7.6	16.1	3.2	11.7	9.0	6.0	9.4	20.5	6.7	5.3	6.9	10.2	6.7	9.0	13.2	20.5	25.2	3.3	16.2	9.6	8.1	12.3	8.9	14.3	12.6	10.1	15.4	13.2	14.0	15.6	17.1	14.9	15.5	3.4	11.6	10.4	15.8	11.4	8.7	13.2	16.9	15.7	15.2	13.8	10.1	11.0	13.8	13.4	12.8	6.0	3.0	7.5	7.2	7.6	6.3	5.2	2.5	13.4	6.8	5.2	9.8	12.3	10.0	9.9	33.1	8.0	1.8	0.0	5.6	15.4	11.2	5.3	5.7	5.8	10.0	4.8	3.5	9.8	10.0	32.0	8.3	6.6	6.8	7.2	6.7	7.1	6.1	0.0	9.2	11.5	6.4	6.5	5.2	19.3	14.7	6.9	3.2	10.2	8.8	4.2
GEMIN8	"FAM51A1, FLJ20514"	ENSG00000046647	"Gem nuclear organelle associated protein 8"	Q9NWZ8	X	14008279-14029893	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028613	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028613: AB_10602905"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (3.87e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (7.73e-5)"	13.4	13.5	14.5	12.9	17.0	12.0	19.9	12.3	20.0	16.5	13.9	24.0	27.3	9.0	21.5	16.9	13.2	22.8	16.4	15.5	14.8	14.0	16.7	12.9	14.5	16.0	16.6	14.7	28.9	22.2	18.7	27.4	10.3	21.0	13.1	11.9	16.8	24.7	30.2	7.6	15.7	10.0	17.1	23.3	12.5	13.6	8.2	12.7	14.6	21.3	7.9	13.2	12.7	13.0	11.3	15.4	0.8	6.9	9.9	15.2	7.5	6.3	6.4	7.5	1.8	12.2	18.7	3.7	6.0	6.7	5.2	3.6	3.3	11.0	14.8	14.2	4.9	6.0	8.5	4.6	10.4	5.0	7.9	9.5	3.8	4.7	7.4	7.1	9.0	8.0	15.0	17.2	9.0	15.7	16.0	11.2	11.4	6.6	13.1	7.8	8.5	9.1	14.2	8.1	7.5	3.7	13.9	5.2	26.3	8.7	6.3	7.4	20.5	6.4	11.9	7.0	17.2	16.3	9.0	8.5	3.8	2.2	11.1	2.4	8.9	4.4	9.3	8.8	5.5	2.2	0.6	6.7	0.2	9.4	6.4	11.6	11.3	15.2	8.9	12.2	9.8	13.1	9.8	0.8	9.9	6.9	15.4	8.4	7.5	14.5	17.0	12.3	20.0	14.8	14.0	16.6	14.7	21.0	12.7	6.0	6.2	8.5	10.4	6.8	3.1	5.0	7.6	13.4	13.6	8.7	0.0	12.2	16.6	18.2	14.8	7.7	3.9	0.0	10.4	14.3	8.3	6.0	5.8	5.9	9.6	9.5	3.4	4.3	4.8	0.8	9.5	5.5	1.7	8.2	9.9	6.0	11.9	5.8	8.1	30.7	5.6	0.0	8.0	4.4	5.3	8.3	7.0	6.4	10.3	7.1
GEN1	"FLJ40869, Gen"	ENSG00000178295	"GEN1, Holliday junction 5' flap endonuclease"	Q17RS7	2	17753858-17788941	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 27.5"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA020078, HPA021141"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020078: AB_2670352, HPA021141: AB_2670599"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-3)"	"unprognostic (7.90e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.70e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.89e-12)"	"unprognostic (3.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-3)"	3.0	3.0	2.8	15.6	4.0	14.9	3.9	2.3	5.1	3.2	5.9	3.7	4.3	3.3	2.1	11.1	9.0	2.4	4.7	2.8	2.9	2.5	3.4	11.2	3.3	11.9	2.3	3.2	1.8	3.8	2.6	8.6	4.4	4.8	4.6	7.6	7.3	8.8	3.7	2.7	8.8	6.9	1.6	2.8	8.5	3.4	27.5	2.2	24.3	3.4	11.3	13.7	2.6	5.2	5.1	2.2	1.1	1.4	1.2	2.1	1.0	16.3	8.6	9.6	7.4	2.3	3.3	14.0	11.8	4.4	7.4	8.0	10.4	8.6	19.7	4.6	4.8	6.4	11.5	9.5	8.6	10.8	11.6	6.1	10.6	9.6	5.9	1.6	12.1	10.9	2.2	3.3	9.5	5.8	2.3	4.8	9.1	11.7	13.0	12.1	9.7	9.4	11.3	6.7	6.8	4.3	10.8	22.0	7.2	4.3	10.8	10.4	13.8	5.9	10.3	4.7	7.1	6.7	5.4	5.6	15.5	7.1	8.5	12.5	8.0	14.1	30.0	6.9	12.7	10.0	0.3	1.4	1.1	1.1	1.1	0.9	5.1	1.2	2.1	2.0	2.9	1.3	1.4	0.7	1.2	1.3	2.2	1.7	1.0	2.8	4.0	2.3	5.1	2.9	2.5	2.3	3.2	4.8	2.2	6.0	2.2	6.5	2.3	2.5	5.5	3.9	2.5	6.7	11.4	3.5	11.8	3.1	0.0	1.9	3.9	1.4	6.4	23.3	2.0	3.6	3.9	2.5	1.1	4.2	3.3	3.2	1.7	1.3	3.5	2.7	1.7	2.6	1.7	2.8	4.8	3.8	2.0	3.5	0.7	2.1	3.2	6.5	3.8	12.3	9.0	1.6	2.7	1.0	4.3	2.6
GFM1	"EFGM, EGF1, GFM"	ENSG00000168827	"G elongation factor mitochondrial 1"	Q96RP9	3	158644278-158692575	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034764, HPA034765, HPA061405"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.62e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.78e-2)"	20.1	23.3	17.6	14.1	18.6	14.7	19.8	32.8	23.4	11.4	20.7	17.8	19.1	18.8	15.4	17.9	16.2	14.3	12.6	27.9	18.0	17.9	34.1	42.2	13.5	13.2	18.9	19.5	13.2	17.0	30.9	16.4	17.4	22.6	15.3	23.3	13.8	16.3	15.4	46.5	15.4	16.0	16.0	18.5	14.2	17.1	19.8	17.8	14.5	21.4	17.6	13.6	15.0	13.2	13.2	16.5	10.8	19.8	16.0	21.1	11.5	30.1	17.3	8.4	10.2	13.5	8.8	11.3	15.6	13.6	21.8	17.1	23.1	18.6	25.9	19.8	11.6	10.4	18.4	18.8	14.5	24.4	14.3	12.7	21.5	11.9	12.8	15.4	27.6	11.7	12.2	17.2	14.1	13.1	6.2	14.6	14.4	22.3	15.9	19.8	16.7	16.2	11.0	19.1	32.4	11.7	15.7	10.1	41.7	17.4	12.7	15.3	14.8	24.6	33.4	26.5	7.0	41.1	22.5	10.7	14.6	7.2	22.8	24.6	30.6	19.3	47.1	13.8	23.2	16.3	10.8	13.2	9.1	16.1	19.8	21.1	13.2	15.0	16.9	16.5	11.9	17.6	18.5	1.9	16.0	14.0	8.6	11.9	11.5	17.6	18.6	32.8	23.4	18.0	17.9	18.9	19.5	22.6	17.8	17.9	14.7	27.9	22.5	19.2	53.1	51.8	17.8	28.1	12.5	12.2	29.5	26.9	10.0	16.6	12.5	28.9	18.2	23.3	21.6	15.7	18.2	17.8	18.5	53.5	25.1	14.3	18.6	25.8	22.5	5.7	21.0	23.4	16.9	31.5	21.4	25.3	16.3	5.8	15.9	31.0	49.5	12.9	21.9	25.1	32.1	18.3	25.7	20.0	24.7	18.2
GFM2	"EFG2, FLJ21661"	ENSG00000164347	"G elongation factor mitochondrial 2"	Q969S9	5	74721204-74767371	"Predicted intracellular proteins"	"Protein biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036863, HPA069871"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036863: AB_2675354, HPA069871: "	"unprognostic (2.58e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (9.55e-2)"	"unprognostic (4.15e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.82e-2)"	9.7	23.8	14.7	8.7	22.4	12.1	13.1	14.2	24.8	10.7	12.8	12.7	17.8	8.3	12.3	16.8	13.0	21.6	8.7	29.5	18.5	15.6	21.9	30.8	9.1	10.3	13.8	18.1	11.6	12.9	19.8	24.9	12.9	20.4	12.5	15.3	11.6	15.7	11.2	26.4	10.5	10.3	10.4	11.7	10.3	16.3	13.7	10.4	18.0	12.3	12.8	14.2	12.3	12.6	8.3	6.1	17.1	9.8	15.6	7.4	4.6	19.4	16.6	14.0	26.6	10.7	14.5	14.3	21.4	13.0	21.9	23.4	18.2	12.7	20.1	22.9	11.3	34.4	16.3	28.2	29.9	28.5	17.7	16.6	11.9	16.8	12.4	13.6	11.6	13.1	16.3	13.4	17.3	20.8	15.6	14.8	19.9	19.9	16.8	24.8	10.9	16.0	7.1	5.8	7.2	15.1	20.1	22.9	22.9	16.0	12.4	23.7	12.8	24.7	19.0	21.1	15.9	16.5	20.2	11.8	8.4	14.4	10.6	13.5	9.8	18.7	20.4	12.8	16.6	12.8	17.1	6.3	8.0	6.6	6.5	6.4	8.3	5.4	7.2	6.1	7.0	7.4	7.2	3.3	15.6	9.8	4.0	6.2	4.6	14.7	22.4	14.2	24.8	18.5	15.6	13.8	18.1	20.4	10.4	11.9	11.7	3.9	6.5	5.4	9.7	10.0	5.1	69.6	6.8	7.0	5.9	15.7	18.3	8.3	5.7	5.8	7.8	23.3	4.6	13.5	5.0	5.3	2.3	19.6	8.4	15.9	5.2	6.7	9.8	1.4	6.6	5.5	8.5	25.2	8.9	12.0	7.6	8.6	7.1	8.4	8.0	0.0	5.2	15.4	9.5	6.0	13.4	4.6	9.0	6.5
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 12.8;NK-cell: 11.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;NK-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"HEL: 18.8;HMC-1: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	15.7	3.8	9.4	4.6	11.5	17.5	8.7	28.5	22.3	5.4	5.0	4.0	0.5	3.5	4.0	2.6	12.1	4.3	11.8	18.5	11.9	7.1	2.1	6.6	8.2	6.6	6.3	14.2	1.7	2.3	3.9	3.3	6.8	6.6	4.4	5.2	1.5	3.4	3.0	15.5	4.7	5.6	8.3	4.2	12.0	8.2	1.5	4.1	1.9	3.9	4.5	6.9	4.7	7.6	2.3	0.2	12.8	0.8	11.4	1.4	0.8	7.4	0.7	0.6	1.3	1.1	1.1	0.8	0.6	0.3	0.4	0.2	0.2	0.5	10.2	10.6	0.7	0.6	6.6	2.0	3.2	0.4	0.7	3.8	18.8	3.9	3.9	1.5	5.4	29.1	0.6	2.5	1.0	2.8	1.6	5.7	2.7	0.6	0.9	0.8	2.4	1.2	3.3	1.0	2.5	2.2	4.1	1.4	5.2	0.3	1.4	3.5	0.6	2.5	0.4	2.4	1.4	0.6	0.5	7.7	0.9	2.0	2.2	3.3	8.5	4.8	12.2	0.8	3.2	0.2	0.1	0.4	12.8	1.4	0.7	0.2	2.3	0.2	0.6	0.2	1.9	0.1	0.5	0.3	11.4	0.8	0.0	0.1	0.8	9.4	11.5	28.5	18.7	11.9	7.1	6.3	14.2	6.6	4.1	0.0	2.6	12.7	4.9	18.0	38.9	87.7	12.7	12.0	0.0	0.0	0.0	0.4	0.0	4.3	0.0	36.2	13.5	46.7	2.7	27.6	5.8	2.3	4.6	16.8	2.4	1.6	8.1	33.2	15.8	0.0	2.3	10.4	11.8	0.0	11.8	2.0	18.1	31.7	1.1	0.5	3.0	12.9	20.8	0.0	1.7	19.6	0.6	34.8	3.3	4.7
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719421	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	9.0	9.4	9.6	7.7	13.8	13.4	8.6	42.9	18.9	10.7	10.6	5.0	9.4	10.7	8.1	5.9	21.8	12.2	8.4	6.8	10.1	12.4	9.8	24.4	7.9	6.9	8.2	11.1	5.6	9.0	14.1	11.7	19.4	10.8	7.4	8.7	6.4	8.7	7.2	6.5	14.1	8.1	8.6	5.7	12.8	7.5	8.3	5.1	6.1	9.7	13.2	12.8	9.0	16.4	9.1	6.5	10.6	5.5	6.4	10.2	4.1	9.3	15.2	9.3	19.2	9.5	7.1	11.0	7.8	10.1	14.6	15.0	12.9	8.6	15.8	7.3	9.0	7.8	11.8	9.6	9.0	12.4	9.4	11.8	4.0	8.1	18.3	7.2	6.5	7.8	5.9	10.4	19.3	5.8	7.2	21.0	16.2	8.2	3.1	8.1	19.9	10.6	7.8	12.6	5.6	8.3	17.0	5.5	12.2	8.9	13.3	19.1	11.2	19.3	6.5	5.9	5.7	9.9	4.3	16.1	11.4	11.4	10.1	7.7	8.0	11.3	17.2	7.0	9.5	8.1	0.7	5.5	5.7	5.6	3.5	9.0	8.0	9.5	9.6	5.6	9.1	8.4	6.6	10.6	6.4	3.4	6.5	10.2	4.1	9.6	13.8	42.9	18.9	10.1	12.4	8.2	11.1	10.8	5.1	0.0	5.9	5.4	11.8	20.4	12.7	3.7	20.4	20.1	10.3	10.4	13.7	8.1	5.0	17.9	77.4	35.6	18.8	0.0	10.2	17.9	10.3	10.3	4.6	39.5	5.8	20.6	41.5	26.4	6.3	21.4	8.1	4.7	8.5	3.6	15.0	11.3	13.3	18.2	10.6	10.1	9.9	6.5	12.3	14.2	17.9	23.8	18.5	10.2	15.6	15.5
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319769-69387254	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 215.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli"	"Nucleoli fibrillar center"	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favorable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	16.7	11.4	6.4	12.7	7.8	5.6	18.3	7.8	10.1	16.8	27.0	6.4	41.2	14.5	10.1	18.7	11.6	9.5	19.4	11.3	6.0	9.8	17.8	49.1	14.1	4.7	6.5	5.7	11.1	34.9	13.9	39.6	36.5	7.0	17.2	27.5	7.7	39.7	34.0	9.2	6.1	28.2	8.7	6.2	8.2	24.6	13.9	4.8	8.5	35.2	7.7	18.1	10.6	16.2	5.6	4.1	5.9	3.4	4.1	6.8	3.0	9.6	6.7	8.7	5.4	24.2	16.7	18.7	18.5	17.2	8.7	11.1	21.4	8.8	8.7	6.7	17.1	10.9	4.7	10.8	5.6	14.4	7.9	4.1	10.1	5.0	22.1	28.7	6.9	4.0	10.5	27.6	16.9	32.4	12.1	8.1	7.5	8.4	14.2	17.0	5.7	7.2	7.2	11.2	19.9	5.6	7.3	18.0	4.4	14.2	7.7	5.3	3.0	6.9	12.8	24.7	18.7	5.1	4.3	12.4	7.8	10.4	13.3	8.8	10.2	6.8	6.6	12.7	4.7	8.9	5.9	2.8	3.4	6.8	3.2	6.5	5.6	6.1	6.6	3.6	3.4	6.1	5.6	1.3	4.1	3.4	4.1	4.3	3.0	6.4	7.8	7.8	10.1	6.0	9.8	6.5	5.7	7.0	4.8	47.6	43.8	21.6	18.1	25.2	14.6	39.1	43.3	62.9	45.5	41.8	11.8	23.5	14.9	29.0	71.7	15.1	126.6	0.0	78.9	58.2	37.0	83.5	24.2	49.7	15.2	6.4	72.2	19.6	8.8	12.1	21.6	14.3	50.6	39.7	215.3	10.9	58.8	74.8	26.5	24.3	13.7	19.4	31.7	89.0	45.3	18.3	28.7	16.6	120.1	30.1
GFPT2	GFAT2	ENSG00000131459	"Glutamine-fructose-6-phosphate transaminase 2"	O94808	5	180300690-180353387	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 65.6"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 28.9;Peritubular cells: 17.7;Smooth muscle cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 7.1"	"Lineage enriched"	"Detected in single"	49	"T-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;ASC TERT1: 41.6;GAMG: 30.6;HSkMC: 26.7;hTEC/SVTERT24-B: 49.5;U-87 MG: 86.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056892, HPA059910"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA056892: AB_2683266, HPA059910: AB_2684157"	"unprognostic (3.48e-1)"	"prognostic unfavorable (9.09e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.58e-14)"	"unprognostic (3.67e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.52e-3)"	65.6	3.9	4.5	15.8	5.6	0.9	11.0	17.0	9.2	10.0	9.2	9.3	5.4	2.1	9.0	16.7	5.9	15.9	14.6	16.4	7.1	3.8	2.8	2.6	11.0	3.1	6.2	6.8	17.5	11.1	3.5	2.5	6.0	8.4	7.7	3.6	2.9	4.0	8.0	6.0	4.0	5.0	10.0	17.2	1.7	6.6	6.3	7.7	0.0	5.6	5.4	3.5	14.3	14.6	0.0	0.1	0.0	0.0	0.1	7.1	0.2	0.0	5.4	4.2	5.5	24.3	41.6	0.4	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.3	4.5	30.6	0.0	2.3	0.0	0.2	0.5	0.8	0.0	2.6	0.0	10.1	0.0	0.0	26.7	0.2	49.5	0.1	8.4	8.0	0.2	0.0	0.0	21.2	0.7	0.0	0.0	9.1	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.2	0.3	8.3	0.1	0.3	5.2	0.3	0.0	3.8	13.7	2.1	8.8	10.0	0.0	0.0	0.0	86.1	0.0	0.3	0.0	0.0	0.0	1.4	0.0	7.1	0.0	0.8	2.4	0.1	0.0	0.8	1.1	0.0	0.1	0.0	0.1	0.0	0.2	4.5	5.6	17.0	9.2	7.1	3.8	6.2	6.8	8.4	7.7	3.0	4.5	0.0	0.3	6.5	0.0	2.2	0.0	2.7	5.7	1.8	0.0	0.9	1.7	0.8	4.5	0.6	0.0	0.0	0.7	0.4	28.9	0.9	1.1	0.0	0.4	0.0	0.0	1.8	0.8	2.0	9.5	1.8	8.5	0.0	0.0	5.2	0.5	0.0	17.7	0.3	0.0	0.0	16.5	9.1	5.3	3.8	2.3	3.8	0.0	0.4
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273467	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Exocrine glandular cells: 12.1;Fibroblasts: 17.1;Hepatocytes: 38.6;Muller glia cells: 12.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 17.1;BJ hTERT+ SV40 Large T+ RasG12V: 29.9;EFO-21: 18.2;fHDF/TERT166: 33.0;HBF TERT88: 25.0;MCF7: 21.8;U-251 MG: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		89000	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	24.0	4.3	6.3	9.5	13.8	0.3	26.8	0.8	8.4	12.5	14.9	1.8	5.9	2.2	6.7	23.4	11.1	12.7	11.5	6.4	4.8	6.7	7.0	21.9	3.2	7.4	9.5	2.7	10.0	7.3	2.2	3.9	0.3	2.9	12.1	4.8	3.4	5.4	6.6	7.5	6.8	7.2	9.8	3.4	5.8	7.8	5.3	1.9	2.6	2.6	10.7	8.1	10.5	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.8	0.0	0.0	0.0	0.0	2.9	0.1	17.1	29.9	0.0	0.0	0.0	18.2	33.0	0.0	0.0	0.0	0.0	25.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	4.3	0.0	1.5	0.0	3.6	0.0	0.0	2.2	21.8	2.7	0.0	1.9	0.0	0.0	0.0	0.7	0.0	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.1	0.0	20.3	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	13.8	0.8	4.6	4.8	6.7	9.5	2.7	2.9	1.9	0.0	0.0	0.9	0.0	5.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	12.1	0.0	17.1	0.1	5.8	38.6	0.0	0.0	5.8	0.0	1.0	8.3	7.5	0.0	5.0	0.0	0.0	12.1	0.2	0.0	0.0	1.1	0.3	0.0	8.6	0.1	0.4	4.0	0.0	0.0	0.0	0.1
GGNBP2	"DIF-3, DIF3, FLJ21230, FLJ22561, LZK1, ZFP403, ZNF403"	ENSG00000278311	"Gametogenetin binding protein 2"	Q9H3C7	17	36544888-36589848	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018914, HPA073392"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA018914: AB_2294667, HPA073392: AB_2686599"	"unprognostic (2.68e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	9.6	7.3	8.7	13.4	10.0	24.7	8.3	11.3	10.7	8.5	11.0	5.7	9.2	9.5	7.4	7.9	8.2	6.3	7.0	7.6	8.3		8.8	10.2	7.6	12.8	7.5	9.9	9.6	8.5	10.8	9.6	8.9	12.4	8.8	9.1	5.6	8.2	10.2	14.0	8.7	12.8	9.5	8.0	11.1	7.3	15.9	8.6	11.7	8.3	7.2	12.6	12.1	12.3	20.6	33.3	24.4	14.1	12.9	26.1	8.4	15.0	17.1	15.2	12.8	17.8	21.2	12.4	20.2	15.1	15.0	14.5	16.2	11.1	20.9	13.6	15.5	15.3	16.8	12.1	18.1	19.6	13.0	14.3	14.1	19.6	14.2	19.1	20.5	16.7	20.8	22.5	15.0	20.5	18.6	12.3	15.8	17.3	21.0	20.1	9.3	20.8	16.5	4.9	9.7	8.7	14.7	20.6	13.8	19.0	31.2	13.1	11.6	20.5	10.9	30.0	16.6	20.8	20.4	14.4	21.4	15.4	14.7	20.1	15.1	17.5	16.6	13.5	11.6	12.7	14.7	12.9	24.4	15.1	13.7	17.7	20.6	18.7	16.0	16.3	19.8	26.1	24.5	17.0	12.9	14.1	33.3	17.3	8.4											62.5	73.4	96.8	86.9	85.3	64.7	70.3	63.7	83.0	92.1	29.6	35.3	68.3	44.7	65.2	295.0	68.7	91.1	46.7	59.8	64.7	78.6	71.7	93.7	58.0	65.0	54.0	55.0	51.0	64.6	83.5	73.6	82.5	55.6	75.7	64.7	66.9	62.7	67.1	67.8	56.8	68.4	58.2	83.9	159.7	97.9	84.3	80.0	101.5	82.1	88.7
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245142	"Enzymes, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Ito cells: 44.2;Sertoli cells: 181.1;Smooth muscle cells: 82.1"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.5"	"Group enriched"	"Detected in some"	4	"ASC diff: 39.5;ASC TERT1: 30.1;HHSteC: 56.4;HSkMC: 65.0;TIME: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		18000000	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	20.2	14.8	2.0	5.2	3.5	0.0	13.2	0.5	4.2	10.7	4.0			5.7	7.9	3.6	2.1	10.2	12.1	14.0	2.4	3.4	13.1	13.7	5.1	12.4	4.7		3.9	5.0	2.2	6.0	3.2		6.5	3.4		5.4	6.8	2.5	5.3	7.2	10.1	2.7	4.8	5.6	1.2			17.2		5.2	6.3	9.3	0.1	0.4	7.5	0.9	0.8	0.1	0.4	0.0	0.3	0.0	0.0	39.5	30.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.1	5.2	56.4	0.6	1.4	65.0	0.0	0.7	0.7	0.0	10.6	0.1	0.1	0.1	10.1	0.1	0.0	4.9	0.6	0.1	0.0	0.0	0.9	0.1	1.1	0.0	0.0	1.4	0.0	1.7	0.0	5.6	0.2	0.3	25.2	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.1	0.0	4.0	0.9	7.5	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.8	0.0	0.1	0.0	0.4											3.0	16.5	0.5	3.1	6.3	0.0	4.8	0.0	2.7	11.4	0.0	0.0	0.2	0.0	0.1	0.5	37.5	0.0	0.0	0.2	0.1	8.7	1.3	1.1	0.0	1.6	0.0	0.0	44.2	1.2	2.6	33.6	2.9	3.3	5.4	0.0	0.2	0.3	0.0	22.3	0.0	0.4	181.1	82.1	0.3	0.4	3.9	0.2	0.0	0.0	0.9
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872860	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 38.6;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1500000	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	6.8	6.7	21.6	6.7	23.7	2.9	8.5	42.6	29.1	9.5	11.5	9.7	14.3	9.8	12.3	19.5	6.4	10.5	11.4	13.8	19.7	17.0	9.9	7.2	9.0	10.3	11.2	32.1	13.4	19.5	20.8	18.3	8.5	19.2	11.4	9.6	6.9	18.8	15.3	31.6	11.1	9.0	9.6	11.0	8.3	12.9	5.0	15.6	4.9	16.3	4.3	8.2	9.3	8.5	6.1	2.6	1.5	3.0	3.2	12.8	1.8	2.2	3.3	17.0	17.4	13.4	12.0	15.1	9.4	9.6	7.8	11.6	17.4	11.1	0.0	11.2	7.3	7.9	1.5	7.3	4.1	5.1	0.7	13.1	6.7	5.9	9.1	12.0	0.3	11.1	17.4	4.7	8.7	4.0	23.3	0.6	8.9	5.0	1.2	5.3	3.8	1.7	3.4	3.9	3.8	1.7	0.0	11.6	10.7	11.3	3.3	9.9	11.6	4.8	7.7	12.1	6.7	5.9	6.1	0.2	26.8	10.7	2.5	5.3	13.1	1.7	0.8	31.5	0.6	9.8	1.5	3.0	1.4	7.4	2.0	2.1	5.6	6.3	2.8	2.6	6.1	12.8	8.9	0.3	3.2	0.7	1.4	4.8	1.8	21.6	23.7	42.6	29.1	19.7	17.0	11.2	32.1	19.2	15.6	3.0	2.4	0.9	17.1	6.5	38.6	1.6	22.9	1.4	3.4	17.4	11.8	18.6	0.0	13.9	2.1	2.1	10.5	0.0	4.9	9.8	11.9	9.2	2.3	10.2	4.0	38.1	10.4	0.6	1.9	0.5	11.5	2.4	10.1	3.6	16.0	9.4	6.7	14.0	7.4	5.1	16.9	6.5	8.6	11.1	10.6	3.8	14.1	4.1	17.8	12.0
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 103.6;Syncytiotrophoblasts: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HSkMC: 13.6;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	2200000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.1	2.1	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.6	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.6	4.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.1	0.4	34.7	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.6	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2	0.0	0.3	0.0	2.8	4.1	0.6	13.6	2.5	0.0	0.0	1.8	0.0	8.6	1.7	0.0	3.3	2.9	0.0	0.0	0.2	0.9	9.3	3.5	0.0	103.6	1.6	0.0	2.9	4.9	1.9	1.8	17.3	0.3	1.7	0.0	2.0	0.8	0.2	0.0	11.3	8.8	0.2	12.9	4.4	0.0	0.3	3.1	33.6	0.0	1.5	0.9
GID4	"C17orf39, VID24"	ENSG00000141034	"GID complex subunit 4 homolog"	Q8IVV7	17	18039292-18068404	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.2"	"Group enriched"	"Detected in many"	17	"Early spermatids: 643.1;Late spermatids: 883.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044348	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA044348: AB_10959602"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.65e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	10.9	5.7	9.6	4.7	9.4	5.6	7.5	13.4	9.3	9.0	9.4	6.9	7.3	4.5	7.9	7.2	13.0	6.7	5.5	10.1	8.8	5.3	6.2	6.2	5.6	5.3	9.5	5.8	8.6	7.8	10.8	3.9	6.7	7.0	9.5	5.1	4.6	7.7	9.3	24.7	11.6	5.1	9.5	7.0	6.3	6.4	55.2	10.2	8.0	7.1	5.8	6.2	13.3	10.8	4.4	3.2	6.8	2.4	3.8	3.6	1.0	6.4	6.7	3.8	6.2	10.0	9.8	6.6	5.4	8.7	6.0	6.8	5.8	2.6	8.2	4.6	6.3	5.6	7.3	5.5	6.0	7.8	4.4	11.0	3.6	5.7	4.2	8.7	2.2	6.4	7.3	10.5	6.0	9.4	8.1	6.7	11.9	3.2	2.4	4.8	1.7	6.9	4.6	3.3	8.1	5.0	5.9	13.5	8.0	4.0	2.6	2.9	4.3	3.6	3.2	3.8	39.5	2.1	2.7	5.5	3.9	2.2	8.9	2.7	4.1	3.6	1.8	5.5	3.7	4.9	6.8	2.4	6.6	2.6	1.3	2.9	4.4	2.4	2.5	1.9	4.4	2.9	2.9	6.3	3.8	1.5	3.2	3.6	1.0	9.6	9.4	13.4	9.3	8.8	5.3	9.5	5.8	7.0	10.2	0.0	0.6	3.4	6.6	9.8	5.2	10.6	2.5	2.7	1.2	1.8	3.9	6.6	8.3	5.0	643.1	7.1	2.6	0.0	4.9	10.6	5.3	7.6	5.7	6.4	6.4	15.9	1.2	7.4	6.3	883.9	11.8	5.3	6.8	5.4	7.2	4.2	8.2	0.0	14.9	9.6	3.7	12.9	5.1	45.4	22.8	15.8	12.9	5.2	5.0	6.5
GIGYF1	"GYF1, PERQ1"	ENSG00000146830	"GRB10 interacting GYF protein 1"	O75420	7	100679507-100694037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 43.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020999, HPA023995"	Enhanced		Approved	Vesicles,Microtubules		NA	NA			Vesicles	Microtubules	"HPA020999: AB_2111744, HPA023995: AB_1855221"	"unprognostic (3.82e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.42e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.43e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.67e-3)"	15.5	17.3	22.1	15.9	23.0	28.2	16.3	66.8	32.4	20.6	14.0	18.9	27.3	17.1	25.1	20.2	11.5	18.3	16.4	13.2	20.3	9.4	14.4	13.3	13.5	18.5	14.1	16.3	29.8	23.8	17.8	26.3	16.2	15.7	17.1	9.3	19.6	26.5	25.7	25.5	31.7	17.6	12.9	9.3	24.0	17.0	18.9	20.4	11.8	20.5	10.4	14.2	14.3	14.0	4.1	3.9	8.8	2.6	2.5	5.1	0.9	7.1	7.3	11.8	17.3	5.7	4.4	21.1	6.7	5.5	4.2	4.9	4.2	12.3	10.0	8.8	4.9	8.6	8.6	5.8	6.8	2.6	10.6	11.8	6.9	18.1	6.1	5.6	7.8	11.9	7.0	5.5	5.4	7.7	7.0	4.2	11.9	19.1	9.9	3.8	16.1	13.9	43.5	14.4	2.8	9.0	22.3	6.2	9.9	3.1	6.5	10.6	16.8	8.7	14.2	7.7	8.4	6.4	13.2	6.5	12.3	15.3	20.1	6.2	8.1	3.5	5.4	7.1	15.8	7.2	3.3	2.6	2.2	5.1	2.3	3.8	2.7	3.4	3.2	1.0	4.1	3.1	3.2	8.8	2.5	2.5	3.9	1.8	0.9	22.1	23.0	66.8	32.4	20.3	9.4	14.1	16.3	15.7	20.4	3.0	5.6	23.1	9.7	28.2	22.4	6.0	30.6	2.7	4.5	17.4	17.7	11.2	13.3	9.7	0.8	16.3	15.7	23.3	8.1	8.8	16.6	8.6	5.7	17.4	9.9	49.3	17.9	20.3	23.8	2.4	22.7	10.7	16.9	4.6	21.7	11.8	10.5	16.9	17.0	7.6	25.7	32.3	17.2	14.0	36.4	19.6	13.6	24.1	15.1	9.2
GIN1	"FLJ20125, GIN-1, TGIN1, ZH2C2"	ENSG00000145723	"Gypsy retrotransposon integrase 1"	Q9NXP7	5	103086000-103120151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037402, HPA061362"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037402: AB_10672790, HPA061362: AB_2684491"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.08e-2)"	6.0	9.3	5.0	5.7	9.5	1.4	8.0	15.0	9.6	9.0	7.0	6.5	6.1	4.9	7.0	5.6	7.2	6.4	3.7	12.7	5.8	5.1	7.9	8.3	5.6	6.6	14.0	4.2	11.0	6.0	8.4	17.4	5.1	9.4	8.3	6.7	3.6	6.1	7.6	14.6	4.5	5.9	5.8	11.4	6.9	6.3	9.3	10.8	8.6	9.1	6.1	6.7	9.4	9.5	4.6	3.3	4.8	7.1	3.7	8.3	2.8	5.5	6.0	7.6	5.5	3.6	9.3	6.2	7.4	5.1	5.6	5.0	3.6	7.2	3.3	7.0	2.9	4.8	6.6	7.0	10.5	7.6	4.2	5.6	4.8	5.8	4.0	7.5	4.3	3.1	3.6	11.7	5.1	10.5	6.0	4.4	5.5	4.2	4.9	8.8	4.0	5.9	2.8	6.5	4.0	9.4	5.3	8.7	8.6	7.4	4.6	6.2	4.5	4.9	4.1	7.1	5.7	12.0	6.5	3.6	5.7	3.5	6.1	5.6	6.0	4.8	4.8	7.3	6.8	4.6	0.4	2.7	4.8	3.4	3.4	3.9	4.6	4.6	5.0	3.3	3.8	5.6	5.6	3.8	3.7	7.1	3.2	8.3	2.8	5.0	9.5	15.0	9.6	5.8	5.1	14.0	4.2	9.4	10.8	8.9	4.0	1.4	4.8	0.8	9.5	16.5	0.0	8.1	3.4	5.2	0.0	6.6	19.9	6.7	1.0	3.0	3.2	0.0	3.7	4.0	2.4	3.6	16.1	3.9	4.8	0.0	4.1	3.1	3.2	0.2	4.6	5.3	0.0	3.6	3.3	8.5	3.6	3.1	6.3	6.7	12.1	6.5	3.9	24.0	12.8	1.8	6.9	4.3	3.2	3.1
GINM1	"C6orf72, dJ12G14.2"	ENSG00000055211	"Glycoprotein integral membrane 1"	Q9NU53	6	149566294-149591748	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 261.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017210, HPA041679"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		8700	"Nucleoli fibrillar center, Plasma membrane"		"HPA017210: AB_1845743, HPA041679: AB_2677611"	"unprognostic (6.09e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.79e-3)"	32.1	26.3	21.3	17.8	34.7	20.0	51.5	26.1	27.6	28.8	25.7	22.4	29.0	14.2	29.3	36.9	21.5	24.1	24.3	48.2	20.3	18.3	51.3	29.6	28.4	32.9	43.6	21.4	31.7	28.3	27.1	17.5	34.0	23.0	23.6	19.8	21.7	20.7	40.1	29.2	20.9	17.3	36.7	31.3	18.6	22.8	31.0	30.2	11.5	41.5	21.6	13.1	28.6	22.6	16.8	12.6	23.7	16.0	8.0	8.1	7.7	7.9	5.7	9.3	12.5	50.2	30.1	15.2	27.2	31.9	20.7	26.0	7.4	10.7	5.9	15.0	25.7	19.1	16.4	6.0	13.6	27.1	9.8	13.4	5.6	5.5	8.8	19.2	11.0	5.4	33.4	11.8	17.5	12.1	22.7	22.2	8.1	7.2	9.8	19.4	10.2	6.9	8.3	3.2	11.7	6.1	7.4	16.7	4.4	29.4	7.0	5.9	5.7	27.1	16.1	5.6	10.7	10.1	11.2	15.5	11.2	11.8	28.5	17.9	9.7	11.2	7.3	20.8	9.9	10.3	11.9	13.7	17.1	6.8	13.2	7.9	16.8	8.1	7.4	10.0	11.7	7.9	6.4	23.7	8.0	16.0	12.6	7.5	7.7	21.3	34.7	26.1	27.6	20.3	18.3	43.6	21.4	23.0	30.2	74.5	47.2	33.3	50.3	41.6	20.9	44.8	30.6	33.5	43.3	62.8	27.5	69.7	33.2	80.6	144.2	73.7	38.6	0.0	70.5	63.5	82.2	48.5	27.8	35.6	40.9	15.9	25.7	88.4	45.9	261.3	120.0	45.3	40.5	82.0	22.0	80.5	55.4	29.4	106.1	117.9	21.9	97.0	65.6	141.4	88.4	41.0	102.6	28.7	25.1	50.0
GINS1	"KIAA0186, PSF1"	ENSG00000101003	"GINS complex subunit 1"	Q14691	20	25407727-25452628	"Predicted intracellular proteins"	"DNA replication"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 21.4"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 43.6;Extravillous trophoblasts: 14.7;Late spermatids: 17.2;Spermatogonia: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA051185	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051185: AB_2681378"	"unprognostic (6.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (5.86e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.42e-11)"	"unprognostic (5.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.55e-1)"	1.5	1.9	4.1	11.7	4.2	4.5	2.2	7.4	4.3	2.2	4.5	1.3	0.0	4.3	2.2	1.0	8.5	1.4	2.3	1.0	2.2	2.2	2.2	2.0	1.4	7.2	1.9	2.1	1.7	1.8	1.1	0.8	5.5	2.2	1.4	5.9	1.3	2.1	0.7	0.7	5.3	4.1	2.8	1.8	3.4	2.9	21.4	0.9	20.1	1.0	6.4	10.5	2.6	3.2	2.6	2.3	1.3	1.0	1.9	3.5	0.9	18.0	16.4	20.2	13.1	1.1	1.6	20.4	8.0	3.9	15.5	16.5	14.2	18.1	22.3	9.2	3.3	11.5	21.0	17.6	14.8	18.0	5.9	6.1	15.3	6.0	17.2	0.4	20.0	7.0	0.7	0.8	14.7	3.0	2.1	8.2	12.8	14.7	14.7	9.2	19.5	30.7	15.0	13.7	12.6	8.6	22.0	23.3	15.1	5.9	12.2	8.5	8.9	8.2	19.6	6.9	11.9	18.6	10.1	3.7	12.2	13.2	7.9	14.6	5.9	16.7	17.6	3.2	19.6	13.7	0.8	0.8	0.5	1.5	1.0	0.9	2.6	1.1	0.5	2.1	1.7	0.8	1.4	1.3	1.9	1.0	2.3	3.5	0.9	4.1	4.2	7.4	4.3	2.2	2.2	1.9	2.1	2.2	0.9	0.0	1.1	0.8	0.4	2.9	1.3	0.3	0.0	2.7	2.3	1.8	0.0	5.0	0.0	1.3	43.6	0.1	0.5	0.0	0.6	14.7	1.4	0.4	1.1	0.0	4.8	0.0	1.2	1.3	1.3	17.2	0.6	1.5	0.0	0.0	1.2	1.3	0.4	0.0	1.1	1.8	0.1	0.0	0.9	8.9	20.9	1.3	2.1	0.0	2.8	0.4
GINS2	"Pfs2, PSF2"	ENSG00000131153	"GINS complex subunit 2"	Q9Y248	16	85676198-85690073	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.2;testis: 21.3"	"Cell type enhanced"	"Detected in many"	11	"Spermatocytes: 65.9;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 72.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA057285	Uncertain		Approved	Nucleoplasm		No	Yes			Nucleoplasm		"HPA057285: AB_2683398"	"unprognostic (3.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.70e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.60e-1)"	0.9	1.5	3.5	15.9	3.7	13.2	3.6	3.8	2.1	1.9	6.5	1.9	1.5	4.7	1.8	2.6	7.1	0.9	2.2	1.6	4.8	1.5	1.3	3.3	1.4	8.7	2.2	1.5	1.9	4.4	2.6	1.4	4.6	1.6	2.6	7.4	1.9	2.0	0.7	3.2	3.1	5.9	1.5	2.3	7.6	2.1	21.3	1.8	25.2	1.8	8.0	13.3	1.9	3.0	1.4	1.7	1.5	3.3	4.3	11.1	2.4	13.4	9.7	19.0	7.9	0.5	1.9	5.0	9.3	3.7	13.7	8.5	12.8	9.0	15.9	5.1	3.2	7.2	10.3	20.0	7.6	13.3	5.5	17.3	7.8	7.4	14.4	0.1	5.4	4.3	0.5	0.9	8.2	3.2	1.7	5.8	12.9	21.4	3.8	7.9	28.2	19.1	20.5	10.6	11.9	7.4	26.8	11.5	8.8	4.4	5.6	26.2	8.3	13.4	2.7	2.7	7.9	27.6	7.4	3.5	9.0	12.1	8.4	10.6	7.1	12.5	72.1	5.2	11.5	10.2	0.7	0.3	1.5	1.4	1.3	0.2	1.4	4.7	3.1	1.7	1.0	2.2	1.6	1.2	4.3	3.3	1.0	11.1	2.4	3.5	3.7	3.8	2.1	4.8	1.5	2.2	1.5	1.6	1.8	3.0	0.0	6.7	6.6	8.1	7.1	1.1	0.0	2.7	4.5	3.5	2.0	17.0	3.3	6.0	8.2	0.6	1.6	23.3	1.3	22.7	3.1	2.7	1.1	1.7	19.7	7.9	2.9	0.0	0.6	22.2	1.1	2.8	0.0	1.0	8.2	3.4	1.5	5.8	1.8	0.3	8.0	19.4	3.1	65.9	96.9	3.3	10.6	5.1	29.9	1.6
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529206-41545046	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"B-cells: 13.0;monocytes: 15.4;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	2.0	3.0	2.3	6.2	4.7	9.0	2.7	1.6	3.7	2.7	3.4	6.8	0.0	2.5	2.4	3.0	6.0	1.6	2.4	5.7	3.7	1.8	2.2	2.2	2.5	7.9	5.9	3.3	2.6	1.3	1.6	1.2	4.8	2.8	1.8	5.1	1.9	2.6	0.8	3.7	3.4	3.7	2.4	4.7	5.0	2.1	8.6	5.6	14.0	2.1	5.7	9.6	2.1	3.0	5.8	5.2	3.9	1.4	2.7	6.7	1.7	9.7	14.0	19.8	8.9	1.2	1.6	8.2	13.9	8.4	14.4	17.0	12.9	8.5	13.5	5.7	7.0	11.0	7.4	15.9	11.4	21.3	5.0	8.9	19.6	10.3	8.7	0.3	4.2	10.2	0.8	0.5	23.8	5.3	3.3	7.1	16.4	9.6	4.5	10.1	6.6	17.6	4.8	11.0	10.4	7.7	16.6	18.5	5.7	5.1	9.3	6.1	4.8	9.8	4.4	4.0	10.5	11.3	4.7	4.9	9.8	14.9	18.0	13.9	5.3	7.8	16.1	7.0	10.1	23.7	2.4	1.4	0.5	3.0	1.3	1.7	2.4	4.8	2.0	0.7	5.8	3.1	2.0	3.9	2.7	0.7	5.2	6.7	1.7	2.3	4.7	1.6	3.7	3.7	1.8	5.9	3.3	2.8	5.6	0.0	1.4	13.0	2.6	2.5	5.0	0.8	0.0	0.0	1.2	8.7	2.0	6.2	0.0	1.3	0.5	0.7	0.4	0.0	1.6	10.0	2.6	1.1	1.1	0.5	4.0	0.0	3.4	1.3	1.9	0.0	1.1	4.0	0.0	15.4	2.3	1.9	1.5	0.0	2.1	0.8	1.8	0.0	1.4	7.7	11.5	1.0	4.9	4.9	3.3	0.8
GIPC1	"C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2"	ENSG00000123159	"GIPC PDZ domain containing family member 1"	O14908	19	14477760-14496149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 262.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043958, HPA061786"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA043958: AB_10963436, HPA061786: AB_2756319"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	16.4	15.1	17.4	12.0	21.0	2.0	11.2	12.1	28.8	19.4	51.0	29.7	15.3	14.2	11.9	14.9	71.2	14.4	21.2	17.9	16.9	14.8	18.7	16.9	20.5	7.9	18.3	23.0	10.2	15.1	6.5	12.4	24.0	23.0	14.0	23.9	15.2	22.1	19.6	26.8	40.4	13.3	15.8	21.8	10.8	35.7	6.5	16.6	11.1	18.2	26.0	24.7	17.1	26.3	2.0	4.0	2.4	1.2	1.5	12.1	1.9	66.0	30.7	9.4	14.7	8.7	8.8	7.4	24.8	12.6	20.5	18.6	16.4	25.1	0.9	46.8	17.5	13.7	38.0	8.0	20.8	7.0	6.8	14.4	12.9	21.0	16.0	26.8	1.3	16.0	10.1	20.8	12.4	10.9	12.2	13.8	9.8	6.0	11.4	10.4	49.3	4.2	2.6	10.2	37.0	30.8	4.4	7.9	8.8	25.2	57.9	8.8	9.8	13.9	34.3	31.8	5.1	21.5	7.2	23.8	29.0	16.0	40.4	26.5	10.7	13.6	3.3	24.3	10.5	30.4	2.4	0.8	0.1	5.8	1.2	5.4	2.0	5.9	5.9	1.2	1.0	4.9	3.9	0.3	1.5	0.5	4.0	12.1	1.9	17.4	21.0	12.1	28.8	16.9	14.8	18.3	23.0	23.0	16.6	26.8	14.6	11.5	47.9	101.2	65.6	12.9	17.8	4.0	15.9	78.5	33.4	29.4	44.7	162.1	0.8	27.0	262.4	0.0	146.8	55.5	40.6	96.5	10.3	16.4	46.4	71.5	41.3	19.0	9.5	1.9	19.0	13.8	55.6	37.9	62.6	60.8	195.2	130.6	23.7	38.4	38.1	19.4	38.2	7.4	20.6	148.3	21.5	13.8	65.5	154.2
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 48.7;Proximal tubular cells: 149.4;Undifferentiated cells: 50.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.9;naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.2;HaCaT: 4.9;Hep G2: 18.3;HUVEC TERT2: 19.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	6.4	17.0	0.8	3.2	0.9	0.0	4.0	0.4	1.0	2.6	27.0	0.3	0.2	19.6	5.4	4.5	5.7	1.4	8.1	3.1	0.5	0.5	21.3	10.4	3.2	2.2	0.5	0.3	3.7	24.7	3.3	2.5	1.6	1.3	2.1	7.8	1.5	6.9	1.0	1.8	2.7	64.0	1.4	0.6	22.7	3.0	2.2	0.4	0.1	1.5	4.9	1.4	2.5	5.1	0.1	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	5.2	0.0	0.8	0.0	0.4	0.9	4.1	2.7	1.2	0.0	0.4	0.0	4.9	0.0	0.0	2.7	0.1	0.0	0.6	0.0	18.3	1.0	0.0	0.0	0.8	0.0	2.9	0.1	0.0	19.3	0.0	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.0	1.0	0.6	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	0.5	0.5	0.5	0.3	1.3	0.4	0.0	2.2	1.3	2.0	11.4	0.4	2.6	25.5	12.0	3.4	8.7	2.0	5.2	28.2	9.6	1.7	13.7	48.7	0.0	29.0	1.9	1.6	0.5	0.0	39.9	10.0	0.0	2.9	11.1	0.6	0.5	1.1	0.2	0.0	1.8	34.6	0.0	18.0	31.7	0.0	149.4	0.5	0.0	1.3	0.5	0.2	19.1	1.4	0.5	50.7	5.6
GIPC3	"C19orf64, DFNB15, DFNB72, DFNB95"	ENSG00000179855	"GIPC PDZ domain containing family member 3"	Q8TF64	19	3585553-3593541	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Ito cells: 16.0;Rod photoreceptor cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 12.3;HMC-1: 7.9;THP-1: 14.8;WM-115: 29.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067765			Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA		13000	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA067765: "	"unprognostic (1.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	5.5	2.4	1.3	1.3	1.3	0.0	3.0	1.3	1.3	3.4	1.5	1.9	5.0	1.0	4.5	3.2	6.0	2.2	2.1	2.7	1.3	0.6	4.1	1.6	4.5	2.0	1.3	1.3	1.3	1.3	4.6	1.3	1.3	1.3	4.3	1.3	1.9	1.3	5.2	1.3	1.1	5.4	9.3	1.3	4.8	2.0	1.3	2.2	2.0	3.8	1.3	1.4	1.3	13.0	0.1	0.1	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.9	0.0	1.0	0.0	0.1	4.4	12.3	0.0	0.5	0.0	7.9	0.1	0.0	0.7	0.0	0.0	1.4	0.1	2.0	0.0	0.2	0.0	0.0	0.7	0.5	0.0	0.8	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.3	0.0	3.0	0.8	0.0	14.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.3	1.3	1.3	1.3	1.3	1.3	0.6	1.3	1.3	1.3	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	16.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	20.5	0.0	1.2	0.0	0.4	0.3	0.1	0.0	0.0	0.0
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573469-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 78.6;Late spermatids: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"		NA	NA		53000	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	13.0	8.5	34.0	11.1	38.1	8.0	9.4	18.9	43.4	7.8	9.8	15.6	2.2	11.6	10.0	5.3	13.2	14.0	10.2	12.2	41.5	16.4	7.0	3.7	12.0	12.6	19.2	21.8	13.6	14.3	10.2	8.1	13.8	15.0	8.4	6.9	7.8	11.9	10.3	10.0	20.2	10.9	8.7	11.9	11.1	9.5	42.9	19.8	10.8	11.0	4.5	9.7	9.8	7.5	1.8	4.7	3.0	6.0	5.6	4.9	3.6	17.5	29.4	14.5	25.8	11.6	7.3	16.8	8.7	8.6	10.5	9.4	11.9	6.6	13.3	14.0	11.4	18.8	29.1	15.2	22.4	5.4	17.1	18.2	9.6	14.4	10.6	14.1	12.1	7.9	8.9	25.8	12.1	18.9	15.0	19.5	17.8	7.8	11.5	7.5	18.1	38.2	16.3	10.8	17.8	7.0	29.1	19.4	19.9	9.5	9.7	30.5	26.1	12.3	28.6	43.0	10.8	14.0	16.2	24.0	10.0	14.5	22.0	17.5	9.6	13.2	14.5	16.5	10.4	16.8	0.3	3.6	3.0	4.7	6.0	2.2	1.8	4.5	4.9	4.7	1.7	3.7	2.7	1.2	5.6	3.7	4.0	2.9	3.6	34.0	38.1	18.9	43.4	41.5	16.4	19.2	21.8	15.0	19.8	3.0	1.0	13.7	6.2	24.2	14.0	7.6	0.0	8.1	1.2	5.2	9.8	4.4	1.7	7.1	78.6	27.4	16.3	0.0	8.1	6.7	8.8	8.0	1.1	2.1	7.3	11.1	14.3	14.7	7.8	70.1	13.3	9.2	8.5	4.6	14.3	9.7	8.1	10.5	9.9	5.0	9.3	12.9	5.1	10.4	10.9	24.6	3.0	7.7	13.7	6.7
GIT2	"KIAA0148, PKL"	ENSG00000139436	"GIT ArfGAP 2"	Q14161	12	109929792-109996389	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004681	Approved		Approved	Microtubules		NA	NA			Microtubules		"CAB004681: AB_425820"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.41e-2)"	13.5	16.4	16.1	19.6	22.6	43.1	15.4	35.5	17.2	10.6	10.5	13.8	9.2	9.1	15.9	9.5	9.9	9.8	12.9	14.0	14.9	12.1	9.7	10.0	14.9	24.7	11.4	13.6	16.3	16.9	13.3	13.5	18.8	14.2	10.8	11.8	11.3	11.6	11.5	11.2	11.4	16.3	16.6	15.1	30.8	9.5	12.6	15.4	31.7	14.0	5.6	25.3	14.0	10.8	14.2	21.5	48.3	21.6	13.3	13.3	16.1	9.4	11.7	7.9	8.8	14.1	13.1	5.7	20.4	19.5	17.9	11.5	5.6	5.1	22.9	8.0	24.2	7.0	7.1	6.7	8.7	18.4	19.1	7.0	14.7	6.7	6.7	9.0	21.0	23.9	11.0	8.3	16.8	8.9	16.5	18.8	13.2	7.7	5.8	22.0	5.6	18.7	30.2	5.6	5.3	9.0	15.6	20.0	12.9	8.8	7.9	4.8	6.9	12.6	5.9	8.0	8.5	8.5	17.9	17.6	12.0	6.3	9.4	10.2	11.9	10.1	22.5	10.5	15.7	10.2	19.7	21.6	48.3	13.0	20.6	12.7	12.7	13.0	13.3	21.5	14.2	11.4	10.1	48.1	13.3	18.9	8.9	13.2	16.1	16.1	22.6	35.5	17.2	14.9	12.1	11.4	13.6	14.2	15.4	17.9	15.4	27.4	6.2	8.5	22.0	7.0	15.3	10.7	11.4	26.2	7.9	10.5	3.3	14.4	5.3	19.6	12.3	0.0	12.0	9.3	12.7	4.7	13.9	13.9	32.1	31.8	7.5	25.2	55.1	4.0	17.3	39.0	13.5	37.9	6.9	10.6	17.3	9.7	18.7	5.7	16.1	12.9	12.0	36.1	20.6	9.9	5.1	37.9	10.2	6.7
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435692-121449727	"Cancer-related genes, Disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 232.3;Basal keratinocytes: 208.6;Cardiomyocytes: 174.1;Fibroblasts: 139.5;Suprabasal keratinocytes: 330.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 73.4;HUVEC TERT2: 56.2;NTERA-2: 57.2;SuSa: 74.9;U-87 MG: 55.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	19.7	65.2	78.6	5.5	69.7	0.4	14.2	32.4	44.4	64.5	4.0	23.8	6.1	4.2	23.5	5.5	17.3	7.8	23.0	36.0	87.3	25.5	3.6	2.5	15.2	4.4	42.9	39.9	10.5	4.5	94.7	5.7	63.8	53.7	20.0	4.8	26.3	7.1	35.7	3.4	86.3	4.4	25.6	38.7	1.1	6.4	8.3	64.3	0.5	38.9	9.9	7.6	14.8	32.2	0.5	0.5	0.4	0.5	0.0	0.4	0.0	0.0	6.6	29.3	0.0	16.0	9.9	0.0	21.9	44.6	7.4	18.1	0.1	0.0	0.0	2.4	8.5	6.3	2.8	0.7	13.4	24.1	0.0	8.0	0.3	2.7	0.0	20.0	0.0	0.0	26.4	14.5	27.1	9.8	73.4	56.2	0.0	0.0	0.6	1.4	1.2	0.0	11.7	57.2	0.0	7.3	0.0	0.0	0.5	29.6	3.2	0.0	0.4	0.0	0.0	0.0	74.9	2.3	0.0	41.3	22.8	6.3	19.2	14.1	0.0	0.0	0.0	55.7	0.0	3.2	0.4	0.5	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.5	0.4	0.4	0.0	0.0	0.1	0.5	0.1	0.0	78.6	69.7	32.4	42.8	87.3	25.5	42.9	39.9	53.7	64.3	232.3	73.8	0.0	121.0	208.6	0.2	174.1	0.0	5.3	14.8	1.8	2.0	46.7	0.0	69.9	0.3	111.0	0.0	0.0	3.5	8.1	139.5	19.9	8.1	0.0	7.5	0.0	0.0	22.7	0.3	1.1	2.3	2.8	42.2	1.0	0.0	0.1	17.0	0.0	3.9	0.0	0.2	0.0	27.8	0.3	0.1	330.6	16.7	0.0	0.0	45.0
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 62.0;Hepatocytes: 24.2;Suprabasal keratinocytes: 25.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 43.7;hTCEpi: 32.6;OE19: 22.7;RT4: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.4	43.7	0.0	0.2	0.0	0.3	8.7	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.6	0.5	6.0	0.0	0.0	0.6	0.0	3.2	0.0	0.4	0.3	0.0	0.1	22.7	4.3	0.0	0.0	2.4	0.0	50.8	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.3	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2	3.0	0.0	0.8	8.0	62.0	0.0	0.4	5.1	0.0	3.4	1.8	0.0	0.0	0.0	3.5	0.7	0.2	19.0	0.0	8.8	0.2	1.6	7.8	0.0	24.2	0.7	0.0	4.1	0.0	0.8	0.9	0.0	1.2	1.7	8.2	3.9	0.0	8.1	15.0	0.0	14.7	0.0	0.0	2.0	0.2	0.4	25.1	0.1	0.0	19.7	15.6
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Group enriched"	"Detected in many"	7	"Basal glandular cells: 49.4;Basal keratinocytes: 123.0;Pancreatic endocrine cells: 70.6;Suprabasal keratinocytes: 149.2;Urothelial cells: 169.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.3;CAPAN-2: 37.4;HaCaT: 30.4;HBEC3-KT: 26.0;hTCEpi: 42.7;OE19: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	3.6	0.0	0.0	30.4	0.0	26.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.7	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	16.3	6.8	0.0	0.0	0.0	12.7	10.0	0.0	0.0	4.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0	3.0	0.0	0.0	49.4	123.0	0.0	0.3	2.5	1.4	2.3	5.2	0.0	0.0	0.0	15.7	0.0	0.1	3.1	0.0	6.3	0.1	3.1	16.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.9	0.0	70.6	7.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	149.2	0.1	0.0	16.1	169.4
GJB7	"bA136M9.1, CX25"	ENSG00000164411	"Gap junction protein beta 7"	Q6PEY0	6	87282978-87329278	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5"	"Cell type enhanced"	"Detected in some"	28	"Ciliated cells: 29.4;Cytotrophoblasts: 7.7;Extravillous trophoblasts: 4.4;Syncytiotrophoblasts: 6.1"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.5;HDLM-2: 10.5;MCF7: 5.8;OE19: 6.7;RT4: 5.2;SuSa: 3.6"					"Low region specificity"	"Detected in many"			HPA014392			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014392: "	"unprognostic (8.30e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-3)"		"unprognostic (2.61e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.10e-2)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0			0.0	0.1	0.0	0.0	12.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	10.0	4.5		0.0	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3			0.0		0.1	0.5	0.0	0.7	0.1	1.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	5.8	0.0	0.1	1.8	6.7	0.0	0.2	0.0	0.0	0.0	5.2	0.1	0.0	1.2	0.0	0.0	3.6	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.6	1.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	29.4	0.0	0.0	0.0	7.7	0.0	0.0	0.6	0.0	0.0	0.0	0.2	4.4	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.2	0.1	0.0	6.1	0.0	0.2	0.1
GJC1	"CX45, GJA7"	ENSG00000182963	"Gap junction protein gamma 1"	P36383	17	44798448-44830816	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	23	"Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071788			Uncertain	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			Nucleoli	"Cell Junctions, Cytosol"	"HPA071788: "	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.55e-8)"	"unprognostic (5.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (7.83e-4)"	7.3	0.8	2.2	4.1	3.4	1.0	4.7	8.2	4.2	14.8	23.0	2.8	7.0	1.6	24.2	3.1	3.2	5.0	5.4	10.0	3.3	1.8	1.5	0.9	6.5	2.3	2.5	4.0	2.2	1.3	2.6	0.7	28.5	3.4	8.2	2.8	3.7	1.7	17.0	5.4	1.9	4.8	27.5	2.2	0.9	7.8	8.0	2.9	1.4	5.3	2.9	1.7	12.6	10.4	1.2	1.0	4.7	1.0	1.9	1.0	0.4	17.4	9.0	22.7	7.8	3.0	4.7	8.9	19.4	15.3	20.9	22.5	5.2	9.7	0.1	1.0	18.1	28.6	4.5	11.8	6.0	29.4	0.1	8.8	0.1	4.8	0.5	1.8	0.1	0.7	3.2	0.6	15.9	5.3	7.8	7.1	3.9	0.8	0.2	12.1	0.1	2.8	1.7	10.2	0.0	7.7	16.5	28.8	0.1	5.0	7.3	4.3	9.9	2.2	0.1	6.5	15.3	4.7	2.7	5.9	18.5	17.9	8.4	16.5	0.1	4.5	12.9	6.4	0.1	17.3	4.7	1.0	1.1	0.9	0.6	0.8	0.9	0.7	0.6	0.3	1.2	0.9	1.0	3.9	1.9	0.7	1.0	0.6	0.4	2.2	3.4	8.2	4.2	3.3	1.8	2.5	4.0	3.4	2.9	0.0	0.0	0.0	1.6	1.8	1.0	18.1	0.0	0.0	0.0	1.8	2.0	0.3	0.0	1.3	1.3	11.7	0.0	0.0	0.0	2.1	5.7	1.2	0.0	0.0	1.2	12.7	0.0	6.2	0.8	0.0	1.4	0.0	3.3	1.0	0.0	0.4	0.6	0.0	2.1	0.3	1.0	155.2	65.3	10.2	32.0	2.6	0.5	0.0	0.0	1.4
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149852-228159826	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 34.3"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 11.8;Peritubular cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 9.9;SCLC-21H: 5.2;TIME: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.4	1.9	4.6	1.2	10.0	0.5	2.0	2.2	14.8	2.8	2.6	34.3	0.0	0.6	4.5	2.0	1.7	4.8	1.4	1.6	9.3	5.3	0.6	0.5	3.1	1.2	27.2	5.6	3.4	0.9	2.9	0.6	1.2	18.3	2.1	0.8	0.0	1.5	4.0	1.5	2.4	1.2	3.8	32.6	1.9	1.2	1.0	15.7	0.0	0.9	0.0	0.7	1.3	1.8	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.5	1.4	0.7	1.9	1.4	0.4	0.6	0.8	0.9	1.2	0.2	9.9	2.6	0.8	1.0	0.3	0.3	0.3	0.4	1.6	0.3	2.5	2.2	2.5	0.0	0.0	0.4	0.2	0.8	0.5	1.2	0.2	1.7	1.1	0.3	0.4	0.6	1.9	0.6	0.6	0.0	2.0	0.4	0.3	0.1	0.8	0.0	5.2	3.0	0.4	0.1	0.3	0.1	0.1	0.3	4.6	1.4	3.8	4.5	1.6	0.3	0.6	0.2	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	4.6	10.0	2.2	10.4	9.3	5.3	27.2	5.6	18.3	15.7	0.0	1.1	0.0	1.2	3.1	1.5	1.4	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.4	0.0	1.2	0.3	0.0	0.0	0.1	3.2	0.0	0.0	0.6	0.0	2.3	0.0	1.7	0.0	0.0	0.3	0.7	0.0	3.9	0.0	0.6	0.0	1.7	0.0	0.0	1.5	0.0	0.0	0.1	0.9
GK5	MGC40579	ENSG00000175066	"Glycerol kinase 5 (putative)"	Q6ZS86	3	142157527-142225607	"Enzymes, Predicted intracellular proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042606, HPA057998"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042606: AB_10795509, HPA057998: AB_2683573"	"unprognostic (7.79e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.59e-3)"	6.1	12.2	5.6	5.7	7.2	10.8	10.9	9.0	9.4	11.5	10.9	8.4	11.5	14.4	10.9	14.8	7.9	7.2	8.3	5.4	5.5	4.1	5.7	3.1	6.2	3.5	9.3	6.0	11.5	4.8	5.4	20.3	3.7	12.6	13.5	11.8	6.7	14.8	14.7	5.0	8.8	14.0	9.4	11.6	3.5	8.1	6.2	5.3	4.6	7.4	4.2	6.1	8.5	6.7	1.3	1.1	3.6	5.3	3.8	3.8	0.5	11.0	2.8	4.0	2.7	8.3	15.9	6.9	3.7	2.6	4.1	2.6	4.2	6.1	8.0	3.3	3.5	4.5	4.7	4.6	3.5	5.4	2.8	4.4	5.2	6.6	3.1	4.5	5.9	6.9	6.5	3.1	2.7	3.6	2.6	2.3	9.2	4.5	4.9	7.3	7.1	5.2	4.9	2.6	7.4	3.2	4.9	4.3	2.9	4.2	6.9	3.9	2.9	10.2	10.8	3.3	2.5	15.0	3.9	2.5	3.2	2.7	7.1	4.0	5.1	4.9	8.1	5.8	3.7	5.4	3.6	1.1	0.7	3.8	0.9	1.9	0.5	1.3	1.4	0.8	1.3	1.0	1.7	3.2	3.8	5.3	1.1	0.6	0.5	5.6	7.2	9.0	9.4	5.5	4.1	9.3	6.0	12.6	5.3	35.7	27.8	0.0	11.1	3.5	30.1	9.3	15.3	21.4	27.3	26.2	27.5	11.1	6.6	12.3	2.0	5.9	31.1	0.0	17.9	6.4	7.8	21.5	8.1	11.1	5.0	14.3	26.9	2.5	10.0	3.6	31.4	8.2	3.3	1.0	51.9	13.2	13.9	39.1	43.9	5.1	35.7	25.8	4.9	4.2	4.7	3.4	5.7	17.5	38.6	11.6
GKAP1	"FKSG21, GKAP42"	ENSG00000165113	"G kinase anchoring protein 1"	Q5VSY0	9	83739421-83829516	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 98.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 991.0;Late spermatids: 314.1;Spermatocytes: 374.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035117, HPA035118, HPA066173"	Enhanced	Supported	Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA035117: AB_2674473, HPA035118: AB_10671100, HPA066173: AB_2732740"	"unprognostic (1.91e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.66e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.18e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (9.73e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.24e-3)"	4.4	4.2	6.0	2.8	6.1	2.5	9.2	15.6	6.1	4.7	5.0	4.1	6.6	3.0	5.5	4.5	3.2	3.9	3.4	9.0	6.1	6.8	4.2	5.1	2.9	2.6	6.5	3.1	7.0	5.2	6.2	7.9	2.0	6.1	6.6	2.7	3.2	4.2	5.9	25.0	1.7	3.0	8.1	8.0	2.4	3.5	98.8	7.2	8.4	8.1	5.2	2.7	6.0	14.7	1.9	0.6	3.0	0.8	5.3	1.9	0.1	4.8	6.0	4.4	5.8	0.6	0.0	6.3	1.9	1.5	3.0	3.1	0.8	2.7	7.5	1.9	0.8	10.1	1.0	4.4	0.5	5.2	9.0	3.9	4.3	3.0	4.3	6.5	2.0	0.4	0.2	3.5	1.5	1.6	8.8	2.7	7.3	3.5	6.3	0.9	4.6	10.5	6.9	3.6	2.3	3.1	7.5	9.9	2.6	3.1	0.8	14.8	8.8	4.3	2.0	3.4	7.1	0.8	4.1	0.9	1.0	7.1	0.7	3.3	10.4	22.7	3.0	2.2	1.4	1.2	3.0	0.8	0.6	1.4	0.0	1.3	1.7	1.3	1.5	0.6	1.9	1.0	1.9	2.5	5.3	0.3	0.3	1.5	0.1	6.0	6.1	15.6	6.1	6.1	6.8	6.5	3.1	6.1	7.2	6.0	9.1	10.2	16.1	6.3	45.6	47.4	12.7	6.7	2.3	14.0	43.2	7.1	11.6	8.8	991.0	11.7	6.2	23.3	5.8	2.3	4.7	20.1	2.3	18.8	3.5	114.4	12.6	10.4	3.2	314.1	24.5	5.2	10.1	1.0	12.0	43.9	6.4	6.8	20.1	11.6	73.0	25.8	8.4	374.4	52.7	4.0	2.4	12.1	10.8	8.1
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.8	10.0	6.5	7.7	39.9	20.7	139.7	9.3	25.2	12.0	15.4	14.2	13.8	2.8	8.3	19.0	8.9	5.6	6.1	11.9	8.9	16.3	5.1	11.2	6.0	7.3	20.5	7.7	11.4	23.9	11.4	10.8	6.4	23.6	18.4	3.9	10.1	10.9	13.1	6.8	4.6	5.1	4.4	12.2	4.4	4.0	4.3	13.2	12.9	8.5	2.0	6.8	12.0	19.4	11.7	12.0	12.9	20.4	10.7	7.7	5.4	10.5	7.9	8.6	13.7	0.9	16.2	11.2	5.8	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0	17.9	22.3	15.9	10.2	5.4	11.3	7.1	35.7	14.7	17.0	26.2	5.9	80.5	23.2	42.1	22.3	10.5	31.5	0.0	31.3	47.6	24.4	11.4	26.5	36.5	70.6	4.8	16.3	18.4	38.2	3.1	14.1	38.3	13.5	81.2	22.4	20.0	27.0	39.5	19.8	24.2	15.0	12.9	10.8	1.1	7.2	3.0	41.1	20.0	28.4	8.4
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 36.2"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 158.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.8;NK-cell: 5.8"	"Group enriched"	"Detected in many"	23	"NK-cells: 5.8;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6.0	13.5	4.5	8.7	3.6	20.5	6.6	3.0	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7.0	0.3	1.4	15.0	5.2	2.6	5.1	2.9	0.2	0.0	0.0	0.0	5.8	5.8	0.8	6.0	0.6	3.3	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.1	19.6	0.0	6.5	0.0	2.7	20.7	9.9	0.1	0.0	0.0	9.4	0.0	2.6	0.2	0.9	0.0	11.4	0.1	0.3	0.0	0.0	0.0	0.0	3.0	9.9	0.0	0.0	5.8	1.6	1.1	1.8	47.6	7.2	0.0	0.0	0.5	5.6	4.3	14.0	5.2	4.4	5.6	0.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	1.2	0.0	0.0	0.0	5.8	0.0	2.3	0.0	1.3	2.3	0.0	0.2	1.6	2.6	0.0	5.8	0.0	0.0	0.0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3	0.0	2.6	0.0	4.2	1.9	6.1	1.0	2.5	8.1	3.4	0.0	39.3	0.2	0.0	2.0	1.7	0.6	9.7	0.0	2.1	0.9	1.5	7.6	0.0	0.0	0.2	4.8	8.6	0.0	0.0	4.9	1.1	0.0	5.0	0.0	5.8	8.1	1.7	8.2	0.7	8.1	158.9	0.0	1.9	2.3	4.2	0.6	0.1	1.3	10.7	2.6
GLCCI1	"FAM117C, GIG18, TSSN1"	ENSG00000106415	"Glucocorticoid induced 1"	Q86VQ1	7	7968794-8094272	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.7"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 77.4;Bipolar cells: 61.8;Early spermatids: 62.5;Spermatocytes: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.7;U-266/70: 41.2;U-698: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001674, HPA005987"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA001674: AB_1078971, HPA005987: AB_1078970"	"unprognostic (6.12e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.20e-3)"	4.6	4.3	5.6	19.1	12.5	7.6	4.1	26.6	8.0	5.4	4.9	3.4	0.9	5.7	3.4	1.8	3.0	2.8	3.9	2.2	3.7	4.1	3.9	3.8	18.4	13.8	3.1	5.6	5.1	2.3	8.0	6.5	9.3	4.4	3.2	4.7	3.1	6.3	2.0	3.0	7.5	5.6	2.5	3.2	9.2	6.4	14.2	3.7	55.7	20.7	1.9	15.9	7.7	3.3	3.1	2.4	3.7	0.4	4.7	4.5	0.7	2.3	0.3	3.9	0.9	1.2	1.7	0.8	2.0	2.8	1.2	1.1	1.2	0.8	6.5	0.5	1.6	2.0	0.4	3.6	1.1	1.6	3.2	2.8	1.9	5.0	0.8	2.0	3.0	2.8	0.8	1.3	0.8	2.7	2.0	1.0	2.4	7.0	17.7	2.1	1.3	1.4	3.0	9.8	1.0	2.4	6.9	3.0	3.4	1.1	2.7	6.5	12.8	3.1	3.9	0.2	11.1	4.6	7.9	0.9	2.2	1.0	1.9	1.0	41.2	13.1	18.6	2.3	3.2	1.6	3.7	0.1	1.5	2.7	0.4	2.5	1.8	2.8	2.0	0.1	3.1	1.6	1.8	1.2	4.7	0.1	2.4	4.5	0.7	5.6	12.5	26.6	8.0	3.7	4.1	3.1	5.6	4.4	3.7	77.4	34.3	13.7	7.2	9.2	61.8	5.7	0.0	5.3	31.8	7.0	41.2	10.4	1.7	0.7	62.5	3.8	2.4	0.0	1.4	7.5	6.9	15.8	5.7	5.9	10.7	7.9	18.6	6.7	3.5	12.3	7.5	5.2	8.5	0.0	6.2	14.3	2.4	3.5	10.6	1.5	20.5	6.5	6.4	66.0	37.4	11.4	24.0	18.7	3.9	8.0
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 58.4"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		78000	Mitochondria		"HPA040481: AB_2677004, HPA048216: AB_2680317"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	8.3	12.2	6.5	4.9	14.2	0.6	8.8	58.4	12.1	8.4	12.1	12.4	7.8	13.5	6.3	6.9	10.2	5.9	7.2	5.5	5.8	8.5	13.3	16.0	8.4	5.3	9.4	8.1	12.9	5.9	9.0	12.0	12.6	14.4	5.7	14.0	10.8	11.7	8.9	4.1	9.8	11.2	6.8	10.2	4.0	8.8	6.1	7.6	5.4	4.1	8.4	5.8	6.3	5.6	0.6	4.0	0.1	4.4	0.5	4.0	1.9	3.9	3.5	2.4	4.2	8.2	7.8	0.8	7.4	9.9	5.8	11.0	2.9	10.0	2.4	3.7	6.0	7.3	6.0	5.2	4.8	11.8	0.9	5.7	4.0	6.7	3.0	7.9	1.7	8.2	5.3	3.3	7.1	8.1	4.2	50.9	1.8	1.6	2.6	10.8	2.4	1.0	3.0	1.2	4.0	2.5	2.4	9.8	3.0	5.3	4.2	7.7	1.6	7.6	4.7	15.7	1.7	3.4	2.4	17.7	5.6	6.9	6.1	6.5	1.1	1.5	0.5	5.6	2.9	8.0	0.0	4.4	0.1	0.7	3.4	1.2	0.6	1.8	0.8	3.6	0.5	1.2	1.5	0.1	0.5	4.4	4.0	4.0	1.9	6.5	14.2	58.4	12.1	5.8	8.5	9.4	8.1	14.4	7.6	0.0	12.5	5.7	9.1	4.2	10.3	6.2	7.6	25.4	5.7	10.4	9.8	20.3	5.0	10.4	3.2	13.9	15.7	0.0	12.1	9.9	5.9	4.9	2.3	24.6	13.5	7.9	19.5	16.5	14.6	3.3	5.8	7.7	8.5	11.8	26.4	12.9	12.9	23.4	16.6	14.0	15.4	12.9	3.9	13.0	13.4	5.6	27.6	4.4	26.5	12.1
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1, RNA export mediator"	Q53GS7	9	128504700-128542288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 55.3;Late spermatids: 44.8;Spermatocytes: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	12.5	17.0	11.1	13.5	13.2	12.2	14.7	22.1	13.8	13.1	15.7	16.5	17.6	14.6	13.8	11.4	18.5	13.5	12.6	13.2	10.5	8.9	13.1	20.4	11.3	23.0	11.2	9.9	15.7	21.1	20.8	16.3	16.4	10.6	13.4	17.2	13.1	13.6	16.7	23.3	18.3	14.9	12.0	9.8	17.5	12.1	42.8	11.8	27.2	12.4	14.6	20.0	14.3	13.5	16.0	19.2	26.2	22.5	22.6	20.5	15.8	10.8	20.4	10.0	17.1	9.9	10.1	13.3	11.0	9.4	15.5	11.0	13.7	7.6	22.0	8.9	12.3	14.9	38.3	17.3	15.7	13.4	20.9	11.3	11.3	22.5	12.7	11.2	18.2	14.9	7.1	15.3	17.5	18.8	8.6	8.7	20.7	16.1	19.5	17.7	25.2	17.9	12.9	8.5	29.2	17.7	18.3	24.6	29.1	10.4	9.7	11.9	8.9	26.8	16.3	9.6	8.5	30.0	12.9	6.3	16.5	11.0	19.2	15.2	19.6	47.1	17.2	15.4	13.9	17.7	26.2	18.1	20.3	20.5	22.5	16.7	12.0	16.0	18.1	19.2	16.0	14.4	16.6	15.4	22.6	22.0	11.4	18.3	15.8	11.1	13.2	22.1	13.8	10.5	8.9	11.2	9.9	10.6	11.8	8.9	7.0	10.2	6.2	5.8	6.6	10.9	0.0	9.4	4.5	7.0	7.9	14.2	5.0	9.6	55.3	3.1	11.4	0.0	5.4	9.5	5.1	4.8	9.2	10.5	13.4	9.5	5.2	3.7	12.6	44.8	9.5	9.9	3.3	20.8	13.4	8.4	7.6	5.8	6.0	11.1	8.2	12.9	5.1	45.3	28.1	5.9	11.1	11.5	13.9	4.3
GLI3	"ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV"	ENSG00000106571	"GLI family zinc finger 3"	P10071	7	41960950-42237870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.6"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 20.8;Syncytiotrophoblasts: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.6;WM-115: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005534	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA005534: AB_1078973"	"unprognostic (2.53e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.48e-5)"	"unprognostic (9.13e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.00e-2)"	7.3	2.6	4.6	6.8	5.4	0.3	9.4	0.8	6.4	21.1	13.1	2.9	10.9	1.4	31.6	10.0	7.3	10.8	7.0	2.0	4.2	1.7	2.3	0.7	5.8	2.4	1.8	2.1	17.6	1.5	0.8	1.9	13.4	1.8	10.6	3.8	5.1	3.7	14.3	2.2	9.7	4.2	13.8	0.9	1.8	3.8	2.3	3.0	1.7	6.1	8.7	4.0	6.4	9.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	26.6	0.2	6.9	12.6	1.7	1.6	5.6	4.8	5.6	0.1	0.0	0.0	1.0	11.1	6.2	5.5	3.6	4.3	4.1	0.0	3.3	0.0	3.3	0.0	4.4	0.0	0.1	10.4	6.3	5.0	4.0	2.8	4.4	2.9	0.0	0.1	2.2	2.4	0.3	0.0	12.0	0.0	10.1	6.3	0.1	0.7	0.0	4.4	0.7	0.0	2.6	3.3	2.0	11.4	4.4	0.0	4.6	5.9	8.5	8.2	2.8	0.0	0.0	0.0	4.4	0.1	19.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.4	0.8	6.4	4.2	1.7	1.8	2.1	1.8	3.0	0.0	4.8	0.0	6.8	20.8	1.8	1.4	0.0	1.4	1.2	1.8	0.0	17.7	0.0	0.0	11.6	2.8	0.0	0.0	0.0	12.0	18.1	3.2	1.1	0.0	2.8	0.0	0.0	2.5	0.3	4.3	17.8	0.0	8.5	0.0	0.0	11.8	0.1	0.0	3.2	3.4	0.8	12.9	14.6	0.4	0.9	13.6	28.6	0.0	0.0	3.7
GLI4	"HKR4, ZNF928"	ENSG00000250571	"GLI family zinc finger 4"	P10075	8	143267433-143276931	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023131	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Nucleoplasm, Cytokinetic bridge"		"HPA023131: AB_2671080"	"unprognostic (4.98e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.45e-3)"	"unprognostic (5.03e-1)"	"unprognostic (6.88e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.71e-3)"	13.5	5.7	14.9	15.7	17.6	11.6	10.6	12.8	12.0	10.0	12.0	13.7	13.7	14.2	10.0	6.9	10.7	8.3	8.9	8.5	16.4	12.4	9.6	11.2	9.6	13.9	10.3	11.6	11.0	18.4	8.0	7.4	5.0	8.5	9.7	8.6	13.5	20.0	14.0	10.3	13.8	13.4	11.8	9.7	13.4	11.6	11.6	6.9	12.0	10.6	12.8	17.1	9.0	8.2	1.5	3.5	0.9	1.1	3.4	2.2	0.6	4.9	10.2	4.8	7.5	7.9	3.2	5.3	2.9	1.8	2.2	2.7	2.9	14.5	6.4	5.6	4.8	3.2	6.5	2.6	3.3	1.5	11.3	7.7	9.9	4.7	3.3	5.6	3.0	3.3	10.1	1.7	3.0	6.6	5.2	4.8	10.0	5.2	10.8	6.1	13.4	14.2	2.5	4.4	9.4	14.3	8.7	2.2	6.4	5.3	11.2	4.6	5.4	8.9	3.8	6.0	4.6	16.9	1.4	2.7	3.4	9.4	4.8	3.0	14.4	6.7	5.1	5.5	5.9	5.5	0.0	1.1	0.0	1.4	1.0	2.2	1.5	1.6	0.9	0.6	1.4	2.0	1.0	0.9	3.4	0.0	3.5	2.1	0.6	14.9	17.6	12.8	12.0	16.4	12.4	10.3	11.6	8.5	6.9	0.0	0.0	12.9	14.5	6.5	14.5	1.4	17.8	0.0	0.0	12.2	19.6	4.5	21.6	2.4	5.2	4.0	13.1	0.0	3.4	3.6	7.8	6.9	4.6	8.1	6.0	6.4	11.1	7.4	9.1	3.1	15.0	5.6	8.5	2.8	7.4	11.3	3.5	17.3	15.6	14.0	11.5	6.5	11.3	13.3	13.3	9.4	2.4	13.8	13.0	5.5
GLIPR1L2	MGC39497	ENSG00000180481	"GLIPR1 like 2"	Q4G1C9	12	75391070-75432688	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 44.0"	"Group enriched"	"Detected in many"	13	"Early spermatids: 154.8;Spermatocytes: 290.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 5.8;SK-BR-3: 8.5;U-2 OS: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039795, HPA039866"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA039795: AB_10805595, HPA039866: AB_10795235"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.57e-2)"	1.3	3.1	5.5	1.2	10.4	0.8	3.0	2.9	5.8	2.2	1.2	4.2	2.9	1.0	2.7	4.2	1.4	3.5	1.5	2.5	5.5	4.6	2.5	1.9	2.7	1.1	6.6	3.9	7.7	3.0	7.3	5.2	1.3	6.2	2.3	0.8	2.0	1.4	3.6	2.4	2.2	1.2	1.5	8.1	1.9	1.0	44.0	5.0	1.4	2.8	0.5	0.8	1.7	1.4	1.4	2.6	2.0	0.7	1.0	3.4	0.6	0.3	0.6	0.3	0.6	4.4	2.6	0.7	0.6	0.5	0.2	0.3	0.1	0.4	0.3	1.5	0.4	1.1	0.2	0.1	0.1	0.4	0.8	0.3	0.1	0.6	5.8	3.3	0.6	0.1	0.9	1.4	0.6	2.3	3.8	0.2	0.2	0.3	0.7	1.1	0.1	0.6	0.4	0.3	1.2	0.2	0.1	0.1	0.3	0.1	0.4	1.1	0.6	0.7	8.5	2.5	0.4	2.5	0.2	1.2	1.0	11.3	1.2	0.4	1.0	1.0	0.3	0.4	0.3	0.8	1.8	0.3	0.5	1.1	0.2	0.7	1.1	1.2	2.0	0.4	1.4	2.2	3.3	2.0	1.0	0.7	2.6	3.4	0.6	5.5	10.4	2.9	5.8	5.5	4.6	6.6	3.9	6.2	5.0	0.0	1.9	0.0	3.9	0.8	4.6	3.6	0.0	14.7	1.2	0.0	0.0	1.3	8.3	0.4	154.8	1.0	0.0	0.0	0.0	0.2	1.1	0.8	1.1	0.0	0.5	1.6	0.0	0.0	0.0	14.7	6.9	0.1	0.0	0.0	0.0	5.6	0.2	0.0	5.3	1.0	2.0	6.5	1.0	290.6	16.8	0.4	0.3	0.0	0.0	2.3
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA031446: AB_2797222, HPA031448: AB_2673888"	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	4.9	6.6	12.5	8.1	14.8	9.0	10.3	21.3	19.5	7.4	6.8	6.6	5.1	5.1	11.5	8.6	10.1	6.3	5.7	7.2	9.4	6.9	6.4	5.2	5.3	10.6	6.8	13.2	8.3	4.7	8.5	13.6	7.9	8.6	7.6	7.3	13.9	4.9	6.9	7.5	13.5	6.6	6.9	8.0	7.6	5.8	11.2	5.7	13.3	9.0	4.8	12.1	7.9	6.9	2.5	2.0	1.4	1.4	9.0	5.5	1.9	12.2	4.7	15.8	8.7	5.6	8.9	14.6	8.5	7.1	10.7	9.6	9.7	4.9	12.4	13.8	5.1	15.3	9.3	8.3	7.8	15.5	8.8	11.7	16.6	9.4	9.6	5.6	20.9	8.7	6.9	4.5	12.5	5.7	4.2	11.5	10.8	13.7	7.6	14.0	2.8	12.8	15.9	24.1	5.8	8.6	11.1	21.7	8.6	12.1	11.9	14.6	7.6	14.9	14.1	8.9	9.2	6.7	20.2	7.2	7.8	7.5	13.3	12.8	6.7	9.2	15.7	2.9	21.1	4.5	0.0	0.7	1.4	3.2	1.4	5.5	2.5	3.5	3.9	2.0	1.5	3.1	3.6	0.2	9.0	0.8	1.4	2.7	1.9	12.5	14.8	21.3	19.5	9.4	6.9	6.8	13.2	8.6	5.7	8.9	8.8	10.0	10.8	7.9	25.7	7.5	5.1	1.4	4.5	12.2	96.2	13.1	1.7	5.2	1.5	6.8	2.0	0.0	4.5	9.1	10.4	6.7	8.1	2.0	7.2	25.4	10.3	4.9	2.4	1.0	11.5	5.3	8.5	4.6	4.2	13.3	4.5	2.9	7.4	6.8	128.0	6.5	8.1	13.0	28.1	7.9	13.2	20.1	3.9	6.3
GLOD4	"C17orf25, CGI-150, HC71"	ENSG00000167699	"Glyoxalase domain containing 4"	Q9HC38	17	757097-783390	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021623, HPA023246, HPA023248"	Enhanced		Approved	Cytosol		NA	NA		3800000	Cytosol		"HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"	21.7	29.5	31.3	16.7	35.6	10.2	19.1	26.0	36.2	17.8	37.1	21.5	16.5	43.0	22.3	23.3	23.6	24.9	20.9	19.7	26.1	38.5	41.6	40.4	16.8	22.8	23.0	34.8	22.9	32.3	13.9	19.4	28.1	28.6	21.1	26.6	21.9	29.2	20.9	21.4	27.5	42.5	24.7	18.2	23.8	43.4	17.9	18.2	22.7	26.0	19.2	24.0	25.2	17.5	27.5	17.9	17.8	24.6	22.8	36.7	26.0	40.2	36.5	42.2	23.3	18.5	18.5	25.8	32.3	19.9	26.2	20.0	29.6	28.9	48.1	35.3	14.5	24.5	29.2	36.7	20.5	27.5	35.2	31.4	23.2	20.3	38.6	18.4	23.8	30.7	12.9	28.6	26.3	23.2	16.8	24.2	40.1	37.8	31.4	27.6	24.9	40.9	18.4	30.8	40.0	12.5	41.0	17.1	22.0	25.9	27.6	19.2	32.3	25.6	18.6	41.4	27.7	23.1	25.4	31.4	25.1	20.1	35.0	40.4	17.7	32.1	29.6	29.8	26.9	26.1	9.2	19.8	17.8	27.7	24.2	30.2	27.0	33.6	33.3	17.5	27.5	28.7	31.3	2.7	22.8	24.6	17.9	36.7	26.0	31.3	35.6	26.0	36.2	26.1	38.5	23.0	34.8	28.6	18.2	53.6	32.8	19.4	36.9	42.6	36.9	27.0	50.9	66.9	60.3	96.0	27.5	93.5	150.9	67.8	30.1	37.6	47.9	0.0	50.6	68.7	47.3	35.9	38.3	57.2	70.9	12.7	27.7	25.8	28.8	47.7	35.9	49.1	64.1	76.7	46.8	36.9	50.1	59.6	43.9	135.3	35.1	45.3	41.9	16.9	26.8	47.9	57.8	47.3	57.4	35.3
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95823005	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 94.4;skeletal muscle: 141.6"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 613.5;Extravillous trophoblasts: 605.3;Proximal tubular cells: 870.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 85.0;RPTEC TERT1: 65.0;U-87 MG: 69.9"	"Low region specificity"	"Detected in all"							"CAB008634, HPA046431, CAB069419"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		13000000	"Plasma membrane, Cytosol"		"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	17.7	20.7	6.2	15.0	6.6	30.6	10.5	15.5	15.5	5.4	22.6	3.1	4.0	40.2	2.9	4.6	3.1	3.7	9.5	25.2	12.1	7.8	45.9	46.9	23.1	21.5	7.8	5.9	3.5	2.6	9.5	6.4	63.9	7.6	5.7	8.8	2.4	17.9	5.5	141.6	7.3	42.5	4.5	7.3	15.2	8.2	2.2	4.0	14.4	6.3	6.4	14.3	11.6	5.8	16.0	52.2	94.4	81.6	11.2	48.9	71.1	3.3	15.0	1.1	2.4	32.4	46.6	0.2	50.1	85.0	5.4	9.1	3.7	1.5	13.0	7.1	15.0	12.2	1.3	1.9	23.8	15.1	11.3	3.7	9.4	9.9	34.4	61.7	10.0	27.9	29.1	2.9	34.3	3.3	12.0	10.3	26.7	1.2	7.8	34.0	1.1	17.2	17.7	3.3	0.4	17.1	27.9	10.2	16.1	65.0	2.4	3.4	1.8	13.1	6.5	5.7	3.1	1.8	9.9	11.9	14.2	16.0	11.3	2.1	5.6	28.7	10.4	69.9	25.1	3.0	3.8	81.6	94.4	26.2	51.0	35.7	16.0	24.1	19.5	52.2	10.7	24.1	22.1	85.7	11.2	40.5	18.0	48.9	71.1	6.2	6.6	15.5	15.5	12.1	7.8	7.8	5.9	7.6	4.0	20.8	27.9	60.2	35.5	15.2	1.5	153.4	79.0	53.5	27.3	89.0	0.0	19.8	613.5	47.8	0.2	38.0	373.9	23.3	81.2	605.3	54.7	75.6	30.1	177.3	241.8	0.0	30.4	44.2	275.4	0.9	17.5	243.9	65.8	117.2	64.0	5.5	118.2	157.8	13.1	870.9	3.3	19.4	70.2	0.5	1.1	18.1	238.6	103.6	64.3	137.4
GLRX2	"bA101E13.1, GRX2"	ENSG00000023572	"Glutaredoxin 2"	Q9NS18	1	193090866-193106114	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"Early spermatids: 789.5;Late spermatids: 1440.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 69.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023087, HPA057224"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA023087: AB_1849778, HPA057224: AB_2683373"	"unprognostic (4.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.21e-2)"	"unprognostic (4.48e-2)"	14.1	17.9	13.8	9.7	12.2	10.7	16.3	7.4	22.0	7.8	14.9	6.6	7.4	14.7	6.7	14.5	13.1	5.1	8.8	23.5	13.0	13.3	14.3	28.2	7.8	6.1	16.5	13.1	5.4	10.4	4.6	9.9	9.5	22.3	21.8	11.7	7.4	8.6	11.6	28.5	8.9	12.7	10.9	12.3	7.6	10.3	27.9	8.7	2.3	7.7	11.6	9.0	9.6	10.2	10.8	17.4	19.6	21.4	11.6	14.1	10.9	13.9	17.2	4.4	9.8	16.3	10.6	7.8	20.5	8.9	17.0	14.1	10.6	13.4	6.2	11.5	8.5	20.7	13.6	5.2	11.7	17.4	13.7	9.7	12.0	11.6	12.3	17.4	9.8	12.1	7.1	10.2	23.3	11.8	6.6	10.7	4.1	17.7	6.6	20.5	19.3	7.8	18.0	5.1	22.3	12.6	7.1	7.1	14.2	16.3	9.2	4.2	3.8	8.3	24.6	69.6	6.8	10.7	11.1	6.5	13.3	3.4	28.9	21.1	13.3	13.7	11.9	12.7	11.3	18.4	7.8	15.2	19.6	10.8	17.9	11.9	10.8	11.3	9.7	17.4	8.2	10.2	11.4	7.6	11.6	21.4	7.3	14.1	10.9	13.8	12.2	7.4	22.0	13.0	13.3	16.5	13.1	22.3	8.7	8.9	8.5	18.7	19.2	16.3	7.1	57.9	15.3	8.1	7.9	15.7	5.9	33.7	24.9	36.1	789.5	17.5	28.0	0.0	35.9	32.5	22.1	28.9	45.1	29.9	40.5	1.6	13.3	10.4	12.1	1440.5	16.1	26.5	25.3	24.4	19.0	6.6	33.9	28.1	17.0	53.0	11.2	6.5	24.5	10.8	26.4	17.3	20.7	13.8	20.9	15.9
GLT8D1	"AD-017, FLJ14611"	ENSG00000016864	"Glycosyltransferase 8 domain containing 1"	Q68CQ7	3	52694488-52706032	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010588	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA010588: AB_1078098"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.42e-3)"	"unprognostic (3.97e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.21e-2)"	18.6	23.7	16.1	14.5	20.9	4.7	21.0	15.3	19.9	29.3	17.3	18.3	22.1	14.6	23.5	26.8	14.1	31.9	19.9	19.3	16.6	17.0	23.2	39.4	16.8	16.0	17.9	14.4	32.4	23.6	24.3	40.8	34.7	18.1	21.1	18.9	19.7	22.0	25.2	11.5	13.0	15.2	18.7	17.4	14.8	16.0	43.3	21.6	17.5	37.8	11.6	14.7	21.8	16.8	8.6	15.7	20.5	8.4	20.1	16.3	6.6	8.1	9.7	19.7	15.5	43.7	55.6	11.0	20.6	31.9	18.2	20.9	4.5	15.5	6.9	5.9	35.7	22.0	9.3	12.4	21.1	24.1	12.4	9.0	6.5	17.8	20.6	21.0	9.7	20.5	31.9	18.8	15.6	20.2	42.3	27.0	12.0	8.3	16.0	23.8	8.3	6.5	14.9	10.0	14.4	18.2	5.0	11.2	23.3	21.2	8.9	8.1	13.9	17.1	8.4	13.9	19.2	14.1	12.8	19.7	13.2	10.3	19.1	11.4	18.1	20.5	7.7	23.1	15.5	16.6	20.5	8.4	14.1	13.3	5.7	13.2	8.6	16.0	14.3	8.1	6.4	16.3	11.5	4.8	20.1	6.0	15.7	10.6	6.6	16.1	20.9	15.3	19.9	16.6	17.0	17.9	14.4	18.1	21.6	0.0	8.1	11.5	17.3	10.8	37.5	11.3	7.6	33.5	15.9	17.4	11.8	47.2	19.9	28.5	40.0	19.6	13.1	0.0	23.8	55.2	49.3	12.9	5.7	29.3	23.5	20.6	17.9	35.0	14.5	13.6	49.8	10.6	23.6	34.3	18.6	33.9	21.1	19.2	45.6	19.8	17.9	25.8	15.9	90.1	50.7	6.9	21.9	21.5	17.5	6.7
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988984-104064183	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 28.7;Fibroblasts: 28.3;Ito cells: 20.9;Leydig cells: 51.8;Peritubular cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.9;BJ hTERT+: 34.4;HSkMC: 25.8;hTERT-RPE1: 20.6;RPTEC TERT1: 17.6"	"Group enriched"	"Detected in many"	5	"amygdala: 8.0;cerebral cortex: 20.1;hippocampal formation: 16.6"	"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	10.2	5.2	2.2	9.9	3.3	0.2	12.0	0.7	2.4	32.8	10.3	1.4	8.8	2.5	24.5	23.1	13.5	13.3	19.1	18.8	2.2	1.8	3.4	2.8	6.9	2.2	2.1	2.1	25.5	2.5	5.9	12.5	6.9	3.5	19.6	5.3	21.8	6.7	8.3	4.0	2.7	6.7	17.3	2.2	1.0	5.5	7.8	0.8	1.0	26.0	10.9	5.7	11.2	13.1	0.8	0.9	0.2	0.6	0.0	2.1	0.0	0.1	0.2	0.2	8.7	11.4	27.9	0.2	12.5	34.4	3.2	4.2	0.1	0.0	0.3	0.7	14.3	0.1	0.0	0.1	4.6	2.8	0.6	3.9	0.2	4.6	0.0	5.1	0.3	0.2	25.8	0.2	3.9	5.5	20.6	1.7	0.2	0.1	0.5	14.1	0.1	0.2	0.1	1.0	0.0	2.6	0.3	13.4	0.1	17.6	0.1	0.5	0.7	13.1	0.3	0.1	1.0	2.3	0.2	0.2	5.3	2.5	0.5	0.7	1.5	0.3	0.1	0.4	0.2	0.4	0.0	0.0	0.0	2.1	0.6	0.7	0.8	0.3	1.3	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.9	0.0	0.0	2.2	3.3	0.7	2.4	2.2	1.8	2.1	2.1	3.5	0.8	0.0	5.8	0.0	3.5	2.5	0.8	2.4	0.0	0.0	0.0	0.0	2.0	3.5	0.0	0.0	28.7	5.9	0.0	0.0	0.0	0.8	28.3	0.5	0.0	0.2	0.5	0.0	1.7	20.9	0.6	9.6	51.8	0.0	3.3	1.0	0.4	0.3	0.5	0.0	48.8	0.0	0.3	6.5	17.0	1.1	0.9	2.0	1.1	0.5	0.0	0.0
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788959-4790390	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 13.0;kidney: 9.8;liver: 44.4"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 65.2;Proximal tubular cells: 128.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.7;CACO-2: 11.8;Hep G2: 15.5;MCF7: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA058295: AB_2683671, HPA065267: AB_2685451"	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.2	0.3	0.5	0.2	0.7	0.8	0.2	0.8	1.8	0.2	8.0	0.3	0.2	8.6	0.3	0.2	0.4	0.3	0.2	0.2	0.5	0.7	9.8	44.4	0.6	0.2	0.5	0.4	0.2	0.5	0.2	0.5	0.2	0.4	0.2	0.0	0.5	0.8	0.2	0.8	1.4	13.0	0.2	0.4	0.8	0.9	0.2	0.2	0.4	0.2	1.6	0.3	0.4	0.3	0.0	0.5	0.0	3.2	0.0	0.2	0.2	0.6	2.5	0.2	2.1	0.0	0.0	4.7	0.4	0.0	0.0	0.0	11.8	0.9	1.2	1.3	0.0	0.4	2.3	0.0	0.1	0.0	2.2	1.8	0.1	1.0	15.5	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.7	0.6	0.0	5.4	0.2	0.2	0.3	0.6	1.0	0.9	0.6	0.3	0.0	0.9	1.6	1.0	2.2	0.4	0.6	0.1	1.4	0.1	2.5	0.8	1.0	0.5	0.4	0.2	0.6	0.1	0.3	0.7	0.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.2	0.5	0.7	0.8	0.7	0.5	0.7	0.5	0.4	0.4	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.3	0.0	65.2	0.1	0.0	0.0	1.8	1.3	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	128.9	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.5
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047588-121050080	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.3;testis: 31.9"	"Cell type enhanced"	"Detected in some"	6	"Cytotrophoblasts: 2.7;Hepatocytes: 3.2;Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.0;K-562: 8.8;SK-MEL-30: 11.3;THP-1: 5.6;WM-115: 12.7"									"HPA042492, HPA044839, HPA061369"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	3.1	2.5	4.8	0.8	7.3	0.5	1.6	2.2	3.5	1.1	0.7	2.0	0.6	0.6	1.0	5.2	0.7	1.0	1.6	1.5	5.7	1.8	4.7	11.3	0.9	0.9	2.7	6.2	0.7	1.5	0.7	0.7	2.7	4.3	0.8	0.6	0.2	0.9	3.1	0.7	0.8	1.0	1.0	1.5	0.5	0.9	31.9	4.1	0.0	1.4	0.0	0.8	0.8	0.6	0.8	1.2	0.7	1.1	1.2	0.7	0.4	0.0	2.1	0.5	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.3	0.0	1.1	0.0	0.8	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	1.7	0.0	0.0	1.6	4.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	11.3	0.3	2.7	5.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.6	0.8	0.7	0.4	1.1	0.7	0.8	0.7	0.7	1.2	0.4	0.7	0.5	0.0	1.2	1.1	0.2	0.7	0.4	4.8	7.3	2.2	3.5	5.7	1.8	2.7	6.2	4.3	4.1	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.0	2.7	1.7	0.1	1.8	0.0	0.0	0.0	0.3	0.3	0.6	0.3	0.0	3.2	0.5	0.0	0.0	0.0	1.9	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.9	1.1	0.1	2.1	0.0	0.0	0.1
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8"	"Cell type enhanced"	"Detected in some"	16	"Basal glandular cells: 2.2;Glandular cells: 1.9;Melanocytes: 1.7;Sertoli cells: 6.5;Suprabasal keratinocytes: 1.8;Urothelial cells: 1.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 16.7;endometrial cancer: 15.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.9;BJ hTERT+ SV40 Large T+ RasG12V: 4.2;HAP1: 6.6;SK-BR-3: 15.8;U-2197: 7.6"					"Not detected"	"Not detected"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favorable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.4	0.0	0.4	0.1	0.2	0.0	11.2	0.1	0.3	18.8	0.1	0.1	0.1	0.1	1.2	0.1	0.8	0.1	6.6	0.2	0.3	0.4	0.1	0.1	0.6	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.0	0.1	25.8	0.1	0.1	1.2	0.1	0.1	1.5	1.1	0.1	0.1	0.1	0.1	0.1	4.4	9.9	0.1	0.3	0.4	0.1	2.1	0.4	0.2	0.2	0.9	0.0	0.0	0.5	0.0	0.9	3.1	0.0	1.9	5.9	2.6	4.2	0.0	0.0	0.2	0.0	1.6	1.2	0.5	6.6	0.0	2.2	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.0	0.6	0.2	2.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	15.8	0.0	0.0	0.0	0.0	0.0	2.2	0.1	7.6	2.3	0.0	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.1	2.1	0.2	0.0	0.1	0.0	0.9	0.4	0.2	0.1	0.3	0.3	0.4	0.6	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	6.5	1.0	0.0	0.0	1.8	0.0	0.0	0.0	1.8
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52293476	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 108.4"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 46.7;Hepatocytes: 151.6;Proximal tubular cells: 59.6"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.0;Hep G2: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	6.4	4.9	1.9	8.4	5.0	5.2	4.8	2.7	6.2	2.3	7.9	7.1	4.2	23.8	4.3	4.8	2.8	2.5	7.2	2.7	1.9	2.2	10.7	108.4	3.1	6.5	2.5	4.9	2.3	3.6	1.9	2.5	3.1	3.9	2.8	3.5	4.7	3.2	3.0	7.0	1.9	17.8	1.9	1.8	5.5	6.0	2.7	1.8	3.3	3.1	2.4	5.9	2.7	2.2	8.3	9.1	10.9	9.5	5.7	11.8	6.3	2.3	5.6	3.0	1.1	16.1	2.2	1.8	2.5	2.6	4.8	3.5	19.0	1.9	5.9	1.6	2.2	3.6	1.5	1.7	6.2	0.9	1.6	2.0	8.3	6.7	25.2	1.6	2.7	5.0	2.2	3.1	7.0	2.7	1.6	9.0	4.8	2.3	4.3	3.6	1.7	4.6	2.2	1.6	12.2	4.6	1.6	2.7	8.9	4.8	3.2	2.2	2.2	2.4	1.3	2.5	0.9	3.2	1.3	3.9	3.7	4.4	2.4	4.8	4.6	3.1	3.9	2.6	4.5	2.8	3.0	9.5	10.9	11.8	5.1	6.1	8.3	9.0	10.3	9.1	5.7	6.8	10.1	7.8	5.7	6.1	5.6	11.7	6.3	1.9	5.0	2.7	6.2	1.9	2.2	2.5	4.9	3.9	1.8	6.0	2.7	9.3	2.6	0.3	1.4	1.2	15.3	1.4	2.3	8.7	0.0	6.7	16.6	4.3	0.1	4.4	29.7	46.7	5.4	4.3	2.1	2.5	1.1	151.6	11.4	0.0	22.4	12.9	16.5	0.0	1.1	7.2	3.3	6.4	9.1	1.0	3.5	34.5	0.0	59.6	1.5	0.0	0.2	0.2	7.7	1.1	9.3	10.2	11.5	3.1
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847342	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favorable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	24.1	33.2	39.1	29.4	37.4	27.5	22.5	26.3	44.8	24.8	32.6	31.0	32.8	30.7	30.0	20.6	32.1	33.9	26.1	28.3	29.8	24.8	39.0	30.5	24.5	27.6	27.0	33.1	22.2	27.4	53.4	34.7	24.1	37.1	30.4	32.3	28.5	29.9	29.4	41.6	24.3	29.9	30.1	27.3	30.7	33.9	17.4	26.0	27.6	29.6	17.2	30.0	35.3	22.7	7.6	8.3	22.2	14.5	5.2	7.5	5.5	13.1	14.7	24.3	15.1	21.4	17.2	23.3	24.9	18.6	19.1	16.4	20.7	23.5	21.5	23.8	22.9	15.7	14.6	30.4	20.9	17.3	34.9	18.3	22.1	17.7	14.5	12.1	35.7	41.2	16.3	16.6	18.0	13.3	18.4	24.2	20.3	37.0	18.6	20.7	21.4	29.0	19.8	28.8	19.8	11.1	37.5	19.1	26.4	23.5	19.8	29.7	15.1	27.0	25.3	11.5	27.9	28.4	37.8	26.8	13.1	14.7	59.1	15.5	15.5	21.6	45.0	9.4	17.8	26.8	6.3	10.9	5.7	7.5	9.8	6.5	5.1	4.9	7.1	7.3	7.6	5.2	4.6	22.2	5.2	14.5	8.3	4.9	5.5	39.1	37.4	26.3	44.8	29.8	24.8	27.0	33.1	37.1	26.0	35.7	45.5	25.1	16.3	16.9	31.8	36.2	30.6	93.7	46.6	29.6	27.5	23.2	56.3	20.8	7.9	26.3	37.1	0.0	16.8	26.4	21.1	25.4	30.1	47.3	28.0	42.9	44.5	25.8	38.6	8.0	22.5	29.5	20.3	44.1	38.4	22.8	24.2	37.4	15.2	42.9	40.9	19.4	16.9	20.9	24.5	21.1	29.9	17.5	33.2	17.0
GMFB	GMF	ENSG00000197045	"Glia maturation factor beta"	P60983	14	54474484-54489196	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Approved	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		1000000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (7.93e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.09e-2)"	14.2	13.2	37.9	12.9	26.7	14.2	15.3	25.1	41.6	11.8	19.8	23.9	6.1	19.1	11.6	8.5	9.3	8.4	9.7	9.6	36.7	30.1	19.9	14.7	13.8	13.3	36.9	28.3	9.8	7.3	10.1	13.6	17.9	25.6	9.0	20.7	6.6	7.0	8.0	4.1	7.8	17.5	10.5	54.4	10.1	10.7	6.2	21.7	6.4	12.8	6.1	13.5	10.0	7.4	9.1	12.8	16.4	14.5	9.0	8.8	6.8	30.9	12.6	25.1	18.4	27.2	34.0	18.8	31.8	23.4	23.1	28.9	14.4	27.5	28.5	15.0	31.2	13.9	11.5	25.3	22.0	36.6	10.3	8.7	14.3	14.1	13.3	23.2	19.9	12.5	25.7	20.6	20.0	19.8	24.1	20.8	13.2	10.4	10.1	36.5	15.4	12.1	7.7	16.2	17.6	13.4	12.3	29.5	8.2	29.5	29.5	14.9	23.2	22.1	18.9	24.1	21.7	20.8	15.8	16.4	33.6	25.5	17.0	19.7	3.6	6.3	17.8	28.3	12.3	21.2	8.7	11.0	9.2	6.1	13.5	8.5	7.6	7.2	6.0	12.8	9.1	7.8	8.2	16.4	9.0	14.5	5.2	8.8	6.8	37.9	26.7	25.1	33.5	36.7	30.1	36.9	28.3	25.6	21.7	23.8	14.4	20.4	43.8	53.1	17.7	15.0	22.9	8.1	19.4	24.4	3.9	33.3	18.3	34.4	20.5	17.5	29.2	0.0	20.1	73.0	27.8	40.5	21.8	23.6	41.6	20.6	28.7	16.0	30.4	3.9	18.7	44.4	43.9	37.9	30.3	17.7	30.2	31.6	14.9	40.9	14.6	12.9	26.8	12.6	9.8	38.1	48.7	22.4	32.6	39.2
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 303.1;Hofbauer cells: 397.1;Ito cells: 301.4;Kupffer cells: 575.9;Macrophages: 461.8;T-cells: 456.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 77.0;JURKAT: 55.8;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		1500000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	22.6	6.1	7.3	29.6	7.4	80.9	16.8	2.2	4.8	6.0	8.8	4.0	1.7	5.3	4.4	9.4	6.4	7.3	8.7	7.5	6.0	4.9	9.4	9.7	28.5	42.2	8.6	2.3	4.7	3.6	1.1	3.1	18.0	5.8	6.1	7.9	4.9	8.1	2.3	5.4	4.2	17.8	6.8	8.2	86.0	5.9	2.9	5.6	109.5	9.8	7.0	37.1	11.1	7.5	39.1	57.2	276.5	79.4	41.6	88.0	106.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.8	33.5	0.3	0.0	0.0	0.2	0.0	0.1	0.1	11.3	0.0	36.4	0.0	0.5	0.6	39.0	77.0	0.1	0.0	0.0	0.1	0.1	2.0	55.8	1.3	59.8	0.3	0.0	35.5	43.6	0.0	0.0	0.0	49.0	0.4	21.9	0.0	5.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	76.8	20.0	0.0	0.4	0.1	0.1	3.4	11.6	38.3	0.2	52.7	0.3	185.2	79.4	178.1	37.7	72.3	40.0	39.1	56.7	46.6	57.2	35.0	55.9	46.4	276.5	41.6	78.9	22.2	88.0	106.7	7.3	7.4	2.2	4.8	6.0	4.9	8.6	2.3	5.8	5.6	26.8	152.0	303.1	2.8	16.6	0.0	3.1	10.2	16.0	31.8	0.0	0.0	3.0	0.0	0.8	9.5	165.1	0.3	23.3	0.6	3.4	16.0	1.1	229.0	5.5	397.1	0.0	0.0	301.4	575.9	18.8	1.7	461.8	70.9	127.2	0.3	0.3	0.3	0.0	0.4	3.9	0.0	45.3	14.6	8.1	3.0	12.9	4.6	456.6	0.3	1.4
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643667	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 20.7;Kupffer cells: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: AB_2678018, HPA045481: AB_2679343"	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.97e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.15e-4)"	6.1	2.8	3.5	20.3	4.9	31.0	4.0	0.9	4.1	2.9	6.9	4.3	2.7	7.0	2.7	3.2	6.2	4.4	7.9	3.3	4.3	3.4	4.2	3.9	11.7	28.0	4.2	2.5	2.4	4.6	10.6	3.0	3.9	3.4	4.1	4.6	2.7	6.0	4.5	1.5	4.9	15.3	2.9	4.9	40.0	11.1	2.2	3.1	26.8	6.2	2.7	23.2	6.1	4.5	6.6	6.7	32.7	13.9	4.2	6.4	4.6	4.4	2.1	2.8	3.0	3.1	1.6	11.2	2.8	2.5	1.7	1.6	1.7	6.1	11.0	5.8	2.0	2.2	5.4	1.8	3.1	1.1	3.8	2.8	3.5	3.3	1.8	0.9	9.8	43.8	2.0	2.1	1.8	1.0	2.0	3.8	9.9	2.3	4.0	1.8	6.6	6.1	16.2	1.6	5.8	3.8	10.6	1.2	6.3	3.2	10.7	2.4	7.2	3.9	4.1	1.6	2.2	3.8	14.1	7.0	3.2	1.8	3.6	2.1	2.0	0.8	9.1	2.0	12.9	2.1	2.9	8.3	21.5	6.4	10.6	5.9	5.9	4.0	5.7	6.7	6.6	4.5	4.6	32.7	4.2	13.9	6.1	4.5	4.6	3.5	4.9	0.9	4.1	4.3	3.4	4.2	2.5	3.4	3.1	0.0	15.1	15.6	1.1	1.0	0.0	0.6	2.5	1.4	2.3	0.0	0.0	0.5	0.0	3.8	0.1	1.4	13.3	0.0	4.2	4.6	0.9	1.6	6.9	0.9	20.7	0.0	0.0	2.5	34.3	0.0	0.6	16.5	1.7	17.2	6.3	0.2	9.4	12.2	0.7	0.6	0.0	0.0	0.9	0.1	1.5	1.0	0.7	15.9	5.8	2.6
GMPPA		ENSG00000144591	"GDP-mannose pyrophosphorylase A"	Q96IJ6	2	219498867-219506989	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035512, HPA035513"	Approved		Approved	Nucleoplasm		NA	NA		17000	Nucleoplasm		"HPA035512: AB_2674660, HPA035513: AB_10671934"	"unprognostic (3.43e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.40e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.57e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.90e-10)"	"prognostic favorable (5.24e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-1)"	12.0	15.8	10.3	13.6	14.7	9.9	12.9	10.2	14.6	21.1	17.7	16.5	23.2	17.1	16.7	44.3	14.8	14.6	12.0	16.2	10.4	7.0	22.5	54.1	12.8	11.0	15.8	11.5	12.7	39.8	17.6	28.8	21.4	12.2	21.2	20.0	12.6	37.4	20.3	12.6	10.2	23.6	16.0	13.2	21.1	17.6	9.6	14.3	8.9	24.8	8.1	18.4	13.7	13.5	16.6	21.8	29.2	27.0	17.2	18.4	16.0	14.2	11.7	7.3	12.8	28.1	25.0	19.4	24.9	33.4	29.3	36.5	21.5	13.6	7.7	17.7	35.9	18.9	13.5	13.4	21.5	25.5	15.0	11.6	15.1	12.0	38.1	25.4	7.8	17.8	19.1	17.5	27.5	31.3	15.3	17.9	10.0	26.7	22.6	22.7	17.8	7.7	14.8	7.5	17.5	12.8	6.1	7.8	13.8	16.8	9.7	9.4	8.2	10.4	15.8	17.0	16.0	10.5	12.7	10.3	17.0	11.8	30.6	13.5	15.6	6.2	9.3	34.8	8.8	19.0	29.2	26.5	17.7	15.8	26.7	18.4	16.6	12.6	16.6	21.7	10.4	9.4	8.7	5.9	17.2	27.0	21.8	16.3	16.0	10.3	14.7	10.2	14.6	10.4	7.0	15.8	11.5	12.2	14.3	14.9	15.6	10.0	10.6	4.9	6.1	11.8	10.2	6.7	11.4	15.7	5.9	32.0	29.9	19.9	0.5	6.3	37.6	0.0	26.4	64.3	15.8	14.8	18.5	33.8	30.0	1.6	10.4	13.5	17.8	1.9	17.0	17.9	11.8	13.6	41.5	10.3	19.7	34.5	12.7	28.1	3.5	12.9	7.2	4.6	6.4	7.4	39.5	8.5	23.6	11.6
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No		160000	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032"	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	18.9	44.2	19.6	14.6	24.2	11.5	26.2	13.6	31.7	22.5	21.1	25.1	20.3	21.3	18.8	26.3	17.8	28.7	23.4	15.0	20.1	21.9	39.1	26.3	19.0	18.1	23.0	21.2	26.1	26.9	49.1	22.4	22.7	26.0	20.3	21.6	21.9	22.6	23.7	16.1	14.4	21.7	18.2	20.3	25.5	21.2	10.6	19.1	21.6	43.0	11.2	21.0	21.8	17.6	7.5	14.4	32.3	14.0	7.6	14.9	11.0	9.2	10.6	14.3	9.3	16.6	23.5	13.1	10.9	19.4	15.3	19.6	12.4	7.3	12.3	9.9	15.9	9.8	12.8	15.8	23.6	21.9	11.6	11.6	9.7	6.6	45.2	15.6	15.8	15.2	22.0	16.9	8.1	16.8	21.4	24.8	17.7	5.6	11.6	15.4	17.2	15.7	14.2	11.1	13.6	13.8	11.9	9.7	10.1	21.1	15.2	10.1	14.4	7.8	17.2	14.6	15.2	14.9	12.7	12.7	7.3	5.8	9.5	7.9	25.9	24.8	8.1	6.0	12.1	7.0	9.0	14.0	7.2	10.1	11.2	10.7	7.5	10.2	11.2	14.4	7.1	9.1	10.2	32.3	7.6	11.3	6.5	14.9	11.0	19.6	24.2	13.6	31.7	20.1	21.9	23.0	21.2	26.0	19.1	23.8	16.0	23.8	32.5	9.7	16.4	10.5	40.8	33.5	25.0	50.6	3.9	53.9	86.2	34.2	9.9	19.0	34.2	0.0	29.0	39.0	17.4	19.6	31.1	22.4	45.3	17.5	9.9	11.6	32.6	7.7	26.7	30.1	20.3	23.4	20.4	34.1	30.5	30.6	23.7	96.9	13.6	25.8	25.8	15.2	9.6	9.4	41.2	23.0	27.6	21.0
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870536-155944026	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 191.9;Late spermatids: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol		No	No			Cytosol		"HPA046630: AB_2679727"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	15.9	18.3	10.4	19.7	14.0	24.6	22.4	22.1	24.9	16.1	13.9	9.8	15.3	10.3	17.5	15.4	19.5	14.0	10.8	15.3	9.2	7.7	11.0	14.7	15.8	19.5	9.3	12.1	15.7	23.5	19.1	14.1	13.5	14.8	13.0	15.3	9.0	21.6	18.6	16.6	21.0	12.6	16.1	8.9	14.6	15.4	60.9	10.5	28.3	13.6	12.5	18.4	15.9	18.5	11.1	17.2	10.9	18.1	19.0	20.7	10.8	56.8	22.5	30.6	25.0	12.5	19.8	29.5	24.3	22.5	32.1	32.5	41.0	38.4	41.1	29.0	18.7	24.6	28.0	26.0	25.5	44.2	23.8	20.0	43.8	16.5	22.2	14.3	44.5	17.1	14.6	15.7	24.8	38.0	17.1	19.6	22.4	30.8	15.8	23.8	38.2	36.1	23.6	29.3	31.3	16.7	35.5	36.3	49.6	16.5	25.1	18.3	17.0	27.0	38.7	24.2	22.0	40.5	29.4	13.8	21.3	17.3	30.0	48.9	22.1	13.6	70.3	21.4	33.2	18.9	10.9	10.4	7.2	17.3	13.1	20.7	11.1	16.8	15.7	17.2	8.8	16.8	15.8	1.4	19.0	18.1	9.5	17.6	10.8	10.4	14.0	22.1	24.9	9.2	7.7	9.3	12.1	14.8	10.5	17.9	19.8	20.4	39.9	35.4	21.9	14.1	15.3	13.4	22.7	7.0	2.0	33.4	21.6	24.9	191.9	28.5	8.4	23.3	25.9	43.0	27.2	23.6	28.8	11.1	26.5	20.6	6.9	14.7	18.3	149.6	21.3	24.7	21.9	29.7	17.8	17.3	20.4	10.5	23.3	22.3	7.7	19.4	31.6	80.1	54.5	33.4	25.7	24.9	24.7	34.5
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	80133955-80219402	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 195.4;Suprabasal keratinocytes: 187.2;Syncytiotrophoblasts: 153.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 20.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 20.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome		NA	NA		9000000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: AB_2677870"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	33.2	23.4	17.2	5.4	26.2	1.5	14.4	14.4	33.7	9.4	10.5	36.9	3.0	6.9	10.0	3.0	16.6	9.0	8.6	5.7	23.8	18.3	25.9	13.1	10.3	3.4	40.3	21.9	14.3	5.4	2.5	7.3	30.4	26.2	10.1	9.0	2.8	4.9	9.5	4.2	32.4	5.3	12.2	49.7	5.7	8.3	11.1	32.0	0.9	11.1	3.2	4.6	15.5	9.0	0.1	3.7	2.1	1.5	20.0	2.3	0.7	2.9	20.8	19.0	0.1	23.7	15.2	8.7	12.6	15.2	11.2	13.9	0.0	3.2	0.1	4.1	13.5	9.6	3.0	10.6	12.9	14.9	0.1	9.7	17.8	18.3	1.3	24.0	2.3	3.8	16.3	32.8	6.0	17.3	9.1	7.5	0.0	1.4	0.0	21.0	0.5	0.1	0.1	5.5	0.1	7.5	8.3	7.3	8.9	33.5	10.0	13.9	9.6	13.5	0.2	10.8	16.3	2.6	0.4	13.3	25.1	17.7	5.8	4.7	0.1	0.0	0.1	6.6	1.3	11.1	2.1	0.7	0.7	0.1	0.7	0.0	0.0	0.3	0.2	3.7	0.1	2.3	0.9	0.3	20.0	1.5	0.3	0.2	0.7	17.2	26.2	14.4	25.5	23.8	18.3	40.3	21.9	26.2	32.0	17.9	14.4	0.8	17.7	195.4	3.7	6.1	15.3	36.1	13.6	27.9	0.0	72.1	74.6	6.5	0.9	24.0	2.9	0.0	3.3	66.5	57.4	6.1	27.9	16.8	8.7	25.4	19.1	18.4	1.0	3.5	31.1	5.8	97.8	4.6	7.3	46.1	6.8	7.0	70.0	9.8	5.0	109.9	38.2	6.2	40.1	187.2	153.4	0.0	8.5	14.5
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548611-109618321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 329.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA		8400000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: AB_2677870"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	25.2	13.0	12.3	15.5	11.3	26.4	15.8	12.8	10.7	19.0	14.7	10.3	14.3	12.1	19.7	15.7	34.8	12.5	13.2	9.3	12.3	9.4	18.1	25.8	13.2	23.8	13.1	8.3	18.4	13.7	10.7	11.0	22.4	11.5	17.2	13.8	8.0	16.2	14.4	8.6	27.9	17.0	15.9	12.9	21.6	12.1	14.0	12.0	22.2	12.9	25.2	20.6	20.0	20.4	6.1	9.6	16.8	13.1	5.8	7.2	9.3	14.1	5.0	9.6	5.6	9.2	11.1	7.9	10.7	8.6	10.9	10.9	7.6	4.9	7.6	7.1	11.4	6.7	7.5	9.0	10.9	15.3	8.5	5.5	6.6	8.6	6.5	7.9	10.3	6.1	8.2	9.3	12.6	8.7	7.6	13.1	5.8	8.6	7.5	10.8	9.6	7.9	8.4	9.6	6.8	5.8	5.7	22.6	4.9	12.1	10.8	6.2	10.8	7.5	8.5	11.7	7.8	6.5	9.1	11.8	9.2	12.7	13.8	12.1	8.0	9.0	8.8	15.3	10.2	14.3	8.5	9.1	16.6	6.8	13.1	7.2	6.1	6.7	6.5	9.6	5.0	5.6	6.4	16.8	5.8	12.3	4.3	6.9	9.3	12.3	11.3	12.8	10.7	12.3	9.4	13.1	8.3	11.5	12.0	41.7	29.8	72.9	89.8	134.3	27.1	11.7	28.1	46.8	34.2	55.8	329.9	74.3	54.7	94.8	7.0	65.3	47.7	23.3	88.0	115.2	72.4	62.2	45.1	49.5	96.4	23.8	80.9	47.9	103.4	6.0	45.1	89.9	70.9	77.5	58.1	44.4	82.3	52.6	44.6	40.9	23.4	51.8	82.4	64.2	49.4	164.6	89.4	82.8	47.9	147.8
GNAL		ENSG00000141404	"G protein subunit alpha L"	P38405	18	11688956-11885685	"Disease related genes, Predicted intracellular proteins"		Transducer	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.7"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 15.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"basal ganglia: 82.7"	"Group enriched"	"Detected in some"	4	"basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.7;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 18.4;HeLa: 18.8;U-2 OS: 9.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	13	"basal ganglia: 183.9"	"CAB015464, HPA051160"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB015464: AB_831819, HPA051160: AB_2732564"	"unprognostic (2.29e-3)"	"unprognostic (7.43e-2)"	"unprognostic (8.14e-3)"	"unprognostic (3.41e-5)"	"unprognostic (4.71e-2)"	"unprognostic (9.58e-3)"	"unprognostic (9.93e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.03e-2)"	7.2	1.5	17.8	3.0	82.7	0.7	4.2	2.7	18.1	8.0	3.7	3.2	3.3	1.6	6.7	2.4	8.2	4.1	4.6	2.2	7.1	7.6	4.2	1.3	2.5	5.1	6.6	5.3	3.2	1.3	1.0	20.7	2.9	8.8	9.9	3.7	2.1	4.6	18.1	18.3	7.0	2.0	9.9	3.3	1.8	2.1	6.2	11.3	0.9	8.0	1.4	5.7	9.5	7.7	0.4	0.2	1.7	0.2	0.5	4.2	1.4	0.5	6.1	7.4	0.5	0.6	0.1	0.8	0.1	0.2	0.5	0.0	6.5	1.1	18.4	1.2	0.1	4.2	0.3	6.9	5.9	0.0	3.8	6.3	0.1	18.8	3.7	0.0	0.2	0.4	0.9	8.8	0.0	0.1	0.3	0.0	0.2	1.6	0.2	0.2	0.2	0.2	0.5	6.1	5.0	0.1	0.1	1.0	0.2	0.4	0.2	6.9	0.1	8.6	0.4	2.1	1.8	0.2	0.2	1.0	0.7	9.7	0.3	1.8	0.3	0.1	0.1	0.3	0.2	0.2	1.1	0.2	0.4	4.2	0.1	0.1	0.4	0.5	2.9	0.0	0.3	0.2	2.2	1.7	0.5	0.1	0.2	0.1	1.4	17.8	82.7	2.7	12.7	7.1	7.6	6.6	5.3	8.8	11.3	3.0	5.1	0.0	10.1	9.4	6.7	3.4	0.0	13.4	7.9	3.5	15.7	0.4	1.7	0.4	3.6	4.4	1.4	0.0	2.7	2.8	5.6	4.9	5.7	1.3	0.9	3.2	0.0	0.6	0.3	2.2	0.9	1.3	13.5	0.0	0.2	0.9	1.2	2.0	2.8	3.8	3.1	6.5	13.9	1.9	5.3	6.6	0.5	1.3	1.2	12.9
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716087-78031458	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 18.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 18.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		28000000	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: AB_2680544"	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	12.7	12.6	24.3	9.9	20.8	21.8	11.6	12.5	29.6	13.1	16.6	17.1	9.1	7.9	13.7	11.2	13.1	10.0	11.6	5.6	24.2	18.3	12.1	12.3	23.1	11.8	19.1	14.6	13.5	8.5	12.7	7.6	12.1	14.3	13.0	16.0	10.4	9.8	15.9	5.9	5.1	9.0	18.2	23.9	5.8	15.5	6.0	14.8	18.6	13.3	4.0	4.8	14.5	13.1	0.8	2.8	18.4	3.5	3.3	2.0	1.2	12.0	13.7	12.2	13.4	15.5	15.9	17.6	16.4	12.4	7.2	8.7	4.2	9.9	0.0	13.3	15.0	10.1	19.8	9.1	9.9	9.0	0.4	5.3	33.0	12.0	8.4	14.0	20.1	12.4	10.8	12.2	13.9	14.2	15.0	17.7	29.8	5.8	0.1	12.6	15.3	23.2	12.8	9.9	19.4	1.9	8.6	15.0	0.1	16.4	25.8	13.7	20.9	11.8	10.0	12.3	12.0	9.1	7.5	22.1	12.7	0.8	17.2	9.5	0.1	0.0	0.1	8.8	11.9	13.1	18.4	2.2	4.6	0.8	1.9	1.6	0.8	1.8	1.0	2.4	0.8	2.0	1.6	7.7	3.3	3.5	2.8	1.9	1.2	24.3	20.8	12.5	24.0	24.2	18.3	19.1	14.6	14.3	14.8	163.8	71.4	6.4	33.6	42.0	29.9	5.9	43.3	42.8	35.2	73.3	15.7	39.3	6.6	28.1	13.1	85.4	69.5	46.7	34.7	42.2	42.9	51.3	49.7	51.3	47.8	77.9	88.6	107.4	139.4	6.8	36.5	92.7	45.5	72.1	90.6	37.0	44.3	48.9	49.1	35.4	4.2	25.8	40.1	4.7	6.6	18.9	24.3	21.8	67.3	50.3
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 1781.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.7	32.8	55.4	25.8	94.2	43.0	49.8	56.4	51.6	64.5	46.3	95.8	50.6	32.0	87.9	73.2	46.2	42.3	50.8	75.1	43.7	21.1	30.6	35.6	49.9	62.7	43.5	20.7	22.4	51.3	38.2	31.3	42.2	51.2	48.9	39.5	31.2	43.7	42.5	133.6	105.4	50.6	17.6	6.4	34.7	64.9	48.5	56.5	51.7	38.7	68.7	157.4	78.4	77.9	62.9	50.7	59.5	56.7	53.7	85.7	77.0	30.8	53.1	76.8	49.5	67.6	37.6	10.1	43.7	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4	205.4	224.1	189.5	151.9	115.9	363.0	884.0	242.0	250.3	255.9	247.7	53.0	672.6	376.4	220.5	577.5	343.9	323.7	303.7	196.1	292.5	221.9	260.9	133.0	165.2	333.8	1781.3	444.7	335.7	327.9	1338.6	245.7	276.8	210.9	147.9	250.3	861.2	313.5	239.3	185.3	130.9	175.1	207.0	226.4	48.2	25.4	103.0	1013.3	142.4	268.2	212.5
GNAZ		ENSG00000128266	"G protein subunit alpha z"	P19086	22	23070361-23125037	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.4"	"Group enriched"	"Detected in many"	6	"Horizontal cells: 117.6;Rod photoreceptor cells: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 25.1;SH-SY5Y: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003011	Enhanced		Approved	Vesicles		NA	NA		6900000	Vesicles		"HPA003011: AB_1078918"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.30e-1)"	8.8	6.9	15.4	3.2	13.4	1.8	3.2	17.8	34.4	2.2	6.0	11.1	6.9	2.3	6.2	3.7	5.9	6.9	12.1	2.0	17.7	14.7	2.2	0.6	1.7	2.2	16.4	13.0	9.9	2.2	4.7	11.1	0.9	13.5	7.8	2.3	6.8	2.4	19.5	1.9	1.2	2.4	12.9	19.0	5.1	5.3	4.3	7.7	0.0	1.9	0.0	1.7	3.6	1.5	1.3	0.1	1.7	1.4	0.2	0.6	5.3	0.0	1.2	4.2	9.0	0.0	0.0	0.2	5.7	11.4	5.6	3.8	0.0	0.0	10.9	0.4	0.5	7.7	0.2	5.3	0.2	4.1	1.4	4.4	0.7	6.4	7.9	0.4	0.0	0.9	0.0	0.2	0.1	0.3	1.4	0.1	0.6	0.1	3.4	0.1	3.9	0.0	0.0	2.6	0.3	3.5	0.0	4.3	1.7	0.1	0.1	25.1	15.5	1.3	2.8	1.1	0.5	1.2	0.1	0.0	4.7	5.4	1.2	0.1	4.3	7.3	5.7	2.3	0.4	1.7	1.7	0.3	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.1	1.3	0.0	0.6	0.9	0.2	1.4	0.0	0.0	5.3	15.4	13.4	17.8	19.4	17.7	14.7	16.4	13.0	13.5	7.7	3.0	0.0	0.0	0.3	0.2	11.7	1.0	7.6	1.4	1.2	3.5	7.9	0.0	0.0	1.7	1.2	2.1	0.0	0.0	1.5	0.0	0.9	0.3	0.0	0.0	0.1	117.6	4.6	3.7	0.0	2.1	3.7	0.4	1.7	0.0	0.2	12.8	0.7	0.0	3.9	0.5	32.2	0.0	4.2	1.6	3.2	0.4	0.0	0.0	0.0	0.1
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 1104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		60000000	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	55.2	42.1	84.7	55.1	82.3	41.7	37.8	78.8	112.5	44.0	52.1	46.4	26.0	55.4	44.3	31.2	41.7	38.8	36.6	39.6	74.7	65.7	43.9	38.7	47.1	47.1	68.5	52.1	45.0	33.9	48.9	36.9	45.3	56.6	40.1	41.0	70.7	37.6	41.7	19.7	35.5	65.3	51.2	61.0	51.0	40.8	31.4	39.2	44.5	37.6	19.5	45.6	42.2	54.1	7.7	18.8	18.4	13.2	10.6	9.9	6.0	54.7	51.8	61.6	42.9	35.2	38.8	23.8	77.8	51.9	70.7	55.6	42.3	54.9	57.2	57.4	78.5	40.1	28.9	61.7	56.4	64.7	87.8	30.3	55.5	49.2	48.0	44.4	33.3	61.0	34.3	39.8	67.5	62.9	47.8	57.3	45.4	34.3	51.8	67.3	34.1	73.0	26.3	35.4	28.2	42.0	71.3	47.6	45.2	48.4	34.1	75.8	86.4	72.1	47.0	63.1	44.3	32.9	45.8	87.3	62.3	41.8	48.4	56.4	35.1	61.2	131.0	53.3	70.4	35.0	7.4	11.1	17.1	8.7	13.2	8.0	7.4	8.7	9.7	10.9	7.7	5.9	6.5	18.4	10.6	13.2	18.8	9.9	6.0	84.7	82.3	78.8	112.5	74.7	65.7	68.5	52.1	56.6	39.2	65.5	41.8	61.1	42.7	76.6	128.2	51.2	58.6	30.8	35.2	71.5	164.9	36.8	39.7	78.1	24.7	107.9	139.4	0.0	86.3	77.4	70.2	78.2	52.0	51.3	89.1	170.0	118.1	93.9	126.8	25.1	70.5	95.3	50.6	74.9	88.7	159.0	130.7	84.2	82.7	56.2	1104.1	77.6	76.5	56.5	67.9	89.0	30.4	48.0	64.7	70.1
GNB1L	"GY2, WDR14"	ENSG00000185838	"G protein subunit beta 1 like"	Q9BYB4	22	19783224-19854939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034627, HPA034628"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA034627: AB_10600662, HPA034628: AB_10600440"	"unprognostic (2.14e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.68e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.26e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.64e-5)"	"unprognostic (9.80e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.86e-2)"	6.1	6.4	6.9	12.4	10.3	7.7	8.7	11.6	16.1	7.4	7.2	5.7	8.2	18.6	8.9	7.1	9.8	8.0	5.7	5.8	6.9	5.7	5.2	5.4	6.2	9.9	6.1	9.9	7.6	12.8	3.1	6.0	11.3	5.4	7.7	2.8	4.6	9.4	7.5	13.9	12.6	10.0	4.3	5.5	13.2	8.9	6.1	4.9	30.3	8.3	4.6	8.6	7.9	8.2	11.6	12.8	14.5	7.3	10.9	16.1	7.6	7.0	5.4	1.6	4.8	0.5	1.0	4.4	4.8	1.4	2.4	2.3	9.7	2.8	9.6	3.2	1.1	1.1	13.6	1.1	2.3	0.3	6.1	18.3	5.7	6.7	4.7	1.5	6.5	1.6	0.8	1.1	2.1	0.8	0.5	0.9	4.4	34.4	3.7	0.4	10.0	14.5	9.4	2.7	2.0	9.2	7.6	4.4	2.1	0.2	2.9	3.2	3.5	1.9	4.7	8.2	0.3	1.2	1.7	2.2	5.4	6.6	8.8	4.9	4.8	4.0	5.0	5.9	5.9	1.8	5.5	5.9	14.5	13.7	7.3	13.2	9.6	13.3	10.4	9.5	11.6	13.0	11.7	5.9	10.9	5.5	12.8	16.1	7.6	6.9	10.3	11.6	16.1	6.9	5.7	6.1	9.9	5.4	4.9	3.0	4.1	5.2	5.4	19.6	7.7	1.2	0.0	0.0	3.4	0.0	11.8	12.9	3.3	4.4	25.3	3.6	4.4	0.0	2.9	11.0	6.9	3.8	12.7	2.6	9.4	0.0	0.0	1.8	4.7	4.7	3.1	7.4	13.5	6.4	2.9	2.5	4.9	3.5	4.6	4.1	4.1	6.5	6.2	4.1	11.4	14.2	3.9	10.2	4.5	3.9
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pituitary gland: 27.0;retina: 79.9"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 509.6;Cone photoreceptor cells: 877.7;Rod photoreceptor cells: 442.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 8.5;NTERA-2: 10.3;U-698: 25.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 10.4"	HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.8	1.6	0.9	1.4	2.0	0.5	0.8	6.9	1.6	1.1	1.0	0.8	0.8	2.3	2.7	0.8	0.8	1.0	1.1	5.4	1.0	1.3	0.8	0.8	0.8	1.4	1.1	0.8	3.5	0.8	3.2	27.0	0.8	1.6	1.6	0.4	79.9	2.6	1.8	1.5	0.6	1.6	4.1	0.9	0.9	0.9	0.8	0.8	0.8	1.2	1.0	1.8	2.1	0.8	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	5.0	0.8	0.6	0.9	0.5	2.9	0.6	1.6	1.1	1.1	0.3	8.5	0.0	3.1	0.1	0.3	4.9	0.2	1.5	0.7	1.1	2.2	2.7	0.7	0.5	0.6	1.4	1.2	0.2	1.5	2.1	5.3	1.4	1.1	0.8	0.7	0.4	0.4	0.4	0.5	10.3	0.0	0.3	0.4	1.7	0.5	0.3	0.2	0.8	1.2	0.2	0.0	0.6	1.7	0.0	0.5	2.6	1.3	2.1	2.5	3.8	0.7	0.5	25.9	0.6	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	2.0	6.9	1.5	1.0	1.3	1.1	0.8	1.6	0.8	0.0	0.0	0.0	0.4	0.3	509.6	4.6	0.0	0.0	0.0	0.0	877.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.0	0.0	0.1	69.9	0.0	0.0	0.0	0.0	3.4	0.0	1.7	0.0	0.0	58.9	0.2	0.0	3.2	0.0	442.8	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.1
GNB5	GB5	ENSG00000069966	"G protein subunit beta 5"	O14775	15	52115105-52191369	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 264.1;Cone photoreceptor cells: 263.1;Horizontal cells: 104.9;Muller glia cells: 196.6;Peritubular cells: 110.0;Rod photoreceptor cells: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032353, HPA041942, HPA044198"	Uncertain		Approved	"Nuclear speckles,Centrosome,Rods & Rings"		NA	NA		11000	"Nuclear speckles"	"Centrosome, Rods & Rings"	"CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: AB_2678853"	"unprognostic (2.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.47e-6)"	"unprognostic (6.15e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.10e-1)"	"prognostic favorable (3.32e-11)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.55e-3)"	"unprognostic (1.52e-1)"	6.2	11.2	17.7	8.2	25.6	3.7	8.9	42.5	30.7	15.2	9.2	4.0	9.6	4.6	21.2	13.4	9.0	20.4	15.4	17.3	13.0	18.6	26.9	10.3	5.8	14.7	13.6	21.9	38.1	13.7	35.5	14.7	4.4	21.3	12.9	4.5	20.4	6.5	20.3	1.7	4.8	7.0	13.3	5.9	8.3	7.5	11.7	9.2	7.0	16.2	1.9	14.1	14.6	14.0	21.6	9.9	3.6	1.9	10.8	19.7	9.3	8.0	20.8	5.8	10.2	9.9	12.4	5.6	15.8	15.4	14.1	15.4	5.8	6.1	14.0	4.9	12.9	23.8	11.9	10.2	15.0	10.7	10.9	7.7	9.4	28.1	6.6	11.8	4.7	34.1	11.4	12.7	11.3	4.2	15.0	8.8	12.4	0.7	13.3	15.4	14.4	7.4	13.4	5.3	2.7	9.2	10.0	20.1	17.1	10.0	24.7	9.3	8.1	15.1	1.4	12.3	7.4	4.9	14.7	21.6	12.7	13.9	14.3	15.8	8.5	16.3	15.4	26.6	11.5	20.4	3.6	1.9	0.2	10.7	1.7	8.9	21.0	14.0	12.8	4.8	21.6	13.2	11.3	1.0	10.8	1.4	9.9	19.7	9.3	17.7	25.6	42.5	30.7	13.0	18.6	13.6	21.9	21.3	9.2	20.8	25.0	36.0	19.7	17.1	264.1	20.9	35.7	28.1	28.4	17.4	263.1	4.3	16.6	22.9	1.3	15.5	1.0	0.0	16.4	22.2	20.2	9.6	28.9	6.6	3.5	104.9	18.9	12.9	4.5	1.6	36.8	9.4	18.6	1.8	1.6	196.6	16.5	3.5	110.0	28.3	285.1	45.3	23.7	2.1	5.1	14.3	2.4	23.0	1.9	15.5
GNG12		ENSG00000172380	"G protein subunit gamma 12"	Q9UBI6	1	67701466-67833467	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA057790, HPA062208"	Enhanced	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA057790: AB_2683527, HPA062208: AB_2684711"	"unprognostic (5.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.46e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.46e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.14e-3)"	28.7	23.8	10.3	13.8	9.4	0.0	49.4	5.1	7.7	28.3	34.5	10.9	16.6	40.1	41.5	20.7	34.0	21.2	27.2	14.2	11.8	9.3	36.1	15.4	16.4	12.4	9.1	6.3	24.9	16.0	23.9	17.1	40.1	14.3	21.4	22.2	14.6	16.4	19.3	9.0	33.0	86.2	51.8	22.9	17.5	19.5	11.6	9.6	3.6	23.1	20.5	16.5	31.5	26.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	10.0	9.4	10.0	5.4	42.8	37.2	10.3	31.1	40.6	27.5	24.8	4.4	9.9	0.0	13.3	43.5	17.2	7.5	6.2	25.5	48.5	0.0	4.8	0.1	8.4	0.0	17.1	0.0	0.5	22.3	15.3	29.3	38.9	38.7	43.1	0.0	0.5	0.0	30.1	1.7	0.0	0.0	7.6	11.0	11.7	0.0	20.7	0.1	26.4	9.0	2.3	4.6	21.5	9.0	41.7	8.9	4.6	0.1	55.4	32.0	20.9	57.5	19.1	0.5	0.0	0.0	20.2	1.2	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	10.3	9.4	5.1	7.7	11.8	9.3	9.1	6.3	14.3	9.6	50.6	25.1	2.4	66.8	178.8	1.5	25.9	48.4	69.6	34.2	55.8	5.9	52.0	63.0	84.4	7.6	66.7	171.8	0.0	120.2	89.1	65.8	79.6	3.5	38.9	22.5	3.2	33.4	86.0	16.9	10.4	66.2	12.4	74.2	6.4	58.8	1.3	115.9	90.3	71.1	129.0	17.2	51.8	74.6	1.7	24.7	189.6	147.1	4.3	51.3	91.1
GNG2		ENSG00000186469	"G protein subunit gamma 2"	P59768	14	51826195-51979342	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 68.4;brain: 50.5;testis: 55.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 648.7;Late spermatids: 811.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.9;fHDF/TERT166: 36.9;MOLT-4: 28.7;SH-SY5Y: 24.3;WM-115: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003534, CAB018380"	Uncertain	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB018380: AB_631547, HPA003534: AB_1079004"	"unprognostic (6.11e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.90e-6)"	"unprognostic (9.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.59e-2)"	22.0	10.4	50.5	17.4	18.5	25.0	11.7	4.9	46.1	5.9	13.0	5.2	1.6	6.8	5.7	4.7	6.5	3.5	7.9	6.6	30.9	50.3	4.0	5.6	8.5	19.4	10.7	20.7	7.1	3.3	1.6	12.2	8.6	8.9	6.6	9.1	8.3	4.5	4.4	2.3	3.5	9.9	8.8	8.5	41.2	7.3	55.7	2.5	39.6	3.9	4.3	19.5	8.5	4.0	8.0	13.9	68.4	34.9	5.0	36.5	27.6	0.0	0.8	20.9	13.0	3.2	4.2	0.3	3.4	4.2	1.6	1.3	1.7	0.0	0.0	0.5	36.9	2.4	0.0	2.7	0.0	1.1	9.4	0.3	0.0	0.2	0.0	1.6	1.9	0.1	6.9	0.0	1.6	0.1	8.8	0.0	18.1	0.0	1.7	10.6	0.0	28.7	3.1	11.0	0.0	2.5	10.2	1.6	0.5	1.7	0.0	3.1	24.3	0.0	0.0	9.0	0.7	0.0	0.0	0.0	5.1	0.8	0.1	2.6	0.0	0.0	1.4	4.2	10.2	66.5	68.4	13.5	36.0	36.5	23.3	24.6	8.0	20.3	29.7	13.9	7.3	12.9	22.8	39.9	5.0	34.9	6.0	28.8	27.6	50.5	18.5	4.9	44.2	30.9	50.3	10.7	20.7	8.9	2.5	6.0	11.1	29.6	0.2	10.2	12.4	0.6	0.0	0.0	0.0	3.5	2.0	0.4	1.7	0.1	648.7	6.3	0.1	0.0	0.0	0.6	18.4	0.2	31.2	0.9	39.5	0.0	168.9	12.3	83.7	811.3	9.2	65.9	52.3	14.4	1.0	0.5	0.8	0.0	5.6	0.8	1.8	38.8	8.0	11.9	3.8	5.8	0.6	100.2	0.4	0.1
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530211-54561071	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	12.7	12.9	10.3	16.1	12.3	19.2	12.5	8.6	13.1	10.8	10.2	14.8	10.5	8.5	15.2	10.2	16.3	11.0	10.1	15.3	8.1	8.0	12.0	12.5	13.0	15.5	13.0	10.8	13.2	17.5	15.9	16.9	12.0	10.2	10.6	13.3	12.3	13.3	12.4	24.0	13.2	13.5	15.0	11.5	17.6	11.7	5.9	13.9	20.5	18.0	12.0	18.6	13.7	13.1	17.2	11.4	20.2	15.2	21.8	17.7	11.5	11.2	28.0	5.8	11.9	6.0	4.1	10.7	6.7	4.9	7.6	6.0	23.6	9.3	15.8	13.0	9.7	9.9	11.0	19.3	8.4	10.5	10.9	10.0	15.9	22.4	11.1	4.6	24.6	15.7	5.8	4.1	17.7	10.7	3.1	8.1	9.0	10.3	16.0	7.6	21.8	13.9	5.1	16.7	6.7	15.7	15.0	13.2	15.3	5.7	17.8	9.4	5.7	22.0	13.6	6.3	12.2	17.9	6.3	11.6	13.8	13.8	13.3	11.4	12.0	15.3	20.3	7.1	20.4	15.3	18.9	14.2	15.1	17.7	12.6	16.1	15.0	16.2	15.4	11.4	17.2	12.4	13.0	20.2	21.8	15.2	9.6	8.6	11.5	10.3	12.3	8.6	13.1	8.1	8.0	13.0	10.8	10.2	13.9	11.9	21.0	11.9	2.9	1.1	9.4	7.0	5.1	12.0	18.2	3.5	11.8	6.4	3.3	6.0	0.2	6.0	4.6	0.0	7.6	5.4	3.3	2.8	10.4	3.9	4.4	7.9	3.4	7.4	11.9	0.0	5.2	6.1	0.0	6.4	4.3	3.7	7.8	3.5	2.8	3.3	8.0	6.5	4.1	1.2	7.4	1.8	4.6	8.2	3.9	3.1
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960758-42963880	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 83.9;pancreas: 100.1"	"Cell type enriched"	"Detected in many"	34	"Hepatocytes: 729.0"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.5;SCLC-21H: 12.4;T-47d: 7.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 17.7"	"Not detected"	"Not detected"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		150000	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0.0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0.0	2.5	0.1	0.4	5.2	0.0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2.0	0.9	0.0	1.2	0.3	0.5	0.4	1.8	5.1	0.6	0.2	0.3	0.4	2.0	0.8	1.2	0.1	0.1	1.7	0.2	0.4	0.9	0.6	0.3	0.3	0.2	2.0	1.6	1.3	1.0	10.5	0.0	1.1	2.4	0.4	0.0	0.4	0.2	1.2	0.0	3.8	1.5	1.9	0.3	2.3	2.0	3.7	0.2	0.5	0.5	1.7	1.6	1.0	0.9	0.2	12.4	1.7	0.1	1.7	0.6	0.5	7.9	3.6	0.4	0.9	0.9	0.5	1.0	1.3	1.2	1.5	0.2	2.1	1.0	0.0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2.0	0.0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1	0.0	2.1	3.4	4.2	0.2	1.2	4.5	15.3	5.3	0.0	1.8	0.0	0.1	3.3	0.4	0.2	0.1	0.0	0.0	0.7	0.1	0.2	16.1	0.0	729.0	0.5	1.6	0.0	16.5	21.5	0.0	0.9	0.3	0.0	0.0	0.0	0.3	0.9	0.0	2.5	2.2	0.3	0.0	0.7	0.5	0.6	0.1	0.1	0.0	0.0	1.6
GNPDA1	"GNPDA, GNPI, GPI, HLN, KIAA0060"	ENSG00000113552	"Glucosamine-6-phosphate deaminase 1"	P46926	5	141991749-142013041	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 107.2;Proximal tubular cells: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		970000	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.05e-3)"	15.6	28.2	13.9	10.0	19.1	4.3	18.7	12.6	22.5	16.5	13.7	13.2	11.7	18.0	24.8	34.0	10.7	11.9	13.7	10.6	12.3	16.1	46.2	10.2	11.0	21.8	14.1	16.5	20.7	7.7	15.1	19.9	18.9	13.4	17.8	14.0	17.1	10.6	18.9	16.5	9.0	18.8	18.4	10.9	18.2	9.5	16.3	10.8	12.4	18.2	9.2	11.8	23.6	11.2	7.9	20.6	5.0	22.7	5.6	32.7	14.7	9.5	14.0	5.5	27.0	18.8	12.7	12.8	7.6	18.3	20.2	23.0	20.9	11.4	0.0	17.4	5.4	90.8	10.1	25.4	22.6	17.9	7.3	10.9	7.0	8.2	14.9	33.4	19.4	9.3	15.2	13.4	12.8	34.4	15.1	21.1	18.7	8.3	25.9	21.6	6.0	14.7	2.2	20.5	14.4	28.3	5.7	17.8	21.3	19.4	26.5	4.8	12.7	15.1	15.7	28.8	16.8	12.8	6.1	10.0	11.8	8.0	18.1	10.7	14.5	27.8	10.7	17.3	6.6	10.3	0.0	19.4	2.6	15.7	22.7	32.7	7.9	12.8	14.4	20.6	3.7	15.5	16.5	5.0	5.6	20.4	11.6	10.6	14.7	13.9	19.1	12.6	22.5	12.3	16.1	14.1	16.5	13.4	10.8	8.9	9.3	7.5	31.0	5.4	9.7	10.9	15.3	8.1	20.5	17.4	7.9	22.9	29.9	25.3	0.9	13.0	9.9	0.0	12.2	39.3	11.5	18.6	11.5	5.9	107.2	6.4	14.5	17.2	52.5	2.5	18.4	36.7	13.5	23.4	6.6	35.2	18.7	6.0	25.1	73.4	6.3	0.0	8.1	5.1	16.8	6.5	24.8	17.0	8.3	32.4
GNPDA2	SB52	ENSG00000163281	"Glucosamine-6-phosphate deaminase 2"	Q8TDQ7	4	44682200-44726595	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		710000	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	12.3	13.7	14.8	11.2	21.5	7.3	14.9	47.5	24.5	15.2	12.3	7.3	8.7	8.0	17.5	15.3	11.2	13.3	10.8	17.8	14.5	13.9	14.3	4.3	10.0	11.7	13.7	17.6	24.2	8.1	13.0	29.9	6.6	16.5	15.7	8.5	11.5	9.8	16.2	10.9	10.2	8.7	16.6	12.7	11.4	9.9	11.1	11.3	10.0	18.9	8.4	10.2	13.5	11.0	11.6	3.3	5.8	4.1	8.4	11.4	4.4	9.0	6.3	6.8	5.7	10.7	14.9	2.2	16.1	17.5	10.4	9.7	3.2	11.2	7.9	9.4	13.8	17.9	3.1	6.3	15.0	11.7	10.5	7.1	11.2	10.3	5.6	11.9	11.7	10.5	17.4	10.6	10.6	8.0	13.4	15.4	10.3	6.7	10.4	19.5	0.4	14.0	6.6	3.2	5.9	11.8	9.3	14.5	4.4	10.3	5.4	11.7	9.5	7.0	4.1	15.2	3.5	8.8	7.0	15.8	14.2	13.3	22.9	18.3	13.6	21.4	11.3	23.3	8.4	12.6	5.8	2.3	4.5	9.7	3.3	11.3	11.6	9.1	9.0	3.3	10.4	11.4	10.9	1.1	8.4	4.1	2.6	9.6	4.4	14.8	21.5	47.5	24.5	14.5	13.9	13.7	17.6	16.5	11.3	8.9	2.9	11.8	7.4	11.1	14.3	11.7	0.0	4.0	6.8	14.0	7.9	0.9	13.3	10.5	24.9	11.4	1.7	23.3	13.1	1.0	15.9	4.1	15.1	1.6	4.3	12.7	6.4	11.1	1.9	2.4	15.0	3.5	8.5	3.6	4.2	18.1	10.0	3.5	22.3	11.6	16.3	12.9	14.4	16.2	27.2	9.4	0.5	16.0	4.2	4.1
GNPTG	"C16orf27, c316G12.3, CAB56184, GNPTAG"	ENSG00000090581	"N-acetylglucosamine-1-phosphate transferase gamma subunit"	Q9UJJ9	16	1351923-1364113	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004055	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		420000000	"Endoplasmic reticulum"	Cytosol	"HPA004055: AB_1079006"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.07e-2)"	23.1	67.3	38.0	16.9	35.7	19.9	20.2	22.0	38.8	19.6	23.5	41.7	22.2	16.5	18.9	28.4	17.3	19.1	22.2	17.8	38.5	31.7	29.9	41.1	21.7	22.6	39.3	28.6	22.3	34.6	33.7	25.1	27.2	28.9	21.1	15.6	20.5	37.8	22.2	28.1	33.4	19.5	15.1	43.3	26.3	21.2	18.0	31.0	11.1	24.0	13.2	13.2	20.0	17.8	15.5	29.3	25.8	37.1	14.6	21.7	20.9	4.7	7.8	5.7	10.0	52.5	19.6	7.3	14.1	18.5	5.6	10.8	6.9	13.6	3.0	16.3	19.0	8.5	8.8	3.4	8.2	2.9	9.7	7.6	4.0	24.1	11.8	22.3	6.5	16.3	26.0	14.4	5.4	7.7	15.8	10.3	5.6	4.8	18.2	9.2	11.0	3.0	6.6	5.3	12.3	4.4	11.0	4.8	13.9	14.0	6.3	4.4	5.9	14.2	14.7	10.1	3.3	13.6	9.9	10.0	11.3	9.7	9.2	6.8	19.2	13.9	6.3	9.3	5.6	7.4	25.8	37.1	22.2	21.7	34.0	19.9	15.5	18.7	20.5	29.3	14.6	17.3	15.8	15.0	14.6	31.9	24.7	21.3	20.9	38.0	35.7	22.0	38.8	38.5	31.7	39.3	28.6	28.9	31.0	38.7	42.0	23.2	23.3	18.5	13.9	7.7	40.8	38.8	58.0	19.2	23.6	22.0	8.3	22.9	2.3	20.2	23.2	0.0	12.6	16.8	30.5	22.2	23.2	26.0	44.9	7.9	8.7	36.2	34.5	2.7	27.9	37.0	32.1	18.0	18.4	24.7	14.7	28.8	16.6	37.7	23.3	19.4	18.4	24.7	27.2	17.8	26.0	20.3	20.0	22.0
GOLGA3	"GCP170, golgin-160, MEA-2"	ENSG00000090615	"Golgin A3"	Q08378	12	132768909-132828858	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039809, HPA040044"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA039809: AB_10962348, HPA040044: AB_10981600"	"unprognostic (1.93e-1)"	"unprognostic (7.91e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (6.47e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-1)"	17.5	14.2	14.7	17.6	17.0	13.8	14.5	23.7	21.4	20.1	19.9	17.6	20.6	12.3	18.2	20.0	18.3	14.3	20.7	17.0	14.6	16.7	11.2	18.7	15.5	16.0	15.8	13.2	20.5	39.1	16.1	32.1	18.8	16.2	18.0	16.8	14.3	26.9	19.8	20.5	21.4	15.5	24.6	12.9	18.2	22.2	13.9	14.1	9.8	15.3	15.4	18.2	17.1	16.1	7.3	8.0	5.1	4.6	7.3	7.5	3.5	9.8	20.1	7.2	12.1	25.3	17.1	13.3	16.9	12.8	10.7	9.3	19.0	4.4	13.4	9.1	24.9	9.0	10.3	7.8	10.2	7.3	3.5	9.0	13.5	20.3	12.4	14.7	14.7	19.9	12.9	12.5	14.4	14.5	13.7	10.3	9.3	13.1	5.3	11.1	15.2	12.8	13.7	7.4	7.7	13.6	10.2	8.0	4.8	6.8	23.5	9.1	5.8	14.0	12.5	8.0	8.1	16.3	10.9	21.1	12.6	9.3	14.1	10.8	16.4	13.7	18.2	15.8	8.8	16.0	5.1	4.2	3.6	7.5	4.5	6.6	4.6	5.5	5.9	4.1	7.3	6.3	6.6	3.2	7.3	4.6	8.0	4.5	3.5	14.7	17.0	23.7	21.4	14.6	16.7	15.8	13.2	16.2	14.1	41.7	37.6	16.4	9.3	19.3	25.8	31.4	10.2	16.0	26.1	14.0	94.2	11.6	6.6	14.1	23.9	20.0	46.6	23.3	24.0	20.0	25.5	24.2	11.5	23.7	14.3	17.5	21.4	18.4	8.8	27.7	23.9	11.4	16.9	12.6	43.4	20.3	26.8	27.5	21.2	8.4	104.5	6.5	19.6	19.4	23.9	29.0	19.3	14.1	19.7	22.6
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	22.3	20.6	16.7	14.0	29.0	11.4	30.6	26.9	27.1	19.1	25.1	14.5	29.1	23.9	12.8	18.4	22.0	11.3	16.7	34.3	18.1	12.3	22.1	32.7	15.2	12.2	30.5	12.8	14.8	27.7	27.1	42.8	34.5	18.9	21.1	18.1	20.2	24.8	24.4	64.6	29.8	29.1	19.0	23.9	14.8	21.2	26.0	24.9	10.3	29.9	22.6	11.8	20.5	24.8	10.0	9.9	19.8	11.0	13.0	14.9	3.2	23.7	16.5	8.5	10.7	22.5	19.4	21.7	30.6	25.7	12.1	14.6	14.1	13.3	8.2	8.0	26.0	13.9	14.0	13.5	21.7	25.2	10.4	9.9	11.1	14.6	22.4	22.6	11.7	8.1	10.4	20.8	19.0	37.2	19.6	17.5	6.2	13.5	12.9	19.4	10.2	8.9	5.1	9.3	12.2	15.7	2.0	25.8	8.6	15.0	25.0	5.5	7.3	18.9	20.5	23.4	17.1	30.2	8.6	21.0	12.4	14.4	23.9	21.8	15.9	11.2	7.2	22.0	10.3	14.5	19.8	5.5	12.0	14.9	6.4	12.5	8.1	9.2	10.3	4.5	10.0	9.6	7.2	7.7	13.0	11.0	9.9	6.0	3.2	16.7	29.0	26.9	27.1	18.1	12.3	30.5	12.8	18.9	24.9	220.3	277.4	69.8	105.1	140.7	166.1	608.0	73.9	104.4	195.7	43.6	337.7	86.2	24.9	103.7	122.0	85.9	153.6	23.3	105.1	100.5	87.0	136.9	59.1	125.8	75.0	178.0	85.9	71.8	62.7	17.5	111.0	62.5	65.8	83.8	108.9	122.0	118.5	95.4	106.8	55.9	360.2	84.1	88.0	351.1	212.3	153.6	208.7	59.7	96.2	157.6
GOLGA6A	"GLP, GOLGA6"	ENSG00000159289	"Golgin A6 family member A"	Q9NYA3	15	74069857-74082550	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"liver: 6.2;testis: 15.7"	"Cell type enriched"	"Detected in some"	16	"Early spermatids: 37.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.9;SuSa: 2.3;U-266/70: 5.2"									"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "					"unprognostic (1.68e-1)"		"unprognostic (2.09e-2)"			"unprognostic (9.50e-2)"				"unprognostic (9.67e-2)"	"unprognostic (6.70e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0			0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	15.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.3	0.1	0.1	0.0	0.0	0.2	0.3	0.0	5.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0
GOLGA6B		ENSG00000215186	"Golgin A6 family member B"	A6NDN3	15	72654738-72666394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	34	"liver: 8.4;testis: 10.5"	"Cell type enriched"	"Detected in single"	60	"Early spermatids: 6.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;SuSa: 1.3;U-266/70: 2.5;U-266/84: 1.1"									"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "					"unprognostic (5.47e-3)"		"unprognostic (1.88e-2)"			"unprognostic (2.07e-1)"				"unprognostic (2.01e-1)"	"unprognostic (2.03e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.6	0.0	0.3	0.8	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6C		ENSG00000167195	"Golgin A6 family member C"	A6NDK9	15	75258599-75270199	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 12.5"	"Cell type enriched"	"Detected in single"	72	"Early spermatids: 7.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.3;SuSa: 1.6"									"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (6.53e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.1	0.0	0.3	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	1.3	0.0	0.1	0.3	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	1.6	0.3	0.0	0.7	0.0	0.1	0.1	0.0	0.8	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6D		ENSG00000140478	"Golgin A6 family member D"	P0CG33	15	75282835-75295807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"testis: 14.2"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 8.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.6;Karpas-707: 1.1;NTERA-2: 1.5;SuSa: 3.2;U-266/70: 2.9;U-266/84: 1.3"									"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (7.95e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	14.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.2	0.3	0.0	0.0	2.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA8A	"GM88, GOLGIN-67"	ENSG00000175265	"Golgin A8 family member A"	A7E2F4	15	34379068-34437466	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 196.5;Alveolar cells type 2: 83.2;Bipolar cells: 84.1;Ciliated cells: 85.6;Club cells: 217.2;Cone photoreceptor cells: 94.2;Horizontal cells: 79.4;Rod photoreceptor cells: 127.5"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"NK-cell: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 22.1;HeLa: 30.5"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (4.80e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.58e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.68e-6)"	2.6	4.7	3.6	5.1	4.4	3.1	5.8	20.1	3.5	6.3	3.5			5.8	5.3	18.0	4.1	3.7	3.6	2.9	3.9	3.7	2.6	0.4	2.3	6.5	3.3		7.4	3.3	8.0	2.4	0.7		4.6	0.8		6.7	5.3	2.6	18.4	4.0	1.2	3.8	8.3	3.3	8.3			5.7		0.6	2.6	5.3	0.7	0.0	0.8	0.0	2.7	0.2	0.0	1.0	6.0	1.7	6.0	0.0	0.0	1.3	9.3	0.0	1.6	0.7	10.5	0.0	0.0	1.7	1.1	3.5	9.8	4.3	3.1	2.5	9.1	3.6	22.1	30.5	6.6	0.7	8.4	6.0	0.0	9.0	1.0	0.2	1.0	0.1	3.3	20.0	18.7	4.2	1.9	2.3	15.4	3.2	2.9	3.3	9.0	5.3	7.5	3.5	6.2	8.1	3.8	6.2	4.2	1.0	0.0	1.6	5.1	4.9	7.5	1.7	0.0	1.6	18.0	5.9	2.5	2.3	18.0	1.6	0.0	0.0	0.8	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0											196.5	83.2	10.2	10.7	23.2	84.1	26.4	2.5	85.6	217.2	1.8	94.2	2.3	0.0	3.8	22.3	15.7	6.7	0.0	2.2	2.8	11.6	7.7	12.8	0.9	2.1	79.4	15.4	14.1	6.5	5.4	29.1	11.1	21.9	1.8	9.1	17.7	4.1	6.0	19.8	0.3	127.5	0.0	17.9	29.0	20.5	18.9	2.7	13.8	11.7	7.5
GOLGA8B		ENSG00000215252	"Golgin A8 family member B"	A8MQT2	15	34525207-34588503	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 25.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 178.6;Club cells: 128.5"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	16	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 14.6;Hep G2: 13.0;NB-4: 20.1"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (2.12e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.90e-3)"	"unprognostic (9.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (2.14e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.79e-4)"	2.6	3.4	0.0	2.8	0.6	6.8	4.3	2.5	2.7	2.5	2.0			0.0	4.1	6.1	0.8	3.8	2.8	1.6	0.0	0.7	3.0	2.3	4.5	8.0	0.0		9.0	25.2	0.1	4.9	0.9		5.4	0.1		4.6	5.2	1.8	3.3	5.4	0.5	0.0	5.2	4.0	5.3			16.4		3.1	3.0	1.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	2.0	2.3	0.2	4.3	2.4	4.7	6.1	1.9	0.6	2.1	3.5	2.2	2.9	0.0	4.1	2.0	0.2	1.7	0.8	1.9	1.8	3.0	7.1	0.3	14.6	13.0	3.5	1.8	2.3	6.7	2.7	1.3	3.9	2.4	2.1	3.3	0.7	0.2	1.9	1.0	0.9	20.1	2.7	4.1	3.9	0.1	0.0	0.3	1.8	4.1	3.2	4.9	1.0	0.3	2.2	3.4	1.9	3.9	0.0	3.1	7.4	0.9	3.3	1.4	1.3	3.0	1.0	0.9	0.8	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											178.6	44.8	21.6	8.2	19.5	41.4	30.9	17.8	53.5	128.5	29.6	68.7	5.9	1.7	7.8	32.7	8.9	3.2	0.0	11.0	3.6	7.6	6.5	9.2	25.1	1.4	42.9	6.9	12.9	8.1	3.9	36.5	6.7	20.3	9.0	8.5	9.4	15.0	3.5	35.3	2.2	68.6	12.9	8.1	34.9	26.8	12.9	2.4	37.1	6.9	6.0
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;T-cells: 2.2"	"Cell line enriched"	"Detected in some"	9	"HEL: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA072646			Approved	Cytosol		NA	NA		400000000	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.3	0.0	0.4	2.1	0.5	1.6	0.3	0.3	0.3	0.6	0.3	0.3	0.3	0.0	0.3	0.3	0.3	2.5	0.3	0.3	0.4	0.6	0.3	0.6	0.9	3.7	0.3	0.3	0.8	0.3	0.0	0.4	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.3	1.7	0.2	0.3	0.3	0.3	1.0	0.3	1.9	0.3	0.5	0.1	1.1	0.2	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.4	0.1	0.1	2.0	2.2	0.1	0.0	0.0	1.1	0.0	0.4	0.4	0.5	0.3	0.3	0.4	0.6	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GP6	GPVI	ENSG00000088053	"Glycoprotein VI platelet"	Q9HCN6	19	55013705-55038264	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.9"	"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 5.9;Early spermatids: 10.5;Late spermatids: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"HEL: 13.9;K-562: 5.9;U-2 OS: 4.0"									HPA066482	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		28000000	Nucleoplasm		"HPA066482: AB_2685674"	"unprognostic (3.06e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.44e-3)"	"unprognostic (2.70e-2)"	0.3	0.3	0.8	0.4	1.4	4.4	0.9	4.6	1.6	1.3	0.4	0.3	0.3	0.1	1.1	0.3	2.1	0.5	0.5	5.4	0.7	0.9	0.4	1.5	1.4	0.3	0.3	0.3	0.6	0.3	0.6	0.3	2.8	0.3	0.6	0.4	2.0	0.7	3.0	0.3	3.2	0.3	0.3	0.3	8.9	0.1	4.2	1.0	0.3	0.6	0.3	0.3	0.7	1.8	0.0	0.3	1.3	0.2	0.0	0.1	4.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.6	0.2	0.0	0.2	0.2	0.5	13.9	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.3	5.9	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.2	0.2	0.1	4.0	0.1	0.0	0.3	0.0	0.4	0.1	0.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	4.0	0.8	1.4	4.6	1.6	0.7	0.9	0.3	0.3	0.3	1.0	0.0	0.0	0.0	0.1	0.0	1.5	0.4	0.0	1.4	0.0	0.0	5.9	0.1	0.0	0.0	10.5	0.3	0.3	0.0	0.3	0.2	0.2	0.3	1.1	0.0	0.1	3.2	0.0	2.5	1.2	6.4	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.9	0.1	0.5	0.0	0.0	0.7
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060767-129062406	"CD markers, Disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5"	"Group enriched"	"Detected in some"	11	"Early spermatids: 14.0;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 8.8;neutrophil: 7.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.8"	"Cell line enriched"	"Detected in some"	14	"HEL: 43.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		68000000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.2	0.1	0.1	0.1	0.1	10.0	0.1	0.0	0.6	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.1	5.0	0.8	0.1	0.1	0.4	4.8	0.0	0.8	0.2	0.5	0.1	0.0	0.3	1.5	0.4	0.1	0.4	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	24.5	0.3	2.2	0.0	0.0	0.6	0.6	0.0	0.6	3.0	0.1	1.5	8.8	0.6	0.0	0.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.6	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	7.5	0.0	0.0	1.5	0.0	27.1	0.1	0.1	0.0	0.6	0.8	0.1	0.8	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	13.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GPAA1	"GAA1, hGAA1"	ENSG00000197858	"Glycosylphosphatidylinositol anchor attachment 1"	O43292	8	144082590-144086216	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077224	Approved		Approved	"Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Centrosome, Mitochondria"	"HPA077224: "	"unprognostic (2.53e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	25.2	35.3	23.0	15.9	25.5	32.1	20.0	19.9	43.7	23.6	24.4	27.1	32.3	28.2	26.3	38.3	23.2	24.0	31.1	35.0	20.3	17.4	29.3	47.2	24.9	31.4	19.9	19.0	23.8	46.6	36.4	17.1	32.9	25.1	23.1	10.7	27.4	46.0	35.4	28.5	23.3	31.0	16.3	22.3	21.9	23.0	24.6	16.1	24.0	29.0	22.2	18.6	19.3	18.6	17.2	41.0	21.7	33.3	24.7	34.5	26.1	16.4	29.1	6.8	21.3	15.8	13.5	23.7	16.9	16.8	14.2	14.8	12.0	27.3	9.0	24.7	18.3	6.7	20.5	4.5	16.8	2.1	15.1	15.3	14.1	13.6	8.8	15.3	6.9	21.3	14.8	15.7	14.5	10.1	11.5	11.7	15.3	10.2	31.9	13.6	57.9	13.3	6.4	6.8	19.4	70.8	9.3	8.6	42.8	12.3	11.6	11.8	16.2	22.1	28.5	12.4	3.9	18.3	19.5	7.7	13.2	23.0	7.5	18.9	17.8	13.7	5.9	23.4	8.5	17.9	11.8	24.8	21.7	34.5	29.9	23.7	15.5	17.4	27.1	23.1	17.2	17.3	24.1	5.8	24.7	33.3	41.0	15.0	26.1	23.0	25.5	19.9	43.7	20.3	17.4	19.9	19.0	25.1	16.1	35.7	40.2	43.2	39.6	25.5	57.0	39.1	40.8	26.8	11.4	41.8	60.9	106.7	21.6	110.5	4.7	29.4	99.5	0.0	78.8	116.9	52.6	52.7	65.6	67.2	78.9	52.4	54.6	43.0	45.7	6.6	37.4	40.2	69.2	59.5	47.2	94.2	69.6	80.7	35.3	71.5	53.5	58.2	37.1	132.9	51.7	19.4	91.4	48.0	73.6	37.1
GPALPP1	"AD029, bA245H20.2, KIAA1704, LSR7"	ENSG00000133114	"GPALPP motifs containing 1"	Q8IXQ4	13	44989529-45037669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038966, HPA058739"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"HPA038966: AB_10672656, HPA058739: AB_2683804"	"unprognostic (4.99e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.94e-2)"	15.6	17.9	19.8	13.8	28.1	16.4	15.0	27.6	24.9	18.1	15.0	15.0	14.5	13.7	18.3	15.5	14.4	13.8	12.5	14.4	19.4	15.3	13.9	13.7	12.7	19.1	14.2	23.3	20.9	12.2	9.1	17.8	19.7	16.8	14.9	15.0	10.8	12.7	16.0	15.0	10.3	14.4	17.6	14.3	16.1	15.3	13.9	19.9	19.4	19.6	12.6	18.8	15.6	15.8	10.4	13.0	11.1	8.5	10.1	10.6	5.1	8.7	7.6	14.3	8.8	6.8	11.3	10.0	12.6	10.4	14.7	14.1	13.2	16.3	20.1	8.4	10.2	10.1	14.8	14.0	10.2	16.5	17.3	16.5	15.2	9.8	9.3	11.0	21.5	7.5	8.8	7.3	9.6	8.7	8.9	11.7	15.1	13.1	4.4	10.8	9.8	20.4	14.9	9.8	21.4	7.1	20.0	11.8	8.5	8.2	8.8	5.8	10.0	10.7	6.3	8.1	10.4	6.6	17.2	13.4	7.9	5.7	9.3	9.5	6.0	7.4	20.2	8.5	13.3	10.2	2.6	8.5	11.1	9.0	7.1	7.6	8.7	9.5	7.6	10.7	10.4	10.6	9.6	4.0	10.1	6.5	13.0	7.8	5.1	19.8	28.1	27.6	24.9	19.4	15.3	14.2	23.3	16.8	19.9	29.8	22.7	5.7	13.2	6.4	23.5	13.2	15.3	32.1	29.6	22.7	17.7	25.3	19.9	11.4	3.8	17.3	7.4	0.0	11.5	10.3	16.4	9.8	20.8	15.3	13.1	22.3	17.2	14.7	14.8	2.0	24.7	11.7	11.8	4.6	10.7	22.5	10.0	10.5	25.1	16.1	24.3	25.8	13.2	44.4	20.4	8.2	15.2	13.8	12.5	11.6
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149864-112215377	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 107.3;liver: 56.6"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 165.5;Horizontal cells: 42.9"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 76.6;Hep G2: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	107.3	17.2	11.4	2.6	12.1	1.8	30.8	6.6	11.0	2.0	3.2	6.5	5.1	2.2	4.1	32.1	2.4	1.9	3.0	5.8	12.2	2.9	2.4	56.6	2.2	2.3	7.2	7.3	3.5	2.8	3.2	2.3	1.8	5.6	2.3	2.6	12.0	6.8	2.9	3.6	1.8	3.3	3.4	3.8	1.7	2.4	2.8	7.2	2.8	6.1	2.4	2.3	3.2	1.6	3.2	2.0	0.5	1.2	1.1	3.4	1.0	2.8	2.1	2.9	3.8	76.6	2.8	3.8	2.7	3.1	1.9	1.5	5.0	1.7	2.0	1.5	1.9	1.8	3.6	4.6	2.3	3.7	1.4	2.4	1.8	2.3	20.6	2.3	3.2	1.0	13.4	3.9	3.5	7.1	15.0	1.7	2.8	2.3	1.8	2.2	1.6	2.7	2.5	2.4	1.6	3.0	2.7	7.6	1.4	1.3	1.9	1.2	3.6	3.7	1.8	4.2	2.8	1.8	1.1	1.3	2.3	1.4	2.8	4.2	1.8	2.0	4.2	2.6	2.8	1.7	0.0	1.0	0.5	2.5	1.2	3.2	1.9	1.9	1.9	1.2	3.2	2.0	3.4	0.0	1.1	1.0	2.0	1.9	1.0	11.4	12.1	6.6	11.0	12.2	2.9	7.2	7.3	5.6	7.2	8.9	19.0	7.8	0.6	0.3	5.8	15.7	17.8	5.3	5.7	5.2	9.8	4.6	1.7	2.5	0.4	4.5	1.7	0.0	2.8	2.1	2.5	1.2	2.3	165.5	2.5	42.9	1.2	5.5	8.9	0.4	4.9	2.1	1.7	0.0	3.8	6.0	2.6	2.9	11.3	2.7	8.9	6.5	1.9	2.9	3.2	0.1	1.6	3.2	4.5	0.5
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661229-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favorable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	8.6	8.0	8.4	9.8	9.0	8.1	11.3	9.8	11.9	8.8	17.5	12.3	4.3	5.6	10.8	10.8	9.3	14.4	8.8	14.6	7.7	6.9	11.7	10.4	11.1	12.1	9.0	6.8	20.8	10.6	1.1	11.5	13.8	9.0	10.8	9.4	11.6	13.7	8.4	16.9	12.2	11.6	7.2	8.8	12.0	9.8	26.7	10.2	40.3	13.8	9.3	10.1	10.7	10.0	3.9	4.8	11.4	3.7	4.7	5.4	2.8	3.2	3.3	1.7	5.0	8.5	6.5	4.7	3.1	4.9	3.8	4.5	0.4	5.0	10.6	5.4	3.3	3.7	4.8	0.0	8.3	2.2	5.9	5.1	11.2	0.0	3.3	5.6	3.2	3.9	2.9	3.8	10.3	7.3	6.3	3.7	10.3	2.6	9.3	3.9	2.5	10.7	3.7	0.0	4.8	1.1	3.9	6.8	6.5	5.1	2.5	13.3	7.9	4.1	1.8	4.5	5.0	4.8	8.0	3.9	6.5	6.9	0.0	0.0	5.9	8.4	3.3	7.4	7.3	4.1	10.9	3.7	11.4	5.4	3.0	5.1	2.4	4.1	3.2	3.8	3.9	5.2	4.3	10.6	4.7	3.1	4.8	5.2	2.8	8.4	9.0	9.8	11.9	7.7	6.9	9.0	6.8	9.0	10.2	35.7	20.0	26.8	20.9	22.1	26.8	33.6	25.5	16.0	18.2	17.4	33.4	24.3	38.1	26.7	27.1	28.6	27.3	0.0	20.7	31.7	23.0	23.7	33.6	28.2	24.1	11.1	26.0	22.1	26.4	38.0	31.9	22.9	18.6	47.7	22.5	36.1	20.0	26.2	23.3	53.2	41.2	19.4	35.7	161.5	75.2	29.9	39.4	34.1	25.0	17.4
GPAT2	CT123	ENSG00000186281	"Glycerol-3-phosphate acyltransferase 2, mitochondrial"	Q6NUI2	2	96021946-96039451	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	23	"Sertoli cells: 97.0;Smooth muscle cells: 18.3;Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 7.1;BJ hTERT+ SV40 Large T+: 17.5;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HBF TERT88: 4.0;OE19: 11.9;U-2 OS: 10.0"	"Low region specificity"	"Detected in single"							HPA036841	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036841: AB_10601479"	"unprognostic (1.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.43e-6)"	"unprognostic (2.11e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.65e-1)"	4.3	1.1	1.5	1.9	3.1	1.5	3.6	0.2	1.6	0.8	1.0			0.0	1.1	5.1	0.9	1.0	2.2	3.9	1.1	0.7	0.5	0.5	1.3	3.2	1.2		0.9	1.1	0.0	0.2	2.0		0.6	1.5		1.8	4.9	1.4	0.5	1.3	2.4	2.3	4.4	3.0	7.3			1.2		2.6	2.6	0.8	4.3	1.1	0.5	2.5	0.2	3.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.0	17.5	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	2.6	1.9	2.8	4.3	1.3	2.0	1.1	4.1	0.8	3.0	0.0	0.2	2.5	0.0	1.3	1.5											0.0	0.6	2.4	0.6	0.9	0.7	1.6	2.5	0.0	0.0	1.8	0.0	0.1	1.7	1.7	1.5	2.9	0.4	0.0	1.6	0.2	2.2	0.5	1.1	0.0	2.2	7.9	0.0	6.7	1.0	4.3	0.6	1.0	1.7	1.0	0.7	0.9	0.8	0.6	0.0	0.0	0.2	97.0	18.3	27.9	16.8	0.1	0.1	0.7	1.3	1.6
GPATCH2L	"C14orf118, FLJ10033, FLJ20689"	ENSG00000089916	"G-patch domain containing 2 like"	Q9NWQ4	14	76151916-76254342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 149.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018856	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA018856: AB_1845553"	"unprognostic (5.98e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.81e-1)"	15.3	12.4	15.5	14.6	20.6	40.1	14.3	17.9	22.4	12.8	14.1	18.1	9.0	10.5	17.0	12.9	14.8	12.3	16.0	20.6	11.2	9.3	12.2	11.2	16.2	14.5	14.3	12.7	16.2	12.4	14.0	20.2	14.1	16.7	14.4	13.9	17.9	13.4	13.8	18.2	13.9	14.0	19.1	12.2	13.0	12.8	19.7	14.4	18.1	14.4	8.7	16.2	15.5	15.0	8.7	10.6	11.5	10.9	7.6	8.1	5.1	12.3	16.4	12.9	10.6	7.8	13.6	10.9	14.7	10.4	14.6	14.2	10.9	20.9	15.0	8.8	11.2	11.7	14.9	15.8	9.8	25.4	16.6	9.0	13.6	16.5	7.0	10.0	8.9	19.3	12.4	9.3	12.2	15.9	11.1	14.6	12.8	13.6	21.0	12.7	20.5	11.9	11.9	16.6	7.4	11.9	13.5	16.1	7.6	10.1	25.2	10.7	13.8	16.7	14.8	8.4	14.1	17.2	14.3	16.1	18.7	10.9	10.4	11.1	21.0	19.8	19.4	15.0	12.4	19.1	6.9	10.9	11.5	5.7	9.3	4.8	8.7	3.1	8.1	10.6	6.8	6.7	4.8	8.3	7.6	6.7	8.2	6.4	5.1	15.5	20.6	17.9	22.4	11.2	9.3	14.3	12.7	16.7	14.4	14.9	15.6	16.6	30.0	20.7	94.4	44.7	17.8	22.7	23.9	17.4	98.2	13.6	3.3	16.8	141.6	25.3	21.3	0.0	11.4	9.6	27.5	39.6	42.7	11.3	21.8	149.4	45.9	26.4	38.7	102.9	23.0	38.6	21.9	26.2	16.2	55.2	22.1	31.6	35.3	9.2	132.1	25.8	33.0	51.4	25.3	23.8	14.5	30.2	17.9	37.0
GPATCH8	"GPATC8, KIAA0553"	ENSG00000186566	"G-patch domain containing 8"	Q9UKJ3	17	44395284-44503430	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044380	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles"	Mitochondria	"HPA044380: AB_10965696"	"unprognostic (3.37e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.84e-3)"	"unprognostic (8.47e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.91e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.49e-1)"	8.6	8.5	7.1	12.0	9.3	11.9	7.7	22.2	11.7	8.3	6.5	9.9	6.4	6.9	10.2	4.7	8.5	7.4	6.7	8.1	7.8	5.6	6.4	4.8	7.5	10.0	8.7	6.8	11.2	7.7	14.7	18.1	11.0	9.0	7.1	7.5	9.2	9.1	5.8	21.0	8.3	8.6	8.0	8.3	9.3	6.5	7.6	10.1	9.6	7.7	3.8	9.5	11.6	12.8	10.1	9.6	10.3	16.0	12.4	13.2	6.1	10.4	7.5	8.9	8.6	5.8	7.9	8.8	8.6	10.2	10.7	11.3	10.3	7.0	13.1	5.0	10.6	8.6	6.9	11.9	8.1	13.1	15.5	7.7	15.4	7.0	5.7	4.2	12.7	10.4	8.1	4.4	11.3	10.6	6.9	8.7	8.9	10.5	11.1	6.4	3.3	16.2	1.1	6.0	3.7	7.4	14.5	11.6	9.2	1.5	7.6	8.4	6.5	10.1	4.4	5.9	8.1	6.2	7.0	7.0	6.7	6.1	10.0	10.1	11.5	10.1	14.2	7.5	5.0	6.7	10.3	8.2	6.7	13.2	7.9	12.4	10.1	10.4	9.4	7.9	9.7	9.7	9.7	6.4	12.4	16.0	9.6	5.2	6.1	7.1	9.3	22.2	11.7	7.8	5.6	8.7	6.8	9.0	10.1	20.8	23.8	50.6	42.6	43.3	67.0	29.0	25.5	30.8	42.1	24.4	115.8	36.1	8.3	27.4	11.0	37.3	24.2	0.0	21.4	32.6	47.0	35.6	40.5	17.1	20.3	138.2	37.2	35.0	27.8	3.4	58.4	36.3	21.9	33.3	16.6	56.6	26.2	21.0	40.7	10.2	119.5	51.8	45.7	62.6	70.0	40.9	44.6	77.1	24.9	50.3
GPBP1	"DKFZp761C169, vasculin"	ENSG00000062194	"GC-rich promoter binding protein 1"	Q86WP2	5	57173948-57264679	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA037773	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Plasma membrane"	"HPA037773: AB_10671721"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (3.70e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (4.15e-5)"	25.6	33.1	33.8	27.0	37.8	38.0	37.2	53.9	34.0	30.6	23.5	29.7	20.3	20.8	29.0	33.1	25.5	32.4	24.5	25.4	32.5	28.4	27.1	28.4	29.9	34.0	41.5	34.0	46.7	23.5	37.6	43.9	35.6	33.2	27.6	24.9	19.7	27.2	26.9	37.3	24.6	25.8	22.0	42.4	31.5	24.0	46.9	37.2	49.9	35.1	20.3	33.7	29.4	50.2	31.7	18.9	35.5	18.9	33.5	37.7	27.1	21.8	17.5	33.5	28.1	21.9	21.8	30.8	16.6	28.4	27.6	35.6	28.2	25.4	29.0	19.5	17.0	34.2	15.1	28.6	19.2	35.0	16.4	19.6	23.8	19.9	23.5	25.6	17.1	24.6	17.7	29.8	22.5	31.6	26.6	22.2	23.7	24.1	47.7	22.0	27.4	27.0	30.0	20.8	10.7	12.2	29.3	27.4	28.4	21.2	22.7	30.1	23.4	24.3	21.8	26.5	22.6	42.6	29.3	14.7	10.1	20.7	14.6	24.0	36.3	30.4	32.3	16.9	25.9	18.8	35.5	17.1	32.3	28.1	17.7	35.2	31.7	34.0	33.1	18.9	26.8	37.7	34.9	33.2	33.5	18.9	13.4	35.3	27.1	33.8	37.8	53.9	34.0	32.5	28.4	41.5	34.0	33.2	37.2	56.6	73.1	104.6	209.8	202.1	136.5	78.6	50.9	156.6	117.2	80.3	139.4	79.0	84.6	64.9	165.9	107.9	88.6	0.0	48.6	61.5	139.8	213.9	141.7	40.1	49.2	127.1	103.2	53.4	59.9	85.3	124.0	98.1	178.8	169.5	57.2	92.1	59.0	101.7	85.9	53.3	176.2	51.8	188.5	265.7	227.4	207.8	135.2	127.1	57.2	255.1
GPBP1L1	SP192	ENSG00000159592	"GC-rich promoter binding protein 1 like 1"	Q9HC44	1	45627304-45688113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028593	Approved		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Focal adhesion sites, Cytosol"	"HPA028593: AB_10602906"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.42e-3)"	"unprognostic (9.79e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.51e-1)"	"unprognostic (7.56e-3)"	"unprognostic (6.13e-2)"	29.9	20.5	16.9	21.2	23.7	24.9	25.2	24.4	18.6	27.4	36.9	33.3	29.7	31.6	26.3	23.8	34.8	22.5	19.7	23.9	17.3	17.0	30.2	38.9	28.3	29.1	33.2	12.4	24.7	46.9	24.4	36.6	25.7	22.1	26.4	37.2	29.8	33.5	35.3	29.6	31.0	58.0	25.7	28.2	30.6	26.2	33.2	27.2	40.5	37.7	30.3	35.4	32.5	27.5	13.5	17.8	29.8	22.1	20.0	20.0	15.4	15.8	9.8	17.1	18.1	20.2	19.7	23.4	12.6	21.0	18.3	23.1	9.8	17.8	22.0	16.5	17.3	19.3	16.6	18.7	19.0	23.3	25.1	13.3	28.5	11.4	15.2	27.8	28.4	26.5	14.3	41.6	14.3	41.0	24.7	23.1	28.3	24.3	19.6	20.8	8.5	25.2	25.6	24.3	21.4	11.2	16.6	22.2	16.1	21.0	15.7	21.1	14.1	20.8	30.8	32.1	34.8	14.0	33.6	19.6	13.2	13.9	14.2	19.1	19.2	17.8	16.2	13.9	23.8	13.8	16.4	16.6	29.8	17.8	21.2	18.9	13.5	17.6	17.4	17.8	11.5	19.4	18.9	17.7	20.0	22.1	10.2	20.0	15.4	16.9	23.7	24.4	18.6	17.3	17.0	33.2	12.4	22.1	27.2	56.6	19.5	31.8	35.2	57.7	23.3	41.7	45.9	16.0	29.6	57.6	33.4	23.0	43.1	29.6	10.8	38.3	66.9	46.7	33.6	29.3	24.3	50.8	58.8	72.6	22.6	35.0	36.8	31.9	45.9	13.4	19.0	33.1	21.9	23.4	66.9	16.0	42.8	46.0	20.1	45.1	32.3	19.4	35.3	70.7	75.4	59.2	38.0	35.1	54.0	53.8
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435671-240468078	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 142.6"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 181.5;Syncytiotrophoblasts: 85.9;Urothelial cells: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030571, HPA070449"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		6500000	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322, HPA070449: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.78e-5)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	13.6	22.8	32.4	7.2	21.0	1.9	8.1	42.7	33.6	11.5	8.1	10.1	9.5	5.4	9.6	9.8	26.3	7.8	7.1	40.7	26.5	11.9	8.5	11.0	7.4	4.0	8.8	22.5	14.1	18.1	5.8	14.4	20.2	13.6	29.5	4.0	6.3	16.3	17.6	62.9	142.6	4.9	12.0	8.3	5.2	6.5	20.0	10.5	1.7	4.5	24.3	10.7	10.5	15.2	0.9	0.1	0.0	0.0	0.1	0.8	0.3	16.2	22.4	5.3	13.9	16.2	15.6	21.6	39.0	19.4	4.5	5.3	7.9	18.2	0.4	5.4	41.3	24.7	44.9	2.8	27.7	0.9	7.8	2.4	0.0	20.6	9.8	23.3	0.3	1.5	13.7	18.1	10.1	5.3	9.5	2.3	0.8	0.1	0.8	11.5	8.5	0.3	0.1	8.3	1.8	5.0	2.9	24.2	3.7	3.6	26.3	5.3	3.5	25.5	22.5	2.3	5.0	7.1	1.6	10.9	24.3	41.2	11.5	16.1	0.1	0.1	0.1	17.3	0.4	27.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.3	32.4	21.0	42.7	33.6	26.5	11.9	8.8	22.5	13.6	10.5	14.9	6.7	0.0	52.5	40.8	12.0	50.2	22.9	8.1	23.9	24.4	2.0	58.0	6.6	25.6	0.6	3.7	0.9	0.0	9.3	181.5	28.8	15.7	4.6	19.2	8.0	23.8	0.0	15.4	0.0	2.1	17.5	2.7	33.7	2.8	4.3	27.8	13.4	0.0	7.1	2.2	4.9	25.8	16.5	0.5	4.9	40.4	85.9	0.7	2.7	90.8
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415490	"Plasma proteins, Predicted membrane proteins"			"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 47.6;Extravillous trophoblasts: 33.8;Proximal tubular cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.7;HAP1: 27.3;NTERA-2: 25.0;RPTEC TERT1: 63.0;SuSa: 57.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		170000	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	39.7	9.9	16.3	10.7	5.3	0.3	6.8	3.7	4.9	14.6	21.6	8.2	3.4	10.0	11.7	16.3	18.6	11.2	23.7	9.6	9.5	5.0	39.6	2.4	25.6	7.1	5.1	6.6	12.4	12.5	9.4	20.4	26.9	9.5	10.3	10.7	9.3	12.2	11.6	20.3	4.3	11.3	16.9	7.9	6.5	19.8	7.2	6.4	5.2	12.4	11.6	2.0	17.1	11.7	0.9	0.6	0.1	0.7	0.0	0.0	0.2	0.0	0.0	47.7	1.8	2.0	0.3	5.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	16.4	0.2	0.0	0.0	27.3	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	25.0	0.0	0.7	0.1	4.3	0.0	63.0	1.8	0.0	0.3	0.2	0.0	0.0	57.9	0.7	0.7	0.0	4.9	5.8	0.0	3.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	16.3	5.3	3.7	4.9	9.5	5.0	5.1	6.6	9.5	6.4	47.6	20.3	0.0	3.3	1.3	0.0	3.4	5.1	9.4	9.1	22.7	0.0	0.3	3.3	6.4	0.4	0.6	2.9	0.0	10.9	33.8	6.9	1.1	0.0	0.0	2.5	0.0	2.4	0.0	0.8	0.9	2.0	2.4	1.7	1.8	9.3	0.8	12.6	3.5	0.4	34.9	0.0	0.0	14.4	1.2	21.2	0.4	2.6	0.0	10.2	0.6
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398607-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;kidney: 14.8;testis: 11.3"	"Cell type enriched"	"Detected in some"	23	"Distal tubular cells: 54.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"CACO-2: 31.4;HeLa: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA040152: AB_2676863, HPA044081: AB_2678801"	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.8	3.8	11.8	1.1	18.3	0.8	0.7	3.1	18.9	0.6	1.5	2.9	0.1	0.7	0.6	0.9	0.6	0.8	1.6	2.3	11.8	6.0	14.8	2.9	6.5	1.0	7.3	5.6	1.5	0.8	0.6	7.7	1.4	19.4	0.9	1.5	0.0	0.8	1.5	0.6	0.7	0.8	0.8	4.4	0.7	0.9	11.3	6.6	0.0	2.7	0.0	0.7	0.6	0.3	0.5	0.4	0.3	1.8	2.0	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	18.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	2.2	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.5	0.1	1.2	0.4	0.2	0.0	0.5	0.3	2.0	1.8	0.0	0.0	0.2	11.8	18.3	3.1	8.6	11.8	6.0	7.3	5.6	19.4	6.6	0.0	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.1	54.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0
GPC6		ENSG00000183098	"Glypican 6"	Q9Y625	13	93226842-94407401	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 47.6;Hepatocytes: 39.9;Rod photoreceptor cells: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"NK-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"NK-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.2;HHSteC: 17.5;HSkMC: 29.7;hTERT-RPE1: 26.6;SuSa: 17.0;U-87 MG: 21.9"	"Low region specificity"	"Detected in all"							HPA017671	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		360000	"Golgi apparatus, Vesicles"		"HPA017671: AB_1849833"	"unprognostic (5.24e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.21e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.35e-3)"	11.0	3.2	3.7	9.7	6.8	0.4	6.5	3.2	7.3	7.6	10.6	3.7	2.6	3.1	5.7	9.9	6.3	6.9	19.9	7.9	3.0	3.0	9.5	21.3	6.6	4.9	2.5	4.7	11.1	2.3	1.2	7.5	1.8	5.1	12.8	8.2	20.8	3.6	19.2	1.8	3.0	7.1	13.7	19.8	3.4	8.1	2.4	2.1	0.2	4.4	1.5	1.4	14.3	15.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	1.9	4.2	1.8	26.2	8.9	0.0	2.9	0.0	2.0	2.7	0.0	0.0	0.1	0.0	6.3	0.0	0.0	2.3	0.5	3.8	0.0	1.7	0.0	0.0	7.9	17.5	0.0	0.0	29.7	0.2	4.8	3.3	26.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.7	0.0	1.4	0.0	0.6	0.0	2.3	0.0	1.7	7.0	0.0	0.8	0.0	17.0	5.7	0.0	0.0	11.1	9.5	10.4	4.8	6.5	0.0	0.0	21.9	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	3.7	6.8	3.2	7.3	3.0	3.0	2.5	4.7	5.1	2.1	0.0	0.3	0.0	0.6	0.6	47.6	1.6	5.1	0.0	1.2	7.0	9.8	0.2	0.0	0.2	4.9	0.5	0.0	0.0	0.0	0.1	6.1	2.0	0.0	39.9	0.4	0.0	0.0	8.0	1.0	3.1	4.4	0.4	1.7	0.0	0.0	2.3	0.1	0.0	1.8	14.3	84.5	0.0	16.1	2.6	0.7	0.4	0.1	0.0	0.0	0.1
GPCPD1	"GDE5, GDPD6, KIAA1434"	ENSG00000125772	"Glycerophosphocholine phosphodiesterase 1"	Q9NPB8	20	5544404-5611026	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042987			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042987: AB_2678254"	"unprognostic (2.25e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (2.93e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-2)"	12.9	12.9	10.6	21.8	17.6	56.7	12.7	29.6	28.2	12.2	8.8	9.1	36.7	7.4	12.5	10.5	10.6	12.6	13.2	12.6	12.2	10.1	8.1	8.1	43.6	30.6	13.1	8.9	18.1	8.9	4.5	10.3	13.4	19.4	9.6	10.6	11.0	34.2	31.2	31.8	9.1	15.1	21.5	14.6	24.9	8.8	8.1	4.0	12.1	13.4	17.0	17.5	13.7	9.8	4.2	4.5	16.2	7.1	3.6	4.6	3.4	3.8	7.3	5.0	4.0	3.3	3.9	5.7	6.1	4.9	3.5	2.4	3.8	3.0	8.6	1.1	3.4	3.2	1.3	6.2	12.1	3.4	1.8	2.0	11.8	0.8	4.4	16.0	7.2	5.4	8.3	15.8	2.1	26.1	3.6	3.7	5.4	6.7	4.5	3.2	2.1	6.5	3.9	2.7	6.8	4.2	4.7	6.0	3.1	4.8	3.2	1.9	2.5	2.7	11.9	5.7	5.2	2.8	20.3	4.1	3.0	2.2	8.2	3.9	4.3	7.4	9.2	0.9	8.9	3.3	2.6	7.1	9.0	4.0	5.5	3.1	4.2	3.0	3.3	4.5	3.8	4.6	3.1	16.2	3.6	5.5	2.0	2.4	3.4	10.6	17.6	29.6	28.2	12.2	10.1	13.1	8.9	19.4	4.0	20.8	56.2	34.4	13.7	14.7	16.4	35.1	15.3	13.4	31.8	21.0	5.9	24.1	3.3	10.4	145.3	24.3	12.0	70.0	7.9	13.9	20.4	21.1	42.7	15.3	42.6	11.1	18.9	20.9	80.0	39.0	5.2	52.4	10.1	10.0	20.3	9.1	6.0	8.6	3.2	6.3	19.4	6.5	35.6	39.0	9.5	24.0	40.7	32.0	10.4	44.4
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 22.2;Kupffer cells: 13.5;Paneth cells: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4"	"Group enriched"	"Detected in many"	18	"dendritic cells: 8.4;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.1;Daudi: 10.6;Hep G2: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	14.2	10.9	12.1	3.6	13.2	1.2	11.5	5.1	11.1	6.4	7.1	5.6	3.5	2.0	5.4	1.8	5.5	4.8	3.2	6.0	8.3	6.2	7.4	19.5	25.6	6.4	8.6	8.7	3.3	4.0	1.8	4.7	13.3	6.1	6.8	3.7	5.2	4.2	11.8	8.6	2.8	2.6	5.5	4.1	6.5	23.9	2.2	8.6	1.3	16.5	2.3	2.8	6.4	7.2	0.3	8.4	0.0	4.3	0.0	0.0	1.6	0.9	0.4	0.2	10.1	2.5	2.4	1.0	5.8	3.9	1.8	3.3	0.2	0.2	10.6	1.0	7.3	0.1	0.5	0.1	0.0	0.2	2.2	1.8	0.0	1.3	19.4	0.3	0.1	0.7	1.3	0.0	1.1	0.0	1.4	0.5	0.2	0.1	0.1	0.4	0.7	0.0	0.3	1.9	2.0	6.9	0.9	0.0	0.0	0.2	0.0	0.1	4.0	0.0	0.4	2.1	0.8	0.2	0.1	1.4	0.4	2.6	6.1	1.8	0.0	0.0	3.6	3.4	0.2	0.2	0.0	4.3	0.0	0.0	4.2	0.0	0.3	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	1.6	12.1	13.2	5.1	11.1	8.3	6.2	8.6	8.7	6.1	8.6	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	2.2	1.3	0.0	2.8	0.5	1.4	0.7	0.0	22.2	0.5	0.0	1.2	0.6	13.5	0.6	2.6	1.7	0.0	0.0	2.5	4.3	0.8	8.2	1.1	3.0	0.4	0.0	4.1	0.3	3.1	0.3	0.0	0.0	1.5	0.0
GPHA2	"A2, GPA2, MGC126572, ZSIG51"	ENSG00000149735	"Glycoprotein hormone alpha 2"	Q96T91	11	64934471-64935888	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 98.0"	"Cell type enhanced"	"Detected in some"	28	"Exocrine glandular cells: 15.7;Pancreatic endocrine cells: 3.7;Spermatocytes: 4.7;Spermatogonia: 2.5"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067068			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA067068: "	"unprognostic (1.13e-1)"	"unprognostic (8.31e-3)"		"unprognostic (1.51e-2)"		"unprognostic (9.22e-4)"		"unprognostic (7.88e-3)"		"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.70e-1)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	6.7	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.7	98.0	0.0	15.1	0.1	0.2	0.7	0.0	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	4.2	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	21.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.4	0.0	0.0	0.0	4.7	2.5	0.0	0.0	0.0	0.0	0.1
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 321.8;Late spermatids: 797.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.8	108.3	9.5	74.2	31.2	23.2	22.7	29.7	23.5	37.5	45.2	61.0	27.3	50.7	44.1	29.0	25.5	53.6	57.3	64.5	42.6	56.3	23.2	65.0	52.2	64.2	20.2	84.2	42.4	31.8	26.7	44.2	23.0	47.4	35.0	34.4	33.1	40.1	26.3	65.2	36.6	29.5	25.7	69.7	38.4	34.3	25.1	95.7	46.9	51.8	51.9	30.2	59.8	105.5	21.6	17.8	23.9	26.9	30.1	14.2	31.2	40.1	45.7	74.2	42.1	46.0	47.2	64.1	28.6	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0	26.8	40.2	23.1	22.0	23.0	92.5	198.3	38.2	21.4	25.0	54.1	70.7	38.6	97.8	77.9	321.8	30.6	90.3	0.0	57.9	60.0	36.8	27.8	22.0	68.1	78.6	224.1	61.2	47.9	41.6	797.8	34.2	41.9	33.7	45.9	67.6	28.6	75.7	25.9	28.7	79.1	62.2	19.4	38.7	6.9	7.6	28.7	32.8	47.1	102.1	32.5
GPN1	"ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1"	ENSG00000198522	"GPN-loop GTPase 1"	Q9HCN4	2	27628247-27651508	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036793, HPA036794, CAB037303"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230"	"unprognostic (9.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (2.88e-5)"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (3.50e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	24.3	24.3	18.8	18.7	23.2	28.1	26.3	22.9	27.2	18.3	21.6	20.7	13.7	19.3	21.3	21.2	26.7	21.0	18.2	21.5	17.2	22.1	29.7	29.2	18.2	29.2	20.0	16.1	24.6	35.4	19.8	18.5	31.1	23.3	18.8	25.6	14.3	23.0	17.6	30.9	25.0	25.3	22.1	16.4	26.6	20.8	30.2	15.9	29.0	26.9	22.5	28.3	21.5	24.3	29.1	35.8	28.5	28.2	39.6	38.6	29.7	32.7	18.6	17.6	12.7	16.6	17.0	17.9	18.3	18.3	26.0	19.3	20.3	17.2	20.5	17.9	20.0	24.1	14.3	24.4	22.8	26.4	19.1	17.0	23.4	15.0	24.7	21.6	34.3	12.3	17.5	20.1	26.7	25.1	18.1	27.1	18.7	29.0	19.3	30.7	19.1	20.7	25.7	30.4	25.0	18.4	20.9	52.1	21.4	21.0	18.9	15.7	24.9	20.1	22.6	20.3	17.1	13.6	19.9	22.0	22.7	33.6	11.2	42.9	22.3	24.0	55.2	32.7	29.8	18.6	28.5	24.7	21.1	33.4	28.2	36.0	29.1	31.1	38.6	35.8	25.2	27.7	34.1	3.7	39.6	26.3	18.5	30.3	29.7	18.8	23.2	22.9	27.2	17.2	22.1	20.0	16.1	23.3	15.9	11.9	7.2	7.2	18.2	19.3	7.9	9.7	17.8	10.7	14.8	14.0	3.9	36.5	19.9	46.3	69.8	14.5	10.8	0.0	31.4	38.5	20.1	18.3	24.3	8.6	29.3	11.1	16.7	15.4	18.9	67.5	13.8	19.3	21.9	33.3	13.3	12.0	35.5	10.5	10.3	15.6	9.1	12.9	20.8	26.2	22.6	16.3	27.7	33.0	19.5	16.6
GPN3	"ATPBD1C, MGC14560"	ENSG00000111231	"GPN-loop GTPase 3"	Q9UHW5	12	110452484-110469268	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039764, HPA047793"	Uncertain		Approved	"Nuclear speckles,Cytosol"		Yes	No			"Nuclear speckles"	Cytosol	"HPA039764: AB_2676669, HPA047793: AB_2680157"	"unprognostic (1.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.82e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (3.98e-5)"	"unprognostic (5.50e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (5.81e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.27e-1)"	17.8	15.1	14.1	11.2	17.3	9.6	26.7	18.4	14.2	13.0	12.5	11.9	10.1	5.9	14.9	11.8	15.6	15.1	10.2	24.8	11.4	10.9	23.3	23.2	13.6	14.8	26.6	11.4	19.4	14.5	19.6	12.2	15.4	18.6	17.0	10.0	11.0	16.6	14.3	35.1	9.6	8.7	17.5	20.0	16.0	13.6	28.3	19.4	11.8	20.1	22.0	12.6	16.5	13.1	20.2	28.0	34.4	31.4	11.8	18.9	16.8	15.4	24.0	16.7	16.3	18.8	11.9	22.1	21.3	13.0	24.1	19.6	22.3	9.3	29.8	14.9	11.6	17.9	14.3	20.6	19.1	32.8	17.0	19.2	17.6	12.9	18.4	13.1	27.4	16.3	12.7	12.1	23.6	15.3	13.5	17.3	25.4	29.6	6.8	16.8	10.5	25.1	52.4	20.4	21.8	24.6	8.6	23.1	22.9	15.1	13.9	12.8	13.3	21.7	14.9	18.0	22.3	25.4	32.5	9.5	20.1	14.7	19.5	24.6	9.4	24.3	31.0	14.7	25.4	22.8	15.3	24.5	34.4	14.0	31.4	15.5	20.2	15.0	15.8	22.6	19.9	18.9	12.6	12.6	11.8	31.1	28.0	12.3	16.8	14.1	17.3	18.4	14.2	11.4	10.9	26.6	11.4	18.6	19.4	23.8	28.0	25.6	41.8	26.6	16.7	38.6	20.4	36.1	26.1	31.4	13.7	52.1	91.2	21.8	68.6	20.5	3.3	0.0	18.6	61.2	26.5	33.4	30.1	31.6	80.2	20.6	7.9	13.5	18.3	13.4	18.4	30.1	15.1	46.9	8.4	17.2	19.9	10.4	22.3	56.6	24.3	25.8	27.8	166.3	65.2	22.2	39.0	16.7	11.8	35.7
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 19.1"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 10.0;Muller glia cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.7;pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HHSteC: 53.7;hTCEpi: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	2.3	5.0	0.5	0.6	10.7	0.1	1.7	0.4	1.2	4.1	0.6	4.8	1.6	0.2	1.3	0.7	6.6	1.1	2.7	3.8	1.6	0.5	0.7	0.0	0.5	3.1	0.2	0.3	3.2	0.1	0.0	0.4	19.1	6.6	0.7	0.6	1.1	1.5	0.4	1.5	6.7	0.5	2.3	0.3	0.2	0.2	1.6	1.0	0.0	0.7	2.2	1.2	3.1	7.7	0.5	0.1	1.4	0.2	0.5	0.2	0.6	0.8	0.1	0.7	0.0	0.1	3.0	0.2	5.5	9.5	3.4	2.9	0.0	0.0	0.0	0.3	2.7	0.2	0.1	0.2	0.0	1.1	0.0	0.1	0.0	1.8	0.0	53.7	0.0	0.0	2.2	24.2	4.9	7.9	4.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	2.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	2.4	1.1	0.0	0.0	0.6	0.0	0.0	0.1	4.1	1.9	4.8	0.4	0.0	0.0	0.0	1.5	0.0	0.1	1.3	0.2	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.5	0.2	0.2	1.4	0.5	0.1	0.1	0.2	0.6	0.5	10.7	0.4	1.2	1.6	0.5	0.2	0.3	6.6	1.0	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.3
GPR107	"FLJ20998, KIAA1624, LUSTR1, RP11-88G17"	ENSG00000148358	"G protein-coupled receptor 107"	Q5VW38	9	130053426-130140169	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031704	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA031704: AB_10601018"	"prognostic unfavorable (3.56e-5)"	"unprognostic (7.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (4.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.34e-3)"	21.0	21.6	24.2	16.6	26.8	12.5	23.7	28.1	28.0	25.0	24.0	35.9	20.5	13.3	24.0	19.1	22.5	26.2	20.9	20.6	22.3	26.6	24.4	22.9	23.0	17.4	29.5	23.1	21.8	26.6	34.4	21.6	40.7	29.9	28.4	26.3	29.3	23.0	24.4	20.5	25.6	15.4	26.7	28.8	17.2	18.9	23.9	22.9	17.3	40.0	15.4	19.7	19.4	17.3	2.0	3.4	6.3	6.3	1.4	2.4	2.3	12.7	18.7	17.9	14.1	19.2	20.4	17.9	20.4	23.0	17.3	17.3	17.9	17.4	7.1	15.1	22.5	20.3	32.2	13.7	12.6	14.9	11.0	9.2	7.5	23.0	10.2	18.6	15.6	11.0	17.0	19.7	17.2	17.4	19.7	15.9	8.6	10.6	7.1	14.8	15.7	8.3	6.3	12.0	26.0	14.2	7.9	26.3	11.2	14.5	17.8	6.3	13.8	26.7	19.0	14.4	16.3	33.3	8.2	18.7	22.0	11.8	17.9	15.4	4.5	15.0	6.8	19.6	7.5	20.7	2.8	5.7	3.4	1.5	6.1	2.1	1.8	1.6	1.7	3.4	2.0	1.0	2.4	6.3	1.4	6.3	2.1	1.5	2.3	24.2	26.8	28.1	27.6	22.3	26.6	29.5	23.1	29.9	22.9	23.8	17.1	3.9	4.2	5.7	15.8	20.6	25.5	13.4	12.5	15.7	37.3	11.3	0.0	11.0	5.3	9.0	11.9	0.0	15.2	14.5	12.6	12.8	5.8	11.5	13.2	17.5	9.2	24.5	18.1	4.9	17.5	8.3	13.5	13.6	17.2	12.0	17.7	10.5	18.0	6.1	15.2	0.0	8.9	11.7	9.5	9.5	22.3	6.5	13.2	7.3
GPR108	LUSTR2	ENSG00000125734	"G protein-coupled receptor 108"	Q9NPR9	19	6729914-6737603	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041924, HPA041951, HPA063863"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.04e-7)"	"unprognostic (1.58e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (8.68e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.13e-3)"	17.6	29.7	15.4	13.8	17.9	14.2	20.1	15.2	23.1	22.2	24.3	24.3	27.0	20.4	20.6	20.8	25.1	26.1	23.5	14.0	14.6	12.3	35.4	33.9	19.6	17.1	20.5	12.9	22.6	41.5	30.9	15.1	27.1	17.2	24.0	17.7	31.3	35.4	27.4	10.6	19.1	29.2	16.9	15.7	20.9	20.6	26.3	19.4	17.2	38.8	14.7	23.1	21.4	19.8	14.8	25.8	54.3	36.3	23.1	26.7	35.5	11.7	12.8	7.9	15.5	31.1	16.9	9.0	9.2	27.9	12.8	13.6	7.9	13.5	5.6	17.1	18.7	15.3	10.1	8.9	19.1	6.6	22.5	10.3	9.1	13.5	10.4	30.6	5.8	12.4	18.3	36.7	12.3	24.9	17.0	14.9	13.7	9.1	37.5	12.9	8.1	10.2	8.4	5.7	21.3	11.4	8.3	9.0	21.2	26.6	11.6	0.0	8.6	9.3	15.2	14.0	7.1	14.5	14.1	12.3	7.3	4.7	23.2	9.7	24.3	13.1	3.9	25.2	18.7	7.8	20.4	35.8	35.7	26.7	32.7	24.3	14.8	21.4	22.5	25.8	14.1	15.5	17.7	54.3	23.1	36.3	9.2	23.4	35.5	15.4	17.9	15.2	23.1	14.6	12.3	20.5	12.9	17.2	19.4	8.9	12.6	24.2	35.3	23.6	27.7	7.3	35.7	17.4	7.9	34.9	21.6	51.9	31.5	69.1	25.9	30.8	74.1	0.0	96.9	31.1	27.5	30.8	25.4	22.9	52.7	20.6	20.8	38.6	25.1	69.5	21.9	38.9	28.7	56.9	51.5	33.6	68.5	77.2	17.3	45.7	33.2	38.8	26.8	22.1	14.0	27.9	49.0	40.7	43.6	33.9
GPR137	"C11orf4, GPR137A, TM7SF1L1"	ENSG00000173264	"G protein-coupled receptor 137"	Q96N19	11	64270062-64289500	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.8"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 157.3;Late spermatids: 445.6;Spermatocytes: 157.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062871	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments"		NA	NA			"Nucleoplasm, Nucleoli"	"Actin filaments"	"HPA062871: AB_2684889"	"unprognostic (2.25e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.61e-3)"	"prognostic favorable (6.18e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.41e-1)"	10.3	12.2	18.6	12.8	21.8	10.4	12.0	20.0	23.1	8.9	10.5	13.2	13.8	11.2	9.0	10.4	10.5	13.3	10.3	9.7	18.5	14.3	14.0	14.1	9.3	10.8	15.4	9.1	7.3	9.4	16.4	10.1	28.9	16.5	10.5	5.8	12.4	13.9	12.8	9.9	15.9	11.4	7.1	12.7	11.3	13.6	64.8	14.4	9.9	14.3	5.5	9.3	9.5	16.2	3.9	3.4	15.7	3.0	1.9	3.4	1.4	9.0	20.3	7.0	20.2	13.7	7.3	29.7	10.8	9.1	10.8	7.0	14.9	12.8	9.3	18.8	6.8	19.4	18.2	9.8	6.0	3.1	29.5	12.3	8.9	20.8	9.5	7.8	5.8	17.3	9.1	9.5	9.4	7.2	7.4	5.8	11.2	7.9	22.8	6.4	23.0	6.5	15.8	9.5	7.4	20.2	13.2	7.5	15.1	7.5	12.4	11.2	13.6	13.1	18.0	11.7	7.4	19.7	2.5	9.3	30.0	20.8	22.6	7.8	18.3	33.5	7.8	21.4	5.0	18.2	1.7	3.0	5.3	2.7	2.8	3.4	2.8	2.3	2.0	3.1	3.9	2.6	2.2	15.7	1.9	2.3	3.4	1.6	1.4	18.6	21.8	20.0	23.1	18.5	14.3	15.4	9.1	16.5	14.4	3.0	9.1	11.8	16.0	12.8	13.4	4.4	10.2	9.4	4.5	12.2	11.8	40.6	13.3	33.8	157.3	14.0	21.2	0.0	23.3	58.9	21.7	17.8	2.3	8.9	21.4	19.1	15.5	9.8	9.1	445.6	17.8	11.8	13.5	20.8	13.8	33.6	24.9	14.0	15.2	15.2	6.0	25.8	12.5	157.6	37.2	13.2	100.0	12.8	13.4	18.0
GPR137C	"DKFZp762F0713, TM7SF1L2"	ENSG00000180998	"G protein-coupled receptor 137C"	Q8N3F9	14	52553148-52637713	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.1;epididymis: 16.6"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 19.6;Rod photoreceptor cells: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003640, HPA030763"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA003640: AB_2667025, HPA030763: AB_10602352"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.84e-2)"	"unprognostic (8.50e-3)"	"unprognostic (7.34e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.32e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.42e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.88e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.60e-1)"	1.4	2.2	7.1	1.0	11.0	3.3	1.9	31.1	20.2	1.4	1.2	7.5	0.2	2.0	2.5	16.6	1.7	1.2	2.8	2.4	5.9	10.6	1.2	1.3	1.7	2.1	6.3	7.5	1.6	0.7	2.3	1.8	1.8	13.3	1.6	1.5	3.2	1.7	1.5	1.3	1.8	1.2	1.5	7.0	2.5	1.4	6.5	8.3	0.0	2.1	0.0	1.2	2.1	0.7	0.7	0.5	2.4	0.5	3.9	4.1	0.8	0.8	0.3	8.2	7.5	2.4	0.7	3.3	3.4	2.3	3.6	8.6	1.5	1.6	0.8	2.5	2.8	7.6	1.9	2.7	0.5	5.3	1.2	1.9	0.9	2.3	0.9	0.3	0.5	1.9	0.4	0.0	3.3	0.2	0.8	1.8	1.8	1.2	3.6	5.1	4.0	0.3	1.1	2.0	1.5	4.8	1.8	5.1	0.3	1.1	5.7	8.3	10.5	1.7	0.5	0.2	3.6	5.1	0.0	0.3	8.2	8.7	5.9	2.8	0.8	2.0	1.8	2.0	0.4	2.4	1.2	0.5	0.5	3.1	0.1	4.1	0.3	2.0	3.9	0.2	0.7	1.5	1.8	2.4	3.9	0.4	0.5	1.4	0.8	7.1	11.0	31.1	14.1	5.9	10.6	6.3	7.5	13.3	8.3	0.0	2.2	0.0	0.7	0.6	19.6	2.2	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	1.3	3.0	0.0	0.0	0.2	0.2	1.5	2.4	0.0	0.4	0.4	6.4	1.2	3.7	1.0	1.5	0.6	0.6	1.7	0.0	0.5	5.1	0.0	0.0	0.7	0.1	19.2	0.0	2.1	4.1	2.8	0.6	0.1	0.0	0.0	0.3
GPR155	"DEP.7, DEPDC3, FLJ31819, PGR22"	ENSG00000163328	"G protein-coupled receptor 155"	Q7Z3F1	2	174431571-174487094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5;stomach 1: 43.2"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 117.8;Melanocytes: 145.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 16.3;WM-115: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036159, HPA057384"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA036159: AB_10671835, HPA057384: AB_2683424"	"unprognostic (3.91e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.11e-4)"	"unprognostic (5.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.54e-2)"	4.5	10.1	9.3	6.6	34.5	2.6	3.0	15.1	17.3	3.2	11.4	6.1	2.2	4.0	2.6	13.1	6.7	2.5	5.9	6.8	15.5	9.4	19.8	7.3	3.3	5.9	7.7	11.5	3.0	16.9	8.0	3.2	4.7	27.4	8.0	4.2	4.9	3.7	8.8	5.1	13.4	5.1	7.8	6.9	5.3	43.2	2.6	9.9	1.6	8.3	0.8	3.8	6.6	3.6	1.5	0.8	9.6	6.8	4.7	7.0	1.9	0.7	0.4	1.0	2.5	5.7	3.2	0.6	4.3	1.5	0.7	2.4	0.3	0.4	2.4	1.4	3.0	1.5	0.4	1.4	1.3	2.4	0.9	1.7	2.6	1.4	0.2	1.1	0.9	1.4	4.6	3.6	2.1	0.7	4.6	1.1	3.4	0.4	6.2	4.8	0.7	1.7	1.2	0.6	2.6	1.7	2.1	6.2	1.2	2.4	1.6	6.7	5.7	1.3	1.0	2.2	3.1	0.4	0.4	3.1	3.1	1.2	4.5	0.6	16.3	2.3	0.4	3.6	0.8	10.8	1.5	2.9	0.1	2.4	5.4	2.2	1.3	4.4	4.0	0.8	1.5	3.5	5.4	9.6	4.7	6.8	0.5	7.0	1.9	9.3	34.5	15.1	16.2	15.5	9.4	7.7	11.5	27.4	9.9	11.9	2.2	11.7	2.9	37.9	30.8	21.8	2.5	0.0	10.3	10.4	117.8	1.2	1.7	2.0	0.3	9.0	0.3	0.0	5.0	1.0	7.7	3.4	1.1	16.1	5.9	47.7	12.2	20.9	36.6	0.9	13.8	21.7	145.1	1.8	0.2	15.6	5.6	0.0	30.1	34.6	22.9	0.0	10.8	3.3	2.6	25.0	0.7	17.9	1.1	1.5
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.1;smooth muscle: 21.0"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 149.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	2.4	0.9	2.1	3.6	1.7	0.0	1.9	1.2	4.0	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3.0	1.2	7.6	11.0	4.9	1.3	1.3	3.0	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21.0	3.0	1.2	2.2	3.0	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.5	9.9	3.7	6.6	0.0	5.9	6.5	5.1	5.4	24.0	1.0	0.0	3.3	8.9	9.6	18.4	3.7	5.8	3.0	2.3	4.8	2.2	3.0	0.1	1.6	0.6	1.5	2.3	3.8	4.4	7.1	11.9	10.2	1.9	2.0	0.1	7.7	0.5	0.7	0.1	6.3	10.3	6.0	1.8	6.7	0.0	2.7	1.7	3.1	13.7	6.5	0.2	17.8	6.1	3.4	0.7	13.7	10.5	5.5	14.1	6.7	0.0	0.0	0.0	2.8	0.0	2.7	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0.0	0.2	2.1	1.7	1.2	4.0	2.8	1.5	3.0	1.2	3.0	0.8	3.0	0.6	0.0	5.0	1.9	1.7	2.0	0.0	1.4	1.2	0.0	0.0	0.4	0.0	3.6	0.4	6.3	0.0	0.0	7.2	0.2	6.3	4.6	0.0	0.0	0.7	149.4	0.0	4.3	1.8	0.6	6.9	1.3	1.7	1.8	1.7	2.7	2.9	0.0	15.9	0.0	1.5	19.4	12.2	0.0	0.7	1.3	0.3	0.0	2.3	2.3
GPR162	"A-2, GRCA"	ENSG00000250510	"G protein-coupled receptor 162"	Q16538	12	6821545-6829972	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.6"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 75.9;Ciliated cells: 49.5;Horizontal cells: 38.1;Muller glia cells: 46.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.3;intermediate monocyte: 3.7;neutrophil: 14.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.7;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"AF22: 13.0;AN3-CA: 15.4;hTERT-RPE1: 13.4;NTERA-2: 14.5;SH-SY5Y: 9.9;U-2 OS: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055135	Enhanced		Approved	"Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Centriolar satellite"		"HPA055135: AB_2682710"	"unprognostic (4.76e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.29e-5)"	"unprognostic (3.82e-3)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (3.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.64e-2)"	2.7	6.7	19.6	4.2	13.2	1.5	2.4	41.3	47.6	2.1	3.4	4.7	0.8	3.1	3.8	2.8	1.9	16.9	5.7	4.2	25.9	18.4	1.4	3.7	6.0	1.7	9.9	17.7	2.0	1.7	5.3	8.4	4.3	10.2	2.1	3.0	3.6	1.3	2.1	1.6	1.7	4.2	5.7	5.3	2.8	2.0	1.2	3.6	0.1	1.1	0.0	1.1	2.4	0.5	0.0	1.8	14.7	6.3	0.0	0.0	1.7	0.0	2.9	13.0	15.4	1.4	1.0	0.0	1.0	3.4	2.9	1.7	0.2	0.0	0.0	0.1	1.8	0.1	0.0	2.0	0.0	1.4	0.0	0.9	1.5	0.1	0.0	2.2	0.3	0.0	2.4	0.0	4.4	0.2	13.4	7.9	1.1	0.7	0.1	1.0	0.0	0.4	1.1	14.5	0.0	0.1	0.0	1.6	2.6	1.0	0.0	1.1	9.9	0.0	0.0	0.4	9.3	0.1	3.8	5.2	2.0	12.3	1.0	1.7	0.0	0.9	0.0	2.2	2.7	0.2	0.0	6.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	14.7	0.0	1.3	1.6	0.0	1.7	19.6	13.2	41.3	32.4	25.9	18.4	9.9	17.7	10.2	3.6	0.0	0.0	0.0	0.1	0.7	75.9	1.1	0.0	49.5	1.2	1.8	3.9	0.1	1.7	0.0	0.0	2.4	0.0	0.0	0.0	0.1	2.1	0.5	0.0	0.4	2.2	38.1	0.0	5.5	3.4	0.4	6.9	3.2	0.0	0.0	0.0	46.3	0.1	0.0	13.8	0.3	7.8	0.0	3.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
GPR17		ENSG00000144230	"G protein-coupled receptor 17"	Q13304	2	127645864-127652639	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 43.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	32	"glioma: 16.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	11	"B-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 4.6;REH: 7.7;TIME: 7.6;U-2 OS: 3.2;U-2197: 3.6;U-251 MG: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029766	Enhanced	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA029766: AB_10612114"	"unprognostic (8.10e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.77e-5)"	"unprognostic (8.40e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	7.0	2.2	23.7	6.8	21.3	0.8	5.4	4.1	25.6	2.4	16.4	43.8	0.0	3.3	11.2	3.3	5.0	4.0	4.3	12.5	20.6	1.2	2.3	1.6	9.3	2.4	9.1	9.9	1.4	4.6	0.5	0.4	2.7	18.8	3.9	0.8	0.1	1.7	0.5	13.1	6.7	3.8	0.5	6.3	12.6	5.0	1.8	22.6	0.0	2.8	0.0	0.5	6.1	3.9	4.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.3	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.6	0.9	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.0	0.6	0.3	0.1	0.0	0.2	7.7	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.0	2.3	0.3	0.0	7.6	0.0	3.2	3.6	4.5	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.7	21.3	4.1	25.6	20.6	1.2	9.1	9.9	18.8	22.6	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR173	SREB3	ENSG00000184194	"G protein-coupled receptor 173"	Q9NS66	X	53049091-53080615	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 6.4;Horizontal cells: 6.4;Intestinal endocrine cells: 3.4;Peritubular cells: 4.2"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.7;NK-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HAP1: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003905			Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA003905: AB_1078922"	"unprognostic (2.68e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.95e-3)"	"prognostic unfavorable (2.88e-6)"	"unprognostic (3.87e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.08e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.95e-2)"	2.5	5.2	8.2	3.0	9.4	2.2	3.1	15.4	23.2	4.2	2.8	11.6	0.8	1.8	6.4	5.0	2.4	7.7	3.3	4.2	7.9	10.0	2.4	1.1	2.8	2.1	7.3	11.2	15.0	1.3	1.3	14.6	4.5	9.7	3.2	2.6	6.4	2.0	5.4	4.6	3.9	2.1	4.5	6.5	4.0	2.1	2.4	9.6	0.7	3.1	0.1	1.5	3.3	2.8	0.9	0.7	5.7	0.4	1.8	0.7	0.0	0.0	0.0	8.1	0.5	4.6	2.7	0.0	1.3	2.9	2.1	2.5	0.8	0.1	0.2	2.0	2.8	6.4	0.6	10.2	0.0	1.9	0.6	1.0	0.5	8.3	0.3	6.7	0.5	0.1	6.6	0.0	3.3	4.6	7.5	3.5	0.0	0.0	5.7	3.2	4.2	0.0	0.0	6.3	0.4	3.6	0.1	2.4	0.3	0.5	0.4	5.9	8.3	0.0	0.4	0.0	5.5	1.1	0.1	6.4	3.5	5.1	2.3	1.1	0.2	0.3	0.7	2.5	0.0	1.9	5.7	0.2	0.3	0.7	0.1	0.5	0.3	0.2	0.1	0.1	0.9	0.5	0.4	1.2	1.8	0.4	0.7	0.0	0.0	8.2	9.4	15.4	15.1	7.9	10.0	7.3	11.2	9.7	9.6	0.0	0.0	0.0	0.4	0.2	6.4	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.2	6.4	3.4	1.8	0.3	0.0	2.8	0.0	1.7	0.0	0.1	2.7	0.1	0.0	4.2	0.0	2.8	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1
GPR180	ITR	ENSG00000152749	"G protein-coupled receptor 180"	Q86V85	13	94601903-94634645	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047250	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA047250: AB_2679998"	"unprognostic (3.91e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.16e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.80e-2)"	14.6	6.8	7.6	6.6	11.4	2.7	15.9	14.7	13.1	8.3	6.1	7.6	5.2	5.7	7.1	5.8	5.3	7.3	5.3	7.6	7.9	8.8	7.5	18.7	6.8	6.3	8.8	7.8	7.3	10.6	7.5	18.8	9.9	10.8	7.6	7.4	12.3	7.5	7.2	5.6	5.7	5.1	8.1	12.1	6.0	7.7	3.5	8.8	8.6	10.2	3.9	7.3	6.4	6.9	1.5	2.5	0.3	1.5	1.5	4.3	1.3	13.2	3.4	4.8	5.1	10.3	11.2	2.0	9.1	7.2	8.9	11.9	4.1	9.2	4.4	4.0	7.8	6.2	8.5	6.8	6.4	12.3	11.5	4.3	8.6	4.6	0.0	8.1	12.3	7.0	6.4	5.5	5.4	7.4	8.0	9.0	6.4	2.4	2.2	8.8	2.0	6.1	2.7	3.2	9.5	3.8	7.1	6.5	1.8	10.0	4.0	7.1	5.1	4.2	9.4	11.1	6.4	6.6	5.1	8.1	5.5	4.4	6.5	7.5	3.6	3.7	2.1	9.1	10.1	7.4	0.3	1.5	0.3	2.4	1.0	4.3	1.5	2.9	1.7	2.5	1.5	3.5	2.9	0.0	1.5	1.1	1.8	3.4	1.3	7.6	11.4	14.7	13.1	7.9	8.8	8.8	7.8	10.8	8.8	3.0	2.6	9.3	5.8	5.4	12.8	4.1	5.1	10.7	2.3	12.2	29.5	8.1	5.0	7.7	0.6	6.7	3.1	0.0	8.9	23.3	9.7	9.6	4.7	27.1	9.6	17.5	9.9	8.6	4.4	0.0	8.9	4.6	6.8	3.6	8.7	14.0	10.3	3.5	5.3	6.3	22.2	6.5	8.2	1.2	10.8	4.1	3.4	5.7	5.2	4.2
GPR183	EBI2	ENSG00000169508	"G protein-coupled receptor 183"	P32249	13	99294530-99307405	"G-protein coupled receptors, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.7"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 189.0;Macrophages: 550.4;monocytes: 424.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"HDLM-2: 53.8;HL-60: 36.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028847, CAB033690, HPA075590"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"CAB033690: AB_2114269, HPA028847: AB_10603672, HPA075590: "	"unprognostic (3.28e-3)"	"prognostic favorable (9.77e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.31e-3)"	"unprognostic (9.86e-3)"	27.0	5.5	3.1	33.8	5.0	40.8	7.6	1.1	2.9	5.9	11.2	7.5	4.5	3.2	3.8	9.2	9.3	6.4	17.3	11.7	4.8	6.1	5.4	7.2	26.5	53.7	7.5	2.6	4.4	2.1	2.1	4.8	11.1	9.3	7.4	9.2	4.8	6.6	2.0	4.1	5.3	19.2	9.0	31.3	46.5	6.0	3.7	7.4	13.2	6.5	8.3	38.9	34.9	5.2	46.8	30.6	101.7	1.2	55.0	60.2	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	53.8	0.0	0.4	0.1	0.0	0.0	36.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	101.7	1.2	46.1	5.7	0.4	34.0	46.8	60.2	30.9	9.3	19.1	38.1	5.2	1.2	55.0	0.4	30.6	47.3	27.8	3.1	5.0	1.1	2.9	4.8	6.1	7.5	2.6	9.3	7.4	14.9	41.9	189.0	0.4	54.7	0.2	1.8	0.0	6.7	10.3	0.0	5.9	0.9	1.7	0.1	0.6	2.3	0.0	0.0	2.5	1.3	21.6	0.4	60.0	0.5	114.3	0.0	0.0	0.6	92.9	1.3	0.3	550.4	138.3	424.8	0.0	0.1	0.7	0.0	0.0	0.3	0.8	6.5	3.6	0.5	0.2	46.7	1.5	126.8	0.0	0.3
GPR20		ENSG00000204882	"G protein-coupled receptor 20"	Q99678	8	141356500-141367267	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 3.7;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 5.4"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 7.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.3"	HPA071337			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA071337: "	"unprognostic (4.47e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.23e-2)"	"unprognostic (4.07e-1)"	2.8	0.5	0.7	2.7	1.4	0.1	2.5	0.2	2.0	10.6	9.1	1.0	4.3	2.2	6.7	1.9	3.4	3.9	6.1	2.1	0.8	0.4	1.1	0.4	3.5	0.3	1.4	0.9	3.7	0.5	0.5	0.5	3.2	2.1	2.2	1.0	1.1	0.5	3.0	2.1	1.0	10.5	4.5	0.5	0.8	4.3	1.6	0.7	0.0	1.4	1.5	0.5	1.7	3.4	0.0	0.3	0.3	5.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	7.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.1	0.7	1.4	0.2	2.0	0.8	0.4	1.4	0.9	2.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	71.1	16.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71754050-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;parathyroid gland: 29.6"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 11.0;Collecting duct cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.7;neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.0;HL-60: 12.5;MCF7: 10.8;NTERA-2: 21.5;RPTEC TERT1: 10.4;SH-SY5Y: 8.2;T-47d: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favorable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.7	4.5	14.9	1.7	23.2	14.5	4.3	4.4	15.4	3.4	1.0	5.8	1.7	0.6	5.5	3.3	2.7	7.7	1.2	3.5	12.8	12.4	3.2	0.9	2.4	5.5	10.6	8.8	5.0	2.6	29.6	5.1	2.0	5.9	5.7	0.7	3.3	1.7	5.1	1.8	1.9	0.7	3.3	16.8	3.7	2.4	4.2	3.6	0.0	6.8	1.2	0.5	2.1	2.8	0.0	0.2	10.5	0.8	0.0	0.4	0.1	0.0	0.8	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	13.0	0.0	0.6	0.0	3.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	12.5	0.7	0.0	2.2	0.0	0.9	0.0	0.0	2.7	0.0	0.0	0.0	10.8	0.9	0.2	21.5	0.0	0.0	0.0	0.0	0.0	10.4	5.8	2.3	8.2	2.8	0.0	0.0	2.9	7.5	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.8	3.7	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	10.5	0.0	0.1	0.0	0.0	0.1	14.9	23.2	4.4	9.9	12.8	12.4	10.6	8.8	5.9	3.6	0.0	1.4	0.0	4.0	1.6	11.0	2.8	5.1	2.7	2.3	12.2	3.9	1.1	1.7	0.4	0.1	0.0	0.0	0.0	0.0	1.1	0.9	4.5	0.0	0.0	1.0	0.0	1.2	0.0	5.1	0.0	0.9	0.5	0.0	0.0	0.0	0.5	0.4	0.0	1.1	0.0	0.3	0.0	0.4	0.2	0.9	1.5	0.2	0.0	0.0	1.8
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124745997-124765627	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 62.4"	"Cell type enriched"	"Detected in many"	36	"Muller glia cells: 779.4"	"Cancer enhanced"	"Detected in many"		"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		48000	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	1.6	1.0	14.5	1.1	19.6	0.9	1.7	2.3	52.6	1.5	1.4	62.4	0.0	1.0	2.1	1.4	7.8	2.1	1.4	0.9	23.9	11.3	1.2	8.8	1.3	1.1	33.5	12.3	1.0	3.0	0.8	0.3	10.0	23.3	1.8	1.5	3.5	1.6	1.8	1.1	4.1	1.3	3.0	49.4	4.3	1.2	15.5	26.5	0.0	0.9	0.0	0.9	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	9.4	0.0	0.0	0.0	2.7	0.5	2.5	2.4	0.6	0.4	0.8	0.0	0.0	22.0	0.3	0.2	2.8	0.0	0.5	0.4	1.2	0.1	5.9	0.0	2.8	0.0	0.4	0.0	9.8	0.0	0.1	0.0	4.5	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.4	0.0	4.5	0.0	0.0	0.0	0.0	0.1	2.2	3.3	0.0	8.5	3.2	10.6	2.2	0.0	15.3	2.0	0.7	0.0	0.0	1.3	0.0	0.0	1.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	19.6	2.3	19.6	23.9	11.3	33.5	12.3	23.3	26.5	0.0	0.0	0.0	0.3	4.0	21.7	0.4	2.5	0.0	0.0	1.8	5.9	7.1	0.0	4.3	0.2	0.5	0.0	0.0	0.5	15.1	2.7	2.1	0.0	21.5	1.0	17.5	0.0	0.0	0.3	0.9	2.6	0.0	3.3	1.0	0.4	779.4	0.4	0.0	0.7	0.0	12.5	0.0	0.9	0.6	0.7	8.9	2.5	0.0	0.0	0.1
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 9.6;SuSa: 8.1"	"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794126-96837463	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	1.8	3.4	3.8	3.1	11.0	0.8	1.6	7.5	10.7	3.3	3.9	1.6	1.0	5.1	1.9	1.5	2.0	2.8	2.7	1.9	3.2	2.2	1.4	0.5	1.4	0.9	2.2	6.4	4.0	5.0	3.9	4.3	2.5	10.1	3.3	6.2	2.5	1.7	2.2	1.0	1.7	3.6	3.6	1.4	1.3	4.1	8.0	5.2	2.5	2.3	0.0	0.9	2.2	4.8	0.8	0.9	2.6	0.6	1.4	1.1	0.1	0.0	0.1	1.5	0.3	2.2	0.8	0.4	0.9	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.1	1.2	1.1	4.9	2.3	0.0	7.8	3.8	4.7	0.4	0.0	12.8	2.9	0.5	2.4	0.4	0.0	3.5	0.3	0.0	7.0	3.4	19.2	0.4	0.4	2.2	0.0	5.0	0.0	0.7	0.0	1.8	3.8	0.3	0.2	2.3	1.4	0.3	3.1	0.5	1.7	1.2	0.6	0.0	1.3	2.0	0.2	1.8	1.5	0.8	0.1	0.8	1.8	1.0	0.8	0.6	0.2	0.6	0.2	0.3	0.7	1.1	0.6	0.1	0.8	1.0	0.9	2.6	1.4	0.2	0.9	0.3	0.1	3.8	11.0	7.5	10.7	3.2	2.2	2.2	6.4	10.1	5.2	0.0	0.0	0.0	0.8	1.6	1.1	0.5	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.4	21.8	0.1	0.0	0.0	0.8	0.6	0.9	1.0	0.0	0.0	0.2	0.0	2.9	1.8	0.0	26.5	3.1	0.0	1.7	0.0	0.4	0.3	0.5	0.0	4.6	0.0	0.2	0.0	1.1	22.8	9.3	0.3	0.1	0.0	0.5	0.3
GPR65	"hTDAG8, TDAG8"	ENSG00000140030	"G protein-coupled receptor 65"	Q8IYL9	14	88005124-88014811	"G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.4;lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in many"	19	"granulocytes: 306.4;Kupffer cells: 79.3;monocytes: 79.4;T-cells: 135.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 6.3;HEL: 6.8;HL-60: 8.1;HMC-1: 10.4;RH-30: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA072624, HPA077397"	Enhanced		Approved	Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoli, Cytosol"	"HPA072624: , HPA077397: "	"unprognostic (8.56e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.80e-1)"	9.8	3.1	1.8	12.1	6.4	15.2	2.3	0.7	3.0	1.9	2.4	0.9	0.9	2.3	2.2	2.2	2.3	2.2	4.1	2.3	6.0	2.1	4.0	6.9	10.6	13.1	8.2	0.0	1.7	1.8	0.8	6.2	3.6	6.3	2.9	2.3	1.2	2.6	0.9	0.9	1.2	7.7	3.3	15.7	40.8	2.5	1.5	6.2	12.5	1.8	2.3	8.9	4.8	2.3	4.3	5.9	19.1	13.7	21.3	30.4	9.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.8	0.0	0.0	0.3	8.1	10.4	0.4	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.2	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	14.6	9.1	19.1	16.5	12.8	30.4	4.3	8.4	12.6	5.9	4.0	4.4	9.7	6.9	21.3	13.7	2.7	4.0	9.4	1.8	6.4	0.7	3.0	6.0	2.1	8.2	0.0	6.3	6.2	3.0	35.3	38.9	0.4	3.8	0.0	0.3	5.1	1.4	2.3	0.0	0.0	0.2	0.0	0.0	5.5	0.1	0.0	0.0	0.0	0.1	1.5	0.2	306.4	1.0	60.2	0.0	0.0	4.3	79.3	1.0	0.6	64.5	3.3	79.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.3	0.0	0.1	4.5	0.3	135.4	0.0	0.1
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No			"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.2	0.0	0.0	11.5	0.0	0.0	0.0	0.1	25.2	0.0	33.5	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	44.8	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	1.1	13.2	0.0	0.0	5.6	0.1	0.0	0.9	0.1	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	127.1	52.7	0.0	0.0	0.0	4.0	20.5	3.5	0.0	46.3	0.0	1.3	0.1	0.2	0.0	0.0	0.6	10.3	2.1	36.4	1.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	59.6	171.4	0.0	0.0	178.7
GPR89A	UNQ192	ENSG00000117262	"G protein-coupled receptor 89A"	B7ZAQ6	1	145607990-145670648	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 40.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.14e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.02e-5)"	"unprognostic (1.42e-1)"	"unprognostic (3.70e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.21e-1)"	4.0	9.3	4.3	3.8	5.4	2.2	9.2	4.6	6.9	6.2	4.7	7.0	7.5	5.4	9.0	4.5	4.1	4.7	5.9	5.9	5.2	5.1	17.5	15.3	4.8	9.6	4.9	4.0	4.2	13.6	5.9	4.2	3.5	3.9	5.5	7.5	4.9	9.0	9.9	7.6	3.3	7.0	6.1	4.7	2.9	8.7	6.7	4.0	3.3	6.6	6.5	7.0	5.2	8.8	6.2	5.5	6.3	5.1	7.6	8.3	2.8	10.4	6.9	8.4	3.7	19.6	17.7	8.2	9.8	10.8	13.9	17.7	14.5	9.0	3.1	5.4	13.4	5.7	9.1	9.0	9.9	12.8	7.6	6.2	3.9	7.8	7.9	11.1	12.1	3.1	18.7	13.8	11.7	13.1	7.0	8.5	7.4	11.2	14.9	22.2	13.4	5.0	6.3	11.0	12.4	11.1	5.5	10.0	18.4	9.4	6.0	2.6	7.8	9.1	20.6	7.4	13.7	15.4	9.4	5.0	13.2	3.4	7.9	10.5	6.0	12.8	8.7	9.5	7.5	9.9	6.3	4.2	4.0	7.1	4.7	8.3	6.2	5.2	7.2	5.5	3.0	5.2	6.1	0.3	7.6	5.1	5.4	6.1	2.8	4.3	5.4	4.6	6.9	5.2	5.1	4.9	4.0	3.9	4.0	20.8	5.1	11.8	7.8	6.8	6.5	11.1	12.7	5.3	6.8	14.0	11.8	17.5	0.0	12.8	5.5	4.7	9.2	0.0	17.6	17.8	8.8	7.2	5.7	9.0	8.2	3.2	13.1	7.4	4.0	6.8	8.9	4.5	10.1	8.2	9.4	6.9	13.3	6.6	6.7	10.2	6.2	12.9	7.6	40.7	17.9	7.4	13.5	14.1	8.9	4.7
GPR89B	"GPR89, GPR89C, SH120"	ENSG00000188092	"G protein-coupled receptor 89B"	P0CG08	1	147928393-147993521	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.15e-4)"	4.0	5.1	4.0	4.0	4.0	2.0	5.4	5.1	5.4	6.0	4.1	4.0	4.0	6.0	4.9	4.0	4.0	3.6	4.0	4.0	4.0	4.8	20.3	9.4	4.0	4.0	4.0	4.0	4.7	5.1	4.4	4.0	4.0	4.0	4.8	3.9	4.0	4.7	4.3	5.2	5.4	7.9	4.0	5.3	4.0	4.8	7.6	4.0	4.0	4.0	4.0	4.0	4.0	4.0	8.2	9.5	9.3	8.1	10.8	12.6	7.1	7.1	1.0	7.1	7.4	8.3	9.0	10.7	8.8	7.9	10.5	11.2	10.2	11.2	13.8	8.4	7.3	8.2	10.2	10.2	7.2	8.5	12.7	11.0	8.4	7.4	4.6	14.6	10.0	5.4	8.5	10.4	6.7	13.9	3.4	9.5	9.8	6.6	11.8	6.6	16.3	11.5	5.9	13.6	17.8	10.8	10.6	11.8	21.1	13.7	6.8	4.7	5.8	19.2	6.1	8.7	13.3	11.8	10.8	3.0	7.6	3.5	11.5	10.7	19.2	16.0	8.5	9.8	7.6	5.4	6.7	7.7	9.3	11.3	6.1	12.6	7.6	12.4	12.0	9.5	8.2	11.3	10.7	4.3	10.8	8.1	7.9	9.7	7.1	4.0	4.0	5.1	4.1	4.0	4.8	4.0	4.0	4.0	4.0	6.0	4.0	6.9	5.2	0.1	3.2	5.7	0.0	6.7	6.8	5.2	2.0	12.1	0.0	6.1	3.4	3.8	7.7	0.0	6.2	11.1	5.1	3.6	6.9	6.6	3.7	0.0	4.6	3.1	1.0	3.6	5.2	2.9	0.0	3.6	6.8	2.9	5.5	7.8	3.2	20.0	3.6	0.0	5.1	23.7	9.1	0.0	13.2	11.8	5.1	3.1
GPRASP2	"FLJ37327, GASP2"	ENSG00000158301	"G protein-coupled receptor associated sorting protein 2"	Q96D09	X	102712176-102717733	"Predicted intracellular proteins"			"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017438	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA017438: AB_1849504"	"unprognostic (8.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.14e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.71e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (4.60e-6)"	"unprognostic (1.19e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (6.63e-5)"	3.7	12.2	13.8	1.5	22.6	0.2	6.1	16.9	30.0	7.7	3.7	3.4	1.7	1.3	13.8	7.4	3.3	8.8	4.0	10.9	15.8	22.3	8.1	5.2	3.9	1.2	8.7	22.5	24.8	7.1	13.3	11.5	2.8	18.7	10.2	2.5	3.6	6.6	9.8	5.2	4.4	1.8	8.3	7.2	3.0	2.2	3.6	4.1	0.8	12.0	1.3	1.3	3.6	3.8	0.4	1.6	0.0	0.6	2.1	4.7	1.2	0.5	5.1	13.7	10.5	4.3	5.2	1.0	7.8	7.0	6.7	13.1	1.7	2.4	0.0	2.7	8.0	3.4	1.8	16.3	4.2	8.5	0.0	6.3	0.7	1.5	0.4	3.1	1.2	1.0	5.4	4.5	7.5	0.3	7.9	4.7	1.3	1.9	0.5	8.1	2.4	3.6	0.5	6.8	1.6	7.1	4.7	2.2	0.0	4.2	1.9	3.0	9.4	7.8	1.6	1.0	4.4	4.4	2.7	4.2	4.8	10.0	9.6	7.4	0.2	0.3	0.0	6.4	0.8	2.6	0.0	0.4	0.0	0.9	0.6	0.8	0.4	1.1	1.3	0.8	0.4	4.7	1.9	0.0	2.1	0.2	1.6	1.6	1.2	13.8	22.6	16.9	30.0	15.8	22.3	8.7	22.5	18.7	4.1	0.0	1.0	0.0	5.3	2.1	16.1	14.9	10.2	0.0	4.5	5.2	2.0	5.0	8.3	1.3	0.4	4.3	0.2	0.0	0.8	0.6	4.9	3.2	0.0	7.3	0.8	15.9	2.9	8.0	1.6	0.8	11.2	0.3	0.0	0.0	1.3	10.0	1.5	1.9	11.7	7.7	6.4	6.5	4.1	4.4	4.3	2.6	1.8	0.0	1.1	0.5
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 108.0"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 172.9;Late spermatids: 145.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive CD4 T-cell: 6.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.2;HHSteC: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"	12.6	4.4	45.2	3.2	55.9	1.0	7.3	22.8	108.0	5.4	2.9	95.1	4.9	4.0	7.1	9.3	5.5	12.7	9.2	22.3	47.8	28.7	12.1	2.7	3.9	4.6	63.1	34.9	13.7	12.7	9.5	3.8	9.3	38.6	6.3	2.3	3.8	20.8	11.5	35.1	2.5	3.3	5.1	61.6	2.2	22.7	19.6	63.1	0.0	7.2	2.6	2.7	6.2	3.0	0.0	0.0	0.0	1.5	0.0	6.5	1.3	0.4	12.6	12.5	2.2	12.9	0.9	2.3	0.1	3.1	1.2	0.8	11.5	0.4	0.0	39.2	0.4	8.2	0.6	9.2	0.0	0.7	0.0	3.3	0.0	0.0	0.0	26.8	0.0	0.0	1.1	0.0	2.1	0.0	3.3	6.1	0.3	2.6	0.2	2.8	0.6	0.0	0.0	13.7	0.0	6.0	3.6	0.0	0.0	0.4	5.8	9.7	0.8	1.4	0.8	11.3	4.1	0.0	0.2	1.2	0.0	1.5	6.1	0.3	0.1	0.0	0.0	0.6	0.1	0.7	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.3	0.0	0.0	1.3	45.2	55.9	22.8	40.5	47.8	28.7	63.1	34.9	38.6	63.1	0.0	4.0	0.9	4.6	1.1	30.1	13.4	35.7	5.3	7.9	29.6	0.0	3.9	1.7	47.7	172.9	30.1	0.0	0.0	56.2	1.2	9.7	4.3	0.0	0.0	3.3	0.0	0.0	6.2	1.0	145.0	22.2	1.1	15.1	1.8	0.0	20.5	53.7	0.0	25.1	0.1	5.7	12.9	9.2	2.8	1.5	1.5	2.1	0.0	0.0	1.7
GPRIN1	"GRIN1, KIAA1893"	ENSG00000169258	"G protein regulated inducer of neurite outgrowth 1"	Q7Z2K8	5	176595802-176610133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 28.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.2;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.7;SCLC-21H: 30.7"					"Low region specificity"	"Detected in all"			"HPA036478, HPA070892"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA036478: AB_2675145, HPA070892: AB_2686321"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.06e-1)"	"unprognostic (4.76e-6)"	"prognostic unfavorable (6.83e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.24e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.32e-3)"	1.3	3.2	16.9	1.8	6.4	0.9	0.9	16.9	28.2	1.1	1.6	0.2	0.0	6.4	1.3	0.6	1.1	0.7	1.1	0.7	11.1	11.1	0.7	0.7	1.1	1.7	3.6	11.4	0.5	1.5	0.7	5.8	1.0	4.4	0.7	1.3	0.7	0.7	0.6	0.7	1.5	4.0	1.7	1.9	0.9	1.9	2.2	0.7	0.0	0.8	0.0	2.3	0.9	0.1	0.9	0.0	0.0	0.0	0.5	0.3	0.0	3.6	3.9	5.0	7.2	1.1	2.4	4.2	4.9	2.5	3.8	5.0	4.7	2.4	8.4	10.1	2.6	11.3	3.2	3.2	3.4	3.4	27.7	2.1	0.1	2.1	1.6	0.4	0.2	2.1	1.2	2.6	4.1	0.6	0.8	2.8	1.9	4.4	12.2	3.2	9.6	0.8	0.0	5.0	2.5	7.8	15.6	5.6	4.9	4.3	3.8	30.7	17.6	5.7	1.6	8.7	0.6	3.8	3.2	3.4	7.2	8.3	2.7	7.2	0.2	1.1	2.4	6.2	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.9	6.4	16.9	14.3	11.1	11.1	3.6	11.4	4.4	0.7	0.0	0.0	0.0	0.0	2.2	13.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.7	0.0	0.0	1.5	0.7	0.4	0.2	0.0	0.0	0.7	20.6	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	3.1	0.0	0.0	0.5	2.3	1.3	0.1	0.0	0.2	0.0
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8.9;lung: 10.5;skin 1: 13.8"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 17.9;Exocrine glandular cells: 18.0;Mucus-secreting cells: 22.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.8;A549: 28.4;SiHa: 5.3;SK-BR-3: 15.7"	"Low region specificity"	"Detected in many"							"HPA038129, HPA070760"	Approved		Approved	"Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Plasma membrane, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA038129: AB_2675846, HPA070760: "	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.0	0.0	0.0	0.6	0.2	0.0	1.1	6.5	0.0	0.2	5.7			6.6	0.0	0.0	2.8	0.1	0.0	0.0	0.0	5.2	1.7	0.0	10.5	0.0	1.2		0.0	4.1	0.0	3.0	0.0		1.6	4.0		4.2	1.5	0.0	13.8	8.9	0.0	0.2	0.0	5.1	1.3			2.3		0.3	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.3	0.0	1.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	0.0	0.0	0.0	0.0	1.5	0.4	0.7	0.1	5.3	15.7	0.0	1.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											17.9	3.0	0.0	2.4	1.4	0.4	0.1	5.1	2.7	1.2	3.5	0.0	0.0	0.0	11.6	7.9	0.0	12.8	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.3	0.0	0.0	12.9	0.3	0.0	0.0	0.0	22.0	0.0	9.1	10.5	0.4	2.4	0.0	0.0	0.0	0.5	0.4	5.4	0.0	0.0	6.3	1.1
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236386-89308010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 75.7;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 53.1"	"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoli	Nucleoplasm	"HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902"	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	7.0	1.8	4.0	11.5	9.1	8.9	3.2	41.0	5.0	3.5	7.2	2.8	0.0	8.4	2.3	1.7	1.8	2.1	5.6	5.4	3.6	4.1	5.5	2.8	11.2	12.7	4.1	3.1	4.8	7.0	1.1	12.4	1.4	6.5	2.1	9.8	6.4	2.9	1.0	2.1	1.6	7.0	2.0	6.0	12.9	4.7	1.1	6.2	5.3	2.9	1.4	10.5	4.5	2.4	0.3	1.5	0.1	2.2	2.9	6.6	1.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	12.1	0.1	0.0	12.6	0.2	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.3	5.7	0.0	0.2	0.0	0.0	0.1	0.5	0.0	4.8	1.7	6.6	0.3	4.7	3.7	1.5	0.1	1.9	1.9	0.1	2.9	2.2	0.0	5.3	1.4	4.0	9.1	41.0	5.0	3.6	4.1	4.1	3.1	6.5	6.2	0.0	19.9	3.7	0.7	1.0	9.4	14.6	5.1	1.4	9.1	3.5	0.0	0.1	1.7	1.1	0.1	3.6	9.6	0.0	8.2	0.0	2.3	0.2	7.0	0.0	18.9	25.4	75.7	2.5	26.9	0.0	0.3	31.5	1.7	5.4	25.1	0.8	1.7	5.8	1.1	1.8	10.3	77.6	8.2	0.1	0.1	0.9	0.2	34.6	21.8	0.3
GPSM1	"AGS3, DKFZP727I051"	ENSG00000160360	"G protein signaling modulator 1"	Q86YR5	9	136327476-136359605	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 32.2;Cone photoreceptor cells: 21.6;Muller glia cells: 33.2;Rod photoreceptor cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042199, HPA060736"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA042199: AB_10959329, HPA060736: "	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.07e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.48e-2)"	7.8	10.2	15.2	5.6	8.3	5.6	4.2	38.6	23.0	10.5	5.3	12.8	4.8	4.7	13.4	10.1	2.6	7.1	8.3	25.5	8.8	11.6	5.5	1.8	13.8	3.2	8.8	14.2	16.4	28.1	4.4	6.6	8.8	10.5	12.7	2.2	20.4	7.7	8.6	2.8	12.0	4.6	9.0	9.1	8.0	6.1	12.0	9.9	2.8	3.9	3.7	2.0	5.0	8.2	0.4	0.7	0.0	2.0	0.0	2.1	0.3	1.7	2.8	6.7	11.7	3.9	6.7	5.6	19.3	8.1	5.5	3.0	5.6	1.8	0.0	8.2	11.7	4.6	1.3	1.0	4.0	1.2	15.2	11.4	2.2	9.1	1.0	16.5	0.1	2.8	10.9	2.7	5.0	2.9	6.8	5.5	2.7	5.8	0.1	3.6	6.3	1.0	2.1	7.1	0.6	10.2	36.1	12.1	5.6	1.5	1.3	16.4	20.4	3.6	0.4	6.0	2.7	8.1	3.8	8.9	10.2	8.1	11.8	3.9	3.5	0.1	0.0	6.1	0.0	9.6	0.0	0.3	0.0	0.7	2.0	0.8	0.0	1.2	0.1	0.7	0.4	0.5	0.3	0.0	0.0	0.0	0.0	2.1	0.3	15.2	8.3	38.6	18.8	8.8	11.6	8.8	14.2	10.5	9.9	3.0	3.5	0.0	2.1	3.8	32.2	9.7	0.0	0.0	0.0	0.0	21.6	0.4	10.0	2.6	0.5	3.6	0.0	0.0	1.6	0.7	8.4	3.9	5.7	0.0	1.0	9.5	1.7	5.5	0.8	1.1	9.8	1.8	8.5	0.0	0.0	33.2	5.9	0.0	8.9	0.0	40.9	0.0	4.7	0.0	1.7	2.9	0.2	0.0	0.0	2.4
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884378-46931297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 103.0;skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 105.1;Muller glia cells: 57.6;Syncytiotrophoblasts: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	19.9	4.1	20.2	2.1	17.8	1.9	6.4	3.9	15.1	2.5	3.4	11.8	10.0	1.3	2.1	13.4	30.8	3.7	4.4	3.0	13.4	8.0	9.8	40.4	1.4	2.1	12.9	7.8	1.5	103.0	4.3	4.3	1.8	11.3	10.2	2.6	1.5	27.6	8.5	60.9	14.9	1.7	1.9	11.3	1.4	15.4	6.0	12.3	0.7	3.6	19.0	14.6	1.9	2.1	4.2	1.4	1.3	0.7	0.0	0.4	0.4	13.0	6.0	7.6	29.0	10.8	2.3	13.9	9.1	3.4	9.9	6.2	20.4	5.5	9.2	8.0	6.5	5.0	10.5	13.7	13.5	6.6	4.3	6.7	3.2	3.4	49.2	7.4	23.1	3.0	5.0	11.9	9.6	15.0	6.6	4.8	17.7	2.6	7.4	3.2	23.4	4.5	19.3	8.1	16.2	17.2	0.1	8.4	21.4	4.0	6.5	23.8	12.2	4.7	24.4	12.4	3.2	6.2	21.1	3.5	6.9	13.5	4.5	7.3	35.6	10.8	26.1	10.6	15.0	3.7	1.3	0.7	0.0	0.3	0.0	0.0	4.2	0.0	0.3	1.4	2.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	20.2	17.8	3.9	15.1	13.4	8.0	12.9	7.8	11.3	12.3	6.0	4.3	3.0	4.2	14.2	13.4	14.7	12.7	0.0	6.8	17.4	21.6	7.1	10.0	7.8	9.4	1.6	5.5	0.0	26.2	22.2	7.7	12.4	3.5	105.1	3.3	6.4	12.6	4.3	3.5	17.1	4.4	2.4	8.5	1.0	7.4	57.6	23.6	4.9	14.5	29.4	5.9	0.0	1.4	2.2	19.2	14.3	69.7	1.5	3.2	3.8
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 126.9;liver: 195.2"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 484.1;Hepatocytes: 821.3;Mucus-secreting cells: 410.2;Undifferentiated cells: 621.9;Urothelial cells: 833.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"OE19: 309.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Not detected"	"Not detected"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	0.1	0.0	0.1	23.8	0.2	0.0	0.8	0.2	0.1	5.5	50.4	0.5	2.0	14.4	0.3	1.0	53.0	0.6	126.9	0.2	0.1	0.2	29.4	195.2	2.0	0.1	0.1	0.1	0.9	7.0	0.0	0.2	0.1	0.2	16.8	71.6	0.1	59.7	4.1	0.3	3.9	35.4	5.6	0.2	0.1	57.8	0.4	0.1	0.5	0.2	44.0	7.4	56.3	15.0	0.2	0.0	0.5	0.8	2.4	0.1	0.0	0.0	71.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.4	0.0	0.1	19.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	66.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	309.4	0.0	0.0	0.0	0.0	0.0	47.5	21.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	11.8	173.3	8.9	0.1	0.4	484.1	2.7	2.3	22.7	0.0	0.1	10.0	152.1	13.5	0.5	203.5	0.0	233.6	0.1	0.4	34.2	13.8	821.3	0.0	0.0	110.6	14.1	19.9	38.7	0.9	0.3	0.0	5.4	410.2	0.0	220.5	261.9	0.0	18.9	0.6	0.0	1.0	0.5	0.0	8.4	0.0	6.9	621.9	833.9
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 13901.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		220000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	163.0	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119.0	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47.0	56.7	64.0	85.2	85.2	28.4	58.5	110.5	28.7	32.7	47.3	100.0	143.5	85.1	52.7	22.8	82.3	43.5	44.4	66.7	39.0	10.4	24.9	46.0	36.8	32.4	27.6	33.0	21.3	58.3	49.9	19.6	29.4	94.1	83.5	23.0	31.5	84.4	50.3	22.0	37.1	78.5	60.8	36.5	27.4	26.3	35.9	73.8	38.9	39.5	44.8	64.1	52.8	53.9	6.4	30.1	47.2	71.5	40.8	25.8	44.7	42.4	46.4	30.3	41.4	56.3	51.4	46.3	30.8	79.3	28.5	92.2	62.5	24.3	43.6	46.2	26.5	75.6	85.2	85.2	37.0	62.0	43.0	56.7	54.3	38.6	64.0	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5	166.7	171.0	287.8	409.7	453.0	334.7	225.6	313.4	467.1	233.2	448.4	92.3	508.2	1349.6	448.1	3338.1	251.8	690.8	163.5	318.5	1086.5	512.4	561.5	339.3	667.2	1047.6	197.0	381.4	302.0	479.7	13901.3	356.4	828.7	642.7	2643.8	270.1	239.3	473.5	361.2	294.2	2040.3	183.4	239.3	381.6	862.4	171.8	408.3	818.0	223.7	258.1	558.8
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160118-55167071	"Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 185.8;Fibroblasts: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 52.6;fHDF/TERT166: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036720	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA036720: AB_2675269"	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (5.13e-9)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	12.6	7.1	0.8	5.8	1.0	0.0	12.2	0.5	0.7	31.4	6.8	1.7	17.3	1.3	23.6	34.5	13.3	13.2	11.2	12.1	1.0	0.9	13.7	2.6	7.3	5.6	1.1	0.9	31.5	5.0	4.5	3.2	40.9	4.0	24.2	4.7	17.8	7.3	16.7	5.0	5.1	4.4	14.1	3.3	7.5	4.9	10.2	0.5	0.7	28.4	11.0	5.4	15.8	19.7	1.0	0.7	2.4	0.5	0.6	0.9	0.2	7.1	5.9	13.0	12.6	34.3	39.0	7.1	36.2	52.6	20.4	40.7	0.6	16.2	0.0	38.6	49.2	17.4	6.1	7.7	10.5	28.0	0.0	3.2	0.3	10.6	1.3	10.8	0.0	0.0	27.6	10.5	12.4	6.5	19.2	23.6	0.0	0.2	0.0	23.1	2.2	0.0	0.0	5.9	0.2	8.4	0.0	7.4	0.0	12.5	0.2	0.0	0.3	12.1	0.9	12.8	15.5	11.6	0.7	21.2	10.9	12.0	16.1	19.4	0.0	0.0	0.0	17.3	0.0	23.6	1.4	0.5	0.3	0.5	0.3	0.5	0.6	0.5	0.5	0.2	1.0	0.9	0.9	2.4	0.6	0.3	0.7	0.2	0.2	0.8	1.0	0.5	0.7	1.0	0.9	1.1	0.9	4.0	0.5	0.0	0.6	0.0	4.8	6.4	0.0	2.6	0.0	14.7	13.6	24.4	0.0	48.1	5.0	12.0	0.4	13.5	0.0	0.0	34.7	185.8	64.1	2.1	4.6	0.0	9.1	0.0	0.0	19.0	0.0	0.2	47.5	1.3	23.6	1.8	3.6	6.6	18.2	0.0	37.4	0.2	0.2	12.9	11.2	0.1	0.1	5.4	11.1	0.7	0.8	1.8
GRAMD1A	"FLJ90346, KIAA1533"	ENSG00000089351	"GRAM domain containing 1A"	Q96CP6	19	34994784-35026471	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 235.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008852, HPA012570"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA008852: AB_1079203, HPA012570: AB_2112577"	"unprognostic (3.09e-2)"	"unprognostic (4.62e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.95e-12)"	"unprognostic (2.04e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.36e-2)"	15.6	19.1	14.6	21.4	14.0	17.1	19.4	13.8	18.1	16.8	13.2	10.4	17.4	13.0	16.9	12.9	7.8	17.2	13.8	17.2	15.9	12.0	13.3	11.0	27.5	42.0	13.7	12.2	21.8	44.1	11.5	14.9	14.1	16.6	15.6	7.5	11.5	45.3	17.2	35.7	6.8	10.9	21.3	12.8	21.1	16.1	11.7	12.1	17.9	12.7	11.5	12.1	17.3	21.4	1.1	4.1	13.1	14.9	3.8	5.5	2.5	5.5	42.9	8.4	16.6	9.8	11.2	7.0	6.7	11.1	9.0	8.9	16.2	4.8	3.1	13.4	10.0	7.9	3.6	8.7	13.2	3.4	13.3	15.2	9.2	10.6	14.9	19.8	6.5	14.7	19.8	8.2	6.4	10.9	14.2	29.2	20.5	10.0	2.2	6.2	5.3	14.8	8.0	13.2	11.0	4.8	14.0	2.6	3.9	9.6	1.0	12.7	25.6	6.8	5.1	11.0	7.7	7.8	7.2	15.9	14.4	7.4	2.9	9.5	2.4	7.9	7.6	9.5	7.2	10.7	13.1	4.5	3.6	2.9	7.3	5.5	0.5	3.9	2.1	4.1	1.1	2.9	4.2	9.8	3.8	14.9	1.4	3.1	2.5	14.6	14.0	13.8	18.1	15.9	12.0	13.7	12.2	16.6	12.1	20.8	34.1	13.4	49.1	18.4	13.5	8.1	0.0	16.0	14.8	15.7	15.7	10.8	3.3	29.5	0.8	46.6	1.8	0.0	49.7	25.1	19.4	49.8	9.2	6.7	44.3	7.9	37.8	51.0	37.3	1.8	23.9	26.0	32.1	235.4	12.5	28.8	44.0	10.5	23.7	11.5	14.9	12.9	32.0	0.0	2.7	13.4	27.7	41.5	18.6	48.2
GRAMD2A	GRAMD2	ENSG00000175318	"GRAM domain containing 2A"	Q8IUY3	15	72159807-72197785	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 24.6;placenta: 49.2"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 65.5;Cytotrophoblasts: 93.9;Syncytiotrophoblasts: 123.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 2.3"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.3"	"Group enriched"	"Detected in some"	12	"BEWO: 59.5;SK-BR-3: 27.1"	"Low region specificity"	"Detected in many"							HPA029435	Uncertain		Approved	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Nucleoli, Nuclear speckles"	Cytosol	"HPA029435: AB_10601811"	"unprognostic (5.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (7.29e-2)"	0.1	0.0	2.0	0.2	4.5	0.0	6.8	1.1	1.0	3.1	0.7	1.2	9.8	0.6	0.4	24.6	1.0	8.2	0.8	0.1	2.9	6.5	1.9	0.1	9.7	0.2	1.1	0.1	1.1	1.0	0.2	0.9	49.2	3.9	1.2	0.5	1.0	1.8	4.0	0.3	1.5	3.6	0.1	1.0	0.1	0.4	0.7	0.9	0.2	7.7	1.3	1.1	0.3	0.6	0.0	2.3	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	59.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	27.1	0.0	2.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.5	1.1	1.0	2.9	6.5	1.1	0.1	3.9	0.9	65.5	13.3	0.0	0.0	0.0	0.0	0.0	0.0	18.7	13.6	3.5	0.0	93.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	1.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	123.0	0.0	0.0	0.0
GRAMD2B	"FLJ21313, GRAMD3, NS3TP2"	ENSG00000155324	"GRAM domain containing 2B"	Q96HH9	5	126360132-126496494	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 89.7;Club cells: 84.2;Collecting duct cells: 38.4;Extravillous trophoblasts: 38.4;Syncytiotrophoblasts: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 39.4;CAPAN-2: 26.5;fHDF/TERT166: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009678, HPA010095"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA009678: AB_2112580, HPA010095: AB_1849952"	"unprognostic (2.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.90e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.12e-2)"	8.3	12.0	30.8	5.2	31.6	1.3	29.5	10.2	25.3	27.5	21.8	38.7	9.7	22.5	24.0	11.9	7.7	26.8	8.7	9.2	38.8	15.9	25.9	18.0	7.8	5.1	21.8	28.3	21.1	6.8	9.0	7.2	44.3	26.4	14.2	23.4	14.9	15.5	20.9	2.8	17.5	26.1	17.6	29.7	4.3	12.9	3.3	31.8	3.6	35.6	3.7	8.6	11.6	11.1	0.8	6.5	0.5	0.7	1.7	5.1	2.1	21.4	1.2	1.0	4.8	21.7	7.5	6.5	22.5	39.4	10.7	14.6	1.0	26.5	0.0	9.7	25.2	0.2	5.5	0.3	9.1	11.4	1.8	1.6	1.0	2.5	1.3	5.1	0.0	0.7	12.6	4.1	9.8	3.3	13.5	0.0	0.0	0.0	0.0	18.5	2.2	0.0	0.3	1.1	4.9	1.5	0.4	6.4	5.0	14.4	23.8	0.4	0.0	4.1	2.3	7.0	5.1	8.1	1.3	1.9	2.1	0.7	3.9	4.2	1.4	1.1	0.0	0.4	0.0	6.4	0.5	0.5	0.0	4.6	0.7	4.8	0.8	2.6	3.9	2.5	0.4	5.1	3.1	0.5	1.7	0.5	6.5	3.8	2.1	30.8	31.6	10.2	25.3	38.8	15.9	21.8	28.3	26.4	31.8	14.9	17.1	0.0	0.0	0.0	0.0	0.0	0.0	89.7	84.2	38.4	0.0	23.4	19.9	13.1	0.0	0.0	0.0	0.0	7.5	38.4	0.0	0.0	3.5	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.8	0.0	0.0	18.5	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0
GRAP		ENSG00000154016	"GRB2-related adaptor protein"	Q13588	17	19020673-19047637	"Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.3;lymphoid tissue: 20.9"	"Cell type enhanced"	"Detected in some"	20	"B-cells: 11.5;Endothelial cells: 11.3;Ito cells: 41.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 28.2;T-cells: 37.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.2;HUVEC TERT2: 13.3;JURKAT: 10.2;REH: 16.9;TIME: 26.1;U-698: 22.6"									"HPA046595, HPA066654"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA046595: AB_10966385, HPA066654: AB_2685699"	"unprognostic (3.02e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.86e-6)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-3)"	2.8	1.4	0.7	5.7	0.9	2.4	2.8	0.1	0.4	1.4	0.6			0.3	1.4	0.0	0.5	1.9	2.1	0.6	0.8	0.6	2.2	2.7	3.5	15.8	1.0		0.6	0.1	0.0	0.7	2.5		1.0	0.4		0.4	1.6	0.3	0.8	7.7	1.1	1.0	20.9	0.5	2.5			2.7		14.2	1.7	0.8	28.2	2.7	5.6	2.5	4.9	37.3	13.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.3	10.2	0.1	0.0	0.0	0.0	6.6	0.5	0.3	0.0	0.0	16.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.2	26.1	0.0	0.0	3.2	0.0	0.0	0.0	22.6	0.0	0.0	0.1	5.6	2.5	0.3	5.9	1.3	5.9	28.2	18.5	7.7	2.7	22.8	37.3	17.9	0.7	4.9	0.1	2.0	15.4	13.0											6.0	2.6	11.5	0.0	0.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.2	1.9	11.3	0.0	0.0	0.0	0.6	0.1	0.0	2.3	0.8	6.4	0.0	0.0	41.7	6.5	0.0	0.0	0.8	0.0	2.8	0.1	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.4	0.9	0.2	6.9	0.0	0.0
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2-related adaptor protein 2"	O75791	22	39901082-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 138.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 142.1;T-cells: 44.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 22.5"	"Cell line enhanced"	"Detected in some"		"HEL: 14.4;JURKAT: 57.1;K-562: 13.9;MOLT-4: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		260000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.6	0.4	0.3	7.7	0.7	7.6	1.5	0.3	0.4	1.1	2.3	0.6	0.4	2.9	2.3	1.6	1.6	1.2	3.5	2.8	0.6	0.4	1.2	1.8	6.4	12.6	0.9	0.4	1.0	0.8	0.0	0.6	1.1	0.6	2.4	1.9	1.2	2.4	1.2	0.5	1.4	6.2	2.0	2.2	13.2	2.9	2.4	0.3	138.0	1.3	1.5	11.3	3.0	1.9	2.1	0.4	2.5	0.2	1.7	22.5	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	14.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	57.1	13.9	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.8	0.2	0.0	19.5	0.1	14.4	1.0	14.4	21.1	0.4	2.1	12.2	22.5	2.5	1.7	0.1	0.3	12.0	25.9	0.3	0.7	0.3	0.4	0.6	0.4	0.9	0.4	0.6	0.3	0.0	10.7	1.3	0.0	1.4	0.7	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.8	0.1	0.0	23.3	0.2	0.0	1.1	0.6	142.1	1.7	0.2	0.0	1.2	1.8	1.8	2.1	0.3	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	4.4	1.5	1.0	0.1	44.5	0.0	0.3
GRAPL		ENSG00000189152	"GRB2 related adaptor protein like"	Q8TC17	17	19127469-19159176	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.0;Ito cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 10.8"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.8"	"Group enriched"	"Detected in some"	6	"Daudi: 22.2;HUVEC TERT2: 9.2;TIME: 24.6;U-698: 20.6"									"HPA051796, HPA066654"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA051796: AB_2681613, HPA066654: AB_2685699"	"unprognostic (2.85e-1)"		"unprognostic (3.37e-1)"		"unprognostic (5.09e-4)"	"unprognostic (4.49e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	4.6	1.6	0.7	9.5	1.7	1.0	1.7	0.4	2.0	1.5	1.3	0.1	2.9	0.7	3.6	1.9	2.5	1.6	2.2	3.4	1.7	0.8	2.8	1.8	4.6	15.6	1.1	1.2	1.1	0.4	0.0	1.0	1.7	1.0	1.4	1.3	1.0	1.4	1.3	2.3	0.7	9.7	1.9	0.9	20.6	0.8	1.1	0.5	7.7	2.7	1.7	17.0	1.7	2.3	10.8	0.1	0.0	0.0	0.0	2.2	0.7	0.0	1.2	1.5	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.3	22.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	3.1	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.7	0.0	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.1	24.6	0.0	0.2	1.1	0.0	0.0	0.0	20.6	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	10.8	1.4	0.3	0.1	4.1	2.2	0.7	0.0	0.0	0.0	0.0	0.9	0.7	0.7	1.7	0.4	2.0	1.7	0.8	1.1	1.2	1.0	0.5	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0
GRASP	Tamalin	ENSG00000161835	"General receptor for phosphoinositides 1 associated scaffold protein"	Q7Z6J2	12	52006940-52015889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 31.7;Ito cells: 73.6;monocytes: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 20.6;TIME: 14.8;WM-115: 27.3"	"Group enriched"	"Detected in many"	6	"amygdala: 31.9;basal ganglia: 22.2;cerebral cortex: 27.5;hippocampal formation: 25.8;olfactory region: 21.0"	"Low region specificity"	"Detected in all"			"HPA040664, HPA062028"	Approved		Approved	"Nuclear bodies,Vesicles"		No	NA			Vesicles	"Nuclear bodies"	"HPA040664: AB_10794066, HPA062028: AB_2684664"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.16e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.99e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.77e-2)"	29.3	5.1	6.4	9.9	16.4	28.6	17.3	2.1	21.0	17.8	7.3	6.3	5.2	3.8	16.2	7.8	6.8	14.5	17.2	10.8	5.2	3.9	8.7	6.9	38.1	6.3	5.3	9.1	12.1	8.4	3.5	4.5	13.0	8.0	8.9	4.0	14.7	4.7	12.8	16.3	7.1	6.8	9.9	4.5	16.9	6.0	2.8	4.5	3.5	11.3	13.5	6.6	9.0	26.3	0.3	0.8	0.0	0.1	0.1	1.2	0.0	0.0	0.0	2.7	0.1	1.2	2.2	0.6	0.1	0.7	0.0	0.7	0.0	0.0	0.0	5.9	0.0	0.2	0.1	0.8	0.0	0.3	0.1	0.7	0.2	0.0	3.7	4.6	0.2	2.1	4.5	0.0	0.2	0.0	0.0	20.6	0.5	0.9	0.0	0.5	0.1	1.9	5.0	2.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.6	0.9	0.0	0.1	3.5	1.7	0.0	0.2	14.8	0.0	1.5	0.1	0.0	0.1	0.0	0.1	0.4	0.0	27.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.3	0.8	0.1	0.2	0.2	0.0	0.1	0.1	0.8	1.2	0.0	6.4	16.4	2.1	20.9	5.2	3.9	5.3	9.1	8.0	4.5	3.0	10.4	11.8	2.3	4.9	0.7	5.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	3.3	0.3	31.7	0.2	0.0	0.2	0.2	10.0	2.9	6.9	0.9	3.4	0.0	10.9	73.6	13.4	0.0	4.9	10.8	6.8	23.4	0.4	0.2	0.6	0.0	1.8	0.0	0.6	0.0	5.7	0.0	1.1	4.8	0.2	3.5	0.5	0.9
GRB14		ENSG00000115290	"Growth factor receptor bound protein 14"	Q14449	2	164492812-164621848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 17.7"	"Cell type enhanced"	"Detected in many"	15	"Distal tubular cells: 77.9;Hepatocytes: 35.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;HUVEC TERT2: 10.8;RPTEC TERT1: 8.9;TIME: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022294, HPA035052, HPA035053"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB022294: , HPA035052: , HPA035053: AB_2674432"	"unprognostic (2.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.47e-2)"	"unprognostic (8.33e-5)"	"unprognostic (5.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (9.27e-2)"	1.6	2.9	1.0	1.2	1.5	0.0	6.0	0.7	3.6	0.8	1.2	0.0	1.1	1.2	0.6	7.5	1.7	0.5	0.3	10.8	5.7	1.1	8.3	17.7	0.7	0.1	0.9	2.0	2.4	6.0	0.0	1.8	2.2	1.4	0.8	0.4	1.2	1.0	0.5	3.2	0.5	0.8	0.6	0.6	0.6	1.1	3.1	0.4	0.0	5.5	3.0	0.1	0.6	1.1	0.0	0.0	0.4	0.1	0.0	0.0	3.0	0.9	5.7	0.4	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	2.4	0.6	0.0	3.5	0.0	1.0	0.4	0.9	1.6	0.4	0.0	4.9	0.0	0.3	1.4	0.1	0.0	0.0	0.4	1.0	2.1	0.0	1.9	10.8	0.0	0.0	0.1	1.7	2.3	0.0	0.0	2.1	0.2	1.4	0.0	0.0	0.1	8.9	0.4	3.4	0.4	0.0	0.3	0.0	1.1	0.6	0.0	13.5	0.2	1.5	0.0	0.1	0.5	0.1	0.0	3.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.0	1.0	1.5	0.7	3.6	5.7	1.1	0.9	2.0	1.4	0.4	0.0	4.8	0.0	0.3	0.1	0.1	16.1	15.3	0.0	0.0	15.7	0.0	0.1	77.9	7.2	1.3	0.8	0.0	0.0	2.9	0.1	0.2	0.5	0.0	35.1	0.0	0.0	0.0	1.8	0.6	2.1	8.6	0.1	18.6	1.0	2.7	0.1	6.3	0.0	16.3	12.2	0.8	12.9	0.0	0.7	2.1	0.0	0.1	0.0	0.2	0.1
GREB1	KIAA0575	ENSG00000196208	"Growth regulation by estrogen in breast cancer 1"	Q4ZG55	2	11482341-11642788	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 74.9"	"Cell type enhanced"	"Detected in many"	18	"Leydig cells: 18.7;Peritubular cells: 51.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 15.1;Hep G2: 14.3;MCF7: 22.4;SH-SY5Y: 15.3;T-47d: 51.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024616, HPA027843, HPA028416"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344"	"unprognostic (1.52e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.80e-2)"	1.2	2.0	3.0	0.6	5.0	0.5	11.1	1.3	5.4	13.7	0.5	2.8	3.0	0.7	21.3	15.6	0.6	11.2	1.8	2.3	3.9	3.0	1.3	1.5	0.6	0.6	3.9	3.5	74.9	2.9	0.6	5.0	9.4	3.8	19.2	0.5	2.8	0.7	2.4	2.1	1.2	0.6	7.3	3.2	0.4	0.8	10.9	3.2	0.0	0.5	0.5	0.5	0.8	5.7	0.8	1.0	2.8	0.6	1.0	1.3	0.4	0.0	0.4	15.1	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.1	0.0	2.6	0.1	1.1	0.0	0.0	1.8	1.3	0.0	0.1	14.3	0.1	0.1	0.8	0.2	0.8	0.2	0.1	0.1	0.0	1.4	0.1	0.3	0.1	22.4	0.4	0.7	4.9	0.0	0.0	10.4	0.0	0.6	0.0	0.0	4.4	15.3	0.3	0.4	11.1	2.1	51.8	0.2	0.0	1.5	0.7	0.1	0.0	2.2	1.5	8.8	2.6	4.3	0.4	2.6	0.6	0.8	0.7	0.3	0.3	0.5	0.5	0.4	0.4	0.8	0.5	1.3	2.8	1.0	0.5	1.0	0.5	0.4	3.0	5.0	1.3	5.4	3.9	3.0	3.9	3.5	3.8	3.2	0.0	0.3	0.0	1.7	0.7	3.1	7.3	7.6	5.3	1.2	0.0	2.0	0.1	0.0	0.4	0.5	1.4	0.0	0.0	0.2	2.1	5.1	9.8	3.5	6.0	2.5	3.2	0.0	0.6	0.0	1.3	18.7	0.3	5.0	0.0	0.0	0.2	0.5	0.0	51.9	1.9	0.3	0.0	0.8	0.9	1.5	0.3	0.2	0.0	0.0	2.6
GREB1L	"C18orf6, FLJ13687, KIAA1772"	ENSG00000141449	"Growth regulation by estrogen in breast cancer 1 like"	Q9C091	18	21242242-21525417	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 25.0"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 49.1;Leydig cells: 42.6;Peritubular cells: 33.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 22.1;BEWO: 44.8;CACO-2: 20.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041647, HPA044218"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041647: AB_2677597, HPA044218: AB_2678859"	"unprognostic (1.88e-3)"	"unprognostic (9.01e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.30e-8)"	"unprognostic (4.72e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-1)"	5.0	3.2	12.5	0.8	5.9	0.8	5.5	2.3	4.5	2.5	1.1	4.0	25.0	0.8	4.9	12.4	0.9	6.7	0.8	9.2	5.5	3.9	1.3	3.9	0.7	0.7	5.6	2.6	7.2	0.5	0.9	3.1	5.4	5.8	3.8	0.7	1.0	1.3	14.2	15.9	2.5	1.5	2.1	2.8	0.6	1.7	12.0	3.0	0.0	7.4	0.0	0.5	0.5	1.7	0.2	0.2	2.8	0.1	0.0	0.6	0.0	0.0	0.3	22.1	0.0	5.1	0.0	44.8	1.1	1.0	1.8	1.7	20.1	1.6	0.0	2.3	3.3	0.0	4.2	8.5	1.0	3.2	0.3	4.2	0.0	5.4	0.1	0.1	0.0	0.0	0.0	0.3	0.0	4.1	0.2	0.0	0.6	0.0	0.1	4.4	1.4	0.1	0.1	2.1	0.2	2.7	0.0	0.0	0.8	2.1	3.7	1.4	0.0	0.0	0.7	0.1	6.0	1.1	0.0	9.2	0.2	1.3	2.1	0.0	0.0	0.2	0.0	0.9	0.0	0.1	2.8	0.1	0.1	0.6	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	12.5	5.9	2.3	4.5	5.5	3.9	5.6	2.6	5.8	3.0	0.0	0.3	0.0	0.1	0.1	49.1	10.6	0.0	4.0	1.2	3.5	2.0	1.3	0.0	0.1	6.6	0.1	0.0	0.0	0.4	11.2	1.8	0.4	0.0	3.0	0.5	0.0	0.0	0.0	0.0	11.7	42.6	0.0	1.7	0.0	0.0	0.7	1.7	0.0	33.6	0.0	1.5	6.5	0.2	0.7	4.7	0.6	1.3	0.0	0.0	0.1
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319322-24364482	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5"	"Group enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 86.8;Urothelial cells: 72.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 28.9"	"Region enhanced"	"Detected in some"		"pons and medulla: 3.6"	"Group enriched"	"Detected in some"	12	"eosinophil: 1.0;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.4;HaCaT: 16.8;MCF7: 25.9;OE19: 9.4;RT4: 29.6;SuSa: 16.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.1	0.1	0.1	0.1	0.9	0.0	1.0	0.2	0.9	9.0	0.1	0.2	0.0	0.2	0.6	0.8	59.0	0.2	0.6	0.1	1.1	0.3	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.1	1.1	3.6	3.6	0.1	0.0	5.9	0.9	0.2	21.7	0.1	0.5	3.0	0.0	0.2	1.1	0.1	0.5	0.1	51.5	60.1	12.3	11.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.5	1.2	0.4	0.0	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	16.8	0.0	1.5	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.6	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	25.9	0.0	0.1	1.1	9.4	0.0	0.0	0.0	0.1	2.1	29.6	0.1	0.0	0.0	2.9	0.0	16.3	1.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.2	0.1	1.1	0.3	0.1	0.0	3.6	0.1	0.0	1.1	0.0	8.8	12.8	0.0	0.4	0.0	2.7	2.3	1.8	0.0	3.5	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.3	9.1	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.0	86.8	15.4	0.0	0.0	72.5
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 172.0"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 748.4;Proximal tubular cells: 664.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1400000	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	12.8	33.7	16.3	13.8	17.4	9.9	12.3	9.5	22.3	12.1	17.6	27.5	11.6	17.2	14.3	18.1	17.6	12.9	18.1	29.2	15.8	14.7	41.9	172.0	9.7	13.8	20.0	16.5	17.0	15.5	9.5	8.8	13.2	15.5	14.2	10.2	13.5	21.6	14.0	40.0	14.8	14.6	14.2	19.4	10.0	13.3	13.0	18.7	9.5	15.1	25.2	13.6	13.4	11.7	30.6	33.2	17.8	30.3	28.9	25.9	22.4	31.9	46.2	26.2	23.9	24.1	26.8	26.5	25.6	34.0	35.0	38.1	17.4	13.9	30.7	15.1	30.0	26.2	14.5	15.0	33.4	20.9	41.0	18.8	18.0	43.0	30.9	38.1	17.1	18.7	31.9	29.4	20.2	26.1	29.6	30.3	21.0	32.9	12.7	30.7	24.5	16.6	17.6	15.9	29.2	20.1	16.4	19.2	17.0	46.6	18.2	10.9	19.6	22.0	42.1	23.9	24.7	23.7	22.1	32.9	19.2	30.9	13.3	22.1	10.1	7.7	20.5	27.3	9.9	28.1	17.8	30.2	15.0	19.4	30.3	16.2	28.6	20.7	22.0	33.2	30.6	20.4	17.3	7.0	28.9	24.7	29.8	25.9	22.4	16.3	17.4	9.5	22.3	15.8	14.7	20.0	16.5	15.5	18.7	53.6	20.9	43.5	39.7	38.5	33.3	86.0	219.1	29.4	26.1	48.8	19.6	128.8	210.5	67.4	10.2	41.4	82.6	46.7	77.8	76.0	63.3	42.0	49.6	748.4	97.6	22.3	59.7	76.1	83.4	10.4	69.0	49.3	75.9	86.6	59.5	85.7	64.8	60.5	92.6	664.7	23.4	77.6	62.6	17.5	16.2	49.2	74.4	37.9	71.9	35.2
GRID2IP		ENSG00000215045	"Grid2 interacting protein"	A4D2P6	7	6497462-6551436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 23.6"	"Cell type enhanced"	"Detected in single"	12	"Rod photoreceptor cells: 1.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 23.6"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"REH: 8.9"	"Group enriched"	"Detected in some"	5	"cerebellum: 25.2;thalamus: 7.9"	"Group enriched"	"Detected in all"	5	"cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7"	HPA045381			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045381: AB_10962495"	"unprognostic (1.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.19e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.17e-1)"	0.2	1.7	0.8	0.6	3.6	1.1	1.1	23.6	6.6	0.6	1.4	6.5	0.0	1.8	0.4	0.1	1.2	1.1	0.6	0.3	1.6	1.6	0.7	0.3	1.2	0.5	0.7	1.2	0.9	1.8	3.9	3.0	0.2	5.5	2.3	0.7	0.3	2.1	1.6	0.2	3.4	1.6	0.0	1.5	1.4	2.2	1.2	6.8	2.5	1.6	0.0	0.6	0.9	0.8	0.7	0.2	0.0	0.2	1.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.0	0.7	0.7	0.0	0.2	0.8	0.0	8.9	0.3	0.2	0.2	0.3	0.1	1.1	0.0	0.8	0.0	0.3	2.0	0.2	0.1	0.0	1.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.6	0.4	0.0	0.0	1.1	0.2	0.2	0.0	0.1	0.8	3.6	23.6	6.6	1.6	1.6	0.7	1.2	5.5	6.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.7	5.4	9.6	2.3	12.2	3.4	2.4	17.2	23.9	2.7	6.9	4.9	1.3	1.2	3.8	2.7	2.4	4.5	2.6	5.6	21.7	8.9	3.8	0.3	0.6	2.6	5.0	5.3	5.3	3.5	17.8	9.1	0.3	5.5	4.5	1.6	5.8	0.7	8.9	1.0	1.1	1.4	6.7	7.6	1.8	2.7	13.6	3.5	1.0	10.3	0.3	1.0	2.2	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	9.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.4	0.0	0.4	0.0	0.1	0.1	0.0	8.9	0.1	0.0	24.4	0.0	0.1	4.0	0.0	7.0	15.5	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	12.2	17.2	12.7	21.7	8.9	5.0	5.3	5.5	3.5	0.0	0.0	0.0	0.1	0.3	21.4	2.3	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.6	0.0	0.0	17.5	0.0	0.0	0.0	2.2	0.9	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.4	0.0	20.6	0.0	0.9	3.8	1.5	0.4	0.0	0.0	0.0	0.0
GRINA	"HNRGW, LFG1, NMDARA1, TMBIM3"	ENSG00000178719	"Glutamate ionotropic receptor NMDA type subunit associated protein 1"	Q7Z429	8	143990058-143993415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 331.5;monocytes: 538.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036980, HPA036981"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	Yes			"Nucleoli fibrillar center"	Cytosol	"HPA036980: AB_10696791, HPA036981: AB_10962980"	"unprognostic (2.73e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.01e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.70e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.72e-2)"	76.4	48.8	46.6	52.3	61.0	89.0	70.2	73.8	85.8	37.1	28.4	34.5	37.1	35.6	33.1	42.1	30.5	41.4	37.5	35.2	54.2	45.1	61.7	143.7	49.7	67.4	47.4	51.5	46.1	32.0	66.8	29.3	42.4	46.5	42.6	17.7	49.3	44.4	99.4	32.8	37.4	33.5	38.0	43.3	82.0	23.2	52.2	24.3	24.3	54.7	19.2	26.8	43.2	31.3	4.5	12.4	10.2	19.3	1.6	2.6	6.4	12.8	25.2	12.9	21.9	68.8	34.7	19.1	18.4	43.6	31.4	29.1	15.3	10.8	9.2	20.3	41.5	21.9	11.6	23.0	27.2	12.9	13.1	15.8	9.6	14.6	18.1	72.9	2.0	15.5	44.7	75.4	22.7	33.2	33.0	15.2	4.0	8.9	13.0	27.0	77.6	5.3	5.2	9.0	12.4	38.2	7.3	6.5	17.8	16.1	36.5	8.8	14.3	26.8	30.2	35.8	18.3	58.1	12.7	15.2	19.9	21.9	26.5	13.4	21.1	12.1	6.9	25.2	12.7	11.3	0.9	16.6	4.6	1.4	19.3	2.0	4.5	1.4	1.6	7.1	4.3	2.6	2.3	10.2	1.6	18.0	12.4	1.2	6.4	46.6	61.0	73.8	85.8	54.2	45.1	47.4	51.5	46.5	24.3	17.9	65.6	14.3	28.0	33.1	86.7	19.7	40.8	17.4	18.2	50.6	74.6	108.2	19.9	63.5	214.4	42.1	42.7	46.7	60.2	47.1	58.4	38.3	15.1	167.7	158.2	31.8	40.5	54.0	188.9	331.5	57.0	128.7	35.4	538.4	24.1	77.3	64.0	46.0	63.6	61.9	71.2	45.3	40.6	89.2	11.3	32.2	220.9	15.9	22.4	21.6
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"		3	14489111-14556075	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 10.3;skeletal muscle: 25.7"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 9.4;Cardiomyocytes: 7.3;Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 21.1;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.2;BJ hTERT+ SV40 Large T+ RasG12V: 3.3;NTERA-2: 3.6;PC-3: 10.2;SCLC-21H: 5.7;U-2 OS: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol		NA	NA			Cytosol		"HPA035673: AB_10669776"	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	0.5	0.8	3.2	0.4	2.6	0.0	0.5	0.7	6.0	0.4	0.4	1.2	1.9	0.1	1.3	0.5	1.7	0.3	1.0	10.3	3.2		1.5	0.1	0.2	0.1	0.0	3.3	2.0	0.2	0.1	0.1	3.0	1.1	0.4	0.7	0.6	0.4	0.2	25.7	1.4	0.4	0.6	0.0	1.0	2.7	0.4	1.0	0.0	0.0	4.6	0.4	0.5	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.5	0.3	0.0	0.5	5.2	0.6	3.3	2.0	0.0	0.0	1.3	0.3	0.9	0.3	1.2	0.0	0.0	0.0	0.4	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	2.4	10.2	0.0	0.1	0.0	0.0	0.0	5.7	1.1	0.5	0.0	1.8	1.9	0.0	0.0	0.0	0.3	3.9	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.1	0.0	9.4	7.3	0.0	0.0	1.2	0.0	13.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.1	0.0	4.1	0.6	0.0	3.4	3.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.1	0.1	21.1	19.4	0.5	0.0	0.8	0.0	0.1	0.0	0.0	0.0
GRIPAP1	"DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3"	ENSG00000068400	"GRIP1 associated protein 1"	Q4V328	X	48973720-49002264	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 200.3;Rod photoreceptor cells: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000282, HPA000615"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA000282: AB_1079022, HPA000615: AB_1079023"	"unprognostic (3.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.93e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (3.92e-7)"	"unprognostic (4.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.63e-7)"	7.3	10.1	12.4	10.0	19.5	14.0	7.1	24.8	20.6	7.3	7.3	7.4	6.8	8.3	7.5	12.0	7.0	9.9	6.4	7.8	9.4	8.6	6.6	8.5	9.0	10.5	9.7	20.8	8.8	7.7	11.7	12.9	7.0	12.9	7.5	6.9	8.7	7.7	7.4	7.0	10.9	11.1	7.0	10.7	13.1	8.5	8.0	9.0	7.4	8.6	3.2	10.6	7.5	8.6	11.5	10.0	21.2	12.2	12.9	9.1	7.0	12.8	20.6	14.8	30.9	8.9	6.9	13.3	10.6	13.2	13.7	13.0	11.1	11.4	19.5	6.1	10.4	14.8	18.5	18.4	11.6	11.1	22.8	9.4	15.8	26.2	11.6	15.4	16.8	28.3	7.1	16.7	18.3	13.6	12.8	12.5	16.8	11.4	25.8	12.6	23.8	14.6	22.7	17.4	9.2	11.2	16.4	22.3	15.6	13.7	16.0	13.1	14.6	22.4	9.0	13.1	22.6	20.5	33.8	14.7	7.2	11.5	14.8	8.6	15.7	12.2	13.7	12.6	25.6	12.4	18.8	12.2	16.9	8.9	10.9	7.5	9.4	9.1	8.4	9.8	11.5	8.0	8.3	21.2	12.9	9.9	10.0	7.2	7.0	12.4	19.5	24.8	16.8	9.4	8.6	9.7	20.8	12.9	9.0	8.9	24.3	31.8	12.5	7.2	62.3	12.2	15.3	18.7	27.3	17.4	200.3	16.9	24.9	14.3	7.6	19.5	20.6	0.0	16.0	8.2	11.2	13.6	42.7	16.3	15.3	65.2	20.8	14.7	26.5	10.3	15.8	21.1	6.8	26.2	16.7	22.1	15.6	20.9	18.0	14.6	178.1	19.4	12.2	7.1	7.9	12.4	21.9	20.1	13.2	17.2
GRK2	"ADRBK1, BARK1"	ENSG00000173020	"G protein-coupled receptor kinase 2"	P25098	11	67266410-67286556	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 78.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 26.5;granulocytes: 19.8;Hofbauer cells: 31.0;monocytes: 15.4;Pancreatic endocrine cells: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 56.3;REH: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005021, CAB037248, HPA048330"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB005021: AB_562360, CAB037248: AB_1078280, HPA048330: AB_2680361"	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.31e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.19e-3)"	13.1	10.7	24.5	35.8	17.0	78.2	17.0	32.9	35.3	12.8	17.2	12.2	12.6	17.5	11.4	9.9	20.2	12.6	17.6	13.6	21.9	17.4	13.0	14.1	19.1	42.8	13.4	19.0	9.8	10.4	9.7	12.2	12.7	15.7	17.8	16.2	9.3	17.4	20.8	20.8	23.5	26.3	12.2	12.5	59.6	17.4	6.8	11.1	35.9	10.1	13.6	37.5	17.1	15.5	4.1	6.0	21.0	18.3	3.8	5.3	7.4	7.6	5.4	5.3	8.9	4.3	3.9	5.3	4.6	4.4	6.3	5.2	12.0	12.8	39.5	7.4	4.2	8.4	10.4	7.7	6.2	3.3	48.1	4.8	22.4	6.2	5.4	5.3	47.0	45.0	3.5	7.3	5.0	6.7	4.7	8.0	16.2	8.1	20.3	5.4	14.3	26.1	56.3	6.6	23.1	8.2	74.7	10.5	11.7	6.4	10.1	10.7	5.8	6.8	10.0	16.3	3.4	9.2	51.1	4.4	5.0	6.6	6.3	5.1	12.9	11.9	35.4	6.5	27.9	4.5	6.9	10.3	10.5	5.3	15.9	4.0	3.8	4.0	4.3	6.0	4.1	3.2	3.1	21.0	3.8	18.3	5.3	2.6	7.4	24.5	17.0	32.9	35.3	21.9	17.4	13.4	19.0	15.7	11.1	3.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.9	5.2	0.0	7.8	1.7	9.4	0.0	0.0	0.0	0.0	10.9	5.1	0.0	0.0	19.8	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	15.4	0.0	0.0	22.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564849-25729294	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.0"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 44.1;Club cells: 30.7;Extravillous trophoblasts: 22.7;Hofbauer cells: 25.0;monocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.4;JURKAT: 33.6;SH-SY5Y: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	28.0	6.0	11.9	12.4	10.8	7.0	11.3	7.9	18.9	4.7	4.0	3.1	0.7	3.0	5.7	3.1	2.7	9.1	5.0	4.6	15.7	8.3	3.0	3.4	9.4	14.1	9.7	9.8	4.1	8.4	4.4	8.2	4.5	9.6	8.2	4.3	4.8	3.7	1.9	1.4	4.1	6.1	6.2	4.9	23.2	4.0	14.8	2.7	11.6	4.5	1.3	15.2	6.7	2.5	6.2	3.7	5.6	8.0	0.0	0.4	1.6	0.0	1.9	5.8	1.9	4.1	0.5	8.5	0.6	1.8	1.8	3.2	3.0	3.3	10.6	0.1	0.1	5.2	0.1	5.8	4.3	5.5	20.4	3.8	4.9	0.6	6.7	0.1	15.8	8.3	1.0	3.0	1.3	2.3	0.3	0.3	33.6	0.5	0.0	2.1	2.6	11.3	1.1	4.1	5.7	0.0	5.1	9.3	1.8	0.0	3.1	13.7	18.5	1.0	0.0	4.4	5.6	1.6	6.3	0.1	0.0	12.0	0.1	2.3	1.2	4.2	8.3	7.8	5.6	1.8	0.6	4.8	5.6	0.0	8.0	0.3	4.9	0.0	0.3	3.7	6.2	0.1	0.2	0.3	0.0	7.4	3.2	0.4	1.6	11.9	10.8	7.9	18.9	15.7	8.3	9.7	9.8	9.6	2.7	14.9	44.1	0.0	0.0	0.0	0.0	0.0	0.0	12.0	30.7	0.0	0.0	1.5	1.7	7.0	0.0	0.0	0.0	0.0	1.6	22.7	0.0	0.0	17.4	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	47.7	0.0	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0
GRK4	"GPRK2L, GPRK4"	ENSG00000125388	"G protein-coupled receptor kinase 4"	P32298	4	2963608-3040747	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.2"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 115.8;Early spermatids: 282.7;Late spermatids: 377.5;Spermatocytes: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028737, HPA057023"	Approved		Approved	Lysosomes		NA	NA			Lysosomes		"HPA028737: AB_2672757, HPA057023: AB_2683313"	"unprognostic (1.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.89e-1)"	3.4	3.6	5.4	1.6	5.1	1.7	4.8	12.5	5.9	3.0	2.1	4.2	1.0	1.5	2.7	3.1	2.4	2.0	3.0	5.6	5.2	4.8	2.8	2.3	2.4	1.6	5.3	5.3	3.4	7.9	3.9	6.2	2.2	5.9	2.4	2.0	3.1	4.0	2.9	5.0	2.9	1.7	2.8	5.4	1.9	2.5	41.2	3.7	1.6	4.1	1.6	1.7	2.5	3.3	1.2	2.5	4.5	2.0	1.6	1.7	1.0	2.5	0.9	3.0	8.7	7.4	7.1	1.9	4.9	2.1	2.8	2.4	2.4	0.8	5.6	2.1	7.7	5.4	0.8	4.0	4.0	2.5	3.8	4.0	6.1	3.5	2.8	4.4	2.4	2.2	4.8	6.3	4.9	2.3	3.1	5.2	6.0	5.7	7.4	6.5	2.8	5.2	5.2	2.4	3.5	6.9	6.6	3.9	2.2	2.6	3.1	17.6	5.4	2.9	1.3	4.4	2.2	6.7	3.8	6.0	7.6	2.0	5.1	4.3	7.6	4.3	4.3	3.7	5.4	2.5	4.5	1.1	2.1	1.1	2.0	1.4	1.1	0.7	0.7	0.3	1.2	1.7	1.6	4.0	1.6	0.7	2.5	0.4	1.0	5.4	5.1	12.5	5.9	5.2	4.8	5.3	5.3	5.9	3.7	3.0	9.0	0.0	2.5	10.0	48.5	9.0	7.6	1.4	7.9	3.5	115.8	1.8	11.6	2.4	282.7	3.8	1.0	0.0	3.3	3.5	9.9	1.5	5.7	2.5	3.0	17.5	9.9	3.1	2.2	377.5	12.0	3.2	6.8	2.8	1.7	10.3	1.8	0.0	7.8	3.6	48.9	6.5	4.4	110.9	13.6	9.9	2.5	4.4	1.2	2.3
GRK6	GPRK6	ENSG00000198055	"G protein-coupled receptor kinase 6"	P43250	5	177403204-177442901	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.1"	"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015327, HPA018903"	Approved		Approved	Mitochondria		NA	NA		7500	Mitochondria		"HPA015327: AB_1850334, HPA018903: AB_1850335"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.66e-6)"	"unprognostic (2.63e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.96e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.47e-1)"	6.8	5.5	7.8	26.8	7.3	68.1	10.2	7.7	10.9	5.9	9.2	6.6	5.0	10.9	8.0	6.0	11.0	6.6	9.3	6.2	8.0	7.3	5.7	6.6	11.1	37.6	7.1	10.7	6.1	12.1	3.5	5.6	4.9	6.7	8.1	5.5	5.0	10.8	5.2	7.4	7.7	14.5	7.8	5.4	34.3	9.1	10.5	5.1	32.3	5.3	6.4	26.5	11.4	6.5	9.2	5.7	32.1	22.6	17.4	11.7	9.1	12.1	13.3	4.8	21.1	1.4	2.4	20.7	8.9	4.7	11.3	11.2	30.8	10.4	14.5	13.7	4.7	16.7	8.9	7.5	20.5	4.4	39.6	23.4	12.8	10.8	10.4	7.9	17.2	16.3	3.8	5.1	11.2	6.6	2.8	6.3	26.7	13.3	52.3	3.4	34.8	17.7	18.1	8.3	6.1	14.7	17.0	7.8	20.9	3.3	9.9	11.2	15.2	7.4	13.1	17.3	2.3	10.4	19.0	8.0	9.2	13.8	9.8	22.4	15.1	18.3	11.8	6.2	28.2	8.9	4.5	9.5	32.1	11.7	16.5	8.4	9.2	9.8	10.7	5.5	9.2	10.4	9.0	23.2	17.4	22.6	5.7	11.7	9.1	7.8	7.3	7.7	10.9	8.0	7.3	7.1	10.7	6.7	5.1	0.0	2.1	37.2	46.6	21.1	9.5	2.0	7.6	0.0	3.4	3.5	5.9	10.9	13.3	3.9	31.4	4.5	11.3	23.3	7.1	10.5	8.0	37.0	14.9	5.3	18.5	15.9	10.9	8.6	27.3	57.4	5.8	20.0	13.5	1.8	13.4	6.1	8.1	13.3	4.9	6.9	7.3	12.9	10.3	2.2	3.6	17.8	10.6	41.1	16.3	52.8
GRK7	GPRK7	ENSG00000114124	"G protein-coupled receptor kinase 7"	Q8WTQ7	3	141778148-141818490	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.4"	"Cell type enriched"	"Detected in some"	168	"Cone photoreceptor cells: 310.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HeLa: 1.5;U-937: 1.8"					"Not detected"	"Not detected"			"HPA075093, HPA078232"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA075093: , HPA078232: "	"unprognostic (1.11e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.91e-1)"	0.2	0.5	0.3	0.5	0.4	1.5	0.2	0.9	0.3	0.2	0.1			0.4	0.3	0.0	0.3	0.3	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2		0.6	0.3	0.7	0.2	0.2		0.3	0.0		0.4	0.2	1.6	1.5	0.4	0.0	0.2	0.4	0.1	1.0			0.1		0.3	0.1	0.3	0.7	0.2	2.4	0.4	0.5	0.6	0.1	0.0	0.1	0.1	0.6	0.4	0.0	4.1	0.1	0.0	0.0	0.1	0.2	0.6	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.5	0.2	1.5	0.2	0.0	0.4	0.3	0.1	1.1	0.0	0.1	0.0	0.0	0.3	0.2	0.2	0.0	0.2	0.2	0.7	0.4	0.2	0.2	0.2	0.1	0.2	0.0	0.5	0.3	0.4	0.2	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	1.8	0.2	0.2	0.4	0.3	0.4	0.2	0.6	0.6	0.5	0.3	0.1	0.7	0.5	0.5	2.4	0.5	0.3	0.2	0.2	0.1											0.0	0.0	0.0	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.0	310.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437598	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 113.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 39.9"	"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.4;GAMG: 2.5;HeLa: 1.2;hTERT-RPE1: 1.5;Karpas-707: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.5	0.5	6.6	0.4	6.0	0.4	0.5	39.9	13.0	0.5	0.5	0.9	0.0	0.4	0.5	0.7	0.5	0.7	0.5	7.7	6.0	2.7	2.7	0.5	0.6	0.5	2.6	4.1	0.5	0.5	0.4	0.2	0.5	3.6	0.5	0.4	2.6	0.5	0.8	0.4	0.5	0.5	0.5	1.0	0.6	0.5	1.3	0.9	0.0	0.8	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.1	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.9	0.5	0.1	0.1	0.4	0.1	0.0	0.4	0.1	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	6.6	6.0	39.9	10.5	6.0	2.7	2.6	4.1	3.6	0.9	0.0	0.0	0.0	0.0	0.0	13.4	3.9	0.0	0.0	0.0	1.8	15.7	0.0	1.7	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	113.7	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0
GSAP	"LOC54103, PION"	ENSG00000186088	"Gamma-secretase activating protein"	A4D1B5	7	77310751-77416400	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lung: 33.1"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 71.5;Alveolar cells type 2: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 11.2;U-937: 14.7"	"Low region specificity"	"Detected in many"							HPA023994			Approved	Vesicles		NA	NA			Vesicles		"HPA023994: AB_1855386"	"prognostic favorable (3.36e-4)"	"unprognostic (3.70e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.53e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.36e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (3.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (4.15e-5)"	5.7	6.3	3.8	19.9	3.9	7.0	5.7	1.7	6.6	3.5	6.4	4.4	2.8	2.0	3.9	6.7	5.0	5.7	8.0	7.3	4.2	5.4	6.2	13.9	33.1	24.0	4.5	2.2	4.0	5.4	9.4	14.0	3.6	4.2	5.8	4.1	5.6	5.6	5.3	2.5	3.7	10.1	8.0	5.5	21.5	6.9	1.9	3.3	3.8	9.4	3.4	14.8	5.5	3.4	13.7	11.7	1.3	9.7	11.2	6.6	5.7	3.2	1.7	0.0	0.0	0.5	2.2	0.3	2.0	6.8	1.1	2.9	0.5	4.7	0.7	0.2	0.0	3.9	1.6	0.1	1.6	3.0	2.1	1.4	3.5	0.2	9.0	3.0	0.3	0.0	0.8	6.2	5.5	11.2	8.2	0.5	0.0	0.0	0.3	9.2	1.8	0.0	7.0	0.5	5.1	2.4	0.0	0.1	0.1	6.2	2.7	0.2	5.2	2.2	1.1	5.3	0.4	2.0	2.9	0.0	1.7	1.2	0.2	6.1	1.3	0.0	1.2	7.9	14.7	1.4	0.0	9.7	0.9	6.6	8.9	3.9	13.7	2.2	4.5	11.7	12.3	2.9	4.8	1.3	11.2	6.4	0.3	0.1	5.7	3.8	3.9	1.7	6.6	4.2	5.4	4.5	2.2	4.2	3.3	71.5	50.8	31.3	9.0	4.6	16.8	7.3	5.1	12.0	29.6	3.5	15.7	2.4	21.6	6.2	0.0	9.9	0.9	0.0	5.3	0.7	2.6	10.5	12.7	13.2	9.6	19.1	5.2	3.7	33.4	0.0	4.9	31.0	8.5	13.6	5.3	37.9	6.0	5.7	3.5	6.8	21.3	6.5	3.1	1.1	0.4	4.0	1.4	15.9	4.3	15.9
GSDMB	"GSDML, PRO2521"	ENSG00000073605	"Gasdermin B"	Q8TAX9	17	39904595-39919854	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 71.3"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 65.9;Mucus-secreting cells: 26.1;Paneth cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"SK-BR-3: 103.0"									"CAB013681, HPA023925, HPA052407"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819"	"unprognostic (5.78e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (5.13e-11)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.91e-2)"	"prognostic favorable (5.91e-9)"	4.0	0.0	1.3	13.3	2.0	1.3	2.8	4.8	1.7	2.1	33.1	1.4	2.0	25.2	1.3	1.7	1.3	1.3	14.4	1.3	1.3	0.6	2.2	17.1	2.4	3.5	1.3	1.3	2.0	2.8	0.0	1.3	1.8	1.3	3.5	22.4	1.3	1.3	2.7	1.3	2.8	71.3	3.9	1.3	4.7	18.1	1.4	1.5	1.6	2.9	1.3	2.8	4.1	4.5	0.8	0.0	1.8	0.0	0.1	2.8	0.4	0.4	0.3	0.6	0.1	1.5	1.0	0.6	0.4	0.2	0.1	0.4	0.3	12.2	0.6	0.5	0.3	0.2	1.6	0.3	0.3	0.9	2.5	0.4	0.2	0.1	0.1	0.4	0.0	0.1	0.6	2.0	0.5	0.7	1.0	0.2	2.0	0.2	0.7	0.1	0.1	0.6	1.3	0.1	3.9	0.4	0.6	0.2	0.9	0.0	0.4	0.2	0.3	0.1	103.0	0.3	3.1	0.5	0.4	0.3	0.4	0.7	1.1	0.2	2.2	1.9	0.6	0.1	0.4	0.0	0.0	0.0	1.8	1.1	0.0	0.0	0.8	2.8	1.4	0.0	0.0	2.6	0.6	0.7	0.1	0.0	0.0	0.4	0.4	1.3	2.0	4.8	1.7	1.3	0.6	1.3	1.3	1.3	1.5	3.0	11.8	4.2	1.2	1.6	2.1	2.4	12.7	2.7	4.5	5.2	3.9	1.2	0.0	1.6	4.4	1.4	65.9	0.0	7.0	0.6	1.4	1.5	1.1	8.1	0.3	1.6	5.8	0.0	1.9	3.3	1.1	1.1	3.3	1.8	26.1	2.0	7.3	57.5	1.8	0.0	2.3	0.0	2.1	0.5	1.1	3.0	0.2	2.5	15.0	5.0
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786888	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 41.3;Suprabasal keratinocytes: 46.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 8.3;HaCaT: 5.9;hTCEpi: 3.1;HUVEC TERT2: 3.3;TIME: 8.7"									"HPA023670, HPA024767, HPA026317"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.2	25.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.4	0.0	0.0	14.1	0.0	0.0	0.2	25.0	0.0	0.0	0.0	0.1	0.1	19.2	17.5	1.4	5.9	0.3	0.3	1.2	0.1	0.4	0.3	0.0	8.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	5.9	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.3	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.7	41.3	0.0	2.4	0.0	0.0	3.4	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	46.4	0.0	0.0	0.0	2.3
GSE1	KIAA0182	ENSG00000131149	"Gse1 coiled-coil protein"	Q14687	16	85169525-85676204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.9"	"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 137.4;Syncytiotrophoblasts: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 43.6;K-562: 48.4;T-47d: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036365, HPA042090"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036365: AB_10601762, HPA042090: "	"unprognostic (1.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.88e-1)"	15.8	11.1	4.9	18.2	6.6	17.3	21.4	18.0	9.5	13.5	14.9	2.9	14.6	9.7	11.0	11.7	11.6	10.9	16.1	18.7	3.8	5.8	11.1	10.1	23.5	6.5	3.8	5.7	17.8	28.0	34.4	26.9	81.9	3.7	8.7	7.2	18.2	17.7	25.2	22.5	13.3	14.8	8.8	4.2	12.1	13.2	10.4	2.1	59.0	14.9	12.0	17.4	10.2	16.9	3.5	2.5	4.5	6.0	1.9	3.2	1.1	4.5	8.2	5.5	13.8	3.5	3.2	43.6	6.2	4.3	3.5	1.3	7.0	6.3	2.7	7.5	7.0	3.1	4.3	8.7	2.3	1.8	5.0	7.3	19.8	7.7	8.6	4.6	9.1	11.3	6.1	5.7	3.7	1.8	3.6	0.9	16.1	48.4	0.5	1.1	30.7	32.6	8.0	9.6	5.0	2.4	21.5	1.8	6.9	3.2	1.7	35.9	24.9	12.2	22.9	1.1	5.2	49.9	22.8	1.5	7.2	9.0	1.9	1.6	7.5	4.5	15.9	4.1	5.8	6.3	4.0	1.6	4.5	3.2	2.9	3.1	3.5	1.2	2.0	2.5	3.4	0.6	2.4	1.3	1.9	6.0	0.0	0.0	1.1	4.9	6.6	18.0	9.5	3.8	5.8	3.8	5.7	3.7	2.1	62.5	65.7	11.5	7.5	12.5	61.9	31.4	33.1	24.1	29.6	36.6	137.4	45.4	1.7	14.3	3.8	19.0	19.6	46.7	10.5	65.7	18.6	12.3	41.7	26.7	11.0	33.4	57.4	15.4	8.9	4.7	43.7	13.5	10.1	3.6	60.0	5.2	16.5	17.3	57.7	4.4	61.6	6.5	7.1	1.8	17.8	26.2	152.4	17.0	22.4	10.5
GSK3A		ENSG00000105723	"Glycogen synthase kinase 3 alpha"	P49840	19	42230186-42242625	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004422, HPA028423"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB004422: AB_627680, HPA028423: AB_10612116"	"unprognostic (5.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.22e-3)"	15.3	19.8	31.0	16.8	38.0	14.4	12.0	31.4	62.2	15.9	16.8	24.3	11.4	28.6	16.9	18.0	17.3	16.7	11.8	21.3	31.3	23.6	17.5	13.1	14.2	15.0	21.8	26.3	20.0	19.3	16.1	14.2	14.7	31.7	15.8	16.1	15.5	18.1	20.3	41.0	25.1	27.0	18.5	18.0	14.5	14.7	19.1	17.7	16.6	15.8	11.9	15.8	15.8	15.5	1.6	2.2	4.0	1.9	1.7	2.0	1.0	23.4	41.6	23.8	22.1	14.3	12.8	10.1	16.5	15.8	21.9	19.8	15.6	14.9	17.0	17.1	12.9	20.6	10.8	19.6	19.2	15.4	13.7	31.4	17.7	13.3	15.4	18.8	20.0	21.6	12.5	20.4	17.9	20.5	19.0	19.8	12.7	29.6	25.3	18.7	28.4	25.9	17.7	17.6	36.7	17.2	23.7	13.8	13.0	20.2	24.6	27.8	28.1	22.6	29.7	15.0	17.1	17.2	26.5	17.6	22.6	17.0	13.1	29.2	25.9	29.7	13.2	26.2	20.2	24.7	2.5	1.5	1.6	2.0	1.9	1.4	1.2	1.2	1.3	1.4	1.6	0.7	1.5	4.0	1.7	1.1	2.2	1.0	1.0	31.0	38.0	31.4	62.2	31.3	23.6	21.8	26.3	31.7	17.7	6.0	21.0	14.9	15.9	21.9	42.9	10.9	10.2	1.4	6.8	15.7	58.9	20.8	3.3	12.4	6.3	20.2	39.2	0.0	14.9	21.1	14.6	22.2	2.3	12.4	17.7	57.2	22.4	16.5	18.9	8.8	16.4	16.9	15.1	6.4	28.2	37.9	18.9	22.9	15.6	13.1	40.2	6.5	16.5	10.2	16.6	24.6	36.8	12.8	23.8	23.5
GSKIP	C14orf129	ENSG00000100744	"GSK3B interacting protein"	Q9P0R6	14	96363452-96387288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 63.0"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 337.2;Late spermatids: 220.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043054, HPA046782"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		No	No			"Golgi apparatus, Vesicles"	Nucleoli	"HPA043054: AB_2678293, HPA046782: AB_2679803"	"unprognostic (3.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	6.6	7.1	11.2	8.0	21.9	7.1	6.7	5.1	14.6	6.6	29.5	5.4	6.7	23.5	5.5	6.4	20.8	5.5	7.0	5.2	12.0	9.6	12.8	36.4	5.3	8.7	9.2	9.7	3.6	6.1	4.0	10.8	11.1	10.7	7.1	28.3	8.7	7.8	5.2	5.5	8.5	63.0	8.0	10.4	6.6	11.3	26.4	7.2	9.0	5.8	10.7	10.7	8.2	9.0	20.1	11.2	27.5	16.6	17.8	34.1	14.8	9.6	13.8	15.5	10.5	11.7	13.6	26.3	18.0	13.8	11.9	13.2	10.2	16.4	9.3	11.0	13.6	7.4	10.7	10.1	10.7	17.4	21.9	9.6	3.8	7.9	7.8	10.9	9.9	6.7	11.0	17.2	15.2	15.3	9.4	15.5	10.6	8.4	8.4	15.1	23.9	7.2	8.0	17.2	15.1	17.5	7.3	14.4	8.4	28.0	36.1	5.5	17.7	20.3	19.2	15.6	16.3	14.4	6.4	17.0	5.5	7.1	11.7	5.6	10.0	28.4	7.8	14.1	7.2	8.8	27.5	10.8	24.3	15.5	12.6	24.0	20.1	21.7	18.3	11.2	16.6	21.4	19.8	21.7	17.8	16.6	9.6	34.1	14.8	11.2	21.9	5.1	14.6	12.0	9.6	9.2	9.7	10.7	7.2	11.9	9.0	19.3	19.8	40.2	24.1	14.2	20.4	14.7	5.7	19.2	39.3	37.6	61.3	30.4	337.2	14.6	80.6	0.0	34.7	35.8	17.9	30.7	19.6	15.5	20.9	22.3	26.9	17.8	22.8	220.8	7.5	17.5	18.6	32.5	63.8	16.2	32.2	98.2	7.4	38.6	79.0	19.4	18.4	37.4	36.7	57.6	100.0	26.1	53.7	34.5
GSPT1	"eRF3a, ETF3A, GST1"	ENSG00000103342	"G1 to S phase transition 1"	P15170	16	11868128-11916082	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052488, HPA074588"	Approved		Approved	Vesicles,Cytosol		NA	NA		150000	Cytosol	Vesicles	"HPA052488: AB_2681849, HPA074588: "	"unprognostic (4.13e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-3)"	"unprognostic (3.13e-2)"	28.5	36.5	27.0	31.2	25.0	30.1	52.5	18.1	33.9	21.7	25.8	18.5	23.3	15.6	20.8	23.1	42.8	18.7	20.1	35.6	22.4	15.3	26.2	46.0	31.3	38.1	26.4	21.6	20.8	48.2	40.9	18.5	23.1	24.1	24.3	29.1	12.6	26.4	30.8	74.1	25.3	20.5	25.6	27.4	26.3	28.1	30.6	23.2	34.8	27.7	24.8	37.0	23.9	30.1	8.8	7.8	7.9	12.0	7.3	11.4	4.6	45.5	45.2	25.2	34.7	36.5	38.0	36.5	50.7	52.8	40.8	40.8	32.2	42.4	61.9	66.7	43.9	28.4	35.1	63.8	46.9	68.9	29.5	33.0	42.2	36.7	67.9	30.8	53.3	22.6	29.7	37.0	46.1	63.4	26.8	45.1	31.2	68.0	32.1	47.3	43.9	45.0	27.8	50.4	34.2	25.8	53.4	43.6	72.2	40.3	40.1	40.7	21.8	72.9	55.4	29.7	37.5	48.0	25.7	34.7	45.5	28.6	32.9	39.9	32.0	47.2	54.0	32.0	54.4	27.5	1.5	6.5	7.9	7.6	12.0	10.6	8.8	9.8	9.0	7.8	6.4	9.9	9.5	2.2	7.3	10.1	4.3	11.4	4.6	27.0	25.0	18.1	33.9	22.4	15.3	26.4	21.6	24.1	23.2	71.5	129.3	55.1	155.8	215.1	43.9	107.2	40.8	52.2	75.1	82.0	47.1	65.7	87.9	49.8	62.7	55.4	46.7	186.9	54.6	102.9	59.8	177.7	24.3	67.4	66.7	49.3	64.0	46.6	44.0	35.3	44.3	65.4	60.8	36.1	80.8	42.0	61.9	70.2	44.6	89.0	38.0	58.2	90.5	110.1	75.2	225.2	85.4	48.0	77.7	195.6
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52846095	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.3"	"Cell type enriched"	"Detected in single"	5	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 163.2;seminal vesicle: 101.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 8.9;Ciliated cells: 9.4;Club cells: 11.4;Ito cells: 8.0;Kupffer cells: 10.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 26.9;HeLa: 32.1;HHSteC: 25.7;hTEC/SVTERT24-B: 23.2;HUVEC TERT2: 19.7;MOLT-4: 34.6"									"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	14.5	25.4	15.2	6.9	15.6	2.9	8.2	5.6	19.2	22.0	7.8	16.9	0.0	7.7	9.8	20.2	22.5	13.8	8.2	6.4	14.4	6.8	14.1	163.2	7.7	1.0	7.8	32.1	29.0	18.2	41.4	5.3	2.9	8.2	38.1	6.6	25.7	11.8	101.4	25.1	18.8	17.7	18.2	6.8	21.7	7.5	15.1	11.2	10.9	7.6	1.6	14.5	30.8	19.5	14.6	34.9	14.1	18.9	13.3	17.3	10.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	8.2	0.0	12.9	0.0	0.4	0.0	0.1	0.2	0.0	0.1	26.9	32.1	0.5	25.7	0.0	0.2	0.0	0.0	23.2	0.1	15.4	19.7	15.8	0.0	18.0	0.8	0.0	34.6	0.2	17.3	0.0	0.0	0.1	0.1	3.4	2.8	0.0	1.7	0.2	0.0	0.1	0.1	0.8	0.3	14.2	0.0	11.5	0.6	0.2	0.0	14.4	19.0	1.1	9.9	0.3	0.6	0.7	12.2	14.1	14.8	18.9	15.7	14.6	15.8	13.7	34.9	14.6	16.5	15.6	1.0	13.3	7.4	19.2	17.3	10.0	15.2	15.6	5.6	19.2	14.4	6.8	7.8	32.1	8.2	11.2	8.9	5.0	0.0	1.0	1.5	0.0	5.6	5.1	9.4	11.4	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	2.3	0.6	0.1	0.0	0.0	8.0	10.1	0.0	3.4	0.8	0.0	1.0	0.0	2.3	0.8	0.0	2.1	0.0	0.0	0.0	0.6	0.2	0.2	1.4	0.0	5.3	0.0	0.1
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 56.8;Ciliated cells: 17.4;Club cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 41.4;HSkMC: 41.0"									"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		930000	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	23.8	27.3	30.7	14.7	48.3	5.7	31.7	13.7	25.0	36.4	20.9	19.9	54.3	14.5	24.0	37.1	15.4	31.4	15.7	35.2	32.5	21.7	15.9	6.0	11.1	7.5	17.0	21.1	90.1	17.8	20.4	40.2	5.8	22.4	30.7	10.7	36.0	26.6	87.5	88.5	39.2	13.6	22.0	24.9	10.7	16.4	9.2	28.9	6.7	20.4	25.6	8.7	20.2	31.0	5.2	16.5	16.0	3.5	8.9	20.9	5.8	0.0	1.2	13.0	13.3	15.5	41.4	2.5	8.2	14.5	7.6	9.7	2.3	0.0	0.3	8.8	20.6	6.2	0.0	1.0	0.0	9.9	0.5	0.3	4.7	0.1	3.1	10.5	0.4	8.7	41.0	0.3	11.3	0.0	20.5	5.4	3.9	1.3	0.2	16.5	0.1	6.3	8.1	2.4	0.2	11.1	7.9	0.0	0.0	2.3	0.2	2.8	6.4	0.0	0.3	4.2	8.1	13.2	2.3	0.1	8.4	0.4	12.1	0.6	4.1	6.0	0.5	12.7	0.1	0.1	1.0	2.2	16.0	1.9	3.5	1.8	5.2	5.3	2.0	12.7	3.7	20.9	8.9	1.3	8.9	2.1	16.5	4.5	5.8	30.7	48.3	13.7	25.0	32.5	21.7	17.0	21.1	22.4	28.9	0.0	3.7	1.5	1.9	4.2	1.5	56.8	2.5	17.4	20.5	3.5	0.0	0.3	0.0	0.1	1.2	2.4	0.3	0.0	0.0	0.2	3.3	0.6	2.3	0.6	1.2	3.2	0.0	1.3	1.5	6.8	14.4	1.0	5.0	0.0	0.8	11.0	0.1	0.0	9.9	0.8	0.2	6.5	3.1	0.4	0.4	2.5	0.5	4.3	0.4	0.7
GSTM3	GST5	ENSG00000134202	"Glutathione S-transferase mu 3"	P21266	1	109733932-109741038	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 115.3;testis: 96.0"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 1724.2;Late spermatids: 2908.0;Spermatocytes: 818.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.1;T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 45.7;T-47d: 96.9;WM-115: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017130, HPA035190, CAB040583, HPA055972"	Enhanced		Approved	Cytosol		NA	NA		560000	Cytosol		"CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992"	"unprognostic (2.13e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.48e-2)"	7.5	11.3	21.4	2.9	27.8	0.9	23.1	8.5	18.4	15.4	11.7	9.9	51.0	12.6	9.0	67.2	11.1	8.8	12.3	27.6	14.0	14.4	54.0	5.3	5.2	2.4	9.6	22.0	32.3	26.5	7.3	9.4	5.8	30.7	13.6	5.6	13.4	4.5	115.3	15.5	15.0	7.5	15.9	13.3	3.3	14.2	96.0	6.4	0.1	15.8	15.6	3.3	17.4	12.0	0.6	0.8	4.1	0.3	1.0	11.1	1.4	0.0	1.3	9.9	0.0	13.5	8.3	1.7	10.7	1.8	11.8	11.5	4.3	0.3	0.0	6.2	5.4	8.2	0.5	2.0	4.4	16.4	0.0	2.9	10.0	32.5	6.4	14.4	0.0	23.3	8.3	5.4	17.7	0.0	13.1	14.5	12.4	0.9	0.1	5.3	5.8	2.7	0.2	1.1	0.0	18.6	0.0	6.4	0.4	3.3	23.0	17.5	9.4	22.4	45.7	2.1	3.0	96.9	14.6	11.4	0.1	4.3	12.0	7.0	1.5	2.4	0.0	0.1	0.0	37.6	0.8	0.3	4.1	4.2	0.1	1.2	0.6	5.3	3.1	0.1	0.6	11.1	5.5	2.0	1.0	0.2	0.8	2.3	1.4	21.4	27.8	8.5	18.4	14.0	14.4	9.6	22.0	30.7	6.4	6.0	11.5	8.1	96.3	127.5	19.3	82.7	40.8	1.4	17.0	211.1	5.9	13.4	679.8	74.2	1724.2	31.5	27.6	0.0	131.2	7.7	152.1	47.5	9.2	2.5	8.6	14.3	48.5	54.0	6.6	2908.0	356.9	16.6	57.3	5.4	23.4	255.3	110.8	25.9	259.6	35.7	14.3	187.5	89.7	818.6	48.1	93.8	8.6	7.9	40.9	29.8
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656081-109674836	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 69.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 69.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		660000	Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"prognostic favorable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	12.5	17.6	14.0	12.3	20.2	3.6	10.9	12.9	24.7	12.6	33.2	18.0	9.4	85.3	12.1	15.3	15.9	11.0	14.5	14.7	13.7	12.3	27.2	22.0	7.4	10.1	14.8	16.9	31.4	12.2	23.1	9.9	5.1	15.8	14.7	23.2	20.5	15.4	26.3	47.4	10.6	77.2	19.0	16.1	16.2	14.7	11.8	14.0	4.0	14.9	14.5	12.8	22.2	14.2	3.6	7.8	69.8	3.0	2.5	3.1	2.3	5.3	2.4	4.3	32.5	9.7	15.0	5.5	1.7	14.0	4.1	5.4	17.1	0.6	5.0	6.7	7.7	8.0	5.5	11.1	5.8	2.6	7.4	0.0	10.9	10.1	15.3	15.8	3.7	13.2	9.5	5.8	5.2	0.0	11.5	3.3	12.9	5.0	7.5	2.8	5.0	3.1	16.4	3.3	22.5	13.0	6.7	2.4	7.3	16.0	3.8	3.1	7.2	0.0	28.2	21.8	3.4	7.6	8.0	1.4	4.7	18.7	5.2	2.5	11.2	19.6	0.4	15.6	5.5	13.3	2.0	2.9	69.8	2.7	3.0	1.6	3.6	2.0	3.1	7.8	2.8	2.0	2.3	0.4	2.5	0.7	2.7	2.8	2.3	14.0	20.2	12.9	24.7	13.7	12.3	14.8	16.9	15.8	14.0	8.9	2.4	13.5	21.7	16.1	5.5	25.8	25.5	10.7	7.9	29.6	0.0	18.5	86.2	40.9	2.6	9.0	85.7	0.0	50.8	15.9	20.4	8.2	20.7	21.9	30.0	4.8	6.9	16.0	14.6	4.7	27.9	17.0	38.8	15.4	33.9	22.1	36.3	28.8	23.3	64.5	4.7	32.3	32.0	5.7	6.9	13.4	7.3	17.8	57.6	10.4
GSTO1	"GSTTLp28, P28"	ENSG00000148834	"Glutathione S-transferase omega 1"	P78417	10	104235356-104267459	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 123.8"	"Low region specificity"	"Detected in all"							"HPA037603, HPA037604"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		200000000	Cytosol	Nucleoplasm	"HPA037603: AB_2675574, HPA037604: AB_10672283"	"prognostic favorable (6.95e-4)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-3)"	"unprognostic (4.57e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.82e-2)"	29.6	31.9	19.9	21.8	24.4	35.8	20.0	15.0	24.3	17.8	29.7	16.8	17.8	36.3	16.5	21.4	22.6	15.2	24.7	67.9	19.7	21.5	32.7	137.3	32.0	35.7	23.2	23.1	19.7	21.2	18.6	23.2	26.3	17.0	18.2	20.8	18.0	25.3	21.2	42.7	13.3	41.0	21.4	18.9	26.8	19.8	7.0	14.2	30.8	32.9	24.0	16.8	28.0	18.8	18.7	55.4	85.5	68.3	21.8	25.5	68.0	31.7	21.8	16.9	28.8	23.7	45.3	7.3	41.5	73.7	27.6	30.0	27.3	34.0	28.3	18.0	27.5	35.2	18.3	11.0	36.8	29.1	14.1	26.4	20.9	15.5	59.6	42.5	26.7	35.1	34.3	15.7	40.0	48.3	39.3	52.7	26.5	42.9	17.7	57.7	17.3	20.7	37.6	15.6	34.4	15.2	15.3	11.1	11.9	40.9	20.4	8.4	10.5	13.4	9.6	123.8	29.8	10.5	21.5	48.6	32.7	17.1	50.8	36.9	0.3	0.4	0.2	61.3	46.5	12.9	85.5	68.3	19.2	18.3	57.2	22.0	18.7	22.6	23.4	55.4	15.0	19.7	19.8	19.5	21.8	43.9	25.7	25.5	68.0	19.9	24.4	15.0	24.3	19.7	21.5	23.2	23.1	17.0	14.2	71.5	58.2	98.7	286.1	83.2	26.3	290.4	244.5	58.9	78.5	96.0	19.6	399.2	281.8	289.2	13.5	118.6	130.2	70.0	215.9	135.5	154.5	94.2	142.1	611.8	643.1	22.3	99.4	338.8	323.0	12.0	106.2	397.5	119.8	265.1	129.8	50.2	258.3	117.9	106.1	410.6	24.7	148.8	123.7	5.4	2.6	68.8	92.8	101.2	167.3	176.7
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B (gene/pseudogene)"	P0CG30	22	23957414-23961186	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"breast: 83.4"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 27.7;Muller glia cells: 19.5;Peritubular cells: 26.9"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.6;HHSteC: 33.3;SK-MEL-30: 23.0;T-47d: 25.5"									HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favorable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	1.6	11.7	2.7	0.7	1.9	0.0	83.4	0.0	4.2	2.6	1.5			0.1	1.7	2.9	2.6	1.4	1.1	2.4	1.7	2.9	1.3	6.1	2.0	0.1	2.5		3.1	3.2	0.9	3.6	0.8		6.1	0.2		1.2	2.5	1.3	11.4	0.7	2.7	1.4	0.9	2.6	0.5			2.5		0.1	0.7	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.5	0.3	0.0	22.6	0.5	0.6	0.9	3.2	1.8	4.6	4.8	9.7	0.0	0.0	5.1	7.9	12.0	9.5	0.0	10.0	2.1	0.0	0.8	0.3	12.7	1.5	33.3	0.0	3.6	13.7	1.6	13.2	2.7	13.3	3.7	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.1	0.3	4.8	0.0	16.8	0.0	10.2	0.0	0.4	9.5	3.1	0.0	23.0	0.0	25.5	0.3	12.3	3.8	2.6	0.5	2.4	0.0	0.0	0.0	2.4	0.0	9.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											3.0	2.2	0.0	8.7	0.0	3.5	0.1	2.5	0.0	2.3	0.0	0.0	1.2	24.9	7.2	0.4	1.6	0.0	23.3	7.9	3.6	0.1	7.9	1.1	27.7	8.3	0.0	1.2	15.4	4.0	1.3	9.2	0.2	0.0	5.4	0.4	19.5	4.7	0.0	26.9	3.8	2.6	6.5	0.3	0.5	0.4	0.0	1.5	0.0	0.0	2.3
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 348.1;Late spermatids: 326.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		62000	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.5	12.5	9.9	7.0	6.3	8.7	16.8	4.1	4.2	7.7	10.9	4.2	16.5	14.6	5.9	4.8	4.8	8.4	6.7	7.9	7.4	7.7	6.7	7.1	4.8	8.9	9.9	2.6	5.9	8.1	8.6	4.4	7.5	4.3	6.6	8.7	5.9	13.5	5.1	60.8	4.0	5.5	2.9	22.6	10.0	7.0	10.4	11.3	11.7	8.0	10.9	9.9	9.1	18.2	12.9	5.8	29.7	3.9	4.5	6.0	20.4	6.8	3.0	10.1	10.8	12.8	15.6	4.0	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2	6.0	8.1	12.7	18.0	11.8	6.8	12.0	50.9	10.7	5.7	8.7	3.9	76.5	39.7	34.9	105.1	8.7	47.2	23.3	59.7	57.9	10.6	19.8	3.5	348.1	39.6	15.9	27.6	9.8	28.3	326.5	10.9	14.4	16.9	35.1	36.9	20.9	39.0	38.6	5.6	58.4	11.2	0.0	10.3	33.5	24.7	12.3	63.7	7.7	45.9	17.7
GSX1	"Gsh-1, GSH1"	ENSG00000169840	"GS homeobox 1"	Q9H4S2	13	27792643-27794768	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	8	"brain: 7.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	29	"glioma: 3.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"JURKAT: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA047096			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA047096: AB_2679929"					"unprognostic (1.62e-1)"													0.1	0.1	1.6	0.1	3.2	0.1	0.1	0.9	4.0	0.1	0.1	2.5	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.7	7.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.9	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.2	0.9	1.5	0.7	7.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GTDC1	"FLJ11753, Hmat-Xa"	ENSG00000121964	"Glycosyltransferase like domain containing 1"	Q4AE62	2	143938068-144332568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036694			Approved	Cytosol		NA	NA			Cytosol		"HPA036694: AB_10671709"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-7)"	"unprognostic (8.01e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-3)"	"unprognostic (6.96e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.44e-1)"	"unprognostic (8.23e-2)"	"unprognostic (6.31e-3)"	"unprognostic (1.89e-1)"	14.5	12.9	22.1	7.1	17.3	12.3	8.9	7.3	26.7	12.9	6.9	15.3	1.6	4.0	6.8	9.8	7.5	6.0	10.1	15.2	21.4	14.1	9.4	6.4	8.0	9.8	18.2	14.9	12.6	7.0	10.9	10.7	9.3	14.1	6.4	6.7	7.0	5.9	6.0	8.8	5.3	4.8	7.1	24.0	12.6	4.8	11.7	11.6	6.1	10.6	3.1	11.2	8.9	6.3	4.3	2.0	10.8	2.5	8.0	12.3	3.4	4.7	2.0	14.2	2.6	14.6	13.5	4.3	3.3	8.3	7.3	10.1	2.2	4.4	10.2	2.3	5.9	4.7	1.3	2.8	4.9	15.7	13.0	3.3	15.7	1.7	2.2	6.0	6.3	8.6	9.3	12.2	7.9	11.6	5.0	10.4	4.2	2.8	11.9	16.7	2.2	1.6	7.0	4.0	3.6	3.2	4.7	7.3	2.7	8.1	9.7	7.1	5.7	6.4	5.5	6.5	9.3	3.6	7.2	6.4	8.1	6.0	3.6	4.1	7.6	0.0	5.7	4.8	4.2	10.9	2.1	2.5	7.3	5.7	2.2	12.3	4.3	3.8	9.5	2.0	3.4	0.8	6.3	10.8	8.0	2.4	0.7	4.7	3.4	22.1	17.3	7.3	26.7	21.4	14.1	18.2	14.9	14.1	11.6	8.9	30.5	7.5	3.9	6.4	19.2	15.9	0.0	18.7	17.0	5.2	3.9	3.4	5.0	3.7	8.5	11.3	3.5	0.0	9.0	3.8	16.5	3.7	16.3	3.0	9.0	17.5	4.1	23.9	16.9	3.6	11.8	12.1	5.0	10.8	2.6	11.0	7.4	3.5	13.1	5.7	3.5	12.9	17.3	3.7	19.6	4.1	3.5	16.0	3.5	7.8
GTF2H2C		ENSG00000183474	"GTF2H2 family member C"	Q6P1K8	5	69560208-69594723	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA047001			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA047001: AB_2679899"	"unprognostic (3.70e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.34e-2)"	"unprognostic (7.12e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.55e-1)"	3.0	3.4	2.3	6.8	2.3	2.0	3.4	2.8	3.2	4.1	2.9			1.1	4.8	1.2	2.6	4.1	1.9	3.2	2.5	2.5	5.0	5.5	4.0	5.9	2.5		7.2	5.4	6.1	3.0	1.9		3.9	3.6		3.6	4.1	3.0	2.4	3.8	7.7	2.7	3.8	3.5	4.2			8.4		1.1	3.3	3.2	4.5	3.2	8.2	2.9	3.4	4.6	3.0	4.5	2.4	3.0	3.4	1.4	2.1	7.4	10.4	5.0	7.8	9.5	3.8	3.2	8.7	16.2	1.9	2.8	1.7	4.0	2.5	13.2	11.4	4.1	13.7	1.7	2.9	1.8	7.9	4.1	1.5	0.8	2.9	1.9	1.6	2.8	4.6	8.9	5.6	0.3	6.5	8.1	0.5	4.1	0.4	1.6	2.9	9.4	13.5	12.1	5.4	3.0	7.6	14.3	1.8	1.7	3.3	3.7	7.1	6.2	6.3	5.3	3.2	15.5	2.9	21.0	7.0	3.4	8.0	13.3	6.0	2.9	3.5	2.4	2.9	3.4	3.2	1.9	3.6	3.2	4.5	2.7	4.6	8.2	3.4	2.1	2.6	3.3	3.0											8.9	7.5	13.8	4.7	3.2	10.2	6.9	12.7	10.7	13.6	14.0	11.8	3.9	8.3	6.4	14.7	5.2	5.4	0.0	5.0	2.2	5.1	5.1	0.0	5.6	3.7	17.5	2.4	9.2	7.3	14.7	8.3	9.0	3.3	1.8	2.7	7.6	5.0	4.2	11.0	7.7	14.8	0.0	6.6	17.6	14.5	3.6	1.1	5.4	4.7	6.4
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602604	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 62.8"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 29.7;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	4.6	7.6	4.3	5.1	6.8	0.6	6.3	4.4	7.8	9.4	8.2	8.2	9.2	7.0	7.4	8.7	16.4	7.0	8.6	7.7	3.9	5.5	9.3	3.6	7.2	2.6	8.5	5.3	8.6	10.0	21.1	25.3	5.3	6.6	8.2	5.5	21.6	11.3	8.3	62.8	15.6	5.2	12.1	5.6	1.6	8.8	4.5	5.7	1.3	16.4	12.9	7.3	10.5	13.2	0.6	1.8	2.7	0.5	0.6	0.7	0.1	9.3	5.9	12.9	14.1	10.4	5.1	0.1	4.0	10.6	7.8	8.2	10.2	13.4	2.4	3.0	8.0	19.2	5.4	10.2	4.7	5.8	0.1	6.1	0.4	19.9	11.4	33.4	0.1	0.3	7.1	19.2	5.4	22.6	18.3	4.0	4.7	6.8	0.0	8.7	11.8	1.2	8.2	10.3	11.3	6.1	12.6	7.5	8.7	14.8	6.5	10.6	14.5	9.8	17.8	8.7	6.8	10.6	9.3	2.2	8.1	8.3	5.2	9.0	0.5	1.4	3.9	3.3	0.1	6.5	1.2	0.5	0.5	0.3	0.2	0.3	0.4	0.7	0.2	1.8	0.6	0.3	0.4	2.7	0.6	0.1	0.6	0.2	0.1	4.3	6.8	4.4	7.8	3.9	5.5	8.5	5.3	6.6	5.7	8.9	8.0	0.0	9.4	7.0	29.7	7.2	7.6	10.7	4.5	8.7	31.4	0.9	10.0	6.4	0.5	2.7	3.3	0.0	8.1	1.4	4.6	16.3	2.3	2.6	2.2	20.6	4.1	1.8	2.4	0.0	3.7	4.0	6.8	1.0	4.0	5.6	8.5	2.9	5.3	12.4	38.9	0.0	4.6	0.0	5.1	5.8	2.4	0.0	6.8	14.2
GTF2IRD2	"FLJ37938, GTF2IRD2A"	ENSG00000196275	"GTF2I repeat domain containing 2"	Q86UP8	7	74796144-74851551	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 35.0"									"HPA056679, HPA056680"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056679: AB_2683205, HPA056680: AB_2683206"	"unprognostic (7.91e-5)"	"unprognostic (3.90e-3)"	"unprognostic (1.43e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.11e-2)"	"unprognostic (4.43e-5)"	"unprognostic (3.18e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.59e-4)"	3.9	4.3	3.1	2.1	2.0	4.0	5.6	2.1	2.1	6.0	5.6			3.2	5.6	3.1	3.1	6.0	2.5	4.6	2.8	2.7	4.6	6.4	4.3	2.8	2.8		9.3	6.6	4.3	5.6	1.9		6.5	3.8		4.9	4.3	21.6	3.2	3.8	4.5	2.7	3.4	5.3	2.6			6.0		2.9	4.5	4.2	14.9	12.4	10.4	6.8	5.0	9.8	6.6	9.7	3.4	4.4	6.6	6.4	4.2	4.0	3.3	3.4	4.0	4.4	0.7	8.1	2.6	0.9	5.4	6.7	2.0	0.1	2.1	3.3	1.2	0.8	2.5	5.0	4.6	6.0	3.4	0.4	3.9	3.2	1.1	3.1	4.8	3.9	1.9	6.0	5.3	3.6	9.0	1.3	9.7	7.3	10.4	2.3	2.5	1.5	9.1	9.2	8.5	3.3	10.3	13.6	35.0	7.5	3.9	7.4	6.5	3.7	5.9	1.5	1.0	5.3	4.1	1.7	2.6	5.1	2.4	12.6	10.4	6.8	7.2	3.4	3.9	5.0	14.9	7.6	9.8	7.0	10.0	9.2	5.9	1.1	5.0	3.3	12.4	6.5	6.6											17.9	20.6	19.7	9.7	2.9	23.8	10.1	22.9	25.4	21.6	12.2	53.0	5.5	3.3	17.6	17.8	5.8	12.5	0.0	24.7	5.1	9.3	11.3	13.9	8.1	3.9	35.0	25.9	16.5	5.1	3.8	40.6	6.9	10.1	8.2	20.3	16.6	22.6	21.0	24.4	4.2	42.7	12.9	8.6	2.7	2.0	3.8	5.4	12.9	24.0	6.8
GTF2IRD2B		ENSG00000174428	"GTF2I repeat domain containing 2B"	Q6EKJ0	7	75092573-75149817	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 12.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA056679, HPA056680"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056679: AB_2683205, HPA056680: AB_2683206"	"prognostic favorable (3.27e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.90e-4)"	"unprognostic (1.54e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.31e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-5)"	7.3	6.7	6.3	9.2	13.4	7.5	9.9	5.9	9.4	11.2	11.0	11.4	4.6	2.7	13.4	4.4	5.4	12.7	9.2	12.3	7.9	4.5	8.7	9.5	8.2	7.3	11.0	6.7	21.7	10.4	10.5	7.5	4.2	10.8	12.9	5.7	9.8	7.2	8.4	18.8	4.7	5.6	11.3	5.8	4.4	8.7	3.5	14.1	6.3	7.8	4.0	7.1	13.0	6.7	12.8	1.5	5.1	1.9	1.6	3.3	0.5	12.1	5.6	8.7	9.8	7.0	9.8	6.6	6.7	10.1	3.2	8.2	2.5	9.8	8.1	6.6	6.9	12.3	4.4	4.1	4.3	3.9	9.8	3.8	6.0	7.2	5.1	13.6	8.8	8.6	9.0	9.0	2.6	11.6	11.2	4.6	3.0	7.6	17.1	10.4	8.7	6.2	20.5	8.7	11.1	8.2	12.0	2.8	11.3	9.0	9.3	8.5	14.9	13.4	14.8	14.3	2.5	14.4	8.9	7.2	8.1	5.4	7.6	8.5	6.7	4.0	20.7	4.2	9.0	17.8	0.5	1.3	5.1	1.2	1.9	2.0	12.8	2.1	2.6	1.2	5.7	3.3	1.3	1.7	1.6	1.1	1.5	2.7	0.5	6.3	13.4	5.9	9.4	7.9	4.5	11.0	6.7	10.8	14.1	0.0	9.6	11.3	4.4	3.9	8.5	20.6	12.7	9.4	2.3	7.0	11.8	1.7	0.0	10.5	11.1	6.6	8.1	0.0	11.3	1.6	8.2	4.5	3.5	11.1	2.2	12.7	18.5	8.0	8.9	3.6	25.3	3.5	20.3	4.6	13.8	4.8	12.0	14.0	15.9	2.9	12.7	12.9	10.3	2.3	1.3	3.8	2.5	5.7	13.8	3.4
GTF3C3	"TFIIIC102, TFiiiC2-102"	ENSG00000119041	"General transcription factor IIIC subunit 3"	Q9Y5Q9	2	196763032-196799725	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069179			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA069179: AB_2686099"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.92e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-2)"	19.3	20.3	14.9	14.3	20.0	34.6	23.4	17.3	21.2	17.3	15.3	16.3	14.1	13.1	19.7	18.7	18.1	17.5	21.5	16.1	12.6	11.7	16.2	16.6	15.1	20.0	20.9	16.4	20.3	23.5	21.5	30.8	20.4	23.4	17.2	18.3	11.8	17.7	15.0	22.6	23.9	20.1	18.3	22.3	19.4	18.0	17.5	20.3	29.8	18.6	19.1	18.7	19.5	25.4	14.3	11.8	16.3	15.0	12.6	14.3	7.4	11.0	11.9	21.4	16.2	10.4	14.3	23.7	18.4	12.4	18.4	17.5	26.1	17.4	22.8	14.4	11.7	22.8	16.1	21.4	17.9	23.7	25.8	20.3	28.7	33.3	23.8	17.9	24.8	21.9	19.9	18.7	15.4	21.0	19.6	17.4	22.8	32.5	33.3	10.0	20.3	24.5	20.3	13.9	13.1	22.0	19.9	17.7	15.6	13.8	26.5	15.8	16.9	14.3	11.8	15.3	33.4	11.1	18.9	15.1	15.8	13.1	12.6	16.4	20.3	24.7	16.8	17.7	18.4	14.5	16.3	11.0	10.8	11.2	10.5	13.4	12.6	11.5	12.2	11.8	14.3	14.3	12.9	7.1	12.6	15.0	10.4	12.4	7.4	14.9	20.0	17.3	21.2	12.6	11.7	20.9	16.4	23.4	20.3	20.8	13.6	6.8	10.9	3.5	18.1	30.2	2.5	41.5	21.6	14.0	17.7	12.7	11.6	11.2	3.0	12.8	8.4	0.0	10.8	10.4	8.9	7.4	13.9	6.8	11.6	0.0	12.0	14.1	10.5	3.8	12.4	10.3	6.8	23.4	9.0	12.6	13.5	7.0	10.3	8.1	14.9	6.5	7.8	43.3	19.0	4.8	13.2	10.2	10.3	6.8
GTPBP1	"GP-1, HSPC018"	ENSG00000100226	"GTP binding protein 1"	O00178	22	38705723-38738299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003166, HPA064702"	Approved		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA003166: AB_10601476, HPA064702: AB_2685329"	"unprognostic (1.42e-3)"	"unprognostic (5.82e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (3.17e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.98e-3)"	18.0	17.1	16.0	22.1	20.6	86.0	16.5	24.9	24.9	16.2	17.4	26.8	20.8	20.6	19.6	15.6	19.3	22.7	20.6	19.5	17.2	14.1	15.9	14.7	24.8	20.9	20.6	21.7	25.9	21.0	23.1	23.1	15.6	17.2	20.8	17.9	28.8	18.7	19.9	28.5	23.0	21.2	20.3	16.1	25.5	18.8	17.2	22.7	18.3	23.1	12.6	23.6	23.6	16.5	7.2	5.0	12.1	7.3	3.4	7.7	4.3	13.6	5.0	18.2	14.6	6.4	9.5	9.0	12.4	14.1	19.4	16.6	10.4	7.2	12.8	4.8	13.0	8.7	12.3	21.5	13.9	10.7	21.8	15.6	22.7	16.2	7.4	12.0	26.7	11.5	10.2	10.6	15.5	24.3	10.6	10.4	9.5	13.6	27.1	10.6	5.6	15.0	11.6	13.2	7.6	9.6	29.1	18.5	15.9	6.7	10.9	24.9	8.7	15.5	10.2	9.5	8.0	9.3	11.4	12.5	10.5	10.6	7.7	9.9	25.1	8.6	17.9	10.0	13.6	8.3	3.6	4.3	5.5	7.5	7.0	6.6	7.2	5.5	7.7	5.0	6.6	4.1	5.7	12.1	3.4	7.3	2.6	4.9	4.3	16.0	20.6	24.9	24.9	17.2	14.1	20.6	21.7	17.2	22.7	8.9	6.7	27.3	30.2	24.6	30.9	8.8	7.6	10.7	7.9	12.2	21.6	6.3	5.0	10.4	3.5	11.1	28.2	23.3	16.8	6.5	11.3	34.0	13.9	11.9	7.7	19.1	15.5	9.2	16.8	4.1	15.0	12.5	10.1	33.3	18.9	10.6	15.3	14.0	18.0	5.4	39.1	25.8	20.2	16.1	5.9	29.9	15.9	18.5	10.5	39.6
GTPBP2		ENSG00000172432	"GTP binding protein 2"	Q9BX10	6	43605316-43629162	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 56.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031418, HPA031419"	Approved		Approved	Vesicles		NA	Yes			Vesicles		"HPA031418: AB_2673872, HPA031419: AB_10600709"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.31e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (1.44e-15)"	"unprognostic (1.13e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	26.8	19.8	21.4	28.0	19.7	27.9	23.5	27.5	26.1	20.1	22.4	19.9	29.6	22.7	19.0	20.5	38.2	14.5	18.6	20.5	19.1	10.8	20.5	22.5	29.1	21.4	15.0	17.4	20.4	26.2	30.9	26.8	24.1	17.9	20.7	20.7	19.9	29.0	25.3	19.2	19.8	21.9	21.0	17.0	28.8	23.8	17.2	20.1	28.2	30.0	13.3	29.6	25.7	25.2	3.0	2.8	7.0	2.5	1.2	3.4	4.4	17.8	4.7	12.6	8.5	9.7	10.5	14.4	17.0	18.4	20.0	22.9	5.4	7.6	6.5	7.3	9.1	16.9	9.7	4.7	6.9	13.8	17.6	10.2	16.0	12.0	4.8	38.8	10.3	17.8	12.3	48.4	22.1	56.8	13.2	10.3	9.1	22.2	33.2	9.9	6.2	7.6	14.9	3.8	19.3	5.5	6.6	9.1	7.2	9.3	10.9	10.8	11.2	5.8	5.3	21.7	7.8	10.2	16.0	11.4	10.1	11.3	6.4	11.3	22.6	10.7	8.7	14.5	9.5	10.5	7.0	2.5	5.0	3.4	1.4	2.0	1.7	0.9	3.0	1.3	3.0	2.4	2.8	3.7	1.2	2.0	2.8	1.5	4.4	21.4	19.7	27.5	26.1	19.1	10.8	15.0	17.4	17.9	20.1	3.0	5.6	5.1	1.9	4.6	6.1	9.2	7.6	0.0	2.3	1.8	7.9	2.1	0.0	8.2	14.5	6.7	9.2	0.0	8.7	9.0	4.9	4.4	1.1	4.0	7.0	1.6	1.2	8.0	13.6	36.8	4.9	5.7	6.8	8.2	7.0	2.2	17.0	6.2	3.9	1.1	8.1	12.9	3.8	7.7	9.1	4.5	2.1	2.1	5.0	9.5
GTPBP6	"FLJ20977, PGPL"	ENSG00000178605	"GTP binding protein 6 (putative)"		X	304529-318819	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013336, CAB034924, HPA035467, HPA055418"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB034924: AB_2115410, HPA013336: , HPA035467: AB_10671104, HPA055418: "	"unprognostic (5.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.38e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	6.3	4.9	22.2	5.6	40.5	8.1	33.6	30.5	29.9	18.9	5.2	0.6	0.6	7.0	17.0	0.6	4.7	6.3	3.1	19.7	22.7	5.9	21.1	4.0	4.1	6.0	39.5	15.0	18.2	11.9	2.1	16.6	16.6	26.4	4.1	1.6	0.6	11.2	4.7	22.8	5.7	7.6	1.9	25.5	6.4	7.5	2.4	34.2	0.6	4.1	0.6	1.9	3.7	25.4	7.3	11.1	8.1	6.3	5.3	9.2	3.8	15.2	25.3	5.6	11.7	6.5	7.1	20.9	9.5	7.1	12.1	11.1	38.7	12.8	19.2	13.6	5.3	16.4	9.5	5.9	9.2	2.0	15.9	17.2	15.8	12.4	26.4	17.6	10.6	15.5	8.8	12.3	8.0	5.9	4.5	9.7	12.8	11.6	9.0	4.9	30.2	18.8	14.0	13.7	3.1	18.1	8.4	9.9	30.6	7.0	17.9	15.8	13.5	10.4	11.8	17.5	3.2	10.6	9.3	12.8	17.7	12.3	26.1	14.6	12.3	11.0	29.6	9.2	14.0	8.1	8.1	6.3	6.7	7.8	6.3	7.6	7.3	6.9	8.7	6.1	6.0	8.5	7.7	0.9	5.3	5.8	11.1	9.2	3.8	22.2	40.5	30.5	29.9	22.7	5.9	39.5	15.0	26.4	34.2	17.9	16.3	23.9	39.0	25.0	27.0	16.8	28.1	5.3	10.3	26.2	25.5	20.5	44.7	10.7	0.9	23.7	23.1	0.0	12.8	38.8	22.6	37.4	11.5	32.1	26.3	12.7	17.1	14.1	12.6	1.4	18.1	23.2	25.3	11.8	23.0	15.2	11.3	8.6	17.7	74.7	25.1	6.5	31.3	5.1	12.1	23.2	24.6	27.7	32.2	44.8
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296741-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0;testis: 22.3"	"Cell type enhanced"	"Detected in many"	18	"Erythroid cells: 93.5;Extravillous trophoblasts: 27.0;Spermatocytes: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"		Yes	Yes			Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.90e-10)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	1.1	1.3	0.3	10.4	0.8	10.2	1.3	1.0	1.1	1.2	2.5	0.7	0.1	4.1	1.1	1.3	6.6	0.4	0.4	0.8	1.0	0.3	0.9	0.9	1.3	9.0	0.6	0.4	0.9	0.5	0.0	0.9	2.8	1.8	0.6	2.6	0.7	1.5	0.1	0.3	2.4	3.3	1.0	0.6	4.6	2.4	22.3	0.3	20.0	0.5	5.8	8.8	1.1	2.1	1.4	1.9	3.0	0.2	1.8	1.6	0.9	21.8	10.4	20.5	16.2	0.4	1.2	9.8	19.0	9.0	27.7	22.9	10.8	8.3	20.7	5.0	7.3	12.7	11.5	18.3	4.8	17.8	12.4	19.7	13.8	14.6	8.4	0.0	24.7	16.9	0.2	0.3	11.9	6.1	2.9	11.9	15.0	10.5	26.0	16.5	12.2	22.1	12.1	14.3	9.0	11.7	22.0	23.0	13.5	4.5	4.0	10.6	14.5	18.1	11.8	8.4	9.6	10.0	9.6	9.4	15.8	30.0	12.9	19.9	14.9	7.1	21.0	10.0	11.9	23.0	0.1	0.2	1.5	1.3	0.1	0.4	1.4	0.6	0.6	0.3	0.6	0.4	0.3	3.0	1.8	0.1	1.9	1.6	0.9	0.3	0.8	1.0	1.1	1.0	0.3	0.6	0.4	1.8	0.3	0.0	0.0	0.8	0.6	2.5	0.6	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	3.9	0.4	0.5	93.5	0.2	27.0	1.1	0.6	0.0	0.5	16.0	0.0	1.2	5.5	6.2	3.8	0.3	3.5	0.0	0.0	2.0	0.2	0.4	0.0	0.7	0.4	0.1	6.5	0.9	47.7	20.4	2.3	1.3	2.9	3.7	1.4
GTSF1	"FAM112B, FLJ32942"	ENSG00000170627	"Gametocyte specific factor 1"	Q8WW33	12	54455950-54473602	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 20.3;testis: 62.3"	"Cell type enhanced"	"Detected in many"	24	"Early spermatids: 927.5;Late spermatids: 1408.5;Spermatocytes: 345.5"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 23.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 47.4;HMC-1: 35.4;K-562: 46.4;NB-4: 71.8;THP-1: 66.2;U-266/84: 53.1;U-937: 35.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA038876, HPA038877"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038876: AB_10670911, HPA038877: AB_2676251"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.97e-5)"	"unprognostic (4.16e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.18e-2)"	0.3	0.2	0.3	1.5	0.4	1.8	0.5	0.1	0.2	0.1	0.2	0.2	0.0	0.3	0.1	0.5	0.3	0.2	0.3	0.3	0.4	0.2	0.3	0.4	0.7	1.7	0.3	0.0	0.2	0.2	0.0	0.2	9.9	0.2	0.2	0.6	0.1	0.2	0.0	0.4	0.2	0.6	0.0	0.3	3.3	0.2	62.3	0.0	3.0	0.2	0.0	3.5	0.5	0.2	19.7	19.7	13.5	6.1	17.6	20.3	9.7	0.1	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	8.9	0.0	0.0	0.0	25.3	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	47.4	35.4	0.0	0.0	0.0	0.0	0.0	0.0	14.2	46.4	19.2	0.0	0.0	0.0	71.8	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	66.2	0.2	0.0	1.7	0.0	0.1	19.3	53.1	0.1	0.0	35.4	0.0	13.5	5.9	10.5	14.4	5.6	17.9	19.7	17.0	20.3	9.7	16.5	15.8	16.6	2.7	17.6	6.1	19.7	17.6	9.7	0.3	0.4	0.1	0.2	0.4	0.2	0.3	0.0	0.2	0.0	0.0	1.1	3.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	927.5	0.0	0.0	0.0	0.0	96.3	0.2	0.0	1.1	0.0	10.8	0.0	0.0	0.0	2.4	1408.5	14.7	3.3	3.3	15.4	0.0	0.0	0.0	0.0	9.6	0.0	0.0	12.9	0.3	345.5	99.5	0.3	22.5	7.5	0.0	0.0
GUCA1A	"C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1"	ENSG00000048545	"Guanylate cyclase activator 1A"	P43080	6	42155406-42180056	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"retina: 91.2;testis: 62.2"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 628.3;Late spermatids: 331.5;Rod photoreceptor cells: 949.8"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Cell type enriched"	"Detected in single"	84	"plasmacytoid DC: 8.4"	"Lineage enriched"	"Detected in single"	84	"dendritic cells: 8.4"	"Group enriched"	"Detected in some"	8	"NTERA-2: 7.2;SH-SY5Y: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005561, HPA075056"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005561: AB_2667361, HPA075056: "	"unprognostic (1.91e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (9.70e-2)"		"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.79e-1)"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (1.16e-1)"	0.2	0.2	2.7	0.3	10.0	0.2	0.2	0.1	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	1.5	5.4	0.1	0.1	0.2	0.3	1.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	91.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.1	62.2	0.1	0.1	0.1	0.1	0.5	0.3	0.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	2.7	10.0	0.1	0.8	1.5	5.4	1.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	118.0	0.3	0.0	0.0	0.0	0.0	628.3	0.4	0.0	0.0	108.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	62.0	0.0	0.0	0.0	331.5	1.7	0.0	0.0	9.0	0.0	125.6	0.0	0.0	1.8	0.0	949.8	0.0	0.0	2.8	1.9	0.0	0.2	0.0	0.0	0.0
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953895	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"heart muscle: 10.2;pancreas: 31.0;retina: 15.7"	"Cell type enriched"	"Detected in some"	6	"Cone photoreceptor cells: 117.8"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	84	"RPTEC TERT1: 18.0"									HPA041597	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.7	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.7	31.0	0.0	0.2	0.0	0.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.0	0.0	2.8	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.7	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	7.4	5.5	0.0	0.0	0.0	0.0	117.8	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	8.2	0.5	0.0	0.0	0.0	19.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
GUCD1	"C22orf13, LLN4, MGC1842"	ENSG00000138867	"Guanylyl cyclase domain containing 1"	Q96NT3	22	24540423-24555935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.3"	"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022786			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022786: AB_1845711"	"unprognostic (1.58e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (2.83e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.01e-2)"	16.7	12.8	7.6	13.6	7.2	25.8	19.0	5.1	7.5	9.0	37.4	8.7	9.7	23.3	7.8	9.8	14.3	7.4	19.7	35.7	7.0	5.6	29.3	73.3	12.2	11.9	8.0	5.3	10.2	30.0	7.0	6.7	11.3	6.8	11.7	12.8	9.0	8.7	8.7	28.9	8.8	59.9	13.5	8.0	14.9	15.8	9.1	5.7	13.4	10.6	14.5	13.8	14.3	8.0	23.3	6.5	23.7	7.0	3.3	4.4	5.5	13.9	13.1	11.7	14.3	24.6	23.1	9.3	13.9	22.4	24.4	23.9	19.9	10.9	26.5	9.1	18.9	15.1	18.6	13.4	16.2	13.1	25.4	16.2	11.3	13.0	18.1	19.9	29.3	22.4	23.3	13.0	24.3	11.2	15.0	25.7	13.3	11.3	26.6	18.3	16.5	16.9	12.6	11.0	35.2	11.3	19.5	19.0	26.0	19.1	15.5	12.2	12.0	16.7	22.8	11.9	9.5	18.0	20.9	17.1	52.6	21.7	16.3	11.7	25.9	17.7	18.6	21.6	16.5	17.7	7.8	7.0	23.7	3.8	7.0	4.4	18.6	3.6	3.9	6.5	23.3	3.5	3.9	7.4	3.3	6.6	4.7	3.4	5.5	7.6	7.2	5.1	7.5	7.0	5.6	8.0	5.3	6.8	5.7	14.9	23.9	38.4	10.3	11.0	4.9	45.6	94.3	2.7	10.3	5.2	5.9	15.8	44.7	22.0	10.3	15.4	117.4	46.7	56.9	16.4	16.6	31.1	15.0	103.6	23.7	3.2	19.0	20.9	20.4	5.8	17.5	13.3	16.9	33.3	46.5	13.7	39.7	66.2	15.2	65.8	12.4	25.8	17.9	20.5	32.8	9.7	13.6	9.5	37.7	15.7
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807591	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.6"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 6.0;Collecting duct cells: 8.7;Ductal cells: 14.1;Proximal tubular cells: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 5.6;non-classical monocyte: 17.8"	"Lineage enriched"	"Detected in many"	12	"monocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"HEL: 25.3;Karpas-707: 13.4;MOLT-4: 16.0;RPTEC TERT1: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA		5200	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	8.8	5.4	18.7	9.8	42.0	1.8	5.5	12.2	36.8	8.1	14.9	5.7	0.4	4.2	11.3	4.7	5.9	9.5	9.2	12.2	16.1	25.0	9.2	5.4	9.4	6.6	14.5	23.2	3.7	7.4	71.6	3.8	28.0	20.6	9.8	6.2	5.8	3.2	8.7	3.8	2.2	5.9	16.3	6.7	7.2	8.9	2.1	5.5	2.6	4.6	2.4	5.1	8.0	6.8	0.2	1.4	1.1	17.8	0.9	0.0	4.8	0.0	0.2	3.6	0.0	1.2	6.8	0.0	1.1	2.0	0.1	0.0	0.0	0.0	0.0	1.7	0.6	2.9	0.0	7.4	0.1	0.4	0.0	2.7	25.3	0.0	0.0	0.7	0.0	0.0	3.0	0.2	0.0	0.1	2.5	0.0	5.7	0.0	13.4	1.8	1.1	16.0	0.0	0.2	0.0	1.9	1.8	0.5	0.4	25.7	2.4	0.4	4.5	0.0	0.1	0.0	3.7	0.0	0.0	0.0	4.2	0.9	7.2	5.3	0.1	0.0	0.0	9.2	0.0	0.0	1.1	0.4	0.3	0.0	5.6	0.0	0.1	0.0	0.0	1.4	0.2	0.0	0.0	0.4	0.9	17.8	1.2	0.0	4.8	18.7	42.0	12.2	36.8	16.1	25.0	14.5	23.2	20.6	5.5	6.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.5	5.0	14.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.1	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678427-44700926	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	10.0	11.3	12.7	7.5	16.6	11.4	10.8	9.7	17.7	7.6	11.5	9.4	8.7	9.4	10.2	9.1	13.2	8.9	7.9	12.3	12.6	9.9	15.1	16.0	6.6	10.8	10.4	11.6	10.6	9.3	11.5	11.3	7.8	13.0	10.6	12.4	7.4	10.4	8.0	31.1	11.5	12.5	7.6	11.8	9.7	15.4	11.7	11.1	13.9	11.2	13.1	9.3	11.7	9.2	4.8	4.7	4.6	6.1	5.2	7.0	3.9	7.7	3.9	7.4	9.4	3.1	6.4	16.3	10.6	5.6	11.1	8.6	7.0	5.6	16.9	8.5	5.2	10.1	6.2	12.7	12.3	12.7	5.7	8.1	20.2	3.4	4.8	10.0	21.9	8.7	6.4	5.6	8.2	7.2	5.2	7.9	10.1	20.3	3.3	8.9	3.8	12.2	4.6	4.8	5.6	9.3	8.8	15.3	7.1	3.3	3.0	10.2	7.6	6.8	2.9	7.5	6.0	4.5	6.4	7.9	7.6	8.8	10.1	12.7	12.2	11.1	12.4	8.3	13.1	6.4	1.1	4.6	4.6	4.7	6.1	6.1	4.8	4.7	4.2	4.3	4.4	4.5	4.6	0.1	5.2	4.0	4.7	7.0	3.9	12.7	16.6	9.7	17.7	12.6	9.9	10.4	11.6	13.0	11.1	6.0	7.4	12.1	7.4	3.5	9.7	19.3	2.5	22.7	10.3	7.0	2.0	11.2	11.6	7.9	1.4	6.8	9.1	23.3	8.8	14.4	7.3	8.4	1.1	13.4	10.4	11.1	10.9	10.4	11.7	1.5	5.2	6.6	6.8	6.4	12.4	8.6	11.9	5.8	6.7	8.4	10.2	0.0	8.2	9.2	9.6	6.1	11.2	8.9	11.9	9.1
GULP1	"CED-6, CED6, GULP"	ENSG00000144366	"GULP, engulfment adaptor PTB domain containing 1"	Q9UBP9	2	188291669-188595931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid transport, Phagocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 86.0"	"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 131.2;Muller glia cells: 100.6;Syncytiotrophoblasts: 170.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 32.7;WM-115: 71.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020587	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA020587: AB_1850452"	"unprognostic (1.95e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.23e-1)"	"prognostic favorable (4.25e-6)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.04e-4)"	8.0	15.0	3.1	7.6	9.8	0.0	9.7	0.7	8.0	22.6	11.8	2.2	14.4	6.5	23.3	40.6	11.5	10.4	8.9	5.1	2.5	4.8	11.4	1.0	9.0	1.2	2.4	4.5	17.9	32.3	23.9	3.7	86.0	14.3	14.3	3.8	19.4	10.7	16.1	5.9	5.0	10.5	15.1	2.8	3.2	11.9	17.0	2.2	0.3	8.0	6.1	3.1	11.3	20.2	0.6	0.4	1.5	1.9	0.6	0.2	0.3	3.8	9.4	32.7	7.3	5.1	5.0	6.1	5.3	9.0	8.7	7.0	5.9	18.9	0.0	4.0	4.2	8.4	2.5	6.5	0.4	6.3	0.0	4.3	8.0	7.1	0.0	4.7	0.0	0.0	3.0	1.2	4.1	4.4	13.3	4.0	0.0	6.7	0.1	5.9	0.5	0.0	0.1	8.3	5.5	14.6	0.0	7.7	3.8	17.3	1.6	0.1	24.6	0.0	4.4	11.3	14.7	1.5	0.0	1.9	2.6	1.2	8.8	2.9	0.0	0.0	0.0	1.4	0.0	71.2	1.3	1.9	0.4	0.2	1.1	0.1	0.3	0.1	0.1	0.4	0.6	0.2	0.2	1.5	0.6	0.7	0.2	0.1	0.3	3.1	9.8	0.7	8.0	2.5	4.8	2.4	4.5	14.3	2.2	14.9	12.0	0.8	22.6	14.0	1.2	1.2	50.9	49.5	37.5	22.7	0.0	32.9	38.1	25.9	3.4	21.5	13.4	0.0	33.1	5.1	35.1	61.3	0.0	0.2	2.8	1.6	131.2	5.5	0.6	4.7	19.0	3.6	33.7	1.8	2.0	100.6	43.4	5.8	57.7	30.0	1.5	6.5	40.6	35.4	22.8	24.1	170.9	0.0	0.8	15.0
GVQW3		ENSG00000179240	"GVQW motif containing 3"	Q3ZCU0	11	76381313-76414619	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"		"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 3.8;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 8.3;granulocytes: 3.5;Proximal tubular cells: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA057405	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Centrosome"		NA	NA			"Nucleoplasm, Centrosome"	"Endoplasmic reticulum"	"HPA057405: AB_2683429"	"unprognostic (8.90e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.56e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.05e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.13e-1)"	3.3	5.8	7.0	4.7	11.8	3.5	5.8	13.9	14.3	5.0	3.2	5.0	2.2	4.5	6.7	4.0	1.8	7.1	2.5	3.2	6.2	5.2	5.1	2.5	2.9	6.0	4.0	7.2	8.4	16.0	3.2	15.9	3.0	8.7	3.5	4.9	7.6	9.1	3.3	2.9	4.5	3.6	3.5	4.2	5.0	4.2	9.6	4.6	5.5	5.5	0.4	5.7	2.8	4.0	3.1	1.7	5.1	1.2	3.8	4.1	1.2	1.7	2.2	9.4	5.0	2.3	4.7	2.5	1.2	1.0	2.2	2.1	6.5	3.9	7.4	3.3	1.2	3.6	5.3	5.1	1.3	3.0	5.1	3.0	3.8	8.4	2.1	1.2	3.4	2.0	1.1	1.5	3.4	1.3	2.1	1.4	9.6	2.4	4.4	0.7	2.1	4.7	5.6	1.5	2.3	3.3	6.9	5.5	4.6	0.7	1.8	12.2	4.3	2.9	1.3	0.8	3.7	3.8	1.0	0.8	3.9	3.8	6.1	1.4	4.8	2.3	6.8	1.2	3.0	2.2	3.5	1.2	1.2	3.7	0.7	2.5	3.1	3.8	1.7	1.7	3.1	4.1	4.1	5.1	3.8	0.8	1.2	3.3	1.2	7.0	11.8	13.9	14.3	6.2	5.2	4.0	7.2	8.7	4.6	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	1.8	0.0	0.9	8.3	1.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888073-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 37.7;Fibroblasts: 14.2;Late spermatids: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 14.6;JURKAT: 14.1;MOLT-4: 22.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	8.7	7.2	3.1	6.2	4.0	2.1	5.2	1.1	4.0	10.2	4.5	8.1	3.4	0.9	8.4	9.3	4.2	6.7	12.4	20.6	3.4	2.4	2.2	1.0	5.2	2.4	5.6	4.7	24.8	11.9	2.8	3.8	4.9	4.2	11.3	2.7	10.7	8.0	5.2	2.2	2.6	2.5	12.0	5.4	1.0	2.6	8.4	4.7	14.9	12.1	3.7	2.3	12.2	6.9	0.4	3.0	1.7	0.1	0.8	1.4	0.1	0.1	1.1	0.0	7.2	6.6	13.0	1.1	1.1	2.7	2.6	6.4	0.3	0.8	0.0	2.0	3.0	14.6	0.1	0.7	1.4	2.5	0.0	0.8	0.0	4.8	7.7	8.4	3.0	0.0	12.5	0.7	6.3	1.0	3.9	0.0	14.1	3.5	0.1	1.5	1.6	22.3	0.1	4.3	0.1	1.4	0.1	6.1	0.0	0.8	1.1	0.7	3.3	6.2	0.3	0.8	1.4	2.4	0.9	0.0	2.8	9.0	8.7	4.1	0.6	0.1	0.1	7.3	1.4	4.9	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.2	1.7	0.8	0.1	3.0	1.4	0.1	3.1	4.0	1.1	4.0	3.4	2.4	5.6	4.7	4.2	4.7	3.0	1.6	0.0	1.5	1.6	0.6	9.8	2.5	1.4	1.2	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.9	0.0	1.0	0.2	14.2	1.3	0.0	0.0	0.3	0.0	3.4	1.3	0.0	17.8	7.5	0.3	0.0	0.0	2.3	2.5	1.2	0.0	6.7	0.4	0.4	0.0	1.0	2.9	3.2	0.4	0.7	0.0	1.5	0.4
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991341-149027668	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.0"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 202.8;Early spermatids: 172.2;Late spermatids: 292.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030497, HPA073229"	Supported		Approved	Vesicles		NA	NA			Vesicles		"HPA030497: AB_10602326, HPA073229: "	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	10.8	7.9	7.0	8.5	8.5	55.7	10.0	9.2	7.5	10.6	31.0	6.0	11.9	4.8	15.6	15.4	18.1	11.1	12.0	32.0	8.0	9.0	8.5	6.3	9.1	14.7	11.6	7.1	13.3	14.3	6.5	7.8	6.5	10.0	16.3	7.6	7.7	11.3	19.4	113.0	4.7	8.4	32.5	8.1	13.6	12.8	47.3	7.4	4.2	9.4	39.6	8.5	28.7	14.6	7.0	26.7	16.8	26.7	17.7	32.5	17.5	18.8	12.2	9.1	10.2	25.3	26.5	12.4	27.8	23.2	40.6	38.1	15.9	19.3	0.0	13.8	32.2	21.7	5.8	23.9	12.3	41.1	6.3	10.3	14.4	5.8	18.0	22.9	14.6	21.8	14.5	20.1	13.4	17.0	21.2	23.3	9.5	8.8	34.3	23.3	33.2	2.8	11.7	10.9	14.6	10.0	8.0	13.8	27.0	11.2	17.7	7.5	3.5	14.7	20.3	15.8	9.0	20.1	15.6	19.3	20.8	6.2	14.9	20.3	31.2	17.3	13.4	17.6	22.6	6.7	7.2	23.4	16.8	17.4	24.5	32.5	7.0	11.6	18.1	26.7	5.1	6.3	10.7	11.6	17.7	26.7	10.7	15.9	17.5	7.0	8.5	9.2	7.5	8.0	9.0	11.6	7.1	10.0	7.4	11.9	12.0	15.2	20.5	10.8	7.4	202.8	10.2	16.0	11.4	31.4	17.7	31.4	23.2	37.5	172.2	32.3	12.4	0.0	67.2	38.6	32.6	36.2	17.4	13.9	84.7	6.4	13.8	43.0	102.9	292.0	49.2	51.1	38.8	27.9	13.4	81.1	32.6	13.3	72.2	12.2	4.9	64.7	60.5	46.6	19.8	13.0	24.5	62.3	12.1	16.9
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828788-2882820	"Enzymes, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 76.7;brain: 21.2;breast: 30.4"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 15.8;Intestinal endocrine cells: 19.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1"					"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favorable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	76.7	1.4	4.6	1.3	4.6	0.5	30.4	2.1	3.7	2.1	3.5	8.2	0.7	1.2	4.2	0.9	1.0	3.6	1.7	1.7	3.9	2.9	1.4	9.9	0.7	0.7	5.5	2.9	1.9	3.2	0.4	0.5	1.6	12.9	2.7	2.0	4.2	2.8	4.4	0.5	1.2	1.3	2.8	21.2	0.5	2.2	0.8	5.1	0.0	1.3	0.5	0.6	2.9	1.4	1.0	0.6	0.6	0.4	1.2	0.7	0.0	0.0	5.2	17.1	0.0	10.2	0.0	12.4	0.5	3.0	3.0	3.8	12.7	0.3	0.0	1.4	2.1	3.1	0.0	9.6	0.2	2.9	0.1	2.7	0.0	0.2	13.7	3.0	0.0	4.2	3.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.8	0.0	0.4	16.9	0.1	0.0	2.8	5.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	36.5	27.1	1.6	10.4	0.0	0.0	3.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.3	0.1	1.0	0.3	0.2	0.6	1.2	0.4	0.6	0.4	0.0	4.6	4.6	2.1	3.7	3.9	2.9	5.5	2.9	12.9	5.1	0.0	0.0	0.0	0.9	0.3	0.9	0.6	2.5	0.0	0.0	0.0	3.9	5.3	5.0	0.8	0.3	0.0	0.2	0.0	3.4	7.0	1.9	1.7	0.0	15.8	0.9	0.0	19.5	0.0	1.3	0.0	0.6	0.0	3.3	0.0	1.3	1.8	2.8	0.0	2.8	2.1	0.0	0.0	0.9	0.3	0.4	0.3	1.9	0.0	2.0	0.5
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140786	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 56.9"	"Cell type enriched"	"Detected in some"	311	"Erythroid cells: 1331.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"HEL: 57.0"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.0	0.2	0.1	0.4	56.9	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.3	1.7	1.3	3.2	0.1	0.3	0.1	0.1	0.1	0.0	0.3	4.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.3	0.4	0.2	0.2	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.2	0.9	0.1	0.2	0.2	1.5	0.2	0.6	0.2	0.2	0.2	0.3	0.0	0.8	0.2	0.4	0.1	0.5	0.2	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.3	0.0	0.0	1331.6	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968125-48993310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		NA	NA		10000	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: AB_2677571"	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	9.7	7.3	5.1	6.1	6.5	16.0	10.6	11.3	6.2	5.3	7.3	6.2	5.8	6.1	6.2	6.9	11.5	5.9	6.1	37.3	6.8	4.0	7.2	4.3	5.0	6.3	5.3	5.5	6.8	4.4	6.4	5.1	5.0	5.9	8.7	6.1	12.4	7.2	7.6	106.1	8.1	6.1	6.8	6.0	5.8	7.3	2.2	5.5	6.4	5.2	42.6	9.0	7.9	6.9	6.7	15.9	8.2	10.5	12.8	10.9	7.3	28.7	11.5	8.5	11.7	19.9	7.8	16.9	20.0	14.1	21.1	24.7	11.2	9.4	12.0	12.2	19.5	5.6	20.6	14.2	25.4	18.5	7.4	20.6	9.9	14.7	9.9	11.2	10.8	7.4	19.2	12.2	13.5	11.5	18.3	17.6	12.7	6.9	16.1	26.4	10.9	13.4	9.4	4.5	12.5	13.2	11.4	14.9	11.8	20.9	30.9	5.3	7.4	17.8	23.3	4.7	11.9	12.3	11.3	13.6	25.9	10.0	11.6	21.6	13.3	13.8	5.9	26.4	9.5	5.8	8.2	10.5	7.5	8.8	6.3	10.9	6.7	7.6	8.2	15.9	5.5	6.3	5.6	4.4	12.8	8.5	8.6	10.1	7.3	5.1	6.5	11.3	6.2	6.8	4.0	5.3	5.5	5.9	5.5	0.0	13.9	2.2	3.1	4.5	2.2	62.1	5.1	6.7	3.4	0.0	15.7	7.4	0.0	6.9	0.2	5.4	9.5	0.0	5.9	22.2	4.6	4.3	4.6	4.4	7.1	0.0	6.9	9.8	6.5	0.7	4.9	3.8	6.8	8.2	11.8	2.7	8.9	10.4	5.3	4.8	11.1	0.0	7.6	1.7	3.1	3.6	3.3	4.4	9.8	3.1
H2AFJ	"FLJ10903, MGC921"	ENSG00000246705	"H2A histone family member J"	Q9BTM1	12	14774383-14778002	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 148.5"	"Group enriched"	"Detected in all"	5	"Early spermatids: 2365.3;Late spermatids: 2711.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 151.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 52.0;MCF7: 67.2;RT4: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.38e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.66e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.87e-3)"	37.8	27.6	3.6	15.0	11.6	14.6	36.7	2.2	5.2	19.1	27.3	9.9	21.7	16.0	15.4	26.7	29.9	13.9	34.0	24.8	4.3	3.8	22.2	16.7	22.7	16.9	9.0	5.1	12.7	47.7	4.8	5.0	25.5	6.8	49.2	8.6	18.2	67.6	25.7	20.4	26.8	18.7	18.6	11.8	15.7	17.8	148.5	5.8	14.4	19.3	25.3	17.4	26.5	29.3	7.2	39.1	23.8	44.5	19.8	25.1	24.2	21.2	52.0	2.0	0.0	23.7	15.8	33.9	16.0	8.9	6.5	6.3	10.2	35.1	0.0	10.1	7.7	0.0	20.4	1.2	12.1	1.7	1.1	0.9	0.8	18.4	8.6	34.1	0.0	8.1	20.5	13.3	8.9	8.3	2.6	12.9	0.0	0.0	0.0	3.2	67.2	0.1	5.6	3.3	15.5	11.9	8.4	0.0	4.1	10.3	48.2	0.6	0.2	20.3	25.2	0.0	7.5	38.4	6.5	12.7	0.0	6.2	9.5	3.1	5.2	7.5	0.0	1.8	0.0	5.1	23.8	44.5	9.3	18.0	24.5	16.3	5.8	17.8	13.4	39.1	7.2	12.7	13.7	15.4	19.8	21.4	19.4	25.1	24.2	3.6	11.6	2.2	5.2	4.3	3.8	9.0	5.1	6.8	5.8	41.7	33.7	49.1	304.8	105.8	15.7	27.9	175.8	202.1	68.2	136.1	21.6	108.3	127.6	141.6	2365.3	89.2	383.6	303.7	335.4	99.7	141.6	500.9	63.4	107.1	207.7	11.1	230.0	119.7	205.3	2711.3	162.8	122.0	217.6	210.2	226.5	28.4	179.6	287.5	91.9	223.3	35.9	265.1	186.8	506.4	29.2	123.0	134.1	87.3	219.6	347.8
H2BFS		ENSG00000234289	"H2B histone family member S"	P57053	21	43565189-43565648	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.0"	"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 3.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"					"unprognostic (1.29e-1)"					"unprognostic (4.33e-3)"				"unprognostic (2.06e-2)"				1.1	0.9	0.2	7.4	0.3	1.8	2.6	0.3	0.8	1.8	1.7	0.4	1.1	2.3	2.4	4.3	4.9	4.2	4.2	4.9	0.5		0.5	4.0	3.3	12.2	0.1	0.5	2.2	4.2	0.0	0.0	4.5	0.4	5.3	1.8	0.8	3.0	2.1	1.0	0.4	3.0	1.8	0.7	5.7	2.0	7.9	0.0	65.0	2.6	7.1	6.1	2.1	1.3	7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.1	3.3	0.6	0.9	2.2	0.9	2.4	2.6	1.3	3.2	2.0	4.6	1.1	0.6	8.8	0.8	2.5	2.5	0.2	0.7	0.9	2.2	3.6	0.6	5.0	0.2	0.3	0.9	4.5	2.5	0.4	0.6	0.0	1.2	0.3	0.4	23.7	2.8	0.9	6.1	1.0	2.2	0.3	4.1	2.6	0.8	0.5	8.7	0.7	0.7	3.5	2.5	10.5	3.2	2.1	0.5	11.1	1.4	0.9	1.7	23.4	1.1	0.6	7.6	23.8	5.0	1.1	11.8	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0
H2BFS		ENSG00000274559	"H2B histone family member S"		21	5972924-5973383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"blood: 16.0"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 2.9;Ciliated cells: 4.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8"									"HPA042205, HPA043013, HPA048671"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"										"unprognostic (3.37e-2)"				"unprognostic (2.63e-1)"				0.4	0.3		0.5		1.0	0.0		0.0	1.0	0.9			1.4	1.3	2.9	3.3	2.8	2.8	0.0			0.0	2.2	0.3	2.3			0.2	1.2	0.0		0.8		3.7	0.9		1.9	0.0	0.0	0.0	1.8	0.7		0.6	1.1	0.9			1.6		1.0	1.2		7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.1	3.3	0.6	0.9	2.2	0.9	2.4	2.6	1.3	3.2	2.0	4.6	1.1	0.6	8.8	0.8	2.5	2.5	0.2	0.7	0.9	2.2	3.6	0.6	5.0	0.2	0.3	0.9	4.5	2.5	0.4	0.6	0.0	1.2	0.3	0.4	23.7	2.8	0.9	6.1	1.0	2.2	0.3	4.1	2.6	0.8	0.5	8.7	0.7	0.7	3.5	2.5	10.5	3.2	2.1	0.5	11.1	1.4	0.9	1.7	23.4	1.1	0.6	7.6	23.8	5.0	1.1	11.8	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2											11.9	2.9	0.9	0.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	1.0	0.0	0.0	0.0	1.8	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.6
HABP4	"IHABP4, SERBP1L"	ENSG00000130956	"Hyaluronan binding protein 4"	Q5JVS0	9	96450201-96491336	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 193.7;Late spermatids: 710.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055969, HPA062366"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA055969: AB_2682991, HPA062366: "	"unprognostic (1.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.62e-2)"	13.2	11.9	31.2	6.1	44.8	1.7	6.5	14.1	40.6	7.9	5.5	12.4	1.5	3.0	8.2	6.8	7.2	5.3	8.1	19.1	26.1	24.9	23.5	5.7	6.1	6.8	27.1	20.5	11.7	4.8	13.8	7.4	3.4	31.6	8.3	4.2	8.4	4.1	10.6	9.4	6.1	3.3	10.6	19.4	5.0	5.0	21.8	13.0	0.4	11.2	2.2	4.9	7.6	6.5	4.1	0.1	0.3	0.8	1.0	4.0	0.7	7.3	8.4	10.7	11.4	23.7	20.3	7.6	10.0	11.2	7.5	8.2	12.5	12.3	3.7	5.0	14.8	24.0	5.4	8.9	1.9	6.1	4.5	5.3	1.4	4.0	20.8	12.1	0.3	1.5	8.2	3.4	8.6	6.8	11.5	5.3	4.3	1.7	11.1	13.5	7.5	0.1	2.3	5.0	10.3	8.2	3.8	9.3	0.1	12.8	3.2	6.8	4.6	5.3	3.2	15.9	8.3	2.3	1.6	9.1	10.4	2.4	19.0	8.4	7.0	6.9	1.6	8.3	2.9	15.3	0.0	0.1	0.0	1.4	0.3	1.4	4.1	4.0	3.2	0.0	1.7	2.8	2.8	0.3	1.0	0.8	0.1	3.0	0.7	31.2	44.8	14.1	33.8	26.1	24.9	27.1	20.5	31.6	13.0	0.0	6.1	3.4	7.8	10.2	22.0	10.6	15.3	1.4	9.1	17.4	0.0	2.2	14.9	3.7	193.7	17.8	0.8	0.0	5.0	6.7	7.8	8.5	1.1	5.0	5.5	22.3	12.6	13.5	1.5	710.5	12.7	4.0	16.9	3.6	0.9	17.1	4.8	0.0	22.3	39.6	11.3	6.5	17.6	18.6	5.9	6.9	1.1	7.5	1.1	5.1
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 29.5;liver: 96.8;skin 1: 26.9"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 46.7;Hepatocytes: 134.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 20.1;neutrophil: 29.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;NB-4: 4.0;THP-1: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		67000	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	0.5	0.0	0.1	1.1	0.3	4.4	0.9	0.1	0.3	0.3	0.2	0.1	0.1	0.1	1.1	0.3	0.5	0.2	0.3	0.2	0.1	0.0	0.2	96.8	1.7	2.3	0.5	0.1	0.3	0.5	0.0	7.4	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.2	26.9	0.2	0.2	0.3	2.7	0.1	0.2	0.2	0.1	0.2	0.9	1.3	0.2	0.5	0.0	1.4	29.5	6.3	0.3	0.1	1.6	0.6	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.2	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.5	0.4	0.2	0.0	0.0	0.6	0.7	0.0	0.9	0.4	0.4	0.1	0.3	0.4	0.0	0.2	0.1	0.0	0.2	4.0	1.3	0.1	0.7	0.3	0.1	0.1	0.1	0.8	0.2	0.4	0.5	0.1	0.0	0.1	0.0	15.5	0.2	0.1	0.2	0.2	0.2	0.7	0.7	0.2	0.0	2.4	0.0	20.1	6.3	0.9	0.0	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	29.5	0.3	5.1	0.1	0.1	1.6	0.1	0.3	0.1	0.3	0.1	0.0	0.5	0.1	0.2	0.2	0.0	1.4	0.0	0.1	0.1	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	46.7	0.2	0.2	0.0	0.1	0.0	134.4	0.3	0.0	0.0	1.8	6.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.1
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 61.4;placenta: 62.9"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 81.1;Leydig cells: 36.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019591, CAB025576"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB025576: , HPA019591: AB_2670199"	"unprognostic (4.11e-2)"	"unprognostic (7.50e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-1)"		"unprognostic (3.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.39e-3)"	4.2	24.2	0.2	10.9	0.2	0.0	4.7	0.4	0.2	34.3	42.7	0.2	7.5	1.9	42.7	7.9	16.6	9.7	61.4	54.1	0.2	0.2	0.2	8.2	0.2	0.1	0.2	0.0	13.4	3.8	0.0	0.3	62.9	0.0	13.1	3.6	5.2	1.1	4.2	0.6	1.7	13.5	37.5	0.2	1.8	19.9	5.4	0.0	0.0	1.5	2.7	2.2	25.7	12.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.9	3.5	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.5	0.0	0.0	0.7	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	81.1	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.0	0.4	1.1	13.7	0.0	0.0	0.0	2.3	0.0	0.0	11.1	0.0	0.8	36.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	2.2	0.1	0.1	0.3	1.9	0.0	0.0	0.0
HAO2	"GIG16, HAOX2"	ENSG00000116882	"Hydroxyacid oxidase 2"	Q9NYQ3	1	119368779-119394130	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 65.1;liver: 90.2"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 210.7;Proximal tubular cells: 261.6"	"Group enriched"	"Detected in some"	26	"liver cancer: 25.6;renal cancer: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BJ hTERT+: 1.2;HL-60: 2.0;SiHa: 1.5;U-698: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050355			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA050355: "	"unprognostic (1.13e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.33e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (5.14e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	65.1	90.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.7	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.3	0.5	0.0	0.6	0.8	2.0	0.4	0.0	0.2	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.8	0.2	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	2.5	0.0	0.0	10.4	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	210.7	0.1	0.0	0.0	3.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877288-88895626	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.4;lymphoid tissue: 23.6"	"Cell type enriched"	"Detected in many"	8	"Extravillous trophoblasts: 899.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 25.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.0;U-2 OS: 21.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1.0	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6.0	4.7	9.8	3.2	1.0	3.0	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6.0	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6.0	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.4	0.9	9.8	2.8	3.0	3.1	2.7	0.6	1.0	1.3	2.8	4.1	0.0	7.8	3.4	1.6	1.0	9.3	1.2	0.0	21.0	8.2	3.0	0.2	0.0	0.4	0.0	0.1	1.1	0.5	2.0	0.1	0.1	4.6	0.4	0.0	6.0	0.4	0.1	0.0	0.0	7.3	0.0	0.1	0.0	0.4	7.3	1.8	0.1	0.1	2.7	0.5	0.5	3.7	1.2	0.0	0.4	0.8	7.1	21.0	5.3	0.4	0.9	0.0	0.0	2.5	0.0	6.1	0.7	0.6	0.0	0.6	0.3	3.0	0.1	10.0	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1.0	2.3	3.2	1.0	3.1	0.9	3.6	1.8	0.0	4.3	0.9	6.0	28.4	2.6	7.7	0.0	1.4	5.7	1.8	9.8	5.6	0.0	5.7	0.0	18.6	0.0	0.0	1.8	899.6	9.3	3.9	1.1	0.0	17.6	0.0	0.0	3.1	0.0	0.0	0.9	2.9	16.9	16.2	0.2	2.4	8.7	0.0	0.7	0.1	108.4	12.9	38.9	0.5	1.7	21.1	17.0	3.2	0.2	6.8
HARS2	"HARSL, HARSR, HO3"	ENSG00000112855	"Histidyl-tRNA synthetase 2, mitochondrial"	P49590	5	140691426-140699318	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035941	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA035941: AB_10671237"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-2)"	17.1	23.8	14.2	22.9	19.4	13.4	25.0	24.7	19.0	15.0	21.6	16.6	19.7	17.7	20.2	16.9	16.7	14.9	16.7	25.2	15.7	12.6	19.6	14.5	21.4	25.2	15.5	11.2	17.4	13.6	22.9	21.1	15.8	14.4	14.3	24.4	16.4	16.4	15.4	32.7	18.3	17.2	15.6	12.9	18.5	17.9	15.1	15.6	16.5	15.8	13.9	18.8	20.6	18.4	13.7	12.0	22.9	15.0	22.8	17.6	9.7	10.9	24.7	10.7	27.5	12.2	16.2	17.7	14.1	16.1	19.9	17.4	22.6	13.8	13.9	22.8	15.6	19.6	13.9	14.8	26.5	18.4	13.9	12.2	10.1	23.7	14.9	11.8	13.5	14.9	15.2	18.1	19.4	22.0	16.1	14.3	14.7	9.3	13.1	19.2	13.9	13.2	16.8	12.3	8.3	15.6	13.5	10.9	14.0	18.6	25.6	14.9	21.4	20.5	33.3	27.9	16.3	29.4	13.5	17.4	17.9	9.9	9.9	18.6	13.0	18.9	13.4	14.1	15.6	17.8	22.9	10.5	21.3	16.2	15.0	17.5	13.7	15.6	16.2	12.0	12.5	16.4	17.6	12.1	22.8	11.4	9.5	15.3	9.7	14.2	19.4	24.7	19.0	15.7	12.6	15.5	11.2	14.4	15.6	3.0	4.3	10.4	3.8	3.1	4.8	16.5	2.5	9.4	6.8	5.2	0.0	16.4	11.6	11.9	0.9	7.1	6.7	0.0	14.0	15.3	6.3	3.7	2.3	5.9	8.8	0.0	7.5	6.7	7.8	1.7	8.6	8.3	3.3	12.6	7.2	7.7	13.2	10.5	9.9	6.7	5.2	0.0	7.2	6.4	14.1	3.4	12.0	7.5	11.2	3.9
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 51.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	51.0	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3	0.0	2.6	0.0	0.1	23.7	4.2	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.1	2.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.3	8.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.6	0.0	24.7	0.0	0.1	15.6	0.1	0.0	0.0	0.1
HAS2		ENSG00000170961	"Hyaluronan synthase 2"	Q92819	8	121612116-121641390	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.8"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 44.7;Fibroblasts: 34.9;Melanocytes: 28.7;Urothelial cells: 95.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HBF TERT88: 34.7;hTEC/SVTERT24-B: 33.4;LHCN-M2: 44.3;U-138 MG: 87.1;U-251 MG: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052060			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA052060: AB_2681712"	"unprognostic (7.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-7)"	"unprognostic (1.47e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-3)"	22.8	0.9	1.6	9.1	2.4	0.0	5.5	0.8	1.7	4.0	8.5	2.0	0.0	2.6	1.5	2.5	4.8	3.9	7.7	8.3	1.7	1.7	1.2	2.7	6.5	4.5	1.8	0.6	1.2	1.8	0.3	0.7	2.1	5.7	4.3	5.6	2.7	1.9	0.1	2.7	3.8	9.5	3.7	4.2	0.3	2.3	3.2	2.6	0.4	1.7	5.5	2.1	5.7	1.4	0.0	0.2	0.7	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	1.0	2.6	0.0	4.9	3.7	6.5	11.2	0.0	0.0	0.0	0.0	4.4	0.0	0.8	0.0	0.0	34.7	0.0	0.1	0.0	0.1	0.0	4.4	0.0	0.0	6.8	0.0	33.4	3.0	0.1	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.7	0.0	0.0	0.4	0.0	0.1	2.1	0.0	1.1	2.0	0.0	0.0	0.0	87.1	0.3	8.1	25.8	0.0	0.0	0.0	1.8	0.0	1.7	0.5	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.3	0.2	0.2	0.1	0.0	1.6	2.4	0.8	1.7	1.7	1.7	1.8	0.6	5.7	2.6	0.0	0.0	0.0	44.7	14.4	0.0	1.2	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.7	12.7	2.2	0.0	0.0	0.0	0.0	34.9	5.5	13.8	0.0	0.2	0.0	1.2	0.0	0.0	1.6	1.7	1.6	28.7	0.0	1.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	10.8	0.2	0.0	10.5	0.1	0.0	3.3	95.7
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105564-69118719	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;urinary bladder: 22.9"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 144.1;Suprabasal keratinocytes: 138.5;Urothelial cells: 89.2"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.4;PC-3: 76.9;RT4: 30.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031554, CAB033850"	Supported		Approved	Microtubules		NA	NA			Microtubules		"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.4	0.2	0.4	0.4	1.0	0.3	5.5	1.1	1.3	3.3	3.7	0.4	0.4	1.9	0.8	1.1	22.6	0.7	3.5	2.4	0.6	0.6	1.2	0.7	18.0	0.4	0.4	0.4	0.9	2.2	0.1	1.0	3.3	1.1	3.5	2.3	0.6	7.6	2.1	0.6	5.7	2.1	1.4	0.4	0.4	9.0	2.0	0.4	0.5	4.0	11.7	11.1	22.9	13.6	1.5	1.2	2.2	1.4	0.4	2.0	1.1	0.9	4.8	0.3	0.2	0.1	0.1	1.8	0.3	0.1	0.2	0.1	1.0	2.5	0.2	0.6	0.1	1.1	14.4	0.8	8.6	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	2.4	0.3	0.8	1.1	0.1	0.1	0.0	0.1	0.0	0.5	0.3	0.1	4.3	5.0	76.9	0.5	0.0	0.0	7.9	30.4	5.4	0.2	0.5	0.0	0.1	0.9	0.2	0.2	0.1	0.2	0.2	8.4	0.5	0.3	0.2	0.0	0.3	0.0	0.1	0.8	1.4	2.2	1.4	0.7	1.3	0.7	1.1	0.5	1.2	1.5	2.0	0.7	0.5	0.4	1.1	1.0	1.5	1.1	0.4	1.0	1.1	1.3	0.6	0.6	0.4	0.4	1.1	0.4	0.0	25.0	0.0	35.3	144.1	1.4	1.4	0.0	0.0	4.5	0.0	2.0	0.9	0.0	3.2	10.2	2.0	2.0	0.0	3.1	0.7	0.8	9.4	0.0	0.0	0.3	0.0	0.0	1.3	0.0	17.0	1.1	0.6	3.3	0.0	0.3	0.1	2.3	0.0	0.4	0.6	0.9	0.0	2.5	0.6	0.4	138.5	0.2	0.5	1.5	89.2
HAUS2	"C15orf25, CEP27, FLJ10460, HsT17025"	ENSG00000137814	"HAUS augmin like complex subunit 2"	Q9NVX0	15	42548810-42569994	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039965	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA039965: AB_10673025"	"unprognostic (5.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.81e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-3)"	18.7	11.3	13.1	12.1	11.5	49.9	18.6	13.3	15.4	9.9	11.9	11.1	5.6	8.9	14.0	10.4	12.8	9.7	9.3	10.8	14.1	13.6	10.3	11.0	16.8	16.6	14.6	13.9	12.1	12.1	8.4	9.9	11.6	13.1	8.8	10.8	8.5	10.5	8.5	13.5	11.8	9.5	12.3	18.7	11.2	9.7	13.7	11.7	18.4	10.1	11.8	13.0	10.8	14.0	10.3	7.2	7.5	13.5	4.4	8.7	4.3	11.4	6.1	11.2	7.2	5.6	6.4	10.9	11.7	7.0	11.0	9.3	12.4	7.3	7.4	5.7	6.4	10.7	19.3	11.9	7.5	11.1	9.6	6.9	10.1	10.7	9.6	8.1	17.7	9.3	5.5	5.7	8.8	9.1	5.7	11.1	9.9	17.6	9.1	10.7	7.2	13.0	14.3	9.8	16.1	8.0	14.7	13.7	9.6	7.0	8.3	9.1	7.6	11.7	11.3	6.9	8.5	11.3	13.2	8.7	17.0	12.4	26.2	21.7	13.9	39.0	22.2	10.6	19.5	12.9	7.3	7.7	7.5	8.4	9.0	8.3	10.3	8.3	6.0	6.5	8.9	6.1	8.3	3.8	4.4	13.5	7.2	8.7	4.3	13.1	11.5	13.3	15.4	14.1	13.6	14.6	13.9	13.1	11.7	11.9	15.6	14.6	18.4	12.0	7.6	4.0	7.6	21.4	11.4	3.5	15.7	11.4	3.3	13.3	21.6	11.3	6.5	0.0	14.3	22.8	9.4	20.3	23.2	7.3	19.4	15.9	16.6	10.4	15.8	5.3	10.3	19.4	1.7	21.6	9.7	6.1	15.3	8.6	10.6	11.0	15.2	19.4	11.2	23.2	8.5	13.4	11.2	15.3	9.0	16.0
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2227464-2242164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040649, HPA048190"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Microtubules, Mitochondria"	"Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	11.7	10.8	15.5	10.9	14.7	44.4	11.5	26.3	14.3	8.6	9.5	10.0	8.6	9.6	11.0	9.1	10.3	8.8	6.9	6.3	11.8	5.9	7.8	8.8	11.1	15.0	11.7	11.0	10.8	13.6	7.3	18.9	10.3	10.5	10.7	8.8	6.0	10.8	8.5	9.0	10.4	11.2	9.6	14.5	15.2	10.5	12.5	13.7	20.7	9.8	4.3	13.0	9.3	9.6	11.0	8.6	14.9	7.8	12.2	15.6	7.6	9.8	5.0	14.5	14.2	6.9	9.6	14.2	15.7	6.9	14.3	13.2	8.7	12.7	18.5	6.7	6.0	17.8	9.1	11.6	7.9	18.3	7.0	7.7	11.0	11.7	7.1	5.5	11.5	12.5	5.5	10.6	12.9	6.5	7.5	11.6	8.8	21.0	22.4	14.4	5.1	16.7	20.0	12.3	9.0	12.0	13.3	12.9	11.1	7.2	7.0	17.9	9.9	9.7	7.1	9.0	12.3	15.4	7.6	8.1	17.8	9.6	10.8	16.6	11.3	11.3	17.2	9.5	17.3	13.4	10.1	5.5	14.9	10.9	7.4	14.4	7.7	11.5	12.2	5.0	11.0	13.4	12.1	6.4	12.2	7.8	8.6	15.6	7.6	15.5	14.7	26.3	14.3	11.8	5.9	11.7	11.0	10.5	13.7	3.0	4.5	4.2	4.8	11.2	11.1	4.6	10.2	4.0	12.5	3.5	11.8	6.4	1.7	6.3	9.9	6.7	3.0	0.0	4.9	9.5	7.8	4.5	12.7	3.0	6.2	23.8	6.9	6.2	4.1	4.9	9.2	8.7	11.8	8.2	5.3	6.9	4.4	0.0	8.1	2.6	11.6	0.0	6.7	20.1	15.1	6.8	4.2	20.2	5.2	2.6
HAUS6	"dgt6, FAM29A, FLJ20060, KIAA1574"	ENSG00000147874	"HAUS augmin like complex subunit 6"	Q7Z4H7	9	19053143-19103119	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 91.7;Spermatocytes: 55.3;Spermatogonia: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020960, HPA020965"	Approved		Supported	"Nuclear speckles,Centriolar satellite,Cytosol"		No	No			"Centriolar satellite, Cytosol"	"Nuclear speckles"	"HPA020960: AB_1848393, HPA020965: AB_1848394"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (6.04e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.03e-1)"	8.7	9.6	10.9	9.2	13.1	17.5	11.1	10.8	10.3	7.7	7.0	9.9	5.6	4.9	8.9	8.0	7.0	7.4	6.4	7.1	10.5	7.3	5.2	11.0	7.1	12.8	15.0	8.9	11.1	6.3	5.8	8.5	8.4	12.4	7.6	7.9	5.6	7.1	7.4	7.2	9.8	7.2	8.9	13.5	10.0	5.8	27.1	13.6	27.3	6.6	3.8	12.7	7.0	7.1	3.6	2.6	10.9	2.2	7.2	6.1	2.5	11.1	7.6	15.6	12.1	6.0	7.3	8.4	11.9	8.5	11.1	17.0	3.9	5.1	13.0	4.4	6.9	8.5	4.6	14.3	7.0	17.2	11.8	6.8	69.2	13.8	8.9	4.0	9.1	15.8	4.5	7.2	10.5	22.8	5.7	8.0	13.4	9.4	8.6	12.7	3.6	17.8	15.5	16.7	6.3	7.6	13.9	10.6	5.3	5.9	6.4	9.1	12.6	5.3	5.0	7.6	10.4	3.9	11.5	7.9	9.9	6.0	8.5	13.6	3.4	7.5	12.8	9.3	7.8	4.3	10.9	2.2	2.2	4.5	2.2	6.1	3.5	4.3	5.6	2.2	3.6	5.2	4.6	3.5	7.2	2.0	2.6	5.4	2.5	10.9	13.1	10.8	10.3	10.5	7.3	15.0	8.9	12.4	13.6	17.9	12.2	10.4	10.2	8.7	11.6	7.4	5.1	1.4	6.8	8.7	9.8	8.4	0.0	8.9	91.7	7.8	4.2	23.3	5.2	13.1	7.6	7.3	10.5	5.7	7.2	11.1	2.4	4.3	3.2	21.2	10.9	13.1	8.5	3.6	4.4	13.1	7.4	3.5	7.8	3.3	9.3	6.5	5.4	55.3	51.9	7.0	4.1	10.0	7.4	8.8
HAVCR1	"CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1"	ENSG00000113249	"Hepatitis A virus cellular receptor 1"	Q96D42	5	157029413-157059119	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 37.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	12	"renal cancer: 26.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"A549: 36.6;CACO-2: 44.0;RPTEC TERT1: 17.5"									"HPA007173, CAB075697"	Uncertain		Approved	Vesicles		NA	NA	155000		Vesicles		"CAB075697: , HPA007173: AB_1080282"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.46e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.20e-2)"		"unprognostic (3.21e-1)"	"unprognostic (8.70e-4)"	"unprognostic (3.81e-3)"	"unprognostic (7.10e-3)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.32e-4)"	0.4	0.1	0.2	1.0	0.2	0.9	0.2	0.2	0.2	0.2	6.7	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.5	0.2	0.3	0.2	37.6	0.5	0.6	0.6	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	5.3	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.5	0.5	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.3	0.2	1.3	1.2	2.0	1.8	2.1	3.4	2.3	0.0	36.6	0.1	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	44.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	1.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.0	1.8	0.5	0.7	1.1	1.0	0.8	1.8	0.9	1.2	1.3	3.4	2.5	1.3	2.1	0.8	0.8	2.8	2.3	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
HBQ1	HBQ	ENSG00000086506	"Hemoglobin subunit theta 1"	P09105	16	180453-181181	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.0;bone marrow: 29.4;brain: 12.2;vagina: 10.7"	"Cell type enriched"	"Detected in some"	8	"Erythroid cells: 303.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;T-cells: 2.3"	"Group enriched"	"Detected in some"	7	"HEL: 13.4;Hep G2: 9.4;K-562: 33.1"					"Low region specificity"	"Detected in all"			HPA062473	Enhanced		Approved	"Lipid droplets"		NA	NA		47000	"Lipid droplets"		"HPA062473: AB_2684774"		"unprognostic (4.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.02e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.55e-1)"	0.5	0.6	12.2	0.5	10.0	29.4	0.5	0.6	6.3	0.5	0.5	0.2	0.0	0.6	0.5	0.5	0.5	0.5	0.5	0.9	5.6	4.0	0.5	0.5	2.1	0.5	2.2	3.7	0.6	0.5	0.5	0.5	2.6	2.4	0.6	0.5	0.0	0.8	0.5	0.9	0.5	0.5	0.5	0.7	2.8	0.5	1.3	0.3	0.0	0.5	0.0	0.5	0.6	10.7	0.4	0.2	2.5	0.0	0.0	2.3	8.0	0.0	0.8	0.2	2.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	2.3	0.0	0.0	0.3	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	13.4	0.5	9.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	33.1	0.0	0.0	0.1	1.4	0.0	1.8	0.0	0.1	0.1	0.0	0.2	0.5	0.0	0.3	1.8	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	2.3	0.4	0.7	1.6	0.1	0.0	0.5	1.2	2.5	0.0	0.0	0.2	0.0	8.0	12.2	10.0	0.6	6.3	5.6	4.0	2.2	3.7	2.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	303.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	2.5	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.8	40.3	0.1	0.2	0.0	0.0	0.0
HBS1L	"DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038"	ENSG00000112339	"HBS1 like translational GTPase"	Q9Y450	6	134960378-135103056	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029728, HPA029729"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA029728: AB_10611112, HPA029729: AB_10601228"	"unprognostic (3.68e-3)"	"unprognostic (6.39e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-2)"	16.9	18.6	17.5	13.0	27.3	31.8	18.0	23.2	34.7	16.7	14.9	18.2	9.2	10.1	15.6	10.8	20.0	13.8	12.0	22.3	18.4	18.8	17.4	28.4	11.7	16.3	21.1	16.0	15.6	20.4	19.5	25.4	18.7	33.6	14.2	13.5	11.0	17.1	14.1	66.4	14.7	15.3	18.6	25.0	14.4	14.2	14.0	17.1	42.5	17.5	19.9	18.5	16.3	13.6	25.2	28.4	38.4	24.6	32.9	38.4	28.3	15.1	10.2	21.3	30.9	19.6	17.5	16.3	30.7	26.5	29.3	36.3	17.1	11.5	26.3	13.9	27.1	21.2	11.4	29.8	22.6	45.8	26.7	20.4	80.4	28.9	22.9	23.5	49.6	22.0	17.2	17.2	27.7	34.1	22.0	24.2	31.5	42.9	22.2	30.9	14.4	30.5	12.6	13.7	18.2	11.2	28.7	23.8	17.9	18.1	14.5	21.1	14.4	21.0	22.0	21.8	17.6	18.3	30.0	22.8	20.8	21.7	25.7	32.4	50.7	36.5	44.7	31.7	25.8	25.8	38.4	24.6	25.4	23.4	22.1	26.3	25.2	28.1	23.8	28.4	22.6	38.4	31.6	11.2	32.9	21.1	22.6	32.9	28.3	17.5	27.3	23.2	34.7	18.4	18.8	21.1	16.0	33.6	17.1	23.8	21.7	26.8	23.0	24.3	42.7	51.6	22.9	28.1	36.4	10.4	13.7	27.2	21.6	20.9	27.5	18.0	9.8	93.5	17.8	26.9	19.6	19.2	56.8	33.1	12.0	20.6	15.6	17.2	22.1	11.0	17.3	14.9	28.7	27.1	11.4	26.1	16.4	13.9	20.8	19.2	26.4	38.8	24.0	25.9	25.7	16.3	33.9	20.3	14.5	22.5
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	152687-154503	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.9;placenta: 5.0;testis: 9.9"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 144.1;Late spermatids: 212.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	79	"K-562: 227.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000000	Cytosol	Nucleoplasm	"HPA063268: , HPA064073: , HPA071726: AB_2732184"					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.8	0.0	0.8	0.1	0.5	8.9	0.6	0.6	0.6	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.6	3.3	0.7	0.3	0.1	1.1	0.6	0.1	1.1	0.1	0.7	0.1	0.0	0.1	5.0	0.1	1.2	0.0	0.1	0.1	0.1	0.9	0.5	0.1	0.1	0.1	0.8	0.1	9.9	0.1	0.1	0.1	0.1	0.1	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.5	0.6	0.6	0.7	0.3	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	41.3	0.7	0.0	23.3	0.0	16.4	1.4	0.0	0.0	0.0	144.1	0.0	0.0	0.0	0.0	212.4	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.4	0.0	0.7	6.5	2.0	1.1	0.9	0.1	8.7	0.0	0.0	0.0
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716892	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 47.7"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 75.5;Basal keratinocytes: 83.9;Suprabasal keratinocytes: 93.0;Urothelial cells: 41.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 3.5"	"Group enriched"	"Detected in some"	6	"basophil: 12.1;neutrophil: 47.7;non-classical monocyte: 21.3"	"Group enriched"	"Detected in many"	49	"granulocytes: 47.7;monocytes: 21.3"	"Group enriched"	"Detected in some"	5	"HaCaT: 7.2;RT4: 27.9"									HPA028660	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (2.32e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.28e-2)"	4.8	0.2	0.6	7.9	0.3	20.8	4.0	0.4	0.5	2.3	0.9	0.2	2.2	0.1	0.4	0.4	18.2	0.5	0.5	1.0	0.3	0.3	0.9	2.5	10.2	3.5	3.5	0.0	1.6	0.2	6.6	1.1	3.0	0.7	4.2	0.0	0.3	2.9	4.3	0.6	13.9	0.3	0.4	1.2	21.6	0.5	1.6	0.4	0.3	0.5	12.0	14.9	5.7	7.2	0.0	0.7	47.7	21.3	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	7.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	12.1	0.5	0.2	0.0	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	47.7	0.0	21.3	0.0	0.0	0.6	0.6	0.3	0.4	0.5	0.3	0.3	3.5	0.0	0.7	0.4	3.0	10.7	0.0	75.5	83.9	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	19.1	2.0	5.3	3.5	0.0	6.1	0.0	0.0	0.0	7.3	0.0	0.0	22.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	93.0	11.6	0.0	0.0	41.6
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947553-153971807	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018312, HPA078588"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA018312: AB_1850522, HPA078588: "	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	16.0	19.2	18.2	23.7	18.5	48.3	14.2	24.4	23.3	13.9	20.0	17.3	14.1	16.8	26.3	13.6	18.2	18.8	20.8	14.7	17.0	12.7	15.6	17.2	19.0	24.9	14.6	16.1	20.4	15.6	21.9	26.4	13.8	15.8	17.7	11.2	13.8	21.5	20.6	27.8	18.2	18.3	19.7	20.0	25.2	18.0	15.3	17.9	52.3	16.4	15.6	17.6	17.4	18.3	4.8	8.0	1.7	5.6	2.8	6.7	3.5	15.4	20.1	13.7	17.3	5.7	4.1	20.1	6.3	4.9	7.5	6.9	21.2	10.4	28.1	16.3	8.2	12.4	12.7	14.7	10.4	3.9	14.8	17.3	16.8	16.0	16.6	3.9	20.6	27.9	6.4	6.8	13.1	5.7	4.5	8.0	20.5	23.3	17.8	5.3	21.6	28.5	26.7	17.7	10.1	12.4	33.3	11.3	16.9	5.7	14.4	15.2	16.5	11.7	12.2	6.5	6.9	11.2	18.6	10.5	14.4	17.8	12.4	20.4	28.3	38.7	35.2	11.7	20.1	13.6	1.7	4.0	1.7	6.0	5.6	4.3	4.8	4.8	4.6	4.5	4.4	4.9	6.7	0.8	2.8	4.0	8.0	3.2	3.5	18.2	18.5	24.4	23.3	17.0	12.7	14.6	16.1	15.8	17.9	17.9	19.1	10.4	11.5	14.7	17.2	34.6	17.8	4.0	9.1	12.2	13.7	13.4	3.3	15.2	0.4	15.8	11.7	0.0	14.1	18.9	12.9	17.4	3.5	23.1	18.5	19.1	18.4	19.0	30.2	1.3	16.1	12.5	5.0	16.2	20.4	15.0	16.1	7.0	20.5	8.6	11.5	6.5	13.7	6.5	25.1	12.2	13.3	17.5	20.9	13.1
HCFC1R1	"FLJ20568, HPIP"	ENSG00000103145	"Host cell factor C1 regulator 1"	Q9NWW0	16	3022620-3024286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 204.8"	"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 247.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 84.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059647	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059647: AB_2684094"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.03e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.23e-1)"	19.7	28.9	49.3	10.2	61.0	7.8	23.9	25.4	37.5	30.4	17.5	13.5	17.7	14.3	20.5	18.4	20.7	19.4	28.0	27.8	37.2	38.6	24.9	11.1	19.1	10.6	40.9	23.9	24.3	10.4	19.9	19.5	16.5	23.0	22.8	10.0	11.5	15.1	42.4	204.8	25.0	13.9	28.7	23.2	9.1	11.2	11.4	14.7	7.5	13.5	37.0	9.1	24.7	17.2	14.1	26.2	8.4	21.6	13.7	20.2	9.6	12.4	32.9	6.6	8.0	27.1	35.7	6.3	3.9	24.9	12.3	33.8	6.9	15.0	8.7	13.5	23.3	10.7	16.4	6.6	24.2	5.7	11.9	15.6	3.8	26.2	11.5	22.2	6.3	7.5	44.1	15.7	12.8	14.0	84.8	17.1	6.6	5.2	17.4	13.7	11.2	3.8	9.9	14.4	7.2	6.9	13.7	5.9	24.3	43.8	2.5	11.4	9.6	9.6	15.4	15.5	16.8	10.2	5.8	4.9	20.3	56.9	17.2	10.6	10.6	10.3	7.6	8.6	3.9	4.6	2.7	21.6	8.4	12.3	15.5	11.6	14.1	15.9	13.3	26.2	13.5	11.8	14.2	4.5	13.7	13.5	13.0	20.2	9.6	49.3	61.0	25.4	37.5	37.2	38.6	40.9	23.9	23.0	14.7	53.6	12.9	28.9	60.6	75.9	26.6	39.3	50.9	16.0	18.2	188.5	5.9	91.7	203.9	41.6	3.8	35.9	68.0	0.0	23.5	101.8	139.4	33.1	39.3	41.9	104.8	19.1	42.0	61.4	66.0	10.1	89.2	41.2	60.8	50.5	33.1	31.3	26.9	48.9	167.6	247.7	19.7	122.9	137.0	14.0	37.3	57.5	45.1	20.8	42.9	31.5
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064457-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 190.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	11.5	10.0	11.9	4.7	13.2	3.2	12.9	3.8	11.1	11.5	14.4	9.1	8.7	7.2	12.6	7.5	9.1	8.5	8.1	7.7	9.3	5.8	8.5	10.2	9.1	5.9	12.5	8.1	11.8	9.1	10.4	14.3	10.6	10.0	10.8	6.3	6.8	8.0	14.6	17.5	7.4	7.5	19.0	10.2	6.8	9.9	19.2	11.0	9.1	10.1	5.1	5.0	12.8	10.3	1.8	2.2	2.8	5.0	2.5	3.2	1.7	1.9	2.1	2.2	1.9	12.4	12.4	1.6	8.5	3.9	6.6	3.8	1.0	0.9	1.9	3.0	6.6	2.4	2.1	2.7	1.5	7.1	3.2	2.6	1.9	2.0	0.9	8.4	1.6	3.1	7.7	4.2	4.1	3.4	9.5	5.0	3.0	2.2	4.1	11.7	1.7	2.8	3.7	0.4	1.2	4.4	2.3	7.3	1.2	2.9	1.3	3.2	2.4	4.2	3.0	3.2	1.6	4.8	1.7	7.5	10.4	1.4	5.3	2.9	5.2	1.5	1.7	4.9	2.1	4.1	1.3	2.0	2.8	2.6	3.7	3.1	1.6	2.5	3.2	2.2	1.8	3.0	3.2	0.5	2.5	5.0	1.2	2.8	1.7	11.9	13.2	3.8	11.1	9.3	5.8	12.5	8.1	10.0	11.0	11.9	16.0	8.4	6.6	7.1	18.4	9.6	0.0	10.7	11.4	5.2	19.6	4.3	8.3	4.8	190.7	11.3	6.9	0.0	2.9	3.5	9.5	3.2	16.2	9.0	6.3	22.3	8.1	15.4	9.4	44.6	20.1	6.9	6.8	4.6	3.3	13.8	2.7	3.2	26.2	7.0	22.6	12.9	10.3	57.9	10.2	6.4	9.0	9.6	3.3	3.1
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902480-35904377	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 237.5;Hofbauer cells: 491.9;Kupffer cells: 329.9;Macrophages: 424.4;T-cells: 835.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 52.9;HL-60: 30.5;HMC-1: 35.3;THP-1: 40.0;U-937: 60.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Vesicles	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	29.4	4.0	6.5	19.9	5.2	84.0	5.9	1.4	3.1	3.9	4.9	4.8	0.5	4.5	5.4	6.0	3.0	4.5	6.3	7.3	5.7	5.9	5.6	6.9	38.4	79.1	7.7	2.2	3.4	2.9	0.7	4.3	10.6	4.9	5.5	3.6	7.1	6.2	3.7	2.4	2.8	10.9	4.5	12.7	49.5	5.6	1.7	4.4	56.8	3.4	3.3	26.7	5.2	3.6	6.1	66.6	15.9	57.0	96.4	134.0	89.5	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.2	0.2	5.7	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	52.9	0.1	0.1	0.1	30.5	35.3	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.4	7.6	0.1	0.0	3.5	11.9	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	40.0	0.1	0.3	0.4	0.0	0.0	0.3	0.2	8.7	0.3	60.0	0.0	7.3	57.0	7.9	134.0	42.0	99.3	6.1	57.4	108.5	32.6	3.7	48.3	96.4	15.9	96.4	23.0	66.6	48.5	89.5	6.5	5.2	1.4	3.1	5.7	5.9	7.7	2.2	4.9	4.4	6.0	65.6	87.2	1.1	25.3	0.2	0.8	5.1	8.1	11.4	8.7	0.0	3.2	0.0	2.1	0.3	9.0	1.4	0.0	1.0	3.2	13.1	0.6	237.5	11.3	491.9	1.6	0.0	19.6	329.9	1.8	2.0	424.4	42.2	31.5	0.7	0.2	1.1	0.9	0.0	4.4	1.9	19.4	1.9	1.7	2.8	18.3	5.0	835.8	1.7	0.8
HDAC3	"HD3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636870	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	15.9	28.8	19.6	12.2	17.6	18.1	18.6	22.6	20.8	15.6	14.1	11.2	13.1	10.6	17.3	17.6	22.8	16.3	14.0	16.8	18.0	8.9	14.5	23.3	24.4	36.4	13.4	14.2	17.3	24.7	20.9	17.3	14.3	18.8	13.6	14.4	13.6	17.5	13.7	24.5	26.7	15.2	17.2	10.8	20.1	15.5	11.9	12.6	18.5	14.4	9.6	23.7	17.5	17.0	22.1	46.7	16.4	22.6	14.1	23.1	16.9	21.3	14.5	27.0	40.9	26.1	20.8	17.5	15.6	34.3	35.4	50.8	31.0	18.3	31.1	20.2	20.2	25.2	18.6	27.1	36.5	43.9	26.5	29.1	24.3	13.3	17.6	18.4	29.2	22.3	17.7	23.5	20.5	26.8	18.4	22.8	28.1	23.7	16.6	22.3	20.2	32.4	25.3	23.8	13.3	11.5	23.5	28.2	22.4	18.9	21.5	22.6	18.3	20.6	21.4	25.7	17.9	22.8	18.5	11.5	22.0	13.8	16.8	25.5	13.5	16.6	29.3	18.5	27.8	18.8	13.2	22.4	16.4	15.9	22.6	20.8	22.1	19.8	19.2	46.7	20.1	21.7	18.0	9.5	14.1	19.0	23.9	23.1	16.9	19.6	17.6	22.6	20.8	18.0	8.9	13.4	14.2	18.8	12.6	8.9	10.4	32.3	23.0	39.3	30.6	12.3	15.3	5.3	11.4	12.2	56.9	47.2	18.3	28.5	7.6	20.2	15.4	0.0	31.4	44.3	29.3	18.8	18.4	14.8	34.9	47.7	17.2	20.9	15.4	3.4	20.8	33.0	30.4	66.7	17.7	27.7	27.2	14.0	20.8	15.7	30.4	25.8	24.0	22.3	24.5	44.9	51.1	31.9	22.7	26.5
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 111.9;Syncytiotrophoblasts: 182.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	15.6	17.6	24.9	7.9	15.8	13.2	18.1	35.9	25.8	16.5	8.8	19.6	9.5	8.4	15.0	11.9	20.1	16.9	11.3	24.4	22.1	24.2	8.6	6.3	13.6	8.8	24.7	22.1	24.5	16.1	28.2	17.5	23.0	19.3	13.6	5.5	11.7	14.2	11.9	42.6	34.0	9.7	12.4	20.5	13.8	9.3	10.3	18.1	7.6	15.0	9.8	8.2	14.9	20.4	7.6	9.4	17.9	13.6	3.5	4.9	5.0	3.6	2.4	6.5	1.5	12.7	9.8	23.6	9.8	24.4	4.9	8.0	5.2	3.9	5.7	3.9	23.2	7.3	2.9	7.6	4.2	2.1	8.8	12.4	11.1	7.8	12.0	5.4	3.6	15.7	13.9	7.2	5.6	7.0	8.4	4.0	4.6	8.2	11.6	28.3	2.8	5.9	10.9	7.1	2.8	5.6	22.9	18.2	14.7	0.5	1.6	17.0	8.9	2.8	12.0	13.3	10.1	17.1	21.0	2.2	12.3	7.9	2.8	4.9	19.2	16.0	6.8	7.1	4.5	5.8	7.1	7.3	7.7	4.9	11.6	3.5	6.6	3.9	4.9	9.4	7.6	4.1	3.5	17.9	3.5	13.6	8.3	3.5	5.0	24.9	15.8	35.9	25.8	22.1	24.2	24.7	22.1	19.3	18.1	11.9	13.6	10.4	30.2	26.0	84.0	21.0	12.7	5.3	7.9	19.2	111.9	12.7	18.3	13.6	17.9	18.3	11.2	0.0	7.5	47.4	24.1	34.1	11.6	9.0	19.6	77.9	44.2	20.3	12.1	8.7	44.8	13.6	13.5	9.0	13.7	17.3	12.1	15.8	41.1	6.4	58.6	64.7	41.8	2.3	33.8	28.7	182.4	17.5	11.2	18.5
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 197.2;Late spermatids: 49.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 29.5"	"Group enriched"	"Detected in many"	9	"B-cells: 21.8;dendritic cells: 29.5;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 55.1;hTERT-HME1: 26.4;SH-SY5Y: 22.0;U-698: 21.8;WM-115: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	10.7	13.5	12.6	10.7	16.2	5.9	8.4	19.1	16.9	11.6	7.4	11.3	7.5	3.8	17.8	6.7	4.7	10.5	7.5	14.9	13.1	12.0	3.9	3.1	5.7	18.9	13.9	14.9	3.0	2.7	3.0	17.7	6.8	11.2	12.5	6.2	9.7	6.9	16.5	15.5	3.8	8.4	14.4	17.6	17.4	9.1	8.7	18.2	2.9	5.5	5.4	19.3	7.1	9.6	21.8	29.5	0.5	9.7	2.0	2.1	4.5	12.5	0.0	2.1	0.0	0.3	2.8	0.0	0.7	7.4	3.1	5.3	0.1	4.1	5.4	13.9	8.3	17.1	1.9	55.1	1.0	8.1	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	1.0	1.0	9.8	26.4	2.7	0.1	0.8	0.0	8.4	4.3	0.0	0.5	1.1	6.7	0.0	1.2	1.5	0.8	3.1	1.7	3.3	3.9	22.0	0.1	0.1	4.0	3.3	0.2	4.9	0.5	11.4	3.6	0.6	7.1	9.7	4.1	21.8	3.0	0.5	22.5	0.1	9.7	0.0	1.7	6.7	1.7	21.8	0.6	0.8	29.5	16.3	0.0	0.9	0.5	2.0	3.8	6.4	2.1	4.5	12.6	16.2	19.1	16.9	13.1	12.0	13.9	14.9	11.2	18.2	6.0	3.2	26.4	0.4	2.2	32.0	12.1	0.0	1.4	4.5	0.0	15.7	0.1	3.3	6.6	197.2	11.1	0.0	0.0	0.6	0.1	5.7	1.4	1.1	0.8	10.5	19.1	6.9	13.5	45.7	49.8	1.4	31.1	15.1	0.0	0.4	5.0	7.0	0.2	0.7	0.0	27.3	6.5	6.9	10.3	8.8	1.8	0.1	8.7	0.0	2.0
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50266026	"Enzymes, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"blood: 83.5;brain: 36.0;epididymis: 36.9"	"Cell type enriched"	"Detected in some"	7	"granulocytes: 556.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	52	"hypothalamus: 36.0"	"Cell type enriched"	"Detected in single"	835	"basophil: 83.5"	"Lineage enriched"	"Detected in single"	835	"granulocytes: 83.5"	"Group enriched"	"Detected in some"	4	"HEL: 61.2;HMC-1: 147.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 51.5"	"Low region specificity"	"Detected in all"			HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	1.7	0.2	0.2	5.1	0.4	2.4	1.1	0.2	0.3	2.7	1.9	0.2	1.2	2.1	3.1	36.9	2.7	0.6	6.6	2.1	0.2	36.0	0.6	0.8	4.9	2.3	0.6	0.1	0.4	0.5	0.3	0.7	0.2	0.3	2.2	1.9	3.0	0.9	1.3	1.8	1.8	2.4	5.4	0.2	0.4	6.9	2.4	0.2	0.4	0.3	0.4	1.7	1.8	2.7	0.0	0.0	83.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	61.2	0.0	0.0	0.0	0.1	147.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.3	0.2	36.0	0.6	0.1	0.3	0.2	11.9	81.4	0.0	0.0	0.7	0.5	0.3	0.0	8.1	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	556.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0
HDDC2	"C6orf74, CGI-130, dJ167O5.2"	ENSG00000111906	"HD domain containing 2"	Q7Z4H3	6	125219962-125302078	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035677	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		19000	Nucleoli	Nucleoplasm	"HPA035677: AB_10603768"	"unprognostic (8.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.54e-2)"	17.5	29.8	50.5	12.0	36.1	11.3	21.1	26.4	31.7	14.8	15.2	11.1	31.6	12.4	12.9	25.2	19.6	17.2	12.4	34.7	41.1	37.0	31.3	8.9	13.4	18.8	45.0	18.9	18.3	22.9	16.3	15.6	11.5	23.4	15.7	16.9	19.3	54.8	42.0	42.8	13.5	16.1	19.0	25.8	12.2	14.4	25.7	16.8	12.9	24.3	35.4	18.2	17.7	11.2	27.3	15.4	4.4	14.2	23.6	33.9	17.7	8.6	24.1	15.0	61.5	12.2	16.8	20.9	11.6	17.7	12.6	13.1	37.9	10.4	40.0	25.2	22.1	29.1	8.6	21.0	17.0	16.1	15.7	49.3	18.5	13.4	37.2	27.8	23.9	13.7	23.5	26.2	17.9	41.3	19.8	9.0	22.2	69.9	17.3	27.2	48.0	18.5	25.2	17.6	25.8	19.6	27.9	11.9	8.4	29.4	11.0	29.4	14.3	14.2	27.7	25.4	14.7	16.2	40.6	5.5	12.7	14.0	19.5	23.4	20.6	14.2	33.1	18.3	43.3	25.9	4.4	14.2	2.5	22.9	12.2	18.7	27.3	25.3	31.0	14.7	22.0	31.4	33.9	3.2	23.6	11.1	15.4	21.5	17.7	50.5	36.1	26.4	31.7	41.1	37.0	45.0	18.9	23.4	16.8	23.8	38.7	42.4	51.6	39.6	51.4	109.7	33.1	34.8	30.7	59.3	13.7	75.6	286.8	71.8	43.7	26.4	42.4	23.3	86.1	127.4	62.7	54.8	36.9	18.1	98.5	65.2	61.9	11.6	46.6	33.2	84.3	41.0	75.9	12.6	64.1	45.8	55.3	45.6	107.8	202.1	18.2	38.8	76.2	115.5	66.8	37.6	38.2	62.3	78.2	45.1
HDDC3	MGC45386	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929964-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	14.3	18.8	16.3	8.9	17.1	10.7	11.3	10.3	17.6	8.2	13.1	9.3	12.6	12.4	5.4	12.8	7.7	12.7	7.1	15.2	12.9	12.3	14.7	18.3	7.8	9.0	14.6	12.5	10.3	30.3	15.1	10.4	10.4	11.0	8.7	11.1	9.7	24.8	14.0	14.2	9.3	17.1	6.1	11.4	13.1	11.2	4.5	8.2	11.8	12.0	10.1	10.7	7.5	7.5	19.9	25.3	5.6	15.6	16.4	21.5	14.3	6.7	8.3	2.9	3.5	6.7	6.8	4.9	4.5	6.2	4.3	6.3	4.1	14.0	12.7	4.8	3.8	3.4	10.5	6.1	10.6	3.6	16.1	12.9	16.0	3.2	9.3	13.7	6.1	7.9	5.9	16.8	7.8	14.0	6.8	9.4	10.6	12.7	11.5	3.8	9.8	8.3	5.3	2.4	25.5	8.5	7.0	1.1	20.3	8.8	7.1	7.4	4.7	3.8	10.7	11.4	6.4	16.2	16.5	5.3	2.7	5.9	4.4	5.8	18.8	21.1	8.8	9.8	12.0	7.9	5.6	11.8	4.7	14.0	15.6	18.4	19.9	18.4	16.2	15.9	17.5	21.5	15.7	2.8	16.4	14.2	25.3	17.4	14.3	16.3	17.1	10.3	17.6	12.9	12.3	14.6	12.5	11.0	8.2	26.8	6.1	27.0	11.4	4.9	12.4	0.8	43.3	20.1	19.4	15.7	3.9	39.0	64.6	34.0	3.9	14.7	23.8	23.3	49.1	27.5	8.7	13.1	6.9	33.8	39.5	14.3	19.1	15.4	12.9	2.4	13.3	18.0	13.5	48.7	31.2	29.5	27.9	30.6	11.0	53.5	35.3	6.5	7.3	16.3	14.0	7.3	20.3	17.5	34.4	10.3
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472287-4502211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.1"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 31.1;Ductal cells: 22.5;Extravillous trophoblasts: 24.9;Hofbauer cells: 21.7;monocytes: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	10.3	9.6	15.4	10.0	13.6	8.1	10.3	15.3	21.0	9.7	8.8	9.0	8.0	10.1	12.3	10.4	6.6	10.2	9.9	8.5	16.6	13.5	9.8	9.9	7.3	10.2	11.9	13.2	15.9	10.6	8.3	10.2	9.6	10.5	10.1	5.0	7.8	11.3	16.8	39.4	10.9	9.2	12.0	8.8	10.3	9.2	49.1	9.5	13.6	7.3	6.2	7.4	7.7	9.0	7.0	2.2	3.6	1.8	2.3	2.4	0.8	27.7	16.4	28.5	26.4	12.4	12.7	19.9	22.4	12.1	24.7	22.0	18.7	12.1	24.5	13.1	16.4	13.0	15.9	18.9	20.4	14.5	27.3	30.0	15.0	12.3	24.6	16.1	14.8	21.5	18.1	11.1	16.9	8.3	17.6	22.5	23.2	17.2	30.9	11.9	19.7	33.4	29.7	32.6	11.2	29.5	33.3	23.5	15.7	15.3	14.2	31.5	31.1	21.8	12.5	18.1	16.3	12.3	23.6	29.7	15.6	21.4	29.3	21.1	38.4	20.0	17.2	21.9	23.9	16.4	0.0	1.8	3.6	1.4	1.1	0.4	1.1	1.5	1.1	1.6	7.0	2.4	0.9	0.5	2.3	0.6	2.2	1.8	0.8	15.4	13.6	15.3	21.0	16.6	13.5	11.9	13.2	10.5	9.5	6.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	17.4	9.1	12.2	0.0	31.1	16.6	22.5	0.0	0.0	0.0	0.0	17.5	24.9	0.0	0.0	1.1	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	26.2	0.0	0.0	19.1	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0
HDHD2	DKFZP564D1378	ENSG00000167220	"Haloacid dehalogenase like hydrolase domain containing 2"	Q9H0R4	18	47107403-47150520	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040697, CAB045978, HPA059818"	Approved		Approved	Vesicles		NA	NA		170000	Vesicles		"CAB045978: AB_11124418, HPA040697: AB_2677084, HPA059818: AB_2684132"	"unprognostic (3.22e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.82e-2)"	"unprognostic (8.64e-3)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.17e-1)"	11.0	23.7	29.3	9.1	24.9	8.5	15.8	34.7	29.0	10.3	14.9	22.2	10.5	11.0	12.6	14.6	12.7	14.5	10.6	23.7	25.6	27.3	20.3	25.2	11.6	15.3	32.1	23.1	13.1	19.3	21.0	15.6	10.3	37.5	15.9	14.7	12.0	12.5	16.8	12.6	10.5	11.9	12.3	30.4	11.3	13.2	9.9	22.2	15.3	23.6	7.9	18.1	11.4	9.4	20.3	18.0	13.5	18.5	21.2	22.1	14.8	7.5	5.1	19.7	9.6	12.1	17.3	5.8	8.4	8.3	14.2	14.5	2.3	6.0	13.5	7.5	10.0	6.6	6.9	10.5	12.2	20.6	10.1	10.6	12.1	10.2	13.3	16.7	17.4	10.9	14.4	15.2	8.3	18.5	15.7	11.8	21.6	12.3	14.6	18.5	10.1	15.4	9.9	19.3	6.4	5.3	14.9	12.3	16.5	17.9	11.6	17.9	14.5	8.4	5.8	10.6	14.1	8.5	23.0	8.2	11.0	8.4	3.2	6.0	19.2	8.7	11.2	13.4	17.6	10.4	12.0	18.5	13.5	16.5	16.8	16.8	20.3	17.1	15.7	18.0	19.8	22.1	17.5	1.8	21.2	16.1	11.7	16.8	14.8	29.3	24.9	34.7	29.0	25.6	27.3	32.1	23.1	37.5	22.2	14.9	15.6	12.8	9.5	6.4	20.3	10.8	10.2	17.4	14.8	10.4	13.7	20.2	61.3	15.2	1.6	9.0	10.2	0.0	15.7	12.3	8.7	18.4	7.0	22.9	19.1	42.9	13.3	10.4	14.0	1.5	16.4	10.8	15.1	21.6	16.3	40.1	15.4	22.6	22.3	41.6	27.6	19.4	11.4	16.1	39.2	5.3	16.5	14.9	21.3	11.9
HDHD5	CECR5	ENSG00000069998	"Haloacid dehalogenase like hydrolase domain containing 5"	Q9BXW7	22	17137511-17165287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 36.5;Ductal cells: 28.6;Exocrine glandular cells: 24.8;Extravillous trophoblasts: 35.3;Hofbauer cells: 38.3;Proximal tubular cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005548	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA005548: AB_1078497"	"unprognostic (4.04e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.54e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.21e-3)"	12.2	22.2	10.3	11.3	13.3	12.8	14.7	13.2	13.2	10.6	23.7	11.3	8.8	23.7	12.6	10.1	15.3	11.9	16.0	29.5	9.9	8.4	14.7	29.8	12.5	12.4	16.4	10.4	13.6	25.3	8.9	9.6	7.4	13.2	12.7	13.1	7.7	17.3	10.0	37.2	15.7	16.5	12.0	9.9	14.6	13.6	12.4	13.7	15.1	9.4	25.9	11.6	11.9	10.7	10.1	29.3	2.9	34.6	11.1	15.0	17.5	22.7	15.1	11.3	15.3	6.7	4.1	14.5	6.5	7.2	17.6	19.0	22.1	8.5	37.4	11.0	7.8	8.6	16.1	14.3	15.3	8.2	11.3	20.9	0.0	10.9	0.0	11.2	16.8	8.8	10.0	19.1	7.8	8.7	9.9	12.3	24.8	10.9	9.7	9.2	22.2	29.5	34.6	17.3	35.2	13.5	16.9	17.1	9.4	12.0	12.6	23.0	17.4	12.7	18.5	19.5	9.4	18.5	21.1	10.6	15.0	11.1	10.5	11.2	15.5	16.8	27.5	12.0	0.0	12.5	2.9	34.6	1.6	11.8	21.4	14.7	10.1	11.2	10.7	29.3	9.6	15.0	12.5	1.7	11.1	11.6	12.1	11.3	17.5	10.3	13.3	13.2	13.2	9.9	8.4	16.4	10.4	13.2	13.7	6.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	9.1	5.2	0.0	21.4	36.5	28.6	0.0	0.0	0.0	0.0	24.8	35.3	0.0	0.0	4.7	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	9.0	0.0	0.0	21.7	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0
HDX	"CXorf43, FLJ30678"	ENSG00000165259	"Highly divergent homeobox"	Q7Z353	X	84317874-84502479	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 19.1;Urothelial cells: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047189	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA047189: AB_10965463"	"unprognostic (7.26e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-5)"	"unprognostic (3.23e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.40e-6)"	"unprognostic (1.14e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.66e-2)"	5.1	7.4	8.3	3.3	7.9	0.6	6.4	23.1	10.2	8.2	4.6	2.6	3.5	1.8	7.4	5.3	4.2	6.3	5.5	4.8	5.5	4.6	4.3	4.5	4.4	2.3	6.5	7.0	8.0	2.2	5.5	16.4	1.4	6.6	6.0	4.5	2.0	4.5	6.2	1.7	1.9	2.9	6.6	5.7	4.2	3.2	4.0	7.1	0.4	5.7	2.7	2.7	5.2	8.3	2.7	6.1	0.0	6.9	1.4	1.4	1.1	0.0	2.2	9.0	0.0	5.4	4.7	0.0	2.9	3.9	6.9	7.8	0.4	1.2	0.0	0.6	3.0	8.8	0.5	0.1	1.1	5.4	0.0	0.6	0.0	1.7	0.0	5.0	0.0	0.0	3.2	0.1	4.4	2.9	3.9	6.9	0.0	0.0	0.0	6.8	0.1	0.0	0.0	6.6	0.0	3.0	0.0	7.6	0.1	3.2	1.5	0.3	5.1	0.0	0.2	0.0	3.8	0.4	0.0	7.3	3.8	2.6	1.2	2.7	0.2	0.0	0.0	1.8	0.0	1.6	0.0	4.3	0.0	1.4	6.9	0.2	2.7	0.4	0.3	6.1	1.0	1.2	0.7	0.0	1.4	5.9	0.6	0.2	1.1	8.3	7.9	23.1	10.2	5.5	4.6	6.5	7.0	6.6	7.1	0.0	2.4	1.3	19.1	2.3	8.5	1.6	2.5	1.4	4.5	5.2	11.8	0.0	0.0	5.2	3.8	7.1	0.7	0.0	1.6	0.0	5.1	11.0	1.1	0.2	0.9	6.4	6.8	1.8	1.6	1.0	3.7	2.6	0.0	3.6	1.3	3.3	2.8	2.0	3.2	1.7	5.0	0.0	3.3	0.5	0.0	1.5	0.1	1.3	0.9	18.0
HEATR5B	"DKFZp686P15184, KIAA1414"	ENSG00000008869	"HEAT repeat containing 5B"	Q9P2D3	2	36968383-37084342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042025, HPA055639"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA042025: AB_10959880, HPA055639: AB_2682870"	"unprognostic (3.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.80e-3)"	"unprognostic (8.69e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.95e-1)"	14.7	13.6	13.5	14.1	23.8	21.8	15.0	23.3	22.8	11.1	10.2	15.4	10.1	10.9	16.5	18.0	14.9	9.7	10.9	10.7	11.4	12.1	9.9	12.9	12.5	29.6	13.0	16.6	12.3	23.8	17.9	16.6	10.3	21.6	12.2	14.0	12.4	18.0	9.6	7.1	18.0	14.9	9.4	16.1	18.0	12.8	9.6	14.5	16.0	13.6	8.4	30.0	11.3	12.9	15.2	10.7	15.8	4.9	7.0	9.1	5.0	10.4	5.3	7.9	11.9	8.2	8.2	10.0	6.6	4.9	6.1	6.2	6.0	7.2	22.4	4.8	5.6	8.1	8.9	7.7	5.4	8.0	10.9	8.4	14.6	7.0	8.5	5.1	15.6	19.3	7.4	7.6	8.7	8.4	6.7	10.1	12.1	13.8	19.9	7.3	6.2	13.6	11.2	5.1	10.9	3.7	13.2	8.0	16.8	7.1	9.0	9.7	8.6	6.9	11.2	5.2	8.3	8.0	5.1	11.3	9.3	5.3	6.6	5.1	12.5	10.2	24.7	7.5	9.4	6.1	15.8	4.9	11.3	7.9	2.6	7.2	9.9	8.8	8.8	8.6	15.2	9.1	7.9	5.1	7.0	3.8	10.7	8.9	5.0	13.5	23.8	23.3	22.8	11.4	12.1	13.0	16.6	21.6	14.5	20.8	9.3	11.1	4.0	8.8	13.3	19.3	7.6	8.1	5.7	5.2	9.8	6.2	1.7	3.8	5.6	9.8	9.9	0.0	5.3	5.4	6.6	6.3	6.9	7.3	5.5	15.9	5.2	14.1	16.5	1.9	8.3	10.3	6.8	3.6	9.6	6.3	6.8	5.8	6.0	4.5	15.0	19.4	7.6	2.7	8.5	10.2	4.7	10.0	6.9	4.6
HEATR6	"ABC1, FLJ22087"	ENSG00000068097	"HEAT repeat containing 6"	Q6AI08	17	60043194-60078931	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 49.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030789, HPA062157"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030789: AB_10601660, HPA062157: AB_2684700"	"unprognostic (1.98e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.22e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.02e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.81e-3)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	8.3	14.5	14.6	9.2	15.4	12.0	10.3	28.5	15.1	12.2	13.0	18.0	11.1	6.8	14.4	12.6	9.4	13.0	9.1	12.3	11.2	9.9	9.0	7.1	11.8	11.0	15.3	12.6	17.8	10.3	16.7	18.4	10.7	13.7	13.2	10.6	10.0	11.3	13.0	12.6	13.3	11.2	15.0	12.8	14.1	9.5	10.5	15.8	10.0	9.5	7.2	9.7	12.3	18.9	10.8	12.8	6.8	10.4	4.1	6.8	4.6	4.7	9.3	8.2	5.6	5.5	8.1	5.9	4.7	7.9	8.9	8.6	4.0	3.5	1.7	7.7	8.3	7.3	5.7	6.5	6.4	11.6	3.3	8.3	9.1	7.3	6.0	7.1	5.7	8.2	8.1	10.4	6.5	9.2	9.8	5.1	5.2	5.2	5.7	5.9	49.1	7.6	2.1	4.2	4.3	8.7	2.9	14.2	5.0	4.8	5.8	5.4	12.4	4.4	1.6	4.7	8.1	7.1	3.9	4.7	8.3	12.6	6.2	7.7	4.8	5.2	0.0	7.3	4.4	6.3	5.1	6.1	6.8	6.8	10.4	5.5	10.8	5.5	5.7	12.8	8.4	5.9	5.1	1.2	4.1	9.9	4.4	5.6	4.6	14.6	15.4	28.5	15.1	11.2	9.9	15.3	12.6	13.7	15.8	11.9	4.6	4.7	3.2	0.8	10.6	8.2	2.5	14.7	10.3	7.0	9.8	4.9	3.3	4.0	0.7	2.2	0.9	0.0	2.9	2.8	3.1	1.8	10.5	2.6	4.1	6.4	6.4	3.7	4.1	0.7	3.1	6.5	1.7	19.8	1.5	8.2	2.4	0.0	10.6	2.8	6.3	6.5	3.3	3.4	7.5	1.9	1.7	2.5	2.5	1.1
HEBP1	"HBP, HEBP"	ENSG00000013583	"Heme binding protein 1"	Q9NRV9	12	12974864-13000273	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056417, HPA075277"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		130000	Vesicles	Nucleoplasm	"HPA056417: AB_2683122, HPA075277: AB_2686741"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.28e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.45e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.43e-2)"	23.4	36.0	12.3	7.6	21.1	16.0	24.5	7.7	14.0	17.7	46.8	18.0	20.0	79.8	14.2	13.9	13.9	13.6	25.4	18.3	11.8	11.7	20.4	48.5	16.2	11.2	16.7	8.0	27.8	27.6	13.3	9.0	13.9	17.2	17.8	7.6	20.0	18.2	16.4	12.8	19.1	79.1	22.9	22.2	19.3	13.4	11.2	15.1	5.5	52.8	13.9	8.7	18.2	23.9	5.3	21.4	9.0	27.4	7.1	9.4	9.9	17.0	10.3	7.2	12.6	54.4	42.4	4.9	15.5	22.1	14.9	19.9	6.5	6.2	5.0	6.2	30.3	12.7	15.5	8.9	12.3	17.3	0.7	7.3	2.8	12.3	16.5	39.1	4.9	2.7	32.6	11.7	19.7	24.5	46.1	30.4	6.0	3.1	4.3	25.2	10.6	4.0	8.1	10.0	16.6	7.3	9.3	20.5	5.1	12.0	16.4	4.0	3.6	20.6	9.6	19.2	21.8	5.0	7.4	33.2	11.0	13.3	17.3	8.0	4.0	3.2	1.8	17.5	9.0	4.4	4.6	27.4	6.8	4.3	19.8	6.0	4.9	7.3	4.7	21.4	5.3	9.4	5.4	9.0	7.1	26.5	10.7	4.1	9.9	12.3	21.1	7.7	14.0	11.8	11.7	16.7	8.0	17.2	15.1	50.6	17.6	17.9	45.0	33.3	5.0	24.6	79.0	4.0	6.8	54.1	3.9	30.7	84.6	74.8	15.7	52.4	88.1	46.7	88.6	23.2	57.2	40.0	1.1	121.3	73.3	6.4	19.5	141.2	67.3	5.6	82.6	41.0	59.1	62.3	33.8	30.7	71.9	44.1	88.4	72.5	5.8	51.8	41.2	13.8	7.4	31.6	22.0	21.8	48.4	46.5
HECA	"dJ225E12.1, HDC, HDCL, hHDC"	ENSG00000112406	"Hdc homolog, cell cycle regulator"	Q9UBI9	6	139135112-139180802	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 111.7;Suprabasal keratinocytes: 124.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012581, HPA042313"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA012581: , HPA042313: AB_10796903"	"unprognostic (2.98e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-3)"	"unprognostic (5.77e-2)"	17.2	8.9	11.7	19.3	12.6	31.5	38.5	10.8	18.7	12.1	17.7	9.2	9.3	15.7	15.5	8.8	21.0	12.0	12.8	26.5	16.6	10.6	7.5	10.3	20.4	34.2	14.1	13.3	19.3	9.6	10.7	8.3	10.4	14.6	10.8	12.3	5.7	16.4	9.7	22.1	24.8	18.8	14.7	14.7	25.2	11.5	9.0	13.3	34.1	11.4	10.8	23.9	16.1	38.3	3.0	1.7	7.5	7.3	2.2	6.9	2.2	3.0	0.6	6.0	6.9	13.9	12.8	4.4	5.5	9.3	2.5	5.8	1.2	3.5	13.2	8.1	11.4	6.0	5.1	3.6	5.0	4.6	20.6	7.7	6.6	3.1	0.2	4.4	11.5	6.0	14.6	12.3	5.5	6.7	6.9	8.4	8.9	2.8	17.9	4.6	3.1	5.6	9.5	1.1	2.6	1.1	8.8	6.1	6.6	2.2	9.7	5.8	1.7	4.5	12.5	3.4	7.0	2.8	15.4	10.5	4.4	4.2	10.0	4.7	10.8	8.0	12.1	1.6	6.8	2.5	6.9	2.0	2.8	4.4	2.6	5.6	2.4	6.9	6.0	1.5	3.0	6.6	6.5	7.5	2.2	7.3	1.7	5.8	2.2	11.7	12.6	10.8	18.7	16.6	10.6	14.1	13.3	14.6	13.3	6.0	15.2	20.0	18.9	111.7	1.4	33.9	7.6	1.4	5.7	10.4	2.0	5.9	0.0	6.7	9.4	34.3	31.1	23.3	8.5	4.8	30.1	27.6	12.7	10.5	16.9	1.6	12.6	37.4	76.3	9.1	14.4	36.1	42.2	3.6	21.1	6.0	12.4	25.2	18.4	2.3	2.5	51.8	34.8	11.1	4.1	124.3	14.5	39.9	15.7	35.1
HECTD2	FLJ37306	ENSG00000165338	"HECT domain E3 ubiquitin protein ligase 2"	Q5U5R9	10	91409280-91514829	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 25.5;Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 6.7"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037767	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037767: AB_10671378"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.37e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (6.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.84e-2)"	8.7	8.8	16.5	6.9	17.9	2.4	10.8	20.3	19.5	14.3	10.1	5.1	9.1	4.6	17.2	16.6	8.3	12.1	11.4	8.1	11.9	8.7	7.3	4.7	8.7	4.7	5.8	11.3	16.8	7.4	14.4	18.6	10.2	6.5	24.8	7.6	7.5	7.7	24.3	7.7	6.8	6.0	18.4	6.8	5.3	7.5	9.7	6.4	2.9	9.8	5.1	3.6	13.7	10.5	0.6	0.4	0.1	0.8	6.7	1.0	0.5	4.1	2.1	21.4	8.8	4.7	5.2	3.8	3.4	4.5	6.9	6.3	0.2	3.9	0.0	2.9	3.4	4.0	0.3	5.8	2.4	8.5	4.4	7.2	2.4	15.0	1.3	2.4	0.4	1.6	5.3	2.2	5.0	4.3	9.7	5.1	5.1	3.1	10.7	10.6	1.9	2.5	1.3	8.9	0.4	2.1	6.4	14.1	2.4	4.8	1.2	5.0	5.4	6.6	1.5	6.7	6.9	9.7	1.4	5.4	6.9	4.8	0.5	6.3	0.7	1.4	5.9	6.1	0.0	4.0	0.0	0.1	0.0	1.0	0.8	0.6	0.2	0.5	0.7	0.4	0.6	0.5	0.6	0.1	6.7	0.2	0.0	0.1	0.5	16.5	17.9	20.3	19.5	11.9	8.7	5.8	11.3	6.5	6.4	0.0	3.2	0.0	7.0	5.5	21.3	6.5	5.1	5.3	5.7	5.2	25.5	0.3	18.3	2.4	1.5	8.3	0.7	0.0	3.0	0.3	11.3	4.2	3.5	0.8	5.3	27.0	8.6	9.2	7.0	1.5	11.2	3.8	6.8	3.6	3.0	12.0	2.5	0.6	13.4	1.3	8.2	12.9	7.6	6.7	8.1	3.9	0.3	1.5	1.3	3.0
HECTD4	"C12orf51, FLJ34154, KIAA0614"	ENSG00000173064	"HECT domain E3 ubiquitin protein ligase 4"		12	112160188-112382439	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 43.3"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 133.5;Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041062, HPA045473"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA041062: AB_2677281, HPA045473: AB_2679338"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.51e-3)"	6.8	7.1	11.3	6.3	16.3	26.6	7.7	43.3	22.7	8.9	9.0	14.0	10.8	5.4	11.1	10.0	10.0	9.0	6.5	6.6	10.1	10.3	7.4	6.3	7.3	8.1	11.4	13.7	10.9	10.1	13.8	14.0	8.0	17.2	12.3	7.4	9.4	8.7	9.6	12.9	16.6	7.0	8.8	13.0	7.4	8.8	14.6	12.7	8.3	12.8	5.0	7.7	8.3	9.0	2.9	2.4	2.8	1.2	1.0	1.8	0.7	5.6	10.7	8.6	7.6	11.7	7.9	4.9	4.2	4.0	5.4	4.6	10.4	1.9	6.0	3.8	6.8	5.7	5.8	11.2	5.5	4.1	7.7	10.1	8.4	11.3	5.8	4.2	6.0	8.3	6.6	6.7	8.3	5.5	10.1	8.2	11.2	10.5	4.7	5.1	6.3	7.1	12.7	4.1	7.8	8.0	9.6	4.4	3.9	4.3	9.0	14.0	9.6	9.7	9.5	3.7	8.4	7.1	8.5	11.9	6.3	4.6	6.6	5.6	15.9	6.0	6.7	5.1	3.9	4.0	2.8	1.2	0.6	1.8	0.5	1.2	1.1	0.6	0.9	0.8	2.9	1.0	0.9	1.4	1.0	1.1	2.4	0.1	0.7	11.3	16.3	43.3	22.7	10.1	10.3	11.4	13.7	17.2	12.7	17.9	17.3	9.3	7.3	10.2	47.4	18.5	12.7	10.7	5.7	12.2	133.5	8.5	0.0	7.5	5.6	10.9	9.7	0.0	7.5	3.9	9.1	13.7	8.1	13.9	5.7	76.3	26.5	16.0	7.6	4.5	10.6	7.0	6.8	7.2	12.4	17.8	8.4	8.6	14.9	4.4	55.4	0.0	8.3	19.1	8.0	13.0	7.4	7.9	11.9	6.5
HEG1	"HEG, KIAA1237"	ENSG00000173706	"Heart development protein with EGF like domains 1"	Q9ULI3	3	124965710-125055958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 80.4;Cardiomyocytes: 80.5;Cone photoreceptor cells: 249.4;Ito cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 42.0;HHSteC: 51.1;hTERT-RPE1: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010952, HPA011559"	Approved		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		360000000	Vesicles	"Plasma membrane"	"HPA010952: AB_2668389, HPA011559: AB_1850580"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.11e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.16e-4)"	23.6	8.2	5.8	12.1	8.4	0.7	16.4	2.6	8.9	12.2	9.6	14.7	8.0	3.9	12.0	7.3	9.0	11.4	29.6	36.3	6.9	5.5	8.9	5.5	42.4	7.7	9.7	4.7	8.1	16.6	14.2	4.0	17.4	11.6	7.2	6.5	26.2	7.1	7.4	6.2	4.3	7.9	14.4	11.9	11.5	7.5	11.3	6.5	3.0	29.1	10.8	8.7	13.0	15.6	1.0	0.9	1.2	3.9	7.3	4.0	1.1	1.8	1.9	13.4	1.1	16.6	14.7	5.0	15.7	20.6	17.5	19.3	13.7	0.2	0.5	10.7	42.0	12.8	3.3	2.0	7.7	21.1	1.4	1.0	0.3	10.2	1.6	51.1	0.3	20.4	18.0	2.2	22.8	5.4	77.1	17.0	1.2	0.0	0.2	5.3	0.2	0.8	0.0	2.3	0.0	1.2	1.2	10.2	0.0	3.0	0.3	0.2	1.2	34.9	2.4	1.3	12.4	5.7	0.8	26.4	9.9	11.0	35.4	6.7	1.4	4.3	0.0	18.6	1.5	19.2	1.2	0.3	0.0	4.0	3.6	2.7	0.9	1.6	3.6	0.7	1.0	2.4	1.5	0.0	7.3	3.9	0.9	0.5	1.1	5.8	8.4	2.6	8.9	6.9	5.5	9.7	4.7	11.6	6.5	80.4	7.2	4.9	7.1	4.4	3.0	80.5	5.1	0.0	4.5	26.2	249.4	0.8	0.0	31.8	5.1	76.0	0.0	0.0	5.8	53.1	23.5	2.8	26.5	2.5	5.7	1.6	0.0	95.2	15.8	7.6	4.6	4.8	6.8	2.8	0.6	4.1	6.9	0.0	13.1	1.2	62.4	0.0	21.2	0.2	0.2	3.9	2.7	14.6	0.1	0.9
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Developmental protein, Helicase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.4"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 69.2;Spermatogonia: 174.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	Yes			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.4	2.0	1.2	28.8	1.5	14.8	3.0	11.9	3.2	4.2	5.0	0.7	3.3	3.5	5.8	6.0	8.6	2.5	3.6	2.1	1.3	2.0	3.9	2.0	2.5	11.9	1.4	1.7	4.3	1.9	2.7	4.7	9.0	1.3	3.4	5.5	3.3	2.8	2.0	0.6	5.2	5.3	2.1	1.7	8.3	3.6	18.7	0.7	46.4	1.7	8.1	15.1	3.6	4.4	13.6	22.0	0.7	0.8	5.6	10.9	1.5	19.9	19.7	25.5	32.3	1.0	2.4	13.8	15.3	9.9	12.8	20.2	26.0	16.2	24.7	6.1	5.1	10.8	20.2	14.6	12.2	18.3	23.9	16.8	13.1	20.0	20.8	0.6	24.7	11.9	1.3	0.7	15.3	7.3	3.5	8.8	16.7	7.1	15.8	15.1	20.1	26.0	12.3	26.4	14.6	8.8	24.3	22.7	5.7	8.7	25.8	10.2	8.3	18.1	5.2	2.7	22.2	22.1	8.0	6.2	14.0	7.1	12.8	18.3	8.2	15.6	26.4	7.0	15.3	6.4	0.1	0.5	0.0	4.4	0.8	1.5	10.9	7.2	6.2	1.3	13.6	3.5	5.0	0.7	5.6	0.6	22.0	10.9	1.5	1.2	1.5	11.9	3.2	1.3	2.0	1.4	1.7	1.3	0.7	8.9	3.8	23.8	8.2	19.2	13.6	0.8	7.6	8.1	17.0	21.0	0.0	25.8	3.3	5.8	0.8	4.9	2.1	23.3	5.5	31.3	11.0	3.1	5.7	2.6	12.8	6.4	10.4	8.0	1.3	3.6	8.3	6.2	1.7	9.0	6.5	5.0	3.9	0.0	5.3	1.4	9.4	19.4	6.2	69.2	174.0	8.7	9.3	12.5	23.7	4.4
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455856	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	10.5	20.8	6.3	12.2	7.8	7.2	10.4	12.6	9.2	10.7	9.8	9.3	8.2	5.6	9.9	8.7	8.2	9.1	9.0	10.5	6.2	5.7	11.9	10.0	8.0	15.3	6.8	5.7	17.4	8.1	13.3	20.7	11.7	9.0	11.4	7.2	11.0	10.0	10.4	14.6	8.7	9.8	8.0	8.4	14.4	8.4	10.7	7.4	18.5	14.3	8.3	13.4	10.2	9.2	10.1	4.6	6.8	4.7	5.5	9.7	2.9	4.3	3.3	7.1	4.6	8.7	9.2	3.7	6.5	9.8	8.5	8.4	3.1	4.5	12.2	5.2	5.6	5.8	4.4	8.6	4.8	8.9	7.0	3.8	7.3	5.4	4.2	5.6	8.8	18.0	7.1	6.5	6.7	7.0	7.5	6.7	8.2	9.6	10.7	8.6	5.1	8.0	6.3	3.6	6.9	2.4	6.2	8.2	4.3	7.0	2.7	5.8	4.8	6.3	6.9	7.1	7.1	4.3	9.5	5.1	6.4	5.6	8.2	5.1	9.9	4.2	10.3	5.4	6.7	7.1	5.4	3.7	6.8	5.7	4.0	5.4	5.8	6.3	6.4	4.6	10.1	9.7	8.7	2.3	5.5	4.7	4.5	7.8	2.9	6.3	7.8	12.6	9.2	6.2	5.7	6.8	5.7	9.0	7.4	3.0	9.4	10.0	8.0	3.8	9.2	9.2	7.6	22.7	7.9	5.2	7.9	9.6	10.0	5.1	20.9	7.1	3.5	0.0	4.8	8.1	6.4	4.9	7.0	4.0	9.1	6.4	0.0	10.4	5.6	5.8	12.0	8.4	6.8	7.2	4.5	9.1	4.7	6.0	7.4	8.8	13.2	0.0	8.2	20.0	12.8	3.3	9.6	13.1	5.2	4.7
HELZ	"DHRC, HUMORF5, KIAA0054"	ENSG00000198265	"Helicase with zinc finger"	P42694	17	67070438-67245989	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028276	Approved		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments"		NA	NA			"Nucleoli, Nucleoli rim"	"Plasma membrane, Actin filaments"	"HPA028276: AB_10601814"	"unprognostic (3.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	17.9	12.9	11.2	14.3	14.3	17.7	12.6	24.3	17.7	14.4	14.0	11.6	12.9	7.9	17.0	13.0	9.1	11.1	11.5	11.1	12.0	9.7	11.8	17.3	14.8	14.6	10.7	6.2	20.5	13.9	34.1	33.5	19.2	16.5	11.9	10.9	12.2	12.4	10.9	18.9	9.0	15.6	12.2	13.5	17.3	11.7	16.4	12.7	34.1	15.3	8.8	13.9	15.3	11.9	4.8	4.4	4.3	4.9	4.0	11.0	3.2	7.6	7.6	9.3	9.6	11.8	6.6	14.3	6.8	6.7	8.9	9.7	11.1	6.0	15.7	5.6	9.0	5.7	8.0	17.8	8.6	14.3	6.0	5.5	20.1	8.4	9.1	5.7	16.6	12.3	7.8	8.2	8.8	11.1	6.9	13.7	11.7	13.9	10.0	7.4	9.7	21.3	5.7	5.7	6.9	7.3	14.4	16.9	6.9	7.2	10.8	9.4	8.6	10.7	8.9	11.7	13.5	10.6	10.3	12.3	11.5	13.2	6.2	6.0	8.3	9.6	11.9	5.7	10.3	11.9	3.6	4.9	4.3	8.8	4.5	11.0	2.9	5.4	5.3	4.4	4.8	3.3	4.5	3.7	4.0	2.9	3.6	4.8	3.2	11.2	14.3	24.3	17.7	12.0	9.7	10.7	6.2	16.5	12.7	17.9	29.6	17.6	21.6	28.5	49.3	24.4	22.9	21.4	29.6	26.2	88.4	26.8	6.6	15.0	3.7	24.5	22.3	0.0	12.2	34.0	24.9	25.4	33.4	40.0	27.1	63.5	36.8	63.8	75.2	7.2	35.9	25.6	13.5	10.8	29.0	24.5	16.1	21.0	40.3	12.1	51.1	12.9	22.6	36.7	24.8	17.7	15.3	76.1	22.6	32.3
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.8;testis: 45.2"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 118.4;Spermatogonia: 74.4;T-cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 25.7;MOLT-4: 23.6;NB-4: 26.4;U-937: 34.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	15	"cerebellum: 18.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favorable (2.56e-4)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	3.5	2.2	6.7	5.1	10.2	7.7	5.5	3.6	11.6	6.1	4.4	4.2	1.4	3.4	2.8	3.4	1.9	1.8	4.5	3.1	9.5	10.1	1.8	1.4	4.9	9.8	8.2	5.6	3.8	1.5	0.6	3.9	3.8	10.7	2.7	6.6	1.3	2.4	2.6	2.0	2.6	5.2	2.5	6.9	8.0	3.2	45.2	2.5	10.3	1.7	1.2	7.3	5.5	1.6	5.4	10.6	18.2	12.0	22.9	28.8	15.9	5.8	3.0	0.2	0.0	0.2	0.2	0.0	1.4	0.5	3.5	0.5	8.8	9.3	0.0	3.2	2.6	0.0	0.0	0.0	0.0	2.2	1.9	0.0	15.0	11.3	0.0	3.0	8.8	13.4	2.9	0.1	0.7	0.0	0.0	0.7	25.7	0.0	6.7	0.1	14.9	23.6	26.4	8.7	4.7	1.3	10.3	0.0	0.5	0.0	6.4	14.7	0.0	12.6	3.5	0.0	0.9	0.0	19.8	0.1	0.0	11.7	6.4	0.0	4.1	5.1	0.0	0.0	34.8	0.1	16.0	8.8	18.2	28.8	10.1	26.0	5.4	14.2	26.0	10.6	2.9	11.8	21.7	8.6	22.9	12.0	8.5	13.1	15.9	6.7	10.2	3.6	11.6	9.5	10.1	8.2	5.6	10.7	2.5	0.0	0.6	0.0	1.4	1.4	3.8	1.5	17.8	1.4	1.2	5.2	0.0	10.4	3.3	2.8	8.7	2.6	3.9	0.0	1.2	16.4	3.1	0.6	6.9	0.4	14.0	0.0	4.7	6.7	11.7	17.0	4.6	8.5	1.7	7.2	2.5	2.0	1.9	6.8	2.8	0.7	2.6	6.5	2.8	118.4	74.4	1.4	4.3	38.3	5.6	2.5
HEPACAM	"FLJ25530, GLIALCAM, hepaCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919193-124936412	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell cycle, Growth arrest, Growth regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 17.3;brain: 64.7;liver: 19.6"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 9.3;Muller glia cells: 13.0"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in single"	31	"Hep G2: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB025486: , HPA017613: AB_1850595"	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			17.3	1.8	25.6	1.7	25.7	1.5	2.6	8.5	64.7	1.6	1.8	55.4	0.0	1.6	1.6	1.7	1.6	1.6	1.6	1.7	31.0	10.8	1.6	19.6	1.6	1.7	30.3	22.4	1.5	1.6	1.5	0.6	1.5	27.9	1.6	1.8	0.0	1.7	2.1	1.6	1.6	1.6	1.6	21.5	1.5	1.6	1.7	35.5	0.0	1.6	0.0	2.3	1.5	0.3	1.5	1.2	3.0	1.4	2.0	1.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	1.1	1.2	1.1	1.2	1.5	1.5	1.4	1.0	1.2	1.3	1.7	1.5	1.3	2.0	1.4	1.0	1.1	1.5	25.6	25.7	8.5	29.7	31.0	10.8	30.3	22.4	27.9	35.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188586-93226524	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 43.4;kidney: 24.5;pituitary gland: 16.1"	"Group enriched"	"Detected in some"	23	"Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"SCLC-21H: 63.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		89000	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.2	0.2	8.5	0.2	0.6	3.4	0.1	0.1	0.1	29.4	0.1	5.3	11.8	0.1	0.4	0.2	0.1	0.8	0.3	0.2	0.2	24.5	0.2	0.4	0.1	0.2	0.1	0.1	5.5	0.0	16.1	0.4	0.2	0.7	38.9	0.1	4.1	1.2	0.1	0.1	43.4	0.4	0.2	0.2	4.0	1.4	0.1	0.3	0.1	0.1	2.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	8.3	0.0	2.1	0.0	6.7	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.0	0.0	209.3	0.0	0.0	1.9	0.0	0.0	6.8	0.0	364.1	0.0	0.0	298.7	0.0	0.0	0.0	0.0	0.0	4.5	0.7	0.1	0.1	0.0	12.4	0.0
HEPN1		ENSG00000221932	"Hepatocellular carcinoma, down-regulated 1"	Q6WQI6	11	124919244-124920677	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"brain: 43.3"	"Cell type enriched"	"Detected in some"	10	"Muller glia cells: 23.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	240	"Hep G2: 34.3"									"HPA043768, HPA063054"	Uncertain		Approved	"Golgi apparatus"		Yes	NA			"Golgi apparatus"		"HPA043768: AB_2678662, HPA063054: AB_2684932"																		8.4	0.5	22.0	0.4	20.4	0.3	0.3	4.2	43.3	0.3	0.4			0.3	0.4	0.3	0.4	0.3	0.3	0.5	17.9	11.0	0.4	4.5	0.3	0.5	19.3		0.4	0.3	0.3	0.0	0.3		0.3	0.3		0.5	0.3	0.5	0.3	0.5	0.3	19.4	0.3	0.4	0.4			0.3		0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.6	0.0	0.4	0.6	0.0	0.0	0.0	0.0	23.5	0.0	0.0	1.1	0.0	1.4	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.0
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: AB_2680382, HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favorable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	2.5	3.3	3.2	2.2	4.5	3.9	3.1	7.0	5.7	3.2	4.6			2.7	4.4	1.7	2.8	4.1	2.1	4.6	3.5	3.6	3.3	1.6	2.5	2.1	3.8		8.5	3.6	9.2	3.5	2.7		3.0	3.0		2.3	3.3	8.2	3.1	3.1	4.1	4.1	2.3	3.4	3.2			5.6		2.4	3.3	2.3	1.0	1.1	0.5	0.4	0.2	1.1	0.4	5.2	10.3	7.2	3.0	6.0	4.5	2.0	3.8	4.5	4.9	4.7	5.3	0.7	5.2	4.6	6.4	7.4	5.3	7.6	3.7	3.6	3.2	4.9	33.3	12.0	1.7	2.3	7.8	2.7	3.7	2.9	5.8	7.3	3.1	6.4	4.4	12.8	2.2	4.6	2.4	1.7	2.6	2.1	4.0	4.5	6.2	10.3	0.4	1.7	11.3	7.9	4.6	9.1	2.6	3.0	3.9	3.0	9.2	9.6	9.1	5.9	3.5	5.6	1.4	2.0	4.9	4.2	3.7	4.8	0.0	0.4	0.5	1.1	0.1	0.6	0.5	0.2	0.5	1.1	1.0	0.9	0.5	0.0	0.2	0.3	0.9	0.4	0.4											20.8	19.7	23.1	13.0	14.5	100.9	54.0	28.1	17.4	25.0	61.1	139.4	22.6	1.7	24.7	11.1	39.4	24.9	0.0	26.5	13.6	21.3	18.7	3.5	30.6	16.6	116.0	27.0	36.8	21.8	10.6	52.0	17.3	65.8	26.2	29.8	46.8	29.3	31.6	49.1	16.6	140.1	64.7	24.7	57.9	59.4	18.3	14.9	30.2	30.9	10.1
HERC3	KIAA0032	ENSG00000138641	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"	Q15034	4	88592423-88708542	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.6;hTERT-HME1: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039170	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039170: AB_10673414"	"unprognostic (2.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.58e-2)"	"prognostic favorable (5.65e-7)"	"unprognostic (1.83e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	12.7	13.3	16.9	13.0	27.1	21.0	15.3	37.8	20.1	14.4	12.0	17.9	11.6	11.2	12.0	10.5	16.8	10.7	12.1	22.0	15.2	13.7	15.8	13.0	15.0	15.3	21.9	15.0	12.7	9.7	33.8	16.1	10.0	21.1	22.0	13.4	22.0	14.0	14.0	17.3	19.1	12.8	13.8	16.3	15.7	12.9	3.6	21.5	16.6	15.7	12.6	16.4	13.3	16.7	5.2	7.0	18.2	9.7	3.1	9.0	3.9	7.3	1.1	1.4	2.4	7.9	16.7	4.7	8.3	15.4	8.7	5.8	1.9	8.6	7.8	4.0	27.6	4.0	2.6	2.0	7.6	8.3	3.4	2.3	5.4	3.3	1.2	4.5	13.4	9.8	7.9	9.4	8.3	37.6	4.9	9.6	4.1	3.9	3.4	17.7	2.2	9.2	3.2	0.4	4.8	2.0	10.4	9.7	3.2	5.6	1.4	1.9	1.9	9.6	6.1	3.2	2.4	1.0	6.0	15.0	9.9	5.4	9.3	6.2	6.5	1.6	4.5	6.2	6.1	4.1	5.7	5.7	7.7	4.7	6.2	5.5	5.2	5.5	4.7	7.0	4.9	8.2	5.8	18.2	3.1	9.7	2.4	9.0	3.9	16.9	27.1	37.8	20.1	15.2	13.7	21.9	15.0	21.1	21.5	6.0	5.8	8.8	7.9	31.9	24.1	18.5	7.6	4.0	2.3	8.7	104.1	5.8	1.7	3.6	2.6	9.3	9.2	23.3	7.9	13.2	7.3	12.5	15.1	11.0	8.3	30.2	26.5	8.6	27.9	2.7	7.8	17.3	13.5	2.8	10.1	9.2	7.4	8.6	12.4	5.0	59.1	6.5	11.3	3.0	7.0	44.4	6.2	13.1	5.2	10.4
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075348	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 55.9;fHDF/TERT166: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: AB_2686247"	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	25.3	29.4	21.9	28.0	28.4	14.6	22.7	30.5	24.9	24.2	20.5	22.2	26.7	20.0	28.1	24.3	22.2	19.2	20.2	20.5	21.9	22.7	20.6	24.5	20.6	30.2	30.9	14.8	24.5	17.1	25.2	35.6	23.8	26.8	19.4	23.9	17.8	17.7	24.1	19.6	20.9	25.8	23.0	28.7	27.0	17.3	22.2	33.6	23.6	19.5	13.8	28.3	24.7	47.9	7.7	10.4	13.5	9.3	9.9	11.5	6.5	22.8	8.2	5.1	8.6	13.4	18.4	4.6	55.9	34.6	21.0	13.6	4.6	10.8	8.0	4.4	62.8	13.1	12.1	5.7	8.3	28.4	5.2	2.8	3.7	13.5	3.5	7.1	4.5	6.6	9.0	9.7	11.2	10.0	26.4	13.0	4.5	3.9	4.1	32.3	9.8	3.2	5.3	3.0	5.3	14.3	4.3	2.1	2.8	9.5	6.5	2.5	2.8	18.2	7.8	7.9	11.1	4.8	5.7	17.7	11.1	6.2	27.2	9.6	2.8	3.3	5.1	20.3	8.7	3.8	13.5	9.3	11.1	8.2	7.9	11.5	7.7	9.1	9.8	10.4	7.5	8.8	9.0	11.7	9.9	7.6	2.7	10.6	6.5	21.9	28.4	30.5	24.9	21.9	22.7	30.9	14.8	26.8	33.6	44.7	27.7	32.0	24.8	44.8	51.3	21.2	12.7	17.4	15.9	17.4	41.2	23.4	6.6	17.2	55.0	28.7	37.8	0.0	10.6	35.6	22.1	32.9	30.0	21.3	20.3	50.9	21.2	31.3	32.9	34.9	24.7	27.8	16.9	16.2	25.6	23.2	28.7	31.6	18.0	18.2	45.2	6.5	25.8	22.4	10.2	53.2	13.0	27.3	17.7	45.1
HERPUD2	FLJ22313	ENSG00000122557	"HERPUD family member 2"	Q9BSE4	7	35632659-35695571	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 290.9;Late spermatids: 471.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015630, HPA076087"	Approved		Approved	"Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"		"HPA015630: AB_1850609, HPA076087: AB_2686774"	"unprognostic (1.85e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	22.7	13.7	19.2	25.6	21.7	34.3	21.9	25.0	21.7	24.2	20.3	18.6	18.8	16.1	24.3	17.1	21.2	19.9	26.4	16.6	17.5	14.0	17.6	25.3	22.7	33.7	16.7	18.3	37.0	31.4	18.0	22.5	21.6	15.4	21.6	19.3	19.5	19.6	23.8	17.9	20.9	20.5	23.9	18.5	24.1	18.0	39.5	18.3	34.3	22.5	15.4	23.2	25.0	22.0	5.7	5.9	19.2	9.2	12.1	12.2	4.8	18.0	6.9	13.0	12.7	19.5	14.9	10.5	12.9	18.1	8.4	9.5	8.2	21.6	13.0	20.5	16.3	28.8	22.8	7.2	9.3	13.1	8.6	9.3	9.0	8.4	5.5	16.8	9.1	11.5	18.6	16.8	10.6	17.2	17.3	13.9	16.1	14.1	17.4	14.5	7.6	10.3	14.9	10.9	11.2	9.5	12.5	15.7	10.4	10.9	8.1	10.8	17.9	16.3	15.5	11.1	20.7	15.6	11.0	16.2	13.2	15.2	12.8	10.2	24.3	27.6	13.7	12.7	14.1	24.1	5.8	6.8	19.2	10.6	7.6	12.2	4.4	9.5	11.3	5.9	5.7	5.9	8.0	11.7	12.1	9.2	3.6	8.6	4.8	19.2	21.7	25.0	21.7	17.5	14.0	16.7	18.3	15.4	18.3	23.8	17.9	41.2	14.4	14.9	13.6	11.8	15.3	10.7	11.4	5.2	7.9	14.5	14.9	21.2	290.9	17.4	20.8	0.0	25.4	21.7	16.6	16.1	35.8	17.9	15.8	11.1	13.7	20.9	26.3	471.7	25.3	19.2	21.9	22.6	12.2	22.4	26.9	14.0	23.7	11.2	13.0	12.9	15.0	27.7	18.3	13.8	26.0	62.3	13.4	18.2
HES3	bHLHb43	ENSG00000173673	"Hes family bHLH transcription factor 3"	Q5TGS1	1	6244192-6245578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 6.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	28	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 16.1"	"Region enriched"	"Detected in single"	30	"cerebellum: 39.0"	"Low region specificity"	"Detected in many"			"HPA047927, HPA072697"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047927: AB_2680213, HPA072697: "															"unprognostic (7.42e-2)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HES4	bHLHb42	ENSG00000188290	"Hes family bHLH transcription factor 4"	Q9HCC6	1	998962-1000172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 291.1;Glandular cells: 254.1;Paneth cells: 238.4;Smooth muscle cells: 271.9;Urothelial cells: 423.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 12.4"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.4"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 66.9"					"Low region specificity"	"Detected in all"			HPA062465			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA062465: AB_2684771"	"unprognostic (6.23e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.08e-3)"	14.8	4.0	8.3	3.9	15.6	2.8	8.7	2.5	16.9	7.6	10.8	2.9	4.8	5.4	7.8	9.0	7.5	6.8	9.6	13.6	5.9	9.4	5.3	3.2	9.1	2.2	7.3	4.0	4.2	14.8	3.1	5.7	6.1	7.2	10.4	2.6	12.8	5.6	9.4	8.0	7.8	4.2	12.1	3.4	8.6	6.1	3.4	3.1	9.0	3.6	8.4	3.3	10.6	5.6	0.0	0.3	12.4	1.4	0.0	0.0	0.0	4.6	0.5	0.5	0.0	0.0	0.0	5.9	2.8	0.3	1.7	1.8	0.7	1.5	0.0	6.7	0.2	0.8	8.2	0.7	0.1	0.0	0.0	66.9	0.0	0.7	0.9	0.6	0.0	0.5	0.0	0.7	0.1	0.1	0.2	0.2	0.8	1.3	0.1	0.0	2.4	3.7	0.2	0.0	1.0	6.5	0.0	0.6	1.4	0.6	0.0	0.4	1.5	1.9	4.7	8.4	0.2	3.5	0.0	0.3	0.5	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	12.4	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.3	15.6	2.5	7.0	5.9	9.4	7.3	4.0	7.2	3.1	0.0	0.0	0.0	291.1	46.2	3.5	11.8	22.9	0.0	2.3	55.8	0.0	0.9	26.6	14.8	0.8	15.3	10.3	0.0	2.5	35.2	22.6	254.1	55.1	0.0	4.4	0.0	10.3	16.0	3.5	0.8	6.9	13.3	109.6	1.0	10.5	119.5	9.0	238.4	14.5	0.6	10.7	161.7	271.9	2.3	28.1	72.3	2.9	0.7	11.0	423.0
HES5	bHLHb38	ENSG00000197921	"Hes family bHLH transcription factor 5"	Q5TA89	1	2528745-2530245	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell type enriched"	"Detected in some"	22	"Muller glia cells: 105.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.7;HaCaT: 5.1;HAP1: 1.1;SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065458, HPA076164"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		No	NA			Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA065458: AB_2685492, HPA076164: AB_2732303"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.60e-4)"	"unprognostic (1.76e-4)"	"unprognostic (1.60e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (9.95e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-1)"	1.1	0.9	11.1	1.1	12.7	1.4	2.8	3.5	16.7	1.0	1.9	1.2	0.4	1.2	1.9	2.7	1.6	1.1	1.2	2.3	9.7	11.2	1.0	1.0	1.4	1.1	4.1	15.8	1.0	0.9	1.0	2.4	2.2	1.6	1.3	1.4	6.3	1.2	1.1	1.6	6.2	1.2	0.9	0.9	1.0	1.2	2.0	1.9	0.0	1.1	1.9	1.4	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	5.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	12.7	3.5	16.7	9.7	11.2	4.1	15.8	1.6	1.9	0.0	0.0	0.0	0.2	0.1	2.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	105.2	0.0	3.5	0.0	0.0	4.8	0.0	0.7	0.0	0.0	1.3	0.0	0.0	1.1	0.1
HES6	bHLHb41	ENSG00000144485	"Hes family bHLH transcription factor 6"	Q96HZ4	2	238238267-238240662	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 105.3;Mucus-secreting cells: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 8.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 51.5;SCLC-21H: 34.1;SK-MEL-30: 49.2;THP-1: 22.8;U-937: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073997			Approved	"Nuclear bodies,Cytosol"		NA	No			"Nuclear bodies"	Cytosol	"HPA073997: "	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.79e-4)"	"prognostic favorable (9.18e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.35e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.49e-2)"	2.1	5.2	15.4	3.4	10.6	10.5	3.0	7.3	47.4	3.7	12.2	17.1	0.8	18.1	6.3	1.5	1.6	14.3	5.7	1.7	17.5	9.1	1.9	2.5	2.2	3.3	11.4	12.3	1.3	13.9	5.3	23.6	1.7	14.3	2.0	9.6	1.5	3.8	1.7	8.2	1.7	12.9	3.3	18.8	4.6	5.2	9.4	11.7	0.4	5.5	1.7	2.8	1.3	1.0	0.3	1.4	8.0	0.3	0.1	1.0	0.2	1.2	1.5	6.5	7.4	0.4	0.2	4.2	0.4	0.5	0.6	1.0	1.2	0.8	0.0	1.0	0.1	2.7	0.8	6.6	0.5	0.2	2.8	7.9	1.5	1.0	13.4	1.1	10.7	9.0	0.6	4.0	0.9	1.3	0.3	0.4	6.9	13.5	0.1	0.4	3.2	1.6	51.5	10.4	1.2	1.1	7.3	16.5	3.1	0.8	0.6	34.1	14.9	2.0	2.9	49.2	0.8	2.6	22.8	0.6	0.6	1.3	3.6	3.8	3.0	0.5	2.2	2.3	26.2	1.1	0.1	0.3	8.0	1.0	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.3	1.4	0.7	0.2	15.4	10.6	7.3	39.3	17.5	9.1	11.4	12.3	14.3	11.7	0.0	1.4	8.0	4.1	3.0	8.1	2.8	0.0	9.4	3.4	3.5	21.6	1.0	6.6	9.9	10.9	3.7	18.1	46.7	27.8	3.1	3.8	5.1	0.0	3.8	4.8	3.2	105.3	3.7	1.6	5.6	1.4	5.5	33.7	11.8	104.6	6.1	11.9	16.9	1.4	3.7	4.7	0.0	14.6	24.6	32.4	1.8	0.2	6.2	33.2	1.8
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120590-8124092	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.3;salivary gland: 10.5"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 2.4;Melanocytes: 3.3;Smooth muscle cells: 4.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.7;Daudi: 7.2;HAP1: 9.2;HDLM-2: 7.3;HeLa: 13.7"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA072105: AB_2686488"	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.4	0.4	1.0	0.3	1.0	0.2	0.5	9.3	2.4	1.4	0.3	0.6	0.2	0.0	2.0	0.2	0.7	0.6	0.6	1.3	1.5	0.5	1.1	0.2	0.9	0.6	1.0	0.2	1.5	0.5	0.0	0.4	3.6	2.1	0.6	0.2	0.9	10.5	2.5	1.1	0.6	0.3	0.4	1.5	0.3	0.2	2.3	0.2	0.2	0.8	0.2	0.5	1.3	0.9	0.2	0.1	0.0	0.1	0.3	0.2	0.1	6.7	0.5	0.5	2.3	0.2	0.3	0.3	0.4	0.6	0.8	2.4	0.1	0.4	7.2	0.1	0.0	1.1	0.7	9.2	0.6	0.0	7.3	4.4	0.3	13.7	0.1	0.8	0.8	0.9	0.2	1.2	2.0	5.2	1.3	0.1	1.2	0.2	3.2	0.1	0.1	0.1	0.4	0.2	0.5	1.7	0.7	0.4	1.2	0.2	0.0	0.3	3.3	0.4	0.0	0.4	0.1	0.1	0.0	0.7	0.0	1.5	1.6	2.3	4.5	0.9	0.4	0.7	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	1.0	1.0	9.3	2.4	1.5	0.5	1.0	0.2	2.1	0.2	0.0	0.0	0.0	0.9	1.9	2.4	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.2	1.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.3	1.0	0.0	0.5	0.0	0.0	0.4	0.0	0.8	0.0	4.2	0.0	0.6	1.4	0.2	0.0	0.0	0.1
HESX1	"ANF, RPX"	ENSG00000163666	"HESX homeobox 1"	Q9UBX0	3	57197843-57226521	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"ductus deferens: 14.7;lymphoid tissue: 15.2"	"Cell type enhanced"	"Detected in some"	11	"Spermatocytes: 10.7;Spermatogonia: 5.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.0;plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 40.4;U-266/84: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024187	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024187: AB_1850620"	"unprognostic (6.47e-2)"	"unprognostic (1.66e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.96e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.14e-1)"	1.5	2.6	2.1	1.4	2.0	4.2	3.5	1.4	2.3	1.4	1.4	1.4	14.7	1.0	1.4	5.7	1.4	1.2	2.1	1.4	2.2	2.3	2.7	4.8	1.5	15.2	3.3	2.4	2.1	2.5	3.4	2.6	3.4	1.4	1.9	0.8	2.3	1.5	7.0	1.4	5.7	1.4	1.4	5.1	4.6	2.1	8.7	2.0	3.0	3.3	1.4	1.8	1.4	1.4	1.5	4.6	0.3	4.0	1.1	0.3	0.5	0.7	0.6	1.4	2.7	0.2	1.0	0.4	0.0	0.2	0.4	0.8	0.2	2.4	1.9	0.4	0.0	0.6	0.1	0.7	0.7	0.5	1.1	1.5	2.7	0.7	0.1	1.8	1.0	0.2	2.5	0.7	0.2	1.5	1.3	0.4	4.3	0.4	2.5	0.1	0.1	1.2	5.1	40.4	0.5	0.5	0.4	0.9	1.0	1.9	0.2	0.6	2.0	0.6	0.8	1.5	0.8	0.6	4.1	0.3	1.8	0.7	0.6	0.8	7.4	12.5	6.0	0.7	1.7	1.0	0.0	2.1	0.3	0.3	4.0	0.0	1.5	0.1	0.0	1.1	1.1	0.2	0.0	0.3	1.1	0.3	4.6	0.0	0.5	2.1	2.0	1.4	2.3	2.2	2.3	3.3	2.4	1.4	2.0	0.0	0.3	0.0	0.8	0.3	0.2	0.5	2.5	0.0	0.0	1.8	0.0	1.4	0.0	0.2	0.3	1.6	0.8	0.0	0.2	1.0	0.6	0.7	0.0	0.9	1.7	1.6	0.0	0.6	1.8	0.0	0.9	1.3	0.0	1.0	0.0	2.0	0.6	0.0	0.4	1.0	2.4	0.0	0.3	10.7	5.8	1.0	0.5	0.5	0.4	0.0
HEXDC	FLJ23825	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 30.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.52e-5)"	12.7	8.5	7.1	16.6	9.3	14.3	8.7	13.2	7.3	10.1	7.6	8.8	12.8	8.0	10.0	11.1	7.9	10.3	9.4	5.7	7.2	4.6	9.9	11.6	12.4	11.6	12.8	5.5	13.6	72.9	10.2	14.6	5.7	7.4	14.1	4.2	7.0	13.3	9.2	20.4	11.3	12.3	6.0	6.1	15.6	8.8	4.7	11.4	8.6	11.7	8.6	10.7	8.3	8.8	5.9	30.3	3.3	11.5	11.9	9.8	4.4	3.0	7.7	3.4	5.3	10.4	9.0	10.5	3.9	4.8	4.1	4.7	2.7	10.4	8.1	4.3	1.6	2.8	4.3	2.0	2.3	1.9	5.6	13.1	3.6	6.8	4.5	9.3	2.4	9.3	6.4	2.3	1.1	4.2	5.6	5.3	6.2	4.6	2.8	1.1	7.0	8.4	9.0	3.1	5.6	4.7	10.0	2.9	15.8	3.1	4.6	4.8	10.2	8.1	5.3	7.3	1.6	8.5	9.2	5.3	2.7	5.1	2.0	2.7	12.7	2.4	6.0	2.1	6.9	2.7	3.3	1.7	2.7	9.8	11.5	6.5	4.6	2.2	3.4	2.0	5.9	3.5	5.1	3.0	11.9	4.9	30.3	1.4	4.4	7.1	9.3	13.2	7.3	7.2	4.6	12.8	5.5	7.4	11.4	3.0	8.5	8.3	9.5	4.1	19.2	4.4	12.7	9.4	12.5	17.4	17.7	4.7	8.3	5.4	1.2	8.0	16.8	0.0	8.2	5.3	6.2	10.5	10.3	12.9	13.7	39.7	13.3	16.0	9.5	2.1	33.1	11.5	5.0	16.2	14.4	18.7	5.8	10.1	23.3	6.1	29.0	19.4	6.2	6.0	10.2	2.0	3.3	12.9	12.0	7.5
HEY1	"bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1"	ENSG00000164683	"Hes related family bHLH transcription factor with YRPW motif 1"	Q9Y5J3	8	79764010-79767863	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.6"	"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 39.4;Extravillous trophoblasts: 39.7;Intestinal endocrine cells: 35.4;Melanocytes: 32.1"	"Cancer enhanced"	"Detected in all"		"glioma: 43.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 49.4;PC-3: 11.2;SK-MEL-30: 33.8;WM-115: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055599, HPA063472"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA055599: AB_2682858, HPA063472: AB_2685018"	"unprognostic (1.15e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.71e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.77e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.00e-1)"	13.3	3.8	13.7	3.6	22.9	1.8	8.8	11.2	60.6	8.9	4.4	10.7	0.0	3.3	3.8	2.4	4.6	3.9	5.7	13.4	11.3	11.6	3.8	2.9	16.4	3.3	11.9	9.3	2.6	4.3	3.0	9.9	20.3	12.5	4.5	3.9	10.3	4.5	3.0	10.3	3.5	3.2	4.4	9.1	2.8	3.6	3.9	10.5	1.3	5.0	3.7	3.7	5.2	2.5	0.0	0.0	9.9	1.7	0.0	0.3	0.1	0.6	0.0	0.4	3.5	0.3	0.3	9.0	0.8	0.8	0.1	0.1	0.1	0.0	1.6	0.9	0.3	0.4	2.2	1.8	0.1	0.2	0.1	49.4	0.0	1.6	0.9	0.5	0.0	0.4	0.5	1.4	0.0	6.2	0.3	1.6	0.0	3.2	1.4	0.5	0.1	0.0	0.2	0.2	0.1	11.2	0.0	1.9	1.4	0.1	1.5	2.0	5.7	0.0	1.0	33.8	8.4	0.0	0.0	1.1	0.2	0.9	0.0	0.6	1.2	0.2	0.0	1.2	0.0	11.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.9	0.0	1.7	0.0	0.0	0.1	13.7	22.9	11.2	12.3	11.3	11.6	11.9	9.3	12.5	10.5	0.0	2.6	0.0	2.2	2.9	5.3	3.2	0.0	8.1	3.4	0.0	0.0	5.4	13.3	2.1	3.3	39.4	0.9	0.0	1.0	39.7	2.7	1.6	10.4	0.5	1.6	20.6	35.4	13.5	0.6	1.6	0.0	2.1	32.1	0.0	1.9	6.0	0.5	5.8	0.4	0.3	11.5	0.0	6.1	0.7	4.1	2.6	19.6	0.0	2.3	1.8
HEY2	"bHLHb32, HERP1, HESR2"	ENSG00000135547	"Hes related family bHLH transcription factor with YRPW motif 2"	Q9UBP5	6	125747664-125761269	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 28.5"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 37.9;Late spermatids: 59.0;Muller glia cells: 32.0;Sertoli cells: 51.8;Smooth muscle cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6;naive CD8 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.2;HEK 293: 6.7;SK-MEL-30: 6.1;TIME: 13.9;U-266/70: 16.9"	"Region enriched"	"Detected in all"	4	"olfactory region: 34.5"	"Low region specificity"	"Detected in all"			"HPA030205, HPA074851"	Approved		Approved	"Nuclear bodies,Aggresome"		NA	NA			"Nuclear bodies"	Aggresome	"HPA030205: AB_10600712, HPA074851: AB_2686718"	"unprognostic (5.10e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.10e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.19e-1)"	6.0	1.8	7.4	1.8	9.2	0.7	5.5	5.7	11.8	10.4	2.9	13.1	0.7	2.2	11.3	24.0	2.8	19.3	7.6	28.5	8.2	6.2	3.6	7.8	3.7	1.2	8.2	11.4	10.7	4.1	7.1	5.4	5.4	12.8	2.3	2.4	10.4	3.0	4.5	19.1	2.1	2.2	2.9	11.3	2.9	2.0	6.5	7.2	0.0	3.6	4.9	1.4	3.5	4.9	0.0	0.0	0.0	0.1	0.0	2.6	0.4	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.4	6.7	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.5	0.0	0.4	0.0	0.0	3.0	0.0	0.3	0.5	0.6	0.8	0.0	0.1	2.2	0.0	0.0	0.0	6.1	3.2	1.8	0.0	13.9	0.3	0.0	0.1	0.7	16.9	0.3	0.1	0.6	0.0	1.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	1.4	0.0	0.0	0.1	0.0	0.0	0.4	7.4	9.2	5.7	5.9	8.2	6.2	8.2	11.4	12.8	7.2	3.0	0.6	0.5	0.3	3.4	0.4	17.9	0.0	6.7	1.2	0.0	7.9	0.0	8.3	0.0	37.9	3.7	0.0	23.3	1.6	0.1	3.0	0.3	0.0	7.3	0.1	1.6	0.0	1.3	0.3	59.0	6.1	0.6	3.3	0.0	0.0	32.0	1.8	0.0	21.9	4.2	5.0	51.8	35.0	10.8	7.0	1.8	0.0	0.5	0.0	0.4
HEYL	"bHLHb33, HESR3, HEY3"	ENSG00000163909	"Hes related family bHLH transcription factor with YRPW motif-like"	Q9NQ87	1	39624153-39639945	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 66.3"	"Cell type enhanced"	"Detected in many"	13	"Leydig cells: 24.2;Peritubular cells: 53.4;Sertoli cells: 51.8;Smooth muscle cells: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 6.5;LHCN-M2: 17.6;RH-30: 21.7;THP-1: 5.0;U-266/84: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001438, HPA076960"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA001438: AB_1079052, HPA076960: AB_2732326"	"unprognostic (1.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.26e-6)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.63e-5)"	10.0	8.3	2.9	4.7	6.2	0.5	6.5	1.8	4.0	14.7	4.4	2.9	5.1	1.9	21.7	13.2	4.0	11.2	13.9	28.2	3.2	4.8	12.3	3.3	12.5	2.0	6.8	2.9	14.4	66.3	1.7	8.2	22.1	7.1	8.1	2.9	10.9	2.3	11.4	8.9	1.9	2.7	18.9	2.4	4.5	3.4	25.4	4.4	0.0	11.0	6.8	1.9	6.0	8.8	1.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	2.4	4.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	1.6	0.2	0.0	1.4	0.4	0.0	0.0	2.2	0.0	0.2	0.0	2.6	4.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.5	0.4	0.5	17.6	1.4	0.0	0.0	0.0	0.2	0.1	1.1	21.7	0.1	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.9	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.2	1.8	4.0	3.2	4.8	6.8	2.9	7.1	4.4	0.0	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.6	0.7	0.0	0.0	3.1	0.2	3.8	0.2	0.0	0.0	0.3	1.6	0.0	1.3	0.0	11.8	24.2	1.1	5.0	0.0	0.0	0.2	4.5	0.0	53.4	0.0	3.7	51.8	35.4	0.1	1.7	0.1	0.2	0.0	0.4	0.1
HFE	HLA-H	ENSG00000010704	Hemochromatosis	Q30201	6	26087281-26098343	"Disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: AB_2682163"	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	7.2	13.7	2.2	4.4	2.7	0.0	6.2	1.2	2.5	6.7	7.1	3.5	10.3	4.2	6.8	13.9	7.6	5.2	13.3	8.9	2.0	1.4	5.4	12.8	9.0	16.1	2.3	2.0	8.1	16.2	14.6	2.2	7.6	4.3	12.6	5.3	13.7	7.0	8.1	3.1	3.2	5.8	10.4	3.2	14.4	6.1	4.9	1.2	2.0	7.7	3.9	5.0	8.6	5.2	3.5	4.6	1.9	10.5	0.2	2.2	3.4	8.2	18.9	0.3	9.2	14.0	10.8	0.0	5.9	14.1	7.6	12.0	1.6	16.8	0.8	16.1	9.7	11.5	5.3	0.0	6.9	9.7	2.1	0.1	0.2	4.5	1.2	2.7	0.0	0.3	11.1	2.0	8.4	0.7	6.7	5.1	0.0	0.3	0.2	6.5	3.4	0.0	0.1	0.4	3.9	0.0	1.1	0.0	0.1	6.3	5.5	0.0	0.0	3.5	0.0	5.1	0.1	26.9	0.9	3.9	5.4	0.5	5.3	5.1	0.1	0.1	0.1	8.0	0.1	11.6	1.2	10.5	0.0	1.7	10.2	1.3	3.5	1.7	2.2	4.6	1.5	0.4	1.2	1.9	0.2	8.2	0.3	0.3	3.4	2.2	2.7	1.2	2.5	2.0	1.4	2.3	2.0	4.3	1.2	3.0	3.2	1.9	2.3	1.4	0.7	2.8	5.1	6.7	7.9	5.2	2.0	1.2	0.0	2.5	0.1	3.0	3.4	0.0	3.0	0.6	3.0	3.8	2.3	8.1	8.8	0.0	1.7	8.6	21.1	0.0	3.4	5.7	0.0	0.0	3.7	3.7	2.5	0.0	5.6	2.2	2.0	0.0	1.4	0.2	1.0	3.0	1.5	0.7	3.7	1.3
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628173-120682571	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 176.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 460.4;Proximal tubular cells: 326.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 119.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.1;Hep G2: 38.7;OE19: 68.2;RPTEC TERT1: 50.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		210000	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.2	0.2	0.2	0.6	0.6	0.0	1.8	0.2	0.5	3.7	7.2	0.3	1.4	4.7	0.6	4.0	0.2	0.4	11.5	0.3	0.2	0.1	33.3	176.7	0.7	0.3	0.2	0.2	0.3	6.9	0.0	0.4	0.3	0.3	6.7	2.7	5.9	3.3	1.0	0.4	0.3	15.0	0.3	0.4	0.3	3.9	0.3	0.2	0.2	8.1	0.3	0.3	0.2	0.2	0.0	0.3	2.8	0.4	0.0	0.0	5.1	0.0	2.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.3	2.6	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	38.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	68.2	0.0	0.0	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	5.1	0.2	0.6	0.2	0.5	0.2	0.1	0.2	0.2	0.3	0.2	0.0	1.3	26.4	0.5	0.0	0.2	0.3	73.9	0.0	0.0	26.2	2.0	0.0	87.9	3.5	0.0	0.0	22.2	23.3	15.6	0.0	0.0	6.7	1.1	460.4	0.2	0.0	42.1	18.4	11.1	0.0	0.0	0.0	0.0	1.8	14.1	2.7	17.1	25.9	0.0	326.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.4	7.0	0.2
HGH1	"Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236"	ENSG00000235173	"HGH1 homolog"	Q9BTY7	8	144137769-144140843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042470	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA042470: AB_2678013"	"unprognostic (2.13e-2)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (4.62e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.48e-1)"	13.4	12.3	6.3	7.7	5.5	4.6	7.6	7.3	8.6	5.5	11.8	5.2	4.9	5.0	6.5	3.8	8.7	5.1	5.5	5.1	5.2	3.6	8.2	15.1	5.1	9.5	5.7	7.3	9.7	12.8	6.8	4.4	3.8	6.1	8.6	4.5	5.9	10.5	6.4	13.2	8.9	5.9	5.8	3.8	8.8	15.7	7.9	4.7	11.3	11.0	4.7	8.6	4.9	7.7	2.1	0.9	0.0	0.9	2.2	2.9	0.6	4.8	1.6	1.2	2.2	1.7	1.1	3.0	8.3	0.7	1.8	1.2	2.1	1.3	14.3	11.5	1.5	0.7	5.1	2.3	1.1	0.5	6.8	8.8	5.4	1.4	1.0	1.6	3.0	3.6	0.7	3.6	2.0	1.2	0.6	0.8	3.0	15.4	0.5	1.1	4.1	10.3	2.8	3.3	1.8	28.4	12.9	1.0	2.1	1.0	1.1	2.5	2.7	3.8	2.1	2.8	0.4	1.8	1.1	2.9	1.0	8.8	3.1	9.9	8.6	5.5	3.5	1.0	5.1	1.7	0.0	0.6	0.0	1.5	0.9	0.9	0.5	1.9	2.9	0.9	2.1	1.8	1.3	0.0	2.2	0.7	0.7	0.6	0.6	6.3	5.5	7.3	8.6	5.2	3.6	5.7	7.3	6.1	4.7	0.0	3.7	7.0	2.2	0.0	4.0	2.0	2.5	2.7	1.2	5.2	0.0	9.8	10.0	2.8	9.3	0.4	2.0	0.0	1.6	10.1	0.9	2.8	0.0	8.3	10.9	6.4	4.7	1.3	1.3	15.4	6.9	2.8	0.0	1.0	5.2	8.6	2.5	4.9	3.2	8.4	3.8	6.5	0.3	6.5	15.2	0.0	2.6	4.3	6.8	1.6
HHAT	"FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn"	ENSG00000054392	"Hedgehog acyltransferase"	Q5VTY9	1	210328252-210676296	"Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 17.4;Muller glia cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 7.1;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.4;LHCN-M2: 11.2;RH-30: 12.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA016462	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA016462: AB_2669360"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.89e-3)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-3)"	"prognostic favorable (8.47e-7)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.67e-2)"	3.8	11.7	5.1	5.4	5.3	1.3	7.5	0.9	5.0	10.4	4.9	3.9	9.7	3.3	12.8	10.6	4.7	8.1	8.5	4.1	3.1	2.6	6.3	4.3	4.1	2.3	2.7	3.8	4.9	5.2	4.2	15.1	3.8	3.3	11.6	4.0	11.5	10.4	6.6	2.8	5.3	4.2	5.1	2.3	3.8	3.9	6.2	2.5	7.1	12.8	3.1	5.7	6.7	4.9	3.0	7.1	0.0	0.7	0.2	2.6	0.7	0.7	0.9	2.3	1.4	1.0	1.3	4.7	1.1	1.0	1.8	3.1	0.2	0.9	0.0	1.2	0.9	3.0	0.6	0.5	0.5	2.2	1.6	1.1	0.0	0.1	1.0	0.2	0.3	13.4	1.2	2.7	1.6	1.2	3.1	0.3	1.1	0.0	0.0	11.2	1.1	0.6	0.0	0.6	0.6	0.1	1.2	12.2	0.0	7.3	2.5	1.9	7.7	2.0	0.0	5.6	6.1	3.9	0.7	1.7	2.8	8.5	1.6	4.3	3.8	0.1	0.0	1.2	0.8	2.3	0.0	0.6	0.0	1.5	0.7	2.6	3.0	1.8	1.7	0.7	2.7	0.1	0.6	0.0	0.2	0.2	7.1	0.4	0.7	5.1	5.3	0.9	5.0	3.1	2.6	2.7	3.8	3.3	2.5	0.0	3.7	1.4	4.9	1.9	0.4	2.2	2.5	17.4	0.0	8.7	0.0	4.0	3.3	2.6	0.7	2.1	1.3	0.0	0.6	2.6	1.1	5.2	0.0	2.1	1.8	0.0	0.0	2.5	2.4	0.0	1.1	0.9	0.0	0.0	3.1	21.1	1.2	2.5	0.4	0.8	0.5	0.0	1.0	0.3	0.9	2.3	1.8	0.8	1.9	4.6
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689951-92695646	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 71.4"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 94.3;Ductal cells: 86.4;Endothelial cells: 66.2;Hepatocytes: 48.7;Hofbauer cells: 58.0;Ito cells: 65.1;Kupffer cells: 61.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 7.9;classical monocyte: 14.7;eosinophil: 21.4;intermediate monocyte: 16.4;memory B-cell: 21.4;myeloid DC: 11.3;naive B-cell: 25.0;neutrophil: 11.8;non-classical monocyte: 17.8;plasmacytoid DC: 13.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.0;HEL: 28.2;HMC-1: 31.3;HUVEC TERT2: 30.9;K-562: 42.9;NB-4: 28.6;U-937: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051894, HPA055460"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051894: AB_2681653, HPA055460: AB_2682820"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	6.3	8.2	2.8	12.0	3.6	28.1	13.7	0.9	2.2	4.5	3.2	3.0	1.1	2.3	3.6	3.8	2.9	2.7	18.0	7.3	2.8	2.1	2.8	33.1	15.3	29.7	3.6	0.9	1.9	15.6	0.7	1.5	6.4	2.8	4.3	2.4	2.3	1.9	1.6	2.8	2.2	8.4	9.3	2.9	18.3	2.7	1.9	2.8	1.8	71.4	2.0	11.3	6.5	7.1	25.0	13.5	21.4	17.8	0.3	0.3	4.9	3.1	5.9	3.1	0.0	0.2	0.2	0.0	1.6	13.5	2.2	1.9	1.1	0.7	3.0	26.0	0.2	0.0	0.6	2.7	0.0	2.7	0.0	3.2	28.2	2.4	19.0	6.3	16.4	31.3	0.0	0.0	1.9	0.0	1.1	30.9	0.0	42.9	0.0	0.1	0.9	0.1	28.6	0.0	8.6	3.4	9.6	0.9	0.0	0.2	1.2	1.4	0.3	1.8	0.0	0.0	0.1	0.9	8.7	10.7	0.0	0.1	0.0	0.0	0.7	0.5	6.0	0.0	22.7	14.9	7.9	14.7	21.4	0.3	16.4	0.1	21.4	0.0	0.0	11.3	25.0	0.0	0.0	11.8	0.3	17.8	13.5	0.1	4.9	2.8	3.6	0.9	2.2	2.8	2.1	3.6	0.9	2.8	2.8	0.0	4.8	30.4	1.6	5.7	0.0	2.0	94.3	1.4	2.3	0.0	0.0	0.5	0.0	86.4	0.2	66.2	0.0	0.0	10.0	0.8	2.1	2.9	6.9	48.7	58.0	0.0	5.1	65.1	61.3	0.4	0.3	22.7	6.8	1.8	0.3	0.0	14.5	0.0	1.1	0.0	0.0	0.0	1.9	0.2	1.4	3.1	0.9	5.2	0.2	0.6
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646021-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.5;lung: 29.7"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.6"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 69.8;TIME: 80.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			Nucleoplasm		"HPA012616: AB_1850687"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	4.0	5.2	9.9	1.7	22.2	2.3	1.1	2.3	16.0	3.4	6.5	31.5	0.0	5.5	4.1	8.1	1.0	1.2	3.0	1.1	16.0	6.3	2.4	12.7	29.7	1.0	21.6	9.9	2.2	4.8	1.0	1.1	1.0	17.5	9.8	6.8	4.4	1.3	6.2	1.3	1.1	8.2	1.3	12.3	1.0	11.2	3.7	26.5	2.3	1.6	0.0	1.0	7.1	1.0	0.1	2.6	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.7	3.8	69.8	6.2	0.0	0.0	1.0	0.0	9.8	0.0	0.9	0.0	0.6	0.1	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.5	0.0	0.8	0.0	0.5	0.4	0.0	2.1	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	2.6	0.0	0.0	9.9	22.2	2.3	16.0	16.0	6.3	21.6	9.9	17.5	26.5	11.9	177.0	0.0	0.0	0.0	1.4	1.1	0.0	8.1	6.8	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.0	0.4	0.0	16.1	0.0	0.1	0.0	0.0	16.0	0.0	1.8	126.0	1.0	1.7	0.0	0.0	0.2	0.1	0.0	41.4	0.0	3.5	0.0	0.4	0.2	0.2	0.5	0.0	0.0	0.0	0.0
HHLA3		ENSG00000197568	"HERV-H LTR-associating 3"	Q9XRX5	1	70354805-70385339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 51.4;Proximal tubular cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA031323	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031323: AB_10601477"	"unprognostic (2.31e-3)"	"unprognostic (8.35e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.24e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.60e-2)"	6.9	20.0	18.2	4.1	19.5	7.6	8.5	6.9	19.3	8.9	6.4	20.1	7.2	4.6	8.2	25.7	8.0	15.8	6.8	5.1	15.8	16.5	16.8	17.6	4.6	9.7	17.5	14.6	18.0	15.5	15.8	14.1	6.8	13.4	11.4	6.1	13.1	14.4	8.6	2.8	11.0	4.3	7.9	17.0	7.3	5.2	8.9	15.4	5.8	13.6	3.2	9.0	7.6	13.2	13.4	8.5	4.5	3.0	5.2	11.2	3.9	7.8	3.6	14.0	7.9	12.1	9.9	2.0	2.2	5.1	3.7	4.8	1.2	9.0	7.4	9.7	9.3	16.8	4.9	13.7	6.3	6.6	21.1	7.9	5.0	7.5	3.5	11.8	2.4	4.0	12.8	7.5	7.9	9.3	8.4	1.2	9.9	9.1	21.1	5.4	5.8	4.9	8.5	13.8	5.6	4.8	10.3	1.0	3.6	17.1	1.2	5.1	4.0	16.8	5.3	9.9	17.6	3.1	5.5	3.1	4.0	2.3	8.3	2.7	10.6	8.5	20.2	8.1	7.5	7.7	4.5	2.5	1.4	6.5	3.0	6.5	10.5	6.7	7.0	3.7	13.4	11.2	9.9	0.7	5.2	2.2	8.5	10.8	3.9	18.2	19.5	6.9	19.3	15.8	16.5	17.5	14.6	13.4	15.4	0.0	3.2	6.0	11.4	4.5	2.8	1.2	20.4	8.1	5.7	21.0	0.0	12.7	51.4	5.7	0.6	4.6	2.6	0.0	6.6	11.5	5.4	10.3	6.9	17.4	6.9	6.4	4.1	11.1	8.6	1.0	6.9	2.7	1.7	12.6	3.9	18.6	6.4	5.8	14.2	35.6	2.8	0.0	5.1	3.7	13.4	7.4	13.3	4.9	5.0	8.3
HIGD1A	"DKFZP564K247, HIG1, RCF1A"	ENSG00000181061	"HIG1 hypoxia inducible domain family member 1A"	Q9Y241	3	42784298-42804531	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 535.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 89.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043336	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA043336: AB_10795039"	"unprognostic (6.46e-2)"	"unprognostic (3.72e-3)"	"prognostic favorable (2.12e-4)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.45e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (3.99e-8)"	"unprognostic (7.37e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	27.7	30.4	50.1	15.5	43.4	9.6	20.4	20.3	56.4	18.3	63.8	25.2	10.8	35.2	15.7	24.8	36.7	13.5	18.8	68.6	43.2	43.3	45.9	78.4	15.3	16.0	54.4	35.9	12.8	12.8	14.7	29.2	17.2	50.9	24.4	67.3	21.8	16.6	26.8	34.9	15.0	28.4	22.8	58.8	13.0	31.6	14.7	20.7	8.9	28.1	30.6	16.9	20.1	25.0	11.9	89.9	25.9	26.6	12.3	18.8	30.1	27.4	15.4	34.3	28.1	87.8	52.5	33.4	37.1	30.5	36.4	33.4	27.2	28.0	16.8	22.3	32.4	22.6	16.6	27.5	40.9	45.5	24.1	30.4	51.9	27.7	50.3	40.1	29.8	24.5	54.4	45.0	27.8	38.8	18.1	31.9	25.6	51.2	18.0	50.7	11.2	16.4	10.9	28.8	23.3	37.6	13.4	24.3	11.9	89.7	68.2	14.5	18.9	32.5	24.7	35.0	35.7	24.7	22.5	27.9	21.5	19.5	60.1	38.3	16.8	34.7	34.7	28.3	31.7	16.6	16.9	14.7	25.9	15.4	22.7	13.7	11.9	15.1	15.1	16.3	8.5	12.9	15.3	14.9	12.3	26.6	89.9	18.8	30.1	50.1	43.4	20.3	56.4	43.2	43.3	54.4	35.9	50.9	20.7	50.6	73.8	43.3	134.0	116.5	33.4	319.5	79.0	48.2	60.3	130.9	9.8	99.0	535.5	105.9	6.7	57.3	183.7	93.5	127.6	162.8	82.5	160.2	92.2	169.5	69.4	27.0	78.7	55.3	46.3	9.1	28.4	70.1	167.0	114.6	120.5	121.0	198.7	300.1	49.1	213.1	25.1	77.6	125.8	135.9	72.8	178.8	250.8	45.7	135.9	173.3
HIGD2A	"MGC2198, RCF1B"	ENSG00000146066	"HIG1 hypoxia inducible domain family member 2A"	Q9BW72	5	176388747-176389771	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA042715	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA042715: AB_2678127"	"unprognostic (9.24e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-2)"	37.2	38.5	31.4	33.5	36.0	34.9	37.5	21.4	33.2	26.8	43.8	22.5	29.7	36.7	25.7	31.1	47.0	31.5	39.4	80.0	28.5	26.6	46.3	56.1	30.1	54.1	30.3	20.0	33.2	42.6	36.6	28.8	26.4	21.0	41.2	30.9	31.2	64.0	32.6	115.9	27.8	38.1	43.3	25.9	37.3	31.6	28.8	15.0	63.1	42.3	53.8	34.3	42.1	28.7	70.4	104.6	25.5	107.7	31.1	67.6	88.9	17.9	31.7	19.0	32.1	19.9	38.1	49.8	11.3	21.6	33.0	41.6	33.1	38.0	32.7	27.6	20.6	40.3	23.2	28.7	50.7	13.2	76.6	45.1	16.1	32.7	45.3	28.0	25.1	43.9	48.3	42.2	18.6	22.6	24.3	27.7	27.5	17.8	65.9	24.2	59.3	28.5	31.9	22.4	34.6	34.9	27.7	14.1	59.1	51.6	29.9	20.0	26.7	12.9	54.6	55.5	20.3	32.6	42.3	17.3	22.5	23.3	20.6	23.5	30.7	36.6	26.6	29.1	45.1	14.1	25.5	84.5	23.8	46.3	106.5	45.8	70.4	64.9	53.5	104.6	52.2	59.6	55.6	14.4	31.1	107.7	68.6	67.6	88.9	31.4	36.0	21.4	33.2	28.5	26.6	30.3	20.0	21.0	15.0	68.5	61.2	245.0	289.8	206.3	55.1	130.4	180.9	116.4	104.6	172.7	11.8	187.5	452.6	160.5	55.4	114.7	272.4	23.3	206.0	150.2	154.5	216.1	128.0	198.8	329.3	62.0	256.0	111.7	344.3	44.7	129.8	304.5	244.6	408.4	365.8	77.7	132.6	412.7	79.9	405.0	38.4	116.4	130.6	108.0	81.6	196.7	234.3	221.4	328.6	443.0
HIGD2B	HIGD2BP	ENSG00000175202	"HIG1 hypoxia inducible domain family member 2B"	Q4VC39	15	72675783-72686149	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	12	"testis: 11.6"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.0;Late spermatids: 7.1;Spermatocytes: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0"									"HPA019016, HPA042715"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA019016: AB_1850711, HPA042715: AB_2678127"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"		"unprognostic (2.24e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.80e-2)"	"unprognostic (6.11e-4)"	"unprognostic (6.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.6	0.2	0.0	0.7	0.0	1.3	0.7	1.1	0.0	0.0	0.4	0.0	0.6	0.6	0.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.2	0.0	0.6	0.0	1.0	0.0	0.5	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.9	0.9	0.7	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	15.1	0.9	0.1	0.1	0.0	0.0	0.1
HIKESHI	"C11orf73, HSPC138, HSPC179, OPI10"	ENSG00000149196	"Hikeshi, heat shock protein nuclear import factor"	Q53FT3	11	86302211-86345931	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 123.6;Extravillous trophoblasts: 118.1;Hofbauer cells: 82.9;monocytes: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012708, HPA035063, HPA035064"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441"	"unprognostic (1.10e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.01e-12)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.71e-1)"	23.4	24.1	25.7	16.0	23.3	15.5	31.1	19.1	24.0	21.1	23.5	20.1	14.5	10.2	27.4	24.9	24.6	18.2	15.5	36.1	23.9	23.8	11.7	20.0	16.9	22.0	30.2	18.9	26.2	22.6	18.7	32.0	26.6	25.9	18.1	19.2	15.7	15.4	29.2	46.9	20.2	13.0	30.0	25.1	18.1	15.9	15.3	26.6	23.8	20.8	23.6	28.1	21.6	24.0	30.0	33.3	20.6	26.7	25.9	39.5	20.7	9.0	9.7	23.8	13.1	20.2	25.2	12.6	13.9	16.9	14.6	17.5	29.0	25.2	9.2	32.3	18.4	27.8	19.4	17.6	30.7	15.6	19.6	15.5	14.8	16.1	21.5	27.3	18.1	12.2	17.8	31.2	17.4	20.8	18.9	27.9	17.7	15.8	21.1	29.8	24.6	21.6	43.1	19.5	59.2	6.6	16.7	11.7	20.6	25.0	17.1	14.8	12.8	17.4	13.0	9.4	25.2	20.9	12.2	14.1	17.3	12.2	34.7	10.3	9.1	20.6	17.7	8.8	17.2	17.0	19.6	26.7	20.6	25.2	24.7	27.7	30.0	30.9	27.3	33.3	24.9	27.2	27.6	5.5	25.9	24.3	25.9	39.5	20.7	25.7	23.3	19.1	24.0	23.9	23.8	30.2	18.9	25.9	26.6	35.7	27.2	0.0	0.0	0.0	0.0	0.0	0.0	50.9	27.3	26.2	0.0	123.6	34.9	65.4	0.0	0.0	0.0	0.0	58.0	118.1	0.0	0.0	20.9	0.0	82.9	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	87.4	0.0	0.0	48.4	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	64.8	0.0	0.0	0.0
HINT3	FLJ33126	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956781-125980244	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.8"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 260.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Nucleoli, Mitochondria"	Cytosol	"HPA027914: AB_10602424"	"prognostic unfavorable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	11.4	16.3	27.4	8.0	23.3	7.2	15.6	19.4	24.3	13.1	13.1	24.8	10.6	10.4	11.5	12.6	15.2	11.4	10.9	19.0	28.1	23.0	15.1	18.5	13.9	7.0	28.7	17.0	10.4	12.8	16.3	13.4	12.1	20.7	20.5	12.1	10.3	16.0	16.2	65.8	11.6	10.5	15.2	40.8	6.8	16.0	21.9	17.0	7.7	15.9	16.8	7.4	16.1	8.8	11.0	11.1	15.0	13.2	7.9	9.9	7.0	7.0	5.6	7.8	16.1	3.1	8.4	9.7	7.6	11.0	5.9	6.1	13.6	3.9	15.3	14.2	5.1	13.1	10.6	9.9	6.4	6.9	14.4	12.8	6.4	8.4	11.4	14.4	10.1	10.9	6.6	14.3	5.9	15.0	15.2	8.8	11.4	19.9	10.3	5.8	10.6	8.0	7.3	2.6	14.4	5.4	6.7	5.3	5.1	12.1	12.9	15.7	9.7	6.9	9.9	35.6	5.9	10.0	15.5	6.2	4.0	5.6	19.2	10.8	15.0	17.2	9.7	11.4	9.6	5.1	14.4	13.2	11.4	7.2	8.4	7.8	11.0	9.2	7.5	11.1	10.4	9.9	8.7	15.0	7.9	10.8	6.9	9.1	7.0	27.4	23.3	19.4	24.3	28.1	23.0	28.7	17.0	20.7	17.0	74.5	57.0	16.0	9.5	16.1	22.3	37.6	10.2	24.1	31.8	15.7	7.9	16.0	28.2	27.0	260.9	11.3	12.3	0.0	17.5	5.7	10.8	19.4	9.2	16.3	23.3	6.4	15.6	6.2	14.5	54.5	9.2	17.0	20.3	9.0	22.7	30.7	20.3	28.1	16.3	21.4	23.9	6.5	13.7	89.1	27.7	15.2	22.1	7.0	19.9	17.1
HIP1R	"FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655"	ENSG00000130787	"Huntingtin interacting protein 1 related"	O75146	12	122834453-122862960	"Cancer-related genes, Predicted intracellular proteins"	Endocytosis	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 57.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.5;naive B-cell: 12.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017187, HPA038135, HPA038136"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852"	"unprognostic (4.52e-1)"	"unprognostic (6.39e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.72e-2)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.54e-3)"	"prognostic favorable (7.26e-4)"	9.8	14.5	24.6	13.2	26.5	11.6	8.0	11.5	31.6	4.6	11.6	40.5	19.7	29.2	4.0	9.1	7.0	4.0	7.8	10.8	29.5	21.7	16.2	9.0	6.3	15.3	31.4	20.6	3.2	27.7	7.4	15.6	5.2	18.0	8.6	5.4	2.9	52.0	24.1	5.7	26.5	21.3	3.0	27.4	11.1	30.4	4.0	30.6	8.1	8.1	5.9	12.6	7.4	6.5	12.3	0.0	2.7	0.0	0.6	3.2	1.6	17.5	5.1	3.8	15.8	1.1	3.0	18.9	2.8	4.5	2.8	2.2	7.8	5.3	16.7	9.3	2.0	4.3	15.2	4.6	10.1	0.2	2.6	6.7	0.4	5.8	8.2	3.5	1.3	11.9	1.9	7.2	3.8	6.5	3.9	19.5	7.9	4.3	0.9	1.6	25.2	7.9	4.1	3.5	15.2	6.1	4.1	4.9	5.8	9.5	21.3	3.9	8.7	3.3	8.6	4.5	2.2	17.6	0.7	15.4	1.8	13.6	5.6	2.6	12.0	6.4	9.9	2.9	2.8	1.5	0.0	0.0	2.7	2.9	0.0	1.7	9.5	1.8	2.2	0.0	12.3	3.2	2.0	0.2	0.6	0.0	0.0	0.4	1.6	24.6	26.5	11.5	19.8	29.5	21.7	31.4	20.6	18.0	30.6	0.0	12.0	32.0	12.8	11.7	8.4	4.1	50.9	8.1	7.9	57.6	27.5	3.0	0.0	34.4	2.3	11.7	36.4	0.0	24.6	10.4	2.1	17.0	5.7	20.8	0.6	17.5	7.5	18.4	1.2	2.2	1.4	0.4	10.1	0.0	24.4	12.3	20.4	22.6	1.1	12.5	17.4	0.0	1.9	4.7	9.8	18.3	1.6	6.7	18.0	25.8
HIST1H2AA	"bA317E16.2, H2AFR"	ENSG00000164508	"Histone cluster 1 H2A family member a"	Q96QV6	6	25726132-25726527	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	518	"testis: 453.1"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 219.3;Spermatogonia: 217.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"HEK 293: 3.0"	"Not detected"	"Not detected"							HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"													"unprognostic (4.53e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	453.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	219.3	217.6	0.0	0.0	0.0	0.0	0.0
HIST1H2AB	"H2A/m, H2AFM"	ENSG00000278463	"Histone cluster 1 H2A family member b"	P04908	6	26033176-26033568	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 133.2"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 2.2;Early spermatids: 2.6;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 9.2"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.53e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.04e-3)"		"unprognostic (3.28e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.47e-3)"	0.7	0.3	0.2	7.6	0.0	9.6	2.6	0.2	0.6	0.5	1.7	0.0	0.0	0.3	0.5	0.3	5.0	0.3	0.7	2.6	0.0		0.6	0.3	1.7	5.9	0.0	0.0	0.3	0.3	0.3	0.0	2.6	0.0	0.5	0.3	0.2	0.3	0.3	0.3	0.3	2.2	0.3	0.1	8.2	0.7	8.3	0.0	133.2	0.3	1.5	12.2	0.3	0.0	4.2	1.8	3.4	1.5	1.4	2.4	0.3	0.2	1.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.0	0.3	1.8	0.9	0.0	0.1	0.6	0.5	0.0	0.6	0.9	2.2	1.1	0.5	9.2	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	1.0	0.0	1.4	2.0	2.0	3.6	0.0	3.5	1.2	0.7	1.5	0.0	3.0	0.4	0.1	2.1	0.0	0.1	0.1	0.6	1.0	0.0	0.3	4.0	0.3	0.2	1.5	2.5	0.1	0.6	3.7	0.3	0.0	0.1	3.4	0.8	1.5	0.0	4.2	1.5	2.4	1.8	3.1	0.6	0.8	0.7	1.4	0.1	0.2	0.6	0.3											0.0	0.0	2.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.6	0.3	1.0	0.0	0.0	1.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	1.1	0.0	0.5	0.0	0.4	0.5
HIST1H2AC	H2AFL	ENSG00000180573	"Histone cluster 1 H2A family member c"	Q93077	6	26124145-26139116	"Cancer-related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 116.1;lymphoid tissue: 202.5"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 177.7;Urothelial cells: 208.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 116.1"	"Lineage enriched"	"Detected in all"	17	"granulocytes: 116.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 31.4;OE19: 26.8;SiHa: 26.9;U-2 OS: 27.1;U-266/84: 27.0"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.89e-3)"	13.6	14.5	13.6	22.5	16.4	19.0	29.9	7.3	9.8	35.6	21.0	12.2	17.9	18.1	13.2	32.8	27.5	23.6	13.9	12.6	18.5	12.4	21.4	34.1	29.2	28.5	18.6	8.5	23.8	15.7	3.7	13.4	26.2	8.5	37.2	15.0	21.1	10.4	17.0	17.5	15.4	21.6	14.4	27.0	26.4	26.9	16.3	10.4	202.5	24.5	9.2	34.9	29.6	25.8	6.6	4.5	116.1	3.6	1.9	2.1	48.3	5.5	1.6	1.9	0.6	16.1	8.8	0.8	2.8	1.7	8.5	7.3	2.1	1.4	0.2	13.8	5.6	5.7	6.7	1.5	2.9	6.1	5.3	0.9	0.9	0.7	0.3	12.6	0.9	6.4	31.4	5.0	1.8	5.5	10.8	0.5	0.7	13.9	10.2	3.7	4.6	0.9	1.0	2.3	26.8	0.5	0.6	1.0	16.3	8.1	0.6	2.9	1.2	26.9	5.7	8.8	8.2	13.1	1.4	1.8	5.2	27.1	2.3	1.2	13.3	27.0	1.5	1.9	14.0	2.2	36.0	2.0	24.4	1.4	1.5	1.2	3.3	1.5	1.0	1.4	6.6	2.1	1.1	116.1	1.9	3.6	4.5	2.0	48.3	13.6	16.4	7.3	9.8	18.5	12.4	18.6	8.5	8.5	10.4	32.8	12.8	27.7	117.6	2.6	22.0	22.6	15.3	24.1	12.5	68.0	7.9	13.9	23.2	18.9	3.5	18.0	86.9	0.0	11.7	21.5	13.7	177.7	10.4	51.3	13.8	17.5	93.4	16.0	10.5	0.5	13.0	8.0	5.0	12.6	30.9	10.9	33.5	129.8	7.1	77.4	22.6	19.4	16.5	2.4	2.2	7.3	63.5	18.7	26.1	208.4
HIST1H2AD	"H2A.3, H2A/g, H2AFG"	ENSG00000196866	"Histone cluster 1 H2A family member d"	P20671	6	26198851-26199243	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	14	"lymphoid tissue: 225.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"U-266/70: 21.2;U-266/84: 6.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.10e-9)"	"unprognostic (2.00e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	2.6	1.8	0.9	13.8	1.1	14.7	6.3	0.8	1.3	8.0	4.6	0.0	3.2	1.5	2.0	3.1	9.2	1.3	2.8	5.5	1.2	1.3	2.3	3.6	4.8	15.9	1.1	0.5	3.4	1.9	1.1	1.5	4.6	1.0	6.8	2.2	1.5	2.5	4.3	1.2	3.2	4.3	2.3	3.6	10.8	1.8	5.7	0.6	225.6	1.4	5.1	14.3	5.3	8.6	7.0	5.7	16.0	1.8	1.1	3.8	0.8	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.6	0.3	1.9	0.0	2.4	0.3	0.0	1.7	0.3	0.2	0.4	0.0	0.3	0.2	0.1	1.3	0.2	1.6	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	3.5	1.7	0.0	0.1	2.9	1.3	1.7	0.0	0.3	1.5	0.5	1.5	0.4	0.1	1.5	0.3	0.7	1.4	0.1	0.0	0.5	0.5	0.0	1.5	4.1	0.0	1.1	21.2	6.9	2.5	0.8	1.8	0.7	2.2	0.2	3.2	1.1	1.8	1.1	2.0	1.5	3.8	1.0	7.0	1.4	1.1	16.0	1.1	1.3	5.7	2.0	0.8	0.9	1.1	0.8	1.3	1.2	1.3	1.1	0.5	1.0	0.6	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3
HIST1H2AG	"H2A.1b, H2A/p, H2AFP, pH2A/f"	ENSG00000196787	"Histone cluster 1 H2A family member g"	P0C0S8	6	27133042-27135291	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 305.4"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 16.3;Enterocytes: 7.3;Late spermatids: 10.6;Paneth cells: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 9.7"	"Group enriched"	"Detected in many"	4	"B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"K-562: 9.9;SiHa: 11.5;U-266/84: 31.2"									HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.86e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.54e-2)"	2.4	1.6	1.1	25.1	1.2	6.3	8.7	0.7	1.0	3.3	9.7	0.0	1.0	3.8	2.0	3.7	15.7	1.0	3.2	2.7	1.3	1.6	1.1	2.6	6.0	13.5	2.3	0.0	1.4	0.9	0.3	1.0	8.7	0.3	2.5	2.3	0.3	2.1	1.5	1.1	1.4	7.1	0.9	2.3	20.2	1.8	16.1	0.0	305.4	1.5	12.3	28.9	2.4	2.0	4.4	1.3	9.7	0.8	1.1	3.8	7.7	1.3	1.8	1.6	1.4	4.9	1.0	1.0	0.5	0.7	1.6	0.2	0.8	1.4	0.4	2.0	0.5	1.5	2.8	1.9	0.8	1.1	2.4	1.1	0.7	3.6	0.0	1.0	0.7	1.5	1.8	0.4	0.5	0.5	0.8	0.5	1.3	9.9	4.7	0.1	1.7	1.8	1.1	0.9	2.0	1.2	1.2	1.5	5.1	0.3	0.3	6.1	1.5	11.5	1.8	0.6	0.7	0.0	0.4	0.6	1.8	4.0	1.4	0.7	8.4	31.2	3.2	0.3	1.1	1.1	9.7	0.4	0.7	0.6	0.3	1.3	3.0	2.3	1.6	0.6	4.4	2.2	1.8	3.5	1.1	0.8	1.3	3.8	7.7	1.1	1.2	0.7	0.9	1.3	1.6	2.3	0.0	0.3	0.0	0.0	1.4	2.2	1.4	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	16.3	0.3	7.3	0.0	0.0	2.9	0.3	1.4	0.0	0.4	2.1	4.8	1.2	0.0	0.6	10.6	0.0	1.0	0.0	1.0	3.1	1.2	0.1	10.5	0.0	0.0	0.0	0.0	0.3	2.2	3.0	0.4	2.5	2.5	2.9	1.0
HIST1H2AH	"dJ86C11.1, H2A/S, H2AFALii"	ENSG00000274997	"Histone cluster 1 H2A family member h"	Q96KK5	6	27147129-27147515	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 301.1"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"naive B-cell: 16.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.0;MOLT-4: 9.3;NB-4: 10.2"									"CAB004030, HPA041189"	Supported		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004030: AB_2118804, HPA041189: AB_2677357"	"unprognostic (4.07e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.35e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"		"unprognostic (9.74e-3)"	"unprognostic (1.87e-1)"		"unprognostic (1.26e-4)"	0.8	0.7	0.0	26.0	0.0	20.2	1.5	0.0	0.4	3.1	6.6	0.0	0.6	1.0	1.8	2.6	6.4	1.0	2.7	1.3	0.0		0.5	0.4	4.1	5.4	0.0	0.0	2.4	0.5	0.4	0.0	9.0	0.0	0.6	0.9	0.1	1.7	0.6	0.4	0.6	6.5	0.9	0.0	13.9	0.7	23.5	0.0	301.1	0.6	9.0	27.3	1.9	0.0	16.2	2.2	0.0	2.4	5.1	4.7	2.3	2.6	3.5	1.1	4.9	0.0	0.0	0.7	0.3	0.6	0.6	0.0	2.6	1.0	3.8	0.9	0.0	0.6	0.3	1.0	0.0	0.0	2.1	9.0	4.7	3.0	0.0	0.0	3.2	1.8	0.0	0.0	1.2	0.0	0.0	0.9	1.8	4.8	2.4	0.9	0.4	9.3	10.2	3.2	0.9	1.2	3.4	3.1	5.0	0.0	0.3	2.5	0.6	1.4	0.5	0.2	0.1	1.0	1.5	0.0	0.8	2.8	0.2	2.7	2.9	2.9	6.1	1.3	4.6	0.8	0.0	0.9	0.0	2.6	2.4	1.2	3.8	4.7	4.2	2.2	16.2	2.4	1.6	0.0	5.1	1.5	1.5	0.8	2.3											0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.3	1.7	0.1	1.6	23.3	0.3	1.9	0.3	0.8	1.1	0.0	0.7	0.0	1.7	1.8	1.2	4.3	0.6	0.6	0.0	0.0	0.3	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.5	0.2	2.5	1.0	0.6
HIST1H2AI	"H2A/c, H2AFC"	ENSG00000196747	"Histone cluster 1 H2A family member i"	P0C0S8	6	27808199-27808701	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 349.3"	"Cell type enhanced"	"Detected in single"	10	"T-cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 17.7;U-266/84: 48.6"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (6.82e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.54e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.50e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.24e-2)"	1.7	1.2	0.7	36.2	0.9	10.7	2.8	0.6	0.7	1.5	6.3	0.0	0.5	2.3	1.1	1.4	14.2	1.4	2.8	4.8	1.1	1.1	1.0	1.3	3.5	25.8	0.6	0.0	1.2	0.4	1.4	0.6	5.4	0.0	1.3	5.8	0.0	1.3	0.3	0.5	1.1	7.1	0.5	4.3	21.9	2.2	4.3	0.0	349.3	1.0	15.2	26.8	2.3	2.0	3.0	2.6	4.8	0.8	2.5	4.0	2.0	0.9	3.7	0.9	0.6	0.4	0.2	0.3	0.7	0.1	1.2	0.9	1.1	0.6	1.0	2.2	0.3	0.6	0.7	0.0	0.6	0.5	3.6	4.8	1.5	5.9	3.1	0.4	0.4	0.8	1.7	0.2	0.4	0.1	1.0	0.2	1.2	17.7	4.2	0.0	4.6	2.6	2.8	0.9	3.1	1.3	1.3	0.0	6.9	1.4	0.7	5.2	1.0	10.3	1.5	0.3	0.3	6.3	0.4	0.2	0.5	2.0	0.4	0.4	3.9	48.6	2.0	0.4	4.1	0.3	0.0	0.5	3.6	0.9	0.8	0.7	2.1	3.2	0.9	2.3	3.0	0.7	0.4	4.8	2.5	0.8	2.6	4.0	2.0	0.7	0.9	0.6	0.7	1.1	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.4
HIST1H2AJ	"H2A/E, H2AFE"	ENSG00000276368	"Histone cluster 1 H2A family member j"	Q99878	6	27814354-27814740	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	22	"lymphoid tissue: 357.7"	"Cell type enriched"	"Detected in some"	29	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.0;Karpas-707: 12.1;MCF7: 16.8"					"Low region specificity"	"Detected in some"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (8.95e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.43e-1)"		"unprognostic (9.35e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.88e-2)"	0.6	0.1	0.0	7.2	0.0	16.5	0.2	0.0	0.2	1.0	5.2	0.0	0.0	0.3	0.3	0.6	6.6	0.3	0.8	0.2	0.0		0.3	0.4	2.2	3.1	0.0	0.0	0.1	0.1	0.1	0.0	3.6	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.4	3.9	0.1	0.0	10.5	0.8	5.2	0.0	357.7	0.1	7.9	23.1	1.5	0.0	4.2	2.7	2.5	0.5	0.4	5.9	5.0	4.0	0.0	1.2	0.0	0.0	0.0	1.0	1.2	1.2	1.1	2.6	2.1	0.2	3.9	0.4	0.7	0.1	1.1	0.0	1.1	0.6	1.9	0.6	5.6	0.5	10.0	0.3	0.0	2.1	0.0	0.3	0.5	0.3	0.0	1.5	2.1	0.0	12.1	0.3	16.8	6.7	6.1	2.0	1.7	3.5	6.0	0.0	2.3	0.2	2.4	0.5	0.8	1.1	1.2	0.5	0.3	0.4	4.1	0.0	0.0	2.4	0.4	0.2	6.2	3.9	3.8	1.3	4.5	2.8	0.0	0.1	0.0	0.7	0.5	0.9	0.7	3.4	3.1	2.7	4.2	1.1	0.4	2.5	0.4	0.2	0.3	5.9	5.0											0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	46.7	0.0	1.6	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.4	0.3
HIST1H2AK	"H2A/d, H2AFD"	ENSG00000275221	"Histone cluster 1 H2A family member k"	P0C0S8	6	27837947-27838339	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 115.7"	"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 1.4;granulocytes: 1.1;Melanocytes: 1.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;AN3-CA: 4.9;HeLa: 5.1;SCLC-21H: 4.8;U-266/84: 7.2"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"																		1.5	4.1	0.0	11.1	0.5	3.2	3.5	0.9	1.3	2.8	2.3	0.2	0.5	1.0	1.7	1.6	4.4	2.7	4.1	2.5	0.0		0.2	0.4	4.4	8.4	0.8	0.0	3.3	0.0	0.0	0.1	1.7	0.3	2.3	0.4	0.9	1.7	1.1	0.7	0.0	1.5	0.3	1.6	7.0	1.3	3.9	0.5	115.7	1.6	2.8	12.3	2.1	0.0	6.0	1.2	0.0	0.6	1.1	3.8	5.1	0.0	4.3	0.0	4.9	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.4	0.0	0.2	0.2	0.8	0.5	2.2	1.0	0.0	0.6	1.4	1.2	1.7	5.1	0.6	0.7	0.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	1.9	0.0	0.0	0.7	1.6	0.0	0.0	0.2	0.0	0.6	0.4	0.0	1.0	0.3	4.8	0.8	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.5	0.5	0.0	0.3	1.9	7.2	1.0	0.0	0.3	0.5	0.0	0.1	0.0	2.3	0.0	1.8	5.8	2.6	2.4	0.0	6.0	3.8	2.8	0.0	1.1	0.6	1.2	2.7	5.1											0.0	0.3	0.5	0.3	0.1	0.7	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0
HIST1H2AL	"dJ193B12.9, H2A/i, H2AFI"	ENSG00000276903	"Histone cluster 1 H2A family member l"	P0C0S8	6	27865355-27865747	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 288.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 7.2;MOLT-4: 8.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"		"unprognostic (2.41e-2)"	"unprognostic (2.12e-1)"		"unprognostic (6.21e-2)"	1.1	0.5	0.0	24.8	0.0	16.4	1.3	0.0	0.5	1.1	4.5	0.0	0.0	1.1	0.8	1.7	7.6	0.3	1.8	1.5	0.0		0.4	0.4	3.4	10.2	0.0	0.0	0.3	0.3	1.5	0.0	5.2	0.0	0.3	0.3	0.0	0.7	0.3	0.3	0.5	4.4	0.3	0.0	12.9	0.7	13.1	0.0	288.3	0.3	9.6	26.4	0.5	0.0	9.6	4.7	8.8	3.6	0.1	2.0	1.1	4.2	1.7	0.9	0.0	0.0	0.0	1.1	1.7	0.7	1.4	1.7	0.0	1.4	3.2	1.2	0.0	1.0	1.2	0.0	0.0	0.4	3.1	7.2	1.2	0.0	1.2	0.0	0.8	1.5	0.0	0.0	0.4	0.0	0.0	0.0	1.7	5.5	3.3	0.5	3.8	8.9	6.4	2.9	1.7	1.3	4.6	0.0	0.5	0.7	2.6	2.1	2.0	1.2	0.0	0.8	0.0	0.4	1.2	0.0	0.2	0.0	1.4	3.0	5.6	0.0	6.5	1.4	4.1	1.3	2.4	2.0	1.3	0.1	1.7	0.0	3.3	1.7	2.0	4.7	9.6	0.7	1.0	8.8	0.1	3.6	3.4	1.7	1.1											0.0	0.0	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.9	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.1	0.0	0.4	0.5
HIST1H2AM	"H2A.1, H2A/n, H2AFN"	ENSG00000278677	"Histone cluster 1 H2A family member m"	P0C0S8	6	27892757-27893149	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 315.3"	"Cell type enhanced"	"Detected in some"	11	"B-cells: 2.2;Ciliated cells: 4.0;granulocytes: 2.3;T-cells: 3.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 25.2"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (6.05e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.24e-1)"	"unprognostic (8.85e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.30e-1)"	1.2	1.5	0.0	30.7	0.0	9.3	2.3	0.2	0.2	2.1	6.1	0.1	2.3	1.4	1.3	2.6	10.7	0.3	3.9	2.2	0.0		0.6	1.7	4.7	12.7	0.0	0.0	0.4	1.2	0.0	0.0	10.4	0.3	0.9	1.8	0.0	1.3	2.2	0.7	1.0	6.5	0.0	1.1	15.3	1.7	4.8	0.0	315.3	1.3	11.4	28.9	2.5	0.0	10.3	14.7	28.7	6.2	4.8	8.5	7.0	3.2	2.7	2.1	5.1	0.3	0.3	4.5	0.9	0.7	2.6	3.5	1.0	1.3	5.4	3.7	0.8	2.5	2.2	1.6	1.7	1.7	3.5	1.3	2.7	3.4	3.6	0.0	1.6	2.2	1.3	0.0	1.8	0.0	0.2	2.6	3.9	11.6	7.5	0.4	5.3	11.0	7.8	3.8	2.0	1.3	6.7	3.5	9.6	1.3	0.7	8.1	1.5	5.6	0.6	0.7	1.1	4.9	1.6	0.0	1.1	0.1	1.2	1.7	8.1	25.2	12.6	1.5	9.5	1.0	28.7	3.4	12.5	6.8	3.8	4.1	8.9	5.9	5.7	11.4	10.3	2.5	2.8	11.5	4.8	6.2	14.7	8.5	7.0											0.0	0.0	2.2	0.1	0.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.1	2.3	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	3.2	0.4	0.0
HIST1H2BB	"H2B/f, H2BFF"	ENSG00000276410	"Histone cluster 1 H2B family member b"	P33778	6	26043277-26043657	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in some"	10	"Enterocytes: 1.6;Spermatogonia: 1.5"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 3.7;Karpas-707: 3.6;MOLT-4: 4.5;NB-4: 4.9;THP-1: 5.5;U-266/84: 6.1"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.4	0.3	1.0	6.4	0.3	6.6	0.6	0.5	1.0	0.5	1.0	0.0	0.0	1.1	0.4	0.5	4.1	0.6	0.3	1.0	0.2		0.8	0.3	1.7	3.0	0.1	0.4	0.3	0.5	0.3	0.0	0.9	1.0	0.3	0.3	0.2	0.3	0.3	1.3	1.0	0.8	0.3	0.8	5.8	0.5	15.8	0.1	104.9	0.3	4.8	7.4	0.3	0.0	2.1	10.5	4.2	1.1	0.2	3.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.4	1.1	1.6	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.7	0.3	0.0	1.3	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.6	0.0	0.3	1.4	0.6	3.7	3.6	0.0	0.0	4.5	4.9	2.2	0.7	2.1	2.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.3	5.5	0.0	0.3	0.3	0.3	0.9	0.8	6.1	0.0	0.7	1.8	1.3	4.2	1.1	0.8	1.5	0.1	3.9	2.1	3.9	1.6	3.3	1.6	2.0	0.8	3.6	0.2	0.4	10.5	2.9	0.6											0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.6	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.3	0.1	0.0	0.3	0.0
HIST1H2BC	"H2B.1, H2B/l, H2BFL"	ENSG00000180596	"Histone cluster 1 H2B family member c"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 115.7;lymphoid tissue: 143.2"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 42.1;Glandular cells: 78.6;Urothelial cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	20	"neutrophil: 115.7"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 115.7"	"Cell line enhanced"	"Detected in many"		"K-562: 17.0;SiHa: 33.6;U-2 OS: 23.5;U-266/70: 19.4;U-266/84: 23.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	7.8	5.8	5.5	21.3	7.1	31.3	10.7	2.1	5.9	12.9	11.5	5.9	12.8	5.2	4.1	13.1	20.9	10.8	8.1	5.8	6.5	4.6	8.4	20.2	15.3	11.4	5.4	4.1	5.6	9.6	1.7	9.9	17.5	3.8	31.7	4.1	5.9	12.4	18.6	20.0	10.0	6.0	4.3	10.4	11.7	10.6	9.4	4.5	143.2	6.4	8.7	23.4	12.9	14.3	4.3	2.8	115.7	1.3	1.2	1.8	2.7	3.0	1.8	0.9	0.9	0.9	0.5	1.1	3.0	1.1	2.0	1.7	2.4	1.8	1.1	5.7	1.0	1.5	2.3	1.2	1.2	1.0	2.7	1.0	0.9	2.7	4.1	1.2	1.4	3.8	12.6	0.7	0.8	0.5	1.0	0.8	0.9	17.0	9.5	3.8	3.4	3.2	3.1	1.0	3.2	5.5	1.4	1.3	7.0	3.5	0.7	4.3	1.4	33.6	2.6	1.2	2.6	14.3	1.3	2.4	2.5	23.5	1.5	1.2	19.4	23.8	5.7	1.1	3.7	1.7	4.5	1.1	5.8	1.2	1.3	1.6	2.3	1.8	1.7	0.8	4.3	1.4	1.0	115.7	1.2	1.2	2.8	1.1	2.7	5.5	7.1	2.1	5.9	6.5	4.6	5.4	4.1	3.8	4.5	6.0	2.7	3.0	40.5	0.8	3.0	1.8	5.1	21.4	7.9	3.5	0.0	3.9	1.7	6.8	42.1	2.9	9.5	0.0	8.0	5.4	4.1	78.6	4.6	13.0	5.8	0.0	1.7	1.8	3.7	4.5	1.4	4.6	0.0	1.8	7.4	2.9	25.5	9.9	1.1	3.5	3.9	0.0	1.8	1.8	3.2	1.0	35.8	10.1	4.9	103.5
HIST1H2BD	"H2B/b, H2BFB"	ENSG00000158373	"Histone cluster 1 H2B family member d"	P58876	6	26158146-26171349	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 174.9"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 105.0;Proximal tubular cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.2;U-266/84: 39.2"					"Low region specificity"	"Detected in some"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	7.9	6.6	6.0	33.2	9.0	36.4	17.3	14.0	8.9	33.6	17.0	2.9	13.2	8.2	9.5	21.4	18.2	17.4	11.1	17.4	7.5	4.2	19.9	25.3	13.8	32.3	7.7	7.1	33.1	21.7	2.2	11.5	10.1	7.4	43.4	12.9	8.3	13.0	14.7	12.0	14.7	9.5	13.0	18.7	11.0	18.8	7.1	5.6	174.9	9.5	23.9	18.9	13.2	32.7	15.6	12.9	19.3	4.5	6.8	9.6	2.0	5.3	12.2	3.7	2.1	29.3	2.7	1.1	4.7	2.7	6.2	3.9	4.1	4.4	2.4	30.1	5.6	6.9	8.5	2.1	2.0	2.9	11.0	5.2	1.6	9.8	4.3	3.1	2.1	4.6	19.2	3.2	1.7	2.4	2.4	1.5	2.3	16.9	13.5	1.1	19.3	4.8	5.4	3.9	23.1	5.7	1.9	2.4	16.0	5.8	3.9	12.0	5.1	29.9	7.8	4.6	7.6	19.8	0.8	0.9	7.7	20.1	3.1	1.0	37.2	39.2	6.1	1.0	10.0	1.5	19.3	1.5	10.5	5.8	3.4	7.4	8.4	8.9	9.6	3.7	15.6	8.4	5.7	16.6	6.8	4.5	12.9	5.8	2.0	6.0	9.0	14.0	8.9	7.5	4.2	7.7	7.1	7.4	5.6	3.0	5.6	15.9	54.2	1.5	13.9	21.3	12.7	53.5	10.3	21.0	0.0	6.4	19.9	4.3	27.1	2.8	22.0	0.0	3.8	6.2	3.0	105.0	2.3	20.7	3.9	41.3	44.7	1.3	4.0	5.4	6.6	6.9	3.3	3.6	20.2	4.0	12.0	33.1	1.4	75.4	10.4	0.0	1.4	0.9	0.7	2.4	33.0	6.9	14.3	63.6
HIST1H2BE	"H2B.h, H2B/h, H2BFH"	ENSG00000274290	"Histone cluster 1 H2B family member e"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	26	"lymphoid tissue: 165.1"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 5.6;Glandular cells: 5.8;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 8.2;REH: 8.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.7	1.1	0.4	12.2	0.8	5.9	1.8	0.6	1.7	2.5	2.9	0.1	1.8	1.1	1.5	2.9	5.5	1.6	1.6	1.9	0.5		1.7	0.3	1.5	6.7	0.0	1.2	2.1	1.2	0.7	0.0	2.4	0.2	5.2	1.5	0.7	4.0	2.2	2.1	1.9	2.0	1.8	1.6	4.5	2.5	5.4	0.0	165.1	1.2	6.4	7.1	1.8	0.0	3.6	3.1	5.5	1.7	1.6	2.9	0.8	0.5	3.7	3.0	0.9	3.0	0.4	0.4	3.1	1.0	0.5	0.3	0.8	2.1	0.7	1.4	0.5	1.7	4.3	0.5	1.1	0.6	1.6	1.0	0.5	1.5	0.2	0.2	0.3	2.5	0.6	0.2	0.6	0.3	1.1	0.3	0.9	2.4	1.8	0.1	1.6	4.6	8.2	2.4	1.6	1.0	8.0	0.2	2.6	1.4	1.8	2.7	3.7	4.0	1.5	0.9	1.6	2.8	1.6	0.8	1.5	2.7	1.1	1.9	2.4	4.5	0.6	0.6	1.4	0.5	5.2	1.7	2.4	2.0	1.3	1.6	2.1	2.0	2.5	0.7	3.6	1.8	1.7	5.5	1.6	1.5	3.1	2.9	0.8											0.0	0.0	5.6	4.5	0.0	4.3	0.3	2.5	2.7	0.0	1.8	3.9	0.7	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.9	0.3	5.8	1.1	1.0	0.8	9.5	1.2	0.6	4.1	0.0	1.4	0.7	0.0	1.0	0.4	1.2	0.2	0.0	0.7	0.4	2.4	0.0	0.0	1.6	0.9	0.0	0.7	0.0	1.6	4.0
HIST1H2BF	"H2B/g, H2BFG"	ENSG00000277224	"Histone cluster 1 H2B family member f"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"lymphoid tissue: 252.2"	"Cell type enhanced"	"Detected in some"	8	"B-cells: 6.7;Basal glandular cells: 3.6;Bipolar cells: 5.4;Glandular cells: 5.5;Urothelial cells: 5.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"U-266/70: 21.8;U-266/84: 15.3"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.4	1.2	0.0	17.3	0.1	3.8	5.7	0.3	0.7	2.7	3.3	0.4	1.0	0.5	1.6	1.3	9.9	1.3	1.2	0.6	0.0		0.5	0.4	2.5	7.0	0.0	0.2	0.8	0.6	0.4	0.0	3.2	0.2	5.4	1.1	0.5	1.4	1.3	0.2	0.4	3.0	0.3	0.9	8.3	1.3	2.2	0.1	252.2	0.4	3.3	14.6	2.4	0.0	3.0	0.7	6.2	0.7	0.4	1.5	1.2	0.4	0.2	0.2	0.4	0.3	0.0	0.2	0.1	0.1	0.6	0.1	0.5	0.0	0.5	0.9	0.0	0.3	0.9	0.4	0.1	0.3	0.7	0.2	0.3	1.4	0.1	0.1	0.1	0.7	0.2	0.0	0.1	0.1	0.0	0.1	0.4	1.7	3.9	0.0	0.1	3.3	1.4	0.5	0.7	0.5	1.2	0.6	2.4	0.1	0.1	2.1	0.3	4.2	0.8	0.0	0.3	3.8	0.2	0.1	0.3	1.9	0.0	0.5	21.8	15.3	1.2	0.1	1.0	0.4	0.0	0.2	1.4	0.7	0.3	1.5	0.7	0.7	0.8	0.4	3.0	0.6	1.2	6.2	0.4	0.7	0.7	0.6	1.2											0.0	0.3	6.7	3.6	0.0	5.4	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.4	0.0	5.5	0.0	0.4	1.0	0.0	0.0	1.3	0.8	0.0	0.0	0.8	0.0	0.0	0.4	1.2	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.5	2.5	1.0	5.1
HIST1H2BG	"H2B.1A, H2B/a, H2BFA"	ENSG00000273802	"Histone cluster 1 H2B family member g"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.2"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 58.7;Glandular cells: 91.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 8.9;T-47d: 18.1;U-266/70: 16.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	0.4	1.5	0.7	16.5	1.2	8.9	20.2	5.1	3.4	4.3	2.9	0.5	5.1	1.8	2.8	4.0	6.6	2.1	1.8	1.7	0.2		1.2	0.6	2.0	7.2	0.1	2.0	1.3	1.9	0.4	0.5	1.6	0.7	10.3	3.0	1.2	5.0	5.8	0.3	1.6	2.2	2.8	4.7	3.1	2.9	6.7	0.3	75.2	1.0	6.9	8.3	4.3	0.0	5.8	14.6	12.0	1.6	1.3	6.2	2.0	2.5	0.1	1.2	0.0	3.9	0.2	0.3	3.1	0.2	2.0	0.8	0.3	2.2	0.0	3.2	0.3	0.8	2.7	1.1	1.0	1.1	2.2	1.3	0.7	1.2	1.1	0.6	0.3	2.1	1.5	0.5	0.6	0.0	0.1	0.4	0.1	7.8	0.1	0.0	1.8	2.2	1.7	1.2	5.9	1.6	1.5	0.7	4.4	1.2	0.6	7.3	1.1	8.9	3.3	1.0	3.4	18.1	0.8	0.2	0.0	1.0	0.3	0.4	16.9	0.1	0.0	0.3	1.1	0.5	12.0	1.2	2.5	2.0	0.9	6.2	3.7	3.1	3.8	4.4	5.8	1.5	1.3	5.6	1.3	1.6	14.6	2.7	2.0											0.0	12.7	29.3	58.7	0.8	40.1	0.7	5.1	4.0	4.5	5.2	5.9	6.3	0.0	4.8	0.6	0.5	27.1	0.0	0.0	6.6	3.2	91.9	9.3	2.5	17.2	23.8	29.8	2.5	3.5	0.0	2.0	8.0	0.0	1.8	17.9	9.5	1.1	16.4	0.0	1.3	3.0	6.5	0.4	1.4	16.2	0.0	20.1	10.7	14.2	42.2
HIST1H2BH	"H2B/j, H2BFJ"	ENSG00000275713	"Histone cluster 1 H2B family member h"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 220.5"	"Cell type enhanced"	"Detected in some"	13	"B-cells: 6.7;Enterocytes: 8.5;Extravillous trophoblasts: 21.0;Paneth cells: 8.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 7.5;U-266/70: 18.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.9	0.6	0.0	25.6	0.0	3.1	2.1	0.0	0.0	0.9	5.5	0.0	0.9	7.8	1.0	2.4	8.4	1.5	4.0	1.8	0.0		0.7	0.0	2.2	11.3	0.0	0.0	0.4	0.1	0.0	0.0	4.9	0.0	1.2	2.2	0.0	1.8	0.1	0.0	0.6	8.1	0.1	0.0	9.6	1.6	3.3	0.0	220.5	0.4	9.5	23.3	1.4	0.0	1.0	0.9	4.7	0.4	1.0	0.7	9.3	1.8	0.1	7.5	0.0	0.0	0.1	1.2	0.9	0.4	1.3	0.6	2.5	1.1	0.0	1.8	0.1	1.9	3.6	0.0	0.6	1.9	0.9	0.1	1.4	5.6	0.4	0.0	0.0	4.3	0.3	0.3	0.5	0.5	0.0	0.3	1.0	2.7	6.6	0.1	2.0	3.8	2.7	1.7	0.0	1.9	4.1	0.0	1.0	0.0	2.8	3.4	3.1	4.4	1.5	0.6	0.3	2.2	3.4	0.0	0.6	0.0	0.8	3.2	18.1	4.5	0.0	0.5	1.5	4.0	3.5	0.4	0.7	0.5	0.0	0.2	1.0	0.3	0.7	0.9	0.6	0.1	0.2	4.7	1.0	0.2	0.4	0.7	9.3											0.0	0.0	6.7	2.8	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.5	0.0	0.2	21.0	0.5	1.0	0.0	0.0	6.1	0.0	0.0	0.6	2.2	0.0	0.0	0.5	0.0	0.0	2.7	0.0	0.0	8.6	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	3.8	4.9	3.7	3.6
HIST1H2BI	"H2B/k, H2BFK"	ENSG00000278588	"Histone cluster 1 H2B family member i"	P62807	6	26272976-26273356	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 150.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 5.4;MOLT-4: 15.1;THP-1: 6.3"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.5	0.1	0.0	19.0	0.0	8.9	1.2	0.4	0.1	1.3	3.1	0.0	0.5	0.1	0.7	2.1	6.6	0.4	2.0	1.3	0.0		0.3	0.1	2.0	6.3	0.0	0.0	0.7	0.1	0.1	0.0	2.8	0.0	0.1	0.3	0.0	1.3	0.3	0.1	1.2	1.9	0.1	0.1	11.1	0.4	1.9	0.0	150.8	0.4	8.2	14.5	2.2	0.0	4.7	0.7	0.9	1.3	0.4	4.6	0.2	1.9	0.8	1.2	0.0	0.0	0.0	0.2	0.7	0.7	2.0	5.4	0.8	0.0	0.9	0.5	0.5	0.7	0.9	1.8	0.5	0.8	2.7	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	1.8	2.2	0.0	3.9	0.0	0.8	15.1	2.5	2.9	0.6	0.0	4.1	0.0	5.0	0.0	0.4	0.3	0.9	1.1	1.0	0.0	0.1	0.0	6.3	0.9	0.9	0.0	0.6	3.1	3.2	0.4	0.0	1.1	0.5	2.2	0.2	0.5	0.0	3.4	1.3	2.2	2.2	3.2	4.6	0.7	4.7	1.4	0.8	0.9	0.4	0.1	0.3	1.5	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1
HIST1H2BJ	"H2B/r, H2BFR"	ENSG00000124635	"Histone cluster 1 H2B family member j"	P06899	6	27125897-27132750	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 124.3"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 63.4;Erythroid cells: 23.3;Glandular cells: 25.8;Spermatocytes: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in many"		"K-562: 42.1;Karpas-707: 24.8;SiHa: 37.9;U-2 OS: 42.0;U-266/70: 35.8;U-266/84: 44.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (4.02e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.1	2.2	1.5	30.0	2.4	10.7	11.3	0.9	1.9	12.8	6.2	1.6	3.9	2.1	3.1	5.9	12.8	5.1	2.8	6.0	2.5	1.7	1.9	3.9	7.3	12.0	3.2	0.9	1.3	5.1	0.6	1.2	5.1	2.9	8.0	3.0	0.5	4.0	4.8	5.9	2.9	2.8	2.8	5.9	12.0	5.1	30.5	2.2	124.3	2.7	10.1	22.3	5.2	9.4	2.2	1.0	13.6	0.6	0.7	2.4	14.7	3.8	4.8	1.4	1.3	7.2	0.5	1.9	2.1	1.3	8.5	3.6	4.1	2.2	0.6	6.9	2.3	3.9	2.8	2.1	1.9	4.7	4.5	3.6	1.1	5.5	0.2	0.6	0.5	3.0	3.4	0.2	1.8	0.8	1.2	0.5	1.7	42.1	24.8	2.2	2.0	1.7	2.5	1.7	3.9	4.5	0.9	1.2	3.8	1.0	1.4	9.4	1.1	37.9	2.5	1.1	2.1	0.1	1.5	1.1	2.1	42.0	1.6	0.9	35.8	44.0	10.1	0.5	11.8	1.0	1.8	0.6	0.7	0.5	0.5	0.8	1.6	0.7	0.3	0.4	2.2	0.4	0.5	13.6	0.7	0.2	1.0	2.4	14.7	1.5	2.4	0.9	1.9	2.5	1.7	3.2	0.9	2.9	2.2	0.0	0.0	0.0	10.4	5.5	0.0	2.0	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.4	63.4	0.6	4.0	23.3	0.3	3.2	2.4	25.8	0.0	1.5	3.3	0.0	12.6	4.9	2.6	19.3	1.1	2.4	6.8	4.6	2.6	0.0	2.4	7.0	1.4	0.0	0.0	0.0	3.1	30.9	9.1	4.6	5.1	4.5	2.3	9.5
HIST1H2BK	"H2BFAiii, H2BFT"	ENSG00000197903	"Histone cluster 1 H2B family member k"	O60814	6	27146418-27146798	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 243.8"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 23.8;Basal keratinocytes: 28.0;Melanocytes: 38.8;Suprabasal keratinocytes: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 117.4;U-2 OS: 107.1;U-266/84: 140.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	9.4	6.0	3.0	39.8	4.1	7.8	8.6	2.4	3.6	14.9	11.0	2.5	10.5	8.4	8.0	14.6	19.1	13.5	10.5	9.8	4.3	3.7	4.0	19.3	12.7	25.9	3.6	2.3	8.5	17.4	0.6	5.9	18.7	2.0	16.0	5.3	3.5	11.3	10.7	3.7	6.3	10.3	6.9	7.6	28.0	13.7	30.6	1.9	243.8	8.9	32.3	26.4	11.5	16.7	26.5	22.1	60.7	16.2	5.0	11.5	12.5	6.2	16.3	2.6	4.5	11.7	4.4	9.0	10.4	7.5	15.0	9.7	14.7	8.3	2.0	35.1	5.9	10.5	8.2	3.1	3.2	2.2	9.3	15.7	3.5	10.2	0.5	5.1	2.7	21.3	21.0	2.8	2.5	2.8	4.2	3.0	1.3	117.4	23.8	6.7	17.1	5.0	5.0	2.3	22.7	7.0	3.2	1.7	26.5	5.6	2.8	13.2	7.6	61.8	21.2	5.6	2.4	54.8	3.2	3.4	6.7	107.1	6.2	1.8	32.7	140.9	18.6	3.9	28.0	3.8	33.8	9.4	60.7	4.1	8.3	3.9	20.3	4.2	4.1	9.6	26.5	5.0	3.9	60.1	5.0	16.2	22.1	11.5	12.5	3.0	4.1	2.4	3.6	4.3	3.7	3.6	2.3	2.0	1.9	23.8	9.4	4.3	0.6	28.0	0.0	0.4	0.0	13.4	6.8	0.0	0.0	1.2	0.0	1.3	0.1	2.1	2.6	0.0	1.0	2.6	1.9	0.5	4.7	1.7	0.9	0.0	0.0	2.5	2.2	0.0	0.0	4.9	38.8	4.6	1.0	0.0	2.0	1.1	0.0	0.0	0.0	0.0	1.5	0.4	3.0	29.2	3.2	9.6	1.2	0.5
HIST1H2BL	"dJ97D16.4, H2B/c, H2BFC"	ENSG00000185130	"Histone cluster 1 H2B family member l"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 217.6"	"Cell type enhanced"	"Detected in single"	13	"Club cells: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.2;U-266/84: 13.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	1.2	1.0	0.2	13.9	1.0	13.7	1.6	1.4	0.6	1.8	5.1	0.0	0.3	0.6	0.8	0.6	7.4	0.9	0.9	1.3	0.9	0.7	0.3	0.6	1.5	3.5	0.5	0.0	1.3	1.2	1.2	0.2	1.9	0.0	1.2	1.1	0.0	0.7	0.2	0.2	0.9	3.9	0.7	2.8	4.8	0.8	1.5	0.0	217.6	1.2	5.9	15.6	1.1	1.2	1.9	1.2	7.7	0.6	0.4	2.0	0.9	2.4	2.2	0.7	2.3	0.0	0.0	0.1	1.4	0.4	1.3	3.3	1.0	1.7	0.9	0.5	0.3	0.7	1.6	0.0	0.2	0.4	1.1	3.2	1.7	3.1	3.8	0.0	2.8	2.4	1.0	0.0	0.0	0.0	0.2	0.7	2.1	2.2	5.8	0.0	6.1	13.2	4.9	2.2	1.6	3.4	3.1	0.0	1.4	0.0	2.2	3.1	1.1	4.0	1.6	0.2	0.2	1.4	1.0	0.5	0.1	1.7	1.3	1.0	3.3	13.0	4.3	0.4	5.1	0.5	0.6	0.5	4.0	1.1	0.2	1.3	1.9	0.6	1.1	1.2	1.3	0.4	0.6	7.7	0.4	0.6	0.7	2.0	0.9	0.2	1.0	1.4	0.5	0.9	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.2
HIST1H2BM	"dJ160A22.3, H2B/e, H2BFE"	ENSG00000273703	"Histone cluster 1 H2B family member m"	Q99879	6	27815044-27815424	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"lymphoid tissue: 232.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.7;NB-4: 11.4;REH: 7.3;U-266/70: 13.7;U-698: 7.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.1	0.1	0.0	19.9	0.0	11.6	0.1	0.0	0.2	1.6	3.4	0.0	0.0	0.1	0.7	0.9	8.4	0.1	1.4	0.3	0.0		0.1	0.3	1.8	7.3	0.0	0.0	0.3	0.1	0.1	0.0	1.5	0.0	0.5	1.1	0.0	0.3	0.1	0.1	0.8	3.8	0.1	0.5	13.9	0.5	3.5	0.0	232.2	0.1	9.4	27.6	0.1	0.0	2.6	0.4	0.3	0.3	1.5	1.7	0.0	1.5	0.0	0.3	0.0	0.0	0.0	1.2	0.4	0.2	0.5	2.1	0.4	0.3	2.3	0.0	0.0	0.5	1.1	0.0	0.0	0.0	1.2	0.0	0.8	0.2	0.8	0.0	0.0	2.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.2	17.7	0.0	0.5	4.6	11.4	3.4	1.1	0.8	7.3	0.0	0.4	0.0	0.0	0.2	2.0	0.8	1.1	0.0	0.1	1.0	3.4	0.0	0.0	2.0	1.2	0.1	13.7	0.5	7.0	1.1	1.3	0.9	0.0	0.1	0.1	1.5	0.3	1.7	1.9	1.7	1.5	0.4	2.6	0.1	1.2	0.3	1.5	0.0	0.2	0.6	0.0											0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0
HIST1H2BN	"H2B/d, H2BFD"	ENSG00000233822	"Histone cluster 1 H2B family member n"	Q99877	6	27837760-27865798	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	13	"lymphoid tissue: 193.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 27.8;Rod photoreceptor cells: 26.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 14.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 8.9;SCLC-21H: 9.8;U-266/84: 9.2"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	2.4	7.2	2.3	14.0	3.3	9.3	3.1	4.9	6.2	3.4	4.5	1.0	4.4	1.8	3.4	3.7	7.6	3.2	3.7	6.4	3.7	2.4	2.3	5.3	5.4	8.0	4.1	4.2	5.0	8.3	4.2	3.8	4.5	1.4	4.0	2.5	1.7	3.3	4.7	4.6	2.3	4.3	2.5	9.4	7.0	2.4	6.8	0.5	193.3	6.1	6.2	10.9	3.6	2.2	6.0	6.2	14.6	2.6	1.0	2.8	1.4	1.4	0.2	1.5	1.5	1.2	2.0	0.9	0.7	1.1	0.7	0.8	0.5	0.9	0.8	3.0	0.7	0.9	2.1	1.3	0.5	0.3	1.5	4.5	0.7	3.7	1.4	1.4	1.0	3.7	1.3	0.4	0.1	1.3	1.1	0.2	1.4	8.9	7.0	0.8	1.8	2.9	4.5	1.4	1.2	1.0	2.1	1.0	5.3	0.4	0.9	9.8	2.0	3.5	1.3	3.0	1.0	2.5	0.8	1.5	2.2	2.1	1.2	0.7	6.1	9.2	3.6	0.7	1.7	0.7	2.3	2.6	1.7	2.6	2.4	1.8	5.8	2.0	1.9	5.0	6.0	1.3	1.2	14.6	1.0	1.8	6.2	2.8	1.4	2.3	3.3	4.9	6.2	3.7	2.4	4.1	4.2	1.4	0.5	0.0	3.2	20.4	5.8	0.9	7.5	2.3	0.0	5.3	2.3	0.0	2.0	9.8	1.7	0.1	3.8	2.7	27.8	0.0	0.7	3.9	3.3	5.0	3.5	1.7	9.0	6.4	4.1	1.8	4.3	0.9	2.8	4.9	6.8	1.0	10.0	15.8	0.8	7.0	1.8	2.0	26.9	0.0	8.3	0.9	2.1	2.0	4.2	20.0	5.2	1.7
HIST1H2BO	"H2B.2, H2B/n, H2BFN"	ENSG00000274641	"Histone cluster 1 H2B family member o"	P23527	6	27893463-27893843	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 164.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 29.4"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.89e-4)"	1.9	0.4	0.0	14.9	0.0	8.1	1.5	0.0	0.0	0.9	3.9	0.0	0.0	0.9	0.6	1.6	9.9	0.0	0.7	1.5	0.0		0.3	0.5	2.6	7.4	0.0	0.0	0.0	0.0	0.7	0.0	4.4	0.1	0.3	1.5	0.0	1.2	0.0	0.3	1.5	2.1	0.1	0.5	8.1	0.7	1.4	0.0	164.5	0.0	7.1	15.4	1.1	0.0	2.6	2.2	6.5	0.8	1.3	1.7	5.5	2.2	2.9	1.5	4.4	0.7	0.0	2.7	0.8	0.1	5.5	5.4	1.1	1.3	2.6	1.9	0.2	1.2	2.3	2.5	0.5	0.7	1.8	1.9	1.7	4.5	1.7	0.0	0.2	1.1	0.3	0.0	0.4	0.5	0.1	1.4	2.1	6.5	7.3	0.2	0.5	11.2	9.4	1.7	1.7	2.2	6.5	1.5	4.9	0.9	0.3	6.3	1.3	4.7	1.2	0.7	0.5	2.0	0.2	0.0	1.5	0.3	1.7	2.0	8.1	29.4	7.5	0.9	9.5	0.7	1.3	0.3	3.8	0.8	0.6	1.1	1.4	0.8	1.7	2.2	2.6	0.5	0.5	6.5	1.3	0.8	1.7	1.4	5.5											0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0
HIST2H2AA3	"H2A.2, H2A/q, H2AFO, HIST2H2AA"	ENSG00000203812	"Histone cluster 2 H2A family member a3"	Q6FI13	1	149842188-149842736	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 67.4"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 76.9;Ciliated cells: 64.3;granulocytes: 22.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.8;U-266/70: 96.9;U-266/84: 53.8"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.41e-2)"				"unprognostic (3.79e-1)"					"unprognostic (1.53e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.20e-1)"				6.1	2.7	3.7	6.8	3.7	67.4	7.8	3.7	5.4	10.1	4.0	3.7	3.7	4.2	3.7	3.7	6.5	5.4	5.0	4.5	3.7	1.6	5.6	9.9	14.6	4.4	3.7	3.7	5.1	3.7	0.4	3.7	8.9	3.7	35.8	1.7	3.7	22.4	3.7	4.5	11.7	3.7	3.7	8.0	12.8	9.6	11.2	3.7	18.9	3.7	3.7	5.4	3.7	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.6	0.0	5.3	2.5	3.6	3.0	0.0	1.0	1.5	3.8	2.3	0.0	0.9	0.3	1.1	0.4	2.5	0.0	0.7	7.0	0.9	2.4	0.0	0.7	11.8	2.0	0.9	1.0	0.0	0.9	0.0	7.8	19.8	1.2	0.0	0.0	5.9	0.0	2.9	4.2	0.8	0.0	7.4	1.4	1.8	0.0	0.0	6.7	0.0	0.2	0.0	5.2	2.0	2.0	0.7	8.9	0.0	0.5	96.9	53.8	2.1	5.6	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.7	3.7	5.4	3.7	1.6	3.7	3.7	3.7	3.7	17.9	76.9	0.0	7.4	10.5	0.0	2.8	0.0	64.3	13.6	1.8	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.1	2.8	4.2	22.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.3	10.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.2	13.7	1.8	1.9	0.0	4.1
HIST2H2AA4	H2A/r	ENSG00000272196	"Histone cluster 2 H2A family member a4"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 164.8;lymphoid tissue: 101.1"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 2: 89.0;Ciliated cells: 155.2;Club cells: 42.1;granulocytes: 40.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Cell type enriched"	"Detected in all"	5	"neutrophil: 164.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 164.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 27.3;U-266/70: 68.1;U-266/84: 60.4"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				4.5	6.5	0.0	9.8	1.2	9.0	2.5	0.3	2.6	5.2	5.7	1.5	2.5	5.7	5.5	3.4	9.1	2.4	4.2	4.0	0.7		3.0	2.5	8.8	7.1	0.1	0.0	4.3	5.0	0.0	0.5	6.5	1.6	9.5	0.0	2.1	4.2	2.6	3.5	5.8	5.4	0.9	0.8	8.4	4.2	21.6	0.1	101.1	1.9	4.8	11.5	5.8	2.3	9.3	17.2	164.8	17.9	3.5	4.2	18.8	3.8	9.7	1.3	2.2	0.0	1.2	3.1	8.2	0.0	0.0	0.0	6.6	3.9	0.0	9.3	0.0	2.6	5.3	0.0	0.0	0.0	5.3	12.8	1.2	8.0	4.3	0.0	1.2	7.5	0.0	0.0	0.0	0.0	2.3	0.0	4.4	8.3	19.7	0.0	24.7	4.2	1.2	3.7	21.0	10.2	3.7	1.5	6.7	0.0	2.0	9.8	4.1	27.3	7.5	2.1	1.3	13.0	2.7	0.0	2.7	20.9	3.8	1.0	68.1	60.4	4.6	0.0	6.2	3.1	24.2	17.9	32.8	3.2	10.5	3.3	5.9	2.8	3.0	12.0	9.3	2.2	2.0	164.8	3.5	12.4	17.2	4.2	18.8											23.8	89.0	0.0	6.7	0.0	0.0	22.0	0.0	155.2	42.1	3.5	0.0	0.3	0.0	0.6	1.5	0.0	0.0	0.0	0.3	0.2	0.3	5.6	40.7	1.6	0.9	0.0	0.0	0.0	0.6	1.0	0.3	0.7	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	2.2	0.9	0.1	4.8
HIST2H2AC	"H2A, H2A/q, H2AFQ"	ENSG00000184260	"Histone cluster 2 H2A family member c"	Q16777	1	149886975-149887364	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 47.7;bone marrow: 86.5;lymphoid tissue: 80.6"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"MCF7: 45.3"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.50e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (1.20e-10)"	"unprognostic (1.42e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.86e-5)"	10.5	8.5	4.2	6.5	4.2	86.5	8.6	3.1	4.1	13.8	7.5	2.8	5.4	4.6	8.1	6.0	10.9	6.4	8.1	13.2	3.9	3.1	8.2	6.1	10.5	12.5	2.9	3.7	15.3	15.8	3.6	7.6	8.4	2.3	10.6	4.3	13.8	6.0	10.1	7.2	10.1	6.4	9.7	7.6	10.7	5.8	4.9	2.4	80.6	6.0	8.1	10.5	16.2	8.9	15.8	11.6	47.7	15.9	7.9	11.0	10.8	2.6	3.2	3.7	11.2	0.0	0.6	5.5	0.7	0.9	1.8	2.7	1.9	0.7	5.5	0.1	0.2	0.3	1.2	0.2	1.2	0.0	0.3	4.4	1.3	0.4	9.4	0.0	3.2	2.9	0.7	0.2	0.1	0.4	0.1	1.3	1.4	1.1	6.7	0.4	45.3	3.8	3.2	4.8	3.1	7.8	1.2	1.5	1.0	0.7	1.9	1.1	5.2	1.5	0.8	2.5	0.3	0.4	3.2	1.1	0.8	7.4	1.4	1.9	3.1	1.9	2.8	2.0	4.4	1.6	17.0	15.9	8.1	11.0	10.6	10.0	6.2	9.7	8.7	8.1	15.8	6.8	6.7	47.7	7.9	10.6	11.6	7.3	10.8	4.2	4.2	3.1	4.1	3.9	3.1	2.9	3.7	2.3	2.4	6.0	6.4	11.2	15.2	3.3	9.8	1.6	7.6	2.7	5.7	1.8	9.8	4.0	8.3	12.0	3.7	6.8	8.0	46.7	11.6	15.4	4.3	7.6	8.1	6.4	8.1	7.9	9.1	6.2	7.6	2.1	7.5	12.4	3.3	19.0	6.1	13.7	11.0	4.3	6.0	3.9	14.1	0.0	6.2	0.4	1.6	5.5	7.3	11.7	6.3	11.2
HIST2H2BE	"H2B, H2B.1, H2B/q, H2BFQ"	ENSG00000184678	"Histone cluster 2 H2B family member e"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.1"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 128.7;Syncytiotrophoblasts: 134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.3;U-266/70: 40.5;U-266/84: 21.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	14.3	16.2	9.8	22.2	10.0	19.4	16.9	17.2	14.0	31.3	9.0	11.2	10.5	6.4	18.5	24.9	25.5	13.3	9.6	51.1	13.1	10.1	12.5	10.2	27.5	24.5	12.4	8.7	28.0	13.4	5.8	15.4	17.2	8.5	72.8	7.6	19.4	24.1	15.3	43.1	33.5	8.6	18.8	18.2	22.0	17.5	9.3	11.6	198.1	12.1	12.4	25.3	27.2	33.8	2.3	4.5	29.9	5.5	0.7	1.2	5.1	1.1	1.1	1.9	0.4	10.3	2.8	0.9	4.1	2.7	1.7	0.5	0.4	1.8	0.2	1.1	3.6	2.4	4.5	1.5	0.7	0.9	1.4	1.2	0.3	4.6	0.8	3.2	0.3	5.4	9.4	3.4	0.7	2.8	2.1	0.5	1.7	4.9	24.3	2.1	6.9	1.2	2.1	1.2	9.4	2.5	1.5	0.7	5.5	1.6	0.9	13.1	2.1	14.1	1.9	1.0	4.8	10.0	0.9	0.7	1.3	14.7	0.9	0.3	40.5	21.7	1.1	1.7	1.5	0.8	8.4	2.1	3.8	0.7	3.2	1.2	0.8	0.9	1.1	1.6	2.3	1.2	1.1	29.9	0.7	5.5	4.5	1.0	5.1	9.8	10.0	17.2	8.5	13.1	10.1	12.4	8.7	8.5	11.6	8.9	11.7	10.4	57.7	5.4	47.2	56.8	2.5	12.0	5.7	34.9	21.6	22.3	23.2	13.5	1.1	4.5	15.3	23.3	5.9	10.4	14.1	128.7	10.5	5.9	22.3	20.6	53.7	8.6	11.0	0.0	4.6	16.7	18.6	4.6	18.8	12.9	8.3	21.0	0.4	8.8	32.5	0.0	9.8	0.5	6.1	11.8	134.0	22.4	9.0	59.1
HIST2H2BF		ENSG00000203814	"Histone cluster 2 H2B family member f"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 117.6"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 21.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 21.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 32.1"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	5.6	17.7	3.9	14.9	3.5	3.7	7.1	8.5	5.6	17.4	3.8	3.7	3.2	1.5	5.6	6.2	7.1	7.9	3.6	12.1	3.4	2.4	5.0	4.2	14.6	27.5	3.2	3.8	24.2	6.2	2.6	4.4	5.1	3.2	16.7	2.5	3.5	3.7	5.5	1.2	10.9	3.4	6.0	7.7	12.7	7.9	5.9	3.1	117.6	4.4	6.3	16.7	6.1	21.5	2.0	0.8	21.7	1.1	0.6	0.8	0.2	0.4	0.6	0.6	0.6	4.6	3.1	0.3	7.9	4.1	6.0	5.3	0.3	2.2	0.4	0.6	4.5	5.2	1.3	0.1	0.5	4.7	1.2	0.9	0.4	1.5	0.0	6.7	0.2	1.8	5.5	0.0	7.8	1.9	1.7	3.4	0.3	1.2	2.4	0.8	0.9	3.1	3.8	0.4	4.1	1.0	0.3	1.1	0.7	2.9	0.4	2.7	7.3	4.2	3.5	0.3	0.7	1.3	9.8	1.4	1.5	0.0	11.5	2.0	32.1	1.0	1.3	5.3	0.3	3.4	0.0	1.0	0.2	0.6	0.8	0.7	0.6	0.8	0.3	0.8	2.0	0.4	0.3	21.7	0.6	1.1	0.8	0.2	0.2	3.9	3.5	8.5	5.6	3.4	2.4	3.2	3.8	3.2	3.1	0.0	0.3	2.2	6.9	0.3	6.0	1.7	0.0	4.0	1.2	1.8	2.0	1.5	3.3	1.0	0.9	0.4	5.1	0.0	0.3	1.2	0.9	16.2	0.0	0.6	6.7	4.8	3.4	2.5	4.9	1.4	2.6	2.9	0.0	1.8	2.7	6.6	0.7	2.9	0.0	0.5	0.9	6.5	1.5	0.2	0.4	0.5	4.3	4.9	1.8	5.7
HIST3H2A	MGC3165	ENSG00000181218	"Histone cluster 3 H2A"	Q7L7L0	1	228456979-228457873	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 35.8;lymphoid tissue: 62.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 35.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 18.7;SCLC-21H: 15.8;U-266/70: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (3.65e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.76e-2)"	2.5	20.5	4.3	7.0	8.3	11.1	5.8	35.8	8.1	9.9	3.8	2.4	2.0	7.7	5.0	4.4	7.0	4.2	3.8	4.9	5.4	4.6	1.6	1.0	2.5	5.1	5.6	5.3	8.3	4.5	3.5	5.0	3.4	6.5	7.0	2.8	13.9	6.6	3.9	1.0	6.4	4.2	1.5	5.2	6.6	4.7	3.5	4.8	62.3	1.9	5.6	9.3	2.9	9.3	3.4	3.4	5.1	7.1	6.8	11.7	4.3	3.6	1.9	2.6	3.5	2.1	2.2	3.1	1.8	1.7	5.2	3.6	1.9	3.0	1.6	2.2	0.4	0.0	8.9	1.8	0.8	1.2	2.6	18.7	2.6	2.5	0.0	5.0	1.8	5.2	4.8	5.3	1.0	2.2	2.1	2.2	3.4	9.0	0.0	0.0	5.1	2.3	0.0	3.9	2.1	4.8	0.0	0.0	13.6	0.8	2.2	15.8	11.1	6.3	5.6	12.1	0.4	9.9	1.3	0.8	0.0	0.0	7.0	1.6	18.8	13.4	0.0	1.8	1.8	1.3	5.1	1.7	0.0	7.1	3.1	5.1	3.4	6.8	5.3	3.4	2.0	5.3	5.2	0.7	6.8	7.1	0.6	11.7	4.3	4.3	8.3	35.8	5.9	5.4	4.6	5.6	5.3	6.5	4.8	0.0	0.3	7.5	21.8	1.1	18.2	5.5	5.1	18.7	13.6	3.5	45.2	11.8	6.6	3.3	0.6	1.0	6.0	23.3	2.7	9.5	3.1	30.8	13.9	0.0	23.0	39.7	35.1	1.3	8.0	1.1	19.2	14.3	3.3	25.2	26.6	24.1	9.7	17.3	8.1	1.1	6.4	0.0	4.6	0.5	2.7	5.1	45.0	41.5	17.4	32.1
HIST3H2BB		ENSG00000196890	"Histone cluster 3 H2B family member b"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 56.0"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 6.0;Cone photoreceptor cells: 5.9;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 12.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 18.5"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	2.0	4.7	1.2	12.1	3.1	2.8	1.3	12.8	3.2	8.9	1.3	1.1	0.6	2.1	1.4	2.0	4.1	6.2	1.7	2.2	1.5	2.2	1.3	0.9	2.1	5.4	1.2	1.5	1.6	1.7	1.7	2.0	1.5	4.1	2.2	1.5	3.4	2.0	2.0	1.8	4.8	1.7	1.2	6.2	4.5	2.4	2.1	0.7	56.0	1.7	5.9	11.8	2.0	7.9	1.5	1.1	3.4	1.5	1.1	0.9	0.5	0.2	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.5	1.0	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.1	0.0	0.4	0.2	0.1	0.0	0.3	0.4	0.1	0.4	0.3	0.2	0.0	0.0	0.8	0.0	0.2	1.5	0.5	1.0	0.4	0.3	0.1	3.7	0.1	0.1	0.0	0.0	0.5	0.1	18.5	4.4	0.0	0.2	0.1	0.1	1.7	1.0	0.5	0.5	0.5	0.7	1.3	0.8	0.9	0.2	1.5	0.9	0.7	3.4	1.1	1.5	1.1	0.7	0.5	1.2	3.1	12.8	3.1	1.5	2.2	1.2	1.5	4.1	0.7	6.0	0.0	0.0	1.2	0.1	3.8	0.8	0.0	4.0	0.0	0.0	5.9	0.2	1.7	0.0	0.0	0.0	0.2	23.3	0.0	0.1	0.0	0.5	0.0	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.7	2.9	0.0	0.3	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.3	0.8	2.5	0.4	0.5
HKR1	ZNF875	ENSG00000181666	"HKR1, GLI-Kruppel zinc finger family member"	P10072	19	37312837-37369365	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 102.1;Rod photoreceptor cells: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA036126, HPA044855"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA036126: AB_10670708, HPA044855: AB_2679113"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.92e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (4.41e-4)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	13.0	25.8	14.6	13.2	22.4	12.6	24.9	29.8	27.2	20.5	14.5	22.9	21.5	7.7	24.8	24.1	12.4	22.9	17.9	26.9	14.6	15.6	19.3	12.3	12.9	14.3	14.9	17.4	22.6	14.2	31.0	35.5	17.2	21.2	27.5	13.8	49.4	18.7	19.3	18.1	27.1	13.4	17.0	13.3	20.2	14.2	22.6	15.5	16.4	30.9	13.7	20.1	15.0	15.6	12.4	7.9	10.0	5.1	9.9	14.8	5.7	4.1	10.4	13.5	17.9	9.9	8.6	9.4	7.0	10.7	13.1	14.2	5.2	4.9	14.6	17.1	7.4	5.9	3.5	8.8	9.4	13.6	7.6	15.0	5.1	12.6	5.6	13.0	4.7	12.5	12.7	11.6	8.8	19.4	13.4	7.9	10.5	0.9	0.9	9.4	8.4	10.5	9.3	27.1	7.2	6.0	7.1	5.9	5.6	11.4	16.8	16.8	22.8	7.0	9.0	8.8	20.6	12.8	9.0	7.1	10.4	7.5	7.8	10.9	18.8	19.7	15.1	1.1	5.8	11.6	10.0	4.2	6.6	8.0	5.1	14.8	10.7	10.6	11.4	6.3	12.4	14.4	12.0	4.0	9.9	3.6	7.9	12.2	5.7	14.6	22.4	29.8	27.2	14.6	15.6	14.9	17.4	21.2	15.5	6.0	2.9	7.8	6.4	4.6	45.3	16.5	2.5	18.7	11.4	10.4	102.1	9.3	16.6	7.7	9.5	11.1	2.9	0.0	6.8	4.6	6.1	9.7	11.5	5.9	6.1	39.7	9.2	9.2	3.7	5.9	11.2	5.5	8.5	9.0	5.0	22.8	5.1	3.5	12.0	10.9	129.7	6.5	7.6	15.5	16.3	5.4	8.2	8.5	5.4	7.3
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	"P04439, P13746, P16188"	6	29941260-29945884	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 4504.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 158.0;fHDF/TERT166: 42.3;HBEC3-KT: 43.4;RPMI-8226: 41.2;U-266/70: 42.1"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	69.4	57.5	16.0	69.1	18.2	41.2	40.8	9.1	20.7	54.4	92.6	20.4	28.6	105.7	38.4	76.2	48.4	27.8	92.3	59.1	14.6	16.6	80.5	47.6	112.0	90.5	19.5	8.9	57.2	30.0	22.5	33.3	38.7	22.7	64.1	38.5	52.4	28.3	19.2	44.0	110.4	129.4	30.3	22.8	150.0	115.9	26.6	12.3	71.1	62.3	38.5	97.7	86.4	41.0	23.0	10.9	65.8	25.2	25.9	46.7	45.4	158.0	4.0	0.0	0.0	25.5	24.1	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.0	42.3	21.5	3.9	0.0	43.4	0.0	0.3	1.6	27.6	1.2	0.8	1.4	0.0	1.8	0.2	0.0	0.3	0.1	0.0	0.0	21.2	0.0	0.1	0.0	0.0	0.1	2.5	0.3	0.0	0.4	3.3	0.3	41.2	29.6	32.5	0.0	1.4	3.5	0.0	1.4	10.4	0.2	3.7	0.6	2.4	0.1	0.7	0.5	42.1	10.7	8.9	0.0	23.3	0.0	65.8	25.2	35.4	38.3	17.9	28.8	23.0	29.6	34.4	4.1	14.9	21.7	29.7	47.9	25.9	19.8	10.9	46.7	45.4	16.0	18.2	9.1	20.7	14.6	16.6	19.5	8.9	22.7	12.3	345.4	508.3	1064.2	718.5	760.7	31.3	128.4	937.6	317.2	366.3	478.1	5.9	16.7	74.6	2692.4	38.8	1227.5	2851.3	186.9	1168.0	15.8	685.4	823.3	585.8	217.5	1814.8	35.0	917.5	1170.5	1323.9	66.9	652.4	1239.0	602.3	4504.1	1496.2	150.9	1505.1	2283.0	455.0	258.2	20.0	549.7	859.0	132.4	24.5	828.4	26.5	2218.3	1070.6	1059.3
HLA-DMA	"D6S222E, RING6"	ENSG00000204257	"Major histocompatibility complex, class II, DM alpha"	P28067	6	32948613-32969094	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"B-cells: 394.3;Hofbauer cells: 370.5;Kupffer cells: 264.8;Macrophages: 648.8;monocytes: 269.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.1;intermediate monocyte: 4.0;memory B-cell: 6.8;myeloid DC: 7.9;naive B-cell: 7.0;plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	12	"B-cells: 7.0;dendritic cells: 7.9;monocytes: 4.1"	"Group enriched"	"Detected in some"	4	"U-266/70: 15.7;U-698: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012750, HPA017295"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA012750: AB_1853926, HPA017295: AB_2669575"	"unprognostic (1.69e-3)"	"unprognostic (3.52e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.99e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (7.01e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.14e-2)"	22.9	20.5	5.1	27.2	7.9	18.9	17.4	1.0	5.0	11.3	18.4	9.8	5.7	3.2	8.0	25.3	6.7	32.1	11.1	13.1	4.6	5.2	19.3	12.4	50.7	24.5	10.1	2.0	14.9	20.2	2.1	5.0	3.2	9.7	7.6	14.3	8.4	17.3	10.1	4.3	7.3	28.4	4.3	15.2	38.5	23.1	3.5	7.9	17.3	10.0	11.9	42.1	5.9	6.0	7.0	7.9	0.5	4.1	0.3	0.4	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.0	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.7	6.9	40.0	0.3	0.0	0.0	0.0	4.1	0.4	0.2	4.0	0.0	6.8	0.1	0.3	7.9	7.0	0.1	0.2	0.5	0.3	1.1	5.7	0.4	3.1	5.1	7.9	1.0	5.0	4.6	5.2	10.1	2.0	9.7	7.9	68.5	147.1	394.3	13.3	42.8	1.6	3.6	50.9	37.5	51.2	50.6	2.0	3.8	14.9	38.3	2.8	85.6	22.0	23.3	46.1	3.5	19.8	18.9	40.4	2.9	370.5	0.0	2.9	32.5	264.8	4.3	15.0	648.8	75.9	269.7	18.9	4.1	34.9	15.3	17.7	36.3	0.8	19.4	18.6	3.6	4.4	36.6	3.3	44.0	22.6	27.6
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075926-33087201	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"	19	"B-cells: 1312.2;Hofbauer cells: 1159.7;Kupffer cells: 1265.6;Macrophages: 2334.4;monocytes: 5192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 90.1"	"Group enriched"	"Detected in all"	8	"B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6"	"Group enriched"	"Detected in some"	6	"HDLM-2: 47.2;REH: 22.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		730000	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	29.6	31.9	9.8	52.8	15.1	6.9	22.0	6.1	7.7	15.5	11.8	14.9	6.9	14.4	15.3	23.4	9.8	11.0	26.6	29.6	9.7	10.4	25.5	12.4	79.9	99.4	23.5	6.0	10.8	10.5	4.3	11.5	6.2	19.6	19.4	6.6	22.2	25.0	15.4	6.1	14.8	33.7	8.9	35.3	88.8	15.8	4.3	16.2	51.9	14.2	20.7	69.3	35.5	11.9	57.8	90.1	1.1	40.6	2.8	7.6	23.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.1	0.0	0.0	0.0	0.0	47.2	2.2	1.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	22.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	6.0	0.1	3.9	0.0	0.0	0.0	0.2	18.7	1.1	5.3	40.6	0.7	57.8	1.9	7.6	90.1	56.9	0.7	4.2	0.4	2.8	17.0	25.7	7.2	23.5	9.8	15.1	6.1	7.7	9.7	10.4	23.5	6.0	19.6	16.2	62.5	286.9	1312.2	21.4	267.0	12.2	9.3	73.9	46.8	77.3	27.9	15.7	5.1	3.3	33.6	3.2	238.9	10.6	0.0	13.0	4.7	50.0	41.9	61.1	5.5	1159.7	7.9	9.2	88.4	1265.6	4.0	25.3	2334.4	307.1	5192.2	12.2	24.1	8.0	4.0	19.8	36.3	19.2	45.3	33.2	1.2	5.9	203.9	7.6	173.0	6.5	13.9
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 74.6"	"Group enriched"	"Detected in many"	4	"B-cells: 690.1;Hofbauer cells: 446.2;Macrophages: 1016.1;monocytes: 1484.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.8;intermediate monocyte: 24.1;memory B-cell: 30.9;myeloid DC: 68.2;naive B-cell: 35.6;plasmacytoid DC: 21.4"	"Group enriched"	"Detected in all"	6	"B-cells: 35.6;dendritic cells: 68.2;monocytes: 27.8"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 114.5"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	23.9	10.0	3.5	40.4	3.0	9.0	17.0	1.0	4.9	11.0	18.8	8.8	4.5	0.0	9.9	42.6	9.6	8.0	21.7	12.7	4.1	5.3	35.4	9.9	61.2	61.1	6.1	4.2	6.3	4.0	0.0	9.2	4.0	7.9	11.3	10.7	13.5	11.8	5.6	7.8	12.4	27.6	4.6	15.5	74.5	32.7	4.6	2.9	63.5	13.3	7.9	74.6	37.9	7.4	35.6	68.2	4.6	27.8	1.5	7.1	31.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.4	0.0	0.0	3.7	0.0	3.7	0.0	114.5	2.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.6	2.1	0.0	0.0	0.1	0.1	0.0	13.7	0.3	12.6	9.5	0.0	0.0	0.0	27.8	4.6	2.4	24.1	1.1	30.9	1.2	3.7	68.2	35.6	0.0	1.1	1.9	1.5	6.6	21.4	7.1	31.9	3.5	3.0	1.0	4.9	4.1	5.3	6.1	4.2	7.9	2.9	38.7	182.5	690.1	8.0	79.8	4.8	2.5	22.9	21.4	40.9	17.4	9.8	1.7	6.6	16.1	13.8	55.5	8.1	0.0	17.6	1.9	15.3	7.5	36.0	0.9	446.2	0.0	21.9	12.3	206.1	4.7	6.1	1016.1	92.8	1484.2	9.0	1.0	19.0	5.8	9.2	15.4	1.7	6.5	4.2	2.1	2.1	58.1	2.5	41.5	4.1	32.4
HLA-E		ENSG00000204592	"Major histocompatibility complex, class I, E"		6	30489467-30494205	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Endothelial cells: 1478.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.2;U-266/70: 35.8"									"CAB024589, HPA031454"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB024589: AB_324025, HPA031454: AB_2673891"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.42e-3)"	81.4	19.4	12.6	42.9	16.9	81.7	49.9	6.5	14.9	37.6	32.7	23.2	15.5	2.1	41.2	30.6	40.1	28.2	44.0	36.7	15.1	13.3	34.8	56.5	129.7	76.7	19.9	10.5	29.1	14.6	33.9	11.6	33.1	24.9	32.2	28.6	33.9	23.1	27.5	34.8	97.2	36.8	22.9	21.7	97.1	50.5	18.1	14.6	35.0	45.7	36.4	72.4	45.9	33.3	23.0	7.8	90.2	28.9	23.2	37.1	56.3	11.3	1.8	0.7	6.7	25.2	20.0	0.0	0.0	0.0	0.0	0.0	4.7	23.1	7.4	11.5	10.1	19.8	14.0	1.5	5.8	0.0	7.5	4.8	8.8	2.2	0.0	0.0	0.0	3.2	15.7	10.9	8.0	0.0	0.0	0.0	4.8	1.1	0.1	6.0	0.0	0.0	0.0	0.0	3.8	0.0	1.6	0.0	9.7	10.2	6.4	0.0	0.5	7.8	6.2	0.0	0.1	0.0	15.1	11.2	7.1	0.0	0.0	1.4	35.8	20.4	2.9	0.0	6.7	18.6	56.6	14.0	52.5	37.0	24.6	31.5	23.0	28.1	37.1	7.8	22.5	28.5	28.4	90.2	23.2	28.9	6.6	29.4	56.3	12.6	16.9	6.5	14.9	15.1	13.3	19.9	10.5	24.9	14.6	288.8	451.7	691.8	327.5	430.6	2.0	80.3	247.1	216.8	225.2	116.9	5.9	69.1	14.9	371.5	3.5	1478.5	407.9	46.7	585.9	231.5	281.0	321.3	504.0	75.0	648.8	4.8	207.4	1236.3	939.1	5.9	122.3	661.4	442.1	534.8	437.5	90.5	562.6	382.2	71.8	70.5	5.3	174.6	453.2	9.2	3.3	372.8	300.2	1180.5	194.8	500.2
HLCS	HCS	ENSG00000159267	"Holocarboxylase synthetase"	P50747	21	36750888-36990236	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017379	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA017379: AB_1850768"	"prognostic unfavorable (7.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.02e-1)"	6.3	9.6	7.1	9.8	10.3	2.9	10.6	12.2	8.5	7.7	7.2	10.3	12.1	5.7	6.4	9.4	7.1	8.1	9.9	5.3	8.4	8.0	9.1	16.4	6.7	5.8	10.2	6.0	5.5	15.6	23.3	23.9	9.9	9.4	12.8	6.4	11.7	9.9	11.6	13.5	4.3	8.1	7.3	10.6	4.5	7.6	7.7	5.1	4.9	14.3	6.1	8.0	9.2	4.9	3.9	5.3	3.2	10.0	8.5	7.8	2.9	18.0	6.7	10.1	7.3	12.1	11.0	9.9	11.0	10.6	5.0	5.6	7.2	8.5	9.8	5.3	15.9	10.4	6.2	5.1	8.4	4.5	19.5	10.5	14.5	6.6	4.6	14.4	7.8	7.5	8.7	13.0	7.6	20.3	9.6	6.3	9.6	15.6	25.1	12.7	10.9	3.5	3.6	15.8	12.4	9.4	6.1	5.8	7.9	7.8	18.2	7.1	7.4	14.5	6.7	11.1	8.3	11.8	8.0	8.5	7.3	2.2	6.6	6.0	24.3	14.9	6.1	10.5	9.8	8.4	3.2	2.1	1.6	7.8	4.0	6.1	2.6	4.5	5.2	2.0	3.9	5.4	5.5	2.7	8.5	10.0	5.3	2.7	2.9	7.1	10.3	12.2	8.5	8.4	8.0	10.2	6.0	9.4	5.1	8.9	12.2	0.5	8.0	3.0	12.5	3.2	15.3	6.7	9.1	12.2	21.6	6.8	6.6	6.7	4.4	2.2	4.0	0.0	6.9	4.9	3.0	9.1	5.7	14.9	3.9	17.5	5.8	4.3	3.1	2.9	4.0	3.4	0.0	3.6	6.5	6.3	7.2	2.9	6.7	5.6	13.6	0.0	6.4	4.4	8.7	3.4	4.2	2.5	5.2	5.4
HLX	"HB24, HLX1"	ENSG00000136630	"H2.0 like homeobox"	Q14774	1	220879400-220885059	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 23.3;Hofbauer cells: 27.0;Ito cells: 38.6;monocytes: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 25.8;neutrophil: 28.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 13.5;THP-1: 47.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA005968	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA005968: AB_1079066"	"unprognostic (6.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.28e-6)"	"unprognostic (8.44e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	27.7	3.0	2.7	8.8	3.0	54.0	18.4	0.9	2.3	5.7	24.3	2.0	3.8	4.5	7.4	3.6	8.7	5.0	7.5	15.2	3.3	0.9	4.0	11.5	14.3	10.5	6.2	0.3	4.9	4.9	1.8	2.0	14.0	2.5	6.9	2.4	4.2	2.3	3.8	10.4	5.7	11.1	4.2	6.4	10.9	3.1	3.9	3.1	1.4	6.3	3.0	3.2	10.4	12.9	2.2	5.5	28.5	6.3	0.2	0.1	1.8	0.0	1.9	0.0	1.4	4.3	6.9	3.6	5.2	8.6	6.0	5.0	0.4	0.1	0.0	0.1	3.2	1.1	0.0	1.1	0.0	2.5	1.3	3.8	0.0	2.2	0.2	7.6	1.7	0.4	8.0	0.2	6.7	0.4	0.5	2.6	0.0	2.2	0.0	0.8	0.0	0.0	6.2	0.2	0.0	3.6	0.1	4.1	0.0	0.6	0.0	0.0	2.0	0.7	0.1	13.5	0.3	0.0	47.4	0.8	4.0	0.0	0.6	4.1	0.0	0.0	0.0	6.5	5.4	1.6	25.8	6.3	10.7	0.0	1.8	0.0	2.2	0.0	0.0	5.5	1.1	0.0	0.0	28.5	0.2	0.3	3.5	0.1	1.8	2.7	3.0	0.9	2.3	3.3	0.9	6.2	0.3	2.5	3.1	8.9	7.7	1.5	0.1	2.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	11.7	0.0	23.3	0.3	0.6	4.6	0.1	3.5	6.7	27.0	0.0	0.0	38.6	17.7	0.0	2.3	17.3	0.0	67.7	0.0	0.0	0.2	0.0	1.4	0.0	0.0	6.5	9.5	0.1	1.0	2.8	0.3	0.0	0.0	0.1
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.2"	"Cell type enriched"	"Detected in many"	16	"Erythroid cells: 794.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		NA	NA		28000000	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: AB_2681206"	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	5.5	11.0	5.3	6.2	9.3	75.2	8.6	5.2	8.0	5.5	8.3	6.0	6.0	7.9	6.9	7.9	9.4	5.5	6.4	11.5	5.9	5.5	9.9	22.2	5.8	14.5	8.8	4.5	3.7	21.2	7.9	5.9	9.7	8.4	5.5	9.2	4.1	10.1	7.2	17.4	6.0	7.9	6.8	9.7	10.4	7.1	7.4	7.5	6.0	8.4	13.0	9.3	5.7	4.8	7.7	19.1	12.0	14.0	3.8	7.4	9.4	9.2	14.1	6.8	12.0	5.4	6.8	10.2	7.4	8.3	10.9	9.4	17.5	14.7	14.3	16.6	9.4	10.3	13.2	10.1	14.4	7.0	9.8	10.4	23.6	5.7	12.8	10.1	8.8	7.7	7.4	9.2	17.2	13.2	4.8	5.0	13.5	34.9	6.4	8.6	37.2	8.5	17.0	7.6	17.1	9.0	9.9	6.7	14.0	11.0	8.5	7.5	10.2	5.9	9.3	6.5	5.1	15.9	12.2	4.7	8.3	6.3	8.1	8.6	3.5	4.1	8.5	5.5	11.6	9.8	12.0	14.0	1.4	5.1	12.2	6.7	7.7	4.8	5.7	19.1	7.2	7.4	5.6	0.4	3.8	7.3	12.3	4.9	9.4	5.3	9.3	5.2	8.0	5.9	5.5	8.8	4.5	8.4	7.5	8.9	7.0	9.3	7.6	7.0	4.7	12.6	7.6	10.7	4.5	10.4	25.5	50.1	16.6	18.3	1.2	4.9	8.5	794.3	27.0	50.5	8.4	10.8	2.3	20.2	25.6	9.5	12.7	6.7	10.8	1.8	5.5	10.1	13.5	15.4	15.5	5.7	19.8	8.6	8.1	18.1	24.3	0.0	8.2	1.1	24.4	7.0	19.5	4.1	27.6	5.9
HMCES	"C3orf37, DC12, SRAPD1"	ENSG00000183624	"5-hydroxymethylcytosine binding, ES cell specific"	Q96FZ2	3	129278828-129306186	"Predicted intracellular proteins"	"DNA damage"	"DNA-binding, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044968	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044968: AB_2679160"	"unprognostic (9.18e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.16e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.08e-3)"	16.4	10.8	15.9	29.8	23.1	15.1	15.2	19.2	22.8	13.2	16.3	9.3	18.1	13.3	13.4	11.8	19.6	12.8	13.9	27.9	13.6	16.7	13.1	24.6	12.5	42.6	14.9	18.6	14.4	7.3	62.2	11.2	10.5	14.4	12.7	14.8	12.2	13.0	13.0	24.9	16.2	13.2	15.5	10.4	14.4	11.9	17.8	9.7	36.5	14.3	14.3	57.5	12.8	15.1	33.3	14.9	32.9	19.7	13.3	24.4	15.5	33.6	15.2	17.5	20.2	21.8	9.0	15.8	11.9	9.6	17.3	13.5	23.8	15.9	65.4	12.9	10.6	13.5	24.7	22.1	25.5	20.1	13.1	11.8	13.5	12.3	16.9	9.4	11.7	10.0	8.6	13.3	14.4	14.2	8.4	10.4	14.6	13.6	57.8	9.5	44.5	16.7	10.1	11.3	24.6	9.9	15.0	15.0	11.4	18.2	20.2	17.5	10.8	26.5	16.7	16.1	11.3	28.5	11.9	8.4	8.7	15.3	20.7	15.2	32.2	19.0	65.8	10.4	9.5	9.6	14.8	13.8	32.9	17.1	14.2	17.7	19.1	20.9	20.1	13.8	33.3	20.8	22.7	27.7	13.3	19.7	14.9	24.4	15.5	15.9	23.1	19.2	22.8	13.6	16.7	14.9	18.6	14.4	9.7	29.8	24.6	19.3	61.1	51.7	17.8	29.9	35.7	14.7	10.3	21.0	9.8	34.4	31.5	32.8	6.8	25.4	21.3	23.3	41.3	29.6	19.4	28.9	21.9	24.3	17.4	25.4	20.2	17.2	6.9	7.8	22.7	20.3	55.6	19.8	13.3	37.7	25.1	17.5	29.4	15.1	10.3	12.9	33.2	68.2	65.8	38.3	29.3	37.3	28.7	50.3
HMCN1	"ARMD1, FBLN6, FIBL-6, FIBL6"	ENSG00000143341	"Hemicentin 1"	Q96RW7	1	185734551-186190949	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Cell division, Sensory transduction, Vision"		"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 8.2;Fibroblasts: 12.4;Horizontal cells: 25.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 14.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"T-reg: 3.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.5;hTERT-RPE1: 9.8;MCF7: 35.5;SK-MEL-30: 23.4;WM-115: 21.0"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"olfactory region: 22.1"	"HPA008220, HPA051677"	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		2000000	"Golgi apparatus, Cytosol"		"HPA008220: , HPA051677: AB_2681572"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.00e-3)"	14.9	1.3	1.0	4.8	2.5	0.0	10.9	0.4	1.7	9.8	8.4	0.8	0.5	0.8	5.9	3.0	12.0	1.9	6.8	13.4	0.9	0.9	2.2	7.9	23.9	2.6	1.3	0.2	4.4	1.1	0.1	6.2	7.7	2.0	8.4	2.9	8.1	7.8	1.3	4.4	4.0	3.7	4.5	1.8	13.1	1.9	2.4	0.4	0.5	3.3	15.8	6.1	3.0	4.3	0.0	0.0	0.3	0.0	0.0	3.0	0.0	0.1	0.0	0.7	0.0	2.3	2.3	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.9	0.1	10.5	0.8	2.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.3	0.0	2.7	0.2	9.8	1.3	0.0	0.0	0.0	0.0	35.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	23.4	2.2	0.0	0.0	0.0	6.7	0.6	0.0	2.4	0.1	0.0	0.1	1.3	0.0	21.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.0	2.5	0.4	1.7	0.9	0.9	1.3	0.2	2.0	0.4	3.0	6.5	0.0	0.2	2.9	0.7	2.3	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.6	12.4	0.1	0.0	1.5	0.1	25.4	0.0	5.5	0.8	1.5	3.4	0.0	5.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1
HMCN2	"DKFZp434P0216, FLJ23816"	ENSG00000148357	"Hemicentin 2"	Q8NDA2	9	130265882-130434123	"Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 15.6;Enterocytes: 21.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.2;RH-30: 19.2;SCLC-21H: 2.8;SH-SY5Y: 4.5;U-138 MG: 3.2;U-87 MG: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053903, HPA070647"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		7700000	Vesicles		"HPA053903: AB_2682301, HPA070647: AB_2686290"	"unprognostic (1.61e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (8.63e-2)"	7.4	1.7	0.2	10.2	0.2	0.1	3.8	0.1	0.4	18.3	25.0	0.0	1.0	5.9	21.9	25.1	4.9	5.1	5.0	8.7	0.4	0.4	1.4	0.4	2.7	2.3	0.0	0.0	8.9	0.8	0.2	0.1	0.3	0.8	5.1	2.3	0.1	1.7	3.4	24.3	2.8	11.2	20.8	0.5	0.3	2.3	6.3	0.0	1.8	2.6	10.9	1.5	12.1	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.2	0.5	0.0	19.2	0.1	0.0	0.1	2.8	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.4	0.4	0.0	0.0	0.8	0.0	3.0	6.9	0.5	0.2	0.8	0.5	3.6	0.0	6.7	6.8	0.0	0.0	0.0	1.7	0.0	15.6	1.3	21.5	0.0	0.0	0.1	2.4	0.7	7.0	1.1	0.3	1.6	0.0	0.6	0.3	8.0	0.0	0.9	1.7	0.0	1.9	0.0	0.1	7.0	0.0	1.1	0.6	0.0	3.8	0.2	0.7	0.5	0.2	0.0	2.9	3.3
HMG20A	"FLJ10739, HMGX1, HMGXB1"	ENSG00000140382	"High mobility group 20A"	Q9NP66	15	77420412-77485607	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008126	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008126: AB_1079072"	"unprognostic (2.04e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	12.5	17.5	19.7	14.7	27.3	8.6	13.0	24.7	28.8	16.8	14.0	21.0	12.6	11.6	20.7	12.5	12.9	12.8	14.3	22.9	18.5	19.5	13.2	22.3	14.3	21.6	17.3	16.7	21.4	11.8	14.2	21.5	19.8	19.8	11.9	16.0	19.4	12.4	13.5	31.9	12.0	12.4	15.1	17.4	31.2	12.0	18.7	14.7	30.5	15.1	10.3	19.6	16.9	13.7	17.7	16.1	9.4	13.7	27.6	21.2	13.8	7.6	12.5	24.1	16.8	10.1	12.6	9.6	10.2	15.2	12.2	13.4	7.7	11.7	13.0	11.9	11.6	9.3	10.5	33.8	12.9	12.5	11.6	16.5	27.0	11.1	10.1	15.0	19.6	16.2	14.0	9.1	10.6	11.9	15.9	23.9	17.1	20.1	11.0	10.6	5.6	15.6	12.6	17.3	6.7	6.0	20.6	23.3	14.6	13.6	13.4	9.4	20.5	16.4	10.1	30.6	24.1	9.7	20.5	15.0	14.2	12.8	6.7	12.3	15.0	31.9	26.1	11.0	28.1	17.0	4.6	12.4	9.4	18.1	12.1	21.2	17.7	14.2	16.7	16.1	16.0	19.2	17.2	2.2	27.6	13.7	12.2	13.2	13.8	19.7	27.3	24.7	28.8	18.5	19.5	17.3	16.7	19.8	14.7	11.9	7.8	11.5	5.2	7.8	19.1	33.9	20.4	1.4	11.4	10.4	23.6	12.0	5.0	8.8	21.4	15.8	8.5	23.3	7.0	7.7	12.4	4.3	12.7	28.8	14.0	36.5	17.2	25.2	32.4	61.1	11.8	12.6	13.5	19.0	17.1	16.2	8.0	14.0	13.1	7.7	19.4	19.4	7.6	21.3	13.7	6.5	11.6	11.5	11.4	4.7
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 784.6;Pancreatic endocrine cells: 1097.2;Urothelial cells: 1250.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB032200, HPA065612, HPA068442"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA		18000	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	15.8	3.5	14.8	35.7	13.5	55.4	13.0	13.8	19.0	26.1	22.0	5.9	7.7	42.3	8.6	7.2	79.4	15.1	17.8	13.0	11.7	12.6	14.6	6.9	16.0	46.1	10.7	8.7	3.9	13.0	4.1	5.1	31.8	12.5	8.7	21.2	9.9	22.0	6.9	33.7	38.3	36.0	3.8	8.4	31.6	24.2	32.6	7.2	107.3	12.5	39.6	72.7	13.0	29.6	26.6	33.4	12.8	10.1	7.3	22.4	11.0	121.6	48.2	24.7	17.2	11.5	85.4	108.0	49.2	56.3	38.2	21.3	31.5	85.4	57.4	24.8	20.1	24.0	26.1	29.1	87.7	30.4	12.5	19.5	17.6	16.2	42.1	24.4	62.8	20.3	36.6	9.8	69.1	36.1	98.7	115.2	32.8	70.8	2.9	53.1	12.3	54.4	77.4	120.4	60.7	81.6	80.9	0.5	63.3	25.8	11.2	43.2	18.3	5.2	25.0	45.4	40.8	10.0	67.4	99.8	19.9	62.8	28.9	46.0	23.6	36.5	74.1	42.1	26.2	99.3	6.2	10.1	12.8	10.2	10.1	13.3	26.6	18.7	16.0	30.7	16.4	22.4	17.7	2.6	7.3	9.4	33.4	21.0	11.0	14.8	13.5	13.8	19.0	11.7	12.6	10.7	8.7	12.5	7.2	26.8	23.7	124.5	686.8	384.1	27.4	24.5	38.2	10.7	36.4	38.4	3.9	784.6	39.7	243.5	6.1	27.0	148.7	46.7	242.2	663.0	71.9	750.7	66.8	10.6	337.7	11.1	112.2	16.0	59.4	17.5	5.2	107.5	86.0	66.7	165.5	27.9	1097.2	162.4	2.5	9.0	27.8	0.0	34.9	38.5	398.0	315.9	688.1	51.7	282.8	1250.0
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell type enhanced"	"Detected in all"	15	"Erythroid cells: 2616.4;Extravillous trophoblasts: 751.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 166.6;MOLT-4: 171.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	Yes		380000	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109"	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.9	8.4	72.2	32.2	9.0	9.0	27.7	26.1	19.9	28.8	25.8	23.7	48.8	118.3	5.9	14.5	15.4	13.7	47.3	14.2	45.0	72.4	22.1	130.0	21.2	34.7	8.8	115.0	50.2	8.7	4.3	14.4	32.8	15.7	29.5	62.9	49.0	166.6	26.3	29.2	171.4	106.6	26.3	20.9	14.6	86.7	37.1	43.9	16.5	15.0	62.5	56.4	26.3	15.3	11.7	26.4	21.2	83.9	16.9	12.9	38.3	15.9	39.1	53.9	30.1	135.4	11.0	84.1	33.6	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6	26.8	58.1	117.6	176.4	141.0	43.0	211.0	35.7	147.2	66.0	52.4	33.4	154.7	121.0	20.6	24.5	124.1	53.3	2616.4	14.4	751.8	109.8	81.7	104.4	22.2	176.6	42.9	71.7	149.1	275.5	29.5	97.5	149.6	64.1	109.2	104.0	79.8	10.0	83.9	54.1	36.3	129.5	77.6	96.6	461.9	435.2	117.1	107.7	264.5	185.0	64.8
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990775	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 54.3"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 337.0;Extravillous trophoblasts: 539.5;Syncytiotrophoblasts: 1171.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 108.8;U-698: 98.0"									HPA062583	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA062583: AB_2684800"	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	4.4	5.4	7.9	4.8	7.1	20.3	4.1	2.8	10.3	10.8	12.0	4.7	3.9	7.3	6.3	13.4	10.2	4.4	3.2	4.5	9.8	7.6	9.0	41.6	5.9	6.3	6.1	7.3	3.1	7.1	18.7	1.6	54.3	9.7	3.7	9.2	5.3	9.7	4.3	20.5	6.8	7.6	3.6	5.0	8.4	4.0	26.0	3.2	18.2	6.2	5.1	9.5	4.9	3.7	3.1	6.5	11.8	5.3	0.9	6.2	2.3	37.7	16.7	52.8	27.5	2.2	6.6	65.8	16.6	10.9	19.3	10.0	13.2	15.7	26.5	53.5	12.7	10.9	18.2	48.1	108.8	21.8	18.0	14.0	23.0	16.2	20.8	3.3	34.6	11.7	5.2	25.8	7.9	20.0	4.9	24.9	16.3	11.9	15.7	22.9	29.0	38.1	26.6	31.3	24.8	20.5	46.8	43.0	15.0	14.2	18.1	38.1	24.9	24.7	26.6	8.2	31.5	23.5	22.9	18.7	8.0	19.0	25.5	36.5	14.3	17.8	98.0	9.6	17.7	16.3	0.0	4.8	11.8	0.5	3.2	0.1	3.1	2.4	3.3	6.5	0.6	0.0	0.2	0.6	0.9	5.3	3.3	6.2	2.3	7.9	7.1	2.8	10.3	9.8	7.6	6.1	7.3	9.7	3.2	35.7	27.4	16.2	16.0	21.1	0.5	13.2	10.2	145.9	134.2	29.6	2.0	337.0	31.5	72.8	184.3	11.3	24.9	186.9	75.5	539.5	20.8	18.7	8.1	72.9	88.3	0.0	63.0	10.4	18.3	46.6	3.4	26.0	20.3	35.1	29.3	3.1	76.6	25.9	3.2	39.4	1.4	0.0	8.3	19.9	49.6	17.8	1171.0	14.0	52.8	17.0
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	26.6	57.2	53.6	22.9	52.7	18.8	37.2	73.1	84.6	26.1	28.3	22.6	28.4	27.7	29.9	55.4	29.0	66.8	26.4	68.6	53.3	33.4	52.5	44.6	34.4	35.5	70.8	36.1	34.9	27.8	38.7	66.8	35.4	53.0	27.4	23.5	28.0	47.4	30.6	41.8	24.8	22.3	33.0	53.2	27.7	31.0	24.8	63.5	21.9	36.1	37.9	32.8	26.1	25.6	28.0	52.3	7.7	38.3	32.8	29.4	36.4	14.3	13.1	45.9	19.8	18.5	15.2	10.4	10.0	10.8	11.2	16.5	73.2	12.2	0.1	18.6	8.1	15.0	9.2	29.8	11.3	11.1	42.3	25.0	50.7	41.0	38.1	11.8	41.4	7.7	18.4	12.7	7.4	4.1	10.9	25.0	10.8	29.6	40.6	18.1	13.1	19.0	80.1	33.6	12.5	32.9	32.6	70.1	14.7	77.1	21.0	18.7	25.1	19.1	22.0	14.1	42.2	12.5	70.0	10.9	3.1	13.7	10.8	22.1	35.0	51.6	0.2	1.7	0.1	15.0	7.7	38.3	3.2	29.4	36.2	25.5	28.0	20.6	24.6	44.8	23.2	24.3	29.2	1.8	32.8	33.3	52.3	21.9	36.4	53.6	52.7	73.1	84.6	53.3	33.4	70.8	36.1	53.0	63.5	89.3	143.6	96.0	158.6	151.9	231.2	376.3	186.0	619.7	254.8	230.3	70.7	769.9	510.6	171.3	36.2	149.3	30.7	0.0	172.6	615.0	191.6	116.6	106.3	217.9	268.2	184.3	262.2	186.6	174.4	27.1	173.2	154.2	244.6	542.8	88.7	204.1	113.5	63.1	157.0	607.4	113.5	142.3	169.0	21.1	50.0	131.0	464.4	124.6	105.7	145.7
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 151.8"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli		NA	NA			Nucleoli		"HPA005967: AB_1080044"	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	12.0	14.2	8.2	14.5	14.4	15.3	16.1	14.5	17.4	11.3	10.3	15.0	15.4	8.3	13.9	20.0	9.3	13.5	12.1	9.4	8.6	8.3	11.6	11.7	14.7	10.3	10.1	11.0	15.0	13.8	151.8	15.3	11.8	12.9	17.6	10.8	16.8	12.4	18.4	12.5	13.1	9.9	12.8	8.9	14.4	12.0	17.7	7.3	15.3	14.7	10.1	12.0	11.2	10.1	5.8	6.2	5.1	5.9	2.2	8.1	3.7	11.5	13.5	9.6	15.0	13.8	11.7	16.7	11.1	20.6	16.8	21.2	18.9	14.1	11.0	13.1	15.2	35.9	8.5	18.1	19.1	14.6	10.2	13.0	9.6	14.2	9.2	19.2	18.4	21.9	15.2	14.4	24.5	19.4	21.4	11.9	8.9	12.6	11.6	17.6	9.1	11.4	9.6	7.2	7.7	20.3	10.0	13.3	10.6	10.0	14.4	12.4	12.4	9.7	23.9	24.7	8.7	11.1	12.0	10.2	25.1	10.7	12.1	20.5	13.6	12.9	15.7	29.3	14.1	12.9	5.1	4.7	4.0	7.0	5.9	5.5	5.8	5.7	4.9	6.2	5.0	4.4	4.6	0.5	2.2	3.9	4.6	8.1	3.7	8.2	14.4	14.5	17.4	8.6	8.3	10.1	11.0	12.9	7.3	8.9	13.8	19.3	22.2	10.1	30.5	6.7	17.8	30.8	21.6	8.7	33.4	13.0	18.3	19.2	5.0	17.9	6.9	0.0	19.0	10.2	11.0	28.3	17.4	11.3	23.8	68.3	14.9	16.0	9.4	1.6	12.4	12.5	3.3	27.1	10.4	22.7	26.2	8.6	11.7	8.5	42.8	12.9	8.5	22.9	20.4	10.7	12.9	12.5	14.0	24.4
HMGXB4	"HMG2L1, THC211630"	ENSG00000100281	"HMG-box containing 4"	Q9UGU5	22	35257452-35295807	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000725, HPA076681"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000725: AB_1079073, HPA076681: "	"unprognostic (2.22e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.24e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (2.85e-2)"	"unprognostic (8.25e-3)"	"unprognostic (6.67e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.54e-2)"	13.6	11.6	11.4	11.4	17.6	28.6	13.6	17.4	15.1	14.4	10.9	17.2	9.5	10.6	17.4	8.4	14.4	14.5	10.8	9.8	10.0	8.6	8.6	8.0	10.2	10.5	14.4	13.8	21.7	10.9	9.4	7.6	20.2	12.4	12.4	12.2	8.7	11.9	12.7	17.2	14.4	13.1	15.0	12.6	10.0	10.3	12.1	16.9	20.0	10.6	10.2	11.6	14.8	13.5	11.8	9.4	22.6	12.5	7.4	13.1	4.7	13.1	2.9	20.6	10.3	5.0	9.9	5.9	13.7	18.0	13.4	12.5	2.2	4.9	15.8	6.1	13.5	8.5	8.1	8.9	9.6	15.6	13.8	10.0	14.5	3.9	2.9	6.8	30.4	14.8	9.0	8.4	11.2	8.6	8.1	9.2	12.1	11.3	13.1	9.9	6.0	18.3	7.3	9.5	9.1	8.8	14.7	19.4	5.5	7.5	9.7	13.0	12.8	12.2	8.9	9.8	6.8	6.1	9.5	8.5	12.2	27.0	14.1	11.2	14.1	13.7	19.7	10.3	9.3	17.3	22.6	11.1	13.8	12.6	12.5	10.8	8.9	12.1	13.1	8.8	11.8	8.1	9.2	16.8	7.4	11.5	9.4	10.1	4.7	11.4	17.6	17.4	15.1	10.0	8.6	14.4	13.8	12.4	16.9	11.9	14.4	20.9	45.0	18.5	60.2	11.2	38.2	10.7	25.0	26.2	33.4	42.1	24.9	34.2	7.5	26.4	25.5	23.3	25.8	44.6	29.1	49.7	52.9	21.9	26.9	63.5	16.3	35.6	29.7	7.7	49.8	31.0	8.5	24.4	24.8	21.2	29.9	24.5	53.4	18.1	66.1	38.8	27.8	50.4	77.1	19.7	54.1	24.1	26.6	46.9
HMOX2	HO-2	ENSG00000103415	"Heme oxygenase 2"	P30519	16	4474690-4510347	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 438.7;Late spermatids: 1517.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025464, HPA040611"	Supported		Approved	Vesicles,Cytosol		NA	NA		1200000	"Vesicles, Cytosol"		"CAB025464: , HPA040611: AB_10961034"	"unprognostic (3.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (2.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (9.87e-2)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.51e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.64e-1)"	19.4	19.2	32.1	15.7	50.7	13.6	16.6	19.7	38.6	13.3	17.9	22.9	12.2	23.5	11.9	18.7	36.6	15.6	19.7	57.2	29.3	22.0	32.2	39.7	15.8	20.8	27.3	35.1	12.5	22.4	20.6	14.7	12.5	36.5	12.1	19.9	8.6	16.0	10.0	20.1	16.6	19.3	16.6	27.2	23.3	29.7	48.1	28.2	8.7	13.8	16.7	25.3	16.5	15.0	14.5	14.5	48.7	8.9	18.7	35.8	25.8	24.9	10.7	6.3	13.8	19.1	9.8	10.6	17.3	8.5	14.7	12.8	13.5	17.0	11.6	19.4	15.8	10.3	15.2	20.0	37.0	16.7	14.8	13.6	8.4	10.3	18.3	12.9	18.2	14.4	15.3	12.4	17.0	12.5	12.3	26.9	14.0	13.6	5.9	13.5	31.0	15.0	14.3	9.7	24.1	10.1	16.0	11.2	24.3	20.4	16.5	10.8	6.3	13.8	29.3	18.6	12.6	18.2	10.2	26.3	8.3	12.3	35.6	8.8	7.3	9.0	25.6	5.3	15.1	10.5	13.7	7.4	48.7	35.2	8.9	29.9	14.5	32.7	35.8	14.5	13.0	31.7	32.7	26.1	18.7	6.5	8.2	30.0	25.8	32.1	50.7	19.7	38.6	29.3	22.0	27.3	35.1	36.5	28.2	32.8	46.9	52.0	27.0	48.7	27.1	59.3	33.1	30.8	38.7	34.9	19.6	64.6	109.5	72.8	438.7	41.7	76.2	0.0	78.6	57.9	43.8	31.4	19.6	78.8	59.5	27.0	30.5	66.3	24.7	1517.1	42.0	39.8	59.1	33.3	27.6	51.0	91.4	52.6	52.6	178.2	20.2	71.1	77.6	151.1	90.1	45.0	32.2	90.0	41.2	25.1
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135962-123137741	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;intestine: 5.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"hypothalamus: 6.8;pons and medulla: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;HEL: 5.6;HeLa: 5.1;K-562: 18.3;NB-4: 6.3;SiHa: 5.1"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.3;hypothalamus: 8.0"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"		Yes	No			Nucleoplasm	"Centriolar satellite"	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				1.9	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.4	0.1	3.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.9	0.0	0.4	0.2	0.0	0.0	0.9	0.7	0.0	1.3	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.0	0.0	0.0	0.8	0.7	5.6	5.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	18.3	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.1	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	6.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686432-37745247	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.7;kidney: 66.2;pancreas: 18.6"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 73.9;Collecting duct cells: 54.1;Distal tubular cells: 38.1;Ductal cells: 37.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"					"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.0"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 53.3"	"Group enriched"	"Detected in some"	5	"basal ganglia: 0.7;hypothalamus: 2.3"	"Not detected"	"Not detected"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (2.51e-6)"	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.1	4.5	0.0	4.8	3.8	0.9	7.8	0.0	2.8	34.7	0.0	0.0		66.2	7.7	3.7	0.0	0.0	0.0	0.8	18.6	1.6	0.0	0.6	0.0	1.6	3.4	0.0	0.0	3.8	0.0	0.0	5.5	0.3	0.0	0.0	3.7	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.8	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	53.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											8.9	10.2	0.0	2.2	0.0	0.0	0.6	73.9	5.3	3.4	54.1	0.0	0.0	38.1	37.2	26.8	0.0	10.9	0.0	22.1	0.0	0.0	1.8	5.7	4.0	0.1	0.0	13.8	0.0	0.3	7.4	0.6	0.0	0.0	1.8	11.4	0.0	25.3	7.0	0.0	31.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	19.4	2.7
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566843	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 139.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 53.6;Mucus-secreting cells: 31.7;Paneth cells: 41.9;Undifferentiated cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"A549: 4.5;CAPAN-2: 16.8;Karpas-707: 4.7;OE19: 10.3;PC-3: 5.1;THP-1: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.2	0.5	5.0	0.5	0.0	0.3	0.3	0.3	0.6	56.2	0.1	0.3	35.9	0.4	1.1	0.4	0.3	12.6	0.2	0.3	0.3	6.1	12.1	0.4	0.0	0.4	0.2	0.2	10.9	0.0	0.2	0.0	0.3	0.6	6.9	0.2	0.4	0.6	0.2	0.2	139.6	0.2	0.3	0.2	2.6	0.9	0.1	0.1	0.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	4.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.8	0.0	2.4	0.0	2.0	0.0	2.1	0.0	0.0	0.0	1.9	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.3	10.3	5.1	0.0	0.0	0.3	2.9	0.1	0.3	1.7	0.3	0.1	0.0	0.2	0.3	5.6	0.0	0.3	0.1	0.1	0.0	1.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.3	0.3	0.4	0.2	0.3	0.1	0.0	0.6	0.5	0.6	0.0	0.0	0.2	17.8	9.4	1.2	3.5	0.0	0.0	5.0	2.2	1.7	0.0	53.6	0.0	3.7	0.0	0.0	1.1	0.0	9.0	0.0	0.0	15.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	31.7	0.0	5.6	41.9	0.0	13.6	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	25.9	2.8
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 259.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6"	"Group enriched"	"Detected in many"	22	"dendritic cells: 20.9;monocytes: 34.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		64000	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	41.4	5.8	12.2	12.3	11.1	3.3	28.8	10.7	11.3	27.6	16.3	8.6	13.9	8.7	22.2	21.4	11.6	14.6	21.6	14.7	12.7	7.8	33.4	74.2	21.9	17.0	13.7	9.2	33.1	14.1	24.5	5.5	14.3	11.2	22.3	17.7	8.7	14.1	20.1	4.9	8.1	11.1	13.2	14.8	18.5	11.5	11.7	14.6	1.0	7.3	8.5	6.5	21.3	12.0	0.5	20.9	1.2	34.6	0.1	0.2	9.2	0.2	0.3	1.5	4.1	17.5	18.8	0.1	1.1	1.7	0.1	0.7	7.8	4.4	0.2	13.8	4.5	0.3	0.4	3.2	0.0	0.0	0.2	1.6	0.1	13.0	60.9	7.9	0.0	0.2	24.9	0.0	6.2	0.0	1.4	4.4	0.1	0.2	0.3	13.1	0.9	0.0	0.2	7.8	10.4	1.6	0.1	0.5	0.0	18.8	31.6	0.1	0.4	5.9	7.7	0.0	31.3	0.2	14.3	1.2	1.3	3.4	1.8	4.4	0.1	0.0	0.2	5.9	7.5	0.9	0.8	34.6	0.2	0.2	26.7	0.1	0.5	0.1	0.1	20.9	0.3	0.1	0.2	1.2	0.1	14.6	0.6	0.2	9.2	12.2	11.1	10.7	11.3	12.7	7.8	13.7	9.2	11.2	14.6	26.8	39.0	13.7	77.1	31.6	0.5	1.6	140.1	52.2	86.4	57.6	0.0	45.4	104.5	84.7	1.2	4.9	45.2	0.0	42.0	69.7	45.8	47.7	0.0	146.0	259.0	0.0	15.7	23.4	235.2	1.6	121.7	155.2	54.0	68.5	65.8	22.3	57.9	100.1	99.0	189.5	0.5	77.6	52.5	0.5	0.6	22.6	31.5	5.0	76.2	102.7
HNRNPLL	HNRPLL	ENSG00000143889	"Heterogeneous nuclear ribonucleoprotein L like"	Q8WVV9	2	38561978-38603586	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046084	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			Nucleoplasm	"Mitochondria, Cytosol"	"HPA046084: AB_10960895"	"unprognostic (2.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-2)"	16.6	19.5	14.9	13.3	16.2	47.3	20.0	22.1	17.5	18.2	16.4	10.8	17.0	16.2	21.9	19.4	14.4	17.6	16.5	14.3	17.8	11.8	12.5	11.6	17.6	12.1	13.2	19.2	19.9	16.8	18.8	16.4	13.8	10.9	16.8	13.0	13.5	14.0	22.8	13.1	12.0	13.6	14.2	12.8	12.0	16.3	24.8	12.4	40.0	19.2	11.5	11.5	20.8	26.4	1.0	6.9	5.3	3.6	3.6	21.7	3.5	16.8	7.9	23.2	13.6	11.3	10.7	14.5	15.9	13.1	14.0	11.7	8.9	9.8	0.2	14.3	14.2	14.9	10.8	14.6	11.9	14.4	25.1	12.7	12.3	14.9	22.5	10.7	22.9	12.7	8.4	9.5	11.5	12.9	13.8	14.5	11.3	20.8	38.2	16.3	7.8	24.9	12.5	23.3	16.3	14.5	4.9	16.3	8.2	11.9	22.2	15.9	17.8	14.0	12.3	11.7	13.5	10.4	9.9	15.0	10.5	15.7	11.4	13.0	20.9	20.9	0.1	9.0	5.7	12.7	5.3	3.6	5.1	6.2	1.8	11.0	0.2	15.1	11.6	6.9	1.0	4.6	2.9	2.5	3.6	0.7	0.1	21.7	3.5	14.9	16.2	22.1	17.5	17.8	11.8	13.2	19.2	10.9	12.4	17.9	18.9	4.2	29.5	25.4	12.6	14.4	2.5	10.7	19.4	26.2	7.9	22.8	16.6	20.6	114.5	19.1	12.9	0.0	21.3	24.7	25.6	21.8	9.2	6.4	22.1	6.4	13.8	19.6	15.4	35.0	25.6	26.7	37.1	31.5	16.9	24.6	17.7	17.5	49.1	16.3	10.4	38.8	23.7	68.1	29.6	18.6	18.5	17.5	18.7	17.6
HOMER1	"HOMER-1B, SYN47, Ves-1"	ENSG00000152413	"Homer scaffolding protein 1"	Q86YM7	5	79372636-79514217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9;skeletal muscle: 28.0"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 87.3;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004437, HPA036521, HPA036522"	Enhanced	Supported	Approved	Cytosol		No	No			Cytosol		"CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171"	"unprognostic (2.80e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.83e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.86e-3)"	3.0	1.6	11.3	2.4	19.7	0.6	2.7	8.4	28.9	4.4	1.6	1.2	0.0	1.0	6.8	4.5	4.7	2.5	6.9	19.1	8.5	4.2	5.9	2.0	5.1	1.3	2.9	13.3	4.7	2.4	4.5	3.6	5.3	5.3	2.0	1.3	2.1	1.9	2.1	28.0	2.6	1.2	4.7	2.2	1.1	2.1	5.1	3.5	1.7	14.4	4.8	1.7	5.0	2.2	2.0	0.6	0.2	0.0	0.4	2.3	0.5	8.4	5.9	8.9	14.0	3.4	2.2	20.5	5.4	4.3	5.5	5.9	9.2	6.0	0.1	16.5	4.6	10.0	4.6	10.9	14.6	9.5	1.2	8.6	10.2	2.5	9.1	5.5	4.8	3.3	3.6	9.5	4.9	13.8	2.2	2.5	15.9	12.4	5.6	7.1	11.9	20.0	3.3	14.9	3.0	5.0	13.1	14.5	12.9	5.8	13.2	9.0	5.4	10.2	7.3	5.4	10.3	10.0	4.2	0.4	4.1	10.3	4.9	9.5	2.7	6.1	5.0	11.6	1.9	7.8	0.0	0.0	0.1	2.3	0.0	1.3	2.0	0.9	0.7	0.0	1.6	0.5	1.7	0.2	0.4	0.0	0.6	0.0	0.5	11.3	19.7	8.4	18.8	8.5	4.2	2.9	13.3	5.3	3.5	47.6	11.1	9.8	25.1	57.1	25.5	87.3	10.2	13.4	13.6	15.7	25.5	45.8	10.0	3.7	3.6	4.7	2.6	0.0	3.7	37.8	15.1	20.5	5.7	7.3	10.1	49.3	10.9	3.7	9.0	3.9	5.2	10.5	20.3	1.8	5.0	3.3	4.6	2.9	8.1	5.3	9.1	12.9	15.1	3.3	8.3	47.9	70.6	4.9	2.5	18.0
HOMER3	HOMER-3	ENSG00000051128	"Homer scaffolding protein 3"	Q9NSC5	19	18929201-18941261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 64.5;Muller glia cells: 59.6;Proximal tubular cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 14.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.1;monocytes: 14.7"	"Cell line enhanced"	"Detected in many"		"NB-4: 62.2;THP-1: 74.8;U-266/84: 64.3"	"Region enriched"	"Detected in many"	6	"cerebellum: 212.2"	"Low region specificity"	"Detected in all"			"CAB032656, HPA040999, CAB079015"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Plasma membrane, Cytoplasmic bodies"	"CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.24e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.07e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	11.4	8.3	11.1	6.5	16.0	12.4	31.0	42.3	12.2	8.7	6.7	17.6	2.1	4.9	8.2	5.2	7.6	4.8	10.9	11.9	15.8	9.0	21.2	4.1	7.0	5.5	19.4	7.2	8.2	5.3	13.6	2.4	9.7	15.5	8.1	4.5	15.4	8.4	7.0	49.2	10.9	5.5	7.6	24.2	64.8	6.5	3.4	14.6	2.2	19.6	7.8	3.3	12.3	16.8	2.4	1.2	5.1	14.7	0.0	0.7	3.6	19.6	5.1	9.7	8.1	9.1	9.2	4.8	19.5	17.3	19.6	9.9	2.6	7.6	0.1	9.2	21.9	14.1	12.3	3.3	25.3	11.0	0.7	2.0	0.0	1.6	4.8	8.5	3.7	0.3	7.4	16.4	10.9	14.7	21.0	23.8	1.4	0.5	5.2	14.2	5.3	0.3	62.2	5.0	1.0	21.1	9.7	2.9	9.2	7.1	5.0	0.0	8.3	4.8	5.7	13.8	1.9	2.5	74.8	18.9	17.5	7.8	21.0	23.4	50.7	64.3	16.3	27.6	48.1	12.7	0.1	14.7	2.6	0.1	5.1	0.0	2.4	0.7	0.3	1.2	1.7	0.1	0.0	5.1	0.0	1.4	0.2	0.7	3.6	11.1	16.0	42.3	12.2	15.8	9.0	19.4	7.2	15.5	14.6	3.0	0.0	2.4	17.6	10.5	1.9	3.4	2.5	0.0	2.3	12.2	0.0	0.6	10.0	17.4	1.3	13.1	0.0	0.0	11.6	1.4	13.0	10.5	10.3	0.8	64.5	1.6	1.7	20.9	18.2	1.7	12.7	16.1	11.8	1.0	0.9	59.6	32.9	0.0	10.3	70.5	4.1	0.0	6.1	1.0	5.1	12.7	0.9	0.5	0.1	19.7
HOOK3	HK3	ENSG00000168172	"Hook microtubule tethering protein 3"	Q86VS8	8	42896932-43030539	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024756	Approved		Supported	"Golgi apparatus,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA024756: AB_1850913"	"unprognostic (1.84e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.73e-1)"	"unprognostic (8.61e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.13e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.12e-2)"	15.5	9.3	11.3	10.1	15.1	13.1	16.3	16.0	19.2	13.5	11.3	10.3	14.1	10.2	13.7	12.0	14.8	11.7	20.0	9.5	11.2	11.3	9.9	10.7	14.6	10.3	14.7	11.7	13.4	13.9	13.4	14.4	12.0	13.1	17.7	10.9	6.8	17.1	15.2	24.1	11.0	11.9	19.3	17.5	11.6	12.8	14.5	14.3	7.4	37.5	8.9	10.1	19.2	17.6	1.8	3.8	10.2	3.2	2.0	2.0	1.8	7.4	7.4	18.1	9.8	13.5	12.0	6.9	9.5	8.0	8.0	7.5	9.8	8.7	9.3	9.7	12.7	7.6	4.2	15.0	6.4	13.0	6.3	4.3	17.5	6.1	6.8	7.5	1.8	10.3	9.7	4.7	10.7	9.2	11.1	11.4	6.6	9.6	11.0	9.6	1.8	14.2	3.4	6.5	5.9	2.2	8.3	18.9	2.3	5.9	11.1	4.6	7.4	10.8	4.6	5.0	8.3	8.4	6.3	20.4	12.0	9.3	14.4	6.0	10.8	11.8	12.3	10.1	6.7	17.6	10.2	3.2	3.1	2.0	3.2	0.8	1.6	1.9	1.5	3.8	1.8	1.1	1.5	3.8	2.0	3.1	2.4	1.4	1.8	11.3	15.1	16.0	13.1	11.2	11.3	14.7	11.7	13.1	14.3	86.4	55.8	23.3	27.0	60.8	36.4	44.2	38.2	33.5	45.5	24.4	31.4	32.3	23.2	37.4	88.6	54.3	28.4	23.3	28.8	21.7	50.3	38.0	52.0	28.4	34.2	71.5	62.8	57.7	83.3	26.1	41.4	65.4	52.3	104.6	20.1	29.9	47.3	25.9	50.5	18.0	31.0	64.7	55.1	30.2	18.9	65.4	95.1	27.4	13.5	63.4
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.8;skin 1: 154.6"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 696.8;Alveolar cells type 2: 414.3;Basal keratinocytes: 368.4;Suprabasal keratinocytes: 329.7;Syncytiotrophoblasts: 269.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 68.6;NK-cell: 90.9"	"Group enriched"	"Detected in many"	14	"NK-cells: 90.9;T-cells: 68.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.4;HUVEC TERT2: 29.7;RT4: 22.1;TIME: 33.6;U-266/70: 11.7"									"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	1.7	5.0	24.1	5.2	13.0	2.0	23.1	4.0	28.2	26.4	3.1	3.6	3.0	3.4	2.5	106.2	90.3	2.3	6.7	5.7	20.0	8.2	2.3	0.7	112.4	3.4	12.1	12.9	1.4	1.1	2.3	1.2	128.8	15.0	4.5	1.6	1.0	19.0	12.9	3.4	154.6	3.4	20.9	11.2	2.3	3.2	9.6	1.9	1.8	65.9	93.2	66.3	6.8	37.8	5.6	0.4	1.5	0.5	90.9	68.6	38.2	0.0	0.0	0.0	0.0	2.3	7.3	2.6	0.0	0.0	0.6	0.4	0.0	0.0	5.4	0.3	0.1	1.0	1.0	0.6	0.0	0.8	13.4	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.2	5.4	1.6	0.0	1.5	29.7	0.0	0.0	0.2	1.4	0.2	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.1	0.0	22.1	0.4	0.2	0.0	0.0	0.0	2.1	0.0	0.0	33.6	0.0	0.1	0.2	0.0	11.7	0.0	0.0	1.4	0.0	0.0	0.6	0.1	0.2	68.6	0.4	37.4	5.6	17.1	30.1	0.3	4.3	3.1	21.0	1.5	90.9	0.5	0.4	1.0	38.2	24.1	13.0	4.0	28.2	20.0	8.2	12.1	12.9	15.0	1.9	696.8	414.3	13.2	36.1	368.4	1.6	11.3	0.0	20.1	221.8	1.8	0.0	1.7	1.7	0.0	27.8	9.0	0.5	0.0	0.2	4.7	21.3	17.3	9.3	0.8	3.5	0.0	8.1	5.5	16.3	34.5	2.8	8.0	33.7	62.3	1.9	104.0	2.3	0.0	2.8	0.2	4.3	32.3	77.3	2.6	10.4	329.7	269.1	177.7	0.3	25.7
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720888	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 78.1"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 709.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.2;neutrophil: 4.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.4;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	1.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	3.2	0.1	0.1	0.1	0.4	0.0	78.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.6	4.4	1.2	0.0	0.2	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.1	6.8	0.0	11.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.2	0.3	0.2	0.4	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	4.4	0.0	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	54.2	0.1	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.6	22.1	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	32.3	0.1	709.1	118.4	8.2	1.8	0.0	0.0	0.0
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200106	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 48.5;prostate: 25.1"	"Group enriched"	"Detected in some"	15	"Basal glandular cells: 2.9;Enterocytes: 7.7;Fibroblasts: 3.5;Glandular cells: 4.8;Intestinal endocrine cells: 8.1;Mucus-secreting cells: 9.8;Paneth cells: 5.8;Undifferentiated cells: 9.7;Urothelial cells: 2.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 15.5;HEK 293: 21.6;PC-3: 10.7;RT4: 23.9;THP-1: 10.2;U-937: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		NA	NA			Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	48.5	6.9	0.0	7.1	0.0	5.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	16.5	0.0	25.1	8.6	0.0	0.1	17.9	1.2	0.4	0.1	15.7	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	12.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	1.4	0.1	0.0	0.0	7.6	8.3	3.0	1.9	1.5	0.1	0.0	0.9	3.5	0.4	0.0	15.5	0.0	2.5	0.0	21.6	1.0	4.1	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	4.9	0.0	6.6	10.7	1.5	0.4	0.0	0.0	23.9	0.4	0.0	1.9	0.0	0.1	1.2	0.0	10.2	0.0	0.3	2.7	0.1	0.1	0.0	0.0	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.7	0.0	0.0	0.1	3.5	4.8	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	9.7	2.8
HOXA2	HOX1K	ENSG00000105996	"Homeobox A2"	O43364	7	27100354-27102811	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 18.1"	"Cell type enhanced"	"Detected in some"	17	"Intestinal endocrine cells: 4.6;Ito cells: 6.2;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	44	"pons and medulla: 15.7"	"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;HaCaT: 6.9;RPTEC TERT1: 5.5"	"Region enriched"	"Detected in single"	35	"pons and medulla: 6.1"	"Region enriched"	"Detected in single"	27	"pons and medulla: 7.7"	HPA078220			Approved	Nucleoplasm,Vesicles		Yes	NA			"Nucleoplasm, Vesicles"		"HPA078220: AB_2686880"	"unprognostic (7.30e-2)"	"unprognostic (4.90e-4)"	"unprognostic (2.81e-1)"	"unprognostic (7.43e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.98e-9)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-2)"	2.7	1.6	0.3	1.9	0.1	0.0	2.6	0.1	0.2	1.4	4.5	0.2	8.7	1.5	3.4	9.7	8.3	6.3	4.9	1.8	0.1	0.0	4.2	0.7	4.7	1.9	0.3	0.1	3.8	0.4	9.6	0.1	0.1	15.7	2.8	3.5	0.1	0.1	4.1	1.2	2.7	4.3	2.4	18.1	2.9	3.7	0.8	0.1	3.8	2.2	2.9	3.3	3.2	3.5	0.0	0.0	1.8	0.3	0.0	0.1	0.0	1.2	0.8	4.2	16.8	0.0	0.0	0.0	0.2	0.1	0.0	0.1	2.2	4.1	0.2	1.9	0.2	2.3	6.9	0.2	0.0	0.0	0.0	2.4	0.0	0.1	0.4	1.9	0.1	0.3	1.0	0.0	3.6	3.4	0.0	2.8	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	1.1	1.0	0.7	0.0	5.5	0.7	1.2	0.0	0.2	0.0	1.1	0.3	0.0	0.0	2.8	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.1	0.7	3.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.1	15.7	0.1	0.0	0.0	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	4.6	6.2	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.3
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.8"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 111.0;Proximal tubular cells: 39.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"pons and medulla: 9.2"	"Cell type enriched"	"Detected in some"	5	"NK-cell: 7.7"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 7.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 19.7;RPTEC TERT1: 24.4;SCLC-21H: 19.7"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	10	"pons and medulla: 2.9"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	6.5	14.5	0.2	4.8	0.2	0.0	11.2	0.3	0.6	7.3	10.0	0.2	7.9	0.0	5.0	15.4	3.0	12.2	0.5	0.2	0.2	0.0	25.4	0.4	2.6	3.5	0.2	0.2	6.2	0.2	0.3	0.2	1.3	9.2	8.2	7.2	0.2	0.2	8.9	27.8	8.2	6.1	8.1	14.3	3.7	3.2	2.7	0.2	1.6	0.9	0.2	1.1	11.4	6.7	0.2	0.9	0.0	0.0	7.7	1.6	0.2	6.9	2.4	0.0	7.5	0.0	0.0	0.4	2.5	4.3	5.2	6.0	3.6	2.7	4.8	7.0	1.9	0.2	4.8	19.7	0.0	3.1	0.0	12.4	0.3	2.8	0.1	0.5	0.4	0.2	4.1	0.2	0.6	7.0	0.0	9.8	8.4	0.0	0.0	1.9	1.2	0.0	1.1	0.3	5.0	0.7	2.5	4.6	0.0	24.4	4.8	19.7	0.0	13.6	0.0	0.0	1.4	0.2	1.9	0.8	0.0	4.7	14.0	2.4	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	7.7	0.0	0.6	0.4	0.2	0.2	0.2	0.3	0.6	0.2	0.0	0.2	0.2	9.2	0.2	0.0	0.0	0.0	7.5	8.0	0.0	0.3	0.0	0.0	0.0	12.2	0.0	0.4	111.0	0.0	15.9	2.2	3.0	0.0	0.0	4.6	2.7	4.0	0.0	0.0	0.2	0.0	15.5	0.0	0.0	2.1	0.6	0.5	3.3	0.0	11.2	0.0	0.1	10.4	0.0	39.0	0.0	0.0	7.3	0.4	0.2	10.8	0.2	0.9	15.7	2.6
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575513-48580111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 13.3"	"Cell type enhanced"	"Detected in many"	15	"Collecting duct cells: 61.1;Cytotrophoblasts: 18.4;Spermatogonia: 21.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.4;HEK 293: 11.3;HMC-1: 14.4;K-562: 11.4"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.7"	"Region enriched"	"Detected in single"	23	"pons and medulla: 7.5"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA057432: AB_2683437"	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	4.4	2.4	0.0	1.5	0.0	0.0	2.9	0.0	0.0	4.2	8.1			1.2	2.3	13.3	2.7	8.5	1.5	0.4	0.0	0.0	5.7	0.7	3.6	0.6	0.0		0.0	0.7	1.8	0.0	1.0		0.6	1.1		0.0	4.8	0.8	0.9	4.3	2.0	2.4	3.0	3.9	0.5			0.6		0.2	1.3	1.7	0.3	2.4	0.0	0.1	0.6	0.7	0.1	0.1	0.3	0.0	0.1	4.9	3.9	1.9	0.0	0.0	0.2	0.1	2.2	2.0	3.1	23.4	1.5	0.4	0.1	4.1	0.0	0.0	8.0	11.3	7.6	0.7	0.0	5.0	0.0	14.4	3.8	0.0	5.7	0.0	0.8	6.6	5.2	11.4	0.2	5.6	0.0	1.8	0.0	0.0	2.1	0.0	0.0	4.4	1.6	4.6	1.9	0.0	0.0	0.6	0.0	2.9	1.6	0.4	1.5	2.5	0.3	0.2	0.8	0.2	1.9	4.0	0.7	1.6	0.0	2.2	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.2	0.5	0.0	0.1	0.2	0.1	0.0	0.6	0.0	2.4	0.0	0.1											0.0	0.0	1.7	0.9	3.4	0.0	0.8	0.0	1.4	0.0	61.1	0.0	18.4	10.0	0.1	0.0	7.1	0.8	0.0	0.0	11.0	9.7	0.4	3.5	0.0	3.2	0.0	0.0	15.4	1.8	0.0	0.3	1.9	5.0	0.0	2.0	0.0	0.0	1.9	0.0	1.4	0.0	0.0	5.2	0.2	21.8	1.6	5.0	10.5	1.5	2.6
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593961	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6"	"Cell type enhanced"	"Detected in some"	16	"Collecting duct cells: 50.6;Distal tubular cells: 21.6;Mucus-secreting cells: 13.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enriched"	"Detected in single"	33	"pons and medulla: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.5;RPTEC TERT1: 16.1"	"Region enriched"	"Detected in single"	90	"pons and medulla: 24.0"	"Region enriched"	"Detected in single"	128	"pons and medulla: 14.7"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA043851: AB_2732509, HPA074454: AB_2686690"	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (8.59e-5)"	3.4	3.1	0.2	2.1	0.2	0.0	5.0	0.2	0.7	5.4	10.5	0.2	25.9	1.5	2.2	18.5	0.6	7.2	0.2	0.7	0.2	0.0	16.0	0.4	5.2	0.8	0.2	0.2	1.9	0.5	0.9	0.2	1.2	25.4	1.3	4.7	0.2	0.6	27.6	0.2	0.5	9.5	1.6	22.5	2.0	4.3	0.7	0.2	0.2	0.7	0.2	0.2	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	4.8	0.0	2.5	2.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	5.2	2.7	0.6	0.0	0.2	0.0	0.0	0.0	21.5	0.9	5.6	0.0	4.2	0.0	1.2	1.4	0.0	2.9	0.0	0.8	1.4	0.1	1.6	0.0	3.3	0.0	0.0	0.0	0.0	2.7	1.7	0.0	1.0	0.0	16.1	1.6	0.0	0.0	0.1	0.0	2.3	0.1	0.4	0.0	5.3	0.7	2.1	0.5	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	25.4	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	50.6	0.0	0.0	21.6	0.0	0.6	2.4	8.9	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.5	0.0	4.1	9.2	5.0	0.0	0.0	0.0	1.7	0.0	13.9	0.0	0.0	3.5	0.4	0.4	0.0	0.0	1.0	7.2	10.8	0.3	0.0	0.0	11.5	0.0
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 73.7;seminal vesicle: 56.7"	"Group enriched"	"Detected in many"	8	"Collecting duct cells: 129.1;Distal tubular cells: 96.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.5"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 13.4;HEK 293: 36.8;RPTEC TERT1: 25.0;TIME: 13.9"	"Region enriched"	"Detected in single"	60	"pons and medulla: 10.6"	"Region enriched"	"Detected in single"	25	"pons and medulla: 14.6"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	5.2	4.3	0.3	18.1	0.3	0.0	3.8	0.3	0.3	12.0	8.5	0.3	73.7	0.5	7.2	30.5	0.4	8.7	0.3	0.3	0.3	0.0	26.6	0.4	3.4	0.3	0.3	0.3	0.6	0.6	1.9	0.3	1.5	0.9	4.3	3.8	0.3	0.3	56.7	1.0	0.6	8.2	1.8	10.0	1.7	5.9	1.8	0.3	0.3	0.3	0.3	0.3	4.2	10.0	1.5	0.2	0.0	0.0	0.0	1.0	0.3	2.3	5.5	0.0	2.9	2.5	2.7	0.0	0.0	0.0	0.0	0.0	2.9	3.6	0.0	13.4	6.5	0.9	0.0	0.6	0.2	0.0	0.1	36.8	3.2	9.1	0.0	3.8	0.2	8.6	3.3	0.1	5.3	0.1	2.0	2.5	0.2	2.1	0.0	7.3	0.1	0.0	0.1	0.0	9.1	2.2	0.0	6.2	0.3	25.0	1.2	0.0	0.0	2.0	0.0	3.6	0.0	0.9	1.2	13.9	0.5	2.9	2.3	10.1	0.0	0.0	0.0	0.4	0.0	4.5	0.0	0.0	0.0	0.7	0.0	0.2	1.4	0.4	1.0	0.2	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.9	0.3	0.0	0.0	0.0	0.4	0.7	0.0	0.2	0.0	0.0	0.0	129.1	0.0	0.2	96.2	0.1	0.6	2.2	14.0	0.0	1.6	1.6	2.6	0.3	0.0	0.0	1.4	0.0	7.5	4.9	14.7	0.0	0.9	1.7	0.0	0.0	7.5	0.0	0.9	14.1	0.0	2.1	0.0	0.0	2.1	4.2	6.8	1.0	0.2	1.0	10.3	0.6
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 7.0;skin 1: 9.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 6.6;Distal tubular cells: 1.7;Fibroblasts: 2.3;Melanocytes: 3.3;Spermatocytes: 3.8;Suprabasal keratinocytes: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;BJ hTERT+: 11.7;HaCaT: 10.3;T-47d: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	4.8	0.0	0.1	0.1	0.1	0.0	1.2	0.1	0.1	2.5	0.1	0.1	0.1	0.8	2.0	1.0	0.1	0.7	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.7	0.1	0.1	0.5	0.1	0.0	0.1	0.6	0.3	0.5	0.0	0.1	0.1	2.0	7.0	9.2	2.7	0.4	0.1	0.1	0.0	1.6	0.1	0.5	0.1	0.1	0.1	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.7	0.0	23.3	2.2	3.4	0.0	3.4	11.7	5.0	3.7	0.2	0.9	0.0	0.2	3.2	0.0	10.3	4.4	0.0	2.3	0.6	0.1	0.1	7.6	0.0	0.0	0.1	0.1	0.6	0.9	0.0	0.3	0.0	0.0	0.2	1.0	0.0	3.2	1.4	0.0	0.0	0.0	6.6	0.0	0.0	0.4	0.0	0.4	0.8	0.0	0.1	2.1	5.3	2.0	0.2	18.4	0.0	0.0	0.0	4.0	0.3	0.2	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	3.8	0.2	3.3	0.0	0.0	0.0	0.0
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54032853-54035358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.8;ovary: 13.4"	"Cell type enhanced"	"Detected in some"	8	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Fibroblasts: 2.4;Leydig cells: 2.3;Peritubular cells: 2.5;Smooth muscle cells: 2.1;Spermatocytes: 3.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Region enriched"	"Detected in single"	14	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.5;ASC diff: 5.1;ASC TERT1: 6.2;HSkMC: 5.8;SH-SY5Y: 9.3"	"Region enriched"	"Detected in single"	40	"pons and medulla: 4.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.8	1.6	0.2	1.0	0.2	0.0	1.8	0.2	0.6	0.2	1.6	0.2	0.2	0.3	0.5	5.3	1.7	8.0	1.5	0.2	0.2	0.0	1.5	0.2	0.2	0.3	0.4	0.2	13.4	0.2	0.0	0.2	1.4	8.8	0.2	0.0	0.8	0.2	0.2	4.2	2.1	4.6	2.5	2.6	0.2	3.9	2.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.9	2.2	0.0	8.5	5.1	6.2	0.0	0.5	0.4	1.0	0.7	3.6	0.5	0.0	0.6	2.5	0.0	1.4	0.2	0.0	0.3	2.7	3.0	0.0	1.0	0.1	0.2	0.0	0.1	5.8	0.6	4.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.0	0.1	0.0	1.5	0.3	0.0	0.0	0.0	1.2	0.0	0.0	9.3	0.6	0.2	4.4	1.2	1.7	0.1	0.0	1.5	0.9	3.2	0.3	0.0	0.0	0.0	0.2	0.2	3.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.4	0.2	8.8	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.9	0.0	0.0	2.1	3.2	0.6	0.6	0.2	0.0	0.0	0.0
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119942	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 21.7;endometrium 1: 38.2"	"Cell type enhanced"	"Detected in some"	16	"Collecting duct cells: 14.0;Distal tubular cells: 13.3;Intestinal endocrine cells: 23.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 7.3;HEK 293: 26.0;RPTEC TERT1: 18.7;SCLC-21H: 7.3;SiHa: 10.9;U-251 MG: 8.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		No	NA			Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA065871: AB_2685573"	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	0.9	0.0	0.1	1.2	0.1	0.0	21.7	0.1	0.1	10.3	9.5	0.1	1.4	0.0	38.2	2.8	1.2	1.6	0.6	0.6	0.1	0.0	16.3	0.1	0.8	0.2	0.1	0.1	2.7	0.1	0.0	0.1	3.0	0.1	9.5	4.3	0.1	0.5	5.1	0.2	1.0	0.1	14.2	0.1	0.1	0.0	3.9	0.1	0.2	0.3	0.4	1.4	2.1	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	7.3	0.0	0.0	0.3	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	18.7	0.0	7.3	1.9	10.9	0.0	0.0	1.4	0.0	0.0	1.6	0.0	1.4	0.6	8.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	4.6	0.8	0.0	0.3	0.0	0.0	0.0	14.0	0.0	0.0	13.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.1	0.0	23.2	0.0	0.0	0.0	1.7	0.0	1.7	0.0	3.9	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	5.2	2.0
HOXD13	"HOX4I, SPD"	ENSG00000128714	"Homeobox D13"	P35453	2	176092891-176095938	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0"	"Cell type enhanced"	"Detected in some"	20	"Basal glandular cells: 10.8;Intestinal endocrine cells: 28.0;Mucus-secreting cells: 11.6;Undifferentiated cells: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.8;HEK 293: 28.1;HL-60: 31.2;JURKAT: 8.8;NB-4: 18.6;SCLC-21H: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064064			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064064: AB_2685186"	"unprognostic (2.04e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.95e-5)"	"unprognostic (2.52e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.08e-2)"		"unprognostic (4.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.66e-1)"		"unprognostic (1.01e-2)"	"unprognostic (2.82e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.70e-2)"		"unprognostic (9.98e-3)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	14.0	13.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	13.8	8.8	0.1	0.1	19.0	0.6	0.0	0.1	3.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	3.8	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.8	0.0	1.5	0.0	28.1	4.2	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	2.0	0.0	0.0	0.0	0.0	18.6	1.0	0.0	1.5	0.0	0.1	0.0	0.0	0.2	8.2	2.0	1.9	0.0	4.5	0.1	0.0	0.0	0.0	1.0	0.0	0.4	2.6	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	10.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	8.3	5.5
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 8.7;Distal tubular cells: 13.3;Early spermatids: 12.5;Leydig cells: 3.7;Peritubular cells: 4.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;HSkMC: 9.5;RPTEC TERT1: 9.9;SCLC-21H: 14.2;SH-SY5Y: 9.5;SK-MEL-30: 3.9"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.8"	"Region enriched"	"Detected in single"	32	"pons and medulla: 6.7"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"		No	NA			Nucleoplasm	"Nuclear bodies"	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	6.2	1.1	0.4	3.2	0.4	0.2	19.6	0.2	0.2	8.7	3.6	0.0	22.5	0.3	25.9	36.4	1.1	4.8	2.0	0.4	0.8	0.5	8.5	0.2	0.3	0.8	1.5	0.0	7.0	0.3	0.2	0.2	0.2	0.5	2.1	0.4	0.0	0.6	22.6	0.7	0.7	0.4	4.0	7.2	1.9	0.3	3.6	0.0	0.0	0.4	0.2	0.3	1.7	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	9.9	0.5	14.2	9.5	0.1	0.1	3.9	0.2	0.0	0.0	0.6	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.8	0.5	1.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	13.3	0.0	12.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	1.6	0.0	0.0	0.3	0.7	0.5	1.1	0.0	0.0	0.5	0.0
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151222-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.0;seminal vesicle: 26.2"	"Cell type enhanced"	"Detected in some"	17	"Collecting duct cells: 15.7;Leydig cells: 4.4;Proximal tubular cells: 5.3;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.3;HEK 293: 22.1;RPTEC TERT1: 16.4;SK-MEL-30: 6.1"					"Region enriched"	"Detected in single"	28	"pons and medulla: 8.2"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	3.4	4.9	0.5	0.5	0.5	0.0	4.0	0.5	0.7	2.8	3.4	0.5	13.8	0.2	15.6	21.0	0.5	7.9	0.5	0.5	0.5	0.0	10.2	0.5	0.5	0.6	1.1	0.5	9.7	0.5	0.0	0.5	0.5	7.6	1.5	0.8	0.5	0.5	26.2	1.3	1.0	3.5	5.3	3.7	4.4	0.4	1.5	0.5	0.5	0.8	0.5	0.5	2.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	1.8	0.0	0.1	0.4	0.0	0.6	0.5	0.0	0.0	9.3	1.6	0.4	0.1	1.5	0.0	0.2	0.0	22.1	0.2	0.0	0.0	0.3	0.0	0.0	5.0	1.5	0.0	0.2	0.1	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	16.4	2.6	1.3	2.2	0.3	0.0	6.1	0.4	0.0	0.0	2.8	0.2	0.1	1.4	1.2	0.0	0.0	0.0	1.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.0	1.1	0.5	7.6	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	3.7	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	4.4	0.0	1.7	0.0	0.6	0.0	0.1	0.0	2.8	5.3	0.0	6.5	0.5	0.2	0.2	0.5	0.0	0.0	1.2	0.0
HP		ENSG00000257017	Haptoglobin	P00738	16	72054592-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"liver: 1156.9"	"Cell type enriched"	"Detected in many"	51	"Hepatocytes: 52541.7"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 20.0;eosinophil: 30.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 30.9;monocytes: 20.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 66.2;HSkMC: 37.9"									"CAB003787, HPA047750"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	998000000000	140000000000	Vesicles		"CAB003787: , HPA047750: AB_2680146"	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	9.8	0.0	0.3	0.4	0.3	4.4	0.3	0.3	0.3	1.5	0.4	0.3	0.3	0.0	0.3	0.5	0.3	1.1	0.3	3.0	0.3	0.0	0.4	1156.9	1.4	0.4	0.3	0.3	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	1.4	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.0	3.5	30.9	20.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	66.2	0.1	9.5	1.8	37.9	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.6	0.1	0.8	0.0	0.0	0.3	7.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	2.1	1.4	0.0	0.2	0.0	0.0	1.2	0.0	4.5	0.0	3.7	0.0	2.6	20.0	30.9	0.0	0.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	5.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	17.9	220.1	295.8	0.8	0.1	0.2	72.5	853.5	10.7	10.3	0.0	0.0	0.0	0.0	0.0	0.1	6.8	0.0	864.3	9.6	0.0	0.2	0.2	3.5	52541.7	2.4	0.0	0.0	971.0	1021.7	0.0	9.5	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.1	0.0	0.9	0.0	0.0	0.3	0.1	23.0	0.0	0.0
HPCAL4	"DKFZp761G122, HLP4"	ENSG00000116983	"Hippocalcin like 4"	Q9UM19	1	39678648-39691689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 80.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 36.4;Distal tubular cells: 10.0"	"Group enriched"	"Detected in some"	11	"glioma: 5.4;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6;naive CD4 T-cell: 5.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.0;SH-SY5Y: 13.4;SK-MEL-30: 4.2;U-2 OS: 2.8;U-266/70: 3.5;U-266/84: 4.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 336.7;basal ganglia: 201.9;cerebral cortex: 348.1;hippocampal formation: 324.0;olfactory region: 266.4"	HPA053808			Approved	Cytosol		NA	NA			Cytosol		"HPA053808: AB_2682270"	"unprognostic (2.62e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.56e-4)"	"unprognostic (4.73e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.63e-1)"	1.2	10.2	35.8	1.8	46.0	1.5	1.2	31.1	80.4	1.2	1.2	3.7	0.0	1.3	1.2	1.5	5.5	1.2	1.3	1.4	28.3	17.0	3.5	1.2	1.7	1.9	7.5	32.7	3.7	4.7	1.2	0.4	1.2	6.8	1.4	1.3	0.0	1.2	1.3	2.1	1.2	1.3	1.2	4.4	1.4	1.3	4.1	3.0	0.0	1.2	0.0	1.8	1.3	0.0	0.0	0.1	0.0	0.0	0.0	5.6	1.8	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	2.1	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	0.0	1.2	13.4	0.4	0.0	4.2	0.3	0.0	0.1	0.0	0.0	2.8	0.0	0.0	3.5	4.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.0	5.6	1.0	0.1	0.0	5.0	1.8	0.0	0.0	0.0	0.0	3.8	1.8	35.8	46.0	31.1	40.4	28.3	17.0	7.5	32.7	6.8	3.0	0.0	0.0	0.0	0.1	0.0	36.4	0.8	0.0	0.0	1.2	1.8	0.0	0.0	10.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	5.0	0.1	0.0	1.4	0.0	1.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326905-45328533	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 38.4"	"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 24.6;Undifferentiated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 47.2;HL-60: 13.3;NB-4: 16.6;SK-BR-3: 29.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	35	"hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8"	"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.9	0.7	2.7	3.1	4.2	3.6	1.0	7.6	3.4	2.0	8.4	2.4	0.0	5.4	1.0	1.3	3.6	1.0	1.8	3.0	2.7	2.4	0.7	0.2	0.8	2.6	2.5	1.8	1.0	0.3	0.2	0.4	5.1	3.1	1.7	7.1	38.4	1.3	0.6	3.3	1.1	4.7	0.9	2.2	2.8	7.8	1.4	0.6	6.4	1.0	4.2	2.3	0.8	1.6	3.1	0.7	0.0	0.3	2.1	1.5	0.8	0.0	0.4	0.1	0.0	0.0	0.1	47.2	0.6	0.0	0.8	0.2	11.7	3.1	2.4	0.1	0.6	0.0	2.8	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.0	0.3	13.3	0.3	0.5	0.1	0.5	0.0	0.0	0.9	0.0	0.0	2.2	0.1	5.8	8.6	16.6	0.2	9.1	0.0	2.6	0.0	7.7	0.1	0.1	9.3	0.6	6.0	29.8	4.6	0.6	0.0	2.5	0.4	0.0	0.1	0.4	0.0	0.3	0.1	8.3	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	1.5	3.1	0.7	1.2	0.7	0.3	0.9	0.8	0.0	2.1	0.0	0.0	0.4	0.8	2.7	4.2	7.6	3.4	2.7	2.4	2.5	1.8	3.1	0.6	0.0	0.0	1.9	1.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	24.6	3.3	0.5	0.1	0.3	0.7	0.0	0.0	1.7	0.4	0.9	0.0	0.0	2.1	0.0	1.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.4	0.0	2.1	1.0	4.2	0.0	6.6	1.0
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729465-169757953	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 58.5;Distal tubular cells: 77.9;Extravillous trophoblasts: 50.1;Hofbauer cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (5.63e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	16.5	18.6	27.3	14.9	26.3	13.7	20.9	22.9	31.7	17.6	17.5	17.6	10.0	11.5	23.2	25.2	17.2	16.9	12.7	20.9	27.3	24.0	17.5	20.8	13.5	18.0	24.9	22.6	23.1	13.1	13.9	22.9	16.0	33.4	17.4	17.6	15.1	12.2	16.0	17.4	18.6	11.3	24.2	23.8	16.4	14.0	12.9	19.8	20.8	18.5	14.9	19.3	19.0	14.8	13.6	15.6	12.8	14.1	14.9	22.2	13.3	12.6	8.0	28.0	14.7	17.1	21.3	11.9	23.1	22.9	28.8	30.6	5.4	13.7	6.6	6.2	15.0	21.1	5.7	19.2	16.8	30.6	20.7	13.1	21.6	11.8	7.7	12.1	18.2	7.9	13.7	17.1	18.5	5.7	17.5	24.9	22.9	16.2	26.0	25.0	10.2	38.1	15.9	11.4	12.2	10.5	16.8	13.3	7.9	16.4	8.4	6.7	25.0	15.3	6.7	20.8	20.3	13.3	16.4	12.0	9.8	15.6	23.0	20.5	12.4	18.4	19.7	27.2	17.8	15.6	8.9	12.3	12.8	18.5	14.1	21.9	13.6	21.5	22.2	15.6	11.1	21.2	21.7	3.3	14.9	13.1	10.7	22.0	13.3	27.3	26.3	22.9	31.7	27.3	24.0	24.9	22.6	33.4	19.8	41.7	23.7	0.0	0.0	0.0	0.0	0.0	0.0	28.1	31.8	26.2	0.0	58.5	77.9	38.2	0.0	0.0	0.0	0.0	40.0	50.1	0.0	0.0	16.3	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	6.4	0.0	0.0	27.9	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Cell line enhanced"	"Detected in some"		"A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.7	0.0	0.0	17.2	1.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	60.6	2.1	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	15.8	1.4	2.8	0.0	0.2	5.7	94.3	0.1	0.1	0.0	0.2	0.6	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5	14.9	46.1	5.2	57.7	15.3	3.1	0.4	43.3	5.3	20.5	21.0	0.0	25.6	18.3	2.4	1.1	0.5	273.6	0.0	86.5	488.8	12.1	51.1	816.1	165.7	20.7	0.0	8.1	18.4	16.1	0.2	18.4	10.6	72.6	1.0	48.2	0.0	26.0	217.5	0.0	68.8	0.6	0.0	6.6	0.4	0.4	19.6	47.4	50.3	31.0	266.0
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063224-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 151.4"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 430.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 33.6"									HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	49000000000	77000000000	Vesicles		"HPA047750: AB_2680146"	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		0.2	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.6	0.1	0.0			0.1	0.0	0.1	0.0	0.0	0.1	15.2	0.7	0.8	0.1	151.4	0.0	0.1	2.1		0.4	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	1.1	2.9	1.1	1.0	0.4	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.6	1.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	1.3	1.0	0.1	0.5	0.4	0.4	0.3	1.1	2.0	1.1	0.3	0.4	0.3	2.9	2.3	0.3											0.0	9.8	0.0	0.0	0.1	0.0	14.9	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	23.3	0.2	0.0	0.2	0.0	0.0	430.8	0.0	0.0	0.0	9.8	7.3	2.1	9.2	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.9	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HPS3	"BLOC2S1, SUTAL"	ENSG00000163755	"HPS3, biogenesis of lysosomal organelles complex 2 subunit 1"	Q969F9	3	149129584-149173732	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Albinism, Disease mutation, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046281, HPA052778"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"		"HPA046281: AB_10961641, HPA052778: AB_2681943"	"unprognostic (1.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.06e-2)"	14.4	17.6	10.5	16.1	11.5	6.3	18.8	8.1	11.8	13.0	11.7	12.8	6.2	13.7	17.1	10.3	10.2	12.4	11.5	8.9	9.9	8.7	15.3	10.1	12.1	25.1	11.5	10.4	18.7	13.8	10.1	11.8	13.3	11.9	13.4	11.8	13.9	13.4	11.5	5.9	8.9	16.3	13.4	17.1	19.8	12.5	8.5	12.6	23.8	13.7	4.5	19.9	16.3	17.9	16.3	19.9	16.1	15.4	9.3	16.0	10.7	19.8	11.0	6.6	6.8	9.3	12.0	5.0	8.2	16.1	10.8	14.0	3.7	13.2	5.1	10.5	9.8	49.5	6.8	7.3	5.6	14.0	12.4	5.8	2.3	5.3	4.1	8.3	6.3	3.9	7.8	5.7	10.4	4.3	22.2	11.0	8.4	2.6	12.4	13.7	12.3	4.5	8.9	15.9	10.8	8.9	5.4	4.3	13.6	5.9	10.0	2.0	5.3	7.0	7.5	15.2	15.0	8.1	8.4	5.5	10.8	1.9	10.9	11.8	10.2	4.0	12.6	16.1	12.4	2.6	16.1	12.8	11.9	13.4	15.4	16.0	16.3	12.2	13.8	19.9	13.3	9.5	12.5	5.8	9.3	10.1	11.3	10.5	10.7	10.5	11.5	8.1	11.8	9.9	8.7	11.5	10.4	11.9	12.6	11.9	15.0	15.9	4.2	3.3	6.4	2.0	5.1	24.1	30.7	7.0	2.0	20.2	5.0	9.2	2.4	7.7	8.4	0.0	15.5	11.9	8.0	7.2	15.0	6.7	18.3	3.2	8.6	20.3	25.2	2.6	10.6	17.8	13.5	3.6	8.6	26.3	10.6	3.5	28.3	18.9	5.0	0.0	5.1	2.6	9.3	4.5	11.8	20.0	6.0	4.4
HPS4	"BLOC3S2, KIAA1667, LE"	ENSG00000100099	"HPS4, biogenesis of lysosomal organelles complex 3 subunit 2"	Q9NQG7	22	26443423-26483837	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 40.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033106, HPA050189"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB033106: AB_2264349, HPA050189: AB_2681046"	"unprognostic (1.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.82e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.46e-2)"	7.9	9.6	10.7	7.4	16.3	11.3	8.4	43.1	16.4	11.9	8.0	14.1	9.5	6.6	11.2	10.1	10.5	11.8	7.4	5.0	9.4	11.8	10.7	7.9	8.0	10.8	10.7	11.9	15.8	15.5	14.5	18.7	6.7	12.0	8.9	6.9	15.7	10.8	10.2	5.0	17.1	7.4	8.9	10.5	9.0	8.8	18.2	8.3	18.0	12.3	4.0	12.7	8.0	8.8	7.8	7.3	12.6	4.0	9.2	6.9	5.7	7.5	3.5	7.5	7.7	5.7	6.8	4.0	4.6	9.0	10.4	9.4	3.7	3.7	7.2	3.7	5.6	5.9	6.3	7.2	10.0	9.5	5.3	7.4	7.3	3.2	6.2	10.2	8.5	8.3	6.6	8.3	9.5	17.0	8.9	6.8	12.2	8.0	9.2	7.5	3.2	14.3	3.0	4.5	7.0	3.9	40.2	8.9	9.4	4.8	4.8	8.6	6.4	4.4	5.2	22.5	5.9	5.5	6.5	4.2	12.3	22.9	6.0	5.7	13.7	10.6	23.8	8.0	5.5	7.8	12.6	4.0	4.0	6.6	3.0	6.2	7.8	5.4	5.6	5.6	6.7	6.4	6.9	1.4	9.2	2.6	7.3	3.6	5.7	10.7	16.3	43.1	16.4	9.4	11.8	10.7	11.9	12.0	8.3	11.9	29.6	43.3	22.6	11.1	48.8	5.5	7.6	25.4	20.5	40.1	108.0	17.7	14.9	16.1	17.5	18.5	12.7	46.7	23.5	16.2	12.7	21.7	40.5	11.3	21.3	41.3	25.5	26.4	15.5	19.4	30.2	16.9	45.5	4.6	18.9	25.2	32.6	14.0	18.7	10.2	120.3	0.0	8.8	33.5	39.0	13.0	16.7	17.9	20.6	22.8
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: AB_2680903, HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	12.3	11.4	25.2	9.1	34.5	5.0	16.2	16.1	25.3	7.9	9.5	8.1	10.8	8.9	6.2	9.2	22.3	8.3	10.9	28.7	22.2	22.4	8.2	6.5	8.9	8.0	23.2	12.9	7.7	9.7	11.7	10.3	10.1	15.0	10.0	6.2	8.2	10.1	12.7	51.8	32.0	8.2	8.4	17.0	6.5	7.2	6.1	11.0	5.9	8.1	24.5	9.3	9.9	19.8	2.1	1.1	0.7	4.6	0.1	2.0	0.3	22.1	19.7	9.4	8.4	5.8	4.1	12.2	11.0	5.9	17.4	14.8	9.9	8.8	8.6	3.4	15.0	12.3	17.6	10.0	26.8	4.9	7.0	22.4	4.4	7.9	8.6	8.9	3.5	3.4	6.3	30.0	9.4	10.2	3.6	8.6	7.2	8.9	12.5	9.7	18.2	12.9	12.2	9.6	7.7	19.5	10.3	11.9	7.6	9.7	5.5	36.7	14.6	10.3	18.3	7.9	5.9	15.0	6.8	13.7	15.5	12.2	5.7	14.2	4.6	6.2	6.5	14.6	6.4	14.5	0.0	0.6	0.7	1.4	1.2	1.6	0.8	1.4	1.3	0.7	2.1	2.0	0.6	0.0	0.1	4.6	1.1	2.0	0.3	25.2	34.5	16.1	21.1	22.2	22.4	23.2	12.9	15.0	11.0	11.9	12.5	12.6	82.5	116.5	44.6	21.9	15.3	17.4	4.5	33.2	17.7	72.6	63.0	32.7	1.1	22.2	44.1	0.0	32.3	45.3	34.0	46.2	2.3	13.4	33.9	46.1	28.2	19.0	7.6	5.2	15.8	17.6	60.8	16.2	22.1	28.3	35.8	21.0	21.5	42.9	29.1	32.3	38.7	4.7	23.4	127.5	65.3	12.2	21.3	96.6
HRASLS	"H-REV107, HRASLS1"	ENSG00000127252	"HRAS like suppressor"		3	193241125-193277738	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"skeletal muscle: 40.9;testis: 42.1"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 449.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;NTERA-2: 7.6;PC-3: 16.8;RH-30: 7.4;SCLC-21H: 15.3;U-2 OS: 9.3;U-251 MG: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"		No	No			"Focal adhesion sites"	Cytosol	"HPA051179: AB_2681375"	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.6	1.1	1.8	0.2	3.1	0.1	1.0	0.6	3.3	0.5	0.6	1.7	0.0	0.1	0.6	3.1	2.4	0.5	0.2	4.3	2.0	1.1	0.6	0.6	0.5	0.1	1.5	2.1	0.6	0.8	0.5	0.7	0.1	2.4	0.5	0.1	3.1	6.1	0.5	40.9	1.7	0.6	0.7	0.6	0.6	0.6	42.1	1.7	0.2	3.7	6.2	0.2	0.5	0.6	0.0	0.2	1.7	0.1	0.0	0.0	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.3	0.0	0.1	0.0	0.1	0.0	3.7	0.0	8.7	0.2	0.4	0.0	3.9	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.6	0.2	16.8	0.0	7.4	0.0	2.5	0.0	15.3	2.9	1.0	2.2	0.0	1.4	4.4	0.0	0.1	0.0	9.3	0.0	11.7	0.0	0.0	0.0	4.8	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.2	1.8	3.1	0.6	3.3	2.0	1.1	1.5	2.1	2.4	1.7	0.0	0.0	0.0	0.1	0.9	10.8	10.6	2.5	0.0	1.2	0.0	31.4	0.7	0.0	0.7	449.3	0.6	0.0	0.0	0.2	0.8	0.4	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.3	85.3	6.9	0.8	1.7	0.0	0.0	1.6	0.5	0.0	4.6	0.1	5.6	0.0	0.4	112.1	25.2	5.4	0.3	0.0	0.0	0.0
HRASLS2	FLJ20556	ENSG00000133328	"HRAS like suppressor 2"	Q9NWW9	11	63552770-63563383	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 16.1;intestine: 42.5"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 19.5;Ciliated cells: 45.5;Enterocytes: 59.0;Proximal tubular cells: 75.2;Urothelial cells: 43.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 16.1;naive B-cell: 5.3"	"Lineage enriched"	"Detected in many"	12	"B-cells: 16.1"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 54.4"									HPA058997	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.4	0.0	0.4	1.5	0.4	0.0	4.7	0.4	0.4	0.6	20.6	0.5	0.4	33.4	0.6	1.1	0.5	2.1	0.4	1.0	0.4	0.2	5.5	1.9	3.3	1.1	0.4	0.4	0.4	0.4	0.0	0.4	1.4	0.4	0.4	6.5	0.4	0.7	0.4	0.4	0.2	42.5	0.4	0.4	0.7	8.8	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	16.1	0.8	0.1	0.1	1.2	0.9	3.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.4	0.0	0.4	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	3.5	0.8	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	54.4	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.9	16.1	0.2	0.9	0.0	5.3	0.2	0.6	0.1	1.2	0.0	0.8	0.0	3.6	0.4	0.4	0.4	0.4	0.4	0.2	0.4	0.4	0.4	0.4	3.0	0.6	3.0	19.5	0.1	0.0	0.3	5.1	45.5	5.7	0.0	0.0	0.1	8.3	0.4	0.3	0.0	59.0	0.0	0.4	0.3	0.0	6.2	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.7	7.0	0.0	75.2	0.0	0.0	0.0	0.7	0.1	0.0	0.7	1.0	0.9	43.6
HRCT1	"LGLL338, PRO537, UNQ338"	ENSG00000196196	"Histidine rich carboxyl terminus 1"	Q6UXD1	9	35906192-35907141	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.3"	"Cell type enhanced"	"Detected in many"	22	"Enterocytes: 63.2;Mucus-secreting cells: 49.5;Paneth cells: 238.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.8;HBEC3-KT: 7.6;HeLa: 11.3;Hep G2: 8.5;U-2197: 20.4;U-251 MG: 9.5"					"Low region specificity"	"Detected in all"			HPA067038			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067038: AB_2685767"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.80e-1)"	"unprognostic (9.43e-2)"	25.3	1.9	1.9	3.6	2.8	0.4	21.4	0.9	3.4	5.3	16.8	1.8	1.4	11.2	4.2	3.9	6.6	3.5	2.1	7.6	2.6	1.6	17.6	1.8	5.2	5.0	2.4	2.3	2.2	1.6	0.3	0.7	4.7	3.6	3.6	14.8	5.8	4.6	4.0	6.1	4.2	14.3	6.5	1.5	0.8	2.5	5.3	1.4	0.0	3.5	1.2	1.5	4.6	3.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.6	4.6	0.0	0.2	0.4	0.1	0.0	0.1	1.2	0.0	13.8	0.3	2.6	0.0	0.0	7.6	0.0	0.0	0.0	0.0	11.3	8.5	1.8	0.0	0.0	4.5	3.9	1.5	0.9	0.6	4.7	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	3.5	1.8	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	3.9	0.2	4.1	20.4	9.5	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.8	0.9	3.4	2.6	1.6	2.4	2.3	3.6	1.4	6.0	1.0	0.0	0.4	1.9	1.5	0.6	2.5	1.4	3.4	0.0	0.0	20.6	1.7	0.8	0.0	21.2	63.2	0.0	0.2	6.6	4.2	0.6	0.0	0.4	1.6	0.0	1.2	35.0	0.8	0.0	10.0	0.9	1.7	0.0	49.5	7.5	2.7	238.4	8.9	9.3	2.6	12.9	4.6	0.0	0.2	1.6	2.2	0.0	18.6	0.1
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 41.0;Club cells: 30.7;Enterocytes: 29.3;Suprabasal keratinocytes: 36.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.5;hTEC/SVTERT24-B: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	9.1	4.4	7.3	4.6	4.4	0.2	9.6	0.5	10.6	8.0	13.5	1.3	2.4	3.8	6.2	7.2	5.7	10.6	9.9	7.0	5.1	4.0	3.3	1.1	8.2	1.8	2.2	2.1	8.7	2.1	1.7	1.2	5.5	3.2	7.2	7.2	2.0	3.4	6.1	3.0	8.0	10.5	9.2	8.6	1.4	3.3	2.4	2.0	0.1	2.5	7.2	3.1	11.2	16.2	0.1	0.3	1.2	0.2	0.1	3.5	0.1	1.5	3.5	0.0	0.0	1.6	17.5	2.4	2.6	8.8	7.8	5.3	0.6	12.6	0.0	7.8	6.1	8.0	9.9	0.0	3.6	10.7	5.5	0.0	0.8	5.7	0.0	5.3	2.4	1.4	6.1	2.2	17.7	6.2	10.9	10.9	0.1	0.0	0.0	3.5	0.0	0.0	1.1	0.0	1.5	3.2	0.2	0.9	0.3	14.0	2.0	0.1	0.0	3.7	2.7	0.0	0.1	0.0	2.0	16.2	8.8	5.5	9.0	13.1	0.0	0.9	0.0	13.5	2.2	7.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	1.3	0.5	0.3	0.1	0.1	0.1	1.2	0.1	0.0	0.1	3.5	0.1	7.3	4.4	0.5	8.4	5.1	4.0	2.2	2.1	3.2	2.0	6.0	1.4	0.0	7.7	41.0	0.0	0.4	0.0	2.7	30.7	1.8	0.0	0.2	0.0	0.4	0.3	9.3	29.3	0.0	0.6	1.0	6.7	3.9	2.3	0.0	21.0	0.0	3.4	0.6	6.9	0.0	3.4	5.7	0.0	0.0	8.0	0.0	8.3	11.4	0.0	0.3	0.1	0.0	2.3	2.3	2.8	36.3	0.5	0.0	8.8	18.2
HRNR	"FLG3, S100A16, S100a18"	ENSG00000197915	Hornerin	Q86YZ3	1	152212082-152224193	"Plasma proteins, Predicted intracellular proteins"	Keratinization	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 4.0"	"Cell type enhanced"	"Detected in some"	24	"Horizontal cells: 1.6;Rod photoreceptor cells: 3.3"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"					"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.6;HaCaT: 1.5;HDLM-2: 1.3;NTERA-2: 6.2;TIME: 1.2;U-2 OS: 1.6;U-2197: 1.5"									HPA031469	Uncertain		Approved	Mitochondria		No	No		210000000	Mitochondria		"HPA031469: AB_10603771"	"unprognostic (1.34e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.72e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.64e-2)"	0.3	0.4	0.0	0.1	0.2	0.1	0.3	0.0	1.3	0.7	0.1			0.1	0.5	0.0	1.8	0.8	0.6	0.5	0.1	0.1	1.0	0.0	0.1	0.4	0.0		1.6	1.5	0.0	0.4	0.1		0.6	0.0		0.2	0.0	0.1	4.0	0.2	0.0	0.1	0.1	0.1	1.3			1.6		0.0	0.4	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.6	1.2	0.1	1.6	1.5	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
HS1BP3	"FLJ14249, HS1-BP3"	ENSG00000118960	"HCLS1 binding protein 3"	Q53T59	2	20560448-20651089	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035050	Approved		Approved	Nucleoli,Cytosol		No	No		32000	Nucleoli	Cytosol	"HPA035050: AB_10601816"	"unprognostic (4.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (2.06e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-1)"	17.9	23.1	10.4	8.8	15.7	10.7	11.8	6.7	17.6	17.6	22.6	21.3	14.3	11.7	17.6	18.6	22.6	13.9	28.4	17.5	11.0	9.1	18.5	47.8	14.2	11.7	16.7	9.4	14.8	13.9	10.6	14.3	22.3	13.5	20.3	11.7	17.0	12.9	17.3	9.6	17.0	16.0	27.3	13.8	14.5	16.4	9.7	14.1	6.6	18.5	8.0	9.9	20.8	17.1	6.0	8.0	14.6	13.3	2.9	5.3	6.1	8.4	9.9	5.0	6.1	26.6	17.9	9.9	3.2	15.0	7.7	10.1	7.7	10.3	5.7	2.6	4.7	35.0	5.3	9.9	10.2	3.7	7.3	8.2	3.0	5.0	25.6	25.0	2.3	13.3	18.9	23.9	8.7	16.2	9.2	14.6	5.1	1.9	12.3	8.7	7.3	1.0	3.9	4.1	12.5	7.2	5.5	10.1	5.5	17.1	10.3	4.7	7.3	2.3	10.1	19.2	10.6	6.3	4.7	9.4	7.7	8.3	11.7	4.9	8.8	9.8	5.2	16.5	10.8	8.1	11.4	11.3	11.0	5.3	11.2	3.7	6.0	3.2	4.0	8.0	4.0	2.7	2.8	14.6	2.9	13.3	3.0	2.9	6.1	10.4	15.7	6.7	17.6	11.0	9.1	16.7	9.4	13.5	14.1	6.0	17.0	9.3	7.5	3.9	3.8	6.1	7.6	10.7	14.8	7.0	0.0	7.7	14.9	17.0	16.8	4.9	13.5	23.3	12.9	14.6	8.0	7.2	2.3	8.2	26.5	14.3	6.4	10.4	16.7	28.4	7.8	10.9	13.5	10.8	6.1	8.6	10.8	7.8	9.9	21.3	4.9	0.0	15.6	11.6	9.6	4.5	14.6	7.5	6.6	4.6
HS2ST1	KIAA0448	ENSG00000153936	"Heparan sulfate 2-O-sulfotransferase 1"	Q7LGA3	1	86914648-87109998	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043069, HPA043603, HPA075001"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No			Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.58e-2)"	8.8	28.7	15.5	9.6	25.2	2.8	7.3	8.9	15.1	10.3	9.5	6.2	5.4	8.6	9.0	9.4	6.4	6.5	9.6	6.8	14.7	10.2	12.8	15.5	8.0	9.7	9.2	13.8	12.3	9.0	15.9	12.1	7.5	10.1	8.9	8.3	8.2	8.3	9.7	5.3	7.2	8.0	7.1	7.6	18.6	7.2	8.0	7.7	16.5	11.8	4.3	10.0	9.2	7.1	5.6	1.3	9.0	4.3	1.8	3.0	1.8	9.9	8.5	25.0	16.3	13.9	40.6	8.7	9.7	12.8	8.2	9.1	32.4	12.8	21.9	9.5	6.7	14.2	6.1	11.4	8.1	13.3	17.1	9.5	26.3	9.4	25.8	5.8	13.5	13.2	16.7	7.2	13.2	11.0	13.0	12.1	12.4	17.9	11.6	11.8	3.5	13.5	8.2	8.7	10.9	5.6	16.8	23.7	4.7	10.0	20.9	5.4	8.1	12.9	11.1	11.2	6.8	7.3	6.2	10.6	10.3	12.8	18.0	12.2	10.7	7.9	20.6	6.3	9.8	10.5	9.0	2.0	1.7	2.6	1.2	3.0	2.0	2.8	2.8	1.3	5.6	2.8	1.8	2.1	1.8	4.3	1.3	1.5	1.8	15.5	25.2	8.9	15.1	14.7	10.2	9.2	13.8	10.1	7.7	14.9	11.3	8.0	7.0	14.7	8.7	11.5	15.3	9.4	19.4	19.2	3.9	8.0	11.6	13.0	3.6	12.6	10.5	0.0	10.0	7.5	16.7	8.7	18.5	24.1	29.9	7.9	22.4	17.2	12.6	3.0	6.4	11.8	11.8	5.4	13.5	26.9	11.0	3.5	19.1	14.7	16.3	0.0	14.2	7.4	13.9	13.8	3.7	7.5	13.0	6.8
HS3ST1	3OST1	ENSG00000002587	"Heparan sulfate-glucosamine 3-sulfotransferase 1"	O14792	4	11393150-11429765	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;gallbladder: 31.9;ovary: 30.3"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 64.3;Club cells: 83.0;granulocytes: 93.6;Peritubular cells: 84.8;Urothelial cells: 90.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"cerebellum: 27.4;cerebral cortex: 9.0"	"Group enriched"	"Detected in some"	39	"memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3"	"Group enriched"	"Detected in many"	99	"B-cells: 15.8;dendritic cells: 22.3"	"Cell line enhanced"	"Detected in some"		"A-431: 4.5;CAPAN-2: 14.4;HaCaT: 4.3;RPTEC TERT1: 12.6;RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002237	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA002237: AB_1079085"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (3.32e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.99e-8)"	"unprognostic (9.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (8.67e-4)"	2.3	2.9	1.6	2.8	2.2	2.8	2.0	27.4	9.0	3.3	2.7	1.1	3.6	3.5	4.3	5.0	10.2	4.3	31.9	2.2	1.7	1.8	10.4	0.9	3.4	2.1	1.9	1.5	30.3	1.1	0.7	8.9	1.0	2.4	3.2	1.7	1.7	3.7	2.4	0.7	0.8	2.9	1.7	2.2	3.0	7.0	3.0	0.3	3.8	1.8	7.0	7.4	7.3	2.4	15.8	22.3	0.1	0.1	0.0	0.1	0.6	4.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.4	0.0	0.4	0.0	0.0	4.3	0.0	2.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.9	1.2	1.0	0.0	0.0	12.6	10.3	3.8	0.0	0.0	0.1	0.5	0.2	0.0	0.0	2.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	7.3	0.0	0.0	0.3	15.8	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.6	1.6	2.2	27.4	9.0	1.7	1.8	1.9	1.5	2.4	0.3	3.0	8.0	2.2	9.8	8.0	1.5	2.4	15.3	64.3	83.0	19.2	3.9	0.5	0.0	17.1	0.8	23.4	3.0	0.0	1.8	31.9	5.0	4.1	93.6	0.0	37.3	1.6	2.4	9.2	2.7	0.8	8.1	9.0	1.7	7.2	5.6	39.8	32.0	2.6	84.8	3.7	2.2	0.0	6.4	6.0	5.5	7.0	1.1	0.9	3.7	90.2
HS3ST3A1	"30ST3A1, 3OST3A1"	ENSG00000153976	"Heparan sulfate-glucosamine 3-sulfotransferase 3A1"	Q9Y663	17	13495689-13601927	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Horizontal cells: 25.4;Ito cells: 8.0;Leydig cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.0;cerebral cortex: 2.2;pons and medulla: 3.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.9;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.2;U-251 MG: 47.9;U-87 MG: 29.7"									"HPA062518, HPA071530"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA062518: AB_2684789, HPA071530: AB_2686411"	"unprognostic (2.88e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.35e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.12e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-9)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.70e-3)"	1.3	3.3	0.2	2.8	1.0	1.5	2.3	0.1	2.2	7.8	1.6	0.3	5.8	2.3	3.3	1.3	8.1	1.9	1.3	3.8	0.3	0.2	1.7	3.4	2.2	9.3	0.1	0.4	12.1	0.4	0.0	1.2	6.8	3.0	9.9	0.5	2.0	3.3	8.6	0.9	1.1	1.7	0.4	1.3	11.7	1.0	2.9	0.0	0.6	0.6	6.3	12.7	1.4	5.3	0.1	3.9	0.5	0.1	0.7	5.1	0.8	0.0	0.1	1.2	0.0	0.8	2.2	2.0	7.7	1.6	1.3	0.8	0.0	0.2	0.0	1.0	4.2	0.0	0.0	0.0	0.0	1.0	0.4	7.9	2.0	0.6	0.7	0.6	0.0	0.5	2.0	0.0	3.4	0.7	1.7	0.0	0.1	7.6	0.0	1.3	1.0	0.0	1.3	1.4	0.0	17.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	1.2	0.1	0.0	47.9	0.0	0.0	0.0	29.7	0.0	3.6	0.0	0.0	0.0	1.7	0.0	0.8	0.0	1.2	1.4	0.0	0.1	1.4	1.4	0.5	0.7	0.1	3.9	5.1	0.8	0.2	1.0	0.1	2.2	0.3	0.2	0.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.2	25.4	0.0	8.0	1.0	0.0	12.7	0.0	0.0	0.0	0.0	1.0	0.7	0.0	2.1	0.0	0.1	0.0	1.4	0.1	0.0	0.5	0.1	0.0	0.0	0.0
HS3ST3B1	"30ST3B1, 3OST3B1"	ENSG00000125430	"Heparan sulfate-glucosamine 3-sulfotransferase 3B1"	Q9Y662	17	14301083-14349404	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 37.3;Hepatocytes: 32.1;Ito cells: 34.4;Syncytiotrophoblasts: 30.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.7;pons and medulla: 6.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 20.6;T-cells: 14.7"	"Cell line enhanced"	"Detected in many"		"AF22: 15.5;BEWO: 11.1;Hep G2: 13.5;HSkMC: 15.4;U-251 MG: 14.2"									HPA064126			Approved	Vesicles		NA	NA			Vesicles		"HPA064126: AB_2685194"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.77e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-3)"	1.4	1.4	0.6	8.7	0.8	1.3	3.0	0.9	2.7	3.8	1.8	0.0	0.8	1.4	1.0	0.3	2.8	1.7	2.6	2.0	0.6	0.7	3.6	29.1	3.7	26.6	0.6	0.0	4.7	1.3	0.4	1.4	33.5	6.0	2.4	1.9	5.3	12.6	2.5	1.8	2.2	2.5	0.6	2.9	4.9	1.4	0.7	0.0	13.2	1.5	2.5	5.9	1.5	5.3	0.4	20.6	0.5	0.4	3.8	14.7	2.7	0.0	0.3	15.5	0.0	4.7	5.3	11.1	4.4	6.4	4.0	4.2	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.4	2.4	2.0	1.3	3.2	0.3	2.0	13.5	6.2	0.5	2.3	15.4	0.8	1.4	3.7	0.9	0.0	0.8	4.6	0.0	3.2	0.8	0.7	0.6	0.5	0.1	0.4	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.3	0.4	0.0	3.9	0.0	0.0	14.2	0.0	0.0	0.0	3.0	0.0	0.9	0.1	0.2	0.0	6.3	0.4	5.0	0.4	7.6	4.9	0.4	0.4	7.7	7.5	0.5	3.8	0.4	20.6	14.7	2.7	0.6	0.8	0.9	2.7	0.6	0.7	0.6	0.0	6.0	0.0	0.0	0.6	1.4	0.2	10.2	2.0	2.2	2.5	4.0	1.2	7.0	37.3	5.1	0.0	0.6	11.1	2.5	0.0	0.0	0.2	10.4	9.0	0.7	0.0	32.1	1.4	7.9	0.0	34.4	3.7	1.4	2.6	4.3	1.7	1.8	0.0	6.0	0.1	0.0	1.1	0.0	15.2	12.9	2.7	0.6	0.4	12.9	30.3	11.7	0.0	0.1
HS6ST1	HS6ST	ENSG00000136720	"Heparan sulfate 6-O-sulfotransferase 1"	O60243	2	128236716-128318577	"Disease related genes, Predicted intracellular proteins"		Transferase	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 71.5;granulocytes: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 39.5;HMC-1: 62.8;SCLC-21H: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044586			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		27000	Nucleoplasm		"HPA044586: AB_10963057"	"unprognostic (9.94e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.94e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	13.2	32.0	22.4	8.0	16.2	4.1	9.2	17.2	33.2	16.2	9.6	13.5	23.8	8.3	8.8	6.4	19.3	17.1	20.1	8.1	17.3	13.9	22.8	29.5	9.1	7.1	17.8	18.8	16.2	24.2	8.9	7.5	11.5	16.5	13.1	6.9	10.5	12.2	23.9	20.1	14.2	11.3	6.4	14.9	18.2	6.3	14.7	15.6	10.9	7.0	6.7	8.0	19.1	11.1	2.0	5.5	5.8	3.0	0.5	2.6	1.2	3.5	5.2	14.0	8.0	5.4	10.2	7.5	4.4	5.7	4.5	2.5	2.6	2.4	3.5	39.5	5.7	2.1	9.6	5.3	8.7	1.7	5.7	5.4	3.0	1.9	25.6	6.6	5.3	62.8	13.7	10.3	3.6	1.1	1.5	2.4	9.5	1.9	3.6	1.6	7.5	14.1	23.5	16.7	1.4	3.2	4.6	3.8	18.0	4.1	10.8	34.4	8.6	3.6	9.1	2.0	9.8	3.7	2.0	2.8	4.0	8.9	14.8	3.5	2.1	2.1	0.7	2.4	3.8	2.9	5.8	1.6	1.4	2.6	1.0	0.4	1.9	1.0	1.6	1.1	2.0	1.0	1.0	0.5	0.5	3.0	5.5	0.5	1.2	22.4	16.2	17.2	33.2	17.3	13.9	17.8	18.8	16.5	15.6	23.8	12.8	5.2	10.5	14.3	8.1	6.1	7.6	10.7	9.1	71.5	29.5	7.4	5.0	10.2	0.8	7.7	7.1	0.0	5.1	34.4	11.6	6.8	54.4	15.1	8.6	20.6	2.9	30.7	11.7	2.0	10.9	6.2	6.8	6.4	5.2	7.8	7.9	8.2	15.9	2.8	33.7	6.5	5.1	1.1	3.1	14.9	19.5	2.5	4.1	7.8
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090839-96839562	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.7"	"Cell type enhanced"	"Detected in some"	13	"Horizontal cells: 3.2;Pancreatic endocrine cells: 1.0;Rod photoreceptor cells: 1.8;Spermatogonia: 1.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RT4: 19.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA		9800	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: AB_2732374"	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	0.9	4.5	1.5	0.0	1.9	0.0	0.0	0.4	18.7	1.9	0.0			0.2	2.1	2.2	0.2	0.1	0.0	0.2	3.2	2.7	0.7	0.0	0.0	0.0	0.9		0.0	2.1	0.0	0.7	0.0		0.1	0.0		0.0	0.1	0.6	0.1	0.0	1.6	0.4	0.0	0.7	0.1			2.4		0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	19.6	1.0	0.8	0.1	0.1	0.0	0.3	0.6	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0
HSBP1L1	"FLJ10967, MGC189743"	ENSG00000226742	"Heat shock factor binding protein 1 like 1"	C9JCN9	18	79964561-79970822	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"granulocytes: 17.0;T-cells: 17.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.5;SK-MEL-30: 29.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA048273	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048273: AB_2680337"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.15e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.76e-2)"	7.2	15.4	10.7	4.8	9.9	2.9	18.2	15.2	13.3	10.9	16.3	3.0	14.2	6.9	7.0	11.5	14.4	9.3	8.3	5.8	11.4	7.8	15.2	37.9	11.1	3.8	9.4	5.9	5.7	21.2	8.3	8.2	11.0	15.5	8.9	13.0	8.9	18.5	19.9	12.4	12.1	5.6	6.3	7.1	5.3	10.5	2.1	9.7	0.7	15.2	14.3	6.4	6.6	9.7	1.8	2.0	17.0	4.2	3.1	17.4	3.9	9.1	2.2	0.0	0.1	1.3	4.5	3.9	4.4	9.5	4.4	3.8	4.6	6.0	0.0	1.1	5.3	0.0	5.2	8.0	5.1	1.9	9.3	2.1	0.0	2.3	2.2	51.5	0.0	0.0	5.1	14.4	0.4	3.2	9.2	0.1	1.3	0.0	0.0	0.2	7.4	0.0	0.0	0.0	5.1	9.8	0.1	0.0	0.0	15.6	2.0	0.1	0.4	4.7	5.8	29.1	0.4	3.3	2.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	2.4	0.1	17.0	4.2	5.2	3.8	2.7	4.6	1.5	6.6	4.1	1.7	1.8	17.4	9.3	0.2	3.1	0.9	2.0	2.9	3.9	10.7	9.9	15.2	13.3	11.4	7.8	9.4	5.9	15.5	9.7	50.6	25.1	0.9	60.6	35.3	8.5	11.5	38.2	46.8	43.3	47.1	21.6	106.1	58.0	53.9	0.9	19.8	71.4	23.3	54.4	55.1	20.9	68.1	18.5	107.1	37.6	19.1	11.1	22.7	19.6	0.7	18.4	16.9	37.1	1.0	74.8	21.2	100.9	96.8	23.0	57.9	28.4	0.0	11.6	1.4	0.6	50.6	98.2	12.5	87.5	81.2
HSCB	"DNAJC20, HSC20, Jac1"	ENSG00000100209	"HscB mitochondrial iron-sulfur cluster cochaperone"	Q8IWL3	22	28742031-28757515	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018447, HPA031518"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA018447: AB_1853867, HPA031518: AB_2673919"	"unprognostic (8.19e-3)"	"unprognostic (6.48e-2)"	"unprognostic (9.62e-3)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.30e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.38e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (8.38e-4)"	9.6	18.8	13.1	9.2	13.9	4.9	12.4	13.7	12.9	14.1	11.6	9.1	20.3	13.7	11.5	8.8	11.8	10.4	11.4	9.6	12.3	8.3	12.9	29.5	7.3	15.5	15.8	9.0	16.5	15.2	6.2	16.1	8.7	10.6	15.9	7.7	8.2	28.2	17.5	14.6	9.2	10.0	8.9	12.2	10.9	12.8	6.0	13.2	6.9	14.4	8.1	10.3	15.0	10.5	12.9	11.3	7.7	14.4	9.7	8.5	5.8	9.3	6.0	2.5	3.8	4.6	11.8	4.8	6.9	9.7	10.3	6.3	2.6	3.4	10.6	3.3	3.8	2.5	6.6	4.8	4.5	4.9	10.0	19.5	3.6	4.7	7.4	9.8	6.6	5.4	7.9	9.9	5.7	9.0	5.3	7.8	3.2	5.6	9.3	4.1	13.5	3.0	6.1	6.0	10.3	14.8	6.0	7.8	11.9	11.1	2.7	8.5	7.7	3.8	14.6	18.4	2.1	6.0	4.1	4.1	14.1	7.4	13.3	6.2	13.1	10.7	9.1	9.9	4.9	9.3	7.7	7.9	3.6	6.3	14.4	7.6	12.9	6.4	7.4	11.3	9.9	7.0	8.5	0.4	9.7	11.0	5.9	4.8	5.8	13.1	13.9	13.7	12.9	12.3	8.3	15.8	9.0	10.6	13.2	20.8	15.8	20.1	22.7	10.3	4.8	6.0	22.9	32.1	26.1	19.2	5.9	13.2	24.9	21.9	3.3	15.8	10.3	0.0	24.7	12.0	16.6	18.9	22.0	33.0	23.7	4.8	19.0	17.2	14.9	2.6	17.3	18.5	13.5	19.8	13.1	9.7	21.0	7.0	11.0	37.1	8.1	6.5	15.6	12.2	16.1	13.7	11.1	17.8	19.7	12.8
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.8;kidney: 119.9;salivary gland: 66.0"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 181.5;Enterocytes: 273.5;Mucus-secreting cells: 229.5;Paneth cells: 137.2;Syncytiotrophoblasts: 95.8;Undifferentiated cells: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.7;OE19: 21.3;RPMI-8226: 10.2;RT4: 10.3;SCLC-21H: 11.4;SK-BR-3: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	0.4	1.0	0.6	22.2	2.3	0.0	3.2	2.0	1.7	4.8	42.8	0.3	1.3	9.4	3.8	3.6	2.5	2.4	8.3	0.5	0.5	0.1	119.9	1.2	2.3	0.7	0.3	0.8	4.8	2.1	0.0	0.4	42.3	1.1	3.7	24.5	0.4	66.0	1.4	0.4	13.8	62.8	4.3	0.3	1.5	2.1	1.4	1.3	0.5	3.8	3.3	1.6	1.5	4.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.8	0.3	1.1	0.1	1.3	2.8	0.0	0.0	0.1	0.1	4.5	1.0	0.0	2.1	0.0	0.1	5.8	3.9	0.4	0.0	0.0	1.3	0.0	0.5	4.8	0.4	0.5	0.0	1.3	2.3	0.2	0.0	0.0	0.0	3.5	0.3	0.0	0.0	2.8	0.1	0.1	8.7	21.3	0.7	0.0	0.1	10.2	0.4	10.3	11.4	0.7	0.6	10.2	0.4	1.0	4.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	2.3	2.0	1.7	0.5	0.1	0.3	0.8	1.1	1.3	0.0	0.3	0.0	8.0	1.3	0.0	0.5	33.1	0.0	1.2	181.5	0.0	0.8	38.1	1.7	0.1	0.0	273.5	0.0	2.7	0.7	3.1	15.6	9.2	1.3	1.3	0.0	25.8	1.3	0.0	0.0	23.6	0.0	1.7	0.0	229.5	0.0	0.8	137.2	6.3	14.6	0.0	12.9	0.4	0.2	1.0	3.0	95.8	0.0	114.3	5.7
HSD17B13	"SCDR9, SDR16C3"	ENSG00000170509	"Hydroxysteroid 17-beta dehydrogenase 13"	Q7Z5P4	4	87303789-87322906	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 158.8"	"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 61.6;Club cells: 78.5;Hepatocytes: 112.8;Urothelial cells: 30.7"	"Cancer enriched"	"Detected in some"	26	"liver cancer: 52.9"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA029125	Uncertain		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA			Vesicles	"Golgi apparatus"	"HPA029125: AB_10601580"	"unprognostic (2.49e-1)"	"unprognostic (7.46e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.86e-4)"	"unprognostic (4.74e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.94e-4)"	"prognostic favorable (7.80e-4)"	"unprognostic (4.97e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.18e-4)"	"unprognostic (3.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-3)"	8.0	0.1	0.1	0.2	0.1	0.3	1.8	1.0	0.1	1.3	0.3	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.9	0.1	0.0	0.1	158.8	0.8	0.1	0.1	0.1	0.1	2.4	0.0	0.1	0.3	0.1	2.4	0.1	0.1	0.2	0.1	0.1	1.4	0.1	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.1	0.3	2.7	1.8	0.6	3.7	0.7	0.8	0.8	0.1	0.2	0.3	0.8	0.9	1.1	0.8	0.6	0.1	0.3	0.0	0.1	0.0	1.8	0.6	0.6	0.3	0.1	0.4	0.2	0.2	0.2	0.6	0.3	1.0	1.1	1.8	0.8	2.6	1.1	0.4	0.0	0.0	0.1	0.9	0.3	0.9	0.8	0.9	0.3	0.3	0.4	4.9	0.4	1.4	0.5	0.8	1.0	0.3	0.3	0.5	0.5	2.1	0.6	0.4	0.2	0.5	0.2	1.6	1.0	0.5	2.7	0.7	0.4	0.5	0.3	0.5	0.3	2.0	1.0	3.7	0.7	1.5	0.4	0.2	0.4	1.8	0.4	0.4	0.1	1.1	0.8	0.7	2.8	0.8	0.3	0.6	0.4	0.1	0.1	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	5.4	0.0	19.6	2.3	0.0	0.3	2.5	61.6	78.5	1.8	0.0	0.1	0.0	0.0	2.1	0.4	0.0	0.0	0.4	0.2	1.0	1.1	0.0	112.8	0.2	0.0	1.7	1.3	1.6	1.8	0.0	0.5	0.0	0.0	0.7	0.3	0.2	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.6	30.7
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.1;liver: 52.9;placenta: 110.8"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 137.6;Enterocytes: 250.1;Hepatocytes: 98.5;Paneth cells: 199.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.4;Hep G2: 17.8;hTERT-HME1: 10.7;OE19: 32.8;RT4: 36.8;TIME: 20.6"	"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 3.5"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	0.7	0.1	0.2	4.1	0.2	0.0	3.9	0.2	0.3	0.7	41.3	0.3	0.2	71.3	0.6	0.2	1.7	0.2	13.3	0.2	0.2	0.2	2.8	52.9	1.0	0.2	0.2	0.2	0.2	16.0	0.0	0.6	110.8	0.4	3.1	9.4	21.3	9.4	0.2	0.3	1.8	83.1	1.5	0.2	0.2	3.2	0.2	0.2	0.2	0.2	1.1	1.3	21.4	6.6	1.3	1.4	3.6	1.1	1.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	22.4	0.0	0.0	4.1	0.6	0.0	4.5	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.1	17.8	0.1	0.1	0.1	0.0	1.2	0.0	10.7	0.2	0.3	0.0	0.0	0.1	3.3	0.0	0.0	0.3	0.1	32.8	8.1	0.0	0.0	0.4	0.4	36.8	0.2	0.6	0.0	1.0	0.1	0.0	0.0	0.0	20.6	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	1.6	1.1	0.6	0.7	0.5	0.4	0.6	0.4	0.4	0.3	1.3	0.4	0.6	3.6	1.0	0.6	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	3.0	3.8	0.0	2.7	0.3	0.1	0.4	137.6	6.7	2.3	0.0	0.0	2.1	0.0	47.5	0.1	0.2	250.1	0.0	5.5	1.5	3.1	1.8	0.0	98.5	3.0	0.0	2.9	3.1	2.4	0.8	0.0	0.0	1.7	0.0	19.3	42.0	13.6	199.9	0.0	1.0	0.6	0.0	0.3	0.0	0.0	1.0	5.4	0.0	33.8	10.0
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 41.9"	"Cell type enriched"	"Detected in some"	8	"Leydig cells: 100.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.0;HEL: 4.4;U-2 OS: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA056833: AB_2683252"	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	0.5	0.4	1.0	0.5	1.0	0.4	0.5	0.5	0.9	0.8	0.5	0.5	0.5	0.4	0.5	0.5	0.5	1.3	0.5	0.5	1.7	0.5	1.0	6.3	0.5	0.5	1.6	0.5	0.5	1.3	0.4	0.5	0.5	0.5	0.8	0.4	0.5	0.5	0.5	0.5	0.5	1.1	0.5	1.9	0.5	0.4	41.9	0.5	0.5	4.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.0	1.0	0.5	0.9	1.7	0.5	1.6	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.4	0.3	0.0	0.4	0.0	0.2	0.1	0.0	1.6	0.0	0.0	1.7	0.0	0.0	7.8	100.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	12.0	0.0	0.2	0.0	0.5	0.3	1.9	0.3	0.1	0.0	0.2	0.0
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 241.2"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 1569.2"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.8;U-266/84: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	1.1	0.5	3.6	1.4	5.2	0.2	0.3	1.2	2.4	9.4	3.3	0.5	2.6	0.6	4.1	0.7	1.6	0.9	2.6	0.4	1.6	1.4	0.5	241.2	8.7	0.3	2.0	2.6	1.1	0.3	0.2	0.0	0.9	0.6	7.9	1.3	1.4	0.2	10.2	0.2	0.2	0.7	11.3	1.0	6.2	0.8	3.2	0.8	0.0	13.3	0.0	0.3	9.9	2.3	2.0	2.0	0.1	1.3	0.1	3.4	0.8	0.3	0.7	1.7	0.3	1.7	1.2	2.0	3.6	3.1	1.7	1.7	0.4	0.4	10.2	1.5	0.4	0.5	0.3	5.3	0.9	1.0	6.5	2.0	3.2	1.0	0.5	1.1	1.6	5.3	0.9	0.3	1.0	0.5	0.5	0.0	9.0	0.9	11.8	0.8	2.1	4.6	1.0	6.6	0.6	0.6	6.3	0.7	2.5	0.2	1.2	9.7	2.0	1.7	3.1	0.8	0.6	0.5	1.3	0.3	0.8	0.8	3.6	0.9	10.3	14.6	6.7	1.2	5.9	0.6	0.0	0.2	0.1	3.0	0.6	3.4	2.0	2.5	2.4	0.6	1.1	3.3	2.2	0.0	0.1	1.3	2.0	2.8	0.8	3.6	5.2	1.2	2.4	1.6	1.4	2.0	2.6	0.6	0.8	160.8	89.7	28.7	2.3	1.1	0.2	0.2	35.7	2.7	17.0	0.0	0.0	1.3	0.0	0.0	2.5	0.4	0.0	23.3	0.0	2.4	4.8	9.9	0.0	1569.2	0.3	0.0	0.0	31.3	41.1	1.5	11.5	0.1	0.0	1.8	0.3	1.0	0.1	0.0	1.4	0.0	0.6	12.9	3.7	13.6	10.6	1.4	0.3	4.4	0.3	0.9
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Group enriched"	"Detected in some"	23	"Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 36.4;SuSa: 16.3"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.0	0.4	0.5	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	115.9	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.8	0.0	0.0	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 223.2"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enriched"	"Detected in single"	198	"basal ganglia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.0	223.2	0.0	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.5	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.4	0.0	0.0	5.1	1.9	0.0	0.0	1.2	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0
HSF2BP		ENSG00000160207	"Heat shock transcription factor 2 binding protein"	O75031	21	43529192-43659493	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 28.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 98.0;Late spermatids: 32.5;Spermatocytes: 127.5;Spermatogonia: 47.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.5;NK-cells: 1.5;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 14.6"	"Low region specificity"	"Detected in some"							"HPA031724, HPA075775"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031724: AB_10601022, HPA075775: "	"unprognostic (1.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.36e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.77e-4)"	"unprognostic (6.00e-2)"	0.7	0.8	1.3	0.6	3.1	0.5	1.1	1.4	4.1	0.9	0.6	3.5	1.8	0.6	1.1	1.1	0.8	1.2	0.7	0.7	1.3	1.5	0.8	0.6	0.6	0.7	2.3	3.0	1.4	0.6	1.2	2.3	1.6	2.7	0.8	0.6	2.6	1.2	1.4	0.5	0.8	0.7	0.7	2.0	0.5	0.7	28.5	1.6	1.0	1.0	0.0	0.6	0.8	0.8	1.5	0.2	0.0	0.1	1.5	2.8	0.8	5.1	1.1	1.4	0.6	0.2	1.4	1.3	1.8	1.1	1.9	1.6	6.9	5.1	3.9	2.9	1.0	6.6	2.0	0.7	14.6	0.6	1.0	1.3	0.6	2.2	0.4	1.7	1.6	0.4	0.9	9.6	0.8	4.5	8.8	0.5	2.3	1.5	1.2	4.5	0.9	2.2	1.6	4.5	1.2	2.2	3.3	1.4	0.5	2.3	1.0	1.5	1.1	3.8	1.9	2.0	0.6	2.0	1.9	2.9	1.0	3.5	0.2	2.7	1.4	0.9	3.1	1.0	3.4	2.6	0.0	0.1	0.0	0.2	0.0	1.6	1.2	0.5	1.4	0.2	1.5	2.7	2.8	0.0	1.5	0.1	0.2	0.0	0.8	1.3	3.1	1.4	3.6	1.3	1.5	2.3	3.0	2.7	1.6	0.0	0.0	0.0	1.2	0.8	1.0	0.4	0.0	4.0	1.2	0.0	0.0	1.5	0.0	1.0	98.0	0.1	0.0	0.0	0.2	2.3	1.0	0.7	0.0	0.0	0.6	0.0	0.0	0.6	0.0	32.5	1.7	0.3	0.0	0.0	0.0	2.3	1.6	0.0	1.4	0.5	2.5	12.9	1.0	127.5	47.1	0.4	0.7	0.0	0.0	1.0
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.4;lymphoid tissue: 33.8"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 71.7;T-cells: 40.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"basophil: 47.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 13.2;HL-60: 13.7;HMC-1: 18.9;NB-4: 44.6;RPMI-8226: 20.0;U-266/84: 12.9;U-937: 43.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (3.47e-5)"	1.2	1.1	1.2	31.5	1.1	19.2	1.2	1.1	1.1	1.4	8.9	0.0	5.2	5.5	1.1	6.2	2.0	1.5	10.3	1.2	1.1	1.1	1.3	1.5	6.0	16.7	1.0	0.0	1.1	4.8	0.9	3.7	2.3	0.3	2.2	4.0	1.0	8.8	5.2	1.1	1.1	12.1	0.7	1.1	21.8	5.4	1.1	0.0	8.5	1.7	2.4	33.8	4.7	1.1	14.5	6.0	47.4	8.4	19.0	4.3	3.6	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	7.0	13.2	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.7	0.0	0.2	0.1	0.8	0.0	13.7	18.9	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	12.4	0.0	2.8	0.0	44.6	0.0	1.7	0.0	0.9	0.0	20.0	0.1	1.8	0.0	0.0	0.0	0.4	0.1	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	1.9	12.9	7.3	0.0	43.8	0.0	47.4	3.7	23.0	4.3	5.0	3.9	14.5	1.9	2.8	6.0	8.6	1.8	2.3	43.7	19.0	8.4	1.8	2.9	3.6	1.2	1.1	1.1	1.1	1.1	1.1	1.0	0.0	0.3	0.0	3.0	9.9	71.7	0.7	0.2	0.0	0.6	2.5	4.0	4.5	5.2	0.0	2.1	0.0	5.3	0.0	0.0	13.5	0.0	4.4	3.1	0.4	4.3	5.8	0.0	1.1	0.0	8.1	1.8	1.5	0.0	0.0	2.5	10.1	2.8	14.1	0.0	6.8	10.5	0.0	0.3	0.0	0.0	0.3	0.0	0.5	0.1	2.9	40.6	7.7	3.2
HSPA12A	"FLJ13874, KIAA0417"	ENSG00000165868	"Heat shock protein family A (Hsp70) member 12A"	O43301	10	116671192-116850236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.7"	"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 58.7;Muller glia cells: 46.8;Peritubular cells: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011273, HPA073244"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA011273: AB_1851190, HPA073244: AB_2686586"	"unprognostic (7.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.31e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (2.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.55e-4)"	21.2	24.9	15.4	4.0	21.8	1.1	7.5	10.2	47.7	7.6	6.3	6.8	3.3	2.1	9.4	8.0	5.3	9.1	5.9	6.4	17.1	15.5	23.5	1.9	2.8	2.0	17.1	17.8	23.5	3.0	4.0	17.2	4.2	23.3	4.1	4.9	7.4	3.6	9.1	4.9	9.5	2.9	8.6	8.2	3.6	2.8	8.2	8.6	0.0	6.8	1.2	1.6	4.1	6.6	0.0	0.0	3.1	0.0	0.0	0.4	0.0	2.3	9.0	0.9	7.9	9.1	6.6	0.4	4.6	9.1	2.3	1.2	8.3	0.1	0.0	2.4	5.6	3.2	5.9	5.8	0.7	7.5	0.0	3.1	0.0	3.2	8.8	1.2	0.0	0.7	2.7	3.6	6.7	0.6	11.7	0.0	0.1	0.0	0.0	1.2	1.5	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.1	34.2	0.1	2.0	11.8	2.6	2.2	3.1	2.0	1.7	0.0	0.0	2.1	3.6	12.0	4.4	0.1	0.0	0.0	3.7	0.0	1.5	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	21.8	10.2	32.4	17.1	15.5	17.1	17.8	23.3	8.6	6.0	2.2	0.0	1.3	9.8	28.7	7.4	0.0	18.7	3.4	12.2	21.6	0.0	13.3	3.5	4.2	2.9	0.0	0.0	2.9	0.1	10.4	1.1	0.0	0.2	0.1	28.6	0.0	4.3	0.0	6.5	58.7	1.1	25.3	0.0	0.0	46.8	2.5	0.0	64.3	21.4	8.6	12.9	15.6	0.6	5.9	4.4	0.2	0.0	0.0	0.7
HSPA12B	"C20orf60, dJ1009E24.2"	ENSG00000132622	"Heat shock protein family A (Hsp70) member 12B"	Q96MM6	20	3732667-3753111	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	17	"Endothelial cells: 38.3;Ito cells: 12.3;Late spermatids: 10.5;Peritubular cells: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.4;EFO-21: 6.7;HUVEC TERT2: 12.8;TIME: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013659, HPA015639"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013659: AB_1234541, HPA015639: AB_1851192"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.66e-2)"	22.7	3.4	2.6	4.6	4.9	1.8	19.4	1.5	5.5	11.0	4.3	3.9	4.3	2.6	11.7	8.1	6.2	6.2	10.7	14.6	3.1	2.7	5.7	3.0	26.8	2.3	4.1	2.8	6.4	4.8	2.1	1.8	13.9	5.1	5.1	2.0	7.2	5.3	5.4	13.5	4.8	3.6	6.1	2.8	21.2	3.2	5.2	1.8	0.4	6.1	9.6	2.1	4.7	7.5	0.1	0.2	0.0	3.1	0.0	0.2	0.0	0.6	2.3	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	6.4	0.2	0.3	6.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	3.4	0.2	0.1	0.1	0.2	0.0	0.1	0.0	2.0	12.8	0.5	0.4	0.2	0.0	1.4	0.5	1.2	1.4	0.0	1.1	2.3	0.3	0.7	0.0	0.0	1.2	1.0	0.4	0.2	0.1	0.2	0.2	0.7	7.1	0.2	3.0	1.0	0.5	0.5	0.4	0.7	0.2	1.1	0.6	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	2.6	4.9	1.5	5.5	3.1	2.7	4.1	2.8	5.1	1.8	0.0	0.0	0.0	0.0	1.6	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.2	38.3	0.0	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.4	0.0	0.0	12.3	2.7	10.5	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	14.5	0.0	0.6	0.0	0.4	1.4	1.1	1.0	0.3	0.0	0.0	0.1
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815464-31817946	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"breast: 216.1;vagina: 741.6"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 6419.7;Glandular cells: 2245.3;Urothelial cells: 2114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5"	"Cell line enriched"	"Detected in some"	10	"HEK 293: 310.1"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes		77000000	"Nucleoplasm, Vesicles"	Cytosol	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	29.1	74.5	35.3	18.4	48.0	3.5	216.1	40.4	36.0	8.8	22.6	27.4	41.1	3.6	33.1	32.3	36.7	14.5	14.6	40.3	37.5	28.8	35.3	49.5	54.7	14.1	89.2	10.8	15.1	31.2	3.5	23.8	22.1	67.4	47.8	11.4	6.1	28.3	52.7	66.7	57.9	17.3	36.4	47.0	35.6	19.3	10.9	85.9	1.3	26.8	16.3	11.8	41.3	741.6	1.0	0.5	8.8	4.7	1.2	4.5	0.5	0.0	31.3	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.7	0.0	0.0	0.0	2.3	0.0	0.2	310.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.4	4.5	1.8	4.7	1.0	1.0	2.5	2.3	0.5	0.4	1.2	1.1	8.8	1.2	2.5	0.5	4.5	0.5	35.3	48.0	40.4	36.0	37.5	28.8	89.2	10.8	67.4	85.9	137.0	84.3	135.2	6419.7	321.9	290.0	857.6	71.4	100.4	76.2	120.4	357.4	38.6	34.9	77.7	73.7	681.4	145.3	0.0	18.8	85.4	940.7	2245.3	456.0	74.4	220.0	193.9	449.0	109.9	284.5	25.8	558.4	1365.8	796.3	117.2	187.3	954.1	43.5	340.1	151.0	60.4	639.2	148.8	1629.0	48.6	175.8	294.0	87.2	208.8	111.9	2114.2
HSPA1B	HSP70-2	ENSG00000204388	"Heat shock protein family A (Hsp70) member 1B"	P0DMV9	6	31827735-31830255	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"vagina: 508.1"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 2896.7;Glandular cells: 1002.7;Smooth muscle cells: 978.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"A549: 24.5;Karpas-707: 72.8"									"CAB008640, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			"Vesicles, Cytosol"	Nucleoplasm	"CAB008640: AB_1617331, HPA052504: AB_2681854"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.69e-2)"	"unprognostic (5.99e-2)"	21.9	89.9	25.0	20.3	31.1	5.7	129.4	30.8	23.6	8.4	14.6	17.0	36.6	6.2	19.9	40.5	24.4	13.2	12.6	29.2	25.5	22.5	18.6	28.7	30.8	6.3	61.9	8.5	29.3	36.7	35.1	21.6	6.4	53.8	31.1	8.4	5.6	39.7	48.5	102.8	11.3	11.0	27.9	33.4	10.0	20.5	11.8	55.1	0.9	32.1	14.3	9.7	43.4	508.1	1.1	0.6	1.4	1.3	0.4	0.4	0.3	0.2	24.5	0.1	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	7.6	1.3	0.0	1.0	0.0	0.0	0.0	0.5	7.6	0.0	0.2	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	72.8	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.4	0.0	0.0	0.1	5.1	0.0	0.1	11.9	0.1	0.1	0.0	0.0	0.0	0.5	1.3	1.4	0.1	0.2	0.1	0.2	0.4	0.0	0.6	1.1	0.0	0.0	0.8	0.4	0.7	0.5	0.3	0.3	25.0	31.1	30.8	23.6	25.5	22.5	61.9	8.5	53.8	55.1	104.2	64.8	61.6	2896.7	212.6	40.4	440.6	20.4	54.9	58.0	66.3	123.7	73.9	16.6	33.6	1.7	185.0	221.9	0.0	13.7	87.7	515.0	1002.7	354.9	16.3	116.6	44.5	304.9	19.6	74.0	3.1	204.3	481.3	609.0	26.2	172.9	237.3	22.8	291.0	51.6	32.9	140.4	103.5	978.7	12.8	50.3	194.0	217.2	75.6	121.8	675.8
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815065	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"testis: 29.1;vagina: 17.0"	"Group enriched"	"Detected in many"	19	"Early spermatids: 201.6;Late spermatids: 418.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.8;U-266/70: 2.8;U-266/84: 2.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		49000000	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: AB_2681854"	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	0.4	0.5	1.8	0.5	2.2	0.5	1.2	1.4	3.1	0.5	0.7	1.5	0.0	0.3	0.8	3.0	0.8	1.5	0.3	0.5	2.0	1.1	0.9	0.7	1.7	0.7	4.5	0.8	1.1	1.5	0.3	0.7	1.0	2.6	1.2	0.6	0.2	0.4	1.5	3.9	0.6	0.8	0.5	4.6	1.1	0.8	29.1	3.2	0.0	2.0	0.0	0.7	0.5	17.0	0.3	0.0	0.4	0.1	0.0	1.7	1.1	0.0	1.7	0.0	0.0	1.9	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.0	1.0	0.0	0.0	6.8	0.0	0.0	0.2	0.2	1.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.2	0.0	0.0	0.2	0.3	0.0	2.8	2.4	0.0	1.7	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	1.0	1.3	0.0	0.3	1.5	1.6	0.3	0.0	0.0	0.0	1.7	1.1	1.8	2.2	1.4	3.1	2.0	1.1	4.5	0.8	2.6	3.2	0.0	0.6	0.0	0.6	0.8	2.1	3.6	0.0	1.4	1.2	0.0	7.9	0.4	0.0	0.7	201.6	1.0	0.5	0.0	0.2	0.4	0.5	1.1	0.0	0.9	1.1	3.2	1.7	3.1	2.4	418.3	4.6	1.5	5.0	1.8	0.6	3.3	0.3	0.8	2.1	0.3	2.8	0.0	1.4	16.4	7.7	0.1	0.3	2.5	1.0	0.3
HSPA2		ENSG00000126803	"Heat shock protein family A (Hsp70) member 2"	P54652	14	64535905-64546173	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0;skeletal muscle: 90.5"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 125.6;Distal tubular cells: 202.2;Extravillous trophoblasts: 456.2;Spermatocytes: 391.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.1;BEWO: 39.2;BJ hTERT+: 33.5;CAPAN-2: 17.8;SCLC-21H: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000798, HPA052504"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA		77000000	Vesicles	Nucleoplasm	"HPA000798: AB_1079090, HPA052504: AB_2681854"	"prognostic favorable (1.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	5.2	3.3	21.1	5.2	45.3	1.5	5.2	3.7	37.6	3.3	23.3	87.0	0.1	4.4	13.8	12.8	25.2	7.2	4.2	22.8	33.2	18.7	26.6	2.6	4.5	3.2	71.0	20.6	2.4	3.8	7.5	4.3	37.6	37.7	3.8	6.9	3.5	10.2	4.0	90.5	14.8	7.8	17.9	83.8	8.5	5.7	58.8	65.2	0.0	2.3	8.2	3.9	12.4	4.0	0.7	0.3	2.4	0.6	0.9	3.7	0.5	9.9	25.1	3.9	0.0	2.8	0.2	39.2	14.2	33.5	5.7	9.4	0.9	17.8	2.4	5.7	15.4	1.2	11.2	0.0	0.7	3.5	1.4	1.9	0.0	1.4	0.0	2.8	0.0	3.4	1.3	0.5	0.8	0.0	1.4	0.4	0.1	0.0	2.0	2.8	4.4	0.1	0.1	2.8	3.8	3.0	1.9	0.0	0.0	8.8	1.5	34.8	2.0	0.6	1.2	0.0	1.4	0.9	1.0	0.5	0.1	0.0	1.2	0.0	2.6	0.0	0.0	3.1	0.0	3.8	0.9	0.2	0.1	1.8	0.4	0.1	0.7	1.7	0.8	0.0	0.5	0.6	0.6	2.4	0.9	0.6	0.3	3.7	0.5	21.1	45.3	3.7	28.3	33.2	18.7	71.0	20.6	37.7	65.2	0.0	6.9	3.7	22.1	48.0	0.8	28.8	5.1	0.0	1.2	125.6	0.0	29.0	202.2	6.3	19.7	28.0	12.9	0.0	4.7	456.2	53.6	6.7	12.7	0.8	13.8	0.0	27.0	29.4	4.3	20.1	8.1	5.5	28.7	0.0	33.0	13.8	5.0	6.6	7.1	1.2	2.3	25.8	25.0	391.8	54.3	36.9	63.5	5.3	9.3	12.3
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133051962-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		10000000	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	20.6	35.0	26.6	25.6	27.6	20.5	39.0	25.9	35.6	19.4	20.5	18.7	19.9	17.4	23.3	20.2	42.0	19.2	18.9	32.9	26.4	31.9	30.3	31.1	17.2	28.9	30.9	24.5	23.2	19.5	37.1	32.8	24.5	34.3	18.9	23.9	16.0	20.3	19.2	48.3	19.6	18.5	23.6	25.9	20.0	20.9	39.8	29.5	27.3	26.8	24.8	38.6	24.5	77.1	27.7	17.9	15.5	23.0	14.1	14.9	11.5	32.4	44.7	31.2	50.9	29.8	25.1	56.8	35.6	26.8	34.6	42.9	83.9	34.1	54.0	37.5	34.2	81.6	29.0	54.2	58.9	50.1	24.9	31.1	39.8	30.0	45.9	23.8	24.7	34.9	24.9	24.9	44.5	29.3	19.8	32.9	26.4	41.6	16.7	37.7	28.6	34.6	18.4	42.8	25.3	20.7	31.8	38.3	28.7	31.2	42.8	24.9	20.5	33.9	17.8	47.3	61.0	26.2	24.2	28.8	31.5	45.3	26.9	42.1	19.3	42.6	41.5	26.9	41.0	31.2	14.8	14.4	15.5	12.6	23.0	14.9	22.6	11.6	13.0	17.9	27.7	12.1	11.2	9.6	14.1	16.4	6.8	11.3	11.5	26.6	27.6	25.9	35.6	26.4	31.9	30.9	24.5	34.3	29.5	59.6	36.4	64.0	74.4	37.2	50.9	98.8	30.6	76.3	54.6	21.0	51.1	57.8	23.2	43.7	30.6	26.4	31.6	23.3	43.2	54.8	30.3	48.9	54.2	27.0	56.2	33.4	45.3	19.0	22.6	20.2	21.6	43.3	28.7	66.7	30.9	56.8	43.7	22.8	24.4	39.4	121.6	25.8	30.7	92.5	94.9	36.5	72.9	27.7	26.5	65.5
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.0;vagina: 32.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 393.1;Late spermatids: 711.4;Spermatocytes: 194.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.6	9.3	7.4	1.4	9.0	2.8	5.5	16.6	11.4	2.9	2.5	1.7	1.6	2.5	1.5	1.7	10.9	5.9	3.5	5.3	6.1	10.1	10.6	5.9	1.9	1.0	6.6	6.6	3.5	3.6	12.2	23.2	2.8	20.1	3.9	3.5	3.5	4.6	4.7	1.5	6.5	1.6	3.8	5.0	1.4	2.1	73.0	5.2	1.0	3.7	4.1	4.0	2.8	32.0	0.7	0.5	3.9	0.4	0.5	0.4	0.1	9.1	12.0	6.5	10.3	4.5	4.6	7.6	4.2	1.7	4.0	4.5	8.8	4.2	0.0	7.7	1.2	3.3	2.1	38.0	15.0	5.6	17.0	11.3	4.9	16.5	10.7	1.7	18.8	8.4	4.2	14.0	2.6	9.6	4.2	5.2	4.3	8.7	5.6	5.0	6.6	6.0	1.6	1.5	9.7	10.0	0.0	0.7	0.9	13.8	4.2	12.0	4.4	7.5	13.1	0.7	4.1	10.0	3.2	1.4	1.4	0.0	1.7	10.0	11.0	12.6	2.9	5.5	12.9	4.3	1.6	0.4	3.9	0.4	0.2	0.2	0.4	0.3	0.3	0.5	0.7	0.4	0.4	1.3	0.5	0.3	0.4	0.3	0.1	7.4	9.0	16.6	11.4	6.1	10.1	6.6	6.6	20.1	5.2	3.0	9.4	0.8	68.9	25.2	54.9	12.6	12.7	56.2	31.8	8.7	98.2	9.5	16.6	6.7	393.1	5.4	0.4	0.0	2.5	1.7	7.0	17.8	15.1	8.3	1.0	38.1	17.6	2.5	1.6	711.4	9.5	7.3	8.5	4.6	2.0	15.2	3.2	0.0	9.2	19.6	62.8	0.0	15.5	194.6	9.3	37.1	14.0	2.9	2.9	72.9
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241330	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal glandular cells: 1106.3;Syncytiotrophoblasts: 1110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1000000000	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	44.2	40.3	26.3	40.8	38.4	125.0	58.8	19.5	26.9	37.7	29.3	19.8	47.0	25.5	31.6	75.3	34.1	31.1	25.5	72.7	23.3	28.6	60.4	147.6	43.6	32.7	34.3	14.3	36.2	110.3	41.1	47.6	62.6	43.5	34.3	33.0	16.5	84.9	40.7	23.9	32.3	38.3	33.8	28.2	33.8	35.1	33.0	41.5	23.2	219.3	21.7	29.8	50.4	75.1	33.3	53.8	57.4	55.3	51.9	63.0	90.0	35.5	24.0	31.7	41.8	37.9	43.9	74.7	64.1	50.9	47.7	56.0	37.2	71.1	41.1	40.0	46.7	103.4	45.5	28.3	57.2	51.3	23.8	14.3	24.6	30.1	67.1	200.5	33.5	46.6	27.0	112.4	38.2	167.8	50.6	74.0	8.7	18.2	57.5	34.6	26.3	14.7	23.7	35.8	87.0	24.2	14.0	32.3	66.6	46.2	23.5	16.4	29.2	40.7	43.7	65.3	51.1	45.0	24.5	49.6	29.1	28.3	29.7	29.7	60.2	57.4	34.8	70.6	28.3	43.8	57.4	55.3	44.3	61.9	54.8	63.0	33.3	45.7	57.7	48.6	24.9	37.6	46.6	44.3	51.9	35.5	53.8	31.2	90.0	26.3	38.4	19.5	26.9	23.3	28.6	34.3	14.3	43.5	41.5	172.7	228.8	134.1	1106.3	260.1	93.3	493.6	73.9	190.1	253.6	106.4	331.8	423.2	38.1	330.8	34.2	189.6	316.5	46.7	227.7	576.5	389.6	402.8	329.8	324.2	392.1	60.4	487.5	159.0	114.8	42.9	162.3	280.8	172.1	141.5	125.9	124.7	293.4	101.7	164.1	109.1	122.6	116.4	222.8	360.8	228.7	206.6	1110.2	140.9	109.4	772.3
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526910	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;vagina: 99.8"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 208.5;Cone photoreceptor cells: 119.8;Glandular cells: 327.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 67.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 67.6"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 34.0"									"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	6.8	11.9	9.4	10.3	12.4	3.5	43.0	3.5	6.0	1.4	1.9	2.2	1.7	1.9	2.2	1.3	3.2	1.1	9.6	4.5	4.5	9.3	3.1	14.6	13.5	2.1	13.7	1.3	9.3	5.4	0.9	5.4	20.8	5.7	3.3	1.9	1.7	2.9	5.8	1.4	4.4	1.7	4.2	13.2	11.2	3.6	1.4	5.0	1.3	5.8	1.8	2.8	3.1	99.8	0.0	2.5	67.6	9.0	1.6	1.4	2.1	0.5	1.0	0.0	0.2	0.0	0.8	0.7	0.4	0.3	0.1	0.3	0.3	0.5	0.1	1.5	0.1	0.5	0.2	0.3	0.2	0.2	0.3	0.0	0.2	0.9	0.0	0.0	0.1	2.2	0.1	0.7	0.3	0.0	0.0	0.0	0.1	0.4	34.0	0.0	0.0	0.1	0.8	0.0	0.2	3.6	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.6	1.9	0.1	0.3	0.4	0.1	0.1	0.3	0.3	2.3	4.7	0.2	0.0	0.9	0.8	1.5	0.8	7.5	2.7	1.4	9.0	0.2	0.0	0.1	0.7	2.5	0.0	0.0	0.3	67.6	1.6	7.3	0.0	0.0	2.1	9.4	12.4	3.5	6.0	4.5	9.3	13.7	1.3	5.7	5.0	8.9	12.4	14.4	208.5	26.1	28.3	9.9	0.0	2.7	2.3	5.2	119.8	0.9	0.0	0.1	1.3	20.4	0.0	0.0	0.0	6.9	58.3	327.0	2.3	0.0	62.4	9.5	68.0	1.3	51.5	0.4	5.2	96.6	97.8	0.0	0.0	27.5	0.4	0.0	0.0	1.0	32.8	0.0	68.0	1.9	0.2	19.1	15.3	34.5	0.0	46.1
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 2008.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	Yes		210000000	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: AB_2681854"	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	70.0	96.8	93.7	78.1	102.8	58.1	73.8	119.5	125.1	52.8	64.1	72.0	77.3	77.7	59.9	98.3	83.4	76.2	76.7	106.4	83.1	102.4	128.6	114.2	68.9	93.3	105.7	72.4	66.7	191.1	97.2	98.3	71.6	169.2	65.3	81.0	53.1	62.4	69.9	224.6	31.2	74.4	75.4	91.8	79.7	92.7	58.3	98.1	92.9	90.9	98.3	124.4	76.1	123.2	77.4	47.5	41.1	84.2	76.1	124.3	200.0	81.9	124.3	82.5	71.3	76.5	82.0	109.4	163.1	90.4	199.5	120.1	186.5	108.0	133.6	103.0	90.7	141.2	111.7	235.9	59.1	199.2	115.5	35.8	144.9	58.5	90.9	20.9	140.8	111.4	43.7	95.7	61.3	19.1	103.7	106.7	18.2	156.8	69.6	159.8	73.0	146.4	104.5	130.6	200.3	110.8	132.1	58.9	75.5	103.3	60.0	84.8	64.2	118.8	129.0	45.0	91.8	112.5	55.1	104.9	100.3	80.5	86.1	144.5	47.0	115.8	114.7	111.7	201.3	120.9	30.3	41.5	41.1	96.5	82.9	115.9	77.4	113.4	105.2	47.5	53.7	109.6	105.1	14.9	76.1	84.2	34.4	124.3	200.0	93.7	102.8	119.5	125.1	83.1	102.4	105.7	72.4	169.2	98.1	178.6	194.1	380.7	2008.3	250.8	192.6	358.3	247.1	397.5	238.8	123.9	119.8	806.4	447.6	560.1	23.5	383.9	634.1	256.9	544.3	848.9	487.1	803.7	432.1	181.5	715.5	171.6	498.1	192.8	238.1	50.8	206.0	453.5	501.0	661.9	246.7	285.3	500.3	403.3	253.8	795.2	189.9	239.3	546.5	180.9	436.7	248.7	1264.6	601.2	394.7	698.3
HSPB11	"C1orf41, HSPCO34, IFT25, PP25"	ENSG00000081870	"Heat shock protein family B (small) member 11"	Q9Y547	1	53916574-53945929	"Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Stress response, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030140	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		18000	Nucleoplasm	Cytosol	"HPA030140: AB_10600713"	"unprognostic (5.73e-2)"	"unprognostic (6.37e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (9.58e-7)"	"unprognostic (5.12e-1)"	"unprognostic (6.70e-3)"	"unprognostic (8.31e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.84e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-2)"	12.2	19.7	21.5	20.1	19.5	22.6	19.5	13.1	18.6	17.4	15.6	9.5	19.4	11.0	19.1	30.6	19.0	31.9	11.0	12.9	15.4	16.0	16.0	20.0	19.9	24.0	15.0	18.7	20.8	13.4	9.5	31.3	18.2	16.8	15.1	14.6	22.4	13.3	25.1	5.6	16.0	13.1	17.8	17.3	16.0	15.6	19.6	10.0	27.1	40.4	15.0	24.2	23.5	14.3	28.6	35.9	37.5	20.0	31.1	35.0	16.8	20.7	8.9	27.5	6.5	9.5	12.6	11.1	18.6	15.9	25.8	30.5	20.5	11.7	25.1	14.5	12.6	46.9	16.9	11.3	17.7	30.9	20.3	16.3	30.8	19.3	27.5	10.3	15.4	21.6	13.1	13.5	24.4	6.9	17.0	13.5	15.4	18.0	6.0	32.1	4.3	34.3	23.8	11.1	16.4	19.3	23.3	34.9	12.9	20.9	23.1	14.0	11.5	26.3	12.1	16.7	27.5	75.5	22.4	10.0	18.1	22.2	20.2	19.5	10.9	16.2	24.8	28.6	14.5	15.5	35.4	14.8	37.5	28.0	19.0	25.1	28.6	27.8	33.0	16.8	22.9	21.9	28.0	10.3	31.1	20.0	35.9	35.0	16.8	21.5	19.5	13.1	18.6	15.4	16.0	15.0	18.7	16.8	10.0	29.8	26.1	55.8	65.1	94.4	20.9	30.8	43.3	235.5	68.2	48.8	7.9	156.8	99.5	53.0	36.0	40.6	41.8	0.0	57.6	83.4	59.6	60.9	60.0	64.4	99.0	12.7	74.2	30.1	40.7	11.5	57.0	60.6	74.2	95.6	37.1	67.6	70.4	49.1	59.8	97.6	16.4	38.8	75.1	103.5	92.0	72.4	97.7	63.3	38.8	99.6
HSPB7	cvHSP	ENSG00000173641	"Heat shock protein family B (small) member 7"	Q9UBY9	1	16014028-16019594	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 524.6;skeletal muscle: 551.1"	"Cell type enriched"	"Detected in many"	48	"Cardiomyocytes: 2261.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"fHDF/TERT166: 83.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027639	Approved		Approved	Nucleoplasm		NA	NA		43000	Nucleoplasm		"HPA027639: AB_10601756"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.35e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (1.26e-4)"	32.3	9.6	0.1	3.3	0.1	0.1	9.0	0.9	0.2	7.0	8.4	0.3	1.3	0.7	12.6	8.0	15.7	4.5	8.2	524.6	0.1	0.0	4.1	0.2	1.2	2.7	0.2	0.3	4.8	1.0	1.1	0.2	0.7	0.9	4.7	0.9	1.7	4.4	2.7	551.1	1.0	2.1	20.1	0.4	0.3	6.1	1.3	0.0	0.0	9.6	70.1	7.2	12.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	19.6	0.8	0.4	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.4	0.0	3.0	0.0	0.3	0.0	0.3	0.0	3.9	0.1	0.4	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.1	2.9	0.2	2261.8	0.0	0.0	0.0	3.5	0.0	2.4	11.6	1.1	29.5	0.7	0.0	0.0	0.2	1.4	11.2	0.3	0.0	0.0	1.4	1.6	0.0	0.0	0.0	47.4	13.3	0.3	0.0	0.0	0.0	3.0	0.0	0.0	6.3	0.0	0.4	0.0	43.4	1.7	1.0	2.3	2.7	0.0	0.0	0.1
HSPB8	"CMT2L, E2IG1, H11, HSP22, HspB8"	ENSG00000152137	"Heat shock protein family B (small) member 8"	Q9UJY1	12	119178642-119221131	"Disease related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 152.6"	"Group enriched"	"Detected in many"	7	"Cardiomyocytes: 553.3;Syncytiotrophoblasts: 1120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.7;HeLa: 21.4;MCF7: 37.7;SuSa: 24.7;U-87 MG: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015876	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA015876: AB_1850458"	"unprognostic (1.52e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.17e-2)"	12.2	4.4	19.3	8.2	22.7	0.7	6.8	2.0	18.1	15.3	52.7	34.1	13.1	2.8	18.6	7.2	42.9	9.6	12.0	107.9	17.4	17.6	16.3	1.7	13.4	3.3	27.4	14.7	5.7	7.7	73.3	3.0	64.3	24.5	40.1	11.9	21.7	11.4	79.4	152.6	10.0	7.9	65.5	35.0	13.6	20.6	3.6	19.3	5.4	8.0	42.1	26.7	55.6	18.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.3	4.9	0.2	0.0	5.7	4.5	18.8	10.6	9.4	2.1	0.1	11.8	0.2	0.0	28.7	14.6	16.9	0.7	0.1	0.0	0.3	0.0	0.4	0.0	21.4	1.0	3.9	0.0	0.0	4.9	1.7	7.1	0.6	7.8	4.3	0.0	0.0	0.0	5.2	37.7	0.0	0.1	2.2	0.0	7.0	0.0	7.8	1.0	15.5	2.0	0.1	0.3	4.0	0.5	2.2	24.7	9.7	0.0	6.0	5.2	13.2	6.8	0.5	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.7	2.0	16.0	17.4	17.6	27.4	14.7	24.5	19.3	41.7	54.8	0.5	84.4	90.9	0.6	553.3	10.2	4.0	6.8	5.2	7.9	125.9	0.0	51.2	12.3	27.0	0.0	0.0	9.8	10.9	43.0	15.6	1.1	0.0	16.9	1.6	0.0	27.0	1.8	8.5	1.4	3.2	11.8	1.8	0.0	46.4	18.4	0.0	0.4	38.9	2.2	6.5	115.6	0.2	0.0	25.1	1120.5	3.2	0.0	73.8
HSPBAP1	"FLJ22623, PASS1"	ENSG00000169087	"HSPB1 associated protein 1"	Q96EW2	3	122740003-122793824	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 56.9;Syncytiotrophoblasts: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044930	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044930: AB_10961122"	"unprognostic (3.40e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.70e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.24e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.12e-3)"	7.2	9.3	6.7	9.2	6.9	4.5	13.1	3.1	6.7	6.8	6.0	7.0	9.1	4.1	7.9	5.3	5.2	5.3	6.0	6.1	6.0	5.3	7.1	5.8	10.4	9.1	7.8	4.5	5.8	6.3	5.3	9.0	17.0	8.7	5.8	5.9	10.2	6.0	6.4	25.4	7.0	5.9	8.1	10.8	11.4	5.4	16.5	8.3	9.1	10.6	8.9	8.8	7.9	5.6	8.3	9.2	22.0	15.5	4.5	7.2	5.8	4.5	3.5	5.1	4.5	6.1	4.6	9.9	2.3	5.8	5.4	7.6	4.7	3.6	5.8	3.7	1.6	13.6	5.5	7.8	4.3	6.3	3.6	2.1	3.8	4.1	2.7	13.8	3.5	5.4	6.8	15.8	4.4	14.4	5.1	5.0	5.9	2.5	5.0	4.8	2.9	5.0	4.4	5.8	3.5	7.1	5.2	6.8	5.6	5.5	1.7	5.6	5.7	5.3	2.1	19.1	5.0	2.5	7.4	5.0	6.3	3.7	2.0	3.1	5.0	5.0	6.9	3.9	5.2	6.1	13.3	12.1	8.3	4.7	8.6	5.8	8.3	6.1	4.6	9.2	5.6	6.8	6.5	22.0	4.5	15.5	3.1	7.2	5.8	6.7	6.9	3.1	6.7	6.0	5.3	7.8	4.5	8.7	8.3	6.0	7.7	8.7	3.7	9.5	5.3	4.1	2.5	5.3	2.3	5.2	56.9	13.9	3.3	4.6	17.2	4.7	3.9	0.0	5.2	9.6	4.2	2.6	5.8	2.5	11.6	7.9	0.0	12.9	18.1	3.6	8.9	21.8	5.0	17.2	2.6	3.4	3.9	2.6	4.6	3.6	10.8	6.5	3.8	22.6	7.1	6.6	40.6	10.2	3.3	1.7
HSPBP1	"FES1, HspBP1"	ENSG00000133265	"HSPA (Hsp70) binding protein 1"	Q9NZL4	19	55262231-55280381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005865, HPA070398, HPA071444"	Supported		Approved	Vesicles,Centrosome,Cytosol		NA	NA			Cytosol	"Vesicles, Centrosome"	"CAB005865: AB_304116, HPA070398: , HPA071444: AB_2686396"	"unprognostic (3.07e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.20e-3)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.14e-2)"	14.1	13.9	24.5	15.8	42.9	16.4	13.8	13.3	32.5	11.3	17.3	9.1	13.0	18.8	14.8	12.4	14.5	30.3	13.3	19.1	25.3	20.1	15.4	18.0	18.2	17.6	16.2	20.0	17.4	21.1	13.0	10.2	9.8	15.2	12.0	8.3	7.6	19.3	13.6	35.4	15.4	17.2	16.8	15.0	11.6	15.3	21.1	9.3	11.7	12.0	24.4	8.9	10.5	10.5	24.0	23.0	3.0	19.0	18.4	20.5	11.5	22.3	40.2	7.1	10.4	4.2	3.5	21.9	11.8	4.7	11.8	10.1	22.7	15.6	14.8	11.5	6.3	7.2	15.6	8.4	11.4	3.1	12.6	69.2	19.7	12.8	20.8	9.2	18.4	10.4	4.9	10.3	11.7	5.6	5.2	5.9	12.1	15.7	8.4	4.1	21.2	16.6	17.1	25.6	19.1	33.8	16.2	11.3	31.9	8.0	14.7	19.6	29.4	14.5	15.0	11.3	4.0	11.4	14.4	8.1	14.2	15.4	8.0	21.4	13.4	31.0	15.3	15.8	16.0	15.0	0.8	11.5	3.0	18.0	19.0	18.7	21.0	19.8	20.5	23.0	24.0	19.9	19.3	0.8	18.4	16.0	13.1	17.8	11.5	24.5	42.9	13.3	32.5	25.3	20.1	16.2	20.0	15.2	9.3	8.9	8.6	26.9	31.3	23.8	14.1	11.0	25.5	60.2	20.5	33.2	5.9	45.1	61.3	55.5	7.9	15.1	23.6	0.0	40.0	45.3	20.7	24.9	10.4	20.8	34.3	12.7	21.7	7.4	12.3	12.8	18.1	14.0	16.9	35.1	29.8	13.7	36.5	41.9	16.6	45.8	11.0	25.8	20.6	34.2	23.9	25.7	31.4	16.0	46.5	36.6
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822245-21937297	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 104.4"	"Cell type enriched"	"Detected in many"	7	"Ito cells: 621.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1700000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60.0	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32.0	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3.0	0.0	0.0	0.0	0.2	0.0	7.0	6.5	2.2	7.7	22.6	17.2	8.6	10.7	2.7	3.1	2.8	7.9	14.5	0.5	46.8	16.5	0.1	4.4	0.5	5.2	0.7	0.1	0.7	2.4	7.0	5.7	4.7	0.0	0.6	10.4	1.6	3.2	0.9	4.7	103.4	0.0	3.1	0.9	4.2	1.9	0.0	3.2	1.9	3.2	2.9	1.0	9.2	0.9	6.0	0.9	0.2	0.6	8.1	3.4	4.7	2.0	1.3	1.2	82.5	6.1	8.0	4.7	0.3	0.0	1.0	0.4	1.6	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7	65.5	28.7	5.2	10.9	23.5	0.7	4.5	40.8	1.4	12.5	87.2	0.0	9.4	0.0	63.1	1.0	75.0	34.2	0.0	21.9	85.1	58.4	6.6	22.0	2.8	6.1	3.2	2.4	621.2	31.6	2.2	69.6	3.5	57.3	2.8	12.8	1.4	55.1	20.7	65.0	0.5	0.5	32.3	38.8	0.4	4.1	15.6	7.8	6.4	13.9	8.3
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90857698	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.8;testis: 14.3"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 4.8;Hofbauer cells: 1.3;Kupffer cells: 1.5;Late spermatids: 2.0;Spermatocytes: 1.4"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"myeloid DC: 4.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.2;hTCEpi: 7.5;hTERT-HME1: 25.0;LHCN-M2: 10.0;U-87 MG: 7.7;WM-115: 9.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved	Supported	Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: AB_2732228"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	1.0	0.5	2.4	1.1	2.5	0.5	0.7	0.3	4.3	0.6	0.8	1.7	1.2	0.8	0.4	0.3	1.0	0.4	1.3	0.6	9.9	5.1	0.3	0.6	0.5	0.7	1.7	1.8	0.4	1.4	30.8	0.2	0.5	3.1	1.0	1.2	0.4	0.6	0.3	1.7	0.9	2.2	3.6	1.5	1.3	1.5	14.3	1.0	0.0	0.3	0.1	0.6	3.5	2.1	0.0	4.6	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.2	0.5	0.8	0.0	0.9	0.0	0.0	0.1	1.5	3.4	0.9	8.2	2.1	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.4	5.9	7.5	2.5	25.0	4.7	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.1	0.9	0.0	1.2	0.7	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	3.9	0.4	0.0	0.2	0.2	4.6	0.0	0.0	6.9	0.0	0.0	0.0	7.7	0.0	9.5	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.1	0.1	2.4	2.5	0.3	4.3	9.9	5.1	1.7	1.8	3.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.6	1.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	0.1	0.1	0.0	0.0	0.2
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269765-8307111	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.9"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 14.0;Fibroblasts: 45.9;Leydig cells: 40.3;Peritubular cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	9	"basal ganglia: 8.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-2197: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.34e-2)"	23.7	1.8	0.6	7.3	8.2	5.3	35.6	0.7	0.9	12.3	9.4	0.8	5.4	3.7	19.6	26.6	14.4	7.9	19.8	57.9	0.7	0.3	1.7	1.6	15.4	4.3	0.8	0.9	30.7	2.8	0.0	5.1	9.6	0.9	15.4	2.0	8.6	6.6	3.0	12.9	9.0	6.7	50.1	0.8	1.8	6.8	7.2	0.6	1.3	9.3	11.6	3.0	28.7	12.7	0.0	0.4	1.3	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	2.1	3.9	0.1	0.8	0.0	1.0	0.2	0.0	0.0	0.0	4.8	2.1	0.5	0.0	0.4	0.0	0.3	0.0	0.8	0.4	5.0	0.0	2.2	0.0	0.2	0.4	0.0	1.4	0.0	0.6	3.4	0.0	0.1	0.0	3.5	0.0	0.0	12.2	2.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.1	9.1	0.1	0.0	10.6	0.0	0.4	2.7	0.5	1.7	64.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.6	8.2	0.7	0.9	0.7	0.3	0.8	0.9	0.9	0.6	0.0	0.0	0.0	0.3	4.6	0.0	14.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.6	3.1	0.0	0.0	0.0	3.7	45.9	0.1	0.0	0.0	1.1	0.0	0.0	4.3	0.0	0.5	40.3	0.9	0.0	0.0	0.0	0.0	0.2	0.0	40.3	0.0	0.0	0.0	5.1	0.2	0.9	4.5	1.1	0.0	0.0	0.1
HUNK		ENSG00000142149	"Hormonally up-regulated Neu-associated kinase"	P57058	21	31873315-32044633	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.6;BEWO: 13.0;RH-30: 14.4;SCLC-21H: 11.7;SiHa: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA027295: AB_2672203, HPA027372: AB_2672239"	"unprognostic (9.09e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.00e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.48e-5)"	"unprognostic (8.84e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.69e-2)"	1.7	1.9	2.7	2.9	3.5	0.5	2.1	3.2	6.4	1.1	5.9	0.2	12.6	2.4	9.0	3.4	1.1	3.3	1.0	1.7	3.7	3.2	6.0	1.3	1.7	0.7	1.2	2.1	1.8	15.7	0.2	4.7	7.6	1.4	4.0	6.5	9.1	1.5	11.1	0.6	5.0	4.4	4.1	0.9	0.4	2.1	1.8	0.2	0.4	1.1	2.2	1.0	3.8	7.7	1.0	0.7	1.7	0.5	0.5	0.5	0.1	0.0	3.0	10.6	0.1	0.0	0.0	13.0	1.0	0.0	0.2	0.0	4.2	0.1	0.0	0.4	4.9	0.2	0.1	6.2	0.0	0.0	0.0	3.2	0.0	2.8	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.9	0.2	0.9	8.0	0.0	0.1	0.1	14.4	0.0	1.1	0.0	11.7	7.8	10.3	0.8	0.4	7.7	4.3	1.1	0.0	0.0	7.5	0.0	0.0	0.1	0.0	1.4	0.0	0.0	5.0	0.8	0.5	0.5	0.5	0.3	0.3	0.5	0.5	0.3	0.2	1.0	0.5	0.5	1.7	0.5	0.3	0.7	0.4	0.1	2.7	3.5	3.2	6.4	3.7	3.2	1.2	2.1	1.4	0.2	6.0	7.8	0.0	1.8	4.5	4.3	3.2	17.8	1.4	4.5	7.0	2.0	8.1	0.0	3.8	0.0	0.9	2.7	0.0	2.9	11.6	10.6	1.6	0.0	0.9	2.3	3.2	4.7	0.0	0.0	0.0	0.3	0.0	3.3	0.0	3.9	11.4	2.6	2.9	0.0	1.5	1.2	0.0	1.4	0.9	0.7	5.1	5.1	0.0	9.0	0.8
HUS1B		ENSG00000188996	"HUS1 checkpoint clamp component B"	Q8NHY5	6	655939-656963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.3"	"Cell type enhanced"	"Detected in some"	9	"monocytes: 3.6;Sertoli cells: 6.5;Spermatocytes: 7.6;Spermatogonia: 4.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.4;U-266/84: 5.1;WM-115: 5.5"	"Not detected"	"Not detected"							"HPA034511, HPA063449"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034511: AB_2674203, HPA063449: AB_2685014"	"unprognostic (3.56e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-10)"	"unprognostic (7.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	0.5	0.1	0.1	0.5	0.1	3.3	0.6	0.0	0.0	1.4	0.4			1.3	0.9	0.7	0.9	0.2	0.6	0.5	0.2	0.1	0.6	0.8	1.0	0.2	0.3		0.8	0.0	0.0	0.8	1.1		1.4	0.2		0.5	0.1	0.0	0.9	0.3	1.0	0.6	1.0	0.1	4.3			0.7		0.2	0.3	1.2	1.6	1.6	0.0	0.7	0.0	1.9	0.6	0.7	0.0	0.0	1.8	0.0	0.0	1.7	0.2	0.1	0.0	0.1	0.8	0.1	0.3	0.5	0.1	0.4	0.0	0.5	0.0	0.4	1.3	4.4	0.9	0.0	0.0	0.4	0.0	1.5	0.0	0.3	0.4	0.4	0.0	0.1	1.1	1.7	1.0	0.5	0.0	0.5	2.4	2.8	0.0	1.4	0.9	0.8	2.5	0.2	0.6	1.0	0.2	0.3	0.0	0.7	0.5	0.1	0.1	0.4	0.7	0.8	1.5	0.4	2.3	5.1	1.0	0.1	0.6	5.5	0.0	0.7	0.0	0.7	0.3	0.5	1.6	1.1	0.9	0.0	0.8	1.0	1.9	0.0	0.0	0.0	1.6	0.7	0.6											0.0	0.0	0.5	0.6	0.6	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	0.7	0.7	0.0	0.0	0.5	1.0	0.4	0.5	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.9	0.0	0.0	3.6	0.0	0.5	0.9	0.0	1.1	0.0	1.7	6.5	0.5	7.6	4.7	1.5	1.3	1.5	0.2	0.3
HYDIN	"CILD5, DKFZp434D0513, KIAA1864, PPP1R31"	ENSG00000157423	"HYDIN, axonemal central pair apparatus protein"	Q4G0P3	16	70807378-71230722	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5;pituitary gland: 23.6;testis: 19.1"	"Cell type enhanced"	"Detected in many"	22	"Ciliated cells: 180.7;Cone photoreceptor cells: 49.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.5;RPTEC TERT1: 5.3;SiHa: 11.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA067155, HPA074129"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA067155: AB_2685792, HPA074129: AB_2686665"	"unprognostic (8.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.88e-4)"	"unprognostic (4.25e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.52e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.97e-2)"	0.8	0.9	6.3	1.2	13.9	1.7	1.5	2.9	4.2	2.1	1.2	13.3	4.4	1.0	2.4	18.4	0.9	14.5	1.9	1.0	6.9	4.3	3.5	1.8	7.1	1.1	2.3	4.1	7.2	1.6	9.0	23.6	0.7	21.5	1.4	0.8	3.9	0.9	1.5	0.8	1.7	1.1	1.0	3.1	1.5	1.1	19.1	3.8	0.0	3.2	0.0	0.6	1.2	0.8	0.9	1.1	3.7	1.3	0.7	1.2	0.2	0.1	0.1	2.1	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.3	0.2	0.4	0.3	3.5	0.7	0.3	0.2	1.6	0.4	0.5	0.1	0.1	0.2	0.4	0.5	0.2	0.4	0.5	0.0	0.0	0.8	0.0	2.2	0.4	0.1	0.1	0.0	0.7	0.8	1.3	0.1	0.7	0.3	0.2	0.8	5.3	0.7	2.5	0.5	11.0	0.3	0.4	0.4	0.7	0.0	0.3	0.3	0.8	0.1	0.3	1.8	0.1	1.0	0.9	0.2	0.6	1.5	1.0	0.8	1.2	0.9	1.2	0.6	1.0	1.1	0.3	0.9	0.9	0.8	3.7	0.7	1.3	1.1	0.6	0.2	6.3	13.9	2.9	4.2	6.9	4.3	2.3	4.1	21.5	3.8	3.0	1.6	0.0	0.2	0.0	13.2	2.0	0.0	180.7	29.6	8.7	49.1	0.0	1.7	1.7	26.1	0.1	0.0	0.0	0.5	0.0	0.9	0.8	0.0	0.0	0.1	0.0	3.4	0.0	0.0	21.2	2.3	0.0	3.3	0.0	0.0	12.9	0.5	0.0	4.2	1.4	26.6	0.0	0.7	17.1	6.1	0.0	0.0	0.0	0.0	0.1
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43451003-43453989	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 130.4;seminal vesicle: 80.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 39.2;WM-115: 33.2"					"Low region specificity"	"Detected in all"			HPA040092	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favorable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.72e-5)"	16.5	12.5	11.6	12.1	10.1	5.3	12.8	11.3	9.7	14.6	16.5	13.0	130.4	23.4	15.8	14.8	8.4	15.3	16.7	10.9	9.2	10.0	15.9	25.8	17.8	6.7	10.9	9.3	25.1	34.0	13.8	11.2	10.8	9.0	15.6	7.5	15.0	20.8	80.0	8.8	8.4	22.1	13.4	14.3	7.6	14.1	4.5	11.1	4.9	12.8	9.6	6.4	10.7	11.3	3.2	21.6	6.2	1.2	4.8	5.4	3.0	17.4	2.2	0.7	1.2	3.4	6.4	0.0	15.2	13.7	19.2	12.9	8.9	30.5	0.0	1.1	9.8	7.7	3.2	0.0	16.1	7.9	4.3	6.3	2.8	8.0	0.0	22.7	0.0	0.0	3.8	4.6	21.8	0.0	19.4	39.2	0.1	0.2	0.0	12.9	0.3	2.6	2.9	3.2	1.6	4.5	13.5	0.0	0.1	13.3	0.6	8.3	6.1	17.1	9.6	3.8	2.8	2.5	21.9	18.1	1.2	0.0	3.4	29.7	0.0	0.0	0.0	1.0	4.0	33.2	6.2	1.1	2.4	3.3	0.9	4.1	3.2	5.4	2.6	4.1	2.7	5.1	1.5	0.1	4.8	1.2	21.6	0.5	3.0	11.6	10.1	11.3	9.7	9.2	10.0	10.9	9.3	9.0	11.1	17.9	66.3	11.9	39.0	24.8	15.2	0.3	68.8	10.7	20.5	54.1	9.8	14.0	38.1	94.3	0.9	20.2	81.2	23.3	74.3	97.6	32.9	36.0	43.7	49.7	24.9	7.9	66.7	21.5	7.0	3.1	29.4	17.5	38.8	23.4	57.1	28.8	107.8	112.2	28.7	115.0	14.1	25.8	53.4	0.9	2.1	19.3	10.1	10.0	43.0	29.2
HYKK	"AGPHD1, LOC123688"	ENSG00000188266	"Hydroxylysine kinase"	A2RU49	15	78507564-78537372	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 24.9;Late spermatids: 27.7;Proximal tubular cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 7.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 17.5;U-266/84: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040706	Approved		Approved	Vesicles,Aggresome		NA	NA			Vesicles	Aggresome	"HPA040706: AB_10795528"	"unprognostic (9.26e-2)"	"unprognostic (1.98e-4)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.90e-2)"	6.3	7.5	6.4	4.8	8.0	1.7	7.7	2.3	6.1	8.2	14.3	2.5	6.8	11.1	6.4	11.0	7.0	6.5	7.5	8.5	4.3	3.5	19.4	10.5	3.6	4.3	3.5	3.6	9.7	15.5	4.0	8.8	1.5	4.3	8.0	6.2	10.1	7.9	10.1	8.9	3.9	21.2	9.4	3.4	1.6	6.8	7.8	2.2	5.7	7.3	3.7	4.1	7.1	5.1	0.4	0.6	0.8	0.2	0.5	7.1	1.2	3.1	5.1	0.5	9.0	2.0	4.4	1.9	1.0	2.1	3.0	3.5	1.7	3.7	2.5	1.1	2.0	5.2	3.6	8.2	2.7	2.8	1.1	17.5	1.1	2.2	4.2	5.1	0.3	1.4	4.0	5.1	1.1	2.3	1.0	2.1	10.7	3.0	6.5	1.7	3.8	2.9	0.5	0.5	7.6	6.5	1.7	9.9	2.0	5.6	3.5	0.9	1.2	2.2	6.7	7.9	1.4	7.6	0.2	0.9	1.9	1.4	3.6	3.3	10.2	17.8	0.1	2.2	0.1	2.7	0.8	0.2	0.5	0.3	0.1	0.4	0.4	2.4	0.4	0.1	0.4	7.1	1.3	0.8	0.5	0.1	0.6	1.0	1.2	6.4	8.0	2.3	6.1	4.3	3.5	3.5	3.6	4.3	2.2	11.9	2.6	0.9	6.2	3.2	2.7	4.4	0.0	4.0	1.2	7.0	2.0	6.0	24.9	1.9	11.0	4.5	2.8	0.0	6.8	3.6	3.6	3.7	0.0	5.0	0.7	0.0	4.1	5.5	0.6	27.7	4.9	0.6	6.8	0.0	3.4	4.8	2.4	3.1	3.5	33.6	1.8	0.0	3.7	3.2	7.5	1.4	2.9	0.0	6.0	3.5
HYLS1	FLJ32915	ENSG00000198331	"HYLS1, centriolar and ciliogenesis associated"	Q96M11	11	125883614-125900648	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 72.7;Late spermatids: 40.2;Spermatocytes: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041210	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA041210: AB_10794987"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.28e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.56e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	4.3	4.3	6.5	3.6	8.8	2.8	5.2	12.3	11.6	5.9	5.5	2.7	6.0	7.0	5.3	8.3	5.7	5.0	3.2	5.7	6.7	7.2	8.7	7.2	3.1	6.7	5.0	8.6	5.0	3.4	3.4	5.5	5.1	7.6	6.2	6.0	2.2	3.9	7.6	3.7	5.7	6.7	7.1	3.5	5.6	6.2	28.6	4.3	7.6	5.1	4.6	9.6	5.0	3.8	11.8	14.3	3.2	6.0	4.6	10.3	4.7	4.6	10.2	3.7	2.7	7.4	5.0	6.5	11.8	4.7	11.1	7.5	0.1	7.7	2.0	5.0	10.3	3.7	7.0	5.3	4.1	12.9	11.4	3.7	1.5	1.1	2.1	5.5	5.2	7.9	3.2	4.8	11.0	12.5	2.4	8.0	4.6	2.6	12.7	14.5	7.9	3.8	15.7	8.3	19.6	17.3	8.0	0.0	6.8	11.9	7.8	5.3	3.3	12.5	9.7	4.7	5.0	23.9	11.6	7.2	0.8	9.7	8.8	2.0	4.7	4.6	4.9	2.3	11.5	9.7	3.2	5.5	1.1	8.1	6.0	7.6	11.5	10.2	9.4	6.7	11.8	10.3	7.4	0.9	4.6	4.2	14.3	10.3	4.7	6.5	8.8	12.3	11.6	6.7	7.2	5.0	8.6	7.6	4.3	0.0	0.3	8.0	2.4	3.8	7.9	4.0	2.5	4.0	0.0	1.8	3.9	12.5	10.0	3.9	72.7	3.5	3.3	23.3	3.6	10.5	5.1	2.6	0.0	5.5	6.3	0.0	4.7	4.3	1.9	40.2	7.8	2.2	6.8	14.4	2.1	4.4	3.9	6.0	5.6	10.2	5.6	6.5	5.0	98.2	33.7	3.8	3.7	6.4	5.0	1.4
HYPK	"C15orf63, FLJ20431, HSPC136"	ENSG00000242028	"Huntingtin interacting protein K"	Q9NX55	15	43796142-43803043	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 51.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055252	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA			Nucleoplasm	Microtubules	"HPA055252: AB_2682759"	"unprognostic (2.89e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.39e-3)"	"unprognostic (6.52e-7)"	"unprognostic (2.05e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.78e-4)"	7.5	11.3	10.8	10.1	13.7	22.1	7.3	29.4	11.1	7.0	8.3	8.4	7.0	8.4	8.5	8.8	8.2	7.9	7.3	17.3	9.3	6.5	13.2	30.5	13.7	11.3	13.3	9.7	10.4	18.0	6.7	11.9	8.1	14.1	13.3	13.5	5.7	11.0	7.1	36.8	13.4	10.2	7.4	8.6	11.1	14.4	14.0	12.0	6.0	11.1	13.1	11.0	8.3	10.8	7.8	3.9	8.3	8.9	4.4	9.6	1.5	1.5	1.9	5.6	3.4	4.7	5.4	3.5	3.0	1.3	2.2	1.6	4.9	1.8	2.5	1.8	1.5	1.3	5.2	4.7	3.6	2.2	2.5	3.3	3.5	9.0	2.7	2.4	2.0	2.7	4.2	6.7	1.6	3.0	6.2	2.3	5.0	3.9	4.9	2.3	4.2	2.5	5.1	1.8	3.0	4.1	3.2	1.8	2.9	3.7	5.5	3.5	2.5	2.4	5.0	0.7	3.9	5.0	2.4	4.5	6.2	3.6	4.1	2.8	5.8	6.1	5.8	4.8	5.9	2.4	6.2	4.4	4.2	5.4	3.2	8.0	3.2	7.5	6.3	3.0	7.8	9.6	7.8	8.3	4.4	8.9	3.9	5.2	1.5	10.8	13.7	29.4	11.1	9.3	6.5	13.3	9.7	14.1	12.0	6.0	12.6	9.5	13.9	26.7	10.4	0.8	5.1	14.7	15.9	7.0	51.1	5.6	8.3	1.5	2.3	5.8	5.5	0.0	7.2	3.8	9.7	13.6	8.1	5.5	3.4	12.7	10.3	8.6	2.1	0.9	4.6	13.4	21.9	2.8	7.6	4.0	4.7	3.6	2.1	8.6	27.1	0.0	15.0	4.2	3.7	32.6	4.1	8.6	7.1	8.1
IAH1		ENSG00000134330	"Isoamyl acetate hydrolyzing esterase 1 (putative)"	Q2TAA2	2	9473658-9496543	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 336.0;Late spermatids: 365.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040523, HPA076040"	Approved		Approved	Nucleoplasm		NA	NA		160000	Nucleoplasm		"HPA040523: AB_2677021, HPA076040: "	"unprognostic (1.51e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.41e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.91e-2)"	27.3	34.5	27.3	21.0	27.0	19.6	28.7	19.6	35.3	26.7	25.6	21.9	19.9	18.3	22.3	30.5	22.8	24.2	24.2	46.2	24.5	25.1	31.4	40.4	20.9	24.6	23.7	24.6	27.0	24.7	24.1	23.0	21.2	25.5	23.2	27.0	19.7	20.8	28.0	28.7	15.4	25.2	30.3	25.9	18.6	20.7	49.9	17.9	21.2	26.9	23.7	27.6	24.6	20.8	27.2	36.4	20.2	25.5	23.2	30.4	15.8	12.3	12.6	1.3	0.1	23.4	43.9	0.2	11.0	23.6	15.6	14.6	0.1	13.8	6.4	5.2	31.8	10.2	8.4	4.6	9.3	15.0	25.7	12.7	8.2	5.0	7.1	43.9	0.0	6.2	26.2	28.0	11.0	13.1	27.0	14.7	11.1	0.1	4.0	30.6	12.1	30.1	0.9	1.8	14.8	12.2	7.5	0.0	1.9	23.5	6.6	9.0	18.3	8.3	10.9	15.2	0.6	11.8	13.9	12.0	11.9	5.2	5.3	16.3	3.2	0.2	2.2	16.7	5.0	13.1	13.9	25.5	20.2	22.7	23.2	24.0	27.2	25.9	24.9	33.9	22.4	20.8	23.5	13.9	23.2	25.3	36.4	30.4	15.8	27.3	27.0	19.6	35.3	24.5	25.1	23.7	24.6	25.5	17.9	29.8	25.8	55.8	83.9	79.8	31.5	39.7	33.1	32.1	21.6	47.1	11.8	63.9	77.9	59.8	336.0	31.5	41.6	46.7	67.5	89.5	85.0	53.7	35.8	48.9	77.7	39.7	24.6	34.4	61.8	365.3	86.9	75.3	87.7	139.7	25.4	36.5	72.8	31.6	68.6	109.3	51.1	97.0	76.9	214.7	46.8	83.7	37.2	66.0	46.0	86.6
ICA1L	"ALS2CR14, ALS2CR15"	ENSG00000163596	"Islet cell autoantigen 1 like"	Q8NDH6	2	202773150-202871985	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 62.5;Cone photoreceptor cells: 56.9;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042507	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042507: AB_10797016"	"unprognostic (4.14e-3)"	"unprognostic (3.60e-3)"	"unprognostic (5.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.05e-4)"	"unprognostic (1.66e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.50e-4)"	"unprognostic (4.15e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.58e-3)"	3.3	7.3	11.6	2.2	15.6	5.4	3.8	24.8	19.8	5.8	5.2	8.5	4.1	2.3	10.1	8.9	4.2	12.6	5.5	6.5	11.1	12.1	3.3	1.2	3.2	2.2	7.3	14.0	9.4	3.2	15.2	22.6	7.6	9.1	8.8	2.7	5.8	1.9	9.5	8.1	3.0	2.0	7.6	7.2	2.2	3.6	11.9	7.8	1.0	7.8	1.8	2.1	4.5	3.2	5.3	4.6	4.2	5.3	6.7	4.2	1.6	1.6	1.2	2.8	8.4	2.8	5.1	20.8	2.7	3.7	1.9	2.5	1.6	0.6	1.6	0.8	3.3	4.7	0.8	4.0	1.4	2.5	2.0	3.2	3.3	1.6	1.8	1.6	4.1	2.2	2.0	2.4	1.9	1.5	4.9	2.3	5.8	2.8	1.5	2.3	0.7	3.5	5.5	7.9	0.5	2.9	4.2	4.1	0.7	1.6	3.7	8.0	8.1	4.1	0.2	1.7	2.5	1.0	3.1	1.6	7.4	1.8	1.5	4.0	5.7	8.1	4.8	4.0	1.3	1.4	2.2	2.6	1.5	2.6	2.7	2.2	4.0	1.9	2.1	4.6	5.3	3.1	4.2	4.2	6.7	5.3	2.8	1.8	1.6	11.6	15.6	24.8	16.9	11.1	12.1	7.3	14.0	9.1	7.8	8.9	11.4	2.9	3.3	1.8	62.5	11.8	2.5	40.2	13.6	17.4	56.9	13.7	0.0	4.2	21.4	4.7	1.1	0.0	4.3	31.3	12.4	4.0	5.8	1.1	3.3	15.9	18.5	4.9	4.1	24.6	29.4	6.8	6.8	1.0	1.5	26.8	3.3	0.0	43.5	2.2	78.4	0.0	5.7	29.9	7.6	1.9	6.3	5.7	1.6	2.2
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10270835-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 68.3;lung: 91.3"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 568.7;Alveolar cells type 2: 522.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 31.6;Karpas-707: 90.1;RPMI-8226: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA	87900000	3100000000	"Plasma membrane, Cytosol"		"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favorable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	26.1	8.6	4.0	41.0	4.1	36.5	15.0	1.0	4.5	5.6	10.0	2.7	1.6	6.1	8.5	7.7	7.9	10.7	19.8	16.3	2.6	2.1	10.9	68.3	91.3	32.8	5.4	1.7	12.4	7.2	2.5	4.0	9.3	6.8	10.4	6.6	10.6	7.2	3.6	13.9	6.9	7.9	8.0	7.8	42.2	7.3	6.5	3.6	8.3	11.6	13.7	13.4	14.8	17.1	2.2	13.3	22.2	14.2	7.9	5.6	8.9	8.4	0.1	1.5	0.0	0.4	0.9	2.1	1.7	18.8	4.2	12.7	2.8	9.5	7.7	26.2	0.7	19.3	1.7	0.3	0.0	8.9	23.1	0.0	0.7	0.2	11.5	31.6	0.2	4.5	11.1	0.7	2.6	4.1	0.4	2.1	0.9	2.9	90.1	0.3	0.6	0.1	6.5	0.5	0.1	4.8	0.2	0.0	28.6	7.2	0.0	0.0	0.2	11.6	0.6	18.4	0.7	1.4	0.5	6.5	4.3	0.4	2.4	0.1	27.5	28.3	4.8	7.0	4.9	6.3	2.2	13.9	2.6	3.0	14.2	5.6	2.2	2.4	3.6	13.3	0.9	1.0	2.2	22.2	7.9	7.9	7.5	3.4	8.9	4.0	4.1	1.0	4.5	2.6	2.1	5.4	1.7	6.8	3.6	568.7	522.3	12.0	22.9	75.8	0.0	0.8	20.4	80.3	159.3	3.5	0.0	1.0	0.0	152.6	1.9	139.3	0.5	0.0	84.4	2.5	171.6	19.1	133.1	12.9	75.0	0.0	2.4	56.4	41.3	1.1	4.4	160.6	72.6	168.7	0.3	2.3	107.4	0.0	1.4	9.4	0.3	6.5	95.4	0.5	1.7	60.6	1.0	12.7	0.5	10.0
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 74.5;lymphoid tissue: 63.9"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 46.1;Endothelial cells: 80.1;Ito cells: 147.3;Kupffer cells: 54.5;T-cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 167.1;TIME: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071155			Approved	"Plasma membrane,Cytosol"		NA	NA		1200000000	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	36.0	3.6	8.4	13.0	11.5	8.3	34.1	3.5	7.7	9.4	9.7	5.6	2.8	6.4	9.8	5.2	9.5	7.4	8.8	22.8	9.5	8.9	10.5	8.7	27.9	24.0	12.3	3.1	6.3	7.4	3.1	4.5	36.8	9.1	7.9	8.5	8.1	8.8	4.3	17.1	5.5	10.8	13.9	10.5	63.9	8.0	4.0	7.4	14.3	11.6	9.0	18.0	12.8	23.6	49.0	30.9	56.5	74.5	26.0	65.3	67.5	0.0	0.0	0.0	0.0	1.4	1.5	0.4	0.1	0.1	0.0	0.1	0.3	6.9	11.7	2.1	0.0	0.0	0.0	0.1	0.0	0.2	2.6	0.0	10.5	0.6	1.2	0.2	1.7	0.0	0.0	0.0	0.1	0.0	0.0	167.1	9.9	8.6	6.9	0.0	0.0	13.1	1.5	0.0	0.0	0.0	7.9	0.0	16.3	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	42.2	0.0	0.1	0.8	0.0	6.6	2.2	10.5	0.0	2.2	0.0	56.5	30.0	8.9	45.8	66.5	52.8	36.5	60.1	42.8	30.9	49.0	65.3	40.7	3.6	26.0	74.5	10.0	64.5	67.5	8.4	11.5	3.5	7.7	9.5	8.9	12.3	3.1	9.1	7.4	0.0	12.5	46.1	3.4	6.5	0.0	0.3	0.0	6.7	6.8	7.0	0.0	0.4	0.0	0.8	0.5	80.1	0.3	0.0	1.2	0.3	6.9	1.6	11.5	1.0	18.7	0.0	1.2	147.3	54.5	0.0	0.3	23.4	27.0	6.4	1.4	0.4	5.1	5.8	1.8	0.5	0.3	6.5	4.4	0.2	0.2	4.6	0.8	52.4	1.7	2.6
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339823	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 138.5;Hepatocytes: 150.6;Kupffer cells: 110.3;T-cells: 189.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 172.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 172.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 65.6;NB-4: 42.3;RPMI-8226: 49.2;U-266/84: 34.9;U-937: 34.5"									"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA		370000000	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	6.8	2.8	1.7	23.5	1.9	51.5	5.5	0.6	1.5	3.0	6.8	1.1	1.2	4.3	1.7	3.0	4.0	2.9	7.2	6.4	1.1	0.9	5.1	28.7	13.2	68.5	1.8	1.4	1.7	6.8	0.2	0.4	4.8	1.5	2.8	3.3	2.4	10.3	1.3	5.0	1.6	11.9	1.8	1.0	39.4	5.4	1.4	1.0	47.6	3.0	5.7	38.4	4.5	4.9	25.5	28.4	172.3	33.5	31.0	41.0	43.1	2.7	1.3	1.0	3.0	1.6	1.3	1.7	1.7	1.1	1.4	1.2	1.1	1.8	0.0	5.8	1.5	0.0	1.1	0.0	1.2	0.4	20.3	0.8	5.2	1.2	5.1	0.8	18.7	21.1	1.1	1.0	1.6	0.6	1.5	0.6	10.9	2.8	65.6	1.6	5.5	2.4	42.3	0.7	6.9	9.2	1.5	0.6	49.2	1.4	2.4	0.3	1.3	1.4	4.6	3.7	0.5	4.0	5.3	1.1	6.5	0.5	7.1	1.6	3.2	34.9	7.8	4.6	34.5	5.0	15.3	33.1	72.0	33.8	24.4	41.0	25.5	32.7	31.2	28.4	23.9	29.3	27.4	172.3	31.0	33.5	4.8	36.9	43.1	1.7	1.9	0.6	1.5	1.1	0.9	1.8	1.4	1.5	1.0	3.0	43.3	138.5	7.1	7.2	0.1	0.0	25.5	9.4	4.5	5.2	0.0	10.4	53.0	13.7	4.2	18.0	53.5	0.0	30.7	20.6	13.1	14.3	30.0	150.6	21.1	1.6	5.2	26.4	110.3	7.2	5.8	19.9	52.3	12.6	29.1	1.5	17.7	45.3	3.9	54.2	1.2	0.0	13.3	0.5	0.9	7.3	3.9	189.2	31.2	8.4
ICK	"KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Intestinal cell kinase"	Q9UPZ9	6	53001279-53061802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	9.8	28.2	10.1	6.5	10.7	2.8	13.4	14.3	12.7	11.5	12.3	20.1	6.6	11.3	10.6	6.8	10.4	9.2	8.3	9.6	10.8	7.7	5.4	9.6	8.2	5.5	13.3	8.1	11.8	8.2	9.0	5.3	44.3	12.3	12.2	13.0	9.7	20.7	12.7	5.9	10.1	14.2	13.7	16.8	6.2	15.0	5.6	12.6	14.8	7.6	7.0	7.9	10.6	9.1	4.5	4.1	6.2	3.1	3.2	5.0	2.1	5.1	1.9	10.1	6.9	6.3	10.0	11.7	4.6	8.5	7.5	8.6	2.7	1.6	3.7	2.8	14.1	2.4	3.4	12.0	4.8	9.9	13.0	4.7	2.8	2.3	14.8	3.2	3.4	3.7	8.8	5.3	3.2	3.7	5.4	6.9	8.2	5.3	15.5	17.0	4.4	3.6	4.2	3.8	18.0	4.2	5.8	4.5	5.0	3.1	3.7	16.3	7.3	4.5	11.2	6.4	10.3	6.5	7.3	5.7	12.0	5.6	4.4	11.4	4.3	3.1	1.5	2.4	3.3	5.8	6.2	3.1	5.6	5.0	2.3	4.8	3.7	3.6	4.1	2.9	4.5	4.2	3.6	1.7	3.2	2.5	4.1	4.8	2.1	10.1	10.7	14.3	12.7	10.8	7.7	13.3	8.1	12.3	12.6	17.9	16.8	7.1	4.3	6.9	30.5	8.7	7.6	17.4	26.1	3.5	35.3	17.7	11.6	8.9	1.8	8.7	9.5	0.0	21.0	27.3	8.2	14.5	19.7	12.3	5.2	25.4	8.6	8.0	10.4	1.1	13.3	6.0	3.3	5.4	25.7	20.1	16.6	2.9	26.9	3.8	41.7	6.5	14.4	6.4	2.7	7.3	48.6	7.5	12.3	8.0
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936748-203961577	"CD markers, Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8"	"Cell type enriched"	"Detected in some"	4	"T-cells: 23.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 18.4"	"Lineage enriched"	"Detected in single"	58	"T-cells: 18.4"	"Group enriched"	"Detected in some"	7	"HEL: 6.0;MOLT-4: 15.7"	"Low region specificity"	"Detected in single"							"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	1.5	0.3	0.2	15.6	0.2	13.8	0.7	0.2	0.2	0.8	1.2	0.0	0.2	0.5	1.2	0.5	1.1	1.2	1.6	0.5	0.2	0.2	1.0	0.8	4.0	19.4	0.3	0.0	0.6	0.3	0.0	0.4	0.1	0.1	0.7	1.1	0.7	2.9	0.0	0.2	0.6	6.2	0.3	0.4	6.1	1.0	0.6	0.0	51.8	1.4	2.4	28.9	3.0	0.9	0.0	0.0	0.0	0.0	0.3	18.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	2.9	0.0	10.5	4.6	0.0	0.0	11.0	5.0	0.0	0.3	0.0	0.0	18.4	3.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	5.8	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.6	0.1	23.5	0.0	0.0
ICOSLG	"B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653"	ENSG00000160223	"Inducible T cell costimulator ligand"	O75144	21	44217014-44240966	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, B-cell activation, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 17.5;monocytes: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 14.1"									"CAB026037, HPA029179"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA		150000000	"Plasma membrane, Cytoplasmic bodies"		"CAB026037: , HPA029179: AB_2732445"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-4)"	"unprognostic (3.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.40e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.84e-1)"	2.3	3.0	5.3	3.9	7.1	14.1	2.3	2.3	5.9	2.9	2.3	2.3	2.3	1.8	2.3	2.3	4.0	2.7	3.5	3.7	8.8	3.7	5.3	2.7	2.3	6.5	6.5	2.3	2.3	2.3	0.0	2.3	2.3	2.3	2.3	1.2	2.3	2.3	2.3	2.3	5.5	2.9	2.3	8.4	3.2	4.2	2.3	2.3	2.3	2.3	2.3	4.5	2.4	2.6	6.5	1.6	1.0	0.8	0.5	1.1	0.4	0.3	3.3	0.1	2.8	0.8	1.1	7.7	0.7	0.7	0.4	0.2	5.6	0.4	14.1	2.1	0.3	1.3	4.3	2.0	1.3	0.2	1.4	1.4	0.4	2.7	1.6	0.7	6.1	10.4	1.1	1.9	0.9	0.9	0.2	0.8	0.5	2.3	1.3	0.2	3.7	0.3	8.0	2.0	9.5	3.5	12.0	0.9	8.2	0.6	7.5	1.4	0.0	9.4	13.3	0.3	1.1	3.9	8.7	0.8	0.4	3.3	0.3	0.2	12.1	8.3	11.8	4.4	5.7	1.9	0.6	0.8	0.4	0.3	0.8	0.3	3.7	0.8	0.5	0.5	6.5	0.8	1.1	1.0	0.5	0.5	1.6	0.4	0.4	5.3	7.1	2.3	2.3	8.8	3.7	6.5	2.3	2.3	2.3	0.0	1.0	17.5	5.3	6.6	0.4	0.3	0.0	0.0	1.2	8.7	0.0	0.3	0.0	1.3	0.7	3.1	4.2	0.0	0.6	0.9	4.8	11.7	0.0	1.9	3.4	0.0	5.1	1.3	6.7	2.7	2.8	10.5	8.5	34.3	4.4	1.3	0.7	1.4	10.3	3.6	0.8	0.0	8.1	0.0	0.2	5.6	0.5	0.0	3.9	5.9
ID2	"bHLHb26, GIG8"	ENSG00000115738	"Inhibitor of DNA binding 2"	Q02363	2	8678845-8684453	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 274.1"	"Cell type enhanced"	"Detected in all"	12	"monocytes: 3286.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 110.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 108.1;HEK 293: 69.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027612			Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA			"Nucleoplasm, Nuclear bodies"	Centrosome	"HPA027612: AB_10599729"	"unprognostic (2.53e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.39e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.92e-3)"	34.2	37.4	24.9	19.1	20.6	69.8	31.5	11.3	57.3	21.9	34.0	22.9	13.2	20.7	18.6	11.6	12.1	28.1	33.5	46.1	20.0	14.6	31.2	117.5	25.4	22.4	19.0	35.3	59.7	15.0	274.1	17.2	14.8	20.0	27.2	26.4	13.3	24.5	72.7	8.8	16.6	20.4	19.2	15.8	21.3	16.2	7.1	14.2	19.0	46.8	15.1	10.2	31.8	38.0	0.3	25.0	110.4	26.0	90.9	42.4	18.0	0.2	20.0	8.2	10.1	13.3	2.1	31.5	22.8	2.7	10.2	4.3	40.0	1.0	0.5	27.1	39.0	2.6	17.2	5.3	0.1	3.0	108.1	69.9	14.4	12.3	48.9	3.9	10.7	40.5	3.6	0.4	4.7	0.2	2.8	0.2	1.0	0.8	17.1	15.8	6.7	1.1	1.2	15.0	47.9	15.7	1.4	5.7	10.7	10.2	9.0	15.6	22.1	1.2	17.3	1.7	21.7	2.9	6.4	4.1	12.6	2.2	18.7	1.3	1.3	1.0	12.4	16.0	33.0	6.8	9.0	8.2	110.4	42.4	24.2	25.3	0.3	13.1	29.5	25.0	0.2	16.4	31.4	11.2	90.9	26.0	1.1	1.0	18.0	24.9	20.6	11.3	57.3	20.0	14.6	19.0	35.3	20.0	14.2	131.0	257.3	44.9	93.2	116.7	9.4	147.7	272.6	71.0	147.9	96.0	15.7	219.0	470.9	258.1	11.1	189.7	226.3	46.7	138.3	130.1	269.8	153.6	916.1	393.6	669.0	6.4	409.1	414.4	336.8	15.3	115.1	499.1	268.2	3286.8	521.6	478.8	95.2	300.6	30.8	190.8	24.4	19.4	173.1	1.6	4.7	91.5	557.0	879.8	224.4	39.6
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK, gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 35.9;liver: 39.1"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 68.0;Proximal tubular cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA020378: AB_1845794, HPA058429: AB_2683716"	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	4.3	6.1	9.4	2.9	20.3	2.2	4.5	12.3	8.3	2.3	11.3	7.0	3.1	14.2	2.5	7.4	4.1	6.8	4.5	2.8	7.6	8.6	27.2	39.1	3.7	4.7	7.3	6.3	3.2	6.6	3.6	5.2	1.8	6.2	4.2	4.7	5.2	4.6	5.0	1.2	3.3	20.2	3.5	7.0	4.2	4.3	2.0	6.8	14.5	7.0	1.2	4.3	2.8	2.1	17.5	9.6	35.9	20.5	15.0	23.0	11.4	3.4	8.2	1.1	1.3	3.7	5.4	6.0	2.3	6.9	2.6	2.1	2.1	3.0	4.3	4.0	3.7	2.5	5.7	0.9	1.6	2.8	9.5	1.0	1.6	3.2	9.4	16.4	1.0	2.0	3.7	2.2	5.7	5.4	3.9	5.9	10.3	1.3	4.6	3.8	19.0	2.6	1.0	0.9	13.8	3.7	3.2	3.1	2.5	6.9	4.0	5.3	6.8	5.5	4.3	5.8	1.6	4.3	5.8	6.0	1.1	0.8	10.7	4.4	6.6	7.6	0.6	5.9	1.8	2.1	35.9	6.1	8.6	14.7	10.6	12.3	17.5	12.7	12.1	8.5	11.4	10.2	13.8	1.1	15.0	20.5	9.6	23.0	11.4	9.4	20.3	12.3	8.3	7.6	8.6	7.3	6.3	6.2	6.8	11.9	5.4	5.9	2.6	6.1	7.5	8.7	15.3	22.7	9.1	5.2	0.0	6.3	68.0	10.1	0.3	6.0	10.8	0.0	14.3	3.8	8.4	5.2	19.7	37.2	10.0	9.5	7.0	3.1	9.5	1.1	4.0	7.7	11.8	27.9	10.6	17.7	5.2	11.5	3.9	149.6	3.1	0.0	9.5	1.1	1.5	5.1	2.5	17.5	7.8	2.7
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell type enriched"	"Detected in some"	552	"monocytes: 4555.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 36.6"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	2.6	0.1	0.3	0.0	36.6	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.5	2.6	0.9	0.0	0.0	6.7	0.0	0.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	8.2	1.3	0.0	6.0	0.0	4555.6	0.0	3.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.4
IDO2	INDOL1	ENSG00000188676	"Indoleamine 2,3-dioxygenase 2"	Q6ZQW0	8	39934614-40016391	"Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"liver: 9.7;placenta: 21.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 16.8;Late spermatids: 5.3;monocytes: 25.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;U-266/70: 1.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA054911			Approved	Cytosol		NA	NA			Cytosol		"HPA054911: "	"unprognostic (2.00e-3)"	"unprognostic (2.34e-5)"	"unprognostic (2.22e-3)"	"unprognostic (4.41e-3)"	"unprognostic (5.37e-2)"	"unprognostic (3.69e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.47e-7)"	"unprognostic (3.25e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.08e-3)"	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	9.7	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0
IER5		ENSG00000162783	"Immediate early response 5"	Q5VY09	1	181088712-181092899	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029894	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA029894: AB_10601433"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (2.42e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.81e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	9.4	7.2	4.7	16.2	5.4	45.7	13.8	6.2	12.6	7.8	7.8	5.1	5.9	6.6	12.8	5.3	20.9	14.3	10.3	22.9	6.0	4.9	3.7	6.7	22.6	9.6	10.1	5.7	4.4	4.3	1.8	4.6	34.5	6.9	6.7	6.9	3.7	5.7	4.9	42.3	16.6	10.8	9.6	7.2	27.3	6.8	5.1	5.0	11.2	4.3	22.9	19.8	8.4	16.3	5.4	1.6	5.4	7.8	1.5	2.1	0.9	12.1	10.7	5.9	5.1	8.2	11.4	15.8	21.6	23.0	12.3	10.9	2.9	6.9	4.0	9.6	8.3	8.6	22.5	1.9	14.7	8.0	23.0	9.3	3.6	5.5	2.0	12.9	4.1	11.7	8.1	15.0	14.2	9.5	9.3	8.3	3.4	14.8	18.3	21.6	5.5	4.1	6.6	6.1	4.6	5.4	4.7	10.3	15.1	4.4	6.7	8.6	9.3	10.9	10.7	23.9	7.5	8.5	3.6	12.5	8.8	15.5	10.0	13.0	12.1	4.2	3.1	6.9	4.4	2.4	5.4	2.1	3.8	1.6	7.8	1.9	5.4	1.4	2.1	1.6	3.6	0.3	0.9	1.8	1.5	7.3	0.2	1.8	0.9	4.7	5.4	6.2	12.6	6.0	4.9	10.1	5.7	6.9	5.0	20.8	75.0	63.8	120.3	62.0	22.9	92.8	17.8	14.7	19.4	8.7	35.3	8.9	0.0	9.0	3.6	66.0	73.5	0.0	6.0	36.7	51.2	79.2	34.7	4.9	43.9	7.9	54.2	36.2	111.7	8.2	11.2	133.8	43.9	41.5	70.2	18.9	15.6	54.7	8.9	1.1	19.9	0.0	68.4	3.6	5.0	52.1	28.6	25.4	34.5	130.7
IER5L	bA247A12.2	ENSG00000188483	"Immediate early response 5 like"	Q5T953	9	129175552-129178262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 15.5;SiHa: 21.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021327			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021327: AB_2121674"	"unprognostic (2.46e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.90e-3)"	"unprognostic (8.49e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.48e-6)"	"unprognostic (6.91e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.29e-1)"	12.6	11.3	6.0	6.4	9.0	3.3	31.3	2.1	15.3	29.6	8.2	3.5	14.9	5.0	17.4	10.8	13.0	11.0	14.3	14.9	6.4	5.0	14.8	15.0	9.4	8.1	5.5	3.9	35.0	5.4	3.2	8.0	9.8	7.9	15.2	3.7	6.1	8.1	30.1	8.4	8.0	5.3	10.5	11.8	5.7	11.1	6.2	4.1	1.2	9.4	4.9	3.8	20.7	25.5	0.0	0.3	2.1	1.1	0.4	0.8	0.2	5.2	15.5	4.4	8.4	3.3	5.2	13.4	7.9	0.7	1.2	1.2	0.8	8.7	0.1	3.2	1.8	3.6	11.5	0.2	0.9	0.2	0.7	1.1	0.0	3.3	1.4	2.5	0.1	0.1	5.7	1.2	0.9	0.1	7.0	0.5	0.1	0.4	2.8	0.2	13.5	0.1	0.6	0.4	1.3	8.2	0.7	0.3	2.2	4.7	0.7	2.0	2.6	21.8	7.1	8.9	1.9	2.2	1.4	3.2	7.6	4.5	5.1	11.2	1.5	1.0	0.1	9.6	1.5	3.3	0.0	1.1	0.0	0.3	0.6	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	2.1	0.4	0.2	0.1	0.0	0.2	6.0	9.0	2.1	9.0	6.4	5.0	5.5	3.9	7.9	4.1	14.9	1.7	2.9	5.9	6.1	6.0	1.4	20.4	2.7	4.5	45.4	0.0	3.5	8.3	10.6	0.7	11.1	16.9	0.0	22.8	5.4	12.9	12.2	0.0	9.7	25.2	3.2	10.3	29.4	15.4	1.1	10.0	9.2	13.5	3.6	14.6	14.0	18.0	9.3	6.7	14.3	2.7	25.8	20.8	0.0	1.7	4.0	6.8	1.0	8.4	6.7
IFFO2		ENSG00000169991	"Intermediate filament family orphan 2"	Q5TF58	1	18904281-18956686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 76.8"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 68.5;Basal keratinocytes: 107.4;Suprabasal keratinocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5"									"HPA015987, HPA064603"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA015987: AB_2121678, HPA064603: AB_2685296"	"unprognostic (1.43e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.27e-3)"	"unprognostic (3.24e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.36e-1)"	3.5	5.1	3.8	5.0	7.8	5.7	8.9	22.3	6.4	6.7	4.6	6.2	4.9	1.4	4.7	2.2	28.7	3.6	4.8	2.7	4.4	4.0	4.9	8.9	5.0	5.3	6.8	3.6	2.4	14.5	13.0	4.0	4.7	9.3	6.6	2.0	3.4	7.9	6.5	4.3	76.8	2.5	13.5	8.9	3.9	2.9	1.4	4.6	3.2	4.3	33.2	11.3	6.3	8.8	0.8	0.6	10.6	0.3	0.3	1.0	0.1	8.4	13.8	3.7	10.3	2.4	1.9	6.0	6.4	4.2	3.5	2.4	18.9	9.9	0.1	8.2	4.8	4.0	21.2	2.8	13.5	2.8	50.5	2.5	0.1	2.6	7.4	1.7	1.4	16.2	1.2	13.8	4.7	6.0	5.8	7.4	0.4	0.6	1.7	2.3	1.7	1.4	1.3	1.6	8.7	3.3	4.7	2.3	3.6	2.0	5.4	11.9	0.6	4.8	6.8	4.7	4.0	1.8	0.7	20.2	4.7	6.6	2.7	18.3	3.6	3.9	0.2	3.2	2.1	5.5	10.6	0.3	0.0	0.6	0.3	0.8	0.8	0.5	0.7	0.1	0.3	0.5	1.0	0.1	0.3	0.0	0.6	0.5	0.1	3.8	7.8	22.3	6.4	4.4	4.0	6.8	3.6	9.3	4.6	3.0	4.8	0.9	68.5	107.4	5.7	5.5	15.3	12.0	4.5	1.8	0.0	4.1	1.7	12.7	1.2	7.1	1.0	0.0	15.2	5.8	3.6	12.6	3.5	3.9	2.0	23.8	2.4	6.2	0.8	2.2	1.1	4.0	13.5	2.8	0.6	5.1	13.4	2.9	2.8	8.1	1.6	0.0	8.5	0.7	0.5	87.7	3.3	2.9	1.0	39.7
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA002134, CAB016293"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099"	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	64.2	21.0	10.9	42.5	18.0	10.2	34.8	6.7	11.4	28.5	18.6	9.6	7.8	7.5	32.5	21.8	32.8	25.0	33.4	24.8	16.5	7.5	13.3	10.2	32.1	51.0	19.5	6.3	32.6	5.5	3.2	7.0	21.4	18.0	23.0	15.2	10.9	33.6	11.2	14.6	23.7	21.6	29.1	32.2	63.2	11.8	14.2	16.0	81.8	19.1	24.2	41.8	30.9	27.6	28.9	20.8	51.2	21.0	27.9	24.6	16.9	7.0	0.5	2.4	0.1	17.0	56.4	0.0	15.0	40.3	42.3	56.3	0.0	9.1	41.5	12.9	9.2	13.6	20.5	0.3	15.2	16.9	12.8	0.1	10.6	3.1	0.0	31.9	3.6	0.7	53.1	27.3	21.6	30.8	20.3	44.4	36.7	0.2	30.4	23.4	0.0	48.7	3.4	6.5	0.0	5.5	23.0	15.6	47.9	5.9	2.7	1.1	0.0	19.6	0.1	42.6	10.2	0.0	4.3	25.0	10.9	5.1	30.6	6.3	28.4	13.2	39.0	31.3	12.0	26.2	2.5	21.0	0.1	18.9	20.5	16.9	27.6	18.1	19.3	20.8	28.9	11.5	14.6	51.2	27.9	18.5	15.6	24.6	16.9	10.9	18.0	6.7	11.4	16.5	7.5	19.5	6.3	18.0	16.0	35.7	66.1	149.1	95.2	84.3	0.2	6.9	22.9	58.9	119.4	40.1	0.0	3.0	1.7	32.6	4.0	196.0	5.6	0.0	40.2	1.9	91.8	23.0	129.9	2.9	175.9	0.0	11.6	126.4	165.6	4.9	108.7	168.3	79.2	49.5	16.2	31.8	42.0	24.6	49.8	4.4	0.9	84.1	124.0	2.6	1.9	59.6	2.7	201.5	21.7	108.0
IFI27L2	"FAM14A, TLH29"	ENSG00000119632	"Interferon alpha inducible protein 27 like 2"	Q9H2X8	14	94127779-94130253	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 57.7"					"Low region specificity"	"Detected in all"			HPA049588			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No			Cytosol	Nucleoli	"HPA049588: "	"unprognostic (9.70e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.76e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.52e-2)"	11.4	39.9	38.6	18.3	23.8	17.0	18.8	15.2	24.7	19.9	16.0	23.5	8.7	11.6	15.8	9.6	24.5	21.9	20.8	38.9	29.7	32.4	13.2	3.7	16.5	21.5	37.1	22.8	25.9	13.2	11.7	20.6	5.4	27.4	10.6	9.7	20.4	7.2	12.5	4.0	16.0	13.5	15.5	35.7	17.0	15.7	9.1	22.9	13.8	8.5	16.0	22.5	12.0	17.2	31.5	29.6	19.8	38.7	6.0	30.5	31.9	8.4	5.9	1.7	12.1	8.7	22.4	1.1	15.9	16.4	12.0	14.1	1.6	3.9	3.7	17.4	17.1	10.6	10.5	1.3	21.1	4.9	25.3	0.9	5.8	5.9	0.5	14.8	6.8	16.0	20.3	7.8	7.1	4.4	20.5	7.9	14.6	0.5	57.7	12.4	15.9	3.9	4.1	2.1	5.6	6.8	0.1	5.6	4.9	18.2	3.3	3.1	4.7	0.4	0.1	10.2	3.3	19.6	11.4	7.7	8.0	4.9	10.7	4.4	23.6	19.5	1.3	25.6	15.2	5.2	19.8	38.7	7.1	25.6	25.9	16.4	31.5	24.4	28.1	29.6	27.4	17.6	23.0	5.7	6.0	18.8	24.6	30.5	31.9	38.6	23.8	15.2	22.8	29.7	32.4	37.1	22.8	27.4	22.9	35.7	60.1	82.7	48.1	82.4	19.9	126.7	48.4	18.7	11.4	169.3	19.6	1.8	150.9	127.6	5.8	62.7	86.6	0.0	26.4	2.5	85.0	7.4	88.9	2.6	167.2	22.3	95.7	122.2	166.9	22.7	169.5	141.7	224.4	80.2	146.1	108.3	55.0	123.8	108.5	51.2	76.6	122.9	100.0	4.5	24.8	58.5	2.4	89.6	75.5	44.4
IFI44	"MTAP44, p44, TLDC5"	ENSG00000137965	"Interferon induced protein 44"	Q8TCB0	1	78649796-78664078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 36.8;Ito cells: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 46.1;BJ hTERT+ SV40 Large T+ RasG12V: 57.0;GAMG: 46.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA027148, HPA043858"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027148: AB_1851411, HPA043858: AB_2678702"	"unprognostic (1.20e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.90e-2)"	35.2	12.6	10.2	16.2	11.7	47.8	13.0	4.3	8.2	10.0	8.1	6.6	10.5	10.5	13.6	29.9	15.2	8.3	24.9	10.7	10.8	9.8	26.9	11.2	18.6	16.5	11.9	10.5	10.9	5.2	3.0	19.6	11.4	10.5	11.0	5.3	11.3	35.4	13.2	7.5	5.5	8.8	10.2	15.1	32.3	11.2	4.8	11.0	22.3	13.8	11.3	8.1	13.6	8.0	2.2	5.9	3.7	13.0	6.1	12.4	5.5	1.9	0.0	0.3	0.0	1.4	9.6	0.0	1.2	16.8	46.1	57.0	0.0	5.6	2.6	13.1	1.2	46.6	1.0	0.0	0.7	7.5	5.6	0.0	6.7	4.9	0.0	1.9	0.0	0.0	6.0	0.0	19.9	0.2	3.6	8.6	1.7	0.0	9.0	10.9	0.0	5.5	0.4	0.0	0.0	3.7	4.3	13.9	0.3	1.3	1.2	0.1	0.3	0.4	0.1	19.7	0.0	0.0	0.2	10.5	8.5	3.6	0.9	8.4	0.7	0.9	0.0	13.1	7.6	2.3	0.3	13.0	0.1	6.2	12.3	12.4	2.2	9.1	5.9	5.9	1.6	3.9	5.0	3.7	6.1	6.3	1.7	4.3	5.5	10.2	11.7	4.3	8.2	10.8	9.8	11.9	10.5	10.5	11.0	26.8	23.9	0.5	8.9	3.2	0.0	4.5	5.1	21.4	15.9	8.7	0.0	0.2	0.0	9.9	0.4	36.8	0.8	0.0	10.8	0.2	9.8	3.6	17.4	2.4	27.7	0.0	6.4	48.5	34.5	0.5	12.4	26.5	5.0	4.6	1.5	0.8	8.5	0.0	16.3	2.1	0.2	19.4	9.5	0.0	0.4	4.0	0.0	12.5	1.5	11.7
IFI44L	"C1orf29, GS3686"	ENSG00000137959	"Interferon induced protein 44 like"	Q53G44	1	78619922-78646145	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 70.0;Peritubular cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 25.6;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;GAMG: 9.2;HSkMC: 14.9;SK-MEL-30: 11.7"					"Low region specificity"	"Detected in all"			"HPA053247, HPA060372"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053247: AB_2682088, HPA060372: AB_2684267"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (2.95e-4)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.03e-2)"	33.6	5.3	9.4	6.2	10.6	36.2	7.6	3.3	10.4	3.8	4.0	12.3	2.7	3.5	10.6	19.7	3.8	4.9	15.0	7.4	9.2	11.0	15.7	4.9	9.5	5.1	10.6	9.4	6.6	2.2	1.9	5.6	8.6	21.6	5.4	3.1	14.4	26.3	5.2	3.5	2.7	3.8	7.0	17.2	23.1	3.7	5.0	12.2	21.6	10.0	4.9	5.2	10.4	3.2	3.6	2.2	2.3	5.6	4.4	2.2	1.5	0.0	0.0	1.0	0.0	0.5	6.9	0.0	0.2	5.3	25.6	27.8	0.0	0.3	5.7	3.1	0.1	9.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.6	0.1	0.1	14.9	0.1	1.9	0.3	4.8	0.2	0.0	0.0	0.8	0.5	0.0	0.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	1.3	0.1	0.0	0.0	6.9	0.0	11.7	0.0	0.0	0.1	0.2	0.2	0.4	0.5	0.7	1.2	0.2	0.0	4.2	0.0	0.0	0.1	5.0	0.3	0.5	5.6	1.6	3.6	2.2	1.7	1.6	1.6	0.8	0.8	2.3	4.4	2.1	2.2	0.5	1.5	9.4	10.6	3.3	10.4	9.2	11.0	10.6	9.4	21.6	12.2	0.0	9.0	7.2	2.5	3.5	0.0	1.7	2.5	17.4	9.1	7.0	0.0	0.1	0.0	4.0	0.6	70.0	0.0	0.0	7.5	0.1	6.1	1.5	2.3	0.0	22.8	0.0	0.0	22.1	13.0	1.8	21.9	14.1	3.3	2.8	0.0	1.2	1.6	0.0	45.3	0.6	0.2	6.5	4.2	0.3	0.0	1.8	0.2	6.2	0.0	3.1
IFI6	"6-16, FAM14C, G1P3, IFI-6-16, IFI616"	ENSG00000126709	"Interferon alpha inducible protein 6"	P09912	1	27666061-27672218	"Predicted membrane proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 225.6"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 3308.6;Extravillous trophoblasts: 1015.8;Syncytiotrophoblasts: 3573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 134.5;BJ hTERT+ SV40 Large T+ RasG12V: 157.3;EFO-21: 54.1;SK-MEL-30: 95.5"					"Low region specificity"	"Detected in all"			HPA005543	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA005543: AB_1849342"	"unprognostic (4.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.96e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.77e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	32.3	27.5	24.9	13.5	28.2	37.3	10.9	14.2	36.1	11.4	13.8	22.9	6.5	16.5	26.8	68.0	8.6	11.9	113.9	19.3	23.0	42.3	44.8	23.5	31.6	5.8	20.0	17.0	14.1	21.3	5.9	60.1	225.6	34.3	13.9	10.1	31.6	111.4	10.1	7.4	5.4	12.5	17.0	26.0	27.3	35.4	15.4	6.8	24.8	35.2	7.9	9.7	7.8	7.6	9.7	19.4	84.9	58.6	15.8	27.5	16.8	1.4	0.4	2.2	1.4	7.3	4.0	9.0	4.7	21.7	134.5	157.3	0.7	5.7	0.5	54.1	2.1	35.6	0.5	0.5	1.0	4.4	11.1	1.8	3.4	1.1	0.4	1.9	1.1	4.5	4.3	0.1	8.1	0.1	2.1	1.2	3.1	0.2	9.5	1.5	0.4	4.1	14.5	0.4	2.7	4.5	2.8	1.2	1.3	1.1	0.0	3.2	2.9	5.8	1.3	95.5	0.7	0.6	4.4	2.1	1.2	1.9	0.9	0.8	11.3	6.4	0.3	2.4	10.1	3.5	29.3	44.4	39.4	22.7	58.6	22.4	9.7	23.0	20.7	19.4	8.0	24.3	23.6	84.9	15.8	38.8	2.0	27.5	16.8	24.9	28.2	14.2	36.1	23.0	42.3	20.0	17.0	34.3	6.8	131.0	105.4	20.9	17.6	20.8	10.1	13.4	73.9	88.3	37.5	61.1	9.8	3308.6	16.6	186.8	2.9	139.0	7.0	0.0	304.1	1015.8	142.9	71.5	60.2	43.3	628.8	3.2	56.0	68.2	47.6	8.5	102.4	129.6	67.4	56.9	22.2	79.9	144.2	8.7	192.3	28.3	5.5	109.9	38.2	1.7	0.9	19.6	3573.6	51.2	8.0	13.6
IFIT2	"cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K"	ENSG00000119922	"Interferon induced protein with tetratricopeptide repeats 2"	P09913	10	89283694-89309276	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 93.4"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 93.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 93.4"	"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 50.6;BJ hTERT+ SV40 Large T+ RasG12V: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003408	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA003408: AB_1079100"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.46e-2)"	15.5	7.7	10.2	8.9	11.9	31.9	5.5	8.1	10.5	4.5	3.7	15.6	2.1	4.7	3.5	7.4	2.3	6.7	9.7	4.8	10.4	9.2	10.5	14.9	14.4	6.5	23.7	6.7	6.9	2.4	4.5	3.3	11.3	20.4	3.9	3.1	5.2	5.8	4.7	1.8	2.5	4.1	4.6	29.4	18.0	2.6	1.3	17.9	3.9	4.2	0.4	3.7	7.3	3.5	4.0	2.9	93.4	17.0	1.7	2.2	3.4	10.0	0.4	0.1	4.7	4.8	5.3	1.4	3.8	10.6	50.6	40.3	0.0	7.4	1.1	2.2	2.6	7.6	10.6	0.2	0.5	5.4	4.2	0.0	1.8	5.4	0.0	8.3	0.2	0.8	3.0	0.2	3.8	0.5	3.1	0.2	1.0	0.0	0.2	0.7	0.0	1.2	2.3	0.1	0.0	2.0	0.7	1.3	0.2	1.7	2.0	0.0	0.0	1.1	0.3	9.1	0.3	0.2	0.5	0.3	0.5	0.1	1.4	0.3	0.4	1.7	0.1	0.8	0.9	1.0	17.9	7.0	21.8	2.2	15.1	1.2	4.0	1.7	1.5	2.3	3.5	1.8	1.6	93.4	1.7	17.0	2.9	0.9	3.4	10.2	11.9	8.1	10.5	10.4	9.2	23.7	6.7	20.4	17.9	38.7	4.1	7.5	5.0	1.3	1.0	5.7	5.1	5.3	12.5	12.2	0.0	1.8	8.3	25.1	0.1	18.3	9.6	0.0	3.7	1.0	5.0	15.4	4.7	5.5	25.2	23.8	3.4	14.1	17.2	0.0	7.5	16.8	6.8	8.2	5.2	12.8	7.5	5.8	11.0	8.4	0.6	0.0	3.1	0.0	0.0	0.5	1.1	11.7	1.5	3.9
IFNGR2	"AF-1, IFNGT1"	ENSG00000159128	"Interferon gamma receptor 2"	P38484	21	33402896-33479348	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"		Receptor	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Glandular cells: 309.5;Urothelial cells: 502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 55.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001535	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA001535: AB_1078432"	"unprognostic (9.58e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (1.13e-10)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.15e-3)"	27.2	13.4	11.9	20.8	12.6	45.1	64.4	4.6	18.0	12.5	21.6	5.7	13.0	18.5	10.6	14.1	21.9	11.5	15.2	17.7	11.1	10.1	14.6	20.2	26.3	46.3	8.7	9.4	13.0	21.7	7.1	12.6	20.5	12.2	14.9	11.7	12.1	21.9	11.7	13.1	16.7	20.0	15.3	18.1	27.4	30.3	14.1	7.2	7.9	18.1	19.4	18.9	14.8	26.8	13.2	7.7	55.1	22.8	0.3	3.3	13.8	3.0	2.6	1.3	2.7	3.8	6.5	4.3	8.8	6.4	2.0	3.3	3.1	1.7	5.3	4.9	5.3	5.9	2.3	2.8	6.1	1.1	20.4	17.2	1.5	1.1	2.7	2.6	7.6	4.8	4.9	4.0	3.5	3.5	3.8	5.2	2.6	8.0	2.6	2.8	0.9	1.8	5.2	4.9	3.6	16.7	4.5	4.2	4.4	2.2	4.1	1.9	4.7	4.4	0.5	8.4	0.7	1.6	4.9	8.8	2.5	5.5	2.1	2.1	5.6	7.6	6.8	2.2	6.8	12.0	12.9	22.2	14.8	0.1	22.0	0.1	11.5	1.3	0.1	7.7	13.2	3.3	1.4	55.1	0.3	22.8	2.4	1.4	13.8	11.9	12.6	4.6	18.0	11.1	10.1	8.7	9.4	12.2	7.2	38.7	25.1	76.3	178.2	64.0	8.7	16.6	43.3	13.4	19.4	26.2	7.9	28.1	23.2	100.9	35.4	41.3	130.0	0.0	48.9	66.1	81.2	309.5	59.9	24.9	150.7	14.3	49.5	36.8	129.5	44.6	38.9	162.5	54.0	211.0	45.2	7.8	102.1	105.2	30.8	39.8	7.2	12.9	30.1	3.9	1.7	61.2	14.5	13.8	35.8	502.7
IFNLR1	"CRF2/12, IFNLR, IL-28R1, IL28RA"	ENSG00000185436	"Interferon lambda receptor 1"	Q8IU57	1	24154157-24187959	"Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 13.9;Urothelial cells: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;dendritic cells: 11.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 30.2;U-266/84: 10.5;U-698: 22.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA017319	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA017319: AB_1851708"	"prognostic favorable (5.12e-4)"	"unprognostic (7.16e-2)"	"unprognostic (8.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.66e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-1)"	3.0	3.0	1.1	9.5	1.9	0.4	2.9	10.2	2.1	2.1	9.9	3.8	3.6	6.5	0.8	6.7	4.7	2.0	2.9	6.4	0.9	2.1	4.3	10.1	9.2	8.2	2.0	1.9	1.5	7.8	5.7	8.2	2.5	2.9	4.1	4.6	1.6	9.3	5.7	3.5	8.3	19.2	0.2	5.3	4.4	3.1	1.2	1.1	1.2	5.3	3.1	10.7	2.0	2.7	6.8	11.9	0.0	0.0	0.0	2.0	0.5	3.7	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.7	0.5	6.3	1.1	8.1	8.8	0.0	3.1	2.8	3.8	6.6	0.5	1.6	2.0	0.0	1.3	1.9	0.0	0.0	0.0	0.0	2.2	0.2	2.0	1.4	0.0	1.6	0.1	0.0	0.0	0.8	0.1	0.2	8.1	0.3	2.4	0.0	0.0	0.6	1.5	1.6	1.2	0.7	2.0	1.1	0.8	1.4	1.5	0.0	0.0	0.0	1.6	0.0	0.0	30.2	10.5	22.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	5.1	0.3	1.5	0.0	6.8	0.6	1.6	0.0	0.0	0.0	11.9	0.3	0.5	1.1	1.9	10.2	2.1	0.9	2.1	2.0	1.9	2.9	1.1	0.0	4.5	2.2	6.8	9.8	2.1	2.9	2.5	5.3	1.2	1.8	0.0	0.3	3.3	2.2	2.0	0.2	13.9	0.0	2.1	1.0	0.4	4.3	0.0	7.8	2.4	0.0	0.0	0.0	0.3	3.4	0.3	2.7	0.0	9.0	3.0	3.3	1.7	4.8	0.0	1.8	2.6	0.0	0.5	0.0	0.6	11.0	0.2	1.3	2.9	12.7
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422968-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 93.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 25.6;neutrophil: 44.2"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 44.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024122, HPA072413"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA024122: AB_1851452, HPA072413: "	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	19.5	18.0	16.7	12.9	19.6	83.1	24.0	14.3	15.7	10.7	18.3	15.6	11.7	18.7	15.7	12.5	12.7	11.4	12.7	16.0	15.2	13.3	11.9	14.1	19.2	7.9	30.9	13.2	16.9	93.0	12.5	23.1	18.7	16.9	14.7	11.7	11.2	14.3	11.0	37.6	12.3	19.0	23.9	28.2	11.7	17.7	17.9	22.0	7.5	16.5	13.5	7.4	14.7	37.5	3.8	2.9	44.2	3.2	3.4	3.7	2.6	15.0	10.1	15.7	14.8	26.9	17.5	14.6	14.9	14.3	19.3	17.4	16.7	12.7	7.3	28.5	7.7	38.4	9.0	10.9	12.6	26.4	12.4	15.5	8.2	18.8	16.0	30.8	11.1	6.5	13.3	27.0	20.4	23.4	15.5	8.0	12.6	25.0	16.5	7.8	13.6	14.1	18.7	35.8	14.0	17.8	12.3	6.3	13.6	5.8	4.2	25.3	13.1	17.0	14.5	48.1	29.7	5.6	12.0	6.9	32.9	7.0	25.6	44.9	14.8	17.5	20.0	8.9	30.9	37.6	5.7	3.2	25.6	3.6	2.8	2.8	3.8	3.5	3.4	2.9	3.0	3.4	3.3	44.2	3.4	2.8	2.1	3.7	2.6	16.7	19.6	14.3	15.7	15.2	13.3	30.9	13.2	16.9	22.0	29.8	31.8	25.5	140.2	175.3	48.0	49.5	22.9	13.4	33.0	17.4	84.4	63.5	14.9	41.7	32.2	54.5	231.2	23.3	49.6	52.8	71.4	123.0	75.8	18.7	104.1	20.6	132.5	47.9	76.5	7.5	33.9	78.9	97.8	73.1	82.8	22.6	50.8	210.5	38.5	11.0	72.9	38.8	197.8	13.7	11.5	110.2	126.9	55.4	87.9	126.0
IFRD2	"IFNRP, SKMc15, SM15"	ENSG00000214706	"Interferon related developmental regulator 2"	Q12894	3	50287732-50292918	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA068560	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068560: AB_2686005"	"prognostic favorable (7.22e-4)"	"unprognostic (5.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.78e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	11.0	10.0	5.2	10.8	7.7	6.9	15.4	9.0	6.6	7.9	13.7	6.4	21.2	10.7	6.9	7.7	11.8	8.0	17.0	23.9	4.9	4.5	11.1	41.1	8.4	6.5	7.8	3.5	9.8	34.7	10.2	7.6	6.7	7.1	15.6	8.3	8.0	23.7	22.3	39.2	7.8	12.0	8.5	4.9	9.4	18.4	9.9	6.9	7.4	15.8	24.3	8.5	7.8	7.5	17.5	17.8	3.9	16.9	18.5	25.2	15.2	22.8	23.6	6.5	20.5	6.7	7.8	15.1	17.6	9.6	21.7	15.4	19.4	23.5	15.7	13.0	12.1	18.6	13.4	13.6	28.2	11.2	14.9	27.3	22.6	31.2	22.8	13.3	22.9	14.3	7.2	24.3	22.6	28.4	7.2	18.3	14.1	14.3	12.9	12.7	21.5	14.9	26.9	16.4	28.5	46.0	9.8	9.5	35.7	12.9	13.8	11.6	11.2	11.1	30.8	11.1	6.6	14.6	22.0	13.2	18.1	22.8	31.2	35.5	9.1	15.5	13.4	14.4	30.1	26.4	3.9	12.5	1.7	17.9	16.9	25.2	17.5	18.9	17.1	17.8	17.3	20.2	18.3	1.1	18.5	9.3	17.5	14.9	15.2	5.2	7.7	9.0	6.6	4.9	4.5	7.8	3.5	7.1	6.9	17.9	27.7	30.0	43.2	59.8	16.6	1.6	33.1	2.7	15.9	19.2	19.6	29.0	24.9	47.3	66.9	24.8	23.6	0.0	77.7	36.7	26.6	71.8	7.0	44.0	28.7	17.5	15.0	9.8	9.4	95.0	12.7	14.5	33.7	19.0	24.8	13.0	62.8	21.0	13.4	43.7	11.7	0.0	48.6	17.2	16.2	60.0	25.4	20.8	46.4	75.9
IFT20		ENSG00000109083	"Intraflagellar transport 20"	Q8IY31	17	28328325-28335489	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 77.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021376	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA021376: AB_1851460"	"unprognostic (1.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (1.67e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.71e-3)"	11.4	17.1	15.3	10.8	15.4	37.6	15.9	20.0	15.9	12.4	16.3	8.8	20.7	16.6	11.9	23.7	10.8	13.5	18.8	9.8	13.8	14.6	15.1	23.3	11.8	12.9	18.7	13.1	11.4	77.1	9.7	26.1	16.9	14.4	14.7	12.0	11.2	26.7	19.2	4.5	8.1	18.3	16.6	13.4	12.7	19.0	28.6	15.9	9.6	20.6	7.7	11.0	15.7	13.9	24.2	41.0	38.1	36.9	17.2	25.2	26.8	10.8	15.2	10.3	8.3	30.7	31.4	9.8	18.9	22.9	11.6	18.2	23.1	5.1	5.3	10.2	23.1	7.0	11.5	6.6	13.8	17.0	21.7	28.8	3.2	16.2	10.6	29.9	13.3	6.7	23.8	18.6	9.9	16.1	20.0	18.4	10.2	9.4	13.6	9.1	14.6	11.7	10.8	6.8	32.5	8.6	5.5	13.6	13.5	18.2	10.5	12.9	18.8	12.6	26.4	28.6	19.0	16.6	14.7	20.5	7.1	10.5	10.2	10.1	19.8	17.1	6.7	25.5	9.7	10.1	20.8	36.9	26.5	21.3	25.7	25.2	22.8	22.3	21.5	41.0	24.2	22.9	20.0	38.1	17.2	23.4	29.6	23.0	26.8	15.3	15.4	20.0	15.9	13.8	14.6	18.7	13.1	14.4	15.9	35.7	48.5	39.6	33.1	32.7	69.0	4.7	43.3	111.1	37.5	48.8	56.9	63.1	119.3	52.5	191.7	45.8	29.3	23.3	98.0	72.8	51.4	47.5	23.1	46.5	47.8	54.0	60.2	31.3	43.7	32.2	55.8	49.4	30.4	57.7	52.5	33.9	70.1	31.6	54.1	73.3	72.1	77.6	35.0	141.9	41.9	37.4	68.1	43.1	43.2	38.2
IFT22	"DKFZp761N0823, FLJ13225, FLJ14117, RABL5"	ENSG00000128581	"Intraflagellar transport 22"	Q9H7X7	7	101313367-101321823	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.5"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 478.2;Late spermatids: 1059.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 47.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042930	Approved		Approved	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA042930: AB_10794537"	"unprognostic (1.55e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-1)"	6.6	12.3	18.1	4.4	19.9	2.9	9.3	4.8	17.1	11.2	9.9	10.1	9.5	3.1	13.0	28.8	7.6	39.9	12.0	15.9	14.6	15.8	25.5	6.1	7.9	5.7	12.9	13.9	15.3	13.2	15.6	16.2	3.9	13.5	11.2	4.6	15.5	10.6	12.7	14.7	6.5	3.5	13.8	8.6	2.9	7.7	59.5	6.4	9.2	26.2	6.7	4.6	9.3	5.8	9.9	6.7	1.5	5.1	8.3	7.9	3.0	15.1	19.0	15.4	29.6	9.8	12.5	3.9	8.0	7.1	10.7	8.3	7.3	13.7	2.2	14.8	12.5	24.8	8.1	7.8	9.3	7.5	3.5	7.6	0.7	9.7	6.3	9.2	5.4	3.1	10.0	8.3	16.2	4.4	19.9	8.6	10.8	6.3	1.4	8.9	47.3	11.5	6.2	11.4	9.3	10.0	9.5	9.0	2.4	17.8	8.2	12.9	22.8	18.2	11.4	7.5	16.6	12.1	2.9	7.6	18.5	15.9	42.3	11.1	1.3	7.1	4.7	14.7	1.2	10.7	1.0	1.2	1.5	6.5	2.0	6.7	9.9	7.9	5.9	2.3	9.3	7.0	6.8	1.1	8.3	5.1	6.7	3.1	3.0	18.1	19.9	4.8	17.1	14.6	15.8	12.9	13.9	13.5	6.4	23.8	11.0	19.2	21.0	0.0	26.4	37.5	48.4	188.7	35.2	47.1	51.1	16.8	117.7	62.7	478.2	9.5	2.0	0.0	32.2	14.6	27.1	19.5	9.2	8.9	15.3	30.2	17.7	14.1	2.6	1059.8	35.1	9.9	0.0	4.6	11.8	43.3	28.1	9.3	38.9	121.8	87.3	12.9	21.1	208.9	81.0	0.0	5.5	5.7	8.5	12.1
IFT27	"BBS19, RABL4, RAYL"	ENSG00000100360	"Intraflagellar transport 27"	Q9BW83	22	36758202-36776256	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Transport"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 246.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"U-138 MG: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018418	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA018418: AB_1856029"	"unprognostic (3.04e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.06e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (9.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.62e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (5.55e-4)"	10.9	17.0	21.1	12.7	27.4	8.5	9.2	13.4	20.6	14.9	12.8	15.8	21.9	13.4	12.5	22.1	10.9	40.5	13.0	18.5	19.3	20.6	16.4	17.4	10.2	9.5	19.4	16.4	14.9	17.6	20.9	30.2	8.9	20.0	16.4	11.0	16.1	15.4	19.6	14.7	9.6	12.9	9.9	17.4	9.3	13.7	20.1	14.5	18.6	23.2	6.0	9.8	11.0	11.8	17.7	27.0	23.3	22.6	14.5	19.9	13.9	6.2	7.9	9.3	10.5	7.5	7.2	5.5	5.2	6.6	6.7	6.0	0.3	5.8	6.9	9.0	4.7	9.8	5.8	5.1	5.7	5.2	13.2	13.5	1.8	1.6	0.0	13.8	2.2	8.6	5.8	9.4	7.2	3.3	5.5	7.1	5.7	3.2	5.7	4.5	11.6	2.7	1.9	5.0	12.3	10.3	13.0	0.0	3.8	6.6	4.1	9.0	9.8	5.4	4.2	12.9	8.2	9.4	3.9	4.2	60.8	3.5	7.8	0.9	13.5	8.2	2.4	9.4	5.5	12.8	8.5	22.6	23.3	18.3	16.4	18.2	16.7	15.2	16.8	27.0	17.7	15.1	14.3	8.1	14.5	19.3	20.9	19.9	13.9	21.1	27.4	13.4	20.6	19.3	20.6	19.4	16.4	20.0	14.5	6.0	17.3	15.2	23.2	20.7	32.7	16.8	20.4	246.3	38.7	38.4	27.5	18.3	89.5	24.7	40.8	18.3	24.3	0.0	20.1	14.0	30.5	29.6	33.4	18.6	34.4	28.6	51.2	27.6	14.9	13.6	25.3	19.2	33.7	9.0	39.8	51.0	18.0	14.4	29.7	43.0	34.6	12.9	18.6	105.4	16.8	29.1	14.6	23.5	29.0	23.3
IFT46	"C11orf2, C11orf60, CFAP32, FLJ21827"	ENSG00000118096	"Intraflagellar transport 46"	Q9NQC8	11	118544528-118572970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037909, HPA057550"	Approved		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA037909: AB_10672731, HPA057550: AB_2683464"	"unprognostic (8.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-1)"	11.0	16.0	17.7	7.2	19.9	4.3	21.8	23.6	23.3	18.6	11.5	17.7	14.3	6.3	16.2	20.4	11.5	51.9	13.1	16.5	17.3	20.8	22.3	13.6	11.9	7.9	13.1	17.0	22.6	16.9	16.2	24.0	7.2	17.0	16.6	9.4	14.8	12.2	16.8	13.4	10.4	6.7	16.6	14.1	8.1	10.1	25.4	15.1	13.1	23.3	8.6	9.9	12.8	13.8	11.8	7.3	5.9	5.6	10.3	11.2	5.2	7.1	8.2	12.2	7.9	20.1	17.1	1.6	15.8	21.0	13.9	13.2	10.2	13.3	10.8	22.8	17.4	3.4	10.1	12.3	14.3	16.1	4.2	10.0	22.2	4.4	3.8	15.1	5.3	6.7	14.8	17.4	22.3	21.5	12.7	13.2	14.7	12.0	7.4	17.1	31.2	13.9	6.5	3.6	12.5	17.3	11.3	9.3	8.7	10.7	10.2	7.9	8.5	10.5	13.9	9.3	7.5	21.4	7.1	10.9	14.9	9.8	8.6	5.5	4.7	6.2	13.2	7.4	9.7	10.5	3.0	5.6	5.9	9.7	4.4	11.2	11.8	8.5	8.7	7.2	9.7	10.6	6.3	1.8	10.3	4.3	7.3	10.1	5.2	17.7	19.9	23.6	23.3	17.3	20.8	13.1	17.0	17.0	15.1	8.9	6.4	6.0	9.3	3.5	11.9	11.5	7.6	104.4	17.0	10.4	17.7	4.6	5.0	13.5	10.2	8.7	2.0	0.0	10.2	5.6	7.7	5.6	11.5	4.9	7.5	1.6	4.1	6.7	1.3	11.4	9.5	3.6	1.7	7.2	5.0	14.1	10.2	4.5	17.3	8.6	15.9	0.0	6.1	37.4	40.7	6.0	1.6	3.8	5.8	2.0
IFT52	"C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5"	ENSG00000101052	"Intraflagellar transport 52"	Q9Y366	20	43590931-43647296	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063367, HPA067423"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA063367: , HPA067423: AB_2685837"	"unprognostic (2.88e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.18e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.30e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	20.1	13.6	14.2	12.7	13.9	18.6	20.3	14.2	24.9	24.1	12.8	13.4	14.5	7.0	22.2	25.9	11.6	29.8	16.8	16.5	13.1	14.2	16.0	7.1	16.3	20.2	12.1	13.9	31.6	16.2	10.8	15.8	13.1	13.8	14.1	13.9	15.0	11.6	19.4	5.1	13.7	9.5	21.7	13.2	11.3	11.2	36.8	10.8	16.3	24.3	12.1	13.8	14.7	16.8	14.6	23.1	12.8	19.2	13.0	15.9	13.2	15.1	11.6	23.6	16.6	20.1	22.4	11.2	9.5	21.3	25.2	24.5	32.0	15.5	8.5	15.5	19.4	20.5	12.7	9.8	17.1	27.8	7.0	9.2	11.1	8.0	29.6	24.7	14.8	7.7	18.1	18.9	16.3	12.8	18.4	19.7	19.1	9.4	12.2	18.5	15.2	20.4	23.0	13.2	10.0	11.5	21.8	26.9	12.4	19.4	15.0	18.3	21.3	29.2	21.8	22.7	12.5	10.1	20.4	12.3	22.4	16.7	12.3	14.0	11.9	11.8	14.9	26.9	10.9	16.1	6.6	18.0	12.8	15.9	16.4	12.9	14.6	12.9	15.0	23.1	12.2	13.8	14.3	5.2	13.0	19.2	17.5	14.2	13.2	14.2	13.9	14.2	24.9	13.1	14.2	12.1	13.9	13.8	10.8	6.0	13.3	6.0	10.4	11.6	9.9	2.4	5.1	52.2	9.1	7.0	0.0	17.0	16.6	21.9	57.0	17.6	5.6	23.3	19.6	16.8	25.7	6.5	13.9	2.0	16.8	7.9	9.1	19.0	18.3	12.1	26.4	12.2	16.9	15.4	10.7	12.4	14.6	10.5	36.0	14.1	9.7	12.9	18.8	42.1	17.6	13.0	8.0	14.4	10.1	5.8
IFT57	"ESRRBL1, FLJ10147, HIPPI, MHS4R2"	ENSG00000114446	"Intraflagellar transport 57"	Q9NWB7	3	108160812-108222570	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding	Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	14	"Ciliated cells: 679.9;Early spermatids: 1393.1;Late spermatids: 2088.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035514, HPA035515"	Supported		Approved	"Nuclear speckles,Mitochondria,Cytosol"		NA	NA			"Nuclear speckles"	"Mitochondria, Cytosol"	"HPA035514: AB_10601757, HPA035515: AB_10696505"	"unprognostic (1.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (2.98e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.59e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (5.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.12e-2)"	8.5	13.1	9.4	12.1	11.0	8.8	10.4	5.5	16.4	13.3	10.9	6.3	15.7	5.0	11.8	36.3	11.6	24.8	11.6	12.1	9.2	11.2	19.7	3.7	34.3	12.2	9.1	9.9	21.6	13.4	16.4	30.6	6.2	13.5	21.9	11.6	9.4	8.2	16.0	5.7	7.1	9.4	13.1	6.2	14.3	10.0	38.6	5.6	8.3	31.3	7.4	12.2	14.1	9.1	22.4	5.8	1.8	6.7	3.6	4.7	2.9	18.6	9.7	7.0	12.5	14.7	15.3	3.9	5.7	14.0	8.5	7.6	6.6	3.3	21.1	7.4	9.5	12.2	7.5	6.2	9.6	14.5	3.3	6.7	7.2	4.3	1.7	11.0	14.9	16.7	9.2	8.9	10.9	19.1	13.5	9.5	3.7	3.3	3.8	9.7	10.4	5.0	13.7	7.5	1.4	11.6	3.2	6.3	3.6	17.4	6.8	11.7	8.1	8.6	2.8	5.2	4.1	6.1	4.6	4.0	10.9	5.6	5.7	6.7	4.5	3.2	11.1	15.8	1.5	4.0	0.1	2.1	1.8	2.2	3.6	3.6	22.4	4.7	2.8	5.8	18.6	4.1	2.3	1.1	3.6	6.7	1.2	2.9	2.9	9.4	11.0	5.5	16.4	9.2	11.2	9.1	9.9	13.5	5.6	437.7	206.1	73.5	89.1	36.5	19.9	27.8	48.4	679.9	320.8	48.8	64.8	19.7	99.5	136.8	1393.1	36.5	31.6	23.3	116.3	16.0	63.9	111.6	42.8	4.9	12.7	27.0	54.9	30.7	7.3	2088.2	60.4	26.4	43.9	5.4	28.2	42.9	82.4	31.7	60.5	97.1	66.9	51.8	57.7	146.9	42.2	32.5	12.5	26.6	47.6	75.8
IFT74	"CCDC2, CMG-1, CMG1, FLJ22621"	ENSG00000096872	"Intraflagellar transport 74"	Q96LB3	9	26947039-27062930	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 137.9;Spermatocytes: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020247, HPA026684"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA020247: AB_1846140, HPA026684: AB_1846141"	"unprognostic (3.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.43e-1)"	7.7	14.4	11.1	7.9	11.2	6.1	11.9	14.5	11.2	13.7	11.5	6.8	13.7	6.2	11.2	22.1	9.8	16.1	8.2	8.3	9.8	8.4	17.7	10.3	8.3	6.4	6.7	9.9	14.0	8.9	17.4	37.8	7.7	11.0	12.8	11.6	9.5	9.1	16.6	9.6	7.5	6.7	17.6	7.5	8.2	7.4	35.9	8.1	12.3	20.3	6.1	5.9	11.7	9.1	11.3	7.2	2.0	5.5	11.0	10.0	3.4	9.9	13.0	13.3	11.3	9.6	16.0	4.2	9.1	13.9	10.9	10.2	1.6	6.5	3.1	7.1	8.5	10.2	6.8	10.0	11.5	13.4	7.9	5.5	9.3	6.2	6.5	15.9	5.3	8.7	11.5	17.1	12.7	22.5	14.0	6.8	0.3	6.0	12.2	14.9	3.9	7.6	18.1	9.4	5.3	7.0	3.1	5.6	9.8	17.8	5.6	10.9	11.4	6.9	8.5	6.1	8.3	11.8	8.5	6.7	0.0	11.7	3.7	8.1	4.6	10.7	2.3	6.2	8.2	5.4	2.0	5.4	0.4	5.8	5.5	4.3	11.3	5.8	5.3	7.2	10.8	10.0	7.2	0.4	11.0	4.2	7.1	4.6	3.4	11.1	11.2	14.5	11.2	9.8	8.4	6.7	9.9	11.0	8.1	29.8	20.6	2.2	13.3	6.9	22.5	24.6	5.1	137.9	38.7	15.7	21.6	19.9	18.3	22.1	45.4	11.9	11.5	0.0	20.0	8.5	11.4	7.2	16.1	8.5	13.1	27.0	12.7	8.0	35.1	19.3	18.7	6.7	5.0	7.2	11.9	27.3	10.8	10.5	17.0	26.1	44.9	19.4	8.1	132.3	27.7	7.3	9.2	4.3	15.4	5.9
IFT81	"CDV-1R, CDV1, MGC4027"	ENSG00000122970	"Intraflagellar transport 81"	Q8WYA0	12	110124335-110218797	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 199.4;Spermatocytes: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019087, HPA020051"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA019087: AB_1851462, HPA020051: AB_1851465"	"unprognostic (2.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.45e-1)"	5.3	9.6	8.9	4.6	13.2	1.7	9.2	14.4	11.9	12.6	11.5	6.6	18.8	3.0	14.9	19.6	6.4	18.8	8.9	7.3	8.9	8.5	10.0	4.4	8.5	3.0	5.9	8.4	14.7	5.1	21.8	30.4	5.2	10.7	13.7	6.2	11.8	8.9	15.5	6.4	5.9	4.6	17.7	8.5	4.0	7.4	29.8	8.4	6.2	14.3	5.4	3.1	13.5	10.4	1.8	3.5	3.0	1.3	2.1	1.9	1.3	7.1	13.6	28.1	11.9	5.2	10.7	2.1	4.6	7.1	9.9	8.5	2.6	4.0	2.3	2.5	8.8	7.1	6.4	10.3	5.4	12.9	3.0	5.6	4.9	8.0	4.2	4.4	3.0	2.4	7.6	6.1	9.4	2.4	24.2	6.2	4.7	6.0	1.3	9.1	1.5	6.1	5.1	13.9	4.1	4.5	7.3	7.4	3.1	12.3	4.8	17.5	19.4	12.5	2.6	18.6	8.2	14.1	4.6	4.1	5.6	2.9	4.6	4.2	4.1	4.0	3.2	13.6	3.9	6.3	0.3	1.3	0.6	0.7	0.8	1.9	1.6	1.7	0.8	3.5	1.8	1.5	0.7	3.0	2.1	1.0	3.5	0.7	1.3	8.9	13.2	14.4	11.9	8.9	8.5	5.9	8.4	10.7	8.4	11.9	16.1	2.0	11.5	5.5	16.8	16.5	10.2	199.4	37.5	14.0	39.3	2.2	13.3	8.9	31.3	4.5	0.7	0.0	3.5	1.2	10.0	4.0	3.5	4.0	2.1	23.8	20.7	3.7	1.9	13.2	13.0	1.8	33.7	1.8	4.8	18.2	5.1	1.7	26.2	8.4	36.1	6.5	12.2	160.5	28.1	5.6	0.8	0.0	3.5	3.8
IGBP1	IBP1	ENSG00000089289	"Immunoglobulin binding protein 1"	P78318	X	70133449-70166324	"Disease related genes, Predicted intracellular proteins"	"B-cell activation"	Chaperone	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA000634, HPA001004, CAB034139"	Approved		Approved	Microtubules		NA	NA		8000	Microtubules		"CAB034139: AB_2295670, HPA000634: AB_1079102, HPA001004: AB_1079104"	"unprognostic (3.59e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.10e-3)"	35.3	20.4	19.1	21.2	17.7	22.6	25.7	22.2	20.8	34.3	38.8	16.4	17.3	26.3	27.7	30.1	34.8	35.0	22.7	23.8	17.4	17.7	26.4	13.1	21.1	24.1	19.4	13.2	57.7	55.5	18.9	19.5	25.5	20.7	36.6	26.3	16.8	39.2	20.0	54.2	26.8	46.6	25.8	22.0	24.1	29.8	14.4	17.3	43.1	48.4	28.3	30.5	37.9	36.4	28.7	28.7	23.2	25.5	20.8	40.9	24.3	12.1	14.3	9.2	10.6	37.5	50.5	13.3	10.4	29.5	14.4	17.3	13.2	16.4	22.8	17.7	18.1	18.8	16.8	21.8	17.3	18.4	8.9	15.7	7.2	16.6	23.7	25.7	16.9	13.2	48.5	42.9	13.2	19.1	50.3	24.2	17.0	14.5	20.7	15.6	12.2	13.7	28.7	11.1	28.3	21.8	12.1	19.5	22.5	23.1	19.6	10.6	13.0	13.6	11.9	24.4	17.7	6.3	17.7	19.2	7.8	12.2	13.7	7.8	19.5	15.0	11.5	11.0	14.6	9.1	23.2	25.2	22.4	20.4	25.5	24.6	28.7	28.6	26.7	28.7	22.3	32.9	29.2	17.8	20.8	20.7	14.4	40.9	24.3	19.1	17.7	22.2	20.8	17.4	17.7	19.4	13.2	20.7	17.3	29.8	41.2	70.6	86.9	89.0	18.6	70.2	48.4	48.2	58.0	26.2	7.9	96.9	87.9	63.9	103.2	66.5	109.8	0.0	124.0	100.0	71.4	63.8	33.5	16.3	73.2	6.4	67.1	58.9	108.0	93.1	75.4	82.2	47.2	68.5	128.2	27.8	89.4	138.2	58.0	119.7	17.0	25.8	63.8	8.8	18.4	105.1	104.5	97.2	100.6	111.1
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381464-65423072	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 14.1"	"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 29.5;Fibroblasts: 17.9;Leydig cells: 32.2;Rod photoreceptor cells: 12.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.1;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.7;SuSa: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA		34000000	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	1.7	6.2	8.3	3.7	5.0	0.2	1.3	2.0	4.9	6.1	1.4	8.0	0.0	1.0	2.3	7.2	2.6	2.9	6.7	2.2	6.2	4.1	0.6	0.3	0.7	1.1	5.6	3.1	13.3	0.7	0.2	2.4	8.2	6.1	0.9	1.2	1.6	1.5	1.3	14.1	1.5	1.7	3.1	5.0	0.5	1.9	2.5	6.5	0.0	4.6	4.0	1.5	4.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	10.2	0.0	0.0	1.1	0.1	0.4	0.0	0.0	0.4	0.6	8.9	0.0	5.1	0.4	0.0	0.0	2.5	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.4	0.0	0.0	5.7	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.8	7.7	0.0	0.0	0.0	2.5	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.5	6.1	0.0	0.0	0.0	4.1	2.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	5.0	2.0	3.9	6.2	4.1	5.6	3.1	6.1	6.5	0.0	0.0	0.0	0.0	2.1	5.8	2.0	0.0	0.0	0.0	3.5	29.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	17.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	32.2	0.4	5.0	0.0	0.0	0.5	0.3	0.0	3.9	0.7	12.0	6.5	0.5	0.4	0.9	1.0	0.7	0.0	0.0	0.0
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2149603	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 330.5"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 871.9;Extravillous trophoblasts: 2792.3;Syncytiotrophoblasts: 1348.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 115.4;Hep G2: 79.2;LHCN-M2: 45.5;RH-30: 56.5;SH-SY5Y: 68.8"	"Low region specificity"	"Detected in all"							"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	609000000	1700000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: AB_2667860, HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	16.6	8.0	1.3	4.5	2.0	0.5	23.3	2.3	1.9	23.4	5.0	3.4	4.7	1.0	9.9	32.0	5.2	17.2	4.5	20.5	1.5	1.6	8.1	39.7	1.9	1.1	3.5	1.6	20.4	5.5	0.7	5.0	330.5	7.6	10.4	1.0	33.2	2.6	6.7	21.9	1.7	2.3	7.5	17.0	2.0	3.2	12.4	0.2	1.8	2.6	14.5	1.8	15.2	14.1	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	15.2	0.1	0.4	0.0	115.4	0.0	0.0	1.1	0.0	0.3	0.0	0.1	0.9	1.1	0.0	0.0	0.0	0.0	79.2	20.3	0.0	0.0	24.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	45.5	0.3	0.0	0.1	0.1	0.0	0.2	0.0	56.5	0.1	0.0	0.1	4.5	68.8	0.0	0.0	0.0	12.0	0.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	1.3	2.0	2.3	1.4	1.5	1.6	3.5	1.6	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	871.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2792.3	0.0	0.0	0.0	0.0	192.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1348.9	0.0	0.0	0.0
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888357-45893668	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"liver: 157.6;placenta: 292.3"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 863.0"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 18.0;U-2197: 29.5;U-87 MG: 51.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	22000000	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	10.7	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.2	157.6	0.1	0.0	0.1	0.0	9.3	0.0	0.0	0.2	292.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.5	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	18.0	0.1	0.3	0.0	0.0	0.2	3.9	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.5	0.0	0.0	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	38.2	0.0	1.2	0.0	0.0	0.7	0.0	6.7	0.1	0.0	0.0	23.3	0.0	2.0	1.0	0.0	0.0	863.0	1.6	0.0	3.4	9.2	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	0.0	0.0	0.0
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 165.3;pancreas: 228.7"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 536.0;Collecting duct cells: 251.2;Hepatocytes: 556.2;Intestinal endocrine cells: 307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 141.7;HMC-1: 330.5;NB-4: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	303000000	1000000000	"Endoplasmic reticulum"		"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	21.7	6.4	0.9	13.7	2.8	2.6	17.5	1.0	10.4	11.9	12.6	4.5	20.6	11.4	28.7	37.7	26.4	19.4	11.8	29.6	1.5	0.9	21.3	165.3	8.7	3.8	1.4	3.4	35.7	228.7	0.8	8.2	32.0	7.6	25.7	5.2	8.0	9.1	32.6	5.3	3.1	7.8	7.5	1.8	46.7	50.2	13.7	1.0	12.1	8.4	29.3	12.9	23.4	11.4	0.0	0.3	0.0	0.4	2.0	0.8	1.3	0.0	3.2	25.9	25.2	141.7	43.3	0.5	7.8	3.9	0.3	0.0	0.0	0.0	0.0	11.1	0.0	0.9	0.7	9.3	9.9	0.0	0.0	5.3	5.6	0.0	1.6	3.5	2.3	330.5	14.4	1.0	0.1	0.4	0.8	0.0	11.7	0.2	0.7	0.1	6.3	9.8	68.2	27.9	6.1	0.3	8.5	0.5	0.1	0.1	7.3	5.4	28.6	0.0	0.2	0.1	24.6	21.2	4.1	0.0	0.1	0.1	0.1	0.3	0.4	0.0	0.5	0.3	10.8	30.2	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	1.3	0.9	2.8	1.0	10.4	1.5	0.9	1.4	3.4	7.6	1.0	3.0	1.1	8.3	536.0	12.2	0.0	11.2	10.2	13.4	3.4	251.2	2.0	1.6	24.9	2.4	0.6	38.2	7.3	0.0	111.9	2.0	21.3	92.5	4.6	556.2	4.8	0.0	307.8	26.4	24.0	2.6	5.2	2.5	3.3	1.8	53.3	3.8	95.4	31.9	74.6	1.0	1.6	103.5	14.6	2.8	44.3	4.8	1.8	13.8	47.1	201.7
IGFBP3	"BP-53, IBP3"	ENSG00000146674	"Insulin like growth factor binding protein 3"	P17936	7	45912245-45921874	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 320.7"	"Cell type enhanced"	"Detected in many"	19	"Basal keratinocytes: 406.6;Extravillous trophoblasts: 1874.7;Urothelial cells: 581.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 28.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 422.0;U-2197: 175.0;U-87 MG: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB010360			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	3250000000	5600000000	Vesicles	"Nucleoplasm, Cytosol"	"CAB010360: AB_2233528"	"unprognostic (4.46e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (8.14e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (5.07e-7)"	"unprognostic (2.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.63e-1)"	47.4	1.6	4.4	10.6	2.7	0.0	52.1	2.7	4.1	44.3	21.3	1.7	3.2	6.9	58.4	8.1	11.7	14.9	5.4	41.6	4.4	2.6	11.1	80.4	11.7	12.7	3.7	1.9	49.2	2.2	0.6	19.2	320.7	4.1	22.5	6.1	9.1	6.4	9.3	13.9	23.9	10.2	22.9	3.8	18.7	8.3	12.1	3.1	2.2	5.6	8.6	8.3	32.0	26.3	0.0	28.9	0.0	0.0	0.0	6.0	1.7	9.6	2.9	5.7	0.0	4.3	1.8	0.0	42.1	7.6	3.6	1.9	0.0	7.8	0.0	13.4	422.0	1.8	23.2	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	14.8	0.6	0.7	2.7	5.7	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	3.9	2.6	20.8	0.6	1.6	14.6	0.5	0.7	13.3	0.0	0.0	0.0	41.7	0.0	175.0	2.3	0.6	0.0	0.0	90.6	0.0	14.0	0.0	0.0	0.0	5.2	0.0	4.3	0.0	6.0	5.6	0.0	0.0	2.8	4.7	0.0	0.0	0.0	28.9	0.3	1.7	4.4	2.7	2.7	4.1	4.4	2.6	3.7	1.9	4.1	3.1	3.0	4.6	0.0	95.2	406.6	0.6	9.7	7.6	33.5	117.2	216.3	0.0	45.9	10.0	71.8	0.8	62.6	0.4	0.0	1.7	1874.7	137.7	80.4	1.1	1.7	72.5	0.0	263.4	181.7	8.2	1.9	266.9	3.0	15.1	12.6	1.6	0.4	19.7	2.9	6.3	0.7	0.6	0.0	28.8	0.4	0.4	213.8	129.0	8.2	0.6	581.2
IGFBP5		ENSG00000115461	"Insulin like growth factor binding protein 5"	P24593	2	216672105-216695525	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 245.3"	"Cell type enhanced"	"Detected in many"	13	"Leydig cells: 1692.8;Muller glia cells: 665.4;Peritubular cells: 922.8;Sertoli cells: 1254.7;Smooth muscle cells: 840.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 79.7;BJ hTERT+: 211.9;T-47d: 51.5;U-138 MG: 70.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059827, HPA070407"		Supported	Approved	"Nuclear bodies,Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	110000000	330000000	"Golgi apparatus, Vesicles"	"Nuclear bodies"	"HPA059827: AB_2732640, HPA070407: "	"unprognostic (7.69e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-3)"	47.3	23.4	6.2	19.2	6.3	0.1	41.3	3.6	6.5	191.7	23.1	19.7	15.8	3.9	94.6	91.0	30.0	96.9	21.4	16.9	8.2	2.4	34.8	7.8	9.3	14.5	12.1	7.4	245.3	3.5	6.5	37.7	32.7	7.0	31.4	7.9	188.5	12.0	15.1	47.0	13.5	14.2	71.8	7.4	7.6	36.9	51.7	12.0	1.5	130.1	34.5	17.6	28.8	45.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	20.5	0.0	23.7	0.7	0.0	79.7	211.9	10.6	1.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	2.5	0.0	0.5	0.0	0.7	20.5	0.4	0.0	10.3	0.0	0.1	3.3	0.0	1.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	6.9	23.7	1.4	0.8	1.4	9.8	0.0	1.3	51.5	0.0	7.6	70.3	4.3	10.6	3.8	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.2	6.3	3.6	6.5	8.2	2.4	12.1	7.4	7.0	12.0	3.0	4.1	2.4	13.8	91.0	5.3	81.7	0.0	100.4	23.9	106.4	5.9	4.0	5.0	13.3	6.4	89.9	0.0	0.0	0.0	5.9	302.8	15.2	2.3	0.9	7.6	3.2	0.0	62.6	0.8	10.9	1692.8	25.6	96.2	1.0	0.0	665.4	3.2	0.0	922.8	1.1	10.8	1254.7	840.1	1.9	2.1	59.5	4.7	1.0	0.0	13.1
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 10593.1;Peritubular cells: 11028.0;Sertoli cells: 8052.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 72.1;BJ hTERT+: 67.4;hTERT-RPE1: 157.3;RPTEC TERT1: 72.4;TIME: 104.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	240000000	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	95.8	46.5	15.1	38.7	23.7	8.5	65.3	5.6	19.2	73.0	47.8	33.1	79.6	22.7	95.2	164.5	50.5	66.3	241.7	121.0	20.4	14.2	187.5	35.5	55.4	109.0	23.9	24.1	53.0	45.6	12.3	29.5	30.4	91.2	78.1	19.0	126.9	22.2	151.6	30.5	21.1	27.0	119.9	21.9	91.7	32.6	68.0	15.7	3.9	128.9	41.2	18.1	96.8	85.3	0.0	8.4	15.5	3.2	8.7	0.1	1.1	0.1	0.4	0.1	0.0	14.6	5.5	0.5	72.1	67.4	6.3	2.0	0.2	0.0	0.0	46.2	3.4	3.7	7.2	0.0	11.5	1.6	0.1	0.5	0.2	8.4	0.0	22.6	1.7	1.8	25.4	5.9	10.2	2.8	157.3	14.5	0.0	0.0	0.0	14.9	0.0	0.0	7.5	0.6	0.0	0.1	1.3	0.0	0.2	72.4	0.0	0.1	0.1	13.5	1.0	0.0	30.7	0.1	6.6	104.5	6.4	4.9	0.8	11.7	4.3	0.0	0.1	17.0	6.0	0.1	1.6	3.0	15.5	0.1	3.1	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.2	8.7	3.2	0.3	0.1	1.1	15.1	23.7	5.6	19.0	20.4	14.2	23.9	24.1	91.2	15.7	104.2	26.5	28.2	113.1	211.8	3.7	148.5	22.9	163.3	72.8	1980.3	21.6	4.6	437.7	2492.0	58.3	2171.1	0.0	0.0	12.7	4.7	511.0	37.3	15.1	7.2	25.9	0.0	1.2	2456.5	118.7	133.2	10593.1	113.8	895.8	35.1	0.0	9.3	120.5	0.0	11028.0	461.5	9.2	8052.1	3278.8	32.0	37.3	156.6	4.8	78.4	1.5	34.4
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 26.8;tongue: 24.8"	"Cell type enhanced"	"Detected in some"	8	"Early spermatids: 5.9;Late spermatids: 3.9;Spermatocytes: 8.0;Spermatogonia: 7.0;Suprabasal keratinocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"memory CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Group enriched"	"Detected in some"	64	"CACO-2: 28.9;OE19: 58.1"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"	NA	NA			Nucleoplasm	"Plasma membrane"	"HPA059137: AB_2683920"	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	1.5	0.0	0.4	0.1	0.1	0.0	1.8	0.1	0.4	0.3	0.3	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.8	1.2	0.4	0.1	0.1	0.1	3.4	0.1	1.6	0.9	0.1	0.7	0.1	0.5	0.1	0.1	26.8	0.1	0.1	0.3	0.1	0.0	2.4	0.1	0.4	0.1	24.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.9	1.9	0.4	0.0	0.0	1.2	0.0	0.0	3.2	0.0	0.0	5.9	0.0	0.5	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.7	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.4	8.0	7.0	4.1	2.2	0.0	1.3	0.0
IGFL4		ENSG00000204869	"IGF like family member 4"	Q6B9Z1	19	46039748-46077118	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 8.5;skin 1: 13.9"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 6.6;HaCaT: 5.9;OE19: 10.3"									HPA047655	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA047655: AB_2680113"	"unprognostic (1.22e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.96e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.59e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	0.1	0.8	4.4	0.3	4.4	0.2	0.3	3.9	8.5	0.2	0.3	0.0	0.0	0.9	1.0	2.9	1.9	0.4	1.1	1.9	2.8	2.8	0.3	0.4	0.7	0.9	1.2	6.0	2.0	0.2	3.3	4.5	0.2	2.1	0.9	0.5	4.6	1.1	0.0	0.5	13.9	0.7	0.1	1.6	0.5	0.7	0.8	0.5	0.0	1.5	0.6	0.2	1.2	0.2	0.3	1.6	1.3	0.7	0.2	0.5	0.1	0.1	6.6	0.2	0.5	0.0	1.1	0.4	0.0	0.0	0.0	0.0	1.4	0.3	0.9	0.1	0.1	0.9	5.9	0.0	0.0	0.0	0.7	1.1	0.0	0.8	1.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.7	0.0	0.7	0.1	0.5	0.3	10.3	0.3	0.1	2.9	1.4	0.0	0.3	0.4	0.4	0.0	0.1	1.7	0.8	0.4	1.2	0.6	0.8	1.4	0.4	0.4	0.8	0.4	0.2	0.1	0.9	1.8	1.3	0.7	0.7	0.5	0.3	0.3	0.3	0.2	0.1	0.1	0.3	0.1	0.4	0.9	0.2	0.1	1.6	0.4	0.1	4.4	4.4	3.9	8.5	2.8	2.8	1.2	6.0	2.1	0.5	0.0	0.0	0.0	0.0	0.9	5.1	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.4	1.3	1.0	0.0	0.0	0.0	0.0
IGFLR1	"FLJ22573, TMEM149, U2AF1L4"	ENSG00000126246	"IGF like family receptor 1"	Q9H665	19	35738801-35742453	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 121.2;liver: 46.2;lymphoid tissue: 40.7"	"Cell type enriched"	"Detected in many"	5	"monocytes: 187.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 121.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 121.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.3;Karpas-707: 17.1;U-266/70: 22.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA012369	Uncertain		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA			"Focal adhesion sites"		"HPA012369: AB_1858095"	"unprognostic (5.97e-3)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.94e-1)"	"unprognostic (5.42e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.34e-4)"	"unprognostic (6.71e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.59e-5)"	"unprognostic (1.44e-3)"	"unprognostic (3.52e-1)"	"unprognostic (8.72e-12)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-3)"	5.3	7.3	4.5	17.8	7.6	10.1	4.1	2.0	5.3	3.1	5.0	3.8	0.0	5.6	2.6	4.7	3.4	4.5	5.9	5.8	4.5	3.1	17.0	46.2	8.5	40.7	7.7	1.6	4.5	6.9	1.1	3.4	3.8	5.6	4.0	5.4	2.2	7.4	1.8	3.9	4.6	8.4	3.5	5.4	20.2	6.3	3.5	4.5	14.6	10.0	3.2	19.3	8.0	4.9	22.3	121.2	28.6	26.5	18.1	17.4	16.3	1.3	6.5	2.3	5.4	0.8	1.2	1.3	1.5	0.7	1.2	3.1	1.9	1.6	2.8	2.1	0.4	0.4	1.0	1.3	1.3	0.6	2.1	3.3	10.0	2.7	6.8	1.9	1.3	22.3	1.8	0.8	2.3	0.5	0.9	1.2	5.0	3.0	17.1	0.3	5.5	3.1	10.5	1.6	5.9	1.7	3.8	2.2	5.2	1.1	2.4	1.6	3.1	2.1	1.5	1.1	1.1	2.4	5.4	0.3	2.8	1.3	1.7	2.5	22.5	4.7	1.7	3.3	3.8	2.1	16.2	26.5	23.6	13.3	22.2	15.2	22.3	15.4	12.6	33.9	21.8	13.9	11.1	28.6	18.1	15.5	121.2	17.4	16.3	4.5	7.6	2.0	5.3	4.5	3.1	7.7	1.6	5.6	4.5	0.0	15.7	9.9	0.3	0.6	0.2	0.6	2.5	6.7	9.1	0.0	0.0	0.4	1.7	1.6	0.0	0.5	0.8	0.0	3.6	1.5	0.7	0.3	38.1	16.4	13.3	0.0	2.9	2.5	14.3	0.2	0.0	28.0	5.0	187.6	1.7	1.2	1.5	0.0	0.0	4.4	0.1	0.0	0.9	0.5	0.5	0.6	0.2	8.5	1.2	0.0
IGFN1	"DKFZp434B1231, EEF1A2BP1"	ENSG00000163395	"Immunoglobulin-like and fibronectin type III domain containing 1"	Q86VF2	1	201190825-201228952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skeletal muscle: 118.8"	"Group enriched"	"Detected in some"	8	"Leydig cells: 20.4;Peritubular cells: 8.5"	"Group enriched"	"Detected in some"	11	"renal cancer: 1.8;thyroid cancer: 8.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HeLa: 37.7"									HPA050415	Enhanced		Approved	"Midbody ring"		Yes	NA			"Midbody ring"		"HPA050415: AB_2681120"	"unprognostic (2.09e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.27e-8)"	"unprognostic (3.55e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	0.5	0.0	0.6	0.1	0.4	0.0	0.1	0.4	1.4	0.3	0.2	0.3	0.1	0.0	4.3	6.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.3	0.2	0.3	4.6	0.0	0.7	0.1	1.7	0.2	0.0	1.6	0.1	0.1	118.8	0.0	0.1	0.3	0.1	0.1	0.0	1.1	0.2	0.1	11.3	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.4	0.3	0.3	0.2	0.3	0.2	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	20.4	0.0	1.7	0.0	0.0	0.0	0.4	0.0	8.5	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0
IGIP	"C5orf53, LOC492311"	ENSG00000182700	"IgA inducing protein"	A6NJ69	5	140125935-140129392	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 13.9"	"Low region specificity"	"Detected in all"							"HPA041877, HPA048615"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA041877: AB_2677721, HPA048615: AB_2680462"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.05e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.94e-1)"	"prognostic favorable (6.25e-6)"	"unprognostic (2.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.98e-2)"	"unprognostic (7.77e-2)"	5.1	7.6	13.9	2.0	13.1	0.0	5.3	16.0	13.7	7.3	3.8	3.4	1.6	2.8	3.8	8.0	2.5	3.5	3.8	4.6	13.4	13.7	7.6	6.2	3.8	3.1	17.8	3.3	5.3	3.6	16.2	6.1	3.7	9.8	5.8	3.1	3.7	4.3	7.3	7.7	7.5	3.7	8.2	14.4	3.8	3.4	1.9	9.4	2.0	7.1	2.8	3.0	3.7	3.4	0.6	0.1	1.0	0.5	0.5	2.2	0.1	2.0	0.6	1.0	2.9	14.4	13.9	1.3	5.1	5.1	1.2	1.5	2.0	1.6	3.8	5.5	6.9	0.7	2.1	1.1	3.1	2.3	3.3	1.9	0.8	2.8	1.5	3.4	1.0	1.4	4.7	7.9	2.3	4.4	8.9	1.5	2.8	0.6	1.5	4.4	1.7	1.1	2.5	0.2	1.6	1.6	1.2	2.4	1.7	6.8	1.8	1.0	1.5	2.8	1.8	2.9	1.1	1.4	3.0	8.9	3.6	0.3	1.2	2.8	3.7	2.4	1.3	3.8	2.6	2.6	0.0	0.2	1.0	0.7	0.1	1.9	0.6	1.0	0.8	0.1	0.5	2.2	1.8	0.0	0.5	0.5	0.1	1.1	0.1	13.9	13.1	16.0	12.9	13.4	13.7	17.8	3.3	9.8	9.4	11.9	3.2	0.5	1.7	1.8	19.0	13.8	10.2	2.7	5.7	3.5	13.7	1.9	0.0	2.5	1.5	3.7	3.9	0.0	1.6	1.1	2.9	3.5	8.1	4.7	0.9	27.0	8.6	4.3	2.6	0.5	6.1	2.2	6.8	1.8	4.4	5.6	2.5	5.1	15.9	2.2	9.4	0.0	5.0	2.3	0.9	3.4	1.5	0.8	3.4	1.7
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580308	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"blood: 11.6;bone marrow: 37.7;lymphoid tissue: 29.4;testis: 20.8"	"Group enriched"	"Detected in some"	10	"Early spermatids: 60.5;Late spermatids: 104.2;Melanocytes: 113.1"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 11.6;naive B-cell: 9.8"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.6"	"Cell line enriched"	"Detected in some"	34	"REH: 129.9"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		100000000000	"Endoplasmic reticulum"		"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.1	0.1	0.2	37.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.0	29.4	0.0	0.0	1.1	0.0	0.0	11.6	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0	129.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	60.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	104.2	1.1	0.0	113.1	0.0	0.0	0.0	0.0	0.0	0.4	4.4	0.0	0.0	0.0	9.7	0.5	0.3	0.0	0.0	0.0	0.1
IGSF1	"IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2"	ENSG00000147255	"Immunoglobulin superfamily member 1"	Q8N6C5	X	131273506-131578899	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pituitary gland: 138.7"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 3.0;Bipolar cells: 11.5;Horizontal cells: 3.2;Melanocytes: 3.3"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 65.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 23.5;SH-SY5Y: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012732, HPA035582"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		430000	Cytosol		"HPA012732: AB_2732404, HPA035582: AB_2674687"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (4.25e-8)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.52e-3)"	"unprognostic (8.03e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.13e-2)"	0.8	11.9	1.4	0.4	5.3	0.0	2.7	0.6	6.2	2.7	0.5	3.3	1.2	0.2	1.1	1.5	1.3	1.6	0.8	5.6	3.3	15.4	0.5	1.5	0.2	0.0	3.8	1.9	1.0	1.7	0.0	138.7	0.6	4.7	3.9	0.2	2.2	2.0	6.4	0.3	0.6	0.4	3.2	2.7	0.2	0.5	11.8	1.9	0.2	5.3	0.8	0.5	0.6	0.5	0.6	0.4	1.5	0.3	0.3	0.3	0.2	0.3	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.2	0.0	0.0	0.0	1.3	0.0	0.0	4.1	0.3	0.0	1.7	23.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.7	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	21.2	0.0	0.2	0.0	3.2	0.4	0.0	0.0	0.3	0.6	0.0	2.4	0.7	0.3	0.0	0.0	0.0	0.0	1.5	0.3	0.2	0.2	0.1	0.2	0.3	0.3	0.3	0.1	0.6	0.3	0.2	1.2	0.3	0.1	0.4	0.3	0.2	1.4	5.3	0.6	2.3	3.3	15.4	3.8	1.9	4.7	1.9	3.0	1.1	0.0	0.2	0.0	11.5	2.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.8	0.2	0.0	0.4	0.0	3.2	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.5	0.0	0.4	0.6	0.5	0.0	0.3	0.0	0.4	0.4	0.2	0.0	0.0	0.1
IGSF10	"CMF608, FLJ25972"	ENSG00000152580	"Immunoglobulin superfamily member 10"	Q6WRI0	3	151425384-151458709	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 17.8"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 118.2;Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 1.5"	"Group enriched"	"Detected in some"	5	"HeLa: 25.6;HL-60: 12.4;REH: 9.2;RPMI-8226: 29.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA012655, HPA012921"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		280000	Vesicles		"HPA012655: , HPA012921: AB_1851526"	"unprognostic (1.78e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.47e-7)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.84e-4)"	"unprognostic (9.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.52e-4)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.57e-4)"	2.5	2.9	0.6	0.1	0.4	0.0	4.5	0.0	0.2	0.3	0.5			0.0	0.7	0.8	2.0	3.4	7.3	4.1	0.7	0.8	0.0	0.0	6.7	0.5	0.3		17.8	0.1	0.7	1.5	0.0		0.0	0.6		3.7	0.0	0.0	1.2	0.7	0.7	0.3	0.2	0.4	0.3			1.3		1.6	1.5	0.1	0.2	1.5	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.2	4.0	25.6	0.0	0.9	12.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	29.6	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	3.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0											0.0	0.3	0.5	1.2	2.2	14.0	1.1	2.5	13.4	10.3	1.8	3.9	18.9	0.0	0.2	118.2	0.7	0.0	0.0	1.2	2.6	5.4	0.9	0.0	0.0	1.2	57.2	5.8	0.0	0.3	22.0	6.4	1.6	3.3	1.0	0.4	23.5	0.3	0.0	1.1	0.3	2.2	0.0	0.9	6.7	2.4	2.0	25.9	0.0	0.0	0.0
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;ovary: 21.1;testis: 39.9"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	1.1	10.5	12.5	1.4	14.6	0.9	1.2	3.4	23.9	1.3	2.6	27.8	0.0	1.1	1.6	2.3	2.0	1.6	1.9	2.2	12.3	6.0	10.6	0.9	1.0	1.0	25.2	8.9	21.1	5.1	3.8	1.4	1.1	15.3	1.3	1.8	7.0	1.4	2.0	2.9	2.6	1.6	1.5	20.5	1.0	1.4	39.9	20.7	0.0	5.0	0.0	1.1	1.1	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	6.0	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	2.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	26.2	1.7	0.5	0.1	0.0	0.0	1.0	0.0	0.0	9.1	10.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.5	14.6	3.4	13.6	12.3	6.0	25.2	8.9	15.3	20.7	0.0	0.0	0.0	0.1	0.3	5.1	1.1	0.0	0.0	0.0	0.0	70.7	0.1	0.0	0.3	226.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	237.3	3.4	0.2	3.3	0.0	0.0	24.3	0.2	0.0	1.8	5.1	24.8	0.0	0.0	11.7	5.9	0.0	0.1	0.0	0.0	0.2
IGSF22	"FLJ37794, IGFN2"	ENSG00000179057	"Immunoglobulin superfamily member 22"	Q8N9C0	11	18704305-18726230	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"salivary gland: 22.7"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 22.7;Distal tubular cells: 18.3"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.9"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RH-30: 2.9"									"CAB026459, HPA037851"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB026459: , HPA037851: "	"unprognostic (4.05e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.99e-4)"	"unprognostic (9.35e-2)"	"unprognostic (3.72e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.94e-3)"	0.3	0.1	0.7	0.2	3.9	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.6	0.3	0.2	0.2	0.1	0.7	0.3	0.4	1.5	0.2	0.2	0.2	0.3	0.3	0.2	1.2	0.5	0.0	0.5	0.2	0.2	0.2	0.0	0.2	22.7	0.2	0.5	4.6	0.4	0.2	0.2	0.2	0.0	2.2	0.2	0.2	0.2	1.3	0.3	0.5	0.2	0.2	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.2	0.7	3.9	0.2	1.1	0.4	1.5	0.3	0.2	0.2	0.2	0.0	0.3	1.5	3.6	2.2	1.3	1.5	0.0	2.7	1.2	22.7	0.0	0.0	18.3	2.6	1.0	0.0	0.7	0.0	3.8	0.0	0.6	3.7	2.3	0.0	1.3	1.6	3.5	0.6	0.3	3.2	1.4	0.8	0.0	1.0	4.9	0.5	7.4	3.5	0.7	1.4	0.9	0.0	0.5	0.0	0.4	1.5	0.0	1.7	2.9	7.5
IGSF23		ENSG00000216588	"Immunoglobulin superfamily member 23"	A1L1A6	19	44613630-44636781	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 6.0;intestine: 19.9;liver: 20.6"	"Group enriched"	"Detected in some"	8	"Cholangiocytes: 7.6;Early spermatids: 7.7;Hepatocytes: 9.2;Late spermatids: 8.1"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 12.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 8.3;SiHa: 6.4"									"HPA051811, HPA054591"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA051811: AB_2681621, HPA054591: AB_2682535"	"unprognostic (1.54e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.20e-6)"	"unprognostic (7.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-8)"	"unprognostic (1.26e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.85e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.8	0.1	0.1	12.2	0.1	0.5	0.1	0.1	0.1	0.6	0.1	0.1	0.4	20.6	0.1	0.1	0.1	0.1	0.1	3.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.1	0.0	19.9	0.1	0.6	0.1	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	6.0	1.2	0.0	0.0	0.2	0.4	0.8	0.0	0.5	0.0	0.0	0.7	0.5	0.7	0.0	0.6	14.0	0.5	0.0	1.0	0.4	0.3	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.3	8.3	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	6.4	2.3	0.0	0.0	0.3	0.0	2.6	0.5	0.5	0.6	0.0	1.2	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	7.7	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.6	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.5;WM-115: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036305: AB_2675050, HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.4	1.5	1.9	1.2	5.1	0.1	7.7	2.5	8.3	5.8	5.7	1.5	3.0	6.7	2.5	6.5	22.0	1.7	3.5	7.9	1.8	2.8	10.7	0.8	7.4	0.3	1.8	2.8	0.7	4.5	1.4	2.7	42.9	4.1	5.1	5.1	7.8	9.3	5.5	1.1	16.1	12.9	2.4	1.7	0.5	7.3	3.6	0.9	6.2	8.1	9.0	9.3	8.2	9.8	0.0	0.2	0.3	0.6	0.0	0.7	0.2	5.4	9.3	7.2	1.8	1.6	3.5	19.3	0.0	0.2	0.7	0.2	5.3	3.1	0.0	2.9	0.0	4.0	15.2	3.2	7.5	0.3	62.5	2.3	2.9	3.6	0.1	0.0	0.2	5.7	0.4	5.9	0.0	1.3	1.3	0.0	1.0	0.9	0.0	0.1	19.1	0.2	0.1	4.5	3.3	0.2	2.2	8.8	0.0	5.5	6.8	4.2	12.8	2.2	21.5	13.7	14.4	7.2	0.3	0.0	1.2	4.3	0.0	5.6	0.0	0.3	0.0	0.5	0.1	60.3	0.0	0.6	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	1.9	5.1	2.5	8.3	1.8	2.8	1.8	2.8	4.1	0.9	14.9	25.2	0.0	7.0	17.4	1.9	14.4	12.7	8.1	5.7	14.0	0.0	10.1	3.3	13.2	1.8	2.1	14.7	0.0	1.7	24.6	6.6	7.2	1.1	0.0	1.9	6.4	2.9	1.8	1.6	2.1	1.1	0.9	8.5	5.4	5.5	12.8	11.2	8.6	0.0	11.3	0.5	0.0	2.1	0.5	4.3	24.2	11.1	0.0	7.1	9.6
IGSF5	JAM4	ENSG00000183067	"Immunoglobulin superfamily member 5"	Q9NSI5	21	39745407-39802096	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 5.8"	"Cell type enriched"	"Detected in some"	9	"Syncytiotrophoblasts: 95.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"					"Cell type enriched"	"Detected in single"	5	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 10.8"					"Low region specificity"	"Detected in all"			HPA057282	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057282: AB_2683395"	"unprognostic (1.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.06e-2)"	"unprognostic (9.73e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.15e-1)"		"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.35e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-2)"	0.0	2.0	0.9	0.0	3.4	0.1	1.3	0.1	0.7	1.1	0.3			0.2	0.9	3.4	0.0	0.9	0.3	5.8	1.2	2.3	0.3	0.3	0.1	0.2	1.3		1.5	2.5	0.3	1.5	4.3		2.4	0.9		0.9	0.4	0.0	0.6	0.1	0.4	0.7	0.3	0.6	1.5			0.8		0.2	0.5	0.2	0.4	0.3	2.2	0.4	0.0	0.4	0.0	1.3	0.7	4.5	1.1	4.4	3.6	1.2	0.8	1.2	1.3	2.0	0.7	1.3	1.4	1.2	1.7	1.7	1.2	1.5	3.0	2.5	2.3	2.1	1.4	3.3	0.5	2.8	1.9	0.6	3.2	5.5	2.9	3.2	2.2	0.6	0.7	2.6	0.9	1.7	1.6	0.3	0.6	2.5	1.1	0.8	0.7	2.0	0.8	1.9	1.9	2.0	0.5	1.2	3.0	1.8	2.1	10.8	1.1	0.4	2.0	2.3	1.0	1.8	1.0	0.8	0.9	1.1	1.4	2.0	0.1	0.4	0.4	0.4	0.0	0.2	0.1	0.3	0.1	0.1	0.4	0.1	0.2	2.2	0.0	0.1	0.3	0.0	0.0											0.0	0.0	0.0	0.2	0.0	1.3	8.7	0.0	0.0	0.0	1.8	0.0	0.9	5.0	0.3	11.1	0.0	0.0	0.0	0.2	0.9	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.4	2.7	0.1	0.0	0.2	0.5	0.1	0.0	95.4	0.0	0.0	0.9
IGSF9B	KIAA1030	ENSG00000080854	"Immunoglobulin superfamily member 9B"	Q9UPX0	11	133908564-133956985	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.7"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 3.1;Bipolar cells: 2.2;Cardiomyocytes: 2.6;Distal tubular cells: 1.7;Muller glia cells: 2.0;Suprabasal keratinocytes: 4.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 39.7"	"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"OE19: 8.2;SCLC-21H: 17.7;SH-SY5Y: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010744, HPA010802"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA010744: AB_2668357, HPA010802: AB_1079194"	"unprognostic (9.04e-4)"	"unprognostic (1.74e-2)"	"unprognostic (7.52e-3)"	"unprognostic (4.38e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.99e-4)"	"unprognostic (3.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-4)"	"unprognostic (3.12e-3)"	2.2	2.1	4.9	3.7	6.8	0.7	1.2	39.7	12.4	7.4	6.8	2.4	4.6	1.1	7.7	4.3	5.9	7.6	4.9	13.4	2.9	3.1	1.1	0.5	1.8	1.6	2.1	4.0	2.4	2.1	1.5	6.2	1.3	3.8	4.2	2.4	6.1	2.1	6.4	5.0	2.4	2.4	12.8	1.6	1.8	3.7	5.0	2.3	0.0	4.9	2.6	1.2	5.2	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.3	1.2	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	2.6	1.6	0.8	0.5	0.4	3.1	2.6	0.0	0.1	2.8	2.4	0.0	0.0	0.0	0.2	0.7	3.8	0.0	0.0	0.0	0.5	0.2	0.0	3.3	0.0	0.0	0.0	1.8	0.3	0.3	1.9	8.2	0.1	0.0	0.0	0.0	0.3	0.0	17.7	9.0	0.1	0.2	0.0	2.9	1.8	0.0	0.0	1.3	1.4	1.1	0.8	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	4.9	6.8	39.7	9.7	2.9	3.1	2.1	4.0	3.8	2.3	0.0	0.0	0.0	0.1	3.1	2.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.4	0.0	0.7	0.0	1.0	0.0	0.1	4.3	0.0	0.0	0.1	0.0
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;bone marrow: 55.2;lymphoid tissue: 86.7"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 46.7;Kupffer cells: 47.2;Macrophages: 43.8;monocytes: 70.3;T-cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 26.9;HDLM-2: 45.8;HMC-1: 42.9;JURKAT: 26.3;MOLT-4: 33.5;REH: 36.3;U-698: 68.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	3.5	1.5	2.9	25.5	3.8	55.2	2.3	0.7	1.8	1.6	3.6	2.8	0.8	2.4	1.6	2.1	2.2	2.4	2.9	1.6	3.4	1.8	2.5	2.3	8.3	44.4	5.9	1.1	1.1	1.3	0.2	1.2	1.2	3.4	2.2	2.5	1.5	5.2	0.7	0.9	1.9	14.5	1.4	5.1	31.0	3.7	1.1	4.1	86.7	2.4	1.2	26.3	4.5	2.9	24.0	12.6	12.8	23.6	12.8	28.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	9.2	0.0	0.0	0.0	16.3	42.9	0.0	0.0	0.0	0.0	0.0	0.0	26.3	11.9	3.2	0.0	0.0	33.5	16.2	0.4	0.0	0.0	36.3	0.0	7.6	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.0	0.0	22.5	0.0	0.0	0.3	0.0	0.0	14.6	7.5	68.8	0.1	17.7	0.1	10.2	7.7	12.8	20.4	23.6	17.0	24.0	21.2	19.9	8.2	21.3	28.7	20.7	11.2	12.8	22.3	12.6	17.1	12.7	2.9	3.8	0.7	1.8	3.4	1.8	5.9	1.1	3.4	4.1	3.0	16.4	46.7	0.1	2.5	0.0	1.1	5.1	2.7	3.4	1.8	0.0	0.3	0.0	0.1	3.0	2.9	0.0	23.3	0.0	0.2	3.4	0.1	22.0	1.0	27.1	0.0	0.0	4.3	47.2	4.5	0.0	43.8	18.6	70.3	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	2.1	0.0	0.7	2.4	0.6	103.3	0.0	0.1
IKZF2	"Helios, ZNFN1A2"	ENSG00000030419	"IKAROS family zinc finger 2"	Q9UKS7	2	212999691-213152427	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.8"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 21.4;T-cells: 23.3;Urothelial cells: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 5.7;NK-cells: 7.2;T-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"JURKAT: 36.7;MOLT-4: 15.5;RT4: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059142	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA059142: AB_2683923"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.93e-3)"	"unprognostic (7.09e-2)"	3.4	2.4	6.1	4.1	12.4	5.9	4.0	8.0	8.6	4.9	2.6	5.3	7.6	1.0	2.3	3.9	24.8	3.4	3.6	2.8	6.3	2.6	2.1	2.1	3.7	7.4	11.8	3.4	2.5	3.0	9.7	6.9	3.2	8.6	5.4	2.0	2.3	13.5	9.2	4.3	10.4	2.5	1.2	9.1	5.9	5.2	2.8	13.4	55.8	9.2	5.5	7.5	11.9	11.6	1.5	0.7	5.7	0.0	7.2	7.1	0.3	1.4	0.5	2.8	0.1	9.2	9.4	1.7	1.7	2.0	0.4	0.9	0.7	2.4	1.9	2.3	1.0	0.2	3.4	0.0	0.9	1.4	0.0	0.4	1.0	1.8	0.2	0.1	4.5	0.3	9.1	0.8	0.0	0.2	2.3	0.0	36.7	0.5	1.6	0.8	2.6	15.5	4.5	0.5	1.1	0.4	9.2	1.8	0.0	0.8	14.7	0.8	0.5	0.0	1.9	0.0	2.4	2.5	0.4	4.7	2.6	2.0	1.2	0.3	3.1	0.9	10.6	1.3	0.0	0.5	4.1	0.0	5.7	2.5	0.0	6.5	0.2	0.8	1.9	0.0	1.5	0.4	1.9	0.0	7.2	0.0	0.7	7.1	0.3	6.1	12.4	8.0	8.6	6.3	2.6	11.8	3.4	8.6	13.4	8.9	9.3	3.9	11.1	5.3	4.0	6.2	0.0	21.4	15.9	7.0	3.9	3.0	0.0	1.6	1.0	2.2	1.1	0.0	2.6	1.1	1.5	14.9	3.5	1.7	1.6	0.0	2.9	1.3	1.3	0.0	1.7	1.8	1.7	1.0	2.3	2.4	3.4	0.0	2.1	0.9	7.0	0.0	2.7	0.7	0.4	7.5	3.3	23.3	1.0	48.0
IL10RB	"CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2"	ENSG00000243646	"Interleukin 10 receptor subunit beta"	Q08334	21	33266358-33310187	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 170.3;Syncytiotrophoblasts: 264.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB020670, HPA047550"	Approved		Approved	Cytosol		NA	NA		1300000	Cytosol		"CAB020670: , HPA047550: AB_2680086"	"unprognostic (8.43e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (5.62e-9)"	"unprognostic (3.09e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	17.6	11.0	5.4	19.6	7.3	8.9	21.5	3.6	4.4	15.2	29.2	10.3	10.6	19.6	17.5	9.6	22.7	13.2	14.8	12.3	5.6	5.4	11.6	27.5	19.3	36.1	6.6	3.1	18.2	23.2	5.5	9.7	47.4	9.3	17.7	20.8	11.7	26.0	9.7	12.4	13.8	53.6	12.2	8.0	31.7	17.6	8.4	7.3	34.0	14.3	15.3	26.2	15.1	22.6	13.8	19.4	57.9	34.7	14.0	19.5	20.4	10.3	8.0	1.5	6.4	32.4	23.8	11.4	7.9	22.5	8.8	12.6	7.5	12.8	2.9	9.1	13.8	17.9	12.9	4.3	5.4	5.8	9.6	5.9	8.0	6.0	5.7	22.6	10.2	19.5	23.9	10.2	15.3	9.0	13.8	11.6	8.6	7.2	24.2	12.1	10.7	6.8	9.9	1.1	21.0	4.3	6.4	3.6	12.2	7.9	6.1	2.1	2.9	16.3	12.1	13.8	3.6	8.0	38.7	10.5	8.8	8.6	14.9	4.3	12.8	14.3	1.7	15.5	14.7	5.6	22.3	30.1	24.8	8.8	34.4	9.6	13.6	11.1	10.6	17.8	13.8	10.5	10.4	57.9	14.0	34.7	19.4	19.5	20.4	5.4	7.3	3.6	4.4	5.6	5.4	6.6	3.1	9.3	7.3	32.8	21.5	27.9	30.6	12.9	6.2	10.4	22.9	5.3	6.8	3.5	13.7	170.3	0.0	16.0	0.7	24.6	75.7	46.7	26.6	126.8	31.9	37.4	35.7	19.5	105.9	7.9	9.8	35.6	102.1	0.7	29.4	27.9	13.5	55.1	53.6	5.6	21.9	73.7	22.3	0.8	5.5	19.4	14.2	2.2	4.7	12.8	264.0	21.8	41.1	53.1
IL12RB1	"CD212, IL12RB"	ENSG00000096996	"Interleukin 12 receptor subunit beta 1"	P42701	19	18058995-18098944	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.6;lymphoid tissue: 21.4"	"Cell type enhanced"	"Detected in some"	20	"B-cells: 9.0;Kupffer cells: 10.0;T-cells: 35.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 10.7;HDLM-2: 18.0;Karpas-707: 30.8;U-698: 9.0"					"Low region specificity"	"Detected in all"			HPA074414			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA074414: AB_2686687"	"unprognostic (7.70e-3)"	"prognostic favorable (3.41e-4)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.93e-2)"	1.9	1.5	1.3	17.5	2.1	5.6	1.2	0.5	1.0	0.9	3.4	2.4	1.1	2.9	1.0	2.4	1.3	1.5	2.5	1.4	1.3	1.2	1.8	1.8	5.0	16.0	2.0	0.2	1.1	1.3	1.2	1.1	2.4	1.4	1.7	2.0	1.1	6.6	0.2	0.9	1.0	8.0	1.0	2.4	21.4	2.3	0.7	2.2	10.1	1.3	0.7	16.9	3.8	1.0	4.9	5.9	6.2	14.0	16.2	28.6	9.0	0.2	0.1	0.1	0.2	0.0	0.1	0.5	0.1	0.1	0.2	0.6	0.2	1.0	10.7	0.1	0.1	0.3	0.2	0.1	0.0	0.0	18.0	0.2	1.2	0.3	0.2	0.4	0.7	1.7	0.0	0.0	0.3	0.1	0.1	0.0	2.4	0.2	30.8	0.0	0.1	5.1	0.2	0.1	0.0	0.1	3.6	0.1	0.5	0.0	0.0	0.3	0.1	0.2	0.2	0.2	0.1	0.2	5.8	0.2	0.3	0.3	0.1	0.1	3.7	5.5	9.0	0.4	6.2	0.7	3.3	5.1	3.6	22.8	14.0	28.6	4.9	15.5	18.3	5.9	3.7	8.7	15.2	6.2	16.2	13.2	3.5	20.5	9.0	1.3	2.1	0.5	1.0	1.3	1.2	2.0	0.2	1.4	2.2	0.0	4.8	9.0	0.6	0.2	0.0	0.8	2.5	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.4	0.4	0.4	4.6	0.0	5.9	0.0	0.0	0.6	10.0	0.0	0.0	5.8	0.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.6	0.1	35.2	0.0	1.0
IL12RB2		ENSG00000081985	"Interleukin 12 receptor subunit beta 2"	Q99665	1	67307364-67396900	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.2;pancreas: 15.0"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 2.9;Hofbauer cells: 2.9;Melanocytes: 1.7;T-cells: 6.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 18.2"	"Group enriched"	"Detected in many"	42	"NK-cells: 18.2;T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.5;SCLC-21H: 8.9;SK-MEL-30: 22.4;THP-1: 13.0"	"Region enhanced"	"Detected in single"		"olfactory region: 1.8"	"Low region specificity"	"Detected in all"			HPA024168	Uncertain		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA024168: AB_1851629"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.90e-1)"	3.8	1.0	1.8	3.1	3.6	1.5	3.7	0.6	7.7	2.4	1.0	0.0	0.0	0.7	0.8	1.1	3.2	0.9	1.1	5.2	9.6	1.1	1.5	1.4	1.8	4.3	1.0	6.0	0.8	15.0	0.9	0.8	14.1	1.6	1.2	0.9	1.3	7.2	1.7	11.4	2.1	1.4	1.0	1.0	2.5	1.0	2.3	0.0	1.1	1.1	3.2	1.6	1.4	1.2	0.0	0.0	0.2	0.0	18.2	6.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	2.1	1.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.4	0.0	0.0	22.4	0.0	0.0	13.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	2.7	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.2	18.2	0.0	0.0	3.9	1.0	1.8	3.6	0.6	7.7	9.6	1.1	1.0	6.0	1.6	0.0	0.0	2.9	0.0	0.2	0.5	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.6	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.4	0.0	0.1
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 20.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 74.4;Late spermatids: 141.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	177	"HDLM-2: 30.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042421			Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	40000		"Plasma membrane, Cytosol"		"HPA042421: AB_10795504"	"unprognostic (2.17e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-1)"	0.3	0.0	0.1	0.8	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	3.0	0.0	0.0	0.1	0.0	0.0	1.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	20.7	0.0	2.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	141.6	2.6	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.2	1.2	0.5	0.0	0.0	0.0	0.0
IL13RA1	"CD213a1, IL-13Ra, NR4"	ENSG00000131724	"Interleukin 13 receptor subunit alpha 1"	P78552	X	118727572-118794539	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 235.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.9;eosinophil: 7.1;myeloid DC: 10.9;neutrophil: 19.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 10.9;granulocytes: 19.0;monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001587			Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		4500000	Vesicles	Nucleoplasm	"HPA001587: AB_1079133"	"unprognostic (5.14e-3)"	"unprognostic (4.72e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.08e-2)"	31.5	17.5	9.3	15.3	13.3	2.1	19.8	3.6	10.2	16.6	23.8	12.6	7.2	18.9	16.6	18.0	33.0	15.4	17.7	17.5	11.4	9.4	22.7	73.3	27.7	33.9	15.2	6.0	25.2	12.9	9.5	16.1	15.2	13.4	15.3	25.2	14.5	21.8	13.0	22.3	10.2	37.7	16.3	24.5	17.4	18.5	9.9	11.9	4.8	24.0	20.1	20.0	16.5	15.4	1.9	10.9	19.0	6.9	0.0	0.1	1.7	8.2	10.3	4.9	13.5	11.2	33.2	8.9	17.4	24.2	8.3	10.8	6.0	15.4	0.0	30.6	23.9	24.1	7.9	5.3	7.4	9.2	45.2	4.1	1.4	9.3	15.1	6.8	0.1	3.6	30.1	6.7	11.3	14.0	25.1	17.3	0.0	4.4	0.9	11.7	12.1	0.0	2.2	4.5	15.8	9.9	0.0	12.1	0.0	12.4	9.1	1.8	1.7	27.3	10.0	6.8	6.7	6.4	7.9	22.0	16.2	7.7	27.3	13.6	0.2	4.1	0.0	35.8	4.3	6.8	0.0	6.9	7.1	0.0	1.7	0.0	1.9	0.0	0.0	10.9	1.8	0.0	0.0	19.0	0.0	0.6	1.9	0.1	1.7	9.3	13.3	3.6	10.2	11.4	9.4	15.2	6.0	13.4	11.9	65.5	43.2	10.0	29.8	15.2	2.0	9.2	53.5	40.2	51.2	27.9	15.7	7.4	8.3	30.4	30.3	46.6	51.4	0.0	85.9	27.9	14.8	39.1	0.0	133.7	39.4	0.0	89.3	79.8	108.2	5.6	22.5	97.3	20.3	235.4	131.1	39.2	63.8	20.1	17.7	20.5	10.7	32.3	30.6	3.6	26.6	10.7	7.9	3.8	25.1	29.4
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 16.1;testis: 31.5"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 253.7;Ito cells: 63.3;Late spermatids: 36.6;Spermatocytes: 64.6"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"PC-3: 27.0;U-2197: 86.8;U-251 MG: 58.3;U-87 MG: 34.6"	"Region enhanced"	"Detected in some"		"olfactory region: 8.7"	"Low region specificity"	"Detected in many"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.5	4.8	3.7	3.9	11.3	0.0	0.8	0.3	3.1	1.2	0.4	2.1	5.7	0.3	0.9	4.4	0.5	0.1	0.8	0.6	5.1	11.2	3.5	9.6	1.0	0.1	1.2	2.6	0.1	0.1	0.5	16.1	2.1	3.9	4.3	0.7	1.6	0.8	3.7	0.0	0.1	0.3	0.4	0.6	0.2	0.1	31.5	1.4	0.0	1.3	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	5.9	5.7	0.0	0.0	0.0	0.0	0.0	0.1	2.9	9.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.9	5.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	86.8	58.3	0.0	0.0	0.0	34.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	11.3	0.3	3.1	5.1	11.2	1.2	2.6	3.9	1.4	0.0	0.0	0.0	2.6	0.1	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	253.7	1.0	0.0	0.0	0.0	0.0	0.4	2.3	0.0	0.4	0.0	0.0	4.1	63.3	4.8	36.6	2.6	0.0	0.0	1.0	0.0	0.0	5.5	0.0	4.6	0.0	0.0	0.0	0.2	64.6	2.1	0.0	0.0	0.0	0.0	2.5
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.7;lymphoid tissue: 97.9"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 169.7;Erythroid cells: 70.0;Kupffer cells: 59.0;T-cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 40.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;HEL: 13.2;HMC-1: 23.8;RPMI-8226: 22.5;U-266/70: 28.3;U-698: 11.7;U-937: 15.8"	"Group enriched"	"Detected in some"	13	"cerebellum: 61.1;hippocampal formation: 29.7"	"Region enriched"	"Detected in single"	37	"cerebellum: 96.7"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	Yes	NA	208000	14000	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	8.8	2.4	4.1	48.0	5.8	19.5	7.8	40.1	4.3	4.7	4.8	4.6	0.9	3.8	5.4	2.9	3.4	9.7	5.6	5.1	4.9	2.1	2.5	3.9	14.7	58.0	5.8	2.3	3.7	1.7	0.7	1.4	3.0	6.7	3.5	5.9	3.4	13.5	1.5	1.8	6.1	19.2	3.3	7.8	38.2	5.0	2.2	5.5	97.9	3.7	2.4	54.8	8.7	5.4	43.3	37.1	75.7	35.0	49.3	60.5	66.5	0.0	0.0	0.0	0.0	8.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	13.2	0.0	0.0	0.4	9.3	23.8	0.4	0.0	0.0	0.2	0.0	0.2	1.6	1.4	5.0	0.0	0.0	0.7	9.9	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	2.1	0.1	0.1	0.1	0.4	0.0	28.3	2.4	11.7	0.8	15.8	0.7	52.7	27.4	75.7	43.1	35.0	48.6	43.3	45.1	47.1	37.1	39.9	60.5	48.6	69.1	49.3	33.7	28.0	47.0	66.5	4.1	5.8	40.1	4.3	4.9	2.1	5.8	2.3	6.7	5.5	3.0	10.0	169.7	0.1	7.2	0.0	1.2	10.2	8.1	3.4	1.8	0.0	0.2	0.0	0.1	1.3	4.9	0.0	70.0	0.2	0.2	6.6	0.1	25.5	2.4	16.6	0.0	0.0	36.2	59.0	0.7	10.0	30.8	27.0	0.0	0.3	0.4	0.0	0.3	17.0	0.3	0.6	6.5	3.7	2.1	4.7	3.1	0.3	92.0	0.0	0.0
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 84.8;Macrophages: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 27.6;NB-4: 24.3;THP-1: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		20000	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	17.7	7.6	6.5	13.6	13.8	40.5	24.7	4.0	6.7	8.6	8.1	7.7	4.6	6.2	7.4	9.4	6.8	7.8	7.4	8.8	6.1	4.9	8.3	11.6	16.8	39.2	10.3	2.0	7.7	7.7	6.9	5.4	6.2	8.3	6.9	5.7	5.3	7.0	5.3	5.3	8.6	9.1	8.3	11.2	23.4	7.3	5.3	9.7	50.0	7.9	3.2	11.0	6.3	12.8	0.5	3.6	15.6	6.9	1.4	2.4	2.0	3.6	2.1	1.9	2.5	3.9	2.3	2.5	5.5	3.6	2.6	3.3	2.0	2.4	3.3	2.3	5.5	3.4	6.0	2.7	2.6	1.8	5.4	3.2	0.0	1.2	1.3	4.5	27.6	8.6	3.4	3.8	2.3	1.8	2.5	2.7	2.7	1.4	3.5	2.6	3.1	3.3	24.3	1.1	4.7	2.1	0.7	0.4	0.6	2.4	2.7	1.3	0.0	3.8	3.3	2.7	2.3	2.5	35.0	7.5	2.0	2.9	3.0	2.0	2.8	1.5	1.6	2.9	13.4	2.1	6.7	6.9	6.1	1.1	3.2	0.9	0.4	1.5	1.1	3.6	0.5	2.4	1.8	15.6	1.4	2.9	1.7	0.9	2.0	6.5	13.8	4.0	6.7	6.1	4.9	10.3	2.0	8.3	9.7	11.9	13.1	6.7	5.5	7.8	2.0	4.5	15.3	5.3	3.4	5.2	7.9	5.4	0.0	8.0	2.5	9.3	15.1	0.0	10.8	10.6	8.2	8.5	7.0	9.6	29.2	3.2	12.7	20.9	84.8	1.4	8.3	43.1	8.5	3.6	13.1	3.8	10.5	11.8	4.2	3.1	3.2	12.9	9.0	1.4	14.7	5.9	5.4	20.0	10.6	9.3
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143251-112164117	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9;skin 1: 57.2"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 160.8;Kupffer cells: 163.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 17.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 26.5;CAPAN-2: 42.1;HaCaT: 38.5;HBEC3-KT: 29.0;hTCEpi: 44.4;PC-3: 25.8;U-2 OS: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	Yes	196000		"Nucleoplasm, Golgi apparatus"	Cytosol	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	9.4	2.6	5.3	12.5	7.9	10.8	5.2	1.3	5.3	18.5	13.1	6.4	2.5	8.6	2.1	3.7	53.9	3.3	11.9	2.1	5.7	3.1	17.5	3.6	15.2	22.6	7.4	1.4	1.4	7.0	0.3	3.3	2.6	8.2	5.5	11.6	2.2	8.3	1.4	3.8	57.2	9.1	4.0	24.7	26.6	5.1	1.7	7.5	3.9	1.8	21.2	26.5	9.1	35.4	0.5	17.1	10.4	6.9	13.8	0.3	1.6	26.5	9.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	5.1	42.1	0.0	6.1	0.0	0.7	38.5	0.0	29.0	0.0	0.0	0.2	4.0	9.5	2.1	0.9	2.1	7.7	0.0	44.4	0.0	10.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	7.3	25.8	0.0	0.0	0.0	19.0	5.7	0.0	0.0	18.3	12.2	0.1	0.2	7.3	5.8	0.0	0.1	50.0	0.3	8.2	0.1	0.0	0.1	0.0	15.4	0.0	3.5	6.0	10.4	0.1	6.9	0.0	0.4	0.0	0.0	17.1	0.5	0.0	0.3	6.7	13.8	3.7	3.8	0.0	1.6	5.3	7.9	1.3	5.3	5.7	3.1	7.4	1.4	8.2	7.5	160.8	35.5	7.5	33.3	109.2	1.7	0.7	22.9	73.6	43.3	8.7	0.0	2.1	68.0	27.4	1.8	2.4	69.7	0.0	126.1	2.6	5.4	10.6	97.2	2.0	69.6	0.0	13.9	6.2	163.5	0.9	0.0	66.1	3.3	30.7	23.3	1.7	111.9	97.0	4.2	13.2	37.2	6.5	2.2	0.6	0.5	97.2	1.5	27.7	45.4	67.4
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998541-72005715	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.3;lymphoid tissue: 71.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 11.8;Hofbauer cells: 10.7;Macrophages: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	3070000	14000000	"Endoplasmic reticulum"		"CAB025980: , HPA041061: AB_2677280"	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	23.7	10.6	6.5	19.7	7.7	6.0	7.2	6.2	5.7	6.3	6.7	6.7	1.0	7.1	6.1	4.1	4.1	5.8	7.2	4.7	3.8	4.1	37.0	54.3	20.8	20.2	7.0	1.9	10.1	4.9	2.8	6.4	28.4	9.0	8.9	9.8	5.3	6.4	4.0	6.2	5.1	9.2	11.4	6.1	71.5	6.1	3.0	6.3	6.1	17.3	3.6	15.6	8.6	6.2	13.6	22.3	22.2	30.5	1.9	23.4	13.9	2.0	2.7	6.2	3.6	1.3	1.9	7.0	3.4	2.0	3.3	4.5	13.2	2.6	1.2	2.7	1.7	3.8	5.1	3.7	2.8	2.6	3.0	4.4	5.2	7.0	3.7	1.4	3.0	12.6	2.9	3.2	3.0	1.6	4.5	6.4	8.1	8.9	2.3	1.8	3.4	3.8	6.5	4.5	2.4	2.5	5.8	6.4	2.1	2.2	5.5	3.3	6.4	3.8	4.3	5.0	6.6	4.3	2.8	13.8	5.4	4.2	6.2	2.1	3.7	2.2	2.5	2.3	11.0	2.6	2.3	8.5	22.2	23.4	30.5	10.5	13.6	12.4	13.8	15.5	7.0	10.4	15.0	3.6	1.9	23.7	22.3	6.1	13.9	6.5	7.7	6.2	5.7	3.8	4.1	7.0	1.9	9.0	6.3	6.0	3.5	5.7	0.4	1.8	3.1	0.8	0.0	2.7	1.2	0.0	9.8	0.7	0.0	1.9	0.0	7.9	0.7	0.0	11.8	0.9	2.3	0.9	7.0	0.5	10.7	3.2	0.0	8.0	7.2	0.0	0.9	11.1	0.0	0.0	0.7	1.6	7.3	0.0	0.7	0.7	3.0	0.0	1.2	0.5	0.4	1.8	0.7	3.2	0.6	0.1
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398775	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.3"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 26.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.8;HHSteC: 29.8;HMC-1: 20.0;U-937: 32.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA007615	Approved		Approved	Mitochondria	"Intracellular and membrane"	Yes	No			Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	17.8	2.6	1.4	8.3	1.7	12.5	11.2	0.8	1.3	8.2	8.1	0.7	6.6	5.1	4.2	5.7	4.5	4.5	14.1	10.5	1.7	1.9	7.4	8.8	39.3	29.6	2.0	0.1	3.3	2.6	0.8	4.6	10.7	1.6	6.3	3.4	5.0	3.0	28.4	2.8	3.2	10.7	7.9	1.9	19.5	4.6	2.4	0.4	2.5	3.2	3.2	6.6	8.2	12.9	0.1	6.8	5.5	0.1	26.8	10.6	1.1	0.9	0.3	0.0	0.0	0.7	0.7	1.6	0.0	0.5	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.5	0.0	1.9	0.0	13.8	0.8	2.5	0.6	0.1	29.8	5.2	20.0	6.8	1.1	2.2	3.6	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.7	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.4	0.6	0.4	2.4	0.4	0.0	0.0	0.0	0.1	32.0	2.3	5.5	0.0	2.4	4.2	0.1	10.6	0.1	2.4	3.0	2.0	0.1	0.4	0.8	4.1	26.8	0.0	6.8	2.4	1.1	1.4	1.7	0.8	1.3	1.7	1.9	2.0	0.1	1.6	0.4	0.0	13.3	0.0	1.0	0.7	0.0	1.5	0.0	5.3	3.4	1.8	0.0	0.0	1.7	0.8	0.0	7.1	0.0	0.0	0.5	0.7	2.2	0.8	104.4	6.2	0.1	0.0	0.0	13.5	3.1	0.0	0.3	19.4	3.3	0.0	0.0	0.3	0.7	0.0	0.0	0.8	0.0	6.5	0.9	0.2	0.4	0.9	0.0	22.4	0.0	0.7
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Club cells: 93.3;Ito cells: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 95.6;ASC TERT1: 42.7;HHSteC: 30.0;HSkMC: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1000000	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	48.6	25.2	2.6	18.2	5.2	4.0	92.4	2.4	3.9	47.8	21.0	2.5	34.3	5.2	15.2	30.2	18.2	17.1	25.8	27.0	4.2	2.5	23.7	74.8	40.5	28.0	5.6	1.1	25.1	17.1	16.9	7.3	66.2	10.9	26.0	8.4	8.6	12.7	36.4	15.5	13.5	13.0	15.1	10.0	19.2	15.6	13.4	2.8	3.5	33.6	9.0	9.6	32.0	36.4	0.1	0.1	4.0	0.5	0.8	1.8	0.2	0.2	1.8	0.0	1.5	95.6	42.7	0.6	4.0	18.2	2.8	4.3	0.8	0.5	0.0	2.9	8.0	5.0	0.8	0.0	0.3	2.4	7.9	0.0	0.1	0.4	4.4	30.0	0.0	0.0	117.7	0.3	3.2	0.7	1.2	1.2	0.0	0.5	0.1	4.1	0.8	0.0	0.1	0.1	0.8	0.1	0.0	0.3	0.0	2.7	1.9	0.0	0.0	1.8	1.1	0.0	0.5	1.6	0.1	0.0	8.2	0.5	13.7	0.3	0.0	0.0	0.0	3.2	0.0	0.5	0.6	0.5	0.1	0.0	0.0	0.7	0.1	1.1	0.0	0.1	0.1	0.0	0.1	4.0	0.8	0.0	0.1	1.8	0.2	2.6	5.2	2.4	3.9	4.2	2.5	5.6	1.1	10.9	2.8	23.8	55.6	3.7	27.6	27.6	0.0	3.9	28.1	40.2	93.3	5.2	0.0	5.3	3.3	21.6	6.4	58.3	0.0	0.0	18.7	76.6	77.2	84.5	1.1	43.2	5.1	0.0	1.2	139.3	12.4	9.4	25.9	21.6	18.6	9.0	0.7	7.3	15.4	0.0	1.4	6.2	1.0	6.5	23.1	0.7	0.9	33.8	20.0	2.6	0.9	19.6
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.5;liver: 91.8;placenta: 35.9"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 100.2;Hepatocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 36.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 36.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 72.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		260000000	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	3.4	1.7	3.7	5.2	4.5	7.8	2.8	0.8	6.0	2.9	1.8	3.4	0.7	1.1	2.6	1.7	9.1	3.2	5.7	3.3	7.4	2.9	1.9	91.8	6.3	12.6	3.5	2.5	2.2	2.0	1.0	1.4	35.9	5.5	2.1	1.4	1.6	4.7	2.0	1.2	5.8	1.5	3.1	6.3	7.1	2.3	1.0	2.9	2.3	2.2	3.8	3.4	3.3	4.4	0.9	1.4	36.5	2.2	0.1	1.3	0.5	3.9	1.0	1.6	0.2	2.9	2.4	3.1	1.7	3.5	4.1	4.0	1.7	8.8	0.7	18.3	4.8	9.5	10.2	0.9	17.1	5.7	0.7	1.0	0.8	1.7	4.2	6.1	5.8	2.8	3.2	7.0	5.9	18.9	8.6	1.8	1.8	0.1	0.0	1.9	1.8	0.5	2.6	2.6	1.7	1.8	2.8	2.5	1.4	1.5	4.2	0.3	0.0	8.0	4.4	72.7	1.6	2.9	4.2	2.4	3.2	3.2	9.7	7.9	1.5	0.0	0.1	5.4	5.3	18.6	3.5	1.5	8.5	0.7	1.7	1.3	0.9	0.8	0.9	1.4	0.9	0.8	0.5	36.5	0.1	2.2	0.2	0.8	0.5	3.7	4.5	0.8	6.0	7.4	2.9	3.5	2.5	5.5	2.9	0.0	14.3	1.4	14.3	39.8	5.4	4.0	43.3	2.7	20.5	3.5	7.9	3.1	0.0	6.5	2.3	7.1	1.3	0.0	6.4	100.2	7.0	5.6	7.0	172.7	6.9	0.0	5.2	8.0	33.0	0.0	4.0	18.3	8.5	1.0	1.3	0.9	14.8	0.0	2.5	0.8	0.6	0.0	3.1	0.0	0.6	32.5	20.3	2.5	1.2	12.8
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Cell type enriched"	"Detected in many"	11	"granulocytes: 477.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Group enriched"	"Detected in some"	6	"HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	1700000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	3.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.7	0.1	0.1	55.4	0.4	82.4	1.1	0.3	1.3	8.9	0.1	40.2	0.0	0.2	0.1	0.1	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3	8.9	22.8	0.0	15.1	7.6	0.0	1.8	0.0	12.0	13.6	1.8	0.0	0.0	0.0	0.0	0.2	29.2	0.0	0.0	0.4	0.1	4.2	8.9	477.2	0.0	0.0	0.0	0.0	44.2	0.3	0.9	0.9	11.2	3.3	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.2	38.8	5.2	0.0	0.0	4.4	0.0	4.3	0.0	11.1
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Cell line enhanced"	"Detected in some"		"A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	NA	NA	291000		Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.4	41.7	0.0	1.2	0.0	0.0	0.0	0.1	0.0	7.0	0.0	0.1	7.9	0.0	5.4	0.2	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.2	0.0	5.6	0.0	4.7	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.8	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.1	4.0	4.7	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2	6.0	10.6	0.5	50.9	163.8	0.0	0.3	12.7	18.7	17.0	3.5	0.0	1.3	0.0	17.2	35.3	2.2	6.5	0.0	25.2	2.5	6.6	30.8	9.3	38.4	319.3	0.0	0.0	3.1	35.8	72.7	0.6	100.5	23.6	1.0	0.6	0.0	89.0	0.0	0.4	0.0	0.0	0.0	6.6	0.7	0.1	294.2	3.8	0.9	2.2	333.6
IL20RA	"IL-20R1, ZCYTOR7"	ENSG00000016402	"Interleukin 20 receptor subunit alpha"	Q9UHF4	6	136999971-137045180	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 28.9"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 33.5;Muller glia cells: 36.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.4;HaCaT: 6.8;OE19: 9.7;RT4: 11.3;SH-SY5Y: 10.9;T-47d: 10.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB024990, HPA042281"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB024990: , HPA042281: AB_10806235"	"unprognostic (3.75e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (1.43e-6)"	"unprognostic (1.57e-2)"	"prognostic favorable (2.29e-5)"	"unprognostic (9.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (8.03e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.85e-6)"	"unprognostic (9.38e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.64e-3)"	0.6	7.0	2.0	1.6	5.9	0.1	21.2	4.4	2.8	13.9	3.5	4.3	0.6	2.4	5.5	3.7	6.4	13.6	7.9	5.9	3.6	3.0	0.4	0.8	4.7	0.1	3.7	2.3	5.4	16.3	0.2	1.8	0.4	4.6	7.3	3.7	3.5	11.8	7.8	0.5	28.9	1.3	2.9	5.5	0.0	4.9	2.9	3.3	1.0	2.2	3.7	5.6	5.6	9.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	9.4	0.0	0.1	1.4	0.1	6.8	1.2	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	9.7	1.4	0.0	0.4	0.0	0.0	11.3	0.7	10.9	0.5	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.9	4.4	2.8	3.6	3.0	3.7	2.3	4.6	3.3	3.0	18.4	0.0	11.2	19.5	1.7	3.9	25.5	33.5	14.8	3.5	0.0	2.4	0.0	11.1	0.2	0.6	5.2	0.0	0.6	6.6	2.4	18.3	2.3	0.0	0.4	0.0	7.0	0.6	0.0	0.5	8.1	1.7	13.5	0.0	18.4	36.8	8.0	2.9	14.2	0.6	0.7	0.0	1.2	0.2	3.4	15.7	6.9	0.0	13.3	17.1
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 64.5;skin 1: 61.2"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 32.6;Early spermatids: 38.8;Late spermatids: 24.0;Suprabasal keratinocytes: 33.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 106.6"	"Region enriched"	"Detected in single"	9	"cerebellum: 0.6"	"Not detected"	"Not detected"			HPA063914			Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	1.6	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	13.2	0.2	0.0	0.0	0.0	1.3	0.3	64.5	0.1	0.1	0.3	0.0	0.0	0.1	2.1	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.2	2.8	0.0	1.6	0.3	0.4	4.1	0.2	0.4	61.2	0.1	0.1	0.3	0.0	0.1	0.9	0.0	0.5	0.2	22.6	17.1	0.9	19.2	0.1	0.4	0.0	0.3	0.0	0.6	0.0	4.9	0.0	0.0	0.0	3.0	12.9	0.5	0.1	0.3	0.0	0.2	0.4	0.6	0.0	2.8	1.8	0.1	16.0	0.0	26.4	0.1	0.0	0.0	0.0	3.3	0.0	17.8	0.0	0.0	2.2	106.6	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.5	0.8	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	32.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	38.8	1.0	0.6	0.0	0.2	1.1	0.8	1.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	24.0	0.3	0.8	3.3	2.8	0.7	0.0	0.8	0.0	0.7	0.1	0.0	0.0	2.3	0.6	1.5	33.2	1.4	0.0	0.5	4.8
IL23A	"IL-23, IL-23A, IL23P19, P19, SGRF"	ENSG00000110944	"Interleukin 23 subunit alpha"	Q9NPF7	12	56334174-56340410	"FDA approved drug targets, Predicted secreted proteins"	"Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling"	Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.0;lymphoid tissue: 15.2;testis: 12.1"	"Cell type enhanced"	"Detected in many"	10	"Ductal cells: 26.3;monocytes: 58.7;Pancreatic endocrine cells: 46.8;Spermatocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"MAIT T-cell: 8.4;memory B-cell: 10.6;memory CD4 T-cell: 15.5;memory CD8 T-cell: 7.4;naive B-cell: 10.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 10.6;T-reg: 8.4"	"Group enriched"	"Detected in many"	14	"B-cells: 10.6;T-cells: 17.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.4;CAPAN-2: 16.5;U-266/70: 27.6;U-266/84: 12.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA001554	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA	11000		Cytosol		"HPA001554: AB_1079135"	"unprognostic (2.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.50e-3)"	0.7	0.5	0.4	3.9	0.5	3.6	0.4	0.3	0.3	0.5	0.6	0.3	0.3	0.0	1.3	0.8	6.0	0.5	2.0	0.3	0.4	0.5	1.3	1.4	1.2	7.5	0.4	0.3	0.3	1.1	0.0	1.1	0.6	0.3	1.0	0.2	0.3	1.8	0.3	0.3	0.8	2.5	1.0	0.4	2.8	0.7	12.1	0.3	12.9	0.6	10.4	15.2	7.4	0.6	10.6	0.5	0.1	0.2	1.0	17.0	5.9	9.4	0.2	0.3	0.3	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.4	16.5	0.5	4.9	0.0	0.5	0.9	0.0	1.6	0.0	0.6	0.3	0.3	0.1	0.7	0.0	0.2	0.6	0.1	0.0	0.0	0.4	2.1	0.0	2.2	0.4	4.1	0.0	0.4	0.3	0.5	1.4	0.2	0.3	0.2	0.1	0.4	5.7	4.7	0.3	0.4	0.2	0.2	0.8	1.4	0.1	4.4	0.3	0.3	0.3	0.3	1.1	27.6	12.4	1.2	0.3	2.4	0.2	0.0	0.2	0.0	1.7	0.0	8.4	10.6	15.5	7.4	0.5	10.6	17.0	10.6	0.1	1.0	0.0	0.0	8.4	5.9	0.4	0.5	0.3	0.3	0.4	0.5	0.4	0.3	0.3	0.3	3.0	2.1	14.5	10.2	3.2	0.0	0.3	0.0	2.7	5.7	1.8	0.0	0.3	1.7	26.3	4.7	0.6	0.3	0.0	6.4	0.3	1.4	5.0	0.0	0.6	2.4	0.0	0.0	0.0	0.0	3.2	0.3	8.1	8.5	58.7	0.0	0.1	46.8	0.0	0.7	0.5	0.1	0.0	1.9	41.1	5.3	3.4	0.0	10.2	0.0	13.9
IL27RA	"CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1"	ENSG00000104998	"Interleukin 27 receptor subunit alpha"	Q6UWB1	19	14031748-14053216	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 25.2;lymphoid tissue: 32.3"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 31.8;Kupffer cells: 33.3;T-cells: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA073441			Approved	Vesicles		NA	NA		4100000	Vesicles		"HPA073441: "	"prognostic favorable (1.74e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (2.58e-10)"	"unprognostic (5.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.87e-3)"	8.4	2.1	2.8	26.0	2.7	3.5	20.6	3.0	3.5	3.5	3.9	1.1	2.7	3.6	3.6	2.0	3.4	4.2	4.1	5.8	3.8	3.6	4.8	2.1	11.8	25.3	2.6	2.3	2.3	3.5	8.1	1.1	2.0	2.5	5.0	3.4	1.2	7.4	2.1	2.8	2.6	9.0	3.0	2.5	18.0	4.1	2.4	1.6	32.3	4.9	2.2	28.3	6.0	6.8	14.6	18.2	5.3	19.7	19.1	25.2	16.9	8.3	3.6	3.7	4.9	0.3	1.9	1.5	3.9	8.2	7.2	10.4	1.7	6.8	0.1	4.2	3.5	3.3	1.6	5.7	2.3	5.6	16.0	3.9	20.3	0.8	3.0	0.6	9.7	0.3	1.9	0.9	3.4	0.7	5.8	2.8	5.1	14.0	15.2	0.3	11.7	7.2	21.1	4.8	5.0	2.5	6.4	2.1	7.7	4.4	2.0	3.2	1.7	5.0	0.3	5.7	2.0	6.4	6.0	4.5	0.7	9.0	7.3	4.2	15.8	7.6	7.4	0.7	19.8	4.7	5.3	19.7	0.5	22.9	16.3	20.2	14.6	22.7	18.9	18.2	12.8	25.2	19.4	1.5	19.1	7.5	6.8	19.9	16.9	2.8	2.7	3.0	3.5	3.8	3.6	2.6	2.3	2.5	1.6	0.0	10.6	31.8	10.6	1.6	0.0	1.2	5.1	0.0	7.9	3.5	0.0	0.5	0.0	9.0	0.3	16.3	0.0	0.0	2.3	1.6	3.0	6.3	17.3	0.8	20.7	1.6	2.4	20.9	33.3	0.0	3.1	26.0	5.0	4.6	0.9	0.2	4.1	0.0	3.2	0.7	0.0	0.0	1.7	0.1	13.4	1.1	0.1	61.2	1.1	3.1
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 115.3;lymphoid tissue: 169.3"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 121.6;Enterocytes: 82.5;monocytes: 130.8;T-cells: 235.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"Karpas-707: 225.6"									"HPA046641, HPA049691"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA046641: AB_2679733, HPA049691: AB_2680851"	"unprognostic (2.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (8.25e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.28e-7)"	"unprognostic (1.73e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.54e-2)"	5.8	1.3	1.4	39.5	1.4	12.8	3.6	0.8	0.9	2.9	16.6	0.9	0.9	8.2	3.0	2.1	5.3	3.1	5.3	2.6	1.4	1.5	3.7	4.7	13.6	70.4	1.8	0.6	2.9	1.5	0.0	1.2	5.3	1.5	3.2	20.8	2.9	10.4	1.8	1.6	2.7	28.6	1.5	2.9	58.7	6.0	2.0	0.9	169.3	3.3	4.2	61.4	7.6	3.1	51.9	30.6	65.6	19.7	94.6	115.3	99.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	17.6	1.3	0.0	0.0	0.1	0.0	0.0	0.0	14.8	0.0	2.3	0.0	0.0	0.0	9.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	21.0	3.9	225.6	0.0	0.0	32.6	17.8	0.0	0.0	0.0	7.5	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	12.9	22.7	11.3	0.2	37.8	0.0	35.2	8.5	13.4	107.2	19.7	105.6	51.9	97.7	110.4	20.3	51.6	68.0	84.9	65.6	94.6	13.5	30.6	115.3	99.0	1.4	1.4	0.8	0.9	1.4	1.5	1.8	0.6	1.5	0.9	3.0	15.7	121.6	6.6	7.2	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	1.0	0.0	4.5	82.5	0.0	2.0	0.2	3.3	3.6	38.1	1.5	32.3	0.0	74.7	6.7	21.7	0.0	0.0	41.4	40.5	130.8	19.5	0.0	16.5	58.8	0.4	1.1	0.2	0.0	4.1	0.0	0.0	5.9	0.2	235.1	18.0	6.8
IL31RA	"CRL, CRL3, GLM-R, Glmr, IL-31RA"	ENSG00000164509	"Interleukin 31 receptor A"	Q8NI17	5	55851379-55922853	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3;tongue: 6.4"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 1.8;Spermatocytes: 2.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	6	"amygdala: 10.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 2.2;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.2;monocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 25.6;HBEC3-KT: 7.8;hTERT-HME1: 9.4;U-2 OS: 13.9;U-87 MG: 16.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.5;hippocampal formation: 1.1"	"HPA051532, HPA068114"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA051532: , HPA068114: AB_2732779"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.75e-5)"	"unprognostic (5.55e-2)"	"unprognostic (2.65e-6)"	"unprognostic (7.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.76e-2)"	0.3	0.1	10.3	1.0	0.1	5.3	0.2	0.1	0.4	0.2	1.5	0.0	0.0	0.4	1.2	1.8	1.7	0.1	0.2	0.4	1.6	0.2	0.3	0.3	0.5	0.1	0.1	0.0	0.5	0.7	0.0	0.7	0.7	0.0	1.0	0.4	0.4	1.3	0.2	2.6	2.5	0.8	1.8	0.1	0.3	0.5	5.9	0.0	1.4	0.5	6.4	0.5	0.5	2.2	0.0	1.2	0.2	2.2	0.0	0.1	0.4	0.0	1.0	0.0	0.0	0.0	0.4	0.4	0.1	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.2	25.6	0.0	0.0	7.8	1.6	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	5.2	2.6	3.7	9.4	0.4	2.9	0.0	0.0	0.3	1.2	0.0	0.0	1.2	0.0	0.0	5.2	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	1.3	0.4	13.9	0.0	0.8	0.0	0.0	0.0	16.1	0.0	2.2	0.1	2.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	10.3	0.1	0.1	0.4	1.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.1	0.9	0.0	0.0	0.0
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.6;testis: 48.8"	"Cell type enriched"	"Detected in many"	12	"monocytes: 1188.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 38.6"	"Group enriched"	"Detected in many"	6	"monocytes: 13.0;T-cells: 38.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 18.0;HDLM-2: 31.2;Karpas-707: 25.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	5.4	3.3	4.0	30.9	4.6	7.1	4.1	5.8	5.6	4.6	4.1	5.5	2.9	8.2	5.9	3.4	4.5	8.2	5.4	4.2	3.9	3.5	11.0	3.5	6.7	15.5	4.0	3.2	6.2	3.7	1.5	5.1	6.8	4.3	5.3	3.8	3.9	4.1	5.0	6.2	3.4	7.4	3.8	7.2	7.6	6.2	48.8	4.4	14.6	4.1	4.4	12.3	6.5	4.9	0.2	4.1	0.1	13.0	0.4	38.6	3.0	0.5	0.6	0.4	0.4	0.0	0.4	0.1	0.3	1.0	0.8	1.1	0.3	1.0	1.8	18.0	0.2	1.5	0.3	0.2	0.0	0.1	31.2	0.1	0.8	0.0	0.2	0.1	0.6	6.4	0.5	0.2	0.3	0.0	0.2	1.4	0.2	0.1	25.3	0.0	0.2	0.4	1.0	0.2	0.4	0.1	0.5	0.5	1.7	1.2	1.6	0.4	0.4	0.2	0.5	0.3	0.1	0.2	1.4	1.5	3.8	0.5	0.0	0.5	2.2	4.7	1.0	0.5	0.2	0.4	0.1	8.0	0.1	2.3	13.0	38.6	0.2	5.0	4.3	4.1	0.1	0.1	0.0	0.1	0.4	1.6	0.4	0.2	3.0	4.0	4.6	5.8	5.6	3.9	3.5	4.0	3.2	4.3	4.4	0.0	0.0	0.0	0.5	8.7	0.0	0.6	0.0	0.0	1.2	3.5	0.0	0.3	0.0	1.9	52.0	3.1	0.0	0.0	3.4	0.6	1.4	1.0	1.1	0.0	102.3	0.0	0.0	1.8	1.8	11.1	0.3	40.3	3.3	1188.5	0.0	0.1	0.5	0.0	0.4	1.6	0.2	0.0	2.1	11.9	2.5	7.2	0.7	5.0	0.1	1.4
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.1;lymphoid tissue: 48.0"	"Cell type enriched"	"Detected in many"	9	"Smooth muscle cells: 589.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8"	"Group enriched"	"Detected in some"	70	"memory B-cell: 6.1;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	77	"B-cells: 7.7"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 208.4;GAMG: 141.1"					"Low region specificity"	"Detected in single"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	5700		Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	60.1	5.6	1.4	48.0	10.0	15.3	11.5	0.7	4.4	2.9	8.1	1.2	0.4	0.7	2.1	4.6	14.3	7.8	16.1	21.6	3.9	1.5	1.3	5.2	34.9	3.0	1.8	0.2	5.3	8.3	5.7	14.2	4.5	12.8	6.5	7.5	3.3	3.1	0.8	6.9	2.8	4.5	8.2	7.0	3.5	6.5	3.2	1.2	0.1	4.5	12.7	3.5	34.9	8.4	7.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.8	208.4	3.9	13.4	0.0	0.0	0.0	6.8	1.3	141.1	0.1	0.0	0.0	5.3	8.2	0.0	0.0	0.3	0.0	4.4	0.0	0.0	0.5	0.0	39.8	5.7	3.8	1.4	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	13.5	0.0	0.0	0.7	0.0	0.0	1.2	1.3	0.1	2.4	0.4	0.0	2.3	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	10.0	0.7	4.4	3.9	1.5	1.8	0.2	12.8	1.2	6.0	27.2	7.2	1.9	39.6	0.0	0.9	0.0	13.4	20.5	3.5	0.0	0.5	0.0	5.8	0.3	40.7	0.0	0.0	2.4	3.1	63.9	7.3	5.8	0.0	4.2	0.0	0.0	3.1	6.1	0.0	0.0	46.2	38.8	7.2	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	589.1	0.0	0.0	29.2	1.1	0.0	0.0	9.0
ILDR2	C1orf32	ENSG00000143195	"Immunoglobulin like domain containing receptor 2"	Q71H61	1	166895711-166975482	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;testis: 18.0"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 116.0"	"Cancer enhanced"	"Detected in some"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;JURKAT: 7.4;MOLT-4: 5.1;U-2 OS: 12.5;U-251 MG: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012545, HPA012815"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA012545: AB_2126894, HPA012815: "	"unprognostic (9.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.89e-5)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	0.8	1.1	9.8	0.9	6.4	1.4	0.5	2.1	14.6	0.7	2.9	3.6	0.1	0.7	0.9	1.4	0.9	0.8	1.3	3.1	7.2	7.7	6.3	1.3	1.4	1.0	2.7	8.0	0.8	0.7	0.5	3.3	0.8	3.1	2.3	1.2	2.8	0.8	2.8	0.8	0.7	0.8	2.0	2.3	0.7	0.7	18.0	3.1	1.9	0.9	0.0	1.1	0.9	0.3	0.0	0.4	0.3	0.0	0.0	0.3	0.5	0.0	0.0	9.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.8	0.3	0.0	0.4	0.0	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.2	0.0	3.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.1	0.2	0.0	5.1	0.0	3.3	0.1	0.0	0.0	0.3	0.7	0.7	0.2	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.0	12.5	0.0	6.6	2.3	0.0	0.5	1.4	1.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.5	9.8	6.4	2.1	11.4	7.2	7.7	2.7	8.0	3.1	3.1	0.0	0.0	0.0	0.0	0.0	3.9	3.2	0.0	0.0	1.2	0.0	5.9	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.1	1.6	1.2	0.0	0.0	13.8	0.6	0.0	0.0	1.0	0.0	116.0	0.1	0.0	0.0	4.6	6.5	0.0	0.1	3.3	1.3	0.0	0.2	0.0	0.2	0.0
ILVBL	"209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535"	ENSG00000105135	"IlvB acetolactate synthase like"	A1L0T0	19	15114984-15125785	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Syncytiotrophoblasts: 211.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067682	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA067682: AB_2685885"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.91e-8)"	"unprognostic (4.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.40e-1)"	13.7	22.1	10.4	8.3	13.6	7.7	12.1	12.4	18.9	11.5	34.9	21.3	16.7	29.1	13.4	11.1	18.9	13.8	24.8	32.9	10.5	9.7	24.9	34.8	10.0	13.2	18.5	9.2	15.9	24.7	21.1	16.5	35.9	14.0	11.1	11.0	29.4	16.1	14.9	10.0	19.4	26.8	10.9	14.3	8.3	18.2	14.7	17.7	10.0	28.6	16.7	12.2	14.8	14.5	9.8	17.5	10.8	20.7	15.3	16.9	15.1	22.1	13.5	11.6	13.6	15.1	10.3	13.4	10.4	14.1	12.6	16.2	21.4	53.9	9.6	20.7	11.2	7.6	16.8	7.0	12.7	3.7	8.9	13.7	14.1	13.8	23.3	24.3	11.9	12.5	15.4	14.8	7.3	9.6	10.3	11.7	9.9	5.7	12.6	9.8	51.4	7.9	9.5	10.7	17.8	19.6	11.6	10.5	15.1	10.9	11.0	9.6	13.0	6.2	27.2	20.5	4.6	12.4	10.2	12.4	19.1	10.6	23.9	14.6	8.8	9.0	4.7	12.2	11.6	14.3	10.8	14.8	3.5	15.1	20.7	16.9	8.6	12.6	15.4	17.5	9.8	16.7	16.9	1.6	15.3	18.7	12.7	12.9	15.1	10.4	13.6	12.4	18.9	10.5	9.7	18.5	9.2	14.0	17.7	23.8	9.4	11.1	19.4	11.3	90.9	28.8	58.6	12.0	9.1	24.4	25.5	78.0	16.6	40.3	3.8	18.0	81.6	23.3	44.3	120.6	15.5	17.9	10.5	49.9	38.6	17.5	42.7	27.0	9.5	3.6	23.9	17.3	79.2	3.6	49.3	51.2	27.7	53.4	18.7	43.1	30.2	19.4	19.4	15.8	19.9	14.2	211.9	12.1	65.7	20.4
IMMP2L	"IMMP2L-IT1, IMP2"	ENSG00000184903	"Inner mitochondrial membrane peptidase subunit 2"	Q96T52	7	110663051-111562517	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA026711	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA026711: AB_1851760"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (5.64e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	12.4	12.4	7.9	7.3	10.8	2.9	11.8	5.4	9.1	12.4	11.1	5.7	10.6	5.2	23.8	10.4	8.0	11.5	5.8	8.6	7.1	6.0	23.8	17.7	7.4	4.4	5.7	6.1	14.4	10.0	13.4	15.7	8.0	6.3	13.8	5.8	31.6	11.6	15.8	18.6	7.5	10.9	14.4	5.6	5.3	9.8	9.0	5.6	8.2	16.7	8.3	9.5	11.0	9.2	18.1	11.7	5.8	8.4	24.3	15.1	5.1	7.9	4.7	2.8	11.8	7.6	7.8	5.0	5.5	5.5	3.7	3.9	2.3	9.2	13.0	15.0	4.7	6.8	4.5	3.0	10.9	6.1	8.1	3.1	4.4	18.9	6.4	11.7	8.2	0.5	13.5	14.6	1.5	10.2	16.7	4.8	12.2	14.2	10.1	2.7	5.5	10.8	9.2	2.8	15.1	7.4	2.3	23.7	6.8	13.3	3.4	3.4	10.5	2.4	11.2	30.2	8.5	4.5	4.8	3.0	5.6	5.9	5.6	6.5	5.8	1.5	7.9	6.2	3.9	29.5	5.8	5.1	1.6	6.4	6.4	11.4	16.3	10.8	7.2	9.4	18.1	15.1	10.5	0.2	24.3	8.4	11.7	6.4	5.1	7.9	10.8	5.4	9.1	7.1	6.0	5.7	6.1	6.3	5.6	17.9	10.4	9.1	30.1	29.2	10.8	17.3	10.2	12.0	18.2	45.4	7.9	18.7	135.9	25.4	7.3	16.5	7.1	0.0	7.2	20.5	12.8	27.2	3.5	21.5	10.0	7.9	18.6	7.4	5.9	4.0	45.8	4.9	20.3	14.4	6.8	10.4	12.7	5.9	32.9	52.2	15.8	12.9	24.0	17.5	9.1	23.2	13.6	4.3	10.0	16.1
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030883	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 90.1"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 373.0;Extravillous trophoblasts: 196.1;Proximal tubular cells: 383.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.4;neutrophil: 18.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 60.5;OE19: 67.8;RPTEC TERT1: 29.2;SiHa: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	6.2	2.8	1.5	5.2	1.9	6.9	10.7	0.3	1.5	6.8	12.2	0.7	1.6	5.6	7.3	3.0	40.3	4.1	17.5	20.1	1.4	0.5	41.3	21.0	6.5	4.6	2.2	0.3	3.1	90.1	1.0	5.7	35.6	1.3	17.5	7.8	3.4	9.8	2.5	55.0	30.4	9.2	40.0	1.4	4.8	13.5	1.5	2.0	3.1	8.0	31.4	10.3	22.6	14.7	0.7	5.3	18.7	6.8	0.1	0.6	1.8	6.2	9.7	2.6	4.6	3.4	2.5	60.5	1.6	4.3	0.7	1.0	7.8	5.0	1.3	3.8	2.3	5.7	4.3	3.1	1.6	0.2	7.4	3.8	0.0	12.7	6.7	2.0	10.7	0.5	5.8	8.7	2.3	1.2	2.0	0.9	7.0	1.5	0.0	2.5	6.2	4.3	5.6	9.1	67.8	7.3	7.3	7.3	6.4	29.2	3.5	3.5	0.0	36.5	8.3	3.5	3.4	7.8	13.4	0.0	1.3	2.5	17.9	1.6	5.0	13.3	3.7	5.8	7.2	2.2	3.3	6.8	14.4	0.4	4.9	0.2	0.7	0.4	0.1	5.3	0.2	0.2	0.3	18.7	0.1	3.0	3.7	0.6	1.8	1.5	1.9	0.3	1.5	1.4	0.5	2.2	0.3	1.3	2.0	17.9	25.4	6.9	15.2	93.8	0.2	10.6	45.9	9.4	9.1	21.0	0.0	35.5	373.0	57.8	2.3	5.8	44.1	0.0	96.5	196.1	13.1	33.2	2.3	62.3	36.5	0.0	16.8	8.6	39.4	4.7	4.4	16.7	13.5	4.6	70.8	21.8	73.4	51.8	3.5	383.7	0.9	103.5	9.5	0.4	11.7	123.6	88.9	4.4	78.2	45.7
IMPACT	RWDD5	ENSG00000154059	"Impact RWD domain protein"	Q9P2X3	18	24426616-24453535	"Predicted intracellular proteins"	"Differentiation, Neurogenesis, Stress response, Translation regulation"	"Actin-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 28.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041045, HPA041968"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041045: AB_10793866, HPA041968: AB_10795603"	"unprognostic (1.13e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (7.90e-4)"	"unprognostic (5.60e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.60e-3)"	16.2	23.9	18.7	12.0	24.4	11.5	21.1	6.1	17.0	14.0	14.5	14.4	16.8	13.3	16.1	23.9	18.7	12.2	14.7	17.7	15.6	28.8	21.0	18.5	12.9	13.5	19.9	12.0	15.9	16.9	22.8	28.5	17.1	22.8	15.6	12.6	13.8	23.6	19.1	15.0	12.2	13.5	20.4	26.9	11.9	13.0	40.3	10.7	10.9	27.7	14.1	11.7	16.3	11.8	3.2	6.7	28.4	6.7	4.9	4.4	3.2	10.3	5.9	10.2	12.7	10.0	15.3	16.8	13.9	16.6	7.8	7.8	2.0	9.1	6.3	14.1	14.7	4.8	12.2	3.4	15.4	11.7	0.0	3.1	9.3	6.3	3.3	15.2	36.7	9.0	13.1	11.8	5.2	32.3	9.5	14.9	0.0	7.8	0.0	12.7	9.6	0.0	6.4	17.0	18.3	6.6	0.0	20.1	3.1	8.5	16.4	8.5	10.6	19.7	8.7	14.2	8.5	12.3	12.4	18.2	31.8	4.2	5.9	5.8	12.1	15.5	0.1	12.8	4.6	13.6	28.4	5.3	9.7	2.5	6.7	3.3	2.2	3.2	2.4	6.7	3.2	3.4	2.9	0.8	4.9	4.7	4.7	4.4	3.2	18.7	24.4	6.1	17.0	15.6	28.8	19.9	12.0	22.8	10.7	17.9	9.3	4.5	10.1	10.1	10.9	23.6	20.4	25.4	20.5	14.0	2.0	25.1	31.5	14.4	11.8	15.3	11.3	0.0	19.5	18.0	20.0	11.5	19.7	29.8	23.9	4.8	15.0	19.6	14.8	14.8	15.0	15.2	18.6	17.2	28.0	35.3	16.5	0.0	25.5	38.3	11.1	12.9	18.5	84.6	69.0	12.7	13.7	10.0	20.0	9.0
IMPAD1	"FLJ20421, gPAPP, IMPA3"	ENSG00000104331	"Inositol monophosphatase domain containing 1"	Q9NX62	8	56957933-56993844	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		560000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	30.6	33.9	17.8	13.9	23.7	9.6	17.6	23.6	33.1	24.7	17.7	30.9	17.8	11.7	23.2	15.2	17.7	15.6	18.0	25.2	19.9	21.6	21.3	32.6	16.5	10.3	23.6	21.1	16.0	25.2	30.4	20.4	23.3	27.2	28.8	16.2	25.2	28.7	22.5	41.4	13.4	12.3	23.0	21.7	13.0	14.7	19.0	19.5	12.0	24.4	18.1	13.0	17.2	14.9	1.9	2.0	6.1	4.6	6.8	2.4	0.6	17.4	14.5	11.2	11.5	34.5	23.7	15.4	26.6	25.9	19.1	16.7	7.2	12.5	10.9	20.4	28.2	13.6	14.3	13.5	17.9	28.4	15.0	9.7	21.3	10.3	12.9	21.5	13.5	15.2	19.0	18.0	17.1	27.8	17.7	25.3	10.3	9.1	19.9	20.9	9.3	16.4	8.1	8.3	20.0	5.4	11.5	10.1	12.3	19.8	10.4	4.3	12.2	14.9	18.4	15.1	12.3	16.4	9.9	21.1	25.9	14.9	25.5	19.0	20.5	17.1	11.7	35.4	11.3	15.8	2.9	1.9	1.1	2.0	1.2	1.6	1.3	1.3	1.2	1.4	1.9	1.5	2.4	6.1	6.8	4.6	2.0	0.9	0.6	17.8	23.7	23.6	33.1	19.9	21.6	23.6	21.1	27.2	19.5	20.8	18.6	9.0	24.5	48.3	29.9	43.1	25.5	8.1	12.5	45.4	15.7	15.1	5.0	17.1	13.5	27.0	19.0	0.0	23.5	68.2	45.0	43.5	9.2	61.6	24.1	38.1	33.4	38.1	25.6	4.2	23.6	23.8	15.1	5.4	33.4	25.1	24.0	17.5	33.6	16.8	27.4	32.3	38.9	34.6	22.2	52.2	28.3	14.9	16.0	33.9
INA	"NEF5, NF-66"	ENSG00000148798	"Internexin neuronal intermediate filament protein alpha"	Q16352	10	103277163-103290351	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 65.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 51.8;Cone photoreceptor cells: 21.6;Early spermatids: 34.2;Horizontal cells: 42.9;Late spermatids: 14.9;Rod photoreceptor cells: 32.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 21.1;SCLC-21H: 41.4;SH-SY5Y: 23.6;SiHa: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002059, HPA007572, HPA008057"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833"	"unprognostic (1.77e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	1.5	15.7	16.6	2.6	21.3	1.3	1.3	26.9	65.2	1.3	2.7	2.3	0.0	2.0	1.3	1.4	1.9	1.3	1.5	1.3	13.2	34.0	1.3	1.4	1.5	1.4	27.2	17.7	1.3	3.6	1.3	12.8	1.5	65.4	1.5	2.8	5.5	1.3	1.4	1.3	2.2	2.5	2.2	7.9	1.3	2.6	4.1	3.3	0.0	1.5	0.0	1.5	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	4.7	0.0	0.0	0.0	7.7	5.2	1.3	1.2	0.1	0.0	0.0	0.0	2.2	0.3	0.6	0.7	4.3	0.0	0.3	9.4	1.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	5.1	0.0	21.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	41.4	23.6	28.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	21.3	26.9	42.0	13.2	34.0	27.2	17.7	65.4	3.3	0.0	0.0	0.0	0.1	0.2	51.8	0.4	0.0	0.0	0.0	0.0	21.6	0.2	0.0	0.1	34.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	42.9	7.5	0.0	0.0	14.9	0.3	0.0	0.0	0.0	0.0	7.6	0.7	0.0	0.4	0.0	32.4	0.0	0.0	4.3	3.8	0.4	0.1	0.0	0.0	0.6
INCA1		ENSG00000196388	"Inhibitor of CDK, cyclin A1 interacting protein 1"	Q0VD86	17	4988130-4997610	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 41.6"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 105.7;Late spermatids: 240.7;Spermatocytes: 81.7;Spermatogonia: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044359, HPA052401"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA044359: AB_10794289, HPA052401: AB_2681816"	"unprognostic (1.78e-2)"	"unprognostic (9.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-2)"	"prognostic favorable (3.61e-5)"	"unprognostic (3.14e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	1.7	2.2	5.5	3.5	6.3	0.5	2.5	10.1	7.2	2.3	2.2	3.1	1.0	7.0	3.3	1.6	3.1	2.0	4.5	3.9	4.9	2.1	2.3	2.6	2.7	5.0	5.1	3.0	5.5	2.2	0.9	4.4	1.6	5.9	2.7	0.3	1.7	3.6	1.5	6.1	5.0	4.9	1.2	4.1	4.3	3.1	41.6	3.6	0.5	5.2	1.3	0.4	2.8	9.4	1.5	1.3	0.7	4.4	0.3	2.4	0.6	4.0	4.6	3.3	3.0	2.2	0.9	3.9	4.4	0.4	1.2	1.2	3.2	4.8	19.1	2.9	1.2	3.8	11.4	0.5	0.2	0.7	8.0	4.8	4.1	5.5	2.1	1.5	0.6	10.2	1.2	0.0	0.7	0.4	7.1	0.4	6.8	5.1	9.0	0.8	2.1	5.8	1.3	1.4	1.8	1.2	7.1	1.7	1.7	0.8	1.3	9.7	2.9	2.1	2.8	2.6	3.6	5.7	0.9	8.8	4.1	1.6	3.9	3.3	1.5	0.8	0.9	4.0	10.2	2.1	0.5	2.4	0.0	0.8	4.4	2.0	1.5	1.2	1.7	0.9	1.0	2.4	1.9	0.7	0.3	3.4	1.3	0.7	0.6	5.5	6.3	10.1	7.2	4.9	2.1	5.1	3.0	5.9	3.6	0.0	0.6	0.5	1.2	1.0	0.4	0.5	2.5	1.4	1.2	3.5	2.0	0.5	0.0	0.6	105.7	0.6	6.8	0.0	1.4	0.6	1.4	0.5	4.6	1.3	1.2	0.0	0.0	0.6	0.0	240.7	6.6	1.2	1.7	1.0	1.6	4.6	1.1	7.0	1.1	1.7	0.8	6.5	1.2	81.7	50.4	0.6	0.7	0.0	1.8	0.9
INF2	"C14orf151, C14orf173, MGC13251"	ENSG00000203485	"Inverted formin, FH2 and WH2 domain containing"	Q27J81	14	104689606-104722535	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 200.6"					HPA000724	Approved		Approved	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		15000000	"Endoplasmic reticulum"	"Nuclear bodies"	"HPA000724: AB_1078325"	"unprognostic (1.42e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (7.24e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.70e-2)"	34.7	13.1	14.4	17.8	49.9	12.7	20.2	4.4	37.9	13.3	27.0	70.2	6.1	43.1	12.8	6.3	12.5	9.3	26.5	14.1	19.7	12.6	17.9	21.3	22.2	15.0	66.2	22.5	7.7	14.8	4.1	4.7	28.0	28.5	13.2	13.2	18.8	15.4	16.3	10.0	23.9	36.5	10.7	36.8	24.4	48.2	18.1	54.6	3.2	11.7	9.8	9.1	16.8	15.5	3.1	11.0	2.3	3.3	2.0	5.3	4.8	17.5	35.8	3.2	7.9	6.6	8.5	47.3	19.3	10.1	10.7	8.0	13.1	39.4	2.5	21.5	13.7	9.0	26.7	4.0	18.9	4.1	7.4	9.7	9.1	24.7	12.9	13.8	2.8	8.8	8.0	10.7	10.1	7.0	10.2	12.6	4.8	4.3	8.9	10.0	39.6	3.4	7.1	8.0	20.5	38.3	14.9	10.7	6.9	13.4	23.9	9.1	4.3	15.7	29.8	10.1	7.0	10.2	6.5	22.3	13.4	9.4	25.8	10.8	3.1	1.4	1.3	23.1	7.9	14.5	1.3	3.3	0.2	1.6	1.1	0.8	3.1	5.3	1.1	4.1	3.1	4.4	2.9	2.3	2.0	0.7	11.0	5.3	4.8	14.4	49.9	4.4	37.9	19.7	12.6	66.2	22.5	28.5	54.6	59.6	14.9	14.7	12.9	20.1	0.2	10.6	40.8	1.4	10.3	3.5	0.0	47.0	5.0	20.7	0.9	24.8	131.6	0.0	21.8	69.2	16.9	24.0	14.9	24.2	28.8	0.0	16.7	24.5	19.1	0.9	5.2	16.4	8.5	19.0	64.2	52.5	41.8	50.4	4.2	6.4	1.8	32.3	28.1	0.9	3.8	16.4	26.4	5.7	33.0	24.4
ING1	"p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a"	ENSG00000153487	"Inhibitor of growth family member 1"	Q9UK53	13	110712736-110723339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 141.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016136, CAB017773, HPA052591"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016136: AB_628077, CAB017773: , HPA052591: AB_2681876"	"unprognostic (1.14e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (5.81e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.40e-3)"	11.8	11.1	8.9	11.7	10.2	24.9	19.8	12.8	12.1	15.7	14.9	6.9	9.5	13.9	16.3	8.3	10.7	13.7	20.0	9.5	9.4	9.0	9.3	16.7	14.1	20.5	11.6	8.0	25.8	11.8	3.8	9.5	13.3	11.7	13.3	6.6	9.5	13.6	10.9	12.2	8.5	13.6	11.1	10.2	17.6	10.0	26.0	12.0	22.0	11.5	8.3	10.6	18.3	14.8	15.5	3.0	21.4	3.7	12.3	11.6	6.1	17.6	7.0	12.7	12.1	6.0	4.1	12.7	9.1	7.7	5.9	7.2	13.3	12.6	11.4	14.9	3.6	9.2	11.2	5.1	4.5	5.0	21.3	9.7	10.0	9.7	9.9	3.4	13.2	9.7	3.7	4.7	5.1	3.1	4.7	4.1	12.4	9.3	9.6	3.8	10.1	22.8	15.3	12.4	11.0	5.9	16.6	6.4	6.4	5.1	9.1	12.5	13.5	9.0	18.1	12.5	4.6	6.1	15.7	6.2	7.3	9.0	7.6	10.2	11.6	11.7	14.5	12.2	10.9	11.9	21.4	2.9	11.1	10.8	3.6	11.1	14.8	9.1	9.7	2.8	15.5	9.4	7.8	4.0	12.3	3.7	3.0	11.6	6.1	8.9	10.2	12.8	12.1	9.4	9.0	11.6	8.0	11.7	12.0	8.9	22.6	17.6	10.5	32.3	15.2	21.4	10.2	21.4	6.8	7.0	13.7	11.0	6.6	9.1	141.8	18.0	28.4	0.0	6.0	70.2	33.8	19.5	2.3	22.9	14.7	3.2	12.0	9.8	17.1	32.8	8.6	12.7	16.9	6.4	20.1	14.5	6.8	19.3	13.8	11.1	20.2	12.9	25.0	17.0	16.6	38.1	12.8	13.1	18.4	17.1
INHA		ENSG00000123999	"Inhibin alpha subunit"	P05111	2	219569162-219575713	"Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 276.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"basal ganglia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;HEL: 5.6;SK-BR-3: 12.8;SuSa: 6.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB000047, HPA019141, HPA048834"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA			Vesicles	"Golgi apparatus"	"CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: "	"unprognostic (8.90e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.61e-3)"	"unprognostic (4.15e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (4.85e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	0.5	24.2	0.8	0.5	8.4	0.0	0.5	1.7	0.9	0.5	0.5	1.4	0.5	0.0	0.5	1.2	0.5	0.6	0.6	4.8	0.8	0.9	0.5	0.5	0.5	0.5	0.5	0.6	31.5	6.5	0.2	1.5	39.3	0.6	0.5	0.0	0.5	0.9	0.7	0.5	1.1	0.5	0.5	0.5	0.5	0.1	77.6	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	2.5	0.8	0.2	4.5	0.5	0.4	0.7	0.2	0.3	4.3	0.0	0.3	1.0	0.7	2.6	0.3	0.7	0.0	0.0	0.8	5.6	2.0	3.0	0.4	0.0	0.0	0.9	1.3	0.0	0.7	2.5	0.0	0.0	3.3	0.0	0.1	3.0	0.0	0.2	1.7	0.2	1.1	0.1	0.2	0.0	0.7	0.3	0.4	1.0	1.6	12.8	0.4	6.6	0.8	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	8.4	1.7	0.9	0.8	0.9	0.5	0.6	0.6	0.5	0.0	0.0	0.0	0.1	0.0	3.4	1.4	0.0	0.0	0.0	7.0	2.0	6.0	0.0	1.5	0.7	0.0	0.0	0.0	7.9	29.6	0.2	0.0	0.0	0.0	2.3	6.4	0.0	1.3	0.3	4.1	3.7	0.0	0.0	0.0	0.0	3.3	3.3	0.0	1.4	0.0	0.0	0.0	0.0	1.1	0.4	0.0	276.8	0.0	0.0	0.0
INMT		ENSG00000241644	"Indolethylamine N-methyltransferase"	O95050	7	30697985-30757602	"Enzymes, Predicted intracellular proteins"	Detoxification	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 73.5"	"Group enriched"	"Detected in many"	10	"Ito cells: 257.8;Leydig cells: 264.1;Peritubular cells: 428.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"CACO-2: 18.7;HHSteC: 8.0"									HPA061343			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA061343: AB_2684483"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-4)"	"prognostic favorable (5.72e-4)"	"unprognostic (3.08e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.58e-2)"	19.7	18.0	0.3	3.0	0.7	0.0	5.9	0.3	0.6	4.9	3.7	1.3	14.0	0.8	9.8	18.9	12.4	16.3	14.7	24.6	0.6	0.4	11.8	24.3	73.5	12.1	1.1	0.8	20.2	4.0	0.7	3.2	12.9	2.5	10.1	1.6	13.0	6.1	19.9	4.7	1.5	3.9	11.3	1.3	6.5	5.0	28.2	0.2	0.5	9.4	3.8	2.8	9.6	6.4	1.7	1.1	4.2	1.0	2.2	1.0	0.6	0.0	0.1	0.1	0.1	1.8	2.6	0.4	0.2	2.4	0.0	0.0	18.7	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	8.0	0.1	0.3	0.9	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.3	0.3	0.1	0.0	0.4	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.6	0.1	0.8	0.0	0.8	0.2	0.1	1.1	0.1	0.8	0.3	0.1	0.8	0.3	0.1	0.2	0.1	0.3	4.2	1.0	0.8	0.7	0.4	0.7	1.2	0.7	0.6	0.4	1.7	1.0	0.8	3.0	2.2	0.4	1.1	0.6	0.6	0.3	0.7	0.3	0.6	0.6	0.4	1.1	0.8	2.5	0.2	0.0	5.1	0.0	0.2	1.9	0.0	7.8	2.5	1.4	4.5	0.0	0.0	0.5	0.0	0.0	1.3	9.7	0.0	0.0	0.0	0.2	21.8	0.2	0.0	3.0	0.7	0.0	1.2	257.8	19.4	8.5	264.1	0.5	3.3	0.0	0.0	0.0	0.0	0.0	428.2	0.0	0.0	32.3	16.0	1.4	1.4	1.9	1.5	0.0	0.0	0.3
INO80C	"C18orf37, FLJ38183, hIes6, IES6"	ENSG00000153391	"INO80 complex subunit C"	Q6PI98	18	35452230-35497991	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 65.5"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 123.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA049060	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA049060: AB_2680617"	"unprognostic (3.40e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (5.56e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.14e-3)"	"unprognostic (5.38e-2)"	6.7	7.7	12.4	13.0	16.7	19.4	7.8	10.9	11.0	7.1	10.6	7.3	4.5	8.7	6.4	7.1	20.1	6.8	10.4	11.8	10.8	12.9	9.5	9.9	8.4	11.3	7.9	9.2	4.6	5.7	2.7	17.8	26.3	8.0	6.0	10.8	11.5	13.2	5.2	18.2	19.8	11.7	5.3	6.7	14.2	15.0	65.5	8.1	11.1	9.1	19.2	13.5	8.2	10.5	17.5	23.9	24.5	14.3	8.1	14.9	8.2	15.9	10.4	9.5	5.1	3.4	8.7	10.5	6.2	4.6	9.7	13.1	12.8	13.6	26.2	13.3	4.0	14.9	11.1	18.2	39.4	8.8	7.6	9.9	33.4	12.6	13.8	7.6	19.2	21.4	3.8	11.4	25.2	13.7	12.1	28.0	11.3	10.0	9.8	15.6	16.5	12.3	16.4	12.3	11.0	6.3	9.6	6.7	8.8	20.3	20.5	13.3	9.1	10.3	11.2	7.7	15.6	11.0	15.5	18.6	11.1	4.9	8.6	11.1	8.7	9.1	46.6	9.0	17.8	6.6	13.9	11.1	24.5	9.4	14.3	9.2	17.5	13.1	12.2	15.8	13.0	13.3	11.0	17.0	8.1	12.4	23.9	14.9	8.2	12.4	16.7	10.9	11.0	10.8	12.9	7.9	9.2	8.0	8.1	6.0	8.5	29.2	18.4	21.3	4.3	13.2	12.7	24.1	10.3	12.2	3.9	51.3	26.6	30.2	123.3	22.4	45.2	0.0	34.8	86.5	15.8	17.9	19.7	16.8	44.0	4.8	14.5	16.5	18.1	32.1	5.8	12.8	21.9	10.8	19.5	16.3	101.7	31.6	6.7	65.2	13.1	0.0	14.5	85.2	40.5	34.9	61.2	11.7	32.2	29.2
INPP1		ENSG00000151689	"Inositol polyphosphate-1-phosphatase"	P49441	2	190343470-190371665	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 658.4;Late spermatids: 591.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036698, HPA036699"	Supported		Approved	"Centriolar satellite,Cytosol"		NA	NA		15000	"Centriolar satellite"	Cytosol	"HPA036698: AB_10672226, HPA036699: AB_2675260"	"unprognostic (1.08e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.12e-5)"	"prognostic favorable (5.70e-4)"	14.9	25.8	18.3	9.1	26.5	10.3	32.5	17.4	25.1	15.0	19.8	20.4	11.5	27.4	12.0	10.8	42.7	9.8	20.6	17.7	21.2	17.9	11.0	24.8	19.9	8.8	21.0	16.5	10.0	25.6	32.3	17.0	10.4	18.6	10.0	16.8	12.0	9.9	16.0	13.1	28.3	28.0	15.5	23.6	15.7	13.9	31.4	17.1	4.6	12.9	14.0	15.4	19.2	18.8	1.8	3.5	36.6	3.4	6.2	8.0	1.9	10.9	3.1	6.0	0.0	6.5	14.1	0.1	13.2	17.6	12.4	16.3	11.9	7.0	0.0	15.8	12.6	4.0	15.2	2.4	8.5	15.2	13.5	4.6	8.2	9.7	7.1	13.8	6.1	2.6	9.6	13.1	14.1	8.2	8.9	23.1	0.1	19.6	6.9	21.8	0.0	0.4	5.8	1.8	17.5	17.0	0.2	4.9	0.1	9.6	26.1	8.9	3.3	9.1	0.5	12.8	6.5	0.0	8.8	21.3	7.9	5.6	14.2	7.6	1.3	1.4	0.1	2.5	2.4	6.3	8.1	3.4	36.6	3.0	3.1	2.7	1.4	1.9	2.0	3.5	1.8	1.0	1.5	1.6	6.2	1.8	0.1	8.0	1.9	18.3	26.5	17.4	25.1	21.2	17.9	21.0	16.5	18.6	17.1	3.0	5.6	13.4	129.9	76.7	14.5	19.3	28.1	8.1	20.5	10.4	5.9	5.3	6.6	24.1	658.4	50.2	44.8	0.0	75.1	2.7	22.1	67.5	8.1	17.8	8.6	15.9	29.9	60.2	6.9	591.7	24.7	15.4	25.3	5.4	20.3	68.5	42.2	20.4	22.3	14.6	11.6	25.8	20.2	15.3	7.6	85.1	3.3	17.0	22.6	190.1
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 163.6;Late spermatids: 196.7;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 19.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 9.1;T-cells: 19.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 52.6;SK-MEL-30: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	15.4	4.7	8.4	8.5	12.5	2.2	21.2	5.1	10.3	28.1	7.1	1.8	5.6	5.0	19.7	18.4	9.1	9.2	8.7	18.4	5.9	6.1	6.1	2.0	9.9	10.8	5.5	8.9	15.4	4.0	2.3	3.8	6.2	4.6	8.3	5.8	1.7	4.9	6.8	10.8	4.7	7.3	10.2	3.1	7.0	7.0	19.6	2.4	8.2	6.5	4.9	7.4	15.8	14.6	0.0	0.0	2.2	0.1	9.1	19.2	3.7	9.3	3.9	2.6	1.2	2.0	1.2	0.5	11.3	13.3	2.9	5.5	1.0	52.6	0.2	3.2	10.1	4.5	14.3	0.0	13.2	6.9	0.0	0.4	2.2	1.5	0.0	0.6	0.4	1.8	2.1	1.8	2.0	7.0	8.8	1.6	0.0	0.0	0.5	6.3	16.7	0.3	0.0	0.1	5.7	2.8	0.1	8.7	0.4	4.0	17.4	0.2	0.2	1.3	4.0	23.4	1.6	12.0	1.6	1.0	6.7	8.2	9.9	0.1	0.1	0.0	0.0	1.5	10.3	17.4	2.2	0.1	0.0	3.3	0.0	6.5	0.0	19.2	8.5	0.0	0.0	13.2	5.7	0.2	9.1	0.0	0.0	9.8	3.7	8.4	12.5	5.1	10.3	5.9	6.1	5.5	8.9	4.6	2.4	0.0	1.1	0.0	9.8	6.0	7.3	36.2	7.6	17.4	9.1	8.7	0.0	1.4	5.0	12.2	163.6	10.8	8.4	0.0	26.9	3.9	4.1	13.4	5.8	0.0	6.2	6.4	8.5	3.7	4.4	196.7	12.7	1.9	69.2	0.0	3.4	0.8	47.4	0.0	6.0	0.8	0.6	84.1	43.7	3.1	2.0	2.3	1.6	16.6	3.4	41.0
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537820-132783480	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	13.6	11.8	10.3	11.3	49.8	5.8	10.3	40.7	20.8	17.4	24.0	10.1	11.5	12.9	25.8	13.9	20.3	15.2	13.6	48.8	9.5	8.5	9.4	7.2	13.8	6.0	9.2	10.4	13.1	11.6	8.9	9.4	19.0	9.1	17.1	11.7	17.1	8.5	16.9	43.7	11.5	14.8	27.9	10.6	8.9	14.8	14.9	16.6	4.2	9.5	12.1	7.8	19.4	22.4	0.3	0.1	8.4	0.2	0.0	0.3	0.6	18.7	7.5	12.6	12.1	19.3	13.6	10.3	19.9	15.3	13.0	8.7	17.7	7.7	1.7	7.7	21.1	8.5	10.7	13.6	8.3	15.7	5.7	7.9	2.7	9.4	24.0	14.0	6.8	6.6	9.2	8.3	8.3	15.9	10.5	9.0	3.6	3.9	10.1	6.9	15.2	1.9	21.9	5.7	11.3	13.4	4.0	8.3	3.0	10.8	10.7	3.0	10.3	9.9	14.7	12.0	12.0	9.5	16.5	7.5	8.4	9.7	11.2	11.6	2.0	9.3	5.8	8.1	4.7	3.6	8.4	0.2	1.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.0	1.5	0.0	0.2	0.0	0.3	0.6	10.3	49.8	40.7	20.8	9.5	8.5	9.2	10.4	9.1	16.6	8.9	22.4	1.4	3.6	4.7	10.7	9.0	5.1	2.7	9.1	7.0	0.0	3.3	0.0	5.7	9.4	6.4	18.4	0.0	7.9	3.3	6.2	6.4	8.1	16.0	2.6	7.9	5.8	19.0	6.3	11.2	6.6	3.1	1.7	0.0	9.3	7.8	9.9	11.5	11.0	3.8	4.9	6.5	20.0	5.5	6.6	5.1	2.1	1.9	10.9	5.0
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 58.1;Kupffer cells: 48.3;T-cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.4;HEL: 31.9;HMC-1: 33.5;hTCEpi: 30.7;NB-4: 29.9;THP-1: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016300, HPA070455"	Enhanced		Approved	Cytosol		No	No			Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	7.1	3.1	7.2	33.0	10.7	24.6	4.7	1.7	6.9	3.6	3.7	12.5	0.7	3.5	4.1	2.9	3.3	3.3	6.7	3.2	6.6	9.1	5.1	3.3	8.0	26.1	8.8	2.6	1.9	2.1	1.6	3.4	7.4	7.6	4.5	4.5	3.3	18.8	3.0	1.9	3.4	15.8	3.4	17.6	40.9	4.1	2.4	9.5	16.7	3.1	3.4	32.3	6.2	3.5	14.5	12.0	10.5	18.2	11.9	16.7	14.0	0.0	0.0	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	5.1	0.0	31.9	0.0	3.0	0.2	9.6	33.5	0.6	30.7	0.1	3.4	0.1	4.4	0.9	0.1	2.8	0.1	0.0	4.4	29.9	1.0	0.0	0.0	9.3	0.0	2.2	0.0	1.8	0.0	0.0	0.0	0.6	0.0	4.1	0.0	21.4	3.6	0.0	0.5	0.0	0.0	0.0	1.7	9.2	0.0	12.4	0.0	9.8	9.8	10.5	16.7	15.8	11.4	14.5	7.5	12.3	12.0	13.9	6.3	8.8	9.9	11.9	18.2	6.0	10.2	14.0	7.2	10.7	1.7	6.9	6.6	9.1	8.8	2.6	7.6	9.5	3.0	25.7	58.1	1.2	1.4	0.1	3.2	2.5	4.0	4.5	3.5	0.0	0.4	0.0	0.3	12.8	17.5	0.0	0.0	0.4	0.6	1.0	0.4	14.0	1.3	24.6	0.0	0.0	13.5	48.3	10.6	0.0	20.7	0.0	13.6	0.2	0.0	0.2	0.9	1.1	0.3	0.0	0.0	1.2	0.4	0.7	1.0	0.9	51.0	0.4	1.0
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.2;thyroid gland: 71.2"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 33.2;Enterocytes: 31.9;Muller glia cells: 20.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 12.3;SK-BR-3: 26.8;T-47d: 16.9;U-698: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034539			Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favorable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	0.9	4.6	0.8	6.3	0.5	3.7	27.4	13.4	1.5	6.4	0.8	16.7	7.9	1.3	0.8	1.0	1.0	1.0	9.5	7.4	2.0	9.5	0.5	1.5	0.7	2.3	4.6	0.8	5.3	65.2	3.7	0.5	5.5	3.5	2.2	5.6	15.5	19.2	1.6	1.7	21.7	1.2	0.9	0.6	3.8	1.6	1.1	0.0	71.2	0.0	0.7	1.1	0.9	0.3	2.4	0.0	0.4	0.0	0.0	0.2	1.3	1.3	0.8	1.5	0.2	0.2	0.7	0.5	0.5	2.7	2.6	0.8	0.8	0.0	0.6	0.2	0.3	1.6	1.6	0.7	1.1	0.0	4.3	0.0	5.6	0.2	0.5	12.3	0.1	0.1	0.8	2.2	0.2	1.8	0.1	0.0	1.1	1.9	0.0	4.1	0.1	0.0	1.5	1.7	0.2	0.0	0.3	2.9	1.1	1.6	6.5	4.9	1.0	26.8	0.3	0.7	16.9	1.0	0.0	0.1	4.9	0.5	0.3	0.0	2.1	11.6	0.4	0.0	2.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	4.6	6.3	27.4	13.4	7.4	2.0	2.3	4.6	5.5	1.1	0.0	2.6	0.0	2.3	0.8	7.9	4.8	0.0	0.0	1.2	33.2	0.0	0.0	10.0	1.2	0.3	0.0	31.9	0.0	1.9	0.1	0.2	3.7	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	5.0	20.3	1.0	10.5	0.0	0.6	2.3	0.0	0.3	1.7	0.9	1.1	0.1	0.0	6.8	0.9
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239105	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	20.9	23.7	22.2	20.4	19.5	25.1	18.6	11.1	18.9	25.2	32.0	22.7	28.8	19.8	24.7	18.4	17.4	24.3	29.6	29.5	24.1	10.3	23.9	17.1	24.9	19.0	27.6	10.4	30.1	22.7	21.6	26.9	31.9	20.4	28.7	13.5	30.7	27.5	24.2	60.0	17.7	23.0	34.7	27.5	28.3	24.5	11.8	24.3	16.0	29.1	19.3	18.3	25.0	18.1	2.6	5.2	7.0	7.6	4.2	4.5	3.3	6.5	14.0	16.8	11.4	8.3	9.9	30.0	30.2	14.1	18.9	12.1	19.1	16.5	18.6	30.8	23.0	13.5	24.9	13.8	8.5	6.5	24.1	14.3	19.3	70.9	7.0	16.3	12.7	43.3	14.0	9.0	18.3	7.3	23.5	10.1	6.9	13.6	8.0	10.3	17.6	9.4	51.6	17.2	4.6	21.9	44.5	38.2	4.1	22.0	11.0	8.2	11.9	32.4	19.6	42.1	8.9	20.7	24.2	17.2	20.3	23.8	31.1	9.8	23.2	3.8	18.2	5.7	12.1	11.0	5.2	7.6	7.0	4.5	4.4	3.7	2.2	3.7	3.0	5.2	2.6	2.7	3.7	5.2	4.2	7.0	3.9	3.3	3.3	22.2	19.5	11.1	18.9	24.1	10.3	27.6	10.4	20.4	24.3	3.0	13.8	2.4	4.6	6.4	1.2	11.2	5.1	5.3	10.3	12.2	25.5	20.7	1.7	10.7	1.1	6.3	16.0	0.0	10.6	12.5	9.8	6.8	7.0	8.6	18.9	9.5	21.8	10.4	26.9	1.5	9.2	18.1	10.1	3.6	15.4	14.3	13.4	17.5	13.1	12.5	17.2	6.5	9.2	1.2	4.1	4.3	27.1	6.7	17.5	5.2
INSL4	EPIL	ENSG00000120211	"Insulin like 4"	Q14641	9	5231419-5235304	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"placenta: 88.0"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 2990.3"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"A549: 23.6"									HPA065145			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA065145: "		"unprognostic (9.77e-2)"						"unprognostic (2.02e-1)"		"unprognostic (4.66e-1)"				"unprognostic (7.74e-2)"				0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.2	0.0	0.1	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	88.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	23.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	269.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2990.3	0.0	0.0	0.0
INSM2	"IA-6, Mlt1"	ENSG00000168348	"INSM transcriptional repressor 2"	Q96T92	14	35534042-35537054	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.3;brain: 5.2;salivary gland: 1.6;testis: 2.9"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 2.0;Rod photoreceptor cells: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	134	"SH-SY5Y: 50.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.3"	"Low region specificity"	"Detected in some"			"HPA044885, HPA051925"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044885: AB_10794779, HPA051925: AB_2681664"	"unprognostic (9.88e-2)"	"unprognostic (8.74e-2)"			"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"		"unprognostic (3.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-3)"		"unprognostic (7.51e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.36e-3)"	"unprognostic (5.00e-1)"	0.3	2.3	1.0	0.5	2.8	0.2	0.3	0.5	5.2	0.2	0.2	1.0	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.8	5.0	0.2	0.2	0.3	0.2	1.9	1.2	0.2	0.2	0.2	0.1	0.2	2.7	0.2	0.2	0.7	1.6	0.2	0.2	0.4	0.2	0.2	0.4	0.2	0.2	2.9	0.2	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	50.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	0.5	4.6	0.8	5.0	1.9	1.2	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294034	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 64.5"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 230.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.3;U-266/70: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		72000	Vesicles	"Plasma membrane"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.9	14.7	7.1	3.5	8.2	4.5	12.0	12.0	8.2	10.3	15.2	11.7	10.6	8.4	15.5	6.1	4.7	13.1	7.7	17.7	6.4	5.8	18.7	32.5	5.3	2.2	10.1	4.9	28.3	64.5	11.6	11.6	26.2	8.0	10.5	8.9	11.0	12.0	10.6	15.1	7.3	16.0	10.6	6.8	47.3	8.7	6.9	9.7	2.2	17.1	5.0	3.2	11.3	16.0	1.1	8.8	5.1	10.5	0.8	0.7	1.3	3.8	2.1	2.0	3.0	10.9	3.8	6.5	2.2	2.0	1.2	1.2	5.4	4.4	4.8	5.4	3.9	2.6	1.0	4.7	1.0	0.7	0.0	3.8	0.0	1.5	11.8	4.7	2.2	3.9	5.9	2.4	0.1	2.8	2.4	2.2	2.7	5.9	31.3	0.9	1.7	1.7	3.9	1.8	2.0	3.4	16.7	1.1	4.2	0.1	15.8	3.7	2.9	3.9	2.1	2.1	3.7	1.0	11.0	2.0	2.3	1.4	4.9	2.8	23.1	12.6	11.2	2.6	3.9	0.0	2.0	8.2	5.1	0.2	7.8	0.3	0.8	0.3	0.1	8.8	1.1	0.7	0.1	1.7	0.8	10.5	7.4	0.0	1.3	7.1	8.2	12.0	8.2	6.4	5.8	10.1	4.9	8.0	9.7	44.7	26.7	8.2	54.6	57.7	38.7	85.3	107.0	41.5	50.0	59.3	74.6	15.8	13.3	41.1	2.9	52.3	87.1	0.0	68.2	39.2	29.8	84.0	3.5	214.7	8.6	36.5	157.1	201.3	47.7	3.6	89.2	26.7	49.0	8.2	103.9	26.9	67.8	56.1	230.5	116.2	22.2	58.2	42.3	6.2	1.2	60.1	32.0	6.4	56.3	113.2
INTS1	"DKFZp586J0619, INT1, KIAA1440, NET28"	ENSG00000164880	"Integrator complex subunit 1"	Q8N201	7	1470277-1504367	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021658, HPA053009"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021658: AB_1852402, HPA053009: AB_2682016"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (7.72e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (4.30e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.81e-3)"	15.4	14.6	17.8	16.1	17.2	28.5	15.2	26.5	28.1	12.2	14.5	19.2	10.1	19.0	15.0	11.0	15.8	13.3	14.4	13.0	13.5	11.0	13.8	13.8	12.0	18.2	13.5	10.1	18.2	23.0	11.6	15.8	12.6	15.2	14.7	6.0	15.6	25.6	14.5	43.3	20.4	17.6	15.1	10.0	19.3	17.9	27.3	14.0	18.0	15.9	10.8	14.9	13.7	14.8	6.0	3.7	4.4	2.7	3.1	4.8	2.1	20.6	18.0	7.0	18.2	5.2	4.0	24.5	8.8	4.9	6.8	6.0	19.8	16.1	11.1	9.3	6.3	13.7	21.4	3.9	10.4	1.9	5.4	21.7	7.9	25.6	13.0	6.0	13.7	11.9	5.4	4.9	7.0	5.0	4.1	7.4	15.9	22.0	8.9	4.1	25.0	7.7	37.6	38.5	7.6	16.2	19.6	8.0	11.3	3.2	15.7	13.3	32.8	12.6	23.2	8.0	4.2	18.4	13.8	13.6	11.2	32.2	9.3	14.3	18.7	9.8	10.8	12.6	11.9	22.9	4.4	2.7	2.9	4.8	2.1	3.0	2.7	3.5	3.8	3.7	6.0	2.2	2.8	2.2	3.1	1.8	2.1	4.2	2.1	17.8	17.2	26.5	28.1	13.5	11.0	13.5	10.1	15.2	14.0	11.9	29.1	6.0	4.2	5.3	30.1	38.9	20.4	4.0	9.1	10.4	23.6	10.7	0.0	14.5	18.4	11.3	33.3	0.0	19.9	8.3	10.3	8.7	1.1	21.2	12.9	46.1	17.3	16.5	23.4	32.2	12.4	11.6	5.0	8.2	18.2	15.8	17.3	15.6	14.5	12.9	36.0	25.8	8.2	19.4	11.0	6.9	12.7	10.1	20.1	5.4
INTS10	"C8orf35, FLJ10569, INT10"	ENSG00000104613	"Integrator complex subunit 10"	Q9NVR2	8	19817140-19852083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039129, HPA050570"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA039129: AB_10794424, HPA050570: AB_2681180"	"unprognostic (9.11e-2)"	"unprognostic (8.41e-3)"	"prognostic favorable (4.00e-4)"	"prognostic favorable (1.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.33e-1)"	21.9	20.9	31.4	18.9	30.2	22.8	23.5	38.5	28.4	23.7	23.2	23.2	19.9	21.3	18.8	17.4	21.8	31.4	17.0	20.9	31.1	27.1	25.0	42.7	19.2	21.9	28.3	18.4	21.6	39.1	18.1	25.5	18.0	21.2	24.5	22.2	17.3	23.2	26.0	20.7	25.7	19.5	22.0	28.7	21.4	19.4	12.0	24.3	26.9	34.9	21.1	25.0	20.8	23.7	17.8	20.0	8.8	15.0	16.9	21.2	12.6	15.0	22.0	12.1	15.8	18.2	20.4	16.6	11.0	18.7	15.4	14.7	12.2	7.6	42.4	19.4	12.0	16.7	16.2	14.3	14.1	17.3	8.4	16.1	19.6	24.6	23.7	13.5	16.9	13.6	16.2	22.3	11.5	17.9	9.6	14.7	24.5	23.6	34.1	10.4	13.1	30.5	20.2	17.2	33.5	12.0	16.5	14.6	27.5	19.1	23.4	12.4	9.8	15.5	19.4	13.6	11.7	10.1	17.3	12.0	9.8	14.1	23.0	15.3	9.6	12.2	32.1	20.0	23.9	16.1	6.6	15.0	8.8	13.9	13.8	21.2	17.8	17.8	17.5	20.0	15.1	19.9	17.6	5.4	16.9	11.5	17.0	19.9	12.6	31.4	30.2	38.5	28.4	31.1	27.1	28.3	18.4	21.2	24.3	14.9	45.6	29.2	34.7	33.4	56.9	17.3	35.7	92.3	43.3	19.2	49.1	29.7	29.9	37.3	45.1	29.2	27.1	0.0	34.7	39.2	34.7	41.9	34.6	51.9	36.5	66.7	19.5	28.8	32.4	20.0	32.2	27.8	16.9	22.6	31.4	31.4	30.6	24.6	32.9	30.0	84.8	12.9	31.5	8.1	27.2	39.4	18.7	35.8	39.8	27.6
INTS13	"ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30"	ENSG00000064102	"Integrator complex subunit 13"	Q9NVM9	12	26905181-26938326	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 20.8;Extravillous trophoblasts: 13.8;Hofbauer cells: 13.1;Pancreatic endocrine cells: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039543, HPA040109, HPA073020"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA039543: AB_10795150, HPA040109: , HPA073020: "	"unprognostic (2.09e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (1.17e-10)"	"unprognostic (5.22e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.78e-2)"	10.0	20.9	10.5	11.5	14.7	15.3	11.5	11.4	11.4	10.5	10.0	22.3	4.6	9.0	10.6	10.4	14.1	8.1	7.5	10.2	12.3	9.8	12.6	14.3	8.0	14.1	18.8	7.4	9.2	11.9	9.3	17.6	9.2	22.4	10.1	10.4	8.9	9.4	6.6	16.9	11.4	8.5	11.6	30.2	17.9	14.1	10.9	14.1	26.6	10.7	11.6	15.1	16.9	9.6	7.4	6.8	5.1	5.4	16.4	18.7	7.1	9.4	10.5	6.4	13.6	9.2	14.8	9.1	13.2	8.0	12.5	14.2	15.7	12.6	24.0	13.9	7.3	12.4	13.6	15.6	12.4	21.3	11.0	9.6	18.7	13.0	12.9	16.5	31.7	11.6	8.1	9.6	20.4	43.4	16.6	16.2	10.6	19.8	9.5	13.7	10.9	16.6	58.3	27.8	13.0	18.9	11.7	18.7	32.1	10.7	8.7	5.1	4.9	11.6	9.2	13.3	23.2	12.5	6.9	10.6	14.9	11.0	24.9	16.0	4.9	5.6	35.1	9.9	22.0	10.4	4.2	5.4	5.1	10.5	3.7	15.5	6.8	13.1	12.9	6.8	7.4	9.4	11.5	1.8	16.4	3.2	4.6	18.7	7.1	10.5	14.7	11.4	11.4	12.3	9.8	18.8	7.4	22.4	14.1	20.8	8.5	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.5	5.2	0.0	10.1	3.3	12.3	0.0	0.0	0.0	0.0	10.4	13.8	0.0	0.0	7.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	10.0	0.0	0.0	13.3	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0
INTS14	"C15orf44, DKFZP564O1664, VWA9"	ENSG00000138614	"Integrator complex subunit 14"	Q96SY0	15	65578753-65611289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 32.4;Extravillous trophoblasts: 24.9;Syncytiotrophoblasts: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040255, HPA040651"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria"		No	No			"Nucleoplasm, Nuclear bodies, Mitochondria"	"Nuclear membrane"	"HPA040255: AB_10805710, HPA040651: AB_10796559"	"unprognostic (2.92e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.30e-1)"	16.6	20.2	12.1	14.1	14.9	13.1	20.2	12.0	19.1	20.1	20.0	20.8	17.3	12.3	25.5	25.3	19.6	22.3	18.4	12.4	11.3	12.9	22.7	23.2	14.4	17.5	14.1	10.4	20.2	22.0	16.1	23.5	23.5	13.9	18.9	21.6	19.9	27.5	21.7	11.8	17.5	19.9	17.0	11.9	23.5	17.5	19.7	9.9	32.4	26.1	16.1	24.0	17.7	16.2	13.4	13.6	12.9	8.6	14.8	20.3	10.4	12.0	21.9	22.1	17.6	12.3	15.5	14.2	13.3	17.3	22.3	20.6	19.5	28.6	19.8	18.8	16.6	18.5	24.5	47.0	22.4	19.6	17.3	28.5	17.2	16.3	21.1	24.6	17.6	22.2	15.0	22.4	16.9	26.0	16.5	24.1	30.8	23.6	11.6	15.6	19.2	19.9	17.0	16.1	30.6	12.2	17.2	18.6	22.6	17.3	22.6	15.9	12.6	16.1	16.4	22.3	19.7	15.3	20.5	11.8	15.4	16.2	13.7	21.0	11.5	21.3	26.7	15.5	32.2	17.9	12.9	7.5	3.9	14.3	8.6	16.2	13.4	14.8	16.3	13.6	10.5	15.7	14.3	0.8	14.8	6.2	12.0	20.3	10.4	12.1	14.9	12.0	19.1	11.3	12.9	14.1	10.4	13.9	9.9	20.8	7.5	0.0	0.0	0.0	0.0	0.0	0.0	20.1	10.3	12.2	0.0	32.4	18.3	15.6	0.0	0.0	0.0	0.0	13.7	24.9	0.0	0.0	7.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	16.2	0.0	0.0	12.8	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	41.6	0.0	0.0	0.0
INTS3	"C1orf60, FLJ21919, INT3, SOSS-A"	ENSG00000143624	"Integrator complex subunit 3"	Q68E01	1	153728067-153774808	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074391	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli	Nucleoplasm	"HPA074391: AB_2686685"	"unprognostic (2.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (6.97e-3)"	"unprognostic (3.26e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.29e-2)"	16.2	21.9	18.8	14.4	20.0	12.0	16.3	20.7	23.1	20.4	19.9	19.5	25.1	10.0	24.4	23.7	14.3	26.7	20.5	15.3	16.0	10.6	17.9	11.1	16.6	12.6	15.9	16.4	30.8	17.5	23.6	23.6	16.5	15.6	15.9	11.4	16.1	14.0	31.0	16.2	16.9	14.7	21.2	13.4	15.4	17.6	16.5	16.0	16.2	18.6	9.2	14.1	19.9	18.8	1.8	3.8	2.7	6.2	2.7	2.5	1.5	13.2	13.9	10.1	14.5	11.5	13.0	10.3	10.1	7.3	12.1	9.8	9.7	12.6	11.5	20.3	13.3	7.2	13.5	19.3	13.0	9.9	12.1	11.3	7.2	21.2	4.6	7.8	10.7	13.0	11.7	6.5	10.4	9.5	11.0	11.6	8.6	10.1	9.4	9.3	10.8	10.0	5.7	12.4	15.3	12.9	13.6	5.7	7.4	6.2	17.4	8.0	11.7	9.6	23.2	6.4	14.7	13.4	14.5	8.5	12.0	5.2	11.8	9.1	8.4	7.7	12.7	13.1	6.6	8.3	1.3	1.8	2.0	2.1	1.4	2.5	1.3	1.3	2.0	3.8	1.8	1.4	1.5	2.7	2.7	6.2	0.8	1.3	1.5	18.8	20.0	20.7	23.1	16.0	10.6	15.9	16.4	15.6	16.0	20.8	21.4	8.8	8.7	9.3	22.5	4.0	10.2	13.4	10.3	29.6	19.6	11.5	0.0	10.1	12.1	12.6	8.1	0.0	7.1	11.7	11.9	9.9	5.7	13.6	10.7	20.6	11.6	27.0	11.8	5.9	8.9	14.3	6.8	13.6	16.1	19.3	9.6	10.8	11.3	12.4	23.9	25.8	9.0	9.3	13.0	8.9	8.6	7.7	12.2	11.2
INTS6	"DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2"	ENSG00000102786	"Integrator complex subunit 6"	Q9UL03	13	51354077-51454264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA001846"	Supported		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA001552: AB_1078659, HPA001846: AB_1847669"	"unprognostic (1.99e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.26e-2)"	13.3	13.7	12.9	14.4	14.6	11.3	23.9	23.8	15.8	12.5	11.9	10.6	17.4	9.5	12.1	10.9	16.4	10.3	12.3	13.0	14.1	8.9	11.1	24.5	13.6	15.7	16.9	9.1	14.6	44.2	14.4	24.1	11.5	13.2	12.2	9.5	8.5	12.3	19.2	10.6	13.3	13.9	12.2	12.3	11.4	12.9	46.4	17.8	21.7	13.0	9.5	13.4	12.3	15.9	6.1	6.5	7.8	2.8	6.7	9.2	3.2	7.7	6.1	14.9	7.1	8.5	18.4	9.9	15.0	15.0	15.9	11.9	7.9	19.3	9.6	3.4	12.6	9.9	13.9	19.4	9.3	23.6	17.4	5.6	16.6	9.9	9.6	20.8	19.7	16.0	13.5	18.1	16.5	26.2	21.5	14.7	13.5	11.1	14.2	17.3	6.0	13.7	15.0	11.3	22.5	7.5	9.4	10.0	7.5	12.6	5.1	8.9	9.5	15.7	12.3	12.0	12.7	7.1	22.5	10.2	8.6	7.0	10.1	9.8	13.9	8.8	14.8	7.7	11.8	14.6	7.3	2.8	4.2	7.9	1.8	8.9	4.9	5.9	7.1	2.8	6.1	8.4	9.2	7.8	6.7	2.0	6.5	6.3	3.2	12.9	14.6	23.8	15.8	14.1	8.9	16.9	9.1	13.2	17.8	23.8	43.8	51.1	45.0	67.9	60.8	71.8	43.3	12.0	20.5	21.0	111.9	60.8	13.3	19.6	64.4	45.0	74.9	0.0	22.6	39.9	44.2	57.5	48.4	31.6	30.7	42.9	72.9	63.8	51.1	64.5	40.9	38.9	21.9	23.4	75.3	60.6	22.3	52.1	29.7	9.9	77.1	25.8	47.4	97.7	42.2	63.2	61.7	60.9	65.3	59.9
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520643-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.2;Ciliated cells: 12.0;Club cells: 6.8;granulocytes: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 16.5;U-937: 15.3"									"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"		NA	NA			Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589"	"unprognostic (2.03e-1)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (2.94e-4)"	4.2	9.8	5.5	10.6	6.7	15.4	5.4	22.6	6.1	8.4	7.8	7.4	3.8	3.6	7.8	4.6	6.4	8.6	6.6	5.9	4.8	3.2	4.4	1.7	5.6	15.6	6.8	6.2	11.5	2.9	3.7	11.5	4.5	6.5	6.5	10.0	5.3	18.2	7.9	1.5	8.3	9.3	5.4	4.9	13.3	4.5	9.7	10.4	17.8	4.6	2.8	15.0	8.6	7.5	5.5	3.6	2.2	2.7	2.7	9.0	4.0	0.1	0.0	6.2	7.2	1.8	2.1	0.0	1.5	3.2	1.8	5.6	0.6	2.6	6.2	5.3	1.3	4.5	4.6	7.0	2.0	1.4	4.6	2.5	5.2	0.5	0.0	1.6	5.3	0.4	2.8	2.0	2.1	2.1	3.2	2.3	4.1	3.3	9.8	1.3	4.5	5.2	16.5	2.9	6.4	2.6	4.3	2.2	5.0	1.5	2.5	1.0	2.3	2.1	2.1	0.2	2.8	2.2	10.0	1.3	4.8	2.7	0.0	1.7	11.3	8.9	9.2	1.6	15.3	0.9	0.0	2.5	2.2	5.1	2.2	6.1	5.5	5.8	5.9	3.6	4.9	9.0	5.8	1.6	2.7	2.7	3.5	3.1	4.0	5.5	6.7	22.6	6.1	4.8	3.2	6.8	6.2	6.5	10.4	11.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	12.0	6.8	3.5	0.0	1.5	0.0	1.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	23.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
INTS8	"C8orf52, FLJ20530, INT8, MGC131633"	ENSG00000164941	"Integrator complex subunit 8"	Q75QN2	8	94813311-94881746	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057299	Approved		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA057299: AB_2683403"	"unprognostic (1.08e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.07e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.24e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-2)"	10.5	10.0	12.7	19.3	16.1	16.6	14.3	17.1	16.0	19.2	15.4	9.1	12.5	9.4	14.4	8.3	15.9	10.6	9.2	15.2	11.6	12.6	10.2	10.8	11.5	19.3	12.4	9.5	15.0	20.1	14.7	22.9	11.4	11.1	14.0	18.2	9.7	12.9	13.7	15.6	12.5	15.1	16.7	12.5	17.0	14.6	35.1	10.7	31.9	13.3	7.6	16.1	17.1	13.2	13.0	9.7	14.4	9.8	10.9	13.0	4.5	22.1	14.1	21.5	18.8	7.8	18.8	11.5	12.4	11.1	15.6	14.5	9.4	16.2	22.4	11.5	8.7	19.5	14.0	26.3	12.4	20.9	25.1	14.0	19.8	8.5	9.2	9.5	10.5	14.6	7.5	5.9	15.0	12.9	17.9	17.1	15.1	18.9	16.9	9.4	14.3	22.4	8.7	12.7	48.5	24.5	18.8	8.7	12.7	13.0	11.4	16.1	8.9	11.7	3.2	10.6	18.4	16.1	13.4	11.9	7.3	8.5	13.6	10.7	10.5	18.1	19.2	9.4	21.1	13.9	2.1	9.8	14.4	5.2	6.8	8.4	13.0	12.2	13.0	9.7	10.4	12.2	7.2	9.9	10.9	6.6	5.7	9.9	4.5	12.7	16.1	17.1	16.0	11.6	12.6	12.4	9.5	11.1	10.7	14.9	7.5	11.3	9.5	5.3	13.4	7.3	5.1	18.7	10.3	7.0	31.4	8.3	3.3	7.1	14.4	9.0	7.4	0.0	11.7	10.7	9.0	7.2	12.7	5.3	8.6	27.0	17.2	9.8	13.5	3.4	15.0	12.4	6.8	16.2	11.4	7.0	10.0	11.5	15.2	3.5	19.6	6.5	8.9	48.8	29.4	6.0	7.1	10.1	9.9	6.7
INVS	NPHP2	ENSG00000119509	Inversin	Q9Y283	9	100099256-100301000	"Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Calmodulin-binding, Developmental protein"	"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 20.2;Late spermatids: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049994			Approved	Cytosol		NA	NA			Cytosol		"HPA049994: "	"unprognostic (3.84e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.53e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.83e-1)"	11.9	13.4	9.5	10.7	15.8	7.9	10.1	18.6	15.7	13.4	11.3	14.6	12.4	7.6	16.5	12.3	9.2	10.3	10.4	9.7	10.4	7.1	16.4	17.1	10.2	10.2	15.8	8.5	19.2	9.7	20.9	26.0	11.1	12.1	12.0	9.1	12.8	8.2	10.4	7.2	7.0	9.4	11.9	15.3	10.1	9.1	12.0	15.5	16.9	12.5	4.6	10.7	10.4	15.4	6.0	3.5	3.9	3.8	4.7	5.3	2.6	6.7	12.4	10.3	11.0	13.3	11.0	8.6	7.9	8.6	7.2	5.8	6.5	4.2	15.6	4.7	9.4	13.1	10.5	8.2	10.4	6.0	12.2	5.5	11.8	10.8	6.7	9.8	11.8	9.8	11.1	13.0	7.7	15.3	9.9	12.9	10.8	10.2	9.6	7.5	6.0	9.3	4.7	6.1	12.2	7.5	8.5	18.2	3.7	6.7	6.3	9.6	7.6	9.0	5.6	9.0	8.8	3.9	6.5	9.6	8.4	6.0	8.4	5.9	9.9	11.7	3.2	8.7	5.1	4.4	0.0	2.5	3.9	4.9	1.7	4.3	5.3	4.1	2.6	3.5	6.0	5.3	5.1	0.2	4.7	3.8	3.5	2.6	2.6	9.5	15.8	18.6	15.7	10.4	7.1	15.8	8.5	12.1	15.5	3.0	2.6	0.9	5.7	1.5	4.1	2.5	10.2	0.0	3.4	0.0	7.9	3.2	3.3	2.0	20.2	3.7	1.6	0.0	1.0	3.2	2.2	2.2	1.1	3.2	3.1	6.4	1.2	0.6	3.4	22.0	4.4	1.9	0.0	3.6	1.4	2.5	1.7	2.0	3.2	5.7	5.7	0.0	3.0	8.6	4.3	1.4	2.9	4.3	1.7	3.4
IP6K2	IHPK2	ENSG00000068745	"Inositol hexakisphosphate kinase 2"	Q9UHH9	3	48688003-48740353	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007532, HPA070811"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA007532: AB_1851542, HPA070811: AB_2732165"	"prognostic favorable (1.25e-4)"	"unprognostic (2.55e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (6.57e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.83e-4)"	18.3	31.1	40.4	20.0	55.9	51.7	28.2	74.1	37.3	29.5	32.5	23.7	34.0	36.9	34.6	56.1	30.0	28.1	24.0	19.0	30.7	19.2	32.4	24.3	18.4	22.5	35.4	27.6	33.9	28.1	23.5	42.3	20.7	29.4	34.9	41.9	22.2	28.3	32.1	19.1	50.0	31.6	21.1	28.3	25.5	27.6	26.0	37.4	31.7	35.7	21.6	19.5	24.1	34.0	27.3	22.8	50.7	25.7	27.9	35.1	19.0	8.5	16.7	34.7	24.4	19.6	24.5	25.1	16.3	18.3	18.7	21.7	13.8	22.9	15.1	13.4	15.2	23.5	22.3	17.3	24.4	17.5	17.8	15.2	17.3	51.7	29.6	15.9	16.4	16.9	23.2	35.6	25.4	21.0	24.9	25.9	49.1	12.9	19.0	21.7	19.0	35.0	22.5	26.6	16.7	31.0	14.7	11.5	16.5	25.4	41.0	21.7	32.8	35.3	24.0	17.3	28.8	23.2	27.7	18.4	20.4	20.3	12.8	16.1	17.6	20.8	21.3	18.5	19.2	17.8	50.7	22.5	38.5	29.7	21.6	26.5	27.3	25.8	27.7	21.7	25.7	24.2	24.9	35.3	27.9	25.7	22.8	35.1	19.0	40.4	55.9	74.1	37.3	30.7	19.2	35.4	27.6	29.4	37.4	65.5	38.7	24.2	78.6	73.7	63.9	10.1	33.1	69.6	69.4	94.2	37.3	101.3	64.6	51.7	30.9	42.0	85.6	0.0	41.6	64.1	64.4	60.2	53.1	20.7	35.7	19.1	105.7	35.0	15.3	14.2	75.1	31.2	25.3	34.3	96.2	28.0	50.1	90.2	64.3	55.6	50.0	51.8	35.7	56.7	54.0	72.5	103.7	47.2	78.7	75.6
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721670-33746905	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 22.5;skeletal muscle: 87.9"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Approved		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	2.2	1.0	2.1	0.8	13.0	0.5	0.9	0.6	6.2	1.2	2.2	11.8	1.4	0.8	1.6	1.4	5.2	1.3	0.6	10.0	3.2	1.3	4.7	7.7	2.0	0.6	22.5	1.1	0.6	0.7	0.5	0.5	3.8	7.7	2.8	1.0	1.2	1.4	1.8	87.9	0.5	1.1	1.8	9.2	1.4	0.9	0.6	15.2	0.0	9.9	8.1	0.5	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.1	0.2	0.2	1.9	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	5.8	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.4	4.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	13.0	0.6	6.2	3.2	1.3	22.5	1.1	7.7	15.2	0.0	0.0	0.0	0.0	0.0	2.2	10.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	5.8	0.2	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.1	6.5	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9"	"Cell type enhanced"	"Detected in many"	17	"Kupffer cells: 14.6;Macrophages: 9.5;T-cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HMC-1: 19.7;THP-1: 10.0;U-937: 10.5"									"HPA028708, HPA028710"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA			"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	1.3	0.7	5.3	6.9	12.9	15.2	1.9	20.0	26.4	3.4	1.6	5.5	0.0	1.1	1.7	1.8	1.9	2.5	3.2	1.0	3.8	4.6	3.4	2.4	2.0	12.4	3.9	14.1	1.3	1.4	0.4	1.3	2.0	5.5	1.3	1.6	0.0	1.4	0.8	0.7	1.2	2.9	1.3	4.2	6.4	2.6	1.5	4.9	10.0	36.9	0.0	11.7	2.4	1.1	0.0	7.1	30.1	6.3	6.0	13.5	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	19.7	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	2.8	1.1	1.0	0.0	0.5	0.2	0.2	0.5	1.0	2.1	0.3	0.4	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.5	0.0	1.4	6.3	30.1	6.1	2.8	13.1	0.0	7.7	5.8	7.1	0.0	13.5	7.9	19.3	6.0	3.4	0.2	9.9	5.3	5.3	12.9	20.0	26.4	3.8	4.6	3.9	14.1	5.5	4.9	0.0	1.7	0.5	0.4	0.6	0.0	0.9	0.0	1.4	2.3	1.8	0.0	1.4	6.6	0.9	0.7	1.4	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.8	2.2	3.2	0.0	2.5	14.6	0.0	0.3	9.5	0.0	0.0	0.3	0.3	0.0	0.0	0.4	1.2	0.1	0.0	0.4	0.2	0.1	0.5	2.3	30.5	0.2	1.2
IPO4	"FLJ23338, Imp4"	ENSG00000196497	"Importin 4"	Q8TEX9	14	24180219-24188964	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.5"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 59.5;Late spermatids: 85.2;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039043, HPA064572"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA039043: AB_10673233, HPA064572: AB_2685291"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (9.45e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (8.59e-4)"	"unprognostic (5.45e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.15e-2)"	5.3	8.1	1.2	5.2	2.2	6.9	6.1	1.7	3.3	6.5	5.8	2.8	5.5	7.5	5.4	6.5	8.8	6.3	4.4	3.6	2.2	1.6	18.0	29.0	4.4	10.8	1.8	1.2	9.8	27.0	2.2	6.4	4.4	4.1	5.0	2.3	3.0	8.7	7.9	17.2	8.5	4.7	5.3	2.4	8.8	6.9	49.5	1.4	8.8	6.5	11.0	7.4	5.7	4.0	3.5	5.3	0.3	3.0	3.6	5.4	2.2	7.8	10.4	0.9	6.2	0.8	1.2	10.7	4.8	0.2	2.3	0.7	8.9	3.9	11.3	7.8	1.7	2.7	8.8	3.7	6.9	0.3	5.4	15.6	7.0	3.3	20.1	0.8	8.5	5.1	1.6	2.2	2.1	0.7	0.5	2.3	6.2	13.1	0.9	2.4	17.4	5.5	7.6	9.5	5.4	22.9	7.5	4.4	6.1	2.2	5.5	8.1	8.7	8.0	3.8	4.1	0.6	6.9	2.0	4.0	4.8	11.6	5.2	7.0	8.0	12.0	10.0	3.2	4.6	7.9	0.0	1.9	0.3	4.8	2.6	5.4	2.8	4.6	4.4	3.1	3.5	3.6	5.0	0.0	3.6	3.0	5.3	2.2	2.2	1.2	2.2	1.7	2.8	2.2	1.6	1.8	1.2	4.1	1.4	0.0	6.4	4.7	3.4	5.3	0.6	1.8	10.2	9.4	11.4	5.2	3.9	10.1	0.0	11.4	59.5	3.5	0.7	0.0	9.4	8.5	4.2	2.5	0.0	5.1	7.2	1.6	4.1	1.3	1.9	85.2	4.6	1.4	0.0	1.0	5.6	1.3	7.2	0.0	5.3	9.8	2.7	6.5	4.4	44.5	17.3	5.5	4.9	1.3	8.3	2.6
IPO8	"IMP8, RANBP8"	ENSG00000133704	"Importin 8"	O15397	12	30628988-30695986	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018439, HPA023765"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018439: AB_1851771, HPA023765: AB_1851773"	"unprognostic (1.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (2.66e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.62e-5)"	"unprognostic (9.75e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.24e-1)"	15.7	20.9	21.2	17.3	22.5	10.0	15.4	19.8	22.6	17.4	25.2	12.3	15.9	17.9	22.4	16.0	22.9	17.2	18.3	18.9	17.9	14.5	22.5	23.3	15.6	17.5	14.8	20.3	21.1	23.9	54.4	27.8	17.2	19.0	18.4	22.6	11.9	16.7	18.5	19.8	16.6	22.6	21.3	15.9	20.4	17.8	27.5	14.6	24.8	22.1	13.1	18.0	21.6	20.4	8.0	3.6	7.3	6.0	6.0	7.5	2.8	16.9	19.9	19.1	14.0	18.0	20.7	26.8	18.8	18.1	15.0	17.7	13.6	17.7	21.9	16.5	23.0	15.9	11.0	21.1	20.3	21.9	25.5	14.9	17.9	23.9	12.4	11.8	25.9	14.1	16.7	12.8	23.9	20.4	27.1	24.7	15.4	15.9	16.5	21.2	8.6	19.5	16.0	37.2	23.4	7.6	16.0	40.1	17.7	18.9	23.5	11.8	14.5	19.7	14.4	10.4	35.5	23.0	9.4	22.0	14.4	12.7	31.0	16.3	16.3	22.1	33.2	17.6	15.6	24.9	7.2	4.5	5.4	4.8	6.0	7.1	5.6	5.4	5.2	3.3	8.0	5.9	7.5	7.3	6.0	5.5	3.6	6.1	2.8	21.2	22.5	19.8	22.6	17.9	14.5	14.8	20.3	19.0	14.6	8.9	18.9	11.0	5.4	8.5	11.5	16.9	10.2	8.1	21.6	10.4	11.8	9.8	3.3	8.6	29.2	13.9	11.7	23.3	11.9	6.0	9.1	6.7	11.5	22.4	13.9	7.9	6.4	24.5	22.2	6.4	8.1	12.1	8.5	3.6	13.0	12.1	11.0	5.8	12.4	12.9	14.6	12.9	11.2	9.1	3.2	8.2	15.0	7.7	13.0	7.5
IPO9	"FLJ10402, Imp9"	ENSG00000198700	"Importin 9"	Q96P70	1	201829141-201884294	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059540			Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		30000	Cytosol	Vesicles	"HPA059540: "	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (8.92e-3)"	"unprognostic (2.23e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.78e-4)"	16.8	18.0	27.1	14.2	26.5	11.0	15.2	29.1	27.8	14.2	14.3	18.7	11.0	11.5	19.7	24.2	15.2	17.4	12.2	12.0	22.3	17.9	14.9	23.1	16.5	15.7	17.7	22.8	20.9	16.5	24.9	26.0	18.1	21.2	16.3	18.1	24.7	11.2	14.7	15.4	21.9	13.3	21.5	15.0	18.3	13.4	12.8	17.2	21.1	18.4	8.4	20.3	14.4	13.7	10.9	14.6	10.7	15.3	11.0	13.3	8.3	17.8	19.0	26.0	21.1	15.1	10.2	19.5	13.8	14.0	23.1	22.5	30.3	15.6	10.6	7.9	13.2	20.3	16.6	17.5	19.1	20.0	9.7	15.5	7.9	30.8	22.6	11.5	10.3	13.1	11.3	8.8	24.8	20.3	15.5	23.1	14.6	15.7	10.1	16.5	17.9	11.9	13.5	26.1	16.1	6.2	12.7	27.1	10.5	12.5	28.5	22.1	25.2	15.2	24.1	12.2	41.9	17.6	13.1	12.5	21.8	19.5	12.2	25.2	7.5	4.5	12.3	10.8	12.2	16.2	10.7	11.7	9.7	12.2	15.3	10.6	10.9	11.9	13.3	14.6	10.3	9.7	10.4	2.9	11.0	14.9	7.7	10.7	8.3	27.1	26.5	29.1	27.8	22.3	17.9	17.7	22.8	21.2	17.2	20.8	42.9	23.1	13.3	14.1	57.4	22.8	7.6	8.1	26.1	7.0	56.9	22.0	1.7	15.1	6.0	18.8	6.3	23.3	16.1	16.8	22.1	10.7	10.5	17.1	16.6	71.5	10.9	21.5	17.0	6.3	18.7	16.7	13.5	10.0	12.7	40.4	15.2	10.5	26.5	7.9	54.1	38.8	21.7	24.9	32.2	12.4	18.9	13.8	15.0	10.8
IPPK	"C9orf12, FLJ13163, INSP5K2, IP5K, IPK1"	ENSG00000127080	"Inositol-pentakisphosphate 2-kinase"	Q9H8X2	9	92613184-92670265	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020603	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA020603: AB_1851853"	"unprognostic (3.51e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.26e-9)"	"unprognostic (1.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.28e-4)"	5.0	7.5	7.6	5.2	12.3	8.3	7.5	13.4	14.1	7.9	4.7	9.7	6.8	3.7	6.0	5.9	29.7	6.4	5.3	8.1	7.9	5.9	5.2	5.8	4.9	6.0	7.1	5.7	6.5	4.2	11.3	11.0	7.1	10.0	5.1	5.3	6.0	10.8	4.3	6.9	31.5	4.6	6.3	6.4	5.8	4.8	12.0	7.7	5.7	5.5	17.8	16.1	4.9	13.7	4.2	3.9	5.8	3.2	1.4	7.5	3.1	11.9	6.4	5.9	5.1	7.3	5.5	19.7	8.6	5.3	8.8	5.0	4.0	4.7	7.5	4.3	11.9	7.8	17.2	10.4	11.9	7.4	9.2	6.7	6.1	13.6	6.1	5.2	10.3	7.2	5.4	11.8	10.5	8.2	8.0	6.5	6.2	8.2	9.1	8.6	16.3	5.9	4.8	10.1	13.2	9.5	5.2	6.4	3.0	5.2	7.3	12.4	7.3	6.9	28.7	5.0	6.1	6.8	2.6	12.6	6.5	7.4	18.3	8.9	8.4	9.7	4.2	8.5	4.7	6.3	0.0	2.3	5.8	6.4	3.1	7.3	4.1	5.6	5.7	3.6	4.2	4.4	4.8	3.6	1.4	3.2	3.9	7.5	3.1	7.6	12.3	13.4	14.1	7.9	5.9	7.1	5.7	10.0	7.7	3.0	4.3	1.5	5.2	22.6	8.3	0.3	0.0	0.0	3.4	1.8	5.9	7.8	5.0	5.2	8.3	5.8	3.3	0.0	6.9	11.0	4.3	5.0	0.0	2.6	4.4	14.3	6.4	10.4	5.9	26.7	2.8	3.9	3.3	1.8	3.4	4.5	6.5	0.0	2.8	3.1	4.1	6.5	2.7	15.7	16.8	25.7	19.1	4.4	3.3	9.0
IQCC	FLJ10547	ENSG00000160051	"IQ motif containing C"	Q4KMZ1	1	32205661-32208687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.6"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 23.3;Spermatocytes: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA028602, HPA028686"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA028602: AB_10600298, HPA028686: AB_10601985"	"unprognostic (1.45e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (7.81e-6)"	"prognostic favorable (5.65e-4)"	"unprognostic (4.97e-2)"	"unprognostic (2.97e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.12e-3)"	"prognostic favorable (3.79e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.66e-1)"	2.2	4.2	5.0	3.3	8.2	4.4	5.0	9.7	11.7	3.8	3.5	5.1	4.4	2.5	5.5	10.2	3.1	8.3	3.4	2.8	4.0	4.3	4.3	1.9	2.9	3.5	3.1	5.9	5.4	8.1	5.6	9.5	2.7	3.4	4.3	3.5	4.7	4.8	5.7	4.1	4.9	3.1	3.0	3.1	3.2	4.4	26.6	4.6	4.4	8.3	1.0	3.7	2.8	2.9	5.1	2.8	3.4	1.1	3.9	3.8	1.2	7.5	2.5	6.2	5.8	1.1	2.3	3.9	4.3	5.0	9.1	8.5	6.1	6.8	2.7	4.8	1.3	1.6	6.4	6.2	3.8	7.7	4.1	7.0	4.8	5.8	2.6	1.5	5.1	3.3	1.6	4.0	8.1	3.6	3.7	1.9	10.5	8.4	0.7	4.1	5.2	8.4	5.3	3.9	4.1	5.7	11.9	3.7	6.2	3.4	2.9	8.7	3.4	8.6	5.0	4.6	5.9	6.0	5.4	2.6	3.4	6.3	4.9	7.3	3.4	2.4	2.4	4.8	4.9	6.9	1.6	1.0	0.4	3.3	1.0	3.1	5.1	3.4	2.5	1.8	2.5	3.8	2.2	3.4	3.9	1.1	2.8	3.7	1.2	5.0	8.2	9.7	11.7	4.0	4.3	3.1	5.9	3.4	4.6	0.0	2.9	0.0	0.8	0.2	4.8	1.6	2.5	4.0	0.0	3.5	5.9	1.4	3.3	1.2	0.6	1.1	0.9	23.3	1.2	1.6	1.6	0.5	1.1	0.5	0.8	6.4	2.9	0.0	0.0	1.1	1.1	0.2	0.0	1.8	2.7	2.3	1.0	1.5	2.5	0.4	8.4	0.0	0.5	18.9	9.8	0.6	0.8	1.9	1.7	0.2
IQCD	"CFAP84, DRC10"	ENSG00000166578	"IQ motif containing D"	Q96DY2	12	113195441-113221094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.4;testis: 33.8"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 124.5;Early spermatids: 118.9;Late spermatids: 69.7;Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.6;classical monocyte: 2.8;myeloid DC: 2.1;plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 3.6;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.4;GAMG: 8.9;RPTEC TERT1: 11.1;U-698: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046810, HPA048782"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046810: AB_2679818, HPA048782: AB_2680519"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.26e-5)"	"unprognostic (2.23e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (3.90e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.20e-2)"	1.2	1.2	2.8	1.3	6.4	0.6	1.8	2.0	3.8	2.6	1.1	6.8	1.7	0.6	2.3	6.3	1.8	22.4	1.4	1.6	3.8	3.2	3.4	0.6	3.0	1.3	4.8	1.5	2.5	1.4	5.4	8.7	1.2	11.4	1.1	1.2	1.6	1.2	1.7	0.7	0.9	0.7	1.4	2.5	0.6	1.0	33.8	6.4	0.0	4.0	1.1	3.3	1.6	1.0	0.6	3.7	3.6	2.8	0.0	0.1	0.5	2.7	3.2	1.1	0.8	1.2	1.3	0.7	0.4	22.4	1.1	1.5	0.5	8.7	3.0	2.4	0.6	8.9	0.5	0.5	0.9	1.8	0.2	0.9	1.0	1.1	0.5	0.7	0.3	0.7	0.5	0.7	3.5	1.1	6.1	0.7	1.2	0.2	0.2	0.2	3.2	0.2	5.8	0.2	1.4	0.8	0.2	0.5	0.8	11.1	3.4	2.5	1.0	0.7	1.1	3.5	0.9	4.0	1.7	0.3	0.5	1.7	1.1	0.6	0.9	0.7	12.0	1.6	0.1	1.9	3.6	2.8	0.0	0.1	0.2	0.0	0.6	0.0	0.0	2.1	0.2	0.0	0.1	0.1	0.0	0.0	3.7	0.0	0.5	2.8	6.4	2.0	3.8	3.8	3.2	4.8	1.5	11.4	6.4	3.0	1.7	0.0	2.7	2.2	0.4	3.4	5.1	124.5	11.4	5.2	13.7	1.2	11.6	2.3	118.9	0.1	1.3	0.0	0.7	0.2	2.4	1.7	0.0	0.4	1.9	0.0	6.3	1.8	0.0	69.7	2.0	1.3	3.3	2.8	0.6	6.5	0.7	0.3	4.9	11.8	4.8	0.0	1.4	74.6	4.7	1.5	1.6	0.8	0.0	3.5
IQCE	KIAA1023	ENSG00000106012	"IQ motif containing E"	Q6IPM2	7	2558972-2614734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 360.6;Late spermatids: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019515	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA019515: AB_1851855"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.91e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.56e-3)"	"unprognostic (3.13e-2)"	5.5	7.6	15.1	6.8	17.0	7.0	7.4	11.1	18.7	6.9	10.2	12.8	6.7	13.1	9.6	12.3	6.6	17.1	11.2	7.1	14.3	15.6	7.1	3.6	9.1	4.7	12.0	12.1	9.7	8.4	12.9	15.4	4.1	11.3	8.1	9.9	7.3	9.8	11.2	4.5	8.1	10.9	7.9	11.1	5.1	10.6	35.3	9.6	2.8	11.9	3.0	3.9	6.0	7.4	0.7	4.3	8.3	2.1	0.3	1.3	0.3	20.0	10.5	4.5	13.8	5.6	8.5	7.8	4.2	7.1	5.6	6.1	5.4	11.6	1.4	4.9	9.8	12.2	10.4	3.1	4.9	5.9	3.5	6.5	2.7	12.7	1.7	4.1	7.2	4.0	3.5	8.1	5.4	5.7	6.5	6.0	5.8	8.6	2.6	7.4	20.4	3.2	5.5	3.9	9.0	7.7	3.1	5.2	5.2	6.0	9.4	9.5	11.2	4.7	20.0	4.4	3.3	24.6	9.8	5.9	4.7	9.5	17.8	7.1	2.9	4.9	0.3	9.2	5.2	13.1	1.1	1.4	3.6	1.3	2.1	0.5	0.5	0.7	0.6	0.6	0.7	0.5	1.1	8.3	0.3	0.7	4.3	0.3	0.3	15.1	17.0	11.1	18.7	14.3	15.6	12.0	12.1	11.3	9.6	11.9	11.0	0.0	5.0	4.8	7.8	7.7	22.9	60.2	14.8	12.2	56.9	3.7	14.9	16.6	360.6	3.6	15.8	0.0	17.4	6.9	6.4	7.3	1.1	2.8	8.7	19.1	8.1	7.4	6.4	290.7	13.0	5.9	0.0	10.8	10.7	14.1	17.5	11.8	14.5	8.1	38.1	19.4	3.6	43.3	53.7	3.8	1.6	4.4	10.0	3.3
IQCG	"CFAP122, DKFZp434B227, DRC9"	ENSG00000114473	"IQ motif containing G"	Q9H095	3	197889075-197960142	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 44.9;testis: 34.2"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 433.6;Early spermatids: 224.8;Late spermatids: 337.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042787, HPA051981"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA042787: AB_10797021, HPA051981: AB_2732572"	"unprognostic (1.50e-2)"	"unprognostic (6.20e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.75e-2)"	6.2	5.0	10.9	3.0	14.6	3.0	5.4	3.6	7.6	5.7	3.0	12.3	4.1	2.5	4.5	11.6	3.9	44.9	4.4	4.2	12.6	12.9	5.9	3.6	8.0	3.9	9.0	5.7	5.0	2.1	4.5	12.0	3.4	20.8	3.9	3.7	5.3	2.5	4.6	2.0	2.8	2.6	4.1	9.2	3.1	3.4	34.2	11.2	1.4	7.4	1.0	3.9	4.5	2.2	8.9	7.3	8.9	8.4	6.6	9.1	5.0	3.9	4.3	5.6	5.4	12.1	12.4	2.2	4.8	5.3	5.7	5.9	0.8	3.8	1.3	5.4	3.9	7.4	3.7	4.0	3.7	9.3	3.0	2.8	2.4	2.3	2.0	2.8	3.1	3.8	6.4	4.7	6.2	2.0	4.7	2.7	6.6	2.5	5.4	4.3	9.0	1.7	1.5	3.4	5.7	5.8	5.0	3.7	1.9	5.5	1.6	4.9	5.9	8.0	3.2	3.3	5.2	24.4	2.1	2.7	3.7	2.5	11.0	4.4	4.7	13.2	2.3	13.6	4.5	5.9	4.6	8.4	8.9	8.2	6.4	5.3	8.9	6.9	5.4	7.3	4.2	6.2	9.1	5.8	6.6	5.7	6.5	6.8	5.0	10.9	14.6	3.6	7.6	12.6	12.9	9.0	5.7	20.8	11.2	6.0	7.7	5.1	2.8	8.2	12.5	9.7	0.0	433.6	42.1	5.2	70.7	5.1	13.3	5.5	224.8	6.9	1.7	0.0	3.7	4.6	6.8	2.4	8.1	3.9	5.8	9.5	4.1	6.7	5.7	337.4	21.0	10.2	13.5	1.0	2.6	13.5	8.6	1.9	22.3	7.8	44.0	6.5	4.6	84.6	32.3	7.9	4.3	11.3	2.3	2.0
IQCH	FLJ12476	ENSG00000103599	"IQ motif containing H"	Q86VS3	15	67254800-67502260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.5;testis: 20.9"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 30.8;Early spermatids: 45.3;Late spermatids: 30.4;Spermatocytes: 43.6;Spermatogonia: 18.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.0;dendritic cells: 1.2;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040845	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA040845: AB_10672898"	"unprognostic (2.69e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.89e-5)"	"unprognostic (2.48e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.16e-3)"	"unprognostic (6.42e-2)"	0.9	1.8	1.3	0.4	2.9	0.2	2.5	0.9	2.8	1.4	0.8	2.9	4.1	0.3	1.3	6.4	0.9	10.0	2.1	1.3	1.6	2.1	3.3	1.5	2.4	0.5	1.2	1.8	2.7	1.4	6.5	14.5	0.5	2.6	1.2	1.1	3.5	1.0	1.4	0.9	1.0	0.8	0.6	1.4	0.8	1.6	20.9	1.4	0.6	6.1	0.7	0.4	1.3	1.0	1.0	1.2	0.1	0.3	0.2	2.1	0.3	2.8	3.0	1.3	2.2	2.0	4.6	1.0	1.5	1.2	2.4	1.6	0.3	3.1	1.8	1.4	2.5	2.6	4.8	4.4	1.8	4.0	0.3	2.1	0.6	3.0	0.4	3.5	0.9	0.6	3.1	1.8	5.0	4.8	2.1	0.9	5.2	4.2	2.0	1.7	3.0	0.7	0.8	1.6	1.8	1.9	0.6	2.1	2.1	2.7	1.2	4.6	1.2	2.0	2.8	7.9	2.9	7.2	0.5	2.0	2.6	1.3	4.1	1.8	4.1	5.4	0.5	5.3	2.2	2.7	0.0	0.3	0.1	1.2	0.0	2.1	0.4	1.0	1.1	1.1	1.0	0.9	0.8	0.0	0.2	0.1	1.2	0.8	0.3	1.3	2.9	0.9	2.8	1.6	2.1	1.2	1.8	2.6	1.4	3.0	0.6	0.0	0.9	1.1	1.4	0.8	0.0	30.8	3.4	1.8	7.9	0.2	0.0	0.8	45.3	0.7	0.0	0.0	0.7	0.3	0.5	0.5	0.0	0.0	0.2	1.6	0.0	0.0	0.0	30.4	0.9	0.0	0.0	1.8	0.5	1.4	0.7	0.0	0.7	1.7	6.0	0.0	0.5	43.6	18.5	0.4	0.2	0.0	0.0	0.9
IQCJ-SCHIP1		ENSG00000283154	"IQCJ-SCHIP1 readthrough"	B3KU38	3	158962235-159897366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 6.0;Basal glandular cells: 6.9;Bipolar cells: 12.0;Cone photoreceptor cells: 5.9"									"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA003243, HPA003445"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA003243: AB_1079877, HPA003445: AB_1079875"																		5.3	2.1	11.1	4.1	12.4	0.5	2.4	1.5	30.0	1.9	3.8	17.8	0.3	1.7	5.6	2.8	7.3	1.4	5.8	16.4	7.7		7.6	6.3	6.8	0.6	18.8	10.6	0.8	0.9	0.2	1.3	10.9	13.1	6.3	3.0	0.4	0.6	10.0	1.8	0.8	1.7	11.8	7.3	1.2	1.0	1.7	15.1	0.0	0.6	0.1	0.4	5.9	0.9	0.0	1.0	0.1	0.0	0.9	0.2	0.2	28.8	5.0	9.9	11.8	2.3	2.2	8.7	24.9	5.9	20.6	14.1	18.6	7.1	1.4	16.1	8.2	7.8	11.7	3.8	8.4	17.0	24.0	9.4	0.0	11.0	0.9	2.7	1.3	0.1	2.3	7.2	9.1	10.9	17.1	15.2	1.6	0.0	0.1	9.4	1.2	0.1	0.0	8.3	2.3	10.9	3.4	20.1	0.0	19.8	1.6	2.0	9.4	13.4	5.7	7.1	11.9	3.3	0.2	12.6	11.9	16.5	7.9	33.7	0.1	0.1	0.1	6.6	4.1	31.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.9	0.0	1.0	0.0	0.2											6.0	0.0	0.0	6.9	1.3	12.0	0.4	0.0	4.0	2.3	1.8	5.9	0.0	0.0	0.6	1.2	0.2	0.0	0.0	0.5	0.0	0.5	0.4	2.3	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.3	0.8	0.0	1.0	0.1	0.4	0.8	0.0	1.1	2.7	0.5	0.0	3.4	0.0	0.4	0.6	0.0	0.0	0.2	1.4
IQCK	"FLJ36575, MGC35048"	ENSG00000174628	"IQ motif containing K"	Q8N0W5	16	19716456-19858467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 107.1;Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 96.8;Spermatocytes: 80.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026792, HPA048786"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA026792: AB_1853889, HPA048786: AB_2680520"	"unprognostic (4.21e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	5.5	4.8	9.3	2.8	11.4	1.1	7.8	3.7	7.1	10.1	3.7	13.9	19.4	5.1	6.3	19.9	2.5	25.2	7.5	4.8	10.4	11.2	11.2	3.0	5.3	2.3	8.3	8.9	8.9	5.7	20.7	14.6	4.4	12.1	5.4	4.2	9.3	8.2	22.4	4.0	3.3	2.7	5.3	8.5	2.6	5.1	27.2	7.9	1.1	21.0	3.2	1.9	5.7	3.5	1.5	1.0	0.0	3.8	0.1	3.0	1.0	2.6	7.2	9.2	6.1	2.8	9.1	0.6	0.0	4.6	4.3	3.4	0.4	5.0	0.3	5.1	2.5	2.7	3.0	2.0	3.5	3.0	1.1	1.9	0.1	1.9	3.5	9.0	1.7	0.1	5.1	3.0	5.5	1.3	4.8	4.6	4.5	2.7	0.8	2.7	8.8	1.6	1.0	2.8	2.8	6.7	5.5	0.7	0.5	10.8	1.9	8.5	3.6	3.7	1.3	5.6	1.8	3.7	0.9	3.1	0.9	1.0	4.9	0.9	0.2	0.5	0.0	5.6	0.2	1.8	0.0	0.7	0.0	1.4	3.8	2.5	1.5	1.6	2.3	0.4	0.6	3.0	1.5	0.0	0.1	3.5	1.0	1.2	1.0	9.3	11.4	3.7	7.1	10.4	11.2	8.3	8.9	12.1	7.9	14.9	3.2	0.8	9.3	5.5	41.5	0.8	20.4	107.1	17.0	43.6	108.0	4.2	39.7	39.8	32.8	16.9	2.7	0.0	25.9	2.1	10.0	6.5	0.0	1.5	4.9	3.2	5.2	9.2	2.7	25.2	16.7	2.6	16.9	1.0	4.3	25.1	23.3	0.0	17.0	27.5	96.8	6.5	9.2	80.7	34.9	4.4	3.4	1.0	5.8	4.3
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403249-76708132	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.1"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 913.2;Late spermatids: 268.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 22.0;Hep G2: 18.2;HMC-1: 65.2;RPMI-8226: 23.8;U-937: 17.0"	"Region enhanced"	"Detected in many"		"hippocampal formation: 34.4"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		8400000	"Vesicles, Plasma membrane"		"CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460"	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	11.1	11.3	1.4	14.7	1.7	6.3	8.0	1.1	1.2	6.1	21.6	0.6	36.2	16.8	2.6	14.7	3.3	2.7	21.7	4.2	1.6	1.6	13.2	66.1	7.8	13.0	1.3	0.7	4.2	14.8	25.5	2.3	42.5	2.1	9.1	6.8	15.2	18.9	34.3	1.4	3.7	35.7	3.4	2.0	16.5	12.4	30.7	0.4	7.7	12.8	2.8	7.7	4.3	4.2	0.6	7.8	14.9	3.2	4.1	5.9	1.3	0.0	2.8	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.2	0.8	0.0	0.8	0.0	3.6	0.0	0.0	2.5	3.6	8.1	2.1	18.2	0.0	4.5	65.2	0.0	0.0	0.0	0.0	0.0	0.3	4.5	7.1	6.5	0.0	0.0	3.9	12.3	4.5	7.5	0.1	1.4	0.0	23.8	0.0	0.0	0.1	1.0	5.1	0.3	0.0	10.1	0.0	2.7	0.1	0.0	0.1	0.0	0.0	6.1	0.0	5.6	0.0	17.0	0.9	14.9	3.2	1.8	4.8	2.4	4.0	0.6	5.0	4.1	2.9	0.2	2.0	3.6	6.3	4.1	3.1	7.8	5.9	1.3	1.4	1.7	1.1	1.2	1.6	1.6	1.3	0.7	2.1	0.4	11.9	16.4	11.2	18.7	4.1	5.9	2.4	101.9	20.1	13.6	33.2	102.1	11.9	6.6	28.5	913.2	3.6	83.5	23.3	58.0	0.6	7.5	28.7	91.4	219.4	58.8	1.6	8.7	20.3	125.0	268.6	6.9	72.8	15.1	19.0	45.0	11.3	23.8	38.6	4.9	53.7	118.4	0.0	2.3	14.9	4.4	3.3	6.1	66.1	31.5	5.5
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.8;intestine: 13.0"	"Cell type enhanced"	"Detected in some"	14	"Cholangiocytes: 5.1;Late spermatids: 16.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	Yes			"Nucleoli rim"	Nucleoplasm	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	3.2	1.2	0.3	5.4	0.3	14.8	0.6	0.3	0.8	1.4	10.1	0.4	1.3	7.0	1.1	3.7	9.8	0.3	1.8	1.8	0.4	0.2	1.5	1.1	2.6	1.4	0.3	0.3	0.5	0.4	0.0	0.3	6.5	0.8	0.8	5.5	0.4	1.8	0.3	0.5	3.8	13.0	2.9	1.5	1.5	5.1	6.8	0.3	12.2	0.4	3.1	7.3	0.9	3.1	0.2	0.9	0.5	0.3	0.6	2.6	0.0	23.5	11.4	10.7	7.5	0.6	1.7	5.2	17.5	11.7	17.2	15.5	13.0	21.8	2.1	6.5	10.3	9.1	22.5	7.3	9.0	15.5	0.0	6.5	3.1	22.4	6.4	0.1	3.8	0.0	0.5	1.0	14.4	21.3	4.2	10.0	5.1	6.3	3.4	12.6	12.4	2.2	5.5	7.8	23.3	11.5	7.6	12.0	2.4	4.4	8.1	6.8	10.5	15.9	18.7	6.4	13.1	14.9	10.3	6.5	15.6	18.7	12.7	20.6	1.6	0.8	1.0	5.2	6.1	17.6	0.5	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.6	0.1	0.1	0.1	0.2	0.6	0.3	0.9	2.6	0.0	0.3	0.3	0.3	0.8	0.4	0.2	0.3	0.3	0.8	0.3	0.0	0.0	0.5	0.0	1.1	0.0	0.8	5.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.7	0.0	1.1	0.0	0.0	3.1	0.5	0.2	0.0	0.0	3.4	0.0	1.2	4.3	0.3	16.8	0.3	2.2	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	3.8	2.4	0.9	0.7	0.0	2.9	0.4
IQSEC1	"ARF-GEP100, BRAG2, GEP100, KIAA0763"	ENSG00000144711	"IQ motif and Sec7 domain 1"	Q6DN90	3	12897220-13073117	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 163.4;Cone photoreceptor cells: 182.6;Horizontal cells: 222.5;Rod photoreceptor cells: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.9;U-266/84: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038143, HPA038144"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Nucleoli, Nucleoli rim, Vesicles"		"HPA038143: AB_10697241, HPA038144: AB_2675860"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.80e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (4.42e-1)"	"prognostic favorable (3.58e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.65e-2)"	17.8	14.1	27.8	12.3	27.0	32.5	7.1	31.9	41.5	9.5	6.7	18.5	3.5	4.8	8.0	4.7	6.1	8.5	7.4	16.0	25.0	17.8	7.0	11.5	12.4	14.8	16.4	24.8	12.3	13.0	25.7	7.8	13.4	36.7	11.6	4.8	17.0	9.3	10.0	21.0	6.2	7.7	8.4	10.6	20.6	6.9	5.6	15.5	2.6	6.3	4.3	14.0	7.8	5.9	6.2	6.8	12.9	4.0	1.8	3.6	2.3	5.0	6.9	6.2	7.0	5.2	7.2	34.9	5.7	4.7	3.8	2.9	4.7	4.5	10.7	6.6	10.7	4.2	2.8	4.7	3.0	2.8	7.2	9.9	6.3	4.1	20.0	5.7	0.1	2.7	7.1	5.5	7.8	4.4	5.2	3.5	4.4	17.9	11.4	2.6	16.2	4.0	6.8	6.5	4.0	14.1	5.4	2.0	15.4	2.2	6.6	5.4	9.9	4.1	14.4	3.3	5.6	6.1	4.4	9.4	4.2	10.6	3.5	0.7	22.8	31.2	4.2	7.9	3.2	3.3	5.0	3.8	4.8	3.6	4.0	2.7	6.2	2.4	2.7	1.9	6.1	2.4	3.0	12.9	1.8	3.9	6.8	1.7	2.3	27.8	27.0	31.9	41.5	25.0	17.8	16.4	24.8	36.7	15.5	3.0	22.7	41.9	6.8	10.2	106.3	163.4	28.1	12.0	7.9	3.5	182.6	7.8	6.6	5.7	2.1	20.1	2.0	23.3	11.1	36.0	17.8	15.7	14.0	38.5	19.4	222.5	9.8	28.3	52.6	3.4	15.5	24.7	6.8	3.6	13.6	16.7	7.9	0.0	21.2	4.7	119.9	25.8	33.0	1.8	1.5	6.8	18.2	16.2	7.6	10.7
IQSEC2	"KIAA0522, MRX1, MRX18, MRX78"	ENSG00000124313	"IQ motif and Sec7 domain 2"	Q5JU85	X	53225828-53321350	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.2"	"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 10.0;plasmacytoid DC: 10.2"	"Group enriched"	"Detected in many"	15	"dendritic cells: 10.2;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"A549: 24.8;GAMG: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003973, HPA076533"			Approved	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"HPA003973: AB_2280343, HPA076533: "	"unprognostic (1.85e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.66e-3)"	"unprognostic (6.02e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.38e-4)"	8.1	10.0	16.6	4.3	22.0	1.5	4.7	32.1	34.2	7.0	6.9	3.7	4.9	9.9	4.7	3.5	4.9	8.5	4.9	6.0	19.4	9.0	10.8	1.3	6.5	2.0	6.7	12.7	4.7	5.4	8.1	6.1	2.9	13.4	6.4	5.6	2.8	5.1	7.8	25.6	5.7	10.7	5.9	4.4	3.5	5.5	4.2	5.2	0.2	5.3	4.3	2.6	4.7	4.1	0.2	10.2	0.6	10.0	0.0	0.1	2.2	2.3	24.8	0.9	2.3	3.5	7.6	2.7	4.0	7.0	3.0	5.7	0.6	9.2	0.1	6.6	9.4	30.4	3.3	0.8	4.0	2.3	2.5	4.3	2.7	10.8	0.6	7.6	0.1	1.5	5.4	6.1	8.6	4.8	7.8	4.2	0.0	8.6	2.8	6.5	5.8	0.0	0.5	7.8	7.4	10.9	1.8	1.9	2.9	4.6	5.2	1.0	0.9	9.3	5.8	3.7	4.6	8.2	1.2	4.8	3.0	5.7	1.6	1.8	0.8	0.1	0.1	18.5	1.8	1.6	0.1	10.0	0.5	0.0	3.6	0.1	0.2	0.0	0.1	5.2	0.1	0.1	0.1	0.6	0.0	1.8	10.2	0.0	2.2	16.6	22.0	32.1	34.2	19.4	9.0	6.7	12.7	13.4	5.2	6.0	5.1	0.5	5.8	3.5	0.4	3.6	12.7	5.3	4.5	14.0	0.0	6.8	18.3	4.8	16.6	4.9	19.6	0.0	6.1	5.4	5.6	11.3	3.5	0.8	12.6	0.0	3.5	6.2	14.6	26.5	1.4	9.1	10.1	10.0	10.3	2.4	5.3	11.8	2.1	29.4	0.0	0.0	5.2	0.7	1.1	3.3	3.8	0.5	11.4	12.9
IQSEC3	"KIAA1110, MGC30156"	ENSG00000120645	"IQ motif and Sec7 domain 3"	Q9UPP2	12	66765-178460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 32.6;Horizontal cells: 108.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 9.7;U-266/70: 13.0;U-266/84: 3.1;U-937: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039025			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039025: AB_10672768"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.83e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-2)"	5.6	1.3	5.6	0.7	4.2	0.8	0.4	19.8	15.5	1.6	0.4	0.5	0.0	0.5	2.0	0.5	0.4	5.2	2.2	1.9	6.5	5.1	2.4	0.2	2.9	0.5	3.7	4.7	2.1	1.2	0.0	2.2	1.3	5.0	1.5	0.2	0.4	0.2	4.5	1.3	0.2	0.7	1.9	1.4	0.3	0.6	1.2	0.8	0.0	0.3	0.0	0.2	1.3	0.6	0.0	2.1	0.0	0.0	0.5	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	13.0	3.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	1.2	0.0	0.5	0.0	2.1	0.0	0.4	5.6	4.2	19.8	12.4	6.5	5.1	3.7	4.7	5.0	0.8	3.0	0.0	0.0	0.0	0.2	32.6	1.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	1.1	0.1	2.3	0.0	1.2	108.1	0.0	1.8	1.0	3.3	0.6	0.0	0.0	0.0	0.0	6.1	0.2	0.0	0.0	4.5	15.7	0.0	0.0	2.2	8.8	0.1	0.0	0.5	0.0	0.0
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452400-123535077	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.8;testis: 35.5"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 91.0;Early spermatids: 206.9;Late spermatids: 121.6;Spermatocytes: 83.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.9;RPTEC TERT1: 7.2;T-47d: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments"	Cytosol	"HPA049626: AB_2732554"	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.6	1.0	1.3	0.3	2.9	0.3	0.9	3.0	3.5	1.2	0.5	1.8	3.2	0.4	1.4	6.9	1.8	5.7	1.6	0.6	2.6	1.2	8.5	0.4	3.2	0.3	0.7	1.2	2.7	0.7	2.7	20.8	0.5	6.4	0.9	0.4	0.3	0.7	4.3	0.6	0.5	0.5	0.6	1.0	0.4	0.6	35.5	2.8	0.0	5.6	0.0	0.3	0.7	0.6	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.3	0.0	1.3	0.6	0.6	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.8	0.8	0.0	0.4	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.7	0.3	0.2	0.3	0.7	0.0	0.2	1.9	0.2	0.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	7.2	1.6	1.1	0.4	0.0	0.0	0.1	1.1	2.5	0.0	0.0	0.5	0.3	0.5	0.2	0.5	0.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.3	0.4	0.2	0.2	0.2	0.0	0.8	0.7	0.2	0.0	0.5	0.1	0.0	0.3	0.0	1.3	2.9	3.0	3.5	2.6	1.2	0.7	1.2	6.4	2.8	6.0	0.3	0.0	0.5	0.5	2.7	1.0	0.0	91.0	15.9	17.4	3.9	0.3	1.7	0.9	206.9	0.4	0.0	0.0	0.4	0.2	0.5	0.6	1.1	0.0	0.1	3.2	1.7	0.6	0.0	121.6	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	2.8	4.3	8.8	6.5	0.9	83.1	7.1	0.1	0.6	0.0	0.0	0.3
IRAK1BP1	"AIP70, SIMPL"	ENSG00000146243	"Interleukin 1 receptor associated kinase 1 binding protein 1"	Q5VVH5	6	78867472-78946440	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 79.6"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 31.4;Early spermatids: 52.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035742, HPA035743"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA035742: AB_10670119, HPA035743: AB_2674764"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.93e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.58e-1)"	2.8	4.0	6.9	3.4	12.4	79.6	3.9	8.8	8.1	6.4	4.1	3.4	6.2	3.5	7.2	7.7	3.2	7.3	5.3	3.6	5.6	4.1	7.0	2.6	4.4	6.0	3.0	6.5	7.0	8.1	4.2	17.9	2.8	4.3	5.2	2.7	5.1	4.2	6.5	2.3	5.7	4.7	4.1	3.6	4.7	5.5	15.4	5.7	8.8	7.6	1.9	2.3	4.5	4.0	1.4	1.6	3.9	1.4	1.3	2.0	0.4	1.6	3.2	5.2	4.7	2.2	4.8	4.5	1.1	2.7	1.1	1.9	3.8	3.0	3.2	1.4	2.5	2.7	3.0	9.4	4.4	1.9	4.8	3.8	4.0	4.7	2.0	2.8	9.7	3.7	4.2	4.5	2.0	2.5	3.6	3.5	6.6	5.1	7.8	1.7	0.8	2.9	6.5	2.4	0.7	2.7	1.1	3.0	2.3	4.8	6.5	6.9	8.3	1.5	1.7	1.2	3.4	3.8	6.5	3.2	2.8	2.6	1.5	4.0	7.8	4.6	4.8	0.8	0.7	3.1	3.9	0.3	0.4	1.5	0.2	1.1	1.4	1.4	0.8	0.6	0.9	1.9	2.0	2.5	1.3	1.4	1.6	1.6	0.4	6.9	12.4	8.8	8.1	5.6	4.1	3.0	6.5	4.3	5.7	17.9	5.6	0.5	4.8	2.3	7.8	13.2	7.6	28.1	14.8	3.5	31.4	3.0	8.3	4.4	52.1	5.8	0.4	0.0	5.2	0.6	2.4	1.2	0.0	2.1	1.4	4.8	6.3	2.5	1.8	27.4	9.8	1.2	0.0	1.0	2.6	12.8	3.7	0.0	7.8	10.2	17.4	12.9	2.1	25.8	14.7	2.3	0.7	1.0	3.5	1.7
IRAK2		ENSG00000134070	"Interleukin 1 receptor associated kinase 2"	O43187	3	10164865-10243743	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 18.1;Glandular cells: 20.2;Urothelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.2;BJ hTERT+: 16.9;CAPAN-2: 17.1;GAMG: 30.8;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"CAB013483: , HPA050520: AB_2681154"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.60e-5)"	12.1	5.8	3.6	8.6	5.9	28.7	5.4	4.5	7.0	3.3	4.0	12.2	2.3	3.3	3.5	2.6	8.4	2.4	6.8	2.7	3.6	5.2	4.3	15.4	12.7	5.3	10.4	3.7	1.9	3.2	2.4	1.8	3.5	7.8	6.4	3.1	2.1	4.8	3.4	19.6	6.2	6.7	3.4	6.1	5.9	5.2	1.7	8.6	3.9	4.1	2.7	16.7	14.3	7.2	5.0	1.3	2.5	1.2	8.4	7.9	2.5	1.2	3.7	0.1	0.5	4.0	3.4	16.2	1.3	16.9	2.3	2.2	1.7	17.1	0.0	0.4	2.0	30.8	0.4	0.4	4.3	3.1	1.0	1.2	0.3	0.8	4.7	2.0	0.0	0.5	2.1	0.7	8.5	11.0	6.1	4.7	0.1	0.8	5.2	2.7	0.0	0.0	0.8	0.1	2.0	3.6	0.8	0.0	0.2	5.1	23.4	0.2	0.1	1.6	0.0	0.1	0.4	0.4	0.8	4.8	5.3	0.4	3.2	3.3	1.7	5.1	1.0	11.3	2.2	0.9	0.2	1.2	0.1	7.5	0.7	7.9	5.0	2.2	4.1	1.3	4.5	1.6	3.9	2.5	8.4	0.2	0.1	0.9	2.5	3.6	5.9	4.5	7.0	3.6	5.2	10.4	3.7	7.8	8.6	0.0	5.5	0.9	18.1	7.1	0.6	1.6	0.0	0.0	2.3	0.0	0.0	0.1	0.0	8.5	3.3	2.1	1.1	0.0	3.5	0.4	1.0	20.2	0.0	4.7	2.9	0.0	0.0	1.3	2.5	1.1	0.9	4.3	5.0	2.8	0.1	1.7	10.4	0.0	0.0	1.0	0.0	0.0	3.1	0.4	0.4	6.5	0.8	1.5	0.4	22.1
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66188879-66254622	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.0"	"Cell type enhanced"	"Detected in many"	14	"Ito cells: 36.2;Kupffer cells: 118.3;Macrophages: 66.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 12.4;HEL: 12.8;HL-60: 17.0;NB-4: 13.6;THP-1: 20.6;U-937: 14.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	21.8	3.7	2.1	10.6	3.6	58.0	13.4	1.0	2.4	8.7	6.5	2.3	5.5	1.7	6.2	8.6	4.9	7.0	7.6	16.0	2.9	2.1	3.6	2.9	22.1	25.6	4.6	0.3	5.9	2.7	1.3	17.9	6.1	3.7	7.0	3.0	5.5	6.0	5.5	5.5	3.3	4.9	6.4	5.9	25.3	6.2	5.1	2.8	1.0	4.9	4.5	5.4	9.5	11.4	0.4	6.2	7.2	20.6	0.9	0.3	3.6	0.0	0.0	0.2	0.0	15.0	12.4	0.0	1.6	0.0	0.9	1.3	0.0	1.2	0.0	0.8	3.0	0.0	0.0	1.8	0.0	0.7	0.0	0.0	12.8	0.7	0.0	7.8	17.0	2.4	7.8	0.0	0.7	0.0	0.0	4.4	0.0	0.0	0.0	0.5	0.0	0.0	13.6	0.7	0.0	0.0	0.0	3.7	0.0	0.1	1.9	0.1	0.0	6.7	0.0	0.7	0.0	0.0	20.6	4.7	0.0	0.0	0.0	0.0	0.5	0.1	1.2	0.0	14.9	0.0	5.6	13.1	2.2	0.0	13.2	0.0	0.0	0.0	0.0	6.2	0.4	0.0	0.0	7.2	0.9	20.6	0.0	0.3	3.6	2.1	3.6	1.0	2.4	2.9	2.1	4.6	0.3	3.7	2.8	8.9	20.8	0.8	4.1	1.3	0.3	2.2	0.0	6.7	20.5	3.5	0.0	0.2	0.0	0.6	3.6	29.3	0.0	0.0	1.0	0.1	17.3	1.4	26.5	0.0	8.9	0.0	0.0	36.2	118.3	3.0	6.6	66.9	5.0	2.8	1.0	0.2	2.8	0.0	10.6	0.2	0.0	0.0	7.2	0.7	0.9	1.1	0.2	2.5	0.2	2.2
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol		NA	NA			Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (4.42e-5)"	18.0	9.4	5.1	15.0	10.4	10.3	11.3	3.7	6.0	10.3	12.2	9.1	12.5	10.2	13.0	14.1	15.0	9.4	10.8	7.6	6.7	5.2	13.3	11.8	12.0	24.0	13.2	3.9	9.3	20.1	9.1	16.1	14.0	9.8	10.5	10.0	11.9	11.9	15.1	4.1	15.2	15.0	11.8	13.0	25.0	12.3	7.1	11.7	30.3	17.0	7.7	18.9	11.1	10.7	5.1	5.8	16.9	6.0	8.8	7.7	4.7	5.3	4.0	2.8	3.7	10.2	17.2	4.0	7.6	5.4	6.0	5.5	3.4	5.2	9.2	7.5	6.3	4.0	4.4	3.1	4.9	8.7	13.2	2.9	8.8	3.1	2.1	5.8	12.1	10.8	9.1	7.8	7.6	4.5	10.6	8.9	9.0	8.1	6.9	16.6	2.9	10.5	6.8	1.0	0.0	4.7	7.0	3.4	4.8	4.7	5.1	2.0	2.0	3.7	4.7	3.6	4.0	5.9	10.8	7.9	7.4	1.4	9.1	5.2	8.4	10.9	8.0	7.7	32.7	4.1	16.9	4.6	9.4	7.4	5.4	7.7	4.0	6.1	6.3	4.5	5.1	5.5	5.9	9.3	8.8	6.0	5.8	7.5	4.7	5.1	10.4	3.7	6.0	6.7	5.2	13.2	3.9	9.8	11.7	17.9	17.0	15.7	9.4	9.6	5.7	4.1	22.9	6.7	10.3	31.4	19.6	12.5	18.3	10.9	12.6	12.4	13.8	0.0	15.4	7.3	9.3	8.1	20.9	7.3	15.2	7.9	3.5	12.9	29.8	16.3	11.5	22.9	10.1	18.0	9.3	9.1	12.5	5.8	10.6	11.3	25.0	6.5	8.6	27.0	12.6	10.3	23.3	41.5	7.8	11.2
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501456	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064"	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	18.9	42.4	12.0	16.2	22.0	22.6	18.3	22.3	24.9	19.0	16.2	14.8	14.3	16.6	20.4	17.9	19.7	17.6	14.4	13.6	10.7	11.8	18.2	21.1	22.4	31.1	10.3	16.7	23.1	17.0	20.3	23.6	23.2	21.7	16.5	19.7	19.2	17.1	15.8	27.3	18.6	25.3	15.5	13.7	25.5	15.7	18.0	12.3	39.6	27.8	14.0	20.3	17.8	18.4	7.1	9.5	7.1	7.8	7.2	8.8	3.4	7.5	13.4	20.8	13.0	18.4	12.1	14.0	12.9	10.0	11.7	10.7	13.2	13.1	27.9	8.8	10.7	8.0	14.7	48.4	13.0	10.4	8.8	16.8	24.1	14.0	9.2	9.6	26.0	26.1	12.7	8.9	9.0	11.0	12.0	13.7	16.5	25.2	10.0	10.0	11.3	15.8	13.3	27.2	9.2	4.9	18.7	20.9	7.9	12.9	20.8	12.5	18.8	17.4	12.4	13.5	24.5	11.6	22.8	11.1	12.1	8.3	6.6	11.1	12.5	27.3	15.9	8.7	24.2	8.6	7.1	5.8	4.4	6.0	7.8	7.7	6.5	6.6	5.9	8.0	7.1	6.5	8.8	6.8	7.2	6.0	9.5	5.3	3.4	12.0	22.0	22.3	24.9	10.7	11.8	10.3	16.7	21.7	12.3	20.8	35.5	37.4	16.1	12.6	53.7	19.9	22.9	14.7	23.9	22.7	62.8	28.6	0.0	17.5	10.0	22.9	41.8	46.7	16.9	20.4	21.6	26.3	17.3	36.2	22.5	74.7	30.7	51.5	44.9	8.1	30.5	32.9	13.5	16.2	28.6	31.2	21.7	38.4	28.7	15.8	44.1	6.5	13.9	30.7	26.0	16.3	25.6	34.5	28.3	19.3
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785623-209806175	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 344.0;Suprabasal keratinocytes: 482.8;Urothelial cells: 297.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 8.6;pons and medulla: 4.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 16.4;HaCaT: 59.6;HBEC3-KT: 21.8;hTCEpi: 48.0;hTERT-HME1: 24.0;RT4: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.0	6.3	1.1	4.1	1.0	0.3	13.3	8.6	0.9	11.7	12.9	1.0	38.6	9.2	3.9	31.4	63.7	7.6	17.5	10.3	1.1	0.8	12.9	18.4	8.8	0.3	0.9	0.7	3.9	13.9	10.3	6.8	26.7	4.4	21.8	11.3	1.5	24.8	34.6	0.6	45.6	20.3	3.1	1.1	1.2	9.5	4.3	0.3	13.0	22.1	32.3	33.8	15.0	19.1	0.9	0.5	2.0	1.0	0.6	2.8	0.7	16.4	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.1	0.0	0.0	3.4	5.8	0.0	0.0	0.0	0.0	59.6	0.0	21.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	24.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.3	4.6	0.0	0.0	0.0	0.0	2.1	21.3	5.3	1.7	0.4	9.5	0.5	1.1	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.2	0.1	2.0	2.8	1.0	1.9	0.6	0.6	0.9	0.5	0.9	2.1	1.1	0.1	0.6	0.1	0.2	0.0	0.7	1.1	1.0	8.6	0.9	1.1	0.8	0.9	0.7	4.4	0.3	14.9	7.2	0.8	177.1	344.0	0.0	23.2	40.8	46.8	50.0	33.2	0.0	79.7	23.2	31.5	0.9	4.3	54.6	0.0	16.8	20.9	7.3	126.3	2.3	30.2	7.1	0.0	57.5	1.3	1.2	0.0	0.6	2.3	33.7	1.8	54.2	5.2	36.6	51.8	0.0	10.3	0.4	0.0	10.3	9.0	3.6	482.8	135.1	0.0	36.4	297.3
IRGQ	"FKSG27, IRGQ1"	ENSG00000167378	"Immunity related GTPase Q"	Q8WZA9	19	43584369-43596135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043254, HPA050338"	Approved		Approved	Vesicles		NA	NA		18000	Vesicles		"HPA043254: AB_10794178, HPA050338: AB_2681094"	"unprognostic (1.98e-1)"	"prognostic favorable (5.17e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.48e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.24e-2)"	"prognostic favorable (3.92e-4)"	"unprognostic (2.82e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.65e-2)"	5.1	6.1	9.0	4.9	8.7	17.4	4.5	17.2	16.0	6.4	4.9	6.5	9.4	5.0	6.7	6.0	5.2	5.7	6.3	9.2	8.2	8.4	9.5	8.9	6.5	3.3	6.7	13.0	8.5	5.8	10.8	7.9	5.4	9.2	6.6	4.6	5.6	5.9	5.8	15.4	5.5	4.7	5.5	6.1	6.6	6.6	4.7	6.5	2.7	5.2	4.5	4.9	5.5	5.4	1.1	1.6	5.4	1.7	1.1	1.2	0.8	3.3	5.5	4.6	9.2	5.1	3.6	4.7	3.0	1.9	3.4	3.5	4.2	2.1	2.1	4.8	3.6	3.4	4.8	4.3	2.4	2.1	3.9	3.1	2.9	6.7	4.1	3.1	3.9	4.3	3.6	4.7	4.5	2.5	3.8	4.3	3.5	4.2	4.4	3.3	2.7	4.8	2.8	2.4	1.0	3.0	8.9	4.3	1.7	2.9	6.9	8.8	7.9	8.0	8.4	2.5	5.2	5.4	3.6	6.8	11.5	8.5	2.9	4.1	4.5	3.8	3.6	7.0	1.7	9.1	5.4	1.7	0.9	0.9	1.4	0.6	0.8	0.7	0.8	1.0	1.1	1.2	0.7	3.5	1.1	1.4	1.6	0.8	0.8	9.0	8.7	17.2	16.0	8.2	8.4	6.7	13.0	9.2	6.5	11.9	17.8	12.0	9.6	5.8	16.3	24.6	25.5	2.7	6.8	3.5	25.5	4.8	1.7	10.8	7.3	7.7	11.8	0.0	11.1	3.1	7.1	14.9	12.7	12.3	7.2	19.1	34.5	9.8	11.8	2.3	2.8	7.0	5.0	6.4	13.6	13.0	14.7	5.8	9.9	9.3	20.2	0.0	6.2	2.1	2.2	5.8	6.4	3.8	9.9	12.2
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752698-109786568	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 18.2;LHCN-M2: 17.3;SH-SY5Y: 19.1;THP-1: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol		NA	NA			Cytosol	Aggresome	"CAB016944: , HPA054664: AB_2682563"	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	38.9	24.3	27.6	10.9	25.2	70.1	33.5	19.6	30.6	13.5	10.9	13.0	6.7	8.7	14.4	12.2	7.1	7.7	8.4	13.5	23.6	14.6	7.7	24.6	11.6	5.3	24.2	22.1	27.1	7.9	6.1	23.0	13.6	19.5	20.0	7.5	9.3	11.5	12.2	20.9	15.3	9.7	9.7	25.1	9.0	8.3	6.3	21.3	2.0	10.7	4.7	5.3	8.4	17.8	0.5	0.1	6.9	1.4	0.2	0.5	0.2	2.6	3.0	2.0	0.0	16.7	3.3	1.1	2.9	3.5	1.8	1.5	0.3	3.3	0.0	1.8	2.0	2.6	1.2	1.0	2.6	2.2	1.0	13.8	1.3	4.3	0.0	17.0	4.8	1.6	7.0	14.1	0.5	18.2	11.7	0.6	0.2	0.8	0.0	17.3	1.3	0.0	14.1	2.1	1.5	0.6	5.9	1.8	1.2	5.0	0.7	2.9	19.1	1.5	0.0	11.8	1.7	0.4	28.8	0.0	3.7	0.0	0.2	3.9	0.0	1.4	0.9	2.8	4.7	6.4	2.7	1.4	1.9	0.2	0.3	0.3	0.1	0.4	0.1	0.1	0.5	0.5	0.4	6.9	0.2	0.4	0.1	0.5	0.2	27.6	25.2	19.6	30.6	23.6	14.6	24.2	22.1	19.5	21.3	29.8	35.6	13.7	47.7	101.2	24.8	56.1	71.4	20.1	43.3	29.6	108.0	17.8	5.0	31.2	32.2	11.3	53.1	23.3	2.7	8.4	42.1	75.9	24.3	103.6	21.1	23.8	117.6	11.6	115.0	5.0	34.5	51.6	123.2	5.4	28.3	37.5	20.9	45.6	19.1	3.3	28.3	25.8	34.0	18.6	8.8	110.3	25.6	24.9	31.0	20.7
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3596054-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.1;breast: 36.0;salivary gland: 20.9"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 6.0;Collecting duct cells: 5.2;Distal tubular cells: 13.3;Smooth muscle cells: 4.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.2;REH: 29.0;U-251 MG: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		5.3	0.4	2.6	0.4	2.1	1.4	36.0	6.6	1.5	0.4	0.4	2.0	6.0	0.4	0.4	1.7	0.8	0.4	0.4	1.0	3.1	3.2	13.9	0.4	8.0	0.6	4.2	1.0	0.4	0.7	0.4	0.7	0.4	16.1	0.5	0.4	2.8	20.9	1.5	0.4	6.8	0.4	0.4	5.1	0.4	0.4	0.5	1.6	3.0	0.5	0.5	0.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.4	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	0.0	0.0	2.3	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	6.6	0.2	3.1	3.2	4.2	1.0	16.1	1.6	6.0	3.0	0.0	0.0	3.2	0.5	2.0	0.0	2.7	1.2	5.2	0.0	0.2	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.5	0.0	0.2	2.6	0.2	0.0	0.0	0.0
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751662	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 101.3;Alveolar cells type 2: 59.1;Basal keratinocytes: 179.6;Suprabasal keratinocytes: 114.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.5;BEWO: 24.3;HaCaT: 13.8;hTCEpi: 26.6;SK-BR-3: 16.3"	"Group enriched"	"Detected in many"	5	"midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3"	"Low region specificity"	"Detected in all"			"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.4	0.1	0.8	0.1	2.8	0.1	27.9	8.4	1.7	0.4	0.7	0.7	4.4	0.1	0.1	2.5	3.1	0.2	0.1	2.1	1.9	1.7	14.3	0.1	32.8	0.3	3.9	0.2	0.1	1.9	2.7	1.4	9.0	36.9	3.9	0.3	1.8	26.6	1.4	0.3	17.7	0.1	0.1	4.8	0.1	8.7	3.1	2.2	0.0	1.4	3.1	3.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	40.5	0.0	2.2	1.6	24.3	2.4	1.3	2.0	1.6	4.8	0.0	0.0	0.0	4.5	0.0	13.8	0.0	9.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	26.6	0.9	8.2	0.0	0.0	0.0	0.0	0.0	1.4	7.8	0.0	0.0	4.5	10.5	0.0	0.0	2.5	0.0	9.0	0.0	1.5	0.0	7.9	16.3	0.0	6.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	8.4	0.5	1.9	1.7	3.9	0.2	36.9	2.2	101.3	59.1	0.0	14.0	179.6	0.5	2.4	0.0	10.7	30.7	7.0	0.0	23.0	23.2	0.1	3.9	0.5	0.5	0.0	0.0	17.1	12.8	15.9	1.1	0.0	2.8	0.0	0.0	0.0	0.0	8.9	0.0	1.3	18.6	0.0	1.5	0.2	0.5	1.9	0.0	0.5	2.4	0.0	16.9	0.7	3.8	114.7	12.7	0.0	1.9	9.2
IRX3	IRX-1	ENSG00000177508	"Iroquois homeobox 3"	P78415	16	54283304-54286763	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 87.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 59.7;Basal glandular cells: 41.5;Ciliated cells: 72.3;Club cells: 48.9;Suprabasal keratinocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 29.1;NB-4: 48.3;RPTEC TERT1: 58.2;T-47d: 30.1;THP-1: 48.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062522			Approved	Vesicles		NA	NA			Vesicles		"HPA062522: AB_2797268"	"unprognostic (4.21e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.25e-1)"	4.4	2.5	1.8	0.1	2.1	0.0	38.3	3.8	0.7	15.3	0.5	1.5	46.8	0.1	4.0	18.1	14.1	5.3	0.2	46.9	3.2	3.6	9.8	1.0	46.8	1.9	4.6	0.3	1.6	2.1	15.4	3.4	1.0	7.8	10.0	0.0	5.9	20.5	87.8	9.1	33.8	0.2	0.6	8.2	0.2	7.7	1.4	3.2	0.4	8.9	9.1	6.5	2.6	6.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.2	0.2	3.8	3.7	2.1	0.8	0.4	1.6	3.5	3.4	0.8	1.0	1.6	0.0	0.5	2.4	1.3	7.1	3.0	0.8	4.6	3.4	2.4	0.0	5.1	3.5	0.1	3.9	1.0	0.6	14.8	6.5	3.0	2.4	0.0	4.6	0.0	0.0	29.1	1.8	7.2	48.3	0.2	0.0	0.0	5.5	4.7	0.0	58.2	1.5	2.6	0.4	4.9	12.6	0.5	0.4	30.1	48.1	0.8	14.4	1.6	2.6	1.2	0.0	0.0	0.0	9.4	12.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.8	2.1	3.8	0.3	3.2	3.6	4.6	0.3	7.8	3.2	17.9	59.7	0.0	41.5	22.1	0.3	10.6	0.0	72.3	48.9	5.2	0.0	0.0	1.7	4.6	0.0	5.1	0.0	0.0	0.2	0.1	14.7	23.1	0.0	2.9	0.3	0.0	0.0	6.2	1.2	0.0	0.0	2.3	10.1	0.0	0.0	10.6	0.2	0.0	0.0	2.2	0.9	0.0	4.2	0.5	0.4	36.1	0.0	0.0	0.0	31.4
IRX5	IRX-2a	ENSG00000176842	"Iroquois homeobox 5"	P78411	16	54930862-54934485	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Vision"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 19.0;heart muscle: 26.5"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 18.7;Ciliated cells: 18.7;Club cells: 21.6;Muller glia cells: 47.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 18.1;T-47d: 24.7;THP-1: 13.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"cerebellum: 4.1;hypothalamus: 3.2;midbrain: 7.6;pons and medulla: 5.7;thalamus: 4.7"	HPA047130			Approved	"Nuclear speckles,Microtubules,Cytosol"		No	NA			"Nuclear speckles"	"Microtubules, Cytosol"	"HPA047130: AB_10962983"	"unprognostic (2.63e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.38e-3)"	"prognostic favorable (4.59e-4)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.28e-2)"	3.3	0.7	0.2	0.2	1.4	0.2	19.0	5.8	0.3	3.6	0.5	1.7	0.2	0.2	0.4	1.9	7.6	0.3	0.4	26.5	0.9	1.3	4.7	0.2	10.3	0.3	2.6	0.0	0.5	0.3	0.5	0.3	0.2	5.3	4.2	0.2	6.5	13.6	0.5	6.7	13.9	0.2	0.3	4.5	0.2	3.3	0.9	2.2	0.4	0.2	1.0	2.4	0.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	5.8	2.2	2.1	0.4	0.2	2.2	5.5	0.7	0.5	1.3	0.5	0.0	0.5	2.9	0.2	5.6	2.0	2.4	0.4	3.9	2.7	0.6	2.4	0.0	0.0	1.3	2.2	0.6	10.3	3.6	1.6	1.0	0.0	3.2	0.3	0.0	4.2	2.1	6.1	8.0	0.1	0.8	1.6	3.2	3.0	0.3	18.1	0.1	2.0	2.0	0.9	5.0	2.4	0.0	24.7	13.2	0.3	4.1	0.1	2.8	0.8	2.5	1.4	1.9	6.6	2.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	5.8	0.2	0.9	1.3	2.6	0.0	5.3	2.2	8.9	18.7	0.0	8.4	7.3	1.1	9.4	0.0	18.7	21.6	0.0	0.0	0.2	0.0	0.2	0.9	0.7	0.0	0.0	0.5	0.0	2.1	4.4	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.7	0.0	0.0	5.0	0.0	0.5	47.9	1.8	0.0	0.0	0.7	1.9	0.0	1.2	0.2	3.0	6.9	0.0	0.0	0.3	6.1
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55323760-55330760	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 5.2;Hofbauer cells: 3.5;Late spermatids: 3.8;Melanocytes: 3.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEK 293: 2.9;RPTEC TERT1: 10.6;SK-MEL-30: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	11.1	0.0	0.2	0.2	1.4	0.0	18.9	0.2	0.5	3.3	0.2	0.2	0.2	0.0	0.6	0.2	0.5	0.0	0.2	11.1	0.2	0.4	1.5	0.2	2.3	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.0	2.0	2.5	0.2	2.7	9.3	0.2	0.2	0.2	1.6	0.0	0.6	0.2	3.5	0.7	0.2	2.3	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	10.6	0.0	0.2	0.1	0.1	1.8	6.8	0.1	0.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.6	1.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.8	0.0	0.0	3.3	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.9	0.1	0.0	0.0	0.0
ISG20L2	FLJ12671	ENSG00000143319	"Interferon stimulated exonuclease gene 20 like 2"	Q9H9L3	1	156721891-156728799	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 98.1"	"Group enriched"	"Detected in many"	29	"Early spermatids: 725.4;Late spermatids: 2397.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028005, HPA054285"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028005: AB_2126319, HPA054285: "	"unprognostic (1.67e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (1.02e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (5.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.32e-1)"	8.0	7.9	8.5	9.5	10.5	12.1	9.7	15.4	11.2	8.6	8.9	10.2	8.9	7.7	10.6	8.5	13.8	9.3	7.9	8.2	7.9	6.1	8.6	10.1	7.9	11.1	8.5	7.6	11.1	9.3	8.4	10.6	10.5	8.3	8.8	11.3	7.5	8.8	9.0	7.2	10.6	10.5	11.6	7.9	10.6	9.2	98.1	9.4	14.1	8.4	7.6	14.3	9.8	9.2	9.5	8.0	20.4	10.6	11.9	9.9	5.5	13.5	10.2	9.5	10.1	9.9	7.7	14.6	9.7	9.2	13.4	9.3	14.0	10.8	25.6	12.3	7.9	6.0	18.8	22.0	16.3	10.3	13.3	13.8	13.8	7.9	7.9	9.8	33.1	15.1	7.7	16.1	12.4	13.6	8.2	12.1	11.8	22.1	12.0	8.6	18.5	15.0	8.6	30.1	29.2	17.6	18.5	10.8	16.9	9.2	10.6	18.6	23.5	11.7	32.0	9.3	14.7	20.6	21.3	7.2	7.6	11.0	8.7	18.8	15.9	24.6	33.3	6.8	16.8	9.8	20.4	8.3	15.5	8.5	10.1	9.9	7.7	7.0	8.7	8.0	9.5	6.8	8.3	16.0	11.9	10.6	5.1	6.2	5.5	8.5	10.5	15.4	11.2	7.9	6.1	8.5	7.6	8.3	9.4	26.8	40.8	21.7	36.3	47.1	22.4	9.3	25.5	21.4	35.2	7.0	23.6	30.5	14.9	20.2	725.4	23.9	29.3	0.0	15.0	33.1	22.9	32.1	26.6	16.8	18.7	22.3	30.6	18.4	19.8	2397.2	27.0	25.7	21.9	10.8	28.3	18.4	18.3	21.0	24.4	10.9	18.9	25.8	24.7	35.8	26.8	53.1	31.4	27.7	23.0	34.6
ISL1	"Isl-1, ISLET1"	ENSG00000016082	"ISL LIM homeobox 1"	P61371	5	51383391-51394738	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 30.3"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 118.7;Horizontal cells: 41.3;Intestinal endocrine cells: 87.9;Syncytiotrophoblasts: 28.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 4.0;hypothalamus: 5.5;pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 82.3"	"Group enriched"	"Detected in some"	8	"basal ganglia: 13.8;hypothalamus: 17.5;thalamus: 6.5"	"Group enriched"	"Detected in some"	11	"basal ganglia: 8.5;hypothalamus: 8.6"	"HPA048613, HPA057416"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Mitochondria"		NA	NA			Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA048613: , HPA057416: AB_2683431"	"unprognostic (4.97e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.41e-3)"		"unprognostic (5.52e-2)"		"unprognostic (6.79e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.77e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.39e-3)"	2.2	1.5	0.0	0.0	4.0	0.0	0.1	0.0	0.2	14.4	1.6	0.0	4.2	2.3	1.3	0.5	0.2	0.0	0.2	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.4	0.0	2.8	10.0	2.0	13.2	2.5	6.4	1.0	30.3	0.1	1.1	0.7	0.6	0.1	0.0	10.7	1.6	0.7	3.1	0.3	0.2	0.4	2.4	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.6	1.2	0.9	0.0	0.0	1.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.8	0.0	0.0	0.0	5.3	82.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.0	0.0	0.2	0.0	5.5	0.0	0.0	2.0	0.7	0.0	0.0	0.0	3.5	1.3	118.7	0.3	0.0	0.0	0.0	0.0	3.9	20.5	0.0	0.0	13.2	0.1	0.0	0.0	0.0	8.9	0.4	1.2	0.0	0.0	2.3	41.3	87.9	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.6	3.4	6.8	0.0	0.0	0.0	11.3	0.0	0.1	0.7	0.7	0.9	28.6	0.0	0.0	3.7
ISL2	FLJ10160	ENSG00000159556	"ISL LIM homeobox 2"	Q96A47	15	76336724-76342476	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.3;pituitary gland: 12.6;salivary gland: 11.8"	"Cell type enriched"	"Detected in some"	8	"Cone photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"neutrophil: 11.3;non-classical monocyte: 3.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.3;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 15.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075192			Approved	"Rods & Rings"		NA	NA			"Rods & Rings"		"HPA075192: AB_2686738"	"unprognostic (7.30e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.55e-15)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-1)"	0.9	0.2	0.0	0.8	1.1	0.3	0.3	0.0	0.9	2.8	3.8	2.0	0.0	2.9	0.2	0.2	1.2	0.2	1.9	0.7	0.3	0.0	0.2	0.2	0.4	0.9	0.7	0.0	0.2	0.2	0.2	12.6	0.3	1.0	4.1	0.5	1.9	11.8	0.3	0.2	1.1	2.0	0.4	1.8	1.0	3.2	2.7	1.9	0.0	0.2	4.0	1.2	0.2	6.4	1.2	0.2	11.3	3.9	0.0	0.6	0.5	1.4	1.7	0.0	1.6	0.1	0.1	1.5	4.4	2.0	1.1	1.5	3.4	0.7	3.3	2.1	0.0	1.1	1.8	6.3	0.1	0.2	3.1	15.7	1.5	3.6	4.0	1.4	3.3	4.2	0.0	0.9	0.0	0.0	0.0	0.0	4.9	4.8	2.5	0.4	0.1	4.1	8.1	0.0	0.6	3.0	2.7	2.0	4.0	0.0	0.6	4.8	5.3	2.8	0.0	0.0	0.9	0.3	7.6	0.0	1.4	3.2	0.6	4.2	3.7	3.9	1.9	1.0	2.4	0.0	0.0	1.0	0.0	0.2	1.0	0.0	1.0	0.0	0.6	0.2	1.2	0.2	0.1	11.3	0.0	3.9	0.0	0.0	0.5	0.0	1.1	0.0	0.9	0.3	0.0	0.7	0.0	1.0	1.9	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	1.7	0.0	0.0	0.2	0.0	0.0	3.0
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173671-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 63.6;Leydig cells: 199.0;Peritubular cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.9;ASC TERT1: 18.2;fHDF/TERT166: 76.1;HSkMC: 13.8;RPMI-8226: 23.3"	"Region enriched"	"Detected in all"	5	"olfactory region: 145.0"	"Low region specificity"	"Detected in many"			"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		110000000	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	24.6	6.8	3.3	10.4	4.6	0.1	21.4	2.0	12.1	72.8	19.7	2.9	13.2	4.1	67.3	36.3	23.0	22.1	29.6	17.7	1.7	1.7	8.0	2.5	10.2	5.8	3.3	7.2	80.2	3.4	1.2	13.8	31.5	3.9	32.2	4.0	36.4	10.0	17.9	12.5	13.6	8.8	27.5	9.0	9.8	10.3	16.3	0.6	1.3	18.9	17.0	9.9	27.9	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	33.9	18.2	0.1	5.2	0.0	0.0	0.0	0.0	2.1	0.0	0.3	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	4.0	0.0	0.1	0.5	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.6	2.0	12.1	1.7	1.7	3.3	7.2	3.9	0.6	0.0	2.2	0.0	0.1	10.4	0.0	3.1	0.0	2.7	1.2	0.0	0.0	1.1	0.0	0.2	1.7	8.7	0.0	0.0	0.2	1.6	63.6	0.1	0.0	0.0	3.5	0.0	0.0	7.4	0.0	3.2	199.0	0.8	11.8	0.0	0.0	0.1	1.3	0.0	150.3	0.0	0.3	25.8	21.7	0.9	0.5	7.8	0.8	0.0	0.0	0.2
ISOC1	CGI-111	ENSG00000066583	"Isochorismatase domain containing 1"	Q96CN7	5	129094751-129114028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070307			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA		1500000	"Endoplasmic reticulum, Vesicles"		"HPA070307: AB_2686249"	"unprognostic (1.67e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.42e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.18e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.32e-2)"	10.5	13.1	9.2	8.9	9.7	4.1	20.7	2.2	8.4	26.3	14.6	7.5	2.1	12.8	44.3	9.0	17.1	13.6	6.4	48.6	7.3	14.2	13.7	40.3	7.1	10.3	11.3	9.5	14.7	22.0	6.8	18.0	7.5	11.2	9.2	9.1	5.4	19.0	3.8	6.6	11.4	19.6	27.1	11.5	5.8	7.9	5.5	9.2	10.4	9.3	11.2	10.2	8.2	10.9	23.2	15.6	24.2	12.8	26.9	32.8	22.0	8.7	6.9	7.2	11.0	11.9	6.3	31.8	3.8	3.3	4.3	7.7	24.2	12.4	6.3	9.5	2.2	13.3	4.8	15.2	11.4	8.1	34.2	17.3	12.4	7.0	17.7	8.4	4.9	4.5	4.1	3.4	6.8	5.9	3.1	10.3	10.0	13.4	10.9	3.8	35.0	9.1	8.0	11.1	8.4	18.9	13.2	21.0	6.1	10.8	17.9	12.2	52.3	10.9	13.9	6.8	6.9	11.5	4.1	4.3	4.9	9.4	3.9	12.2	9.1	7.1	10.4	5.5	15.5	5.5	24.2	12.8	18.1	28.5	12.2	31.9	23.2	26.8	30.0	15.6	21.1	23.7	27.9	15.9	26.9	11.5	14.2	32.8	22.0	9.2	9.7	2.2	8.4	7.3	14.2	11.3	9.5	11.2	9.2	11.9	15.0	21.0	35.7	117.1	7.6	53.2	28.1	6.7	12.5	19.2	9.8	68.2	106.1	19.6	1.0	9.7	23.6	0.0	24.6	63.8	32.8	34.2	18.4	71.8	21.7	0.0	30.5	4.3	6.5	2.1	12.7	11.0	27.0	26.2	25.2	50.0	17.1	28.1	18.0	69.2	6.4	0.0	17.6	5.7	29.3	73.5	42.6	21.4	33.2	32.4
ISOC2	FLJ23469	ENSG00000063241	"Isochorismatase domain containing 2"	Q96AB3	19	55452985-55462343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.9"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 256.8;Proximal tubular cells: 330.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 68.8"					"Low region specificity"	"Detected in all"			HPA043142	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		230000	Mitochondria	Cytosol	"HPA043142: AB_10794653"	"unprognostic (2.74e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.90e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.09e-2)"	12.7	16.4	13.4	12.8	15.0	10.5	28.1	9.0	15.6	10.9	15.9	9.9	17.1	20.6	8.9	13.5	14.7	10.7	19.2	20.9	13.4	12.9	33.2	93.9	11.2	10.2	15.4	11.2	9.1	23.8	12.8	14.2	5.5	14.6	12.0	10.0	7.2	23.3	21.2	47.2	10.0	20.5	12.0	13.9	15.8	12.9	23.3	13.4	5.9	14.9	22.9	11.8	12.8	8.8	11.5	18.1	0.5	20.0	14.1	10.4	9.1	12.7	19.4	5.4	14.4	3.7	7.8	17.2	9.1	9.6	12.1	12.4	9.6	22.8	24.4	17.0	11.1	11.7	12.9	10.4	12.0	4.0	9.3	68.8	13.8	4.7	31.5	14.9	15.4	42.4	11.5	11.6	7.7	5.9	5.5	10.9	10.0	22.5	16.3	7.7	25.3	0.0	18.1	8.3	29.0	55.4	17.5	11.1	31.9	20.0	12.1	6.4	18.1	8.8	20.0	10.3	3.3	16.7	27.6	7.8	8.8	12.6	9.9	10.9	19.8	17.1	19.0	13.9	19.7	15.2	0.4	9.9	0.5	8.3	20.0	8.2	11.5	7.7	10.4	18.1	8.8	7.8	7.8	0.4	14.1	16.1	14.8	9.1	9.1	13.4	15.0	9.0	15.6	13.4	12.9	15.4	11.2	14.6	13.4	6.0	4.6	47.7	58.7	52.9	10.1	19.8	40.8	6.7	4.5	59.3	2.0	32.1	137.6	59.7	16.0	29.2	194.8	0.0	59.2	95.0	50.3	45.4	46.0	256.8	86.3	12.7	68.5	30.1	38.8	34.9	35.9	49.5	59.1	27.9	102.3	53.5	50.1	94.8	29.0	330.6	8.4	25.8	37.6	55.3	11.7	60.0	18.1	24.9	124.1	54.8
ISPD	"hCG_1745121, IspD, Nip"	ENSG00000214960	"Isoprenoid synthase domain containing"	A4D126	7	16087527-16421322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.7"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.5;HEL: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043810, HPA053554"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA043810: AB_10964489, HPA053554: AB_2682185"	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	3.0	3.8	4.2	1.9	4.5	2.6	3.0	7.7	7.7	3.7	2.9	3.9	3.4	1.8	4.7	2.4	2.0	2.8	3.2	7.1	4.4	4.5	7.0	10.0	2.9	1.5	4.7	3.9	2.7	3.9	3.6	5.7	8.0	4.6	3.5	3.0	5.7	5.5	10.1	4.5	2.6	1.8	3.7	4.9	1.4	10.2	3.9	2.4	1.1	2.6	2.4	1.4	3.2	3.7	0.3	0.4	10.7	0.1	0.4	0.3	0.0	0.3	2.4	1.3	1.9	1.1	1.5	8.5	1.9	1.3	1.6	1.4	2.7	2.2	0.0	4.1	2.7	0.8	3.1	1.4	0.0	2.9	1.0	1.5	11.7	1.5	0.6	1.4	0.9	1.5	2.7	1.2	1.3	0.2	0.8	1.2	1.0	2.8	0.3	4.2	0.5	1.1	1.1	2.2	1.0	0.3	0.0	1.9	0.1	2.8	0.8	2.0	1.3	1.4	2.5	2.5	2.7	1.7	2.6	1.3	2.3	2.1	0.3	2.2	0.2	0.0	0.0	1.9	2.7	2.8	10.7	0.1	0.4	0.3	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.6	0.4	0.0	0.4	0.0	0.0	4.2	4.5	7.7	7.7	4.4	4.5	4.7	3.9	4.6	2.4	0.0	2.9	0.0	1.6	0.3	6.0	7.3	0.0	2.7	4.5	3.5	7.9	2.1	1.7	1.0	7.5	2.2	0.4	0.0	0.6	7.9	2.2	2.2	1.1	4.7	0.7	4.8	1.2	4.9	0.3	1.2	1.4	0.0	1.7	0.0	2.0	4.1	2.6	0.0	3.2	5.8	5.8	0.0	0.7	6.6	6.1	0.9	2.4	0.5	1.2	1.7
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438301	"Enzymes, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.6"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 829.0;Sertoli cells: 310.4;Syncytiotrophoblasts: 865.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5"	"Cell line enriched"	"Detected in many"	4	"BEWO: 103.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	7.9	8.4	7.1	3.0	5.7	4.5	7.1	2.7	6.7	9.9	3.5	10.0	44.2	3.4	13.9	12.3	4.5	20.0	6.5	8.0	5.7	7.4	12.7	4.1	4.7	3.8	4.1	4.1	31.6	25.5	7.7	12.6	44.2	16.2	9.5	1.3	19.3	8.8	34.4	8.2	3.4	3.9	3.0	2.3	10.5	3.7	83.6	3.5	3.0	5.6	3.8	3.3	5.9	7.8	4.0	1.9	0.9	0.2	11.9	8.5	4.9	2.8	8.6	20.5	6.1	0.1	0.0	103.8	1.3	0.2	0.1	0.0	4.9	5.2	0.0	7.0	0.6	0.0	7.4	0.6	0.0	0.0	7.7	23.6	10.3	0.5	15.9	2.2	0.1	0.2	1.6	0.1	0.6	0.1	0.0	1.3	0.2	21.1	0.4	0.0	16.6	0.7	0.7	10.7	2.6	6.9	14.2	0.0	4.8	1.7	0.0	6.3	15.8	0.3	1.9	10.5	4.4	14.0	1.1	3.9	0.1	0.2	0.1	0.3	3.3	1.4	0.6	0.6	0.4	3.6	0.9	0.1	0.0	7.6	0.2	5.9	4.0	7.4	6.7	0.7	2.3	6.1	8.5	0.8	11.9	0.1	1.9	5.2	4.9	7.1	5.7	2.7	6.7	5.7	7.4	4.1	4.1	16.2	3.5	3.0	0.6	2.2	67.1	10.6	0.0	4.2	7.6	4.0	4.5	45.4	2.0	829.0	44.7	34.8	81.2	19.7	1.3	0.0	7.5	57.3	25.4	8.5	13.9	0.9	73.6	0.0	62.2	19.0	5.3	178.1	34.5	3.7	21.9	7.2	2.6	7.2	4.6	0.0	47.4	4.7	0.5	310.4	167.1	59.2	21.8	5.0	865.2	9.6	4.6	31.8
ITFG1	"CDA08, LNKN-1, TIP"	ENSG00000129636	"Integrin alpha FG-GAP repeat containing 1"	Q8TB96	16	47154387-47464149	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015590, HPA019728"	Approved		Approved	"Intermediate filaments,Aggresome"	"Intracellular and membrane"	NA	NA		21000	"Intermediate filaments"	Aggresome	"HPA015590: AB_1846347, HPA019728: AB_1846348"	"unprognostic (6.53e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-3)"	14.0	26.6	19.9	8.8	52.4	6.4	15.0	31.2	34.6	18.3	20.0	14.8	9.8	17.3	17.5	19.0	11.5	15.8	17.1	26.0	20.7	26.6	28.7	26.5	15.8	11.0	17.0	19.0	17.4	20.2	43.0	22.9	30.7	28.7	17.9	19.9	13.8	15.1	18.1	14.6	10.8	19.4	17.4	17.6	12.4	16.0	20.7	15.7	13.4	25.8	7.6	11.5	15.3	11.6	12.8	18.7	23.4	24.4	16.6	18.3	17.7	8.0	9.4	17.1	11.9	33.5	25.9	20.5	19.5	27.8	17.7	9.5	5.3	19.7	9.8	26.6	24.0	12.0	12.0	8.3	12.4	17.7	4.2	5.7	5.1	9.0	12.4	15.7	12.1	22.8	19.0	21.7	9.0	11.8	37.6	17.0	9.2	14.6	12.9	22.2	7.8	7.5	5.6	5.5	10.2	9.2	11.5	16.9	24.2	23.5	6.0	8.4	11.9	17.7	20.6	8.6	17.8	9.0	11.1	16.4	18.9	9.2	10.0	7.4	18.2	23.9	18.2	18.9	7.7	14.7	13.5	24.4	23.4	12.4	23.8	12.0	12.8	15.4	13.7	18.7	11.4	16.9	14.1	15.4	16.6	21.9	13.0	18.3	17.7	19.9	52.4	31.2	34.6	20.7	26.6	17.0	19.0	28.7	15.7	47.6	29.1	31.2	36.5	34.1	48.8	52.0	33.1	21.4	20.5	78.5	45.2	90.9	8.3	48.2	66.3	35.8	59.3	46.7	46.4	73.7	50.5	38.7	8.1	58.9	45.3	38.1	59.5	36.8	54.3	25.1	32.5	33.8	27.0	41.5	40.4	43.5	41.4	31.7	57.7	48.2	40.9	77.6	42.2	46.1	97.5	26.5	95.3	20.6	32.4	30.2
ITFG2	"FGGAP1, MDS028"	ENSG00000111203	"Integrin alpha FG-GAP repeat containing 2"	Q969R8	12	2812622-2859791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038664, HPA038665"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytokinetic bridge"		Yes	No			"Nucleoplasm, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA038664: AB_10672722, HPA038665: AB_2676138"	"unprognostic (5.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.24e-1)"	"unprognostic (5.89e-1)"	"unprognostic (4.35e-2)"	"unprognostic (7.43e-2)"	12.2	16.1	11.1	15.4	14.0	12.0	14.3	17.8	17.2	16.2	13.2	23.2	21.3	11.8	19.6	16.6	13.2	17.2	14.7	12.0	8.7	9.8	15.0	11.4	14.4	14.0	13.3	9.9	29.0	28.4	22.7	23.0	13.8	13.3	13.8	14.7	22.1	23.0	19.5	7.8	10.9	13.9	13.5	10.6	20.3	14.8	10.6	15.2	25.4	26.2	9.3	23.0	14.4	15.3	17.7	12.9	5.4	21.2	13.8	14.4	10.0	4.8	7.1	8.3	6.6	7.2	8.3	7.7	10.8	6.1	13.1	9.7	15.3	12.0	11.1	3.0	10.1	6.6	6.2	12.7	10.7	9.8	9.8	7.6	15.7	8.1	6.1	13.3	14.2	8.5	11.1	12.8	11.9	18.4	10.8	8.9	10.7	8.4	12.1	7.4	14.6	20.5	8.3	16.9	11.0	5.5	10.4	9.2	6.4	7.8	8.2	4.0	12.7	13.4	11.8	4.8	11.7	7.3	6.6	9.1	8.7	5.4	8.3	20.6	1.6	0.9	16.9	5.7	8.3	8.6	2.8	10.9	5.4	13.7	14.3	12.8	17.7	10.5	13.4	12.9	17.1	14.4	13.5	1.3	13.8	21.2	9.8	8.5	10.0	11.1	14.0	17.8	17.2	8.7	9.8	13.3	9.9	13.3	15.2	11.9	19.9	25.1	8.5	3.0	34.9	15.1	15.3	9.4	13.6	12.2	60.9	23.3	10.0	7.9	42.6	6.0	13.5	0.0	6.3	8.5	9.4	7.3	5.8	10.2	11.3	30.2	9.1	13.5	7.2	9.0	15.5	9.8	1.7	9.0	12.6	14.7	6.1	16.1	12.4	4.4	52.4	6.5	8.4	12.6	17.9	3.4	14.5	25.9	16.4	4.6
ITGA2	CD49b	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989326-53094779	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 300.3;Glandular cells: 266.4;Pancreatic endocrine cells: 350.7;Urothelial cells: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.9;HaCaT: 30.2;hTERT-RPE1: 28.1;HUVEC TERT2: 27.8;TIME: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		46000000	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.9	14.0	2.9	4.7	13.4	0.4	7.9	1.8	6.8	7.1	6.5	22.5	12.1	7.6	5.1	10.4	16.7	2.8	9.3	2.5	5.4	3.6	15.1	1.8	17.2	1.4	18.3	4.5	1.8	2.7	16.1	2.5	4.8	10.7	8.5	6.0	0.8	15.8	16.8	1.2	16.9	17.0	2.5	8.4	9.1	7.4	1.3	13.0	1.5	2.5	7.4	10.0	7.5	11.1	0.5	1.5	1.7	0.6	0.2	0.6	0.3	19.4	5.0	0.4	0.2	1.3	2.4	1.5	19.6	29.9	0.7	1.2	9.3	13.7	0.0	3.4	8.3	11.5	30.2	1.6	22.1	2.8	0.0	1.5	1.4	1.2	5.5	4.5	0.2	0.4	0.9	3.8	19.7	3.5	28.1	27.8	1.0	0.0	0.0	0.5	3.6	0.2	0.0	1.2	5.0	10.0	0.0	0.1	0.0	6.3	10.3	0.2	1.1	1.0	1.3	2.0	0.8	3.2	0.0	23.8	3.6	2.1	0.5	3.9	0.0	0.0	0.0	21.6	0.0	15.8	1.7	0.6	0.2	0.6	0.2	0.4	0.4	0.5	0.5	0.1	0.5	0.5	0.6	0.8	0.2	0.1	1.5	0.4	0.3	2.9	13.4	1.8	6.8	5.4	3.6	18.3	4.5	10.7	13.0	53.6	13.6	0.0	300.3	134.2	2.3	1.2	20.4	88.3	161.5	50.6	3.9	0.2	8.3	157.1	0.0	15.8	20.6	0.0	144.3	1.6	1.9	266.4	1.1	0.0	0.3	0.0	13.3	5.5	0.0	0.0	1.1	3.8	11.8	1.8	32.4	18.0	350.7	15.2	0.0	2.9	5.0	0.0	4.2	0.0	0.9	32.5	0.3	1.9	28.1	321.7
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389505	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8"	"Cell type enhanced"	"Detected in some"	11	"Cone photoreceptor cells: 7.9;Early spermatids: 14.4;granulocytes: 18.4;Late spermatids: 20.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 28.5"	"Group enriched"	"Detected in some"	13	"HEL: 71.0;HMC-1: 121.4"	"Low region specificity"	"Detected in single"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		NA	NA		1100000000	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.7	0.2	1.4	0.4	1.0	15.2	0.6	3.8	2.4	1.2	0.9	0.4	0.4	0.1	1.1	25.2	0.7	1.9	1.4	10.6	0.9	1.6	1.0	0.4	6.5	0.5	0.7	0.8	2.1	2.5	0.1	2.5	1.9	1.1	0.6	0.3	0.6	0.4	1.6	0.8	0.1	0.6	0.4	0.8	22.8	0.2	3.0	0.4	0.4	5.2	1.0	0.6	0.7	1.9	0.0	0.5	28.5	0.2	0.0	0.2	11.1	0.0	0.1	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	71.0	0.1	0.7	0.0	0.0	121.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	7.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	28.5	0.2	2.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	11.1	1.4	1.0	3.8	2.4	0.9	1.6	0.7	0.8	1.1	0.4	0.0	1.0	0.0	0.5	0.2	4.5	1.2	0.0	0.0	2.3	5.2	7.9	0.5	0.0	0.0	14.4	0.6	0.0	0.0	0.0	1.1	0.8	0.3	18.4	0.0	0.2	3.2	0.0	0.6	0.3	20.0	1.7	0.0	0.0	0.0	0.0	1.9	0.1	0.0	1.8	0.0	3.1	0.0	0.0	0.7	3.4	0.0	0.6	0.0	0.0	0.1
ITGA4	CD49d	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181536187	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.4;lymphoid tissue: 101.6"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 42.0;Erythroid cells: 70.0;monocytes: 36.1;T-cells: 59.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 39.1;HEL: 62.0;JURKAT: 32.6;MOLT-4: 72.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 26.0"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		100000	"Plasma membrane"		"HPA074961: AB_2732273"	"unprognostic (5.31e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.76e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (2.26e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.57e-2)"	3.8	1.7	1.3	39.7	1.1	19.2	3.2	2.4	1.9	6.7	4.8	0.5	1.1	3.8	3.0	3.1	2.9	2.1	6.9	1.7	2.9	1.3	3.0	2.5	13.6	33.7	1.2	0.5	1.8	1.6	0.0	1.3	7.1	0.9	3.8	4.9	2.9	7.5	2.0	1.0	1.5	11.6	2.4	1.6	36.0	4.4	1.2	0.2	101.6	2.6	1.5	14.3	6.0	4.1	11.0	19.1	38.4	38.3	8.8	15.9	16.2	0.0	0.2	1.0	0.0	9.2	13.9	0.0	9.0	11.3	4.8	10.2	0.0	0.0	7.2	0.0	39.1	4.2	5.3	3.2	0.1	5.8	0.0	0.7	62.0	0.2	0.0	0.9	27.4	1.5	9.9	0.0	0.3	0.0	4.7	0.5	32.6	0.0	10.5	3.0	0.0	72.3	19.2	0.8	0.0	0.0	15.9	4.5	1.0	0.0	0.0	1.6	0.6	0.0	0.0	0.3	0.4	0.0	18.1	4.9	1.5	0.9	0.1	1.8	20.5	15.2	4.1	0.8	13.6	20.8	6.7	16.2	38.4	12.9	38.3	9.7	11.0	14.6	15.9	19.1	10.0	8.5	10.4	2.1	8.8	37.5	5.0	3.7	16.2	1.3	1.1	2.4	1.9	2.9	1.3	1.2	0.5	0.9	0.2	0.0	7.9	42.0	0.2	0.2	2.4	0.8	5.1	1.4	3.4	0.0	5.9	0.1	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.2	2.9	0.3	17.4	0.0	5.8	0.0	0.0	1.8	21.0	0.0	0.6	22.7	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	1.6	0.4	0.9	0.5	0.3	59.7	0.0	0.2
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 66.4;skeletal muscle: 81.3"	"Group enriched"	"Detected in many"	17	"Cardiomyocytes: 123.1;Sertoli cells: 161.7;Smooth muscle cells: 105.1"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 85.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA		770000	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (9.59e-5)"	46.2	3.4	6.1	7.2	6.8	0.9	20.6	3.6	7.6	6.3	22.4	5.7	5.9	6.6	15.1	13.5	11.6	12.9	14.8	66.4	7.8	2.6	3.1	4.1	3.4	2.9	3.9	7.6	5.1	1.9	3.4	3.1	1.0	5.7	8.9	3.7	5.6	3.3	14.6	81.3	3.6	7.2	33.3	4.5	2.4	10.3	2.9	5.3	0.2	6.5	10.6	2.2	13.6	14.1	0.5	1.7	0.0	1.0	0.0	0.8	0.3	0.0	1.0	1.9	3.2	18.2	3.6	0.2	1.3	2.3	3.1	3.2	2.1	1.7	0.6	1.9	0.8	0.2	0.2	1.3	0.0	2.7	0.0	1.0	0.2	0.6	0.8	0.1	0.0	0.7	5.1	0.0	17.2	0.1	85.4	0.0	0.5	0.2	0.4	10.4	1.3	0.0	0.7	5.6	0.4	0.1	0.0	7.5	0.1	0.0	0.0	0.2	0.7	0.1	0.0	12.6	1.1	0.2	3.5	0.0	0.3	3.4	0.2	2.1	0.8	0.5	0.2	15.6	2.1	0.1	0.0	0.7	0.0	0.4	1.0	0.0	0.1	0.0	0.8	1.7	0.5	0.3	0.4	0.0	0.0	1.0	0.6	0.0	0.3	6.1	6.8	3.6	7.6	7.8	2.6	3.9	7.6	5.7	5.3	0.0	0.0	0.0	0.5	1.6	1.0	123.1	5.1	0.0	0.0	1.8	3.9	0.0	0.0	0.2	0.1	5.1	1.1	0.0	0.0	0.1	1.1	0.6	0.0	0.9	0.5	0.0	7.5	1.3	1.8	0.0	6.1	1.2	3.3	0.0	1.1	4.4	0.4	0.0	6.0	0.6	0.2	161.7	105.1	3.7	2.2	1.9	0.1	0.0	0.8	0.3
ITGA8		ENSG00000077943	"Integrin subunit alpha 8"	P53708	10	15513949-15720125	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, Integrin, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Muller glia cells: 17.3;Sertoli cells: 51.8;Smooth muscle cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 7.9;HMC-1: 19.0;HSkMC: 8.4;U-266/70: 3.6;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003432	Approved		Approved	"Plasma membrane"		NA	NA		110000	"Plasma membrane"		"HPA003432: AB_1851825"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.03e-2)"	7.1	7.8	2.3	2.4	1.9	0.1	3.1	1.4	3.7	36.1	5.5	1.5	4.1	4.8	17.9	22.8	12.4	7.1	10.7	10.3	3.0	1.6	7.4	0.8	22.1	3.7	1.7	2.6	17.0	0.8	0.7	3.3	0.2	2.9	28.3	4.6	18.8	3.0	22.9	3.3	3.1	4.9	21.2	1.5	17.0	19.4	12.1	1.2	0.0	5.3	5.5	4.3	21.3	10.8	0.2	0.2	0.6	0.4	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	7.9	2.3	0.0	0.0	0.0	0.0	19.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	8.6	0.0	0.0	0.1	1.6	0.6	0.0	0.2	0.2	0.4	0.2	0.2	0.3	0.3	0.0	0.2	0.5	0.5	0.5	0.2	0.4	0.2	0.8	0.0	2.3	1.9	1.4	3.7	3.0	1.6	1.7	2.6	2.9	1.2	0.0	2.2	0.0	1.9	0.9	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	2.4	1.2	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.9	1.0	1.7	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.2	51.8	54.5	0.0	0.2	1.0	0.0	0.0	0.0	1.4
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823514	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Ito cells: 62.0;Kupffer cells: 24.9;Leydig cells: 38.3;Peritubular cells: 70.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HEL: 7.5;SH-SY5Y: 11.2;SuSa: 17.0;WM-115: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		250000	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.5	15.5	3.1	5.3	3.7	5.8	9.6	1.6	5.7	17.9	11.1	2.9	5.8	4.6	17.3	7.5	12.3	6.9	17.8	25.0	4.5	2.0	4.6	13.6	8.3	16.8	3.4	2.7	7.5	2.1	2.4	3.0	7.3	2.6	10.0	5.3	8.4	4.7	8.7	3.7	3.5	8.7	16.2	4.0	30.5	10.9	10.2	2.7	1.0	35.4	7.2	3.6	7.4	8.4	0.0	0.7	2.1	0.2	0.0	0.0	0.4	0.2	0.0	4.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	9.4	0.0	3.0	1.3	0.0	0.1	0.2	3.6	0.0	0.0	0.0	0.6	7.5	0.1	0.2	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.5	11.2	0.1	0.5	0.6	17.0	0.0	2.9	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	5.8	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	3.1	3.7	1.6	5.7	4.5	2.0	3.4	2.7	2.6	2.7	0.0	14.3	0.0	1.0	2.3	0.8	13.2	2.5	0.0	5.7	1.8	0.0	0.2	0.0	0.1	0.9	18.0	0.0	0.0	0.0	0.2	3.2	0.2	5.8	0.2	2.2	0.0	0.0	62.0	24.9	3.1	38.3	1.3	3.3	0.0	0.0	0.5	0.0	0.0	70.4	0.0	0.0	0.0	3.3	0.5	0.9	1.5	0.2	0.0	0.0	0.3
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32900319-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ductal cells: 1163.1;Pancreatic endocrine cells: 917.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		540000000	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	95.2	30.6	13.7	32.1	19.7	9.7	107.7	6.5	14.8	55.1	61.3	17.0	80.2	20.2	84.2	56.2	59.9	45.0	49.8	68.7	15.0	14.4	47.3	85.8	55.4	34.5	23.0	11.1	47.4	37.4	17.6	35.2	83.3	19.5	53.1	32.2	18.6	30.3	76.2	58.0	19.5	42.3	109.3	30.1	59.8	45.4	26.9	18.8	12.7	36.8	27.6	19.4	92.7	47.4	31.3	9.1	4.3	27.1	21.9	68.4	26.2	45.6	67.0	36.2	40.1	87.3	75.2	31.6	153.5	89.0	73.1	66.9	15.0	106.9	12.3	27.8	128.7	48.0	31.9	10.9	87.3	81.6	12.1	8.8	14.8	31.9	17.5	61.5	3.3	14.7	76.2	47.8	76.9	31.3	196.1	89.8	6.1	10.2	5.4	120.5	7.5	5.7	3.3	8.0	13.9	34.0	3.7	26.8	2.2	104.2	13.2	8.6	21.4	47.8	8.1	34.4	61.5	10.9	11.9	100.4	94.2	54.7	66.9	51.1	5.0	1.1	6.9	69.4	14.1	36.9	1.6	9.8	4.3	25.5	17.8	6.0	31.3	54.6	37.5	9.1	8.6	7.1	19.1	2.3	21.9	27.1	3.7	68.4	26.2	13.7	19.7	6.5	14.8	15.0	14.4	23.0	11.1	19.5	18.8	318.6	128.6	76.4	295.7	485.6	32.6	175.3	242.0	164.6	252.5	214.6	29.5	156.7	11.6	1163.1	4.3	314.7	83.6	70.0	355.7	460.3	265.1	177.2	86.6	221.3	161.3	36.5	185.6	387.9	152.7	9.7	235.6	174.3	325.6	83.0	81.4	76.8	917.0	113.2	565.7	64.3	45.2	627.3	497.4	10.0	63.7	149.1	183.8	106.6	98.8	257.2
ITGB1BP1	"ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B"	ENSG00000119185	"Integrin subunit beta 1 binding protein 1"	O14713	2	9403475-9423547	"Predicted intracellular proteins"	"Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 331.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067348, HPA071538"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA067348: AB_2732765, HPA071538: AB_2686413"	"unprognostic (2.21e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.39e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (4.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (3.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.08e-3)"	61.1	15.0	19.0	11.6	29.2	16.1	73.0	17.6	24.0	24.5	16.3	9.9	10.2	7.7	18.0	16.6	13.3	15.0	14.4	23.9	17.1	15.6	23.6	7.7	13.4	12.1	19.7	18.7	14.3	7.6	14.8	9.7	14.1	19.4	11.1	14.8	11.4	7.7	15.1	16.0	16.6	8.6	22.1	19.2	8.6	11.2	5.6	17.0	10.2	11.2	12.1	14.8	12.8	33.6	20.7	29.5	35.2	27.3	24.1	31.3	24.9	16.2	11.7	13.8	15.8	49.4	41.9	7.5	29.9	20.5	27.1	21.1	15.5	10.2	18.0	13.5	41.0	17.7	15.4	21.1	19.6	30.0	48.6	10.6	16.4	13.8	19.4	17.2	12.6	17.9	23.6	16.2	24.8	17.7	23.5	23.6	13.8	9.1	14.9	33.5	14.5	22.3	8.2	11.2	27.0	19.7	12.8	19.0	16.7	27.4	13.4	15.0	14.5	16.6	12.9	20.2	13.4	9.4	9.6	15.0	24.3	17.9	32.3	33.2	15.0	32.2	26.3	33.3	17.4	16.8	35.2	23.0	27.9	30.4	27.3	28.9	20.7	26.5	29.4	29.5	17.5	20.6	26.5	5.0	24.1	20.0	26.6	31.3	24.9	19.0	29.2	17.6	24.0	17.1	15.6	19.7	18.7	19.4	17.0	26.8	17.8	55.0	30.0	54.4	22.1	77.9	25.5	26.8	17.0	36.6	2.0	41.1	331.5	76.9	20.7	75.2	19.2	23.3	63.1	65.6	89.2	30.0	39.4	18.4	81.8	33.4	31.9	48.5	32.7	17.0	50.3	60.8	92.8	103.6	36.3	33.6	74.4	28.1	53.7	63.2	23.3	90.5	99.4	10.4	19.0	55.2	26.3	45.7	35.3	48.0
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301734-71305371	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 69.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040721			Approved	Cytosol		NA	NA			Cytosol		"HPA040721: AB_10805827"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.3	0.2	1.0	0.3	0.6	0.3	0.6	0.2	2.7	2.8	0.0	2.3	0.4	12.8	3.4	4.0	1.8	4.8	43.0	0.2	0.2	0.4	0.6	0.5	0.5	0.3	0.0	2.4	0.3	0.0	0.3	0.2	0.2	3.2	0.9	3.5	0.7	5.8	21.3	0.3	1.0	18.6	0.3	0.6	1.1	1.6	0.1	0.0	0.4	19.6	0.7	5.6	0.8	0.2	0.2	1.5	0.2	0.0	0.5	0.0	0.7	2.1	3.2	2.8	0.1	0.1	0.7	1.0	1.4	0.7	0.9	1.6	1.6	3.1	0.4	1.6	0.8	1.5	2.9	0.8	1.8	1.0	1.3	1.9	1.9	0.6	0.4	0.7	14.0	1.7	1.3	0.5	0.5	0.7	1.2	3.4	1.4	0.8	1.6	0.9	1.2	3.5	4.7	2.1	1.3	2.1	2.5	1.2	1.6	2.0	1.5	0.5	0.7	0.1	0.8	2.2	0.9	0.4	0.0	1.4	2.8	0.3	0.6	2.9	3.8	4.8	0.4	2.4	0.6	0.0	0.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	1.5	69.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.1	0.3	0.9	0.0	1.7	0.3	0.3	0.3	0.0	0.0	0.3	0.0
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 620.8;Kupffer cells: 458.1;Macrophages: 428.6;T-cells: 303.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"THP-1: 117.5;U-937: 87.3"					"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		2500000	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	59.1	9.8	9.0	47.5	16.8	91.4	8.4	1.7	8.0	5.6	7.4	12.2	1.2	6.3	4.9	9.0	4.8	10.7	10.3	9.7	7.2	6.4	8.1	7.0	32.9	73.8	14.3	2.9	6.6	5.1	1.1	3.3	12.7	12.1	6.9	4.2	5.2	8.8	2.7	3.0	4.1	13.2	12.3	18.3	75.6	7.6	4.2	12.2	53.5	4.5	2.2	29.0	15.7	4.2	9.5	76.0	104.6	122.9	41.0	57.4	159.7	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.5	20.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.4	0.0	0.4	0.0	15.3	4.0	0.2	0.0	0.0	0.0	0.0	0.0	8.1	0.1	0.2	1.0	0.5	17.4	18.5	0.0	0.0	0.3	0.2	3.6	9.5	0.7	0.0	0.1	0.2	0.5	0.3	0.3	0.0	0.0	117.5	0.3	0.0	1.0	0.0	0.5	0.1	0.8	0.4	0.0	87.3	0.1	10.5	122.9	85.7	57.4	84.1	25.8	6.7	28.4	39.5	76.0	9.5	19.1	32.0	104.6	41.0	81.0	11.6	20.7	159.7	9.0	16.8	1.7	8.0	7.2	6.4	14.3	2.9	12.1	12.2	14.9	42.5	86.5	0.5	4.8	0.0	3.5	15.3	5.3	19.4	5.2	0.0	3.4	0.0	2.7	0.5	5.2	0.0	0.0	0.3	3.3	5.7	0.5	23.1	4.3	620.8	0.0	0.0	11.6	458.1	2.1	0.6	428.6	5.0	109.2	0.1	0.3	0.4	0.0	1.4	3.4	0.6	6.5	3.1	0.2	1.1	4.4	4.7	303.6	0.2	0.6
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"		NA	NA		95000	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	72.5	13.8	9.7	9.7	10.0	0.8	50.1	5.7	8.2	34.2	18.8	14.8	28.0	12.9	31.7	17.2	25.6	13.9	29.1	32.9	9.4	5.1	19.6	22.1	20.4	3.5	12.0	6.2	17.4	12.1	8.9	8.4	36.4	13.0	23.0	10.1	27.1	18.6	23.1	15.9	33.3	16.1	25.1	9.0	18.7	12.4	17.0	8.7	2.8	18.8	16.2	10.9	24.4	27.1	0.1	1.1	0.4	0.6	0.9	2.1	5.8	28.5	71.2	5.1	12.9	48.3	14.1	26.4	30.6	19.0	5.7	9.2	14.2	37.3	0.1	14.9	51.9	28.1	22.9	4.6	15.9	5.0	0.3	3.1	10.1	11.0	14.9	8.4	0.0	18.5	8.4	3.7	14.3	7.5	81.6	19.1	0.0	9.0	15.3	19.5	29.0	0.1	0.1	22.9	16.0	7.9	0.0	8.2	10.7	16.1	6.3	0.1	10.7	22.7	33.8	25.8	9.4	19.1	0.6	49.1	21.5	32.5	18.6	15.8	2.6	2.7	0.1	22.5	0.1	74.2	0.4	0.6	0.2	2.1	0.2	0.0	0.0	0.2	0.0	1.1	0.1	0.3	0.4	0.4	0.9	0.4	0.1	0.0	5.8	9.7	10.0	5.7	8.2	9.4	5.1	12.0	6.2	13.0	8.7	6.0	7.9	2.2	18.8	15.2	6.2	26.4	43.3	5.3	10.3	27.9	3.9	56.6	10.0	34.5	7.5	22.6	19.6	0.0	16.3	4.7	30.7	22.0	0.0	32.1	60.3	33.4	3.4	41.1	27.6	2.3	18.7	16.7	10.1	0.0	13.3	47.4	43.9	27.4	15.6	10.2	15.2	38.8	35.3	1.4	6.4	19.4	46.1	0.0	15.0	12.0
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191318-53207307	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.3;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 35.7;granulocytes: 29.9;T-cells: 27.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	99	"Karpas-707: 295.2;RPMI-8226: 230.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA042277			Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		NA	NA		42000	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear membrane, Vesicles"	"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"	1.8	1.4	1.4	29.1	1.8	7.5	1.5	0.6	1.2	1.8	8.7	2.9	0.8	6.7	2.3	2.8	6.6	2.0	5.6	1.4	1.5	1.0	5.4	5.1	4.9	26.4	1.9	1.0	1.1	1.3	0.7	1.7	1.8	2.4	2.7	5.6	2.1	10.7	2.2	1.0	6.4	15.1	1.5	2.0	26.7	4.3	0.9	2.0	7.8	3.6	4.4	37.6	4.6	3.0	10.1	15.4	31.3	1.9	7.5	23.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	295.2	0.0	0.0	0.0	0.4	0.0	2.4	0.0	0.1	0.0	230.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.2	0.2	0.1	0.1	22.6	1.9	31.3	19.3	0.5	14.3	10.1	19.4	23.0	15.4	8.3	16.3	17.1	0.5	7.5	0.1	4.2	22.7	5.2	1.4	1.8	0.6	1.2	1.5	1.0	1.9	1.0	2.4	2.0	3.0	8.5	35.7	0.3	1.9	0.0	0.4	2.5	0.0	0.0	7.0	3.9	0.1	6.6	0.2	0.0	0.1	0.0	0.0	0.5	0.1	1.0	0.1	29.9	1.6	13.8	0.0	0.0	0.6	3.0	0.0	0.0	7.0	6.8	7.2	0.3	6.6	0.6	0.0	0.0	4.4	0.7	0.0	0.4	0.2	1.1	3.1	0.1	27.7	0.9	1.3
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 99.3;Ciliated cells: 78.9;Glandular cells: 109.9;Urothelial cells: 146.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	105	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"AF22: 16.6;EFO-21: 21.4;RPTEC TERT1: 33.2;WM-115: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	4.7	4.1	18.0	5.8	20.0	1.2	12.7	7.8	24.3	22.1	4.6	19.4	9.0	4.6	10.5	19.0	8.8	10.4	11.7	3.9	19.4	12.5	28.1	1.7	3.7	1.3	29.3	14.5	7.1	17.5	8.1	7.7	10.7	22.8	9.6	4.4	37.5	16.6	13.1	0.9	8.5	6.0	7.0	23.1	0.8	6.2	8.7	24.0	0.0	3.4	1.3	9.0	6.8	9.9	0.0	0.0	13.8	0.1	0.0	0.1	0.0	10.2	0.4	16.6	2.1	1.4	5.9	0.0	0.0	0.1	0.1	0.6	0.1	2.6	0.0	21.4	0.7	0.6	11.4	0.7	1.6	0.2	0.0	0.2	0.0	8.0	0.0	0.7	0.0	0.0	0.7	4.7	0.2	0.9	10.2	0.8	0.0	0.0	3.1	0.3	0.0	0.0	0.0	1.2	0.1	1.8	0.0	1.4	0.0	33.2	0.9	0.2	0.7	3.2	0.0	8.3	0.3	0.2	0.0	1.1	4.3	2.8	1.2	2.1	3.9	0.0	0.0	1.0	0.0	47.5	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	18.0	20.0	7.8	14.2	19.4	12.5	29.3	14.5	22.8	24.0	11.9	3.7	0.8	99.3	29.5	5.2	3.1	43.3	78.9	30.7	36.6	0.0	12.5	6.6	22.1	2.3	1.9	4.6	0.0	15.3	0.9	3.2	109.9	1.1	0.0	3.1	1.6	32.6	1.3	1.5	3.5	40.9	12.4	3.3	55.1	6.8	26.0	24.5	6.2	42.1	44.6	1.2	0.0	1.4	0.5	0.7	10.8	4.1	0.5	7.3	146.8
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777592-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	95	"liver: 321.2"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 864.9"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.9;Hep G2: 3.3;HL-60: 2.5;RH-30: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	4490000	31000000000	Vesicles		"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	321.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	864.9	0.1	0.0	0.0	18.4	14.8	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.5	0.0	0.0
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703269-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	202	"liver: 249.0"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 455.1"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	445	"Hep G2: 155.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		22000000000	"Golgi apparatus"		"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	249.0	0.1	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.3	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.6	0.1	0.4	0.4	0.6	0.4	0.1	0.5	0.3	0.6	0.2	0.8	0.2	1.2	0.1	0.0	0.1	0.6	0.1	0.4	0.4	0.3	0.5	0.5	1.1	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.3	94.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	455.1	0.1	0.0	0.0	11.1	9.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ITIH4	"H4P, IHRP, ITIHL1"	ENSG00000055955	"Inter-alpha-trypsin inhibitor heavy chain family member 4"	Q14624	3	52812975-52831479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 461.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 104.1;Hepatocytes: 95.7;Late spermatids: 94.2"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 7.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.3;JURKAT: 4.5;U-266/70: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001835, HPA003948, CAB072872"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	3060000	53000000000	Vesicles		"CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433"	"unprognostic (6.08e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-14)"	"unprognostic (1.71e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.21e-5)"	0.5	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.1	1.3	0.2	0.1	0.1	0.6	0.1	0.0	0.2	461.4	0.2	0.1	0.1	0.2	0.2	22.8	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.2	4.1	0.1	0.1	0.2	0.1	0.5	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.3	0.3	0.6	0.6	2.6	0.8	0.0	0.0	0.4	1.0	2.1	1.1	0.0	0.4	0.1	0.0	0.0	0.2	0.3	0.2	1.3	0.0	0.5	0.2	1.1	0.0	0.0	0.5	5.3	0.2	2.2	0.0	2.8	0.9	2.4	0.2	0.3	0.3	0.0	0.1	0.0	0.0	4.5	0.6	1.8	0.0	0.2	0.5	0.7	1.0	0.2	0.0	1.8	1.0	0.0	0.8	0.7	0.1	1.0	0.7	0.0	0.4	1.1	1.1	0.7	0.2	0.0	0.9	1.0	0.0	6.5	3.0	0.5	0.1	0.7	1.2	0.0	0.6	0.0	0.1	0.1	0.1	0.3	0.7	0.0	0.0	0.2	0.0	0.8	0.6	2.6	0.1	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.6	1.9	0.2	0.7	10.2	0.4	5.1	0.0	1.2	0.0	11.8	0.0	0.0	0.3	104.1	0.6	0.0	23.3	2.3	0.0	0.4	0.3	0.0	95.7	0.4	4.8	0.0	3.1	2.6	94.2	1.1	1.6	0.0	1.0	0.0	1.7	3.5	0.0	1.8	0.0	5.6	6.5	2.1	0.9	1.4	0.3	0.2	1.3	0.0	0.1
ITIH5	MGC10848	ENSG00000123243	"Inter-alpha-trypsin inhibitor heavy chain family member 5"		10	7559270-7666998	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"placenta: 58.6"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 223.5;Sertoli cells: 77.6;Smooth muscle cells: 89.6;Syncytiotrophoblasts: 185.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"WM-115: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038305	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Vesicles	"HPA038305: AB_10670662"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.48e-2)"	42.6	2.4	3.7	15.2	5.0	0.0	33.7	2.9	5.1	8.1	9.4	3.6	4.4	4.1	12.0	8.6	6.9	3.4	18.8	4.8	4.4	4.0	5.3	2.3	6.9	3.2	4.4	4.3	7.2	4.4	1.4	3.1	58.6	4.6	11.0	5.3	12.7	3.4	16.2	4.7	4.1	5.7	37.5	3.9	2.2	5.6	4.0	2.2	0.0	6.4	5.2	5.5	24.0	11.7	0.8	0.4	1.4	0.5	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	7.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.0	1.4	0.3	0.3	0.4	0.4	0.5	0.4	0.6	0.4	0.2	0.8	0.6	0.5	1.0	0.5	0.5	0.4	0.5	0.1	3.7	5.0	2.9	5.1	4.4	4.0	4.4	4.3	4.6	2.2	3.0	2.4	0.0	2.3	10.1	1.3	4.0	5.1	1.4	6.8	0.0	2.0	223.5	0.0	15.3	1.6	30.5	0.0	0.0	0.3	45.7	53.7	1.2	2.3	0.0	18.1	0.0	0.0	1.8	0.0	1.6	4.9	3.3	13.5	1.0	0.0	25.4	0.5	0.0	14.5	1.0	2.1	77.6	89.6	1.9	7.5	7.8	185.6	0.0	0.0	1.4
ITM2A	"BRICD2A, E25A"	ENSG00000078596	"Integral membrane protein 2A"	O43736	X	79360384-79367667	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 252.4;granulocytes: 190.5;Leydig cells: 310.7;Muller glia cells: 153.0;T-cells: 187.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 191.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000296			Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Golgi apparatus, Plasma membrane"	"HPA000296: "	"unprognostic (1.05e-2)"	"unprognostic (5.22e-3)"	"unprognostic (2.77e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-3)"	"prognostic favorable (3.66e-6)"	"unprognostic (1.57e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.30e-1)"	27.2	4.1	27.0	9.1	37.8	13.6	27.4	7.8	25.8	21.8	11.0	16.1	6.5	5.4	16.4	19.4	14.8	15.3	10.6	42.1	33.6	22.5	7.7	2.2	19.0	28.5	34.8	19.5	69.6	6.3	2.7	9.3	10.6	25.8	16.7	11.9	16.2	28.2	8.8	13.2	10.3	8.8	20.9	33.9	8.4	9.6	8.0	12.5	100.7	31.1	14.1	16.5	14.7	16.6	4.7	1.1	26.5	0.2	25.2	48.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.3	0.0	0.5	0.0	7.8	0.0	0.0	0.0	12.4	14.4	2.3	0.0	0.0	0.0	0.0	0.0	37.7	8.8	0.0	0.0	0.0	191.0	8.6	2.8	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.2	0.0	0.1	0.0	2.1	0.2	0.2	0.3	0.0	0.2	0.0	0.1	24.1	0.0	0.0	0.0	0.0	0.9	26.5	0.1	16.8	23.2	0.2	17.0	4.6	44.6	36.5	0.1	4.7	48.0	22.6	0.8	25.2	0.2	1.1	32.4	22.6	27.0	37.8	7.8	25.8	33.6	22.5	34.8	19.5	25.8	12.5	3.0	20.8	15.9	13.6	59.9	2.3	25.4	5.1	1.4	7.9	1.8	0.0	0.4	5.0	0.2	2.4	252.4	0.0	0.0	46.7	0.1	64.7	9.2	190.5	0.8	1.0	1.6	2.4	119.7	10.6	4.7	310.7	4.2	59.1	1.0	66.9	153.0	0.9	0.0	110.7	1.1	5.8	0.0	20.2	0.4	1.1	41.0	0.2	187.1	2.3	2.3
ITPK1		ENSG00000100605	"Inositol-tetrakisphosphate 1-kinase"	Q13572	14	92936914-93116320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Isomerase, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 24.2;monocytes: 13.0"	"Cell line enhanced"	"Detected in all"		"WM-115: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055230	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055230: AB_2682748"	"unprognostic (1.93e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.56e-4)"	"unprognostic (4.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.20e-1)"	"unprognostic (7.25e-3)"	32.0	10.2	44.3	11.9	49.5	12.2	14.4	19.3	50.5	23.8	20.0	29.7	9.6	34.9	20.2	10.2	18.7	15.9	16.1	18.4	49.0	30.6	11.4	13.4	13.0	7.6	42.1	27.1	11.4	15.0	13.2	5.3	11.2	18.5	15.1	13.6	14.5	8.3	19.1	9.4	5.5	36.6	19.4	44.8	14.1	11.9	9.4	26.1	3.4	10.0	3.2	5.5	16.7	16.2	1.9	3.9	24.2	13.0	1.3	1.9	2.4	10.3	21.5	4.0	10.2	9.0	5.0	10.8	4.4	6.7	8.9	5.4	12.3	18.7	6.6	22.2	7.0	3.4	12.3	11.5	19.1	2.8	24.4	5.0	14.5	5.7	10.6	6.7	6.6	16.2	3.2	11.5	4.5	10.4	3.9	8.7	6.9	7.9	7.6	4.3	27.9	5.6	9.4	8.4	13.6	9.7	10.8	5.9	9.8	6.0	17.5	10.9	13.8	11.2	22.8	19.0	3.2	30.6	8.1	6.8	6.2	6.8	10.4	7.0	7.5	6.8	4.2	5.7	5.2	42.6	2.5	5.2	9.5	1.9	8.6	1.1	1.9	1.2	1.2	3.9	0.7	0.7	1.3	24.2	1.3	13.0	1.9	1.7	2.4	44.3	49.5	19.3	50.5	49.0	30.6	42.1	27.1	18.5	26.1	11.9	12.0	6.7	6.5	6.5	9.7	21.5	15.3	4.0	5.7	27.9	17.7	6.9	11.6	20.4	8.3	10.1	79.1	0.0	23.9	8.8	7.8	13.3	16.1	25.9	18.3	6.4	27.6	12.3	38.1	17.6	13.8	26.0	25.3	15.4	25.6	15.5	29.8	38.6	45.3	17.0	9.3	19.4	15.3	2.8	12.8	3.9	5.7	9.6	25.9	7.9
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.8;intestine: 19.8;stomach 1: 10.7"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 36.6;Enterocytes: 34.8;Late spermatids: 119.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2"	"Cell type enriched"	"Detected in single"	8	"MAIT T-cell: 4.7"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.7;OE19: 12.5"	"Group enriched"	"Detected in many"	13	"amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9"	"Group enriched"	"Detected in many"	7	"amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6"	HPA040454	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		No	No			Vesicles	"Plasma membrane"	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.4	3.0	12.3	1.1	21.2	0.8	0.4	3.0	28.8	0.6	8.5	0.3	0.0	19.8	0.6	0.5	0.4	0.6	0.6	0.7	10.4	0.9	0.4	0.8	0.4	0.4	1.6	8.2	0.6	2.5	1.7	0.0	0.7	0.3	0.8	3.4	0.0	2.1	0.8	1.4	0.4	19.7	0.7	0.2	0.4	10.7	3.5	0.6	0.0	0.4	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.3	4.7	0.0	4.7	1.3	0.2	5.6	0.0	1.8	10.2	3.0	2.4	2.0	2.1	11.2	0.2	0.0	2.5	0.2	4.5	0.5	2.4	0.2	0.1	4.5	3.0	6.8	3.0	22.7	9.2	2.3	0.3	0.1	0.1	1.9	0.6	1.1	0.1	0.9	8.6	1.3	0.7	3.1	0.2	4.4	0.6	12.5	4.0	1.1	1.0	0.4	0.2	0.3	0.5	1.1	2.2	0.0	0.2	0.0	0.6	3.4	0.2	4.9	5.1	5.4	8.1	0.7	7.1	0.0	9.1	9.0	1.6	0.0	0.0	0.0	0.3	0.0	4.7	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.3	21.2	3.0	28.8	10.4	0.9	1.6	8.2	0.3	0.6	0.0	0.0	0.0	0.4	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	36.6	0.0	34.8	0.0	0.6	0.4	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	119.2	2.3	0.0	0.0	0.0	12.0	7.3	0.4	19.3	1.4	0.0	0.1	6.5	0.7	1.9	3.0	0.0	0.1	0.0	14.4	0.1
ITPKB	"IP3-3KB, IP3KB"	ENSG00000143772	"Inositol-trisphosphate 3-kinase B"	P27987	1	226631690-226739323	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.1"	"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 35.8;Ito cells: 27.0;Smooth muscle cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030273, HPA072923"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030273: AB_10601127, HPA072923: AB_2686558"	"unprognostic (4.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.24e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.87e-2)"	23.8	4.2	34.7	13.0	35.1	14.8	15.2	11.1	33.6	14.3	19.7	32.4	8.5	6.0	27.1	15.6	12.6	15.3	8.9	7.8	27.9	24.8	9.7	3.2	13.4	22.7	50.4	16.3	8.8	4.8	10.1	4.2	13.5	40.0	13.1	6.3	20.8	24.9	21.3	9.8	10.5	12.5	32.6	63.1	19.0	12.4	3.2	34.0	20.0	5.9	4.3	17.1	19.6	8.5	3.1	0.9	7.7	3.5	3.0	7.9	2.6	2.8	3.0	4.9	5.7	3.9	2.5	1.3	0.8	3.4	1.6	3.7	0.5	3.6	13.1	4.7	0.7	0.3	4.2	6.3	2.5	0.8	1.8	4.3	5.8	3.4	0.0	1.5	5.4	10.3	2.8	3.7	1.7	1.6	4.4	10.7	6.7	0.0	1.8	0.2	2.7	9.9	7.3	10.9	2.1	4.9	3.8	8.9	2.9	11.5	4.6	2.9	3.8	2.3	1.7	28.6	5.1	7.3	6.1	7.4	2.1	1.6	1.8	4.6	0.1	4.6	16.0	0.5	4.9	7.5	1.2	1.4	7.7	4.4	2.1	3.9	1.9	5.3	4.5	0.9	3.1	7.9	5.7	5.4	3.0	3.5	0.8	3.0	2.6	34.7	35.1	11.1	27.9	27.9	24.8	50.4	16.3	40.0	34.0	0.0	6.1	11.1	3.8	10.9	0.3	5.6	0.0	2.7	5.7	7.0	0.0	0.5	3.3	2.0	2.0	35.8	1.3	0.0	2.0	1.1	8.5	6.5	9.3	0.9	16.4	0.0	4.1	27.0	17.7	16.5	6.6	8.6	18.6	2.8	2.6	1.4	2.3	3.2	8.9	0.5	0.0	0.0	32.0	0.9	2.3	8.8	0.3	22.3	2.9	2.1
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493348-4847840	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 46.6"	"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 49.5;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.0;HeLa: 25.5;HMC-1: 16.9;U-87 MG: 20.8"	"Region enhanced"	"Detected in all"		"cerebellum: 782.1"	"Low region specificity"	"Detected in all"			"HPA014765, HPA016487"	Approved		Approved	Vesicles		NA	NA		37000	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.40e-1)"	4.8	8.2	6.1	7.4	18.6	3.2	11.9	39.5	30.2	10.2	7.4	1.7	21.5	2.4	18.4	13.2	7.8	10.1	11.8	5.3	8.7	5.1	8.7	2.5	6.4	7.1	4.8	10.4	14.2	2.7	46.6	7.3	4.6	3.8	15.0	3.7	12.5	9.6	27.4	3.2	3.2	5.0	17.4	3.7	6.0	5.5	3.0	4.3	7.0	19.3	0.6	8.6	14.1	10.6	8.9	3.6	5.4	1.6	1.2	2.2	1.2	0.0	1.3	0.2	0.6	10.0	0.4	3.2	0.2	0.2	0.3	0.3	0.3	0.3	4.4	0.4	0.4	1.8	0.0	0.9	1.1	0.5	35.0	1.4	12.7	25.5	1.6	13.8	5.4	16.9	2.6	0.7	1.7	0.5	3.6	1.4	3.4	1.4	5.1	1.3	0.5	2.4	1.8	0.9	0.2	3.9	1.4	0.2	0.3	1.1	1.1	0.1	8.5	2.3	1.4	2.3	0.3	0.9	7.7	1.7	0.8	1.4	1.1	1.0	7.8	3.7	2.9	20.8	5.8	1.8	5.4	1.6	1.9	1.5	1.0	1.9	6.6	1.7	1.5	2.1	8.9	2.2	1.9	0.8	1.2	0.7	3.6	1.3	1.2	6.1	18.6	39.5	30.2	8.7	5.1	4.8	10.4	3.8	4.3	0.0	31.8	25.3	4.8	3.4	1.6	4.8	5.1	21.4	14.8	8.7	0.0	0.5	3.3	1.5	4.4	22.4	0.0	0.0	4.5	0.4	13.0	6.1	24.4	1.8	4.7	1.6	3.4	22.1	13.3	5.7	27.9	15.3	6.8	6.4	0.8	3.9	1.5	0.3	49.5	3.5	1.0	38.8	26.4	1.4	2.6	2.8	0.8	19.5	0.6	3.1
ITPRIPL2	"FLJ22994, LOC162073, MGC126798, MGC126800"	ENSG00000205730	"ITPRIP like 2"	Q3MIP1	16	19113932-19121629	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042011			Approved	Centrosome		NA	NA			Centrosome		"HPA042011: AB_2677795"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.26e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	32.6	10.7	6.2	8.3	6.0	0.9	25.8	1.2	4.1	16.0	11.4	4.3	8.2	6.1	12.7	10.6	16.4	10.2	12.7	9.9	3.8	2.8	6.4	9.5	16.7	5.1	5.6	2.1	11.6	15.0	8.5	4.7	26.5	5.7	19.1	5.9	9.5	8.5	8.9	7.3	19.7	9.1	11.3	4.0	7.8	9.9	4.9	5.7	2.0	12.0	12.8	8.0	14.2	25.7	0.5	1.9	1.3	6.6	0.2	0.6	0.6	9.1	5.4	2.1	7.1	18.5	28.3	14.2	14.7	10.4	4.3	4.0	2.2	16.6	0.0	15.1	11.5	5.1	10.5	3.0	4.5	5.7	0.0	3.0	0.7	10.9	3.8	12.0	0.0	0.0	18.7	12.5	8.3	9.5	7.8	5.6	0.0	1.3	0.0	10.2	6.2	0.0	0.2	2.2	1.9	7.2	0.0	0.3	0.0	6.5	15.5	0.2	2.7	12.0	1.2	7.1	3.6	7.2	1.4	11.1	15.1	6.5	7.7	5.5	0.1	0.0	0.0	8.8	0.3	7.5	1.3	2.8	0.3	0.6	3.4	0.3	0.5	0.3	0.5	1.9	0.3	0.2	0.5	1.0	0.2	6.6	1.2	0.1	0.6	6.2	6.0	1.2	4.1	3.8	2.8	5.6	2.1	5.7	5.7	47.6	33.6	2.4	22.3	11.3	0.5	5.6	7.6	22.7	33.0	24.4	2.0	13.4	1.7	13.6	0.3	28.7	14.4	0.0	27.1	8.2	28.3	27.3	5.7	22.2	21.0	4.8	13.8	41.1	49.9	0.4	24.7	27.1	13.5	27.9	19.6	1.7	33.4	8.6	28.3	0.1	0.3	38.8	24.5	0.2	1.9	15.2	12.0	1.3	16.3	29.4
ITSN2	"KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP"	ENSG00000198399	"Intersectin 2"	Q9NZM3	2	24202864-24360714	"Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036475	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA036475: AB_10670718"	"unprognostic (2.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.95e-2)"	"unprognostic (4.64e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.12e-2)"	16.8	18.8	13.4	30.7	14.8	41.4	16.6	15.2	18.3	17.4	16.8	11.5	17.9	11.3	15.1	11.8	31.4	13.3	12.6	17.3	12.0	10.3	15.3	17.7	23.6	31.7	15.0	11.7	16.4	42.6	16.1	27.2	15.9	14.3	19.1	13.5	9.9	17.2	17.2	23.5	20.5	20.2	18.0	13.3	27.8	16.2	9.6	17.0	27.0	35.1	15.6	31.8	19.8	22.9	27.2	10.6	43.0	20.4	8.9	13.0	6.8	16.3	8.0	2.0	5.9	5.8	7.8	18.0	10.0	9.4	4.6	5.6	7.7	8.7	25.4	8.8	8.2	13.7	7.4	9.0	6.3	7.7	20.1	8.4	34.5	4.9	8.6	9.8	17.6	19.9	6.0	7.4	8.1	14.2	8.9	14.5	9.7	9.8	19.4	7.2	6.7	7.2	8.7	3.7	10.0	7.9	9.1	23.2	7.5	8.2	30.8	1.3	4.1	7.9	8.5	12.0	8.4	5.8	9.5	19.9	9.9	8.7	8.2	9.2	21.2	23.4	26.6	7.9	16.4	8.6	20.6	11.4	19.9	12.4	13.9	13.0	24.1	10.8	10.8	10.6	27.2	11.0	9.9	43.0	8.9	20.4	7.0	11.2	6.8	13.4	14.8	15.2	18.3	12.0	10.3	15.0	11.7	14.3	17.0	89.3	88.9	91.3	70.6	45.9	22.7	60.0	28.1	38.8	61.4	27.9	19.6	21.9	14.9	44.1	3.8	51.3	36.0	23.3	66.3	28.1	26.7	69.2	100.6	25.2	37.6	12.7	23.5	39.3	73.8	3.3	27.9	98.8	23.6	86.6	22.0	17.9	67.9	45.6	17.0	28.3	34.8	12.9	26.8	64.6	43.3	50.7	20.3	66.0	19.3	94.5
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405795-40435947	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		66000	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	12.3	32.0	15.4	13.2	20.6	6.7	24.3	14.4	18.0	12.7	13.7	20.5	23.3	12.3	11.8	16.6	8.9	17.2	22.7	30.4	13.8	16.1	28.9	71.9	14.2	10.4	16.1	15.9	19.4	18.9	19.5	23.9	7.4	16.3	21.0	13.0	14.4	11.8	31.9	30.6	3.5	9.8	13.7	14.7	11.0	14.4	11.2	15.7	8.6	55.7	12.2	9.0	11.2	7.9	11.6	34.1	14.3	29.8	14.7	13.5	8.6	8.7	5.3	9.7	17.4	15.4	13.5	0.4	13.5	13.2	17.3	10.8	19.8	7.6	0.3	25.8	17.0	14.9	10.3	18.4	19.9	10.7	12.6	14.8	22.7	15.4	19.0	27.1	9.2	22.6	20.6	6.9	9.6	20.2	20.0	17.1	24.4	1.0	1.1	15.5	13.8	11.4	14.3	8.2	0.5	16.9	16.7	13.3	10.4	20.5	23.7	16.6	9.2	18.6	40.5	8.2	9.4	34.9	40.7	14.5	14.4	9.4	10.1	10.8	21.8	14.9	0.3	13.5	9.2	14.1	5.8	10.2	14.3	13.5	16.1	12.6	11.6	7.5	11.4	22.3	9.9	8.4	11.7	1.3	14.7	29.8	34.1	9.7	8.6	15.4	20.6	14.4	18.0	13.8	16.1	16.1	15.9	16.3	15.7	26.8	46.2	14.3	16.6	2.1	24.6	72.6	45.9	42.8	40.9	41.8	13.7	16.5	81.2	15.9	4.4	18.0	17.7	23.3	13.0	4.8	15.4	16.0	32.5	123.8	25.1	15.9	18.9	17.2	20.2	4.9	19.0	13.9	5.0	31.5	22.5	25.1	14.1	3.5	23.3	60.9	18.9	19.4	13.9	19.0	4.3	0.5	8.2	12.2	33.1	11.2
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 97.1;tongue: 152.1"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 62.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"HaCaT: 78.9;RT4: 20.7;SK-BR-3: 23.8"									"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		NA	NA		8000000	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	39.0	0.1	0.0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	1.8	0.1	0.0	18.7	0.1	0.2	34.2	0.1	1.0	0.0	0.1	0.1	0.1	0.0	1.9	0.1	152.1	49.1	4.9	43.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	78.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	23.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	0.0	0.0	7.4
JADE1	"JADE-1, PHF17"	ENSG00000077684	"Jade family PHD finger 1"	Q6IE81	4	128809623-128875224	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020016	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020016: AB_1855292"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.93e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (8.22e-6)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.68e-1)"	20.5	14.6	5.7	12.7	7.9	25.9	27.9	16.3	9.7	10.8	9.8	4.6	18.9	5.6	8.4	9.0	8.1	11.8	14.3	14.2	5.7	7.1	22.1	7.4	12.6	13.2	6.9	4.9	18.6	55.7	17.4	10.8	7.2	7.3	12.0	4.3	8.5	25.6	16.8	10.5	8.6	10.6	16.3	5.4	10.2	12.5	6.1	8.5	13.3	28.7	7.2	7.9	12.1	31.1	12.6	6.9	23.0	14.3	20.1	18.4	10.4	6.1	12.3	12.2	9.0	16.8	11.9	16.1	10.0	6.0	10.9	10.0	10.7	11.0	19.1	11.9	5.7	4.8	2.2	14.3	3.5	12.3	14.8	6.3	10.6	16.9	9.7	29.0	17.3	8.6	13.2	5.7	13.3	9.9	9.1	11.8	12.5	16.9	26.4	8.5	7.5	21.8	13.0	32.8	6.3	6.2	15.6	8.4	10.3	17.4	3.0	15.9	11.6	9.6	7.8	7.7	17.9	6.3	9.8	8.1	10.8	17.8	8.2	11.7	17.5	13.9	21.7	11.8	17.4	8.8	17.2	7.2	23.0	12.3	11.6	15.3	9.5	13.4	13.5	6.9	12.6	18.4	14.5	9.1	20.1	14.3	3.3	9.4	10.4	5.7	7.9	16.3	9.7	5.7	7.1	6.9	4.9	7.3	8.5	35.7	20.1	17.2	15.1	13.3	37.9	30.3	33.1	32.1	19.4	47.1	47.1	22.1	16.6	28.2	2.8	23.2	6.3	0.0	42.1	12.0	18.5	12.6	17.3	35.0	9.1	27.0	9.8	16.5	28.2	3.2	33.4	11.9	20.3	4.6	7.2	27.1	37.2	7.6	45.3	28.6	26.8	84.1	34.0	4.8	22.2	11.7	3.3	31.9	7.3	5.2
JADE3	"JADE-3, KIAA0215, PHF16"	ENSG00000102221	"Jade family PHD finger 3"	Q92613	X	46912276-47061242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatogonia: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 4.8;naive B-cell: 3.7;plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	9	"B-cells: 4.8;dendritic cells: 1.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 36.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006007, HPA064697"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA006007: AB_1079605, HPA064697: AB_2685326"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-3)"	"unprognostic (4.55e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.18e-2)"	"unprognostic (9.70e-2)"	4.9	12.6	3.5	2.7	5.1	1.5	6.2	3.3	4.9	5.7	4.5	7.1	14.0	1.9	9.5	16.3	4.7	4.3	3.2	5.2	3.9	3.3	3.7	7.7	4.3	4.1	9.2	1.4	7.2	8.7	3.0	2.1	15.9	4.7	5.4	3.2	2.1	4.3	12.2	3.3	3.8	3.5	6.0	8.5	9.8	4.7	14.5	8.4	8.4	4.2	1.4	7.5	7.6	13.1	4.8	1.7	0.0	0.3	0.2	0.2	0.4	6.4	5.8	9.5	6.5	3.5	2.6	36.4	3.8	3.2	4.3	4.9	6.6	5.6	0.0	2.7	2.8	6.4	2.5	11.5	3.1	6.3	17.1	7.5	5.1	6.5	6.4	5.7	3.8	2.7	2.0	4.3	3.0	9.9	2.6	8.1	9.8	3.5	3.0	3.3	6.6	13.8	4.6	7.4	4.1	4.9	14.2	10.7	8.9	3.6	5.9	8.2	7.3	11.0	10.2	6.0	16.4	6.8	4.0	5.0	4.6	8.0	6.4	2.5	2.3	2.0	12.2	1.2	3.3	4.4	0.0	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.1	3.7	0.0	0.0	0.0	0.2	0.3	1.7	0.0	0.4	3.5	5.1	3.3	4.9	3.9	3.3	9.2	1.4	4.7	8.4	0.0	8.5	0.5	2.3	3.8	1.5	3.3	2.5	0.0	1.2	5.2	0.0	7.9	0.0	2.1	0.3	4.5	0.9	0.0	3.2	8.1	2.2	3.8	0.0	11.1	1.5	0.0	8.1	3.7	1.2	2.0	4.4	0.8	3.3	4.6	1.9	1.2	2.9	0.0	3.5	2.1	1.6	6.5	1.9	9.2	26.6	7.0	11.9	0.5	2.3	3.3
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Smooth muscle cells: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.7;hTERT-HME1: 35.0;U-251 MG: 47.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		14000000	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-3)"	27.7	5.6	6.8	14.5	5.4	9.7	56.5	2.9	6.7	34.2	20.1	4.3	17.4	7.2	26.1	22.8	33.9	16.7	23.1	18.8	5.4	5.1	12.9	3.8	22.0	12.4	5.4	4.0	14.7	22.2	21.7	6.0	36.3	6.0	19.2	12.7	21.4	11.2	23.4	16.8	34.8	11.7	21.4	13.0	14.2	13.4	9.1	3.8	1.5	14.5	24.6	16.1	18.7	31.4	0.0	0.9	2.4	2.0	0.4	0.1	0.4	1.0	5.3	16.6	20.4	3.2	3.1	0.6	0.6	3.1	0.9	0.4	4.7	2.9	0.1	15.7	0.6	4.7	22.2	2.4	56.7	0.7	0.0	1.1	1.7	0.5	22.2	1.5	7.1	0.1	1.2	16.8	2.8	35.0	3.3	5.5	0.0	0.0	2.3	1.5	0.0	0.0	5.1	4.8	17.5	5.3	1.3	1.0	3.3	8.0	6.5	0.7	0.5	1.6	1.1	6.7	13.8	0.1	0.8	20.7	3.8	2.6	3.1	47.7	0.9	0.1	0.2	2.4	2.6	2.9	0.0	2.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.6	0.4	0.3	0.9	0.0	0.4	6.8	5.4	2.9	6.7	5.4	5.1	5.4	4.0	6.0	3.8	38.7	12.5	0.0	46.4	93.0	10.0	12.5	35.7	20.1	22.7	15.7	41.2	12.0	1.7	26.8	3.9	70.8	26.0	0.0	27.0	0.9	33.7	18.4	6.9	1.5	3.7	20.6	5.1	38.1	3.7	6.3	19.8	7.7	13.5	1.8	10.2	9.3	60.7	22.4	31.8	2.1	72.6	84.1	154.6	0.7	2.8	93.3	1.8	0.0	22.9	32.5
JAGN1	"FLJ14602, GL009"	ENSG00000171135	"Jagunal homolog 1"	Q8N5M9	3	9890554-9894349	"Disease related genes, Predicted membrane proteins"	"Immunity, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067610			Approved	Vesicles		NA	NA			Vesicles		"HPA067610: "	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.49e-1)"	19.7	31.6	9.8	12.7	11.5	6.8	18.4	10.5	15.4	15.8	27.1	14.1	15.7	16.8	16.9	25.7	13.2	16.8	16.6	13.7	9.7	11.6	21.4	39.6	12.1	18.2	10.8	10.7	18.1	42.3	17.0	12.5	19.6	12.6	17.3	19.1	14.3	21.3	14.2	23.2	17.7	29.4	13.3	11.0	12.8	19.3	12.8	9.7	24.1	27.3	13.7	15.0	16.6	21.7	24.8	26.0	39.0	27.9	21.4	25.1	28.4	9.7	17.2	12.0	7.0	36.8	38.7	40.1	13.6	20.2	15.3	15.6	12.3	12.9	15.6	6.1	13.5	16.6	8.5	19.0	18.2	15.0	11.4	20.6	19.0	17.7	21.3	31.5	13.7	11.9	36.9	27.4	19.9	22.9	15.3	14.5	13.9	20.5	10.5	17.4	28.8	11.2	23.6	15.9	19.0	22.3	9.5	10.0	19.0	21.7	14.0	7.6	14.7	8.9	9.3	16.8	11.3	15.4	17.1	12.3	8.2	8.9	8.9	10.8	19.4	27.2	18.1	10.8	16.3	13.6	39.0	27.9	13.5	22.9	21.2	24.3	24.1	22.7	22.0	25.6	24.8	25.1	23.1	11.2	21.4	15.8	26.0	23.9	28.4	9.8	11.5	10.5	15.4	9.7	11.6	10.8	10.7	12.6	9.7	29.8	13.7	44.5	40.0	24.5	28.0	12.1	38.2	28.1	22.7	36.6	9.8	65.9	18.3	67.2	2.3	32.2	60.0	0.0	85.4	70.3	33.6	53.3	8.1	50.5	49.2	22.3	24.8	27.6	35.9	5.3	36.5	26.2	35.4	82.0	47.9	47.2	66.6	49.1	36.4	48.8	15.8	45.3	21.7	60.6	36.4	32.1	44.3	31.0	53.6	30.1
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 40.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 40.8"	"Group enriched"	"Detected in many"	5	"ASC diff: 19.4;HDLM-2: 27.4;HEL: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	19.8	8.8	11.5	19.0	10.5	19.0	17.7	14.7	14.4	17.8	10.6	7.0	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7.0	10.5	15.9	6.7	10.1	7.5	12.0	10.0	12.0	7.4	9.4	7.2	7.4	14.4	19.0	12.3	10.4	11.7	21.5	14.1	10.1	9.0	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.5	1.5	2.5	19.4	5.0	0.4	3.5	3.0	2.7	1.8	0.1	0.8	0.1	0.8	2.1	2.2	0.9	1.6	2.1	2.0	27.4	0.5	56.1	3.0	0.7	4.0	3.8	2.9	4.1	0.9	1.1	1.8	3.3	2.5	2.0	4.0	6.5	4.8	0.9	0.9	5.4	1.3	1.3	1.7	1.9	2.8	0.8	2.0	1.3	1.7	0.9	1.0	1.5	1.1	1.6	0.8	6.7	5.1	4.1	1.4	4.2	2.4	1.2	2.3	0.5	5.3	1.9	2.0	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7.0	10.5	10.0	9.0	14.9	6.4	6.9	2.8	8.7	7.4	22.0	0.0	5.3	7.9	7.0	7.9	1.8	1.7	3.0	7.4	8.7	3.9	23.3	3.4	0.8	7.0	1.7	13.9	1.6	11.9	7.9	2.9	4.9	36.0	5.3	21.9	27.7	5.0	16.2	4.2	12.2	5.4	14.4	31.5	2.5	11.1	0.0	5.0	14.9	5.7	7.3	2.9	5.0	3.3	4.1
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 68.3"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 18.2;Ito cells: 14.1;Peritubular cells: 13.8;T-cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.6;HEL: 9.2;HMC-1: 9.4;Karpas-707: 24.0;U-266/70: 9.3;U-266/84: 13.8;U-937: 14.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favorable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.8	1.7	4.0	24.5	8.5	12.0	2.7	2.4	3.1	1.9	2.3	1.0	0.0	2.2	1.7	2.0	2.5	3.5	3.6	4.3	2.7	2.8	3.8	2.0	8.4	68.3	7.5	0.0	11.0	2.0	0.4	2.3	4.1	5.3	3.0	2.4	1.6	6.1	1.5	0.7	1.3	9.5	2.5	8.4	36.1	3.2	1.8	5.8	20.9	3.4	1.7	28.8	5.3	2.4	7.4	4.5	16.9	9.6	8.4	15.0	6.8	0.1	0.3	0.3	1.1	0.4	1.5	0.2	0.5	0.0	0.0	0.1	0.0	0.9	0.4	2.0	0.4	0.3	0.1	0.0	0.2	0.0	20.6	0.0	9.2	0.0	0.8	0.7	0.0	9.4	5.1	0.2	0.0	0.0	0.0	0.2	2.1	0.0	24.0	0.0	0.4	3.6	0.0	0.2	0.5	0.7	4.7	0.0	0.4	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.1	2.0	1.4	0.4	0.0	0.4	0.0	0.0	9.3	13.8	2.5	0.1	14.0	0.2	1.2	4.9	0.2	12.6	9.6	14.5	6.5	15.0	13.1	4.5	7.4	14.9	13.0	16.9	8.4	8.8	3.7	11.8	6.8	4.0	8.5	2.4	3.1	2.7	2.8	7.5	0.0	5.3	5.8	0.0	5.8	18.2	0.5	0.7	0.3	1.4	0.0	0.0	1.2	1.8	0.0	0.9	0.0	0.6	1.0	5.8	0.0	0.0	0.3	0.7	2.3	0.2	4.7	0.0	11.5	0.0	0.0	14.1	10.8	0.9	11.5	3.5	3.3	12.6	0.0	0.8	0.4	0.0	13.8	0.1	0.5	6.5	2.1	0.3	0.7	0.9	1.1	24.5	0.0	0.5
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639272-25717562	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.7"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 31.9;Endothelial cells: 151.0;Ito cells: 49.7"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.2;BJ hTERT+: 11.6;HDLM-2: 11.3;hTERT-RPE1: 16.2;U-138 MG: 13.1;U-87 MG: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA		17000	"Plasma membrane"	Nucleoplasm	"HPA028789: AB_2732443, HPA077346: AB_2732341"	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	16.6	17.2	13.8	8.4	18.9	1.5	14.6	9.9	23.4	18.1	14.7	14.5	8.0	7.5	20.5	13.5	13.3	12.0	14.4	21.9	13.5	12.5	6.5	3.5	17.1	4.6	17.6	13.5	18.9	3.9	5.8	7.7	66.7	18.5	12.0	9.7	11.1	5.5	18.0	8.4	6.9	9.2	21.8	23.0	2.8	9.7	25.8	12.2	0.6	9.5	10.1	6.3	13.5	15.1	3.1	1.9	1.9	0.7	2.8	1.1	0.4	0.0	0.0	18.2	0.1	0.7	0.2	0.4	0.5	11.6	1.5	5.5	0.0	0.0	0.1	0.0	0.2	7.0	0.0	1.6	0.0	3.4	11.3	0.5	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.0	1.3	0.0	16.2	0.0	0.4	0.0	0.2	5.6	0.1	0.3	0.1	5.7	0.1	0.0	2.1	3.7	0.0	0.0	0.0	0.3	2.7	0.1	0.2	0.0	0.2	0.6	0.1	0.0	13.1	1.2	0.1	1.8	1.5	0.0	0.0	9.6	0.1	0.5	1.4	0.7	0.3	0.4	0.5	0.6	0.3	0.4	0.9	0.4	3.1	0.7	1.1	1.9	2.8	0.6	1.9	0.2	0.4	13.8	18.9	9.9	20.5	13.5	12.5	17.6	13.5	18.5	12.2	0.0	2.9	1.4	1.4	6.6	1.5	31.9	0.0	1.4	0.0	3.5	13.7	0.3	0.0	0.3	12.9	151.0	0.0	0.0	0.2	2.2	18.5	1.2	0.0	0.0	1.0	0.0	0.0	49.7	2.2	13.2	9.2	1.4	15.1	0.0	0.0	0.9	0.1	0.0	23.0	0.0	3.6	0.0	7.6	4.8	3.9	5.8	0.7	0.0	0.0	0.7
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 32.2;SuSa: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	5.2	3.6	15.0	8.6	1.8	1.8	14.9	1.5	3.6	2.0	2.5	3.8	4.1	2.8	5.4	3.0	3.0	2.7	3.5	8.7	1.8	5.4	5.3	9.8	4.3	4.8	2.0	9.9	11.5	2.6	5.5	2.9	11.7	6.0	2.1	32.2	12.7	4.7	1.1	5.2	19.7	18.7	16.0	2.6	1.6	8.8	4.6	7.8	1.8	5.5	11.6	6.6	3.1	10.9	13.7	36.6	3.8	10.7	3.6	9.2	5.1	5.0	5.2	3.0	7.2	4.9	3.1	9.3	11.5	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5	6.0	10.9	22.2	9.5	71.4	71.0	8.9	10.2	4.0	11.4	5.2	82.5	23.3	1.7	6.8	59.2	24.1	12.3	0.0	3.9	19.3	18.6	5.7	24.3	12.9	21.4	146.2	25.7	14.1	48.4	29.9	8.1	37.2	25.3	20.8	16.0	167.6	11.0	11.5	8.1	2.6	91.1	6.5	25.0	7.0	67.9	132.5	21.1	30.5	13.4	13.6
JAZF1	"DKFZp761K2222, TIP27, ZNF802"	ENSG00000153814	"JAZF zinc finger 1"	Q86VZ6	7	27830573-28180743	"Disease related genes, Predicted intracellular proteins"	"Lipid metabolism, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 85.4;Late spermatids: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019271, HPA066967"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB019271: , HPA066967: AB_2685758"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-2)"	11.9	65.2	18.7	13.4	13.1	16.7	17.7	26.9	19.2	50.1	23.0	8.5	12.8	3.4	34.1	18.4	8.4	11.9	9.9	17.0	14.0	14.8	4.8	12.2	9.9	10.8	8.9	16.9	11.6	5.7	5.6	19.0	12.3	11.1	23.6	7.3	4.8	4.2	28.1	5.6	5.9	6.7	29.7	12.2	11.0	7.4	14.3	10.0	6.3	12.1	5.5	11.9	18.7	24.3	4.6	12.5	17.6	3.7	4.3	4.6	2.4	0.7	0.6	2.4	0.6	18.6	22.7	0.0	5.8	14.7	9.7	11.8	0.0	3.8	16.8	11.8	11.7	6.5	0.3	3.2	4.2	7.7	2.5	5.1	6.0	4.2	0.0	12.7	2.5	1.7	10.2	5.2	7.2	4.8	7.3	5.9	1.3	0.1	27.5	5.2	0.7	0.7	8.7	5.2	0.1	3.9	1.8	1.1	5.1	3.4	0.1	1.5	2.6	4.6	0.1	6.0	7.7	1.7	3.0	5.8	15.3	6.0	4.1	6.4	5.0	1.4	6.5	4.9	6.2	8.4	17.6	3.7	5.5	4.6	3.0	1.3	2.9	1.4	3.1	3.3	4.6	0.6	3.1	3.2	4.3	3.2	12.5	2.9	2.4	18.7	13.1	26.9	18.7	14.0	14.8	8.9	16.9	11.1	10.0	3.0	6.5	8.0	2.6	13.1	7.4	23.4	10.2	14.7	3.4	1.8	5.9	0.5	6.6	12.7	85.4	8.0	0.0	23.3	2.1	1.0	21.1	2.5	24.2	4.2	9.1	15.9	5.2	2.5	22.5	64.7	50.9	27.7	21.9	17.2	0.7	3.9	4.3	0.0	32.5	1.4	3.9	12.9	15.5	8.4	15.8	9.8	1.1	13.4	0.2	1.4
JCAD	KIAA1462	ENSG00000165757	"Junctional cadherin 5 associated"	Q9P266	10	30012800-30115494	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 5.6;Ciliated cells: 5.3;Ductal cells: 15.6;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 15.1;HUVEC TERT2: 15.7;LHCN-M2: 13.0;TIME: 35.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017956	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA017956: AB_1852408"	"unprognostic (1.78e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.37e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.09e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (2.54e-4)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.34e-2)"	27.0	7.5	6.2	9.1	12.4	0.5	18.0	2.2	8.8	10.1	29.4	3.2	5.4	1.7	16.5	8.1	5.9	10.8	9.9	16.3	6.2	4.7	6.0	2.0	22.3	3.2	6.7	8.9	11.3	15.7	4.7	4.8	30.5	8.9	14.1	4.1	24.4	2.5	9.7	9.2	3.7	3.7	27.8	6.8	1.2	5.0	13.0	4.4	1.4	13.0	3.9	2.0	18.3	22.8	0.2	0.1	0.8	0.0	0.3	0.2	0.0	7.7	3.4	3.1	0.0	2.0	0.4	4.6	4.2	4.4	0.6	1.0	1.3	0.0	0.0	0.3	15.1	0.9	0.1	0.8	0.3	1.8	0.8	1.9	0.0	0.0	0.0	8.7	0.0	0.5	4.9	0.1	10.6	0.8	0.2	15.7	0.2	0.0	0.0	13.0	0.3	0.0	0.3	0.6	0.4	5.3	0.0	1.7	0.0	0.6	0.2	0.4	0.1	0.1	0.0	0.0	4.7	0.0	0.7	35.1	8.0	2.0	2.5	0.4	3.3	0.4	0.0	1.8	5.4	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.0	6.2	12.4	2.2	8.7	6.2	4.7	6.7	8.9	8.9	4.4	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	1.2	0.0	15.6	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
JDP2	JUNDM2	ENSG00000140044	"Jun dimerization protein 2"	Q8WYK2	14	75427716-75474111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 71.9;Muller glia cells: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 11.0;granulocytes: 6.9;monocytes: 10.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059511	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA059511: AB_2684046"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.30e-3)"	27.0	14.4	11.2	19.3	12.5	46.0	59.6	10.6	15.1	16.3	15.3	13.7	6.5	15.3	12.7	10.5	17.1	14.8	21.3	20.7	13.5	9.0	9.7	14.3	24.8	13.2	14.0	8.7	21.8	15.8	7.4	10.1	12.0	11.2	13.9	8.1	16.6	19.5	11.4	13.3	15.2	22.4	17.8	15.7	39.7	15.8	4.7	11.8	1.4	20.7	18.7	9.7	14.2	60.4	11.0	2.1	6.9	10.5	0.1	0.2	1.1	4.4	3.9	0.7	7.8	24.7	18.4	26.8	13.8	15.0	9.0	11.4	9.5	3.9	3.5	7.0	26.2	1.6	17.4	4.9	4.7	3.9	4.7	0.5	4.8	7.3	3.4	50.8	6.8	0.3	32.4	28.3	3.7	9.1	3.5	0.4	4.0	0.6	6.8	8.1	21.7	0.3	11.2	2.7	8.6	2.5	2.4	0.1	9.5	4.3	2.4	0.6	3.1	14.2	20.4	15.8	9.2	19.5	14.9	1.8	11.4	17.7	0.7	2.0	5.7	1.6	8.3	3.4	25.8	5.6	0.1	4.1	3.8	0.0	7.0	0.0	11.0	0.2	0.0	2.1	5.1	0.0	0.0	6.9	0.1	10.5	1.8	0.2	1.1	11.2	12.5	10.6	15.1	13.5	9.0	14.0	8.7	11.2	11.8	11.9	31.0	5.6	5.5	14.5	14.3	16.9	12.7	6.7	7.9	8.7	9.8	1.6	0.0	2.3	0.3	11.3	14.9	0.0	5.7	4.7	22.2	3.7	2.3	7.4	8.9	7.9	5.2	11.1	71.9	0.2	16.7	9.4	11.8	2.8	12.7	43.2	6.9	8.6	15.6	2.2	30.5	6.5	7.1	0.1	0.4	7.9	0.2	0.0	8.0	9.1
JHY	"C11orf63, FLJ23554, Jhy"	ENSG00000109944	"Junctional cadherin complex regulator"	Q6NUN7	11	122882528-122959798	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 51.0"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 11.9;Ciliated cells: 34.8;Club cells: 13.6;Proximal tubular cells: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039612, HPA040344, HPA077658, HPA077748"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (9.97e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.77e-4)"	"unprognostic (6.46e-3)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (7.79e-2)"	3.6	0.9	1.9	1.6	2.1	0.2	2.3	1.6	2.2	2.1	2.4	1.2	1.0	0.7	1.5	2.5	1.0	5.1	1.5	1.6	1.5	2.6	5.3	1.0	2.8	1.0	1.7	1.4	2.1	1.5	6.3	4.2	2.3	1.7	2.3	0.8	1.9	1.0	1.5	2.4	1.0	1.2	1.0	2.2	1.3	1.0	51.0	1.3	1.4	3.4	1.5	1.2	1.7	1.2	2.4	4.9	0.3	0.6	4.3	4.1	1.1	2.6	3.7	2.2	0.1	0.6	0.4	0.7	5.7	6.6	2.4	1.0	0.2	9.9	0.0	1.4	8.8	13.4	2.3	2.6	1.3	1.1	8.8	2.7	0.1	1.8	0.1	0.9	1.5	4.6	2.8	7.3	0.4	0.6	6.2	3.6	3.9	0.0	0.0	1.8	1.6	0.0	0.6	0.3	7.7	3.4	0.9	0.0	1.2	6.9	3.0	5.7	4.0	6.8	3.7	2.4	2.9	4.5	0.6	1.2	7.8	1.0	0.2	4.5	0.1	0.0	0.0	2.0	2.0	5.2	0.3	0.6	0.1	2.9	0.1	4.1	2.4	3.0	3.9	4.9	1.4	2.1	2.1	0.3	4.3	0.0	1.1	0.6	1.1	1.9	2.1	1.6	2.2	1.5	2.6	1.7	1.4	1.7	1.3	11.9	4.1	0.0	0.0	0.0	0.0	0.0	0.0	34.8	13.6	5.2	0.0	0.0	3.3	4.9	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	2.9	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
JKAMP	"C14orf100, CDA06, HSPC213, HSPC327, JAMP"	ENSG00000050130	"JNK1/MAPK8 associated membrane protein"	Q9P055	14	59484443-59505410	"Cancer-related genes, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031172, HPA071650"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA031172: AB_10670563, HPA071650: AB_2686429"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.09e-6)"	"unprognostic (2.68e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-1)"	19.0	29.5	19.3	13.0	25.5	15.7	24.2	16.7	28.4	17.5	21.3	25.0	18.1	13.8	22.8	19.6	18.6	23.2	21.7	18.3	18.8	29.4	38.9	26.1	22.2	16.2	29.5	19.5	19.7	18.7	42.3	44.5	24.1	36.9	22.9	22.5	22.8	24.9	20.3	15.9	17.5	25.0	20.7	30.3	22.1	18.7	24.6	27.0	18.6	24.6	18.0	14.7	21.0	16.7	14.9	29.0	37.0	31.7	18.0	18.3	21.5	19.9	23.6	20.3	16.6	15.2	20.1	15.5	31.3	26.8	18.5	22.1	7.4	36.6	9.9	28.1	28.9	21.3	14.5	14.9	19.3	25.0	29.7	8.5	10.0	15.2	14.7	20.2	16.6	19.7	21.9	21.9	17.3	11.9	29.7	18.8	13.8	9.0	19.9	34.7	18.0	9.1	12.8	11.1	16.9	20.8	10.7	24.7	9.1	31.9	19.8	8.7	15.2	28.4	22.8	16.6	15.5	23.0	12.8	24.7	19.5	25.6	17.8	20.5	9.3	16.5	11.5	27.6	11.3	24.5	28.2	25.2	32.5	15.1	29.8	14.6	14.9	16.5	15.9	21.2	13.6	17.7	16.6	37.0	18.0	31.7	29.0	18.3	21.5	19.3	25.5	16.7	28.4	18.8	29.4	29.5	19.5	36.9	27.0	20.8	28.2	18.6	27.3	26.7	28.5	9.4	48.4	64.3	19.4	43.6	17.7	52.1	6.6	41.7	127.9	21.5	16.0	70.0	47.9	55.4	37.6	25.8	34.6	34.4	51.7	27.0	30.0	31.9	57.1	50.5	32.8	38.3	45.5	31.5	24.3	40.3	41.2	21.0	29.7	46.2	24.2	12.9	28.6	93.1	41.2	25.5	24.9	26.6	23.5	13.7
JMJD1C	"DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8"	ENSG00000171988	"Jumonji domain containing 1C"	Q15652	10	63167221-63521850	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056175, HPA066195"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA056175: AB_2683057, HPA066195: AB_2685634"	"unprognostic (7.72e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.13e-1)"	31.7	10.9	8.7	26.0	10.9	25.9	16.2	43.0	11.1	21.8	16.6	5.4	11.8	12.2	18.1	17.4	16.4	13.1	18.5	11.7	10.8	8.1	14.1	16.7	29.9	20.9	9.6	6.5	19.2	12.6	27.1	18.6	10.3	14.1	14.1	9.2	13.8	15.3	15.6	13.4	11.0	22.2	11.7	17.6	29.1	12.9	10.9	13.3	27.2	15.6	20.1	15.3	21.9	11.8	4.8	4.2	15.2	2.8	1.7	3.1	1.1	11.0	5.6	13.2	10.1	7.0	13.0	4.6	7.7	16.0	7.0	9.6	9.5	11.9	15.0	4.7	7.2	6.3	9.1	3.7	7.4	12.5	4.0	4.7	5.7	5.8	6.9	8.6	12.2	2.1	12.9	7.7	12.3	36.1	15.9	12.5	10.8	10.0	11.4	16.3	3.0	9.3	6.6	14.1	2.5	19.8	16.2	28.7	7.1	7.1	8.0	7.2	11.8	11.6	7.3	11.1	10.1	7.2	22.2	14.9	6.5	9.2	5.6	9.6	10.2	8.1	14.3	7.9	7.3	5.8	0.6	2.8	3.1	2.0	1.9	3.1	4.7	2.2	2.1	2.4	4.8	3.1	2.6	15.2	1.7	1.6	4.2	1.9	1.1	8.7	10.9	43.0	11.1	10.8	8.1	9.6	6.5	14.1	13.3	104.2	81.3	88.7	263.2	135.0	89.5	52.3	45.9	113.8	121.7	52.4	143.3	28.1	11.6	51.6	31.8	129.1	72.6	0.0	41.5	23.6	115.8	122.0	90.2	30.6	51.0	111.2	82.5	89.6	79.2	32.2	96.1	141.3	72.6	41.5	51.6	62.3	60.4	56.1	84.1	23.1	170.7	71.1	102.3	135.2	137.3	117.1	27.8	76.7	33.1	223.6
JMJD7		ENSG00000243789	"Jumonji domain containing 7"	P0C870	15	41828085-41837581	"Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.9;Ciliated cells: 1.4;Club cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 19.5;RT4: 27.5"	"Low region specificity"	"Detected in all"							HPA005726	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA005726: AB_1852017"	"unprognostic (2.92e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	5.8	7.3	9.8	10.7	10.2	9.3	8.1	39.2	10.8	8.9	6.3	12.3	11.2	6.4	5.5	7.4	26.1	8.8	8.6	14.1	10.2	9.6	6.1	7.1	11.2	8.5	10.8	7.8	11.9	19.1	8.0	9.1	4.3	11.2	11.5	4.4	10.9	26.7	15.1	7.1	29.2	6.1	7.6	13.9	6.4	8.5	5.9	10.7	4.9	13.1	11.9	13.9	11.0	13.6	7.9	8.7	8.3	12.6	9.8	17.7	10.0	4.8	4.6	6.0	1.7	1.6	1.1	3.7	1.9	4.2	3.2	2.6	6.5	3.8	0.6	4.1	1.2	3.4	12.3	2.8	9.7	1.0	4.8	2.9	6.5	6.2	3.9	2.7	3.2	7.0	0.7	8.8	2.2	4.7	3.1	3.7	6.3	4.3	4.0	2.3	6.6	3.9	3.0	2.5	19.5	3.1	1.8	4.0	4.8	7.3	27.5	6.4	2.2	1.7	8.7	2.7	1.8	16.8	3.3	3.4	2.4	5.4	5.1	3.8	6.6	2.2	1.9	3.2	7.7	3.6	5.1	12.4	8.3	12.3	12.6	12.9	5.8	13.9	16.2	8.7	7.9	17.7	14.0	3.3	9.8	11.9	5.4	13.3	10.0	9.8	10.2	39.2	10.8	10.2	9.6	10.8	7.8	11.2	10.7	3.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0
JMJD7-PLA2G4B		ENSG00000168970	"JMJD7-PLA2G4B readthrough"		15	41828095-41848155	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.5;Club cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 5.6"									HPA005726	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA005726: AB_1852017"	"unprognostic (9.87e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.75e-3)"	6.6	2.8	4.7	5.2	4.9	6.8	4.5	21.4	5.3	6.0	4.3	6.1	5.5	2.7	4.9	3.5	8.7	6.5	3.8	3.9	4.9	2.2	2.9	3.0	6.7	3.8	5.3	3.6	5.5	5.8	2.7	4.3	1.9	5.5	4.3	2.5	5.3	9.0	7.7	4.9	12.0	4.4	4.2	3.7	3.6	4.0	2.6	5.2	1.9	4.6	5.9	7.0	6.4	6.3	0.7	1.3	0.0	1.5	0.7	4.0	1.0	0.8	0.5	1.2	4.2	1.1	3.1	1.9	0.9	2.2	1.4	2.0	2.0	0.1	0.4	1.8	1.1	0.1	4.3	0.4	3.4	0.3	0.0	0.4	0.6	0.9	0.6	4.7	0.0	2.5	1.6	2.3	0.5	1.1	0.0	0.5	1.7	0.0	0.6	0.4	0.7	0.9	0.1	0.1	1.1	0.2	0.6	0.0	1.5	1.1	5.6	1.5	1.8	3.8	0.0	0.5	0.2	0.9	4.4	0.7	0.7	0.6	4.8	1.7	1.2	0.4	0.0	2.2	0.6	0.4	0.0	1.1	0.0	4.0	1.5	1.9	0.7	0.4	0.6	1.3	0.1	0.7	0.0	0.0	0.7	1.0	0.0	0.1	1.0	4.7	4.9	21.4	5.3	4.9	2.2	5.3	3.6	5.5	5.2	8.9	4.5	0.0	0.1	0.1	0.6	0.4	0.0	1.4	4.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.8	0.0	0.4	0.1	0.2	0.1	1.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.9	0.0
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 44.2"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 25.0;Cone photoreceptor cells: 21.6;Early spermatids: 44.0;Horizontal cells: 47.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.8;SH-SY5Y: 7.5;SiHa: 4.9;U-2 OS: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	1.3	3.6	27.2	1.6	24.1	1.1	1.2	18.9	44.2	1.5	1.4	1.2	0.0	1.4	1.3	1.2	2.4	1.4	1.2	1.2	30.9	14.6	1.2	1.2	1.2	1.2	8.3	12.2	1.1	1.5	1.2	4.4	1.2	6.4	1.3	1.3	0.8	1.2	1.7	1.1	1.2	1.7	1.3	3.3	1.2	1.5	1.8	3.5	0.0	1.2	0.0	1.2	1.1	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	1.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	6.5	0.0	0.0	5.8	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	7.5	4.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	27.2	24.1	18.9	30.3	30.9	14.6	8.3	12.2	6.4	3.5	0.0	0.0	0.0	0.0	0.0	25.0	2.8	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	44.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	47.7	0.0	0.0	0.0	9.9	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.9	3.4	0.0	0.1	0.0	0.0	0.0
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 109.4;testis: 101.3"	"Cell type enhanced"	"Detected in many"	13	"Ductal cells: 365.7;Exocrine glandular cells: 382.5;Extravillous trophoblasts: 1210.3;monocytes: 655.6;Pancreatic endocrine cells: 967.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 109.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	8.0	18.5	15.6	25.9	22.2	23.0	8.1	30.7	25.4	9.4	43.3	4.6	7.7	37.5	6.1	5.4	52.8	4.3	23.7	6.1	17.9	19.6	15.5	12.8	13.9	26.3	11.1	15.0	5.6	6.5	1.2	6.6	29.2	13.7	7.0	23.7	3.3	15.9	17.6	23.7	9.3	51.3	7.3	8.3	26.2	42.5	101.3	4.9	32.6	5.8	28.9	28.7	17.9	17.0	15.4	14.5	109.4	28.4	10.2	28.7	14.6	92.5	92.3	48.6	48.2	10.3	10.6	38.8	48.7	14.5	47.9	36.9	75.5	55.6	26.1	31.3	39.0	50.4	55.4	45.3	60.7	36.2	26.0	57.0	41.9	36.7	74.7	24.2	31.4	40.5	16.2	29.1	39.0	40.1	14.1	87.1	49.7	23.6	53.7	43.8	67.0	100.7	30.7	28.3	76.6	121.7	64.4	58.0	40.4	51.2	58.2	60.4	49.1	69.8	37.0	25.9	53.6	99.1	19.3	50.1	27.5	77.6	38.5	56.6	21.0	33.9	39.0	23.9	29.5	31.3	27.5	18.5	51.6	12.4	26.6	8.9	15.4	17.2	14.9	14.5	8.0	8.2	12.0	109.4	10.2	28.4	9.6	28.7	14.6	15.6	22.2	30.7	25.4	17.9	19.6	11.1	15.0	13.7	4.9	23.8	17.8	0.0	0.0	0.0	0.0	0.0	0.0	30.8	33.0	233.8	0.0	95.9	84.6	365.7	0.0	0.0	0.0	0.0	382.5	1210.3	0.0	0.0	7.0	0.0	299.4	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	655.6	0.0	0.0	967.6	0.0	0.0	121.9	0.0	0.0	0.0	0.0	0.0	0.0	81.0	0.0	0.0	0.0
JRK	"jerky, JH8"	ENSG00000234616	"Jrk helix-turn-helix protein"		8	142657460-142681968	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3;Spermatogonia: 21.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052675			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		No	No			"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA052675: AB_2681910"	"unprognostic (3.65e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.58e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.69e-2)"	2.6	3.3	6.4	4.0	6.5	1.6	3.7	11.1	7.1	2.8	2.8	6.1	6.8	2.9	5.4	3.6	3.1	4.7	2.6	3.7	4.4		2.9	0.7	2.6	5.3	5.2	5.2	9.6	4.6	5.6	4.4	3.0	4.3	4.5	2.8	5.4	4.1	4.5	6.2	6.5	3.2	4.9	3.5	4.8	4.3	6.1	5.3	4.3	4.2	2.6	6.1	2.6	7.9	4.5	2.3	3.3	2.3	2.0	4.4	1.2	5.5	6.0	7.0	5.7	6.8	10.0	4.4	8.6	3.6	10.6	6.1	5.3	11.5	9.5	3.7	7.1	7.3	7.5	6.2	5.3	5.4	7.2	10.5	9.5	19.0	6.2	2.8	7.3	6.7	6.4	4.7	6.7	3.9	5.3	5.9	11.2	10.1	4.2	8.9	9.5	8.4	4.1	6.0	3.9	8.5	11.1	4.4	5.3	3.7	9.5	12.9	8.6	15.8	6.5	3.7	4.6	6.4	4.6	7.0	8.3	17.7	8.1	4.7	5.6	6.2	5.6	6.2	9.2	7.9	3.3	2.3	2.9	3.1	1.6	1.8	1.4	3.5	3.1	2.3	4.5	4.4	3.5	2.5	2.0	0.8	2.2	2.0	1.2											6.0	0.6	5.1	1.9	0.0	12.9	9.6	7.6	1.4	1.2	7.0	19.6	3.6	3.3	2.7	1.3	6.2	2.3	23.3	2.2	2.1	1.1	3.6	1.1	2.4	2.6	9.5	8.7	10.4	5.6	1.1	10.6	1.9	0.0	1.8	3.1	5.4	4.1	0.0	11.0	2.4	10.2	0.0	1.4	9.8	21.3	0.0	1.8	0.0	4.5	4.1
JRKL	HHMJG	ENSG00000183340	"JRK like"	Q9Y4A0	11	96389989-96507574	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ciliated cells: 36.1;Early spermatids: 121.0;Late spermatids: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046184, HPA060341"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA046184: AB_10963576, HPA060341: AB_2732646"	"unprognostic (4.59e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	"unprognostic (4.94e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.57e-3)"	11.5	7.8	10.4	10.2	12.3	1.4	10.3	11.1	9.8	12.5	10.1	6.2	7.9	8.2	13.0	9.1	9.7	12.3	8.7	8.4	9.2	6.8	9.1	5.9	8.0	9.7	10.0	7.8	16.4	7.0	13.4	15.6	12.0	10.0	13.5	10.7	6.0	9.7	11.7	9.9	8.9	12.4	12.8	17.9	10.4	9.9	17.9	13.1	11.6	14.0	6.3	10.3	12.4	14.8	5.3	9.0	6.0	5.7	3.9	7.6	3.4	6.8	4.3	9.0	6.6	18.2	20.2	6.5	11.6	8.0	8.4	11.0	7.3	16.6	9.4	17.0	10.7	10.7	10.7	4.4	7.9	9.8	10.1	4.1	8.7	11.1	5.5	14.6	4.9	5.6	9.6	12.6	12.1	15.2	15.6	7.5	10.9	4.6	4.1	13.5	1.4	6.3	14.1	1.3	12.3	5.9	6.5	8.7	7.6	10.3	7.2	3.6	6.5	6.7	4.7	5.1	8.8	5.7	6.7	9.2	16.2	7.2	14.1	4.6	3.5	7.7	5.5	7.5	7.9	6.9	6.0	5.7	5.5	3.8	4.5	5.3	5.3	6.0	4.7	5.7	4.1	7.6	6.8	2.1	3.9	5.2	9.0	2.8	3.4	10.4	12.3	11.1	9.8	9.2	6.8	10.0	7.8	10.0	13.1	8.9	4.3	5.0	9.5	4.1	7.1	5.5	12.7	36.1	15.9	0.0	3.9	5.3	1.7	9.6	121.0	5.5	5.7	0.0	4.5	4.6	7.1	6.7	3.5	2.1	4.3	7.9	5.8	7.4	4.1	37.3	7.8	5.2	1.7	4.6	8.8	4.5	6.4	5.5	8.9	5.4	11.5	0.0	9.0	9.5	4.3	5.3	3.3	3.8	7.3	6.4
JSRP1	"FLJ32416, JP-45"	ENSG00000167476	"Junctional sarcoplasmic reticulum protein 1"	Q96MG2	19	2252252-2269759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"skeletal muscle: 92.0;tongue: 33.9"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 13.1;Late spermatids: 14.7;Melanocytes: 43.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 4.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 35.8;RPMI-8226: 22.4;U-266/70: 97.8;U-266/84: 11.7"	"Group enriched"	"Detected in many"	6	"amygdala: 8.6;basal ganglia: 11.5;cerebral cortex: 10.1;hippocampal formation: 4.9"					HPA044741	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044741: AB_10794295"	"unprognostic (9.41e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.64e-5)"	"unprognostic (3.63e-1)"	"unprognostic (4.43e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.71e-1)"	1.1	0.1	0.0	0.9	0.1	0.2	0.1	0.0	0.1	0.4	3.0	0.0	0.0	0.9	0.1	4.5	1.7	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.2	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	2.7	0.0	92.0	0.0	0.6	0.0	0.0	1.4	0.6	0.3	0.0	0.0	1.8	33.9	5.0	0.6	0.1	4.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.8	11.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.5	0.3	0.8	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	0.5	0.7	0.4	0.0	2.7	0.0	0.0	2.0	0.2	0.0	1.3	13.1	0.3	0.7	0.0	0.9	0.6	0.5	0.2	5.8	0.5	0.4	0.0	5.2	1.3	1.5	14.7	0.6	1.0	43.9	0.0	1.6	0.3	0.6	0.0	0.0	0.1	0.5	0.0	0.4	4.7	2.1	0.9	0.2	3.8	0.6	0.1
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977688	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006514	Approved		Approved	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	23.9	30.2	28.5	23.0	32.7	43.2	32.6	30.7	32.3	31.8	36.0	23.6	51.3	35.9	25.1	41.0	30.4	26.1	37.1	36.2	25.4	23.9	34.2	81.1	27.7	34.7	27.7	19.8	26.9	106.8	24.8	49.8	30.0	24.4	33.4	36.0	24.9	100.6	45.9	42.1	23.4	45.6	21.6	20.5	35.9	42.4	15.3	25.2	30.5	58.5	32.0	34.0	25.2	33.0	47.4	54.1	60.7	43.0	30.4	46.4	30.2	38.4	26.6	11.5	21.0	37.7	23.5	32.4	28.1	27.4	18.8	18.9	25.6	32.0	36.8	39.9	32.5	11.6	35.2	29.0	21.6	15.4	34.7	58.0	21.4	31.7	25.9	39.7	41.0	32.9	22.2	40.9	19.8	23.5	26.0	22.2	42.9	31.6	27.1	13.2	67.0	29.6	52.8	24.6	75.6	47.0	31.3	15.6	73.9	23.8	21.1	31.5	31.9	22.2	64.8	37.6	22.0	40.6	59.7	17.3	9.3	16.1	28.1	35.8	40.4	45.0	39.9	22.9	39.5	20.0	32.6	43.0	60.7	29.4	30.3	35.5	47.4	41.1	46.4	33.4	45.2	42.4	33.7	39.9	30.4	33.4	54.1	33.6	30.2	28.5	32.7	30.7	32.3	25.4	23.9	27.7	19.8	24.4	25.2	74.5	93.5	143.8	144.8	139.2	56.2	87.0	188.5	84.3	73.9	94.2	21.6	271.1	218.8	215.2	5.3	130.2	265.0	46.7	360.4	333.7	188.8	298.2	81.8	277.1	261.0	54.0	203.5	111.1	203.5	13.6	140.4	174.8	161.9	144.3	351.4	98.5	241.9	276.3	116.0	209.1	47.9	103.5	125.2	54.7	68.8	166.2	242.1	188.1	283.1	216.6
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 146.3;skin 1: 126.1;tongue: 122.8"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 335.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 81.5;OE19: 288.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		61000000	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	12.5	2.6	2.8	9.5	4.5	3.3	13.0	6.5	3.7	34.5	17.9	8.7	12.3	15.6	12.2	9.6	146.3	13.0	19.0	34.5	3.3	1.6	31.6	11.7	13.2	4.0	5.3	2.2	12.5	12.8	3.6	5.8	42.4	4.0	14.0	8.8	8.3	34.3	14.3	17.6	126.1	36.1	4.3	3.2	4.5	15.4	3.6	4.6	10.8	27.9	122.8	84.8	12.5	55.4	7.9	7.8	14.8	20.6	0.3	0.1	2.9	19.5	16.2	1.6	1.4	0.0	0.0	25.4	1.1	6.7	0.4	0.4	24.6	21.7	0.3	12.1	0.7	0.5	81.5	2.3	18.1	0.0	0.0	5.8	0.8	12.9	5.4	2.7	0.5	8.7	0.0	41.2	0.0	3.3	4.9	7.2	0.5	7.2	7.1	0.0	25.1	0.1	7.0	3.2	288.5	2.7	22.9	0.0	14.6	12.6	50.1	4.0	2.9	2.5	49.5	0.1	7.9	41.3	0.5	11.4	0.0	1.1	0.5	0.3	0.6	2.2	0.3	0.1	0.9	0.1	1.7	7.6	14.8	0.0	12.8	0.0	7.9	0.0	0.1	7.8	7.4	0.1	0.1	0.3	0.3	20.6	2.5	0.0	2.9	2.8	4.5	6.5	3.7	3.3	1.6	5.3	2.2	4.0	4.6	56.6	33.7	8.4	158.6	174.9	1.1	80.3	53.5	18.7	43.3	125.6	3.9	81.5	23.2	189.4	28.7	23.2	158.5	0.0	119.3	141.0	19.6	196.2	10.5	29.3	12.8	0.0	64.1	28.3	5.6	6.4	4.6	9.8	11.8	6.4	91.0	16.2	237.1	128.7	0.0	33.8	4.3	6.5	14.0	2.1	4.2	335.0	155.3	5.1	94.4	236.4
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;retina: 31.2"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 71.2;Early spermatids: 45.5;Ito cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.4;HEL: 19.8;OE19: 11.2;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in many"							"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		110000	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	5.5	4.3	12.7	2.4	14.1	0.6	4.2	1.8	35.2	4.0	3.8	3.7	0.5	2.7	5.6	2.3	9.6	4.2	3.1	12.1	17.6	3.9	2.6	7.3	2.9	1.1	4.1	15.8	2.3	11.9	2.5	14.4	6.8	9.4	3.1	2.1	31.2	2.2	5.4	23.5	1.5	7.2	6.4	3.6	8.0	11.5	2.2	2.4	0.0	5.3	6.7	3.1	2.9	4.1	0.1	0.0	0.9	0.0	0.1	4.3	1.2	0.3	0.6	3.6	0.7	0.5	0.1	4.7	1.4	0.9	1.4	0.6	32.4	2.5	0.1	0.4	3.6	2.2	0.2	0.8	0.0	1.1	0.0	0.3	19.8	0.3	4.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.5	1.6	0.0	4.5	0.1	0.4	2.4	0.0	0.0	2.0	11.2	3.2	1.0	1.6	0.0	0.1	0.3	1.2	9.3	0.4	0.3	0.3	3.6	0.7	0.1	8.2	4.1	1.6	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.0	2.4	0.7	0.9	0.1	0.0	0.0	4.3	1.2	12.7	14.1	1.8	35.2	17.6	3.9	4.1	15.8	9.4	2.4	3.0	3.8	0.0	1.4	1.4	71.2	33.4	17.8	8.1	0.0	15.7	5.9	7.3	1.7	4.7	45.5	26.9	30.6	0.0	7.2	0.7	4.8	2.8	3.5	17.4	0.8	0.0	9.2	50.3	2.6	34.6	3.4	0.7	3.3	0.0	12.2	5.4	3.9	20.4	31.1	2.4	2.7	19.4	14.6	1.9	1.7	1.0	11.9	0.7	10.0	1.4
KANK3	"ANKRD47, FLJ46061"	ENSG00000186994	"KN motif and ankyrin repeat domains 3"	Q6NY19	19	8322584-8343262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 58.3;Ito cells: 34.4;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 1.0;NK-cells: 3.6;T-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 9.3;TIME: 16.8;U-266/70: 6.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"olfactory region: 34.0"	HPA051153	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA051153: AB_2681365"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-4)"	"unprognostic (1.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.77e-1)"	"prognostic favorable (1.69e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.24e-1)"	23.3	3.6	5.2	3.8	4.8	1.2	13.2	2.7	6.5	3.8	5.6	1.6	2.9	4.0	5.4	6.2	4.7	5.2	3.4	9.6	6.2	2.9	7.7	2.3	19.0	6.3	4.4	1.6	3.1	3.1	1.6	3.5	18.3	4.8	3.3	1.2	6.4	3.4	2.8	15.5	3.5	4.0	3.5	2.8	21.0	3.1	2.5	5.0	0.3	7.9	3.0	1.6	2.5	6.7	0.5	0.3	1.0	0.3	3.6	3.5	0.7	0.1	0.7	0.3	0.6	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.8	0.2	0.0	2.7	0.0	0.1	0.1	0.6	2.9	0.0	0.8	1.6	0.4	0.4	0.5	0.1	0.2	1.5	0.0	0.9	0.0	0.0	0.0	9.3	0.7	0.0	0.4	0.0	0.5	0.0	0.5	0.6	0.6	0.3	1.5	0.0	0.8	0.1	0.2	0.0	0.1	0.0	0.8	0.1	0.0	0.6	0.0	16.8	0.1	1.6	0.4	0.1	6.9	0.2	0.3	0.2	0.1	0.2	0.8	0.3	0.1	3.5	0.1	1.6	0.3	1.9	0.6	0.1	0.5	0.8	1.3	1.0	3.6	0.1	0.3	1.3	0.7	5.2	4.8	2.7	6.5	6.2	2.9	4.4	1.6	4.8	5.0	6.0	5.6	0.0	0.2	2.3	0.2	0.8	0.0	0.0	0.0	0.0	3.9	0.3	5.0	0.2	4.0	58.3	0.0	0.0	1.6	0.2	1.7	0.8	0.0	0.8	0.4	0.0	0.0	34.4	1.6	4.1	0.6	0.7	5.0	0.0	0.0	0.2	0.4	0.0	0.4	0.3	0.7	19.4	2.5	1.1	3.1	1.1	0.2	2.5	0.0	0.5
KANSL1L	"C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2"	ENSG00000144445	"KAT8 regulatory NSL complex subunit 1 like"	A0AUZ9	2	210021423-210171383	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 178.9"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 44.2;Spermatocytes: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043102, HPA046790"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA043102: AB_2678316, HPA046790: AB_2679808"	"unprognostic (3.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.55e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.99e-3)"	"unprognostic (4.65e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.95e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-3)"	8.4	5.6	8.3	6.0	12.9	3.8	8.8	12.7	10.9	10.4	6.9	7.5	11.1	4.4	11.3	9.9	5.9	8.9	8.9	7.9	8.8	5.7	12.3	5.8	9.8	4.3	12.1	5.5	16.2	10.0	178.9	14.4	5.3	9.5	14.3	4.7	6.2	7.6	9.9	8.8	7.7	4.9	9.8	13.0	4.5	7.2	12.4	13.6	21.6	14.2	4.4	3.8	11.1	33.0	2.1	2.1	2.7	2.2	3.1	1.7	0.5	2.4	1.3	12.7	5.4	10.3	7.8	3.7	3.6	4.6	2.3	6.5	2.5	9.5	6.7	4.9	2.3	5.7	3.5	2.9	1.2	3.7	2.9	2.4	5.5	4.9	4.3	6.4	6.4	4.0	4.9	5.6	2.3	1.7	10.2	5.2	6.2	4.1	6.2	3.5	2.3	7.1	16.5	7.7	4.2	1.8	5.2	3.6	5.2	14.0	3.7	8.0	7.6	3.3	2.2	2.6	13.3	2.2	13.7	4.5	5.1	4.1	1.7	2.7	4.4	1.9	6.6	6.2	3.2	6.1	1.1	1.4	2.7	1.2	2.2	1.1	0.9	1.0	1.4	2.1	2.1	1.7	1.7	2.4	3.1	0.9	1.4	0.8	0.5	8.3	12.9	12.7	10.9	8.8	5.7	12.1	5.5	9.5	13.6	26.8	15.3	2.0	7.6	6.5	9.3	7.6	7.6	44.2	7.9	29.6	13.7	1.3	3.3	8.2	20.3	7.8	1.8	0.0	4.8	0.8	9.3	6.6	10.4	5.5	2.3	4.8	5.8	5.5	2.6	17.2	13.6	6.0	6.8	1.8	2.8	9.7	7.7	2.5	28.3	10.2	8.9	12.9	9.2	38.9	6.4	9.7	1.6	3.2	2.4	3.0
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051990	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Approved	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414"	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	20.8	10.9	15.3	19.8	20.3	36.8	22.6	29.9	18.7	19.7	14.6	19.4	14.4	10.7	20.6	12.1	16.9	16.5	14.3	13.0	15.5	11.5	12.3	13.6	26.9	28.2	23.2	10.3	27.2	13.1	26.8	22.3	20.9	15.7	14.1	12.0	12.8	15.1	17.0	21.0	25.5	18.0	25.0	22.9	20.4	14.0	14.1	21.7	30.4	17.9	14.3	20.1	16.9	24.2	4.7	1.8	10.9	1.6	3.1	3.9	1.4	13.1	10.8	17.8	11.3	10.0	11.4	6.0	8.8	11.5	10.9	8.5	6.8	6.3	19.5	8.9	8.7	10.6	8.5	13.8	8.4	13.0	10.0	8.1	28.1	6.7	5.1	7.5	14.8	12.9	9.5	9.6	10.1	12.6	8.0	10.5	17.3	23.5	12.4	10.0	5.8	30.0	4.7	6.8	9.9	4.3	24.0	19.9	6.2	5.4	15.1	11.1	9.5	10.3	6.9	7.1	8.4	15.9	6.5	12.2	13.5	9.6	12.0	9.4	10.1	16.4	21.2	7.3	6.7	11.6	3.5	1.6	2.8	3.5	1.2	3.9	2.4	2.6	3.3	1.0	4.7	3.6	2.9	10.9	3.1	1.2	1.8	3.5	1.4	15.3	20.3	29.9	18.7	15.5	11.5	23.2	10.3	15.7	21.7	32.8	30.4	27.2	23.8	44.8	44.6	22.6	25.5	21.4	30.7	12.2	51.1	12.1	3.3	11.8	1.8	50.4	18.7	46.7	10.4	13.1	28.5	21.6	33.6	22.2	14.6	55.6	23.7	43.0	37.4	3.5	26.2	31.3	21.9	8.2	25.7	32.4	13.2	17.5	21.5	9.3	45.4	19.4	33.9	41.9	36.2	53.4	17.6	45.8	18.9	26.1
KAT6B	"Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B"	ENSG00000156650	"Lysine acetyltransferase 6B"	Q8WYB5	10	74825582-75032622	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006104	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006104: AB_1079445"	"unprognostic (4.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.78e-2)"	"prognostic favorable (4.82e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.15e-1)"	11.6	9.5	11.1	13.2	11.9	15.1	12.4	19.0	11.6	16.7	12.2	13.3	15.3	7.2	25.1	13.0	12.0	13.2	12.0	10.0	10.6	9.5	9.0	7.3	9.2	9.0	9.0	9.9	24.6	13.3	24.8	31.1	9.4	8.9	13.5	9.6	10.1	17.9	12.0	15.3	10.6	11.3	16.2	9.3	10.4	13.0	12.8	12.1	26.6	13.0	8.9	12.5	14.3	12.7	3.2	1.9	1.6	1.1	5.3	3.7	1.5	3.9	4.1	7.4	6.3	5.9	8.7	3.6	3.5	7.0	3.0	3.4	2.7	4.6	8.5	1.9	6.4	3.2	3.1	3.9	3.1	5.0	3.6	5.7	3.1	3.3	3.9	4.4	7.4	2.1	5.6	5.0	4.2	6.7	9.9	3.5	6.7	3.3	7.3	3.8	4.3	7.1	3.4	4.1	4.3	22.9	11.1	3.8	1.8	2.2	2.0	3.7	6.2	3.6	6.6	3.2	2.8	3.7	2.9	4.2	4.3	5.1	2.8	3.3	5.4	6.3	5.7	4.6	7.8	0.9	0.7	1.1	1.6	3.2	0.9	3.4	2.4	2.4	2.7	1.2	3.2	3.7	3.4	0.9	5.3	0.8	1.9	2.4	1.5	11.1	11.9	19.0	11.6	10.6	9.5	9.0	9.9	8.9	12.1	41.7	50.1	23.2	20.4	17.6	50.8	43.1	10.2	38.8	35.2	8.7	64.8	8.7	8.3	8.6	4.4	18.6	17.3	23.3	15.8	8.8	28.2	22.8	39.4	14.4	9.7	41.3	22.8	13.5	11.0	6.7	39.1	13.9	13.5	4.6	18.3	49.8	10.2	14.4	37.8	8.0	53.6	25.8	24.0	25.6	21.2	15.3	19.0	34.6	15.5	17.1
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788555-49835030	"Enzymes, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	15.8	14.3	16.9	16.2	25.9	44.4	17.5	37.0	35.0	19.5	17.3	23.8	17.9	13.1	27.3	18.6	18.8	19.5	14.6	25.3	16.8	21.8	18.7	11.3	13.9	15.3	17.0	23.6	21.9	13.6	44.4	19.8	19.8	21.9	20.4	14.9	20.8	18.9	23.3	31.7	22.7	14.7	21.8	17.9	15.8	15.5	63.7	19.1	25.9	28.6	14.5	20.6	22.7	17.4	13.0	12.7	15.2	11.4	20.6	20.7	14.2	13.0	18.3	17.8	12.4	8.4	11.1	21.5	11.3	13.2	20.4	14.6	28.3	9.3	14.9	18.4	12.0	17.8	11.4	16.9	11.8	24.1	16.2	16.7	17.7	13.3	11.7	12.5	18.1	14.8	10.6	11.9	18.3	22.9	11.8	15.0	16.6	19.6	14.9	19.1	19.8	25.7	13.0	44.1	27.9	16.0	16.2	28.4	12.9	9.5	14.7	19.3	16.4	11.6	6.9	10.6	28.1	25.5	16.0	9.0	25.9	14.0	11.3	14.7	21.8	23.8	17.5	11.7	10.9	16.1	15.2	11.0	15.1	16.9	8.9	20.7	13.0	16.3	17.1	12.7	12.2	20.6	16.2	13.1	20.6	11.4	6.6	14.3	14.2	16.9	25.9	37.0	35.0	16.8	21.8	17.0	23.6	21.9	19.1	23.8	17.6	14.7	9.0	14.9	30.8	23.6	20.4	24.1	20.5	26.2	29.5	18.8	8.3	9.4	17.4	18.6	10.4	0.0	6.5	13.0	11.4	13.2	23.1	9.0	11.5	42.9	24.1	12.3	16.1	11.0	15.5	11.1	13.5	12.6	12.1	15.3	8.2	8.6	17.3	8.7	25.3	38.8	13.9	69.0	33.2	17.6	28.3	20.2	11.4	7.2
KATNAL2	"DKFZP667C165, MGC33211"	ENSG00000167216	"Katanin catalytic subunit A1 like 2"	Q8IYT4	18	46917492-47102243	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 30.3;testis: 33.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 46.8;Early spermatids: 59.9;Late spermatids: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040712, HPA042029"	Approved		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Nucleoplasm, Intermediate filaments"		"HPA040712: AB_2677092, HPA042029: AB_2677807"	"unprognostic (3.40e-1)"	"unprognostic (7.75e-2)"	"unprognostic (9.00e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.52e-6)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.24e-7)"	"unprognostic (1.64e-1)"	"unprognostic (7.14e-4)"	"unprognostic (1.06e-3)"	"unprognostic (1.61e-1)"	5.5	2.9	8.2	4.1	9.7	2.8	7.1	4.0	7.5	2.5	2.4	11.3	2.5	1.8	2.8	7.1	2.7	8.6	5.1	4.3	8.1	7.6	9.5	5.2	4.6	3.4	9.6	6.2	3.1	3.3	30.3	7.0	2.2	9.0	3.4	3.1	6.4	3.4	3.7	6.0	8.0	1.5	2.3	8.7	3.3	2.0	33.2	6.3	2.4	15.5	1.1	3.0	2.3	2.5	3.1	0.6	2.7	1.3	0.8	1.5	0.3	1.9	4.3	2.4	15.0	4.9	5.9	1.1	1.8	1.6	1.5	1.9	0.2	5.1	19.8	1.5	2.8	1.9	0.6	4.7	0.5	1.1	2.0	2.5	0.8	1.3	0.3	2.0	1.2	1.9	12.2	1.8	2.5	0.6	3.4	0.5	9.1	0.7	1.6	8.5	1.9	1.2	2.6	5.4	2.5	2.7	5.5	1.1	0.0	4.7	0.4	5.4	6.0	1.9	0.4	0.6	8.8	11.4	11.0	1.0	5.0	0.5	2.0	1.2	1.3	1.0	13.3	2.7	12.5	9.6	1.7	0.7	0.5	1.1	1.3	0.9	2.2	0.9	0.5	0.3	3.1	1.5	1.4	2.7	0.8	0.9	0.6	0.2	0.3	8.2	9.7	4.0	7.5	8.1	7.6	9.6	6.2	9.0	6.3	0.0	1.4	0.0	2.6	1.3	10.4	2.2	0.0	46.8	6.8	3.5	5.9	0.0	11.6	0.4	59.9	1.4	0.8	0.0	0.2	0.0	1.5	1.2	0.0	3.9	2.8	11.1	0.0	3.1	1.0	47.0	1.4	0.6	3.3	1.0	0.3	2.4	0.2	0.0	2.1	5.2	2.1	0.0	0.8	11.2	4.3	1.0	0.1	0.0	1.5	1.4
KATNB1		ENSG00000140854	"Katanin regulatory subunit B1"	Q9BVA0	16	57735730-57757250	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041165, HPA041839"	Enhanced		Supported	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Microtubules	"HPA041165: AB_10795584, HPA041839: AB_10795598"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (2.89e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.54e-1)"	6.9	9.1	15.3	9.3	21.4	18.7	6.3	13.2	29.0	7.0	7.4	8.8	6.7	9.4	6.6	5.8	11.0	18.7	5.9	8.5	16.0	14.5	5.8	10.3	8.0	8.8	9.3	14.1	7.0	9.4	9.5	8.0	7.9	10.6	6.3	5.2	6.2	11.9	8.0	7.1	21.4	8.5	6.0	6.9	8.0	9.1	32.7	8.1	10.8	7.2	10.3	8.6	7.4	6.4	5.8	9.8	24.6	11.6	8.4	12.4	10.5	7.4	13.7	7.5	9.7	4.2	3.7	13.3	5.3	7.0	13.9	7.7	11.4	6.7	6.1	10.6	3.4	5.1	10.1	10.1	10.6	6.3	4.1	28.7	8.0	7.6	15.6	4.4	17.3	29.9	3.8	6.5	10.9	6.4	5.8	8.2	22.3	15.6	3.0	5.5	8.0	25.0	22.5	13.2	5.4	23.8	20.1	9.4	22.0	4.2	3.7	38.1	11.4	8.6	10.4	6.2	3.1	3.9	8.9	5.8	9.8	8.6	8.5	11.4	7.0	5.5	7.4	13.6	13.4	6.0	24.1	10.1	24.6	12.4	11.2	12.4	5.6	10.5	9.9	9.8	5.8	10.1	10.0	15.5	8.4	11.6	7.4	10.9	10.5	15.3	21.4	13.2	29.0	16.0	14.5	9.3	14.1	10.6	8.1	3.0	5.6	3.7	6.3	8.0	8.0	1.7	5.1	14.7	4.5	5.2	5.9	14.7	10.0	10.8	86.6	5.3	9.2	0.0	11.9	10.0	8.5	6.7	4.7	3.8	8.6	17.5	4.6	5.5	5.3	24.3	7.2	5.3	6.8	6.4	8.3	8.7	7.8	3.5	4.6	5.9	9.4	6.5	5.0	25.9	8.3	12.0	6.4	11.7	11.9	8.2
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 75.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 46.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"		Yes	No			"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: AB_2684796"	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	13.2	7.9	16.2	14.0	22.6	9.1	22.7	16.7	26.0	11.7	12.2	10.7	10.5	9.6	13.5	12.5	28.8	10.9	10.2	9.0	11.2	9.0	9.1	10.9	20.2	10.7	13.8	10.3	10.9	14.3	8.7	10.4	75.0	15.0	11.9	13.6	8.9	10.5	9.0	7.4	19.7	9.4	16.1	17.8	12.0	11.0	11.0	12.8	7.5	8.3	8.6	12.3	10.2	19.1	9.1	10.2	46.0	6.8	4.3	8.9	4.5	17.7	15.6	24.9	16.6	20.2	20.2	18.5	24.2	14.7	19.4	19.4	8.8	9.9	8.7	15.9	15.7	27.4	23.5	12.1	13.9	23.0	17.8	6.5	15.3	16.5	10.4	14.0	16.0	16.7	12.0	20.5	13.1	26.0	20.2	34.7	22.4	16.3	18.3	26.4	8.7	10.0	13.2	18.2	22.9	12.4	15.5	15.1	8.1	17.9	24.0	14.1	12.6	14.8	10.9	7.1	25.8	13.5	19.2	19.9	26.4	13.6	23.4	19.1	11.4	15.3	17.9	23.7	17.5	19.6	16.5	6.8	10.3	7.0	6.3	8.9	8.5	7.7	7.2	7.4	9.1	8.6	7.6	46.0	4.3	4.0	10.2	6.3	4.5	16.2	22.6	16.7	26.0	11.2	9.0	13.8	10.3	15.0	12.8	35.7	25.1	24.1	50.0	36.7	53.1	11.8	28.1	44.2	34.2	24.4	49.1	52.9	28.2	51.7	63.2	41.9	19.0	0.0	47.3	69.4	32.9	72.1	42.8	18.4	34.4	63.5	23.0	32.5	28.5	42.2	29.4	37.7	30.4	56.9	30.5	52.5	80.0	38.6	31.1	34.2	40.0	58.2	43.0	37.0	44.8	47.4	150.1	31.6	35.9	104.3
KBTBD11	"KIAA0711, KLHDC7C"	ENSG00000176595	"Kelch repeat and BTB domain containing 11"	O94819	8	1973878-2006936	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 33.4;Enterocytes: 28.4;Rod photoreceptor cells: 29.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.6;monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.4;NB-4: 7.5;SCLC-21H: 9.1;THP-1: 14.7;U-937: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051159	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA051159: AB_2681367"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.76e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-2)"	3.2	6.8	17.6	2.6	17.7	8.7	1.8	16.3	22.4	4.5	8.2	10.9	0.0	10.9	1.6	1.7	1.7	3.8	3.8	2.1	16.1	10.8	13.9	6.7	2.3	3.1	13.2	16.7	1.9	3.2	5.1	2.0	0.8	11.4	5.0	6.6	3.1	2.1	2.9	1.8	1.0	12.7	1.7	12.4	6.4	1.9	1.6	9.3	4.7	2.4	0.0	2.0	1.4	0.7	0.0	0.4	4.6	1.4	0.0	0.6	0.4	1.5	1.0	4.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.9	0.4	0.1	0.4	0.1	0.0	2.1	0.0	0.0	10.4	1.2	0.0	0.0	0.0	1.0	4.5	0.2	0.2	0.0	0.0	0.0	0.7	0.0	4.0	0.0	0.0	2.1	0.8	4.6	7.5	1.0	1.6	0.0	1.3	0.0	0.0	2.2	0.3	9.1	4.6	0.0	0.0	0.1	0.4	0.1	14.7	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.1	20.9	0.8	0.7	1.4	4.6	0.0	0.6	0.2	0.0	0.2	0.1	0.4	0.0	0.6	0.3	0.9	0.0	0.3	0.0	0.5	0.4	17.6	17.7	16.3	21.9	16.1	10.8	13.2	16.7	11.4	9.3	0.0	7.2	0.5	0.4	0.9	21.8	4.5	10.2	2.7	0.0	12.2	33.4	0.0	21.6	1.6	0.6	4.1	28.4	0.0	3.3	0.1	1.1	2.7	0.0	10.6	3.3	19.1	5.8	4.9	9.5	0.0	4.6	2.1	1.7	3.6	13.6	6.4	7.4	10.1	9.9	22.4	29.5	0.0	1.0	0.4	3.6	0.6	0.2	0.0	14.9	0.7
KBTBD2	"BKLHD1, DKFZP566C134"	ENSG00000170852	"Kelch repeat and BTB domain containing 2"	Q8IY47	7	32868172-32894131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021133	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"		"HPA021133: AB_1852093"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (3.96e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.96e-1)"	20.9	12.3	13.9	15.0	15.7	34.4	16.4	18.3	18.0	13.6	12.2	12.9	10.2	11.3	17.3	8.1	12.8	12.0	18.5	17.0	13.8	14.3	11.2	15.3	17.5	24.9	18.2	13.4	13.9	9.6	16.2	13.8	18.4	17.5	12.5	14.6	12.1	11.7	11.6	36.5	12.2	13.4	18.3	21.1	21.1	10.9	12.5	13.8	26.3	15.2	18.2	16.8	13.6	20.4	6.9	3.5	25.1	8.6	6.8	7.4	2.3	18.3	9.2	23.9	11.8	14.4	14.6	8.6	16.5	16.8	15.7	19.1	9.1	14.3	15.5	11.5	17.0	26.5	13.6	12.1	12.9	19.9	6.1	8.7	13.1	15.2	11.7	14.9	14.0	17.3	15.4	13.6	17.1	16.7	14.6	17.3	14.2	23.7	23.1	23.1	15.1	11.7	23.0	19.3	12.8	8.8	11.3	20.9	13.0	13.9	11.1	12.5	23.5	10.6	14.5	18.2	20.9	10.3	24.0	14.9	15.3	19.8	14.2	22.5	19.2	18.9	28.4	15.0	17.0	38.1	9.2	4.2	13.0	7.4	7.7	6.2	4.5	3.6	6.5	3.5	6.9	2.8	4.7	25.1	6.8	8.6	1.8	4.7	2.3	13.9	15.7	18.3	18.0	13.8	14.3	18.2	13.4	17.5	13.8	26.8	19.2	12.7	14.0	35.8	14.2	16.5	15.3	4.0	31.8	1.8	9.8	5.5	0.0	10.3	3.9	43.6	14.7	0.0	10.5	7.5	19.3	14.5	42.7	13.2	11.6	7.9	14.3	32.5	21.6	4.3	12.0	20.7	23.6	4.6	11.9	9.0	12.8	13.1	5.6	3.6	7.9	19.4	18.1	15.8	7.0	31.6	6.3	13.8	10.5	13.9
KBTBD4	"BKLHD4, FLJ10450, HSPC252"	ENSG00000123444	"Kelch repeat and BTB domain containing 4"	Q9NVX7	11	47572197-47579015	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037792, HPA037793"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA037792: AB_10671633, HPA037793: AB_2675671"	"unprognostic (5.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (2.70e-7)"	"unprognostic (4.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.25e-2)"	8.4	13.4	7.9	6.7	15.9	11.7	9.0	16.2	25.8	9.0	9.7	13.6	13.3	6.5	12.3	13.7	8.0	15.5	7.6	9.5	7.5	8.7	12.0	9.4	8.6	10.7	7.0	7.1	13.2	8.4	23.0	11.9	10.0	11.7	12.1	9.2	13.6	8.6	10.5	19.1	10.8	10.3	10.0	6.2	9.9	9.0	11.6	4.6	13.5	12.4	9.4	14.2	10.9	8.1	12.4	6.6	11.8	5.3	12.3	14.7	10.4	5.1	10.6	11.4	9.6	7.0	9.4	4.0	8.6	10.2	11.2	9.7	4.4	9.5	9.3	4.9	9.8	9.0	8.4	6.3	11.3	9.5	12.1	10.2	6.8	14.7	4.9	5.2	14.1	13.7	8.6	7.9	4.5	6.1	8.6	11.3	6.9	5.4	7.3	8.7	12.7	10.3	4.5	6.2	12.4	7.6	10.3	15.5	5.9	11.9	10.7	15.9	10.5	7.4	9.9	6.5	4.4	16.6	4.5	10.3	8.1	9.0	11.1	8.5	11.3	17.4	12.9	11.2	4.1	8.3	10.7	5.3	11.8	13.7	4.3	14.7	12.4	11.0	12.6	6.6	11.0	11.7	12.5	8.0	12.3	4.1	3.1	12.8	10.4	7.9	15.9	16.2	25.8	7.5	8.7	7.0	7.1	11.7	4.6	6.0	2.2	2.4	5.9	4.2	14.7	0.1	7.6	12.0	6.8	10.4	7.9	10.2	19.9	11.8	9.0	5.2	4.4	23.3	11.9	5.9	6.4	4.0	10.4	7.7	7.1	12.7	6.9	7.4	3.7	13.8	4.6	4.3	1.7	13.6	4.8	22.8	7.7	3.5	8.9	9.1	10.4	12.9	4.2	18.0	16.4	4.0	11.8	11.7	5.0	2.8
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.1;thyroid gland: 25.7"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 54.8;Cone photoreceptor cells: 29.5;Sertoli cells: 77.6;Smooth muscle cells: 66.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 5.9;hTEC/SVTERT24-B: 9.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 300.5"	"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	12.6	5.9	7.5	1.1	41.1	1.4	3.5	10.7	16.4	5.7	2.9	4.6	2.5	1.6	3.4	11.9	2.1	2.7	2.7	4.8	12.3	4.3	1.8	2.3	3.1	0.9	3.7	10.3	2.8	3.7	1.8	1.2	1.3	3.0	21.1	1.8	7.2	3.4	17.9	1.7	1.3	1.9	2.6	2.6	4.3	1.3	2.7	12.3	0.0	25.7	1.0	0.5	2.0	3.0	1.0	4.3	2.4	1.2	0.9	2.7	0.4	0.9	0.8	1.3	0.3	0.1	0.0	2.5	2.2	0.0	0.0	0.2	1.7	0.2	0.6	1.2	0.0	0.5	0.6	0.0	0.0	0.0	0.7	1.7	5.9	1.1	2.7	0.0	1.7	0.5	0.0	0.0	9.2	0.0	2.1	3.7	0.9	0.2	0.5	0.4	0.2	0.5	1.0	1.9	2.6	0.5	0.9	1.3	4.7	0.0	0.4	1.4	1.4	0.5	1.1	1.2	0.9	1.5	0.9	3.8	1.5	0.9	2.5	2.0	3.2	0.7	0.7	4.5	1.9	1.7	2.4	0.6	0.2	1.5	0.7	2.7	0.9	1.4	1.3	0.9	1.0	1.2	1.3	0.1	0.9	1.2	4.3	1.7	0.4	7.5	41.1	10.7	16.4	12.3	4.3	3.7	10.3	3.0	12.3	0.0	0.0	0.5	0.1	0.7	54.8	4.1	0.0	0.0	1.2	0.0	29.5	0.1	0.0	0.4	11.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	3.6	0.0	0.0	1.3	9.3	4.7	0.0	1.1	1.7	0.0	0.0	1.6	0.0	0.0	2.5	0.0	6.1	77.6	66.2	0.1	0.9	0.6	0.1	0.0	0.0	0.1
KCNAB3	"AKR6A9, KCNA3B"	ENSG00000170049	"Potassium voltage-gated channel subfamily A regulatory beta subunit 3"	O43448	17	7921859-7929803	"Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 36.1;endometrium 1: 17.2"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 123.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"cerebellum: 36.1;cerebral cortex: 31.6"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.5;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"REH: 14.9;SH-SY5Y: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077993			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077993: AB_2686872"	"unprognostic (3.02e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.84e-4)"	"unprognostic (2.19e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.27e-4)"	"unprognostic (7.47e-3)"	"unprognostic (3.03e-6)"	"unprognostic (2.12e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.97e-2)"	"unprognostic (9.54e-3)"	1.4	0.7	4.2	2.7	5.2	5.5	1.2	36.1	31.6	1.8	1.4	0.8	0.0	1.3	17.2	2.2	0.8	3.5	2.1	0.7	4.7	2.9	1.7	1.1	1.5	3.8	2.4	6.3	2.1	1.0	0.8	4.9	1.6	5.9	2.3	2.0	3.8	1.3	1.4	1.0	3.3	1.9	11.4	5.2	2.6	2.2	1.7	1.9	0.8	1.6	0.0	3.3	1.0	1.0	0.1	1.7	0.5	0.2	0.0	0.7	0.1	1.3	1.1	5.5	1.4	0.6	1.4	2.0	4.9	3.1	4.2	4.8	0.7	0.3	2.2	0.3	0.8	0.2	0.4	1.5	0.7	6.0	1.8	2.3	0.7	0.9	0.0	5.1	0.2	3.0	2.2	1.6	4.6	0.2	0.2	0.3	6.1	0.5	0.3	0.7	1.0	0.8	2.6	0.8	0.0	0.7	14.9	1.5	0.6	0.5	1.7	0.3	8.1	0.4	0.0	0.9	0.2	1.4	0.1	0.3	0.7	2.8	1.1	0.4	1.1	1.2	1.2	2.1	3.0	1.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.2	0.2	0.5	0.0	0.0	1.7	0.0	0.1	4.2	5.2	36.1	31.6	4.7	2.9	2.4	6.3	5.9	1.9	3.0	2.4	0.0	0.6	0.5	22.9	0.8	0.0	0.0	1.2	0.0	3.9	0.2	0.0	0.5	0.3	0.1	0.4	0.0	0.5	0.2	1.1	0.6	1.1	0.2	0.7	123.9	0.0	0.6	0.0	0.0	1.7	0.8	0.0	1.8	0.3	12.0	0.5	0.0	0.7	0.0	6.3	0.0	0.3	3.1	1.5	0.4	0.1	0.0	0.2	0.1
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537391-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2"	"Cell type enriched"	"Detected in some"	15	"Cone photoreceptor cells: 249.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"		Yes	NA			"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0.0	0.0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0.0	0.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4	0.0	0.0	0.0	0.0	0.0	12.9	0.2	0.0	0.0	0.0	1.8	249.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	17.1	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.4	0.0	2.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 67.5"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 36.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 67.5"	"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.7	2.3	8.2	1.0	10.0	2.9	0.9	67.5	33.3	3.0	1.0	1.0	0.0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1.0	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1.0	1.3	2.9	2.0	0.0	1.5	0.0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.1	1.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.2	0.0	0.9	1.1	1.8	0.0	0.3	0.3	2.1	0.6	3.0	0.2	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	1.4	0.0	0.5	0.5	1.2	1.5	0.0	0.0	0.8	7.5	0.9	0.0	0.4	7.1	4.4	0.4	0.5	0.0	0.4	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1.0	0.5	0.3	1.0	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10.0	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2.0	0.0	0.0	0.0	0.0	0.0	36.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	7.5	0.0	0.0	8.4	0.3	0.0	0.0	1.0	0.0	1.5	0.2	0.0	0.0	0.1	7.4	0.0	0.4	5.4	4.5	0.0	0.0	0.0	0.0	0.0
KCNC4	"C1orf30, HKSHIIIC, Kv3.4"	ENSG00000116396	"Potassium voltage-gated channel subfamily C member 4"	Q03721	1	110211343-110283100	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 39.3;Ito cells: 63.3;Rod photoreceptor cells: 44.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.5;U-87 MG: 14.7;WM-115: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014740			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA014740: AB_1855580"	"unprognostic (9.16e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.25e-2)"	2.3	4.7	12.1	1.6	3.2	0.7	3.3	9.2	12.7	1.9	1.4	1.9	1.1	0.8	4.5	3.1	2.1	3.7	4.8	4.5	9.1	14.2	5.1	1.1	3.0	1.9	6.8	2.0	3.4	4.3	11.2	3.8	2.8	14.3	2.4	1.3	4.7	7.1	3.7	4.5	4.0	2.0	2.6	3.6	3.3	2.8	2.2	1.1	7.2	2.3	7.8	2.3	1.2	1.5	0.8	0.7	0.9	0.4	0.3	1.5	0.1	1.9	1.5	0.4	2.9	1.1	0.3	3.5	8.5	1.5	0.6	0.8	4.8	0.9	3.3	3.4	3.1	2.6	3.2	1.4	0.7	0.4	16.5	1.6	0.1	3.3	0.7	0.5	2.7	0.8	0.3	0.3	1.9	0.2	0.5	4.4	1.8	0.6	1.4	0.0	0.4	1.8	0.6	1.7	0.7	3.9	2.7	0.1	0.5	4.1	0.1	0.6	0.8	0.4	8.3	0.8	2.7	1.1	1.4	1.6	1.1	4.0	0.7	0.3	2.1	1.9	0.6	14.7	2.3	9.5	0.8	0.4	0.2	0.5	0.2	1.5	0.6	0.9	0.4	0.0	0.8	1.3	0.5	0.9	0.3	0.3	0.7	0.4	0.1	12.1	3.2	9.2	12.7	9.1	14.2	6.8	2.0	14.3	1.1	0.0	1.4	0.0	12.5	2.9	1.4	6.7	7.6	4.0	2.3	3.5	39.3	0.3	0.0	5.0	0.3	9.8	2.2	0.0	14.8	0.3	2.4	7.4	1.1	0.5	1.2	3.2	12.7	63.3	3.1	0.4	1.4	0.5	1.7	1.8	5.7	3.7	8.7	6.6	3.9	0.5	44.8	25.8	5.1	0.0	5.7	2.6	0.9	1.3	8.3	10.3
KCNE4	MiRP3	ENSG00000152049	"Potassium voltage-gated channel subfamily E regulatory subunit 4"	Q8WWG9	2	223051814-223198399	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 27.0"	"Group enriched"	"Detected in many"	5	"Sertoli cells: 116.4;Smooth muscle cells: 171.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 20.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011420	Approved		Approved	"Nuclear bodies,Microtubules"		NA	NA			Microtubules	"Nuclear bodies"	"HPA011420: AB_1079170"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (9.42e-5)"	"unprognostic (2.17e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.70e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-3)"	"unprognostic (9.08e-3)"	9.0	2.4	5.5	7.5	5.7	0.2	6.6	2.6	11.9	4.5	3.3	1.2	1.4	0.8	21.9	4.4	3.7	3.4	14.8	3.5	6.5	2.5	2.4	3.6	2.1	3.3	9.4	0.7	9.2	6.4	0.7	5.3	4.6	8.7	3.7	1.4	11.6	2.3	4.2	2.1	2.1	2.3	27.0	21.5	4.7	4.9	2.2	8.4	0.0	5.2	1.7	0.6	7.7	12.5	0.7	0.3	2.3	0.3	0.4	0.3	0.0	0.0	0.3	0.0	61.0	14.0	1.4	0.0	1.4	1.4	0.3	0.7	0.0	0.0	0.0	0.0	0.9	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	2.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	2.4	0.0	4.5	0.2	0.0	0.0	0.0	1.4	0.0	1.1	2.3	0.3	0.2	0.3	0.1	0.3	0.2	0.3	0.2	0.0	0.7	0.3	0.3	0.9	0.4	0.2	0.3	0.1	0.0	5.5	5.7	2.6	11.9	6.5	2.5	9.4	0.7	8.7	8.4	0.0	2.1	0.0	0.2	3.4	0.0	1.2	0.0	6.7	2.3	0.0	0.0	0.3	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.2	12.9	0.6	3.5	0.0	0.1	3.2	4.6	6.2	0.0	0.0	19.5	2.2	30.4	0.0	0.0	4.8	0.6	0.0	15.9	0.0	0.2	116.4	171.0	0.0	0.2	2.8	0.2	0.0	0.0	1.1
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911937-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 36.9"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 10.2;Syncytiotrophoblasts: 6.4"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 16.9;MCF7: 6.0;T-47d: 7.3"	"Group enriched"	"Detected in many"	4	"amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1"	"Low region specificity"	"Detected in all"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.9	0.9	11.5	1.0	25.5	0.8	1.2	0.8	36.9	0.9	1.2	2.4	0.0	1.2	1.9	0.8	1.6	1.1	1.0	1.1	13.1	4.7	1.1	0.9	1.0	1.0	3.1	10.5	0.9	2.2	0.8	0.2	0.9	3.6	1.0	1.2	0.0	0.8	1.4	0.8	0.8	1.1	1.0	1.0	1.5	1.1	1.0	3.1	0.5	0.8	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	16.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	2.6	0.1	1.8	0.0	0.1	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.2	7.3	0.8	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.5	25.5	0.8	28.5	13.1	4.7	3.1	10.5	3.6	3.1	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
KCNG1	"K13, KCNG, kH2, Kv6.1"	ENSG00000026559	"Potassium voltage-gated channel modifier subfamily G member 1"	Q9UIX4	20	51003656-51023129	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 25.8;endometrium 1: 48.3"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 45.1;Syncytiotrophoblasts: 81.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	27	"naive B-cell: 10.8"	"Lineage enriched"	"Detected in single"	87	"B-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.7;U-138 MG: 20.3;WM-115: 17.0"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7"	"Group enriched"	"Detected in all"	4	"amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1"	"HPA039530, HPA040024"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA039530: AB_10795144, HPA040024: AB_10796338"	"unprognostic (1.19e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.05e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.83e-9)"	"unprognostic (1.52e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-2)"	0.5	4.5	13.3	2.9	7.0	0.3	0.7	2.3	11.9	9.6	2.4	1.6	25.8	0.6	48.3	2.8	3.7	11.9	1.9	1.0	7.9	2.9	0.5	0.4	0.5	3.0	2.0	9.5	0.9	3.7	1.3	0.8	9.3	6.7	5.6	1.3	0.7	1.4	18.3	0.3	0.5	7.2	5.8	1.0	3.5	0.8	5.4	2.6	0.0	0.5	0.0	1.4	2.8	3.4	10.8	0.0	0.0	0.1	0.0	0.0	0.1	0.4	1.7	1.3	6.5	0.7	1.7	0.1	5.7	0.0	3.4	2.6	0.1	0.1	0.0	3.5	1.7	9.4	1.6	0.8	1.7	3.4	0.2	2.2	0.0	6.3	0.0	11.9	0.0	0.2	3.4	26.7	12.8	13.1	0.6	0.9	0.0	0.1	0.0	0.3	6.3	0.0	0.1	6.8	0.0	11.8	0.0	0.0	0.0	0.0	2.0	2.0	7.4	12.4	14.5	9.3	2.2	1.0	0.9	0.3	20.3	12.0	0.1	1.6	0.0	0.0	0.0	6.0	0.4	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.3	7.0	2.3	11.9	7.9	2.9	2.0	9.5	6.7	2.6	3.0	1.4	1.5	9.3	1.0	0.3	0.8	0.0	1.4	1.2	0.0	0.0	45.1	0.0	2.9	14.5	0.3	3.5	0.0	0.0	2.4	1.0	5.6	0.0	0.0	2.9	1.6	0.0	0.0	0.0	14.4	1.4	0.0	0.0	0.0	0.2	0.2	0.3	3.5	3.9	0.0	0.1	0.0	1.0	1.2	0.9	0.3	81.1	0.0	0.3	7.9
KCNG3	Kv6.3	ENSG00000171126	"Potassium voltage-gated channel modifier subfamily G member 3"	Q8TAE7	2	42442017-42494097	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.4"	"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 3.0;Intestinal endocrine cells: 1.7;Leydig cells: 1.7;Muller glia cells: 2.1;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 9.0;basal ganglia: 11.4;cerebral cortex: 7.1;hippocampal formation: 4.4;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 5.1;HMC-1: 17.7;NTERA-2: 11.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"amygdala: 3.9;basal ganglia: 4.7;cerebral cortex: 5.3;hippocampal formation: 6.6;midbrain: 3.0"	HPA041625			Approved	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA041625: "	"unprognostic (1.56e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.67e-3)"	"unprognostic (7.95e-2)"	"unprognostic (9.14e-3)"		"unprognostic (4.83e-3)"	"unprognostic (6.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.23e-1)"	0.4	5.2	9.0	2.5	11.4	0.3	0.5	0.2	7.1	0.8	2.3	0.1	1.6	0.4	1.6	0.7	0.4	0.5	0.7	0.3	4.4	0.9	1.2	0.3	1.2	0.4	1.2	3.6	0.9	2.9	0.3	1.8	0.3	0.5	1.2	1.3	0.6	0.3	1.7	0.3	0.6	0.5	0.6	0.3	0.4	0.3	3.3	1.1	4.9	0.3	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	5.1	0.0	0.0	0.0	2.7	0.0	0.5	0.9	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.9	0.0	11.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.6	0.7	1.1	1.7	0.5	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	11.4	0.2	7.1	4.4	0.9	1.2	3.6	0.5	1.1	3.0	0.6	0.0	0.2	1.1	1.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	2.1	0.2	0.0	2.5	0.0	0.0	0.0	0.4	0.2	1.0	1.0	0.1	0.0	0.0	0.1
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539157-49558308	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 9.4;Early spermatids: 4.1;Late spermatids: 3.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"A549: 9.6;AN3-CA: 4.5;HMC-1: 4.6;RPTEC TERT1: 11.8;U-2 OS: 12.5"	"Group enriched"	"Detected in many"	11	"amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0"	"Low region specificity"	"Detected in many"			HPA051088			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051088: AB_2681340"	"unprognostic (5.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-4)"	"unprognostic (8.24e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.91e-3)"	"unprognostic (5.28e-2)"	"unprognostic (6.39e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.07e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	0.9	3.8	24.3	1.5	18.5	1.4	1.0	5.8	30.7	0.9	0.8	0.5	0.0	0.9	1.3	0.9	0.7	8.7	1.7	1.2	22.0	3.0	1.6	0.7	1.2	1.9	1.9	13.0	0.8	1.4	6.3	9.3	0.8	0.0	1.2	0.7	0.0	1.1	1.6	0.8	1.1	1.0	1.0	0.6	1.4	1.4	2.6	2.1	0.0	1.7	0.0	1.4	0.9	0.0	0.0	0.1	0.6	0.8	0.4	3.6	0.5	1.0	9.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.6	0.0	0.3	2.3	0.7	0.2	0.0	0.1	0.4	0.0	0.5	0.1	0.1	0.0	4.6	0.0	0.0	0.1	0.0	1.8	0.0	0.2	0.0	0.3	0.0	1.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	11.8	0.0	1.8	0.3	0.3	0.0	0.3	0.0	1.1	0.2	0.1	0.0	12.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.7	0.0	3.6	0.0	0.3	1.1	0.1	0.0	1.1	2.6	0.6	0.4	0.1	0.0	0.4	0.5	24.3	18.5	5.8	30.7	22.0	3.0	1.9	13.0	0.0	2.1	0.0	0.3	0.0	0.2	0.1	0.0	0.6	2.5	9.4	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.6	2.4	1.3	0.8	3.6	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.9	2.5	0.3	0.0	1.0	0.0	0.0
KCNH5	"eag2, H-EAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699454-63102037	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 9.2;retina: 5.7"	"Cell type enriched"	"Detected in some"	15	"Bipolar cells: 64.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 10.1;RT4: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.9	4.6	1.7	0.5	3.6	0.3	0.4	0.2	9.2	0.3	0.4	0.4	0.0	0.3	0.4	0.5	0.3	0.3	0.3	0.3	1.3	3.0	0.4	0.3	0.3	0.3	1.2	4.2	0.3	0.3	0.3	1.5	1.2	6.5	0.7	0.3	5.7	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	1.7	0.0	0.0	0.3	0.0	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	1.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.1	0.0	1.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.6	0.2	9.2	1.3	3.0	1.2	4.2	6.5	0.0	0.0	0.0	0.0	0.1	0.0	64.7	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.4	0.7	0.0	1.0	0.0	0.0	0.0
KCNIP1	KCHIP1	ENSG00000182132	"Potassium voltage-gated channel interacting protein 1"	Q9NZI2	5	170353487-170736632	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2;epididymis: 27.8"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 47.7"	"Cancer enriched"	"Detected in some"	18	"glioma: 22.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022864, HPA066717"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA022864: AB_1858712, HPA066717: "	"unprognostic (7.75e-5)"	"unprognostic (2.66e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.22e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.46e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-2)"	1.1	5.9	20.6	1.2	27.9	0.6	1.9	6.4	31.2	4.0	1.0	6.0	5.2	0.9	2.7	27.8	1.0	2.8	2.9	1.2	11.7	20.5	4.9	0.8	1.9	1.2	12.9	7.3	0.9	2.4	5.1	0.7	2.1	11.1	2.3	1.3	0.8	1.3	7.9	0.8	0.7	1.1	2.1	6.9	2.2	1.1	5.2	5.3	0.0	1.2	0.0	1.2	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	27.9	6.4	14.6	11.7	20.5	12.9	7.3	11.1	5.3	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNIP2	KCHIP2	ENSG00000120049	"Potassium voltage-gated channel interacting protein 2"	Q9NS61	10	101825974-101843920	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 86.5;brain: 54.5;heart muscle: 74.8"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 37.5;Cardiomyocytes: 109.6;Cone photoreceptor cells: 23.6;Horizontal cells: 46.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.9;intermediate monocyte: 1.2;memory B-cell: 2.9;naive B-cell: 4.6"	"Group enriched"	"Detected in many"	5	"B-cells: 4.6;granulocytes: 1.9;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HEL: 20.1;HMC-1: 12.5"	"Group enriched"	"Detected in many"	5	"amygdala: 96.2;basal ganglia: 204.2;cerebral cortex: 97.2;hippocampal formation: 151.4;olfactory region: 172.7"	"Low region specificity"	"Detected in all"			HPA066717			Approved	Vesicles		NA	NA			Vesicles		"HPA066717: "	"unprognostic (5.92e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.77e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.80e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.49e-9)"	"unprognostic (9.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.37e-4)"	86.5	3.5	15.5	2.0	54.5	0.9	10.4	8.3	26.1	1.8	2.4	2.6	0.0	1.4	2.3	2.4	1.2	2.2	1.9	74.8	19.6	5.0	1.0	1.0	1.4	3.7	4.2	11.3	5.7	1.6	1.2	3.3	1.8	4.3	1.6	2.7	1.7	4.6	2.1	3.8	3.0	1.6	1.8	2.1	2.8	1.6	4.1	9.8	0.0	1.3	0.8	3.9	1.6	0.7	4.6	0.5	1.9	1.2	0.0	0.4	0.4	1.6	2.5	2.5	3.1	1.0	1.1	0.6	1.1	1.0	0.6	0.9	3.6	3.2	1.6	1.0	0.7	0.6	1.7	0.8	0.4	0.6	2.2	1.9	20.1	2.4	1.9	0.9	1.3	12.5	2.6	1.7	1.0	1.3	3.6	1.0	4.5	5.8	1.8	1.0	1.1	0.7	3.9	0.8	0.7	0.6	0.9	0.2	1.2	1.0	1.0	7.3	1.2	0.8	0.5	2.4	1.6	2.1	0.8	2.2	1.4	2.1	0.6	1.1	1.7	1.7	1.7	1.5	5.1	0.2	0.0	0.1	1.9	0.1	1.2	0.4	2.9	0.3	0.0	0.4	4.6	0.0	0.1	0.0	0.0	0.5	0.5	0.3	0.4	15.5	54.5	8.3	26.1	19.6	5.0	4.2	11.3	4.3	9.8	0.0	0.0	1.3	0.1	0.3	37.5	109.6	0.0	0.0	0.0	1.8	23.6	0.2	0.0	0.1	5.6	0.0	0.4	0.0	0.0	0.1	0.2	0.2	0.0	0.0	1.8	46.1	0.0	0.6	0.6	5.3	1.7	0.3	0.0	0.0	0.1	6.3	0.2	0.0	0.7	0.0	4.8	0.0	0.4	1.4	5.3	0.0	0.2	0.0	0.3	0.0
KCNIP3	"CSEN, DREAM, KCHIP3"	ENSG00000115041	"Potassium voltage-gated channel interacting protein 3"	Q9Y2W7	2	95297304-95386083	"Predicted intracellular proteins, Transporters"	"Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport"	"Ion channel, Potassium channel, Repressor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.8;parathyroid gland: 32.5"	"Group enriched"	"Detected in some"	5	"Leydig cells: 23.6;Peritubular cells: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.1;hTERT-RPE1: 15.9;RPTEC TERT1: 23.8;U-138 MG: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066717, HPA069797"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA066717: , HPA069797: AB_2686199"	"unprognostic (1.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.33e-3)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.44e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-1)"	4.2	1.8	19.8	1.5	20.1	0.7	2.8	3.7	39.8	6.0	4.6	12.9	0.6	2.1	5.8	4.9	3.5	5.3	2.4	3.4	16.7	7.8	4.6	1.2	1.5	1.1	9.1	19.5	8.8	2.5	32.5	5.6	6.5	8.2	5.7	1.8	1.4	6.9	18.6	2.2	3.9	1.9	6.4	6.3	2.2	2.9	9.2	15.9	5.4	19.5	0.0	1.3	4.5	5.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.9	0.0	0.5	4.1	3.6	2.9	0.0	4.2	12.1	6.9	6.4	0.0	0.0	0.0	0.4	5.5	3.7	0.1	2.7	0.7	2.9	0.0	0.9	0.0	1.1	0.0	1.5	0.0	0.0	2.0	2.4	1.5	6.8	15.9	0.0	0.7	0.0	0.0	0.5	5.2	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	23.8	0.0	0.4	0.1	0.2	0.2	4.6	0.0	0.2	0.0	0.2	11.2	2.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	20.1	3.7	39.8	16.7	7.8	9.1	19.5	8.2	15.9	0.0	0.6	0.0	0.7	0.3	0.6	0.9	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.3	0.3	0.6	0.2	0.0	0.0	0.0	3.3	0.4	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	23.6	0.0	6.8	1.0	0.0	0.7	0.3	0.0	40.3	0.6	0.0	0.0	2.3	0.0	0.9	0.6	0.0	0.0	0.1	0.0
KCNIP4	"CALP, KCHIP4, MGC44947"	ENSG00000185774	"Potassium voltage-gated channel interacting protein 4"	Q6PIL6	4	20728616-21948799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 32.3;Distal tubular cells: 53.0;Muller glia cells: 43.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 10.1;SCLC-21H: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022862, HPA066717"		Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA022862: AB_1852654, HPA066717: "	"unprognostic (8.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.10e-2)"	1.1	3.6	15.8	2.2	28.3	1.0	0.9	22.4	38.9	15.0	4.2	1.8	0.0	2.4	9.6	1.1	5.6	3.9	2.6	1.8	11.9	16.2	7.8	0.7	1.1	1.1	11.6	19.3	1.9	1.0	0.5	5.1	1.8	16.9	1.0	5.2	3.5	1.4	0.8	1.3	2.3	5.5	7.8	3.9	1.1	1.3	1.3	3.5	0.0	8.9	0.0	0.5	2.7	1.1	0.3	0.7	0.0	0.7	0.8	0.7	0.3	1.7	1.5	2.2	2.2	0.0	0.0	1.1	1.3	0.0	0.0	0.0	1.9	1.7	3.4	1.4	0.5	1.7	0.9	0.0	0.1	0.0	0.4	2.3	1.2	2.5	1.2	0.0	3.2	0.5	0.0	0.8	0.0	1.4	2.9	0.6	1.3	2.0	1.1	0.0	0.6	2.8	1.9	2.8	1.3	1.4	0.8	4.2	1.3	10.1	1.0	7.9	4.7	1.4	1.7	2.2	2.7	0.9	1.2	2.2	1.1	1.5	2.4	3.2	1.0	0.1	1.2	3.7	2.7	1.7	0.0	0.3	0.0	0.2	0.7	0.7	0.2	0.1	0.2	0.7	0.3	0.5	0.5	0.0	0.8	0.5	0.3	0.2	0.3	15.8	28.3	22.4	33.0	11.9	16.2	11.6	19.3	16.9	3.5	0.0	0.0	0.0	0.0	0.0	32.3	0.4	0.0	0.0	0.0	14.0	0.0	0.0	53.0	0.0	6.9	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	3.2	0.0	0.0	3.3	1.0	0.0	43.9	0.0	7.0	0.0	4.7	11.8	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.3	0.0
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium voltage-gated channel subfamily J member 13"	O60928	2	232766464-232776568	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;intestine: 49.5;retina: 70.3"	"Group enriched"	"Detected in some"	14	"Melanocytes: 20.3;Muller glia cells: 44.0"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Region enriched"	"Detected in some"	7	"pons and medulla: 22.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CACO-2: 2.6;SuSa: 3.1;U-2197: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.2	0.2	0.5	0.0	0.7	0.1	0.3	0.4	0.9	0.2	10.1	7.0	1.3	4.3	0.2	0.3	0.2	0.1	1.6	0.2	3.2	0.5	1.9	0.3	0.2	0.0	0.4	0.4	0.3	0.4	8.5	0.3	0.0	22.9	0.3	0.0	70.3	0.3	1.6	0.2	1.8	49.5	0.0	0.6	0.2	1.1	0.5	0.1	0.0	3.8	0.0	0.0	0.3	0.3	1.1	0.8	5.4	1.1	1.1	2.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.5	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	1.0	3.1	0.2	0.3	0.0	0.1	0.0	4.6	0.3	1.3	0.1	0.8	0.8	0.4	0.0	5.4	1.1	0.9	1.0	0.2	1.2	0.8	1.8	0.7	0.4	1.1	2.1	1.1	0.8	1.1	1.0	0.8	2.7	0.1	0.5	0.7	0.4	0.9	3.2	0.5	0.4	0.4	22.9	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	2.4	0.0	1.0	0.0	1.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	44.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium voltage-gated channel subfamily J member 14"	Q9UNX9	19	48455509-48466980	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9"	"Cell type enriched"	"Detected in many"	8	"Rod photoreceptor cells: 311.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071765			Approved	Nucleoli		NA	NA			Nucleoli		"HPA071765: AB_2686444"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.33e-5)"	"unprognostic (5.77e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.05e-4)"	"unprognostic (7.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.02e-6)"	"unprognostic (1.47e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.82e-3)"	"unprognostic (4.41e-2)"	1.0	0.4	1.1	0.9	6.1	4.9	1.8	2.3	2.2	0.9	0.9	0.9	0.9	0.6	0.9	1.8	1.5	1.1	1.0	0.9	1.4	1.3	0.9	0.9	0.9	1.2	1.2	0.9	1.3	1.4	1.0	1.0	1.4	1.4	1.5	0.7	22.9	0.9	0.9	3.3	4.9	0.9	0.9	0.9	0.9	0.6	2.8	0.9	0.9	1.6	0.9	0.9	0.9	1.1	1.5	0.8	3.5	0.8	0.6	1.0	0.2	1.6	3.8	0.8	2.5	1.7	1.7	2.6	0.6	0.3	0.8	1.3	3.9	2.2	1.8	0.8	0.6	2.0	5.5	1.2	0.6	2.1	1.3	2.0	1.1	2.2	1.0	1.0	1.6	3.2	1.6	2.8	2.0	2.3	1.1	0.5	1.7	1.8	2.0	0.5	2.4	0.6	12.4	1.4	2.0	2.2	2.6	1.5	0.4	0.6	4.6	1.4	1.7	1.8	2.6	1.4	1.5	1.8	1.3	1.1	2.7	3.6	2.7	3.0	2.1	3.1	1.3	0.7	4.0	2.8	3.5	0.8	0.6	0.6	0.6	0.5	1.2	0.7	1.0	0.4	1.5	0.8	1.0	2.9	0.6	0.3	0.8	0.6	0.2	1.1	6.1	2.3	2.0	1.4	1.3	1.2	0.9	1.4	0.9	0.0	4.3	0.0	3.7	3.9	15.0	0.4	2.5	1.4	0.0	1.8	39.3	1.3	0.0	0.8	4.1	1.0	0.4	0.0	0.9	2.1	0.8	2.5	0.0	0.5	0.5	14.3	0.0	0.6	0.0	0.0	1.1	0.2	0.0	0.0	1.2	17.5	2.1	0.0	0.4	0.0	311.1	0.0	0.9	3.4	2.7	4.6	0.8	0.0	1.7	2.1
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium voltage-gated channel subfamily J member 15"	Q99712	21	38155549-38307357	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 74.8;kidney: 99.7"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 56.6;Alveolar cells type 2: 153.4;Cholangiocytes: 63.7;Proximal tubular cells: 211.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	21	"neutrophil: 74.8"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 74.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 26.1;GAMG: 37.4;HBEC3-KT: 25.1;RPTEC TERT1: 25.0;RT4: 29.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (1.95e-4)"	6.0	0.3	0.4	5.3	0.3	3.2	1.4	0.2	0.3	3.5	0.4	0.2	27.1	0.2	0.5	12.8	6.0	0.8	17.7	1.0	0.2	0.1	99.7	1.5	34.1	0.8	0.5	0.2	0.6	16.7	0.0	0.3	1.0	0.6	4.0	0.0	0.2	14.4	26.8	1.0	1.7	0.2	0.9	0.4	6.8	10.7	1.1	0.2	0.4	36.8	3.2	1.9	11.3	4.3	0.0	0.2	74.8	3.5	0.0	0.0	0.7	0.6	0.0	0.1	0.2	5.1	26.1	0.2	0.3	1.7	0.0	0.0	0.0	0.2	0.1	0.0	2.7	37.4	8.8	0.0	25.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	7.7	2.5	6.5	1.4	0.5	1.2	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	25.0	29.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	1.3	0.0	0.6	0.1	0.0	2.1	1.5	0.1	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	0.7	0.4	0.3	0.2	0.3	0.2	0.1	0.5	0.2	0.6	0.2	56.6	153.4	0.8	8.5	2.5	0.0	1.2	63.7	9.4	52.4	29.6	0.0	0.1	14.9	23.3	1.4	1.4	0.0	0.0	7.8	0.4	0.8	0.4	5.8	0.0	0.3	0.0	0.0	1.3	5.1	1.9	0.6	2.6	1.7	0.0	0.0	0.0	26.3	0.0	0.0	211.6	0.0	0.0	1.0	0.9	1.0	1.4	0.1	0.0	0.0	4.1
KCNK1	"DPK, K2p1.1, TWIK-1"	ENSG00000135750	"Potassium two pore domain channel subfamily K member 1"	O00180	1	233614004-233672512	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 117.0;Glandular cells: 169.9;Horizontal cells: 189.1;Urothelial cells: 247.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 75.3"	"Cell type enriched"	"Detected in single"	98	"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in single"	98	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 21.0;SCLC-21H: 19.8;U-266/70: 45.5;U-266/84: 41.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 236.2"	"HPA016049, CAB022588"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB022588: , HPA016049: AB_1855571"	"unprognostic (7.06e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.64e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.84e-4)"	"unprognostic (4.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (7.29e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	1.9	3.3	15.2	2.2	12.7	0.3	4.5	75.3	22.8	5.5	11.5	7.9	5.1	12.5	4.5	22.9	12.0	8.4	9.3	20.8	10.3	5.2	7.2	10.8	3.4	0.8	8.9	11.1	3.8	4.4	2.5	11.3	5.0	22.3	4.6	10.6	2.6	7.2	9.3	0.5	8.7	9.6	3.2	12.3	0.8	28.0	0.7	7.8	0.0	5.6	1.6	3.2	4.3	6.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	10.3	5.6	0.0	0.0	0.0	0.0	15.8	2.8	0.0	0.0	0.0	0.0	17.0	0.0	6.7	2.0	2.3	15.0	2.8	4.9	0.0	0.0	4.9	0.0	21.0	0.0	0.1	0.0	0.5	1.2	5.3	0.0	3.9	0.3	0.0	5.7	2.4	4.5	0.0	3.8	3.7	0.0	3.4	12.1	12.8	0.0	0.8	1.1	4.9	8.6	19.8	3.9	10.3	4.5	0.0	0.3	1.3	0.0	0.0	0.0	8.4	0.0	0.3	45.5	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	15.2	12.7	75.3	17.1	10.3	5.2	8.9	11.1	22.3	7.8	8.9	15.6	0.0	117.0	56.2	1.2	37.7	5.1	28.1	33.0	17.4	3.9	0.2	1.7	19.6	0.9	0.7	34.8	0.0	42.5	13.5	15.3	169.9	0.0	8.2	0.6	189.1	28.2	0.0	0.8	0.0	1.4	0.8	10.1	0.0	45.4	65.8	61.4	22.8	0.0	11.3	5.0	0.0	3.4	0.4	0.7	41.7	0.7	1.5	21.1	247.4
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061765-90185857	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;parathyroid gland: 14.3;testis: 13.2"	"Cell type enhanced"	"Detected in some"	24	"Hofbauer cells: 5.6;Kupffer cells: 2.5;Macrophages: 5.3;monocytes: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.4;RT4: 4.2;SuSa: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.8	1.1	2.9	2.2	3.5	0.1	0.4	0.2	4.2	0.4	0.6	4.0	0.0	0.6	0.3	1.5	0.3	0.4	0.5	2.7	2.9	2.4	4.8	0.7	0.7	1.6	6.3	1.4	0.4	2.7	14.3	0.6	1.2	3.6	0.4	0.7	0.1	1.1	0.7	0.1	0.1	0.7	0.4	8.3	1.1	0.5	13.2	5.4	0.7	2.7	0.0	0.6	0.8	0.1	0.0	3.8	0.0	1.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.9	0.0	0.0	0.8	1.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.4	4.2	1.8	0.5	0.0	1.8	1.2	7.1	0.0	1.6	0.0	0.0	2.1	0.0	0.6	0.6	1.8	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	2.9	3.5	0.2	4.2	2.9	2.4	6.3	1.4	3.6	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	2.5	0.6	0.0	5.3	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.1	0.0	0.0	0.1
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314553	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.1;retina: 20.0"	"Group enriched"	"Detected in some"	4	"Exocrine glandular cells: 7.3;granulocytes: 5.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	34	"plasmacytoid DC: 29.1"	"Lineage enriched"	"Detected in single"	34	"dendritic cells: 29.1"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 42.5"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.7	0.4	0.3	0.6	1.1	1.4	3.3	0.3	0.8	0.7	1.3	0.8	1.9	3.0	1.9	0.5	1.0	1.3	6.5	7.9	0.6	0.6	0.3	4.6	10.4	0.9	2.6	0.8	0.4	6.1	0.4	2.7	6.3	1.9	1.1	0.6	20.0	2.9	1.0	0.2	0.1	1.7	1.5	0.6	1.1	5.4	0.6	0.1	3.4	9.3	2.6	2.4	0.9	0.5	0.0	29.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	29.1	0.0	0.1	0.3	1.1	0.3	0.8	0.6	0.6	2.6	0.8	1.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK5	"K2p5.1, TASK-2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188973-39229450	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.4;intestine: 74.2;kidney: 46.3"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	2.2	1.3	0.3	4.5	0.4	4.5	3.9	0.4	0.5	4.3	25.5	0.8	2.6	16.1	5.6	4.0	4.3	1.4	48.4	1.5	0.3	0.0	46.3	12.6	3.6	1.1	0.8	0.4	4.0	15.3	1.2	1.0	15.2	0.8	2.3	4.7	3.6	16.0	1.6	0.5	15.8	74.2	1.3	0.6	1.2	9.4	0.9	0.3	2.0	9.0	2.2	4.1	2.2	3.8	0.0	0.9	0.2	0.1	0.0	1.4	0.5	3.4	3.2	4.3	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	18.8	7.8	0.0	5.7	0.0	0.4	7.2	3.3	0.1	0.0	0.0	2.4	19.3	1.5	0.1	0.0	3.9	17.8	0.0	0.0	0.1	0.0	0.0	0.0	4.3	18.0	0.0	0.0	6.1	8.7	4.3	7.9	14.7	0.0	0.0	0.8	7.3	3.0	2.9	1.0	0.8	3.1	4.0	0.0	1.7	14.3	6.5	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.3	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.9	1.4	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.9	0.2	0.5	0.3	0.4	0.4	0.5	0.3	0.0	0.8	0.4	0.8	0.3	0.0	19.2	0.0	1.8	3.3	0.0	0.4	43.3	0.0	6.8	1.8	0.0	22.6	5.0	13.0	0.0	0.2	50.9	0.0	10.8	3.9	1.9	1.8	0.0	23.1	1.8	0.0	0.0	0.0	0.3	0.0	0.6	0.7	1.7	1.0	10.8	0.0	7.5	10.5	0.0	29.1	0.0	0.0	0.4	0.0	0.7	2.4	38.1	1.0	6.4	10.7
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319844-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ito cells: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 16.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.9;granulocytes: 16.2;monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HEL: 21.9;HMC-1: 24.6;T-47d: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.0	2.0	2.1	7.4	2.5	2.8	4.9	0.8	2.0	25.3	9.2	1.7	10.6	3.8	20.1	5.2	21.7	8.6	13.1	4.3	2.1	1.0	2.8	2.7	7.1	8.9	2.0	1.3	8.0	21.3	0.2	1.7	11.6	2.3	7.3	8.3	2.3	29.0	13.5	0.9	15.1	10.1	13.4	3.7	12.7	7.0	2.0	2.2	4.2	1.7	17.5	18.8	14.3	12.5	1.2	8.9	16.2	5.4	0.6	1.9	1.5	5.3	2.0	0.3	0.3	3.2	2.1	0.4	4.6	2.3	1.2	1.6	1.5	5.9	0.4	2.2	6.6	1.3	7.0	2.5	10.5	0.8	0.2	0.2	21.9	1.0	0.2	2.9	1.6	24.6	0.5	9.5	1.5	2.9	6.4	3.2	3.6	0.3	1.7	3.4	11.7	1.5	1.4	0.3	11.3	1.3	2.3	0.4	1.6	4.3	0.5	0.3	0.5	0.5	0.5	0.2	1.1	13.8	6.2	3.5	0.4	2.8	2.5	0.2	0.6	0.1	0.6	0.4	7.9	0.2	16.2	5.4	11.7	1.3	4.8	1.1	1.2	1.7	1.6	8.9	1.1	1.5	1.1	4.2	0.6	5.1	2.5	1.9	1.5	2.1	2.5	0.8	2.0	2.1	1.0	2.0	1.3	2.3	2.2	0.0	14.6	13.7	23.5	38.2	2.8	10.2	22.9	6.7	9.1	7.0	5.9	1.3	0.0	19.0	1.1	17.5	33.5	70.0	41.6	3.3	11.7	39.3	21.9	1.0	34.5	0.0	12.1	179.2	66.5	0.5	23.9	52.6	5.0	14.4	56.7	0.9	47.3	39.3	19.1	0.3	5.0	25.8	6.9	9.3	2.7	58.7	2.1	10.1	24.1	88.8
KCNK7	K2p7.1	ENSG00000173338	"Potassium two pore domain channel subfamily K member 7"	Q9Y2U2	11	65592855-65595996	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 35.0;tongue: 20.7"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 90.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6"	"Group enriched"	"Detected in many"	12	"B-cells: 2.9;granulocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077577			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077577: AB_2686845"	"unprognostic (1.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.08e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.11e-2)"	0.6	0.6	0.8	0.3	0.7	3.9	2.6	1.6	2.1	1.4	0.5	0.8	0.3	0.4	0.4	0.3	10.8	0.6	0.3	0.5	0.8	0.4	0.3	0.3	0.3	0.3	0.6	1.1	0.6	0.3	0.1	0.3	0.5	0.4	0.3	0.1	0.3	0.8	0.4	1.8	35.0	0.5	0.3	0.7	0.5	0.3	0.3	0.5	0.7	0.3	20.7	5.7	0.3	3.4	2.9	0.0	4.8	0.2	0.2	0.3	0.1	0.5	2.3	0.1	0.7	0.0	0.0	0.2	0.3	0.0	0.5	0.1	0.3	1.7	0.8	0.7	0.2	0.4	3.8	0.0	0.0	0.0	0.8	2.6	0.8	1.2	1.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.4	0.0	1.6	1.4	2.2	0.7	1.7	0.9	0.7	1.0	1.0	2.2	1.6	0.0	0.4	1.0	0.2	12.4	2.8	0.5	0.7	1.2	0.1	0.7	2.2	0.0	0.6	1.9	1.9	0.1	2.0	1.3	0.5	1.4	1.1	1.0	4.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.9	0.1	0.0	3.6	0.2	0.2	0.0	0.0	0.1	0.8	0.7	1.6	2.1	0.8	0.4	0.6	1.1	0.4	0.5	0.0	0.3	0.0	0.4	16.9	2.3	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.5	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.0	1.2	0.0	1.5	1.3	0.6	0.0	3.3	0.0	0.3	0.2	0.1	2.8	0.0	0.0	0.8	6.5	1.9	0.1	0.5	90.7	0.0	0.0	0.5	1.0
KCNK9	"K2p9.1, TASK-3, TASK3"	ENSG00000169427	"Potassium two pore domain channel subfamily K member 9"	Q9NPC2	8	139600838-139703056	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adrenal gland: 9.4;brain: 15.4"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Exocrine glandular cells: 2.2;Late spermatids: 4.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 6.6;SCLC-21H: 2.9;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075842			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA075842: "	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.96e-8)"	"unprognostic (1.91e-1)"	"unprognostic (8.17e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.12e-6)"	"unprognostic (2.94e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.76e-1)"	0.2	9.4	0.5	0.5	1.0	0.1	0.1	15.4	7.7	1.3	0.5	0.0	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.2	1.6	1.4	0.1	0.1	0.1	0.1	0.7	1.7	0.1	0.1	0.1	1.1	0.2	6.6	0.1	0.2	0.2	0.1	0.1	1.4	0.1	0.1	0.6	0.6	0.1	0.3	0.5	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	2.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	15.4	3.7	1.6	1.4	0.7	1.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.2	1.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 13.7;Late spermatids: 10.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 11.2;NB-4: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	3.0	2.0	0.7	2.9	0.7	1.2	3.3	0.2	0.6	1.8	2.0			1.9	2.0	2.3	0.7	1.0	2.4	1.8	1.0	0.9	2.2	4.0	1.2	2.9	1.1		1.6	5.3	3.7	2.1	6.6		2.9	2.2		2.7	1.4	0.5	0.6	2.2	1.9	1.5	5.9	2.6	4.5			2.4		2.6	1.9	1.5	3.5	0.3	2.3	0.4	3.6	1.0	0.0	3.0	0.7	1.2	0.0	1.4	1.1	1.9	0.8	0.5	1.3	0.6	6.5	2.6	0.1	3.0	0.6	2.7	1.1	0.0	0.2	1.5	3.8	0.4	11.2	2.9	2.5	1.2	0.2	3.7	1.9	0.6	0.9	0.0	1.0	1.1	0.1	0.4	0.1	1.5	1.8	0.1	7.6	0.0	1.2	2.3	3.3	0.0	0.1	1.0	2.1	1.5	0.4	1.0	1.2	0.7	1.1	3.1	6.1	0.7	0.6	1.1	0.3	0.9	1.0	0.4	3.6	0.6	4.3	0.8	2.3	0.4	0.5	1.0	0.3	0.6	3.5	0.6	0.8	0.1	2.1	0.4	0.7	1.9	3.6	0.1	0.3	0.9	0.0											0.0	2.2	0.8	1.8	0.2	2.3	0.6	2.5	1.4	2.3	0.0	13.7	1.0	0.0	4.3	8.0	2.7	1.5	0.0	3.1	1.0	1.2	1.6	2.3	1.5	1.0	0.0	4.7	1.8	1.6	10.9	2.6	0.8	0.0	1.0	1.3	1.9	2.7	0.0	2.8	0.0	5.3	6.5	1.4	1.6	1.4	0.1	1.0	0.0	1.1	0.7
KCNMB4		ENSG00000135643	"Potassium calcium-activated channel subfamily M regulatory beta subunit 4"	Q86W47	12	70366276-70434292	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 24.4;brain: 37.7"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 16.9;Collecting duct cells: 22.7;Ito cells: 24.5;Peritubular cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.9;RH-30: 9.5;RT4: 10.4;SuSa: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072287	Enhanced	Approved	Approved	Cytosol		NA	NA			Cytosol		"HPA072287: AB_2686507"	"unprognostic (3.90e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.05e-2)"	4.4	24.4	19.8	2.6	24.6	1.3	2.6	13.8	37.7	3.5	5.0	28.4	1.0	2.5	3.2	2.8	2.6	3.3	3.2	5.9	25.9	10.4	5.8	1.8	4.6	2.8	28.6	19.3	5.4	1.5	1.3	1.4	4.9	11.6	2.9	2.9	2.0	3.8	4.5	4.2	4.9	3.0	2.8	15.2	2.8	1.8	3.8	26.0	0.8	3.3	0.0	2.6	2.4	2.1	1.7	0.6	0.3	0.3	0.2	2.8	0.5	0.0	0.3	5.6	3.1	0.3	0.3	0.6	0.6	1.0	0.3	0.9	0.2	2.1	2.7	0.3	0.0	1.2	0.1	6.0	0.9	0.2	1.3	3.5	1.4	1.3	3.2	0.0	0.1	0.1	1.6	0.1	0.0	0.0	0.6	0.2	4.0	0.0	0.0	1.1	0.7	1.9	0.4	8.9	0.1	6.4	2.8	9.5	0.2	0.2	10.4	2.7	3.4	0.8	1.1	0.1	8.9	3.1	0.1	0.1	0.4	1.5	0.1	0.3	2.0	0.0	2.8	0.5	0.0	0.9	0.3	0.3	0.0	0.3	0.3	0.3	0.6	0.6	0.6	0.6	1.7	2.2	2.8	0.3	0.2	0.1	0.2	0.6	0.5	19.8	24.6	13.8	19.1	25.9	10.4	28.6	19.3	11.6	26.0	0.0	1.1	0.0	0.1	2.9	16.9	3.1	0.0	0.0	0.0	22.7	0.0	0.2	0.0	0.0	0.9	6.0	0.0	0.0	0.0	0.2	2.2	0.4	0.0	0.2	1.1	0.0	0.0	24.5	9.5	1.8	6.1	2.0	1.7	0.0	0.0	0.4	0.0	0.0	17.0	7.8	2.7	0.0	1.7	1.5	4.9	4.8	0.2	0.5	0.0	0.0
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	12	"brain: 32.5"	"Cell type enhanced"	"Detected in some"	6	"Melanocytes: 5.0;monocytes: 3.6;Spermatogonia: 4.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.3"	"Cell line enriched"	"Detected in some"	12	"REH: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"		Yes	No			"Actin filaments, Cytosol"		"HPA065938: AB_2685582"	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.8	0.9	25.8	1.5	11.3	0.9	0.8	3.3	27.0	1.6	1.0	0.5	0.1	1.0	1.7	1.0	1.0	0.9	1.0	1.3	32.5	3.3	0.9	0.8	0.8	1.0	5.0	8.7	2.6	0.9	0.7	0.2	0.8	4.1	1.2	0.8	0.0	1.5	1.3	1.0	0.9	1.2	0.9	1.2	0.9	0.9	2.8	1.6	0.0	0.9	0.0	1.0	0.9	0.0	0.2	0.2	2.3	0.1	0.1	0.2	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	2.1	0.0	0.1	0.1	0.9	1.9	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	58.8	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.0	0.2	0.0	0.0	25.8	11.3	3.3	22.4	32.5	3.3	5.0	8.7	4.1	1.6	0.0	0.0	0.0	2.5	2.3	2.2	0.8	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.0	2.3	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.9	0.9	5.0	3.6	0.0	1.3	0.2	0.0	1.8	0.0	0.9	0.0	1.9	0.4	4.3	3.3	0.1	0.7	0.0	1.4
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870280	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 11.9;Ciliated cells: 32.1;Endothelial cells: 16.9"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.8;memory B-cell: 4.8"	"Group enriched"	"Detected in many"	9	"B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.1;HMC-1: 12.5;Karpas-707: 31.0;RPMI-8226: 8.4;U-266/70: 29.9;U-698: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057127	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057127: AB_2683345"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"	1.7	2.5	20.6	6.5	21.7	1.0	1.8	5.7	26.7	9.3	9.1	12.4	1.1	5.4	12.6	1.7	3.5	10.3	3.1	4.0	21.6	8.0	3.5	1.0	3.1	5.8	12.0	10.9	2.1	1.0	1.5	2.6	0.7	13.3	3.4	4.6	0.1	2.7	2.7	8.5	1.1	3.9	10.6	8.1	5.0	4.4	1.3	15.5	0.2	3.7	3.5	9.2	8.3	4.9	4.8	0.4	5.8	2.7	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	31.0	0.3	0.0	0.1	0.0	0.4	0.0	1.2	0.0	7.7	8.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	29.9	3.9	10.0	0.3	0.0	2.9	5.8	0.0	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.4	20.6	21.7	5.7	10.3	21.6	8.0	12.0	10.9	13.3	15.5	11.9	2.4	0.0	0.5	1.1	0.2	2.2	0.0	32.1	3.4	0.0	2.0	0.0	3.3	0.2	2.6	16.9	0.0	0.0	0.2	0.0	2.3	0.4	0.0	0.0	0.4	0.0	4.1	5.5	0.0	6.2	0.3	0.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.5	0.1	1.5	0.0	0.0	0.0	0.1
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400210-63472677	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 10.8;Horizontal cells: 12.7;Late spermatids: 5.7;Spermatocytes: 6.6;Spermatogonia: 17.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.2;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"AF22: 8.5;AN3-CA: 14.0;NTERA-2: 7.8;SCLC-21H: 27.5;SH-SY5Y: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	1.2	10.0	18.7	1.3	21.4	1.2	1.2	24.1	50.8	1.2	1.3	2.4	0.0	1.3	1.2	1.3	1.2	1.7	1.7	1.2	15.4	10.0	1.2	1.2	1.2	1.2	8.4	14.1	1.2	1.9	1.2	9.2	1.2	8.9	2.8	1.2	0.0	1.2	1.2	1.2	1.2	1.3	1.2	2.6	1.2	1.3	6.9	4.2	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.5	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	27.5	48.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	1.5	0.0	18.7	21.4	24.1	31.2	15.4	10.0	8.4	14.1	8.9	4.2	0.0	0.0	0.0	0.0	0.1	1.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	12.7	0.0	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	2.1	0.0	0.0	6.6	17.0	0.0	0.0	0.0	0.0	0.0
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198851	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 3.2;Cardiomyocytes: 2.0;Horizontal cells: 1.6;Melanocytes: 1.7;Smooth muscle cells: 1.4;T-cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 20.4;HEL: 13.3;HL-60: 17.9;U-251 MG: 13.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016655	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.7	2.8	4.2	3.0	14.9	6.6	1.1	0.6	19.6	0.6	0.9	0.0	0.0	0.8	0.7	0.6	1.7	1.0	0.9	0.6	6.9	2.7	0.6	0.8	0.8	3.4	3.0	7.5	0.7	0.6	0.6	0.5	1.0	23.0	2.4	0.9	2.2	2.1	1.9	26.1	0.6	0.9	1.7	0.9	2.0	0.8	2.0	0.7	1.6	6.9	0.4	3.1	1.2	0.7	2.7	0.5	1.2	0.0	2.2	1.7	0.2	2.5	0.6	0.0	0.1	0.0	0.9	0.0	20.4	3.0	3.0	2.6	0.0	0.0	12.2	0.0	6.9	0.3	0.4	0.1	1.2	3.6	0.1	4.3	13.3	0.0	0.0	0.5	17.9	0.0	0.2	0.5	8.7	9.1	2.0	0.0	0.0	0.7	8.4	6.0	0.1	0.0	7.7	0.8	0.0	4.3	0.0	0.7	8.4	1.2	0.0	3.4	1.6	0.0	0.0	8.3	0.1	2.5	1.3	0.0	12.7	5.6	0.1	13.5	8.8	0.2	5.6	0.1	8.6	0.7	1.2	0.0	0.0	0.2	0.0	1.1	2.7	0.5	1.5	0.5	1.4	1.7	1.2	0.0	2.2	0.0	0.0	0.0	0.2	4.2	14.9	0.6	19.6	6.9	2.7	3.0	7.5	23.0	0.7	0.0	0.0	0.8	3.2	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	0.3	0.2	2.2	0.0	0.3
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 26.8;Intestinal endocrine cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.8;RPMI-8226: 13.6;RT4: 23.0;U-266/84: 15.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.2	1.1	2.7	5.6	3.2	0.4	14.8	0.5	5.1	6.8	7.9	4.8	1.3	3.1	4.5	2.4	7.2	3.3	5.3	4.6	3.9	3.4	4.2	2.6	17.6	1.2	6.8	1.4	1.1	7.7	1.9	0.8	8.3	15.2	4.4	4.1	9.9	7.6	2.8	54.4	3.7	4.3	9.7	4.7	1.1	7.0	3.9	1.4	0.2	2.4	19.0	3.6	5.0	4.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.7	0.3	0.0	0.8	0.4	1.8	1.3	4.1	0.8	1.0	0.0	8.3	0.0	0.4	1.4	0.9	1.2	10.0	0.0	0.9	0.0	2.6	0.0	0.1	0.0	4.0	0.1	0.3	0.3	6.3	0.0	0.6	7.7	0.2	1.8	0.2	0.0	0.5	1.0	0.0	0.0	5.0	5.4	0.1	1.1	33.8	13.6	0.8	23.0	10.0	0.3	0.0	2.6	2.7	2.4	1.3	0.0	0.1	1.3	0.0	0.1	10.1	0.0	15.7	0.0	7.5	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.2	0.5	5.1	3.9	3.4	6.8	1.4	15.2	1.4	26.8	5.1	0.0	10.1	12.4	0.0	0.4	20.4	0.0	4.5	10.4	0.0	0.5	0.0	16.1	0.2	6.0	3.2	0.0	0.3	2.9	16.6	8.1	1.1	3.2	0.4	0.0	31.2	3.1	0.0	0.2	1.4	0.6	20.3	1.0	3.0	0.1	3.7	3.5	3.5	2.6	0.1	6.5	9.5	0.2	3.1	5.1	0.7	0.0	9.9	5.4
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 38.7;Early spermatids: 12.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 4.3;hTERT-RPE1: 12.4;SCLC-21H: 9.3;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA051218: AB_2681392"	"unprognostic (5.06e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.10e-6)"	"unprognostic (1.22e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (3.30e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.72e-3)"	3.9	2.8	4.8	1.3	5.5	0.6	2.2	1.4	8.3	1.8	2.3	0.6	0.0	2.1	2.2	1.7	4.0	2.7	5.9	6.8	9.4	3.1	1.8	10.5	5.5	1.3	1.8	5.2	14.9	1.1	0.9	14.1	1.8	3.7	4.2	2.5	2.9	2.6	2.5	1.2	1.9	2.1	2.6	5.2	1.4	2.6	3.3	1.0	0.0	4.5	3.4	1.2	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.1	0.3	0.0	0.0	1.3	0.3	2.7	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	1.6	0.0	4.3	0.0	0.0	1.0	0.0	0.4	0.1	12.4	0.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.3	0.0	0.2	0.0	0.3	0.0	0.0	0.7	9.3	8.4	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.5	1.4	8.3	9.4	3.1	1.8	5.2	3.7	1.0	38.7	0.6	0.0	0.3	0.3	0.0	1.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.9	0.0	0.0	0.0	2.5	0.0	2.3	6.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1
KCTD1	C18orf5	ENSG00000134504	"Potassium channel tetramerization domain containing 1"	Q719H9	18	26454910-26657401	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 35.9;HaCaT: 37.3;hTCEpi: 33.7;RPTEC TERT1: 32.8"									"HPA057808, HPA062486"			Approved	"Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite"		NA	NA			Nucleoplasm	"Nucleoli, Cytokinetic bridge, Centriolar satellite"	"HPA057808: , HPA062486: "	"unprognostic (1.15e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.35e-4)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (3.65e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.60e-8)"	"unprognostic (3.87e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.02e-2)"	3.9	11.8	15.9	2.1	37.3	0.7	22.2	13.7	29.0	12.6	5.0	6.9	6.2	3.2	10.0	15.8	32.8	33.8	5.8	12.9	16.7	6.7	20.1	2.6	4.0	2.0	6.6	18.4	11.1	5.2	7.4	6.1	17.2	6.8	15.3	7.3	8.4	12.5	16.4	2.8	39.3	2.2	8.7	6.0	2.9	7.0	4.1	10.7	5.7	13.6	20.1	11.7	8.5	18.3	0.3	0.7	0.7	0.3	0.0	1.8	0.2	5.5	19.1	35.9	3.8	21.1	3.4	4.6	4.6	7.0	7.4	7.4	1.8	6.4	1.1	17.9	9.8	6.1	37.3	6.8	10.1	7.0	1.0	3.3	1.2	4.2	3.0	4.0	0.6	1.8	5.7	33.7	2.1	14.0	9.5	7.0	8.2	0.4	0.5	5.2	7.9	5.5	1.7	3.6	18.4	8.8	2.9	2.1	0.8	32.8	8.2	3.7	14.2	6.8	9.2	3.1	21.6	8.4	1.5	3.8	8.3	2.6	1.6	5.1	1.7	1.4	0.1	3.1	3.7	12.3	0.0	0.1	0.7	0.8	0.1	1.6	0.0	1.8	0.6	0.7	0.3	0.7	0.5	0.0	0.0	0.3	0.3	0.0	0.2	15.9	37.3	13.7	29.0	16.7	6.7	6.6	18.4	6.8	10.7	3.0	2.6	0.0	39.9	28.2	3.9	10.1	5.1	29.4	14.8	24.4	7.9	41.6	99.5	7.7	26.4	2.4	1.3	0.0	3.2	5.2	2.6	13.8	0.0	1.8	3.9	20.6	1.2	2.5	1.0	6.7	4.9	1.0	21.9	0.0	4.3	19.5	8.6	0.0	2.8	6.8	6.3	0.0	3.1	1.9	3.7	38.9	27.8	0.0	4.7	35.3
KCTD10	"BTBD28, MSTP028"	ENSG00000110906	"Potassium channel tetramerization domain containing 10"	Q9H3F6	12	109448656-109477544	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014273	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA014273: AB_1852159"	"unprognostic (7.21e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	29.1	16.2	10.4	16.3	17.1	8.4	21.3	10.6	20.0	25.3	26.9	14.1	15.1	8.5	30.5	15.6	24.4	18.1	23.2	16.1	11.0	16.4	23.2	9.3	20.5	13.9	11.7	8.4	16.7	7.9	14.6	12.7	19.2	16.9	19.8	22.2	29.4	14.4	29.8	9.9	19.3	14.1	36.4	9.6	17.5	19.4	13.5	12.6	12.8	30.8	15.4	17.5	27.8	19.0	6.2	10.4	7.9	14.0	20.8	12.7	11.8	9.2	9.8	28.7	9.5	23.2	33.2	6.4	20.2	26.6	13.4	13.4	9.2	7.6	9.0	11.9	46.1	6.8	7.3	10.2	16.7	12.9	8.7	6.9	10.4	6.3	5.8	14.9	7.6	9.1	31.6	10.3	17.7	9.7	19.6	31.4	8.8	6.9	3.9	23.4	4.8	9.8	10.3	17.0	4.1	12.2	9.7	12.5	7.0	13.5	16.0	10.2	15.3	12.2	12.6	12.7	18.0	15.5	6.2	23.1	14.3	5.5	8.1	11.1	8.8	16.6	12.5	16.1	6.7	21.0	7.9	8.1	5.4	12.7	12.4	9.3	6.2	7.6	9.2	10.4	6.2	8.4	10.5	5.9	20.8	14.0	7.9	8.4	11.8	10.4	17.1	10.6	20.0	11.0	16.4	11.7	8.4	16.9	12.6	14.9	34.6	5.7	16.8	13.1	5.2	10.5	15.3	8.1	9.1	5.2	15.7	7.3	5.0	14.0	8.4	22.7	13.6	0.0	11.3	10.5	16.9	12.3	13.9	4.0	10.5	7.9	11.1	26.4	12.3	7.8	10.6	10.4	15.1	19.0	12.5	2.6	17.7	11.5	17.7	8.4	4.6	25.8	28.8	9.1	5.6	14.4	11.3	10.2	13.3	16.5
KCTD11	"C17orf36, KCASH1, REN"	ENSG00000213859	"Potassium channel tetramerization domain containing 11"	Q693B1	17	7351889-7354944	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Ubl conjugation pathway"	"Developmental protein, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 29.2;hTCEpi: 21.5"	"Not detected"	"Not detected"							HPA052035	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052035: AB_2681704"	"unprognostic (1.98e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (6.78e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	7.4	5.7	4.7	5.3	6.5	0.9	16.2	5.8	5.7	20.1	6.9	7.6	5.1	5.2	8.9	7.5	32.9	8.0	9.8	4.9	3.6	3.6	5.2	5.1	8.6	9.4	10.2	3.4	8.6	10.5	8.2	5.2	15.2	6.0	10.5	5.2	6.5	11.1	9.8	4.3	23.0	6.5	7.1	5.0	8.1	7.9	4.0	5.5	1.5	17.2	23.3	17.0	19.2	22.0	1.8	2.5	8.8	6.0	1.6	2.3	2.5	10.2	4.1	3.1	2.3	13.3	7.8	3.3	6.6	10.7	7.2	6.3	3.7	4.5	1.5	3.7	11.2	6.7	17.9	0.4	29.2	6.1	6.1	1.2	0.1	2.9	0.6	7.0	0.1	5.9	6.1	21.5	7.7	4.2	14.4	2.2	1.2	1.3	1.7	5.3	4.4	0.9	1.4	1.0	4.5	2.4	1.3	2.8	1.4	7.3	4.0	0.1	1.7	4.7	4.7	0.7	4.0	6.7	0.6	4.3	5.8	5.2	3.9	3.4	1.2	0.6	0.4	7.1	3.3	4.3	8.8	3.6	2.4	2.3	6.0	0.8	1.8	1.1	1.0	2.5	1.4	0.6	1.6	0.5	1.6	4.3	0.1	0.2	2.5	4.7	6.5	5.8	5.7	3.6	3.6	10.2	3.4	6.0	5.5	8.9	0.6	1.7	16.0	1.5	3.3	0.4	2.5	10.7	4.5	5.2	2.0	4.2	3.3	11.3	12.7	2.7	7.7	0.0	8.4	5.3	11.4	7.7	4.6	2.4	4.2	1.6	6.9	6.7	3.7	5.3	16.4	5.4	1.7	8.2	4.3	3.9	21.3	4.8	20.5	2.7	1.4	19.4	17.2	0.7	1.0	3.9	8.2	4.3	3.3	17.4
KCTD12	"C13orf2, KIAA1778, PFET1"	ENSG00000178695	"Potassium channel tetramerization domain containing 12"	Q96CX2	13	76880166-76886390	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 180.7;Intestinal endocrine cells: 371.5;Kupffer cells: 375.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.4;myeloid DC: 5.9"	"Group enriched"	"Detected in many"	17	"dendritic cells: 5.9;granulocytes: 1.6;monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 31.0;HUVEC TERT2: 61.5;TIME: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056987, HPA077376"		Supported	Approved	Mitochondria		NA	NA		19000000	Mitochondria		"HPA056987: , HPA077376: "	"unprognostic (6.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.82e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	29.6	7.5	12.1	14.3	17.9	2.1	24.7	11.7	9.4	13.1	10.3	10.3	5.1	5.5	14.2	9.2	10.7	21.6	15.1	10.3	10.5	8.2	8.5	6.4	17.2	21.5	17.0	5.9	13.6	6.8	8.2	6.6	22.9	13.8	9.9	11.7	13.8	8.4	4.9	11.2	7.7	8.4	17.9	14.0	21.3	8.3	10.0	13.5	3.1	8.4	5.8	8.4	11.0	15.0	0.0	5.9	1.6	6.4	0.0	0.2	1.4	0.4	0.4	4.1	0.0	31.0	14.7	1.1	1.8	0.4	1.1	1.5	0.1	0.0	0.0	1.0	4.9	1.3	14.4	1.7	17.6	0.9	0.3	9.4	0.0	10.6	0.0	1.3	4.8	0.0	5.9	5.8	0.7	13.4	2.3	61.5	3.5	0.0	0.0	14.5	0.3	2.1	0.0	2.1	4.3	2.0	0.1	2.0	5.1	4.7	0.0	1.1	2.1	4.6	0.1	0.6	5.2	0.2	3.1	49.3	0.7	1.3	0.1	3.6	0.7	0.1	0.0	11.6	1.0	4.3	0.0	6.4	1.1	0.0	4.1	0.0	0.0	0.1	0.0	5.9	0.0	0.1	0.2	1.6	0.0	2.3	3.0	0.0	1.4	12.1	17.9	11.7	7.5	10.5	8.2	17.0	5.9	13.8	13.5	23.8	9.6	6.7	2.5	35.5	1.8	19.3	2.5	116.4	23.9	92.5	13.7	2.6	14.9	3.0	3.1	150.3	2.9	0.0	0.5	82.6	78.3	3.2	6.9	2.1	180.7	0.0	371.5	47.3	375.3	5.6	145.6	119.3	49.0	2.8	70.7	4.3	0.6	0.0	42.1	5.4	1.0	25.8	26.9	1.4	6.0	30.1	3.5	2.2	48.5	1.4
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 14.8;Mucus-secreting cells: 15.2;Pancreatic endocrine cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 5.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.4;Hep G2: 16.8;RPTEC TERT1: 27.3;U-2 OS: 12.4"									"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.96e-5)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.63e-1)"	2.6	18.9	1.2	1.5	0.8	0.0	11.6	5.5	0.8	6.5	4.8	1.2	40.8	2.5	2.3	10.8	2.1	6.8	10.3	0.7	1.0	1.3	10.7	14.4	9.6	0.3	0.9	0.5	2.4	42.8	6.2	2.5	5.1	1.3	5.3	6.9	5.8	43.9	47.8	0.7	1.5	6.1	0.9	0.8	0.7	12.1	1.9	0.8	0.7	12.4	2.9	3.6	1.4	1.1	0.4	1.4	0.6	1.1	1.1	1.8	0.4	0.0	2.1	0.3	0.3	0.8	0.5	2.1	1.1	1.0	2.1	5.1	8.0	5.2	0.0	5.7	0.6	0.2	0.6	0.3	15.4	5.4	0.2	7.8	0.0	1.8	16.8	3.1	0.1	0.1	2.4	0.4	8.4	6.6	1.5	0.5	0.1	0.1	0.0	0.8	0.1	0.2	0.4	3.9	0.2	0.3	0.2	0.0	0.0	27.3	2.0	1.4	0.1	0.0	0.1	2.5	0.5	0.8	0.6	0.4	0.1	12.4	0.4	0.2	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.7	0.6	0.7	0.9	0.5	0.0	0.7	1.8	1.4	0.4	0.8	1.8	0.2	1.1	1.1	1.3	0.0	0.4	1.2	0.8	5.5	0.8	1.0	1.3	0.9	0.5	1.3	0.8	3.0	9.6	0.0	9.5	0.3	0.0	0.0	2.5	0.0	5.7	5.2	0.0	0.6	3.3	2.0	0.1	0.0	2.5	0.0	14.8	1.2	0.8	10.5	1.1	4.0	0.2	0.0	4.6	0.0	0.0	0.0	3.1	0.0	1.7	0.0	15.2	1.7	12.8	7.0	4.9	11.3	0.0	0.0	1.9	0.2	0.2	0.1	0.6	0.0	8.5	5.8
KCTD15	MGC25497	ENSG00000153885	"Potassium channel tetramerization domain containing 15"	Q96SI1	19	33795933-33815763	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 47.3"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 14.1;Ito cells: 25.8;Suprabasal keratinocytes: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 2.5;eosinophil: 7.7;intermediate monocyte: 4.6;myeloid DC: 3.4;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.4;granulocytes: 7.7;monocytes: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050822			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA050822: AB_2681250"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.65e-8)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.30e-2)"	8.7	4.0	10.5	7.1	7.9	3.4	7.7	7.7	11.0	15.5	13.6	8.6	4.6	4.7	20.3	6.2	14.6	12.7	9.4	6.8	13.0	5.1	6.2	7.1	13.3	4.1	5.8	8.4	14.3	15.6	1.6	3.4	7.3	9.4	9.0	4.2	12.4	3.7	13.7	4.8	47.3	5.8	13.8	9.3	8.3	8.1	10.6	8.9	1.0	8.9	5.1	4.6	9.4	13.0	0.0	3.4	7.7	6.3	0.0	1.2	0.9	5.8	13.4	12.1	18.5	4.0	2.1	9.6	7.7	1.4	4.3	2.2	7.5	4.0	0.0	17.6	10.8	2.0	6.9	8.8	6.0	1.6	6.3	15.4	24.1	8.3	7.2	11.2	4.6	4.4	4.2	25.5	1.6	9.8	0.0	8.4	3.5	5.9	0.1	0.7	14.8	0.1	13.2	11.1	9.8	22.7	11.2	6.5	2.2	4.8	2.7	9.4	32.4	15.1	21.5	28.0	5.4	15.9	12.3	13.7	20.3	18.2	0.4	1.3	15.0	0.7	9.5	0.0	8.1	24.7	0.6	2.5	7.7	0.0	4.6	0.1	0.0	1.2	0.2	3.4	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.7	0.9	10.5	7.9	7.7	9.2	13.0	5.1	5.8	8.4	9.4	8.9	0.0	1.7	0.0	3.2	14.1	2.9	2.0	0.0	0.0	3.4	0.0	9.8	0.2	3.3	0.8	0.5	8.0	0.8	0.0	7.2	0.2	4.9	2.2	8.1	1.6	1.2	1.6	1.2	25.8	3.5	1.4	4.0	4.7	5.0	0.0	2.9	2.8	3.0	0.0	8.5	0.2	10.7	0.0	5.2	0.0	0.4	16.9	0.2	0.0	0.9	2.5
KCTD16	KIAA1317	ENSG00000183775	"Potassium channel tetramerization domain containing 16"	Q68DU8	5	144170832-144485686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 25.1"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 12.9;Early spermatids: 7.6;Horizontal cells: 19.1"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Group enriched"	"Detected in many"	5	"amygdala: 11.4;basal ganglia: 14.5;cerebral cortex: 25.1;hippocampal formation: 14.5;olfactory region: 12.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 7.1;TIME: 13.4;U-87 MG: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044590, HPA050154"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA044590: AB_2679008, HPA050154: AB_2681034"	"unprognostic (7.22e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.81e-5)"	"unprognostic (9.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (2.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.80e-3)"	"unprognostic (1.22e-2)"	1.0	2.0	11.4	0.7	14.5	0.6	0.9	0.7	25.1	1.5	0.8	0.4	0.0	1.0	0.9	1.5	0.8	1.2	1.4	0.9	14.5	3.2	2.9	0.8	2.4	0.7	1.7	12.0	1.0	5.2	0.8	1.7	0.9	1.3	0.8	0.7	0.0	0.7	1.1	0.6	0.7	1.2	0.9	1.6	0.7	0.8	4.4	2.4	0.0	2.2	0.0	0.7	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.1	0.7	0.0	1.9	1.6	0.6	0.8	0.4	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.3	0.9	0.2	0.1	0.0	0.5	0.1	0.2	0.1	0.0	0.4	0.1	1.2	0.1	1.5	0.0	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	7.1	0.3	0.1	0.0	0.1	0.3	0.0	0.0	13.4	1.1	0.7	0.2	0.0	0.2	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	14.5	0.7	25.1	14.5	3.2	1.7	12.0	1.3	2.4	0.0	0.0	0.0	0.0	0.0	12.9	0.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.7	7.6	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	19.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.7	2.3	0.0	0.0	0.7	2.4	0.0	0.8	3.8	1.9	0.0	0.0	0.0	0.0	0.0
KCTD18	"6530404F10Rik, FLJ31322, FLJ37818"	ENSG00000155729	"Potassium channel tetramerization domain containing 18"	Q6PI47	2	200488952-200519784	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045498, HPA058028"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045498: AB_10959387, HPA058028: AB_2683583"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	14.3	14.6	13.7	13.1	15.4	11.5	14.3	9.2	14.8	12.3	13.8	17.4	15.5	11.6	13.5	19.4	16.1	12.5	16.5	14.8	13.6	11.2	13.8	13.3	11.4	14.9	16.3	11.4	15.0	16.5	17.1	13.2	10.0	14.9	15.9	11.7	13.7	14.1	14.0	14.7	12.3	11.3	24.0	17.6	13.0	12.9	9.3	14.6	18.0	19.4	19.9	14.6	17.4	11.7	7.2	7.2	11.4	7.9	7.1	9.6	5.6	7.3	6.8	3.4	12.6	16.4	20.4	8.7	9.0	11.5	5.8	7.7	5.4	8.4	5.2	6.9	9.1	9.5	7.1	3.3	10.9	7.5	12.4	3.6	7.4	4.9	3.8	11.1	6.0	8.8	13.6	20.7	6.7	12.9	13.6	5.0	7.8	5.0	7.1	10.3	7.5	12.9	5.9	1.9	6.3	6.2	9.0	7.7	6.0	7.6	7.3	3.9	5.4	7.1	6.2	10.7	7.7	8.2	9.7	8.3	11.9	2.7	6.0	4.3	13.6	9.8	5.9	13.7	6.4	8.4	11.4	5.5	10.4	5.9	7.9	9.0	7.2	7.7	8.5	5.9	7.1	9.6	9.6	4.4	7.1	5.2	7.2	8.5	5.6	13.7	15.4	9.2	14.8	13.6	11.2	16.3	11.4	14.9	14.6	6.0	6.5	7.5	5.0	3.9	7.0	5.3	10.2	8.1	6.8	3.5	0.0	6.5	1.7	5.8	17.3	5.1	5.9	0.0	7.5	5.9	5.4	4.4	2.3	7.8	6.5	9.5	1.2	9.2	8.3	4.5	10.9	7.6	6.8	16.2	7.9	10.0	5.1	7.0	11.7	9.4	9.3	19.4	4.7	17.6	14.5	3.4	4.2	6.7	8.0	3.1
KCTD20	"C6orf69, dJ108K11.3, MGC14254"	ENSG00000112078	"Potassium channel tetramerization domain containing 20"	Q7Z5Y7	6	36442767-36491143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030092	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear speckles"	"HPA030092: AB_10601437"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.94e-2)"	34.3	23.1	18.4	22.8	17.6	20.1	39.0	15.7	21.4	22.2	20.7	18.7	22.4	12.0	25.5	23.1	24.6	22.0	25.1	21.0	16.3	17.1	16.2	29.7	20.5	26.2	18.0	14.4	25.6	12.7	15.7	16.1	21.7	16.5	17.5	16.0	17.9	16.2	19.2	20.4	24.6	17.6	30.8	17.3	24.2	16.6	10.2	13.3	31.6	13.6	18.1	24.9	21.5	18.3	6.2	14.0	19.4	14.4	6.4	8.5	10.9	11.0	5.0	14.7	28.1	20.2	13.0	7.1	13.5	18.7	14.7	16.5	13.0	6.3	37.4	12.2	21.9	8.4	10.3	19.2	9.8	24.5	26.6	10.6	21.3	8.0	13.7	9.4	20.6	14.8	13.1	10.1	11.2	7.2	9.8	15.0	19.9	32.8	21.4	13.8	9.7	23.3	7.8	5.4	8.8	4.6	23.2	16.7	21.0	8.0	12.5	3.5	20.8	11.8	12.0	35.9	15.2	16.5	20.5	17.1	40.0	13.7	11.8	16.7	16.9	39.3	27.1	6.9	28.4	40.7	19.4	14.4	9.2	7.5	13.1	8.5	6.2	5.9	6.2	14.0	5.1	6.2	6.1	10.6	6.4	7.2	7.6	6.9	10.9	18.4	17.6	15.7	21.4	16.3	17.1	18.0	14.4	16.5	13.3	35.7	21.3	25.3	14.7	44.5	17.2	13.2	33.1	21.4	23.9	15.7	9.8	22.6	1.7	14.7	0.4	31.4	13.2	70.0	12.3	15.4	34.9	16.2	52.0	41.2	23.8	14.3	14.6	49.1	52.1	1.5	29.4	33.6	32.1	32.5	15.2	17.9	16.3	14.0	50.2	16.1	9.5	19.4	53.6	5.2	26.0	55.5	19.2	29.9	15.1	27.3
KCTD21	KCASH2	ENSG00000188997	"Potassium channel tetramerization domain containing 21"	Q4G0X4	11	78171249-78188822	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 8.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041964	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA041964: AB_10795647"	"unprognostic (1.17e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.40e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.70e-1)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	8.6	18.1	13.2	7.3	12.5	4.0	15.8	8.4	14.0	7.7	7.7	9.7	7.5	6.2	6.5	11.8	12.1	8.2	9.8	12.4	10.3	12.2	6.8	18.9	8.2	6.1	15.2	9.7	17.9	9.0	11.3	8.4	9.5	10.0	5.9	6.1	6.2	6.7	6.8	9.3	6.0	5.5	11.9	12.3	5.4	5.5	5.6	8.4	7.2	13.8	5.3	7.4	10.1	7.4	2.0	4.3	9.5	7.1	1.9	2.1	2.3	3.7	8.8	4.9	3.7	17.5	12.7	3.1	7.4	7.1	5.2	5.2	8.1	5.7	3.6	7.4	8.0	7.0	7.6	4.6	6.1	5.3	4.9	2.9	2.6	10.1	7.2	9.8	1.7	3.5	12.1	11.1	11.6	6.6	11.1	7.9	4.4	5.6	3.3	7.0	5.1	2.7	5.2	2.3	13.3	6.5	3.7	3.7	2.2	6.1	6.8	3.5	5.2	4.7	3.3	3.4	9.3	8.0	1.9	9.7	8.3	8.3	22.5	2.8	6.4	6.4	3.5	4.4	2.8	4.7	2.1	6.5	8.3	1.2	7.1	1.7	0.8	1.8	2.1	4.3	2.0	1.8	1.3	9.5	1.9	5.6	1.0	1.4	2.3	13.2	12.5	8.4	13.3	10.3	12.2	15.2	9.7	10.0	8.4	0.0	2.4	0.8	1.0	1.5	1.0	3.0	5.1	0.0	1.2	0.0	0.0	1.0	1.7	1.4	0.3	1.7	1.8	0.0	1.8	1.0	2.6	1.6	5.7	6.4	1.9	6.4	0.0	2.5	3.4	0.2	4.0	0.6	1.7	1.0	1.7	1.0	2.0	1.4	8.5	2.2	0.9	0.0	2.3	1.4	1.2	1.3	1.6	1.0	1.5	1.7
KCTD3	NY-REN-45	ENSG00000136636	"Potassium channel tetramerization domain containing 3"	Q9Y597	1	215567392-215621807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 70.8"	"Low region specificity"	"Detected in all"							HPA015142	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA015142: AB_1852174"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.60e-3)"	"unprognostic (9.27e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (2.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.27e-1)"	"unprognostic (3.31e-3)"	18.4	47.6	17.3	7.3	16.6	7.7	37.5	23.6	16.9	19.8	35.1	24.1	20.3	25.1	22.6	18.4	25.8	12.1	15.7	10.3	17.4	14.4	16.3	39.6	10.9	4.4	18.7	13.1	13.8	18.2	24.5	12.4	18.1	19.5	22.7	16.4	13.9	24.5	17.9	10.0	10.6	35.1	17.1	26.6	7.5	16.6	13.3	15.0	5.3	15.8	11.0	9.2	18.1	21.9	2.6	2.6	3.3	2.1	2.5	1.3	0.6	15.7	11.4	12.9	7.5	11.0	18.6	17.9	13.0	12.2	11.6	12.2	10.0	26.4	4.4	7.3	13.5	3.5	15.5	13.5	13.3	13.4	2.4	14.1	7.9	22.0	14.0	9.1	8.0	1.5	17.1	9.3	14.8	11.3	14.7	10.5	5.9	15.3	4.3	12.7	13.7	3.4	4.2	21.7	22.9	14.6	5.3	18.3	17.1	13.6	10.7	15.3	17.1	20.2	29.6	11.0	17.0	70.8	10.4	9.4	11.7	11.6	14.3	14.8	3.9	5.3	1.5	9.1	4.2	8.8	1.8	2.1	1.0	1.0	1.1	0.8	1.6	1.1	1.0	2.0	2.6	1.2	1.3	3.3	2.5	1.0	2.6	0.6	0.6	17.3	16.6	23.6	16.2	17.4	14.4	18.7	13.1	19.5	15.0	8.9	12.3	5.1	20.2	16.0	27.6	12.2	20.4	16.0	21.6	10.4	17.7	22.5	19.9	19.6	1.1	12.1	16.9	0.0	18.1	13.1	21.6	24.9	4.7	56.2	6.9	17.5	38.1	19.0	10.5	2.0	25.6	5.8	15.1	4.6	38.5	19.2	13.9	22.0	21.2	23.7	22.3	25.8	16.5	6.7	16.1	15.4	14.6	1.7	24.8	37.9
KCTD4	bA321C24.3	ENSG00000180332	"Potassium channel tetramerization domain containing 4"	Q8WVF5	13	45192853-45194717	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 45.5"	"Cell type enriched"	"Detected in single"	4	"Melanocytes: 1.7"	"Group enriched"	"Detected in some"	5	"glioma: 1.2;renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 15.8;hTERT-RPE1: 9.6;RPTEC TERT1: 8.9;U-138 MG: 10.7;U-87 MG: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040734	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA040734: AB_10963227"	"unprognostic (1.36e-1)"		"unprognostic (1.02e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.19e-2)"		"unprognostic (1.70e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"			0.5	0.6	33.1	0.6	45.5	0.7	1.5	0.2	22.0	0.7	1.1	1.5	0.0	0.9	0.5	0.6	0.5	0.5	1.8	0.9	9.8	4.0	0.9	0.5	0.5	0.5	3.6	4.8	0.5	0.9	0.5	1.1	0.9	3.9	0.5	0.9	1.8	1.5	0.8	0.5	6.4	1.0	1.8	2.7	0.5	0.5	0.5	7.0	0.0	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.5	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.5	15.8	0.0	0.0	2.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.4	9.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.7	0.0	0.0	2.2	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.7	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	33.1	45.5	0.2	9.3	9.8	4.0	3.6	4.8	3.9	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KCTD6	"KCASH3, MGC27385"	ENSG00000168301	"Potassium channel tetramerization domain containing 6"	Q8NC69	3	58492114-58502360	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036100, HPA036101"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA036100: AB_10673230, HPA036101: AB_2674941"	"unprognostic (8.63e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.00e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.67e-3)"	"unprognostic (9.36e-3)"	"unprognostic (7.48e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.44e-2)"	7.8	8.4	15.3	4.4	13.2	13.5	11.4	35.9	21.8	11.1	7.9	10.0	6.4	5.6	12.3	28.8	10.9	12.4	8.8	7.7	16.9	11.7	15.4	12.2	6.6	9.1	15.3	10.5	13.1	7.1	10.4	14.4	10.9	11.9	9.2	8.1	14.7	7.3	9.4	6.8	7.5	5.3	11.2	12.5	8.8	5.7	5.7	12.4	6.3	14.1	6.3	7.3	6.4	11.9	13.0	20.2	17.1	14.6	8.2	15.6	6.6	5.5	5.3	15.9	6.8	14.0	10.0	5.9	6.7	6.0	9.9	11.7	5.1	3.1	11.0	2.2	4.8	11.7	3.0	12.8	3.9	8.9	11.3	5.8	5.1	12.1	6.3	6.6	4.0	4.1	6.0	6.2	7.9	5.0	23.6	6.5	3.9	2.8	5.3	8.6	5.2	5.9	6.1	11.7	5.0	10.1	5.9	4.4	7.7	9.4	2.6	9.0	7.8	3.8	8.8	4.8	12.7	35.4	2.9	3.5	9.1	8.2	11.6	10.0	5.8	8.9	13.0	7.8	8.2	6.9	17.1	14.6	9.8	13.7	14.6	15.6	13.0	10.1	12.8	20.2	10.3	11.5	9.8	5.0	8.2	10.5	7.8	9.5	6.6	15.3	13.2	35.9	16.2	16.9	11.7	15.3	10.5	11.9	12.4	3.0	2.4	0.9	10.6	7.9	14.6	7.5	7.6	5.3	10.3	8.7	23.6	8.7	16.6	7.1	3.7	9.0	2.1	0.0	3.7	6.3	12.4	5.1	0.0	4.7	6.2	23.8	8.7	4.9	10.3	1.7	10.0	7.2	11.8	4.6	4.2	19.3	3.3	5.5	11.3	24.5	17.9	0.0	12.0	5.6	20.7	8.8	7.3	0.0	7.0	3.0
KCTD8		ENSG00000183783	"Potassium channel tetramerization domain containing 8"	Q6ZWB6	4	44173909-44448807	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.5"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 7.6;Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 16.2"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.1;NTERA-2: 2.9;PC-3: 1.8;SCLC-21H: 10.9;U-2 OS: 3.3"	"Low region specificity"	"Detected in all"							HPA031562	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA031562: AB_10602609"	"unprognostic (1.49e-2)"	"unprognostic (7.70e-3)"		"unprognostic (1.53e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.77e-2)"		"unprognostic (1.48e-1)"		"unprognostic (7.85e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.44e-1)"	2.0	1.4	5.4	0.9	12.2	0.7	0.9	19.5	18.9	2.2	1.0	8.5	3.5	0.8	4.2	1.3	0.8	1.1	1.5	1.1	4.8	5.2	2.8	0.7	1.0	0.7	8.9	4.0	4.3	2.4	0.7	0.2	0.7	6.8	1.5	1.1	2.3	1.7	3.1	2.6	0.8	0.9	2.3	8.0	0.7	2.6	3.8	8.3	0.0	8.6	0.4	0.7	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	12.2	19.5	8.5	4.8	5.2	8.9	4.0	6.8	8.3	0.0	0.0	0.0	0.6	0.0	2.7	0.2	7.6	0.0	0.0	3.5	3.9	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	1.0	16.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
KCTD9	"BTBD27, FLJ20038"	ENSG00000104756	"Potassium channel tetramerization domain containing 9"	Q7L273	8	25427847-25458476	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042468, HPA047902"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No			Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA042468: , HPA047902: AB_2680205"	"unprognostic (4.18e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (7.88e-4)"	"unprognostic (7.04e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.97e-3)"	14.4	5.8	7.4	17.3	7.7	11.5	14.6	17.7	10.1	15.7	14.1	5.4	16.8	12.4	15.6	12.2	18.2	11.3	12.8	48.4	5.9	5.2	9.6	6.6	10.3	6.9	7.4	5.3	12.4	8.3	7.3	11.2	7.4	14.6	11.8	14.8	9.4	14.6	18.4	19.0	15.0	10.9	16.7	10.8	8.6	10.6	11.2	6.6	11.8	8.7	11.7	8.7	19.1	14.8	2.2	3.2	3.7	2.9	0.9	3.8	1.5	18.1	12.9	14.1	4.9	18.4	24.5	11.6	27.6	24.9	18.2	18.5	9.2	13.4	11.9	11.8	27.5	25.7	12.3	12.3	13.0	22.0	6.1	7.3	13.9	12.6	8.5	22.4	4.8	10.4	18.8	15.8	16.5	13.8	11.1	15.3	12.0	14.6	9.4	20.6	4.8	18.7	8.4	6.9	14.1	6.9	7.3	16.4	4.4	18.5	10.4	3.6	4.7	21.2	9.4	14.3	13.3	7.2	5.6	16.9	20.1	11.7	38.5	14.9	2.7	4.9	15.7	14.1	8.6	14.4	2.6	1.7	3.7	3.4	2.5	3.8	2.2	3.6	3.6	1.1	1.2	2.2	3.6	1.8	0.9	2.9	3.2	3.5	1.5	7.4	7.7	17.7	10.1	5.9	5.2	7.4	5.3	14.6	6.6	29.8	11.5	4.5	33.0	66.1	13.0	55.7	5.1	16.0	22.7	26.2	23.6	8.1	11.6	15.4	3.8	15.4	29.0	0.0	23.8	14.2	32.6	43.6	19.7	8.3	8.1	3.2	9.8	12.3	8.1	2.1	28.4	15.1	28.7	7.2	12.4	7.8	24.5	22.1	52.3	8.4	18.3	6.5	26.5	24.6	30.7	47.8	9.4	15.2	16.5	40.5
KDELC2	MGC33424	ENSG00000178202	"KDEL motif containing 2"	Q7Z4H8	11	108472105-108498432	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.0"	"Cell type enhanced"	"Detected in many"	4	"Fibroblasts: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039315, HPA039817, HPA066134"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Nucleoplasm	Vesicles	"HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624"	"unprognostic (1.29e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.00e-3)"	"unprognostic (4.08e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (6.27e-5)"	20.8	7.8	4.2	12.7	4.7	2.7	19.7	3.6	3.2	27.2	11.1	4.8	9.7	4.1	21.8	21.1	16.1	17.6	18.0	13.3	4.1	4.2	11.4	13.5	12.5	10.0	4.6	2.7	25.6	9.5	19.8	5.1	65.0	4.6	20.6	8.0	13.4	13.0	14.5	8.1	6.9	7.3	24.4	5.0	9.9	8.9	9.5	4.4	10.0	9.2	8.7	6.5	19.5	20.0	0.9	2.0	0.2	1.5	4.5	4.6	1.0	3.1	3.6	14.2	14.5	24.0	27.9	13.7	14.2	13.2	20.3	22.1	17.3	23.6	0.0	8.8	18.4	22.5	2.4	10.7	0.3	21.5	5.6	8.3	5.3	4.0	8.0	9.7	13.9	0.0	16.0	4.5	10.7	0.3	12.4	17.1	0.0	11.9	0.1	30.6	2.3	8.9	8.0	6.2	3.4	10.5	0.4	22.2	0.0	3.7	8.9	3.0	9.1	26.7	1.8	3.9	6.8	12.8	5.3	17.0	39.3	7.8	3.3	14.7	0.1	0.0	0.0	10.1	14.6	31.1	0.1	0.3	0.0	4.6	1.5	3.9	0.5	2.3	3.8	1.1	0.9	2.4	3.6	0.2	4.5	0.7	2.0	1.9	1.0	4.2	4.7	3.6	3.2	4.1	4.2	4.6	2.7	4.6	4.4	3.0	10.1	3.2	5.2	10.3	9.9	5.0	2.5	10.7	9.1	15.7	5.9	21.7	1.7	2.2	0.9	11.2	1.5	0.0	6.3	13.2	35.1	7.9	3.5	9.7	14.2	0.0	1.7	14.7	2.4	0.0	26.2	6.9	5.0	3.6	8.3	3.8	4.2	3.5	29.4	5.2	6.0	12.9	16.7	0.5	1.0	8.3	17.7	8.5	6.8	2.3
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382570-48391553	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 488.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.49e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	46.9	49.3	22.6	23.4	21.5	14.5	60.6	16.1	28.8	51.8	43.3	24.4	64.8	47.7	44.0	45.2	41.3	40.3	56.5	42.8	20.9	20.4	57.3	81.3	38.0	44.6	18.6	20.4	68.9	61.0	63.5	45.7	81.4	20.9	44.8	47.7	39.7	65.8	69.9	31.8	37.4	59.9	39.6	26.0	33.7	42.5	33.2	18.6	26.2	75.5	32.9	42.3	53.2	54.4	10.6	26.5	6.8	23.3	11.6	12.8	9.3	30.2	43.8	25.4	26.9	57.2	67.0	18.6	29.9	52.9	36.5	41.9	28.8	34.6	12.6	19.6	65.3	22.8	27.2	30.6	32.0	34.9	10.2	32.6	10.5	15.6	53.7	49.8	11.7	19.7	63.2	39.5	24.7	26.5	57.6	33.9	10.9	18.2	23.5	48.4	24.4	11.0	120.4	18.4	60.6	17.8	15.8	15.2	19.7	46.3	25.2	25.5	19.9	26.2	23.5	15.6	30.4	18.5	14.5	26.2	25.8	21.4	21.3	25.4	66.6	52.1	8.5	16.4	15.9	26.3	5.9	23.3	6.8	11.2	19.8	12.8	10.6	11.0	12.1	17.7	9.6	9.2	9.9	5.9	11.6	16.5	26.5	11.7	9.3	22.6	21.5	16.1	28.8	20.9	20.4	18.6	20.4	20.9	18.6	32.8	44.6	55.9	109.7	66.9	36.0	25.0	94.3	48.2	69.4	89.0	5.9	200.0	48.0	191.8	3.8	91.1	175.8	46.7	148.2	488.3	138.8	143.5	61.2	66.0	162.8	38.1	139.2	77.3	97.8	10.5	151.3	75.4	87.7	106.4	269.4	89.6	162.2	178.9	124.1	122.0	21.4	84.1	77.3	41.2	38.1	61.4	324.3	45.4	168.0	114.5
KDF1	"C1orf172, FLJ34633, RP11-344H11.3"	ENSG00000175707	"Keratinocyte differentiation factor 1"	Q8NAX2	1	26949562-26960406	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.6"	"Group enriched"	"Detected in many"	36	"B-cells: 3.7;T-cells: 8.6"	"Cell line enhanced"	"Detected in some"		"A-431: 13.3;BEWO: 11.7;CAPAN-2: 12.5;HaCaT: 11.8;HBEC3-KT: 16.2;hTCEpi: 21.3;OE19: 20.5;SK-BR-3: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028639, HPA068312"	Uncertain		Supported	"Nucleoplasm,Cell Junctions,Mitotic spindle"		NA	NA			"Cell Junctions"	"Nucleoplasm, Mitotic spindle"	"HPA028639: AB_10599191, HPA068312: AB_2685972"	"unprognostic (2.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (3.04e-13)"	"unprognostic (1.38e-3)"	"unprognostic (7.83e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.40e-4)"	0.2	1.1	0.6	3.8	0.7	0.0	7.9	1.5	3.6	2.9	11.9	0.4	13.6	9.3	1.0	17.3	16.1	5.5	4.2	0.5	0.8	0.1	7.9	3.5	7.5	6.7	0.2	0.6	1.0	23.8	6.6	9.0	12.4	0.8	6.0	5.1	2.0	14.3	11.5	0.2	13.3	12.5	0.2	0.2	1.0	7.7	5.8	0.5	1.6	14.5	7.2	8.6	5.2	6.0	3.7	0.1	0.0	0.0	0.0	8.6	2.4	13.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	6.6	12.5	0.0	0.5	0.0	0.0	11.8	0.0	16.2	0.0	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	21.3	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	7.9	0.0	0.0	0.9	20.5	0.1	0.0	0.0	1.9	2.9	6.3	8.2	0.0	0.1	13.9	0.0	1.5	9.0	0.2	0.1	0.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.5	3.5	5.9	4.2	0.1	3.7	8.6	5.1	0.0	0.0	0.0	0.0	0.3	2.4	0.6	0.7	1.5	3.6	0.8	0.1	0.2	0.6	0.8	0.5	11.9	9.1	0.5	10.7	0.0	0.4	0.3	12.7	9.4	4.5	14.0	0.0	28.2	21.6	24.5	0.3	0.1	17.1	0.0	20.6	20.1	0.8	11.8	0.0	2.9	2.4	0.0	7.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.1	1.0	18.2	22.9	0.0	7.3	2.1	0.0	0.2	5.8	7.0	0.0	24.8	1.5	17.2	16.2
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153595	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 67.3;Cone photoreceptor cells: 92.3;Horizontal cells: 69.9;Rod photoreceptor cells: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.1;dendritic cells: 2.5;granulocytes: 6.9"	"Cell line enhanced"	"Detected in all"		"T-47d: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062872			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA062872: AB_2684890"	"prognostic favorable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.74e-4)"	"prognostic favorable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"	13.3	16.0	14.8	15.1	13.4	22.0	20.0	26.1	18.7	19.4	12.6	18.3	24.3	12.1	24.2	18.1	15.9	18.4	12.0	12.6	13.3	9.2	10.4	18.2	11.8	19.2	13.8	12.9	18.5	19.0	12.1	17.9	29.4	11.2	24.8	6.0	18.8	16.5	22.6	38.0	21.1	12.9	16.2	13.3	21.2	12.0	19.9	13.8	14.6	28.9	8.8	13.7	13.3	21.9	7.1	2.5	6.9	0.9	1.3	0.8	0.5	8.9	3.1	7.4	8.9	4.3	4.3	15.0	4.5	3.4	4.0	5.0	5.3	2.5	12.5	4.8	5.1	3.2	5.1	4.5	5.3	2.5	5.6	11.4	4.2	5.4	4.4	8.1	4.2	9.8	6.6	5.7	3.3	2.7	7.2	5.3	7.1	10.3	7.7	3.5	4.6	4.8	6.4	6.5	3.2	7.8	8.2	5.6	10.4	4.0	5.9	13.8	10.6	5.8	6.5	7.1	7.5	35.5	11.1	7.7	6.0	3.4	7.2	4.5	21.3	8.8	9.6	11.7	8.5	3.4	1.6	0.9	2.6	0.5	0.3	0.3	6.1	0.4	0.4	0.4	7.1	0.6	0.8	6.9	1.3	0.4	2.5	0.5	0.5	14.8	13.4	26.1	18.7	13.3	9.2	13.8	12.9	11.2	13.8	6.0	7.2	13.7	11.9	6.5	67.3	12.7	15.3	2.7	5.7	7.0	92.3	21.3	6.6	9.5	13.7	10.5	8.4	0.0	6.6	19.1	10.3	19.8	8.1	23.7	8.0	69.9	8.1	12.3	11.8	8.8	17.0	9.1	10.1	9.0	16.5	20.7	14.6	13.3	21.9	5.2	74.4	6.5	8.1	18.4	7.7	13.4	20.1	10.2	8.4	10.8
KDM4C	"GASC1, JMJD2C, KIAA0780, TDRD14C"	ENSG00000107077	"Lysine demethylase 4C"	Q9H3R0	9	6720863-7175648	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 73.8;Late spermatids: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069357			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069357: AB_2686128"	"unprognostic (1.56e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.64e-3)"	12.1	12.1	13.3	21.5	15.0	27.5	12.7	51.2	14.3	12.4	14.9	18.0	14.6	14.2	14.7	13.9	12.5	12.0	11.9	10.0	11.1	11.9	9.9	12.2	16.1	21.1	15.1	10.5	13.5	18.9	26.0	24.0	10.6	13.7	11.5	18.5	15.3	15.1	13.9	9.7	16.9	16.6	15.4	13.8	15.2	16.2	10.4	16.0	29.0	14.9	7.9	25.7	13.5	14.2	13.8	8.4	13.0	11.1	10.8	11.8	6.9	9.4	5.6	2.4	3.5	8.2	9.2	6.8	4.3	5.9	5.2	5.0	6.6	5.4	11.1	2.7	6.0	5.1	2.9	5.2	7.5	6.7	32.0	3.8	15.5	8.0	8.9	7.8	5.9	10.7	7.9	5.2	4.1	8.8	13.1	6.2	9.7	2.4	7.6	5.4	4.9	9.7	23.1	4.0	10.4	2.1	5.8	2.1	6.8	7.6	5.6	8.2	4.9	4.0	7.8	3.8	6.9	3.8	10.2	6.6	5.1	2.4	5.8	4.1	5.7	4.1	11.2	5.0	5.7	1.9	7.2	6.4	13.0	9.8	6.9	10.8	11.9	10.9	10.7	8.4	13.8	11.8	8.8	1.5	10.8	11.1	3.4	9.2	6.9	13.3	15.0	51.2	14.3	11.1	11.9	15.1	10.5	13.7	16.0	6.0	11.8	5.3	5.9	17.6	22.2	7.0	12.7	8.1	6.8	7.0	43.2	4.3	3.3	5.7	73.8	7.9	11.1	0.0	5.5	4.6	6.2	5.5	8.1	9.0	5.8	11.1	9.4	8.0	9.1	64.8	8.9	15.0	6.8	8.2	13.0	5.6	6.5	12.4	8.9	3.1	30.6	12.9	7.6	5.4	3.7	20.8	4.9	17.3	9.3	6.5
KDM4D	"FLJ10251, JMJD2D"	ENSG00000186280	"Lysine demethylase 4D"	Q6B0I6	11	94973681-94999518	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 37.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 69.2;Late spermatids: 28.4;Spermatocytes: 52.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA055854, HPA064037"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055854: AB_2682944, HPA064037: AB_2685180"	"unprognostic (1.98e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	0.6	0.8	1.2	0.4	2.0	0.1	0.8	1.4	2.1	0.6	0.3	1.2	1.7	0.2	0.6	0.9	0.4	1.0	0.5	1.0	0.7	0.7	0.6	0.4	0.4	0.7	0.6	1.3	1.3	0.4	1.4	2.1	0.5	1.1	0.6	0.4	1.2	0.7	0.7	1.0	0.7	0.5	0.6	0.9	0.7	0.4	37.5	1.0	0.3	0.8	0.6	0.6	0.6	0.4	1.3	1.2	0.0	5.1	0.1	1.4	0.2	0.9	1.4	5.6	4.1	1.2	1.4	2.6	1.9	2.1	5.2	4.6	1.5	1.8	2.1	6.1	1.6	5.0	1.7	3.6	3.9	4.0	2.3	3.7	1.8	0.6	2.1	1.1	0.9	0.6	2.7	2.1	5.2	4.7	0.8	2.0	7.4	2.0	1.0	2.0	1.7	3.1	2.1	2.5	1.4	6.8	4.3	2.4	1.5	1.2	0.6	3.3	4.0	2.2	2.0	1.5	3.2	2.1	0.6	1.5	3.6	2.1	5.5	2.8	1.3	4.1	0.3	1.2	1.1	3.9	0.0	0.3	0.0	0.3	0.2	0.2	1.3	0.6	1.0	0.0	0.2	0.8	0.1	0.0	0.1	5.1	1.2	1.4	0.2	1.2	2.0	1.4	2.1	0.7	0.7	0.6	1.3	1.1	1.0	0.0	0.0	0.0	0.2	0.0	6.6	0.8	2.5	1.4	0.0	0.0	2.0	0.8	3.3	0.6	69.2	0.4	0.0	0.0	0.5	0.7	0.3	0.1	0.0	1.0	0.5	3.2	0.0	1.8	0.3	28.4	2.0	0.7	0.0	1.0	0.0	4.3	0.2	0.0	1.1	1.0	2.9	0.0	0.9	52.0	12.4	0.0	0.2	0.0	0.2	0.1
KDM5A	"JARID1A, RBBP2"	ENSG00000073614	"Lysine demethylase 5A"	P29375	12	280129-389454	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006201			Supported	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"HPA006201: AB_1079160"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.81e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.69e-2)"	13.6	14.4	10.6	13.7	13.0	41.6	13.1	21.8	13.2	11.8	10.3	14.8	11.3	7.8	14.2	8.1	13.6	11.2	10.0	10.1	11.5	5.7	9.0	10.7	13.1	14.9	15.1	9.1	15.2	11.5	16.8	13.8	12.4	11.3	10.6	10.9	10.6	12.9	8.6	9.7	20.3	13.0	10.4	10.1	15.5	10.6	21.2	14.8	28.8	11.4	7.1	16.1	13.1	18.8	17.2	16.8	33.7	14.1	18.6	18.1	10.1	7.7	14.0	10.3	7.9	9.3	8.8	11.5	6.9	9.2	10.4	11.3	8.3	9.4	13.0	2.2	11.5	9.1	7.4	10.7	7.8	12.5	20.5	8.9	15.9	14.6	4.9	7.5	20.7	12.6	9.6	7.4	12.8	17.1	10.7	10.5	11.7	9.5	18.3	8.8	5.2	14.8	5.9	16.0	6.7	4.4	13.9	26.9	6.1	5.0	17.9	4.0	11.6	13.6	6.2	7.3	14.9	6.7	13.1	14.3	6.9	9.9	7.6	11.5	6.5	7.1	29.9	8.8	9.1	10.1	30.2	11.3	22.2	17.7	13.1	18.1	14.1	13.8	14.2	11.8	17.2	15.1	12.9	33.7	18.6	14.1	16.8	10.5	10.1	10.6	13.0	21.8	13.2	11.5	5.7	15.1	9.1	11.3	14.8	59.6	53.6	57.8	19.7	29.3	64.2	35.8	35.7	40.2	39.8	33.2	110.0	38.1	3.3	31.6	79.2	46.6	34.3	0.0	27.4	28.3	35.7	25.6	52.1	23.6	26.7	82.6	66.8	42.4	53.2	21.3	44.8	47.2	25.3	60.5	35.6	48.0	31.1	37.9	52.3	10.5	68.8	58.2	30.9	105.6	111.6	41.7	59.5	62.5	36.0	33.9
KDM5D	"HY, HYA, JARID1D, KIAA0234, SMCY"	ENSG00000012817	"Lysine demethylase 5D"	Q9BY66	Y	19703865-19744939	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 27.0;U-698: 23.6"	"Low region specificity"	"Detected in all"							HPA049086			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA049086: "			"unprognostic (8.38e-2)"		"unprognostic (2.20e-1)"	"prognostic favorable (3.58e-5)"	"unprognostic (6.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.10e-2)"		"unprognostic (4.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-2)"	8.0	15.6	3.3	28.7	15.7	11.6	6.5	11.4	23.0	0.3	15.8	20.7	16.4	14.3	0.3	17.4	10.2	0.3	15.8	7.6	4.6	5.3	6.7	6.8	10.1	15.9	5.0	0.0	0.3	12.5	0.3	9.3	8.0	16.1	17.2	18.8	21.4	14.5	20.4	14.9	8.7	28.6	25.6	6.1	17.1	10.2	14.0	0.0	29.8	10.7	15.3	19.5	14.9	0.0	6.3	5.1	3.8	3.1	3.4	5.1	1.8	0.0	3.8	0.0	0.0	0.0	0.0	7.7	6.8	5.9	4.0	4.6	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	4.4	10.2	0.0	27.0	0.0	8.9	5.8	0.0	0.0	6.3	6.2	0.0	0.0	0.0	0.0	4.8	0.0	0.0	9.4	0.0	10.8	0.0	5.7	0.0	0.0	0.0	4.7	4.9	8.5	13.3	6.3	0.0	0.0	0.0	2.8	13.6	0.0	5.6	8.9	12.5	0.1	0.1	3.1	11.4	7.3	23.6	1.2	0.0	0.0	0.0	3.1	3.8	4.6	2.2	3.5	6.3	4.3	4.4	3.3	5.6	5.1	3.7	0.4	3.4	1.9	5.1	3.5	1.8	3.3	15.7	11.4	23.0	4.6	5.3	5.0	0.0	16.1	0.0	17.9	13.9	20.4	8.9	5.7	37.4	8.1	0.0	4.0	9.1	17.4	19.6	5.5	5.0	3.2	0.7	10.8	2.6	23.3	0.0	1.2	13.2	8.9	10.5	0.4	3.7	12.7	3.4	11.6	3.5	1.5	33.9	12.3	10.1	12.6	2.4	10.0	2.8	0.0	31.8	3.1	32.5	25.8	7.8	2.8	7.8	9.5	4.7	15.2	0.0	6.7
KDM6A	UTX	ENSG00000147050	"Lysine demethylase 6A"	O15550	X	44873177-45112602	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000568, HPA001165, HPA002111"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704"	"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.16e-2)"	12.3	12.1	16.5	17.6	24.5	47.9	21.4	26.1	22.0	16.9	11.8	16.7	12.0	13.1	22.6	11.3	15.4	16.9	15.2	9.1	18.2	6.5	11.6	13.5	19.7	15.1	28.8	11.3	23.8	14.9	21.3	20.2	13.3	18.3	10.3	11.3	10.3	16.1	12.6	15.1	21.3	17.6	13.5	14.9	18.1	15.0	17.7	26.1	19.1	14.5	6.9	13.6	14.9	22.8	5.5	7.1	15.7	7.5	6.2	7.9	3.5	8.7	7.6	11.3	11.4	8.1	8.4	24.2	6.8	4.8	8.2	8.6	17.9	7.5	5.7	3.7	6.3	17.0	18.8	14.5	12.0	7.6	8.3	15.5	7.1	9.6	6.7	5.7	3.8	20.2	4.5	9.9	13.5	14.1	8.8	6.3	7.0	9.8	14.2	5.1	5.7	7.8	11.2	9.4	6.7	8.8	8.7	10.9	1.0	4.7	16.3	9.7	5.2	21.7	10.9	9.2	24.8	10.6	0.1	5.3	7.8	6.0	7.8	3.5	9.0	10.8	8.6	5.4	4.0	4.5	15.7	3.8	3.5	5.3	7.5	6.0	5.5	7.2	7.9	7.1	3.8	7.0	6.3	7.3	6.2	7.2	3.8	5.6	3.5	16.5	24.5	26.1	22.0	18.2	6.5	28.8	11.3	18.3	26.1	6.0	8.8	5.2	11.3	23.2	6.5	11.4	10.2	5.3	7.9	7.0	13.7	3.8	0.0	6.5	1.0	9.4	18.8	0.0	6.6	4.9	8.9	11.4	2.3	13.9	6.1	23.8	12.6	6.2	8.9	1.1	6.1	9.7	10.1	7.2	14.2	7.4	7.7	14.4	6.7	3.3	8.4	6.5	10.3	5.6	11.7	23.1	9.2	10.1	11.0	16.3
KDM6B	"JMJD3, KIAA0346"	ENSG00000132510	"Lysine demethylase 6B"	O15054	17	7839904-7854796	"Predicted intracellular proteins"	"Inflammatory response"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 190.4;granulocytes: 180.6;Suprabasal keratinocytes: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 3.7;neutrophil: 11.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037988	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA037988: AB_10672502"	"unprognostic (3.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.89e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.85e-1)"	10.7	6.7	3.1	10.6	5.3	17.5	4.4	9.0	7.6	3.9	5.0	6.7	3.1	7.5	6.3	6.1	4.8	6.7	10.4	6.9	3.1	2.5	6.0	6.2	9.8	12.2	5.6	3.1	12.3	9.6	4.0	8.7	6.6	6.6	5.4	1.7	10.2	4.2	3.3	4.7	5.5	8.0	7.6	8.0	8.4	6.1	7.2	3.1	5.9	6.1	7.1	3.1	5.2	4.3	0.7	0.9	11.6	0.8	0.1	0.6	0.4	4.0	5.7	10.9	16.0	4.0	3.0	13.7	3.2	4.8	2.3	2.5	8.2	3.0	9.4	3.9	2.6	3.3	10.1	5.2	4.5	1.4	3.7	3.9	4.4	5.4	5.2	11.5	5.7	13.6	4.6	6.9	5.6	4.6	6.2	4.1	10.1	7.2	4.0	1.0	6.7	8.7	5.2	5.5	3.9	3.3	9.8	2.4	2.5	4.2	7.0	5.8	18.3	4.1	9.6	8.3	6.3	5.4	7.3	2.0	3.4	6.3	6.1	4.5	4.9	0.9	3.2	4.8	3.4	6.7	3.7	0.8	1.3	0.4	0.5	0.4	0.4	0.3	0.2	0.5	0.7	0.4	0.6	11.6	0.1	0.3	0.9	0.1	0.4	3.1	5.3	9.0	7.6	3.1	2.5	5.6	3.1	6.6	3.1	23.8	34.8	16.9	105.1	190.4	43.9	9.9	28.1	6.7	28.4	7.0	29.5	13.0	1.7	24.3	25.9	38.3	46.3	0.0	21.8	12.3	68.9	86.7	180.6	19.5	22.0	36.5	76.6	28.3	40.4	6.5	15.3	69.4	54.0	9.0	35.8	8.9	40.4	43.5	13.1	7.7	16.8	19.4	94.7	18.6	17.3	164.4	43.5	15.2	34.6	91.6
KDM7A	"JHDM1D, KIAA1718"	ENSG00000006459	"Lysine demethylase 7A"	Q6ZMT4	7	140084746-140177035	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012114	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA012114: AB_1852429"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"	20.1	3.2	6.6	15.2	4.7	18.7	10.4	8.7	6.1	13.2	12.0	4.7	4.6	10.3	8.9	5.8	13.0	5.8	6.0	8.0	5.7	3.5	4.9	8.5	9.7	10.1	4.8	2.8	5.0	6.4	7.0	6.7	15.5	6.7	6.9	12.2	3.7	11.4	4.5	24.6	15.0	16.3	9.3	6.0	6.7	11.9	9.4	5.9	10.8	6.4	10.3	15.2	13.1	9.1	2.8	3.0	6.1	2.3	1.8	1.6	0.8	0.9	0.4	2.9	3.1	2.7	2.3	5.9	1.3	1.9	0.5	0.6	0.3	0.4	2.0	2.0	1.3	1.6	1.1	4.1	2.5	0.9	11.3	2.5	0.1	0.4	5.3	2.7	1.9	2.1	2.7	5.6	1.6	8.8	1.4	2.8	5.4	6.4	8.9	0.5	0.8	3.5	3.1	4.7	6.5	1.6	4.0	0.2	4.0	1.0	1.2	5.2	6.3	3.0	7.0	3.0	4.9	9.6	0.7	4.9	0.6	1.1	1.9	0.8	3.1	0.4	6.6	1.6	5.2	1.1	1.6	2.3	0.9	1.1	1.3	0.9	1.5	1.6	1.5	3.0	2.8	1.5	1.0	6.1	1.8	0.5	1.2	1.3	0.8	6.6	4.7	8.7	6.1	5.7	3.5	4.8	2.8	6.7	5.9	14.9	27.5	13.2	37.9	44.3	12.4	12.1	10.2	26.8	25.0	15.7	25.5	7.1	1.7	6.4	4.1	20.3	28.2	23.3	8.2	2.5	15.4	28.1	8.1	16.9	9.7	6.4	50.6	24.5	36.3	3.4	7.2	33.7	3.3	3.6	38.6	3.7	10.2	26.8	3.9	2.6	9.5	6.5	17.6	24.7	10.0	40.7	31.7	13.1	21.9	43.9
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203495-27221768	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026545: AB_1852015"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	1.9	3.2	2.7	3.6	3.5	1.4	2.1	5.9	5.9	2.2	4.2	3.7	3.2	12.0	3.1	2.2	2.1	2.5	2.5	2.0	2.7	3.2	2.3	44.9	2.0	3.3	2.3	5.1	3.0	4.5	2.8	3.3	1.7	3.7	2.9	1.9	2.1	2.6	2.5	4.0	1.9	16.8	1.9	2.2	3.7	2.3	2.2	2.2	5.9	2.9	2.0	3.7	2.8	2.2	5.6	6.5	1.3	3.4	2.2	8.2	3.5	1.6	3.7	6.4	3.3	1.6	1.9	3.4	2.1	2.4	4.8	4.3	3.1	2.9	9.6	3.7	3.5	2.4	1.9	3.7	3.2	2.8	11.0	5.5	6.1	4.1	7.3	3.4	4.3	7.3	2.5	2.6	3.2	2.1	2.8	3.7	4.6	7.7	5.9	2.9	2.8	4.3	7.7	11.1	1.3	2.2	6.3	3.9	8.6	1.8	1.9	6.0	3.8	0.9	3.0	2.3	2.2	3.2	5.7	4.1	5.7	3.0	2.1	2.2	3.7	3.8	7.7	2.3	4.0	0.5	0.4	3.2	1.3	4.2	3.4	3.6	3.2	6.2	6.0	3.0	5.6	6.0	8.2	0.1	2.2	2.9	6.5	3.6	3.5	2.7	3.5	5.9	5.9	2.7	3.2	2.3	5.1	3.7	2.2	0.0	1.7	0.5	0.2	0.2	1.0	1.0	0.0	9.4	2.3	0.0	2.0	1.3	3.3	0.9	0.4	1.0	1.6	0.0	0.6	0.4	0.8	0.4	0.0	46.0	1.6	0.0	5.2	1.3	1.3	0.0	0.3	1.2	0.0	1.0	1.3	1.6	0.7	0.0	1.1	1.2	2.5	0.0	0.8	0.9	2.5	0.0	1.1	0.5	1.1	0.1
KEAP1	"INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454"	ENSG00000079999	"Kelch like ECH associated protein 1"	Q14145	19	10486120-10503741	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005558, CAB025337"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Nucleoplasm, Centriolar satellite"	Cytosol	"CAB025337: , HPA005558: AB_1079175"	"unprognostic (1.98e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.06e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	16.0	13.7	13.5	10.4	14.3	9.1	12.4	13.2	15.1	13.1	15.7	15.4	13.8	13.6	11.0	12.7	26.3	15.1	12.7	19.7	13.9	13.7	13.2	22.0	10.8	15.5	16.7	7.4	11.8	14.3	11.1	10.2	11.5	14.3	13.9	8.8	11.8	11.3	13.9	63.9	16.8	13.8	11.6	16.5	11.3	10.6	12.2	13.8	13.1	14.5	29.1	16.1	14.5	11.2	14.6	23.7	21.3	19.8	21.0	30.8	19.6	17.3	31.8	8.8	11.7	18.2	15.5	9.4	14.8	11.0	15.2	13.6	22.6	17.5	24.7	39.0	16.4	11.3	15.6	17.5	11.5	7.5	23.9	19.2	37.3	9.5	26.7	17.6	19.5	20.3	16.0	15.6	17.1	8.0	12.7	14.4	7.4	22.8	45.8	13.2	24.0	14.1	53.6	25.7	16.6	26.8	25.7	11.0	28.9	9.8	20.8	24.3	12.7	20.6	13.8	12.8	8.1	11.9	26.1	17.7	24.5	13.2	27.4	17.9	26.7	33.4	24.2	18.9	23.3	17.9	16.1	19.8	21.3	30.8	17.0	29.3	14.6	21.5	28.3	23.7	5.7	13.5	19.1	10.9	21.0	16.6	16.3	25.4	19.6	13.5	14.3	13.2	12.8	13.9	13.7	16.7	7.4	14.3	13.8	26.8	17.3	19.6	22.6	19.5	21.5	20.3	20.4	13.4	17.0	10.4	7.9	22.5	11.6	29.0	22.3	24.1	31.5	0.0	31.3	21.0	19.7	21.7	11.5	28.8	25.7	25.4	25.8	27.0	14.8	34.6	27.0	14.9	10.1	57.7	20.6	39.6	26.7	21.0	24.4	19.1	11.1	12.9	15.6	19.5	17.3	19.3	22.4	22.4	27.9	21.7
KHDC1	"bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1"	ENSG00000135314	"KH domain containing 1"	Q4VXA5	6	73241314-73310365	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 19.4;Spermatocytes: 29.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA029032			Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA029032: AB_10602914"	"unprognostic (3.46e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.83e-4)"	"unprognostic (8.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.17e-3)"	2.9	2.9	10.3	2.0	12.9	0.9	2.2	8.8	14.6	4.7	1.3	2.6	1.2	0.6	3.9	3.3	2.7	6.2	2.6	3.4	8.5	8.4	1.3	0.4	1.8	3.1	8.6	5.7	7.4	4.4	5.0	9.6	1.5	4.7	4.4	1.4	2.9	1.3	3.6	2.7	1.0	1.1	2.4	6.2	0.9	2.9	8.2	4.1	5.4	5.9	1.7	3.4	2.2	2.1	2.7	2.6	3.8	0.2	2.5	5.2	2.0	2.9	4.2	0.8	2.3	4.0	4.6	2.0	5.7	5.5	8.8	13.1	4.0	2.3	6.2	2.2	2.5	4.5	2.8	5.9	1.2	6.7	5.9	4.2	4.1	3.4	0.0	5.2	2.0	0.1	5.9	2.5	8.7	2.4	3.7	1.9	6.5	3.0	7.5	3.5	6.9	0.4	1.9	3.9	0.5	8.4	0.9	0.0	5.0	1.4	0.1	10.5	2.2	3.2	0.1	0.2	2.9	0.1	6.2	0.1	1.9	4.0	1.1	6.0	12.7	7.6	4.5	0.1	1.7	0.7	3.8	0.2	0.0	4.4	0.0	2.6	2.7	2.8	4.9	0.7	1.9	2.2	3.4	0.0	2.5	0.0	2.6	5.2	2.0	10.3	12.9	8.8	12.4	8.5	8.4	8.6	5.7	4.7	4.1	0.0	1.0	3.0	3.2	0.7	7.8	1.8	0.0	0.0	2.3	3.5	2.0	1.5	1.7	0.8	9.3	0.3	0.0	0.0	3.3	0.3	3.1	1.7	0.0	0.0	0.4	12.7	0.0	0.0	0.0	12.1	2.0	0.0	3.3	1.0	0.5	11.5	2.3	0.0	3.2	0.0	6.8	19.4	1.9	29.8	12.9	0.5	0.1	4.3	0.9	0.4
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 359.6;Proximal tubular cells: 948.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.6;Hep G2: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol		NA	NA		320000	Cytosol		"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	14.0	10.7	1.7	6.4	1.2	0.3	1.4	1.0	0.6	1.3	0.8	5.1	3.1	2.1	3.4	0.0	1.5	6.2	5.5	1.8	0.4	5.0	10.1	18.6	2.8	27.1	0.6	2.5	2.2	0.1	0.8	1.6	0.1	0.7	1.2	3.0	3.3	3.6	0.1	9.1	3.0	2.0	2.3	12.7	4.2	10.7	0.8	11.8	1.6	1.7	6.0	9.4	2.1	3.6	4.0	0.6	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.9	3.6	1.8	6.1	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6	3.0	5.9	9.6	2.3	3.2	3.6	1.9	15.3	0.0	1.2	38.4	2.0	2.6	109.5	3.1	0.8	5.8	12.3	0.0	2.6	3.6	1.9	0.9	4.6	359.6	7.5	6.4	5.8	6.7	13.2	3.6	1.7	5.8	8.5	1.0	5.9	8.5	2.7	1.7	1.4	948.1	5.2	0.0	4.5	0.9	6.8	5.9	7.9	4.6	14.3	1.0
KHNYN	KIAA0323	ENSG00000100441	"KH and NYN domain containing"	O15037	14	24429286-24441834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003402	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003402: AB_1079190"	"unprognostic (2.95e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.03e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.73e-1)"	18.3	16.7	8.3	24.2	12.8	21.1	18.1	18.9	9.4	21.6	22.4	14.3	25.2	16.9	18.7	19.5	24.3	18.3	28.8	11.2	8.6	5.9	11.8	12.5	16.8	19.2	12.9	7.2	30.7	23.2	17.6	12.8	31.5	11.3	21.5	16.1	10.8	17.0	20.0	15.1	16.9	21.2	24.5	13.6	22.7	24.6	9.3	12.5	20.1	16.1	16.6	26.0	19.7	30.7	6.6	4.5	7.0	5.8	4.5	5.8	3.7	12.6	15.3	12.7	10.1	14.1	13.9	13.5	12.4	14.4	14.4	11.2	9.5	21.8	17.9	7.2	11.0	11.9	12.0	11.2	19.6	10.3	27.2	5.6	8.0	13.7	17.2	15.1	11.6	17.0	14.1	44.2	15.4	19.2	18.6	16.1	13.0	10.3	15.9	8.3	17.0	4.0	7.0	3.4	22.6	13.3	6.4	0.1	8.8	8.7	18.2	9.4	9.9	10.5	6.6	16.3	13.3	7.7	13.1	16.2	12.6	11.3	14.9	7.0	30.7	16.5	11.9	6.9	6.2	11.7	4.7	4.1	7.0	5.8	5.8	3.4	4.6	4.5	4.9	3.1	6.6	3.5	3.3	5.7	4.5	4.8	4.5	4.4	3.7	8.3	12.8	18.9	9.4	8.6	5.9	12.9	7.2	11.3	12.5	11.9	12.3	7.8	20.6	7.9	2.5	2.9	17.8	1.4	7.9	7.0	2.0	17.5	1.7	15.2	0.3	13.4	27.4	0.0	36.6	11.0	8.5	26.7	13.9	7.6	12.3	0.0	10.4	9.2	10.8	2.0	13.0	9.0	11.8	14.4	22.1	8.3	32.5	14.4	10.6	3.3	7.6	12.9	15.6	1.4	1.5	11.2	22.4	12.5	15.3	26.9
KIAA0040		ENSG00000235750	KIAA0040	Q15053	1	175156987-175192999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 315.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.8;RPMI-8226: 23.3;U-698: 42.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA016895, HPA068812"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016895: AB_2669476, HPA068812: AB_2686041"	"unprognostic (5.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-1)"	25.7	4.0	2.7	18.4	7.4	5.1	16.0	2.0	3.9	8.0	7.7	1.8	3.5	5.2	8.6	7.9	7.0	9.2	11.0	16.3	3.2	2.9	17.8	12.1	25.3	16.1	6.9	1.0	5.0	17.9	4.6	13.6	45.6	7.6	7.9	5.6	12.2	15.2	4.1	11.1	5.1	10.2	6.0	5.4	27.6	9.8	3.4	3.5	14.8	9.6	7.2	18.6	6.6	10.7	16.5	5.4	26.4	6.1	3.3	9.6	5.4	3.1	0.1	0.1	0.0	0.0	0.0	0.0	1.4	3.8	0.0	0.0	1.6	4.6	32.8	7.8	0.0	0.1	13.2	2.3	15.4	0.0	11.1	1.9	3.5	7.2	0.2	0.4	0.2	0.4	0.0	4.2	0.0	5.9	0.0	5.1	4.8	2.8	5.5	0.0	0.7	4.1	0.0	1.0	2.7	2.8	3.5	1.7	23.3	5.0	7.9	0.2	1.2	2.4	12.9	0.3	8.4	8.2	0.7	2.0	0.0	1.5	0.0	0.3	13.6	16.5	42.2	0.6	0.0	3.5	12.8	6.1	1.0	5.9	3.3	5.3	16.2	6.5	4.9	5.4	16.5	6.9	5.9	26.4	3.3	1.2	1.2	9.6	5.4	2.7	7.4	2.0	3.9	3.2	2.9	6.9	1.0	7.6	3.5	35.7	5.6	53.8	61.7	23.7	0.0	3.1	12.7	20.1	15.9	12.2	0.0	57.4	11.6	11.3	0.5	20.2	11.2	0.0	20.8	5.6	39.4	46.5	10.5	6.0	10.4	0.0	4.1	13.5	10.6	1.2	15.5	16.9	6.8	10.0	5.5	4.3	17.8	14.2	9.9	4.7	0.0	25.8	65.9	0.3	3.3	9.7	315.3	25.4	10.3	30.7
KIAA0100	"BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488"	ENSG00000007202	KIAA0100	Q14667	17	28614440-28645454	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042781	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	No	No			"Nuclear speckles, Cytosol"		"HPA042781: AB_10797020"	"unprognostic (1.91e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.24e-3)"	"unprognostic (7.58e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	27.7	31.2	22.3	21.3	34.7	21.9	26.3	28.1	40.1	20.0	24.0	28.2	20.9	15.5	24.7	21.6	25.4	24.0	20.1	21.4	22.0	22.4	38.1	30.7	24.1	26.3	23.1	19.6	25.6	24.6	48.0	27.0	32.7	35.6	22.7	28.5	22.1	27.0	23.3	40.7	25.0	27.9	28.4	21.4	26.4	22.8	24.8	18.6	26.3	28.6	20.2	26.6	22.7	18.8	2.9	7.2	3.5	3.0	2.0	3.3	1.3	19.6	37.6	19.1	18.1	34.8	20.8	13.9	18.4	24.6	22.6	21.3	25.8	9.0	27.4	22.2	33.6	23.6	26.3	28.0	27.3	27.4	30.3	26.2	21.8	29.8	14.1	15.0	38.0	37.9	21.2	21.2	30.5	23.3	17.6	32.2	19.6	20.5	8.9	20.5	28.2	27.7	18.1	8.3	35.7	13.9	21.3	21.4	17.9	13.6	35.4	18.8	14.5	23.2	63.6	15.5	24.8	38.0	26.6	29.7	17.3	19.1	23.1	34.7	8.4	9.7	17.7	19.7	24.7	20.1	0.8	3.0	3.5	3.0	2.5	3.3	2.9	1.5	2.7	3.3	1.7	1.8	1.8	1.8	2.0	2.7	7.2	1.7	1.3	22.3	34.7	28.1	40.1	22.0	22.4	23.1	19.6	35.6	18.6	14.9	19.1	3.9	6.3	9.2	31.3	27.1	15.3	12.0	12.5	12.2	27.5	10.4	5.0	8.4	12.4	10.5	22.7	23.3	9.4	8.0	8.9	11.1	8.1	28.0	9.4	27.0	11.6	21.5	29.7	18.3	8.6	15.0	10.1	14.4	15.6	12.6	9.2	8.6	6.0	13.8	22.8	0.0	7.8	16.9	20.9	9.7	38.1	8.6	16.1	11.2
KIAA0232		ENSG00000170871	KIAA0232	Q92628	4	6781375-6884170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 13.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036891, HPA036892, HPA061498"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541"	"unprognostic (6.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.91e-10)"	"unprognostic (1.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.18e-2)"	12.5	12.7	18.7	8.1	22.2	14.0	13.8	22.8	25.5	13.3	13.8	20.5	12.4	8.5	15.8	13.4	21.1	15.9	12.7	32.2	19.8	18.8	19.5	15.0	12.0	7.0	20.7	17.5	13.9	10.6	25.4	22.2	25.8	25.4	15.5	12.7	11.5	10.6	15.7	32.4	7.7	18.8	13.5	19.8	12.3	11.0	13.5	17.9	10.0	15.5	13.3	8.5	12.1	13.2	1.6	2.4	13.1	2.5	2.1	3.8	0.9	9.0	8.7	18.3	11.4	13.3	14.4	9.7	11.8	12.3	8.3	7.0	5.5	7.6	5.9	4.0	13.2	12.8	4.7	9.3	5.2	10.8	3.3	3.8	17.6	7.5	7.2	7.0	7.6	23.3	9.6	12.3	9.2	5.1	10.7	8.5	6.0	13.3	5.2	10.5	4.4	14.5	7.7	9.7	6.8	9.7	10.4	18.8	2.7	14.0	8.6	14.0	9.0	8.7	7.8	8.1	13.2	9.9	14.0	10.8	7.6	9.1	6.8	10.0	9.0	9.0	4.8	9.4	8.2	20.6	1.9	2.4	6.3	2.8	1.6	3.8	1.6	2.1	3.1	1.6	1.6	2.0	2.0	13.1	2.1	2.5	2.4	1.9	0.9	18.7	22.2	22.8	25.5	19.8	18.8	20.7	17.5	25.4	17.9	29.8	31.7	8.3	22.9	11.3	72.9	121.5	7.6	66.9	34.2	12.2	35.3	11.7	34.9	20.0	36.5	15.7	31.1	46.7	10.2	5.9	11.8	25.5	11.6	36.0	9.6	93.8	24.1	16.0	24.8	44.7	23.0	17.7	6.8	16.2	16.6	51.2	15.7	24.6	31.1	21.7	41.3	25.8	13.1	27.2	17.9	9.7	18.8	12.8	13.7	24.3
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646155	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 23.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 57.8;Late spermatids: 47.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 1.4;neutrophil: 5.0"	"Group enriched"	"Detected in many"	32	"B-cells: 1.4;granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"A549: 4.1;GAMG: 4.3;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.9	1.9	9.9	1.3	10.2	0.9	1.1	10.7	23.5	0.9	1.6	4.0	0.0	0.9	0.9	0.9	0.8	4.8	1.4	0.8	9.7	7.7	0.9	0.8	2.2	0.9	5.8	12.1	0.8	3.0	0.8	3.8	1.1	10.2	1.7	1.7	0.0	0.8	0.9	0.8	2.4	1.1	1.1	1.4	1.1	3.2	3.5	2.3	0.0	0.8	0.0	1.1	0.9	0.1	1.4	0.0	5.0	0.0	0.0	0.0	0.0	3.6	4.1	0.2	2.6	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	1.5	1.1	2.0	0.0	4.3	1.7	0.7	0.0	0.0	4.8	1.8	0.0	3.5	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	1.9	0.0	0.2	0.0	1.2	0.1	0.0	0.5	0.2	0.3	0.2	0.0	0.8	0.1	0.2	7.8	0.5	0.1	2.2	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.4	0.8	0.6	6.3	0.3	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	9.9	10.2	10.7	14.9	9.7	7.7	5.8	12.1	10.2	2.3	3.0	0.3	0.0	0.0	0.0	1.8	1.2	0.0	10.7	2.3	0.0	0.0	0.0	0.0	0.2	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	47.2	0.6	0.0	0.0	1.0	0.7	0.2	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.9	1.4	0.0	0.6	0.0	0.3	0.2
KIAA0319L	"AAVR, KIAA1837"	ENSG00000142687	"KIAA0319 like"	Q8IZA0	1	35433490-35557950	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 27.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072692	Supported		Supported	"Nucleoli,Golgi apparatus"		NA	NA		870000	"Golgi apparatus"	Nucleoli	"HPA072692: AB_2686549"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-1)"	10.6	23.5	20.3	10.6	29.0	9.9	20.1	21.9	37.2	19.2	17.7	24.1	17.0	18.1	19.7	19.2	14.4	25.1	15.7	30.7	19.4	20.0	27.5	32.1	21.3	11.0	19.4	20.1	13.0	32.8	38.5	28.1	21.1	23.0	25.3	21.3	24.5	33.9	20.5	27.4	13.8	19.8	12.7	16.6	17.1	23.3	14.0	17.5	11.9	29.3	11.9	17.4	12.9	12.0	2.3	3.2	27.1	11.0	5.5	3.5	4.5	5.4	8.1	16.9	13.3	23.0	16.2	16.1	7.4	15.9	10.9	16.2	8.7	22.2	6.1	20.6	8.1	16.3	10.9	12.5	12.0	12.5	9.7	9.1	8.3	9.9	9.6	18.0	6.8	11.4	22.8	15.5	12.5	16.4	36.2	17.7	7.6	10.8	8.9	14.7	5.5	4.0	5.8	19.2	15.3	4.9	4.6	14.4	7.6	18.0	13.4	3.7	10.5	10.8	13.0	22.2	38.9	13.6	9.7	18.1	7.5	8.1	6.3	11.5	13.3	10.6	4.0	19.1	9.0	7.4	4.5	11.0	5.0	3.0	3.6	2.9	2.0	2.5	2.8	3.2	2.3	3.5	2.5	27.1	5.5	2.2	2.1	2.3	4.5	20.3	29.0	21.9	37.2	19.4	20.0	19.4	20.1	23.0	17.5	68.5	67.8	11.2	13.5	7.0	71.9	47.3	48.4	52.2	52.4	33.2	102.1	26.5	3.3	15.2	7.8	22.2	31.6	0.0	28.2	18.9	16.7	25.7	20.8	40.4	16.3	60.4	20.7	21.5	29.5	4.9	16.1	17.1	13.5	11.8	53.3	28.9	26.4	24.6	16.3	17.3	62.2	6.5	8.2	21.2	17.7	8.2	26.1	17.3	28.1	10.8
KIAA0355		ENSG00000166398	KIAA0355	O15063	19	34254537-34355586	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ito cells: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014570	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA014570: AB_1852307"	"unprognostic (1.88e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.05e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-1)"	19.8	7.2	9.3	10.8	14.7	4.4	19.5	16.3	15.0	12.3	8.5	22.1	9.3	7.5	16.6	9.4	11.3	11.8	13.1	14.0	9.0	8.9	10.2	8.8	14.9	11.7	15.6	11.1	12.5	14.5	18.9	21.8	31.0	15.7	11.2	8.1	16.6	9.4	9.7	17.4	12.2	9.8	12.3	16.2	20.7	8.2	22.2	13.5	8.4	14.1	5.4	12.7	10.7	12.1	6.3	2.0	4.4	3.4	2.6	5.8	1.4	2.3	6.9	6.2	3.2	4.3	4.1	8.2	5.2	4.3	4.0	6.0	5.5	2.8	5.2	11.6	4.8	5.0	1.6	4.6	2.4	4.4	7.4	4.0	3.2	2.7	4.2	5.5	1.4	2.6	4.8	4.3	5.2	7.8	15.9	16.3	2.9	9.5	2.6	4.3	1.2	0.9	1.2	4.7	3.1	2.6	2.3	4.3	2.7	3.3	2.6	7.2	5.9	6.0	23.5	7.6	9.5	1.8	2.6	13.5	13.8	5.2	3.5	5.4	4.5	6.2	1.6	2.6	0.5	6.7	0.0	1.2	0.0	1.8	2.7	2.7	4.7	3.8	1.6	1.5	6.3	3.2	2.0	4.4	2.6	3.4	2.0	5.8	1.4	9.3	14.7	16.3	15.0	9.0	8.9	15.6	11.1	15.7	13.5	23.8	18.8	27.0	6.6	16.5	44.8	10.9	30.6	10.7	7.9	26.2	37.3	18.8	11.6	15.4	3.0	69.9	15.4	23.3	14.6	22.0	19.0	14.8	13.9	29.8	9.5	25.4	60.6	122.2	18.6	3.1	13.8	10.8	18.6	10.8	22.6	16.9	15.1	24.5	14.9	6.9	78.9	12.9	16.5	29.2	43.4	17.1	28.5	20.3	18.0	8.6
KIAA0391	"MRPP3, PRORP"	ENSG00000100890	KIAA0391	O15091	14	35121846-35277614	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA020459: AB_2670449"	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	13.9	26.1	18.8	17.6	20.1	12.5	17.5	23.1	21.9	17.4	22.4	20.6	15.6	16.6	13.0	19.4	26.1	14.7	13.2	16.7	17.6	16.3	31.1	29.5	20.9	29.5	20.2	17.7	10.8	16.5	29.8	27.4	13.4	19.2	14.1	24.9	15.8	18.0	21.8	22.2	23.0	16.5	15.0	23.0	18.7	15.8	17.1	20.9	31.2	18.9	21.3	24.8	18.2	16.0	10.0	9.7	10.9	5.4	12.1	25.5	12.4	22.8	18.3	12.7	16.8	13.9	16.5	11.2	15.4	13.8	19.7	17.1	17.3	14.2	25.1	20.1	14.6	5.6	17.8	23.3	26.6	22.3	19.7	7.2	11.3	14.1	36.9	14.4	13.9	12.4	17.6	20.5	18.6	17.2	17.0	28.5	21.6	18.2	7.3	24.0	25.9	21.0	15.3	13.6	19.8	18.1	20.2	21.1	14.5	27.7	23.4	11.8	13.4	19.9	22.1	12.8	17.1	32.2	11.5	21.6	15.2	13.7	11.7	13.2	8.0	18.6	26.3	7.7	15.1	15.9	10.9	5.4	3.4	15.4	5.2	22.4	10.0	23.8	16.6	7.2	7.0	21.2	15.6	6.3	12.1	4.3	9.7	25.5	12.4	18.8	20.1	23.1	21.9	17.6	16.3	20.2	17.7	19.2	20.9	3.0	1.3	1.3	0.5	0.0	1.3	1.5	0.0	1.4	2.3	0.0	0.0	0.8	1.7	1.0	0.0	1.0	1.4	0.0	0.8	0.5	0.8	1.0	2.3	1.6	1.0	0.0	0.0	1.8	0.8	0.0	0.6	0.8	0.0	0.0	0.9	1.2	1.5	0.0	0.4	1.4	1.5	0.0	0.3	0.5	1.1	0.0	0.6	0.0	1.6	0.9
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127440343-127459391	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6;smooth muscle: 37.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 86.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.5;GAMG: 10.9;SCLC-21H: 31.5;SH-SY5Y: 15.6;U-138 MG: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	22.9	3.1	9.1	3.4	6.9	0.0	2.8	12.4	21.0	7.4	12.0	0.6	1.9	1.1	2.6	4.7	16.7	1.1	2.9	2.6	10.2	9.7	0.6	0.7	15.3	0.5	11.5	0.7	3.3	0.5	0.0	6.8	1.1	0.9	20.4	5.0	0.7	1.9	1.7	38.6	0.4	6.7	37.2	13.1	2.0	3.7	3.4	1.2	0.7	1.5	15.4	0.8	25.2	11.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	2.9	12.5	0.0	1.1	3.0	0.0	0.3	2.2	1.9	4.5	0.0	0.0	0.0	0.0	0.4	10.9	0.0	1.2	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	0.0	8.1	0.0	1.4	0.0	1.2	0.0	0.3	2.3	0.0	4.3	0.0	4.2	0.0	0.1	0.0	2.1	0.0	0.7	0.0	31.5	15.6	0.0	0.0	0.3	0.0	0.0	0.9	0.0	8.6	1.4	0.0	2.0	0.0	0.0	0.0	5.0	0.2	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.1	6.9	12.4	11.8	10.2	9.7	11.5	0.7	0.9	1.2	86.4	19.0	0.0	0.1	0.0	3.3	0.0	0.0	6.7	5.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	7.9	0.0	1.3	0.8	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.2	0.9	0.1	0.0	0.1	0.0	0.0	0.0
KIAA0556	"JBTS26, KATNIP"	ENSG00000047578	KIAA0556	O60303	16	27550133-27780369	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 33.6;Ciliated cells: 36.1;Cone photoreceptor cells: 64.8;Rod photoreceptor cells: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.0"	"Group enriched"	"Detected in all"	4	"granulocytes: 11.0;NK-cells: 5.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035089, HPA035090"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA035089: AB_10671509, HPA035090: AB_10601129"	"unprognostic (1.81e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.76e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.72e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.45e-1)"	6.1	6.2	7.1	8.7	10.9	7.9	6.8	6.3	10.8	8.4	8.2	12.0	13.2	6.5	15.1	13.1	11.2	38.6	7.5	7.0	7.1	6.7	9.7	5.0	8.2	5.6	6.5	7.3	8.2	11.7	14.9	19.0	6.8	8.6	11.9	9.8	11.8	9.8	9.7	4.1	11.0	7.9	8.4	9.3	7.9	12.1	22.8	8.4	8.7	20.9	5.0	11.1	7.6	9.0	1.4	1.5	11.0	2.0	5.5	1.8	0.4	5.4	11.2	6.3	5.9	9.6	8.8	10.5	7.4	8.0	6.6	9.0	9.8	9.1	4.6	10.6	10.5	12.8	9.1	8.0	9.5	13.2	21.4	5.6	3.6	11.3	5.7	5.7	4.9	9.3	9.3	8.4	14.4	15.6	8.5	12.9	5.3	5.8	3.9	9.3	12.5	5.4	6.0	3.8	7.0	4.6	7.7	7.7	5.0	12.1	7.6	8.1	5.2	7.4	6.7	4.1	9.2	14.9	4.3	11.1	8.4	5.4	6.5	6.4	5.3	4.5	5.0	9.7	4.8	7.5	9.5	2.0	3.8	0.8	1.3	0.8	0.9	0.4	1.4	1.3	1.4	1.8	0.3	11.0	5.5	0.5	1.5	1.5	0.4	7.1	10.9	6.3	10.8	7.1	6.7	6.5	7.3	8.6	8.4	6.0	1.9	2.9	4.8	1.3	33.6	4.5	0.0	36.1	9.1	1.8	64.8	2.5	0.0	3.0	11.2	3.5	5.9	0.0	3.2	2.2	2.7	6.5	0.0	0.8	2.3	3.2	11.6	3.1	1.8	12.0	2.3	3.2	5.0	2.8	3.3	6.5	3.6	3.5	1.1	1.7	54.4	0.0	2.0	9.9	4.9	1.3	1.8	3.3	3.3	4.4
KIAA0586	"JBTS23, Talpid3"	ENSG00000100578	KIAA0586	Q9BVV6	14	58427385-58551289	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 76.6;Early spermatids: 97.7;Late spermatids: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000846, HPA050249"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA000846: AB_2234167, HPA050249: "	"unprognostic (1.90e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.20e-4)"	"unprognostic (8.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-1)"	9.5	9.9	10.2	9.2	14.7	9.8	9.9	23.9	13.0	9.9	8.3	7.5	8.0	6.1	9.4	10.7	9.4	7.5	8.3	8.0	12.4	9.6	7.4	11.1	7.9	11.2	15.3	10.7	13.5	8.2	14.6	33.2	6.7	14.5	9.7	11.0	7.0	8.1	8.6	10.4	9.1	8.3	15.8	19.8	9.5	7.6	25.0	14.8	24.5	9.0	7.4	12.7	10.0	8.6	9.1	5.0	13.5	3.6	13.1	10.9	3.1	14.3	10.7	17.8	7.4	12.2	11.0	6.6	13.4	9.5	11.4	10.4	4.3	8.0	17.9	8.5	8.8	5.2	9.2	16.5	8.0	19.6	15.8	6.0	14.6	9.2	12.4	7.2	19.8	10.8	7.0	3.4	9.4	12.4	6.1	13.4	16.4	14.8	9.5	18.4	9.0	10.7	8.5	7.1	9.0	17.4	15.3	20.1	10.8	8.2	6.7	11.1	6.9	13.8	8.3	6.5	9.1	10.6	10.5	12.7	16.9	14.6	9.5	10.6	4.8	8.6	14.3	11.2	14.6	10.5	13.5	2.8	6.1	9.3	2.4	8.6	7.3	9.0	7.1	3.2	9.1	10.9	8.7	3.2	13.1	3.6	5.0	8.5	3.1	10.2	14.7	23.9	13.0	12.4	9.6	15.3	10.7	14.5	14.8	11.9	12.6	13.0	5.3	2.9	27.5	11.3	10.2	29.4	12.5	8.7	76.6	5.9	5.0	5.7	97.7	11.7	3.3	0.0	4.6	6.5	5.6	3.5	19.8	4.3	7.9	30.2	10.3	8.0	7.3	81.1	9.5	6.9	8.5	4.6	6.5	21.5	5.6	2.9	11.3	5.4	50.2	0.0	6.6	51.5	21.3	4.0	4.0	13.8	6.5	3.1
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324221-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 69.3;Late spermatids: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: AB_2670571, HPA061066: AB_2684423"	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.5	9.9	8.1	1.3	11.0	2.8	5.2	28.9	13.5	3.7	3.0	5.8	6.0	3.0	4.6	9.1	3.6	8.6	4.6	2.6	6.2	8.1	13.1	10.4	4.2	0.7	4.2	8.2	12.7	12.4	18.6	14.7	2.0	8.0	4.6	2.1	6.6	4.1	4.7	2.1	7.8	1.7	4.4	4.7	1.2	14.3	27.1	4.9	2.1	5.5	1.5	0.9	2.3	2.7	0.6	0.5	1.3	0.1	0.5	1.5	0.4	7.3	4.5	9.3	9.1	0.2	0.2	2.1	2.0	2.3	4.4	5.4	1.9	3.8	0.0	2.0	0.4	7.7	4.2	12.0	3.9	3.9	0.6	7.6	0.1	7.0	1.7	1.6	1.2	0.2	1.0	7.1	3.9	5.0	5.4	0.1	4.0	2.9	0.1	0.5	2.4	3.6	2.6	0.4	1.9	1.1	1.4	0.4	0.0	10.1	0.8	28.4	9.9	3.6	8.6	2.6	6.6	8.6	1.3	0.0	0.6	2.2	1.3	2.9	4.2	9.4	0.0	1.8	0.3	2.1	0.8	0.1	0.3	0.1	0.1	1.3	0.3	0.9	0.2	0.1	0.6	1.4	0.6	1.3	0.5	0.1	0.5	1.5	0.4	8.1	11.0	28.9	13.5	6.2	8.1	4.2	8.2	8.0	4.9	6.0	2.4	0.0	4.2	8.7	17.4	2.6	5.1	16.0	3.4	3.5	25.5	1.9	5.0	4.7	69.3	1.1	0.4	0.0	2.5	1.3	0.9	3.6	1.1	5.0	0.4	11.1	8.1	0.0	0.0	54.0	2.6	0.2	3.3	0.0	1.0	5.0	3.7	1.4	0.4	9.4	15.7	6.5	1.0	21.6	12.4	7.5	0.6	0.0	1.0	1.4
KIAA0895L	LOC653319	ENSG00000196123	"KIAA0895 like"	Q68EN5	16	67175602-67184040	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 69.1;Cone photoreceptor cells: 41.2;Early spermatids: 91.4;Horizontal cells: 101.7;Late spermatids: 145.2;Rod photoreceptor cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.3;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065996	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA065996: AB_2685593"	"unprognostic (8.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.90e-1)"	"prognostic favorable (3.16e-4)"	"unprognostic (3.74e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.00e-3)"	9.5	20.7	18.1	8.1	19.8	5.2	5.9	46.3	25.0	8.8	6.8	11.5	11.5	10.7	15.4	13.4	6.6	15.0	10.0	7.7	15.1	10.6	9.8	4.6	8.7	3.6	13.0	27.7	21.8	7.6	18.0	24.1	9.5	18.5	10.5	8.8	13.2	8.4	10.3	5.9	9.8	9.5	11.7	16.2	11.0	13.7	13.5	12.4	4.4	13.2	4.3	3.2	7.2	6.8	0.0	2.8	0.0	0.8	0.2	1.1	0.3	2.3	4.1	14.7	9.2	2.7	6.5	9.8	6.4	1.6	2.8	2.6	4.0	2.4	4.4	4.2	2.4	2.5	9.2	4.1	3.5	1.7	4.3	5.7	6.5	10.5	3.8	2.2	2.8	13.3	3.6	1.5	3.5	1.3	10.2	4.6	9.5	6.6	4.3	3.6	3.7	6.7	4.9	3.3	2.2	6.7	18.6	7.2	8.3	4.8	5.6	17.5	14.7	7.2	3.7	1.8	7.0	8.1	4.7	5.4	10.0	7.1	4.6	2.6	5.7	4.6	4.6	12.6	4.3	5.2	0.0	0.8	0.0	0.2	0.7	0.0	0.0	0.9	1.1	2.3	0.0	0.1	0.2	0.0	0.2	0.4	2.8	0.0	0.3	18.1	19.8	46.3	24.1	15.1	10.6	13.0	27.7	18.5	12.4	3.0	9.3	1.7	3.6	2.6	69.1	2.8	5.1	2.7	11.4	7.0	41.2	3.3	3.3	4.8	91.4	3.8	4.2	0.0	2.2	5.4	3.7	5.3	4.6	3.6	3.5	101.7	12.6	9.8	0.6	145.2	6.4	1.7	5.0	1.0	4.4	18.9	3.6	4.5	10.3	1.1	68.7	19.4	3.9	4.7	10.2	2.0	2.5	0.9	5.4	3.7
KIAA0930	"bK268H5.C22.1, C22orf9"	ENSG00000100364	KIAA0930	Q6ICG6	22	45190338-45240769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.8"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 60.5;Kupffer cells: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 9.1;eosinophil: 6.5;intermediate monocyte: 11.1;myeloid DC: 9.8;non-classical monocyte: 12.9;plasmacytoid DC: 8.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 9.8;granulocytes: 6.5;monocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 83.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038091	Uncertain		Approved	"Nuclear membrane,Mitochondria"		No	No			"Nuclear membrane, Mitochondria"		"HPA038091: AB_10675627"	"unprognostic (4.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (6.90e-8)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavorable (8.95e-7)"	"unprognostic (6.89e-3)"	"unprognostic (5.32e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.15e-1)"	13.4	18.0	51.3	17.1	50.0	14.4	12.9	9.9	41.3	15.3	11.6	52.8	10.3	9.6	8.3	28.4	14.2	10.0	10.7	6.6	50.2	39.9	5.9	12.7	12.5	16.6	48.2	36.8	6.7	8.2	10.2	5.6	7.9	28.9	9.5	7.6	4.9	8.6	18.1	15.6	34.2	12.9	10.3	29.3	15.4	8.5	10.1	50.0	6.5	5.2	6.7	14.3	14.1	9.6	1.8	9.8	6.5	12.9	1.5	2.2	2.6	12.4	8.1	5.0	9.9	17.2	8.1	5.0	6.9	6.9	7.4	6.4	7.4	6.8	8.3	10.3	10.9	5.9	14.0	7.6	30.6	2.8	8.9	12.0	0.0	10.0	8.5	6.9	22.2	5.1	4.6	15.5	7.1	12.0	5.6	6.9	6.1	2.9	13.8	4.4	14.3	9.8	20.7	4.9	9.0	6.8	12.1	3.4	27.4	11.1	7.6	4.2	7.4	10.9	15.0	18.9	10.1	7.3	83.1	9.3	7.6	13.5	10.3	3.9	11.8	7.9	8.0	8.9	33.9	7.8	0.9	9.1	6.5	2.0	11.1	1.3	1.8	0.8	2.2	9.8	1.6	0.8	1.4	2.2	1.5	12.9	8.2	1.5	2.6	51.3	50.0	9.9	41.3	50.2	39.9	48.2	36.8	28.9	50.0	6.0	9.1	9.0	15.2	46.9	4.4	9.9	7.6	5.3	4.5	17.4	5.9	1.5	0.0	16.3	2.3	10.3	12.9	0.0	17.8	4.7	23.4	14.4	2.3	19.8	60.5	4.8	10.3	20.9	61.7	6.1	10.0	44.0	42.2	22.6	10.8	5.5	15.6	11.6	13.8	11.2	4.7	0.0	16.9	7.5	4.7	50.1	2.3	10.7	10.2	23.7
KIAA1024		ENSG00000169330	KIAA1024	Q9UPX6	15	79432516-79472290	"Predicted membrane proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 16.8;brain: 10.8"	"Group enriched"	"Detected in some"	12	"Horizontal cells: 15.9;Muller glia cells: 22.6"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"cerebellum: 10.8;pons and medulla: 8.5"	"Group enriched"	"Detected in some"	12	"eosinophil: 2.5;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	12	"granulocytes: 2.5;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011545	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA011545: AB_1852361"	"unprognostic (5.45e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.82e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.66e-13)"	"unprognostic (7.08e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	0.1	16.8	0.8	0.2	0.6	0.7	0.5	10.8	2.0	0.6	0.2	0.4	0.1	0.0	0.4	0.5	0.5	0.1	0.6	0.1	0.5	1.4	0.2	0.1	0.1	0.6	1.2	1.5	0.2	3.5	0.0	0.7	0.5	8.5	1.2	0.3	0.7	4.2	0.2	0.6	0.2	0.2	0.2	1.7	0.3	0.2	1.1	1.0	0.1	0.2	0.1	0.4	0.2	0.1	0.1	0.1	2.5	1.9	0.0	0.1	0.0	0.4	0.3	0.6	0.8	1.8	1.7	0.7	0.9	1.5	0.7	0.8	0.0	0.4	1.1	0.2	1.3	1.0	0.3	1.5	0.1	0.5	1.3	1.7	3.0	0.7	0.0	1.0	4.1	1.5	0.7	0.3	1.2	0.2	1.5	0.8	1.4	0.2	0.0	0.3	0.0	0.6	1.5	0.7	0.7	0.7	0.6	0.2	0.6	0.2	0.0	3.1	1.6	0.3	2.7	1.6	1.3	0.4	2.0	0.5	14.5	0.5	0.0	3.0	1.8	2.1	0.5	1.4	2.3	1.7	0.0	0.0	2.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.8	0.6	10.8	2.0	0.5	1.4	1.2	1.5	8.5	1.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.3	1.5	0.0	0.0	0.0	0.4	0.1	0.3	0.3	0.0	0.0	0.1	15.9	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	22.6	0.3	0.6	0.0	0.0	0.5	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.1
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152333-122362758	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	18.4	17.1	25.6	18.0	34.1	42.9	26.1	33.4	34.2	22.9	18.7	24.1	17.9	15.6	20.9	25.4	12.3	16.8	16.4	15.3	25.5	22.0	24.0	17.4	19.5	14.8	26.4	26.2	34.3	16.6	68.2	33.1	14.3	33.6	19.1	18.8	22.6	16.6	21.5	40.1	23.1	20.8	18.6	29.3	20.0	15.2	20.4	24.2	15.3	25.4	12.6	13.6	18.0	18.5	3.1	2.3	7.7	3.6	1.7	3.5	0.7	16.4	5.4	12.5	8.3	21.0	27.3	6.5	7.5	14.1	7.7	8.5	4.0	8.7	8.7	4.4	17.6	10.4	6.2	7.7	9.2	12.6	6.5	4.9	9.5	9.8	7.4	10.9	8.9	5.3	15.7	11.1	9.2	12.8	21.1	16.4	9.4	6.2	10.5	15.8	5.5	7.7	7.0	4.2	7.9	5.9	4.4	17.5	2.2	13.6	12.4	7.4	6.6	4.7	5.4	10.5	21.2	5.9	7.3	21.9	9.6	9.6	7.9	7.6	10.2	6.5	6.3	10.2	7.9	7.0	3.3	1.4	7.7	3.3	3.6	3.5	2.5	2.3	2.3	1.4	3.1	2.0	2.3	6.6	1.7	1.7	2.3	2.9	0.7	25.6	34.1	33.4	34.2	25.5	22.0	26.4	26.2	33.6	24.2	80.4	33.9	13.7	17.7	18.5	114.9	62.7	7.6	37.5	44.3	40.1	117.8	8.9	1.7	11.4	26.6	33.8	40.9	23.3	15.1	5.7	21.1	21.2	20.8	21.5	11.1	87.4	20.7	36.2	31.0	20.3	47.5	20.1	15.1	17.2	25.2	59.6	17.8	25.9	47.7	10.5	143.8	32.3	29.9	49.5	31.9	21.3	10.9	32.4	23.9	23.0
KIAA1147	LCHN	ENSG00000257093	KIAA1147	A4D1U4	7	141656728-141702153	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 84.4;Muller glia cells: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029467, HPA061437"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA029467: AB_10602915, HPA061437: AB_2684517"	"unprognostic (1.27e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (6.24e-4)"	"unprognostic (6.49e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.78e-1)"	7.6	6.7	18.6	12.5	23.1	5.9	14.1	18.0	23.2	8.1	12.4	24.8	7.1	10.8	8.9	9.9	11.1	9.9	7.5	6.2	20.1	13.2	17.9	13.9	14.1	15.7	28.9	14.0	7.4	16.1	18.8	10.8	5.0	19.6	11.4	17.5	10.1	17.4	10.7	5.0	9.4	13.3	8.3	17.9	20.7	24.1	2.3	28.2	11.6	16.6	4.6	16.2	9.2	9.6	1.6	0.7	5.5	0.4	2.0	1.8	0.5	3.9	3.8	7.3	6.3	2.4	1.1	1.6	1.7	2.1	2.0	2.5	8.2	5.8	0.5	11.8	1.5	3.9	3.0	5.5	3.5	3.7	10.8	5.7	2.1	3.3	1.8	0.9	6.6	2.2	0.8	3.6	1.1	1.4	4.8	7.5	4.3	0.4	1.5	1.0	3.1	4.9	5.4	7.9	12.7	3.2	5.0	1.0	7.9	3.0	6.5	11.5	4.9	3.8	10.4	1.4	3.9	5.0	1.2	13.7	1.0	2.7	2.7	13.6	11.1	2.6	5.9	4.9	9.9	2.8	5.5	0.2	0.0	1.1	0.4	1.5	1.4	1.4	1.0	0.2	1.6	1.5	1.8	0.0	2.0	0.1	0.7	1.0	0.5	18.6	23.1	18.0	20.2	20.1	13.2	28.9	14.0	19.6	28.2	11.9	14.6	23.1	6.7	6.9	26.4	3.5	5.1	16.0	17.0	7.0	84.4	0.2	1.7	6.8	0.6	13.3	5.7	0.0	19.7	0.3	3.6	16.5	11.5	14.5	6.8	7.9	17.9	16.5	25.7	0.0	6.9	8.8	3.3	3.6	31.9	106.6	10.2	7.0	8.9	11.3	7.4	6.5	6.0	0.6	0.5	8.5	0.2	11.7	16.3	10.1
KIAA1191	"FLJ21022, p33MONOX, p60MONOX"	ENSG00000122203	KIAA1191	Q96A73	5	176346061-176361968	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Proximal tubular cells: 207.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044701, HPA048145"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044701: AB_2679053, HPA048145: AB_2680283"	"unprognostic (7.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.39e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (5.02e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.73e-2)"	16.7	22.0	31.3	11.0	35.5	12.0	19.6	32.4	43.0	22.5	20.6	21.2	19.2	20.8	22.3	24.1	26.6	29.5	17.8	34.3	25.9	28.1	84.1	29.3	20.4	10.9	24.6	28.8	41.6	25.1	24.0	22.9	16.1	30.5	24.5	20.0	24.0	29.3	29.1	29.1	17.8	23.1	24.0	18.9	14.0	25.5	7.5	18.6	10.8	28.5	14.0	17.5	26.4	18.4	17.9	16.1	22.3	19.7	19.1	27.7	19.1	17.1	16.7	30.8	40.1	27.3	20.5	23.6	24.9	24.0	27.7	30.2	33.1	17.4	6.5	33.2	29.7	41.3	15.1	18.8	43.9	33.1	34.5	20.7	7.6	11.7	17.4	31.2	6.7	13.9	20.2	31.3	24.4	20.8	31.3	33.7	10.8	11.5	14.8	29.9	21.9	9.6	4.0	13.3	17.5	21.8	7.2	19.4	5.6	25.9	16.9	23.8	25.7	26.6	13.0	29.5	28.0	18.8	7.1	31.6	25.5	11.7	18.1	29.7	9.6	13.0	7.8	20.4	12.8	19.7	20.1	16.7	22.3	21.8	19.7	24.2	17.9	20.8	20.9	16.1	14.6	22.1	23.1	8.0	19.1	19.0	13.2	27.7	19.1	31.3	35.5	32.4	43.0	25.9	28.1	24.6	28.8	30.5	18.6	50.6	37.1	20.7	37.8	30.2	29.8	54.8	30.6	33.5	39.8	31.4	23.6	18.8	79.6	31.8	1.9	28.9	32.5	0.0	23.9	12.1	24.7	29.2	17.3	41.4	13.8	46.1	41.5	22.1	19.1	5.9	28.7	20.9	20.3	36.1	28.0	25.8	29.8	33.7	36.0	207.7	29.3	12.9	29.2	7.5	6.4	27.7	27.9	17.5	27.1	40.6
KIAA1210		ENSG00000250423	KIAA1210	Q9ULL0	X	119078635-119150579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 24.6;seminal vesicle: 12.3;testis: 19.8"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 2.6;Late spermatids: 7.0;Leydig cells: 3.4;Peritubular cells: 5.6"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.3"					"Group enriched"	"Detected in some"	5	"basophil: 2.0;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	8	"Daudi: 2.2;MCF7: 4.2;SK-BR-3: 2.3;U-2 OS: 2.6"									"HPA000551, HPA048322"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA000551: AB_1079165, HPA048322: AB_2680358"	"unprognostic (2.48e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.26e-4)"	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.7	24.6	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		2.7	0.0		0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8			0.0		0.0	0.1	0.0	0.2	0.2	2.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	2.3	0.2	0.3	0.1	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.2	0.3	0.1	0.2	0.0	0.0											0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.4	1.1	0.0	0.2	0.0	0.0	0.0
KIAA1211		ENSG00000109265	KIAA1211	Q6ZU35	4	56049073-56328625	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.9;testis: 27.0"	"Group enriched"	"Detected in some"	15	"Early spermatids: 102.6;Late spermatids: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 16.0;SH-SY5Y: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043249, HPA048148"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA043249: AB_2678388, HPA048148: AB_2680286"	"unprognostic (1.65e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.04e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.05e-6)"	"unprognostic (1.02e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.93e-1)"	1.0	2.1	4.5	4.2	3.7	3.0	0.8	4.2	6.8	2.3	12.6	3.3	3.2	11.8	3.7	3.9	1.0	2.7	14.4	1.6	5.7	7.0	1.6	1.0	1.4	1.8	5.3	3.0	2.2	1.6	7.6	1.9	2.3	13.4	1.6	7.2	4.7	0.9	5.5	0.7	0.9	39.9	4.0	4.8	2.1	2.4	27.0	1.5	0.2	0.8	0.0	1.6	1.5	2.2	1.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	1.7	6.7	0.5	0.2	0.0	2.4	0.0	0.2	0.3	0.7	1.9	0.2	5.9	0.1	0.0	5.4	0.0	5.6	0.1	0.2	0.5	3.3	3.2	3.0	0.3	0.9	2.7	0.5	0.3	0.1	0.0	0.1	2.2	3.1	5.3	0.0	5.8	0.0	0.8	4.0	0.2	3.6	5.0	4.3	3.9	3.7	0.1	0.0	1.5	16.0	34.2	0.6	0.2	4.1	5.9	1.4	0.3	1.2	0.1	1.7	0.4	1.5	5.8	3.9	0.0	1.7	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	3.7	4.2	6.8	5.7	7.0	5.3	3.0	13.4	1.5	0.0	0.0	0.0	0.0	0.1	2.3	2.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	102.6	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.4	4.7	0.6	0.0	87.5	0.6	0.0	0.0	0.0	0.7	2.7	1.8	0.9	0.4	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.1	0.0	1.1	0.0
KIAA1211L	"C2orf55, MGC42367"	ENSG00000196872	"KIAA1211 like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;epididymis: 27.7"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 95.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 22.3;HDLM-2: 32.0;Karpas-707: 9.4;MCF7: 8.5;SiHa: 9.1;SK-BR-3: 12.2"					"Group enriched"	"Detected in many"	15	"amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"		Yes	No			"Microtubules, Centrosome"	"Cytokinetic bridge"	"HPA051082: AB_2681337, HPA061678: AB_2684584"	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (2.22e-2)"	2.7	0.8	19.0	1.3	23.7	0.5	3.5	2.4	27.4	4.6	5.0	0.8	3.5	6.7	1.5	27.7	9.1	19.3	2.5	1.4	12.9	1.9	2.5	0.4	3.9	0.6	2.7	18.3	1.4	3.7	9.6	4.3	4.0	0.1	1.6	4.0	0.0	9.0	4.3	1.3	4.3	6.1	2.1	1.2	1.0	6.8	3.6	3.6	0.0	4.3	3.3	2.5	2.4	3.2	0.0	0.7	1.4	0.3	0.2	0.9	0.0	4.3	0.2	0.1	1.7	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.2	2.6	0.0	5.7	0.0	0.1	3.9	0.1	0.2	0.0	32.0	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.6	0.0	1.3	0.0	0.0	9.4	0.0	8.5	0.1	0.6	0.0	4.3	0.4	0.0	0.0	0.4	1.7	3.4	3.2	0.5	9.1	12.2	0.0	0.0	4.7	0.7	5.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.7	0.0	0.0	19.0	23.7	2.4	27.4	12.9	1.9	2.7	18.3	0.1	3.6	14.9	2.9	0.0	3.1	0.6	0.0	4.2	5.1	95.0	23.9	3.5	0.0	0.3	3.3	3.7	11.8	9.0	10.0	0.0	6.5	1.1	0.2	1.7	0.0	0.0	2.6	0.0	15.1	6.7	1.5	17.2	0.3	0.9	0.0	0.0	11.4	0.0	4.8	8.6	0.4	2.2	0.0	0.0	0.4	15.9	12.6	5.3	0.3	0.0	8.8	5.1
KIAA1217	"DKFZP761L0424, ETL4, SKT"	ENSG00000120549	KIAA1217	Q5T5P2	10	23694746-24547848	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 91.1"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 107.7;Club cells: 95.5;Muller glia cells: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 34.0;Karpas-707: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004941	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA004941: AB_2130659"	"unprognostic (3.60e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-1)"	24.9	12.7	3.3	6.6	8.7	0.0	21.6	5.5	16.2	10.2	15.1	2.7	18.0	7.5	7.2	16.5	22.6	10.4	11.9	8.6	5.1	3.7	13.5	10.4	8.6	1.4	4.3	8.1	8.4	10.1	34.1	5.5	12.2	8.8	15.1	8.9	16.9	28.8	26.6	91.1	12.0	13.7	4.1	3.8	5.7	10.1	16.8	1.8	3.3	20.5	20.4	8.8	10.1	13.0	0.0	0.0	0.0	0.0	0.9	2.8	0.0	7.6	3.9	1.5	0.0	1.0	2.8	34.0	1.5	2.4	3.5	7.6	6.6	12.3	0.4	7.7	3.0	7.2	12.8	1.9	14.5	3.9	2.8	1.4	0.1	8.9	7.7	1.7	0.0	0.1	10.7	9.4	7.8	2.1	1.6	0.0	0.7	0.0	30.9	1.8	2.7	4.2	0.2	3.5	7.5	3.5	0.3	9.1	6.3	8.3	10.1	1.0	0.5	3.8	12.9	0.0	16.6	6.2	0.0	8.1	5.4	5.9	21.7	1.9	13.8	11.6	0.0	18.1	0.2	0.2	0.0	0.0	0.0	0.5	0.0	2.8	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.3	8.7	5.5	16.2	5.1	3.7	4.3	8.1	8.8	1.8	35.7	24.2	0.8	63.7	107.7	12.4	33.1	17.8	32.1	95.5	31.4	7.9	43.5	3.3	26.0	24.9	10.8	21.2	0.0	23.1	16.7	14.6	36.0	1.1	21.2	4.6	0.0	23.0	25.8	10.5	7.0	16.4	2.7	1.7	0.0	21.3	121.7	20.1	22.0	31.1	4.5	2.7	12.9	19.6	0.5	0.7	44.5	54.5	0.7	16.6	47.2
KIAA1324L	"EIG121L, FLJ31340"	ENSG00000164659	"KIAA1324 like"	A8MWY0	7	86876906-87059699	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 73.9;Early spermatids: 53.7;Horizontal cells: 31.8;Late spermatids: 70.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.7;NK-cells: 4.8;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;hTERT-HME1: 17.9;HUVEC TERT2: 15.0;K-562: 23.0;SCLC-21H: 19.1;SuSa: 17.5;TIME: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044527, HPA076093"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044527: AB_10963793, HPA076093: AB_2686776"	"unprognostic (2.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.37e-1)"	11.1	4.5	7.7	2.3	17.3	1.0	6.5	15.6	15.8	4.0	5.0	28.9	1.2	1.8	4.3	1.0	4.5	3.9	5.0	5.5	10.8	8.7	2.9	1.5	24.4	3.8	22.4	10.4	2.7	5.5	11.7	13.5	9.0	22.7	7.6	6.5	2.4	3.6	6.3	3.5	3.4	2.7	6.4	23.5	6.4	4.1	3.6	21.7	0.0	6.1	1.0	4.0	5.9	2.8	2.7	0.9	0.4	0.0	4.8	5.8	0.7	0.9	0.0	15.4	0.0	0.2	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	3.8	0.3	0.1	0.0	1.6	0.0	0.0	3.7	0.3	11.8	4.1	1.3	0.1	0.1	1.5	1.2	0.0	0.0	17.9	0.1	15.0	5.8	23.0	0.4	1.7	4.7	0.3	0.0	8.4	0.0	3.8	0.0	1.0	2.4	1.6	6.8	19.1	14.3	4.1	5.4	1.7	17.5	1.6	0.3	17.6	0.2	6.0	0.1	0.0	8.5	5.0	0.1	4.5	0.0	0.2	0.0	0.0	0.4	0.7	0.0	5.8	0.9	2.1	1.3	0.4	2.7	2.2	1.2	0.0	4.8	0.0	0.9	0.7	0.7	7.7	17.3	15.6	15.8	10.8	8.7	22.4	10.4	22.7	21.7	11.9	73.9	0.0	1.4	1.0	11.6	2.0	0.0	6.7	3.4	3.5	9.8	0.4	3.3	1.3	53.7	10.0	1.7	0.0	1.0	0.4	3.1	3.6	2.3	0.0	0.3	31.8	8.1	0.6	0.8	70.4	2.3	1.6	0.0	0.0	2.7	1.1	1.0	1.9	2.1	0.7	3.2	6.5	6.2	0.7	2.1	1.4	0.1	0.7	2.6	1.4
KIAA1328		ENSG00000150477	KIAA1328	Q86T90	18	36829106-37232172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 214.4;Alveolar cells type 2: 181.7;Ciliated cells: 219.5;Club cells: 190.0;granulocytes: 99.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040946	Approved		Approved	"Nuclear speckles,Vesicles,Lipid droplets"		NA	NA			"Nuclear speckles"	"Vesicles, Lipid droplets"	"HPA040946: AB_10794998"	"unprognostic (3.66e-2)"	"unprognostic (5.37e-4)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.64e-3)"	11.1	8.1	14.0	10.7	14.3	23.1	11.1	27.4	13.0	13.7	7.5	13.0	6.1	9.2	12.6	11.1	7.9	9.4	8.3	9.8	10.7	8.5	9.2	7.7	10.4	8.5	12.3	9.0	18.3	6.9	9.0	18.6	9.7	10.3	11.1	7.4	10.9	10.9	9.5	11.4	15.7	9.7	15.8	13.2	8.9	10.7	19.6	14.4	5.4	11.1	9.7	11.5	10.1	11.0	12.7	5.7	17.1	7.4	7.5	10.4	3.6	14.8	4.5	6.6	8.1	2.3	3.2	6.4	5.7	2.2	2.6	1.9	7.8	9.8	9.6	21.5	2.2	4.9	6.6	2.6	2.7	3.5	7.5	2.7	12.6	12.1	4.9	1.8	8.0	6.1	3.3	3.1	3.1	2.8	3.3	2.4	6.1	10.0	24.1	2.7	14.5	5.6	6.0	15.1	5.6	7.8	8.0	6.9	7.1	2.6	15.0	7.2	8.3	7.7	9.4	3.8	13.7	15.1	4.6	8.1	13.2	19.3	7.6	6.8	19.1	24.4	7.7	6.7	5.7	8.7	17.1	6.8	9.2	9.0	4.8	10.4	7.5	8.0	7.4	3.1	12.7	10.1	8.4	15.1	7.5	7.4	5.7	8.9	3.6	14.0	14.3	27.4	13.0	10.7	8.5	12.3	9.0	10.3	14.4	214.4	181.7	8.3	6.8	5.0	31.7	5.3	0.0	219.5	190.0	5.2	19.6	7.1	5.0	5.9	34.1	8.4	1.7	0.0	5.1	6.8	8.8	3.8	99.9	2.4	5.4	15.9	2.9	7.4	3.5	10.2	8.6	7.0	6.8	3.6	2.5	14.1	5.1	3.5	7.4	3.6	32.2	0.0	8.3	36.1	19.6	6.0	3.2	9.6	3.9	3.4
KIAA1468	"FLJ33841, HsT3308, HsT885"	ENSG00000134444	KIAA1468	Q9P260	18	62187255-62310217	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039708, HPA040038"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA039708: AB_10794753, HPA040038: AB_10793860"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.71e-2)"	11.7	13.3	14.8	15.7	31.6	18.3	17.8	25.7	25.9	14.3	16.5	14.3	16.6	13.8	13.9	18.3	36.5	11.8	13.9	10.3	12.5	14.4	14.8	11.5	11.8	15.8	13.7	16.0	12.8	12.6	20.2	20.0	11.9	22.8	18.5	21.7	13.5	18.8	14.1	11.8	29.6	15.5	11.1	11.4	17.1	18.0	8.0	16.8	18.3	14.4	16.6	22.0	15.5	21.7	3.7	3.5	6.0	3.5	4.0	4.7	1.9	7.7	7.1	8.7	8.3	9.3	11.0	9.3	14.0	11.7	12.6	14.0	3.7	7.3	5.4	7.3	12.3	8.3	16.3	12.4	8.4	15.5	4.9	7.7	4.5	8.0	8.3	8.3	8.6	6.3	8.0	10.3	10.7	6.6	10.4	8.6	5.2	3.4	5.5	13.2	4.5	5.3	7.4	5.1	5.3	6.1	6.6	11.0	6.3	14.4	15.7	12.4	6.6	8.4	12.4	7.2	11.8	6.4	9.4	10.9	13.5	4.2	5.9	6.9	16.1	3.0	5.3	9.5	9.3	10.7	5.0	3.5	4.1	4.1	3.0	3.3	3.0	3.8	3.9	3.5	3.7	4.1	4.7	6.0	4.0	2.5	2.4	4.4	1.9	14.8	31.6	25.7	25.9	12.5	14.4	13.7	16.0	22.8	16.8	14.9	16.3	7.5	6.2	7.6	23.5	8.1	5.1	8.1	14.8	0.0	9.8	5.5	0.0	5.8	0.4	8.3	12.9	23.3	7.4	3.4	5.4	9.4	7.0	7.8	6.3	20.6	12.1	7.4	15.3	0.0	6.9	14.5	10.1	7.2	16.0	5.2	7.1	5.8	7.4	5.0	13.9	6.5	4.7	9.9	4.9	18.7	5.5	9.5	14.3	9.7
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741885-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.4;hTCEpi: 32.0;RT4: 35.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	3.7	39.4	12.1	8.6	8.7	0.7	14.1	1.6	15.8	8.7	25.9	2.7	27.8	28.1	5.4	8.7	33.8	13.5	28.8	2.3	6.4	4.5	23.1	5.9	13.4	0.8	2.4	6.6	18.0	32.8	21.7	4.8	19.3	7.3	18.5	17.4	10.0	36.9	44.6	1.8	33.4	36.0	6.8	1.6	1.1	25.5	2.9	3.0	3.1	19.2	17.9	20.3	15.0	22.3	0.0	2.1	0.0	1.0	0.0	0.4	0.2	19.4	10.2	1.6	2.8	0.7	1.5	7.6	2.4	4.7	2.8	2.7	11.1	38.4	0.0	10.1	3.5	8.2	29.0	3.1	20.6	1.4	0.0	4.1	4.0	14.5	9.0	1.2	0.0	10.4	0.5	32.0	7.3	8.8	12.5	5.7	0.8	5.8	0.1	1.3	16.1	0.1	0.1	3.4	16.8	6.4	2.6	2.1	4.9	26.5	35.5	1.4	1.4	15.0	21.6	2.9	10.9	23.0	1.3	5.3	4.6	12.6	4.2	5.1	0.2	0.1	0.1	4.7	0.7	5.3	0.0	0.6	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	12.1	8.7	1.6	15.8	6.4	4.5	2.4	6.6	7.3	3.0	11.9	49.9	0.5	31.7	65.7	0.5	3.3	76.5	20.1	23.9	26.2	2.0	12.1	8.3	38.3	3.6	6.7	90.1	0.0	57.6	3.7	5.6	56.0	26.6	8.6	2.5	0.0	27.9	1.3	0.3	3.6	8.1	2.5	6.8	3.6	55.5	0.8	52.7	49.1	4.6	12.5	0.0	6.5	5.0	1.8	2.5	72.6	6.6	1.9	54.5	60.9
KIAA1549		ENSG00000122778	KIAA1549	Q9HCM3	7	138831381-138981318	"Disease related genes, Predicted membrane proteins"			"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 27.5;seminal vesicle: 39.0"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.2;neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.4;SH-SY5Y: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019560	Uncertain		Approved	"Nuclear membrane,Intermediate filaments"		NA	NA			"Nuclear membrane"	"Intermediate filaments"	"HPA019560: AB_1852418"	"unprognostic (7.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (8.30e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.28e-2)"	2.1	3.2	3.3	0.6	4.4	0.6	2.9	1.2	8.3	2.7	1.8	1.6	27.5	1.5	3.7	4.1	1.4	4.9	2.5	1.9	3.1	2.0	8.0	1.5	4.7	0.3	1.6	3.8	2.6	12.9	6.5	3.6	4.6	3.7	3.1	1.5	2.0	4.4	39.0	1.4	2.6	1.8	2.9	3.3	1.2	3.0	2.9	1.2	3.1	2.2	0.1	0.4	3.8	4.4	0.3	0.1	1.5	0.1	0.3	0.2	0.0	5.1	9.7	8.6	15.0	0.1	0.0	5.0	5.2	4.7	3.0	3.9	9.0	3.1	0.0	3.2	7.9	9.3	1.0	5.3	1.5	3.7	2.4	3.3	2.4	10.4	2.3	1.3	3.7	3.5	1.3	2.4	1.1	1.6	2.9	5.0	3.4	1.9	0.1	3.4	4.8	2.6	3.6	8.1	3.7	20.4	7.2	4.4	0.0	1.5	3.1	11.4	19.5	2.8	5.2	2.3	5.2	4.3	2.3	3.2	3.1	3.2	0.0	4.9	0.7	0.0	0.2	4.1	1.5	7.2	1.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.5	0.3	0.1	0.1	0.0	0.0	3.3	4.4	1.2	8.3	3.1	2.0	1.6	3.8	3.7	1.2	0.0	2.1	0.0	2.1	0.5	13.5	2.2	0.0	9.4	3.4	7.0	53.0	2.1	0.0	2.3	0.3	4.5	0.1	0.0	2.8	1.9	2.1	3.0	16.1	0.5	0.4	3.2	10.4	1.8	1.0	0.0	1.4	0.2	1.7	0.0	2.0	7.7	4.7	0.6	2.5	6.9	26.7	6.5	1.6	0.0	7.7	0.6	1.3	1.0	1.5	1.4
KIAA1549L	"C11orf41, C11orf69, G2, MGC34830"	ENSG00000110427	"KIAA1549 like"	Q6ZVL6	11	33376466-33674102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 30.4;parathyroid gland: 64.4"	"Cell type enriched"	"Detected in some"	4	"Melanocytes: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 23.0;U-138 MG: 30.4;WM-115: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010132, HPA051594"			Approved	Nucleoplasm,Vesicles		NA	NA		27000	Nucleoplasm	Vesicles	"HPA010132: AB_1078313, HPA051594: "	"unprognostic (3.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.34e-5)"	"unprognostic (2.63e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.59e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.09e-1)"	0.8	0.9	8.2	0.7	20.5	0.6	1.2	6.2	30.4	0.7	0.7	1.7	0.0	0.6	0.7	0.6	0.9	0.6	0.8	0.6	5.3	2.4	0.9	0.6	0.6	0.7	1.6	17.1	0.7	0.8	64.4	1.0	1.4	2.3	0.7	0.7	0.0	0.7	0.6	0.6	1.9	0.6	0.7	1.1	0.6	0.7	1.3	1.6	0.0	0.6	0.0	1.1	0.9	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	3.3	0.1	0.5	3.7	0.0	13.3	7.8	2.1	1.2	0.0	0.3	10.2	0.1	11.7	10.2	0.7	0.4	3.8	3.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.3	5.8	7.6	9.5	0.2	0.0	9.7	8.3	0.0	0.1	0.0	0.7	0.0	4.9	0.0	0.8	0.0	0.0	5.1	1.1	1.2	0.1	0.0	3.2	0.1	0.0	0.0	23.0	30.4	6.4	0.7	10.6	0.0	0.0	0.0	8.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.2	20.5	6.2	30.4	5.3	2.4	1.6	17.1	2.3	1.6	0.0	0.0	0.0	0.3	1.8	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.6	0.4	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.3	3.2	0.0	1.8	0.0	0.4	0.0	0.2	16.9	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.5
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Cell type enhanced"	"Detected in many"	7	"Urothelial cells: 190.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"	"Cell line enhanced"	"Detected in all"		"SuSa: 44.6"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.7	4.8	8.4	3.2	3.8	4.6	12.6	3.3	3.3	2.4	2.6	18.3	18.0	13.1	8.3	2.7	8.1	3.6	11.5	2.2	3.4	9.6	1.6	18.3	2.4	2.4	7.5	13.2	29.7	2.5	3.4	2.6	4.4	9.6	18.5	9.0	10.4	20.9	2.5	1.3	18.5	5.5	18.0	10.4	2.0	8.6	8.0	5.7	2.3	5.1	3.4	3.0	4.3	2.2	2.3	44.6	7.7	14.6	11.7	2.5	4.0	4.3	3.5	12.7	13.4	16.1	1.3	7.4	2.7	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9	32.8	30.1	76.8	35.9	16.7	12.1	16.6	12.7	10.7	22.7	7.0	9.8	10.5	0.0	11.8	4.8	41.3	43.3	0.0	10.4	2.2	15.8	43.7	43.9	40.9	27.9	17.5	8.6	25.8	50.9	5.2	23.9	40.7	10.1	26.2	12.5	8.5	24.6	14.0	22.3	6.7	15.8	77.6	22.7	5.2	36.4	30.5	4.2	83.0	13.0	190.4
KIAA1586		ENSG00000168116	KIAA1586	Q9HCI6	6	57046532-57055239	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036370	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA036370: AB_10672219"	"unprognostic (7.17e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.64e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.07e-1)"	7.2	8.7	11.9	5.7	19.7	11.7	9.0	33.8	15.7	9.1	6.8	2.9	6.5	3.6	10.4	6.5	5.7	6.1	7.8	6.0	10.4	8.7	6.1	8.0	5.9	6.9	10.9	9.3	13.3	5.4	9.8	19.7	15.3	12.4	9.1	4.5	2.6	5.0	6.5	4.1	4.3	5.3	7.5	8.4	7.4	4.7	12.5	10.4	6.2	9.6	3.6	6.4	9.0	6.6	5.5	6.3	3.1	4.2	8.2	7.1	3.2	4.9	2.1	13.1	14.9	5.3	8.6	7.3	8.3	6.9	7.3	8.7	3.4	1.6	1.9	6.9	6.1	6.4	2.5	10.0	4.9	10.0	6.2	7.6	20.6	4.8	7.8	6.9	16.5	7.7	6.2	3.6	6.4	7.1	5.2	6.8	5.4	28.3	1.6	8.5	3.9	7.9	10.1	8.5	1.7	3.1	7.3	9.6	4.7	4.8	10.3	11.1	10.3	5.4	1.8	6.2	9.4	4.3	15.0	5.5	11.2	4.7	10.7	5.9	6.6	8.7	9.7	6.9	12.2	4.5	0.3	4.2	3.1	3.9	3.0	4.3	5.5	5.7	4.9	5.9	4.4	7.1	6.0	0.3	8.2	2.8	6.3	6.5	3.2	11.9	19.7	33.8	15.7	10.4	8.7	10.9	9.3	12.4	10.4	8.9	4.6	9.0	4.2	9.3	14.8	20.8	2.5	12.0	7.9	7.0	2.0	36.3	10.0	5.7	45.2	7.1	0.7	0.0	4.7	25.6	16.5	1.6	12.7	3.9	10.7	9.5	5.2	8.0	7.3	18.2	11.8	5.6	3.3	7.2	2.3	8.9	3.2	0.0	13.8	12.4	7.8	19.4	10.3	18.1	18.9	3.9	8.9	7.4	3.3	1.6
KIAA1614		ENSG00000135835	KIAA1614	Q5VZ46	1	180913154-180951614	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 58.8;retina: 23.8"	"Group enriched"	"Detected in many"	17	"Bipolar cells: 91.9;Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 171.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.8"	"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 12.3;SH-SY5Y: 31.1"					"Low region specificity"	"Detected in all"			"HPA028227, HPA061684"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA028227: AB_10601765, HPA061684: AB_2684585"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.61e-5)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.35e-2)"	4.6	1.5	2.4	1.4	2.6	0.1	2.2	58.8	11.3	4.5	4.6	1.8	0.8	3.0	5.2	1.6	4.6	3.5	3.1	7.5	2.7	1.4	3.0	0.4	3.2	1.1	1.5	3.8	6.3	2.1	0.0	1.3	3.6	3.3	3.5	0.5	23.8	4.6	2.8	2.1	3.0	2.5	4.1	1.4	2.6	2.2	1.2	2.5	0.4	7.6	0.9	0.4	4.3	5.1	0.5	0.5	4.4	0.5	0.5	0.6	0.3	1.1	0.5	0.9	2.1	3.0	7.5	3.3	2.2	2.6	1.1	0.6	1.0	1.2	0.5	2.1	2.7	0.5	2.2	0.2	0.0	0.3	0.6	0.9	1.6	0.4	1.4	4.1	1.0	1.2	3.5	0.1	0.1	0.0	1.8	1.5	1.7	1.3	0.8	1.0	0.9	1.3	0.4	2.3	0.3	0.3	0.7	12.3	1.6	1.8	1.0	8.5	31.1	0.7	0.8	4.9	1.0	0.9	1.4	3.5	2.4	1.8	2.8	0.9	1.6	2.0	1.0	0.3	0.8	1.6	4.4	0.5	1.2	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.4	0.6	0.4	0.7	0.5	0.1	0.5	0.2	0.3	2.4	2.6	58.8	11.3	2.7	1.4	1.5	3.8	3.3	2.5	0.0	2.6	0.0	0.8	0.3	91.9	2.8	0.0	0.0	2.3	1.8	123.7	0.2	1.7	0.2	3.4	1.7	0.0	0.0	0.2	0.4	2.8	0.3	1.1	0.0	1.4	3.2	0.0	2.5	0.0	1.3	7.2	0.0	3.3	1.8	0.0	7.6	1.0	0.0	5.3	1.3	171.7	6.5	1.4	0.7	0.2	0.3	0.2	0.0	0.0	0.0
KIAA1671		ENSG00000197077	KIAA1671	Q9BY89	22	24952730-25197448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"OE19: 20.7"									HPA018135	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA018135: AB_1859551"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.68e-2)"	"prognostic favorable (3.19e-6)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.87e-2)"	9.8	13.3	9.1	12.3	18.4	0.9	20.6	4.5	14.1	10.3	14.5	8.0	13.7	13.1	11.8	12.2	23.2	18.9	24.4	10.0	10.6	7.7	10.7	30.9	14.8	4.8	6.3	10.2	9.1	14.4	11.0	12.1	4.0	9.6	12.7	13.4	17.0	24.1	21.3	33.4	23.9	21.5	11.7	10.8	3.5	11.3	4.6	5.4	8.0	24.6	18.8	11.2	9.6	16.1	0.5	0.3	0.6	0.2	1.2	5.0	0.7	12.9	8.2	1.7	3.1	0.1	0.0	1.4	0.1	0.0	0.7	0.0	6.6	4.8	0.0	6.3	0.6	3.7	15.8	13.6	13.3	0.5	0.1	5.7	0.0	8.9	8.7	1.8	0.0	0.1	0.3	12.1	4.2	13.3	9.0	15.4	0.2	0.1	0.0	1.8	6.0	0.0	0.1	2.8	20.7	4.4	0.5	14.3	2.6	8.8	5.4	4.3	3.6	10.7	7.5	0.7	6.1	4.1	0.1	10.3	0.7	15.0	8.9	2.3	0.0	0.2	0.0	5.5	0.0	2.2	0.3	0.2	0.1	5.0	0.1	0.7	0.2	1.5	3.5	0.1	0.5	0.7	2.2	0.6	1.2	0.1	0.3	0.2	0.7	9.1	18.4	4.5	14.1	10.6	7.7	6.3	10.2	9.6	5.4	11.9	21.6	2.7	20.4	9.6	4.2	8.1	20.4	18.7	14.8	5.2	21.6	0.1	0.0	18.4	2.0	28.7	33.9	0.0	16.6	0.0	3.5	18.2	1.1	41.8	1.8	15.9	6.9	25.8	1.8	2.6	6.6	3.3	10.1	1.0	10.6	20.0	17.4	31.7	8.5	10.2	16.6	0.0	11.3	5.8	7.1	12.7	0.8	6.1	13.7	22.0
KIAA1755	RP5-1054A22.3	ENSG00000149633	KIAA1755	Q5JYT7	20	38210488-38260772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2"	"Cell type enhanced"	"Detected in some"	16	"Leydig cells: 3.4;Peritubular cells: 7.1;Proximal tubular cells: 2.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 40.9;ASC diff: 6.2;ASC TERT1: 9.4;WM-115: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051064	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			Nucleoli	"Golgi apparatus, Vesicles"	"HPA051064: AB_2681331"	"unprognostic (3.98e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-8)"	"unprognostic (1.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.53e-3)"	6.1	2.5	13.6	5.8	27.3	0.7	3.8	4.8	22.1	13.2	8.1	47.2	3.1	2.7	15.5	7.2	5.6	10.0	16.9	11.5	13.9	8.4	4.6	1.7	2.7	4.9	22.7	13.7	14.7	1.5	0.3	3.1	0.4	24.5	7.3	4.7	8.8	6.1	8.2	1.3	1.6	4.5	15.8	20.4	2.8	4.1	2.9	29.2	0.0	2.6	1.6	4.9	6.8	5.4	0.3	0.5	0.9	0.4	0.4	0.7	0.0	1.5	0.2	40.9	0.0	6.2	9.4	0.0	4.0	2.3	0.0	0.0	0.2	1.2	0.0	0.2	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	1.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.6	0.2	0.7	0.0	0.0	0.0	0.1	0.0	10.3	0.9	0.4	0.1	0.7	0.2	0.5	0.1	0.5	0.6	0.1	0.3	0.4	0.4	0.7	0.4	0.1	0.5	0.0	0.0	13.6	27.3	4.8	15.7	13.9	8.4	22.7	13.7	24.5	29.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.0	1.3	3.4	0.0	1.7	0.0	0.0	0.0	0.3	0.0	7.1	2.9	0.0	0.0	0.9	0.4	0.2	0.3	0.0	0.0	0.0	0.0
KIAA1841		ENSG00000162929	KIAA1841	Q6NSI8	2	61065871-61138034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 69.6;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051240	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051240: AB_2681401"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.71e-8)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.85e-6)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	5.1	3.6	9.8	3.9	8.9	2.3	4.3	13.3	12.4	10.0	7.1	7.0	1.0	5.5	4.4	6.8	3.8	7.5	3.6	5.2	9.6	11.6	2.6	2.3	8.0	3.2	8.8	12.1	2.4	3.6	3.9	8.2	3.5	20.6	9.6	8.3	3.6	3.6	3.1	3.7	8.5	5.9	5.4	10.1	3.3	5.6	7.5	6.2	3.3	4.0	2.7	3.5	4.3	3.7	1.5	1.2	4.8	2.5	1.4	3.7	0.6	4.6	9.0	11.8	5.1	6.8	7.7	3.7	8.9	2.2	4.6	4.3	2.7	3.0	1.9	2.4	6.8	9.5	5.9	7.5	3.0	6.5	8.1	1.8	1.7	6.2	7.5	3.7	2.1	1.7	3.6	4.9	8.3	2.9	5.3	6.4	2.7	1.7	1.5	12.8	0.4	1.8	1.4	3.7	5.4	1.8	6.0	9.7	0.4	5.8	9.5	7.0	4.4	10.7	2.4	3.2	9.2	1.8	2.5	8.4	7.5	2.8	6.0	6.0	0.8	2.4	2.8	5.4	1.5	5.1	0.8	1.4	4.8	1.3	1.5	1.2	1.5	1.2	0.6	1.2	0.6	0.2	1.0	3.0	1.4	2.5	0.8	3.7	0.6	9.8	8.9	13.3	12.4	9.6	11.6	8.8	12.1	20.6	6.2	6.0	4.3	0.0	2.9	2.3	12.4	6.5	2.5	69.6	15.9	3.5	53.0	0.9	0.0	3.1	2.4	3.8	5.1	0.0	5.4	2.2	6.6	4.4	1.1	1.0	5.0	7.9	7.5	5.5	4.0	1.7	3.4	4.2	3.3	9.0	4.3	4.8	7.6	7.0	1.8	0.5	45.8	0.0	3.6	10.4	19.2	2.9	0.3	2.2	4.5	2.6
KIAA1958	FLJ39294	ENSG00000165185	KIAA1958	Q8N8K9	9	112486847-112669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020625	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA020625: AB_1852451"	"unprognostic (3.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.58e-1)"	2.6	14.7	8.6	2.8	14.4	8.7	6.3	21.2	11.7	10.4	3.0	10.8	5.6	3.7	7.0	3.1	3.6	6.3	3.1	2.8	7.8	5.2	11.7	6.9	7.8	2.9	14.0	6.2	19.9	10.8	4.1	8.0	1.9	11.3	3.5	3.4	5.5	5.5	8.0	2.7	4.0	3.9	6.5	10.6	3.2	8.8	11.0	16.5	4.7	5.0	0.4	2.9	3.8	4.8	2.1	2.4	2.6	2.8	2.4	2.7	1.5	2.9	4.2	17.3	5.0	1.2	0.3	8.3	2.2	0.7	2.7	3.0	7.7	2.0	9.5	2.6	7.2	1.8	2.6	12.7	1.2	3.8	2.9	5.1	3.7	5.7	5.4	0.7	5.6	4.7	0.5	1.0	3.5	1.7	2.4	2.1	9.0	8.6	2.4	0.8	3.4	8.7	3.2	9.5	6.9	2.0	7.1	9.9	2.7	3.6	4.1	8.9	9.4	3.7	3.9	2.2	10.0	3.5	5.7	0.4	0.9	5.2	0.6	2.7	4.5	8.1	5.7	1.2	3.9	0.7	1.4	2.8	0.2	2.1	0.9	0.9	0.3	0.8	1.6	0.9	2.1	2.0	2.7	2.6	2.4	0.8	2.4	0.4	1.5	8.6	14.4	21.2	11.7	7.8	5.2	14.0	6.2	11.3	16.5	3.0	13.4	0.0	3.6	4.1	19.3	3.6	2.5	2.7	9.1	1.8	13.7	1.0	6.6	2.5	3.4	0.8	3.6	0.0	5.9	0.9	1.7	5.6	0.0	6.8	0.8	6.4	4.6	0.6	3.5	1.5	6.1	4.1	1.7	0.0	4.4	11.6	3.3	4.3	4.9	9.8	11.0	6.5	2.1	1.1	4.7	4.1	0.7	1.0	5.2	3.5
KIAA2013	"MGC33867, RP5-1077B9.1"	ENSG00000116685	KIAA2013	Q8IYS2	1	11919591-11926428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052677, HPA060536"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA052677: AB_2681911, HPA060536: AB_2684313"	"unprognostic (3.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.51e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.74e-3)"	13.8	13.9	12.0	10.6	16.7	10.9	12.9	11.9	18.7	13.7	32.0	25.2	16.7	42.6	19.1	24.9	15.4	14.7	19.7	18.9	12.5	10.8	17.1	34.4	12.4	12.6	22.8	10.6	12.2	34.0	9.6	17.7	24.6	16.1	15.1	13.5	14.8	26.2	18.6	24.4	18.6	55.1	14.4	16.0	19.2	16.0	21.7	19.0	15.0	19.8	11.2	14.1	17.4	13.1	7.0	10.8	13.8	6.3	4.6	6.3	3.0	23.7	17.7	8.3	16.4	14.2	9.8	13.8	15.2	16.1	18.5	19.2	21.8	24.8	15.7	23.4	14.4	14.4	27.8	11.2	15.0	9.9	18.0	28.8	10.7	16.4	37.2	16.1	22.2	22.2	12.4	16.8	18.0	8.0	20.1	17.6	12.6	16.4	20.9	11.0	18.0	14.1	31.3	10.9	10.6	24.5	18.1	15.3	37.8	11.7	6.5	31.2	17.6	12.3	13.8	29.0	8.7	11.6	20.8	16.8	15.6	20.5	22.9	20.6	25.3	17.8	17.8	18.6	36.2	16.5	4.2	6.3	6.1	6.2	5.3	4.9	6.1	3.4	4.7	4.3	7.0	3.4	4.5	13.8	4.6	4.2	10.8	6.3	3.0	12.0	16.7	11.9	18.7	12.5	10.8	22.8	10.6	16.1	19.0	20.8	11.2	32.1	8.7	19.7	20.2	16.9	25.5	13.4	9.1	24.4	11.8	15.2	3.3	14.9	19.3	18.7	101.7	23.3	16.5	23.6	14.4	15.6	12.7	63.7	23.1	30.2	39.3	30.1	29.1	27.2	21.0	21.6	18.6	9.0	52.1	20.8	20.2	63.3	21.5	21.4	21.4	19.4	12.0	21.8	10.0	24.6	11.1	17.8	48.7	16.6
KIAA2026	FLJ20375	ENSG00000183354	KIAA2026	Q5HYC2	9	5881596-6007901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 22.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002109	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Vesicles, Cytosol"	Nucleoplasm	"HPA002109: AB_1078071"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.41e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (8.34e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	7.0	6.3	10.3	13.7	11.1	6.6	6.7	21.4	12.4	10.2	7.5	8.6	5.7	5.5	9.7	7.0	7.2	6.7	7.4	6.2	11.7	9.0	7.5	5.4	6.4	7.0	16.7	7.1	13.0	6.0	13.9	14.5	8.1	9.9	8.0	5.9	5.9	12.8	15.6	15.3	9.4	6.7	7.7	11.2	9.1	7.8	13.3	12.9	11.0	10.3	3.7	7.5	8.0	17.8	7.0	4.1	9.4	5.9	7.0	7.5	1.2	5.9	2.9	6.0	3.9	4.6	7.4	2.9	4.1	5.7	3.7	3.5	1.9	3.3	7.5	1.5	4.9	4.6	3.0	3.5	3.1	5.6	17.2	2.9	22.4	6.5	2.9	3.6	7.9	10.4	4.5	4.2	3.2	5.4	7.0	5.8	4.7	2.4	13.4	4.7	1.7	4.2	13.6	3.4	3.3	2.5	4.7	3.9	3.8	4.0	3.8	8.3	4.9	3.8	3.3	3.1	4.3	3.4	10.1	6.8	7.1	4.3	3.6	4.4	10.4	8.2	7.5	3.6	3.7	2.0	5.2	3.4	9.4	6.4	2.6	7.3	7.0	6.2	5.7	1.3	6.1	6.8	7.5	8.8	7.0	5.9	4.1	3.6	1.2	10.3	11.1	21.4	12.4	11.7	9.0	16.7	7.1	9.9	12.9	41.7	31.3	33.5	27.5	39.6	86.1	47.2	25.5	16.0	17.0	36.6	74.6	12.9	6.6	15.8	25.2	35.7	26.7	23.3	11.7	8.8	23.6	29.1	18.6	14.5	14.8	42.9	37.0	29.4	26.4	11.5	65.3	26.1	21.9	29.7	28.8	49.5	15.0	30.8	71.8	8.6	74.2	45.3	32.0	129.1	110.7	45.8	25.1	37.4	25.6	35.9
KIDINS220	ARMS	ENSG00000134313	"Kinase D interacting substrate 220"	Q9ULH0	2	8721081-8837630	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis		"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014790	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA014790: AB_1852460"	"unprognostic (3.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (1.68e-1)"	"unprognostic (9.21e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (9.29e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-1)"	16.5	16.4	21.6	9.4	26.9	14.7	14.7	35.3	30.3	16.9	17.2	21.9	7.2	7.8	23.2	11.2	13.0	15.7	12.3	14.7	16.6	8.1	16.0	10.7	16.1	8.2	25.6	15.9	27.5	12.8	45.8	20.2	14.5	25.5	14.5	11.7	11.1	14.8	13.3	17.4	12.7	11.6	17.5	30.3	11.1	14.0	7.1	24.3	11.2	14.9	6.3	8.3	19.6	16.7	3.6	5.1	10.0	8.1	5.7	7.2	3.7	7.1	11.6	23.2	14.8	29.3	19.4	12.2	14.3	11.8	9.1	8.5	11.5	7.4	13.5	14.6	21.3	17.6	12.3	20.8	8.8	13.5	19.3	14.1	12.0	9.0	12.1	20.7	12.4	16.7	20.1	13.9	14.5	19.0	14.1	14.2	11.8	23.4	16.9	16.1	7.9	12.6	6.7	12.6	11.9	10.3	12.1	17.1	6.7	12.1	13.8	19.7	33.2	11.3	11.4	12.8	12.7	7.3	14.3	18.7	20.3	10.7	20.2	15.3	12.5	10.9	18.3	11.8	16.8	15.4	7.4	6.2	7.5	7.2	7.4	5.4	3.6	5.3	6.0	5.1	3.6	5.5	6.1	10.0	5.7	8.1	3.4	4.3	3.7	21.6	26.9	35.3	30.3	16.6	8.1	25.6	15.9	25.5	24.3	92.3	90.8	17.1	22.8	29.1	86.9	34.8	17.8	34.8	60.3	27.9	131.6	14.0	0.0	28.3	1.0	42.5	22.2	46.7	20.3	8.6	44.1	27.7	33.6	26.8	24.5	146.2	41.6	47.9	43.5	3.9	64.5	42.8	23.6	19.0	21.7	76.6	23.5	27.7	61.5	10.9	56.2	6.5	32.3	23.7	25.5	25.7	9.2	27.4	21.8	32.3
KIF12		ENSG00000136883	"Kinesin family member 12"	Q96FN5	9	114086126-114099291	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.1;kidney: 51.5;pancreas: 42.1"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 101.9;Collecting duct cells: 85.5;Distal tubular cells: 68.0;Intestinal endocrine cells: 61.7;Proximal tubular cells: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.5;OE19: 11.2;RPTEC TERT1: 30.9;SCLC-21H: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA020192, HPA024127"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020192: AB_1852467, HPA024127: AB_1852469"	"unprognostic (5.29e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	0.4	0.0	0.8	0.8	1.2	0.0	9.1	0.8	0.6	3.3	5.8	0.4	3.3	11.8	4.7	18.0	0.5	3.8	33.1	0.4	0.4	0.2	51.5	9.8	1.0	0.4	0.4	0.5	1.1	42.1	0.0	0.6	1.3	0.4	2.4	1.7	0.8	1.8	4.2	0.4	0.4	7.3	0.4	0.4	0.4	5.5	1.5	0.4	1.0	11.6	0.4	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	3.6	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.1	11.2	0.4	0.0	0.0	0.0	30.9	0.1	4.5	0.1	0.0	0.6	0.0	0.1	3.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.8	0.6	0.4	0.2	0.4	0.5	0.4	0.4	0.0	4.1	0.8	0.8	0.0	0.0	0.4	101.9	0.0	0.0	85.5	0.0	0.1	68.0	28.9	5.4	0.0	7.1	0.0	10.4	6.4	0.2	2.2	0.0	7.4	0.3	0.0	61.7	0.0	0.0	9.5	0.6	0.0	0.0	1.8	22.5	0.0	8.1	20.9	0.0	57.8	0.0	0.0	0.0	1.5	4.5	0.0	0.5	0.0	23.4	0.1
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;testis: 19.4"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 35.8;Ito cells: 16.5;Late spermatids: 60.3;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.8;hTERT-HME1: 8.4;U-2 OS: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.1	0.4	2.4	0.2	5.2	0.1	0.1	0.0	3.9	0.4	0.2	0.4	0.0	0.3	0.4	0.8	0.1	3.1	0.2	0.2	1.8	3.5	0.2	0.1	0.4	0.1	0.4	0.7	0.6	0.1	0.2	1.5	0.7	0.5	0.4	0.1	0.0	0.1	0.8	0.1	0.1	0.2	0.9	0.3	0.1	0.1	19.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.9	0.0	0.0	0.1	0.2	2.7	3.8	1.5	0.9	0.4	1.0	0.0	1.2	2.0	0.7	0.0	1.3	0.9	1.1	0.0	0.3	0.0	0.0	0.4	1.6	0.0	0.0	0.3	0.8	1.0	8.4	1.0	0.0	0.1	0.6	0.0	1.8	0.1	0.0	0.0	2.5	0.1	1.8	0.0	0.1	0.0	0.6	0.0	0.7	1.5	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.6	5.1	0.5	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	5.2	0.0	3.6	1.8	3.5	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	2.7	0.0	1.8	3.9	0.1	0.0	0.0	35.8	12.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.4	4.0	0.0	0.0	16.5	1.5	60.3	1.1	3.3	1.7	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	19.4	1.4	1.5	4.2	1.1	1.4	0.0	0.0	0.1
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947711	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 12.3;lymphoid tissue: 34.7"	"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 1.6;Extravillous trophoblasts: 3.6;Hofbauer cells: 1.9;Kupffer cells: 1.8;Spermatogonia: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"		Yes	Yes			"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.7	0.6	0.5	8.2	0.4	12.3	0.4	0.4	0.5	0.9	1.6	0.3	0.7	2.9	0.5	0.6	3.2	0.3	1.3	1.5	0.5	0.5	0.5	0.7	0.8	5.9	0.6	0.1	0.6	0.4	0.0	0.4	1.9	0.2	0.5	1.5	0.1	0.7	0.1	0.4	2.9	2.5	0.8	0.4	1.7	1.5	3.8	0.1	34.7	0.4	2.7	7.6	0.7	1.1	1.1	0.8	2.0	0.6	1.0	1.4	0.4	14.4	18.8	16.2	15.1	0.4	1.4	13.6	12.4	4.6	15.6	12.3	15.6	12.5	12.8	5.3	4.7	10.0	15.9	11.1	5.0	7.9	26.3	16.6	16.5	21.2	9.6	0.0	13.6	14.5	0.3	0.2	13.5	5.4	2.1	7.9	13.3	12.4	21.8	8.0	11.2	25.3	13.4	11.9	13.1	13.0	19.4	24.7	8.5	2.5	7.9	12.2	11.8	8.3	7.5	4.6	7.8	14.1	9.7	5.2	23.3	23.1	13.7	26.0	7.0	6.9	15.7	7.5	10.4	15.0	1.8	0.6	0.4	0.5	0.3	0.4	0.8	0.7	0.5	0.3	1.1	0.4	0.5	2.0	1.0	0.3	0.8	1.4	0.4	0.5	0.4	0.4	0.4	0.5	0.5	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.4	0.1	0.0	0.0	1.9	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.5	0.4	0.7	0.5	0.6	0.1
KIF19	"FLJ37300, KIF19A"	ENSG00000196169	"Kinesin family member 19"	Q2TAC6	17	74326210-74355820	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;fallopian tube: 25.2"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 34.8;Intestinal endocrine cells: 22.8;Ito cells: 19.6;Mucus-secreting cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 5.5"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.5"	"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043638, HPA073303"	Enhanced		Approved	"Plasma membrane,Actin filaments,Centrosome"		NA	NA			"Plasma membrane"	"Actin filaments, Centrosome"	"HPA043638: AB_10962579, HPA073303: AB_2686593"	"unprognostic (1.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-9)"	"unprognostic (5.16e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.53e-1)"	1.6	0.9	9.3	1.6	29.5	1.1	1.1	25.8	14.1	2.1	3.1	17.4	0.0	6.6	1.1	1.1	1.1	25.2	1.6	1.1	11.9	6.6	0.9	1.6	3.1	1.0	25.0	4.2	1.1	3.0	0.9	0.3	0.8	6.5	0.9	2.1	0.8	2.5	1.3	1.0	0.8	5.2	1.6	6.2	11.6	2.2	1.2	29.9	0.0	2.3	0.0	1.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.9	1.6	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	9.3	29.5	25.8	14.1	11.9	6.6	25.0	4.2	6.5	29.9	0.0	0.0	0.0	0.3	0.0	0.9	1.1	0.0	34.8	7.9	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.2	0.0	0.0	2.5	0.2	0.2	0.0	0.0	0.1	0.0	22.8	19.6	1.2	0.0	0.0	0.0	3.3	0.0	10.6	7.5	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.2	1.4	0.1	0.0	0.0	1.3	0.1
KIF1A	"ATSV, C2orf20, SPG30, UNC104"	ENSG00000130294	"Kinesin family member 1A"	Q12756	2	240713764-240820308	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 144.1"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 383.7;Cone photoreceptor cells: 394.7;Horizontal cells: 506.9;Rod photoreceptor cells: 168.7"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 19.2;HAP1: 34.1;K-562: 29.8;SCLC-21H: 91.8;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"							HPA005442			Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA005442: AB_1079210"	"unprognostic (1.19e-1)"	"unprognostic (2.17e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.90e-2)"	2.1	15.2	47.0	2.9	37.0	2.0	2.0	28.4	144.1	1.9	2.7	35.8	0.0	2.9	2.3	3.1	2.0	2.3	2.1	8.2	40.9	28.4	2.1	2.3	2.1	2.0	35.1	46.8	3.5	31.3	2.0	15.7	2.0	38.7	6.4	2.6	8.6	2.0	2.2	1.9	2.8	2.9	2.3	35.0	2.2	5.0	10.0	30.9	0.0	2.9	0.0	1.9	2.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	1.0	0.0	0.5	0.0	34.1	0.0	0.0	2.6	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.1	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	14.7	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	47.0	37.0	28.4	62.2	40.9	28.4	35.1	46.8	38.7	30.9	0.0	0.0	0.0	0.1	0.8	383.7	18.7	0.0	0.0	0.0	0.0	394.7	0.0	0.0	0.3	1.7	0.4	0.0	0.0	21.2	0.0	0.0	9.0	0.0	0.2	0.1	506.9	32.8	0.0	0.0	4.5	0.9	0.0	16.9	0.0	0.0	91.7	23.8	0.0	0.4	0.1	168.7	0.0	1.1	4.7	1.7	0.0	0.0	0.0	0.0	0.4
KIF1B	"CMT2, CMT2A, HMSNII, KIAA0591, KLP"	ENSG00000054523	"Kinesin family member 1B"	O60333	1	10210805-10381603	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Motor protein"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.9"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 224.2;Cone photoreceptor cells: 545.8;Rod photoreceptor cells: 364.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015177	Approved		Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			Microtubules	"Nucleoli fibrillar center"	"CAB015177: AB_2296564"	"unprognostic (1.30e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.82e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.91e-6)"	"unprognostic (1.51e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	7.8	11.0	32.9	6.2	30.2	10.3	9.0	37.0	43.2	7.4	7.6	31.0	2.0	7.1	10.0	5.7	12.9	7.4	7.8	19.3	28.3	23.7	10.8	7.4	7.4	3.5	29.2	21.5	11.7	8.9	21.2	5.8	7.5	29.9	8.9	7.2	9.5	8.2	7.5	112.9	9.1	7.7	10.9	25.2	5.3	5.4	13.1	25.6	0.3	8.2	13.0	4.2	6.2	5.4	0.8	1.1	8.0	1.8	0.8	1.2	0.7	10.8	7.8	36.7	14.3	10.2	11.4	3.1	10.6	7.4	11.2	11.4	8.5	5.4	1.5	10.7	17.1	6.0	7.9	26.3	8.3	15.7	15.1	8.7	6.4	11.6	10.0	8.2	2.2	2.0	8.8	8.5	19.1	12.2	8.2	13.8	6.8	7.1	6.4	12.4	3.2	2.5	2.2	8.1	4.7	5.8	10.7	21.3	2.8	4.7	5.3	25.2	12.3	14.9	7.2	14.8	15.9	5.1	3.0	16.0	13.3	8.5	14.9	10.1	3.5	5.9	3.4	11.5	6.9	6.6	2.9	1.4	8.0	1.1	1.4	0.5	0.7	1.1	1.2	1.1	0.8	0.7	0.6	7.5	0.8	1.8	0.8	1.2	0.7	32.9	30.2	37.0	29.5	28.3	23.7	29.2	21.5	29.9	25.6	56.6	16.3	5.6	21.4	45.2	224.2	104.1	12.7	16.0	14.8	21.0	545.8	5.7	0.0	16.6	61.9	34.4	23.8	0.0	15.5	5.0	34.2	27.1	6.9	31.1	19.1	131.9	27.6	19.6	23.7	36.2	17.3	22.4	49.0	8.2	18.0	52.7	19.9	20.1	19.4	13.4	364.1	19.4	44.3	19.6	32.1	51.7	5.6	10.1	17.7	17.0
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187715	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.7;testis: 18.2"	"Cell type enhanced"	"Detected in some"	23	"Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 10.0;T-reg: 3.2"	"Group enriched"	"Detected in many"	64	"NK-cells: 10.0;T-cells: 3.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036909, HPA036910"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cleavage furrow"		Yes	Yes			"Nucleoplasm, Cleavage furrow"	"Cytokinetic bridge"	"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (2.14e-12)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	2.3	1.7	0.3	3.6	0.4	10.4	0.7	0.3	0.7	1.7	2.7	0.4	0.3	2.7	1.6	2.2	10.7	0.3	0.3	0.8	0.3	0.3	1.2	1.2	2.3	6.7	0.6	0.4	0.8	0.5	0.0	0.3	6.6	0.5	1.0	4.2	0.4	2.0	0.3	0.5	3.5	2.7	4.4	0.5	3.8	2.1	18.2	0.3	47.7	0.5	6.1	11.7	1.8	3.0	0.1	0.0	0.0	0.0	10.0	3.2	0.4	22.2	15.0	33.2	22.0	1.7	3.3	14.3	19.3	17.7	42.1	31.8	28.2	20.8	9.6	10.4	24.3	15.8	22.1	31.1	36.1	42.2	14.0	14.7	14.2	26.8	17.9	0.1	6.9	6.6	1.2	0.6	22.4	12.9	7.1	27.2	13.7	5.9	18.4	29.1	20.4	11.6	6.8	21.0	13.1	16.4	12.8	33.3	9.9	11.5	11.0	9.9	9.8	36.5	12.4	8.5	44.5	15.8	7.2	12.9	11.0	16.4	9.9	32.2	9.5	9.1	10.7	7.1	20.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.2	0.4	0.3	0.4	0.3	0.7	0.3	0.3	0.6	0.4	0.5	0.3	0.0	1.7	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.0	0.4	46.7	0.0	10.5	0.4	0.1	4.6	0.0	4.9	0.0	0.0	3.7	1.0	1.0	0.3	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	17.9	4.6	0.4	0.8	0.0	1.6	0.0
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023700	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;brain: 20.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 21.3;Cone photoreceptor cells: 55.0;Late spermatids: 57.7;Muller glia cells: 22.6;Rod photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 15.7;HMC-1: 16.8;JURKAT: 31.6;Karpas-707: 19.8;RPMI-8226: 16.8;U-266/70: 36.2;U-266/84: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	2.2	1.6	19.8	10.0	12.9	34.3	1.5	3.7	20.4	1.5	2.8	6.0	1.0	2.7	1.4	1.0	1.5	1.4	2.9	1.5	15.1	12.5	1.4	1.7	4.3	15.7	8.3	12.7	1.4	1.5	11.3	0.9	1.6	7.1	1.2	2.6	8.6	2.1	1.7	0.9	1.3	6.1	1.5	4.3	11.5	3.2	11.1	4.9	10.8	1.2	0.0	9.1	3.7	1.1	0.9	0.2	8.0	0.5	2.4	1.7	0.6	0.5	0.5	4.7	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.1	15.7	0.2	0.0	1.4	0.1	0.4	0.1	0.1	0.7	0.1	3.7	0.1	0.0	0.4	11.4	16.8	0.3	1.6	0.1	0.3	0.0	0.6	31.6	1.7	19.8	0.0	0.0	9.1	4.1	2.0	1.5	0.0	3.2	0.0	16.8	0.1	0.0	3.2	0.4	0.2	0.2	0.2	0.8	0.0	3.4	1.1	0.0	1.4	0.0	0.1	36.2	16.7	7.8	1.6	4.9	0.1	8.0	0.1	1.0	1.6	0.4	1.7	0.9	1.2	1.7	0.1	0.7	1.0	1.1	2.0	2.4	0.5	0.2	1.0	0.6	19.8	12.9	3.7	20.0	15.1	12.5	8.3	12.7	7.1	4.9	0.0	6.7	6.1	0.2	0.9	21.3	1.2	0.0	0.0	0.0	1.8	55.0	0.0	0.0	0.6	20.0	1.8	0.0	0.0	1.4	0.1	0.9	0.3	5.8	0.0	1.4	1.6	0.0	0.6	3.8	57.7	0.9	2.5	0.0	2.8	1.1	22.6	1.7	0.0	0.0	0.0	23.6	6.5	1.2	1.4	2.5	0.9	0.0	11.7	0.7	1.8
KIF26A	"DKFZP434N178, KIAA1236"	ENSG00000066735	"Kinesin family member 26A"	Q9ULI4	14	104138723-104180894	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Horizontal cells: 17.5;Intestinal endocrine cells: 7.5;Ito cells: 11.1;Spermatogonia: 7.5"	"Group enriched"	"Detected in many"	5	"stomach cancer: 3.8;testis cancer: 14.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 17.2;MCF7: 14.6;NTERA-2: 12.8;REH: 11.1;SCLC-21H: 11.9;SH-SY5Y: 24.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046882, HPA060346"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046882: AB_2679856, HPA060346: AB_2684259"	"unprognostic (3.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.24e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.68e-3)"	12.0	6.8	1.8	4.9	2.1	5.0	15.9	1.3	3.9	8.9	3.3	1.5	4.9	1.7	5.9	3.9	2.1	3.7	4.9	10.1	1.6	2.6	3.4	2.5	8.5	2.5	1.9	2.8	23.5	9.4	1.6	4.4	6.8	2.0	2.5	1.6	6.9	2.5	4.0	9.1	3.9	2.5	2.3	1.0	9.3	2.5	4.1	0.9	1.9	2.3	5.6	0.9	2.6	8.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	2.4	0.0	0.0	4.1	0.2	0.0	0.0	0.0	1.9	0.0	0.0	3.3	0.0	0.4	1.5	1.9	0.0	0.0	0.0	3.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	14.6	0.0	0.0	12.8	0.1	1.2	11.1	4.9	1.2	0.0	0.0	11.9	24.3	2.6	0.4	0.0	1.6	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.3	3.5	1.6	2.6	1.9	2.8	2.0	0.9	0.0	0.0	0.0	0.0	1.0	1.2	2.2	0.0	0.0	0.0	1.8	0.0	0.8	1.7	0.8	0.2	5.4	0.0	0.0	0.2	0.8	3.1	0.1	0.0	0.0	1.9	17.5	7.5	11.1	0.0	0.0	0.0	0.0	1.7	0.0	1.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.1	7.5	1.5	0.3	0.0	3.3	0.0
KIF26B	FLJ10157	ENSG00000162849	"Kinesin family member 26B"	Q2KJY2	1	245154985-245709431	"Predicted intracellular proteins"		"Developmental protein, Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 7.0;Cone photoreceptor cells: 3.9;Exocrine glandular cells: 4.4;Pancreatic endocrine cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 6.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 10.6;REH: 18.9;SH-SY5Y: 10.3;U-937: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027709, HPA028478, HPA028561, HPA028562"	Enhanced		Approved	"Plasma membrane,Microtubules"		NA	NA			"Plasma membrane, Microtubules"		"HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417"	"unprognostic (3.66e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.30e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-4)"	"unprognostic (7.22e-3)"	0.7	3.9	7.1	3.0	6.3	0.7	2.1	10.2	9.7	5.2	1.7	8.7	6.0	1.2	3.7	2.9	1.3	2.1	4.2	1.3	5.6	7.2	3.2	1.1	2.7	1.7	7.8	4.6	1.2	1.8	1.4	1.4	7.6	9.6	3.7	0.8	1.1	1.2	7.7	0.9	2.7	1.1	2.3	4.9	1.1	2.9	2.9	3.7	1.3	3.4	1.2	1.4	4.0	0.8	0.0	6.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	2.6	0.5	0.8	1.9	2.1	1.5	0.1	0.1	3.2	0.0	0.0	3.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.3	10.6	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	18.9	0.1	0.0	1.9	0.0	2.6	10.3	0.0	0.0	0.0	1.8	0.0	1.0	0.3	2.0	0.1	0.0	0.8	0.0	0.0	0.1	0.3	9.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	7.1	6.3	10.2	9.7	5.6	7.2	7.8	4.6	9.6	3.7	0.0	0.3	0.0	0.1	0.8	0.8	2.2	0.0	2.7	0.0	7.0	3.9	1.8	0.0	1.8	1.7	0.0	0.0	0.0	4.4	2.0	0.9	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.6	0.4	3.3	1.0	0.0	0.3	5.5	0.0	0.0	0.0	0.1	0.0	0.4	0.5	1.0	1.1	2.1	0.0	0.0	0.0
KIF2B		ENSG00000141200	"Kinesin family member 2B"	Q8N4N8	17	53822901-53825213	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	261	"testis: 103.6"	"Group enriched"	"Detected in some"	82	"Early spermatids: 638.1;Late spermatids: 419.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023081, HPA023103, HPA024795"	Uncertain		Supported	"Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"	Nucleoli	"HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	638.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	6.5	0.0	4.2	2.0	0.0	0.0	0.0	0.0	0.0
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.9;testis: 61.4"	"Group enriched"	"Detected in many"	18	"Early spermatids: 430.2;Late spermatids: 1559.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	1.1	0.7	0.4	8.7	0.4	12.7	0.8	0.5	0.5	1.2	2.4	0.4	0.2	2.1	1.3	1.4	4.6	0.6	0.7	0.9	0.6	0.5	0.7	0.6	1.6	6.7	0.4	0.2	0.7	0.4	0.3	0.6	2.2	0.6	0.6	3.2	0.4	1.1	0.2	0.4	2.3	2.2	1.1	0.4	3.3	1.4	61.4	0.2	39.9	0.8	4.7	12.0	0.9	1.7	1.3	1.5	0.0	0.2	3.9	5.8	1.0	29.0	11.3	25.3	20.2	1.4	2.9	17.0	21.8	15.6	44.7	39.0	19.1	21.1	33.5	10.5	10.7	30.9	13.9	25.7	14.7	40.9	21.6	11.1	39.6	20.0	15.9	0.1	29.2	18.4	0.7	1.4	31.8	15.6	4.1	14.4	23.8	31.2	28.8	28.2	11.3	30.7	17.7	24.7	14.3	14.2	24.7	38.2	21.0	7.5	10.6	17.4	12.4	29.0	20.7	18.3	19.1	11.9	22.2	8.5	16.2	32.3	17.6	38.2	15.2	15.5	48.3	10.4	28.5	31.2	0.0	0.0	0.0	1.9	0.0	0.1	1.3	3.4	2.6	0.3	0.2	0.7	0.5	0.0	3.9	0.2	1.5	5.8	1.0	0.4	0.4	0.5	0.5	0.6	0.5	0.4	0.2	0.6	0.2	0.0	0.3	0.8	0.5	1.5	1.0	0.8	0.0	0.0	2.3	1.8	2.0	1.1	1.7	0.3	430.2	0.1	0.0	23.3	0.3	20.1	0.7	0.6	0.0	0.0	7.4	0.0	0.0	4.3	1.0	1559.3	8.6	1.3	0.0	7.2	0.9	0.3	0.1	0.0	6.3	0.0	0.2	6.5	0.3	55.1	28.0	0.4	3.1	0.7	1.6	0.4
KIF3A	"FLA10, KLP-20"	ENSG00000131437	"Kinesin family member 3A"	Q9Y496	5	132692628-132737638	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.5"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 131.2;Cone photoreceptor cells: 117.8;Horizontal cells: 174.8;Spermatocytes: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 27.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 27.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037085	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Nucleoplasm, Intermediate filaments, Cytosol"		"CAB037085: AB_477147"	"unprognostic (8.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.21e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.23e-1)"	3.4	9.9	19.6	5.0	21.0	2.5	6.6	23.8	54.5	6.2	3.6	8.1	3.2	3.5	6.5	7.1	4.5	8.7	5.3	7.0	28.0	22.9	7.6	2.5	5.7	4.8	18.7	25.5	6.9	4.0	15.8	18.5	4.3	37.7	6.6	3.8	3.8	3.8	6.6	3.5	5.1	3.0	5.7	15.0	3.8	4.9	23.9	11.1	3.5	6.9	0.1	4.7	5.3	3.5	3.4	0.7	27.1	1.1	2.4	4.3	1.1	7.0	8.8	7.8	14.1	5.2	5.2	6.2	5.9	4.6	5.6	7.9	8.5	5.7	19.3	8.2	6.8	16.8	4.6	6.1	11.7	11.7	5.7	7.1	2.8	4.4	3.2	5.2	3.6	7.6	4.0	6.0	8.1	9.1	7.6	7.0	12.4	2.9	11.2	6.8	5.1	22.7	2.7	3.8	2.6	3.3	6.4	6.2	2.3	5.6	6.0	24.2	7.6	8.9	2.9	8.9	13.2	8.9	1.1	7.3	7.0	12.3	5.1	7.1	8.1	11.8	11.1	8.6	2.9	7.7	27.1	0.4	1.1	3.9	0.8	4.1	3.4	4.0	3.6	0.7	2.1	3.9	4.3	0.3	2.4	1.1	0.7	3.0	1.1	19.6	21.0	23.8	32.3	28.0	22.9	18.7	25.5	37.7	11.1	50.6	33.1	5.4	13.8	12.0	70.6	23.3	7.6	131.2	38.7	36.6	117.8	13.0	24.9	16.7	49.7	8.5	0.9	0.0	11.3	9.8	12.6	8.0	12.8	2.4	5.5	174.8	19.0	9.2	3.3	16.3	15.3	5.0	40.5	6.4	3.4	51.3	11.4	2.3	23.0	7.3	94.7	12.9	10.8	129.4	94.9	13.9	8.2	16.0	1.7	6.0
KIF3C		ENSG00000084731	"Kinesin family member 3C"	O14782	2	25926596-25982749	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 72.9"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 15.5;Horizontal cells: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035755			Approved	"Nuclear membrane,Nuclear bodies,Intermediate filaments"		NA	NA			"Nuclear bodies, Intermediate filaments"	"Nuclear membrane"	"HPA035755: AB_10602242"	"unprognostic (3.95e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.53e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	3.0	7.3	22.8	2.9	21.2	2.2	2.6	22.7	72.9	3.6	2.4	3.8	0.0	2.1	3.9	2.6	3.0	3.3	4.1	3.0	21.6	18.9	2.0	1.6	2.6	2.0	17.5	20.3	7.3	2.3	4.5	4.8	2.8	22.8	3.3	2.6	1.9	1.9	4.6	2.4	2.3	2.7	4.8	6.2	2.2	2.0	3.0	5.2	0.5	2.5	0.0	2.0	3.5	1.5	0.1	0.3	2.4	0.2	0.7	2.0	1.3	13.0	19.8	10.5	8.1	6.2	7.2	8.5	6.8	3.4	4.1	4.7	3.5	2.0	0.0	5.6	6.2	12.9	1.4	8.0	4.1	2.8	2.1	3.8	4.7	1.5	7.1	3.6	1.2	4.1	5.2	1.2	12.9	2.6	15.9	13.5	3.8	1.6	1.7	4.3	0.9	3.3	1.6	10.8	0.3	5.8	5.3	5.2	0.8	9.4	3.2	12.9	29.0	2.7	1.2	14.2	9.1	0.4	1.6	10.7	7.2	7.4	3.2	6.6	0.4	2.3	1.5	16.3	6.4	6.1	0.0	0.2	0.0	0.4	0.0	1.1	0.0	1.6	1.5	0.3	0.1	0.5	0.6	2.4	0.7	0.0	0.2	2.0	1.3	22.8	21.2	22.7	40.0	21.6	18.9	17.5	20.3	22.8	5.2	0.0	0.0	0.0	1.2	0.5	15.5	3.1	2.5	1.4	1.2	0.0	5.9	0.3	0.0	7.7	2.5	3.9	0.0	0.0	1.2	3.3	1.3	0.9	6.9	0.0	2.8	39.7	2.9	9.8	2.7	3.6	1.7	1.1	3.3	2.8	0.2	6.4	8.3	0.0	4.2	0.7	5.9	6.5	2.3	0.2	1.1	0.3	1.0	2.2	0.1	0.5
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57549998-57586632	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 138.6"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 36.9;Horizontal cells: 25.4;Late spermatids: 11.4;Spermatogonia: 9.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.4;naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.4;K-562: 8.6;NTERA-2: 10.6;SCLC-21H: 21.8;U-87 MG: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: AB_2686601"	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	1.8	7.6	85.4	3.0	47.6	1.9	1.9	15.2	138.6	2.1	2.8	4.0	0.0	2.4	3.4	2.1	1.9	2.0	1.9	1.7	52.4	18.3	2.0	1.7	1.8	1.8	12.9	43.6	1.8	2.3	6.0	2.5	1.7	21.6	1.9	2.8	0.6	2.0	2.0	1.7	1.7	3.0	2.8	9.0	1.8	2.1	4.4	12.9	0.0	2.8	0.0	1.8	1.8	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.8	3.3	0.0	0.0	0.1	0.2	0.7	1.3	1.7	0.0	0.0	1.6	0.0	0.7	0.6	0.1	2.0	0.0	1.0	20.4	1.5	0.1	0.1	1.6	0.6	0.0	0.1	0.2	0.1	1.0	0.0	0.0	0.2	1.8	8.6	4.5	0.0	0.0	0.3	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.8	4.9	0.0	0.2	0.0	0.6	0.4	0.0	0.0	0.0	2.4	0.0	0.9	2.9	3.5	0.3	8.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.4	0.8	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.3	0.0	85.4	47.6	15.2	112.0	52.4	18.3	12.9	43.6	21.6	12.9	0.0	0.0	0.0	0.1	0.0	36.9	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	25.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	5.8	0.2	0.0	0.4	0.0	8.7	0.0	0.9	2.3	9.3	0.1	0.0	0.0	0.0	0.0
KIF5C		ENSG00000168280	"Kinesin family member 5C"	O60282	2	148875250-149026759	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 95.8"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 265.2;Early spermatids: 558.1;Late spermatids: 572.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 5.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 66.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035210, HPA062272"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA035210: AB_10671931, HPA062272: AB_2732678"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.70e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.55e-6)"	"unprognostic (8.34e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.46e-2)"	1.8	10.5	32.0	2.3	31.8	1.3	1.6	33.8	95.8	2.2	2.5	21.7	0.0	1.6	1.8	11.0	1.4	1.6	1.7	1.6	25.4	13.7	1.6	1.2	1.5	1.8	15.8	25.5	3.3	2.5	1.5	12.6	1.3	27.1	21.9	3.2	0.4	1.4	7.5	1.3	1.4	2.3	2.0	20.1	1.6	2.4	13.5	18.3	0.0	3.6	0.0	1.7	2.4	1.0	0.8	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	12.9	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.6	0.0	0.1	2.8	0.0	7.5	0.0	1.5	3.8	1.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.4	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	13.0	0.0	4.0	0.0	0.1	0.0	0.0	2.7	66.9	15.4	0.0	0.3	0.2	2.7	0.0	0.0	0.0	0.0	1.1	0.0	1.9	1.3	0.2	0.0	4.7	0.2	0.4	0.0	0.0	0.0	0.3	0.0	5.9	0.5	1.1	1.4	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.7	0.0	32.0	31.8	33.8	40.3	25.4	13.7	15.8	25.5	27.1	18.3	0.0	0.0	1.3	5.9	1.1	265.2	12.9	7.6	0.0	0.0	17.4	102.1	0.0	0.0	0.2	558.1	2.2	0.0	0.0	0.0	0.1	2.1	48.5	0.0	0.0	0.2	93.8	124.7	1.3	0.8	572.0	7.5	0.6	5.0	1.0	1.3	6.8	1.5	2.9	12.0	0.0	12.9	6.5	8.5	11.8	9.7	0.4	0.0	5.7	0.6	1.7
KIF6	"C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317"	ENSG00000164627	"Kinesin family member 6"	Q6ZMV9	6	39329990-39725405	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 18.8;fallopian tube: 9.9;pituitary gland: 5.6;testis: 12.6"	"Cell type enhanced"	"Detected in many"	19	"Ciliated cells: 58.9;Muller glia cells: 13.8;Rod photoreceptor cells: 14.4;Spermatocytes: 18.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 20.8;RPMI-8226: 8.1;SCLC-21H: 11.4;SK-MEL-30: 4.6"	"Low region specificity"	"Detected in many"							"HPA038811, HPA058624"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA038811: AB_10795140, HPA058624: AB_2683781"	"unprognostic (4.94e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.25e-4)"	"unprognostic (3.12e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.12e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	1.3	1.4	5.1	0.7	9.1	0.9	1.9	2.2	11.4	1.4	1.0	18.8	0.1	1.7	1.0	2.6	1.3	9.9	1.6	1.3	7.3	7.1	1.4	1.3	2.4	1.2	11.8	3.2	1.8	1.6	1.2	5.6	1.2	8.6	1.1	0.9	1.7	1.0	0.9	1.6	1.2	1.1	0.8	10.6	0.9	0.9	12.6	7.8	0.0	2.0	0.0	0.9	0.7	0.4	1.2	2.7	2.5	0.6	1.3	0.7	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.9	0.2	0.5	0.1	0.0	0.1	0.1	0.9	20.8	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.6	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.4	8.1	0.2	0.0	11.4	0.1	0.0	0.1	4.6	0.3	0.1	0.0	0.1	0.0	0.1	2.7	0.6	0.2	0.0	0.0	0.6	0.0	1.4	1.9	0.6	0.4	0.5	0.3	0.5	0.7	0.5	0.4	0.2	1.2	0.6	0.7	2.5	1.3	0.4	2.7	0.3	0.1	5.1	9.1	2.2	5.4	7.3	7.1	11.8	3.2	8.6	7.8	0.0	1.1	0.0	0.6	0.1	3.1	1.2	0.0	58.9	2.3	0.0	9.8	0.3	1.7	1.1	7.8	0.7	0.0	0.0	0.7	0.2	1.1	0.2	0.0	0.0	0.2	3.2	2.4	0.0	0.0	8.0	0.3	0.0	0.0	0.0	0.0	13.8	0.1	0.0	0.0	2.4	14.4	0.0	0.6	18.2	2.5	0.4	0.2	0.0	0.0	0.3
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391536-33409924	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 60.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 21.5;Erythroid cells: 70.0;Extravillous trophoblasts: 32.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome		NA	Yes			Centrosome		"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	0.9	0.8	0.0	18.0	0.3	9.6	1.5	0.0	0.5	1.7	5.7	0.1	0.3	3.0	0.9	1.6	10.1	0.5	2.2	0.8	0.0	0.0	0.7	0.7	2.2	6.3	0.1	0.2	1.5	0.3	0.2	0.2	3.6	0.4	0.6	2.5	0.6	1.7	0.1	0.4	3.3	4.2	0.7	0.4	4.7	2.5	9.7	0.2	60.9	0.4	7.4	14.6	0.6	2.8	0.8	0.3	0.0	0.1	0.2	1.4	0.7	10.7	1.8	10.3	10.9	0.2	0.4	6.3	7.8	2.0	6.2	5.2	3.8	4.8	7.1	3.0	1.6	8.2	5.8	2.6	3.6	6.8	4.2	5.9	5.7	8.7	5.5	0.0	4.7	6.4	0.0	0.9	5.1	1.5	0.7	0.6	5.2	1.7	17.6	4.6	2.7	2.8	9.4	4.7	3.0	2.2	7.1	5.8	2.4	0.9	2.4	9.4	4.2	2.8	6.0	1.5	4.1	6.3	4.9	1.4	3.3	10.1	5.4	11.6	5.8	11.0	6.9	0.0	7.0	5.8	0.0	0.1	0.0	0.4	0.0	0.6	0.8	0.3	1.4	0.3	0.8	0.3	0.3	0.0	0.2	0.0	0.1	0.6	0.7	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.2	0.4	0.2	0.0	4.5	5.2	0.7	4.9	0.4	0.4	0.0	0.0	2.3	0.0	0.0	6.7	0.0	0.6	21.5	1.4	2.9	70.0	0.0	32.5	2.9	0.8	1.1	0.0	11.9	0.0	0.0	2.5	2.5	9.8	0.3	4.9	3.3	5.4	3.4	0.2	0.2	2.8	0.7	0.0	0.5	0.0	1.0	11.2	6.9	3.1	5.6	4.3	4.6	2.4
KIFC2		ENSG00000167702	"Kinesin family member C2"	Q96AC6	8	144466043-144474202	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 36.2;skin 1: 48.2"	"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029264	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA029264: AB_10609999"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-3)"	"unprognostic (4.12e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.71e-2)"	4.2	5.1	18.7	4.2	28.4	4.5	3.4	36.2	35.0	3.1	6.3	2.3	6.6	8.8	2.7	5.2	7.0	2.9	4.4	2.2	13.5	7.2	4.7	2.8	3.8	4.8	4.4	16.8	2.1	7.9	9.8	7.9	2.5	8.3	7.2	4.8	2.2	7.5	6.5	2.3	48.2	7.9	2.1	2.6	8.1	8.7	5.2	6.6	1.6	4.1	1.3	3.5	5.0	4.9	0.8	0.1	0.1	0.1	0.0	0.8	0.1	8.0	6.9	3.3	7.4	4.9	2.9	7.9	4.9	3.5	2.6	2.6	2.7	10.0	8.4	2.8	2.7	4.4	16.5	3.3	4.4	1.1	8.5	2.9	5.1	17.0	3.5	6.3	1.4	15.0	3.8	15.7	2.6	3.4	12.5	1.7	8.3	5.5	8.8	2.0	13.8	6.1	4.3	0.5	8.9	10.3	15.3	0.2	5.0	11.0	12.7	10.6	9.7	3.5	10.7	3.9	2.8	28.4	2.8	4.7	5.2	15.7	5.5	4.9	4.3	2.1	2.3	10.1	7.1	2.8	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.3	0.6	0.1	0.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	18.7	28.4	36.2	35.0	13.5	7.2	4.4	16.8	8.3	6.6	8.9	9.9	2.2	2.6	5.4	8.9	0.8	7.6	2.7	6.8	14.0	5.9	1.6	1.7	3.2	5.2	0.6	17.3	0.0	1.2	1.5	2.6	3.1	8.1	5.4	2.4	14.3	22.4	2.5	6.2	6.9	7.2	4.8	3.3	1.0	9.9	7.2	2.7	14.0	2.8	4.3	3.3	0.0	1.9	5.1	5.5	9.9	2.5	5.7	9.9	2.6
KISS1		ENSG00000170498	"KiSS-1 metastasis suppressor"	Q15726	1	204190341-204196486	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"placenta: 267.2"	"Cell type enriched"	"Detected in many"	41	"Syncytiotrophoblasts: 1117.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.2"	"Group enriched"	"Detected in some"	8	"basal ganglia: 11.3;hypothalamus: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"BJ: 55.9;U-2 OS: 22.8"					"Low region specificity"	"Detected in all"			"CAB017775, HPA035542"	Enhanced		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"CAB017775: , HPA035542: AB_2674677"	"unprognostic (9.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"		"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.98e-12)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.29e-6)"	0.2	0.0	0.2	0.2	11.3	0.0	0.2	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.2	1.1	2.7	0.5	0.2	0.2	0.2	0.2	0.4	0.1	2.5	267.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.5	0.2	0.2	0.7	1.4	3.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	55.9	0.7	1.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	22.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.3	1.0	0.2	0.2	4.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	3.3	27.0	0.3	5.1	0.0	4.0	4.1	0.4	1.8	0.0	2.9	14.5	0.0	0.0	1.3	0.0	3.1	0.3	0.0	0.0	0.0	0.6	0.0	2.9	0.8	0.0	1.2	0.0	0.0	0.1	0.1	0.4	0.0	1117.8	0.0	1.9	2.2
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921015	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;lymphoid tissue: 12.4"	"Cell type enriched"	"Detected in some"	18	"Extravillous trophoblasts: 31.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;neutrophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 10.8;RPMI-8226: 26.3;SCLC-21H: 5.5;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: AB_2686471"	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavorable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.2	0.2	2.1	2.1	4.1	0.2	0.3	0.1	4.7	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.1	0.2	0.1	0.1	1.0	6.8	1.4	0.1	0.3	12.4	1.1	0.1	0.4	3.6	0.1	2.0	1.0	0.8	0.2	0.2	0.3	0.3	0.1	0.1	0.1	0.7	0.5	1.0	2.4	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.6	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	2.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.2	0.1	0.0	0.4	0.8	0.3	0.7	0.0	26.3	0.0	0.0	5.5	14.7	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.7	0.0	0.0	0.1	2.0	0.6	1.8	0.0	0.0	0.0	0.1	0.0	2.1	4.1	0.1	1.5	1.0	6.8	1.1	0.1	0.8	0.1	0.0	0.0	1.4	0.1	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.2	31.2	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.3	1.4	0.0	0.0	0.0
KITLG	"DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF"	ENSG00000049130	"KIT ligand"	P21583	12	88492793-88580851	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Cell adhesion"	"Growth factor"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 83.5;SK-BR-3: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070395	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		150000	Vesicles		"HPA070395: AB_2686264"	"unprognostic (7.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.61e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.47e-3)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.81e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-2)"	10.1	3.8	7.8	8.0	6.4	0.0	11.2	4.8	11.5	9.6	16.1	2.9	8.5	6.2	11.7	8.7	16.7	4.7	13.9	5.6	8.4	3.9	21.9	2.8	22.9	6.1	3.3	7.7	4.4	5.0	1.9	3.2	10.1	4.0	17.9	15.9	7.8	11.8	14.8	4.8	5.3	9.5	21.0	3.7	2.6	13.0	5.8	2.9	0.7	6.5	5.8	6.6	17.5	17.8	0.0	0.2	0.0	0.5	0.0	0.0	0.0	3.5	1.9	1.8	0.2	7.3	15.6	0.0	21.4	15.4	3.7	1.7	83.5	3.3	0.0	0.6	18.0	4.4	12.9	2.7	4.8	3.5	0.0	2.4	0.0	2.9	0.6	1.1	0.4	0.0	13.5	5.1	11.6	7.0	1.5	4.4	0.0	0.0	0.0	1.6	0.6	0.0	0.0	1.3	4.2	4.8	0.0	3.4	0.0	6.2	1.7	0.5	1.2	5.2	29.2	0.5	1.7	15.0	1.0	2.9	16.9	2.4	19.7	1.7	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	6.4	4.8	11.5	8.4	3.9	3.3	7.7	4.0	2.9	17.9	28.1	0.0	11.7	11.9	2.2	3.2	2.5	12.0	25.0	66.3	0.0	0.0	1.7	2.6	0.5	19.6	4.5	0.0	15.9	0.1	14.1	7.5	0.0	0.2	0.9	20.6	9.1	3.1	2.9	0.0	13.0	1.8	11.8	0.0	7.5	0.2	9.2	0.0	3.5	1.4	1.1	12.9	20.5	0.0	0.2	4.5	0.0	0.0	9.3	2.6
KLC2	FLJ12387	ENSG00000174996	"Kinesin light chain 2"	Q9H0B6	11	66257294-66267860	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.7"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040416, HPA040434"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Mitochondria"	"HPA040416: AB_10795524, HPA040434: AB_10795367"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.57e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.08e-2)"	7.5	12.5	15.9	7.9	20.7	2.9	6.6	51.7	49.4	7.4	7.8	7.5	6.5	8.5	11.3	6.0	8.8	9.0	8.0	15.3	20.0	17.4	6.7	2.4	6.6	7.5	13.8	26.0	11.3	11.2	15.4	15.4	6.4	29.0	13.6	4.4	8.2	8.4	15.5	23.8	9.3	7.7	10.1	8.6	6.6	9.8	17.4	10.0	13.5	6.3	4.5	5.6	8.8	8.5	4.7	4.1	0.8	0.4	2.3	6.2	1.5	20.4	25.1	12.2	7.3	7.4	6.0	9.5	14.5	10.4	14.9	11.5	13.6	6.1	9.3	14.0	10.7	19.2	17.3	12.5	14.0	5.0	14.8	15.8	1.8	19.8	9.2	14.3	4.1	9.9	6.0	18.6	17.4	14.2	9.6	6.9	11.2	9.9	12.5	11.8	28.8	23.2	6.2	12.1	5.9	20.9	8.9	6.3	12.6	11.6	11.5	33.4	16.1	10.6	9.5	17.3	7.1	15.7	2.8	11.3	24.5	21.9	29.6	19.0	13.1	10.9	5.0	17.3	2.8	9.8	0.0	0.4	0.8	4.6	0.1	6.2	3.6	2.2	3.1	0.6	4.7	2.2	2.7	0.7	2.3	0.3	4.1	0.6	1.5	15.9	20.7	51.7	49.4	20.0	17.4	13.8	26.0	29.0	10.0	3.0	1.0	5.6	8.0	7.9	32.1	1.4	0.0	5.3	1.2	12.2	11.8	8.8	11.6	15.0	8.9	4.5	2.9	0.0	7.2	16.4	4.8	12.0	0.0	2.1	2.7	52.4	35.6	4.3	4.6	3.4	8.1	2.8	11.8	10.0	5.8	14.1	13.4	3.6	13.1	9.1	26.5	0.0	16.2	24.4	25.6	8.4	10.6	3.3	3.7	7.1
KLC3	"KLC2L, KLCt, KNS2B"	ENSG00000104892	"Kinesin light chain 3"	Q6P597	19	45333434-45351520	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 39.5;tongue: 25.3"	"Cell type enhanced"	"Detected in many"	17	"Basal keratinocytes: 126.0;Ductal cells: 38.6;Suprabasal keratinocytes: 160.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 25.8;HaCaT: 12.0;HBEC3-KT: 7.7;hTCEpi: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052797, HPA056508"	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Actin filaments"	"Nucleoplasm, Cytosol"	"HPA052797: AB_2681954, HPA056508: AB_2683159"	"unprognostic (4.11e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.07e-4)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (3.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.14e-1)"	"unprognostic (2.37e-1)"	0.1	0.2	0.0	0.2	1.2	1.9	1.9	0.0	0.5	4.0	0.1	0.0	0.0	0.1	0.6	2.9	10.6	0.1	0.2	0.1	0.2	0.0	1.9	0.1	0.7	0.2	0.0	0.0	0.3	4.5	1.5	1.1	0.9	0.5	1.7	0.2	4.0	7.8	2.2	0.6	39.5	0.3	0.0	0.0	0.2	0.2	2.8	0.2	0.3	1.1	25.3	9.2	0.2	7.9	1.5	1.0	3.3	0.9	1.0	1.3	0.6	25.8	0.2	0.1	0.3	0.1	0.1	2.1	0.2	0.0	0.0	0.1	2.6	4.8	0.2	2.1	0.0	2.8	12.0	1.7	7.7	0.1	0.6	3.9	0.1	0.7	0.5	0.0	0.2	1.7	0.0	9.8	0.1	1.9	0.3	0.0	0.4	0.4	0.3	0.1	3.4	0.1	0.4	0.6	0.4	0.8	4.0	0.0	0.2	0.2	0.9	3.4	0.6	0.2	5.5	0.7	0.3	4.8	0.1	0.0	0.3	2.8	0.2	0.3	0.6	0.5	0.2	0.1	0.1	0.3	3.3	0.7	0.6	0.8	0.5	0.7	0.9	1.0	0.9	0.3	1.5	1.0	1.3	2.6	1.0	0.9	1.0	0.8	0.6	0.0	1.2	0.0	0.5	0.2	0.0	0.0	0.0	0.5	0.2	0.0	3.7	0.0	35.4	126.0	0.9	0.4	2.5	2.7	2.3	1.8	0.0	0.2	8.3	38.6	3.0	0.0	0.0	0.0	2.6	0.4	1.2	9.3	0.0	0.0	0.3	1.6	0.0	0.6	0.0	8.5	1.7	1.4	13.5	1.0	0.0	0.8	11.5	0.0	0.4	1.4	1.9	0.0	4.1	0.5	8.3	160.2	0.6	0.0	0.0	19.7
KLC4	"bA387M24.3, KNSL8"	ENSG00000137171	"Kinesin light chain 4"	Q9NSK0	6	43040777-43075099	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 55.7"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 103.2;Paneth cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030168, HPA030169"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA030168: AB_10599285, HPA030169: AB_10601105"	"unprognostic (2.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.36e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (6.99e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	6.1	9.7	13.1	8.5	11.5	5.3	6.9	25.0	15.2	7.6	35.0	10.2	8.1	35.1	8.5	12.3	5.6	9.3	15.2	12.2	13.8	10.8	13.6	47.2	8.2	5.8	12.2	13.7	11.2	9.1	17.6	13.3	5.9	12.1	8.6	17.4	9.0	11.4	8.4	9.9	8.7	55.7	7.4	9.2	6.6	16.0	22.6	13.2	6.7	10.9	4.5	5.4	10.2	9.9	5.6	12.2	9.0	3.7	6.1	7.0	3.3	3.5	3.2	8.7	10.4	8.6	8.5	7.7	2.9	4.8	5.3	8.2	5.3	6.3	5.3	10.7	7.0	7.0	6.3	8.7	8.2	4.3	5.3	10.6	6.2	9.2	23.4	8.3	3.0	4.9	11.1	10.3	6.4	6.3	16.8	6.7	11.0	4.2	7.1	4.4	7.2	7.9	6.5	3.4	35.5	4.4	6.4	4.9	10.2	8.1	3.6	14.3	7.0	5.7	5.0	11.1	8.3	9.1	7.6	4.8	6.1	7.2	3.0	3.0	14.1	5.0	12.9	3.3	4.5	2.1	2.6	3.7	4.4	4.0	3.6	5.1	5.6	5.5	3.9	4.2	4.3	7.0	4.8	9.0	6.1	3.6	12.2	6.4	3.3	13.1	11.5	25.0	15.2	13.8	10.8	12.2	13.7	12.1	13.2	14.9	11.8	3.9	8.3	3.3	20.8	10.2	22.9	21.4	5.7	14.0	27.5	9.4	16.6	6.6	6.1	4.4	103.2	0.0	8.7	4.1	5.1	5.1	6.9	51.3	5.8	11.1	21.5	5.5	3.7	6.8	9.5	2.5	3.3	6.4	36.2	15.8	6.6	59.6	6.3	20.0	25.7	12.9	4.4	20.9	15.5	4.0	11.3	4.9	35.1	5.0
KLF11	"MODY7, TIEG2, Tieg3"	ENSG00000172059	"Kruppel like factor 11"	O14901	2	10042849-10054836	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 120.7;Suprabasal keratinocytes: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058276			Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol"		Yes	No			Nucleoplasm	"Nuclear bodies, Focal adhesion sites, Cytosol"	"HPA058276: AB_2683664"	"unprognostic (9.66e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.63e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.24e-2)"	28.7	9.1	2.5	7.0	3.5	11.8	33.1	8.2	4.4	12.9	13.0	5.1	10.8	3.5	12.8	11.7	8.3	11.2	11.6	19.4	2.9	2.3	12.7	27.9	14.6	15.9	5.5	2.4	13.7	38.3	7.3	2.4	9.9	3.4	13.9	4.7	9.2	11.3	10.9	14.0	19.1	7.7	30.4	3.5	16.1	10.2	16.7	2.7	1.5	9.1	8.5	5.6	11.1	42.7	2.9	6.6	1.7	12.7	5.4	2.7	3.8	3.7	1.8	4.4	0.4	3.1	5.5	10.7	4.4	4.5	2.5	2.6	4.3	8.8	0.0	8.0	5.3	10.2	0.9	3.8	3.4	1.7	25.9	2.9	1.9	5.4	0.8	3.0	7.9	12.6	8.6	12.7	4.8	1.3	6.5	2.2	0.7	5.2	17.5	2.5	4.4	0.0	1.4	7.1	3.0	3.8	4.2	0.1	7.3	6.1	4.7	5.7	3.5	6.7	13.9	12.9	7.3	3.2	10.8	6.2	11.1	9.3	8.3	1.4	15.9	18.9	10.2	2.9	2.1	5.9	0.0	6.9	1.7	2.6	11.0	0.8	2.8	1.7	1.8	6.6	2.9	0.5	1.0	0.2	5.4	12.7	0.3	2.7	3.8	2.5	3.5	8.2	4.4	2.9	2.3	5.5	2.4	3.4	2.7	6.0	5.8	3.2	13.5	53.8	5.2	2.8	7.6	5.3	7.9	7.0	5.9	2.4	24.9	7.7	120.7	16.6	3.1	0.0	7.4	3.3	9.7	13.1	8.1	34.1	11.6	3.2	6.8	43.0	29.9	21.5	13.6	21.1	28.7	3.6	6.8	2.3	8.2	0.0	15.6	5.3	4.7	32.3	44.3	14.1	35.0	75.4	6.9	5.7	7.4	9.5
KLF12	"AP-2rep, AP2REP, HSPC122"	ENSG00000118922	"Kruppel like factor 12"	Q9Y4X4	13	73686089-73995056	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 35.3;Peritubular cells: 26.9;T-cells: 26.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064146, HPA075652"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064146: AB_2685198, HPA075652: "	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.67e-3)"	2.1	0.9	0.4	2.9	0.4	0.9	1.9	0.6	3.4	2.1	1.5			0.1	1.7	7.1	0.7	1.1	1.1	3.2	0.4	0.5	2.9	5.8	2.0	6.1	0.5		2.8	0.6	0.0	3.5	0.0		1.2	1.1		0.9	1.4	1.9	1.4	1.2	1.4	1.3	3.9	1.4	1.5			2.1		5.5	1.7	2.1	1.7	0.9	0.9	0.6	2.6	5.1	1.4	0.0	1.0	10.2	0.0	5.7	12.7	0.1	4.0	2.0	4.5	4.7	0.8	2.5	7.6	1.9	6.0	1.8	2.7	2.7	3.1	12.0	4.9	3.7	0.2	4.5	0.0	1.9	5.0	1.9	11.0	0.8	6.3	5.1	8.6	8.8	5.9	0.0	1.9	13.4	0.8	9.6	0.0	1.4	0.3	2.0	5.3	3.7	0.0	2.5	0.2	2.4	10.5	2.8	1.3	4.6	4.0	0.3	0.8	0.0	8.7	2.7	3.9	1.9	5.3	6.7	2.4	15.4	0.0	4.4	0.9	0.1	0.1	4.2	0.4	5.1	1.7	3.7	4.7	0.5	1.4	2.6	4.0	0.0	2.6	0.6	0.9	1.9	1.4											6.0	2.6	10.8	1.3	3.8	16.4	14.6	5.1	4.0	4.5	3.5	35.3	0.0	3.3	1.8	0.5	3.6	0.9	0.0	0.0	0.1	5.1	2.5	0.0	18.1	0.1	7.9	0.0	2.5	6.0	1.1	19.2	3.5	3.3	5.4	0.7	11.7	0.3	2.9	26.9	6.0	12.5	0.0	10.3	0.4	0.4	5.8	0.1	26.6	4.6	1.0
KLF2	LKLF	ENSG00000127528	"Kruppel like factor 2"	Q9Y5W3	19	16324817-16327874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 353.6;Ito cells: 251.0;Smooth muscle cells: 179.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 33.3;U-266/70: 22.9;U-266/84: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055964	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055964: AB_2682989"	"unprognostic (3.22e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.56e-2)"	59.2	17.9	4.4	35.3	6.4	51.2	33.6	3.1	8.7	33.7	16.3	8.5	15.6	6.4	46.3	30.8	28.2	35.3	35.9	29.5	5.2	4.3	12.3	8.1	58.9	64.6	6.3	4.2	54.4	6.6	5.4	9.4	15.9	10.2	26.8	4.9	38.3	10.3	11.1	43.7	19.5	14.4	42.6	7.6	35.6	46.1	23.2	2.5	10.9	16.7	39.4	24.1	50.2	36.1	19.4	1.3	32.0	12.4	10.6	23.5	7.1	3.4	1.1	0.1	0.8	0.2	0.5	1.4	8.3	1.2	3.1	1.3	0.1	11.5	0.3	1.8	4.3	0.6	1.2	0.3	0.0	1.0	0.3	1.4	0.0	0.6	0.1	3.0	0.0	6.0	0.8	0.1	1.0	0.1	4.8	6.9	7.3	0.2	7.5	1.6	0.2	0.7	1.5	0.1	4.9	1.1	0.2	2.2	12.2	0.1	0.2	0.2	0.1	0.6	6.0	4.5	0.0	0.2	4.0	33.3	6.3	4.5	0.4	11.2	22.9	22.0	0.8	2.8	0.0	2.8	21.6	3.3	9.4	17.8	12.4	14.4	17.4	23.5	18.0	1.3	19.4	22.7	18.6	32.0	10.6	10.5	0.2	22.1	7.1	4.4	6.4	3.1	8.7	5.2	4.3	6.3	4.2	10.2	2.5	32.8	89.9	111.6	9.0	21.2	4.3	39.3	7.6	4.0	7.9	3.5	7.9	3.9	0.0	6.4	1.8	353.6	13.6	0.0	5.1	6.9	75.5	10.2	32.4	7.6	71.7	0.0	44.5	251.0	130.3	3.5	82.8	76.1	60.8	0.0	41.9	5.2	38.7	3.5	68.6	1.3	5.9	64.7	179.5	0.9	1.3	23.1	5.5	58.6	4.9	13.1
KLHDC10	"KIAA0265, slim"	ENSG00000128607	"Kelch domain containing 10"	Q6PID8	7	130070510-130135720	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020119	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020119: AB_2249467"	"unprognostic (2.83e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.64e-2)"	11.7	18.6	15.5	9.1	21.1	7.2	14.8	27.1	24.1	13.4	12.6	16.9	13.6	11.0	13.4	14.4	13.0	15.5	9.7	14.9	14.2	24.8	21.3	22.8	11.8	7.9	17.0	18.6	15.2	15.3	37.4	25.1	13.6	23.4	13.4	13.0	15.0	10.7	17.1	23.2	13.1	11.7	11.9	14.1	11.0	11.9	35.3	10.2	9.8	18.3	8.9	11.6	9.6	12.3	3.3	1.9	1.8	2.5	0.6	3.4	0.6	11.3	10.6	7.3	40.0	9.7	10.8	3.4	10.8	8.3	8.2	8.6	5.7	8.6	9.6	7.7	9.9	13.8	8.9	11.7	6.9	10.4	7.8	7.0	5.6	11.9	6.7	7.7	10.3	6.9	6.7	11.9	12.7	8.0	10.3	11.5	6.7	27.2	6.1	9.2	9.5	8.9	10.0	1.2	8.3	6.9	7.3	13.8	6.9	11.3	7.8	11.9	9.5	17.4	31.1	8.8	9.4	7.6	7.7	13.0	10.6	4.6	14.1	12.9	8.0	10.4	8.9	22.2	10.0	14.3	0.0	1.8	1.8	2.4	2.5	2.0	1.7	1.7	2.8	1.9	3.3	1.5	2.8	1.6	0.6	1.9	1.6	3.4	0.6	15.5	21.1	27.1	24.1	14.2	24.8	17.0	18.6	23.4	10.2	17.9	13.2	6.0	6.4	20.6	19.5	19.4	33.1	16.0	20.5	33.2	37.3	10.1	3.3	15.5	51.3	15.6	11.8	23.3	20.5	7.9	20.1	11.2	5.8	37.5	10.8	33.4	19.1	32.5	22.9	12.4	14.1	11.7	16.9	13.6	15.5	18.1	18.9	3.5	23.0	23.2	21.6	0.0	10.3	29.7	4.5	25.5	9.4	7.5	18.2	11.5
KLHDC4	DKFZp434G0522	ENSG00000104731	"Kelch domain containing 4"	Q8TBB5	16	87696485-87765992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041665	Approved		Approved	Nucleoli		Yes	No			Nucleoli		"HPA041665: AB_10796352"	"unprognostic (2.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.61e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.88e-1)"	"prognostic favorable (1.69e-4)"	12.7	12.1	13.5	23.1	15.5	17.0	12.7	15.5	15.8	9.9	13.8	14.6	16.1	13.1	17.5	14.4	12.8	13.1	17.7	10.2	14.7	12.9	11.4	16.1	12.5	21.0	14.7	13.6	12.1	20.6	15.6	14.2	8.7	12.9	11.0	15.8	10.7	16.6	16.3	30.7	15.9	12.0	12.7	15.5	14.9	14.5	26.6	12.9	22.7	14.0	14.5	19.5	12.7	11.8	6.1	6.1	4.4	11.1	17.6	14.4	6.4	6.7	12.4	6.3	9.5	2.5	3.4	9.8	6.4	6.0	10.6	5.0	18.3	9.7	10.7	8.6	5.0	3.7	11.1	9.6	8.5	7.6	1.6	10.7	6.1	7.8	12.0	6.5	5.6	6.4	1.5	4.5	9.5	10.7	5.2	8.8	18.1	19.5	5.6	7.0	29.0	13.1	16.6	10.6	7.6	9.3	12.7	7.3	6.1	6.3	7.9	9.7	9.3	13.4	6.9	3.1	5.4	10.9	9.0	5.5	5.9	10.1	3.0	12.1	27.3	9.3	46.5	5.7	14.5	4.0	0.0	6.0	4.4	14.4	7.8	12.6	6.1	6.0	11.6	4.4	5.5	6.1	9.2	0.4	17.6	11.1	6.1	5.0	6.4	13.5	15.5	15.5	15.8	14.7	12.9	14.7	13.6	12.9	12.9	0.0	15.6	9.0	8.9	4.0	14.4	8.5	12.7	9.4	15.9	8.7	25.5	12.5	10.0	9.5	50.2	6.7	11.1	23.3	14.4	7.3	5.9	11.1	3.5	11.3	11.7	11.1	23.1	9.8	16.5	59.9	6.1	6.8	8.5	9.0	12.0	6.2	11.7	11.5	7.1	19.2	17.7	0.0	6.2	19.4	11.7	5.8	10.0	30.2	18.5	15.3
KLHDC7A	FLJ38753	ENSG00000179023	"Kelch domain containing 7A"	Q5VTJ3	1	18480982-18486126	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 36.4"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 7.6;Ciliated cells: 6.7;Collecting duct cells: 8.7;Hepatocytes: 5.7;Proximal tubular cells: 8.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.9"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.3;CAPAN-2: 10.4;EFO-21: 5.4;NTERA-2: 5.8;RPTEC TERT1: 11.9;RT4: 9.4;T-47d: 10.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA056616	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA056616: AB_2683193"	"unprognostic (4.63e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.81e-9)"	"unprognostic (4.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.88e-4)"	0.6	0.0	0.0	0.3	0.2	0.0	5.0	0.5	0.5	2.5	0.6	0.7	2.6	0.3	0.0	2.6	1.8	0.8	7.4	0.3	0.0	0.0	36.4	6.9	1.4	0.0	0.1	0.6	0.2	5.7	0.0	0.3	0.3	2.9	0.5	0.7	2.8	2.2	1.2	0.0	0.1	0.4	1.0	0.1	0.0	4.8	0.2	0.0	0.0	1.6	0.3	0.8	5.5	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	5.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.1	10.4	0.0	5.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.1	0.0	0.2	0.0	0.0	11.9	9.4	2.9	0.0	0.0	0.8	0.0	1.1	10.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.5	0.5	0.0	0.0	0.1	0.6	2.9	0.0	0.0	2.7	0.0	0.1	0.1	0.0	1.2	7.6	6.7	1.2	8.7	0.0	0.0	1.7	2.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.9	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50548033-50551022	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.4;parathyroid gland: 12.5"	"Cell type enriched"	"Detected in some"	5	"monocytes: 30.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 42.3;urothelial cancer: 40.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 47.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA000518: AB_1079213, HPA076540: "	"prognostic favorable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.4	0.4	0.3	3.9	1.2	1.2	0.7	0.3	1.5	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.2	0.3	0.3	0.3	0.1	8.4	1.1	1.1	4.0	0.3	0.3	0.8	0.3	12.5	2.2	0.3	0.9	0.7	0.0	0.8	3.0	0.3	0.3	0.3	2.0	0.3	0.3	5.4	0.5	0.3	0.3	6.5	2.9	0.3	1.7	3.0	0.3	3.8	2.0	2.4	4.0	1.4	5.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.1	47.5	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.4	2.2	0.2	4.5	4.0	3.3	3.8	4.7	5.7	2.0	3.1	5.2	4.3	0.4	1.4	2.8	0.7	4.1	2.5	0.3	1.2	0.3	1.5	0.3	0.1	0.3	0.3	0.9	0.3	0.0	1.1	3.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	5.7	0.0	1.6	0.0	0.0	0.0	4.7	0.0	0.0	1.7	0.0	30.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	4.4	0.0	0.1
KLHDC9	KARCA1	ENSG00000162755	"Kelch domain containing 9"	Q8NEP7	1	161098361-161100346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 336.6;Late spermatids: 352.6;Spermatocytes: 259.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.0;HDLM-2: 3.5;HEK 293: 3.7;MCF7: 3.4;T-47d: 3.3;U-266/70: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032058, HPA043197"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA			"Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA032058: AB_10601439, HPA043197: AB_2678359"	"unprognostic (1.79e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.31e-2)"	"prognostic favorable (4.20e-6)"	"unprognostic (1.81e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	1.0	3.7	4.0	1.0	8.4	0.9	1.4	3.1	9.5	1.8	2.4	2.3	5.6	1.6	2.4	3.9	1.1	5.7	2.4	1.7	3.3	4.9	5.9	2.6	1.7	1.0	3.6	7.4	2.5	3.6	4.1	4.8	1.0	5.6	3.2	1.6	3.5	2.9	2.4	2.5	0.8	1.6	1.1	1.6	1.1	2.4	24.3	2.2	0.0	5.0	0.0	1.1	1.5	0.6	0.9	0.1	0.0	0.2	0.0	1.1	0.1	0.4	2.7	1.0	2.9	0.0	0.3	0.3	0.0	0.7	0.1	0.0	0.0	0.2	0.0	5.0	0.0	0.0	1.6	0.0	0.0	0.0	3.5	3.7	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.5	0.0	1.5	0.5	2.4	2.6	0.0	1.9	0.6	0.0	2.5	1.1	0.0	1.0	0.0	0.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	4.0	8.4	3.1	9.5	3.3	4.9	3.6	7.4	5.6	2.2	0.0	4.1	0.0	11.1	0.8	13.0	8.5	7.6	53.5	9.1	27.9	2.0	2.3	48.0	6.8	336.6	3.3	3.2	0.0	4.9	2.8	3.5	10.5	1.1	7.3	0.5	3.2	5.2	1.8	0.3	352.6	7.5	0.3	6.8	1.0	12.5	27.9	4.2	7.0	7.8	29.8	16.9	12.9	1.9	259.8	11.1	0.6	0.7	0.0	7.6	5.6
KLHL11	FLJ10572	ENSG00000178502	"Kelch like family member 11"	Q9NVR0	17	41853545-41865431	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"Early spermatids: 91.3;Late spermatids: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023021, HPA052403, HPA054269"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432"	"unprognostic (9.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.82e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.07e-2)"	4.0	4.6	7.0	3.5	10.6	15.5	5.1	10.4	13.3	4.7	6.3	6.4	3.4	3.0	6.0	3.3	4.2	6.1	3.2	7.1	5.8	5.5	4.5	3.6	4.4	4.4	5.9	9.3	7.0	5.4	9.2	7.7	4.0	10.9	5.4	3.8	5.1	4.7	6.0	12.2	5.0	5.2	4.2	3.9	4.6	4.8	25.0	5.9	5.7	8.4	2.8	5.4	6.1	4.0	3.7	2.0	0.3	1.3	1.2	3.1	1.0	2.8	7.6	4.2	8.9	3.6	2.3	6.6	2.9	3.0	3.4	3.7	6.0	1.8	9.0	3.2	3.5	3.1	8.8	11.1	4.1	6.2	4.5	5.6	3.4	10.0	4.6	2.7	4.2	3.9	2.5	1.8	4.6	7.6	2.7	3.4	5.9	3.5	9.5	3.6	2.8	7.0	1.9	3.2	1.5	1.8	6.3	9.8	5.7	1.2	6.9	10.3	4.5	5.7	18.0	2.1	4.2	9.8	1.6	4.7	4.7	6.8	4.7	4.8	5.8	5.0	7.8	5.1	3.2	4.7	0.0	1.3	0.0	1.4	0.2	3.1	2.4	2.0	1.1	2.0	3.7	1.7	1.3	0.3	1.2	1.2	0.3	1.2	1.0	7.0	10.6	10.4	13.3	5.8	5.5	5.9	9.3	10.9	5.9	0.0	0.3	0.0	1.0	0.5	2.7	0.1	0.0	0.0	2.3	0.0	3.9	0.4	0.0	0.3	91.3	0.6	0.3	0.0	0.2	0.3	0.4	0.6	0.0	0.0	0.2	7.9	0.0	0.0	0.0	33.4	0.3	1.1	1.7	1.0	0.3	2.3	0.5	0.0	0.0	0.0	3.4	6.5	0.8	2.6	2.0	0.3	0.3	1.0	0.2	0.9
KLHL12	C3IP1	ENSG00000117153	"Kelch like family member 12"	Q53G59	1	202891100-202928636	"Predicted intracellular proteins"	"ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 101.2;Late spermatids: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071324			Supported	"Vesicles,Centriolar satellite"		NA	NA		9600000	"Vesicles, Centriolar satellite"		"HPA071324: AB_2686389"	"unprognostic (1.69e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.11e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.22e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.87e-2)"	14.1	18.3	19.3	17.1	20.2	16.1	20.1	18.6	35.5	14.1	18.4	14.2	13.5	13.9	14.7	23.2	17.2	18.5	12.6	25.2	19.2	25.6	21.5	17.1	20.4	29.6	19.6	20.1	18.1	25.6	17.9	19.0	15.0	24.7	19.6	23.2	12.7	13.8	16.6	14.6	13.5	14.3	19.7	25.2	19.4	15.4	41.3	14.6	15.9	19.6	10.1	20.6	16.1	16.2	9.5	12.7	18.4	14.9	10.2	13.3	9.9	10.1	12.1	15.5	17.4	24.0	18.2	18.1	12.2	14.2	15.4	14.1	11.4	16.6	28.2	9.5	13.8	15.6	12.9	20.7	17.1	16.9	14.7	8.7	9.9	9.5	11.4	17.4	20.6	16.5	17.3	21.8	13.3	29.3	12.1	13.7	28.8	24.6	18.7	20.9	13.6	17.1	10.0	22.0	12.7	9.2	18.2	27.1	18.0	13.3	12.5	11.5	13.1	15.2	13.9	16.4	29.4	25.3	14.5	11.1	15.1	10.6	3.6	10.8	13.5	10.8	23.8	14.7	14.8	14.3	9.2	12.0	18.4	9.1	14.9	13.2	9.5	9.1	10.8	12.7	9.3	9.6	10.3	12.4	10.2	14.7	7.6	13.3	9.9	19.3	20.2	18.6	35.5	19.2	25.6	19.6	20.1	24.7	14.6	6.0	8.6	6.9	9.0	4.7	9.9	14.6	7.6	2.7	4.5	15.7	11.8	9.8	19.9	10.1	101.2	6.4	11.1	0.0	7.9	10.1	6.7	8.5	3.5	5.9	14.9	4.8	10.4	11.1	12.3	66.5	7.8	9.8	5.0	15.4	14.3	10.8	10.2	10.5	7.8	12.3	9.0	6.5	6.2	16.9	45.6	5.8	9.3	11.4	12.1	6.4
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 35.6"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 25.4;Distal tubular cells: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;eosinophil: 9.3;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;granulocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 12.8;HeLa: 22.7;RH-30: 14.3;RPTEC TERT1: 40.8;SH-SY5Y: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.4	5.5	3.4	3.9	11.9	0.2	19.0	2.5	3.7	24.9	5.3	3.1	6.6	2.2	35.6	5.6	5.4	8.1	10.1	9.0	2.3	4.0	15.4	3.3	1.4	0.4	4.7	2.1	7.7	3.3	3.5	5.0	1.7	6.6	7.3	3.0	5.6	2.6	9.7	2.3	1.5	4.9	22.2	3.5	1.1	3.5	2.8	4.9	3.6	1.4	3.1	1.2	8.2	5.0	0.0	5.6	9.3	0.1	1.4	0.9	0.4	0.4	0.1	2.6	5.5	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.4	0.0	0.0	6.3	0.0	0.2	6.3	12.8	2.1	0.0	0.0	4.9	0.1	22.7	0.0	0.3	0.4	0.8	0.7	0.9	0.0	0.2	2.7	9.7	0.0	0.0	0.0	0.0	0.5	2.1	0.5	5.1	0.0	3.6	0.0	14.3	0.0	40.8	1.5	0.0	36.4	0.1	0.4	0.3	1.1	7.9	0.0	0.2	0.9	1.1	0.7	3.2	0.1	0.0	0.0	3.9	0.0	1.5	3.2	0.1	9.3	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.9	0.8	0.0	1.4	0.0	5.6	0.4	0.4	3.4	11.9	2.5	3.5	2.3	4.0	4.7	2.1	6.6	4.9	0.0	0.0	0.0	5.5	0.7	3.9	5.8	0.0	25.4	5.7	1.8	0.0	0.1	24.9	1.1	0.3	0.7	1.6	0.0	2.9	0.1	2.6	1.5	0.0	1.0	0.5	0.0	1.2	4.3	0.0	0.7	5.8	0.0	1.7	0.0	2.0	8.4	1.2	3.5	1.8	8.5	1.1	6.5	3.2	1.2	12.0	0.4	0.0	0.0	2.3	1.7
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672671-32773062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 14.6;seminal vesicle: 19.3"	"Cell type enhanced"	"Detected in some"	23	"B-cells: 6.0;Collecting duct cells: 7.0;Muller glia cells: 21.8"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	97	"memory B-cell: 10.7;naive B-cell: 8.5"	"Lineage enriched"	"Detected in single"	108	"B-cells: 10.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;Hep G2: 16.8;REH: 4.5;RPTEC TERT1: 9.4;SCLC-21H: 3.6;U-698: 4.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"hippocampal formation: 22.7;olfactory region: 20.4"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.6	0.1	0.4	1.0	0.4	1.5	0.6	0.4	1.0	2.4	0.4	0.4	14.6	0.0	1.5	1.4	0.4	6.3	0.4	0.4	0.4	0.3	4.3	0.4	0.4	5.1	0.4	0.4	1.1	0.4	10.3	1.1	0.4	1.5	1.6	0.0	1.0	0.4	19.3	0.4	0.1	2.3	0.4	0.4	9.5	0.1	2.8	0.4	0.4	11.7	0.4	3.8	0.4	0.7	10.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.5	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	16.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.5	1.5	0.0	9.4	0.0	3.6	0.4	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.4	1.0	0.4	0.3	0.4	0.4	1.5	0.4	0.0	0.0	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	3.3	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.3	1.0	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0
KLHL15	KIAA1677	ENSG00000174010	"Kelch like family member 15"	Q96M94	X	23983720-24027186	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 25.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065730	Uncertain		Approved	Aggresome,Cytosol		NA	NA			Cytosol	Aggresome	"HPA065730: AB_2685547"	"unprognostic (5.89e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-3)"	"unprognostic (7.42e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.40e-2)"	2.9	6.1	1.7	1.3	2.3	25.1	1.3	2.8	1.8	1.9	2.0			1.0	2.3	4.0	4.3	3.8	1.9	2.1	1.6	1.9	2.2	6.4	1.6	1.4	1.3		4.6	2.9	4.3	2.6	1.2		2.8	1.2		1.3	1.8	2.6	1.0	1.5	2.2	1.6	1.5	3.4	9.0			2.3		1.2	1.3	1.1	1.4	2.1	2.8	2.6	1.6	2.8	1.3	4.3	4.2	4.7	6.8	7.0	5.0	4.8	7.0	6.1	3.2	3.9	3.8	3.9	11.3	2.5	4.5	5.1	3.3	7.4	3.8	7.9	4.4	15.3	7.2	11.3	2.0	4.4	9.4	5.1	5.2	2.0	5.5	5.5	2.9	2.3	6.8	4.6	16.0	6.0	1.5	8.4	9.2	8.8	2.2	5.2	6.7	8.5	7.0	3.0	3.8	12.4	5.8	9.7	2.4	8.0	6.2	3.2	8.4	2.9	5.0	3.0	9.8	4.5	8.9	8.9	13.1	3.9	6.1	3.9	1.5	1.1	2.8	2.0	2.6	2.8	1.0	1.8	2.3	2.1	1.4	2.4	2.4	1.5	1.6	2.6	1.7	1.8	1.3											6.0	6.4	7.5	3.7	16.0	7.7	9.8	2.5	1.4	6.8	3.5	11.8	0.4	0.0	1.2	1.8	4.4	2.6	0.0	1.2	0.7	6.1	5.3	8.1	11.5	3.2	19.1	8.1	6.2	9.8	1.7	3.1	7.2	11.8	1.8	2.9	11.8	1.7	0.0	3.9	2.1	7.4	0.0	19.6	3.0	13.5	8.7	1.1	5.0	4.0	2.5
KLHL18	"FLJ13703, KIAA0795"	ENSG00000114648	"Kelch like family member 18"	O94889	3	47282917-47346816	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035027, HPA035028"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA035027: AB_10602340, HPA035028: AB_10669899"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.67e-1)"	9.1	9.0	11.5	9.7	12.2	21.1	7.1	16.7	15.7	7.8	8.2	10.4	11.7	6.8	9.1	8.4	13.8	7.7	8.5	9.3	8.8	9.4	7.2	5.8	9.6	9.7	7.7	13.5	6.6	8.5	13.9	9.8	8.6	10.6	8.2	7.4	16.0	7.2	10.7	23.7	20.0	8.4	10.3	6.3	13.9	7.6	9.6	9.9	7.0	11.3	9.3	11.2	9.5	10.1	3.5	6.7	4.6	14.0	1.1	3.7	4.5	7.4	9.6	7.4	10.9	8.2	5.9	5.3	10.2	5.3	10.4	8.5	10.1	4.6	14.5	5.8	8.5	9.5	4.6	22.2	10.8	10.8	11.4	7.4	21.3	13.8	9.2	8.4	11.3	9.8	6.8	8.4	14.9	14.0	5.8	11.5	8.0	25.7	6.1	8.3	6.1	8.6	6.6	13.5	6.0	19.3	6.0	4.9	8.5	9.8	14.1	5.1	6.8	7.1	8.8	5.1	7.9	5.1	6.3	12.0	9.7	9.9	11.0	12.8	6.9	13.2	12.7	6.2	13.2	10.1	4.6	10.2	3.2	1.9	9.2	2.9	3.5	1.5	3.7	6.7	2.1	1.3	1.8	4.5	1.1	14.0	1.8	1.5	4.5	11.5	12.2	16.7	15.7	8.8	9.4	7.7	13.5	10.6	9.9	11.9	10.7	16.7	8.4	10.1	66.8	53.4	2.5	5.3	5.7	3.5	19.6	9.3	18.3	13.9	2.4	13.5	11.0	23.3	12.8	10.4	6.6	8.2	34.7	16.3	25.5	12.7	9.1	16.5	25.7	2.1	5.5	16.7	0.0	10.8	8.2	12.5	14.5	10.5	7.8	19.2	47.9	6.5	11.7	10.1	15.0	18.3	11.8	10.0	8.9	9.5
KLHL2	MAV	ENSG00000109466	"Kelch like family member 2"	O95198	4	165207618-165323156	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.6"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 10.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051637			Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA051637: "	"unprognostic (1.14e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.67e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.81e-1)"	10.5	11.2	25.1	10.4	36.0	16.4	12.1	9.7	41.6	6.1	5.8	19.6	4.0	5.0	7.0	13.4	15.8	8.9	9.5	5.0	37.2	17.7	13.3	23.8	10.6	9.4	25.7	14.7	3.8	6.6	5.3	18.4	6.9	15.1	7.8	6.5	4.0	16.3	9.7	3.2	4.7	5.6	9.6	25.7	11.1	7.4	5.4	25.0	1.6	11.3	3.4	8.4	10.9	7.2	1.3	1.2	10.8	1.9	0.3	1.6	0.6	8.7	8.1	5.6	5.8	8.7	7.8	6.0	11.9	9.4	6.2	6.7	4.8	6.6	9.1	3.0	6.0	11.0	6.1	9.1	6.3	8.0	14.8	3.5	7.6	7.2	7.5	7.6	7.8	11.1	6.5	18.0	5.6	21.2	10.9	14.8	3.4	3.4	19.2	9.5	3.3	0.2	2.5	3.4	5.0	3.6	3.1	4.2	2.8	11.3	8.5	28.8	4.8	7.5	2.7	7.2	10.9	1.8	8.9	20.4	4.9	10.1	5.6	8.0	12.5	8.7	7.3	6.0	5.6	9.6	1.9	1.4	1.9	0.8	1.4	0.5	0.4	0.6	0.5	1.2	1.3	1.4	1.6	10.8	0.3	1.9	0.7	0.7	0.6	25.1	36.0	9.7	24.7	37.2	17.7	25.7	14.7	15.1	25.0	6.0	14.1	5.6	11.1	5.4	8.3	4.0	7.6	5.3	7.9	21.0	13.7	3.5	23.2	6.7	1.1	13.4	4.1	0.0	11.3	8.3	5.4	10.1	9.2	30.8	7.4	30.2	14.9	17.2	40.5	1.3	3.7	20.7	5.0	4.6	4.7	3.2	8.8	4.8	4.2	14.7	6.4	0.0	6.8	2.1	7.1	6.6	3.1	7.0	3.1	16.1
KLHL22	"FLJ14360, KELCHL"	ENSG00000099910	"Kelch like family member 22"	Q53GT1	22	20441519-20495883	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040766			Supported	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA040766: AB_2732488"	"unprognostic (4.15e-1)"	"unprognostic (9.34e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.88e-6)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.99e-2)"	"prognostic favorable (3.85e-6)"	"unprognostic (3.94e-2)"	"prognostic favorable (1.34e-8)"	"unprognostic (3.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.08e-2)"	10.8	12.4	15.2	11.2	17.8	8.6	9.6	26.9	24.0	15.4	10.7	11.8	13.1	6.5	17.8	15.7	8.5	15.1	15.9	11.2	14.2	14.9	13.7	9.0	11.1	13.1	11.5	16.3	19.8	16.3	20.7	14.7	13.2	10.9	16.6	9.2	17.0	11.3	16.2	16.3	9.9	8.0	19.0	7.8	12.5	9.9	8.3	9.6	5.0	18.5	6.8	17.1	11.1	12.3	7.1	12.9	15.1	6.6	13.7	16.0	5.1	9.0	8.9	20.1	16.7	17.2	19.8	5.0	11.6	19.2	11.9	13.1	4.6	3.4	6.0	3.9	20.4	9.2	11.6	13.9	5.2	10.6	12.3	7.5	5.7	8.7	4.5	15.8	1.4	6.7	15.3	7.9	10.3	7.3	14.7	16.5	4.9	16.7	6.4	11.5	14.2	1.2	8.5	3.5	7.1	6.4	12.5	7.4	0.3	6.9	11.0	10.9	11.3	12.0	9.3	8.4	7.3	8.2	5.0	7.3	14.4	6.9	9.7	4.8	3.6	3.7	4.5	7.6	5.6	9.3	5.4	3.6	15.1	7.3	5.1	5.7	7.1	9.3	6.6	12.9	6.1	7.3	7.3	8.7	13.7	6.6	4.9	16.0	5.1	15.2	17.8	26.9	24.0	14.2	14.9	11.5	16.3	10.9	9.6	0.0	3.0	3.7	2.7	1.4	10.8	4.1	10.2	4.0	3.4	8.7	3.9	13.9	3.3	7.6	0.2	3.0	2.1	0.0	2.2	5.8	5.5	3.4	4.7	5.0	6.9	12.7	2.9	4.3	4.3	1.3	11.2	3.4	1.7	1.8	4.8	12.8	5.3	3.2	18.7	7.3	5.9	6.5	4.7	6.2	7.7	1.3	11.2	6.9	3.5	1.3
KLHL23	"FLJ37812, MGC22679, MGC2610"	ENSG00000213160	"Kelch like family member 23"	Q8NBE8	2	169694488-169776989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 108.6;Cone photoreceptor cells: 84.4;Sertoli cells: 168.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.0;NK-cells: 6.6;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047593			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA047593: "	"unprognostic (4.77e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.87e-3)"	6.8	2.5	14.1	6.1	13.6	1.8	8.3	16.4	16.4	11.9	26.0	6.9	7.5	11.3	26.7	5.8	12.7	11.4	8.7	10.8	12.7	10.7	7.1	6.3	7.8	3.2	8.9	14.3	19.3	7.9	8.8	17.2	13.0	8.1	14.6	14.7	8.6	8.1	13.8	11.0	2.5	11.8	25.4	8.7	2.9	8.6	20.1	7.9	9.1	10.3	4.5	3.3	11.0	6.2	0.8	2.0	0.1	0.1	6.6	2.3	0.7	6.2	3.2	24.6	6.9	1.4	0.5	16.8	3.0	2.3	5.5	6.1	6.8	5.4	3.9	2.5	0.3	8.0	1.0	25.5	2.1	8.4	13.7	12.5	11.5	6.5	11.0	2.1	16.0	1.8	1.0	1.8	2.3	3.9	3.6	4.2	14.4	15.6	0.5	1.8	3.0	23.4	6.5	20.1	3.3	2.5	7.5	21.0	0.4	5.0	18.6	32.0	22.0	4.7	0.4	2.8	8.1	4.0	5.2	1.5	2.2	7.2	2.1	5.0	1.8	1.7	17.5	1.7	4.8	3.4	0.0	0.1	0.0	1.6	0.0	2.2	0.6	1.4	1.2	0.2	0.8	2.3	2.2	0.1	6.6	0.0	2.0	1.6	0.7	14.1	13.6	16.4	13.1	12.7	10.7	8.9	14.3	8.1	7.9	3.0	5.4	0.0	5.8	1.3	108.6	41.9	17.8	6.7	6.8	0.0	84.4	3.7	3.3	15.1	3.0	5.6	8.0	0.0	27.4	7.4	3.9	14.9	0.0	10.2	0.8	38.1	30.6	8.6	1.0	2.7	2.3	1.0	0.0	0.0	19.5	12.9	16.7	14.1	8.1	13.4	35.6	168.1	38.7	3.2	9.8	0.9	1.0	4.3	20.2	3.9
KLHL25	"ENC-2, ENC2, FLJ12587"	ENSG00000183655	"Kelch like family member 25"	Q9H0H3	15	85759323-85795030	"Predicted intracellular proteins"	"Translation regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 31.5"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 12.1;Horizontal cells: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 6.1;NK-cells: 5.1;T-cells: 3.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 36.7;hippocampal formation: 25.8"	HPA023450	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023450: AB_1852583"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.66e-2)"	10.6	4.2	5.2	6.8	12.1	1.5	12.7	3.9	21.5	4.7	4.8	7.5	7.7	9.9	7.9	7.2	8.2	6.2	5.2	4.2	5.7	5.9	4.3	18.3	4.8	4.0	5.3	5.8	4.4	3.6	4.4	4.6	2.8	5.4	5.7	2.9	3.8	6.2	7.6	7.8	9.7	7.0	6.2	3.0	2.6	7.5	16.3	4.3	3.7	4.7	2.5	3.9	4.1	31.5	0.6	1.2	0.5	6.1	5.1	3.5	1.0	2.3	7.2	10.5	5.1	2.1	1.2	5.4	3.0	1.4	4.3	3.2	9.6	4.0	1.5	1.6	2.5	2.7	5.9	11.3	5.7	0.9	1.4	5.2	0.4	3.0	7.3	2.5	0.4	1.9	2.2	1.9	4.1	1.4	1.9	2.3	5.2	0.6	1.4	1.8	4.4	3.7	2.3	9.5	4.1	3.8	7.6	6.3	2.4	1.6	5.0	14.7	10.2	4.4	5.1	1.9	4.5	9.3	0.6	1.9	4.5	8.2	2.9	5.4	1.5	3.1	1.5	2.0	2.6	2.5	0.0	0.2	0.5	2.0	2.3	1.1	0.1	2.1	1.5	0.5	0.6	3.5	2.2	0.0	5.1	6.1	1.2	1.8	1.0	5.2	12.1	3.9	11.1	5.7	5.9	5.3	5.8	5.4	4.3	0.0	3.4	0.0	4.2	2.4	1.9	2.5	2.5	1.4	1.2	0.0	0.0	0.7	1.7	1.8	12.1	2.1	3.8	0.0	2.3	1.2	1.9	3.4	0.0	9.6	0.7	12.7	10.3	3.1	1.5	3.1	0.9	0.7	6.8	1.0	6.6	2.2	3.8	2.9	1.4	1.7	0.9	6.5	2.3	3.2	3.9	4.1	1.5	1.5	2.8	3.5
KLHL28	"BTBD5, FLJ20081"	ENSG00000179454	"Kelch like family member 28"	Q9NXS3	14	44924319-45042322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000988			Approved	Cytosol		NA	NA			Cytosol		"HPA000988: AB_1845480"	"unprognostic (8.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.84e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.36e-3)"	"unprognostic (4.92e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.53e-2)"	10.9	9.0	8.8	11.6	12.7	39.2	10.4	22.9	15.5	12.1	9.9	11.1	10.5	9.1	12.6	9.4	12.8	11.2	9.9	8.9	10.3	10.4	8.6	11.2	10.1	13.5	11.2	9.4	14.4	10.6	9.8	18.1	9.9	16.7	10.2	10.8	12.2	12.6	9.0	13.8	11.5	11.0	10.5	12.8	11.5	8.8	14.2	10.9	27.9	13.6	8.6	12.7	11.3	10.8	10.2	6.0	17.7	7.0	13.0	23.1	4.5	4.5	6.9	9.2	6.0	8.4	7.6	7.0	6.1	6.8	9.1	7.7	3.0	7.2	6.8	6.7	10.6	2.4	8.0	8.2	6.5	10.0	12.6	4.4	5.9	7.1	3.5	7.5	9.4	12.9	5.8	9.1	5.8	9.3	5.2	7.2	10.7	5.2	17.0	5.2	6.6	7.4	4.8	5.7	5.2	6.6	6.5	10.3	3.7	5.2	8.3	10.6	6.5	7.9	5.3	8.4	6.2	10.0	4.0	9.1	8.1	9.5	5.7	3.4	10.1	11.0	9.4	2.8	4.2	4.9	17.7	5.0	11.9	12.4	6.9	23.1	10.2	12.4	13.0	4.4	9.6	14.9	12.6	11.6	13.0	7.0	6.0	9.3	4.5	8.8	12.7	22.9	15.5	10.3	10.4	11.2	9.4	16.7	10.9	14.9	6.5	22.3	14.8	21.8	23.0	10.7	7.6	18.7	11.4	17.4	33.4	6.0	6.6	8.4	28.5	11.7	10.5	23.3	4.9	6.4	12.6	10.9	18.5	10.5	8.1	14.3	13.4	14.7	16.2	34.2	20.1	15.3	21.9	12.6	11.1	27.6	9.0	11.6	16.6	6.3	20.9	12.9	16.0	9.9	4.2	26.3	11.8	25.5	10.0	13.6
KLHL29	"KBTBD9, KIAA1921"	ENSG00000119771	"Kelch like family member 29"	Q96CT2	2	23385217-23708611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.5;RH-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049057, HPA057379"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA049057: AB_2680615, HPA057379: AB_2683422"	"unprognostic (8.08e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.12e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.25e-4)"	9.5	20.8	8.9	6.4	14.5	0.8	7.4	9.0	11.7	6.7	9.4	2.6	5.2	2.6	10.9	3.5	5.4	4.8	10.7	3.3	6.7	7.5	4.7	5.4	6.2	5.7	3.6	9.0	4.0	4.7	5.8	17.7	7.6	6.3	10.8	3.4	11.7	4.2	11.7	12.0	6.9	4.2	7.2	2.7	10.6	5.5	2.5	3.7	0.5	1.9	1.8	4.0	7.5	6.4	0.1	0.4	0.0	0.0	0.9	0.7	0.0	1.0	0.9	6.0	3.0	5.7	3.8	10.3	6.1	4.7	2.5	1.8	0.0	0.3	3.9	2.1	2.3	13.5	0.2	1.4	5.2	1.7	0.0	6.3	0.0	5.1	0.0	2.0	0.0	7.9	2.7	7.1	3.3	9.3	0.8	4.2	0.1	0.0	0.0	1.3	0.5	1.3	0.0	3.0	0.0	1.8	0.3	15.4	0.0	4.6	1.8	9.0	1.8	0.8	0.6	3.5	2.5	0.0	0.0	4.2	2.5	11.7	5.3	2.1	0.1	0.0	0.0	9.5	0.4	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.9	0.0	0.4	0.0	0.0	8.9	14.5	9.0	11.7	6.7	7.5	3.6	9.0	6.3	3.7	6.0	4.0	0.0	9.1	4.1	2.3	2.0	5.1	1.4	1.2	1.8	25.5	0.7	0.0	1.0	1.7	1.4	0.0	0.0	0.2	0.9	1.7	1.7	0.0	0.4	0.2	1.6	4.1	0.6	0.0	0.0	4.6	0.0	1.7	0.0	0.6	1.3	0.4	0.0	3.9	1.3	23.5	6.5	5.1	0.0	1.1	5.1	0.7	0.0	0.2	1.3
KLHL30	FLJ43374	ENSG00000168427	"Kelch like family member 30"	Q0D2K2	2	238138722-238152947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 62.8"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 11.5;Smooth muscle cells: 5.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;CAPAN-2: 3.2;EFO-21: 3.1;REH: 2.6;RH-30: 8.8;THP-1: 4.3"	"Region enriched"	"Detected in single"	35	"olfactory region: 11.6"	"Low region specificity"	"Detected in all"			HPA062095			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA062095: AB_2684680"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.07e-4)"	"unprognostic (6.02e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.17e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	4.4	0.1	0.1	0.3	0.1	0.1	2.4	0.1	0.1	1.2	0.5	0.1	0.1	0.2	1.2	2.3	1.3	0.4	0.4	6.1	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.7	0.3	1.4	0.1	0.8	1.7	0.6	62.8	0.2	0.3	1.5	0.1	0.1	0.3	0.4	0.0	0.0	0.9	8.7	0.2	1.6	1.4	0.7	1.4	1.1	2.5	0.5	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.0	6.1	0.0	0.1	0.1	0.0	0.2	3.2	0.0	3.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.5	0.0	0.3	2.2	0.2	0.0	0.0	2.6	8.8	1.4	0.7	0.0	0.1	0.2	0.1	0.8	0.3	0.5	0.0	4.3	0.0	0.1	0.5	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.1	0.5	2.5	0.3	0.2	0.5	0.2	0.7	0.1	0.1	1.4	0.6	0.2	0.3	1.1	0.5	0.3	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL35	FLJ33790	ENSG00000149243	"Kelch like family member 35"	Q6PF15	11	75422394-75430629	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1;testis: 11.2"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 33.0;Early spermatids: 21.7;Late spermatids: 21.4;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.4;T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.2;HMC-1: 9.5;PC-3: 8.2;SiHa: 16.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039864, HPA070736"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		NA	NA			"Nucleoplasm, Centrosome"	"Nucleoli fibrillar center"	"HPA039864: AB_10794204, HPA070736: "	"unprognostic (3.53e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.28e-1)"	1.1	3.4	4.5	0.7	14.1	0.7	3.5	1.8	8.2	3.2	1.0	3.0	0.2	0.7	0.5	1.0	1.0	2.0	1.1	1.1	3.7	6.2	0.6	0.6	2.7	0.7	3.1	3.3	0.5	4.5	0.5	0.8	0.8	6.2	0.7	0.6	0.7	1.3	1.0	0.9	1.2	0.5	1.1	4.3	1.0	2.3	11.2	2.4	0.0	1.4	0.0	0.7	0.7	0.2	0.2	0.8	5.4	0.3	0.0	2.1	1.2	0.0	0.3	0.1	0.0	0.2	1.3	0.0	0.8	0.0	0.8	0.1	14.2	1.2	0.0	4.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.8	3.6	9.5	0.2	0.2	0.0	0.0	0.1	0.4	2.5	0.0	0.0	1.0	0.6	0.3	0.1	0.1	2.8	8.2	0.0	0.0	0.8	0.7	0.1	1.1	0.9	16.7	3.1	0.0	0.0	3.2	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	2.1	0.0	0.5	0.0	1.2	0.7	0.8	0.2	0.3	0.5	0.1	0.0	0.3	0.0	0.0	1.2	4.5	14.1	1.8	7.1	3.7	6.2	3.1	3.3	6.2	2.4	8.9	4.3	0.0	1.5	1.1	33.0	0.8	0.0	2.7	4.5	3.5	7.9	1.3	3.3	1.7	21.7	1.0	0.2	0.0	2.7	1.4	2.5	0.9	4.6	0.0	1.1	1.6	4.1	3.7	0.0	21.4	2.6	2.1	1.7	2.8	1.0	2.0	2.6	0.0	1.1	0.1	11.0	6.5	1.4	7.5	37.1	1.9	2.1	0.0	0.6	0.7
KLHL36	"C16orf44, FLJ12543"	ENSG00000135686	"Kelch like family member 36"	Q8N4N3	16	84648525-84667686	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023423	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA023423: AB_10962985"	"unprognostic (6.50e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.59e-2)"	"prognostic favorable (9.81e-5)"	"unprognostic (3.79e-3)"	"prognostic favorable (5.52e-10)"	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.67e-3)"	14.6	10.3	13.7	10.8	14.8	26.3	12.2	12.1	11.7	8.9	9.7	7.5	13.0	13.7	11.1	11.1	13.8	10.4	10.1	12.6	10.8	6.0	11.6	16.2	12.7	12.3	10.2	8.6	14.7	21.9	12.7	10.1	9.2	8.7	12.1	5.6	8.8	13.5	12.4	7.8	11.9	14.9	12.0	6.7	16.8	13.1	21.3	10.5	8.4	13.9	7.2	14.0	15.1	22.6	5.9	5.4	8.8	3.7	3.1	10.4	3.2	12.4	13.4	2.5	6.7	2.6	4.8	13.2	8.7	4.8	3.9	2.1	11.8	8.9	8.6	12.8	5.3	3.9	13.3	2.7	7.2	1.8	5.6	5.4	3.0	4.4	6.5	3.5	3.7	8.6	4.6	5.4	5.1	4.0	4.2	4.7	2.6	9.6	1.5	2.8	19.6	0.5	5.3	4.9	4.1	5.9	11.8	3.3	4.2	5.4	11.6	3.8	2.8	11.0	2.8	5.4	3.2	12.0	8.7	10.6	5.0	9.3	5.5	5.8	5.1	6.4	14.8	6.8	4.5	14.9	5.3	3.7	8.8	4.9	2.5	4.1	5.9	8.7	7.1	5.4	5.7	10.4	7.2	4.8	3.1	2.6	4.9	4.0	3.2	13.7	14.8	12.1	11.7	10.8	6.0	10.2	8.6	8.7	10.5	17.9	14.4	23.8	31.2	14.2	21.2	22.4	40.8	10.7	7.9	21.0	33.4	19.3	5.0	22.4	31.8	16.8	29.1	0.0	12.6	9.5	14.3	40.6	6.9	17.9	16.8	25.4	17.9	18.4	15.8	11.8	21.6	15.6	20.3	19.8	20.4	8.6	17.7	24.6	23.7	23.0	22.3	32.3	21.7	14.8	4.7	15.4	16.1	20.8	18.6	36.1
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 72.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.5;SK-MEL-30: 1.7;U-2197: 9.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.5	0.7	0.6	0.1	0.1	16.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.1	72.0	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.8	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.7	0.0	1.0	0.0	0.0	0.0	0.2	9.7	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL4	"DKELCHL, KHL4, KIAA1687"	ENSG00000102271	"Kelch like family member 4"	Q9C0H6	X	87517749-87670050	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 34.4;brain: 16.3"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 4.0;Cone photoreceptor cells: 7.9;Endothelial cells: 5.7;Ito cells: 9.8;Rod photoreceptor cells: 4.2"	"Cancer enriched"	"Detected in some"	8	"glioma: 9.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;GAMG: 13.0;hTERT-RPE1: 9.2;HUVEC TERT2: 20.2;NTERA-2: 15.2;SuSa: 11.3;TIME: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029192	Approved		Supported	"Microtubules,Centriolar satellite"		NA	NA			Microtubules	"Centriolar satellite"	"HPA029192: AB_10602341"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.25e-4)"	2.3	34.4	6.8	1.0	12.1	0.5	1.9	1.1	11.2	2.4	1.0	16.3	0.9	0.7	4.8	1.4	1.3	3.7	2.5	1.5	7.0	4.0	2.1	1.4	1.8	1.0	15.9	7.4	11.7	0.9	0.6	0.6	0.6	11.9	1.1	1.1	0.0	0.5	2.8	0.8	0.6	0.9	8.0	12.7	2.4	0.9	9.7	16.2	0.0	1.4	0.2	0.7	1.9	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.2	0.0	2.8	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.7	0.0	0.9	0.2	0.0	1.9	0.0	8.0	0.1	0.0	1.3	3.8	4.1	1.0	9.2	20.2	0.0	0.1	1.7	5.4	0.0	0.0	0.0	15.2	0.1	3.9	0.0	8.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	11.3	0.0	0.0	22.1	0.0	4.7	0.0	0.3	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.2	6.8	12.1	1.1	11.2	7.0	4.0	15.9	7.4	11.9	16.2	0.0	0.0	0.0	0.0	0.1	2.2	1.4	0.0	4.0	0.0	0.0	7.9	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.3	0.9	0.9	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.4	2.8	4.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487531-183555689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.2"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 16.2;Ciliated cells: 18.7;granulocytes: 47.6;Hofbauer cells: 22.0;Kupffer cells: 16.7;Macrophages: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.4;HEL: 9.8;HMC-1: 10.3;U-266/70: 31.6;U-266/84: 16.4;U-698: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"		Yes	NA			"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	4.4	1.2	1.4	43.2	3.3	2.9	2.2	0.5	1.8	1.7	4.1	2.4	0.5	2.3	1.1	0.3	1.7	4.2	2.3	1.9	1.8	1.3	1.4	1.4	8.0	23.8	4.4	0.0	0.7	0.8	0.2	1.0	1.8	2.8	1.4	2.2	0.8	4.6	0.6	0.7	0.8	9.9	0.7	8.8	15.1	3.5	0.7	2.3	21.4	1.6	0.5	34.5	2.8	2.7	4.4	5.2	13.3	3.3	2.8	4.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	9.8	0.0	0.0	0.0	2.6	10.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.1	7.0	0.0	0.0	3.2	1.5	0.0	0.0	0.0	5.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.0	0.0	31.6	16.4	46.4	0.0	2.9	0.0	7.1	3.3	13.3	0.8	2.7	0.9	4.4	3.0	1.3	2.3	3.3	3.6	2.2	3.1	2.8	3.0	5.2	4.8	2.7	1.4	3.3	0.5	1.8	1.8	1.3	4.4	0.0	2.8	2.3	6.0	9.2	16.2	1.5	1.0	0.6	3.2	0.0	18.7	9.1	0.0	2.0	0.2	0.0	0.0	1.5	2.9	0.0	0.0	0.0	0.2	1.1	1.1	47.6	0.0	22.0	0.0	0.0	1.8	16.7	0.0	0.3	17.0	8.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.5	0.5	10.8	0.0	1.0
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 452.0;Late spermatids: 236.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	7.5	14.6	9.2	5.6	13.0	8.2	10.3	12.6	15.1	8.8	5.7	7.9	4.7	5.9	9.1	9.9	7.7	7.4	7.6	37.1	8.1	8.7	9.2	7.7	6.4	5.8	8.3	9.7	9.6	5.9	7.1	6.1	6.5	15.9	8.1	6.3	8.6	7.2	6.8	7.4	8.6	5.8	8.1	10.6	5.8	5.2	40.7	6.2	9.6	7.2	5.1	6.7	6.9	7.1	5.5	5.5	32.0	8.7	4.2	8.0	6.0	10.9	9.4	25.9	30.6	12.7	11.1	9.5	9.7	14.4	14.3	16.7	11.4	8.0	10.8	7.9	11.8	23.7	11.9	9.9	6.8	12.1	2.8	7.1	7.1	8.1	14.6	9.5	14.3	5.6	9.8	8.9	16.4	13.5	11.4	18.2	13.4	12.4	11.8	23.3	12.6	11.9	22.8	35.7	7.5	11.2	10.6	14.5	9.8	13.4	9.5	15.6	15.3	21.1	10.5	9.9	16.6	8.7	7.5	7.7	12.1	12.6	26.5	11.5	18.6	15.2	25.7	8.0	15.2	14.4	18.7	7.8	32.0	6.8	8.7	7.1	4.5	7.3	6.4	5.5	5.5	5.5	5.4	7.4	4.2	7.5	4.0	8.0	6.0	9.2	13.0	12.6	15.1	8.1	8.7	8.3	9.7	15.9	6.2	20.8	5.6	13.3	15.2	20.9	19.9	85.8	5.1	16.0	9.1	8.7	27.5	18.6	10.0	15.7	452.0	14.1	4.9	0.0	15.3	24.1	17.0	11.5	20.8	5.9	16.7	35.0	10.4	14.1	15.3	236.4	15.5	14.1	11.8	12.6	7.6	23.5	14.7	0.0	19.4	9.8	15.0	6.5	19.1	94.0	10.6	29.5	19.8	15.2	6.4	22.7
KLHL9	"FLJ13568, KIAA1354"	ENSG00000198642	"Kelch like family member 9"	Q9P2J3	9	21329671-21335380	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (7.82e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (9.43e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.33e-3)"	17.8	15.1	16.4	12.4	15.6	9.3	20.8	18.0	19.5	19.7	14.4	19.4	12.7	8.7	19.5	18.7	14.8	16.8	12.6	13.6	15.8	19.9	17.8	15.1	13.6	13.2	16.9	11.9	25.3	20.4	18.1	16.9	22.6	15.7	20.0	15.1	15.3	16.2	14.8	9.3	10.1	15.6	17.6	16.9	17.3	16.1	9.9	13.2	23.0	19.9	11.6	13.5	15.7	16.5	3.4	5.0	16.7	7.2	6.0	8.3	4.5	6.0	7.3	16.7	9.0	21.6	21.5	3.6	11.3	11.5	8.6	9.7	2.7	4.8	2.7	7.3	16.5	8.6	3.3	9.7	11.0	10.7	15.0	7.0	0.0	13.8	7.1	15.1	4.7	3.3	21.1	11.9	6.7	10.9	14.1	13.0	0.0	0.0	3.6	19.6	3.8	9.8	16.6	6.8	6.2	6.3	0.0	7.3	3.2	10.6	7.5	5.3	10.1	6.5	5.9	6.9	16.1	10.7	0.0	15.6	0.0	6.1	4.8	6.5	3.9	5.3	2.9	0.0	5.0	5.8	7.5	6.2	16.7	5.5	6.9	6.2	3.4	6.7	5.0	5.0	2.6	8.3	5.6	2.0	6.0	7.2	3.7	4.6	4.5	16.4	15.6	18.0	19.5	15.8	19.9	16.9	11.9	15.7	13.2	23.8	15.6	6.9	27.6	9.2	23.8	16.3	17.8	16.0	29.6	15.7	17.7	13.6	10.0	13.1	0.6	16.1	14.7	0.0	13.1	6.3	14.6	21.4	11.5	19.5	12.9	17.5	26.5	43.6	22.7	0.9	19.8	10.3	16.9	6.4	23.0	18.7	11.5	17.5	22.6	20.3	16.7	12.9	10.3	12.5	9.5	9.2	8.4	14.9	14.5	18.0
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6;esophagus: 48.9"	"Cell type enhanced"	"Detected in some"	22	"Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 70.0;CAPAN-2: 167.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 175.6"	"Group enriched"	"Detected in many"	8	"midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		6800000	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.9	0.9	9.7	0.9	23.5	0.9	6.5	3.3	42.2	10.0	1.0	82.0	0.0	1.1	2.0	1.2	48.9	24.6	3.8	0.9	20.1	11.8	9.0	0.9	0.9	0.9	46.1	14.9	0.9	0.9	0.9	0.2	0.9	44.3	1.0	0.9	0.0	5.9	2.8	0.9	2.9	0.9	1.0	97.6	5.1	1.0	1.5	32.6	0.0	0.9	15.7	28.1	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	167.5	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	15.4	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.1	0.2	0.0	0.1	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	23.5	3.3	23.1	20.1	11.8	46.1	14.9	44.3	32.6	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	2.7
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976482-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 29.1;skin 1: 77.5;tongue: 90.2"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 6.0;Basal keratinocytes: 4.4;Suprabasal keratinocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.7;HaCaT: 26.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		960000	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	2.1	0.3	5.4	0.3	4.3	0.4	5.6	0.5	11.3	5.4	0.3	0.0	0.0	0.5	0.7	0.3	29.1	7.8	3.3	0.2	4.8	0.5	2.6	0.2	1.6	0.3	0.3	3.5	1.0	0.2	0.2	0.1	0.5	4.2	0.3	0.2	0.0	7.4	0.3	0.6	77.5	0.3	0.4	0.3	0.5	0.4	0.3	0.0	0.0	0.4	90.2	15.3	0.2	9.0	1.1	0.4	1.3	0.8	2.1	1.0	0.6	2.7	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	6.7	0.0	1.0	0.0	0.1	26.6	0.0	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	1.3	0.8	0.4	0.4	0.4	0.7	0.6	0.6	0.4	0.4	1.1	1.0	0.9	0.9	2.1	0.4	0.4	0.7	0.6	5.4	4.3	0.5	11.3	4.8	0.5	0.3	3.5	4.2	0.0	6.0	0.6	0.0	0.1	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.0	0.0	0.0	1.8
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.6;skin 1: 40.4;tongue: 46.9"	"Group enriched"	"Detected in some"	13	"Basal keratinocytes: 58.6;Suprabasal keratinocytes: 157.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 32.2;CAPAN-2: 42.3;HaCaT: 31.2"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 39.6"					"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		950000	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	1.6	0.0	0.1	0.4	0.1	0.0	4.5	1.0	0.3	8.1	0.7	0.1	0.1	0.0	1.1	0.7	43.6	6.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.4	0.6	0.3	0.0	0.3	6.0	0.1	0.3	40.4	0.1	0.1	0.6	0.3	0.0	0.7	0.1	0.5	0.3	46.9	11.1	0.3	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.2	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.6	42.3	0.0	0.8	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.7	0.0	8.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.4	157.5	0.0	0.0	0.0	0.1
KLRC1	"CD159a, NKG2, NKG2-A, NKG2-B"	ENSG00000134545	"Killer cell lectin like receptor C1"	P26715	12	10442264-10454685	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 64.3;lymphoid tissue: 22.1"	"Cell type enriched"	"Detected in some"	22	"T-cells: 112.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 45.7;NK-cell: 64.3"	"Group enriched"	"Detected in many"	42	"NK-cells: 64.3;T-cells: 45.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 9.3;Karpas-707: 3.8;SuSa: 3.7"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (8.17e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.58e-7)"	"unprognostic (3.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-3)"	2.4	0.5	1.2	5.8	1.4	5.6	2.3	1.0	2.7	1.7	3.3	0.7	1.2	1.5	5.5	3.9	1.7	2.5	2.4	2.6	1.6	1.3	1.9	2.0	5.9	10.3	2.3	0.6	1.2	1.4	0.3	1.3	3.6	1.5	1.9	2.5	2.0	3.1	0.3	0.5	1.0	5.0	2.1	2.6	22.1	5.2	1.4	0.5	3.5	1.9	3.0	2.9	2.9	1.8	0.1	0.0	1.2	0.1	64.3	45.7	5.1	0.4	1.6	0.1	0.1	0.5	0.4	0.8	0.0	0.0	0.8	1.7	0.0	1.3	0.2	0.1	0.4	3.3	0.3	0.6	2.8	1.1	0.9	0.4	2.1	9.3	0.0	0.1	0.6	0.4	1.0	0.0	0.3	0.0	0.0	0.8	0.7	1.3	3.8	0.8	0.0	0.2	2.8	0.0	0.1	0.0	0.9	0.2	0.3	0.2	0.0	0.5	0.1	0.8	0.0	0.3	3.7	0.3	0.0	2.6	0.4	0.0	0.0	0.3	0.0	0.0	0.7	2.1	0.8	0.0	0.2	0.0	0.0	45.7	0.0	5.8	0.1	0.0	7.9	0.0	0.0	0.0	6.9	1.2	64.3	0.1	0.0	0.0	5.1	1.2	1.4	1.0	0.9	1.6	1.3	2.3	0.6	1.5	0.5	0.0	1.1	0.0	0.2	0.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.8	0.1	1.6	1.7	1.3	3.2	0.0	0.6	0.0	5.0	0.0	1.9	0.0	0.0	0.3	1.1	0.6	1.5	0.0	0.3	0.5	0.2	0.1	0.1	112.3	0.0	0.4
KLRC2	"CD159c, NKG2-C"	ENSG00000205809	"Killer cell lectin like receptor C2"	P26717	12	10426854-10442300	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 32.8;brain: 16.2"	"Group enriched"	"Detected in some"	20	"Intestinal endocrine cells: 9.2;T-cells: 36.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 10.7;NK-cell: 32.8"	"Group enriched"	"Detected in many"	92	"NK-cells: 32.8;T-cells: 10.7"	"Cell line enhanced"	"Detected in some"		"GAMG: 17.9;HEL: 5.3;HeLa: 16.4;HSkMC: 4.0"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (9.05e-4)"	"unprognostic (2.54e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-9)"	"unprognostic (8.10e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.31e-3)"	0.5	0.2	8.2	0.6	4.6	2.8	1.1	1.2	16.2	0.4	1.9	2.3	0.1	1.0	1.4	1.0	0.8	0.6	1.7	0.2	6.1	5.4	0.1	1.1	1.4	1.5	6.2	2.6	1.5	0.1	0.0	0.1	0.6	3.7	0.3	1.3	0.1	0.5	0.3	0.1	0.2	1.8	0.1	4.1	8.1	3.2	0.5	1.7	2.2	0.2	0.1	2.0	1.2	0.1	0.0	0.0	0.2	0.0	32.8	10.7	1.7	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	17.9	0.0	0.0	2.0	0.0	0.0	0.0	5.3	16.4	0.3	0.0	0.5	0.0	4.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.1	1.1	0.1	0.4	0.0	0.0	0.0	0.0	0.5	2.7	0.1	0.1	0.0	0.0	0.0	10.7	0.0	0.2	0.0	0.0	4.7	0.0	0.0	0.0	3.7	0.2	32.8	0.0	0.0	0.0	1.7	8.2	4.6	1.2	3.6	6.1	5.4	6.2	2.6	3.7	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0
KLRF1	"CLEC5C, NKp80"	ENSG00000150045	"Killer cell lectin like receptor F1"	Q9NZS2	12	9827481-9845007	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 95.2;lymphoid tissue: 24.7"	"Cell type enriched"	"Detected in many"	10	"T-cells: 119.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 95.2"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 95.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;CAPAN-2: 1.9;HAP1: 3.0;U-937: 9.5"					"Low region specificity"	"Detected in some"			HPA054038			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA054038: "	"unprognostic (2.96e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.95e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.43e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.89e-3)"	3.3	0.7	0.9	3.0	1.2	8.8	1.4	0.6	0.8	1.0	0.6	0.3	0.1	0.0	0.7	3.3	0.8	1.1	0.9	1.0	1.0	0.8	0.8	5.8	10.0	4.0	0.9	0.7	0.7	1.1	0.0	0.9	1.7	0.4	1.5	0.5	0.9	1.5	0.8	1.3	0.8	1.0	0.5	1.0	24.7	0.7	1.0	0.4	2.0	0.8	0.5	2.8	1.0	0.7	0.4	0.3	0.9	0.2	95.2	14.9	11.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	3.3	0.0	0.2	0.0	1.9	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.1	0.1	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.5	1.4	0.0	0.1	0.1	11.6	0.2	14.9	0.4	0.6	5.5	0.2	0.1	0.2	5.8	0.9	95.2	0.1	0.3	0.1	11.1	0.9	1.2	0.6	0.8	1.0	0.8	0.9	0.7	0.4	0.4	0.0	2.1	0.0	1.1	1.3	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.8	8.3	0.2	0.4	1.2	0.0	0.0	0.2	0.5	0.7	0.6	1.1	0.9	1.2	0.0	0.0	8.0	10.1	0.9	0.0	1.4	11.8	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.1	1.5	1.0	0.5	119.3	0.2	2.1
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	12.1	5.6	15.2	11.4	9.3	11.1	4.5	5.5	8.0	5.8	6.7	11.3	8.8	15.0	11.3	8.0	10.3	10.6	16.1	6.1	11.6	16.5	6.2	29.4	5.2	6.1	5.2	17.5	5.7	5.3	6.2	12.7	17.0	7.3	9.0	9.8	19.1	12.8	7.3	9.5	11.6	10.3	9.2	5.0	8.4	8.8	14.6	5.0	8.5	9.2	12.5	8.1	13.8	4.5	2.9	8.3	7.8	5.9	13.2	9.9	9.0	7.2	9.8	3.7	2.9	10.1	3.7	12.9	5.9	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4	65.5	59.8	31.5	64.8	77.2	147.8	34.4	38.2	53.5	35.2	36.6	143.3	12.2	3.3	26.8	6.6	70.1	19.7	0.0	22.3	8.1	43.5	71.4	26.7	23.1	14.2	184.3	63.8	45.4	32.6	4.7	61.9	26.1	40.5	33.3	29.3	117.0	23.2	14.4	73.9	6.9	144.6	64.7	59.7	11.1	14.9	70.4	5.0	50.7	27.3	49.9
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35718019-35738878	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 61.2;Rod photoreceptor cells: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006487			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	10.2	9.3	11.4	14.2	13.1	18.4	10.4	23.9	11.4	10.0	12.0	14.2	12.9	13.8	13.0	7.1	11.4	11.6	12.6	7.5	11.0	5.3	9.9	8.9	10.6	14.7	14.7	6.8	15.3	19.6	10.8	13.3	9.3	11.2	12.1	5.6	13.8	14.7	10.0	13.3	19.9	12.3	12.2	12.4	15.8	12.1	21.5	14.9	14.1	14.9	7.0	14.2	12.4	14.2	0.4	0.7	3.2	0.7	2.1	0.7	0.2	11.5	19.5	9.0	9.9	4.7	4.6	9.4	5.6	4.1	5.7	4.4	13.0	5.9	10.3	8.8	4.6	6.1	7.6	8.1	4.8	2.5	15.2	9.0	18.5	9.1	6.5	4.6	11.2	21.2	6.2	6.5	5.8	6.4	5.1	5.5	10.7	15.4	12.9	3.7	11.8	9.5	9.7	8.3	10.0	6.9	15.0	5.9	5.6	3.1	10.3	10.2	8.2	8.5	13.8	5.9	5.0	8.4	12.0	7.7	11.4	12.4	7.6	11.8	17.8	10.9	8.2	6.2	10.4	7.9	1.0	0.7	0.6	0.7	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.4	3.2	2.1	0.3	0.7	0.2	0.2	11.4	13.1	23.9	11.4	11.0	5.3	14.7	6.8	11.2	14.9	8.9	19.1	13.3	8.5	11.3	61.2	7.7	10.2	4.0	5.7	8.7	49.1	5.2	0.0	5.5	2.1	11.7	14.0	0.0	6.7	4.9	8.1	13.1	4.7	9.7	7.3	33.4	19.4	11.6	8.7	4.1	7.5	6.4	5.0	6.4	10.4	27.2	7.1	11.4	11.7	4.2	74.2	0.0	8.2	28.1	36.4	11.3	7.9	10.2	11.3	12.8
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436005	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	13.9	12.6	11.7	16.7	18.6	29.7	14.5	24.8	14.1	18.4	12.6	15.5	21.4	9.7	20.2	20.6	14.4	12.8	12.7	10.8	13.4	9.5	10.3	11.4	13.0	12.1	17.7	9.4	18.8	18.4	18.8	18.9	38.0	12.6	14.0	11.8	12.6	15.8	22.9	30.3	25.2	13.1	13.6	16.0	14.6	14.9	13.6	19.6	22.6	16.9	9.3	16.8	17.8	31.6	5.6	3.5	16.1	3.9	5.5	2.9	0.6	9.7	4.9	9.1	9.7	16.5	10.0	10.7	5.1	3.9	4.1	5.0	9.3	5.9	15.5	7.4	9.2	5.6	5.6	9.8	7.4	6.9	9.8	5.0	9.2	7.4	6.4	8.0	15.5	11.3	8.4	10.3	5.8	7.8	6.6	5.8	8.1	14.8	13.4	8.9	13.6	11.2	14.1	5.5	7.6	4.9	7.6	8.3	8.1	7.0	10.0	13.3	10.5	8.4	15.0	5.5	9.9	4.9	12.8	7.3	6.8	3.6	7.3	7.2	14.1	6.9	16.7	8.9	12.8	7.0	8.8	3.5	4.3	2.1	2.2	2.9	5.6	1.7	1.7	1.7	3.8	2.7	1.8	16.1	5.5	3.9	3.5	1.3	0.6	11.7	18.6	24.8	14.1	13.4	9.5	17.7	9.4	12.6	19.6	71.5	66.6	54.7	36.1	79.1	82.8	58.2	45.9	44.2	92.1	43.6	163.0	29.7	5.0	30.2	18.6	49.2	41.0	23.3	28.7	45.7	47.0	48.1	62.5	36.6	29.6	76.3	65.1	41.7	48.8	11.0	62.5	61.0	40.5	25.2	44.5	62.2	33.0	43.8	56.6	15.7	75.2	25.8	50.1	33.5	31.5	84.2	106.4	50.4	30.3	55.0
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018975-49059774	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	12.1	7.6	4.9	6.7	10.8	26.1	6.8	11.7	10.5	9.5	6.5	5.8	13.0	5.5	15.7	7.4	8.8	8.9	5.8	9.1	6.1	3.5	6.2	6.5	22.9	9.6	6.7	3.3	9.7	11.6	13.3	9.2	12.9	13.7	6.7	6.6	9.8	7.6	8.0	16.1	13.6	9.4	7.1	9.1	13.6	8.3	7.3	5.7	6.2	11.0	6.1	7.6	7.0	6.3	2.0	2.2	5.9	0.5	1.5	0.8	0.6	17.1	16.3	16.5	13.3	17.1	11.5	17.7	9.1	9.5	11.8	6.3	28.6	7.3	17.8	11.8	12.7	8.5	11.6	21.7	10.0	9.8	10.4	17.4	22.6	17.1	15.3	11.7	26.8	22.7	9.7	14.4	16.5	17.1	14.1	17.5	18.5	28.3	9.9	13.3	18.9	13.3	25.0	15.6	23.7	14.1	20.0	10.2	6.4	9.9	19.0	13.8	11.7	14.0	13.8	9.5	15.0	13.7	23.5	23.3	9.3	16.6	8.1	15.2	14.1	9.1	17.3	10.7	13.9	6.9	0.6	0.5	3.0	0.8	0.2	0.4	0.3	0.3	0.5	0.3	2.0	0.3	0.8	5.9	1.5	0.1	2.2	0.0	0.6	4.9	10.8	11.7	10.5	6.1	3.5	6.7	3.3	13.7	5.7	8.9	18.4	11.1	6.5	12.5	25.2	4.7	12.7	5.3	9.1	17.4	49.1	6.6	1.7	5.8	2.5	12.6	11.1	0.0	5.2	4.6	8.5	8.3	8.1	12.3	8.3	20.6	12.6	17.2	19.7	1.1	8.9	9.6	10.1	4.6	10.5	5.2	7.2	8.6	10.3	4.3	38.9	6.5	3.3	3.7	3.2	15.4	9.5	10.4	10.1	8.4
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E"	Q8IZD2	7	105014179-105114361	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	22.7	11.8	18.6	24.5	23.5	44.8	20.9	41.6	22.4	26.4	20.9	18.6	21.7	14.7	25.3	15.8	16.5	18.6	18.2	16.8	20.6	15.1	14.2	11.6	22.8	20.1	22.7	17.4	33.5	15.6	20.5	20.1	18.7	18.6	21.2	20.5	17.6	19.6	19.2	21.3	25.7	18.5	26.2	23.1	21.6	17.9	12.9	27.2	24.6	21.7	15.1	22.7	26.6	21.4	38.2	24.7	72.9	20.8	20.3	30.6	14.7	15.1	10.7	22.7	19.5	14.1	16.9	5.8	11.6	17.4	9.8	12.1	8.7	13.9	12.6	11.6	13.6	13.2	11.8	12.5	11.5	16.3	20.3	7.2	12.7	14.0	7.4	13.3	17.0	16.0	11.8	10.8	13.6	14.6	17.9	17.7	14.1	17.3	36.1	13.8	11.9	27.1	14.6	7.9	8.3	8.6	23.4	14.0	14.6	9.7	15.4	13.0	15.7	16.1	13.9	8.8	15.9	6.0	10.2	21.8	23.2	16.2	26.5	11.5	27.6	21.8	29.1	15.2	13.0	15.9	48.5	18.0	39.4	30.6	13.6	30.3	35.6	28.4	26.1	12.8	38.2	28.0	26.0	72.9	20.3	20.8	24.7	23.6	14.7	18.6	23.5	41.6	22.4	20.6	15.1	22.7	17.4	18.6	27.2	131.0	136.3	133.9	100.8	130.3	219.2	86.5	76.5	84.3	142.1	109.9	237.6	33.5	29.9	70.0	19.2	197.7	91.8	93.5	59.6	38.6	151.9	115.7	236.2	33.7	53.7	174.8	96.0	86.5	76.0	18.6	130.6	138.7	133.3	110.0	88.5	114.4	63.9	84.2	123.8	28.6	269.1	122.9	222.6	98.9	71.7	117.7	54.6	186.4	107.4	119.5
KMT5C	"MGC2705, SUV420H2"	ENSG00000133247	"Lysine methyltransferase 5C"	Q86Y97	19	55339853-55348120	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 47.4;Cone photoreceptor cells: 47.1;Horizontal cells: 63.5;Rod photoreceptor cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.6;SCLC-21H: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052294	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052294: AB_2681788"	"unprognostic (4.02e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.05e-8)"	"unprognostic (7.39e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.39e-2)"	5.0	5.6	8.5	7.3	15.7	13.4	5.4	20.0	10.7	5.1	7.5	11.2	4.9	11.9	7.0	5.4	4.6	11.0	7.4	4.2	11.2	4.5	5.1	4.4	5.5	4.6	17.1	5.3	6.1	8.5	6.2	11.7	6.5	9.6	6.6	3.8	6.3	7.7	6.3	6.6	13.5	8.5	3.6	6.2	6.2	9.8	7.0	14.7	10.1	5.1	2.3	3.5	6.3	4.6	0.3	0.8	0.9	0.6	1.1	0.8	0.3	5.0	3.5	3.3	2.8	0.7	0.9	9.3	1.4	0.6	0.5	1.3	2.2	4.3	5.0	1.8	1.1	0.2	2.8	2.1	1.8	0.6	4.5	16.6	4.0	2.5	2.2	1.2	2.3	4.8	0.8	2.5	1.7	0.9	0.7	1.1	5.5	9.8	2.8	0.6	5.8	6.6	5.2	6.0	3.0	5.2	9.8	3.9	4.9	0.8	1.3	16.2	6.9	0.7	3.7	2.0	1.9	4.2	2.9	1.2	1.6	4.0	0.5	1.0	8.3	4.1	3.2	0.8	5.6	2.2	0.3	0.6	0.3	0.7	0.4	0.0	0.1	0.5	0.7	0.6	0.3	0.3	0.8	0.9	1.1	0.0	0.8	0.2	0.3	8.5	15.7	20.0	10.7	11.2	4.5	17.1	5.3	9.6	14.7	6.0	5.5	1.9	11.9	0.0	47.4	0.0	10.2	6.7	5.7	3.5	47.1	25.7	1.7	5.8	1.6	2.2	8.4	23.3	2.6	16.4	3.1	9.2	2.3	1.0	8.3	63.5	7.0	4.9	3.1	1.5	6.9	4.9	0.0	1.0	14.9	28.9	6.1	15.3	6.0	2.1	46.0	6.5	0.0	8.4	11.1	0.0	16.6	9.6	13.3	9.8
KNDC1	"bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND"	ENSG00000171798	"Kinase non-catalytic C-lobe domain containing 1"	Q76NI1	10	133160447-133226412	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 7.0;Ciliated cells: 22.7;Club cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 1.4;non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	10	"monocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;EFO-21: 2.9;MCF7: 2.6;NTERA-2: 3.6;RPMI-8226: 5.0;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039624, HPA056143"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA039624: AB_10671045, HPA056143: "	"unprognostic (2.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (1.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.41e-2)"	1.1	11.4	14.7	1.2	13.2	1.0	1.2	23.9	26.2	2.1	1.1	5.4	0.0	1.1	3.9	2.7	1.0	14.6	1.5	1.2	11.3	12.1	1.5	5.5	4.2	1.1	8.3	13.2	10.9	2.1	1.0	13.2	1.9	8.5	2.0	1.1	0.7	2.5	3.2	1.2	1.2	1.2	1.9	3.2	1.7	1.4	2.8	3.5	0.0	2.4	0.0	1.1	1.1	0.3	0.3	0.0	0.0	3.1	0.0	0.0	0.1	0.6	0.9	0.5	4.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	1.5	0.6	0.0	2.9	0.3	1.4	0.6	0.1	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	3.6	0.1	0.0	0.0	0.1	5.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	4.9	0.4	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	14.7	13.2	23.9	25.2	11.3	12.1	8.3	13.2	8.5	3.5	0.0	7.0	0.0	0.0	0.0	0.8	2.0	2.5	22.7	6.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	4.3	0.2	1.6	2.9	0.0	1.0	0.8	3.4	0.4	0.0	0.0	0.0	4.0	0.0	0.0	1.1	0.0	1.1	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0
KNOP1	"101F10.1, C16orf88, FAM191A, TSG118"	ENSG00000103550	"Lysine rich nucleolar protein 1"	Q1ED39	16	19701934-19718235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041079, HPA066169"	Uncertain		Enhanced	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA041079: AB_10962350, HPA066169: AB_2685628"	"unprognostic (6.55e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.75e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	6.9	7.1	13.9	7.6	34.7	3.9	13.8	11.1	23.7	7.1	9.5	20.9	8.5	8.2	8.5	10.9	10.1	8.1	7.3	6.9	17.0	10.5	6.2	7.6	5.5	9.4	33.1	9.1	12.8	19.6	17.2	6.4	10.3	18.1	8.1	11.1	4.9	13.9	9.8	15.2	15.0	8.2	5.8	21.2	6.4	9.3	10.0	33.2	4.9	7.3	5.8	7.5	8.4	7.7	7.0	5.2	1.6	8.0	4.5	12.8	4.4	12.4	19.2	21.4	16.2	5.3	5.0	11.0	7.7	4.2	7.4	7.5	13.5	10.9	14.9	31.7	4.7	6.5	11.6	16.6	10.6	7.2	10.0	11.6	8.8	10.9	17.7	9.7	13.7	6.9	3.2	15.2	9.7	8.0	6.5	7.8	10.6	26.9	6.7	6.9	16.3	12.1	11.4	41.7	12.4	7.7	26.1	11.5	17.3	7.8	11.9	19.3	16.3	9.6	12.4	12.6	12.8	14.5	9.3	9.0	11.7	12.0	7.1	10.2	9.9	20.5	18.7	6.3	10.5	11.3	0.4	3.5	1.6	4.8	8.0	7.2	6.6	6.9	4.8	4.2	7.0	12.8	7.2	1.0	4.5	7.0	5.2	4.4	4.4	13.9	34.7	11.1	23.7	17.0	10.5	33.1	9.1	18.1	33.2	6.0	16.2	27.4	24.0	10.9	38.4	6.5	40.8	17.4	12.5	36.6	82.5	46.7	39.7	78.4	1.8	39.8	26.2	0.0	57.5	34.0	26.3	21.6	5.8	47.9	31.3	33.4	14.5	23.4	23.1	5.2	56.1	24.0	11.8	27.1	35.8	17.1	64.2	10.5	50.5	25.8	56.7	45.3	37.1	37.0	132.6	14.1	20.6	20.0	51.0	21.1
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin/SPAG5 binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 321.9;Late spermatids: 423.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	5.5	4.4	6.7	5.5	6.3	7.3	9.0	8.1	7.0	3.3	4.5	4.0	8.0	5.3	3.9	7.8	6.2	3.4	2.5	4.1	6.0	5.3	4.2	7.0	4.1	8.0	4.6	7.1	3.4	3.5	6.0	4.2	7.4	6.8	4.4	6.3	2.5	6.4	5.0	7.5	4.2	4.1	5.9	4.3	4.8	6.2	40.1	4.5	18.4	59.8	6.0	9.1	3.8	3.7	5.9	11.0	10.0	26.2	5.5	5.5	4.0	31.2	14.7	29.4	19.2	6.5	10.1	15.3	21.7	16.9	44.9	39.7	31.5	13.8	12.1	11.1	14.6	35.8	36.2	31.3	20.1	40.7	21.5	15.3	35.9	33.0	19.8	6.1	19.2	18.8	5.2	11.6	22.6	22.7	11.0	25.1	30.5	25.8	21.0	37.7	15.8	16.6	15.5	18.5	26.8	22.4	17.1	22.1	14.0	15.6	13.0	28.7	19.9	18.1	20.0	4.8	18.6	20.9	13.8	12.9	21.7	22.2	22.1	30.0	18.0	29.1	21.8	13.4	25.8	17.7	4.8	10.3	10.0	4.8	14.5	4.4	5.9	3.6	4.4	11.0	5.4	3.5	3.6	5.9	5.5	26.2	7.5	5.5	4.0	6.7	6.3	8.1	7.0	6.0	5.3	4.6	7.1	6.8	4.5	8.9	0.6	0.8	3.1	1.9	7.8	4.7	2.5	9.4	5.7	0.0	7.9	14.3	3.3	9.5	321.9	1.7	1.6	46.7	8.1	35.4	6.2	3.8	1.1	5.7	18.4	4.8	2.4	3.1	7.5	423.6	8.3	7.6	3.3	8.2	3.6	7.0	8.7	0.0	6.7	4.4	7.4	0.0	2.7	83.7	18.1	1.3	17.6	3.2	3.0	2.8
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 23.5;Erythroid cells: 23.3;Spermatocytes: 24.6;Spermatogonia: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favorable (8.69e-4)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	5.6	5.6	4.5	15.3	5.4	28.9	5.8	7.5	5.6	5.2	6.4	2.7	3.9	7.0	5.4	5.5	9.6	4.9	2.9	2.9	4.6	1.8	4.9	4.5	5.8	11.8	4.0	3.8	6.7	4.9	3.5	5.9	8.1	3.6	5.3	9.7	3.9	6.1	2.8	1.6	11.7	10.9	7.7	3.1	14.1	5.5	23.2	2.8	39.6	4.0	7.0	15.6	4.4	6.6	4.8	2.1	5.0	2.6	2.2	3.6	0.8	13.1	11.0	31.7	7.3	2.5	4.5	14.3	12.2	7.9	12.1	11.5	10.4	11.1	15.8	6.4	5.9	8.0	18.2	13.7	7.6	16.1	11.2	9.5	19.4	20.5	10.6	0.8	19.0	13.4	2.4	1.7	12.5	8.3	6.3	8.2	20.2	19.3	11.9	9.1	9.7	15.7	44.1	16.0	6.4	13.9	21.6	15.4	17.5	7.2	14.1	9.8	12.7	22.2	4.7	6.5	19.7	17.9	11.0	6.0	13.9	13.3	13.5	14.2	16.1	16.1	24.3	8.3	12.4	15.8	5.0	1.4	4.6	2.0	1.9	1.8	4.8	3.3	3.6	1.3	3.0	2.5	2.9	4.4	2.2	2.6	2.1	1.4	0.8	4.5	5.4	7.5	5.6	4.6	1.8	4.0	3.8	3.6	2.8	0.0	1.6	6.0	1.2	3.8	2.5	1.2	0.0	6.7	2.3	5.2	3.9	5.0	0.0	1.2	23.5	2.1	1.0	23.3	0.3	5.0	2.1	0.8	1.1	0.9	4.0	0.0	0.0	1.3	2.4	13.7	4.4	3.1	1.7	1.8	1.2	0.9	0.7	0.0	2.8	0.3	3.6	6.5	1.4	24.6	35.8	1.9	2.4	3.3	5.2	0.6
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699307-49792921	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 71.8"	"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 254.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046852, HPA077643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA046852: AB_2679840, HPA077643: "	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	12.4	8.0	15.2	9.1	11.8	14.1	12.4	10.9	14.4	8.5	11.4	7.5	8.1	7.0	9.5	6.8	14.5	7.3	8.4	17.2	12.3	11.4	8.0	13.6	9.6	9.4	11.1	11.4	8.1	6.3	9.1	8.1	8.3	13.0	9.4	9.7	5.9	8.3	11.4	71.8	9.0	8.5	14.3	13.2	8.1	8.3	15.1	11.8	11.4	10.9	14.6	10.8	15.0	16.3	6.0	5.0	7.6	6.8	8.1	12.1	4.1	14.1	9.8	18.9	15.8	19.4	21.3	9.5	25.8	21.4	22.7	16.6	29.8	13.2	30.6	5.3	30.0	15.3	16.7	22.5	20.7	38.0	18.3	15.8	22.4	9.7	34.6	18.9	33.4	14.6	15.6	15.1	19.0	25.1	15.0	28.0	12.9	12.3	8.3	31.2	6.5	17.9	18.2	21.8	19.8	6.9	23.5	18.6	9.3	13.9	11.8	7.9	12.6	9.4	11.8	10.2	16.4	7.0	13.5	25.4	16.8	13.7	15.3	17.1	6.7	9.4	27.0	10.2	15.5	16.6	7.6	4.6	4.3	8.6	5.5	12.1	6.0	8.8	8.4	5.0	4.0	8.8	7.9	2.8	8.1	6.8	2.9	10.1	4.1	15.2	11.8	10.9	14.4	12.3	11.4	11.1	11.4	13.0	11.8	62.5	29.8	19.7	23.8	38.2	22.9	70.2	10.2	37.5	25.0	12.2	31.4	13.2	14.9	42.7	254.1	35.9	17.7	23.3	46.6	15.0	28.3	24.7	32.3	33.4	29.7	49.3	29.2	35.0	34.0	136.0	20.4	32.3	18.6	37.9	17.6	46.9	45.4	10.5	47.0	20.9	62.4	25.8	29.3	52.1	29.9	43.5	8.8	27.7	20.2	28.7
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108038-32176568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 204.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		11000	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	16.1	18.7	24.6	14.6	19.0	22.9	18.1	23.9	25.2	16.3	18.8	15.7	23.0	11.5	21.3	17.5	21.4	15.9	12.1	23.4	22.7	18.2	18.3	18.0	17.3	13.2	15.4	19.8	16.9	17.1	40.9	18.0	23.5	29.7	17.6	17.3	14.1	16.2	19.8	54.0	20.5	14.2	23.1	29.2	14.8	17.4	22.2	17.6	12.6	17.8	14.5	18.3	17.9	17.8	9.1	9.3	9.5	12.5	5.0	11.2	6.4	17.0	13.5	12.1	15.5	18.6	16.4	14.2	13.8	16.3	20.2	19.6	15.0	18.7	14.3	16.4	24.8	12.2	14.8	18.5	21.1	25.9	14.4	10.2	14.7	20.8	12.1	16.5	16.1	12.1	16.5	20.1	25.0	24.0	17.1	21.0	11.3	14.2	13.2	19.1	9.4	13.0	9.2	28.1	11.1	10.1	13.1	17.4	11.7	17.6	15.7	11.6	9.8	25.1	15.1	13.4	30.9	10.6	8.6	24.4	18.8	13.0	24.4	19.8	9.5	10.8	11.3	20.5	15.1	17.9	4.0	10.2	9.5	11.2	12.5	11.0	7.8	9.7	8.7	8.3	9.1	11.2	10.8	6.0	5.0	12.5	9.3	9.6	6.4	24.6	19.0	23.9	25.2	22.7	18.2	15.4	19.8	29.7	17.6	38.7	37.4	43.4	31.3	56.4	47.6	28.5	33.1	40.2	21.6	27.9	55.0	38.1	14.9	32.5	204.0	37.9	20.6	0.0	27.4	36.4	38.2	41.3	12.8	56.3	26.8	49.3	44.3	35.6	32.3	48.0	31.7	26.8	23.6	28.9	37.1	29.8	38.9	17.5	38.2	28.3	40.5	32.3	29.9	55.9	52.6	74.4	113.5	32.6	29.2	51.1
KPTN	2E4	ENSG00000118162	"Kaptin, actin binding protein"	Q9Y664	19	47475144-47484268	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 18.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041710, HPA041796"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA041710: AB_10961904, HPA041796: AB_10962832"	"unprognostic (4.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.54e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (9.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (1.40e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-1)"	6.0	5.8	7.1	5.3	15.6	8.9	6.2	17.2	11.0	4.6	5.4	5.7	3.4	6.0	4.5	3.0	7.3	3.6	4.4	6.5	9.5	7.1	5.8	6.8	4.5	5.5	13.0	6.3	2.7	5.5	9.2	8.9	6.3	8.9	6.5	4.2	3.7	17.6	3.9	8.7	5.4	5.1	4.8	8.5	5.0	3.9	3.9	9.6	12.5	4.8	6.2	3.9	5.1	4.7	1.4	18.5	2.6	3.8	0.9	1.3	1.7	6.3	11.1	8.7	5.4	9.0	7.1	6.1	3.5	6.7	19.4	12.2	8.0	7.6	7.6	2.7	6.3	7.0	7.3	7.4	12.8	5.4	7.1	11.5	3.2	7.5	7.1	8.1	6.4	9.3	8.1	8.3	6.4	6.0	4.9	7.4	10.3	6.4	7.4	5.6	4.9	11.4	27.5	7.8	6.9	6.8	8.3	4.4	3.2	6.0	9.5	18.7	14.4	5.9	6.8	4.4	4.5	5.6	9.4	4.2	4.6	5.3	2.5	7.9	1.9	2.9	3.3	4.2	4.2	6.9	0.0	3.0	1.2	1.2	2.5	0.4	1.3	0.8	1.0	3.6	1.4	1.1	0.9	2.6	0.9	3.8	18.5	1.3	1.7	7.1	15.6	17.2	11.0	9.5	7.1	13.0	6.3	8.9	9.6	3.0	2.4	5.6	6.1	2.5	5.6	2.8	7.6	0.0	5.7	5.2	5.9	12.8	8.3	8.7	0.6	2.3	3.5	0.0	3.5	10.6	4.1	5.5	2.3	5.5	7.5	9.5	2.9	3.7	5.1	1.9	1.1	5.3	1.7	1.8	1.5	6.5	5.3	1.9	0.7	5.8	4.1	0.0	2.1	3.2	18.5	2.8	12.8	2.5	2.8	5.8
KRBA1	KIAA1862	ENSG00000133619	"KRAB-A domain containing 1"	A5PL33	7	149714781-149734575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 30.6"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 8.9;Muller glia cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021237, HPA050448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021237: AB_2134145, HPA050448: AB_2681129"	"unprognostic (2.19e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (7.48e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.01e-5)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (2.55e-1)"	"unprognostic (6.33e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.31e-2)"	3.8	4.6	5.6	6.2	8.1	4.7	5.6	8.7	12.8	5.2	5.2	7.6	11.0	2.2	7.8	4.9	5.5	5.2	5.8	30.6	6.7	5.2	5.3	2.2	4.5	5.7	6.3	9.0	7.9	7.0	9.7	16.9	3.1	7.1	6.0	1.9	9.4	17.2	9.5	7.4	6.4	3.6	8.5	5.1	6.4	5.0	5.7	6.5	2.5	4.3	5.5	4.8	5.0	5.3	4.1	3.7	1.3	3.7	0.3	4.2	1.7	6.2	3.9	7.8	16.2	3.5	3.5	6.8	3.3	4.2	5.4	6.2	0.4	1.7	1.9	7.1	4.2	11.0	6.2	5.8	11.2	2.7	8.7	11.0	3.5	5.0	3.6	4.4	0.0	9.8	7.7	5.3	3.7	2.0	6.4	4.9	10.5	14.1	2.0	2.7	2.4	9.0	5.3	9.3	2.9	3.8	9.5	3.1	1.0	4.1	5.0	6.2	10.4	5.1	14.9	3.5	3.7	2.6	5.4	5.0	6.6	2.9	0.0	4.6	9.6	3.1	8.4	3.9	6.0	6.8	0.0	1.8	0.4	3.8	1.7	2.6	1.8	1.9	2.2	2.6	4.1	3.4	2.9	1.3	0.3	3.7	3.7	4.2	1.7	5.6	8.1	8.7	12.8	6.7	5.2	6.3	9.0	7.1	6.5	0.0	2.7	1.5	2.1	1.5	6.3	8.9	0.0	0.0	0.0	3.5	3.9	0.9	0.0	4.5	0.5	0.9	0.0	0.0	2.3	1.9	2.3	2.2	0.0	0.8	4.2	7.9	0.0	0.6	3.0	0.9	3.7	1.1	0.0	1.0	0.0	11.2	1.2	0.0	3.2	1.5	4.4	6.5	1.7	0.7	3.6	1.6	1.0	1.0	0.0	1.5
KRBA2		ENSG00000184619	"KRAB-A domain containing 2"	Q6ZNG9	17	8368637-8376711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 28.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA022849	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA022849: AB_1852996"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.98e-2)"	"unprognostic (8.35e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.61e-4)"	"unprognostic (6.14e-2)"	"unprognostic (5.02e-7)"	"unprognostic (1.82e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.08e-1)"	10.2	6.5	7.2	3.9	9.7	1.6	6.1	7.8	7.6	6.4	4.5	9.9	4.1	3.7	6.6	5.1	3.9	5.0	3.9	27.5	8.2	4.4	9.6	2.7	4.0	4.0	9.9	6.4	7.1	5.0	11.2	8.8	4.7	7.6	6.9	4.0	11.0	7.7	4.9	11.0	6.4	4.2	4.6	9.1	3.9	4.5	6.2	8.7	6.3	7.5	6.0	3.4	7.5	5.7	5.0	2.8	12.7	3.8	1.8	6.0	0.7	0.6	6.2	7.1	6.6	3.9	5.8	3.9	0.9	2.6	3.1	3.8	0.1	2.4	0.6	4.5	1.0	1.8	1.5	2.6	1.0	4.1	3.1	2.2	1.0	4.0	2.8	1.4	0.4	1.8	4.5	0.0	2.6	1.3	2.1	4.8	4.0	0.0	0.8	2.3	1.0	2.7	0.3	0.7	0.2	2.2	5.0	4.5	0.6	2.0	4.3	2.4	4.9	6.3	2.1	1.6	5.8	3.1	0.4	2.9	2.2	3.8	0.9	0.9	2.6	1.5	0.4	2.8	0.0	5.1	12.7	2.3	3.5	3.4	1.8	3.2	2.9	3.4	2.6	1.2	5.0	6.0	3.3	2.2	1.8	3.8	2.8	3.2	0.7	7.2	9.7	7.8	7.6	8.2	4.4	9.9	6.4	7.6	8.7	0.0	0.6	0.0	1.2	0.2	2.0	0.4	0.0	4.0	0.0	1.8	15.7	2.0	3.3	2.4	0.3	1.5	1.0	0.0	1.0	0.5	0.9	0.5	4.7	0.0	0.8	3.2	4.1	2.5	1.0	0.0	1.4	1.1	1.7	0.0	1.0	2.4	1.6	0.0	2.8	0.9	28.5	0.0	1.2	1.8	1.5	0.6	1.0	1.3	1.2	0.3
KRBOX1		ENSG00000240747	"KRAB box domain containing 1"	C9JBD0	3	42809483-42942792	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	8	"placenta: 78.4;testis: 68.5"	"Cell type enriched"	"Detected in many"	7	"Spermatocytes: 1048.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 9.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 9.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.6;CAPAN-2: 22.9;EFO-21: 11.2;GAMG: 17.6;hTEC/SVTERT24-B: 16.1;hTERT-HME1: 10.8;U-2197: 31.8"									HPA046901			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA046901: AB_2797232"	"unprognostic (2.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.95e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	1.1	1.8	1.6	0.3	2.1	0.3	1.4	2.1	2.3	1.9	1.6	1.8	1.2	0.8	2.6	5.4	2.1	1.9	1.2	2.3	1.4	1.2	1.4	0.3	0.7	0.7	1.4	1.2	3.2	2.3	0.3	1.9	78.4	1.6	1.6	1.0	2.3	2.1	2.7	0.5	2.5	1.0	2.3	1.8	0.7	1.1	68.5	0.6	0.2	2.5	1.1	0.8	1.2	1.1	0.8	1.7	1.2	1.2	9.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	10.6	0.0	0.0	0.0	22.9	0.0	11.2	0.8	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.5	0.0	16.1	10.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	8.2	0.0	31.8	0.0	3.4	1.1	0.0	1.7	0.0	0.6	0.0	0.6	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.9	0.0	9.0	1.2	1.7	0.5	0.2	1.6	2.1	2.1	2.3	1.4	1.2	1.4	1.2	1.6	0.6	0.0	1.6	0.0	2.5	0.0	6.5	4.8	5.1	1.4	3.4	5.2	2.0	9.4	16.6	4.1	134.8	0.4	0.7	0.0	10.5	8.6	1.6	1.5	0.0	0.5	2.0	1.6	0.0	1.3	0.0	72.9	18.7	0.0	0.0	0.0	0.8	12.4	6.2	1.9	12.7	1.7	7.4	12.9	3.3	1048.9	159.2	0.0	7.6	0.0	1.7	0.8
KRBOX4	"FLJ20344, ZNF673"	ENSG00000147121	"KRAB box domain containing 4"	Q5JUW0	X	46446857-46497422	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA065295			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065295: AB_2685456"	"unprognostic (4.12e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (2.87e-6)"	"prognostic favorable (4.67e-5)"	"unprognostic (1.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (1.98e-7)"	"unprognostic (7.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.17e-4)"	17.8	11.3	16.9	10.5	22.3	6.8	17.0	24.9	21.0	14.4	14.2	19.9	11.7	7.9	25.6	27.9	8.5	16.0	14.1	10.6	13.6	16.6	12.0	16.4	13.5	15.5	16.1	16.8	22.4	14.0	17.3	24.5	20.3	22.2	16.8	11.1	13.2	9.8	14.6	8.7	13.4	10.5	18.1	17.2	19.7	10.3	6.4	19.0	12.6	17.0	9.3	14.5	14.3	12.9	17.4	12.5	13.7	8.8	13.8	17.8	8.2	14.8	8.5	13.7	10.4	13.5	14.2	8.3	14.5	13.3	13.5	12.4	7.5	13.7	8.5	9.7	12.4	22.1	10.6	16.9	8.1	16.0	8.3	7.2	7.0	17.6	7.1	14.6	10.3	11.5	15.8	9.0	18.5	15.4	12.0	12.6	13.1	7.5	9.4	12.1	8.6	10.6	5.2	12.3	5.8	15.6	7.5	12.7	10.5	8.7	6.2	5.0	9.7	12.5	6.1	13.9	24.3	10.1	10.4	11.3	15.2	15.1	19.7	11.8	10.3	11.6	12.2	13.0	0.5	13.6	12.2	6.7	13.7	12.7	8.2	13.3	13.2	13.7	12.2	6.6	17.4	17.8	12.7	5.1	13.8	8.8	12.5	11.6	8.2	16.9	22.3	24.9	21.0	13.6	16.6	16.1	16.8	22.2	19.0	6.0	6.7	12.3	3.7	1.9	5.7	6.3	10.2	5.3	4.5	5.2	3.9	11.8	8.3	7.0	0.2	12.3	2.0	0.0	4.0	6.6	7.5	4.3	7.0	4.0	8.1	9.5	1.2	16.5	6.5	0.9	7.2	4.6	6.8	3.6	3.6	10.1	3.1	4.3	10.6	4.5	7.8	12.9	5.1	1.9	5.1	2.4	11.3	8.7	4.3	1.4
KRCC1	FLJ22333	ENSG00000172086	"Lysine rich coiled-coil 1"	Q9NPI7	2	88027205-88055729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA045618, HPA052666"	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA045618: AB_10960406, HPA052666: AB_2681907"	"unprognostic (7.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-3)"	22.5	15.0	23.1	30.6	27.3	5.7	25.9	23.5	20.4	23.3	29.9	15.8	19.9	20.7	17.8	29.1	26.4	18.4	16.5	21.4	27.0	15.7	21.5	28.1	23.4	22.3	30.3	15.2	20.3	19.4	24.8	23.8	17.3	23.8	24.0	29.7	12.1	20.8	37.9	23.0	16.7	28.9	24.7	28.2	22.0	17.5	10.0	29.9	20.2	26.9	14.5	20.5	22.1	20.2	18.3	12.7	37.2	11.6	14.8	16.5	8.0	11.5	7.1	11.2	8.2	27.1	32.1	8.3	18.3	20.5	9.8	9.7	0.6	15.6	16.4	6.6	11.6	15.0	6.0	2.5	3.8	11.1	17.2	3.5	3.1	1.9	1.1	19.8	4.7	2.2	16.0	19.1	6.5	14.1	25.7	11.0	13.3	4.4	8.2	21.1	9.8	5.4	6.6	8.5	16.8	4.8	11.1	2.0	1.7	14.8	6.3	8.7	8.8	7.0	9.7	21.3	8.7	6.8	19.6	15.3	11.7	0.8	19.1	5.7	18.7	13.0	13.1	12.5	12.7	27.4	24.7	11.0	37.2	10.1	11.6	11.7	18.3	12.4	12.3	12.7	16.9	14.2	11.2	17.9	14.8	10.0	11.2	16.5	8.0	23.1	27.3	23.5	20.4	27.0	15.7	30.3	15.2	23.8	29.9	32.8	32.4	29.1	30.1	29.3	9.3	36.0	35.7	69.6	47.8	33.2	2.0	40.4	51.4	41.9	2.6	25.4	58.0	0.0	62.9	15.7	37.7	49.3	41.6	47.4	42.5	9.5	40.0	35.6	34.9	3.1	44.3	35.7	27.0	47.7	57.8	33.8	42.5	69.1	40.7	60.7	5.4	19.4	29.2	38.7	19.0	37.3	35.0	34.6	65.3	23.8
KREMEN1	"KREMEN, KRM1"	ENSG00000183762	"Kringle containing transmembrane protein 1"	Q96MU8	22	29073078-29168333	"Disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 18.3;U-2197: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058513			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		400000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA058513: AB_2683739"																		5.2	11.8	7.1	6.8	17.8	2.7	5.8	5.0	6.9	9.6	9.6	7.6	25.7	4.9	6.0	13.2	27.8	8.6	5.0	16.8	8.3	3.6	10.5	3.2	8.3	9.1	5.2	4.3	17.4	3.4	16.3	8.0	7.2	4.2	7.1	8.5	21.2	35.4	20.6	18.9	26.5	8.1	4.7	3.0	13.9	6.4	14.5	6.8	19.0	17.1	33.4	20.0	5.9	10.0	0.7	1.2	9.0	0.6	0.8	0.4	0.2	2.6	1.8	6.2	3.2	2.1	6.4	5.3	0.7	6.2	2.0	3.0	8.4	1.2	0.1	2.4	2.9	5.1	12.8	12.8	5.1	2.2	3.1	8.1	0.7	0.9	7.9	2.2	0.1	0.7	6.2	10.4	2.2	1.2	0.9	0.3	5.2	2.7	0.2	2.5	2.2	0.0	0.8	0.3	17.3	1.4	0.4	18.3	0.2	2.2	4.9	12.5	7.0	7.3	2.6	9.6	2.1	9.7	0.4	0.2	8.4	2.6	31.2	0.9	0.6	0.2	0.2	5.3	1.1	9.7	2.1	0.6	0.3	0.3	0.5	0.3	0.3	0.3	0.2	0.1	0.7	0.4	0.4	9.0	0.8	0.4	1.2	0.2	0.2	7.1	17.8	5.0	6.9	8.3	3.6	5.2	4.3	4.2	6.8	14.9	20.2	0.0	11.3	13.6	3.3	19.9	7.6	16.0	26.1	7.0	0.0	11.2	1.7	4.8	2.5	4.1	2.6	0.0	3.6	1.2	9.9	8.7	18.5	2.4	2.3	0.0	0.0	6.7	17.9	7.7	16.4	3.9	0.0	2.8	16.3	29.9	3.3	5.5	9.9	4.4	2.7	12.9	4.2	7.7	6.4	16.9	4.5	2.2	7.3	8.9
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2963944-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1;skin 1: 12.5"	"Cell type enhanced"	"Detected in some"	9	"Basal keratinocytes: 12.6;Cone photoreceptor cells: 5.9;Mucus-secreting cells: 9.5;Rod photoreceptor cells: 10.0;Spermatogonia: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.2;monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 20.3;MCF7: 10.2;RPMI-8226: 19.1;T-47d: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli		"HPA003223: AB_1079217"	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.2	0.1	1.6	2.0	0.7	1.7	0.2	0.2	3.0	1.8	0.4	0.2	4.5	0.3	0.3	0.8	3.8	0.6	0.3	0.2	1.9	0.3	0.2	0.2	0.2	0.8	0.7	0.2	0.2	0.4	0.0	0.2	0.2	0.3	1.6	0.0	1.9	1.6	0.2	0.6	12.5	0.6	0.2	1.7	0.9	0.5	2.1	0.2	13.1	0.2	1.8	6.8	0.2	0.6	3.2	0.3	0.0	1.4	0.0	0.0	0.0	1.2	0.8	0.3	7.3	0.0	0.0	1.1	0.4	0.0	0.0	0.0	2.9	1.1	5.3	1.5	0.0	0.8	6.0	0.9	0.5	0.0	0.8	0.8	0.3	1.7	1.7	0.0	0.4	20.3	0.2	0.0	0.0	0.1	0.6	0.0	0.6	2.1	2.1	0.0	10.2	1.2	2.4	2.0	2.1	1.5	3.2	8.3	19.1	0.0	0.2	2.1	1.2	1.4	3.3	3.3	0.2	10.3	1.9	0.1	0.6	8.9	0.7	0.5	3.8	0.8	3.2	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.7	0.2	2.3	1.9	0.3	0.7	0.2	0.3	0.2	0.0	0.0	0.0	0.6	12.6	0.4	0.8	0.0	0.0	0.0	0.0	5.9	0.2	0.0	0.0	0.4	0.0	0.5	0.0	2.4	1.6	0.0	2.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	3.3	0.0	9.5	0.2	0.2	0.2	0.0	0.0	10.0	0.0	0.0	0.5	5.9	4.8	0.1	0.0	0.2	0.3
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1, small subunit processome component homolog"	Q13601	12	75490861-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	22.5	18.4	14.2	15.1	22.0	38.0	17.8	29.1	23.3	21.2	14.3	6.7	14.6	12.6	18.3	15.2	24.2	14.7	10.5	12.5	12.6	10.8	23.7	25.0	13.5	18.2	12.8	16.4	21.7	15.0	17.8	33.5	21.4	19.8	20.9	11.8	6.3	20.7	14.2	28.8	16.6	15.2	15.7	16.1	19.8	15.1	12.3	17.3	24.3	20.5	22.4	18.1	19.6	16.4	15.8	10.8	8.9	4.6	8.6	14.7	5.6	25.4	21.1	13.3	11.8	10.5	9.6	24.3	22.3	14.2	17.6	11.3	15.4	13.4	27.1	18.2	11.0	17.6	13.4	17.8	19.6	19.9	22.3	18.1	26.2	11.7	17.9	12.7	46.1	16.6	9.9	16.8	20.2	19.3	17.8	12.0	25.9	28.9	8.7	17.2	16.8	26.8	13.1	19.6	14.1	19.3	21.3	25.6	16.3	19.6	32.2	16.0	13.3	21.1	15.0	26.3	13.3	24.9	18.8	14.9	16.3	10.8	16.8	23.1	17.4	21.8	17.0	8.8	16.3	29.3	7.7	2.4	8.9	10.1	4.6	12.4	15.8	14.1	11.4	3.9	14.4	14.7	13.8	1.1	8.6	3.7	10.8	12.5	5.6	14.2	22.0	29.1	23.3	12.6	10.8	12.8	16.4	19.8	17.3	65.5	42.2	31.8	91.0	43.6	53.3	22.4	15.3	48.2	54.6	38.4	31.4	56.6	49.7	37.5	4.0	32.2	15.1	0.0	42.7	45.8	41.4	40.8	36.9	36.7	26.1	69.9	17.2	22.1	18.8	5.3	48.6	29.3	11.8	32.5	23.2	65.0	33.7	27.9	50.2	37.3	53.6	12.9	36.3	55.6	54.8	38.8	58.9	48.4	29.3	62.9
KRT16	NEPPK	ENSG00000186832	"Keratin 16"	P08779	17	41609778-41615899	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 503.5"	"Group enriched"	"Detected in some"	8	"Basal glandular cells: 391.0;Basal keratinocytes: 804.9;Suprabasal keratinocytes: 1178.6;Urothelial cells: 555.3"	"Group enriched"	"Detected in many"	7	"cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 137.6"	"Not detected"	"Not detected"							"CAB000136, HPA000539"	Approved		Approved	"Intermediate filaments"		NA	NA		2200000000	"Intermediate filaments"		"CAB000136: , HPA000539: "	"unprognostic (3.95e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (8.23e-2)"	"unprognostic (6.53e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.61e-2)"	1.6	0.2	0.2	0.2	0.2	0.0	2.1	0.2	0.2	32.4	0.2	0.2	0.2	0.0	1.1	0.2	112.4	0.1	0.6	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.6	0.2	0.7	0.0	0.3	15.5	9.9	0.4	41.4	0.2	0.2	0.2	0.2	0.1	0.6	0.2	3.0	0.2	503.5	26.4	0.6	50.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	4.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.1	0.0	0.0	15.6	0.1	1.0	0.0	0.0	9.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	391.0	804.9	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	2.5	20.6	95.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	60.8	0.0	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	1178.6	0.1	0.0	0.0	555.3
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652164	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 289.9"	"Cell type enriched"	"Detected in some"	15	"Suprabasal keratinocytes: 232.0"	"Group enriched"	"Detected in some"	35	"head and neck cancer: 4.7;melanoma: 23.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Group enriched"	"Detected in some"	4	"HEL: 6.3;HMC-1: 2.7;JURKAT: 2.4;OE19: 2.9"	"Group enriched"	"Detected in some"	6	"amygdala: 1.8;hippocampal formation: 2.9"	"Not detected"	"Not detected"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"		NA	NA		14000000000	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	9.5	0.1	0.1	18.3	0.1	0.1	0.1	0.0	2.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.4	289.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	6.8	0.1	19.2	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	4.4	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	15.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.2	0.6	0.8	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.0	0.1	0.0	0.1	0.0
KRT222	"KA21, KRT222P, MGC45562"	ENSG00000213424	"Keratin 222"	Q8N1A0	17	40654665-40665181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 22.0;Cholangiocytes: 12.7;Horizontal cells: 27.0;Muller glia cells: 33.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 16.3"									"HPA054586, HPA068724, HPA069774"	Enhanced		Approved	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"HPA054586: AB_2682532, HPA068724: , HPA069774: AB_2686195"	"unprognostic (2.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.41e-2)"	3.8	5.0	9.6	0.7	18.3	0.6	1.3	15.6	21.7	2.3	1.8	0.2	0.9	1.2	1.9	11.8	1.2	1.2	8.3	1.0	10.0	10.0	1.3	9.4	1.4	1.1	8.6	13.4	0.9	1.7	1.6	5.2	0.6	14.3	3.2	2.3	0.8	0.7	4.6	0.6	0.8	2.3	3.1	3.3	3.4	1.0	1.4	3.3	0.0	1.2	0.3	1.1	2.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	18.3	15.6	21.7	10.0	10.0	8.6	13.4	14.3	3.3	0.0	0.3	0.0	0.5	0.1	22.0	0.4	12.7	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.3	1.4	0.0	0.0	0.2	0.1	0.0	0.1	2.3	2.9	0.0	27.0	0.0	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	33.2	0.1	0.0	0.7	1.2	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KRT23	"CK23, DKFZP434G032, HAIK1, K23, MGC26158"	ENSG00000108244	"Keratin 23"	Q9C075	17	40922696-40937634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.3;salivary gland: 99.8;skin 1: 48.2"	"Cell type enhanced"	"Detected in many"	24	"Basal glandular cells: 835.0;Cytotrophoblasts: 634.9;Glandular cells: 639.4;Syncytiotrophoblasts: 3253.9;Urothelial cells: 1153.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	12	"neutrophil: 30.1"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 30.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 21.1;Hep G2: 13.1;SuSa: 7.6;T-47d: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012050, HPA016959, CAB017091"	Approved		Approved	"Intermediate filaments,Cytosol"		NA	NA		170000	"Intermediate filaments"	Cytosol	"CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228"	"unprognostic (1.62e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.18e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (8.26e-4)"	0.3	0.0	0.2	0.5	0.2	0.5	10.0	0.3	0.3	9.8	0.2	0.2	2.1	0.0	1.1	1.2	2.5	1.5	4.5	0.2	0.2	0.0	0.3	0.6	1.1	0.6	0.2	0.2	0.6	1.2	0.0	0.9	128.3	0.2	6.9	0.0	0.3	99.8	2.8	0.3	48.2	0.2	0.3	0.2	1.0	0.0	9.1	0.2	2.0	0.3	11.7	9.5	2.3	3.2	0.0	0.0	30.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.3	0.0	0.0	0.6	0.0	21.1	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	7.6	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	2.2	0.0	835.0	4.0	0.0	0.3	20.4	21.4	10.3	3.5	0.0	634.9	1.7	211.1	47.4	0.7	0.0	0.0	0.7	68.7	0.5	639.4	0.0	0.0	56.0	0.0	6.8	0.0	0.0	5.4	0.6	0.7	5.0	7.2	0.0	11.8	19.4	0.0	0.7	0.0	0.2	0.0	0.4	29.7	0.7	7.0	3253.9	0.0	0.0	1153.1
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703750	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 4.0;Extravillous trophoblasts: 1.2;Leydig cells: 2.8;Syncytiotrophoblasts: 3.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 12.8"	"Region enriched"	"Detected in single"	18	"cerebellum: 1.1"	"Not detected"	"Not detected"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"		No	NA			"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	9.2	4.1	0.0	0.0	0.0	0.7	9.3	62.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	48.6	0.0	0.1	3.1	0.0	1.2	0.8	0.1	0.1	0.2	3.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	1.4	68.9	0.6	3.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0
KRT25	KRT25A	ENSG00000204897	"Keratin 25"	Q7Z3Z0	17	40748021-40755332	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 44.5"	"Group enriched"	"Detected in some"	9	"Early spermatids: 8.0;Late spermatids: 6.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 5.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 9.7"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 8.3;hippocampal formation: 6.1"	"HPA053977, HPA058943"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA053977: AB_2682329, HPA058943: AB_2683859"						"unprognostic (8.19e-2)"							"unprognostic (5.89e-8)"		"unprognostic (1.79e-1)"			1.6	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	44.5	0.1	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
KRT34	"Ha-4, KRTHA4"	ENSG00000131737	"Keratin 34"	O76011	17	41377650-41382403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2"	"Group enriched"	"Detected in some"	17	"Early spermatids: 4.5;Late spermatids: 11.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BJ: 66.1"									"HPA055194, HPA072208"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		170000000	"Nucleoplasm, Vesicles"		"HPA055194: AB_2682733, HPA072208: AB_2686494"		"unprognostic (2.52e-1)"		"unprognostic (2.14e-1)"		"unprognostic (9.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-3)"		"unprognostic (5.12e-7)"				"unprognostic (3.84e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	18.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	66.1	2.9	7.9	15.6	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	8.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
KRT35	"Ha-5, KRTHA5"	ENSG00000197079	"Keratin 35"	Q92764	17	41476689-41481140	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025750, HPA078713"	Enhanced		Approved	"Intermediate filaments"		NA	NA		270000000	"Intermediate filaments"		"HPA025750: , HPA078713: "																		1.8	0.0	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	33.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520687	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 463.1;skin 1: 338.1;tongue: 522.3"	"Cell type enhanced"	"Detected in some"	30	"Basal glandular cells: 909.3;Basal keratinocytes: 5214.3;Suprabasal keratinocytes: 1765.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3340.4"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.7"	"Cell type enriched"	"Detected in single"	197	"plasmacytoid DC: 19.6"	"Lineage enriched"	"Detected in single"	197	"dendritic cells: 19.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 120.8;HBEC3-KT: 216.3;hTCEpi: 494.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		6500000000	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	0.3	0.0	0.1	0.3	0.2	0.2	15.9	0.1	0.2	74.2	0.2	0.3	6.2	0.0	4.9	6.4	463.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	4.4	1.7	5.8	0.0	0.4	46.9	7.8	0.5	338.1	0.1	0.3	0.1	0.1	0.1	0.7	0.1	31.7	0.1	522.3	128.9	4.0	96.8	0.0	19.6	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	120.8	0.0	216.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	494.5	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.2	1.7	0.1	0.0	0.6	0.0	909.3	5214.3	0.0	0.6	0.0	30.8	153.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	28.8	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	271.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	66.8	0.0	0.0	1765.9	0.0	0.0	0.0	372.4
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452126	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 135.3;tongue: 232.4"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 18.3;Ductal cells: 33.5;Suprabasal keratinocytes: 28.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1424.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 57.1"									"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440"	"prognostic favorable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavorable (9.52e-4)"	0.2	0.1	0.1	0.5	0.1	0.1	3.9	0.1	0.1	33.3	0.1	0.1	0.1	0.1	0.7	0.1	135.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	17.8	0.1	0.1	34.9	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	232.4	15.4	0.1	26.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.4	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.8	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	1.5	0.0	0.0	0.0	1.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.5	0.0	0.0	0.0	4.8
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473785	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 109.4;esophagus: 125.8;tongue: 244.2"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 3.1;Suprabasal keratinocytes: 2.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 564.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 46.0"									"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavorable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	109.4	0.2	0.0	0.0	0.2	1.1	0.2	125.8	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	16.3	0.2	0.2	2.7	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	244.2	6.7	0.2	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434525	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skin 1: 22.9;tongue: 18.8"	"Cell type enhanced"	"Detected in some"	14	"Basal keratinocytes: 2.5;Ductal cells: 1.2;Early spermatids: 2.0;Late spermatids: 1.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"PC-3: 22.2;U-2 OS: 29.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		2200000000	Cytosol	"Plasma membrane"	"HPA019367: AB_1852239, HPA076201: AB_2686786"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	3.5	0.0	18.8	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703463	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 77.7"	"Cell type enriched"	"Detected in some"	9	"Suprabasal keratinocytes: 17.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"HaCaT: 9.1"	"Group enriched"	"Detected in many"	5	"amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3"	"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"		NA	NA		2100000000	"Nuclear membrane, Plasma membrane"		"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	6.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	77.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821410-52834295	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 11.3;skin 1: 34.3"	"Group enriched"	"Detected in some"	5	"granulocytes: 4.6;Melanocytes: 3.3"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"HMC-1: 99.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA		950000000	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA059347: AB_2683986"	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	4.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	34.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	11.3	0.1	0.1	0.2	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	99.9	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KRT86	"Hb6, KRTHB6, MNX"	ENSG00000170442	"Keratin 86"	O43790	12	52249300-52309163	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.5;skin 1: 60.4;testis: 23.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 21.8;Late spermatids: 19.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 31.5"	"Cell line enhanced"	"Detected in some"		"A-431: 13.9;A549: 14.7;hTERT-RPE1: 7.5;MCF7: 28.9;RPMI-8226: 18.2;U-251 MG: 8.1"									"HPA039798, HPA049778"	Supported		Approved	Cytosol		NA	NA		240000000	Cytosol		"HPA039798: AB_10674986, HPA049778: AB_2680877"	"unprognostic (4.52e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.22e-2)"	0.8	0.3	0.2	0.1	0.2	3.5	0.9	0.5	1.1	0.4	0.3	0.1	1.0	0.6	0.6	2.4	0.3	1.1	1.0	0.1	0.2	0.3	3.8	0.2	1.0	0.1	0.3	0.1	0.6	7.9	0.0	0.2	0.6	0.3	0.5	0.0	0.3	6.3	0.4	1.5	60.4	0.2	0.1	0.7	0.1	0.2	23.0	0.1	0.1	7.6	0.1	0.3	1.2	0.2	0.0	0.0	31.5	0.0	3.8	0.0	0.2	13.9	14.7	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.2	0.0	0.1	0.7	0.0	0.6	0.0	0.3	0.9	0.0	2.6	0.0	6.1	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	7.5	0.0	0.0	0.0	1.0	0.0	28.9	0.0	1.6	0.0	0.1	3.5	0.0	0.0	18.2	0.2	1.8	1.7	0.0	2.6	1.1	1.1	0.0	0.8	0.0	0.4	0.0	0.7	0.0	8.1	0.0	0.0	0.0	0.0	3.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.5	0.2	0.3	0.3	0.1	0.3	0.1	0.0	1.1	0.0	3.2	0.6	0.2	0.4	2.5	0.0	1.2	0.0	0.0	0.1	0.0	2.0	21.8	0.0	0.0	0.0	4.2	1.4	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.3	0.0	1.7	0.0	0.0	0.2	2.9	0.0	0.0	0.5	0.1	0.0	0.3	0.7	0.3	0.1	1.0	3.2	0.0	3.1
KRTAP25-1	KAP25.1	ENSG00000232263	"Keratin associated protein 25-1"	Q3LHN0	21	30289145-30289514	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031438	Uncertain		Approved	"Nuclear membrane,Plasma membrane,Cytosol"		NA	NA			"Nuclear membrane"	"Plasma membrane, Cytosol"	"HPA031438: AB_10610000"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTCAP3	KCP3	ENSG00000157992	"Keratinocyte associated protein 3"	Q53RY4	2	27442366-27446481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.8"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 157.5;Undifferentiated cells: 162.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8"	"Group enriched"	"Detected in many"	19	"B-cells: 5.4;T-cells: 7.0"	"Cell line enhanced"	"Detected in some"		"A-431: 28.1;CAPAN-2: 32.2;HaCaT: 10.3;OE19: 14.3;SCLC-21H: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047136, HPA060203"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA047136: AB_2679949, HPA060203: AB_2684221"	"prognostic favorable (2.67e-5)"	"unprognostic (5.93e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.42e-3)"	0.9	1.0	0.5	10.0	0.8	0.5	6.3	1.3	1.7	4.6	24.4	0.7	13.3	16.2	1.5	3.2	8.5	9.8	16.5	1.7	0.7	0.3	4.8	6.5	11.8	1.9	0.7	1.4	2.7	28.8	3.3	6.9	1.5	1.5	9.7	6.2	1.9	17.4	22.6	1.0	4.9	34.8	0.9	0.9	1.0	16.7	1.8	0.8	2.3	12.3	6.9	5.4	7.6	4.5	5.4	0.0	0.1	0.0	0.3	7.0	1.8	28.1	0.2	0.7	0.5	0.0	0.0	5.9	0.0	0.0	0.0	0.1	9.0	32.2	0.2	0.2	0.0	0.0	10.3	0.2	7.3	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.1	0.0	0.7	0.3	0.1	0.0	7.5	0.3	1.9	6.1	14.3	0.1	0.1	0.2	0.7	0.0	0.0	15.1	0.5	0.4	9.4	0.6	0.5	0.2	0.2	0.0	0.3	0.7	0.3	0.2	1.6	1.1	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.6	0.0	6.9	5.4	6.2	3.2	0.0	4.6	7.0	3.3	0.0	0.3	0.0	0.0	4.8	1.8	0.5	0.8	1.3	1.7	0.7	0.3	0.7	1.4	1.5	0.8	20.8	18.0	3.7	106.9	20.7	2.6	0.2	86.6	56.2	43.3	40.1	7.9	15.0	5.0	85.6	4.7	0.8	81.3	0.0	157.5	26.3	1.5	101.7	4.6	12.1	1.8	1.6	59.7	1.3	0.6	3.6	0.3	1.8	6.8	4.6	108.5	1.5	121.7	98.2	0.0	4.9	5.9	0.0	1.0	2.7	33.8	13.6	6.6	1.0	162.2	123.8
KTI12	"MGC20419, SBBI81, TOT4"	ENSG00000198841	"KTI12 chromatin associated homolog"	Q96EK9	1	52032103-52033816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031203, HPA031204, HPA031205"	Approved		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles, Cytoplasmic bodies"		"HPA031203: AB_2732464, HPA031204: AB_10600110, HPA031205: AB_10611380"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.36e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.08e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.64e-2)"	14.9	14.6	5.9	9.9	7.4	22.1	9.7	8.1	9.3	7.8	8.4	6.7	7.2	7.4	10.5	7.6	8.1	10.6	10.9	8.1	5.6	7.6	14.1	14.1	6.4	11.9	5.4	5.9	16.1	10.7	4.3	11.0	15.5	5.5	9.6	6.3	9.1	6.4	7.7	9.4	7.3	10.0	8.9	3.9	12.2	9.5	10.6	4.8	15.4	14.5	9.2	11.3	9.7	10.5	19.4	27.7	9.7	15.2	13.4	19.9	11.7	9.2	9.2	3.6	8.7	12.6	10.6	11.6	9.4	11.7	13.9	11.9	10.2	4.6	10.7	10.7	9.8	20.8	10.6	12.8	11.2	9.7	10.8	14.3	11.0	10.4	9.9	8.8	15.8	11.0	10.0	8.6	11.1	6.0	6.1	9.4	9.5	16.4	5.7	11.6	7.3	11.5	17.6	7.2	8.1	10.4	11.1	10.1	14.3	13.2	6.7	6.6	9.5	9.1	16.2	16.9	8.7	3.1	24.9	7.0	11.4	7.0	13.6	17.7	19.9	16.5	16.6	12.5	16.8	8.2	7.8	13.9	9.7	14.8	15.2	16.3	19.4	16.7	17.9	18.4	15.2	19.9	14.0	2.9	13.4	11.4	27.7	16.2	11.7	5.9	7.4	8.1	9.3	5.6	7.6	5.4	5.9	5.5	4.8	3.0	6.1	10.0	11.8	6.4	6.0	2.4	10.2	2.7	3.4	3.5	0.0	10.5	5.0	10.1	0.8	6.9	2.0	0.0	9.4	16.1	9.3	5.5	5.8	5.3	8.7	9.5	2.4	10.4	3.8	0.5	10.6	6.0	5.0	12.6	3.4	8.0	9.5	3.5	9.6	8.3	4.4	19.4	12.3	16.8	7.0	6.5	15.3	10.0	4.7	11.2
KXD1	"BORCS4, C19orf50, FLJ25480, KXDL, MGC2749"	ENSG00000105700	"KxDL motif containing 1"	Q9BQD3	19	18557762-18569387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041507, HPA041599"	Approved		Approved	"Nucleoli fibrillar center,Centrosome,Cytosol"		NA	NA			"Nucleoli fibrillar center, Centrosome, Cytosol"		"HPA041507: AB_10795698, HPA041599: AB_10795502"	"unprognostic (8.48e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (7.36e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (7.71e-10)"	"unprognostic (7.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-1)"	52.9	42.2	47.2	48.7	44.9	49.1	42.8	28.4	60.9	37.2	44.5	56.7	34.3	43.7	48.9	43.2	45.9	45.6	44.1	43.2	43.3	41.8	39.6	73.3	42.2	56.1	46.7	34.2	52.3	58.9	33.6	48.2	53.7	43.7	46.6	43.2	40.0	60.4	45.4	58.3	46.8	39.9	49.3	56.2	48.3	44.5	75.4	38.9	42.1	47.0	45.5	53.2	57.2	54.0	26.9	37.1	41.3	46.4	29.7	37.6	30.6	33.3	33.8	27.7	31.5	28.8	33.3	45.4	37.0	29.8	27.7	32.2	27.6	40.0	23.1	43.6	32.9	23.1	25.5	42.6	45.3	25.0	27.9	60.1	25.3	26.4	24.9	33.3	39.4	27.8	35.3	32.3	41.6	49.8	30.3	39.2	31.4	39.2	36.5	28.8	38.8	35.4	29.0	34.9	41.9	51.7	34.2	21.8	33.6	28.2	30.6	25.8	33.2	24.2	21.7	31.0	30.3	18.4	27.2	31.8	25.0	22.0	79.8	48.0	43.5	32.4	34.5	43.2	46.4	36.1	15.0	41.0	35.0	29.8	46.4	27.7	26.9	27.6	29.5	37.1	26.4	22.2	24.2	41.3	29.7	43.4	22.1	37.6	30.6	47.2	44.9	28.4	60.9	43.3	41.8	46.7	34.2	43.7	38.9	17.9	34.3	40.9	62.3	30.7	19.6	4.2	28.1	18.7	25.0	15.7	11.8	92.1	68.0	73.5	155.9	50.4	48.5	23.3	98.7	103.8	57.5	68.0	42.7	30.5	108.5	15.9	41.3	44.8	50.9	25.8	31.1	50.7	55.6	151.5	43.0	22.9	81.0	40.7	27.6	42.9	16.0	38.8	55.6	29.3	19.8	36.3	93.3	49.0	44.2	59.1
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134603138-134651636	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease"	"Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 19.5;tongue: 36.2"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 3.0;Late spermatids: 5.2;Muller glia cells: 2.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 7.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.4;U-2197: 4.6;U-87 MG: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036492: AB_10672222, HPA036668: AB_2675239"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.3	5.7	3.5	0.4	2.3	0.5	1.4	2.5	4.6	2.2	1.7	2.1	1.7	0.9	3.9	2.3	3.1	3.7	0.9	4.8	4.9	2.1	0.7	0.2	0.3	0.2	1.7	6.9	1.7	0.2	8.5	6.8	0.2	3.2	3.6	0.6	3.3	1.7	2.8	19.5	12.6	0.5	7.4	2.0	0.3	1.7	0.7	3.6	0.5	5.2	36.2	1.1	1.3	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	13.9	0.7	0.0	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.5	2.3	2.5	4.6	4.9	2.1	1.7	6.9	3.2	3.6	0.0	0.0	0.0	0.0	0.6	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 59.0;monocytes: 55.9;Syncytiotrophoblasts: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	22.2	26.8	16.6	13.2	19.3	10.6	27.5	14.9	23.5	23.7	17.5	20.0	13.0	19.4	24.1	21.2	27.2	18.9	17.8	13.2	18.6	14.2	27.3	23.8	17.1	17.6	16.9	22.2	27.4	28.6	27.0	19.5	21.9	23.4	19.0	19.6	19.5	21.0	20.7	10.4	22.0	17.2	22.1	14.8	20.7	23.5	15.6	17.2	15.5	24.5	13.4	20.2	25.2	17.7	9.6	17.0	9.2	12.7	11.5	16.7	8.2	20.8	4.4	21.4	7.1	7.7	21.5	18.6	12.8	24.2	16.5	21.5	6.4	7.3	13.8	9.8	9.5	11.0	5.9	6.0	9.9	25.2	8.1	8.6	12.3	4.2	10.5	25.1	17.2	3.4	18.1	10.0	11.3	20.4	10.5	15.9	16.2	15.9	7.3	15.5	6.9	18.4	8.4	12.7	16.1	3.8	18.8	15.0	7.3	34.6	21.3	15.6	19.1	17.0	22.8	11.1	14.3	12.6	4.2	10.6	6.9	4.6	22.1	9.3	9.9	4.9	9.2	3.4	7.7	5.9	5.6	12.7	7.1	9.1	7.9	12.6	9.6	11.8	10.5	17.0	9.3	12.4	10.4	9.2	11.5	10.2	6.3	16.7	8.2	16.6	19.3	14.9	23.5	18.6	14.2	16.9	22.2	23.4	17.2	11.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.8	12.2	0.0	59.0	21.6	29.8	0.0	0.0	0.0	0.0	33.6	33.1	0.0	0.0	4.7	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	55.9	0.0	0.0	21.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell type enhanced"	"Detected in many"	18	"Macrophages: 94.5;monocytes: 360.7;Syncytiotrophoblasts: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Cell line enhanced"	"Detected in some"		"A549: 37.9;GAMG: 62.8;HeLa: 42.3;Hep G2: 25.7;hTEC/SVTERT24-B: 22.2;U-87 MG: 66.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		360000	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	37.9	0.1	0.1	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.6	0.5	2.2	0.1	0.0	62.8	0.1	0.0	0.0	0.0	0.1	0.0	0.8	42.3	25.7	0.5	0.1	0.2	3.6	3.1	22.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	19.3	0.0	2.3	0.1	0.0	0.1	0.0	0.2	0.1	0.6	19.6	0.1	0.0	21.0	3.1	0.2	0.2	10.5	5.4	0.3	1.2	0.1	18.5	0.0	0.1	0.0	0.0	66.4	4.4	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6	3.0	2.4	22.6	0.5	3.5	0.1	1.2	5.1	2.7	10.3	3.5	3.9	2.8	5.0	12.1	34.6	2.9	0.0	0.0	7.8	1.5	3.3	0.8	0.0	44.8	38.5	9.5	0.0	3.1	59.7	39.6	1.7	94.5	1.7	360.7	0.0	0.2	37.4	0.0	0.4	23.0	0.5	6.5	1.3	40.0	8.0	2.8	87.5	0.0	0.0	4.2
L3MBTL1	"dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3"	ENSG00000185513	"L3MBTL1, histone methyl-lysine binding protein"	Q9Y468	20	43507680-43550950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 16.2;Cone photoreceptor cells: 13.7;Spermatocytes: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.7;SuSa: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068051			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA068051: AB_2732778"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.65e-4)"	"unprognostic (6.02e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-4)"	3.3	5.7	12.6	4.3	11.7	6.4	5.2	25.0	14.3	5.6	4.9	10.5	8.3	4.3	8.2	10.7	4.0	10.4	3.9	5.7	13.8	16.4	4.5	1.8	4.2	4.7	16.3	9.6	11.2	3.3	7.1	14.6	5.1	10.1	6.6	4.4	7.5	8.1	8.0	9.0	9.7	4.7	6.0	7.4	5.6	4.2	13.3	14.5	4.6	7.2	0.7	5.5	4.3	5.4	0.5	1.3	1.5	0.2	2.5	1.8	1.4	0.2	2.0	5.5	3.7	0.1	0.0	10.7	1.2	1.5	1.8	3.1	0.5	5.7	3.1	2.0	2.0	2.4	4.8	0.0	1.1	1.5	0.0	4.9	2.5	4.9	3.8	1.4	0.0	2.9	2.2	2.5	1.2	0.0	5.1	1.1	4.3	2.9	2.1	1.0	0.6	1.3	3.2	2.7	2.0	2.9	2.4	1.3	0.8	4.1	1.3	2.0	6.2	2.0	1.3	0.3	11.1	2.7	3.2	2.0	1.0	3.7	0.0	0.9	4.0	1.0	1.1	3.9	3.9	1.1	0.0	0.2	0.6	0.8	0.2	1.3	0.5	1.0	1.0	0.9	0.4	1.8	0.6	1.5	2.5	0.1	1.3	0.3	1.4	12.6	11.7	25.0	14.3	13.8	16.4	16.3	9.6	10.1	14.5	3.0	2.7	0.0	1.9	0.8	16.2	1.6	0.0	6.7	5.7	5.2	13.7	1.9	1.7	1.1	1.6	1.0	1.1	0.0	0.2	2.8	1.1	2.0	4.7	0.8	1.1	6.4	1.2	1.3	1.9	2.1	4.6	2.4	3.3	0.0	1.1	6.4	0.6	1.9	5.6	0.3	11.7	0.0	1.4	15.1	10.2	1.0	1.6	1.5	1.7	1.4
L3MBTL2	"dJ756G23.3, DKFZP761I141, H-l(3)mbt-l"	ENSG00000100395	"L3MBTL2, polycomb repressive complex 1 subunit"	Q969R5	22	41205205-41231271	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000815			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000815: AB_1079220"	"unprognostic (2.42e-1)"	"prognostic favorable (6.39e-5)"	"unprognostic (3.98e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (3.48e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.19e-1)"	10.8	15.8	15.2	13.5	26.4	11.1	12.9	20.6	32.7	15.5	12.8	16.8	17.9	10.1	15.0	15.2	12.6	24.0	11.4	14.3	15.6	16.6	12.4	16.9	13.9	18.5	14.5	19.2	18.7	15.9	23.6	22.6	12.4	15.4	15.1	12.5	15.2	15.8	17.9	11.6	15.6	11.8	16.9	12.6	16.9	13.2	14.5	16.0	16.7	14.7	9.3	20.4	13.8	10.9	13.1	13.2	7.2	13.3	14.5	17.7	15.2	9.8	9.9	8.3	17.2	10.6	7.9	9.9	9.5	11.2	18.7	15.5	6.2	7.2	16.1	7.6	13.0	11.3	9.7	20.2	12.7	12.0	20.0	25.7	6.3	17.9	15.0	11.2	30.7	15.0	10.8	4.9	14.9	14.0	8.0	13.3	12.7	11.4	13.3	8.8	17.3	15.3	10.3	11.7	36.2	11.6	15.8	6.7	19.0	9.3	10.1	7.0	4.9	16.7	12.4	9.9	8.8	8.2	17.2	10.6	9.9	9.3	7.9	10.5	10.8	19.8	13.5	11.6	14.1	12.7	6.5	10.4	7.2	17.7	12.9	16.3	13.1	14.1	13.9	13.2	9.3	16.9	15.9	1.1	14.5	13.3	9.8	13.5	15.2	15.2	26.4	20.6	32.7	15.6	16.6	14.5	19.2	15.4	16.0	14.9	18.7	6.0	5.1	2.4	23.9	9.2	17.8	26.8	22.7	10.4	15.7	14.9	10.0	8.4	10.3	6.8	7.1	23.3	6.7	16.3	5.7	5.8	10.5	12.3	11.1	15.9	14.5	8.0	9.1	23.9	6.6	9.9	3.3	10.8	7.5	14.1	7.2	5.8	8.9	6.7	14.2	6.5	8.2	18.4	12.4	3.3	14.3	12.5	8.0	5.3
L3MBTL4	"FLJ35936, HsT1031"	ENSG00000154655	"L3MBTL4, histone methyl-lysine binding protein"	Q8NA19	18	5954706-6415237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 50.7;Late spermatids: 66.8;monocytes: 45.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.3;NK-cell: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.3;Karpas-707: 5.9;RPMI-8226: 13.8;SCLC-21H: 6.7;SH-SY5Y: 7.3;U-2 OS: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA064194, HPA069042"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA064194: AB_2685208, HPA069042: AB_2686071"	"unprognostic (1.33e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	6.3	6.9	8.4	3.7	12.8	2.1	6.8	0.8	8.1	6.2	3.4	12.3	4.8	4.2	4.9	5.4	5.9	6.2	4.3	8.6	9.6	3.5	9.9	12.0	5.9	2.7	13.7	5.5	12.3	14.2	18.8	8.2	1.1	4.6	3.4	3.0	6.0	5.9	9.6	1.4	9.9	4.8	2.0	3.6	4.0	4.4	17.0	13.4	0.6	8.2	2.5	2.3	3.1	7.1	5.3	1.3	0.4	2.2	6.4	1.4	0.8	0.0	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.6	0.0	0.0	4.3	0.2	0.0	0.0	0.1	0.0	2.0	0.1	0.2	2.9	2.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.3	0.0	1.8	3.8	0.0	13.8	0.0	2.4	6.7	7.3	0.0	0.1	0.3	0.5	0.0	0.0	0.1	0.1	4.4	0.1	1.7	0.2	0.0	0.1	1.7	0.1	2.1	0.4	2.2	0.1	1.4	0.6	0.1	1.1	0.2	0.2	1.3	5.3	0.3	0.4	0.3	6.4	1.4	0.3	0.1	0.8	8.4	12.8	0.8	8.1	9.6	3.5	13.7	5.5	4.6	13.4	3.0	9.8	0.0	5.5	6.9	0.8	4.5	12.7	1.4	6.8	5.2	15.7	0.1	3.3	7.1	50.7	3.6	0.9	0.0	4.5	0.0	2.8	4.9	1.1	8.5	3.3	0.0	10.9	1.3	2.5	66.8	9.5	2.6	1.7	45.1	1.3	1.0	3.8	1.9	12.0	6.0	0.3	6.5	6.2	11.8	1.3	7.2	0.1	1.0	3.8	3.9
LACTBL1		ENSG00000215906	"Lactamase beta like 1"	A8MY62	1	22953043-22965338	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 2.2"	"Cell type enriched"	"Detected in single"	7	"Bipolar cells: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066810			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA066810: "																		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAMA3	"BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa"	ENSG00000053747	"Laminin subunit alpha 3"	Q16787	18	23689443-23955066	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 70.8"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 107.2;Pancreatic endocrine cells: 340.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 154.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009309, CAB010757"	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		810000	"Endoplasmic reticulum"		"CAB010757: AB_477162, HPA009309: AB_1079224"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.91e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.13e-1)"	8.2	0.9	2.9	8.2	1.9	0.0	16.7	0.6	2.3	18.2	13.3	2.4	5.4	11.2	19.1	9.5	12.4	7.8	8.1	2.7	1.8	1.5	3.1	1.3	26.2	7.0	2.4	0.9	5.8	3.1	10.3	2.3	70.8	1.6	8.7	5.2	5.7	14.9	9.1	2.2	20.7	27.8	10.2	1.3	0.8	19.7	3.8	0.5	3.3	1.8	9.7	8.0	11.5	15.2	0.0	0.0	0.8	0.0	0.0	1.3	0.2	17.3	2.2	0.0	0.0	0.9	0.2	0.0	0.3	0.2	0.1	0.2	0.7	20.1	0.0	2.3	0.2	0.0	31.7	0.0	154.2	0.1	0.0	1.2	0.0	0.6	0.3	0.1	0.0	0.0	0.2	17.3	0.1	18.3	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	5.4	2.0	0.3	0.0	0.0	6.8	2.0	0.0	0.3	0.7	0.3	0.0	0.0	0.6	0.2	1.6	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.6	2.3	1.8	1.5	2.4	0.9	1.6	0.5	107.2	23.7	0.5	53.6	27.8	3.8	2.0	5.1	13.4	23.9	1.8	0.0	0.1	0.0	30.0	3.7	2.8	50.4	0.0	30.6	0.2	2.0	16.7	5.7	0.8	0.2	0.0	7.9	1.8	0.0	2.8	5.5	1.1	1.7	1.0	11.0	0.0	340.7	31.6	3.2	0.0	1.9	6.5	19.6	3.1	1.9	8.7	0.1	0.7	6.6	15.4
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112108760-112254939	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 76.6;Fibroblasts: 77.1;Leydig cells: 154.2;Peritubular cells: 76.4;Smooth muscle cells: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.9;ASC TERT1: 79.0;HSkMC: 61.5;hTERT-RPE1: 38.0;HUVEC TERT2: 64.8;TIME: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		350000	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	42.3	3.6	5.8	20.7	5.4	0.0	21.7	3.7	4.6	28.7	28.6	4.7	12.9	6.3	41.0	24.8	29.7	29.6	23.3	13.8	5.1	4.1	4.6	1.8	27.9	8.8	5.5	2.1	19.9	1.6	3.6	5.6	25.4	5.0	21.3	13.2	18.4	22.9	15.7	5.7	6.8	13.1	53.6	3.6	0.4	15.6	9.4	2.5	1.1	9.1	15.2	6.6	35.6	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	51.9	79.0	0.0	13.0	7.8	1.3	0.2	0.0	4.9	0.0	8.6	22.4	3.0	0.0	0.5	0.0	0.2	0.0	6.7	0.0	6.5	0.0	10.6	0.0	0.0	61.5	0.0	9.4	0.0	38.0	64.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	21.2	0.3	0.0	0.3	2.0	0.0	10.0	0.2	0.0	0.0	59.2	21.4	1.1	23.8	4.3	0.0	0.0	0.0	5.3	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.4	3.7	4.6	5.1	4.1	5.5	2.1	5.0	2.5	3.0	5.0	0.0	1.2	20.1	1.0	47.4	0.0	0.0	3.4	3.5	0.0	0.9	3.3	0.4	76.6	56.3	0.0	0.0	0.6	71.2	77.1	1.1	1.1	28.2	2.7	0.0	0.0	19.6	2.2	34.0	154.2	1.7	54.0	1.0	0.0	0.0	0.6	0.0	76.4	0.0	0.2	64.7	100.7	0.7	0.5	16.3	2.5	0.0	0.0	5.2
LAMA5		ENSG00000130702	"Laminin subunit alpha 5"	O15230	20	62307955-62367312	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 71.5;Cytotrophoblasts: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 30.9;CACO-2: 42.6;EFO-21: 31.8;HaCaT: 29.0;HeLa: 27.8;TIME: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054609, CAB078157"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA		1200000	Vesicles	Nucleoplasm	"CAB078157: AB_2665809, HPA054609: AB_2682540"	"unprognostic (8.01e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.90e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-3)"	"unprognostic (4.04e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.33e-2)"	22.6	5.9	5.6	8.1	5.9	2.5	16.8	24.0	6.6	16.7	28.0	3.1	18.6	7.6	23.2	13.8	18.0	14.2	27.4	13.7	4.7	2.9	17.0	7.3	19.7	4.4	3.7	2.3	6.9	13.9	8.3	6.0	33.3	5.5	17.4	2.6	18.6	12.7	25.0	9.4	45.2	9.0	25.0	4.5	8.8	13.3	4.4	3.4	2.0	18.4	11.8	10.4	19.4	24.9	0.9	1.2	0.2	0.0	0.0	0.0	0.0	3.9	30.9	0.6	4.0	0.7	8.8	23.8	1.1	0.6	0.9	0.1	42.6	16.0	0.3	31.8	0.0	0.9	29.0	0.8	12.4	0.0	0.1	1.7	1.0	27.8	12.1	2.8	0.0	4.6	0.4	8.2	2.1	2.2	1.5	4.1	0.0	1.8	0.4	0.0	5.9	0.0	0.1	2.0	5.1	18.0	0.0	0.3	3.3	8.0	18.9	0.3	12.3	17.1	17.1	0.3	3.3	17.0	0.2	37.3	0.4	11.8	0.2	5.0	0.2	0.0	0.1	8.8	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	5.6	5.9	24.0	6.6	4.7	2.9	3.7	2.3	5.5	3.4	71.5	26.6	8.3	15.9	15.1	1.3	15.3	22.9	13.4	35.2	36.6	7.9	73.3	0.0	28.3	4.3	36.5	0.0	0.0	3.8	24.9	7.8	13.3	2.3	9.4	11.6	3.2	2.4	17.8	0.0	1.1	9.2	2.5	1.7	1.8	0.0	8.2	10.9	0.0	18.4	10.2	1.7	25.8	31.9	0.7	1.9	11.0	47.9	1.0	0.2	24.5
LAMB2	"LAMS, NPHS5"	ENSG00000172037	"Laminin subunit beta 2"	P55268	3	49121114-49133118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 142.0;Leydig cells: 135.4;Peritubular cells: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;myeloid DC: 2.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.0;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000053, HPA001895, HPA050033, CAB078160"	Supported		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		18000000	Vesicles	Cytosol	"CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: "	"unprognostic (1.12e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.24e-2)"	46.1	35.3	7.4	13.0	7.7	0.9	29.0	5.1	8.3	55.0	25.9	10.5	41.3	9.3	43.4	38.6	34.3	27.1	37.7	62.5	9.7	4.1	30.6	29.6	28.2	5.7	8.2	6.1	56.0	12.9	51.7	8.0	41.3	9.9	37.7	7.3	45.1	17.4	39.2	22.7	17.0	23.0	31.5	6.9	16.7	22.7	24.1	8.1	2.1	36.5	21.8	11.4	45.3	38.4	0.0	2.0	0.2	2.4	0.0	0.0	0.4	3.2	8.0	7.4	26.4	43.4	45.0	6.7	28.0	34.7	16.7	16.8	3.8	11.1	0.0	9.7	63.2	8.4	10.5	6.4	10.0	11.5	0.0	2.0	1.4	12.6	6.6	29.3	0.0	0.0	39.1	15.0	13.3	13.6	40.5	16.3	0.0	0.8	0.0	13.5	6.2	0.0	0.0	3.2	4.2	6.7	0.0	3.6	0.1	11.7	4.1	0.0	4.4	16.0	9.3	14.6	13.1	20.2	0.2	27.0	18.1	7.9	6.4	7.3	0.0	0.0	0.0	8.6	0.0	12.2	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	7.4	7.7	5.1	8.3	9.7	4.1	8.2	6.1	9.9	8.1	110.2	52.2	0.0	12.0	27.7	1.3	142.0	43.3	2.7	38.7	52.4	5.9	8.5	5.0	25.4	2.6	76.6	5.9	0.0	8.0	4.8	81.7	11.7	1.1	44.7	9.0	7.9	0.0	93.9	11.6	7.1	135.4	9.2	40.5	3.6	2.2	44.2	14.8	8.6	132.2	36.6	2.1	116.4	74.5	3.5	7.3	21.3	7.9	2.2	4.7	7.1
LAMB3	"BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa"	ENSG00000196878	"Laminin subunit beta 3"	Q13751	1	209614870-209652466	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Amelogenesis imperfecta, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 205.4;Basal glandular cells: 278.5;Pancreatic endocrine cells: 523.1;Urothelial cells: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.9;neutrophil: 3.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.5;HaCaT: 66.0;HBEC3-KT: 161.1;hTCEpi: 51.6;hTERT-HME1: 32.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA007584, HPA008069, CAB078183"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		15000	Vesicles		"CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228"	"prognostic favorable (8.43e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.92e-3)"	24.5	8.4	1.2	5.5	1.7	3.3	11.7	0.8	4.1	10.2	9.9	0.9	3.2	12.1	7.0	3.1	22.1	6.3	8.4	8.9	1.1	0.8	4.7	4.7	11.0	1.6	1.2	2.2	1.4	2.1	0.0	1.1	16.1	1.1	11.9	6.3	0.8	19.1	10.3	1.9	17.9	22.8	2.7	1.4	2.1	28.7	1.7	0.8	4.9	1.1	35.8	30.2	16.2	13.3	0.1	1.9	3.4	0.5	0.4	0.4	0.1	21.1	3.1	0.0	0.0	2.3	1.5	0.1	0.6	1.9	0.7	1.1	8.3	43.5	0.0	1.8	0.4	1.1	66.0	0.0	161.1	1.1	1.5	0.1	0.1	11.2	0.1	0.3	0.1	0.1	0.3	51.6	2.4	32.1	1.4	0.7	0.0	0.3	0.8	0.2	0.0	0.0	0.1	0.0	9.7	9.1	0.0	2.1	19.3	8.9	13.2	0.0	0.0	9.0	1.0	1.8	0.1	0.2	1.1	16.8	3.6	7.8	0.1	12.6	0.2	0.4	0.0	5.3	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.4	0.0	1.9	0.1	0.4	0.0	3.4	0.4	0.0	0.0	0.0	0.1	1.2	1.7	0.8	4.1	1.1	0.8	1.2	2.2	1.1	0.8	205.4	75.6	2.2	278.5	97.4	0.2	6.9	2.5	44.2	151.2	45.4	0.0	0.1	0.0	174.0	4.1	1.1	142.2	0.0	132.9	1.1	4.3	108.8	18.4	3.9	2.1	3.2	7.5	0.0	0.0	7.4	1.7	10.1	8.5	3.6	43.8	0.8	523.1	80.7	0.7	1.9	0.3	0.0	4.2	0.3	0.7	22.7	0.5	0.0	20.5	285.9
LAMC1	LAMB2	ENSG00000135862	"Laminin subunit gamma 1"	P11047	1	183023460-183145592	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	15	"B-cells: 3.2;dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 170.5;ASC TERT1: 93.8;HSkMC: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001908, HPA001909, CAB004486, CAB078163"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		90000000	"Endoplasmic reticulum, Plasma membrane"		"CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.30e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.85e-5)"	49.0	6.8	2.9	11.3	4.0	0.2	51.5	5.9	3.4	30.4	27.7	2.8	12.8	4.9	30.5	28.7	31.5	21.5	25.9	39.5	3.4	2.0	10.0	6.8	22.5	10.6	3.9	2.7	22.7	9.8	7.4	4.1	73.1	3.5	23.9	11.4	11.7	11.6	17.3	32.2	15.6	17.6	41.3	3.0	4.7	22.3	16.1	2.7	3.5	21.7	16.4	7.3	40.2	37.6	3.2	1.3	0.0	0.1	0.0	0.0	0.2	5.2	8.5	28.2	8.0	170.5	93.8	42.7	38.6	38.8	15.6	9.2	25.3	6.0	1.9	17.8	18.5	9.2	13.1	5.3	10.2	11.9	0.0	5.4	0.0	7.7	9.2	26.8	1.6	0.9	105.6	5.5	18.6	14.7	27.9	27.1	0.0	0.0	5.7	18.9	2.3	0.0	1.7	11.4	9.7	1.6	1.3	23.8	0.9	25.2	14.0	1.8	5.3	10.1	0.0	9.9	50.7	2.2	4.4	50.0	19.1	7.5	17.6	9.6	2.2	0.0	1.2	15.8	1.2	18.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	2.9	4.0	5.9	3.4	3.4	2.0	3.9	2.7	3.5	2.7	32.8	16.3	4.5	38.6	27.8	1.9	48.8	25.5	10.7	17.0	34.9	3.9	80.1	1.7	50.0	5.4	59.4	0.7	0.0	19.8	53.9	99.3	48.3	2.3	17.8	16.1	1.6	1.2	26.4	10.8	3.8	111.9	5.3	32.1	10.0	1.7	2.0	39.3	3.5	58.7	10.2	0.6	71.1	83.0	7.0	39.9	14.8	60.3	0.5	2.6	21.6
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183244900	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Pancreatic endocrine cells: 902.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 49.4;CAPAN-2: 44.7;HBEC3-KT: 221.9;hTERT-HME1: 137.0;RPTEC TERT1: 53.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, CAB078165"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	No	No			Cytosol		"CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689"	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	2.6	0.0	1.0	20.6	4.1	0.0	11.4	3.6	1.2	8.7	8.4	0.9	2.4	0.9	6.6	2.9	6.5	19.0	12.8	1.8	0.7	0.1	10.5	0.8	18.3	3.3	1.6	1.1	1.9	2.9	0.0	7.0	21.2	1.5	3.7	6.8	0.9	11.2	3.2	1.3	12.8	14.3	1.8	0.7	0.7	7.6	1.9	0.9	3.5	9.8	10.0	15.6	3.4	4.8	0.9	0.8	1.7	0.5	0.4	0.6	0.1	49.4	2.2	0.0	0.0	0.4	1.1	3.6	0.3	0.4	0.1	0.0	3.6	44.7	0.0	19.0	0.1	1.4	22.3	0.0	221.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	17.2	0.5	137.0	0.2	2.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	18.1	3.1	0.0	0.1	0.0	53.2	12.9	2.7	0.0	1.3	0.0	0.0	1.4	0.1	0.2	0.3	0.2	2.7	1.3	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.4	0.6	0.4	0.3	0.4	0.5	0.4	0.4	0.1	0.9	0.5	0.6	1.7	0.4	0.5	0.8	0.3	0.1	1.0	4.1	3.6	1.2	0.7	0.1	1.6	1.1	1.5	0.9	202.5	19.1	0.0	163.7	76.6	0.0	1.1	15.3	66.9	51.2	22.7	0.0	26.6	0.0	197.8	16.4	0.5	28.1	0.0	81.6	9.8	7.8	209.4	0.0	0.0	2.2	0.0	8.6	0.0	0.0	8.3	3.1	2.9	8.5	4.6	13.0	0.0	902.6	26.0	0.4	0.0	0.0	0.0	2.3	3.7	1.0	26.0	69.7	0.7	7.1	119.2
LAMTOR2	"ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3"	ENSG00000116586	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2"	Q9Y2Q5	1	156054752-156058510	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004126	Approved		Approved	Nucleoplasm,Vesicles		No	No		17000	"Nucleoplasm, Vesicles"		"HPA004126: AB_1849916"	"unprognostic (2.09e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.35e-1)"	24.3	33.5	30.3	18.8	27.2	23.4	35.3	14.2	30.6	22.5	27.5	13.8	34.3	24.5	17.0	38.1	27.6	25.4	25.7	37.2	25.8	24.9	31.7	63.5	27.7	37.9	26.4	22.8	11.4	75.2	16.6	18.0	21.1	23.4	18.8	27.5	16.4	35.9	34.3	35.5	20.4	26.2	26.2	19.3	26.0	27.3	12.1	20.3	20.2	20.9	30.2	23.6	21.9	17.0	47.2	89.8	60.4	80.6	32.6	47.6	56.7	15.1	34.5	16.4	22.4	33.3	27.1	18.0	13.6	23.1	17.0	19.5	15.8	26.0	22.5	23.7	26.2	15.0	22.4	16.6	36.7	9.6	18.7	25.2	13.1	23.4	20.8	26.4	18.5	21.4	31.9	23.0	18.1	23.3	23.8	34.6	33.8	11.8	16.9	24.4	30.6	19.1	26.4	17.2	60.3	51.9	16.2	12.2	32.9	37.3	22.3	6.3	36.5	17.3	48.2	27.5	27.2	33.9	54.5	23.4	14.4	13.3	20.9	12.7	25.6	37.5	13.1	25.7	20.6	15.4	41.8	80.6	60.4	30.9	71.6	30.2	47.2	34.2	33.5	89.8	38.3	26.2	28.2	39.6	32.6	56.5	47.5	47.6	56.7	30.3	27.2	14.2	30.6	25.8	24.9	26.4	22.8	23.4	20.3	53.6	42.8	84.0	54.8	42.9	27.7	101.0	124.9	48.2	29.6	102.9	5.9	124.2	328.3	164.5	35.9	83.1	242.4	23.3	156.0	159.6	83.8	73.9	107.1	259.1	359.6	6.4	121.0	78.0	197.4	46.6	43.7	177.6	150.1	338.2	124.1	62.7	171.6	238.4	47.7	425.0	20.8	32.3	55.6	21.8	36.0	69.9	64.5	60.9	143.9	71.1
LANCL3	FLJ42925	ENSG00000147036	"LanC like 3"	Q6ZV70	X	37571569-37684463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 7.1;lung: 6.8"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 7.8;Suprabasal keratinocytes: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 7.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 17.2;HMC-1: 5.6;K-562: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005470, HPA076575"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA005470: AB_2134886, HPA076575: AB_2732315"	"unprognostic (6.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.01e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-2)"	1.2	0.8	0.7	0.3	2.3	0.9	0.4	2.5	2.4	1.2	3.8	0.7	0.2	0.6	0.5	0.3	4.6	0.2	0.9	0.7	1.1	2.8	0.4	0.2	6.8	0.4	1.3	1.3	1.3	0.2	0.1	1.7	0.2	2.2	0.6	2.8	2.5	1.1	0.9	1.0	2.6	1.1	1.9	1.8	0.2	2.2	1.8	0.9	0.2	1.2	1.7	1.2	1.8	2.9	0.3	0.2	7.1	0.2	1.1	1.8	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	1.1	2.5	0.3	0.0	0.0	0.3	17.2	1.8	0.0	0.0	0.0	5.6	0.0	0.5	0.0	0.1	0.0	0.3	0.0	3.9	0.0	1.2	0.0	0.2	0.3	0.4	0.2	1.7	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	1.2	0.0	0.0	1.6	0.7	0.0	0.0	2.9	0.0	0.4	7.1	0.2	0.9	1.0	0.2	0.8	0.2	0.4	1.8	0.1	0.3	0.1	1.0	1.1	1.1	0.2	0.2	0.6	0.7	0.7	2.3	2.5	2.4	1.1	2.8	1.3	1.3	2.2	0.9	3.0	2.6	0.0	1.1	7.8	0.4	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.2	0.1	0.4	0.5	1.1	0.0	0.1	3.2	1.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.5	1.3	0.9	1.4	0.0	1.4	0.0	1.7	0.2	1.7	3.9	0.1	1.0	0.6	2.2
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.9	9.6	9.2	8.7	18.3	22.3	0.1	17.3	19.5	62.9	76.5	17.5	20.9	43.2	11.5	13.3	37.5	6.8	34.5	12.2	24.0	16.4	9.9	23.9	10.6	22.8	21.3	21.5	15.4	22.7	7.8	20.6	10.9	7.2	21.8	11.4	23.1	30.9	14.8	11.8	19.1	29.5	19.2	20.6	18.4	29.7	8.8	21.8	16.4	12.9	13.6	11.2	15.8	9.8	33.8	13.3	8.3	8.3	14.1	16.0	10.8	16.8	30.0	28.4	43.4	37.3	21.6	35.9	15.4	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7	26.8	44.7	44.2	21.0	19.6	8.0	43.2	10.2	46.8	26.1	26.2	2.0	31.2	99.5	46.8	71.4	104.1	38.5	0.0	96.6	44.5	25.9	23.1	63.4	92.3	227.4	6.4	15.6	68.2	96.6	22.8	21.3	135.7	40.5	251.5	30.0	93.7	42.5	30.2	32.9	217.2	12.6	32.3	24.7	46.4	13.2	19.9	46.6	30.5	39.9	21.7
LAPTM4A	"HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp"	ENSG00000068697	"Lysosomal protein transmembrane 4 alpha"	Q15012	2	20032650-20052028	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 133.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031402, HPA031404, HPA068554"	Approved		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles"	"Plasma membrane"	"HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: AB_2686003"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.73e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (8.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (7.98e-3)"	"unprognostic (2.36e-1)"	59.2	63.8	23.4	20.1	22.8	19.8	53.6	15.9	23.4	85.7	44.0	25.9	181.0	26.0	80.3	57.4	50.4	53.0	49.9	50.1	22.3	19.0	95.9	83.0	48.7	24.3	22.0	17.3	72.7	63.6	28.9	46.5	137.6	24.9	64.9	28.4	56.8	49.9	175.6	33.6	41.2	44.9	56.4	21.6	34.8	40.7	83.3	18.6	13.7	75.3	37.9	37.7	65.3	57.8	27.2	37.4	82.4	53.4	16.5	19.4	48.0	37.5	20.8	12.8	26.5	133.1	99.0	47.9	47.7	59.9	32.7	37.2	16.3	37.0	6.6	11.0	57.9	34.0	37.4	10.6	22.9	29.9	16.2	16.9	10.1	24.6	46.3	51.4	7.8	28.1	66.1	46.6	31.7	36.5	45.7	33.7	5.7	7.6	12.7	48.4	21.6	4.6	10.2	28.2	32.2	19.1	8.1	37.5	12.5	80.0	31.5	20.3	19.6	44.3	36.7	30.0	48.7	15.8	6.4	42.9	55.0	19.7	47.2	30.6	21.2	30.4	10.7	43.5	15.6	21.8	82.4	53.4	38.5	14.2	44.2	17.1	27.2	17.0	15.7	37.4	26.2	19.4	17.3	28.1	16.5	50.3	31.3	15.9	48.0	23.4	22.8	15.9	23.4	22.3	19.0	22.0	17.3	24.9	18.6	181.7	179.3	127.9	498.3	585.3	19.7	191.2	331.2	204.8	200.2	525.1	11.8	156.0	137.6	412.4	1117.0	311.4	159.7	46.7	306.5	887.8	890.1	264.1	506.1	427.2	285.9	19.1	132.5	307.6	307.4	952.2	773.5	352.6	558.5	334.6	176.2	293.0	282.2	210.1	564.6	774.3	23.0	523.9	560.6	321.9	146.0	620.4	253.3	94.8	178.7	415.2
LAPTM4B	LC27	ENSG00000104341	"Lysosomal protein transmembrane 4 beta"	Q86VI4	8	97775057-97853013	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 397.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.0;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"HEL: 86.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020782, HPA068830"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB020782: , HPA068830: AB_2686044"	"prognostic unfavorable (5.63e-4)"	"unprognostic (1.91e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (9.25e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	12.3	19.7	12.2	6.1	14.2	1.6	14.9	5.9	27.3	19.7	14.4	21.0	4.0	26.8	24.8	11.5	13.2	24.2	25.8	75.1	10.3	13.7	33.9	12.5	14.8	9.4	15.3	8.4	25.8	28.1	16.1	9.8	9.6	21.9	14.7	11.4	56.1	29.8	16.1	50.6	14.8	41.9	17.0	16.2	20.4	14.4	32.2	9.0	2.6	18.1	27.1	8.9	17.9	13.4	1.0	0.5	5.0	0.2	0.9	3.5	0.6	34.7	30.2	24.0	48.1	12.3	8.6	17.3	16.3	7.4	31.5	27.0	15.5	23.3	0.1	70.3	12.0	11.3	37.9	35.2	15.8	36.2	0.2	52.9	86.2	25.2	21.8	9.7	0.0	16.8	12.9	10.0	22.5	11.5	10.6	4.7	10.9	62.8	0.1	12.5	22.3	8.1	4.4	46.0	15.2	19.0	0.0	12.2	0.0	74.0	17.0	25.8	43.7	18.7	8.6	21.0	28.0	22.1	10.9	1.3	8.3	16.3	14.7	10.7	3.9	11.9	0.2	9.3	0.0	20.5	5.0	0.2	0.0	1.4	0.0	3.5	1.0	1.3	1.1	0.5	0.3	2.3	2.5	0.4	0.9	0.1	0.3	0.7	0.6	12.2	14.2	5.9	27.3	10.3	13.7	15.3	8.4	21.9	9.0	95.3	44.3	3.6	46.8	49.0	192.0	174.6	91.7	6.7	19.4	101.2	210.1	23.4	33.2	202.9	6.3	36.0	24.5	0.0	110.3	32.0	43.2	49.2	12.7	30.4	6.9	127.1	34.0	98.8	3.2	7.0	22.2	7.7	40.5	4.6	24.5	101.1	68.4	34.3	29.0	46.1	397.0	58.2	31.9	7.6	39.3	38.8	11.8	7.5	49.0	77.9
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757820	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5"	"Group enriched"	"Detected in many"	5	"B-cells: 749.7;granulocytes: 621.6;Hofbauer cells: 1099.3;Kupffer cells: 831.6;Macrophages: 787.9;T-cells: 409.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 47.1;HEL: 89.3;HL-60: 56.6;HMC-1: 211.5;REH: 66.3;U-698: 76.8;U-937: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	56.0	15.5	11.5	59.1	17.8	157.5	15.0	2.2	10.4	8.2	11.2	20.7	1.8	9.5	7.5	6.8	8.3	13.7	19.9	9.2	11.2	12.7	14.0	18.2	60.8	144.5	19.0	3.3	7.7	6.3	2.0	6.8	20.1	14.6	8.2	13.2	7.4	11.7	4.7	4.0	5.5	37.1	12.9	33.8	130.9	9.5	6.7	15.8	75.2	10.1	5.2	91.2	21.4	6.4	98.2	69.1	145.1	109.3	26.0	55.4	166.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	47.1	4.9	0.1	0.1	0.1	0.0	0.0	0.0	5.2	0.0	89.3	0.0	0.1	0.0	56.6	211.5	0.0	0.1	0.0	0.3	0.0	10.8	6.1	1.1	2.9	0.7	0.0	9.7	11.9	0.0	0.0	0.0	66.3	8.7	32.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	36.0	12.5	0.0	0.2	0.0	0.2	0.2	0.0	76.8	0.2	46.2	0.1	73.5	109.3	115.3	47.7	87.9	55.4	70.2	43.7	44.6	69.1	98.2	44.2	43.1	145.1	26.0	83.9	33.2	53.7	166.6	11.5	17.8	2.2	10.1	11.2	12.7	19.0	3.3	14.6	15.8	23.8	148.6	749.7	1.1	21.2	0.0	5.6	10.2	18.7	25.0	3.5	0.0	5.6	0.0	0.4	1.5	31.3	0.7	0.0	0.6	5.1	16.6	0.8	621.6	4.2	1099.3	0.0	1.2	36.2	831.6	1.7	1.4	787.9	47.2	70.3	0.6	0.2	0.9	0.0	0.4	2.2	1.3	0.0	6.8	0.3	0.3	17.6	7.4	409.7	0.3	1.6
LARP1	"KIAA0731, LARP, MGC19556"	ENSG00000155506	"La ribonucleoprotein domain family member 1"	Q6PKG0	5	154712902-154817607	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	24.9	30.1	30.5	21.9	31.9	18.9	20.3	25.7	46.5	21.3	20.4	27.3	23.2	21.0	26.5	23.0	29.2	25.4	18.5	28.5	27.8	29.1	25.6	22.6	19.9	23.1	26.8	29.7	28.4	81.2	55.9	23.6	25.1	29.2	18.2	21.3	18.9	38.8	21.4	41.7	24.7	22.3	23.8	22.2	21.5	24.4	27.8	27.4	26.1	33.5	16.4	25.8	22.1	28.7	5.2	6.4	2.8	7.9	10.1	5.8	2.5	26.2	36.7	28.7	32.9	25.0	20.3	31.8	26.7	27.3	31.3	30.6	57.7	31.6	69.3	37.9	33.3	45.8	26.4	52.3	49.1	36.2	22.9	29.5	50.1	38.2	26.6	31.8	67.0	23.3	25.1	28.5	38.9	49.7	17.8	27.5	31.3	41.1	48.1	29.0	25.9	39.6	26.2	30.5	22.8	18.5	44.4	27.3	33.0	19.2	32.7	52.1	28.0	36.2	58.2	32.1	30.8	34.6	31.7	36.4	39.4	24.7	29.7	47.8	43.0	30.9	59.1	26.1	37.1	27.5	2.8	4.0	1.1	4.5	4.9	5.8	4.3	5.4	5.3	4.0	5.2	4.3	4.7	2.4	10.1	7.9	6.4	3.4	2.5	30.5	31.9	25.7	46.5	27.8	29.1	26.8	29.7	29.2	27.4	41.7	26.0	38.9	30.3	69.5	60.5	94.4	40.8	37.5	26.1	38.4	35.3	37.5	24.9	38.5	9.8	50.1	45.7	23.3	70.6	28.5	46.8	41.1	17.3	58.2	49.0	82.6	42.2	50.3	51.5	7.7	64.5	38.5	35.4	31.5	52.6	32.3	54.8	28.1	75.3	40.9	38.4	12.9	41.1	37.6	41.4	73.9	20.0	24.9	61.7	53.6
LARP1B	"DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2"	ENSG00000138709	"La ribonucleoprotein domain family member 1B"	Q659C4	4	128061268-128222931	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 378.6;Late spermatids: 340.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036280	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA036280: AB_10673126"	"unprognostic (1.84e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.39e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.13e-5)"	"unprognostic (8.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.50e-2)"	9.3	7.1	8.1	6.5	9.8	10.1	9.8	11.7	11.4	11.2	12.6	6.2	21.4	11.7	8.9	20.3	10.3	8.1	8.2	8.7	7.8	9.0	14.8	39.9	9.1	5.1	8.5	10.3	10.1	37.9	12.3	21.4	17.2	9.4	9.3	13.5	4.8	17.0	17.2	26.2	9.7	13.9	9.6	8.4	6.4	12.1	41.9	7.1	5.3	11.3	8.8	7.4	13.2	9.2	3.1	8.5	2.3	3.9	4.6	6.2	1.5	10.7	3.8	6.9	8.9	7.3	8.4	14.4	9.3	10.3	9.0	5.7	8.6	8.6	13.4	13.0	9.1	6.7	4.3	17.3	10.5	10.7	12.6	10.9	10.6	6.5	21.1	16.0	20.2	4.3	4.4	15.2	7.2	26.3	8.5	10.3	10.0	18.6	22.4	5.0	12.6	17.6	11.7	8.0	16.7	6.3	9.7	10.7	15.1	10.1	8.4	20.9	8.2	8.1	18.9	8.4	9.7	5.5	8.9	8.3	5.7	6.3	9.2	9.2	29.5	11.2	15.5	7.4	15.9	6.0	0.3	3.9	2.3	3.4	2.8	6.2	3.1	3.8	4.3	4.4	3.0	3.1	3.3	1.0	4.6	3.0	8.5	3.0	1.5	8.1	9.8	11.7	11.4	7.8	9.0	8.5	10.3	9.4	7.1	32.8	25.7	18.2	21.4	24.6	34.4	27.1	35.7	42.8	48.9	19.2	49.1	27.6	11.6	20.2	378.6	17.5	36.5	46.7	25.7	20.4	16.4	36.2	19.7	143.6	10.9	22.3	32.6	16.5	12.9	340.9	33.6	15.7	16.9	10.8	61.0	15.5	27.3	34.5	18.7	37.6	67.1	19.4	26.9	140.5	12.9	30.4	43.0	12.8	44.7	23.4
LARP4	PP13296	ENSG00000161813	"La ribonucleoprotein domain family member 4"	Q71RC2	12	50392383-50480004	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039306, HPA039673"	Approved		Enhanced	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA039306: AB_10805362, HPA039673: AB_10795110"	"unprognostic (4.41e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.93e-3)"	"unprognostic (9.08e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.99e-3)"	15.1	22.5	12.3	13.5	14.4	9.4	15.0	12.2	13.1	12.1	13.8	8.1	17.7	13.0	12.4	11.6	15.1	10.7	10.4	14.7	11.3	10.4	28.5	47.8	13.6	11.3	15.6	9.0	11.5	17.1	18.3	23.1	17.7	14.8	13.1	11.7	13.4	17.3	14.7	31.3	10.2	14.8	15.7	17.9	10.9	13.2	11.2	13.5	14.0	15.9	11.2	11.8	14.0	21.4	11.8	15.6	8.9	14.6	10.9	12.1	8.9	14.9	21.4	14.2	10.4	13.3	11.1	24.2	18.5	11.0	18.3	14.7	41.7	17.5	35.4	22.9	11.5	17.0	14.4	30.9	12.5	24.2	21.9	12.7	28.7	20.1	14.8	12.4	31.8	17.0	10.0	12.1	21.6	23.4	12.1	16.1	13.0	41.2	16.9	17.0	13.4	26.0	10.7	20.5	9.7	18.7	19.2	22.6	20.9	9.9	22.6	16.9	9.9	32.8	17.1	19.1	13.8	14.9	12.9	23.2	12.2	18.1	14.0	17.4	16.6	44.2	31.4	16.9	13.1	10.1	8.9	11.6	7.7	11.4	13.0	10.8	11.7	10.1	6.4	15.6	11.8	12.1	9.6	6.5	10.9	14.6	13.5	9.8	8.9	12.3	14.4	12.2	13.1	11.3	10.4	15.6	9.0	14.8	13.5	44.7	33.6	18.1	22.2	63.1	38.6	40.9	22.9	24.1	25.0	27.9	82.5	21.5	8.3	17.0	7.2	19.1	23.3	70.0	20.6	14.9	30.6	32.6	19.6	105.2	23.1	17.5	23.1	26.4	35.8	21.2	13.8	20.7	25.3	28.9	20.6	20.5	24.0	17.3	18.0	37.0	50.8	6.5	33.0	33.5	42.6	65.0	28.6	15.2	22.3	25.5
LARP6	"acheron, FLJ11196"	ENSG00000166173	"La ribonucleoprotein domain family member 6"	Q9BRS8	15	70829130-70854159	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 324.8;Late spermatids: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"U-2197: 58.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020338, HPA049029"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			Microtubules	"Cytokinetic bridge"	"HPA020338: AB_1844500, HPA049029: AB_2680604"	"unprognostic (1.35e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.63e-3)"	"unprognostic (2.96e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (4.51e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.43e-1)"	28.3	10.1	25.5	7.7	36.9	1.3	27.4	10.8	57.2	24.1	6.2	44.7	3.4	3.4	17.6	32.6	9.4	13.4	12.6	27.9	33.1	20.9	17.1	4.6	6.3	3.4	36.0	19.3	24.7	8.6	11.4	8.8	9.1	25.1	16.6	5.6	4.3	12.3	17.1	10.8	4.9	4.1	14.1	43.1	2.5	9.3	9.7	31.7	0.7	27.0	4.0	2.7	10.3	16.9	0.3	0.3	2.6	0.3	0.5	0.4	0.1	10.1	10.8	3.5	7.0	18.0	20.2	0.0	31.4	24.5	17.0	18.1	3.1	2.9	0.0	12.9	17.0	16.5	5.5	7.9	2.7	16.9	0.1	19.4	0.0	9.0	2.8	32.7	0.0	0.0	12.6	11.5	17.0	27.3	17.9	5.5	3.8	0.0	0.1	7.5	1.7	0.0	0.0	3.7	0.0	28.3	0.0	12.7	0.0	5.5	8.7	2.1	4.6	10.4	0.1	21.5	5.7	0.5	0.5	7.2	6.9	27.8	58.3	25.9	0.0	0.0	0.0	29.7	0.0	3.5	1.1	0.3	0.3	0.4	0.2	0.3	0.2	0.3	0.2	0.0	0.3	0.2	0.3	2.6	0.5	0.2	0.3	0.2	0.1	25.5	36.9	10.8	34.8	33.1	20.9	36.0	19.3	25.1	31.7	0.0	1.4	0.0	40.1	16.1	28.7	16.9	25.5	12.0	6.8	12.2	2.0	0.4	46.4	51.0	324.8	12.8	0.0	0.0	21.7	0.7	58.7	51.8	0.0	13.1	1.1	23.8	11.5	11.6	0.3	173.4	67.9	2.6	18.6	0.0	0.2	21.0	44.8	0.0	43.2	62.8	4.8	19.4	22.7	17.4	8.0	7.9	0.3	0.5	0.4	22.5
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein domain family member 7"	Q4G0J3	4	112636964-112657592	"Disease related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	RNA-binding	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	22.9	20.2	26.5	24.2	37.0	23.9	23.9	32.5	33.2	26.8	24.7	15.0	24.5	20.7	26.8	23.3	26.4	21.9	20.0	38.3	34.3	21.3	38.8	26.9	18.1	25.6	33.3	26.5	26.3	14.4	21.4	42.6	23.1	34.7	27.3	23.9	11.5	19.2	19.9	35.5	19.1	35.2	31.1	46.9	32.4	20.0	16.0	41.2	27.5	26.4	21.2	25.2	30.1	20.9	23.8	34.6	30.7	27.8	17.8	19.2	10.4	11.2	11.2	23.6	11.9	16.2	18.9	11.9	14.3	12.0	13.3	12.7	7.7	17.9	27.6	12.7	13.7	12.6	7.6	22.2	12.9	18.0	23.1	15.7	15.8	9.4	12.1	12.0	37.4	23.5	15.1	15.3	11.9	7.0	18.6	12.5	13.4	19.2	14.2	17.2	9.7	30.0	13.9	60.8	19.2	8.4	16.9	18.9	12.0	20.6	12.3	13.0	17.9	9.2	22.8	14.1	41.2	10.0	14.7	12.0	12.6	12.7	12.7	15.2	9.5	15.9	28.0	16.2	14.0	13.3	30.7	15.0	25.3	18.5	20.7	16.5	23.8	18.8	19.2	12.3	22.8	18.4	17.8	18.3	17.8	27.8	34.6	18.1	10.4	26.5	37.0	32.5	33.2	34.3	21.3	33.3	26.5	34.7	41.2	89.3	68.1	68.6	56.9	22.0	61.3	101.6	96.8	136.5	94.4	45.4	27.5	68.0	94.5	57.3	9.9	57.6	66.6	0.0	56.1	62.9	53.2	37.8	100.6	146.5	61.4	55.6	37.3	81.6	89.8	8.5	87.5	66.9	23.6	73.1	66.9	107.4	53.1	75.9	94.0	93.8	47.4	116.4	44.3	77.9	66.8	18.2	84.0	66.0	67.8	40.9
LARS	"FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase"	Q9P2J5	5	146113038-146182660	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA		14000	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: AB_2677185"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.96e-2)"	32.2	30.1	27.0	25.8	31.2	17.8	38.6	31.8	33.7	25.5	25.3	30.1	23.9	16.8	35.8	31.3	28.5	26.8	16.4	29.0	24.2	22.2	26.5	18.4	20.0	24.8	27.3	26.1	32.0	40.8	35.0	43.0	20.6	31.6	26.3	29.9	19.5	39.9	24.8	55.5	24.1	21.5	32.5	30.9	25.2	24.9	20.5	30.5	25.6	30.8	22.8	28.9	30.9	29.2	21.3	28.0	5.8	18.3	19.0	21.8	11.2	20.5	24.3	28.2	46.2	23.4	30.5	43.9	24.1	17.8	24.4	35.3	25.4	22.5	31.3	14.9	31.6	30.9	17.6	47.6	39.6	42.7	26.9	28.0	35.7	30.8	14.7	32.4	50.7	23.7	23.9	39.9	39.9	69.3	22.0	33.2	46.5	39.7	58.7	26.1	17.0	39.1	31.1	43.7	16.6	27.0	30.3	35.5	31.2	18.6	18.6	27.8	35.1	26.2	28.9	60.8	28.0	32.8	43.8	32.5	28.5	19.0	25.8	36.0	30.5	45.0	51.2	31.0	53.6	33.2	2.5	13.5	5.8	14.8	18.3	19.8	21.1	16.4	13.6	18.6	21.3	21.8	18.0	1.2	19.0	13.6	28.0	14.8	11.2	27.0	31.2	31.8	33.7	24.2	22.2	27.3	26.1	31.6	30.5	26.8	57.1	43.4	48.5	24.6	46.8	120.8	22.9	81.7	77.3	45.4	39.3	32.4	43.1	59.7	27.5	55.0	26.5	0.0	47.0	33.7	27.8	49.5	77.6	28.0	32.9	20.6	30.6	29.4	40.0	22.8	58.1	39.7	21.9	59.5	33.8	40.2	49.7	28.1	56.6	52.5	48.0	32.3	59.7	106.6	46.2	31.0	27.6	32.0	43.8	38.2
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388506-45549421	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	9.6	14.3	18.8	9.6	21.8	6.7	8.1	11.9	17.9	9.2	14.8	13.1	8.3	9.6	9.8	8.9	10.4	11.2	8.4	14.2	14.6	13.6	18.9	17.2	7.0	10.3	15.7	9.5	10.2	8.2	20.0	14.0	10.6	12.3	10.8	15.3	10.0	8.7	9.8	14.1	7.8	8.8	11.0	8.8	10.0	8.9	7.3	11.8	16.1	10.5	8.3	12.8	11.3	7.8	5.1	5.9	2.4	3.3	8.4	6.0	3.7	6.4	8.0	9.4	8.9	8.6	9.7	10.1	10.0	10.3	18.7	13.9	14.2	8.9	13.3	8.6	11.6	13.7	7.0	34.9	20.9	14.2	11.6	8.8	14.4	13.0	13.8	9.0	20.8	5.3	12.5	12.9	17.8	9.4	9.7	11.6	16.1	22.3	7.5	11.6	7.0	14.9	7.6	23.5	10.8	14.9	8.5	9.3	14.8	16.6	15.5	7.4	9.3	15.9	9.0	8.3	11.2	14.3	12.2	10.2	11.4	8.5	9.5	12.0	6.0	10.8	14.2	13.5	14.1	10.1	0.6	2.8	2.4	6.0	3.3	5.8	5.1	4.4	5.4	5.9	4.0	4.8	5.4	1.2	8.4	3.0	4.5	3.9	3.7	18.8	21.8	11.9	17.9	14.6	13.6	15.7	9.5	12.3	11.8	0.0	1.3	2.7	1.1	1.0	5.0	7.8	2.5	2.7	1.2	5.2	3.9	4.1	5.0	2.5	0.6	3.8	2.3	0.0	2.4	4.2	1.6	2.2	1.1	6.7	4.4	1.6	4.6	2.5	3.7	1.1	1.1	1.6	1.7	2.8	4.3	3.6	2.8	6.6	2.1	2.1	4.4	0.0	1.2	0.7	2.4	1.1	2.4	1.8	6.3	1.6
LAS1L	FLJ12525	ENSG00000001497	"LAS1 like, ribosome biogenesis factor"	Q9Y4W2	X	65512582-65534775	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044431, HPA061463"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA044431: AB_10965695, HPA061463: AB_2684530"	"unprognostic (9.71e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.53e-1)"	16.4	14.7	22.6	17.8	26.4	27.9	21.4	38.3	26.1	18.0	17.9	30.1	14.1	11.1	21.9	17.4	17.1	23.8	14.2	14.0	24.2	22.0	15.7	24.4	15.5	23.2	26.4	23.4	26.2	19.8	29.0	13.8	16.3	26.0	17.8	17.2	19.7	19.5	22.5	20.4	23.9	13.4	20.4	29.7	17.8	14.6	23.7	25.7	26.7	16.4	15.4	26.7	15.3	16.2	20.7	22.0	12.4	20.8	17.8	22.5	17.3	20.3	33.8	16.1	13.4	7.0	9.0	15.7	12.3	7.9	19.2	17.0	16.5	15.2	31.8	17.7	9.2	14.2	14.5	32.4	21.6	21.7	12.1	26.5	14.3	29.6	16.2	8.5	36.6	13.0	9.2	12.8	19.2	13.7	8.4	12.7	19.8	33.5	33.2	11.3	24.2	27.8	28.1	23.8	24.0	31.3	24.0	22.5	35.2	13.2	9.2	12.8	14.7	19.6	14.4	8.9	14.3	10.8	19.5	9.1	11.9	23.6	36.2	18.5	12.1	14.2	35.0	11.6	38.8	6.3	12.4	15.7	7.8	18.8	20.8	20.8	20.2	17.6	22.3	22.0	20.7	22.5	18.5	1.7	17.8	15.0	16.4	17.6	17.3	22.6	26.4	38.3	26.1	24.2	22.0	26.4	23.4	26.0	25.7	11.9	18.2	15.2	17.8	16.3	32.6	8.3	15.3	32.1	28.4	3.5	27.5	27.9	13.3	18.3	44.1	14.8	7.4	0.0	23.0	25.7	15.1	11.9	17.4	12.9	14.3	42.9	16.0	11.6	7.1	108.3	16.1	12.3	10.1	20.8	7.9	15.2	17.5	7.0	14.5	12.9	33.2	12.9	20.2	20.5	20.0	16.3	14.9	11.8	12.8	14.4
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 124.5"	"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 467.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		26000000	"Plasma membrane, Cytosol"	"Focal adhesion sites"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"	51.2	20.0	23.8	40.3	22.4	45.4	35.5	15.5	25.7	23.6	57.4	16.3	18.7	54.4	23.4	24.1	22.4	20.8	48.3	15.2	18.4	23.3	33.1	47.5	33.3	44.2	20.0	14.3	28.4	30.1	10.1	17.6	40.0	16.1	18.9	38.6	24.2	22.4	24.1	10.7	18.3	124.5	21.3	12.2	43.1	39.5	13.9	12.9	40.5	18.3	18.7	33.7	22.0	28.3	6.4	13.9	34.0	19.9	17.3	16.5	13.1	35.4	73.9	21.6	19.1	31.8	34.5	37.3	44.6	43.6	47.0	34.6	22.0	38.6	16.2	37.3	68.9	26.7	56.5	9.8	33.9	41.2	11.8	5.3	7.7	21.4	38.3	30.2	17.8	23.4	30.6	11.9	39.8	11.3	29.4	31.5	10.0	13.1	5.4	65.4	11.7	21.1	27.5	10.8	31.2	18.5	11.9	11.5	20.4	57.7	31.2	3.2	7.9	26.5	27.9	23.1	41.8	44.0	21.8	55.0	28.2	41.2	33.0	27.0	14.0	18.4	12.6	29.8	16.0	33.9	9.9	14.8	16.8	16.5	17.1	11.3	6.4	8.4	11.0	13.9	6.3	7.2	10.9	34.0	17.3	19.9	10.7	10.7	13.1	23.8	22.4	15.5	25.7	18.4	23.3	20.0	14.3	16.1	12.9	38.7	25.9	38.3	19.5	37.2	55.7	0.8	66.2	32.1	19.4	69.8	9.8	4.3	14.9	58.2	85.5	48.9	225.0	0.0	65.7	33.5	47.6	22.3	51.8	85.9	75.8	25.4	83.1	70.6	116.7	467.6	48.1	58.0	33.7	52.3	91.2	21.1	95.7	106.3	37.4	62.1	22.0	64.7	29.7	2.1	4.1	24.8	5.4	60.9	75.9	23.8
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990783	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"blood: 58.1;lymphoid tissue: 193.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 73.2;T-cells: 103.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1"	"Group enriched"	"Detected in many"	134	"granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1"	"Cell line enhanced"	"Detected in some"		"HEL: 31.0;HMC-1: 131.1;MOLT-4: 44.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002223, HPA011157, CAB012978"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		75000	"Plasma membrane"	"Golgi apparatus"	"CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	4.8	1.8	1.6	27.6	3.0	8.5	2.5	6.6	2.3	3.9	10.8	2.0	2.0	4.9	7.7	3.1	4.3	4.2	5.8	3.1	1.9	1.9	6.0	3.3	7.8	33.2	1.7	1.7	3.0	2.7	1.4	6.0	2.8	1.8	8.5	2.8	3.1	12.2	5.4	2.0	5.8	9.0	3.1	1.9	13.9	5.1	2.3	1.7	193.6	7.3	4.6	50.3	6.4	5.4	0.2	0.2	38.2	0.2	15.7	58.1	26.8	0.1	0.3	0.2	0.4	0.6	0.3	0.8	0.8	0.2	0.2	0.3	0.3	0.5	0.1	1.1	0.3	0.1	0.4	0.4	0.2	0.1	0.2	0.5	31.0	0.7	0.5	0.1	0.9	131.1	0.3	0.6	0.2	0.1	0.4	0.1	10.5	0.4	3.7	0.1	0.8	44.6	6.1	0.5	0.0	0.4	0.5	0.1	3.9	0.3	0.2	0.8	0.1	0.1	0.3	0.3	0.2	0.4	5.1	0.6	0.6	3.0	0.6	0.2	1.2	1.0	0.4	7.9	0.4	0.5	38.2	0.2	0.1	47.9	0.2	33.5	0.2	46.9	47.9	0.1	0.2	44.6	42.6	2.3	15.7	0.1	0.2	58.1	26.8	1.6	3.0	6.6	2.3	1.9	1.9	1.7	1.7	1.8	1.7	0.0	19.1	1.9	1.7	6.4	10.4	0.4	7.6	0.0	4.5	8.7	5.9	1.9	1.7	1.3	0.1	2.4	0.7	0.0	0.5	0.8	2.7	1.8	73.2	2.6	14.9	6.4	0.0	8.6	6.5	0.0	1.4	9.0	10.1	1.8	1.5	5.7	0.7	0.0	0.7	0.4	10.7	0.0	3.4	1.4	2.4	4.5	2.3	103.8	1.3	0.7
LATS2		ENSG00000150457	"Large tumor suppressor kinase 2"	Q9NRM7	13	20973032-21061547	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA039191: AB_2676385, HPA049037: AB_2680609"	"unprognostic (2.77e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-1)"	"unprognostic (6.57e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-2)"	22.9	13.0	3.0	8.6	5.7	12.8	33.0	7.9	3.7	16.6	14.0	6.8	9.3	2.9	21.2	12.7	15.1	11.0	20.6	14.1	5.4	2.6	12.4	11.0	19.8	10.9	5.2	2.4	17.4	10.2	5.0	3.5	18.3	6.3	13.7	4.5	16.7	8.0	11.1	23.0	9.3	7.4	34.6	7.5	15.2	10.4	27.8	5.2	1.4	17.2	13.8	7.0	20.3	28.0	0.1	1.5	3.3	1.9	1.3	3.1	0.5	3.4	3.8	8.5	5.1	10.0	13.2	7.8	11.4	11.9	12.0	10.3	10.8	5.2	0.0	5.6	17.4	4.7	5.0	5.0	5.2	17.8	1.9	1.3	6.3	4.8	8.1	15.5	1.7	2.2	19.5	9.6	7.9	5.3	6.0	16.7	1.4	1.1	0.2	15.1	5.9	0.2	5.9	2.0	3.5	1.8	1.5	15.1	0.0	8.5	1.6	0.1	0.0	9.0	6.0	11.9	7.7	5.1	3.2	21.0	12.8	8.5	9.3	7.2	1.5	0.8	0.0	3.0	1.9	9.7	0.4	1.9	1.8	1.6	1.5	3.1	0.1	0.2	0.5	1.5	0.0	0.1	0.3	3.3	1.3	0.6	0.1	0.0	0.5	3.0	5.7	7.9	3.7	5.4	2.6	5.2	2.4	6.3	5.2	38.7	6.9	2.4	13.7	29.2	0.0	20.6	15.3	12.0	11.4	5.2	0.0	18.7	3.3	8.7	94.1	30.9	3.2	0.0	6.4	7.9	22.8	18.0	4.7	14.5	9.0	0.0	0.0	43.0	13.7	6.2	23.6	16.6	16.9	0.0	1.6	4.5	14.9	1.7	32.5	6.4	0.7	6.5	25.9	6.7	13.7	22.1	40.2	4.4	1.0	9.4
LAYN	"FLJ30977, FLJ31092"	ENSG00000204381	Layilin	Q6UX15	11	111540280-111561745	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 43.8;Endothelial cells: 33.1;Peritubular cells: 51.9;Sertoli cells: 32.3;Urothelial cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"myeloid DC: 10.3;T-reg: 11.8"	"Group enriched"	"Detected in many"	111	"dendritic cells: 10.3;T-cells: 11.8"	"Cell line enhanced"	"Detected in many"		"BJ: 39.7;BJ hTERT+: 43.3;BJ hTERT+ SV40 Large T+ RasG12V: 27.6;fHDF/TERT166: 25.7;HSkMC: 25.5;hTERT-RPE1: 25.7;U-138 MG: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040087	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA040087: AB_10793927"	"unprognostic (2.27e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-2)"	7.7	2.3	9.3	5.9	12.8	1.3	8.0	1.7	12.5	11.3	21.2	28.9	3.0	4.0	15.1	10.5	5.3	12.8	17.0	5.6	12.6	7.5	4.1	1.4	9.6	12.4	20.6	5.9	39.5	2.3	1.6	5.4	13.1	12.3	13.2	3.8	10.9	4.4	17.9	4.8	2.1	8.2	21.7	10.1	7.5	12.1	4.6	13.1	4.6	26.9	4.8	5.0	11.3	10.1	0.0	10.3	0.0	0.0	0.0	11.8	0.4	0.1	1.0	0.2	0.0	7.1	13.7	1.9	39.7	43.3	20.1	27.6	0.0	0.0	0.0	0.3	25.7	5.0	0.8	2.5	0.2	20.8	0.0	0.1	0.2	0.0	0.0	12.1	0.0	0.0	25.5	0.0	8.3	0.0	25.7	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.1	0.0	0.1	0.0	1.3	4.8	0.1	0.0	0.1	9.9	0.0	0.1	0.1	29.8	22.0	0.2	19.3	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	10.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	11.8	0.4	9.3	12.8	1.7	12.5	12.6	7.5	20.6	5.9	12.3	13.1	17.9	3.2	0.0	43.8	1.9	0.2	1.4	5.1	18.7	13.6	0.0	0.0	1.1	0.0	5.9	2.2	33.1	0.0	0.0	0.2	1.2	6.5	13.4	1.1	0.0	0.7	0.0	0.0	4.3	1.2	1.3	21.0	1.3	0.0	0.0	0.0	0.2	0.7	0.0	51.9	0.0	0.1	32.3	10.8	0.0	0.7	1.9	0.5	2.2	0.0	40.4
LBH		ENSG00000213626	"Limb bud and heart development"	Q53QV2	2	30231531-30323730	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 198.3;Pancreatic endocrine cells: 178.1;Smooth muscle cells: 316.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.5;MAIT T-cell: 28.5;memory B-cell: 22.8;memory CD4 T-cell: 21.5;memory CD8 T-cell: 21.6;naive B-cell: 33.4;naive CD4 T-cell: 36.7;naive CD8 T-cell: 31.3;T-reg: 20.7"	"Group enriched"	"Detected in many"	8	"B-cells: 33.4;T-cells: 36.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 75.0;hTERT-RPE1: 38.7;U-2 OS: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034669	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA034669: AB_10600820"	"unprognostic (2.13e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.77e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.67e-1)"	13.7	3.8	3.7	25.5	5.3	6.7	29.8	1.8	9.2	22.1	10.1	2.7	7.6	3.8	36.4	17.2	12.3	18.2	21.0	59.3	4.5	11.5	15.4	6.0	66.1	53.6	6.2	5.0	44.3	4.5	21.4	6.6	15.9	9.4	10.2	5.1	32.0	45.8	12.0	7.0	11.8	15.1	14.0	3.4	33.5	8.9	8.1	0.8	78.1	48.6	9.5	32.7	13.1	9.5	33.4	2.9	0.9	0.7	4.2	36.7	21.2	0.0	2.8	3.5	0.6	0.9	0.5	0.3	3.6	4.8	0.9	0.1	14.6	3.8	7.0	8.5	75.0	0.9	4.8	20.3	0.2	0.1	10.0	0.8	1.1	3.1	0.0	2.8	0.1	1.0	3.4	0.2	1.2	0.0	38.7	0.1	4.7	3.5	0.0	3.5	0.0	7.7	0.0	21.5	0.6	0.1	8.0	19.1	2.4	0.6	1.2	1.0	2.5	5.9	0.5	0.2	13.3	0.0	0.3	4.7	6.9	25.3	13.2	0.4	13.7	0.7	0.6	3.0	0.4	2.1	0.1	0.1	0.2	28.5	0.3	28.5	22.8	21.5	21.6	0.2	33.4	36.7	31.3	0.9	4.2	0.7	2.9	20.7	21.2	3.7	5.3	1.8	9.2	4.5	11.5	6.2	5.0	9.4	0.8	101.3	24.8	81.5	50.3	11.0	17.2	59.8	7.6	105.7	53.4	24.4	198.3	15.6	11.6	68.7	24.4	39.6	1.6	23.3	51.4	10.7	31.9	45.3	15.1	1.5	25.3	7.9	22.8	29.4	9.8	84.4	9.8	5.6	21.9	1.8	0.7	12.8	178.1	8.6	25.1	15.3	44.9	174.6	316.5	0.9	2.1	9.4	7.8	117.0	1.7	51.8
LBHD1	"C11orf48, MGC2477"	ENSG00000162194	"LBH domain containing 1"	Q9BQE6	11	62662817-62672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"heart muscle: 67.7"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 16.0;Club cells: 4.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.1;JURKAT: 33.3"									"HPA012127, HPA023592"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012127: AB_1845527, HPA023592: AB_1845528"	"unprognostic (4.34e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.18e-8)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.78e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.72e-3)"	4.7	14.7	1.7	6.2	3.9	6.9	4.2	3.4	3.6	3.8	4.0	3.9	7.6	4.0	2.3	5.4	4.0	4.1	5.3	67.7	3.4	2.1	4.1	8.3	4.4	8.3	1.8	3.3	3.3	4.1	7.5	4.4	2.3	3.7	4.6	4.1	4.5	4.2	10.0	4.8	2.6	6.0	2.5	3.1	10.4	4.6	6.7	2.3	6.2	4.6	3.0	6.5	4.8	2.6	4.9	7.1	5.7	6.2	8.0	7.0	4.3	1.6	2.8	1.7	1.3	2.7	5.1	3.9	2.2	3.3	3.7	2.9	2.3	19.1	5.7	4.9	2.7	3.8	7.4	1.9	5.2	2.9	7.7	5.9	4.8	7.8	1.6	4.0	4.4	6.3	7.0	0.6	6.5	2.0	4.1	2.0	33.3	4.9	5.2	2.3	2.8	2.8	6.7	2.2	3.9	2.5	6.8	4.3	10.4	4.8	3.3	1.9	2.9	2.5	3.5	7.1	2.5	6.3	6.7	1.5	2.3	1.4	2.3	2.4	8.6	7.4	5.4	2.1	4.5	2.4	2.2	6.2	5.7	6.6	4.5	5.7	4.6	3.7	7.0	5.4	4.9	5.1	4.1	1.8	8.0	3.4	7.1	2.2	4.3	1.7	3.9	3.4	3.6	3.4	2.1	1.8	3.3	3.7	2.3	3.0	2.4	0.0	0.1	0.0	1.9	0.8	0.0	16.0	4.5	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	2.3	0.2	0.2	1.6	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	1.3	0.2	0.0	0.4	0.3	7.3	0.0	0.0	0.6	0.9	0.0	0.2	0.0	0.0	0.3
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	76	"brain: 11.8;skeletal muscle: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"cerebellum: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 5.0;RH-30: 6.4;SCLC-21H: 13.6"	"Group enriched"	"Detected in some"	24	"cerebellum: 1.8;pons and medulla: 3.2"	"Group enriched"	"Detected in some"	21	"cerebellum: 2.9;pons and medulla: 2.8"	"HPA002016, HPA002086, CAB079927"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.4	0.0	0.0	0.0	13.6	0.0	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LBX2		ENSG00000179528	"Ladybird homeobox 2"	Q6XYB7	2	74497517-74503316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"liver: 13.8"	"Cell type enhanced"	"Detected in some"	11	"Hepatocytes: 2.8;Ito cells: 2.5;Proximal tubular cells: 6.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.3;Hep G2: 19.3;SK-MEL-30: 8.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.3;olfactory region: 0.9"	HPA044257	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA044257: AB_2678880"	"unprognostic (5.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.35e-5)"	"unprognostic (8.22e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.43e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	4.4	0.4	1.5	1.0	0.5	0.3	1.3	0.5	0.5	1.1	6.8	0.0	1.5	8.3	2.2	2.6	0.5	0.6	3.9	1.8	0.3	0.3	1.9	13.8	3.7	0.4	0.3	0.6	0.6	3.4	0.0	0.3	2.6	0.5	0.6	0.0	0.2	1.5	0.4	0.8	1.3	7.3	0.1	0.4	1.9	4.9	1.3	0.0	0.3	1.1	1.7	2.1	0.8	0.6	0.2	2.1	1.6	4.8	2.5	1.0	1.5	3.8	1.4	0.0	0.1	1.7	1.4	6.5	0.3	0.2	0.4	0.4	9.3	5.7	0.2	1.6	0.7	0.6	1.5	0.0	0.3	0.0	8.0	1.7	4.1	0.5	19.3	1.3	0.2	2.6	1.8	1.4	1.4	0.3	0.2	1.6	0.1	2.7	2.0	0.3	2.0	0.1	0.8	0.4	1.6	0.2	0.4	0.4	0.2	0.2	1.2	0.2	1.1	2.3	0.3	8.4	0.1	0.2	0.3	3.6	1.4	6.1	7.4	0.1	2.6	2.0	0.2	1.4	0.7	4.3	0.8	4.0	0.3	0.8	1.9	0.5	0.2	0.2	1.0	2.1	0.2	0.2	0.7	1.6	2.5	4.8	0.6	0.1	1.5	1.5	0.5	0.5	0.5	0.3	0.3	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.5	0.0	0.0	1.6	0.0	0.6	0.4	0.3	0.0	0.0	2.8	0.9	0.0	2.4	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	6.3	0.0	6.5	0.2	0.0	0.0	0.1	0.5	0.0	0.8	0.1
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 64.4;liver: 154.2"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 204.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 64.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 35.6;Hep G2: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	9500000000	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3.0	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5.0	1.1	1.3	1.4	0.1	2.5	4.0	6.0	6.8	5.2	7.4	35.6	9.9	4.3	6.7	4.7	13.3	3.1	1.3	1.9	14.3	2.4	8.8	1.4	13.6	4.2	0.6	3.6	1.7	8.9	27.7	7.2	0.3	4.7	12.8	12.9	13.9	4.8	9.1	4.9	4.0	3.8	0.6	4.7	4.1	1.6	4.2	3.9	0.4	2.2	1.7	6.5	1.4	1.9	4.3	0.2	3.1	15.0	0.7	1.7	12.9	8.5	2.7	9.3	8.7	13.6	9.5	3.5	8.2	2.2	3.7	4.1	1.1	7.5	2.4	1.1	5.0	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0.0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1	8.9	4.5	0.0	4.1	8.4	0.2	4.2	7.6	2.7	3.4	3.5	2.0	6.0	0.0	1.6	0.0	4.3	0.0	0.0	0.9	2.7	7.1	2.9	1.1	204.0	2.1	0.0	1.2	12.3	3.2	0.5	8.1	1.6	6.8	2.8	0.0	7.5	1.4	0.0	8.1	0.0	0.5	12.9	7.1	1.0	1.5	2.3	10.2	0.0	0.0	1.4
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 112.2;lymphoid tissue: 153.0"	"Cell type enriched"	"Detected in many"	10	"T-cells: 207.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"gdT-cell: 83.4;MAIT T-cell: 77.5;memory CD4 T-cell: 86.1;memory CD8 T-cell: 90.2;naive CD4 T-cell: 97.0;naive CD8 T-cell: 91.3;NK-cell: 42.8;T-reg: 112.2"	"Group enriched"	"Detected in many"	13	"NK-cells: 42.8;T-cells: 112.2"	"Group enriched"	"Detected in some"	6	"JURKAT: 66.9;MOLT-4: 93.9;U-698: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB003816: AB_562158, HPA003494: AB_1852751"	"unprognostic (6.38e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.39e-2)"	"prognostic favorable (2.96e-6)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (4.78e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (3.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-2)"	2.6	0.7	0.4	28.2	0.5	3.8	1.3	0.3	0.5	1.7	3.9	0.5	0.9	2.2	1.1	4.5	2.3	1.6	3.8	1.0	0.4	0.4	3.0	2.3	6.6	34.9	0.9	0.5	1.2	0.8	0.0	0.8	0.7	0.6	2.2	1.9	1.3	8.4	1.3	0.9	1.0	16.5	0.7	1.0	28.9	3.5	0.7	0.5	153.0	2.9	1.5	27.1	5.8	2.1	6.1	0.5	2.5	0.3	42.8	112.2	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	11.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	93.9	0.0	1.0	0.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	54.1	0.0	0.0	0.0	0.6	0.3	0.4	83.4	0.3	77.5	4.0	86.1	90.2	0.3	6.1	97.0	91.3	2.5	42.8	0.3	0.5	112.2	109.3	0.4	0.5	0.3	0.5	0.4	0.4	0.9	0.5	0.6	0.5	0.0	16.0	20.4	0.9	4.0	0.0	1.1	2.5	2.7	2.3	3.5	0.0	0.2	0.0	0.3	0.1	1.6	0.0	0.0	0.4	0.1	2.0	0.8	4.7	1.0	0.3	0.0	2.4	3.7	4.9	0.0	0.0	0.6	3.3	0.0	0.0	0.0	2.7	0.0	0.4	1.1	0.0	0.0	0.9	3.7	1.9	2.8	0.3	207.5	0.4	1.0
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	7.7	9.7	7.0	13.7	8.7	12.3	7.1	10.2	10.1	11.6	10.7	5.2	12.6	15.7	18.7	15.0	13.0	9.9	12.6	21.7	7.5	9.2	15.2	13.8	10.0	12.5	6.1	6.0	15.4	16.7	10.8	21.8	5.7	7.0	10.7	10.6	9.7	9.5	16.3	10.9	9.4	25.0	11.3	5.5	8.0	8.4	12.1	4.2	20.7	17.9	11.9	11.7	9.1	10.4	9.6	2.8	10.5	3.9	4.1	12.6	2.8	11.0	14.6	7.9	13.3	1.8	4.2	11.3	8.0	8.0	8.5	7.2	14.7	13.0	7.1	7.4	12.4	10.6	12.5	26.1	10.8	8.5	9.0	8.9	13.1	9.2	14.1	8.4	18.5	10.0	3.2	8.5	9.0	12.6	5.6	5.9	4.1	12.0	6.8	6.5	8.6	10.5	10.9	8.6	9.0	8.4	10.3	15.8	14.5	6.8	16.2	9.2	14.2	17.9	11.9	10.3	5.7	8.6	6.4	6.7	15.5	12.9	8.3	12.5	4.9	10.3	16.0	15.8	13.6	11.8	10.5	2.5	4.8	5.6	3.9	6.6	7.5	8.7	7.1	2.8	9.6	12.6	12.1	7.4	4.1	3.5	2.2	4.0	2.8	7.0	8.7	10.2	10.1	7.5	9.2	6.1	6.0	7.0	4.2	8.9	5.8	4.5	4.6	6.4	12.5	15.1	22.9	13.4	7.9	14.0	25.5	4.3	0.0	7.2	3.1	6.7	11.5	0.0	14.3	4.3	5.5	7.7	3.5	19.0	4.9	14.3	12.6	11.1	5.4	1.2	5.2	2.7	5.0	0.0	15.3	7.3	10.3	7.0	8.5	12.2	16.7	6.5	16.2	8.9	20.5	5.8	1.6	8.7	14.3	4.4
LCMT1	"CGI-68, PPMT1"	ENSG00000205629	"Leucine carboxyl methyltransferase 1"	Q9UIC8	16	25111729-25178231	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 149.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041559, HPA043530"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041559: AB_2677548, HPA043530: AB_2678532"	"unprognostic (9.08e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.41e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-3)"	"unprognostic (6.71e-2)"	9.8	18.0	27.9	11.6	30.6	13.9	18.1	27.5	36.4	15.4	17.1	15.5	17.5	13.1	16.2	26.7	13.4	16.8	14.1	25.3	22.8	27.5	17.8	7.5	10.8	11.9	21.7	26.7	23.8	31.4	25.3	20.5	18.9	24.8	15.7	17.2	15.0	14.4	18.3	31.6	16.5	12.7	15.1	18.9	10.1	12.6	29.8	14.4	16.9	15.5	14.3	15.3	11.7	12.1	19.7	17.6	21.6	18.9	15.8	38.9	19.5	17.0	16.1	15.0	20.8	13.5	19.8	15.4	10.7	17.7	15.6	20.6	20.3	15.7	10.4	15.3	16.2	19.9	8.8	15.5	14.7	21.2	10.6	23.7	5.6	16.4	32.9	30.9	13.4	9.3	22.4	16.3	17.8	18.6	23.0	14.2	23.7	8.9	13.7	17.2	43.6	16.0	25.8	22.9	10.8	16.7	19.0	13.8	20.2	17.7	12.1	24.5	15.2	12.8	19.9	24.4	18.4	20.1	6.2	8.4	15.6	10.9	10.1	10.5	17.9	18.1	11.0	19.1	11.8	11.4	12.7	18.9	21.6	20.6	16.7	22.6	19.7	25.6	22.3	17.6	14.3	23.1	21.1	7.4	15.8	17.5	9.1	38.9	19.5	27.9	30.6	27.5	36.4	22.8	27.5	21.7	26.7	24.8	14.4	14.9	13.7	23.2	24.4	21.4	25.3	30.5	15.3	22.7	7.9	31.4	2.0	149.0	41.4	46.1	60.5	21.8	58.0	0.0	58.2	63.7	29.6	28.2	9.2	9.0	41.1	22.3	49.3	17.8	33.7	98.3	24.2	25.1	32.1	33.3	47.4	20.7	45.5	40.3	22.6	69.2	18.9	25.8	18.4	50.2	46.6	27.9	137.0	33.1	48.4	31.3
LCMT2	"KIAA0547, MGC9534, PPM2, TYW4"	ENSG00000168806	"Leucine carboxyl methyltransferase 2"	O60294	15	43323649-43330605	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039401, HPA048176"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA039401: AB_10805478, HPA048176: AB_2680299"	"unprognostic (4.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.33e-3)"	"unprognostic (9.57e-2)"	"prognostic favorable (5.69e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	7.9	10.9	6.5	8.3	8.1	2.5	25.9	11.4	10.1	10.8	7.4	7.2	10.6	5.2	10.3	12.7	11.0	10.2	6.7	8.4	6.7	8.4	11.9	9.2	6.2	9.9	6.1	7.6	13.0	8.2	13.7	10.1	6.4	9.6	10.2	7.5	8.9	10.3	13.8	7.9	6.2	8.4	8.6	4.8	9.6	8.7	7.1	9.6	12.2	9.8	11.2	13.9	7.4	9.6	6.3	6.9	5.5	4.0	3.3	10.5	5.0	6.0	4.9	11.5	9.9	12.3	3.8	5.6	7.5	9.0	9.8	10.8	7.2	2.8	5.2	15.3	8.5	10.3	14.4	0.0	9.9	7.5	8.0	5.3	9.3	13.0	4.2	7.5	0.0	7.0	5.8	9.6	7.2	6.7	6.6	3.1	12.1	11.7	7.0	11.8	9.5	10.4	4.4	4.9	13.5	4.1	12.3	10.1	5.0	17.1	7.0	15.4	13.1	9.9	8.3	4.3	9.4	10.2	14.3	2.6	11.6	5.2	13.1	12.2	4.7	11.1	2.2	7.2	7.7	11.9	2.4	4.0	5.5	4.0	3.8	5.5	5.0	6.7	4.8	6.9	6.3	10.5	6.8	1.3	3.3	3.5	3.9	5.3	5.0	6.5	8.1	11.4	10.1	6.7	8.4	6.1	7.6	9.6	9.6	0.0	1.9	3.2	3.5	2.7	6.9	2.8	7.6	6.7	7.9	3.5	7.9	3.6	3.3	5.4	1.4	2.8	1.3	0.0	3.5	2.1	2.2	2.8	1.1	3.4	2.3	3.2	5.2	5.5	1.6	1.3	4.6	1.5	0.0	2.8	2.7	8.6	3.2	2.3	1.4	4.2	6.6	6.5	3.1	7.5	8.3	2.5	2.1	2.5	3.4	2.0
LCORL	"FLJ30696, MLR1"	ENSG00000178177	"Ligand dependent nuclear receptor corepressor like"	Q8N3X6	4	17841199-18021876	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028794, HPA028795, HPA060033"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192"	"unprognostic (1.06e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (3.22e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.90e-4)"	"unprognostic (3.46e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	8.3	7.8	11.3	5.7	11.9	5.1	6.6	21.9	10.4	7.0	9.2	6.9	4.7	14.2	6.3	5.1	7.3	4.6	7.1	3.9	10.3	9.8	9.6	7.2	7.5	8.0	14.8	6.5	7.6	6.4	8.4	11.3	8.7	8.9	5.9	8.8	5.0	7.0	5.3	7.9	8.6	22.3	5.8	16.2	12.6	9.1	12.2	15.3	17.1	8.1	2.7	5.7	6.5	5.4	4.4	3.8	8.2	4.6	2.4	3.2	1.5	4.8	3.2	13.0	4.0	6.9	10.8	3.3	6.0	5.9	5.2	6.8	1.6	6.5	9.4	3.2	4.0	8.0	2.2	6.2	2.5	7.3	2.6	3.9	7.5	5.7	3.9	4.4	6.0	6.1	5.9	3.0	3.5	7.3	7.6	7.0	6.1	4.5	15.0	7.0	1.3	5.8	12.3	4.5	4.3	4.7	5.8	8.0	5.2	8.4	2.6	9.7	9.3	4.3	2.2	4.2	5.1	3.9	5.8	4.7	8.2	4.1	5.1	9.4	12.2	4.6	7.9	6.7	8.1	6.5	8.2	4.5	4.9	2.9	4.6	2.4	4.4	2.0	1.8	3.8	3.0	2.3	2.7	2.2	2.4	3.6	2.6	3.2	1.5	11.3	11.9	21.9	10.4	10.3	9.8	14.8	6.5	8.9	15.3	11.9	10.4	17.9	3.8	21.2	18.3	8.1	40.8	17.4	6.8	7.0	39.3	7.3	8.3	9.7	26.0	20.2	18.1	0.0	9.7	7.4	8.7	8.5	18.5	11.9	13.9	19.1	34.0	9.2	11.7	15.2	13.6	22.6	3.3	8.2	17.8	9.8	10.0	14.1	7.1	14.0	20.9	19.4	6.1	40.8	15.6	16.7	8.2	6.9	14.9	4.2
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 188.6;lymphoid tissue: 118.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 106.9;B-cells: 102.2;Early spermatids: 108.1;granulocytes: 292.1;Hofbauer cells: 246.0;Kupffer cells: 369.7;Late spermatids: 220.3;Macrophages: 303.2;monocytes: 275.9;T-cells: 260.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 82.8;HDLM-2: 75.7;HL-60: 80.4;HMC-1: 85.3;JURKAT: 76.6;THP-1: 75.0;U-698: 106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		2200000000	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	57.1	10.0	5.6	44.3	9.4	71.2	8.7	3.9	4.6	3.6	6.2	4.5	5.0	4.5	5.3	43.1	6.2	8.3	8.9	5.5	4.3	3.8	7.2	12.2	33.7	59.1	12.0	1.0	5.7	3.9	0.1	2.8	24.7	7.7	21.5	8.1	5.5	9.5	2.5	3.5	6.8	21.7	6.5	11.9	112.9	6.1	8.2	9.2	118.2	4.5	4.1	68.7	14.0	7.1	25.4	79.3	133.5	127.6	43.2	67.2	188.6	3.3	0.0	0.1	0.0	0.0	0.0	40.2	0.0	0.1	0.3	0.2	22.2	0.1	82.8	17.6	0.0	24.6	0.1	0.0	0.0	0.3	75.7	19.7	17.9	0.0	0.0	0.0	80.4	85.3	0.2	0.0	0.1	0.1	0.0	0.0	76.6	9.3	55.1	0.0	0.1	56.9	55.7	0.0	0.0	0.8	42.4	0.1	59.2	0.0	22.9	0.1	0.7	0.1	8.8	0.6	2.5	0.4	75.0	0.2	2.1	1.3	0.1	2.4	13.2	27.4	106.5	1.6	49.0	0.3	57.1	96.6	54.3	67.2	127.6	60.8	25.4	40.4	55.5	79.3	18.3	25.2	42.3	133.5	43.2	118.1	20.8	40.5	188.6	5.6	9.4	3.9	4.6	4.3	3.8	12.0	1.0	7.7	9.2	29.8	106.9	102.2	0.8	10.6	0.4	3.1	2.5	25.4	33.0	3.5	0.0	8.6	0.0	19.4	108.1	6.6	0.0	23.3	14.4	53.7	6.6	52.4	292.1	26.8	246.0	0.0	1.2	14.1	369.7	220.3	1.1	303.2	21.9	275.9	0.0	19.2	4.7	0.6	1.8	1.4	0.9	0.0	7.9	1.8	1.7	10.3	11.3	260.3	0.1	2.2
LCTL	"FLJ33279, KLG, KLPH"	ENSG00000188501	"Lactase like"	Q6UWM7	15	66547179-66565979	"Cancer-related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 10.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 5.0;Late spermatids: 7.5;Spermatogonia: 2.7"	"Group enriched"	"Detected in some"	5	"glioma: 1.5;melanoma: 0.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;hTERT-RPE1: 7.5;NTERA-2: 5.8;SuSa: 7.0;U-2 OS: 16.2;U-251 MG: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071640			Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Plasma membrane"	"Endoplasmic reticulum"	"HPA071640: AB_2686428"	"unprognostic (4.60e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.51e-3)"	"unprognostic (4.44e-16)"	"unprognostic (6.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	0.4	0.7	6.0	0.9	4.3	3.1	0.4	0.7	3.1	0.4	0.5	3.1	0.0	1.4	0.8	0.9	0.7	0.3	1.0	0.4	3.3	1.2	0.4	0.4	0.4	1.0	5.3	3.1	0.6	0.7	0.2	0.4	0.3	4.9	0.4	0.3	1.1	0.6	0.3	3.0	2.6	0.7	0.4	10.4	0.8	0.7	1.5	2.3	0.0	0.5	0.0	0.2	0.3	0.3	0.9	0.6	3.9	0.7	1.0	0.5	0.2	0.3	0.3	3.2	0.3	0.1	0.1	0.8	0.8	0.0	0.0	0.3	0.4	0.4	0.4	6.3	0.2	0.6	0.6	0.0	0.0	0.2	0.2	0.2	0.7	1.0	1.5	0.0	0.2	0.4	0.4	0.0	0.3	0.0	7.5	0.0	0.2	0.4	0.4	0.2	0.1	0.2	0.4	5.8	0.4	0.1	0.2	3.4	0.3	0.0	0.4	0.4	0.3	0.1	0.3	1.8	7.0	0.4	0.5	0.4	1.6	16.2	0.6	6.9	0.2	0.2	0.2	2.1	0.7	2.9	1.6	0.7	0.5	0.5	0.4	0.3	0.4	0.5	0.3	0.2	0.9	0.5	0.4	3.9	1.0	0.4	0.6	0.5	0.2	6.0	4.3	0.7	2.7	3.3	1.2	5.3	3.1	4.9	2.3	0.0	0.0	0.0	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.1	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	7.5	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.1	0.0	0.4	1.2	2.7	0.3	0.2	0.0	0.0	0.3
LDB1	"CLIM2, NLI"	ENSG00000198728	"LIM domain binding 1"	Q86U70	10	102107560-102120453	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034488	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034488: AB_10669783"	"unprognostic (8.83e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.26e-2)"	18.6	18.7	20.6	20.7	31.1	46.3	21.3	23.2	43.0	35.5	30.4	26.5	24.5	14.0	37.4	19.4	25.2	31.8	27.3	26.9	20.1	13.1	20.7	9.5	21.1	25.1	19.5	24.5	58.0	13.5	24.6	25.5	22.0	20.4	27.6	12.7	36.3	28.8	37.5	21.1	64.3	23.3	31.2	13.9	29.0	20.5	15.3	22.0	27.4	24.2	20.5	27.4	32.2	33.9	4.6	2.4	8.5	7.8	3.0	4.4	2.0	11.4	14.1	27.4	34.0	10.7	12.4	14.2	11.9	19.1	13.4	11.6	9.6	9.9	17.8	17.4	14.7	6.3	22.9	13.0	22.8	7.2	15.4	11.9	53.0	14.4	9.4	13.0	14.5	18.8	26.1	18.1	10.8	12.6	47.0	13.8	15.4	32.4	19.4	10.3	10.7	26.3	20.8	13.9	5.1	6.9	29.8	18.0	12.5	12.1	12.3	11.4	28.1	7.8	9.5	13.4	19.1	46.0	9.4	13.6	8.3	17.5	7.3	9.9	17.0	14.4	12.0	13.6	31.9	7.5	3.1	4.1	3.3	4.4	4.8	2.7	3.4	3.0	4.1	2.3	4.6	4.0	3.0	8.5	3.0	7.8	2.4	2.4	2.0	20.6	31.1	23.2	43.0	20.1	13.1	19.5	24.5	20.4	22.0	29.8	8.3	11.6	2.8	20.3	17.8	7.3	2.5	5.3	9.1	3.5	3.9	4.0	0.0	7.1	1.7	4.2	1.8	23.3	4.9	5.1	5.8	2.4	9.2	2.0	7.9	14.3	7.9	3.1	3.8	2.0	5.8	5.9	3.3	1.8	1.3	10.4	6.0	2.0	6.0	1.4	5.7	0.0	5.3	6.7	6.6	18.4	6.5	6.9	1.9	1.8
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668449-86736068	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3"	"Cell type enriched"	"Detected in some"	41	"Cardiomyocytes: 1579.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HSkMC: 5.9;hTERT-RPE1: 5.8;SCLC-21H: 9.6;SK-MEL-30: 4.6"	"Low region specificity"	"Detected in all"							HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		450000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0.0	4.9	0.4	4.2	9.9	9.9	1.3	1.0	213.9	1.7	1.0	0.3	0.2	0.4	0.2	2.6	0.0	1.5	0.3	0.3	0.1	0.5	0.0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0.0	0.0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0.0	0.3	0.2	0.4	3.1	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.2	0.6	0.0	0.7	0.4	0.2	0.0	0.1	0.9	0.7	0.7	0.9	0.1	0.1	0.1	1.6	5.9	0.5	0.1	0.0	5.8	0.0	0.7	0.2	1.8	0.3	1.5	0.4	0.2	0.4	0.4	0.3	0.0	2.0	0.1	0.0	1.1	9.6	1.8	0.3	0.2	4.6	1.4	0.3	0.2	0.0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.7	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0.0	0.9	1.6	0.1	0.6	1.7	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.7	1579.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	18.3	0.7	0.0	0.0	1.0	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.2	10.3	0.4	1.7	0.0	0.0	1.0	0.1	0.0	6.3	0.0	3.4	38.8	33.0	0.6	1.0	0.0	0.0	0.0	0.0	0.1
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 1952.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	80.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	189.0	66.1	31.6	48.6	48.0	131.1	34.9	70.0	53.9	19.8	43.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	50.2	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9	68.5	191.6	171.4	331.5	1952.6	415.5	222.7	142.7	85.6	187.7	293.1	137.4	475.1	368.1	1059.9	147.3	475.2	671.1	0.0	1350.8	1780.5	725.6	281.3	256.4	438.3	607.6	486.3	43.8	182.3	215.4	106.3	266.3	427.9	1116.8	1462.6	176.8	316.6	1380.9	487.5	192.7	408.8	354.8	187.5	1239.9	102.9	38.5	1506.3	419.6	213.6	251.8	384.9
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116771	"Enzymes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3;skeletal muscle: 39.7"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 33.6;Enterocytes: 38.8;Hepatocytes: 81.8;Proximal tubular cells: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 8.9;classical monocyte: 2.7;intermediate monocyte: 4.6;non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 8.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 8.7;HMC-1: 12.0;T-47d: 23.5;U-266/70: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol		No	NA			Cytosol		"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	15.3	5.5	6.8	1.6	6.7	0.8	3.7	4.9	11.7	4.1	12.5	7.6	4.5	6.1	1.5	3.0	3.8	2.1	3.6	25.3	6.6	5.8	21.5	44.3	2.8	0.9	8.1	9.7	7.9	7.7	8.5	4.4	2.1	9.9	4.4	6.8	5.1	14.2	4.5	39.7	1.8	2.5	1.2	4.5	0.7	11.2	1.0	4.0	0.0	4.3	14.4	2.7	1.1	1.2	0.0	0.2	8.9	5.7	0.1	0.1	0.9	0.6	1.6	0.0	0.3	1.3	1.1	5.1	0.1	0.1	0.1	0.2	2.1	2.2	0.0	1.8	0.7	0.8	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.7	2.1	0.0	12.0	1.6	0.3	0.0	0.0	0.4	0.1	0.3	0.6	1.9	0.0	4.0	0.0	0.6	1.1	2.1	1.0	0.0	0.0	6.0	1.1	0.1	0.0	0.0	0.0	4.1	0.3	0.6	23.5	2.6	0.0	0.0	0.2	0.0	0.0	9.3	0.5	0.0	1.6	0.0	0.0	8.9	2.7	0.8	0.0	4.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.9	6.8	6.7	4.9	11.7	6.6	5.8	8.1	9.7	9.9	4.0	0.0	7.9	2.2	2.1	0.6	0.0	33.6	10.2	1.4	1.2	10.4	0.0	1.6	31.5	1.3	0.3	0.6	38.8	0.0	5.5	1.1	0.5	1.6	10.3	81.8	6.2	1.6	2.9	4.3	5.3	0.2	0.0	1.6	5.0	1.0	9.4	11.0	3.7	19.9	0.0	75.5	1.0	0.0	0.4	0.0	0.3	0.3	2.6	1.3	11.0	1.7
LDLRAD3	LRAD3	ENSG00000179241	"Low density lipoprotein receptor class A domain containing 3"	Q86YD5	11	35943981-36232136	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.5"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 19.0;Peritubular cells: 23.3;Suprabasal keratinocytes: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;non-classical monocyte: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.5;RH-30: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038251	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA038251: AB_10675790"	"unprognostic (1.59e-3)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (9.34e-6)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (5.05e-8)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (2.14e-5)"	12.0	5.0	9.5	6.0	13.7	2.0	23.4	32.5	17.9	9.3	2.8	20.7	1.7	2.9	8.2	4.7	8.8	5.0	6.5	3.6	10.8	7.2	3.0	2.6	3.3	4.4	18.0	4.0	15.0	5.1	1.5	9.2	3.4	18.1	14.8	3.2	5.3	23.9	6.0	5.5	17.0	3.3	7.2	24.4	2.9	3.4	4.8	13.5	0.1	3.0	2.6	4.8	5.3	6.5	0.0	4.1	1.9	7.7	0.0	0.0	2.0	4.8	4.6	14.4	8.7	11.5	12.6	11.0	2.8	2.5	6.4	5.7	3.4	3.0	0.0	2.1	3.0	9.6	2.5	4.4	6.3	9.0	0.4	9.3	15.7	3.0	1.0	15.2	3.4	1.9	15.1	28.5	2.9	25.2	2.6	10.7	0.0	4.0	0.6	11.7	2.7	0.0	0.8	5.9	0.5	8.1	0.0	26.9	1.5	1.1	0.7	4.9	11.1	4.9	5.4	15.8	5.8	7.5	4.6	10.7	7.7	6.9	0.6	9.3	0.3	0.0	0.0	3.8	4.2	13.7	1.9	6.1	0.6	0.0	6.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	7.7	0.3	0.0	2.0	9.5	13.7	32.5	9.1	10.8	7.2	18.0	4.0	18.1	13.5	0.0	5.6	0.5	6.7	13.7	0.2	0.4	0.0	0.0	1.2	0.0	0.0	2.1	0.0	3.6	12.5	5.5	0.0	0.0	0.9	11.4	4.4	19.0	0.0	0.6	3.8	0.0	0.0	9.8	13.5	11.9	8.9	5.1	6.8	1.0	0.0	0.5	1.2	0.0	23.3	1.6	0.0	12.9	8.2	0.5	3.0	22.7	1.1	0.0	0.4	2.2
LDLRAP1	"ARH, ARH2, DKFZp586D0624, FHCB1, FHCB2, MGC34705"	ENSG00000157978	"Low density lipoprotein receptor adaptor protein 1"	Q5SW96	1	25543580-25568886	"Disease related genes, Predicted intracellular proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Atherosclerosis, Disease mutation, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 60.6"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 36.7"	"Group enriched"	"Detected in all"	7	"NK-cells: 11.3;T-cells: 36.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB003705, HPA050358"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"CAB003705: AB_425923, HPA050358: AB_2681103"	"unprognostic (2.52e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.49e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.79e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.96e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.24e-1)"	5.9	10.9	5.4	11.0	16.7	4.7	8.1	60.6	10.4	6.4	11.7	31.8	9.7	7.2	5.9	6.2	10.5	6.2	6.3	6.0	9.3	5.7	8.3	14.0	10.2	21.3	23.4	6.9	6.7	26.1	8.5	11.1	15.8	16.4	11.4	10.8	9.9	22.6	7.6	7.4	13.6	8.8	6.8	34.3	31.1	8.7	3.2	15.8	2.8	11.0	8.0	13.8	6.2	8.3	3.5	2.9	1.0	2.1	11.3	36.7	15.0	13.4	5.3	7.6	8.0	4.8	5.6	6.2	8.6	8.4	13.2	9.2	2.1	11.2	3.0	6.3	11.7	9.2	14.3	5.2	8.7	6.7	3.6	8.0	4.8	6.3	4.1	7.7	5.4	7.2	6.0	12.5	10.6	4.0	3.2	11.3	3.1	6.6	29.7	4.3	7.8	0.1	9.3	9.6	10.9	5.7	0.8	8.6	24.2	4.9	2.8	3.8	2.1	11.9	19.1	13.6	6.5	8.7	9.4	6.7	5.8	8.5	10.9	5.9	28.5	33.2	8.6	19.6	4.6	7.0	0.0	2.1	0.0	7.7	1.7	9.1	3.5	18.2	14.3	2.9	1.8	36.7	29.4	1.0	11.3	1.7	0.4	14.9	15.0	5.4	16.7	60.6	10.4	9.3	5.7	23.4	6.9	16.4	15.8	0.0	14.1	13.7	18.3	7.3	3.3	3.2	7.6	2.7	13.6	7.0	17.7	29.3	3.3	9.2	0.2	9.2	14.7	0.0	15.7	6.3	8.4	16.3	2.3	18.3	9.4	66.7	6.4	13.5	5.7	0.0	9.5	4.6	16.9	0.0	21.5	3.8	11.3	24.6	8.1	4.4	13.2	25.8	7.2	1.2	7.5	5.0	19.8	13.1	17.8	17.1
LECT2	"chm-II, chm2"	ENSG00000145826	"Leukocyte cell derived chemotaxin 2"	O14960	5	135922279-135955034	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 100.7"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 116.8;Erythroid cells: 23.3;Hepatocytes: 93.6;Late spermatids: 39.1"	"Cancer enriched"	"Detected in single"	216	"liver cancer: 35.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043883, HPA058246"	Enhanced		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	26500000	820000	Cytosol	Vesicles	"HPA043883: AB_2678714, HPA058246: "							"prognostic favorable (4.16e-5)"						"unprognostic (2.57e-2)"		"unprognostic (3.52e-1)"			0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	100.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.5	2.5	1.2	0.1	0.8	0.3	1.0	1.2	1.5	2.5	0.6	2.2	2.3	0.5	0.2	0.0	0.0	0.9	1.4	2.4	1.9	1.0	1.1	1.5	0.2	0.7	0.2	0.9	3.2	2.4	3.3	4.1	1.0	3.0	0.5	0.8	0.7	1.1	1.1	2.0	1.1	2.6	0.9	2.0	2.0	1.5	1.2	1.3	1.7	0.8	1.9	1.6	1.4	0.7	1.6	2.7	1.0	1.9	0.0	0.6	0.1	3.3	0.3	1.6	2.5	0.9	1.5	1.3	0.4	3.6	1.7	1.0	1.1	2.8	2.4	2.4	1.2	0.4	0.7	0.8	0.5	1.3	0.8	0.8	0.2	1.0	0.7	0.5	2.5	0.1	0.6	0.5	0.7	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.8	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	93.6	0.0	0.0	0.0	3.7	2.2	39.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	6.5	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 231.5"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 11.6;Melanocytes: 32.1;Spermatocytes: 21.3;T-cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 42.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 42.2"	"Group enriched"	"Detected in many"	5	"JURKAT: 98.3;MOLT-4: 93.3;REH: 72.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	0.9	13.5	3.5	9.3	5.4	7.6	2.0	1.6	3.4	3.6	1.0	2.9	0.8	0.4	6.0	3.5	3.4	5.0	2.8	0.5	4.7	5.2	2.7	0.3	2.4	25.3	4.9	1.9	1.8	0.8	0.0	1.1	7.8	3.1	2.8	1.0	1.6	3.1	0.7	0.5	2.4	3.9	2.9	4.4	7.0	0.9	8.2	2.3	231.5	2.7	1.3	20.6	4.8	3.2	0.3	0.1	0.5	0.0	8.9	42.2	9.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.7	4.1	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.5	0.0	2.9	1.0	0.0	0.0	0.0	3.6	0.5	0.0	0.1	0.0	0.1	0.6	0.0	98.3	2.1	0.0	0.4	0.1	93.3	0.0	0.2	1.0	0.2	72.0	1.4	0.0	0.3	0.2	0.4	0.8	0.0	0.0	13.8	1.1	0.3	0.0	0.0	1.9	1.6	0.0	2.4	6.0	2.5	16.5	1.2	0.0	7.9	0.0	0.0	0.0	2.6	0.0	0.5	0.1	19.7	8.8	0.0	0.3	42.2	29.2	0.5	8.9	0.0	0.1	25.7	9.5	3.5	5.4	1.6	3.4	4.7	5.2	4.9	1.9	3.1	2.3	3.0	3.4	0.0	1.1	3.0	0.0	1.2	0.0	4.0	1.2	0.0	0.0	0.1	11.6	0.0	3.1	3.6	0.0	0.0	0.0	0.1	1.8	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.9	0.6	0.8	32.1	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.0	5.9	21.3	9.6	1.1	0.3	13.1	0.1	0.3
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"	Q6ZMV7	3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 29.8"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 34.8;Early spermatids: 63.2;Late spermatids: 32.2;Spermatocytes: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 6.6;U-266/70: 6.2"	"Low region specificity"	"Detected in all"							"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	1.4	1.7	1.4	2.5	4.6	0.6	2.7	1.4	2.2	1.5	1.0	1.6	3.5	1.7	1.3	8.2	0.9	6.3	1.7	1.4	1.5	2.0	2.8	1.3	3.0	1.6	1.1	1.4	2.9	2.7	4.8	4.5	0.5	2.2	1.7	1.1	2.5	1.6	4.9	0.7	0.9	1.6	0.8	1.9	1.8	1.5	29.8	0.7	4.4	4.0	0.7	1.4	1.2	1.8	3.2	1.9	2.5	0.3	2.5	2.0	0.4	6.6	2.7	0.1	1.6	1.2	0.6	0.4	0.4	1.0	1.4	1.1	0.3	3.8	0.1	2.0	1.1	2.6	2.5	0.0	0.5	2.7	1.2	0.6	2.5	0.5	0.0	0.0	2.1	0.6	3.1	1.6	0.5	1.9	0.8	0.6	0.1	1.5	1.6	2.4	2.4	0.0	1.9	2.2	1.9	1.5	0.0	1.8	1.5	2.1	0.6	4.2	1.7	2.2	1.5	0.1	0.5	4.6	3.6	0.0	0.4	0.7	0.5	1.0	6.2	1.0	0.0	1.2	1.5	2.3	2.5	0.3	0.3	0.7	0.1	1.4	3.1	1.6	0.6	1.2	3.2	1.8	0.9	0.3	2.5	0.2	1.9	2.0	0.4	1.4	4.6	1.4	2.2	1.5	2.0	1.1	1.4	2.2	0.7	0.0	1.4	0.0	1.1	1.1	1.3	0.8	2.5	34.8	3.4	3.5	2.0	0.2	3.3	0.6	63.2	0.4	1.3	0.0	1.4	0.1	0.5	0.7	1.1	1.6	0.2	3.2	0.0	0.0	1.8	32.2	1.4	1.1	1.7	1.8	0.6	1.4	0.7	0.0	1.8	3.3	4.5	0.0	0.3	49.4	3.2	0.6	0.1	1.3	0.8	0.8
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Group enriched"	"Detected in some"	129	"Early spermatids: 869.0;Late spermatids: 3077.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.9	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.9	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0	0.0	1.6	0.0	1.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.4	869.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3077.5	11.8	0.0	0.0	0.0	0.0	0.9	4.0	0.0	13.1	1.5	0.7	6.5	0.0	15.3	7.2	0.0	0.3	0.0	0.0	2.2
LENG1		ENSG00000105617	"Leukocyte receptor cluster member 1"	Q96BZ8	19	54155161-54159882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 5.7;HaCaT: 8.3;HDLM-2: 5.1;HSkMC: 3.9;LHCN-M2: 4.8;U-87 MG: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043541	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA043541: AB_10961190"	"unprognostic (8.75e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.73e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.22e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-2)"	9.6	8.0	8.2	8.0	11.1	6.1	7.3	10.1	9.5	7.5	10.8	11.5	10.8	7.6	13.4	8.7	6.1	11.9	9.6	12.7	8.2	7.9	7.6	7.2	8.9	6.3	11.2	7.6	10.3	9.7	7.3	8.5	7.3	10.3	9.3	10.7	6.6	21.6	10.4	13.1	9.9	14.8	7.5	10.8	21.8	8.8	12.3	13.1	10.1	10.8	7.6	6.8	8.2	15.8	3.8	3.2	4.1	3.3	2.8	3.8	0.8	0.1	0.4	5.7	0.2	0.6	0.2	0.4	0.8	0.1	0.6	0.3	0.2	0.0	0.0	0.2	0.0	0.5	8.3	0.3	0.2	0.2	5.1	1.3	0.0	0.5	0.1	0.0	0.0	0.5	3.9	0.7	0.2	0.5	0.2	0.1	0.5	0.1	0.0	4.8	0.6	0.4	0.5	0.0	0.2	0.6	0.0	0.1	0.8	0.5	0.5	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.1	0.7	0.4	0.4	0.2	0.4	0.1	0.2	0.0	5.6	0.1	2.7	1.0	2.7	4.1	2.5	3.3	2.8	1.6	3.7	3.8	2.2	3.8	3.7	2.9	3.7	2.8	1.6	3.2	2.7	0.8	8.2	11.1	10.1	9.5	8.2	7.9	11.2	7.6	10.3	13.1	17.9	9.1	29.1	20.5	18.3	10.2	6.4	15.3	18.7	6.8	17.4	0.0	24.4	19.9	18.7	76.0	20.3	33.5	0.0	24.7	12.4	18.9	14.1	54.2	15.5	26.7	6.4	25.9	25.8	16.2	6.4	20.8	26.0	20.3	26.2	20.4	14.5	21.8	17.8	14.2	21.2	13.9	38.8	26.8	23.1	29.4	18.7	35.8	35.5	16.6	14.7
LENG8	"KIAA1932, MGC40108, pp13842"	ENSG00000167615	"Leukocyte receptor cluster member 8"	Q96PV6	19	54448887-54462037	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 564.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 102.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042004, HPA042056, HPA061571"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042004: AB_10794642, HPA042056: AB_10795389, HPA061571: AB_2684562"	"unprognostic (2.09e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.45e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.85e-3)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (3.64e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.73e-6)"	58.7	37.3	45.7	53.2	47.3	48.4	30.7	81.5	55.3	37.9	32.9	48.1	54.4	78.1	56.3	66.3	22.9	44.8	39.2	24.1	42.2	21.6	35.0	22.7	36.2	45.8	52.1	30.2	50.3	62.7	13.8	46.4	27.4	38.1	41.9	22.1	48.9	66.7	59.1	36.5	37.2	75.5	35.6	34.3	80.0	53.2	32.6	57.5	24.8	42.2	18.7	33.5	31.5	32.0	4.0	5.6	8.0	1.9	1.7	1.6	0.6	14.5	11.4	14.6	7.4	4.6	7.5	7.8	12.2	1.9	2.3	4.5	9.2	21.1	11.4	5.3	9.9	0.6	19.3	4.7	5.6	1.7	19.2	102.5	17.4	31.4	6.4	5.0	2.6	14.0	16.8	8.7	1.4	5.8	20.0	3.5	8.8	13.2	16.5	2.9	5.0	10.7	13.6	3.4	3.3	2.6	17.3	4.3	16.1	6.0	4.3	11.8	6.1	1.3	9.0	2.8	7.8	8.8	3.8	16.9	10.3	10.7	1.6	12.9	15.6	7.3	4.6	8.4	18.6	6.7	3.9	1.9	2.3	1.6	1.2	1.6	1.4	0.8	1.5	1.0	4.0	1.5	1.1	8.0	1.7	0.9	5.6	1.0	0.6	45.7	47.3	81.5	55.3	42.2	21.6	52.1	30.2	38.1	57.5	17.9	30.7	24.9	18.7	25.5	123.6	1.7	45.9	21.4	29.6	38.4	106.0	15.1	1.7	17.8	25.8	24.8	65.9	23.3	27.1	10.2	22.7	34.5	10.5	37.6	22.3	90.6	100.9	44.2	43.7	9.1	40.3	25.1	23.6	18.0	78.8	36.3	27.0	52.6	34.6	5.3	564.9	19.4	19.6	16.7	13.6	33.6	17.6	19.5	50.5	29.3
LENG9		ENSG00000275183	"Leukocyte receptor cluster member 9"		19	54461796-54463711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"pancreas: 19.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 25.9;Mucus-secreting cells: 25.8;Rod photoreceptor cells: 25.8;Undifferentiated cells: 21.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 8.0;OE19: 9.7;RPMI-8226: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051671, HPA053556"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA051671: AB_2681568, HPA053556: AB_2682187"	"unprognostic (8.38e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.99e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.76e-2)"	2.9	0.6	0.0	2.6	0.9	0.2	1.8	0.0	1.0	1.4	5.7	0.9	0.7	6.8	1.3	0.3	3.0	0.7	5.0	1.9	0.4		0.5	6.4	2.1	2.0	0.8	0.2	2.2	19.3	0.1	0.0	0.2	0.7	3.4	1.5	0.0	7.0	2.2	2.6	0.2	5.8	1.0	0.5	1.7	4.7	0.7	0.2	0.2	0.7	2.8	2.6	0.7	0.4	0.5	0.0	1.9	0.4	0.0	0.7	0.0	4.8	1.5	0.1	0.1	2.1	2.0	0.0	0.7	1.9	0.3	0.3	0.6	4.5	0.0	2.3	1.8	0.0	8.0	0.5	1.4	0.0	4.8	0.0	1.1	0.0	0.2	2.7	0.0	0.0	2.8	2.4	0.0	1.6	1.3	0.9	0.8	0.0	6.8	0.6	4.4	2.1	2.9	1.1	9.7	0.0	4.1	0.4	8.4	0.8	0.0	0.8	0.3	0.0	2.8	1.3	0.5	4.6	0.0	2.1	0.2	0.1	0.0	1.6	0.6	0.0	0.6	1.3	2.9	4.0	1.9	0.4	0.1	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.4	2.2	10.3	0.8	4.0	0.2	0.0	1.4	0.0	1.8	2.0	0.2	0.0	2.5	1.1	2.2	25.9	0.0	3.7	2.5	2.7	11.2	0.0	2.1	3.3	4.8	5.2	3.7	7.2	0.0	6.1	2.1	1.7	0.0	25.8	9.2	2.9	17.8	1.8	2.8	25.8	0.0	6.6	0.5	2.5	2.8	0.3	3.8	21.4	13.7
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971806	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"granulocytes: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	No			"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.7	15.2	15.0	15.3	27.9	8.3	17.0	42.6	24.4	13.4	17.8	14.1	9.7	13.9	12.6	11.2	24.4	9.7	14.2	10.6	14.0	14.0	21.4	27.8	10.2	17.2	14.8	14.9	10.6	10.3	25.2	22.4	12.7	22.7	13.8	21.0	9.1	21.2	12.5	13.5	21.8	19.8	12.6	15.3	14.3	13.9	9.8	18.5	23.4	12.0	9.4	18.2	16.9	15.7	12.3	15.3	9.6	15.3	18.9	19.7	10.0	9.6	22.6	14.6	11.7	15.1	13.1	10.5	15.8	13.1	13.6	12.4	15.6	6.4	19.6	9.3	16.2	15.1	19.0	19.4	14.1	13.1	13.0	8.8	30.9	18.4	27.3	11.9	27.8	43.2	14.0	11.1	10.6	13.8	12.9	13.2	16.6	18.7	10.8	16.1	41.2	14.7	21.1	6.3	28.9	9.7	16.5	25.3	20.5	11.9	27.2	10.4	15.9	12.0	18.5	12.3	16.7	15.4	25.4	15.7	13.5	9.3	12.4	18.8	8.5	26.5	18.1	11.8	39.9	14.3	5.4	9.4	9.6	18.7	14.6	17.5	12.3	18.7	15.2	15.3	10.1	19.5	17.5	2.3	18.9	15.3	11.5	19.7	10.0	15.0	27.9	42.6	24.4	14.0	14.0	14.8	14.9	22.7	18.5	32.8	27.7	10.4	12.9	23.2	35.2	17.1	20.4	45.5	39.8	7.0	9.8	21.3	13.3	21.4	1.6	15.0	19.3	0.0	21.0	22.3	16.2	9.1	262.5	12.3	16.9	25.4	7.5	8.6	12.3	2.1	7.5	7.8	3.3	14.4	16.3	20.9	17.2	14.0	12.7	17.9	20.8	6.5	9.2	15.6	9.0	21.7	14.8	15.4	13.9	20.1
LEPROT	"FLJ90360, OB-RGRP, OBRGRP, VPS55"	ENSG00000213625	"Leptin receptor overlapping transcript"	O15243	1	65420587-65436007	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069444			Approved	Centrosome		NA	NA			Centrosome		"HPA069444: AB_2686137"	"unprognostic (3.64e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-2)"	37.3	30.0	13.9	12.6	14.0	17.1	37.8	9.2	13.3	25.4	20.5	18.0	16.1	12.5	42.6	18.4	25.5	20.7	20.8	22.1	11.4	11.0	50.7	31.1	26.3	24.5	16.5	10.1	28.7	30.8	22.5	21.7	44.3	18.9	25.4	16.9	30.4	21.4	20.5	13.6	16.2	23.5	26.2	20.0	24.3	18.1	17.4	11.7	6.5	34.2	14.0	14.7	28.5	19.5	2.2	8.1	15.3	18.0	4.1	4.9	8.4	10.7	4.5	4.7	2.0	41.7	28.2	15.0	16.6	23.3	13.5	13.7	3.8	6.8	2.5	9.6	16.6	16.0	6.7	2.5	6.9	17.3	11.5	2.6	12.3	5.8	6.9	11.5	2.4	6.6	38.6	17.6	10.8	8.5	17.9	15.4	1.7	7.3	6.1	24.2	2.7	0.9	2.8	7.5	3.7	4.9	0.5	10.4	3.8	60.6	8.0	4.8	6.4	10.1	9.0	9.6	18.9	6.9	4.6	18.0	13.7	10.1	10.5	6.2	7.5	6.6	1.1	11.0	6.3	8.7	15.3	12.7	10.7	4.1	12.7	4.9	2.2	3.9	3.7	8.1	1.5	3.9	3.8	11.8	4.1	18.0	6.7	3.0	8.4	13.9	14.0	9.2	13.3	11.4	11.0	16.5	10.1	18.9	11.7	154.9	49.4	25.7	74.0	51.2	17.8	51.3	89.2	85.6	66.0	169.3	21.6	193.8	69.6	117.2	5.0	175.0	47.0	46.7	125.5	93.2	138.0	69.9	60.2	71.7	95.6	36.5	53.6	190.3	110.3	5.1	184.1	107.1	69.2	63.1	58.2	82.8	129.1	63.0	140.0	131.1	26.2	187.5	142.2	17.1	17.5	58.5	307.6	40.3	43.3	74.9
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.8;testis: 28.6"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 41.6;Late spermatids: 34.7;Pancreatic endocrine cells: 29.9;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 16.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.8;hTERT-HME1: 15.3"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 50.6"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	2.3	1.3	3.3	1.7	7.9	6.8	1.5	9.9	6.6	2.6	1.3	2.9	0.5	1.5	2.1	2.1	2.1	2.1	2.0	1.4	4.3	4.1	3.5	1.4	3.2	1.7	3.1	4.2	2.6	1.4	3.6	5.5	6.7	3.3	1.9	1.5	3.0	1.4	1.4	0.8	1.8	1.1	1.2	3.2	2.3	4.1	28.6	1.6	3.8	1.6	1.0	2.2	3.1	1.7	1.4	1.3	16.8	3.8	1.2	4.0	1.2	13.8	2.5	1.9	1.8	1.5	4.3	1.4	4.7	5.6	6.7	4.1	1.0	5.5	1.7	11.1	1.0	2.0	1.5	3.8	16.8	7.0	0.8	1.6	2.0	1.9	2.5	1.9	0.3	1.9	1.2	4.7	7.1	15.3	3.6	7.0	2.2	1.7	2.7	5.9	2.9	5.0	1.2	0.4	1.0	11.8	1.7	3.1	1.0	11.0	0.6	1.6	1.6	1.6	0.3	0.5	1.3	1.6	0.8	12.1	2.1	14.8	3.8	1.1	1.8	1.0	1.3	3.3	2.2	1.6	0.9	3.4	0.5	0.9	1.3	1.5	1.4	0.8	1.3	1.3	1.4	1.6	1.5	16.8	1.2	3.8	0.6	4.0	1.2	3.3	7.9	9.9	6.6	4.3	4.1	3.1	4.2	3.3	1.6	3.0	5.4	0.5	11.6	0.5	7.0	1.6	5.1	4.0	2.3	5.2	5.9	1.4	1.7	3.5	41.6	2.6	0.2	0.0	17.9	4.8	2.2	2.1	9.2	0.0	1.3	6.4	0.0	1.3	1.5	34.7	2.0	2.5	1.7	1.0	1.4	3.5	29.9	0.0	1.4	2.2	8.2	0.0	2.8	24.4	1.5	0.6	6.8	3.8	1.0	4.4
LEUTX		ENSG00000213921	"Leucine twenty homeobox"	A8MZ59	19	39776595-39786167	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 1.0;HDLM-2: 2.3"									HPA041498	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041498: AB_10796346"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.6		0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675608-37679806	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 4031.4;Hofbauer cells: 3788.4;monocytes: 10290.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	No	No		19000000	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (5.10e-4)"	167.5	49.3	23.0	56.0	22.9	29.8	213.7	7.6	30.9	158.6	94.5	20.1	44.2	22.0	150.9	80.3	74.0	66.8	78.8	108.6	18.9	29.3	24.0	20.8	55.8	45.4	41.4	28.9	105.1	18.2	5.1	17.5	80.1	53.6	85.9	23.4	35.7	34.9	89.6	117.1	29.2	29.2	145.8	88.3	40.3	40.0	42.4	20.5	16.7	19.6	59.1	20.4	99.8	81.7	29.0	185.2	44.0	149.1	19.6	73.1	180.2	94.5	55.8	1.2	49.5	116.0	227.9	1.1	219.9	258.2	162.9	162.4	6.2	12.5	0.1	22.6	222.0	56.2	10.1	1.9	144.6	57.0	97.1	1.0	8.3	58.6	25.6	75.7	4.8	110.9	141.1	9.9	129.9	55.6	149.1	178.8	0.0	6.0	40.1	126.0	42.2	0.1	67.3	0.4	21.0	132.4	0.1	83.0	25.9	67.0	0.2	0.1	29.4	43.9	7.7	54.9	2.4	40.9	56.9	241.8	217.7	108.9	96.6	112.2	24.6	16.4	0.4	255.8	25.1	86.6	44.0	149.1	5.3	40.8	114.2	6.1	29.0	38.0	39.8	185.2	10.8	6.6	26.8	6.3	19.6	120.0	45.7	73.1	180.2	23.0	22.9	7.6	30.9	18.9	29.3	41.4	28.9	53.6	20.5	154.9	138.0	222.9	146.3	648.8	7.2	914.1	63.7	54.9	94.4	155.3	5.9	84.3	14.9	558.2	21.5	662.6	6.4	23.3	75.7	807.6	4031.4	43.7	528.7	472.3	3788.4	7.9	2.9	939.1	2674.9	59.6	903.3	2724.8	2709.5	10290.5	1.7	156.0	264.8	1.7	1222.7	15.1	31.2	1623.4	2845.4	14.7	12.1	513.9	126.7	373.6	0.9	48.4
LGALS12	GRIP1	ENSG00000133317	"Galectin 12"	Q96DT0	11	63506084-63516774	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 45.1;blood: 90.2;breast: 28.6"	"Cell type enriched"	"Detected in some"	8	"granulocytes: 18.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enriched"	"Detected in some"	19	"eosinophil: 90.2"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 90.2"	"Group enriched"	"Detected in some"	14	"ASC diff: 11.8;HL-60: 20.4;NB-4: 40.2;U-937: 43.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA021124			Approved	Cytosol		NA	NA			Cytosol		"HPA021124: "	"unprognostic (3.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (4.60e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.22e-2)"	"unprognostic (8.60e-2)"	45.1	0.5	0.1	5.8	1.1	10.1	28.6	0.0	0.1	0.1	10.6	0.0	0.0	0.3	0.2	1.1	0.1	0.7	7.7	2.2	0.1	0.1	0.4	0.2	1.4	5.3	0.1	0.0	0.5	0.5	0.0	0.1	0.1	0.2	0.7	0.4	0.1	5.9	1.6	1.6	0.6	1.4	0.6	0.2	0.8	0.4	0.1	0.0	0.1	0.5	2.4	0.2	0.9	0.2	0.0	1.2	90.2	4.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	20.4	1.3	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	43.1	0.0	1.8	4.7	90.2	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	2.8	0.1	1.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570246-37582616	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 800.0;Enterocytes: 838.5;Pancreatic endocrine cells: 476.7;Proximal tubular cells: 1320.5;Undifferentiated cells: 571.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5"	"Group enriched"	"Detected in many"	51	"dendritic cells: 100.5;monocytes: 129.0"	"Group enriched"	"Detected in some"	4	"CACO-2: 46.8;Hep G2: 26.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	3.1	0.4	0.6	4.3	0.5	1.8	0.6	0.4	0.5	0.5	12.6	0.5	0.4	6.1	1.0	1.9	0.8	0.6	91.7	0.7	0.4	0.4	35.3	1.0	2.3	7.9	0.5	0.4	0.6	87.3	0.0	0.4	0.9	0.5	0.5	13.0	0.5	1.8	0.4	0.4	0.9	43.0	0.4	0.5	8.3	1.5	0.6	0.4	4.5	0.5	1.0	9.6	0.7	0.6	0.6	100.5	2.2	129.0	0.1	0.2	70.1	1.1	0.6	0.4	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.0	46.8	0.0	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	26.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.4	0.2	9.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.7	0.8	1.1	0.2	0.7	0.7	2.7	0.9	0.4	1.9	0.3	0.0	0.1	0.1	1.2	0.0	0.5	0.6	129.0	0.6	0.1	47.0	0.2	0.6	0.1	0.2	100.5	0.2	0.2	0.1	2.2	0.1	2.9	0.8	0.2	70.1	0.6	0.5	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.4	6.0	4.6	32.7	0.1	15.1	0.0	0.1	800.0	1.4	2.3	27.9	0.0	0.1	107.8	20.9	0.0	0.1	838.5	0.0	175.0	0.2	3.5	0.1	2.3	0.6	27.7	0.0	70.9	0.6	23.7	0.0	0.6	71.1	23.6	13.6	374.8	0.0	476.7	354.2	0.0	1320.5	0.0	0.0	6.2	0.0	0.2	10.8	0.2	2.5	571.4	0.1
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145413	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 3145.4;Paneth cells: 2942.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 90.9;CAPAN-2: 72.2;OE19: 119.2;SK-MEL-30: 169.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA003162, CAB005191"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		2300000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937"	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	95.7	11.0	10.4	50.9	13.6	29.8	53.2	6.5	11.7	54.1	127.1	6.1	42.4	75.7	50.3	30.7	76.1	26.1	83.9	42.3	8.4	5.7	19.9	3.9	65.5	16.6	8.5	9.4	58.9	24.2	0.5	11.0	78.7	5.5	51.7	93.7	25.7	78.3	51.7	31.3	76.1	182.4	48.2	8.7	11.1	36.9	20.4	5.7	5.5	18.0	65.7	41.7	41.1	44.4	1.3	41.7	3.6	67.4	2.5	25.9	37.2	21.7	6.9	0.2	0.1	45.3	90.9	26.5	17.4	36.7	4.8	8.6	15.0	72.2	0.0	9.2	20.3	8.8	21.8	0.4	18.2	2.7	25.7	0.3	0.0	7.7	6.9	34.4	0.0	0.0	28.3	27.8	5.6	11.7	11.0	7.5	0.0	0.0	21.0	10.9	14.7	0.0	5.3	0.3	119.2	19.6	0.0	0.9	1.5	45.3	29.1	0.6	1.7	40.7	0.0	169.5	1.2	17.9	2.4	13.7	23.0	3.2	8.5	0.3	11.7	37.1	0.1	33.0	1.4	2.4	1.7	67.4	3.4	1.8	55.4	11.4	1.3	6.8	5.1	41.7	0.4	0.3	1.0	3.6	2.5	44.2	1.1	25.9	37.2	10.4	13.6	6.5	11.7	8.4	5.7	8.5	9.4	5.5	5.7	670.0	300.6	39.7	543.1	560.7	2.0	183.5	254.8	1263.4	586.9	113.4	0.0	565.8	570.3	541.1	17.4	423.0	3145.4	116.8	951.7	754.6	506.8	590.1	552.4	0.9	1164.5	1.6	166.8	50.3	236.1	23.5	514.6	722.3	804.8	642.0	1587.7	215.8	859.9	2942.3	361.0	42.5	11.3	142.3	241.1	7.7	3.6	697.2	404.6	52.2	1480.8	936.7
LGALS8	PCTA-1	ENSG00000116977	"Galectin 8"	O00214	1	236518000-236552981	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012734, HPA030491"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA012734: AB_2668720, HPA030491: AB_10602345"	"unprognostic (2.03e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.93e-7)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.21e-2)"	27.8	14.0	15.0	17.0	30.5	28.9	18.6	21.7	22.6	14.1	14.8	9.5	10.7	15.5	13.6	19.2	18.5	12.4	17.2	36.0	16.2	14.8	18.5	34.1	21.0	28.2	13.7	17.0	18.3	18.8	22.5	22.7	43.1	25.2	19.8	14.9	10.0	22.4	17.5	7.7	25.3	18.1	15.3	18.1	41.3	13.6	39.9	14.6	19.9	16.8	13.0	16.4	20.7	14.6	4.4	12.7	38.5	14.2	5.3	8.9	9.3	17.7	9.3	1.3	7.0	16.6	14.1	20.6	13.2	15.1	16.5	19.2	12.6	21.7	0.5	12.9	10.9	9.7	19.9	3.7	18.9	15.5	10.3	2.8	12.0	8.1	22.4	20.9	15.9	28.4	13.0	15.1	14.8	5.0	15.9	18.2	9.2	14.2	9.0	11.9	10.9	7.5	3.1	4.8	1.5	7.0	9.1	0.3	1.1	11.7	28.9	4.5	9.3	8.5	28.0	4.7	0.8	20.8	12.6	13.3	0.3	8.2	9.9	16.5	3.4	2.6	0.4	17.1	22.3	10.5	38.5	14.2	7.2	5.4	12.9	7.4	4.4	7.8	5.8	12.7	2.9	5.2	5.4	6.7	5.3	8.7	5.8	8.9	9.3	15.0	30.5	21.7	22.6	16.2	14.8	13.7	17.0	25.2	14.6	71.5	57.4	15.2	26.4	28.8	24.1	47.0	28.1	68.3	67.1	14.0	23.6	53.8	5.0	47.7	244.5	34.9	23.1	0.0	34.4	48.3	22.6	20.5	104.2	22.4	48.8	36.5	17.4	38.6	85.5	157.7	21.9	34.0	6.8	4.6	17.8	6.5	38.3	26.2	13.1	10.3	18.2	25.8	20.0	24.6	8.7	32.4	147.4	34.6	14.5	18.7
LGALS9	LGALS9A	ENSG00000168961	"Galectin 9"	O00182	17	27629798-27649560	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.9"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 273.5;Kupffer cells: 189.6;Paneth cells: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 11.4;HMC-1: 29.7;MOLT-4: 14.7;REH: 10.4;THP-1: 26.6;U-937: 22.8"									"HPA046876, HPA047218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA	448000		Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (2.62e-2)"	"prognostic favorable (2.35e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (4.76e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	25.7	3.9	6.4	15.6	11.2	22.2	6.1	2.0	5.3	5.7	26.9	12.6	0.2	8.6	4.3	6.1	6.0	8.5	13.9	4.6	5.6	3.4	5.0	9.0	14.7	29.6	9.7	2.7	5.9	6.0	0.5	2.9	8.5	8.7	4.2	26.0	10.9	5.7	2.1	2.5	3.7	15.0	5.1	13.2	48.9	20.2	2.2	7.9	22.1	3.8	2.0	17.1	14.8	3.6	6.6	28.7	12.0	35.2	4.2	7.0	10.9	0.4	0.3	0.2	0.1	0.0	0.1	0.5	0.2	0.4	3.4	11.4	0.0	2.3	0.4	2.5	0.5	0.3	1.2	0.1	0.0	0.2	3.4	0.4	3.6	0.4	0.0	0.1	7.5	29.7	0.1	0.0	0.2	0.0	0.1	4.0	2.1	0.2	0.2	0.0	0.0	14.7	3.6	0.1	5.3	0.0	10.4	0.0	0.3	1.6	0.3	0.1	0.3	0.0	1.0	0.0	0.2	0.1	26.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	22.8	0.1	5.6	16.4	12.0	1.0	35.2	0.6	4.5	2.6	1.3	28.7	6.6	1.5	0.7	7.2	4.2	31.2	4.5	7.0	10.9	6.4	11.2	2.0	5.3	5.6	3.4	9.7	2.7	8.7	7.9	8.9	7.5	29.3	6.0	2.9	0.1	0.8	25.5	10.7	12.5	7.0	0.0	2.0	3.3	99.7	1.1	23.3	125.2	0.0	111.9	2.5	6.8	2.9	31.1	0.8	273.5	0.0	38.8	18.4	189.6	1.5	4.0	133.7	1.7	127.2	146.3	0.4	119.4	182.0	2.8	0.4	0.5	19.4	3.1	0.1	0.7	1.5	3.1	24.5	106.1	25.8
LGALS9C		ENSG00000171916	"Galectin 9C"	Q6DKI2	17	18476737-18494945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 8.9;esophagus: 15.8;intestine: 8.3;lymphoid tissue: 8.5;stomach 1: 15.4"	"Cell type enhanced"	"Detected in some"	23	"Enterocytes: 16.8;Mucus-secreting cells: 22.5;Paneth cells: 54.7;Undifferentiated cells: 11.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 3.2;NK-cell: 8.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 8.9"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;CAPAN-2: 2.9;Daudi: 1.0;Karpas-707: 2.8;RPMI-8226: 1.6;U-937: 2.9"									"HPA046876, HPA047218"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.47e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.17e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.84e-2)"	0.1	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	2.1	8.3	0.2	0.0	1.6	0.0	0.0	15.8	0.0	4.7	1.0	0.0	0.0	0.0	0.8	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.9	0.0	1.6	1.0	0.0	0.2	5.1	0.1	0.0	1.5	15.4	0.0	0.0	0.4	0.0	3.0	7.5	0.0	2.1	0.0	0.4	3.2	1.2	8.9	0.6	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.9	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.5	0.5	0.6	1.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.2	3.2	8.9	1.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	7.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.3	54.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	11.0	0.1
LGALSL	"GRP, HSPC159"	ENSG00000119862	"Galectin like"	Q3ZCW2	2	64453969-64461381	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 50.8;tongue: 90.3"	"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 124.1;Suprabasal keratinocytes: 119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 3.7;MAIT T-cell: 1.9;neutrophil: 4.1"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.1;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.0;HAP1: 36.4"					"Low region specificity"	"Detected in all"			HPA046079	Approved		Approved	Nucleoplasm		NA	NA		9700000	Nucleoplasm		"HPA046079: AB_10967075"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.77e-2)"	6.5	9.2	4.8	3.4	6.2	3.5	12.0	11.0	7.2	6.9	11.5	2.7	2.4	5.0	4.2	6.4	12.7	3.5	4.9	8.1	4.6	5.0	5.6	4.8	18.0	2.9	3.8	3.9	5.7	5.5	10.0	6.3	5.3	4.3	8.2	6.1	14.7	6.4	3.9	30.7	50.8	13.4	5.2	2.8	4.0	4.4	4.0	1.2	0.8	3.1	90.3	13.6	5.1	6.2	0.3	0.1	4.1	0.3	0.0	1.9	3.8	5.8	3.7	10.6	25.0	0.3	0.1	3.1	1.6	4.0	3.1	3.0	17.4	1.2	0.0	2.4	0.8	6.1	7.0	36.4	6.7	2.5	6.6	9.5	0.1	1.9	8.5	3.2	1.6	2.4	1.6	4.3	1.3	4.8	2.8	1.9	3.9	0.0	1.7	0.0	4.5	2.4	0.3	8.3	3.4	4.4	2.7	6.5	1.9	3.7	4.2	1.7	7.0	5.2	3.5	3.0	6.6	2.5	0.2	0.8	2.0	6.4	1.3	3.1	7.4	3.5	4.9	0.0	1.0	2.7	0.0	0.3	3.7	0.0	0.0	1.9	0.3	0.4	0.4	0.1	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	3.8	4.8	6.2	11.0	7.2	4.6	5.0	3.8	3.9	4.3	1.2	20.8	55.7	0.8	19.8	60.0	27.5	11.8	5.1	0.0	3.4	10.4	31.4	1.2	13.3	5.6	9.7	11.7	35.4	0.0	11.7	2.3	9.3	20.9	1.1	9.5	0.9	12.7	8.7	12.9	4.8	1.5	7.5	2.8	10.1	1.8	29.0	68.8	14.0	20.1	4.2	10.2	124.1	19.4	32.3	4.7	1.3	119.7	1.3	0.0	16.6	28.5
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146825-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 20.3;Melanocytes: 38.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;GAMG: 2.1;SCLC-21H: 4.6;SK-MEL-30: 4.6;U-2 OS: 2.6;WM-115: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"	NA	NA			Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	1.2	4.8	13.1	1.1	26.4	1.1	1.2	7.7	52.2	2.6	1.2	35.5	0.0	1.4	1.5	1.3	6.1	2.0	1.1	1.5	20.7	15.7	1.1	1.0	17.7	1.0	24.2	10.4	1.1	1.5	0.9	0.7	1.0	24.9	2.3	1.1	4.6	1.2	4.2	1.0	16.3	1.4	1.7	29.8	1.1	1.3	1.4	14.8	0.0	14.9	0.0	1.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.0	2.1	1.1	0.8	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.4	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.3	0.0	4.6	0.6	0.0	0.0	4.6	0.0	0.5	0.0	0.0	0.0	2.6	0.4	0.0	0.0	0.0	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	26.4	7.7	32.1	20.7	15.7	24.2	10.4	24.9	14.8	0.0	20.3	0.0	0.0	2.1	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	38.8	0.0	0.0	1.0	0.1	0.0	6.7	0.0	2.3	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0
LGI4		ENSG00000153902	"Leucine rich repeat LGI family member 4"	Q8N135	19	35124513-35142451	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.3;skeletal muscle: 59.4"	"Group enriched"	"Detected in many"	7	"Muller glia cells: 88.9;Sertoli cells: 77.6;Smooth muscle cells: 120.2"	"Group enriched"	"Detected in many"	6	"glioma: 4.5;melanoma: 11.5;renal cancer: 13.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 1.2"	"Cell line enriched"	"Detected in single"	30	"WM-115: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042116, HPA043556"	Approved		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA			"Golgi apparatus"		"HPA042116: AB_2677855, HPA043556: AB_2678550"	"unprognostic (3.79e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.71e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.73e-2)"	"unprognostic (7.13e-2)"	35.6	10.7	31.7	7.9	18.5	2.0	9.9	16.3	36.5	22.3	26.9	17.1	6.3	7.4	13.2	8.9	9.0	12.2	9.4	12.2	23.3	7.9	3.4	4.7	5.3	4.5	15.4	31.5	5.8	4.5	4.4	1.0	7.6	26.0	10.4	8.1	8.7	8.7	24.7	59.4	5.9	11.7	9.6	50.3	3.5	8.5	3.1	15.1	0.0	5.6	4.8	2.4	9.6	24.4	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	26.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	31.7	18.5	16.3	36.5	23.3	7.9	15.4	31.5	26.0	15.1	0.0	0.0	0.0	0.4	2.3	0.8	10.4	0.0	1.4	1.2	1.8	2.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.2	8.0	0.6	0.0	1.7	0.1	0.0	1.7	12.9	0.0	0.0	13.6	1.1	10.1	0.0	0.1	88.9	0.1	2.5	6.7	0.0	2.8	77.6	120.2	0.6	0.9	2.0	0.0	0.0	0.2	0.7
LGMN	"LGMN1, PRSC1"	ENSG00000100600	Legumain	Q99538	14	92703807-92748702	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 1236.6;Ito cells: 365.8;Syncytiotrophoblasts: 348.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"plasmacytoid DC: 54.2"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 54.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 129.9;U-266/70: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001426	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA001426: AB_1079247"	"unprognostic (1.19e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.18e-3)"	"unprognostic (7.24e-2)"	42.9	16.3	8.6	17.4	10.7	3.5	19.9	5.8	17.9	13.3	22.3	11.7	13.9	24.2	12.1	48.1	17.4	14.1	32.7	38.8	10.3	10.1	87.6	44.6	31.5	42.4	8.3	10.1	20.5	14.6	54.4	9.7	113.6	9.9	22.0	24.5	23.2	22.6	8.4	17.3	11.9	37.1	23.3	11.5	58.3	23.7	14.0	7.9	17.2	36.8	19.2	17.3	31.4	18.2	4.7	54.2	0.7	0.8	1.0	4.3	1.7	4.9	7.1	4.8	8.7	14.9	12.0	16.7	10.6	10.2	11.1	13.1	5.5	8.9	2.7	15.8	17.4	6.9	12.3	0.0	9.2	5.3	0.2	5.5	0.1	3.9	6.3	4.4	0.1	0.4	8.5	4.5	10.7	6.2	3.3	13.1	5.1	1.0	23.0	0.8	6.6	1.3	0.2	2.3	31.1	4.9	1.2	4.2	129.9	12.0	19.3	5.2	3.5	14.8	9.1	7.7	11.0	6.7	0.0	7.1	5.5	7.0	9.9	3.2	71.5	8.4	3.7	3.1	0.1	10.5	0.7	0.4	0.1	0.2	0.8	0.4	4.7	1.4	0.4	5.0	3.4	4.3	2.5	0.5	1.0	0.2	54.2	2.6	1.7	8.6	10.7	5.8	17.9	10.3	10.1	8.3	10.1	9.9	7.9	53.6	113.7	33.9	33.3	20.5	9.9	25.0	45.9	18.7	34.2	29.6	88.4	130.6	8.3	49.8	0.8	31.3	68.2	0.0	45.2	121.5	45.8	47.6	8.1	36.1	1236.6	12.7	35.1	365.8	242.3	2.3	28.1	82.0	45.5	62.3	31.1	25.8	41.2	52.6	54.5	101.8	15.3	19.4	64.6	22.3	17.7	15.3	348.2	8.5	40.4	39.9
LGR4	GPR48	ENSG00000205213	"Leucine rich repeat containing G protein-coupled receptor 4"	Q9BXB1	11	27365961-27472775	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 134.9;Syncytiotrophoblasts: 107.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.4;intermediate monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 29.2;RPTEC TERT1: 35.8;U-2197: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030267, HPA054350"	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA030267: AB_10610004, HPA054350: "	"unprognostic (5.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.00e-7)"	"unprognostic (5.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.76e-1)"	7.6	10.4	9.4	4.0	11.2	0.9	8.2	15.6	7.6	6.0	18.7	7.8	8.5	11.4	6.5	7.3	9.5	5.7	9.5	14.7	7.1	3.7	30.6	30.5	2.3	0.5	9.1	6.9	12.5	37.0	5.0	5.6	24.9	12.1	8.3	19.3	15.7	8.7	13.3	7.5	11.7	17.5	6.8	8.2	6.5	15.8	7.5	6.8	2.1	7.9	7.2	3.3	7.0	8.4	0.5	0.2	1.4	1.3	0.1	0.5	0.0	9.6	17.6	17.6	2.0	1.6	1.1	19.9	5.5	5.2	4.9	4.2	2.6	0.2	0.0	3.6	7.3	8.3	16.1	29.2	10.8	8.4	0.0	13.0	5.2	10.2	12.3	0.5	0.5	0.0	1.5	6.9	3.3	7.5	20.4	2.4	0.0	1.5	0.0	2.0	3.0	0.0	0.9	16.9	26.1	7.2	0.0	12.0	1.1	35.8	4.2	0.2	2.1	2.7	16.2	1.6	14.0	5.3	8.0	7.8	3.6	3.0	29.3	5.0	6.7	5.1	0.0	6.2	0.0	2.2	1.4	0.3	0.0	0.2	1.3	0.2	0.3	0.0	0.5	0.2	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	9.4	11.2	15.6	7.6	7.1	3.7	9.1	6.9	12.1	6.8	3.0	0.3	0.9	10.7	27.0	12.4	22.9	12.7	5.3	4.5	41.8	23.6	44.8	3.3	18.8	3.8	2.9	55.1	0.0	43.6	26.7	12.5	10.0	0.0	58.0	7.1	23.8	16.1	2.5	5.0	1.3	4.6	1.6	6.8	2.8	51.6	134.9	32.9	51.6	15.9	18.9	13.2	6.5	6.6	0.5	1.8	19.2	107.6	2.5	47.3	17.2
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439770-71586310	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6"	"Cell type enhanced"	"Detected in some"	23	"Cytotrophoblasts: 46.3;Syncytiotrophoblasts: 22.1;Undifferentiated cells: 11.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 16.2;SH-SY5Y: 47.7"	"Region enriched"	"Detected in some"	8	"olfactory region: 41.8"	"Low region specificity"	"Detected in many"			HPA012530	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	2.3	2.2	3.5	0.8	18.1	0.4	2.1	0.9	9.5	2.2	4.2	24.5	0.0	6.1	4.9	1.7	0.6	19.9	0.8	0.8	5.0	3.4	0.9	1.4	1.4	0.4	32.3	5.1	1.5	0.6	1.0	2.0	21.6	10.8	1.8	4.6	0.9	3.1	9.0	26.6	4.0	6.5	0.7	15.0	0.6	2.9	0.7	25.7	0.0	0.9	0.9	2.1	0.7	1.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.4	16.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	5.3	0.7	1.0	0.0	0.0	0.0	6.5	0.1	47.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	18.1	0.9	9.5	5.0	3.4	32.3	5.1	10.8	25.7	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	46.3	0.0	0.0	0.3	0.1	0.4	0.0	0.0	1.7	1.7	0.0	0.0	0.4	5.5	0.0	4.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	22.1	0.0	11.5	0.0
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193901-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.6"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	41	"T-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0"	"Region enriched"	"Detected in some"	9	"olfactory region: 30.0"					HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.1	0.9	0.8	3.2	1.8	7.9	6.0	2.4	2.6	2.2	1.5	0.5	0.2	1.6	7.3	4.4	13.8	49.6	12.3	0.7	3.3	0.9	1.4	6.9	1.1	6.8	0.2	2.2	0.5	0.1	15.9	0.9	9.3	6.7	1.1	0.8	8.5	2.5	0.3	3.2	1.6	2.6	1.6	5.3	0.7	4.9	3.9	0.2	4.1	2.6	3.4	3.2	2.9	0.0	0.0	0.0	0.0	0.3	14.3	2.5	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	1.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.9	0.0	1.7	8.3	0.0	0.0	0.7	4.7	0.0	0.3	0.0	0.0	0.4	2.5	0.9	3.2	6.0	2.4	0.7	3.3	6.8	0.2	9.3	3.9	0.0	0.0	0.0	2.8	1.1	0.0	8.3	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	3.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.0	3.3	0.1	0.7	0.5	1.7	0.3
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319977	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.2;liver: 9.3"	"Cell type enhanced"	"Detected in some"	9	"Ciliated cells: 4.0;Club cells: 3.4;Late spermatids: 2.2;Proximal tubular cells: 2.4"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 10.6;BEWO: 5.7;CACO-2: 3.4;HeLa: 3.9;Karpas-707: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	5.2	9.3	0.7	0.2	0.4	0.2	0.2	0.5	0.0	0.2	2.3	2.9	0.5	0.1	0.2	0.2	0.2	0.3	0.1	0.4	0.2	1.6	0.3	0.8	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	1.0	3.4	0.7	0.3	0.5	0.1	0.1	10.6	0.1	0.1	0.0	0.0	5.7	0.1	0.1	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.3	0.1	0.6	0.4	0.0	0.0	0.0	0.1	3.9	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.6	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.1	1.9	0.1	0.4	0.1	0.1	0.4	0.1	0.0	0.2	0.3	0.2	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	1.6	0.7	0.3	0.5	0.3	0.2	0.7	0.5	0.3	0.1	0.7	0.4	0.5	3.4	0.3	0.3	1.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.1	0.4	0.2	2.9	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	4.0	3.4	0.0	0.0	1.7	1.7	0.0	0.8	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.3	2.2	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.5	0.0
LHB	"CGB4, hLHB, LSH-B"	ENSG00000104826	"Luteinizing hormone beta polypeptide"	P01229	19	49015980-49017081	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pituitary gland: 301.4"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 2.3;Late spermatids: 3.3;Pancreatic endocrine cells: 4.8;Syncytiotrophoblasts: 8.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.8;T-reg: 1.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A549: 6.6;U-266/84: 7.1"									"CAB022241, CAB022707, HPA038925"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"CAB022241: , CAB022707: , HPA038925: AB_2676272"	"unprognostic (8.12e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.69e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (9.52e-2)"	"unprognostic (4.86e-2)"	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	23.1	0.0	301.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.5	0.1	0.1	0.1	0.5	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.1	1.3	6.6	0.3	1.3	0.0	0.0	1.8	0.5	0.0	1.0	0.5	5.4	1.9	1.8	0.1	0.0	0.3	0.5	0.0	0.4	0.0	1.7	5.2	0.3	1.7	2.5	0.3	0.4	1.8	0.0	0.0	0.3	0.0	0.0	0.3	1.1	4.8	2.9	0.3	0.4	0.1	0.6	0.7	0.3	0.5	2.8	1.2	1.3	0.0	1.4	3.0	1.2	2.0	0.4	2.2	0.0	2.0	0.0	0.0	2.7	2.8	0.3	3.3	2.5	7.1	1.8	1.4	3.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.3	0.0	0.0	0.0	0.7	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.5	0.0	8.6	0.0	0.0	0.1
LHFPL2	KIAA0206	ENSG00000145685	"LHFPL tetraspan subfamily member 2"	Q6ZUX7	5	78485215-78770021	"Predicted membrane proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0;plasmacytoid DC: 7.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.9;granulocytes: 8.0;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"GAMG: 41.5;hTERT-HME1: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042402, HPA076743"	Uncertain		Approved	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA		110000	"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA042402: AB_10794276, HPA076743: "	"unprognostic (2.19e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (3.40e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.85e-2)"	17.1	18.2	10.3	16.1	11.7	11.5	34.7	3.5	9.1	15.8	15.4	12.0	14.1	17.6	14.6	15.0	7.6	10.7	17.6	14.1	11.7	7.6	3.8	4.7	17.2	10.3	15.2	7.2	18.7	18.0	9.2	7.3	11.3	12.9	13.3	13.5	18.2	21.4	20.5	4.6	6.7	27.1	16.6	18.0	4.7	10.8	10.9	13.1	5.7	10.3	4.9	10.4	15.4	18.2	0.9	7.9	8.0	4.7	0.0	0.1	1.5	3.2	12.3	3.7	4.9	22.8	6.6	11.6	3.8	9.7	6.6	11.6	4.3	9.9	8.3	1.7	7.4	41.5	5.8	3.5	4.1	11.0	0.0	3.2	8.2	2.5	7.3	16.9	0.0	0.0	7.5	16.5	20.3	31.7	10.5	15.6	0.3	0.0	6.2	15.0	1.7	0.0	0.4	4.1	2.7	3.6	1.6	5.3	2.3	2.5	14.7	0.7	5.1	6.2	2.3	21.1	8.2	1.3	1.0	10.2	7.7	4.2	21.2	11.3	0.2	0.0	11.9	20.6	0.0	13.8	8.0	4.7	4.8	0.0	1.8	0.1	0.9	0.0	0.0	1.1	0.9	0.0	0.0	1.0	0.0	0.6	7.9	0.1	1.5	10.3	11.7	3.5	9.1	11.7	7.6	15.2	7.2	12.9	13.1	3.0	4.3	4.2	6.0	7.7	6.1	3.4	2.5	2.7	7.9	7.0	0.0	3.2	0.0	6.9	1.1	22.2	23.7	23.3	11.2	2.0	20.9	10.4	0.0	0.5	56.6	3.2	2.4	33.7	28.3	0.5	17.8	20.5	10.1	1.0	10.7	5.0	15.0	8.6	31.5	0.3	2.1	6.5	8.2	0.5	0.9	4.3	6.1	0.0	8.6	11.1
LHFPL3	LHFPL4	ENSG00000187416	"LHFPL tetraspan subfamily member 3"	Q86UP9	7	104328656-104907232	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"brain: 36.5"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 7.0"	"Cancer enriched"	"Detected in some"	12	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;K-562: 2.2;SCLC-21H: 4.1;SH-SY5Y: 5.5;SK-BR-3: 4.6;SK-MEL-30: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069691			Approved	Vesicles		No	NA			Vesicles		"HPA069691: AB_2686171"		"unprognostic (1.20e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.59e-3)"	"unprognostic (5.03e-2)"			"unprognostic (2.27e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.96e-2)"	"unprognostic (5.81e-2)"	"unprognostic (5.99e-3)"	"unprognostic (8.50e-3)"	"unprognostic (3.07e-1)"		"unprognostic (1.33e-1)"	0.5	0.6	6.4	0.6	7.7	0.5	0.5	2.3	36.5	4.3	0.8	6.1	0.0	2.0	0.7	0.5	0.5	0.9	0.5	0.5	4.9	5.6	1.4	0.5	2.2	0.5	4.8	4.2	0.7	1.5	0.5	0.1	0.5	5.6	0.7	0.6	3.8	0.5	0.5	0.5	0.7	1.4	0.5	6.0	0.9	0.8	0.7	6.7	0.0	0.5	0.0	0.6	0.5	0.2	0.5	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.2	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.1	5.5	0.0	4.6	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	7.7	2.3	7.1	4.9	5.6	4.8	4.2	5.6	6.7	0.0	0.3	0.0	0.0	0.0	0.7	0.2	0.0	1.4	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
LHFPL4		ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553802	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 29.1;pituitary gland: 9.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 39.8;Cone photoreceptor cells: 17.7;Horizontal cells: 14.3;Rod photoreceptor cells: 16.4"	"Group enriched"	"Detected in some"	13	"glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.3;SCLC-21H: 10.1;SH-SY5Y: 12.5;U-266/84: 10.5;WM-115: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.9	4.9	8.0	1.0	11.4	0.9	0.9	16.0	29.1	0.9	1.4	1.5	0.0	1.2	0.9	0.8	0.9	0.9	0.9	0.8	8.4	8.5	0.9	0.8	1.0	0.8	4.2	8.6	0.8	1.8	1.2	9.0	0.8	9.2	0.9	1.4	1.7	0.9	0.9	0.8	0.9	1.3	0.9	4.2	0.8	1.3	1.6	1.8	0.0	0.9	0.0	0.8	0.8	0.1	0.0	1.2	0.6	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	10.1	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.8	0.0	10.5	0.0	0.5	0.0	3.8	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.0	0.0	8.0	11.4	16.0	15.6	8.4	8.5	4.2	8.6	9.2	1.8	0.0	0.0	0.0	2.6	0.0	39.8	0.6	0.0	0.0	0.0	0.0	17.7	0.5	0.0	0.3	0.4	0.0	0.5	0.0	0.2	0.8	0.3	1.5	1.1	0.0	0.2	14.3	1.2	4.9	0.3	0.4	0.0	0.0	0.0	0.0	0.6	1.3	0.3	1.4	0.0	0.1	16.4	0.0	0.1	1.7	1.0	0.0	1.1	0.0	1.0	2.5
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39342892-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"Extravillous trophoblasts: 146.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 9.4;plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 9.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 66.1;HSkMC: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA058975: AB_2683866"	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (2.30e-4)"	57.2	26.8	12.5	14.8	17.7	0.9	45.7	40.8	19.0	20.3	16.4	12.3	8.5	5.3	28.6	23.7	17.9	27.0	34.9	49.4	12.7	12.9	12.8	6.9	27.0	27.4	19.3	12.6	25.7	8.3	7.1	14.3	62.0	16.8	21.4	8.4	19.8	11.4	18.8	13.6	13.1	9.6	33.1	18.5	18.5	10.2	16.2	11.9	1.3	22.7	22.1	8.3	20.1	25.8	0.2	9.4	0.1	0.6	0.0	0.0	0.4	2.7	1.0	30.0	1.3	66.1	30.0	13.1	15.3	22.1	7.8	5.9	0.1	2.9	4.2	0.3	21.3	10.2	4.3	3.7	8.9	6.5	4.1	4.4	11.5	0.9	0.0	6.9	0.2	0.3	48.3	1.2	7.0	11.7	7.0	7.2	0.2	0.0	0.0	15.0	2.4	0.0	3.5	2.2	0.0	4.0	1.8	13.0	0.0	5.2	3.7	0.1	0.9	1.4	1.8	4.1	17.9	1.7	0.0	13.5	19.9	2.9	6.1	8.3	0.2	0.0	12.0	8.3	0.0	14.3	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.1	0.0	0.1	3.2	0.0	0.4	12.5	17.7	40.8	19.0	12.7	12.9	19.3	12.6	16.8	11.9	3.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	18.2	0.0	0.0	3.1	1.7	0.6	0.0	0.0	0.0	0.0	0.6	146.6	0.0	0.0	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.0;kidney: 5.7;seminal vesicle: 7.1"	"Cell type enriched"	"Detected in some"	9	"Horizontal cells: 341.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 8.1"					"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.3;HMC-1: 2.7;WM-115: 11.7"	"Region enhanced"	"Detected in many"		"cerebellum: 21.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 20.4"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	15.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1		5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.2	0.0	6.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.1	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	1.9	0.0	1.5	0.0	0.0	0.0	0.1	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1											0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	341.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.2	1.7	0.0	0.0	0.9	1.2	0.0	0.3	0.0	0.0	0.0
LHX2	"hLhx2, LH-2"	ENSG00000106689	"LIM homeobox 2"	P50458	9	124001670-124033301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 44.7;retina: 17.0"	"Cell type enriched"	"Detected in some"	9	"Muller glia cells: 245.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5"	"Group enriched"	"Detected in many"	6	"amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.7;GAMG: 12.3;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.5;U-138 MG: 10.2"	"Group enriched"	"Detected in many"	5	"amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7"	"Group enriched"	"Detected in many"	6	"amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5"	HPA000838		Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000838: AB_2666109"	"unprognostic (3.60e-3)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.52e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.66e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.77e-1)"	0.9	1.0	30.7	1.1	20.5	0.9	1.1	0.0	44.7	0.8	0.9	4.7	0.0	1.0	0.8	0.8	0.8	0.8	1.0	0.8	23.6	2.4	0.8	6.1	0.9	1.1	1.5	16.1	1.1	0.8	0.8	4.6	5.1	0.0	0.8	1.1	17.0	1.1	0.8	0.8	2.2	0.9	0.8	0.2	0.9	0.9	4.0	4.2	0.0	0.8	0.0	1.1	0.9	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	4.9	0.1	15.7	0.0	0.2	1.6	0.4	0.2	1.2	0.1	4.9	0.0	0.1	2.1	0.9	12.3	0.1	15.7	0.0	0.6	0.0	3.4	0.0	10.9	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	7.8	0.0	0.1	19.5	0.0	4.6	4.2	0.0	0.0	0.0	0.0	6.4	0.0	4.0	0.0	0.0	0.1	5.6	2.0	0.0	10.2	0.4	2.9	0.7	0.2	3.2	0.0	0.6	2.2	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	30.7	20.5	0.0	26.6	23.6	2.4	1.5	16.1	0.0	4.2	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	3.0	7.9	0.0	6.7	0.0	16.0	0.0	0.0	0.0	0.0	0.0	245.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	1.0	0.6	0.0	0.1	0.0	0.0	0.0
LHX4	Gsh4	ENSG00000121454	"LIM homeobox 4"	Q969G2	1	180230286-180278982	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"retina: 21.0"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 48.5;Cone photoreceptor cells: 49.1;Early spermatids: 42.7;Late spermatids: 55.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 6.1;BEWO: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055705			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055705: AB_2682892"	"unprognostic (2.83e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.86e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.76e-5)"	"unprognostic (9.39e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-3)"	"unprognostic (4.07e-8)"	"unprognostic (3.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.44e-3)"	"unprognostic (7.83e-3)"	0.8	1.4	0.8	2.3	0.8	1.5	0.9	4.3	1.4	0.9	1.2	0.8	0.8	2.5	1.3	0.8	1.2	1.3	1.2	0.8	0.8	0.4	4.6	0.8	1.0	2.2	0.8	0.8	2.2	2.5	0.0	2.4	2.8	2.1	1.2	1.1	21.0	1.4	0.8	1.3	3.4	2.4	0.8	1.4	2.2	1.4	3.6	0.8	0.8	1.9	0.8	0.8	1.3	1.5	0.6	0.1	0.6	0.7	0.2	0.7	0.0	1.4	6.1	1.6	3.3	0.0	0.0	14.7	1.6	0.4	0.4	0.1	1.2	2.7	1.5	0.4	0.0	0.6	2.6	2.9	0.0	0.7	0.8	2.4	1.0	5.8	0.6	0.0	1.7	1.8	0.0	0.0	0.0	0.0	0.6	0.0	1.6	1.7	0.6	0.0	3.1	0.9	3.0	1.3	0.5	0.3	1.0	3.9	0.6	0.0	1.2	1.5	1.3	1.7	1.3	0.5	1.4	3.4	0.3	1.9	1.4	2.6	1.5	1.0	1.1	0.4	1.4	0.5	1.3	1.5	0.0	0.7	0.0	0.6	0.2	0.4	0.6	0.3	0.4	0.0	0.5	0.6	0.3	0.6	0.2	0.5	0.1	0.7	0.0	0.8	0.8	4.3	0.8	0.8	0.4	0.8	0.8	2.1	0.8	0.0	0.0	0.0	0.0	0.1	48.5	0.3	0.0	0.0	0.0	0.0	49.1	0.1	0.0	0.0	42.7	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	55.3	0.6	0.0	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.8	5.3	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.2	0.0
LHX5		ENSG00000089116	"LIM homeobox 5"	Q9H2C1	12	113462034-113472280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.0;stomach 1: 2.1;testis: 2.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"cerebellum: 4.8;hypothalamus: 6.7;pons and medulla: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;HMC-1: 4.6;K-562: 1.2;SiHa: 3.3;U-2 OS: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053908			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA053908: AB_2682304"		"unprognostic (5.20e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-2)"		"unprognostic (1.06e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.56e-1)"			"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.54e-3)"	0.0	0.1	0.0	0.0	0.3	0.0	0.0	4.8	4.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	2.1	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.8	0.0	0.0	6.7	1.2	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9"	"Cell type enhanced"	"Detected in single"	26	"Spermatogonia: 2.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 9.5;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 23.8;U-266/70: 8.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 9.9"	"Group enriched"	"Detected in some"	32	"basal ganglia: 15.3;hypothalamus: 4.4"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	2.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.0	3.9	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.3	0.0	0.5	4.9	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.2	0.0	0.0	8.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.5	0.0	1.1	0.0	0.6	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0
LHX9		ENSG00000143355	"LIM homeobox 9"	Q9NQ69	1	197911902-197935478	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ovary: 22.1;retina: 24.3;testis: 17.5"	"Group enriched"	"Detected in some"	10	"Leydig cells: 145.9;Peritubular cells: 47.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"fHDF/TERT166: 78.9"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 6.9;midbrain: 20.7;thalamus: 13.3"	"Group enriched"	"Detected in many"	5	"midbrain: 38.1;pons and medulla: 11.9;thalamus: 24.4"	HPA009695	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009695: AB_1079251"	"unprognostic (8.05e-2)"	"unprognostic (1.18e-1)"		"unprognostic (1.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.42e-1)"		"unprognostic (1.88e-1)"	0.3	0.2	1.7	0.1	1.0	0.1	0.1	0.1	0.5	1.1	0.3	0.7	0.4	0.2	0.8	4.1	0.1	0.4	0.2	1.5	0.7	2.6	0.1	1.2	2.7	0.1	0.8	0.0	22.1	0.1	0.1	1.4	0.1	3.1	0.1	0.2	24.3	0.1	0.2	0.9	0.1	0.2	0.1	0.5	0.1	0.1	17.5	0.5	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	2.2	0.1	0.0	0.0	0.0	0.0	78.9	0.0	0.0	1.9	0.0	0.6	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.4	2.3	0.9	0.0	0.0	0.0	0.0	1.9	0.0	0.7	0.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.1	0.5	0.7	2.6	0.8	0.0	3.1	0.5	3.0	9.6	0.0	0.0	0.0	0.0	1.4	0.0	1.4	1.2	0.0	0.0	0.0	1.7	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.8	145.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	47.4	0.0	0.3	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.0	0.0
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39458587-39485109	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 82.3;Late spermatids: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	9.8	12.9	9.9	7.0	12.7	10.2	11.3	10.2	13.3	7.0	10.7	12.9	8.1	10.4	9.1	10.7	11.6	11.9	7.4	14.0	10.6	10.6	15.7	15.5	5.7	9.0	12.3	10.5	19.2	12.4	10.0	11.5	6.8	15.7	8.2	12.4	9.0	7.8	7.0	42.7	8.8	9.9	13.6	12.4	8.9	9.9	20.1	13.2	8.7	8.8	13.5	8.3	10.0	7.9	9.6	5.8	3.7	7.1	6.9	16.7	4.3	4.0	3.1	4.0	3.8	8.4	8.2	3.4	4.6	2.6	4.3	2.9	5.0	5.5	14.6	5.3	1.7	10.9	3.6	11.3	6.3	5.8	1.6	2.8	6.1	1.6	5.0	7.7	13.2	4.0	7.9	10.5	5.1	16.2	9.6	4.9	9.1	14.4	3.6	5.2	2.5	7.4	17.0	5.3	10.6	10.1	6.5	10.8	8.8	5.1	2.1	4.4	3.8	2.7	3.6	14.9	5.8	4.0	6.1	1.8	3.5	7.7	4.5	10.7	7.1	10.8	10.2	5.4	15.4	3.0	2.0	6.2	3.7	6.1	7.1	12.6	9.6	8.3	8.0	5.8	8.5	16.7	11.5	3.3	6.9	5.1	5.4	5.2	4.3	9.9	12.7	10.2	13.3	10.6	10.6	12.3	10.5	15.7	13.2	8.9	9.3	13.4	11.9	8.7	24.0	16.5	10.2	20.1	13.6	17.4	9.8	21.5	18.3	10.7	82.3	7.1	13.1	0.0	5.5	12.9	8.0	5.2	17.3	17.0	15.4	9.5	17.4	5.5	11.7	80.7	9.5	10.9	1.7	17.2	12.1	15.2	9.0	10.5	11.7	23.2	23.3	0.0	9.5	47.0	20.9	8.2	8.0	12.9	18.1	8.4
LIG1		ENSG00000105486	"DNA ligase 1"	P18858	19	48115445-48170603	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037015, HPA041431, HPA048071"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248"	"unprognostic (1.83e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.45e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.47e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.10e-3)"	"prognostic unfavorable (5.75e-5)"	"unprognostic (3.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	4.1	5.6	8.1	25.2	10.4	37.8	6.4	17.2	10.6	6.5	9.2	6.5	8.7	12.0	6.8	6.1	11.0	7.8	6.9	2.6	6.3	5.3	6.0	6.2	5.9	18.6	7.7	7.4	10.8	10.3	9.1	9.7	11.7	8.1	7.5	6.0	4.6	7.2	7.9	6.1	12.5	12.8	3.6	7.1	11.2	6.7	15.1	11.5	34.7	10.7	12.1	16.9	6.6	8.6	10.4	1.3	2.0	5.6	10.9	11.5	4.8	15.8	20.4	21.9	14.1	0.9	1.1	15.8	9.2	6.8	14.8	16.4	11.5	15.6	28.7	5.7	3.9	4.1	10.7	9.0	9.0	6.4	15.4	15.5	17.7	14.4	14.9	0.3	22.0	14.7	2.0	0.7	7.9	1.2	1.9	7.9	17.5	15.0	10.8	7.5	12.7	35.1	32.7	12.4	17.1	4.7	30.3	17.1	14.1	4.6	24.2	13.8	13.8	11.1	13.0	3.1	5.2	8.4	16.9	7.8	11.8	20.0	9.9	14.3	10.7	16.8	29.2	4.8	12.4	13.1	0.0	1.4	2.0	7.6	5.6	6.8	10.3	8.4	7.6	1.3	10.4	11.5	8.0	1.1	10.9	2.7	1.2	8.9	4.8	8.1	10.4	17.2	10.6	6.3	5.3	7.7	7.4	8.1	11.5	3.0	9.9	14.6	6.7	7.3	17.6	3.9	2.5	25.4	12.5	3.5	9.8	16.2	6.6	5.1	17.7	5.5	4.5	0.0	4.5	29.3	5.0	2.8	5.8	3.9	13.9	7.9	0.0	4.3	5.2	6.4	2.0	5.8	3.3	10.8	6.8	11.9	3.5	5.8	1.8	3.7	11.6	12.9	4.9	9.8	28.5	8.0	8.4	11.4	8.1	5.5
LIMCH1	"DKFZP686A01247, LIMCH1A, LMO7B"	ENSG00000064042	"LIM and calponin homology domains 1"	Q9UPQ0	4	41359607-41700044	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 87.1"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 604.5;Cardiomyocytes: 206.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 4.4"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 27.6;HeLa: 47.6;hTERT-RPE1: 38.2;RT4: 45.4;SiHa: 25.8;WM-115: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004184, HPA063840"	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA004184: AB_1078673, HPA063840: AB_2685133"	"prognostic unfavorable (5.55e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.82e-7)"	"unprognostic (2.84e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.24e-3)"	19.4	18.7	24.9	3.1	27.6	0.9	11.7	13.8	24.6	6.7	4.3	30.2	8.4	3.0	4.0	6.5	8.8	9.3	11.2	45.0	29.1	21.3	15.0	6.4	58.2	1.9	34.4	18.2	19.1	5.8	59.6	8.6	15.8	23.3	28.7	4.5	13.6	32.5	13.6	87.1	6.6	4.2	7.2	43.3	49.1	5.4	5.1	25.2	0.2	20.6	23.5	2.4	12.4	9.4	0.0	4.4	0.0	0.4	0.0	0.0	0.1	0.6	6.7	10.4	0.6	0.0	0.0	1.0	8.5	4.3	8.6	4.3	1.0	2.6	0.0	27.6	22.6	0.2	4.7	5.8	3.9	9.7	0.0	0.8	0.0	47.6	0.0	8.8	0.0	0.0	0.1	11.5	0.0	2.7	38.2	0.8	0.0	0.0	0.0	2.4	3.7	0.0	0.0	0.7	1.4	0.7	0.0	12.7	0.1	7.2	45.4	9.8	19.9	25.8	10.3	0.1	8.7	0.7	0.0	0.0	0.1	10.2	2.3	6.5	0.0	0.0	0.0	0.6	0.0	36.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.9	27.6	13.8	21.6	29.1	21.3	34.4	18.2	23.3	25.2	604.5	166.2	0.0	43.2	34.7	24.7	206.0	17.8	105.7	147.9	90.7	35.3	12.1	18.3	32.7	54.1	58.8	4.2	0.0	12.0	30.0	23.8	134.4	4.7	9.3	10.2	0.0	9.2	108.6	17.8	20.9	1.7	5.5	13.5	33.3	5.1	100.0	7.4	8.6	7.1	9.3	73.0	0.0	6.2	5.1	12.0	26.7	38.6	5.4	5.1	49.4
LIMS3		ENSG00000256977	"LIM zinc finger domain containing 3"	P0CW19	2	109898428-109924868	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 11.9;endometrium 1: 9.7"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 1.7;Club cells: 1.2;Distal tubular cells: 1.7;Exocrine glandular cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 9.8;HMC-1: 29.8"									HPA058455	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723"										"unprognostic (2.23e-2)"								1.2	2.8	0.5	2.2	0.5	0.0	1.0	0.8	0.5	1.0	0.7	0.3	4.2	0.2	9.7	2.8	1.2	7.1	0.9	2.6	0.5	0.5	2.6	0.6	0.8	2.8	0.6	0.3	2.2	0.7	0.3	2.4	5.6	0.3	1.0	0.8	0.6	2.2	0.6	3.0	0.8	0.5	1.2	0.6	0.6	0.7	3.7	0.3	0.3	1.0	0.3	0.3	2.6	0.7	0.7	2.5	11.9	5.5	1.1	6.2	8.0	0.0	0.1	1.3	1.5	0.5	0.4	0.0	1.5	0.0	0.2	0.7	1.5	0.0	0.0	4.7	0.3	3.1	0.8	0.0	1.8	1.3	2.4	0.0	9.8	0.5	0.9	1.4	1.7	29.8	2.2	1.1	1.1	1.3	0.0	2.4	0.0	2.0	1.6	3.3	0.1	0.0	0.2	1.6	0.9	0.6	1.8	3.1	1.0	0.8	1.5	0.4	3.6	4.0	0.0	0.8	0.0	0.0	0.5	7.3	6.4	5.9	3.3	0.3	0.0	0.0	1.9	0.8	0.0	1.9	4.7	3.3	11.9	0.9	5.5	1.5	0.7	5.0	1.7	2.5	0.2	0.9	0.3	0.7	1.1	5.2	0.2	6.2	8.0	0.5	0.5	0.8	0.5	0.5	0.5	0.6	0.3	0.3	0.3	0.0	0.3	0.0	0.1	0.1	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410778-26429722	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 9.8"	"Group enriched"	"Detected in some"	42	"Early spermatids: 24.2;Late spermatids: 49.8"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"NTERA-2: 136.8;SuSa: 50.5"	"Not detected"	"Not detected"							"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"		NA	NA			Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.5	0.1	0.1	0.1	0.2	0.3	9.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.6	2.3	0.5	1.0	0.8	0.1	0.0	0.0	13.5	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.7	0.7	0.3	0.4	1.0	0.5	0.6	0.2	1.3	0.8	0.7	2.2	1.0	0.3	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.4	0.1	0.0	0.0	0.0	0.1
LIN52	C14orf46	ENSG00000205659	"Lin-52 DREAM MuvB core complex component"	Q52LA3	14	74084796-74201235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000900, HPA001777"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA000900: AB_2135058, HPA001777: AB_2666431"	"unprognostic (2.34e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.90e-3)"	"prognostic favorable (6.60e-4)"	"prognostic unfavorable (6.08e-5)"	"unprognostic (2.48e-3)"	"unprognostic (9.34e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-1)"	10.8	11.7	12.8	7.3	13.9	4.8	9.1	19.5	17.8	8.8	12.0	12.2	5.6	8.4	10.6	9.6	6.8	7.5	7.0	13.4	11.3	16.8	26.0	9.9	6.9	8.0	13.3	10.3	12.5	10.6	7.5	15.3	7.1	16.5	9.7	8.0	14.2	6.6	8.6	7.7	5.9	14.2	9.0	8.7	7.0	6.9	10.8	7.9	9.3	7.2	5.1	9.3	8.7	6.1	7.4	6.8	16.1	5.3	8.3	13.8	8.2	5.9	4.4	15.1	7.6	9.6	4.2	6.1	9.1	8.3	12.0	13.5	7.7	5.2	3.3	3.2	4.5	5.1	5.1	11.3	3.9	18.5	26.9	4.9	4.4	5.4	11.7	9.6	4.8	6.6	4.4	4.4	7.1	9.0	3.6	5.8	10.6	5.1	16.0	6.5	8.4	7.8	7.7	4.6	8.1	6.5	10.1	13.1	5.9	3.5	3.8	10.9	8.9	8.5	7.1	7.6	5.8	9.8	7.5	3.4	6.5	11.9	6.5	8.0	10.0	21.5	6.8	7.0	6.0	10.6	4.8	5.1	16.1	9.2	5.3	13.8	7.1	8.1	9.0	6.8	7.4	11.9	11.2	3.0	8.3	3.5	6.3	11.5	8.2	12.8	13.9	19.5	17.8	11.3	16.8	13.3	10.3	16.5	7.9	8.9	7.0	4.5	2.8	4.2	5.7	8.1	7.6	8.1	9.1	5.2	7.9	5.0	6.6	2.2	0.7	6.3	4.2	23.3	2.1	4.6	4.9	3.5	2.3	11.3	5.2	15.9	2.9	6.2	3.5	1.3	4.9	3.7	0.0	7.2	5.4	8.2	1.8	3.2	9.2	14.2	7.6	6.5	3.1	13.7	11.8	4.8	7.3	6.9	4.7	1.3
LIN54	"CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1"	ENSG00000189308	"Lin-54 DREAM MuvB core complex component"	Q6MZP7	4	82909973-83012926	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 27.1;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056606	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA056606: AB_2683187"	"unprognostic (2.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.56e-3)"	"unprognostic (6.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (3.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-2)"	6.9	6.2	9.0	6.7	13.7	16.5	7.1	13.3	12.4	8.4	8.4	12.2	2.0	7.6	6.5	6.1	15.4	5.5	5.6	6.0	10.2	8.6	10.9	11.6	6.1	8.5	15.7	7.5	7.6	4.6	9.8	8.5	8.8	10.5	5.9	10.2	6.7	8.1	6.7	10.6	7.7	6.0	6.5	15.2	7.8	6.4	9.5	12.7	27.2	14.9	8.5	11.9	7.5	8.2	3.4	2.2	8.1	8.8	6.9	7.6	3.6	7.1	4.2	6.7	7.6	3.5	3.4	5.0	11.6	8.1	8.8	8.5	5.0	8.3	7.8	6.4	11.9	5.8	5.6	9.1	3.7	10.8	8.4	4.0	7.1	6.7	5.6	3.1	8.7	52.6	2.9	2.2	9.7	4.7	2.7	5.3	7.4	7.7	15.7	8.5	5.0	18.5	3.6	2.8	8.8	2.8	10.1	7.4	5.5	4.2	6.2	7.0	3.7	7.0	11.3	4.6	4.4	4.9	5.7	4.1	10.6	7.9	9.8	5.2	7.8	5.8	13.3	5.9	5.5	8.3	5.3	3.8	7.7	6.1	3.0	6.9	2.7	6.1	6.6	2.2	3.4	7.6	6.4	8.1	6.9	8.8	1.7	6.8	3.6	9.0	13.7	13.3	12.4	10.2	8.6	15.7	7.5	10.5	12.7	6.0	5.6	7.0	3.2	10.8	8.6	5.1	5.1	4.0	3.4	5.2	2.0	2.9	0.0	2.7	27.1	4.3	4.9	23.3	3.1	4.0	4.3	4.1	2.3	6.2	5.5	4.8	4.1	5.5	4.9	11.6	2.3	5.9	8.5	1.0	3.8	6.3	3.1	2.9	4.6	5.4	8.0	12.9	4.4	2.2	2.8	10.9	2.9	5.1	4.6	6.8
LINC02203		ENSG00000280709	"Long intergenic non-protein coding RNA 2203"		15	21552795-21653276	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	15	"testis: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"U-2 OS: 11.9"									HPA057442	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA057442: AB_2683442"																		0.0	0.0		0.0		0.0	0.0		0.7	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	11.7			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LINGO3	"LERN2, LRRN6B"	ENSG00000220008	"Leucine rich repeat and Ig domain containing 3"	P0C6S8	19	2289784-2292024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.9;brain: 15.7;lymphoid tissue: 7.1"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 32.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"					"Cell type enhanced"	"Detected in some"		"eosinophil: 6.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 6.9"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 19.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5"	"HPA043781, HPA059558"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043781: AB_2678668, HPA059558: AB_2684062"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.16e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.03e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	0.1	0.2	2.2	3.1	15.7	2.8	0.0	4.6	2.9	0.0	0.4			0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.2	2.7	1.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.3	0.1	1.2	0.0	0.4	7.1	1.2	0.1			0.0		0.0	0.0	0.0	1.0	0.1	6.9	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	2.1	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	2.6	0.2	0.0	0.1	1.9	0.0	4.8	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	1.9	0.1	6.9	0.4	0.0	0.4	0.5	0.0	0.2	0.1	1.0	0.1	0.0	2.9	0.3	0.1	0.0	0.6	0.0											0.0	0.0	0.0	0.0	0.1	32.9	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.2	3.2	0.0	0.0	2.1	0.0	0.0	0.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0
LINS1	"LINS, WINS1"	ENSG00000140471	"Lines homolog 1"	Q8NG48	15	100559369-100603230	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038578, HPA038579"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038578: AB_2676095, HPA038579: AB_10697393"	"unprognostic (9.87e-2)"	"unprognostic (3.32e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.28e-2)"	10.0	10.2	12.2	13.2	13.4	8.1	13.6	16.9	13.8	13.7	10.2	10.1	13.3	6.8	13.5	16.7	14.9	12.0	7.7	8.6	11.2	6.8	10.4	9.2	10.3	17.6	8.2	11.1	13.1	9.4	12.8	19.8	11.4	9.6	10.9	12.1	10.2	14.1	13.2	11.4	15.7	11.6	10.6	10.7	13.4	10.4	11.8	10.4	16.6	14.7	9.2	15.9	13.3	12.8	7.7	5.1	6.9	5.0	9.0	23.3	6.6	4.1	6.6	8.2	8.1	6.1	8.2	7.1	6.8	7.3	7.5	8.2	6.0	8.2	11.1	4.0	6.1	5.7	18.2	7.6	8.5	8.0	3.8	11.0	10.0	10.0	4.7	4.9	8.4	6.1	7.3	7.4	5.8	9.3	7.5	8.9	6.3	15.9	8.9	4.7	5.5	5.0	7.2	9.3	16.1	8.1	7.5	13.1	10.4	6.5	11.6	4.2	5.5	6.4	6.1	9.9	10.8	10.3	6.5	6.4	9.6	8.7	6.7	8.6	9.7	12.4	10.0	6.1	11.0	7.6	6.9	5.0	6.9	10.9	4.6	15.2	7.7	17.0	11.6	5.1	6.8	23.3	16.6	6.4	9.0	3.8	4.1	10.2	6.6	12.2	13.4	16.9	13.8	11.2	6.8	8.2	11.1	9.6	10.4	17.9	5.1	2.4	8.9	0.0	15.5	0.0	5.1	13.4	4.5	12.2	17.7	6.7	5.0	4.9	5.4	2.9	7.8	0.0	4.5	4.5	3.1	7.3	1.1	7.4	12.3	15.9	4.7	4.9	5.7	1.1	11.2	3.2	0.0	4.6	7.0	10.0	4.0	0.0	6.7	3.6	14.0	12.9	0.0	16.4	11.1	0.0	10.4	10.2	5.3	6.8
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.0"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.3;monocytes: 68.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.6;ASC TERT1: 77.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		150000	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	139.0	16.3	15.8	14.4	22.7	7.8	19.9	8.8	21.4	13.4	28.1	61.3	3.4	37.4	10.2	5.2	9.5	9.0	19.4	8.7	22.5	13.8	10.8	49.3	38.5	45.7	41.6	13.4	10.4	9.5	17.5	6.3	17.8	28.4	7.4	16.7	5.7	11.0	8.8	4.1	6.8	65.8	11.3	55.1	87.3	7.9	3.1	37.2	7.0	8.3	4.7	10.0	15.1	8.6	7.0	23.3	3.2	68.4	5.5	8.3	25.5	55.0	8.5	5.6	61.6	58.1	77.3	1.6	29.2	34.2	12.2	21.9	3.2	29.7	10.2	5.7	45.7	13.1	55.2	2.4	15.8	9.1	14.3	5.7	4.2	3.6	13.1	15.3	8.1	8.4	34.3	11.4	13.0	7.0	14.8	2.4	7.7	0.0	19.0	9.5	4.6	7.0	5.5	3.6	9.8	9.6	4.6	6.6	9.4	11.3	8.7	1.9	3.9	7.1	9.2	21.5	3.9	10.5	10.5	4.4	10.4	2.7	22.2	7.1	9.9	10.5	4.2	12.4	18.0	13.0	0.8	31.8	3.2	8.2	68.4	8.2	6.5	7.3	7.8	23.3	7.0	7.7	8.3	1.4	5.5	35.6	4.7	7.1	25.5	15.8	22.7	8.8	21.4	22.5	13.8	41.6	13.4	28.4	37.2	38.7	42.2	50.6	22.0	15.8	5.2	8.5	45.9	14.7	13.6	31.4	0.0	28.4	18.3	29.7	4.4	53.1	3.9	23.3	31.7	28.0	34.8	15.2	27.7	46.5	503.3	15.9	20.9	52.8	514.1	1.8	10.6	167.0	45.5	27.9	9.4	29.4	17.5	5.9	20.5	14.6	1.3	6.5	21.8	4.8	10.9	10.9	16.7	33.0	8.7	20.1
LIPJ	"bA425M17.2, LIPL1"	ENSG00000204022	"Lipase family member J"	Q5W064	10	88586753-88606976	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 11.5"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 32.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.7;NB-4: 1.0;SK-MEL-30: 2.4;U-2197: 1.0"									HPA048594	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA048594: AB_2680456"	"unprognostic (4.79e-3)"	"unprognostic (6.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.90e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.21e-4)"	"unprognostic (9.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.88e-1)"	0.2	0.0	0.3	0.0	0.3	0.0	0.2	1.0	0.3	0.1	0.0			0.4	0.2	1.6	0.0	1.1	0.1	0.1	0.4	0.5	0.2	0.7	0.0	0.3	0.0		0.1	0.6	0.0	0.1	0.0		0.3	0.2		0.6	0.0	0.4	0.1	0.1	0.3	0.1	0.1	0.3	11.5			0.9		0.4	0.5	0.1	0.7	0.0	1.0	0.1	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.1	0.7	1.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142872	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 35.9"	"Cell type enriched"	"Detected in some"	16	"Muller glia cells: 199.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"naive B-cell: 5.9"	"Lineage enriched"	"Detected in single"	9	"B-cells: 5.9"	"Group enriched"	"Detected in some"	11	"RPTEC TERT1: 24.5;SuSa: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"		Yes	NA			Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: AB_2683715"	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	1.0	1.2	14.9	1.3	16.9	1.4	1.1	6.1	35.9	1.0	1.3	19.2	1.0	1.2	1.2	1.2	1.0	1.2	1.1	1.1	24.6	10.7	4.9	1.0	1.1	1.6	11.7	13.2	1.0	1.0	1.0	1.2	1.4	12.4	3.0	1.4	3.3	1.1	8.3	1.1	1.1	1.2	1.2	10.1	1.2	1.2	1.1	13.0	0.0	6.5	0.0	1.0	1.0	0.2	5.9	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.2	1.2	0.1	0.0	0.0	5.9	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	14.9	16.9	6.1	11.9	24.6	10.7	11.7	13.2	12.4	13.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.8	0.0	0.0	0.0	1.4	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIX1L	MGC46719	ENSG00000271601	"Limb and CNS expressed 1 like"	Q8IVB5	1	145933423-145958001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 53.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063598			Approved	Cytosol		NA	NA			Cytosol		"HPA063598: AB_2685055"	"unprognostic (5.21e-2)"	"unprognostic (4.09e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.95e-1)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (5.27e-4)"	13.8	8.9	4.6	6.5	4.4	2.1	6.0	4.1	5.9	14.4	8.0	7.1	3.2	2.7	15.9	7.6	5.8	6.3	10.6	10.0	4.3		4.2	5.4	6.4	9.2	5.7	4.0	19.6	1.7	4.4	9.4	7.5	4.0	11.6	4.2	11.4	3.3	10.7	10.5	2.4	4.0	12.7	4.2	9.4	2.6	7.4	5.8	11.1	4.6	4.5	9.5	11.8	8.4	4.3	4.2	5.1	4.4	4.8	11.1	3.1	3.2	4.6	14.2	15.7	29.7	25.2	0.2	7.3	13.3	11.4	8.4	0.3	3.0	8.6	8.1	14.7	4.3	0.1	6.5	6.1	10.8	7.9	2.1	4.8	5.2	4.6	9.8	11.3	11.4	15.4	2.8	9.3	13.5	18.4	22.0	11.6	7.0	13.9	18.0	0.1	14.9	9.5	4.1	0.0	6.0	10.1	7.1	14.2	11.7	0.0	5.1	14.5	15.0	0.0	10.8	6.1	0.5	9.0	16.9	19.4	5.3	12.6	12.2	11.2	7.9	8.9	13.7	9.5	9.3	4.8	2.9	4.6	8.0	2.7	9.7	4.0	9.2	8.0	2.7	4.3	8.6	11.1	5.1	4.8	4.4	4.2	6.7	3.1											0.0	7.2	19.0	10.3	10.1	15.1	14.6	12.7	1.4	3.4	10.4	7.9	1.3	3.3	8.4	5.7	31.4	0.0	23.3	8.5	3.8	21.4	7.3	4.7	17.3	18.5	12.7	12.1	35.6	19.6	3.2	33.1	14.0	27.0	21.6	2.2	22.7	8.5	0.0	53.0	5.7	12.0	25.8	37.6	13.6	3.4	6.8	0.7	21.9	1.8	3.8
LKAAEAR1	C20orf201	ENSG00000171695	"LKAAEAR motif containing 1"	Q8TD35	20	64083380-64084359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.5;testis: 18.0"	"Group enriched"	"Detected in some"	36	"Early spermatids: 401.3;Late spermatids: 525.6"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	9	"intermediate monocyte: 7.9;non-classical monocyte: 12.5"	"Lineage enriched"	"Detected in many"	11	"monocytes: 12.5"	"Group enriched"	"Detected in some"	4	"REH: 9.3;SCLC-21H: 9.6"					"Low region specificity"	"Detected in many"			HPA056463			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056463: AB_2683139"	"unprognostic (5.47e-3)"	"unprognostic (1.18e-1)"		"unprognostic (1.20e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.78e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.16e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.30e-2)"	0.5	0.0	3.4	0.3	2.9	0.6	0.1	1.5	2.9	0.0	0.2			0.6	0.1	0.0	0.0	1.8	0.0	0.0	1.7	3.1	0.1	0.0	0.3	0.2	1.2		0.0	0.7	0.7	0.1	0.0		0.2	0.0		0.3	0.0	0.2	0.3	0.0	0.0	0.3	0.5	0.3	18.0			0.1		0.0	0.0	0.0	0.1	1.0	0.8	12.5	0.0	0.8	0.8	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	1.8	0.7	0.3	0.0	1.5	9.3	0.0	0.2	0.0	0.0	9.6	2.3	0.0	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.8	0.1	7.9	0.6	0.1	0.7	0.2	1.0	0.0	0.8	0.2	0.0	0.0	12.5	0.2	0.0	0.8											0.0	0.0	0.0	0.1	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	401.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	1.5	0.0	0.0	1.3	2.4	525.6	3.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.8	0.0	0.7	12.9	0.5	3.7	5.5	0.0	0.1	0.0	0.0	0.0
LLGL2	"HGL, Hugl-2"	ENSG00000073350	"LLGL2, scribble cell polarity complex component"	Q6P1M3	17	75525080-75575208	"Predicted intracellular proteins"	"Cell cycle, Cell division, Exocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 157.1;Enterocytes: 176.2;Pancreatic endocrine cells: 171.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 6.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.2;NK-cells: 4.1;T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;CAPAN-2: 38.2;MCF7: 36.7;OE19: 28.3;RT4: 26.1;SK-BR-3: 36.6;T-47d: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022913	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA022913: AB_1852930"	"unprognostic (1.18e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.00e-5)"	"unprognostic (6.22e-3)"	"prognostic favorable (6.14e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.56e-2)"	1.7	3.9	1.5	17.3	4.2	1.4	4.2	5.1	3.7	7.1	27.5	5.2	23.0	22.9	2.8	17.1	24.3	6.4	45.7	1.7	1.7	1.0	35.6	17.1	16.0	2.1	11.2	1.8	4.6	37.5	5.0	8.3	5.1	3.6	6.6	11.9	6.3	21.4	20.0	0.7	13.9	36.0	1.2	2.5	9.6	27.7	4.3	4.9	1.5	13.4	13.0	13.6	7.0	10.6	0.6	2.2	0.3	0.6	4.1	6.2	0.9	16.5	15.4	0.0	2.9	0.0	0.0	6.5	0.1	0.1	0.3	0.2	25.9	38.2	1.1	3.9	0.0	1.4	20.9	2.9	2.8	0.0	1.4	5.2	1.1	4.3	9.8	0.1	0.1	2.5	0.0	3.9	0.0	0.6	0.3	0.6	1.6	2.1	1.5	0.0	36.7	0.9	1.9	2.1	28.3	6.1	1.9	0.0	4.1	8.2	26.1	6.4	1.2	3.3	36.6	1.1	3.7	27.7	2.6	0.1	0.0	0.1	0.0	0.2	1.8	2.4	0.4	0.1	0.1	0.7	0.0	0.3	0.1	6.2	0.6	1.4	0.6	1.5	4.2	0.3	0.6	0.2	2.5	0.3	4.1	0.2	2.2	1.0	0.9	1.5	4.2	5.1	3.7	1.7	1.0	11.2	1.8	3.6	4.9	83.4	42.2	11.5	27.2	9.4	5.9	2.8	76.5	26.8	35.2	85.5	157.1	2.8	26.6	74.4	0.5	6.7	176.2	0.0	122.1	7.5	2.2	34.1	21.9	22.9	5.2	7.9	91.3	1.8	2.4	0.2	4.4	4.7	3.3	8.2	85.6	35.2	171.3	90.5	3.9	35.9	116.4	6.5	3.9	1.6	19.4	19.1	3.7	12.9	82.9	76.2
LMBR1	"ACHP, C7orf2, FLJ11665, ZRS"	ENSG00000105983	"Limb development membrane protein 1"	Q8WVP7	7	156668946-156893230	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016592	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA016592: AB_1852943"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (3.35e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.10e-2)"	15.8	30.5	15.2	12.4	23.7	7.1	12.9	20.4	25.5	16.3	10.1	13.4	12.8	9.1	19.0	19.4	12.1	16.9	12.8	12.9	15.9	17.4	17.5	15.9	11.5	11.3	17.8	11.5	18.9	12.0	38.2	22.7	11.6	24.4	14.1	12.2	11.3	10.6	13.1	14.8	11.2	10.9	15.1	14.4	9.4	12.7	20.3	13.2	14.7	20.9	8.7	12.8	13.9	12.3	2.3	3.6	4.2	2.0	0.9	4.1	1.5	12.5	11.0	12.5	15.4	10.1	12.2	8.5	7.3	9.2	6.6	7.3	7.9	20.5	12.3	14.0	9.4	12.4	10.1	13.1	13.6	14.0	8.8	13.3	9.1	6.1	9.5	7.0	11.2	6.3	9.2	12.3	9.6	12.6	10.5	14.2	10.5	17.4	11.3	13.4	11.8	11.2	9.0	14.5	13.3	9.9	6.1	8.9	15.0	10.4	12.5	13.3	24.8	9.6	13.1	7.0	8.4	9.2	6.2	19.9	11.9	4.6	40.9	9.2	13.7	10.7	12.2	20.2	14.3	7.3	4.2	2.0	2.7	1.7	1.0	4.1	1.3	3.6	2.6	3.6	2.3	4.0	2.5	1.5	0.9	1.7	2.2	2.2	1.5	15.2	23.7	20.4	25.5	15.9	17.4	17.8	11.5	24.4	13.2	3.0	7.2	6.4	11.5	9.3	11.2	15.4	12.7	5.3	4.5	12.2	2.0	12.6	5.0	9.4	6.0	20.0	8.4	0.0	8.9	4.8	11.6	16.2	5.7	18.1	8.5	7.9	7.9	8.6	8.6	8.0	9.8	6.1	6.8	4.6	9.7	6.5	10.3	7.0	8.1	9.4	10.6	0.0	6.0	9.6	27.4	11.2	19.3	5.7	11.0	13.3
LMBRD2	DKFZp434H2226	ENSG00000164187	"LMBR1 domain containing 2"	Q68DH5	5	36098412-36151961	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 11.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 11.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012165	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA012165: AB_2136131"	"unprognostic (9.43e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.45e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.35e-2)"	6.2	9.7	12.1	6.6	21.4	2.2	8.8	12.8	25.5	7.3	8.7	9.5	7.6	9.6	5.3	7.2	6.8	4.8	5.8	8.2	14.2	11.4	10.5	14.2	5.7	7.6	9.9	15.6	5.0	7.7	16.9	16.9	8.4	14.1	9.7	9.1	4.8	7.6	6.8	11.1	7.7	9.6	5.5	10.5	6.7	10.1	5.2	8.6	8.4	12.8	2.9	7.4	7.6	6.1	1.5	1.2	11.0	1.2	1.0	2.3	0.8	4.9	3.7	4.5	7.4	9.4	8.3	15.9	10.3	5.4	7.6	7.6	4.6	10.8	8.9	5.2	5.4	7.8	6.8	5.9	3.6	12.5	12.7	3.6	6.9	12.6	0.8	6.0	8.3	9.2	4.9	6.4	6.5	6.5	5.7	4.1	6.9	8.1	9.4	9.1	3.3	7.1	5.5	2.5	7.7	4.7	5.4	10.5	5.4	6.5	4.4	8.5	6.6	14.8	8.8	3.6	4.6	10.0	10.1	5.4	9.1	2.4	11.5	5.4	7.7	11.3	7.8	8.6	9.5	6.2	11.0	1.2	2.0	1.6	1.2	1.1	1.5	1.4	1.4	1.0	1.3	1.9	1.9	0.8	1.0	1.2	1.2	2.3	0.8	12.1	21.4	12.8	25.5	14.2	11.4	9.9	15.6	14.1	8.6	8.9	9.8	5.6	4.2	6.2	10.8	22.2	10.2	9.4	2.3	12.2	7.9	8.0	3.3	4.4	1.3	5.8	11.8	0.0	6.6	5.6	6.6	8.8	6.9	25.2	9.7	14.3	6.4	9.8	13.2	1.4	4.4	7.7	6.8	6.4	14.8	11.6	5.6	3.5	6.7	10.2	10.7	12.9	7.9	21.2	8.1	8.8	16.2	6.7	10.4	2.5
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501707-8574673	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 189.9"	"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 99.6;Horizontal cells: 92.2;Smooth muscle cells: 171.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 30.4;HSkMC: 42.6;hTEC/SVTERT24-B: 31.3;U-2197: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No			"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	38.6	3.3	1.6	10.1	1.8	0.0	36.4	3.9	1.9	11.7	4.4	3.8	5.2	1.9	22.3	20.8	8.3	11.9	15.4	15.9	2.3	1.7	5.5	2.2	25.9	3.8	2.4	1.7	17.9	8.5	5.8	2.0	14.1	4.5	16.1	1.6	4.6	19.2	7.0	189.9	5.7	3.3	72.9	3.7	14.3	10.6	9.3	1.3	0.8	4.6	34.3	7.1	29.4	15.7	1.8	2.7	0.0	0.3	0.0	17.0	0.2	2.9	16.9	2.8	2.1	21.1	11.9	2.9	12.4	6.4	6.8	16.9	12.5	3.8	0.0	1.4	14.3	2.9	0.2	1.6	3.2	2.8	5.1	1.1	3.7	1.1	2.4	30.4	0.0	0.3	42.6	0.0	31.3	0.2	4.0	3.3	0.0	0.0	0.0	8.8	2.1	0.0	0.0	5.5	3.8	0.7	0.0	9.4	0.0	6.3	1.1	0.1	7.1	2.0	10.3	6.4	8.4	13.4	0.0	1.6	6.9	13.8	27.6	8.3	1.7	1.9	0.8	1.4	0.9	8.8	0.0	0.0	0.0	0.0	0.3	0.1	1.8	2.6	0.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.9	17.0	0.2	1.6	1.8	3.9	1.9	2.3	1.7	2.4	1.7	4.5	1.3	8.9	15.4	0.0	47.6	28.0	13.3	13.7	20.4	20.1	15.9	5.2	9.8	2.6	3.3	99.6	0.9	70.2	0.5	0.0	42.3	3.5	58.2	6.1	10.3	11.3	3.1	92.2	11.6	36.2	0.6	1.5	10.6	4.0	50.6	15.4	2.2	34.8	83.3	0.0	30.4	29.2	7.9	0.0	171.0	5.0	7.0	23.7	3.7	2.2	3.3	5.2
LMF2	"TMEM112B, TMEM153"	ENSG00000100258	"Lipase maturation factor 2"	Q9BU23	22	50502949-50507691	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 122.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062626	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA062626: AB_2684812"	"unprognostic (2.69e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (8.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.75e-2)"	18.2	13.7	7.7	14.3	10.1	20.9	16.9	14.6	16.6	16.9	20.0	16.1	11.0	18.7	14.7	19.3	17.5	13.0	19.0	11.2	8.1	8.7	18.5	34.7	14.2	15.3	10.7	10.1	18.0	122.0	8.7	20.8	14.2	11.3	15.8	5.3	16.9	27.3	16.4	10.8	17.8	21.3	11.3	7.8	19.0	12.9	12.0	7.8	12.8	20.4	13.9	19.9	13.3	14.1	10.8	25.3	16.1	17.7	12.1	21.0	12.6	18.0	13.6	7.8	14.8	11.3	9.7	18.2	32.4	17.2	20.9	23.5	13.4	9.4	8.0	8.8	17.0	9.3	21.8	2.6	10.2	2.9	6.3	28.5	4.4	25.0	14.1	14.2	8.2	17.6	14.3	9.5	14.2	3.5	9.0	11.6	6.3	5.2	27.1	9.0	13.0	5.8	9.7	4.6	4.6	17.0	13.3	12.5	21.8	8.4	9.8	7.0	10.3	22.1	19.2	14.9	3.9	11.0	5.8	16.8	29.6	16.8	21.1	1.6	10.5	3.4	4.8	21.5	5.1	24.1	10.3	13.2	16.1	21.0	17.7	15.9	10.8	17.5	19.4	14.0	7.3	10.4	10.9	12.4	12.1	14.5	25.3	15.9	12.6	7.7	10.1	14.6	16.6	8.1	8.7	10.7	10.1	11.3	7.8	11.9	9.6	31.3	14.9	16.6	13.7	8.1	35.7	5.3	12.5	14.0	21.6	50.7	3.3	33.0	7.3	17.9	48.5	0.0	65.4	89.5	42.9	11.0	15.1	31.6	38.4	11.1	14.5	23.4	17.3	14.8	27.0	23.9	23.6	19.0	25.4	24.6	31.0	59.6	24.1	19.5	14.1	19.4	19.4	11.2	20.1	15.2	23.8	34.6	24.4	13.1
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 32.1;Early spermatids: 29.2;Spermatocytes: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	3.9	4.9	5.2	2.5	11.0	2.3	4.5	6.1	9.1	6.2	3.5	5.8	14.3	2.2	4.8	20.3	3.5	9.3	5.1	5.9	5.7	7.4	6.6	3.7	8.1	3.5	5.6	8.9	6.5	6.1	8.8	15.0	3.9	11.6	4.6	4.1	5.4	4.2	11.7	3.7	6.5	2.3	4.0	5.5	3.0	3.9	27.0	4.4	1.2	7.6	3.0	2.6	3.5	3.7	1.9	1.9	0.8	2.4	1.8	2.4	1.2	6.5	2.5	2.9	3.5	5.8	8.2	2.5	3.4	3.1	6.1	5.1	2.4	2.4	2.1	15.8	2.4	13.3	2.5	2.7	2.7	9.0	0.3	2.0	1.2	2.1	1.8	3.6	3.6	1.8	3.9	6.1	7.6	5.0	3.6	2.6	5.3	6.3	4.0	5.9	4.8	2.2	3.2	3.3	4.7	5.9	2.5	0.7	2.2	6.3	1.7	4.8	1.4	4.7	4.2	3.4	3.5	11.0	2.8	5.7	7.6	1.1	9.1	5.7	7.1	13.7	0.6	10.8	6.4	6.8	0.2	0.6	0.5	1.2	2.4	1.7	1.9	0.8	1.6	1.9	1.1	2.2	2.4	0.8	1.8	0.9	0.5	0.0	1.2	5.2	11.0	6.1	9.1	5.7	7.4	5.6	8.9	11.6	4.4	14.9	11.3	1.9	1.5	1.8	7.7	9.2	2.5	32.1	13.6	8.7	15.7	2.5	0.0	2.5	29.2	2.5	1.0	0.0	2.3	2.1	3.3	1.9	2.3	2.4	4.2	7.9	4.6	4.3	2.8	18.6	4.4	2.0	3.3	0.0	3.1	7.7	1.8	0.0	5.3	3.7	16.3	0.0	3.2	29.2	24.7	1.5	2.4	1.3	2.3	1.3
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 26.8;Early spermatids: 38.5;Late spermatids: 35.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.5;RT4: 6.7;SH-SY5Y: 6.9;U-2197: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA038640: AB_2676127"				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.3	4.3	0.7	6.7	0.4	1.1	3.3	1.6	1.4	3.9	7.1	0.0	1.5	0.8	6.0	0.3	19.0	0.9	0.5	8.5	2.8	0.8	0.2	4.1	0.4	1.1	3.0	4.0	0.7	0.1	21.3	0.3	13.4	0.4	3.8	1.3	0.2	0.3	0.2	0.6	0.6	1.2	4.1	0.6	0.6	15.0	6.5	0.0	1.1	0.0	0.2	0.4	0.3	2.6	2.2	2.7	0.9	0.7	1.6	0.6	0.3	0.3	0.1	0.2	0.2	1.6	2.4	3.1	5.5	1.2	0.2	0.0	0.3	0.2	0.1	0.0	3.5	0.1	0.2	0.1	0.3	0.9	0.1	1.0	0.8	2.0	0.3	0.1	0.1	0.5	0.2	1.6	0.4	0.1	0.1	0.1	1.9	0.3	0.0	0.4	0.0	0.3	1.7	0.1	0.5	0.4	0.2	0.2	0.2	6.7	0.1	6.9	0.2	0.4	3.9	0.8	0.3	1.5	0.3	0.2	0.9	24.0	0.2	0.8	1.3	1.7	0.3	1.6	2.6	1.9	0.9	0.6	1.4	0.3	0.5	2.1	1.0	1.3	0.4	2.6	1.4	1.6	2.7	0.7	0.4	2.2	0.5	0.6	4.3	6.7	3.3	1.6	8.5	2.8	1.1	3.0	13.4	6.5	0.0	0.0	0.5	1.1	0.0	0.0	0.4	0.0	26.8	2.3	0.0	0.0	0.2	1.7	0.0	38.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.8	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	0.0	0.0	0.7
LMNTD2	"C11orf35, MGC35138"	ENSG00000185522	"Lamin tail domain containing 2"	Q8IXW0	11	554855-560779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Early spermatids: 57.2;Late spermatids: 64.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTERT-RPE1: 21.6"					"Not detected"	"Not detected"			"HPA058474, HPA073912"	Uncertain		Approved	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA058474: AB_2683727, HPA073912: AB_2686642"	"unprognostic (2.20e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (1.33e-3)"	"unprognostic (7.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.02e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.48e-3)"	1.1	1.9	1.5	5.7	2.1	2.4	2.1	1.5	1.4	0.9	3.6	0.9	7.1	7.9	1.6	7.2	3.4	7.7	4.6	2.0	2.1	0.2	5.3	15.2	5.3	4.6	1.0	0.4	1.4	11.7	0.0	4.2	3.3	1.7	3.8	0.5	3.4	7.4	11.3	0.4	5.5	10.1	1.2	1.1	3.8	3.9	17.6	1.2	2.5	8.9	2.0	4.7	2.1	1.6	0.8	0.2	0.0	0.5	0.0	0.4	0.0	0.0	2.5	0.6	4.4	0.0	0.0	0.0	0.6	0.3	0.2	0.4	3.7	0.0	2.4	0.0	0.1	1.2	3.3	0.7	0.9	0.1	0.0	0.3	0.5	4.6	2.2	0.4	0.1	1.8	0.4	0.0	0.1	0.1	21.6	0.3	0.6	0.0	2.9	0.0	0.0	0.5	0.0	0.5	2.3	1.2	0.0	0.0	1.5	1.5	0.0	0.3	0.8	0.0	2.5	0.0	4.4	4.8	1.1	0.1	0.4	0.4	0.3	0.4	4.2	0.9	0.2	0.0	0.0	0.6	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.4	0.1	0.2	0.8	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	2.1	1.5	1.4	2.1	0.2	1.0	0.4	1.7	1.2	0.0	0.0	1.3	2.1	0.0	0.4	0.8	10.2	0.0	0.0	3.5	0.0	1.5	6.6	2.4	57.2	0.0	2.6	0.0	2.0	1.0	0.0	1.4	0.0	5.0	1.1	0.0	0.0	0.6	0.0	64.2	2.0	0.0	0.0	1.0	2.3	4.4	3.3	1.5	0.0	2.2	0.9	0.0	0.2	1.8	3.8	0.0	0.8	0.0	1.8	3.0
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328468-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 105.3;T-47d: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	19.3	7.5	39.8	11.7	36.4	8.0	13.9	10.3	102.4	22.7	16.2	9.8	10.9	11.5	19.4	18.1	22.2	13.7	21.0	17.2	62.3	18.0	12.8	14.5	16.6	11.5	21.0	50.9	18.4	10.4	11.6	13.3	27.5	13.0	26.0	14.3	11.2	36.2	37.9	18.4	17.1	21.1	15.3	16.5	15.8	38.6	12.0	11.0	4.4	14.2	12.5	36.3	15.4	21.4	7.8	7.2	18.9	8.2	15.3	6.9	3.6	9.4	7.4	5.8	105.3	17.9	21.3	14.8	8.6	6.8	8.1	9.1	18.2	6.0	22.2	11.0	10.0	13.2	7.9	2.3	6.0	8.1	11.8	5.8	20.2	16.2	5.6	17.2	10.9	27.5	11.1	13.9	12.6	7.2	14.7	5.5	8.6	4.5	19.7	4.3	3.8	0.3	7.1	21.3	10.2	7.0	12.6	8.1	4.8	10.0	36.4	4.8	0.3	34.6	5.1	25.5	11.6	67.0	30.0	3.5	38.2	7.2	9.1	28.1	18.1	11.9	5.0	4.7	2.4	5.4	18.9	6.8	13.0	6.0	8.2	6.9	7.8	5.4	6.1	5.0	4.4	1.4	3.5	10.9	15.3	7.7	7.2	1.4	3.6	39.8	36.4	10.3	102.4	62.3	18.0	21.0	50.9	13.0	11.0	41.7	27.4	50.6	46.8	87.3	192.0	49.2	163.1	29.4	48.9	34.9	68.7	270.0	53.0	48.7	1.6	54.7	57.7	23.3	112.7	251.2	186.2	38.4	292.9	75.1	64.5	104.9	29.9	81.6	115.9	4.5	88.1	61.6	62.4	25.2	66.7	78.4	77.9	34.8	221.3	42.6	34.0	32.3	148.3	3.9	34.7	81.2	214.1	67.1	38.3	32.9
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 1563.3;Club cells: 396.9;Urothelial cells: 377.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.1"	"Cell line enhanced"	"Detected in many"		"BJ: 55.4;fHDF/TERT166: 91.4;LHCN-M2: 86.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2"	"HPA020923, HPA050184"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA020923: AB_1852963, HPA050184: AB_2681045"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	2.2	2.2	10.1	6.3	32.6	0.9	2.5	2.7	13.2	6.7	24.3	0.5	2.4	17.5	2.3	7.8	42.5	4.0	16.3	65.6	9.8	2.5	21.7	19.9	57.0	2.6	2.3	8.8	5.5	6.8	6.2	3.1	10.9	1.1	7.6	8.9	2.7	14.3	7.0	44.4	8.6	55.0	2.1	2.0	1.5	16.7	4.7	4.1	16.2	25.7	36.3	23.7	4.6	15.4	2.4	1.1	3.0	0.5	0.5	14.1	2.6	12.2	7.0	0.2	0.2	14.6	10.4	2.4	55.4	27.4	14.1	15.3	17.1	15.9	1.0	4.2	91.4	3.5	11.9	3.0	2.6	16.3	16.5	0.7	7.5	37.2	16.0	4.2	2.4	3.9	7.1	5.2	6.1	7.0	34.6	5.9	2.4	0.2	0.1	86.0	4.8	1.8	1.0	0.3	19.0	10.6	1.1	25.9	0.2	6.0	2.8	0.9	1.9	10.1	1.7	2.2	1.5	2.3	1.8	9.0	34.9	6.5	4.1	13.5	3.7	2.7	4.4	10.2	2.7	15.8	3.0	0.2	2.4	0.7	0.5	0.9	1.1	3.2	1.0	0.4	2.4	14.1	8.5	0.1	0.5	0.3	1.1	1.2	2.6	10.1	32.6	2.7	13.2	9.8	2.5	2.3	8.8	1.1	4.1	1563.3	242.1	2.7	51.2	21.3	5.2	309.1	48.4	234.2	396.9	59.3	2.0	38.6	13.3	56.6	4.7	11.3	219.0	0.0	32.9	6.2	66.8	251.0	19.7	61.7	5.1	6.4	68.3	6.7	3.7	5.6	38.9	4.9	15.1	1.8	69.4	1.7	146.0	64.9	40.0	13.6	10.9	12.9	19.1	8.1	3.2	39.5	14.2	7.0	44.1	377.1
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896452-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 199.7;urinary bladder: 165.5"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 127.6;Leydig cells: 116.2;Peritubular cells: 258.9;Rod photoreceptor cells: 66.8;Sertoli cells: 194.1;Smooth muscle cells: 158.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.2;BJ: 11.9;BJ hTERT+: 19.3;fHDF/TERT166: 9.6;HSkMC: 8.5;hTERT-RPE1: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No			Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	27.4	12.7	1.9	26.7	6.2	0.0	20.5	2.2	1.9	65.6	83.5	1.8	42.7	6.0	84.9	29.0	94.6	33.2	80.7	8.3	1.6	1.6	5.3	1.0	11.0	5.5	2.3	3.2	38.1	1.6	7.4	1.3	10.2	4.1	77.1	12.0	28.9	6.8	63.8	29.5	7.4	20.9	199.7	1.8	6.3	47.0	23.3	0.7	0.0	7.9	12.3	2.7	165.5	39.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	9.2	1.1	0.7	11.9	19.3	0.7	0.9	0.0	0.1	0.0	0.4	9.6	0.1	0.2	0.3	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	8.5	0.0	0.5	0.0	31.2	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.3	0.2	5.6	0.4	0.0	0.0	0.1	0.4	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	6.2	2.2	1.9	1.6	1.6	2.3	3.2	4.1	0.7	0.0	1.4	0.0	0.7	1.1	4.9	22.4	0.0	1.4	0.0	0.0	127.6	1.1	0.0	0.0	1.9	2.1	0.0	0.0	0.5	0.2	13.9	0.6	0.0	0.0	0.8	3.2	0.0	13.5	0.0	3.6	116.2	0.0	3.3	0.0	0.0	4.5	0.0	0.0	258.9	0.0	66.8	194.1	158.8	1.4	0.2	1.9	1.0	0.0	0.0	0.3
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106885-98209633	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: AB_2677698"	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	5.1	10.3	13.7	5.6	21.3	17.3	5.6	16.6	34.3	7.3	13.8	6.1	5.6	12.6	6.1	6.3	12.7	6.4	7.9	16.9	11.0	10.1	10.1	8.5	10.0	5.1	7.5	18.9	8.0	21.0	22.2	10.0	4.8	13.2	7.9	11.8	5.4	10.5	6.5	17.5	11.5	13.8	5.7	5.5	6.8	9.4	8.0	6.9	7.2	8.7	5.7	7.4	8.3	8.1	0.6	0.7	4.8	0.9	0.3	1.6	0.5	9.8	11.6	9.0	9.2	4.8	3.9	8.4	4.1	4.5	4.0	4.9	9.1	9.0	5.2	11.8	5.2	15.3	10.8	10.4	6.3	6.3	7.4	7.3	3.5	10.4	9.1	5.9	6.2	6.3	2.6	8.7	8.3	11.3	4.1	6.0	6.0	9.1	10.9	3.6	13.3	6.6	3.7	11.0	13.5	5.7	7.2	6.1	10.2	6.7	17.3	6.5	12.9	8.2	15.0	6.0	9.5	4.1	2.5	7.3	8.4	13.8	16.8	9.3	4.9	8.5	10.3	5.7	4.9	10.0	1.2	0.6	0.5	0.8	0.3	0.5	0.6	0.9	0.9	0.3	0.6	1.1	1.6	4.8	0.3	0.9	0.7	0.8	0.5	13.7	21.3	16.6	34.3	11.0	10.1	7.5	18.9	13.2	6.9	26.8	10.5	0.0	4.2	8.7	14.0	18.7	17.8	10.7	9.1	1.8	13.7	2.3	1.7	5.0	0.8	3.1	26.2	0.0	7.9	1.6	3.5	6.2	2.3	6.8	1.8	6.4	11.5	3.1	2.6	2.1	1.7	2.3	1.7	0.0	13.5	5.8	8.6	13.1	4.2	2.4	9.9	0.0	3.8	6.3	4.7	9.5	2.5	2.9	12.6	13.2
LMX1A	"LMX1, LMX1.1"	ENSG00000162761	"LIM homeobox transcription factor 1 alpha"	Q8TE12	1	165201867-165356715	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 7.3;pituitary gland: 8.0"	"Group enriched"	"Detected in some"	33	"Early spermatids: 29.1;Intestinal endocrine cells: 40.3;Late spermatids: 14.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SCLC-21H: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA028051, HPA030088"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA028051: AB_10599731, HPA030088: AB_10601106"	"unprognostic (1.73e-1)"		"unprognostic (9.57e-2)"	"unprognostic (7.58e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.82e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.22e-2)"			"unprognostic (2.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.82e-3)"		2.2	0.0	0.0	2.0	0.0	0.0	1.2	2.6	0.5	0.5	1.7	3.4	3.1	4.0	0.1	1.3	1.1	0.5	0.2	0.2	0.9	1.5	0.0	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	8.0	0.0	7.3	0.2	2.1	0.5	1.5	0.3	1.4	0.3	2.2	0.9	0.1	0.0	0.2	4.3	0.3	0.0	0.3	3.5	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.9	1.5	2.2	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126614443-126701032	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 16.5;salivary gland: 35.3"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 1.4;Early spermatids: 1.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 17.2;OE19: 10.9;T-47d: 10.6"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Region enhanced"	"Detected in some"		"midbrain: 7.9"	HPA073716			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073716: AB_2686630"	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	1.3	0.1	0.0	0.1	0.0	0.1	7.5	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	1.9	0.1	0.2	1.4	0.0	0.1	0.0	0.6	0.0	0.1	0.8	0.0	0.6	0.0	2.9	0.1	0.0	16.5	35.3	0.0	0.4	1.5	0.2	0.0	2.4	0.0	0.1	3.1	0.0	0.0	0.9	0.1	0.0	0.2	0.1	0.6	0.4	1.2	0.3	0.9	0.5	0.0	2.4	1.1	0.4	3.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.2	1.3	0.0	0.5	0.0	2.8	1.2	3.8	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.5	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	17.2	0.0	0.0	0.0	10.9	0.2	0.0	3.2	0.0	0.0	0.3	0.0	1.5	0.3	0.1	0.4	0.1	10.6	0.2	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.5	0.4	1.2	0.9	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0
LNP1	NP3	ENSG00000206535	"Leukemia NUP98 fusion partner 1"	A1A4G5	3	100401193-100456319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.9"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 107.8;Horizontal cells: 243.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4"	HPA047926			Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA			Vesicles	"Nuclear speckles, Cytosol"	"HPA047926: "	"unprognostic (1.78e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.40e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.08e-2)"	3.1	2.8	6.5	1.7	11.4	0.6	2.7	7.9	9.7	3.4	2.3	1.5	3.4	1.2	4.6	8.4	1.9	4.0	2.7	9.5	5.3	7.2	4.8	7.4	3.8	1.4	5.7	5.6	6.3	4.5	3.0	17.0	3.7	7.4	2.8	2.2	9.0	2.4	3.3	4.3	1.0	1.5	4.5	4.2	1.8	1.9	31.9	3.5	1.6	5.3	0.8	1.7	3.1	1.8	0.9	0.2	0.0	0.4	0.2	2.7	0.8	2.9	1.6	8.5	1.2	5.5	2.4	0.7	2.3	5.6	1.9	2.2	0.6	0.7	2.6	1.0	1.6	3.0	1.9	2.2	2.0	2.2	2.6	2.3	6.2	0.8	2.8	1.7	3.6	0.7	2.6	0.7	1.0	4.8	2.5	0.4	1.3	2.4	9.7	1.7	2.1	5.0	3.6	5.8	1.7	12.8	3.8	4.7	5.1	1.7	0.3	8.8	4.4	1.7	2.5	3.5	2.5	0.6	0.4	0.6	0.9	9.0	0.8	2.0	11.4	12.2	7.5	2.6	3.1	1.6	0.0	0.4	0.0	1.1	0.2	2.5	0.9	1.1	0.6	0.2	0.9	1.0	1.1	0.0	0.2	0.0	0.0	2.7	0.8	6.5	11.4	7.9	9.7	5.3	7.2	5.7	5.6	7.4	3.5	0.0	0.3	4.2	1.2	0.9	32.6	9.6	0.0	5.3	2.3	1.8	47.1	1.2	6.6	0.4	107.8	0.7	0.4	23.3	0.8	1.6	3.1	0.9	0.0	1.6	0.6	243.1	2.4	0.0	0.3	17.2	3.1	0.0	20.3	1.0	1.0	9.4	0.6	0.0	1.1	3.1	35.6	0.0	2.2	31.5	2.7	0.5	0.3	0.0	0.6	0.1
LNX2	"MGC46315, PDZRN1"	ENSG00000139517	"Ligand of numb-protein X 2"	Q8N448	13	27545911-27620404	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040698	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA040698: AB_10673138"	"unprognostic (4.97e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.79e-2)"	"prognostic favorable (7.09e-13)"	"unprognostic (4.18e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-2)"	4.6	10.3	2.5	6.7	4.2	2.7	9.8	7.6	4.1	6.0	13.2	2.3	8.3	12.2	4.4	4.3	12.4	4.1	9.7	8.8	2.8	2.9	9.2	24.5	22.1	4.9	3.4	3.1	6.3	24.7	7.6	9.6	10.8	3.7	7.0	9.3	10.2	12.1	9.9	8.0	7.6	19.6	6.5	3.3	4.6	9.0	10.3	2.6	13.4	9.9	4.2	10.0	6.2	8.5	1.6	0.8	5.3	0.9	3.3	2.8	0.6	4.8	2.6	5.1	5.6	5.3	2.4	5.3	4.3	3.7	4.2	3.8	9.5	9.6	7.3	3.7	3.8	7.7	9.1	9.0	11.4	5.6	4.4	3.8	9.2	5.6	6.9	8.4	4.9	5.9	2.0	17.8	2.9	11.6	12.0	7.6	7.6	2.8	2.8	6.1	5.8	7.3	3.2	5.6	21.7	3.0	6.8	9.9	3.7	9.2	8.4	13.0	2.7	5.9	11.8	7.5	6.6	8.3	3.8	9.6	2.4	3.4	2.4	3.5	2.7	4.6	7.6	1.6	4.7	3.4	5.3	0.9	2.4	1.7	0.3	2.3	1.6	1.8	2.1	0.8	1.3	1.9	1.8	1.1	3.3	0.7	0.4	2.8	0.6	2.5	4.2	7.6	4.1	2.8	2.9	3.4	3.1	3.7	2.6	29.8	22.2	3.7	22.5	22.6	3.8	9.2	25.5	16.0	6.8	19.2	2.0	1.2	3.3	8.1	10.5	5.9	18.6	0.0	12.1	6.8	3.1	19.8	1.1	45.5	1.9	4.8	9.8	10.4	5.2	5.3	2.6	5.2	10.1	1.0	14.5	4.5	10.7	23.0	3.2	6.7	16.7	0.0	3.1	16.1	15.8	19.3	2.5	5.2	10.7	16.5
LONRF1	"FLJ23749, RNF191"	ENSG00000154359	"LON peptidase N-terminal domain and ring finger 1"	Q17RB8	8	12721894-12756073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023584, HPA024814"	Uncertain		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Centrosome	"HPA023584: AB_1853233, HPA024814: AB_1853235"	"unprognostic (2.59e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.15e-1)"	16.5	7.6	7.6	4.9	9.9	4.9	10.4	9.9	8.4	14.0	8.1	6.3	8.8	2.2	11.1	13.0	12.9	11.2	9.4	6.5	8.9	5.3	6.3	9.3	8.1	8.7	6.9	6.9	20.4	10.3	12.6	4.9	9.6	5.5	12.8	4.2	13.9	7.9	10.9	18.4	29.7	5.3	10.0	6.1	9.2	6.9	16.1	4.5	6.2	8.6	7.3	7.3	10.6	19.0	1.1	0.9	2.4	2.1	0.1	1.6	0.2	0.6	1.6	8.6	2.6	9.1	4.4	5.7	2.1	3.6	2.3	3.3	0.5	2.2	13.2	0.5	3.7	7.5	1.0	6.8	2.6	2.6	2.0	3.8	4.3	0.3	3.5	8.5	1.1	1.7	4.1	4.7	1.5	5.2	2.2	3.6	5.4	0.6	32.4	1.5	2.4	5.6	3.8	8.8	2.7	0.5	3.1	5.9	2.4	2.1	5.7	18.0	2.1	1.2	2.9	16.8	6.4	0.6	5.8	1.6	1.3	2.2	5.1	1.6	2.4	11.0	6.9	6.9	4.0	3.9	0.0	0.5	2.4	0.5	1.8	1.6	1.0	1.0	0.6	0.4	1.1	0.0	0.0	1.9	0.1	2.1	0.9	0.0	0.2	7.6	9.9	9.9	8.4	8.9	5.3	6.9	6.9	5.5	4.5	8.9	18.9	3.9	28.3	54.0	22.8	8.7	7.6	13.4	15.9	10.4	15.7	2.8	6.6	5.4	50.1	13.5	3.2	0.0	3.5	6.8	12.7	23.1	5.8	11.9	4.9	7.9	2.4	6.7	7.3	44.0	27.0	10.1	42.2	1.8	5.4	9.2	4.5	5.8	18.7	5.7	12.9	19.4	29.5	7.7	17.7	64.4	6.1	5.0	4.7	22.2
LONRF2	"FLJ45273, RNF192"	ENSG00000170500	"LON peptidase N-terminal domain and ring finger 2"	Q1L5Z9	2	100273291-100322733	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.9;epididymis: 32.6"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 74.2;Cardiomyocytes: 34.4;Horizontal cells: 104.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 6.5;GAMG: 8.1;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057366	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057366: AB_2683420"	"unprognostic (9.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.72e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.86e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.42e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.66e-3)"	"unprognostic (6.34e-2)"	1.6	23.0	8.4	0.6	32.9	0.2	2.2	21.1	15.4	5.1	1.7	1.3	2.3	0.5	19.0	32.6	2.0	17.8	1.7	4.3	5.6	9.9	1.3	0.7	1.5	0.5	3.9	7.0	10.5	4.4	9.6	7.8	0.6	6.4	3.2	0.7	1.6	1.5	3.2	4.6	0.4	0.5	19.8	4.5	0.5	1.5	1.8	4.3	0.4	3.5	0.8	0.4	1.4	1.3	0.7	0.5	1.7	0.4	0.7	0.5	0.1	0.0	6.5	2.0	2.4	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.2	0.0	1.1	0.0	8.1	0.0	6.4	0.0	0.0	0.5	6.9	0.0	0.4	0.0	0.2	0.1	5.7	0.0	0.0	0.3	0.0	0.4	0.0	1.8	3.7	0.1	0.0	4.2	0.0	0.3	0.4	1.2	5.9	0.0	0.0	0.0	1.6	0.2	14.0	3.8	0.0	0.0	1.0	2.3	3.5	0.1	0.1	0.1	0.8	0.0	0.4	0.0	0.0	0.0	2.8	0.0	0.3	1.1	0.4	0.4	0.3	0.3	0.3	0.4	0.3	0.3	0.2	0.7	0.4	0.5	1.7	0.7	0.3	0.5	0.2	0.1	8.4	32.9	21.1	9.7	5.6	9.9	3.9	7.0	6.4	4.3	0.0	13.2	0.0	1.2	0.7	74.2	34.4	5.1	5.3	5.7	5.2	29.5	1.7	5.0	2.4	0.4	1.0	0.0	0.0	1.8	0.2	1.5	5.8	5.7	0.5	0.4	104.9	10.9	0.0	0.0	1.5	3.1	0.3	1.7	0.0	0.1	10.0	2.1	0.0	11.0	0.3	18.2	6.5	3.3	0.5	0.2	0.1	2.4	0.0	0.4	0.5
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 14.9;Basal glandular cells: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 9.9;K-562: 10.6;OE19: 12.0;PC-3: 12.1;SiHa: 11.0;SK-MEL-30: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA050422: AB_2681122, HPA061162: AB_2732658"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.8	3.9	4.2	2.1	3.4	4.6	10.8	15.8	6.1	1.9	4.1	2.0	1.6	2.9	2.4	3.1	1.7	2.5	3.9	3.9	5.0	1.9	3.6	15.4	11.8	0.8	1.7	3.7	2.0	8.1	0.4	3.5	0.9	4.4	3.0	5.5	4.1	8.1	3.0	13.8	1.4	2.3	10.8	2.7	1.1	4.5	2.7	2.5	0.0	9.9	1.9	1.1	4.7	6.6	0.0	0.1	0.8	0.8	0.0	7.4	0.7	3.7	5.5	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.6	0.0	2.7	0.0	9.9	0.0	1.1	0.0	0.0	0.1	3.1	4.7	9.0	5.3	3.1	4.0	0.6	0.0	0.0	0.0	0.0	1.7	1.4	0.4	10.6	0.0	0.8	4.5	0.0	1.8	0.0	12.0	12.1	0.0	2.5	0.0	3.3	1.5	0.2	0.0	11.0	0.3	9.6	0.1	0.0	3.5	0.2	0.1	0.2	0.0	5.8	1.2	4.7	0.0	2.6	4.1	2.4	0.0	0.8	0.0	4.5	0.0	7.4	0.0	2.0	1.5	0.1	0.0	1.1	1.6	0.8	0.0	0.0	0.0	0.7	0.7	4.2	3.4	15.8	6.1	5.0	1.9	1.7	3.7	4.4	2.5	6.0	14.9	0.0	13.8	1.3	3.6	3.2	0.0	0.0	10.3	1.8	0.0	0.5	1.7	2.4	1.3	1.9	5.8	0.0	3.8	0.0	2.8	4.7	5.8	4.0	2.9	1.6	1.2	3.1	3.7	0.4	0.9	3.8	3.3	0.0	2.3	6.1	4.6	3.1	1.4	0.7	0.2	0.0	3.1	1.7	4.1	0.1	0.3	1.3	2.5	9.8
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 34.9;Fibroblasts: 69.8;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 105.1;fHDF/TERT166: 160.3;HSkMC: 39.1;hTERT-RPE1: 42.3;U-138 MG: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043930			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		290000	"Endoplasmic reticulum"		"HPA043930: AB_2678736"	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.3	0.1	18.3	21.6	0.0	105.1	22.1	8.1	28.7	0.1	0.0	0.0	2.5	160.3	0.4	0.0	0.4	0.2	17.4	0.0	0.3	0.0	2.1	0.8	23.1	0.0	0.0	39.1	0.4	13.5	0.6	42.3	10.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.4	0.0	0.7	3.4	0.0	0.0	0.8	53.3	3.6	31.5	1.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1	8.9	0.6	0.0	1.6	6.9	0.6	1.2	0.0	4.0	1.2	0.0	0.0	0.7	0.0	7.1	34.9	3.3	0.0	0.0	0.5	17.3	69.8	1.8	0.0	0.4	1.9	1.6	0.0	14.1	1.5	2.4	13.0	0.3	5.0	1.0	0.0	0.0	1.4	0.0	36.7	0.0	1.1	19.4	8.2	0.5	0.0	9.4	4.0	0.0	0.0	0.7
LOXHD1	"DFNB77, FLJ32670, LH2D1"	ENSG00000167210	"Lipoxygenase homology domains 1"	Q8IVV2	18	46476972-46657220	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.5;epididymis: 9.7;testis: 22.0"	"Group enriched"	"Detected in some"	84	"Early spermatids: 168.6;Late spermatids: 330.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.4;cerebral cortex: 1.9;thalamus: 1.1"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"THP-1: 3.5;WM-115: 1.4"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.0"	HPA077128			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077128: "	"unprognostic (6.95e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.75e-4)"	"unprognostic (9.53e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.48e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.66e-3)"	1.7	0.0	0.4	0.0	2.4	2.7	0.4	0.1	1.9	0.0	0.1	0.2	15.5	0.0	0.0	9.7	0.1	1.7	0.1	0.5	0.2	0.1	0.5	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.4	4.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.0	0.7	0.1	22.0	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.4	2.4	0.1	1.9	0.2	0.1	0.0	0.0	0.0	1.1	3.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	1.7	0.0	168.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	330.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.8	1.5	0.0	0.0	0.0	0.0	0.0
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 84.0;Extravillous trophoblasts: 135.9;Fibroblasts: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.5"	"Lineage enriched"	"Detected in single"	45	"T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"BJ: 23.4;BJ hTERT+: 26.8;hTERT-RPE1: 26.7;U-87 MG: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		120000	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: AB_2685050"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	9.4	2.5	2.4	6.7	1.2	0.9	5.0	0.4	1.8	19.3	7.0	1.6	7.0	2.3	12.3	8.4	9.9	6.9	12.4	19.1	2.4	1.6	7.9	1.3	7.0	13.6	1.3	1.6	9.6	3.0	3.8	7.4	16.1	4.4	14.8	1.7	26.7	5.7	15.5	4.2	4.7	5.3	26.6	2.1	2.8	6.5	3.7	1.3	1.2	3.9	10.5	10.4	16.9	11.7	0.1	0.0	0.0	0.0	0.0	6.5	0.6	1.1	0.0	0.3	0.0	16.7	20.3	0.7	23.4	26.8	9.9	17.6	0.4	0.6	0.0	4.3	17.2	2.5	6.9	0.1	0.0	2.4	0.0	1.5	0.0	0.7	0.1	2.3	0.0	0.0	16.5	0.0	7.4	0.0	26.7	0.3	0.4	0.0	0.1	11.8	0.8	0.1	0.4	2.2	1.5	16.0	0.0	13.8	0.2	0.9	4.1	1.9	0.0	0.7	0.1	0.0	2.4	0.1	0.0	1.7	19.5	17.3	15.3	8.9	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.1	2.9	1.5	0.0	0.1	0.7	0.8	0.0	0.0	0.0	0.0	6.5	0.6	2.4	1.2	0.4	1.8	2.4	1.6	1.3	1.6	4.4	1.3	0.0	1.1	0.0	5.2	5.3	0.4	84.0	0.0	0.0	0.0	8.7	0.0	1.8	3.3	2.5	1.2	2.9	0.0	0.0	1.2	135.9	59.0	2.9	1.1	0.0	5.6	0.0	3.4	19.0	0.0	1.0	9.2	0.0	10.1	0.0	0.1	5.2	8.2	0.0	19.8	1.4	0.2	0.0	20.5	2.6	1.9	3.0	4.2	0.0	0.9	3.1
LOXL4	"FLJ21889, LOXC"	ENSG00000138131	"Lysyl oxidase like 4"	Q96JB6	10	98247690-98268250	"Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 29.1"	"Cell type enhanced"	"Detected in many"	15	"Club cells: 9.1;Collecting duct cells: 29.6;Ductal cells: 8.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 60.1;CAPAN-2: 72.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033876, HPA037609"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"CAB033876: AB_2135101, HPA037609: AB_2675579"	"unprognostic (9.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (7.71e-2)"	"unprognostic (1.75e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (2.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.40e-3)"	6.3	1.8	1.1	1.1	4.2	0.1	10.7	1.0	1.7	20.7	7.3	4.6	1.4	1.4	8.0	4.6	2.3	7.4	4.6	1.8	1.6	0.3	4.4	29.1	3.1	0.6	1.1	1.2	6.1	14.5	1.7	1.4	5.1	8.2	5.1	1.5	3.2	15.7	10.7	14.7	3.1	2.5	7.1	3.0	1.8	2.3	10.8	1.0	1.4	5.7	1.9	1.7	3.1	6.0	0.8	1.2	0.1	0.2	2.3	0.0	0.0	0.0	0.4	0.0	0.0	1.7	7.4	0.2	7.6	60.1	0.6	6.5	1.2	72.2	0.0	6.9	5.9	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	3.1	1.6	0.0	0.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.1	0.0	13.6	0.8	0.2	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.3	0.0	1.2	0.0	0.0	1.1	4.2	1.0	1.7	1.6	0.3	1.1	1.2	8.2	1.0	6.0	1.0	0.0	1.9	0.8	0.2	1.1	5.1	4.0	9.1	29.6	0.0	0.2	0.0	8.6	0.2	0.6	0.0	0.0	0.5	0.3	5.1	2.0	1.1	0.2	0.2	0.0	0.0	3.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	4.9	3.3	0.0	1.4	0.5	0.0	0.0	1.6	0.0	0.2	0.6	0.3	0.0	0.0	1.6
LPAR1	"edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1"	ENSG00000198121	"Lysophosphatidic acid receptor 1"	Q92633	9	110873263-111038458	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.4"	"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 45.6;Leydig cells: 35.9;Peritubular cells: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.5;eosinophil: 15.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.6;monocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.3;ASC TERT1: 57.4;BJ hTERT+: 69.5;HSkMC: 41.7"	"Low region specificity"	"Detected in all"							HPA050667			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA050667: "	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	16.3	9.5	55.8	12.0	56.2	0.3	14.8	4.7	30.9	43.7	12.3	71.4	3.4	9.4	12.1	12.3	10.6	10.1	9.8	8.5	55.6	30.6	5.7	1.9	7.3	10.5	59.4	17.0	8.9	4.6	1.1	2.3	25.7	29.1	9.4	12.8	3.5	5.6	17.2	3.3	6.9	10.2	14.0	69.8	9.5	6.5	4.8	49.4	0.1	6.2	3.2	11.3	15.4	17.8	0.0	1.9	15.6	7.5	1.8	0.0	1.6	1.8	3.5	5.0	0.0	98.3	57.4	0.0	24.5	69.5	17.2	7.8	0.4	0.3	0.0	0.0	25.3	3.1	7.3	0.0	19.1	14.2	0.0	0.6	0.0	0.2	0.0	26.6	0.0	0.0	41.7	1.1	8.5	16.2	10.3	0.3	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.9	0.0	19.8	0.0	3.7	0.0	3.9	3.3	0.1	1.2	0.5	0.0	0.0	1.0	1.7	0.0	0.0	8.1	0.2	5.8	0.0	0.2	0.0	0.0	1.2	0.0	8.9	0.9	7.5	15.6	0.0	2.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.6	1.8	1.1	0.1	0.0	1.6	55.8	56.2	4.7	29.5	55.6	30.6	59.4	17.0	29.1	49.4	0.0	0.6	0.0	10.4	11.6	0.0	0.8	0.0	2.7	10.3	0.0	0.0	0.5	1.7	1.3	1.0	1.7	5.1	0.0	2.5	0.3	45.6	9.6	0.0	0.0	3.3	0.0	0.0	3.1	3.3	1.5	35.9	2.5	13.5	12.6	3.7	1.1	1.7	0.0	66.4	0.0	0.0	0.0	7.2	0.0	2.4	8.2	0.7	0.0	4.0	5.5
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 15.8;ovary: 10.0"	"Cell type enriched"	"Detected in some"	7	"Leydig cells: 18.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.3;NTERA-2: 16.7;RH-30: 7.0;SuSa: 4.0;U-937: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853"	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	1.5	0.2	6.0	1.0	2.1	0.6	2.0	4.9	3.7	1.8	0.9	7.4	0.7	0.2	2.9	0.8	1.8	1.1	2.1	1.9	15.8	1.4	0.3	0.3	0.3	0.2	2.4	4.0	10.0	0.7	0.1	0.7	0.2	3.6	0.6	1.2	0.5	1.0	1.6	0.2	1.6	0.9	1.3	3.8	0.4	1.5	0.8	5.6	0.0	0.6	0.8	1.2	1.4	0.9	0.0	0.5	7.4	0.0	0.0	0.0	0.1	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.6	1.1	1.4	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.7	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.1	2.3	0.0	0.5	1.8	16.7	0.0	0.2	0.9	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	2.7	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.7	0.7	4.0	1.6	7.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	6.0	2.1	4.9	3.5	15.8	1.4	2.4	4.0	3.6	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.7	0.0	1.7	1.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1310.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	18.1	10.1	13.0	10.7	18.3	6.0	22.1	20.0	16.4	10.5	8.6	10.9	7.3	8.9	11.0	15.0	20.0	7.0	10.4	12.8	11.6	11.9	7.6	13.2	8.0	15.4	13.2	11.2	19.3	7.5	17.2	32.0	9.0	17.9	9.6	7.1	9.0	14.4	11.6	88.4	6.5	9.2	11.0	10.3	8.4	7.6	39.0	13.2	8.3	8.1	14.0	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8.0	11.1	3.2	5.5	6.6	5.5	12.3	25.5	28.4	2.8	7.8	13.4	5.0	8.7	2.4	5.5	2.7	1.0	6.6	14.8	6.0	6.2	17.0	4.6	11.4	3.4	6.8	3.7	3.5	9.0	4.7	32.1	25.6	7.7	20.8	7.9	14.7	9.7	6.7	9.4	24.7	3.7	2.1	4.4	4.1	5.7	1.8	6.7	6.1	10.1	17.3	12.7	3.6	15.3	12.1	2.8	6.8	17.5	5.5	1.7	2.6	6.8	8.0	7.2	5.1	6.7	38.8	30.0	5.2	11.3	8.4	5.9	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5.0	8.4	7.1	1.1	8.0	2.1	9.6	10.5	3.2	13.0	18.3	20.0	14.4	11.6	11.9	13.2	11.2	17.9	13.2	20.8	49.1	22.9	38.9	16.9	40.6	49.5	25.5	61.6	63.7	10.4	80.5	7.3	6.6	18.7	314.7	24.6	9.7	0.0	24.2	5.3	24.6	29.2	33.6	21.9	8.1	46.1	34.7	15.4	15.7	1310.7	110.1	27.2	16.9	7.2	23.9	16.4	25.5	11.6	169.0	3.4	47.2	32.3	20.6	18.4	17.8	10.5	10.3	57.5	13.6	26.8
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013315	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Cell type enhanced"	"Detected in all"	5	"Cholangiocytes: 140.1;Hepatocytes: 111.5;Horizontal cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	6.8	5.6	13.0	10.5	18.4	9.2	7.7	11.9	16.5	6.6	25.2	10.4	2.4	31.6	6.7	3.9	5.9	6.3	14.3	5.1	11.0	14.5	20.7	83.9	11.8	11.8	11.2	9.8	8.8	9.0	9.7	8.2	16.3	15.3	5.8	7.4	6.8	4.4	5.3	2.2	2.7	43.3	6.1	9.6	10.7	15.6	13.5	9.6	6.3	7.5	1.5	10.0	6.8	6.7	1.2	1.1	20.8	2.0	10.1	9.5	2.1	4.9	6.7	10.6	3.7	18.4	17.1	6.3	12.0	14.6	11.9	11.6	8.7	4.2	3.6	7.3	18.3	18.6	0.2	8.7	3.7	9.4	7.0	1.8	9.2	5.2	9.9	17.2	7.3	10.2	17.2	2.5	11.8	10.3	17.3	14.8	8.8	8.3	1.9	16.7	3.7	9.1	6.3	3.4	7.4	9.6	16.1	9.2	13.4	9.5	11.1	9.0	6.2	11.2	5.3	3.8	6.4	0.0	10.1	20.8	15.4	18.7	19.7	8.8	3.5	5.3	7.8	13.6	7.5	5.4	6.5	2.0	6.1	9.3	1.3	9.5	0.9	7.1	5.3	0.8	1.2	7.3	4.7	20.8	10.1	0.6	1.1	6.3	2.1	13.0	18.4	11.9	16.5	11.0	14.5	11.2	9.8	15.3	9.6	62.5	38.2	16.9	8.2	4.9	31.9	10.4	140.1	21.4	35.2	36.6	13.7	17.4	14.9	9.7	2.1	17.5	52.0	46.7	16.6	9.6	15.9	14.5	11.6	111.5	19.6	109.7	14.3	20.3	21.0	6.9	21.0	19.9	8.5	24.4	30.3	16.0	18.6	10.5	29.4	40.8	14.8	6.5	9.9	28.8	59.6	1.8	41.4	39.9	11.9	3.4
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264531-151015727	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cone photoreceptor cells: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		190000	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.6	15.8	7.1	14.7	10.9	7.2	16.5	14.4	8.3	11.3	12.2	7.3	17.9	9.8	12.9	11.8	21.4	11.9	12.7	10.5	6.4	4.3	18.4	10.2	10.1	14.2	7.4	5.6	10.1	13.8	33.0	32.1	8.8	7.7	14.3	13.0	8.3	18.2	15.1	10.5	20.5	14.7	7.9	8.3	11.3	12.8	10.1	7.8	26.5	15.2	11.0	17.9	14.0	12.4	5.7	2.6	5.9	0.8	3.8	7.9	2.3	15.5	8.0	7.3	6.3	7.8	10.8	9.1	3.3	8.9	6.3	6.2	17.3	19.8	18.0	4.1	5.0	4.6	8.0	12.2	19.5	9.6	13.5	8.8	12.7	12.4	9.3	4.6	17.0	10.2	8.4	11.7	9.3	14.5	14.2	19.0	8.5	13.2	12.8	7.4	10.4	12.4	2.2	6.2	11.6	6.0	10.2	7.6	6.6	20.4	20.6	18.9	7.7	8.9	18.1	4.4	11.3	17.9	3.3	10.0	9.1	6.7	5.0	6.4	12.0	11.6	12.3	14.2	7.0	4.6	5.9	0.7	1.6	7.9	0.3	4.7	5.7	5.3	6.9	1.5	3.5	3.7	5.6	0.2	3.8	0.8	2.6	5.9	2.3	7.1	10.9	14.4	8.3	6.4	4.3	7.4	5.6	7.7	7.8	14.9	9.3	40.2	13.9	15.5	29.4	50.2	20.4	22.7	15.9	48.8	139.4	19.8	8.3	13.5	14.3	11.7	19.3	23.3	11.7	9.5	8.8	23.4	5.8	18.7	5.4	28.6	40.4	11.6	8.5	3.1	8.9	9.2	15.1	5.4	25.0	21.7	13.7	21.8	9.6	13.6	68.2	6.5	6.6	8.1	21.3	20.7	20.3	34.9	29.8	21.2
LRCH1	"CHDC1, KIAA1016"	ENSG00000136141	"Leucine rich repeats and calponin homology domain containing 1"	Q9Y2L9	13	46553168-46753040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 46.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021536	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"	Nucleoli	"HPA021536: AB_1853258"	"unprognostic (7.13e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (3.59e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.98e-2)"	17.9	5.0	6.5	20.3	5.9	7.2	15.2	46.4	7.2	17.5	14.6	4.6	11.5	7.0	24.6	9.8	10.6	11.9	14.1	8.0	6.3	5.9	13.8	10.9	14.3	13.5	6.6	4.9	9.5	5.1	5.2	13.1	24.1	8.0	12.8	9.3	8.4	11.3	14.5	5.3	18.1	12.0	20.9	8.5	13.7	14.6	5.0	6.0	31.7	7.8	6.4	13.7	16.6	18.3	6.2	2.3	1.8	2.0	5.1	3.6	1.8	4.3	6.3	5.7	5.9	4.2	8.0	14.7	7.5	9.9	9.4	8.9	14.2	7.5	14.0	2.1	7.1	6.1	6.3	4.3	7.6	13.6	14.4	4.1	12.6	2.5	6.6	5.2	8.1	21.6	5.1	6.0	8.6	10.5	7.7	8.0	9.5	2.4	4.3	6.9	8.5	8.7	10.2	3.2	27.7	3.3	4.8	6.2	3.7	17.5	4.6	9.1	9.1	4.2	4.2	11.2	10.6	3.2	11.0	7.6	5.5	3.7	6.8	7.1	0.8	2.1	6.3	6.4	7.2	6.6	1.5	2.0	1.8	3.6	1.6	2.1	5.3	2.7	2.6	1.9	6.2	2.1	2.1	0.7	5.1	1.2	2.3	1.9	1.8	6.5	5.9	46.4	7.2	6.3	5.9	6.6	4.9	8.0	6.0	6.0	6.7	15.1	9.1	33.3	8.2	6.7	25.5	1.4	6.8	21.0	21.6	11.1	8.3	7.2	1.2	25.9	6.9	0.0	3.5	10.0	10.5	7.9	27.6	7.9	11.4	3.2	1.7	16.5	16.7	1.1	12.0	9.9	28.7	5.4	9.7	6.4	9.5	5.8	15.9	7.3	8.9	12.9	21.7	0.7	3.2	29.1	8.1	10.2	6.5	7.8
LRCH2	KIAA1495	ENSG00000130224	"Leucine rich repeats and calponin homology domain containing 2"	Q5VUJ6	X	115110616-115234072	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 10.5;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;hTERT-RPE1: 9.1;U-266/70: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003233	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			Nucleoli	"Plasma membrane"	"HPA003233: AB_2265929"	"unprognostic (9.74e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.09e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.16e-2)"	5.1	8.7	11.6	3.4	10.2	0.7	3.3	11.2	10.6	11.2	11.6	5.5	4.0	1.6	9.9	4.5	3.6	4.6	5.3	4.7	7.9	8.9	2.6	1.0	5.7	1.8	5.7	4.6	13.8	1.6	1.3	20.9	13.7	7.6	16.4	4.2	2.5	1.3	14.5	1.2	1.1	3.2	13.7	6.4	3.7	3.6	4.3	7.9	0.0	4.8	0.4	1.1	11.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.9	5.5	4.6	0.0	3.5	7.6	3.4	7.9	0.0	0.0	0.1	0.0	4.6	2.7	0.3	17.8	0.0	5.2	0.0	4.8	0.0	0.0	0.0	4.4	0.0	0.1	2.7	0.0	1.4	0.2	9.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	5.2	0.0	3.8	0.0	4.3	0.5	0.0	6.8	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	2.1	0.0	4.9	11.8	2.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	10.2	11.2	8.4	7.9	8.9	5.7	4.6	7.6	7.9	3.0	10.5	0.0	0.0	0.6	6.7	5.5	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.0	5.7	4.5	0.0	0.0	0.0	0.1	5.4	1.2	0.0	0.0	0.5	1.6	0.0	1.8	0.0	1.5	8.1	0.0	1.7	0.0	0.0	6.6	0.0	0.0	6.0	0.0	2.4	25.8	7.1	3.6	3.0	0.1	0.2	0.0	0.0	0.0
LRCH4	"LRN, LRRN1"	ENSG00000077454	"Leucine rich repeats and calponin homology domain containing 4"	O75427	7	100574011-100586153	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 153.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 45.7;NB-4: 70.7"					"Low region specificity"	"Detected in all"			"HPA037667, HPA037668"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA037667: AB_10671882, HPA037668: AB_10672910"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.32e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.98e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.63e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.26e-2)"	11.4	15.2	14.5	32.0	25.7	52.7	13.8	19.7	22.2	12.0	14.0	16.4	11.8	22.0	12.3	9.6	14.4	14.0	15.9	10.2	16.2	9.1	16.1	12.2	20.8	39.1	25.8	13.1	23.7	17.3	8.9	22.8	26.4	19.2	14.6	7.2	18.3	23.5	13.0	15.8	15.0	27.8	8.1	25.7	54.5	14.9	43.3	23.1	31.1	20.0	6.8	25.2	9.9	12.0	5.9	6.2	24.2	8.4	1.4	7.3	2.9	7.9	4.5	4.5	4.0	2.7	2.1	8.6	7.7	3.5	4.5	3.7	7.5	11.7	5.8	8.7	2.3	4.8	6.9	2.2	3.2	1.3	5.7	6.0	6.6	5.3	3.5	8.6	11.4	45.7	3.5	3.5	3.8	2.1	2.9	4.6	15.2	8.2	11.9	3.2	15.0	13.1	70.7	4.7	7.4	5.3	14.6	3.7	7.1	3.5	2.8	5.9	8.8	3.7	11.8	9.0	6.1	7.9	24.9	7.2	6.2	11.3	8.6	4.6	12.1	5.7	5.2	4.8	28.3	10.6	12.6	8.4	11.9	5.2	6.8	4.7	4.7	5.1	5.9	6.2	5.9	7.3	5.9	24.2	1.4	4.7	5.9	5.2	2.9	14.5	25.7	19.7	22.2	16.2	9.1	25.8	13.1	19.2	23.1	8.9	16.7	24.7	13.8	10.6	13.6	0.7	25.5	6.7	6.8	21.0	39.3	33.4	13.3	27.1	153.1	9.5	22.2	0.0	21.3	11.2	9.5	12.1	18.5	11.3	30.3	12.7	5.8	15.4	53.4	19.7	23.0	33.3	13.5	52.3	12.9	15.5	23.1	14.0	9.6	6.2	29.9	19.4	12.2	42.6	28.7	10.0	86.4	42.9	11.0	14.2
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536409-4540474	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 636.5"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 728.6"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	19	"neutrophil: 58.9"	"Lineage enriched"	"Detected in many"	42	"granulocytes: 58.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.2;HMC-1: 8.3;SK-BR-3: 8.8;THP-1: 14.8;U-937: 27.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	21000000000	74000000000	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.60e-2)"	1.7	0.9	0.2	3.3	0.4	5.4	0.9	0.2	0.3	1.7	1.3	0.2	2.2	1.1	0.3	1.1	4.5	1.9	3.0	0.9	0.4	0.2	3.5	636.5	2.2	5.7	0.7	0.1	1.5	8.1	0.0	0.7	0.4	0.4	1.1	0.8	0.3	4.1	3.0	0.5	0.8	0.6	0.2	0.3	4.3	2.3	0.5	0.3	0.3	0.9	1.7	3.4	1.4	1.3	0.1	0.3	58.9	1.4	0.0	0.2	0.4	5.9	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.6	4.3	2.1	7.7	0.0	0.3	0.8	0.0	1.0	0.0	7.7	0.2	0.1	0.1	8.2	0.0	0.2	8.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.3	0.0	6.0	0.1	4.7	0.0	0.0	0.1	6.2	0.6	1.1	0.0	0.0	0.0	8.8	0.1	0.8	2.6	14.8	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	27.4	0.0	0.5	1.4	3.0	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	58.9	0.0	0.2	0.0	0.2	0.4	0.2	0.4	0.2	0.3	0.4	0.2	0.7	0.1	0.4	0.3	11.9	51.2	16.5	26.9	7.1	0.0	0.4	58.6	78.9	39.8	14.0	0.0	0.5	1.7	54.6	0.0	8.3	25.4	0.0	54.4	10.6	1.4	2.9	11.5	728.6	5.4	1.6	4.7	42.4	17.4	0.0	0.0	7.6	1.7	10.0	20.0	0.0	55.9	7.0	0.0	3.6	0.0	0.0	2.1	0.0	0.2	5.1	1.1	2.9	16.7	29.6
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947185-110964079	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"	9.0	11.2	13.7	15.4	15.5	5.9	20.7	15.6	14.7	7.9	7.5	6.6	7.8	7.0	8.1	23.9	8.1	9.6	6.7	16.1	12.7	13.3	9.6	16.7	11.9	17.6	10.5	7.5	18.4	6.9	5.8	17.5	25.1	10.3	9.9	7.6	7.3	8.6	9.2	20.5	10.6	8.4	6.0	12.4	14.0	8.1	27.7	10.1	16.8	12.6	10.2	19.0	10.0	28.5	21.0	11.4	21.4	8.2	18.0	19.4	8.4	12.0	5.3	10.2	6.9	4.7	7.7	11.5	7.4	8.6	13.1	10.6	13.4	15.3	9.2	10.7	5.6	14.0	7.9	4.8	4.4	15.9	16.7	5.7	10.2	5.4	13.8	14.0	19.2	12.5	4.8	12.4	9.0	15.9	5.5	7.0	9.9	31.8	42.6	8.7	4.0	1.9	15.3	15.3	7.4	12.3	12.8	16.7	11.2	3.4	6.3	8.5	9.4	0.0	12.9	21.6	6.5	10.6	31.3	4.9	11.6	0.4	13.6	6.0	19.8	6.8	17.4	6.6	22.0	20.0	13.0	5.7	12.3	15.3	6.3	19.4	21.0	12.1	15.8	11.4	15.5	13.5	18.5	21.4	18.0	8.2	10.3	11.1	8.4	13.7	15.5	15.6	14.7	12.7	13.3	10.5	7.5	10.3	10.1	11.9	6.7	21.2	56.0	12.8	19.8	20.2	10.2	21.4	10.3	8.7	17.7	16.2	13.3	13.9	9.9	18.0	11.4	0.0	17.5	26.9	16.6	45.6	8.1	25.1	12.1	14.3	10.9	13.5	8.5	8.9	14.7	18.8	30.4	19.0	10.4	26.9	17.0	13.9	13.1	7.9	30.3	12.9	23.0	32.1	49.1	15.4	31.6	28.7	9.8	43.3
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 64.0"	"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 48.2;Muller glia cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.7"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.8;hTEC/SVTERT24-B: 18.7;U-698: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		21000	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	12.6	1.7	22.3	8.1	21.1	2.4	13.4	9.6	31.8	15.5	24.6	20.3	0.7	8.2	12.7	2.6	6.9	13.3	13.8	16.8	24.6	7.1	2.5	15.8	8.6	4.1	19.8	12.4	8.8	64.0	4.2	6.7	2.8	18.9	12.2	7.6	4.8	9.4	4.3	16.6	6.6	7.5	14.5	10.9	2.4	21.2	6.4	19.8	0.2	8.1	5.0	5.0	5.1	5.4	0.3	0.0	0.7	0.0	0.0	2.7	0.4	0.4	0.4	9.5	0.1	2.6	1.7	0.8	1.5	8.9	1.5	4.8	7.4	0.0	23.8	4.1	0.7	2.1	0.0	1.8	3.2	3.4	0.0	4.9	0.0	1.4	0.6	0.6	0.2	5.4	2.1	1.8	18.7	3.1	6.5	8.2	0.1	0.0	0.0	0.3	1.1	0.0	0.0	7.1	0.7	0.0	4.3	2.8	1.2	1.8	0.0	1.2	0.3	1.4	1.4	0.0	1.7	8.5	2.1	2.5	4.7	2.0	9.2	3.9	1.9	0.9	18.2	8.3	0.0	1.6	0.0	0.0	0.7	0.4	0.0	1.4	0.3	1.1	1.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	2.7	0.4	22.3	21.1	9.6	20.2	24.6	7.1	19.8	12.4	18.9	19.8	35.7	42.0	2.7	7.5	10.1	1.7	28.8	7.6	48.2	30.7	0.0	7.9	0.2	1.7	5.5	1.5	9.8	7.1	0.0	14.9	0.1	9.4	18.3	1.1	17.4	1.5	7.9	25.4	4.3	1.0	1.3	10.6	3.1	10.1	1.8	24.4	47.3	6.2	7.0	16.3	1.0	6.5	0.0	9.2	1.5	18.1	10.0	0.1	9.6	19.5	3.7
LRIG2	KIAA0806	ENSG00000198799	"Leucine rich repeats and immunoglobulin like domains 2"	O94898	1	113073209-113132260	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015538	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		510000	"Golgi apparatus"	Nucleoplasm	"HPA015538: AB_2250170"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	8.3	7.7	10.1	11.4	10.6	4.7	10.7	15.6	10.0	11.6	9.2	16.1	6.0	10.8	15.1	14.9	7.8	9.2	8.2	7.3	9.3	9.1	9.2	6.3	8.0	9.7	13.0	6.7	15.0	8.5	13.4	11.6	10.1	9.2	9.3	8.6	14.6	9.0	11.2	13.1	16.6	9.5	8.9	11.6	10.1	8.1	9.4	13.4	10.4	12.6	5.0	10.7	8.6	10.7	4.4	2.6	4.9	2.5	4.8	3.9	1.7	4.3	2.4	6.7	5.0	6.4	6.6	3.8	2.8	4.2	3.4	5.8	3.5	2.8	4.5	5.0	3.5	1.9	5.0	4.6	3.0	5.7	3.1	2.7	4.8	4.5	1.7	6.5	5.7	2.3	6.5	5.5	5.4	7.1	5.3	4.4	6.3	5.7	4.3	4.2	3.2	5.7	6.1	6.2	1.8	4.0	5.3	8.4	2.2	3.3	2.9	4.8	3.8	5.0	3.3	6.4	5.7	2.5	6.4	6.6	6.4	3.4	8.7	4.5	4.7	2.2	4.6	6.8	3.6	5.9	4.9	2.5	1.5	3.1	2.0	3.5	3.1	3.4	3.2	1.9	4.4	3.9	3.6	1.7	4.8	2.1	2.6	2.6	1.7	10.1	10.6	15.6	10.0	9.3	9.1	13.0	6.7	9.2	13.4	0.0	13.3	5.9	2.5	7.4	19.1	8.1	12.7	12.0	6.8	14.0	35.3	5.8	0.0	3.2	0.9	6.3	9.9	0.0	2.3	3.7	5.7	4.7	5.7	4.3	4.1	17.5	5.2	6.2	8.5	0.0	17.0	5.9	6.8	1.8	7.1	27.0	2.7	7.0	15.2	4.1	21.3	0.0	4.2	8.6	14.9	5.8	4.5	7.0	8.3	3.4
LRIG3	"FLJ90440, KIAA3016"	ENSG00000139263	"Leucine rich repeats and immunoglobulin like domains 3"	Q6UXM1	12	58872149-58920522	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 27.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010773	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA010773: AB_1853275"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.46e-2)"	15.8	1.7	3.6	11.8	4.1	0.0	16.4	1.0	3.7	18.7	14.8	7.8	12.1	8.4	14.2	13.8	17.1	9.9	17.8	4.7	4.6	1.8	6.5	6.1	9.6	5.0	3.6	2.6	14.7	15.3	4.8	10.3	6.8	5.8	15.5	16.0	13.5	24.9	11.6	5.0	25.9	10.0	21.6	3.0	7.2	13.5	6.4	6.6	5.4	37.6	15.0	12.8	15.7	20.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	1.9	7.4	0.5	13.6	15.9	1.7	4.9	14.3	4.8	5.1	5.8	2.7	1.9	10.0	5.4	5.8	9.6	2.7	12.6	3.5	14.6	9.6	0.5	3.3	2.8	2.6	0.8	0.2	15.7	27.4	5.1	11.0	9.4	13.1	2.2	0.1	2.4	3.2	0.9	2.3	0.0	7.9	2.4	2.9	0.0	6.3	4.8	3.7	10.6	7.5	0.0	4.3	2.7	4.5	11.0	5.0	0.1	5.6	6.5	4.5	3.9	6.4	1.0	0.0	0.0	1.3	0.0	3.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	4.1	1.0	3.7	4.6	1.8	3.6	2.6	5.8	6.6	14.9	17.4	0.0	7.5	19.9	2.6	4.1	33.1	13.4	23.9	1.8	0.0	0.7	0.0	9.0	0.3	11.4	10.7	0.0	15.8	0.4	8.2	2.6	0.0	6.8	1.9	3.2	11.1	4.3	0.3	0.0	25.0	0.2	3.3	0.0	11.8	2.8	7.5	14.0	27.3	4.2	0.1	6.5	11.3	0.4	1.5	19.6	0.2	0.0	25.9	2.7
LRIT3	"CSNB1F, FIGLER4, FLJ44691"	ENSG00000183423	"Leucine rich repeat, Ig-like and transmembrane domains 3"	Q3SXY7	4	109848202-109872315	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 17.1"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013454	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA013454: AB_1853277"	"unprognostic (5.41e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.14e-2)"	0.6	0.6	0.7	0.6	1.2	0.4	1.7	2.0	1.3	1.2	0.6	0.6	0.6	0.3	0.7	1.8	0.6	1.0	0.6	0.6	0.8	0.7	4.4	0.7	0.6	0.6	0.6	0.6	0.6	0.7	0.7	0.6	0.6	0.6	0.9	0.5	17.1	0.8	0.6	1.6	3.2	0.6	0.6	0.6	0.8	0.2	1.3	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.1	0.3	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.0	0.6	0.6	0.0	0.0	0.1	1.3	0.1	0.2	0.3	1.6	0.3	0.4	0.2	0.1	1.3	0.0	0.0	2.0	0.1	0.3	0.2	0.1	1.3	0.3	0.6	0.0	0.0	0.9	1.0	0.2	0.8	0.2	0.6	0.0	0.2	1.0	0.3	0.5	0.0	0.0	0.4	0.0	0.3	0.1	1.2	0.0	0.3	0.3	0.6	0.3	0.6	1.0	0.0	0.3	0.9	0.3	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.7	1.2	2.0	1.3	0.8	0.7	0.6	0.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	31.4	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LRMDA	"C10orf11, CDA017, OCA7"	ENSG00000148655	"Leucine rich melanocyte differentiation associated"	Q9H2I8	10	75431453-76560167	"Disease related genes, Predicted intracellular proteins"	Differentiation		Albinism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Distal tubular cells: 28.2;Hofbauer cells: 48.4;Proximal tubular cells: 72.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 23.6;myeloid DC: 27.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 27.3;granulocytes: 8.7;monocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 18.4;HMC-1: 14.3;NB-4: 26.5;SK-MEL-30: 37.3;THP-1: 19.8;U-937: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047446, HPA050419"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047446: AB_2680050, HPA050419: AB_2756316"	"unprognostic (1.04e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (6.80e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.26e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.64e-2)"	12.7	35.3	4.6	4.7	6.4	13.2	6.1	2.6	3.6	7.1	4.6	8.2	12.5	3.1	12.5	34.9	5.3	5.7	8.9	13.2	3.7	5.1	11.5	19.1	13.1	5.6	7.4	3.1	8.6	21.0	6.8	9.7	6.9	6.7	8.3	4.0	19.8	10.7	8.8	2.2	2.3	4.5	5.3	8.1	7.8	8.6	5.8	5.0	0.1	13.2	6.9	3.9	5.5	5.3	0.0	27.3	8.7	23.6	2.6	0.1	6.7	0.1	2.6	0.1	0.0	1.2	1.5	0.0	0.3	0.0	0.1	0.2	3.1	5.5	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.6	1.3	18.4	0.5	3.7	14.3	0.7	0.5	0.3	0.0	2.3	0.5	0.0	0.0	0.6	0.0	0.4	0.0	26.5	0.1	1.6	1.1	0.0	0.1	0.0	0.2	3.4	0.1	0.2	3.3	0.0	37.3	0.1	0.2	19.8	0.3	0.1	1.4	1.0	2.1	0.2	0.0	0.0	9.6	17.7	4.7	2.6	23.6	8.7	0.0	11.2	0.1	0.0	0.0	0.0	27.3	0.0	0.0	0.0	1.3	2.6	6.4	0.2	0.0	6.7	4.6	6.4	2.6	3.6	3.7	5.1	7.4	3.1	6.7	5.0	20.8	17.5	0.0	0.0	0.0	0.0	0.0	0.0	12.0	6.8	12.2	0.0	0.9	28.2	17.1	0.0	0.0	0.0	0.0	13.8	0.8	0.0	0.0	7.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	11.8	0.0	0.0	15.2	0.0	0.0	72.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128493-57213351	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	"Developmental protein, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 153.3;Leydig cells: 216.0;Peritubular cells: 173.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 7.6;intermediate monocyte: 4.0;myeloid DC: 2.8;non-classical monocyte: 3.7"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.8;monocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 83.1;ASC TERT1: 84.4;fHDF/TERT166: 36.2;HSkMC: 54.7;hTERT-RPE1: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		88000000	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	77.8	12.0	19.8	21.5	21.3	6.1	27.7	28.1	25.3	31.4	19.7	11.9	9.0	17.8	26.9	18.2	19.2	21.0	24.1	26.0	18.6	10.4	6.3	31.4	24.7	5.5	13.9	15.6	56.9	8.8	8.5	8.0	29.4	17.1	21.4	9.5	20.0	14.8	17.0	11.3	15.7	14.2	22.4	14.3	11.3	11.8	11.1	15.4	0.3	13.2	9.3	3.1	22.9	39.4	0.0	2.8	0.1	7.6	0.0	0.2	1.9	1.2	2.3	5.1	4.0	83.1	84.4	15.3	14.0	18.1	4.6	4.5	4.3	2.0	0.0	1.7	36.2	1.0	5.5	0.8	1.4	1.6	0.1	0.2	0.0	2.7	9.0	11.4	0.0	2.4	54.7	0.5	10.3	1.2	42.1	0.2	0.1	0.0	0.2	14.4	0.2	0.0	0.0	5.8	1.7	1.4	0.5	28.8	0.2	0.3	0.3	0.2	2.8	3.1	0.1	2.2	7.4	0.4	0.2	0.2	16.2	6.0	9.0	0.8	0.1	0.0	0.0	28.4	0.0	3.1	0.0	7.6	0.0	0.0	4.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.2	0.1	0.0	3.7	0.0	0.0	1.9	19.8	21.3	28.1	19.7	18.6	10.4	13.9	15.6	17.1	15.4	11.9	9.6	3.7	11.4	21.3	25.5	12.1	20.4	5.3	11.4	1.8	0.0	65.3	0.0	7.8	1.6	5.8	72.1	0.0	1.6	42.2	117.6	4.4	5.8	153.3	72.0	7.9	4.1	16.0	118.9	3.6	216.0	50.7	27.0	3.6	14.3	130.1	9.9	18.6	173.2	2.2	3.8	38.8	44.2	1.4	2.2	14.1	105.3	0.9	20.9	10.2
LRP10	"DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087"	ENSG00000197324	"LDL receptor related protein 10"	Q7Z4F1	14	22871613-22881580	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000932			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA000932: AB_2281523"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (3.54e-7)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.55e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (3.06e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.14e-2)"	33.1	20.1	12.7	26.0	13.1	23.7	37.2	5.8	10.3	32.0	52.4	16.2	41.0	31.7	39.0	46.8	66.1	27.1	65.1	27.7	13.6	6.0	46.5	63.3	34.1	30.0	14.2	8.1	30.7	36.6	31.4	11.7	32.0	14.4	36.9	19.0	22.6	36.1	41.1	21.2	32.9	65.9	32.0	11.2	26.1	37.9	19.1	12.9	20.7	46.9	34.1	36.2	43.3	42.8	3.8	2.3	29.7	2.6	2.4	6.3	3.4	15.4	18.9	4.1	10.8	56.7	32.9	14.1	24.5	46.6	15.5	21.5	5.8	55.1	8.1	12.3	55.1	17.7	22.2	2.7	28.0	6.1	13.2	2.9	2.8	10.4	4.0	25.3	6.4	25.9	35.9	32.8	23.1	12.0	43.0	28.2	3.7	3.4	31.4	20.8	17.8	1.8	1.9	0.9	15.0	25.5	4.1	4.2	8.1	16.6	27.6	0.3	4.5	13.5	26.0	10.6	3.2	13.6	4.6	29.3	23.9	6.8	12.3	10.0	14.7	8.7	3.7	12.3	2.6	10.2	5.9	2.2	15.8	5.1	2.3	5.0	3.8	6.3	6.0	2.3	2.7	5.5	3.1	29.7	2.4	2.6	1.9	6.0	3.4	12.7	13.1	5.8	10.3	13.6	6.0	14.2	8.1	14.4	12.9	98.3	51.7	60.9	74.0	34.2	2.2	27.2	107.0	37.5	59.1	78.5	0.0	55.7	8.3	146.7	9.9	50.6	243.0	46.7	208.6	82.1	65.3	100.3	34.6	35.4	52.6	0.0	63.9	69.3	49.2	11.4	52.6	36.1	52.3	101.0	99.6	89.2	227.5	199.9	68.6	40.8	8.3	64.7	65.9	2.6	6.7	41.5	110.6	62.3	73.3	132.4
LRP11	"bA350J20.3, MANSC3"	ENSG00000120256	"LDL receptor related protein 11"	Q86VZ4	6	149818798-149864026	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017267			Approved	"Vesicles,Plasma membrane"		NA	NA		640000	"Plasma membrane"	Vesicles	"HPA017267: "	"prognostic unfavorable (2.31e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.23e-2)"	12.0	16.5	17.8	4.4	26.9	1.6	11.2	17.9	25.6	14.0	11.5	15.1	9.4	10.5	10.6	14.8	20.2	20.2	10.5	8.0	19.7	19.3	18.2	9.0	12.1	2.2	15.0	16.9	15.3	17.2	46.2	15.2	14.7	20.6	23.3	11.4	10.8	14.2	12.3	8.1	20.2	8.7	10.9	13.3	3.6	14.4	7.2	15.6	0.8	20.8	13.8	6.4	17.3	14.2	3.5	1.0	0.0	1.7	0.0	0.7	0.1	9.5	8.4	6.4	5.6	14.3	26.2	1.2	10.0	19.6	7.0	8.5	2.5	20.0	0.1	13.7	15.7	30.9	25.6	7.2	18.2	5.0	15.4	7.2	4.5	30.9	11.0	8.8	4.6	0.1	16.3	35.5	9.0	17.8	19.9	10.8	4.4	9.3	4.3	8.3	16.5	0.1	0.1	3.8	19.0	8.4	5.0	9.6	2.2	12.6	19.6	8.5	5.7	31.6	17.7	6.0	3.3	14.5	9.6	8.4	8.8	2.0	18.3	7.6	0.0	3.0	2.2	15.9	4.7	5.1	0.0	0.1	0.0	0.2	0.4	0.0	3.5	0.7	0.6	1.0	0.6	0.2	0.3	0.0	0.0	1.7	0.0	0.0	0.1	17.8	26.9	17.9	25.6	19.7	19.3	15.0	16.9	20.6	15.6	6.0	3.2	0.8	10.9	10.1	10.5	7.6	20.4	24.1	5.7	19.2	2.0	1.4	5.0	5.6	26.8	6.8	3.9	0.0	19.4	2.2	12.9	21.0	0.0	8.3	2.9	7.9	28.3	11.1	1.8	24.2	15.3	1.1	13.5	0.0	3.7	6.3	16.2	2.9	13.8	5.4	5.4	0.0	5.6	6.1	5.9	12.5	4.7	0.0	11.3	20.6
LRP12	"FLJ12929, ST7"	ENSG00000147650	"LDL receptor related protein 12"	Q9Y561	8	104489231-104589024	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 22.6"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 22.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017245	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane,Mitochondria"		NA	NA			"Nucleoli fibrillar center, Plasma membrane, Mitochondria"		"HPA017245: AB_1857532"	"unprognostic (2.17e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.87e-4)"	"unprognostic (2.96e-2)"	"unprognostic (3.96e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	6.1	5.3	10.7	4.0	23.4	2.1	4.7	11.3	16.3	7.4	5.1	4.3	5.1	3.3	18.2	4.5	4.6	6.9	8.1	14.2	8.7	6.5	7.2	1.6	4.8	1.6	4.6	9.5	6.9	5.4	13.0	11.0	5.6	7.1	7.4	5.3	3.3	5.0	6.8	11.8	5.1	3.1	20.2	4.1	3.8	3.8	5.0	5.2	18.0	7.4	3.4	2.4	6.2	5.4	0.0	0.3	22.6	0.4	0.4	1.0	0.2	7.3	4.3	8.8	15.4	10.0	8.0	1.9	21.1	21.2	7.4	10.4	0.9	7.3	0.0	8.5	19.9	8.9	3.3	3.6	9.0	15.9	13.7	3.4	11.5	2.0	0.3	6.2	0.1	9.3	10.6	6.4	12.3	10.1	26.8	3.8	9.0	2.4	0.0	26.4	1.2	10.5	0.2	2.2	0.6	7.5	0.8	8.6	1.6	5.9	0.3	11.3	6.9	6.7	0.3	18.0	6.9	2.0	2.2	10.5	20.4	13.2	6.5	13.6	10.0	7.8	0.0	11.0	0.0	22.3	22.6	0.2	3.5	0.1	0.4	1.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.3	0.0	0.2	10.7	23.4	11.3	16.3	8.7	6.5	4.6	9.5	7.1	5.2	14.9	2.1	0.0	5.3	10.2	16.6	9.8	7.6	4.0	3.4	14.0	5.9	0.2	0.0	3.9	3.3	6.7	0.8	0.0	3.9	0.3	9.4	5.6	8.1	0.5	5.1	27.0	13.8	3.7	7.3	1.6	8.1	4.8	6.8	8.2	2.3	4.8	4.4	0.0	8.5	2.9	7.4	6.5	9.0	7.2	11.0	9.5	0.2	4.9	1.7	4.3
LRP1B	"LRP-DIT, LRPDIT"	ENSG00000168702	"LDL receptor related protein 1B"	Q9NZR2	2	140231423-142131701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7;thyroid gland: 14.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 15.8;Early spermatids: 4.6;Late spermatids: 4.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.4;plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;HEK 293: 4.5;HeLa: 2.3;HSkMC: 2.2;U-138 MG: 4.9;U-87 MG: 2.6"	"Low region specificity"	"Detected in all"							"HPA069094, HPA074788"	Approved		Approved	Vesicles		NA	NA		63000	Vesicles		"HPA069094: AB_2686082, HPA074788: AB_2797273"	"unprognostic (5.31e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.36e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.85e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-1)"	4.8	4.5	17.6	1.3	14.1	1.2	2.6	23.2	25.7	1.4	1.3	6.5	0.0	1.2	1.3	6.8	1.3	1.9	1.4	1.6	18.3	9.3	2.2	1.6	1.4	1.2	10.8	16.7	3.0	1.2	1.1	12.7	1.2	12.8	3.5	1.3	0.1	2.5	3.8	10.5	1.7	1.3	1.3	8.2	1.2	1.5	1.9	10.6	0.0	14.9	0.0	1.3	1.2	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.2	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	1.0	0.2	0.2	0.6	4.5	0.0	2.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.4	1.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	0.0	0.0	0.4	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	17.6	14.1	23.2	21.3	18.3	9.3	10.8	16.7	12.8	10.6	0.0	0.0	0.0	0.3	0.2	15.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.7	0.0	0.8	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.6
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362685	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 61.7;parathyroid gland: 61.4"	"Cell type enhanced"	"Detected in many"	23	"Cone photoreceptor cells: 82.5;Cytotrophoblasts: 52.4;Proximal tubular cells: 250.3"	"Group enriched"	"Detected in many"	6	"breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 21.9;CACO-2: 36.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA			"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.7	0.4	2.7	0.4	12.9	0.5	7.4	0.7	5.7	0.6	0.4	18.5	0.0	0.4	0.5	4.8	0.4	0.4	0.6	0.5	6.2	3.4	61.7	0.6	1.8	0.4	20.7	1.9	0.4	0.4	61.4	0.4	10.5	8.5	0.5	0.4	7.9	1.1	0.5	0.5	0.5	0.4	0.4	17.2	0.4	0.5	0.6	17.0	0.0	18.2	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.7	12.9	0.7	5.7	6.2	3.4	20.7	1.9	8.5	17.0	6.0	39.5	0.0	0.1	0.2	1.9	1.7	2.5	4.0	4.5	3.5	82.5	52.4	14.9	0.0	1.4	0.0	0.0	0.0	0.0	1.9	0.8	0.0	2.3	0.0	4.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	250.3	18.0	0.0	0.0	0.0	0.5	0.0	19.3	0.0	0.0	0.1
LRP3	"hLRp105, LRP-3"	ENSG00000130881	"LDL receptor related protein 3"	O75074	19	33177603-33208867	"Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 28.5;Hepatocytes: 25.9;Leydig cells: 24.2;Peritubular cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.8;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"THP-1: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041658			Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA041658: "	"unprognostic (3.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.32e-1)"	23.5	16.6	28.3	5.1	33.1	15.3	15.6	14.2	41.2	12.1	7.8	6.6	4.4	7.1	11.2	8.8	7.4	12.4	8.2	10.9	27.6	13.0	4.2	15.5	5.3	3.2	15.4	19.4	50.0	16.8	9.8	10.3	3.8	11.0	15.5	3.4	10.0	14.4	12.7	21.9	5.0	6.6	10.6	6.3	4.8	7.0	5.6	7.7	0.0	9.5	4.7	3.1	9.0	9.1	0.0	0.0	0.6	2.8	0.5	0.1	0.7	0.0	20.7	5.7	20.6	14.4	5.4	4.3	5.3	5.2	4.9	1.9	5.9	0.2	0.0	13.9	6.5	6.9	0.0	5.5	0.5	0.4	0.0	11.2	0.0	4.6	20.7	5.5	7.4	0.7	8.2	4.9	1.3	0.7	0.8	4.0	0.0	0.0	0.0	6.2	19.1	0.0	8.4	11.7	4.1	1.0	0.0	2.6	0.0	0.0	8.3	12.6	19.0	8.6	0.0	1.5	0.6	8.7	26.2	0.0	10.2	9.1	15.1	3.0	0.0	0.0	0.1	0.0	12.5	3.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	2.6	0.0	0.0	0.7	28.3	33.1	14.2	41.2	27.6	13.0	15.4	19.4	11.0	7.7	0.0	2.2	0.9	2.1	3.0	28.5	0.4	10.2	0.0	3.4	5.2	3.9	0.1	0.0	5.8	2.2	1.8	0.9	0.0	6.5	0.6	7.0	8.2	0.0	25.9	8.2	22.3	1.7	6.2	10.0	5.2	24.2	2.3	3.3	1.8	6.6	23.0	8.9	0.0	30.8	0.5	3.6	6.5	5.2	0.2	0.4	2.3	0.0	0.0	4.9	1.4
LRP5L	DKFZp434O0213	ENSG00000100068	"LDL receptor related protein 5 like"	A4QPB2	22	25351418-25405377	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 6.3;NK-cell: 10.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.3;NK-cells: 10.7"	"Low cell line specificity"	"Detected in many"											HPA028717	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028717: AB_10601767"	"unprognostic (5.90e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.11e-1)"	"unprognostic (9.64e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.38e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (6.93e-6)"	6.0	4.7	4.8	8.0	3.8	17.6	18.5	1.5	6.2	10.0	7.0	4.1	11.4	4.1	8.2	8.1	3.9	6.3	8.0	5.3	3.9	2.0	9.1	17.4	5.9	8.5	8.1	1.7	7.7	8.0	6.3	3.8	2.1	4.1	8.9	4.7	6.5	11.0	12.2	2.7	6.1	5.7	7.7	3.4	8.4	4.8	5.0	3.6	3.7	15.5	4.3	6.7	6.3	7.5	1.1	0.2	6.3	0.5	10.7	1.0	0.3	2.0	3.1	1.2	6.2	2.3	1.0	2.2	1.8	2.8	2.4	2.6	2.9	1.0	0.8	2.4	2.0	1.9	4.0	2.2	3.1	1.5	2.9	7.0	4.0	5.1	7.3	2.8	7.7	8.2	4.1	3.0	2.7	11.5	3.9	1.0	3.6	2.5	2.5	1.6	6.9	1.4	7.2	2.8	6.5	4.5	6.9	2.7	3.0	2.8	4.8	4.0	4.7	1.4	2.2	2.2	1.3	2.6	2.8	1.8	2.7	11.7	1.8	3.0	6.4	1.3	1.7	1.6	4.7	1.4	6.3	0.5	2.1	1.0	0.4	0.9	0.2	0.3	0.3	0.1	1.1	0.1	0.3	0.2	10.7	0.2	0.2	0.0	0.3	4.8	3.8	1.5	6.2	3.9	2.0	8.1	1.7	4.1	3.6	0.0	2.7	0.9	3.4	6.0	1.7	1.4	2.5	2.7	6.8	1.8	0.0	0.4	0.0	2.5	0.5	2.9	2.6	0.0	1.0	0.4	1.1	3.7	0.0	4.4	2.2	9.5	3.5	2.5	4.3	0.0	3.7	4.0	1.7	1.8	5.2	1.5	2.6	5.8	1.8	0.3	1.5	12.9	5.2	0.9	3.4	3.4	0.2	4.4	4.3	2.8
LRR1	"LRR-1, MGC20689, PPIL5"	ENSG00000165501	"Leucine rich repeat protein 1"	Q96L50	14	49598697-49614672	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 43.9"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 77.7;Erythroid cells: 70.0;Spermatocytes: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA065703, HPA069364"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	No			"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065703: AB_2685537, HPA069364: AB_2686129"	"unprognostic (2.73e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (7.34e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.90e-7)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.04e-2)"	5.7	6.0	1.7	7.8	2.5	14.2	5.0	2.4	2.8	3.2	8.5	2.5	2.6	7.8	4.2	2.8	7.2	3.7	4.6	6.9	1.5	1.1	4.3	5.6	4.5	9.6	2.5	1.6	3.1	6.5	1.3	1.6	4.8	2.3	3.3	6.2	4.3	6.0	5.5	7.5	4.8	7.9	3.5	3.3	8.1	4.9	43.9	2.0	28.0	3.8	7.7	9.2	4.7	4.6	12.5	14.6	20.3	18.8	7.3	12.7	8.5	22.3	16.0	12.8	12.7	2.9	2.1	14.8	12.1	11.1	27.6	24.9	14.3	18.8	20.3	8.4	7.2	8.0	14.6	15.3	11.0	19.4	20.7	12.1	9.8	11.6	9.1	2.3	23.2	12.9	2.2	3.8	12.3	5.6	1.9	13.0	17.5	9.9	13.7	13.6	20.1	27.0	19.4	7.7	10.7	20.9	19.1	21.6	14.6	9.3	9.2	12.8	7.2	11.6	13.9	8.3	3.4	17.9	15.1	5.0	19.1	31.7	8.4	14.9	7.5	10.7	22.2	9.8	16.3	14.3	16.9	12.3	20.3	9.3	18.8	11.8	12.5	11.9	12.6	12.7	9.2	9.5	10.7	6.6	7.3	13.1	14.6	12.7	8.5	1.7	2.5	2.4	2.8	1.5	1.1	2.5	1.6	2.3	2.0	3.0	6.2	3.0	4.9	13.9	3.6	2.8	10.2	2.7	7.9	3.5	2.0	8.3	1.7	11.3	77.7	8.4	10.5	70.0	19.7	27.5	7.5	7.5	13.9	5.6	18.9	1.6	4.6	6.2	11.1	26.3	6.9	12.4	10.1	14.4	8.4	4.5	10.8	0.0	3.2	6.2	5.0	6.5	7.1	63.9	10.0	13.0	6.4	6.4	12.4	5.9
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508800-61511018	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 20.1;Muller glia cells: 7.8;Sertoli cells: 19.4;Smooth muscle cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.2;RH-30: 13.2;SCLC-21H: 6.8"	"Region enriched"	"Detected in many"	7	"basal ganglia: 202.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 39.3;hippocampal formation: 35.0"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	2.4	1.6	4.8	0.9	27.8	0.5	1.9	0.2	5.8	3.4	1.6	1.2	1.0	0.9	2.2	3.7	1.1	36.2	0.8	1.2	5.2	1.9	0.9	0.6	3.7	0.5	1.1	4.3	3.0	1.5	2.1	14.8	1.2	1.2	0.9	1.0	0.0	1.1	1.2	0.7	0.5	0.9	2.5	0.2	0.6	1.0	2.4	8.3	0.9	0.8	0.2	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.0	0.0	13.2	0.0	0.0	0.0	6.8	0.6	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	27.8	0.2	5.8	5.2	1.9	1.1	4.3	1.2	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	20.1	4.5	1.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	7.8	0.1	0.0	0.0	0.0	0.0	19.4	11.8	0.5	0.9	0.3	0.1	0.0	0.0	0.0
LRRC14	"KIAA0014, LRRC14A"	ENSG00000160959	"Leucine rich repeat containing 14"	Q15048	8	144517992-144525178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021047	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021047: AB_1853298"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.04e-3)"	9.4	10.3	11.9	15.0	11.9	9.5	26.5	14.3	22.3	10.4	10.5	15.1	5.0	11.0	13.7	8.9	11.5	10.6	11.3	9.7	12.4	8.2	9.4	8.9	10.0	12.2	15.3	16.0	11.2	17.5	16.9	13.5	8.4	12.7	15.6	7.9	9.4	16.8	12.9	9.8	17.6	10.6	12.7	9.2	11.9	11.0	9.6	12.1	9.7	13.8	6.2	9.8	11.9	9.4	10.6	9.8	4.7	8.6	13.1	10.3	8.7	9.6	19.9	5.4	8.7	5.8	4.7	7.7	8.7	3.8	7.0	6.0	8.8	11.8	7.9	9.2	6.4	4.3	10.6	8.4	8.6	3.2	10.5	19.4	11.7	21.2	3.6	5.4	5.0	9.7	5.7	7.4	7.0	3.5	5.8	6.0	9.1	15.4	9.5	6.8	11.9	18.3	6.5	4.4	8.5	28.8	15.7	4.5	11.1	4.2	8.5	14.7	8.2	13.3	10.7	6.2	3.3	16.4	5.5	6.4	12.0	21.3	10.6	12.7	5.3	3.1	9.8	11.3	11.6	7.3	1.9	8.6	1.8	10.3	8.1	10.2	9.0	7.7	9.6	8.4	10.6	8.6	7.0	4.7	13.1	6.7	9.8	7.2	8.7	11.9	11.9	14.3	22.3	12.4	8.2	15.3	16.0	12.7	12.1	6.0	1.9	12.4	4.6	5.7	11.7	3.5	12.7	5.3	5.7	8.7	2.0	5.7	5.0	4.8	1.1	4.5	7.9	0.0	7.0	5.8	3.9	6.7	6.9	9.0	6.6	11.1	5.2	10.4	5.2	2.4	6.9	3.7	1.7	7.2	6.6	8.9	5.7	3.5	7.4	6.0	7.6	6.5	5.2	27.9	24.3	5.1	4.6	6.9	11.4	3.5
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191511-195353	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.8"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 29.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	30.6	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.9	0.4	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	14.3	0.7	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	7.1	29.2	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355247-194369743	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 48.1"	"Cell type enhanced"	"Detected in some"	17	"Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 48.9;U-138 MG: 9.5;U-87 MG: 26.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		1800000	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	3.3	0.5	0.5	3.1	0.6	0.0	5.3	0.5	0.5	4.6	2.1	0.2	0.0	0.4	3.5	0.3	1.0	1.3	2.0	1.8	0.5	0.5	0.5	0.5	2.5	0.8	0.5	0.0	3.1	0.8	0.0	0.5	48.1	0.3	0.6	4.2	0.7	1.6	0.0	1.0	9.1	0.8	0.7	0.5	1.3	1.9	0.9	0.0	1.1	1.8	7.7	7.7	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.4	48.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.5	1.6	1.2	0.0	0.0	0.0	0.0	26.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0
LRRC17	"H_RG318M05.3, P37NB"	ENSG00000128606	"Leucine rich repeat containing 17"	Q8N6Y2	7	102912991-102944949	"Predicted secreted proteins"	Osteogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.0"	"Group enriched"	"Detected in some"	4	"Leydig cells: 94.3;Peritubular cells: 29.7;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 172.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073458			Approved	"Vesicles,Cytokinetic bridge"	"Secreted in other tissues"	NA	NA			Vesicles	"Cytokinetic bridge"	"HPA073458: "	"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (8.57e-3)"	"unprognostic (4.48e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.30e-4)"	5.1	1.3	1.1	0.5	1.2	0.0	6.2	1.4	2.0	15.0	1.4	1.5	5.6	0.5	8.3	17.1	5.2	8.9	13.5	6.4	1.2	1.3	1.5	1.4	1.6	1.6	1.1	2.1	39.0	2.6	1.2	1.7	1.8	2.5	7.8	1.4	2.7	2.8	2.5	5.3	2.0	2.6	5.1	1.2	1.2	3.5	5.1	0.2	2.2	2.6	6.7	1.3	6.7	4.2	0.1	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.8	4.3	0.0	0.2	2.5	0.0	0.4	0.0	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	4.0	0.1	3.0	0.0	20.0	19.6	0.0	0.0	0.0	172.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	33.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.2	2.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.4	2.0	1.2	1.3	1.1	2.1	2.5	0.2	0.0	0.6	0.0	0.1	0.8	3.7	0.8	0.0	0.0	0.0	1.8	2.0	0.2	0.0	1.5	2.4	3.6	0.0	0.0	0.3	0.1	11.8	0.2	1.1	0.6	0.3	0.0	0.0	9.2	0.0	0.7	94.3	0.0	5.0	1.0	0.0	0.2	0.2	0.0	29.7	0.0	1.9	64.7	14.3	0.6	0.3	0.5	0.0	0.0	0.1	0.1
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515423-46580099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0"	"Cell type enriched"	"Detected in many"	17	"Cardiomyocytes: 175.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.8;HEL: 6.2;LHCN-M2: 6.2;TIME: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039138, HPA064844"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA039138: AB_10795461, HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	1.8	0.5	1.9	0.4	1.4	0.4	1.0	1.4	3.0	2.6	1.1	0.2	0.0	0.4	3.9	1.4	1.1	1.1	1.4	53.9	1.3	0.4	2.2	2.5	0.6	0.3	0.5	2.3	2.8	0.7	0.1	2.2	0.5	1.0	1.2	0.8	0.4	1.4	0.2	70.3	1.2	0.6	2.3	0.4	1.3	1.0	0.4	0.0	1.4	10.1	20.0	1.2	1.7	1.8	1.2	0.8	2.6	0.7	1.1	2.5	0.3	0.2	0.1	0.2	0.3	1.0	2.3	0.1	0.8	1.5	0.6	0.8	0.0	0.2	0.3	0.2	10.8	0.1	0.2	3.8	0.0	1.4	0.5	0.1	6.2	0.4	0.2	0.3	0.2	0.1	0.2	0.1	4.3	0.0	3.6	0.2	0.8	0.1	0.4	6.2	0.1	0.8	0.1	1.5	0.5	0.2	0.1	0.1	0.3	0.1	0.3	0.5	1.2	0.8	0.2	1.6	1.3	0.2	0.8	4.9	0.3	0.6	2.5	1.6	0.4	0.3	2.9	0.2	0.1	1.4	2.2	0.7	0.6	0.6	0.4	0.4	0.7	1.6	0.3	0.2	1.2	0.8	0.6	2.6	1.1	0.5	0.8	2.5	0.3	1.9	1.4	1.4	3.0	1.3	0.4	0.5	2.3	1.0	0.0	8.9	0.6	0.0	0.8	1.6	0.0	175.7	2.5	1.4	0.0	1.8	0.0	0.1	8.3	0.2	2.0	1.5	0.0	0.0	0.8	0.0	4.3	0.4	10.3	8.9	1.5	0.0	2.9	5.5	0.0	1.7	0.6	1.1	10.1	0.0	1.5	0.3	1.5	0.0	0.0	0.5	0.1	0.0	3.9	0.6	0.2	2.0	0.1	0.7	1.7	0.4
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 111.8"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 28.5;Early spermatids: 20.2;Hepatocytes: 14.5;Late spermatids: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA039630: AB_10795467"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	1.3	2.5	5.6	1.4	7.2	1.6	1.4	5.2	11.2	3.3	3.2	2.5	0.0	1.4	2.7	3.1	7.1	2.4	2.1	15.8	5.0	3.9	1.2	8.3	2.2	1.7	3.7	6.3	2.2	1.3	2.1	3.6	1.1	4.9	2.6	2.0	1.8	1.8	2.4	111.8	1.6	1.4	3.5	2.0	1.4	1.6	3.5	1.9	1.6	2.6	14.3	3.1	2.2	4.8	0.9	2.6	0.0	1.0	1.1	4.1	1.1	14.6	11.3	7.3	15.6	4.1	3.3	0.0	1.9	6.6	5.0	4.7	9.6	15.3	2.9	7.8	1.4	15.6	5.3	7.1	10.6	3.5	8.2	2.3	1.7	2.5	22.0	4.5	4.2	1.4	1.3	3.2	6.9	2.3	4.9	9.7	19.4	2.1	4.7	4.6	2.3	16.0	3.5	2.4	11.0	25.7	13.4	4.2	8.3	6.5	1.5	18.5	8.0	1.2	1.3	5.1	1.9	1.9	4.3	5.9	4.0	34.6	5.3	4.5	7.6	13.4	4.8	6.5	17.4	0.8	0.0	0.9	0.0	1.7	1.0	1.4	0.9	1.3	1.9	2.6	0.0	4.1	1.5	0.0	1.1	0.7	0.4	0.2	1.1	5.6	7.2	5.2	11.2	5.0	3.9	3.7	6.3	4.9	1.9	0.0	5.8	0.0	0.5	1.3	8.0	28.5	2.5	0.0	1.2	0.0	3.9	0.1	0.0	3.5	20.2	2.7	0.4	0.0	4.2	0.1	2.0	0.7	0.0	14.5	0.4	1.6	5.2	1.3	0.3	32.8	2.8	0.0	1.7	1.0	1.3	7.8	4.1	1.7	1.4	1.4	1.7	0.0	1.7	4.3	4.5	0.5	0.0	0.8	1.9	0.6
LRRC24	LRRC14OS	ENSG00000254402	"Leucine rich repeat containing 24"	Q50LG9	8	144522377-144527032	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 100.1;Cone photoreceptor cells: 68.7;Late spermatids: 50.7;Rod photoreceptor cells: 63.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 4.2;SCLC-21H: 4.5;SH-SY5Y: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028171, HPA052250"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA028171: AB_2672504, HPA052250: AB_2681774"					"unprognostic (1.75e-1)"					"unprognostic (5.76e-2)"		"unprognostic (2.33e-3)"		"unprognostic (3.63e-2)"				2.5	4.0	5.1	1.4	9.3	1.7	1.5	12.3	16.9	2.3	2.1	1.6	0.6	2.0	2.5	1.7	1.7	2.8	1.3	1.5	4.5	7.9	2.2	1.6	2.0	1.4	4.5	8.4	4.5	3.2	9.3	8.4	1.5	5.9	11.4	1.1	10.3	2.8	3.2	2.3	1.7	2.0	1.6	2.1	2.2	1.9	1.5	1.3	0.6	1.6	1.0	1.1	1.4	1.6	0.0	0.5	0.0	0.1	0.1	0.5	0.0	0.4	0.8	0.6	1.6	0.8	0.5	1.8	0.5	0.6	0.7	0.6	0.2	1.6	0.8	3.5	0.2	0.3	0.1	0.0	0.0	0.1	1.2	2.3	0.5	1.0	0.3	0.6	0.0	1.0	0.7	0.4	0.5	0.1	0.4	0.3	0.9	0.9	0.1	0.1	4.2	1.2	1.7	0.2	0.2	0.8	1.8	0.1	0.6	0.1	0.5	4.5	12.4	0.4	0.1	0.4	0.0	3.8	1.3	0.0	0.1	1.2	0.5	0.2	1.0	0.1	0.1	0.6	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	9.3	12.3	16.9	4.5	7.9	4.5	8.4	5.9	1.3	0.0	2.9	0.0	0.5	0.8	100.1	0.0	2.5	0.0	1.2	1.8	68.7	0.4	3.3	0.2	19.3	0.0	1.8	0.0	0.2	0.4	0.8	1.5	0.0	2.4	0.4	28.6	10.3	0.0	1.5	50.7	2.6	0.8	5.0	0.0	1.7	12.1	0.4	1.9	2.8	3.0	63.8	0.0	1.4	4.8	2.9	0.4	0.3	0.0	1.6	0.5
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 173.1"	"Cell type enriched"	"Detected in some"	9	"Mucus-secreting cells: 513.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	408	"plasmacytoid DC: 40.8"	"Lineage enriched"	"Detected in single"	408	"dendritic cells: 40.8"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 52.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favorable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.0	1.3	0.0	0.0	2.1	0.7	0.1	0.3	6.8	0.0	11.2	1.2	0.3	0.1	0.7	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.4	0.4	0.0	173.1	20.0	0.0	1.3	4.0	0.0	0.0	0.1	1.0	0.0	0.0	0.7	0.0	10.3	4.6	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.3	8.7	0.0	52.8	0.0	0.0	0.4	0.1	0.2	2.6	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	13.9	0.0	0.4	0.0	0.1	45.8	0.0	0.0	0.1	0.0	8.6	0.0	0.0	0.6	0.0	0.0	54.0	1.0	513.0	0.0	0.2	12.5	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	16.2	3.3
LRRC27	KIAA1674	ENSG00000148814	"Leucine rich repeat containing 27"	Q9C0I9	10	132332154-132379918	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"testis: 52.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 394.8;Late spermatids: 739.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.5;hTERT-RPE1: 18.9"	"Low region specificity"	"Detected in all"							"HPA037595, HPA067395"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA037595: , HPA067395: AB_2732766"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-4)"	"unprognostic (1.48e-3)"	"unprognostic (1.94e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.27e-4)"	2.1	2.8	8.1	1.5	8.4	1.0	4.1	2.2	8.9	3.6	2.1	6.1	7.5	2.0	3.8	5.6	1.6	10.5	3.5	2.2	6.6	5.4	4.4	2.4	3.1	1.9	4.3	7.3	5.4	3.1	7.5	5.8	2.1	6.5	4.1	2.1	4.8	3.1	4.0	1.2	2.1	2.6	3.4	3.5	3.3	3.0	52.9	4.5	0.7	5.1	1.0	1.2	2.5	1.8	4.7	7.8	4.4	6.8	3.1	2.8	2.7	2.5	4.7	10.3	14.5	9.1	9.3	1.0	2.5	8.1	4.2	3.8	0.8	5.2	1.4	1.5	5.8	3.2	1.8	2.3	1.2	2.6	2.9	2.0	0.3	3.3	2.4	6.5	1.1	1.7	4.0	8.0	4.2	5.7	18.9	3.0	3.6	0.8	1.0	3.2	4.3	2.2	3.2	2.9	1.8	1.6	1.9	1.7	0.8	7.5	0.6	1.8	5.2	1.2	0.8	3.3	2.2	2.3	2.6	3.9	1.7	2.1	3.8	1.5	0.7	0.3	0.8	7.7	2.2	1.0	4.4	6.8	1.1	1.7	5.7	1.3	3.4	1.1	1.0	7.3	4.7	2.8	1.6	0.5	3.1	3.6	7.8	0.7	2.7	8.1	8.4	2.2	8.9	6.6	5.4	4.3	7.3	6.5	4.5	8.9	10.9	1.3	2.4	2.5	7.8	4.4	7.6	48.2	7.9	3.5	9.8	3.1	16.6	5.9	394.8	4.5	1.7	0.0	4.6	1.0	5.2	2.9	8.1	2.1	6.6	7.9	5.2	14.7	8.0	739.5	4.4	7.1	6.8	7.2	1.9	8.9	3.3	0.0	11.0	11.9	17.7	6.5	2.3	75.2	20.4	2.8	1.1	4.9	3.3	1.4
LRRC28	"FLJ34269, FLJ45242, MGC24976"	ENSG00000168904	"Leucine rich repeat containing 28"	Q86X40	15	99251362-99390729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 131.5;Late spermatids: 330.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039378, HPA040784, HPA066130"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		No	No			Nucleoplasm	"Golgi apparatus, Mitochondria"	"HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623"	"unprognostic (4.84e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.82e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.41e-1)"	9.1	9.5	7.5	5.3	12.7	7.4	7.3	12.7	15.4	7.7	10.4	8.1	6.1	15.8	6.9	7.6	9.9	5.0	8.8	10.8	7.5	6.5	17.7	42.3	6.2	6.3	6.9	8.4	5.8	18.1	9.1	10.8	5.9	9.8	6.3	9.5	9.3	8.6	6.9	18.0	12.1	18.2	7.8	6.7	6.3	9.1	24.1	5.2	17.7	7.4	8.2	8.6	7.9	7.3	4.8	6.0	21.8	6.9	3.4	7.0	4.2	2.9	7.1	7.1	9.1	10.2	14.4	3.0	3.1	8.7	5.3	6.3	5.5	6.3	5.9	5.7	7.3	6.6	6.5	5.1	9.8	7.8	3.6	7.5	4.0	3.3	5.5	9.0	3.9	6.5	8.5	13.6	5.0	10.0	12.0	16.7	9.5	3.5	5.9	11.0	5.6	10.6	6.5	2.9	22.4	2.5	6.5	6.0	5.3	11.3	9.3	3.2	4.1	7.3	4.0	11.4	11.2	6.2	7.4	6.0	5.2	3.6	4.0	6.0	12.1	16.7	3.6	6.7	3.8	9.7	15.6	6.9	21.8	5.5	5.5	4.3	4.8	5.2	5.7	6.0	4.1	4.8	4.1	3.6	3.4	5.3	5.0	7.0	4.2	7.5	12.7	12.7	15.4	7.5	6.5	6.9	8.4	9.8	5.2	14.9	2.6	9.7	11.4	12.2	20.0	13.3	10.2	10.7	6.8	10.4	21.6	15.0	23.2	11.2	131.5	10.5	25.7	23.3	25.7	18.2	9.3	9.5	2.3	32.1	16.9	20.6	8.7	11.1	19.8	330.3	11.8	8.6	13.5	17.2	15.4	14.3	13.6	20.1	8.1	54.9	19.0	0.0	12.0	42.3	35.8	13.8	10.9	15.0	13.6	11.9
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793428-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 13.7;testis: 23.8"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 144.6;Cone photoreceptor cells: 35.3;Early spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	7	"B-cells: 2.2;dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.4;HEL: 9.3;HL-60: 9.8;JURKAT: 8.1;NTERA-2: 9.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Cell Junctions, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	2.8	1.1	4.8	1.2	9.6	2.7	2.3	1.1	4.0	2.3	0.9	4.2	1.4	1.0	1.9	3.9	1.0	13.7	1.1	2.0	4.1	3.8	2.1	0.9	3.4	1.9	3.5	5.6	2.2	0.5	1.0	7.9	0.9	11.8	2.0	0.7	2.6	1.3	2.4	0.9	1.0	1.1	2.0	3.6	1.8	1.1	23.8	4.8	1.7	2.7	0.5	1.2	1.0	0.9	2.2	4.6	0.1	0.3	0.0	0.5	0.4	2.7	0.4	0.8	0.0	1.1	4.1	0.0	1.2	2.4	2.8	2.7	0.1	0.0	1.6	0.0	0.7	3.8	0.0	2.5	0.0	1.0	0.4	7.4	9.3	0.1	0.0	0.7	9.8	2.4	1.4	0.4	1.1	0.0	0.1	1.7	8.1	0.2	0.0	1.0	0.0	0.9	1.9	9.9	0.0	3.1	4.9	0.0	0.5	2.3	0.2	4.9	3.8	0.8	0.1	0.0	0.3	0.0	4.7	0.4	0.6	0.0	0.3	0.0	0.0	0.0	2.3	4.5	0.1	2.6	0.0	0.2	0.0	0.0	0.3	0.2	2.2	0.0	0.0	1.4	1.5	0.0	0.0	0.1	0.0	0.0	4.6	0.5	0.4	4.8	9.6	1.1	4.0	4.1	3.8	3.5	5.6	11.8	4.8	3.0	1.6	0.0	0.9	0.3	5.3	2.8	0.0	144.6	15.9	5.2	35.3	0.2	1.7	0.5	74.2	1.5	0.0	0.0	0.2	0.2	3.2	0.7	1.1	0.0	2.2	11.1	4.1	11.1	0.3	23.5	9.8	1.7	0.0	6.4	0.5	6.0	0.2	0.0	9.9	3.2	18.6	0.0	1.7	29.6	8.6	0.3	0.5	0.7	0.1	0.3
LRRC37A	KIAA0563	ENSG00000176681	"Leucine rich repeat containing 37A"	A6NMS7	17	46292733-46337794	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 9.4;testis: 15.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 18.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 8.0"									"HPA042121, HPA043056, HPA045090, HPA049080"	Supported		Approved	Vesicles		NA	NA			Vesicles		"HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.75e-2)"	"unprognostic (6.02e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.37e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.30e-2)"	0.9	0.4	1.4	2.0	1.8	1.4	1.7	2.6	1.7	0.7	0.9			0.5	1.1	0.4	1.1	1.0	0.5	1.1	1.5	1.2	0.9	0.6	0.9	1.5	0.6		1.2	0.9	0.5	2.1	0.7		1.3	1.0		1.0	0.9	9.4	1.8	1.3	0.6	0.8	1.2	0.8	15.2			1.2		0.9	1.1	1.1	1.4	1.7	2.1	1.4	2.1	1.5	0.2	0.2	0.2	1.6	0.2	0.3	0.0	0.5	0.1	0.4	0.1	0.2	3.6	0.3	8.0	0.3	0.3	2.5	0.3	0.0	0.0	0.0	0.5	1.2	0.4	4.0	2.7	0.6	0.0	0.2	0.0	1.0	0.0	0.0	0.2	0.5	0.3	0.2	0.6	0.9	0.0	0.3	0.7	1.2	0.0	0.0	2.7	2.9	1.8	0.0	1.9	0.5	1.1	0.2	0.6	0.1	0.0	0.5	3.6	1.2	1.4	2.4	0.4	0.2	3.6	2.5	0.5	1.3	2.4	2.3	2.1	1.1	1.0	1.0	1.0	0.9	0.8	0.8	1.5	1.1	1.4	1.3	1.1	1.9	2.1	1.4	1.7	1.0	0.2											3.0	0.3	0.0	0.3	0.1	0.6	3.6	0.0	1.4	0.0	0.0	0.0	0.1	1.7	0.2	18.2	0.0	1.3	0.0	0.4	0.0	0.2	0.1	1.1	0.0	0.3	0.0	1.2	0.0	2.7	1.0	0.0	0.4	0.0	0.0	1.1	0.0	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.7	0.2	0.1	0.1	0.5	1.0	0.0
LRRC37A2	FLJ45049	ENSG00000238083	"Leucine rich repeat containing 37 member A2"	A6NM11	17	46511511-46555650	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 13.5"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 20.8;Early spermatids: 32.7"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	7	"eosinophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;THP-1: 4.3;U-138 MG: 2.5"									"HPA042121, HPA043056, HPA045090, HPA049080"	Supported		Approved	Vesicles		NA	NA			Vesicles		"HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624"	"unprognostic (1.59e-2)"	"unprognostic (3.75e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (8.00e-2)"	"unprognostic (3.02e-7)"	"unprognostic (8.40e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-2)"	0.5	0.0	0.3	0.4	0.7	0.9	0.8	0.9	0.4	0.1	0.4			0.0	0.2	0.1	0.5	0.3	0.0	0.1	0.4	0.4	0.5	0.4	0.7	0.5	0.1		0.3	0.1	0.1	1.2	0.1		0.4	0.9		0.4	0.7	0.6	0.9	0.4	0.5	0.2	0.0	0.5	13.5			0.4		0.5	0.6	0.3	0.2	0.3	2.9	0.1	0.1	0.4	0.0	0.5	0.7	0.4	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.9	0.0	4.0	0.1	0.3	0.8	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.9	0.5	0.7	0.0	0.0	0.0	0.8	0.0	0.3	0.0	2.0	0.1	0.0	0.8	2.0	0.0	0.3	0.1	0.2	0.0	0.1	1.8	0.8	0.4	0.0	1.4	0.2	0.4	0.3	0.0	0.3	0.0	1.4	4.3	0.8	2.5	1.9	0.0	0.8	1.4	1.1	0.5	0.2	1.0	1.6	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0											20.8	10.5	0.8	3.8	1.3	7.1	2.0	2.5	14.7	7.9	0.0	11.8	1.0	0.0	1.9	32.7	1.9	1.0	0.0	0.8	0.8	1.9	1.9	10.5	0.4	1.2	12.7	1.7	1.3	1.5	7.5	3.1	3.2	0.0	0.0	1.7	2.8	0.9	1.4	1.8	0.3	8.4	12.9	2.0	6.8	2.5	1.9	0.6	4.4	1.0	2.7
LRRC37A3	"FLJ34306, KIAA0563"	ENSG00000176809	"Leucine rich repeat containing 37 member A3"	O60309	17	64854312-64919480	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 23.2;Horizontal cells: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA042121, HPA043056, HPA045090"	Supported		Approved	Vesicles		NA	NA			Vesicles		"HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211"	"unprognostic (2.28e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.31e-6)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (2.26e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.43e-3)"	4.4	6.6	14.8	5.5	14.0	6.2	8.8	27.9	16.0	4.3	3.6	7.4	5.4	3.2	6.9	16.0	3.9	7.8	6.8	3.8	15.1	15.0	15.7	3.4	4.8	4.3	12.8	7.2	8.4	5.2	5.7	18.8	4.6	12.1	6.7	4.0	8.3	4.3	6.2	6.4	7.1	4.0	4.2	6.6	4.6	4.2	25.8	12.6	7.3	14.3	0.3	3.1	4.6	10.0	2.3	2.3	5.3	1.0	3.1	1.2	0.3	2.3	4.5	4.4	9.8	4.9	3.1	3.1	3.2	2.6	2.4	2.5	2.0	3.4	2.3	1.5	1.6	3.9	1.9	1.2	0.9	1.0	3.0	4.4	7.1	2.7	1.4	2.0	2.7	1.8	2.1	1.7	1.6	0.7	9.9	1.6	3.0	1.4	1.3	1.6	6.1	1.3	4.6	3.4	0.5	1.3	1.5	2.3	1.0	5.0	2.1	2.9	11.0	1.2	5.6	1.3	13.1	2.5	4.9	5.3	4.0	1.3	1.6	1.7	1.9	1.8	1.8	2.8	11.3	6.8	5.3	0.4	0.7	0.7	0.7	0.8	0.6	1.0	0.4	0.6	2.3	1.2	1.1	2.0	3.1	1.0	2.3	0.9	0.3	14.8	14.0	27.9	16.0	15.1	15.0	12.8	7.2	12.1	12.6	0.0	2.1	1.4	1.8	1.5	10.2	2.1	0.0	9.4	2.3	1.8	3.9	1.1	1.7	1.8	23.2	2.6	1.2	0.0	1.2	0.1	1.6	1.7	2.3	0.8	1.4	23.8	1.2	3.7	1.9	5.6	2.0	0.8	1.7	1.8	0.8	4.3	0.7	1.4	2.8	5.1	3.6	6.5	1.2	6.0	1.7	0.9	0.8	1.3	0.6	1.4
LRRC37B		ENSG00000185158	"Leucine rich repeat containing 37B"	Q96QE4	17	32007872-32053504	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 71.2;Spermatocytes: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9"	"Low cell line specificity"	"Detected in all"											HPA015135	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA015135: AB_1853309"	"unprognostic (5.46e-3)"	"unprognostic (2.56e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.60e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.72e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.72e-3)"	"unprognostic (6.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-3)"	4.7	5.0	13.7	4.8	15.0	28.5	6.4	35.5	14.4	5.9	5.2	7.2	5.0	4.5	8.3	6.5	4.6	8.2	4.8	2.7	10.7	8.5	3.7	3.0	6.7	5.5	8.6	10.2	12.1	4.3	7.4	13.8	4.6	8.9	5.3	6.4	6.1	6.5	4.2	3.5	11.7	6.3	7.2	8.5	7.6	6.6	24.5	10.3	8.3	4.4	1.8	5.8	5.3	10.2	0.8	1.1	2.8	0.5	6.4	4.9	0.5	2.1	3.9	12.5	7.1	3.2	4.0	3.9	1.9	7.1	5.5	7.1	5.4	2.1	5.6	4.0	4.3	6.9	2.8	7.4	1.5	4.4	1.6	6.3	2.6	5.8	2.0	4.7	10.1	4.8	4.2	4.7	5.0	12.8	5.3	4.6	9.6	6.1	5.4	2.1	1.9	17.6	15.6	3.8	1.9	2.7	12.4	2.9	4.5	3.1	5.2	2.4	4.0	4.8	3.1	6.5	4.3	8.2	16.3	3.9	3.9	2.7	8.6	4.6	5.4	7.7	5.6	2.8	10.2	2.8	0.0	0.4	2.8	1.1	0.5	2.1	0.2	2.2	3.0	0.8	0.8	3.0	0.8	1.1	6.4	0.2	1.1	4.9	0.5	13.7	15.0	35.5	14.4	10.7	8.5	8.6	10.2	8.9	10.3	6.0	7.8	2.7	6.4	3.7	7.8	4.4	10.2	8.1	10.3	1.8	0.0	1.8	8.3	8.5	71.2	5.0	2.9	23.3	9.0	1.9	5.0	8.3	3.5	2.9	8.3	3.2	1.7	7.4	7.9	11.8	6.4	8.3	8.5	7.2	5.5	9.2	8.3	0.0	6.7	6.9	8.7	0.0	9.6	37.1	10.6	4.4	1.8	10.1	5.4	6.5
LRRC4	NAG14	ENSG00000128594	"Leucine rich repeat containing 4"	Q9HBW1	7	128027071-128032107	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 57.6;Club cells: 43.3;Horizontal cells: 52.4;Rod photoreceptor cells: 40.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 14.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 14.3"	"Group enriched"	"Detected in some"	6	"AF22: 10.7;NTERA-2: 23.8;REH: 21.9;SCLC-21H: 12.2;SH-SY5Y: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051100			Approved	"Golgi apparatus"		NA	NA		1100000	"Golgi apparatus"		"HPA051100: AB_2797241"	"unprognostic (7.98e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.98e-4)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.84e-3)"	2.6	7.7	11.6	2.9	13.1	10.0	0.8	22.3	33.2	2.3	1.1	3.2	0.7	0.9	3.4	0.5	4.0	7.3	3.4	2.0	10.1	6.6	4.6	2.2	6.3	1.9	5.1	15.5	5.5	0.6	8.6	1.5	4.7	3.1	0.9	0.8	1.7	1.5	3.5	1.0	0.5	1.0	1.9	3.4	4.7	1.5	6.3	2.9	0.8	0.8	3.6	2.4	1.5	2.0	0.0	0.0	14.3	0.6	0.0	0.1	0.1	0.0	0.1	10.7	0.0	0.4	0.0	0.0	0.6	0.0	0.9	0.3	0.0	0.0	0.0	0.8	0.9	0.0	1.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.1	0.0	23.8	0.0	0.0	21.9	0.0	0.2	0.1	0.0	12.2	7.6	0.0	0.0	0.9	1.8	0.0	2.4	0.3	0.7	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.3	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.3	0.0	0.6	0.0	0.0	0.1	11.6	13.1	22.3	28.4	10.1	6.6	5.1	15.5	3.1	2.9	14.9	14.7	0.0	1.1	0.1	12.7	1.1	0.0	57.6	43.3	1.8	25.5	0.1	0.0	0.0	4.3	1.6	0.0	0.0	0.0	0.2	0.4	2.5	1.1	0.0	14.9	52.4	0.0	15.4	7.6	0.0	0.0	0.6	1.7	0.0	0.0	1.2	0.0	0.0	0.7	0.3	40.6	0.0	0.4	4.7	4.8	0.0	0.3	0.0	0.1	16.9
LRRC40	FLJ20331	ENSG00000066557	"Leucine rich repeat containing 40"	Q9H9A6	1	70144805-70205620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026564	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA026564: AB_2250054"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.54e-4)"	"unprognostic (6.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.94e-2)"	"unprognostic (7.69e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	14.3	10.4	15.7	10.0	18.5	16.4	13.2	22.0	27.4	13.4	10.7	10.4	8.0	17.0	12.6	10.2	11.5	9.0	10.1	13.5	16.5	16.6	20.4	27.2	9.6	14.2	13.7	15.7	11.3	8.8	7.9	13.8	13.9	19.8	10.6	11.8	7.5	9.0	8.8	13.6	9.0	18.0	13.3	15.6	13.2	9.0	13.4	11.0	23.0	9.9	10.0	14.2	11.1	9.6	10.4	8.4	7.4	8.2	9.8	10.9	6.5	11.3	4.7	18.9	14.8	6.9	7.7	11.4	11.0	8.0	16.7	20.6	6.9	6.4	15.3	9.7	8.5	16.5	8.4	44.3	9.8	22.8	12.2	8.9	11.5	8.7	11.1	8.7	15.0	2.8	6.4	5.7	11.1	11.2	7.7	9.6	9.8	14.2	7.4	14.0	2.9	18.1	11.8	24.8	7.5	10.0	14.5	19.5	9.9	15.2	7.0	9.7	9.8	13.2	13.3	12.2	14.0	6.3	8.6	11.9	11.8	9.5	17.8	12.4	6.3	6.0	24.8	9.5	15.9	12.1	6.8	6.6	7.4	8.5	8.2	10.9	10.4	9.0	7.9	8.4	9.2	10.6	8.8	0.9	9.8	7.6	6.5	10.8	6.5	15.7	18.5	22.0	27.4	16.5	16.6	13.7	15.7	19.8	11.0	11.9	9.3	7.5	7.2	11.4	14.9	9.2	5.1	6.7	6.8	14.0	5.9	14.2	10.0	11.9	0.9	8.9	6.7	23.3	7.6	11.1	13.9	5.2	15.0	17.4	10.1	14.3	22.3	12.3	11.7	1.9	9.5	8.0	5.0	10.8	5.8	6.6	7.9	3.5	9.6	20.3	11.9	19.4	12.3	19.1	25.5	9.7	6.1	12.9	7.7	5.0
LRRC41	MUF1	ENSG00000132128	"Leucine rich repeat containing 41"	Q15345	1	46261196-46303608	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051941	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA051941: AB_2681669"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.66e-9)"	"unprognostic (6.09e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-2)"	24.2	27.6	19.7	14.6	20.3	14.1	23.3	26.0	31.9	29.9	23.6	25.7	32.6	18.4	35.0	25.1	29.1	36.2	25.2	25.7	19.5	17.3	21.8	27.6	21.5	16.4	17.5	20.2	38.3	30.6	37.4	29.4	45.2	17.7	28.8	16.6	25.4	27.0	36.7	32.2	26.3	25.1	29.4	15.3	19.1	22.6	26.1	17.9	30.4	31.7	21.8	24.1	29.5	25.1	14.8	29.1	16.4	20.1	19.4	16.9	17.0	14.3	10.5	18.2	19.7	24.6	30.9	17.1	14.9	27.7	21.7	14.6	8.8	4.8	9.1	19.9	35.3	29.1	11.2	17.7	21.1	11.1	11.0	19.2	14.8	12.1	12.8	34.6	9.1	7.9	37.8	28.5	20.3	24.5	31.3	27.7	17.3	14.7	9.4	23.7	9.1	12.1	12.2	27.2	9.4	10.3	10.1	9.4	14.7	24.3	17.6	17.0	19.3	20.1	20.0	24.0	29.3	11.8	27.8	18.2	19.1	8.7	15.9	14.2	15.5	7.2	4.0	17.9	7.0	13.2	16.4	20.1	9.2	14.3	19.0	15.1	12.7	15.4	15.9	29.1	14.8	16.9	13.0	2.0	19.4	12.7	16.6	14.9	17.0	19.7	20.3	26.0	31.9	19.5	17.3	17.5	20.2	17.7	17.9	17.9	24.3	13.3	31.1	25.2	23.2	10.9	17.8	14.7	14.8	33.2	23.6	74.9	33.2	37.3	20.8	17.5	29.6	23.3	26.2	40.3	30.1	28.8	6.9	25.6	31.5	44.5	35.2	27.0	17.7	13.8	32.2	15.8	10.1	23.4	26.7	27.3	26.9	20.1	31.1	24.0	26.3	38.8	32.0	27.4	33.6	25.3	119.2	19.8	26.6	28.1
LRRC43	MGC35140	ENSG00000158113	"Leucine rich repeat containing 43"	Q8N309	12	122167738-122203471	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.6"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 40.2;Early spermatids: 18.7;Late spermatids: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.9;HSkMC: 3.3;HUVEC TERT2: 6.5;SCLC-21H: 5.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA039425			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA039425: AB_2676501"	"unprognostic (6.42e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.03e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.21e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.49e-1)"	0.9	0.9	3.0	0.3	5.0	0.8	0.7	1.2	4.6	1.5	0.7	4.1	1.3	1.0	1.4	6.6	0.4	26.6	1.6	1.5	4.5	3.0	3.1	0.5	2.5	0.4	3.1	1.5	3.3	1.2	3.5	3.4	0.5	6.4	1.3	0.5	2.9	1.8	2.2	0.4	0.8	0.5	0.6	1.0	0.8	0.7	10.8	1.8	0.0	2.5	0.0	0.4	0.7	0.3	0.0	0.9	0.0	0.6	2.9	1.9	0.8	0.0	0.0	0.3	0.0	0.3	0.7	0.4	0.0	1.8	0.5	0.5	0.6	0.1	0.0	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	2.9	0.1	0.7	3.3	0.0	1.0	0.0	0.0	6.5	0.6	0.0	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.3	5.3	1.2	0.0	0.2	0.3	0.0	0.8	1.6	0.5	0.0	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.8	0.0	0.0	1.9	0.0	2.9	0.6	0.9	0.0	0.8	3.0	5.0	1.2	4.6	4.5	3.0	3.1	1.5	6.4	1.8	6.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	40.2	3.4	1.8	3.9	0.0	1.7	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.6	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	8.3	0.0	0.0	0.0	8.4	1.1	0.0	0.1	0.0	0.0	0.0
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023302-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.1	4.9	7.1	7.0	9.3	12.0	4.5	20.3	10.8	4.6	7.0	5.7	9.5	11.1	4.4	5.0	8.0	10.5	5.8	3.1	7.7	3.9	5.9	12.9	5.6	6.5	8.3	4.7	3.7	15.5	4.5	4.8	4.9	6.5	6.6	3.6	4.9	13.6	5.0	4.3	10.2	9.4	5.2	3.3	7.6	10.4	3.1	9.9	7.1	9.8	6.8	6.5	5.0	5.1	2.3	3.3	5.0	3.2	2.8	4.6	3.1	9.8	11.2	3.4	7.0	1.4	1.9	13.4	6.9	2.9	4.2	3.5	10.0	6.8	7.4	6.2	1.4	4.3	11.6	3.3	4.1	0.9	4.5	21.3	4.7	20.5	13.5	1.2	5.5	11.8	1.9	1.7	2.5	0.6	1.7	6.1	7.2	3.3	3.3	1.1	16.7	12.3	18.4	3.5	8.0	15.1	10.1	6.7	4.1	2.7	9.2	10.6	10.4	3.1	16.5	5.8	1.8	13.5	6.4	3.5	7.3	9.3	11.6	11.7	6.4	1.6	1.1	3.9	4.8	7.6	5.0	3.2	3.6	3.9	2.4	4.0	1.5	4.5	4.6	2.2	2.3	2.4	3.1	0.2	2.8	1.0	3.3	3.8	3.1	7.1	9.3	20.3	10.8	7.7	3.9	8.3	4.7	6.5	9.9	6.0	2.1	1.9	4.2	3.9	4.5	2.4	10.2	14.7	7.9	3.5	0.0	8.9	5.0	6.8	1.1	3.1	9.1	0.0	4.2	22.5	4.0	3.5	4.6	11.1	7.4	4.8	4.6	8.6	5.9	1.1	6.6	2.5	8.5	2.8	9.8	5.0	5.0	8.6	6.0	6.5	4.0	0.0	3.8	1.4	11.0	2.0	2.5	5.3	10.3	2.0
LRRC46	MGC16309	ENSG00000141294	"Leucine rich repeat containing 46"	Q96FV0	17	47831627-47837713	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 51.2;testis: 94.4"	"Cell type enhanced"	"Detected in some"	24	"Ciliated cells: 239.6;Early spermatids: 97.9;Late spermatids: 46.8;Spermatocytes: 76.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.4"	"Region enriched"	"Detected in many"	4	"pons and medulla: 14.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 6.4;T-47d: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021882, HPA074893"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA021882: AB_1853320, HPA074893: AB_2732271"	"unprognostic (1.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-1)"	0.3	0.4	1.8	0.3	3.3	0.6	0.5	0.4	0.5	2.3	0.3	5.2	1.6	0.4	1.5	13.8	0.4	51.2	0.5	0.5	2.0	2.4	0.7	0.4	11.8	0.5	0.3	0.1	8.8	0.5	0.3	4.2	0.4	14.0	0.5	0.3	1.8	0.4	1.3	0.3	0.3	0.3	0.3	0.6	0.5	0.3	94.4	1.1	1.2	1.4	0.0	0.4	0.3	0.1	0.6	2.5	4.4	1.6	2.4	1.0	0.5	1.5	6.4	0.8	3.2	0.5	1.4	1.8	0.2	1.7	1.7	3.3	3.0	1.4	0.7	4.1	0.8	1.7	1.4	0.8	1.1	2.6	2.8	2.8	1.3	1.8	1.0	0.3	0.1	1.5	0.0	1.0	3.5	1.3	0.5	0.3	1.1	1.2	0.8	2.3	2.4	2.1	0.3	0.2	0.5	1.3	2.0	0.2	1.3	2.8	1.1	2.7	2.0	0.7	0.0	0.9	0.3	7.6	0.2	0.5	3.5	1.3	0.6	0.4	1.4	1.3	1.3	2.4	0.5	0.3	4.4	1.3	2.0	0.2	1.6	0.0	0.6	0.1	1.0	2.5	0.4	0.7	0.0	1.6	2.4	1.5	1.3	0.2	0.5	1.8	3.3	0.4	0.5	2.0	2.4	0.3	0.1	14.0	1.1	0.0	2.9	0.0	0.3	0.0	0.6	0.3	0.0	239.6	27.3	5.2	2.0	0.1	0.0	0.3	97.9	0.0	0.0	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	46.8	2.6	0.7	0.0	1.0	0.1	0.9	0.5	0.0	1.8	1.0	5.4	0.0	0.1	76.7	4.0	0.0	0.1	0.0	0.0	0.1
LRRC47	"KIAA1185, RP1-286D6.3"	ENSG00000130764	"Leucine rich repeat containing 47"	Q8N1G4	1	3778558-3796504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008512, HPA012018"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		16000	"Nucleoli fibrillar center"		"HPA008512: AB_1853324, HPA012018: AB_1853322"	"unprognostic (2.25e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.07e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.89e-2)"	"unprognostic (2.25e-1)"	14.4	14.6	14.5	10.3	17.4	14.1	11.9	22.4	28.6	14.9	14.5	15.9	9.2	13.8	16.1	13.0	15.0	15.2	13.7	24.5	13.3	14.9	12.3	22.8	11.2	12.6	12.8	19.2	20.3	23.8	16.5	13.3	16.3	15.0	15.3	9.7	13.6	19.6	17.2	61.2	17.4	12.1	13.8	11.4	13.3	13.9	12.4	12.7	18.3	18.9	16.3	11.7	14.9	14.7	4.9	7.8	6.7	7.2	6.5	8.6	3.5	10.5	12.5	9.1	14.9	9.8	7.9	9.1	9.2	7.1	12.2	9.6	15.4	11.8	11.1	13.6	10.0	9.3	14.9	11.1	11.4	6.7	14.1	20.3	20.4	14.2	16.9	15.2	13.8	7.6	9.3	10.1	12.1	9.8	8.0	8.6	14.5	18.6	3.3	8.8	11.2	15.1	16.0	20.6	10.5	19.2	14.9	9.1	13.2	8.4	7.8	19.1	18.7	11.5	17.5	17.9	9.3	9.5	10.4	11.6	10.2	5.9	15.1	11.9	24.7	22.8	12.7	6.0	18.9	4.0	6.7	6.4	3.2	5.7	7.2	5.9	4.0	6.2	8.6	7.8	4.9	7.0	7.3	4.0	6.5	5.5	6.6	5.6	3.5	14.5	17.4	22.4	28.6	13.3	14.9	12.8	19.2	15.0	12.7	14.9	17.9	20.1	15.7	13.9	30.8	50.4	35.7	10.7	17.0	26.2	13.7	50.0	16.6	10.9	1.3	13.5	22.3	0.0	12.7	34.7	16.0	15.8	11.5	26.0	22.9	36.5	20.7	19.0	14.0	1.9	20.4	11.6	8.5	11.8	22.3	29.8	12.9	25.2	22.3	18.8	15.9	12.9	22.0	15.6	38.4	18.9	40.3	15.4	28.6	11.9
LRRC4C	"KIAA1580, NGL-1"	ENSG00000148948	"Leucine rich repeat containing 4C"	Q9HCJ2	11	40114203-41459773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 31.5"	"Group enriched"	"Detected in some"	12	"Muller glia cells: 106.3;Rod photoreceptor cells: 97.7"	"Cancer enhanced"	"Detected in some"		"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.7"	"Group enriched"	"Detected in some"	6	"AF22: 17.3;U-2 OS: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054800, HPA075816"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA054800: AB_2682603, HPA075816: "	"unprognostic (4.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (7.62e-3)"	"unprognostic (4.87e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-13)"	"unprognostic (5.05e-4)"	"unprognostic (5.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-3)"	1.6	5.7	20.2	1.6	23.7	0.5	2.6	3.6	31.5	5.3	1.9	3.3	0.0	1.1	2.3	1.0	1.2	1.3	1.8	2.6	16.7	8.7	0.9	2.1	1.6	1.4	7.5	10.3	1.6	1.0	4.3	3.2	0.5	8.7	1.5	1.6	1.3	1.4	3.0	0.7	0.7	1.3	2.4	6.0	1.3	0.9	0.9	7.9	0.0	4.0	0.0	1.6	1.1	1.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	19.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	23.7	3.6	16.4	16.7	8.7	7.5	10.3	8.7	7.9	0.0	2.2	0.0	0.0	0.1	8.7	1.0	0.0	0.0	1.2	0.0	5.9	0.0	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.0	0.0	106.3	0.2	0.0	1.4	0.6	97.7	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0
LRRC57	FLJ36812	ENSG00000180979	"Leucine rich repeat containing 57"	Q8N9N7	15	42537820-42548802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 56.9;Rod photoreceptor cells: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040894	Approved		Approved	Mitochondria,Cytosol		NA	NA		230000	"Mitochondria, Cytosol"		"HPA040894: AB_10794996"	"unprognostic (8.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (7.45e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	13.9	14.7	15.8	11.6	13.6	32.7	19.2	12.4	19.1	11.8	16.0	10.6	9.7	12.3	15.7	12.2	18.0	15.3	10.2	15.6	18.0	8.4	14.2	11.1	15.9	11.2	11.8	16.5	17.6	14.5	13.2	12.2	14.4	9.9	12.3	18.9	16.4	15.7	11.6	11.0	16.5	14.5	12.8	10.3	13.0	14.1	12.4	11.3	14.9	15.1	10.0	12.8	13.1	15.6	4.8	6.9	22.1	12.0	11.1	6.7	4.3	10.4	7.9	14.4	10.8	12.0	9.5	7.8	15.0	8.0	10.6	11.2	16.3	8.4	4.9	10.5	11.6	12.0	17.2	9.6	11.7	10.8	10.4	9.0	19.5	17.4	7.3	11.6	12.0	12.6	10.4	15.7	9.6	11.9	7.6	16.9	13.0	15.0	11.8	9.6	4.9	7.0	5.4	3.8	17.7	7.1	11.0	13.9	7.7	7.3	17.1	7.4	8.9	17.3	12.5	8.7	9.9	11.6	14.4	17.2	12.8	9.0	13.1	11.1	10.0	24.8	20.3	7.3	12.1	15.6	22.1	6.5	20.5	5.4	9.4	6.7	4.2	5.2	4.9	6.9	4.8	4.3	5.3	8.5	11.1	12.0	4.0	5.2	4.3	15.8	13.6	12.4	19.1	18.0	8.4	11.8	16.5	9.9	11.3	8.9	13.3	5.4	11.0	5.0	13.4	9.5	10.2	21.4	7.9	8.7	56.9	9.9	11.6	9.6	13.9	12.9	11.6	0.0	8.5	15.7	7.4	12.9	13.9	6.4	12.0	19.1	12.0	18.4	11.9	13.2	8.9	12.9	6.8	22.6	13.5	18.4	11.4	10.2	15.2	6.6	81.1	6.5	8.2	5.0	5.3	4.8	13.3	10.9	11.9	10.1
LRRC58		ENSG00000163428	"Leucine rich repeat containing 58"	Q96CX6	3	120324509-120349339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057574	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA057574: AB_2683474"	"unprognostic (7.87e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.06e-1)"	15.8	30.1	12.7	10.7	14.3	10.0	15.4	13.9	14.8	15.4	13.3	16.3	11.3	9.6	14.5	11.3	14.6	11.0	9.7	9.6	12.9	9.6	19.2	14.1	10.9	12.7	15.9	10.5	19.7	13.1	21.0	9.8	12.1	14.4	15.1	9.9	13.2	11.6	12.1	9.2	13.8	12.2	15.5	22.9	14.6	10.0	7.9	15.5	27.9	18.3	9.0	11.0	17.2	16.1	5.7	6.4	3.5	5.8	3.7	8.4	3.4	24.8	8.8	6.0	7.7	14.0	13.4	9.6	8.9	7.8	9.6	12.0	8.2	7.7	16.3	11.2	9.6	13.6	10.9	11.1	8.8	18.3	6.3	6.9	17.4	12.0	9.5	9.4	28.1	9.0	9.8	11.3	11.6	15.0	6.2	5.6	10.5	9.8	21.0	10.3	11.3	22.0	9.0	6.1	11.0	16.1	4.9	16.2	10.5	7.3	9.2	7.7	10.3	15.7	10.8	22.3	4.4	11.8	12.8	8.3	16.1	17.9	10.7	11.3	18.1	20.8	34.6	16.2	21.3	13.4	2.4	5.8	2.3	4.4	5.1	6.4	5.4	5.5	5.6	5.5	5.7	8.4	6.2	3.5	3.7	3.9	6.4	5.4	3.4	12.7	14.3	13.9	13.5	12.9	9.6	15.9	10.5	14.4	15.5	68.5	57.6	28.8	17.3	45.2	28.0	15.5	28.1	37.5	38.7	17.4	53.0	14.2	10.0	19.4	6.7	20.4	18.0	23.3	26.5	21.7	39.0	27.8	33.6	31.0	24.2	23.8	16.1	25.2	43.8	4.0	51.8	30.3	32.1	8.2	22.2	43.2	26.4	14.4	68.6	33.1	20.4	25.8	33.5	17.4	24.0	49.8	11.3	27.7	29.0	14.4
LRRC61	"FLJ31392, HSPC295, MGC3036"	ENSG00000127399	"Leucine rich repeat containing 61"	Q9BV99	7	150322639-150338150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.1;Hep G2: 20.7;NTERA-2: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019355	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019355: AB_1853339"	"unprognostic (4.05e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.69e-3)"	2.8	14.7	6.7	9.0	9.3	2.3	4.1	7.5	7.3	6.7	6.0	3.5	4.5	5.8	7.0	4.0	6.4	20.8	8.0	3.3	5.4	13.1	10.8	18.3	4.8	9.1	5.0	3.4	18.5	12.7	12.2	10.9	7.3	5.1	6.4	2.9	10.6	6.2	6.7	3.0	5.4	7.9	3.8	3.0	10.1	6.6	6.6	3.9	41.0	16.4	3.0	11.8	4.2	9.0	9.5	15.1	11.6	2.4	6.5	10.5	4.2	7.8	0.2	0.2	0.0	0.0	0.0	3.7	0.0	0.0	1.0	3.2	14.8	7.8	2.4	3.3	0.1	0.0	7.1	0.0	0.0	0.5	31.1	10.1	2.8	9.5	20.7	5.7	0.0	1.5	0.6	3.2	0.0	0.0	0.2	0.0	16.2	9.8	4.6	0.0	14.2	14.3	1.2	27.3	5.3	0.0	0.0	0.0	6.4	2.3	5.1	14.1	13.8	13.2	2.9	5.4	2.3	2.2	1.7	0.0	0.0	0.0	0.0	0.0	5.1	1.6	0.0	0.0	0.0	0.0	2.3	2.4	6.7	9.5	1.0	7.6	8.0	6.8	7.3	2.6	9.5	6.7	7.7	11.6	6.5	1.0	15.1	10.5	4.2	6.7	9.3	7.5	7.3	5.4	13.1	5.0	3.4	5.1	3.9	6.0	1.0	6.5	4.0	1.0	7.7	2.1	10.2	20.1	4.5	15.7	0.0	22.6	16.6	22.1	4.7	2.1	9.6	0.0	24.7	21.2	2.4	4.0	1.1	18.3	5.5	12.7	18.6	1.3	1.3	12.9	9.5	1.8	3.3	24.4	7.6	13.0	27.0	13.9	5.3	27.2	4.7	0.0	0.8	20.4	22.8	2.4	22.5	8.7	9.5	2.6
LRRC63	RP11-139H14.4	ENSG00000173988	"Leucine rich repeat containing 63"		13	46211943-46277366	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 16.3;epididymis: 7.2"	"Cell type enhanced"	"Detected in some"	23	"Ciliated cells: 8.1;Cone photoreceptor cells: 5.9;Early spermatids: 23.3;Late spermatids: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.6;JURKAT: 6.4;MOLT-4: 1.6;THP-1: 1.9"									"HPA039318, HPA039763"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA039318: AB_10796224, HPA039763: AB_10795408"	"unprognostic (3.40e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.33e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.18e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.31e-2)"	0.6	1.3	1.5	1.0	9.9	1.0	0.7	0.7	5.0	1.2	0.7	11.9	0.0	0.6	0.5	7.2	0.5	1.3	0.4	0.5	3.0	1.8	0.8	0.7	1.1	1.3	16.3	2.3	0.5	0.5	0.7	0.5	0.7	10.0	1.1	0.7	0.7	0.7	0.8	0.5	0.6	0.6	0.4	15.9	0.8	0.8	6.2	10.0	3.6	0.6	0.0	0.4	0.8	0.5	0.0	0.9	0.2	0.1	0.0	1.8	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.3	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.2	0.7	0.0	1.9	0.0	0.1	0.0	0.0	0.4	0.8	0.3	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.4	0.4	0.1	0.0	1.8	1.7	0.2	0.0	0.0	0.9	0.0	0.5	1.5	9.9	0.7	5.0	3.0	1.8	16.3	2.3	10.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.0	5.9	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	1.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0
LRRC69		ENSG00000214954	"Leucine rich repeat containing 69"	Q6ZNQ3	8	91101832-91219236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 6.6"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 38.9;Late spermatids: 11.9"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.8;SuSa: 6.1;U-266/70: 17.7;U-266/84: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046337	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA046337: AB_2679626"	"unprognostic (1.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.69e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-6)"	"unprognostic (6.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.68e-5)"	0.8	0.9	0.2	1.5	0.2	0.0	1.0	0.0	0.1	0.7	0.5			0.1	0.5	1.9	0.7	0.4	0.5	1.1	0.1	0.1	0.9	0.7	0.7	1.9	0.3		0.4	0.7	0.3	0.6	0.5		1.0	1.5		1.1	0.3	0.6	3.5	0.6	1.4	0.3	1.2	0.6	6.6			1.3		1.1	1.0	0.8	1.9	2.0	1.5	1.1	0.4	2.3	0.1	0.6	0.7	0.2	0.5	0.7	1.5	1.2	0.4	0.1	0.3	0.3	1.1	0.9	1.0	0.5	0.2	0.1	0.6	0.7	1.2	0.3	0.3	6.8	1.5	1.8	0.5	0.2	0.5	1.1	0.4	1.1	0.4	0.8	0.4	0.1	1.2	1.1	0.6	0.4	0.2	0.3	0.5	0.7	1.1	0.4	0.8	0.0	0.7	0.2	0.7	0.0	0.2	0.0	0.4	1.0	6.1	1.6	1.2	0.2	0.3	0.7	0.2	0.9	17.7	9.8	4.0	0.1	2.2	0.9	1.3	0.6	1.5	1.5	1.1	1.5	1.2	1.6	0.6	0.1	1.9	2.3	1.2	0.1	0.4	0.6	2.0	2.1	0.1											0.0	0.6	0.8	2.4	4.1	1.8	2.4	0.0	6.7	1.2	3.5	3.9	1.9	3.3	1.3	38.9	2.1	0.5	0.0	1.0	1.5	2.2	3.1	0.0	0.8	0.8	0.0	2.4	3.7	2.1	11.9	2.6	1.7	6.8	4.6	1.4	1.1	1.5	0.9	1.1	0.2	3.2	0.0	2.1	2.3	2.5	4.5	0.8	0.0	1.4	2.0
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"	Q96NW7	1	69568398-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 29.1"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 37.9;Early spermatids: 20.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 1.4;T-cells: 1.7"	"Group enriched"	"Detected in some"	6	"HaCaT: 10.5;HEL: 31.3"	"Low region specificity"	"Detected in many"							HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	1.0	1.3	20.2	1.0	29.1	1.0	0.8	0.5	21.9	1.2	1.9	5.0	0.0	1.0	1.2	1.0	1.3	0.8	3.2	2.8	15.4	5.8	2.8	1.2	0.8	0.9	4.4	17.6	1.0	2.7	0.7	0.4	1.2	2.4	1.5	2.4	0.2	0.9	1.1	2.8	1.1	1.3	1.2	2.5	0.8	0.8	5.8	7.6	0.0	6.7	0.0	0.8	0.9	0.5	0.0	0.1	1.4	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.3	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.5	31.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	20.2	29.1	0.5	19.2	15.4	5.8	4.4	17.6	2.4	7.6	0.0	0.0	5.1	0.5	0.7	37.9	5.8	2.5	0.0	0.0	0.0	2.0	0.4	0.0	0.0	20.2	1.4	0.0	0.0	0.0	0.4	2.1	0.7	0.0	5.5	0.3	6.4	0.0	1.8	1.5	4.6	0.6	0.7	5.0	0.0	0.0	0.5	0.0	0.0	2.8	1.3	7.9	0.0	1.4	7.4	2.7	1.1	0.1	2.5	0.0	0.1
LRRC73	"C6orf154, dJ337H4.2"	ENSG00000204052	"Leucine rich repeat containing 73"	Q5JTD7	6	43506969-43510686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5;testis: 31.6"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 299.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.7;MCF7: 5.7;OE19: 8.0;T-47d: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046698	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA046698: AB_10959526"	"unprognostic (3.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.89e-2)"	1.2	6.1	10.4	0.9	19.4	0.8	1.1	2.3	23.5	1.4	1.3	2.3	0.9	2.1	1.4	1.5	1.0	11.3	1.8	1.8	8.9	5.2	3.0	1.2	1.6	0.9	3.1	12.1	2.0	2.8	7.5	4.1	1.2	6.2	1.9	1.1	0.6	1.4	2.1	1.0	1.1	1.2	1.5	1.1	1.2	1.8	31.6	1.8	0.0	1.6	0.0	0.9	1.4	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.8	5.7	0.9	2.9	0.2	0.2	1.6	0.5	0.3	0.0	0.3	0.2	0.1	1.0	0.8	2.2	0.7	0.7	0.0	0.1	0.9	0.0	0.4	0.2	0.9	0.0	0.1	0.5	1.1	1.8	0.3	2.8	0.1	0.3	0.3	0.5	1.0	5.7	0.0	0.0	0.1	8.0	0.7	0.0	0.0	0.1	1.5	0.0	2.1	2.5	0.5	0.4	0.2	0.0	5.8	0.0	0.2	0.4	0.6	2.1	0.2	0.5	0.3	0.2	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	19.4	2.3	23.5	8.9	5.2	3.1	12.1	6.2	1.8	0.0	0.0	0.0	2.4	0.3	4.9	0.8	0.0	8.1	2.3	3.5	0.0	0.1	6.6	0.6	299.6	0.1	1.3	0.0	0.7	0.1	0.6	2.3	0.0	0.4	0.1	27.0	5.2	0.0	0.0	27.3	4.0	0.0	1.7	0.0	2.0	8.3	0.2	0.0	3.9	5.1	6.6	6.5	1.1	41.7	9.7	0.0	0.2	0.0	0.6	0.6
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 42.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 12.0;HUVEC TERT2: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	1.0	8.9	5.2	2.8	3.7	1.7	0.6	0.7	6.3	2.2	26.3	1.5	1.4	15.0	1.9	0.5	0.4	0.9	0.5	0.4	4.1	2.4	0.8	0.2	1.6	1.9	1.6	3.2	1.8	1.6	3.7	4.1	1.5	2.1	1.1	10.4	1.9	0.3	1.7	0.4	0.4	42.3	3.0	0.8	6.4	1.3	8.5	0.4	0.5	1.2	0.0	1.9	1.3	0.7	0.8	0.0	0.3	0.6	0.3	0.6	0.2	1.2	1.0	1.2	0.8	0.3	0.5	0.1	0.3	0.8	2.8	2.3	1.1	0.3	0.0	0.8	0.1	0.5	0.4	0.3	0.2	0.1	0.4	0.9	12.0	0.6	0.0	0.4	0.2	0.9	0.0	0.0	0.6	0.0	0.4	3.9	1.3	0.5	0.2	0.0	2.0	1.9	0.8	0.2	2.8	0.1	0.7	0.7	0.1	0.6	0.2	2.3	0.6	0.0	0.2	2.8	0.5	0.2	0.1	0.0	0.3	1.4	0.9	1.5	1.5	0.3	0.2	0.1	0.7	1.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.6	0.3	0.3	0.6	0.0	0.0	0.2	5.2	3.7	0.7	6.3	4.1	2.4	1.6	3.2	2.1	0.4	38.7	51.3	11.9	7.2	0.0	8.7	0.3	7.6	16.0	36.4	1.8	5.9	13.7	16.6	3.8	5.3	6.0	49.1	23.3	6.1	16.9	3.9	6.4	27.8	8.1	10.5	3.2	23.7	9.2	10.7	5.9	15.3	6.7	0.0	1.8	44.8	16.7	5.7	23.0	10.6	15.2	16.4	12.9	2.3	3.8	6.7	0.0	14.0	8.9	47.2	6.2
LRRC75B	"C22orf36, FAM211B, MGC131773"	ENSG00000178026	"Leucine rich repeat containing 75B"	Q2VPJ9	22	24585620-24593208	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 22.2;Muller glia cells: 39.6;Proximal tubular cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.7;NK-cell: 2.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.7;NK-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 8.3;MCF7: 7.4;SH-SY5Y: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002540	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002540: AB_1079263"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.69e-2)"	4.2	1.9	7.5	1.4	6.0	3.0	2.6	3.8	6.6	3.5	3.8	2.6	11.5	1.4	2.4	5.8	3.4	3.3	9.8	4.3	5.5	9.1	6.0	3.4	1.7	1.7	7.8	4.0	7.3	7.2	1.4	1.5	2.3	4.1	6.9	2.0	4.9	7.5	15.0	10.7	4.3	8.2	6.7	7.0	2.7	2.6	8.3	0.5	0.0	8.6	3.0	2.1	5.5	2.7	0.0	0.3	2.7	0.4	2.0	0.2	0.0	0.1	4.2	0.0	2.3	0.6	1.7	0.4	0.6	0.7	1.5	1.6	3.1	0.0	0.0	1.0	1.2	1.2	4.7	0.4	2.3	0.0	1.3	2.8	0.3	0.6	8.3	4.2	0.0	0.0	0.0	1.8	1.5	0.2	0.9	1.1	0.0	0.4	0.0	0.1	7.4	0.0	1.5	2.1	5.0	1.7	0.0	0.2	0.0	1.9	0.4	2.2	6.6	2.2	0.7	0.6	0.5	0.0	0.7	2.4	2.5	1.6	0.9	0.8	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.3	2.7	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	7.5	6.0	3.8	5.6	5.5	9.1	7.8	4.0	4.1	0.5	11.9	5.1	0.0	2.0	0.0	2.2	3.1	17.8	0.0	0.0	7.0	0.0	1.7	10.0	8.0	1.1	0.8	14.2	0.0	7.9	0.3	1.8	7.4	0.0	22.2	1.0	1.6	1.2	1.3	1.6	5.8	11.8	0.5	0.0	0.0	5.5	39.6	4.2	3.4	9.2	38.2	0.9	0.0	4.1	0.5	0.7	0.0	0.9	0.0	4.5	1.0
LRRC8B	"KIAA0231, TA-LRRP"	ENSG00000197147	"Leucine rich repeat containing 8 VRAC subunit B"	Q6P9F7	1	89524836-89597864	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 81.5;Late spermatids: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017950	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA017950: AB_1853346"	"unprognostic (2.50e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.15e-4)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	8.1	18.0	13.0	4.4	19.3	3.0	6.6	2.5	27.8	3.8	5.6	15.4	0.5	7.4	2.6	6.9	5.0	4.3	6.2	3.3	15.3	6.5	4.9	4.8	5.8	4.9	8.8	17.1	2.6	8.5	12.4	5.1	2.4	8.3	5.6	6.8	4.4	5.0	1.6	5.9	6.9	4.9	3.6	16.2	4.3	6.4	17.4	8.2	3.1	6.1	2.7	5.9	3.3	3.3	3.0	2.4	1.5	2.2	0.9	3.7	1.6	8.5	3.3	2.4	8.4	12.2	7.3	9.7	0.2	2.5	1.1	1.6	5.2	5.2	0.7	3.5	1.2	3.3	4.5	22.3	1.9	1.4	4.1	4.5	16.6	2.2	4.5	1.2	7.9	11.8	4.0	7.1	0.9	3.7	0.4	11.9	6.7	18.5	5.7	1.3	4.6	3.9	3.8	13.8	3.5	4.8	8.8	1.1	3.0	2.7	10.7	7.0	11.2	4.7	11.4	8.1	3.0	6.9	3.8	3.9	1.0	5.7	2.6	2.7	4.2	3.4	4.2	1.4	2.0	2.0	1.4	2.2	1.5	1.1	1.1	1.7	3.0	2.1	1.7	2.4	2.3	3.7	2.9	0.7	0.9	1.2	2.1	3.4	1.6	13.0	19.3	2.5	27.5	15.3	6.5	8.8	17.1	8.3	8.2	14.9	11.5	5.6	11.4	29.3	34.9	3.4	12.7	20.1	14.8	7.0	45.2	2.6	1.7	12.0	81.5	8.4	5.1	0.0	16.2	9.6	1.5	17.3	2.3	6.7	6.1	0.0	25.8	19.6	13.2	55.3	2.3	7.7	1.7	3.6	13.0	5.5	12.8	3.5	2.5	4.5	21.5	6.5	14.7	6.9	4.1	24.1	2.1	2.5	11.0	8.9
LRRC8C	AD158	ENSG00000171488	"Leucine rich repeat containing 8 VRAC subunit C"	Q8TDW0	1	89633072-89769903	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 40.3;Endothelial cells: 39.4;Suprabasal keratinocytes: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 9.1;monocytes: 6.1;T-cells: 11.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029347	Uncertain		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA029347: AB_10601544"	"unprognostic (2.61e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.76e-3)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.78e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.38e-2)"	19.8	12.6	8.3	11.7	11.4	9.2	27.8	2.0	11.0	6.6	4.8	12.9	1.4	4.5	11.9	7.3	4.4	6.0	9.2	8.2	7.8	7.4	4.5	4.8	10.4	14.8	13.0	7.6	7.8	3.0	5.8	6.9	9.0	9.0	4.5	5.5	6.4	5.0	3.2	5.9	8.3	7.7	21.3	10.8	12.1	4.5	6.4	10.2	3.4	7.6	6.1	10.3	7.5	7.5	0.8	9.1	0.9	6.1	1.9	11.3	3.3	0.1	2.0	1.7	1.5	5.1	5.8	0.8	10.6	11.9	4.8	4.5	0.0	0.7	3.2	3.0	4.6	8.3	7.2	5.5	15.8	11.8	7.9	3.3	3.1	1.7	0.1	4.2	14.1	1.0	2.5	3.2	10.5	5.6	3.2	19.5	5.1	2.0	4.4	4.1	0.3	2.0	13.9	1.8	0.0	4.3	14.1	0.8	1.1	1.0	1.7	1.3	6.0	3.9	0.3	8.8	2.7	0.1	22.2	16.3	8.6	4.1	2.9	8.0	1.6	1.3	1.7	2.7	10.6	1.4	0.4	6.1	0.0	4.2	5.5	3.7	0.8	6.7	5.5	9.1	0.5	5.4	5.0	0.9	1.9	6.1	0.7	11.3	3.3	8.3	11.4	2.0	11.0	7.8	7.4	13.0	7.6	9.0	10.2	3.0	5.1	4.7	3.0	40.3	2.5	5.2	5.1	4.0	3.4	0.0	0.0	0.1	0.0	1.5	29.1	39.4	0.0	0.0	2.2	0.4	4.0	0.9	0.0	0.0	12.1	1.6	1.2	31.3	28.6	17.3	0.0	24.5	25.3	16.2	0.2	0.4	7.7	1.9	0.7	0.6	1.3	0.0	16.5	1.4	1.7	39.3	0.2	17.5	0.2	1.7
LRRC9	FLJ46156	ENSG00000131951	"Leucine rich repeat containing 9"	Q6ZRR7	14	59919713-60063559	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.4;pituitary gland: 13.9;testis: 14.3"	"Group enriched"	"Detected in some"	9	"Early spermatids: 98.5;Late spermatids: 64.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 7.3;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 2.0;GAMG: 1.1;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;SuSa: 1.7;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040965, HPA041381, HPA077675"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Nuclear bodies"	"HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: "	"unprognostic (1.01e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.62e-3)"	"unprognostic (8.54e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-2)"	0.6	0.4	0.6	0.1	7.3	0.2	0.1	0.2	1.1	0.3	0.1	3.2	0.0	0.1	0.2	1.4	0.1	3.4	0.1	0.1	1.4	1.2	0.2	0.2	0.1	0.1	0.5	1.3	1.0	0.2	4.8	13.9	0.1	16.4	1.3	0.1	0.0	0.1	0.2	0.1	0.1	0.7	0.1	0.9	0.1	0.2	14.3	2.2	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.2	1.1	1.4	1.2	0.5	1.3	16.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	64.1	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	8.8	0.9	0.0	0.1	0.0	0.0	0.0
LRRD1	IMAGE:4798971	ENSG00000240720	"Leucine rich repeats and death domain containing 1"	A4D1F6	7	92112159-92179531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 19.1"	"Group enriched"	"Detected in some"	82	"Early spermatids: 257.1;Late spermatids: 670.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055670, HPA079440"	Enhanced		Approved	Vesicles,Mitochondria		NA	NA			Mitochondria	Vesicles	"HPA055670: , HPA079440: "	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.13e-3)"	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	19.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.7	3.8	0.6	0.7	0.8	0.1	0.9	0.2	0.9	0.9	0.4	1.7	0.6	0.8	0.0	0.5	0.4	0.3	1.3	0.9	0.2	0.0	0.5	0.7	0.1	0.0	0.7	0.9	0.9	0.6	1.0	0.3	0.4	3.3	1.1	0.2	0.4	0.7	0.3	0.9	0.5	1.3	1.2	2.4	0.9	2.0	0.8	2.5	0.4	0.1	0.7	0.5	0.9	0.5	0.1	0.7	0.7	0.6	0.1	0.3	0.1	0.7	0.5	0.4	1.3	1.0	1.2	1.0	0.7	1.2	0.3	1.3	0.4	0.9	0.4	3.8	0.6	0.4	0.5	0.3	0.4	0.5	0.5	0.4	0.1	1.0	0.4	0.5	1.9	0.7	0.4	0.7	0.8	0.1	0.1	0.1	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.3	0.2	0.7	0.2	0.0	2.7	1.2	0.0	0.0	0.1	0.0	0.0	257.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.1	0.0	0.1	1.6	0.0	0.0	0.0	670.8	4.4	0.3	0.0	0.0	0.0	0.5	0.0	0.0	2.8	0.0	0.4	0.0	0.1	5.6	2.7	0.3	0.0	0.0	0.0	0.3
LRRFIP2	HUFI-2	ENSG00000093167	"LRR binding FLII interacting protein 2"	Q9Y608	3	37052656-37183689	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 388.9;Urothelial cells: 309.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035956, HPA042023"	Uncertain		Approved	"Plasma membrane,Actin filaments"		NA	NA		1000000	"Plasma membrane, Actin filaments"		"HPA035956: AB_10671238, HPA042023: AB_2677802"	"unprognostic (2.03e-3)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.16e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.84e-3)"	"unprognostic (3.76e-2)"	15.4	17.3	23.0	17.5	22.0	27.5	21.9	30.0	22.8	35.7	35.8	26.5	17.7	24.7	28.2	20.0	33.0	15.7	22.8	47.4	23.8	25.3	19.8	33.9	18.7	19.3	24.2	19.4	20.6	16.9	33.9	18.3	16.9	24.4	30.3	24.8	19.6	19.3	19.5	58.5	23.2	37.1	27.3	31.2	29.7	17.0	47.2	24.8	11.6	20.6	33.6	21.6	23.7	25.1	7.1	9.8	22.7	17.2	11.9	8.8	7.5	15.6	8.7	10.1	7.9	13.5	20.8	8.8	42.7	42.6	24.1	27.8	8.1	7.2	6.2	7.0	41.1	11.9	8.2	7.4	21.1	39.5	13.8	5.8	11.1	12.5	7.9	19.3	8.7	6.8	9.2	15.2	31.3	32.5	13.4	16.7	9.7	8.8	10.9	20.0	4.0	7.4	4.7	6.6	6.4	11.2	3.6	28.9	6.3	16.9	6.1	3.6	5.8	16.5	15.3	13.8	8.5	8.8	9.1	16.0	18.5	12.5	27.1	20.0	8.5	15.2	9.5	10.9	7.9	26.2	12.2	15.0	22.7	6.6	10.4	8.5	7.1	7.0	7.0	9.8	5.4	5.2	6.2	14.0	11.9	17.2	5.5	8.8	7.5	23.0	22.0	30.0	22.8	23.8	25.3	24.2	19.4	24.4	24.8	26.8	32.2	18.0	127.0	120.9	34.6	89.3	25.5	36.1	66.0	22.7	27.5	25.5	54.7	70.3	388.9	46.3	105.3	23.3	82.3	35.6	59.0	267.5	50.8	52.9	22.7	116.0	51.9	60.8	39.4	269.5	39.1	42.2	70.9	77.5	39.2	48.7	85.8	59.6	54.1	33.1	51.1	38.8	54.0	116.1	61.4	149.1	32.8	24.5	60.8	309.6
LRRIQ3	"LRRC44, MGC22773"	ENSG00000162620	"Leucine rich repeats and IQ motif containing 3"	A6PVS8	1	74026015-74198187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 34.1"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 144.3;Late spermatids: 74.3;Spermatocytes: 156.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 12.2;JURKAT: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030799	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA030799: AB_10601337"	"unprognostic (5.94e-3)"	"unprognostic (6.00e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.65e-2)"	1.8	1.3	0.9	0.9	2.7	0.2	0.9	0.3	1.5	0.8	0.4	1.1	0.1	0.3	0.4	1.2	0.6	2.8	0.6	0.6	1.0	1.1	3.5	1.7	1.6	0.9	2.5	1.4	2.5	0.6	2.1	7.2	0.3	2.4	0.6	0.3	0.6	0.8	0.6	0.4	0.3	0.4	0.2	1.3	1.6	0.5	34.1	1.0	1.4	1.9	0.0	0.8	0.5	0.4	3.9	1.1	1.9	1.1	1.1	4.0	0.9	0.3	1.5	0.2	0.6	1.6	0.6	1.0	0.9	0.6	1.3	1.4	0.2	2.1	2.1	1.9	0.2	12.2	0.2	3.3	3.0	1.6	5.2	0.0	1.9	0.5	1.0	0.2	3.4	1.1	1.1	1.6	2.2	0.8	0.5	0.6	7.3	1.6	3.0	2.1	0.0	1.3	0.5	1.7	3.7	1.0	1.6	1.2	2.1	1.9	0.2	1.6	1.1	0.2	0.2	4.6	0.3	1.3	1.9	0.2	0.2	1.1	0.8	1.8	3.1	1.1	1.7	2.3	0.3	1.6	0.0	0.2	1.9	2.3	1.1	2.9	3.9	2.6	2.9	0.3	2.0	2.5	3.5	0.0	1.1	0.3	1.1	4.0	0.9	0.9	2.7	0.3	1.5	1.0	1.1	2.5	1.4	2.4	1.0	0.0	1.0	0.0	1.0	1.0	0.8	0.4	0.0	36.1	1.2	0.0	3.9	1.4	11.6	1.4	144.3	0.1	0.0	0.0	1.6	1.5	0.2	1.2	0.0	1.0	1.1	0.0	2.9	0.0	0.6	74.3	1.7	0.4	0.0	1.0	0.9	1.1	0.7	0.0	1.4	4.2	0.6	0.0	0.4	156.8	22.6	0.1	0.2	0.7	0.6	0.7
LRRIQ4	LRRC64	ENSG00000188306	"Leucine rich repeats and IQ motif containing 4"	A6NIV6	3	169821922-169837775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 7.1"	"Group enriched"	"Detected in some"	51	"Early spermatids: 39.4;Late spermatids: 18.7"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HEL: 2.6;JURKAT: 2.3;RT4: 4.8;T-47d: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036271, HPA036706"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036271: , HPA036706: AB_2675264"	"unprognostic (5.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-4)"	"unprognostic (5.26e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (4.56e-3)"	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	1.0			0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1		0.3	0.0	0.0	0.2	0.0		0.1	0.1		0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.6	7.1			0.0		0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.3	0.0	0.3	0.2	0.0	0.4	0.0	0.0	1.7	0.3	0.2	1.6	0.0	0.7	0.0	0.4	2.0	0.1	2.6	0.0	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.2	0.0	0.1	0.5	0.4	1.1	0.7	1.0	0.0	0.0	0.1	4.8	1.9	0.6	0.1	0.4	0.0	0.0	4.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	"Leucine rich repeat kinase 1"	Q38SD2	15	100919215-101078254	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 30.0;monocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.5;Karpas-707: 17.3;U-266/84: 15.6;U-698: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010537	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA010537: AB_1079283"	"unprognostic (3.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.25e-2)"	6.1	1.9	4.5	26.3	3.9	6.5	5.0	2.1	8.1	6.4	8.0	5.9	2.2	2.9	7.9	6.0	5.4	7.1	4.2	3.4	4.0	1.5	2.7	1.0	4.7	15.0	4.5	4.0	6.3	5.3	2.8	2.3	4.4	2.5	7.1	6.5	2.8	7.7	6.8	1.6	7.3	8.5	5.7	3.7	11.1	3.9	5.1	3.4	1.2	3.5	2.1	17.4	7.5	6.7	2.3	3.3	3.2	1.1	0.0	0.0	0.1	0.8	4.8	0.0	0.0	7.4	7.6	0.0	2.9	2.1	2.7	1.9	0.8	2.1	23.5	1.1	7.8	0.0	4.8	0.7	0.5	1.4	0.4	1.1	7.1	1.1	0.0	0.5	3.8	5.5	6.0	1.0	1.7	1.5	0.7	4.7	0.0	1.2	17.3	0.5	0.0	0.0	2.4	0.2	4.3	2.0	1.7	0.4	6.4	0.0	0.0	0.0	1.7	1.8	2.7	5.4	0.0	0.3	4.6	5.4	0.0	0.8	1.0	0.0	8.8	15.6	15.2	0.3	0.5	4.4	0.0	0.7	3.2	0.0	0.3	0.0	2.3	0.0	0.0	0.9	1.5	0.0	0.0	0.8	0.0	1.1	3.3	0.0	0.1	4.5	3.9	2.1	8.1	4.0	1.5	4.5	4.0	2.5	3.4	14.9	12.8	11.9	6.5	2.9	0.6	2.8	2.5	8.1	7.9	0.0	5.9	8.4	0.0	3.6	3.0	5.7	12.0	0.0	2.7	3.1	3.5	6.3	1.1	0.0	9.5	0.0	13.2	12.3	14.3	2.4	30.0	14.0	3.3	32.5	12.8	0.8	6.7	10.5	20.1	0.3	0.4	6.5	2.1	5.2	1.1	3.0	3.0	0.5	10.8	9.3
LRRN2	"FIGLER7, GAC1, LRANK1, LRRN5"	ENSG00000170382	"Leucine rich repeat neuronal 2"	O75325	1	204617170-204685733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 49.3"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;NTERA-2: 14.3;RPMI-8226: 22.2;SuSa: 8.2;T-47d: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029124	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029124: AB_10601545"	"unprognostic (2.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-3)"	4.9	6.6	11.8	3.7	16.5	2.4	3.3	9.7	20.3	1.9	7.9	5.3	1.0	1.9	3.9	0.8	2.4	10.2	6.1	6.0	11.7	12.8	7.3	0.7	2.5	2.9	6.3	13.8	3.3	1.4	19.1	9.7	1.3	8.1	1.6	7.5	12.2	2.8	3.7	2.2	0.7	3.3	9.9	3.1	6.3	1.4	3.8	6.1	3.2	2.8	0.0	1.3	2.1	1.5	0.4	0.1	1.7	0.3	0.7	0.8	0.2	0.0	3.3	2.7	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	7.1	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	1.1	0.0	14.3	0.0	0.1	0.2	0.0	22.2	0.0	0.1	1.9	0.3	4.4	0.1	0.0	8.2	7.9	0.0	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.7	0.7	0.0	0.1	0.8	0.2	11.8	16.5	9.7	15.7	11.7	12.8	6.3	13.8	8.1	6.1	0.0	0.0	0.0	0.5	0.3	4.6	1.0	0.0	0.0	0.0	1.8	2.0	0.1	0.0	2.7	0.0	0.7	1.7	0.0	0.8	0.1	1.1	0.3	0.0	0.0	5.3	49.3	10.9	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.9	3.3	0.3	0.0	2.7	0.9	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.7	0.3
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.5;brain: 23.8"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 33.5;Leydig cells: 52.0;Peritubular cells: 15.2"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 20.3"	"Cell line enhanced"	"Detected in some"		"AF22: 14.7;BJ: 8.3;BJ hTERT+: 18.2;GAMG: 9.3;SH-SY5Y: 26.4;SuSa: 8.5;T-47d: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043820: AB_2678687, HPA046792: AB_2679810"	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.8	26.5	12.7	1.6	21.2	1.1	2.1	20.0	23.8	3.6	1.4	1.9	0.8	1.0	1.0	3.1	1.9	1.3	1.6	9.0	10.4	10.7	0.9	2.7	8.7	3.6	7.7	13.0	7.9	1.5	0.7	4.9	6.7	9.0	4.7	1.6	0.8	1.9	6.4	4.0	0.8	2.1	1.0	2.9	2.0	0.9	16.4	6.3	8.8	22.3	0.0	4.4	1.6	1.3	0.2	0.0	0.1	0.0	0.0	20.3	4.0	0.0	0.0	14.7	1.8	6.8	2.9	0.0	8.3	18.2	0.8	0.7	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.9	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	26.4	0.0	0.0	0.0	8.5	14.4	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	1.2	0.0	0.0	20.3	18.4	0.1	0.0	0.0	0.0	0.2	4.0	12.7	21.2	20.0	23.8	10.4	10.7	7.7	13.0	9.0	6.3	0.0	7.0	0.0	0.0	0.0	33.5	12.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.3	9.6	0.0	1.1	0.0	0.7	3.2	1.7	1.3	0.0	3.4	52.0	0.0	1.7	0.0	0.0	10.8	0.0	0.0	15.2	0.0	3.9	0.0	1.2	0.9	0.5	0.1	0.3	3.2	0.0	0.1
LRRN4CL		ENSG00000177363	"LRRN4 C-terminal like"	Q8ND94	11	62686402-62689899	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 17.2;Leydig cells: 25.0;Melanocytes: 32.1;Peritubular cells: 16.3"	"Cancer enriched"	"Detected in many"	5	"melanoma: 26.5"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;ASC TERT1: 19.1;HHSteC: 14.9;HSkMC: 8.0;LHCN-M2: 9.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA050317	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA050317: AB_2681084"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.95e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-7)"	"unprognostic (2.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-2)"	15.7	4.8	0.2	5.0	0.6	0.6	11.6	0.6	0.9	27.2	12.1	0.1	3.5	2.1	27.0	14.0	19.1	11.4	6.7	9.3	0.3	0.2	0.8	0.2	3.1	1.8	0.3	0.6	24.9	2.1	0.4	1.2	4.4	2.2	10.8	2.5	17.8	3.2	6.7	17.0	6.8	4.3	15.1	1.9	0.3	5.7	8.5	0.0	0.0	3.5	10.4	2.4	18.2	11.2	0.9	0.6	3.3	0.8	0.8	0.6	0.1	0.0	0.1	0.2	0.2	5.7	19.1	0.2	2.0	2.9	0.2	1.0	0.2	0.1	0.1	0.2	3.2	0.0	0.3	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.1	14.9	0.2	0.1	8.0	0.2	0.4	0.0	0.1	0.0	0.3	0.2	0.1	9.7	0.1	0.2	0.4	0.4	0.1	0.1	0.1	1.3	0.3	0.0	0.1	0.6	0.2	0.3	0.2	0.6	0.1	0.1	0.2	0.2	1.8	0.1	2.0	0.1	0.2	0.2	0.2	1.1	0.2	0.0	0.9	0.8	0.3	0.4	0.3	0.3	0.4	0.4	0.3	0.1	0.9	0.5	0.6	3.3	0.8	0.4	0.6	0.2	0.1	0.2	0.6	0.6	0.9	0.3	0.2	0.3	0.6	2.2	0.0	0.0	2.6	0.0	1.9	6.0	1.9	1.1	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.1	17.2	0.8	1.1	0.0	0.3	1.6	1.2	1.3	1.2	0.0	25.0	1.5	32.1	0.0	0.1	0.3	0.0	0.0	16.3	0.1	0.7	0.0	1.7	0.4	0.2	6.0	0.1	0.0	0.0	1.0
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926006-67099830	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 137.5;Late spermatids: 100.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.8;Daudi: 2.3;HAP1: 10.8;NTERA-2: 2.3;RPMI-8226: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.9	7.3	12.9	1.0	18.7	0.9	0.9	19.7	29.1	1.7	0.9	3.2	0.0	1.0	1.2	0.9	1.4	0.9	0.9	0.9	7.0	6.5	1.0	0.9	1.4	0.9	3.7	16.0	8.0	3.7	0.9	26.6	0.9	4.5	1.2	0.9	0.0	1.0	1.2	1.0	0.9	1.1	1.0	2.8	0.9	0.9	1.9	5.9	0.0	0.9	0.0	0.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	18.7	19.7	21.3	7.0	6.5	3.7	16.0	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	100.5	8.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	11.3	0.0	0.3	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0
LRSAM1	"CMT2P, FLJ31641"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451486-127503501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	9.5	13.6	15.6	10.1	17.2	15.3	9.2	24.2	22.6	10.7	18.0	15.3	10.9	10.8	12.6	17.6	12.3	11.0	11.9	18.7	13.3	17.3	11.2	15.6	11.7	11.5	13.5	22.7	16.0	9.6	17.6	11.8	9.2	17.9	13.6	8.6	10.2	11.9	13.7	20.4	28.3	11.1	16.0	18.7	12.6	12.2	6.1	13.9	5.5	11.6	9.6	11.5	17.2	12.9	4.1	5.4	17.4	6.6	1.3	4.8	3.2	5.7	8.8	5.3	10.2	9.0	8.9	8.4	5.4	6.8	8.4	6.2	10.1	5.6	9.9	5.6	7.5	4.3	19.1	6.5	11.4	3.3	10.4	4.9	5.4	11.4	8.8	7.2	5.9	11.4	5.1	9.4	5.7	11.0	10.8	9.0	8.2	4.7	10.3	3.7	14.6	4.1	5.1	5.0	13.4	8.9	6.7	4.8	15.4	9.1	5.0	9.8	8.1	3.5	12.1	7.1	5.3	24.9	3.2	10.5	5.6	5.7	7.0	3.7	11.4	8.5	1.6	9.3	5.5	2.9	14.6	4.9	17.4	4.4	6.6	4.8	4.1	3.0	3.7	5.4	3.1	1.5	2.0	5.7	1.3	5.5	4.6	2.4	3.2	15.6	17.2	24.2	22.6	13.3	17.3	13.5	22.7	17.9	13.9	8.9	4.6	2.7	2.8	1.0	5.6	18.3	5.1	6.7	10.3	0.0	5.9	4.1	5.0	5.4	0.6	3.6	5.6	0.0	1.2	1.7	2.4	3.6	9.2	5.9	5.4	11.1	1.2	4.3	6.6	0.2	2.6	4.5	3.3	10.8	5.2	5.7	4.2	4.3	4.9	5.0	4.8	0.0	4.1	4.6	3.0	2.4	5.8	5.0	4.9	3.0
LRTM2		ENSG00000166159	"Leucine rich repeats and transmembrane domains 2"	Q8N967	12	1820267-1836752	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"brain: 18.7"	"Cell type enhanced"	"Detected in some"	29	"Bipolar cells: 3.7;Cone photoreceptor cells: 2.0;Horizontal cells: 11.1;Rod photoreceptor cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 9.2;SCLC-21H: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055094, HPA062745"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA055094: AB_2682693, HPA062745: "	"unprognostic (1.84e-3)"			"unprognostic (4.83e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.24e-1)"		"unprognostic (6.20e-4)"	"unprognostic (2.21e-1)"	"unprognostic (8.02e-2)"		0.7	0.7	5.1	0.7	12.3	0.7	0.7	0.8	18.7	0.7	0.7	1.7	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.7	3.3	5.0	0.7	0.7	0.7	0.7	1.7	10.5	0.7	0.7	0.7	0.1	0.7	4.7	0.7	0.7	0.1	0.7	0.8	0.7	0.7	0.7	0.7	1.7	0.7	0.8	0.9	4.3	0.0	0.7	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.3	0.8	18.7	3.3	5.0	1.7	10.5	4.7	4.3	0.0	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464929-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 129.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 733.2;Spermatocytes: 397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	2.7	4.6	3.6	3.8	5.0	7.6	1.9	7.9	5.8	2.5	2.5	3.4	3.4	2.9	2.8	2.8	2.1	7.1	2.5	2.6	4.3	4.0	4.0	5.1	2.6	4.4	3.4	3.7	3.1	3.4	3.4	4.9	2.0	4.2	2.2	1.6	1.7	3.3	4.0	3.6	2.2	4.3	2.7	2.4	6.6	3.3	129.9	3.8	3.9	2.7	1.6	4.2	2.3	1.8	12.6	9.8	9.2	4.0	9.9	10.4	5.8	7.4	10.3	5.6	15.7	4.3	3.2	8.7	7.9	5.2	13.6	9.4	9.9	4.3	18.4	11.4	6.0	16.0	7.9	8.2	7.1	4.0	6.4	15.9	3.8	4.7	6.1	5.7	7.1	7.4	3.0	4.3	15.7	3.3	4.6	7.1	14.4	17.8	5.7	7.3	22.4	21.3	16.9	11.9	9.4	15.0	11.3	5.2	19.8	4.0	4.7	7.4	21.1	8.7	8.4	7.7	6.8	4.8	5.9	4.1	7.5	16.1	23.2	12.6	20.9	36.0	17.6	8.3	6.6	13.0	9.1	2.5	9.2	10.4	4.0	9.9	11.1	9.1	9.1	2.8	12.6	5.8	7.4	5.9	9.9	3.5	9.8	9.0	5.8	3.6	5.0	7.9	5.8	4.3	4.0	3.4	3.7	4.2	3.8	0.0	0.6	5.2	5.8	9.3	11.7	0.7	2.5	16.0	6.8	12.2	2.0	7.7	6.6	12.2	733.2	5.8	7.9	0.0	9.2	9.8	5.7	3.5	0.0	6.8	7.8	4.8	7.5	5.5	5.7	71.5	17.5	3.9	5.0	10.0	6.3	8.6	9.9	6.0	14.9	11.5	8.1	0.0	5.1	397.6	39.9	8.5	5.1	7.0	6.3	3.3
LSM1	"CASM, YJL124C"	ENSG00000175324	"LSM1 homolog, mRNA degradation associated"	O15116	8	38163321-38176730	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024601			Approved	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Cytosol	"HPA024601: AB_1853379"	"unprognostic (1.19e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.97e-1)"	21.8	27.6	25.5	20.0	23.5	21.6	34.1	20.8	23.2	19.5	23.4	15.3	21.2	20.6	24.9	27.2	24.9	17.8	21.6	44.2	21.2	23.2	35.3	30.7	16.2	22.5	25.1	18.4	18.0	24.7	14.5	23.2	29.8	22.5	21.3	21.5	18.7	27.7	29.0	26.6	17.7	26.3	31.3	17.1	20.5	22.6	17.6	19.9	18.8	25.7	25.6	22.2	23.5	22.7	21.1	38.2	42.8	26.0	19.9	27.3	26.5	21.7	25.6	15.0	18.4	27.7	23.2	13.9	26.7	27.2	24.7	26.5	17.4	15.0	10.8	23.9	31.6	25.5	11.6	20.3	22.1	26.1	16.4	25.5	34.0	18.3	21.5	24.6	11.5	21.7	24.2	20.3	21.4	17.0	19.0	21.0	22.5	26.9	25.8	30.5	23.2	35.8	22.5	23.6	31.3	26.0	17.5	16.5	12.7	34.1	24.3	28.3	23.5	11.8	17.7	31.4	15.9	14.0	24.7	22.1	22.2	27.2	32.6	21.0	28.5	37.0	21.3	25.5	24.0	22.6	42.8	24.0	32.7	21.8	24.7	23.2	21.1	24.5	23.8	23.2	16.4	22.2	25.5	18.3	19.9	26.0	38.2	27.3	26.5	25.5	23.5	20.8	23.2	21.2	23.2	25.1	18.4	22.5	19.9	11.9	21.1	58.1	39.1	58.8	25.9	4.8	33.1	17.4	23.9	64.6	9.8	87.8	152.5	80.9	5.7	40.5	31.9	0.0	104.6	114.9	46.0	70.8	24.2	49.5	75.1	12.7	44.9	43.6	44.7	7.5	57.0	49.3	45.5	123.6	40.5	32.3	93.7	51.5	53.4	93.6	17.4	51.8	46.2	47.4	123.3	61.5	85.5	56.3	47.0	70.7
LSM12	FLJ30656	ENSG00000161654	"LSM12 homolog"	Q3MHD2	17	44034635-44067619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 220.5;Late spermatids: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051934	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA051934: AB_2681666"	"unprognostic (3.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.98e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (8.91e-3)"	"unprognostic (2.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.18e-2)"	26.7	26.6	26.9	19.8	22.1	30.1	35.1	22.5	30.0	19.5	23.8	23.0	20.7	20.8	22.6	31.5	32.8	18.8	23.8	42.7	24.6	28.9	24.8	44.8	20.4	26.8	25.5	21.2	24.5	36.8	27.4	23.7	30.5	20.4	20.7	30.0	21.7	21.8	26.6	40.8	19.6	19.6	29.2	23.6	23.4	23.4	37.5	18.6	27.7	24.2	17.4	29.1	30.5	19.8	25.4	36.3	16.8	40.1	22.8	29.4	27.0	20.4	22.9	16.1	25.3	21.4	23.3	29.1	23.4	23.0	29.7	30.1	26.3	22.6	34.3	17.0	26.3	23.6	16.9	33.9	30.2	45.2	25.4	35.4	23.8	17.7	31.7	19.7	41.1	25.5	20.7	24.4	27.9	40.6	19.6	25.7	22.4	34.4	25.5	20.2	20.2	39.0	22.5	23.7	20.4	32.4	24.9	31.8	33.1	27.7	30.5	22.6	14.9	18.8	20.5	24.4	35.4	42.6	27.4	22.7	38.0	22.5	20.4	37.8	20.2	20.6	37.5	32.4	29.5	28.6	16.7	32.6	13.6	26.3	40.1	29.4	25.4	29.3	27.9	36.0	23.0	26.3	25.8	16.8	22.8	36.8	36.3	28.7	27.0	26.9	22.1	22.5	30.0	24.6	28.9	25.5	21.2	20.4	18.6	14.9	13.7	22.0	33.6	44.8	40.9	15.7	28.1	14.7	14.8	15.7	82.5	42.0	36.5	47.6	220.5	35.1	29.2	0.0	88.6	80.1	36.6	58.3	7.0	41.9	39.3	33.4	38.2	25.2	29.8	409.2	32.5	34.3	32.1	43.3	44.1	22.7	71.0	35.1	29.7	46.8	61.7	25.8	33.3	54.9	61.7	42.8	70.0	21.8	38.8	70.1
LSM14B	"bA11M20.3, C20orf40, FAM61B, FLJ25473, FT005, LSM13, RAP55B"	ENSG00000149657	"LSM family member 14B"	Q9BX40	20	62122461-62135378	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 205.8;Late spermatids: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041274, HPA061189"	Approved		Supported	"Nucleoli fibrillar center,Vesicles"		NA	NA			Vesicles	"Nucleoli fibrillar center"	"HPA041274: AB_2677388, HPA061189: AB_2684448"	"unprognostic (2.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.93e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.98e-1)"	13.6	19.6	21.4	17.3	24.4	20.2	24.0	50.0	38.6	19.5	16.1	15.9	11.9	20.4	21.9	15.6	20.1	16.8	16.1	28.7	20.8	18.9	14.9	15.1	15.3	18.9	17.3	28.2	30.6	26.5	19.4	16.9	13.2	20.4	18.2	13.2	16.8	20.2	16.9	55.5	23.4	19.5	17.9	18.6	18.1	18.3	35.2	12.2	28.8	16.6	20.1	16.7	19.1	17.7	1.4	1.3	5.8	1.1	0.1	1.2	0.2	14.1	13.6	21.6	20.7	9.9	10.4	18.6	15.0	11.3	31.4	13.8	39.8	9.9	15.0	17.5	10.3	22.7	20.6	10.4	13.0	15.6	6.1	7.5	36.1	17.3	23.7	13.7	15.4	21.9	8.9	23.6	13.1	12.1	12.3	8.0	17.7	19.3	10.8	10.9	18.7	25.5	23.2	13.4	22.8	20.1	33.4	42.8	11.8	8.5	16.8	29.8	25.8	27.4	24.4	19.2	13.2	30.3	19.6	10.3	44.8	30.7	23.0	15.2	13.8	16.2	18.5	19.7	10.3	14.2	0.2	1.1	5.8	1.0	1.0	0.4	1.2	0.7	1.2	0.9	1.4	0.8	0.8	1.8	0.1	0.5	1.3	0.5	0.2	21.4	24.4	50.0	38.6	20.8	18.9	17.3	28.2	20.4	12.2	8.9	5.0	4.9	3.2	8.7	15.0	20.1	2.5	16.0	10.3	1.8	7.9	5.4	1.7	4.2	205.8	5.9	8.4	0.0	4.5	5.2	6.2	7.3	4.7	10.2	7.4	7.9	13.4	4.3	11.6	432.7	12.4	8.2	3.3	1.8	14.1	16.0	6.7	7.0	14.9	5.7	19.3	0.0	5.0	11.7	22.2	8.8	4.3	4.4	12.4	2.1
LSM3	"SMX4, USS2, YLR438C"	ENSG00000170860	"LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62310	3	14178358-14201119	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044966	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA044966: AB_2679159"	"unprognostic (3.84e-3)"	"unprognostic (7.00e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.07e-3)"	"unprognostic (4.93e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-3)"	14.1	13.6	18.2	12.5	17.1	18.9	15.5	13.2	17.3	11.5	15.6	11.8	7.6	15.0	11.6	13.4	19.1	10.3	11.3	20.1	15.1	12.5	27.6	26.7	10.1	14.2	14.2	13.5	12.4	15.6	7.3	12.4	16.5	14.4	14.2	13.9	12.3	13.3	11.0	31.9	12.1	17.6	15.8	15.0	16.3	12.5	21.5	13.9	24.4	19.7	21.4	13.9	12.9	11.1	21.3	23.1	27.2	18.3	17.1	17.7	18.7	14.6	11.9	12.8	13.2	6.0	7.0	32.7	12.2	8.1	15.6	15.0	13.4	11.6	16.2	10.1	8.4	11.0	6.9	14.4	11.8	15.4	15.3	17.9	17.1	17.2	12.8	3.1	19.1	12.5	5.2	8.6	15.6	6.7	7.0	8.0	14.2	18.4	13.0	11.5	16.8	20.2	26.1	22.2	16.5	16.2	11.2	15.9	17.8	14.5	15.2	7.2	11.7	13.9	19.5	11.3	15.4	22.5	24.4	7.2	10.0	16.0	12.1	20.7	9.2	26.9	30.5	12.7	18.8	14.2	27.2	15.9	23.3	12.8	18.3	15.0	21.3	15.0	14.9	14.6	17.1	16.5	17.3	15.2	17.1	15.3	23.1	17.7	18.7	18.2	17.1	13.2	17.3	15.1	12.5	14.2	13.5	14.4	13.9	62.5	87.7	130.3	102.5	86.8	44.5	230.9	170.7	87.0	91.0	120.4	17.7	322.3	411.1	178.6	266.0	108.5	137.9	70.0	230.7	336.7	102.8	94.5	135.1	199.8	207.0	52.4	100.7	114.8	112.2	107.8	129.8	142.9	92.8	201.0	161.2	94.1	180.4	182.4	131.5	513.1	53.0	103.5	91.2	226.0	285.5	88.3	266.3	100.1	174.8	132.7
LSM4	YER112W	ENSG00000130520	"LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y4Z0	19	18306230-18323274	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 551.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040932	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA040932: AB_10795529"	"unprognostic (2.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.34e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (2.51e-2)"	"unprognostic (7.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.34e-1)"	19.0	41.0	42.7	22.3	37.8	35.8	31.5	23.9	40.7	25.0	41.2	16.4	29.6	38.6	17.9	26.5	31.4	26.6	28.2	33.3	35.1	35.4	37.9	37.9	22.2	41.0	38.6	34.0	20.1	34.2	18.4	25.2	29.4	25.5	21.0	31.9	25.3	21.3	29.7	55.5	21.1	35.6	21.9	24.1	24.3	34.2	50.9	19.2	40.3	27.4	37.5	25.3	18.2	18.6	35.4	77.8	34.5	54.2	42.3	40.6	52.0	47.8	25.5	43.8	39.2	17.4	16.4	49.7	22.1	20.0	29.3	28.1	22.8	51.8	28.3	47.2	23.8	26.5	32.4	48.6	46.8	22.5	32.9	85.0	25.5	40.7	27.2	17.1	24.2	15.3	14.9	28.5	27.2	32.4	17.0	24.2	42.3	53.4	29.9	30.7	78.6	66.4	52.4	56.2	70.2	79.9	37.6	19.1	52.6	36.9	17.1	48.9	45.2	18.9	24.2	32.6	32.5	23.9	26.3	13.4	17.1	19.6	41.9	41.2	27.6	23.3	32.8	23.0	47.8	29.1	27.8	49.7	34.5	33.8	54.2	40.6	34.6	36.4	34.8	54.8	35.4	39.2	39.2	4.1	42.3	41.8	77.8	34.3	52.0	42.7	37.8	23.9	40.7	35.1	35.4	38.6	34.0	25.5	19.2	26.8	35.0	96.1	78.8	59.9	70.0	43.9	81.5	57.6	35.2	109.9	13.7	223.3	253.7	181.2	231.0	66.1	189.6	0.0	160.4	388.0	70.2	118.7	116.4	95.1	248.7	55.6	119.5	44.2	87.6	551.5	57.8	137.7	99.5	329.2	138.8	71.0	136.3	192.9	44.6	260.5	52.1	45.3	61.8	169.2	334.8	62.9	142.6	79.8	214.2	95.3
LSM6	YDR378C	ENSG00000164167	"LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62312	4	146175685-146200000	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing, tRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045079	Approved		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA045079: AB_10961320"	"unprognostic (5.04e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.36e-1)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.08e-3)"	17.8	14.0	14.7	16.1	14.6	14.6	18.5	14.2	14.8	11.1	12.8	10.8	4.8	11.4	12.4	13.7	13.7	11.2	12.8	15.0	14.1	18.0	14.5	16.6	16.8	28.0	16.1	11.6	15.8	20.6	6.2	11.6	16.6	12.8	15.0	12.3	11.0	14.4	10.2	14.2	10.6	15.3	13.8	11.8	21.6	12.4	14.1	10.0	25.0	11.7	15.5	25.4	12.8	12.5	11.8	8.7	7.7	20.7	8.6	13.0	9.9	6.6	2.1	8.2	4.3	6.2	7.2	8.3	5.4	6.2	8.2	7.7	5.3	10.1	13.8	2.8	3.8	6.3	3.8	9.1	6.4	11.4	14.1	5.8	6.7	4.3	11.5	6.2	14.3	5.8	4.1	5.6	5.5	5.3	4.0	5.8	6.7	10.5	13.4	7.5	5.8	17.3	17.8	10.4	6.1	5.8	11.8	5.2	6.4	5.6	8.7	9.9	4.4	2.8	5.1	6.8	7.5	3.6	13.8	3.9	7.2	6.9	5.5	10.4	9.6	8.4	8.7	7.3	7.2	8.1	2.8	11.3	7.7	7.4	14.9	10.7	11.8	11.1	9.7	8.7	9.9	13.0	11.4	5.4	8.6	20.7	7.8	11.0	9.9	14.7	14.6	14.2	14.8	14.1	18.0	16.1	11.6	12.8	10.0	20.8	25.6	91.0	75.1	61.6	19.1	21.9	53.5	33.5	29.6	26.2	2.0	123.1	58.0	54.6	2.3	61.8	39.3	23.3	58.0	156.0	62.1	96.1	55.4	57.0	111.9	17.5	22.5	47.3	104.5	10.0	70.5	97.4	49.0	119.0	56.5	20.5	48.8	75.3	54.5	80.2	21.2	32.3	50.8	104.8	189.9	62.7	61.7	49.8	74.7	81.4
LSM7	YNL147W	ENSG00000130332	"LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9UK45	19	2321517-2328620	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041850	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA041850: AB_10964065"	"unprognostic (8.33e-2)"	"prognostic favorable (3.28e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (4.19e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-3)"	"unprognostic (9.65e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.65e-3)"	"unprognostic (9.48e-3)"	"unprognostic (8.45e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.96e-4)"	21.5	21.1	27.5	29.3	26.3	57.2	29.0	32.6	29.9	23.9	41.1	20.3	18.3	37.6	25.3	17.9	29.1	26.0	19.3	18.7	24.8	23.6	20.8	21.6	17.1	37.8	26.9	30.2	26.8	29.9	9.7	27.3	27.9	25.4	21.3	20.1	12.9	24.3	21.6	31.5	21.5	36.5	17.2	26.4	28.7	31.4	22.0	18.8	28.7	24.1	29.4	28.8	18.6	25.6	79.5	53.4	32.9	43.1	31.5	44.4	42.1	42.1	25.9	26.5	30.0	11.9	11.2	22.0	20.6	14.5	23.1	17.9	49.5	16.4	50.1	22.5	16.0	13.6	21.6	25.3	28.2	10.9	35.6	58.2	35.4	21.8	63.0	12.1	66.4	26.2	13.3	16.5	15.6	16.1	10.2	19.7	39.5	44.3	38.5	10.1	53.0	57.2	56.1	49.6	37.6	35.2	41.9	29.5	71.5	14.2	33.4	49.7	35.9	23.4	17.9	26.9	14.5	15.1	46.2	20.9	17.1	23.5	28.0	38.5	33.6	37.0	63.4	16.6	58.8	29.3	18.0	38.9	32.9	31.9	43.1	31.8	79.5	44.4	36.9	51.4	73.8	43.2	39.6	8.1	31.5	35.4	53.4	42.7	42.1	27.5	26.3	32.6	29.9	24.8	23.6	26.9	30.2	25.4	18.8	89.3	85.5	250.2	147.7	205.1	36.4	77.5	91.7	108.4	111.5	120.4	31.4	339.3	165.8	159.8	8.4	110.1	185.5	46.7	190.6	285.4	194.0	135.2	113.2	71.3	193.1	33.4	161.5	79.2	108.1	14.7	107.0	163.8	133.3	146.9	251.8	59.9	209.5	227.4	85.2	137.3	50.2	84.1	181.1	55.6	213.0	189.2	202.9	132.1	302.7	196.2
LSM8	YJR022W	ENSG00000128534	"LSM8 homolog, U6 small nuclear RNA associated"	O95777	7	118184032-118192824	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020116	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA020116: AB_1853385"	"unprognostic (1.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.46e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.00e-3)"	27.5	20.8	16.8	30.8	19.7	39.7	27.1	33.1	25.9	18.5	20.1	12.8	18.8	20.6	23.0	25.4	26.2	19.3	16.2	25.1	19.1	10.1	20.2	19.9	23.1	34.1	19.8	17.2	22.9	27.0	13.2	28.3	16.8	20.1	22.3	22.8	13.6	24.5	21.2	21.4	21.9	26.2	23.6	28.3	33.8	22.3	21.0	20.2	30.0	24.6	23.2	38.2	22.1	21.6	29.8	40.6	22.0	28.2	18.2	35.3	16.2	14.7	9.8	22.5	17.1	8.2	13.3	9.2	16.1	14.0	11.1	14.5	8.0	15.5	30.6	33.6	8.3	21.6	10.5	13.5	10.4	11.8	15.8	14.5	20.4	20.6	15.9	18.3	26.5	23.6	12.0	12.7	13.6	12.7	10.8	11.3	23.2	21.2	30.5	13.8	6.7	46.8	66.8	20.4	12.9	15.0	14.8	13.3	21.2	11.6	9.9	13.4	17.1	14.3	36.4	30.8	19.4	7.6	29.7	9.3	17.8	10.1	20.9	20.0	26.1	18.5	35.4	13.1	32.5	22.7	22.0	21.0	19.1	29.0	28.2	28.1	29.8	32.2	35.3	22.4	26.5	31.2	31.7	7.0	18.2	26.6	40.6	31.4	16.2	16.8	19.7	33.1	25.9	19.1	10.1	19.8	17.2	20.1	20.2	23.8	61.2	138.3	86.7	0.0	39.3	40.2	61.1	66.9	64.8	59.3	45.2	106.7	76.3	84.3	27.9	60.3	67.5	70.0	148.8	162.8	58.6	85.5	99.3	65.7	119.9	39.7	83.0	72.4	145.9	11.0	90.0	92.8	0.0	140.7	82.5	44.7	124.3	90.0	71.5	76.7	38.2	84.1	22.3	105.0	109.7	0.0	101.0	138.4	90.9	91.2
LSMEM1	"C7orf53, FLJ39575"	ENSG00000181016	"Leucine rich single-pass membrane protein 1"	Q8N8F7	7	112480853-112491062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 51.3;tongue: 19.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 43.6;Late spermatids: 47.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.6"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013753, HPA047988"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA013753: AB_1848926, HPA047988: AB_2680229"	"unprognostic (6.87e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.47e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.42e-2)"	1.1	0.7	0.6	0.6	0.6	0.8	0.9	3.6	0.7	0.6	0.6	0.6	0.6	1.3	0.6	1.7	0.7	0.4	0.6	2.1	0.7	0.8	1.4	3.5	1.8	0.6	0.7	0.6	0.6	2.8	0.3	0.9	0.6	0.6	0.9	0.8	0.6	1.9	0.6	51.3	0.8	0.8	0.6	0.6	1.9	0.8	1.1	0.6	0.6	0.9	19.2	1.5	0.6	0.6	0.0	0.1	2.7	0.1	0.0	0.2	2.2	0.8	1.3	0.7	2.8	2.9	3.2	0.1	1.3	0.9	0.6	0.5	2.2	1.9	1.2	1.9	0.3	1.9	0.7	0.8	1.0	1.2	0.6	0.8	0.8	12.5	2.3	1.3	1.2	0.7	2.2	3.8	0.8	0.8	2.7	0.8	1.1	0.9	2.8	0.4	1.1	1.0	3.7	0.6	1.1	0.9	0.4	0.2	0.6	2.4	1.5	2.7	1.4	2.3	1.1	1.5	3.4	0.4	0.5	0.5	2.8	1.0	0.8	1.1	0.9	1.7	1.1	0.8	0.8	0.9	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	2.2	0.6	0.6	3.6	0.7	0.7	0.8	0.7	0.6	0.6	0.6	0.0	3.2	0.8	2.4	4.8	2.2	7.7	5.1	1.4	2.3	1.8	2.0	1.2	0.0	0.6	43.6	2.9	7.1	0.0	0.8	0.7	2.8	7.4	0.0	1.0	3.2	0.0	2.9	1.8	2.7	47.7	0.9	1.3	1.7	2.8	4.0	0.3	1.0	4.3	0.4	0.1	3.4	0.0	6.6	0.5	0.6	4.1	1.6	0.7	3.2	2.2
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279027-50288114	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 197.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.7;WM-115: 3.5"					"Low region specificity"	"Detected in many"			HPA079523			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA079523: "	"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.6	0.3	1.2	0.2	2.1	0.4	0.2	0.7	1.9	1.1	0.3	2.1	0.1	0.4	1.4	0.4	0.7	0.8	0.4	26.6	1.4	0.7	0.3	0.1	0.3	0.1	1.3	0.6	0.9	0.3	0.1	0.1	0.2	1.3	0.4	0.3	1.6	1.4	0.5	16.3	0.1	0.5	0.5	1.6	0.2	0.2	3.0	0.9	0.1	0.2	7.2	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.4	0.4	0.4	0.2	0.3	0.5	0.1	0.1	0.0	0.5	0.1	0.1	1.1	0.1	0.0	0.5	0.2	3.7	0.2	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.5	0.0	1.1	0.0	1.0	0.0	0.2	0.1	0.7	0.5	0.4	0.0	0.0	0.3	0.0	0.3	0.3	0.1	0.5	0.0	0.8	1.0	0.4	0.0	0.0	0.0	0.2	1.3	0.4	0.4	0.9	0.6	0.6	0.1	0.9	3.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	0.7	1.9	1.4	0.7	1.3	0.6	1.3	0.9	0.0	1.1	0.0	0.1	0.9	0.1	3.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	41.7	0.0	0.9	0.0	0.2	0.1	0.3	0.3	4.7	0.0	0.1	0.0	0.0	0.0	0.0	197.4	1.1	0.0	1.7	0.0	0.4	0.5	0.1	0.0	0.7	0.0	0.2	0.0	0.7	1.6	1.0	1.1	0.1	0.0	0.6	0.1
LSS	OSC	ENSG00000160285	"Lanosterol synthase"	P48449	21	46188141-46228824	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Isomerase	"Cataract, Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032060, HPA032062, CAB034116"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: AB_2674134"	"unprognostic (2.78e-3)"	"unprognostic (8.53e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.07e-4)"	21.1	22.9	17.9	9.9	38.8	5.0	14.7	22.5	33.9	11.2	16.9	37.7	5.8	26.4	16.6	12.5	23.4	11.0	12.1	17.8	19.0	17.3	8.4	33.8	19.7	8.3	49.5	14.9	25.7	15.8	10.4	22.7	10.3	42.7	24.0	10.7	13.2	11.0	13.2	24.5	26.2	10.3	12.2	33.3	7.1	14.1	13.8	46.9	6.0	7.5	9.8	8.3	12.3	11.8	4.8	8.0	5.2	3.3	2.7	8.3	5.0	18.1	5.9	19.2	8.2	26.1	25.1	5.4	7.0	49.9	8.7	17.1	19.4	14.5	3.9	6.0	13.6	63.9	8.6	16.9	29.4	3.5	3.8	9.1	9.7	9.7	12.5	23.8	3.5	6.8	24.7	11.2	16.2	7.0	6.0	7.2	19.3	9.4	23.5	7.4	6.1	7.6	5.0	31.2	2.9	5.3	9.0	5.9	23.7	22.6	10.0	11.2	9.9	8.3	6.4	7.2	8.6	10.2	8.8	10.7	10.3	8.4	9.1	5.4	8.6	7.3	7.9	10.8	15.6	4.4	5.2	3.3	3.5	6.9	3.0	4.7	4.8	5.0	8.3	3.8	3.0	4.2	6.2	0.0	2.7	2.5	8.0	2.3	5.0	17.9	38.8	22.5	33.9	19.0	17.3	49.5	14.9	42.7	46.9	11.9	33.7	11.5	3.8	32.7	12.9	13.4	12.7	8.1	7.9	10.4	3.9	3.4	0.0	9.7	4.2	9.8	5.3	23.3	15.0	5.1	25.7	14.9	3.5	23.8	8.1	22.3	18.9	9.8	7.8	5.3	19.5	5.0	20.3	19.0	10.0	8.7	10.9	0.0	12.7	3.8	15.2	0.0	10.0	13.6	9.4	47.2	5.3	5.0	10.0	4.1
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.1;lymphoid tissue: 81.5"	"Cell type enriched"	"Detected in many"	4	"B-cells: 1026.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.1;Daudi: 19.8;HDLM-2: 11.2;HMC-1: 5.8;NB-4: 12.8;REH: 12.2;U-698: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048884	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA048884: AB_2680543"	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favorable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"	1.0	0.2	0.2	35.9	0.2	3.4	0.5	0.1	0.1	0.2	1.5	0.0	0.0	1.3	0.2	0.3	2.7	0.4	0.7	1.9	0.2	0.1	4.2	1.3	4.2	27.8	0.2	0.0	0.5	0.8	0.0	0.2	0.3	0.1	0.7	0.6	0.5	6.1	0.3	0.1	0.6	18.0	0.3	0.3	69.7	2.0	0.2	0.0	81.5	1.1	0.8	41.6	1.6	0.5	44.1	15.6	17.8	3.6	5.2	39.3	10.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	19.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	12.8	0.0	0.0	0.0	12.2	0.0	2.7	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	2.5	0.4	17.8	3.7	2.0	26.8	42.5	39.3	17.3	0.6	44.1	33.5	14.2	14.5	5.2	3.6	15.6	22.2	10.7	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	13.6	1026.5	0.2	14.4	0.2	0.4	0.0	0.0	4.5	85.5	0.0	0.3	1.7	211.4	1.9	3.8	0.0	0.0	97.9	0.2	5.6	1.2	13.9	2.8	8.9	0.0	0.0	6.7	27.5	0.0	0.6	21.2	40.5	10.0	0.3	1.0	243.4	1.5	0.0	8.6	0.1	6.5	10.8	0.1	1.1	10.8	0.2	247.3	0.4	0.3
LTBP1		ENSG00000049323	"Latent transforming growth factor beta binding protein 1"	Q14766	2	32946972-33399509	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 79.5;Fibroblasts: 97.9;Leydig cells: 83.7;Peritubular cells: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 106.2;HSkMC: 34.2;HUVEC TERT2: 34.7;U-87 MG: 46.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005707, CAB025428"	Approved		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		200000000	Cytosol		"CAB025428: , HPA005707: AB_1853394"	"unprognostic (1.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (4.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.62e-4)"	10.4	4.9	4.5	16.3	5.4	3.4	9.2	1.3	3.9	66.7	15.6	9.5	10.2	3.6	28.5	22.9	22.9	21.7	64.9	45.6	5.7	2.9	10.6	6.5	15.5	3.4	3.5	4.9	23.4	3.1	0.6	7.0	28.7	11.7	29.6	6.1	10.0	10.6	27.6	8.0	6.6	8.6	38.9	10.9	3.7	22.7	16.2	4.7	2.1	4.4	16.4	10.0	37.4	18.1	0.1	0.3	4.3	0.1	0.0	0.1	8.1	0.0	2.2	5.7	0.0	4.8	106.2	2.4	8.2	17.1	1.1	1.7	4.4	0.8	7.2	0.1	1.0	1.6	0.4	0.1	0.2	4.0	0.1	2.7	23.7	2.8	0.7	22.0	0.0	2.8	34.2	0.8	25.5	1.2	11.2	34.7	1.1	1.5	0.0	9.1	3.4	0.9	0.0	4.0	0.1	7.0	0.8	11.9	0.1	0.0	3.9	1.1	0.6	1.6	13.0	0.1	9.3	5.0	0.0	22.2	1.1	4.8	32.6	6.5	13.6	13.6	10.4	46.7	0.9	1.9	4.3	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	8.1	4.5	5.4	1.3	3.9	5.7	2.9	3.5	4.9	11.7	4.7	0.0	1.1	0.0	4.2	11.9	0.0	79.5	5.1	5.3	1.2	1.8	0.0	38.5	0.0	5.5	5.3	26.2	5.3	23.3	5.7	19.4	97.9	11.5	0.0	9.5	6.8	0.0	1.2	26.4	0.3	4.5	83.7	0.9	18.6	0.0	2.1	0.0	18.1	3.1	151.4	0.0	0.1	58.2	59.0	0.5	7.2	8.5	36.4	0.0	3.4	18.7
LTBP2	"C14orf141, LTBP3"	ENSG00000119681	"Latent transforming growth factor beta binding protein 2"	Q14767	14	74498170-74612378	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Heparin-binding"	"Disease mutation, Dwarfism, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	18	"Fibroblasts: 19.4;Peritubular cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 44.9;HUVEC TERT2: 24.5;LHCN-M2: 24.4;TIME: 107.9"	"Group enriched"	"Detected in some"	10	"cerebellum: 5.9;olfactory region: 3.0"	"Region enriched"	"Detected in some"	5	"olfactory region: 31.6"	HPA003415	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		13000000	Nucleoplasm		"HPA003415: AB_1079284"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.94e-4)"	25.0	1.7	0.8	8.0	1.3	0.0	21.5	1.0	1.0	50.3	5.0	1.2	4.8	1.2	18.0	11.8	16.2	6.2	20.1	20.3	0.8	0.8	2.4	1.4	29.5	4.8	1.6	1.9	32.1	3.9	0.4	4.2	19.0	3.1	15.7	0.9	51.8	13.6	9.7	20.5	6.0	3.2	8.6	2.6	2.5	4.3	12.2	0.4	2.2	44.8	14.4	6.0	14.7	11.6	0.4	1.7	0.3	0.2	0.0	1.2	0.2	0.5	0.9	0.2	0.0	7.2	13.3	0.0	9.0	3.1	1.7	1.1	0.0	3.3	0.0	2.7	44.9	0.8	0.9	0.0	3.3	0.7	0.0	0.1	0.1	0.4	0.3	1.7	0.0	0.1	13.7	1.4	9.6	5.6	13.3	24.5	0.0	0.0	0.0	24.4	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	2.1	1.2	0.2	0.6	6.4	0.0	0.2	0.6	0.2	0.0	107.9	0.6	10.8	3.3	3.3	0.1	0.1	0.0	2.4	0.0	0.3	0.1	0.1	0.1	1.2	0.1	1.0	0.2	0.6	0.2	0.2	0.4	0.7	0.6	0.3	0.0	0.2	1.7	0.0	0.2	0.8	1.3	1.0	1.0	0.8	0.8	1.6	1.9	3.1	0.4	0.0	2.1	0.0	14.7	4.9	2.3	5.0	0.0	0.0	10.3	0.0	0.0	0.3	5.0	1.2	1.2	3.5	0.0	0.0	0.3	0.4	19.4	1.6	1.1	0.2	4.1	3.2	0.0	12.9	0.0	4.5	15.3	1.5	0.0	0.0	0.0	0.4	2.8	0.0	77.4	0.0	0.6	6.5	6.2	0.7	2.7	0.9	1.0	0.0	0.0	1.7
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.3"	"Cell type enriched"	"Detected in many"	6	"granulocytes: 332.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 8.5;eosinophil: 31.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 31.3"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	9.0	6.7	3.5	2.8	3.5	8.6	4.6	1.7	5.0	6.9	5.0	9.4	5.4	3.6	8.7	10.4	4.2	13.0	15.7	11.3	3.9	3.1	6.2	2.3	28.3	8.0	6.8	4.2	5.8	2.4	2.0	3.2	2.9	4.3	5.6	1.9	3.3	7.4	11.6	2.7	3.5	5.7	4.5	6.3	6.7	5.0	3.3	3.9	0.8	5.3	5.6	3.2	3.6	3.9	0.1	4.5	31.3	0.3	2.2	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	5.3	0.0	0.2	0.2	0.3	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	8.5	0.2	31.3	0.5	0.3	1.7	0.1	1.2	0.8	4.5	0.1	0.2	0.5	0.1	2.2	0.0	0.2	0.1	0.3	3.5	3.5	1.7	5.0	3.9	3.1	6.8	4.2	4.3	3.9	0.0	5.6	2.2	7.5	8.9	0.2	0.0	12.7	4.0	3.4	14.0	0.0	6.9	1.7	4.1	0.3	11.3	0.4	0.0	2.1	1.5	4.7	3.1	332.3	0.8	33.8	0.0	2.9	53.4	8.9	0.0	15.3	23.5	1.7	1.0	1.6	0.0	2.1	0.0	44.6	40.2	0.3	0.0	0.9	0.0	0.7	6.0	2.5	5.0	2.6	5.0
LTK	TYK1	ENSG00000062524	"Leukocyte receptor tyrosine kinase"	P29376	15	41503638-41513887	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 15.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 13.4;Ito cells: 14.7;Mucus-secreting cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 8.3;plasmacytoid DC: 7.0"	"Group enriched"	"Detected in many"	10	"dendritic cells: 7.0;T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;NB-4: 10.5;RH-30: 5.1;THP-1: 16.1"	"Low region specificity"	"Detected in many"							HPA059545			Approved	Vesicles		NA	NA			Vesicles		"HPA059545: AB_2684057"	"unprognostic (9.47e-4)"	"unprognostic (5.52e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.36e-3)"	"unprognostic (5.36e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	1.0	0.5	0.5	5.1	1.6	3.1	0.5	2.0	3.2	0.6	8.2	0.5	1.9	10.6	1.3	1.1	1.2	0.3	2.0	2.2	0.5	0.1	3.5	4.3	15.1	0.6	0.5	0.5	1.0	0.5	1.0	0.7	8.9	0.5	0.7	4.8	4.3	11.7	0.5	2.0	0.9	10.7	0.5	0.5	5.5	8.3	2.4	0.8	0.5	0.7	0.5	2.2	0.6	0.7	0.7	7.0	0.0	0.0	0.0	8.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.1	0.6	1.0	1.3	2.4	0.0	0.0	0.1	0.7	0.0	0.0	2.9	0.0	0.4	0.2	1.4	5.4	0.0	0.0	2.4	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	2.0	0.0	2.1	0.0	0.0	10.5	0.4	2.0	0.2	0.2	5.1	0.2	0.0	0.0	0.5	3.4	0.1	0.2	0.0	3.0	0.2	16.1	0.0	0.0	0.2	0.2	0.1	0.4	0.2	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.6	0.0	8.3	0.7	0.5	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.2	0.5	1.6	2.0	3.2	0.5	0.1	0.5	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	5.1	4.0	1.2	0.0	0.0	0.2	0.0	0.0	2.1	0.1	13.4	0.0	0.2	1.1	0.2	0.0	0.0	0.2	0.1	0.0	1.7	14.7	3.2	1.7	0.0	0.0	3.3	0.0	7.8	0.0	0.5	3.5	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.1	0.3	1.3	2.8	0.0
LUC7L	"hLuc7B1, Luc7, LUC7B1"	ENSG00000007392	"LUC7 like"	Q9NQ29	16	188969-229463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056424, HPA069321"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA056424: AB_2683126, HPA069321: AB_2686119"	"unprognostic (9.55e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-3)"	23.8	24.5	30.4	26.5	30.9	25.3	24.0	42.6	30.0	21.9	20.1	29.9	25.8	21.3	29.4	37.7	15.5	19.2	24.5	12.7	34.1	26.5	26.9	19.9	18.8	31.0	33.1	24.3	29.3	24.2	31.2	40.3	23.1	25.4	35.2	18.2	24.3	25.1	25.2	20.3	28.8	23.9	24.4	29.2	32.1	22.6	29.8	33.1	23.2	40.2	15.9	21.0	16.6	26.3	6.5	11.1	3.5	11.7	3.9	6.9	5.6	5.4	24.4	25.9	9.7	10.0	7.7	11.4	10.1	7.7	16.5	12.0	25.4	6.4	9.9	13.3	5.8	8.7	6.9	30.8	9.2	16.6	17.7	21.1	12.1	16.6	29.7	11.2	14.0	13.6	6.9	10.7	13.3	5.3	14.3	12.7	8.6	14.3	6.4	13.2	26.2	23.0	24.4	38.6	12.3	11.8	19.8	11.3	10.4	23.6	5.8	15.4	17.3	10.9	7.6	9.4	16.0	9.8	7.6	10.3	12.0	18.1	5.0	12.1	7.0	9.3	10.5	3.6	10.0	10.7	0.3	9.1	3.5	6.7	10.4	5.2	6.5	6.3	6.5	9.8	3.0	3.7	2.8	1.2	3.9	11.7	11.1	6.9	5.6	30.4	30.9	42.6	30.0	34.1	26.5	33.1	24.3	25.4	33.1	47.6	61.1	29.6	38.6	47.3	48.4	18.3	12.7	40.2	58.0	22.7	35.3	24.9	10.0	29.4	34.2	45.0	22.2	0.0	18.2	33.5	35.8	31.0	39.4	10.0	21.2	42.9	40.6	25.2	14.5	14.7	30.2	28.9	37.1	35.1	16.5	30.8	22.7	28.1	30.4	11.3	61.8	25.8	46.4	62.1	51.9	47.4	41.8	27.7	17.1	27.1
LUC7L2	"CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2"	ENSG00000146963	"LUC7 like 2, pre-mRNA splicing factor"	Q9Y383	7	139340359-139423457	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051631	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051631: AB_2681558"	"unprognostic (1.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.28e-3)"	27.2	24.7	32.2	34.7	35.0	59.3	41.3	35.6	33.9	35.1	34.7	41.6	28.0	22.6	35.7	36.8	33.1	32.7	29.3	35.0	33.3	30.4	29.7	33.3	26.6	39.0	33.2	30.5	41.3	34.7	47.7	29.0	31.6	33.8	39.8	31.4	27.3	29.5	40.1	58.4	41.8	27.5	35.2	37.3	32.0	29.0	37.0	32.4	66.3	53.3	23.6	44.8	34.0	33.7	14.3	11.3	15.0	13.7	13.5	20.8	10.6	18.9	10.9	22.8	21.4	15.9	13.1	17.6	21.7	20.8	20.8	21.9	12.1	18.0	31.3	13.3	17.0	13.1	13.7	27.7	21.6	29.7	14.8	27.4	26.8	16.6	12.0	13.4	42.8	22.5	11.3	27.6	19.6	24.2	14.5	16.6	16.2	34.0	16.6	22.6	17.6	50.9	39.0	18.7	24.7	15.8	30.9	23.3	28.2	23.8	21.0	20.2	19.7	23.8	24.1	20.9	17.8	16.8	16.8	16.3	16.4	9.8	18.4	20.0	26.1	24.3	68.5	18.0	41.4	22.0	8.0	8.1	15.0	16.7	12.5	18.7	14.3	16.3	17.5	11.1	13.1	20.8	17.4	8.2	13.5	13.7	11.3	16.3	10.6	32.2	35.0	35.6	33.9	33.3	30.4	33.2	30.5	33.8	32.4	50.6	46.2	14.9	66.6	0.0	52.0	0.0	38.2	68.3	72.8	36.6	49.1	65.1	46.4	37.4	8.6	43.3	25.3	0.0	33.9	61.0	40.1	52.5	55.8	49.7	38.8	41.3	21.1	33.2	38.6	4.2	49.2	33.4	0.0	42.3	38.2	40.5	31.1	21.0	63.6	30.1	47.3	58.2	0.0	57.2	71.0	0.1	68.9	66.1	33.4	47.7
LURAP1	"C1orf190, FLJ25163, LRAP35a"	ENSG00000171357	"Leucine rich adaptor protein 1"	Q96LR2	1	46203334-46221261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Early spermatids: 111.8;Late spermatids: 227.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 7.8;RPTEC TERT1: 7.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 110.5"	"HPA030060, HPA030061"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA030060: AB_10599997, HPA030061: AB_10601990"	"unprognostic (3.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (8.81e-8)"	"unprognostic (1.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.39e-2)"	3.0	7.3	7.1	2.2	13.2	3.4	3.9	12.7	12.7	5.8	3.8	15.2	2.2	2.0	5.5	4.9	4.0	4.0	3.7	8.7	6.7	5.8	7.4	1.1	3.2	1.6	18.8	6.0	7.2	1.1	21.5	3.2	2.3	11.2	7.5	2.5	4.7	5.2	9.8	2.5	4.2	1.9	5.6	17.5	3.5	3.7	10.8	13.6	0.0	19.6	0.0	2.1	5.6	5.3	1.0	0.7	6.2	1.1	1.9	0.8	0.3	0.2	0.2	3.0	0.2	4.0	5.5	3.1	2.0	5.3	2.8	3.4	0.1	0.2	0.2	0.1	5.0	1.0	0.3	3.2	6.7	2.4	0.6	1.5	0.2	0.6	0.3	1.2	0.2	0.1	2.8	4.5	5.6	2.6	7.8	4.2	0.8	2.5	0.5	1.6	0.3	0.3	0.3	1.1	0.0	0.5	1.0	1.5	0.0	7.5	0.1	0.4	1.2	0.1	0.2	4.8	1.3	1.5	0.2	0.2	1.8	2.3	1.4	0.4	0.3	0.1	0.3	1.7	0.3	0.4	1.3	1.1	0.4	0.3	0.5	0.8	0.5	0.4	0.3	0.4	1.0	0.8	0.6	6.2	1.9	0.5	0.7	0.1	0.3	7.1	13.2	12.7	12.7	6.7	5.8	18.8	6.0	11.2	13.6	0.0	0.0	0.0	13.1	4.4	0.0	2.2	0.0	0.0	0.0	10.4	0.0	1.9	13.3	0.0	111.8	2.8	0.0	0.0	0.4	1.9	2.3	7.3	0.0	0.0	3.6	0.0	1.2	0.0	0.3	227.3	8.6	1.5	13.5	1.0	0.0	1.6	0.0	0.0	9.2	2.6	0.0	6.5	6.2	8.2	2.0	3.0	6.4	0.0	0.0	4.8
LURAP1L	"bA3L8.2, C9orf150, FLJ38505, MGC46502"	ENSG00000153714	"Leucine rich adaptor protein 1 like"	Q8IV03	9	12775021-12822131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 48.7"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 80.1;Glandular cells: 116.6;Paneth cells: 77.2;Urothelial cells: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 45.3;hTERT-HME1: 36.3;T-47d: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024407	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA024407: AB_10603780"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.38e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-2)"	10.6	7.2	2.9	7.9	9.2	0.1	13.0	23.4	5.5	11.5	13.7	7.1	2.9	4.0	5.0	7.9	8.5	4.1	14.7	3.5	3.5	3.3	4.1	48.7	17.8	5.3	7.7	4.0	4.5	19.9	0.2	7.3	21.0	5.9	8.0	9.6	4.7	21.6	7.3	2.4	8.8	6.6	13.2	8.1	11.0	9.9	3.7	7.9	0.9	8.6	2.8	5.3	10.3	9.4	0.0	0.1	1.2	0.0	0.0	0.0	1.6	0.9	3.2	0.0	1.0	4.9	6.8	0.0	1.7	9.1	2.2	2.5	0.0	1.1	0.0	0.6	8.7	10.8	1.3	0.0	0.1	1.7	0.0	0.4	0.4	3.0	1.7	45.3	0.0	0.0	2.6	4.3	8.1	36.3	3.8	1.5	0.0	0.0	11.9	1.2	0.7	0.0	0.0	0.0	4.1	3.5	0.0	0.6	0.0	8.9	0.5	6.9	0.6	1.9	1.2	1.5	0.8	52.1	0.1	0.5	2.0	0.3	5.0	1.2	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	9.2	23.4	5.5	3.5	3.3	7.7	4.0	5.9	7.9	8.9	17.3	0.0	29.2	80.1	4.1	5.3	15.3	5.3	17.0	1.8	2.0	0.4	6.6	56.6	2.6	6.3	32.8	0.0	10.3	1.2	27.7	116.6	10.4	28.7	0.5	17.5	25.6	1.8	0.0	0.8	8.6	0.6	25.3	0.0	8.9	3.6	22.9	77.2	2.8	4.1	9.3	38.8	40.0	0.1	0.3	56.2	0.9	0.0	13.4	93.3
LUZP1	LUZP	ENSG00000169641	"Leucine zipper protein 1"	Q86V48	1	23084023-23177808	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 318.3;Early spermatids: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028506, HPA028542"	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA028506: AB_10600083, HPA028542: AB_10601986"	"unprognostic (3.04e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.46e-3)"	"unprognostic (9.77e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.50e-1)"	"prognostic favorable (1.46e-7)"	"unprognostic (4.49e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.33e-1)"	9.7	10.3	5.2	6.5	10.7	8.3	7.3	7.8	18.2	7.5	11.7	2.5	4.4	15.7	9.6	4.5	7.5	6.6	9.1	9.2	6.3	6.1	8.1	4.0	9.1	4.0	5.4	9.5	6.6	4.4	21.8	4.9	8.6	21.8	7.0	9.4	4.6	7.1	7.1	4.2	6.8	27.1	8.9	5.0	9.4	5.9	20.4	3.4	5.2	7.9	4.7	5.5	7.9	9.9	4.5	11.9	21.5	7.4	4.8	10.5	2.1	9.6	6.7	9.4	10.9	9.7	12.4	6.9	9.5	15.2	12.0	12.6	3.8	4.5	0.2	8.8	16.1	7.7	13.2	9.3	25.8	14.7	3.5	6.1	13.6	8.3	3.5	6.4	6.7	8.8	10.9	10.2	17.5	13.9	9.9	26.8	3.8	5.0	0.8	9.6	2.6	4.5	2.9	8.0	3.0	7.3	6.9	14.1	1.1	5.4	6.4	1.7	4.5	22.8	6.5	7.8	19.8	3.6	3.6	47.8	14.1	10.7	10.5	9.4	1.2	2.8	3.8	6.3	11.1	12.1	21.5	5.8	6.1	9.3	4.0	10.5	2.4	7.0	5.8	5.6	4.5	5.6	5.5	3.2	4.8	7.4	11.9	3.7	2.1	5.2	10.7	7.8	18.2	6.3	6.1	5.4	9.5	21.8	3.4	8.9	16.8	7.8	318.3	120.2	18.9	43.7	30.6	24.1	25.0	19.2	2.0	22.0	13.3	54.6	217.4	97.6	99.2	0.0	27.1	42.6	62.2	74.9	22.0	10.5	23.5	20.6	20.6	64.4	12.7	34.3	33.6	37.9	32.1	125.4	35.2	15.4	52.9	27.4	41.1	21.0	6.0	32.3	60.4	36.3	33.2	61.9	20.7	26.6	28.7	180.2
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082631	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 11.1;brain: 32.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 18.8;Paneth cells: 21.8"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1"	"Low region specificity"	"Detected in all"							"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"	NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: AB_2676307, HPA046161: AB_2679564"	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	1.2	11.1	14.5	0.9	10.8	0.9	1.6	2.6	32.7	0.9	2.1	5.9	0.0	0.9	1.0	0.8	0.9	0.8	1.0	1.0	10.3	13.8	1.0	2.3	1.1	0.8	13.7	5.6	0.8	0.8	0.7	1.9	0.8	26.7	4.5	1.7	0.0	1.0	0.9	0.8	0.9	1.1	1.2	30.0	0.9	0.9	1.6	14.5	0.0	0.8	0.9	0.8	1.6	0.3	0.5	0.4	1.9	0.3	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	14.2	7.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	6.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.2	0.2	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.5	0.3	0.4	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.5	0.3	0.2	1.9	0.3	0.2	0.4	0.1	0.0	14.5	10.8	2.6	9.3	10.3	13.8	13.7	5.6	26.7	14.5	0.0	0.0	0.0	0.1	0.6	2.3	0.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.6	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	1.8	0.2	0.1	21.8	0.0	0.6	0.6	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.9	0.7
LUZP6	"MPD6, MTPNUT"	ENSG00000267697	"Leucine zipper protein 6"	Q538Z0	7	135927274-135927450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 2.4;naive CD8 T-cell: 2.7;plasmacytoid DC: 2.9;T-reg: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;T-cells: 4.4"	"Group enriched"	"Detected in some"	5	"MOLT-4: 9.8;OE19: 6.1;SK-MEL-30: 19.4"									HPA077907			Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA077907: AB_2686869"																		1.2	1.2	2.3	1.2	3.5	1.2	1.2	1.2	1.8	3.6	1.2			1.2	1.2	1.2	4.9	2.9	1.2	1.2	2.1	0.8	1.2	1.3	1.2	1.2	1.9		1.2	1.2	1.2	2.0	1.2		1.2	1.2		1.2	1.2	7.2	1.2	1.2	1.2	0.5	3.4	1.2	1.2			1.2		1.2	1.2	1.2	0.5	2.9	0.1	0.0	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	9.8	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	2.4	2.7	0.0	0.6	0.0	2.9	4.4	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LXN		ENSG00000079257	Latexin	Q9BS40	3	158645822-158672693	"Predicted intracellular proteins"	"Inflammatory response"	"Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 129.8;granulocytes: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"hTERT-RPE1: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014179, CAB025128"	Approved		Approved	Nucleoplasm,Cytosol		No	NA		4200000	"Nucleoplasm, Cytosol"		"CAB025128: , HPA014179: AB_1853404"	"unprognostic (4.46e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (8.45e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.84e-2)"	32.3	31.5	2.8	13.6	3.3	9.4	35.8	11.7	3.5	11.8	20.9	1.2	12.7	12.4	9.8	17.7	14.0	15.2	17.2	24.4	5.7	3.6	13.6	4.0	16.9	17.8	3.0	2.1	37.1	15.0	7.9	20.6	15.5	4.4	34.0	18.6	11.1	29.3	11.3	7.8	4.8	24.1	22.8	2.6	10.0	7.0	8.5	1.3	12.4	15.8	6.6	7.3	29.3	31.5	5.9	4.5	22.2	3.6	5.2	17.0	4.2	0.0	5.3	0.4	0.0	2.3	8.0	0.4	4.1	10.5	1.0	2.0	0.0	12.0	0.0	3.8	1.1	0.0	1.8	1.0	1.6	1.5	0.0	5.2	2.5	4.6	0.0	2.6	0.6	0.0	17.9	0.3	1.9	0.3	161.2	38.9	0.0	0.0	0.1	0.0	21.2	0.2	0.0	0.4	0.9	1.3	0.7	0.0	5.0	3.6	14.7	0.6	0.0	0.0	5.6	1.3	1.3	0.0	0.0	5.5	0.0	0.0	5.6	0.0	0.1	0.0	0.0	2.0	0.2	0.0	13.8	3.6	5.0	3.7	3.4	3.6	5.9	7.6	5.9	4.3	4.1	8.5	4.7	22.2	5.2	2.1	4.5	17.0	4.2	2.8	3.3	11.7	3.5	5.7	3.6	3.0	2.1	4.4	1.3	14.9	8.6	7.5	61.6	4.9	0.2	3.4	2.5	129.8	31.8	15.7	3.9	11.7	13.3	14.9	2.9	28.6	33.3	23.3	23.6	13.4	20.3	29.5	113.9	0.4	21.7	0.0	33.7	49.1	4.0	7.2	7.8	14.2	18.6	27.9	63.3	8.3	13.1	69.1	2.5	11.5	1.4	12.9	3.7	0.4	8.8	7.2	3.3	7.7	25.5	71.1
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HDLM-2: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.4	0.0	0.5	2.1	2.5	1.1	0.3	4.6	3.8	0.0	0.0			0.2	0.3	0.4	0.0	0.5	2.0	0.8	0.4	0.7	0.0	0.9	0.5	1.2	0.3		0.4	2.5	0.0	1.0	0.4		0.1	0.0		0.2	0.0	1.3	0.3	0.3	0.0	0.4	0.8	1.2	2.1			0.2		0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.4	2.1	3.1	0.1	0.1	0.1	0.3	0.3	0.8	0.0	2.4	1.5	0.1	0.1	0.0	0.6	0.0	0.0	0.9	2.7	1.4	1.1	0.0	0.5	0.0	0.3	1.2	0.0	0.0	0.7	1.7	0.1	0.0	0.9	0.0	1.5	0.1	0.0	2.3	0.4	0.1	0.1	0.0	1.0	0.4	0.8	0.1	0.5	0.3	0.2	0.9	0.0	0.5	0.0	0.1	1.8	0.0	0.2	1.1	1.8	0.1	0.4	0.5	0.5	2.3	1.5	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0											3.0	1.0	0.0	1.7	1.4	3.1	0.8	2.5	17.4	1.2	1.8	2.0	0.4	3.3	1.5	9.4	4.3	2.9	0.0	4.3	0.1	1.2	2.4	4.7	1.7	5.2	0.0	3.4	7.4	6.5	4.4	1.1	2.2	1.7	1.8	1.7	5.7	3.7	2.5	1.4	3.8	0.9	0.0	1.9	12.9	13.4	0.6	0.2	4.4	2.5	0.9
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	111	"HEL: 23.1"									HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.3	0.0	2.9	0.0	0.5	4.3	0.0	0.0	5.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.3	0.2	1.7	0.1	0.0	0.3	3.9	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.6	2.2	0.0	0.1	0.2	0.4	0.4	0.8	1.1	0.4	0.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.4	0.4	0.4	0.7	0.4	0.0	0.2	0.3	0.4	1.1	0.1	0.3	0.8	0.7	1.0	2.9	0.5	0.0	5.2	1.7	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.3"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 5.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2"									"HPA017770, CAB075742, CAB075743"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane"	Nucleoplasm	"CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	6.6	0.4	1.4	0.3	1.8	0.4	7.6	0.9	3.8	1.8	1.6	0.1	9.8	0.5	0.7	0.8	10.9	0.8	1.2	1.2	1.5	1.9	2.0	0.2	0.6	1.9	1.7	0.0	0.7	0.4	0.0	0.3	6.3	1.0	1.1	0.1	0.1	1.4	7.0	6.3	4.3	0.2	0.6	1.1	0.3	0.4	39.3	0.2	0.2	1.1	4.5	6.8	1.0	3.2	0.1	0.1	5.3	0.2	0.4	0.2	0.0	28.8	0.5	0.0	1.5	0.6	1.9	0.3	31.3	3.7	9.7	5.9	0.0	0.2	0.0	2.6	3.5	3.4	2.6	0.0	1.7	8.2	0.3	0.0	0.0	34.1	0.0	0.4	0.0	0.0	2.9	5.1	7.2	9.3	0.0	0.8	0.0	0.0	0.1	18.2	0.2	0.0	0.0	1.0	0.9	0.5	0.0	0.1	0.0	1.6	0.4	0.9	0.1	49.0	0.6	9.5	1.7	0.1	0.0	1.2	0.4	2.8	66.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.5	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	5.3	0.4	0.1	0.1	0.0	0.0	1.4	1.8	0.9	1.7	1.5	1.9	1.7	0.0	1.0	0.2	3.0	0.3	0.0	65.7	34.6	0.3	0.1	10.2	1.4	7.9	24.4	0.0	11.3	0.0	0.5	5.0	3.3	0.0	0.0	0.0	132.9	2.9	88.0	0.0	0.0	5.3	0.0	0.0	1.3	0.0	10.1	3.7	2.8	11.8	0.0	0.0	0.5	3.9	0.0	2.8	0.0	0.7	0.0	13.3	359.5	76.0	39.3	21.2	0.0	0.0	76.5
LY75	"CD205, CLEC13B, DEC-205"	ENSG00000054219	"Lymphocyte antigen 75"	O60449	2	159803355-159904749	"CD markers, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 28.8;lymphoid tissue: 61.9"	"Cell type enriched"	"Detected in many"	7	"monocytes: 150.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.5;HDLM-2: 9.9;Karpas-707: 42.2;RT4: 14.3;THP-1: 10.6"									"CAB001450, HPA049108, HPA054073"	Enhanced		Approved	"Golgi apparatus"		NA	NA		960000	"Golgi apparatus"		"CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: AB_2682370"	"unprognostic (7.29e-3)"	"unprognostic (1.92e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (2.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.86e-4)"	3.5	1.8	1.9	21.4	2.6	4.9	6.1	1.2	1.8	4.5	9.3	2.0	1.0	10.8	2.1	1.9	4.5	5.0	10.7	2.8	1.8	1.7	2.8	1.2	10.3	33.9	2.5	1.1	1.6	2.3	0.2	1.9	0.8	2.4	2.0	7.2	1.3	7.2	1.3	0.8	6.5	28.8	1.3	3.4	17.2	3.8	1.1	3.0	61.9	10.7	3.6	17.1	6.9	3.8	5.8	4.3	5.9	2.6	7.5	8.0	2.3	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	10.5	7.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	9.9	0.0	2.1	0.0	0.0	0.2	1.6	0.0	0.2	0.0	0.2	0.1	0.0	5.4	0.0	0.0	42.2	0.0	0.0	0.0	2.7	0.2	0.2	0.0	2.7	0.0	1.8	3.2	14.3	0.0	0.0	3.4	2.4	0.0	0.1	0.0	10.6	8.1	0.0	0.0	0.0	0.0	6.5	1.1	1.4	0.0	3.6	0.0	3.4	2.0	3.5	6.5	2.6	7.1	5.8	5.9	7.5	4.3	4.5	6.7	8.0	5.9	7.5	1.0	1.5	4.3	2.3	1.9	2.6	1.2	1.8	1.8	1.7	2.5	1.1	2.4	3.0	0.0	4.3	8.8	1.9	6.6	0.0	0.4	5.1	6.7	4.5	22.7	2.0	0.1	0.0	0.9	0.3	2.2	20.2	0.0	4.9	0.1	1.5	1.1	11.5	0.0	4.2	0.0	1.7	3.1	7.9	0.0	2.3	11.0	5.0	150.5	11.0	0.5	3.2	10.5	0.4	1.2	0.2	0.0	0.7	0.0	0.7	5.8	0.2	8.7	12.4	4.3
LY96	MD-2	ENSG00000154589	"Lymphocyte antigen 96"	Q9Y6Y9	8	73991352-74029087	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.6"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 473.5;Kupffer cells: 449.9;Macrophages: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 92.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 92.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.0;GAMG: 21.8;Karpas-707: 52.3;RPMI-8226: 25.2;U-87 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053060			Approved	Vesicles	"Secreted to blood"	NA	NA		95000	Vesicles		"HPA053060: AB_2682029"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.38e-11)"	"unprognostic (2.87e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.90e-2)"	23.4	9.6	5.7	20.9	9.6	7.3	12.6	1.6	7.8	7.5	10.3	2.5	2.7	6.0	6.2	12.3	9.6	7.6	17.1	18.8	11.2	5.8	7.4	10.9	17.3	36.3	11.6	1.9	12.7	3.2	0.7	7.2	21.8	9.2	9.6	7.4	3.9	9.0	3.4	6.0	3.5	7.0	10.0	19.6	47.3	4.9	7.2	6.6	5.3	6.5	5.2	18.4	15.3	16.1	4.0	6.8	92.6	14.2	0.0	3.1	4.6	0.4	0.0	0.1	0.0	10.1	21.0	0.0	14.0	17.0	3.7	8.8	0.0	0.1	4.3	4.8	8.9	21.8	0.1	0.0	0.2	9.8	4.6	0.1	0.1	0.0	0.5	5.0	0.7	0.2	6.1	0.1	6.1	1.2	0.6	18.6	2.7	0.0	52.3	13.4	0.0	1.7	0.6	0.0	0.0	0.3	1.7	0.0	25.2	0.7	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.0	0.9	14.4	9.7	0.7	5.1	3.3	13.8	6.4	2.6	27.0	0.2	4.1	1.6	14.2	0.0	0.0	12.3	0.2	4.0	2.0	0.3	6.8	1.8	1.3	0.4	92.6	0.0	9.8	5.6	3.1	4.6	5.7	9.6	1.6	7.8	11.2	5.8	11.6	1.9	9.2	6.6	14.9	15.4	42.6	1.0	12.2	0.1	0.7	0.0	4.0	13.6	3.5	0.0	2.4	0.0	3.2	22.0	45.8	0.0	0.0	6.3	2.6	16.0	0.6	3.5	2.0	473.5	0.0	0.0	102.5	449.9	2.0	13.3	173.5	72.6	46.9	0.0	0.0	13.2	0.0	6.3	0.6	0.1	6.5	14.7	0.5	0.1	10.2	5.4	15.9	0.0	1.0
LYL1	bHLHa18	ENSG00000104903	"LYL1, basic helix-loop-helix family member"	P12980	19	13099033-13103161	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4;lymphoid tissue: 25.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 274.5;Late spermatids: 496.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 33.0;HL-60: 23.1;HMC-1: 55.7;K-562: 25.9;NB-4: 33.8;REH: 24.8;THP-1: 22.4;U-937: 22.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA075004			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA075004: AB_2686728"	"unprognostic (8.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.18e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.28e-1)"	6.3	3.0	3.4	19.9	5.8	37.4	8.0	1.1	3.8	4.0	3.7	5.5	1.3	3.0	5.3	3.9	5.9	3.8	3.5	4.9	4.5	2.9	3.9	2.0	8.1	24.0	7.1	1.6	3.2	1.6	0.8	1.7	8.0	5.1	6.2	1.4	4.4	6.4	2.4	3.5	2.0	8.8	3.3	6.0	25.4	4.2	11.9	4.1	3.6	3.5	1.4	18.9	3.3	7.0	4.6	1.4	8.8	3.6	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	6.4	2.2	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	33.0	0.0	0.3	0.3	23.1	55.7	0.1	0.0	0.0	0.0	0.0	8.5	0.0	25.9	1.1	0.0	0.0	0.1	33.8	0.0	0.1	0.8	24.8	0.0	2.8	0.0	0.0	0.0	2.4	0.7	0.0	1.5	0.0	0.0	22.4	13.6	0.0	0.0	0.9	0.0	0.0	0.0	5.2	0.0	22.3	0.0	2.5	2.3	8.8	0.1	2.9	0.2	2.8	0.3	0.2	1.4	4.6	0.2	0.2	3.6	0.0	3.6	0.4	0.5	0.6	3.4	5.8	1.1	3.7	4.5	2.9	7.1	1.6	5.1	4.1	0.0	0.3	46.4	0.5	2.3	0.0	2.0	2.5	1.4	0.0	1.8	0.0	0.6	0.0	0.2	274.5	27.4	1.1	70.0	0.0	0.8	4.7	0.2	44.9	0.8	92.6	0.0	1.7	20.9	52.2	496.4	7.5	33.5	6.8	2.8	1.1	1.4	1.2	1.5	11.3	0.2	0.1	12.9	1.8	39.2	5.5	1.6	1.3	2.2	0.8	0.4
LYPD1	"LYPDC1, MGC29643"	ENSG00000150551	"LY6/PLAUR domain containing 1"	Q8N2G4	2	132644853-132671579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;fallopian tube: 74.6"	"Group enriched"	"Detected in many"	5	"Ductal cells: 49.4;Exocrine glandular cells: 65.7;monocytes: 108.2;Pancreatic endocrine cells: 67.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 57.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 10.9"	"Lineage enriched"	"Detected in single"	36	"granulocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 17.4;HUVEC TERT2: 14.8;SK-MEL-30: 15.2;SuSa: 13.7;U-251 MG: 31.7;WM-115: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068333			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA068333: "	"unprognostic (9.25e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.40e-3)"	"unprognostic (5.60e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	1.5	2.5	16.4	1.7	27.8	1.2	1.4	3.8	16.8	1.3	2.5	4.6	0.0	1.4	2.5	1.8	1.4	74.6	3.6	1.8	18.9	19.0	3.2	1.6	1.4	3.5	16.9	5.4	8.4	3.5	2.0	12.4	1.2	11.8	1.4	1.4	5.4	21.7	1.4	1.2	1.5	1.4	1.8	7.0	1.3	1.4	1.5	3.4	1.2	1.3	1.1	2.5	1.4	0.0	0.3	0.0	10.9	0.0	0.0	0.0	0.0	0.2	4.8	5.4	0.0	0.0	0.0	0.0	1.1	0.6	2.4	0.5	0.4	0.6	0.0	10.1	2.0	1.6	5.2	0.0	0.0	1.2	0.0	1.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	1.0	14.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.3	0.1	2.1	0.0	0.0	0.0	7.1	0.1	0.7	1.3	0.6	0.0	15.2	13.7	0.0	0.1	0.7	0.3	7.6	3.2	31.7	0.0	0.0	0.0	6.2	0.0	63.9	1.3	0.0	10.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	27.8	3.8	11.0	18.9	19.0	16.9	5.4	11.8	3.4	0.0	0.0	0.0	0.0	0.1	0.8	0.2	5.1	0.0	0.0	5.2	0.0	0.0	1.7	49.4	4.4	0.0	0.0	0.0	65.7	0.0	0.1	0.1	0.0	0.0	0.1	14.3	1.7	0.6	0.3	6.3	3.7	0.0	0.0	108.2	0.0	1.5	67.6	0.0	0.0	2.2	0.8	0.0	5.3	1.1	1.8	0.0	0.0	0.0	0.0	0.0
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465660	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6"	"Cell type enhanced"	"Detected in many"	25	"Basal keratinocytes: 448.4;Suprabasal keratinocytes: 2015.9;Syncytiotrophoblasts: 598.6;Urothelial cells: 616.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 235.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.8;HaCaT: 30.1;MCF7: 33.6;RT4: 32.3;SK-BR-3: 48.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA		9700000	"Endoplasmic reticulum, Vesicles"		"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	0.3	0.4	0.3	0.4	0.3	0.8	5.8	0.3	0.3	28.0	0.3	0.3	0.3	0.0	2.1	0.7	110.5	0.5	0.3	0.3	0.3	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.0	0.3	7.4	0.3	1.4	0.0	0.5	21.7	0.3	0.6	86.4	0.4	0.8	0.3	0.3	0.1	0.3	0.3	1.9	0.3	70.6	75.2	4.1	48.3	0.2	3.5	3.0	0.4	0.1	7.9	1.9	11.2	0.1	0.0	0.2	0.1	0.0	4.7	0.4	1.2	0.4	0.5	0.1	12.8	0.0	0.5	0.3	1.7	30.1	0.0	1.3	0.2	0.0	0.1	0.2	1.5	0.2	0.1	0.0	0.2	0.5	11.4	0.0	0.1	0.5	0.0	0.9	0.0	0.0	0.0	33.6	0.2	0.0	0.0	7.2	2.5	0.1	0.0	0.0	0.3	32.3	0.0	0.1	0.1	48.4	0.5	1.5	5.3	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	1.6	0.2	4.2	1.6	3.5	0.0	7.9	6.7	3.0	0.1	0.0	0.4	1.2	1.9	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.6	0.5	55.8	448.4	0.6	0.5	5.1	0.0	1.2	14.0	0.0	74.6	1.7	1.6	0.0	2.2	0.3	0.0	0.2	59.2	26.8	34.6	5.7	0.0	12.7	3.2	0.0	0.0	0.0	0.0	0.6	2.7	140.0	1.0	1.0	3.2	2.8	0.0	0.4	0.6	0.2	0.0	18.6	0.0	0.9	2015.9	598.6	2.5	0.7	616.2
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43795929-43827206	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 39.6;skin 1: 39.8;tongue: 34.7"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 25.8;Late spermatids: 48.7;Melanocytes: 16.9;Syncytiotrophoblasts: 18.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	4	"monocytes: 3.8;T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"A-431: 5.9;BEWO: 9.1;HaCaT: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Nucleoplasm, Cytosol"		"HPA042511: AB_10794279, HPA054670: AB_2682567"	"unprognostic (4.27e-3)"	"prognostic favorable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.5	1.2	3.4	2.1	7.9	0.7	4.2	2.4	8.8	5.7	1.4	3.5	0.5	1.2	1.3	2.4	7.8	1.6	1.9	1.3	3.9	4.8	0.9	1.0	3.4	1.4	4.5	4.0	0.8	0.9	1.1	1.4	39.6	9.3	1.3	1.5	0.7	2.1	1.5	0.7	39.8	1.1	1.9	3.3	5.9	1.3	7.4	2.7	0.6	1.4	34.7	3.4	2.4	5.4	0.4	0.0	0.5	3.8	0.0	1.2	0.5	5.9	0.0	0.3	0.0	0.1	0.0	9.1	0.5	0.0	0.8	1.0	0.7	2.1	0.3	1.1	0.7	2.3	9.5	0.0	1.1	0.5	1.0	0.0	0.2	0.6	0.0	2.5	0.1	0.1	2.9	2.6	0.4	1.1	0.0	0.3	0.2	0.1	0.3	0.0	0.3	0.2	0.1	0.6	3.1	1.9	0.0	0.1	0.1	0.6	0.9	0.7	0.2	1.2	1.4	0.0	1.9	0.6	0.2	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	1.2	0.0	0.0	3.8	0.3	0.0	0.8	0.1	0.0	0.4	0.4	1.2	0.5	0.0	1.4	0.0	0.0	0.5	3.4	7.9	2.4	8.8	3.9	4.8	4.5	4.0	9.3	2.7	0.0	0.0	0.0	2.6	3.2	1.5	0.6	0.0	1.4	0.0	0.0	0.0	0.9	3.3	0.4	25.8	1.7	0.0	0.0	0.8	7.4	0.2	1.4	0.0	0.0	2.0	0.0	0.0	0.6	0.0	48.7	0.3	0.7	16.9	0.0	1.8	1.0	0.4	0.2	1.1	0.0	0.6	0.0	0.1	1.1	2.6	2.5	18.1	0.0	0.4	5.1
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474148	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 17.7;placenta: 22.7"	"Group enriched"	"Detected in many"	33	"Early spermatids: 54.3;Late spermatids: 174.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.6;fHDF/TERT166: 23.9;HBF TERT88: 13.1;LHCN-M2: 23.7;RT4: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.72e-4)"	2.6	1.0	8.7	1.8	7.9	0.4	14.6	3.3	8.2	2.0	4.4	4.3	1.1	2.8	4.0	1.0	1.2	2.9	17.7	1.4	6.2	11.5	3.4	0.8	1.3	0.8	6.2	5.3	1.4	3.2	2.6	0.9	22.7	7.2	2.5	4.1	2.8	0.8	2.6	0.7	1.4	5.6	4.7	5.1	1.3	6.2	4.5	2.6	0.0	0.6	0.0	2.3	4.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.5	18.6	0.0	0.0	0.2	7.6	3.3	9.6	6.1	0.1	1.5	0.0	0.4	23.9	4.7	1.9	2.7	0.0	13.1	0.0	0.9	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.8	0.1	0.1	0.0	0.0	0.0	23.7	3.0	0.0	1.7	2.7	1.6	2.2	0.0	10.3	0.0	1.2	19.5	0.7	3.4	5.1	5.8	0.6	6.3	0.7	0.3	0.0	0.2	3.0	0.2	4.1	0.0	0.0	0.0	1.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	8.7	7.9	3.3	8.2	6.2	11.5	6.2	5.3	7.2	2.6	0.0	0.0	0.0	0.5	0.1	1.9	0.3	2.5	1.4	3.4	0.0	0.0	0.0	3.3	2.2	54.3	0.2	1.0	0.0	0.7	0.2	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	174.5	2.8	0.0	0.0	0.0	2.5	3.5	3.3	0.0	0.4	0.0	3.2	0.0	0.1	0.7	1.1	0.0	0.2	0.0	1.9	1.1
LYPLA1	LPL1	ENSG00000120992	"Lysophospholipase I"	O75608	8	54046367-54102017	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 729.6;Late spermatids: 528.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1700000	"Nucleoplasm, Cytosol"		"HPA050941: AB_2681284, HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	14.1	17.7	7.2	12.2	8.9	13.4	16.4	10.8	15.2	10.7	14.6	6.9	4.7	15.4	8.0	11.1	30.4	8.0	11.9	27.1	6.8	6.8	31.1	37.3	13.6	23.4	7.3	4.9	12.3	24.3	9.0	7.4	51.1	12.0	15.3	15.2	17.0	23.3	7.1	26.4	22.1	17.6	10.4	6.3	14.0	14.9	64.8	4.1	21.3	13.3	19.3	19.7	24.6	17.3	29.1	37.1	42.7	40.4	27.1	29.2	35.1	30.2	17.1	22.3	20.0	8.1	13.2	28.1	18.1	10.4	16.8	15.8	12.3	29.4	53.0	21.2	11.7	18.5	20.3	31.3	30.1	23.4	19.2	17.1	36.9	10.9	19.8	13.3	22.5	50.1	11.6	26.6	13.0	29.4	14.4	43.3	23.1	37.4	16.1	23.2	8.0	34.3	17.2	33.1	50.7	7.9	20.8	11.8	24.2	25.8	41.0	11.7	20.0	12.7	23.8	27.8	22.1	34.7	20.2	20.8	10.1	14.8	17.5	16.7	22.5	33.8	47.8	13.7	24.0	19.8	31.4	33.1	42.7	19.1	31.1	19.0	29.1	18.2	18.4	37.1	23.9	18.4	17.8	19.5	27.1	40.4	23.8	29.2	35.1	7.2	8.9	10.8	15.2	6.8	6.8	7.3	4.9	12.0	4.1	26.8	44.0	77.0	68.7	54.8	33.9	58.1	45.9	38.8	33.0	59.3	49.1	180.5	257.0	74.6	729.6	72.2	62.9	0.0	77.4	255.5	43.3	142.6	49.5	102.9	105.0	17.5	55.2	78.0	108.6	528.5	26.2	78.4	70.9	59.5	73.4	26.2	94.9	67.1	21.5	145.1	62.5	45.3	42.2	70.4	176.9	70.9	279.5	61.2	78.8	160.0
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 101.6"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 144.2;Late spermatids: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA059840: AB_2684137"	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favorable (9.50e-4)"	25.4	18.9	19.1	15.0	17.4	12.8	25.5	12.6	17.8	17.5	16.6	9.6	14.0	9.5	17.1	21.1	16.2	24.9	17.0	34.2	15.4	18.2	30.6	101.6	11.2	19.2	18.8	13.8	25.3	26.1	20.5	13.9	9.0	24.9	21.1	14.0	13.1	14.1	19.1	28.7	10.6	12.6	27.6	17.9	11.5	15.7	22.9	9.0	16.2	19.4	14.9	12.9	25.3	19.7	12.7	7.2	47.4	10.2	8.4	14.2	10.1	12.1	13.0	12.1	9.6	32.9	26.2	4.0	10.1	16.9	5.8	8.8	14.6	15.2	8.5	39.5	12.1	8.5	8.5	5.3	10.6	9.5	15.9	8.3	3.9	3.6	37.6	24.5	12.7	7.7	19.0	9.4	16.3	46.8	16.5	24.1	12.7	8.5	15.1	25.2	16.1	12.5	8.6	12.6	18.1	6.9	17.2	6.7	10.2	21.0	7.1	11.9	11.4	6.3	10.5	16.8	7.0	10.8	7.4	6.4	8.4	6.1	13.2	6.9	14.9	20.9	13.3	21.9	13.7	7.3	47.4	7.2	23.3	8.6	9.1	11.8	12.7	13.2	10.6	5.9	11.2	10.7	10.8	26.8	8.4	10.2	7.2	14.2	10.1	19.1	17.4	12.6	17.8	15.4	18.2	18.8	13.8	24.9	9.0	17.9	13.9	29.7	49.4	18.7	29.4	53.1	25.5	24.1	10.3	22.7	13.7	23.9	64.6	36.2	144.2	28.7	7.0	0.0	38.2	7.9	24.2	36.6	15.1	41.4	13.8	14.3	28.8	11.1	11.6	327.6	26.7	12.7	16.9	55.9	15.3	26.4	29.5	14.0	35.7	98.2	27.2	12.9	22.0	66.8	24.3	18.2	12.5	26.1	25.2	44.5
LYRM2	DJ122O8.2	ENSG00000083099	"LYR motif containing 2"	Q9NU23	6	89568144-89638753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063932	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA063932: AB_2685155"	"unprognostic (3.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.52e-3)"	"unprognostic (8.49e-2)"	"unprognostic (4.27e-2)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (8.07e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.64e-2)"	11.2	17.5	21.6	9.8	22.0	12.5	14.5	11.9	22.5	10.3	13.6	15.2	15.1	8.6	13.4	15.4	12.8	14.1	10.7	17.3	19.2	19.6	18.2	13.8	10.2	11.8	22.2	23.0	11.3	10.3	24.9	34.0	16.1	19.0	14.1	16.8	9.0	10.9	10.2	20.9	7.0	10.0	12.5	19.8	9.4	12.9	11.0	22.2	9.8	26.2	13.2	10.8	12.0	8.9	21.9	17.5	9.2	21.0	16.6	20.2	9.6	9.5	5.1	17.5	10.4	8.9	13.5	7.2	16.7	11.9	13.0	13.2	4.5	5.1	13.2	16.1	15.7	19.5	8.8	11.1	15.7	17.0	16.6	19.3	20.7	5.5	3.8	13.3	22.0	16.2	16.5	15.4	14.8	20.0	10.7	10.1	14.4	21.2	17.1	15.0	8.6	5.0	7.8	4.0	7.8	6.4	10.5	21.7	9.8	14.7	9.5	19.5	13.2	9.6	6.1	16.7	8.5	8.5	22.6	16.0	8.2	7.3	14.9	23.0	12.3	17.7	6.8	17.3	15.9	15.5	8.7	14.4	9.2	15.3	16.2	16.3	21.9	17.4	20.2	13.1	20.3	19.8	18.2	4.1	16.6	21.0	17.5	15.7	9.6	21.6	22.0	11.9	22.5	19.2	19.6	22.2	23.0	19.0	22.2	38.7	39.9	36.7	24.6	10.5	26.7	79.5	28.1	89.7	54.6	26.2	15.7	71.6	79.6	33.6	48.2	24.8	26.1	23.3	42.9	26.6	24.6	23.5	31.3	25.1	48.9	23.8	39.0	19.6	27.2	11.4	28.4	37.5	28.7	34.3	38.2	89.1	34.2	35.1	25.5	53.0	48.0	51.8	25.8	46.4	37.1	14.2	60.5	28.7	37.7	23.5
LYSMD2	MGC35274	ENSG00000140280	"LysM domain containing 2"	Q8IV50	15	51723011-51751585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.7"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 122.7;monocytes: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040460	Approved		Approved	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA040460: AB_10794874"	"unprognostic (7.71e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.98e-1)"	"unprognostic (4.17e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.03e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	5.3	13.4	17.7	13.8	26.2	7.9	5.1	19.9	35.8	6.5	6.1	7.9	7.2	10.0	6.1	7.5	4.6	6.9	7.6	3.6	17.9	19.1	6.7	13.9	9.3	17.2	14.6	17.6	5.8	8.6	7.1	15.2	6.1	25.2	6.2	6.5	4.1	4.3	9.8	10.9	2.7	8.1	7.8	8.2	12.9	7.7	15.6	5.9	6.1	4.9	2.3	16.7	7.4	4.6	17.0	18.2	38.7	20.4	11.9	16.3	12.2	6.0	4.5	0.8	6.0	2.0	3.5	0.0	7.2	4.2	9.2	11.9	0.5	5.5	23.7	1.0	4.0	10.7	8.6	4.9	4.8	6.5	20.0	2.3	7.0	4.2	0.1	4.4	16.3	3.0	3.9	9.8	3.6	3.9	4.1	5.4	9.1	0.3	0.0	2.8	9.1	6.1	20.5	1.9	0.2	5.1	9.3	0.1	8.8	8.9	5.0	18.2	4.5	6.7	0.1	12.1	1.2	5.1	12.5	3.2	9.0	4.6	9.4	10.0	0.0	0.0	0.1	4.5	33.3	6.7	0.0	13.2	24.4	10.9	15.9	16.3	17.0	11.0	13.1	11.1	16.2	13.3	11.0	38.7	11.9	20.4	18.2	6.4	12.2	17.7	26.2	19.9	35.8	17.9	19.1	14.6	17.6	25.2	5.9	3.0	7.4	58.5	17.6	17.2	14.3	1.8	17.8	2.7	5.7	14.0	0.0	1.0	21.6	16.6	122.7	22.4	5.2	23.3	16.1	0.8	13.6	16.4	12.7	13.4	37.2	30.2	76.7	23.4	39.6	55.5	15.0	28.8	6.8	101.8	13.3	5.6	9.7	15.9	14.9	23.3	3.6	25.8	20.0	3.5	3.8	14.2	0.7	47.3	20.3	17.2
LYSMD3	FLJ13542	ENSG00000176018	"LysM domain containing 3"	Q7Z3D4	5	90515611-90529584	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018024	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA018024: AB_2138525"	"unprognostic (4.50e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (5.59e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (1.81e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.97e-3)"	"unprognostic (9.46e-2)"	12.7	14.0	8.9	11.1	10.5	9.3	11.1	16.0	11.2	15.8	14.1	4.7	16.2	11.8	13.1	9.3	12.0	11.2	12.8	15.7	10.2	8.9	21.1	33.6	15.6	12.9	11.9	6.1	19.1	13.1	24.5	31.1	19.0	12.2	12.9	10.8	7.3	13.3	21.2	16.6	6.4	17.4	10.5	12.1	14.6	9.5	6.6	12.7	18.5	18.8	9.0	11.4	15.4	12.5	6.4	7.3	27.7	9.4	11.9	10.4	7.4	10.3	6.9	8.9	9.4	14.0	14.3	8.8	16.6	18.1	11.6	19.1	5.9	10.7	12.8	7.2	14.5	18.1	5.3	13.7	16.2	22.7	9.4	8.6	9.7	8.6	9.6	14.5	8.1	16.5	10.5	11.4	10.6	17.8	12.4	16.5	8.4	9.3	19.6	12.9	9.1	9.3	4.7	4.4	2.6	11.8	8.8	15.1	18.4	12.7	7.1	2.7	5.5	9.8	7.5	13.5	7.4	8.5	7.7	20.5	7.0	9.9	15.3	11.9	22.4	14.2	10.9	11.9	13.9	10.9	27.7	7.7	11.6	6.5	9.4	10.4	6.4	7.5	7.9	7.3	5.4	10.3	8.8	11.5	11.9	9.3	3.5	8.1	7.4	8.9	10.5	16.0	11.2	10.2	8.9	11.9	6.1	12.2	12.7	32.8	21.9	13.7	9.3	12.7	10.2	22.1	7.6	14.7	21.6	12.2	3.9	8.4	1.7	6.4	0.8	15.5	13.7	23.3	7.0	8.2	18.2	18.7	25.4	28.8	7.7	19.1	20.7	16.0	14.0	1.3	15.5	14.4	6.8	6.4	11.1	18.9	5.9	8.6	12.4	10.1	12.8	19.4	17.8	7.0	4.1	14.4	11.7	15.4	9.0	8.0
LYSMD4	FLJ33008	ENSG00000183060	"LysM domain containing 4"	Q5XG99	15	99715697-99733561	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA029152, HPA059824"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			Cytosol	"Actin filaments"	"HPA029152: AB_10602033, HPA059824: AB_2684135"	"unprognostic (2.43e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.30e-1)"	8.8	4.7	5.8	11.6	8.7	4.7	11.1	8.6	14.1	9.5	6.4	7.8	3.6	8.1	9.3	11.4	11.4	5.5	8.3	9.2	7.1	5.6	4.7	6.6	7.0	3.9	4.7	5.7	7.8	6.5	14.9	5.4	5.0	6.7	6.3	5.9	8.3	15.9	7.7	12.3	25.2	6.5	6.9	7.9	4.5	5.6	6.8	6.3	5.4	4.1	11.1	6.3	4.6	8.4	3.1	4.8	8.0	4.0	1.0	6.2	3.4	3.7	3.5	7.2	4.2	8.1	7.4	4.3	4.3	3.0	3.7	5.4	8.8	3.3	4.1	2.5	3.9	6.4	11.0	5.6	6.9	4.3	0.8	10.1	2.7	7.2	6.0	4.6	1.9	5.1	4.2	10.2	3.4	4.0	2.3	4.9	12.0	6.5	5.3	2.4	4.4	5.1	5.4	4.8	10.4	4.1	3.6	5.1	2.0	6.6	9.8	4.2	3.7	7.8	2.4	4.1	9.7	1.7	3.7	6.3	3.0	8.3	4.1	1.8	7.0	9.3	3.3	3.9	4.8	3.2	0.0	2.0	8.0	3.8	3.3	2.9	1.8	5.2	4.5	1.1	3.1	6.2	2.8	0.7	1.0	4.0	4.8	5.0	3.4	5.8	8.7	8.6	14.1	7.1	5.6	4.7	5.7	6.7	6.3	6.0	3.5	0.8	7.0	7.7	8.9	9.7	7.6	2.7	3.4	3.5	9.8	2.0	1.7	3.4	5.6	4.6	4.0	23.3	8.4	2.1	4.5	1.5	0.0	3.6	3.6	9.5	2.9	5.5	2.2	4.3	4.9	4.7	1.7	11.8	4.0	10.8	5.7	2.9	6.3	3.8	10.0	12.9	6.1	10.8	5.5	8.0	1.1	2.5	2.2	3.9
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.8"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 236.3;Rod photoreceptor cells: 167.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.0;monocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.7;SK-MEL-30: 12.7;THP-1: 44.9;U-937: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		Yes	No			Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: AB_2682129, HPA055725: AB_2682898"	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	10.3	5.2	6.4	9.0	8.8	31.3	10.6	10.5	7.1	8.8	5.3	3.8	3.4	3.4	6.8	4.3	6.6	5.6	5.8	4.7	4.3	2.4	5.0	6.1	10.9	7.8	4.2	6.0	6.2	5.0	9.1	12.6	5.5	5.3	6.0	5.0	9.6	8.2	4.8	3.9	11.7	6.3	9.8	9.2	11.3	8.4	6.4	6.3	38.8	8.5	4.0	7.6	9.3	10.6	1.6	1.7	13.0	5.9	1.7	1.0	0.7	3.8	0.9	0.4	0.9	6.0	6.9	0.6	1.4	5.7	1.5	1.4	0.0	1.0	0.5	0.6	3.1	3.6	1.8	0.5	0.7	1.3	13.7	1.2	1.2	0.8	0.3	1.1	1.8	1.7	2.3	3.6	1.9	4.7	2.2	1.2	0.6	0.1	0.8	1.2	0.2	2.3	3.9	0.1	0.7	0.4	0.1	0.5	0.0	4.4	4.2	2.5	0.5	1.5	0.0	12.7	0.5	0.5	44.9	2.6	1.1	0.5	1.3	1.2	0.9	0.0	0.0	1.9	17.2	3.2	0.4	3.1	5.7	0.6	3.5	1.0	1.1	0.3	0.7	1.7	1.6	0.2	0.5	13.0	1.7	5.9	0.2	0.2	0.7	6.4	8.8	10.5	7.1	4.3	2.4	4.2	6.0	5.3	6.3	17.9	50.4	48.0	71.9	63.1	61.8	9.2	10.2	24.1	39.8	10.4	88.4	5.4	10.0	5.6	9.9	41.7	11.5	0.0	10.7	4.0	23.9	49.0	106.6	14.5	28.2	49.3	9.2	15.4	73.1	13.4	25.9	70.4	114.7	236.3	11.3	23.7	24.4	14.2	20.5	9.0	167.4	12.9	28.6	79.6	22.6	57.0	7.3	65.4	6.3	82.9
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 240.8;Spermatocytes: 162.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		110000	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: AB_2683779"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	13.6	14.2	21.4	12.8	18.0	11.4	17.7	13.6	21.6	18.2	19.2	24.5	15.1	19.5	18.3	13.5	17.6	16.9	14.1	21.0	19.8	16.5	20.0	20.4	11.5	13.6	24.3	10.3	25.5	15.3	26.1	15.9	14.9	20.5	15.8	19.4	13.0	16.6	14.6	21.7	13.9	23.7	21.3	28.2	11.0	12.2	44.3	20.1	20.2	17.2	13.2	15.6	14.9	23.1	13.9	28.1	28.3	22.7	16.8	21.0	12.9	16.1	10.7	20.6	14.6	12.8	21.3	9.2	14.7	12.5	20.8	20.2	13.3	28.4	19.6	16.8	18.5	13.1	12.3	19.4	21.3	31.3	18.1	13.3	28.5	13.9	21.8	12.4	26.0	14.8	13.9	30.6	29.1	27.6	14.9	16.3	26.0	35.3	11.2	19.1	11.4	21.3	12.7	10.4	20.4	17.5	22.8	27.3	15.7	11.2	7.3	10.3	16.3	18.0	7.9	34.6	20.5	13.1	13.4	14.8	14.5	19.8	20.5	15.4	9.2	21.0	33.6	14.8	38.9	19.2	22.0	18.8	28.3	16.0	20.7	14.0	13.9	16.3	15.5	18.1	13.8	16.3	16.9	18.9	16.8	22.7	28.1	21.0	12.9	21.4	18.0	13.6	21.6	19.8	16.5	24.3	10.3	20.5	20.1	6.0	12.9	11.9	18.9	11.3	8.9	52.1	10.2	33.5	11.4	7.0	5.9	24.8	41.4	22.9	240.8	16.9	27.5	0.0	18.4	37.8	16.2	18.9	30.0	19.2	37.4	39.7	8.7	11.6	21.1	51.9	24.5	26.4	13.5	28.9	17.2	47.0	20.3	25.9	25.8	42.9	14.5	19.4	17.6	162.6	67.1	14.6	28.8	17.5	20.6	18.3
LZTR1	"BTBD29, LZTR-1"	ENSG00000099949	"Leucine zipper like transcription regulator 1"	Q8N653	22	20982013-20999038	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067852, HPA068772, HPA071248"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			Nucleoplasm	"Centrosome, Cytosol"	"HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.25e-2)"	21.2	16.9	17.3	15.6	17.4	10.3	17.9	20.7	24.7	18.5	18.3	25.3	20.6	18.9	24.9	14.0	16.5	18.3	21.2	15.8	15.4	10.9	17.2	13.1	16.2	12.8	19.6	16.5	21.7	16.2	24.9	26.0	18.8	19.0	16.9	12.9	18.9	17.5	18.0	17.2	15.0	15.7	21.9	14.0	19.3	14.5	10.8	19.2	10.8	19.6	12.6	12.5	18.5	16.4	1.6	2.2	0.2	3.4	1.8	3.0	1.5	6.3	5.2	7.8	9.4	17.9	12.4	6.3	13.0	9.1	7.4	10.2	3.0	2.6	6.7	4.8	14.5	6.9	8.6	5.8	10.6	3.0	12.5	13.6	7.2	6.8	4.5	9.6	3.9	9.6	11.4	5.4	9.4	6.8	11.8	14.4	6.3	30.0	11.7	8.4	3.8	6.9	3.7	2.4	7.7	5.7	8.2	11.3	2.6	5.9	8.6	7.7	11.4	7.1	12.3	7.6	4.9	5.7	7.2	12.8	17.4	8.9	7.8	7.0	5.1	4.4	2.0	7.8	3.8	8.4	0.0	2.5	0.2	3.0	3.1	1.6	1.6	1.5	2.8	2.2	1.0	2.1	1.5	0.1	1.8	3.4	1.2	0.5	1.5	17.3	17.4	20.7	24.7	15.4	10.9	19.6	16.5	19.0	19.2	11.9	10.4	9.7	1.4	1.9	8.1	11.2	2.5	6.7	5.7	8.7	5.9	3.6	1.7	6.6	0.8	9.5	7.8	0.0	4.3	3.2	5.4	2.0	5.7	6.2	6.9	3.2	8.7	12.3	11.6	1.3	8.1	4.9	6.8	4.6	9.1	6.6	5.7	5.9	9.2	6.1	9.3	0.0	7.2	2.6	1.7	3.1	3.0	6.9	5.8	0.9
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 19.0;parathyroid gland: 64.9"	"Cell type enhanced"	"Detected in some"	21	"Horizontal cells: 19.1;Melanocytes: 18.6;Rod photoreceptor cells: 17.9;Sertoli cells: 64.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 36.7;U-698: 11.2;WM-115: 24.8"	"Group enriched"	"Detected in many"	5	"amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1"	"Group enriched"	"Detected in many"	9	"amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	2.4	2.1	13.3	1.8	19.0	0.8	1.9	0.6	19.0	1.6	1.1	2.2	0.4	1.1	2.2	1.5	3.5	1.4	3.5	2.3	8.9	2.6	1.9	1.1	4.0	1.5	2.5	8.8	1.7	1.6	64.9	1.4	5.8	1.9	1.7	1.1	10.3	1.3	1.7	1.6	4.2	1.2	2.7	0.8	1.1	1.3	6.6	1.5	0.3	2.0	0.9	1.1	1.9	1.0	0.2	0.1	0.7	0.1	0.1	2.2	0.5	0.0	0.0	4.8	4.0	0.0	0.0	0.6	2.4	0.0	2.1	1.8	0.1	0.0	5.3	1.7	1.5	0.8	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.8	0.0	0.3	0.0	5.7	0.0	0.0	7.0	0.0	9.2	0.0	6.0	0.0	0.0	0.0	7.7	0.0	1.3	0.2	7.4	6.4	0.0	0.0	36.7	4.2	0.0	0.2	0.0	2.5	1.7	0.0	0.7	0.0	0.0	11.2	0.0	0.5	24.8	0.2	0.1	0.0	2.2	0.0	0.8	0.0	0.7	0.4	0.0	0.2	0.2	0.3	0.7	0.1	0.0	0.1	0.0	0.5	13.3	19.0	0.6	19.0	8.9	2.6	2.5	8.8	1.9	1.5	0.0	0.0	0.0	0.6	1.1	1.5	1.0	0.0	0.0	0.0	0.0	3.9	6.1	1.7	0.0	0.4	0.7	0.0	0.0	0.0	1.6	1.0	0.1	0.0	0.0	0.8	19.1	0.0	0.0	0.0	0.4	1.1	0.0	18.6	0.0	0.0	0.9	0.0	0.0	0.4	0.2	17.9	64.7	10.5	0.2	1.1	0.1	0.7	0.0	0.0	0.0
LZTS3	"KIAA0552, ProSAPiP1"	ENSG00000088899	"Leucine zipper tumor suppressor family member 3"	O60299	20	3162617-3173592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.9;salivary gland: 36.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 9.3;Cardiomyocytes: 12.0;Club cells: 11.4;Collecting duct cells: 10.4;Distal tubular cells: 10.0;Proximal tubular cells: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031008, HPA031009"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA031008: AB_10601610, HPA031009: AB_10670162"	"unprognostic (4.09e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.69e-3)"	"prognostic favorable (5.92e-8)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.38e-1)"	2.4	5.3	17.6	1.4	31.1	1.7	3.5	51.9	45.7	11.5	2.4	4.2	2.1	8.6	4.6	3.7	1.7	6.4	6.8	5.4	16.4	10.7	11.9	2.7	5.6	1.2	7.1	17.4	9.0	17.0	11.8	4.1	2.2	10.5	5.0	2.2	7.4	36.2	7.9	5.1	1.4	6.5	2.7	4.5	1.7	7.7	1.9	6.0	0.0	7.1	0.4	1.0	2.6	1.5	0.2	0.8	0.0	0.0	0.0	0.9	0.0	2.8	2.7	3.8	4.2	5.3	1.5	2.6	2.8	6.1	4.8	7.1	15.3	8.0	4.8	1.6	5.5	6.3	1.4	2.1	3.0	3.7	0.1	2.7	0.2	0.5	12.5	12.0	0.2	1.3	1.9	6.6	6.7	2.6	1.8	0.7	4.5	2.7	1.5	2.3	1.2	0.3	0.6	8.5	6.5	2.6	1.3	1.3	5.1	6.0	1.0	15.0	4.6	2.3	3.3	2.3	5.8	7.7	0.1	4.3	5.2	9.8	2.0	0.8	3.0	0.4	1.4	2.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.8	0.5	0.0	17.6	31.1	51.9	45.7	16.4	10.7	7.1	17.4	10.5	6.0	17.9	9.3	2.2	0.0	1.3	0.0	12.0	0.0	4.0	11.4	10.4	0.0	1.1	10.0	4.9	0.0	0.7	0.0	0.0	4.3	0.3	0.7	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	8.1	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.0
M1AP	"C2orf65, D6Mm5e, SPATA37"	ENSG00000159374	"Meiosis 1 associated protein"	Q8TC57	2	74557883-74648338	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.8;testis: 13.2"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 8.7;Spermatogonia: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"NTERA-2: 6.1;RT4: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045420, HPA059302"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA045420: AB_10961177, HPA059302: AB_2683972"	"unprognostic (1.76e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	0.7	0.6	5.2	0.2	1.5	3.7	3.7	1.2	3.4	4.6	0.2	0.3	1.0	0.2	2.1	0.5	0.3	4.6	0.5	0.1	0.9	1.8	1.5	0.1	0.6	0.1	0.5	1.6	0.3	0.4	1.7	8.8	1.2	0.9	0.2	0.0	2.0	1.5	1.0	0.1	0.2	0.2	0.2	0.7	0.4	0.7	13.2	0.2	1.0	3.6	0.0	0.5	0.9	0.5	0.0	0.9	0.2	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.5	0.2	0.5	0.6	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	6.1	0.8	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	5.2	1.5	1.2	3.4	0.9	1.8	0.5	1.6	0.9	0.2	0.0	1.4	0.0	0.0	0.1	0.3	0.3	0.0	2.7	0.0	3.5	0.0	0.3	0.0	0.2	2.5	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	3.5	0.0	0.0	0.0	1.0	3.1	0.0	2.3	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	1.3	0.0	0.0	8.7	22.0	0.0	0.2	0.0	0.0	0.1
MAB21L1	CAGR1	ENSG00000180660	"Mab-21 like 1"	Q13394	13	35474182-35477209	"Predicted intracellular proteins"		"Developmental protein, Nucleotidyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.0;skeletal muscle: 8.5"	"Group enriched"	"Detected in some"	38	"Bipolar cells: 51.8;Cone photoreceptor cells: 47.1;Horizontal cells: 82.6;Muller glia cells: 136.9;Rod photoreceptor cells: 120.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 12.9;BJ hTERT+: 10.5;BJ hTERT+ SV40 Large T+: 14.9;HBF TERT88: 16.2;hTERT-RPE1: 31.2;SH-SY5Y: 48.0"	"Group enriched"	"Detected in some"	9	"cerebellum: 45.8;midbrain: 22.3;pons and medulla: 12.9"	"Low region specificity"	"Detected in all"			"HPA049324, HPA059864"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (4.44e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.79e-3)"	"unprognostic (3.87e-4)"	"unprognostic (5.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.86e-1)"	2.9	6.4	0.3	0.5	0.0	0.0	6.3	24.0	0.0	0.0	1.2			0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.8	0.6		1.1	0.0	0.0	0.0	0.0		1.8	0.5		3.7	0.2	8.5	1.2	1.1	0.0	0.8	0.0	0.3	0.0			0.6		0.2	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.9	10.5	14.9	8.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	16.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.2	48.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.4	0.7	51.8	0.3	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.2	2.3	0.0	0.1	82.6	0.0	1.3	0.0	0.0	0.3	0.0	1.7	0.0	0.0	136.9	0.0	0.0	0.4	0.0	120.3	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.2
MAB21L3	"C1orf161, FLJ38716"	ENSG00000173212	"Mab-21 like 3"	Q8N8X9	1	116111755-116135240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.9;skin 1: 8.7"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 41.7;Alveolar cells type 2: 51.9;Ciliated cells: 24.1;Club cells: 33.0;granulocytes: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 15.7;RT4: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039551			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039551: AB_2676565"	"unprognostic (9.25e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-3)"	"unprognostic (5.23e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.61e-2)"	0.3	0.0	0.3	2.7	0.3	0.8	0.5	0.3	0.3	2.8	2.1	0.3	0.3	0.2	0.3	0.3	9.9	0.0	0.3	0.3	0.3	0.2	2.0	3.1	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	2.2	0.3	1.1	1.8	0.3	1.3	0.7	0.6	8.7	3.4	0.3	0.3	0.3	0.4	0.7	0.3	0.3	0.3	2.5	1.7	2.1	4.2	2.6	1.3	5.5	1.2	4.4	0.7	0.0	3.4	0.1	0.8	0.6	0.1	0.0	5.3	0.6	0.2	0.0	0.0	0.3	1.3	2.1	15.7	0.1	0.3	2.9	0.1	0.1	0.1	0.7	0.1	0.9	0.4	2.8	0.0	0.9	0.5	0.0	0.4	0.1	0.3	0.1	0.0	0.5	0.9	2.4	0.0	0.3	0.5	0.5	2.2	0.7	1.0	0.8	0.8	0.4	0.6	15.1	0.5	0.8	2.4	2.0	0.6	2.5	2.5	0.4	0.5	1.0	2.5	0.7	0.6	2.3	4.0	1.0	0.5	0.3	1.0	2.6	1.2	0.3	0.6	0.6	0.5	0.8	0.4	0.5	0.3	2.6	0.7	0.7	5.5	4.4	0.7	1.3	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3	41.7	51.9	0.0	2.3	0.6	0.0	0.4	0.0	24.1	33.0	3.5	0.0	3.8	1.7	0.0	0.1	0.0	0.7	0.0	0.2	0.5	0.0	0.7	16.3	0.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.5	11.4	0.0	1.0	0.6
MACC1	"7A5, SH3BP4L"	ENSG00000183742	"MACC1, MET transcriptional regulator"	Q6ZN28	7	20134655-20217404	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.5;kidney: 23.9"	"Cell type enhanced"	"Detected in many"	11	"Club cells: 103.5;Pancreatic endocrine cells: 96.6;Urothelial cells: 233.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 41.3;CAPAN-2: 9.7;HaCaT: 29.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020081, HPA020103, HPA029476, CAB068194"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"CAB068194: AB_2665682, HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136"	"unprognostic (1.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.71e-9)"	"unprognostic (4.49e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.93e-3)"	4.8	2.6	0.5	5.6	0.4	0.7	4.5	0.4	0.5	8.3	13.7	0.0	4.4	10.1	0.7	6.1	14.1	0.9	9.6	0.5	0.5	0.5	23.9	1.0	13.3	1.1	0.4	0.0	1.3	11.3	0.1	4.0	1.6	0.1	3.9	3.3	0.1	11.4	6.0	0.5	4.5	29.5	0.1	0.8	6.0	5.0	0.8	0.0	1.7	1.5	16.0	13.6	4.0	5.1	2.3	1.0	1.4	1.0	0.8	0.6	0.5	41.3	0.1	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	9.2	9.7	5.8	0.4	0.0	0.0	29.1	0.1	0.4	0.0	0.0	0.1	5.5	0.1	0.0	0.0	2.3	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	5.9	2.8	0.0	3.4	0.0	0.5	0.4	8.1	0.0	0.0	0.3	4.4	7.3	2.8	0.1	0.2	0.0	3.3	0.0	0.2	1.7	0.1	0.1	0.1	0.0	0.0	0.1	8.9	0.4	2.2	0.0	0.3	0.0	1.0	0.6	0.3	0.3	0.7	0.6	2.3	0.2	0.5	0.3	2.0	0.3	0.3	1.4	0.8	1.0	1.0	0.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.4	0.0	0.1	0.0	65.5	63.4	1.4	71.9	2.5	2.1	0.6	22.9	58.9	103.5	38.4	2.0	0.5	6.6	49.2	2.2	0.7	25.7	0.0	55.2	0.1	2.3	64.3	11.6	1.0	4.6	1.6	37.1	3.7	2.4	0.8	2.0	4.4	1.7	13.6	15.0	0.5	96.6	14.0	2.5	12.9	1.0	0.0	0.4	0.2	0.4	3.4	0.2	3.9	13.3	233.0
MACO1	"FLJ10747, TMEM57"	ENSG00000204178	"Macoilin 1"	Q8N5G2	1	25430858-25500209	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 25.4;Ductal cells: 30.7;Exocrine glandular cells: 53.7;Pancreatic endocrine cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019680			Approved	Cytosol		NA	NA			Cytosol		"HPA019680: AB_1858125"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (7.13e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.35e-3)"	9.8	16.5	12.1	6.9	11.3	26.5	8.9	27.8	13.2	9.2	8.9	11.3	12.7	9.5	9.7	11.9	17.2	7.9	8.8	8.8	8.7	9.4	11.9	33.0	9.4	7.8	12.9	11.5	17.2	28.1	11.4	12.8	8.1	11.3	12.9	9.2	10.4	20.7	13.5	31.2	10.7	9.7	8.5	10.1	9.6	11.5	15.6	13.8	17.9	13.2	12.5	11.1	10.5	10.2	2.6	4.0	6.8	2.5	1.5	3.0	0.7	10.2	3.4	10.5	18.9	12.7	9.7	5.6	11.0	11.5	9.9	10.9	3.1	13.7	20.7	12.8	12.1	6.3	10.6	8.9	10.4	10.4	10.7	8.7	25.7	5.8	8.5	9.0	9.1	18.9	9.6	12.8	14.5	9.7	8.9	11.2	12.7	16.9	7.5	9.7	6.2	22.0	11.8	12.4	9.4	5.6	13.5	11.1	16.3	10.9	5.2	17.8	19.3	8.3	21.1	13.2	9.3	7.7	11.2	13.1	11.8	7.6	14.7	7.1	13.4	8.7	12.0	12.9	12.6	9.2	6.8	1.1	6.2	2.1	0.9	3.0	1.6	2.4	2.7	1.4	2.6	2.5	3.0	0.5	1.5	2.5	4.0	1.4	0.7	12.1	11.3	27.8	13.2	8.7	9.4	12.9	11.5	11.3	13.8	17.9	20.5	0.0	0.0	0.0	0.0	0.0	0.0	25.4	20.5	7.0	0.0	11.1	5.0	30.7	0.0	0.0	0.0	0.0	53.7	16.7	0.0	0.0	9.3	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	12.6	0.0	0.0	38.1	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0
MAD2L1	"HSMAD2, MAD2"	ENSG00000164109	"Mitotic arrest deficient 2 like 1"	Q13257	4	120055608-120067074	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.3"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 100.5;Spermatocytes: 142.5;Spermatogonia: 91.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003348	Uncertain		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA003348: AB_10603014"	"unprognostic (4.08e-3)"	"unprognostic (7.31e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (5.15e-5)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (6.74e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (3.07e-11)"	"unprognostic (3.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	1.4	1.8	2.4	4.2	5.7	10.3	2.4	4.4	4.1	1.9	4.4	1.2	0.3	3.8	1.7	1.4	6.5	2.9	1.1	1.7	2.7	2.7	1.2	1.2	1.5	7.6	2.3	3.6	1.7	1.2	0.7	1.0	3.5	2.4	1.6	5.5	0.7	2.4	1.2	1.2	2.3	4.2	1.8	2.8	3.8	1.9	13.7	1.2	27.3	1.2	8.2	7.3	2.1	2.4	1.8	2.2	2.0	0.8	2.5	3.9	1.7	14.7	6.4	15.2	9.9	1.6	2.0	6.5	11.7	6.6	12.2	9.5	8.6	9.1	21.7	3.9	4.2	5.4	4.0	15.1	8.9	17.2	10.2	10.6	12.0	6.3	8.1	0.5	19.5	6.9	1.1	1.3	8.3	5.2	3.1	7.0	9.3	14.3	12.4	6.4	6.5	18.7	8.5	10.4	7.7	7.4	9.7	20.4	8.9	5.0	5.7	16.2	11.5	5.8	7.2	3.6	7.8	4.8	7.2	4.4	8.3	9.4	8.3	14.7	11.6	12.4	14.2	7.7	10.1	10.8	2.0	0.5	0.4	1.6	0.5	2.1	1.8	3.8	3.0	0.4	1.4	3.5	3.5	1.3	2.5	0.8	2.2	3.9	1.7	2.4	5.7	4.4	4.1	2.7	2.7	2.3	3.6	2.4	1.2	0.0	2.2	6.0	6.3	15.3	8.5	3.0	2.5	6.7	2.3	7.0	2.0	18.3	0.0	2.9	1.8	3.1	2.9	23.3	1.4	100.5	6.1	4.5	15.0	1.6	23.3	19.1	1.7	2.5	6.3	3.6	4.4	6.2	8.5	4.6	8.1	10.6	1.7	2.9	1.4	4.3	3.6	12.9	6.6	142.5	91.0	7.9	9.0	17.9	16.2	4.5
MADD	"DENN, KIAA0358, RAB3GEP"	ENSG00000110514	"MAP kinase activating death domain"	Q8WXG6	11	47269161-47330031	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.3"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 72.8;Cone photoreceptor cells: 117.8;Horizontal cells: 125.5;Rod photoreceptor cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038568	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038568: AB_10795030"	"unprognostic (3.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (6.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.36e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.25e-4)"	7.7	18.2	18.3	11.5	27.6	16.9	8.7	66.3	46.5	9.2	10.8	15.5	13.1	8.6	9.4	8.9	6.9	9.4	8.6	13.8	20.2	18.4	9.8	7.7	11.0	13.2	15.5	19.8	14.0	12.2	18.8	26.7	11.2	20.7	12.5	12.0	16.0	10.2	14.0	16.1	14.0	9.8	10.5	11.3	12.3	13.2	19.4	11.0	14.6	8.4	6.0	12.2	11.0	7.8	3.5	4.1	20.8	5.8	4.5	5.7	4.4	6.5	13.6	14.9	13.3	10.2	7.1	3.3	9.2	12.3	11.7	12.7	9.9	6.2	13.8	2.9	10.0	15.2	12.9	12.0	6.4	10.2	15.3	12.3	24.5	25.2	8.4	7.4	16.6	33.8	6.9	6.9	6.2	7.8	8.0	10.7	8.9	15.7	10.2	10.3	9.1	7.8	17.9	8.9	15.3	9.4	10.8	24.0	9.1	6.1	31.1	23.6	15.3	11.8	14.0	8.1	9.2	11.0	12.7	9.1	11.0	7.0	15.6	6.1	12.1	12.5	7.9	10.2	11.8	10.3	20.8	2.6	4.8	4.8	4.6	4.2	3.5	3.4	4.0	4.1	3.3	4.0	3.1	0.7	4.5	5.8	2.2	5.7	4.4	18.3	27.6	66.3	44.6	20.2	18.4	15.5	19.8	20.7	11.0	11.9	8.6	9.0	3.5	9.5	72.8	22.6	10.2	1.4	3.4	7.0	117.8	3.9	0.0	7.0	11.4	9.5	12.1	0.0	4.2	1.9	6.1	7.5	26.5	5.0	10.1	125.5	15.6	17.8	18.3	4.0	6.6	10.6	10.1	9.0	17.0	13.7	8.8	10.5	12.0	4.2	106.1	6.5	6.2	14.6	21.5	7.2	3.7	6.9	11.2	4.8
MAF1	DKFZp586G1123	ENSG00000179632	"MAF1 homolog, negative regulator of RNA polymerase III"	Q9H063	8	144104499-144107611	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024821, HPA058548"	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA024821: AB_2671696, HPA058548: AB_2683751"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.12e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.02e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.99e-2)"	26.8	23.2	17.5	18.4	17.5	43.6	35.7	20.5	26.3	27.3	47.2	23.7	22.8	19.5	33.0	22.5	34.4	26.1	33.6	72.5	17.3	15.5	24.1	21.4	21.2	28.2	19.7	18.6	36.3	39.8	25.2	20.8	23.8	14.9	36.8	18.9	23.8	28.7	32.3	114.3	18.7	29.8	50.9	17.2	27.7	28.9	30.2	16.2	35.5	40.4	38.7	22.8	35.2	46.7	48.0	39.9	45.1	34.5	33.2	46.2	32.6	24.2	39.1	18.1	18.1	49.6	24.8	14.7	19.1	31.6	29.9	30.6	14.3	27.1	27.0	32.6	31.9	16.6	15.0	24.6	27.0	22.1	23.8	29.8	29.5	26.9	22.3	33.5	12.5	20.3	21.8	31.7	23.9	45.3	33.5	32.2	19.8	22.7	18.4	17.8	57.9	46.6	23.0	13.6	44.2	105.0	18.7	25.4	28.7	18.7	18.3	26.5	22.1	25.4	33.1	30.9	17.7	22.5	19.2	19.3	14.0	31.9	24.6	24.0	22.3	16.9	12.6	23.2	23.4	9.2	15.8	34.5	45.1	28.5	26.8	32.3	40.1	41.0	46.2	39.9	48.0	44.2	41.4	19.9	33.2	27.0	29.8	29.2	32.6	17.5	17.5	20.5	26.3	17.3	15.5	19.7	18.6	14.9	16.2	14.9	17.0	89.7	75.9	82.5	41.2	46.4	7.6	4.0	3.4	41.8	13.7	87.2	89.5	88.1	49.3	67.4	88.9	70.0	94.2	87.3	63.4	114.9	33.3	25.2	87.3	35.0	89.6	44.8	58.6	27.8	81.7	78.7	74.2	166.9	77.1	55.4	88.3	79.3	87.7	90.2	29.0	97.0	72.8	85.0	43.7	78.4	120.7	94.5	78.4	80.6
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.6;parathyroid gland: 154.1"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 322.7;Kupffer cells: 488.8;Macrophages: 252.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 27.4;non-classical monocyte: 36.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 36.7"	"Cell line enhanced"	"Detected in some"		"HSkMC: 16.2;hTCEpi: 34.0;SCLC-21H: 9.3;SiHa: 8.4;U-138 MG: 9.2;U-2197: 13.4;U-87 MG: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	38.3	7.9	3.2	13.0	4.0	17.0	19.5	1.0	9.7	10.6	6.9	3.0	1.2	3.3	5.6	8.9	16.8	7.0	9.2	12.4	3.6	2.3	10.9	14.0	21.9	28.9	4.7	3.4	7.0	6.1	154.1	2.3	9.4	5.0	7.6	3.3	5.6	10.4	2.7	11.0	41.6	7.6	5.5	7.7	87.6	4.7	7.5	3.8	6.9	18.2	20.5	11.4	8.2	10.9	0.0	2.5	0.7	36.7	0.0	0.0	2.5	0.0	0.0	0.0	1.4	0.8	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.5	0.0	0.1	16.2	34.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	3.9	1.4	3.3	0.0	0.0	0.0	0.0	0.3	0.2	9.3	0.7	8.4	0.8	2.0	3.1	0.8	0.1	0.2	9.2	0.1	13.4	0.0	0.0	0.0	0.0	8.9	0.3	0.0	0.1	7.3	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.7	0.0	36.7	0.0	0.0	2.5	3.2	4.0	1.0	9.7	3.6	2.3	4.7	3.4	5.0	3.8	20.8	32.3	6.7	25.3	60.9	14.6	153.6	7.6	0.0	13.6	48.8	23.6	7.5	1.7	2.0	0.6	19.9	50.9	0.0	3.0	2.1	61.9	37.1	10.4	32.6	322.7	3.2	55.5	34.4	488.8	0.7	27.3	252.1	20.3	0.0	13.7	25.8	5.4	24.6	23.0	0.8	8.2	12.9	44.3	0.5	0.9	77.0	10.4	4.4	8.1	17.7
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 48.7"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 4.0;Sertoli cells: 6.5;Spermatocytes: 12.1;Spermatogonia: 8.9;Syncytiotrophoblasts: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"GAMG: 42.1"									"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: AB_2686310"		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	48.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.9	0.8	2.6	0.8	1.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	42.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.9	0.0	0.2	0.0	7.0	2.6	0.8	0.7	0.4	0.7	0.4	0.7	0.5	0.4	0.3	0.9	0.6	0.7	2.6	1.2	0.5	0.8	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	12.1	8.9	0.0	9.4	0.0	0.0	0.0
MAGEA4	"CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336"	ENSG00000147381	"MAGE family member A4"	P43358	X	151912509-151925170	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"placenta: 12.1;testis: 23.5"	"Cell type enriched"	"Detected in some"	7	"Spermatogonia: 190.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 62.8;AN3-CA: 39.2;HMC-1: 74.8;U-2 OS: 20.0;U-266/84: 116.4"									"HPA021942, CAB040535"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB040535: , HPA021942: AB_1853490"						"unprognostic (7.90e-3)"		"unprognostic (6.66e-3)"	"unprognostic (5.39e-1)"	"unprognostic (1.36e-1)"				"unprognostic (5.81e-2)"	"unprognostic (2.94e-2)"		"unprognostic (4.10e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.8	0.0	0.0	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	20.0	0.0	0.3	15.9	116.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	23.4	190.5	0.0	27.6	0.0	0.0	0.0
MAGEA9	"CT1.9, MAGE9, MGC8421"	ENSG00000123584	"MAGE family member A9"	P43362	X	149781930-149787737	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"U-266/70: 29.6;U-266/84: 20.1"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0
MAGEA9B		ENSG00000267978	"MAGE family member A9B"	P43362	X	149581653-149587453	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 14.2"	"Group enriched"	"Detected in some"	22	"Sertoli cells: 6.5;Spermatocytes: 10.7;Spermatogonia: 4.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"OE19: 29.3;RT4: 47.2;U-266/70: 20.4;U-266/84: 25.2"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "															"unprognostic (6.12e-3)"		"unprognostic (3.26e-1)"	0.2	0.0		0.1		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.4		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	14.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	2.2	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	20.4	25.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	10.7	4.8	0.0	0.1	0.0	0.0	0.0
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	44	"testis: 9.0"	"Group enriched"	"Detected in some"	25	"Spermatocytes: 4.7;Spermatogonia: 9.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/70: 37.0"									"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA055743: AB_2682902, HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	9.7	0.0	0.0	0.0	0.0	0.0
MAGEB2	"CT3.2, DAM6, MAGE-XP-2, MGC26438"	ENSG00000099399	"MAGE family member B2"	O15479	X	30215560-30220089	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 35.8"	"Group enriched"	"Detected in some"	11	"Sertoli cells: 12.9;Spermatocytes: 16.1;Spermatogonia: 45.1"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 33.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 26.1;K-562: 18.8;Karpas-707: 22.8;U-2 OS: 27.2;U-266/70: 44.8;U-266/84: 46.8"									"HPA065224, HPA074544, HPA075519"	Enhanced		Approved	Cytosol		NA	Yes			Cytosol		"HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294"					"unprognostic (4.52e-1)"	"unprognostic (2.55e-2)"		"unprognostic (6.39e-2)"	"unprognostic (5.02e-1)"					"unprognostic (6.57e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	0.0	0.0	27.2	0.0	0.0	44.8	46.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	12.9	0.0	16.1	45.1	0.0	0.0	0.0	0.0	0.0
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909388	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 23.5"	"Group enriched"	"Detected in some"	7	"Sertoli cells: 6.5;Spermatocytes: 5.9;Spermatogonia: 14.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 22.9;Karpas-707: 22.9;U-2 OS: 15.4;U-2197: 29.1;U-266/70: 20.9;U-266/84: 18.4"									"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	15.4	29.1	0.0	20.9	18.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	5.9	14.9	0.0	0.0	0.0	0.0	0.0
MAGED1	"DLXIN-1, NRAGE"	ENSG00000179222	"MAGE family member D1"	Q9Y5V3	X	51803007-51902357	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 308.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 83.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043645			Approved	Cytosol		NA	NA			Cytosol		"HPA043645: AB_2678597"	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.14e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.71e-3)"	15.4	57.6	35.3	16.8	52.9	6.9	18.6	34.6	61.8	50.9	18.8	25.9	38.9	15.2	27.6	67.4	13.1	31.6	28.1	32.4	42.2	58.4	22.5	48.6	17.5	13.6	32.2	38.0	30.7	37.2	42.9	69.6	53.5	39.4	35.1	19.3	34.7	38.1	45.5	19.6	12.7	13.4	36.3	25.7	15.9	25.8	33.8	16.1	24.6	35.4	12.5	17.9	23.9	15.8	10.1	28.8	1.5	3.2	7.7	11.6	6.9	3.2	11.9	38.3	33.0	30.3	54.7	20.6	44.2	56.9	24.6	39.0	24.4	11.2	4.6	8.6	83.5	8.8	2.4	34.1	15.7	18.5	4.9	13.2	3.1	0.0	31.6	23.2	11.6	5.8	51.4	5.6	20.7	4.7	43.3	29.3	12.2	4.8	9.2	49.2	29.9	13.2	3.9	30.1	10.7	24.6	13.6	24.8	0.6	25.3	5.9	9.9	55.0	0.0	13.0	6.5	39.2	23.2	2.9	29.1	10.7	27.6	37.6	4.9	6.1	8.9	9.5	41.9	1.0	27.8	0.7	2.2	1.5	11.6	3.2	10.3	9.3	7.6	10.0	6.8	10.1	9.6	11.3	0.7	7.7	2.8	28.8	10.5	6.9	35.3	52.9	34.6	61.8	42.2	58.4	32.2	38.0	39.4	16.1	71.5	28.0	32.1	16.5	10.2	30.8	38.2	40.8	45.5	42.1	33.2	7.9	308.7	24.9	39.2	2.2	19.4	15.3	0.0	43.5	143.1	55.9	27.2	17.3	57.0	89.9	42.9	54.9	52.2	9.4	6.0	40.0	6.3	23.6	4.6	76.3	37.5	33.2	10.5	54.1	29.1	10.5	12.9	17.6	5.6	6.3	7.2	155.3	11.4	21.8	13.6
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427724-76431353	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.9"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 9.4;Horizontal cells: 27.0;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 9.4"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favorable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	2.6	5.8	13.8	3.0	23.5	1.1	3.3	18.7	33.9	4.7	1.9	3.2	0.5	1.5	5.4	3.5	2.3	4.8	2.3	3.9	18.9	20.3	4.1	1.1	2.6	4.1	10.2	22.0	8.4	4.1	15.1	5.1	0.8	19.8	5.9	2.1	2.3	3.4	7.4	2.2	3.3	2.0	4.8	5.4	4.5	2.6	1.3	4.9	1.1	4.0	0.1	3.6	2.4	1.8	1.0	0.0	0.0	0.0	1.5	2.4	0.4	0.2	4.5	4.7	8.9	3.3	1.9	4.1	3.4	3.4	2.9	1.6	1.0	0.7	0.9	1.7	3.0	9.4	3.4	6.9	6.4	2.4	2.2	0.1	0.0	0.0	2.9	0.7	1.8	0.6	1.4	2.9	0.8	0.8	0.1	1.1	4.9	0.3	0.0	4.4	0.6	4.9	0.2	5.6	0.0	6.9	3.9	3.5	0.0	3.7	0.0	0.0	2.4	0.0	0.4	0.6	5.0	2.1	0.1	0.6	4.4	5.6	4.6	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.8	0.8	1.1	2.3	0.0	1.0	1.4	1.3	0.0	1.5	0.0	0.0	0.0	0.4	13.8	23.5	18.7	33.9	18.9	20.3	10.2	22.0	19.8	4.9	3.0	1.6	0.0	0.6	0.5	9.4	1.6	0.0	0.0	1.2	1.8	3.9	0.1	1.7	1.5	0.0	1.0	0.0	0.0	1.3	0.4	0.7	0.2	1.1	0.0	0.1	27.0	0.0	0.6	0.3	0.0	1.4	0.0	0.0	0.0	0.2	4.3	0.8	0.0	4.2	0.9	5.1	19.4	1.4	0.2	0.2	0.1	0.1	4.3	0.0	0.1
MAGEF1		ENSG00000177383	"MAGE family member F1"	Q9HAY2	3	184710367-184712002	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046899, HPA054190"	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA046899: AB_2679859, HPA054190: AB_2682411"	"unprognostic (7.36e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.46e-3)"	"unprognostic (2.34e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (7.59e-4)"	"unprognostic (7.65e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.19e-1)"	10.6	20.4	26.0	16.9	27.3	2.3	21.9	30.4	35.7	27.5	17.6	16.3	15.4	15.3	21.8	33.6	13.1	21.2	22.5	20.2	23.3	31.6	23.5	16.5	16.7	17.1	22.4	22.9	25.8	18.1	26.1	40.9	20.4	27.5	28.0	15.8	21.7	22.4	25.9	25.4	13.9	12.3	17.5	19.0	13.3	23.8	8.7	16.3	14.3	27.0	14.1	15.2	18.4	14.0	5.5	7.8	3.2	1.9	1.6	8.6	1.1	27.2	7.2	29.8	18.4	10.9	4.4	20.5	10.4	11.5	17.8	17.9	17.7	10.2	18.9	21.9	9.4	29.4	19.5	15.2	9.0	16.5	30.5	21.3	5.5	10.2	24.6	10.7	8.6	9.1	10.1	11.5	11.3	3.6	8.5	4.2	6.3	9.5	13.2	10.4	34.5	3.2	19.3	18.8	17.5	12.6	9.5	24.1	5.8	13.0	18.3	33.0	31.6	16.1	27.4	23.5	17.4	43.6	3.2	2.9	11.7	20.7	13.6	20.1	27.6	20.3	25.2	9.3	3.1	15.1	0.1	1.9	3.2	2.3	0.5	1.1	3.8	3.2	2.6	7.8	5.5	8.6	4.4	0.3	1.6	0.3	0.5	2.9	1.1	26.0	27.3	30.4	35.7	23.3	31.6	22.4	22.9	27.5	16.3	29.8	19.6	13.8	47.1	16.7	60.4	16.9	28.1	18.7	10.3	40.1	9.8	85.4	124.3	47.5	1.0	9.8	8.5	0.0	36.4	48.2	33.6	36.6	5.7	25.4	53.7	60.4	47.4	18.4	4.6	1.6	51.2	10.1	23.6	42.3	40.7	58.4	28.8	28.1	53.7	49.6	42.7	32.3	27.8	11.3	4.3	12.0	50.6	7.5	29.6	57.8
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031852, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031852: AB_2674074, HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	18.0	6.0	10.1	6.4	9.8	1.0	16.5	38.6	16.8	6.9	11.2	10.1	25.7	10.7	11.6	7.6	9.4	12.6	19.7	11.1	9.4	11.8	14.3	17.6	13.3	2.9	8.8	10.4	4.3	16.7	18.7	13.1	11.1	9.6	9.2	9.5	7.7	17.4	37.9	7.7	13.0	11.6	7.9	8.3	13.9	19.8	10.7	7.7	0.6	23.2	5.8	4.4	6.9	13.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.8	1.5	8.8	0.9	1.8	1.3	3.9	4.9	4.2	1.9	2.9	10.5	2.5	0.0	0.7	5.8	1.5	0.9	2.4	1.7	3.0	0.0	1.4	24.8	3.0	7.0	1.1	0.0	0.8	1.9	1.5	6.4	1.3	4.9	4.2	3.3	10.5	0.0	1.9	2.1	0.0	0.0	11.8	8.4	1.5	0.0	2.5	0.6	2.3	9.4	2.8	7.7	1.9	2.3	0.0	6.0	4.5	0.0	1.1	6.0	4.4	1.5	2.0	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	9.8	38.6	15.5	9.4	11.8	8.8	10.4	9.6	7.7	71.5	24.3	2.2	16.9	19.8	93.8	31.3	91.7	37.5	30.7	22.7	70.7	11.8	3.3	33.9	112.5	42.5	30.4	0.0	28.1	2.1	7.3	19.7	1.1	50.5	3.7	219.3	35.1	72.4	7.8	11.8	6.1	1.9	5.0	1.0	37.8	13.0	33.5	25.1	8.1	12.4	23.8	32.3	13.0	16.9	9.7	16.4	4.2	1.0	22.1	10.8
MAGIX	"FLJ21687, JM10, PDZX"	ENSG00000269313	"MAGI family member, X-linked"		X	49162564-49168483	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 39.7;Proximal tubular cells: 31.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"neutrophil: 7.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.7;RT4: 15.5;SK-BR-3: 7.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA007390, HPA035302"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome"		NA	NA			Nucleoplasm	"Mitotic chromosome"	"HPA007390: , HPA035302: AB_10603015"	"unprognostic (1.11e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.64e-6)"	"unprognostic (6.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"prognostic favorable (6.91e-9)"	"unprognostic (4.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (2.10e-4)"	0.5	0.3	0.0	0.9	1.2	0.5	0.0	3.9	1.2	1.6	1.2	0.5	8.0	1.0	1.5	4.0	0.7	1.8	6.2	2.6	1.8		5.0	4.2	1.1	0.0	0.0	0.0	0.5	5.9	3.1	0.0	0.4	1.0	2.0	0.4	1.1	9.0	5.7	1.2	0.8	0.6	0.0	0.8	0.3	4.5	0.0	0.0	0.3	0.7	0.8	0.7	0.8	0.0	1.2	2.6	7.9	2.0	1.2	1.1	1.1	0.3	2.4	0.5	0.6	0.7	0.2	1.8	0.3	0.4	0.4	0.3	1.4	6.7	0.7	0.6	0.7	0.9	1.5	0.4	1.5	0.0	1.9	2.2	2.8	3.8	0.8	0.3	0.7	5.9	0.7	0.2	0.5	0.1	0.7	0.6	1.0	0.4	2.5	0.5	0.8	0.6	2.0	0.6	1.8	1.2	0.4	0.1	1.2	1.2	15.5	3.0	0.7	1.3	7.1	0.6	0.4	5.6	0.6	0.3	0.8	1.8	0.7	0.5	1.7	0.9	0.5	2.9	0.9	2.2	4.3	2.0	3.3	0.2	1.8	0.8	1.1	0.9	0.1	1.3	1.2	0.6	1.1	7.9	1.2	1.8	2.6	0.1	1.1											3.0	4.8	0.9	6.6	2.9	7.2	6.5	10.2	10.7	3.4	12.2	2.0	1.8	39.7	9.3	0.2	2.2	29.3	0.0	18.2	3.7	1.9	6.2	0.0	29.9	4.4	7.9	16.8	3.1	1.6	0.0	0.6	4.7	1.7	6.4	17.6	7.3	10.6	22.1	0.4	31.6	9.2	0.0	2.3	2.1	1.5	3.9	3.2	2.2	12.3	8.9
MAIP1	"C2orf47, DKFZp666A212, FLJ22555"	ENSG00000162972	"Matrix AAA peptidase interacting protein 1"	Q8WWC4	2	199955317-200008540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 31.5;Ductal cells: 26.6;Extravillous trophoblasts: 27.2;Proximal tubular cells: 51.4;Syncytiotrophoblasts: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064013, HPA072231"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA064013: AB_2685175, HPA072231: AB_2732196"	"unprognostic (4.89e-2)"	"unprognostic (7.36e-2)"	"unprognostic (7.40e-3)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.02e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-2)"	11.3	16.7	10.5	8.6	10.7	14.4	18.5	13.6	14.4	7.1	12.6	5.9	9.2	18.3	8.2	7.5	11.6	8.3	11.0	16.2	8.3	8.1	26.8	39.4	11.3	14.6	10.3	8.4	7.6	14.7	7.6	7.2	10.5	9.0	8.5	11.9	6.1	9.3	8.8	18.1	9.2	16.3	8.8	7.8	8.7	11.4	5.2	10.4	13.6	9.1	12.7	8.9	8.6	7.8	13.2	16.9	9.0	13.1	8.9	14.0	8.3	12.9	12.1	11.0	8.6	9.8	9.9	25.4	11.8	11.4	17.6	16.9	32.8	11.8	8.6	17.0	8.1	14.6	14.4	16.1	12.6	16.6	13.4	18.5	14.5	11.2	29.9	13.2	19.8	10.3	10.5	10.4	11.6	12.6	10.1	11.1	16.8	18.9	11.2	11.4	17.1	14.9	18.5	14.0	13.8	29.2	14.4	13.0	17.2	20.7	16.9	12.5	8.7	12.1	13.8	21.4	14.5	12.2	12.2	9.8	10.3	14.8	8.8	13.0	10.7	12.4	18.6	15.5	11.6	10.5	7.2	13.1	9.0	11.4	12.5	14.0	13.2	11.6	8.2	16.9	12.0	11.1	9.4	2.2	8.9	11.9	13.7	13.6	8.3	10.5	10.7	13.6	14.4	8.3	8.1	10.3	8.4	9.0	10.4	8.9	12.2	0.0	0.0	0.0	0.0	0.0	0.0	10.7	9.1	3.5	0.0	24.6	31.5	26.6	0.0	0.0	0.0	0.0	24.5	27.2	0.0	0.0	3.5	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	11.8	0.0	0.0	20.2	0.0	0.0	51.4	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0
MAL		ENSG00000172005	"Mal, T cell differentiation protein"	P21145	2	95025677-95053996	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"esophagus: 447.4"	"Cell type enhanced"	"Detected in many"	24	"Collecting duct cells: 354.2;Distal tubular cells: 200.6;Muller glia cells: 85.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1"	"Lineage enriched"	"Detected in many"	44	"T-cells: 57.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 45.9;MOLT-4: 64.2;RPMI-8226: 22.7;RPTEC TERT1: 232.7"	"Low region specificity"	"Detected in all"							HPA065691			Approved	"Golgi apparatus,Centrosome"		NA	NA			"Golgi apparatus"	Centrosome	"HPA065691: AB_2685533"	"unprognostic (1.57e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (5.18e-6)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.89e-2)"	"prognostic favorable (3.96e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.57e-1)"	2.3	2.0	14.3	3.5	21.8	3.7	2.0	1.8	20.6	35.8	3.7	43.2	0.4	2.0	1.8	3.4	447.4	3.4	2.2	3.3	18.2	8.3	53.1	1.7	4.3	5.9	27.4	13.2	2.0	1.9	1.6	0.2	2.2	11.8	2.5	2.9	2.8	42.5	3.9	2.0	3.7	2.4	2.1	27.6	3.2	9.3	1.7	27.2	35.0	5.8	56.1	90.1	2.6	64.8	0.6	0.2	0.4	0.1	1.3	57.9	13.7	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	22.7	232.7	5.8	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.4	0.6	42.0	7.5	0.0	0.5	57.9	26.4	0.4	1.3	0.0	0.2	40.1	13.7	14.3	21.8	1.8	20.6	18.2	8.3	27.4	13.2	11.8	27.2	0.0	0.0	0.0	0.1	1.0	1.1	8.1	0.0	0.0	0.0	354.2	3.9	0.1	200.6	0.1	5.3	0.1	0.0	0.0	0.0	0.0	1.9	0.2	1.1	0.0	0.1	4.8	0.0	4.3	0.0	16.2	0.9	0.5	16.9	0.0	0.0	85.5	0.1	0.0	0.0	2.8	2.5	6.5	1.5	0.0	0.4	0.9	0.2	17.0	0.0	0.7
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671386-58754477	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 80.5;monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 51.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: AB_2680389"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	11.2	3.9	4.1	21.7	5.6	10.2	10.6	9.1	6.8	11.0	10.7	3.9	10.9	5.5	8.1	10.5	16.4	6.6	8.1	8.7	4.0	4.3	14.9	10.5	14.3	29.0	4.1	1.8	8.1	6.2	10.0	9.3	8.8	4.9	18.1	7.9	7.5	10.7	8.4	10.7	12.6	12.2	6.6	6.2	19.9	6.2	11.8	4.8	22.4	7.9	12.4	24.0	9.6	12.3	6.3	3.6	1.2	1.7	1.6	4.8	1.1	7.5	10.8	13.2	3.3	2.6	5.9	6.0	13.6	9.6	11.8	10.1	8.8	9.8	12.0	6.1	16.8	8.5	7.4	5.7	5.6	14.6	8.1	3.1	4.2	7.7	14.1	4.3	8.6	5.8	3.7	11.9	9.3	9.4	6.2	2.5	3.4	7.0	21.0	6.4	2.4	1.9	3.7	3.3	3.1	3.7	6.5	7.8	8.5	51.8	3.1	1.4	3.0	7.5	3.8	5.1	9.8	3.8	5.0	3.5	15.3	6.7	4.5	12.5	18.8	22.2	10.5	6.1	6.5	6.0	0.8	1.5	1.0	2.7	1.7	2.1	3.6	4.8	2.9	2.2	6.3	4.3	2.8	1.2	1.6	1.6	3.6	2.9	1.1	4.1	5.6	9.1	6.8	4.0	4.3	4.1	1.8	4.9	4.8	20.8	19.2	15.7	28.7	29.3	12.4	13.1	10.2	6.7	7.9	10.4	80.5	5.2	3.3	14.7	9.8	21.6	6.8	0.0	7.2	5.0	8.0	52.3	31.1	8.9	10.4	52.4	6.4	9.8	16.4	5.3	9.5	23.0	11.8	107.4	8.2	29.6	11.9	20.1	6.7	17.3	17.2	19.4	12.0	33.4	32.5	21.7	7.6	22.4	9.1	29.1
MAMDC2	MGC21981	ENSG00000165072	"MAM domain containing 2"	Q7Z304	9	70043581-70226970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 37.9;Leydig cells: 89.5;Peritubular cells: 77.1;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.6"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.0;HHSteC: 24.0;LHCN-M2: 29.9;TIME: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021814, HPA022249"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Nuclear speckles, Plasma membrane"		"HPA021814: AB_1853508, HPA022249: AB_2139157"	"unprognostic (1.88e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (2.79e-3)"	9.0	4.3	0.6	11.1	0.5	0.0	14.7	0.6	0.8	32.3	27.7	0.3	9.1	4.3	40.7	33.7	31.6	28.7	44.9	13.5	0.6	0.6	2.0	1.0	42.4	2.3	0.7	0.8	35.5	2.4	1.0	0.8	2.6	1.3	13.9	6.6	16.1	5.4	10.8	15.5	5.0	14.2	46.3	2.6	12.0	10.7	20.0	0.0	0.3	6.8	24.6	6.1	36.4	27.5	0.0	0.3	0.0	0.0	2.6	0.6	0.0	0.1	0.0	0.2	0.0	23.0	7.8	0.7	4.5	2.0	1.0	1.9	0.0	0.5	0.0	0.3	0.8	0.6	3.6	0.0	0.3	0.9	0.0	0.0	0.0	7.4	0.0	24.0	0.0	0.0	1.4	0.2	0.6	0.4	8.2	1.9	0.0	0.0	0.2	29.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.6	2.8	10.1	0.0	0.3	0.0	0.0	0.0	0.0	8.9	0.0	0.0	28.7	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.8	0.6	0.6	0.7	0.8	1.3	0.0	0.0	1.0	0.0	0.4	5.5	0.4	3.1	0.0	0.0	0.0	3.5	3.9	0.1	0.0	0.0	37.9	2.9	0.0	0.0	0.2	5.7	21.0	0.1	1.1	0.0	2.6	0.0	0.0	0.0	0.0	9.1	89.5	0.7	10.1	0.0	0.0	15.4	0.3	0.0	77.1	0.3	0.2	38.8	25.0	0.3	0.4	4.3	0.2	0.0	0.0	0.0
MAMDC4	"AEGP, DKFZp434M1411"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;liver: 48.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	10	"cerebellum: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB026377: , HPA059977: AB_2684186"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favorable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.0	1.6	1.2	1.9	1.5	1.4	1.2	14.9	1.2	1.2	2.3	1.2	1.2	5.0	1.2	1.2	1.2	1.7	1.2	1.6	1.2	0.4	2.6	48.9	1.2	2.5	1.2	1.2	1.2	3.4	0.5	7.2	1.2	1.2	3.2	0.9	1.2	3.5	1.4	1.7	1.5	6.1	1.2	1.2	5.1	2.3	6.5	1.2	1.2	5.1	1.2	1.2	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	1.6	2.6	1.5	2.9	0.6	0.1	18.9	2.7	0.3	0.3	0.6	2.0	1.6	1.4	0.6	0.7	0.8	2.2	0.3	1.3	0.0	2.1	0.9	0.8	5.3	2.3	1.2	0.2	4.9	0.8	1.7	1.4	0.6	1.4	0.6	2.5	2.7	1.2	0.2	4.2	1.0	3.7	1.4	1.1	0.7	1.6	0.4	2.5	0.9	1.4	1.7	2.1	0.6	1.3	1.1	1.0	4.4	0.9	0.8	7.6	4.8	1.5	0.4	3.1	1.6	0.4	1.7	2.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	14.9	1.2	1.2	0.4	1.2	1.2	1.2	1.2	0.0	4.3	0.0	0.8	0.7	5.4	6.2	12.7	2.7	0.0	1.8	0.0	2.2	1.7	0.8	1.7	1.4	19.8	0.0	4.4	2.8	2.6	1.3	0.0	16.6	2.4	15.9	0.0	2.5	2.4	1.9	1.7	2.2	0.0	1.0	19.5	2.6	0.9	12.5	1.4	2.1	7.4	0.0	1.4	1.2	2.2	0.4	1.9	1.3	10.3	0.7
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343180	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 86.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.9"					"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	26.3	5.5	10.2	16.1	8.1	4.2	19.7	27.8	13.4	15.8	9.2	10.4	8.4	4.3	11.2	8.5	9.3	11.7	10.8	8.9	10.5	6.9	13.8	3.5	15.0	10.9	6.9	3.4	11.7	8.2	13.3	15.2	18.8	9.3	12.3	8.9	10.8	16.6	12.3	4.4	14.2	8.9	10.2	14.4	16.8	6.5	4.3	10.6	21.2	11.8	4.8	13.6	16.0	15.3	2.1	1.2	4.7	1.1	4.2	6.4	2.0	5.6	1.1	9.8	2.6	10.2	11.8	2.1	6.5	9.8	4.3	4.5	0.7	12.0	1.2	15.5	15.1	2.3	5.2	2.0	6.3	6.0	27.9	0.7	0.7	2.0	2.1	6.0	0.0	0.0	17.2	0.6	7.7	4.5	8.0	2.4	0.1	3.1	1.8	7.6	0.4	0.1	1.5	1.0	2.9	1.8	1.9	1.8	6.5	6.4	8.0	0.1	0.9	2.4	1.0	2.7	3.3	0.9	0.3	10.6	7.6	1.8	2.6	4.1	1.2	0.2	1.8	3.6	1.1	13.9	0.1	1.1	0.0	1.5	0.6	2.6	1.9	3.2	4.1	1.2	2.1	6.4	4.3	4.7	4.2	0.7	0.9	1.2	2.0	10.2	8.1	27.8	7.0	10.5	6.9	6.9	3.4	9.3	10.6	14.9	7.5	12.1	17.3	17.3	40.8	4.1	12.7	18.7	19.4	12.2	86.4	10.3	10.0	14.8	1.1	20.5	18.4	0.0	0.4	20.6	19.5	17.4	1.1	0.2	16.3	0.0	6.4	6.7	12.6	1.4	8.1	15.7	11.8	16.2	6.2	24.7	9.5	14.4	8.1	11.8	21.9	32.3	17.3	0.5	0.6	11.8	10.9	16.0	11.8	13.1
MAMSTR	"FLJ36070, MASTR"	ENSG00000176909	"MEF2 activating motif and SAP domain containing transcriptional regulator"	Q6ZN01	19	48712742-48719721	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.9"	"Cell type enhanced"	"Detected in many"	5	"Melanocytes: 6.8;Peritubular cells: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.6;RH-30: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049765			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049765: AB_2680870"	"unprognostic (6.00e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.50e-3)"	"unprognostic (4.34e-4)"	"unprognostic (2.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.39e-2)"	2.4	14.7	1.8	1.0	1.9	0.5	0.9	8.0	4.3	7.9	1.0	2.2	1.1	0.7	13.5	3.5	2.7	4.8	1.0	2.7	1.6	1.0	0.7	0.4	0.9	0.7	1.0	4.3	9.5	1.0	2.7	2.7	1.4	0.7	4.7	0.8	3.3	1.5	1.7	53.9	1.7	0.9	3.6	0.8	2.9	0.7	7.7	1.1	0.0	0.9	9.2	1.1	1.4	2.4	4.1	2.9	1.1	0.9	0.7	4.0	0.6	0.6	1.4	1.5	3.8	3.0	5.2	1.5	5.1	4.1	2.5	4.0	1.5	1.0	0.7	0.3	4.8	1.5	1.1	0.2	0.9	1.0	0.5	1.7	0.3	0.5	7.6	1.6	0.1	1.1	3.1	1.0	3.5	0.5	3.5	0.9	1.5	0.3	1.0	1.6	0.7	1.2	0.6	0.1	1.2	1.1	1.4	18.3	0.4	0.3	0.3	1.7	3.1	0.8	0.4	0.3	0.4	0.6	0.0	0.3	5.2	0.9	4.2	0.7	1.1	0.7	0.5	1.9	0.6	1.0	0.0	0.5	1.1	3.9	0.9	2.5	3.1	4.0	3.8	1.0	4.1	4.0	3.5	0.4	0.7	0.9	2.9	1.7	0.6	1.8	1.9	8.0	4.3	1.6	1.0	1.0	4.3	0.7	1.1	0.0	0.0	0.0	1.5	0.8	1.7	2.8	0.0	0.0	2.3	1.8	2.0	0.8	5.0	1.4	0.4	1.6	0.4	0.0	0.9	2.4	2.5	0.5	0.0	0.0	1.0	0.0	0.0	2.5	0.0	1.4	5.2	1.6	6.8	1.8	0.3	4.8	0.5	0.0	5.6	0.6	2.5	0.0	2.2	0.5	1.7	0.6	0.8	0.9	0.6	1.0
MAN2A2	"HsT19662, MANA2X"	ENSG00000196547	"Mannosidase alpha class 2A member 2"	P49641	15	90902218-90922584	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.4;neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077930			Approved	"Cytoplasmic bodies"		NA	NA		30000000	"Cytoplasmic bodies"		"HPA077930: AB_2732363"	"unprognostic (5.17e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (7.55e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.33e-2)"	17.8	12.1	15.9	11.5	24.3	58.1	17.3	33.7	31.2	7.2	9.9	52.4	6.3	12.0	8.9	9.8	7.6	8.0	9.4	22.7	17.8	14.0	8.1	16.7	13.3	12.4	31.6	19.7	9.7	24.0	13.0	15.2	12.4	31.0	9.2	9.0	17.2	20.6	12.6	41.8	14.8	13.0	7.6	33.1	19.1	12.4	12.7	28.3	3.8	13.8	2.7	9.1	7.5	10.7	1.5	2.1	10.0	3.2	0.1	1.4	1.5	5.8	6.1	4.3	10.2	13.0	3.5	8.4	4.3	3.9	4.5	3.5	4.9	4.4	0.8	10.6	5.0	4.1	6.7	4.5	2.5	2.8	14.5	10.6	40.0	9.2	3.3	4.3	5.8	21.7	2.5	4.7	5.4	4.4	9.0	5.9	10.7	15.0	5.3	2.0	7.9	3.8	11.6	1.4	9.7	1.9	5.2	4.1	6.1	5.6	14.1	10.4	6.0	5.9	11.1	8.4	4.5	5.2	19.1	5.0	3.7	4.0	4.5	5.6	8.1	24.9	2.1	4.3	8.5	6.2	8.4	1.6	0.6	1.4	1.1	0.9	1.0	0.6	0.8	0.3	1.5	0.4	0.4	10.0	0.1	3.2	2.1	1.3	1.5	15.9	24.3	33.7	31.2	17.8	14.0	31.6	19.7	31.0	28.3	11.9	23.5	5.6	2.9	5.4	24.8	12.6	7.6	5.3	10.3	8.7	25.5	7.3	0.0	3.9	5.9	7.9	8.1	23.3	5.6	1.8	6.4	5.8	15.1	19.2	5.4	23.8	4.1	7.4	12.2	5.2	6.4	13.5	28.7	10.0	7.2	18.0	4.1	5.7	4.6	3.0	69.2	12.9	8.5	8.8	6.1	4.1	6.3	8.7	7.9	3.0
MANBAL	dJ1141E15.2	ENSG00000101363	"Mannosidase beta like"	Q9NQG1	20	37289638-37317260	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052348	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA052348: AB_2681795"	"unprognostic (1.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.21e-3)"	"prognostic unfavorable (7.07e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.70e-2)"	17.3	25.2	19.6	10.7	27.6	2.9	29.8	11.4	32.7	22.5	22.1	15.9	21.9	17.0	26.7	29.7	22.1	28.9	23.3	13.9	20.8	20.1	19.0	14.5	15.1	19.3	18.9	23.2	28.5	21.4	15.1	16.9	16.1	22.1	24.0	20.3	27.5	16.6	32.9	7.1	19.8	15.6	33.5	13.4	11.1	18.7	17.6	11.2	9.8	23.2	13.7	13.7	20.5	28.3	18.0	21.7	25.4	19.3	14.5	17.3	11.1	17.2	33.9	17.3	17.4	28.4	20.7	15.0	24.1	25.2	23.4	18.5	39.9	23.6	4.4	29.0	29.3	23.9	23.8	16.3	37.7	16.1	3.3	16.9	4.7	14.2	35.4	30.7	4.9	3.0	22.5	26.8	21.7	36.1	23.6	16.3	5.9	7.5	4.9	23.3	20.3	6.2	6.5	13.7	29.0	31.8	3.7	22.7	5.2	22.2	24.1	16.6	19.0	24.5	36.9	19.8	15.5	24.8	8.0	17.8	43.2	16.2	24.2	18.5	6.6	8.9	3.7	31.0	2.7	22.2	9.2	17.0	23.7	11.8	19.3	13.6	18.0	14.2	14.0	15.5	17.8	17.3	16.6	25.4	14.5	15.1	21.7	9.3	11.1	19.6	27.6	11.4	32.7	20.8	20.1	18.9	23.2	22.1	11.2	23.8	31.4	8.3	66.3	26.8	21.0	16.9	33.1	13.4	25.0	41.8	3.9	82.3	33.2	65.8	4.1	25.8	22.5	0.0	96.6	107.8	49.0	70.0	7.0	18.7	26.4	19.1	29.3	30.7	12.6	5.7	43.4	19.2	43.9	21.6	32.4	50.8	77.2	44.8	64.3	47.6	11.3	19.4	44.2	23.2	48.1	26.6	64.3	10.7	32.7	98.7
MANEAL	FLJ31434	ENSG00000185090	"Mannosidase endo-alpha like"	Q5VSG8	1	37793802-37801137	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.6;Horizontal cells: 25.4;Intestinal endocrine cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.6"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063423			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		24000	"Golgi apparatus"		"HPA063423: AB_2685011"	"unprognostic (8.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.92e-2)"	"prognostic favorable (5.28e-4)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.26e-1)"	1.6	9.5	12.3	2.6	15.2	0.4	6.4	11.2	21.7	4.1	7.6	6.6	2.4	4.5	2.6	8.8	4.8	3.8	2.4	1.5	12.0	20.3	3.8	11.4	3.9	1.5	10.4	9.6	1.8	12.8	6.2	16.2	1.3	15.4	5.6	8.2	4.1	4.4	3.8	4.6	5.2	4.4	3.1	6.2	1.9	6.3	3.5	3.8	0.8	7.3	1.8	2.4	2.7	2.1	0.6	0.3	0.1	0.4	0.0	3.6	0.6	8.1	10.4	1.9	20.1	2.6	0.9	18.2	1.5	9.0	7.8	3.4	17.2	19.3	13.5	6.7	1.0	9.3	1.8	3.8	2.0	2.8	16.0	8.2	10.0	9.4	13.7	0.2	14.2	8.3	0.3	10.8	0.4	0.3	11.0	0.2	2.4	5.8	10.8	1.2	16.0	3.9	0.0	6.3	19.4	11.0	6.2	13.8	15.8	4.6	21.6	50.0	15.1	21.9	0.7	8.1	0.4	9.6	1.5	1.2	11.1	6.8	10.7	13.9	15.6	14.7	4.5	1.8	4.7	8.2	0.0	0.0	0.0	1.5	0.1	3.6	0.6	0.7	0.8	0.0	0.6	0.0	1.2	0.1	0.0	0.4	0.3	0.6	0.6	12.3	15.2	11.2	21.7	12.0	20.3	10.4	9.6	15.4	3.8	3.0	2.4	0.8	0.9	0.5	15.6	0.7	2.5	0.0	0.0	3.5	3.9	0.1	0.0	1.5	0.2	0.4	1.1	0.0	5.0	1.3	0.3	1.2	0.0	2.9	0.8	25.4	29.2	0.0	0.3	0.0	0.3	0.2	3.3	0.0	4.5	4.1	3.2	0.0	0.0	0.2	8.4	0.0	0.4	0.0	1.4	0.0	0.1	0.0	3.0	1.1
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350541	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	24	"neutrophil: 37.5"	"Lineage enriched"	"Detected in many"	36	"granulocytes: 37.5"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 27.2;OE19: 28.5;RPTEC TERT1: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		28000000	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	13.1	8.8	9.7	5.1	13.7	4.2	14.7	10.1	18.4	13.5	17.8	7.5	12.9	13.4	15.1	14.1	27.3	11.2	19.3	7.9	9.2	7.6	9.5	7.6	8.4	6.6	6.9	9.0	11.3	26.4	18.5	19.5	11.0	9.0	15.0	18.5	12.8	42.6	15.2	3.6	13.3	13.3	14.4	5.8	8.4	21.3	9.1	6.2	0.0	9.5	16.7	18.2	12.6	12.9	0.2	0.2	37.5	0.5	0.2	1.0	0.1	0.1	3.0	0.9	0.0	3.1	3.0	3.3	2.1	2.5	1.1	1.4	2.5	9.7	0.0	2.3	2.0	1.1	0.4	3.8	1.7	0.8	0.0	3.4	4.3	3.8	2.0	0.5	0.6	1.2	1.9	2.9	0.7	0.5	7.6	27.2	0.1	2.7	0.0	0.3	5.7	0.0	0.3	3.4	28.5	1.6	0.1	0.0	0.0	14.1	9.9	1.3	5.4	1.1	9.1	3.1	1.6	8.2	2.7	10.6	1.5	1.3	0.4	2.8	0.2	0.1	1.4	1.1	0.0	1.1	1.5	0.5	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.2	1.0	0.1	37.5	0.2	0.1	0.0	0.0	0.1	9.7	13.7	10.1	18.4	9.2	7.6	6.9	9.0	9.0	6.2	8.9	20.5	6.9	7.0	3.5	6.8	2.1	28.1	18.7	6.8	22.7	7.9	28.7	1.7	15.0	0.8	20.4	18.1	0.0	33.2	5.4	6.9	10.2	2.3	7.5	6.5	9.5	20.8	30.1	5.9	1.8	12.7	1.4	0.0	1.0	32.2	11.7	15.8	28.1	15.6	1.6	12.6	0.0	4.7	1.7	1.5	4.1	14.2	4.4	25.5	7.2
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 103.6"	"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 71.0;Horizontal cells: 282.9;Peritubular cells: 71.8"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	74	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in single"	74	"dendritic cells: 12.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.8;BJ hTERT+: 21.4;fHDF/TERT166: 32.0;hTEC/SVTERT24-B: 20.4;U-87 MG: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol		No	No			Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (1.09e-5)"	"prognostic unfavorable (1.66e-5)"	5.2	7.9	43.6	5.4	42.8	2.5	4.3	24.5	103.6	10.5	5.4	18.3	1.0	3.0	5.6	4.3	4.8	9.1	5.9	14.8	40.9	30.2	2.8	1.9	3.4	2.7	34.7	31.3	7.1	2.7	4.1	4.4	4.4	56.2	6.7	5.3	3.1	2.5	9.6	4.5	3.1	3.2	14.5	21.4	2.6	2.7	5.4	12.6	6.5	3.7	0.1	2.7	6.3	2.8	0.0	12.3	0.0	0.0	0.0	0.1	0.2	0.1	0.8	3.9	2.2	21.8	15.0	0.0	12.5	21.4	3.7	3.6	1.5	0.0	0.0	5.4	32.0	1.1	0.1	5.2	0.0	2.1	1.8	0.5	4.8	1.2	0.1	2.1	0.1	2.0	11.2	0.0	20.4	0.1	5.6	2.7	14.2	7.9	0.1	14.8	0.1	8.7	0.2	2.8	0.0	0.3	2.4	11.3	0.0	0.0	0.0	12.2	3.7	0.4	0.0	0.1	5.4	0.8	0.2	0.5	11.9	4.0	3.9	0.1	0.0	0.5	1.7	43.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.2	43.6	42.8	24.5	63.1	40.9	30.2	34.7	31.3	56.2	12.6	3.0	0.6	0.0	1.1	4.8	35.3	48.5	0.0	71.0	12.5	3.5	23.6	0.3	0.0	0.4	10.6	4.3	0.0	0.0	0.0	0.6	30.1	0.7	6.9	0.0	1.9	282.9	10.9	4.9	0.8	5.2	47.2	1.4	8.5	0.0	0.0	15.3	1.2	0.0	71.8	0.3	20.6	32.3	49.5	9.2	27.3	3.6	0.9	0.7	0.0	0.5
MAP1LC3A	"ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3"	ENSG00000101460	"Microtubule associated protein 1 light chain 3 alpha"	Q9H492	20	34546854-34560345	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 529.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 30.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in many"		"HHSteC: 19.7;HSkMC: 29.8;SCLC-21H: 19.0;SK-BR-3: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007649, CAB037174, HPA042824, HPA052474, HPA052484"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB037174: AB_1079382, HPA007649: AB_1853943, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (5.31e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.76e-1)"	29.8	15.1	38.3	10.3	33.6	10.7	16.8	45.6	59.8	15.8	22.7	17.8	9.6	24.2	16.1	15.8	13.6	16.1	18.7	30.3	39.0	46.8	15.3	31.9	11.8	20.4	41.6	46.7	11.9	20.7	17.8	26.6	9.7	38.3	16.9	16.2	13.6	14.2	15.4	29.7	23.3	26.8	18.8	29.0	12.1	13.5	15.7	18.2	1.1	17.6	10.2	24.5	13.0	13.5	3.4	1.4	30.6	1.6	1.1	4.0	1.0	0.0	1.6	1.9	0.0	12.8	17.9	0.0	9.4	9.0	7.0	6.7	0.0	0.1	0.0	0.1	9.5	14.6	1.9	0.0	3.5	1.4	2.1	0.7	0.0	6.8	0.0	19.7	0.0	4.2	29.8	0.4	4.7	1.7	0.0	4.2	0.0	0.0	0.0	7.5	0.0	0.0	0.2	0.6	1.3	1.8	0.0	0.0	0.0	0.0	0.0	19.0	10.9	10.7	26.4	0.0	8.1	0.1	7.8	7.2	15.0	0.1	3.0	4.0	0.0	2.0	0.0	9.9	0.0	6.2	1.3	1.3	3.6	1.9	1.6	1.4	3.4	2.0	2.0	0.4	1.6	0.6	1.2	30.6	1.1	0.6	1.4	4.0	1.0	38.3	33.6	45.6	59.3	39.0	46.8	41.6	46.7	38.3	18.2	0.0	10.0	22.9	100.3	51.3	101.3	26.0	38.2	0.0	4.5	43.6	80.5	21.4	96.2	37.2	114.7	50.7	91.8	0.0	21.1	13.1	62.2	110.0	18.4	30.0	30.5	66.7	158.5	72.4	15.0	529.1	88.1	21.5	59.1	34.3	62.1	64.8	36.7	74.8	102.2	83.7	109.6	135.8	103.0	48.2	14.0	44.9	177.1	20.3	71.0	69.8
MAP1LC3B	ATG8F	ENSG00000140941	"Microtubule associated protein 1 light chain 3 beta"	Q9GZQ8	16	87383995-87404779	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037216, HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253"	"unprognostic (4.70e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.21e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.98e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (2.77e-7)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	35.8	36.4	37.4	15.3	34.6	89.0	35.9	58.5	46.6	21.2	18.7	25.8	22.9	11.1	22.7	20.0	19.5	17.5	24.5	41.0	35.6	40.5	24.7	22.2	20.6	22.3	49.0	40.2	19.6	15.9	27.9	20.5	31.2	46.7	19.6	20.4	18.6	19.6	22.4	67.4	22.9	13.6	28.3	43.1	18.0	15.8	27.5	28.8	13.6	27.2	23.1	20.9	22.0	31.9	15.5	15.8	50.0	18.6	20.8	21.8	19.9	10.5	6.1	12.0	10.9	36.2	28.1	8.0	20.9	24.0	16.5	11.4	9.9	7.7	6.8	16.1	28.3	18.3	9.6	17.5	13.2	23.5	8.9	15.4	7.1	7.8	16.7	60.1	5.1	8.0	37.3	44.0	25.6	61.3	24.9	19.5	10.6	19.0	14.6	27.8	10.9	9.0	11.4	12.6	4.8	14.9	14.3	8.0	6.7	22.0	5.0	9.8	11.3	32.2	5.4	40.3	16.7	8.9	6.2	24.6	17.9	11.5	16.2	11.7	19.4	23.7	24.9	25.4	12.3	12.8	48.1	18.6	42.0	17.5	16.5	17.8	15.5	16.9	17.7	14.4	12.8	13.1	13.8	50.0	20.8	17.2	15.8	21.8	19.9	37.4	34.6	58.5	46.6	35.6	40.5	49.0	40.2	46.7	28.8	83.4	75.1	94.3	175.2	196.3	67.1	164.8	63.7	120.5	68.2	73.3	49.1	124.6	222.2	290.4	163.3	131.2	195.1	256.9	117.1	101.7	121.4	182.7	127.1	55.7	184.9	82.6	126.6	77.3	139.1	218.9	84.0	179.4	178.8	251.5	103.4	145.6	263.3	235.0	83.8	141.7	98.8	58.2	173.1	309.4	159.5	186.7	528.2	136.3	87.6	216.2
MAP1LC3B2	ATG8G	ENSG00000258102	"Microtubule associated protein 1 light chain 3 beta 2"	A6NCE7	12	116548105-116576448	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"blood: 33.1"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 31.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 11.2"									"HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253"	"unprognostic (1.50e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-3)"	"unprognostic (6.66e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.42e-1)"	0.4	3.5	0.4	0.4	0.4	2.0	0.4	0.4	1.8	0.4	0.7	0.4	0.4	2.2	1.0	0.4	0.5	0.0	0.4	0.4	0.4		0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.0	0.4	0.4	2.6	0.4	0.2	0.4	0.8	0.4	3.9	1.1	0.8	0.6	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.7	0.4	7.0	8.0	33.1	10.1	7.2	11.4	8.5	2.7	0.0	0.7	3.0	0.4	1.5	1.6	3.0	0.6	0.2	0.4	3.7	2.6	0.2	3.7	0.7	2.2	1.6	1.1	0.8	1.2	0.7	0.0	0.0	0.6	3.2	2.3	1.9	1.8	0.4	1.0	2.3	1.9	0.7	0.5	0.3	1.6	4.7	0.7	0.9	1.4	2.9	1.7	0.1	0.7	2.0	0.4	0.6	0.4	1.4	0.9	4.4	1.2	1.1	11.2	0.4	1.5	0.2	0.9	4.1	1.1	3.6	2.6	3.8	3.0	4.7	4.7	1.2	2.4	22.7	9.3	25.1	6.6	8.9	6.2	7.0	7.4	6.3	7.7	6.1	5.1	5.6	33.1	7.2	10.1	8.0	11.4	8.5											0.0	1.7	1.4	17.3	21.5	1.1	31.3	0.0	1.4	3.4	0.0	0.0	2.2	6.6	0.2	9.2	8.2	3.5	0.0	0.0	1.9	8.9	10.1	6.9	1.5	3.9	12.7	1.7	3.1	8.1	13.4	4.4	10.2	10.1	0.0	1.0	0.5	0.3	3.5	3.5	1.3	1.2	0.0	14.4	20.0	8.4	18.7	9.5	6.9	0.8	18.6
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734516	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 78.9;Late spermatids: 220.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Cell Junctions"	"HPA050934: AB_2681281, HPA054637: AB_2682552"	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	14.7	7.1	18.9	14.0	27.0	14.9	13.4	15.4	42.1	12.3	11.5	15.5	4.9	12.5	13.4	9.8	11.6	11.1	13.1	9.3	17.2	12.9	8.3	6.9	17.6	13.2	11.4	18.1	16.8	13.8	8.9	11.9	16.1	14.3	10.0	4.7	8.4	12.6	12.1	21.2	6.0	10.5	8.8	10.3	14.2	16.0	34.1	13.1	13.2	8.5	4.3	8.6	12.6	7.6	13.1	20.7	24.9	17.7	9.4	13.3	12.5	13.0	20.5	6.2	8.1	5.2	7.8	15.7	8.6	4.4	5.5	6.2	27.9	7.5	7.7	15.9	5.5	6.4	7.2	5.0	7.0	2.3	9.6	28.7	6.9	18.2	18.2	11.1	7.6	10.0	8.5	4.0	8.3	5.2	3.9	10.9	5.9	10.7	4.4	2.9	18.3	9.3	19.3	13.6	8.2	24.0	15.1	4.8	7.8	7.1	20.0	11.0	12.1	4.8	7.4	8.6	4.7	4.7	8.4	16.8	10.1	8.7	19.5	12.9	8.3	10.0	7.8	11.6	12.2	11.8	13.3	17.0	19.2	13.3	17.7	12.8	13.1	10.4	13.1	20.7	13.1	8.8	11.7	24.9	9.4	13.1	16.7	9.5	12.5	18.9	27.0	15.4	42.1	17.2	12.9	11.4	18.1	14.3	13.1	3.0	6.9	9.5	12.3	9.2	10.0	4.8	10.2	0.0	4.5	3.5	7.9	17.5	3.3	18.4	78.9	12.8	21.7	0.0	14.9	13.7	10.1	12.1	10.3	3.9	23.4	38.1	19.5	25.8	19.1	220.0	20.8	18.7	1.7	16.2	12.9	7.8	17.9	14.0	29.7	5.2	5.9	12.9	11.4	16.3	26.4	2.9	28.3	10.9	13.1	12.3
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424058-209734118	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 122.3"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 824.7;Rod photoreceptor cells: 453.2"	"Cancer enhanced"	"Detected in many"		"glioma: 30.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 2.6;naive B-cell: 3.4"	"Lineage enriched"	"Detected in single"	15	"B-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"AF22: 76.3;NTERA-2: 27.3;SCLC-21H: 38.4;SH-SY5Y: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012558, HPA012828"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946"	"unprognostic (2.47e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (1.98e-6)"	"unprognostic (2.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.10e-5)"	4.6	9.2	62.1	2.1	63.1	1.5	4.9	24.7	122.3	4.4	2.5	3.8	0.0	2.0	2.9	4.0	5.6	2.8	6.3	6.2	73.6	53.8	3.9	3.7	9.3	2.4	31.0	48.8	6.4	8.2	12.5	14.7	1.9	35.4	6.5	2.5	7.6	4.9	4.7	2.2	12.1	2.0	3.2	19.9	2.4	2.6	5.4	11.4	0.0	12.2	0.4	2.9	2.8	1.5	3.4	0.1	0.0	0.0	0.0	0.2	0.3	0.6	0.1	76.3	0.0	1.0	0.5	0.0	0.4	0.5	0.1	0.5	0.0	4.0	0.0	0.4	0.9	3.6	1.0	5.9	0.4	0.2	0.0	0.3	0.2	2.4	0.0	9.7	0.0	0.0	0.8	2.4	0.0	1.5	4.4	2.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	27.3	0.1	0.1	0.0	0.1	0.0	1.0	0.0	38.4	21.5	1.6	0.2	0.9	9.4	2.1	0.0	0.0	0.0	0.4	0.0	1.0	0.5	0.0	0.0	4.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	62.1	63.1	24.7	79.6	73.6	53.8	31.0	48.8	35.4	11.4	89.3	2.7	0.0	3.1	5.3	111.0	3.6	30.6	1.4	4.5	5.2	824.7	0.3	3.3	19.1	16.8	7.1	0.0	0.0	9.4	0.0	1.9	10.4	1.1	0.0	0.5	31.8	31.2	16.0	3.0	7.5	26.4	0.8	18.6	0.0	0.0	125.4	13.7	0.0	14.5	0.4	453.2	32.3	17.6	3.3	19.9	5.6	0.2	0.0	0.0	0.6
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020824-12143830	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SuSa: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: AB_2684197"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	10.7	13.2	23.7	9.4	21.0	3.1	14.4	25.0	42.7	12.5	11.5	7.9	8.5	9.6	12.1	17.8	18.5	11.5	10.7	14.9	31.7	29.3	15.8	20.6	11.4	14.6	24.5	27.1	13.0	11.1	19.6	16.7	15.1	23.4	14.5	13.1	6.5	9.8	13.2	20.6	14.4	9.9	13.5	16.3	10.7	10.7	10.3	9.8	10.3	16.5	11.6	13.4	11.1	11.2	2.8	1.8	13.2	4.3	3.5	3.3	2.3	10.6	9.2	12.1	6.2	6.7	8.7	7.7	7.3	9.6	8.3	8.0	5.4	3.7	4.4	5.9	11.3	5.4	7.1	10.5	10.1	12.5	7.8	12.3	4.9	5.4	10.2	7.9	4.7	7.4	7.2	10.0	9.7	10.2	8.6	7.5	6.3	5.2	2.6	10.4	3.9	5.6	4.4	7.0	11.5	4.5	7.0	13.6	3.0	11.4	6.9	2.4	7.2	8.4	4.5	7.0	67.1	5.7	3.4	6.8	4.1	6.3	5.6	8.6	5.1	5.7	3.5	7.7	3.7	5.9	0.6	2.7	2.0	3.0	1.5	2.7	2.8	2.4	2.4	1.8	2.7	2.0	3.3	13.2	3.5	4.3	1.8	2.6	2.3	23.7	21.0	25.0	42.7	31.7	29.3	24.5	27.1	23.4	9.8	8.9	14.2	10.8	26.3	36.9	14.2	21.2	10.2	2.7	21.6	14.0	7.9	10.7	21.6	11.2	6.3	8.7	11.8	0.0	12.4	8.6	12.9	32.3	1.1	16.3	10.2	17.5	11.5	10.4	17.7	5.8	10.9	11.7	11.8	19.0	13.8	10.3	14.7	11.5	12.0	17.7	9.7	12.9	12.0	7.9	8.1	34.4	21.2	9.5	10.6	40.3
MAP2K5	"HsT17454, MAPKK5, MEK5, PRKMK5"	ENSG00000137764	"Mitogen-activated protein kinase kinase 5"	Q13163	15	67542709-67807123	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 115.1;Late spermatids: 149.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022094, HPA027347, HPA027755"	Supported		Approved	Nucleoli,Microtubules		NA	NA			"Nucleoli, Microtubules"		"CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883"	"unprognostic (4.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.41e-2)"	"prognostic favorable (8.03e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.73e-2)"	18.6	22.2	20.3	13.8	30.9	14.6	23.7	25.0	25.4	17.0	19.3	17.2	19.9	14.7	17.4	11.3	13.5	16.2	14.4	18.8	17.1	16.4	14.2	15.5	13.5	27.9	12.6	11.5	29.0	21.0	34.1	14.4	17.7	22.2	15.9	14.8	15.6	15.7	18.5	28.5	18.7	15.0	19.4	17.2	13.0	15.4	20.3	16.2	40.2	16.9	9.2	11.9	17.0	17.9	6.6	10.2	10.3	7.3	11.7	11.2	5.5	5.3	14.2	8.5	10.0	12.6	22.2	6.7	5.4	10.9	10.1	11.1	5.7	9.6	8.8	11.4	8.9	11.0	8.1	14.5	8.6	8.4	12.8	14.5	12.0	10.6	6.1	15.9	7.2	7.5	15.2	11.3	7.3	16.6	22.3	13.3	20.5	10.5	14.8	8.3	6.9	11.8	8.6	12.0	6.2	6.9	11.7	9.9	14.7	6.1	9.8	5.4	8.4	6.0	8.9	21.4	15.4	11.2	14.2	11.0	10.5	6.9	7.2	7.2	21.0	24.6	10.3	14.0	16.6	7.5	10.3	7.3	6.6	7.7	5.6	11.2	6.6	7.3	9.0	10.2	6.2	10.4	9.5	1.7	11.7	6.2	3.9	7.4	5.5	20.3	30.9	25.0	25.4	17.1	16.4	12.6	11.5	22.2	16.2	6.0	4.3	4.2	7.5	6.2	10.0	8.0	2.5	1.4	1.2	5.2	9.8	10.3	6.6	7.7	115.1	7.0	8.8	0.0	7.4	9.1	7.1	4.5	2.3	6.8	8.8	4.8	9.1	9.8	9.2	149.4	11.5	5.3	10.1	2.8	8.4	16.0	6.9	10.5	11.0	6.8	7.2	0.0	5.1	10.4	8.2	7.2	8.2	8.7	9.4	2.7
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331"	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (1.56e-4)"	16.3	14.9	13.5	16.4	16.4	23.8	13.6	28.7	21.5	14.3	15.6	23.2	15.1	19.3	19.1	9.9	13.6	13.1	14.3	15.8	14.6	11.9	12.8	15.9	12.5	15.9	17.2	13.9	18.4	22.3	13.9	17.0	16.4	16.2	14.4	7.9	14.2	23.0	13.4	61.6	21.3	18.7	14.1	12.5	19.4	14.8	21.5	16.5	9.8	13.7	17.3	12.8	15.4	15.2	3.0	2.6	4.8	2.7	3.3	2.5	1.0	12.9	7.4	6.4	10.6	5.2	5.0	12.1	8.5	4.2	5.8	6.0	10.7	7.9	15.4	13.8	4.5	5.7	11.9	5.6	6.5	2.3	12.2	27.8	10.8	9.8	7.9	6.7	10.1	13.8	5.8	8.5	4.6	5.2	7.7	5.2	11.3	15.8	20.3	3.3	6.8	14.3	24.5	11.4	6.9	16.7	14.3	7.0	15.6	5.2	10.8	11.9	11.9	5.8	10.2	11.8	4.0	11.0	11.5	7.8	17.7	10.1	12.4	11.5	29.4	13.6	14.5	8.9	14.9	7.1	0.0	2.7	1.9	2.3	2.5	1.5	2.1	1.9	2.0	1.3	3.0	1.7	2.5	4.8	3.3	1.5	2.6	0.7	1.0	13.5	16.4	28.7	21.5	14.6	11.9	17.2	13.9	16.2	16.5	23.8	21.5	21.9	31.0	34.3	50.6	12.6	22.9	9.4	5.7	19.2	72.6	23.2	11.6	19.1	3.8	18.7	26.2	0.0	16.4	25.3	18.1	32.9	10.4	17.4	16.3	54.0	35.1	19.0	12.4	8.6	26.7	15.7	30.4	16.2	23.6	25.8	19.2	21.0	11.7	14.7	70.3	32.3	26.9	14.2	26.4	37.3	41.2	28.0	24.2	25.2
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815574-56896152	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 27.5;THP-1: 25.7"	"Region enriched"	"Detected in many"	6	"olfactory region: 22.5"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB004500: AB_627926, HPA046509: AB_2679678"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	6.7	4.9	5.4	14.6	4.8	15.2	14.9	8.0	4.5	7.6	6.7	5.4	7.3	4.3	7.1	9.4	12.7	7.2	5.9	4.3	3.7	3.2	9.5	4.4	8.8	21.4	6.4	3.1	8.4	9.2	6.3	7.9	8.1	4.5	8.3	4.5	12.6	15.4	9.7	3.5	21.8	11.2	4.0	3.8	21.3	5.5	8.5	5.1	11.7	19.2	6.6	18.2	6.0	11.7	6.6	2.8	6.7	7.2	2.7	5.8	2.3	6.6	4.0	6.3	4.2	1.0	0.8	10.6	1.3	1.7	4.0	5.6	18.7	5.0	5.9	0.4	1.5	3.4	3.4	5.2	2.3	5.6	2.0	2.3	3.3	1.8	8.8	2.5	5.2	9.2	1.0	2.5	1.2	2.0	1.1	1.7	2.0	2.8	10.7	1.0	2.9	3.6	7.1	2.9	3.4	0.5	5.7	4.4	20.3	7.0	6.9	2.6	27.5	3.9	4.9	11.2	5.8	13.4	25.7	5.0	0.4	3.4	1.5	2.4	7.8	4.0	11.3	0.6	3.1	6.8	6.7	4.5	1.0	1.2	6.8	1.2	6.6	3.8	1.8	2.8	5.1	2.5	0.9	2.6	2.7	7.2	1.5	5.8	2.3	5.4	4.8	8.0	4.5	3.7	3.2	6.4	3.1	4.5	5.1	6.0	9.8	47.7	14.5	46.5	15.2	2.7	50.9	4.0	12.5	34.9	45.2	12.9	6.6	14.2	1.6	13.5	6.6	0.0	12.8	7.7	11.3	11.9	7.0	12.1	26.3	27.0	9.8	17.2	81.7	1.9	4.9	40.3	35.4	45.9	10.1	10.6	13.0	7.0	1.8	20.1	34.7	6.5	5.2	10.0	15.0	47.8	5.6	16.6	8.9	10.0
MAP3K10	"MEKK10, MLK2, MST"	ENSG00000130758	"Mitogen-activated protein kinase kinase kinase 10"	Q02779	19	40191744-40215575	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 13.9;Horizontal cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007039	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Actin filaments, Cytosol"		"HPA007039: AB_1079357"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.69e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.62e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.77e-3)"	"prognostic favorable (2.13e-4)"	7.7	7.0	29.6	4.7	22.8	3.7	2.2	14.3	32.0	3.3	3.4	5.3	1.8	4.4	4.5	1.8	3.7	3.1	4.0	8.2	28.2	11.2	4.7	2.1	4.2	4.6	11.5	9.4	4.3	8.1	4.7	5.2	3.7	9.0	4.6	2.0	2.4	6.9	4.8	22.9	5.6	5.0	4.0	5.3	6.7	6.2	6.6	7.1	2.3	3.3	2.6	2.4	3.8	5.4	0.8	0.0	0.0	0.2	0.0	0.9	0.0	6.3	7.6	2.4	5.6	2.2	1.3	6.5	4.4	2.2	2.0	2.1	1.7	1.8	5.8	4.6	1.5	5.1	2.1	0.9	2.3	0.3	11.0	7.2	1.5	3.2	1.7	4.2	1.3	3.7	1.2	5.5	2.2	1.5	2.3	1.9	8.2	5.5	9.9	0.6	3.8	4.8	2.3	2.8	2.1	5.0	5.9	2.5	3.4	1.8	4.0	7.9	11.4	5.1	1.9	10.4	1.5	2.5	2.3	3.1	5.4	5.2	7.8	8.5	13.1	7.5	2.6	6.2	2.4	7.8	0.0	0.1	0.0	0.4	0.2	0.0	0.8	0.2	0.9	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	29.6	22.8	14.3	28.7	28.2	11.2	11.5	9.4	9.0	7.1	0.0	0.0	2.2	1.5	1.3	13.9	2.4	0.0	0.0	0.0	7.0	7.9	0.6	0.0	2.3	2.6	2.3	2.6	0.0	3.6	0.7	1.9	2.0	0.0	2.6	2.2	22.3	4.1	3.7	2.2	6.5	2.8	1.1	1.7	1.0	1.9	5.2	3.4	1.9	4.6	3.7	7.3	6.5	2.6	2.6	1.7	2.4	1.1	1.9	2.1	1.7
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	8.0	8.7	12.3	5.8	16.0	3.0	5.1	40.3	20.6	14.1	6.1	7.0	7.8	3.6	15.1	5.8	4.6	11.5	16.1	4.2	9.4	7.7	4.5	1.4	8.8	4.5	6.4	14.7	13.7	1.8	3.0	12.7	7.3	10.8	5.9	4.6	9.5	2.4	13.5	1.2	4.5	4.1	16.9	5.3	5.3	3.9	6.5	7.4	2.7	4.3	1.4	3.2	11.3	6.4	0.3	0.6	3.4	1.7	0.6	2.8	0.5	0.2	7.0	4.4	6.8	26.4	14.1	0.5	4.7	8.9	5.2	5.3	0.1	0.8	1.5	2.7	5.1	4.2	0.0	2.0	3.1	2.1	2.3	2.4	1.7	3.6	0.0	25.2	0.0	1.7	25.1	2.3	7.1	3.7	33.3	8.1	3.5	0.0	7.5	4.9	3.0	1.7	0.3	1.5	0.0	2.6	2.4	2.9	0.4	2.6	0.0	4.4	6.0	2.5	3.2	6.7	1.0	2.2	4.4	5.9	5.0	5.4	2.3	1.2	3.0	3.4	0.0	8.1	3.0	4.9	0.0	1.7	0.0	1.5	1.3	2.8	0.3	2.1	2.3	0.6	0.0	0.9	1.2	3.4	0.6	0.4	0.3	0.4	0.5	12.3	16.0	40.3	20.6	9.4	7.7	6.4	14.7	10.8	7.4	6.0	13.4	5.6	1.9	0.7	26.7	0.7	10.2	8.1	11.4	1.8	35.3	1.6	8.3	5.4	1.2	3.7	4.6	0.0	1.6	1.8	3.8	2.7	12.7	7.7	3.6	28.6	3.4	7.4	12.7	1.4	7.5	5.9	0.0	7.2	2.5	17.4	4.5	2.6	7.8	7.0	81.9	6.5	4.9	2.3	1.9	0.9	1.8	7.5	3.5	2.0
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489097	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 456.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (1.11e-4)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	9.8	24.8	21.7	8.7	22.2	9.5	15.1	16.4	26.1	12.9	16.9	18.4	10.5	16.8	12.9	42.1	15.2	14.6	13.1	8.1	19.2	18.6	21.9	20.7	15.2	7.4	23.2	17.1	16.5	24.9	20.9	24.5	9.1	21.8	14.5	18.9	18.6	26.2	11.4	3.3	9.8	23.4	12.1	26.4	8.7	16.4	12.9	15.8	4.4	18.6	8.3	10.3	12.5	11.5	23.7	21.5	21.1	13.2	11.5	17.4	7.8	29.1	5.8	11.3	0.3	10.3	12.7	6.7	6.7	4.6	10.9	13.2	11.2	11.0	0.2	23.0	12.2	18.2	16.7	0.3	15.5	19.4	32.5	15.0	0.1	7.9	9.2	11.2	15.3	8.4	11.5	13.6	9.3	11.7	11.3	12.1	0.3	0.3	23.7	9.7	9.1	1.8	7.2	13.0	22.5	13.7	0.2	13.5	16.0	19.2	7.6	18.6	12.4	11.3	17.1	23.2	12.9	25.8	8.6	8.0	9.0	11.7	16.2	14.5	12.1	15.6	9.6	13.2	7.8	14.7	6.4	13.2	5.1	10.3	12.2	15.8	23.7	12.4	12.8	21.5	19.0	17.4	16.8	21.1	11.5	8.6	9.4	4.8	7.8	21.7	22.2	16.4	26.1	19.2	18.6	23.2	17.1	21.8	15.8	50.6	76.2	44.7	172.9	125.7	111.5	22.1	104.4	64.3	84.2	75.0	86.4	120.9	243.7	92.5	109.7	52.6	82.0	0.0	111.2	29.4	48.3	249.1	28.9	83.1	55.4	42.9	102.2	83.4	50.4	168.4	40.0	59.4	81.0	456.3	109.9	93.7	112.0	96.2	50.9	224.8	81.3	45.3	74.0	119.3	28.8	127.2	170.1	31.2	98.7	249.0
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263121-45317040	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 49.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 22.4;HDLM-2: 23.0;U-251 MG: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_2732436, HPA027270: AB_2732437"	"unprognostic (1.05e-2)"	"prognostic favorable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	3.7	3.4	3.0	14.7	4.0	3.4	2.7	4.9	3.6	5.0	7.3	4.5	3.5	6.0	5.5	3.3	6.8	4.2	6.2	4.5	3.0		4.4	5.1	4.9	12.0	3.0	0.6	3.5	5.7	3.5	7.7	1.5	4.6	5.2	3.5	4.3	7.5	4.8	14.5	6.1	9.6	5.2	4.1	8.4	4.0	4.5	4.5	7.1	2.2	6.9	18.0	4.9	2.8	9.5	4.8	7.7	3.6	5.6	5.2	2.3	9.5	22.4	2.3	4.0	1.6	3.8	5.7	2.6	1.8	8.5	5.2	3.4	11.9	4.2	13.6	2.8	8.5	6.8	1.0	3.6	4.4	23.0	1.7	0.9	6.1	1.5	4.1	0.7	4.5	5.9	2.3	4.2	2.2	9.0	1.6	2.0	1.8	18.3	4.3	3.5	4.0	1.5	1.2	5.9	3.1	5.2	6.9	9.6	6.2	1.9	2.4	1.9	4.1	2.7	2.9	3.4	1.7	0.4	3.6	3.9	6.0	3.3	22.5	17.5	6.5	2.2	2.2	2.5	5.2	1.5	3.4	1.6	3.5	3.6	2.0	7.6	2.4	2.5	2.3	9.5	2.6	2.5	7.7	5.6	2.2	4.8	5.2	2.3											3.0	13.8	9.7	13.7	0.0	3.6	2.0	15.3	9.4	4.5	0.0	3.9	0.7	0.0	4.2	3.7	1.6	11.2	0.0	2.3	1.2	1.8	6.5	1.1	8.1	4.4	1.6	12.6	4.9	7.8	4.5	4.4	6.2	0.0	49.5	6.4	2.2	3.3	7.8	1.1	2.5	2.7	0.0	0.6	4.5	2.4	0.0	0.0	5.1	6.7	5.0
MAP3K15	"ASK3, bA723P2.3, FLJ16518"	ENSG00000180815	"Mitogen-activated protein kinase kinase kinase 15"	Q6ZN16	X	19360056-19515261	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 17.3;brain: 13.2"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.9;Cardiomyocytes: 2.5;Collecting duct cells: 5.2;Cone photoreceptor cells: 3.9;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	6	"pons and medulla: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;HAP1: 7.9;HEK 293: 6.7;JURKAT: 3.9;REH: 4.1;SuSa: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA004006			Approved	Vesicles		NA	NA			Vesicles		"HPA004006: AB_1079358"	"unprognostic (2.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.56e-8)"	"unprognostic (3.47e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.20e-2)"	0.1	17.3	0.5	0.4	0.3	0.5	0.1	2.3	0.1	0.1	0.1	5.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.5	3.6	0.1	0.5	0.0	0.1	0.0	1.3	4.1	0.4	5.7	0.0	13.2	0.1	0.0	4.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	2.6	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.4	0.0	7.9	0.0	0.0	1.3	6.7	2.7	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.0	0.2	0.0	2.1	2.0	0.0	0.8	4.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.3	0.1	0.4	0.5	0.1	0.0	13.2	0.0	0.0	1.9	0.0	0.6	0.1	0.6	2.5	0.0	0.0	0.0	5.2	3.9	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.6	0.0	0.0	0.2	1.2	0.0	0.1	0.0	0.0	0.0
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327768-233385148	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 28.9"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 7.7;Collecting duct cells: 14.0;Ductal cells: 9.7;Exocrine glandular cells: 8.4;Pancreatic endocrine cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.6	3.2	2.0	3.4	2.2	1.3	2.2	10.0	3.3	1.5	11.4	0.6	9.1	9.9	0.8	5.2	2.4	3.9	3.9	0.7	1.3	2.1	12.5	13.3	5.6	0.5	0.9	1.7	0.8	28.9	4.4	2.6	1.0	1.2	1.3	6.0	1.0	3.7	2.5	0.4	2.7	17.2	0.3	0.9	0.7	10.1	12.4	0.6	0.5	2.4	0.8	1.3	1.1	1.6	0.5	0.8	0.1	0.3	5.0	0.2	0.1	7.4	12.7	0.2	0.0	0.0	0.0	6.4	0.2	0.0	0.3	0.5	7.0	6.5	0.7	5.2	0.1	2.4	4.0	9.5	3.9	0.8	13.8	18.3	0.1	7.1	0.0	0.5	12.1	2.9	0.1	5.2	0.2	7.4	1.4	0.4	5.8	0.1	2.4	0.0	1.6	3.8	4.3	9.1	8.7	5.6	0.0	0.0	13.3	8.8	3.1	9.4	2.5	4.3	0.2	0.0	1.0	3.7	3.9	0.0	0.0	1.2	0.0	7.4	2.3	2.9	0.0	1.2	3.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.8	0.5	0.0	0.0	0.1	5.0	0.0	0.2	0.2	0.1	2.0	2.2	10.0	3.3	1.3	2.1	0.9	1.7	1.2	0.6	32.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	14.0	0.0	0.0	3.3	9.7	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	7.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MAP3K3	"MAPKKK3, MEKK3"	ENSG00000198909	"Mitogen-activated protein kinase kinase kinase 3"	Q99759	17	63622415-63696303	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007764, HPA035410, HPA035411"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB007764: AB_562314, HPA035410: AB_2674614, HPA035411: AB_2674615"	"unprognostic (9.65e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	23.9	11.8	10.5	20.5	15.0	24.8	19.1	26.8	14.9	22.2	21.8	15.0	14.0	8.0	24.5	13.2	16.6	18.3	20.6	37.4	11.3	8.4	17.1	12.4	23.1	21.4	14.4	9.6	21.6	11.4	16.9	12.3	21.0	11.9	18.4	8.3	21.7	12.8	18.5	19.6	15.4	14.7	20.4	13.2	30.4	16.4	26.5	12.3	12.9	15.5	12.8	15.4	19.0	26.8	1.9	3.5	18.3	8.5	1.1	2.6	2.3	10.2	7.7	9.8	9.6	18.9	15.2	4.5	10.2	11.2	12.7	10.3	3.5	2.1	11.1	7.2	19.9	9.3	3.8	6.4	7.2	8.1	9.7	14.1	9.0	10.5	5.0	9.9	6.9	9.7	10.9	5.0	15.8	8.3	8.1	30.8	8.2	5.5	14.7	10.1	7.3	12.4	7.3	6.1	2.1	8.3	6.6	25.2	7.2	4.6	4.7	5.0	12.1	6.9	8.3	8.5	12.9	8.3	6.9	27.7	32.5	8.6	17.6	12.3	14.7	14.8	4.1	7.0	5.6	8.4	8.8	8.5	10.4	2.2	8.3	2.3	1.5	2.6	2.1	3.5	1.9	2.5	2.5	18.3	1.1	8.2	1.3	1.9	2.3	10.5	15.0	26.8	14.9	11.3	8.4	14.4	9.6	11.9	12.3	17.9	12.6	8.8	5.9	6.9	13.9	9.9	2.5	4.0	5.7	15.7	13.7	2.7	8.3	3.7	7.1	33.7	2.1	0.0	6.9	2.9	7.4	8.9	3.5	8.3	13.8	17.5	4.1	39.3	38.3	4.4	13.8	15.3	21.9	8.2	3.3	7.5	4.9	0.0	12.4	2.1	15.0	19.4	11.4	18.0	6.1	9.8	1.1	8.7	4.4	3.7
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	"Mitogen-activated protein kinase kinase kinase 4"	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007625	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007625: AB_1853770"	"unprognostic (3.05e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.84e-2)"	12.0	8.0	13.1	17.7	12.6	9.1	14.6	23.1	14.0	16.4	13.9	9.3	12.2	9.5	22.2	11.9	21.4	14.1	11.4	12.4	11.9	7.8	9.4	8.2	15.9	14.4	12.8	8.9	17.4	12.1	15.8	16.2	12.4	9.2	14.2	9.8	9.4	15.0	15.4	24.4	15.1	13.3	13.9	7.7	10.6	11.1	13.5	12.4	16.2	10.6	13.0	16.8	15.8	23.9	8.8	5.4	17.5	3.8	3.5	8.9	2.2	4.7	5.4	10.3	8.8	6.4	7.5	6.7	5.4	4.8	6.2	6.6	7.7	3.5	9.8	3.9	13.7	8.9	11.9	10.5	10.8	7.6	7.1	8.6	12.8	5.0	7.5	4.9	13.2	6.2	4.7	12.6	6.5	5.9	9.7	8.1	7.4	32.2	11.3	6.6	4.9	8.9	6.7	6.3	3.4	8.3	9.8	9.5	7.8	5.7	3.5	5.9	5.3	10.1	10.8	0.9	9.4	4.4	16.2	7.5	7.6	9.8	7.1	25.5	6.6	5.3	9.0	9.0	13.7	8.0	17.5	3.8	2.3	5.0	3.0	8.9	6.2	7.1	4.5	4.3	8.8	5.0	4.9	0.2	3.5	1.7	5.4	4.8	2.2	13.1	12.6	23.1	14.0	11.9	7.8	12.8	8.9	9.2	12.4	17.9	12.6	14.2	8.2	8.8	15.7	17.9	10.2	8.1	19.4	14.0	21.6	16.7	3.3	8.0	2.6	11.3	5.9	0.0	6.5	9.4	7.8	10.8	3.5	7.3	6.4	22.3	14.8	4.3	7.0	2.5	10.6	9.0	0.0	18.0	9.4	18.9	9.7	7.0	11.7	5.9	28.6	6.5	8.0	13.5	29.6	10.3	27.7	12.1	10.9	12.9
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.9"	"Cell type enhanced"	"Detected in many"	4	"Ito cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9.0	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5.0	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16.0	11.7	8.7	9.0	6.7	7.0	0.6	12.0	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.5	7.0	6.3	7.0	8.8	15.4	1.6	9.4	5.4	7.1	5.4	2.1	10.2	0.1	8.4	14.2	2.8	11.9	2.1	6.5	3.6	6.2	5.2	0.5	16.2	3.1	2.7	0.5	0.6	12.4	16.1	7.4	2.6	7.9	4.8	0.5	2.3	4.1	11.3	18.7	0.3	8.6	2.0	7.5	5.8	2.7	4.2	1.7	10.6	7.9	2.3	3.5	9.9	8.7	7.4	2.7	4.6	6.4	9.9	17.9	7.5	19.9	4.9	3.4	4.2	0.1	15.8	6.1	5.2	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0.0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7.0	17.9	16.2	4.7	10.4	11.1	0.5	8.9	10.2	1.4	11.4	3.5	0.0	0.9	3.3	2.3	0.4	15.8	1.7	0.0	3.8	1.7	7.7	7.3	2.3	0.8	2.5	4.8	0.0	28.8	12.5	1.1	15.0	5.1	5.0	13.6	4.9	5.2	8.9	0.0	14.2	1.5	0.4	6.5	10.5	8.7	2.1	12.9	0.1	10.2	4.3	14.4
MAP3K7CL	"C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4"	ENSG00000156265	"MAP3K7 C-terminal like"	P57077	21	29077471-29175889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.9;skeletal muscle: 50.4;tongue: 28.8"	"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 17.1;Sertoli cells: 19.4;Smooth muscle cells: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 7.6;granulocytes: 12.0;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 17.4;LHCN-M2: 18.5;RH-30: 74.0"									"HPA030079, HPA042439"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030079: AB_2673299, HPA042439: AB_10794422"	"unprognostic (2.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.00e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (8.31e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.10e-2)"	6.9	5.1	1.6	4.6	2.2	1.4	2.5	1.2	1.7	4.0	4.6	2.4	1.7	0.9	8.6	11.7	3.4	3.0	5.2	16.2	1.4	1.9	4.4	3.2	6.6	5.2	1.8	1.9	4.7	4.3	2.5	2.9	1.7	2.7	4.4	1.8	2.4	1.8	2.6	50.4	2.7	3.1	3.8	3.1	3.9	1.7	3.2	1.4	2.3	2.7	28.8	7.8	3.6	2.1	7.6	0.8	12.0	5.7	0.6	1.5	37.9	0.9	0.2	0.1	0.3	0.1	5.7	0.1	1.3	3.7	3.4	9.3	1.5	0.4	8.0	0.5	5.3	0.1	0.0	0.1	4.2	17.4	1.6	0.0	0.8	0.6	0.1	0.8	0.0	0.0	2.0	8.1	11.9	11.3	1.7	0.6	0.2	0.5	3.3	18.5	0.2	0.1	0.0	0.4	0.7	0.3	0.0	74.0	0.2	0.5	0.2	0.5	0.3	0.0	0.0	0.4	1.5	0.0	0.4	0.6	7.3	6.2	1.6	0.2	1.4	0.2	0.3	1.1	0.6	1.5	12.0	5.7	1.1	0.6	4.2	1.5	7.6	0.4	0.6	0.7	5.3	0.7	1.1	8.6	0.6	1.9	0.8	1.1	37.9	1.6	2.2	1.2	1.7	1.4	1.9	1.8	1.9	2.7	1.4	0.0	4.0	3.7	5.5	7.6	2.3	1.4	2.5	1.4	0.0	0.0	2.0	0.2	0.0	1.1	1.1	3.6	1.3	0.0	1.4	0.2	3.4	3.0	1.1	4.0	3.3	0.0	4.6	1.3	17.1	0.6	0.6	5.5	5.0	1.8	2.2	1.3	2.6	2.9	4.2	2.1	1.2	19.4	26.7	1.1	1.4	8.3	0.3	2.6	1.3	2.1
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 28.6;Urothelial cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.5	2.2	5.8	2.0	9.2	1.4	2.8	20.1	16.5	2.4	3.1	1.8	0.4	3.0	1.1	3.4	10.1	2.2	1.5	1.2	5.7	7.1	3.1	2.4	3.9	2.6	5.9	5.9	1.4	4.3	6.8	4.7	2.8	12.8	2.0	3.1	3.1	3.2	1.3	1.9	7.8	2.9	0.7	1.6	1.9	3.4	10.1	1.8	0.6	5.3	3.2	6.8	2.0	3.9	2.3	0.5	1.3	0.2	1.1	1.4	0.3	18.1	8.4	1.6	2.0	0.0	0.0	5.6	0.4	0.2	1.7	1.6	6.0	7.0	3.7	2.5	0.1	3.7	8.6	5.3	10.2	1.9	2.4	1.5	0.2	2.9	4.0	0.3	0.4	0.8	0.1	5.6	1.2	10.6	3.1	0.0	3.3	1.3	0.8	0.4	7.3	2.8	0.4	3.5	7.2	3.9	1.0	3.2	0.7	3.9	8.3	11.6	2.5	5.2	6.2	1.0	3.2	5.6	0.6	0.0	0.0	7.4	0.0	2.8	1.9	4.4	1.9	2.8	0.3	1.1	0.5	0.2	0.8	0.6	0.1	0.1	1.0	0.6	1.0	0.0	2.3	1.0	0.7	1.3	1.1	0.2	0.5	1.4	0.3	5.8	9.2	20.1	16.5	5.7	7.1	5.9	5.9	12.8	1.8	6.0	14.9	0.9	10.9	7.7	15.8	1.8	15.3	0.0	10.3	7.0	11.8	2.5	1.7	5.5	13.2	0.7	3.1	0.0	4.0	1.3	0.8	9.0	1.1	4.9	1.0	28.6	8.1	0.6	0.8	15.9	0.6	1.4	3.3	0.0	3.4	3.4	7.4	3.5	0.0	1.9	12.3	0.0	1.0	5.4	8.5	8.0	3.3	2.9	5.0	25.4
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 29.0;Rod photoreceptor cells: 58.2;T-cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 20.8;HDLM-2: 20.6;Karpas-707: 21.4;REH: 11.4;RPMI-8226: 12.9;U-266/70: 16.9;U-266/84: 16.6;U-698: 26.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	1.6	0.9	1.2	31.4	2.3	6.3	1.1	1.0	1.2	1.0	3.1	1.7	0.1	2.1	0.9	1.4	2.6	1.2	2.9	0.9	1.1	1.4	2.2	1.6	3.9	23.0	2.3	0.7	0.8	1.2	0.2	1.2	1.4	2.1	1.6	1.9	2.0	4.4	0.8	0.5	1.2	16.9	0.7	3.4	34.4	2.3	0.9	1.3	19.1	1.9	1.4	39.2	3.1	1.3	16.2	15.9	1.3	6.2	3.7	14.6	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	4.4	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.1	21.4	0.0	0.1	4.9	5.2	0.6	0.1	0.0	11.4	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	4.7	0.0	0.0	0.1	0.0	0.0	16.9	16.6	26.2	0.0	5.9	0.0	1.3	3.2	1.2	13.4	6.2	12.4	16.2	11.2	14.0	15.9	10.7	6.2	8.7	0.3	3.7	3.4	14.0	14.6	7.3	1.2	2.3	1.0	1.2	1.1	1.4	2.3	0.7	2.1	1.3	3.0	8.2	29.0	0.1	2.1	6.1	0.6	0.0	0.0	1.2	0.0	11.8	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.2	1.0	0.3	15.1	0.0	2.5	1.6	0.0	1.3	7.1	0.0	0.0	11.7	3.3	2.8	0.0	6.7	0.0	0.0	0.0	0.2	58.2	0.0	0.4	0.6	4.3	0.9	0.1	33.2	0.2	0.1
MAP4K2	"BL44, GCK, RAB8IP"	ENSG00000168067	"Mitogen-activated protein kinase kinase kinase kinase 2"	Q12851	11	64784914-64803241	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007330	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA007330: AB_1079361"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.07e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (4.51e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	6.9	6.2	9.4	15.2	10.0	19.1	5.8	12.1	15.6	5.2	5.8	10.1	6.9	4.9	6.2	4.0	4.3	4.4	6.3	5.5	9.4	9.2	6.2	3.1	12.0	22.3	8.3	7.3	4.2	7.2	5.2	8.0	12.3	12.5	6.1	4.7	6.7	9.0	8.9	3.4	5.0	9.9	5.6	6.7	22.6	7.1	5.5	6.6	11.5	8.7	3.9	18.8	6.1	5.1	10.8	5.0	8.2	14.8	2.3	9.6	7.1	6.0	5.5	3.6	6.4	3.2	2.0	8.5	4.5	4.3	5.5	3.9	2.4	2.8	10.5	8.4	5.2	9.7	1.8	4.3	4.4	3.3	13.7	2.1	18.5	7.6	5.0	3.9	9.7	7.0	1.9	2.2	4.3	2.7	3.8	13.4	18.4	1.5	1.0	1.6	7.5	5.7	9.7	2.4	3.6	7.4	12.0	0.4	12.1	3.1	3.0	4.3	6.2	3.9	5.1	4.0	4.3	10.3	15.0	10.3	4.6	10.3	4.2	1.9	1.2	2.3	11.4	4.1	14.7	3.4	2.2	4.2	5.6	5.2	12.2	5.3	10.8	7.0	4.7	4.4	7.6	8.6	6.3	8.2	2.3	14.8	5.0	9.6	7.1	9.4	10.0	12.1	15.6	9.4	9.2	8.3	7.3	12.5	6.6	3.0	4.5	18.1	3.3	1.1	19.5	3.6	2.5	1.4	2.3	1.8	23.6	6.4	3.3	1.3	29.3	15.5	1.8	0.0	1.5	10.2	2.8	2.6	1.1	1.8	9.1	11.1	5.8	20.3	8.5	25.2	3.7	8.3	1.7	8.2	2.0	7.0	0.9	11.5	6.7	2.8	13.8	6.5	2.5	1.8	11.1	1.3	4.2	10.0	1.9	1.6
MAP4K3	"GLK, MAPKKKK3, RAB8IPL1"	ENSG00000011566	"Mitogen-activated protein kinase kinase kinase kinase 3"	Q8IVH8	2	39249266-39437312	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 41.6;RT4: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030380	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Centriolar satellite"	Nucleoplasm	"HPA030380: AB_10601132"	"unprognostic (4.82e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.87e-3)"	"unprognostic (7.34e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.08e-2)"	19.7	18.9	17.6	15.4	17.6	9.6	17.8	37.1	19.6	19.2	16.9	14.6	9.8	13.7	23.5	14.8	11.1	15.3	18.7	19.5	15.4	12.5	26.2	15.4	15.6	5.8	15.4	13.4	24.6	14.0	25.7	24.6	30.8	14.4	18.6	14.1	17.9	13.3	15.7	33.0	17.8	17.2	18.6	15.3	11.5	26.1	21.0	16.5	9.4	25.9	11.3	7.5	18.8	32.6	0.7	0.5	2.5	1.9	1.0	1.3	0.4	9.9	6.2	41.6	6.6	6.8	13.6	11.4	8.8	11.3	8.8	7.5	5.2	5.0	2.1	10.0	6.0	9.1	5.4	15.6	7.8	13.4	2.4	6.4	3.6	4.4	12.1	17.7	1.6	5.9	12.2	7.8	11.4	12.4	9.3	7.5	2.0	4.6	4.1	11.7	5.4	3.4	2.3	12.5	9.4	9.4	3.8	13.5	1.6	11.6	38.5	7.4	8.5	5.2	8.3	23.0	13.7	5.6	2.2	6.1	6.8	8.1	6.1	4.7	6.2	3.5	0.7	8.4	2.6	7.9	2.5	0.7	0.0	1.2	1.1	0.1	0.1	1.2	0.9	0.1	0.7	1.1	1.3	0.0	1.0	1.9	0.5	0.6	0.4	17.6	17.6	37.1	19.6	15.4	12.5	15.4	13.4	14.4	16.5	3.0	6.7	5.1	15.6	15.7	23.8	32.7	17.8	13.4	15.9	21.0	23.6	9.2	16.6	9.0	38.6	10.3	11.9	0.0	10.7	5.5	15.6	20.0	2.3	16.2	9.1	6.4	9.2	15.4	9.5	80.0	19.2	12.2	5.0	1.8	12.5	15.2	12.8	7.0	16.6	10.9	41.2	19.4	12.7	19.5	20.8	16.8	8.7	4.4	9.3	29.0
MAP4K5	"GCKR, KHS, KHS1"	ENSG00000012983	"Mitogen-activated protein kinase kinase kinase kinase 5"		14	50418501-50561126	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 26.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 26.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036696, HPA078030"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA036696: AB_10672362, HPA078030: "	"unprognostic (1.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.58e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.53e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.02e-2)"	17.4	11.8	23.4	12.1	44.4	16.5	19.7	24.6	32.3	25.8	17.1	43.5	13.4	11.3	29.9	12.1	18.7	17.4	19.3	10.3	24.4	14.0	10.9	8.7	15.2	9.9	48.8	17.1	29.9	13.3	16.7	17.5	17.3	26.0	16.6	15.1	9.1	16.9	19.9	10.7	24.8	12.7	22.3	30.7	13.0	14.4	6.8	51.1	8.4	15.3	8.7	11.2	19.3	21.2	5.0	2.7	26.1	1.8	5.4	3.9	1.0	22.9	6.9	17.0	14.6	15.7	16.6	16.6	27.1	24.5	18.5	16.5	8.7	16.1	15.9	16.2	24.8	9.8	16.5	15.8	14.6	28.2	13.1	11.5	9.7	12.2	7.8	13.3	8.7	15.4	12.0	12.0	16.2	17.0	29.6	24.2	14.5	9.2	10.4	27.0	8.7	11.7	8.3	8.3	7.4	13.6	14.2	25.8	6.0	18.3	17.9	5.5	12.5	15.3	10.7	10.5	14.3	11.9	6.6	24.6	24.1	16.8	16.4	12.7	7.6	7.7	10.6	9.0	6.1	17.1	26.1	1.5	13.5	3.9	1.8	2.2	3.2	2.4	3.3	1.6	5.0	2.6	2.7	0.6	5.4	1.1	2.7	0.5	1.0	23.4	44.4	24.6	32.3	24.4	14.0	48.8	17.1	26.0	51.1	38.7	17.3	14.6	29.9	62.2	51.9	7.3	20.4	26.8	27.3	26.2	45.2	9.4	16.6	24.0	2.8	33.1	15.9	23.3	18.3	16.7	46.1	53.8	28.9	7.8	7.5	31.8	22.5	35.6	13.9	2.2	39.4	20.9	21.9	17.2	14.2	18.2	23.1	15.0	48.1	9.9	33.6	12.9	40.4	11.2	13.6	75.3	5.5	21.8	16.2	55.0
MAP6D1	"FLJ12748, SL21"	ENSG00000180834	"MAP6 domain containing 1"	Q9H9H5	3	183815876-183825594	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 48.1;skeletal muscle: 33.5"	"Cell type enhanced"	"Detected in some"	5	"Early spermatids: 2.4;Glandular cells: 2.6;Intestinal endocrine cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.7"	"Cell line enriched"	"Detected in many"	5	"T-47d: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037991	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"HPA037991: AB_10672503"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (8.81e-12)"	"unprognostic (1.08e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.72e-2)"	1.1	1.2	11.8	1.5	16.0	1.1	2.0	30.9	32.1	1.5	1.4	48.1	0.0	1.9	1.4	2.0	1.1	1.5	1.3	1.9	18.8	9.2	1.2	1.3	1.4	1.7	24.7	8.7	1.7	6.0	1.8	0.5	1.3	18.4	2.7	1.4	0.0	1.6	2.0	33.5	4.6	1.5	1.4	37.7	1.5	1.2	1.3	20.4	2.2	1.1	0.0	1.4	1.1	0.2	0.5	0.3	0.2	0.2	0.0	2.7	0.3	1.9	1.4	2.2	0.4	0.5	0.7	1.7	2.4	0.4	4.6	3.1	1.8	0.1	0.2	3.1	3.6	2.3	1.4	4.5	1.2	3.1	1.3	6.8	0.2	0.0	0.0	1.3	2.4	0.8	0.3	0.3	1.1	0.4	0.6	0.9	3.6	0.3	0.0	0.6	8.4	5.9	3.4	2.0	1.1	3.9	2.9	3.4	0.0	0.2	0.0	7.2	1.3	1.8	1.3	2.5	1.6	39.9	2.4	0.4	1.1	1.6	1.6	3.5	1.5	0.9	1.1	0.3	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.5	2.7	0.3	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.3	11.8	16.0	30.9	19.9	18.8	9.2	24.7	8.7	18.4	20.4	0.0	0.0	0.0	0.5	1.0	2.2	1.3	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.4	0.5	2.6	0.0	0.0	0.8	1.6	2.4	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.4	1.7	1.3	0.6	0.0	0.3	0.6
MAP7D1	"FLJ10350, FLJ39022, PARCC1, RPRC1"	ENSG00000116871	"MAP7 domain containing 1"	Q3KQU3	1	36155579-36180849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 144.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028075	Approved		Approved	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA028075: AB_10603778"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.49e-6)"	"unprognostic (6.00e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.32e-3)"	39.4	12.8	25.4	24.4	27.8	19.4	17.4	26.4	44.7	11.2	24.0	32.4	4.6	12.4	16.6	5.5	25.9	10.6	18.4	51.7	25.1	22.5	7.4	4.9	21.3	14.7	31.2	24.1	10.2	10.0	8.3	12.2	15.4	30.8	18.4	7.1	10.2	11.0	19.5	144.7	20.9	10.9	21.1	40.7	17.8	14.2	6.7	22.8	14.9	10.5	18.6	11.5	22.8	12.4	0.4	0.8	4.7	1.4	0.4	1.9	0.2	29.2	17.2	27.1	17.1	16.6	12.6	20.0	29.4	29.9	31.0	27.4	9.6	30.2	12.3	25.3	26.6	17.0	32.2	11.1	39.9	10.2	20.9	9.9	8.3	12.9	3.6	26.2	12.3	21.5	22.0	11.4	41.8	26.0	24.1	21.1	17.3	8.0	19.0	17.1	5.9	22.6	10.4	24.7	4.1	9.7	23.5	20.0	11.6	15.7	10.1	10.5	20.2	16.9	9.4	22.8	15.3	6.2	8.7	39.6	36.6	27.9	30.9	39.7	18.9	5.6	14.3	31.4	8.4	21.9	0.5	1.4	1.4	1.1	0.7	1.5	0.1	1.0	0.8	0.6	0.4	1.9	0.6	4.7	0.4	0.5	0.8	0.3	0.2	25.4	27.8	26.4	43.8	25.1	22.5	31.2	24.1	30.8	22.8	41.7	15.6	16.1	127.0	127.2	31.7	140.8	17.8	0.0	13.6	22.7	9.8	41.0	14.9	35.7	29.9	48.9	40.4	0.0	23.7	93.6	61.5	85.8	12.7	8.6	62.7	46.1	9.7	27.0	38.3	58.1	28.4	52.1	30.4	27.9	12.4	29.4	46.9	17.5	44.9	9.2	38.5	19.4	64.5	7.6	15.3	124.0	108.9	52.3	17.2	165.9
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;epididymis: 38.7"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 80.1;Spermatocytes: 34.1;Spermatogonia: 117.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 8.8;CACO-2: 12.7;HEK 293: 17.4;HeLa: 15.1;Hep G2: 7.5;SCLC-21H: 20.0;SiHa: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.7	3.6	11.1	0.9	18.5	1.3	1.0	12.9	30.8	0.7	1.3	0.8	0.7	1.3	1.2	38.7	0.9	3.0	1.1	0.9	16.5	10.3	4.1	0.7	0.9	0.8	10.4	15.0	0.8	1.7	0.7	3.0	8.1	24.2	1.5	1.5	0.8	0.8	2.8	1.0	1.5	1.8	1.0	7.1	0.7	8.9	9.7	2.1	0.0	0.6	0.0	0.9	0.7	0.5	0.0	0.8	5.5	0.1	0.0	0.3	0.0	0.0	8.8	0.8	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.1	12.7	0.3	1.5	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	17.4	0.0	15.1	7.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.6	0.0	0.2	0.0	0.0	1.0	0.0	20.0	3.4	8.5	3.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	1.0	0.0	0.9	5.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	11.1	18.5	12.9	21.7	16.5	10.3	10.4	15.0	24.2	2.1	3.0	0.0	0.0	0.4	1.5	29.4	1.1	0.0	9.4	1.2	0.0	2.0	80.1	3.3	1.1	10.2	0.5	2.0	0.0	0.7	5.5	1.0	0.6	0.0	0.0	5.1	17.5	9.2	0.0	0.0	16.3	0.6	0.7	0.0	0.0	0.3	1.9	0.6	3.2	1.8	13.3	7.3	0.0	0.1	34.1	117.0	1.4	25.6	0.0	1.4	0.4
MAPK11	"p38-2, p38Beta, PRKM11, SAPK2"	ENSG00000185386	"Mitogen-activated protein kinase 11"	Q15759	22	50263713-50270767	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 13.2;Ito cells: 14.7;Rod photoreceptor cells: 10.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012961, HPA045069"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB012961: AB_2533144, HPA045069: AB_2679207"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.02e-6)"	"unprognostic (9.84e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	20.4	5.7	14.2	7.5	17.3	0.8	8.2	22.0	23.7	6.6	2.7	2.8	1.0	1.9	8.2	6.2	5.3	7.0	8.8	8.8	11.7	9.1	5.0	1.5	8.5	8.5	7.2	19.9	5.3	3.1	6.4	10.9	8.4	6.6	7.2	2.7	4.1	5.7	8.0	5.0	6.4	2.6	9.8	5.5	7.3	4.6	3.1	4.1	0.9	4.5	5.3	6.1	6.0	4.4	1.1	0.0	0.0	0.3	0.0	0.9	0.0	1.7	4.2	4.7	17.6	6.2	9.4	0.1	6.6	4.7	4.4	1.7	1.7	3.2	0.0	5.9	6.1	7.3	4.3	3.1	2.6	0.3	9.1	2.1	6.2	5.6	0.4	7.1	1.5	9.7	13.0	7.8	1.2	0.5	4.9	9.6	6.7	5.0	17.0	4.3	7.5	0.3	5.7	0.4	5.2	4.9	17.0	0.1	6.0	6.6	0.0	4.4	11.8	5.6	2.3	4.6	0.6	7.7	4.9	15.0	13.2	11.0	0.9	2.4	0.7	2.0	7.2	6.7	1.8	11.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.4	0.2	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	14.2	17.3	22.0	23.7	11.7	9.1	7.2	19.9	6.6	4.1	0.0	1.4	1.3	1.1	1.6	2.6	2.8	0.0	0.0	0.0	0.0	5.9	0.0	1.7	0.8	3.7	13.2	0.0	0.0	0.2	0.3	1.7	3.3	0.0	1.0	0.2	0.0	0.0	14.7	2.6	5.7	2.8	0.0	5.0	0.0	0.0	5.6	0.7	0.0	2.1	1.4	10.9	0.0	1.0	1.2	2.1	1.1	0.0	1.0	0.0	0.9
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261825	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skeletal muscle: 104.2"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"NK-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"NK-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	3.0	1.6	4.5	2.1	4.5	1.0	1.8	9.0	7.0	2.1	1.4	2.1	1.6	2.0	5.4	5.1	3.3	2.9	2.4	5.1	3.9	3.6	2.5	1.0	2.1	2.0	3.5	5.7	3.0	1.4	1.2	7.0	2.3	2.6	2.9	1.1	2.2	1.4	3.7	104.2	0.9	1.5	4.2	2.6	1.6	1.5	1.6	2.4	0.0	1.3	10.8	1.1	2.4	1.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	10.4	6.4	2.5	7.5	5.7	6.3	3.5	8.0	6.9	13.4	8.5	9.3	3.3	19.6	10.9	8.8	8.0	7.0	11.1	1.6	2.6	5.6	15.6	12.8	19.5	11.5	18.1	12.0	25.4	13.5	2.9	3.0	0.0	7.3	15.2	1.8	11.3	18.2	6.2	5.7	0.0	16.0	7.5	3.5	10.5	18.3	6.7	19.9	7.9	1.4	8.6	2.9	6.2	0.2	9.9	1.9	3.4	14.0	7.9	13.9	12.5	3.0	5.0	4.2	3.2	10.5	3.5	11.3	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	4.5	4.5	9.0	7.0	3.9	3.6	3.5	5.7	2.6	2.4	0.0	5.6	1.3	0.4	0.7	5.1	7.8	2.5	1.4	0.0	0.0	0.0	0.3	1.7	0.4	0.3	9.5	0.0	0.0	0.0	1.8	2.8	3.0	10.4	1.0	4.9	1.6	1.7	22.1	2.8	1.3	6.1	0.8	0.0	1.0	0.0	5.1	0.6	0.0	3.5	6.5	1.7	6.5	2.4	0.2	9.7	0.5	0.3	1.0	0.2	0.0
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 143.1;Late spermatids: 214.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 16.5;T-cells: 27.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2;RPMI-8226: 27.9;RT4: 28.9"	"Region enhanced"	"Detected in some"		"cerebellum: 6.5"	"Region enriched"	"Detected in some"	15	"cerebellum: 59.9"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	6.5	22.0	2.2	5.4	4.0	2.9	6.8	2.8	7.3	6.8	18.9	0.5	36.8	18.8	1.9	10.3	41.1	2.4	12.0	1.2	1.7	1.8	6.5	2.8	9.6	11.2	0.8	3.8	3.9	24.6	18.8	12.4	10.5	2.5	6.8	16.0	2.4	20.7	26.3	0.9	28.6	37.7	2.1	0.8	5.9	12.2	23.7	1.1	5.0	13.8	16.0	18.5	7.3	13.9	16.5	0.1	5.2	0.3	2.8	27.8	6.7	19.6	0.1	0.3	0.2	1.2	5.7	2.7	1.6	0.2	0.2	0.5	16.3	19.4	4.7	1.2	1.5	2.8	15.2	0.0	46.2	0.4	12.0	5.2	0.1	0.5	16.2	2.0	0.1	1.2	4.9	16.4	3.0	0.6	2.3	3.0	0.5	0.3	5.3	0.5	10.3	0.1	1.2	0.1	19.4	0.3	11.6	0.2	27.9	9.0	28.9	19.6	0.3	1.7	0.3	0.1	0.6	22.0	2.5	4.1	1.4	0.2	0.5	0.3	0.3	7.0	1.4	0.0	0.5	0.1	5.2	0.3	4.5	16.2	0.0	10.5	10.8	11.6	13.0	0.1	16.5	10.6	11.9	3.9	2.8	0.0	0.0	27.8	6.7	2.2	4.0	2.8	7.3	1.7	1.8	0.8	3.8	2.5	1.1	26.8	24.1	11.5	34.8	24.3	0.8	1.6	22.9	1.4	22.7	27.9	5.9	41.4	13.3	48.4	89.5	2.3	143.1	0.0	102.6	8.3	3.2	28.0	2.3	1.6	35.8	0.0	63.0	0.6	6.1	214.3	6.6	6.4	16.9	22.6	80.8	1.5	76.0	89.2	9.2	7.9	2.2	0.0	1.0	6.1	1.5	46.5	27.0	20.2	93.7	47.8
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716259-143722458	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;epididymis: 27.6;fallopian tube: 29.5"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 85.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2.0	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3.0	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.7	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	7.2	0.0	1.3	0.0	0.0	5.4	0.1	0.2	0.0	1.1	1.6	0.0	14.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.3	2.7	0.0	0.0	13.9	0.0	0.0	2.0	1.2	1.1	0.0	3.0	0.4	0.9	1.3	4.0	4.0	0.0	2.8	0.0	0.2	12.5	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4	0.0	8.3	0.0	0.2	0.3	0.0	0.8	0.0	85.6	13.6	0.0	0.0	0.0	0.0	0.6	12.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.3	0.1	0.0	0.1	0.0
MAPK1IP1L	C14orf32	ENSG00000168175	"Mitogen-activated protein kinase 1 interacting protein 1 like"	Q8NDC0	14	55051631-55070192	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034506	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA034506: AB_10669784"	"unprognostic (3.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.17e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (4.82e-5)"	"unprognostic (7.96e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.40e-2)"	37.7	27.1	22.9	23.9	23.7	65.9	27.9	25.7	29.3	26.3	24.7	24.2	20.0	17.3	32.1	28.6	28.6	31.5	24.9	32.6	20.1	25.8	41.9	32.6	27.6	33.6	21.3	18.0	41.1	21.2	25.7	32.8	36.4	22.8	23.9	23.6	28.5	33.8	30.6	38.5	26.7	29.5	32.8	19.9	33.3	26.7	30.8	17.4	37.7	25.9	26.6	39.1	32.9	24.2	27.5	30.8	28.8	30.4	21.4	30.7	19.6	19.6	17.4	30.7	19.5	24.9	24.6	23.9	22.1	23.6	27.6	32.1	13.9	17.5	22.8	18.9	29.5	16.6	21.8	33.0	33.6	38.8	20.6	21.1	22.0	17.0	20.9	27.3	26.8	24.3	31.7	25.3	23.0	36.7	20.2	36.5	14.7	20.3	20.4	39.8	23.7	22.5	20.8	22.3	18.7	29.4	19.4	33.9	13.7	37.8	22.2	20.1	23.3	21.4	15.4	20.0	28.8	27.4	15.6	27.5	28.4	37.3	17.5	19.7	12.6	18.1	30.2	22.7	14.1	20.3	28.8	22.2	25.7	21.4	30.4	28.2	27.5	25.5	23.1	23.9	23.6	23.8	23.4	16.5	21.4	28.1	30.8	30.7	19.6	22.9	23.7	25.7	29.3	20.1	25.8	21.3	18.0	22.8	17.4	65.5	67.1	61.8	149.4	63.8	21.0	62.4	25.5	29.4	52.4	45.4	35.3	104.9	59.7	58.1	17.0	57.5	43.4	46.7	60.7	94.2	53.6	91.3	81.9	48.3	65.8	36.5	55.6	41.7	57.7	6.7	47.5	53.4	47.2	65.9	50.1	56.2	70.4	41.2	50.9	82.4	22.3	32.3	53.6	84.9	56.9	62.6	126.5	57.4	37.9	127.6
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560078-50731824	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 20.1;Early spermatids: 20.2;Late spermatids: 42.4;Muller glia cells: 55.0"	"Group enriched"	"Detected in many"	5	"glioma: 15.2;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.0;HeLa: 4.5;NTERA-2: 3.0;SCLC-21H: 15.7;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		NA	NA			"Nucleoplasm, Golgi apparatus"	Midbody	"HPA007461: AB_1079308"	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	1.9	26.4	16.9	1.1	33.4	0.9	1.8	15.9	23.9	1.4	2.6	9.5	3.8	1.6	1.8	4.5	3.5	1.5	3.0	16.9	13.0	14.3	4.5	7.0	3.5	0.9	17.1	9.1	4.2	2.5	43.5	8.3	3.7	20.5	5.3	1.8	4.1	1.8	12.4	1.7	1.0	1.9	5.2	11.8	1.1	1.3	3.5	12.4	1.7	7.8	0.0	0.9	2.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	1.5	1.4	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.9	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.7	3.8	0.1	1.1	2.6	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	33.4	15.9	14.5	13.0	14.3	17.1	9.1	20.5	12.4	8.9	0.0	0.0	0.1	0.0	11.0	20.1	2.5	0.0	0.0	0.0	0.0	3.6	5.0	1.0	20.2	0.0	0.0	0.0	0.0	0.3	0.4	0.8	0.0	0.8	0.3	4.8	0.0	0.0	0.0	42.4	0.9	0.0	0.0	0.0	0.0	55.0	0.5	0.0	1.4	0.0	0.6	0.0	1.0	0.6	0.6	0.0	1.5	0.0	0.0	0.0
MAPK8IP3	"JIP3, JSAP1, KIAA1066, syd"	ENSG00000138834	"Mitogen-activated protein kinase 8 interacting protein 3"	Q9UPT6	16	1706183-1770317	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005580, HPA041785, HPA069311"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB005580: AB_627840, HPA041785: AB_2677671, HPA069311: AB_2686116"	"unprognostic (1.49e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.28e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.83e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (5.25e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (3.95e-4)"	9.6	13.8	29.3	14.0	35.7	24.7	6.7	54.9	56.8	8.4	7.7	25.8	5.7	14.9	10.4	5.4	5.5	7.2	9.2	15.1	24.4	19.4	9.1	7.5	8.5	16.4	20.3	35.7	14.6	21.8	12.0	21.3	9.8	32.9	11.1	5.1	8.8	18.1	9.5	12.8	25.1	13.8	8.0	15.3	20.6	13.8	11.1	22.0	4.6	10.0	2.4	7.7	9.8	7.6	1.5	1.6	2.4	1.3	0.0	1.4	0.4	3.7	7.3	7.7	6.9	3.8	6.5	6.1	6.3	2.4	3.2	2.8	10.2	12.6	4.4	4.0	4.0	2.2	7.2	1.9	4.2	1.0	6.9	8.5	5.8	16.6	7.8	5.3	3.8	10.3	12.9	5.6	4.6	2.3	14.1	4.2	8.5	4.9	8.5	3.3	9.6	5.9	16.6	5.2	1.8	4.1	25.8	3.8	7.4	3.9	5.0	16.2	12.9	7.6	7.2	3.0	3.7	3.8	5.4	13.0	13.5	7.5	5.7	5.0	19.2	3.3	5.7	3.5	4.0	6.7	0.0	1.3	2.4	1.4	0.3	0.8	1.5	0.3	0.5	0.4	1.4	0.4	0.4	1.1	0.0	0.3	1.6	0.8	0.4	29.3	35.7	54.9	53.1	24.4	19.4	20.3	35.7	32.9	22.0	3.0	8.5	6.2	4.0	8.8	36.3	5.9	10.2	4.0	7.9	3.5	35.3	4.4	1.7	4.2	19.9	6.3	12.0	0.0	3.2	4.9	6.4	4.9	1.1	7.8	6.1	82.6	9.8	8.0	11.3	15.6	7.2	7.5	6.8	8.2	9.6	7.2	6.0	10.4	8.5	0.7	17.5	6.5	2.1	14.2	3.1	8.4	4.7	6.1	8.9	5.1
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"Mitogen-activated protein kinase associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	27.2	33.9	35.0	24.4	41.4	20.4	22.6	20.3	30.4	27.0	30.1	21.0	20.6	20.1	26.4	25.6	30.3	20.5	21.3	44.9	29.5	24.9	37.5	37.5	20.1	21.3	28.3	20.4	29.1	24.8	29.8	24.1	31.3	27.1	21.7	26.7	22.8	29.7	26.2	60.7	18.2	23.3	33.2	28.5	27.0	25.1	24.9	22.1	24.1	32.7	23.2	24.7	27.2	25.7	7.6	7.1	18.8	6.1	5.4	7.5	2.5	23.7	27.0	18.2	19.3	25.2	24.1	30.4	30.1	30.9	23.4	16.5	27.3	26.8	24.4	18.5	42.0	25.7	33.2	28.2	35.4	31.9	27.6	11.5	17.5	32.6	25.8	28.4	31.3	20.5	23.6	32.7	33.4	35.1	26.2	34.5	24.1	27.8	19.3	49.6	49.6	23.1	12.6	29.0	56.1	33.9	19.6	43.2	32.4	25.7	17.3	22.2	21.8	30.2	28.5	18.9	25.9	33.0	18.4	22.2	33.3	22.0	39.9	50.0	24.2	59.4	24.9	47.5	14.5	35.9	3.6	6.1	5.3	4.6	5.8	6.2	7.5	5.0	5.0	4.8	7.6	4.4	7.5	18.8	5.4	5.2	7.1	5.4	2.5	35.0	41.4	20.3	30.4	29.5	24.9	28.3	20.4	27.1	22.1	11.9	14.2	27.4	23.3	14.1	24.1	59.7	30.6	14.7	36.4	14.0	39.3	28.8	46.4	43.0	56.5	22.7	24.3	23.3	57.0	40.4	18.6	34.5	17.3	28.8	47.0	30.2	9.2	14.1	24.3	91.3	17.5	38.5	21.9	66.7	20.1	28.1	47.7	20.1	16.6	60.6	25.2	6.5	23.4	54.5	81.3	16.9	42.6	24.5	23.4	26.9
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894382-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 89.9;skeletal muscle: 43.7"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 300.5;Early spermatids: 153.8;Horizontal cells: 341.7;Late spermatids: 194.8;Muller glia cells: 139.1"	"Group enriched"	"Detected in many"	11	"breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 27.9;SCLC-21H: 10.1;T-47d: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	3.8	7.1	28.9	2.4	31.2	2.1	8.8	40.1	89.9	2.4	2.7	21.4	1.7	2.5	2.6	2.3	6.4	2.5	2.8	6.5	28.7	29.7	15.3	2.2	2.4	2.3	22.6	35.2	2.3	2.8	8.5	8.8	5.2	29.1	5.1	2.5	2.2	8.1	5.3	43.7	4.6	2.8	2.5	13.6	2.2	2.3	6.5	27.7	0.0	2.3	3.1	2.3	3.2	0.8	0.0	0.0	0.3	0.1	0.5	1.7	0.1	0.8	0.3	0.2	2.6	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	1.3	0.1	0.0	27.9	1.4	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	1.6	0.2	1.4	0.0	4.2	0.5	0.1	0.0	0.4	1.1	0.0	2.3	2.8	0.0	3.6	10.1	4.7	1.0	0.0	1.0	0.6	12.7	0.0	0.0	0.2	0.3	0.6	0.1	0.5	0.2	0.0	0.2	0.5	0.3	0.0	0.1	0.3	0.8	0.0	0.6	0.0	0.4	1.2	0.0	0.0	0.9	0.9	0.0	0.5	0.1	0.0	1.7	0.1	28.9	31.2	40.1	46.3	28.7	29.7	22.6	35.2	29.1	27.7	0.0	9.8	0.8	1.1	0.9	300.5	32.3	0.0	0.0	0.0	1.8	60.9	0.1	6.6	0.4	153.8	1.3	0.0	0.0	0.4	8.0	1.9	2.9	4.6	0.5	0.3	341.7	0.0	0.6	0.3	194.8	2.6	1.3	5.0	1.0	0.0	139.1	0.6	0.0	2.5	44.6	24.8	0.0	4.1	11.4	5.9	2.9	0.2	0.0	0.1	0.5
MARCH10	"FLJ35757, MARCH-X, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 80.2"	"Group enriched"	"Detected in some"	7	"Early spermatids: 371.3;Late spermatids: 1043.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;EFO-21: 7.3;HSkMC: 3.2;SCLC-21H: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.2	0.1	0.7	0.2	1.6	0.0	0.1	0.1	0.3	0.5	0.1	1.9	0.6	0.0	0.3	4.8	0.1	7.9	0.1	0.1	1.0	1.0	0.6	0.1	1.4	0.1	0.2	0.5	1.0	0.1	0.3	4.5	0.1	1.8	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	80.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.6	3.4	0.3	0.1	0.0	0.2	0.0	0.0	0.2	3.9	1.7	0.2	1.2	0.3	0.0	0.1	0.0	7.3	0.5	0.1	0.0	0.0	0.4	1.4	0.0	0.0	1.3	0.7	0.0	1.5	0.0	0.0	3.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.5	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.2	1.1	0.0	12.7	0.0	0.0	0.7	0.1	0.5	0.2	0.0	0.0	0.0	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.7	0.3	0.7	0.1	0.6	1.8	0.0	0.6	0.0	0.0	0.7	0.3	0.7	1.6	0.1	0.3	1.0	1.0	0.2	0.5	1.8	0.3	3.0	1.0	0.0	0.0	0.1	0.0	0.3	0.0	105.7	15.9	3.5	0.0	0.1	44.7	0.0	371.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.0	1043.9	4.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.5	0.0	42.4	10.6	0.0	0.1	0.5	0.0	0.0
MARCH2	"HSPC240, MARCH-II, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	37.7	12.4	30.7	13.5	28.3	17.5	23.9	8.6	39.1	9.8	29.8	20.7	9.7	11.2	12.5	39.0	19.3	10.0	11.4	38.9	23.5	21.9	11.0	17.9	18.2	15.0	30.8	19.8	8.2	10.0	10.5	11.3	13.9	20.2	16.0	10.3	12.7	13.4	21.8	46.9	12.7	11.7	28.5	27.8	18.9	13.3	8.6	13.3	8.4	21.3	14.1	10.0	20.4	9.7	3.6	26.5	20.4	14.6	3.7	7.3	10.1	5.6	7.2	3.2	15.1	19.9	6.5	5.5	6.1	7.5	4.9	5.1	3.5	2.6	2.2	18.0	13.1	6.5	4.0	4.2	8.6	3.8	11.1	9.9	17.0	3.3	7.8	10.8	2.5	25.7	7.8	9.9	4.7	4.2	7.1	19.2	9.0	2.4	12.5	3.8	10.7	3.4	8.1	6.8	6.8	17.4	5.4	1.0	5.6	11.3	6.7	1.6	9.1	0.4	6.6	11.5	11.6	5.0	5.4	19.3	6.9	4.2	22.8	5.1	11.2	13.3	2.5	11.2	5.1	5.2	20.4	10.0	15.4	5.7	14.6	5.9	3.6	5.9	4.6	6.7	3.5	4.0	5.4	12.5	3.7	12.8	26.5	7.3	10.1	30.7	28.3	8.6	39.1	23.5	21.9	30.8	19.8	20.2	13.3	3.0	10.9	4.5	0.0	6.6	10.7	38.1	7.6	2.7	3.4	19.2	2.0	6.6	33.2	0.0	8.1	27.0	13.6	23.3	0.0	9.3	10.5	0.0	12.7	24.6	57.4	22.3	11.6	47.9	48.6	36.4	8.6	19.4	23.6	0.0	5.5	17.5	0.0	7.4	11.0	43.4	7.7	12.9	20.6	5.4	8.5	11.3	4.8	18.1	4.6	0.0
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857362-113863471	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 652.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 10.1;neutrophil: 15.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"AF22: 74.7;TIME: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		17000000	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	13.0	5.0	11.2	17.0	12.9	26.9	16.0	18.5	43.3	12.1	23.2	17.9	0.9	11.6	9.7	4.0	17.0	8.4	10.9	9.7	10.5		5.3	8.7	12.9	13.3	8.8	15.9	12.6	11.2	1.2	6.5	39.5	13.8	14.1	21.6	11.4	8.2	5.6	5.0	9.5	12.9	9.1	42.3	20.9	18.8	5.2	8.5	30.0	4.9	7.9	13.6	23.5	7.8	3.9	0.9	15.0	10.1	0.0	0.0	0.4	6.8	4.0	74.7	4.0	25.3	16.5	0.4	22.2	31.2	15.7	26.2	7.2	9.8	0.0	4.7	40.9	12.4	21.3	12.3	6.4	20.5	0.0	7.3	0.0	4.3	9.4	16.9	1.8	0.1	17.0	12.7	15.1	14.4	43.1	44.2	0.0	0.8	19.7	22.2	0.0	0.2	0.0	9.6	7.7	5.3	0.0	7.5	0.7	4.9	13.2	10.4	30.3	14.2	7.2	15.2	18.4	0.3	2.0	58.7	14.6	0.1	23.9	37.8	53.3	3.8	2.0	11.2	9.9	27.9	0.0	3.4	0.0	0.0	10.1	0.0	3.9	0.0	0.0	0.9	1.6	0.0	0.0	15.0	0.0	5.5	0.0	0.0	0.4											8.9	19.9	84.3	477.4	447.8	131.4	10.5	56.0	99.0	62.6	36.6	27.5	5.0	31.5	120.8	46.4	214.9	254.5	0.0	195.2	5.5	224.2	281.9	2.3	4.3	324.8	79.4	322.8	234.5	223.1	24.8	111.7	249.4	259.8	652.8	331.8	330.7	220.9	241.8	62.9	3.4	33.7	38.8	128.7	20.0	15.6	558.1	24.6	7.5	259.9	481.3
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942166-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 66.3;lung: 65.6;lymphoid tissue: 58.7"	"Cell type enriched"	"Detected in some"	6	"Kupffer cells: 829.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 15.8;intermediate monocyte: 26.7"	"Lineage enriched"	"Detected in many"	5	"monocytes: 26.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;THP-1: 5.7;U-2 OS: 6.2;U-266/70: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		24000000	"Golgi apparatus"	Vesicles	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	22.8	11.7	0.8	29.6	1.1	0.9	3.3	2.3	1.3	0.3	2.8	0.9	0.0	0.6	0.3	12.9	5.2	13.8	0.8	10.8	0.6	0.4	1.6	66.3	65.6	29.3	1.3	3.1	4.7	0.4	0.2	0.8	2.3	2.7	4.5	0.7	1.0	2.9	0.8	6.8	1.1	1.3	9.6	1.7	58.7	2.2	2.8	0.6	0.0	3.0	0.5	0.4	8.8	1.1	0.0	5.0	0.3	26.7	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.9	4.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.7	0.0	0.0	6.2	0.9	0.0	3.6	0.0	0.2	0.0	1.3	0.0	0.0	15.8	0.0	0.0	26.7	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.3	0.0	3.2	0.4	0.0	3.4	0.8	1.1	2.3	1.3	0.6	0.4	1.3	3.1	2.7	0.6	23.8	42.6	0.0	0.0	1.0	0.0	0.4	0.0	24.1	30.7	3.5	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.7	1.5	0.1	11.6	0.8	145.4	0.0	0.0	13.5	829.9	0.0	0.0	63.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.6	1.3	0.0	0.0
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911019	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: AB_2686722"	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	9.7	11.6	16.5	16.3	21.4	18.5	13.8	24.7	26.1	15.2	20.5	20.0	11.1	21.3	13.6	7.5	48.4	13.6	14.4	14.7	17.0	10.1	11.9	12.4	15.4	16.3	18.1	13.7	11.0	17.3	21.8	22.4	21.1	15.0	14.9	19.8	10.6	20.7	14.3	15.7	35.8	26.9	13.3	13.3	21.6	16.8	9.8	18.7	22.9	15.9	13.6	23.5	14.8	21.3	2.9	1.9	9.8	1.9	3.3	4.5	1.2	22.7	15.2	12.5	13.1	6.9	9.0	17.3	9.3	8.9	13.4	10.4	16.3	24.1	16.8	16.4	9.7	14.5	29.5	12.0	14.5	11.6	11.6	9.4	18.5	12.0	10.6	7.7	20.1	24.5	4.9	19.8	12.3	10.7	6.3	11.0	15.9	15.7	19.4	8.8	28.0	21.0	14.3	14.2	18.4	11.1	17.4	9.3	18.6	10.0	18.8	17.2	11.6	16.0	41.1	10.7	14.0	29.9	12.0	10.4	14.2	8.9	18.3	10.3	11.8	12.2	16.5	9.7	10.6	11.3	2.7	1.7	4.4	2.9	1.5	4.5	2.3	3.2	3.1	1.9	2.9	2.6	2.4	9.8	3.3	1.9	1.7	1.5	1.2	16.5	21.4	24.7	26.1	17.0	10.1	18.1	13.7	15.0	18.7	6.0	5.0	13.9	16.2	22.3	26.0	10.9	35.7	6.7	6.8	19.2	7.9	19.2	1.7	18.5	0.4	11.9	59.3	0.0	18.5	16.8	10.6	28.8	17.3	12.1	15.7	19.1	28.7	13.5	19.5	0.7	11.8	11.3	3.3	8.2	35.1	19.1	20.0	35.9	10.3	6.9	17.8	19.4	9.2	8.4	21.8	30.1	54.3	23.6	28.2	30.9
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.9;pancreas: 34.5"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 154.2;Paneth cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 11.7;BEWO: 17.6;CACO-2: 13.0;CAPAN-2: 12.6;HaCaT: 11.9;MCF7: 22.2;RT4: 10.4;SK-BR-3: 10.5;T-47d: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"		No	NA			Vesicles	"Intermediate filaments"	"HPA043514: AB_10959475, HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favorable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.4	0.3	0.4	12.5	0.3	0.0	5.0	0.7	1.2	2.0	35.7	0.3	5.2	17.3	1.3	8.6	4.1	2.1	15.4	0.5	0.5	0.4	14.2	4.3	3.3	0.5	0.3	0.1	1.0	34.5	5.4	1.2	5.3	2.4	6.5	10.5	2.4	10.4	4.3	0.3	3.0	52.9	0.7	0.4	0.4	2.1	1.2	0.1	1.3	8.3	2.3	4.6	3.0	3.4	1.5	1.4	4.1	0.8	1.5	0.8	0.2	11.7	0.4	0.2	0.5	0.0	0.1	17.6	0.0	0.0	0.0	0.0	13.0	12.6	0.1	1.3	0.0	0.0	11.9	1.1	5.7	0.0	0.0	6.8	0.0	0.1	3.4	0.0	0.1	0.1	0.5	7.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	22.2	0.1	0.2	2.0	7.4	0.1	0.0	0.0	4.7	0.2	10.4	2.1	0.1	0.2	10.5	0.0	1.5	14.9	0.2	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	4.1	0.8	0.8	0.7	0.5	0.4	0.8	0.8	0.6	0.3	1.5	0.7	0.7	4.0	1.5	0.5	1.4	0.7	0.2	0.4	0.3	0.7	0.5	0.5	0.4	0.3	0.1	2.4	0.1	8.9	5.9	0.0	25.0	7.0	5.9	0.4	38.2	20.1	12.5	8.7	0.0	31.8	1.7	23.0	4.2	0.0	154.2	0.0	29.6	0.7	1.0	32.3	0.0	5.0	2.5	0.0	59.0	0.6	1.2	2.2	0.3	1.0	0.0	1.0	62.0	0.8	24.0	84.2	0.7	20.2	19.7	0.0	1.0	7.7	4.3	3.1	4.0	1.3	44.3	38.8
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 7.5;epididymis: 4.0"	"Cell type enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"HEL: 3.9"									HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	7.5	1.3			0.4	1.2	4.0	2.1	0.2	1.2	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0		0.0	0.1	0.0	0.0	0.0		0.8	1.1		1.5	0.3	0.2	1.7	1.5	1.1	0.0	0.0	0.5	0.3			0.0		0.5	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874951	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 51.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 22.6;Cone photoreceptor cells: 41.2;Early spermatids: 13.0;Horizontal cells: 14.3;Rod photoreceptor cells: 18.7"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 3.6;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.0;SCLC-21H: 26.5;SH-SY5Y: 13.2;U-266/70: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	1.2	5.2	20.4	1.7	13.6	1.6	1.5	51.0	40.1	1.1	1.5	1.4	0.0	1.7	1.3	1.2	1.3	1.2	1.6	1.3	16.1	16.3	1.2	1.3	1.2	1.3	8.8	19.5	1.5	1.6	1.2	10.4	1.2	19.9	1.2	1.3	1.6	1.3	1.2	1.2	4.1	1.6	1.3	4.2	1.2	1.5	3.9	2.7	0.0	1.2	0.0	1.3	1.2	0.2	0.4	0.0	0.0	0.2	0.0	3.6	0.1	2.2	1.0	1.0	15.0	0.0	0.0	1.2	0.1	0.1	0.2	0.6	0.5	0.9	3.6	1.7	0.0	2.5	0.0	4.4	0.0	0.0	2.5	2.9	0.3	3.6	1.6	0.0	0.8	0.8	0.3	0.0	0.5	0.5	0.8	0.0	9.8	3.1	1.9	0.0	0.5	1.5	0.4	4.5	0.4	4.6	9.9	3.0	5.1	0.2	0.1	26.5	13.2	0.5	0.9	2.7	0.8	2.4	1.3	0.0	1.8	2.8	2.0	0.5	10.8	8.6	2.1	3.3	2.0	0.1	0.0	0.2	0.0	0.0	0.2	3.6	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	2.0	0.1	20.4	13.6	51.0	34.3	16.1	16.3	8.8	19.5	19.9	2.7	0.0	3.7	0.0	1.9	0.8	22.6	0.8	0.0	1.4	0.0	0.0	41.2	0.4	0.0	0.1	13.0	1.0	0.7	0.0	0.4	0.4	0.7	0.9	1.1	0.8	0.2	14.3	0.0	0.6	1.2	6.5	0.6	1.0	5.0	0.0	0.0	3.6	0.3	2.9	1.1	0.1	18.7	0.0	0.8	2.8	4.1	1.3	0.2	1.0	0.4	0.6
MAST2	"KIAA0807, MAST205"	ENSG00000086015	"Microtubule associated serine/threonine kinase 2"	Q6P0Q8	1	45786987-46036124	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.3;Cone photoreceptor cells: 51.1;Enterocytes: 45.1;Late spermatids: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039722, HPA040155"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039722: AB_10795294, HPA040155: AB_10793957"	"unprognostic (7.80e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (4.31e-8)"	"unprognostic (8.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (6.85e-13)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.90e-1)"	8.9	4.3	7.0	9.9	8.1	3.7	7.1	7.1	11.8	13.6	15.2	8.4	6.6	11.2	16.7	7.7	8.8	9.5	9.9	25.5	5.0	7.6	4.8	6.1	5.9	4.4	8.9	7.3	19.8	3.6	9.1	10.5	5.5	10.1	13.9	13.9	7.2	8.3	8.6	83.3	5.5	21.3	14.9	5.8	2.5	9.0	24.8	4.8	3.5	5.7	27.4	7.5	16.3	10.6	0.5	1.9	1.4	4.3	1.4	1.4	0.5	14.9	12.1	12.3	9.4	16.1	23.1	13.6	16.0	11.6	14.8	16.5	13.9	4.9	23.4	7.5	19.5	30.0	7.4	14.8	9.1	15.7	11.2	8.0	10.6	13.7	12.7	14.0	5.6	13.6	17.7	11.8	24.8	19.8	18.6	13.8	6.1	8.1	7.2	17.6	10.2	8.2	5.8	10.1	10.1	13.9	12.2	20.6	4.4	7.7	8.1	17.1	10.1	18.8	24.6	8.0	14.1	11.2	5.6	13.4	28.7	18.5	14.9	15.8	9.7	8.7	8.5	19.1	7.7	11.8	0.0	1.1	1.4	1.4	0.6	1.4	0.2	0.7	1.4	1.9	0.5	0.5	1.0	0.0	1.4	4.3	0.1	0.0	0.5	7.0	8.1	7.1	11.8	5.0	7.6	8.9	7.3	10.1	4.8	0.0	1.3	0.0	4.2	3.8	14.9	43.3	2.5	1.4	7.9	3.5	51.1	4.4	1.7	4.2	27.6	5.3	45.1	0.0	5.4	4.0	6.6	7.8	0.0	5.6	5.5	4.8	11.6	3.1	1.6	44.9	8.3	6.4	6.8	1.0	18.3	3.0	6.7	26.6	9.6	4.2	12.7	6.5	6.1	28.4	11.7	2.4	4.6	1.9	18.1	6.0
MAST3	KIAA0561	ENSG00000099308	"Microtubule associated serine/threonine kinase 3"	O60307	19	18097793-18151692	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.5"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 21.5;Late spermatids: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035061, HPA035062"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035061: AB_10670585, HPA035062: AB_10671508"	"unprognostic (5.94e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (1.93e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-3)"	4.6	3.5	20.7	8.3	36.1	12.3	1.8	1.1	72.5	3.8	5.3	19.0	0.2	9.1	3.6	4.9	2.2	4.9	3.1	2.1	19.7	9.3	3.6	6.4	4.6	9.9	13.0	33.6	4.6	14.3	7.1	7.7	2.6	13.0	2.7	4.4	0.7	4.6	4.2	2.6	6.9	8.8	3.0	7.9	11.4	3.9	2.1	12.5	1.8	2.4	0.3	9.4	3.3	2.4	4.4	10.3	23.2	9.7	5.8	8.4	3.1	3.3	5.0	2.3	10.1	6.8	5.5	5.5	3.4	2.2	2.4	3.5	5.0	4.7	8.7	5.2	3.4	2.6	1.8	3.3	1.9	1.7	7.4	4.1	4.0	5.2	7.9	5.8	2.1	13.3	6.3	5.7	3.6	1.4	3.3	1.1	6.0	4.0	5.7	2.7	6.0	4.4	7.0	2.4	7.4	6.2	12.1	2.0	6.4	1.8	1.5	3.8	6.2	4.8	2.8	2.0	1.7	3.2	4.9	4.0	3.1	3.3	13.0	1.4	6.2	8.4	8.0	6.8	11.2	2.8	0.1	4.5	9.4	8.4	5.6	6.2	4.1	4.7	3.3	2.1	4.4	3.7	6.4	23.2	5.8	9.7	10.3	5.0	3.1	20.7	36.1	1.1	72.5	19.7	9.3	13.0	33.6	13.0	12.5	6.0	10.3	7.8	0.7	0.5	3.2	1.1	7.6	0.0	3.4	8.7	2.0	0.5	3.3	2.8	9.1	1.6	20.0	0.0	9.2	1.2	2.2	0.8	2.3	12.5	6.9	0.0	2.4	7.4	21.5	24.6	3.7	7.9	5.0	6.4	6.9	0.8	6.1	8.6	6.3	8.7	0.6	0.0	1.8	0.6	2.8	1.9	0.3	9.6	8.6	0.6
MAST4	KIAA0303	ENSG00000069020	"Microtubule associated serine/threonine kinase family member 4"	O15021	5	66596361-67169595	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 428.6;Basal keratinocytes: 327.4;Glandular cells: 324.3;Suprabasal keratinocytes: 348.9;Urothelial cells: 641.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 17.8;HDLM-2: 22.6;HEL: 18.7;RT4: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000544	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000544: AB_1079315"	"unprognostic (1.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (9.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.08e-2)"	16.2	12.9	10.2	6.9	11.8	2.5	12.6	6.2	19.4	13.9	6.9	6.3	6.3	6.3	14.4	8.9	31.2	11.6	9.7	24.5	9.9	8.1	14.2	9.5	13.1	5.0	6.5	9.2	20.2	5.9	35.6	16.7	18.4	11.1	10.1	5.3	5.7	13.7	8.7	12.7	16.9	6.8	11.4	5.6	6.0	8.2	10.7	5.0	37.5	8.1	21.8	20.6	13.6	22.3	3.4	1.1	12.1	0.9	2.4	7.5	1.4	7.6	4.2	2.1	0.1	6.9	6.2	5.0	1.7	2.6	0.6	0.5	3.8	2.1	0.5	3.6	1.4	1.6	6.9	6.4	17.8	0.7	22.6	2.1	18.7	2.4	1.6	0.5	0.0	6.6	10.3	9.8	3.9	7.9	7.3	14.1	1.7	1.8	2.1	4.8	6.6	2.7	0.1	1.4	0.6	3.4	0.6	1.8	0.4	1.7	22.9	3.0	2.4	2.3	0.9	0.1	1.5	1.5	0.1	13.5	1.6	2.3	2.5	2.9	5.5	2.4	0.1	4.3	0.0	1.3	12.1	0.4	0.8	1.2	0.5	2.9	3.4	4.7	1.2	0.4	2.1	5.0	2.1	4.1	2.4	0.9	1.1	7.5	1.4	10.2	11.8	6.2	19.4	9.9	8.1	6.5	9.2	11.1	5.0	29.8	44.7	9.0	428.6	327.4	18.2	114.6	17.8	29.4	59.1	17.4	2.0	33.2	31.5	46.4	104.5	72.0	17.3	0.0	103.5	42.2	34.0	324.3	92.3	37.2	4.6	7.9	30.9	60.2	6.0	92.7	38.3	9.8	45.5	2.8	14.9	56.5	55.6	15.6	30.8	73.9	3.5	38.8	35.8	11.4	8.5	348.9	114.8	15.2	15.0	641.7
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539165-85545280	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 205.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		950000	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	55.9	68.9	37.4	35.3	54.1	20.4	30.3	37.5	50.0	28.6	35.3	74.5	39.7	33.6	35.8	59.8	33.5	44.9	51.6	35.0	41.7	28.5	52.3	26.4	32.9	27.0	74.8	37.6	44.2	205.8	38.8	60.5	29.3	48.9	40.6	36.8	35.0	28.2	31.3	51.4	33.7	35.8	47.6	57.7	24.7	44.6	34.9	69.4	22.7	94.0	34.1	30.8	46.9	33.4	13.8	15.3	4.9	17.2	16.9	22.8	14.9	30.0	44.6	52.4	32.5	36.1	44.1	31.0	37.8	34.9	39.8	42.5	36.4	101.4	70.5	24.9	45.9	32.5	46.9	65.9	56.4	51.2	35.7	48.4	42.1	64.6	31.5	66.0	62.4	47.1	39.9	57.2	42.9	30.0	50.7	37.7	41.0	47.3	55.5	90.3	25.8	56.9	68.8	34.8	25.9	57.5	60.6	49.6	45.7	60.1	47.7	41.3	38.1	34.2	33.0	60.9	27.7	27.9	33.5	36.6	48.9	29.5	26.9	45.1	34.3	27.2	51.0	31.9	78.4	25.6	4.8	15.2	4.9	15.4	17.2	22.8	13.8	17.5	16.2	15.3	12.2	16.4	14.3	1.6	16.9	13.7	10.9	15.3	14.9	37.4	54.1	37.5	50.0	41.7	28.5	74.8	37.6	48.9	69.4	44.7	76.0	36.8	172.0	127.5	81.9	4.5	86.6	34.8	63.7	68.0	64.8	30.7	16.6	50.4	46.3	49.1	61.0	23.3	49.9	34.3	63.9	55.3	83.1	40.6	57.5	25.4	79.9	36.2	106.8	20.7	66.7	92.6	64.1	35.1	55.5	59.7	55.5	42.1	78.8	119.6	80.9	109.9	101.9	51.4	57.7	103.4	31.9	36.2	51.7	86.6
MAT2B	"MATIIbeta, SDR23E1"	ENSG00000038274	"Methionine adenosyltransferase 2B"	Q9NZL9	5	163503114-163519336	"Predicted intracellular proteins"	"One-carbon metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037721, HPA037722"	Uncertain		Approved	"Plasma membrane"		NA	NA		1000000	"Plasma membrane"		"HPA037721: AB_10672389, HPA037722: AB_10671718"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.19e-3)"	"unprognostic (3.57e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-3)"	25.1	32.5	25.2	29.1	28.6	12.1	23.9	37.1	39.6	25.3	41.6	20.1	25.1	38.9	28.0	29.0	27.9	31.9	20.4	41.8	24.2	28.6	48.4	37.2	26.6	41.7	24.7	24.9	35.9	16.4	25.7	17.1	23.9	27.6	30.7	31.4	24.3	28.6	26.8	28.7	20.9	57.2	21.3	21.4	45.5	24.9	18.1	17.7	50.8	53.3	20.1	41.0	32.5	32.9	60.4	34.5	82.4	46.0	62.4	86.8	98.8	19.5	17.0	29.9	16.2	22.2	22.1	17.9	17.5	19.9	20.1	29.5	11.9	37.2	20.9	36.8	19.0	29.5	16.1	24.8	36.3	26.7	68.8	20.5	19.0	19.9	17.7	29.2	19.9	12.9	18.3	30.0	25.6	19.9	24.4	43.5	22.2	15.1	26.4	24.6	11.5	27.4	24.0	11.3	12.4	11.6	31.6	14.5	34.4	32.9	21.3	11.8	17.2	23.3	15.7	25.3	13.7	21.9	26.9	35.0	22.0	14.3	14.6	30.2	22.5	21.7	19.1	16.0	36.5	14.8	82.4	38.3	75.6	58.7	44.6	64.3	60.4	64.8	63.2	34.5	56.6	66.2	63.6	58.8	62.4	46.0	27.8	86.8	98.8	25.2	28.6	37.1	39.6	24.2	28.6	24.7	24.9	27.6	17.7	44.7	37.1	50.2	31.8	37.9	20.3	51.5	35.7	54.9	26.1	41.8	7.9	48.4	53.0	29.8	30.6	40.9	34.6	93.5	23.0	24.4	26.9	37.0	26.7	47.9	41.2	17.5	14.5	33.7	74.1	10.9	31.9	43.7	40.5	50.5	44.3	33.3	25.6	24.6	29.4	77.8	15.0	45.3	29.9	21.6	29.8	31.7	31.5	64.2	48.1	35.5
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.3;bone marrow: 19.1;brain: 27.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.9;Hofbauer cells: 58.6;T-cells: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 19.4;NK-cell: 29.3"	"Group enriched"	"Detected in many"	54	"NK-cells: 29.3;T-cells: 19.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 41.6;HMC-1: 12.8;K-562: 18.5;MCF7: 13.5;NB-4: 29.0;SCLC-21H: 12.7;THP-1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	11.2	1.6	22.1	6.8	18.1	19.1	2.2	1.5	27.4	1.5	2.3	1.7	0.0	7.0	1.2	0.4	1.1	4.7	5.1	1.7	25.1	10.0	1.1	2.8	7.3	9.6	7.0	11.0	1.0	1.6	0.1	1.4	1.4	6.1	1.2	1.4	0.6	3.8	1.0	0.8	1.6	6.7	1.1	2.8	14.8	4.1	2.1	1.3	3.5	0.9	0.0	4.5	2.4	0.7	0.4	0.3	0.4	0.0	29.3	19.4	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.4	4.2	5.5	0.1	0.0	0.0	7.2	4.6	0.5	1.1	0.0	41.6	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	18.5	0.0	0.0	13.5	0.1	29.0	3.4	3.5	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.4	0.0	10.9	1.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	13.2	0.0	2.5	12.2	0.3	0.4	1.2	7.1	0.4	29.3	0.0	0.1	0.1	2.7	22.1	18.1	1.5	27.4	25.1	10.0	7.0	11.0	6.1	1.3	0.0	1.4	2.4	0.0	0.3	1.7	1.1	0.0	1.4	0.0	0.0	11.8	0.2	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.3	0.5	0.1	44.9	0.8	58.6	0.0	6.8	11.6	3.5	4.0	0.0	7.2	1.7	1.0	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.3	2.7	1.0	0.2	105.8	0.1	0.0
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992111-20012694	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.5;placenta: 16.6"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 35.7;Sertoli cells: 25.8;Smooth muscle cells: 11.4"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 13.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"Hep G2: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051250			Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"HPA051250: AB_2681406"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.51e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.15e-2)"	2.4	1.3	6.6	1.0	5.1	0.3	3.4	1.8	7.9	4.1	1.0	2.4	2.6	0.9	2.7	1.8	1.4	2.6	3.4	0.9	6.2	4.9	4.1	0.4	19.5	0.7	8.6	3.7	1.1	1.3	0.4	0.3	16.6	7.4	2.7	1.0	1.9	0.8	7.2	0.5	0.9	0.8	2.8	7.9	0.7	2.8	1.6	6.0	0.0	1.7	0.0	0.7	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	1.9	6.5	0.0	1.9	4.1	0.4	0.8	0.4	2.6	3.4	1.8	1.1	0.0	0.3	0.6	2.5	0.4	0.1	5.0	3.8	0.0	0.1	0.0	0.4	56.1	0.4	0.0	0.0	8.8	0.3	2.9	0.7	1.8	3.5	0.0	0.0	0.0	5.5	0.9	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	7.9	1.7	0.0	0.8	4.2	0.7	2.4	11.6	7.7	0.0	1.9	3.9	4.8	0.1	0.4	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	5.1	1.8	7.9	6.2	4.9	8.6	3.7	7.4	6.0	35.7	2.1	0.0	0.3	0.2	0.0	0.2	0.0	2.7	2.3	1.8	0.0	0.0	0.0	0.2	0.4	1.4	0.0	0.0	0.2	1.6	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.7	0.0	4.2	0.3	0.0	25.8	11.4	0.0	1.5	0.1	0.1	0.0	0.0	0.1
MATR3	"KIAA0723, MGC9105, MPD2, VCPDM"	ENSG00000015479	"Matrin 3"	P43243	5	139293648-139331677	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	RNA-binding	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	12	"Cytotrophoblasts: 1.0;Hofbauer cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB033552, HPA036564, HPA036565"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		140000	Nucleoplasm		"CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (9.33e-2)"	"unprognostic (6.57e-2)"	"unprognostic (8.37e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.86e-2)"	"unprognostic (7.90e-2)"	32.9	39.7	62.4	25.8	77.3	82.2	49.0	103.4	81.6	46.9	32.2	35.3	27.1	22.4	50.6	38.6	31.4	40.5	34.6	36.1	61.5	62.0	46.3	33.3	34.0	42.0	50.1	58.5	62.6	30.2	61.7	61.0	36.1	59.0	40.7	32.6	28.8	28.4	43.3	44.3	23.7	27.5	43.5	51.3	35.0	25.5	32.7	36.8	64.8	58.0	23.9	48.5	36.7	30.4	36.6	28.3	45.5	30.4	45.4	44.8	42.9	36.9	34.7	104.5	47.9	36.7	40.7	52.9	31.6	55.5	56.2	65.6	49.4	38.6	62.4	44.2	44.1	53.2	24.6	69.0	49.1	75.8	49.3	33.8	42.3	41.1	51.6	35.0	45.9	32.5	41.9	37.8	45.6	42.4	46.3	54.3	39.9	38.0	31.4	57.6	33.6	87.3	51.4	56.4	37.0	33.1	54.0	78.2	38.9	52.1	57.7	52.3	65.8	45.5	33.1	46.4	83.5	36.2	45.4	35.0	51.5	33.7	33.7	44.2	32.0	52.0	76.0	35.9	40.3	49.5	45.5	20.9	33.9	36.3	25.1	44.8	36.6	38.2	40.9	28.3	30.7	42.3	38.8	10.4	45.4	30.4	15.7	40.8	42.9	62.4	77.3	103.4	81.6	61.5	62.0	50.1	58.5	59.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
MATR3		ENSG00000280987	"Matrin 3"		5	139273752-139331671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 101.8;Ciliated cells: 112.4;Club cells: 72.8;granulocytes: 100.2;Intestinal endocrine cells: 79.9;Melanocytes: 97.8;Suprabasal keratinocytes: 97.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA036564, HPA036565"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (3.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.69e-9)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.91e-10)"	"unprognostic (2.91e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-2)"	1.9	3.5	4.4	5.4	11.1	4.3	5.5	3.0	14.5	2.0	4.4	3.9	1.2	3.6	3.6	5.3	3.0	4.4	1.6	9.6	4.6		1.9	2.0	1.1	7.6	3.8	6.8	4.0	4.2	1.8	1.1	2.1	10.1	3.7	6.3	0.7	6.1	1.8	12.8	3.1	2.4	3.2	3.3	4.0	3.9	4.7	4.5	2.2	1.5	5.2	6.7	2.8	5.3	5.8	4.9	0.5	1.8	1.6	4.3	2.2	14.5	10.7	6.9	32.8	17.5	19.8	12.3	9.6	7.6	13.4	16.4	16.5	13.4	56.3	14.1	13.8	9.4	17.5	51.4	27.3	25.6	11.3	23.7	33.7	14.4	12.8	14.2	33.6	14.2	21.4	19.3	17.3	21.6	9.7	13.4	21.2	28.7	9.7	15.3	6.3	21.8	9.4	27.0	7.6	7.5	43.2	21.7	23.4	6.9	8.9	21.8	12.3	12.3	13.1	24.7	16.8	10.9	17.3	10.3	11.3	17.2	9.3	13.6	5.0	5.3	31.0	9.5	29.0	13.8	0.1	1.4	0.2	0.9	1.8	2.1	5.8	2.9	3.4	4.9	3.6	4.3	3.3	0.5	1.6	0.8	0.2	1.5	2.2											41.7	33.3	0.0	0.6	101.8	1.8	0.0	0.0	112.4	72.8	0.0	2.0	0.3	0.0	0.0	0.2	0.7	2.3	0.0	0.0	0.2	0.8	0.7	100.2	0.0	0.7	1.6	79.9	0.0	0.0	0.4	0.6	23.2	97.8	0.0	2.0	0.5	0.1	0.8	0.7	0.0	0.9	0.0	0.3	1.4	0.4	97.2	0.2	0.0	1.5	0.9
MAX	"bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8"	ENSG00000125952	"MYC associated factor X"	P61244	14	65006174-65102695	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 94.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000328, HPA003474"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB000328: AB_2281783, HPA003474: AB_1079317"	"unprognostic (4.50e-3)"	"unprognostic (1.51e-3)"	"unprognostic (4.08e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (6.03e-2)"	33.4	25.5	31.3	31.5	38.6	68.7	25.8	59.0	38.2	34.6	29.4	37.2	26.3	31.5	34.3	24.0	47.6	38.2	27.9	30.1	29.9	28.4	26.3	21.8	31.4	43.4	37.1	21.6	39.7	20.0	17.4	23.7	30.2	32.7	31.9	25.0	26.8	33.6	37.7	27.8	32.1	40.2	30.7	34.8	42.9	24.8	15.7	40.9	41.3	30.2	22.5	40.7	35.1	40.7	18.7	19.1	87.5	23.6	19.2	30.0	44.8	28.9	11.3	7.0	11.3	18.4	14.4	9.1	10.2	15.6	12.7	15.7	7.2	20.4	24.1	8.6	12.2	11.3	14.5	17.5	14.2	9.6	24.3	10.6	37.5	7.5	7.9	21.6	14.1	94.4	17.2	10.1	11.7	13.0	16.6	14.1	16.3	17.6	9.8	12.9	16.0	32.6	48.6	9.3	17.1	18.6	18.5	11.0	10.8	11.8	9.7	15.1	9.8	13.4	14.3	13.1	6.5	14.0	18.0	17.6	11.7	14.2	10.8	8.1	12.1	10.2	15.3	14.6	13.6	11.7	87.5	23.6	80.6	21.7	20.1	23.7	18.7	25.4	22.1	19.1	17.6	26.6	22.3	49.5	19.2	17.4	18.3	30.0	44.8	31.3	38.6	59.0	38.2	29.9	28.4	37.1	21.6	32.7	40.9	26.8	27.2	50.6	55.5	151.2	22.4	25.5	22.9	21.4	27.3	17.4	19.6	34.8	44.7	33.9	34.8	46.7	63.2	0.0	27.8	36.5	43.0	52.7	62.2	19.1	53.4	44.5	42.5	68.2	78.5	71.7	72.2	46.3	54.0	34.3	40.5	43.3	45.6	87.7	56.6	49.1	15.0	135.8	55.6	40.5	26.6	157.8	45.2	59.0	24.2	65.0
MB21D2	C3orf59	ENSG00000180611	"Mab-21 domain containing 2"	Q8IYB1	3	192796815-192918161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 34.9"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 55.7;Syncytiotrophoblasts: 92.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 6.6;T-reg: 5.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044026	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA044026: AB_10962840"	"unprognostic (3.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (2.76e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.28e-2)"	5.7	6.0	4.4	4.4	6.9	1.6	5.1	11.1	10.9	5.8	6.9	5.6	2.7	12.0	7.3	2.9	3.2	5.3	10.1	7.6	3.9	5.0	5.8	2.3	5.9	3.1	4.4	3.5	6.5	2.8	5.6	8.6	34.9	4.6	4.9	4.3	4.0	3.1	3.9	4.9	8.6	15.7	7.8	3.5	3.0	5.1	11.4	3.3	1.2	3.3	2.5	2.5	8.7	5.0	0.3	0.6	0.0	0.6	0.0	6.6	1.8	9.9	1.4	2.4	7.3	1.5	2.3	4.4	7.2	6.7	13.0	7.8	6.4	1.6	0.0	4.3	17.6	5.4	4.4	5.6	1.8	14.2	43.0	3.1	1.2	0.7	0.7	2.9	0.1	0.6	3.0	2.8	3.6	2.2	1.0	2.5	1.2	0.0	0.6	2.2	7.3	0.1	0.0	5.1	5.4	17.8	0.2	4.0	2.0	3.0	5.7	3.8	1.9	1.5	4.9	0.7	5.2	7.7	0.1	0.8	2.4	7.3	4.3	13.7	19.1	15.1	0.0	1.7	1.5	3.3	0.0	0.3	0.0	0.3	0.6	2.9	0.3	6.6	1.7	0.6	0.0	4.2	1.2	0.0	0.0	0.0	0.0	5.5	1.8	4.4	6.9	11.1	10.9	3.9	5.0	4.4	3.5	4.6	3.3	6.0	0.3	0.9	0.8	8.1	10.6	1.0	0.0	1.4	1.2	0.0	2.0	55.7	0.0	5.2	0.1	4.8	2.9	0.0	0.2	7.2	7.6	0.7	0.0	0.0	5.0	7.9	9.8	9.8	4.3	1.3	2.8	10.7	13.5	22.6	2.4	1.0	1.6	5.8	5.6	8.4	0.7	12.9	4.7	2.1	19.4	7.5	92.3	1.3	2.5	0.9
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151601-54224788	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 8.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872"	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favorable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	29.8	11.9	8.5	27.9	9.8	15.3	24.0	9.9	9.0	17.5	22.5	7.4	20.1	10.5	12.5	14.8	33.1	11.3	18.7	17.9	7.9	8.1	23.3	23.2	21.3	33.7	10.0	5.3	15.3	19.3	13.1	12.5	38.1	8.6	18.3	15.0	12.1	23.3	17.3	13.9	24.1	26.7	15.7	11.7	36.9	12.5	26.1	9.4	31.0	31.0	25.4	32.2	22.8	27.1	2.0	1.5	2.2	8.2	0.4	2.6	0.8	12.7	5.8	10.8	5.3	12.7	10.8	10.6	12.1	15.2	14.0	12.3	3.7	7.1	30.2	6.2	18.6	6.2	20.5	9.1	16.3	15.4	22.5	5.0	4.4	9.1	8.0	13.2	14.1	8.2	9.4	18.4	10.7	15.7	9.3	16.1	9.3	3.4	28.1	12.6	6.1	14.2	7.9	11.3	5.0	7.8	9.6	6.3	12.2	20.1	13.2	11.8	5.0	9.4	9.5	6.3	14.9	4.9	7.2	13.9	14.3	6.6	4.9	10.7	30.5	16.6	23.3	12.6	12.0	8.5	0.1	2.6	1.2	1.2	4.6	1.6	1.4	1.3	1.9	1.5	2.0	0.7	1.2	2.2	0.4	8.2	1.2	2.6	0.8	8.5	9.8	9.9	9.0	7.9	8.1	10.0	5.3	8.6	9.4	26.8	16.0	24.2	25.1	43.8	17.7	28.8	20.4	24.1	20.5	31.4	15.7	11.3	6.6	23.6	1.7	25.3	29.7	23.3	49.8	45.1	20.5	42.9	8.1	17.9	28.1	20.6	15.6	24.5	111.1	3.3	23.3	44.3	25.3	33.3	38.0	36.6	44.0	20.1	24.8	19.0	23.2	25.8	18.1	5.2	4.3	54.6	15.3	17.5	33.1	78.0
MBD3L3		ENSG00000182315	"Methyl-CpG binding domain protein 3 like 3"	A6NE82	19	7056209-7058640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	19	"testis: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HUVEC TERT2: 1.3"									HPA060924			Approved	Mitochondria		NA	NA			Mitochondria		"HPA060924: "																		0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L4		ENSG00000205718	"Methyl-CpG binding domain protein 3 like 4"	A6NDZ8	19	7037748-7040179	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	5	"testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.6"									HPA060924			Approved	Mitochondria		NA	NA			Mitochondria		"HPA060924: "																		0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L5		ENSG00000237247	"Methyl-CpG binding domain protein 3 like 5"	A6NJ08	19	7030578-7033011	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"smooth muscle: 1.0;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060924			Approved	Mitochondria		NA	NA			Mitochondria		"HPA060924: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD5	"FLJ11113, KIAA1461"	ENSG00000204406	"Methyl-CpG binding domain protein 5"	Q9P267	2	148021011-148516971	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035964			Supported	Nucleoplasm,Midbody		NA	NA			"Nucleoplasm, Midbody"		"HPA035964: AB_2674891"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.82e-1)"	8.5	11.3	13.9	14.1	13.7	6.8	9.0	26.1	14.7	13.7	16.3	10.1	8.9	7.2	12.6	8.7	9.9	9.6	13.4	10.3	11.7	10.6	13.7	6.9	8.2	8.7	9.3	9.9	14.2	5.7	25.5	24.7	10.4	11.3	11.5	8.1	10.8	7.5	11.6	9.9	6.6	8.2	15.7	11.8	9.8	9.1	11.0	12.5	17.3	12.8	6.0	8.6	15.1	10.1	1.3	1.1	3.6	1.2	1.0	2.2	0.7	1.4	1.5	9.0	6.5	6.5	7.4	4.0	6.7	7.3	4.5	3.8	3.4	4.5	2.5	1.7	5.7	2.2	1.0	4.7	7.4	6.4	2.2	2.2	5.4	4.9	1.7	2.7	0.7	0.8	5.6	6.5	6.0	4.0	9.3	7.5	4.5	2.0	6.1	7.6	3.4	2.9	3.9	3.0	4.0	2.4	2.9	1.5	0.9	6.0	7.2	5.2	7.3	4.3	2.3	4.5	5.5	2.9	4.5	5.5	5.3	2.2	0.7	2.9	4.4	1.7	2.2	9.0	2.5	6.1	3.6	0.4	1.9	1.6	0.3	1.1	0.7	1.8	1.5	0.9	1.3	1.4	2.2	0.6	1.0	1.2	1.1	0.6	0.7	13.9	13.7	26.1	14.7	11.7	10.6	9.3	9.9	11.3	12.5	14.9	10.7	3.9	10.8	3.4	23.3	8.7	12.7	12.0	23.9	12.2	35.3	6.1	3.3	16.7	52.0	9.0	4.6	0.0	13.8	7.3	7.9	8.0	3.5	7.4	6.0	12.7	11.1	11.6	14.9	28.9	16.7	14.6	0.0	10.8	5.5	9.0	16.2	3.5	9.9	11.6	16.8	6.5	5.2	5.1	7.3	2.9	7.1	13.8	6.9	10.7
MBLAC2	"DKFZp686P15118, MGC46734"	ENSG00000176055	"Metallo-beta-lactamase domain containing 2"	Q68D91	5	90458203-90474768	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037757, HPA037758"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA037757: AB_10670528, HPA037758: "	"unprognostic (6.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.96e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-2)"	5.2	7.4	11.2	5.7	16.8	2.7	9.5	16.7	14.7	8.7	5.7	7.4	7.4	6.1	9.6	6.6	7.2	7.5	5.0	5.2	12.7	14.2	9.3	11.1	5.5	11.1	10.6	9.8	16.3	7.4	21.8	10.0	5.4	9.7	8.6	6.2	4.8	7.8	7.8	4.3	9.5	5.4	7.1	10.7	6.6	4.8	6.1	7.0	8.1	9.7	3.1	7.0	6.5	6.9	5.3	2.9	1.1	3.8	3.3	4.8	2.3	5.8	2.5	4.4	5.5	5.8	7.9	5.4	4.6	4.3	4.0	4.3	1.9	4.4	13.7	2.8	4.1	5.6	6.0	5.7	7.0	6.3	7.7	3.9	6.1	4.1	4.4	6.1	6.0	2.7	6.8	9.4	2.9	11.2	4.7	5.1	7.4	9.2	7.6	6.8	3.6	5.8	8.3	2.8	1.2	12.3	6.3	7.3	18.6	6.1	2.2	7.6	8.9	4.2	6.2	11.2	2.7	5.1	4.5	6.3	5.0	3.5	6.1	6.0	5.4	6.0	6.1	4.3	12.7	6.8	0.0	1.5	1.1	3.2	3.8	3.9	3.1	3.6	3.5	2.9	5.3	4.8	3.7	0.1	3.3	1.9	1.0	1.3	2.3	11.2	16.8	16.7	14.7	12.7	14.2	10.6	9.8	9.7	7.0	3.0	2.2	1.4	0.8	2.4	6.4	4.0	5.1	2.7	1.2	1.8	7.9	3.0	1.7	1.6	0.3	4.4	2.0	0.0	1.1	2.7	2.2	0.8	0.0	4.9	2.2	3.2	4.1	3.7	5.3	0.6	3.7	1.2	1.7	1.0	2.8	5.6	2.0	0.0	4.9	3.9	6.2	0.0	2.7	2.8	4.6	2.9	0.7	2.1	3.5	0.7
MBNL3	"CHCR, FLJ11316, MBLX39, MBXL"	ENSG00000076770	"Muscleblind like splicing regulator 3"	Q9NUK0	X	132369317-132489968	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 67.0"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 253.9;Hepatocytes: 109.0;Syncytiotrophoblasts: 287.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 39.8;Hep G2: 54.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001584	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA001584: AB_1079326"	"unprognostic (3.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.37e-1)"	6.6	10.4	1.8	14.7	1.9	5.1	7.5	0.9	1.6	3.8	5.9	2.8	10.8	4.0	4.8	25.8	9.6	4.6	4.6	14.2	1.6	1.9	5.6	23.5	12.0	16.2	3.0	1.1	5.5	10.4	2.4	6.3	67.0	1.8	5.4	4.7	2.8	5.5	6.1	1.6	5.5	9.7	6.7	3.5	15.2	5.2	23.8	1.9	18.6	3.5	7.9	10.8	8.3	8.3	18.1	12.3	7.2	14.0	13.4	12.5	6.2	2.2	0.0	2.8	0.4	0.5	1.2	5.2	0.1	1.0	0.3	0.0	39.8	7.4	10.4	0.2	0.4	0.3	2.5	6.5	2.6	0.2	1.0	2.5	9.3	8.6	54.6	0.5	10.3	3.4	0.5	2.4	0.0	1.2	0.0	0.3	6.6	0.8	3.0	0.5	6.1	17.6	3.9	0.4	8.8	0.5	16.8	3.5	5.9	1.9	6.0	1.0	3.5	4.8	2.8	1.4	5.2	1.0	2.7	1.2	2.1	0.4	2.7	2.1	6.0	4.0	15.3	0.4	7.0	6.6	7.2	5.9	3.7	12.5	6.9	11.1	15.0	7.7	8.6	6.2	18.1	7.8	8.7	0.9	13.4	14.0	12.3	1.5	6.2	1.8	1.9	0.9	1.6	1.6	1.9	3.0	1.1	1.8	1.9	3.0	5.0	11.9	1.8	7.8	0.3	8.9	45.9	6.7	6.8	10.4	0.0	253.9	3.3	1.3	4.2	2.4	8.8	46.7	4.7	36.5	5.1	1.2	8.1	109.0	25.7	0.0	6.4	6.7	23.7	6.2	21.3	5.6	6.8	1.0	11.4	0.3	1.2	0.0	47.7	5.9	1.8	0.0	1.2	0.9	1.2	7.4	287.8	10.0	8.3	3.3
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003813	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.7"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 133.5;Muller glia cells: 95.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.32e-4)"	2.3	2.9	12.8	2.9	18.0	24.2	10.1	10.1	20.2	6.0	8.2	16.6	1.2	3.1	5.3	3.5	14.2	3.7	4.3	5.1	14.7	12.4	8.0	1.3	10.9	2.9	23.3	10.3	6.8	2.1	34.7	5.5	3.8	16.2	16.1	9.3	6.4	5.6	4.1	1.2	12.3	4.3	4.6	18.5	2.5	6.9	2.7	17.8	1.9	5.3	16.1	10.3	4.4	7.5	0.0	0.8	6.7	0.7	0.0	0.2	0.3	8.4	2.6	7.9	3.4	3.6	8.0	4.6	4.1	1.5	5.3	3.5	0.7	13.5	2.4	4.9	9.7	4.2	6.5	7.0	8.2	8.0	7.5	12.1	10.1	3.7	0.0	4.4	0.0	3.2	5.8	4.9	5.0	3.5	11.7	2.8	3.5	8.6	1.9	4.6	2.2	3.0	0.2	3.1	3.8	10.0	4.5	12.5	0.1	7.8	1.2	4.7	14.5	4.2	25.5	4.0	4.1	4.8	2.9	1.5	9.4	5.0	7.2	11.6	0.7	0.2	2.7	14.7	1.4	3.1	6.3	0.7	2.8	0.0	0.2	0.0	0.0	0.2	0.1	0.8	0.0	0.2	0.1	6.7	0.0	0.2	0.1	0.0	0.3	12.8	18.0	10.1	15.8	14.7	12.4	23.3	10.3	16.2	17.8	17.9	10.1	4.5	2.9	3.0	18.3	10.6	5.1	16.0	19.4	38.4	7.9	2.5	5.0	4.5	7.3	8.8	10.3	46.7	1.4	1.3	9.8	21.0	8.1	0.0	1.7	133.5	36.0	4.3	2.1	7.8	4.9	4.3	13.5	44.1	49.8	95.3	52.2	20.4	7.1	8.4	7.2	6.5	12.0	10.7	23.7	4.4	1.6	2.1	11.9	29.8
MBOAT7	"BB1, hMBOA-7, LENG4, LPIAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA055967: AB_2682990"	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (5.55e-6)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favorable (4.31e-4)"	10.7	63.1	16.8	14.8	24.2	15.9	7.9	11.3	37.8	10.3	17.7	9.2	15.6	30.3	10.5	8.0	10.5	11.5	14.3	6.9	18.5	23.4	10.5	11.6	11.5	14.7	10.0	18.8	15.1	24.4	23.8	12.4	11.9	21.6	11.4	6.1	8.1	10.8	28.8	7.9	10.0	28.5	6.5	9.2	14.4	16.4	30.8	6.8	7.6	12.7	5.0	6.3	22.6	17.5	0.3	2.9	30.6	2.1	0.9	0.5	0.8	14.2	8.5	1.3	14.0	4.6	3.6	12.3	25.0	8.9	5.8	11.5	4.8	16.2	3.7	11.2	5.4	2.5	29.2	0.0	5.1	1.1	5.1	16.6	3.9	9.2	3.1	4.5	9.0	57.3	6.7	3.4	2.8	2.0	4.6	10.4	2.7	14.7	11.8	2.0	8.6	2.6	3.2	5.9	2.5	18.2	8.4	2.4	7.5	5.8	17.3	0.5	3.7	16.7	10.2	5.1	0.1	10.3	0.8	20.7	12.3	4.4	3.6	9.9	5.4	9.3	1.5	17.7	6.4	8.1	15.7	2.1	30.6	0.2	1.5	0.5	0.2	0.2	0.2	2.9	0.3	0.1	0.2	30.0	0.9	0.8	0.8	0.2	0.8	16.8	24.2	11.3	37.8	18.5	23.4	10.0	18.8	21.6	6.8	11.9	26.6	12.2	44.1	12.4	15.8	6.5	30.6	13.4	14.8	41.8	5.9	38.6	5.0	45.1	1.1	16.6	88.9	0.0	28.7	43.8	12.7	39.8	76.1	13.9	28.4	28.6	40.8	14.7	36.9	1.9	17.8	32.1	8.5	19.8	45.8	22.4	34.4	40.3	14.5	12.2	6.8	38.8	23.4	3.9	14.5	18.9	43.1	11.4	38.5	48.0
MBP		ENSG00000197971	"Myelin basic protein"	P02686	18	76978827-77133683	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autoimmune encephalomyelitis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	43	"brain: 1297.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"glioma: 47.5;melanoma: 20.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 29.0;SK-MEL-30: 60.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002300, HPA049222, HPA064368"	Enhanced	Supported	Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247"	"unprognostic (9.36e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.48e-12)"	"unprognostic (2.90e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	4.0	3.4	271.6	6.1	244.9	10.1	4.5	28.7	418.9	5.6	5.5	487.7	0.0	5.9	4.4	3.6	6.4	9.0	5.7	6.8	355.0	247.6	6.2	5.9	6.2	7.1	645.5	43.4	3.7	6.8	16.4	0.7	2.7	242.9	4.5	5.6	0.4	5.0	4.9	29.9	7.9	6.2	3.8	1297.7	7.6	5.1	2.9	224.3	0.0	6.8	0.0	7.7	6.0	0.6	3.4	6.8	23.7	4.7	15.4	17.1	5.6	7.5	6.6	0.0	0.2	11.2	16.7	2.6	0.2	0.2	0.2	0.1	0.9	11.8	4.7	1.3	0.5	0.0	15.0	1.1	6.6	0.2	18.2	1.6	3.0	1.1	1.5	7.0	29.0	20.2	2.4	5.6	6.0	9.3	5.0	1.9	11.4	0.0	1.0	0.0	0.9	1.1	14.9	0.6	4.5	5.3	0.4	0.1	10.5	10.6	10.3	0.5	0.1	0.9	0.0	60.4	1.9	0.2	17.8	0.0	0.0	0.1	0.0	0.8	0.0	0.1	5.0	1.8	18.3	0.7	11.0	4.7	17.8	13.2	4.6	8.0	3.4	9.4	17.1	5.3	3.3	5.7	10.5	23.7	15.4	4.4	6.8	7.9	5.6	271.6	244.9	28.7	127.7	355.0	247.6	645.5	43.4	242.9	224.3	44.7	33.2	33.8	46.5	105.6	50.2	38.2	38.2	56.2	44.3	97.7	2.0	0.6	34.9	38.1	4.8	9.9	40.8	46.7	31.6	0.6	21.8	82.0	69.4	25.5	41.0	1.6	47.8	11.1	60.5	4.5	26.2	83.3	87.7	24.4	45.4	26.0	43.3	23.0	13.4	28.1	6.2	0.0	6.6	4.8	0.7	135.3	0.6	123.7	33.3	87.7
MBTD1	"FLJ20055, SA49P01"	ENSG00000011258	"Mbt domain containing 1"	Q05BQ5	17	51177425-51260163	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021876	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021876: AB_2140367"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-3)"	9.0	6.8	8.8	10.6	14.2	11.0	13.5	21.2	12.0	10.7	8.8	13.2	8.6	9.2	14.3	9.6	9.3	8.3	7.1	5.8	9.9	5.8	7.4	11.2	7.2	9.3	12.6	8.1	15.4	11.0	8.8	9.6	10.0	8.8	8.9	9.3	8.3	9.0	8.8	7.9	16.7	9.8	11.9	7.7	11.7	9.5	27.9	11.7	32.4	10.1	4.8	9.0	9.5	10.5	0.9	1.1	5.1	0.4	0.4	0.9	0.1	3.7	3.5	19.0	7.6	4.6	5.3	10.0	2.9	3.6	3.1	3.9	4.2	4.9	14.8	6.9	2.1	2.2	3.7	8.6	2.1	5.9	4.1	7.9	15.3	4.0	6.4	3.1	10.2	4.6	4.6	4.1	2.3	4.3	6.2	5.5	13.1	11.8	3.7	2.4	3.8	13.9	10.7	10.8	8.1	3.2	16.1	11.5	7.3	4.8	7.2	12.1	18.4	2.6	5.1	6.1	16.7	7.3	20.2	3.3	3.4	3.4	2.5	3.1	9.2	5.8	13.3	2.0	6.8	1.9	5.1	0.4	1.9	0.7	0.3	0.2	0.9	0.7	0.5	0.7	0.6	0.4	0.9	0.9	0.4	0.4	1.1	0.8	0.1	8.8	14.2	21.2	12.0	9.9	5.8	12.6	8.1	8.8	11.7	14.9	12.9	8.2	5.9	15.2	7.9	6.2	15.3	5.3	6.8	7.0	15.7	6.4	1.7	4.3	44.2	8.9	7.3	0.0	4.5	4.2	7.6	8.0	4.7	10.0	5.0	9.5	13.2	9.8	13.1	11.1	13.6	8.4	10.1	7.2	14.7	5.6	5.7	10.5	9.9	3.9	11.4	0.0	8.0	28.1	14.5	19.3	7.2	8.2	11.6	6.8
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839636-21885424	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	12.0	17.4	9.3	7.2	13.9	2.5	12.7	20.8	18.5	11.8	9.3	13.4	6.9	7.6	14.7	9.1	9.3	10.9	10.1	11.6	9.9	10.7	13.9	26.0	8.6	6.6	10.6	13.0	18.7	12.2	17.9	15.6	22.3	17.4	15.7	9.1	12.4	14.1	13.1	14.5	8.2	8.1	14.6	14.6	7.5	9.1	6.9	7.0	7.1	13.1	7.4	6.7	11.4	9.1	3.9	6.9	1.5	4.8	4.6	5.9	3.3	8.9	18.6	8.9	9.1	11.3	14.0	4.3	13.3	13.6	12.7	11.1	7.4	12.3	7.8	6.9	14.2	24.8	8.4	12.3	7.6	15.7	5.8	9.8	3.8	11.8	6.1	15.5	8.2	3.8	13.2	8.3	19.1	14.1	12.9	9.7	4.6	10.6	8.7	14.4	5.6	3.3	4.3	8.3	4.7	13.8	4.2	16.6	8.7	8.8	4.6	2.2	18.3	18.7	11.9	16.4	12.4	15.9	7.1	11.5	16.0	3.7	23.2	9.9	10.7	13.5	3.8	17.8	3.4	15.3	0.1	4.3	1.5	4.5	4.8	4.2	3.9	3.5	4.1	6.9	3.8	4.7	5.6	0.5	4.6	4.8	4.8	5.9	3.3	9.3	13.9	20.8	18.5	9.9	10.7	10.6	13.0	17.4	7.0	8.9	7.8	3.0	3.4	4.8	11.7	12.0	7.6	10.7	6.8	7.0	17.7	5.6	0.0	5.1	0.3	4.6	3.3	0.0	7.7	5.4	8.9	6.6	10.4	16.1	8.0	28.6	2.4	10.4	9.5	0.9	9.8	4.4	10.1	3.6	3.3	7.7	5.3	3.1	12.4	7.5	14.0	0.0	6.9	2.8	1.7	2.4	4.0	4.3	4.2	4.1
MCAM	"CD146, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Endothelial cells: 83.4;Muller glia cells: 87.4;Sertoli cells: 316.9;Smooth muscle cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"HUVEC TERT2: 128.2;TIME: 125.2;WM-115: 99.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Approved	"Plasma membrane"		NA	NA		2600000000	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (8.75e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.79e-3)"	88.2	8.9	6.4	18.5	10.3	0.4	86.1	17.7	13.4	22.3	33.2	13.3	11.7	8.3	40.1	32.5	27.6	29.3	50.9	32.0	7.1	8.2	7.5	3.8	23.8	13.0	7.4	8.1	23.6	6.2	54.5	3.9	47.4	11.1	22.9	9.7	25.0	9.4	44.9	21.1	10.5	15.6	67.1	6.5	9.6	25.0	18.4	5.4	2.2	13.1	15.7	4.8	55.0	24.3	0.8	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.5	0.5	0.0	2.5	0.0	2.6	0.3	0.0	3.4	1.5	1.9	0.1	0.1	10.9	1.2	5.2	0.3	4.4	0.9	1.7	6.2	1.5	0.1	12.3	2.2	6.0	0.0	0.0	1.8	0.0	4.7	2.2	0.1	128.2	0.8	4.1	0.1	0.7	0.0	0.1	1.0	2.2	0.0	0.5	0.1	17.1	3.6	3.1	0.0	1.4	0.4	9.8	0.2	28.2	5.6	0.5	0.1	125.2	0.3	18.4	0.0	9.9	0.2	0.2	0.0	5.0	0.0	99.5	0.0	0.0	0.0	0.0	0.0	2.2	0.8	0.6	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	6.4	10.3	17.7	13.4	7.1	8.2	7.4	8.1	11.1	5.4	0.0	2.9	0.8	0.5	4.1	1.3	57.3	12.7	1.4	1.2	0.0	21.6	0.3	0.0	14.3	1.6	83.4	0.0	0.0	0.3	34.2	4.4	1.1	0.0	0.0	0.7	0.0	0.0	74.9	1.6	0.6	0.9	2.7	20.3	1.0	0.0	87.4	2.5	0.0	23.7	0.0	2.1	316.9	214.2	2.2	1.2	2.9	0.3	0.7	0.0	0.7
MCEE	GLOD2	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 76.7;Distal tubular cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"	No	No		16000	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.76e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	10.5	20.4	8.5	10.1	9.2	4.3	18.9	10.5	9.8	14.1	13.8	9.4	24.6	11.1	8.8	19.7	16.9	8.6	12.6	19.8	6.6	6.2	18.8	39.7	9.1	9.5	13.1	6.6	12.4	29.0	9.8	24.5	9.9	9.1	13.7	13.5	11.1	28.9	20.5	18.2	15.2	14.9	10.9	11.5	10.1	13.1	5.7	11.4	9.3	11.0	18.7	10.9	13.0	13.3	15.9	17.6	20.0	18.4	11.2	24.9	11.1	6.4	3.1	5.7	4.1	19.4	26.4	16.5	9.9	12.6	5.0	7.6	7.7	8.0	9.9	3.0	9.7	3.8	6.7	6.9	5.1	5.3	9.2	6.0	6.8	8.7	22.1	10.9	7.6	5.6	17.5	7.5	3.4	6.7	11.2	5.7	7.9	8.9	17.4	4.8	8.2	5.6	8.9	5.2	17.7	7.7	6.7	6.5	18.4	7.7	5.2	6.5	4.7	3.7	21.9	9.7	6.9	17.3	7.3	7.4	5.9	4.6	6.0	3.9	16.7	6.8	10.5	9.6	12.4	5.3	13.0	18.3	20.0	12.8	18.4	17.3	15.9	15.7	12.3	14.9	13.2	14.6	12.3	4.5	11.2	17.6	17.6	24.9	11.1	8.5	9.2	10.5	9.8	6.6	6.2	13.1	6.6	9.1	11.4	23.8	8.3	13.7	11.3	7.6	2.6	76.7	22.9	17.4	9.1	5.2	2.0	30.6	77.9	10.4	0.8	9.0	14.7	0.0	16.1	27.7	21.1	8.8	0.0	60.2	13.5	4.8	8.6	9.8	11.6	0.9	27.0	11.2	13.5	3.6	28.7	6.7	10.6	10.5	16.6	64.3	8.7	25.8	10.8	2.4	4.1	18.2	9.5	12.9	25.1	9.2
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.4;brain: 23.7"	"Group enriched"	"Detected in many"	11	"Bipolar cells: 64.6;Cone photoreceptor cells: 208.1;Early spermatids: 86.7;Rod photoreceptor cells: 135.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"T-reg: 4.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.4;Karpas-707: 8.2;REH: 5.4"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655"	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.9	16.4	12.8	1.4	14.9	1.1	1.1	11.3	23.7	1.3	1.4	3.6	0.0	0.9	1.3	1.3	1.3	1.0	1.5	1.1	12.2	7.6	1.4	0.8	1.2	1.7	5.6	13.0	1.2	1.2	10.5	8.9	0.8	7.3	2.1	1.4	7.5	0.8	1.6	1.4	1.0	1.2	1.4	4.5	5.3	1.2	5.5	4.3	0.0	0.9	0.0	2.1	1.6	0.4	0.1	0.0	0.6	0.0	0.1	4.6	0.2	0.1	0.6	0.2	1.8	0.1	0.2	0.4	0.0	0.1	0.3	0.0	1.2	0.2	1.5	0.2	0.1	1.9	0.0	0.3	0.2	0.1	9.4	1.4	4.0	0.3	0.0	0.3	1.2	0.8	0.3	0.0	0.0	0.7	0.0	0.7	2.5	1.2	8.2	0.5	1.2	1.2	0.9	1.3	0.0	1.6	5.4	0.0	1.5	0.4	0.2	2.6	0.9	1.0	0.0	2.1	0.6	0.5	0.9	0.6	0.0	0.9	0.1	0.1	3.3	3.5	1.7	0.8	1.4	0.1	0.1	0.0	0.1	0.4	0.0	1.0	0.0	1.0	0.6	0.0	0.1	0.0	0.9	0.6	0.1	0.0	0.0	4.6	0.2	12.8	14.9	11.3	23.7	12.2	7.6	5.6	13.0	7.3	4.3	0.0	2.1	0.0	0.4	0.3	64.6	1.2	0.0	4.0	0.0	5.2	208.1	0.2	0.0	0.1	86.7	0.7	0.3	0.0	0.2	0.1	0.7	0.2	1.1	0.0	0.4	7.9	0.0	3.1	0.6	11.7	0.9	1.0	1.7	2.8	0.0	3.0	0.2	0.0	0.4	0.0	135.4	0.0	0.4	0.7	3.4	0.4	1.1	2.1	0.0	0.6
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031137	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	8.6	7.2	5.9	11.9	8.4	14.5	17.7	5.2	6.9	9.4	11.2	8.2	9.8	7.3	9.0	16.0	10.2	8.6	8.2	6.6	5.9	4.0	9.3	7.6	15.6	12.1	11.5	4.7	8.7	12.2	11.9	11.2	13.8	6.3	10.5	8.4	7.0	11.8	8.7	4.2	9.8	12.6	10.9	5.7	10.2	7.3	7.9	8.1	27.0	13.1	7.1	9.9	9.6	10.5	3.1	5.2	8.0	5.3	10.2	6.4	3.9	4.6	7.4	11.9	12.8	5.4	5.3	9.1	4.4	7.9	6.5	8.3	6.1	8.4	14.1	5.5	7.6	4.3	14.0	8.3	4.8	9.2	8.3	11.4	11.2	8.8	5.9	3.2	12.0	7.6	5.8	5.7	6.7	7.7	4.1	6.2	8.8	13.5	6.5	4.3	9.8	10.6	9.7	5.8	7.7	3.4	8.4	7.5	3.7	6.6	9.3	10.3	7.4	7.8	5.7	4.1	3.2	8.5	17.0	6.3	5.2	4.6	3.7	6.5	8.7	7.2	16.7	6.6	9.8	6.0	7.2	4.5	8.0	4.9	5.3	3.8	3.1	3.0	5.0	5.2	3.0	3.6	3.5	5.4	10.2	3.2	3.7	6.4	3.9	5.9	8.4	5.2	6.9	5.9	4.0	11.5	4.7	6.3	8.1	6.0	4.1	4.4	3.1	2.6	3.5	3.9	2.5	12.0	4.5	7.0	9.8	9.1	3.3	2.3	1.5	4.4	5.1	0.0	2.5	2.9	2.8	3.4	6.9	2.4	3.0	1.6	6.9	3.7	5.3	1.9	3.4	4.5	0.0	2.8	5.9	2.1	2.1	5.8	3.9	2.9	5.4	0.0	2.1	4.8	2.7	1.8	6.1	5.3	4.1	4.1
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	33.6	15.3	11.7	23.2	13.8	14.6	35.5	17.2	13.8	27.0	26.3	16.9	11.4	15.5	28.0	14.9	26.4	23.0	18.7	26.3	12.0	10.2	18.7	23.7	28.5	38.6	17.4	8.5	29.2	18.2	23.2	17.6	35.4	14.2	22.5	21.4	15.7	21.0	17.4	30.1	23.8	20.7	26.0	16.8	26.0	20.7	15.4	15.5	38.0	24.5	28.2	24.7	32.5	28.6	4.5	6.9	12.1	9.7	4.1	5.1	2.4	31.0	22.1	31.0	21.4	15.7	19.3	18.2	28.8	31.6	36.7	38.0	28.8	25.5	36.2	13.3	23.0	16.7	29.0	37.0	29.0	43.0	26.5	27.3	18.6	17.6	22.0	24.4	34.3	45.0	15.8	16.4	33.2	43.8	20.2	25.1	23.7	17.1	27.3	24.0	23.0	43.0	20.7	15.6	23.1	16.0	27.2	60.0	18.4	15.7	21.4	13.4	17.2	21.0	17.5	24.0	24.3	11.9	24.5	19.4	18.1	17.8	18.3	34.3	19.7	21.9	40.1	21.6	23.1	11.1	12.1	5.3	3.6	4.2	9.7	5.1	4.5	3.9	4.4	6.9	1.8	4.2	3.8	6.4	4.1	6.1	3.5	3.9	2.4	11.7	13.8	17.2	13.8	12.0	10.2	17.4	8.5	14.2	15.5	14.9	13.9	20.1	27.2	38.0	10.0	16.2	12.7	10.7	18.2	19.2	3.9	30.7	11.6	9.6	3.3	32.4	15.1	0.0	11.5	42.5	26.3	18.7	17.4	23.1	33.4	30.2	10.4	30.1	35.7	4.9	27.9	31.3	21.9	8.2	18.5	16.9	12.8	7.0	21.2	17.5	17.1	19.4	29.9	27.6	61.5	37.4	33.2	27.4	26.9	24.5
MCMDC2	"C8orf45, FLJ25692"	ENSG00000178460	"Minichromosome maintenance domain containing 2"	Q4G0Z9	8	66870749-66922048	"Predicted intracellular proteins"	"DNA damage, DNA repair, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 32.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 30.9;Spermatocytes: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA026522			Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA026522: AB_10603453"	"unprognostic (6.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.04e-1)"	"unprognostic (6.79e-3)"	"unprognostic (7.87e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.31e-5)"	1.2	2.0	1.1	1.2	2.2	3.9	1.2	0.9	2.1	1.1	1.0	3.7	0.7	1.4	1.2	1.9	1.7	1.0	1.0	3.0	1.3	1.2	1.6	1.1	2.0	2.7	1.2	0.3	3.6	1.8	1.6	7.0	0.7	3.0	1.0	0.5	2.0	1.3	0.7	6.1	2.3	1.3	0.3	2.1	1.1	1.1	32.8	1.6	0.4	1.4	1.3	0.3	1.4	1.2	3.1	3.4	1.9	1.4	3.6	4.7	1.6	2.9	6.3	3.2	3.8	0.4	1.5	1.7	2.8	0.4	0.2	0.2	5.2	4.0	4.5	1.1	0.2	1.7	2.5	0.0	0.2	0.9	2.3	7.8	5.6	9.1	6.3	0.8	2.5	3.0	1.0	0.9	0.1	0.0	4.7	0.2	4.3	3.5	4.3	1.3	5.8	6.2	7.8	4.0	4.9	5.8	2.2	1.2	2.0	0.6	4.5	2.2	4.0	0.9	1.1	12.7	1.9	4.0	6.6	1.3	2.1	3.1	3.6	3.4	3.5	1.9	4.2	2.4	5.3	2.2	1.9	1.4	0.6	2.6	1.0	3.3	2.9	4.2	3.3	3.0	3.1	4.7	3.8	0.6	3.6	0.9	3.4	3.0	1.6	1.1	2.2	0.9	1.8	1.3	1.2	1.2	0.3	3.0	1.6	0.0	0.3	0.0	0.4	0.3	1.7	2.0	0.0	4.0	0.0	1.8	5.9	0.9	0.0	0.1	30.9	0.2	0.0	0.0	0.2	0.6	0.2	0.3	0.0	0.0	0.4	1.6	0.0	0.0	1.8	8.5	1.7	0.0	1.7	0.0	0.2	2.0	0.1	0.0	0.7	0.7	1.7	0.0	0.0	53.3	6.1	0.9	0.0	0.0	1.2	0.7
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522626-7534009	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 91.8;Kupffer cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 30.9;monocytes: 28.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	18.9	27.5	10.1	10.3	11.9	10.0	10.3	8.2	19.7	7.7	9.6	11.2	7.2	9.6	8.8	9.5	11.2	8.4	11.7	11.7	9.0	9.2	11.5	20.6	17.9	20.6	10.6	10.0	7.8	10.5	9.8	26.0	17.9	13.6	8.8	6.9	9.7	9.2	8.0	14.2	13.9	8.0	9.5	10.4	38.3	8.9	6.5	9.4	7.0	6.2	7.6	5.1	12.5	8.7	1.3	6.2	30.9	28.9	2.8	2.7	4.4	6.4	6.6	3.2	11.0	18.9	6.1	9.3	12.0	9.7	14.6	12.6	5.0	5.7	3.6	14.8	8.1	12.9	3.0	5.4	4.1	4.3	7.0	12.0	3.2	6.5	4.0	16.6	3.6	14.2	8.6	9.7	13.9	2.4	4.6	6.1	8.1	5.9	16.1	8.4	2.1	4.9	3.6	7.2	3.4	14.2	6.9	5.4	7.7	5.5	5.6	8.4	10.3	5.1	9.1	15.2	3.7	5.5	6.4	7.6	7.0	4.0	28.1	8.9	12.4	19.0	2.5	11.2	5.1	10.4	30.9	13.7	29.7	2.3	27.5	2.0	1.1	2.0	1.9	5.6	1.3	1.9	2.0	12.2	2.8	28.9	6.2	2.7	4.4	10.1	11.9	8.2	19.7	9.0	9.2	10.6	10.0	13.6	9.4	3.0	1.6	10.4	6.1	11.8	26.9	2.0	17.8	4.0	1.2	29.6	21.6	10.4	1.7	20.9	4.9	11.9	19.5	46.7	19.9	15.2	17.9	4.5	1.1	12.4	91.8	55.6	16.1	11.1	81.2	10.8	15.3	42.0	20.3	5.4	8.6	23.6	17.7	20.1	14.9	9.2	37.0	6.5	9.2	10.2	11.9	15.2	24.7	10.2	8.6	4.1
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048499	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.2;pituitary gland: 38.3"	"Group enriched"	"Detected in many"	8	"Intestinal endocrine cells: 109.0;Melanocytes: 143.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 1.7"	"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	4.7	29.2	1.5	0.8	0.8	0.0	3.0	0.2	0.4	6.1	2.8	0.9	2.1	3.2	5.4	15.6	0.8	1.1	0.6	5.1	3.4	0.3	4.5	0.2	4.1	0.0	0.5	0.0	2.2	6.5	17.9	38.3	1.8	2.7	0.5	0.5	4.5	8.1	0.4	1.9	2.5	1.9	1.1	0.3	0.9	1.6	0.4	0.3	2.6	1.5	0.9	0.4	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.9	0.7	6.5	1.5	0.0	0.0	5.3	4.8	1.7	0.1	10.1	2.5	7.0	0.5	1.2	0.0	0.7	0.1	2.3	0.0	10.0	3.2	1.6	2.6	5.9	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.2	2.1	1.2	2.6	0.0	0.0	0.0	0.0	4.9	0.6	0.0	0.0	0.7	0.0	0.6	0.0	12.2	0.0	0.3	0.0	0.4	0.0	0.3	0.0	21.6	0.8	4.1	5.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.2	0.4	3.4	0.3	0.5	0.0	2.7	0.3	14.9	1.7	0.0	3.6	7.7	0.0	6.9	10.2	0.0	1.2	3.5	0.0	6.4	0.0	1.9	0.3	0.5	1.3	0.0	8.4	0.1	5.1	1.1	0.0	0.0	3.4	0.0	109.0	0.0	0.0	0.0	1.7	0.8	143.4	2.8	0.6	0.0	4.9	7.8	0.0	2.2	0.0	6.5	1.2	0.9	1.6	3.0	2.2	0.0	0.6	0.3
MCPH1	"BRIT1, FLJ12847"	ENSG00000147316	"Microcephalin 1"	Q8NEM0	8	6406592-6648504	"Disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008238, HPA012064, CAB012177"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: "	"unprognostic (1.00e-1)"	"unprognostic (2.17e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.79e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.94e-1)"	13.5	10.0	11.6	10.7	14.6	35.0	14.0	19.9	16.8	13.6	11.7	12.4	15.1	9.1	17.2	10.0	12.2	12.5	9.4	11.9	12.2	10.0	11.4	11.0	10.8	15.0	11.0	11.3	14.3	13.4	13.2	19.4	14.4	13.9	13.6	10.6	10.2	14.4	15.4	24.9	11.9	11.2	12.3	14.2	15.3	11.7	17.1	12.5	21.6	14.0	10.7	17.0	14.3	17.6	6.9	4.1	11.7	4.1	6.0	6.2	3.0	4.6	4.1	7.5	5.2	3.7	6.7	6.4	7.0	6.2	9.0	6.7	5.2	3.5	8.9	1.9	5.7	8.2	5.4	9.4	6.7	10.7	3.7	5.2	11.4	4.2	6.9	6.2	5.7	9.0	6.4	7.0	6.1	8.8	6.3	6.5	9.7	13.8	9.0	6.8	3.0	15.3	6.2	12.9	8.5	4.1	9.2	7.1	5.4	5.2	8.5	5.2	6.9	5.2	5.5	7.6	8.7	4.8	8.1	5.4	7.0	3.8	2.3	6.6	4.2	5.7	13.3	6.4	6.6	9.5	2.2	3.0	11.7	4.8	3.4	6.2	6.0	4.2	5.5	3.0	6.9	5.4	5.6	0.5	6.0	4.1	4.1	4.2	3.0	11.6	14.6	19.9	16.8	12.2	10.0	11.0	11.3	13.9	12.5	3.0	10.7	14.5	11.1	4.0	12.6	12.4	17.8	40.2	25.0	14.0	15.7	9.3	3.3	9.4	34.4	10.8	4.2	46.7	9.2	8.6	6.2	7.7	19.6	6.4	6.1	28.6	0.0	9.8	12.9	20.9	11.2	6.7	0.0	10.8	5.9	14.2	8.6	8.0	12.4	6.5	9.5	6.5	9.6	17.0	10.9	5.3	10.3	17.0	6.4	9.1
MCRIP1	"FAM195B, GRAN2, MCRIP"	ENSG00000225663	"MAPK regulated corepressor interacting protein 1"	C9JLW8	17	81822361-81833302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 209.6;Extravillous trophoblasts: 120.1;Hofbauer cells: 139.9;Pancreatic endocrine cells: 110.1;Proximal tubular cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045542	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045542: AB_2679363"	"unprognostic (3.11e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (2.26e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.86e-1)"	34.8	29.8	43.1	23.9	29.9	32.2	19.7	27.4	47.8	20.9	29.4	23.3	13.9	12.9	26.3	19.6	20.2	28.2	25.9	46.0	36.4	32.8	21.9	17.9	21.3	28.6	37.0	34.6	28.5	36.3	11.9	22.8	25.4	34.3	24.1	5.6	18.3	33.6	24.7	25.4	11.1	14.2	22.5	32.4	24.3	16.8	35.9	27.4	33.3	29.0	14.2	11.2	28.0	19.9	33.2	37.4	49.8	40.7	23.6	38.2	33.7	13.1	20.7	23.1	24.3	15.0	17.5	18.2	15.7	11.4	19.3	21.2	5.4	13.2	8.2	9.2	13.2	7.1	3.0	2.7	9.4	4.6	8.8	29.4	14.4	3.5	20.8	15.2	9.4	13.4	19.0	9.4	10.9	4.7	10.4	34.3	19.1	11.5	7.1	12.8	8.7	30.3	22.7	14.3	5.4	12.0	12.0	14.8	3.7	6.5	11.9	19.7	61.6	7.7	10.2	47.7	9.4	9.1	13.0	20.8	27.4	29.2	29.9	28.4	3.7	1.1	5.3	25.5	8.7	21.6	49.8	30.5	40.1	38.2	39.1	29.0	23.3	29.9	33.9	27.4	33.2	24.5	28.0	23.5	23.6	40.7	37.4	35.0	33.7	43.1	29.9	27.4	47.8	36.4	32.8	37.0	34.6	34.3	27.4	17.9	37.8	0.0	0.0	0.0	0.0	0.0	0.0	25.4	20.5	36.6	0.0	100.3	63.0	86.4	0.0	0.0	0.0	0.0	209.6	120.1	0.0	0.0	18.6	0.0	139.9	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	85.6	0.0	0.0	110.1	0.0	0.0	118.3	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 49.2;brain: 42.4"	"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 29.9;granulocytes: 61.2;Kupffer cells: 33.5;Macrophages: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	41	"basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	49.2	2.7	6.5	11.4	42.4	36.9	18.3	18.3	16.5	6.9	7.2	0.3	4.4	5.0	11.1	9.2	6.5	4.1	16.7	4.6	8.5	7.4	3.0	3.8	11.3	5.5	4.1	3.8	3.3	3.4	3.1	5.2	7.1	3.9	5.9	7.3	1.0	4.3	2.7	5.1	4.5	4.8	10.9	5.7	8.2	5.3	4.0	8.1	5.5	5.0	21.2	4.3	17.3	12.6	0.3	10.1	18.7	19.2	0.2	0.2	3.3	0.1	2.0	1.3	0.0	20.0	8.0	0.0	0.1	9.8	0.9	3.2	0.0	5.2	7.2	7.7	0.0	20.5	0.0	0.1	0.1	1.1	0.0	1.4	4.3	4.9	0.0	2.6	8.9	5.8	2.9	0.0	3.6	13.1	8.5	20.7	3.0	0.1	28.3	7.4	0.2	0.5	6.8	1.6	0.1	8.2	0.3	0.0	28.0	21.3	11.3	4.0	0.2	0.6	0.0	14.6	0.6	0.0	8.4	0.1	3.6	5.6	0.1	1.6	2.0	0.0	0.0	16.9	14.9	3.6	11.5	12.9	5.8	0.0	19.2	0.0	0.3	0.0	0.1	10.1	0.1	0.2	0.0	18.7	0.2	17.6	5.3	0.0	3.3	6.5	42.4	18.3	12.2	8.5	7.4	4.1	3.8	3.9	8.1	3.0	9.6	0.0	0.1	16.1	2.0	2.5	0.0	4.0	6.8	3.5	0.0	0.3	0.0	0.0	20.6	29.9	0.0	0.0	0.2	0.1	3.0	0.6	61.2	0.5	10.7	3.2	0.0	1.8	33.5	12.2	0.6	35.3	11.8	0.0	0.0	3.6	0.8	0.0	0.0	0.0	3.7	0.0	2.2	1.4	1.4	11.7	0.2	2.2	0.0	0.4
MCUB	"CCDC109B, FLJ20647"	ENSG00000005059	"Mitochondrial calcium uniporter dominant negative beta subunit"	Q9NWR8	4	109560205-109688726	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 39.3;lymphoid tissue: 45.3"	"Cell type enhanced"	"Detected in some"	9	"Cytotrophoblasts: 107.3;Exocrine glandular cells: 99.3;Extravillous trophoblasts: 82.0;Hofbauer cells: 95.7;Pancreatic endocrine cells: 50.6;Syncytiotrophoblasts: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048776	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Vesicles, Mitochondria"		"HPA048776: AB_2680518"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.35e-6)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	11.6	2.2	4.1	21.0	3.2	8.3	16.6	0.4	3.7	8.2	4.9	4.6	1.4	3.5	12.3	5.5	9.2	6.3	7.3	14.9	4.5	4.7	3.9	2.1	7.8	44.2	3.5	2.6	7.5	2.1	2.3	5.1	9.9	6.5	5.4	6.1	4.1	6.5	2.2	4.3	7.6	8.8	8.4	8.5	13.8	4.2	3.6	1.9	45.3	4.7	9.5	24.8	7.3	9.0	14.0	15.7	1.1	16.0	20.0	39.3	25.7	10.4	4.5	2.5	12.8	2.8	7.4	9.7	9.0	5.5	9.9	8.9	0.2	8.5	36.7	1.9	7.7	5.5	3.0	9.4	5.5	8.8	23.3	7.4	4.4	5.0	0.6	4.9	8.9	0.1	4.7	1.5	6.0	5.1	7.0	13.2	13.6	1.3	23.4	7.5	12.8	20.4	0.1	11.6	1.8	6.5	7.8	19.4	4.1	11.6	4.6	10.3	4.5	9.7	28.9	3.0	2.1	3.6	0.4	9.4	3.9	5.1	20.6	15.6	9.1	6.3	8.9	12.0	1.9	2.7	0.0	16.0	0.2	6.3	9.7	9.0	13.5	26.7	19.0	15.7	14.0	39.3	22.2	1.1	20.0	7.2	11.0	22.4	25.7	4.1	3.2	0.4	3.7	4.5	4.7	3.5	2.6	6.5	1.9	8.9	6.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	5.2	0.0	107.3	0.0	22.4	0.0	0.0	0.0	0.0	99.3	82.0	0.0	0.0	1.1	0.0	95.7	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	25.2	0.0	0.0	50.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	0.0
MDFI	I-mfa	ENSG00000112559	"MyoD family inhibitor"	Q99750	6	41636882-41654246	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 196.5;Extravillous trophoblasts: 103.1;Pancreatic endocrine cells: 86.6;Syncytiotrophoblasts: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.6;HBEC3-KT: 29.3;OE19: 24.7;REH: 77.3"	"Region enriched"	"Detected in single"	8	"cerebellum: 19.0"	"Low region specificity"	"Detected in all"			HPA049973	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049973: AB_2680975"	"unprognostic (9.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.82e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.32e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.66e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.22e-2)"	29.5	2.1	2.9	5.3	3.1	0.4	10.5	0.9	10.8	14.0	3.2	2.5	3.5	1.9	4.8	4.6	20.5	4.1	12.3	4.0	2.3	2.1	2.5	2.3	10.1	4.5	2.4	1.3	15.7	1.6	0.9	4.2	17.8	3.4	13.3	0.6	6.3	10.1	4.7	1.0	6.7	1.3	2.9	2.0	0.7	3.2	4.6	1.3	0.8	7.0	31.0	19.6	8.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	12.9	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	7.1	0.0	5.4	0.0	0.0	13.6	3.5	29.3	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.0	0.9	13.6	0.1	6.4	0.0	9.7	4.0	0.0	0.0	0.0	0.0	10.1	0.1	8.8	24.7	0.5	77.3	7.4	0.1	0.8	2.2	2.4	5.9	0.1	11.0	0.0	9.3	0.0	0.9	10.7	0.0	12.6	0.1	0.4	0.0	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.9	2.0	2.3	2.1	2.4	1.3	3.4	1.3	0.0	0.0	0.0	26.4	21.8	0.0	0.8	0.0	0.0	0.0	5.2	0.0	196.5	0.0	24.1	0.5	3.0	0.0	0.0	44.9	103.1	11.5	36.3	0.0	0.0	16.7	0.0	0.0	3.7	0.0	0.0	36.2	0.5	0.0	1.0	0.0	0.0	86.6	0.0	5.6	0.0	0.0	0.0	1.9	0.1	1.5	8.0	116.0	0.0	0.0	51.1
MDFIC	"HIC, MDFIC1"	ENSG00000135272	"MyoD family inhibitor domain containing"	Q9P1T7	7	114922154-115019202	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Muller glia cells: 111.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030716	Approved		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA030716: AB_10671364"	"unprognostic (1.24e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (6.13e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.55e-1)"	39.4	21.1	4.6	29.3	4.6	5.1	62.4	2.5	4.0	18.4	15.5	5.1	13.9	3.7	22.8	8.8	18.2	7.7	9.7	15.9	4.4	4.7	8.3	8.6	17.5	48.0	4.7	4.1	11.2	5.9	15.2	6.6	11.2	13.6	11.9	5.8	11.2	14.4	19.4	13.7	8.1	9.4	16.7	13.7	28.3	6.6	4.0	3.4	17.8	16.1	11.2	24.1	18.0	25.4	3.6	8.1	1.1	2.5	2.7	6.9	1.2	0.0	4.8	6.4	0.0	13.7	19.0	2.7	24.4	29.4	5.6	7.1	0.1	14.5	3.4	0.3	16.0	9.0	2.8	2.0	4.2	9.7	12.0	5.7	0.0	6.0	0.0	7.0	7.4	5.0	15.8	4.1	12.7	4.0	14.4	3.7	3.3	0.0	23.6	19.0	0.0	0.0	0.6	5.2	0.3	5.5	0.0	18.9	7.3	5.7	5.9	0.2	0.0	10.6	10.0	11.0	9.2	3.1	6.7	10.4	20.9	5.9	38.6	11.7	9.6	0.0	0.0	14.6	0.0	17.8	0.2	1.5	1.1	3.0	1.9	4.6	3.6	6.9	6.4	2.4	3.2	4.0	3.4	0.1	2.7	2.5	8.1	5.6	1.2	4.6	4.6	2.5	4.0	4.4	4.7	4.7	4.1	13.6	3.4	14.9	25.0	24.0	5.8	8.4	0.5	23.2	10.2	20.1	17.0	14.0	0.0	6.9	8.3	2.0	1.3	27.3	0.0	0.0	2.5	4.5	13.4	6.6	2.3	13.9	22.0	0.0	0.0	48.5	50.6	0.9	4.0	28.8	35.4	5.4	2.1	111.3	6.0	2.0	2.5	4.1	3.4	6.5	8.3	0.0	0.5	12.0	3.1	40.1	4.2	6.4
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 1859.7;Proximal tubular cells: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		63000000	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.2	36.3	49.1	32.1	69.7	51.7	50.8	34.9	51.6	53.1	53.9	42.9	39.4	55.8	20.7	45.7	66.4	39.0	55.2	64.6	76.3	33.7	42.6	52.3	33.9	68.2	38.3	60.2	41.5	51.2	44.2	49.8	29.4	43.3	40.5	56.8	28.9	40.6	69.9	26.6	52.7	60.8	28.7	66.4	45.2	42.1	57.8	54.7	88.0	42.0	45.5	27.1	29.2	47.2	66.8	39.1	34.4	62.9	23.6	40.8	40.0	33.9	43.8	50.7	44.4	68.3	50.4	54.5	33.7	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2	56.6	41.7	76.8	91.9	72.5	153.0	1859.7	86.6	136.5	79.6	127.4	66.8	222.4	533.9	152.0	8.3	50.1	143.7	70.0	94.8	211.6	90.4	54.0	78.5	143.3	336.7	116.0	60.3	41.1	68.1	11.1	92.6	78.1	168.7	212.0	97.2	112.7	85.3	103.5	102.6	683.5	120.0	58.2	87.6	48.3	49.0	73.4	125.1	76.2	138.8	88.5
MDK	"FLJ27379, MK, NEGF2"	ENSG00000110492	Midkine	P21741	11	46380756-46383837	"Cancer-related genes, Predicted secreted proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 115.9"	"Cell type enhanced"	"Detected in many"	11	"Intestinal endocrine cells: 971.2;Paneth cells: 1226.4;Urothelial cells: 439.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.6;neutrophil: 4.9"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;granulocytes: 4.9;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 89.4;REH: 130.0;SH-SY5Y: 111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010055, HPA057126"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	158000	1200000	Vesicles		"CAB010055: AB_627949, HPA057126: AB_2683344"	"unprognostic (8.87e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.15e-1)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (8.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	8.0	16.2	4.7	11.9	5.6	1.7	13.5	5.3	5.9	62.5	36.3	5.3	13.9	50.6	41.0	33.9	6.5	34.6	35.0	6.4	4.0	5.9	6.1	2.0	8.0	3.6	4.9	4.4	115.9	13.1	8.9	64.8	11.5	5.5	47.7	7.4	59.0	22.2	24.5	4.7	4.1	58.4	16.6	4.0	13.9	21.0	9.3	2.1	22.5	5.2	5.5	12.4	15.3	23.0	3.6	0.2	4.9	0.6	0.2	2.0	1.5	4.9	6.5	76.3	0.2	0.5	6.4	1.8	3.8	7.7	14.7	13.1	49.5	21.8	0.3	53.8	5.6	0.6	42.5	43.0	0.0	1.3	15.1	9.0	2.1	0.6	67.8	34.8	0.1	0.3	10.3	1.3	8.9	0.0	3.1	21.4	2.9	36.6	0.3	8.2	33.8	1.8	0.9	89.4	26.7	38.8	130.0	2.9	0.4	0.1	0.1	42.4	111.0	12.7	1.1	1.0	70.5	34.8	34.3	5.8	22.6	54.3	0.3	2.6	0.2	1.0	0.4	0.6	1.3	19.6	0.0	0.1	0.0	0.3	0.5	0.0	3.6	0.2	0.5	0.1	1.1	0.2	0.0	4.9	0.2	0.6	0.2	2.0	1.5	4.7	5.6	5.3	5.9	4.0	5.9	4.9	4.4	5.5	2.1	0.0	4.8	2.4	142.7	9.8	0.1	5.8	40.8	41.5	46.6	45.4	0.0	140.1	1.7	217.8	16.4	56.2	413.9	0.0	92.4	97.9	99.4	135.8	4.6	5.9	43.2	0.0	971.2	77.3	4.0	90.5	101.5	7.1	35.4	16.2	245.7	23.8	203.6	1226.4	17.7	13.5	0.7	84.1	56.5	14.9	29.0	7.0	128.0	3.2	126.6	439.7
MDP1	"FN6Pase, MGC5987"	ENSG00000213920	"Magnesium dependent phosphatase 1"	Q86V88	14	24213937-24216070	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003064, HPA070338"	Uncertain		Approved	Nucleoplasm		NA	NA		34000	Nucleoplasm		"HPA003064: AB_10602350, HPA070338: AB_2686256"	"unprognostic (2.70e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-2)"	12.2	17.6	18.5	8.3	15.0	8.1	18.7	18.6	18.3	13.3	10.2	13.1	21.0	6.7	10.6	19.0	8.9	14.3	12.0	17.8	13.8	13.9	16.6	14.7	8.7	13.5	15.1	14.5	12.9	20.2	14.8	18.3	9.4	16.6	13.3	8.6	13.5	14.3	16.3	11.4	10.6	9.8	10.9	13.9	10.4	10.0	6.6	17.0	14.3	14.6	10.6	10.8	10.0	9.6	10.1	23.0	12.2	11.1	9.0	11.9	7.9	3.1	7.9	6.0	3.9	6.0	5.6	0.2	3.4	7.4	6.9	7.2	4.2	9.1	12.8	8.8	3.5	2.1	3.1	2.9	6.8	4.3	4.3	3.2	4.9	2.9	9.6	5.8	6.2	3.6	3.9	6.3	4.2	8.0	7.1	4.9	9.3	1.5	9.6	6.2	17.2	8.8	10.2	1.7	6.3	14.2	6.3	4.2	10.1	6.7	4.6	7.4	7.2	5.4	11.6	7.2	3.4	7.0	3.3	2.9	7.6	7.3	3.2	3.4	15.6	6.2	9.3	7.1	3.1	5.8	3.1	10.9	12.2	6.3	11.1	5.9	10.1	8.1	7.3	12.4	9.5	9.9	8.2	3.8	9.0	9.4	23.0	11.9	7.9	18.5	15.0	18.6	18.3	13.8	13.9	15.1	14.5	16.6	17.0	6.0	11.7	7.5	2.8	4.0	3.4	0.0	5.1	21.4	0.0	5.2	0.0	3.1	11.6	10.4	3.0	5.2	8.1	0.0	17.0	4.4	5.6	2.4	4.7	5.0	7.0	3.2	11.1	6.2	2.2	2.9	5.8	11.0	16.9	29.7	11.1	3.1	12.6	2.9	7.1	15.7	2.7	12.9	7.2	1.9	3.2	4.0	2.1	5.1	10.7	2.0
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 109.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 615.5;Late spermatids: 1508.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	16.8	17.4	26.6	13.9	23.4	11.8	17.4	13.1	29.9	16.2	14.3	17.2	14.0	12.7	20.1	25.2	16.8	20.5	17.2	12.5	20.9	25.4	16.5	18.7	15.2	14.2	21.9	20.8	22.7	26.7	13.2	17.7	17.3	17.5	20.9	17.0	19.6	16.6	20.3	14.6	15.2	13.1	19.5	15.7	12.8	13.0	109.4	8.7	19.1	15.8	13.4	21.2	21.5	14.1	61.2	40.9	70.6	51.0	46.6	51.7	59.9	38.7	22.4	33.6	26.6	30.8	20.6	13.4	26.0	27.7	32.5	35.7	33.3	10.2	20.3	27.3	31.7	47.5	19.7	25.9	35.3	30.6	23.2	35.1	37.7	24.5	35.9	15.9	27.4	19.8	16.4	17.6	43.1	28.2	33.1	19.5	33.3	25.4	22.8	35.5	74.3	36.7	31.8	15.8	110.3	19.8	18.0	20.0	20.2	22.4	36.8	32.5	22.8	20.0	17.2	29.5	28.3	26.2	30.0	14.4	35.9	28.9	23.2	44.8	26.0	21.5	33.9	18.0	20.6	29.1	64.5	39.2	70.6	46.7	44.5	42.9	61.2	42.9	45.6	40.9	56.8	43.2	45.8	35.9	46.6	51.0	40.0	51.7	59.9	26.6	23.4	13.1	29.9	20.9	25.4	21.9	20.8	17.5	8.7	23.8	11.8	43.2	62.1	58.8	20.2	24.9	43.3	58.9	39.8	52.4	3.9	94.6	142.6	74.9	615.5	56.2	55.4	0.0	80.2	87.3	55.2	61.8	46.1	39.4	95.1	15.9	28.7	41.7	31.9	1508.8	58.7	50.6	64.1	93.8	42.8	52.2	71.4	49.1	56.3	121.5	14.8	116.4	68.9	194.8	94.1	60.9	71.1	58.2	45.3	74.3
MECP2	"MRX16, MRX79, RTT"	ENSG00000169057	"Methyl-CpG binding protein 2"	P51608	X	154021573-154137103	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 194.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000593, HPA001341, CAB037264"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347"	"unprognostic (1.27e-3)"	"unprognostic (2.60e-3)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.22e-1)"	"prognostic favorable (7.32e-9)"	"unprognostic (7.63e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.05e-2)"	18.6	21.4	29.2	17.0	27.1	33.8	17.6	39.1	33.5	20.2	19.2	17.6	15.9	13.9	20.0	15.1	18.8	21.1	19.5	23.1	22.5	14.0	17.1	16.4	22.8	19.7	22.5	26.7	29.0	21.2	24.3	22.9	13.9	25.4	23.0	8.0	20.8	18.7	23.7	31.6	14.1	15.3	16.2	21.1	23.3	15.0	9.7	24.4	13.8	19.1	8.7	14.3	18.7	28.6	5.6	4.2	22.4	4.9	2.9	6.8	1.8	19.4	11.6	9.8	12.2	8.4	6.0	8.3	9.8	11.0	12.0	19.6	8.9	9.5	23.4	23.2	8.6	19.0	9.3	14.7	11.5	6.1	17.7	17.7	9.0	10.6	5.6	10.3	11.3	18.9	6.1	6.5	11.2	13.2	9.5	9.3	11.5	9.7	20.0	7.2	11.6	13.6	13.0	7.6	14.7	13.0	11.8	10.7	7.7	8.5	8.9	13.8	8.0	7.6	8.9	18.7	5.5	5.8	14.7	9.7	9.1	18.1	18.5	19.7	24.0	17.8	26.6	13.2	22.3	15.6	22.4	3.5	13.3	6.8	3.2	4.8	5.6	4.8	5.5	2.4	4.9	4.6	4.4	16.9	2.9	4.9	4.2	5.0	1.8	29.2	27.1	39.1	33.5	22.5	14.0	22.5	26.7	25.4	24.4	6.0	33.8	38.3	36.3	27.4	82.7	40.4	30.6	17.4	33.0	43.6	194.4	13.1	56.3	31.6	0.5	36.8	24.4	0.0	27.0	13.6	26.3	29.6	50.8	30.8	23.4	93.8	35.1	60.8	37.0	2.1	49.5	41.8	28.7	60.5	17.4	46.1	29.3	28.1	69.3	21.9	81.7	32.3	40.0	7.7	36.0	25.3	15.4	82.9	16.4	29.4
MED11	"HSPC296, MGC88387"	ENSG00000161920	"Mediator complex subunit 11"	Q9P086	17	4731428-4733610	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056669	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA056669: AB_2683204"	"unprognostic (4.01e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (8.24e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	12.8	30.8	15.5	16.5	26.4	7.0	16.2	14.5	19.3	16.6	20.9	16.4	22.3	20.7	14.7	22.8	20.5	19.7	21.5	22.0	16.9	13.2	29.5	35.4	16.4	19.6	25.0	19.7	13.8	30.6	24.3	14.4	19.0	22.8	17.5	18.4	13.7	27.7	16.4	24.7	20.8	26.8	18.8	21.9	25.4	20.3	11.7	23.3	13.9	22.8	25.9	19.9	16.4	14.7	23.8	18.6	51.3	23.3	14.2	21.5	13.0	12.2	35.9	13.3	13.7	14.4	17.7	10.4	8.8	15.1	13.2	16.3	12.4	9.7	17.1	9.5	10.9	8.7	18.9	13.4	25.1	9.7	20.3	30.7	8.3	20.1	18.9	9.0	6.0	10.2	15.3	17.7	14.0	8.8	14.3	14.8	17.8	8.5	13.1	11.4	17.9	11.7	7.6	7.9	19.0	11.5	11.6	9.7	11.1	26.7	12.8	5.4	9.0	11.5	15.6	8.6	11.4	13.9	7.2	8.7	7.1	7.1	13.5	14.1	6.2	5.4	6.5	12.2	10.5	9.2	14.7	11.8	28.0	16.8	16.6	17.9	22.8	16.5	16.8	11.6	23.8	19.6	21.5	51.3	14.2	23.3	18.6	12.4	13.0	15.5	26.4	14.5	19.3	16.9	13.2	25.0	19.7	22.8	23.3	6.0	16.8	45.4	26.9	10.9	21.7	11.5	35.7	36.1	21.6	14.0	9.8	37.6	54.7	29.5	1.1	10.8	45.9	0.0	31.1	29.4	14.7	21.4	27.8	23.1	29.5	28.6	10.4	20.9	18.3	2.1	16.1	26.6	10.1	54.1	26.4	17.5	22.4	48.9	13.1	52.6	25.3	19.4	18.6	31.6	30.4	16.4	20.9	25.9	26.5	27.1
MED12	"CAGH45, FGS1, HOPA, KIAA0192, OKS, OPA1, TNRC11, TRAP230"	ENSG00000184634	"Mediator complex subunit 12"	Q93074	X	71118556-71142454	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003184, HPA003185"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003184: AB_1079349, HPA003185: AB_1079350"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.89e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.16e-2)"	18.2	31.3	12.3	15.3	14.7	16.6	18.1	18.0	15.1	16.8	12.8	19.8	21.3	10.2	21.7	16.5	13.1	17.7	14.2	12.9	12.9	8.5	13.3	9.8	14.0	15.3	15.7	10.7	28.8	14.2	20.1	17.9	23.0	11.6	16.5	11.8	18.6	14.6	20.3	14.9	17.6	14.8	16.4	11.2	27.3	14.2	15.3	12.9	33.1	17.8	12.6	15.9	15.4	16.4	4.0	5.1	9.7	3.7	5.0	7.4	3.6	8.7	10.3	16.3	9.7	12.0	10.7	24.1	6.2	8.9	9.9	7.1	12.4	8.3	11.5	8.2	10.7	6.8	8.7	19.0	7.8	7.9	12.1	14.7	19.1	23.2	16.7	9.4	17.5	16.9	12.4	8.5	12.9	15.0	12.7	15.2	14.7	17.7	20.2	9.7	14.7	18.4	10.0	9.3	11.2	13.5	17.3	18.2	8.7	7.5	17.4	9.1	11.0	14.3	7.3	8.1	17.5	8.8	8.7	13.2	10.8	12.8	9.9	4.3	10.0	5.5	8.4	6.3	9.8	7.2	9.7	3.7	7.2	5.9	3.6	5.0	4.0	4.1	5.4	3.9	4.0	4.6	3.9	7.7	5.0	2.4	5.1	7.4	3.6	12.3	14.7	18.0	15.1	12.9	8.5	15.7	10.7	11.6	12.9	8.9	3.4	5.2	5.2	5.4	7.1	8.1	15.3	2.7	6.8	8.7	5.9	17.0	1.7	5.4	0.2	8.7	6.8	0.0	5.4	6.2	7.8	5.7	9.2	3.4	8.0	12.7	7.5	14.1	6.7	0.9	13.0	9.2	5.0	6.4	7.8	5.8	8.6	8.4	12.7	2.2	4.5	0.0	5.0	6.4	7.4	5.0	22.8	6.4	6.4	6.8
MED12L	"KIAA1635, TNRC11L, TRALP, TRALPUSH"	ENSG00000144893	"Mediator complex subunit 12 like"	Q86YW9	3	151085697-151437072	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 14.2;Horizontal cells: 31.8;Muller glia cells: 35.7;Syncytiotrophoblasts: 22.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 15.8;HEL: 17.1;JURKAT: 10.9;MOLT-4: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036807	Enhanced		Approved	Nucleoli		NA	NA			Nucleoli		"HPA036807: AB_10670242"	"unprognostic (1.01e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.12e-2)"	"unprognostic (8.14e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	2.8	5.2	6.4	1.2	11.1	5.5	0.5	4.9	23.1	1.6	0.6	4.4	0.0	2.2	0.9	3.0	0.9	0.6	1.8	1.7	5.5	5.1	0.4	0.4	0.7	4.4	5.8	2.6	1.0	1.7	0.5	5.4	2.0	3.9	1.2	0.3	1.9	1.7	0.7	0.5	0.4	1.6	0.6	6.1	2.1	0.8	6.1	5.7	0.6	1.0	0.0	1.5	1.3	0.8	1.0	5.1	3.1	2.8	0.1	0.4	0.8	0.7	0.3	2.5	0.2	0.1	0.0	15.8	0.0	0.2	0.6	0.7	0.8	0.3	0.0	0.2	0.1	1.8	0.1	3.2	0.2	0.7	0.0	1.5	17.1	0.1	0.1	0.0	0.5	6.1	0.0	0.1	0.1	0.1	0.1	0.0	10.9	0.0	2.6	0.0	2.5	7.9	0.0	2.9	0.1	0.5	0.1	0.9	0.4	0.2	2.5	4.2	0.6	0.4	0.2	0.0	4.6	0.8	0.1	0.0	0.0	1.9	0.0	1.3	5.0	0.0	6.1	0.2	1.5	0.9	3.1	0.3	0.0	0.1	2.8	0.4	0.1	0.1	0.2	1.6	1.0	0.0	0.0	0.3	0.1	0.8	5.1	0.0	0.8	6.4	11.1	4.9	6.9	5.5	5.1	5.8	2.6	3.9	5.7	0.0	0.0	0.0	1.2	1.0	9.0	1.2	0.0	1.4	2.3	1.8	3.9	14.2	0.0	0.1	9.9	0.1	0.0	0.0	0.5	0.6	0.6	1.0	0.0	0.0	1.6	31.8	0.0	0.6	1.0	4.5	0.9	0.9	0.0	1.8	0.0	35.7	0.2	0.0	0.4	0.1	1.8	0.0	0.1	7.5	1.5	0.1	22.5	0.0	0.0	0.1
MED13L	"KIAA1025, THRAP2, TRAP240L"	ENSG00000123066	"Mediator complex subunit 13 like"	Q71F56	12	115953872-116277338	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in all"		"T-47d: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA039445: AB_10673532"	"unprognostic (1.81e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (4.64e-1)"	21.3	7.9	9.8	14.7	10.6	39.1	22.0	29.7	11.1	17.3	13.6	12.1	12.3	7.8	21.6	11.1	13.2	13.9	12.2	9.4	11.0	7.0	9.0	7.3	15.2	16.7	11.5	9.1	20.5	15.6	14.3	13.6	13.4	9.6	14.6	10.9	11.7	14.2	14.2	18.1	21.9	13.1	15.3	11.9	14.3	12.8	14.9	11.2	55.9	14.0	10.8	15.4	13.8	22.7	2.5	1.9	13.1	1.1	1.4	1.1	0.7	6.4	15.4	7.2	8.1	9.7	16.0	7.7	6.8	9.0	9.4	6.7	15.3	2.3	4.4	5.7	12.2	5.9	4.7	8.2	5.4	12.4	10.0	5.3	9.1	4.6	5.7	10.7	8.1	12.2	12.8	9.3	10.3	15.8	7.3	6.8	11.9	9.9	4.4	8.1	14.5	15.9	17.1	4.0	2.3	3.6	11.3	7.8	10.7	6.1	5.9	7.4	6.4	6.1	3.2	6.0	16.8	50.7	17.9	8.4	10.7	7.1	7.8	8.1	8.4	3.8	8.1	5.0	8.9	5.6	13.1	1.1	3.6	1.0	0.9	1.1	2.5	1.0	1.1	1.5	1.3	0.8	0.9	4.1	1.4	1.1	1.9	0.7	0.7	9.8	10.6	29.7	11.1	11.0	7.0	11.5	9.1	9.6	11.2	59.6	40.0	33.7	33.5	88.0	49.8	29.5	20.4	28.1	45.5	24.4	51.1	8.0	3.3	11.3	48.2	59.1	24.3	0.0	22.2	18.4	39.9	36.4	13.9	25.2	18.1	54.0	30.1	55.9	55.0	39.2	85.4	26.9	30.4	13.6	34.1	23.6	22.2	14.4	62.9	11.7	43.8	45.3	53.1	19.1	18.8	88.8	11.9	22.7	25.1	43.3
MED14	"CRSP150, CRSP2, CSRP, CXorf4, EXLM1, RGR1, TRAP170"	ENSG00000180182	"Mediator complex subunit 14"	O60244	X	40648306-40735858	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064182			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064182: AB_2685204"	"unprognostic (5.21e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.38e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.64e-1)"	11.0	11.4	12.0	18.5	14.7	19.6	10.5	19.2	16.8	12.9	17.7	20.5	11.4	18.1	14.4	21.9	15.0	10.0	11.1	14.6	13.8	12.5	13.0	15.5	12.4	16.2	12.4	11.5	14.9	12.9	21.5	15.9	13.5	15.1	12.0	15.6	14.7	10.6	12.2	53.8	16.7	19.8	16.2	12.8	13.5	12.8	5.7	11.7	31.7	16.2	18.4	20.9	17.5	12.8	4.0	5.7	6.0	7.3	7.7	5.2	2.4	22.2	11.0	17.8	15.7	7.9	10.3	3.6	8.8	11.1	12.8	16.3	10.1	11.1	12.9	6.0	11.1	27.4	17.0	30.1	14.0	19.2	11.7	22.7	13.0	13.5	9.1	8.5	13.6	13.5	7.4	8.6	18.6	16.3	15.1	15.3	8.6	8.8	12.6	13.3	11.5	12.5	12.2	19.6	14.2	12.9	6.3	19.0	12.9	12.2	10.3	11.5	10.1	20.9	9.6	9.7	34.7	14.0	8.2	13.9	13.1	13.7	16.4	10.8	11.8	12.0	12.8	12.7	9.4	9.4	4.3	3.6	6.0	4.5	7.3	5.2	3.9	4.3	4.4	5.7	4.0	4.9	3.8	1.9	7.7	3.9	3.1	3.9	2.4	12.0	14.7	19.2	16.8	13.8	12.5	12.4	11.5	15.1	11.7	14.9	11.8	11.3	8.1	21.1	15.3	12.9	12.7	2.7	11.4	12.2	17.7	5.5	5.0	7.0	0.4	8.3	15.8	0.0	8.7	4.4	10.9	12.9	10.4	18.7	8.0	17.5	19.7	8.0	16.7	0.8	8.1	14.9	11.8	11.8	20.8	6.5	10.3	14.4	8.1	8.6	15.6	25.8	11.4	11.4	3.2	26.5	5.5	8.7	15.3	25.3
MED16	"DRIP92, THRAP5, TRAP95"	ENSG00000175221	"Mediator complex subunit 16"	Q9Y2X0	19	867630-893218	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030685, HPA046495"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA030685: AB_10601872, HPA046495: AB_2679674"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-2)"	"unprognostic (4.93e-3)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (4.83e-2)"	"unprognostic (5.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-2)"	17.8	19.8	17.0	24.2	21.1	16.1	15.9	16.8	34.5	21.8	20.4	21.4	12.5	20.5	20.7	14.9	21.0	20.3	21.9	14.0	16.0	15.4	19.4	29.5	16.2	19.4	13.4	16.3	28.6	46.1	18.9	18.8	21.9	14.7	20.6	8.5	19.4	24.4	15.6	31.1	24.6	24.4	14.9	11.2	22.3	27.0	20.1	14.0	27.0	21.6	16.1	21.6	20.5	18.9	30.3	20.8	24.7	17.0	19.2	40.3	25.4	14.1	12.3	12.4	8.3	5.3	5.6	13.6	9.6	9.5	14.8	11.4	16.0	13.6	14.7	11.9	8.9	5.1	11.2	4.7	11.9	2.5	18.2	14.9	14.7	9.2	14.7	10.3	13.8	13.3	9.7	6.0	9.1	6.0	8.9	10.9	15.7	17.1	34.0	8.6	21.3	22.2	16.3	19.2	5.5	16.0	23.3	8.9	18.7	9.9	22.8	15.4	15.0	13.4	9.2	10.8	4.9	10.5	11.1	10.9	15.3	15.4	23.1	11.1	25.7	9.2	13.4	19.6	13.1	11.0	24.7	15.7	19.0	27.6	17.0	25.0	30.3	30.3	31.5	20.8	23.1	25.8	23.8	22.2	19.2	16.9	13.6	40.3	25.4	17.0	21.1	16.8	34.5	16.0	15.4	13.4	16.3	14.7	14.0	32.8	21.9	14.5	10.0	10.3	14.2	6.4	15.3	12.0	12.5	21.0	5.9	50.4	14.9	19.5	2.9	10.9	35.5	0.0	20.9	26.3	11.3	12.1	13.9	22.5	22.0	14.3	24.6	18.4	16.8	4.7	12.7	9.4	10.1	29.7	24.7	16.5	20.5	27.5	13.8	14.6	19.2	6.5	11.3	13.7	30.5	14.1	53.3	16.6	22.2	12.9
MED17	"CRSP6, CRSP77, DRIP80, SRB4, TRAP80"	ENSG00000042429	"Mediator complex subunit 17"	Q9NVC6	11	93784227-93814963	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA046619			Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA046619: "	"prognostic unfavorable (4.94e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.48e-1)"	9.0	7.4	5.8	9.9	8.0	9.5	9.2	13.9	10.7	10.7	10.2	9.0	9.4	4.3	12.1	7.5	7.9	10.4	7.3	11.5	6.3	5.4	6.4	4.6	8.2	8.1	9.5	7.3	13.8	9.9	5.4	13.1	9.5	6.1	8.2	4.9	8.0	9.4	6.6	9.3	10.2	14.0	7.7	7.7	13.9	12.1	7.9	8.8	20.7	7.8	5.5	9.8	11.2	11.6	10.5	6.8	10.8	5.7	10.2	8.5	5.1	3.0	1.0	2.6	5.5	3.2	0.4	5.1	6.7	2.3	4.5	2.8	5.3	6.3	5.0	11.3	0.6	1.3	9.4	2.4	1.4	1.2	6.0	2.7	5.6	3.4	1.5	1.7	9.3	9.5	1.3	3.3	3.3	2.2	1.1	1.8	1.3	4.9	3.0	2.7	0.8	11.2	2.7	4.8	0.7	0.8	8.6	7.6	4.1	2.7	2.1	9.1	11.7	5.6	4.6	2.8	0.7	7.0	2.3	6.0	7.0	5.6	9.3	5.8	4.6	9.1	3.6	1.8	6.6	7.9	4.9	4.6	10.8	6.4	5.7	7.6	10.5	8.2	8.0	6.0	9.0	8.5	4.8	4.7	10.2	3.3	6.8	8.1	5.1	5.8	8.0	13.9	7.9	6.3	5.4	9.5	7.3	6.1	8.8	6.0	9.4	35.0	34.7	26.8	21.7	12.1	12.7	18.7	14.8	7.0	15.7	32.8	1.7	12.8	0.7	13.4	11.5	0.0	8.5	22.7	17.1	21.5	10.4	6.8	12.9	14.3	25.7	13.5	13.7	2.2	14.7	12.1	13.5	11.8	11.2	17.1	9.7	14.1	20.1	1.5	35.0	64.7	19.8	24.7	15.4	22.5	28.5	20.3	13.8	32.7
MED18	"FLJ20045, p28b, SRB5"	ENSG00000130772	"Mediator complex subunit 18"	Q9BUE0	1	28329002-28335967	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027429	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027429: AB_10610137"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.78e-3)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.38e-5)"	"prognostic favorable (6.72e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.69e-2)"	9.8	11.2	6.2	9.2	6.7	5.9	7.9	5.5	12.1	7.7	11.4	7.1	8.9	9.7	8.1	9.1	13.3	9.9	9.5	8.4	6.6	6.7	11.6	19.2	6.7	11.8	8.5	6.6	7.0	12.3	5.7	7.1	12.4	8.6	8.6	10.3	7.8	10.2	7.3	10.9	9.1	13.0	6.9	6.0	14.3	9.9	8.5	6.9	17.0	11.0	6.1	18.5	8.4	6.6	8.3	8.3	11.6	8.3	5.4	7.5	7.1	13.2	6.6	6.6	5.6	8.9	8.6	7.4	7.9	9.5	10.4	9.0	3.7	12.5	16.5	8.2	8.1	6.3	8.3	10.5	9.8	8.1	11.2	7.4	12.7	6.0	8.2	12.3	7.6	13.6	9.2	12.1	8.1	12.5	6.2	8.9	8.3	12.0	4.4	9.6	6.4	9.6	9.7	7.8	7.4	3.8	7.0	9.5	8.7	9.1	6.7	6.7	6.7	8.0	8.1	11.0	7.3	6.9	7.3	10.7	6.3	7.2	10.4	8.2	7.6	10.1	9.2	9.3	16.2	4.5	6.2	7.5	10.4	7.5	7.4	5.5	8.3	5.9	6.2	6.2	6.7	7.4	7.3	11.6	5.4	8.3	8.3	7.5	7.1	6.2	6.7	5.5	12.1	6.6	6.7	8.5	6.6	8.6	6.9	8.9	4.5	6.0	3.4	0.7	3.2	4.1	2.5	4.0	5.7	1.8	11.8	9.8	6.6	6.2	0.4	2.3	6.3	23.3	5.2	11.1	2.1	2.5	1.1	3.4	6.8	9.5	3.4	4.3	3.2	0.7	4.4	3.3	1.7	6.4	4.8	4.6	5.0	6.8	4.9	6.4	4.6	19.4	3.1	7.2	6.3	1.1	12.4	5.1	4.1	5.3
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	11.8	22.1	12.4	12.1	14.2	7.0	14.2	17.0	15.4	15.3	14.0	16.4	17.4	13.1	16.1	17.8	17.0	13.2	9.9	15.3	12.7	9.5	17.5	14.7	10.4	11.4	14.8	9.3	12.8	17.6	14.5	23.5	17.4	13.8	16.3	15.4	13.2	15.3	14.0	23.0	12.1	15.4	15.3	9.6	13.3	12.9	14.6	11.5	20.9	15.5	13.1	16.4	16.0	12.9	15.0	20.0	13.6	22.1	11.6	10.8	11.5	13.5	11.5	12.4	14.8	11.7	13.0	15.3	8.6	8.3	12.3	9.9	14.6	9.3	18.4	17.1	10.1	7.0	10.3	21.1	11.6	15.6	10.6	6.7	16.5	8.9	12.8	11.2	14.0	10.4	10.1	18.2	11.7	17.6	9.8	15.2	17.8	22.3	8.9	14.7	12.1	15.6	10.0	16.1	43.1	9.3	21.7	14.9	6.6	17.6	8.7	11.5	9.1	12.3	5.8	11.6	15.4	11.7	14.7	14.8	8.7	19.0	5.3	10.6	9.2	12.3	38.9	4.8	15.6	12.3	13.0	19.6	13.6	8.7	22.1	10.8	14.2	5.8	9.8	20.0	15.0	7.9	9.3	7.3	11.6	14.8	17.8	10.2	11.5	12.4	14.2	17.0	15.4	12.7	9.5	14.8	9.3	13.8	11.5	8.9	3.8	7.7	3.5	3.3	2.1	4.0	0.0	4.0	5.7	7.0	0.0	19.8	6.6	5.5	0.4	2.8	5.1	0.0	2.9	15.6	5.3	4.1	6.9	7.3	7.2	1.6	9.2	8.6	6.0	0.0	3.1	3.0	1.7	1.8	6.4	4.0	4.1	3.5	6.3	8.0	3.7	0.0	3.4	4.1	13.4	5.0	20.8	2.5	6.6	4.7
MED21	"SRB7, SURB7"	ENSG00000152944	"Mediator complex subunit 21"	Q13503	12	27022546-27066343	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 190.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017177	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA017177: AB_1857665"	"unprognostic (3.02e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.74e-8)"	"unprognostic (3.18e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-2)"	20.7	31.5	20.7	13.3	32.4	31.9	23.9	25.9	31.9	24.8	21.9	18.0	18.8	14.9	25.9	21.7	30.4	20.8	19.6	31.3	19.5	21.9	34.1	18.8	20.8	15.7	21.1	26.2	30.8	17.1	30.3	26.0	19.8	23.6	27.6	20.6	18.3	25.3	24.5	30.7	19.3	17.4	27.3	20.2	16.0	19.6	28.9	22.1	22.1	28.2	28.7	19.9	31.6	27.2	20.1	15.8	35.5	18.6	12.8	28.0	19.1	16.6	17.6	9.3	14.8	20.8	21.0	15.4	19.0	14.3	16.1	21.0	18.4	19.0	11.0	12.1	14.5	23.4	13.8	19.8	17.6	27.8	9.6	17.7	15.8	18.2	11.3	11.6	19.3	11.4	14.8	25.8	19.9	23.9	26.1	23.3	14.9	12.8	14.7	18.1	12.5	16.9	35.6	28.5	21.2	23.3	14.6	59.7	12.4	16.7	19.1	7.1	10.4	23.2	10.0	15.0	37.3	17.7	12.9	16.8	18.0	14.0	22.3	19.2	4.5	9.3	18.1	17.1	21.6	12.1	35.5	17.5	23.9	20.4	18.6	20.8	20.1	24.6	23.9	15.8	16.6	28.0	25.3	14.0	12.8	16.5	12.9	23.8	19.1	20.7	32.4	25.9	31.9	19.5	21.9	21.1	26.2	23.6	22.1	14.9	16.5	22.6	105.7	87.8	9.2	30.8	7.6	12.0	29.6	50.6	0.0	52.6	79.6	36.3	190.1	33.7	16.5	23.3	33.3	49.3	57.0	71.3	18.4	20.0	27.5	12.7	17.1	22.1	17.5	59.3	44.8	27.0	67.4	36.9	17.6	15.1	29.2	17.3	44.6	72.5	13.1	19.4	58.7	92.2	54.3	88.5	51.0	27.7	17.2	125.9
MED22	"Med24, SRB6, SURF5"	ENSG00000148297	"Mediator complex subunit 22"	Q15528	9	133338323-133348131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020391, HPA063694"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020391: AB_1857668, HPA063694: AB_2685093"	"unprognostic (2.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.56e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (4.99e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.46e-4)"	"unprognostic (3.99e-1)"	"prognostic favorable (3.76e-11)"	"unprognostic (9.25e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.62e-1)"	12.6	14.4	15.2	15.9	16.5	11.9	11.3	19.6	26.0	19.0	16.6	15.5	12.6	14.3	18.4	12.6	13.4	16.2	14.3	15.4	13.7	14.3	14.0	10.6	13.8	15.6	14.5	16.2	19.7	15.0	19.3	13.0	16.2	15.7	18.1	8.7	14.6	14.7	21.7	14.5	14.9	14.4	20.4	15.4	16.9	12.2	8.3	12.7	11.4	20.4	7.5	13.4	14.5	12.3	4.6	4.8	6.3	4.9	1.6	2.9	2.4	7.0	8.3	13.0	9.3	2.9	4.9	15.2	8.6	6.0	10.7	7.2	18.1	6.6	14.2	5.1	6.1	9.4	14.0	9.7	8.3	4.4	11.1	5.6	7.5	18.1	5.0	4.9	9.6	7.8	3.8	6.6	9.6	6.4	5.0	5.2	8.3	10.9	6.9	5.1	9.7	13.6	8.1	18.2	8.8	10.0	18.7	10.5	13.0	4.4	5.2	10.6	8.6	10.0	12.7	7.5	5.6	14.4	3.4	6.8	14.0	9.8	9.5	11.2	4.7	6.3	13.7	8.0	7.5	11.5	2.2	3.9	6.3	2.0	3.7	2.6	3.4	2.4	2.6	3.0	4.6	2.9	2.2	6.0	1.6	4.9	4.8	2.0	2.4	15.2	16.5	19.6	26.0	13.7	14.3	14.5	16.2	15.7	12.7	20.8	13.2	5.1	9.2	7.3	12.8	7.5	10.2	0.0	2.3	15.7	0.0	5.2	3.3	5.2	1.7	7.2	7.4	0.0	4.5	4.4	10.1	7.1	7.0	5.0	6.7	12.7	6.4	5.5	6.9	1.6	10.9	7.5	1.7	1.0	6.7	8.4	6.1	0.0	15.6	4.9	10.9	25.8	21.5	7.1	10.4	5.6	4.6	5.0	5.6	3.6
MED23	"CRSP130, CRSP3, DRIP130, Sur2"	ENSG00000112282	"Mediator complex subunit 23"	Q9ULK4	6	131573966-131628229	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070341			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA070341: AB_2686257"	"unprognostic (1.11e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.53e-2)"	14.0	17.1	12.1	19.7	12.7	21.8	16.3	23.0	17.6	14.7	12.3	12.1	17.8	12.7	21.6	13.3	14.9	14.6	10.2	10.2	11.7	8.3	12.2	9.6	13.1	15.4	15.9	12.3	20.5	18.7	23.9	16.1	12.3	11.3	13.9	14.4	12.3	19.8	16.8	14.8	15.0	15.4	14.3	11.0	13.7	14.9	13.1	13.3	22.7	18.0	7.4	16.7	16.2	20.7	6.0	6.8	8.8	5.7	15.0	10.9	4.6	5.2	5.9	14.0	17.6	17.4	13.3	12.9	13.3	15.0	12.3	17.9	6.1	7.4	11.7	9.7	13.6	11.8	9.5	7.5	8.6	19.2	13.3	10.5	12.3	10.7	10.3	12.6	20.2	20.9	11.7	10.3	13.6	13.9	14.4	15.2	12.8	15.7	12.3	12.9	8.1	15.3	12.8	6.6	9.1	5.9	13.9	8.7	7.0	9.5	7.8	10.5	9.5	9.4	13.3	8.6	16.9	3.6	14.3	15.3	9.2	10.4	14.6	12.0	13.1	8.8	16.9	11.3	9.3	12.2	4.5	5.3	8.8	7.3	5.7	10.9	6.0	7.2	8.0	6.8	5.2	7.4	6.7	4.5	15.0	3.9	3.6	7.8	4.6	12.1	12.7	23.0	17.6	11.7	8.3	15.9	12.3	11.3	13.3	17.9	8.1	15.2	5.3	8.1	21.1	5.7	5.1	5.3	12.5	22.7	15.7	7.2	3.3	6.7	1.4	9.8	12.5	0.0	6.6	5.7	9.0	11.5	13.9	10.6	7.1	11.1	13.8	12.3	15.4	0.9	13.3	9.1	5.0	6.4	17.6	8.9	7.4	17.3	9.6	7.3	20.5	12.9	6.9	13.0	4.8	7.5	6.5	15.4	13.2	6.3
MED26	"CRSP7, CRSP70"	ENSG00000105085	"Mediator complex subunit 26"	O95402	19	16574907-16629062	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 45.5;Late spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA057997, HPA071835"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			Nucleoplasm	"Vesicles, Cytosol"	"HPA057997: AB_2732618, HPA071835: AB_2686455"	"unprognostic (2.02e-2)"	"prognostic favorable (2.46e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.98e-3)"	5.5	4.6	5.9	8.3	6.2	14.0	7.3	8.7	6.2	6.0	5.1	4.2	5.2	4.0	5.7	6.0	6.2	4.3	4.4	4.0	5.1	4.5	3.7	5.9	9.0	7.6	4.8	4.5	6.2	6.8	6.8	5.4	7.9	4.9	5.4	3.3	3.8	7.2	7.9	9.9	7.1	4.8	4.2	4.5	6.8	5.1	34.7	4.6	8.5	5.0	6.0	6.9	4.8	5.7	2.6	4.4	2.3	1.0	1.2	2.3	0.4	9.1	3.6	3.3	7.1	4.3	3.4	9.7	5.4	3.8	5.8	5.3	5.3	5.5	14.7	5.7	3.4	1.9	6.9	5.1	5.4	4.0	10.8	10.5	5.8	3.3	4.2	4.2	6.5	5.5	4.1	5.3	4.9	5.2	3.5	3.1	7.8	9.4	17.8	3.6	9.1	6.9	6.2	7.8	4.4	11.5	7.2	5.0	16.0	3.4	3.6	8.8	4.6	4.7	4.6	5.3	2.4	3.4	8.6	3.7	7.4	5.9	9.0	7.1	12.4	10.0	11.8	5.2	8.7	4.3	2.3	0.4	0.4	1.6	1.0	0.3	1.4	0.2	0.7	0.8	2.6	1.0	0.2	1.2	1.2	0.4	4.4	2.3	0.4	5.9	6.2	8.7	6.2	5.1	4.5	4.8	4.5	4.9	4.6	3.0	10.1	12.7	3.9	12.6	3.9	0.7	2.5	1.4	1.2	5.2	9.8	5.8	3.3	3.7	45.5	4.7	4.3	0.0	3.4	8.8	6.2	4.9	1.1	4.0	4.3	4.8	2.4	3.7	9.4	52.0	6.1	4.7	1.7	2.8	4.3	5.2	5.1	3.5	3.5	1.9	5.7	0.0	6.4	21.0	16.9	9.4	14.1	4.9	5.0	7.6
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131860107-132079908	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	11.1	12.1	18.0	9.5	18.1	15.5	11.5	14.0	21.4	10.9	11.7	19.5	10.1	7.8	18.6	23.5	15.5	13.9	9.5	17.5	17.5	11.2	10.4	7.5	10.9	13.5	18.6	19.1	12.7	7.9	10.6	17.8	12.7	17.4	12.7	10.7	16.0	17.7	14.4	15.2	15.7	8.6	16.3	16.1	11.7	10.2	14.7	14.0	17.9	13.2	9.6	15.8	12.3	10.5	12.9	19.8	13.4	18.6	18.0	19.7	11.8	16.1	15.9	18.4	14.6	13.2	12.2	15.5	16.8	22.4	33.8	26.5	23.8	13.1	16.0	11.4	17.5	22.6	29.4	25.4	23.9	22.2	17.2	15.0	12.0	16.7	14.1	19.8	21.5	15.2	13.4	16.5	26.6	27.3	10.7	17.6	23.5	17.5	13.4	24.6	25.7	23.1	12.5	18.7	15.9	27.1	20.4	26.0	19.6	13.6	9.0	34.4	13.9	21.7	11.2	11.2	12.3	17.8	10.1	14.7	34.4	15.1	25.4	25.3	5.4	16.6	28.4	19.1	15.0	23.4	3.5	12.2	13.4	18.9	18.6	15.3	11.6	14.8	18.5	19.2	12.9	12.7	15.5	4.8	18.0	16.0	19.8	19.7	11.8	18.0	18.1	14.0	21.4	17.5	11.2	18.6	19.1	17.4	14.0	14.9	8.5	3.0	11.2	5.4	24.5	5.9	5.1	6.7	10.3	12.2	17.7	28.2	11.6	13.9	12.9	10.6	2.1	0.0	14.5	17.3	8.9	5.1	10.4	4.9	15.2	20.6	5.1	5.5	3.7	5.4	13.3	8.8	6.8	11.8	4.2	23.3	12.9	0.0	15.9	6.0	17.8	6.5	8.3	20.7	22.2	4.4	45.8	10.2	4.7	10.7
MED30	"THRAP6, TRAP25"	ENSG00000164758	"Mediator complex subunit 30"	Q96HR3	8	117520713-117540262	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 151.0;Suprabasal keratinocytes: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045767			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045767: AB_2679446"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (5.38e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-2)"	18.5	12.5	10.8	16.1	12.1	46.7	18.8	12.9	14.8	16.8	14.9	15.4	12.0	11.9	17.8	21.0	15.8	18.3	9.2	14.9	11.1	10.0	9.9	19.0	16.2	19.7	13.7	8.6	23.0	10.1	4.2	14.5	14.3	12.1	16.1	15.2	10.5	11.1	14.2	12.2	16.9	12.9	15.8	14.1	17.0	12.4	18.9	13.1	34.3	19.3	12.9	18.5	17.5	16.1	28.7	34.8	45.4	27.3	16.9	24.3	17.5	22.2	2.3	9.0	5.9	6.3	5.9	9.9	6.7	7.3	10.3	12.9	4.2	11.1	17.8	10.8	3.6	7.9	10.1	7.9	5.2	13.3	23.7	9.8	14.4	1.4	5.5	6.9	11.4	12.5	5.4	6.0	5.3	12.0	3.8	6.3	25.9	8.0	10.9	4.8	5.2	35.0	29.3	5.0	21.1	16.6	13.0	11.3	7.8	5.2	3.9	12.7	10.8	7.9	18.3	10.1	8.5	4.4	14.6	3.0	5.0	13.2	9.2	11.6	9.5	6.4	20.5	4.7	13.0	8.4	24.7	16.7	45.4	21.3	18.8	22.3	24.0	21.6	20.9	18.1	28.7	24.3	23.0	38.8	16.9	27.3	34.8	22.8	17.5	10.8	12.1	12.9	14.8	11.1	10.0	13.7	8.6	12.1	13.1	8.9	17.1	45.0	68.1	151.0	5.5	5.1	17.8	60.2	15.9	8.7	5.9	43.1	10.0	19.7	20.7	26.7	20.8	0.0	19.7	56.3	56.7	49.8	20.8	20.4	27.1	0.0	36.1	33.2	28.6	10.4	55.3	33.3	38.8	17.2	32.4	7.8	16.3	30.8	35.0	14.3	4.5	32.3	41.0	32.1	36.6	133.1	51.5	58.0	37.7	53.3
MED31	"CGI-125, Soh1"	ENSG00000108590	"Mediator complex subunit 31"	Q9Y3C7	17	6643315-6651634	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035947	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA035947: AB_10696646"	"unprognostic (1.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.87e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	9.7	19.7	18.7	9.6	21.6	9.4	16.2	25.3	25.5	12.1	10.0	10.2	8.9	9.4	11.9	30.5	20.8	14.3	13.9	16.0	19.0	21.4	15.4	15.9	10.1	14.1	16.0	15.1	14.0	9.5	9.1	22.3	12.5	19.4	11.3	9.7	10.5	14.3	10.4	11.4	21.8	11.3	13.6	13.7	14.5	10.0	17.6	11.5	17.5	16.3	13.4	15.4	16.9	11.9	12.5	13.4	33.3	12.2	11.8	15.7	11.0	18.0	20.3	18.3	11.6	16.6	14.2	6.5	14.2	14.6	21.9	28.7	10.0	9.5	2.4	18.0	6.9	16.3	19.9	14.4	17.3	19.1	13.1	24.2	4.4	18.6	15.4	12.5	5.0	9.5	7.6	19.1	19.8	6.8	11.8	16.2	9.6	7.8	4.7	15.8	6.6	9.6	13.1	6.5	8.2	11.8	7.2	8.1	6.6	18.2	9.0	7.1	8.0	7.2	5.9	15.4	9.0	6.1	5.5	7.3	10.9	9.4	13.7	14.1	4.3	5.5	6.0	15.0	6.0	7.7	28.6	12.2	19.5	14.7	8.3	13.9	12.0	13.6	14.1	10.4	12.5	12.4	13.1	33.3	11.8	10.0	13.4	15.7	11.0	18.7	21.6	25.3	25.5	19.0	21.4	16.0	15.1	19.4	11.5	14.9	19.3	37.2	41.8	94.9	7.5	4.5	43.3	61.6	19.4	31.4	9.8	37.0	46.4	32.6	26.3	32.3	17.8	0.0	27.5	35.1	31.5	42.1	26.5	51.9	29.6	12.7	12.1	38.6	27.8	40.6	41.1	29.6	38.8	27.9	17.2	16.7	35.8	14.0	24.8	41.8	10.6	38.8	32.0	75.1	83.7	105.0	40.0	35.4	18.3	56.1
MED8	"ARC32, MGC17544, MGC19641"	ENSG00000159479	"Mediator complex subunit 8"	Q96G25	1	43383917-43389808	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028377, HPA028438"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA028377: AB_10600112, HPA028438: AB_10600057"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.11e-7)"	"unprognostic (7.08e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-1)"	22.7	21.9	19.0	18.3	22.0	22.0	22.9	30.0	25.8	20.4	21.1	21.9	19.0	21.7	18.4	24.8	33.4	15.0	16.1	15.9	18.5	19.0	22.1	34.6	19.4	18.3	21.0	17.2	19.2	25.6	17.7	34.5	26.8	20.3	19.3	24.5	19.2	25.0	21.1	16.5	27.3	21.2	23.5	21.3	20.9	22.5	18.5	20.6	14.2	27.0	19.3	25.9	24.9	20.6	27.0	34.6	32.5	35.0	18.4	25.5	22.1	22.2	14.0	13.2	15.7	20.4	20.5	17.4	22.4	20.6	27.0	28.6	26.6	16.4	13.5	16.1	28.1	17.8	14.2	20.7	19.0	26.3	18.7	20.3	22.2	24.3	33.3	34.8	19.5	23.6	20.0	25.2	28.5	35.1	16.2	21.5	12.5	19.6	23.1	17.3	14.3	10.2	16.0	12.6	20.9	16.3	12.0	15.2	20.7	18.0	14.6	13.9	10.4	13.3	21.8	44.0	19.1	14.8	39.3	15.9	11.8	21.5	23.1	31.7	27.6	31.8	15.8	25.1	24.4	15.7	25.3	35.0	32.5	22.0	31.3	20.9	27.0	20.2	24.8	34.6	21.1	20.7	21.5	28.0	18.4	27.3	16.0	25.5	22.1	19.0	22.0	30.0	25.8	18.5	19.0	21.0	17.2	20.3	20.6	14.9	8.0	15.6	20.0	16.7	28.3	11.8	25.5	8.1	11.4	14.0	13.7	44.7	28.2	39.6	9.7	21.0	24.2	93.5	65.5	56.4	27.8	21.2	31.1	23.1	52.8	15.9	18.6	18.4	20.8	18.1	22.7	29.1	18.6	38.7	19.9	27.7	46.2	19.3	20.5	41.8	47.9	25.8	17.9	66.2	30.9	22.2	73.9	24.9	19.6	25.5
MED9	"FLJ10193, MED25"	ENSG00000141026	"Mediator complex subunit 9"	Q9NWA0	17	17476986-17493226	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056415	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA056415: AB_2683120"	"unprognostic (1.81e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (3.96e-2)"	"prognostic favorable (2.83e-9)"	"unprognostic (2.26e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-1)"	10.2	12.7	16.0	6.5	23.5	12.3	14.1	16.3	29.1	13.0	11.2	9.2	10.9	11.2	11.7	17.3	8.2	11.7	6.6	30.0	14.3	13.6	13.9	19.1	8.2	11.5	13.6	14.5	12.4	10.2	20.3	11.3	7.9	12.6	11.4	10.5	8.9	15.8	14.9	34.4	11.3	10.5	8.6	10.3	9.5	10.1	12.9	8.6	14.9	13.4	15.2	9.1	7.5	7.8	11.4	12.8	11.8	11.4	10.3	13.4	7.4	7.3	9.4	8.1	8.7	6.6	5.9	7.0	6.0	7.4	9.3	8.4	13.7	3.7	9.1	6.9	6.2	5.6	9.6	10.3	8.3	8.8	5.7	16.4	5.5	6.2	9.8	7.0	4.4	4.8	9.6	7.9	7.8	8.1	7.0	6.3	13.3	6.5	4.2	6.2	6.2	19.7	9.1	7.5	15.3	9.7	15.3	18.4	5.9	8.1	5.2	5.3	8.4	7.9	6.3	13.3	32.1	7.4	5.8	4.3	6.9	8.0	11.8	9.4	8.0	5.6	5.0	8.6	7.8	7.2	2.7	7.0	11.8	10.3	9.6	13.4	11.4	10.7	10.6	7.8	10.4	11.6	12.8	2.4	10.3	11.4	12.8	10.3	7.4	16.0	23.5	16.3	29.1	14.3	13.6	13.6	14.5	12.6	8.6	3.0	4.1	0.9	8.0	4.0	14.2	17.7	7.6	5.3	4.5	8.7	13.7	7.7	10.0	5.6	5.3	3.7	6.6	0.0	4.0	4.5	5.5	7.3	0.0	4.5	5.3	15.9	15.1	5.5	2.4	5.2	5.2	3.8	1.7	3.6	9.3	22.1	2.9	5.8	8.9	4.5	22.8	0.0	6.1	8.8	25.4	4.3	8.0	5.0	7.3	7.4
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145568-19170289	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"lymphoid tissue: 81.2"	"Cell type enriched"	"Detected in single"	16	"Sertoli cells: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"Daudi: 50.9;U-266/70: 51.2;U-698: 67.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	2.0	1.0	0.8	81.2	1.2	1.4	1.9	0.6	1.4	2.7	3.0	0.9	0.6	1.5	2.2	1.1	1.5	2.3	2.2	1.9	1.0	0.6	1.8	2.9	2.0	32.3	1.1	0.9	3.7	0.8	0.8	2.1	0.8	1.0	3.7	1.0	1.8	3.5	1.1	1.4	2.3	3.1	1.1	1.2	6.7	1.7	1.7	0.8	1.6	3.0	3.5	58.7	1.9	2.9	0.1	0.2	1.1	0.9	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	50.9	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.1	0.5	0.0	0.2	0.3	0.3	0.0	0.0	0.9	0.4	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.4	0.5	0.1	51.2	4.7	67.3	0.1	0.3	0.0	0.0	0.9	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.4	1.0	0.6	1.1	0.9	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.8"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 255.0;Ito cells: 239.4;Sertoli cells: 329.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	5	"B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.2;HEL: 53.4;Karpas-707: 29.4;REH: 60.8;U-266/70: 22.3;WM-115: 34.8"	"Group enriched"	"Detected in many"	7	"amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3"	"Group enriched"	"Detected in all"	4	"amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	13.9	10.8	17.0	15.0	26.7	3.8	10.7	4.3	52.8	8.2	6.8	6.1	1.5	2.8	10.9	5.4	5.0	6.4	9.8	11.2	11.1	6.8	4.5	4.0	8.3	19.3	6.6	28.0	12.3	2.9	5.2	6.5	14.8	4.8	7.1	5.7	4.6	6.6	6.6	154.8	3.9	7.4	10.8	8.3	16.0	4.5	3.6	4.4	1.6	9.6	3.5	24.0	8.9	5.8	48.2	23.8	5.8	19.5	4.0	0.1	7.2	0.3	0.0	1.7	0.0	1.9	1.1	0.0	0.5	1.0	0.0	0.2	0.0	0.2	24.2	0.1	2.8	0.6	0.7	2.3	2.1	0.0	7.3	3.0	53.4	3.2	0.0	0.6	2.3	0.1	5.3	0.0	0.0	0.0	0.3	8.4	0.0	2.8	29.4	2.1	0.0	0.0	0.0	0.5	0.0	2.0	60.8	15.3	11.6	0.0	0.3	0.0	2.0	0.0	0.1	7.0	1.0	0.0	13.5	9.6	1.3	0.2	0.1	1.2	22.3	2.5	14.6	0.3	16.5	34.8	0.1	17.2	0.0	0.0	19.5	0.0	32.6	0.0	0.0	22.3	48.2	0.0	0.0	5.8	4.0	15.9	23.8	0.1	7.2	17.0	26.7	4.3	52.8	11.1	6.8	6.6	28.0	4.8	4.4	29.8	48.3	255.0	4.7	9.5	22.0	80.9	12.7	6.7	39.8	1.8	202.2	0.8	23.2	0.8	6.9	155.1	1.6	70.0	11.1	1.1	13.9	1.6	4.7	3.0	134.1	4.8	1.2	239.4	207.6	5.3	27.6	138.9	64.1	28.9	0.3	65.1	0.4	2.9	67.5	0.5	196.7	329.8	171.0	1.2	16.6	7.3	1.4	7.9	1.9	1.6
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3489920-3611495	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 19.4;Basal keratinocytes: 16.4;Ito cells: 16.5;Melanocytes: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 22.5;HeLa: 20.3;hTERT-RPE1: 26.6;U-2197: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted - unknown location"	Yes	No		580000	Microtubules	"Cytokinetic bridge"	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	15.0	2.3	0.5	8.5	1.0	9.2	13.4	0.8	2.0	8.1	5.9	1.8	7.5	2.3	5.1	13.1	6.6	14.6	21.0	6.1	1.4	0.5	2.7	1.9	12.6	12.6	0.7	1.9	8.8	4.8	0.8	1.5	2.8	2.3	12.0	0.9	11.0	8.7	5.5	6.1	37.8	4.2	3.0	0.8	5.7	4.2	4.6	1.4	5.0	5.2	12.0	12.0	6.7	10.1	0.8	0.3	4.8	0.1	0.0	1.9	0.2	4.5	7.2	1.6	3.1	0.1	0.1	0.5	22.5	6.3	1.9	0.6	1.5	5.3	0.0	7.2	7.7	1.3	2.8	0.0	0.2	0.2	0.0	0.1	0.0	20.3	1.3	0.0	0.1	0.4	0.0	0.2	0.1	0.2	26.6	2.4	0.0	0.0	0.0	0.0	2.5	0.0	4.1	1.0	1.0	0.4	0.9	0.9	2.7	0.4	1.4	1.6	1.5	8.1	0.5	2.8	2.3	2.2	0.4	1.0	8.2	0.8	20.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	4.8	0.1	0.0	0.4	0.0	0.4	0.4	0.3	0.8	0.8	0.1	2.2	0.0	0.0	0.0	1.9	0.2	0.5	1.0	0.8	2.0	1.4	0.5	0.7	1.9	2.3	1.4	20.8	19.4	0.0	7.5	16.4	0.8	3.0	5.1	0.0	6.8	1.8	0.0	0.1	0.0	3.0	0.2	8.7	0.3	0.0	1.2	1.0	6.4	3.4	1.1	0.9	1.0	0.0	0.0	16.5	0.8	0.0	10.6	2.8	18.6	0.0	1.3	9.5	3.6	0.0	3.2	1.7	1.0	0.0	2.1	0.5	0.6	9.9	0.3	0.0	0.7	3.0
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600813-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 80.4;Cone photoreceptor cells: 200.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.1;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		32000000	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: AB_2681060"	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favorable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	15.0	9.6	22.4	9.9	21.7	15.4	12.8	27.9	26.2	11.7	6.7	29.3	2.1	6.4	6.1	5.5	12.8	12.8	7.9	6.1	24.6	16.4	12.5	33.8	17.9	7.0	28.6	16.0	9.3	5.4	15.6	6.8	4.8	22.6	8.4	5.8	21.4	7.8	6.6	6.0	19.0	6.5	8.1	21.1	12.9	7.2	3.1	25.8	3.2	25.5	4.6	5.6	11.3	9.6	0.3	2.2	19.1	5.7	0.3	0.6	1.3	2.7	10.7	9.4	2.9	13.1	8.1	3.0	2.8	2.4	0.7	1.0	0.6	1.6	10.1	4.2	2.6	3.4	11.8	13.5	4.8	2.0	8.2	3.9	1.4	20.1	4.4	5.6	4.0	8.7	3.8	14.8	4.6	3.7	26.3	6.6	5.5	3.2	4.8	7.8	7.8	7.9	1.4	0.4	6.0	2.9	6.0	10.5	4.3	19.3	8.9	9.3	7.9	3.3	2.7	7.9	1.6	8.1	4.1	7.7	2.8	1.6	10.4	4.2	8.8	10.3	3.3	4.0	4.8	16.1	0.4	5.7	3.6	0.6	1.9	0.2	0.3	0.6	0.5	2.2	0.3	0.5	0.4	19.1	0.3	3.0	0.2	0.5	1.3	22.4	21.7	27.9	21.5	24.6	16.4	28.6	16.0	22.6	25.8	80.4	47.6	4.9	4.8	24.4	27.8	23.0	15.3	6.7	21.6	22.7	200.3	0.3	0.0	3.9	0.6	7.3	6.5	23.3	4.7	1.1	6.1	8.8	6.9	41.0	5.9	12.7	6.3	10.4	54.2	0.9	10.6	18.5	25.3	2.8	3.3	28.2	11.0	6.8	11.0	5.0	70.5	12.9	9.9	8.4	6.1	38.3	1.0	9.6	6.0	5.7
MEIS1		ENSG00000143995	"Meis homeobox 1"	O00470	2	66433452-66573869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	Transcription	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 104.1;Horizontal cells: 77.9;Paneth cells: 51.8;Rod photoreceptor cells: 125.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.3;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.9;granulocytes: 1.9;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 25.4;HeLa: 15.9;HHSteC: 19.0;SH-SY5Y: 16.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011521, HPA056000"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011521: AB_776272, HPA056000: AB_2683004"	"unprognostic (6.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-2)"	7.9	21.2	2.5	14.1	5.1	1.1	9.0	27.5	5.1	52.6	24.0	6.8	13.1	3.0	49.3	15.6	18.2	30.5	15.5	9.0	2.0	1.5	4.7	1.8	14.7	5.3	8.9	3.6	25.4	33.8	4.4	1.4	8.0	9.4	14.8	7.0	10.8	26.4	20.2	2.6	4.8	7.7	31.9	7.7	7.2	14.1	5.9	5.6	0.7	2.7	6.6	6.2	20.6	22.7	0.1	2.9	1.9	0.4	3.3	0.6	5.3	0.1	0.9	7.5	1.5	9.8	6.4	1.0	9.8	25.4	8.4	8.8	0.8	7.1	0.0	2.5	7.5	0.5	1.2	4.4	4.4	8.4	0.0	4.3	12.4	15.9	1.8	19.0	0.0	3.3	5.8	5.1	3.4	1.5	6.8	3.9	2.0	1.1	0.0	0.3	0.5	0.9	0.2	0.2	0.9	1.0	0.0	2.0	1.8	0.7	2.3	2.4	16.2	1.8	0.5	0.7	5.9	0.7	1.4	1.2	1.8	3.0	1.3	2.7	1.9	0.6	0.1	1.6	10.9	0.5	1.9	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.6	1.4	3.3	0.0	2.9	0.2	5.3	2.5	5.1	27.5	5.1	2.0	1.5	8.9	3.6	9.4	5.6	0.0	0.3	0.0	11.4	2.9	10.6	16.1	0.0	2.7	6.8	0.0	104.1	4.1	0.0	16.5	8.7	3.8	0.9	0.0	15.3	1.6	11.0	1.7	0.0	1.6	2.0	77.9	1.2	16.5	1.9	10.4	31.9	0.5	3.3	0.0	0.3	19.9	16.8	51.8	26.5	2.9	125.2	19.4	10.6	1.4	0.9	1.9	1.6	0.0	0.9	13.7
MEIS2	"HsT18361, MRG1"	ENSG00000134138	"Meis homeobox 2"	O14770	15	36889204-37101299	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 108.0;Cone photoreceptor cells: 239.5;Ito cells: 148.5;Rod photoreceptor cells: 121.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	49	"basophil: 4.8;eosinophil: 4.9"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 41.7;SH-SY5Y: 39.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 83.2;olfactory region: 364.7"	"HPA003256, CAB004999"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004999: AB_425545, HPA003256: AB_1079356"	"unprognostic (4.33e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.71e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (6.47e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.15e-1)"	6.3	16.5	9.6	6.5	36.8	0.4	7.7	7.4	12.4	26.4	17.0	4.3	12.0	15.1	35.6	6.3	10.6	17.8	16.9	11.3	6.7	3.9	7.3	5.9	7.5	5.2	3.9	6.9	16.4	10.0	2.8	19.8	6.4	10.7	28.8	5.2	6.4	39.0	16.7	1.0	2.9	5.2	34.6	6.2	5.6	11.3	2.6	8.6	2.2	3.5	4.6	3.2	19.5	16.9	0.0	0.0	4.9	0.0	0.0	0.0	0.0	4.7	4.4	5.7	16.2	6.5	8.0	1.3	10.3	5.8	12.3	6.9	6.2	3.9	2.7	0.2	41.7	7.9	8.3	10.0	2.6	6.9	3.9	6.4	21.0	5.9	5.1	11.0	6.2	21.5	10.6	2.3	8.3	2.5	16.4	7.0	1.0	7.0	0.0	2.5	5.0	0.0	2.4	0.0	5.7	1.4	0.0	4.2	1.5	0.0	9.3	4.4	39.4	3.9	2.7	3.0	6.6	1.2	4.9	9.9	14.2	1.7	3.7	4.4	2.8	2.8	5.3	16.8	3.5	3.5	4.8	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	36.8	7.4	8.0	6.7	3.9	3.9	6.9	10.7	8.6	0.0	8.2	2.9	108.0	15.5	14.5	21.8	66.2	25.4	6.8	1.8	239.5	21.3	0.0	42.0	11.8	23.5	0.9	0.0	24.0	5.7	46.8	24.7	61.2	7.9	2.8	3.2	1.7	148.5	6.6	4.4	44.3	1.7	8.5	1.0	0.0	11.8	22.0	0.0	38.9	0.0	121.2	32.3	43.2	1.8	2.7	5.4	3.8	1.9	0.6	43.1
MEIS3	"DKFZp547H236, MRG2"	ENSG00000105419	"Meis homeobox 3"	Q99687	19	47403124-47419523	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 35.3;endometrium 1: 28.8"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 22.3;Horizontal cells: 42.9;Late spermatids: 47.6;Muller glia cells: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 28.4;HMC-1: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046699	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046699: AB_2616456"	"unprognostic (3.27e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.49e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (9.29e-3)"	"unprognostic (9.21e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.80e-3)"	5.6	3.9	35.3	4.7	10.6	0.0	5.0	11.0	25.3	8.4	4.7	2.4	3.8	3.5	28.8	2.2	6.0	14.2	6.0	3.7	23.2	11.6	1.5	1.1	3.1	1.2	2.6	14.6	7.4	1.7	1.1	4.9	7.4	3.8	7.0	2.1	4.1	3.6	6.4	1.4	1.6	3.8	22.5	1.7	2.4	2.6	3.3	2.0	0.5	3.4	1.6	1.4	6.1	4.7	0.0	0.2	0.5	0.7	0.0	0.1	0.4	0.3	12.1	28.4	0.1	15.4	13.3	0.4	12.7	19.4	9.9	17.5	1.1	1.9	0.0	1.4	20.8	8.2	1.4	2.9	3.5	3.4	18.9	4.3	0.0	4.4	0.1	10.0	0.2	24.6	9.8	0.7	3.9	2.1	3.5	0.0	0.0	0.2	2.8	1.1	11.5	0.0	0.1	8.3	0.3	0.7	0.0	2.1	0.3	0.6	0.9	1.1	23.0	10.9	0.9	5.2	11.8	0.6	3.5	0.0	7.6	19.3	5.5	1.7	0.0	0.0	0.0	21.2	1.1	15.2	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.4	35.3	10.6	11.0	25.3	23.2	11.6	2.6	14.6	3.8	2.0	0.0	2.7	0.0	1.0	0.7	4.8	0.8	0.0	2.7	3.4	3.5	5.9	0.1	0.0	0.0	22.3	0.5	0.0	0.0	0.0	0.2	9.9	3.2	0.0	0.0	0.5	42.9	0.0	1.8	0.0	47.6	10.6	1.1	6.8	0.0	0.0	18.0	0.1	0.0	3.9	0.0	2.7	12.9	6.9	2.6	4.7	0.9	0.7	0.0	0.0	0.7
MEMO1	"C2orf4, CGI-27, MEMO"	ENSG00000162959	"Mediator of cell motility 1"	Q9Y316	2	31865060-32011230	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042603, HPA057952"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA042603: AB_10806243, HPA057952: AB_2683562"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.94e-5)"	"unprognostic (1.02e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.95e-9)"	"unprognostic (6.57e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.23e-2)"	9.3	14.9	11.5	12.1	24.2	22.4	8.3	23.5	21.5	9.1	9.5	9.4	12.5	9.4	8.9	9.8	19.6	7.8	7.6	19.8	12.9	10.1	9.2	20.0	8.2	16.2	10.2	13.8	6.7	10.2	9.3	13.0	11.4	12.1	11.4	12.0	11.6	9.9	10.5	31.3	11.0	8.9	11.0	9.8	12.4	9.8	33.0	9.1	32.4	8.2	3.9	18.4	14.2	10.6	6.9	17.0	11.4	18.2	8.7	12.0	6.8	32.0	14.0	15.5	14.4	13.8	19.6	27.8	27.5	17.4	15.9	12.4	18.9	18.3	34.2	8.9	19.0	20.8	16.3	18.3	24.2	21.2	22.6	10.0	24.6	9.2	23.0	19.2	24.7	20.6	14.6	15.9	15.6	16.0	18.1	24.9	8.2	17.7	15.8	27.5	14.1	29.4	50.6	22.9	27.7	17.6	20.0	17.7	26.4	31.4	31.6	13.1	24.3	14.2	34.7	21.8	13.7	14.5	29.7	22.7	22.2	24.4	17.6	30.2	16.6	24.9	29.2	20.2	35.5	17.3	1.2	11.8	11.4	5.6	16.3	4.3	6.9	7.0	6.8	17.0	5.3	5.0	5.1	9.7	8.7	18.2	6.5	12.0	6.8	11.5	24.2	23.5	21.5	12.9	10.1	10.2	13.8	12.1	9.1	6.0	14.1	7.7	13.6	24.6	14.2	3.9	7.6	8.1	7.9	10.4	15.7	10.5	1.7	4.2	2.7	11.3	5.4	0.0	2.1	8.7	11.3	12.0	9.3	11.1	8.7	11.1	12.6	15.4	21.6	1.7	12.0	16.6	11.8	12.6	5.0	6.7	6.3	9.3	8.1	1.3	9.7	6.5	8.2	8.1	6.1	14.4	13.8	9.2	8.9	16.5
MEN1		ENSG00000133895	"Menin 1"	O00255	11	64803510-64811294	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030342	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030342: AB_10610138"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (1.40e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	12.1	20.6	13.2	15.6	17.7	11.8	12.5	25.8	26.9	15.5	14.9	16.4	22.2	16.9	14.8	18.4	18.9	17.6	14.7	9.0	12.4	11.5	15.9	23.0	12.8	22.1	12.5	15.6	19.7	25.9	16.8	18.0	16.1	16.0	15.9	11.6	16.6	23.3	19.9	8.4	21.6	15.8	11.0	9.8	20.6	15.3	21.2	12.3	33.2	23.9	6.2	20.3	13.7	15.5	5.2	2.9	3.4	1.5	1.8	4.8	1.0	16.3	22.0	14.1	22.1	15.8	10.2	16.6	11.8	11.7	18.4	12.4	12.7	16.2	23.3	19.3	9.1	15.4	23.4	19.1	16.3	11.1	19.9	28.2	19.3	17.7	16.9	14.0	12.4	13.1	11.7	12.3	15.5	12.8	11.1	17.0	30.0	28.0	8.9	10.2	30.6	31.3	25.1	18.4	13.8	33.1	24.3	16.0	22.3	11.9	15.2	19.9	17.5	13.9	19.7	14.3	10.5	29.3	13.8	10.7	17.4	16.7	20.8	9.9	14.0	16.2	11.8	13.8	9.7	11.0	0.9	1.3	3.4	3.7	1.5	4.8	3.7	2.6	4.6	1.3	5.2	4.5	2.6	0.2	1.8	0.5	2.9	1.9	1.0	13.2	17.7	25.8	26.9	12.4	11.5	12.5	15.6	16.0	12.3	3.0	4.8	19.3	3.8	5.0	8.3	3.7	2.5	1.4	1.2	3.5	5.9	15.7	3.3	7.3	0.9	4.4	8.4	0.0	6.2	18.5	4.6	4.9	1.1	9.4	7.9	3.2	4.1	8.0	0.3	0.6	11.2	2.6	8.5	6.4	8.7	8.4	7.1	10.1	3.5	6.2	5.7	12.9	2.7	16.6	15.5	6.0	13.6	6.7	9.5	3.0
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640388-43661954	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	25	"Basal keratinocytes: 3.7;Endothelial cells: 15.5;Melanocytes: 5.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 17.9"	"Lineage enriched"	"Detected in single"	66	"T-cells: 17.9"	"Cell line enriched"	"Detected in some"	13	"HeLa: 24.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		NA	NA			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	24.3	0.3	0.1	7.4	0.1	0.0	17.3	0.1	0.1	12.4	3.2	0.1	2.3	1.2	11.6	5.7	10.9	6.7	6.5	17.8	0.1	0.1	0.2	0.3	1.2	5.4	0.1	0.1	4.8	1.2	1.5	0.5	0.3	0.1	8.2	1.9	0.8	5.8	2.0	19.8	4.6	3.5	8.6	0.1	8.9	2.4	3.5	0.1	3.2	1.7	15.4	7.1	6.1	16.7	0.0	0.0	0.0	0.0	0.2	17.9	0.9	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	1.7	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.6	3.0	0.0	0.0	1.8	0.5	0.0	0.2	0.0	0.0	17.9	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	1.6	0.1	0.0	0.0	0.0
MEPCE	"BCDIN3, FLJ20257, MePCE"	ENSG00000146834	"Methylphosphate capping enzyme"	Q7L2J0	7	100428790-100434126	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026384, HPA051587"	Supported		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB026384: , HPA051587: AB_2681544"	"unprognostic (8.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (6.01e-6)"	"unprognostic (1.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.01e-10)"	"unprognostic (9.66e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.57e-1)"	"unprognostic (9.50e-3)"	17.5	24.1	17.7	13.9	22.8	18.5	15.0	24.1	24.1	15.7	14.0	16.7	26.9	14.1	18.8	22.5	16.1	18.6	22.9	12.4	20.1	13.7	18.7	20.8	13.5	19.7	19.7	16.4	29.2	18.3	32.5	15.0	19.0	19.3	15.8	10.2	17.2	18.5	24.2	21.4	26.1	15.8	15.7	17.7	34.9	14.4	63.1	20.4	21.7	25.7	17.1	17.9	16.3	20.4	8.4	8.7	9.3	3.6	7.3	9.1	10.6	13.5	17.6	13.1	14.0	12.7	12.8	9.7	15.2	22.3	16.5	12.8	14.3	20.0	28.0	25.4	9.5	13.0	12.6	14.2	11.5	10.9	12.5	16.2	14.4	13.6	10.8	10.7	18.4	17.9	13.2	13.8	18.8	23.9	9.0	13.7	9.0	28.5	20.8	15.7	50.5	21.0	42.0	24.1	11.4	19.6	17.0	10.5	25.4	11.0	8.4	19.7	17.0	23.8	46.7	15.9	6.8	11.9	16.9	11.7	27.8	21.6	18.7	20.0	13.8	13.1	31.2	15.6	23.1	24.3	2.5	3.6	4.8	5.6	3.2	6.5	8.0	6.4	6.0	4.4	8.4	9.1	8.0	9.3	7.3	2.6	8.7	5.7	10.6	17.7	22.8	24.1	24.1	20.1	13.7	19.7	16.4	19.3	20.4	8.9	20.5	18.0	14.7	26.9	8.9	19.8	17.8	9.4	7.9	21.0	7.9	13.3	13.3	9.0	21.7	18.0	26.9	0.0	10.4	7.0	12.5	12.5	17.4	17.9	10.9	11.1	10.3	33.2	27.3	44.1	16.1	14.2	8.5	18.0	18.8	16.7	8.8	24.6	14.5	11.7	9.1	6.5	12.8	34.9	13.7	22.0	17.7	15.8	15.5	8.6
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Ito cells: 36.8;Kupffer cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 10.3;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;Hep G2: 22.1;HUVEC TERT2: 22.0;RT4: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		NA	NA		29000000	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9.0	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2.0	8.4	14.1	26.6	0.0	0.2	0.1	10.3	0.0	0.0	0.3	0.5	0.9	4.4	10.0	0.2	0.1	7.1	0.0	0.1	0.5	1.0	21.3	1.3	0.1	4.7	0.0	4.6	0.1	5.8	0.0	0.8	0.8	3.1	3.8	0.0	22.1	0.1	0.1	0.9	0.2	0.0	5.1	0.3	2.3	22.0	0.8	1.2	2.0	1.7	1.0	0.0	5.0	2.7	0.6	3.4	1.4	1.2	1.7	11.2	13.1	0.1	4.2	0.1	0.3	1.7	1.6	0.0	0.2	3.3	0.6	2.0	0.0	0.0	1.7	2.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.4	0.1	0.0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8	3.0	20.1	0.8	2.9	1.4	0.6	2.1	5.1	1.4	11.4	0.0	2.0	2.6	1.7	0.8	1.6	7.1	1.6	0.0	0.8	1.0	4.1	2.0	0.0	8.9	23.6	0.0	0.0	36.8	92.6	1.5	4.6	11.0	0.0	0.0	2.3	8.6	1.7	1.9	6.3	1.9	9.2	6.5	11.3	0.5	1.5	1.1	15.8	0.8	1.8	1.4
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.1;prostate: 10.9"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 37.0;Glandular cells: 36.0;Spermatocytes: 42.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 6.3;prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HDLM-2: 5.0;HEK 293: 5.0;PC-3: 9.5;SCLC-21H: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA069981: AB_2686225"	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	14.1	1.6	6.8	1.4	4.3	1.1	3.8	7.3	8.8	2.5	1.9	1.1	0.1	1.3	1.0	1.0	0.9	1.0	2.9	3.9	4.9	5.0	1.3	1.2	1.1	1.1	3.3	4.3	1.0	1.2	1.1	1.1	0.8	2.4	10.9	1.0	1.3	3.0	1.2	7.0	0.9	1.1	0.9	1.4	0.9	1.0	1.4	1.9	0.0	1.0	2.2	0.9	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	5.7	2.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.3	0.0	2.3	0.0	0.7	0.0	0.4	0.0	0.0	5.0	5.0	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.1	0.8	1.4	0.0	0.0	9.5	0.2	0.0	1.3	0.1	0.0	4.4	0.1	1.1	1.9	1.2	0.0	0.1	0.7	0.0	0.0	0.3	3.4	1.1	2.3	0.8	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.8	4.3	7.3	8.8	4.9	5.0	3.3	4.3	2.4	1.9	0.0	0.6	0.8	2.6	0.2	10.5	5.2	12.7	0.0	0.0	1.8	9.8	1.8	10.0	16.5	3.7	0.7	17.0	0.0	37.0	0.1	1.0	36.0	4.6	11.5	2.0	7.9	5.8	3.1	2.2	1.0	1.1	2.1	6.8	2.8	4.6	12.7	7.1	10.5	0.0	11.1	15.3	0.0	1.0	42.6	14.3	0.3	0.2	4.4	11.0	5.0
MEST	PEG1	ENSG00000106484	"Mesoderm specific transcript"	Q5EB52	7	130486171-130506465	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.8;placenta: 193.5"	"Group enriched"	"Detected in many"	8	"Cytotrophoblasts: 680.5;Syncytiotrophoblasts: 836.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 18.8"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"AN3-CA: 525.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005623			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"		"HPA005623: AB_1079364"	"unprognostic (6.14e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.36e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.81e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (6.20e-5)"	"unprognostic (7.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.67e-2)"	44.9	26.0	7.8	4.7	12.9	3.4	63.8	2.6	22.7	2.4	7.5	3.4	1.1	7.9	7.3	4.6	2.6	5.2	6.6	3.7	7.9	8.0	6.7	13.7	18.8	4.1	3.3	9.0	7.8	13.0	2.5	15.4	193.5	15.5	4.1	6.1	8.4	7.0	2.5	2.2	2.1	7.2	5.3	3.2	22.4	3.0	10.1	3.3	2.0	4.3	2.5	1.9	4.5	3.7	3.1	6.7	8.6	2.0	2.7	18.8	5.3	3.2	1.7	8.5	525.5	0.1	0.0	0.0	3.5	1.6	3.7	1.7	10.1	4.9	1.6	1.2	0.1	3.2	0.4	0.1	0.0	1.4	0.0	0.0	2.8	2.7	1.6	14.5	0.1	0.0	0.2	0.1	2.7	0.0	18.9	1.4	0.0	3.1	0.0	7.1	4.5	0.3	3.5	5.3	4.8	0.8	0.0	94.6	1.0	4.0	3.0	30.0	0.0	3.1	10.2	0.0	9.0	0.3	2.4	1.4	1.2	0.0	11.7	0.2	0.1	0.3	0.0	4.5	0.0	0.4	8.6	1.9	6.2	0.7	2.0	1.7	3.1	2.0	1.4	6.7	2.8	7.6	18.8	1.1	2.7	1.2	0.3	0.1	5.3	7.8	12.9	2.6	22.7	7.9	8.0	3.3	9.0	15.5	3.3	6.0	3.8	2.4	36.0	3.9	9.1	0.6	17.8	4.0	5.7	15.7	3.9	680.5	10.0	19.8	53.5	3.4	10.9	0.0	35.4	99.2	31.1	18.0	0.0	15.8	79.5	1.6	28.4	35.6	7.7	27.3	78.6	1.9	1.7	1.0	19.5	40.4	28.9	28.1	12.7	9.2	19.9	19.4	5.2	33.9	38.5	0.5	836.0	0.0	33.2	16.5
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 45.3;CAPAN-2: 49.5"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.3	26.1	0.0	0.1	2.0	2.0	1.8	25.9	10.5	14.0	11.8	5.4	49.5	2.0	43.2	16.2	37.7	12.0	4.4	24.7	28.6	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.0	25.3	9.6	0.0	0.9	0.2	25.9	1.0	0.0	0.0	3.9	7.2	26.6	0.0	22.0	0.0	24.5	5.2	3.8	0.0	10.6	3.4	10.1	4.7	0.0	0.2	17.6	20.9	7.4	11.0	20.0	0.5	4.0	0.2	22.9	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4	26.8	78.1	2.4	56.1	34.7	0.9	10.0	15.3	22.7	116.0	29.6	0.0	57.9	0.0	28.0	0.0	11.7	11.2	0.0	39.8	5.0	4.0	55.8	0.0	26.0	6.1	0.0	6.9	1.3	1.0	0.0	0.6	2.0	3.3	1.8	19.7	7.4	69.4	7.0	0.0	13.5	0.3	0.0	2.3	0.0	0.6	15.6	18.2	0.0	12.7	88.5
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995620-99062813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 345.0;Late spermatids: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	12.1	8.3	10.0	16.0	10.1	11.8	18.6	9.2	13.8	16.0	17.9	7.0	22.9	13.4	24.1	25.9	37.2	14.0	12.3	27.9	9.5	7.1	14.3	13.7	10.7	12.6	7.9	9.8	11.3	13.0	7.8	14.4	9.2	9.9	19.1	19.3	7.5	19.0	21.5	27.2	16.4	15.2	27.8	10.1	13.9	11.6	46.8	8.1	27.0	10.8	21.8	19.1	36.6	22.6	12.7	11.7	10.4	11.1	12.5	19.2	10.8	21.7	21.5	18.9	20.3	15.0	24.1	21.0	31.2	20.1	26.7	25.5	24.1	32.5	32.3	12.5	25.2	16.0	21.9	33.1	31.2	37.1	22.5	15.8	28.8	15.7	25.9	16.3	38.9	24.2	17.3	22.8	22.7	24.1	20.8	21.9	18.3	22.5	19.5	28.5	16.6	34.1	18.6	23.2	37.1	17.5	22.4	29.5	17.2	42.9	28.2	25.9	15.3	10.4	32.4	12.3	22.1	12.4	14.9	17.8	21.6	27.5	19.8	27.2	14.2	19.9	25.5	18.6	20.0	21.4	10.4	9.4	4.2	14.9	11.1	19.2	12.7	15.4	14.5	11.7	10.1	15.1	13.5	2.3	12.5	10.7	5.8	13.4	10.8	10.0	10.1	9.2	13.8	9.5	7.1	7.9	9.8	9.9	8.1	38.7	10.5	13.7	44.1	37.7	4.6	49.8	20.4	18.7	17.0	14.0	2.0	22.0	11.6	26.9	345.0	13.5	29.0	0.0	25.4	55.9	12.3	21.8	3.5	16.4	15.6	3.2	7.5	16.5	19.6	1171.9	17.8	14.6	15.1	6.4	25.2	8.3	22.3	34.2	21.2	22.9	3.5	25.8	22.1	15.1	46.4	33.9	6.4	15.2	32.6	39.6
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		22000	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	24.2	36.4	25.8	49.9	33.7	39.1	25.1	25.9	32.3	23.9	26.2	16.3	102.5	16.6	28.7	25.4	30.1	22.5	21.7	30.7	29.6	24.0	26.0	46.8	22.1	32.6	29.1	23.4	29.4	31.9	21.0	36.1	25.1	42.9	24.2	24.0	10.1	22.1	140.7	94.4	28.7	19.7	26.1	48.2	25.2	22.2	26.3	27.7	32.1	24.1	29.0	55.2	33.4	37.3	39.4	31.8	21.3	27.1	25.7	32.0	16.2	33.9	28.6	30.6	23.8	18.7	30.0	23.6	33.5	23.4	33.0	23.5	41.5	16.3	98.8	21.1	23.9	19.2	21.9	34.4	25.6	38.0	23.5	29.7	44.2	21.8	29.2	19.9	54.7	21.7	25.9	27.4	31.2	30.6	39.6	35.1	34.1	57.2	11.2	24.4	22.3	40.5	37.4	37.5	19.6	42.8	31.9	26.5	32.4	22.6	36.0	23.8	31.3	29.7	24.3	29.3	27.6	29.3	26.0	30.1	19.0	18.4	21.2	35.3	16.2	42.1	105.9	10.8	30.9	23.8	21.3	27.1	11.1	23.8	19.1	29.2	39.4	26.7	26.6	24.4	37.6	32.0	29.7	1.2	25.7	22.3	31.8	25.3	16.2	25.8	33.7	25.9	32.3	29.6	24.0	29.1	23.4	42.9	27.7	262.0	228.6	96.8	102.9	207.2	62.7	117.4	91.7	104.4	160.3	275.7	62.8	125.5	139.3	94.7	135.8	104.6	80.2	256.9	126.2	136.4	102.7	68.6	119.0	278.9	86.9	71.5	88.0	102.5	122.4	83.3	92.9	93.2	87.7	80.2	109.6	67.6	105.7	83.4	100.4	81.6	68.7	97.0	97.6	340.7	217.0	187.9	143.8	93.5	118.5	90.7
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715115-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.9"	"Cell type enriched"	"Detected in many"	8	"Muller glia cells: 554.6"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 53.4;PC-3: 41.3"	"Region enriched"	"Detected in all"	5	"cerebellum: 549.1"	"Low region specificity"	"Detected in all"			HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"	NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: AB_2681369"	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	7.7	14.9	44.7	5.1	58.9	2.6	4.6	14.2	45.4	4.1	7.0	24.1	19.8	5.6	5.3	7.8	3.1	27.4	6.4	12.4	39.6	31.6	10.5	8.5	6.0	4.2	45.7	15.1	2.7	43.1	5.2	15.1	5.3	15.3	7.4	2.5	9.2	27.3	16.8	21.5	3.9	5.9	4.4	39.5	5.4	8.3	4.6	19.0	2.5	6.6	3.4	3.0	3.9	5.0	3.2	0.9	0.8	1.0	1.7	2.9	0.5	2.6	22.5	4.4	22.5	7.9	4.4	7.2	5.3	2.7	2.1	1.4	3.3	6.6	0.4	12.5	3.7	8.2	9.9	0.6	5.2	0.3	1.4	9.9	0.9	4.1	17.0	4.8	1.9	2.9	10.7	5.7	0.6	1.3	6.7	0.7	6.3	1.5	0.5	1.6	53.4	0.7	6.5	1.6	2.9	41.3	7.3	5.1	7.3	5.5	0.7	7.0	8.9	2.1	5.9	27.4	0.5	8.9	3.8	2.4	6.1	11.7	7.1	4.6	3.4	0.9	0.4	9.6	1.4	14.4	0.0	0.3	0.8	2.9	1.0	1.7	3.2	1.5	2.7	0.2	0.5	0.9	1.9	0.0	1.7	1.0	0.9	2.8	0.5	44.7	58.9	14.2	27.4	39.6	31.6	45.7	15.1	15.3	19.0	0.0	2.1	4.2	14.7	3.4	38.6	14.0	50.9	2.7	0.0	15.7	13.7	0.6	43.1	6.3	6.5	12.6	15.0	0.0	4.2	1.8	8.7	28.3	0.0	27.2	5.2	66.7	26.2	19.0	5.1	14.5	10.3	4.8	10.1	0.0	8.1	554.6	5.4	14.7	8.9	43.5	29.1	25.8	15.3	3.9	11.3	2.6	0.3	6.4	8.6	14.2
METTL13	"CGI-01, KIAA0859"	ENSG00000010165	"Methyltransferase like 13"	Q8N6R0	1	171781664-171814023	"Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044498, HPA053705"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA044498: AB_10960884, HPA053705: AB_2682235"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.12e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.12e-1)"	"unprognostic (6.86e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.13e-1)"	13.0	20.7	18.3	13.3	17.8	9.0	14.7	19.0	21.8	14.6	13.6	14.7	13.6	15.1	16.5	24.8	14.9	16.2	11.2	11.7	14.1	10.9	13.2	16.9	15.1	15.9	16.3	17.9	15.3	16.0	14.0	11.0	11.4	14.7	12.6	15.1	11.7	19.2	14.5	18.4	14.2	14.0	15.4	11.4	16.8	14.7	18.9	16.2	16.3	13.1	9.4	17.7	13.7	12.6	10.2	10.0	3.2	8.7	11.5	12.0	7.8	11.8	28.2	7.4	7.8	10.8	9.9	20.5	15.0	11.8	18.2	14.2	21.2	12.3	21.9	18.0	10.4	11.9	12.2	23.1	12.0	14.3	14.0	13.2	15.1	14.6	9.3	8.0	19.8	15.4	8.6	11.2	18.9	8.3	8.3	10.8	11.9	30.2	7.5	13.8	9.0	15.8	13.6	29.0	23.9	38.2	14.6	10.0	20.0	10.5	12.2	12.5	17.1	11.1	25.8	13.7	19.5	18.8	17.6	8.9	12.3	11.3	12.4	17.6	19.5	21.8	25.2	9.3	13.8	10.9	1.8	8.7	3.2	9.9	8.5	11.5	10.2	9.9	8.4	8.6	8.0	9.1	12.0	2.6	11.5	7.4	10.0	7.4	7.8	18.3	17.8	19.0	21.8	14.1	10.9	16.3	17.9	14.7	16.2	8.9	3.2	7.7	6.4	7.6	7.2	7.5	20.4	6.7	5.7	3.5	5.9	14.0	10.0	17.2	33.4	10.5	9.8	0.0	13.4	20.0	7.6	8.6	9.2	11.6	15.1	4.8	10.4	11.6	14.9	8.4	9.2	8.5	3.3	12.6	11.5	8.1	16.0	7.0	7.4	10.9	6.9	12.9	7.2	4.7	14.5	7.9	8.0	7.2	11.1	7.5
METTL15	"FLJ33979, METT5D1"	ENSG00000169519	"Methyltransferase like 15"	A6NJ78	11	28108248-28527041	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039885			Approved	"Golgi apparatus,Plasma membrane,Actin filaments"		NA	NA			"Golgi apparatus, Plasma membrane"	"Actin filaments"	"HPA039885: AB_2676725"	"unprognostic (2.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.93e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.95e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.84e-3)"	10.3	17.5	11.2	13.4	11.2	4.3	12.4	16.0	13.4	13.6	13.4	12.2	15.0	9.9	21.0	14.8	10.8	11.8	12.3	14.7	11.3	12.0	15.4	17.9	9.6	9.5	10.5	10.1	12.3	11.4	18.8	32.6	11.1	13.6	12.9	13.8	15.5	12.4	13.7	16.9	10.0	9.8	13.3	12.7	9.8	10.3	11.8	11.2	16.5	15.3	11.0	14.3	10.6	9.8	6.4	3.3	6.0	2.7	7.6	6.8	2.9	7.3	7.9	8.0	6.1	10.0	16.1	5.6	9.1	7.0	9.2	9.5	5.3	5.0	16.9	5.4	7.4	5.8	6.2	10.5	9.3	17.8	10.4	9.2	5.3	5.9	6.1	11.2	9.9	4.8	9.1	13.9	5.1	13.3	10.0	8.8	5.6	11.2	7.7	10.8	5.0	6.9	6.2	6.2	7.7	5.9	3.7	17.5	6.2	13.7	4.2	7.1	5.9	7.4	6.7	10.6	8.1	13.3	6.1	6.6	8.4	6.5	10.7	7.9	5.2	6.1	9.9	11.9	10.1	9.1	3.1	2.7	6.0	4.2	1.7	5.3	6.4	5.2	5.5	3.0	3.3	5.6	6.8	1.3	7.6	2.2	3.3	5.5	2.9	11.2	11.2	16.0	13.4	11.3	12.0	10.5	10.1	13.6	11.2	11.9	25.3	12.7	27.9	39.0	12.6	12.6	7.6	14.7	15.9	10.4	17.7	9.6	10.0	9.4	22.3	10.0	13.9	0.0	10.3	11.4	16.4	28.7	4.7	12.5	9.3	12.7	9.2	14.7	8.8	10.2	10.0	10.2	13.5	3.6	17.1	7.0	7.7	10.5	7.8	12.9	16.4	6.5	26.8	16.5	8.2	31.1	7.1	25.4	16.0	46.3
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	12.7	14.0	13.1	11.0	15.2	13.1	14.1	22.5	14.4	14.9	13.1	19.8	11.2	8.6	21.6	10.6	11.0	16.5	9.6	12.4	12.6	9.7	11.5	6.9	12.2	13.1	18.3	9.7	22.5	13.5	19.7	22.8	7.5	13.6	13.5	10.4	18.3	12.1	13.1	14.2	14.7	10.4	16.5	14.6	11.1	11.2	11.0	17.5	15.7	16.5	8.8	17.5	15.3	12.7	5.7	3.1	2.3	3.2	2.0	8.1	2.0	6.1	16.4	9.3	8.9	7.0	8.9	8.7	7.8	6.8	8.9	7.4	21.8	4.0	19.3	8.5	7.1	9.5	8.9	21.4	10.7	12.2	7.3	13.6	9.9	13.5	9.9	7.6	9.1	8.0	7.5	10.2	12.3	18.2	6.1	9.2	11.3	12.9	10.4	6.0	6.7	13.0	5.4	10.6	7.6	6.9	21.7	9.8	8.7	6.5	5.6	4.9	7.7	11.7	6.4	6.9	10.0	8.1	5.8	6.7	8.2	5.3	11.6	11.3	6.1	7.5	13.8	11.1	7.6	11.1	2.3	3.2	1.2	5.7	2.1	7.2	5.7	5.6	5.5	2.2	5.0	8.1	5.9	0.1	2.0	1.5	3.1	3.5	2.0	13.1	15.2	22.5	14.4	12.6	9.7	18.3	9.7	13.6	17.5	11.9	31.0	7.0	19.7	10.2	26.4	14.0	15.3	34.8	36.4	7.0	43.2	7.3	11.6	8.4	12.4	12.9	15.8	0.0	9.2	7.9	8.9	15.5	24.3	7.3	8.9	25.4	19.5	19.6	9.2	5.4	13.8	8.2	8.5	9.0	12.7	25.1	8.0	3.5	12.0	7.0	38.8	6.5	13.2	11.4	17.4	11.2	5.0	20.8	14.0	13.5
METTL18	"AsTP2, C1orf156, HPM1, MGC9084"	ENSG00000171806	"Methyltransferase like 18"	O95568	1	169792529-169794966	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035314	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035314: AB_10601146"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.28e-4)"	8.7	7.3	12.1	9.9	9.0	3.8	11.5	13.5	11.8	6.5	6.8	3.5	8.4	5.6	7.7	9.8	7.8	8.2	5.2	10.2	8.5	6.8	8.6	8.5	5.9	16.5	11.1	10.1	10.4	9.4	31.9	9.4	6.3	9.2	11.2	6.8	3.4	8.4	7.5	5.0	6.5	9.2	6.3	12.7	14.3	8.2	6.7	11.2	9.8	10.0	8.0	11.8	7.8	8.9	13.4	5.4	12.2	5.8	12.4	19.3	9.8	9.0	5.2	8.5	5.8	5.0	9.3	5.9	4.2	4.9	5.4	4.7	6.6	14.7	15.4	11.8	5.6	7.9	10.4	8.5	9.6	7.3	9.2	6.8	11.0	4.7	5.4	10.3	11.6	5.1	4.2	10.1	5.5	6.0	5.5	10.3	11.9	11.6	7.3	7.2	4.4	12.2	7.9	10.7	19.5	13.1	9.1	8.4	11.6	8.7	9.1	6.3	9.7	9.0	10.2	12.4	13.2	13.5	12.8	4.6	6.8	6.5	6.8	9.8	14.3	18.6	20.8	5.0	9.3	6.8	9.3	5.2	12.2	14.6	5.8	18.5	12.1	16.3	17.0	5.4	13.4	19.3	18.3	3.0	12.4	3.4	4.2	18.4	9.8	12.1	9.0	13.5	11.8	8.5	6.8	11.1	10.1	9.2	11.2	3.0	5.8	1.5	5.6	1.3	7.5	5.3	5.1	13.4	5.7	5.2	0.0	11.5	21.6	9.3	13.7	7.8	3.9	0.0	6.9	4.9	5.6	3.4	6.9	2.6	6.5	6.4	2.9	2.5	4.7	3.6	5.8	2.8	5.0	1.0	4.9	8.5	5.3	5.8	4.9	7.0	6.1	0.0	2.8	14.4	9.4	0.6	9.6	10.0	4.9	2.1
METTL21A	"FAM119A, HCA557b, HSPA-KMT, LOC151194"	ENSG00000144401	"Methyltransferase like 21A"	Q8WXB1	2	207580631-207625928	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034712	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034712: AB_10670160"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (4.80e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	10.4	9.1	16.5	13.8	18.2	20.2	14.6	14.0	16.9	9.0	9.3	8.7	3.8	8.1	10.0	8.4	6.7	8.3	7.1	13.2	16.3	15.4	11.1	20.9	8.9	15.4	25.8	10.6	12.0	10.6	11.6	10.1	12.7	20.2	8.8	9.2	8.8	8.4	7.1	19.5	9.0	8.3	8.3	19.2	15.4	12.3	7.1	18.8	18.5	15.2	6.2	14.8	10.1	24.3	25.2	14.8	25.9	20.6	7.5	14.4	8.3	8.0	7.6	12.6	9.5	5.6	5.9	24.5	4.5	5.6	7.3	7.4	14.4	13.0	11.7	10.0	3.5	12.9	4.7	18.0	5.9	6.1	6.8	12.4	13.6	12.2	23.7	9.9	17.8	13.8	5.2	7.9	3.6	6.1	9.1	8.2	19.6	19.6	6.9	4.8	13.1	17.9	30.5	20.9	11.0	5.4	13.2	5.3	16.9	10.5	6.8	14.9	12.3	9.7	3.4	9.4	18.3	4.7	26.4	4.2	6.4	14.0	5.9	7.9	10.2	12.8	24.1	10.5	14.0	9.5	13.8	14.4	25.9	5.0	13.9	8.3	25.2	7.6	7.1	11.8	21.6	14.4	9.2	5.0	7.5	20.6	14.8	5.9	8.3	16.5	18.2	14.0	16.9	16.3	15.4	25.8	10.6	20.2	18.8	14.9	22.3	43.0	29.8	14.2	19.9	23.8	15.3	25.4	21.6	10.4	7.9	32.6	24.9	21.2	24.4	14.8	9.7	0.0	22.0	25.1	20.5	35.0	46.1	10.9	26.1	17.5	5.2	12.3	20.6	28.4	9.2	39.1	42.2	19.0	14.2	15.6	18.5	61.9	7.1	19.3	19.9	12.9	12.5	9.8	17.2	11.0	8.8	18.3	16.6	16.6
METTL23	"C17orf95, LOC124512"	ENSG00000181038	"Methyltransferase like 23"	Q86XA0	17	76726830-76733936	"Disease related genes, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA022889			Approved	Vesicles		No	No			Vesicles		"HPA022889: "	"unprognostic (5.45e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (3.93e-7)"	"unprognostic (1.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.65e-1)"	19.6	21.9	13.4	20.8	14.3	16.3	25.8	12.1	16.2	19.2	19.5	20.6	24.6	15.1	18.8	25.3	22.5	18.5	22.7	17.5	12.6	12.2	25.3	35.1	18.6	32.8	17.8	12.9	23.3	28.3	28.7	23.0	14.1	15.8	22.6	19.2	21.5	21.6	23.7	20.8	18.7	19.6	16.2	14.5	32.3	18.9	43.7	19.5	29.4	38.8	29.5	27.0	19.5	16.4	24.6	22.5	15.2	13.7	23.8	26.7	14.8	25.0	21.9	12.6	11.4	31.3	26.3	12.0	12.8	25.9	16.8	16.3	10.9	17.8	14.2	12.5	16.0	22.0	14.1	8.9	22.9	19.0	7.0	21.0	18.2	14.3	20.8	30.8	12.9	16.1	25.2	22.0	20.8	29.0	26.7	26.3	17.5	17.3	17.7	20.2	14.1	16.0	11.0	9.3	28.0	24.8	11.0	21.0	39.1	24.0	12.7	12.0	17.3	12.7	19.7	44.0	32.0	27.6	16.3	9.6	19.3	9.7	18.8	22.3	24.4	9.2	14.2	18.5	9.2	17.5	9.2	13.5	15.2	24.0	13.7	26.6	24.6	26.7	26.4	15.1	21.5	26.1	25.7	4.5	23.8	12.0	22.5	26.3	14.8	13.4	14.3	12.1	16.2	12.6	12.2	17.8	12.9	15.8	19.5	26.8	12.6	49.6	37.7	14.5	13.6	16.1	33.1	20.1	22.7	19.2	9.8	36.8	101.2	34.8	122.2	29.8	14.7	0.0	34.4	34.4	20.7	30.5	31.1	47.9	49.9	6.4	21.9	26.4	30.4	28.4	30.2	34.1	23.6	50.5	22.8	30.1	30.6	34.5	24.4	66.3	19.1	51.8	27.7	117.2	44.1	14.2	14.4	52.3	31.0	31.0
METTL26	"C16orf13, MGC13114"	ENSG00000130731	"Methyltransferase like 26"	Q96S19	16	634427-636366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 142.6;Extravillous trophoblasts: 149.4;Proximal tubular cells: 227.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044004, HPA067414"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA044004: AB_10964777, HPA067414: "	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.93e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.72e-2)"	21.0	26.8	41.8	14.8	39.8	19.9	54.7	27.3	49.9	19.9	21.6	13.8	13.8	18.5	17.7	27.8	14.3	21.1	18.8	35.7	33.2	24.2	20.2	28.6	23.2	25.7	21.1	24.8	24.8	31.5	18.5	16.3	13.9	16.5	17.2	11.3	10.5	33.3	24.4	62.4	18.1	15.3	14.1	18.0	16.8	23.9	20.0	12.7	28.6	17.8	16.5	12.5	14.1	16.3	42.4	51.3	24.7	48.6	35.2	48.0	35.3	17.7	18.6	6.2	15.0	9.2	15.2	22.6	14.2	12.2	12.6	9.6	16.9	15.5	21.7	24.5	11.6	15.0	22.7	8.9	22.6	3.9	16.1	43.2	13.8	26.6	24.6	22.0	20.4	13.0	13.8	13.0	16.7	12.6	14.9	15.1	27.0	16.3	9.1	7.2	28.1	22.4	35.9	19.2	25.1	54.0	31.5	7.2	44.0	19.6	7.7	27.2	18.8	13.2	24.3	16.9	4.7	17.8	20.5	10.7	12.8	16.7	21.0	13.9	21.9	13.6	15.2	13.0	13.1	11.0	24.7	39.6	20.7	37.1	43.7	40.9	42.4	39.3	36.5	47.7	37.5	37.8	36.4	8.6	35.2	48.6	51.3	48.0	35.3	41.8	39.8	27.3	49.9	33.2	24.2	21.1	24.8	16.5	12.7	29.8	54.9	0.0	0.0	0.0	0.0	0.0	0.0	52.2	35.2	47.1	0.0	104.1	142.6	103.0	0.0	0.0	0.0	0.0	81.8	149.4	0.0	0.0	23.3	0.0	94.6	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	72.1	0.0	0.0	87.4	0.0	0.0	227.7	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0
METTL27	WBSCR27	ENSG00000165171	"Methyltransferase like 27"	Q8N6F8	7	73834590-73842535	"Disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 56.2;Collecting duct cells: 19.2;Distal tubular cells: 24.9;Proximal tubular cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.6;RPMI-8226: 40.8;T-47d: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA022420, HPA074662"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA022420: AB_2304370, HPA074662: "	"unprognostic (6.70e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.24e-2)"	5.7	2.7	1.5	1.4	2.6	0.3	5.2	4.2	3.9	10.2	3.6	3.8	14.5	3.3	5.3	4.4	5.8	9.3	12.4	0.9	1.4	1.3	9.2	2.7	4.7	6.0	1.2	6.0	5.2	11.1	10.0	4.0	8.7	2.8	8.0	1.3	2.4	20.3	12.4	2.3	2.0	4.5	1.3	1.3	5.1	1.7	10.6	0.8	3.0	6.6	0.9	3.1	4.3	3.6	2.4	1.4	2.0	3.4	0.0	9.2	0.3	6.4	7.9	0.0	0.6	1.2	3.5	1.3	0.0	0.1	0.2	0.2	0.4	9.6	1.5	1.5	1.3	5.6	0.6	0.0	2.5	0.1	1.0	0.1	0.0	2.3	2.4	1.4	0.0	0.0	1.4	0.6	4.1	2.0	0.4	1.5	0.5	0.1	1.3	0.9	1.8	0.0	0.0	0.1	5.1	2.0	0.4	1.8	40.8	2.1	1.2	0.7	0.2	0.9	0.7	0.7	1.9	11.9	0.4	1.7	2.5	0.6	4.9	2.5	1.8	0.6	0.0	0.5	0.0	0.8	0.0	1.0	2.0	0.1	3.4	0.0	2.4	0.6	0.0	1.4	1.0	1.2	0.8	1.0	0.0	0.8	1.0	9.2	0.3	1.5	2.6	4.2	3.9	1.4	1.3	1.2	6.0	2.8	0.8	6.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	56.2	4.5	19.2	0.0	3.4	24.9	12.8	0.0	0.0	0.0	0.0	1.9	1.5	0.0	0.0	2.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	7.4	0.0	0.0	40.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
METTL4	"FLJ23017, HsT661"	ENSG00000101574	"Methyltransferase like 4"	Q8N3J2	18	2537525-2571509	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040061, HPA046734"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA040061: AB_10697713, HPA046734: AB_2732532"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.12e-5)"	"unprognostic (1.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-3)"	13.2	8.9	10.1	13.5	15.7	6.1	15.8	18.4	15.6	13.5	10.6	8.6	15.7	9.7	14.0	12.3	11.9	11.1	10.9	9.9	10.1	11.8	10.5	9.2	11.2	19.9	15.9	8.5	13.9	8.6	16.3	23.6	10.4	14.2	12.9	12.7	10.1	17.7	15.6	6.4	11.0	14.6	12.6	17.3	19.9	10.0	12.4	15.8	15.3	16.2	7.2	19.5	13.8	16.8	7.5	3.5	14.4	2.5	5.6	9.4	4.8	7.8	3.4	10.8	6.4	4.9	7.6	12.4	12.3	11.2	12.9	12.8	6.9	5.9	16.5	7.8	5.8	10.5	7.0	17.4	6.6	16.6	11.9	6.0	6.3	6.8	5.9	7.5	14.6	8.4	4.9	14.8	13.2	8.5	7.4	13.3	10.2	8.8	20.7	11.0	3.8	10.9	4.8	6.2	6.9	5.6	7.5	8.6	11.3	7.6	4.9	19.4	8.9	9.8	6.8	12.9	9.5	7.6	10.1	8.6	14.8	18.5	14.3	17.6	10.3	26.4	9.6	9.9	10.3	17.1	14.4	2.5	6.5	6.6	2.3	8.0	6.8	7.6	8.6	1.9	7.5	9.4	8.6	10.1	5.6	2.0	3.5	8.4	4.8	10.1	15.7	18.4	15.6	10.1	11.8	15.9	8.5	14.2	15.8	11.9	8.0	10.0	10.0	4.2	10.1	3.1	5.1	13.4	12.5	3.5	13.7	6.4	0.0	4.9	2.5	9.0	7.8	0.0	6.3	7.9	5.7	9.4	6.9	3.8	5.1	7.9	2.4	12.9	7.6	2.6	11.8	5.7	3.3	1.8	5.1	8.0	6.6	4.2	10.3	4.0	5.8	12.9	6.6	27.0	20.9	4.3	8.7	10.9	4.9	15.4
METTL5	HSPC133	ENSG00000138382	"Methyltransferase like 5"	Q9NRN9	2	169810081-169824931	"Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038223	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA038223: AB_10672509"	"unprognostic (2.55e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.73e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (3.06e-8)"	"unprognostic (8.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.87e-3)"	28.9	25.2	30.1	15.8	29.3	17.6	31.2	18.1	30.2	19.8	28.6	14.2	14.9	17.7	18.8	40.4	29.0	17.9	17.3	38.2	25.6	28.5	27.8	29.2	15.8	19.4	25.6	20.8	16.6	32.5	18.0	24.2	22.3	30.2	25.3	26.5	11.9	27.9	20.9	50.1	19.6	24.9	38.4	26.5	17.8	25.1	14.1	23.9	18.1	26.1	33.9	22.3	31.6	26.5	28.6	21.9	15.0	14.1	18.8	29.1	15.1	24.3	13.5	19.6	21.7	18.0	27.1	32.3	20.7	19.4	25.2	20.3	42.0	28.9	31.2	25.2	16.9	33.6	25.5	26.7	43.3	35.5	24.0	19.2	47.0	11.0	45.7	24.6	58.9	23.2	19.8	58.1	31.9	39.3	26.4	23.3	42.9	43.6	26.2	32.0	23.6	28.2	47.9	26.5	31.9	25.6	28.6	18.4	48.2	43.2	22.4	23.9	17.9	13.3	21.0	35.9	23.3	19.8	26.6	16.0	27.6	22.4	17.2	26.4	25.6	38.6	51.7	23.0	28.9	24.7	15.0	11.7	9.0	19.0	14.1	29.1	28.6	26.3	25.2	14.2	24.1	27.5	24.9	3.5	18.8	12.9	21.9	24.9	15.1	30.1	29.3	18.1	30.2	25.6	28.5	25.6	20.8	30.2	23.9	11.9	24.5	38.7	74.0	34.3	24.2	70.2	53.5	52.2	44.3	41.8	15.7	76.3	94.5	98.0	3.3	34.7	33.8	0.0	128.2	98.7	39.5	65.1	45.1	44.3	68.6	22.3	58.3	36.8	31.3	6.8	46.6	34.4	52.3	48.7	58.4	27.4	118.7	49.1	56.6	81.1	18.3	51.8	54.3	46.4	73.5	35.8	32.7	42.8	68.9	70.1
METTL6	MGC24132	ENSG00000206562	"Methyltransferase like 6"	Q8TCB7	3	15381275-15440566	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.3;Late spermatids: 95.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035166	Uncertain		Approved	Vesicles		No	No			Vesicles		"HPA035166: AB_10602709"	"unprognostic (2.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (3.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	8.6	9.6	19.4	8.6	19.3	5.0	11.7	18.4	18.9	11.7	7.1	16.8	6.2	7.1	10.7	10.6	10.0	11.5	7.7	9.3	13.1	14.3	8.4	7.9	7.8	10.3	13.3	9.6	14.8	10.7	12.5	17.9	11.0	13.7	10.6	8.7	12.0	7.5	11.3	7.8	8.8	6.4	12.4	14.2	8.7	7.8	20.2	11.3	11.8	11.8	3.8	12.0	9.0	8.3	14.1	16.5	15.7	14.0	14.2	14.5	9.4	8.0	13.4	14.6	12.6	13.1	15.4	39.1	14.8	16.2	19.8	19.8	8.5	10.9	13.7	9.6	14.4	15.1	6.8	15.1	12.9	20.3	9.6	16.9	13.3	13.2	12.0	26.4	12.6	11.5	13.5	16.6	23.3	10.7	14.7	16.9	13.9	13.7	14.0	19.3	18.1	13.2	9.9	16.2	8.9	17.0	10.2	18.8	13.5	11.3	11.6	6.5	11.7	12.6	12.5	12.0	11.1	18.1	11.0	10.9	14.2	9.1	13.8	13.3	15.0	25.3	16.7	14.9	12.3	13.3	9.0	11.1	15.7	13.8	14.0	13.4	10.6	13.1	13.5	12.3	14.1	13.4	14.5	6.7	14.2	13.0	16.5	11.9	9.4	19.4	19.3	18.4	18.9	13.1	14.3	13.3	9.6	13.7	11.3	3.0	5.6	0.8	6.7	3.5	16.3	5.2	2.5	10.7	4.5	8.7	5.9	7.9	5.0	9.2	171.3	6.8	1.7	0.0	11.8	16.3	5.4	4.1	4.7	1.9	8.0	19.1	1.7	4.9	5.4	95.3	8.3	6.6	5.0	7.2	2.2	11.0	7.0	3.5	8.5	5.0	14.0	6.5	5.3	30.2	13.8	2.5	9.7	8.5	3.9	5.3
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681546-55684611	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 50.8;Hepatocytes: 89.3;Hofbauer cells: 55.0;Proximal tubular cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0"	"Group enriched"	"Detected in many"	56	"B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.9;CAPAN-2: 24.1;EFO-21: 18.1;LHCN-M2: 19.9;OE19: 13.5;THP-1: 17.6;U-87 MG: 18.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038644	Enhanced		Approved	Vesicles,Microtubules		NA	NA			Microtubules	Vesicles	"HPA038644: AB_2676130"	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (2.43e-1)"	1.3	0.9	1.2	2.1	0.9	0.1	0.5	0.5	2.2	0.4	15.2	3.0	0.0	15.2	0.4	35.7	0.3	0.7	8.1	46.1	4.6	0.6	12.6	82.4	0.8	0.8	1.8	1.5	0.3	1.2	0.0	1.3	4.3	3.2	0.3	6.0	1.4	0.4	0.1	2.7	0.5	44.7	0.4	1.0	3.1	1.0	0.4	0.6	0.0	1.0	0.1	0.0	0.3	0.3	2.5	8.6	0.0	5.4	0.0	0.0	0.4	0.2	9.2	0.0	0.2	1.9	6.8	0.1	0.3	1.4	0.1	0.6	11.9	24.1	4.8	18.1	0.5	0.5	0.0	1.7	0.1	0.3	0.0	2.3	0.4	1.5	11.7	0.0	0.2	0.0	1.7	0.0	0.4	0.0	1.8	0.0	0.0	0.1	0.0	19.9	8.3	0.0	0.1	2.4	13.5	1.1	0.0	0.6	1.1	0.2	0.0	0.0	0.1	0.9	0.0	1.6	0.1	1.6	17.6	0.0	1.3	1.6	0.2	1.2	0.0	0.2	1.4	18.3	4.1	0.1	0.0	1.0	0.0	0.0	5.4	0.0	0.7	0.0	0.0	8.6	2.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.4	1.2	0.9	0.5	2.2	4.6	0.6	1.8	1.5	3.2	0.6	0.0	1.0	0.0	0.1	0.0	0.0	14.9	25.5	0.0	1.2	0.0	0.0	0.4	3.3	3.3	0.0	0.0	50.8	0.0	4.6	0.4	0.4	0.0	0.0	89.3	55.0	0.0	1.2	1.8	14.6	0.0	0.0	0.0	0.0	0.0	8.5	0.5	3.8	17.3	1.1	31.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	17.2	0.1
METTL8	"FLJ13984, TIP"	ENSG00000123600	"Methyltransferase like 8"	Q9H825	2	171317405-171434802	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035421	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035421: AB_10670116"	"unprognostic (3.13e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.94e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.83e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.59e-3)"	10.8	8.0	7.4	8.4	9.6	6.8	8.8	6.2	8.5	9.4	12.6	10.4	9.2	4.6	8.4	6.3	21.0	5.9	7.2	6.7	8.7	6.4	8.6	8.6	5.5	6.0	13.2	4.5	6.4	8.1	6.1	5.0	7.8	10.9	10.9	14.1	5.2	6.2	11.6	6.9	15.1	8.2	20.5	12.5	7.8	6.3	11.2	10.1	4.0	4.7	13.5	8.9	13.7	10.3	6.6	10.1	1.2	4.4	7.0	7.5	3.6	8.4	6.4	3.1	9.5	10.4	12.4	17.2	10.5	8.0	9.9	12.4	14.0	11.8	17.5	8.4	5.0	8.5	8.6	11.2	17.1	12.5	9.2	5.8	9.7	5.7	19.7	8.4	14.8	7.5	12.2	18.9	15.7	24.7	2.5	19.5	9.3	17.9	4.0	13.5	9.2	10.4	3.6	13.1	7.4	5.8	5.5	12.2	19.0	7.4	8.3	11.5	4.5	11.1	8.5	7.7	5.4	6.1	5.6	9.6	8.7	6.8	6.1	5.8	2.1	9.3	10.6	6.9	10.5	9.0	0.8	3.0	0.9	5.4	4.4	7.5	4.3	6.3	5.0	4.0	6.6	2.9	3.3	1.2	7.0	2.1	10.1	6.3	3.6	7.4	9.6	6.2	8.5	8.7	6.4	13.2	4.5	10.9	10.1	6.0	6.7	33.5	8.2	22.7	7.5	7.5	17.8	8.1	17.0	3.5	2.0	14.4	10.0	7.3	11.1	8.1	7.4	23.3	5.3	17.3	10.8	7.0	5.8	8.6	10.6	11.1	6.4	5.5	9.4	2.9	13.0	11.6	10.1	7.2	4.2	7.7	7.5	2.9	15.2	14.4	9.6	6.5	10.5	6.1	18.1	23.3	10.8	12.5	12.5	8.1
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 326.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: AB_2682203, HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	24.0	45.5	29.6	18.8	34.9	50.0	45.1	12.2	31.9	34.2	19.1	18.7	15.5	14.9	23.4	35.6	30.2	23.8	19.4	32.0	22.2	20.0	61.0	8.7	24.0	38.8	26.8	8.4	22.8	28.8	37.2	25.0	25.4	17.7	23.8	20.3	32.5	22.1	19.3	30.6	21.5	20.6	21.1	25.0	29.6	18.8	10.8	18.1	39.8	37.8	20.0	25.9	24.9	24.6	4.9	14.1	30.5	24.5	5.6	7.3	7.6	13.6	10.4	26.4	22.8	27.3	49.5	9.5	21.9	31.4	17.3	21.0	7.5	24.9	24.0	18.7	38.3	16.7	8.6	17.5	19.6	23.7	18.2	14.3	10.4	10.5	27.9	19.6	8.1	21.6	29.1	20.9	17.9	23.4	32.6	33.1	26.9	15.3	19.8	34.2	15.1	21.1	13.6	23.7	17.0	10.8	30.8	20.5	21.8	28.5	13.4	15.3	27.6	18.6	12.9	46.7	20.7	13.1	4.2	18.7	28.8	12.6	17.6	13.4	16.8	27.0	19.3	28.3	20.2	20.3	30.5	24.5	10.7	4.0	4.5	4.8	4.6	6.8	7.3	14.1	4.9	7.3	5.4	12.5	5.6	3.9	4.4	5.4	7.6	29.6	34.9	12.2	31.9	22.2	20.0	26.8	8.4	17.7	18.1	17.9	25.0	67.7	73.4	63.7	38.7	50.8	28.1	17.4	25.0	82.0	43.2	62.9	238.8	101.7	6.4	91.1	45.1	0.0	107.0	99.3	82.6	115.4	48.3	10.4	80.8	42.9	81.5	80.4	211.5	4.5	58.7	86.5	99.5	101.8	76.5	49.9	98.9	45.6	61.2	326.8	37.5	64.7	68.4	13.2	20.0	67.2	116.4	146.0	75.0	107.4
MEX3B	"DKFZp434J0617, RKHD3, RNF195"	ENSG00000183496	"Mex-3 RNA binding family member B"	Q6ZN04	15	82041778-82046141	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 15.6;testis: 33.3"	"Group enriched"	"Detected in many"	21	"Early spermatids: 185.8;Late spermatids: 144.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.5;HEL: 24.6;SH-SY5Y: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041093	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041093: AB_10793868"	"unprognostic (2.42e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.93e-8)"	"unprognostic (1.24e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.51e-2)"	2.0	0.6	1.5	1.8	1.6	2.0	1.6	3.8	4.5	15.6	2.8	1.6	2.5	0.8	7.9	0.6	1.1	1.2	2.8	2.0	2.0	1.4	1.0	1.0	1.4	2.8	2.2	3.3	6.8	0.7	0.2	0.9	3.3	1.0	3.7	0.9	1.2	3.0	3.8	1.6	1.1	1.1	4.0	1.0	1.2	1.0	33.3	0.7	8.4	1.0	1.8	1.2	3.1	4.2	0.0	1.3	0.0	0.1	0.4	0.1	0.0	0.1	1.2	8.8	33.5	0.7	1.0	2.5	1.0	0.5	1.8	1.6	0.2	0.2	1.5	0.6	1.9	0.5	0.2	4.1	0.1	1.3	0.3	2.7	24.6	1.4	1.1	1.4	0.3	7.8	0.5	0.7	1.0	2.0	4.3	3.8	3.1	1.2	0.0	3.1	0.8	4.0	2.1	11.4	0.0	0.3	5.6	5.4	0.8	0.0	0.0	7.0	13.7	1.7	0.3	1.1	2.6	0.1	0.4	3.5	4.6	5.4	2.5	1.5	3.2	1.6	1.8	1.5	2.4	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	1.6	3.8	4.5	2.0	1.4	2.2	3.3	1.0	0.7	0.0	1.1	0.0	0.4	2.5	3.3	3.7	0.0	0.0	0.0	0.0	2.0	7.7	0.0	0.8	185.8	1.9	0.0	0.0	0.2	7.2	4.3	0.9	1.1	0.0	1.5	0.0	1.2	3.7	1.0	144.1	6.1	3.6	6.8	0.0	1.6	5.7	0.6	0.0	4.2	0.0	2.8	6.5	4.0	2.6	4.3	1.8	2.1	0.0	1.1	0.3
MEX3C	"FLJ38871, RKHD2, RNF194"	ENSG00000176624	"Mex-3 RNA binding family member C"	Q5U5Q3	18	51174550-51218304	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Early spermatids: 519.8;Late spermatids: 374.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040603	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA040603: AB_10805714"	"unprognostic (1.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (8.49e-5)"	"unprognostic (4.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.17e-1)"	12.6	12.2	13.8	14.5	13.5	27.5	19.4	21.7	13.7	14.7	11.3	10.7	8.8	8.7	13.4	9.5	11.7	11.1	13.0	11.3	15.1	9.1	9.3	10.3	12.0	19.8	16.3	8.3	14.5	10.1	16.6	9.5	11.7	12.3	10.3	9.8	7.6	12.4	10.1	9.0	10.2	12.7	13.6	12.6	16.3	10.5	43.7	12.7	40.0	13.6	9.3	18.4	13.0	17.5	2.8	2.0	10.3	1.3	5.8	3.8	1.5	7.6	4.5	22.1	8.3	12.3	15.1	17.2	10.9	14.3	6.3	7.8	7.3	5.8	15.6	3.8	14.5	10.2	14.0	9.5	15.6	12.3	11.4	4.2	3.3	4.6	9.5	19.8	21.2	6.3	12.8	22.0	8.9	28.0	18.5	16.4	12.5	3.5	27.3	16.4	5.6	15.8	10.5	10.6	4.8	4.6	16.0	11.5	16.0	14.7	2.5	9.8	13.4	8.2	4.5	43.0	21.6	4.4	11.8	12.2	15.4	10.3	4.6	9.3	19.8	2.9	24.9	10.6	10.8	34.7	10.3	1.3	1.5	3.6	1.3	3.1	2.8	3.8	3.7	2.0	2.1	1.6	3.8	0.7	5.8	0.9	2.0	3.1	1.5	13.8	13.5	21.7	13.7	15.1	9.1	16.3	8.3	12.3	12.7	17.9	5.3	9.3	8.7	34.0	12.9	11.1	17.8	2.7	9.1	3.5	19.6	4.1	5.0	9.9	519.8	25.3	7.3	0.0	7.5	6.3	17.5	10.6	12.7	6.8	6.7	11.1	6.4	8.6	12.6	374.0	15.0	4.4	18.6	3.6	8.4	8.0	12.4	0.0	14.2	6.2	13.8	0.0	10.3	13.0	12.4	40.1	3.5	21.7	11.2	17.0
MFAP3		ENSG00000037749	"Microfibril associated protein 3"	P55082	5	154038906-154220478	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015883, HPA049198"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA015883: AB_1853840, HPA049198: AB_2680672"	"unprognostic (6.02e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (9.35e-3)"	21.3	7.6	5.8	8.0	12.2	7.9	11.3	12.6	11.4	11.1	8.3	6.3	7.8	7.2	14.1	7.3	11.6	7.5	8.9	9.2	7.2	6.8	9.5	9.4	10.9	6.8	6.4	7.1	9.4	6.3	27.2	9.6	15.0	8.8	7.8	8.4	9.5	8.8	6.4	13.2	6.4	9.5	11.7	8.9	7.9	7.4	8.3	7.0	9.1	11.3	6.3	9.2	12.2	10.1	3.0	10.6	14.6	10.3	7.7	9.6	5.4	9.7	12.7	21.6	22.7	19.5	18.3	21.2	17.6	18.9	18.4	23.8	19.1	22.2	14.0	20.5	16.6	18.3	22.0	20.3	22.0	29.5	6.3	13.3	9.2	19.5	6.9	18.6	16.4	10.8	19.7	21.9	22.0	18.7	15.2	25.7	12.7	10.4	15.2	16.0	6.4	9.1	3.7	11.2	10.4	7.5	8.7	25.6	12.8	11.9	13.8	22.3	24.9	19.3	21.8	17.4	20.0	22.9	8.1	23.3	24.0	16.8	13.2	17.9	15.3	19.6	13.2	12.2	11.3	18.8	8.1	10.3	14.6	6.5	9.8	9.6	3.0	5.6	4.9	10.6	3.0	7.4	5.4	8.4	7.7	7.0	3.8	4.9	5.4	5.8	12.2	12.6	11.4	7.2	6.8	6.4	7.1	8.8	7.0	0.0	0.3	0.0	0.9	5.4	3.3	2.0	0.0	0.0	0.0	5.2	5.9	3.5	1.7	0.9	4.5	4.8	2.0	0.0	1.0	2.4	2.7	1.1	4.6	1.6	1.6	3.2	0.0	0.0	1.2	3.3	1.7	2.5	8.5	1.0	0.6	7.8	0.9	0.0	0.0	1.1	4.3	0.0	3.0	2.1	2.1	4.8	5.0	1.3	0.6	1.4
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387240	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 593.8;Peritubular cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 2.3;intermediate monocyte: 4.0;non-classical monocyte: 4.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 60.2;ASC TERT1: 91.9;fHDF/TERT166: 41.1;HHSteC: 42.1;HSkMC: 63.7;MOLT-4: 52.6;SH-SY5Y: 52.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		140000000	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	41.5	10.0	1.3	37.3	4.1	0.0	34.9	1.3	3.7	62.5	44.8	5.1	18.1	12.1	64.3	58.7	64.2	32.2	150.2	46.9	1.8	1.3	15.9	12.0	106.1	10.7	2.4	5.8	57.6	8.5	0.0	15.8	43.3	6.8	102.4	17.2	102.5	16.3	16.6	18.7	25.9	43.8	88.9	3.2	7.6	31.4	26.2	1.3	8.4	20.3	55.3	39.0	79.2	73.7	0.0	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	60.2	91.9	0.1	6.5	23.5	0.6	0.4	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	42.1	2.0	0.0	63.7	0.0	0.3	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	52.6	4.8	1.0	0.0	0.0	3.7	3.7	0.0	0.0	0.0	5.3	52.5	0.0	0.0	0.0	0.3	0.0	11.8	0.0	7.6	0.5	0.3	0.0	0.0	0.0	0.0	7.3	2.2	0.0	0.0	0.3	2.3	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.3	4.1	1.3	3.7	1.8	1.3	2.4	5.8	6.8	1.3	3.0	15.5	0.0	0.5	42.2	0.7	9.5	0.0	5.3	5.7	1.8	0.0	5.9	0.0	0.0	0.3	4.4	0.0	0.0	0.0	3.1	593.8	1.2	1.1	0.0	8.2	0.0	0.0	19.0	0.0	2.0	72.5	2.4	64.1	0.0	0.0	71.0	0.1	0.0	225.6	0.0	2.9	19.4	95.8	0.2	0.5	35.9	16.2	0.0	0.0	0.4
MFGE8	"BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10"	ENSG00000140545	"Milk fat globule-EGF factor 8 protein"	Q08431	15	88898683-88913411	"Cancer-related genes, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 363.2;Rod photoreceptor cells: 972.8;Sertoli cells: 1067.2;Smooth muscle cells: 475.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.6;NK-cells: 6.3;T-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 181.9;ASC TERT1: 94.5;fHDF/TERT166: 64.0;HSkMC: 95.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002753, HPA002807"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	2830000	1100000	Cytosol		"CAB002753: , HPA002807: AB_1078072"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (6.06e-9)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (4.85e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.41e-3)"	34.2	23.2	5.4	14.5	11.2	0.9	73.4	5.7	14.8	43.4	15.8	9.6	11.3	5.2	73.2	38.6	32.8	56.2	30.2	115.4	5.6	4.1	12.4	3.9	20.8	14.9	6.0	8.3	49.8	6.6	2.9	8.1	23.1	10.8	29.5	7.3	59.5	15.6	50.7	57.8	18.3	15.4	39.6	8.8	6.5	22.2	23.6	4.4	8.5	21.7	21.1	12.6	32.8	68.3	1.2	0.0	3.6	0.2	6.3	13.3	2.0	1.8	7.1	7.8	9.5	181.9	94.5	0.6	46.9	14.0	9.4	11.2	6.2	2.2	0.0	14.5	64.0	14.1	0.9	2.7	9.3	3.1	7.5	4.7	13.6	0.4	0.6	47.9	0.0	4.8	95.7	25.0	7.4	12.4	20.5	3.6	3.4	2.1	4.1	18.2	0.1	2.1	0.3	39.9	0.7	2.5	2.1	7.4	2.4	3.3	0.6	0.8	4.1	2.5	0.2	21.2	17.1	0.2	1.0	3.9	23.4	12.6	6.0	3.4	14.4	2.8	1.4	3.1	1.1	9.0	3.6	0.2	0.4	1.2	0.0	4.2	1.2	4.2	3.0	0.0	0.8	4.4	3.1	0.0	6.3	0.1	0.0	13.3	2.0	5.4	11.2	5.7	14.8	5.6	4.1	6.0	8.3	10.8	4.4	11.9	4.8	1.9	27.2	43.3	16.8	80.8	12.7	0.0	2.3	3.5	363.2	4.3	0.0	12.8	9.7	36.0	0.8	0.0	3.6	16.7	111.8	11.6	4.7	7.4	7.1	15.9	42.9	28.3	35.4	22.8	173.2	16.6	113.1	2.8	5.4	69.0	18.8	0.0	102.6	0.0	972.8	1067.2	475.7	2.7	8.6	31.5	4.5	12.2	1.2	7.4
MFHAS1	"LRRC65, MASL1, ROCO4"	ENSG00000147324	"Malignant fibrous histiocytoma amplified sequence 1"	Q9Y4C4	8	8783354-8893645	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Signal transduction inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.5;MAIT T-cell: 2.1;memory B-cell: 1.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive B-cell: 1.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.7;T-reg: 3.1"	"Group enriched"	"Detected in many"	5	"B-cells: 1.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051213, HPA054471"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051213: AB_2681391, HPA054471: AB_2682498"	"unprognostic (1.33e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.23e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.01e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-1)"	8.0	2.7	10.1	14.9	10.2	12.5	5.8	10.3	10.0	8.7	16.6	5.0	5.0	7.6	7.7	4.8	7.6	9.9	10.7	7.6	10.0	6.5	15.8	10.5	12.5	12.1	6.2	4.7	6.8	6.3	6.2	3.3	11.1	7.4	8.9	14.9	5.4	7.6	6.1	4.4	8.5	9.5	10.4	3.6	13.5	9.0	7.6	5.2	24.9	10.8	3.6	10.6	9.3	15.0	1.1	0.5	0.0	0.3	0.4	3.9	0.9	7.9	6.0	3.6	2.7	3.4	4.4	12.0	3.3	7.1	2.4	3.2	9.5	1.5	11.6	4.1	3.1	6.9	2.7	3.8	3.0	2.1	15.0	3.4	0.8	2.2	6.1	4.1	3.3	1.2	2.4	6.4	3.2	3.2	2.6	5.2	14.5	5.3	0.0	1.9	2.8	51.2	2.9	7.1	10.5	2.5	7.0	5.6	1.8	16.7	8.3	5.8	4.7	1.9	3.0	5.2	6.5	2.0	4.5	2.2	2.9	4.3	11.5	6.3	0.6	2.7	9.1	5.4	4.4	1.7	0.0	0.3	0.0	2.5	0.1	2.1	1.1	3.9	2.2	0.5	1.0	1.9	1.7	0.0	0.4	0.0	0.1	3.1	0.9	10.1	10.2	10.3	10.0	10.0	6.5	6.2	4.7	7.4	5.2	50.6	44.0	7.4	22.5	33.3	17.4	14.0	22.9	5.3	25.0	29.6	3.9	2.5	11.6	10.6	1.9	16.1	8.6	23.3	13.2	2.5	21.6	32.3	21.9	15.3	25.5	3.2	18.1	27.0	25.7	1.9	10.6	10.6	10.1	2.8	28.4	21.8	21.5	5.8	7.8	14.6	8.1	0.0	42.2	1.9	20.2	43.7	1.9	20.8	24.0	15.4
MFNG		ENSG00000100060	"MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	O00587	22	37469063-37486401	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.7;lymphoid tissue: 42.1"	"Group enriched"	"Detected in many"	5	"B-cells: 44.1;Endothelial cells: 25.5;granulocytes: 30.1;Hofbauer cells: 28.8;Ito cells: 45.4;Kupffer cells: 36.8;Macrophages: 23.4;monocytes: 20.8;T-cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.8;HEL: 25.3;HL-60: 41.3;HMC-1: 54.8;HUVEC TERT2: 44.2;U-698: 31.7;U-937: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048936, HPA056479"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		28000	Vesicles		"HPA048936: AB_2680564, HPA056479: "	"unprognostic (1.21e-1)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (5.12e-4)"	"prognostic favorable (1.65e-4)"	"unprognostic (6.41e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (2.67e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	10.0	4.5	2.6	16.6	5.1	14.4	13.4	1.0	3.3	6.0	6.5	3.0	2.0	3.7	6.5	3.5	4.4	7.1	6.3	6.7	2.8	2.6	6.1	5.6	14.9	42.1	5.6	1.2	3.6	3.7	0.8	2.2	14.0	8.3	5.6	3.7	4.4	5.7	2.5	3.4	3.0	14.1	5.1	4.4	37.6	4.1	2.6	3.6	33.9	6.3	4.5	19.3	8.8	4.2	24.1	40.5	72.7	40.8	40.9	53.3	53.2	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.6	32.8	0.1	0.0	0.1	2.3	9.6	1.9	0.0	12.9	0.2	25.3	0.1	0.3	0.1	41.3	54.8	0.0	0.5	0.3	0.7	0.2	44.2	11.4	0.1	15.7	0.0	0.1	4.7	0.5	0.1	1.2	0.1	12.1	0.4	24.7	0.1	0.0	19.8	0.2	0.1	0.0	0.0	0.2	0.3	2.8	24.6	0.0	1.2	4.9	0.1	0.0	0.1	31.7	0.2	37.2	0.5	36.8	40.1	72.7	41.3	38.8	45.1	21.8	48.0	43.3	40.5	24.1	52.9	45.5	25.5	40.9	40.8	10.1	53.3	53.2	2.6	5.1	1.0	3.3	2.8	2.6	5.6	1.2	8.3	3.6	0.0	6.7	44.1	0.2	3.3	0.6	1.4	5.1	0.0	5.7	0.0	0.0	0.3	0.0	3.0	0.1	25.5	1.1	0.0	0.8	0.2	1.1	0.4	30.1	1.0	28.8	0.0	1.2	45.4	36.8	0.0	0.0	23.4	3.3	20.8	2.2	0.0	2.1	0.6	0.0	0.3	0.3	0.0	1.0	0.0	0.5	2.0	0.6	53.8	0.6	0.3
MFSD1	"FLJ14153, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Hofbauer cells: 192.2;Kupffer cells: 259.8;Macrophages: 135.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065858	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		14000	"Plasma membrane"	Cytosol	"HPA065858: AB_2685569"	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	26.2	29.5	11.4	22.0	11.8	17.2	24.2	9.1	14.0	18.7	15.7	13.4	18.9	13.2	18.3	20.6	37.0	18.4	17.5	17.7	10.8	10.3	20.7	24.8	24.9	39.8	15.7	11.7	15.3	16.8	16.5	16.8	18.3	13.6	14.7	11.5	14.5	34.5	17.9	9.2	18.6	16.8	15.0	14.5	29.1	19.9	15.0	14.3	11.3	18.7	16.3	16.7	23.8	24.1	10.5	45.3	42.6	49.6	5.4	7.3	35.3	14.9	6.4	1.6	5.0	8.7	8.2	10.3	23.4	10.5	8.3	8.2	2.6	14.8	4.2	17.2	14.9	5.0	7.8	4.0	5.1	7.8	16.6	10.9	11.2	4.9	1.1	9.4	41.3	28.1	12.2	6.7	7.5	2.1	3.3	6.5	2.8	8.7	8.6	14.7	3.4	2.5	12.2	1.6	6.3	16.4	5.6	2.4	36.6	3.0	3.9	4.8	7.2	17.2	13.3	4.1	2.0	10.5	16.2	21.3	11.9	4.6	17.6	11.5	27.4	19.2	2.3	15.0	30.0	8.3	14.0	49.6	42.6	7.3	38.5	6.6	10.5	5.8	6.5	45.3	8.5	6.4	7.0	17.6	5.4	31.6	14.7	6.8	35.3	11.4	11.8	9.1	14.0	10.8	10.3	15.7	11.7	13.6	14.3	17.9	31.3	39.5	33.3	19.1	11.9	17.1	12.7	40.2	29.6	21.0	5.9	23.7	16.6	28.2	3.5	25.1	25.5	23.3	24.8	27.2	23.6	39.9	47.4	30.1	192.2	17.5	21.9	39.3	259.8	5.3	11.2	135.3	30.4	15.4	26.6	23.4	26.7	20.1	10.6	25.9	10.0	12.9	15.5	8.8	7.0	22.7	46.8	15.4	24.0	47.5
MFSD10	"IT10C3, TETRAN"	ENSG00000109736	"Major facilitator superfamily domain containing 10"	Q14728	4	2930561-2934859	"Predicted membrane proteins"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043209	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nuclear membrane"	Nucleoplasm	"HPA043209: AB_2678364"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.76e-2)"	"unprognostic (9.43e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (8.32e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.00e-2)"	21.6	9.1	10.3	15.2	10.7	62.9	34.4	20.2	13.0	17.1	18.1	8.9	17.5	13.8	16.0	17.1	18.0	16.3	23.5	13.5	9.6	10.1	15.7	6.0	16.8	17.6	9.1	10.1	20.6	20.9	4.2	13.3	13.5	8.4	22.0	5.2	7.1	27.1	14.5	10.3	10.0	19.0	10.9	7.7	16.3	18.7	11.1	7.4	8.3	29.9	15.0	14.9	15.2	16.7	18.4	22.2	42.5	33.1	16.1	33.2	15.0	12.9	12.3	3.5	9.0	6.0	4.3	9.8	12.0	5.9	5.9	6.8	6.5	31.4	2.3	6.4	7.5	10.9	12.2	3.2	17.3	1.6	14.6	11.1	4.9	10.5	6.7	10.1	15.5	7.2	6.5	10.2	6.6	4.2	9.1	6.7	5.2	6.8	4.8	4.4	14.0	4.4	71.8	11.7	10.2	14.8	5.4	1.7	10.8	8.7	8.0	9.3	11.1	2.8	8.4	12.5	3.8	22.1	29.5	9.8	4.7	8.3	5.9	9.5	3.2	1.4	3.5	13.7	39.7	7.5	21.0	21.4	42.5	29.9	26.4	25.3	18.4	19.3	33.2	22.2	14.8	9.9	17.3	16.8	16.1	33.1	17.4	12.6	15.0	10.3	10.7	20.2	13.0	9.6	10.1	9.1	10.1	8.4	7.4	35.7	29.0	29.6	60.0	27.8	6.7	4.6	28.1	29.4	21.6	43.6	7.9	55.4	3.3	85.0	10.1	33.1	37.5	0.0	39.9	70.0	33.4	67.6	32.3	2.9	65.2	14.3	27.1	38.6	37.6	12.2	33.6	46.5	40.5	72.1	34.1	9.8	74.5	42.1	21.2	17.3	9.4	90.5	37.6	14.3	16.0	23.5	70.0	69.2	41.7	89.7
MFSD11	"FLJ20226, FLJ22196"	ENSG00000092931	"Major facilitator superfamily domain containing 11"	O43934	17	76735865-76781449	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 231.7;Early spermatids: 185.4;Late spermatids: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022001	Uncertain		Approved	"Nuclear speckles"		Yes	No			"Nuclear speckles"		"HPA022001: AB_2297599"	"unprognostic (2.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (7.90e-4)"	17.2	20.7	13.9	14.3	21.3	15.6	18.7	20.4	25.0	18.0	20.9	19.6	16.9	17.4	18.8	18.8	24.1	13.4	14.3	23.5	13.3	14.8	13.3	19.2	17.4	22.0	20.1	16.1	14.4	17.4	24.6	27.9	27.4	18.1	14.8	22.8	32.8	21.3	17.3	26.8	20.8	17.7	16.8	17.9	19.0	21.7	28.6	19.7	15.6	18.0	16.8	18.6	16.8	21.6	8.0	14.9	16.7	16.1	6.3	18.3	8.2	13.8	7.9	9.3	8.8	20.0	12.2	10.9	12.3	11.5	11.9	10.6	15.8	25.4	11.2	10.5	12.5	13.1	13.6	6.5	6.4	12.4	5.1	13.1	11.3	14.9	10.9	9.6	6.0	11.2	14.4	10.5	15.2	6.9	17.3	22.6	15.1	13.5	16.8	15.1	10.6	13.5	9.8	3.9	15.8	4.6	10.7	12.1	23.3	9.2	10.3	9.0	15.2	11.8	16.8	10.5	14.3	29.5	9.2	15.9	21.7	10.7	13.6	10.2	18.7	7.4	17.0	16.8	5.3	14.3	11.2	14.1	11.3	15.2	16.1	6.4	7.5	13.6	15.3	14.9	8.0	8.5	10.6	16.7	6.3	12.5	10.7	18.3	8.2	13.9	21.3	20.4	25.0	13.3	14.8	20.1	16.1	18.1	19.7	11.9	12.3	7.5	17.8	14.9	36.0	15.1	10.2	4.0	14.8	14.0	231.7	33.6	5.0	13.3	185.4	14.8	23.9	0.0	15.9	60.6	17.0	13.3	26.5	15.6	29.3	38.1	16.1	17.2	21.9	141.7	17.0	18.6	18.6	21.6	14.2	18.8	16.6	10.5	13.1	8.7	96.6	6.5	12.8	33.4	10.4	15.1	34.6	17.5	14.3	12.5
MFSD12	"C19orf28, MGC20700, PP3501"	ENSG00000161091	"Major facilitator superfamily domain containing 12"	Q6NUT3	19	3538261-3574290	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 101.3;Extravillous trophoblasts: 117.0;Melanocytes: 185.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 124.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 59.6;WM-115: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042149, HPA043088"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA042149: AB_2677875, HPA043088: AB_2678308"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.66e-6)"	"unprognostic (1.56e-2)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (6.61e-4)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (3.19e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	25.9	13.0	15.4	19.0	14.4	23.5	9.3	10.4	22.9	8.1	8.9	24.3	11.2	12.5	10.2	12.7	11.1	14.3	10.0	7.6	23.9	12.8	38.0	21.5	13.8	15.2	20.7	10.0	9.7	19.8	15.7	11.9	46.6	15.6	10.2	5.7	13.5	23.7	10.5	8.1	43.6	13.8	9.9	18.6	19.7	14.1	7.5	16.1	37.0	9.1	6.1	11.8	7.9	7.8	2.4	12.9	2.6	7.9	0.5	3.1	1.6	17.0	13.8	3.4	8.9	7.1	5.5	12.3	10.5	5.7	12.3	13.5	5.9	5.8	4.8	8.0	5.5	19.6	10.7	4.4	5.4	4.4	10.5	12.5	2.8	44.2	6.0	8.9	6.0	9.5	4.9	8.2	12.6	2.9	4.7	3.3	7.2	13.4	7.0	3.1	10.2	5.9	10.8	6.4	7.5	11.2	4.3	4.9	20.3	5.1	7.3	12.9	6.5	20.7	9.7	59.6	4.4	3.3	12.6	13.5	5.6	8.2	22.7	11.8	8.0	4.5	4.4	24.6	15.6	113.8	0.1	4.0	2.6	2.1	7.9	2.1	2.4	3.1	1.6	2.8	1.7	2.7	2.1	1.3	0.5	7.6	12.9	0.5	1.6	15.4	14.4	10.4	22.9	23.9	12.8	20.7	10.0	15.6	16.1	6.0	3.2	15.2	3.8	23.6	15.8	1.6	12.7	4.0	4.5	19.2	5.9	10.7	0.0	19.3	101.3	10.8	13.8	0.0	26.4	117.0	8.0	13.6	0.0	19.2	73.9	35.0	26.9	8.6	19.6	20.9	2.3	32.4	185.5	19.8	9.3	8.3	29.4	17.3	3.2	33.8	11.5	12.9	5.0	4.2	9.1	22.2	77.5	7.5	8.6	13.2
MFSD13A	"bA18I14.8, C10orf77, FLJ22529, TMEM180"	ENSG00000138111	"Major facilitator superfamily domain containing 13A"	Q14CX5	10	102461395-102477045	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Horizontal cells: 20.6;Syncytiotrophoblasts: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018031	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA018031: AB_2204891"	"unprognostic (2.24e-2)"	"prognostic favorable (8.29e-4)"	"unprognostic (7.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.16e-3)"	"unprognostic (4.70e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.02e-2)"	3.8	3.3	8.8	5.9	15.7	9.0	2.6	18.0	18.7	2.4	7.0	8.5	0.4	10.2	4.3	1.8	3.0	2.4	4.7	5.2	9.0	6.5	3.3	5.7	14.1	5.6	7.9	8.7	2.3	5.1	2.8	4.4	7.2	8.2	3.1	6.4	3.9	3.0	2.3	3.9	17.4	7.5	4.9	5.2	6.9	7.1	5.8	8.6	2.3	5.7	1.8	6.7	3.1	2.5	5.0	7.5	5.5	7.2	2.2	5.8	3.4	9.3	4.3	3.3	7.9	0.3	0.3	5.1	1.9	4.9	3.7	8.7	8.5	12.9	8.4	9.8	0.7	3.6	11.7	6.2	5.0	1.4	10.6	5.5	10.3	6.1	4.4	8.5	5.2	10.1	4.3	2.1	2.1	3.8	3.1	4.3	11.4	2.3	4.6	0.3	1.9	8.7	3.4	5.6	8.2	4.2	10.6	0.5	1.4	1.7	2.5	8.2	7.8	1.8	1.0	4.2	1.2	4.8	3.5	1.3	1.7	2.1	2.1	2.6	1.6	4.1	10.9	9.6	8.6	2.4	0.7	7.2	5.5	5.2	5.3	5.2	5.0	5.0	4.1	7.5	2.8	5.2	5.8	4.4	2.2	3.0	0.8	1.4	3.4	8.8	15.7	18.0	18.7	9.0	6.5	7.9	8.7	8.2	8.6	17.9	9.6	0.0	1.2	0.0	6.8	0.0	2.5	1.4	1.2	1.8	3.9	1.5	0.0	2.4	1.1	2.3	2.9	0.0	3.2	2.5	0.7	1.4	1.1	4.9	15.8	20.6	2.4	4.9	3.5	0.4	0.9	7.8	0.0	4.6	3.9	3.0	2.8	5.7	2.1	1.2	13.5	0.0	0.0	3.4	2.9	0.0	23.8	1.5	6.0	0.9
MFSD14A	"DKFZP564L0864, HIAT1"	ENSG00000156875	"Major facilitator superfamily domain containing 14A"	Q96MC6	1	100038097-100083377	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 248.4;Late spermatids: 274.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA073127, HPA073681"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA073127: , HPA073681: AB_2686625"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.15e-2)"	24.3	23.7	21.8	23.9	23.5	55.7	34.7	16.3	28.3	22.0	23.5	30.2	21.2	14.7	29.4	20.6	24.5	22.9	19.3	17.0	19.9	20.8	22.7	21.7	27.1	24.1	24.5	16.8	27.0	29.2	92.6	19.4	25.0	23.6	26.0	17.1	20.5	23.0	32.0	18.8	22.4	18.5	29.3	33.9	20.6	21.7	28.3	22.3	24.4	21.3	15.9	21.0	23.0	22.9	24.1	27.0	47.1	28.1	26.9	29.8	30.8	23.5	9.8	22.2	11.4	26.0	24.7	18.7	17.3	29.6	23.5	27.5	8.3	16.5	17.7	28.3	22.4	15.5	22.7	19.7	19.0	22.6	15.4	15.6	17.4	15.0	12.4	23.0	28.0	22.9	20.1	29.2	20.7	26.6	20.8	18.0	20.1	21.3	34.8	21.6	6.9	21.0	16.5	25.5	11.5	14.5	14.8	27.1	17.3	25.1	20.7	23.1	20.6	19.5	28.5	28.5	14.7	11.0	28.6	19.7	19.4	13.7	20.3	17.8	33.2	34.9	24.7	21.1	20.5	8.3	32.8	28.1	26.1	25.9	25.2	29.2	24.1	26.5	28.3	27.0	19.4	29.8	27.6	47.1	26.9	20.7	12.6	28.6	30.8	21.8	23.5	16.3	28.3	19.9	20.8	24.5	16.8	23.6	22.3	6.0	8.6	16.2	37.8	0.0	16.3	0.0	25.5	10.7	6.8	3.5	9.8	31.3	1.7	8.7	248.4	19.6	4.3	46.7	6.2	26.8	8.2	35.5	2.3	14.3	20.0	12.7	12.9	17.2	28.9	274.7	21.0	4.2	0.0	7.2	13.2	20.5	5.7	19.3	28.7	0.6	10.5	12.9	0.0	16.3	20.7	0.0	48.7	13.8	13.6	47.7
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374551-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.0"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	15.1	18.9	13.3	14.3	14.7	9.0	20.2	11.6	12.8	14.9	14.2	19.7	15.5	9.9	18.6	16.1	28.1	14.4	12.5	13.4	13.3	12.4	14.7	9.0	25.7	21.5	14.6	7.8	15.9	21.5	86.0	9.2	24.2	28.3	14.5	15.4	21.6	15.9	14.2	7.3	21.8	16.0	12.8	19.1	19.3	13.0	9.2	13.2	24.0	16.7	14.2	23.9	14.1	18.8	4.6	7.8	10.4	11.4	3.6	7.1	3.6	25.9	16.7	13.1	10.2	28.8	20.7	20.9	25.3	22.0	22.5	22.1	8.4	31.1	31.3	15.1	21.7	26.1	57.4	15.6	16.1	22.0	22.3	8.4	10.7	16.1	12.6	20.5	33.8	20.0	18.9	24.4	23.8	18.3	12.6	19.2	17.2	20.3	18.6	29.9	19.7	24.7	19.4	19.2	38.0	13.5	12.4	30.1	10.1	24.0	20.0	12.6	16.6	21.5	25.5	26.7	16.4	11.6	20.0	20.6	23.6	16.7	36.2	23.3	20.6	25.5	8.6	21.0	16.6	21.1	0.6	7.9	5.9	5.6	11.4	5.1	4.6	5.1	5.6	7.8	2.9	5.1	7.1	10.4	3.6	7.7	7.7	5.1	3.6	13.3	14.7	11.6	12.8	13.3	12.4	14.6	7.8	28.3	13.2	6.0	21.9	13.7	20.2	0.0	11.2	0.0	17.8	13.4	12.5	41.8	3.9	12.4	6.6	15.2	2.6	11.3	7.1	0.0	16.4	22.4	13.2	30.5	3.5	10.4	25.8	4.8	7.0	27.0	63.5	2.1	15.5	18.5	0.0	10.8	26.6	18.1	22.0	15.8	15.2	5.7	9.1	12.9	0.0	10.4	17.5	0.0	16.0	13.8	14.9	41.4
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 112.2;Enterocytes: 112.9;Hepatocytes: 268.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.9;THP-1: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.5	6.8	3.2	0.6	0.0	2.0	4.0	4.6	5.5	0.2	1.2	13.3	1.2	1.0	3.2	5.3	4.4	7.7	3.6	1.7	2.1	1.6	0.0	0.0	10.7	2.3	7.9	3.6	4.8	18.9	7.8	0.8	1.1	4.1	0.0	3.4	2.0	0.2	3.6	3.6	3.6	7.4	1.6	2.5	6.6	3.0	0.7	6.3	1.6	2.4	1.6	11.4	1.1	0.4	0.5	59.5	0.7	1.0	2.0	3.4	8.7	0.6	1.2	2.9	10.6	9.0	3.3	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3	17.9	112.2	11.5	13.4	46.9	1.9	0.6	12.7	12.0	31.8	15.7	0.0	0.3	0.0	3.2	0.6	6.7	112.9	0.0	22.5	6.5	9.7	5.7	17.3	268.3	6.4	0.0	1.2	10.4	12.4	0.9	0.6	11.4	0.0	2.8	16.4	41.8	16.3	3.5	0.4	3.7	1.8	0.0	3.4	1.1	1.0	47.9	43.9	2.2	10.0	23.0
MFSD3		ENSG00000167700	"Major facilitator superfamily domain containing 3"	Q96ES6	8	144509074-144511213	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056013	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA056013: AB_2683009"	"unprognostic (7.92e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (2.00e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.44e-7)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	7.7	12.3	12.5	7.4	12.5	3.0	7.2	12.0	17.3	5.6	12.7	5.6	19.6	19.8	4.3	12.5	8.0	6.3	10.3	10.2	8.8	9.2	17.7	21.2	8.0	6.4	10.0	15.3	3.5	19.2	14.3	9.7	4.8	10.4	10.5	5.5	5.0	24.0	9.4	23.5	11.3	13.1	3.0	4.6	6.4	12.7	4.1	9.1	4.2	12.8	8.7	5.5	5.8	4.9	4.7	17.2	3.4	6.6	3.2	4.0	3.2	7.8	10.9	2.7	2.3	3.0	2.3	9.0	2.5	2.7	1.4	2.1	3.6	5.6	11.5	8.9	2.4	2.9	7.7	1.3	6.0	0.2	5.4	22.2	3.6	9.7	8.9	5.8	1.7	5.1	3.4	11.4	0.9	4.0	6.3	3.7	8.1	6.8	3.1	3.4	26.3	4.3	9.2	7.3	11.3	18.7	4.9	1.5	20.1	6.7	4.7	20.1	10.1	6.5	16.1	5.4	1.8	16.8	2.5	3.9	1.9	5.1	2.1	3.5	3.1	1.2	3.9	4.1	5.6	3.3	1.6	6.6	3.4	3.7	5.6	3.5	4.7	3.6	3.8	9.9	2.4	3.5	3.5	0.4	3.2	3.1	17.2	4.0	3.2	12.5	12.5	12.0	17.3	8.8	9.2	10.0	15.3	10.4	9.1	3.0	3.0	13.7	9.1	5.4	8.0	8.5	25.5	0.0	3.4	26.2	9.8	13.2	31.5	15.6	0.4	3.7	33.3	23.3	18.4	11.6	4.1	11.3	0.0	16.3	13.7	15.9	19.0	2.5	2.8	0.2	4.0	6.8	8.5	4.6	15.9	14.3	14.0	17.8	4.6	53.6	9.1	0.0	2.3	3.2	12.6	6.1	7.8	2.9	24.5	6.7
MFSD6	FLJ20160	ENSG00000151690	"Major facilitator superfamily domain containing 6"	Q6ZSS7	2	190408355-190509205	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022274	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA022274: AB_2142776"	"unprognostic (9.47e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.14e-2)"	"unprognostic (9.18e-2)"	12.3	26.9	20.8	9.3	23.3	4.2	13.8	19.4	33.1	15.3	20.0	29.0	29.0	12.6	7.1	22.3	26.6	13.0	10.3	11.1	25.4	26.5	7.4	2.0	16.9	8.7	36.2	22.9	3.5	10.9	28.2	35.7	5.6	43.1	15.7	19.0	12.2	19.2	29.6	3.8	18.9	15.4	9.5	36.7	12.7	20.2	4.9	18.3	13.0	25.5	10.8	12.7	13.3	13.6	2.4	2.6	8.1	2.0	3.3	5.6	1.2	10.6	6.6	0.2	2.3	4.8	6.2	9.1	5.5	11.1	3.7	4.7	2.4	13.6	16.7	2.6	11.4	7.0	18.2	3.2	9.6	4.2	33.9	5.0	8.9	6.5	1.2	1.9	3.5	2.8	0.9	17.5	5.5	3.6	12.2	1.3	13.3	2.2	18.6	0.9	4.1	16.3	0.7	1.5	11.6	7.1	3.6	0.5	14.3	7.1	19.5	21.2	5.4	7.8	18.4	10.6	0.7	6.0	4.1	5.5	0.6	1.3	7.3	8.4	8.6	3.5	6.0	6.1	7.3	3.0	8.1	2.0	0.6	2.6	0.6	2.7	2.4	3.5	3.6	2.6	1.3	1.6	3.6	0.1	3.3	0.9	1.3	5.6	1.2	20.8	23.3	19.4	33.1	25.4	26.5	36.2	22.9	43.1	18.3	29.8	21.2	3.9	9.9	5.7	8.3	17.9	5.1	108.4	37.5	22.7	7.9	0.1	0.0	12.6	37.9	12.8	13.4	0.0	17.7	0.1	2.3	15.4	22.1	0.6	4.2	27.0	34.0	11.1	2.1	9.9	5.2	9.2	8.5	4.6	38.6	7.1	20.1	17.5	4.9	1.3	7.7	0.0	3.1	0.9	1.1	15.9	0.0	10.2	14.4	19.0
MFSD9	MGC11332	ENSG00000135953	"Major facilitator superfamily domain containing 9"	Q8NBP5	2	102715840-102736888	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055293, HPA061859"	Approved		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA055293: AB_2682775, HPA061859: AB_2684627"	"unprognostic (1.27e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.28e-2)"	4.3	4.1	3.0	3.5	3.1	6.2	6.2	12.9	5.2	4.6	8.4	2.4	11.0	11.6	2.8	3.8	7.2	2.7	4.1	3.8	2.3	2.8	7.2	16.2	3.0	4.5	2.3	1.5	3.3	16.8	6.3	10.7	3.4	4.8	3.4	7.9	5.1	9.0	6.8	2.2	4.4	16.0	4.0	2.7	4.8	6.7	2.7	1.7	10.0	5.0	3.9	6.3	5.5	3.5	3.0	4.4	6.4	3.2	4.1	4.3	3.0	3.9	3.3	3.6	6.3	4.2	1.8	8.7	2.6	2.4	3.9	3.9	10.0	6.0	3.2	4.2	1.8	6.4	6.2	4.9	2.6	2.7	13.0	5.0	5.8	3.6	13.1	3.6	4.5	7.7	2.1	6.5	2.7	1.4	3.4	2.6	9.2	3.5	2.0	1.8	3.8	4.3	7.0	3.4	7.8	3.7	3.5	5.6	3.3	6.7	13.5	6.9	5.1	2.6	7.8	7.7	3.9	3.3	6.5	1.9	3.1	5.7	4.2	3.4	4.7	3.7	2.4	2.8	9.7	3.6	3.7	1.2	6.4	4.3	3.2	3.3	3.0	3.4	3.1	2.6	2.7	3.7	3.8	5.0	4.1	1.9	4.4	2.2	3.0	3.0	3.1	12.9	5.2	2.3	2.8	2.3	1.5	4.8	1.7	0.0	1.0	4.4	2.9	3.0	1.5	2.2	2.5	2.7	4.5	7.0	3.9	7.3	0.0	5.3	13.0	1.2	8.4	0.0	7.4	7.2	2.1	3.9	3.5	7.8	4.1	0.0	2.9	0.6	1.2	3.0	0.9	2.1	0.0	4.6	7.9	1.7	8.5	8.6	1.1	2.9	2.6	6.5	1.2	0.9	4.9	3.9	9.6	5.2	6.3	8.0
MGA	"FLJ12634, KIAA0518, MAD5, MXD5"	ENSG00000174197	"MGA, MAX dimerization protein"	Q8IWI9	15	41621224-41773081	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042278, HPA058183"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA042278: AB_10794647, HPA058183: AB_2683632"	"unprognostic (5.78e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.97e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.82e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.89e-1)"	9.3	11.3	13.8	13.6	15.3	14.3	13.0	28.2	16.9	14.5	10.1	13.3	12.2	6.8	14.2	11.5	9.8	11.3	7.8	10.1	11.2	7.7	10.1	8.5	8.5	12.7	18.7	10.5	22.7	12.0	18.0	27.6	12.4	13.7	11.0	9.7	7.2	10.3	10.8	11.8	11.2	10.6	11.8	16.1	12.5	9.8	16.4	14.7	22.4	13.9	5.3	13.4	11.6	11.5	5.0	4.1	4.9	4.9	9.8	5.0	1.5	1.4	8.5	10.7	7.0	8.4	6.7	8.6	4.2	4.3	5.1	5.0	9.0	5.0	10.0	7.7	4.9	9.2	5.9	16.5	3.7	7.0	4.7	5.4	21.3	14.0	8.0	7.5	19.5	10.6	5.1	4.6	7.0	7.0	2.1	6.5	9.8	24.7	4.6	4.5	4.1	11.8	7.6	6.6	4.3	4.4	13.4	10.9	5.2	2.7	6.1	10.2	9.9	15.1	5.3	2.7	8.2	4.3	12.5	6.9	6.1	8.7	6.3	5.0	6.3	9.4	9.8	3.9	7.5	3.0	4.9	2.3	2.5	4.7	1.8	4.6	4.8	3.7	5.0	2.4	5.0	3.9	4.3	1.2	9.8	4.9	4.1	1.8	1.5	13.8	15.3	28.2	16.9	11.2	7.7	18.7	10.5	13.7	14.7	20.8	17.5	20.6	9.5	7.0	24.2	25.5	5.1	20.1	21.6	12.2	31.4	14.6	6.6	10.4	11.7	15.0	7.0	23.3	4.6	10.4	12.5	11.4	13.9	8.1	10.1	12.7	7.5	15.4	11.0	4.6	19.2	11.8	8.5	2.8	9.2	13.5	7.3	11.5	19.4	4.2	21.2	38.8	13.4	27.3	40.0	9.8	21.7	17.5	10.5	8.7
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 61.2;pancreas: 15.6;salivary gland: 35.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 21.0;Late spermatids: 12.0"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	8	"OE19: 5.5;RH-30: 4.0"					"Low region specificity"	"Detected in many"			HPA055697	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.2	0.1	0.1	2.5	0.1	0.2	1.3	0.1	0.1	0.1	28.8	0.0	0.0	15.0	0.1	0.4	0.1	0.3	7.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.1	15.6	0.0	0.1	0.0	0.1	0.1	1.4	0.7	35.4	0.0	0.1	0.2	61.2	0.0	0.5	1.5	0.7	1.0	0.0	0.0	0.1	1.7	0.8	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.0	0.0	4.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MGAT4A	"GnT-4a, GnT-Iva"	ENSG00000071073	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A"	Q9UM21	2	98619106-98731126	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;HUVEC TERT2: 17.2;JURKAT: 30.7;TIME: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007608	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA007608: AB_10602008"	"prognostic unfavorable (4.30e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.48e-8)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.04e-1)"	8.1	5.1	11.3	11.9	15.6	49.2	8.2	28.5	14.3	6.1	14.6	8.3	6.8	17.6	5.2	4.1	4.1	6.2	8.0	5.1	11.3	10.4	17.1	6.0	13.7	16.7	9.9	8.3	2.9	26.7	33.3	14.1	11.9	10.4	6.6	15.8	5.6	14.5	4.4	3.3	3.4	38.5	7.2	16.1	7.0	8.4	3.9	14.3	20.3	6.4	3.1	11.6	8.3	5.0	2.0	9.3	7.6	2.9	7.7	19.7	7.4	3.0	0.6	1.2	2.6	0.0	0.0	46.0	0.0	0.0	0.3	0.0	7.3	3.7	0.0	6.9	0.0	0.9	0.1	2.5	0.3	0.0	3.6	2.8	0.1	0.0	12.7	0.0	6.1	2.3	0.0	1.7	0.0	0.2	0.1	17.2	30.7	0.5	3.3	0.0	5.9	13.3	10.7	0.4	2.6	0.5	3.3	0.0	3.6	8.9	6.2	3.7	1.2	0.8	11.5	1.6	3.4	2.7	8.3	27.8	0.0	1.4	0.0	0.9	1.1	2.5	0.7	0.0	9.2	0.2	3.3	2.9	6.6	12.3	0.5	15.9	2.0	14.9	13.7	2.0	1.1	19.7	16.1	7.6	7.7	1.1	9.3	8.4	7.4	11.3	15.6	28.5	14.3	11.3	10.4	9.9	8.3	10.4	14.3	50.6	31.3	18.2	18.4	8.9	20.9	11.7	10.2	5.3	13.6	21.0	3.9	3.9	18.3	15.5	10.0	32.8	84.5	0.0	25.8	66.5	5.4	17.8	12.7	8.5	53.2	46.1	50.8	20.3	30.7	13.9	2.3	33.8	10.1	10.0	34.5	13.6	22.1	48.9	2.1	25.6	4.8	6.5	5.1	2.8	3.4	9.3	12.5	74.0	30.1	20.1
MGAT4B	GnT-Ivb	ENSG00000161013	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B"	Q9UQ53	5	179797597-179806952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 125.6;liver: 100.0"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 212.8;Paneth cells: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"eosinophil: 8.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012804, HPA052134"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles, Cytosol"	"HPA012804: , HPA052134: AB_2681741"	"unprognostic (2.01e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (3.61e-3)"	"unprognostic (7.57e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.42e-1)"	13.2	22.8	9.1	19.5	8.2	9.5	18.7	15.3	13.5	8.7	77.3	5.9	10.1	61.7	9.2	10.4	16.8	10.7	26.0	20.6	9.5	5.4	31.9	100.0	17.1	15.6	6.3	5.2	9.1	13.4	10.3	8.3	14.4	6.3	8.8	30.9	10.1	19.2	8.2	8.4	12.1	125.6	7.5	4.9	12.5	22.3	11.2	5.6	7.0	16.6	14.6	10.0	9.5	13.7	0.9	0.6	8.5	0.7	0.0	0.6	0.2	20.8	21.1	10.4	24.1	32.0	17.2	18.1	12.4	24.9	11.3	8.9	23.1	58.2	3.5	31.9	28.6	50.4	15.8	15.2	27.9	8.6	29.2	8.1	10.7	19.2	20.1	22.6	13.5	3.3	18.6	19.6	11.5	14.3	44.4	23.2	4.2	6.9	9.6	19.0	23.3	2.0	11.2	6.4	31.9	8.5	5.2	8.3	9.9	33.9	40.6	17.2	10.1	18.6	19.3	33.4	9.2	13.2	13.7	28.3	28.6	12.7	16.0	19.8	8.2	9.4	8.8	34.3	17.0	20.6	0.0	0.7	8.5	0.3	0.1	0.1	0.0	0.5	0.2	0.6	0.9	0.4	0.6	0.3	0.0	0.5	0.5	0.0	0.2	9.1	8.2	15.3	13.5	9.5	5.4	6.3	5.2	6.3	5.6	11.9	8.6	8.5	16.0	11.1	15.5	21.6	25.5	0.0	5.7	26.2	3.9	6.8	3.3	60.0	0.5	14.3	212.8	0.0	46.0	9.9	10.4	29.2	4.7	75.0	15.1	28.6	22.0	31.9	17.0	1.6	14.1	11.7	10.1	18.0	64.6	23.5	79.0	114.3	15.9	20.7	10.4	12.9	8.6	1.6	4.8	10.5	11.7	5.0	102.6	39.7
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 99.1;Late spermatids: 74.0"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 11.0;SCLC-21H: 4.8;SuSa: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016418	Approved		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Vesicles, Plasma membrane"	"Centriolar satellite"	"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	1.0	3.0	5.5	1.0	12.3	1.1	0.9	4.9	12.8	1.3	1.2	2.5	0.4	0.9	1.0	10.9	1.1	1.1	1.2	3.6	9.4	3.9	1.0	0.9	1.0	0.9	3.0	9.3	0.9	0.9	0.9	25.9	0.8	10.6	1.1	1.2	0.0	0.9	2.4	0.8	1.0	1.0	1.0	4.3	0.9	1.0	7.8	5.1	0.0	18.0	0.0	0.8	0.9	0.6	0.5	0.3	0.8	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	11.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.8	0.2	0.1	0.3	0.2	0.0	5.5	12.3	4.9	12.8	9.4	3.9	3.0	9.3	10.6	5.1	6.0	0.6	0.0	0.1	0.1	9.7	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	74.0	15.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	3.9	0.0	1.6	0.0	0.0	1.7	0.6	0.1	0.0	0.0	0.0	0.3
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B"	Q3V5L5	17	76868456-76950393	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 28.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	1.1	1.2	9.3	1.1	13.4	1.0	0.9	4.4	28.1	1.0	0.9	1.1	0.0	0.8	1.1	0.7	0.9	1.0	0.9	0.8	5.5	2.8	0.9	0.7	1.0	0.9	2.3	8.1	1.2	0.8	1.0	0.6	1.1	2.6	0.8	0.8	1.1	0.8	0.8	0.7	0.9	0.9	0.8	0.7	1.4	1.0	2.3	1.7	0.0	0.8	0.0	0.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	21.8	4.4	2.2	0.0	0.0	2.3	0.3	0.9	8.0	4.7	0.0	0.5	0.0	1.7	1.0	9.4	0.1	1.0	0.2	2.1	0.0	0.3	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.3	3.6	1.4	0.4	0.1	0.0	0.0	1.0	0.0	0.0	1.2	0.5	2.3	3.0	3.9	4.5	6.2	0.0	11.2	4.3	3.8	1.7	3.4	0.2	0.1	0.1	4.0	13.2	14.3	0.2	4.1	0.0	0.0	0.5	0.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	13.4	4.4	27.4	5.5	2.8	2.3	8.1	2.6	1.7	0.0	0.0	0.0	0.1	0.1	5.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	2.1	0.0	0.2	0.9	2.2	0.0	0.1	0.0	0.0	0.0
MGRN1	"KIAA0544, RNF156"	ENSG00000102858	"Mahogunin ring finger 1"	O60291	16	4616493-4690974	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 16.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 16.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007653, HPA008033"	Approved		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA007653: AB_1846304, HPA008033: "	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.04e-2)"	18.7	23.1	22.9	24.0	24.3	29.7	19.9	43.1	37.6	16.3	16.6	28.7	16.8	28.9	23.7	13.8	14.7	20.9	20.2	20.7	24.3	18.6	15.9	30.4	21.6	22.2	27.9	21.5	21.3	34.9	19.7	21.5	18.8	18.6	19.0	11.6	20.7	23.8	22.9	29.9	13.5	28.6	20.0	17.2	26.2	25.2	11.5	24.5	12.9	19.7	10.4	11.0	18.7	14.2	1.7	4.1	16.6	3.9	1.4	3.3	2.9	5.3	25.4	13.2	13.4	7.9	7.7	17.9	11.4	8.1	9.6	8.2	16.7	12.8	15.7	14.8	13.8	7.2	8.5	10.4	9.4	2.9	21.8	11.6	8.6	17.7	23.0	14.5	12.4	21.4	14.3	6.1	13.4	5.7	6.9	9.2	10.4	12.5	11.5	6.6	23.3	12.9	16.6	19.4	7.5	11.1	23.7	6.9	21.1	8.5	15.6	21.1	17.5	19.0	20.5	11.4	6.6	12.4	12.3	16.2	18.0	10.0	50.5	9.8	18.3	14.2	10.6	7.6	12.5	12.9	4.5	3.5	3.4	2.7	3.9	2.5	1.4	1.5	2.3	2.3	1.7	3.3	2.0	16.6	1.4	2.4	4.1	1.7	2.9	22.9	24.3	43.1	37.6	24.3	18.6	27.9	21.5	18.6	24.5	23.8	30.6	16.0	25.4	8.1	26.6	8.9	20.4	5.3	6.8	17.4	41.2	19.1	5.0	16.7	16.3	14.6	24.5	0.0	19.7	14.0	16.1	20.3	13.9	27.7	25.8	23.8	35.5	14.1	21.9	20.6	24.7	20.4	20.3	31.5	18.9	21.5	25.2	18.6	23.3	11.0	28.4	0.0	13.7	9.6	11.8	14.3	28.6	21.3	18.7	22.0
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 382.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 3471.1;Proximal tubular cells: 978.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 46.1;myeloid DC: 34.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 34.1;monocytes: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 342.0;ASC TERT1: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	127.9	106.0	18.5	10.8	32.6	9.5	116.8	10.3	14.0	9.3	39.7	9.6	2.6	17.0	4.1	6.4	19.5	6.9	26.6	12.1	19.6	13.9	56.9	382.8	42.0	2.7	18.9	8.9	3.1	12.4	0.8	5.3	8.7	18.4	23.5	28.3	3.0	14.7	8.2	8.9	7.0	15.5	11.5	20.1	0.9	10.3	6.8	12.0	0.0	69.9	13.9	3.6	32.6	37.2	0.2	34.1	2.7	46.1	0.0	0.2	13.0	0.0	30.6	7.3	8.5	342.0	132.0	0.0	25.1	25.7	13.7	21.3	11.6	51.3	0.0	3.0	32.1	43.1	0.1	19.0	40.2	12.4	0.0	2.5	10.4	17.0	40.7	79.9	20.2	0.0	85.6	44.8	41.8	44.1	34.0	24.0	0.0	7.3	0.0	29.4	6.2	0.0	8.1	60.9	0.0	24.3	0.0	4.3	13.8	30.8	60.5	1.3	1.1	39.2	25.2	1.0	41.3	27.1	11.4	15.1	14.1	1.9	27.7	32.3	0.0	0.0	0.0	46.4	32.3	0.4	2.7	46.1	0.4	0.0	7.0	0.1	0.2	0.0	0.0	34.1	0.0	0.0	0.0	1.5	0.0	1.5	9.6	0.2	13.0	18.5	32.6	10.3	14.0	19.6	13.9	18.9	8.9	18.4	12.0	247.1	493.0	46.4	120.5	22.8	0.0	5.3	738.8	293.1	502.7	68.0	0.0	2.3	154.2	22.7	20.8	14.2	262.1	46.7	371.4	189.8	162.1	379.2	32.4	3471.1	168.6	0.0	43.8	78.5	223.7	10.9	30.8	51.0	37.1	187.6	224.9	0.0	374.3	135.3	106.4	978.0	1.0	0.0	12.2	0.5	2.2	15.4	6.6	37.4	362.2	564.6
MGST3	GST-III	ENSG00000143198	"Microsomal glutathione S-transferase 3"	O14880	1	165630861-165661796	"Enzymes, Predicted membrane proteins"		"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 1846.4;Syncytiotrophoblasts: 1983.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 88.9;HDLM-2: 94.3;OE19: 97.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053311, HPA077929"	Enhanced		Approved	Nucleoplasm		NA	NA		40000	Nucleoplasm		"HPA053311: AB_2682108, HPA077929: "	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	42.8	30.8	52.5	9.7	30.5	19.0	51.2	17.9	56.0	18.4	39.7	18.4	19.1	65.2	19.5	101.8	19.7	20.6	26.5	133.6	38.1	33.9	45.2	29.5	20.8	11.0	44.2	37.6	22.7	17.7	11.1	18.3	30.9	39.6	21.2	40.4	20.3	29.8	20.6	87.2	15.6	53.4	24.7	38.7	12.4	29.8	19.4	23.3	2.7	25.7	41.8	8.2	19.9	17.3	21.3	35.1	20.7	47.0	15.7	38.0	40.7	22.2	16.3	17.7	13.9	62.1	37.3	88.9	18.6	30.0	14.5	25.3	17.0	29.0	1.4	14.7	22.7	14.3	27.2	4.3	18.2	14.7	94.3	11.1	3.4	12.8	7.7	17.5	5.3	7.5	31.8	14.7	20.0	7.7	28.6	23.6	6.1	8.3	8.5	27.1	4.9	5.9	12.3	38.7	97.4	21.0	5.6	7.6	2.8	76.5	20.9	13.7	16.8	18.7	24.3	37.0	37.1	18.5	26.2	21.4	18.0	10.7	12.4	13.4	6.3	4.3	0.7	33.4	14.1	11.6	10.4	45.7	20.7	30.1	37.0	30.3	21.3	38.0	33.5	35.1	19.9	24.4	26.7	9.8	15.7	47.0	15.1	32.3	40.7	52.5	30.5	17.9	56.0	38.1	33.9	44.2	37.6	39.6	23.3	95.3	125.6	83.1	202.5	202.9	129.1	591.8	331.2	242.2	134.2	528.7	251.3	1846.4	848.8	339.3	13.2	253.1	716.8	630.8	371.6	1154.8	298.4	174.8	89.0	248.3	760.5	123.9	146.8	184.8	114.8	21.3	359.3	238.2	492.6	405.8	197.9	162.7	335.4	599.7	375.8	841.2	122.6	498.0	374.9	15.6	33.3	203.4	1983.2	87.4	339.8	197.4
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	12.1	9.1	15.3	7.9	20.6	5.9	15.7	16.1	17.4	16.6	10.9	16.3	9.7	6.9	19.1	13.7	11.4	11.5	12.0	9.4	16.3	12.9	15.7	14.1	10.1	9.6	17.4	16.5	17.2	11.7	18.4	11.5	14.9	15.5	14.7	10.1	14.6	12.0	12.6	9.6	12.5	8.4	17.9	13.8	9.4	10.7	11.5	18.1	13.9	19.1	9.8	10.6	13.0	13.8	1.2	1.2	3.5	1.7	2.5	2.0	0.6	8.5	3.4	16.8	11.7	9.0	10.8	4.0	6.9	7.8	5.0	7.3	5.0	3.2	7.3	6.4	9.6	5.4	5.8	9.7	9.4	11.3	9.6	4.5	8.2	4.4	6.9	7.3	16.6	3.5	6.9	10.4	5.8	14.9	7.3	12.4	2.9	11.2	21.7	7.7	4.2	8.0	6.3	4.2	5.3	4.5	52.4	13.9	18.1	8.5	7.6	5.5	13.6	11.9	5.6	6.1	8.9	3.9	10.9	10.6	12.8	6.4	5.3	9.2	11.4	4.0	11.3	5.4	10.6	7.6	3.5	1.7	0.6	1.0	0.9	1.2	1.2	1.5	1.0	0.6	0.6	1.2	0.9	1.5	2.5	0.5	1.2	2.0	0.6	15.3	20.6	16.1	17.4	16.3	12.9	17.4	16.5	15.5	18.1	44.7	17.7	5.9	14.0	19.5	29.4	15.1	20.4	21.4	34.2	15.7	23.6	10.7	3.3	11.3	3.3	22.5	10.5	0.0	11.2	6.2	22.6	33.3	13.9	26.3	10.8	14.3	23.1	21.5	18.7	3.7	19.0	11.5	25.3	5.4	15.4	16.5	16.7	5.8	23.3	14.4	14.7	0.0	23.4	16.7	11.5	21.5	21.2	10.1	9.4	14.4
MICB	PERB11.2	ENSG00000204516	"MHC class I polypeptide-related sequence B"	Q29980	6	31494881-31511124	"Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Cytolysis, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 26.5"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 23.3;Hofbauer cells: 9.9;Kupffer cells: 12.9;monocytes: 10.0;T-cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.6;U-266/84: 26.5"									HPA064618			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA064618: AB_2685301"	"unprognostic (3.63e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (7.04e-5)"	"unprognostic (2.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.94e-9)"	"unprognostic (1.91e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.21e-2)"	3.3	1.2	0.8	9.1	0.8	6.1	3.5	3.0	1.0	1.8	1.6	0.9	0.0	1.0	2.1	1.3	2.1	1.1	1.7	2.2	1.0	0.6	2.9	1.3	6.9	7.8	1.2	0.8	1.3	2.9	0.2	0.6	0.8	1.2	1.1	1.9	1.1	1.9	0.7	0.8	1.0	5.0	1.7	1.5	11.7	1.4	2.3	1.1	8.1	2.4	0.7	8.1	3.2	26.5	2.2	2.1	4.1	4.8	1.9	4.4	1.9	2.4	0.8	0.0	0.0	1.5	2.5	0.0	1.7	1.7	2.2	2.9	0.0	0.3	2.8	6.2	3.2	7.1	0.6	0.7	2.9	0.8	2.4	2.6	3.2	0.5	1.1	0.5	1.0	2.7	3.1	0.6	3.8	2.2	2.3	1.4	4.4	3.3	5.9	2.6	0.0	0.9	4.2	0.3	0.0	0.4	3.4	0.0	5.9	2.6	0.1	0.0	0.0	1.1	0.0	0.5	0.9	1.5	1.2	1.4	1.7	0.0	1.5	0.0	11.6	26.5	6.2	0.4	8.7	3.7	4.1	3.1	4.0	2.9	3.6	3.6	2.2	2.9	3.9	2.1	2.0	1.6	3.1	3.1	1.9	4.8	1.3	4.4	1.9	0.8	0.8	3.0	1.0	1.0	0.6	1.2	0.8	1.2	1.1	3.0	1.0	5.1	0.6	2.6	0.0	0.3	2.5	0.0	1.2	0.0	0.0	0.1	1.7	1.2	0.0	1.9	0.3	23.3	0.6	0.2	3.3	1.7	0.0	0.0	9.9	0.0	0.0	3.1	12.9	0.0	0.3	8.1	1.7	10.0	0.7	0.0	1.5	2.0	0.4	0.3	0.0	0.0	3.9	0.7	1.5	1.0	0.1	10.0	1.7	1.1
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604214	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	14.8	32.4	23.9	23.5	23.2	20.9	22.9	28.6	25.4	19.5	25.4	17.3	16.1	18.0	16.7	21.1	19.9	17.8	16.3	41.7	22.9	24.1	52.8	24.5	15.6	16.8	23.4	25.6	17.0	16.9	19.5	30.3	31.2	20.6	20.3	23.9	14.5	16.9	23.6	39.6	15.5	21.0	14.7	28.1	19.4	20.1	17.5	22.6	25.2	26.3	25.6	19.4	15.6	15.4	33.2	21.8	26.5	23.5	22.8	30.7	17.2	11.8	6.8	16.2	10.3	14.5	19.5	14.0	20.1	16.5	21.5	15.0	9.9	19.2	18.5	13.1	19.1	11.1	15.9	15.9	16.9	29.7	18.7	16.5	31.9	7.4	11.4	17.5	23.9	18.6	16.8	16.8	12.1	8.6	19.3	14.3	17.5	11.2	8.3	35.0	10.2	15.9	22.8	11.0	41.9	10.8	17.5	41.4	12.3	42.3	9.7	13.1	10.1	13.7	16.2	13.0	14.8	15.8	22.6	17.6	9.4	8.4	19.0	16.5	6.2	8.2	13.5	9.2	20.0	23.2	22.1	20.1	26.5	26.1	23.5	24.1	33.2	23.0	26.0	21.8	20.8	20.9	26.0	18.7	22.8	19.3	20.1	30.7	17.2	23.9	23.2	28.6	25.4	22.9	24.1	23.4	25.6	20.6	22.6	35.7	23.2	29.6	35.2	26.7	24.7	68.6	30.6	50.9	37.5	48.8	21.6	50.6	122.7	36.4	20.1	21.0	30.6	23.3	23.9	37.2	35.7	25.7	24.3	21.3	32.4	39.7	29.2	19.6	34.1	10.0	31.4	30.0	45.5	39.7	26.0	60.5	29.6	54.7	33.9	82.6	49.4	58.2	27.8	59.5	48.0	22.3	58.8	35.4	29.2	26.8
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 65.2;Ito cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 57.2;AF22: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002878, HPA003715"	Approved		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	13.4	3.6	6.5	10.4	8.4	0.3	8.6	16.3	7.1	17.5	21.5	3.8	11.7	7.7	17.9	11.3	12.2	7.7	13.1	13.2	6.2	4.2	7.9	4.9	10.4	4.2	4.5	3.7	12.0	4.8	2.7	6.6	7.8	4.9	14.6	12.8	15.9	7.1	19.1	2.8	3.9	8.7	30.6	2.6	1.3	5.3	6.5	4.1	0.8	6.2	7.1	5.8	17.1	20.5	1.0	0.7	3.3	0.0	0.0	0.1	0.1	12.3	57.2	43.3	6.6	2.5	3.6	5.3	7.7	6.5	8.0	8.2	10.5	3.7	4.2	2.5	7.0	22.4	8.5	3.5	5.4	6.0	0.2	5.2	0.9	8.1	0.2	1.1	0.0	0.2	4.1	2.8	5.2	5.5	7.5	7.6	1.9	0.6	0.7	3.1	2.0	1.6	0.1	13.8	1.6	4.2	1.2	11.0	0.0	5.9	11.4	3.0	1.1	3.3	9.8	3.6	14.6	6.8	0.0	4.8	2.6	0.3	13.4	6.8	0.6	0.3	0.1	5.7	0.0	12.9	0.1	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.1	6.5	8.4	16.3	5.2	6.2	4.2	4.5	3.7	4.9	4.1	32.8	16.5	0.0	25.6	19.1	7.7	4.1	7.6	14.7	21.6	22.7	17.7	7.1	1.7	12.3	1.5	24.5	14.4	0.0	7.5	22.8	11.8	5.9	1.1	5.4	1.4	65.2	11.6	85.3	4.4	4.5	27.9	1.1	3.3	0.0	8.1	44.8	5.7	14.4	38.9	1.4	2.5	6.5	2.3	0.2	1.9	8.8	16.7	0.0	18.0	51.2
MIDN		ENSG00000167470	Midnolin	Q504T8	19	1248553-1259140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 13.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 13.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042018, HPA049432"	Uncertain		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA042018: AB_2677800, HPA049432: AB_2680765"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.19e-2)"	28.0	32.6	9.7	22.7	16.1	59.4	16.6	8.9	19.5	19.5	24.7	17.6	12.6	19.0	14.1	14.2	38.7	28.3	40.8	27.8	10.4	9.8	17.9	19.3	28.7	19.9	10.2	6.5	36.7	20.0	8.2	32.7	19.7	22.3	20.1	11.1	19.5	18.8	22.2	48.2	26.6	31.6	14.6	14.6	30.7	21.9	10.5	9.2	28.6	14.0	31.3	34.5	19.4	20.1	0.4	0.5	13.5	1.2	1.4	1.2	0.6	5.2	11.6	19.9	9.2	4.2	7.3	14.6	9.1	5.5	4.7	3.3	15.1	5.9	8.4	10.0	6.8	2.5	10.8	6.0	9.7	1.8	11.7	11.0	11.7	7.6	11.8	8.7	11.8	17.5	11.2	9.1	5.6	5.4	7.3	7.7	10.0	15.0	8.8	4.9	21.0	15.7	4.8	43.7	10.3	7.7	24.5	5.6	3.8	8.8	6.2	16.0	20.9	19.3	18.6	12.0	10.8	7.4	13.5	9.5	8.6	9.6	39.5	9.8	8.4	4.5	11.4	16.5	5.3	29.2	1.1	1.2	1.2	1.2	1.2	0.8	0.3	0.4	0.8	0.5	0.4	0.2	0.6	13.5	1.4	1.2	0.5	0.1	0.6	9.7	16.1	8.9	15.5	10.4	9.8	10.2	6.5	22.3	9.2	35.7	74.9	43.3	105.5	87.8	56.5	71.4	104.4	30.8	33.0	127.4	29.5	12.3	16.6	100.6	27.2	122.8	266.9	0.0	134.4	37.6	65.2	167.2	60.0	71.2	67.2	20.6	157.9	183.5	91.3	20.0	46.1	71.9	40.5	13.6	163.9	48.5	185.5	221.8	31.1	33.6	32.7	38.8	178.2	2.7	14.0	129.5	68.0	56.7	123.5	150.3
MIEN1	"C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4"	ENSG00000141741	"Migration and invasion enhancer 1"	Q9BRT3	17	39728496-39730787	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"OE19: 214.8;SK-BR-3: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056650, HPA061344"	Approved		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Centriolar satellite, Cytosol"	"HPA056650: , HPA061344: AB_2684484"	"unprognostic (2.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.22e-3)"	16.9	18.6	27.0	16.7	38.6	23.2	19.8	14.9	26.1	12.4	25.2	18.0	37.5	30.2	13.6	19.1	26.3	17.2	19.4	37.2	25.8	21.8	32.2	40.6	16.1	19.7	27.1	17.5	11.7	26.3	14.1	18.9	27.0	18.3	23.5	13.9	12.5	45.6	30.1	24.5	16.0	26.8	11.5	27.2	17.3	32.8	18.6	20.9	21.4	34.5	17.5	14.9	15.6	19.6	41.2	37.8	59.2	45.4	23.7	40.4	48.1	4.6	9.1	1.9	4.4	3.2	2.1	2.1	4.9	3.7	4.5	4.2	2.4	3.6	3.5	6.8	2.6	5.0	5.9	2.1	2.5	1.0	6.8	10.0	3.1	4.3	5.4	5.9	4.2	5.0	2.4	4.5	2.0	1.7	2.5	3.0	8.0	4.7	6.3	2.4	3.7	9.1	4.9	1.5	214.8	4.4	3.9	3.0	7.2	2.0	3.1	5.8	5.4	5.1	64.0	8.7	1.4	8.3	5.5	5.1	2.0	5.2	9.8	5.5	7.8	7.1	6.7	9.0	5.2	4.0	51.7	37.3	47.1	38.0	43.9	21.6	41.2	27.0	33.8	25.9	35.7	20.5	30.2	59.2	23.7	45.4	37.8	40.4	48.1	27.0	38.6	14.9	26.1	25.8	21.8	27.1	17.5	18.3	20.9	41.7	48.6	67.4	114.7	53.3	25.2	45.2	58.6	85.6	33.0	94.2	3.9	131.8	257.0	122.9	87.4	56.2	154.8	46.7	153.4	61.5	51.5	183.7	80.7	101.9	128.4	33.4	181.2	58.3	96.9	55.5	39.1	66.0	131.6	84.8	136.7	78.2	163.9	235.0	46.7	153.1	13.5	45.3	67.4	80.7	70.9	61.5	222.5	83.1	110.2	164.5
MIER2	KIAA1193	ENSG00000105556	"MIER family member 2"	Q8N344	19	301444-344815	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041439	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041439: AB_2677481"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.89e-4)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.71e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (7.22e-6)"	"unprognostic (8.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.68e-2)"	15.5	6.8	9.1	9.3	11.8	4.3	9.7	14.4	12.5	8.6	7.5	10.0	6.6	9.8	12.0	7.8	9.4	7.9	8.5	9.1	9.8	6.7	6.4	3.4	12.5	8.5	9.1	7.8	8.5	11.6	3.7	9.8	13.5	9.1	10.9	3.3	8.3	12.9	10.9	17.0	18.4	9.3	6.4	6.4	17.2	10.3	31.5	12.1	4.6	8.3	7.1	6.6	9.1	16.5	2.2	6.6	6.4	5.8	1.6	3.3	3.0	8.9	5.7	5.1	5.9	1.9	2.8	11.1	7.4	3.5	5.6	5.9	8.8	2.9	4.7	4.0	3.8	2.2	7.7	3.3	4.3	1.7	11.2	15.8	2.8	4.5	6.6	5.6	0.0	22.2	3.6	3.3	4.5	1.6	3.7	6.3	6.4	7.8	0.0	3.1	9.5	7.3	10.0	13.2	2.7	0.0	6.4	1.7	1.2	2.7	5.1	8.2	7.4	4.3	3.2	7.3	3.2	3.7	5.0	6.6	7.6	5.3	11.6	8.2	13.6	6.7	3.8	7.2	4.0	7.5	6.4	5.8	4.2	2.0	5.2	1.8	0.9	2.7	3.0	6.6	2.2	3.3	2.2	0.5	1.6	5.8	3.7	1.1	3.0	9.1	11.8	14.4	12.5	9.8	6.7	9.1	7.8	9.1	12.1	0.0	4.8	6.0	10.5	10.0	6.4	1.1	7.6	2.7	3.4	3.5	15.7	19.2	1.7	7.9	4.7	8.7	3.5	0.0	4.8	14.6	4.7	8.4	0.0	1.6	9.0	3.2	10.3	9.8	7.0	13.3	5.8	6.5	5.0	4.6	4.2	6.6	6.4	6.2	5.3	1.0	11.5	6.5	4.2	17.7	25.6	9.4	24.6	5.2	4.9	11.3
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 9.0;Club cells: 5.7;Collecting duct cells: 7.0;monocytes: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favorable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	10.1	14.3	7.7	11.5	10.2	17.3	6.8	17.6	16.0	5.6	17.2	8.9	14.6	23.7	7.6	8.7	11.5	7.1	13.3	24.4	7.9	11.6	7.6	7.4	5.2	7.5	9.0	10.9	8.4	6.8	7.5	8.5	3.1	9.4	9.3	5.5	8.7	11.1	12.3	13.0	9.8	21.6	9.0	7.6	7.1	9.9	7.0	7.2	8.0	9.6	5.3	10.8	10.0	9.8	2.8	3.9	8.5	3.1	1.2	6.5	2.2	4.0	8.3	2.6	13.0	7.1	3.7	5.8	7.3	5.5	8.4	5.3	7.2	8.5	6.1	3.3	5.6	7.3	19.3	3.5	5.4	1.3	5.6	5.1	4.4	16.2	5.3	7.9	5.0	10.1	5.2	4.3	7.6	3.9	2.7	5.8	5.8	6.4	2.6	4.5	10.6	5.0	10.3	6.0	9.7	12.1	10.3	7.6	10.1	4.4	7.8	8.2	5.8	8.1	12.9	4.5	1.6	9.3	5.4	5.7	5.5	6.3	9.1	5.5	3.5	5.1	5.7	7.8	4.0	6.4	8.5	2.6	2.4	3.0	3.1	6.5	2.3	2.2	3.9	2.9	2.8	2.2	1.3	4.8	1.2	1.7	3.9	1.9	2.2	7.7	10.2	17.6	16.0	7.9	11.6	9.0	10.9	9.4	7.2	3.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.7	7.0	0.0	2.5	1.7	4.7	0.0	0.0	0.0	0.0	4.0	1.9	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	6.4	0.0	0.0	4.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0
MIIP	"FLJ12438, IIp45"	ENSG00000116691	"Migration and invasion inhibitory protein"	Q5JXC2	1	12019466-12032045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"HDLM-2: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044948	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044948: AB_10795887"	"unprognostic (1.36e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (8.02e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	13.2	9.4	12.2	17.0	17.3	53.4	10.8	13.7	15.3	11.1	11.4	11.9	11.6	11.0	16.5	8.8	11.1	13.0	8.9	13.3	12.9	10.1	9.2	11.7	13.3	18.3	15.9	10.6	20.4	13.5	5.8	7.1	14.6	17.0	11.3	4.5	8.5	18.1	14.2	26.3	14.8	12.7	12.3	11.0	20.4	10.0	18.2	15.2	10.5	22.5	9.7	12.5	12.3	11.9	14.8	45.0	18.3	27.1	10.6	19.0	12.5	5.0	3.4	2.7	5.2	1.4	1.6	9.4	2.7	1.4	5.4	4.1	6.6	8.1	6.4	6.6	1.4	3.8	5.3	2.0	3.1	0.7	90.6	7.5	4.0	5.4	7.0	3.1	6.1	12.4	2.2	4.0	4.7	2.1	0.9	3.0	8.8	11.9	5.9	1.6	5.1	6.0	9.1	4.8	3.7	5.1	8.6	3.4	9.8	2.3	1.5	5.0	5.3	4.0	5.1	9.8	1.5	3.4	10.6	3.2	5.0	5.3	9.9	4.2	5.0	6.3	8.6	3.2	10.7	5.0	4.9	23.2	7.1	9.0	25.9	8.4	14.8	9.3	7.8	14.2	13.0	5.8	4.5	18.3	10.6	27.1	45.0	19.0	12.5	12.2	17.3	13.7	15.3	12.9	10.1	15.9	10.6	17.0	15.2	11.9	7.7	14.7	6.9	11.6	14.2	5.0	2.5	6.7	2.3	8.7	7.9	31.4	21.6	13.8	26.0	9.8	14.7	23.3	15.9	82.3	17.4	10.1	17.3	12.5	36.1	7.9	16.0	9.2	17.8	38.7	7.8	20.3	15.1	64.1	9.7	14.2	13.7	14.4	6.3	10.1	14.5	12.9	14.7	14.7	41.9	15.1	27.7	20.8	13.4	5.9
MIPOL1	CCDC193	ENSG00000151338	"Mirror-image polydactyly 1"	Q8TD10	14	37197913-37552361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 99.0;Club cells: 96.7;Early spermatids: 128.1;Late spermatids: 106.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002893, HPA050179"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA002893: AB_1079386, HPA050179: AB_2681043"	"unprognostic (3.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.61e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.85e-2)"	5.8	6.1	8.8	4.5	8.4	1.5	8.6	2.1	11.1	14.0	5.7	1.4	7.8	3.0	9.3	5.1	7.4	7.6	7.0	7.0	8.1	3.9	8.9	4.2	5.3	1.1	4.6	8.4	13.2	8.7	12.6	24.4	3.2	6.6	13.7	4.7	4.6	8.0	9.1	10.1	4.2	3.2	13.7	7.6	2.7	7.5	14.7	8.0	0.0	11.2	5.4	1.7	8.7	15.8	0.8	0.8	4.2	0.3	0.5	0.5	0.3	3.9	1.7	0.6	5.7	4.2	7.0	0.0	3.7	2.4	3.2	4.7	2.2	2.4	0.0	3.6	3.1	1.3	4.7	0.0	5.0	4.3	0.0	6.0	0.0	2.9	9.7	2.7	0.0	0.1	4.5	5.3	0.8	10.2	3.9	19.6	0.0	7.7	0.1	4.7	4.0	0.0	0.0	2.4	2.6	12.7	0.0	0.6	0.0	4.6	4.5	4.9	0.0	4.7	4.1	4.3	4.4	5.1	0.0	10.2	0.0	3.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	7.3	1.1	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.2	0.1	0.8	0.4	0.3	4.2	0.5	0.3	0.8	0.4	0.3	8.8	8.4	2.1	11.1	8.1	3.9	4.6	8.4	6.6	8.0	71.5	49.9	0.9	13.5	3.8	14.5	12.3	12.7	99.0	96.7	8.7	49.1	0.0	8.3	3.6	128.1	5.3	0.9	0.0	6.1	0.1	5.3	14.0	43.0	2.1	0.1	11.1	8.7	4.3	1.0	106.6	7.8	1.8	6.8	0.0	2.1	5.8	9.4	0.0	8.5	3.6	25.3	0.0	5.2	29.2	13.6	5.5	0.0	2.2	2.7	7.6
MIS18A	"B28, C21orf45, C21orf46, FASP1, hMis18alpha"	ENSG00000159055	"MIS18 kinetochore protein A"	Q9NYP9	21	32268219-32279069	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 118.1;Spermatogonia: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA018286, HPA020585"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA018286: AB_1845693, HPA020585: AB_1845694"	"unprognostic (1.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.28e-1)"	5.5	7.5	7.8	6.6	10.7	13.8	7.4	16.4	8.3	6.1	8.9	5.4	1.9	7.9	6.6	6.3	11.4	5.6	5.3	3.9	6.8	4.7	6.7	5.7	3.7	9.7	6.8	9.3	9.8	5.8	3.3	4.3	7.1	6.6	5.5	10.6	4.4	6.0	4.1	4.0	7.8	8.5	7.7	6.2	7.3	6.1	26.6	5.4	19.3	3.9	6.8	11.3	5.3	6.5	18.5	13.2	8.2	11.7	10.4	15.5	6.4	21.1	5.3	15.3	14.6	2.3	4.0	23.5	11.2	5.8	11.0	9.6	10.5	11.8	23.2	8.3	4.2	13.3	7.2	15.0	8.5	13.3	13.2	16.6	26.6	5.6	13.5	1.5	22.7	9.0	1.7	3.7	9.2	6.7	3.6	7.7	23.7	30.9	19.6	10.7	14.5	26.0	20.7	31.6	14.7	15.5	22.8	22.9	21.7	7.6	7.3	18.4	9.1	17.1	14.6	10.5	11.5	17.6	13.9	4.5	13.9	25.7	10.8	11.5	10.6	16.8	29.3	8.9	36.6	12.5	2.4	5.3	8.2	10.2	6.8	10.2	18.2	11.2	11.7	4.9	18.5	15.5	11.5	1.7	10.4	11.7	13.2	14.6	6.4	7.8	10.7	16.4	8.3	6.8	4.7	6.8	9.3	6.6	5.4	17.9	6.2	11.5	6.8	13.9	10.1	5.2	5.1	10.7	5.7	10.4	3.9	29.4	11.6	9.4	4.3	6.8	2.0	0.0	10.7	41.8	12.1	4.6	3.5	7.3	14.5	7.9	5.8	14.1	5.4	5.3	9.8	6.3	5.0	6.4	17.5	9.7	8.2	7.8	9.6	13.7	7.4	19.4	6.6	118.1	79.0	12.9	12.2	8.9	15.3	3.5
MIS18BP1	"C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1"	ENSG00000129534	"MIS18 binding protein 1"	Q6P0N0	14	45203190-45253540	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA006504	Approved		Approved	Nucleoli,Cytosol		NA	Yes			Nucleoli	Cytosol	"HPA006504: AB_1078317"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-1)"	10.3	5.2	5.1	22.5	5.7	26.3	14.1	1.8	5.7	9.0	11.8	2.3	7.6	6.0	9.8	9.5	10.2	8.6	5.7	5.3	5.1	2.8	5.0	4.3	14.3	23.9	4.5	4.1	12.5	7.1	1.8	5.2	9.5	6.7	7.9	7.6	1.9	12.5	10.2	3.0	8.4	10.7	7.3	10.2	22.5	6.9	9.5	3.1	38.4	7.1	8.2	15.5	8.2	7.7	13.1	14.7	23.6	22.6	4.5	4.8	4.0	21.0	7.9	16.5	7.2	5.1	7.3	12.2	14.6	7.7	12.2	15.2	4.2	20.4	29.1	6.4	7.2	5.2	14.8	9.7	7.4	23.0	15.3	6.1	17.4	9.8	5.4	3.4	40.1	16.3	5.2	3.0	7.2	6.8	7.9	14.8	5.6	7.6	6.9	11.8	7.7	16.7	17.7	12.5	10.4	9.9	20.0	6.7	11.2	6.2	8.8	11.6	5.1	5.9	10.0	5.3	10.3	11.9	23.0	8.1	6.5	19.8	7.9	6.4	6.2	8.2	13.6	3.6	16.8	9.1	23.6	14.2	16.2	3.9	13.2	4.1	13.1	3.6	3.2	9.6	12.9	2.4	2.5	8.5	4.5	22.6	14.7	4.8	4.0	5.1	5.7	1.8	5.7	5.1	2.8	4.5	4.1	6.7	3.1	23.8	23.8	43.1	9.7	17.9	7.9	11.8	10.2	20.1	35.2	8.7	15.7	30.2	5.0	11.5	2.9	28.7	11.1	23.3	9.7	38.0	14.2	17.4	41.7	6.7	32.5	0.0	26.5	30.1	69.4	3.6	51.2	58.2	5.0	70.3	23.5	4.8	11.1	34.8	57.0	3.6	8.2	0.0	14.2	67.2	107.7	23.1	16.2	47.3	24.4	11.0
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227054	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 23.9;lymphoid tissue: 8.9"	"Cell type enhanced"	"Detected in single"	17	"Melanocytes: 1.7"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Group enriched"	"Detected in some"	5	"cerebellum: 5.1;cerebral cortex: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;Hep G2: 13.3;SuSa: 3.1;U-698: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA005662			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.6	0.2	0.6	8.9	0.4	0.3	0.3	5.1	1.8	0.7	1.4	0.4	0.0	2.7	0.4	0.1	0.6	0.3	0.2	0.4	0.6	0.6	0.3	0.6	0.5	8.2	0.6	0.0	1.2	0.2	2.3	0.3	0.3	0.6	1.0	1.1	0.2	4.9	0.4	0.2	0.3	1.3	0.0	0.5	7.8	1.4	2.2	0.0	1.0	0.4	0.7	7.0	2.6	0.3	7.5	7.7	23.9	12.2	14.6	9.5	4.0	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.1	2.7	0.0	0.2	0.0	0.1	0.2	0.2	13.3	0.7	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.2	1.9	0.0	0.1	0.1	0.0	0.1	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	3.1	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	23.9	4.7	8.4	4.8	7.1	9.5	7.5	5.6	5.4	4.8	7.2	7.4	7.3	12.9	14.6	12.2	7.7	7.1	4.0	0.6	0.4	5.1	1.8	0.6	0.6	0.6	0.0	0.6	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0
MKLN1	TWA2	ENSG00000128585	"Muskelin 1"	Q9UL63	7	131110096-131496636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022817, HPA041810"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA022817: AB_1853974, HPA041810: AB_2677686"	"unprognostic (1.97e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.32e-1)"	22.7	21.1	22.1	15.7	27.6	12.8	34.4	27.5	25.8	18.8	15.0	11.7	26.6	14.2	19.3	19.8	11.8	19.6	11.6	16.7	21.9	14.4	23.0	22.8	19.3	18.7	26.6	17.5	23.2	12.6	20.9	28.8	18.2	25.0	26.4	12.2	10.0	18.1	28.9	28.6	15.4	13.5	20.8	30.3	13.1	14.4	16.9	24.0	14.7	18.0	9.9	12.0	17.8	21.5	2.3	1.6	12.4	1.6	0.9	2.3	0.5	8.3	9.7	8.4	8.5	20.9	18.8	5.1	8.1	18.9	9.3	11.9	4.4	7.2	8.7	5.5	10.1	18.3	5.8	8.8	7.7	15.2	8.4	4.3	3.7	7.5	5.1	10.0	6.1	5.4	11.3	5.5	12.5	6.3	10.0	8.4	5.4	13.6	6.3	11.4	3.1	7.2	6.6	9.6	6.8	5.1	4.5	10.0	6.0	10.3	4.9	4.4	9.4	15.9	15.9	7.3	9.2	3.1	7.7	8.6	7.3	4.1	13.1	6.6	15.4	5.7	14.9	25.0	7.4	10.6	1.2	1.0	1.7	1.6	1.1	1.2	1.2	1.5	1.3	1.0	2.3	2.3	1.9	12.4	0.9	1.6	1.6	0.9	0.5	22.1	27.6	27.5	25.8	21.9	14.4	26.6	17.5	25.0	24.0	47.6	36.6	23.7	26.7	39.2	45.2	21.2	38.2	10.7	22.7	43.6	66.8	14.7	6.6	17.8	2.6	48.1	26.9	0.0	20.5	13.9	40.1	45.0	33.5	67.6	18.7	50.9	35.6	60.2	36.9	3.6	63.0	28.4	33.7	24.4	27.8	54.4	22.4	31.9	79.2	25.0	67.1	84.1	41.9	34.6	26.5	40.1	12.4	26.1	25.0	33.3
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453040-140479569	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	16.8	17.6	26.8	20.8	28.8	69.9	20.1	37.2	32.6	20.4	39.6	16.1	19.7	28.4	20.1	18.6	23.3	22.2	22.4	38.5	24.9	29.8	20.6	17.5	23.6	18.3	25.7	23.3	24.9	27.3	28.2	21.5	31.7	29.4	21.0	33.7	19.4	24.8	23.1	38.5	24.4	26.6	26.3	20.5	22.5	21.7	95.4	20.2	21.0	23.6	18.8	22.3	25.3	36.4	13.1	7.5	39.3	10.5	12.8	17.8	6.4	28.4	22.0	17.2	25.5	27.3	23.9	24.3	19.6	25.5	15.5	17.9	9.0	30.0	20.7	30.8	19.1	31.0	13.9	19.3	21.6	19.7	40.9	16.7	21.5	13.2	16.6	22.0	18.4	33.2	23.8	32.6	17.4	16.5	25.6	15.4	14.3	16.9	26.1	14.8	24.5	21.5	32.9	44.2	24.0	16.3	15.6	14.7	31.6	24.8	33.0	23.8	24.6	24.6	33.4	35.1	26.5	16.4	16.0	21.8	10.9	8.7	26.5	17.9	62.3	45.6	18.1	31.2	28.9	22.4	19.4	9.2	39.3	6.7	8.7	8.0	13.1	13.0	10.1	7.5	10.9	17.8	11.3	18.1	12.8	10.5	2.5	14.0	6.4	26.8	28.8	37.2	32.6	24.9	29.8	25.7	23.3	29.4	20.2	47.6	30.4	57.3	58.0	72.9	58.8	51.3	63.7	33.5	43.3	40.1	33.4	63.4	87.9	55.8	227.6	33.8	112.4	256.9	59.7	76.6	47.0	74.5	36.9	38.9	53.2	112.8	93.6	40.5	91.7	263.0	61.5	68.3	65.8	87.4	100.7	52.1	52.9	123.8	58.7	39.1	43.2	45.3	49.5	153.2	47.1	83.4	115.4	66.0	96.2	100.8
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557014-12583713	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 562.3;Late spermatids: 587.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favorable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	13.7	10.4	15.1	11.1	18.3	16.4	11.6	29.3	19.5	13.7	12.7	12.4	16.1	12.5	15.2	12.3	16.2	13.1	10.9	26.3	14.0	15.1	13.7	12.5	12.1	12.6	15.2	14.8	20.8	26.6	17.3	11.9	14.4	16.0	11.3	11.5	13.2	12.8	13.1	24.5	12.8	10.9	15.9	16.2	10.1	11.7	46.1	14.7	15.4	18.2	17.0	13.7	13.0	12.6	21.3	19.0	30.0	20.3	25.3	26.2	18.7	10.7	12.5	14.9	11.2	23.3	22.7	28.8	16.7	17.9	21.3	17.9	12.0	10.7	15.3	9.6	18.4	9.8	6.6	19.3	16.4	19.0	17.3	16.3	21.8	14.3	16.1	26.9	21.4	9.9	25.2	15.3	24.8	15.6	19.1	17.4	21.3	20.3	21.7	18.3	15.2	26.2	11.1	9.9	10.5	22.0	25.3	14.4	17.2	14.9	14.3	8.7	14.8	14.5	7.4	14.8	11.0	16.8	19.0	17.6	14.6	14.3	17.3	22.6	16.5	33.7	32.8	15.8	25.7	21.9	18.9	17.2	30.0	21.5	15.6	26.2	21.3	22.1	22.0	19.0	16.4	23.9	22.3	15.0	25.3	20.3	15.1	23.4	18.7	15.1	18.3	29.3	19.2	14.0	15.1	15.2	14.8	16.0	14.7	17.9	8.1	9.3	8.8	8.5	14.5	12.1	2.5	17.4	11.4	5.2	3.9	16.1	16.6	13.6	562.3	11.6	7.3	0.0	14.7	16.7	10.4	6.8	18.5	5.4	13.3	11.1	2.4	6.7	9.8	587.8	19.0	7.9	15.1	24.4	11.9	18.1	12.7	12.9	19.4	8.1	12.4	12.9	14.7	60.0	42.8	8.2	13.5	9.6	11.4	7.9
MKRN2OS	"C3orf83, MKRN2-AS1"	ENSG00000225526	"MKRN2 opposite strand"	H3BPM6	3	12514934-12561059	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.1;epididymis: 8.8"	"Cell type enhanced"	"Detected in some"	10	"Cholangiocytes: 5.1;Ciliated cells: 8.1;Collecting duct cells: 3.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.4;CAPAN-2: 16.7;HBEC3-KT: 4.3;MCF7: 3.8;RT4: 7.0;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA065586, HPA065753"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA065586: AB_2685514, HPA065753: AB_2685553"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.03e-3)"	"unprognostic (3.81e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.53e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.17e-3)"	0.0	0.0	0.0	0.0	0.6	0.0	0.9	10.1	0.5	1.4	3.7			7.0	0.2	8.8	5.5	1.5	1.7	1.4	0.0	0.3	0.5	0.0	0.1	0.0	0.0		0.1	5.1	1.1	1.9	0.0		0.6	4.3		5.8	1.5	0.3	2.0	6.6	0.0	0.0	0.0	4.5	0.0			0.1		0.3	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	16.7	0.0	0.4	0.0	0.0	0.7	0.0	4.3	0.0	0.0	1.1	0.0	0.3	0.4	0.0	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.1	0.1	0.1	0.9	0.0	0.0	0.0	0.2	2.7	7.0	0.3	0.0	0.0	1.1	0.0	0.1	3.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.7	0.0	0.7	0.6	5.1	8.1	1.2	3.5	0.0	2.1	0.0	1.1	1.3	0.0	2.1	0.0	2.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	2.6	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.9
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565678-23630075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 12.6;Cone photoreceptor cells: 23.6;Horizontal cells: 6.4;Rod photoreceptor cells: 6.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 16.0;K-562: 17.1"	"Low region specificity"	"Detected in many"							HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	1.0	0.7	5.1	1.2	10.4	4.0	1.2	1.0	11.1	0.5	1.1	8.4	0.0	1.3	1.3	3.2	5.6	0.9	0.8	0.8	6.4	3.4	1.1	0.7	1.0	1.9	14.4	3.0	1.2	1.7	0.5	3.8	8.5	5.1	1.2	0.8	3.1	5.2	1.0	1.4	1.2	1.9	0.8	8.2	1.5	0.9	5.7	13.3	5.0	0.9	1.1	1.7	0.7	0.6	1.0	0.9	1.3	0.5	0.4	5.7	0.7	4.6	3.3	3.0	3.1	0.0	0.0	7.0	0.3	0.0	2.8	1.9	8.3	0.0	0.2	0.1	0.0	6.2	8.0	1.3	0.0	0.7	0.0	0.3	6.7	8.9	0.3	0.1	7.8	6.0	0.1	0.0	5.8	0.0	1.2	0.0	16.0	17.1	7.3	0.8	0.0	8.2	3.4	0.0	4.4	10.1	5.9	1.1	4.1	0.0	0.1	0.7	2.4	0.0	3.4	0.0	0.2	2.6	2.3	0.0	7.8	6.6	0.4	5.5	9.2	11.3	5.5	4.5	0.1	0.1	1.3	0.5	0.4	1.8	0.2	1.0	1.0	0.6	1.4	0.2	0.9	2.0	5.7	1.3	0.4	0.3	0.9	0.4	0.7	5.1	10.4	1.0	6.8	6.4	3.4	14.4	3.0	5.1	13.3	0.0	0.0	0.0	1.1	0.5	12.6	0.4	0.0	0.0	0.0	0.0	23.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.9	0.3	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	3.4	0.0	0.0	0.4	0.0	6.4	0.0	1.2	2.4	1.0	0.0	0.5	0.0	0.0	0.4
MKX	"C10orf48, IRXL1, MGC39616"	ENSG00000150051	"Mohawk homeobox"	Q8IYA7	10	27672875-27746060	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 21.3;prostate: 24.3"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 3.4;Ciliated cells: 6.7;Club cells: 2.3;Peritubular cells: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 19.3;BJ hTERT+: 11.1;BJ hTERT+ SV40 Large T+: 12.7;BJ hTERT+ SV40 Large T+ RasG12V: 8.7;fHDF/TERT166: 55.2;SiHa: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006927	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA006927: AB_1853981"	"unprognostic (2.04e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.38e-3)"	3.7	3.2	1.6	1.4	2.1	0.3	3.0	2.6	5.9	4.9	4.3	1.4	0.9	0.5	1.8	3.4	1.8	7.1	2.7	0.8	1.4	2.5	0.6	1.9	1.2	0.5	2.7	1.4	21.3	1.0	0.3	13.9	0.3	6.7	24.3	1.5	2.9	0.9	7.7	0.5	1.0	0.7	10.6	2.7	0.8	3.4	1.3	0.1	0.0	4.5	0.5	0.3	8.7	1.6	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.3	11.1	12.7	8.7	0.0	0.0	0.0	0.0	55.2	0.5	0.0	0.1	0.0	3.4	0.0	1.2	0.0	3.5	0.0	0.5	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	1.2	0.0	2.4	0.3	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	8.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	2.6	5.9	1.4	2.5	2.7	1.4	6.7	0.1	0.0	3.4	0.0	0.0	0.0	0.1	1.4	0.0	6.7	2.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0
MLF1		ENSG00000178053	"Myeloid leukemia factor 1"	P58340	3	158571163-158607252	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1"	"Group enriched"	"Detected in many"	15	"Early spermatids: 4250.8;Late spermatids: 9284.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in single"	12	"T-cells: 10.4"	"Cell line enhanced"	"Detected in many"		"A-431: 33.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA069479, HPA079339"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA069479: AB_2686140, HPA079339: "	"unprognostic (6.49e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.72e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (9.34e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.36e-2)"	3.5	2.6	6.0	1.8	11.9	0.9	5.3	3.4	7.1	3.1	2.7	6.5	0.5	0.8	4.9	5.6	3.5	18.3	4.9	41.4	6.3	6.3	5.7	1.2	5.2	1.0	4.9	6.3	6.2	3.1	5.2	10.4	1.0	20.1	2.0	1.7	2.8	2.2	1.6	53.6	1.8	1.3	4.5	4.7	1.2	1.9	101.1	5.7	0.0	5.3	18.9	1.4	4.2	1.5	0.6	0.3	0.4	0.3	0.8	10.4	2.3	33.7	4.4	11.4	0.0	6.0	7.1	3.4	3.5	3.3	12.8	11.7	0.0	19.2	0.0	13.4	6.0	18.7	6.6	0.1	5.9	17.1	0.0	7.4	2.0	3.3	0.3	4.1	0.0	2.5	4.4	8.7	6.1	3.4	13.4	3.0	0.0	2.5	0.0	8.4	4.9	0.0	0.1	2.7	18.0	9.9	0.0	6.4	0.4	9.8	2.4	14.7	8.7	15.9	5.6	16.7	11.7	16.2	3.4	1.1	12.0	12.2	14.1	13.6	6.1	3.8	0.0	8.7	0.0	8.6	0.0	0.0	0.0	3.6	0.0	1.6	0.6	8.3	8.7	0.3	0.3	2.1	4.4	0.4	0.8	0.3	0.2	10.4	2.3	6.0	11.9	3.4	7.1	6.3	6.3	4.9	6.3	20.1	5.7	23.8	26.2	2.2	109.9	39.8	12.6	168.2	0.0	238.3	60.3	19.2	31.4	0.6	61.3	22.4	4250.8	23.3	4.2	0.0	6.9	3.5	36.8	26.1	43.8	0.0	6.4	9.5	32.5	8.0	2.7	9284.2	64.7	13.2	21.9	1.8	14.3	25.9	7.6	14.4	47.4	27.5	58.5	19.4	36.9	440.7	150.0	29.9	1.4	8.9	10.3	65.9
MLF2	NTN4	ENSG00000089693	"Myeloid leukemia factor 2"	Q15773	12	6747996-6767475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010811, HPA010859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA010811: AB_1079389, HPA010859: AB_1079388"	"unprognostic (1.65e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.42e-1)"	"unprognostic (9.88e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.63e-1)"	31.4	45.6	55.8	23.3	65.4	36.9	24.9	50.5	100.5	28.6	30.9	44.0	23.9	36.5	32.1	30.5	39.3	31.7	28.6	44.1	54.4	47.2	37.9	77.4	24.8	21.5	40.2	42.5	28.3	33.4	43.3	31.1	32.5	44.8	38.4	27.6	28.2	43.1	36.7	45.3	33.6	35.1	35.9	33.7	21.8	27.7	21.0	30.7	26.0	36.3	28.9	29.4	29.3	23.6	17.0	38.9	86.7	20.1	11.8	14.8	16.9	39.1	64.9	33.4	58.7	31.3	31.9	51.3	38.6	46.4	66.4	58.3	62.7	38.9	28.3	10.2	50.2	43.4	32.9	41.0	55.8	41.3	44.5	38.0	20.0	34.4	35.9	34.6	21.2	27.6	29.8	45.6	51.3	39.3	48.8	27.0	27.0	25.1	11.8	46.2	55.6	29.1	32.8	107.8	42.5	22.4	18.6	30.7	25.1	55.4	49.5	21.3	42.2	34.8	61.6	37.3	73.7	17.9	35.1	26.6	39.6	52.8	41.8	56.3	14.4	16.3	37.6	52.9	18.5	46.6	35.4	20.1	73.9	14.8	18.0	14.3	15.3	11.5	13.9	22.6	17.0	12.2	13.5	86.7	11.8	19.5	38.9	11.2	16.9	55.8	65.4	50.5	100.5	54.4	47.2	40.2	42.5	44.8	30.7	35.7	25.7	57.9	127.1	121.2	102.4	55.8	104.4	45.5	36.4	104.7	39.3	229.6	237.1	156.1	7.9	68.0	134.5	0.0	110.6	175.2	95.0	155.3	83.1	146.5	129.4	76.3	96.6	62.0	41.9	7.0	105.6	62.0	97.8	201.0	116.3	120.9	125.1	111.0	100.8	262.4	48.7	51.8	117.9	51.9	90.7	109.8	357.4	59.8	120.9	152.3
MLH3		ENSG00000119684	"MutL homolog 3"	Q9UHC1	14	75013764-75051532	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060570			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060570: AB_2684323"	"unprognostic (2.94e-1)"	"unprognostic (6.70e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.35e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.11e-2)"	13.6	15.6	10.3	9.0	14.4	3.3	13.4	15.2	18.6	13.7	11.8	17.3	17.0	8.4	13.1	12.9	9.4	10.9	10.7	11.0	11.2	10.6	12.8	11.7	8.6	10.3	18.5	15.4	13.3	9.4	24.6	33.6	10.3	16.6	13.4	11.0	8.4	9.2	19.4	13.6	8.0	13.3	12.0	15.6	9.9	7.9	10.7	18.5	7.7	19.2	5.7	12.6	12.0	9.6	8.1	4.1	4.6	3.8	9.8	7.0	8.3	10.4	10.4	7.4	1.3	8.3	13.9	7.9	3.3	3.2	6.2	5.5	8.1	12.5	12.1	3.2	4.0	7.2	7.7	0.1	3.8	8.8	11.5	0.1	7.4	6.8	5.0	6.8	3.4	5.1	5.6	7.8	6.1	0.4	6.4	10.0	0.0	7.5	9.4	13.4	7.9	4.8	3.2	6.8	7.8	5.8	9.3	4.9	2.3	13.4	10.9	12.0	9.2	11.2	8.1	0.6	8.4	10.9	6.8	5.3	2.6	4.9	3.5	3.6	11.1	10.9	11.7	9.2	0.3	11.4	4.6	3.8	2.4	7.0	2.9	5.8	4.8	4.1	6.4	4.1	8.1	6.4	5.1	1.9	9.8	2.0	3.5	4.5	8.3	10.3	14.4	15.2	18.6	11.2	10.6	18.5	15.4	16.6	18.5	23.8	15.9	16.4	20.6	7.0	53.7	15.9	20.4	20.1	17.0	34.9	41.2	12.8	6.6	12.4	5.2	13.7	11.6	0.0	9.6	5.6	12.6	11.4	23.1	13.7	8.8	33.4	12.6	12.9	6.5	4.7	36.8	9.4	15.1	6.4	13.1	35.6	11.0	13.1	48.1	13.2	58.1	45.3	14.6	21.5	8.9	7.5	8.5	12.2	16.4	10.0
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 190.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 18.1;SK-MEL-30: 17.4"					"Low region specificity"	"Detected in many"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	5.7	1.9	4.2	0.2	5.2	0.1	1.6	0.8	11.5	0.8	0.5	0.0	0.0	0.3	0.4	3.5	4.9	0.5	0.8	61.7	1.8	0.8	0.5	47.4	0.4	0.2	7.2	8.3	0.4	0.6	0.3	0.5	0.2	1.8	0.8	0.4	1.3	2.6	0.3	101.9	6.5	1.1	0.3	2.9	0.3	0.4	0.5	0.0	0.0	2.7	31.6	2.2	0.6	1.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	0.0	18.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.3	1.2	0.0	0.1	0.6	1.3	0.0	0.0	0.5	17.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	5.2	0.8	11.5	1.8	0.8	7.2	8.3	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	190.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	11.7	0.5	0.0	0.0	0.0	0.0	0.3	0.1	0.0	18.3	0.0	12.7	0.0	0.6	1.5	8.2	0.3	0.0	6.8	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.2	0.1	1.8	0.0	0.0	0.0	0.1
MLLT6	"AF17, FLJ23480"	ENSG00000275023	"MLLT6, PHD finger containing"		17	38705542-38729803	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 244.7;Cone photoreceptor cells: 192.4;Rod photoreceptor cells: 215.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004021	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004021: AB_1853995"	"prognostic favorable (4.18e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.12e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-3)"	6.5	7.6	10.0	10.3	10.6	7.3	6.3	14.1	16.9	6.2	6.8	7.2	11.1	7.2	9.2	8.6	5.5	10.3	9.2	7.5	9.7		5.8	1.2	8.5	11.8	8.5	9.6	13.0	9.0	12.8	10.1	4.8	7.2	7.3	5.7	10.0	10.3	12.5	22.3	8.5	8.9	8.2	8.1	11.7	6.7	4.1	9.2	6.3	7.2	4.8	10.1	5.5	11.5	1.4	0.9	2.0	0.8	2.8	6.0	1.7	5.8	6.5	6.6	14.4	7.3	6.6	3.4	3.6	6.7	4.5	5.4	2.4	11.5	16.6	5.3	4.3	6.4	15.2	4.2	7.5	4.0	17.7	11.5	6.1	10.8	10.6	3.5	9.3	8.3	6.7	7.7	3.9	8.9	10.9	7.3	12.6	10.1	14.0	3.8	4.9	18.2	9.0	0.8	5.0	3.4	10.8	9.0	15.3	5.2	13.5	14.8	16.4	3.8	12.6	10.7	4.3	12.4	6.8	9.6	5.2	7.8	7.3	6.6	23.9	7.8	11.2	7.7	8.6	5.5	1.7	0.8	0.4	6.0	0.5	4.6	1.4	3.2	4.2	0.4	1.4	3.1	4.1	2.0	2.8	0.3	0.9	1.7	1.7											44.7	51.0	32.0	22.5	27.1	244.7	23.4	30.6	14.7	36.4	31.4	192.4	15.0	10.0	20.0	2.7	38.7	26.1	0.0	35.9	4.1	20.2	29.7	35.9	9.4	12.0	112.8	47.7	31.9	18.3	3.1	43.4	18.1	18.6	23.4	30.0	32.6	28.3	21.0	39.6	13.5	215.1	32.3	25.4	16.1	23.5	25.5	32.0	48.9	37.7	23.0
MLST8	"GbetaL, GBL, Lst8, Pop3"	ENSG00000167965	"MTOR associated protein, LST8 homolog"	Q9BVC4	16	2204248-2209416	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019935, HPA041841"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions"		NA	NA			Nucleoplasm	"Golgi apparatus, Cell Junctions"	"CAB019935: AB_561447, HPA041841: AB_2677701"	"unprognostic (2.19e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.70e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.60e-4)"	"unprognostic (8.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	12.4	18.6	24.0	11.9	22.8	15.7	10.4	23.1	39.1	11.6	14.4	15.7	12.5	16.6	9.9	14.0	15.9	17.4	12.6	18.4	23.9	18.5	15.5	17.9	9.1	13.3	20.7	20.0	16.0	32.3	11.1	12.6	15.5	16.1	14.4	6.8	17.3	25.5	13.0	36.6	13.5	13.9	8.7	14.1	10.5	15.6	25.5	13.3	13.4	20.8	13.9	11.8	13.2	9.0	8.5	14.8	2.5	18.6	7.4	9.6	11.5	7.2	20.7	8.6	21.9	11.3	8.0	14.2	5.9	8.1	10.4	9.6	28.0	10.1	18.6	15.0	7.1	4.3	8.8	8.7	18.0	1.2	14.1	39.7	12.6	20.5	18.0	16.4	19.3	17.8	11.4	12.9	12.1	15.7	8.5	11.1	25.8	18.1	12.9	5.5	30.3	18.3	25.8	16.6	6.2	19.3	19.2	8.6	32.6	7.8	4.3	27.2	13.9	9.8	22.2	15.8	3.3	13.1	18.9	7.8	12.2	13.8	9.8	8.0	14.8	8.9	20.3	6.0	17.1	10.2	0.0	15.2	2.5	8.5	18.6	6.6	8.5	7.5	9.6	14.8	7.2	9.0	9.0	1.7	7.4	16.9	8.2	7.2	11.5	24.0	22.8	23.1	39.1	23.9	18.5	20.7	20.0	16.1	13.3	6.0	13.6	23.8	14.5	13.1	30.3	3.0	10.2	10.7	6.8	15.7	19.6	58.4	29.9	30.2	39.4	11.9	36.0	23.3	37.0	37.8	20.1	13.3	8.1	14.5	41.0	28.6	27.6	19.6	22.1	78.3	13.8	14.5	16.9	34.3	26.7	26.0	26.7	37.4	14.2	30.7	24.7	19.4	15.5	24.7	25.4	13.6	44.1	18.7	37.1	11.1
MLX	"bHLHd13, MAD7, MXD7, TCFL4"	ENSG00000108788	"MLX, MAX dimerization protein"	Q9UH92	17	42567068-42573239	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025329, HPA052766, HPA064438"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.55e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.25e-1)"	21.3	19.2	10.4	12.6	11.9	8.3	22.5	10.3	14.3	12.3	32.2	10.8	15.4	27.5	11.0	15.1	18.8	10.5	19.2	38.1	9.8	9.8	23.5	34.7	19.0	18.6	11.3	6.6	10.4	36.8	8.5	13.0	13.7	9.4	13.4	23.1	11.6	18.5	14.8	43.3	15.6	42.5	12.1	10.2	18.7	20.6	7.4	8.9	20.3	23.5	24.9	19.7	16.5	13.1	14.6	26.3	34.7	33.5	12.8	18.2	23.0	15.8	18.3	14.4	14.6	22.0	25.4	10.0	23.8	21.1	25.7	23.3	16.5	16.5	19.1	16.8	20.2	23.4	24.0	26.2	15.4	22.6	15.1	24.6	19.7	13.2	18.3	25.9	26.4	28.5	22.0	17.2	20.6	18.9	17.4	18.9	23.1	21.5	17.1	29.3	21.0	37.0	13.0	10.2	39.3	16.6	16.8	29.9	20.4	20.8	19.6	22.5	11.2	10.6	13.7	26.7	20.0	28.1	31.3	13.4	22.9	14.8	25.0	35.1	17.4	19.7	18.0	25.7	16.9	26.9	14.2	25.0	34.7	14.3	30.8	15.8	14.6	14.8	14.3	26.3	11.8	13.1	13.1	32.3	12.8	33.5	14.1	18.2	23.0	10.4	11.9	10.3	14.3	9.8	9.8	11.3	6.6	9.4	8.9	62.5	76.9	37.4	23.4	37.3	27.5	22.9	40.8	30.8	50.0	26.2	23.6	33.1	51.4	35.7	17.8	23.2	101.9	0.0	60.3	38.8	28.7	21.1	44.1	46.0	60.8	23.8	24.8	23.4	50.2	21.2	32.5	61.4	30.4	50.5	40.2	12.3	61.7	61.4	29.4	44.4	24.5	51.8	33.9	8.4	38.4	43.5	36.8	35.8	48.8	32.5
MMAA	cblA	ENSG00000151611	"Methylmalonic aciduria (cobalamin deficiency) cblA type"	Q8IVH4	4	145618263-145660035	"Disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.7"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 28.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037361, HPA058187"	Supported		Approved	Cytosol		No	No			Cytosol		"HPA037361: AB_10672107, HPA058187: "	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.21e-4)"	1.7	3.3	1.4	1.4	1.7	0.5	2.6	2.3	1.5	1.5	3.1			4.2	1.4	2.6	2.3	1.5	2.0	1.8	1.2	1.5	4.3	14.7	1.7	1.3	1.4		1.3	2.5	1.4	0.9	1.1		1.3	3.5		2.0	1.3	5.2	2.3	3.4	1.2	1.2	1.6	1.9	2.0			2.2		1.7	1.6	1.6	4.2	4.2	4.1	10.0	5.8	7.8	2.9	2.3	1.3	4.3	2.2	10.4	10.4	0.9	5.9	4.7	2.4	1.4	1.8	4.7	7.9	2.0	3.9	1.2	1.9	2.1	4.5	1.6	5.5	1.0	3.5	0.9	1.4	7.5	4.2	3.2	6.5	6.4	2.5	6.6	4.1	7.4	9.5	1.0	5.4	5.1	2.9	7.6	1.6	1.6	6.1	2.2	3.6	1.5	1.5	14.1	1.8	2.1	1.7	3.4	7.2	3.2	2.2	3.7	2.0	6.1	3.8	1.6	4.6	1.5	3.0	1.9	3.6	4.0	4.2	3.4	4.1	3.8	3.2	6.3	8.4	5.8	4.2	7.8	6.4	3.6	3.3	5.9	7.8	0.0	5.8	10.0	4.2	6.1	2.9											11.9	3.5	2.2	7.3	2.6	2.9	7.0	12.7	4.0	15.9	10.4	2.0	6.9	13.3	8.5	7.0	3.3	8.8	0.0	10.8	2.8	3.8	5.2	8.1	28.6	4.5	0.0	2.4	7.4	2.7	4.7	4.4	2.6	1.7	3.6	4.9	2.2	7.8	7.0	2.8	15.3	1.5	0.0	3.1	6.7	4.9	1.0	6.4	1.7	5.9	9.5
MMAB	"cblB, CFAP23"	ENSG00000139428	"Methylmalonic aciduria (cobalamin deficiency) cblB type"	Q96EY8	12	109553737-109573874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 187.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039017	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039017: AB_10673603"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.65e-2)"	7.3	26.1	12.7	7.2	12.2	5.2	13.0	7.2	17.2	7.0	12.2	12.6	9.4	12.7	7.7	21.9	14.8	9.8	11.8	18.1	11.6	11.5	13.6	47.9	11.8	13.0	12.4	8.2	14.2	20.2	9.1	11.7	5.3	14.0	15.7	8.3	11.2	15.1	10.6	16.5	8.9	8.5	8.7	15.7	6.7	10.7	7.8	14.8	4.3	16.6	15.7	7.5	6.0	7.5	14.1	9.4	3.8	8.1	8.5	13.9	9.2	13.4	9.1	9.5	7.5	3.9	8.0	4.9	3.0	6.9	4.4	4.7	10.6	12.6	8.6	8.7	3.4	8.4	14.1	6.2	23.3	2.0	3.4	25.6	3.5	6.8	17.4	13.9	7.5	3.1	10.6	14.6	9.6	4.2	5.4	4.1	6.9	11.2	6.6	3.1	31.1	6.8	12.1	11.7	1.4	13.1	5.7	3.6	22.4	19.5	12.7	14.8	6.4	6.7	12.6	5.2	2.7	26.2	21.2	2.3	3.8	1.6	2.7	4.3	5.2	3.8	9.7	8.3	9.2	10.3	3.8	5.9	0.8	13.5	8.1	10.8	11.1	9.9	10.7	9.4	14.1	13.9	13.1	1.7	8.5	8.0	7.7	4.7	9.2	12.7	12.2	7.2	17.2	11.6	11.5	12.4	8.2	14.0	14.8	32.8	66.2	26.6	23.6	9.2	31.3	44.8	66.2	65.6	43.3	40.1	27.5	51.9	127.6	40.5	30.4	16.2	42.1	0.0	62.2	27.8	17.9	25.9	16.1	187.6	29.6	98.5	31.8	24.5	19.7	56.0	37.4	16.3	25.3	35.1	43.5	29.1	27.3	31.6	28.7	102.6	27.3	12.9	16.0	30.5	15.1	17.2	51.7	21.7	53.3	20.1
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria"	Q9Y4U1	1	45500053-45513382	"Disease related genes, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.1"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	3.5	7.4	5.8	3.3	10.2	2.2	6.1	3.6	12.2	5.4	6.3	11.8	3.2	5.6	4.1	5.6	4.0	6.2	2.9	11.1	6.2	5.1	7.6	30.1	2.7	3.1	7.3	6.9	6.4	9.8	9.5	5.4	2.9	8.5	3.9	7.6	4.0	11.9	7.5	14.7	3.8	4.1	4.2	6.7	3.6	4.5	7.3	5.7	4.1	4.4	3.7	3.6	3.9	3.1	2.1	3.6	5.0	6.1	2.6	3.9	1.1	6.8	3.5	6.1	9.2	5.8	3.5	7.6	5.3	3.5	9.7	8.8	7.3	4.2	10.7	6.9	4.4	1.8	5.7	11.2	12.7	8.9	2.9	10.2	8.3	5.9	8.2	5.5	11.8	3.0	5.0	7.2	10.7	11.8	3.5	4.6	11.3	9.4	6.1	7.4	7.3	7.9	3.8	10.0	7.8	8.3	9.8	2.5	11.9	5.6	5.4	9.8	5.0	8.0	13.3	17.3	4.8	7.6	4.3	2.1	6.8	9.3	7.6	2.8	9.2	7.4	6.2	4.9	5.7	6.3	5.0	1.6	1.6	1.7	2.4	2.8	2.0	2.0	1.4	1.7	2.1	3.9	2.0	3.5	2.6	6.1	3.6	1.4	1.1	5.8	10.2	3.6	12.2	6.2	5.1	7.3	6.9	8.5	5.7	3.0	5.6	1.5	1.7	0.1	0.9	8.7	2.5	1.4	3.4	1.8	0.0	3.1	5.0	1.1	0.6	0.7	1.6	0.0	1.2	3.7	1.8	1.3	2.3	21.9	2.9	3.2	4.1	2.5	3.1	0.0	1.7	0.9	0.0	0.0	2.6	1.0	1.8	0.0	1.4	3.2	4.4	0.0	1.7	8.1	2.0	0.1	2.3	1.3	6.0	1.6
MMD	"MMA, PAQR11"	ENSG00000108960	"Monocyte to macrophage differentiation associated"	Q15546	17	55392613-55421992	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.1;brain: 40.5;breast: 46.0"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 32.8;HSkMC: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026978			Approved	Vesicles		NA	NA			Vesicles		"HPA026978: AB_2672068"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.52e-5)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (8.07e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (3.71e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.12e-2)"	61.1	6.6	33.4	7.1	40.5	5.3	46.0	2.0	23.7	2.6	5.6	4.1	1.7	5.0	3.2	4.9	3.6	1.8	4.7	5.0	26.9	7.5	3.2	6.0	4.7	9.0	11.2	5.1	1.5	1.6	0.9	2.1	13.4	4.6	3.2	6.5	3.2	2.2	4.1	2.5	2.5	4.7	5.4	6.5	8.7	2.4	7.8	5.0	1.4	3.3	1.2	5.6	5.7	4.1	4.1	3.6	9.6	1.6	2.2	4.2	15.9	5.1	13.2	19.5	3.8	32.8	25.9	9.6	3.2	1.5	2.0	3.0	2.0	15.3	7.4	9.4	1.1	5.8	0.3	5.4	4.1	4.3	9.7	1.9	2.7	0.7	23.9	8.8	2.6	0.8	59.3	1.3	2.9	3.3	4.6	2.6	7.2	0.9	5.9	4.3	0.7	7.3	1.9	5.3	0.9	3.4	2.9	12.6	2.7	5.7	1.4	1.8	18.6	1.1	2.0	2.9	12.7	4.3	4.7	2.4	5.4	6.5	4.3	3.6	2.6	1.3	10.4	7.8	2.2	4.3	9.6	1.3	1.5	1.4	1.6	4.2	3.6	1.6	2.9	3.6	4.1	2.7	2.9	3.8	2.2	1.5	1.1	1.7	15.9	33.4	40.5	2.0	16.9	26.9	7.5	11.2	5.1	4.6	5.0	3.0	1.1	10.5	17.0	4.7	24.9	4.3	7.6	0.0	1.2	7.0	3.9	8.1	13.3	22.9	2.1	11.3	2.6	46.7	1.2	13.7	8.0	18.3	0.0	17.0	32.6	15.9	7.5	10.4	35.9	2.5	1.7	28.4	6.8	74.9	5.8	11.5	12.0	0.0	3.2	7.1	9.3	19.4	5.2	15.6	16.0	15.3	16.7	12.5	7.9	4.0
MMP1	CLG	ENSG00000196611	"Matrix metallopeptidase 1"	P03956	11	102789920-102798160	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation, Host-virus interaction"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 62.4;stomach 1: 27.2"	"Cell type enriched"	"Detected in some"	7	"Pancreatic endocrine cells: 1303.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 344.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 90.2;HBF TERT88: 89.3;HUVEC TERT2: 234.8;WM-115: 115.7"									HPA004920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	7730000	430000	Vesicles		"HPA004920: AB_2667293"	"unprognostic (4.11e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.46e-2)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (7.83e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.86e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.11e-2)"	0.2	0.1	0.3	12.3	0.3	0.0	0.9	0.3	0.3	0.3	2.7	0.3	0.2	3.2	4.8	0.2	3.3	0.1	62.4	0.4	0.2	0.1	0.7	1.3	4.7	0.2	0.2	0.2	0.2	1.6	0.0	0.2	8.6	0.5	0.7	3.0	0.3	2.0	0.2	0.2	0.3	8.8	0.2	0.4	1.8	27.2	2.2	0.2	0.4	0.3	1.3	0.9	11.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	90.2	36.9	9.6	0.7	0.0	0.0	0.4	21.6	14.2	0.3	0.0	12.6	89.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	37.9	3.2	0.0	234.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	12.1	30.6	0.0	1.3	0.1	0.0	0.0	0.0	0.7	0.0	115.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.2	0.5	0.2	3.0	1.6	0.0	14.4	2.1	0.0	0.0	35.7	0.0	23.9	3.5	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	184.0	0.0	0.2	5.4	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	7.2	0.0	0.0	1303.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	25.0
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770503-102780628	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"endometrium 1: 89.4"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 38.9;Club cells: 70.5;Collecting duct cells: 27.9;Pancreatic endocrine cells: 62.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 102.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 12.6;HUVEC TERT2: 16.2;SCLC-21H: 5.2"	"Not detected"	"Not detected"							CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000		Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.1	0.0	2.6	0.2	0.1	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.4	89.4	0.1	0.2	0.1	0.5	0.1	0.0	0.1	0.1	3.6	11.0	0.1	0.0	0.0	0.5	0.3	0.1	0.9	19.8	2.8	3.2	0.2	0.0	2.9	0.1	0.1	0.1	0.7	0.1	0.0	0.2	3.3	0.5	0.0	1.2	0.1	0.0	1.9	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	12.6	0.7	0.1	0.1	0.3	0.0	0.0	3.7	1.9	0.2	2.9	0.0	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	0.0	16.2	0.0	0.7	0.0	0.0	0.0	0.0	0.3	3.0	0.5	1.7	0.0	0.0	0.0	0.0	0.7	5.2	0.0	2.5	0.0	0.0	0.9	0.0	0.0	2.0	3.9	1.3	0.4	0.5	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	38.9	0.7	0.0	0.0	0.0	5.3	70.5	27.9	0.0	0.0	0.0	9.8	5.0	0.0	0.0	0.0	12.9	0.0	0.2	5.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.8	0.0	0.0	62.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	7.4
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836557-22849027	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 96.4;HHSteC: 91.2;HSkMC: 92.7;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		570000	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	60.9	10.5	2.4	16.6	4.7	0.2	64.2	2.2	3.2	56.3	35.0	8.2	12.7	12.0	53.1	24.1	47.0	21.9	39.6	17.5	3.4	1.8	16.8	9.0	29.8	16.9	5.8	2.9	39.3	11.2	34.4	4.7	73.5	16.4	39.1	11.3	27.1	24.4	16.7	20.4	37.0	22.9	28.5	20.7	22.5	18.2	26.3	4.6	5.4	22.3	14.6	16.7	52.5	53.9	0.1	0.7	0.0	0.7	0.0	0.0	0.1	7.8	0.1	2.4	0.1	96.4	61.3	44.3	24.7	49.8	7.5	13.4	2.3	29.4	0.1	13.8	26.0	2.3	20.0	0.0	25.7	9.6	0.1	0.1	3.6	0.1	0.5	91.2	0.0	0.1	92.7	15.5	31.2	26.8	91.6	45.3	0.1	0.0	0.2	17.6	0.1	0.0	8.8	1.4	1.7	4.3	0.3	8.5	0.0	6.8	13.5	0.0	0.0	16.1	0.0	53.5	10.8	0.1	7.9	40.0	60.9	5.2	17.7	28.1	0.1	0.1	0.1	37.1	0.0	35.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	4.7	2.2	3.2	3.4	1.8	5.8	2.9	16.4	4.6	11.9	4.8	3.7	19.4	30.2	0.0	3.6	53.5	2.7	3.4	7.0	0.0	83.6	10.0	61.2	0.4	13.5	16.8	0.0	24.9	216.8	65.7	13.9	3.5	2.9	79.3	0.0	7.5	41.1	18.3	0.7	66.7	26.5	35.4	34.3	32.5	17.1	102.2	28.5	51.6	13.0	0.8	38.8	34.8	0.9	0.7	29.9	102.6	1.0	17.1	28.7
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025566-58046901	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.2"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 56.0;Enterocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.1;Hep G2: 19.3;SK-BR-3: 18.6;WM-115: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: AB_2676956"	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.08e-4)"	5.9	2.3	2.0	5.5	3.0	0.1	7.7	3.7	7.2	3.3	19.5	4.2	16.3	22.6	2.9	1.7	2.5	3.6	15.9	17.6	2.3	3.7	8.4	26.4	6.1	2.0	2.5	2.2	2.1	10.3	7.3	5.2	28.5	10.4	3.6	8.2	9.5	4.7	14.7	3.4	2.3	43.2	3.4	3.4	5.2	14.7	28.0	2.1	1.1	26.8	2.5	2.2	3.3	4.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.7	4.4	2.3	11.9	2.4	0.1	37.1	0.5	0.3	2.1	0.5	3.5	14.9	0.0	7.0	0.6	1.6	8.1	2.0	1.7	0.6	0.0	3.9	0.0	1.9	19.3	3.1	0.1	7.7	1.2	3.1	0.3	0.9	3.3	1.4	3.3	4.8	0.0	0.7	2.9	0.2	0.9	6.8	17.0	1.2	2.9	0.3	3.1	6.5	2.1	0.6	4.1	7.7	18.6	3.5	5.5	2.0	3.1	1.3	0.1	3.7	1.4	0.5	0.0	0.0	0.1	0.7	0.9	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	3.0	3.7	7.2	2.3	3.7	2.5	2.2	10.4	2.1	17.9	11.8	0.9	1.0	2.3	1.9	19.3	56.0	5.3	9.1	17.4	15.7	33.4	1.7	33.5	2.2	6.0	81.1	0.0	10.5	19.6	2.8	1.6	0.0	29.0	10.2	1.6	10.9	19.6	3.5	4.8	0.9	0.1	1.7	0.0	31.8	1.7	13.5	40.7	3.2	5.4	1.4	0.0	0.8	0.9	4.9	1.9	40.5	1.5	28.3	1.4
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032009-88328025	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 3.9;Early spermatids: 4.9;Fibroblasts: 9.9;Late spermatids: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.4;HUVEC TERT2: 8.8;SH-SY5Y: 11.4;U-138 MG: 9.7;WM-115: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	2.4	1.3	11.0	1.4	6.8	0.5	4.9	8.3	15.9	5.3	2.2	2.9	0.7	0.8	4.9	2.1	1.7	2.1	7.3	2.7	8.7	6.9	0.8	0.9	1.0	1.0	5.5	9.1	3.3	2.1	1.5	1.7	3.0	6.3	3.2	1.7	0.6	1.2	2.4	0.7	1.1	1.3	4.0	4.6	1.5	1.4	1.5	5.5	0.0	3.2	0.7	1.0	2.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	20.4	0.7	1.4	0.0	7.5	1.1	2.1	1.3	0.0	0.0	0.0	0.0	3.3	1.2	0.0	4.0	0.0	2.6	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.3	1.0	0.0	3.1	0.9	3.8	8.8	0.0	0.0	0.7	1.1	0.0	0.0	0.0	1.2	0.0	2.0	0.2	0.4	0.0	0.4	0.0	0.1	11.4	0.0	0.0	0.1	1.6	0.8	0.0	4.9	9.7	5.5	0.1	2.8	0.0	0.0	0.0	3.9	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	6.8	8.3	14.1	8.7	6.9	5.5	9.1	6.3	5.5	0.0	0.0	0.0	0.0	1.0	3.9	0.6	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.0	4.9	2.9	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.3	1.6	0.0	0.6	0.0	4.7	0.9	0.6	1.7	0.0	0.0	3.2	0.2	0.0	1.1	0.0	0.3	0.0	1.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.7"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 42.0;Hofbauer cells: 31.2;Kupffer cells: 30.5;Macrophages: 48.2;monocytes: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"classical monocyte: 3.2;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.0;monocytes: 3.2"	"Cell line enriched"	"Detected in many"	6	"BEWO: 57.2"	"Region enriched"	"Detected in single"	6	"olfactory region: 8.8"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		800000	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	60.7	1.9	0.2	10.9	0.7	0.0	9.9	0.2	0.5	7.6	3.9	0.4	1.4	0.8	12.7	6.0	3.6	11.8	30.3	4.7	0.6	0.1	4.1	3.0	14.0	15.5	0.5	0.2	7.4	8.1	0.0	0.5	24.5	1.0	2.9	2.8	3.1	2.0	3.5	2.1	2.7	4.1	7.7	0.8	27.4	5.0	2.9	0.2	2.7	3.3	1.8	7.1	5.9	3.5	0.0	1.0	0.1	3.2	0.0	0.0	0.6	0.8	0.0	0.0	0.0	6.3	8.1	57.2	6.0	7.1	2.5	2.9	0.3	0.2	0.0	0.0	8.4	0.1	0.0	0.0	1.8	3.4	0.3	0.0	0.0	0.0	0.1	5.2	0.0	0.2	8.4	0.2	1.5	1.6	3.0	0.4	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.1	2.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	9.7	1.5	3.3	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.7	0.2	0.5	0.6	0.1	0.5	0.2	1.0	0.2	0.0	5.8	0.9	0.2	6.4	0.5	0.6	5.1	2.7	5.7	0.0	3.9	14.4	0.0	0.3	0.4	2.1	0.0	0.0	0.4	42.0	24.0	0.4	2.3	0.5	31.2	0.0	0.0	4.9	30.5	0.4	5.5	48.2	11.8	38.7	0.0	0.3	0.1	0.0	4.9	0.0	1.7	0.0	9.6	0.0	0.2	3.8	15.7	0.0	0.0	0.1
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 217.4;Fibroblasts: 249.9;Leydig cells: 315.0;Peritubular cells: 393.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 292.5;ASC TERT1: 85.2;hTERT-RPE1: 329.2;U-87 MG: 93.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	160000000	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	197.5	9.0	1.2	13.2	1.6	0.0	136.4	0.8	1.4	74.3	74.4	2.4	36.9	5.6	85.0	123.0	52.3	25.7	115.4	54.0	0.9	0.5	9.4	3.5	38.9	3.9	1.5	1.1	71.0	6.5	0.7	2.2	58.9	2.2	66.8	18.7	36.4	18.6	20.4	68.6	68.2	22.6	57.1	1.8	12.4	20.5	57.0	1.1	1.3	20.6	31.8	9.1	84.1	105.3	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.3	0.1	9.7	0.1	292.5	85.2	15.9	25.0	57.5	5.0	4.0	0.0	0.1	0.0	20.1	44.1	1.9	2.7	0.0	0.2	2.9	0.0	0.0	0.0	0.6	0.1	27.7	0.0	0.7	72.6	0.0	26.0	0.2	329.2	32.7	0.0	0.0	0.1	16.8	0.0	0.0	0.3	7.7	0.0	0.0	0.0	2.3	0.0	0.8	0.3	0.1	17.6	4.6	0.0	0.1	45.4	0.0	1.7	45.9	79.6	7.6	15.2	3.2	0.0	0.0	0.0	93.1	1.3	14.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	1.2	1.6	0.8	1.4	0.9	0.5	1.5	1.1	2.2	1.1	0.0	0.3	0.0	13.0	108.4	5.2	3.1	0.0	0.0	3.4	10.4	0.0	5.4	0.0	1.7	11.5	11.9	0.0	0.0	0.3	217.4	249.9	2.7	0.0	0.0	25.6	1.6	27.1	15.4	0.0	26.9	315.0	5.3	121.4	0.0	0.0	5.0	6.9	0.0	393.8	0.0	1.8	12.9	70.0	1.2	2.1	89.5	14.4	0.0	0.0	3.8
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	20.1	0.0	0.1	0.1	0.0	0.6	1.1	1.3	2.1	1.1	30.6	5.4	0.0	9.0	1.4	0.7	0.3	4.7	0.0	0.9	0.1	0.2	1.1	0.6	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	7.7	0.0	1.4	0.0	0.1	0.0	13.8	0.1	8.0	5.5	1.4	0.5	0.2	1.8	0.3	0.1	0.3	4.3	10.4	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4	14.9	1.0	0.0	0.1	0.1	3.6	0.6	12.7	0.0	2.3	1.8	0.0	0.0	5.0	7.5	0.6	0.7	0.3	0.0	0.8	0.1	0.2	0.4	0.0	0.2	0.0	14.3	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.2	2.1	0.0	0.0	7.3	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 34.2;Enterocytes: 39.1;Mucus-secreting cells: 31.9;Paneth cells: 47.6;Urothelial cells: 34.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.2"	"Cell line enriched"	"Detected in some"	7	"HaCaT: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	8.0	1.6	1.8	2.7	3.7	0.5	4.3	0.0	5.1	1.7	7.3	1.6	1.4	3.0	3.2	4.8	4.3	1.5	12.3	0.5	2.8		0.8	0.2	10.3	0.4	0.0	2.9	0.1	1.3	0.5	0.0	0.7	1.3	2.9	4.1	2.7	0.1	2.1	0.6	4.5	9.3	4.3	0.2	0.6	7.2	13.4	0.2	0.0	4.2	4.4	2.5	5.5	2.2	1.1	1.5	0.1	0.2	1.3	7.2	0.9	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.7	0.0	0.1	28.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.0	3.9	0.2	0.6	0.0	0.0	0.0	1.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.0	1.1	0.4	1.7	0.1	0.9	7.2	5.9	0.1	1.3	0.2	1.5	0.0	0.9											26.8	20.8	0.0	5.1	34.2	0.4	1.0	2.5	5.3	5.7	7.0	0.0	0.0	0.0	0.1	5.0	8.1	39.1	0.0	0.3	0.0	1.6	1.8	0.0	0.0	0.1	1.6	3.5	6.2	0.0	7.1	1.1	0.9	3.3	0.0	31.9	9.1	9.7	47.6	2.8	0.7	0.5	6.5	2.0	0.5	2.5	29.0	0.0	0.7	18.5	34.5
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell type enriched"	"Detected in many"	6	"Ductal cells: 5335.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000		"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	129.5	0.0	30.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	56.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	80.4	30.5	0.0	310.5	0.9	0.0	0.6	119.8	113.8	646.0	964.8	0.0	0.3	0.0	5335.6	3.9	0.3	0.0	0.0	184.1	0.2	0.4	323.2	2.3	0.0	103.8	0.0	0.0	0.0	0.0	6.5	10.9	7.3	0.0	113.6	0.0	0.0	723.2	0.0	0.0	6.0	0.0	0.0	0.4	0.0	0.1	2.0	0.7	0.0	0.0	640.3
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"	25	"Hofbauer cells: 273.8;Macrophages: 115.1;Melanocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Cell line enriched"	"Detected in some"	12	"NB-4: 89.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	57000000	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	89.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.0	0.0	0.3	0.0	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0	0.0	8.5	0.0	0.0	30.5	1.6	0.4	0.0	0.0	0.0	0.0	7.9	0.9	0.0	0.8	0.6	0.5	0.0	0.0	1.5	2.0	1.7	0.1	1.1	0.0	273.8	3.2	0.0	0.0	1.9	0.0	0.0	115.1	54.0	3.6	0.0	0.5	1.6	0.0	0.0	0.3	4.3	0.0	12.3	5.4	5.5	24.6	1.6	0.0	0.0	0.0
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endothelial cells: 46.9;Ito cells: 114.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"NK-cell: 9.3;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.4;NK-cells: 9.3"	"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 168.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		300000000	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	13.9	1.9	1.4	5.3	1.4	0.5	14.8	0.7	1.3	22.8	14.9	0.1	9.0	2.6	9.2	12.2	17.4	18.1	11.5	4.9	1.6	1.3	3.3	9.5	22.4	30.7	2.6	0.0	10.2	2.2	0.1	1.3	38.1	2.7	10.0	8.1	3.7	3.3	2.4	6.8	6.5	10.1	14.2	3.4	1.6	5.3	16.7	2.1	2.3	43.1	7.0	3.7	19.6	30.4	0.8	3.4	0.1	0.0	9.3	0.3	1.7	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.3	0.0	0.1	9.3	0.0	3.4	0.3	1.7	1.4	1.4	0.7	1.3	1.6	1.3	2.6	0.0	2.7	2.1	0.0	11.8	6.1	0.1	3.8	0.0	2.0	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	11.8	46.9	0.0	0.0	0.0	0.0	1.5	0.1	2.3	0.8	0.4	0.0	0.0	114.2	6.3	3.2	0.3	2.5	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	1.4	1.7	0.0	4.0	0.0	0.0	0.0	0.1
MMRN2	"EMILIN3, EndoGlyx-1, FLJ13465"	ENSG00000173269	"Multimerin 2"	Q9H8L6	10	86935540-86969481	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"Endothelial cells: 80.1;Ito cells: 127.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.1"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 24.6;HUVEC TERT2: 51.7;TIME: 61.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA020741			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		86000000	Vesicles		"HPA020741: AB_1848154"	"unprognostic (4.17e-1)"	"unprognostic (7.87e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.66e-1)"	61.0	8.0	5.4	5.7	6.5	0.4	63.6	4.1	6.8	17.2	10.1	3.5	9.5	5.0	19.0	12.0	12.5	12.5	10.2	51.0	8.2	4.9	11.1	11.1	26.1	7.5	5.9	2.5	12.2	5.4	6.7	5.2	41.9	7.4	13.1	4.4	13.8	12.8	15.2	20.2	19.5	8.1	13.9	6.3	30.8	7.5	10.5	6.0	2.0	16.2	17.6	6.2	23.4	42.2	0.5	0.1	0.1	0.3	0.0	3.1	0.1	3.0	0.8	0.1	0.0	0.3	1.8	2.0	1.1	3.0	1.3	1.9	1.7	24.6	0.0	10.6	2.0	3.3	6.0	0.0	1.4	1.8	2.2	0.0	0.6	2.4	0.0	0.2	0.0	1.3	0.4	7.4	1.6	10.9	3.7	51.7	0.6	0.5	9.8	0.5	1.9	0.1	1.1	0.5	0.1	1.3	0.0	0.0	0.0	0.5	4.7	1.3	0.0	0.8	1.0	0.3	0.2	4.1	0.3	61.7	0.5	3.2	0.5	0.0	0.7	1.0	0.0	1.6	0.0	0.7	0.1	0.3	0.0	0.3	0.0	3.1	0.5	0.9	0.7	0.1	0.2	0.3	0.1	0.1	0.0	0.1	0.0	0.9	0.1	5.4	6.5	4.1	6.8	8.2	4.9	5.9	2.5	7.4	6.0	0.0	8.0	0.0	0.9	8.4	0.0	8.3	5.1	0.0	1.2	1.8	0.0	0.6	0.0	0.0	0.9	80.1	0.0	0.0	0.0	0.1	3.6	0.5	0.0	3.4	1.3	0.0	0.0	127.1	8.1	1.5	2.3	0.5	3.3	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.5	6.5	4.7	1.5	1.8	6.8	0.2	0.0	0.0	0.9
MN1	"MGCR, MGCR1, MGCR1-PEN"	ENSG00000169184	"MN1 proto-oncogene, transcriptional regulator"	Q10571	22	27748277-27801498	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 9.8;Early spermatids: 22.6;Fibroblasts: 10.0;Late spermatids: 12.6;Peritubular cells: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"AF22: 22.1;HeLa: 8.9;hTERT-RPE1: 9.9;RH-30: 8.9;TIME: 14.0;U-2 OS: 12.1;U-2197: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003072	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003072: AB_1079399"	"unprognostic (5.64e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.13e-7)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.21e-4)"	3.7	2.0	3.4	4.2	17.3	2.4	1.9	1.3	5.6	5.9	4.2	2.6	2.5	2.1	3.0	9.0	7.0	3.4	11.1	5.1	2.5	2.7	1.6	1.4	4.3	1.3	3.3	3.5	12.4	1.5	1.3	2.3	2.6	4.5	3.1	2.2	10.8	2.1	2.7	62.7	2.9	2.1	5.8	1.0	1.5	3.5	2.0	5.4	0.0	1.8	14.8	2.1	5.0	4.7	0.0	0.2	0.0	1.7	0.0	0.1	0.0	0.0	1.0	22.1	0.6	0.4	0.9	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	2.2	3.9	0.9	1.8	1.1	1.3	0.0	0.0	0.6	0.0	8.9	0.0	0.5	0.0	0.2	0.0	2.5	0.5	2.2	9.9	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.2	2.9	0.0	2.0	3.6	8.9	0.0	0.3	0.0	0.0	0.3	1.9	0.0	0.0	5.6	0.2	0.0	14.0	0.7	12.1	12.7	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	3.4	17.3	1.3	4.2	2.5	2.7	3.3	3.5	4.5	5.4	3.0	2.9	0.5	0.1	3.8	9.8	3.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	22.6	4.1	0.0	0.0	0.9	0.1	10.0	0.1	0.0	0.4	0.2	0.0	0.0	0.6	0.3	12.6	4.6	0.7	0.0	0.0	0.0	4.3	1.7	0.0	9.6	0.0	0.6	0.0	2.1	0.5	0.9	2.4	0.0	0.0	0.0	0.1
MNS1	"FLJ11222, SPATA40"	ENSG00000138587	"Meiosis specific nuclear structural 1"	Q8NEH6	15	56421544-56465137	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;testis: 36.4"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 285.0;Early spermatids: 279.9;Spermatocytes: 128.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039975, HPA040382"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA039975: AB_10793858, HPA040382: AB_10794740"	"unprognostic (7.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.20e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.71e-2)"	1.6	1.4	3.2	2.7	4.9	3.2	2.6	35.2	6.7	4.3	2.0	2.1	0.6	2.0	3.2	5.4	2.4	17.6	2.9	2.1	4.1	4.0	7.9	1.8	2.9	1.2	2.1	4.9	4.0	2.1	0.8	10.7	1.4	11.4	3.8	1.9	1.1	1.8	1.7	1.2	1.3	1.8	1.9	3.2	1.3	1.9	36.4	2.4	3.3	2.6	1.4	1.1	1.6	2.2	0.1	0.8	0.0	0.4	0.0	0.0	0.0	19.2	4.5	2.4	7.1	2.0	4.3	0.4	4.7	2.7	5.6	11.9	6.4	9.3	10.8	6.0	2.0	8.1	7.6	2.9	2.7	11.4	0.0	1.2	13.9	5.0	1.1	0.7	4.7	1.5	1.7	0.1	11.3	1.6	2.3	1.0	4.2	3.1	0.0	4.7	2.5	0.1	5.9	0.7	10.0	2.7	9.0	14.2	0.1	5.4	3.8	18.7	5.7	7.8	2.4	8.2	0.6	5.7	7.3	0.4	7.6	8.7	7.3	11.4	2.2	7.1	0.2	8.5	11.2	8.7	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	3.2	4.9	35.2	6.7	4.1	4.0	2.1	4.9	11.4	2.4	0.0	6.6	0.8	7.2	3.0	9.7	5.2	5.1	285.0	42.1	33.2	23.6	0.5	10.0	7.1	279.9	1.4	0.0	0.0	1.7	3.1	10.3	2.0	0.0	0.0	5.6	14.3	1.2	7.4	1.0	16.7	11.8	3.0	0.0	1.0	0.7	12.0	1.2	0.0	8.1	9.1	31.9	0.0	3.6	128.6	20.6	1.3	0.5	0.0	3.7	0.9
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010651	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 43.3"	"Cell type enhanced"	"Detected in some"	15	"Intestinal endocrine cells: 24.1;Mucus-secreting cells: 18.0;Paneth cells: 9.0;Undifferentiated cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.8;BEWO: 8.8;EFO-21: 11.3;HEK 293: 9.0;RPMI-8226: 24.7;SCLC-21H: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: AB_2686437"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.1	6.0	0.2	0.1	9.0	0.1	0.1	0.3	0.0	7.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	43.3	0.0	3.2	0.1	0.2	0.8	3.7	0.1	1.9	0.1	0.1	0.1	7.3	0.1	0.2	0.1	2.7	1.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	3.9	0.0	11.8	0.0	0.0	8.8	0.0	0.0	0.1	0.0	5.1	1.7	0.9	11.3	0.0	0.3	0.2	2.0	1.6	0.9	1.4	9.0	0.0	0.8	2.3	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	4.1	3.7	1.9	0.0	6.6	0.6	0.1	0.0	1.1	0.7	0.0	1.7	24.7	4.4	0.4	13.3	0.0	1.7	1.5	0.2	0.1	3.7	2.9	0.0	0.0	0.0	0.0	0.0	3.7	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.7	0.0	4.3	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	24.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	18.0	0.0	2.5	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	12.4	0.0
MOAP1	"MAP-1, PNMA4"	ENSG00000165943	"Modulator of apoptosis 1"	Q96BY2	14	93182196-93184928	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000939, HPA076948"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA000939: AB_1079402, HPA076948: "	"unprognostic (9.40e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.37e-9)"	"unprognostic (1.98e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (6.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	6.9	14.5	21.9	5.7	30.0	15.9	8.6	30.5	69.5	12.8	10.1	7.1	7.7	7.1	9.3	12.0	8.0	11.1	8.2	23.9	24.2	35.9	14.2	9.0	9.7	7.9	22.9	27.8	8.6	9.0	25.0	12.0	7.1	27.8	15.0	7.4	10.1	8.2	14.9	13.9	5.2	7.0	10.1	11.2	7.8	8.3	4.4	7.8	5.9	10.6	3.6	7.5	8.4	3.8	6.3	4.2	16.4	4.4	8.8	14.3	7.5	3.8	3.0	7.3	9.8	6.3	2.4	4.9	4.5	5.2	4.7	5.3	3.2	3.8	11.6	8.3	5.2	3.3	6.0	5.2	4.5	5.2	5.3	6.6	6.5	6.1	4.3	8.2	5.8	11.8	4.3	6.8	2.8	5.7	11.2	5.7	14.1	2.3	7.1	5.3	15.9	9.1	5.5	3.4	7.7	3.9	5.6	9.9	7.0	11.9	10.9	16.9	14.6	4.6	6.5	18.4	6.1	10.0	4.3	6.2	1.8	2.9	4.2	2.2	13.4	13.7	7.0	4.8	3.7	3.2	16.4	4.0	10.3	11.3	4.4	12.6	6.0	10.5	11.5	4.2	6.3	14.3	12.2	3.7	8.8	4.4	4.0	9.8	7.5	21.9	30.0	30.5	69.5	24.2	35.9	22.9	27.8	27.8	7.8	29.8	27.2	31.3	16.6	14.3	94.0	64.3	12.7	6.7	12.5	19.2	47.1	23.2	34.9	26.8	3.8	15.8	10.7	0.0	13.3	4.8	12.5	23.4	26.6	6.4	14.5	79.4	46.6	11.6	10.8	0.9	16.4	10.1	11.8	18.0	18.8	76.4	16.9	10.2	25.8	13.9	85.3	19.4	26.1	9.6	21.3	13.6	39.9	31.9	13.1	18.6
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 381.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	32.2	18.0	12.2	41.5	16.3	36.6	36.2	10.8	11.3	24.5	21.5	12.6	16.1	19.7	27.1	19.8	28.9	22.0	19.9	20.9	11.0	10.4	34.7	21.4	28.4	65.1	14.7	6.9	28.4	12.6	13.8	11.5	20.9	15.9	21.0	20.7	14.3	18.1	18.8	12.8	22.9	30.2	31.6	21.8	51.1	18.7	17.9	12.8	57.0	25.4	16.9	42.4	29.2	24.6	22.3	22.2	32.3	42.8	20.6	15.9	25.2	21.0	12.1	15.2	16.4	25.1	27.5	18.0	17.0	22.9	22.2	21.9	16.5	15.4	43.3	14.6	21.3	16.5	17.7	19.4	19.4	33.7	30.4	11.6	39.1	8.4	17.4	20.1	33.8	63.2	23.2	19.0	17.7	15.0	16.7	23.2	16.8	16.7	16.1	21.5	11.4	42.4	28.8	14.1	18.1	9.9	29.3	52.4	23.0	19.1	26.4	7.7	10.1	24.1	17.9	15.5	12.0	14.3	16.1	22.0	28.9	15.2	20.2	26.9	12.0	10.6	33.3	19.4	28.9	15.4	30.8	24.0	32.3	14.8	39.0	15.9	22.3	13.3	15.7	22.2	17.2	12.3	14.6	24.0	20.6	42.8	15.5	13.4	25.2	12.2	16.3	10.8	11.3	11.0	10.4	14.7	6.9	15.9	12.8	47.6	54.3	138.1	70.9	121.6	12.3	37.0	43.3	80.3	58.0	78.5	5.9	57.5	77.9	53.0	5.0	60.8	83.6	46.7	46.0	83.4	58.3	90.4	109.5	38.0	153.8	25.4	36.1	63.3	177.0	8.5	57.8	185.9	64.1	381.5	63.9	22.4	63.0	74.8	64.3	137.3	13.0	71.1	74.1	87.4	46.2	115.4	55.5	96.5	62.4	139.8
MOB1B	"MOB4A, MOBKL1A"	ENSG00000173542	"MOB kinase activator 1B"	Q7L9L4	4	70902326-71022449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 70.0;monocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 34.3"	"Low region specificity"	"Detected in all"							"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-3)"	9.8	10.1	15.7	17.8	13.0	30.9	11.1	10.4	20.0	10.5	9.7	17.3	4.8	6.1	13.9	8.6	9.9	11.8	9.1	11.1	19.8	10.6	29.3	8.3	20.6	13.4	15.5	18.6	13.8	11.0	18.0	10.9	11.2	12.8	12.7	8.5	8.0	11.1	8.6	10.8	11.2	8.4	14.1	17.4	10.6	10.1	7.6	15.4	52.3	14.4	8.2	12.8	10.8	9.8	0.6	5.3	2.5	3.1	0.7	1.4	1.2	3.9	3.2	12.2	9.9	6.6	8.4	10.0	11.9	6.5	6.7	5.9	4.2	7.6	22.0	5.7	10.5	4.5	2.8	7.5	10.0	16.2	11.6	2.6	34.3	3.6	3.3	6.6	7.5	6.9	6.9	5.5	7.5	6.1	7.5	7.9	11.4	21.0	7.2	10.5	4.2	23.2	4.6	4.0	2.6	4.2	7.5	11.8	3.0	11.1	6.9	4.2	8.1	5.1	2.3	15.9	6.8	5.4	4.8	9.4	18.6	9.5	8.4	4.8	4.6	1.5	9.4	6.5	5.5	8.5	0.8	3.1	2.5	1.3	1.6	1.1	0.5	0.6	0.6	4.0	0.6	0.8	0.7	0.4	0.7	0.9	5.3	1.4	1.2	15.7	13.0	10.4	20.0	19.8	10.6	15.5	18.6	12.8	15.4	23.8	15.5	2.2	5.2	15.9	2.0	14.7	7.6	21.4	12.5	41.8	17.7	4.6	8.3	4.9	0.4	9.5	0.9	70.0	4.0	4.9	11.2	9.8	10.4	6.4	9.9	6.4	36.4	9.8	34.3	1.4	4.0	21.6	10.1	52.3	8.4	6.0	8.0	0.0	8.1	15.9	4.3	25.8	21.7	7.2	9.8	14.9	4.8	5.4	5.6	8.4
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187519-36272157	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.0;liver: 36.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 30.1;monocytes: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.8;hTERT-HME1: 25.6;SiHa: 27.4;SK-MEL-30: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	3.7	12.7	0.6	1.6	0.5	0.2	6.4	0.4	0.4	1.4	10.4	0.7	8.0	6.7	1.3	4.6	4.8	1.9	5.8	1.3	0.4	0.5	1.7	36.6	1.8	0.2	0.4	0.1	17.2	3.2	1.1	9.4	11.2	2.2	2.8	1.8	2.1	2.5	7.2	1.3	2.6	33.0	1.0	0.4	0.7	1.7	1.3	0.2	0.0	1.2	2.9	3.5	2.6	1.7	0.4	0.3	1.9	0.3	1.1	0.3	0.1	6.9	2.4	0.1	0.0	2.2	2.9	1.5	4.1	2.3	2.0	5.1	1.5	2.2	0.0	1.3	6.6	0.5	4.3	1.5	6.5	2.8	1.2	1.2	0.1	6.9	5.7	7.6	0.0	2.0	4.5	20.8	7.7	25.6	0.2	0.3	0.0	2.3	0.0	3.2	1.8	0.0	0.0	0.4	1.6	2.0	0.0	0.0	0.0	2.8	9.1	0.0	0.6	27.4	1.7	19.1	0.4	1.3	0.1	1.3	1.6	1.9	3.4	0.7	0.0	0.0	0.0	4.0	0.0	0.7	1.7	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.2	0.3	1.9	1.1	0.2	0.3	0.1	0.1	0.6	0.5	0.4	0.4	0.4	0.5	0.4	0.1	2.2	0.2	11.9	5.3	3.4	1.2	0.6	0.2	0.4	0.0	2.7	6.8	0.0	2.0	0.4	0.0	2.7	5.7	0.9	2.6	0.0	10.9	3.3	1.5	1.2	0.0	30.1	0.5	0.0	2.9	0.0	0.6	1.7	1.7	1.4	3.3	20.8	2.3	7.6	4.3	2.8	8.5	0.0	0.3	0.0	0.5	0.1	0.2	1.1	1.9	0.0	2.8	2.2
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201021	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 61.6;liver: 16.0"	"Cell type enhanced"	"Detected in some"	22	"Enterocytes: 76.6;Paneth cells: 56.1;Undifferentiated cells: 21.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.0;liver cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CACO-2: 4.8;Hep G2: 16.2"									HPA011940	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.2	0.1	0.2	2.6	0.2	0.4	0.2	0.2	0.2	0.2	17.3	0.2	0.2	19.7	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.1	0.9	16.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.1	61.6	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.7	1.2	5.3	0.9	1.9	1.2	0.3	0.6	0.2	0.2	0.5	0.0	0.2	0.4	0.6	0.0	0.0	0.0	4.8	1.1	0.4	0.6	0.1	0.6	0.4	0.2	0.1	0.1	0.1	0.2	0.6	0.6	16.2	0.2	0.5	0.6	0.1	0.1	0.0	0.1	0.4	0.1	0.3	0.2	0.7	0.1	0.3	0.3	0.5	0.2	0.5	0.6	0.3	0.1	0.4	0.7	0.6	0.3	0.3	0.3	0.6	0.1	0.8	0.3	0.3	0.8	0.9	0.2	1.0	0.5	0.4	0.2	0.1	1.7	0.6	1.4	2.2	0.9	1.1	1.0	0.7	0.7	1.0	0.8	0.7	0.5	1.7	0.9	1.2	5.3	1.9	0.6	1.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	76.6	0.0	0.0	0.0	0.2	0.2	0.0	5.5	0.0	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.1	56.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.5	0.4
MON1A	"MGC13272, SAND1"	ENSG00000164077	"MON1 homolog A, secretory trafficking associated"	Q86VX9	3	49907160-49930173	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3;Late spermatids: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053752, HPA058032"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA053752: AB_2682250, HPA058032: AB_2683584"	"unprognostic (1.81e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-1)"	7.1	6.5	11.7	6.1	10.4	4.1	4.6	5.2	17.8	5.9	9.3	7.6	3.8	27.9	5.6	3.2	5.6	5.1	6.3	5.4	10.8	10.3	6.0	11.0	4.9	5.2	10.3	8.8	4.7	10.9	5.8	7.4	4.9	8.9	5.0	4.0	5.6	6.0	6.7	15.2	6.9	17.6	5.9	9.7	4.6	5.8	12.6	6.6	6.6	6.3	4.1	4.5	4.6	4.4	8.8	7.8	3.3	6.4	13.6	13.5	7.8	4.6	3.9	2.4	7.5	7.7	4.6	3.4	6.7	3.3	6.5	7.3	5.8	3.1	14.2	6.1	6.2	5.6	5.9	5.2	8.4	2.7	11.8	13.1	6.2	4.6	7.4	9.7	7.2	9.0	6.3	9.1	12.6	4.4	3.3	9.4	6.1	9.6	5.0	4.9	7.7	8.2	10.6	5.4	10.1	20.1	5.1	2.7	10.9	4.6	3.4	7.0	4.2	2.8	5.6	6.7	1.7	4.3	4.9	7.4	4.3	5.1	11.9	10.6	10.5	10.3	8.8	6.6	11.2	6.4	0.1	6.4	3.3	11.9	4.9	13.5	8.8	10.0	11.9	7.8	4.8	12.4	10.0	1.9	13.6	3.9	3.9	10.1	7.8	11.7	10.4	5.2	17.8	10.8	10.3	10.3	8.8	8.9	6.6	3.0	4.8	4.3	1.7	13.3	2.8	5.3	0.0	4.0	3.4	1.8	3.9	3.7	1.7	4.2	11.9	3.8	9.3	23.3	5.8	2.6	3.5	3.7	4.6	12.9	4.7	0.0	6.4	4.3	3.8	25.2	3.1	2.5	5.0	1.8	4.0	4.6	9.6	5.8	5.3	10.5	2.2	0.0	6.2	14.0	5.7	8.0	3.3	4.9	4.9	1.8
MON1B	"HSRG1, KIAA0872, SAND2"	ENSG00000103111	"MON1 homolog B, secretory trafficking associated"	Q7L1V2	16	77190835-77202405	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046285	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046285: AB_10959467"	"unprognostic (1.73e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (1.94e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.42e-5)"	"unprognostic (2.21e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.75e-1)"	15.7	12.3	21.8	19.1	22.5	16.5	12.4	17.5	22.9	14.7	19.1	25.3	18.5	17.1	14.6	14.4	16.7	13.6	16.1	12.5	21.7	19.4	17.4	26.9	14.9	19.3	26.8	17.9	11.5	17.7	25.1	13.0	11.8	19.9	23.7	15.7	15.2	22.9	13.3	11.5	15.9	23.1	11.6	28.0	18.0	16.9	10.8	24.0	23.5	23.2	11.2	17.7	15.1	12.0	5.7	7.2	19.8	14.5	9.2	8.6	6.7	8.2	19.7	7.5	8.4	8.3	8.2	10.6	7.0	9.1	7.2	7.1	11.2	12.6	13.3	13.9	5.5	12.1	15.2	7.8	7.5	5.9	10.5	8.0	9.3	6.9	11.0	11.5	9.8	28.7	8.6	14.5	10.4	8.7	7.0	12.9	12.8	13.2	4.7	5.8	15.5	14.9	11.8	7.9	9.5	4.9	18.6	5.2	14.2	7.4	5.8	11.6	9.6	13.5	5.2	8.9	5.6	13.3	14.9	13.3	8.6	10.4	10.3	7.1	17.0	10.8	37.7	14.3	10.9	11.0	10.4	8.3	14.1	8.6	14.5	8.6	5.7	6.8	8.4	7.2	5.4	5.2	6.6	19.8	9.2	8.7	3.9	8.4	6.7	21.8	22.5	17.5	22.1	21.7	19.4	26.8	17.9	19.9	24.0	35.7	33.3	8.0	9.8	6.6	14.8	9.6	10.2	9.4	20.5	14.0	17.7	8.8	3.3	11.7	15.0	19.4	25.6	0.0	17.0	10.5	7.8	20.2	12.7	25.2	11.7	7.9	23.1	20.9	26.4	11.3	8.3	13.6	8.5	16.2	23.9	20.3	15.9	17.5	9.6	9.9	21.2	19.4	7.2	10.4	4.9	8.3	14.1	20.2	19.5	16.9
MON2	KIAA1040	ENSG00000061987	"MON2 homolog, regulator of endosome-to-Golgi trafficking"	Q7Z3U7	12	62466817-62600479	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038697, HPA057607"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA038697: AB_10697396, HPA057607: AB_2683482"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.69e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.36e-2)"	16.4	14.8	12.1	16.9	20.7	13.3	16.8	28.6	20.6	20.8	14.4	25.8	21.3	13.3	22.3	16.8	16.2	16.8	15.6	14.5	14.2	13.0	17.5	22.6	14.3	14.3	20.4	18.7	22.8	24.0	36.7	31.9	17.8	22.6	16.9	17.3	16.7	22.4	24.3	15.7	16.4	15.0	15.2	17.4	15.7	17.0	11.2	18.1	21.8	21.3	10.9	17.6	15.8	17.2	6.2	5.5	8.9	6.2	3.7	7.2	3.6	10.4	16.2	12.2	6.4	15.9	14.8	11.2	11.4	9.6	10.5	10.5	7.2	4.2	7.4	8.9	11.0	8.2	10.1	12.0	8.3	14.5	9.5	9.4	11.7	11.9	7.3	6.8	10.1	8.3	10.0	6.4	11.4	14.1	14.1	10.1	6.9	11.0	18.0	9.2	12.1	8.9	4.8	7.2	6.4	9.0	8.3	11.0	10.2	5.9	14.2	5.3	5.8	19.2	10.4	7.8	13.1	22.6	7.5	14.1	10.2	7.5	12.8	7.3	10.0	9.2	8.4	10.9	6.4	11.4	2.0	6.1	6.3	5.5	6.2	7.0	5.0	4.4	7.2	5.5	6.2	6.2	6.9	8.9	3.7	4.6	3.2	5.0	3.6	12.1	20.7	28.6	20.6	14.2	13.0	20.4	18.7	22.6	18.1	32.8	18.5	10.7	12.5	14.9	35.8	12.0	15.3	21.4	25.0	26.2	55.0	11.1	0.0	6.5	2.2	15.5	15.3	0.0	9.4	6.0	17.5	19.3	16.2	31.0	9.4	20.6	13.8	23.9	17.6	1.5	20.1	16.2	8.5	8.2	19.8	17.0	8.8	17.3	17.0	4.8	57.6	25.8	20.8	7.9	9.7	17.1	17.0	15.4	13.3	14.1
MORN1	FLJ13941	ENSG00000116151	"MORN repeat containing 1"	Q5T089	1	2321253-2391707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 34.8;Rod photoreceptor cells: 21.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005858, HPA070703"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA005858: AB_1848709, HPA070703: AB_2686299"	"unprognostic (1.39e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.21e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.88e-3)"	"unprognostic (2.53e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	4.2	4.0	6.9	5.6	15.1	2.5	4.9	25.8	6.6	7.3	4.4	6.1	14.4	4.5	9.3	13.9	3.7	23.5	7.4	3.0	5.5	5.7	7.8	4.1	5.8	3.5	3.9	8.0	15.2	8.6	4.9	11.6	2.5	11.7	6.7	3.1	8.8	9.1	11.7	4.7	6.4	4.3	6.0	4.9	4.6	5.4	17.3	4.8	5.8	15.0	3.3	3.8	3.5	4.6	2.1	3.7	4.2	4.3	0.8	2.6	1.0	6.4	7.8	5.4	4.9	1.9	0.9	5.6	2.0	1.4	3.2	2.7	3.7	7.3	1.7	4.2	1.2	2.4	8.0	1.1	3.1	3.1	3.9	8.3	1.7	14.3	4.2	1.6	2.1	0.9	1.1	0.7	3.0	2.7	2.4	2.2	3.4	2.7	2.0	1.1	8.9	2.1	0.8	3.2	3.4	6.9	2.2	5.0	2.7	2.5	2.9	8.9	4.3	5.2	9.5	4.1	2.5	5.0	0.6	0.7	3.7	5.3	2.6	2.3	4.8	1.7	1.1	7.4	1.3	2.5	0.0	0.8	0.2	1.4	0.3	0.8	1.0	1.5	1.1	1.0	2.1	2.6	1.2	4.2	0.8	4.3	3.7	0.1	1.0	6.9	15.1	25.8	6.6	5.5	5.7	3.9	8.0	11.7	4.8	3.0	2.7	1.5	3.6	1.4	8.5	3.2	5.1	34.8	4.5	14.0	19.6	3.1	3.3	1.8	16.8	1.0	2.1	0.0	1.2	1.4	2.1	2.7	5.7	1.0	2.3	9.5	5.2	1.8	0.6	19.5	2.3	0.6	1.7	1.0	0.6	8.4	1.4	0.0	2.8	7.9	21.9	0.0	2.0	19.2	5.9	1.9	1.6	0.8	1.9	2.3
MORN2	MOPT	ENSG00000188010	"MORN repeat containing 2"	Q502X0	2	38875962-38929072	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 88.7"	"Cell type enhanced"	"Detected in many"	21	"Ciliated cells: 638.4;Early spermatids: 1599.5;Late spermatids: 2860.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057815			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057815: AB_2683537"	"unprognostic (7.28e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.80e-2)"	5.9	14.4	20.5	3.1	22.7	4.1	10.2	6.8	14.8	14.9	6.5	10.3	13.8	3.4	8.3	34.6	5.0	43.7	9.1	10.7	16.4	18.6	31.4	8.6	8.6	2.9	16.5	12.7	9.6	9.5	22.7	27.1	4.0	30.1	8.4	6.8	8.3	11.4	9.7	7.1	3.6	3.3	5.7	11.1	3.1	6.9	88.7	9.5	2.0	21.9	7.2	2.9	6.1	4.4	3.6	7.5	2.0	11.0	3.1	4.8	4.8	23.4	12.4	15.2	18.5	16.7	25.2	8.5	10.9	17.2	17.5	16.9	7.2	13.4	1.5	9.2	16.2	17.5	6.5	6.8	14.1	26.0	9.9	13.1	5.1	14.0	19.1	14.6	8.2	3.7	15.0	17.4	21.4	7.8	22.0	16.0	4.7	8.7	3.5	14.3	23.5	3.7	15.8	11.6	15.6	13.0	2.0	16.0	5.3	32.6	14.1	15.3	20.1	16.2	10.8	23.1	9.2	14.8	11.4	10.7	12.2	12.2	19.3	17.3	6.9	9.9	0.9	28.2	2.4	21.9	2.0	11.0	1.5	2.2	8.4	4.1	3.4	2.6	3.3	7.5	3.6	4.4	4.6	0.9	3.1	6.9	3.8	4.8	4.8	20.5	22.7	6.8	14.8	16.4	18.6	16.5	12.7	30.1	9.5	14.9	16.4	6.4	23.2	8.7	14.8	36.7	38.2	638.4	66.0	57.6	9.8	13.2	228.8	53.3	1599.5	11.8	8.3	0.0	38.9	19.6	23.9	32.1	9.2	17.9	21.0	15.9	22.0	14.1	7.8	2860.4	49.5	14.9	21.9	5.4	18.5	60.4	35.0	28.8	48.4	323.7	28.1	25.8	13.4	365.9	74.1	9.3	6.4	4.1	23.9	21.4
MORN3		ENSG00000139714	"MORN repeat containing 3"	Q6PF18	12	121648742-121672631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"placenta: 30.1;testis: 51.5"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 1766.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"BEWO: 12.6;CACO-2: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038709, HPA038710"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038709: AB_2676164, HPA038710: AB_2676165"	"prognostic favorable (1.16e-4)"	"unprognostic (2.70e-3)"	"unprognostic (5.56e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	0.3	0.2	1.2	0.5	1.4	0.9	0.3	0.3	1.6	0.4	0.3	0.3	0.3	0.2	0.3	1.4	0.3	5.6	0.4	0.3	1.4	1.2	0.4	0.3	1.0	1.4	0.3	0.3	0.3	0.4	3.4	0.7	30.1	0.3	0.3	0.0	0.3	0.3	0.3	0.3	2.5	0.3	0.3	0.3	0.8	0.8	51.5	0.3	0.3	0.5	0.3	0.6	0.3	0.3	1.2	1.2	3.1	0.6	2.2	2.3	0.6	0.1	0.2	0.4	0.2	0.0	0.3	12.6	0.2	0.0	0.1	0.1	6.8	0.3	0.2	0.2	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.5	0.3	0.4	0.3	0.4	0.9	0.1	0.3	0.3	0.0	0.1	0.2	0.8	0.2	0.3	0.1	0.2	0.8	0.6	0.2	0.0	0.1	0.3	0.0	0.1	0.4	0.2	1.1	1.1	0.1	0.2	0.0	0.5	0.9	0.1	0.1	0.2	0.2	0.3	0.1	0.2	0.1	0.4	0.9	0.3	0.1	2.3	0.6	0.4	2.1	0.3	2.0	0.8	2.3	1.3	0.2	1.2	2.1	1.4	3.1	2.2	0.5	1.2	2.0	0.6	1.2	1.4	0.3	1.2	1.4	1.2	0.3	0.3	0.3	0.3	3.0	2.2	0.5	1.1	2.9	1.1	1.1	5.1	50.9	11.4	1.8	0.0	0.2	6.6	3.3	357.0	1.5	0.0	0.0	1.2	0.4	1.3	0.3	2.3	0.0	0.8	0.0	0.0	0.6	0.0	1766.8	8.6	0.1	0.0	1.8	0.0	3.7	1.7	0.0	8.9	0.8	1.7	0.0	0.0	7.0	5.6	3.4	6.1	3.3	0.1	1.0
MOSPD1	dJ473B4	ENSG00000101928	"Motile sperm domain containing 1"	Q9UJG1	X	134887626-134915267	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 80.8;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031158	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031158: AB_10603874"	"unprognostic (2.23e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.45e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.15e-1)"	11.0	19.7	6.2	6.5	8.0	12.3	7.9	7.8	10.4	11.1	6.9	8.8	5.5	5.4	19.3	12.5	20.5	25.1	6.6	17.4	7.3	6.2	11.8	10.3	8.0	5.5	9.9	7.4	12.9	8.9	10.3	8.1	23.2	21.2	8.1	7.0	10.3	14.6	7.6	17.6	14.5	6.9	10.7	9.0	8.3	7.5	16.4	7.5	10.2	9.1	13.5	10.1	9.5	12.0	6.2	8.3	12.3	6.8	6.0	14.3	5.1	7.7	6.1	5.2	3.6	8.2	4.8	11.3	13.1	23.8	12.6	12.3	15.0	3.1	2.6	18.3	8.3	22.9	2.8	8.0	6.8	16.7	8.7	4.7	2.2	16.2	6.0	34.9	6.1	3.8	8.7	8.3	14.2	6.1	14.4	9.2	5.4	2.7	10.7	15.2	10.8	4.3	2.8	5.3	4.1	13.9	3.3	9.2	4.8	5.4	22.3	3.1	3.8	6.6	6.7	22.5	26.3	2.7	3.8	4.6	6.2	3.8	23.2	11.6	8.3	11.1	4.2	8.5	10.6	8.1	6.0	6.8	12.3	7.6	5.0	10.0	6.2	9.0	8.3	7.5	5.1	10.2	9.8	4.0	6.0	5.5	8.3	14.3	5.1	6.2	8.0	7.8	10.4	7.3	6.2	9.9	7.4	21.2	7.5	6.0	4.3	6.7	9.8	18.9	9.0	42.3	5.1	16.0	6.8	10.4	2.0	6.1	18.3	21.3	80.8	12.7	5.7	46.7	10.7	12.5	9.1	9.7	5.7	4.9	13.2	4.8	4.1	13.5	11.4	57.7	6.4	7.2	28.7	5.4	7.2	8.3	17.9	11.5	10.3	20.2	9.0	6.5	15.3	3.0	5.3	17.9	21.9	10.1	6.6	8.1
MOSPD2	MGC26706	ENSG00000130150	"Motile sperm domain containing 2"	Q8NHP6	X	14873441-14922327	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 30.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 30.2;monocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003334	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003334: AB_2146004"	"unprognostic (2.74e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.51e-1)"	"unprognostic (7.24e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.96e-2)"	11.2	7.1	11.9	10.4	20.8	12.4	8.5	8.0	18.0	11.3	6.2	24.6	8.5	7.4	9.1	9.9	11.9	6.5	10.9	5.9	16.7	11.1	8.6	8.3	12.2	11.1	33.0	13.8	10.4	7.8	6.6	11.5	14.1	33.9	7.1	8.1	4.9	18.5	6.4	3.7	21.4	7.3	8.0	40.4	12.0	7.3	5.6	27.0	7.8	13.1	6.2	9.2	7.8	10.6	2.3	2.7	30.2	8.4	4.3	2.3	2.7	5.5	7.4	5.6	3.0	18.9	11.9	6.0	12.6	11.9	9.0	10.9	3.7	6.8	7.0	3.5	21.1	14.3	8.9	6.9	5.3	12.0	5.3	6.3	2.4	7.1	3.4	11.7	4.6	7.0	10.8	7.6	8.0	10.8	9.0	8.0	7.7	3.2	10.1	8.6	2.4	4.6	3.8	3.8	4.9	6.7	4.4	7.4	5.9	7.4	3.7	1.8	4.2	9.7	4.5	20.5	22.7	3.9	6.8	8.0	8.6	3.6	29.0	4.9	6.0	5.6	4.7	11.2	3.8	11.7	7.8	8.3	3.9	2.0	7.9	2.1	1.2	1.8	1.2	2.7	2.3	2.0	2.3	30.2	4.3	8.4	1.1	1.9	2.7	11.9	20.8	8.0	18.0	16.7	11.1	33.0	13.8	33.9	27.0	20.8	15.6	11.3	5.6	7.6	6.2	5.7	5.1	17.4	13.6	21.0	5.9	8.8	8.3	5.5	4.4	12.3	5.9	0.0	5.4	7.5	12.6	7.4	7.0	6.8	19.6	6.4	12.1	22.1	28.4	12.1	9.8	26.2	10.1	23.4	7.7	6.8	5.9	5.8	14.2	9.1	4.3	12.9	7.4	3.4	8.3	11.2	19.7	6.9	5.9	5.8
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1149.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: AB_2680325"	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	13.8	22.3	13.0	7.7	12.8	17.4	9.8	9.0	16.9	14.7	9.1	14.5	13.9	9.9	12.0	12.9	22.5	12.0	14.9	10.2	11.2	10.8	19.3	29.8	11.1	18.5	10.6	11.6	13.1	17.1	6.7	9.8	7.8	12.0	12.9	4.8	14.9	19.1	11.3	11.3	24.4	10.6	10.3	9.5	11.8	14.7	37.0	9.9	16.6	12.2	13.6	16.8	12.4	13.4	11.6	17.9	22.2	16.7	20.9	29.7	8.0	6.0	8.2	6.6	11.4	3.5	2.6	4.7	4.6	5.5	4.8	4.9	7.6	8.1	3.8	10.2	4.2	6.8	4.7	3.8	6.6	0.9	9.8	5.1	3.9	6.1	11.4	4.5	3.0	15.1	7.4	5.7	4.1	2.4	4.2	8.2	6.4	9.1	7.8	4.9	17.9	8.4	23.0	6.0	7.9	12.4	7.9	6.9	9.1	7.6	9.1	3.6	21.7	8.6	13.4	4.6	2.8	8.1	8.9	9.2	9.3	14.7	19.3	4.4	6.2	5.8	2.6	9.3	33.7	11.4	18.5	16.7	22.2	18.8	12.4	22.2	11.6	21.8	21.8	17.9	11.3	13.0	13.5	12.3	20.9	8.5	12.0	29.7	8.0	13.0	12.8	9.0	16.9	11.2	10.8	10.6	11.6	12.0	9.9	8.9	6.5	11.9	14.9	10.8	6.6	3.2	17.8	9.4	4.5	19.2	5.9	6.0	36.5	33.9	271.2	15.7	8.7	0.0	37.6	23.2	22.0	20.1	3.5	26.2	25.2	6.4	20.7	19.0	23.0	1149.7	25.6	15.1	25.3	14.4	14.9	11.4	39.0	17.5	20.5	35.7	3.4	12.9	20.0	17.7	21.5	17.1	5.1	29.3	16.9	17.8
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031627			Approved	Cytosol		NA	NA			Cytosol		"HPA031627: AB_2673966"	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	12.5	17.0	6.2	12.6	6.9	3.5	15.0	1.9	6.3	11.4	23.1	9.3	12.3	18.8	16.4	12.6	15.8	12.2	15.3	5.8	8.6	5.1	13.3	19.4	9.7	7.7	5.9	5.1	14.5	12.9	13.1	14.1	20.2	8.2	14.0	9.3	13.8	13.5	16.5	3.1	23.2	33.8	9.4	6.3	12.9	10.4	17.7	6.0	14.5	12.1	6.9	10.9	11.0	12.5	1.9	5.6	0.9	9.5	9.9	10.8	5.9	12.0	7.4	4.4	17.0	3.6	10.4	16.8	8.3	19.7	24.4	35.0	13.7	13.3	0.0	5.7	11.4	9.1	12.8	16.8	19.9	8.5	13.2	10.2	8.3	10.8	15.4	15.5	3.4	8.3	17.5	6.1	14.8	4.7	16.1	20.7	17.2	11.0	4.2	7.5	22.3	13.1	2.7	9.9	5.0	7.6	23.7	11.2	0.5	11.3	13.2	1.9	6.4	17.1	11.6	13.4	9.1	9.0	8.0	12.3	7.6	13.7	5.3	7.3	4.8	1.3	0.0	15.1	7.2	21.7	0.7	2.8	0.5	10.7	8.4	10.8	1.9	9.7	9.7	5.6	1.4	9.4	7.1	0.9	9.9	9.5	0.9	8.2	5.9	6.2	6.9	1.9	6.3	8.6	5.1	5.9	5.1	8.2	6.0	8.9	10.9	5.4	9.8	7.8	2.1	2.5	7.6	6.7	10.3	15.7	0.0	42.2	3.3	13.7	4.2	14.7	31.4	0.0	13.3	16.6	5.1	9.2	1.1	14.0	13.8	4.8	14.5	17.8	9.4	4.9	8.6	7.1	3.3	18.0	15.3	20.4	13.7	28.1	7.1	11.2	0.8	12.9	6.2	2.6	2.6	6.0	31.9	5.7	11.5	9.5
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401545	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 57.2;smooth muscle: 41.1"	"Cell type enhanced"	"Detected in some"	15	"Basal keratinocytes: 24.8;Early spermatids: 36.8;Muller glia cells: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	47	"memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	58	"B-cells: 4.9;dendritic cells: 7.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.5;ASC TERT1: 31.0;BJ: 23.4;fHDF/TERT166: 43.5;HBF TERT88: 28.1;U-2197: 69.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035740	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	1.9	19.5	13.4	3.8	12.5	0.2	1.4	0.3	16.0	17.2	7.7	6.7	7.3	2.7	57.2	7.8	17.4	1.9	15.1	3.2	9.8	1.1	21.4	1.2	15.3	2.9	1.0	6.4	2.4	1.7	0.1	4.3	3.3	0.2	17.6	4.9	0.9	10.6	21.5	0.4	7.4	4.5	41.1	0.8	3.2	3.1	3.1	4.6	0.8	1.5	7.7	7.7	9.4	8.6	4.9	7.8	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	38.5	31.0	0.0	23.4	15.9	8.6	15.1	0.0	0.2	0.1	0.0	43.5	7.1	0.0	0.3	0.1	28.1	0.0	4.3	0.0	0.0	0.0	0.3	0.0	0.0	7.3	0.0	17.3	0.5	10.7	0.0	0.0	0.0	1.7	5.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.1	0.0	10.5	0.0	0.6	0.0	0.0	0.1	0.5	2.3	0.0	1.3	0.1	3.9	3.7	69.7	12.2	0.9	0.0	0.0	10.0	0.0	11.5	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.3	13.4	12.5	0.3	16.0	9.8	1.1	1.0	6.4	0.2	4.6	0.0	2.2	3.4	0.4	24.8	0.2	0.6	0.0	0.0	4.5	1.8	0.0	0.6	0.0	0.4	36.8	0.0	0.0	0.0	0.0	1.0	9.6	0.2	3.5	0.0	0.4	0.0	0.0	0.0	0.0	6.8	0.3	0.6	6.8	0.0	0.0	14.0	0.4	0.0	0.4	0.0	0.8	0.0	0.4	0.5	0.4	5.9	0.0	0.0	0.0	0.0
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170226	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	13.7	15.5	32.0	17.5	25.1	12.3	54.1	37.1	32.6	18.5	16.0	9.3	7.0	9.9	18.9	17.1	26.5	11.9	12.3	9.4	25.4	22.2	12.0	11.5	13.6	16.1	17.5	21.9	10.4	7.2	13.6	43.5	17.4	24.0	11.3	18.7	10.8	18.1	10.3	15.4	28.4	11.0	16.8	31.7	12.7	11.2	9.9	17.9	10.8	8.7	12.9	18.2	19.6	18.5	18.6	24.6	19.4	25.2	17.1	28.3	15.6	19.6	10.7	24.1	11.7	11.7	16.6	13.3	21.2	25.5	18.5	9.0	17.3	11.5	16.2	12.9	11.6	13.7	20.7	22.9	22.0	24.9	12.0	15.0	13.0	9.0	31.1	11.7	32.3	20.2	10.4	19.8	11.0	31.7	9.4	21.2	22.7	30.5	4.6	28.1	15.9	24.8	38.2	22.0	24.5	14.9	30.8	11.1	10.7	16.7	20.7	16.5	7.1	35.7	15.9	15.2	10.3	27.9	20.1	16.6	17.4	17.3	15.3	15.0	6.8	16.4	64.4	15.7	26.6	22.0	13.0	22.0	19.4	22.3	25.2	28.3	18.6	23.1	23.2	24.6	14.6	24.8	23.6	2.7	17.1	17.4	14.7	23.0	15.6	32.0	25.1	37.1	32.6	25.4	22.2	17.5	21.9	24.0	17.9	17.9	37.6	25.3	34.6	34.5	13.8	29.0	12.7	34.8	35.2	19.2	9.8	52.1	43.1	41.7	4.8	14.3	15.1	46.7	24.5	35.8	39.3	21.5	17.4	13.0	43.1	19.1	8.6	19.0	33.6	7.6	10.3	56.9	30.4	71.3	17.4	31.2	42.3	28.1	9.6	33.9	22.5	19.4	25.8	30.3	54.8	47.2	27.5	22.9	28.6	40.1
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		170000	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	13.6	33.3	24.2	11.2	26.2	7.4	14.7	19.2	33.7	16.7	22.6	26.1	15.3	32.6	15.7	26.8	17.1	20.7	13.4	28.8	22.7	22.2	22.5	30.2	10.6	16.2	28.1	28.3	23.2	34.2	24.7	15.0	11.4	37.4	20.6	23.1	18.3	18.6	17.9	33.3	11.7	27.4	16.4	21.7	14.7	14.3	23.5	17.7	16.4	17.1	15.0	16.6	15.6	11.7	12.8	10.2	2.4	7.4	17.7	27.1	12.9	10.6	14.7	12.2	13.8	28.0	13.6	10.7	9.2	15.0	15.8	22.1	14.5	14.1	15.1	20.0	13.4	12.6	26.6	24.2	26.7	15.0	11.5	30.3	27.1	14.0	15.6	19.9	12.5	8.0	18.1	6.9	14.8	26.7	24.0	21.4	18.2	9.0	12.4	20.3	9.1	13.3	5.5	6.7	16.1	12.6	13.7	11.5	37.0	18.5	12.1	22.9	10.0	10.7	19.4	11.5	18.7	26.5	8.6	9.6	9.5	8.1	7.0	8.9	30.8	18.2	9.9	19.8	18.1	6.9	0.7	7.2	2.4	13.5	7.4	17.5	12.8	18.3	15.4	10.2	12.5	27.1	19.7	1.1	17.7	6.3	8.5	22.7	12.9	24.2	26.2	19.2	33.7	22.7	22.2	28.1	28.3	37.4	17.7	6.0	15.9	13.7	6.7	1.6	21.7	47.5	10.2	5.3	7.9	14.0	3.9	26.1	13.3	15.5	13.7	8.7	34.2	0.0	7.5	9.1	12.2	5.4	15.0	15.8	20.6	33.4	10.4	6.2	5.3	24.3	10.3	5.6	3.3	11.8	18.1	18.3	14.3	17.3	8.1	25.8	16.8	6.5	6.6	23.8	10.1	2.4	13.6	6.9	11.8	4.7
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.2"	"Cell type enriched"	"Detected in single"	30	"granulocytes: 9.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.0;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.8;NK-cells: 3.0"	"Cell line enriched"	"Detected in single"	17	"HEL: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		7400000	"Golgi apparatus"	"Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol"	"HPA054404: , HPA073017: AB_2686566"	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.8	0.2	0.0	1.2	0.5	5.3	0.7	0.1	0.4	1.0	0.9	0.0	0.0	0.9	1.0	0.8	2.0	0.7	1.5	7.4	0.2	0.0	0.4	0.5	7.6	2.8	1.0	0.0	2.7	0.2	0.2	0.2	1.4	0.7	0.9	0.2	1.1	1.8	0.3	1.2	10.5	0.8	1.9	0.6	33.2	0.4	2.7	0.1	1.2	1.0	1.4	0.8	1.6	1.6	0.2	1.8	0.5	0.1	3.0	0.1	5.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.5	3.0	0.1	1.8	0.0	5.7	0.0	0.5	0.1	0.4	0.2	0.0	1.0	0.0	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MPND	FLJ14981	ENSG00000008382	"MPN domain containing"	Q8N594	19	4343527-4360086	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043274, HPA045475"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		No	No			"Nucleoli rim"	Nucleoplasm	"HPA043274: AB_2678403, HPA045475: AB_2679339"	"unprognostic (3.16e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.85e-2)"	"prognostic favorable (6.12e-4)"	"unprognostic (8.60e-2)"	"unprognostic (5.37e-3)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.04e-2)"	7.7	13.7	18.9	14.1	12.3	11.5	8.0	12.1	21.6	6.5	19.9	6.6	15.7	25.9	8.5	7.8	13.8	8.2	11.8	12.1	14.2	11.3	12.8	25.1	14.3	8.5	12.7	20.0	8.7	20.7	14.5	7.2	7.0	11.9	12.1	13.9	11.5	14.3	9.0	17.4	12.5	20.7	9.3	8.9	10.1	12.5	4.2	6.7	13.5	8.6	8.3	10.1	9.3	11.0	3.1	4.5	10.3	6.0	2.4	5.6	1.9	7.9	6.7	11.1	12.7	7.0	3.3	11.3	3.9	3.8	3.2	4.0	12.9	4.1	7.2	12.2	5.0	9.5	8.2	5.0	6.7	1.8	8.1	11.3	5.5	9.5	20.9	5.6	7.4	10.0	5.0	4.9	3.5	3.7	5.0	9.9	19.2	2.9	18.8	4.0	23.0	17.4	6.3	5.1	13.5	9.7	14.3	3.4	10.4	8.2	14.1	12.4	12.7	7.1	10.0	5.3	6.6	6.7	9.1	3.7	5.2	5.6	31.4	7.7	15.7	9.6	4.8	5.7	4.1	5.9	10.3	5.1	2.4	2.2	6.0	3.4	1.8	2.6	3.1	4.5	3.1	1.7	1.9	1.2	2.4	2.7	4.5	5.6	1.9	18.9	12.3	12.1	21.6	14.2	11.3	12.7	20.0	11.9	6.7	0.0	3.0	4.5	6.6	4.7	7.2	11.5	10.2	1.4	3.4	10.4	2.0	11.3	0.0	4.3	0.5	4.9	65.9	0.0	4.4	9.3	3.9	9.1	4.6	21.2	13.6	6.4	16.0	6.7	23.8	2.2	5.8	10.2	3.3	6.4	27.9	3.9	4.9	32.5	3.5	11.4	3.4	6.5	5.1	0.0	5.3	7.3	8.7	5.3	28.8	7.1
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269856-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 315.2"	"Cell type enhanced"	"Detected in some"	11	"Distal tubular cells: 1.7;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0"	"Group enriched"	"Detected in many"	30	"dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6"	"Group enriched"	"Detected in some"	93	"HL-60: 218.1;NB-4: 285.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	15000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.2	0.1	0.5	0.1	0.8	315.2	0.1	0.4	1.0	0.1	0.1	1.4	0.0	0.1	0.2	0.2	0.1	0.1	0.1	21.5	0.6	0.8	0.1	1.4	6.9	0.8	0.6	0.0	0.6	0.1	0.1	1.0	2.9	0.4	0.2	0.1	0.2	6.3	0.1	0.7	0.5	0.1	0.1	0.4	17.8	0.1	0.4	0.2	19.7	0.6	0.0	0.5	0.1	0.0	0.0	3.2	2.0	7.6	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	285.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.1	7.2	0.5	0.8	0.4	1.0	0.6	0.8	0.6	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	1.2	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
MPP1	"DXS552E, PEMP"	ENSG00000130830	"Membrane palmitoylated protein 1"	Q00013	X	154778684-154821007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 338.8;Erythroid cells: 163.5;Hofbauer cells: 251.9;Syncytiotrophoblasts: 380.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 46.4;neutrophil: 45.3"	"Group enriched"	"Detected in all"	7	"dendritic cells: 12.7;granulocytes: 46.4;monocytes: 20.9"	"Cell line enhanced"	"Detected in many"		"HEL: 59.4;REH: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076675	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		4300000	"Plasma membrane"	"Centriolar satellite"	"HPA076675: "	"unprognostic (2.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.60e-6)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.67e-3)"	18.7	18.2	12.7	14.4	19.2	52.9	9.9	25.8	30.9	7.1	18.3	10.0	15.1	32.0	8.9	9.5	6.1	10.0	13.5	14.1	14.3	13.0	23.3	20.4	18.2	11.9	15.9	13.5	7.2	18.9	19.5	6.5	45.6	28.8	9.1	10.1	6.4	17.1	10.9	14.6	6.3	42.7	11.0	15.8	27.4	7.9	4.1	7.4	27.1	8.3	6.4	6.9	10.0	7.1	1.6	12.7	46.4	20.9	2.0	3.8	15.8	11.3	2.3	5.3	5.3	5.5	5.8	17.1	4.3	6.5	7.2	8.9	6.4	1.0	8.8	8.4	4.7	19.3	1.3	6.0	1.9	5.7	9.4	10.6	59.4	1.6	6.8	8.3	12.1	34.5	5.6	2.5	7.9	2.0	7.4	16.3	12.0	25.6	1.4	8.1	0.0	27.4	16.0	0.5	1.0	7.8	37.5	1.3	4.2	4.1	0.9	1.3	2.1	3.5	0.3	3.7	5.5	0.9	7.1	7.5	6.6	3.6	14.5	11.5	10.4	14.2	3.4	9.3	17.0	3.1	9.0	20.9	46.4	1.2	16.7	1.4	1.6	1.4	1.3	12.7	0.7	3.8	1.9	45.3	2.0	20.3	3.5	0.7	15.8	12.7	19.2	25.8	30.9	14.3	13.0	15.9	13.5	28.8	7.4	3.0	15.7	7.6	4.2	7.7	10.2	15.7	25.5	4.0	11.4	7.0	3.9	338.8	18.3	8.9	0.5	15.7	22.0	163.5	2.4	10.5	13.4	3.6	87.8	9.6	251.9	15.9	11.1	9.2	95.5	1.9	8.1	69.1	10.1	33.3	4.1	14.8	4.2	4.3	12.4	51.8	6.7	0.0	12.0	0.7	2.5	5.3	380.0	8.9	4.6	0.7
MPP2	"DKFZp761D0712, DLG2"	ENSG00000108852	"Membrane palmitoylated protein 2"	Q14168	17	43875357-43909711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 89.3;Early spermatids: 63.3;Horizontal cells: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026486, HPA073483"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA026486: AB_1854085, HPA073483: "	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (4.37e-2)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.89e-4)"	2.1	5.0	12.1	2.1	11.8	1.1	3.1	19.5	26.3	3.5	5.1	19.8	2.7	1.9	4.6	31.0	4.1	3.3	3.0	9.0	13.8	14.2	2.0	0.9	2.0	1.2	15.3	14.4	2.8	4.4	31.1	8.4	3.4	11.5	7.1	2.0	6.5	2.3	10.7	1.7	2.0	2.0	6.5	20.3	1.3	2.5	13.8	12.3	0.0	4.5	0.0	1.4	3.6	2.8	0.1	0.0	0.0	0.1	0.0	1.9	0.7	4.9	7.2	7.8	11.3	1.1	0.7	4.3	1.7	0.2	6.8	6.4	2.5	3.3	7.1	4.0	1.7	8.7	2.0	10.5	4.1	5.3	0.0	8.0	0.6	6.7	0.1	0.2	0.0	2.1	1.1	0.3	4.9	0.0	3.8	0.4	11.6	2.6	0.0	2.0	1.9	1.0	0.5	14.0	0.6	4.5	5.0	11.2	0.5	0.1	0.1	8.4	7.8	2.1	0.7	2.9	7.3	17.2	3.4	0.1	7.5	9.6	2.9	3.1	2.4	4.9	0.0	11.4	4.8	1.4	0.0	0.1	0.0	1.4	0.0	0.2	0.0	0.5	1.2	0.0	0.1	1.6	1.9	0.0	0.0	0.0	0.0	0.1	0.7	12.1	11.8	19.5	22.5	13.8	14.2	15.3	14.4	11.5	12.3	0.0	0.0	0.0	1.5	0.3	89.3	8.5	0.0	0.0	0.0	0.0	2.0	4.5	0.0	0.5	63.3	0.5	0.0	0.0	0.3	0.3	2.4	0.0	0.0	0.0	0.6	33.4	0.0	0.0	0.0	16.0	3.4	0.0	0.0	0.0	0.0	15.3	0.8	0.0	5.3	0.0	6.4	0.0	2.8	18.2	18.0	0.1	2.3	0.0	0.0	0.0
MPP3	DLG3	ENSG00000161647	"Membrane palmitoylated protein 3"	Q13368	17	43800799-43833170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 24.5;Early spermatids: 39.4;Late spermatids: 56.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 46.7;pons and medulla: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 6.6;SCLC-21H: 13.3;T-47d: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021818, HPA024742"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021818: AB_1854086, HPA024742: AB_1854087"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.23e-5)"	"unprognostic (4.59e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.02e-11)"	"unprognostic (9.98e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.75e-2)"	5.1	2.0	4.8	2.1	2.9	0.6	5.1	46.7	5.2	3.3	1.7	2.2	4.5	1.4	3.5	4.0	3.0	2.7	5.4	12.3	2.7	5.0	2.1	1.2	7.4	1.3	3.0	1.5	1.7	5.9	3.0	2.6	2.1	13.0	3.0	1.1	1.7	1.6	4.3	1.5	2.4	1.3	3.5	2.5	2.2	4.3	3.7	1.1	0.0	1.7	0.9	1.4	1.6	4.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.6	3.1	0.8	0.8	1.8	1.4	0.0	1.6	0.6	1.2	0.7	1.2	1.9	0.0	0.6	1.3	0.8	1.5	1.2	2.3	1.8	0.0	1.6	1.5	3.7	0.7	0.1	0.0	0.1	0.9	3.1	2.1	6.6	3.7	1.6	0.3	0.9	0.0	0.6	0.9	0.0	0.0	0.8	0.7	1.2	0.0	1.0	0.4	4.4	0.6	13.3	3.5	0.8	2.8	0.5	1.1	7.1	1.6	1.4	3.5	3.3	0.9	3.0	0.9	0.4	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	2.9	46.7	3.3	2.7	5.0	3.0	1.5	13.0	1.1	11.9	2.6	0.0	5.5	3.5	1.9	24.5	7.6	0.0	6.8	1.8	0.0	0.1	0.0	3.4	39.4	2.7	0.7	0.0	1.2	0.5	2.6	4.8	1.1	0.9	0.9	9.5	1.2	1.3	0.0	56.6	3.4	2.8	1.7	2.8	0.9	0.8	2.2	3.1	2.5	0.3	1.9	6.5	4.1	0.7	1.9	2.4	0.1	0.0	1.7	2.5
MPP4	DLG6	ENSG00000082126	"Membrane palmitoylated protein 4"	Q96JB8	2	201644870-201698694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 78.2"	"Group enriched"	"Detected in many"	41	"Cone photoreceptor cells: 1494.2;Rod photoreceptor cells: 807.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 11.2;hTEC/SVTERT24-B: 10.5;LHCN-M2: 42.4;TIME: 8.4;U-87 MG: 11.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 8.1"	HPA057393			Supported	"Actin filaments,Cytosol"		No	No			Cytosol	"Actin filaments"	"HPA057393: AB_2732612"	"unprognostic (1.42e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.33e-16)"	"unprognostic (1.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	0.4	1.7	0.3	0.5	0.6	0.0	0.3	4.9	1.1	1.2	0.2	0.2	0.2	0.0	0.8	0.4	0.3	0.1	0.4	0.2	0.5	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.0	0.7	0.7	0.3	0.3	0.3	78.2	0.2	0.5	0.6	4.1	0.2	0.3	0.2	3.8	0.1	2.2	0.2	0.2	0.6	0.6	0.2	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	5.5	1.3	3.4	3.3	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	10.5	0.0	1.6	6.2	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.4	4.3	1.3	0.9	3.8	0.0	0.0	0.0	11.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	4.9	0.6	0.5	0.4	0.2	0.2	0.3	0.2	3.0	10.4	0.0	0.0	0.3	13.4	0.3	2.5	12.0	11.4	1.8	1494.2	0.1	0.0	0.2	2.9	0.1	0.0	0.0	0.2	0.0	0.3	0.0	3.5	0.0	0.1	17.5	0.0	0.0	0.3	2.1	0.0	0.3	1.7	0.0	0.0	28.2	0.1	0.0	0.0	0.0	807.6	0.0	1.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67241109-67335819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.1	9.2	14.8	6.8	29.2	7.0	10.1	9.4	18.0	9.0	12.5	15.9	13.7	18.5	6.9	20.8	14.4	7.2	9.0	7.3	16.4	17.0	28.8	17.2	11.5	4.5	30.6	10.2	6.4	8.6	22.9	11.4	27.9	20.5	15.8	11.6	7.6	15.9	18.6	14.6	8.6	18.7	11.9	23.3	6.2	9.7	8.2	25.4	6.8	24.1	6.9	5.8	9.1	9.1	3.6	2.4	3.7	2.8	6.7	4.4	1.2	54.9	8.8	8.9	7.2	5.2	4.7	7.9	16.8	8.8	12.3	8.3	8.7	16.9	4.7	8.0	13.6	4.3	11.5	5.1	9.7	18.9	2.2	3.5	4.3	9.3	6.0	6.0	1.6	3.3	5.0	3.7	7.1	9.1	8.9	6.8	5.4	4.5	2.1	19.6	7.4	5.2	2.0	3.0	8.0	6.0	4.7	14.2	5.6	11.2	13.7	5.0	3.6	10.4	10.2	5.8	8.2	10.5	3.3	10.6	15.7	33.4	5.5	7.3	3.2	2.9	7.2	10.5	3.7	5.4	0.4	2.2	3.7	1.7	2.8	1.4	3.6	2.0	1.9	2.4	1.9	4.4	2.4	0.8	6.7	2.3	2.4	1.1	1.2	14.8	29.2	9.4	18.0	16.4	17.0	30.6	10.2	20.5	25.4	59.6	21.6	6.0	21.7	18.7	9.4	22.4	12.7	9.4	17.0	21.0	41.2	18.5	11.6	19.2	4.4	14.3	41.0	0.0	23.5	8.9	16.6	25.6	4.7	16.8	14.2	3.2	5.2	16.5	9.6	3.9	7.5	7.2	3.3	7.2	18.4	24.1	20.2	31.6	10.6	28.4	34.5	6.5	19.6	8.3	33.8	15.2	14.6	4.4	19.5	31.5
MPPED2	"239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638"	ENSG00000066382	"Metallophosphoesterase domain containing 2"	Q15777	11	30384493-30586872	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 31.0;thyroid gland: 30.0"	"Cell type enhanced"	"Detected in many"	21	"Cone photoreceptor cells: 269.0;Horizontal cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 19.2;HAP1: 11.4;JURKAT: 10.0;RT4: 8.0;SH-SY5Y: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062575			Approved	Nucleoli,Vesicles,Mitochondria		NA	NA			Nucleoli	"Vesicles, Mitochondria"	"HPA062575: AB_2684797"	"unprognostic (9.60e-3)"	"unprognostic (6.12e-3)"	"unprognostic (3.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-4)"	"unprognostic (6.82e-2)"	"unprognostic (2.47e-7)"	"unprognostic (3.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.57e-2)"	2.9	7.0	6.3	1.7	19.3	1.1	5.5	4.6	8.9	31.0	4.2	1.8	4.4	1.5	8.3	7.9	1.6	11.1	1.9	4.6	8.5	9.7	12.2	1.2	1.1	0.9	7.0	6.7	1.2	2.5	5.0	10.7	2.5	11.2	15.6	1.4	7.1	12.1	10.1	5.7	1.0	1.4	5.1	4.6	3.1	1.9	3.8	3.4	9.1	30.0	1.2	1.0	4.7	4.9	1.3	0.7	0.3	0.2	2.0	4.8	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	11.4	0.0	0.0	0.0	2.1	0.0	0.2	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.8	0.0	0.2	3.2	0.1	0.0	0.0	3.1	0.2	0.0	8.0	0.1	6.1	0.0	0.0	3.1	1.3	1.7	0.0	0.1	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.9	0.0	4.8	0.0	0.0	0.6	0.4	1.3	1.3	0.2	0.2	2.0	0.0	0.7	0.1	0.2	6.3	19.3	4.6	8.8	8.5	9.7	7.0	6.7	11.2	3.4	0.0	2.1	0.0	47.3	0.9	23.4	3.1	0.0	5.3	0.0	43.6	269.0	0.2	21.6	2.9	1.6	5.0	0.0	0.0	0.0	0.1	4.1	21.0	4.7	0.2	3.2	77.9	0.0	0.6	15.9	0.5	0.3	2.3	5.0	0.0	0.0	40.1	0.1	0.0	3.2	2.2	17.1	0.0	1.4	0.1	0.7	1.0	0.5	0.0	0.0	18.4
MPRIP	"M-RIP, p116Rip, RHOIP3"	ENSG00000133030	"Myosin phosphatase Rho interacting protein"	Q6WCQ1	17	17042545-17217679	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 27.5"	"Lineage enriched"	"Detected in all"	6	"T-cells: 27.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022034, HPA022901"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA022034: AB_1854093, HPA022901: AB_2297761"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.81e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	46.5	38.7	46.7	33.7	58.8	27.7	47.4	47.7	62.0	48.4	35.3	45.8	31.9	36.1	54.9	40.9	51.6	32.9	38.2	63.7	46.9	39.7	30.2	31.3	40.2	34.5	46.8	44.9	33.5	46.6	55.0	35.8	37.4	36.5	33.4	29.0	41.0	34.0	46.8	66.7	35.1	32.9	63.0	38.2	35.3	45.9	31.4	47.7	19.9	38.4	30.1	35.4	39.8	55.3	4.4	4.8	1.5	1.2	1.9	27.5	5.0	59.7	43.8	18.8	15.4	20.0	15.0	28.3	30.9	21.3	24.4	18.3	33.9	44.0	23.5	31.8	45.2	20.0	57.4	23.8	41.0	25.7	24.2	12.6	12.8	37.6	11.9	13.5	6.7	10.2	14.3	24.8	27.3	21.1	34.9	25.1	17.6	7.9	13.3	39.0	19.7	27.4	23.0	9.1	56.9	50.5	24.4	30.6	8.7	18.6	27.5	10.8	17.6	32.8	26.9	14.7	80.2	12.6	10.6	24.3	22.8	25.8	60.4	52.7	10.4	8.2	10.9	41.2	12.2	54.3	1.1	1.2	1.5	4.5	0.8	9.2	4.4	17.5	7.3	1.1	3.8	12.6	6.0	0.5	1.9	0.8	4.8	27.5	5.0	46.7	58.8	47.7	62.0	46.9	39.7	46.8	44.9	36.5	47.7	29.8	40.0	22.0	18.6	24.0	107.8	52.3	38.2	24.1	31.8	24.4	76.6	22.0	3.3	28.6	25.8	47.2	27.1	23.3	24.7	31.0	37.5	32.3	16.1	17.5	10.5	92.2	21.8	33.7	9.4	22.6	27.0	15.1	30.4	1.8	17.1	26.6	59.6	23.0	40.7	7.3	45.9	77.6	90.5	19.2	26.5	24.0	26.5	24.9	25.9	105.7
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029822	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 780.2;Hepatocytes: 473.7;Paneth cells: 550.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2800000	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	8.7	7.2	4.5	6.8	6.4	10.5	22.7	2.6	5.4	8.8	39.1	8.0	2.8	36.8	6.1	3.0	19.8	4.3	15.3	14.1	4.6	2.3	14.1	106.2	10.3	5.4	8.8	3.8	12.6	20.7	0.7	2.7	4.2	5.6	6.6	5.7	3.8	13.4	3.9	11.5	15.9	33.7	4.8	4.8	4.1	12.8	24.9	7.1	2.1	6.3	6.2	5.1	8.7	11.6	9.6	37.1	18.5	26.5	28.8	16.1	12.5	14.3	17.0	8.3	17.1	9.8	6.1	13.2	7.8	7.1	8.6	11.5	16.2	6.4	22.6	11.4	5.6	5.7	10.1	7.2	11.4	1.2	13.6	40.3	8.7	7.4	38.0	31.0	9.4	12.2	10.6	22.2	5.6	5.2	7.9	17.3	11.2	15.5	6.6	2.3	11.1	0.8	32.0	15.7	18.8	17.7	24.3	9.9	16.8	8.6	4.7	4.2	32.0	5.2	8.3	14.9	4.4	8.9	15.2	13.3	7.4	21.0	8.1	5.3	11.6	5.3	6.8	2.6	11.5	3.7	15.3	26.5	18.5	11.8	9.4	16.1	9.6	7.7	9.9	37.1	9.6	1.1	4.1	7.9	28.8	4.3	6.0	15.2	12.5	4.5	6.4	2.6	5.4	4.6	2.3	8.8	3.8	5.6	7.1	32.8	55.2	24.6	70.3	72.5	4.6	26.6	188.5	1.4	19.4	57.6	0.0	50.1	112.7	124.1	138.8	35.9	780.2	116.8	129.7	102.0	53.0	67.5	17.3	473.7	65.5	3.2	104.3	84.7	67.1	60.3	84.3	59.9	55.6	57.7	299.4	16.4	119.7	550.6	79.5	318.0	2.6	45.3	28.3	7.9	12.0	133.6	41.9	42.6	311.7	103.6
MPZL1	"FLJ21047, PZR"	ENSG00000197965	"Myelin protein zero like 1"	O95297	1	167721192-167791919	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026966, HPA063538"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA026966: AB_10600931, HPA063538: AB_2685034"	"unprognostic (6.54e-2)"	"unprognostic (9.26e-3)"	"unprognostic (4.59e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.27e-6)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (3.55e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (4.21e-2)"	34.4	19.1	13.6	21.4	13.9	3.2	42.0	14.3	13.7	32.2	27.3	15.4	15.9	18.5	34.8	25.2	32.1	30.1	34.3	29.2	12.0	14.0	22.2	20.9	22.2	20.7	14.4	10.0	38.3	25.4	13.7	24.3	34.0	14.3	28.3	28.2	28.0	51.7	19.4	11.0	17.7	26.6	30.5	13.0	19.6	21.3	27.7	10.9	9.7	29.0	25.8	28.0	33.6	35.0	4.2	12.5	51.4	8.9	2.9	2.4	3.0	18.1	26.5	20.8	16.1	67.3	30.5	65.9	28.4	36.8	18.6	23.2	48.9	25.4	6.4	33.3	35.9	16.4	30.7	20.7	31.4	15.8	14.5	11.2	5.3	14.2	11.7	41.9	6.2	3.4	28.0	39.7	29.7	33.4	26.3	24.7	19.7	19.7	13.5	22.0	6.0	20.9	7.4	13.2	36.6	11.4	12.8	17.9	28.3	28.5	17.6	12.1	19.9	25.3	26.4	14.6	50.2	14.2	3.3	28.0	21.4	9.6	27.4	15.3	20.3	31.3	29.8	30.6	7.3	3.3	1.9	8.1	5.4	0.8	6.8	0.4	4.2	0.8	1.2	10.9	2.5	2.4	0.8	51.4	2.9	8.9	12.5	0.1	3.0	13.6	13.9	14.3	13.7	12.0	14.0	14.4	10.0	14.3	10.9	26.8	25.9	20.1	58.0	67.9	7.6	5.3	20.4	21.4	37.5	19.2	5.9	107.3	5.0	59.9	1.4	40.7	44.8	0.0	66.1	111.2	70.6	98.3	3.5	16.9	33.1	9.5	45.9	22.7	24.2	2.4	64.7	22.2	15.1	124.4	41.1	10.6	61.2	28.8	78.8	10.2	13.2	19.4	47.4	9.7	24.9	48.6	64.3	5.2	51.7	53.8
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253403-118264536	"Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 405.2;Basal keratinocytes: 295.4;Suprabasal keratinocytes: 408.6;Urothelial cells: 416.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 9.3;intermediate monocyte: 7.2;myeloid DC: 13.4;neutrophil: 10.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 13.4;granulocytes: 10.9;monocytes: 9.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.3;EFO-21: 27.9;HaCaT: 34.9;RT4: 66.3;TIME: 72.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	11.7	1.7	1.5	2.8	1.5	0.0	17.1	1.5	1.6	31.0	8.5	1.0	26.3	4.4	6.8	17.8	103.8	13.4	12.3	4.7	2.4	1.5	11.7	7.9	21.7	1.8	2.4	0.6	7.4	4.6	10.2	9.2	1.5	4.0	17.8	8.7	6.2	21.6	32.8	7.8	11.4	4.4	5.6	4.3	1.3	10.0	3.7	1.3	5.7	21.7	52.3	41.1	29.4	37.4	0.0	13.4	10.9	9.3	0.3	1.0	2.8	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	25.3	0.0	27.9	0.0	0.1	34.9	0.0	8.0	0.0	0.0	2.0	0.0	0.3	7.3	0.0	0.0	0.0	0.0	19.2	0.0	0.6	0.0	18.2	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.3	7.0	0.0	0.0	0.0	1.3	3.1	66.3	0.0	0.0	1.2	12.9	0.0	0.1	5.5	0.1	72.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	9.3	2.3	0.1	7.2	1.0	0.0	0.5	0.4	13.4	0.0	0.6	0.7	10.9	0.3	1.0	0.2	0.2	2.8	1.5	1.5	1.5	1.6	2.4	1.5	2.4	0.6	4.0	1.3	77.4	91.1	0.0	405.2	295.4	0.0	3.4	28.1	46.8	146.7	122.1	0.0	1.0	0.0	32.1	0.0	28.8	29.1	0.0	45.6	0.1	7.2	133.5	6.9	13.6	0.8	0.0	5.1	23.4	4.0	0.0	0.0	11.0	20.3	0.0	3.3	0.0	45.3	14.8	0.0	5.6	0.0	0.0	7.1	0.0	0.6	408.6	14.9	2.6	32.4	416.5
MPZL3		ENSG00000160588	"Myelin protein zero like 3"	Q6UWV2	11	118226690-118252350	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 55.8;Urothelial cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 11.4;eosinophil: 33.0;MAIT T-cell: 10.6;neutrophil: 30.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 33.0;T-cells: 10.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.7;HMC-1: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029116			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA029116: AB_10610142"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.20e-1)"	3.5	0.7	0.8	3.6	3.0	5.2	7.1	6.9	1.4	9.2	5.5	0.5	8.4	4.3	5.2	6.8	28.5	4.4	8.7	1.4	0.8	1.0	4.7	9.4	10.6	4.4	0.8	0.4	1.5	9.0	7.4	12.4	2.6	2.4	5.3	5.1	1.4	19.6	11.1	1.0	23.1	8.3	1.5	1.2	5.4	5.6	2.6	0.4	5.8	7.3	27.1	32.6	6.5	12.8	0.6	2.8	33.0	2.1	2.8	10.6	1.7	3.2	0.4	0.0	0.5	0.0	0.0	0.5	0.4	0.0	0.0	0.1	11.1	17.7	3.2	8.6	0.0	1.3	4.6	0.8	3.7	0.1	0.2	1.3	2.0	0.9	5.3	0.1	2.6	20.0	0.2	9.4	0.0	3.7	0.0	6.0	2.2	2.5	1.8	0.0	11.2	1.2	1.4	1.6	10.9	0.8	0.0	0.0	4.8	6.8	4.2	2.3	0.2	4.4	5.8	0.3	0.9	10.5	1.4	2.8	0.1	0.9	0.0	0.1	0.3	3.2	2.0	0.1	0.1	0.2	11.4	2.1	33.0	2.6	1.2	10.6	0.6	4.2	3.5	2.8	0.6	3.2	2.5	30.6	2.8	0.8	0.3	2.8	1.7	0.8	3.0	6.9	1.4	0.8	1.0	0.8	0.4	2.4	0.4	14.9	24.0	0.8	20.0	31.6	0.3	1.4	5.1	22.7	9.1	8.7	2.0	0.6	0.0	9.4	6.5	3.8	10.6	0.0	7.5	0.5	1.7	30.2	1.1	6.6	1.1	0.0	11.5	0.6	6.8	4.9	0.0	6.9	10.1	0.0	4.0	0.3	12.7	7.0	0.4	0.6	1.6	0.0	2.0	0.5	1.1	55.8	1.4	26.1	6.7	36.6
MRAS	"M-RAs, R-RAS3, RRAS3"	ENSG00000158186	"Muscle RAS oncogene homolog"	O14807	3	138347648-138405534	"Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 69.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 103.5;Distal tubular cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 18.9"	"Lineage enriched"	"Detected in many"	9	"monocytes: 18.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;BJ: 31.3;EFO-21: 39.0;fHDF/TERT166: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042728	Approved		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA042728: AB_10796582"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.69e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.23e-2)"	49.3	32.6	32.0	6.4	37.6	1.3	17.7	12.3	37.3	6.4	5.4	9.4	1.7	2.3	11.9	5.2	5.1	6.8	8.6	69.1	29.0	23.9	8.9	3.7	8.9	3.3	31.3	18.0	17.2	3.4	7.6	4.7	6.9	25.2	7.6	3.4	8.2	8.0	12.0	22.5	2.7	2.7	16.9	21.5	7.3	3.4	5.9	19.3	0.0	12.1	2.4	2.8	10.0	6.4	0.0	2.1	0.3	18.9	0.6	0.0	0.5	0.2	2.5	6.7	8.8	29.2	13.4	13.9	31.3	7.9	3.2	3.9	1.1	1.0	0.1	39.0	30.6	8.3	0.0	3.3	0.7	2.5	2.7	1.0	0.1	1.6	6.4	7.4	0.0	0.6	19.2	3.0	0.2	0.5	5.9	0.5	0.0	3.5	0.2	14.4	1.1	0.0	7.6	7.3	0.0	0.9	0.3	12.2	0.0	14.1	0.6	7.0	15.5	20.5	0.2	16.4	5.0	6.0	15.2	0.1	8.2	9.3	8.9	0.8	0.0	0.3	0.3	8.3	0.0	4.5	0.1	1.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.6	18.9	0.1	0.0	0.5	32.0	37.6	12.3	28.9	29.0	23.9	31.3	18.0	25.2	19.3	8.9	1.0	0.5	2.6	1.9	4.1	103.5	5.1	1.4	4.5	8.7	9.8	16.8	49.7	8.5	9.6	16.3	0.0	0.0	2.7	2.0	11.9	1.9	5.8	1.5	26.7	27.0	1.7	8.6	13.8	26.2	21.6	13.8	27.0	15.4	0.0	15.8	4.3	0.0	32.2	23.1	10.4	6.5	19.8	4.6	11.9	0.9	12.0	0.0	0.0	0.5
MREG	"DSU, FLJ10116, WDT2"	ENSG00000118242	Melanoregulin	Q8N565	2	215942805-216034096	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 56.9;monocytes: 36.9;Rod photoreceptor cells: 37.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 24.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 42.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068583			Approved	Vesicles		NA	NA			Vesicles		"HPA068583: AB_2686009"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.85e-3)"	"unprognostic (8.11e-3)"	"unprognostic (8.93e-2)"	"unprognostic (6.38e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.92e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.99e-2)"	5.6	5.8	3.1	4.3	4.5	3.4	16.0	24.4	6.6	6.1	3.6	0.9	11.8	4.2	2.2	5.6	25.8	4.0	1.8	1.7	2.9	3.7	3.8	12.1	12.4	8.3	4.1	2.4	1.6	4.1	6.1	10.6	10.0	6.4	1.8	4.0	18.6	5.0	4.9	1.0	14.3	3.4	1.1	3.0	2.7	4.7	1.6	1.7	9.6	4.6	11.9	18.5	3.5	11.3	2.8	4.9	2.0	0.2	2.0	3.5	0.3	9.6	2.4	2.7	1.6	2.0	1.2	6.5	3.4	2.7	2.4	4.4	12.7	7.6	3.4	3.1	1.9	5.4	6.2	8.6	12.6	5.1	6.8	7.3	4.7	2.5	19.4	1.1	2.8	1.8	1.8	5.6	2.6	3.4	2.1	1.9	7.2	2.6	8.2	1.5	42.6	8.1	2.6	11.3	5.9	2.3	4.5	6.6	5.0	5.6	14.3	7.7	4.1	2.0	17.3	17.7	6.9	9.6	1.2	0.2	4.5	1.3	2.3	4.9	11.5	6.9	8.0	3.0	10.2	3.4	2.0	0.1	0.2	1.9	0.0	3.5	2.8	1.7	2.8	0.3	1.3	0.8	1.2	0.8	2.0	0.2	4.9	2.9	0.3	3.1	4.5	24.4	6.6	2.9	3.7	4.1	2.4	6.4	1.7	3.0	11.2	4.2	8.7	2.4	10.8	0.7	2.5	5.3	15.9	7.0	56.9	16.3	3.3	2.6	0.3	1.0	2.9	0.0	2.1	3.4	1.6	6.0	1.1	6.8	13.8	1.6	1.7	1.3	0.6	0.0	2.3	3.6	5.0	36.9	2.2	3.9	5.1	3.5	7.1	1.0	37.7	6.5	0.4	0.7	3.2	1.4	21.6	2.9	2.4	19.5
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013409	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 34.7;Leydig cells: 61.2;Peritubular cells: 94.7;Sertoli cells: 51.8;Smooth muscle cells: 90.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 26.8;ASC TERT1: 12.0;BJ: 15.1;BJ hTERT+: 38.1;BJ hTERT+ SV40 Large T+: 14.3;fHDF/TERT166: 11.6;U-2197: 18.2"	"Region enriched"	"Detected in some"	5	"cerebellum: 16.6"	"Low region specificity"	"Detected in all"			HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	10.8	1.7	0.8	7.6	1.2	0.0	26.6	7.8	1.5	61.9	39.5	1.2	13.9	4.8	49.2	22.3	28.2	28.0	30.6	6.2	0.7	0.4	4.2	2.1	4.8	5.6	1.1	1.3	25.6	0.9	0.4	1.1	5.9	1.8	29.6	4.8	5.8	2.9	25.5	3.1	4.0	10.1	41.1	1.0	8.2	14.2	13.1	0.6	0.1	3.8	6.4	2.7	42.2	19.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.8	12.0	0.5	15.1	38.1	14.3	9.5	0.0	0.6	0.0	0.3	11.6	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.1	0.0	3.3	0.0	0.0	8.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.8	0.0	18.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	7.8	1.5	0.7	0.4	1.1	1.3	1.8	0.6	0.0	0.0	0.0	0.2	4.4	0.0	0.6	2.5	0.0	0.0	10.4	0.0	0.6	0.0	0.0	3.6	0.6	0.0	0.0	0.0	0.6	34.7	0.3	0.0	3.4	0.9	0.0	0.0	5.5	0.0	5.2	61.2	0.0	6.8	0.0	0.0	2.8	0.1	0.0	94.7	0.6	0.2	51.8	90.4	1.0	0.5	3.3	0.9	0.0	0.0	0.2
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764532-13774282	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No		2600000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: AB_2678141"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	14.5	18.5	12.5	21.8	18.3	16.6	16.8	24.5	21.8	21.5	17.2	23.6	23.5	19.0	24.2	21.3	20.7	19.9	17.6	13.5	14.6	12.1	24.4	20.1	15.4	19.5	16.5	14.3	24.0	20.5	21.3	17.3	24.2	17.2	17.8	13.4	18.5	23.4	21.6	13.0	28.6	18.5	13.3	16.6	22.0	19.8	5.0	16.7	20.0	21.8	10.5	18.2	18.1	20.6	5.7	8.9	6.9	5.8	5.0	6.6	3.6	10.7	8.0	4.0	9.6	4.4	8.2	9.8	12.8	7.4	11.6	10.6	8.4	8.6	5.8	5.1	4.7	5.5	18.1	18.6	13.2	7.1	10.1	32.2	4.6	12.7	9.0	3.9	13.9	10.8	8.2	7.3	5.9	4.7	10.5	10.7	5.7	8.8	0.3	5.0	15.8	15.4	8.9	6.6	3.9	22.9	14.5	5.4	13.1	5.9	8.4	8.0	7.2	4.6	10.5	10.0	5.6	8.2	5.1	6.5	6.0	5.5	21.2	6.2	7.9	8.3	1.7	5.1	16.1	7.1	6.9	5.5	1.9	6.2	5.8	6.0	5.0	5.3	6.6	4.7	5.7	4.3	3.3	4.1	5.0	3.2	8.9	4.8	3.6	12.5	18.3	24.5	21.8	14.6	12.1	16.5	14.3	17.2	16.7	8.9	16.6	10.8	9.0	9.8	3.1	0.8	5.1	20.1	14.8	15.7	7.9	10.1	5.0	8.2	0.6	6.0	9.1	0.0	11.0	7.7	8.5	6.0	12.7	9.0	6.3	1.6	8.7	12.3	8.9	1.4	16.1	8.5	1.7	6.4	9.4	3.3	5.8	11.0	14.2	8.1	6.3	25.8	5.5	0.4	3.9	9.9	4.5	14.4	9.1	8.0
MRNIP	"C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537"	ENSG00000161010	"MRN complex interacting protein"	Q6NTE8	5	179835133-179862173	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 54.9;Club cells: 21.6;Distal tubular cells: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043975	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043975: AB_2678754"	"unprognostic (4.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-3)"	6.6	6.3	11.8	10.7	12.2	4.6	10.8	30.0	16.1	14.8	8.5	14.2	14.3	7.8	13.7	16.1	4.8	23.5	7.7	7.8	12.6	11.8	8.8	6.0	8.8	14.1	16.0	13.4	21.1	9.7	11.2	22.7	5.0	12.1	11.1	8.4	12.9	9.1	19.8	5.8	12.0	11.0	11.7	10.1	13.3	7.1	8.0	14.7	2.7	11.6	3.5	14.0	8.6	10.5	10.7	5.5	2.9	1.0	4.0	8.1	2.8	1.3	2.8	4.5	10.9	9.1	8.2	5.4	3.2	2.8	4.0	5.8	4.6	4.2	5.2	3.8	1.5	1.9	3.5	5.0	10.3	3.1	4.9	5.0	1.7	4.9	3.2	5.6	2.2	2.1	6.1	8.3	4.6	3.6	3.2	4.4	5.4	2.5	2.5	4.1	5.3	3.4	2.2	2.2	1.6	2.5	4.1	1.7	3.8	7.1	1.0	8.5	2.7	1.5	4.4	3.7	3.7	5.5	1.8	1.0	2.5	2.0	1.9	2.2	3.0	1.8	3.6	2.4	3.6	1.7	1.3	0.7	2.9	3.4	0.7	4.5	10.7	5.1	4.2	0.9	10.3	8.1	5.9	1.1	4.0	1.0	5.5	2.9	2.8	11.8	12.2	30.0	16.1	12.6	11.8	16.0	13.4	12.1	14.7	14.9	14.1	0.0	0.0	0.0	0.0	0.0	0.0	54.9	21.6	17.4	0.0	8.6	39.7	3.6	0.0	0.0	0.0	0.0	2.0	5.9	0.0	0.0	10.5	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	3.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0
MROH1	"HEATR7A, KIAA1833"	ENSG00000179832	"Maestro heat like repeat family member 1"	Q8NDA8	8	144148016-144261940	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024287, HPA044465"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024287: , HPA044465: AB_10960985"	"unprognostic (1.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.74e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-2)"	5.7	7.5	11.9	7.6	10.0	19.7	6.1	17.8	16.0	6.0	8.5	4.5	13.0	16.7	5.4	7.3	9.2	6.8	7.0	5.4	7.0	6.0	8.3	5.8	9.4	8.1	5.2	11.7	5.1	17.3	5.4	11.1	8.3	10.3	9.0	4.5	6.9	14.3	9.8	5.2	13.4	14.3	6.5	3.9	11.5	14.0	7.5	5.0	5.2	33.3	3.9	7.5	8.5	6.6	1.9	5.5	4.4	9.5	1.1	5.6	2.8	9.8	4.1	0.5	4.0	1.9	2.1	18.0	4.4	3.1	2.4	3.4	6.9	17.9	5.3	6.4	2.5	6.0	9.5	0.6	6.7	1.1	3.0	5.8	6.3	12.0	6.2	4.9	2.8	6.7	3.8	7.0	3.9	5.7	2.9	3.5	4.3	2.6	2.4	2.7	21.2	4.8	5.9	1.5	6.8	19.4	6.3	1.3	5.4	3.6	19.7	4.5	3.9	11.0	10.6	3.3	1.6	7.8	3.9	8.7	5.0	9.5	10.1	3.6	4.2	2.0	5.6	9.8	8.5	2.9	4.4	7.4	1.9	2.4	9.5	1.9	1.1	2.1	2.5	5.5	1.9	2.0	1.4	1.5	1.1	7.9	1.7	5.6	2.8	11.9	10.0	17.8	16.0	7.0	6.0	5.2	11.7	10.3	5.0	8.9	29.5	3.9	7.0	5.6	34.8	9.5	2.5	9.4	15.9	5.2	11.8	23.8	3.3	10.4	3.8	5.8	32.2	0.0	14.2	16.8	5.9	13.3	13.9	7.6	17.4	35.0	22.5	3.1	11.3	9.9	2.8	12.0	1.7	8.2	20.3	6.7	14.9	14.4	2.5	4.9	3.5	6.5	5.8	9.3	14.5	5.1	41.9	5.7	18.1	10.6
MROH6	C8orf73	ENSG00000204839	"Maestro heat like repeat family member 6"	A6NGR9	8	143566187-143572971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 11.8;HaCaT: 10.0;OE19: 10.2;SK-BR-3: 21.4;U-937: 12.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068049	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068049: AB_2685945"	"unprognostic (2.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.04e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.18e-1)"	1.8	2.3	3.4	2.3	2.8	15.8	1.5	7.6	3.9	5.8	2.7	2.0	3.6	5.7	1.9	2.6	17.4	1.6	11.0	1.3	2.4	0.9	3.1	5.3	2.8	5.4	1.1	1.2	2.6	1.2	2.1	1.4	8.7	2.4	3.7	1.2	4.8	3.1	3.3	1.2	10.1	4.7	4.1	2.6	3.6	6.7	4.1	1.5	0.7	1.2	7.8	15.0	3.2	6.3	0.1	0.8	1.6	1.0	0.0	0.4	0.1	11.8	2.7	0.2	0.5	0.6	0.5	1.3	0.3	0.3	0.2	0.1	0.8	6.5	1.2	0.6	0.1	0.1	10.0	0.3	3.4	0.0	1.6	2.0	1.2	3.7	0.4	0.4	0.4	1.6	0.6	0.9	0.3	0.2	0.0	0.1	1.3	0.9	1.0	0.0	6.7	0.5	1.1	0.3	10.2	2.0	1.1	0.2	2.0	0.5	1.2	0.5	0.2	0.4	21.4	1.0	0.1	2.3	0.8	0.0	0.2	7.5	0.8	1.8	1.0	0.7	0.2	0.4	12.2	0.3	0.0	1.0	0.0	0.1	0.4	0.1	0.0	0.2	0.1	0.8	0.1	0.3	0.4	1.6	0.0	0.6	0.4	0.0	0.1	3.4	2.8	7.6	3.9	2.4	0.9	1.1	1.2	2.4	1.5	0.0	6.6	1.4	1.9	2.5	1.5	1.2	5.1	0.0	2.3	8.7	0.0	0.8	1.7	1.2	0.0	2.1	8.3	0.0	0.6	2.7	2.1	1.4	1.1	10.4	4.6	1.6	1.7	1.3	9.1	0.5	4.4	3.0	3.3	1.0	4.0	3.8	4.3	4.0	2.5	1.9	0.2	0.0	2.3	0.7	2.1	2.3	0.8	1.9	4.9	2.1
MROH8	"C20orf131, C20orf132, dJ621N11.3, dJ621N11.4"	ENSG00000101353	"Maestro heat like repeat family member 8"	Q9H579	20	37101226-37179588	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.7"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 27.0;Late spermatids: 25.0;Spermatocytes: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA060298	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060298: AB_2684246"	"unprognostic (1.16e-2)"	"unprognostic (6.65e-3)"	"unprognostic (5.88e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.17e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.50e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (9.70e-3)"	"unprognostic (5.00e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.62e-1)"	3.6	3.1	4.0	1.8	5.9	2.7	2.9	6.6	7.7	3.4	3.4	4.6	2.4	2.1	4.3	9.5	2.0	4.0	2.2	4.9	3.6	5.0	3.6	4.0	1.7	5.5	3.8	5.0	3.7	4.5	4.8	7.3	1.9	4.1	3.4	2.1	6.2	4.7	5.9	12.0	3.4	1.9	4.1	3.4	2.6	2.5	33.7	2.7	3.1	4.8	2.4	3.7	2.8	2.0	2.6	7.2	8.0	2.2	1.0	2.0	1.1	1.3	3.6	8.9	2.2	3.5	3.6	1.4	1.3	5.0	3.1	3.8	2.3	1.8	7.7	0.4	1.3	5.8	2.2	2.3	1.0	2.5	1.3	0.2	2.4	1.9	1.9	3.1	2.5	3.8	2.1	2.2	1.2	0.1	2.6	2.4	3.6	3.2	1.6	2.0	0.7	6.9	7.0	1.0	1.0	2.2	5.9	1.9	1.5	1.7	1.4	3.1	4.2	2.3	0.9	1.5	2.5	2.2	2.7	2.8	9.5	1.5	0.5	0.6	2.9	2.2	4.8	3.2	1.6	3.1	1.9	2.1	0.7	1.8	2.2	2.0	2.6	1.2	2.0	1.0	2.5	0.6	1.4	8.0	1.0	1.0	7.2	0.7	1.1	4.0	5.9	6.6	7.7	3.6	5.0	3.8	5.0	4.1	2.7	3.0	1.1	0.0	0.8	0.6	5.7	2.8	0.0	1.4	0.0	0.0	7.9	3.5	0.0	0.1	27.0	2.4	1.3	0.0	0.2	0.9	3.1	0.8	0.0	3.4	2.4	0.0	1.2	1.3	2.6	25.0	1.4	0.2	1.7	1.0	1.0	3.3	0.1	0.8	2.8	1.7	4.2	0.0	1.0	18.2	3.7	0.4	1.1	0.7	1.3	0.3
MRPL1	BM022	ENSG00000169288	"Mitochondrial ribosomal protein L1"	Q9BYD6	4	77862520-77952790	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043656	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043656: AB_2678601"	"unprognostic (9.03e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.14e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (7.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"unprognostic (9.17e-3)"	13.6	16.5	14.8	10.9	16.0	13.5	14.0	12.3	20.3	13.6	16.2	4.4	9.6	11.8	12.5	13.6	17.2	10.5	6.9	23.5	18.5	14.7	22.4	22.4	7.6	12.4	13.5	14.0	12.0	12.0	10.5	18.9	16.1	16.6	17.3	17.9	4.3	11.1	11.5	46.6	8.2	12.0	20.3	12.1	15.4	12.3	5.4	9.5	11.9	11.7	24.7	13.4	17.2	14.3	14.9	12.0	4.7	10.1	12.6	18.3	8.9	12.2	7.7	15.2	12.7	11.7	15.4	13.2	14.1	8.8	18.2	12.5	15.6	22.2	21.7	17.6	11.3	11.7	10.4	21.9	25.3	23.8	14.5	11.5	18.4	8.3	16.4	15.5	38.0	9.0	11.9	23.9	16.1	16.4	12.0	21.8	15.5	26.6	7.3	22.8	13.1	23.9	24.7	16.9	28.6	10.2	27.3	19.0	12.4	35.4	11.8	16.5	8.4	10.9	28.3	26.0	12.8	13.7	19.2	12.8	12.1	18.2	12.1	19.9	6.5	8.2	22.6	10.2	21.6	15.4	4.7	6.5	3.9	12.7	10.1	12.5	14.9	14.0	13.9	12.0	14.3	16.8	18.3	1.1	12.6	8.5	9.8	16.6	8.9	14.8	16.0	12.3	20.3	18.5	14.7	13.5	14.0	16.6	9.5	23.8	33.1	40.2	16.9	11.3	24.1	104.6	61.1	17.4	22.7	31.4	17.7	59.7	114.4	39.4	8.2	35.1	21.4	23.3	31.6	43.1	28.8	13.4	40.5	105.0	42.2	23.8	46.0	44.8	26.3	4.9	28.7	23.1	15.1	31.5	58.4	19.3	32.8	17.5	31.5	99.5	36.0	38.8	23.7	17.6	52.2	11.2	29.2	50.3	64.2	8.9
MRPL21		ENSG00000197345	"Mitochondrial ribosomal protein L21"	Q7Z2W9	11	68891276-68903835	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051657	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Mitochondria"		"HPA051657: AB_2681565"	"unprognostic (1.80e-1)"	"unprognostic (6.09e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.12e-1)"	16.5	18.0	30.5	21.4	29.7	25.5	26.5	27.7	28.0	19.6	24.0	13.3	26.8	18.9	20.4	25.2	24.2	23.0	28.3	47.3	24.6	26.1	33.1	33.7	12.4	30.0	27.6	21.0	21.4	23.8	13.2	17.7	16.1	25.6	18.0	21.8	14.4	56.9	39.4	56.6	17.9	25.0	17.6	16.4	14.9	19.3	18.7	21.9	21.3	22.2	40.3	20.4	17.2	16.5	49.1	42.2	20.3	39.3	29.1	36.4	34.6	23.1	32.2	19.6	18.7	13.8	15.1	23.3	16.2	17.4	30.6	21.1	65.9	29.9	35.9	36.2	17.5	28.1	28.9	32.7	30.8	24.1	23.5	24.6	25.3	24.8	39.5	27.6	43.5	19.2	22.2	15.9	30.5	36.3	14.9	21.0	25.6	49.1	27.3	18.2	42.7	20.5	46.1	17.9	68.0	47.5	29.2	23.7	55.8	30.1	26.8	31.9	25.4	20.6	41.4	64.1	16.6	42.8	25.2	17.5	21.0	21.0	45.9	29.5	20.4	31.4	50.5	28.0	26.8	28.4	20.3	39.3	19.4	25.9	39.3	27.2	49.1	34.1	28.7	42.2	33.4	32.7	27.0	10.8	29.1	36.1	31.0	36.4	34.6	30.5	29.7	27.7	28.0	24.6	26.1	27.6	21.0	25.6	21.9	32.8	37.1	55.8	62.8	44.6	34.3	172.9	79.0	53.5	53.4	76.8	7.9	109.3	253.7	83.0	140.3	46.6	123.2	70.0	91.4	93.2	51.5	65.5	62.5	89.7	95.9	11.1	59.3	38.1	59.5	153.5	69.3	54.4	74.2	72.1	93.9	45.9	78.4	86.8	67.8	152.2	34.6	25.8	64.9	54.9	57.3	45.4	68.0	41.5	111.2	58.8
MRPL22	"HSPC158, MRP-L25, RPML25"	ENSG00000082515	"Mitochondrial ribosomal protein L22"	Q9NWU5	5	154941070-154969411	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047063	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047063: AB_2679919"	"unprognostic (9.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.29e-2)"	16.3	29.7	16.7	14.5	21.8	25.9	20.2	18.8	19.6	15.2	21.0	18.8	8.3	19.3	16.5	20.6	23.0	14.6	11.9	29.7	16.8	16.2	27.8	38.9	14.7	19.2	21.1	19.5	14.6	25.2	15.9	22.6	19.2	21.6	14.5	21.6	15.6	24.4	18.8	28.2	16.5	18.4	18.3	17.7	20.0	19.3	29.0	16.0	20.1	19.7	20.7	19.3	17.3	15.8	35.7	34.0	21.6	29.5	30.6	36.7	30.7	20.5	20.3	18.0	24.9	14.1	17.9	21.4	14.7	17.4	29.8	37.8	58.5	25.7	28.5	26.4	12.3	31.7	18.9	25.9	27.8	31.9	9.7	29.4	10.9	21.1	33.1	18.5	24.3	14.9	11.7	18.8	20.0	24.5	13.3	50.3	26.2	16.4	25.7	18.3	30.3	22.0	23.5	13.6	22.5	15.8	20.3	15.6	29.4	28.9	15.6	20.7	7.7	19.3	27.9	31.0	13.6	40.8	21.7	14.6	18.4	18.4	16.0	27.1	13.7	16.9	31.2	18.5	30.3	17.2	15.3	26.1	21.6	26.1	29.5	26.1	35.7	28.8	27.7	34.0	29.4	26.9	30.6	10.1	30.6	28.8	26.4	36.7	30.7	16.7	21.8	18.8	19.6	16.8	16.2	21.1	19.5	21.6	16.0	23.8	22.6	43.2	46.3	56.7	28.3	207.4	50.9	54.9	33.0	57.6	25.5	126.5	189.0	94.4	21.3	64.6	46.2	23.3	110.2	113.6	72.3	40.4	43.9	83.1	86.1	30.2	47.6	52.2	29.7	19.6	61.2	50.3	49.0	79.4	45.4	23.0	97.4	77.2	70.7	152.4	21.6	32.3	60.8	102.1	69.2	57.5	65.7	42.4	71.2	45.7
MRPL23	"L23MRP, RPL23L"	ENSG00000214026	"Mitochondrial ribosomal protein L23"	Q16540	11	1947278-1984522	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 117.7"									HPA050406	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"	"unprognostic (5.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.33e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.08e-2)"	19.4	32.7	19.3	21.8	19.3	37.3	22.1	14.0	25.1	18.1	21.0	17.2	22.5	28.7	19.9	31.4	31.5	30.7	29.9	39.8	16.6	16.8	25.1	43.8	17.4	42.9	18.4	16.9	29.4	69.1	22.6	25.8	14.5	17.4	17.9	21.0	21.2	48.7	25.9	61.0	35.5	23.8	15.9	14.3	22.4	25.6	11.1	11.4	32.5	21.1	44.3	30.1	12.7	17.9	24.1	20.2	12.6	14.5	6.8	22.1	3.3	23.6	27.9	15.0	17.9	6.1	17.3	21.9	7.1	10.5	12.1	9.0	1.7	28.8	24.1	14.2	16.4	16.7	23.7	24.2	33.1	5.8	26.8	117.7	8.6	8.7	34.1	16.3	22.7	13.6	13.6	12.9	8.3	2.4	14.3	8.6	14.1	6.5	13.0	17.5	26.0	18.1	4.7	20.5	21.3	21.2	25.0	7.8	25.1	10.7	9.3	30.2	25.6	8.9	21.1	13.1	8.8	0.5	28.7	10.8	16.5	10.2	4.1	15.6	18.2	16.2	22.6	25.7	19.8	0.0	1.9	14.5	12.6	7.0	10.7	5.6	24.1	10.3	7.8	20.2	20.3	22.1	6.7	0.8	6.8	7.8	8.6	14.6	3.3	19.3	19.3	14.0	25.1	16.6	16.8	18.4	16.9	17.4	11.4	11.9	4.6	111.7	57.4	165.5	6.8	63.0	104.4	28.1	33.0	36.6	0.0	122.5	104.5	95.9	8.1	41.5	179.4	93.5	203.3	208.2	58.0	53.8	97.8	151.5	158.7	4.8	130.7	55.3	173.8	10.3	21.3	115.0	190.6	101.8	117.6	20.1	153.1	173.2	34.3	212.5	8.2	38.8	82.9	24.7	40.3	226.1	75.7	66.0	150.6	57.5
MRPL36	"BRIP1, L36mt, MRP-L36, PRPL36, RPMJ"	ENSG00000171421	"Mitochondrial ribosomal protein L36"	Q9P0J6	5	1798386-1801366	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 90.2"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 359.0;Late spermatids: 373.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047238	Approved		Supported	"Nuclear bodies,Mitochondria"		No	No			"Nuclear bodies, Mitochondria"		"HPA047238: AB_10965331"	"unprognostic (2.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (8.53e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	16.8	20.7	14.3	12.9	14.8	8.2	17.9	9.3	15.4	12.3	15.9	9.0	13.7	14.1	13.5	15.1	20.8	12.7	19.0	32.4	13.5	13.0	22.4	44.6	11.6	13.6	14.2	8.6	16.5	28.9	9.0	10.1	13.9	12.3	17.0	10.5	9.6	27.3	12.3	52.5	11.7	16.2	16.1	11.9	11.5	14.4	46.0	11.1	14.1	18.1	35.8	15.3	16.3	14.4	24.5	90.2	12.9	20.3	18.4	25.8	24.1	23.2	34.6	16.1	30.4	29.8	24.7	21.2	20.4	18.0	24.4	23.4	25.0	19.0	31.4	37.1	21.8	35.9	25.5	36.2	33.6	17.7	34.1	40.3	15.2	76.9	39.6	38.2	19.7	12.0	21.7	26.0	27.2	35.3	21.4	23.6	18.6	23.1	20.3	34.6	42.7	23.0	44.5	15.6	25.8	42.6	18.5	12.0	37.8	22.0	19.1	18.0	12.3	44.4	34.7	21.2	15.5	20.3	21.4	14.2	21.2	23.0	14.3	22.5	19.5	24.3	41.3	26.6	36.5	28.8	12.9	20.3	12.5	18.6	19.4	22.1	24.5	21.0	22.4	24.3	17.9	18.6	22.1	5.8	18.4	16.5	90.2	25.8	24.1	14.3	14.8	9.3	15.4	13.5	13.0	14.2	8.6	12.3	11.1	29.8	25.3	33.5	68.7	94.2	19.7	152.3	53.5	38.8	42.1	55.8	5.9	78.6	260.2	71.7	359.0	51.5	50.4	0.0	65.2	52.4	60.6	90.8	27.6	108.3	76.3	14.3	25.3	34.4	38.0	373.3	69.3	34.3	57.3	73.9	47.9	48.5	78.1	49.2	56.3	144.3	22.1	64.7	83.4	78.8	62.6	109.2	73.1	35.2	55.9	94.5
MRPL40	"MRP-L22, NLVCF"	ENSG00000185608	"Mitochondrial ribosomal protein L40"	Q9NQ50	22	19431902-19436075	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006181	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA006181: AB_1079411"	"unprognostic (4.12e-2)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.14e-2)"	4.0	6.6	5.5	2.5	6.6	1.3	3.9	5.1	5.4	4.3	2.6			2.9	3.0	5.0	3.7	5.0	2.9	11.8	4.6	4.7	6.1	10.3	2.2	3.0	5.1		4.7	7.0	6.4	4.9	2.5		4.6	2.2		8.7	4.2	14.8	3.6	2.3	2.4	5.0	2.7	3.1	2.8			8.2		2.8	3.7	2.5	28.1	21.6	10.3	15.1	10.9	16.4	16.6	13.2	9.2	2.2	8.4	13.7	12.7	7.0	10.0	11.6	14.1	17.6	10.8	7.7	11.6	10.4	11.0	8.1	13.1	13.9	15.9	11.9	11.8	21.3	10.5	6.6	13.3	20.2	15.0	7.0	13.1	15.5	10.4	18.6	9.5	9.4	4.4	42.5	11.1	13.6	10.1	7.8	8.9	3.6	18.7	12.5	7.4	14.5	5.3	16.8	5.6	7.6	7.0	15.3	12.9	19.2	5.2	11.4	8.8	11.8	18.8	17.4	7.4	9.7	10.6	14.2	16.9	12.3	10.2	13.6	5.9	13.8	10.3	13.0	15.1	14.0	28.1	13.2	13.5	15.0	25.5	16.4	14.3	1.6	10.9	12.0	21.6	15.0	16.6											41.7	33.6	52.8	60.0	35.8	28.7	83.9	76.5	109.7	53.4	45.4	11.8	118.0	220.5	67.0	81.1	33.6	39.3	0.0	84.9	110.0	43.1	49.9	33.4	122.0	116.9	20.6	33.6	40.5	35.4	118.1	67.0	37.7	81.0	100.0	42.0	80.3	63.8	42.4	67.8	201.9	38.4	45.3	58.7	83.7	70.0	33.6	52.6	34.6	45.0	39.2
MRPL42	"HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31"	ENSG00000198015	"Mitochondrial ribosomal protein L42"	Q9Y6G3	12	93467488-93516213	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 276.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039398	Approved		Supported	"Plasma membrane,Mitochondria"		NA	NA			"Plasma membrane, Mitochondria"		"HPA039398: AB_10673529"	"unprognostic (9.32e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (6.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.12e-4)"	18.4	35.6	16.7	13.9	23.6	14.6	22.5	23.2	24.4	22.0	21.5	16.6	16.3	17.0	18.7	16.5	26.7	20.5	15.1	24.2	16.8	16.4	31.0	28.9	16.0	15.3	21.4	16.7	18.4	16.3	26.1	35.8	18.5	26.2	19.3	26.4	13.7	17.8	19.0	15.1	15.8	18.4	19.8	20.4	18.8	18.1	34.5	17.1	25.7	19.5	14.9	21.5	19.1	21.0	29.9	18.8	23.3	23.1	29.3	32.0	21.0	17.3	18.7	30.1	24.4	18.0	27.1	25.4	21.5	21.8	32.9	26.6	25.1	13.9	24.5	9.4	19.6	15.6	15.7	38.7	29.0	50.4	28.7	29.9	28.2	12.8	31.1	24.6	32.6	14.2	20.0	31.8	28.5	42.3	24.9	31.8	27.6	37.2	13.4	37.4	18.5	36.5	25.5	45.0	27.7	34.4	30.3	15.2	29.9	36.3	35.7	36.9	20.1	18.4	30.8	23.1	25.6	30.5	18.0	15.7	24.2	13.8	15.3	28.8	16.0	23.2	27.0	9.5	25.7	36.2	18.0	17.7	23.3	19.0	23.1	24.4	29.9	24.9	20.9	18.8	23.9	26.1	26.8	7.4	29.3	21.5	13.3	32.0	21.0	16.7	23.6	23.2	24.4	16.8	16.4	21.4	16.7	26.2	17.1	26.8	28.6	54.8	70.8	59.8	33.3	73.5	40.8	62.9	31.8	43.6	56.9	85.2	180.8	81.9	276.9	50.6	37.0	0.0	67.3	120.5	56.8	91.3	58.7	45.9	48.2	44.5	89.3	28.3	38.6	81.3	47.8	37.0	57.3	27.9	49.8	19.9	75.9	42.1	52.6	106.7	35.0	51.8	64.3	114.9	71.6	65.6	79.9	55.1	63.5	104.3
MRPL54		ENSG00000183617	"Mitochondrial ribosomal protein L54"	Q6P161	19	3762664-3768575	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042117, HPA046767"	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA042117: AB_2677856, HPA046767: AB_2679795"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.54e-3)"	23.8	34.2	26.2	20.7	27.0	42.4	24.4	19.4	28.8	16.5	27.8	12.7	32.9	25.0	20.5	29.2	26.2	27.5	32.3	34.1	22.2	20.7	28.9	56.7	26.2	35.5	23.2	30.0	20.6	54.0	16.0	26.4	28.6	19.5	22.3	20.7	16.5	44.4	29.7	32.9	19.8	22.1	25.8	21.8	21.8	26.0	38.2	16.0	20.6	26.7	26.9	22.4	18.7	19.5	46.1	45.6	26.0	43.0	41.5	54.4	45.4	33.7	19.3	18.0	17.6	10.7	17.2	15.3	16.2	20.8	39.0	33.6	16.5	12.0	24.4	16.9	19.9	14.7	21.6	23.6	21.3	16.6	15.6	35.9	12.4	11.1	21.0	28.0	26.2	29.4	20.1	37.0	16.3	28.7	15.2	31.9	17.1	23.2	48.2	20.3	22.9	23.5	27.8	23.8	23.7	14.2	20.5	10.2	36.1	29.4	17.2	25.2	20.9	13.2	31.7	24.0	9.0	21.3	37.7	22.7	24.8	14.3	42.0	34.6	29.6	39.2	23.7	24.5	41.9	18.4	24.9	41.7	26.0	37.0	43.0	34.1	46.1	40.8	43.3	45.6	42.5	39.4	36.2	12.0	41.5	40.9	41.4	54.4	45.4	26.2	27.0	19.4	28.8	22.2	20.7	23.2	30.0	19.5	16.0	71.5	74.8	103.6	80.6	43.6	44.6	48.7	79.0	56.2	61.4	75.0	17.7	113.4	303.4	100.7	72.5	51.5	181.4	23.3	166.5	107.6	51.5	96.0	105.0	203.6	139.3	36.5	101.2	58.3	100.5	47.0	52.0	71.8	67.4	108.2	157.0	67.6	120.5	178.9	42.1	295.9	62.3	25.8	55.3	118.3	50.5	50.1	147.9	79.9	127.3	97.4
MRPS10	FLJ10567	ENSG00000048544	"Mitochondrial ribosomal protein S10"	P82664	6	42206801-42217865	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 79.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029133, HPA029134"	Supported		Approved	"Actin filaments,Mitochondria"		NA	NA			Mitochondria	"Actin filaments"	"HPA029133: AB_10600084, HPA029134: AB_10600058"	"unprognostic (1.06e-1)"	"unprognostic (3.90e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.50e-3)"	"unprognostic (5.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.04e-2)"	17.3	21.0	16.6	14.2	23.3	15.3	16.3	16.4	22.9	15.5	15.0	17.2	8.6	13.9	16.2	14.0	34.3	12.0	11.9	33.4	15.2	16.8	21.7	30.5	11.7	16.2	16.8	14.7	13.7	14.1	13.0	20.3	18.8	22.1	14.1	17.9	17.1	16.9	13.5	47.7	14.7	14.9	18.1	16.2	14.7	14.2	13.3	16.5	19.3	18.7	25.6	21.4	15.6	18.4	22.5	28.4	14.4	22.7	21.2	25.7	20.1	26.3	9.5	10.0	17.0	14.0	13.6	9.0	17.5	17.4	17.0	15.0	10.8	10.5	18.8	11.7	16.3	19.1	9.7	16.5	23.8	23.0	17.1	13.5	16.7	9.3	18.0	14.7	24.6	10.9	11.8	18.4	15.9	34.1	11.6	17.2	20.1	29.0	14.8	20.5	16.9	16.0	17.9	8.5	79.3	15.7	13.8	15.1	17.8	29.2	12.0	15.4	11.3	10.0	13.8	32.2	9.8	22.9	33.6	11.0	14.6	14.4	14.0	26.0	11.1	16.7	40.1	9.9	24.6	14.5	13.4	19.6	14.4	19.3	22.7	22.4	22.5	23.7	22.8	22.0	20.5	24.4	23.7	10.1	21.2	20.4	28.4	25.7	20.1	16.6	23.3	16.4	22.9	15.2	16.8	16.8	14.7	22.1	16.5	20.8	16.3	43.8	41.8	35.9	25.1	113.8	17.8	58.9	15.9	36.6	29.5	90.5	77.9	52.6	6.7	35.8	23.6	23.3	40.9	53.7	40.1	48.9	31.3	52.1	47.5	30.2	14.3	25.8	22.9	4.7	26.7	35.2	28.7	161.5	23.3	46.4	50.7	26.6	34.3	69.7	55.4	19.4	33.3	60.2	77.9	35.5	63.0	30.5	27.3	62.1
MRPS16	CGI-132	ENSG00000182180	"Mitochondrial ribosomal protein S16"	Q9Y3D3	10	73248843-73252693	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050081, HPA054538"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA050081: AB_2681007, HPA054538: AB_2682519"	"unprognostic (9.19e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.84e-2)"	16.6	28.4	16.4	16.9	15.8	15.8	28.6	12.6	26.6	13.3	22.1	12.4	18.0	20.8	16.3	16.8	22.7	16.5	20.8	42.2	17.6	15.7	23.4	35.1	17.7	30.0	16.2	16.0	16.5	37.0	15.7	15.5	17.0	15.9	15.4	21.1	14.4	18.4	19.0	53.2	16.8	18.4	18.0	14.7	18.4	18.3	13.7	9.8	32.7	16.9	26.1	20.1	15.5	13.9	30.0	28.3	17.0	24.2	17.7	22.3	24.3	22.8	33.1	12.8	16.9	10.3	8.4	18.8	10.6	18.5	14.8	15.4	39.2	22.5	27.7	11.8	11.1	13.4	21.4	14.7	21.1	9.3	15.6	14.4	17.4	17.9	29.6	17.4	22.5	15.6	12.7	16.1	15.1	36.3	12.9	16.1	24.5	25.5	15.6	15.3	25.4	24.2	20.8	15.5	15.1	62.2	22.0	17.2	20.0	15.5	13.7	8.6	15.9	12.1	50.0	23.2	8.2	35.2	12.0	12.7	14.1	24.6	15.2	20.5	23.4	24.8	21.6	15.4	26.2	9.5	16.7	22.7	17.0	19.0	24.2	20.5	28.7	20.8	17.8	18.5	30.0	22.3	19.6	10.4	17.7	19.1	28.3	20.6	24.3	16.4	15.8	12.6	26.6	17.6	15.7	16.2	16.0	15.9	9.8	6.0	25.9	52.8	58.4	31.1	26.8	89.2	63.7	37.5	47.8	45.4	29.5	103.9	210.5	89.2	46.6	48.4	69.2	23.3	103.5	134.8	44.9	77.2	30.0	123.8	134.2	19.1	52.3	41.7	57.2	29.0	57.5	59.6	62.4	83.0	89.7	45.0	115.2	38.6	39.3	179.3	33.2	0.0	45.3	128.1	75.4	38.6	89.4	44.9	103.6	86.7
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617709-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA043485: AB_2678506, HPA050334: AB_2681091"	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	17.1	18.9	9.9	10.3	10.7	5.4	16.0	8.5	13.1	11.6	13.4	12.8	11.9	12.8	9.3	15.5	15.5	16.5	12.3	26.6	9.0	8.0	22.4	49.1	10.5	17.3	13.1	9.3	16.4	21.8	17.4	10.2	11.8	9.1	10.9	16.4	10.1	17.1	18.0	55.4	13.7	14.0	10.4	12.4	14.4	13.5	10.2	11.2	13.5	21.5	31.1	15.6	11.2	9.3	15.7	8.9	6.3	10.2	12.4	15.2	11.2	9.7	5.9	4.7	6.7	7.2	9.7	8.7	3.6	8.4	11.5	7.1	9.2	4.6	10.0	8.4	5.7	8.6	7.8	10.9	10.2	11.3	6.0	11.6	9.7	4.6	10.7	6.3	9.1	4.2	8.4	12.8	9.4	26.1	7.8	6.4	9.5	14.7	9.6	10.4	7.4	6.0	5.6	3.4	7.8	7.6	8.0	6.4	19.1	10.7	4.1	10.3	3.3	3.2	13.6	13.7	4.6	17.6	4.8	3.7	7.5	7.3	4.3	6.2	8.2	9.8	8.5	3.6	13.8	11.0	6.3	8.0	4.0	9.1	10.1	12.3	15.7	12.1	9.8	8.9	14.7	15.2	12.2	0.6	12.4	10.2	8.1	11.4	11.2	9.9	10.7	8.5	13.1	9.0	8.0	13.1	9.3	9.1	11.2	56.6	44.3	53.6	61.6	32.6	43.2	135.7	101.9	53.5	46.6	45.4	60.9	106.9	164.2	89.2	46.6	63.4	48.4	23.3	80.0	101.6	52.1	46.2	36.9	95.6	72.2	41.3	30.1	49.1	44.0	26.6	65.0	42.1	57.3	93.8	55.1	39.2	65.0	59.6	42.1	161.2	51.1	51.8	67.0	22.6	60.7	39.3	80.7	41.7	80.3	30.1
MRPS23	"CGI-138, HSPC329, MRP-S23"	ENSG00000181610	"Mitochondrial ribosomal protein S23"	Q9Y3D9	17	57834781-57850056	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023453	Supported		Supported	"Nuclear membrane,Mitochondria"		No	No			Mitochondria	"Nuclear membrane"	"HPA023453: AB_1854125"	"unprognostic (3.84e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (3.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.39e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.83e-1)"	15.1	28.5	23.0	19.0	27.5	16.0	19.9	16.4	32.0	13.4	16.4	17.6	28.3	18.1	18.0	23.1	18.1	19.3	17.2	53.5	22.5	22.1	36.6	19.9	16.5	21.3	23.6	26.2	16.3	29.9	17.3	16.7	15.5	23.7	28.3	16.0	15.3	16.9	24.7	39.2	14.1	15.5	17.0	19.4	17.4	25.7	21.9	17.2	14.8	28.4	19.8	19.7	15.3	16.5	25.1	30.8	33.4	26.7	23.5	24.3	22.8	32.4	32.8	17.8	18.6	10.8	12.6	20.5	21.1	15.9	29.5	22.8	24.7	19.6	41.2	62.9	16.2	27.3	16.1	28.0	24.9	24.7	32.7	32.5	29.8	13.7	42.6	20.7	39.0	28.9	11.5	22.5	21.8	22.8	13.5	18.5	22.2	44.1	14.9	23.1	27.8	36.1	22.5	21.5	36.9	34.3	26.3	29.7	34.4	22.8	15.6	23.9	37.2	15.9	13.4	42.0	13.6	41.8	29.1	15.7	25.1	32.0	25.0	44.6	32.8	69.1	45.9	23.9	24.5	23.0	24.9	21.8	33.4	22.4	26.7	23.4	23.6	22.4	22.6	30.8	25.1	24.3	24.0	3.5	23.5	18.8	29.0	21.4	22.8	23.0	27.5	16.4	32.0	22.5	22.1	23.6	26.2	23.7	17.2	44.7	28.1	29.0	30.7	29.8	41.5	148.1	33.1	41.5	36.4	45.4	11.8	68.7	126.0	75.4	4.7	33.0	13.5	0.0	86.9	68.6	37.0	43.2	22.0	38.1	75.9	47.7	21.2	24.5	28.2	7.0	30.2	38.1	38.8	71.3	27.2	49.9	70.7	17.5	37.1	149.9	53.1	25.8	28.4	27.1	87.3	28.4	35.6	32.4	38.2	27.8
MRPS35	"MDS023, MRPS28"	ENSG00000061794	"Mitochondrial ribosomal protein S35"	P82673	12	27710773-27756295	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 205.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038513	Supported		Approved	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"HPA038513: AB_10794084"	"prognostic unfavorable (9.41e-4)"	"unprognostic (8.35e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.51e-5)"	"unprognostic (4.63e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	18.3	32.3	21.0	19.4	22.4	14.2	23.2	21.2	25.7	14.0	31.0	16.3	18.5	27.7	17.1	17.6	25.0	16.1	20.5	31.9	19.5	20.6	42.2	52.1	15.9	20.2	20.1	19.4	17.3	18.4	18.2	11.9	18.8	24.4	17.5	33.2	11.9	17.6	14.8	46.3	15.1	24.5	19.9	18.1	17.3	23.1	13.5	13.5	19.3	28.9	27.6	18.5	17.8	14.3	12.4	17.4	4.2	24.8	14.2	14.7	12.6	23.6	26.0	10.9	16.7	15.7	19.2	40.8	15.8	13.5	22.1	20.2	31.9	33.9	22.1	23.3	16.0	17.2	17.9	22.6	19.9	26.0	18.8	22.3	25.0	11.0	25.8	15.6	34.0	13.4	16.3	24.8	18.6	37.6	20.3	17.8	18.8	27.3	15.2	20.0	14.4	23.9	56.5	41.3	58.3	39.1	25.4	28.5	36.3	33.9	19.5	6.3	12.7	21.7	33.9	26.3	25.6	34.6	27.1	13.9	13.5	14.6	30.6	28.0	6.0	9.0	47.7	18.0	26.3	17.6	4.2	12.2	4.1	9.3	21.4	14.5	12.4	11.7	11.3	17.4	11.9	13.9	12.4	0.7	14.2	24.8	8.1	14.7	12.6	21.0	22.4	21.2	25.7	19.5	20.6	20.1	19.4	24.4	13.5	68.5	32.3	38.3	32.8	42.0	19.5	84.0	50.9	89.7	45.5	48.8	3.9	92.7	205.6	67.5	9.7	23.4	54.6	0.0	51.8	95.3	26.6	44.8	53.1	52.9	64.9	17.5	57.9	16.5	31.2	5.0	23.6	48.6	40.5	65.9	65.4	26.2	51.0	42.1	23.0	153.4	13.6	25.8	33.1	24.4	24.8	45.7	51.6	29.9	92.5	38.4
MRPS7	"MRP-S, RP-S7, RPMS7"	ENSG00000125445	"Mitochondrial ribosomal protein S7"	Q9Y2R9	17	75261674-75266373	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 335.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022522, HPA023007"	Supported		Approved	Mitochondria		No	No			Mitochondria		"HPA022522: AB_1854131, HPA023007: AB_1854132"	"unprognostic (1.24e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (5.82e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.05e-3)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.95e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.15e-1)"	17.4	22.1	16.8	15.7	17.9	11.6	15.3	15.6	23.5	11.0	19.6	11.2	15.5	19.8	11.2	14.0	20.9	15.0	16.7	56.7	15.0	14.7	22.9	30.6	12.3	15.0	17.8	13.1	12.2	18.1	15.7	14.0	19.6	14.9	13.6	17.1	13.9	16.9	16.9	79.5	11.1	19.6	13.5	12.1	15.1	16.2	29.4	9.4	17.4	16.2	33.9	15.8	13.4	12.2	30.6	38.0	9.9	33.6	26.4	30.8	43.9	23.7	41.1	16.0	12.7	13.0	7.5	31.0	15.9	11.7	28.6	20.8	44.8	20.3	21.3	14.1	15.5	18.4	23.0	25.0	26.3	16.3	11.4	43.4	28.6	27.9	41.8	12.2	26.4	15.0	11.2	26.0	22.0	21.8	14.2	34.6	25.4	28.0	19.2	17.3	44.6	30.4	23.8	18.8	30.2	41.0	21.2	49.8	29.4	25.0	24.6	29.4	27.4	20.8	51.3	29.5	17.6	40.0	23.0	15.8	26.9	28.1	14.0	32.1	21.8	12.7	22.1	19.4	18.6	20.4	7.1	33.6	9.9	26.1	33.2	28.0	30.6	25.9	28.3	36.8	27.5	30.8	28.1	2.6	26.4	27.8	38.0	29.0	43.9	16.8	17.9	15.6	23.5	15.0	14.7	17.8	13.1	14.9	9.4	47.6	42.4	81.1	60.2	35.0	65.6	62.9	61.1	75.0	37.5	54.1	92.3	161.9	195.6	96.6	117.8	44.3	99.5	70.0	90.2	134.4	47.3	56.2	38.1	79.5	131.5	44.5	45.6	37.4	62.3	335.2	44.8	54.2	40.5	135.3	66.7	64.2	79.3	63.1	37.4	178.2	99.5	58.2	54.7	64.1	74.1	36.6	115.3	60.9	107.4	67.2
MRRF	RRF	ENSG00000148187	"Mitochondrial ribosome recycling factor"	Q96E11	9	122264603-122331343	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 205.6;Late spermatids: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047177, HPA049987"	Supported		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Microtubules, Cytokinetic bridge"		"HPA047177: AB_2679970, HPA049987: AB_2680984"	"unprognostic (8.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.01e-2)"	"prognostic favorable (2.14e-8)"	"unprognostic (3.89e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.02e-2)"	"unprognostic (8.88e-3)"	20.1	17.0	10.1	12.6	14.8	13.4	21.0	15.0	14.5	13.0	26.3	14.0	20.3	25.3	23.3	17.8	21.6	10.4	9.9	18.8	10.5	11.2	23.3	21.7	12.5	14.8	17.1	11.7	12.1	17.6	24.3	20.1	12.7	15.9	14.3	31.6	14.8	15.8	14.7	31.1	19.1	19.4	15.7	15.4	15.7	13.5	17.1	15.1	10.6	16.1	23.3	20.9	15.2	14.3	10.3	19.6	3.8	18.7	13.7	11.6	7.1	13.1	17.7	10.1	16.9	14.5	13.3	19.3	13.1	16.8	17.7	10.4	21.1	15.8	28.6	6.6	10.4	14.1	38.6	28.9	30.6	14.5	9.5	11.8	9.7	21.7	11.5	9.6	27.2	13.0	12.4	20.9	15.8	28.4	9.0	19.7	11.5	16.5	11.0	17.7	20.9	13.5	8.9	11.8	32.9	17.9	10.2	19.3	30.3	30.1	13.4	12.0	7.9	14.1	22.9	10.4	10.1	24.7	7.0	10.5	7.8	11.9	20.2	16.0	7.6	18.4	12.9	14.8	16.3	8.9	2.7	11.5	3.8	9.3	18.7	10.0	10.3	9.4	8.7	19.6	9.2	9.8	11.6	1.4	13.7	18.7	8.4	10.4	7.1	10.1	14.8	15.0	14.5	10.5	11.2	17.1	11.7	15.9	15.1	3.0	7.8	16.1	18.7	13.7	10.7	17.9	22.9	18.7	12.5	14.0	11.8	24.2	29.9	32.2	205.6	19.9	25.2	0.0	25.7	44.0	10.8	12.9	24.3	16.3	27.3	4.8	7.5	11.6	10.5	142.3	8.9	17.2	13.5	22.6	21.2	6.1	23.3	21.0	7.1	29.2	23.1	19.4	12.2	33.2	15.7	19.6	31.0	10.2	32.9	16.3
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251539-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	17.2	16.5	20.4	16.9	18.5	12.0	21.6	10.7	21.7	12.1	13.8	12.4	10.2	17.5	15.6	15.2	21.6	18.8	11.8	11.7	19.1	15.9	13.6	23.7	10.5	23.0	16.1	19.1	18.7	41.2	10.2	8.8	12.5	15.1	12.2	17.6	10.6	13.2	11.9	22.8	15.3	19.3	17.3	10.0	14.5	13.7	21.6	11.6	14.5	12.9	29.3	22.7	11.4	12.4	14.7	12.8	1.0	8.2	10.6	15.7	7.2	24.3	17.3	14.4	18.8	7.0	11.2	12.7	19.1	10.8	32.7	21.6	24.9	25.3	36.0	16.0	15.8	14.3	19.4	39.7	28.8	33.0	12.8	30.3	26.6	15.5	21.4	8.8	35.1	11.2	9.8	19.1	36.9	19.2	8.7	18.3	16.4	40.2	11.6	19.3	17.8	28.5	25.4	18.4	25.6	26.4	26.8	17.5	27.8	17.8	8.3	23.1	17.0	14.6	20.1	20.1	10.7	14.3	20.7	12.0	17.9	22.2	27.4	32.4	9.5	16.5	47.4	17.4	45.1	28.5	0.7	7.5	0.7	7.9	8.2	15.7	14.7	9.6	10.8	11.4	13.1	13.0	11.6	1.0	10.6	6.2	12.8	6.7	7.2	20.4	18.5	10.7	21.7	19.1	15.9	16.1	19.1	15.1	11.6	6.0	12.6	26.1	38.7	33.2	19.2	9.0	35.7	17.4	23.9	7.0	9.8	42.2	34.9	44.9	14.5	23.3	5.4	0.0	47.2	51.2	28.2	15.4	25.4	14.4	42.9	14.3	20.7	11.6	12.1	27.6	21.3	21.7	18.6	39.7	19.8	19.2	44.4	14.0	19.1	30.1	13.8	19.4	28.8	37.0	43.7	29.4	21.7	14.6	31.2	31.2
MRVI1	"IRAG, JAW1L"	ENSG00000072952	"Murine retrovirus integration site 1 homolog"	Q9Y6F6	11	10573091-10693988	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Peritubular cells: 82.0;Sertoli cells: 51.8;Smooth muscle cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 18.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 18.0;BJ: 12.7;BJ hTERT+: 14.7;fHDF/TERT166: 5.7;REH: 5.5"	"Region enriched"	"Detected in many"	5	"thalamus: 8.3"	"Low region specificity"	"Detected in many"			HPA008704	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA		280000	Cytosol	"Nuclear bodies"	"HPA008704: AB_1079413"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.30e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-3)"	15.7	6.3	19.4	12.4	22.0	1.5	6.6	4.4	13.7	31.6	26.7	15.5	10.7	6.3	42.1	17.1	27.1	19.6	23.2	6.3	13.8	12.0	5.3	1.7	5.5	2.9	21.3	10.6	16.4	1.9	2.8	1.8	8.7	18.2	24.8	12.9	37.6	3.3	29.0	4.1	4.0	9.4	47.3	12.1	3.5	16.4	8.3	10.3	0.0	4.5	2.3	1.8	27.3	10.4	0.7	0.4	18.5	4.1	0.0	0.0	0.5	0.1	0.0	3.6	0.0	18.0	3.5	0.1	12.7	14.7	0.0	0.0	0.3	1.4	0.0	0.1	5.7	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.2	0.0	0.2	4.1	0.3	0.0	0.1	0.0	1.0	0.0	0.5	0.1	0.2	0.0	0.1	0.3	0.4	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	2.6	0.0	2.2	0.0	3.9	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.9	0.0	0.6	1.7	1.2	0.0	2.9	0.0	0.5	0.0	0.0	0.4	0.7	0.0	0.0	18.5	0.0	4.1	0.1	0.0	0.5	19.4	22.0	4.4	13.2	13.8	12.0	21.3	10.6	18.2	10.3	0.0	4.5	0.5	0.3	1.8	6.8	6.1	0.0	0.0	2.3	0.0	3.9	0.3	1.7	0.0	25.8	1.6	0.0	0.0	0.0	0.1	3.1	0.3	1.1	0.0	8.4	7.9	0.0	3.1	12.0	23.3	19.8	2.1	1.7	0.0	0.0	2.1	0.0	0.0	82.0	0.0	1.0	51.8	82.4	1.7	2.2	1.6	1.4	0.0	0.0	0.6
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 64.7;lymphoid tissue: 28.6"	"Group enriched"	"Detected in some"	6	"Enterocytes: 108.9;Paneth cells: 59.6"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;LHCN-M2: 2.2;NTERA-2: 3.1;RH-30: 4.3;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.1	0.0	0.1	28.6	0.1	0.0	0.1	0.1	0.1	0.1	57.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	64.7	0.1	0.1	0.1	0.1	0.0	0.2	1.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.1	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	1.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	108.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	59.6	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	13.2	0.0
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 79.3;testis: 53.6"	"Group enriched"	"Detected in some"	41	"Early spermatids: 207.0;Late spermatids: 514.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.8;non-classical monocyte: 9.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 9.2"	"Cell line enriched"	"Detected in single"	24	"THP-1: 14.6"									HPA058973			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	14.5	4.4	2.0	4.6	2.3	1.5	5.4	0.8	1.5	2.4	3.9	1.9	1.1	1.5	1.9	6.4	1.8	1.3	2.3	6.4	2.5	2.3	3.5	13.3	18.0	11.3	2.4	0.1	1.3	1.5	1.2	3.2	6.0	2.4	3.0	2.2	4.5	2.1	1.6	1.3	1.3	4.0	2.4	5.5	79.3	1.5	53.6	1.5	3.7	1.7	0.7	3.0	2.4	1.7	0.5	1.8	0.1	9.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	4.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.1	0.0	9.2	0.0	0.0	0.9	2.0	2.3	0.8	1.5	2.5	2.3	2.4	0.1	2.4	1.5	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	207.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	7.5	514.6	3.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	6.5	0.0	5.7	2.4	0.3	0.1	0.0	0.0	0.0
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756953-60776732	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 9.9;lung: 32.4"	"Cell type enriched"	"Detected in some"	8	"Alveolar cells type 1: 89.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 9.9"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.9"	"Cell line enhanced"	"Detected in some"		"HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7"	"Region enriched"	"Detected in single"	28	"olfactory region: 205.0"	"Region enriched"	"Detected in single"	30	"olfactory region: 39.1"	HPA054563			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.3	0.3	0.3	0.0	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	1.8	0.3	0.4	1.0	0.3	0.3	0.3	0.2	0.3	0.3	32.4	0.3	0.3	0.3	2.4	0.3	0.0	0.3	1.1	0.3	0.3	0.5	0.3	0.3	1.9	0.3	0.2	1.4	1.7	0.3	0.3	0.2	0.6	0.3	0.3	0.3	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.0	0.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	9.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.4	1.6	3.8	0.0	0.0	4.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.1	0.0	0.0	0.0	0.5	0.0	0.0	13.5	5.7	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.9	0.5	0.0	0.0	1.8	0.7	0.0	0.6	0.0	0.0	9.9	0.7	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3	89.3	4.8	0.0	0.0	0.0	0.0	0.2	0.0	2.7	11.4	0.0	0.0	0.7	0.0	0.0	4.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.7	0.0	0.0	0.0
MS4A3	"CD20L, HTM4"	ENSG00000149516	"Membrane spanning 4-domains A3"	Q96HJ5	11	60056587-60071128	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 196.2;bone marrow: 105.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.6"	"Cell type enriched"	"Detected in single"	1061	"basophil: 196.2"	"Lineage enriched"	"Detected in single"	1963	"granulocytes: 196.2"	"Group enriched"	"Detected in some"	4	"HEL: 37.1;K-562: 31.7;NB-4: 25.7;THP-1: 75.0;U-937: 29.6"	"Not detected"	"Not detected"							HPA019210	Supported		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus"	"Vesicles, Cytosol"	"HPA019210: AB_1854134"					"unprognostic (6.37e-3)"			"unprognostic (1.25e-1)"						"unprognostic (2.67e-1)"	"unprognostic (3.77e-1)"			0.2	0.0	0.1	0.1	0.3	105.4	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	14.7	0.1	0.1	0.1	0.5	6.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.1	8.6	0.0	1.0	0.0	7.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	9.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	196.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A6A	"CD20L3, MS4A6"	ENSG00000110077	"Membrane spanning 4-domains A6A"	Q9H2W1	11	60172014-60184666	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 112.4;lymphoid tissue: 89.5"	"Group enriched"	"Detected in many"	14	"Hofbauer cells: 335.3;Ito cells: 767.3;Kupffer cells: 1329.9;Macrophages: 569.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 32.4;classical monocyte: 112.4;intermediate monocyte: 35.6;myeloid DC: 65.3;plasmacytoid DC: 46.3"	"Group enriched"	"Detected in many"	96	"dendritic cells: 65.3;granulocytes: 32.4;monocytes: 112.4"	"Cell line enriched"	"Detected in some"	9	"THP-1: 32.6"									"HPA011391, HPA076623"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA011391: AB_10603876, HPA076623: AB_2686809"	"unprognostic (1.17e-1)"	"prognostic favorable (6.33e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.97e-2)"	29.3	17.8	12.3	18.3	26.7	9.1	18.1	2.8	14.6	10.2	14.9	4.7	4.0	9.0	7.0	28.3	8.7	11.3	21.0	23.1	10.7	6.9	18.0	35.6	23.0	89.5	22.2	2.4	7.7	6.0	2.4	8.8	21.5	20.5	9.6	19.0	10.2	11.8	6.3	6.0	5.1	20.4	17.2	32.0	78.1	8.5	8.3	19.4	8.5	7.0	6.7	15.4	21.5	6.3	0.7	65.3	32.4	112.4	0.2	0.3	61.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	3.8	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	32.4	112.4	0.7	0.1	35.6	0.3	0.7	0.2	0.1	65.3	0.1	0.1	0.1	7.4	0.2	2.3	46.3	0.1	61.3	12.3	26.7	2.8	14.6	10.7	6.9	22.2	2.4	20.5	19.4	6.0	31.7	53.0	0.4	8.2	0.0	2.4	30.6	2.7	4.5	3.5	0.0	1.6	0.0	0.0	2.0	8.5	0.0	0.0	0.0	1.7	7.3	0.2	12.8	6.0	335.3	0.0	0.0	767.3	1329.9	1.1	1.4	569.3	13.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	45.3	7.2	0.3	1.0	6.9	1.7	27.7	0.0	0.1
MS4A6E		ENSG00000166926	"Membrane spanning 4-domains A6E"	Q96DS6	11	60334831-60396596	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"testis: 28.2"	"Cell type enriched"	"Detected in some"	21	"Early spermatids: 1123.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.2"	"Group enriched"	"Detected in some"	7	"K-562: 2.1;SuSa: 4.2"									HPA076623			Approved	Vesicles		NA	NA			Vesicles		"HPA076623: AB_2686809"					"unprognostic (2.58e-1)"	"unprognostic (3.35e-1)"		"unprognostic (3.47e-1)"			"unprognostic (6.81e-3)"		"unprognostic (4.55e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.76e-1)"		2.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.1		0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	28.2			0.0		0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1123.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	53.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	5.1	2.5	0.0	0.0	0.0	0.0	0.0
MSANTD3	"C9orf30, MGC17337"	ENSG00000066697	"Myb/SANT DNA binding domain containing 3"	Q96H12	9	100427156-100451711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062662			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062662: AB_2684826"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.66e-5)"	"prognostic unfavorable (3.23e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.61e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (3.22e-7)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.16e-2)"	11.4	12.5	17.0	16.8	17.5	14.7	21.2	22.7	22.6	15.1	13.2	15.8	5.5	8.8	16.4	12.2	12.6	8.6	19.3	21.5	16.9	14.9	13.0	15.1	15.5	9.3	19.6	18.2	11.1	15.0	10.4	11.3	16.7	20.1	11.6	10.1	9.7	10.9	14.9	21.5	10.9	7.9	20.4	17.6	7.2	11.6	7.8	14.5	5.4	18.2	11.6	11.0	17.3	13.0	3.7	1.5	9.0	0.6	5.7	6.2	2.7	14.9	13.6	9.9	9.7	15.5	18.2	11.2	21.7	24.5	21.3	16.0	8.5	14.1	9.0	11.1	21.3	47.7	17.1	6.7	22.8	25.1	13.2	4.6	4.2	10.9	7.1	16.2	6.0	5.3	8.0	9.8	19.1	37.8	20.1	24.3	7.7	7.5	3.4	31.5	10.7	8.0	4.4	14.6	16.3	23.6	9.5	26.1	2.7	22.0	4.2	11.7	14.6	7.8	6.9	18.5	12.0	2.9	6.8	26.4	27.5	34.8	21.4	32.3	4.9	9.1	4.1	38.4	4.1	20.7	9.0	0.6	3.3	4.2	0.3	6.2	3.6	3.6	5.0	1.5	3.7	4.4	4.0	0.5	5.7	0.2	0.8	2.9	2.7	17.0	17.5	22.7	22.6	16.9	14.9	19.6	18.2	20.1	14.5	14.9	3.4	1.4	7.5	5.3	16.0	13.3	10.2	9.4	9.1	7.0	2.0	28.2	26.6	24.5	1.5	10.5	1.3	0.0	21.1	11.6	8.9	7.2	3.5	8.3	9.9	19.1	9.2	8.0	1.6	3.0	6.9	6.6	6.8	39.7	4.4	6.3	36.9	5.7	8.1	5.3	7.9	6.5	8.2	2.3	11.7	3.8	9.0	6.9	5.8	4.3
MSANTD4	KIAA1826	ENSG00000170903	"Myb/SANT DNA binding domain containing 4 with coiled-coils"	Q8NCY6	11	105995623-106022403	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Muller glia cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014411	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA014411: AB_2668995"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.04e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.90e-1)"	8.5	11.3	15.4	8.5	16.5	2.9	9.0	21.6	20.7	13.8	8.6	12.6	6.0	5.4	12.8	7.7	9.6	8.3	7.7	17.0	19.2	14.2	10.6	7.4	9.0	9.6	17.1	18.2	12.4	10.2	12.1	20.6	7.7	15.9	10.9	6.9	7.8	7.3	13.9	14.6	4.8	6.9	11.6	13.1	8.5	7.5	10.6	17.9	7.2	14.7	6.0	10.4	10.9	9.0	8.9	8.5	3.6	10.0	9.2	11.8	6.1	4.3	6.5	14.6	0.1	16.0	17.7	0.1	12.5	17.2	9.8	12.6	11.3	8.6	9.6	21.2	10.5	10.8	11.3	16.3	8.0	12.2	17.5	7.9	18.8	7.6	6.9	24.1	14.6	14.9	11.9	9.9	13.2	26.3	12.2	8.7	10.4	8.7	6.2	14.3	1.8	13.9	7.3	5.6	6.5	13.3	9.3	19.0	13.7	13.5	5.4	9.7	18.6	3.3	11.4	9.1	9.5	9.0	7.5	12.4	14.5	11.4	7.5	12.5	6.2	7.1	4.9	6.7	5.8	10.5	2.8	6.9	3.6	10.7	10.0	10.5	8.3	10.0	7.7	8.5	8.9	11.8	10.1	1.7	9.2	5.9	7.3	7.1	6.1	15.4	16.5	21.6	20.7	19.2	14.2	17.1	18.2	15.9	17.9	14.9	12.5	2.2	2.9	4.7	41.7	20.2	15.3	10.7	22.7	3.5	19.6	1.4	1.7	5.8	26.9	8.3	1.7	0.0	5.1	1.2	8.5	1.1	5.8	5.7	4.5	35.0	8.1	6.2	6.9	11.1	13.0	7.1	11.8	6.4	2.7	124.6	5.9	0.0	9.2	7.3	19.5	0.0	6.3	9.1	5.6	5.1	0.2	5.0	2.9	1.4
MSH3	"DUP, MRP1"	ENSG00000113318	"MutS homolog 3"	P20585	5	80654648-80876460	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036081			Approved	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Nuclear bodies"		"HPA036081: AB_10673229"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	14.8	11.7	11.1	24.9	13.1	11.3	19.4	12.1	22.5	13.7	14.0	9.7	17.3	10.8	12.3	16.8	13.4	16.8	13.4	10.4	11.1	10.7	23.4	20.4	20.9	12.6	11.8	10.3	11.6	14.5	17.9	13.1	8.7	10.3	10.9	11.8	10.6	12.5	24.2	14.6	12.0	12.1	13.4	14.6	9.2	10.4	9.4	8.5	20.2	19.5	12.1	10.7	13.1	11.9	7.3	6.1	4.4	8.3	5.1	8.4	3.9	10.4	12.6	10.3	11.2	6.3	11.5	14.7	10.5	9.8	11.1	14.5	9.1	12.8	18.5	12.1	12.7	10.9	9.3	12.4	16.8	14.7	11.6	12.3	7.7	12.9	8.9	6.4	8.3	7.9	10.1	8.6	12.8	14.8	11.8	10.6	7.2	10.0	12.8	13.6	10.0	14.4	6.1	8.3	4.4	6.9	11.5	19.8	13.8	16.0	11.4	10.5	12.3	10.1	9.8	12.5	13.0	13.4	9.0	10.8	7.1	9.2	7.8	18.8	8.3	13.3	17.6	10.5	14.7	8.9	1.3	6.0	3.5	7.4	5.9	7.9	7.3	7.8	7.7	5.7	5.9	6.4	6.3	4.4	5.1	8.3	6.1	8.4	3.9	11.1	13.1	12.1	22.5	11.1	10.7	11.8	10.3	10.3	8.5	32.8	5.7	13.3	10.8	9.3	24.7	15.9	12.7	81.7	13.6	14.0	13.7	16.2	13.3	10.8	12.8	7.0	15.0	0.0	9.0	11.1	8.9	6.1	8.1	17.1	10.0	20.6	13.9	8.6	14.3	14.7	12.7	8.3	3.3	15.4	10.7	22.1	8.7	10.5	24.4	33.8	27.5	19.4	8.2	18.2	25.0	8.8	11.0	20.8	15.0	8.0
MSH5	G7	ENSG00000204410	"MutS homolog 5"	O43196	6	31739948-31762834	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Meiosis"	DNA-binding	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 6.9;Spermatogonia: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"basophil: 9.3"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 9.3"	"Low cell line specificity"	"Detected in many"											HPA062688			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA062688: AB_2684835"	"unprognostic (3.21e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.51e-1)"	"unprognostic (9.20e-4)"	"unprognostic (7.67e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.59e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.19e-5)"	"unprognostic (3.75e-2)"	"unprognostic (8.83e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.34e-4)"	3.6	2.7	3.2	8.0	4.4	6.8	4.1	1.6	4.4	3.9	5.8	6.9	9.3	3.0	9.8	8.5	4.7	5.8	15.2	2.0	3.2	2.1	10.5	4.7	4.3	5.7	4.0	3.6	6.9	4.0	1.6	6.5	3.0	4.1	7.9	5.3	12.4	4.7	9.2	2.3	12.3	5.2	6.0	5.7	7.6	6.8	15.9	3.8	12.0	4.3	2.7	10.6	3.6	4.0	1.0	0.5	9.3	0.9	0.1	0.8	0.0	2.0	2.0	2.3	4.7	0.8	0.8	0.7	0.6	0.2	0.8	0.3	1.2	2.6	2.5	0.7	0.6	0.7	2.9	0.0	1.2	0.3	0.4	1.1	2.4	0.6	1.4	0.3	1.9	2.0	0.8	0.5	1.9	2.4	1.0	0.9	3.7	4.9	6.1	0.7	2.6	3.6	4.2	0.9	0.4	0.4	1.3	1.0	3.9	1.4	0.4	0.6	2.5	0.8	0.0	0.0	1.7	1.3	2.8	0.7	1.7	3.5	0.0	1.6	2.7	1.0	2.9	0.8	4.0	3.6	9.3	0.4	0.0	0.7	0.3	0.2	1.0	0.4	0.2	0.2	0.5	0.1	0.0	0.0	0.1	0.9	0.5	0.8	0.0	3.2	4.4	1.6	4.4	3.2	2.1	4.0	3.6	4.1	3.8	0.0	2.9	0.0	0.5	0.5	0.7	0.3	0.0	1.4	1.2	3.5	17.7	0.6	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.2	0.4	0.5	3.5	0.0	0.4	0.0	1.2	0.6	0.3	0.0	1.1	1.0	0.0	0.0	1.1	0.4	0.3	0.0	0.7	0.6	6.9	0.0	0.5	2.6	5.1	0.4	0.5	0.0	1.7	0.3
MSI1		ENSG00000135097	"Musashi RNA binding protein 1"	O43347	12	120341330-120369180	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.3;skeletal muscle: 23.2"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 51.1;Early spermatids: 46.0;Late spermatids: 40.7;Muller glia cells: 68.3;Rod photoreceptor cells: 92.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 43.8;HAP1: 20.0;NTERA-2: 22.8;SCLC-21H: 32.5;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074923, HPA075573"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA074923: , HPA075573: "	"unprognostic (1.21e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	0.8	6.8	8.7	0.6	7.4	0.4	1.2	3.9	14.2	1.9	1.5	8.6	2.2	7.8	4.3	2.7	1.5	3.1	1.4	4.0	11.3	5.9	0.7	1.0	1.0	0.6	4.7	6.1	2.9	7.3	1.3	12.8	1.4	4.6	4.5	1.5	27.3	1.3	2.5	23.2	0.5	5.2	2.2	4.7	0.7	3.1	12.5	5.4	0.0	1.3	0.0	0.4	0.9	0.9	0.1	0.4	0.6	0.2	0.2	0.3	0.0	0.0	0.5	43.8	11.1	0.0	0.0	5.6	0.0	0.0	0.3	0.5	7.7	0.2	0.0	0.6	0.0	0.2	0.1	20.0	0.0	0.1	0.2	4.5	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.1	22.8	0.2	0.2	0.1	0.0	0.1	0.0	0.0	32.5	15.8	0.0	0.3	0.3	4.4	6.7	0.0	0.0	0.1	6.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.6	0.2	0.2	0.4	0.1	0.0	8.7	7.4	3.9	7.2	11.3	5.9	4.7	6.1	4.6	5.4	0.0	0.0	0.0	1.0	0.9	20.9	2.6	0.0	0.0	0.0	0.0	51.1	0.0	1.7	1.0	46.0	0.3	0.5	0.0	4.5	0.5	0.5	5.5	0.0	0.0	0.1	3.2	9.7	0.0	0.0	40.7	0.3	0.0	0.0	1.0	0.7	68.3	2.0	5.5	0.4	0.0	92.6	12.9	2.1	7.0	1.3	0.0	0.3	0.0	2.5	0.3
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148922-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003413	Uncertain		Approved	Nucleoplasm,Cytosol		NA	No			"Nucleoplasm, Cytosol"		"HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	13.1	10.1	13.3	16.2	15.6	40.2	13.5	31.0	15.8	13.7	11.3	14.8	9.9	11.1	15.5	8.2	12.2	14.1	10.0	9.8	12.4	9.0	10.0	14.1	13.4	23.7	12.6	11.2	18.3	12.7	19.9	19.8	15.9	12.0	13.0	10.1	10.6	13.2	9.8	14.9	14.1	18.2	9.6	14.2	24.2	12.3	13.6	15.6	59.3	13.8	7.4	23.9	13.4	12.9	7.6	3.8	8.7	3.9	6.6	13.3	5.4	12.6	4.2	8.7	9.9	6.0	6.8	15.9	7.7	6.5	6.1	6.2	8.4	6.7	23.7	10.6	5.7	7.5	9.1	10.0	6.6	9.7	12.5	7.7	25.8	8.4	4.7	6.2	21.2	13.5	5.3	7.3	5.0	14.2	6.0	6.1	20.8	9.2	20.6	5.1	7.7	38.3	12.4	11.6	6.0	7.4	17.9	14.8	15.1	3.1	9.0	11.3	8.1	17.5	7.2	11.6	7.0	6.4	13.9	9.6	8.3	7.3	7.7	7.1	24.5	12.7	35.5	7.1	9.0	5.5	5.2	3.7	5.0	7.0	3.9	8.8	4.5	6.6	8.2	3.8	7.6	13.3	8.9	8.7	6.6	2.8	2.5	5.0	5.4	13.3	15.6	31.0	15.8	12.4	9.0	12.6	11.2	12.0	15.6	17.9	9.1	20.4	14.9	24.8	12.8	13.4	10.2	4.0	6.8	12.2	3.9	7.2	3.3	4.6	2.3	10.7	6.9	0.0	4.7	5.4	8.2	10.7	6.9	17.8	7.6	15.9	17.2	19.0	22.8	1.6	8.6	10.5	20.3	9.0	14.4	7.2	5.5	3.5	8.1	5.6	10.1	6.5	12.3	12.6	10.5	23.3	4.0	25.4	10.9	11.2
MSL3	MSL3L1	ENSG00000005302	"MSL complex subunit 3"	Q8N5Y2	X	11758159-11775753	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034535, HPA034536"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034535: AB_10603878, HPA034536: AB_10670973"	"unprognostic (2.58e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.36e-2)"	"prognostic favorable (3.28e-4)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.14e-9)"	"unprognostic (1.20e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.35e-1)"	"prognostic favorable (2.17e-4)"	11.4	8.1	11.7	23.4	13.3	19.0	10.7	11.9	18.8	7.8	9.3	10.0	6.4	8.6	9.6	7.5	11.9	9.4	10.9	7.7	11.1	11.2	9.9	9.2	14.4	32.5	11.8	10.5	8.6	7.5	7.0	7.9	12.3	15.7	9.7	10.5	4.6	9.9	8.9	24.0	13.7	16.2	10.1	11.3	34.1	9.5	10.5	10.0	49.1	10.1	9.4	30.2	13.9	15.5	25.7	27.1	39.0	33.4	24.5	37.1	30.9	11.5	12.5	16.6	14.5	13.8	19.1	7.1	14.8	13.3	16.2	19.5	7.7	11.7	16.5	15.3	14.1	11.4	9.6	19.7	12.1	19.7	10.6	13.9	8.8	14.3	3.9	12.6	13.4	17.1	11.8	15.5	19.5	8.5	15.2	27.6	21.2	16.0	10.5	16.2	11.8	10.7	15.2	13.6	12.2	20.7	7.8	16.9	20.0	11.3	14.4	10.9	13.1	16.0	6.9	9.6	16.7	11.6	8.8	26.4	15.7	11.0	25.5	13.6	8.3	9.9	19.1	11.4	7.6	13.0	26.7	31.1	22.4	24.2	27.5	23.0	25.7	28.6	27.8	24.0	25.3	37.1	34.5	39.0	24.5	33.4	27.1	33.6	30.9	11.7	13.3	11.9	18.8	11.1	11.2	11.8	10.5	15.7	10.0	8.9	16.3	29.8	12.1	11.7	9.9	13.3	22.9	26.8	13.6	7.0	7.9	18.5	8.3	14.7	38.4	20.4	9.2	0.0	14.8	27.4	15.3	10.0	25.5	14.1	20.2	7.9	6.4	27.0	54.7	16.2	11.5	37.3	13.5	14.4	14.3	7.2	19.6	11.5	15.6	9.8	7.3	6.5	13.7	32.0	11.7	16.2	9.8	32.0	12.4	10.9
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760762-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 85.5;lung: 88.5"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 175.7;Alveolar cells type 2: 67.0;Club cells: 66.0;Paneth cells: 190.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.0"	"Group enriched"	"Detected in many"	59	"dendritic cells: 9.0;monocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 104.2;EFO-21: 16.1;HeLa: 31.8;hTCEpi: 23.1;OE19: 19.3"	"Low region specificity"	"Detected in many"							"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		14000000	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	36.5	0.0	0.4	6.7	0.5	0.7	0.3	0.1	0.4	5.4	5.4	0.8	26.8	2.1	4.8	18.9	3.1	85.5	9.6	4.3	0.4	0.3	2.6	0.2	88.5	0.4	0.6	0.0	22.3	0.4	0.0	0.6	13.7	0.9	1.9	1.2	0.2	14.4	33.1	0.0	0.5	0.7	1.0	0.8	0.1	3.7	2.1	0.0	0.1	0.1	0.6	7.8	1.4	1.3	0.0	9.0	0.0	2.6	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.5	1.8	0.4	1.5	104.2	0.0	16.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	31.8	1.2	0.9	0.0	0.0	0.0	23.1	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	19.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.4	0.5	0.1	0.4	0.4	0.3	0.6	0.0	0.9	0.0	175.7	67.0	0.0	1.3	0.2	1.3	1.2	50.9	25.4	66.0	24.4	0.0	0.1	0.0	1.6	1.1	0.0	1.9	0.0	0.7	0.0	0.6	1.2	0.0	0.0	2.9	0.0	2.9	0.0	0.6	4.5	4.4	2.6	1.7	7.2	1.3	0.0	19.2	190.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.1	0.0	2.5	37.2
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 6.0;placenta: 5.7"	"Group enriched"	"Detected in some"	67	"Early spermatids: 95.5;Late spermatids: 142.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.9"	"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 35.1;PC-3: 44.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in male reproductive system"	No	No			Vesicles	Cytosol	"HPA055174: AB_2682726"																		0.5	0.0	1.2	1.1	0.6	0.0	0.8	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.1	0.1	0.4	0.0	0.4	0.9	3.9	0.0	0.0	0.0	0.0	6.0	5.7	0.8	0.7	0.5	0.0	0.0	0.3	1.3	0.5	1.5	0.3	2.2	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.1	0.0	0.1	3.2	0.3	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	1.2	0.3	0.1	0.3	0.4	1.2	0.6	0.0	0.6	0.1	0.1	3.9	0.0	0.8	0.0	0.0	0.6	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	95.5	0.3	0.0	0.0	1.8	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	142.6	0.3	0.0	1.7	0.0	0.0	0.8	1.3	0.0	0.7	0.2	0.6	0.0	0.0	0.7	0.4	0.1	0.2	0.0	0.0	1.1
MST1R	"CD136, CDw136, PTK8, RON"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 34.3;skin 1: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 23.8;Enterocytes: 29.1;Mucus-secreting cells: 21.5;Pancreatic endocrine cells: 19.7;Paneth cells: 20.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.9;HaCaT: 19.8;HBEC3-KT: 21.6;hTCEpi: 30.3;RT4: 23.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favorable (2.33e-5)"	1.7	0.1	0.4	7.5	0.6	0.0	2.4	0.5	0.7	1.8	20.5	0.7	2.0	11.2	1.2	1.3	6.1	0.6	27.7	0.9	0.5	0.1	1.4	0.4	5.0	1.1	0.4	0.6	0.5	4.1	0.0	1.3	0.8	0.9	1.7	9.7	2.5	2.1	0.4	0.5	28.7	34.3	0.7	0.4	0.6	19.1	1.9	0.4	7.7	1.3	6.0	4.5	4.3	3.5	0.2	0.0	0.0	0.0	0.6	2.1	0.0	12.9	5.0	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.2	35.9	0.5	3.1	0.2	0.0	19.8	0.0	21.6	0.0	0.3	0.3	0.0	8.5	0.3	0.3	0.0	0.4	0.1	30.3	0.1	4.3	0.1	0.0	0.0	0.2	0.1	0.0	1.8	0.0	0.0	0.1	11.6	10.5	0.9	0.0	0.3	13.3	23.1	0.3	0.0	3.6	8.4	0.0	0.0	6.6	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.4	0.6	0.5	0.7	0.5	0.1	0.4	0.6	0.9	0.4	23.8	10.1	0.0	2.2	7.8	0.0	1.2	0.0	2.7	9.1	0.0	0.0	0.1	0.0	5.2	13.7	0.0	29.1	0.0	8.7	0.4	0.4	1.7	0.0	0.0	0.1	0.0	4.1	0.0	0.0	7.9	0.3	0.0	0.0	1.0	21.5	0.0	19.7	20.4	0.0	0.0	0.0	0.0	0.4	1.6	0.8	4.1	0.0	0.0	12.4	4.6
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 434.4;skeletal muscle: 294.4"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 16050.3;Hepatocytes: 4100.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 885.9"	"Low region specificity"	"Detected in all"							HPA075648			Approved	Centrosome,Mitochondria		NA	NA			Mitochondria	Centrosome	"HPA075648: AB_2686760"	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	101.1	71.9	102.4	20.3	114.5	13.2	39.4	41.5	73.3	39.4	83.8			48.0	26.1	34.1	30.7	23.9	23.4	187.5	102.7	79.1	123.5	185.7	20.2	13.1	88.6		26.2	43.4	29.7	18.5	30.9		34.2	80.0		43.2	75.4	294.4	31.8	38.4	38.6	59.2	16.1	62.5	27.5			24.6		24.4	25.8	14.3	200.8	111.2	434.4	139.9	112.1	153.0	66.8	97.1	90.4	163.1	166.1	571.6	120.3	71.9	208.6	52.3	32.7	59.8	150.2	89.8	241.1	85.5	140.9	53.6	185.3	25.3	223.3	65.2	94.9	104.4	173.3	885.9	279.0	83.9	178.2	155.8	210.6	228.8	62.4	218.5	246.4	65.5	125.0	95.5	172.9	119.9	173.6	67.7	228.6	41.1	103.4	109.2	39.3	70.3	107.2	174.1	205.2	49.5	67.0	102.3	162.1	69.9	366.4	115.3	224.3	209.4	86.0	107.1	125.8	79.8	156.5	73.2	128.4	61.7	242.4	40.1	434.4	139.9	290.0	102.4	110.6	140.6	166.9	110.0	117.5	86.1	200.8	132.4	153.0	78.4	112.1	99.4	111.2	79.0	66.8											208.4	153.9	1221.6	193.7	203.1	0.0	16050.3	1630.6	940.9	684.7	307.1	0.0	0.0	76.3	127.4	46.0	141.8	949.6	2499.6	297.1	0.0	116.0	126.2	448.0	4100.6	0.0	0.0	246.6	1665.3	1966.8	217.5	386.3	249.3	243.0	242.5	657.8	0.0	237.0	573.3	217.1	415.7	0.0	342.8	211.1	226.8	167.2	211.8	0.0	631.2	458.3	137.0
MT1E	"MT1, MTD"	ENSG00000169715	"Metallothionein 1E"	P04732	16	56625475-56627112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 248.5"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 3009.6;Hepatocytes: 2806.6;Mucus-secreting cells: 2755.2;Paneth cells: 3720.3;Proximal tubular cells: 4546.8;Undifferentiated cells: 2435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.9;T-cells: 14.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 124.0;LHCN-M2: 94.5;RPTEC TERT1: 107.0;U-2 OS: 60.4"									HPA041152	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041152: AB_2732490"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.86e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.78e-2)"	68.4	71.5	38.0	18.4	104.6	2.5	47.7	13.8	42.3	10.1	75.3	20.0	10.7	36.2	7.3	18.4	27.1	33.1	44.2	19.6	40.0	27.0	66.1	248.5	21.1	13.7	66.0	27.4	13.4	145.0	4.5	5.1	7.8	94.3	22.6	64.3	13.9	9.1	9.1	28.0	16.4	114.5	29.8	58.6	5.4	47.0	4.1	24.5	0.0	110.7	21.3	4.9	9.4	11.8	0.3	3.9	0.0	2.0	0.1	14.2	1.9	11.2	0.0	0.0	0.0	18.2	21.1	0.1	29.8	32.0	8.2	9.6	0.1	15.1	0.0	2.3	10.3	1.2	24.5	27.5	124.0	11.3	11.3	0.0	0.4	16.4	1.9	8.2	0.0	0.0	14.5	42.1	21.4	24.7	49.8	4.9	0.0	0.0	0.0	94.5	0.0	0.0	7.4	10.8	0.0	0.1	0.0	0.0	0.3	107.0	0.0	1.6	0.0	0.0	0.0	0.1	2.1	0.0	13.8	12.2	0.0	60.4	9.5	5.7	0.0	0.2	0.2	34.7	18.9	0.1	0.0	2.0	0.0	10.5	1.4	3.7	0.3	5.9	14.2	3.9	0.0	2.7	10.7	0.0	0.1	1.2	0.2	13.7	1.9	38.0	104.6	13.8	42.3	40.0	27.0	66.0	27.4	94.3	24.5	366.3	115.6	55.5	220.6	158.7	0.0	67.5	448.4	238.3	298.0	471.1	0.0	12.9	1188.7	375.5	1.5	49.3	3009.6	93.5	167.4	775.1	142.5	750.7	27.7	2806.6	30.0	0.0	233.0	171.2	56.5	2.4	138.4	87.0	104.6	99.2	2755.2	0.0	423.2	3720.3	48.1	4546.8	0.0	213.4	278.2	0.2	2.7	129.5	66.7	38.7	2435.9	51.9
MTA3	KIAA1266	ENSG00000057935	"Metastasis associated 1 family member 3"	Q9BTC8	2	42494569-42756947	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039433	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA039433: AB_10794747"	"unprognostic (5.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.28e-2)"	8.8	35.0	19.2	16.7	21.0	1.6	14.6	11.4	23.7	14.5	12.5	10.2	16.8	9.0	17.2	25.0	16.7	14.1	11.3	11.1	18.3	14.0	14.5	7.6	8.3	11.5	12.3	14.6	33.3	15.0	18.3	15.8	16.1	12.5	15.0	14.1	12.6	10.6	20.8	9.8	15.4	8.7	14.3	10.4	6.4	12.5	21.0	9.3	74.3	13.0	7.7	15.0	13.5	13.4	2.9	3.2	7.7	1.9	3.3	8.8	3.3	7.6	8.0	12.0	7.2	9.6	13.4	23.8	4.8	8.7	10.8	9.3	10.1	13.3	25.1	8.3	10.4	8.2	4.8	25.4	11.4	15.9	9.3	8.6	4.5	4.7	15.9	10.4	2.7	15.3	14.2	12.8	7.3	7.9	14.8	14.5	12.7	8.2	2.9	11.8	11.3	17.5	8.4	42.9	10.2	4.9	10.1	10.5	0.0	10.8	6.3	6.4	20.8	7.4	23.3	9.8	32.7	12.6	3.4	9.0	5.2	8.5	3.8	4.6	6.0	2.8	36.8	6.9	2.8	6.6	7.7	1.9	0.0	4.1	0.7	5.7	2.5	4.4	6.2	3.2	2.9	8.8	5.9	0.3	3.3	1.2	1.0	2.2	3.3	19.2	21.0	11.4	23.7	18.3	14.0	12.3	14.6	12.5	9.3	11.9	12.2	9.0	18.9	13.6	0.0	10.6	10.2	9.4	12.5	21.0	0.0	48.3	14.9	20.3	8.2	11.1	20.0	0.0	24.6	35.3	15.4	16.9	11.5	12.3	10.4	0.0	9.2	16.0	7.3	17.2	31.4	5.9	16.9	8.2	20.7	0.0	18.5	23.5	37.4	26.2	0.0	12.9	14.4	20.0	42.4	15.9	50.1	6.9	19.7	15.3
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802543-21937651	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046915			Supported	Nucleoplasm,Cytosol		NA	NA		3100000	Cytosol	Nucleoplasm	"HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	17.0	12.6	7.8	12.6	10.4	8.4	13.9	4.6	10.2	17.3	14.5	12.8	13.4	8.0	21.2	11.6	19.6	12.2	16.9	11.4	7.9	7.7	13.0	17.5	11.4	13.0	12.0	6.2	20.5	17.2	17.6	14.4	17.5	12.3	17.0	13.1	14.3	14.6	15.9	10.8	11.8	10.3	19.9	14.3	17.9	11.7	7.9	10.1	19.1	11.7	14.3	16.2	19.7	17.2	9.3	8.4	1.4	6.9	8.5	8.2	3.5	14.4	2.2	11.7	9.9	9.7	10.0	13.2	21.2	10.4	10.7	12.4	9.9	6.8	7.2	6.6	10.0	8.8	6.7	12.0	29.9	18.3	0.1	9.8	0.1	27.4	13.1	9.4	11.5	12.9	12.0	0.0	19.8	21.7	12.4	11.1	0.2	0.1	9.7	11.2	2.0	13.2	0.3	13.7	6.7	17.7	0.2	8.9	12.7	9.3	0.1	6.7	7.6	6.9	8.1	10.5	8.9	5.2	0.2	12.1	0.1	7.6	0.1	16.8	6.5	11.4	15.1	0.1	11.5	6.2	1.4	6.9	0.3	5.0	5.4	8.2	7.7	7.2	5.6	8.4	9.3	6.5	5.9	1.0	8.5	3.4	8.0	4.1	3.5	7.8	10.4	4.6	10.2	7.9	7.7	12.0	6.2	12.3	10.1	20.8	16.6	17.1	39.8	12.6	0.0	21.0	25.5	16.0	28.4	14.0	0.0	42.6	13.3	34.0	42.8	11.2	6.9	0.0	24.4	68.9	13.3	17.2	10.4	19.8	23.3	0.0	9.2	16.5	21.0	8.8	13.8	17.0	10.1	12.6	13.2	0.0	37.3	0.0	13.8	15.3	0.0	12.9	13.2	0.9	16.0	11.4	18.9	13.4	18.8	44.6
MTBP		ENSG00000172167	"MDM2 binding protein"	Q96DY7	8	120445400-120542133	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Erythroid cells: 23.3;Spermatocytes: 9.2;Spermatogonia: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 30.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA025694, HPA050594"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"HPA025694: AB_1854169, HPA050594: AB_2681185"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.40e-3)"	"unprognostic (2.77e-6)"	"unprognostic (3.99e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.20e-10)"	"unprognostic (3.41e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.86e-2)"	3.7	2.4	4.9	8.3	6.9	7.1	5.4	16.8	7.3	3.8	3.4	4.1	3.2	3.0	5.8	5.2	4.2	3.6	2.5	2.2	3.6	3.2	2.3	1.8	2.6	8.2	4.8	3.3	5.3	2.7	2.6	3.9	4.2	5.1	3.2	5.5	3.2	3.6	2.3	2.0	6.0	3.2	4.2	4.6	4.6	2.7	11.0	4.8	12.6	2.3	3.4	8.0	2.9	3.5	2.7	0.6	0.6	2.0	1.7	3.2	1.1	9.8	2.9	9.8	4.0	1.4	2.4	4.8	7.5	4.3	11.1	14.4	3.1	5.5	9.0	7.7	2.5	3.3	8.5	9.2	4.5	13.7	7.4	7.0	7.5	4.2	3.7	0.7	7.9	5.8	0.9	2.0	8.5	5.5	1.7	4.9	8.3	4.8	6.8	6.4	4.4	12.6	4.9	4.4	7.8	5.9	7.3	10.1	6.4	2.6	3.5	5.1	5.9	5.1	30.1	4.5	5.6	5.6	5.8	2.9	4.8	8.7	6.1	12.1	2.7	5.6	5.2	4.5	9.9	5.4	0.0	0.4	0.6	1.3	2.0	2.0	2.7	1.9	2.3	0.6	1.9	3.2	2.7	0.2	1.7	1.0	0.0	2.2	1.1	4.9	6.9	16.8	7.3	3.6	3.2	4.8	3.3	5.1	4.8	0.0	1.0	0.0	1.3	0.7	0.0	1.1	0.0	2.7	1.2	1.8	0.0	1.6	0.0	0.7	0.6	0.0	0.0	23.3	1.5	2.6	1.1	0.9	2.3	0.8	1.4	0.0	0.0	1.3	0.8	0.0	1.4	1.6	1.7	1.0	1.3	0.0	0.3	0.0	1.1	0.0	0.0	0.0	1.6	9.2	7.0	0.5	0.6	2.2	1.0	0.8
MTCH2	SLC25A50	ENSG00000109919	"Mitochondrial carrier 2"	Q9Y6C9	11	47617315-47642623	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.8"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 432.9;Proximal tubular cells: 398.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038390	Approved		Approved	Mitochondria		NA	NA		55000	Mitochondria		"HPA038390: AB_10669723"	"unprognostic (4.94e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.12e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	13.6	19.6	15.6	12.8	20.3	8.3	12.5	14.1	21.3	10.4	22.3	19.3	8.7	28.3	12.6	15.1	21.6	9.9	11.6	15.0	14.0	13.8	40.8	74.8	9.1	13.9	15.2	12.2	9.3	14.4	16.8	9.3	9.5	15.4	11.8	24.7	13.6	13.4	10.0	31.4	12.1	33.9	16.1	11.4	11.4	10.1	44.2	10.2	15.1	15.5	24.9	16.4	11.6	10.7	13.7	25.7	7.9	21.3	12.1	13.6	17.5	18.9	20.8	17.8	24.0	21.1	19.6	13.2	20.6	18.9	27.8	26.4	16.5	19.4	26.2	11.2	25.2	30.1	23.9	31.9	27.1	33.9	13.1	29.8	15.0	29.7	32.9	29.1	31.2	15.1	22.1	21.4	18.5	27.7	16.2	25.1	22.6	27.7	15.8	33.9	27.6	23.9	23.5	19.3	37.2	31.6	22.4	27.1	18.8	32.2	24.6	21.2	14.9	28.2	28.5	14.5	17.6	41.0	14.7	20.8	25.7	22.4	42.5	26.4	16.8	19.1	29.6	21.2	27.2	22.9	5.9	19.8	7.9	12.7	21.3	12.0	13.7	11.1	11.7	25.7	10.9	9.7	11.2	1.9	12.1	17.0	16.9	13.6	17.5	15.6	20.3	14.1	21.3	14.0	13.8	15.2	12.2	15.4	10.2	20.8	33.9	37.2	43.0	41.8	0.0	61.0	81.5	46.8	37.5	50.6	0.0	75.5	154.2	136.5	432.9	25.1	133.4	0.0	95.3	101.6	32.1	64.6	35.9	265.9	146.4	0.0	76.7	35.0	64.2	110.8	26.7	50.7	77.6	112.8	82.5	0.0	85.1	63.1	54.8	398.6	0.0	32.3	38.1	327.5	81.0	47.3	106.9	37.6	134.8	50.4
MTCP1	"P13MTCP1, p8MTCP1"	ENSG00000214827	"Mature T cell proliferation 1"	P56278	X	155061622-155147937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Ciliated cells: 4.0;Club cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032040			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA032040: AB_2674122"	"unprognostic (2.42e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.29e-3)"	"unprognostic (8.30e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.40e-5)"	"unprognostic (9.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (4.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-2)"	6.4	7.1	4.1	5.3	5.3	7.2	15.8	4.4	4.8	6.0	6.2	3.4	7.7	5.7	6.0	8.2	7.0	6.1	4.4	30.1	4.7	2.9	6.7	12.8	8.5	15.5	4.5	2.7	9.1	20.7	3.9	6.5	3.5	6.4	5.8	6.1	3.9	7.3	7.0	11.4	12.0	6.7	8.7	7.2	6.7	6.2	16.1	3.8	2.5	8.2	5.4	7.2	6.9	4.0	0.2	0.0	0.8	0.7	0.5	2.0	0.1	1.4	4.9	2.4	3.9	1.6	1.3	2.7	3.0	1.5	1.9	4.8	4.3	7.5	2.7	3.1	0.6	3.0	4.8	3.2	3.5	2.4	1.8	3.2	1.2	14.3	2.3	1.4	2.9	3.3	2.4	1.7	3.2	3.0	2.3	1.8	4.7	1.1	4.9	1.3	2.0	3.7	6.1	1.1	1.8	0.8	4.0	2.6	6.1	2.4	2.1	1.2	1.8	2.2	1.2	2.1	1.7	2.2	1.3	1.8	2.2	3.9	2.1	2.2	10.7	4.6	5.2	4.3	3.5	3.1	0.0	0.6	0.8	1.1	0.0	2.0	0.2	1.2	0.4	0.0	0.1	0.2	1.4	0.0	0.5	0.7	0.0	0.0	0.1	4.1	5.3	4.4	4.8	4.7	2.9	4.5	2.7	6.4	3.8	0.0	1.0	0.0	0.2	0.2	0.0	0.6	0.0	4.0	2.3	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	1.1	0.2	0.3	0.3	0.0	1.0	0.4	0.0	1.7	0.0	1.0	0.2	1.1	0.5	1.7	1.0	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.0	0.3	0.5	0.2	0.6	0.2	0.0	0.5	0.0
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	14.2	15.5	14.4	17.6	22.1	17.2	18.6	42.2	21.7	16.2	14.6	25.3	12.5	13.4	23.2	14.1	17.6	17.7	12.1	13.4	14.4	12.1	13.4	16.5	14.2	29.8	19.2	19.4	25.7	20.9	11.7	25.7	11.6	20.4	28.9	17.2	16.3	19.5	18.1	38.8	15.5	19.6	17.3	17.8	20.3	14.7	12.7	22.3	23.7	29.4	20.5	29.7	14.3	15.2	16.6	6.2	11.4	5.4	8.0	24.9	10.2	8.7	8.3	16.5	9.5	22.5	10.1	12.3	14.9	16.6	14.5	20.7	5.7	13.2	13.6	5.4	17.3	16.5	9.9	22.5	21.3	19.7	18.4	16.3	17.4	15.9	25.1	14.8	20.7	13.3	17.2	20.9	17.0	19.7	18.9	16.5	18.6	15.5	6.0	17.4	12.4	15.1	14.3	18.9	18.1	14.3	14.8	18.8	7.7	13.8	17.6	15.2	13.2	12.2	15.2	11.3	11.7	11.2	10.7	22.8	13.4	13.1	15.7	13.3	16.1	4.1	33.2	11.3	13.2	12.3	4.2	5.4	11.4	10.0	5.2	12.5	16.6	15.5	13.7	6.2	15.4	24.9	19.5	1.9	8.0	4.4	4.7	15.8	10.2	14.4	22.1	42.2	21.7	14.4	12.1	19.2	19.4	20.4	22.3	11.9	23.0	29.4	17.6	0.0	0.0	17.5	25.5	32.1	23.9	19.2	0.0	24.9	34.9	21.1	40.5	13.6	19.2	23.3	21.3	22.9	13.5	15.6	10.5	27.2	22.0	0.0	10.5	14.7	21.8	48.5	21.6	18.0	0.0	19.8	26.7	0.0	20.5	25.8	24.8	32.1	0.0	38.8	15.9	42.6	38.1	0.0	19.8	30.5	22.5	14.8
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	8.7	10.2	7.9	10.0	11.5	11.6	7.5	13.5	12.7	9.5	12.7	6.8	8.0	9.7	11.8	10.6	9.5	10.9	9.7	13.8	8.0	7.8	12.8	13.4	8.4	8.6	6.8	9.4	14.0	5.9	7.3	9.3	7.5	10.3	10.8	10.8	12.2	8.7	9.8	13.3	11.6	13.9	12.0	5.7	9.2	8.7	7.2	5.2	9.2	11.7	4.6	8.8	12.0	9.1	5.0	9.6	16.9	3.6	4.6	5.9	1.9	2.5	3.5	3.4	6.0	4.9	3.4	3.0	2.4	4.2	3.1	3.0	2.2	3.0	9.0	3.2	4.3	5.1	7.6	6.4	4.2	3.0	3.4	4.7	3.8	3.4	2.5	5.7	5.2	1.2	4.9	5.3	1.7	3.7	4.4	2.8	8.0	4.0	4.3	4.7	3.5	4.1	5.5	4.7	7.3	6.1	3.8	5.0	4.1	5.1	3.0	3.5	3.6	5.7	5.3	4.3	4.7	3.3	3.7	5.2	3.7	3.8	4.3	4.7	3.7	5.3	3.5	3.3	8.4	3.8	3.1	3.6	2.4	4.9	2.9	4.9	4.7	4.9	5.2	5.6	5.0	5.5	5.9	16.9	4.6	2.0	9.6	4.9	1.9	7.9	11.5	13.5	12.7	8.0	7.8	6.8	9.4	10.3	5.2	3.0	8.9	11.5	12.6	3.0	0.0	15.0	7.6	5.3	9.1	3.5	0.0	9.0	21.6	10.4	1.6	6.5	11.9	0.0	8.5	10.3	10.0	11.7	8.1	9.5	14.2	0.0	7.5	10.4	10.8	1.4	14.4	11.1	8.5	2.8	9.0	0.0	9.2	16.4	14.5	15.3	0.0	0.0	10.3	10.9	21.6	4.0	7.4	9.6	15.3	13.2
MTFP1	"HSPC242, MTP18"	ENSG00000242114	"Mitochondrial fission process 1"	Q9UDX5	22	30425530-30429053	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 56.3;Exocrine glandular cells: 45.3;monocytes: 60.5;Pancreatic endocrine cells: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077396			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077396: AB_2686837"	"unprognostic (2.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.12e-1)"	"unprognostic (6.20e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.66e-2)"	8.9	9.6	6.4	13.0	6.6	9.8	13.5	3.7	6.5	7.6	13.3	2.8	14.5	11.7	2.9	16.2	12.3	2.8	10.2	18.3	5.0	6.0	27.4	20.8	8.3	17.3	7.2	2.2	9.3	12.9	10.3	5.7	9.2	9.8	8.5	12.9	9.8	9.0	4.4	14.6	4.6	10.2	4.1	3.8	17.4	11.3	3.2	5.9	5.3	11.2	8.9	13.0	7.7	5.6	13.0	7.6	0.7	6.4	4.8	25.7	9.9	26.2	19.5	6.8	11.0	1.4	0.7	8.2	2.5	1.7	15.0	23.4	9.2	16.0	27.9	7.1	1.4	11.9	12.2	23.8	18.3	13.1	15.1	27.1	8.1	11.6	19.3	4.1	20.4	15.7	2.1	7.2	8.1	13.9	3.8	10.3	13.1	12.8	11.0	5.0	31.5	18.4	23.0	12.3	24.7	20.0	23.7	6.8	26.7	19.0	6.9	12.3	12.8	5.3	28.4	10.3	6.8	8.7	10.1	5.2	16.0	21.5	8.2	6.6	5.7	3.9	25.0	6.3	23.0	6.7	0.0	5.5	0.0	19.3	6.4	25.7	13.0	16.2	16.5	7.6	9.3	16.8	19.6	0.7	4.8	3.8	3.7	13.3	9.9	6.4	6.6	3.7	6.5	5.0	6.0	7.2	2.2	9.8	5.9	6.0	4.0	28.4	1.4	4.9	0.0	4.0	7.6	0.0	3.4	3.5	0.0	10.1	13.3	56.3	0.0	3.1	25.2	0.0	45.3	27.0	4.3	3.0	9.2	12.5	15.5	0.0	8.1	4.3	8.7	0.0	0.6	3.7	3.3	60.5	17.7	0.0	42.1	11.5	0.4	9.2	0.0	0.0	1.9	0.4	1.4	4.8	14.1	14.6	36.7	1.6
MTFR1L	FAM54B	ENSG00000117640	"Mitochondrial fission regulator 1 like"	Q9H019	1	25818640-25832942	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 175.3;Late spermatids: 418.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027124, HPA027130"	Approved		Approved	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA027124: AB_10600211, HPA027130: AB_10611251"	"unprognostic (9.90e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-3)"	"unprognostic (5.33e-2)"	"prognostic favorable (5.89e-12)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.33e-1)"	13.2	43.5	17.8	8.1	23.9	6.2	14.0	19.4	26.5	13.8	20.2	17.1	21.6	18.2	16.7	23.3	19.2	17.1	13.4	58.7	16.8	17.6	27.7	25.1	10.7	9.0	17.7	20.7	26.8	14.5	38.7	16.4	15.6	19.2	19.9	14.8	24.2	16.3	28.8	76.9	11.4	15.3	28.0	13.0	13.4	16.4	46.4	15.0	5.8	16.5	23.1	9.9	21.1	16.6	10.1	21.1	41.1	20.3	10.3	10.6	18.1	7.6	10.6	21.5	21.8	27.9	26.4	9.1	17.9	25.6	18.4	20.3	3.5	16.1	2.6	16.0	31.7	16.2	7.0	17.6	15.3	18.1	17.3	15.8	22.0	17.8	13.9	26.8	18.0	22.1	27.1	14.5	19.6	14.7	27.3	15.1	10.8	13.3	11.8	26.2	8.1	10.2	12.8	11.8	10.1	15.6	10.2	19.4	7.7	18.9	7.0	22.0	20.1	13.4	13.0	26.7	15.1	10.9	16.7	15.6	15.2	12.1	35.5	11.2	12.4	7.4	9.2	26.6	24.5	16.9	20.4	19.4	41.1	10.4	18.8	6.2	10.1	9.9	9.3	21.1	10.0	10.6	9.7	5.2	10.3	20.3	8.5	10.3	18.1	17.8	23.9	19.4	26.5	16.8	17.6	17.7	20.7	19.2	15.0	14.9	23.2	21.5	23.3	11.9	0.0	129.8	15.3	8.1	15.9	21.0	0.0	46.0	87.9	28.6	175.3	16.8	19.0	0.0	29.3	32.3	25.4	13.0	34.7	29.4	29.9	0.0	15.0	16.5	13.4	418.5	31.7	18.9	42.2	59.5	13.1	0.0	23.1	14.8	36.7	58.4	0.0	25.8	29.7	84.9	35.7	11.3	49.7	10.2	18.8	11.5
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806920	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA063389: AB_2685001, HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.97e-5)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favorable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	11.7	11.0	8.9	10.3	12.4	24.5	9.7	15.3	15.8	9.0	10.4	13.5	8.3	10.7	10.4	54.5	11.3	12.7	10.9	23.4	9.2	8.6	12.0	12.4	16.2	13.3	9.9	10.7	28.8	11.2	6.7	17.5	6.6	10.7	10.2	9.1	14.1	7.3	7.2	15.3	13.2	13.6	10.9	7.4	18.3	13.6	10.6	10.9	10.2	15.8	9.8	11.7	10.4	17.9	4.9	3.2	4.7	7.4	3.4	4.7	2.3	1.3	5.9	6.8	7.8	6.8	10.5	1.1	4.2	8.8	4.0	3.5	5.4	8.7	11.4	2.3	4.3	9.3	2.6	4.8	4.0	1.7	5.4	4.4	8.4	7.4	1.5	9.1	4.6	10.9	9.2	4.0	3.0	3.3	6.6	6.2	10.8	27.4	7.5	4.1	1.8	5.0	2.2	2.3	5.9	2.1	5.2	3.7	12.6	6.4	7.2	6.8	11.6	5.2	5.1	8.2	4.3	8.1	7.2	5.5	4.0	3.3	4.7	1.0	4.2	5.7	21.3	4.9	10.6	3.6	1.1	3.8	1.9	4.7	7.4	1.8	3.0	1.6	2.5	3.2	4.9	2.4	2.7	4.7	3.4	6.9	1.5	1.0	2.3	8.9	12.4	15.3	15.8	9.2	8.6	9.9	10.7	10.7	10.9	23.8	50.3	12.3	6.7	7.4	0.0	35.5	10.2	5.3	10.3	26.2	0.0	4.1	1.7	7.7	13.8	16.2	32.7	46.7	22.0	2.7	16.0	9.3	8.1	19.5	18.8	0.0	11.6	38.6	38.0	28.3	17.0	26.2	11.8	10.8	15.4	0.0	15.7	17.8	8.5	14.3	0.0	19.4	24.7	6.0	4.7	8.2	2.4	8.7	16.5	8.1
MTHFSD	FLJ12998	ENSG00000103248	"Methenyltetrahydrofolate synthetase domain containing"	Q2M296	16	86530176-86555235	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041333	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA041333: AB_10795006"	"unprognostic (4.09e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (9.88e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.77e-1)"	"unprognostic (5.85e-3)"	12.6	12.6	10.9	10.0	11.4	7.1	13.1	17.1	16.5	12.1	10.8	19.3	18.2	9.1	17.5	15.6	14.4	16.8	11.9	10.0	11.1	7.9	12.2	11.9	10.4	13.3	13.4	13.6	14.8	14.2	24.0	15.8	10.1	14.4	15.9	13.4	16.2	17.2	15.7	14.7	15.6	12.5	14.1	9.5	15.9	12.1	21.5	12.8	14.7	14.7	13.3	14.9	13.3	18.7	8.3	9.9	10.1	7.6	9.3	9.3	7.2	9.5	9.2	8.9	7.8	7.8	11.9	11.0	9.6	7.1	12.2	6.1	8.0	16.3	8.6	10.4	8.3	6.5	13.3	9.9	9.4	11.5	5.7	8.1	7.6	12.0	7.5	10.4	6.0	4.4	7.5	15.2	15.6	13.5	10.6	7.3	12.9	16.2	0.0	8.8	12.2	7.6	9.2	5.9	8.0	11.5	23.2	5.3	6.8	7.1	5.9	8.8	6.0	21.8	4.3	8.0	9.4	21.8	6.4	7.4	11.8	10.2	7.8	9.2	7.1	8.7	25.3	10.8	9.9	11.5	10.1	7.6	3.8	8.5	5.8	8.8	8.3	9.3	8.5	9.9	6.8	7.8	8.8	3.1	9.3	7.1	4.5	7.6	7.2	10.9	11.4	17.1	16.5	11.1	7.9	13.4	13.6	14.4	12.8	6.0	5.1	5.1	2.5	1.0	0.0	3.5	2.5	8.1	3.4	5.2	0.0	6.1	10.0	4.4	28.8	3.6	5.3	0.0	3.7	4.2	3.0	2.4	4.6	2.8	5.2	0.0	4.1	4.3	5.3	11.9	6.1	3.3	3.3	4.6	4.8	0.0	3.1	3.5	7.8	3.3	0.0	6.5	4.7	9.9	3.2	1.3	6.4	2.9	4.7	1.7
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765103	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002977, HPA018502"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA002977: AB_2666735, HPA018502: AB_1854185"	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.9	6.8	20.4	14.0	17.9	9.9	11.8	14.5	15.6	8.3	8.6	8.7	7.2	8.3	9.4	9.2	19.7	9.3	9.0	12.0	17.8	13.4	8.1	10.2	9.7	18.7	12.1	11.5	7.4	11.7	16.3	10.2	37.9	8.8	10.8	9.1	7.9	12.1	13.0	22.2	19.8	10.9	8.3	8.2	18.0	9.7	11.0	9.3	32.6	9.6	10.7	23.1	10.4	7.7	3.3	7.8	7.4	1.5	6.2	4.8	1.8	13.2	8.5	9.2	7.5	2.1	2.5	12.4	11.8	15.2	12.0	17.1	8.2	10.5	29.0	17.5	9.5	11.6	12.1	18.5	17.1	18.8	11.7	11.2	1.8	13.2	3.5	6.4	8.5	6.3	6.8	11.9	13.2	0.2	11.5	7.2	9.7	5.6	7.5	8.6	11.4	12.4	2.2	4.2	14.8	12.9	6.6	14.6	12.8	9.4	15.2	13.7	8.5	4.5	10.1	3.7	7.6	12.9	4.9	9.1	7.9	6.3	1.0	17.5	9.6	9.8	44.2	1.6	5.5	6.1	0.0	0.9	7.4	3.5	1.5	2.6	2.7	3.9	3.2	2.2	3.3	3.5	4.7	2.4	6.2	1.3	7.8	4.8	1.8	20.4	17.9	14.5	15.6	17.8	13.4	12.1	11.5	8.8	9.3	14.9	6.2	3.4	9.6	10.0	0.0	7.9	2.5	1.4	5.7	5.2	0.0	8.8	0.0	5.1	0.0	3.6	2.8	0.0	5.7	6.0	4.3	6.1	1.1	8.1	4.0	0.0	9.2	3.1	8.2	0.4	5.2	5.2	3.3	1.0	7.6	0.0	8.1	6.5	4.9	2.9	0.0	6.5	2.7	1.2	2.3	14.6	8.7	6.9	5.2	10.8
MTMR10	FLJ20313	ENSG00000166912	"Myotubularin related protein 10"	Q9NXD2	15	30938941-30991607	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006081	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA006081: AB_2667508"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (7.77e-12)"	"unprognostic (9.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-1)"	13.9	7.3	19.9	7.8	22.8	12.0	16.3	8.4	19.3	10.0	8.4	32.9	4.2	9.6	7.4	8.1	17.1	6.4	7.5	10.2	22.5	13.3	25.9	19.2	10.6	9.6	30.9	11.9	9.5	9.8	14.8	4.3	32.7	29.4	9.2	8.5	9.5	11.1	10.0	24.3	7.6	8.9	8.3	84.0	10.7	10.0	6.6	24.9	8.9	11.7	6.0	8.3	9.5	7.2	3.4	3.8	14.1	6.9	1.4	1.6	1.6	5.5	6.3	5.8	3.1	12.9	7.0	4.2	8.0	16.8	6.8	6.7	4.0	1.9	2.3	11.0	10.7	6.7	8.2	4.5	4.8	6.4	8.3	1.2	2.9	4.1	5.9	7.5	5.5	5.9	9.4	3.8	4.3	4.8	8.0	16.7	6.8	3.1	6.5	6.1	1.6	5.8	1.6	2.9	6.9	2.6	4.4	5.0	13.1	25.3	8.8	2.1	5.4	3.8	4.6	1.6	8.4	2.9	10.4	7.9	7.9	5.0	4.1	4.9	5.9	5.0	6.0	4.6	2.0	8.8	3.3	3.2	3.0	0.8	4.2	0.8	2.1	0.9	0.6	3.2	3.4	1.6	1.3	14.1	1.4	6.9	3.8	1.3	1.6	19.9	22.8	8.4	19.3	22.5	13.3	30.9	11.9	29.4	24.9	23.8	14.6	5.9	3.7	7.9	0.0	20.2	5.1	4.0	7.9	31.4	0.0	14.7	1.7	2.9	11.5	11.7	10.0	0.0	3.2	2.6	7.6	7.4	16.2	28.7	10.3	0.0	5.8	10.4	21.9	17.8	9.8	17.2	8.5	2.8	9.0	0.0	4.2	8.6	7.1	13.3	0.0	0.0	5.3	12.1	6.6	9.7	32.2	5.7	6.8	5.2
MTMR11	CRA	ENSG00000014914	"Myotubularin related protein 11"	A4FU01	1	149928651-149936869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 108.3;Mucus-secreting cells: 58.0;Paneth cells: 72.4;Undifferentiated cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	37	"dendritic cells: 4.2;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.7;OE19: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030351, HPA072906"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA030351: AB_10602185, HPA072906: "	"unprognostic (1.14e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.12e-2)"	3.2	12.0	4.9	15.0	8.4	0.0	5.4	1.5	3.9	9.5	36.8	2.7	5.8	15.9	10.0	6.2	4.4	7.2	17.0	3.1	2.6	2.8	9.7	1.8	3.4	1.5	2.0	2.8	14.5	2.2	5.8	6.3	9.6	5.2	5.5	20.8	4.5	2.1	6.5	1.1	7.4	49.9	11.4	5.0	1.8	4.0	4.9	2.5	0.0	1.6	4.0	1.5	5.8	6.8	0.0	4.2	0.0	3.2	0.0	0.0	0.5	2.3	5.7	2.5	2.1	7.4	8.4	4.7	2.4	8.2	3.2	4.0	0.1	10.3	0.0	5.6	8.4	4.0	3.3	0.3	4.1	1.8	0.1	0.0	0.0	1.7	0.7	1.9	0.0	0.0	5.2	1.3	3.2	5.3	13.7	3.8	0.0	0.1	0.1	6.3	7.7	0.0	0.0	0.5	16.5	2.0	0.0	0.9	0.1	4.8	0.7	0.1	0.2	1.4	2.3	0.8	1.2	2.5	0.0	2.6	3.5	4.3	2.9	1.9	0.2	0.9	0.0	3.3	0.0	0.3	0.0	1.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.5	4.9	8.4	1.5	3.9	2.6	2.8	2.0	2.8	5.2	2.5	0.0	1.1	0.0	2.5	3.7	0.0	1.6	10.2	1.4	3.4	14.0	0.0	11.9	1.7	12.5	0.5	2.1	108.3	0.0	15.3	9.0	8.1	2.6	0.0	1.1	4.9	0.0	15.1	4.9	13.3	0.0	5.2	6.4	1.7	3.6	58.0	0.0	28.8	72.4	11.3	15.3	0.0	6.5	6.2	0.3	0.2	5.6	23.8	1.3	48.1	3.7
MTMR9	"C8orf9, DKFZp434K171, LIP-STYX, MTMR8"	ENSG00000104643	"Myotubularin related protein 9"	Q96QG7	8	11284416-11328146	"Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070944			Approved	"Actin filaments,Centrosome"		NA	NA			Centrosome	"Actin filaments"	"HPA070944: AB_2686325"	"unprognostic (1.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.43e-2)"	8.2	7.0	11.5	7.5	14.0	8.0	9.2	18.2	26.2	6.6	9.9	10.3	2.7	4.4	8.3	5.7	6.4	5.6	5.9	12.9	11.6	14.4	8.2	5.7	6.6	6.9	11.7	12.2	6.9	7.2	9.4	8.4	7.8	13.1	9.3	6.3	6.4	4.8	7.6	9.1	6.9	5.2	11.1	10.8	6.6	5.3	16.8	7.4	8.2	7.1	3.7	7.4	6.4	5.6	4.5	4.1	3.6	3.9	2.3	3.7	1.2	2.6	7.3	6.6	5.2	8.2	7.0	5.2	8.3	5.5	6.7	6.2	6.6	2.0	6.8	2.2	9.9	6.3	3.8	7.3	7.3	7.7	1.4	4.5	9.0	5.9	3.3	8.9	2.3	5.3	6.9	5.9	9.5	12.1	5.5	10.4	4.1	6.1	5.5	10.8	2.0	4.0	2.4	11.9	7.8	4.4	2.9	10.8	2.1	7.3	6.7	2.5	10.1	5.6	2.5	5.9	11.0	3.0	4.8	12.9	7.9	5.9	4.4	4.4	1.5	3.0	3.9	6.6	5.1	7.7	1.5	3.2	3.6	3.2	3.9	2.8	3.5	2.7	2.7	2.8	4.5	3.2	3.7	3.1	2.3	3.2	4.1	2.0	1.2	11.5	14.0	18.2	23.2	11.6	14.4	11.7	12.2	13.1	7.4	11.9	12.6	15.9	10.8	12.0	0.0	22.1	30.6	13.4	13.6	14.0	0.0	9.8	3.3	10.1	9.5	16.1	8.4	0.0	6.1	11.2	15.4	20.3	13.9	12.9	12.6	0.0	15.5	26.4	20.8	5.2	21.6	22.5	15.1	13.6	9.7	0.0	10.9	6.8	18.4	9.1	0.0	38.8	13.9	65.6	27.4	11.3	3.8	21.8	8.2	7.3
MTO1		ENSG00000135297	"Mitochondrial tRNA translation optimization 1"	Q9Y2Z2	6	73461578-73509236	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030230, HPA030232"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030230: AB_10598910, HPA030232: AB_10600891"	"unprognostic (2.17e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.64e-1)"	10.4	11.0	11.1	13.5	13.7	14.7	11.5	21.8	13.6	14.0	14.0	11.3	12.4	12.7	12.6	11.2	12.1	10.0	8.1	13.3	10.0	10.9	19.7	28.4	9.8	15.8	19.3	10.0	14.5	12.1	24.6	15.6	8.7	13.9	12.2	12.7	10.1	10.7	12.3	15.8	9.8	13.6	11.9	12.1	18.6	11.9	20.5	15.0	13.0	14.0	11.0	16.6	12.1	15.0	10.4	7.4	5.3	7.8	10.5	14.0	8.7	5.1	4.7	6.5	5.3	9.4	11.0	5.9	10.7	9.8	10.5	12.8	9.7	3.9	13.5	8.4	10.0	8.2	8.8	11.9	8.6	16.1	7.8	7.8	10.3	11.4	10.5	12.4	18.5	7.0	9.5	13.6	11.3	12.7	7.4	7.9	12.0	17.6	13.0	10.9	8.9	5.1	16.0	4.8	7.7	4.8	8.5	18.7	22.4	8.4	8.1	5.5	3.3	5.5	9.3	9.6	6.2	6.1	19.6	5.0	6.2	6.1	3.5	10.1	8.5	13.1	5.4	3.2	13.8	8.2	1.7	6.4	5.3	9.7	7.2	11.9	10.4	11.7	9.8	7.4	7.9	12.9	10.5	1.8	10.5	7.8	5.5	14.0	8.7	11.1	13.7	21.8	13.6	10.0	10.9	19.3	10.0	13.9	15.0	14.9	17.0	14.3	13.5	6.9	0.0	12.9	7.6	6.7	11.4	10.4	0.0	10.2	18.3	6.5	108.3	9.0	9.0	0.0	6.4	6.5	6.9	10.3	5.8	18.4	7.8	0.0	8.1	9.2	5.9	11.0	10.3	10.8	0.0	8.2	8.1	0.0	6.1	7.0	9.2	12.6	0.0	6.5	10.2	21.7	10.2	8.8	8.6	24.2	9.8	9.7
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	"Mechanistic target of rapamycin kinase"	P42345	1	11106535-11262507	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 38.8;Spermatocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069425, HPA071227"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB069425: , HPA071227: AB_2686367"	"unprognostic (3.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.55e-2)"	11.3	13.9	18.7	13.0	22.5	12.3	14.9	25.2	25.2	11.3	14.5	18.2	10.4	11.2	13.8	23.6	13.1	10.5	15.7	14.2	14.5	13.6	15.8	19.4	10.8	14.3	14.0	14.4	10.7	16.6	26.5	16.0	12.5	15.5	15.2	17.1	14.4	14.2	15.2	24.6	16.5	13.6	15.2	10.4	15.4	13.1	38.6	13.1	16.6	13.2	9.9	15.7	11.7	10.2	3.9	4.0	3.0	6.4	2.6	5.6	2.3	15.2	13.9	18.7	14.2	22.7	10.8	9.4	12.9	12.4	17.3	17.0	14.2	14.1	17.0	11.1	15.2	10.7	18.2	25.3	19.8	22.4	13.5	18.5	22.6	28.7	17.9	14.2	21.9	16.8	13.8	15.1	24.7	25.1	8.2	21.8	16.4	25.2	14.6	12.0	17.4	15.1	16.8	14.2	16.0	13.1	15.2	22.1	11.4	15.3	13.9	18.9	13.9	27.6	15.0	16.9	21.5	12.2	13.0	23.3	15.1	13.7	11.5	17.3	14.4	13.4	33.4	10.9	23.8	15.9	0.7	2.9	3.0	5.2	6.4	4.3	3.9	3.0	2.7	4.0	3.4	3.6	3.1	2.0	2.6	3.3	3.1	5.6	2.3	18.7	22.5	25.2	25.2	14.5	13.6	14.0	14.4	15.5	13.1	14.9	10.2	5.2	4.5	3.1	0.0	25.7	2.5	2.7	10.3	8.7	0.0	6.5	1.7	6.3	31.2	7.8	7.9	0.0	5.4	5.9	5.1	7.5	12.7	13.0	6.1	0.0	9.9	5.5	7.3	29.3	7.2	6.0	8.5	5.4	6.8	0.0	8.6	3.5	7.8	4.3	0.0	38.8	6.9	48.4	31.3	5.0	8.2	6.5	9.5	5.5
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926761-135977353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	31.0	22.1	40.2	28.5	53.2	55.1	39.6	34.4	50.0	30.9	21.4	20.4	16.0	17.2	29.5	21.9	62.1	27.0	23.7	31.6	38.0	31.6	25.1	20.5	31.6	49.3	24.2	32.4	22.0	10.7	29.2	22.5	26.3	22.9	23.4	23.6	21.5	22.2	24.0	27.4	19.1	23.1	27.9	23.3	42.4	17.6	23.4	19.9	36.4	36.9	24.9	42.8	26.1	30.5	37.9	24.6	50.6	43.5	12.8	16.7	17.0	27.7	22.0	24.3	36.3	34.9	41.5	12.7	44.0	44.7	28.2	30.9	25.0	30.0	49.0	32.6	54.0	43.2	17.7	22.7	34.5	52.4	36.2	22.4	33.4	23.8	16.3	28.7	44.8	48.2	30.3	34.2	33.5	31.5	39.1	43.9	39.3	39.6	29.6	53.1	21.2	45.1	33.2	34.4	25.6	31.3	26.3	18.6	39.8	30.6	23.0	31.3	57.2	35.8	22.3	33.8	23.0	16.4	27.4	47.0	42.7	19.6	42.4	41.4	24.7	36.3	72.3	68.3	39.4	90.8	25.4	21.4	22.6	16.7	28.9	14.3	30.9	10.4	12.5	24.6	37.9	6.9	9.9	50.6	12.8	43.5	24.2	9.0	17.0	40.2	53.2	34.4	50.0	38.0	31.6	24.2	32.4	22.9	19.9	44.7	37.6	120.5	45.1	105.9	0.0	68.2	66.2	34.8	50.0	66.3	0.0	53.8	76.3	60.3	68.1	93.1	49.6	70.0	44.7	56.8	87.2	72.5	93.8	50.8	91.4	0.0	31.8	97.0	229.9	24.5	80.0	156.1	96.2	119.0	41.0	0.0	73.4	59.1	116.3	67.4	0.0	90.5	53.6	60.7	100.9	130.2	57.6	66.6	47.3	89.4
MTSS1	"KIAA0429, MIM, MIMA, MIMB"	ENSG00000170873	"MTSS1, I-BAR domain containing"	O43312	8	124550790-124728429	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 44.8"	"Group enriched"	"Detected in many"	4	"B-cells: 16.1;monocytes: 44.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.1;HDLM-2: 24.2;HEL: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019613, HPA064003, HPA075540"	Approved	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA		10000	"Plasma membrane, Cytosol"		"HPA019613: , HPA064003: , HPA075540: AB_2686756"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.11e-7)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-3)"	18.7	27.3	14.0	9.2	16.3	8.5	12.4	36.0	19.1	8.1	8.2	32.1	1.7	5.0	5.6	15.8	32.4	8.9	7.0	13.4	13.5	13.6	18.2	51.5	12.0	12.1	18.1	10.3	8.2	21.0	2.6	10.5	25.3	16.9	7.9	7.0	19.8	10.2	5.3	16.5	21.3	5.0	7.2	20.9	23.9	9.0	15.8	20.0	8.2	4.1	12.1	12.2	9.7	13.7	16.1	3.3	0.6	44.8	0.6	6.9	6.8	0.9	0.2	13.2	0.3	21.1	10.9	0.0	0.5	3.5	0.2	0.1	1.2	0.1	0.4	1.3	0.0	0.1	0.2	0.1	7.3	0.2	24.2	0.4	83.0	0.2	6.6	4.8	0.0	8.9	17.3	16.8	4.0	10.5	0.5	7.9	0.1	0.1	0.1	1.4	0.7	0.2	1.0	0.5	13.5	0.1	0.1	0.0	0.1	2.9	2.8	9.5	0.8	2.0	2.0	6.7	0.7	0.3	0.2	4.1	0.7	0.4	0.0	0.2	0.2	0.2	1.4	7.6	0.2	2.7	0.6	3.9	0.0	6.9	25.6	0.8	13.2	1.5	2.6	3.3	16.1	0.7	2.1	0.6	0.6	44.8	0.0	0.1	6.8	14.0	16.3	36.0	16.7	13.5	13.6	18.1	10.3	16.9	20.0	0.0	21.1	45.6	48.9	31.8	0.0	27.4	30.6	33.5	18.2	62.8	0.0	25.3	18.3	13.8	44.0	23.2	2.5	0.0	4.6	1.9	16.6	37.6	45.1	69.1	57.6	0.0	42.4	74.3	152.0	42.3	3.4	94.8	25.3	120.0	19.1	0.0	21.1	14.0	4.2	16.2	0.0	38.8	12.2	2.8	11.5	55.5	78.9	13.4	15.0	51.5
MTURN	"C7orf41, Ells1, FLJ25903"	ENSG00000180354	"Maturin, neural progenitor differentiation regulator homolog"	Q8N3F0	7	30134810-30162762	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 189.2"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 9.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.9;NK-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;HEL: 40.2;SCLC-21H: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029507	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA029507: AB_10601149"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.64e-13)"	"unprognostic (9.50e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (3.26e-1)"	35.9	5.7	113.5	4.8	86.7	9.3	14.2	21.7	100.8	12.9	5.2	97.0	3.3	3.0	7.9	45.6	9.6	8.2	5.3	11.2	122.8	79.5	24.7	2.3	10.1	2.8	162.4	26.2	16.5	6.2	9.7	2.7	4.0	54.2	9.2	5.3	2.9	14.9	12.0	14.3	7.8	3.4	8.5	189.2	4.1	10.0	4.5	49.4	0.0	6.7	2.4	3.0	6.0	6.5	0.7	1.4	9.9	0.4	3.0	0.8	2.4	5.1	0.9	3.0	3.2	23.1	15.8	2.7	2.5	2.9	0.8	1.2	0.4	2.1	0.3	2.1	5.5	4.8	1.0	6.8	9.8	2.8	2.2	5.5	40.2	6.4	2.8	1.8	2.0	13.3	7.8	4.6	2.6	4.7	3.7	1.3	5.5	2.5	2.1	5.8	1.9	2.3	0.9	2.1	4.8	3.2	0.2	7.1	8.6	10.3	2.1	29.7	7.9	1.6	8.1	8.1	3.0	5.7	3.0	6.5	3.4	3.7	7.1	3.5	3.6	5.1	0.4	4.5	4.3	1.7	9.9	0.4	4.8	0.5	0.2	0.1	0.7	0.3	0.2	0.6	0.5	0.2	0.5	3.1	3.0	0.0	1.4	0.8	2.4	113.5	86.7	21.7	51.7	122.8	79.5	162.4	26.2	54.2	49.4	14.9	18.3	2.9	13.7	33.3	0.0	22.0	17.8	22.7	9.1	41.8	0.0	1.8	132.6	7.5	10.1	17.9	0.4	0.0	7.6	5.5	12.8	24.6	5.8	4.4	4.8	0.0	52.0	18.4	18.2	26.7	15.8	6.5	52.3	10.8	9.2	0.0	8.6	5.7	11.7	9.1	0.0	6.5	31.2	1.4	3.4	32.1	1.8	6.9	3.0	16.5
MTX1	"MTX, MTXN"	ENSG00000173171	"Metaxin 1"	Q13505	1	155208699-155213824	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 517.8;Late spermatids: 1060.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011543	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA011543: AB_1853824"	"unprognostic (2.57e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-2)"	15.4	19.8	11.6	9.9	12.6	22.9	15.8	5.7	18.1	15.8	15.9	12.2	14.8	12.4	14.9	13.9	18.0	21.4	13.5	11.8	10.8	10.0	24.4	36.4	12.8	18.7	11.8	12.9	14.0	26.3	23.4	12.0	28.4	11.7	12.3	12.7	14.6	20.7	19.2	10.4	13.8	13.7	12.7	10.2	17.1	14.7	60.0	9.0	14.5	19.3	14.3	18.0	11.6	11.5	14.4	23.1	43.8	26.8	12.2	14.0	14.4	17.4	28.7	9.2	13.1	17.2	15.5	29.1	9.0	18.3	26.9	18.8	35.7	29.2	14.4	29.9	20.7	8.5	17.5	13.5	25.5	9.8	10.5	31.7	9.1	23.0	34.4	27.2	16.8	12.9	19.8	23.9	27.7	18.7	10.3	23.7	21.3	18.4	7.2	15.9	42.3	18.8	21.2	18.3	24.8	33.4	15.5	5.8	34.1	24.2	15.1	15.0	18.7	11.2	35.6	10.3	14.7	28.8	27.3	9.8	12.9	14.5	8.5	15.1	13.9	11.5	14.6	17.0	8.6	13.7	10.2	26.8	6.3	9.8	13.7	9.2	14.4	12.1	10.3	23.1	12.4	12.1	10.9	43.8	12.2	7.9	12.4	14.0	14.4	11.6	12.6	5.7	18.1	10.8	10.0	11.8	12.9	11.7	9.0	8.9	17.1	31.2	37.1	18.0	0.0	1.1	30.6	36.1	9.1	33.2	0.0	91.6	82.9	61.0	517.8	26.4	34.8	0.0	73.6	112.1	34.7	39.6	26.5	48.6	89.5	0.0	19.0	20.9	42.2	1060.3	40.0	30.1	47.2	74.9	33.2	0.0	60.6	41.8	37.1	103.2	0.0	45.3	25.4	80.9	35.8	18.3	74.1	22.4	48.1	34.2
MTX3		ENSG00000177034	"Metaxin 3"	Q5HYI7	5	79976731-79991265	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047858, HPA062061"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047858: AB_2680185, HPA062061: AB_2684672"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (5.08e-5)"	"unprognostic (4.02e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (8.58e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.28e-1)"	9.4	13.9	11.8	8.9	18.7	8.6	12.0	10.9	20.7	9.9	9.4	8.5	5.9	6.2	13.4	10.1	10.6	11.2	6.4	8.5	14.5	5.8	10.7	6.5	7.6	11.8	7.4	10.8	17.7	9.9	21.0	11.1	6.8	15.9	12.0	7.6	8.3	12.0	11.1	11.6	10.0	12.2	13.0	12.0	8.5	9.3	6.2	8.2	2.8	12.3	7.0	11.6	12.2	10.1	3.7	0.9	1.2	1.1	1.4	3.6	1.0	6.8	4.6	10.2	5.8	4.9	10.1	2.6	6.1	5.0	5.7	6.7	1.7	7.6	10.8	2.0	6.2	9.1	7.9	0.0	14.8	10.2	2.8	7.1	4.3	11.3	4.7	9.4	0.0	5.5	7.7	13.9	9.9	16.8	7.5	4.0	0.0	2.5	6.8	9.2	6.9	0.0	0.1	10.5	2.0	4.2	0.0	15.7	4.6	4.5	8.0	14.2	10.4	8.8	5.7	12.0	8.8	9.7	6.9	4.0	10.1	8.4	8.0	14.0	9.0	9.0	9.8	14.6	0.0	11.6	0.7	0.8	1.2	2.6	1.1	1.9	3.7	2.9	3.5	0.4	2.6	3.6	2.8	1.0	1.4	0.5	0.9	1.4	1.0	11.8	18.7	10.9	20.7	14.5	5.8	7.4	10.8	15.9	8.2	26.8	4.0	1.9	4.1	1.3	0.0	8.7	12.7	16.0	11.4	12.2	0.0	4.1	5.0	3.7	2.1	4.2	2.8	0.0	2.2	2.2	4.6	7.9	1.1	6.8	2.8	0.0	0.0	9.2	4.3	3.1	11.8	3.3	0.0	1.8	6.8	0.0	4.3	5.3	11.7	6.7	0.0	12.9	2.8	7.1	6.3	3.0	1.5	6.9	6.4	4.2
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720882-195741123	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 50.6"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 60.2;Urothelial cells: 102.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 25.3"									HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		11000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	1.7	1.2	1.1	3.4	2.1	1.2	1.8	2.5	1.2	6.3	15.2	1.1	4.7	3.2	1.5	5.2	15.9	5.7	8.7	1.1	1.1	0.7	50.6	4.8	6.4	1.1	1.1	1.1	4.6	7.6	1.0	4.6	13.3	1.1	4.9	7.6	1.2	10.6	1.8	2.5	2.1	4.1	2.0	1.1	1.6	2.3	1.8	1.1	3.0	3.9	1.9	14.9	10.6	26.6	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	3.0	0.1	0.5	0.0	0.2	1.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.5	3.4	0.1	0.8	0.1	0.8	0.0	1.9	1.0	0.3	0.0	25.3	0.2	0.4	0.1	0.0	0.0	0.2	0.7	0.9	0.1	1.1	1.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	2.5	1.2	1.1	0.7	1.1	1.1	1.1	1.1	32.8	14.7	0.0	8.8	1.5	20.2	0.5	10.2	60.2	37.5	21.0	33.4	0.0	1.7	32.3	0.0	1.3	15.6	0.0	8.7	0.1	1.5	12.8	1.1	6.4	0.4	11.1	13.3	1.8	0.6	0.0	4.9	0.9	3.3	0.0	7.2	5.6	13.7	18.6	6.0	1.4	22.0	0.0	1.6	1.1	0.7	1.6	0.0	0.5	13.5	102.7
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508161	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	13.3	15.9	10.3	12.9	12.3	20.6	20.4	9.2	22.2	13.1	15.8	19.0	8.0	11.6	18.2	10.7	17.2	17.0	18.5	26.2	11.7	12.5	20.5	20.1	16.3	12.1	16.8	9.5	17.5	26.8	21.9	13.0	21.6	17.6	13.9	13.3	14.3	15.3	18.1	26.7	17.4	19.5	17.0	11.7	13.6	15.2	14.1	11.6	18.5	15.1	14.6	14.0	16.3	13.6	23.2	26.0	31.9	30.4	25.2	32.1	27.5	17.1	16.6	9.6	19.8	20.8	11.7	10.4	17.0	20.4	21.2	20.5	10.2	28.5	12.9	19.1	24.0	16.1	26.1	17.2	24.6	15.5	12.8	13.6	9.9	11.2	14.8	24.5	13.5	17.0	19.1	32.5	21.7	22.6	12.5	13.8	11.7	12.9	15.8	23.0	8.7	8.1	9.1	9.8	14.3	15.9	8.0	12.1	16.7	25.0	9.6	9.8	14.5	15.3	16.4	20.9	8.1	11.5	13.0	15.6	20.7	11.9	18.0	15.2	18.5	16.1	13.9	16.2	18.4	19.1	26.3	26.5	31.9	30.9	30.4	32.1	23.2	23.6	31.4	26.0	21.5	27.1	26.3	24.0	25.2	25.4	20.1	32.1	27.5	10.3	12.3	9.2	22.2	11.7	12.5	16.8	9.5	17.6	11.6	20.8	9.3	11.7	7.8	4.6	12.5	14.6	12.7	9.4	6.8	17.4	5.9	33.7	10.0	21.4	1.6	9.7	12.0	0.0	20.3	20.8	12.1	8.1	3.5	11.9	19.7	12.7	8.2	10.4	11.4	2.8	12.0	7.7	18.6	21.6	11.8	15.6	19.7	11.5	14.5	8.7	10.5	19.4	8.5	10.6	13.4	6.1	31.5	10.8	10.1	9.0
MUS81	"FLJ44872, SLX3"	ENSG00000172732	"MUS81 structure-specific endonuclease subunit"	Q96NY9	11	65857126-65867653	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059530	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA059530: AB_2684052"	"unprognostic (2.34e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.86e-2)"	15.6	14.3	17.2	21.4	19.5	13.6	24.7	21.6	19.5	19.3	22.2	19.1	18.3	22.1	28.2	12.4	14.4	20.4	19.5	18.4	16.6	12.3	17.7	13.8	17.9	22.2	24.0	14.1	23.5	17.0	19.5	17.2	16.6	17.2	19.4	9.8	13.4	14.9	23.2	28.1	18.2	26.5	19.4	17.5	21.6	17.7	11.3	22.4	32.2	17.8	15.6	17.7	18.2	21.7	12.5	13.2	23.2	15.2	10.8	20.0	11.2	10.8	6.9	11.8	11.6	5.2	6.4	15.0	11.7	9.5	15.2	10.2	9.1	17.9	10.5	16.0	9.3	18.9	10.6	10.5	10.5	3.4	22.6	7.7	19.0	18.6	5.5	16.0	13.4	20.3	10.1	19.5	19.2	15.2	11.2	12.8	19.1	11.4	29.6	10.0	7.3	19.1	20.8	8.4	7.3	15.5	18.9	5.6	20.0	11.6	6.9	11.8	13.5	8.0	14.6	25.4	7.6	17.0	14.1	11.2	11.4	9.7	14.5	12.7	19.9	13.2	15.1	12.9	9.0	18.9	16.2	12.4	23.2	20.0	14.3	19.6	12.5	15.1	17.2	13.0	10.6	12.0	14.7	8.5	10.8	15.2	13.2	12.8	11.2	17.2	19.5	21.6	19.5	16.6	12.3	24.0	14.1	17.2	22.4	11.9	17.3	13.7	18.5	7.1	18.0	6.7	15.3	18.7	15.9	7.0	19.6	18.3	5.0	21.3	50.1	11.3	25.7	0.0	19.4	19.4	11.8	9.8	13.9	8.3	16.9	22.3	16.1	14.1	14.6	97.2	20.1	15.3	10.1	36.1	20.9	13.8	21.1	21.0	25.5	12.1	22.2	38.8	16.7	23.6	13.8	6.5	16.5	21.9	18.9	11.2
MUT		ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463191	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.5"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	10.7	14.3	10.9	5.7	13.4	4.1	9.7	10.0	12.1	8.9	12.7	8.6	9.0	13.6	8.7	8.6	13.2	8.4	7.5	16.6	10.1	10.0	25.5	96.5	7.8	5.7	11.8	9.5	13.1	15.7	15.8	13.5	7.5	12.0	11.2	11.2	8.0	9.3	9.2	13.7	9.0	14.7	11.8	9.7	6.4	10.9	9.1	9.9	8.2	11.2	9.1	5.8	12.8	8.1	9.4	8.9	14.0	15.2	14.2	12.0	6.7	13.4	4.8	14.5	16.9	28.9	27.5	8.0	12.1	16.0	12.8	19.0	5.5	7.0	12.5	9.7	12.9	19.4	7.7	16.1	8.6	18.1	10.6	11.7	6.6	11.0	14.4	21.1	8.5	6.4	16.6	12.8	13.0	15.2	11.5	12.3	13.6	12.0	15.0	15.0	8.4	9.9	8.4	6.2	14.2	3.5	8.9	18.2	17.2	14.8	12.9	13.5	9.4	13.3	9.6	20.0	15.9	8.3	13.6	8.8	11.9	8.8	16.1	16.3	5.9	6.7	10.7	16.8	10.0	10.4	14.0	7.5	12.5	7.9	9.9	9.9	9.4	9.5	9.9	8.9	8.3	12.0	9.0	4.3	14.2	15.2	6.3	11.9	6.7	10.9	13.4	10.0	12.1	10.1	10.0	11.8	9.5	12.0	9.9	17.9	17.4	10.4	16.2	17.7	16.5	60.2	22.9	18.7	21.6	31.4	2.0	21.2	24.9	14.4	5.7	10.0	27.4	0.0	12.8	11.2	13.8	13.3	10.4	117.7	10.8	19.1	50.0	14.1	10.0	2.1	22.2	9.4	8.5	2.8	23.1	28.2	10.5	23.0	26.2	34.2	15.2	32.3	12.2	18.6	14.3	17.6	27.9	7.9	21.2	11.5
MVB12A	"FAM125A, FLJ32495"	ENSG00000141971	"Multivesicular body subunit 12A"	Q96EY5	19	17405722-17433724	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041885, HPA042231"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA041885: AB_10964218, HPA042231: AB_10961043"	"unprognostic (1.34e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.96e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.93e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.33e-2)"	18.4	24.6	9.4	16.2	9.8	14.1	21.1	10.1	12.3	13.4	16.3	13.3	22.2	19.0	16.4	15.2	24.0	16.8	17.1	10.4	8.2	6.1	17.4	16.6	12.4	21.1	11.8	7.1	33.8	16.8	9.6	7.2	15.1	8.8	12.5	9.5	15.6	17.0	17.3	11.4	20.0	20.4	9.0	9.2	17.7	14.2	10.7	11.3	19.6	29.5	12.4	22.8	15.6	15.3	13.8	28.2	24.6	30.6	17.7	26.3	17.4	16.6	9.4	4.3	13.1	6.1	9.8	24.0	5.2	10.4	14.1	17.4	8.6	24.8	13.3	17.3	11.4	10.0	8.1	8.5	12.7	3.8	14.1	23.8	3.0	19.4	20.1	18.9	5.3	12.8	10.7	9.9	10.9	6.8	9.2	15.5	10.5	9.3	26.0	5.6	12.5	9.4	8.3	6.3	13.2	26.4	12.0	4.8	19.5	11.5	9.2	8.4	12.4	7.6	11.2	26.9	4.5	14.8	11.1	7.5	10.6	5.6	11.4	6.2	18.5	23.0	14.5	11.1	18.7	13.0	24.6	30.1	19.2	17.3	30.6	16.2	11.9	17.5	16.3	28.2	13.8	14.7	14.4	17.6	17.7	23.8	25.5	26.3	17.4	9.4	9.8	10.1	12.3	8.2	6.1	11.8	7.1	8.8	11.3	8.9	8.0	13.4	34.3	34.7	5.6	5.2	50.9	24.1	6.8	43.6	5.9	48.6	46.4	68.9	9.1	33.7	66.4	0.0	42.2	82.3	43.2	18.8	21.8	25.5	61.9	3.2	25.4	59.5	39.5	12.8	40.3	24.2	30.4	44.1	43.8	29.5	52.9	66.6	44.2	47.1	13.2	6.5	36.3	13.6	10.4	38.3	34.0	23.5	54.2	41.4
MVB12B	"C9orf28, FAM125B, FLJ00001"	ENSG00000196814	"Multivesicular body subunit 12B"	Q9H7P6	9	126326849-126507041	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 1.5;gdT-cell: 3.1;MAIT T-cell: 5.7;memory CD4 T-cell: 1.4;memory CD8 T-cell: 5.0;myeloid DC: 2.0;naive CD8 T-cell: 2.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;monocytes: 1.5;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"AF22: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043683, HPA049383"			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA043683: AB_2678616, HPA049383: AB_2680737"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.82e-2)"	"unprognostic (9.59e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.12e-3)"	5.6	5.5	15.2	4.3	21.2	10.7	5.0	7.3	22.9	6.3	6.1	52.0	2.4	3.7	5.9	3.3	4.3	10.2	3.9	4.6	22.8	15.3	3.4	4.0	17.7	5.9	31.1	9.8	6.6	3.3	8.8	5.3	14.8	28.2	5.9	6.4	5.8	3.1	9.0	21.4	3.3	4.2	6.6	62.2	10.3	4.0	5.4	28.8	4.8	5.7	1.5	2.6	6.9	3.2	0.4	2.0	0.2	1.5	0.1	5.7	1.4	2.9	4.0	21.9	12.0	0.7	0.2	13.0	2.4	2.0	4.4	0.8	3.4	0.1	0.0	1.5	2.3	6.5	1.3	6.7	1.1	2.7	4.8	4.2	1.0	0.7	14.9	1.8	1.9	0.9	1.7	2.2	0.9	0.0	3.7	3.4	15.9	0.0	0.0	3.2	2.3	3.1	6.1	4.8	0.5	5.5	4.6	12.0	0.0	0.2	12.0	5.5	10.1	4.0	2.9	2.5	9.6	2.9	11.7	4.9	5.0	3.7	2.8	5.0	0.0	0.0	1.2	1.4	8.7	2.6	0.0	1.5	0.2	3.1	0.4	5.7	0.2	1.4	5.0	2.0	0.4	0.3	2.2	0.1	0.1	0.4	0.1	0.0	1.4	15.2	21.2	7.3	15.9	22.8	15.3	31.1	9.8	28.2	28.8	6.0	5.3	0.0	2.8	3.2	8.8	3.1	5.1	9.4	1.2	1.8	3.9	10.2	0.0	1.1	0.5	4.8	1.3	0.0	1.2	1.8	3.8	1.2	6.9	5.0	1.4	9.5	2.4	1.3	18.0	1.7	2.6	4.0	0.0	1.8	2.1	8.8	0.9	5.9	6.0	0.0	5.5	0.0	1.8	1.4	3.3	2.3	2.9	4.4	2.3	1.4
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		30000	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	11.9	18.5	15.8	16.9	19.7	7.6	12.5	21.7	27.9	10.8	19.4	17.1	10.8	39.6	8.4	7.3	30.0	7.4	8.7	11.9	17.2	18.2	9.2	25.9	14.6	12.6	14.6	17.3	11.1	19.0	11.0	7.8	7.6	24.5	13.7	5.1	10.8	16.1	8.7	27.8	18.3	20.7	6.6	23.8	11.1	21.2	23.0	14.6	4.3	9.2	18.6	12.2	7.3	13.8	15.0	17.6	2.5	8.9	18.1	18.1	9.4	14.7	9.5	15.9	10.3	5.4	11.9	9.0	7.3	7.7	5.0	4.3	25.1	37.5	7.1	11.9	4.3	18.6	22.0	7.1	39.0	1.4	4.5	12.1	5.2	5.2	38.1	10.9	3.3	3.7	9.4	7.5	13.3	4.2	2.5	5.3	17.5	14.6	3.9	2.7	34.5	11.3	17.0	19.1	5.1	9.3	11.8	4.6	18.5	14.8	9.3	16.1	5.4	18.3	4.2	5.3	3.4	20.8	15.0	11.5	4.7	9.5	8.3	4.1	11.0	4.8	24.4	5.6	16.4	7.7	2.5	8.2	1.5	18.1	8.6	13.5	10.3	12.1	11.9	9.5	15.0	9.4	11.5	1.1	18.1	8.9	17.6	12.6	9.4	15.8	19.7	21.7	27.9	17.2	18.2	14.6	17.3	24.5	14.6	23.8	45.3	22.0	10.8	13.5	19.2	11.9	28.1	10.7	15.9	19.2	5.9	20.1	21.6	27.8	48.8	12.0	73.8	0.0	53.8	25.2	18.8	15.9	16.1	17.8	31.6	22.3	31.6	23.9	28.8	70.6	7.5	16.4	20.3	45.9	40.3	14.8	24.2	38.6	8.5	16.5	16.5	6.5	14.2	32.0	13.5	18.9	40.8	32.0	29.4	16.7
MVK	"LRBP, MK"	ENSG00000110921	"Mevalonate kinase"	Q03426	12	109573255-109598117	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.6;Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016961, HPA044110"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA016961: AB_1854220, HPA044110: "	"unprognostic (3.10e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.28e-1)"	4.7	14.3	6.8	5.9	11.7	6.8	11.2	6.3	13.1	7.1	7.8	16.7	5.1	11.5	4.2	9.5	23.0	5.1	5.3	6.7	7.8	9.0	16.5	33.1	8.7	4.9	12.5	8.3	8.5	9.3	7.0	6.5	5.5	22.5	9.0	6.3	6.4	8.1	5.8	6.3	19.5	6.9	3.7	18.0	3.8	6.1	17.5	10.5	2.8	11.9	8.5	8.8	5.5	9.9	11.5	7.4	3.4	5.9	8.3	12.2	5.4	12.4	10.5	12.8	6.3	4.1	10.1	6.8	4.5	8.4	11.9	13.0	15.0	15.1	8.7	3.5	4.5	19.3	15.1	13.5	21.3	5.8	8.6	9.6	4.7	7.1	22.5	12.7	4.9	6.0	11.0	18.0	21.5	5.8	5.1	8.0	8.5	8.0	8.3	5.3	15.7	5.1	15.8	10.7	5.8	16.2	4.6	9.8	17.1	27.4	18.4	11.8	10.3	8.9	25.2	6.3	5.3	23.2	8.7	7.1	5.5	7.1	5.2	5.8	7.0	9.2	12.9	6.5	12.8	7.4	0.7	5.9	3.4	12.2	5.8	9.9	8.4	7.4	11.6	7.4	11.5	11.7	8.3	1.7	8.3	3.7	6.2	6.2	5.4	6.8	11.7	6.3	13.1	7.8	9.0	12.5	8.3	22.5	10.5	11.9	11.3	13.4	4.5	4.1	10.2	4.4	15.3	9.4	10.3	14.0	17.7	28.9	18.3	11.3	59.6	5.6	12.5	0.0	15.7	10.9	4.7	4.6	1.1	18.5	13.2	58.8	8.6	6.2	4.1	29.2	7.5	3.3	6.8	17.2	7.2	10.0	9.4	2.9	6.7	32.6	11.5	6.5	4.7	19.9	19.0	7.4	40.0	7.5	9.8	4.5
MXD3	"bHLHc13, MAD3"	ENSG00000213347	"MAX dimerization protein 3"	Q9BW11	5	177301461-177312757	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.1;lymphoid tissue: 59.4"	"Cell type enriched"	"Detected in many"	7	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.1;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 59.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA070111			Approved	Nucleoplasm,Nucleoli		NA	Yes			"Nucleoplasm, Nucleoli"		"HPA070111: AB_2686228"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.33e-16)"	"unprognostic (8.55e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-3)"	2.5	1.8	1.3	28.2	1.9	32.1	5.4	1.2	3.4	2.4	6.8	1.2	2.8	6.9	2.7	6.2	6.6	3.6	2.8	2.4	1.6	0.8	2.7	6.6	5.4	7.3	2.2	1.2	2.6	5.8	0.7	4.3	4.5	2.1	5.0	0.9	1.1	4.7	2.1	3.6	10.3	5.6	1.4	1.3	10.3	3.8	3.1	2.9	59.4	3.5	3.7	13.5	2.7	3.6	2.0	1.6	14.1	8.7	0.7	0.8	1.1	8.1	5.6	3.5	9.5	0.2	0.5	5.8	10.6	3.5	4.8	4.6	3.7	8.5	4.3	4.4	1.4	2.6	4.0	0.4	1.2	0.2	59.2	7.2	2.4	8.1	5.4	0.5	2.3	7.5	0.3	0.6	0.3	0.2	0.4	4.4	19.2	1.5	13.6	0.9	10.4	21.6	6.5	1.2	2.5	9.8	10.6	10.8	6.2	1.0	1.1	8.6	7.1	6.8	6.9	3.7	0.5	10.9	6.2	3.2	5.8	15.0	4.6	5.6	18.0	5.9	4.7	4.5	8.1	3.3	3.5	2.6	7.7	0.7	7.2	0.0	1.6	0.1	0.1	1.6	2.0	0.0	0.3	14.1	0.7	8.7	1.0	0.8	1.1	1.3	1.9	1.2	3.4	1.6	0.8	2.2	1.2	2.1	2.9	3.0	2.2	0.0	1.5	4.9	2.8	1.2	5.1	5.3	4.5	5.2	0.0	4.5	0.0	1.3	16.3	2.3	4.0	116.8	3.5	7.2	3.4	2.4	9.2	3.9	8.8	3.2	1.7	4.3	4.9	1.9	1.7	5.1	3.3	1.0	5.0	1.0	1.9	3.1	1.4	0.3	2.2	0.0	3.1	0.7	5.9	5.0	11.0	5.1	6.9	1.8
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 32.0;SK-MEL-30: 52.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		Yes	No			Nucleoplasm	"Nucleoli, Nucleoli rim, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229"	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavorable (9.17e-4)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	16.9	19.4	37.2	7.5	34.9	32.7	26.5	56.4	36.9	20.3	26.4	33.9	20.1	12.0	26.0	23.8	39.5	19.1	17.4	36.0	35.1	26.6	23.9	30.5	16.5	7.1	37.0	25.9	46.4	23.1	25.6	12.1	14.4	26.2	24.5	22.1	15.8	41.2	32.7	22.8	25.4	22.5	18.2	44.7	7.8	14.7	13.5	38.1	7.0	29.2	13.4	9.8	32.8	33.9	4.5	2.2	11.0	4.7	1.4	8.6	2.3	5.4	2.2	5.6	11.2	8.8	6.7	2.4	3.2	10.8	2.1	6.6	0.9	9.8	7.2	5.2	5.5	3.5	7.1	6.7	7.6	5.6	3.6	9.0	1.9	4.4	4.1	5.8	3.8	4.3	7.1	29.0	3.7	14.8	32.0	2.0	5.7	7.1	15.6	3.5	3.5	2.5	7.8	2.4	8.9	6.7	1.6	7.3	11.4	7.3	0.5	9.5	15.7	3.1	2.3	52.2	7.3	2.6	12.5	2.0	3.7	6.4	4.0	1.6	12.9	6.8	2.6	10.0	14.2	3.9	2.2	3.1	11.0	3.1	2.5	5.8	3.9	6.7	3.6	1.7	4.5	8.6	2.2	7.8	1.4	4.7	2.2	5.0	2.3	37.2	34.9	56.4	36.9	35.1	26.6	37.0	25.9	26.2	38.1	14.9	15.6	8.3	48.3	51.5	37.3	78.1	28.1	21.4	31.8	31.4	45.2	3.4	39.7	15.1	4.1	38.3	50.6	116.8	12.7	13.2	31.9	46.8	3.5	46.4	10.1	49.3	16.3	19.6	18.4	7.0	41.7	19.0	99.5	18.0	20.8	127.5	14.4	35.1	52.3	53.0	43.0	45.3	88.6	8.6	26.0	58.8	8.1	21.3	15.6	33.1
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Extravillous trophoblasts: 236.0;Fibroblasts: 92.6;Leydig cells: 163.1;Peritubular cells: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"naive CD8 T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.7;BJ: 50.0;BJ hTERT+: 23.5;fHDF/TERT166: 24.8;HHSteC: 15.7;HSkMC: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		450000	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	45.6	5.3	2.3	11.4	4.6	1.1	25.2	3.9	3.8	34.8	14.3	4.8	6.2	6.5	34.0	16.3	13.7	14.4	20.5	12.7	3.6	1.1	7.6	3.5	13.4	5.6	2.6	2.6	30.4	3.7	1.6	6.0	25.0	5.4	23.4	2.3	36.6	8.4	12.3	15.5	10.9	8.6	22.0	4.5	9.5	8.7	16.4	2.9	0.3	13.9	11.8	4.5	22.3	17.8	0.0	0.0	0.0	0.0	0.0	9.8	0.3	1.3	0.3	0.4	0.3	6.0	16.7	15.1	50.0	23.5	5.9	7.0	2.7	1.1	0.5	0.2	24.8	0.0	1.0	0.3	0.0	1.1	1.0	0.4	0.4	0.9	4.2	15.7	0.0	0.5	19.9	0.0	2.2	0.0	11.1	0.0	0.3	5.8	0.5	7.4	0.1	0.1	0.1	4.9	0.1	1.6	0.2	0.1	0.1	0.0	0.2	1.1	3.1	0.1	0.5	0.0	3.6	3.9	0.2	0.4	0.2	8.3	7.7	0.2	1.1	0.1	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	9.8	0.0	0.0	0.0	0.0	0.0	0.3	2.3	4.6	3.9	2.7	3.6	1.1	2.6	2.6	5.4	2.9	3.0	0.0	0.0	0.8	9.5	0.7	3.2	0.0	0.0	0.0	8.7	0.0	5.9	0.0	4.6	1.4	1.6	0.0	0.0	0.0	236.0	92.6	0.5	0.0	0.0	8.3	0.0	0.0	9.8	0.0	6.1	163.1	1.6	10.1	1.0	0.0	44.6	0.8	0.0	172.5	1.5	1.0	12.9	36.9	0.7	5.2	9.3	24.6	0.0	0.0	0.3
MYADM		ENSG00000179820	"Myeloid associated differentiation marker"	Q96S97	19	53866223-53876437	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 52.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA056301			Approved	"Nuclear speckles"		NA	NA		34000	"Nuclear speckles"		"HPA056301: "	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (7.71e-7)"	"unprognostic (2.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.14e-3)"	58.2	9.5	9.2	26.4	13.9	53.5	39.2	7.4	17.1	67.9	58.9	18.8	25.1	15.8	105.6	33.0	44.6	66.1	40.8	39.9	9.3	11.7	13.0	15.6	42.4	22.3	8.2	11.4	51.7	31.8	8.7	8.9	46.5	13.3	41.9	13.4	22.2	21.1	45.4	13.2	19.5	26.8	76.8	9.6	22.6	37.6	28.7	9.4	20.3	20.5	32.6	15.3	81.6	30.5	2.0	14.3	52.2	11.6	4.1	5.4	3.9	6.5	55.1	7.0	5.7	24.1	16.6	11.3	35.1	25.2	13.9	14.2	22.6	20.4	0.6	12.5	44.6	15.1	13.5	3.5	13.3	12.1	8.2	8.3	9.0	9.1	17.2	55.1	18.4	32.5	18.1	3.1	17.8	2.5	23.0	12.5	3.5	9.4	16.9	8.8	7.9	4.9	14.4	6.7	24.7	15.7	19.4	7.6	3.3	15.6	0.7	0.1	10.9	0.3	11.0	3.4	15.0	10.7	15.8	25.5	31.3	11.2	4.1	15.7	11.0	6.9	0.1	19.2	9.0	0.5	14.1	11.6	38.3	5.4	6.7	5.1	1.4	3.5	3.9	14.3	2.0	3.4	2.8	52.2	4.1	5.4	5.5	1.3	3.9	9.2	13.9	7.4	17.1	9.3	11.7	8.2	11.4	13.3	9.4	151.8	58.6	29.9	149.5	91.5	3.9	57.6	43.3	57.6	119.4	19.2	3.9	32.7	0.0	107.8	2.1	93.1	5.4	0.0	45.1	208.7	179.0	42.1	336.4	16.3	69.9	9.5	194.1	115.4	66.4	2.0	83.4	144.1	57.3	15.4	91.5	1.7	54.2	52.6	109.6	0.3	0.9	148.8	157.7	22.0	7.7	52.2	41.4	54.3	65.7	78.1
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 44.2;granulocytes: 25.4;Intestinal endocrine cells: 16.9;Mucus-secreting cells: 26.5;Undifferentiated cells: 37.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 39.5;MOLT-4: 72.0;NB-4: 37.5;REH: 44.5;THP-1: 62.8;U-937: 34.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	25.2	0.1	0.0	0.0	39.5	20.0	0.0	0.0	0.1	0.0	0.0	0.0	24.8	20.4	3.8	0.2	2.0	72.0	37.5	0.2	3.5	0.3	44.5	1.0	6.1	0.0	0.2	1.9	1.2	0.0	2.0	0.0	0.1	1.5	62.8	0.0	0.0	0.3	1.5	0.4	4.8	1.2	12.2	0.0	34.2	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6	0.0	2.2	2.9	1.1	2.4	0.6	0.4	2.5	44.2	10.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	2.9	0.0	0.7	0.6	0.4	2.7	25.4	0.0	0.9	0.0	16.9	0.0	1.2	0.0	0.0	1.5	8.5	0.0	26.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	6.0	0.2	1.9	37.5	2.0
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716496	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"	22	"Erythroid cells: 93.5;Extravillous trophoblasts: 28.3;Spermatogonia: 25.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	30	"plasmacytoid DC: 35.9"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 35.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 103.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.7	0.7	0.2	48.3	0.2	33.0	1.0	0.2	0.2	1.0	4.4	0.2	0.1	2.7	1.1	1.1	8.4	0.3	1.7	0.9	0.2	0.2	1.0	1.2	1.8	22.3	0.3	0.1	0.8	9.4	0.0	0.4	4.0	0.2	0.7	2.7	0.3	2.9	0.1	0.3	1.8	6.4	0.6	0.3	43.9	2.9	12.6	0.1	49.2	0.6	6.4	33.8	1.9	2.1	1.1	35.9	0.0	0.0	0.0	0.4	0.3	26.3	16.8	14.9	15.4	0.1	0.5	19.3	11.9	4.0	37.8	27.9	82.4	16.6	53.3	6.9	5.2	7.9	16.1	26.9	8.2	14.2	9.9	17.2	24.9	16.8	22.2	0.0	22.7	17.3	0.3	0.7	14.4	3.2	0.8	10.1	26.5	24.8	66.3	3.3	103.7	46.1	32.0	17.1	21.2	14.7	32.1	30.6	30.5	7.0	5.4	13.7	20.0	35.5	35.7	3.6	16.4	23.5	24.9	4.7	2.3	38.0	16.7	20.5	23.0	47.4	83.8	4.9	19.5	14.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	35.9	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.0	13.4	0.2	3.8	0.0	1.7	2.5	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.3	0.0	0.5	93.5	0.8	28.3	0.4	0.1	0.0	0.0	11.2	0.0	0.0	1.3	1.6	10.0	0.0	0.5	1.7	0.0	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	3.4	25.7	2.0	3.1	2.1	2.2	0.9
MYBPH		ENSG00000133055	"Myosin binding protein H"	Q13203	1	203167811-203175813	"Predicted intracellular proteins"	"Cell adhesion"	"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 53.8"	"Cell type enhanced"	"Detected in single"	33	"Alveolar cells type 2: 2.2"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;head and neck cancer: 20.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 6.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 17.6;HSkMC: 34.5;THP-1: 8.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA061383	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA061383: AB_2684497"	"unprognostic (2.26e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.62e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.74e-1)"	0.8	0.1	1.1	0.8	0.8	0.3	0.4	0.4	0.6	0.1	0.1	0.0	0.0	0.1	0.4	4.4	3.9	0.2	0.1	0.2	0.4	0.3	1.1	1.5	0.2	0.3	1.3	0.0	0.1	0.2	0.1	0.6	0.3	1.0	4.2	0.1	0.0	8.8	0.1	53.8	0.2	0.1	0.1	0.4	0.4	0.1	0.2	2.1	0.9	3.9	12.7	2.0	0.3	0.8	0.0	6.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	1.1	0.8	0.4	0.6	0.4	0.3	1.3	0.0	1.0	2.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYBPHL		ENSG00000221986	"Myosin binding protein H like"	A2RUH7	1	109292365-109307041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"heart muscle: 64.6"	"Cell type enriched"	"Detected in some"	14	"Cardiomyocytes: 139.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;Daudi: 1.5;Hep G2: 6.7;K-562: 1.7;RH-30: 3.9;THP-1: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA077633			Approved	Vesicles		NA	NA			Vesicles		"HPA077633: "	"unprognostic (6.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (5.89e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.10e-1)"	"unprognostic (7.05e-9)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.64e-1)"	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.3	1.3	0.0	64.6	0.4	0.1	0.0	0.0	0.7	0.0	1.4	0.1	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.8	0.5	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.1	0.6	0.4	0.1	1.4	0.1	0.4	0.9	0.0	3.2	0.0	0.1	0.0	1.1	139.3	0.0	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.7	0.0	9.8	0.0	0.3	0.3	0.3	0.1	0.0	0.0	0.0	0.5
MYCBP	AMY-1	ENSG00000214114	"MYC binding protein"	Q99417	1	38862964-38874105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041188, HPA078331"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (2.42e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (7.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.34e-3)"	"unprognostic (5.81e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.41e-2)"	8.6	10.5	4.8	13.6	7.4	9.0	14.5	4.6	4.9	11.6	14.9	3.6	21.3	10.5	9.6	18.2	23.4	17.7	15.6	16.8	5.2	4.9	26.5	21.1	16.1	20.7	4.6	3.1	9.3	20.0	13.9	12.5	24.8	11.2	13.6	15.6	6.6	22.9	17.3	11.8	12.0	24.4	14.6	4.9	16.8	13.1	28.9	5.2	16.8	24.3	18.1	19.6	13.0	11.9	9.0	21.7	32.1	15.1	11.0	12.9	8.1	18.5	8.1	7.2	5.2	4.2	7.4	28.7	14.9	4.9	15.1	11.9	9.5	22.3	15.3	16.6	6.8	2.4	13.9	11.2	19.4	18.3	19.2	18.6	16.3	11.6	10.0	1.1	40.4	14.8	6.6	15.5	12.5	7.9	5.8	11.0	17.6	23.6	14.2	15.8	10.9	12.9	19.4	18.2	28.1	20.4	12.4	21.2	21.4	19.7	15.7	13.6	9.3	14.3	19.0	9.6	17.2	13.0	19.5	8.7	7.9	13.3	12.1	17.0	9.5	17.0	16.9	7.9	23.8	10.3	14.8	12.6	32.1	7.8	15.1	8.9	9.0	9.7	9.3	16.0	6.4	8.4	9.3	25.1	11.0	13.5	21.7	12.9	8.1	4.8	7.4	4.6	4.9	5.2	4.9	4.6	3.1	11.2	5.2	8.9	13.3	18.6	14.6	9.4	0.6	7.3	22.9	163.3	36.4	26.2	0.0	96.0	54.7	19.6	63.4	10.8	26.5	23.3	23.9	75.4	7.3	14.2	26.4	13.4	19.0	9.5	9.2	6.2	15.1	16.8	6.6	15.9	18.6	23.4	25.1	3.8	23.0	38.6	8.5	34.2	4.5	6.5	12.2	22.9	68.8	15.6	73.7	21.5	26.9	20.0
MYCN	"bHLHe37, MYCNOT, N-myc, NMYC"	ENSG00000134323	"MYCN proto-oncogene, bHLH transcription factor"	P04198	2	15940564-15947007	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 16.8"	"Cell type enriched"	"Detected in some"	8	"Extravillous trophoblasts: 75.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 45.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.9;BEWO: 70.2;HMC-1: 16.9;NTERA-2: 26.6;RH-30: 18.6;SuSa: 12.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057420			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA057420: AB_2683434"	"unprognostic (8.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.23e-1)"	0.9	1.9	5.1	1.8	5.5	1.6	1.2	1.4	8.4	3.1	1.2	12.1	0.0	3.0	1.9	0.8	1.3	1.4	2.6	2.3	7.0	4.7	6.0	1.5	1.6	2.9	6.0	2.2	10.3	0.7	0.4	0.7	16.8	6.8	0.6	1.3	1.1	6.6	0.7	1.0	2.4	1.7	0.9	8.9	0.9	8.5	6.5	4.0	5.7	5.1	2.3	3.5	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	70.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	26.6	0.6	0.0	0.0	18.6	3.5	0.0	0.9	0.2	4.7	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.5	1.4	7.0	7.0	4.7	6.0	2.2	6.8	4.0	0.0	0.0	0.0	0.1	0.5	2.6	0.7	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	0.2	0.0	0.0	0.0	75.4	0.6	0.0	0.0	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.2	0.0	0.4	2.1	0.1	0.0	0.0	0.5	3.6	0.0	9.6	0.0	0.2	0.0
MYD88		ENSG00000172936	"Myeloid differentiation primary response 88"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 68.0"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favorable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	25.0	11.3	5.9	19.5	6.9	18.1	14.7	5.2	4.6	10.0	13.4	5.8	5.0	15.1	9.5	12.3	25.5	9.8	12.4	10.4	5.3	3.2	15.1	47.9	25.6	40.1	6.2	3.5	13.3	10.3	5.4	10.4	17.8	6.7	11.3	14.3	8.8	13.9	5.4	3.9	12.5	30.4	10.7	7.0	39.0	12.5	5.8	5.1	28.5	10.4	17.5	30.8	13.9	13.7	7.8	34.7	49.0	68.0	8.3	14.3	34.6	8.1	12.2	1.8	10.8	8.6	11.2	3.8	8.1	13.2	22.8	24.3	7.6	10.0	17.6	4.8	14.5	5.2	10.3	14.4	8.1	7.6	13.6	3.0	9.5	6.2	11.5	7.1	12.1	24.8	12.9	8.6	12.9	4.8	4.3	13.0	13.5	4.1	7.2	12.0	8.3	19.8	3.9	7.7	17.2	12.1	8.5	2.3	7.5	11.7	19.3	0.8	4.0	11.5	55.1	7.1	1.5	8.6	13.7	12.0	4.5	2.7	20.7	7.7	10.7	11.8	13.1	8.7	21.1	9.7	38.3	37.6	48.1	12.2	56.5	10.4	7.8	11.0	12.2	34.7	6.7	7.7	10.9	49.0	8.3	68.0	16.6	14.3	34.6	5.9	6.9	5.2	4.6	5.3	3.2	6.2	3.5	6.7	5.1	6.0	14.6	17.4	10.4	12.8	0.9	1.5	7.6	10.7	11.4	5.2	0.0	12.2	6.6	22.7	0.7	10.5	25.9	0.0	24.0	20.1	9.1	11.9	24.2	27.6	30.3	0.0	9.2	9.8	75.0	0.6	12.7	48.3	3.3	18.0	16.3	3.5	43.6	34.5	9.9	9.2	0.0	12.9	7.0	2.1	0.4	15.1	10.1	20.3	13.1	37.7
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294138-69367726	"Predicted membrane proteins"			Proto-oncogene	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.4;breast: 16.9;esophagus: 17.3"	"Cell type enriched"	"Detected in some"	8	"Pancreatic endocrine cells: 116.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 59.2;A549: 28.4;CAPAN-2: 8.7;U-2 OS: 13.1"									HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	29.4	0.2	0.0	2.4	0.0	0.2	16.9	0.1	0.0	2.6	1.1	0.0	0.4	0.4	0.5	8.1	17.3	0.0	1.3	0.1	0.0	0.2	0.2	8.6	0.1	0.2	0.0	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.1	0.6	0.9	2.0	0.0	0.6	4.9	0.8	0.1	0.0	0.3	10.7	0.4	0.0	0.1	0.1	5.3	13.6	0.2	4.7	0.5	0.0	0.0	0.1	1.0	0.3	2.1	59.2	28.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	8.7	0.2	2.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	1.0	2.3	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.0	0.1	0.8	0.0	13.1	0.0	0.6	0.1	0.6	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	0.0	15.5	10.5	0.0	0.4	0.0	8.4	0.2	0.2	1.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	4.7	0.3	0.0	0.0	0.0	1.0	0.0	116.0	12.5	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.1	0.1	0.0	0.5	6.8
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474205-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 96.0;Cytotrophoblasts: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 56.0"	"Low region specificity"	"Detected in all"							"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		130000000	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	18.3	12.3	12.6	5.4	24.7	7.9	9.6	15.6	30.8	16.9	7.3	5.4	5.3	1.9	19.9	12.4	5.0	18.0	18.2	25.7	15.1	12.9	23.7	13.0	40.0	4.2	9.5	16.7	21.8	6.9	14.7	18.4	35.9	19.2	12.9	3.1	8.6	4.7	19.6	3.3	5.1	3.9	15.7	4.9	3.3	7.1	5.3	5.9	2.7	9.7	2.6	3.0	9.8	7.4	0.5	0.2	2.8	0.1	0.0	1.1	0.2	13.3	8.8	56.0	18.7	7.3	8.8	25.2	11.2	10.1	13.6	14.6	23.7	2.0	0.1	7.4	11.0	7.4	1.3	27.8	13.4	15.2	0.3	22.6	15.5	5.7	20.6	17.2	1.3	1.0	12.5	4.9	17.5	6.8	8.4	21.8	18.1	21.5	0.0	8.4	5.3	16.4	0.4	26.3	0.9	1.9	26.3	16.6	0.0	15.4	5.6	4.6	25.2	17.5	0.8	17.9	44.9	4.7	0.9	0.7	12.8	9.4	0.0	9.6	2.1	2.6	3.4	0.0	1.2	28.6	0.0	0.1	0.1	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.2	1.1	0.5	2.8	0.0	0.0	0.2	0.3	0.2	12.6	24.7	15.6	30.8	15.1	12.9	9.5	16.7	19.2	5.9	20.8	13.1	0.5	8.0	4.1	35.4	26.9	7.6	26.8	14.8	96.0	47.1	123.2	14.9	10.8	44.7	37.5	0.0	23.3	1.6	73.0	63.0	8.6	1.1	13.1	13.8	33.4	2.4	60.2	3.8	18.2	3.4	1.4	1.7	1.0	1.4	23.8	2.7	0.0	37.4	12.9	34.3	0.0	10.8	8.2	29.6	3.4	64.0	2.2	1.7	3.1
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310544	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease mutation, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;skeletal muscle: 53.1"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 373.2;Paneth cells: 214.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 15.2;CAPAN-2: 19.2;HaCaT: 38.2;MCF7: 18.5;OE19: 19.5;RT4: 47.4;SK-BR-3: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		NA	NA		59000000	Nucleoplasm		"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.97e-8)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	5.5	0.5	6.1	8.4	6.1	0.1	2.7	4.6	9.4	3.4	63.9	10.5	3.5	38.7	1.1	4.6	14.7	7.5	9.2	16.2	6.4	5.4	4.3	8.7	11.5	0.2	8.5	3.9	1.1	7.5	7.3	4.5	0.7	7.8	3.2	9.4	4.6	12.0	3.1	53.1	20.3	78.6	0.8	11.1	0.2	21.0	0.7	4.2	0.4	16.7	11.4	9.5	4.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	1.6	0.0	8.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	10.5	19.2	0.0	9.9	0.0	1.2	38.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	8.0	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	18.5	0.0	0.1	0.2	19.5	0.2	0.0	9.6	0.2	0.0	47.4	0.0	0.0	0.9	16.9	0.0	0.0	3.1	0.5	0.0	0.0	3.9	0.0	0.0	0.3	3.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	6.1	4.6	9.4	6.4	5.4	8.5	3.9	7.8	4.2	74.5	32.2	4.7	15.0	3.0	4.6	18.6	50.9	42.8	37.5	54.1	2.0	0.0	0.0	46.2	0.9	0.7	373.2	0.0	24.4	0.1	0.9	28.7	14.9	41.5	0.1	15.9	49.7	3.7	1.2	0.4	0.3	1.7	5.0	0.0	88.8	19.2	45.9	214.0	0.0	6.4	10.8	0.0	2.8	0.4	4.1	18.3	0.0	0.8	86.0	79.7
MYH15	KIAA1000	ENSG00000144821	"Myosin heavy chain 15"	Q9Y2K3	3	108380369-108529322	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell type enhanced"	"Detected in some"	13	"Muller glia cells: 7.0;Rod photoreceptor cells: 5.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.4;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	13	"B-cells: 1.4;dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"GAMG: 7.9;Karpas-707: 4.1;PC-3: 8.9;SH-SY5Y: 3.2;U-87 MG: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034871, HPA057915"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA034871: AB_10669996, HPA057915: "	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.57e-2)"	0.1	0.9	2.9	0.3	2.4	0.1	0.1	1.1	4.6	0.3	1.4			1.5	0.0	1.1	0.0	0.5	0.8	1.3	2.8	2.3	0.0	0.0	1.1	0.2	3.3		0.0	0.1	0.0	1.5	0.0		0.7	1.0		0.0	0.0	0.7	1.2	2.3	0.0	3.3	0.6	0.5	1.4			0.3		0.1	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.8	1.7	0.2	0.4	0.1	0.7	0.0	0.2	0.0	7.9	0.1	0.2	0.0	1.4	0.0	0.1	0.2	0.0	0.0	0.3	2.3	0.0	0.1	0.0	0.5	0.3	0.4	0.5	0.3	0.0	4.1	2.1	0.0	0.0	0.0	0.1	0.0	8.9	0.2	0.1	0.0	0.0	0.0	0.5	3.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.8	0.9	0.0	0.9	2.2	0.3	0.0	3.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0											0.0	0.3	0.0	0.1	0.0	1.3	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.0	7.0	0.3	0.0	0.0	0.0	5.3	0.0	0.0	1.2	0.2	0.1	0.0	0.0	1.0	0.0
MYL12A	"MLCB, MRCL3, MRLC3, MYL2B"	ENSG00000101608	"Myosin light chain 12A"	P19105	18	3247481-3256236	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 245.4;heart muscle: 248.0;skeletal muscle: 423.8"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 5937.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004503, HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes		70000000	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (2.14e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.58e-3)"	"unprognostic (7.13e-2)"	60.9	19.9	7.1	31.1	13.1	21.7	63.9	5.1	7.6	25.1	31.2	7.4	22.5	15.6	24.1	29.0	43.6	22.8	32.4	248.0	8.2	6.8	52.7	43.1	58.3	58.4	14.6	5.7	28.6	24.8	24.9	11.1	49.5	18.9	24.3	27.2	14.7	26.5	18.6	423.8	24.2	41.5	27.9	22.1	68.6	22.5	20.4	10.3	40.3	38.6	80.1	42.0	30.6	31.2	103.4	166.8	173.4	91.9	104.2	168.7	245.4	31.3	20.0	45.6	19.1	53.9	56.8	27.9	71.6	94.5	68.1	74.3	30.2	39.8	15.2	18.9	103.9	47.6	13.7	26.4	44.9	61.1	21.4	9.4	15.5	23.8	26.5	90.3	44.1	30.3	88.8	63.7	52.8	32.0	62.5	106.8	20.4	19.4	53.2	139.6	53.7	20.5	44.4	18.7	36.4	14.8	11.9	23.9	26.7	149.3	50.9	6.4	15.6	56.6	24.4	49.5	44.0	17.2	65.2	114.2	16.9	38.5	46.2	56.5	12.1	17.5	24.6	50.7	17.7	60.4	173.4	74.5	154.6	166.4	77.4	166.7	103.4	156.8	168.7	109.0	80.4	142.5	167.0	122.8	104.2	91.9	166.8	133.2	245.4	7.1	13.1	5.1	7.6	8.2	6.8	14.6	5.7	18.9	10.3	684.9	287.2	341.2	723.8	564.8	28.8	5937.2	466.2	370.7	324.2	485.1	11.8	673.0	399.6	1177.4	18.9	908.8	703.7	0.0	1306.6	996.1	418.1	441.5	501.9	258.7	758.2	54.0	101.2	852.6	651.0	20.6	309.8	806.5	420.1	2189.4	519.0	67.5	1678.2	662.9	372.7	509.4	40.9	562.7	473.8	61.2	173.0	476.5	557.0	1044.7	325.5	594.7
MYL12B	MRLC2	ENSG00000118680	"Myosin light chain 12B"	O14950	18	3261909-3278284	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (2.55e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.69e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.77e-1)"	"prognostic favorable (6.62e-6)"	"unprognostic (1.27e-2)"	64.1	82.2	38.7	46.1	38.2	41.9	66.1	27.0	48.9	63.9	84.8	21.4	58.7	67.6	52.9	86.8	106.9	49.6	65.2	53.0	37.8	34.0	150.0	105.3	85.9	68.7	36.0	31.9	53.4	48.9	48.4	37.5	139.8	46.8	56.8	75.0	37.1	69.8	52.8	71.8	59.6	129.4	54.7	30.9	62.2	52.8	42.8	26.0	65.1	107.2	89.8	61.1	58.6	61.5	46.7	83.6	151.5	78.1	47.6	77.7	109.0	49.0	26.0	23.1	22.2	67.3	57.4	39.8	74.9	65.9	70.1	72.2	54.5	39.4	24.6	33.0	101.7	52.8	24.9	38.1	86.1	72.0	14.3	16.1	24.8	29.5	43.7	69.4	55.5	39.1	49.4	82.7	46.6	29.8	61.2	104.8	25.3	21.2	24.2	90.8	99.6	31.7	40.1	15.4	58.9	22.3	15.8	29.1	19.7	147.6	91.0	19.0	19.8	74.4	45.3	45.1	39.9	38.7	33.3	126.2	68.1	101.7	59.4	90.6	13.5	12.9	30.0	41.4	22.6	52.9	123.3	51.4	151.5	72.2	68.0	61.4	46.7	70.7	77.7	60.9	37.8	58.0	66.8	120.5	47.6	78.1	83.6	75.2	109.0	38.7	38.2	27.0	48.9	37.8	34.0	36.0	31.9	46.8	26.0	750.4	480.3	216.3	748.4	563.6	73.7	716.9	471.3	642.4	558.4	514.7	23.6	919.9	888.6	1342.8	114.5	450.9	1252.4	93.5	1292.5	904.2	420.1	592.5	429.2	253.2	547.6	62.0	234.2	683.2	403.1	161.2	413.3	509.2	327.3	1202.0	540.9	131.6	1740.8	831.1	407.3	1106.8	72.8	349.3	305.9	216.8	195.5	496.8	1173.0	496.0	458.6	860.6
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46857872-46882169	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 398.1;skeletal muscle: 319.8"	"Cell type enriched"	"Detected in some"	65	"Cardiomyocytes: 3031.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA		15000000	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	0.9	0.2	0.5	0.2	0.4	0.0	0.6	0.2	0.4	0.5	0.1	0.3	0.0	0.0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0.0	0.0	0.3	0.3	1.6	0.0	0.3	5.5	0.0	319.8	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.4	0.0	1.1	30.1	3.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	1.6	0.3	0.1	0.0	0.1	5.9	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4	0.0	0.0	0.0	0.1	0.7	0.1	3031.1	0.0	0.0	0.0	1.8	0.0	0.4	46.4	0.0	2.0	0.3	0.0	0.0	0.0	5.0	7.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.5	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.7	46.2	0.4	6.5	1.3	0.0	0.4	0.4	0.7	0.0	0.0	0.0
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"heart muscle: 712.3"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2384.1"	"Group enriched"	"Detected in some"	7	"testis cancer: 2.4;thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.2"	"Cell line enriched"	"Detected in some"	4	"HEL: 109.9"	"Group enriched"	"Detected in many"	6	"amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8"	"Not detected"	"Not detected"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		NA	NA		140000	"Plasma membrane"		"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	0.1	0.0	0.0	0.1	0.0	10.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	712.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.8	3.3	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.0	0.1	0.6	4.6	0.1	0.1	0.2	0.2	5.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	109.9	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.2	0.3	26.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.7	4.5	2384.1	0.0	0.0	0.0	0.0	60.9	0.4	0.0	0.0	16.3	3.0	0.3	443.9	0.0	2.6	2.1	0.0	0.0	0.0	1.8	1.6	0.0	1.3	0.0	42.1	3.1	0.0	11.8	0.0	0.0	4.9	0.1	0.0	1.4	0.0	17.0	0.0	2.0	1.5	0.4	0.6	1.1	0.0	0.0	0.0
MYL6B	MLC1SA	ENSG00000196465	"Myosin light chain 6B"	P14649	12	56152256-56159647	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.0"	"Cell type enhanced"	"Detected in many"	13	"Late spermatids: 863.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.6"	"Group enriched"	"Detected in all"	5	"B-cells: 5.3;dendritic cells: 15.6;T-cells: 12.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038887, HPA046859, HPA063034"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA038887: AB_10674842, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.29e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-2)"	5.6	10.0	32.0	4.8	33.1	5.4	8.7	11.9	26.7	13.9	4.1	8.0	8.5	3.0	9.8	12.8	8.4	13.2	9.7	13.6	24.1	21.8	9.3	6.2	4.5	6.9	20.7	21.6	20.0	4.8	17.4	14.1	5.1	13.4	12.6	4.0	11.0	7.3	8.3	129.0	5.1	4.1	8.4	10.7	3.9	5.1	24.9	10.2	11.5	9.9	10.7	8.8	5.6	5.0	5.3	15.6	1.8	2.3	2.0	12.0	3.1	7.5	13.0	35.4	33.8	7.5	27.0	24.7	8.8	39.1	35.3	34.5	9.3	12.6	12.7	19.6	19.0	13.5	4.3	16.6	21.5	19.1	22.9	24.1	13.3	13.4	16.3	23.8	9.7	9.3	45.2	8.7	32.6	12.7	75.2	38.1	30.9	14.0	13.1	29.0	9.9	26.5	32.2	29.7	7.2	22.5	28.0	21.9	16.7	26.8	5.1	32.6	47.9	9.8	12.0	17.8	27.1	9.9	16.6	21.1	20.8	17.8	10.7	18.9	18.6	10.6	10.5	22.2	9.8	22.7	0.7	2.3	0.7	1.8	2.2	1.0	5.3	3.7	3.0	5.4	3.5	2.7	2.2	1.8	2.0	0.9	15.6	12.0	3.1	32.0	33.1	11.9	26.7	24.1	21.8	20.7	21.6	13.4	10.2	62.5	29.6	26.0	41.8	29.5	53.0	14.1	30.6	21.4	20.5	104.7	23.6	31.3	127.6	41.5	257.0	40.5	19.3	0.0	17.8	53.4	50.7	40.2	12.7	25.5	36.1	31.8	151.1	46.1	17.2	863.2	74.8	25.0	38.8	73.9	31.3	69.7	27.9	20.1	62.6	129.3	46.7	51.8	46.7	90.0	52.8	22.2	18.9	13.8	36.0	36.2
MYL9	"LC20, MLC2, MRLC1, MYRL2"	ENSG00000101335	"Myosin light chain 9"	P24844	20	36541484-36551447	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 717.2;urinary bladder: 496.7"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 1565.8;Peritubular cells: 1778.4;Sertoli cells: 2108.4;Smooth muscle cells: 1718.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.6;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 85.3;BJ: 110.6;fHDF/TERT166: 87.8;hTERT-RPE1: 70.2"					"Low region specificity"	"Detected in single"			"HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		92000000	"Nucleoplasm, Nucleoli fibrillar center"		"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (1.15e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.67e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (7.92e-7)"	"unprognostic (1.90e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-2)"	61.9	46.0	2.0	58.1	5.8	0.2	64.8	1.4	6.4	123.3	361.6	6.0	162.9	22.7	278.8	102.0	242.7	80.3	199.0	169.8	1.9	2.1	27.7	6.8	36.0	14.9	4.7	8.7	107.8	5.4	2.8	4.8	31.7	10.5	218.9	30.4	71.8	22.6	203.9	22.2	14.7	70.3	717.2	5.2	22.8	120.7	55.1	1.4	1.4	48.8	21.9	8.7	496.7	107.7	1.2	0.5	2.7	0.2	0.3	0.1	10.8	8.0	0.1	6.4	0.1	85.3	32.8	28.4	110.6	47.9	58.0	37.6	63.8	0.9	0.0	58.0	87.8	12.7	3.0	0.0	0.2	13.7	0.0	0.0	1.6	12.5	5.9	55.1	0.0	1.9	45.9	5.8	38.3	0.1	70.2	2.0	0.0	0.2	2.9	48.6	0.0	0.0	0.8	2.5	1.6	0.5	0.0	0.0	0.5	0.4	0.6	0.0	0.4	1.1	2.8	0.0	29.2	24.7	1.6	14.2	55.4	23.4	8.0	0.1	0.0	0.4	0.2	21.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.1	1.2	0.0	0.1	0.3	0.2	0.0	0.0	2.7	0.3	0.0	0.5	0.0	10.8	2.0	5.8	1.4	6.4	1.9	2.1	4.7	8.7	10.5	1.4	366.3	53.6	10.5	235.7	53.9	0.8	1565.8	30.6	20.1	50.0	85.5	0.0	24.0	23.2	211.4	5.9	105.7	0.0	0.0	105.2	66.4	237.6	45.8	15.0	1.1	29.4	1.6	0.0	219.1	4.8	25.6	307.2	19.2	69.2	26.2	0.1	179.9	56.1	0.0	1778.4	24.0	5.5	2108.4	1718.3	4.2	6.9	46.7	22.4	10.2	0.6	57.0
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46703369-46790407	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 162.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.8;hippocampal formation: 5.7"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 5.2"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	0.7	0.0	1.7	0.1	0.0	0.1	0.2	0.2	0.0	3.8	0.0	0.0	0.1	3.4	2.0	0.8	0.1	62.2	1.5	1.4	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1.0	0.0	0.0	1.3	0.0	20.8	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.3	0.0	0.1	31.1	1.1	0.1	0.0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0.0	0.1	0.1	0.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	1.6	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	6.1	0.2	2.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3	0.0	3.5	0.0	0.7	0.0	0.5	162.4	0.0	16.0	6.8	0.0	2.0	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.2	0.4	1.4	0.6	1.1	0.0	0.4	0.0	0.0	0.6	0.0	3.2	0.6	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.2	0.0	0.2	0.0	0.0	0.2
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750966	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	17	"skeletal muscle: 23.6;tongue: 63.6"	"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Proximal tubular cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"HEL: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	0.5	0.3	0.3	0.3	0.4	0.4	0.8	1.4	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	1.0	0.2	0.3	1.0	0.5	0.5	2.6	0.3	0.5	0.3	0.4	0.3	0.3	1.1	0.7	0.7	0.4	0.4	0.4	0.1	0.4	2.4	0.4	23.6	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.0	63.6	1.5	0.5	0.3	0.1	0.8	0.3	0.3	0.9	1.4	0.1	0.3	0.2	0.6	1.2	1.0	1.2	0.6	0.7	1.6	0.5	0.4	0.5	1.1	1.1	1.6	0.8	0.2	1.9	0.2	0.5	0.7	0.2	0.6	12.7	0.6	0.1	0.3	0.3	0.6	1.5	0.5	0.1	1.2	0.6	0.5	0.2	0.1	0.1	0.3	0.5	0.1	1.4	0.2	0.4	0.0	0.9	0.0	0.0	0.9	0.3	1.0	0.6	0.3	0.2	0.5	1.1	0.4	0.8	0.7	0.5	0.1	0.2	0.4	0.4	0.2	0.1	0.2	0.3	1.3	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.2	1.4	0.2	0.1	0.6	0.1	0.3	0.9	0.3	0.8	0.1	0.1	0.3	0.4	1.4	0.7	0.5	0.5	0.4	0.3	0.4	0.3	3.0	0.6	0.0	0.1	0.1	0.8	1.2	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	1.6	1.2	0.0	0.3	0.0	0.3	1.0	0.0	1.8	0.0	0.2	0.0	0.0	1.4	2.9	0.2	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.1
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216939-44218236	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"adipose tissue: 27.4;blood: 12.2;pancreas: 9.0"	"Cell type enhanced"	"Detected in some"	24	"Distal tubular cells: 3.3;Exocrine glandular cells: 2.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"					"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	121	"dendritic cells: 12.2"	"Cell line enriched"	"Detected in some"	31	"RH-30: 56.5"	"Not detected"	"Not detected"							HPA051451	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			Vesicles	"Mitochondria, Cytosol"	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	27.4	0.0	0.0	1.0	0.0	0.0	2.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.8	0.0		1.1	0.0	0.5	1.4	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.7	0.0	2.2	0.0	0.1	0.0	0.0	1.8	3.2	0.6	0.0	2.8	0.4	0.0	0.4	0.5	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	56.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYO15B	MYO15BP	ENSG00000266714	"Myosin XVB"		17	75588058-75626501	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in all"	10	"intestine: 155.3"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 148.8;Paneth cells: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 26.0;HEL: 10.9;HMC-1: 14.9;THP-1: 21.5"	"Not detected"	"Not detected"							"HPA022857, HPA023105"			Approved	Cytosol		No	No			Cytosol		"HPA022857: AB_1848813, HPA023105: AB_1859526"	"prognostic favorable (9.34e-4)"	"unprognostic (7.55e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.59e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.90e-5)"	7.5	2.8	4.2	7.3	5.3	13.8	8.9	1.6	4.3	8.0	58.9	8.1	5.4	48.9	13.6	4.5	2.8	10.8	13.5	5.8	4.5	1.7	13.0	2.0	10.7	5.0	6.5	5.5	14.9	3.6	1.8	3.7	4.0	5.1	7.1	5.9	6.5	5.2	4.5	3.1	3.9	155.3	5.9	4.0	13.2	4.8	3.1	5.9	5.5	14.0	2.3	4.0	4.9	7.2	2.8	2.0	6.2	1.5	1.9	1.4	1.1	0.3	26.0	0.3	1.0	0.2	0.4	0.4	0.1	0.0	0.0	0.0	3.4	7.4	0.4	1.0	0.0	0.3	0.4	0.0	0.0	0.0	0.3	2.0	10.9	5.0	6.4	0.7	0.0	14.9	0.7	0.5	0.0	0.0	0.5	0.1	4.6	0.6	2.9	0.0	3.5	0.2	4.3	0.5	7.2	6.5	6.8	0.2	1.1	0.1	0.5	1.0	2.0	0.2	0.4	0.8	0.9	2.3	21.5	0.5	0.1	1.1	0.1	0.1	1.4	0.8	0.1	0.6	5.3	0.4	2.4	1.5	1.2	1.4	1.4	0.9	1.5	0.7	0.5	0.8	2.8	0.5	1.0	6.2	1.9	1.5	2.0	0.2	1.1	4.2	5.3	1.6	4.3	4.5	1.7	6.5	5.5	5.1	5.9	0.0	3.5	8.0	2.1	2.2	3.8	5.6	10.2	6.7	2.3	8.7	15.7	0.1	1.7	1.5	0.5	9.8	148.8	0.0	1.4	0.1	5.1	1.7	13.9	1.6	4.7	1.6	30.4	25.2	9.1	0.4	5.2	10.2	3.3	1.8	31.9	6.1	5.2	56.1	4.6	12.7	14.2	6.5	3.8	3.5	3.6	2.6	0.1	4.3	11.1	1.6
MYO16	"KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107"	ENSG00000041515	"Myosin XVI"	Q9Y6X6	13	108596152-109208007	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Cell type enhanced"	"Detected in some"	9	"Early spermatids: 8.0;Hepatocytes: 4.7;Late spermatids: 8.9;Muller glia cells: 3.9;Spermatocytes: 4.2;Spermatogonia: 6.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;SH-SY5Y: 6.7;U-2197: 4.0"	"Group enriched"	"Detected in all"	4	"basal ganglia: 21.9;olfactory region: 88.9"	"Low region specificity"	"Detected in all"			"HPA040110, HPA058769, HPA071948"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA040110: AB_10796339, HPA058769: AB_2683814, HPA071948: AB_2686475"	"unprognostic (7.55e-3)"	"unprognostic (7.74e-3)"	"unprognostic (4.52e-4)"	"unprognostic (5.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.01e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.68e-4)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.34e-2)"	3.4	2.2	4.0	0.9	3.7	0.4	0.8	2.4	9.2	0.9	0.6	1.5	0.0	0.6	0.5	0.5	1.0	0.5	0.5	2.4	7.5	3.2	0.6	4.8	0.8	0.9	1.8	4.5	0.5	0.7	0.3	5.7	0.6	5.7	1.1	0.6	0.7	0.6	2.0	0.4	0.7	0.5	1.4	5.1	0.5	0.6	3.0	0.0	0.0	0.5	0.0	1.1	0.5	1.2	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	4.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	3.7	2.4	9.2	7.5	3.2	1.8	4.5	5.7	0.0	0.0	1.1	0.0	0.0	0.2	3.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	1.1	4.7	0.1	0.0	0.0	0.0	0.0	8.9	0.9	0.0	1.7	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	4.2	6.8	0.0	0.2	0.0	0.0	0.0
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"intestine: 148.0"	"Cell type enhanced"	"Detected in some"	25	"Enterocytes: 221.7;Mucus-secreting cells: 59.5;Paneth cells: 51.8;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;monocytes: 1.2"	"Cell line enriched"	"Detected in some"	5	"OE19: 30.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.1	0.1	0.1	5.2	0.2	0.0	0.1	0.1	0.2	0.1	57.2	0.3	0.1	70.0	0.1	0.1	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.2	1.3	0.1	14.1	0.1	0.2	0.1	0.1	0.1	148.0	0.4	4.7	0.1	3.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	2.9	0.0	1.2	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	1.1	0.0	30.9	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.5	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	221.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.7	0.0	0.3	0.2	0.0	0.9	0.0	0.0	59.5	0.0	0.2	51.8	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.0	76.4	0.0
MYO1D	"KIAA0727, myr4, PPP1R108"	ENSG00000176658	"Myosin ID"	O94832	17	32492522-32877177	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 110.8;Enterocytes: 119.8;Mucus-secreting cells: 86.3;Paneth cells: 95.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 2.6"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.4;CACO-2: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054744	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA054744: AB_2682589"	"unprognostic (3.83e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.70e-3)"	"unprognostic (3.95e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.01e-6)"	"unprognostic (1.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.53e-6)"	20.3	16.9	4.4	21.6	14.4	1.8	13.9	8.8	9.7	12.8	53.1	26.2	4.8	40.5	12.5	11.8	19.8	9.2	26.9	7.4	6.4	3.7	15.7	8.1	17.7	6.9	18.4	6.8	14.7	15.2	19.6	7.4	8.4	11.6	11.3	45.6	10.2	18.7	7.1	3.8	22.0	46.5	9.4	20.9	5.9	13.1	6.4	15.7	2.5	21.9	10.6	13.4	12.7	13.9	1.7	0.2	0.3	0.0	0.4	2.6	0.5	9.7	0.4	0.3	0.1	34.4	19.9	0.4	5.8	11.5	1.1	6.8	45.7	15.7	5.5	1.2	26.0	0.2	9.2	1.2	14.7	1.7	0.7	11.8	5.0	0.0	3.2	2.2	0.0	2.7	5.7	9.3	8.5	7.8	0.1	14.4	3.0	8.3	9.2	5.2	11.8	0.0	0.1	1.8	11.1	8.8	0.0	6.7	6.3	4.7	19.3	11.5	1.9	1.9	3.6	29.1	3.0	15.9	0.0	17.8	5.2	2.6	0.2	0.1	11.1	12.7	0.0	7.0	0.0	1.5	0.0	0.0	0.0	1.1	0.0	2.6	1.7	1.2	1.4	0.2	0.3	0.3	0.4	0.3	0.4	0.0	0.0	1.1	0.5	4.4	14.4	8.8	9.7	6.4	3.7	18.4	6.8	11.6	15.7	20.8	12.5	9.3	7.7	7.1	0.6	3.4	25.5	14.7	9.1	22.7	17.7	15.0	5.0	18.0	110.8	9.4	119.8	0.0	20.4	3.3	8.0	13.6	1.1	10.5	7.3	0.0	25.5	4.9	1.0	24.7	5.5	2.8	15.1	0.0	86.3	0.9	36.4	95.1	17.3	1.8	0.8	6.5	15.5	14.6	6.8	9.8	10.4	1.9	66.0	16.9
MYO1E	"HuncM-IC, MGC104638, MYO1C"	ENSG00000157483	"Myosin IE"	Q12965	15	59132434-59372900	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 51.5;HaCaT: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003003, HPA023886"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"HPA003003: , HPA023886: AB_1854253"	"unprognostic (7.90e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (5.38e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	25.9	4.6	7.9	18.4	19.0	0.7	13.3	2.3	12.6	13.6	28.5	40.6	26.5	13.6	18.1	17.0	22.1	10.0	21.5	6.8	12.6	7.6	22.4	33.4	11.6	18.9	27.2	7.6	6.8	8.8	23.7	6.6	18.7	17.2	15.6	19.4	13.0	12.4	43.5	7.2	28.8	25.9	12.3	25.5	11.4	17.1	4.7	22.4	2.6	9.9	10.6	21.7	15.6	16.2	7.0	16.9	0.4	3.4	2.5	0.4	1.6	29.6	51.5	2.8	1.9	22.1	18.1	14.6	12.1	5.9	6.7	7.9	12.7	11.6	11.8	8.7	9.4	27.7	47.8	4.3	18.7	9.0	5.4	2.4	0.1	43.0	11.2	20.5	0.0	1.6	24.7	11.5	8.6	25.4	21.4	11.0	0.2	0.0	0.1	11.4	2.7	0.1	0.2	6.8	4.8	11.5	0.0	12.5	7.2	36.4	14.0	1.5	5.1	26.9	5.6	10.4	8.9	3.7	1.3	13.3	13.6	3.9	41.3	11.8	0.0	0.7	0.2	24.9	0.1	12.2	0.0	3.1	0.0	0.1	3.4	0.0	6.6	0.0	0.0	11.0	7.0	0.0	0.0	0.4	2.5	1.2	16.9	0.4	1.6	7.9	19.0	2.3	12.6	12.6	7.6	27.2	7.6	17.2	22.4	6.0	7.7	0.0	21.2	22.0	0.0	3.2	20.4	34.8	6.8	24.4	0.0	3.3	3.3	39.7	3.4	16.1	46.1	0.0	15.8	17.7	9.9	27.4	4.6	9.4	29.8	0.0	18.9	4.3	3.3	5.2	8.6	16.2	18.6	7.2	21.7	11.7	42.3	31.6	11.3	3.0	0.9	12.9	23.0	1.0	3.8	21.0	10.8	1.0	19.6	34.4
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 127.9;Late spermatids: 34.5;Muller glia cells: 68.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.7;SCLC-21H: 2.5;U-2 OS: 4.4;U-698: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No			"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	1.5	0.0	0.0	1.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8	0.0	0.3	0.0	0.3	1.5	0.9	0.6	0.0	0.0	4.5	0.0	0.0	0.0	1.7	0.5	127.9	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	34.5	1.1	0.0	0.0	0.0	0.2	68.5	0.3	0.0	1.1	1.4	3.4	0.0	0.0	20.0	5.8	0.9	0.0	0.0	0.0	0.1
MYO5A	"GS1, MYH12, MYO5, MYR12"	ENSG00000197535	"Myosin VA"	Q9Y4I1	15	52307283-52529050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5;parathyroid gland: 47.6"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 82.8;Melanocytes: 92.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;RPMI-8226: 40.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001356	Enhanced		Approved	"Focal adhesion sites,Centriolar satellite"		NA	NA			"Focal adhesion sites, Centriolar satellite"		"HPA001356: AB_1079441"	"unprognostic (1.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.74e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (4.22e-4)"	8.4	7.1	16.6	9.5	27.5	15.7	5.5	27.4	34.5	6.2	4.4	7.8	0.4	3.3	4.2	3.2	5.0	3.6	7.3	4.6	15.9	15.4	4.6	2.7	7.3	11.2	15.6	17.6	5.4	4.3	47.6	10.5	5.2	29.3	4.5	5.2	9.9	4.0	3.4	4.1	10.4	3.9	7.7	10.1	7.3	4.1	4.6	7.1	3.1	6.8	2.7	10.3	7.3	4.2	2.3	5.2	6.3	4.4	0.7	4.5	1.9	5.5	9.8	5.2	6.3	5.3	6.5	5.6	10.1	9.1	5.4	4.2	0.9	2.2	5.3	2.6	12.0	7.9	4.6	12.0	10.4	6.7	30.0	2.8	4.9	2.5	1.2	2.7	2.6	4.8	4.3	6.5	7.9	15.8	5.3	31.4	3.5	0.1	60.0	10.4	9.8	2.3	0.3	2.4	0.1	7.8	4.2	8.4	40.7	4.4	4.0	3.8	2.3	9.4	7.8	18.3	4.0	4.1	2.9	15.0	10.9	4.7	5.1	9.8	6.2	13.8	6.4	11.9	7.5	15.7	0.9	4.4	5.4	2.9	3.6	4.5	2.3	2.9	1.9	5.2	1.6	0.5	1.0	6.3	0.7	2.6	3.1	4.1	1.9	16.6	27.5	27.4	34.5	15.9	15.4	15.6	17.6	29.3	7.1	11.9	10.7	12.3	8.4	18.4	82.8	8.7	5.1	9.4	29.6	14.0	37.3	0.5	0.0	4.8	16.0	9.0	0.0	0.0	5.4	0.4	6.0	6.8	22.0	1.0	21.3	25.4	1.2	1.8	24.4	6.4	3.4	39.4	92.8	27.9	0.0	4.5	5.0	0.8	1.8	2.2	27.1	6.5	4.7	8.7	7.0	10.2	0.9	12.9	0.0	7.4
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822813-50195093	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 92.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 114.3;Pancreatic endocrine cells: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 21.0;HaCaT: 33.2;RH-30: 51.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	2.0	1.2	1.1	12.7	1.3	0.0	5.2	0.4	2.5	7.5	56.9	1.0	13.7	23.5	1.8	10.4	20.3	4.6	20.6	2.0	1.8	1.2	19.1	13.9	9.4	0.6	0.7	1.5	1.7	16.4	9.3	10.5	13.5	2.1	6.0	17.5	8.4	21.6	8.7	0.6	14.5	92.2	0.8	0.7	0.9	13.1	5.5	0.3	2.4	16.3	14.9	17.4	4.0	11.8	1.0	0.1	0.0	0.0	2.4	0.6	0.0	21.0	5.7	0.1	0.1	0.0	0.0	11.5	0.1	0.8	0.4	0.0	14.9	9.0	0.0	5.3	0.0	1.7	33.2	7.5	9.0	0.4	0.0	2.3	0.0	2.5	10.5	0.0	0.0	0.1	0.0	7.9	0.2	5.5	1.7	0.7	0.1	0.1	8.3	0.9	8.1	0.0	0.0	1.5	12.3	2.3	0.0	51.4	3.5	19.0	4.3	11.4	0.2	8.0	9.5	0.0	3.0	5.6	0.0	0.5	0.0	11.6	0.1	2.2	5.6	3.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	1.0	0.4	0.1	0.0	0.0	0.2	0.4	0.0	2.4	0.0	0.1	0.1	0.0	1.1	1.3	0.4	2.5	1.8	1.2	0.7	1.5	2.1	0.3	50.6	12.0	0.8	8.3	0.3	8.2	1.9	15.3	24.1	19.4	7.0	9.8	3.2	5.0	40.6	14.7	0.6	114.3	0.0	41.1	1.1	0.5	42.9	0.0	15.3	0.7	0.0	6.4	0.0	0.3	1.5	0.9	0.9	3.3	3.6	33.5	29.9	76.1	53.7	0.7	13.0	29.0	0.0	0.2	9.5	3.8	5.6	3.9	0.0	38.0	58.3
MYO7A	"DFNA11, DFNB2, NSRD2, USH1B"	ENSG00000137474	"Myosin VIIA"	Q13402	11	77128264-77215241	"Disease related genes, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease mutation, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.3;retina: 30.9"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 45.2;Cytotrophoblasts: 34.1;Hofbauer cells: 24.3;Ito cells: 21.5;Kupffer cells: 20.9;Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 5.6;intermediate monocyte: 4.0;NK-cell: 1.4"	"Group enriched"	"Detected in many"	10	"monocytes: 5.6;NK-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.6;CACO-2: 7.1;RH-30: 15.9;RPMI-8226: 10.4;SK-BR-3: 8.7;U-937: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA028918, CAB034059"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB034059: AB_2148626, HPA028918: AB_10603022"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.03e-2)"	5.8	26.3	3.6	3.7	5.6	1.1	5.0	0.7	3.0	1.3	1.7	3.5	0.9	2.2	1.3	2.9	1.2	2.3	2.8	1.7	4.0	3.8	5.3	14.8	1.6	4.5	5.2	1.7	4.4	3.8	1.2	25.1	16.9	7.2	13.6	1.4	30.9	1.1	0.9	1.0	0.6	2.4	2.4	3.9	11.2	2.0	22.9	4.7	0.5	1.5	0.3	1.1	1.9	4.4	0.0	0.3	0.0	5.6	1.4	0.1	1.8	0.0	1.1	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	7.1	2.0	0.0	1.6	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.3	4.3	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	3.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.3	0.0	15.9	10.4	0.0	0.2	2.5	0.8	0.1	8.7	0.1	1.9	1.2	1.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	5.6	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	1.8	3.6	5.6	0.7	3.0	4.0	3.8	5.2	1.7	7.2	4.7	0.0	0.0	0.0	0.2	0.2	7.3	3.6	7.6	0.0	0.0	0.0	45.2	34.1	0.0	0.6	1.5	0.7	0.0	0.0	1.5	7.0	0.8	0.1	0.0	12.4	24.3	0.0	1.2	21.5	20.9	3.7	2.8	1.1	0.0	0.0	0.5	15.1	1.0	0.0	0.4	2.2	31.8	0.0	0.3	0.3	0.4	0.3	13.5	0.0	0.4	0.1
MYO9A	"FLJ11061, FLJ13244, MGC71859"	ENSG00000066933	"Myosin IXA"	B2RTY4	15	71822289-72118577	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, GTPase activation, Motor protein, Myosin"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Rod photoreceptor cells: 446.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039812, HPA040071"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA039812: AB_10961421, HPA040071: AB_10961117"	"unprognostic (7.53e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.44e-1)"	"unprognostic (4.41e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"	10.5	6.0	13.8	9.6	17.9	6.1	14.8	18.3	16.4	13.3	11.1	7.5	10.6	3.4	15.0	11.0	11.2	10.8	7.5	9.3	9.5	9.3	19.6	5.5	12.2	8.4	9.1	12.0	17.5	5.0	15.9	14.7	10.5	14.6	11.9	9.2	9.1	8.3	11.3	12.9	12.0	8.0	14.4	9.0	10.0	9.7	35.6	11.2	9.1	18.4	6.6	8.8	11.9	13.9	6.1	9.3	5.2	3.4	3.7	7.6	1.3	6.4	9.9	6.5	4.6	10.1	11.9	3.9	6.1	6.7	6.2	6.4	4.8	4.4	28.9	3.6	12.1	8.2	6.1	13.1	7.0	8.3	6.3	7.6	7.3	5.6	2.1	6.4	7.3	5.9	6.7	7.1	7.4	10.6	5.2	7.9	5.2	4.7	6.9	8.4	4.0	4.1	3.0	3.5	2.4	4.0	2.9	12.6	2.8	7.6	9.6	3.7	4.1	7.9	6.9	6.4	8.3	5.4	3.5	10.5	12.5	6.1	20.1	6.9	4.4	10.9	7.8	7.4	6.1	5.5	2.2	2.2	5.2	5.6	2.0	7.6	4.7	5.4	4.6	2.2	6.1	5.7	5.3	0.3	3.7	3.4	9.3	4.5	1.3	13.8	17.9	18.3	16.4	9.5	9.3	9.1	12.0	14.6	11.2	107.2	59.0	9.1	19.4	18.5	49.1	28.5	0.0	33.5	31.8	27.9	51.1	9.2	14.9	5.8	102.4	24.2	12.5	23.3	7.0	9.5	20.2	21.2	9.3	4.5	8.0	50.9	12.1	20.9	36.4	117.2	35.9	10.6	21.9	11.8	10.2	22.7	9.6	14.4	40.3	11.0	446.4	19.4	27.4	104.1	36.6	20.8	10.1	7.7	10.6	14.8
MYOCD	MYCD	ENSG00000141052	Myocardin	Q8IZQ8	17	12665890-12768949	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 63.4"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 26.6;Peritubular cells: 94.7;Sertoli cells: 25.8;Smooth muscle cells: 30.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 6.3;BJ hTERT+: 6.4;HBF TERT88: 10.6;hTEC/SVTERT24-B: 11.7;REH: 8.0;SuSa: 13.5"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 6.4"	"CAB046485, HPA071528, HPA072582"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB046485: AB_10600720, HPA071528: , HPA072582: "	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.79e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.15e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.91e-2)"	3.1	0.8	0.6	5.1	1.0	0.0	1.9	0.3	0.5	19.6	19.9	0.2	17.6	2.1	16.6	10.9	14.4	7.4	12.2	18.6	0.4	0.4	0.9	0.4	2.5	0.0	0.5	0.8	10.6	0.4	0.0	0.5	2.6	0.6	17.2	4.2	5.1	0.4	18.7	1.2	1.5	6.6	63.4	0.6	0.5	6.7	3.7	0.1	0.0	1.0	1.2	0.0	33.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.3	6.4	2.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	13.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.3	0.5	0.4	0.4	0.5	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	1.1	0.1	0.0	0.0	0.1	0.0	7.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.7	0.0	0.0	25.8	30.6	0.2	0.7	0.6	0.5	0.0	0.0	0.0
MYOM2		ENSG00000036448	"Myomesin 2"	P54296	8	2045040-2165552	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"heart muscle: 170.7;skeletal muscle: 75.9"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 554.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"HEK 293: 10.1;SCLC-21H: 4.3;U-266/84: 5.3"	"Not detected"	"Not detected"							"HPA001765, HPA005953"	Enhanced		Approved	Mitochondria		NA	NA		120000	Mitochondria		"HPA001765: AB_1079443, HPA005953: AB_1854258"	"unprognostic (2.81e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.30e-5)"	"unprognostic (1.10e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.14e-1)"	2.0	0.0	0.3	0.1	0.4	0.0	1.7	0.9	0.9	0.2	0.2	0.0	0.2	0.0	0.5	2.7	1.2	0.1	0.1	170.7	0.3	0.1	0.7	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.2	1.2	1.0	75.9	0.2	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.6	8.9	1.2	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	10.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.2	0.0	1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.4	0.9	0.9	0.3	0.1	0.2	0.0	0.1	0.0	6.0	4.0	0.0	2.3	3.2	2.8	554.8	17.8	6.7	0.0	3.5	0.0	0.0	11.6	3.4	5.4	2.3	1.0	0.0	1.5	0.0	1.4	1.0	5.7	6.4	1.4	6.4	0.0	5.5	2.8	6.2	0.6	2.3	3.3	3.6	2.5	7.0	2.5	0.0	1.4	21.4	4.1	0.0	17.0	36.9	22.7	2.5	0.1	8.7	1.1	1.4
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 168.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"A549: 5.2;Hep G2: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		Yes	No		680000	Vesicles	"Golgi apparatus, Cytokinetic bridge"	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	6.3	2.7	0.2	0.0	59.5	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.7	0.0	104.6	0.4	1.5	0.0	0.0	0.0	0.0	1.9	0.1	0.0	2.7	39.7	2.8	0.2	0.1	0.8	0.4	2.3	0.4	0.2	0.4	0.0	0.1	5.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	1.5	0.0	2.2	0.6	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	19.8	0.0	0.1	0.1	0.6	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.2	0.1	1.1	0.2	0.6	0.7	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.4	0.1	0.3	0.4	0.1	0.4	0.2	0.2	0.0	0.8	0.3	0.4	2.3	0.2	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	168.2	0.0	0.0	0.0	3.5	0.0	0.0	1.7	0.1	15.5	0.1	4.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.6	0.6	0.0	0.0	0.0	0.0	0.0	1.4	2.9	0.0	25.9	2.8	6.5	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.3
MYORG	"KIAA1161, NET37"	ENSG00000164976	"Myogenesis regulating glycosidase (putative)"	Q6NSJ0	9	34366670-34376853	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 56.1"	"Cell type enhanced"	"Detected in some"	18	"Cytotrophoblasts: 41.5;Exocrine glandular cells: 10.3;Syncytiotrophoblasts: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 17.6;SK-BR-3: 29.4;T-47d: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060533, HPA067487"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060533: AB_2684311, HPA067487: AB_2685848"	"unprognostic (6.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.08e-3)"	"unprognostic (3.68e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.00e-3)"	6.3	5.6	16.7	4.7	20.5	2.1	3.5	6.9	16.0	2.0	19.9	9.8	1.3	20.9	2.2	2.8	4.8	3.6	11.6	2.9	11.1	8.7	11.7	31.8	3.1	1.7	11.2	12.6	1.6	16.6	2.0	4.0	15.4	10.7	3.2	13.1	0.5	4.7	4.9	56.1	3.6	26.7	4.8	7.0	1.7	9.9	1.7	6.9	0.0	2.2	6.4	2.1	3.5	1.9	1.1	0.8	1.9	0.8	1.9	3.3	0.6	4.1	2.9	4.9	2.9	2.0	0.7	10.4	0.8	0.6	0.4	0.7	7.1	4.3	2.3	8.4	0.7	2.1	8.4	3.4	7.8	0.6	0.7	1.9	0.4	13.0	17.6	0.3	0.4	1.4	1.0	3.8	1.3	1.6	2.3	1.9	1.7	0.5	2.4	1.1	6.8	1.3	0.7	2.9	13.7	2.3	2.1	2.5	0.7	2.6	1.5	0.7	6.8	5.8	29.4	0.5	4.3	27.3	0.7	1.7	1.1	6.0	0.9	1.8	1.5	3.2	0.9	0.9	1.6	0.9	1.9	0.6	1.2	3.3	0.6	2.6	0.8	2.0	1.9	0.3	1.1	1.3	1.6	1.6	1.9	0.8	0.8	2.6	0.6	16.7	20.5	6.9	16.0	11.1	8.7	11.2	12.6	10.7	6.9	8.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	3.5	0.0	41.5	1.7	5.6	0.0	0.0	0.0	0.0	10.3	1.9	0.0	0.0	1.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	9.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0
MYOZ2	"C4orf5, CS-1"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135784-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 219.1;skeletal muscle: 188.6"	"Cell type enriched"	"Detected in some"	343	"Cardiomyocytes: 2214.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.3;HSkMC: 3.7;SK-MEL-30: 9.5;U-87 MG: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	3.7	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	2.4	2.6	0.2	0.1	219.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.9	0.1	188.6	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.0	13.9	3.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.5	1.7	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	10.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2214.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.7	0.7	0.0	6.5	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 94.6"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"BJ: 16.6;fHDF/TERT166: 46.6;GAMG: 9.2;HBF TERT88: 11.0;LHCN-M2: 20.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Nucleoplasm, Vesicles"	Cytosol	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	4.5	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	2.1	0.0	0.0	23.6	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.1	2.1	0.0	114.9	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.9	46.3	3.4	0.0	0.0	0.3	0.1	3.8	0.1	0.2	0.1	0.0	1.2	0.5	0.0	0.0	0.3	1.8	0.0	16.6	8.3	6.3	2.3	0.0	0.0	0.0	0.0	46.6	9.2	0.3	0.0	0.1	11.0	0.1	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.8	0.0	3.3	0.4	1.5	0.1	0.0	0.0	0.1	20.1	3.5	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	1.7	0.0	0.0	0.0	0.0	2.0	0.0	1.8	3.8	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	94.6	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MYPOP	P42pop	ENSG00000176182	"Myb related transcription factor, partner of profilin"	Q86VE0	19	45890020-45902604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 19.2;NB-4: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065307			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065307: AB_2685460"	"unprognostic (5.13e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.67e-5)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-3)"	7.6	9.4	15.7	7.9	14.3	4.2	8.0	15.1	25.9	6.5	7.5	6.8	5.9	11.4	7.2	7.0	6.4	6.1	7.1	8.0	15.9	9.2	9.5	6.1	5.9	8.3	8.5	7.7	6.5	8.5	7.0	12.9	6.1	11.3	7.7	6.0	6.3	9.5	8.2	36.4	10.1	10.1	6.5	9.0	12.3	8.5	6.8	8.7	5.3	5.0	4.3	7.0	6.8	10.7	1.0	1.5	2.7	1.4	0.6	1.1	0.4	4.2	6.8	2.6	5.3	3.4	2.2	5.2	3.2	3.3	3.5	4.6	2.7	2.7	4.1	3.1	1.6	3.4	3.6	1.9	1.4	2.5	19.2	11.1	1.9	3.8	4.4	3.7	1.9	6.2	2.1	4.1	1.9	1.8	3.7	2.8	7.0	2.6	3.7	2.2	1.8	10.1	26.2	2.9	5.5	6.9	8.1	1.1	2.3	2.0	2.4	5.4	4.1	3.1	3.4	3.3	2.0	2.3	7.1	3.6	3.3	5.5	3.0	5.0	10.9	7.8	2.7	4.8	5.2	3.9	0.0	1.4	2.7	1.1	0.6	0.3	1.0	0.8	0.6	1.5	0.3	0.6	0.7	1.6	0.6	0.7	1.0	0.7	0.4	15.7	14.3	15.1	25.9	15.9	9.2	8.5	7.7	11.3	8.7	3.0	1.3	3.7	4.4	10.2	10.1	11.8	5.1	1.4	0.0	5.2	7.9	4.5	19.9	7.0	5.2	3.8	7.8	0.0	7.9	14.2	6.6	2.9	0.0	3.2	5.1	6.4	8.6	3.7	4.9	1.0	6.6	5.3	3.3	6.4	4.5	3.2	6.0	5.9	7.1	5.1	11.4	19.4	4.5	2.4	4.9	8.5	4.5	6.9	4.6	2.0
MYRF	"C11orf9, MRF, Ndt80, pqn-47"	ENSG00000124920	"Myelin regulatory factor"	Q9Y2G1	11	61752642-61788518	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.7;stomach 1: 57.2"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 44.7;Cholangiocytes: 58.6;Ductal cells: 29.2;Exocrine glandular cells: 31.5;Pancreatic endocrine cells: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 17.5;CACO-2: 29.3;CAPAN-2: 16.9;EFO-21: 22.9;Hep G2: 12.4;HHSteC: 13.1;OE19: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018310			Approved	Nucleoplasm,Cytosol		NA	NA		550000	Nucleoplasm	Cytosol	"HPA018310: AB_1845534"	"unprognostic (3.51e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	4.6	1.3	16.4	2.1	42.9	1.4	1.5	3.3	38.5	3.7	4.3	96.7	0.0	12.8	6.9	1.6	2.0	8.0	22.4	1.5	29.2	13.9	4.5	5.8	15.8	1.2	54.3	19.9	5.8	19.7	1.2	0.2	2.6	35.7	1.2	4.0	11.6	1.7	1.6	1.0	1.4	11.4	5.4	53.8	1.3	57.2	3.0	51.4	0.0	1.2	0.0	1.2	1.3	0.3	0.0	0.0	0.2	0.3	0.5	2.1	0.5	1.3	17.5	3.1	1.0	0.0	0.0	0.1	0.1	0.0	0.6	0.7	29.3	16.9	0.6	22.9	0.0	0.8	0.7	1.0	0.1	1.2	0.0	0.3	0.1	0.3	12.4	13.1	0.0	0.3	0.3	0.1	0.4	0.0	7.7	0.1	0.9	5.4	0.2	0.1	0.3	0.0	0.6	0.8	25.8	2.3	0.0	0.1	1.1	7.8	0.1	0.1	0.6	0.1	1.2	0.3	10.9	0.3	0.1	0.6	0.2	10.2	0.2	0.3	0.3	0.1	0.1	0.1	1.2	0.2	0.0	0.0	0.2	2.1	0.3	1.2	0.0	0.7	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.5	16.4	42.9	3.3	29.3	29.2	13.9	54.3	19.9	35.7	51.4	44.7	6.1	0.0	0.0	0.1	0.1	0.8	58.6	0.0	2.3	3.5	0.0	0.2	0.0	29.2	0.3	0.0	8.4	0.0	31.5	0.2	4.9	0.2	0.0	5.3	0.8	0.0	1.2	0.6	0.0	0.2	5.5	0.6	3.3	1.8	3.2	3.7	47.6	11.5	3.5	1.0	0.0	0.0	0.3	1.0	3.2	0.0	0.7	0.0	5.2	0.7
MYRFL	"bcm1377, C12orf15, C12orf28, FLJ25056"	ENSG00000166268	"Myelin regulatory factor-like"	Q96LU7	12	69825304-69959097	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"intestine: 56.1"	"Cell type enhanced"	"Detected in some"	21	"Collecting duct cells: 5.2;Early spermatids: 12.4;Late spermatids: 22.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.0;SK-BR-3: 3.5;T-47d: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049340	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli		"HPA049340: AB_2680719"	"unprognostic (2.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	0.3	0.3	0.5	0.0	0.6	0.0	0.5	3.6	0.6	0.1	20.7	0.0	0.4	21.4	0.1	0.9	0.1	0.1	0.7	0.2	0.4	0.2	2.0	0.3	0.2	0.2	0.5	0.2	0.0	0.8	0.0	1.0	0.3	0.7	0.6	0.1	0.3	1.3	0.4	0.0	1.6	56.1	0.1	1.0	0.1	0.1	2.4	0.5	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.1	0.0	0.1	0.0	1.1	1.0	0.0	0.3	0.1	0.0	3.5	0.0	1.2	15.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.5	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	3.6	0.6	0.4	0.2	0.5	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.0	0.0	0.0	5.2	0.0	0.2	3.3	0.8	12.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	22.2	0.9	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.4	0.5	0.0	0.0	0.0	0.7	0.4	1.0	0.0	0.0	0.0	0.0
MYRIP	"DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C"	ENSG00000170011	"Myosin VIIA and Rab interacting protein"	Q8NFW9	3	39808914-40260321	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;retina: 36.3"	"Cell type enhanced"	"Detected in many"	17	"Hepatocytes: 14.7;Ito cells: 44.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.5;HUVEC TERT2: 17.0;REH: 3.9;SCLC-21H: 3.6;SH-SY5Y: 10.5;T-47d: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006433			Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"		"HPA006433: AB_10603023"	"unprognostic (1.87e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.96e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.16e-2)"	4.8	2.0	31.0	2.2	7.8	0.5	3.4	23.7	19.4	9.0	4.2	3.9	1.3	2.9	6.0	3.8	2.4	3.3	4.3	2.8	13.9	9.6	2.7	16.7	1.7	2.6	8.5	11.0	5.3	13.1	2.1	8.4	0.6	10.8	3.4	4.4	36.3	16.0	1.8	2.7	1.8	2.8	3.9	5.5	10.2	7.7	1.7	4.2	0.0	2.1	1.6	2.9	2.8	2.7	0.8	0.1	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	1.1	0.0	0.1	3.9	0.0	0.0	0.4	2.2	3.6	10.5	0.0	0.0	0.0	0.0	4.2	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	31.0	7.8	23.7	18.4	13.9	9.6	8.5	11.0	10.8	4.2	0.0	5.6	0.0	0.1	0.7	2.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	9.9	0.0	0.0	2.3	0.0	0.2	1.7	2.3	14.7	0.0	4.8	0.0	44.8	4.3	3.6	0.9	0.0	0.0	0.0	9.6	6.3	1.0	0.0	0.0	0.8	4.3	0.0	0.5	2.7	0.2	0.5	0.0	0.0	0.6	0.0
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 69.5"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 28.8;Cone photoreceptor cells: 56.9;Horizontal cells: 25.4;Rod photoreceptor cells: 27.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	13	"cerebellum: 69.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.8;REH: 13.3;SCLC-21H: 16.6;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.4	7.4	4.3	0.5	5.0	2.4	0.4	69.5	11.0	0.3	0.7	2.7	0.0	0.9	0.4	0.5	0.3	0.6	0.5	0.8	4.2	5.3	0.6	0.4	0.4	0.4	3.7	2.2	0.4	4.7	0.4	3.7	0.4	5.1	0.6	0.6	3.7	0.3	0.4	0.3	0.4	0.6	0.4	2.0	0.5	1.0	2.1	4.8	0.0	1.4	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.6	0.0	0.5	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	1.0	0.0	0.0	1.4	0.0	0.7	0.0	0.3	13.3	0.0	0.0	0.0	0.0	16.6	4.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.9	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.3	5.0	69.5	3.1	4.2	5.3	3.7	2.2	5.1	4.8	0.0	0.0	0.0	0.2	0.0	28.8	1.1	5.1	0.0	0.0	0.0	56.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	25.4	2.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.5	9.8	0.0	0.0	0.0	0.0	0.0
MYT1L	"KIAA1106, NZF1, ZC2H2C2, ZC2HC4B"	ENSG00000186487	"Myelin transcription factor 1 like"	Q9UL68	2	1789113-2331348	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.2"	"Cell type enhanced"	"Detected in many"	20	"Bipolar cells: 49.9;Horizontal cells: 111.2;Spermatocytes: 36.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 2.3;T-cells: 1.6"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 11.3;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060245			Approved	Vesicles		NA	NA			Vesicles		"HPA060245: AB_2732643"	"unprognostic (9.90e-3)"	"unprognostic (3.74e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.61e-3)"	"unprognostic (7.17e-2)"		"unprognostic (3.73e-2)"		"unprognostic (2.44e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	1.2	3.4	11.0	1.4	20.0	1.1	1.1	19.5	50.2	1.1	1.2	0.5	0.0	1.1	1.2	1.1	1.3	1.1	1.1	1.1	15.6	10.3	1.1	1.1	1.1	1.2	5.1	14.5	1.1	1.5	1.0	10.7	1.1	6.8	1.3	1.3	0.4	1.1	1.1	1.1	1.1	1.2	1.1	1.5	1.0	1.1	4.6	2.0	0.0	1.1	0.0	1.1	1.1	0.0	0.0	0.2	2.3	0.0	0.0	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.6	0.1	0.0	0.0	11.3	8.4	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.2	0.0	0.6	11.0	20.0	19.5	26.7	15.6	10.3	5.1	14.5	6.8	2.0	6.0	6.7	0.0	0.5	1.5	49.9	3.6	0.0	2.7	5.7	1.8	2.0	0.1	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.1	0.8	0.2	5.8	0.4	0.1	111.2	0.0	1.3	0.3	2.9	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.0	1.4	0.0	6.8	6.5	0.3	36.2	17.4	0.9	0.2	0.0	0.0	0.5
MZB1	"HSPC190, MEDA-7, MGC29506, PACAP, pERp1"	ENSG00000170476	"Marginal zone B and B1 cell specific protein"	Q8WU39	5	139387480-139390081	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 97.7;lymphoid tissue: 152.6"	"Group enriched"	"Detected in many"	6	"Erythroid cells: 280.4;Melanocytes: 512.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 29.5;plasmacytoid DC: 97.7"	"Group enriched"	"Detected in many"	115	"B-cells: 29.5;dendritic cells: 97.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 66.2;RPMI-8226: 234.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA043745, HPA052694"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		670000	"Golgi apparatus"		"HPA043745: AB_10960359, HPA052694: AB_2681919"	"unprognostic (4.97e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.27e-4)"	"unprognostic (2.21e-2)"	"prognostic favorable (4.60e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.45e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.15e-8)"	"unprognostic (7.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	2.2	1.9	0.6	37.8	0.6	6.2	4.4	0.5	0.6	5.7	25.5	0.4	0.3	21.6	1.2	0.6	13.6	2.9	5.6	0.8	0.6	0.6	4.2	2.6	6.7	54.7	0.6	0.3	1.7	2.1	0.0	0.8	0.4	0.4	2.4	9.8	2.0	30.2	7.1	0.7	0.7	13.3	0.5	0.6	92.6	15.0	3.7	0.3	152.6	3.3	3.1	54.3	26.6	2.0	29.5	97.7	0.5	0.0	0.3	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	66.2	0.0	0.0	25.6	0.2	0.0	0.0	0.0	10.6	0.0	234.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	31.7	1.8	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	29.5	0.1	0.1	0.0	11.0	0.0	0.0	0.5	0.3	0.0	97.7	0.0	4.5	0.6	0.6	0.5	0.6	0.6	0.6	0.6	0.3	0.4	0.3	6.0	18.0	63.0	0.6	2.3	0.0	0.8	5.1	1.4	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	280.4	0.0	0.0	1.0	2.4	2.3	1.6	0.1	0.0	1.2	12.3	4.7	0.7	0.0	0.7	512.8	0.0	0.7	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.1	2.0	1.8	7.9	0.8	0.3
MZT2A	"FAM128A, MOZART2A"	ENSG00000173272	"Mitotic spindle organizing protein 2A"	Q6P582	2	131464900-131492743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 70.8"									"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"prognostic favorable (3.04e-4)"	"unprognostic (3.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.04e-11)"	"unprognostic (1.51e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-1)"	17.7	17.1	34.7	22.1	22.6	31.3	17.1	9.6	25.1	17.5	20.3	7.6	23.0	30.0	11.9	22.3	23.5	14.0	17.5	57.5	28.0	20.7	14.4	15.9	7.5	15.6	18.9	16.4	20.8	55.4	5.6	7.2	5.3	8.8	16.4	3.4	9.3	48.5	19.7	40.7	12.6	22.8	17.3	12.0	15.5	24.0	11.1	5.5	28.3	17.8	23.8	17.0	16.2	12.8	11.9	5.4	31.9	1.0	2.6	9.3	2.2	36.0	19.5	0.4	7.5	0.5	1.3	7.8	12.2	2.9	4.7	4.6	47.7	12.5	23.4	15.9	0.5	0.5	16.3	1.2	8.2	0.1	9.2	59.4	9.6	21.8	56.4	2.9	16.8	3.6	3.7	4.5	3.0	1.4	1.0	3.8	20.6	18.9	24.6	1.1	32.6	23.2	70.8	12.6	4.6	44.6	19.8	6.7	52.3	2.9	16.7	28.3	3.5	12.4	8.5	22.3	0.3	13.3	30.4	10.7	12.4	30.2	5.2	11.9	23.1	17.1	18.8	17.4	10.9	7.3	6.9	1.0	31.9	3.8	0.6	4.2	11.9	8.5	4.9	3.4	6.2	9.3	4.5	0.4	2.6	0.3	5.4	8.4	2.2	34.7	22.6	9.6	23.1	28.0	20.7	18.9	16.4	8.8	5.5	14.9	14.4	124.6	117.1	131.5	40.9	255.9	112.1	8.1	19.4	68.0	19.6	68.5	144.2	181.3	20.5	65.2	170.0	23.3	144.3	204.7	90.3	143.8	24.1	118.5	108.3	25.4	104.6	85.3	77.6	66.4	141.5	90.6	97.8	130.8	207.2	54.1	253.1	157.8	193.0	188.7	35.9	90.5	69.3	35.8	155.3	125.0	35.5	160.8	232.9	112.8
MZT2B	"FAM128B, FLJ14346, MOZART2B"	ENSG00000152082	"Mitotic spindle organizing protein 2B"	Q6NZ67	2	130181737-130190729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 93.9"									"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"unprognostic (8.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (9.37e-8)"	"unprognostic (1.67e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-1)"	28.9	39.1	50.8	23.9	33.5	63.4	23.8	19.5	35.1	24.3	31.3	14.4	27.7	34.2	24.7	24.0	30.6	19.4	26.7	56.6	33.7	29.3	22.5	31.1	14.4	27.8	32.8	33.3	31.0	104.2	10.9	17.1	16.2	19.7	28.4	11.6	18.6	63.6	24.9	87.5	20.9	32.1	31.8	21.7	26.8	33.8	26.1	15.4	35.3	36.0	27.1	22.2	24.4	34.9	15.3	21.7	31.7	9.3	12.1	13.3	4.9	41.2	17.4	4.4	21.2	1.7	6.4	20.5	19.8	7.3	7.6	5.6	35.6	21.5	22.7	30.9	4.5	5.1	23.4	2.3	6.5	1.2	33.6	53.9	12.3	25.5	38.9	7.6	16.1	12.2	7.0	9.1	5.1	2.6	5.7	8.4	30.0	16.1	34.0	5.5	47.8	36.1	93.9	14.1	8.7	32.0	42.2	11.1	71.2	4.5	13.7	30.7	37.6	11.9	21.6	32.1	2.0	25.5	47.8	15.0	22.1	35.8	17.6	18.7	41.4	25.9	28.0	33.3	23.9	15.9	0.1	9.3	31.7	7.7	9.1	6.2	15.3	11.3	10.7	11.2	14.8	13.3	10.7	4.6	12.1	8.4	21.7	8.7	4.9	50.8	33.5	19.5	35.1	33.7	29.3	32.8	33.3	19.7	15.4	38.7	21.9	238.2	264.1	264.0	158.4	293.3	170.7	40.2	50.0	230.3	41.2	229.1	396.3	323.5	266.4	198.6	241.8	140.2	511.3	411.3	250.4	326.9	50.7	320.9	295.2	123.9	166.1	171.9	146.8	852.0	231.3	260.0	254.8	212.0	316.3	142.6	514.2	241.6	135.1	586.2	76.3	161.7	241.9	132.8	161.7	329.7	138.1	211.9	294.6	315.0
N4BP1		ENSG00000102921	"NEDD4 binding protein 1"	O75113	16	48538726-48620148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 11.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040849, HPA041080"	Approved		Approved	"Nucleoli fibrillar center"		No	No			"Nucleoli fibrillar center"		"HPA040849: AB_10794866, HPA041080: AB_10794186"	"unprognostic (1.07e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.03e-8)"	"unprognostic (9.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.36e-2)"	15.4	9.2	12.5	10.4	13.3	13.4	11.6	18.2	12.7	12.6	12.0	11.1	8.5	8.8	12.1	12.9	23.5	12.2	12.0	8.5	10.8	11.3	9.9	8.8	21.4	17.7	11.3	9.7	15.3	12.9	21.3	15.9	17.0	10.2	11.4	9.7	10.1	14.0	10.3	13.8	24.2	11.7	10.1	9.6	14.8	11.7	6.1	12.1	16.3	11.4	17.3	14.9	11.8	13.8	1.4	1.4	11.8	1.8	0.5	2.3	0.8	6.8	11.7	8.3	8.4	11.7	9.3	7.0	6.4	9.7	12.5	6.4	9.1	5.7	7.7	6.0	9.7	5.5	14.2	7.4	10.1	6.9	4.7	6.1	4.0	4.6	8.0	11.4	5.9	10.9	13.3	15.6	4.4	6.5	9.2	6.2	8.0	6.0	8.2	7.4	3.8	7.0	10.8	6.6	7.1	6.6	10.7	13.6	11.9	6.1	11.6	9.4	6.7	5.4	10.0	8.7	9.1	4.2	8.3	9.1	6.4	5.8	3.4	3.7	12.3	7.2	11.3	7.4	4.7	5.5	1.0	1.8	2.2	1.5	1.6	1.9	1.4	1.9	2.3	1.1	1.0	1.6	1.7	11.8	0.5	1.2	1.4	1.3	0.8	12.5	13.3	18.2	12.7	10.8	11.3	11.3	9.7	10.2	12.1	125.0	28.3	16.4	16.3	17.7	23.0	12.6	22.9	12.0	25.0	7.0	15.7	11.7	5.0	7.4	5.4	18.6	17.6	23.3	11.4	8.1	11.0	26.9	11.6	12.5	16.7	25.4	9.2	22.1	24.3	2.4	15.0	31.8	5.0	20.8	19.5	18.6	19.9	17.8	19.4	7.9	19.5	0.0	10.3	13.4	22.8	19.8	23.8	15.2	11.2	40.6
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056826-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 35.6"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	3.5	3.1	3.4	7.4	5.1	7.0	5.8	6.1	3.2	5.5	4.3	1.2	7.1	4.7	7.0	6.6	5.2	4.8	3.8	3.5	2.5	3.6	3.2	11.3	7.5	9.2	1.9	1.6	7.0	13.1	2.5	14.3	11.9	2.8	4.9	4.5	4.3	10.7	11.0	2.9	5.4	5.3	3.2	3.1	4.3	3.8	3.5	2.1	35.6	7.2	3.5	7.8	5.6	5.2	2.4	8.1	5.7	1.2	10.6	4.5	1.2	1.5	1.6	9.4	1.5	0.6	3.1	7.7	1.8	1.9	1.0	2.2	3.0	3.1	8.3	3.5	1.7	1.7	1.2	6.0	1.9	2.5	2.6	1.9	3.7	1.4	1.4	1.6	10.0	8.9	3.5	2.7	1.7	3.7	0.3	2.7	7.9	8.2	3.6	2.0	1.5	20.2	4.3	4.7	1.2	1.3	11.8	11.1	1.9	0.8	3.7	3.8	6.7	1.6	1.3	1.5	6.3	1.1	2.7	3.7	1.1	5.9	0.7	1.3	5.9	6.0	5.7	1.2	3.6	2.3	5.7	1.1	0.5	2.3	1.2	2.4	1.7	3.0	1.7	1.7	2.4	4.5	2.5	0.3	10.6	1.0	8.1	1.3	1.2	3.4	5.1	6.1	3.2	2.5	3.6	1.9	1.6	2.8	2.1	20.8	19.5	2.9	12.0	10.6	30.6	12.3	12.7	6.7	18.2	21.0	25.5	34.4	0.0	5.4	2.6	6.6	6.0	23.3	10.7	11.4	12.3	12.2	4.7	15.5	10.4	68.3	18.6	4.9	16.3	2.7	9.2	17.8	6.8	9.0	15.0	11.8	9.7	8.6	3.5	3.1	20.2	12.9	5.7	13.6	27.0	11.4	22.5	13.8	8.0	8.4
N4BP2L2	"CG005, PFAAP5"	ENSG00000244754	"NEDD4 binding protein 2 like 2"	Q92802	13	32432417-32538885	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039338, HPA039434, HPA059327"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039338: AB_2676453, HPA039434: AB_10673143, HPA059327: AB_2683981"	"unprognostic (1.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.51e-2)"	"unprognostic (8.95e-2)"	"unprognostic (6.29e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.03e-3)"	24.4	22.6	22.8	27.3	28.0	17.4	29.7	43.4	34.0	34.1	25.2	18.0	31.6	13.9	38.3	25.8	19.5	26.3	22.1	30.3	23.7	18.8	23.7	25.4	26.2	20.1	30.2	23.3	38.5	19.5	19.1	75.7	20.6	24.6	28.1	23.3	15.5	22.4	27.3	49.3	23.0	21.4	28.7	39.8	24.3	23.1	14.7	29.6	31.4	27.8	21.1	20.4	29.4	27.1	12.7	10.2	23.0	12.5	14.2	17.7	7.7	7.7	5.4	17.6	12.4	14.8	18.5	14.4	15.0	14.7	12.5	11.7	10.0	20.4	9.8	8.5	15.1	21.3	13.4	17.1	14.0	15.9	20.8	7.6	19.6	12.1	10.9	22.6	21.0	9.5	19.4	18.7	10.9	14.0	21.8	18.7	16.0	14.1	9.8	18.2	9.1	17.7	18.4	17.2	34.6	7.2	13.4	16.4	9.6	15.4	9.7	6.8	14.8	10.9	12.0	21.4	18.9	12.7	24.7	14.8	7.9	8.1	7.2	7.5	7.5	7.8	8.0	9.1	14.7	11.8	23.0	8.6	19.7	12.4	9.6	17.0	12.7	14.4	12.4	7.7	11.4	17.7	15.2	15.4	14.2	12.5	10.2	13.3	7.7	22.8	28.0	43.4	34.0	23.7	18.8	30.2	23.3	24.6	29.6	160.8	148.3	169.0	254.9	122.5	229.6	159.8	99.3	147.2	134.2	205.9	233.7	140.7	77.9	107.5	102.8	157.2	207.2	93.5	65.1	67.9	132.2	215.5	205.8	114.9	103.8	235.2	168.7	154.7	146.4	89.3	342.6	171.5	118.1	247.1	126.1	127.5	94.1	273.5	283.5	60.3	318.6	310.4	155.5	171.9	86.9	120.3	160.2	246.8	107.6	246.1
N4BP3	LZTS4	ENSG00000145911	"NEDD4 binding protein 3"	O15049	5	178113443-178126087	"Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.5"	"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 120.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4"	"Group enriched"	"Detected in many"	18	"B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.0;MCF7: 10.9;RH-30: 10.9;SK-BR-3: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030972, HPA030973, HPA061387"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: "	"unprognostic (1.84e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.88e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.55e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	6.6	1.3	1.9	2.6	2.1	3.5	13.9	6.5	4.3	2.5	1.8	0.7	0.5	0.8	1.1	0.6	16.2	1.5	1.3	3.2	1.8	2.6	2.5	0.2	8.4	4.0	2.1	1.2	1.4	1.1	10.1	2.5	31.5	3.1	2.0	0.6	1.5	9.5	1.3	5.7	7.8	1.9	1.3	1.2	5.9	3.1	1.4	1.3	0.4	2.0	4.7	11.2	4.9	3.8	4.0	4.4	0.0	0.0	0.2	2.6	0.5	0.0	0.0	1.2	0.9	0.1	0.0	8.0	0.0	0.0	0.0	0.0	1.7	0.6	0.7	1.1	0.0	0.1	2.5	0.2	0.0	0.0	1.2	0.4	2.1	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	6.4	0.7	1.3	0.5	0.0	10.9	0.1	0.1	6.0	1.8	0.0	6.0	10.9	2.7	0.6	1.2	0.9	0.4	0.3	38.8	2.5	1.6	1.4	0.0	1.2	0.0	0.9	0.0	0.0	1.7	1.2	6.8	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.3	4.0	0.2	0.2	0.0	4.0	0.9	2.6	0.0	0.2	0.0	4.4	0.0	0.5	1.9	2.1	6.5	4.3	1.8	2.6	2.1	1.2	3.1	1.3	3.0	1.1	5.9	11.5	8.4	27.3	1.5	2.5	0.0	0.0	1.8	11.8	1.7	11.6	3.4	0.1	4.0	2.6	0.0	0.7	120.1	0.9	9.9	4.6	0.0	2.0	1.6	4.1	0.0	0.0	0.4	0.6	1.1	11.8	1.8	1.8	1.9	4.7	5.3	1.8	0.3	8.9	0.0	0.9	0.1	6.9	5.9	19.3	1.0	1.9	10.6
N6AMT1	"C21orf127, HEMK2, MTQ2, N6AMT, PRED28"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome		Yes	No			Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957"	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	5.4	10.9	10.1	6.0	18.6	2.0	10.5	7.4	14.8	9.9	7.0	17.0	6.0	6.7	13.8	13.7	5.6	9.3	6.2	10.8	10.8	9.2	9.0	6.3	5.5	6.7	21.3	8.4	18.3	6.6	14.6	15.6	13.1	14.1	10.1	7.4	8.4	6.5	9.0	11.3	8.0	6.2	7.8	14.5	7.9	6.7	7.6	19.3	3.9	12.1	4.0	6.9	8.7	9.2	2.2	2.0	1.6	2.1	4.1	4.8	1.8	3.4	3.1	7.8	10.8	6.5	7.2	6.0	7.4	3.1	4.4	2.6	3.8	6.2	3.8	3.8	4.0	7.8	4.1	6.6	3.7	5.4	4.8	5.1	8.0	4.7	4.8	5.8	4.8	3.1	3.7	8.0	4.4	3.1	8.2	3.2	4.7	9.9	6.8	9.0	3.4	2.3	3.9	9.8	7.2	4.3	3.4	7.4	2.9	8.0	5.0	5.9	8.3	6.7	2.4	2.7	7.3	3.3	4.2	7.5	3.7	6.6	6.7	4.5	4.1	4.6	2.1	5.8	12.6	6.8	1.1	1.5	1.6	1.8	2.1	2.0	2.2	3.4	2.3	2.0	2.2	4.8	3.4	0.5	4.1	1.6	1.7	1.4	1.8	10.1	18.6	7.4	14.8	10.8	9.2	21.3	8.4	14.1	19.3	3.0	4.8	1.4	5.3	1.6	11.1	14.0	7.6	21.4	6.8	12.2	7.9	15.0	6.6	9.7	2.5	4.9	0.9	23.3	5.5	9.8	6.1	3.4	1.1	2.8	6.2	9.5	0.0	4.9	1.2	3.4	8.9	2.6	1.7	2.8	2.6	10.3	6.4	4.8	9.6	7.3	10.0	0.0	8.2	2.6	8.1	3.1	12.5	2.5	3.3	4.8
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: AB_2673579"	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	32.1	33.9	6.4	20.8	9.1	9.6	18.1	11.3	6.6	15.5	13.6	22.0	10.2	24.5	37.7	9.3	20.1	15.4	13.4	13.6	6.0	10.2	62.5	8.8	23.7	22.1	12.5	17.1	19.5	7.3	15.3	14.4	15.0	7.8	17.5	9.6	17.6	10.4	10.2	42.2	27.3	25.5	10.7	30.4	47.1	21.7	16.5	26.8	11.3	14.8	13.7	16.5	4.4	17.9	26.7	6.3	9.6	14.2	10.1	6.5	22.3	22.5	34.3	22.0	24.5	46.0	8.8	22.1	18.9	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8	8.9	27.5	83.3	53.7	62.3	28.9	38.0	53.5	29.4	26.1	36.6	11.8	113.1	81.2	114.3	2.1	90.5	71.7	46.7	129.7	161.7	59.9	66.0	66.9	63.8	109.5	35.0	55.8	64.4	62.9	8.3	43.1	71.4	113.1	75.7	61.8	26.2	121.2	58.3	43.9	155.0	22.4	64.7	78.5	5.8	39.4	79.2	91.0	68.3	80.9	64.7
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N(alpha)-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112109022	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 137.4;monocytes: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"		No	No			"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	12.8	11.4	12.7	12.3	19.3	18.4	14.9	21.0	17.0	10.4	11.7	17.9	11.2	8.3	18.1	10.3	14.7	11.3	8.5	10.7	11.6	10.7	8.0	10.2	9.0	12.9	21.7	12.4	15.8	15.1	14.3	13.5	11.4	16.3	11.7	9.4	15.6	9.5	10.5	25.9	15.7	8.8	11.9	16.7	10.3	9.2	10.8	17.9	8.7	12.5	10.8	14.2	10.2	12.1	4.7	5.5	0.5	3.6	2.3	7.0	2.5	10.3	10.3	9.7	7.4	5.4	9.4	11.7	9.8	7.9	12.4	8.3	10.8	5.4	18.1	9.8	7.8	6.9	12.4	21.6	8.1	16.5	10.2	14.8	14.7	10.5	9.5	9.0	20.7	9.2	8.2	10.3	14.0	14.2	10.2	10.5	8.0	21.5	2.2	10.9	8.5	12.2	15.7	15.0	22.0	12.3	13.4	9.9	12.5	9.3	17.3	12.3	6.8	11.3	12.8	9.3	9.9	12.6	8.5	8.4	10.0	9.1	11.1	13.5	9.6	18.4	21.3	13.2	9.2	9.8	0.0	2.7	0.5	4.0	3.1	6.1	4.1	4.7	3.6	5.4	4.7	7.0	6.5	0.1	2.3	3.6	5.5	3.6	2.5	12.7	19.3	21.0	17.0	11.6	10.7	21.7	12.4	16.3	17.9	8.9	14.4	17.2	29.4	59.2	38.1	20.9	17.8	25.4	30.7	7.0	137.4	21.0	3.3	13.4	16.8	15.8	6.7	0.0	16.6	19.0	17.4	38.4	19.7	15.8	12.5	22.3	15.5	16.5	15.1	4.5	16.1	18.0	15.1	128.0	10.9	11.8	15.0	7.0	12.0	3.7	67.7	6.5	18.9	28.1	31.3	61.4	18.9	13.8	13.4	35.7
NAALAD2	"GCPIII, NAALADASE2"	ENSG00000077616	"N-acetylated alpha-linked acidic dipeptidase 2"	Q9Y3Q0	11	90131515-90192894	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 44.1"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 15.8;Early spermatids: 37.5;Horizontal cells: 66.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	12	"monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 20.0;SH-SY5Y: 6.7;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060820, HPA065419"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060820: AB_2684373, HPA065419: AB_2685487"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.97e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.93e-1)"	7.7	13.0	5.3	1.8	9.9	1.1	3.1	2.1	9.8	7.8	2.1	3.7	2.8	1.3	10.3	5.4	1.8	4.7	3.7	2.5	5.5	7.4	2.7	1.7	2.8	1.6	6.5	5.0	12.9	2.5	0.9	44.1	8.8	11.9	5.2	2.2	5.8	1.9	3.7	2.1	1.5	2.1	3.5	6.2	4.4	1.8	16.6	7.4	0.0	1.7	1.7	1.2	1.8	3.8	0.0	0.1	0.0	2.4	0.0	0.1	0.1	0.1	0.2	1.9	0.1	0.6	0.1	2.4	0.1	0.1	0.1	0.0	20.0	0.7	0.3	0.2	0.0	0.3	0.3	1.4	0.0	0.0	0.0	0.4	1.9	0.4	1.8	0.2	0.1	0.1	2.3	0.0	0.0	0.0	0.6	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.3	1.9	0.5	0.2	0.3	0.0	0.2	0.0	0.0	0.2	6.7	0.0	0.2	0.0	4.9	0.2	0.4	2.6	0.1	1.6	0.4	0.3	1.1	0.3	0.3	0.7	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	5.3	9.9	2.1	9.8	5.5	7.4	6.5	5.0	11.9	7.4	0.0	0.0	0.0	0.1	0.2	15.8	0.8	2.5	0.0	1.2	0.0	0.0	0.8	0.0	0.0	37.5	0.7	0.0	0.0	0.0	0.5	3.4	0.2	0.0	0.0	0.3	66.7	0.0	1.3	5.4	13.2	10.3	0.2	0.0	0.0	0.0	10.1	0.0	0.0	13.8	0.0	2.3	0.0	4.7	0.3	4.4	0.0	0.7	0.0	0.0	0.0
NAB1		ENSG00000138386	"NGFI-A binding protein 1"	Q13506	2	190646746-190692766	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 90.6;Suprabasal keratinocytes: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002738	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"HPA002738: AB_1079447"	"unprognostic (1.44e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.04e-3)"	"unprognostic (9.05e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.52e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.85e-2)"	19.1	10.3	12.1	12.5	13.7	7.6	28.3	28.2	15.7	18.5	19.9	10.4	7.2	7.4	16.2	26.4	32.3	14.1	13.9	21.2	12.1	9.7	10.6	18.6	12.5	13.8	14.5	12.0	15.7	9.3	16.4	20.2	12.8	12.4	16.3	12.9	19.8	15.9	17.5	6.9	33.2	10.9	13.3	14.3	9.3	18.4	12.3	12.4	13.6	19.0	15.7	13.0	13.0	25.8	1.4	1.7	5.4	6.1	4.6	6.0	1.4	12.2	9.1	23.2	8.1	9.1	15.8	40.2	12.5	19.7	9.4	10.8	22.1	13.6	13.7	14.7	9.8	17.6	31.4	13.2	16.1	18.8	43.7	11.2	16.1	32.5	10.5	5.9	6.7	8.1	9.1	25.8	20.0	6.2	13.5	14.6	8.4	15.7	11.8	14.5	6.0	9.7	7.0	8.2	13.2	12.6	12.0	16.7	5.4	7.2	12.0	21.0	17.0	14.7	5.0	13.1	31.0	4.0	10.6	10.1	19.9	15.8	11.2	7.4	9.4	10.1	10.2	21.0	6.2	15.5	0.0	2.6	1.1	2.7	2.0	4.0	1.4	2.8	3.5	1.7	0.9	2.9	3.1	5.4	4.6	6.1	1.6	6.0	1.4	12.1	13.7	28.2	15.7	12.1	9.7	14.5	12.0	12.4	12.4	6.0	23.4	2.2	21.8	90.6	15.9	15.7	17.8	21.4	31.8	12.2	11.8	3.8	3.3	8.7	1.1	28.6	7.3	0.0	6.9	8.3	21.6	24.1	19.7	23.7	6.0	6.4	13.8	35.0	19.5	3.2	12.4	18.1	37.1	6.4	15.0	11.5	7.4	28.8	13.8	3.6	14.1	45.3	59.7	1.4	36.3	121.5	1.0	12.8	13.6	26.5
NAB2	MADER	ENSG00000166886	"NGFI-A binding protein 2"	Q15742	12	57088894-57095476	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004510, HPA027464"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB004510: AB_627982, HPA027464: AB_10601138"	"prognostic favorable (7.41e-4)"	"unprognostic (4.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (5.67e-3)"	"unprognostic (6.19e-3)"	9.5	12.6	11.7	9.9	14.2	4.8	7.9	33.3	20.4	18.7	13.7	5.3	9.6	8.2	22.8	18.9	10.5	15.6	14.5	9.6	8.6	6.8	8.4	18.7	12.8	9.1	4.4	14.6	29.2	8.5	14.5	17.0	13.4	6.8	15.0	4.4	8.5	5.6	14.5	7.1	18.6	7.1	14.5	4.1	8.0	8.2	11.8	7.0	12.4	9.8	7.7	8.6	14.5	26.5	4.2	1.2	0.9	5.4	0.9	2.5	1.2	5.5	3.6	18.9	17.3	17.0	22.3	2.0	16.8	15.2	10.6	8.9	5.8	3.3	3.5	6.9	16.5	3.2	10.1	6.5	12.4	5.7	1.5	1.7	4.2	2.8	5.9	12.9	3.4	10.1	24.7	13.7	12.6	4.3	16.9	2.8	2.6	9.5	3.7	12.3	26.0	5.1	16.3	3.8	4.8	6.3	3.8	24.9	1.8	4.5	2.2	2.1	5.0	8.1	4.7	35.2	5.1	10.6	7.4	3.2	15.7	13.1	11.1	4.9	8.7	2.1	1.8	15.3	2.2	9.4	0.0	2.3	0.3	1.2	5.3	1.4	2.1	2.0	1.5	1.2	4.2	2.5	2.5	0.9	0.9	5.4	0.0	1.9	1.2	11.7	14.2	33.3	20.4	8.6	6.8	4.4	14.6	6.8	7.0	11.9	15.4	9.0	20.1	26.3	18.7	2.4	0.0	1.4	13.6	8.7	2.0	2.7	6.6	7.2	0.4	10.5	2.6	0.0	1.2	8.8	23.4	12.6	16.2	13.0	10.6	9.5	6.3	16.5	13.7	2.1	18.1	18.0	20.3	0.0	0.5	7.5	3.3	0.0	17.7	4.4	3.8	19.4	16.0	1.6	15.0	28.4	47.0	5.1	1.3	8.4
NACA	NACA1	ENSG00000196531	"Nascent polypeptide-associated complex alpha subunit"	"E9PAV3, Q13765"	12	56712428-56731628	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	"Activator, Chaperone, DNA-binding"	Allergen	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA073152, HPA073648"			Approved	Cytosol		NA	Yes			Cytosol		"HPA073152: AB_2686575, HPA073648: AB_2686621"	"unprognostic (3.35e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (4.58e-11)"	"unprognostic (9.47e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.79e-2)"	106.9	85.3	72.2	77.6	63.0	120.7	149.8	71.7	65.5	115.5	89.1	40.5	76.7	57.3	83.3	107.7	142.6	95.2	69.2	111.5	58.9	52.7	79.8	130.1	68.5	148.3	63.7	51.3	213.8	119.9	58.1	61.3	80.8	63.7	112.3	79.7	45.9	95.5	72.9	241.6	124.5	71.2	115.1	74.1	81.9	72.3	53.2	53.8	97.8	109.0	149.1	125.1	144.8	139.1	91.8	101.6	45.4	160.0	66.3	97.4	146.6	78.5	91.5	109.0	86.1	130.5	223.6	108.3	78.8	113.8	107.4	74.8	110.2	87.3	141.4	88.3	73.9	44.3	69.2	96.5	126.6	114.5	69.2	150.1	102.6	64.1	109.6	122.4	144.6	66.2	176.7	162.8	87.2	178.1	193.1	118.5	83.8	127.1	184.9	104.9	76.4	93.4	178.8	111.2	76.1	102.2	106.3	91.9	150.0	149.2	79.8	80.9	87.4	58.5	139.6	121.0	79.5	152.0	166.3	76.7	56.8	69.7	60.3	79.1	88.6	98.6	125.9	83.3	99.2	72.2	33.2	88.1	45.4	58.5	124.6	85.6	91.8	83.4	72.5	94.4	74.6	97.4	83.9	33.2	66.3	160.0	101.6	85.9	146.6	72.2	63.0	71.7	65.5	58.9	52.7	63.7	51.3	63.7	53.8	413.9	563.5	1474.2	1870.1	1800.9	294.5	578.3	937.6	440.3	720.0	375.1	62.8	1562.4	1507.1	1062.8	561.3	1209.8	673.8	420.4	1761.3	2399.9	1079.6	1341.5	713.0	646.1	1391.2	173.2	622.3	710.2	1196.9	484.6	2231.3	1465.0	1175.9	1424.7	1175.0	458.5	1465.8	1052.1	1345.3	1857.7	337.7	789.0	1297.8	499.0	489.8	1950.7	1943.0	1208.8	1657.0	2037.8
NACA2	"MGC71999, NACAL"	ENSG00000253506	"Nascent polypeptide associated complex alpha subunit 2"	Q9H009	17	61590426-61591202	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 76.7"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 120.7;Early spermatids: 304.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 7.7;SK-MEL-30: 4.4"									"HPA073152, HPA073648"			Approved	Cytosol		NA	NA			Cytosol		"HPA073152: AB_2686575, HPA073648: AB_2686621"	"unprognostic (2.37e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.14e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.53e-3)"	"unprognostic (5.45e-3)"	"unprognostic (3.09e-3)"	2.5	2.5	2.4	2.7	2.8	2.2	5.6	2.2	2.8	6.6	2.4	1.0	0.8	2.2	2.1	2.6	5.0	2.2	1.9	3.7	2.2	2.0	4.7	5.5	3.3	6.5	2.2	2.1	9.5	14.3	2.3	2.1	3.6	1.3	3.3	2.1	1.3	2.2	2.0	7.2	2.8	4.1	5.4	2.9	4.2	2.2	76.7	2.8	4.8	4.1	3.2	2.7	6.3	2.4	2.1	1.9	0.7	3.2	1.7	2.0	2.9	0.8	0.0	0.8	0.8	0.3	0.6	2.3	0.2	0.8	0.3	0.5	0.7	0.4	0.0	1.3	0.0	0.3	0.2	0.2	0.2	0.6	0.6	0.2	0.2	0.8	0.8	0.2	0.3	0.8	0.0	0.9	0.0	0.0	0.3	0.4	0.1	0.2	2.6	0.2	0.2	1.1	7.7	1.9	0.1	0.2	1.0	0.5	2.5	0.3	0.1	1.0	1.9	0.5	1.2	4.4	0.0	2.0	2.8	0.0	0.4	1.0	1.5	0.8	0.9	0.7	0.8	1.0	0.5	0.7	0.4	1.4	0.7	1.2	3.2	1.4	2.1	1.6	1.6	1.9	1.8	2.0	1.8	0.4	1.7	3.0	1.8	1.9	2.9	2.4	2.8	2.2	2.8	2.2	2.0	2.2	2.1	1.3	2.8	0.0	0.0	26.2	34.9	61.6	0.7	120.7	33.1	0.0	0.0	1.8	0.0	16.5	72.9	0.3	304.8	29.2	2.8	0.0	0.7	19.1	22.7	38.5	0.0	16.2	12.6	0.0	3.5	22.7	59.5	103.0	31.4	21.0	43.9	0.0	6.5	1.2	0.5	10.5	10.6	5.1	0.8	12.9	44.3	61.4	10.7	69.4	20.1	27.7	11.9	38.7
NACAD	KIAA0363	ENSG00000136274	"NAC alpha domain containing"	O15069	7	45080438-45088914	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.0"	"Cell type enhanced"	"Detected in many"	16	"Horizontal cells: 30.2;Peritubular cells: 11.3"	"Group enriched"	"Detected in many"	7	"glioma: 12.1;testis cancer: 16.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	12	"monocytes: 1.8;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 24.1;SCLC-21H: 18.5;SH-SY5Y: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020981, HPA079208"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020981: AB_2670549, HPA079208: "	"unprognostic (5.54e-6)"	"unprognostic (1.89e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.72e-3)"	"unprognostic (2.72e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	4.7	8.9	11.5	2.7	19.4	1.1	2.1	16.7	45.0	4.8	3.5	43.1	0.1	2.1	6.9	2.3	3.9	4.8	3.7	5.1	16.7	15.9	2.2	1.2	3.0	1.9	30.2	12.9	10.4	2.4	3.2	11.7	3.8	26.7	4.7	2.3	1.1	3.2	5.7	2.0	2.1	2.7	7.4	30.8	2.7	2.5	4.5	21.5	0.0	1.4	0.0	1.5	3.2	2.3	0.1	0.0	0.0	1.8	0.0	1.4	0.1	0.0	0.0	1.8	0.0	1.1	0.5	0.0	2.0	2.5	5.6	3.5	0.1	0.1	0.0	1.6	3.6	24.1	0.1	1.6	1.3	2.0	0.0	0.5	0.0	1.2	0.0	1.3	0.0	0.0	1.2	0.0	2.4	0.2	2.9	1.7	0.0	0.0	2.5	1.4	0.0	0.0	0.0	1.6	0.0	1.5	0.0	0.7	0.0	0.2	0.0	18.5	12.8	0.0	0.0	0.1	5.0	0.0	0.0	0.6	0.0	0.0	0.1	0.3	1.3	0.7	0.0	1.1	0.0	3.7	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.1	11.5	19.4	16.7	24.1	16.7	15.9	30.2	12.9	26.7	21.5	0.0	0.0	0.0	2.7	0.6	5.1	4.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.4	2.0	1.0	0.0	0.0	0.2	0.0	3.8	1.7	1.1	0.0	0.1	30.2	1.2	0.6	0.0	3.6	6.4	0.0	1.7	1.8	0.0	1.9	0.1	0.0	11.3	0.0	1.4	6.5	2.2	1.5	0.6	0.1	0.1	0.0	0.0	0.6
NACC2	"BEND9, BTBD14A, BTBD31, MGC23427"	ENSG00000148411	"NACC family member 2"	Q96BF6	9	136006537-136095285	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 71.6;Late spermatids: 228.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047924, HPA052962"	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA047924: AB_2680212, HPA052962: AB_2681998"	"unprognostic (1.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (8.28e-5)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.12e-2)"	15.3	9.0	27.4	10.9	26.3	2.7	12.8	16.3	37.3	10.0	15.5	14.5	11.7	8.3	11.4	6.9	11.6	10.1	16.6	16.8	20.7	16.7	8.0	15.2	8.3	7.6	30.3	6.4	10.3	10.0	6.2	3.8	3.9	15.2	12.7	5.5	10.2	9.9	23.8	12.6	5.8	9.5	31.7	33.4	7.8	8.2	7.8	11.0	0.0	5.8	4.7	3.1	21.8	4.6	0.0	2.4	5.7	4.5	0.5	1.7	1.4	3.1	17.3	1.9	26.3	8.5	4.8	2.4	7.7	5.2	2.5	0.8	7.3	5.7	0.0	9.3	12.2	4.0	12.4	4.2	4.2	0.8	9.6	3.8	2.1	16.6	9.1	8.7	0.0	4.0	8.0	3.9	2.3	2.3	10.3	6.9	0.0	6.5	0.0	4.8	10.6	0.0	6.0	5.9	5.0	10.8	0.0	2.0	5.2	10.3	3.6	0.7	0.8	10.9	9.2	9.5	9.2	9.3	19.8	11.4	6.7	7.6	5.6	5.3	0.0	0.0	0.1	8.9	0.7	13.4	2.8	4.5	1.5	1.7	3.6	0.7	0.0	0.6	1.5	2.4	0.0	0.5	0.6	5.7	0.5	3.4	0.3	0.4	1.4	27.4	26.3	16.3	17.7	20.7	16.7	30.3	6.4	15.2	11.0	11.9	5.3	1.5	4.0	4.0	2.1	25.0	10.2	1.4	4.5	5.2	0.0	0.6	0.0	10.1	71.6	13.0	6.8	0.0	11.7	1.6	6.4	8.7	2.3	31.1	6.9	3.2	2.4	17.8	38.6	228.0	16.7	10.8	5.0	5.4	4.1	16.7	15.4	8.6	18.0	12.6	1.8	25.8	18.9	1.8	4.5	4.4	0.3	2.9	4.5	7.0
NADK	FLJ13052	ENSG00000008130	"NAD kinase"	O95544	1	1751232-1780457	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.4;monocytes: 24.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048909, HPA053368"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048909: AB_2680553, HPA053368: AB_2682130"	"unprognostic (1.29e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.03e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	24.7	34.3	11.1	19.0	11.9	49.0	25.5	9.9	12.6	12.4	18.2	10.8	14.1	20.3	13.9	14.5	12.5	14.3	17.1	11.9	9.9	7.9	12.7	52.3	17.5	27.0	15.8	8.6	16.9	32.2	8.3	11.9	22.5	10.3	13.7	14.1	13.9	21.4	14.5	10.6	11.7	19.4	14.4	8.3	39.4	22.1	17.3	9.6	10.8	14.0	12.0	19.2	13.7	28.3	1.8	7.2	80.4	24.7	0.5	1.4	10.4	15.1	14.6	13.1	19.2	18.7	13.6	16.9	15.3	13.4	17.5	15.6	15.6	27.9	20.1	11.7	11.3	5.6	12.9	14.0	12.1	7.8	19.5	22.3	16.4	22.9	26.9	18.1	23.0	27.6	15.9	11.0	10.8	15.5	9.5	16.9	16.0	20.1	28.8	13.0	17.3	17.3	20.0	8.9	25.5	16.5	22.0	11.2	41.1	15.1	12.6	17.7	13.5	17.1	37.7	15.7	8.1	12.9	16.1	16.3	12.8	9.2	13.1	13.7	25.7	11.6	45.0	12.6	25.5	6.6	11.8	21.1	49.5	1.2	24.7	1.4	1.8	0.7	0.9	7.2	1.7	0.5	0.7	80.4	0.5	23.8	5.9	1.0	10.4	11.1	11.9	9.9	12.6	9.9	7.9	15.8	8.6	10.3	9.6	11.9	30.7	29.2	12.9	8.8	7.3	5.6	28.1	9.4	18.2	14.0	15.7	22.0	13.3	18.5	13.2	18.0	35.4	23.3	25.3	21.4	15.7	25.2	2.3	80.8	33.4	6.4	21.9	14.7	54.6	20.0	34.8	30.2	8.5	40.5	34.0	5.1	24.7	33.1	32.5	18.2	15.9	12.9	17.0	10.8	20.5	11.2	35.8	13.8	26.2	19.2
NADSYN1	FLJ10631	ENSG00000172890	"NAD synthetase 1"	Q6IA69	11	71453109-71524107	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017798, HPA038523, HPA038524"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			Vesicles	"Golgi apparatus, Cytosol"	"CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (1.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.10e-4)"	14.5	16.9	10.8	23.2	21.2	39.6	14.0	12.2	18.5	12.4	30.6	21.9	24.1	26.3	15.0	17.5	29.1	16.4	33.1	10.6	10.4	9.5	16.5	24.8	18.1	20.5	22.7	9.2	15.6	20.6	13.5	20.2	17.1	15.6	23.9	25.3	12.9	18.0	17.2	9.8	15.0	36.8	13.6	14.6	30.7	19.2	17.4	20.0	26.4	17.3	21.7	29.8	26.1	17.1	9.5	22.3	12.8	19.7	11.9	12.6	13.1	6.1	14.9	4.8	8.8	14.6	21.4	13.3	12.0	10.9	6.3	6.9	12.7	10.5	5.4	13.7	14.1	8.4	22.1	6.3	17.2	3.3	10.9	5.1	8.8	10.0	14.1	18.3	17.6	17.0	30.3	27.1	8.1	7.4	14.4	22.1	9.8	4.5	7.6	8.9	19.3	8.6	11.5	2.9	27.5	8.7	10.8	15.3	5.3	15.5	28.6	3.6	5.2	8.6	11.3	22.0	7.6	10.0	9.6	26.6	7.0	6.0	12.7	4.6	9.8	4.2	4.6	12.3	10.1	4.8	4.5	19.7	11.8	11.7	17.4	9.9	9.5	10.5	10.6	22.3	7.4	7.0	8.8	12.8	11.9	15.1	16.7	12.6	13.1	10.8	21.2	12.2	18.5	10.4	9.5	22.7	9.2	15.6	20.0	20.8	35.4	18.2	14.5	5.6	6.5	6.9	15.3	14.7	18.2	10.4	3.9	14.5	3.3	15.1	16.8	15.8	63.6	23.3	14.9	11.8	10.8	15.4	20.9	14.4	17.4	12.7	22.5	9.2	22.1	49.9	8.6	20.8	8.5	20.8	28.6	6.9	16.9	54.7	9.6	13.9	7.7	12.9	7.8	16.4	4.3	11.2	14.4	21.3	38.6	20.2
NAE1	"APP-BP1, APPBP1, ula-1"	ENSG00000159593	"NEDD8 activating enzyme E1 subunit 1"	Q13564	16	66802875-66873256	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatogonia: 205.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041178, HPA042041"	Enhanced		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA		53000	Nucleoplasm	"Microtubules, Centrosome"	"HPA041178: AB_10964773, HPA042041: AB_10964772"	"unprognostic (3.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (3.92e-8)"	"unprognostic (2.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (9.44e-5)"	"unprognostic (1.97e-1)"	23.6	27.4	25.3	20.2	31.8	27.2	27.3	36.7	41.7	26.0	25.8	24.4	23.7	26.2	27.9	31.0	27.5	23.9	20.2	23.6	25.4	29.0	24.3	25.9	18.3	27.0	27.7	31.9	31.0	26.6	38.8	42.2	26.4	34.9	24.9	30.0	22.1	24.3	23.5	33.2	26.9	27.6	25.4	25.3	18.4	22.2	36.9	25.9	28.9	27.9	28.0	24.9	24.7	22.4	9.4	6.4	6.7	3.2	8.6	19.4	9.4	23.0	17.8	31.8	31.2	12.7	18.1	26.4	17.6	17.9	26.1	31.8	21.6	18.0	25.6	20.2	13.2	16.9	23.4	23.9	21.2	37.1	9.4	27.2	18.1	12.3	33.5	14.6	33.7	22.8	14.7	15.7	20.8	18.3	13.9	18.2	31.2	42.9	9.0	20.1	8.1	35.2	38.6	44.0	18.1	32.2	37.8	37.8	34.1	20.1	20.3	34.2	25.1	52.7	11.3	20.3	20.4	12.1	22.8	14.2	18.3	18.3	19.0	20.3	17.1	26.4	92.1	16.5	22.4	22.1	1.3	3.1	6.7	15.4	3.0	19.4	9.4	16.4	16.6	4.2	7.9	17.8	17.7	1.4	8.6	3.2	6.4	14.0	9.4	25.3	31.8	36.7	41.7	25.4	29.0	27.7	31.9	34.9	25.9	29.8	25.1	24.4	55.4	29.3	47.7	26.2	15.3	37.5	40.9	29.6	11.8	87.4	33.2	58.5	2.8	22.8	26.7	23.3	52.6	55.3	37.2	37.1	33.6	18.8	25.1	47.7	22.0	20.9	11.6	10.1	45.1	15.5	47.2	33.3	27.8	58.9	51.8	82.6	50.9	40.7	33.6	19.4	49.5	120.6	205.2	28.1	43.8	31.6	33.7	41.4
NAGK	GNK	ENSG00000124357	"N-acetylglucosamine kinase"	Q9UJ70	2	71064344-71079805	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 191.3;Syncytiotrophoblasts: 266.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035206, HPA035207"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		690000	Cytosol	Nucleoplasm	"HPA035206: AB_2674517, HPA035207: AB_10602031"	"unprognostic (6.15e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.44e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (8.60e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.13e-2)"	20.0	17.6	21.8	30.9	24.5	9.8	15.7	13.9	18.8	23.6	15.5	23.7	17.4	11.4	16.4	19.7	67.0	13.7	20.0	14.0	17.6	20.4	16.9	20.2	18.3	30.6	31.1	20.3	15.0	25.8	27.5	21.8	43.9	26.2	15.8	15.8	14.7	49.0	17.8	11.3	29.5	14.6	22.8	21.6	43.4	15.5	24.8	26.7	20.2	13.0	27.2	39.9	24.5	26.1	14.3	53.0	37.4	79.3	8.5	7.1	52.2	19.0	15.5	8.7	8.9	34.8	21.3	34.3	42.5	18.4	28.5	25.9	18.1	10.0	10.6	10.1	29.4	33.6	9.2	6.6	12.6	17.7	15.1	5.2	6.0	5.1	11.2	26.1	3.7	15.2	19.0	13.2	30.6	4.8	20.6	29.9	9.3	2.7	12.0	39.4	17.4	9.4	13.3	9.3	15.2	12.0	7.4	24.4	5.4	17.2	34.1	9.0	5.0	12.8	20.2	13.3	15.6	10.5	4.8	26.2	34.0	13.2	13.1	14.8	8.4	7.3	6.2	23.2	10.2	18.6	10.3	79.3	31.5	5.4	69.8	5.5	14.3	6.4	5.2	53.0	13.3	5.5	4.5	37.4	8.5	46.6	42.4	7.1	52.2	21.8	24.5	13.9	18.8	17.6	20.4	31.1	20.3	26.2	26.7	35.7	38.8	52.2	25.0	23.9	42.8	14.8	22.9	24.1	28.4	36.6	21.6	111.0	34.9	60.8	114.8	28.1	13.8	0.0	39.8	106.9	36.8	15.4	49.8	12.1	191.3	44.5	22.4	30.7	107.2	16.6	27.9	97.6	37.1	45.1	18.1	42.9	52.7	22.6	35.3	46.9	53.5	19.4	33.0	33.7	22.6	36.4	266.6	23.8	13.8	37.2
NAIF1	"bA379C10.2, C9orf90, DKFZp762G199"	ENSG00000171169	"Nuclear apoptosis inducing factor 1"	Q69YI7	9	128061233-128068206	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054898, HPA064931"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054898: AB_2682633, HPA064931: AB_2732725"	"unprognostic (7.09e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.60e-1)"	"unprognostic (6.15e-2)"	"unprognostic (9.41e-2)"	"prognostic favorable (1.02e-5)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.30e-5)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.92e-2)"	7.1	7.2	4.5	5.1	4.5	11.3	10.3	5.6	5.5	6.0	4.5	2.4	10.9	6.0	6.3	5.1	7.1	5.4	6.6	7.4	5.5	3.4	5.2	8.3	9.3	8.3	3.8	4.2	5.4	7.3	3.4	4.5	7.3	5.3	6.0	3.7	5.5	6.5	9.5	7.1	5.5	6.2	5.2	4.8	9.0	5.5	15.6	2.9	12.5	6.2	6.1	7.8	5.5	16.3	3.4	2.2	4.5	3.0	1.6	3.4	1.5	4.8	4.2	2.7	6.9	2.5	2.3	6.1	3.7	2.2	3.2	2.6	3.3	3.9	5.9	3.3	2.3	4.5	3.6	2.8	2.8	2.6	18.0	3.7	4.4	5.0	1.9	4.2	6.0	12.4	2.1	3.4	2.4	4.0	2.5	2.9	6.7	10.3	3.8	2.9	5.6	5.8	7.3	2.9	6.6	7.2	5.6	4.3	5.3	2.4	3.0	3.9	4.5	3.6	5.1	3.8	2.0	3.9	6.0	1.9	3.8	11.9	3.1	4.2	6.2	12.9	3.9	3.6	3.9	5.0	0.0	2.2	3.3	1.7	2.0	1.4	1.1	3.4	2.5	2.2	3.4	2.6	2.2	4.5	1.6	3.0	1.7	0.9	1.5	4.5	4.5	5.6	5.5	5.5	3.4	3.8	4.2	5.3	2.9	0.0	4.0	8.8	4.0	4.2	3.3	3.9	5.1	0.0	2.3	5.2	0.0	5.0	3.3	3.1	5.9	4.7	5.1	0.0	5.8	5.0	3.3	3.0	8.1	2.4	4.8	9.5	5.2	5.5	4.7	9.2	5.8	4.4	0.0	4.6	2.5	4.1	3.4	4.0	2.8	3.4	5.0	0.0	3.3	10.8	7.6	3.3	3.9	7.2	3.1	2.0
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 597.4;Macrophages: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	19.2	12.9	4.6	7.8	19.7	23.0	7.6	6.1	34.6	12.4	21.9	7.6	11.7	16.1	14.7	6.8	37.2	15.2	8.6	18.4	27.2	9.5	9.2	6.5	5.5	5.9	73.7	12.6	12.1	21.9	21.1	22.2	26.0	18.6	39.5	8.0	13.6	62.0	14.8	10.1	12.6	5.3	9.0	12.2	10.4	6.0	6.6	35.5	11.8	18.2	9.5	5.2	8.6	18.8	21.8	13.4	6.0	3.6	33.6	18.5	14.3	26.5	11.2	42.7	24.2	23.3	110.0	14.3	27.4	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1	122.1	246.8	48.1	258.1	184.4	22.1	87.9	163.1	104.4	177.5	40.1	11.8	23.8	39.7	250.8	6.3	173.0	92.2	0.0	120.5	44.2	117.9	276.9	178.5	597.4	98.8	38.1	24.1	141.8	340.8	4.5	37.4	479.6	153.5	65.9	46.4	19.5	161.8	35.1	29.4	36.0	28.4	25.8	234.9	14.9	57.9	181.7	21.2	41.5	63.9	273.8
NANP	"C20orf147, dJ694B14.3, HDHD4, MGC26833"	ENSG00000170191	"N-acetylneuraminic acid phosphatase"	Q8TBE9	20	25612935-25624175	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050342	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA050342: AB_2681098"	"unprognostic (8.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (6.01e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.01e-6)"	"unprognostic (3.20e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.42e-2)"	10.0	14.0	6.3	6.0	7.4	6.9	7.2	13.3	8.2	6.3	6.4	4.1	4.3	7.1	6.9	5.7	9.5	6.2	6.2	6.8	4.3	4.8	11.6	12.5	6.7	4.4	4.2	3.3	12.0	7.4	8.0	8.6	6.0	6.5	5.6	6.2	7.1	7.8	6.1	9.2	4.9	7.6	6.9	5.6	7.1	6.2	6.6	3.7	18.2	9.0	6.0	6.8	7.4	6.8	1.7	6.4	1.7	4.5	4.9	4.2	2.3	11.1	6.5	5.3	7.7	8.6	9.2	7.8	5.7	11.2	7.6	9.8	5.9	7.7	4.0	6.5	10.8	9.0	7.1	8.1	8.2	14.8	1.4	4.8	10.0	3.1	15.7	7.2	7.6	3.0	8.0	4.1	8.5	10.9	4.2	6.4	13.8	8.4	7.2	9.2	6.1	15.0	3.8	3.9	9.7	10.2	7.5	11.2	4.9	4.4	6.0	10.2	4.2	6.3	10.2	6.7	5.6	4.4	6.5	5.4	12.1	9.0	11.1	8.0	3.8	3.5	10.0	3.4	17.7	7.2	0.4	4.5	1.7	2.8	4.5	4.2	1.4	2.0	2.1	6.4	1.7	1.8	3.1	0.3	4.9	2.4	1.4	1.7	2.3	6.3	7.4	13.3	8.2	4.3	4.8	4.2	3.3	6.5	3.7	3.0	1.0	1.5	3.4	5.3	4.6	3.1	5.1	0.0	2.3	7.0	0.0	3.4	11.6	4.4	0.3	4.5	1.3	0.0	3.7	1.6	4.6	2.4	5.7	4.9	3.9	6.4	2.9	4.3	2.5	0.0	2.8	3.7	5.0	1.0	2.6	5.6	4.4	2.0	2.5	7.1	6.8	0.0	3.9	2.6	10.7	4.4	1.6	1.5	2.5	2.3
NAP1L3	"MB20, MGC26312, NPL3"	ENSG00000186310	"Nucleosome assembly protein 1 like 3"	Q99457	X	93670930-93673568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.2"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 38.8;Horizontal cells: 58.8;Peritubular cells: 18.4"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 6.9"	"Group enriched"	"Detected in many"	24	"NK-cells: 4.5;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.9;HAP1: 9.5;NTERA-2: 17.4;SuSa: 15.8;U-2197: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026075			Approved	Vesicles		NA	NA			Vesicles		"HPA026075: AB_1854301"	"unprognostic (7.18e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.83e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.23e-4)"	2.3	10.4	24.4	2.4	25.7	1.2	2.4	44.9	60.2	16.0	2.4	5.3	0.0	1.6	9.5	4.7	1.5	8.1	4.4	8.4	22.0	42.3	2.9	1.4	1.8	2.1	18.5	31.0	13.1	1.5	1.1	7.9	1.6	20.9	3.9	2.3	2.4	1.6	4.6	0.8	1.7	2.0	6.5	13.1	3.6	1.4	11.9	7.0	0.0	4.6	0.0	1.5	3.3	1.2	0.0	0.0	0.2	0.0	4.5	6.9	1.6	0.0	0.1	9.9	7.2	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.4	0.2	0.0	9.5	0.0	0.0	0.0	0.2	4.5	0.0	0.1	0.5	0.0	0.3	4.5	0.0	0.5	4.6	0.0	0.0	4.9	0.0	0.0	0.5	0.0	0.0	0.0	17.4	0.0	4.1	0.0	7.7	0.0	0.3	0.0	0.1	1.0	0.0	0.0	0.1	15.8	0.0	0.5	0.0	5.5	8.0	11.7	0.4	7.5	3.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.1	0.0	4.3	1.6	0.0	0.0	6.9	4.8	0.2	4.5	0.0	0.0	1.3	1.6	24.4	25.7	44.9	60.2	22.0	42.3	18.5	31.0	20.9	7.0	0.0	0.0	0.0	0.2	0.6	38.8	7.3	0.0	2.7	1.2	0.0	5.9	0.2	14.9	0.0	0.8	0.7	0.0	0.0	0.0	0.1	6.6	0.0	5.7	0.0	0.3	58.8	0.0	1.8	0.0	1.7	10.9	0.0	5.0	0.0	0.0	14.5	0.3	0.0	18.4	0.3	11.1	0.0	3.4	2.2	6.9	0.4	0.2	0.0	0.0	0.0
NAP1L5	DRLM	ENSG00000177432	"Nucleosome assembly protein 1 like 5"	Q96NT1	4	88695915-88697829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.4"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 32.4;granulocytes: 31.1;Muller glia cells: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 29.5"	"Low region specificity"	"Detected in all"							HPA058227	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA058227: AB_2683644"	"unprognostic (1.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.39e-1)"	7.3	21.8	24.5	3.6	23.3	4.9	4.9	25.8	53.4	6.2	3.1	4.2	2.1	1.9	6.4	10.5	4.1	4.9	5.4	5.6	23.9	52.8	6.1	5.0	3.1	3.0	28.4	33.6	8.2	2.8	7.9	12.9	4.7	35.6	6.7	3.1	3.6	2.5	8.7	1.8	1.7	2.4	6.4	11.5	3.5	2.8	4.9	5.4	0.5	9.3	1.3	2.4	5.2	2.0	0.7	0.9	0.6	0.8	1.5	3.9	1.0	0.0	1.1	7.3	4.4	10.7	6.9	0.0	7.8	4.8	4.0	6.3	0.0	0.9	0.0	3.2	4.5	1.7	1.5	12.9	3.1	7.3	2.4	0.0	13.5	4.7	1.1	9.3	6.9	8.9	10.8	1.0	4.7	0.7	5.2	7.1	7.6	3.8	0.0	11.8	0.1	8.5	0.5	3.0	3.7	0.0	4.6	2.1	0.8	2.7	3.3	9.7	29.5	0.0	1.4	5.7	8.2	0.0	2.0	5.1	4.6	1.1	2.9	3.9	2.0	0.0	0.0	9.8	0.0	3.5	0.0	0.2	0.4	3.9	0.4	2.6	0.0	1.9	3.0	0.9	0.7	3.5	3.3	0.6	1.5	0.8	0.7	1.7	1.0	24.5	23.3	25.8	41.9	23.9	52.8	28.4	33.6	35.6	5.4	3.0	7.0	2.4	3.4	1.5	32.4	4.8	0.0	1.4	6.8	5.2	13.7	12.6	13.3	1.7	0.6	5.4	0.0	0.0	2.2	1.6	8.5	2.9	31.1	2.9	4.8	14.3	16.6	10.4	0.0	0.4	10.0	1.2	5.0	2.8	1.4	32.8	1.0	0.2	17.0	3.4	17.3	19.4	9.8	5.6	2.1	1.3	18.5	7.9	0.9	1.7
NAPEPLD	"C7orf18, FMP30, NAPE-PLD"	ENSG00000161048	"N-acyl phosphatidylethanolamine phospholipase D"	Q6IQ20	7	103099776-103149560	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 74.1;Early spermatids: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019832, HPA024338"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA019832: AB_1844422, HPA024338: AB_2671533"	"unprognostic (3.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.32e-6)"	"unprognostic (8.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.41e-2)"	3.8	5.3	8.6	3.8	14.0	3.1	3.9	13.9	18.5	5.1	8.8	17.2	3.7	15.9	4.9	3.5	2.6	6.5	6.1	4.2	6.4	5.5	15.1	7.4	4.3	3.8	15.0	11.6	9.7	4.1	8.5	6.2	2.9	10.3	5.4	10.1	5.0	4.2	4.1	5.0	5.7	10.8	4.5	9.7	6.6	11.2	11.1	16.7	5.3	8.8	0.9	3.8	6.9	4.6	7.9	3.7	5.7	4.6	2.9	7.6	2.5	4.6	6.2	4.0	3.6	3.6	3.9	0.6	3.0	2.8	2.1	3.4	2.7	6.2	4.2	5.1	2.3	4.7	4.3	2.8	1.0	2.5	6.5	3.9	1.7	3.7	1.2	0.9	3.7	1.8	2.2	1.2	1.9	0.0	7.8	3.4	3.0	2.0	4.5	4.0	1.7	4.4	2.0	3.7	7.3	7.3	2.8	1.8	2.2	7.6	2.1	2.9	3.9	8.2	2.6	1.8	2.2	1.7	2.1	3.0	5.9	4.2	12.0	3.7	5.6	6.1	3.6	4.2	2.7	11.3	0.2	3.1	5.7	4.9	4.6	4.4	7.4	5.3	5.8	3.7	7.9	7.6	5.6	0.3	2.9	3.0	2.7	4.7	2.5	8.6	14.0	13.9	18.5	6.4	5.5	15.0	11.6	10.3	16.7	17.9	7.7	9.8	4.8	6.0	74.1	10.2	20.4	1.4	6.8	50.6	49.1	7.3	8.3	4.4	112.3	2.9	30.7	0.0	2.3	3.1	4.6	8.5	4.6	18.4	3.5	47.7	13.3	4.9	3.5	31.4	29.4	2.7	13.5	4.6	26.3	21.0	3.7	28.6	31.5	26.7	34.0	6.5	2.3	14.6	10.9	2.5	2.4	4.3	23.0	5.5
NAPG		ENSG00000134265	"NSF attachment protein gamma"	Q99747	18	10525905-10552761	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008208, HPA011389"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA008208: AB_1854305, HPA011389: AB_1854306"	"unprognostic (1.23e-1)"	"unprognostic (7.64e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.46e-3)"	"unprognostic (5.85e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.96e-2)"	11.0	14.0	20.5	9.1	31.2	6.1	12.1	24.0	40.2	11.6	11.6	17.8	4.9	9.3	11.0	12.7	12.3	11.3	13.5	19.3	26.3	20.8	16.9	13.3	9.6	8.7	24.1	21.4	7.6	12.4	12.8	10.5	13.7	54.1	14.3	14.1	10.1	10.7	11.6	9.0	8.8	10.3	12.5	25.2	8.5	13.4	7.1	11.9	6.9	14.8	8.2	10.6	12.6	8.7	8.4	4.7	15.2	7.1	6.6	7.1	3.6	5.0	3.0	5.3	4.6	15.2	10.5	7.7	10.7	15.4	10.5	13.4	6.6	7.6	6.7	8.6	14.6	9.6	4.9	7.0	9.7	15.1	5.7	4.3	4.9	5.3	6.8	14.6	13.5	9.2	11.0	11.2	12.0	9.0	6.9	9.8	8.7	7.9	16.0	15.3	7.0	10.4	5.8	4.1	38.5	4.5	4.6	8.8	11.2	12.3	11.9	21.2	5.6	8.7	9.3	12.3	9.0	4.2	9.0	11.0	16.6	8.0	15.2	11.3	10.3	10.5	7.4	11.1	9.5	7.6	11.3	5.7	15.2	6.5	7.1	5.8	8.4	5.2	6.3	4.2	4.1	7.1	6.1	9.7	6.6	6.9	4.7	5.1	3.6	20.5	31.2	24.0	40.2	26.3	20.8	24.1	21.4	54.1	11.9	26.8	26.7	24.1	23.8	21.6	62.1	30.5	22.9	17.4	22.7	26.2	11.8	20.2	34.9	43.8	12.0	21.5	22.5	0.0	37.3	25.1	18.2	29.7	43.9	18.8	22.3	42.9	22.5	17.2	23.1	2.1	7.2	19.7	25.3	19.8	17.1	28.2	53.8	34.5	19.8	31.9	31.3	25.8	21.7	12.7	37.9	18.4	37.8	20.1	14.3	46.1
NAPRT	"NAPRT1, PP3856"	ENSG00000147813	"Nicotinate phosphoribosyltransferase"	Q6XQN6	8	143574785-143578649	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Ligase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.3;SK-BR-3: 23.9;U-937: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023739, HPA024017, CAB068206, CAB068207"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		2000000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309"	"unprognostic (7.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-2)"	9.7	6.4	4.9	9.7	6.2	21.1	13.2	10.7	5.4	6.7	25.2	2.3	9.9	33.0	4.7	4.7	16.4	4.8	15.5	4.9	3.9	2.1	10.7	28.3	8.3	12.1	3.7	0.1	5.9	6.5	2.4	2.8	8.6	4.1	6.9	3.8	5.2	12.8	3.8	7.1	12.4	34.4	5.2	2.2	9.8	11.8	5.5	4.0	3.0	6.8	8.9	9.5	7.6	8.1	0.8	4.7	4.6	8.4	0.5	1.6	2.4	3.4	4.0	0.4	0.8	0.3	1.2	2.6	0.8	0.4	1.3	0.8	3.3	22.3	0.9	6.3	0.2	0.0	7.7	0.2	6.3	0.0	4.1	6.4	5.3	10.5	0.9	2.8	1.3	2.8	0.1	2.2	0.1	0.0	0.0	1.4	4.4	4.9	4.1	0.1	4.3	2.6	2.7	1.0	4.7	2.5	4.6	0.1	11.0	0.9	1.3	1.8	0.4	10.0	23.9	3.0	0.1	0.9	3.1	4.2	0.7	6.4	4.7	1.7	0.5	0.2	1.1	1.1	18.5	3.3	0.0	4.4	4.6	1.6	8.4	0.5	0.8	0.7	1.5	4.7	0.2	0.8	0.7	2.7	0.5	8.4	1.5	0.2	2.4	4.9	6.2	10.7	5.4	3.9	2.1	3.7	0.1	4.1	4.0	32.8	29.7	8.2	53.6	0.0	11.6	7.8	50.9	2.7	17.0	71.5	17.7	41.1	58.0	56.8	30.9	28.6	149.9	23.3	48.4	46.0	12.4	35.0	7.0	99.2	70.9	15.9	10.5	37.4	86.2	46.4	29.7	44.6	0.0	92.0	73.3	27.1	82.3	117.4	20.5	160.6	12.5	12.9	11.5	15.6	17.6	0.0	47.0	17.5	111.6	67.7
NARF	"DKFZp434G0420, FLJ10067, IOP2"	ENSG00000141562	"Nuclear prelamin A recognition factor"	Q9UHQ1	17	82458180-82490537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 375.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053006			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA053006: AB_2682013"	"unprognostic (1.84e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (1.48e-10)"	"unprognostic (3.57e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.83e-2)"	13.7	10.6	21.2	15.7	20.2	35.0	17.4	24.2	23.5	8.2	13.1	10.1	11.1	13.8	9.5	11.0	13.1	11.2	10.6	28.5	15.7	12.3	10.1	21.3	11.8	15.1	16.4	15.0	11.2	13.8	9.0	11.9	10.2	16.3	10.9	9.0	14.7	13.6	12.0	44.4	15.4	11.0	9.8	10.6	17.7	13.6	35.4	18.1	12.4	11.7	11.2	11.5	11.7	12.4	11.6	10.1	50.6	10.6	15.9	13.6	11.5	8.7	8.2	14.0	22.1	6.6	6.5	7.9	5.2	5.5	9.0	9.3	9.5	3.1	5.6	5.9	4.2	10.3	7.8	10.2	6.6	6.2	5.9	22.7	11.8	11.8	11.7	5.9	12.0	21.0	9.7	11.0	7.1	2.4	9.1	17.0	18.5	26.8	4.2	4.0	7.5	21.0	19.4	5.9	6.8	17.9	17.5	14.2	8.9	4.2	9.1	17.1	24.3	13.7	9.3	16.0	9.5	8.0	9.8	8.5	11.7	10.0	9.6	8.9	38.7	14.6	12.4	10.7	8.5	6.9	24.4	10.6	29.5	11.6	9.4	12.7	11.6	11.4	11.2	10.1	11.0	13.1	10.9	50.6	15.9	7.0	8.3	13.6	11.5	21.2	20.2	24.2	23.5	15.7	12.3	16.4	15.0	16.3	18.1	11.9	21.0	45.4	29.2	33.2	32.8	37.2	17.8	30.8	12.5	5.2	51.1	27.5	33.2	47.7	143.2	38.3	36.0	93.5	57.8	48.2	29.1	28.2	52.9	17.3	29.6	47.7	54.6	43.0	21.3	375.7	23.3	29.7	59.1	68.5	24.8	23.0	67.6	26.0	17.0	18.3	34.2	12.9	37.1	136.6	75.4	30.9	25.6	45.7	31.0	25.5
NARFL	"FLJ21988, HPRN, IOP1, NAR1, PRN"	ENSG00000103245	"Nuclear prelamin A recognition factor like"	Q9H6Q4	16	729753-741329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040851	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA040851: AB_10794427"	"unprognostic (6.31e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (7.61e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (9.83e-5)"	"unprognostic (2.49e-2)"	"unprognostic (8.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.33e-3)"	10.2	11.9	16.4	15.3	19.7	15.0	10.3	21.8	28.8	10.0	12.6	21.6	21.1	20.9	11.1	19.2	15.2	13.7	10.6	20.9	18.1	14.2	16.1	17.6	9.1	16.2	15.1	9.8	11.3	18.4	18.5	13.1	11.1	16.7	15.7	8.1	14.3	25.4	17.5	24.1	14.9	15.5	8.7	14.1	15.0	14.5	8.7	13.1	18.4	12.6	13.7	18.9	11.7	11.3	16.0	11.8	8.3	10.9	13.9	12.9	9.4	3.5	10.5	4.2	6.0	4.4	3.1	10.1	5.1	3.8	7.2	6.2	7.4	8.9	5.1	7.9	3.2	5.2	8.1	4.1	6.2	2.6	9.4	9.3	4.3	6.0	6.0	5.6	7.6	6.2	3.8	7.8	4.2	3.5	4.7	5.2	20.5	7.9	4.9	3.5	13.2	6.8	3.5	3.4	7.3	6.7	56.0	6.3	9.2	4.3	3.6	4.8	6.6	6.1	14.7	5.2	2.6	13.4	7.7	5.6	6.0	5.6	6.6	4.5	6.4	4.5	14.1	4.1	4.3	7.7	2.7	10.9	8.3	11.5	9.9	8.9	16.0	11.7	9.5	11.8	10.5	9.5	12.9	2.3	13.9	10.6	9.5	11.1	9.4	16.4	19.7	21.8	28.8	18.1	14.2	15.1	9.8	16.7	13.1	6.0	6.4	14.5	7.7	4.9	20.9	9.7	7.6	5.3	5.7	14.0	13.7	17.8	6.6	15.0	1.0	7.2	23.1	0.0	13.6	10.0	4.7	8.1	15.0	5.9	13.5	36.5	7.5	4.9	9.5	1.9	9.5	7.2	10.1	29.7	16.3	14.6	10.4	15.0	9.9	11.3	16.3	12.9	4.7	11.3	8.9	5.3	11.9	8.7	15.0	7.0
NAT14	KLP1	ENSG00000090971	"N-acetyltransferase 14 (putative)"	Q8WUY8	19	55485004-55487568	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 42.2"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 60.2;Horizontal cells: 139.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047187			Approved	Mitochondria		NA	NA			Mitochondria		"HPA047187: AB_2679974"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (7.00e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.58e-1)"	3.6	10.1	15.8	5.7	19.6	4.5	5.5	25.8	25.8	8.2	7.0	8.9	3.1	3.5	12.6	10.1	2.9	24.1	6.5	5.9	15.4	16.7	9.2	2.5	7.8	4.6	10.8	15.5	14.1	5.6	11.2	19.2	8.5	10.6	6.8	3.1	7.8	5.0	10.5	2.9	4.1	3.4	11.1	6.5	3.7	5.6	4.9	9.5	42.2	9.8	1.3	3.8	6.0	4.3	1.8	1.8	2.3	0.3	0.3	1.0	0.6	2.4	8.9	9.8	18.1	4.1	5.1	6.2	9.2	10.7	10.1	14.4	3.1	7.9	1.0	3.2	5.9	5.0	3.3	6.4	5.6	6.2	9.9	55.3	8.0	11.9	6.7	7.4	5.9	8.1	7.3	2.1	7.4	1.9	19.9	7.3	14.5	9.9	2.8	5.8	3.0	9.9	9.0	14.0	4.7	4.9	9.8	6.3	3.6	23.0	4.6	30.3	20.6	3.7	5.4	8.1	3.8	4.4	5.7	8.8	3.7	10.2	0.5	7.3	5.7	2.3	4.2	8.2	1.0	9.2	0.0	0.3	0.2	0.5	0.3	1.0	0.6	0.4	0.3	0.0	1.8	0.7	0.7	2.3	0.3	0.3	1.8	0.0	0.6	15.8	19.6	25.8	25.8	15.4	16.7	10.8	15.5	10.6	9.5	6.0	2.7	7.3	6.1	2.6	60.2	4.5	2.5	14.7	2.3	27.9	33.4	10.6	13.3	14.0	1.4	4.3	0.7	0.0	1.0	6.9	8.2	4.4	0.0	2.9	2.6	139.8	12.2	4.9	0.8	1.7	10.9	0.7	5.0	3.6	1.8	34.9	4.7	0.0	9.9	3.5	34.0	0.0	9.2	4.1	2.9	0.5	5.0	1.3	0.9	1.4
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170493-101180276	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6"	"Cell type enriched"	"Detected in some"	45	"Horizontal cells: 276.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Group enriched"	"Detected in many"	4	"amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4"									HPA021918	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6.0	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0.0	4.6	0.0	0.0	0.1	0.0	1.2	0.7	2.2	0.6	1.3	0.8	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.3	0.5	0.5	0.1	0.1	0.8	0.0	0.6	0.2	0.1	4.6	0.1	0.5	0.1	6.9	0.0	0.3	5.2	0.5	0.3	0.0	0.0	0.4	6.1	0.5	0.1	0.1	0.0	0.1	3.4	0.0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0.0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2	0.0	0.0	0.0	0.0	0.0	1.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640832-73642393	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 140.4"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 1951.9"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 16.9"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	140.4	15.8	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	1.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	16.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	159.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.0	22.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1951.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NAT8L	"FLJ37478, Hcml3"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059512-2069089	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 45.9;brain: 45.9;testis: 11.8"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 76.3;Muller glia cells: 25.6"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.7;SCLC-21H: 19.0;SK-MEL-30: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	45.9	2.0	23.5	1.3	28.3	1.2	7.9	16.4	45.9	1.2	1.5	7.4	0.3	1.3	1.6	2.8	1.3	2.4	1.3	2.1	20.8	12.9	8.2	1.2	1.2	1.4	16.4	12.6	1.4	3.9	1.2	5.6	1.3	12.8	2.4	1.3	1.2	3.8	3.2	7.3	2.4	1.5	1.4	6.5	1.5	1.6	11.8	8.2	0.0	1.6	0.0	1.2	1.2	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	6.6	3.6	7.3	0.7	0.0	4.2	0.1	0.0	0.2	0.0	2.9	0.2	0.0	1.3	0.0	1.1	0.1	8.2	0.0	0.1	0.0	9.6	0.1	1.4	4.7	1.2	10.1	5.0	0.0	0.1	0.0	0.0	1.4	0.0	2.5	7.8	0.0	0.3	4.4	0.1	14.7	10.3	0.0	3.0	0.5	1.7	0.2	0.1	0.3	19.0	6.3	4.8	0.0	15.1	0.6	0.5	5.9	0.0	0.0	2.5	0.1	3.9	0.0	0.0	0.1	0.0	4.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	23.5	28.3	16.4	32.7	20.8	12.9	16.4	12.6	12.8	8.2	0.0	0.0	0.0	0.0	0.2	7.1	2.0	0.0	0.0	0.0	1.8	5.9	0.0	0.0	4.2	0.8	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.7	76.3	1.7	0.0	0.0	3.1	0.0	0.1	10.1	0.0	0.0	25.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0
NAT9	DKFZP564C103	ENSG00000109065	"N-acetyltransferase 9 (putative)"	Q9BTE0	17	74770547-74776367	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021820, HPA057149"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021820: AB_1847958, HPA057149: AB_2683350"	"unprognostic (7.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.26e-6)"	"prognostic favorable (7.80e-4)"	"unprognostic (8.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.03e-3)"	9.4	31.6	20.1	11.3	17.8	11.8	13.5	20.0	20.6	13.6	11.2	9.9	21.7	8.0	11.6	24.5	9.1	16.8	12.9	11.3	18.4	12.1	12.9	16.6	10.5	12.0	18.1	17.8	21.5	14.5	18.5	25.1	13.8	23.1	15.8	9.9	11.6	18.1	13.2	9.5	10.9	8.5	11.2	17.0	12.1	11.2	12.2	20.7	7.9	14.9	7.0	10.8	11.3	10.3	19.6	13.7	9.7	16.7	10.9	21.5	8.4	9.5	13.9	8.9	8.1	14.6	18.3	10.7	18.1	16.2	19.4	16.8	24.0	10.6	26.1	7.0	14.5	12.5	10.5	12.0	20.1	12.5	5.4	18.0	16.7	10.3	21.3	17.0	8.6	10.8	16.7	15.0	19.3	29.5	16.2	21.1	16.9	20.8	8.3	14.1	9.1	17.2	7.0	6.9	18.6	20.4	11.5	26.2	15.1	14.0	15.6	12.8	17.1	7.6	22.5	35.1	12.8	20.9	11.6	12.1	22.4	18.2	9.7	17.1	11.5	4.1	14.6	9.3	5.9	14.2	9.7	11.5	4.6	6.9	16.7	13.7	14.0	12.3	10.1	13.7	19.6	21.5	15.5	2.9	10.9	9.4	10.3	6.5	8.4	20.1	17.8	20.0	20.6	18.4	12.1	18.1	17.8	23.1	20.7	6.0	12.6	22.2	30.8	31.1	35.9	5.0	5.1	5.3	6.8	17.4	45.2	18.9	6.6	13.9	4.5	17.4	10.0	0.0	17.0	16.5	18.5	26.9	1.1	8.5	15.7	42.9	25.3	7.4	8.3	2.9	27.3	15.2	10.1	19.0	12.9	12.4	16.5	16.9	15.9	9.8	39.2	6.5	18.6	17.9	24.3	26.0	18.5	12.9	16.4	31.4
NAV1	"DKFZp781D0314, FLJ12560, FLJ14203, KIAA1151, MGC14961, POMFIL3, steerin-1"	ENSG00000134369	"Neuron navigator 1"	Q8NEY1	1	201622885-201826969	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 47.0;Intestinal endocrine cells: 50.7;monocytes: 100.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.2;myeloid DC: 4.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.4;granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"TIME: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012302, HPA018127, HPA027887"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"CAB012302: AB_776716, HPA018127: AB_1854317, HPA027887: AB_10601040"	"unprognostic (2.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (3.45e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	17.0	4.3	28.4	10.9	20.6	2.3	12.0	6.9	27.4	8.8	9.4	26.7	1.6	5.3	8.5	6.5	9.5	6.0	10.5	20.1	22.4	11.8	4.5	3.0	9.1	5.4	14.9	20.5	4.2	5.5	9.0	5.6	16.1	16.8	7.4	7.9	6.0	10.3	10.1	6.1	8.8	5.2	14.4	17.8	4.9	7.6	9.6	21.8	0.5	8.6	4.9	5.2	11.1	12.3	0.7	4.4	6.2	1.0	0.3	0.6	0.5	0.4	0.8	8.6	1.1	25.8	21.4	15.5	13.0	12.7	10.6	9.3	0.0	4.6	0.1	0.2	17.8	5.8	6.3	6.5	4.3	8.6	0.7	0.9	0.4	1.6	0.0	6.9	0.0	5.7	9.3	1.6	18.7	10.9	28.6	23.8	0.5	0.2	0.7	8.8	0.1	0.0	0.0	12.6	0.2	0.5	1.1	19.4	2.6	1.4	1.2	6.6	1.3	3.2	14.1	4.5	6.0	0.1	0.3	54.9	16.5	3.4	16.3	11.3	2.4	0.6	0.0	17.9	1.7	14.0	6.2	1.0	0.3	0.4	0.8	0.3	0.6	0.5	0.1	4.4	0.7	0.6	0.3	0.1	0.3	0.7	1.2	0.0	0.5	28.4	20.6	6.9	22.8	22.4	11.8	14.9	20.5	16.8	21.8	3.0	1.0	1.5	2.0	9.7	32.4	31.9	2.5	4.0	2.3	12.2	0.0	12.0	0.0	11.5	1.7	21.8	1.4	0.0	7.3	47.0	16.2	1.6	16.3	0.9	12.7	23.8	50.7	28.3	11.3	2.2	10.0	8.8	21.9	100.0	3.0	12.9	16.4	3.5	0.7	0.6	3.7	6.5	11.3	0.4	2.1	6.0	13.2	0.7	3.4	2.3
NAV3	"KIAA0938, POMFIL1"	ENSG00000067798	"Neuron navigator 3"	Q8IVL0	12	77324641-78213008	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.2;ovary: 29.6"	"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 47.7;Leydig cells: 22.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 1.9;neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 23.8;THP-1: 20.9;U-138 MG: 16.0;WM-115: 19.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032111, HPA061392"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane"	Cytosol	"HPA032111: AB_10603881, HPA061392: "	"unprognostic (3.51e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.68e-7)"	"unprognostic (6.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.29e-3)"	6.2	8.5	17.8	2.4	14.2	1.5	7.1	14.7	25.2	2.8	2.1	9.7	2.6	1.2	4.1	5.8	3.8	3.6	8.6	3.7	14.2	7.5	1.4	2.3	3.8	1.6	7.8	13.0	29.6	1.4	2.2	9.3	4.3	7.1	4.5	2.0	12.3	2.2	5.1	2.6	4.1	1.3	4.6	10.6	12.7	1.6	5.0	8.3	0.0	1.7	0.0	1.4	3.9	2.3	0.3	0.1	3.8	0.2	0.1	0.0	0.0	1.8	4.4	0.3	0.1	4.6	9.5	0.1	13.4	10.5	5.5	2.9	1.2	0.3	0.1	1.0	10.7	3.8	1.4	3.9	2.0	9.8	0.0	0.0	0.0	1.8	0.1	3.6	0.0	0.1	3.5	0.0	23.8	6.0	4.9	8.2	0.0	0.0	0.0	13.5	0.1	0.1	6.0	1.5	0.1	1.2	0.6	1.1	0.0	0.9	0.0	0.4	0.0	0.9	0.1	1.9	0.5	0.0	20.9	7.1	16.0	4.5	6.8	9.1	0.7	0.0	0.4	4.8	0.2	19.8	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.1	0.2	0.1	0.0	0.0	17.8	14.2	14.7	20.5	14.2	7.5	7.8	13.0	7.1	8.3	17.9	7.7	0.0	7.4	3.2	3.1	2.1	0.0	16.0	13.6	0.0	0.0	0.1	0.0	1.7	7.6	3.5	0.0	0.0	1.3	0.1	8.7	1.8	10.5	0.0	5.4	47.7	15.7	2.5	0.0	3.6	22.2	1.3	11.8	0.0	0.0	19.9	11.8	0.0	7.1	0.0	2.1	0.0	2.8	0.2	0.5	1.3	0.2	0.0	0.0	2.8
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591762-156594299	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid transport, Transport"	Isomerase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 120.4;Distal tubular cells: 170.8;Proximal tubular cells: 189.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		3300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	19.1	29.9	31.6	14.4	28.5	12.1	22.6	17.6	42.5	23.0	30.0	31.0	17.4	28.4	28.5	57.9	23.4	29.4	25.8	46.3	28.5	25.0	41.6	41.0	17.2	16.9	33.2	29.3	29.3	37.3	36.3	29.0	21.8	28.8	27.9	26.6	23.0	29.5	36.3	30.9	20.2	25.9	25.0	29.1	17.4	25.0	29.5	22.2	17.7	32.4	19.5	20.4	20.8	18.3	52.4	53.8	12.4	26.5	31.6	32.5	40.6	31.6	42.0	13.4	24.0	17.9	12.3	16.0	10.9	16.7	18.7	19.8	34.9	21.3	21.5	33.2	13.9	16.2	30.9	13.4	26.1	13.3	22.7	29.3	17.8	24.0	23.1	20.5	22.3	18.3	12.3	33.8	23.8	22.2	15.0	25.4	29.0	18.1	19.6	19.1	56.3	24.5	27.2	16.6	43.8	32.8	24.7	12.6	56.8	25.3	26.3	32.5	31.0	26.2	50.1	38.5	19.8	48.6	32.9	14.8	13.5	21.1	19.1	23.8	50.8	30.7	20.5	18.6	13.3	20.8	4.9	24.1	12.4	31.6	26.5	31.3	52.4	29.2	32.2	21.7	41.7	32.5	30.9	2.9	31.6	20.6	53.8	25.5	40.6	31.6	28.5	17.6	42.5	28.5	25.0	33.2	29.3	28.8	22.2	38.7	23.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	43.3	64.6	0.0	120.4	170.8	89.3	0.0	0.0	0.0	0.0	87.1	28.1	0.0	0.0	4.7	0.0	80.7	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	71.3	0.0	0.0	83.0	0.0	0.0	189.4	0.0	0.0	0.0	0.0	0.0	0.0	68.0	0.0	0.0	0.0
NBAS	NAG	ENSG00000151779	"Neuroblastoma amplified sequence"	A2RRP1	2	15166909-15561330	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036817	Approved		Approved	"Nuclear membrane,Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nuclear membrane, Nucleoli"	"HPA036817: AB_10670925"	"unprognostic (1.72e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (5.84e-5)"	16.8	18.1	23.2	16.3	30.9	21.9	22.5	21.5	28.3	21.9	17.1	20.6	17.4	13.3	27.1	23.4	14.1	18.7	13.5	21.6	20.9	21.5	19.1	16.9	15.4	16.3	19.3	20.8	24.1	28.6	34.1	35.5	16.2	24.9	16.9	17.7	16.8	22.9	19.0	26.5	23.4	20.5	21.0	18.1	18.1	19.0	31.4	16.7	23.8	20.1	14.6	20.0	14.4	15.2	5.3	6.0	3.2	8.7	9.4	9.9	3.6	5.5	7.3	8.1	5.6	21.3	23.4	8.4	10.3	11.3	8.0	8.1	7.3	8.0	7.1	2.3	15.6	8.3	6.7	8.8	12.9	9.6	7.0	5.6	27.1	6.5	20.4	21.9	7.0	13.8	15.4	10.3	10.6	17.8	16.6	16.5	10.1	21.0	8.2	12.2	6.8	5.8	15.8	7.0	9.0	7.0	6.2	14.3	8.4	16.6	7.5	4.8	7.8	8.7	7.2	12.9	10.6	5.1	6.4	14.3	10.2	6.3	7.2	7.4	12.2	10.3	10.1	18.1	8.2	9.1	1.4	5.7	3.2	7.6	3.9	9.5	5.3	5.9	9.9	5.2	5.1	5.9	6.1	1.0	9.4	8.7	6.0	6.9	3.6	23.2	30.9	21.5	28.3	20.9	21.5	19.3	20.8	24.9	16.7	17.9	14.4	12.9	8.3	6.5	15.6	26.3	22.9	25.4	13.6	17.4	27.5	9.8	0.0	9.6	29.5	10.5	11.9	0.0	12.1	11.2	8.0	7.9	37.0	7.8	7.7	12.7	7.0	7.4	9.5	46.9	10.6	8.2	5.0	19.0	13.5	15.2	8.1	9.3	15.6	7.7	22.9	0.0	11.7	30.4	16.6	9.8	8.7	11.8	11.0	5.8
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942287-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 130.3;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 84.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 16.5;SH-SY5Y: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	3.9	11.9	12.2	2.7	20.6	1.0	8.2	32.6	28.5	7.4	9.8	3.9	10.9	2.7	10.3	6.2	6.2	9.4	5.4	11.7	13.5	10.6	6.6	1.7	3.6	2.6	6.9	22.2	10.4	5.7	9.3	25.0	1.5	14.2	11.9	4.8	13.3	7.0	14.2	8.5	2.0	3.8	11.4	4.7	5.1	4.8	7.7	6.0	6.1	9.6	0.7	2.4	7.1	6.4	1.1	1.3	0.0	0.5	0.4	1.4	0.1	0.0	2.3	5.3	3.0	0.4	0.0	0.1	3.4	5.2	4.0	3.3	0.0	0.5	1.4	0.0	5.8	2.2	0.1	1.8	0.7	8.4	0.6	1.8	0.0	1.6	0.5	0.3	0.9	2.2	0.9	0.6	0.0	0.4	16.5	0.7	0.6	0.0	9.7	0.5	1.0	0.5	0.0	2.3	2.9	0.9	0.6	2.3	0.4	4.6	1.0	3.1	41.0	2.5	0.0	1.7	4.3	0.9	0.2	0.0	1.0	0.6	0.0	0.7	0.9	0.2	0.7	2.5	0.3	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.2	0.0	1.1	1.4	1.3	0.0	0.4	0.0	1.3	0.0	0.1	12.2	20.6	32.6	18.4	13.5	10.6	6.9	22.2	14.2	6.0	26.8	8.6	0.5	5.0	0.9	130.3	43.7	12.7	61.6	14.8	8.7	137.4	0.1	1.7	7.3	14.9	6.3	0.0	0.0	1.5	0.1	8.3	8.7	23.3	0.0	0.7	44.5	22.0	9.2	2.4	11.0	16.4	2.9	6.8	1.0	1.4	66.5	2.3	0.0	18.0	7.1	84.5	6.5	12.2	4.9	5.9	0.6	0.0	0.0	0.8	13.1
NBEAL1	"ALS2CR16, ALS2CR17, MGC164581"	ENSG00000144426	"Neurobeachin like 1"	Q6ZS30	2	203014879-203226378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 915.3;Suprabasal keratinocytes: 1140.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA049189, HPA049447"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049189: AB_2680669, HPA049447: AB_2680771"	"unprognostic (3.66e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.59e-2)"	11.2	7.8	5.2	7.3	7.9	2.7	13.4	7.5	6.0	9.2	14.5	6.5	8.4	9.9	19.1	7.0	8.7	7.9	8.9	8.2	4.8	2.9	14.4	12.3	14.7	3.3	5.1	2.7	8.8	8.5	9.2	13.6	10.2	7.0	6.7	14.4	9.7	8.1	10.6	6.9	6.6	11.7	11.9	7.3	5.0	14.7	9.9	6.2	2.8	10.1	6.4	5.3	9.8	9.5	0.9	0.7	0.9	0.6	0.6	3.0	0.2	4.9	4.7	2.0	1.7	12.2	9.5	2.8	4.8	3.5	2.6	3.9	5.2	2.6	1.1	4.0	8.1	5.0	4.1	3.9	5.6	6.0	2.2	1.7	1.9	7.0	2.9	2.9	1.7	2.3	3.6	3.7	4.2	5.3	6.2	4.0	2.0	3.3	1.8	5.8	3.5	0.7	0.9	1.0	2.1	4.3	0.8	3.2	1.1	7.2	9.4	1.3	1.0	4.1	3.1	3.1	5.1	3.6	1.7	6.8	6.8	5.8	3.2	2.2	2.9	2.2	1.5	4.1	0.8	2.3	0.0	0.5	0.9	0.8	0.4	1.0	0.4	0.9	0.5	0.4	0.9	0.7	0.5	0.3	0.6	0.6	0.7	3.0	0.2	5.2	7.9	7.5	6.0	4.8	2.9	5.1	2.7	7.0	6.2	35.7	64.5	271.2	252.7	915.3	18.0	15.9	229.3	49.5	45.5	36.6	25.5	175.9	71.3	47.8	23.3	102.0	184.3	0.0	85.7	226.2	143.2	257.6	106.1	170.8	139.2	77.9	282.5	298.9	603.4	33.7	254.0	131.4	597.2	39.7	387.3	18.1	70.0	210.5	121.6	72.5	26.3	116.4	186.6	37.7	34.6	1140.0	191.8	258.9	547.2	252.4
NBN	"AT-V1, AT-V2, ATV, NBS, NBS1"	ENSG00000104320	Nibrin	O60934	8	89933336-90003228	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001429, CAB003836"	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB003836: AB_562172, HPA001429: AB_1854460"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (5.05e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.03e-1)"	19.2	16.1	17.9	23.6	29.5	41.3	23.0	17.4	21.0	19.3	22.6	12.2	16.9	13.3	33.2	16.6	19.7	17.5	20.2	14.2	19.4	16.7	25.9	19.3	17.9	26.7	16.9	18.1	19.3	17.1	21.0	29.4	13.2	18.4	17.6	20.9	7.1	18.4	17.6	15.7	11.2	18.0	22.2	18.1	26.5	14.7	13.9	18.9	23.4	20.8	14.7	22.8	17.5	16.0	10.1	12.0	21.8	18.5	9.7	8.6	7.6	15.4	8.7	8.8	4.6	4.8	12.0	5.6	11.0	14.6	14.0	15.3	5.0	11.8	23.4	12.9	10.0	5.7	5.2	10.6	10.3	18.0	10.9	6.1	19.8	5.4	7.0	9.4	11.8	10.5	9.0	5.5	7.9	17.5	6.9	11.3	9.5	14.5	13.6	15.9	13.7	18.0	7.5	2.5	11.5	9.5	12.1	7.6	13.8	18.1	21.3	2.5	8.1	6.9	78.3	6.5	5.1	14.7	8.8	8.4	12.2	8.7	7.4	10.8	6.3	7.2	13.0	12.3	11.2	11.3	14.1	11.1	20.3	8.1	12.5	8.6	10.1	5.9	5.9	12.0	6.1	5.7	6.2	21.8	9.7	18.5	6.6	3.7	7.6	17.9	29.5	17.4	21.0	19.4	16.7	16.9	18.1	18.4	18.9	44.7	13.9	32.5	12.1	10.5	23.3	25.0	17.8	42.8	42.1	26.2	2.0	18.9	36.5	30.4	10.9	17.9	8.9	0.0	27.9	17.4	18.4	8.7	76.4	27.6	22.9	12.7	11.6	17.2	22.4	5.9	17.5	30.7	11.8	52.3	15.1	27.1	19.1	5.8	24.8	31.1	10.3	6.5	20.6	11.2	43.3	11.8	9.0	23.2	17.4	8.6
NBPF1	"FLJ20719, KIAA1693"	ENSG00000219481	"NBPF member 1"		1	16562319-16613562	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (8.16e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.15e-5)"	"unprognostic (2.16e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-1)"	6.8	23.3	14.2	6.4	18.3	4.5	7.4	32.7	13.1	11.7	11.6	21.5	6.0	7.5	9.5	6.2	6.6	13.9	7.9	5.2	13.4	9.3	8.1	7.7	7.3	3.2	32.8	4.2	18.6	5.5	22.3	12.3	9.7	18.4	9.0	11.3	9.3	6.5	9.6	4.5	5.9	16.6	12.2	21.3	6.7	7.3	22.3	21.5	3.7	9.5	3.3	4.3	10.4	8.5	2.0	0.9	4.3	1.0	0.4	1.7	0.5	5.4	7.8	8.0	4.8	2.2	2.6	1.5	3.8	4.9	7.2	6.5	2.8	2.3	4.3	1.1	10.6	2.9	5.1	3.8	2.3	8.5	2.7	4.2	1.4	2.6	2.7	3.5	2.1	3.4	2.8	2.9	10.4	3.1	3.8	3.2	10.2	4.6	2.5	2.8	4.3	9.3	1.6	1.5	0.9	15.5	8.0	4.3	0.4	2.0	1.1	9.8	9.7	9.7	4.0	5.4	2.4	6.2	1.5	3.8	6.4	3.5	8.6	3.3	1.3	5.9	2.4	1.5	3.2	2.6	0.4	0.7	4.3	1.2	0.8	1.4	1.1	1.1	1.5	0.5	2.0	1.3	1.7	0.2	0.4	1.0	0.9	0.0	0.5	14.2	18.3	32.7	13.1	13.4	9.3	32.8	4.2	18.4	21.5	14.9	11.3	0.0	2.8	7.2	7.6	9.6	12.7	13.4	10.3	10.4	7.9	5.4	3.3	4.7	4.6	7.1	27.6	0.0	2.9	7.4	10.3	5.7	5.8	4.4	10.4	9.5	2.9	4.3	4.5	5.4	6.4	8.1	8.5	2.8	23.2	4.5	4.6	12.9	6.7	7.7	5.7	6.5	17.0	52.6	23.0	6.8	2.6	2.9	10.1	1.8
NBPF10	AG1	ENSG00000271425	"NBPF member 10"		1	146064699-146144804	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 71.5;Basal keratinocytes: 50.6;Suprabasal keratinocytes: 92.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.05e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.64e-5)"	"unprognostic (1.60e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.68e-2)"	1.5	0.0		0.9		3.3	2.3		0.0	3.0	0.9			0.0	1.6	1.9	1.0	1.3	0.5	0.0			0.4	1.2	1.3	0.6			3.2	1.1	1.5		0.7		1.1	1.1		0.3	1.3	0.0	4.2	0.0	1.5		2.0	0.1	1.2			0.7		0.6	0.2		1.3	2.4	3.7	1.5	0.4	0.4	0.2	5.3	1.4	3.2	2.3	11.3	13.4	2.8	3.1	4.1	3.1	3.2	1.4	2.5	2.5	0.6	6.0	2.7	2.6	3.8	4.1	6.4	2.8	2.4	5.4	3.8	0.7	4.5	2.5	1.7	12.3	4.0	8.3	8.5	10.4	3.7	1.4	1.7	7.6	6.7	6.7	1.0	2.1	1.5	1.5	4.4	1.3	2.0	3.2	2.4	3.6	0.3	0.4	4.7	4.7	1.6	5.5	3.8	3.1	11.3	3.1	2.7	2.8	3.8	4.7	1.9	3.0	2.8	2.7	2.4	0.8	1.5	1.8	0.4	1.1	0.2	1.1	0.2	0.3	0.7	1.3	0.4	0.3	3.7	0.4	1.2	2.4	0.3	0.2											71.5	40.3	0.5	3.4	50.6	0.5	7.2	0.0	14.7	12.5	0.0	0.0	0.6	0.0	4.1	6.4	3.6	1.3	0.0	2.3	4.1	26.7	1.3	18.6	1.3	1.3	0.0	0.0	1.3	4.6	1.3	6.1	18.6	28.7	1.8	2.6	1.7	4.4	28.3	7.8	0.0	2.2	0.0	30.9	9.0	4.3	92.5	0.5	1.8	3.0	3.4
NBPF11	NBPF24	ENSG00000263956	"NBPF member 11"	Q86T75	1	148102046-148152322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (8.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.78e-2)"	"unprognostic (6.67e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (3.20e-5)"	1.5	2.1	3.4	2.1	3.9	3.0	3.8	5.7	5.3	4.6	1.5	3.1	9.6	1.4	5.7	9.6	1.2	3.0	1.5	0.7	3.0		1.4	3.7	3.3	3.0	6.0	1.1	5.3	3.2	5.4	1.6	3.3	4.4	2.9	2.4	3.4	3.2	5.6	0.6	5.7	2.0	3.0	5.7	3.1	2.1	1.5	3.1	1.5	3.0	0.0	3.5	1.3	0.0	5.2	3.9	6.1	3.5	1.0	4.1	1.0	5.5	4.4	8.8	8.4	6.1	5.2	5.9	5.0	4.6	4.3	4.5	3.4	5.6	9.2	3.9	5.9	3.9	7.2	5.5	1.8	5.2	5.1	6.0	4.0	13.8	3.7	4.3	5.8	14.9	4.4	5.1	5.4	10.2	6.3	3.1	8.0	6.6	0.6	4.3	10.8	6.6	10.5	7.6	12.3	5.7	8.9	5.1	3.5	4.2	10.7	3.5	9.3	7.9	5.4	7.4	12.1	7.9	9.9	7.6	5.6	4.6	8.6	6.3	5.5	4.5	6.4	5.3	3.7	3.1	6.1	1.9	5.7	4.1	1.3	2.9	3.3	3.4	2.4	1.9	5.2	3.8	2.9	0.3	1.0	3.5	3.9	1.3	1.0											11.9	11.8	0.8	2.0	1.0	4.8	5.1	2.5	6.7	9.1	3.5	9.8	3.9	0.0	2.5	3.5	5.8	3.9	0.0	2.9	2.8	4.1	1.6	12.8	16.6	2.9	4.8	3.4	5.5	7.3	1.0	4.9	3.1	6.8	2.8	6.3	2.7	3.4	7.0	2.5	1.9	7.0	6.5	1.4	6.2	4.5	1.3	2.4	5.0	9.0	1.1
NBPF12	"COAS1, KIAA1245"	ENSG00000268043	"NBPF member 12"		1	146938744-146996202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"pancreas: 29.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.48e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-2)"	"unprognostic (5.76e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (9.01e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.47e-5)"	2.7	1.7	2.2	4.0	3.9	5.1	3.2	4.4	4.7	2.6	1.9	5.8	2.2	2.4	6.0	3.6	1.5	2.4	3.1	0.9	2.3		1.7	6.1	2.8	3.4	4.2	4.2	4.3	29.8	4.2	5.0	1.8	3.8	2.5	1.8	4.2	3.5	4.0	0.9	2.5	1.9	3.0	3.2	3.1	5.3	7.0	1.1	3.3	2.9	0.9	2.9	1.2	3.9	3.8	2.6	6.1	2.3	0.9	3.5	0.8	6.7	5.4	11.4	9.8	5.4	5.0	7.4	7.0	5.3	5.0	5.1	4.9	6.4	15.1	4.4	6.0	5.3	5.0	8.1	4.0	4.8	5.6	5.7	6.6	11.7	4.2	4.5	4.9	9.8	5.3	7.2	4.9	11.4	6.5	4.5	10.9	10.4	2.6	4.0	10.3	10.6	6.2	6.6	8.2	7.1	10.3	4.2	3.6	3.8	14.9	5.7	12.0	9.2	8.2	4.6	17.8	6.9	14.9	5.3	4.4	7.3	10.0	9.7	9.2	6.8	6.3	4.8	3.5	5.0	6.1	2.3	1.8	3.5	1.1	2.0	3.4	2.3	1.9	1.0	3.8	2.6	2.0	0.7	0.9	1.4	2.6	2.2	0.8											29.8	20.0	11.1	2.6	3.4	16.0	7.2	0.0	9.4	11.4	5.2	43.2	3.3	0.0	9.6	5.2	4.5	6.5	0.0	7.5	3.0	5.0	1.4	23.2	11.3	3.3	9.5	10.3	8.6	14.3	2.5	5.2	7.1	1.7	9.0	9.9	9.5	10.0	14.0	9.9	0.8	17.2	6.5	5.0	12.2	5.7	3.8	1.6	10.9	11.5	0.9
NBPF14	DJ328E19.C1.1	ENSG00000270629	"NBPF member 14"		1	148531385-148679751	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 25.2"	"Cell type enhanced"	"Detected in many"	9	"Paneth cells: 190.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in all"	5	"basophil: 9.8;classical monocyte: 17.2;eosinophil: 25.2;intermediate monocyte: 11.5;memory B-cell: 21.8;myeloid DC: 14.9;naive B-cell: 15.1;neutrophil: 22.9;non-classical monocyte: 13.1;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.28e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.92e-3)"	"unprognostic (7.13e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.69e-4)"	"unprognostic (7.23e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.15e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.52e-2)"	4.4	0.7	2.5	3.2	4.6	6.7	4.3	2.1	4.3	5.4	2.4	2.1	0.9	0.4	4.3	11.2	3.9	3.4	2.9	6.7	4.2		3.4	3.4	3.4	4.0	2.6	2.8	7.7	6.3	3.1	0.9	1.8	4.6	3.6	2.7	6.9	3.2	1.9	1.2	8.5	1.9	4.1	3.8	4.5	0.8	5.2	5.1	2.8	2.6	9.1	4.7	1.8	4.7	21.8	16.5	25.2	17.2	3.4	3.1	3.5	26.7	5.1	10.1	7.4	21.1	29.5	5.0	10.0	10.2	6.9	8.0	4.1	8.9	5.0	2.6	10.3	9.5	8.1	6.7	10.5	10.1	9.8	7.6	13.2	16.4	1.0	8.3	10.4	5.4	29.5	8.7	18.5	24.7	32.9	10.7	4.6	4.4	27.1	16.4	16.0	2.7	7.5	4.3	5.6	12.3	4.3	9.1	15.8	8.6	11.1	0.1	0.1	20.4	11.3	4.8	10.1	14.1	9.0	42.8	7.9	8.8	9.5	16.6	47.8	15.3	12.3	14.3	9.1	11.8	9.8	17.2	25.2	2.3	11.5	1.7	21.8	2.4	2.1	14.9	15.1	3.1	2.6	22.9	3.4	13.1	16.5	3.1	3.5											83.4	73.1	16.4	35.4	1.9	2.0	17.3	10.2	16.0	27.3	12.2	3.9	1.1	0.0	29.4	29.3	0.8	7.7	0.0	13.9	12.6	12.9	19.5	49.9	8.1	12.9	0.0	3.5	3.7	40.0	30.3	26.2	27.4	1.7	20.8	5.3	17.1	21.9	190.4	15.9	4.4	9.8	12.9	11.4	57.2	10.2	5.5	1.3	6.9	16.2	27.9
NBPF15	"MGC8902, NBPF16"	ENSG00000266338	"NBPF member 15"	Q8N660	1	144421386-144461674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 41.7;Club cells: 22.7;Paneth cells: 30.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 3.1;NK-cells: 2.7;T-cells: 5.5"	"Low cell line specificity"	"Detected in many"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.84e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.26e-2)"	2.2	1.1	1.3	2.7	3.3	0.0	4.9	6.1	3.6	3.2	1.1	1.8	2.9	0.4	4.0	7.7	1.7	2.4	1.9	0.5	7.1		1.5	4.9	2.8	5.0	1.4	1.5	3.4	1.7	3.6	3.2	2.7	4.2	2.8	2.1	3.0	5.2	3.1	0.7	2.2	0.7	3.8	6.3	3.6	0.9	0.9	4.8	1.0	3.0	1.9	3.7	1.4	0.5	3.1	0.2	0.6	0.4	2.7	5.5	1.8	7.5	4.9	8.9	16.7	10.6	16.7	11.0	13.6	13.3	8.3	8.6	4.2	8.1	3.8	3.8	9.9	9.7	5.9	9.8	4.3	13.3	12.5	5.3	0.3	11.1	5.3	8.0	0.3	3.7	13.6	7.6	9.9	20.7	12.0	11.6	1.5	1.7	11.5	20.1	16.1	0.2	3.4	3.6	2.7	11.1	3.3	5.3	5.9	9.2	6.8	0.8	20.2	5.7	8.9	9.4	12.0	8.9	3.4	12.4	13.5	8.9	11.9	12.6	10.2	11.0	6.4	0.2	0.4	6.2	0.2	0.3	0.1	1.3	0.0	1.9	3.1	3.5	2.4	0.2	1.8	4.2	1.6	0.6	2.7	0.4	0.2	5.5	1.8											41.7	21.0	0.9	0.8	1.8	2.5	7.5	5.1	8.1	22.7	1.8	5.9	1.3	0.0	5.3	1.6	3.8	1.0	0.0	3.7	2.6	3.9	1.2	14.0	7.8	1.4	3.2	5.8	6.2	9.2	0.5	8.1	1.8	1.7	3.6	3.7	2.7	6.0	30.2	9.9	0.9	7.0	0.0	6.2	2.6	1.7	1.1	0.2	2.5	5.0	0.3
NBPF19		ENSG00000271383	"NBPF member 19"	A0A087WUL8	1	149390623-149556361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Paneth cells: 94.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (7.92e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.59e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (3.54e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.61e-2)"	6.8	0.9	3.2	10.4	2.7	9.5	8.4	1.7	4.5	6.6	3.7	4.0	10.1	1.1	8.8	8.0	5.3	6.0	7.3	4.8	3.4		2.3	3.1	12.1	6.0	3.2	4.7	10.6	6.2	4.0	0.9	7.0	5.5	5.0	3.9	7.5	7.7	8.6	6.2	13.0	1.7	6.0	2.6	6.7	1.7	9.5	2.9	2.5	6.3	5.2	5.2	3.9	7.4	6.2	11.7	18.0	16.7	6.9	7.0	1.5	23.8	6.4	13.9	7.1	27.1	23.5	6.5	11.8	9.1	8.3	8.2	5.6	8.7	7.0	2.9	18.2	10.7	11.0	19.0	11.0	12.9	12.6	10.6	20.0	17.8	1.9	5.6	19.9	7.3	16.3	4.9	23.8	31.1	11.0	5.3	10.4	4.8	11.4	17.4	17.5	10.9	11.9	12.0	6.7	9.9	9.9	15.1	11.5	5.2	12.1	1.2	2.9	27.9	9.8	5.3	20.1	18.1	27.3	31.6	16.6	12.3	10.3	18.2	9.5	5.4	22.1	19.0	13.9	4.9	9.8	16.7	5.3	7.0	6.4	4.7	2.3	3.8	2.5	3.2	6.2	5.2	6.5	18.0	6.9	5.2	11.7	1.4	1.5											47.6	49.9	6.4	15.8	0.0	7.8	21.2	2.5	21.4	18.2	3.5	25.5	1.3	1.7	14.5	16.9	1.9	1.1	23.3	5.3	5.4	5.3	6.2	18.6	7.4	6.5	3.2	1.2	0.6	29.4	4.2	30.0	33.9	0.0	15.4	3.4	25.4	8.8	94.8	28.3	0.3	51.8	19.4	4.2	26.5	6.0	0.0	1.1	7.5	7.7	8.6
NBPF20		ENSG00000162825	"NBPF member 20"		1	145289900-145405778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 13.3"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 27.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (6.25e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.54e-1)"	"unprognostic (4.26e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.45e-4)"	"unprognostic (9.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.70e-1)"	1.1	1.2	1.1	1.2	1.2	1.0	1.5	2.5	1.2	1.4	1.1			0.0	1.3	1.8	1.1	1.2	0.7	1.1	1.1	1.1	1.1	2.6	1.1	1.2	1.0		2.2	1.3	5.9	1.1	0.0		1.5	1.1		1.6	2.1	1.1	2.4	1.1	1.7	1.0	1.1	1.1	3.6			1.1		1.5	1.4	1.1	4.0	13.3	1.0	1.8	2.9	1.0	0.3	14.7	7.5	2.1	5.9	13.2	23.2	5.4	7.2	1.8	2.6	2.7	8.1	1.8	3.5	2.8	7.4	4.1	4.5	7.3	8.5	7.3	7.0	9.0	2.3	9.4	5.9	2.7	4.0	4.0	6.9	6.6	14.2	12.1	4.8	6.8	1.9	9.2	5.2	10.5	9.6	0.6	1.8	2.0	3.3	12.0	3.5	6.1	2.2	3.8	2.7	3.8	6.7	14.7	7.6	4.1	5.7	5.8	5.6	12.4	12.7	15.9	6.7	16.7	3.1	2.6	8.0	6.9	1.7	1.8	0.5	1.5	0.5	1.0	0.9	0.8	1.5	0.7	1.0	0.4	4.0	1.0	0.9	1.0	2.9	1.8	13.3	0.9	0.3											20.8	27.1	1.9	1.4	2.6	4.3	3.3	0.0	8.1	3.4	0.0	17.7	1.2	0.0	6.7	13.7	2.4	0.6	0.0	9.6	4.0	3.1	1.1	7.0	14.5	1.6	1.6	5.8	2.5	3.7	1.1	5.2	3.8	3.3	5.4	2.8	1.3	8.9	10.5	3.5	0.0	7.5	0.0	2.2	12.7	9.8	2.8	0.6	0.7	4.0	0.9
NBPF26		ENSG00000273136	"NBPF member 26"		1	120723923-120841481	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 17.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 50.6;Alveolar cells type 2: 23.7;granulocytes: 15.1;Paneth cells: 23.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in all"		"neutrophil: 17.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 17.7;monocytes: 10.0"	"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.31e-5)"	"unprognostic (9.78e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.65e-1)"	2.7	0.8	2.3	4.3	2.2	2.1	1.8	1.1	2.5	3.2	1.9	1.1	1.1	0.0	3.0	5.6	4.8	2.4	3.1	1.1	1.1		3.5	1.7	2.3	2.0	1.1	1.1	3.6	1.1	1.1	1.1	1.1	2.0	2.5	1.4	1.7	1.6	1.3	1.1	9.9	1.1	6.0	2.4	10.6	0.5	3.4	1.1	1.1	1.8	3.3	1.8	2.0	1.1	3.4	2.8	17.7	10.0	2.4	2.1	1.0	27.0	0.1	8.1	8.9	11.5	9.4	0.6	9.6	4.9	6.0	6.5	5.8	1.0	1.9	9.1	11.1	10.7	8.0	13.1	13.8	8.4	12.8	0.5	18.5	2.9	2.3	5.2	7.6	5.6	5.7	6.0	15.7	17.4	19.4	0.3	4.9	1.5	16.7	15.8	15.1	2.1	12.3	2.9	1.0	11.0	3.0	9.2	4.9	4.7	11.0	0.8	0.5	11.2	16.4	8.4	9.6	0.6	3.4	8.2	7.2	19.2	23.8	7.6	7.4	2.0	7.9	6.8	11.5	1.0	7.7	6.4	7.2	1.9	5.2	1.7	1.2	2.0	1.9	2.8	3.4	1.7	2.1	17.7	2.4	10.0	2.1	1.1	1.0											50.6	23.7	1.4	1.3	0.0	0.6	1.4	0.0	6.7	6.8	0.0	0.0	0.4	3.3	3.5	2.2	0.0	0.0	0.0	2.6	1.7	1.0	0.7	15.1	1.3	0.2	0.0	0.0	1.3	3.7	0.0	6.1	1.8	0.0	1.0	0.6	0.8	3.2	23.2	4.2	0.6	1.6	0.0	0.5	4.3	2.6	0.0	0.3	0.0	2.5	0.4
NBPF3	AE2	ENSG00000142794	"NBPF member 3"	Q9H094	1	21440128-21485005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 29.5"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 9.4;Early spermatids: 10.3;Spermatocytes: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.4;HHSteC: 14.9"									"HPA042595, HPA043692, HPA044023, HPA046971, HPA058050"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.49e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.31e-5)"	"unprognostic (8.35e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.66e-2)"	3.2	5.1	4.5	2.6	4.6	2.3	6.5	12.7	5.3	4.1	3.5	3.7	4.2	1.5	3.7	4.6	3.7	3.6	2.9	2.8	4.7	3.5	4.0	4.6	3.0	3.0	5.0	3.8	4.7	4.3	2.6	9.4	11.7	4.5	4.5	3.6	3.3	4.9	4.0	2.2	6.2	4.0	5.3	4.6	3.2	4.7	29.5	4.9	2.4	4.8	1.3	4.5	5.1	5.6	1.1	0.3	2.3	0.7	1.1	5.3	1.6	1.8	2.5	0.2	5.7	3.8	1.3	4.8	3.2	15.4	4.5	3.8	3.4	5.8	2.9	1.3	8.4	1.3	0.2	2.7	3.8	0.5	1.5	2.9	2.0	0.1	1.2	14.9	1.2	2.0	1.0	1.1	4.1	0.7	2.2	0.4	0.0	0.8	1.0	1.0	6.4	0.0	2.8	0.8	2.6	3.6	0.0	0.0	2.7	0.7	2.4	3.9	4.1	5.0	1.3	3.9	1.4	1.8	2.4	3.7	1.9	2.2	5.6	1.3	0.0	1.6	4.5	0.4	2.5	2.5	0.0	0.5	2.3	3.8	0.7	5.3	1.1	1.6	3.0	0.3	0.5	2.8	3.5	0.2	1.1	0.0	0.0	1.5	1.6	4.5	4.6	12.7	5.3	4.7	3.5	5.0	3.8	4.5	4.9	0.0	3.0	0.8	2.2	1.1	1.4	2.6	2.5	9.4	1.2	1.8	5.9	2.5	0.0	1.0	10.3	1.4	0.0	0.0	2.2	1.0	3.1	1.5	2.3	1.0	0.8	0.0	0.0	3.7	0.6	1.6	2.6	2.2	0.0	0.0	3.3	1.0	2.0	0.0	1.8	1.6	1.8	0.0	1.0	14.4	7.0	2.6	2.1	1.3	1.2	1.6
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.1;testis: 8.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 8.2;K-562: 11.8;Karpas-707: 3.5;MCF7: 13.9;THP-1: 4.2"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.6			0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.5	1.4		0.0	0.8		0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	3.5	0.0	13.9	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	1.7	0.0	0.2	4.2	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 1.9;testis: 7.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;K-562: 14.0;SK-BR-3: 3.3;SK-MEL-30: 2.5"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.1			0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.6	1.4		0.0	0.9		0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.1			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	1.5	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.5	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF9	AE01	ENSG00000269713	"NBPF member 9"		1	149054027-149103561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 21.9"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 35.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.25e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.42e-6)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.63e-3)"	"unprognostic (8.80e-2)"	3.3	2.0	5.6	6.5	5.3	2.4	2.6	12.3	5.0	4.2	3.3	2.1	4.5	1.7	4.9	7.2	2.8	2.9	4.7	3.8	5.3		3.6	5.4	8.3	4.6	2.8	1.8	4.9	6.3	4.4	1.9	2.2	4.3	3.0	3.1	6.8	2.2	2.4	1.7	4.5	3.2	4.4	2.0	2.7	1.8	2.9	2.0	1.8	5.2	2.5	4.0	2.3	0.0	4.2	5.2	21.9	7.6	5.6	1.8	0.8	22.2	9.8	12.2	16.5	11.1	13.5	9.7	20.6	15.0	10.9	11.8	7.3	9.7	5.3	5.7	10.5	13.1	6.7	8.5	9.6	18.7	13.5	8.9	1.7	16.5	4.4	12.9	2.2	6.5	13.3	7.2	11.9	20.9	20.1	9.5	4.1	6.2	14.0	13.3	17.6	0.7	3.6	4.6	4.0	13.4	6.0	7.6	8.1	8.9	10.3	7.9	16.5	6.7	16.6	9.1	8.0	12.3	4.2	22.2	24.6	7.2	17.9	31.6	17.2	9.1	10.6	9.0	1.6	8.6	21.9	7.6	0.3	0.4	3.6	0.7	1.9	1.3	0.4	1.3	4.2	1.8	1.0	5.8	5.6	1.2	5.2	1.6	0.8											35.7	13.6	5.4	6.7	4.8	4.3	3.9	7.6	8.1	19.4	5.2	5.9	2.3	0.0	2.9	2.8	2.4	0.7	0.0	1.6	3.4	9.1	4.1	17.4	24.5	3.2	0.0	1.7	2.5	9.5	2.1	6.6	14.0	3.3	1.8	0.4	3.7	2.5	7.8	3.9	0.4	11.4	6.5	3.9	9.7	4.1	12.4	1.1	2.2	0.6	5.8
NBR1	"1A1-3B, CA125, KIAA0049, M17S2"	ENSG00000188554	"NBR1, autophagy cargo receptor"	Q14596	17	43170481-43211689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 246.4;Late spermatids: 675.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022944, HPA022999, HPA023999"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Nuclear bodies"	"HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (1.65e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	26.3	29.5	27.1	17.2	27.3	7.7	28.0	27.3	29.4	25.6	32.9	33.3	29.0	31.0	28.4	25.5	23.1	25.6	20.7	29.8	26.0	22.0	38.3	39.6	21.1	25.4	27.2	21.8	34.1	26.5	55.8	25.0	31.2	22.8	30.1	32.1	20.7	25.5	29.5	62.9	23.9	37.7	24.2	34.2	23.3	23.2	57.0	31.7	29.8	32.1	24.5	19.8	32.5	23.7	9.6	12.6	25.2	21.5	15.5	17.1	14.4	12.6	15.4	13.2	14.0	30.1	31.3	12.7	23.8	47.3	19.8	16.4	8.0	20.1	6.7	24.8	33.1	19.7	13.9	15.0	30.8	28.8	21.0	16.0	8.0	19.6	17.2	28.8	6.7	12.4	35.5	34.9	21.7	42.8	40.4	30.8	15.6	17.1	18.1	26.2	7.1	14.4	4.9	4.2	14.7	10.0	4.8	20.8	22.0	25.1	14.3	8.0	14.2	16.4	8.1	23.8	23.2	22.1	11.1	25.5	29.1	10.9	13.3	9.4	21.7	17.6	8.8	19.7	9.3	20.0	23.5	16.1	25.2	14.2	15.3	14.6	9.6	12.9	13.7	12.6	6.7	12.4	11.9	23.1	15.5	21.5	8.0	17.1	14.4	27.1	27.3	27.3	29.4	26.0	22.0	27.2	21.8	22.8	31.7	38.7	36.1	13.0	29.2	21.2	32.9	75.1	40.8	54.9	43.3	34.9	37.3	22.6	16.6	20.6	246.4	37.9	79.4	0.0	19.1	15.5	24.6	46.9	24.4	55.7	18.8	19.1	38.7	46.1	53.8	675.8	54.4	30.1	25.3	7.2	58.7	45.6	24.4	63.7	41.8	46.8	51.6	38.8	23.9	41.7	27.0	23.8	13.2	29.6	48.7	29.1
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998315-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 15.9;brain: 52.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 44.1;Late spermatids: 20.9"	"Cancer enhanced"	"Detected in some"		"glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"		No	No		100000000	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: AB_2673650"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	2.0	15.9	25.8	2.0	22.3	1.1	3.1	7.0	52.7	3.3	2.1	14.7	0.0	1.3	2.3	1.8	1.7	1.8	2.6	3.1	18.7	13.9	1.3	9.1	4.4	1.2	21.6	19.4	1.4	1.3	1.1	1.0	1.7	17.9	2.2	2.4	0.5	1.8	2.3	1.5	2.0	1.9	2.7	17.3	2.0	1.3	8.3	26.6	0.0	1.5	0.0	1.3	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.6	0.0	1.1	0.0	0.0	5.7	0.0	1.7	0.0	0.2	0.0	0.0	5.3	1.2	0.1	7.2	0.1	0.0	0.2	0.0	0.0	0.5	0.0	2.2	0.0	0.0	0.0	2.6	0.0	0.4	0.3	0.0	45.2	3.4	0.0	0.6	0.4	0.0	0.0	0.3	0.0	0.0	1.2	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	22.3	7.0	22.4	18.7	13.9	21.6	19.4	17.9	26.6	3.0	2.2	0.0	0.2	0.5	0.2	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.4	2.4	0.8	0.0	0.0	0.3	0.0	0.0	3.7	0.0	20.9	0.9	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.1	3.3	8.0	0.1	0.2	0.0	0.0	0.1
NCBP3	"C17orf85, ELG, HSA277841"	ENSG00000074356	"Nuclear cap binding subunit 3"	Q53F19	17	3802165-3846251	"Predicted intracellular proteins"	"Antiviral defense, mRNA capping, mRNA processing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008959, HPA013195"	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA008959: AB_2668184, HPA013195: AB_2668800"	"unprognostic (1.39e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.36e-2)"	14.4	12.8	11.9	20.8	18.4	36.3	14.2	14.3	14.8	17.1	17.8	26.1	17.4	20.5	20.5	18.2	16.9	16.6	15.7	15.9	14.4	11.0	12.3	11.3	13.5	15.1	15.0	13.3	20.5	18.2	17.5	16.4	17.3	15.2	13.8	15.1	12.4	14.4	17.8	20.7	19.6	17.6	16.2	18.9	16.7	15.2	25.4	17.1	29.3	14.7	9.0	17.7	16.6	17.9	3.4	4.4	6.1	3.9	2.9	6.6	2.1	9.2	12.0	11.1	8.2	5.8	4.3	5.5	6.4	4.4	9.0	5.7	4.8	3.7	8.2	5.8	6.7	4.3	17.0	8.3	8.4	11.5	10.2	11.5	6.7	5.5	5.3	4.9	4.0	9.9	6.6	3.6	8.6	9.1	7.2	7.4	12.3	8.2	8.7	6.6	3.1	14.5	7.3	10.2	4.2	4.6	25.3	8.8	5.3	4.6	4.8	4.1	8.8	13.3	4.6	8.4	9.5	7.0	8.5	7.5	5.2	7.1	8.0	13.7	4.7	4.2	6.6	6.6	7.3	8.0	1.5	3.9	4.8	4.7	2.6	4.1	3.4	4.0	6.6	2.6	2.4	6.5	5.4	6.1	2.9	1.6	4.4	6.0	2.1	11.9	18.4	14.3	14.4	14.4	11.0	15.0	13.3	15.2	17.1	47.6	32.1	6.7	21.1	0.0	42.8	0.0	25.5	64.3	44.3	24.4	33.4	77.5	11.6	20.6	9.2	23.3	9.7	0.0	20.4	16.0	21.3	25.1	22.1	19.5	20.3	31.8	10.5	29.4	24.7	12.4	23.0	21.5	0.0	28.9	22.5	20.1	20.7	21.0	17.7	15.4	46.1	32.3	0.0	45.3	45.3	0.0	83.1	26.1	24.7	24.5
NCEH1	"AADACL1, KIAA1363, NCEH"	ENSG00000144959	"Neutral cholesterol ester hydrolase 1"	Q6PIU2	3	172630249-172711218	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 30.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.8;LHCN-M2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026888, HPA043873"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA026888: AB_10601557, HPA043873: "	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.88e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (5.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.28e-1)"	17.0	14.8	6.5	7.1	23.8	6.0	5.1	14.3	30.1	4.1	9.8	2.3	1.4	3.5	3.9	2.9	4.4	3.5	6.0	14.6	13.2	9.6	18.8	4.2	17.0	11.2	6.6	11.4	2.5	4.0	6.3	4.2	5.7	17.7	6.0	10.7	4.3	8.2	4.2	6.6	2.7	4.1	2.9	5.0	9.1	10.9	2.0	4.0	1.9	3.9	3.1	9.3	5.1	3.4	3.0	10.6	4.8	15.1	2.8	2.3	4.8	23.3	13.6	0.4	0.7	0.8	0.9	1.9	17.6	11.7	11.7	6.8	3.4	70.8	1.9	26.5	10.6	11.2	4.7	0.5	8.6	27.2	6.5	1.1	1.3	2.2	2.6	1.0	3.5	4.9	0.4	0.8	8.0	12.0	11.0	7.8	1.0	0.3	1.7	33.1	1.9	0.5	1.2	0.6	6.6	11.2	0.5	1.3	2.4	20.9	3.1	0.4	0.2	10.6	11.2	2.3	0.8	3.8	1.6	21.1	18.0	2.7	8.4	31.8	2.0	3.8	1.6	13.4	3.4	13.6	4.8	15.1	0.5	2.3	9.6	1.5	3.0	1.5	1.6	10.6	1.9	1.5	1.8	0.5	2.8	6.2	0.6	1.3	4.8	6.5	23.8	14.3	30.1	13.2	9.6	6.6	11.4	17.7	4.0	44.7	19.9	6.4	16.9	6.1	12.9	27.7	25.5	30.8	28.4	15.7	21.6	6.2	3.3	54.9	4.5	8.7	13.1	46.7	26.6	3.8	6.1	23.2	4.7	1.6	48.4	4.8	7.5	5.5	34.7	2.6	0.9	14.5	5.0	1.8	9.7	4.9	50.0	10.5	2.5	25.4	19.2	6.5	5.8	0.0	0.9	3.0	8.8	3.8	6.0	22.8
NCKAP1	"HEM2, Nap1, NAP125"	ENSG00000061676	"NCK associated protein 1"	Q9Y2A7	2	182909115-183038858	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020449	Enhanced		Approved	Cytosol		NA	NA		210000	Cytosol		"HPA020449: AB_1854327"	"unprognostic (7.92e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (5.06e-2)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.61e-2)"	25.2	23.7	35.8	12.6	49.7	0.6	25.5	32.9	47.2	30.8	29.1	12.9	17.8	28.2	27.9	28.6	42.6	22.6	22.0	46.1	34.0	26.8	37.0	20.8	20.5	4.9	25.8	36.4	24.5	21.9	47.9	26.2	29.4	25.5	30.0	25.6	16.9	24.2	35.9	45.4	26.2	28.5	38.2	20.0	10.2	28.4	16.0	20.4	4.3	44.3	21.0	12.2	33.3	40.9	0.2	0.2	2.8	0.2	0.5	0.9	0.3	23.3	14.7	22.6	14.4	32.0	31.2	25.2	30.6	27.8	20.8	26.3	22.7	20.1	0.1	20.6	36.3	31.3	22.3	19.1	28.8	34.8	5.6	14.9	5.2	16.6	18.8	33.0	0.0	4.5	23.3	35.7	30.1	49.5	28.5	33.0	1.4	12.6	0.0	39.2	15.0	0.4	0.1	23.2	18.9	25.5	1.5	24.7	0.1	29.3	31.6	16.7	15.9	27.7	22.1	28.6	37.5	11.8	0.1	35.7	35.5	20.0	19.9	18.7	3.0	5.6	0.1	27.4	0.0	17.9	2.1	0.2	2.8	0.8	0.1	0.7	0.1	0.6	0.6	0.2	0.2	0.2	0.8	0.9	0.5	0.2	0.2	0.9	0.3	35.8	49.7	32.9	42.3	34.0	26.8	25.8	36.4	25.5	20.4	44.7	40.1	0.9	54.6	77.4	82.1	92.1	56.0	17.4	39.8	76.8	66.8	26.6	23.2	49.3	3.9	76.4	44.4	0.0	53.6	42.5	61.5	90.7	13.9	36.6	4.6	116.0	48.5	68.7	7.0	6.0	72.8	6.1	52.3	1.0	58.2	92.2	72.3	65.1	99.0	50.0	60.1	58.2	79.6	45.9	29.8	98.2	43.6	7.5	47.8	94.9
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671799-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.3;lung: 19.2"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 244.2;Bipolar cells: 119.6;Muller glia cells: 83.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Cell line enriched"	"Detected in some"	6	"AF22: 32.3"	"Low region specificity"	"Detected in all"							"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: AB_2679114"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	3.6	2.0	6.6	1.5	6.3	0.2	5.4	5.2	5.6	3.1	5.8	6.2	0.9	3.8	3.6	6.2	6.9	1.0	1.5	4.6	6.0	3.9	16.3	6.7	19.2	2.2	6.6	4.7	4.5	1.8	2.2	1.3	4.6	4.2	1.6	1.9	7.5	7.8	1.0	1.1	3.7	18.3	1.0	6.3	2.9	3.0	2.1	6.6	0.3	2.1	5.4	2.3	1.3	3.1	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	1.5	32.3	0.0	0.0	0.3	0.1	0.5	5.7	0.5	0.6	0.0	0.0	2.4	0.0	0.3	0.3	0.1	0.2	0.4	1.8	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.3	2.7	3.1	0.4	5.3	0.5	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.7	0.2	1.0	0.3	0.0	1.3	0.7	0.7	0.1	1.0	0.0	1.2	1.6	0.3	0.5	0.0	1.6	0.2	0.2	4.7	0.0	0.1	0.0	0.9	0.3	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	6.3	5.2	5.6	6.0	3.9	6.6	4.7	4.2	6.6	244.2	14.1	0.0	0.4	7.9	119.6	16.1	0.0	1.4	51.2	1.8	39.3	0.0	3.3	0.4	5.4	0.8	11.0	0.0	0.2	0.1	5.2	0.9	1.1	5.3	0.5	31.8	3.5	0.6	5.1	2.7	24.5	6.8	1.7	6.4	3.3	83.1	0.9	4.9	7.1	9.0	5.6	6.5	8.1	0.1	0.7	2.5	0.0	0.0	0.9	1.6
NCKAP5L	KIAA1602	ENSG00000167566	"NCK associated protein 5 like"	Q9HCH0	12	49791146-49828750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 106.0;Leydig cells: 63.3;Peritubular cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041034	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA041034: AB_10796235"	"unprognostic (3.35e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.15e-1)"	15.8	21.5	8.2	13.1	13.4	6.3	8.8	12.7	15.3	11.1	8.8	26.2	4.0	6.6	10.5	10.8	8.0	10.1	11.7	16.3	10.1	9.0	10.1	8.2	13.4	8.6	19.7	6.0	13.0	10.9	11.2	11.6	18.8	14.4	11.8	2.9	16.0	11.3	11.0	14.8	6.7	5.7	10.4	11.1	12.7	6.7	12.3	17.1	16.2	11.4	10.0	6.5	9.7	8.1	0.6	2.3	1.0	2.6	0.8	0.7	1.0	3.4	5.8	10.3	10.2	6.6	5.0	13.8	5.8	6.3	8.5	7.1	8.0	1.0	2.0	10.1	5.9	3.3	1.1	4.2	6.1	2.3	2.1	5.9	7.5	6.9	7.7	16.7	2.9	16.4	11.6	7.2	9.2	4.3	10.8	10.0	7.7	7.2	0.0	5.4	8.2	7.5	10.5	12.4	1.1	6.6	9.3	10.7	0.6	6.6	4.7	3.6	16.3	8.9	9.7	16.2	5.9	16.9	6.1	7.8	8.1	8.6	4.1	2.7	0.2	0.0	2.6	6.5	3.4	2.3	0.2	2.6	0.0	0.5	1.9	0.6	0.2	0.2	0.6	2.1	0.6	0.4	0.7	1.0	0.8	1.8	2.3	0.1	1.0	8.2	13.4	12.7	15.3	10.1	9.0	19.7	6.0	14.4	17.1	6.0	1.4	2.2	7.6	11.3	44.8	2.5	5.1	5.3	6.8	10.4	106.0	9.2	0.0	5.2	1.0	9.8	0.5	0.0	3.3	10.9	19.9	4.5	0.0	4.9	14.2	28.6	8.6	9.8	10.4	1.7	63.3	14.0	5.0	3.6	1.1	8.0	2.8	0.0	77.8	1.7	23.5	0.0	14.2	2.6	4.9	6.4	2.1	5.0	0.8	3.1
NCLN	"NET59, NICALIN"	ENSG00000125912	Nicalin	Q969V3	19	3185563-3209575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006625	Approved		Approved	"Nucleoplasm,Lipid droplets"		NA	NA		12000	"Lipid droplets"	Nucleoplasm	"HPA006625: AB_1079453"	"unprognostic (4.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-4)"	"unprognostic (8.55e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (8.37e-5)"	"prognostic favorable (8.82e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	15.8	27.4	10.2	18.2	15.3	31.1	10.2	21.2	23.6	9.3	20.4	14.7	14.9	32.9	12.7	7.2	14.1	11.0	15.5	10.5	12.2	8.5	13.3	48.3	15.5	19.8	9.7	9.0	12.1	41.3	9.5	11.5	11.3	10.8	13.3	9.7	13.0	18.7	9.9	16.3	14.9	27.8	9.5	8.0	20.6	18.9	17.2	12.1	11.8	11.8	11.8	13.2	9.4	11.8	5.3	17.8	8.8	12.2	4.3	7.7	7.1	27.0	31.6	7.9	24.4	7.8	6.4	20.5	29.8	12.5	22.5	18.3	42.8	15.7	16.3	26.0	19.5	14.4	32.1	9.3	22.7	5.0	21.4	21.4	11.4	19.5	29.1	15.5	20.3	21.3	11.2	14.4	18.1	9.9	5.7	12.4	16.2	29.2	18.3	10.2	24.0	17.6	21.7	22.2	16.1	22.4	28.6	8.4	26.0	13.3	18.6	17.0	16.8	12.0	22.5	18.9	4.0	16.3	23.4	16.7	19.5	17.0	31.8	35.9	23.0	20.8	12.6	20.6	26.1	29.9	1.1	11.9	8.8	6.9	12.2	6.1	5.3	4.2	7.7	8.7	4.4	4.6	6.1	7.3	4.3	4.9	17.8	3.8	7.1	10.2	15.3	21.2	23.6	12.2	8.5	9.7	9.0	10.8	12.1	14.9	17.1	21.6	7.6	7.3	14.5	8.7	17.8	5.3	9.1	10.4	9.8	17.5	3.3	30.0	12.3	11.3	71.0	0.0	31.8	38.3	11.6	13.6	16.1	39.4	37.7	22.3	12.1	14.7	22.2	39.2	8.6	12.5	13.5	14.4	38.1	5.0	30.8	40.3	8.5	10.3	12.2	12.9	10.3	12.5	18.3	10.9	14.2	12.8	53.7	13.3
NCOA4	"ARA70, DKFZp762E1112, ELE1, PTC3, RFG"	ENSG00000266412	"Nuclear receptor coactivator 4"	Q13772	10	46005088-46030714	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 30.2;granulocytes: 100.1;monocytes: 40.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051260, HPA065208"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			Nucleoli	"Golgi apparatus, Cytosol"	"HPA051260: AB_2681412, HPA065208: AB_2685432"	"unprognostic (4.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (8.04e-6)"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	18.5	6.9	5.5	9.5	10.0	17.4	10.0	5.5	11.3	10.8	22.5	13.6	5.9	27.0	9.9	9.4	17.0	6.3	9.0	16.6	5.7		20.8	40.9	11.6	11.6	8.7	7.1	11.0	9.1	9.3	9.6	28.4	13.5	14.7	12.4	9.9	12.6	8.5	15.5	6.8	36.4	11.2	9.7	23.8	8.9	6.4	8.1	26.8	13.2	13.9	16.3	13.0	6.4	7.3	30.2	100.1	40.4	13.4	10.9	53.9	31.8	13.5	15.9	16.3	42.1	38.2	39.8	29.3	47.4	28.9	28.4	20.8	23.6	36.0	35.3	47.8	16.2	32.6	16.6	32.3	32.3	25.4	17.1	24.3	18.6	59.4	29.5	61.8	54.3	37.1	32.4	24.6	41.4	30.9	42.5	18.2	26.4	21.7	39.4	14.2	30.0	23.2	9.6	24.6	8.0	17.8	23.1	21.5	34.6	27.1	16.0	10.8	29.6	33.8	29.3	32.9	24.4	30.4	39.1	17.9	21.5	18.9	19.7	16.2	17.3	35.8	22.4	52.1	9.5	69.1	40.4	70.7	10.0	26.8	10.9	7.3	9.4	9.5	30.2	6.6	10.2	8.6	100.1	13.4	30.4	9.3	10.8	53.9											47.6	78.0	32.8	33.2	44.0	13.3	136.0	38.2	50.9	59.1	41.8	27.5	85.3	68.0	41.7	72.4	47.2	113.4	186.9	45.2	92.9	44.2	51.5	191.6	148.1	148.2	19.1	25.8	53.4	209.6	51.8	34.5	96.2	49.0	73.1	41.3	37.9	41.1	57.5	44.6	100.4	11.3	12.9	47.2	22.7	15.1	49.4	132.3	41.5	50.4	45.0
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932030	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 348.4;Ciliated cells: 413.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	32.0	37.6	24.8	26.6	33.7	23.1	20.4	39.7	32.6	19.2	18.0	17.9	3.9	19.8	13.9	6.4	22.7	11.3	28.9	12.3	23.2	24.1	33.7	21.5	30.8	19.0	35.7	25.6	12.5	11.8	7.4	49.3	8.0	39.5	12.2	18.4	7.6	31.6	8.5	6.3	8.7	23.1	17.1	30.9	16.2	18.7	4.9	35.4	4.7	15.6	12.0	16.6	44.1	20.8	12.8	22.6	10.5	8.8	9.1	17.5	3.5	4.3	11.9	0.7	5.3	26.6	15.8	7.8	5.9	23.5	7.3	10.1	11.0	4.1	17.4	31.9	3.2	36.1	25.8	4.0	4.0	4.5	37.0	4.6	8.9	15.2	4.1	15.1	5.0	8.5	11.2	9.8	7.0	5.4	13.1	15.2	5.7	12.5	10.4	4.5	4.9	4.9	5.3	0.9	10.8	2.4	3.7	1.8	3.2	13.0	29.9	12.2	10.6	30.2	8.2	13.2	2.3	2.0	6.6	8.7	1.7	3.7	8.6	4.4	12.8	10.4	9.1	3.7	7.1	5.8	10.5	8.1	2.8	14.1	6.3	17.5	12.8	13.4	11.2	6.5	7.5	7.4	7.2	5.0	9.1	8.8	22.6	5.2	3.5	24.8	33.7	39.7	32.0	23.2	24.1	35.7	25.6	39.5	35.4	291.8	348.4	26.9	190.5	87.1	48.0	8.5	68.8	413.6	277.5	59.3	41.2	6.8	68.0	215.9	0.7	103.4	38.3	0.0	123.8	8.9	57.0	95.1	35.9	21.9	11.7	35.0	34.3	88.4	26.4	3.2	39.1	30.8	49.0	32.5	25.4	86.2	116.6	101.7	27.6	77.2	48.8	12.9	29.8	8.4	33.0	51.8	3.2	39.2	37.9	172.9
NCR1	"CD335, LY94, NK-p46, NKP46"	ENSG00000189430	"Natural cytotoxicity triggering receptor 1"	O76036	19	54906150-54916140	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 5.5;lymphoid tissue: 13.9"	"Cell type enriched"	"Detected in some"	9	"T-cells: 10.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049311			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049311: AB_2680707"	"unprognostic (3.92e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.87e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.32e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.05e-3)"	1.4	0.2	0.1	3.7	0.4	2.1	0.3	0.1	0.3	0.3	2.1	0.0	0.5	0.1	1.2	1.3	0.3	0.2	2.1	1.9	0.2	0.2	0.3	2.5	5.5	3.8	0.2	0.0	0.2	0.1	0.1	0.2	0.4	0.0	0.6	0.2	1.0	0.4	0.1	0.3	0.5	3.4	1.2	0.2	13.9	0.3	0.4	0.0	2.0	0.3	0.1	2.6	0.7	0.3	0.2	0.2	1.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1
NCSTN	"APH2, KIAA0253"	ENSG00000162736	Nicastrin	Q92542	1	160343272-160358952	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021982, HPA054846, HPA070642"	Approved		Approved	Cytosol		NA	NA		120000	Cytosol		"CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.75e-9)"	"unprognostic (1.36e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.89e-2)"	25.6	23.8	12.7	15.3	20.9	12.8	23.3	15.8	24.3	21.8	24.1	39.0	16.5	31.7	24.1	23.3	23.3	19.9	19.5	23.7	13.8	13.9	25.3	37.8	24.7	19.8	28.2	14.2	29.5	41.3	38.9	21.8	63.3	21.5	18.5	24.6	25.1	49.2	19.6	24.2	20.2	38.5	20.7	25.4	25.8	21.4	22.4	22.8	20.3	25.9	13.6	20.6	26.1	20.1	12.5	28.8	27.0	30.5	13.1	11.1	16.8	10.4	12.9	22.2	18.1	68.0	34.4	24.5	21.5	39.4	20.9	24.6	10.0	30.8	7.7	44.8	44.0	14.5	17.8	10.0	20.5	17.7	12.3	8.8	7.3	16.0	15.0	27.0	15.8	33.7	35.0	20.4	19.9	20.8	45.9	30.6	11.9	13.6	22.2	29.8	7.3	5.6	8.3	18.1	27.3	7.2	7.7	13.7	21.7	29.2	14.6	7.4	16.7	23.2	26.5	15.7	37.0	23.7	39.5	24.6	15.7	10.3	10.9	16.3	28.8	40.7	7.7	24.5	10.0	28.6	17.8	29.9	25.0	11.1	30.5	10.4	12.5	9.5	9.5	28.8	11.2	9.9	9.4	27.0	13.1	27.9	16.9	10.0	16.8	12.7	20.9	15.8	24.3	13.8	13.9	28.2	14.2	21.5	22.8	6.0	9.4	20.1	21.7	9.3	17.2	15.2	35.7	12.0	12.5	50.6	49.1	93.6	6.6	34.8	2.1	17.5	49.8	0.0	23.7	84.3	24.4	16.5	12.7	26.8	52.0	17.5	19.4	28.3	43.7	3.1	25.0	26.3	16.9	14.4	31.1	35.8	29.7	28.1	19.8	21.9	19.7	25.8	15.0	43.2	41.7	9.9	123.2	16.0	27.7	17.4
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765460-53838860	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	8.8	6.7	3.3	8.6	5.7	4.9	12.9	10.9	7.7	4.8	8.4	5.1	1.9	6.2	6.0	5.4	11.0	5.3	2.9	5.5	4.3	2.8	4.9	11.7	4.4	10.6	8.0	1.5	4.6	6.0	7.6	5.5	5.5	6.6	4.0	10.7	5.5	6.4	3.7	7.1	6.8	6.5	5.0	7.5	7.1	5.8	17.4	7.5	9.1	5.8	6.7	13.0	6.4	5.8	5.5	3.8	2.0	7.2	4.0	8.2	3.4	20.0	10.6	14.4	14.7	5.3	5.4	17.0	13.8	10.3	21.6	17.5	15.6	13.5	39.6	9.0	6.1	17.5	24.2	24.3	14.3	30.6	9.8	17.5	19.3	15.5	13.2	5.0	30.9	11.0	3.2	5.7	21.3	12.7	6.3	13.0	14.8	22.0	5.7	11.8	7.2	15.1	12.3	34.3	17.0	16.9	17.1	23.3	21.6	10.1	13.8	8.7	11.1	12.3	24.0	11.8	16.0	18.6	16.4	7.6	11.3	11.3	15.5	24.7	6.3	15.6	28.2	9.4	23.5	14.1	0.0	3.2	2.0	4.5	7.2	6.9	5.5	4.3	4.0	3.8	4.1	8.2	6.3	0.2	4.0	4.5	3.3	4.7	3.4	3.3	5.7	10.9	7.7	4.3	2.8	8.0	1.5	6.6	7.5	6.0	4.6	3.7	6.1	9.0	4.1	7.6	2.5	2.7	2.3	5.2	2.0	8.2	0.0	5.9	1.7	4.8	3.3	0.0	7.7	16.4	5.9	5.0	7.0	5.9	10.3	3.2	0.0	4.3	9.1	1.7	2.6	6.7	6.8	2.8	8.4	4.1	6.1	2.9	3.2	4.5	3.2	6.5	4.7	9.3	13.1	7.4	5.7	4.1	15.1	5.4
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80, kinetochore complex component"	O14777	18	2571511-2616635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 51.3"	"Cell type enhanced"	"Detected in many"	15	"Erythroid cells: 23.3;Spermatocytes: 84.6;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066330			Supported	Nucleoplasm,Centrosome		NA	Yes			Nucleoplasm	Centrosome	"HPA066330: AB_2685661"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	2.9	1.3	0.8	15.3	0.8	14.6	0.9	0.7	0.9	2.9	3.8	0.8	0.6	2.7	4.2	3.8	8.3	1.3	1.8	2.7	0.6	0.4	1.6	1.4	2.9	10.1	0.6	0.8	1.2	0.8	0.0	0.6	6.0	1.1	4.3	5.1	0.8	1.9	7.6	0.6	4.0	4.8	2.2	0.6	7.9	3.0	15.9	0.6	51.3	0.9	8.1	9.9	2.2	6.7	7.9	1.6	9.3	0.7	2.2	11.5	1.4	21.9	5.0	24.8	11.0	1.3	3.0	12.8	25.8	13.9	33.8	28.9	13.6	12.5	24.0	11.7	10.0	14.3	13.6	27.7	11.1	35.8	9.0	7.0	18.9	14.2	10.4	0.5	36.2	15.9	1.5	1.0	19.4	13.8	3.5	15.3	14.9	15.4	30.6	29.5	9.9	17.6	15.8	12.8	14.2	7.3	19.5	25.4	19.2	8.8	10.6	20.1	9.0	23.6	6.2	9.4	10.3	10.4	14.5	9.3	22.1	49.2	17.4	34.0	13.4	21.1	32.2	9.7	16.8	18.6	3.7	0.7	2.8	2.2	0.6	2.0	7.9	3.7	4.3	0.3	5.7	2.4	2.4	9.3	2.2	0.5	1.6	11.5	1.4	0.8	0.8	0.7	0.9	0.6	0.4	0.6	0.8	1.1	0.6	0.0	1.1	3.7	0.8	2.1	0.0	17.3	0.0	1.4	3.4	0.0	0.0	1.7	0.0	0.9	9.7	0.3	0.2	23.3	0.3	20.1	1.9	0.1	0.0	0.0	9.3	0.0	0.0	6.2	2.5	3.6	6.9	2.2	0.0	0.0	0.9	0.0	0.2	0.0	21.9	0.1	0.0	19.4	3.1	84.6	25.0	0.5	1.7	6.9	2.3	0.9
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687330	"Plasma proteins, Predicted membrane proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 218.9;Peritubular cells: 195.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.5;plasmacytoid DC: 4.3"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 20.6;ASC diff: 20.3;HSkMC: 27.3;NTERA-2: 16.4;SuSa: 22.6;U-2 OS: 30.6;U-266/70: 19.4;U-266/84: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA074457: AB_2686691"	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	29.9	35.5	19.2	7.7	39.1	1.3	25.0	2.6	28.2	32.7	12.9	12.9	8.1	8.0	29.9	17.7	12.3	21.4	19.1	20.3	18.1	40.3	6.9	3.0	10.3	8.9	14.8	17.6	50.7	7.1	2.1	23.2	22.4	19.0	18.8	8.1	16.5	9.2	29.3	9.2	4.7	8.4	23.5	11.8	11.8	8.6	16.4	7.3	7.1	8.4	8.7	4.9	13.1	17.3	0.0	4.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	20.6	0.0	20.3	7.8	0.0	13.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	3.9	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	12.0	27.3	0.0	3.8	0.0	0.0	0.0	8.0	0.4	0.0	6.7	0.0	9.7	0.0	16.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.1	0.0	22.6	3.5	0.0	0.0	0.9	30.6	0.0	0.0	19.4	18.0	0.0	2.1	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.6	4.3	0.0	0.0	19.2	39.1	2.6	28.2	18.1	40.3	14.8	17.6	19.0	7.3	23.8	8.3	0.0	15.5	11.6	59.9	32.5	12.7	6.7	2.3	12.2	19.6	1.7	19.9	16.4	1.9	15.7	4.6	0.0	9.4	1.1	70.8	4.8	0.0	0.2	6.3	47.7	6.4	30.1	7.8	3.8	218.9	3.2	37.1	0.0	4.5	81.6	7.3	0.0	195.2	0.5	41.1	97.0	76.9	10.9	21.7	7.2	2.1	0.7	6.9	3.1
NDOR1	"bA350O14.9, NR1"	ENSG00000188566	"NADPH dependent diflavin oxidoreductase 1"	Q9UHB4	9	137205685-137217009	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA024504	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA024504: AB_1854338"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.74e-3)"	9.6	11.4	10.6	18.4	17.4	29.2	10.0	15.0	16.2	9.4	10.4	18.7	7.4	19.1	11.4	10.5	11.2	11.0	10.4	7.4	11.6	7.7	12.1	9.4	11.6	20.5	18.6	8.6	10.2	14.7	9.7	12.2	9.2	13.5	13.0	6.8	12.5	17.3	16.1	6.5	18.5	16.5	8.7	14.2	19.9	13.9	22.2	14.2	20.6	14.4	4.9	15.8	9.7	9.4	2.7	3.7	6.6	4.8	1.6	4.0	3.0	7.2	10.9	7.5	11.4	3.2	3.2	22.5	10.6	4.9	10.4	7.2	10.9	8.6	10.1	8.4	4.1	8.3	27.1	5.4	7.5	2.1	13.0	8.4	9.0	26.2	5.8	5.3	10.1	19.3	4.3	5.3	11.6	4.3	2.8	4.8	13.7	14.5	10.8	3.7	13.0	10.4	17.9	11.9	6.7	13.6	19.2	8.8	14.4	3.3	6.3	9.4	9.3	8.8	8.9	5.5	3.4	14.4	11.7	6.2	19.1	12.5	22.0	11.8	6.7	13.2	10.5	8.3	9.2	10.8	1.7	4.4	6.3	3.2	4.8	2.7	1.3	2.8	2.7	3.7	2.7	1.6	1.4	6.6	1.6	3.8	2.4	4.0	3.0	10.6	17.4	15.0	16.2	11.6	7.7	18.6	8.6	13.5	14.2	0.0	1.6	0.8	0.6	0.5	0.2	1.1	0.0	0.0	2.3	3.5	0.0	4.2	1.7	0.9	0.6	1.5	2.2	0.0	1.0	2.8	0.6	0.5	1.1	0.6	2.3	0.0	2.4	1.8	3.7	0.8	0.6	1.6	1.7	4.6	1.4	0.1	1.5	0.8	0.4	1.1	1.0	0.0	0.8	1.9	1.1	0.3	3.1	0.0	1.7	0.7
NDP	"EVR2, norrin"	ENSG00000124479	"NDP, norrin cystine knot growth factor"	Q00604	X	43948776-43973504	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 40.4"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 100.6"	"Cancer enhanced"	"Detected in many"		"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	17	"U-87 MG: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15.0	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18.0	0.9	1.4	14.0	7.8	0.7	0.5	0.6	0.7	11.0	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0.0	1.2	0.0	0.7	1.0	1.7	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.1	1.1	0.7	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	41.2	0.4	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	18.6	14.6	15.0	14.0	7.8	11.0	10.9	13.1	12.2	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	12.4	0.0	0.0	0.0	0.0	100.6	0.7	0.0	9.2	0.0	3.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 310.5;skeletal muscle: 253.0"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 411.1;Leydig cells: 322.7;Muller glia cells: 402.9;Sertoli cells: 588.6"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"myeloid DC: 54.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 54.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 27.9;HMC-1: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		150000	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	19.3	45.3	140.2	4.8	135.1	1.4	50.3	93.5	110.0	35.5	21.0	89.6	23.8	12.2	30.7	44.4	37.3	29.5	21.5	45.2	103.6	86.1	24.3	84.8	13.7	7.7	128.9	73.5	79.7	15.5	35.6	6.0	8.1	95.4	23.7	18.8	8.9	310.5	37.3	253.0	18.9	12.0	22.0	73.0	21.1	11.2	5.2	71.2	0.4	13.6	53.4	16.1	13.9	19.3	1.8	54.5	0.4	1.8	0.7	5.4	4.0	5.3	1.1	3.4	6.4	0.5	0.0	0.5	0.1	2.2	2.0	1.1	7.4	10.0	0.3	2.0	0.1	3.2	8.8	15.3	3.1	2.7	0.0	5.5	6.9	1.2	27.9	0.7	0.6	20.0	6.1	6.7	0.4	0.9	3.2	0.0	6.3	13.9	0.6	0.3	4.5	2.4	1.9	9.1	17.3	0.4	7.1	0.3	1.6	3.8	13.6	0.0	9.9	1.5	1.7	7.0	9.3	13.5	4.0	0.0	0.6	10.9	0.2	0.2	3.1	2.2	0.1	0.9	0.1	2.3	0.0	1.8	0.2	2.4	0.4	3.2	1.8	3.6	3.3	54.5	1.3	5.4	4.0	0.4	0.7	0.0	1.9	2.4	4.0	140.2	135.1	93.5	110.0	103.6	86.1	128.9	73.5	95.4	71.2	0.0	14.8	8.5	70.8	25.4	6.7	160.9	140.1	20.1	13.6	38.4	9.8	8.0	411.1	69.3	4.7	52.6	25.5	0.0	18.9	0.6	20.1	71.2	47.4	183.0	19.8	3.2	32.1	116.6	25.7	5.9	322.7	43.4	305.4	6.4	71.2	402.9	14.6	28.8	156.3	32.0	12.8	588.6	188.5	1.1	3.4	26.6	18.1	10.1	86.6	132.0
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 50.8"									HPA051515	Approved		Approved	Cytosol		NA	NA		72000	Cytosol		"HPA051515: AB_2681517"	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	12.6	14.6	7.9	19.2	11.3	37.5	11.8	30.2	12.2	16.6	10.7	13.8	13.4	8.9	18.4	14.8	14.4	12.8	15.5	9.3	9.6	8.4	11.0	9.4	14.7	21.9	7.3	8.8	15.1	12.3	17.3	26.5	14.1	9.2	13.6	10.5	14.7	20.1	17.2	16.4	15.1	14.4	13.4	7.5	31.8	11.8	13.5	9.2	35.3	12.2	8.2	19.3	12.3	13.3	3.1	6.8	5.8	5.3	2.2	7.1	3.2	4.3	3.6	7.5	11.5	9.3	10.8	3.9	5.1	10.9	5.9	6.1	1.9	5.3	3.9	3.1	9.7	6.0	5.0	3.7	5.4	4.8	10.4	3.6	3.9	2.7	3.0	16.4	5.0	50.8	10.2	6.6	10.2	10.5	18.4	7.7	7.9	3.7	15.1	7.4	3.3	5.8	5.5	2.1	2.7	15.3	3.6	3.7	2.4	5.0	3.0	2.5	4.2	4.5	10.7	3.5	5.2	8.2	7.7	12.3	3.0	3.5	3.9	3.6	7.5	3.3	5.2	3.5	7.7	2.3	1.4	5.3	2.1	5.5	3.7	6.5	2.5	4.7	4.8	4.0	3.1	5.6	7.1	5.8	2.2	3.5	6.8	3.1	3.2	7.9	11.3	30.2	12.2	9.6	8.4	7.3	8.8	9.2	9.2	0.0	4.8	3.7	0.3	1.1	0.6	1.4	0.0	4.0	2.3	0.0	0.0	1.2	0.0	4.4	5.7	0.5	3.5	0.0	8.4	1.4	1.0	1.5	13.9	3.8	4.5	1.6	2.4	0.0	6.7	6.8	0.0	3.5	1.7	4.6	2.3	0.7	5.5	2.6	0.0	5.6	0.7	0.0	1.0	2.4	1.4	1.4	5.1	3.2	1.7	2.1
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871487-119876662	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 144.8;skeletal muscle: 138.8"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3052.5;Distal tubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029768, HPA054359"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA029768: AB_2673192, HPA054359: AB_2682461"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	24.5	30.1	37.9	20.1	42.5	25.2	23.8	27.9	37.8	19.7	38.4	8.7	27.3	41.0	13.5	25.8	21.6	15.9	24.8	144.8	30.1	28.5	46.0	40.2	21.1	22.2	34.6	32.8	14.6	40.4	22.7	21.7	15.4	29.5	17.9	31.1	15.5	38.4	29.6	138.8	12.1	34.6	19.3	31.5	17.1	28.1	7.7	21.1	9.2	16.2	67.4	16.7	14.0	14.9	66.3	90.5	96.3	85.7	49.8	75.5	73.8	33.6	36.4	26.0	27.7	31.4	19.9	32.6	26.6	24.3	18.7	23.4	20.3	28.2	27.5	41.1	27.8	40.0	32.5	36.5	25.6	21.5	37.9	50.4	28.5	66.4	45.5	24.4	43.5	31.7	32.4	34.8	19.9	15.5	30.6	23.2	28.1	15.5	42.7	25.7	59.6	30.9	41.2	38.4	87.9	65.0	31.3	24.8	82.5	56.4	48.0	19.0	25.1	54.7	67.9	36.5	36.6	17.2	51.3	29.9	16.0	16.2	33.2	51.9	39.4	48.8	35.9	29.0	51.7	19.7	96.3	79.0	91.6	60.2	80.4	57.1	66.3	67.1	62.8	84.0	52.7	56.1	65.7	94.6	49.8	85.7	90.5	75.5	73.8	37.9	42.5	27.9	37.8	30.1	28.5	34.6	32.8	29.5	21.1	148.9	173.3	221.0	195.7	189.9	139.0	3052.5	636.9	330.6	205.9	533.9	74.6	331.6	1856.9	408.0	28.1	249.5	1244.9	256.9	444.8	351.6	251.4	215.4	204.5	881.4	567.3	77.9	441.2	254.8	408.9	27.3	272.7	346.6	541.6	587.1	745.3	168.3	446.0	706.9	268.0	1089.7	161.0	213.4	269.6	46.1	78.8	217.9	318.3	243.7	663.1	282.7
NDUFA4	"CI-9k, MLRQ"	ENSG00000189043	"NDUFA4, mitochondrial complex associated"	O00483	7	10931951-10940256	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.9;skeletal muscle: 151.6"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 3966.4;Distal tubular cells: 3355.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055323, HPA078265"	Approved		Approved	Mitochondria		NA	NA		18000	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	21.9	22.0	72.8	13.6	55.3	19.8	27.0	33.1	74.4	20.5	18.3	12.0	16.8	25.1	16.9	29.6	15.8	20.2	16.7	149.9	56.1	32.1	46.2	46.7	15.9	13.5	47.6	48.9	17.1	23.7	18.9	5.6	11.4	33.0	23.1	20.4	14.1	36.0	31.1	151.6	12.1	17.3	21.4	26.3	13.6	23.6	7.4	23.2	6.8	20.4	60.1	15.6	15.8	11.6	29.0	41.1	52.8	39.6	21.7	37.5	48.0	11.4	19.7	33.6	38.7	19.1	18.0	15.5	14.5	13.8	13.7	12.1	24.7	31.5	22.4	13.9	20.9	37.5	20.3	22.3	17.3	15.0	11.0	16.3	18.7	23.2	23.0	16.7	25.8	18.5	19.3	17.4	16.7	14.8	26.1	19.0	20.2	27.8	30.5	28.5	22.1	11.5	22.7	36.8	78.1	40.0	15.6	24.0	25.1	34.7	24.9	21.1	21.9	23.1	66.5	13.1	49.0	42.0	31.7	16.6	16.3	22.6	23.4	24.0	18.5	23.6	25.7	22.6	27.9	50.7	52.8	32.5	44.4	23.4	38.6	27.4	29.0	32.7	29.3	41.1	22.0	34.1	29.7	7.4	21.7	39.6	38.5	37.5	48.0	72.8	55.3	33.1	74.4	56.1	32.1	47.6	48.9	33.0	23.2	455.6	386.9	389.1	472.6	361.6	472.0	3966.4	996.2	704.0	533.5	903.7	251.3	756.7	3355.6	748.9	115.7	549.6	532.5	186.9	833.3	599.3	543.2	716.7	552.0	1498.2	844.7	149.4	201.3	748.3	552.8	81.7	457.0	587.9	868.9	625.8	610.1	384.0	636.5	584.4	737.2	2069.7	472.4	329.8	932.8	105.9	274.8	422.2	550.9	350.3	618.2	678.3
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581002-23596356	"Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 118.2;skeletal muscle: 112.0"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 1253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054364, HPA076020"	Approved		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA054364: AB_2682463, HPA076020: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	21.6	25.5	29.4	14.8	28.0	15.1	20.4	21.2	37.7	13.4	31.2	11.4	16.2	30.2	13.7	15.5	19.4	16.2	17.4	118.2	24.1	25.6	32.5	38.8	12.0	15.2	27.0	21.6	10.9	29.1	21.9	18.6	15.2	23.3	16.0	26.5	15.3	24.3	19.2	112.0	12.4	25.7	18.1	15.5	14.0	20.1	11.4	11.5	14.5	15.8	54.3	16.7	13.4	12.7	39.3	61.8	17.4	49.3	25.0	39.5	43.1	28.2	20.9	26.2	23.3	18.7	20.2	36.4	21.8	16.2	22.0	18.1	18.1	23.0	46.8	35.8	15.7	27.4	23.4	45.5	25.9	17.5	26.5	52.6	25.1	37.5	88.9	19.6	46.6	20.9	18.8	36.0	16.2	17.5	20.7	27.9	42.3	52.6	23.8	23.8	42.8	36.0	70.9	68.0	42.2	48.6	49.6	29.5	63.7	20.2	25.4	36.0	28.1	24.4	44.7	40.7	30.1	36.1	39.0	21.9	20.2	21.2	19.5	29.9	30.4	44.2	52.5	22.6	37.7	22.8	15.1	43.1	17.4	31.7	49.3	34.6	39.3	37.7	35.0	55.2	34.6	35.2	36.5	8.9	25.0	38.0	61.8	39.5	43.1	29.4	28.0	21.2	37.7	24.1	25.6	27.0	21.6	23.3	11.5	92.3	83.8	96.1	105.6	108.4	80.0	1253.7	109.5	175.3	81.9	106.4	43.2	246.2	600.2	140.5	81.4	113.0	204.9	70.0	182.7	251.9	115.6	117.8	83.1	281.9	233.1	49.3	194.3	96.3	110.6	24.0	89.8	100.2	148.5	155.9	210.6	118.9	192.1	168.4	114.2	541.1	90.3	90.5	123.0	114.6	115.3	124.3	187.8	90.6	317.0	150.7
NDUFAF8	C17orf89	ENSG00000224877	"NADH:ubiquinone oxidoreductase complex assembly factor 8"	A1L188	17	81239239-81241281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 237.1;Exocrine glandular cells: 106.9;Hofbauer cells: 113.1;Proximal tubular cells: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA057732	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057732: AB_2683513"	"unprognostic (4.33e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (5.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-2)"	21.6	24.6	44.7	16.6	45.9	19.1	18.2	16.9	33.3	13.0	18.5	18.3	14.0	13.6	10.1	22.5	12.6	12.1	17.5	28.5	36.6	25.0	23.9	30.0	13.4	14.8	34.8	23.2	13.3	24.5	14.6	15.8	9.3	17.0	14.7	19.3	15.0	22.9	15.1	78.1	9.0	11.7	19.1	22.8	11.5	15.4	10.8	16.4	8.4	11.3	29.0	19.2	10.3	8.8	34.2	46.7	22.9	27.8	25.7	36.5	25.3	29.8	45.4	16.8	16.4	18.9	19.9	17.6	25.9	11.2	18.9	11.0	23.0	13.6	27.4	12.9	19.2	15.8	14.9	15.6	26.3	22.7	6.7	87.6	21.3	48.5	51.4	19.8	30.0	13.6	26.7	32.1	13.6	29.0	20.4	30.1	23.4	25.5	17.6	24.3	28.6	40.7	30.9	9.1	25.4	57.4	25.1	24.0	21.2	20.2	21.5	19.3	24.1	21.9	18.8	26.2	25.9	26.2	28.4	16.9	23.6	34.1	16.8	26.6	23.0	8.1	26.5	21.3	15.9	18.1	12.9	27.8	22.9	26.4	21.3	27.0	34.2	29.9	32.8	28.7	29.3	36.5	35.2	3.7	25.7	24.2	46.7	29.3	25.3	44.7	45.9	16.9	33.3	36.6	25.0	34.8	23.2	17.0	16.4	17.9	15.9	0.0	0.0	0.0	0.0	0.0	0.0	6.7	17.0	96.0	0.0	100.5	237.1	95.7	0.0	0.0	0.0	0.0	106.9	76.2	0.0	0.0	1.1	0.0	113.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	89.2	0.0	0.0	100.1	0.0	0.0	188.8	0.0	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0
NDUFB11	"ESSS, Np15, NP17.3"	ENSG00000147123	"NADH:ubiquinone oxidoreductase subunit B11"	Q9NX14	X	47142216-47145504	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030367	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030367: AB_10603882"	"unprognostic (2.20e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.46e-3)"	16.9	33.4	26.1	21.2	24.8	25.2	29.2	18.9	29.7	17.6	23.3	10.5	24.7	24.2	14.3	25.1	23.3	18.8	24.0	64.4	22.4	20.6	24.4	48.8	18.1	36.5	22.5	22.0	14.9	50.9	15.6	24.5	14.2	24.4	18.1	21.2	13.0	37.0	30.2	164.0	17.3	22.8	16.0	18.3	19.2	22.8	9.7	12.3	30.4	38.5	53.6	21.2	14.3	20.5	58.9	69.0	22.2	44.7	27.7	54.6	59.5	19.9	29.7	23.5	27.1	20.3	17.5	25.0	14.5	16.9	23.8	23.1	31.6	24.5	24.6	12.6	15.8	25.1	25.6	26.4	15.4	16.0	23.7	70.6	14.1	40.6	26.1	20.4	23.6	21.7	19.1	14.1	20.6	13.7	15.3	17.7	32.1	16.8	32.4	13.3	45.1	27.8	65.3	36.7	23.8	54.6	30.3	23.2	55.8	24.1	21.3	43.3	32.0	27.6	31.8	22.0	31.3	45.6	30.9	13.5	16.7	22.8	31.0	17.0	32.0	27.9	27.5	18.2	14.8	22.2	22.2	44.7	19.8	34.0	32.0	42.2	58.9	48.4	39.0	52.8	52.8	54.6	43.6	9.5	27.7	23.7	69.0	51.0	59.5	26.1	24.8	18.9	29.7	22.4	20.6	22.5	22.0	24.4	12.3	98.3	106.3	255.4	204.6	230.6	88.2	209.9	272.6	84.3	121.7	275.7	35.3	385.7	494.0	274.0	3.3	148.1	318.7	303.7	319.8	368.1	203.9	216.1	191.4	557.4	340.7	52.4	317.3	186.6	292.7	7.4	168.2	251.5	251.4	301.2	382.3	151.0	288.4	321.1	165.9	606.1	75.5	161.7	184.4	17.2	37.7	253.9	377.1	200.3	398.2	277.3
NDUFB2	"AGGG, CI-AGGG"	ENSG00000090266	"NADH:ubiquinone oxidoreductase subunit B2"	O95178	7	140690777-140722790	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 153.5"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051377	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA051377: AB_2681460"	"unprognostic (1.17e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (7.60e-7)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	25.1	31.2	45.1	19.9	52.5	20.2	27.3	29.1	43.3	21.5	39.0	26.0	25.1	28.3	20.1	29.5	27.7	22.0	25.7	105.5	37.0	36.0	46.6	41.2	18.4	23.8	46.0	35.6	14.5	47.0	26.5	23.9	17.7	33.3	20.7	30.8	28.1	37.6	27.4	127.2	17.2	28.1	38.1	37.7	19.7	26.9	14.3	25.2	15.6	57.6	48.1	21.1	25.5	17.5	94.7	116.5	55.2	108.5	75.9	87.8	153.5	41.1	67.0	24.0	52.4	38.6	39.2	34.9	29.9	26.2	31.0	29.6	51.7	41.1	31.3	44.8	36.2	58.7	20.4	21.4	42.1	24.7	52.2	73.6	22.9	57.3	58.1	30.6	35.3	30.9	43.6	36.5	29.4	18.1	26.6	46.1	44.5	38.7	37.9	42.9	122.0	55.3	91.1	55.6	84.7	76.6	31.9	23.4	72.2	62.1	81.8	48.9	48.3	41.0	67.2	35.9	28.6	29.2	40.5	38.4	41.0	24.1	48.4	51.5	36.2	67.2	54.9	62.4	56.8	51.3	55.2	108.5	48.1	83.5	107.8	71.3	94.7	82.1	81.4	116.5	72.9	87.8	87.7	9.0	75.9	97.1	92.8	73.9	153.5	45.1	52.5	29.1	43.3	37.0	36.0	46.0	35.6	33.3	25.2	175.7	232.0	217.4	229.1	201.1	175.8	3102.3	435.7	235.5	197.9	638.6	92.3	489.8	1692.7	343.0	795.3	237.8	727.9	70.0	273.3	377.8	291.6	360.2	272.6	944.1	632.0	131.9	411.8	215.5	261.6	154.7	206.2	385.8	411.7	381.5	493.4	197.7	268.8	531.3	229.1	1640.6	200.8	194.1	278.2	77.7	190.5	245.3	430.7	214.4	506.9	369.0
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596309-120602500	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.7"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 1416.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051739, HPA064441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			Mitochondria	"Nucleoplasm, Nuclear membrane"	"HPA051739: AB_2681585, HPA064441: "	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.79e-4)"	25.5	68.2	37.6	20.1	37.7	22.4	59.4	40.7	51.6	25.6	37.2	19.1	25.6	33.6	23.2	32.2	30.2	24.3	27.8	130.2	32.5	30.8	53.3	46.9	25.4	42.0	37.3	29.4	25.8	36.5	34.1	32.8	18.5	36.7	26.8	34.8	24.6	33.9	29.5	195.7	27.3	30.6	37.6	32.4	22.6	28.7	26.6	25.6	31.1	25.9	64.8	25.4	32.3	29.1	64.5	73.4	52.1	60.5	39.1	79.7	49.0	51.3	37.5	44.9	44.9	28.3	33.8	36.5	28.9	38.4	37.6	41.6	36.4	39.5	26.1	58.7	32.3	47.2	49.8	34.6	36.8	28.4	40.0	39.8	40.3	39.4	36.6	17.2	35.4	47.8	30.5	49.1	18.3	24.1	45.6	46.9	49.7	23.8	40.2	40.3	40.3	70.0	51.3	35.7	84.6	102.8	40.6	25.6	57.4	60.9	32.1	50.6	51.8	33.9	38.0	61.5	31.3	64.0	56.5	36.0	33.3	43.9	14.1	40.2	49.6	44.7	78.9	52.6	49.9	45.1	46.2	46.2	52.1	45.5	60.5	47.4	64.5	63.5	51.3	58.4	47.2	54.8	53.4	28.1	39.1	60.5	73.4	79.7	49.0	37.6	37.7	40.7	51.6	32.5	30.8	37.3	29.4	36.7	25.6	151.8	116.9	147.4	227.4	197.5	114.3	1416.5	333.7	208.8	175.1	303.6	55.0	310.4	1039.5	474.7	797.6	248.2	436.8	93.5	541.7	349.0	180.0	247.2	169.9	411.5	288.6	79.4	286.7	153.4	221.7	73.1	254.9	235.4	411.7	399.5	378.0	175.1	503.3	436.8	260.6	758.9	123.5	252.2	270.2	329.1	90.3	219.8	294.7	162.0	391.3	307.0
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	32.2	39.6	41.3	16.0	44.6	12.1	27.2	20.0	45.7	23.7	32.3	22.0	21.2	43.7	16.2	15.4	26.4	20.0	20.5	86.9	34.1	31.7	48.1	42.3	17.8	21.7	39.4	33.6	22.1	23.2	31.1	18.7	21.3	37.6	19.6	29.9	24.8	35.8	21.3	96.3	17.5	38.5	21.3	30.9	20.4	24.9	21.8	18.4	22.7	27.7	47.3	18.5	26.5	17.3	27.7	41.4	19.5	44.9	14.6	25.0	26.7	23.4	6.6	16.4	19.9	21.7	29.2	22.2	14.9	18.8	21.3	21.6	19.7	17.1	20.5	45.2	12.6	36.6	26.0	17.7	19.7	21.5	42.4	14.8	22.0	12.0	16.4	19.9	26.3	17.5	26.9	25.5	12.0	20.0	22.1	24.4	20.0	18.6	29.9	22.8	16.7	15.1	20.4	23.7	45.5	26.7	16.8	19.0	63.6	38.6	18.1	11.7	19.6	9.0	50.9	35.1	15.4	77.6	42.9	15.7	14.1	13.4	19.2	35.4	39.8	41.2	30.3	22.8	28.2	20.0	19.5	29.9	14.4	13.9	37.6	22.1	27.7	20.0	17.0	41.4	19.5	20.8	21.0	6.7	14.6	44.9	24.0	25.0	26.7	41.3	44.6	20.0	45.7	34.1	31.7	39.4	33.6	37.6	18.4	44.7	44.0	87.9	92.8	75.7	45.3	340.1	112.1	52.2	53.4	83.7	31.4	192.8	431.0	110.3	85.8	85.1	125.2	0.0	92.5	115.9	83.1	75.7	92.3	108.0	222.8	38.1	112.9	97.6	229.9	13.7	75.1	156.2	128.2	124.4	173.7	74.4	86.7	189.4	65.7	379.0	54.1	71.1	81.4	233.1	125.2	77.5	192.3	81.2	242.9	137.2
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.1"	"Cell type enhanced"	"Detected in all"	8	"Cardiomyocytes: 1810.7;Distal tubular cells: 963.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044556, HPA062427"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA044556: AB_10794402, HPA062427: "	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (7.25e-4)"	7.4	17.0	15.2	6.4	15.8	5.6	8.3	12.2	15.7	8.5	13.1	11.8	7.0	15.2	6.6	12.0	11.7	8.3	7.7	55.5	12.4	14.6	20.3	17.1	8.4	6.7	13.0	12.1	9.7	13.1	11.4	14.3	8.9	10.0	8.1	12.6	11.3	10.9	10.5	164.1	9.1	16.4	7.2	10.4	10.5	11.9	27.1	8.5	6.1	11.6	57.6	9.4	7.0	7.3	32.7	40.0	40.8	24.4	12.8	31.4	26.1	8.7	3.7	10.7	13.3	7.7	8.4	8.6	10.8	7.2	8.0	6.1	6.5	11.0	3.8	3.9	7.6	7.9	5.2	20.9	7.1	6.3	5.5	6.7	6.1	7.1	10.4	9.7	5.0	3.3	12.1	10.7	7.6	11.2	10.3	7.9	8.8	14.0	16.4	5.5	6.2	7.4	12.4	8.2	16.4	5.0	6.3	6.6	29.1	12.8	5.7	9.1	6.9	7.7	9.5	4.9	9.0	10.4	9.9	3.9	7.9	3.7	5.5	6.1	13.2	23.2	9.6	8.5	13.3	6.3	16.0	24.4	40.8	21.7	17.3	17.3	28.3	24.4	23.2	24.0	32.7	31.4	23.1	15.4	12.8	18.8	40.0	28.3	26.1	15.2	15.8	12.2	15.7	12.4	14.6	13.0	12.1	10.0	8.5	83.4	126.2	85.5	146.6	124.6	118.7	1810.7	239.5	211.5	137.6	417.0	31.4	127.4	963.3	232.9	260.2	150.4	371.3	93.5	293.9	141.6	109.0	170.1	69.5	334.5	190.8	112.8	212.7	108.1	87.2	30.8	156.8	98.4	253.1	220.0	288.1	223.0	228.9	313.4	194.1	826.9	103.1	97.0	148.0	386.4	224.2	156.7	98.7	62.3	275.8	158.3
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004484, CAB034894"	Enhanced		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"CAB034894: AB_2151118, HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	13.4	22.9	29.7	13.2	46.3	25.5	18.1	23.9	35.0	16.6	28.4	16.5	16.1	31.4	12.7	16.0	19.1	17.3	16.3	45.8	26.0	24.8	34.1	32.0	12.0	13.9	29.4	24.9	12.2	23.0	21.4	17.0	12.0	26.0	13.9	30.9	14.4	20.1	17.4	100.9	15.1	28.9	15.9	17.1	14.2	18.9	15.1	15.4	20.5	16.1	51.6	18.8	14.5	11.7	25.0	36.1	18.7	31.2	16.4	23.8	31.5	11.5	22.0	18.6	19.4	16.1	16.7	15.9	11.0	18.8	27.2	25.9	32.3	20.4	25.8	11.0	15.7	19.3	21.4	26.3	19.8	22.2	13.8	42.5	15.6	30.9	31.2	16.6	38.1	20.3	16.3	14.3	10.3	17.0	11.6	17.1	21.3	22.7	17.8	17.6	35.4	26.1	49.4	26.4	32.0	31.2	31.8	26.9	21.2	23.3	18.1	20.9	15.1	14.1	24.2	24.9	11.6	27.0	36.4	11.9	16.3	18.3	18.9	24.8	20.5	27.1	28.5	16.5	29.3	16.1	12.2	28.6	18.7	18.7	31.2	19.8	25.0	19.7	20.3	33.7	23.1	18.8	20.1	7.5	16.4	25.0	36.1	23.8	31.5	29.7	46.3	23.9	35.0	26.0	24.8	29.4	24.9	26.0	15.4	50.6	35.2	47.4	60.2	58.3	41.3	154.2	96.8	75.0	45.5	66.3	39.3	103.3	343.2	99.0	93.6	59.9	204.6	23.3	97.2	97.6	64.9	43.1	56.6	108.3	166.7	57.2	81.3	52.8	54.3	46.0	62.5	73.9	113.1	83.8	120.8	100.0	80.5	103.7	65.0	231.7	51.0	103.5	79.3	76.9	75.2	66.4	74.5	62.9	167.5	58.5
NDUFS8	"CI-23k, TYKY"	ENSG00000110717	"NADH:ubiquinone oxidoreductase core subunit S8"	O00217	11	68030617-68036644	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 706.2;Proximal tubular cells: 686.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018524, HPA067429"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA018524: AB_1854355, HPA067429: "	"unprognostic (2.90e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (3.27e-8)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.45e-2)"	26.0	62.0	29.9	16.9	40.5	21.0	19.1	18.4	50.1	18.6	24.7	19.7	24.3	34.7	18.2	15.1	28.3	19.0	22.7	82.4	26.5	27.5	50.3	47.6	16.3	19.1	28.3	22.4	20.8	41.3	25.4	26.7	18.0	25.9	22.9	18.3	30.1	41.3	32.2	156.6	17.3	26.7	19.8	18.2	20.3	25.0	21.1	15.7	29.6	29.2	53.9	24.2	19.1	14.8	37.3	66.6	23.6	46.1	59.0	39.6	42.6	26.4	65.7	18.2	24.7	13.6	12.2	23.9	18.8	16.3	29.1	22.7	61.1	28.3	20.5	34.3	16.3	26.2	32.7	20.8	22.8	10.5	24.5	48.0	18.6	41.9	32.1	32.5	17.4	20.5	15.4	23.7	21.4	24.5	16.1	19.5	28.9	19.1	22.2	19.0	62.7	38.3	37.3	22.3	70.4	55.7	26.7	17.7	66.2	36.6	21.5	22.9	18.6	13.7	31.7	66.4	13.6	43.5	19.1	15.1	28.3	24.9	40.9	25.9	30.5	32.0	17.4	45.5	21.0	19.7	15.8	46.1	23.6	39.6	45.1	37.0	37.3	34.2	36.0	63.3	30.2	33.0	36.7	4.4	59.0	24.9	66.6	39.6	42.6	29.9	40.5	18.4	50.1	26.5	27.5	28.3	22.4	25.9	15.7	83.4	69.0	76.7	81.4	75.9	80.5	251.3	155.4	84.3	69.4	202.4	51.1	253.0	706.2	176.2	170.4	79.8	264.8	0.0	174.1	132.3	109.2	89.4	94.6	216.5	241.0	47.7	197.0	64.4	119.9	632.4	93.2	101.9	155.3	202.8	173.3	94.1	168.6	178.9	101.5	686.8	98.3	58.2	128.2	84.2	59.4	101.6	144.2	120.4	242.9	99.3
NECAP1	DKFZP566B183	ENSG00000089818	"NECAP endocytosis associated 1"	Q8NC96	12	8076939-8097859	"Disease related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053980, HPA063300"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA053980: AB_2682331, HPA063300: AB_2684981"	"unprognostic (1.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.56e-1)"	"unprognostic (5.79e-3)"	"unprognostic (5.72e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.94e-2)"	7.5	19.1	25.5	9.2	34.1	6.5	10.5	45.9	53.2	11.9	13.1	9.6	5.1	12.1	8.4	8.1	9.3	12.0	7.8	9.4	27.6	36.8	12.5	11.1	8.5	6.0	19.2	22.1	13.1	17.4	16.3	17.9	11.6	32.5	12.7	13.3	11.1	10.9	10.1	5.0	5.9	11.8	9.0	9.6	7.0	12.0	10.0	7.5	5.3	9.6	4.4	8.0	8.9	5.8	7.0	8.9	25.4	14.3	6.8	12.0	8.5	10.3	9.4	6.8	9.4	15.8	12.0	15.3	22.4	13.6	18.8	18.9	20.4	11.9	5.3	3.9	10.6	14.1	7.2	18.2	11.7	16.1	14.2	14.3	5.8	12.1	10.2	14.4	5.4	17.1	15.3	14.2	20.6	25.8	14.4	13.5	7.9	13.4	7.9	19.9	12.7	9.1	1.8	18.6	29.1	8.7	3.6	16.5	4.9	13.0	15.7	11.0	8.5	11.1	15.8	8.8	22.4	5.3	4.7	13.2	9.1	18.4	10.7	15.4	5.2	9.2	10.8	15.9	6.0	13.2	18.5	11.5	25.4	8.4	11.5	9.4	6.6	7.9	8.6	8.9	7.0	9.5	8.8	18.8	6.8	14.3	4.8	12.0	8.5	25.5	34.1	45.9	47.0	27.6	36.8	19.2	22.1	32.5	7.5	35.7	20.0	25.7	18.8	22.7	49.9	10.1	7.6	12.0	15.9	22.7	25.5	13.2	21.6	14.6	19.8	16.3	20.6	0.0	14.6	12.1	18.7	18.9	28.8	12.1	12.4	27.0	15.5	12.9	12.3	10.2	21.6	22.0	27.0	6.4	14.2	29.7	14.4	14.7	13.8	16.1	43.1	6.5	22.7	14.7	23.0	18.6	18.8	28.0	11.7	17.3
NECAP2	FLJ10420	ENSG00000157191	"NECAP endocytosis associated 2"	Q9NVZ3	1	16440672-16460078	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 296.5;monocytes: 288.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028077	Approved		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA028077: AB_10601273"	"unprognostic (6.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.38e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.58e-2)"	23.6	22.0	13.6	25.0	15.0	12.6	19.4	10.2	13.8	15.9	18.6	19.8	12.6	11.9	18.2	15.9	24.1	17.6	18.6	12.5	12.6	11.0	19.3	23.6	26.5	39.4	17.5	12.2	28.0	19.5	12.0	12.4	37.8	14.4	16.9	15.6	15.6	21.1	11.7	9.8	25.7	19.2	15.5	18.1	48.1	15.1	27.4	14.5	43.3	20.8	15.9	36.1	22.1	17.5	25.7	27.5	24.8	57.1	26.7	47.9	54.4	16.7	9.3	9.7	11.4	19.8	21.5	5.7	19.3	26.4	25.0	22.0	10.0	28.3	15.1	23.2	35.1	11.4	11.2	13.6	19.0	20.7	31.4	14.0	14.8	11.1	13.6	25.8	18.4	13.8	23.9	19.8	17.5	14.4	21.3	40.7	17.2	20.5	49.7	21.7	11.0	17.1	19.4	8.6	12.7	13.3	19.3	8.9	24.1	24.6	9.6	6.1	15.9	14.8	8.8	19.0	15.2	10.0	20.4	47.6	16.2	8.8	18.6	12.9	23.6	22.9	14.8	13.7	26.7	15.6	17.3	40.2	24.8	23.8	53.7	23.3	25.7	40.9	28.1	27.5	23.2	42.2	26.7	15.5	26.7	57.1	16.4	47.9	54.4	13.6	15.0	10.2	13.8	12.6	11.0	17.5	12.2	14.4	14.5	20.8	30.2	42.2	31.9	46.4	24.0	6.5	17.8	24.1	14.8	19.2	296.5	43.0	19.9	64.1	42.7	55.5	29.6	23.3	47.5	51.8	39.4	35.2	26.6	11.0	106.9	14.3	18.0	94.5	78.3	29.5	27.6	75.8	23.6	288.6	28.3	23.1	86.4	42.1	31.8	18.6	50.9	38.8	26.5	25.6	26.1	48.9	41.3	67.3	20.6	51.6
NECTIN2	"CD112, HVEB, PRR2, PVRL2, PVRR2"	ENSG00000130202	"Nectin cell adhesion molecule 2"	Q92692	19	44846175-44889228	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 182.4;Exocrine glandular cells: 136.8;monocytes: 139.7;Pancreatic endocrine cells: 178.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 11.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012759, CAB026138, HPA073459"	Enhanced		Approved	"Nucleoli fibrillar center,Cell Junctions"		NA	NA		3400000	"Nucleoli fibrillar center, Cell Junctions"		"CAB026138: , HPA012759: AB_1846227, HPA073459: "	"unprognostic (3.30e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.05e-1)"	29.5	28.2	7.9	15.6	7.7	5.6	38.0	4.5	9.0	24.2	34.0	9.3	22.3	24.2	23.2	27.4	33.6	16.7	54.1	21.9	10.5	8.1	29.0	53.7	39.6	23.0	8.2	6.8	25.5	20.6	22.5	15.9	45.8	11.2	25.8	14.8	22.9	24.4	28.9	14.6	18.3	42.9	13.8	8.4	31.4	26.2	38.7	5.8	3.8	32.2	19.2	24.1	21.6	31.4	0.0	3.3	11.5	2.6	0.0	0.3	0.7	16.9	20.3	26.2	31.0	13.3	8.1	30.5	14.5	18.0	25.7	29.7	41.9	37.3	0.1	19.6	16.7	13.5	23.2	23.2	12.0	20.5	0.7	12.1	10.3	7.0	27.0	31.9	0.1	27.5	14.1	4.8	12.2	10.0	27.4	33.2	0.6	16.7	0.1	12.8	30.8	0.1	1.2	21.8	53.0	6.1	0.9	8.9	0.6	30.4	20.9	1.2	3.5	18.0	27.4	6.2	49.0	21.4	10.0	33.1	7.1	24.9	5.2	10.7	2.1	6.0	0.1	12.9	2.2	18.3	1.5	2.6	11.5	0.0	0.9	0.3	0.0	0.1	0.0	3.3	0.0	0.0	0.0	2.4	0.0	0.5	0.3	0.0	0.7	7.9	7.7	4.5	9.0	10.5	8.1	8.2	6.8	11.2	5.8	32.8	33.2	0.0	0.0	0.0	0.0	0.0	0.0	6.7	12.5	55.8	0.0	82.4	3.3	182.4	0.0	0.0	0.0	0.0	136.8	82.2	0.0	0.0	3.5	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	139.7	0.0	0.0	178.3	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	85.1	0.0	0.0	0.0
NECTIN3	"CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3"	ENSG00000177707	"Nectin cell adhesion molecule 3"	Q9NQS3	3	111070071-111275563	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 94.2"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"AF22: 33.5;TIME: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009869, HPA011038"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		20000000	Cytosol	"Cell Junctions"	"CAB009869: AB_2284699, HPA011038: AB_1079719"	"unprognostic (3.76e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.77e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.04e-2)"	"prognostic favorable (9.82e-7)"	"unprognostic (2.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.05e-1)"	5.6	4.0	5.4	4.4	6.0	0.0	4.5	1.3	8.9	4.6	12.6	6.5	2.8	17.8	5.0	2.2	3.5	5.4	4.4	4.8	6.3	5.0	6.9	16.4	5.6	1.9	6.0	4.1	9.2	4.7	1.9	1.9	94.2	5.5	6.9	12.6	10.7	3.4	4.8	2.3	1.8	18.9	7.2	8.9	1.8	13.2	27.6	4.5	0.4	24.1	2.0	1.4	5.4	7.7	0.1	0.0	0.3	0.0	0.2	1.7	0.7	0.0	10.1	33.5	2.2	13.6	25.2	2.0	22.0	23.3	13.7	11.7	9.3	4.7	0.0	7.3	31.3	7.6	0.1	9.3	3.2	25.2	0.2	2.5	0.0	3.6	0.7	23.0	1.6	0.3	12.7	1.4	9.0	8.7	12.3	11.5	0.4	0.0	8.8	29.5	0.0	2.2	0.0	9.4	3.1	3.6	0.0	16.6	0.0	8.5	5.3	0.8	6.1	0.4	0.0	4.6	11.7	0.3	0.1	47.5	17.4	7.2	3.1	13.1	4.9	0.0	0.0	11.0	0.0	16.0	0.0	0.0	0.3	0.1	0.0	1.2	0.0	1.7	1.0	0.0	0.1	0.3	0.4	0.0	0.2	0.0	0.0	0.1	0.7	5.4	6.0	1.3	8.9	6.3	5.0	6.0	4.1	5.5	4.5	23.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.7	12.2	0.0	3.3	0.0	3.9	0.0	0.0	0.0	0.0	16.4	7.6	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	13.3	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	98.1	0.0	0.0	0.0
NEDD1	"GCP-WD, TUBGCP7"	ENSG00000139350	"Neural precursor cell expressed, developmentally down-regulated 1"	Q8NHV4	12	96907223-96953777	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 165.2;Late spermatids: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038591	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Nucleoplasm, Centrosome"	"Plasma membrane"	"HPA038591: AB_10674688"	"unprognostic (7.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.94e-4)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.59e-2)"	10.7	6.2	5.7	10.0	6.6	9.8	9.8	2.5	7.1	10.8	9.3	7.1	1.7	4.9	13.5	8.3	11.6	10.0	5.5	8.3	6.0	4.4	12.6	5.4	9.4	10.3	7.0	3.7	13.3	7.7	14.9	13.5	7.9	6.5	11.9	7.2	6.3	8.5	6.3	25.5	7.8	10.3	15.4	8.4	14.5	7.2	17.8	8.3	30.6	11.9	24.3	10.7	15.1	9.6	9.4	5.9	19.9	11.1	15.6	14.0	7.3	13.7	9.1	15.8	9.6	7.8	7.1	11.2	47.8	17.0	22.1	19.1	6.0	5.1	8.5	4.6	38.2	10.3	12.4	10.6	11.0	29.8	16.3	9.1	10.6	6.0	5.3	6.5	14.4	9.6	5.2	9.1	13.4	10.4	14.6	10.8	14.7	6.1	6.3	15.8	5.6	26.2	6.6	8.7	7.2	29.2	13.9	16.0	8.4	9.0	9.0	4.9	8.7	13.4	7.6	8.3	12.9	10.2	5.1	7.7	13.9	10.7	9.9	11.2	6.2	7.5	11.4	4.3	7.3	16.8	10.0	6.9	19.9	12.1	11.1	13.7	9.4	13.4	12.9	5.9	8.1	14.0	10.9	5.4	15.6	7.8	4.6	14.0	7.3	5.7	6.6	2.5	7.1	6.0	4.4	7.0	3.7	6.5	8.3	8.9	8.6	11.3	24.7	17.2	8.1	8.9	7.6	25.4	15.9	15.7	0.0	7.5	8.3	8.1	165.2	9.1	5.3	0.0	7.0	11.4	8.4	20.9	16.1	4.9	7.5	17.5	5.8	12.3	4.3	65.3	11.5	9.3	6.8	3.6	7.0	12.9	6.8	7.0	9.6	10.5	8.4	19.4	8.2	26.7	24.6	12.3	3.3	18.1	6.6	16.3
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase"	P46934	15	55826922-55993746	"Enzymes, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 86.4;Alveolar cells type 2: 87.7;Ciliated cells: 135.1;Club cells: 79.6;granulocytes: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	14.1	4.1	2.5	3.1	3.3	4.5	8.7	1.5	2.7	9.9	9.4	2.8	3.4	3.4	10.1	4.1	8.2	3.8	4.5	4.1	2.9	2.4	8.6	21.5	7.2	2.1	3.5	1.3	6.6	2.8	6.5	6.7	20.1	3.5	8.4	3.4	5.4	4.0	6.4	57.7	7.1	15.2	10.9	6.0	5.9	4.4	2.6	3.1	9.4	5.7	9.0	3.3	11.9	8.9	0.1	1.6	1.2	2.8	1.2	2.9	0.9	7.3	11.5	3.1	3.0	4.1	6.8	5.1	14.1	22.3	10.5	10.5	5.1	2.2	1.8	3.7	5.4	25.5	12.2	3.4	9.3	17.2	4.1	2.1	9.1	2.7	2.6	21.9	4.0	0.9	11.6	23.1	12.5	21.1	5.1	8.6	5.4	3.9	0.0	30.6	3.8	5.3	0.0	0.8	3.9	1.7	3.9	24.8	1.0	4.3	14.6	0.3	2.0	6.3	4.5	5.6	5.9	5.6	3.0	29.6	23.3	7.7	4.9	22.9	1.2	2.7	4.8	15.7	8.6	5.5	0.6	1.0	0.0	1.3	2.8	2.9	0.1	1.5	1.2	0.8	0.0	1.4	1.6	1.2	1.2	1.9	1.6	1.3	0.9	2.5	3.3	1.5	2.7	2.9	2.4	3.5	1.3	3.5	3.1	86.4	87.7	2.0	3.3	10.8	0.3	4.8	7.6	135.1	79.6	0.0	21.6	16.5	1.7	3.2	1.3	16.8	6.9	0.0	4.8	6.4	6.3	3.4	67.4	17.9	4.0	0.0	0.0	15.4	1.8	1.0	5.2	3.8	1.7	0.0	4.2	8.4	3.3	0.0	6.7	10.8	6.0	0.0	8.2	1.2	5.9	9.2	11.6	2.2	2.9	1.6
NEDD8-MDP1		ENSG00000255526	"NEDD8-MDP1 readthrough"		14	24213955-24232352	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"Alveolar cells type 2: 1.9;Ciliated cells: 4.0;granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.8;U-266/70: 5.0"					"Low region specificity"	"Detected in all"			"HPA003064, HPA060254"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003064: AB_10602350, HPA060254: AB_2732644"	"unprognostic (2.72e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.83e-2)"	4.8	6.0	6.6	5.6	9.0	5.0	4.5	5.7	8.5	4.0	8.8	3.2	4.3	3.0	4.1	5.0	5.2	4.7	4.1	7.6	5.3	5.2	6.2	6.1	4.6	4.7	4.9	8.3	4.1	4.5	11.2	5.9	5.6	6.6	4.8	5.2	3.3	5.1	4.5	20.1	6.7	8.6	4.4	4.2	4.2	5.5	16.4	4.6	3.3	5.2	6.5	3.8	4.0	4.1	0.7	1.9	1.0	0.9	0.4	2.3	1.0	3.3	0.0	0.8	0.5	0.8	0.0	0.0	4.1	0.1	0.2	0.2	0.4	1.0	0.2	1.7	1.2	0.3	1.4	0.6	1.0	0.5	2.2	0.4	1.1	0.0	0.0	0.0	1.5	0.0	0.6	1.5	0.0	0.4	0.6	0.0	1.5	0.3	0.0	0.2	3.0	7.8	0.6	0.4	1.9	0.0	0.5	0.0	2.1	0.2	0.0	1.0	0.5	0.0	1.3	1.4	0.3	0.6	1.1	0.0	0.0	3.6	0.0	1.3	5.0	3.7	3.4	0.5	0.0	0.6	0.8	0.3	1.0	0.6	0.8	0.2	0.7	2.3	0.0	0.2	0.5	1.8	0.5	0.4	0.4	0.9	1.9	1.4	1.0	6.6	9.0	5.7	8.5	5.3	5.2	4.9	8.3	6.6	4.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 72.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 437.7;Basal glandular cells: 247.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 49.8;HSkMC: 24.9"	"Low region specificity"	"Detected in all"							"HPA009689, CAB009720, HPA038768, HPA039270, HPA072955"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	72.8	4.7	4.5	14.9	5.6	3.3	35.7	2.2	5.9	14.0	16.6	5.1	14.2	7.1	17.3	21.7	10.3	11.5	15.3	17.3	4.6	4.1	34.6	9.5	58.4	15.0	4.9	3.9	11.1	7.9	4.2	6.1	32.6	6.6	13.4	14.7	12.8	15.4	15.4	22.4	12.3	17.9	12.4	5.3	25.7	10.9	12.2	4.3	18.8	15.8	6.8	18.6	17.6	9.9	5.8	6.0	34.8	19.8	5.1	8.3	6.3	1.5	10.2	9.5	0.1	6.5	0.8	10.0	2.3	2.9	4.4	8.1	3.2	0.6	3.2	49.8	5.1	0.5	4.4	12.7	4.7	5.7	1.4	0.3	0.3	1.5	21.4	3.0	3.4	0.2	24.9	1.4	2.8	0.5	1.6	7.4	0.2	0.0	2.7	9.8	0.4	1.9	1.3	1.4	11.9	1.0	0.5	0.2	1.8	2.2	13.9	0.2	1.7	0.4	11.2	19.3	11.0	0.8	2.6	18.8	3.0	5.3	0.3	5.7	2.8	11.5	3.9	0.0	2.7	12.9	9.1	5.5	15.4	8.3	12.2	6.8	5.0	5.6	8.0	6.0	5.8	3.0	4.7	34.8	5.1	19.8	3.7	5.0	6.3	4.5	5.6	2.2	5.9	4.6	4.1	4.9	3.9	6.6	4.3	437.7	110.8	20.8	247.6	53.8	4.8	7.3	53.5	97.7	139.9	41.8	23.6	41.8	8.3	54.6	6.0	101.8	77.5	0.0	17.3	34.2	31.7	54.5	61.4	16.3	13.3	9.5	103.9	91.4	24.8	2.9	6.9	22.9	23.6	1.8	90.0	104.5	46.5	35.1	27.3	20.3	12.2	25.8	25.0	1.1	0.5	18.1	35.8	41.5	37.6	69.7
NEFL	"CMT1F, CMT2E, NF68, NFL, PPP1R110"	ENSG00000277586	"Neurofilament light"	P07196	8	24950955-24957110	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.1"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 32.2;Distal tubular cells: 87.9;Horizontal cells: 28.6;Intestinal endocrine cells: 32.1;Muller glia cells: 29.9;Rod photoreceptor cells: 73.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.0"					"Cell type enriched"	"Detected in some"	5	"memory CD4 T-cell: 13.7"	"Lineage enriched"	"Detected in single"	138	"T-cells: 13.7"	"Group enriched"	"Detected in some"	5	"HEK 293: 114.9;PC-3: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014850, HPA015021"	Enhanced	Supported	Approved	"Nucleoplasm,Intermediate filaments,Midbody"		NA	NA			"Nucleoplasm, Intermediate filaments"	Midbody	"HPA014850: AB_1854397, HPA015021: AB_2669135"	"unprognostic (7.63e-2)"	"unprognostic (1.36e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (5.76e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.17e-3)"	0.7	12.0	10.3	1.4	20.1	0.6	0.6	2.3	92.1	1.8	1.8	3.0	0.0	1.0	0.7	0.8	3.8	0.7	0.6	0.6	14.1		3.5	0.6	0.6	0.7	0.0	23.8	0.7	0.7	0.6	0.0	0.6	95.1	1.6	1.5	5.0	0.6	9.5	0.6	0.7	1.7	1.2	18.0	0.7	1.1	1.6	2.1	0.0	1.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	13.7	2.1	0.0	0.1	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.0	114.9	0.0	0.0	0.0	5.1	0.0	0.1	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.9	0.0	30.8	0.0	0.0	0.0	7.1	1.0	6.4	6.5	2.6	0.0	0.4	0.5	0.0	0.0	0.0	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.7	1.5	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.2	2.1											0.0	0.0	0.0	0.0	0.0	32.2	0.4	0.0	0.0	0.0	0.0	7.9	0.0	87.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	8.9	0.0	73.4	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395940-72282734	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.5"	"Cell type enhanced"	"Detected in many"	20	"Bipolar cells: 41.5;Leydig cells: 194.8;Peritubular cells: 42.1;Rod photoreceptor cells: 57.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;TIME: 16.3;U-2 OS: 13.6;U-251 MG: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"		NA	NA		390000000	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	17.5	7.8	18.1	7.6	16.3	2.2	7.3	24.1	41.5	8.0	14.7	2.6	2.4	3.8	7.1	5.9	13.6	5.9	13.5	10.7	11.2	14.8	8.8	1.1	5.4	2.4	8.7	26.3	8.4	6.0	1.5	4.6	4.1	5.9	9.9	10.3	3.2	3.6	7.6	5.9	5.5	6.3	25.5	10.2	1.5	7.6	4.4	3.0	0.3	3.8	1.5	1.6	20.1	9.1	0.5	3.3	1.1	0.4	0.4	0.4	0.1	0.2	0.1	0.5	0.2	16.0	12.7	0.1	11.1	4.2	6.1	7.5	0.1	0.1	0.2	0.1	12.2	0.2	0.3	0.0	0.0	13.3	0.2	0.1	0.1	2.2	0.1	1.3	0.2	0.3	6.1	0.0	5.2	0.9	9.1	7.2	0.2	0.1	0.5	11.3	0.1	0.1	0.2	1.8	0.2	6.4	7.7	11.9	0.2	1.0	0.2	0.9	1.0	3.9	0.1	0.1	0.3	0.1	0.2	16.3	1.4	13.6	0.6	13.8	0.3	0.2	0.1	3.1	7.4	4.8	1.1	0.4	0.3	0.4	0.2	0.3	0.3	0.3	0.3	3.1	0.5	0.3	0.3	0.8	0.4	0.4	3.3	0.2	0.1	18.1	16.3	24.1	31.8	11.2	14.8	8.7	26.3	5.9	3.0	0.0	0.3	0.0	0.5	4.4	41.5	4.0	0.0	12.0	4.5	0.0	25.5	0.0	0.0	1.5	4.9	2.9	0.0	0.0	0.0	0.0	29.4	1.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	7.1	194.8	2.2	8.5	0.0	0.0	10.8	0.6	0.0	42.1	1.4	57.5	32.3	6.6	0.7	1.5	3.0	0.0	0.0	0.0	0.7
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787346	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA073029: AB_2732216, HPA073916: AB_2732245"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.05e-1)"	10.2	21.8	18.7	6.8	17.7	2.7	10.3	11.8	20.9	11.3	5.6	9.0	7.0	3.6	9.9	15.4	6.5	17.9	6.9	14.2	15.4	20.0	9.3	11.0	7.7	8.4	18.4	16.1	12.6	10.9	7.8	13.2	7.6	20.3	10.5	6.1	9.7	11.5	10.3	24.7	18.1	4.6	10.2	12.3	9.5	5.1	26.8	13.3	1.8	15.5	7.1	7.9	7.4	15.8	14.7	5.5	0.8	2.5	9.1	13.6	4.7	4.9	14.0	8.8	17.2	4.2	7.9	3.9	7.9	6.6	7.7	5.3	4.3	5.5	1.9	3.1	9.5	16.6	4.4	8.4	8.7	10.6	5.8	4.2	6.8	3.3	8.4	3.4	2.9	5.1	6.9	12.9	6.7	6.2	7.5	7.2	2.3	9.6	6.7	9.1	5.2	0.5	3.1	7.9	20.5	7.5	8.7	11.3	5.3	9.0	7.5	13.6	10.7	6.2	3.3	11.3	7.4	5.2	0.5	8.8	8.8	12.7	2.3	11.1	6.3	13.1	3.5	23.2	10.2	17.8	0.4	1.5	0.1	9.1	2.5	12.1	14.7	9.3	10.8	3.0	11.4	13.6	12.0	0.8	9.1	1.1	5.5	5.8	4.7	18.7	17.7	11.8	19.8	15.4	20.0	18.4	16.1	20.3	13.3	0.0	4.3	12.6	14.3	7.6	25.6	17.8	17.8	5.3	6.8	7.0	15.7	15.6	28.2	17.4	0.8	9.3	0.9	0.0	20.5	13.6	10.8	15.1	2.3	21.2	12.1	7.9	9.7	7.4	4.7	2.1	13.0	6.6	13.5	10.0	4.5	27.9	14.2	0.0	23.0	24.7	13.2	6.5	13.2	14.2	45.1	11.2	4.5	7.2	5.0	9.1
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392857-169612629	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 85.6;Early spermatids: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	9.6	10.5	13.5	9.2	15.8	6.0	8.7	20.7	14.5	13.6	8.4	12.5	7.1	5.4	12.4	9.1	7.9	15.7	10.2	11.4	13.7	13.2	10.2	6.9	7.7	8.0	15.9	11.3	16.3	6.6	15.3	16.5	7.2	16.0	11.6	7.7	8.9	6.4	10.6	7.1	4.7	5.7	11.1	18.2	8.0	8.1	18.3	14.8	14.7	13.3	6.4	7.4	10.0	8.2	4.5	3.3	6.7	3.3	2.2	5.3	1.3	4.2	1.8	7.8	8.4	12.1	13.5	2.5	8.9	8.0	7.2	6.8	2.4	5.0	11.3	1.7	7.8	6.9	1.4	7.3	7.6	8.2	12.4	5.0	7.6	7.7	2.9	7.1	7.6	6.1	10.8	4.3	7.3	12.8	14.7	7.0	10.9	13.4	21.5	9.2	2.7	9.8	3.4	2.5	2.7	4.5	6.1	5.1	3.6	7.6	5.0	8.5	9.7	6.5	3.2	6.0	6.2	4.0	3.4	8.4	4.6	4.2	4.7	6.0	8.7	13.3	8.6	7.6	3.8	8.0	6.7	2.1	1.8	4.4	3.3	4.8	4.4	3.4	2.7	1.5	4.5	5.1	5.3	1.1	2.2	1.6	3.3	3.2	1.3	13.5	15.8	20.7	12.9	13.7	13.2	15.9	11.3	16.0	14.8	11.9	13.1	13.3	12.5	8.5	20.5	31.9	0.0	85.6	22.7	17.4	27.5	17.5	14.9	8.5	83.6	9.0	5.4	23.3	5.5	6.7	16.2	7.0	17.4	6.6	9.1	17.5	6.9	8.6	6.9	39.7	21.9	8.9	5.0	2.8	5.0	23.4	6.9	4.2	29.7	8.1	24.4	12.9	18.6	59.1	27.4	5.5	24.7	8.6	6.8	9.5
NEK10	FLJ32685	ENSG00000163491	"NIMA related kinase 10"	Q6ZWH5	3	27110085-27369460	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 97.7;Cone photoreceptor cells: 82.5;Early spermatids: 98.7;Late spermatids: 45.8"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 1.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 7.7;LHCN-M2: 10.6;U-2 OS: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038941	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA038941: AB_10673600"	"prognostic favorable (4.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.14e-1)"	0.4	0.5	4.5	0.5	14.6	0.4	14.2	0.6	6.8	1.6	2.0	1.1	2.0	2.5	0.9	8.3	2.0	10.5	2.1	3.1	8.4	3.8	1.4	2.5	4.5	0.6	0.8	6.7	2.7	0.8	0.5	9.0	0.3	3.4	1.9	0.7	1.3	0.5	1.4	10.5	0.4	1.0	1.2	0.8	0.6	1.1	31.4	1.3	0.3	0.8	0.3	0.7	1.4	0.4	0.4	0.2	1.9	0.1	0.1	0.6	0.1	1.0	2.1	1.1	1.2	0.9	2.1	0.4	7.7	1.2	2.1	1.9	0.0	0.5	0.7	1.9	3.2	1.5	0.1	0.5	0.5	2.3	1.4	0.8	0.2	4.1	3.7	0.2	0.4	1.0	2.5	0.5	3.3	0.1	2.7	1.5	4.4	0.1	0.7	10.6	0.1	0.8	0.5	0.7	0.2	0.3	1.0	0.4	0.3	4.1	0.6	0.2	0.2	1.2	0.5	0.6	0.8	6.2	0.4	0.9	5.7	9.0	0.3	0.8	0.3	0.2	0.5	4.8	0.9	2.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.5	0.4	0.0	0.4	0.1	0.5	1.9	0.1	0.0	0.2	0.0	0.1	4.5	14.6	0.6	6.8	8.4	3.8	0.8	6.7	3.4	1.3	6.0	0.0	0.0	0.2	0.2	4.0	10.2	2.5	97.7	13.6	1.8	82.5	0.0	0.0	0.3	98.7	0.7	0.7	0.0	0.0	0.2	2.9	1.5	0.0	0.5	0.2	0.0	0.0	0.6	1.3	45.8	1.7	0.4	0.0	0.0	0.1	1.4	0.2	0.6	1.1	0.0	19.6	0.0	1.1	25.4	1.7	0.4	0.0	0.0	0.1	0.1
NEK3	"HSPK36, MGC29949"	ENSG00000136098	"NIMA related kinase 3"	P51956	13	52132639-52159861	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019062, HPA043230"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA019062: AB_2670037, HPA043230: AB_2678374"	"unprognostic (8.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.34e-2)"	7.7	2.8	7.1	5.4	12.9	7.1	7.3	3.2	7.1	7.0	13.8	20.4	3.1	7.8	9.1	5.8	3.9	6.0	6.4	5.0	8.7	5.2	6.1	5.7	7.2	4.2	14.0	9.5	7.9	6.4	2.2	3.7	14.8	11.3	5.4	15.0	6.8	5.2	5.0	4.1	5.4	11.7	7.3	9.6	3.9	4.6	14.7	13.3	2.4	5.0	2.7	4.3	6.5	6.0	4.4	7.8	5.9	7.7	2.0	3.5	1.6	0.2	1.4	13.2	7.5	4.2	6.6	0.2	4.2	4.3	5.1	5.7	5.1	7.3	0.0	0.2	5.3	4.2	0.9	0.2	3.2	3.1	8.7	6.9	1.0	1.4	13.7	5.4	12.7	6.8	4.8	5.9	2.6	12.2	3.7	7.8	0.6	1.8	4.4	5.2	3.6	0.6	15.3	12.9	2.7	0.3	0.3	1.1	4.8	7.3	1.3	1.3	9.1	1.9	4.0	8.9	13.0	1.7	16.3	6.7	0.7	4.3	4.0	4.5	4.7	1.6	8.8	1.1	5.0	7.2	5.9	7.7	5.3	2.1	6.6	1.3	4.4	2.5	1.3	7.8	2.5	1.7	0.6	0.5	2.0	1.5	6.9	3.5	1.6	7.1	12.9	3.2	7.1	8.7	5.2	14.0	9.5	11.3	13.3	6.0	6.2	1.9	3.8	2.5	2.2	6.1	7.6	8.1	7.9	7.0	0.0	10.1	11.6	5.4	6.3	21.2	18.6	0.0	15.1	12.1	7.0	4.2	9.3	6.2	15.3	3.2	5.8	20.9	9.9	2.7	6.6	7.9	11.8	34.3	14.6	3.7	11.3	14.0	6.3	5.0	5.8	0.0	7.6	40.9	27.9	3.0	4.0	1.3	17.2	4.8
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	17.0	20.4	12.7	17.7	17.4	7.3	15.1	15.4	13.3	18.6	18.7	18.3	23.5	14.0	25.0	13.8	15.6	20.0	15.9	23.5	11.4	8.7	14.0	13.3	12.9	16.2	20.2	10.6	25.6	15.7	24.7	23.6	14.3	13.0	15.3	8.1	15.4	12.4	18.9	36.2	10.6	15.3	24.7	14.5	14.7	14.8	16.6	18.2	21.5	17.0	14.1	14.4	23.6	18.7	6.0	6.4	7.5	5.4	5.5	6.2	3.1	10.1	12.0	15.2	17.0	19.6	26.9	17.4	16.5	11.7	8.1	7.9	10.1	8.9	17.5	0.1	11.3	6.7	14.0	11.6	6.4	9.0	14.2	6.7	8.5	12.0	7.3	12.8	5.1	11.4	18.3	7.6	8.4	6.4	21.5	10.1	12.1	9.6	11.3	9.7	1.1	10.8	5.2	9.0	12.9	6.1	17.5	19.4	9.0	6.1	12.5	7.4	18.7	13.3	6.4	12.8	16.7	15.9	14.8	15.3	12.3	5.2	14.3	6.4	18.3	19.5	17.6	9.0	8.7	8.3	7.5	5.4	5.8	4.2	5.0	5.9	2.8	4.8	3.9	6.4	6.0	6.2	5.9	5.5	5.5	3.5	1.8	2.6	3.1	12.7	17.4	15.4	13.3	11.4	8.7	20.2	10.6	13.0	18.2	11.9	33.3	10.4	7.4	7.8	16.5	47.6	5.1	14.7	19.4	10.4	33.4	13.4	6.6	5.0	9.2	14.3	10.6	0.0	4.3	13.7	11.8	6.1	15.1	28.4	12.0	12.7	5.2	17.8	18.7	6.4	23.0	12.6	3.3	6.4	10.5	12.1	5.0	9.0	24.8	7.8	22.6	0.0	12.3	23.8	12.8	8.9	11.7	10.0	10.6	4.8
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"		20	58981208-58995133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262, HPA074936"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	9.1	11.1	10.2	9.4	13.0	8.8	12.7	18.1	13.7	10.2	10.8	15.2	9.2	8.4	11.2	8.2	14.6	12.5	8.6	9.2	10.9	8.2	16.4	15.9	7.9	11.2	16.7	13.4	15.4	10.3	19.1	18.1	12.1	12.5	10.2	8.9	9.4	14.7	9.1	12.0	11.9	8.8	8.1	11.8	9.2	8.9	26.1	12.4	17.4	14.4	10.0	13.6	9.8	11.3	22.7	29.6	9.4	27.7	19.4	24.6	20.5	12.5	14.5	17.4	18.6	6.0	10.7	11.2	10.2	10.0	31.0	18.0	48.0	18.1	16.5	16.1	10.2	16.1	22.0	23.4	25.8	25.1	5.1	16.6	21.8	18.1	37.5	7.2	15.6	15.0	11.3	8.3	11.3	7.9	8.1	17.8	13.4	29.0	12.7	14.1	49.9	33.7	23.6	10.1	39.1	32.2	18.9	14.5	30.7	13.0	19.5	19.2	28.7	31.9	38.5	21.2	10.4	41.5	18.3	7.1	23.9	22.7	9.2	16.9	10.0	18.6	16.9	14.2	13.9	20.6	7.2	20.4	9.4	20.3	22.8	23.9	22.7	19.3	24.6	29.6	20.0	18.9	19.9	2.2	19.4	27.7	15.0	17.6	20.5	10.2	13.0	18.1	13.7	10.9	8.2	16.7	13.4	12.5	12.4	8.9	25.1	37.2	47.8	26.9	66.4	9.8	22.9	12.0	13.6	21.0	39.3	113.3	43.1	46.4	10.6	25.5	19.3	23.3	27.3	56.4	21.7	32.6	16.1	21.3	33.3	52.4	22.4	17.8	14.5	18.1	34.2	21.7	25.3	58.7	19.2	42.7	32.2	14.0	24.8	35.6	57.2	38.8	32.5	57.5	97.9	27.5	86.2	40.8	33.2	48.7
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;brain: 73.3;fallopian tube: 35.1"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 38.4;Ciliated cells: 40.2;Club cells: 11.4;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 43.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8"	"Lineage enriched"	"Detected in many"	11	"T-cells: 36.8"	"Cell line enhanced"	"Detected in some"		"AF22: 41.8;HEK 293: 10.9;NTERA-2: 16.4;SCLC-21H: 30.4;U-266/70: 11.1;U-266/84: 11.1;U-698: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA		4700000	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	2.0	10.5	22.4	6.1	24.8	4.2	1.6	15.7	73.3	14.9	2.9	3.6	0.0	15.3	1.9	0.8	1.3	35.1	1.7	0.8	40.2	20.4	1.2	1.1	3.4	11.2	6.6	27.0	1.0	1.1	0.6	18.4	0.8	7.5	18.8	1.8	9.3	1.5	1.8	0.7	5.0	8.6	2.2	2.6	3.8	2.1	2.2	2.4	0.4	4.4	0.0	9.1	2.3	2.0	0.0	0.0	0.1	0.0	3.3	36.8	8.5	0.1	0.0	41.8	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	5.0	0.0	0.0	0.1	9.9	0.0	0.0	0.0	10.9	0.1	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	16.4	0.0	5.4	0.0	5.0	0.0	0.0	0.0	30.4	0.7	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.2	1.5	0.0	0.7	11.1	11.1	15.1	0.1	0.1	0.2	0.0	0.0	0.0	1.6	0.0	8.5	0.0	10.3	18.1	0.0	0.0	24.5	36.8	0.1	3.3	0.0	0.0	0.1	8.5	22.4	24.8	15.7	50.4	40.2	20.4	6.6	27.0	7.5	2.4	0.0	2.2	0.0	0.0	1.0	38.4	0.4	0.0	40.2	11.4	0.0	31.4	0.1	0.0	0.0	0.2	0.5	5.4	0.0	0.2	0.2	1.4	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	5.2	0.3	0.0	0.4	0.1	43.8	0.0	1.4	1.5	3.4	1.0	0.1	5.3	0.6	0.0
NEMF	"FLJ10051, NY-CO-1, SDCCAG1"	ENSG00000165525	"Nuclear export mediator factor"	O60524	14	49782083-49853203	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004160	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA004160: AB_1079884"	"unprognostic (9.92e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.15e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.81e-2)"	13.6	12.2	15.0	14.8	20.9	30.9	12.5	28.0	22.1	15.0	14.4	14.6	14.4	8.1	14.3	12.2	18.2	11.6	11.2	15.0	16.9	15.0	14.6	11.2	11.6	13.4	21.1	17.2	15.2	13.1	26.4	30.9	15.5	27.9	13.9	12.4	10.7	14.8	14.8	17.4	11.5	15.1	13.9	24.8	14.7	13.7	8.4	23.2	17.0	15.7	9.8	14.5	13.5	13.4	36.1	33.0	28.4	21.9	20.3	26.8	7.8	18.8	21.1	20.2	13.4	22.9	18.5	18.1	23.8	15.8	15.7	15.5	10.8	20.3	5.2	18.3	19.6	12.3	27.0	19.0	14.9	25.4	21.0	10.9	20.9	20.1	16.3	13.4	27.3	19.2	16.4	11.0	16.6	15.5	21.3	22.4	12.1	25.8	19.8	21.5	17.3	16.2	9.0	12.1	15.1	21.3	16.8	20.0	11.9	18.6	25.0	13.4	12.5	22.1	23.8	22.1	22.8	20.5	17.8	26.4	23.1	20.3	15.0	16.3	14.1	25.1	22.4	8.6	12.9	20.6	27.6	18.2	20.1	20.5	16.3	19.5	32.8	21.0	19.2	15.2	36.1	24.8	26.8	28.4	20.3	21.9	33.0	17.9	7.8	15.0	20.9	28.0	22.1	16.9	15.0	21.1	17.2	27.9	23.2	38.7	66.5	52.5	59.9	30.6	90.1	88.4	30.6	92.3	58.0	41.8	94.2	66.4	31.5	48.3	7.7	60.9	51.0	23.3	34.1	50.5	56.0	46.7	86.6	27.6	51.0	123.9	51.9	44.2	43.5	8.9	60.9	57.0	23.6	64.1	43.0	55.4	40.2	57.5	63.3	24.8	92.1	71.1	53.6	79.2	54.9	29.7	90.6	62.3	45.2	79.7
NEMP1	"KIAA0286, TMEM194, TMEM194A"	ENSG00000166881	"Nuclear envelope integral membrane protein 1"	O14524	12	57055643-57088063	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 20.8;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014394	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA014394: AB_2204899"	"unprognostic (9.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.05e-2)"	9.5	7.3	7.6	16.7	7.8	7.8	8.6	10.6	8.5	8.1	12.2	8.1	3.6	4.9	14.8	7.6	8.8	9.4	5.8	4.8	6.6	3.8	6.0	8.1	9.7	15.1	7.7	5.8	12.3	6.4	5.9	12.7	20.6	6.2	9.6	9.4	8.2	7.2	7.5	3.6	14.3	11.0	12.8	8.3	11.4	8.5	15.4	6.9	26.6	8.7	4.1	15.1	9.3	8.9	4.6	2.2	5.5	3.5	5.4	4.7	2.0	8.1	6.9	15.9	17.1	5.3	5.3	9.1	12.6	7.2	17.6	14.3	8.2	15.6	19.3	16.3	4.3	15.0	12.0	21.1	5.4	20.3	10.2	9.6	11.4	8.0	4.3	2.3	14.1	13.1	1.8	5.2	14.4	9.0	7.3	4.8	17.6	23.1	38.6	14.7	4.4	15.4	12.0	8.9	7.7	7.7	15.7	22.6	8.8	3.8	5.0	9.5	6.4	10.7	9.0	10.1	11.8	16.2	14.2	3.4	16.8	9.8	15.4	11.7	17.4	33.1	17.0	9.9	13.6	17.2	5.5	1.1	1.9	2.8	3.5	3.7	4.6	3.1	3.6	1.2	3.6	4.7	3.9	0.5	5.4	2.0	2.2	2.8	2.0	7.6	7.8	10.6	8.5	6.6	3.8	7.7	5.8	6.2	6.9	20.8	1.6	0.0	2.9	0.0	2.3	1.2	0.0	5.3	3.4	5.2	3.9	3.2	0.0	1.7	1.0	2.9	0.4	0.0	0.7	3.1	2.1	3.6	0.0	3.9	4.8	1.6	0.0	5.5	5.3	0.2	5.8	5.9	0.0	3.6	1.7	2.9	2.1	0.0	4.9	0.6	3.9	12.9	1.9	10.1	6.9	0.0	2.5	3.2	1.8	2.0
NEMP2	TMEM194B	ENSG00000189362	"Nuclear envelope integral membrane protein 2"	A6NFY4	2	190504342-190534722	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 27.3"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA057719			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057719: AB_2683510"	"unprognostic (3.51e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.65e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.82e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.32e-1)"	7.8	4.9	2.9	14.5	2.9	4.5	4.3	7.5	3.6	6.0	3.6	4.3	2.2	2.5	8.5	6.8	4.4	3.3	3.0	4.3	3.5	2.9	5.7	5.7	9.3	11.3	3.8	3.2	5.6	3.2	2.6	4.0	3.7	3.4	3.9	2.6	6.6	9.3	4.8	1.7	5.1	4.5	3.4	3.4	12.3	5.1	8.1	2.4	27.3	5.4	3.5	15.8	4.4	4.3	3.6	3.4	0.2	0.8	2.4	5.6	2.2	5.2	2.8	1.9	2.4	1.1	3.0	5.1	3.8	3.3	3.8	4.7	4.2	7.3	7.6	2.5	1.9	2.7	9.3	3.0	8.1	7.6	5.6	2.6	5.5	2.8	2.9	2.9	5.9	1.9	3.1	3.4	17.3	4.5	3.5	1.7	8.5	4.7	9.0	7.3	2.4	6.4	2.8	2.1	2.9	3.1	2.7	4.2	3.5	3.4	3.9	3.5	3.0	5.9	0.6	5.7	3.4	1.5	6.4	3.1	8.5	6.6	1.6	4.1	4.9	5.3	4.1	6.5	6.2	6.1	0.1	0.8	0.1	3.0	0.7	3.9	2.7	3.3	2.7	0.9	3.6	5.4	4.6	0.2	2.4	0.6	3.4	5.6	2.2	2.9	2.9	7.5	3.6	3.5	2.9	3.8	3.2	3.4	2.4	0.0	1.1	2.4	1.3	0.0	4.5	1.6	0.0	0.0	0.0	1.8	0.0	2.1	0.0	1.5	2.5	3.8	0.0	0.0	1.7	2.8	1.3	1.5	1.1	2.5	2.6	3.2	0.0	3.1	5.4	4.2	2.6	2.3	0.0	1.8	1.2	3.3	0.6	1.5	1.1	2.1	2.1	0.0	2.5	16.7	5.9	0.0	1.0	5.7	1.8	1.3
NET1	"ARHGEF8, NET1A"	ENSG00000173848	"Neuroepithelial cell transforming 1"	Q7Z628	10	5412551-5458463	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 63.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020068	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA020068: AB_2670348"	"unprognostic (1.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (8.27e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.46e-1)"	19.4	4.8	14.2	25.8	16.7	15.0	39.8	11.8	15.2	30.2	39.3	21.0	32.1	24.1	19.4	25.7	38.2	20.7	25.9	8.4	16.5	12.7	21.3	19.0	9.5	10.5	19.0	9.4	15.2	19.4	2.9	6.6	51.8	20.8	23.0	38.9	20.3	43.0	23.2	16.7	21.8	54.7	33.4	19.9	3.9	33.5	11.8	10.9	14.8	18.1	26.8	20.2	28.0	31.8	1.8	5.9	2.7	1.2	1.0	11.5	2.4	27.9	16.7	11.6	12.9	6.8	3.1	63.7	17.0	9.3	13.7	13.1	9.1	53.3	10.3	7.1	10.3	3.0	45.8	14.0	25.6	16.5	9.6	10.1	18.6	5.6	20.3	1.8	5.3	8.1	4.6	15.3	13.5	3.2	12.0	7.9	10.8	32.8	16.3	7.5	13.3	17.9	7.4	15.6	38.6	12.7	11.3	21.4	8.0	8.4	14.1	10.0	5.5	14.9	27.7	5.0	20.2	9.2	15.9	7.2	5.2	8.2	8.0	13.7	10.0	5.4	13.5	4.7	8.1	10.8	2.7	0.8	1.8	0.9	1.2	0.0	1.8	1.6	0.5	5.9	0.9	11.5	2.1	0.1	1.0	0.6	2.5	5.1	2.4	14.2	16.7	11.8	15.2	16.5	12.7	19.0	9.4	20.8	10.9	29.8	38.9	8.2	74.8	35.7	7.7	10.1	45.9	77.6	83.0	12.2	3.9	84.2	5.0	11.3	2.0	33.2	153.4	0.0	21.4	96.0	33.1	71.1	15.0	45.0	12.6	3.2	77.6	14.1	12.4	1.7	20.1	13.0	33.7	83.0	146.5	3.4	41.8	114.6	82.4	21.2	3.1	109.9	58.2	24.9	18.6	28.2	98.2	7.0	102.0	186.5
NETO1	"BCTL1, BTCL1"	ENSG00000166342	"Neuropilin and tolloid like 1"	Q8TDF5	18	72742314-72868146	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 47.9"	"Cell type enriched"	"Detected in some"	38	"Bipolar cells: 163.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	27	"memory B-cell: 1.6;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	38	"B-cells: 3.7"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 15.1;NTERA-2: 6.9;REH: 14.9;RPMI-8226: 23.7;RT4: 15.7;SCLC-21H: 20.9;U-2 OS: 7.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064630			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA064630: AB_2685305"	"unprognostic (4.02e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.35e-5)"	"unprognostic (4.05e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.13e-3)"	2.0	0.8	9.1	1.3	18.3	1.0	1.7	0.4	47.9	0.9	0.9	0.7	0.0	0.8	0.9	0.9	1.0	0.8	0.9	1.4	15.9	3.9	1.0	0.8	0.9	3.8	3.0	15.1	0.8	0.8	1.0	0.3	0.8	5.0	0.9	1.1	3.9	1.1	0.8	0.8	1.2	0.8	0.8	1.1	4.0	0.9	2.0	2.8	0.8	2.3	0.0	2.7	1.2	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	6.9	0.0	0.0	14.9	0.0	23.7	3.7	15.7	20.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	18.3	0.4	22.8	15.9	3.9	3.0	15.1	5.0	2.8	0.0	0.0	0.0	0.0	0.0	163.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
NETO2	"FLJ10430, NEOT2"	ENSG00000171208	"Neuropilin and tolloid like 2"	Q8NC67	16	47077703-47143997	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.6;lymphoid tissue: 23.8"	"Cell type enhanced"	"Detected in many"	11	"Muller glia cells: 40.0;Spermatogonia: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013180	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA013180: AB_1854383"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavorable (5.53e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.32e-1)"	3.3	6.7	6.9	6.9	23.6	2.4	3.4	11.8	15.8	1.8	9.5	2.1	0.6	1.9	2.8	0.9	5.6	1.1	5.5	2.4	8.3	5.9	2.5	0.9	5.3	6.6	4.9	7.1	2.0	9.8	11.6	1.4	3.8	13.5	1.4	2.8	10.1	2.6	1.6	4.5	1.7	2.7	1.9	2.5	23.8	1.9	8.6	4.7	1.9	10.0	3.1	6.8	4.2	2.5	1.0	2.1	0.9	3.3	0.3	2.2	0.7	25.0	28.0	40.6	0.1	6.0	35.0	6.7	25.0	4.0	22.2	12.1	5.8	16.1	6.2	15.4	5.3	21.4	11.3	25.9	24.8	27.3	0.1	16.7	5.0	10.0	6.2	7.4	16.0	13.3	21.0	16.6	8.9	12.6	21.6	14.7	15.0	7.4	7.7	14.2	6.8	9.1	8.8	19.5	7.5	20.6	0.0	7.9	12.6	15.6	5.4	26.7	19.4	33.0	2.6	3.7	6.9	0.5	11.8	7.1	0.0	0.0	0.0	0.1	8.3	6.8	13.8	18.1	11.4	17.8	0.9	3.3	0.1	0.1	1.6	1.3	1.0	1.3	0.1	2.1	0.4	0.0	0.1	0.9	0.3	1.5	0.2	2.2	0.7	6.9	23.6	11.8	15.8	8.3	5.9	4.9	7.1	13.5	4.7	0.0	5.0	0.0	0.6	6.9	0.7	1.2	0.0	2.7	3.4	0.0	0.0	0.7	0.0	0.4	2.5	4.4	3.5	0.0	2.6	0.4	2.6	2.0	2.3	0.0	6.3	0.0	10.4	0.6	9.4	4.2	0.6	11.3	3.3	6.4	1.3	40.0	1.1	1.1	0.0	0.0	0.8	6.5	2.5	7.7	22.0	2.9	0.7	1.9	1.6	0.9
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988134-75018893	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 58.9;Spermatocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	5.4	13.4	3.7	10.5	6.9	17.0	5.4	7.9	9.1	4.0	3.9	3.0	4.1	3.6	5.4	4.8	3.9	4.4	3.6	5.9	4.0	4.5	4.3	6.7	8.7	9.0	3.8	6.6	7.2	7.3	15.1	11.2	3.1	4.2	9.7	5.4	5.6	4.8	4.6	19.1	6.7	4.7	4.0	3.5	5.5	5.1	44.6	3.0	19.0	6.8	3.5	7.5	4.5	3.1	3.2	3.8	5.8	6.4	1.2	4.2	2.2	4.6	4.0	3.4	6.6	2.6	2.5	3.8	4.5	2.9	5.2	4.0	13.7	3.9	13.3	4.6	3.6	6.6	4.3	8.2	5.8	7.9	7.0	4.4	10.9	7.4	5.6	2.9	17.2	10.6	3.0	4.9	5.2	8.1	3.4	3.7	19.0	17.7	10.0	5.9	5.0	16.9	8.9	4.2	9.1	5.4	14.8	9.0	11.7	6.4	4.9	6.3	4.0	6.9	4.6	20.2	4.2	9.8	4.4	5.6	6.5	6.5	4.3	4.5	8.2	8.0	26.6	1.9	8.9	5.5	2.1	6.4	5.8	4.1	3.7	3.0	2.8	3.2	3.9	3.8	3.2	3.5	4.2	3.3	1.2	4.6	2.7	2.3	2.2	3.7	6.9	7.9	9.1	4.0	4.5	3.8	6.6	4.2	3.0	3.0	5.8	2.2	1.8	0.5	7.2	7.3	2.5	2.7	4.5	1.8	58.9	1.8	0.0	1.0	5.7	1.6	1.3	0.0	2.6	1.2	1.5	2.7	1.1	7.2	4.8	11.1	6.9	4.3	8.6	5.3	1.4	4.5	0.0	4.6	2.9	2.9	2.7	0.0	1.8	3.3	5.8	0.0	2.2	32.5	1.7	0.5	1.1	3.5	3.2	0.4
NEURL2	"C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3"	ENSG00000124257	"Neuralized E3 ubiquitin protein ligase 2"	Q9BR09	20	45888625-45891287	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 10.0;Proximal tubular cells: 11.1;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043402, HPA059842"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA043402: AB_2678464, HPA059842: AB_2684139"	"unprognostic (6.26e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.58e-1)"	7.9	6.3	2.8	3.0	2.6	1.3	4.8	5.5	3.3	4.6	7.6	2.9	4.5	5.2	5.7	6.0	3.3	5.2	9.0	7.6	1.9	1.6	8.8	12.3	2.4	1.5	1.5	2.3	8.7	2.8	6.2	4.2	3.7	2.7	5.7	2.7	5.9	4.0	3.7	21.6	4.3	10.3	10.2	2.3	4.5	3.3	3.2	1.1	1.1	4.0	21.5	2.1	6.6	2.8	5.4	0.8	3.6	1.3	2.3	3.8	0.9	1.0	0.9	2.5	1.9	4.0	1.7	2.3	1.5	2.1	1.7	0.8	10.0	6.5	1.5	2.2	1.1	3.1	3.4	2.0	0.2	1.1	0.8	1.8	0.8	7.2	9.9	5.6	0.7	1.7	3.9	1.4	1.7	0.7	2.6	1.6	2.1	0.6	2.6	0.9	4.0	1.2	0.7	1.6	0.6	3.6	2.0	1.8	0.7	1.0	0.9	5.7	4.7	2.0	5.2	6.2	0.6	4.2	2.1	2.5	2.0	1.6	1.4	1.3	8.2	1.5	0.3	2.1	1.0	1.7	0.0	1.3	3.6	0.9	0.7	0.5	5.4	1.8	1.6	0.4	2.6	3.8	3.5	0.7	2.3	0.4	0.8	1.0	0.9	2.8	2.6	5.5	3.0	1.9	1.6	1.5	2.3	2.7	1.1	0.0	0.0	1.3	1.9	0.1	3.6	4.8	0.0	0.0	0.0	0.0	3.9	0.6	6.6	2.5	2.0	1.9	4.2	0.0	1.8	0.6	1.7	2.0	0.0	3.8	10.0	0.0	2.9	6.7	3.7	6.5	4.9	0.1	0.0	1.8	1.7	2.5	3.1	0.0	3.5	11.1	2.8	12.9	3.4	0.0	0.3	1.0	0.5	0.0	2.1	1.6
NEUROG1	"AKA, bHLHa6, Math4C, NEUROD3, ngn1"	ENSG00000181965	"Neurogenin 1"	Q92886	5	135534282-135535949	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 2.1;retina: 7.7;testis: 2.3"	"Cell type enhanced"	"Detected in single"	24	"Bipolar cells: 1.3"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 1.1"	"Region enhanced"	"Detected in single"		"midbrain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 1.3;SCLC-21H: 1.1;THP-1: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072232			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA072232: "															"unprognostic (3.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NEUROG3	"Atoh5, bHLHa7, Math4B, ngn3"	ENSG00000122859	"Neurogenin 3"	Q9Y4Z2	10	69571698-69573238	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 7.5;intestine: 8.4"	"Group enriched"	"Detected in some"	49	"Cardiomyocytes: 4.8;Intestinal endocrine cells: 5.1"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Region enriched"	"Detected in single"	20	"hippocampal formation: 7.5"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;memory B-cell: 1.1"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;T-cells: 2.1"	"Cell line enriched"	"Detected in some"	5	"THP-1: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039785	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA039785: AB_10795114"	"unprognostic (1.22e-2)"		"unprognostic (7.33e-2)"		"unprognostic (3.04e-2)"			"unprognostic (2.42e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"		"unprognostic (5.85e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.19e-1)"			0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	7.6	0.0	0.0	8.0	0.0	0.0	0.9	0.0	1.8	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.3	7.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 110.8;skeletal muscle: 198.5"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2090.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 43.5;LHCN-M2: 40.0;RH-30: 31.7"	"Low region specificity"	"Detected in many"							"HPA011185, HPA011904"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA		12000000	"Plasma membrane, Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	8.9	4.3	0.4	10.4	0.8	0.0	5.0	0.5	0.4	14.1	17.0	0.2	12.5	1.9	16.6	12.5	24.1	9.9	8.7	110.8	0.4	0.5	4.0	1.2	6.2	3.8	0.6	0.5	8.2	2.0	0.3	0.5	2.6	0.7	13.1	3.2	0.9	4.1	14.8	198.5	1.4	5.5	45.8	0.8	3.9	10.6	4.2	1.2	0.0	5.1	40.1	1.0	29.7	10.3	1.4	1.7	2.9	3.4	0.6	0.6	7.0	7.1	0.4	1.3	0.0	23.5	22.8	3.5	43.5	19.3	8.9	6.0	1.2	0.0	0.0	2.5	15.8	10.1	0.9	0.9	4.1	16.0	0.2	0.9	1.7	2.2	0.4	17.6	0.3	0.0	17.0	0.9	12.3	6.9	19.0	6.7	1.7	0.0	0.0	40.0	0.0	8.1	0.5	6.9	0.0	5.3	6.8	31.7	0.0	10.4	0.3	0.0	0.3	3.8	0.0	0.2	9.1	0.0	0.9	6.8	21.3	15.6	9.0	21.6	0.0	0.0	0.0	1.2	0.8	0.0	0.0	3.4	0.0	0.4	2.0	0.1	1.4	0.3	0.4	1.7	1.1	0.6	0.2	2.9	0.6	1.4	1.2	0.0	7.0	0.4	0.8	0.5	0.4	0.4	0.5	0.6	0.5	0.7	1.2	98.3	8.2	0.0	0.8	1.5	2.8	2090.8	0.0	0.0	9.1	0.0	3.9	0.3	1.7	15.9	15.1	11.3	0.9	0.0	27.4	2.8	19.0	0.9	1.1	0.8	1.1	1.6	0.0	53.4	2.6	5.4	67.9	5.3	0.0	0.0	0.0	0.2	23.5	0.0	325.3	0.5	2.6	213.4	98.6	0.7	2.1	0.6	0.2	2.2	0.3	0.2
NF1		ENSG00000196712	"Neurofibromin 1"	P21359	17	31094927-31382116	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 149.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.3;granulocytes: 6.5;T-cells: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045502	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA045502: AB_2679352"	"unprognostic (6.69e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-1)"	12.9	15.9	22.6	13.3	25.9	5.5	18.5	30.2	26.0	17.6	13.6	19.8	12.2	11.0	16.9	17.0	10.5	15.2	13.1	17.3	21.6	19.6	20.0	15.1	12.7	11.5	19.4	25.6	22.9	16.5	34.1	19.0	19.4	20.9	16.1	14.7	12.1	14.4	20.5	14.8	12.0	12.1	14.5	21.4	11.9	13.0	15.4	21.5	11.6	31.1	7.6	12.4	15.3	19.5	2.3	0.7	6.5	0.4	0.9	8.4	1.0	9.8	12.9	15.7	8.4	13.4	17.5	7.9	8.6	15.5	12.7	14.4	11.6	6.7	9.5	2.5	16.0	15.0	17.3	14.2	12.0	21.5	4.6	8.9	8.4	12.1	5.9	9.5	15.0	7.0	13.8	7.7	13.5	16.5	14.4	6.1	10.1	12.0	9.5	12.1	7.8	12.5	5.5	4.6	6.1	4.3	9.8	24.0	7.6	9.6	14.2	6.5	9.8	15.9	5.3	8.8	11.6	16.2	9.6	8.9	10.2	14.2	12.0	3.2	8.7	4.2	10.5	8.3	6.3	10.5	6.5	0.4	0.9	2.3	0.2	1.6	2.3	4.4	3.9	0.5	2.1	3.3	3.2	1.0	0.9	0.4	0.7	8.4	1.0	22.6	25.9	30.2	23.5	21.6	19.6	19.4	25.6	20.9	21.5	29.8	23.6	12.7	38.9	34.3	61.1	39.2	40.8	29.4	20.5	38.4	129.6	44.8	19.9	23.9	149.0	31.8	28.2	0.0	19.3	22.1	28.2	47.4	10.4	31.7	18.9	66.7	19.0	31.9	24.3	70.0	34.5	21.8	20.3	16.2	26.8	49.7	28.6	35.4	47.4	23.7	66.0	45.3	36.7	28.2	25.6	29.6	41.2	18.5	22.6	60.1
NFATC2IP	"ESC2, FLJ14639, NIP45, RAD60"	ENSG00000176953	"Nuclear factor of activated T cells 2 interacting protein"	Q8NCF5	16	28950807-28967097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053587			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053587: AB_2682202"	"unprognostic (6.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.90e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (5.23e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (8.00e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.25e-1)"	"unprognostic (5.94e-2)"	14.0	11.9	16.6	26.5	15.0	32.5	16.1	29.9	16.8	14.6	23.6	12.7	19.0	16.1	17.8	11.8	20.4	17.5	15.8	15.6	13.0	7.8	15.9	18.9	18.1	26.0	16.5	18.0	18.6	16.2	21.9	11.2	14.0	12.0	17.1	25.7	15.7	17.1	12.9	20.7	24.8	25.1	19.4	12.2	32.7	17.8	27.1	15.3	37.7	16.3	6.9	28.6	19.8	16.0	3.5	6.3	8.7	3.7	5.8	4.9	1.3	18.0	13.1	17.8	17.9	10.9	11.5	22.6	17.6	13.3	20.7	26.6	15.1	22.6	19.3	13.4	12.5	12.6	21.5	21.4	19.3	28.2	16.4	15.7	17.6	34.0	18.7	6.9	15.9	27.0	8.1	15.8	22.5	13.7	10.3	16.5	19.7	15.9	24.1	18.3	22.4	20.6	28.2	17.5	14.6	15.5	36.1	15.9	17.7	14.8	16.3	13.8	9.8	11.8	18.4	6.8	15.2	19.0	11.9	18.2	23.0	13.0	17.9	13.2	17.9	23.4	23.6	12.7	26.3	13.4	8.7	3.2	3.2	4.1	3.7	3.8	3.2	3.1	4.7	1.8	3.5	4.9	4.4	2.4	5.8	2.3	6.3	4.5	1.3	16.6	15.0	29.9	16.8	13.0	7.8	16.5	18.0	12.0	15.3	32.8	50.0	43.4	20.5	28.2	62.9	14.8	22.9	17.4	35.2	27.9	94.2	24.6	16.6	19.0	3.9	28.0	38.7	70.0	20.0	25.0	22.1	29.7	34.8	17.9	20.3	41.3	39.3	39.3	30.1	4.3	27.3	31.4	21.9	35.1	53.9	16.0	32.1	31.7	19.1	14.0	87.9	38.8	18.4	64.9	95.4	26.5	21.9	40.1	47.3	40.4
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 93.5;Kupffer cells: 38.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 119.7;neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 119.7"	"Group enriched"	"Detected in some"	4	"HEL: 85.6;K-562: 37.0;NB-4: 26.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 1.4"	HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	2.3	0.3	0.9	3.5	1.5	54.3	0.5	0.4	1.7	0.9	0.4	0.2	0.0	0.5	0.4	0.4	0.7	2.0	0.9	7.8	1.5	0.4	0.9	2.6	9.6	20.9	5.2	0.2	1.2	0.6	1.2	0.8	15.9	1.2	1.0	0.3	1.2	0.5	0.2	1.0	2.9	0.5	1.1	1.0	32.2	0.7	0.9	0.7	1.8	1.7	0.2	0.5	1.2	8.1	0.0	15.2	119.7	23.1	0.0	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	1.5	0.1	0.2	1.2	2.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	85.6	0.2	1.9	0.0	1.2	11.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	37.0	0.0	0.0	0.0	3.3	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.2	4.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	5.1	0.0	119.7	23.1	21.7	0.0	6.4	0.1	0.0	0.0	0.0	15.2	0.0	0.1	0.0	80.0	0.0	3.8	0.2	0.0	12.9	0.9	1.5	0.4	1.7	1.5	0.4	5.2	0.2	1.2	0.7	0.0	4.8	0.0	0.0	0.1	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	93.5	0.0	0.4	0.0	0.0	3.5	0.0	0.9	0.0	0.0	0.0	38.4	11.0	0.0	1.6	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.3	1.0	0.0	0.0	0.0
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061487	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 194.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 262.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA063384: AB_2684998, HPA065424: AB_2685488"	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	24.2	25.7	15.5	13.1	15.5	4.6	50.3	9.1	19.8	18.8	17.5	17.4	32.3	17.4	31.4	30.5	21.4	22.7	16.3	85.5	18.2	19.2	27.9	18.4	13.9	12.6	21.7	21.2	26.2	11.1	16.6	16.3	16.6	25.0	16.5	13.6	22.6	17.7	26.1	194.7	19.9	18.3	24.3	27.5	17.7	13.9	18.8	16.5	5.8	22.4	58.9	10.7	17.3	24.2	4.1	9.4	19.7	9.4	2.1	2.6	0.9	19.2	43.0	28.2	23.8	59.2	28.9	21.2	31.5	43.8	22.4	25.0	52.4	22.3	22.2	64.0	39.7	29.1	40.1	19.9	25.1	24.1	38.0	16.6	12.5	29.1	17.5	70.3	27.8	20.2	39.4	62.8	40.7	45.8	37.5	34.9	15.0	22.1	61.6	27.5	16.5	17.6	8.7	18.2	17.4	16.4	12.5	39.9	21.1	24.7	28.9	17.4	26.3	21.5	14.5	44.4	38.3	28.6	19.1	46.7	54.9	23.8	18.5	31.5	103.1	69.0	20.8	52.1	11.8	31.1	7.9	9.4	2.7	2.6	4.8	1.5	3.8	2.5	2.6	1.9	4.1	1.9	2.1	19.7	2.1	5.6	9.4	0.9	0.9	15.5	15.5	9.1	19.8	18.2	19.2	21.7	21.2	25.0	16.5	53.6	49.6	9.7	17.8	49.5	67.0	262.2	61.1	40.2	31.8	73.3	33.4	18.6	21.6	36.9	6.0	55.4	91.6	0.0	31.5	17.7	25.0	31.4	26.7	111.7	30.3	68.3	28.9	55.9	33.7	7.9	94.6	19.5	20.3	41.5	46.8	24.4	46.3	54.1	78.8	38.4	33.8	58.2	41.2	22.3	20.4	42.3	18.7	14.4	38.2	19.7
NFE2L3	Nrf3	ENSG00000050344	"Nuclear factor, erythroid 2 like 3"	Q9Y4A8	7	26152240-26187125	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 54.9"	"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 226.3;Syncytiotrophoblasts: 584.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.0;NTERA-2: 36.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055889	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA055889: AB_2682958"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.88e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (7.58e-12)"	"prognostic favorable (2.14e-4)"	"unprognostic (2.40e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.13e-3)"	3.5	2.5	0.8	7.8	1.2	1.6	4.1	6.2	1.6	1.8	6.7	4.0	2.4	6.2	1.9	1.7	3.1	2.4	7.1	3.6	1.3	1.1	4.2	2.3	5.8	6.9	2.5	0.8	1.7	7.5	0.0	2.1	54.9	2.1	3.7	4.0	2.1	7.7	0.4	3.4	8.2	7.1	0.8	3.7	10.4	5.6	2.5	1.5	11.2	1.6	1.5	8.9	3.1	2.1	1.4	2.8	0.8	1.1	1.1	2.6	0.4	12.7	1.1	0.5	1.3	0.0	0.0	44.0	2.5	5.0	4.9	9.1	8.4	22.3	0.9	16.8	0.2	18.6	2.7	1.9	4.3	11.3	8.7	2.7	1.7	1.8	6.1	3.4	1.5	17.0	0.4	0.5	2.0	0.7	7.3	11.4	3.6	2.6	22.6	1.0	1.7	1.0	2.7	36.9	3.5	4.5	1.5	0.1	6.3	6.7	12.6	4.0	4.7	0.0	1.0	0.4	12.8	0.6	0.9	23.9	0.4	0.7	0.2	10.2	13.8	21.9	1.0	0.0	5.5	17.0	0.0	1.1	0.0	0.5	1.1	1.6	1.0	2.1	1.0	2.8	1.4	1.2	0.7	0.8	1.1	0.3	0.9	2.6	0.4	0.8	1.2	6.2	1.6	1.3	1.1	2.5	0.8	2.1	1.5	6.0	3.2	0.8	2.8	1.5	1.2	1.4	17.8	1.4	5.7	10.4	0.0	226.3	0.0	9.8	0.7	3.8	3.3	0.0	4.7	28.3	2.3	3.6	27.6	0.0	21.3	0.0	1.2	3.1	12.9	0.0	0.0	11.1	1.7	5.4	6.5	0.9	11.2	4.3	0.0	0.3	1.3	0.0	1.0	0.3	5.7	1.4	584.2	4.9	8.3	5.4
NFIL3	"E4BP4, IL3BP1, NF-IL3A, NFIL3A"	ENSG00000165030	"Nuclear factor, interleukin 3 regulated"	Q16649	9	91409045-91423862	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Smooth muscle cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 22.8;neutrophil: 14.7"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 22.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;HDLM-2: 44.3;hTCEpi: 36.7;hTERT-HME1: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003261	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA003261: AB_1079477"	"unprognostic (2.18e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.23e-6)"	"unprognostic (5.44e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.37e-2)"	34.9	34.3	6.0	14.2	10.7	73.6	80.5	8.0	9.8	21.0	14.4	2.7	7.0	7.1	18.3	18.7	11.1	24.1	19.0	20.8	7.2	4.0	11.4	32.4	20.2	16.3	7.6	4.1	37.5	11.9	7.2	9.0	17.9	16.8	22.7	8.9	3.5	6.5	12.3	51.7	15.4	7.7	24.4	22.4	6.9	13.8	12.2	7.4	2.3	11.4	6.1	4.7	28.8	69.6	0.2	0.5	22.8	0.8	0.0	0.7	0.3	4.5	2.7	3.3	1.8	40.4	31.5	16.1	5.4	15.6	6.2	9.4	1.8	2.2	2.0	3.3	4.4	18.1	2.9	3.8	5.4	7.1	44.3	1.6	2.1	2.7	15.4	33.0	2.9	13.2	31.9	36.7	5.5	39.1	3.5	2.7	5.1	3.5	23.0	4.0	2.2	0.3	3.9	2.5	7.8	2.4	7.2	3.6	2.9	7.6	2.1	4.1	3.0	3.7	3.4	5.3	6.1	1.9	3.9	2.9	13.6	3.0	11.7	2.7	19.8	4.5	0.8	7.2	2.8	2.4	22.8	0.8	5.4	0.7	0.4	0.3	0.2	0.0	0.2	0.5	0.0	0.1	0.1	14.7	0.0	0.5	0.3	0.0	0.3	6.0	10.7	8.0	9.8	7.2	4.0	7.6	4.1	16.8	7.4	20.8	36.2	2.9	13.1	41.0	14.6	72.2	10.2	9.4	17.0	0.0	15.7	7.5	8.3	7.4	21.3	31.9	18.6	0.0	8.4	14.7	30.2	31.9	9.2	25.1	10.1	19.1	15.4	13.5	30.3	4.5	10.0	26.0	32.1	18.0	7.4	17.0	9.3	8.6	11.0	7.3	13.7	6.5	115.4	0.7	1.9	34.5	19.3	6.9	7.1	12.6
NFKB2	"LYT-10, NF-kB2, p105, p49/p100, p52"	ENSG00000077150	"Nuclear factor kappa B subunit 2"	Q00653	10	102394110-102402529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5;Karpas-707: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008422, CAB022098, HPA023900"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435"	"unprognostic (1.10e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.98e-2)"	"prognostic favorable (8.45e-5)"	"unprognostic (4.04e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.69e-12)"	"unprognostic (2.37e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.56e-1)"	14.9	10.8	5.6	43.6	7.1	40.6	18.7	2.0	4.9	12.5	20.1	4.2	9.4	11.3	18.8	11.0	12.9	10.8	20.4	10.9	4.6	2.5	15.5	14.5	20.6	34.2	6.6	2.5	15.1	17.4	5.2	6.3	12.8	7.9	19.6	5.2	7.3	16.7	15.1	13.6	10.4	14.1	24.0	7.7	28.0	13.1	6.6	5.8	19.5	11.5	14.8	39.2	21.9	24.4	5.2	1.4	7.5	3.4	1.3	2.0	0.9	21.4	13.4	2.7	10.7	3.3	5.1	6.4	6.1	19.6	6.2	9.0	8.0	17.6	9.9	15.3	3.7	15.5	13.0	6.1	8.4	2.5	50.5	3.6	2.5	3.2	4.6	9.4	1.6	14.4	7.0	4.1	10.4	10.3	8.6	2.2	5.2	2.3	55.2	2.4	7.3	2.5	6.7	3.4	4.7	4.8	5.4	7.4	7.8	10.5	6.3	0.5	3.0	5.0	12.2	8.6	2.9	9.4	4.8	6.4	6.5	9.5	9.1	16.3	36.5	33.8	10.4	10.6	4.2	3.4	0.3	2.4	0.1	1.4	1.5	1.4	5.2	1.7	1.5	1.4	4.5	1.8	1.5	7.5	1.3	3.4	0.9	2.0	0.9	5.6	7.1	2.0	4.9	4.6	2.5	6.6	2.5	7.9	5.8	8.9	9.1	51.9	51.4	38.6	1.9	2.2	17.8	1.4	18.2	17.4	15.7	4.7	5.0	29.4	1.1	15.8	40.4	0.0	18.1	14.3	9.4	46.1	72.5	3.4	19.0	0.0	15.6	9.8	13.8	0.9	6.9	24.3	28.7	115.4	13.1	4.9	35.6	14.0	4.6	9.2	5.1	0.0	25.6	1.7	10.2	39.0	19.3	24.9	10.6	38.3
NFKBIB	"IKBB, TRIP9"	ENSG00000104825	"NFKB inhibitor beta"	Q15653	19	38899700-38908893	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 80.2"	"Group enriched"	"Detected in all"	13	"Early spermatids: 932.5;Late spermatids: 859.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063734			Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA063734: AB_2685107"	"unprognostic (2.73e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.50e-3)"	7.9	7.1	7.0	12.5	9.8	22.0	6.8	2.9	7.3	3.9	7.6	8.1	7.6	10.8	5.8	5.7	8.6	5.1	7.6	7.1	7.3	5.8	7.9	14.6	6.7	8.7	11.2	5.2	4.3	9.7	4.0	3.9	7.2	7.2	5.0	3.6	5.1	8.6	6.6	13.9	8.0	11.7	5.1	9.9	9.2	12.4	80.2	9.3	6.0	6.6	8.7	8.7	6.6	5.1	3.8	5.4	12.4	5.8	8.7	7.2	2.9	8.1	10.2	1.5	3.6	1.5	0.9	4.8	5.5	2.2	3.0	3.4	7.2	4.4	9.0	6.2	1.2	2.8	4.5	3.8	2.7	0.9	27.5	4.9	6.0	1.9	4.1	5.3	6.9	12.8	1.2	3.0	3.3	4.2	0.8	1.6	6.7	7.0	8.3	1.1	5.3	8.5	6.8	5.1	6.9	4.2	12.0	6.3	8.2	1.4	3.2	8.9	5.3	3.5	5.1	3.9	0.9	3.0	5.9	3.9	5.1	6.5	8.7	8.4	17.3	15.3	19.2	3.3	7.2	6.2	1.5	4.3	12.4	5.3	5.8	4.1	3.6	3.1	4.5	3.8	3.8	2.3	3.4	9.0	8.7	4.7	5.4	7.2	2.9	7.0	9.8	2.9	7.3	7.3	5.8	11.2	5.2	7.2	9.3	8.9	22.4	22.8	35.7	28.0	10.9	6.5	10.2	4.0	11.4	12.2	3.9	24.4	6.6	26.6	932.5	20.4	53.1	23.3	27.0	21.6	13.5	31.8	66.8	18.7	21.9	23.8	21.2	8.0	14.6	859.8	12.7	18.6	16.9	37.9	17.0	13.0	38.2	17.5	14.2	19.2	11.5	19.4	18.9	20.1	14.9	21.1	49.4	29.9	18.2	31.5
NFKBID	"IkappaBNS, TA-NFKBH"	ENSG00000167604	"NFKB inhibitor delta"	Q8NI38	19	35887653-35902303	"Predicted intracellular proteins, Transcription factors"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 91.9;Macrophages: 54.1;monocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054778			Uncertain	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nuclear bodies, Plasma membrane"	"HPA054778: "	"prognostic favorable (6.01e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.34e-6)"	4.1	2.8	0.9	13.5	2.5	21.0	7.0	4.5	2.4	1.9	2.1	4.4	0.9	1.9	2.3	2.7	3.0	3.7	6.9	2.1	0.7	1.1	3.4	1.8	11.4	9.1	2.3	0.4	4.3	3.5	1.9	5.5	1.6	2.0	2.6	1.5	2.7	2.3	3.4	0.9	3.6	4.8	5.1	2.4	6.8	2.8	1.5	1.1	14.4	5.1	1.0	14.7	2.8	7.4	9.4	1.9	4.8	1.6	2.0	2.3	0.6	4.7	4.4	0.9	3.0	0.6	0.7	2.1	3.0	3.5	3.2	2.3	1.0	3.9	5.8	2.3	3.1	2.8	2.5	3.1	2.3	1.3	3.3	0.6	3.5	6.2	1.1	0.8	3.0	10.5	1.0	1.6	5.9	1.5	0.8	1.1	2.7	0.7	3.6	0.7	3.7	2.5	3.6	1.3	0.9	0.9	1.3	0.7	1.2	2.8	2.0	1.6	1.2	4.0	3.1	0.3	0.8	1.4	3.0	1.2	5.0	4.5	2.2	2.0	2.5	0.9	6.8	2.7	7.1	0.7	0.0	1.4	2.5	2.3	0.9	1.7	5.4	1.0	1.8	1.4	9.4	1.7	1.0	4.8	2.0	1.6	1.9	2.2	0.6	0.9	2.5	4.5	2.4	0.7	1.1	2.3	0.4	2.0	1.1	0.0	13.7	34.0	7.1	26.4	8.1	0.8	5.1	4.0	2.3	1.8	19.6	1.1	0.0	2.3	0.0	8.7	2.9	0.0	0.9	2.2	15.4	12.3	91.9	0.0	32.9	0.0	2.9	2.5	30.8	0.0	1.1	54.1	18.6	51.3	2.6	1.1	2.7	2.5	1.8	0.9	9.7	0.0	9.5	0.5	0.5	29.2	0.8	15.2	4.8	7.9
NFKBIZ	"FLJ34463, INAP, MAIL"	ENSG00000144802	"NFKB inhibitor zeta"	Q9BYH8	3	101827991-101861022	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.9"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 368.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 20.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.8;monocytes: 20.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.5;RPTEC TERT1: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010547, HPA075363"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA010547: AB_1854442, HPA075363: AB_2686745"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (2.69e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.52e-3)"	26.4	4.4	2.2	35.5	3.4	116.9	46.9	2.4	2.0	17.4	23.7	3.6	5.5	16.8	21.3	13.0	22.1	39.5	31.5	17.3	2.8	1.9	13.8	26.8	29.6	21.3	4.4	0.3	18.2	15.7	2.4	7.2	18.8	5.0	16.3	10.4	10.9	37.4	8.1	9.8	21.0	18.5	17.9	5.2	21.5	16.8	7.1	3.3	3.3	26.5	30.8	23.8	18.7	20.0	3.2	3.8	15.8	20.0	0.5	4.1	1.1	2.8	2.2	1.5	1.9	4.4	7.7	2.4	11.4	31.5	5.1	4.8	2.7	3.4	5.2	14.6	3.1	15.7	9.0	1.1	4.9	13.1	15.3	1.0	5.0	3.9	1.4	6.9	0.3	0.3	5.3	7.7	13.5	6.2	12.5	3.7	0.2	0.8	10.9	7.2	3.5	0.1	2.9	2.6	0.9	6.7	0.6	6.9	0.7	31.5	18.4	0.7	0.9	1.9	2.3	12.2	3.4	2.8	2.1	4.7	8.2	8.2	3.0	3.7	9.2	3.2	3.6	14.9	1.0	1.1	4.9	3.6	1.0	1.0	8.3	1.1	1.9	1.4	1.0	2.4	3.2	4.1	2.7	15.8	0.5	20.0	3.8	0.7	1.1	2.2	3.4	2.4	2.0	2.8	1.9	4.4	0.3	5.0	3.3	80.4	236.3	41.4	30.7	250.1	8.8	17.3	45.9	72.3	110.3	62.8	2.0	14.6	0.0	152.4	3.7	112.8	123.3	0.0	113.5	33.8	98.5	56.9	368.8	58.2	52.3	9.5	70.7	47.9	91.7	1.1	18.7	186.1	67.4	68.5	64.5	19.2	152.1	109.7	0.7	1.9	7.4	19.4	108.2	0.0	0.6	220.1	21.4	55.3	73.5	38.8
NFXL1	HOZFP	ENSG00000170448	"Nuclear transcription factor, X-box binding like 1"	Q6ZNB6	4	47847233-47914667	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 100.7;Spermatocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059132	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059132: AB_2683917"	"unprognostic (5.37e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (1.13e-2)"	"unprognostic (6.26e-3)"	"unprognostic (8.48e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (4.72e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.01e-2)"	8.3	5.8	7.8	7.2	8.7	6.5	10.8	19.1	9.4	10.1	7.4	6.2	12.2	7.8	13.3	19.2	9.7	9.6	6.9	5.5	6.7	5.5	7.4	9.5	7.4	6.5	7.0	9.6	10.9	12.8	11.9	19.6	8.7	7.6	9.0	8.6	5.3	12.4	10.2	7.1	9.3	7.4	8.8	8.8	7.5	8.2	21.3	7.0	5.9	17.2	4.4	7.7	9.2	10.9	2.5	1.9	5.6	2.3	1.5	3.5	1.7	5.5	3.5	3.9	8.1	7.5	12.4	13.4	3.8	5.4	6.2	7.8	5.9	12.7	4.4	7.3	2.5	12.1	5.7	10.1	7.6	7.4	3.4	3.9	4.7	6.5	10.8	9.7	11.5	9.5	8.1	10.2	4.3	25.6	7.4	5.4	9.3	8.4	5.5	6.4	5.3	9.0	5.4	9.5	7.6	5.5	8.1	7.6	7.3	7.9	10.6	12.5	6.0	2.8	8.0	5.5	7.9	5.5	3.4	4.4	8.2	5.1	3.8	8.4	8.9	5.4	8.9	4.7	6.5	7.1	0.0	1.7	1.7	2.3	2.3	2.8	2.2	3.2	2.5	1.6	2.5	3.5	3.4	5.6	1.5	1.1	1.9	2.0	1.7	7.8	8.7	19.1	9.4	6.7	5.5	7.0	9.6	7.6	7.0	6.0	8.3	1.5	4.0	4.7	19.0	100.7	15.3	8.1	13.6	7.0	9.8	5.0	10.0	7.2	28.3	7.3	5.8	0.0	6.0	9.5	8.0	6.1	2.3	7.2	4.3	7.9	10.9	4.3	3.5	12.4	11.8	6.2	1.7	4.6	7.4	9.1	6.3	3.5	9.6	3.1	16.0	0.0	3.6	72.2	24.3	3.8	5.6	4.9	6.9	5.1
NGDN	"C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD"	ENSG00000129460	Neuroguidin	Q8NEJ9	14	23469688-23509862	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000944	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA000944: AB_1079483"	"unprognostic (2.63e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.70e-1)"	20.1	17.6	17.2	19.3	23.6	35.7	26.9	28.9	25.8	17.8	17.8	21.2	18.7	15.0	29.1	22.3	17.4	21.7	12.1	14.8	17.6	15.7	20.6	21.0	15.5	20.4	23.5	17.4	27.2	16.6	20.9	20.7	19.7	19.1	19.7	19.4	17.4	24.0	19.9	32.8	22.7	17.9	21.0	21.6	19.7	17.5	19.0	25.2	19.6	23.7	17.2	22.8	17.3	19.7	42.0	26.7	18.9	23.4	35.2	44.6	28.2	11.0	21.9	16.8	15.7	16.3	11.8	22.2	14.6	15.3	31.3	25.4	21.6	20.2	27.4	10.8	13.3	22.2	19.2	33.2	18.1	36.9	18.2	17.5	24.5	13.3	66.7	22.2	32.4	17.5	14.7	23.1	24.6	29.4	12.4	15.8	21.2	27.1	19.6	15.2	26.2	24.1	24.5	21.2	25.4	29.5	19.7	20.1	14.0	20.0	21.0	17.2	19.4	17.3	20.8	23.9	17.8	12.9	20.8	11.9	14.8	17.6	13.9	21.2	24.5	42.5	39.8	6.4	16.6	15.8	17.5	21.5	18.9	31.6	23.4	33.5	42.0	34.3	32.1	25.3	36.6	44.6	35.1	6.6	35.2	22.4	26.7	37.4	28.2	17.2	23.6	28.9	25.8	17.6	15.7	23.5	17.4	19.1	25.2	32.8	26.9	41.2	49.3	62.7	21.0	17.7	17.8	28.1	29.6	26.2	15.7	50.7	28.2	31.1	4.1	34.3	17.4	23.3	31.3	36.0	37.0	25.4	43.9	18.1	26.5	23.8	23.6	16.0	16.4	4.5	32.5	29.5	30.4	36.1	18.8	20.7	28.1	19.9	26.5	27.0	24.7	19.4	38.7	57.2	69.0	59.1	47.8	41.5	22.0	44.2
NGEF	ARHGEF27	ENSG00000066248	"Neuronal guanine nucleotide exchange factor"	Q8N5V2	2	232878686-233013272	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.1;brain: 55.6;intestine: 23.2"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 44.3;Hepatocytes: 17.7;Paneth cells: 20.1;Undifferentiated cells: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 25.6;HDLM-2: 21.6;HeLa: 10.4;PC-3: 28.1;T-47d: 15.9"	"Group enriched"	"Detected in many"	4	"amygdala: 177.2;basal ganglia: 332.1;cerebral cortex: 231.3;hippocampal formation: 147.2"	"Low region specificity"	"Detected in many"			HPA008160	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA008160: AB_1854450"	"unprognostic (3.92e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.39e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.74e-1)"	0.8	29.1	15.8	1.4	55.6	0.3	1.4	0.8	53.8	1.4	7.9	1.6	0.0	23.2	2.8	2.6	5.3	3.1	2.0	0.9	7.0	5.1	4.2	9.7	0.6	0.3	3.2	26.7	1.5	1.8	7.9	0.9	0.4	5.4	1.3	6.1	0.0	0.8	0.7	0.7	16.5	16.6	4.0	1.4	0.5	6.2	2.3	12.0	0.0	0.8	1.0	0.4	0.9	1.6	0.0	0.5	0.5	0.3	0.0	0.0	0.0	25.6	7.5	0.3	0.1	0.1	4.2	0.4	0.4	0.0	0.2	0.0	0.3	2.5	0.0	7.6	5.3	2.7	3.3	5.7	1.4	0.2	21.6	1.8	0.0	10.4	8.0	0.1	0.0	0.1	0.0	0.1	1.7	0.3	0.1	0.9	0.1	0.1	0.1	0.2	1.9	0.0	0.0	0.6	0.1	28.1	0.0	0.0	0.0	0.5	0.7	0.9	0.2	3.2	1.6	0.0	1.0	15.9	0.2	0.0	0.2	2.3	0.1	0.5	0.2	0.1	0.0	1.9	0.0	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	15.8	55.6	0.8	53.8	7.0	5.1	3.2	26.7	5.4	12.0	0.0	0.0	0.0	1.0	8.9	0.2	2.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.6	0.4	44.3	0.0	9.2	0.2	0.3	0.6	0.0	17.7	0.1	1.6	4.7	0.0	0.3	1.3	0.0	0.2	1.7	0.0	13.6	5.2	7.7	20.1	1.1	6.3	0.0	0.0	0.7	1.1	0.4	6.6	0.0	0.0	17.8	0.3
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90278141	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	13.3	21.3	49.2	11.0	43.2	19.4	18.7	27.6	61.5	18.5	15.6	13.8	8.4	9.3	18.9	21.0	13.1	15.2	14.1	19.1	38.9	42.2	11.2	13.3	15.3	11.9	38.9	37.7	19.4	18.9	21.1	17.1	12.3	30.9	15.5	12.1	11.4	14.4	14.5	47.6	17.7	11.3	12.4	25.7	14.0	13.9	13.8	14.0	3.8	23.3	15.4	11.4	12.7	15.4	5.2	2.4	6.0	3.1	4.2	4.8	2.5	2.9	7.4	9.8	15.4	8.6	3.7	1.2	4.2	3.3	4.0	2.9	3.5	1.7	4.7	2.8	5.0	3.4	4.9	9.5	2.4	5.8	1.9	8.8	4.5	4.5	5.4	5.5	5.2	3.4	5.1	8.7	3.7	4.8	3.8	3.6	4.8	5.6	5.8	2.4	3.5	4.9	2.2	4.6	3.6	4.4	7.5	5.5	2.3	4.2	13.1	9.8	12.3	8.1	6.5	3.5	7.0	2.6	7.4	5.8	9.6	4.1	6.2	7.5	3.8	20.0	5.0	4.2	5.4	7.8	6.0	2.3	3.6	3.2	3.1	4.0	3.5	3.1	2.7	1.2	5.2	3.7	4.4	5.0	4.2	1.9	2.4	4.8	2.5	49.2	43.2	27.6	61.5	38.9	42.2	38.9	37.7	30.9	14.0	17.9	20.6	6.7	10.6	6.4	10.7	7.8	2.5	103.1	36.4	5.2	9.8	5.1	5.0	27.1	1.5	8.4	7.3	0.0	20.6	3.7	5.0	7.7	19.7	3.4	3.7	15.9	25.4	5.5	4.0	2.2	8.3	5.9	8.5	17.2	15.6	13.3	25.7	17.5	8.1	6.7	10.4	12.9	8.6	4.8	3.6	4.4	5.6	8.5	15.7	6.4
NHLH1	"bHLHa35, HEN1, NSCL, NSCL1"	ENSG00000171786	"Nescient helix-loop-helix 1"	Q02575	1	160367067-160372848	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 10.8;skin 1: 4.2"	"Cell type enhanced"	"Detected in some"	11	"Cone photoreceptor cells: 2.0;Horizontal cells: 3.2;Intestinal endocrine cells: 1.7;Kupffer cells: 1.5;Rod photoreceptor cells: 1.3"	"Group enriched"	"Detected in some"	6	"glioma: 2.4;testis cancer: 0.8;urothelial cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebellum: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 24.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"Region enriched"	"Detected in some"	12	"cerebellum: 37.9"	HPA017943			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA017943: AB_2732421"	"unprognostic (6.95e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-8)"	"unprognostic (4.09e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.36e-1)"	1.0	0.5	0.9	1.1	4.1	0.4	0.3	10.8	2.0	0.3	0.8	0.3	0.3	0.4	0.3	0.5	0.3	0.2	0.4	0.3	3.2	2.2	0.3	0.3	0.3	0.5	0.8	0.3	0.3	0.5	0.2	0.4	0.3	2.3	0.3	0.3	0.6	1.3	0.3	0.6	4.2	0.6	0.5	2.5	1.0	0.4	0.8	0.3	0.3	0.3	0.3	0.4	0.4	0.3	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.1	2.5	0.0	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.2	1.1	0.5	0.2	0.5	0.0	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.4	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.0	24.8	0.2	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.7	0.6	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	4.1	10.8	1.6	3.2	2.2	0.8	0.3	2.3	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	3.2	1.7	0.6	1.5	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	1.3	0.0	0.2	0.7	0.5	0.0	0.2	0.0	0.0	0.0
NHLH2	"bHLHa34, HEN2, NSCL2"	ENSG00000177551	"Nescient helix-loop-helix 2"	Q02577	1	115836377-115843917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 16.6;skin 1: 10.5"	"Group enriched"	"Detected in some"	7	"Basal glandular cells: 2.1;Basal keratinocytes: 2.5;Cardiomyocytes: 2.6;Intestinal endocrine cells: 1.7;Spermatocytes: 4.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 36.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055238	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nuclear bodies"	Nucleoplasm	"HPA055238: AB_2682752"	"unprognostic (2.20e-2)"	"unprognostic (2.28e-1)"		"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.11e-2)"	"unprognostic (5.26e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.25e-1)"	0.2	0.2	3.4	0.2	0.9	0.2	0.6	16.6	2.4	0.3	0.3	0.4	0.5	0.3	0.2	1.4	2.5	0.2	0.3	0.2	7.1	9.1	0.2	0.2	0.9	0.2	4.1	1.5	0.2	0.2	0.2	0.1	0.5	16.3	0.7	0.4	1.0	0.4	0.7	0.6	10.5	0.3	0.2	3.1	0.2	1.0	1.6	0.6	0.0	0.2	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	16.6	2.4	7.1	9.1	4.1	1.5	16.3	0.6	0.0	0.0	0.0	2.1	2.5	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	4.9	1.5	1.9	0.0	0.0	0.0	0.3
NHLRC2	"DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492"	ENSG00000196865	"NHL repeat containing 2"	Q8NBF2	10	113854661-113917194	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 67.2;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038493, HPA057564"	Approved		Approved	Nucleoplasm		NA	NA		73000	Nucleoplasm		"HPA038493: AB_10672519, HPA057564: AB_2683469"	"unprognostic (7.09e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.88e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-2)"	11.2	10.3	7.7	8.1	8.4	5.2	10.3	10.5	8.7	10.2	11.7	7.0	14.7	7.5	10.5	10.2	8.9	8.9	10.5	24.8	8.0	4.1	8.1	12.0	10.9	7.6	8.1	6.6	12.3	13.1	17.0	17.9	12.3	7.3	13.1	8.5	11.4	12.5	10.3	18.7	9.8	13.1	9.8	8.4	9.7	9.4	5.3	9.3	8.7	10.9	6.1	7.6	10.8	10.7	3.6	3.9	3.9	3.9	3.2	3.7	1.4	10.2	6.5	13.0	10.6	4.7	8.6	8.2	7.2	8.6	6.3	6.9	4.5	10.1	5.5	5.2	7.2	5.5	9.2	10.6	5.9	10.7	6.6	5.3	5.8	5.3	6.4	7.2	8.4	6.8	5.9	7.4	7.0	14.4	12.1	7.5	4.0	6.9	6.4	8.4	4.8	4.8	6.6	3.8	6.3	3.3	4.4	18.6	3.2	7.7	5.7	3.4	6.9	5.6	7.2	8.7	6.3	5.3	6.3	9.5	7.6	7.6	4.7	10.8	4.4	2.2	5.6	6.2	13.4	5.0	3.9	2.7	3.1	3.3	2.2	3.1	3.4	2.6	3.7	3.2	3.6	2.3	3.0	2.1	3.2	3.9	3.9	2.3	1.4	7.7	8.4	10.5	8.7	8.0	4.1	8.1	6.6	7.3	9.3	17.9	17.6	9.2	11.1	7.0	18.4	67.2	25.5	5.3	25.0	34.9	13.7	13.8	6.6	9.2	4.0	16.4	8.4	23.3	10.6	10.9	9.2	19.7	10.4	22.7	8.6	27.0	9.9	20.3	15.9	6.0	16.7	9.0	6.8	11.8	16.3	22.5	8.9	12.4	24.8	9.8	25.3	64.7	5.7	13.3	11.4	7.3	15.2	8.7	11.7	11.2
NHLRC4		ENSG00000257108	"NHL repeat containing 4"	P0CG21	16	566996-569495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 17.3"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 9.4;Collecting duct cells: 22.7;Erythroid cells: 23.3;Leydig cells: 7.5;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 4.6;HMC-1: 13.8;REH: 3.6;RPMI-8226: 5.8"	"Low region specificity"	"Detected in single"							HPA077301			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077301: "	"unprognostic (7.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.60e-1)"	1.3	6.9	1.6	1.4	2.3	3.4	1.4	1.4	1.8	2.4	0.9	1.7	9.5	1.4	2.5	21.1	0.7	17.3	1.5	1.8	2.4	2.4	7.0	0.3	4.8	3.8	0.5	0.9	5.1	0.2	5.9	1.4	1.5	2.0	2.2	0.3	2.1	3.1	10.9	2.3	0.3	1.7	0.5	0.8	4.8	0.8	2.8	0.7	7.8	0.4	0.4	1.2	1.3	0.7	1.1	4.4	5.0	0.5	0.7	1.5	0.7	0.0	0.0	0.6	0.1	0.1	0.3	0.1	0.0	0.8	0.2	0.2	0.1	0.2	0.8	0.6	0.1	0.0	0.1	0.0	0.1	0.0	2.4	0.2	4.6	0.0	1.0	1.0	0.3	13.8	2.9	0.0	0.1	0.3	0.0	0.3	0.8	1.4	1.6	0.0	0.0	0.5	3.4	0.3	0.0	0.0	3.6	0.0	5.8	0.3	0.2	0.0	1.3	0.0	0.0	0.5	0.1	0.6	0.7	0.7	0.0	0.1	0.0	0.0	2.1	1.9	0.9	0.0	0.2	0.4	0.0	0.5	5.0	0.4	0.2	0.7	1.1	1.3	0.6	0.6	0.7	1.5	0.8	0.0	0.7	0.2	4.4	1.4	0.7	1.6	2.3	1.4	1.8	2.4	2.4	0.5	0.9	2.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	9.4	2.3	22.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.3	0.2	0.0	0.4	0.2	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	7.5	0.5	0.0	0.0	0.0	0.8	0.0	0.0	4.2	0.0	0.0	6.5	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3
NHP2	"FLJ20479, NOLA2"	ENSG00000145912	"NHP2 ribonucleoprotein"	Q9NX24	5	178149460-178153967	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044171, HPA050400"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044171: AB_2678844, HPA050400: AB_2681113"	"unprognostic (1.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (4.05e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (8.87e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.63e-2)"	35.4	41.0	42.5	37.5	46.4	44.2	37.9	26.2	54.2	27.1	37.3	23.7	26.2	29.0	31.9	34.4	59.4	37.6	33.6	52.3	37.7	33.6	31.3	57.1	24.9	60.3	37.1	29.3	38.2	62.1	15.1	25.3	25.0	26.7	28.0	22.4	18.6	40.0	35.5	50.9	39.1	26.7	34.2	34.1	29.9	30.4	26.9	25.6	40.6	34.5	61.9	32.9	26.8	33.4	50.8	78.2	7.1	38.9	37.9	43.8	51.2	32.7	49.5	16.0	46.4	11.0	14.5	55.9	25.6	12.4	27.4	23.8	29.0	28.0	47.0	47.4	14.1	25.5	20.5	24.0	52.9	14.6	89.3	80.8	24.8	38.6	32.5	18.7	42.3	26.8	17.5	25.1	21.5	19.4	10.8	25.6	31.2	25.0	30.3	15.3	142.0	58.6	29.4	24.7	28.3	76.7	39.7	22.0	70.1	20.5	20.9	41.4	48.0	19.2	51.8	44.5	10.3	26.6	29.9	25.9	28.8	32.3	24.3	57.3	38.2	77.0	55.9	29.9	56.0	31.5	7.1	35.3	4.8	31.6	38.9	43.8	50.8	39.2	36.3	48.7	50.0	40.8	42.0	2.7	37.9	27.0	78.2	36.3	51.2	42.5	46.4	26.2	54.2	37.7	33.6	37.1	29.3	26.7	25.6	56.6	57.1	131.8	167.2	171.7	49.1	10.9	119.8	60.2	96.7	120.4	17.7	208.0	303.4	170.3	42.0	112.3	43.9	23.3	260.6	296.0	121.9	161.1	78.4	142.5	155.5	28.6	121.6	77.3	74.8	92.9	124.8	98.1	138.3	123.6	126.5	46.8	190.5	31.6	91.6	215.9	23.6	58.2	119.3	92.2	127.8	212.3	139.6	90.9	179.9	243.4
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 93.0"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.4;TIME: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	7.4	1.1	6.0	5.4	5.7	0.2	2.4	3.7	8.6	2.2	46.3	4.3	3.4	13.4	3.0	11.2	10.0	0.9	7.2	18.4	4.8	3.4	17.4	19.5	15.0	2.0	4.2	1.3	1.2	4.6	2.8	1.7	3.5	6.3	1.7	10.0	7.9	3.4	0.4	2.3	10.5	93.0	3.0	2.8	2.0	6.8	1.6	1.6	0.2	1.2	3.6	1.7	2.4	3.9	0.1	1.2	1.0	3.8	0.1	0.1	0.7	2.6	2.3	16.6	6.9	4.8	6.0	6.2	2.4	1.1	0.9	0.8	3.0	1.5	0.0	3.1	2.0	1.6	6.1	10.0	6.2	0.4	0.2	6.7	1.6	1.1	22.4	7.2	5.9	1.2	8.6	3.5	0.4	7.2	0.9	11.7	0.9	0.0	0.9	3.6	5.2	0.6	0.4	6.6	1.5	4.4	6.8	1.7	0.5	5.7	6.8	6.3	0.0	2.5	5.2	16.7	11.5	1.6	1.9	31.9	2.3	2.3	2.3	6.5	0.6	1.2	0.0	0.2	2.4	12.8	1.0	3.4	0.5	0.1	3.8	0.1	0.1	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	3.8	0.7	0.0	0.7	6.0	5.7	3.7	3.5	4.8	3.4	4.2	1.3	6.3	1.6	56.6	50.9	0.8	2.4	38.0	0.7	20.3	5.1	25.4	12.5	27.9	27.5	12.0	8.3	3.0	0.8	8.3	65.2	0.0	3.1	3.0	11.6	3.5	8.1	32.7	3.9	35.0	19.4	29.4	6.7	0.0	0.6	3.8	20.3	0.0	29.8	14.7	3.5	45.6	0.0	12.9	0.9	6.5	4.6	0.0	0.7	43.0	36.3	0.9	40.2	7.4
NHSL2		ENSG00000204131	"NHS like 2"	Q5HYW2	X	71910818-72161750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 52.1;Glandular cells: 82.4;Ito cells: 55.3;Kupffer cells: 52.6;Urothelial cells: 89.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.8;EFO-21: 19.9;HUVEC TERT2: 18.3;TIME: 10.6;U-937: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049771	Uncertain		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cell Junctions"	"Plasma membrane"	"HPA049771: AB_2680872"	"unprognostic (9.71e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.72e-4)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.37e-4)"	7.8	2.3	11.0	4.8	22.5	3.4	5.2	27.1	9.4	6.6	5.5	1.5	0.9	1.3	8.7	2.7	5.5	3.8	7.4	3.6	4.9	3.2	2.0	1.6	5.5	1.3	2.2	4.9	3.1	1.6	3.1	6.1	3.7	4.3	6.4	3.3	6.2	2.6	8.7	2.8	2.3	2.6	11.7	2.4	4.5	3.4	9.6	2.7	0.3	5.3	4.6	1.6	6.3	4.4	0.0	3.5	13.5	5.7	0.9	1.8	1.7	0.2	0.4	16.8	0.1	0.2	0.7	0.1	0.5	3.1	0.1	0.2	0.1	0.0	0.1	19.9	1.7	0.0	0.0	1.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.6	0.0	0.0	18.3	0.0	0.0	2.7	0.1	0.1	0.1	1.3	3.2	0.0	0.0	0.0	1.0	0.0	0.1	1.9	0.4	3.8	0.0	0.0	0.0	4.9	0.0	1.1	10.6	0.0	1.1	1.3	0.0	0.0	0.0	0.1	0.8	13.3	0.0	4.1	5.7	11.8	1.8	3.9	1.7	0.0	1.0	1.6	3.5	0.0	0.1	0.2	13.5	0.9	3.0	0.0	0.1	1.7	11.0	22.5	27.1	9.4	4.9	3.2	2.2	4.9	4.3	2.7	0.0	3.4	0.0	52.1	0.5	0.6	16.3	10.2	0.0	0.0	1.8	0.0	15.3	0.0	0.2	3.0	21.8	2.4	23.3	0.6	18.6	11.2	82.4	7.0	14.3	16.2	0.0	1.2	55.3	52.6	4.9	29.4	3.4	1.7	0.0	4.5	1.2	0.3	0.0	20.1	1.4	0.3	25.8	2.2	2.5	1.7	0.3	20.8	27.7	4.9	89.4
NIF3L1	"ALS2CR1, CALS-7, MDS015"	ENSG00000196290	"NGG1 interacting factor 3 like 1"	Q9GZT8	2	200889327-200903930	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036335, HPA036336, HPA061466"	Supported		Approved	Vesicles		NA	NA		8700000	Vesicles		"HPA036335: AB_10696654, HPA036336: AB_2675068, HPA061466: AB_2684532"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (2.48e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (1.94e-1)"	"unprognostic (8.53e-3)"	"unprognostic (6.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.04e-3)"	"unprognostic (8.61e-2)"	12.8	21.6	14.4	17.8	29.1	7.2	19.6	21.1	31.0	14.9	16.9	19.3	10.0	12.9	16.0	21.8	17.2	18.4	11.5	16.5	19.6	14.2	19.5	17.6	12.1	19.0	15.1	13.4	17.8	15.6	20.8	12.0	18.0	25.6	14.3	22.9	16.3	16.5	17.0	21.4	16.8	15.2	15.2	17.9	18.7	16.2	15.2	13.2	20.8	16.3	15.8	24.8	15.1	12.4	20.3	18.5	32.6	21.3	20.2	23.9	14.4	15.0	16.3	26.7	16.3	12.2	15.4	18.3	16.6	17.8	35.4	28.7	25.5	17.5	12.1	16.1	14.1	25.6	16.7	37.8	21.8	38.2	16.1	35.9	18.2	29.0	27.1	11.0	21.4	12.6	12.9	21.2	23.3	22.4	16.1	11.7	25.7	26.5	12.4	20.8	19.8	26.1	26.8	31.3	17.2	29.0	15.7	14.9	23.7	18.7	15.8	16.9	20.0	14.2	14.6	19.6	39.5	14.4	19.6	6.0	17.2	16.1	15.2	14.9	11.4	21.5	26.4	16.6	17.6	16.3	32.6	14.5	18.4	18.3	21.3	19.2	20.3	21.1	23.2	17.8	15.6	23.9	19.7	4.9	20.2	17.8	18.5	19.2	14.4	14.4	29.1	21.1	31.0	19.6	14.2	15.1	13.4	25.6	13.2	0.0	6.5	13.7	7.4	3.3	24.4	11.8	2.5	24.1	15.9	5.2	13.7	27.3	13.3	17.0	6.8	5.0	6.4	0.0	16.0	31.4	5.1	4.9	9.2	8.6	15.1	17.5	1.7	7.4	6.3	4.5	15.0	9.6	5.0	20.8	10.2	17.8	11.7	10.5	18.0	14.0	24.0	6.5	6.7	27.0	21.8	7.2	18.9	6.7	11.0	4.3
NIM1K	"MGC42105, NIM1"	ENSG00000177453	"NIM1 serine/threonine protein kinase"	Q8IY84	5	43192071-43280850	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 23.7;pituitary gland: 9.7"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 7.1;Cone photoreceptor cells: 5.9;Horizontal cells: 17.5;Muller glia cells: 8.2;Rod photoreceptor cells: 6.1"	"Cancer enriched"	"Detected in some"	11	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.2;T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.5;HDLM-2: 4.9;PC-3: 5.6;U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007695	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007695: AB_2667897"	"unprognostic (7.97e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.84e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-5)"	"unprognostic (2.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.46e-3)"	"unprognostic (4.98e-3)"	1.4	3.5	9.4	1.6	10.9	0.9	1.3	4.9	23.7	1.6	1.4	6.3	0.0	1.1	1.2	1.6	1.6	1.4	1.5	1.8	8.7	7.7	1.4	1.2	3.6	1.2	5.6	5.8	1.2	1.5	1.2	9.7	1.8	6.4	1.4	1.7	1.7	2.3	2.4	2.0	1.8	1.2	1.3	4.9	1.0	3.0	1.4	8.1	0.0	2.7	0.0	1.0	1.1	0.8	0.1	1.2	0.0	0.0	0.2	3.2	0.0	0.2	0.6	0.1	0.1	0.9	0.6	0.0	1.0	3.2	1.2	4.5	0.1	0.0	0.5	0.6	0.8	1.6	0.3	0.6	0.0	2.8	4.9	0.3	0.1	0.6	0.2	1.6	0.2	0.7	1.9	0.1	0.5	0.0	1.7	0.0	0.1	0.2	0.3	0.9	0.2	0.3	0.2	0.0	0.0	5.6	0.2	0.3	0.5	0.1	0.7	0.9	0.1	1.8	0.5	0.3	0.2	0.4	1.5	0.0	0.9	0.8	0.8	0.7	1.6	0.4	0.3	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.2	3.2	0.0	9.4	10.9	4.9	11.6	8.7	7.7	5.6	5.8	6.4	8.1	0.0	4.1	0.0	0.1	0.5	7.1	0.3	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.3	0.1	0.0	0.0	0.1	17.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	8.2	0.2	0.0	0.7	0.0	6.1	0.0	0.4	0.4	0.5	0.4	0.0	0.0	0.0	0.0
NINJ2		ENSG00000171840	"Ninjurin 2"	Q9NZG7	12	564296-663779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.7;brain: 43.6"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 32.8;Hofbauer cells: 25.9;Kupffer cells: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 41.4;MOLT-4: 70.0;THP-1: 14.8;U-698: 13.3"	"Low region specificity"	"Detected in many"							"HPA058980, HPA067226"			Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol"	"HPA058980: AB_2683869, HPA067226: "	"unprognostic (1.16e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.60e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.23e-1)"	11.8	1.4	9.8	9.2	14.1	27.8	9.2	2.4	18.5	7.3	5.0	43.6	1.6	4.6	2.9	3.3	8.4	3.8	4.7	7.9	16.4	8.7	1.4	13.8	31.3	10.8	21.8	10.2	0.8	1.8	0.9	1.1	3.9	17.2	2.7	4.5	2.9	4.5	2.8	20.1	6.7	3.9	4.8	26.4	8.8	3.6	3.9	21.1	3.6	2.6	2.2	9.2	9.0	3.9	5.6	14.9	34.2	17.7	5.7	44.7	9.1	0.4	0.1	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.8	3.2	0.0	0.1	1.6	0.4	0.0	0.0	0.0	0.0	2.3	0.0	41.4	9.9	0.5	0.0	1.1	1.7	0.6	0.0	0.0	0.0	0.0	0.8	0.8	2.4	7.1	0.0	0.0	70.0	2.2	0.7	0.0	0.0	1.8	0.0	0.2	0.7	0.0	0.0	0.0	7.8	0.0	0.0	0.1	0.0	14.8	0.2	0.0	0.4	2.7	0.0	0.0	1.1	13.3	0.1	7.7	0.0	2.0	17.7	14.1	10.5	13.7	3.1	5.6	11.8	11.1	14.9	4.5	2.6	5.5	34.2	5.7	11.2	7.8	44.7	9.1	9.8	14.1	2.4	18.5	16.4	8.7	21.8	10.2	17.2	21.1	20.8	32.8	6.5	0.2	5.0	0.0	1.2	0.0	6.7	14.8	0.0	0.0	2.3	1.7	0.0	2.1	5.4	1.6	0.0	0.0	3.2	5.6	0.2	2.3	10.6	25.9	0.0	4.1	5.5	33.3	1.9	7.5	17.3	6.8	6.4	3.2	0.3	0.5	3.5	3.9	0.0	0.0	0.0	1.0	3.2	2.5	4.8	0.7	14.4	3.3	0.0
NIPA2	SLC57A2	ENSG00000140157	"Non imprinted in Prader-Willi/Angelman syndrome 2"	Q8N8Q9	15	22838641-22868384	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067160, HPA071342"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA067160: AB_2685794, HPA071342: AB_2686391"	"unprognostic (2.88e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.93e-2)"	19.3	26.9	18.6	26.1	22.2	22.1	19.9	17.7	28.2	16.8	30.0	16.6	23.9	28.4	21.7	18.3	26.5	16.1	21.3	17.4	16.7	21.3	26.3	27.8	22.5	35.0	17.9	13.8	19.0	30.8	21.1	24.7	31.3	18.5	20.6	30.1	20.0	26.9	14.0	18.8	16.4	37.1	18.2	13.5	43.9	21.4	19.5	13.1	27.9	21.1	19.2	31.5	22.2	17.2	38.1	40.3	27.2	26.5	22.1	24.6	21.5	30.1	30.8	15.8	18.6	15.2	17.3	17.9	33.9	30.0	23.3	27.3	22.8	19.2	29.8	21.6	19.5	24.0	24.2	29.1	17.1	23.7	31.6	18.8	26.7	20.6	18.4	22.6	37.8	25.3	16.9	19.3	19.2	20.1	15.1	27.2	24.6	40.0	35.8	29.8	12.0	12.0	17.7	18.5	32.4	28.5	26.2	26.8	22.6	22.3	37.1	21.3	22.5	25.9	25.7	28.5	15.3	23.3	35.6	28.2	30.9	20.1	22.3	68.6	28.4	41.1	32.3	23.6	38.3	26.5	27.2	21.4	18.0	21.4	26.5	24.4	38.1	19.3	23.5	26.2	32.7	18.4	18.7	15.8	22.1	24.9	40.3	24.6	21.5	18.6	22.2	17.7	28.2	16.7	21.3	17.9	13.8	18.5	13.1	14.9	20.2	64.8	29.3	40.1	8.8	2.0	15.3	16.0	14.8	12.2	11.8	35.4	18.3	36.8	4.8	28.5	29.6	0.0	38.2	54.4	23.4	34.7	9.3	19.4	43.1	20.6	23.4	24.5	25.4	2.2	12.4	28.7	21.9	27.9	26.1	23.6	43.8	31.3	19.8	18.6	11.6	12.9	29.9	21.5	32.4	50.6	70.6	34.6	32.2	91.1
NIPAL1	"DKFZp686A06115, NPAL1"	ENSG00000163293	"NIPA like domain containing 1"	Q6NVV3	4	47914142-48040173	"Predicted membrane proteins"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.8"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 40.1;Paneth cells: 31.6;Urothelial cells: 36.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 11.0;CAPAN-2: 9.9;HaCaT: 13.1;HBEC3-KT: 9.4;RT4: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA036765	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036765: AB_10672366"	"unprognostic (3.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.03e-7)"	"unprognostic (2.55e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	0.5	0.4	0.4	5.4	1.4	0.0	2.2	0.8	0.7	3.6	9.1	0.1	0.0	3.3	0.4	6.3	18.5	1.1	1.8	0.6	0.7	0.7	4.6	10.7	0.5	0.0	0.4	0.2	0.8	6.6	2.9	5.5	30.8	0.7	3.0	8.9	1.2	5.3	0.6	0.7	17.1	12.6	1.0	0.6	0.4	4.3	0.8	0.3	0.2	2.0	9.8	11.2	4.2	5.3	1.0	1.4	1.4	0.8	0.6	0.9	0.0	11.0	0.2	0.0	0.0	0.0	0.0	1.8	2.1	2.0	1.6	2.8	6.6	9.9	0.0	1.5	0.0	2.9	13.1	1.9	9.4	4.1	0.1	2.4	0.0	0.1	0.4	0.0	0.1	0.1	0.1	3.5	0.1	2.3	2.7	0.5	0.7	0.1	0.0	2.3	4.2	0.1	0.1	1.7	7.6	2.9	0.0	0.0	0.0	5.6	15.1	1.0	0.3	1.0	3.7	1.6	0.9	2.4	0.0	4.2	0.1	3.9	0.0	0.2	0.1	0.1	0.0	0.2	0.0	4.2	0.9	0.8	0.5	0.8	0.4	0.6	0.4	0.5	0.3	0.1	1.0	0.7	0.9	1.4	0.6	0.5	1.4	0.3	0.0	0.4	1.4	0.8	0.7	0.7	0.7	0.4	0.2	0.7	0.3	8.9	6.7	0.0	22.7	12.8	0.1	2.6	0.0	2.7	14.8	40.1	0.0	1.6	0.0	8.8	0.5	0.3	27.6	0.0	5.8	1.0	1.3	24.9	0.0	10.4	0.3	0.0	11.1	0.6	0.0	0.0	0.0	0.2	1.7	1.0	27.4	0.5	10.3	31.6	0.0	1.0	3.8	0.0	2.1	1.0	1.5	28.9	3.0	0.7	29.9	36.3
NIPAL3	"DJ462O23.2, NPAL3"	ENSG00000001461	"NIPA like domain containing 3"	Q6P499	1	24415794-24472976	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.4"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039978	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039978: AB_10697712"	"unprognostic (9.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (3.03e-7)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.85e-1)"	5.3	5.1	21.4	5.2	21.8	4.9	8.3	41.2	29.4	6.9	8.9	42.4	5.6	7.1	4.2	7.4	10.3	10.4	6.3	9.2	25.5	21.3	9.4	2.3	9.2	7.1	32.9	14.7	5.5	11.3	14.0	6.5	2.8	31.5	38.4	9.3	7.1	9.9	5.7	3.5	7.7	8.5	8.1	34.8	4.8	9.6	3.1	22.5	5.8	20.7	2.3	7.9	7.8	5.4	12.9	8.4	8.9	3.6	9.2	26.0	9.7	12.8	5.2	0.5	1.7	7.9	8.8	1.9	41.7	29.9	15.3	11.3	1.8	14.7	6.0	13.4	23.0	3.1	12.6	5.1	15.5	15.0	12.2	15.9	6.6	8.7	2.1	7.3	5.8	6.0	8.8	14.4	10.1	30.9	13.9	5.2	11.8	3.8	3.8	9.2	2.8	4.7	2.4	3.2	6.2	14.7	2.2	0.0	6.8	16.2	4.1	19.4	1.8	5.6	7.9	11.2	3.6	10.8	4.4	7.5	13.7	2.9	4.5	9.1	11.9	9.7	2.1	9.2	10.6	12.2	8.9	3.6	4.7	10.8	3.4	10.7	12.9	18.2	14.0	6.5	10.9	26.0	16.1	1.6	9.2	2.3	8.4	17.6	9.7	21.4	21.8	41.2	24.6	25.5	21.3	32.9	14.7	31.5	22.5	44.7	28.0	14.5	11.0	8.1	52.0	21.5	17.8	9.4	19.4	38.4	104.1	3.0	3.3	11.5	2.8	8.5	24.1	46.7	13.4	4.0	8.5	26.1	12.7	3.2	4.2	12.7	18.0	7.4	3.8	5.6	3.7	7.1	13.5	6.4	14.9	15.3	17.2	14.4	4.9	3.6	53.0	0.0	6.2	2.4	5.5	14.3	3.5	20.8	16.3	16.1
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL, cohesin loading factor"	Q6KC79	5	36876759-37066413	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: AB_2683650"	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	16.8	13.9	13.3	21.9	15.7	22.7	15.8	22.9	15.9	17.3	19.2	10.8	20.1	10.4	18.7	16.5	16.6	14.3	15.9	12.4	13.5	7.1	12.6	13.2	16.0	16.0	17.2	11.1	21.2	14.6	30.0	20.9	17.4	13.5	15.1	13.2	8.5	17.1	24.7	18.9	18.2	18.4	13.2	11.9	18.5	14.7	14.1	19.0	42.5	18.1	14.0	16.9	17.6	29.2	4.8	4.6	11.1	4.3	3.8	4.9	1.9	10.3	6.1	16.0	7.5	10.2	11.2	11.8	8.3	9.3	9.2	7.7	8.6	10.7	15.7	5.4	10.3	10.6	9.1	13.6	7.7	13.3	12.9	7.1	19.1	27.2	6.3	7.0	22.3	12.8	8.2	9.5	10.3	13.6	8.8	11.5	9.9	18.1	11.8	8.6	5.0	15.2	8.5	7.6	6.1	5.3	13.0	25.2	6.0	6.5	14.8	11.9	8.4	40.3	10.8	8.5	13.2	11.0	13.0	12.5	12.2	13.3	10.3	6.2	8.6	11.4	18.6	6.7	15.3	9.1	10.0	4.1	5.7	4.8	3.2	4.4	4.0	3.9	4.2	3.3	4.8	4.3	4.9	11.1	3.8	4.3	4.6	2.9	1.9	13.3	15.7	22.9	15.9	13.5	7.1	17.2	11.1	13.5	19.0	122.1	90.0	21.9	65.0	42.9	59.8	76.5	43.3	84.3	83.0	31.4	72.6	34.3	5.0	46.3	10.9	63.8	39.1	70.0	40.4	27.0	34.9	58.3	78.9	22.9	32.7	38.1	39.9	33.7	44.3	10.2	61.5	61.2	23.6	64.9	38.5	49.5	45.0	45.6	53.0	10.2	67.9	51.8	44.3	162.2	75.4	41.0	63.5	61.8	38.0	88.6
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		960000	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.2	8.9	12.1	6.2	4.1	6.1	9.7	9.3	8.4	11.2	10.0	6.2	5.9	4.2	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.9	4.7	4.9	7.6	16.8	5.2	8.5	5.1	6.2	5.7	3.3	8.1	11.8	9.5	3.1	4.3	4.4	12.5	15.1	3.5	4.2	9.8	16.0	6.3	6.9	3.2	5.6	9.6	6.1	3.3	7.1	4.5	4.5	6.1	2.5	2.9	3.5	5.0	5.5	8.5	9.6	8.0	7.7	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3	11.9	12.1	26.5	41.3	29.0	11.3	49.4	30.6	38.8	26.1	55.8	15.7	80.0	159.2	63.8	2.3	15.5	14.9	0.0	46.2	64.1	34.7	40.0	20.7	147.3	56.1	12.7	23.1	16.0	18.8	2.4	40.9	33.3	47.2	136.1	20.8	11.7	55.0	25.7	35.3	436.2	23.6	38.8	46.4	1.5	14.5	36.4	49.5	26.2	34.7	40.6
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123804141-124825657	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 43.2"	"Group enriched"	"Detected in some"	16	"Horizontal cells: 44.5;Muller glia cells: 20.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.9;HEK 293: 6.5;HEL: 8.2;Karpas-707: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol		NA	NA			Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	2.2	1.6	12.9	1.1	12.1	1.9	1.3	17.3	43.2	1.4	1.7	24.9	0.0	1.1	1.2	1.6	1.4	1.4	1.3	2.6	17.5	8.8	1.3	1.2	1.3	1.3	18.1	10.9	1.2	1.0	1.0	1.1	1.2	18.0	1.4	1.3	0.5	1.1	1.3	4.8	1.1	1.5	1.5	42.9	1.1	1.0	1.6	16.1	0.0	1.2	0.5	1.3	1.5	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.2	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.5	0.1	0.0	0.0	0.0	13.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.1	17.3	15.3	17.5	8.8	18.1	10.9	18.0	16.1	0.0	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	44.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
NKAP	FLJ22626	ENSG00000101882	"NFKB activating protein"	Q8N5F7	X	119920672-119943772	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000916	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA000916: AB_1079486"	"prognostic unfavorable (4.20e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	13.9	17.5	12.2	11.2	16.8	15.9	14.0	11.6	16.9	13.0	13.2	15.6	9.9	10.1	16.2	12.4	12.0	15.2	14.0	15.5	12.9	14.0	14.8	19.5	12.6	14.1	14.5	9.7	23.9	13.5	14.1	21.7	18.1	16.6	16.0	8.5	10.3	13.9	15.0	23.9	13.5	13.7	12.0	19.5	15.8	12.3	11.8	16.7	20.1	16.4	11.6	12.2	17.9	15.3	11.8	9.7	16.5	8.0	7.0	8.1	4.4	6.3	7.6	6.1	5.5	4.9	8.3	8.3	4.9	4.6	6.2	4.7	4.6	4.9	6.5	7.8	4.4	7.8	4.6	11.4	4.6	5.4	8.9	10.9	3.1	5.3	4.0	6.5	7.3	6.3	5.7	8.0	5.8	5.0	6.4	4.3	7.8	7.5	6.3	4.8	7.8	8.0	10.4	6.0	5.0	9.9	8.3	6.7	8.4	3.4	2.4	6.9	8.4	9.7	4.7	10.0	3.7	4.2	6.6	6.5	4.4	2.2	10.4	6.3	8.0	6.4	7.4	6.1	6.9	6.4	11.3	8.0	10.8	6.9	5.9	6.8	9.7	8.1	6.5	6.0	11.8	8.1	7.5	16.5	7.0	6.6	9.7	7.5	4.4	12.2	16.8	11.6	14.6	12.9	14.0	14.5	9.7	16.6	16.7	20.8	36.8	31.3	29.8	23.0	31.8	24.6	17.8	53.5	42.1	19.2	23.6	52.3	31.5	32.4	6.3	40.4	20.0	23.3	38.4	96.9	34.2	30.7	45.2	40.3	46.7	52.4	21.9	35.6	26.7	5.0	41.7	39.0	33.7	35.1	23.0	50.3	32.5	24.1	51.9	32.9	36.1	12.9	39.1	33.7	68.2	25.1	61.0	34.9	24.1	27.3
NKAPD1	"C11orf57, FLJ10726"	ENSG00000150776	"NKAP domain containing 1"	Q6ZUT1	11	112074086-112085150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 29.8;Ciliated cells: 32.1;Club cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039493, HPA039892"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039493: AB_10795036, HPA039892: AB_10795372"	"unprognostic (5.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.41e-1)"	20.6	16.2	20.6	14.1	19.1	13.5	20.6	34.8	21.6	21.5	16.0	13.9	13.1	13.4	19.3	15.7	18.1	17.6	15.6	14.7	19.6	21.1	21.7	14.5	13.4	17.6	20.7	14.7	26.0	17.9	17.4	15.8	24.0	20.7	18.9	14.6	13.2	18.0	14.8	28.2	14.6	16.2	23.3	19.6	19.6	13.9	18.8	15.9	29.7	26.7	15.6	16.4	21.6	19.4	9.1	19.4	7.5	7.7	12.2	11.2	4.3	8.0	5.4	11.5	18.5	11.9	13.9	8.5	11.9	10.2	10.0	11.5	16.7	14.6	22.7	18.3	10.7	11.4	11.7	13.7	12.8	13.1	16.2	9.6	17.3	5.4	8.0	11.0	26.1	11.4	14.1	17.6	12.1	28.0	15.3	8.9	18.7	25.5	14.0	10.0	4.9	23.3	16.2	11.5	13.7	12.0	18.1	14.2	18.5	11.6	7.2	9.7	17.7	12.3	15.3	11.1	10.7	19.1	10.9	9.0	13.5	15.2	8.2	10.2	10.6	23.2	46.6	5.7	24.8	13.6	7.5	7.2	4.3	9.9	7.1	10.1	8.3	10.5	6.7	7.6	9.1	11.2	9.5	3.8	12.2	7.7	19.4	8.1	4.3	20.6	19.1	34.8	21.6	19.6	21.1	20.7	14.7	20.7	15.9	29.8	20.2	0.0	0.0	0.0	0.0	0.0	0.0	32.1	31.8	15.7	0.0	16.4	11.6	17.6	0.0	0.0	0.0	0.0	18.5	14.6	0.0	0.0	8.1	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	24.4	0.0	0.0	18.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0
NKD1		ENSG00000140807	"Naked cuticle homolog 1"	Q969G9	16	50548330-50649249	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Melanocytes: 8.5;Sertoli cells: 12.9;Smooth muscle cells: 16.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 12.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 5.0;CACO-2: 10.3;Hep G2: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041352, HPA049413"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA041352: AB_2677428, HPA049413: AB_2680753"	"unprognostic (1.58e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.02e-3)"	"unprognostic (5.59e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.88e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.44e-2)"	3.7	2.4	5.4	3.5	7.0	0.9	2.7	4.3	8.3	6.6	4.9	14.3	6.2	3.3	7.8	11.0	8.3	6.0	17.1	1.7	6.7	5.1	3.2	2.0	12.7	1.5	8.2	4.0	6.4	2.4	0.8	1.3	5.2	12.6	9.3	4.2	7.1	1.4	7.5	0.9	4.2	3.5	13.6	13.7	3.4	3.3	4.5	10.0	0.9	1.0	1.3	1.9	4.0	5.8	0.8	0.8	0.8	0.4	0.5	1.1	0.0	0.0	0.0	5.0	0.3	2.0	0.0	0.1	0.0	0.0	0.0	0.0	10.3	0.2	0.0	0.2	0.0	0.1	0.0	1.7	0.1	0.0	0.0	0.5	0.5	0.0	27.4	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	1.1	0.4	0.4	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.4	0.3	0.8	0.4	0.5	0.4	0.6	0.6	0.2	0.8	0.8	1.1	0.8	0.5	0.3	0.8	0.2	0.0	5.4	7.0	4.3	7.5	6.7	5.1	8.2	4.0	12.6	10.0	0.0	0.0	0.0	1.0	1.3	2.4	0.8	0.0	0.0	0.0	0.0	5.9	2.2	0.0	0.4	5.5	0.7	0.0	0.0	0.4	0.3	5.8	1.1	0.0	1.7	0.4	0.0	1.7	0.6	0.0	2.1	1.7	0.6	8.5	0.0	0.0	6.7	0.5	0.0	3.2	0.0	0.6	12.9	16.0	0.9	6.5	1.0	1.9	0.0	0.1	1.2
NKG7	"GIG1, GMP-17"	ENSG00000105374	"Natural killer cell granule protein 7"	Q16617	19	51371606-51372715	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 270.6;bone marrow: 108.2"	"Cell type enriched"	"Detected in many"	16	"T-cells: 1698.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 270.6;MAIT T-cell: 113.5;memory CD8 T-cell: 168.7;naive CD8 T-cell: 130.3;NK-cell: 166.7"	"Group enriched"	"Detected in all"	46	"NK-cells: 166.7;T-cells: 270.6"	"Group enriched"	"Detected in some"	5	"NB-4: 60.2;THP-1: 17.9;U-937: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071454			Approved	Vesicles		NA	NA			Vesicles		"HPA071454: AB_2686399"	"unprognostic (1.56e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (7.42e-6)"	"unprognostic (1.27e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.89e-3)"	"unprognostic (3.39e-1)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (7.62e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.44e-3)"	7.4	1.8	1.3	11.2	1.7	108.2	3.3	0.7	1.0	2.9	2.2	0.8	0.4	2.2	5.4	6.3	3.8	1.8	10.6	6.0	1.2	1.2	3.2	9.4	26.1	31.0	2.3	0.7	4.1	2.6	0.0	1.8	9.3	1.3	6.8	1.6	6.2	3.5	0.9	5.6	1.0	7.6	2.5	2.8	63.3	2.5	1.9	0.2	7.3	3.1	2.0	16.0	5.1	2.3	1.1	3.2	4.5	4.7	166.7	270.6	141.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.6	0.2	0.0	0.0	6.4	1.2	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.2	0.0	0.0	0.7	60.2	0.0	0.0	0.1	1.4	3.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	17.9	0.1	0.0	0.0	0.2	0.0	0.9	0.2	0.3	0.0	15.6	0.0	2.2	1.3	0.5	270.6	4.7	113.5	1.1	34.1	168.7	3.2	0.5	11.5	130.3	4.5	166.7	3.6	2.5	0.6	141.5	1.3	1.7	0.7	1.0	1.2	1.2	2.3	0.7	1.3	0.2	3.0	10.1	16.0	0.0	4.4	0.0	0.4	10.2	1.4	2.3	5.2	0.0	0.4	3.3	0.0	0.0	2.8	0.3	0.0	0.0	0.4	2.3	0.0	24.2	3.4	12.4	0.0	0.0	45.4	103.5	0.0	0.0	26.0	16.9	1.8	0.0	0.0	0.0	0.3	0.0	6.9	0.0	0.0	0.5	0.0	0.2	5.6	0.9	1698.3	0.0	0.1
NKIRAS2	"DKFZP434N1526, kappaB-Ras2, KBRAS2"	ENSG00000168256	"NFKB inhibitor interacting Ras like 2"	Q9NYR9	17	42011382-42025644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062861			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA062861: AB_2684884"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (9.37e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.42e-3)"	15.3	10.9	6.7	11.5	8.4	12.5	12.9	9.2	10.3	12.0	14.6	11.0	10.3	8.7	15.4	12.5	22.0	10.5	14.1	27.5	6.1	5.6	14.0	16.1	11.7	10.4	8.5	3.6	14.9	10.7	8.4	9.0	30.8	7.2	12.5	9.9	14.6	12.3	11.1	31.5	16.1	15.6	15.7	8.3	12.4	11.3	17.1	6.0	17.7	9.5	15.4	19.1	14.5	12.7	8.2	23.0	21.0	25.5	12.0	7.4	10.4	9.2	15.9	24.5	12.7	17.2	11.6	14.6	15.7	11.9	24.7	18.5	17.3	13.0	15.3	24.8	15.9	16.4	19.5	19.8	11.8	12.6	12.7	21.6	13.7	14.8	12.7	27.0	18.2	11.3	17.2	21.0	16.3	12.6	16.4	29.9	19.5	19.3	15.5	14.0	9.1	35.1	11.3	14.4	11.9	12.2	27.7	28.2	14.3	15.9	9.5	29.4	38.5	11.5	34.8	15.5	25.0	22.1	22.1	21.6	15.6	16.7	16.7	17.5	20.4	33.0	12.6	10.4	10.9	21.8	21.0	25.5	20.5	7.0	20.5	6.9	7.8	7.1	7.0	20.5	8.2	7.4	7.1	14.4	12.0	21.5	23.0	6.0	10.4	6.7	8.4	9.2	10.3	6.1	5.6	8.5	3.6	7.2	6.0	14.9	9.3	12.9	16.9	15.0	20.3	22.4	2.5	8.1	17.0	15.7	19.6	45.4	18.3	25.5	5.4	22.4	18.3	0.0	24.7	32.7	21.6	17.9	13.9	13.4	33.2	22.3	18.4	12.3	22.5	4.0	18.1	26.6	10.1	33.3	17.6	22.0	22.8	14.0	17.3	15.0	25.1	6.5	19.6	28.1	33.2	22.5	52.1	10.0	14.0	18.0
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119605895	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	3.8	7.9	14.5	6.2	24.3	7.6	6.5	11.4	34.9	4.9	4.0	4.4	1.1	4.7	4.8	5.6	5.6	5.2	4.1	3.8	15.4	14.0	6.9	6.9	4.1	9.7	8.1	24.6	7.4	3.9	8.3	6.5	7.5	25.7	4.9	4.5	2.9	4.6	4.3	4.8	6.4	4.4	4.7	6.0	6.4	4.0	1.9	3.5	7.4	5.4	1.4	9.7	5.2	4.8	3.8	2.7	2.8	2.2	1.3	5.5	1.7	11.0	11.2	6.6	7.7	5.8	5.9	10.1	6.7	5.5	9.1	9.9	11.9	9.5	19.6	11.8	5.8	7.8	13.0	27.7	10.3	11.2	9.8	18.9	10.3	13.4	7.9	5.4	20.0	8.0	6.2	8.5	10.5	12.3	6.2	9.2	9.7	11.1	8.3	8.1	17.0	12.7	16.0	14.8	16.1	12.6	10.0	9.5	20.1	12.0	8.2	10.9	9.1	9.4	14.7	9.9	7.2	6.2	12.2	7.5	5.8	6.2	12.4	16.8	6.8	8.2	20.7	6.0	22.4	6.5	2.8	1.3	1.5	3.3	2.2	3.1	3.7	3.6	3.7	1.3	3.8	5.5	4.8	0.2	1.3	1.1	2.7	4.3	1.7	14.5	24.3	11.4	34.9	15.4	14.0	8.1	24.6	25.7	3.5	6.0	6.2	9.0	9.2	17.2	13.3	4.0	10.2	2.7	2.3	5.2	25.5	11.6	1.7	3.8	0.1	4.5	2.6	0.0	3.1	13.2	6.2	8.4	14.9	3.4	5.6	7.9	10.3	4.3	6.0	0.0	7.2	7.8	5.0	6.4	3.8	4.0	3.1	0.0	6.3	3.7	8.3	0.0	8.2	0.5	1.1	22.5	12.5	7.0	5.7	8.7
NKX1-2	"bB238F13.2, C10orf121"	ENSG00000229544	"NK1 homeobox 2"	Q9UD57	10	124445239-124450184	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;intestine: 2.9;skin 1: 2.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 3.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.0;hTCEpi: 5.9;NTERA-2: 11.6;SCLC-21H: 5.1;SuSa: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA029367	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA029367: AB_2673011"	"unprognostic (2.43e-1)"	"unprognostic (7.85e-3)"		"unprognostic (6.81e-5)"	"unprognostic (1.55e-2)"	"unprognostic (3.61e-2)"		"unprognostic (5.40e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.20e-1)"		"unprognostic (3.73e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.7	0.0	2.0	0.0	0.9	0.2	2.9	0.4	0.0	1.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.4	0.0	0.7	3.7	0.3	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	1.2	0.0	0.0	2.2	2.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	6.0	0.5	0.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.1	14.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.2	2.9	0.6	0.3	0.7	3.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKX2-4	"NKX2.4, NKX2D"	ENSG00000125816	"NK2 homeobox 4"	Q9H2Z4	20	21395367-21398028	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5;pituitary gland: 1.2;testis: 5.2"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 1.2;Early spermatids: 2.4;Late spermatids: 1.9;Spermatocytes: 3.8;Spermatogonia: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HEK 293: 7.8;SCLC-21H: 5.1;SK-MEL-30: 5.9;WM-115: 1.8"	"Region enriched"	"Detected in single"	22	"hypothalamus: 3.1"	"Region enriched"	"Detected in single"	32	"hypothalamus: 1.4"	HPA074996			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA074996: AB_2686725"					"unprognostic (3.77e-1)"				"unprognostic (2.15e-1)"						"unprognostic (1.68e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	1.2	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.2	0.0	0.0	0.0	0.0	0.0
NKX2-5	"CSX, CSX1, NKX2.5, NKX2E, NKX4-1"	ENSG00000183072	"NK2 homeobox 5"	P52952	5	173232109-173235357	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Atrial septal defect, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 95.6"	"Cell type enriched"	"Detected in some"	32	"Cardiomyocytes: 56.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 21.0;NTERA-2: 7.6;SK-MEL-30: 9.3;U-2 OS: 17.3;U-251 MG: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065034			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA065034: AB_2685409"	"unprognostic (3.81e-1)"	"unprognostic (8.53e-2)"		"unprognostic (2.62e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.22e-3)"		"unprognostic (6.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.31e-1)"			"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"		"unprognostic (1.77e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	95.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.1	0.0	0.0	0.2	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.0	1.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	4.9	21.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.3	4.2	0.0	9.3	2.9	0.0	0.0	0.0	4.0	17.3	5.3	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.1	0.1	0.0	0.0	0.0
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580579-36582607	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.6;lung: 7.7;testis: 22.9"	"Cell type enhanced"	"Detected in single"	18	"Basal glandular cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;HaCaT: 10.0;HEK 293: 2.4;PC-3: 5.8;SiHa: 2.3"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.3"	"Low region specificity"	"Detected in many"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA062879: AB_2684892"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.3	0.3	0.2	0.4	0.7	0.3	0.3	0.0	1.2	0.3	0.3	2.0	0.0	0.3	0.3	0.3	5.3	0.3	0.3	0.3	0.3	2.0	0.3	0.3	7.7	0.3	2.0	0.0	0.3	0.3	1.5	2.1	0.3	5.7	0.4	0.3	0.0	2.0	0.3	0.3	1.1	0.3	0.3	9.6	0.3	0.3	22.9	0.5	0.0	4.2	1.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.5	10.0	0.0	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.3	0.4	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.2	0.3	2.0	2.0	0.0	5.7	0.5	0.0	0.0	0.0	2.3	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.3
NKX3-1	"BAPX2, NKX3.1, NKX3A"	ENSG00000167034	"NK3 homeobox 1"	Q99801	8	23678693-23682927	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"prostate: 95.3"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 52.8;Glandular cells: 96.8"	"Cancer enriched"	"Detected in many"	65	"prostate cancer: 392.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"eosinophil: 23.5;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 23.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 16.9;SiHa: 16.7;U-138 MG: 17.0;U-251 MG: 14.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA025693, HPA078571"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA025693: AB_1854522, HPA078571: AB_2732384"	"unprognostic (1.47e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.56e-6)"	"unprognostic (6.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.69e-1)"	0.6	1.3	0.3	0.6	0.9	0.6	1.5	0.1	0.8	1.1	0.6	0.2	0.5	0.5	0.7	0.5	1.2	0.7	0.8	2.4	0.8	0.3	0.4	1.6	0.8	0.7	0.6	0.2	1.6	0.6	0.5	0.4	0.3	1.2	95.3	0.2	0.5	17.9	0.7	2.0	0.2	0.4	0.7	0.6	0.3	0.5	12.3	0.7	0.0	0.6	3.2	20.5	0.7	2.5	1.0	0.0	23.5	0.0	0.2	1.2	0.1	3.0	2.3	0.0	5.6	2.1	0.5	4.6	4.2	2.7	9.0	10.7	1.3	3.5	0.0	0.6	3.1	16.9	0.8	2.2	4.8	7.1	0.0	1.1	2.1	1.7	3.4	4.0	0.0	0.8	0.8	1.3	9.1	0.5	5.6	0.5	12.9	0.1	0.0	3.5	1.0	7.3	0.6	1.3	0.0	1.6	0.0	3.6	0.3	0.5	3.6	1.1	0.3	16.7	3.1	0.3	6.8	2.2	0.3	0.6	17.0	6.0	1.3	14.5	0.0	0.0	0.0	8.3	1.6	2.0	3.4	0.0	23.5	0.5	0.0	0.1	1.0	0.2	0.5	0.0	0.9	0.7	1.2	23.4	0.2	0.0	0.0	0.0	0.1	0.3	0.9	0.1	0.8	0.8	0.3	0.6	0.2	1.2	0.7	3.0	4.0	0.5	52.8	4.9	1.7	7.0	0.0	1.4	5.7	0.0	7.9	0.3	0.0	2.4	2.0	6.8	0.4	0.0	6.1	1.2	4.1	96.8	0.0	3.8	0.2	3.2	6.3	4.9	0.3	4.5	2.0	2.9	1.7	1.0	0.4	4.3	4.7	0.0	6.0	0.5	4.5	0.0	13.3	0.7	1.4	1.8	0.2	0.5	0.5	9.3
NKX3-2	"BAPX1, NKX3.2, NKX3B"	ENSG00000109705	"NK3 homeobox 2"	P78367	4	13540830-13545050	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 18.3;lymphoid tissue: 6.5"	"Cell type enriched"	"Detected in single"	31	"Cardiomyocytes: 3.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.6;NB-4: 12.7;NTERA-2: 7.2;THP-1: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027564	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027564: AB_10601973"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.24e-5)"	"unprognostic (3.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.93e-8)"	"unprognostic (5.81e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	1.7	0.0	0.1	6.5	0.1	0.0	0.1	0.1	0.1	1.1	18.3	0.1	0.1	1.6	0.9	0.1	2.3	0.2	0.4	1.8	0.1	0.0	0.4	0.1	0.1	2.0	0.1	0.1	2.9	0.2	0.0	0.9	0.1	0.1	0.6	2.4	0.1	1.5	0.6	0.1	0.1	2.0	3.2	0.1	5.3	2.8	0.9	0.1	0.1	0.3	0.9	0.1	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	1.9	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	1.0	0.0	4.6	0.0	0.0	0.0	2.6	0.6	1.7	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	1.9	0.0	0.7	1.7	0.0	0.7	0.0	0.4	12.7	7.2	0.0	0.5	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	2.3	1.0	7.6	0.0	0.5	3.0	0.1	0.5	2.2	0.0	0.0	0.4	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491987-84498450	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 6.0;esophagus: 11.0;pancreas: 10.8"	"Cell type enhanced"	"Detected in some"	19	"Ductal cells: 7.1;Early spermatids: 2.5;Spermatocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;HAP1: 8.1;HEK 293: 7.1;HMC-1: 5.5;PC-3: 4.8;U-2197: 9.0"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.7"	"Low region specificity"	"Detected in many"			"HPA036774, CAB070169"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.2	0.0	0.3	0.2	2.2	0.0	6.0	1.0	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	11.0	0.0	0.2	0.2	0.4	1.3	0.2	0.2	0.2	0.2	2.5	0.2	0.2	10.8	0.0	0.2	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	1.3	0.2	1.5	2.1	0.2	0.2	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.6	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.2	2.3	0.0	8.1	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.1	4.8	0.0	2.4	0.0	0.0	0.3	1.5	0.0	0.7	0.0	0.0	1.5	0.0	0.8	0.1	0.0	2.5	9.0	2.3	0.0	0.0	0.0	1.5	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	1.0	1.1	0.4	1.3	2.5	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	2.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.0	0.0	0.0	0.0	0.0	0.0
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128753-35142315	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 40.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (6.39e-4)"	6.3	6.9	7.0	8.2	7.6	6.4	11.4	7.6	9.1	5.6	5.8	5.4	3.3	5.1	10.0	5.5	7.9	10.0	8.3	4.8	6.0	6.4	4.8	6.9	4.5	9.1	5.6	7.7	16.3	40.3	5.1	4.2	6.1	5.4	9.2	5.3	6.2	9.1	7.5	8.8	7.6	5.1	10.2	5.1	8.3	6.8	7.2	6.4	10.0	10.0	6.6	8.3	6.3	5.4	6.4	4.5	0.4	3.2	2.4	9.1	3.0	8.2	20.0	6.7	12.0	4.2	6.3	10.8	7.4	7.0	13.3	11.0	13.8	8.0	18.2	10.2	6.2	9.7	11.0	15.3	19.0	9.1	2.9	23.8	8.2	9.6	17.2	5.7	15.7	6.6	7.1	10.2	13.7	21.0	5.9	8.5	17.9	22.0	6.7	7.8	11.3	24.1	12.8	12.7	6.9	8.9	19.5	11.8	20.1	7.8	8.0	13.9	8.4	7.0	7.2	8.8	6.5	17.6	11.4	7.6	7.2	10.1	6.9	24.8	5.2	4.0	15.3	5.0	13.0	13.7	0.1	3.0	0.0	5.7	3.2	9.1	4.8	5.4	6.0	4.5	6.4	7.4	5.1	0.4	2.4	1.6	1.0	3.0	3.0	7.0	7.6	7.6	9.1	6.0	6.4	5.6	7.7	5.4	6.4	3.0	0.6	12.4	6.2	7.7	4.1	2.0	12.7	4.0	3.4	3.5	2.0	9.0	0.0	8.7	0.6	4.2	1.6	0.0	12.9	16.0	8.2	4.0	3.5	5.5	6.7	1.6	4.7	4.3	2.8	4.7	3.7	2.2	1.7	3.6	7.8	1.4	9.4	2.9	4.6	5.6	2.9	0.0	4.1	3.6	5.3	8.8	4.1	4.4	12.0	5.1
NLGN2	KIAA1366	ENSG00000169992	"Neuroligin 2"	Q8NFZ4	17	7404874-7419860	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.0"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 31.6;Horizontal cells: 54.0;Muller glia cells: 23.0;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 26.1"	"Low region specificity"	"Detected in all"							"HPA055321, HPA069278"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055321: AB_2682783, HPA069278: AB_2686105"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.81e-2)"	13.0	10.9	31.3	9.9	45.3	2.4	7.4	32.7	47.0	16.9	11.3	18.3	9.5	4.4	25.3	16.4	9.0	13.8	15.5	6.6	28.8	16.0	5.7	3.3	6.2	6.1	13.9	27.5	24.3	7.4	20.7	8.3	8.5	21.3	11.6	5.9	11.2	6.5	19.2	6.3	8.7	5.4	24.3	19.4	7.5	5.9	4.8	15.9	0.0	4.8	1.7	5.0	9.8	11.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	4.2	5.9	26.1	15.1	8.0	11.2	0.6	7.0	11.1	11.9	11.0	1.3	1.4	0.0	3.4	9.7	7.0	2.4	4.8	2.9	6.4	6.3	4.9	1.8	5.3	1.0	4.1	1.8	6.4	9.0	2.4	9.8	1.6	18.0	4.0	2.3	1.7	3.4	5.0	4.0	0.8	1.8	4.4	0.2	2.8	7.5	3.1	0.8	3.5	0.9	0.4	10.5	3.2	1.5	1.8	5.4	4.2	0.2	5.5	10.3	13.1	6.5	3.4	3.9	1.3	0.7	10.7	1.7	3.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	31.3	45.3	32.7	37.2	28.8	16.0	13.9	27.5	21.3	15.9	0.0	1.6	0.0	2.5	4.1	31.6	10.9	0.0	0.0	0.0	0.0	7.9	0.3	0.0	2.7	1.3	5.2	0.0	0.0	0.3	5.7	11.2	2.1	0.0	2.1	0.8	54.0	0.0	4.9	0.3	2.5	15.8	0.0	1.7	1.0	0.0	23.0	2.1	0.0	20.8	1.0	15.3	32.3	10.3	0.3	1.3	3.3	0.7	1.0	0.0	1.0
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.9"	"Cell type enriched"	"Detected in some"	6	"Peritubular cells: 16.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"AF22: 11.1;NTERA-2: 8.1;SH-SY5Y: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: AB_2732397"	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	1.4	8.9	16.3	1.6	19.4	2.2	1.3	11.5	45.9	3.2	1.6	30.0	0.1	1.1	4.2	8.1	1.5	6.0	2.4	2.1	15.7	9.7	1.2	0.9	1.3	1.2	12.7	13.1	6.1	1.2	1.4	1.1	1.5	15.2	7.9	1.4	1.6	1.6	16.0	0.8	1.6	1.6	2.9	12.9	1.4	1.5	3.8	12.3	0.0	1.0	0.0	1.1	1.5	1.3	0.2	0.1	3.3	0.3	0.3	0.5	0.0	0.1	0.8	11.1	0.3	2.6	1.1	1.9	0.3	0.1	0.0	0.2	0.1	0.5	0.8	0.8	0.1	0.0	0.2	0.4	0.0	0.2	0.7	1.3	0.5	0.5	0.1	0.0	0.2	0.9	0.6	0.1	0.3	0.0	0.5	0.1	3.1	0.7	2.1	0.1	0.6	0.7	1.7	8.1	0.1	0.0	0.9	0.4	0.5	0.0	1.2	2.7	4.4	0.3	0.0	1.0	1.4	0.0	0.5	0.3	0.2	1.3	0.5	0.1	1.7	1.5	0.6	0.3	0.5	0.6	0.3	0.3	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.1	3.3	0.3	0.0	0.1	0.1	0.0	16.3	19.4	11.5	23.1	15.7	9.7	12.7	13.1	15.2	12.3	0.0	0.0	0.0	0.4	0.6	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.5	2.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	16.3	0.0	0.5	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.0	0.3
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 93.3;Cone photoreceptor cells: 145.3;Early spermatids: 243.8;Late spermatids: 250.1;Rod photoreceptor cells: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"basophil: 17.6"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 17.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	6.4	30.5	19.4	10.9	14.1	7.4	7.5	7.5	38.2	6.2	6.7	8.3	14.4	8.3	5.7	8.8	4.5	5.1	8.2	8.5	18.2	12.0	13.0	8.2	7.1	11.7	15.2	23.6	4.6	11.5	20.8	9.4	9.1	7.0	6.7	7.1	12.7	5.8	17.4	4.9	4.5	8.3	4.6	15.3	10.1	7.0	17.4	7.5	10.9	13.2	3.7	11.0	7.2	4.4	0.5	0.3	17.6	0.3	0.1	0.5	0.2	4.6	5.4	13.0	4.5	2.8	3.6	5.8	4.7	4.8	7.8	6.0	27.1	4.2	6.3	7.1	3.8	9.9	4.4	9.2	8.5	9.0	14.6	5.8	24.8	5.0	4.6	4.7	5.2	25.6	4.7	5.3	5.1	6.2	7.6	9.1	18.0	9.5	7.7	7.1	5.5	13.4	6.0	5.0	9.1	2.7	11.2	8.4	4.6	14.2	5.7	9.5	3.6	7.1	6.8	29.1	16.4	10.6	8.3	9.3	5.6	7.6	4.6	9.4	9.0	8.6	6.1	5.5	5.7	6.1	17.6	0.2	0.2	0.3	0.3	0.1	0.5	0.4	0.4	0.2	0.3	0.2	0.5	0.1	0.1	0.3	0.3	0.4	0.2	19.4	14.1	7.5	38.2	18.2	12.0	15.2	23.6	7.0	7.5	20.8	5.9	4.7	3.5	4.7	93.3	23.0	10.2	6.7	4.5	31.4	145.3	2.5	1.7	3.3	243.8	10.6	5.9	0.0	5.5	3.0	3.7	5.4	24.2	8.9	7.2	35.0	27.1	10.4	14.2	250.1	5.2	5.0	15.1	4.6	9.4	9.4	5.7	7.0	2.5	6.3	92.4	12.9	3.9	25.8	9.5	4.3	5.4	5.1	8.3	5.8
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722196-65871725	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;monocytes: 5.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		53000	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	4.5	2.4	7.6	4.7	10.5	2.9	7.3	2.8	11.9	4.1	6.8	5.8	1.0	2.4	5.8	5.0	5.2	3.3	2.7	5.1	7.2	7.6	7.5	18.9	3.4	5.1	8.7	8.5	4.0	11.0	3.6	2.4	4.9	9.8	5.4	6.5	2.0	4.3	2.6	15.0	5.7	5.3	5.5	10.9	5.8	7.5	2.4	6.2	1.8	5.5	7.9	4.0	4.3	3.3	0.9	4.1	0.6	5.9	0.9	0.7	1.8	9.2	8.9	5.3	8.7	6.7	11.5	10.6	9.4	4.0	5.5	6.0	5.1	5.5	13.2	11.9	11.2	11.1	7.4	6.8	14.4	9.7	3.9	4.6	3.6	6.7	12.8	5.8	8.3	2.2	8.7	7.9	7.6	9.1	4.7	15.5	5.9	7.8	2.8	11.9	7.1	5.7	7.5	16.1	4.7	2.6	6.7	11.2	20.9	9.1	4.1	16.4	8.5	7.6	7.8	7.7	14.9	9.3	9.9	8.9	3.7	4.4	5.4	7.0	2.4	4.8	5.8	5.7	16.4	5.5	0.2	4.7	0.2	0.2	5.9	0.3	0.9	0.4	0.3	4.1	0.9	0.7	0.5	0.6	0.9	4.1	0.2	0.1	1.8	7.6	10.5	2.8	11.9	7.2	7.6	8.7	8.5	9.8	6.2	6.0	3.2	1.5	5.1	5.0	0.6	13.2	10.2	2.7	11.4	12.2	3.9	5.2	5.0	15.3	0.2	5.0	20.6	0.0	12.3	12.1	5.2	8.8	15.0	26.4	24.7	4.8	1.7	5.5	23.4	0.0	4.0	8.4	1.7	2.8	7.1	13.2	23.5	10.7	2.1	17.4	3.5	0.0	3.1	1.4	4.3	4.5	2.4	0.9	7.1	5.5
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.0"	"Cell type enhanced"	"Detected in some"	14	"Ito cells: 6.2;T-cells: 15.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 6.3;HL-60: 13.1;HMC-1: 6.6;JURKAT: 6.5;NB-4: 14.0;U-698: 20.2;U-937: 9.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	0.2	0.4	0.0	20.1	0.1	2.8	0.0	0.0	0.2	0.4	1.3	0.0	0.2	1.2	1.0	0.1	1.0	0.0	1.8	0.8	0.0		0.6	0.5	6.0	11.2	0.2	0.0	0.1	1.5	0.0	0.0	0.6	0.2	0.9	0.7	0.9	2.7	0.2	0.5	0.0	2.4	0.1	0.0	10.5	1.4	0.0	0.0	27.0	0.4	1.1	18.1	1.6	1.0	1.0	0.0	2.6	0.0	4.7	4.1	3.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.3	0.1	0.0	0.0	13.1	6.6	0.0	0.0	0.0	0.0	0.3	0.2	6.5	0.1	0.0	0.0	0.3	5.4	14.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.2	0.0	0.2	0.1	0.3	0.0	20.2	0.1	9.8	0.0	2.6	0.0	0.0	3.7	0.0	4.1	1.0	2.7	3.8	0.0	0.8	2.1	2.0	0.0	4.7	0.0	0.0	3.1	3.3											3.0	0.0	4.2	0.2	0.0	1.6	3.7	0.0	1.4	1.2	1.8	3.9	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	6.2	0.6	0.7	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.5	0.2	0.0	0.0	15.2	0.0	0.1
NLRC5	"CLR16.1, FLJ21709, NOD27"	ENSG00000140853	"NLR family CARD domain containing 5"	Q86WI3	16	56989485-57083531	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"B-cells: 22.9;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 41.5;NB-4: 22.8;U-2197: 15.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA060405, HPA074724"			Supported	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA060405: AB_2684277, HPA074724: "	"unprognostic (9.66e-2)"	"prognostic favorable (9.69e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.75e-3)"	10.0	5.7	3.4	26.4	7.0	24.9	6.0	1.6	6.2	5.4	7.0	4.2	2.9	4.9	10.8	4.4	6.4	4.9	8.9	3.7	4.3	2.4	5.5	5.5	12.8	21.3	7.0	2.0	3.9	3.6	2.1	20.2	2.3	6.0	5.2	5.6	4.7	8.9	3.0	3.5	10.9	16.1	5.8	7.8	24.6	7.2	1.3	6.3	9.4	5.9	6.6	29.7	7.3	7.0	5.4	1.7	13.2	4.0	2.7	7.0	2.7	4.9	0.9	0.1	0.3	0.3	1.7	0.0	2.7	4.3	8.8	8.6	0.0	8.6	10.1	2.1	4.5	3.5	3.3	1.1	0.3	1.0	0.4	0.3	41.5	8.8	1.0	3.1	1.4	2.5	3.3	0.1	7.1	0.8	2.8	3.4	1.4	0.0	2.0	1.8	0.1	2.2	22.8	0.0	0.1	0.9	10.8	3.1	4.2	1.0	0.4	0.3	0.3	5.6	0.5	1.2	0.0	0.6	5.5	4.3	4.2	1.5	15.4	2.2	4.1	2.1	10.3	7.5	3.1	0.8	6.4	4.0	13.2	7.0	2.2	4.2	5.4	4.0	6.6	1.7	3.1	2.6	2.7	9.8	2.7	2.5	1.3	4.6	2.7	3.4	7.0	1.6	6.2	4.3	2.4	7.0	2.0	6.0	6.3	0.0	15.7	22.9	0.8	6.1	0.4	3.1	0.0	2.7	5.7	5.2	0.0	0.0	0.0	5.5	0.4	10.5	19.1	0.0	7.2	0.1	2.8	1.7	9.2	3.9	4.4	0.0	8.1	9.8	17.0	0.0	0.9	7.3	0.0	6.4	10.5	0.3	6.9	10.5	0.4	0.6	1.3	0.0	5.7	0.0	0.0	8.7	0.1	30.5	9.0	3.8
NLRP10	"CLR11.1, NALP10, NOD8, PAN5, Pynod"	ENSG00000182261	"NLR family pyrin domain containing 10"	Q86W26	11	7959424-7965426	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"placenta: 13.2;skin 1: 10.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 18.0;BJ: 5.5;HBF TERT88: 7.8;LHCN-M2: 3.4"	"Region enhanced"	"Detected in some"		"olfactory region: 2.6"					"HPA039498, HPA040101"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA039498: AB_10795679, HPA040101: AB_10795519"						"unprognostic (4.06e-1)"			"unprognostic (4.34e-1)"						"unprognostic (9.78e-3)"		"unprognostic (2.87e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	18.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	2.7	1.3	2.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRP2	"CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2"	ENSG00000022556	"NLR family pyrin domain containing 2"	Q9NX02	19	54953130-55001142	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.3"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 180.1;Syncytiotrophoblasts: 81.4"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 78.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 25.0;K-562: 10.4;SuSa: 11.1;U-266/84: 11.3"									HPA021183			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles, Cytosol"		"HPA021183: AB_2670615"	"unprognostic (1.66e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.60e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.57e-2)"	0.6	0.9	1.1	5.0	3.8	1.7	1.4	0.6	2.7	2.6	2.6	0.9	0.2	2.5	2.1	3.7	10.8	1.0	3.7	0.7	2.0	1.8	4.7	0.9	2.2	5.0	0.8	0.8	1.0	6.1	0.3	1.7	8.1	2.9	2.1	1.2	2.4	4.1	1.6	1.4	3.5	2.9	1.1	1.0	3.0	3.1	14.3	0.9	4.2	3.1	0.2	3.5	4.7	5.6	3.8	1.8	0.6	0.9	3.4	2.6	0.8	2.3	3.9	1.9	0.4	0.1	0.1	25.0	0.1	0.0	0.2	0.1	5.0	0.5	2.6	0.2	0.1	0.1	4.1	0.0	4.2	0.2	2.5	0.2	2.5	0.3	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	10.4	0.3	0.0	0.3	0.2	1.0	3.0	4.4	0.0	2.8	0.0	1.4	2.3	0.9	2.4	0.6	0.1	1.1	0.0	11.1	3.4	0.8	0.0	0.2	0.5	0.3	0.3	2.7	11.3	0.9	0.3	0.7	0.1	0.6	0.7	0.3	2.6	0.9	1.5	3.8	1.1	1.0	0.6	2.6	0.8	1.5	0.5	3.4	0.5	1.8	1.2	0.8	1.1	3.8	0.6	2.7	2.0	1.8	0.8	0.8	2.9	0.9	8.9	5.3	0.5	1.3	0.5	2.1	0.6	2.5	6.7	7.9	1.8	3.9	28.7	0.0	4.2	18.8	0.2	1.3	0.0	1.8	180.1	0.4	2.2	4.6	0.0	10.4	0.0	2.4	0.0	0.0	4.9	0.9	0.5	0.0	4.6	2.8	1.1	4.4	0.0	0.0	0.3	2.2	0.0	0.3	13.5	11.4	1.1	81.4	0.5	2.3	3.1
NLRP4	"CLR19.5, CT58, FLJ32126, NALP4, PAN2, PYPAF4, RNH2"	ENSG00000160505	"NLR family pyrin domain containing 4"	Q96MN2	19	55836578-55881854	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 9.4;lymphoid tissue: 9.0;testis: 12.1"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 10.4;Late spermatids: 5.5;Spermatogonia: 2.3"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.4"	"Cell line enriched"	"Detected in some"	8	"Daudi: 42.9"									HPA062128			Approved	Mitochondria		NA	NA			Mitochondria		"HPA062128: "	"unprognostic (2.48e-1)"			"unprognostic (7.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"		0.2	0.2	1.9	1.0	1.8	0.0	0.2	0.2	2.9	0.2	0.2	2.7	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.2	1.0	0.3	0.2	0.2	0.2	2.8	5.1	0.6	0.4	0.2	0.1	0.3	0.0	2.9	0.2	0.1	0.0	0.8	0.0	0.2	0.2	0.3	0.1	9.4	0.3	0.2	12.1	2.2	0.0	0.2	0.4	9.0	0.2	0.2	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	1.8	0.2	2.9	1.0	0.3	5.1	0.6	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.0
NLRP7	"CLR19.4, NALP7, NOD12, PAN7, PYPAF3"	ENSG00000167634	"NLR family pyrin domain containing 7"	Q8WX94	19	54923509-54966312	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 7.4;testis: 7.1"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 6.5;Extravillous trophoblasts: 4.7;Late spermatids: 11.4;Spermatocytes: 4.7"	"Cancer enriched"	"Detected in many"	30	"testis cancer: 146.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 7.4"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 7.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.0;RT4: 2.0;SuSa: 3.3;U-266/84: 9.7"									HPA051382	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA051382: AB_2681461"	"unprognostic (2.15e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.25e-8)"	"unprognostic (1.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.45e-1)"	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	1.5	0.0	7.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	7.4	0.4	0.0	1.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.7	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	7.4	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.7	2.3	0.0	1.6	0.0	0.0	0.3
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA		35000	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favorable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	4.8	6.1	1.9	3.3	3.7	3.6	3.6	2.5	4.9	8.9	5.1	2.9	8.0	2.9	5.6	5.3	34.9	6.7	4.9	8.7	2.9	1.6	4.3	4.4	3.4	3.4	1.8	2.7	2.9	6.2	5.6	2.5	3.3	3.0	4.4	2.0	5.4	5.6	4.8	14.3	11.6	3.2	4.6	2.4	4.5	4.0	3.2	1.3	3.8	4.3	38.9	37.5	5.3	8.5	0.6	2.0	14.3	3.3	1.3	1.3	1.9	4.1	12.2	1.3	9.7	4.2	4.8	1.9	5.5	6.4	2.8	4.8	0.7	10.2	7.4	16.9	7.0	4.1	10.3	3.7	3.1	0.9	9.5	4.0	9.7	4.2	6.6	6.4	3.4	5.7	5.4	13.2	3.6	7.0	5.6	5.6	9.9	0.1	4.9	2.8	10.9	5.7	8.2	6.0	5.3	6.8	11.2	1.7	2.4	6.6	5.3	1.8	6.4	8.1	4.3	3.5	2.0	14.0	10.1	6.5	5.5	4.9	4.9	2.8	1.8	1.9	2.5	0.8	10.4	3.9	2.8	3.3	14.3	0.9	1.5	1.0	0.6	0.8	1.3	2.0	0.4	1.0	1.1	8.1	1.3	1.3	0.9	1.3	1.9	1.9	3.7	2.5	4.9	2.9	1.6	1.8	2.7	3.0	1.3	0.0	6.4	1.7	1.6	2.3	1.2	10.8	5.1	6.7	2.3	7.0	2.0	3.0	1.7	6.0	1.5	3.0	4.2	0.0	3.4	1.7	2.5	1.8	0.0	9.6	5.7	0.0	2.4	4.3	5.3	2.7	1.1	1.9	1.7	5.4	4.1	5.6	5.1	7.0	1.1	4.3	3.2	0.0	2.1	1.9	1.9	4.1	0.5	0.5	4.5	0.9
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 37.2;brain: 28.5;breast: 59.9"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 91.4"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 28.0"	"Region enriched"	"Detected in many"	16	"olfactory region: 206.6"	"Group enriched"	"Detected in many"	6	"olfactory region: 80.6;pons and medulla: 17.5"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"	NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	37.2	8.0	4.6	2.8	7.5	3.3	59.9	2.4	28.5	4.0	6.5	13.7	1.0	2.3	3.1	3.2	2.5	5.0	4.5	7.0	7.0	12.2	4.4	1.9	3.8	3.6	6.6	3.5	3.4	3.3	2.7	4.2	1.4	5.6	1.9	2.1	2.6	4.6	1.8	2.0	1.8	1.4	2.9	9.9	2.0	2.5	6.4	4.8	2.2	8.9	4.9	1.9	4.7	8.5	7.0	10.4	5.9	0.8	1.3	6.4	2.6	28.0	10.7	2.0	0.4	5.5	2.5	0.2	1.7	3.3	3.8	5.2	3.7	7.7	1.2	4.5	4.4	0.0	5.0	10.7	2.2	2.2	10.5	13.5	4.3	4.2	17.4	1.4	2.9	4.7	2.5	0.9	5.9	2.3	2.5	5.5	7.7	0.0	0.4	2.1	16.4	2.7	9.5	7.9	5.9	3.1	8.4	0.0	12.4	3.6	2.2	1.1	12.2	2.8	1.6	12.7	2.1	1.9	11.2	1.4	0.7	3.7	3.5	2.7	0.2	3.0	2.6	8.7	16.2	4.5	0.0	0.8	5.9	6.3	0.6	2.3	4.9	5.0	6.4	3.5	7.0	4.8	3.6	1.2	1.3	0.3	10.4	5.6	2.6	4.6	7.5	2.4	8.5	7.0	12.2	6.6	3.5	5.6	4.8	3.0	2.4	14.3	22.9	13.9	1.6	2.2	7.6	10.7	7.9	29.6	0.0	1.7	11.6	91.4	24.0	11.3	1.7	0.0	50.2	7.5	17.3	30.7	5.7	2.9	30.9	4.8	17.9	4.9	4.8	7.5	4.0	28.4	32.1	29.7	4.9	7.0	39.2	7.0	3.5	22.5	2.3	12.9	29.9	11.1	21.2	11.2	2.6	11.4	8.0	39.6
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	46.6	93.2	32.2	44.9	13.5	21.6	54.1	36.4	25.3	75.5	57.3	73.3	28.3	82.1	38.0	33.6	30.0	25.1	61.5	61.9	64.6	39.8	82.8	53.8	72.4	101.8	27.4	59.0	24.7	20.5	39.0	56.8	53.2	13.3	45.5	26.4	79.4	27.3	44.7	79.0	70.1	67.8	38.6	103.3	85.0	43.0	63.6	75.6	57.9	32.6	44.7	51.5	19.1	52.3	33.9	28.8	54.4	39.9	28.6	48.7	44.2	30.3	74.7	35.2	81.2	96.7	29.5	50.1	37.0	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3	29.8	22.5	33.5	67.6	117.7	287.4	27.7	63.7	36.1	59.1	68.0	269.0	166.3	127.6	180.3	23.8	58.6	14.6	46.7	172.7	210.0	82.7	60.4	46.0	102.6	183.6	38.1	86.1	27.0	26.9	65.0	56.7	62.9	123.2	55.9	70.8	61.6	165.1	38.6	55.2	140.8	268.7	12.9	66.0	19.8	83.3	116.3	74.0	40.6	110.8	81.0
NME1-NME2	"NM23-LV, NMELV"	ENSG00000011052	"NME1-NME2 readthrough"		17	51153590-51171744	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 41.6;Basal keratinocytes: 34.1;Ciliated cells: 25.4;Club cells: 45.5;granulocytes: 20.9;Melanocytes: 21.9;Suprabasal keratinocytes: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB002169, HPA008467, HPA041113, CAB076057"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (6.66e-4)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-6)"	"unprognostic (1.84e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	12.8	29.3	19.7	35.5	16.7	20.6	8.5	13.9	31.2	5.4	7.2	6.7	4.9	14.7	10.6	6.2	10.6	7.4	6.8	8.0	23.0	17.0	10.4	31.3	7.8	18.3	16.9	18.7	8.1	24.1	6.5	11.4	13.6	21.5	6.7	5.7	7.7	23.5	4.7	10.1	8.2	10.7	11.7	11.0	11.9	14.8	5.8	5.6	10.0	8.6	17.9	12.7	9.5	7.6	19.6	37.6	1.0	21.1	14.6	21.9	16.2	29.0	2.0	9.4	34.6	8.8	4.5	7.4	23.0	7.5	6.1	3.8	3.8	19.6	17.0	24.1	11.8	15.3	18.1	9.2	14.8	4.0	25.6	13.8	14.1	3.5	7.3	10.7	23.8	23.5	8.1	11.1	7.7	11.0	14.3	9.7	17.0	11.1	22.0	3.8	4.8	58.2	16.4	28.2	34.6	2.9	34.5	23.1	50.3	7.1	3.8	30.4	17.8	12.1	52.6	26.4	14.4	53.8	40.4	19.4	38.8	28.3	37.6	47.0	37.7	40.7	33.1	22.3	17.2	33.3	0.2	15.1	0.3	15.0	21.1	21.9	19.6	14.7	16.1	37.6	18.4	13.7	16.8	1.0	14.6	11.6	25.7	13.7	16.2	19.7	16.7	13.9	26.4	23.0	17.0	16.9	18.7	21.5	5.6	14.9	41.6	0.0	0.0	34.1	0.0	1.7	0.0	25.4	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	20.9	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.3	8.1	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	45.4	0.0	0.0	0.0	0.0
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171747	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 115.1;Club cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	62.1	54.6	42.3	58.2	44.1	44.2	188.9	20.1	43.7	58.9	74.0	16.3	67.7	52.5	65.0	52.0	104.3	56.8	65.3	115.1	38.2	32.1	77.3	115.7	59.0	174.7	45.0	23.7	90.7	234.3	17.5	30.4	37.9	34.0	64.0	62.7	29.9	109.4	65.8	105.3	63.3	45.1	88.3	34.6	69.4	50.2	32.3	24.4	42.5	66.9	102.0	56.6	81.3	140.8	49.3	71.3	8.3	43.7	32.6	34.5	38.2	89.1	131.0	31.4	54.7	70.2	102.4	86.6	61.8	64.3	94.6	72.1	105.7	47.5	75.0	100.2	63.3	48.6	57.1	65.8	84.3	78.0	90.4	194.5	63.0	91.4	153.0	76.6	99.5	44.2	92.6	98.5	61.0	107.4	67.1	56.3	53.7	86.3	50.6	68.1	158.5	49.8	124.4	46.7	205.0	201.3	47.8	104.0	119.7	102.4	112.7	71.5	44.3	38.0	95.6	92.8	61.7	65.9	76.3	57.1	91.3	66.0	64.8	98.2	88.4	114.8	85.9	49.3	50.7	45.7	8.3	35.1	2.0	24.7	43.7	34.5	49.3	33.0	26.9	61.5	36.2	23.8	25.6	2.1	32.6	38.0	71.3	29.9	38.2	42.3	44.1	20.1	43.7	38.2	32.1	45.0	23.7	34.0	24.4	26.8	56.3	13.7	6.1	12.9	0.9	0.0	22.9	115.1	150.2	5.2	0.0	10.6	31.5	37.0	0.4	14.4	5.6	23.3	30.1	24.4	10.8	3.7	39.5	37.1	14.9	0.0	14.0	31.9	41.2	1.1	23.9	13.6	10.1	88.4	24.3	0.2	47.4	14.0	12.0	26.2	0.8	6.5	5.7	0.5	5.0	13.0	7.3	18.1	29.3	6.8
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7900000	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	20.6	45.6	18.0	12.9	19.8	6.6	20.0	21.9	18.2	16.6	18.0	11.0	31.6	25.7	14.4	19.1	12.9	14.3	21.5	11.8	17.5	16.1	17.7	11.2	17.3	11.3	18.4	15.9	22.1	26.8	15.1	24.1	9.7	14.4	26.9	6.4	13.8	34.3	41.4	15.2	9.2	24.6	14.6	14.1	20.4	17.5	7.2	14.6	5.1	24.1	11.7	8.8	11.5	17.9	19.3	34.1	15.5	25.6	20.1	24.4	20.0	0.7	11.7	0.2	9.6	2.7	1.4	1.1	6.8	2.0	1.2	0.9	0.0	14.0	0.1	19.2	0.9	1.2	10.0	0.6	3.8	0.1	13.7	31.3	0.0	5.5	5.5	5.2	2.3	4.4	6.4	3.5	1.2	0.7	2.3	2.5	0.1	4.7	1.9	1.2	17.0	0.2	4.6	12.5	2.3	9.5	6.5	0.1	18.3	2.0	0.5	13.7	10.6	20.7	15.6	1.7	0.5	14.9	5.6	8.7	2.6	9.7	8.3	4.6	5.0	1.5	1.0	3.5	0.4	5.8	4.9	25.6	15.5	17.5	22.9	17.1	19.3	24.4	16.4	22.0	16.3	21.4	16.8	5.3	20.1	24.5	34.1	21.8	20.0	18.0	19.8	21.9	18.2	17.5	16.1	18.4	15.9	14.4	14.6	32.8	63.8	51.1	124.1	64.5	115.4	25.8	76.5	58.9	55.7	120.4	56.9	65.8	51.4	53.1	16.8	69.7	85.0	0.0	33.3	35.7	82.8	109.1	50.7	52.9	65.1	62.0	130.1	72.4	57.8	13.2	138.4	78.5	77.6	175.9	94.2	102.4	38.5	89.7	119.9	123.2	117.3	116.4	86.4	1.4	41.7	57.3	38.6	61.8	96.6	69.8
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115172-138139443	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.1;testis: 36.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 327.9;Early spermatids: 516.0;Late spermatids: 184.0;Spermatocytes: 142.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.3	5.2	12.3	0.6	18.4	0.3	3.7	3.5	13.9	7.1	1.2	3.9	4.7	0.5	4.1	18.2	1.0	28.1	6.8	2.9	12.0	10.7	15.4	0.6	3.6	0.6	9.4	9.9	4.5	3.5	12.1	8.9	0.4	13.1	4.2	1.1	4.8	3.1	3.9	0.4	0.4	0.5	2.6	4.2	0.4	2.2	36.2	4.8	0.0	9.6	0.3	0.4	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	0.0	0.0	0.0	0.6	0.4	0.6	0.2	0.1	1.5	0.0	0.9	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	1.9	0.0	0.8	0.0	3.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	25.6	0.0	5.9	2.2	0.0	0.7	3.8	1.5	0.5	1.3	0.0	0.6	0.0	0.0	0.8	0.4	0.6	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	18.4	3.5	13.9	12.0	10.7	9.4	9.9	13.1	4.8	6.0	6.9	0.0	9.1	0.6	11.4	2.8	2.5	327.9	26.1	31.4	13.7	0.4	72.9	18.8	516.0	3.4	0.0	0.0	3.6	0.0	3.2	7.9	0.0	0.5	0.1	6.4	5.2	1.3	0.0	184.0	8.3	0.7	10.1	1.0	2.5	15.8	5.2	0.0	13.1	66.5	21.6	0.0	1.0	142.0	20.4	0.3	0.0	0.0	1.1	5.6
NME6	"IPIA-ALPHA, NM23-H6"	ENSG00000172113	"NME/NM23 nucleoside diphosphate kinase 6"	O75414	3	48290722-48301685	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017909	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA017909: AB_1854530"	"unprognostic (7.31e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (1.98e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.50e-2)"	11.7	12.2	7.0	14.4	11.0	7.7	13.5	9.2	10.9	12.2	12.0	11.9	14.6	13.5	16.1	13.2	16.1	16.3	8.8	13.7	9.9	6.8	18.0	17.5	11.1	12.9	9.2	10.3	14.5	20.6	12.1	13.3	22.1	8.8	13.2	12.7	13.5	20.8	17.6	20.1	10.3	13.4	13.3	7.1	14.2	13.4	9.0	8.2	12.6	17.5	14.3	15.1	13.9	15.7	26.4	23.5	43.3	22.7	23.0	25.8	14.3	17.9	11.2	15.3	11.1	12.5	16.8	13.7	17.6	13.6	25.9	19.7	18.7	15.8	18.1	9.2	13.7	24.3	6.3	13.7	19.4	15.4	21.6	13.3	11.8	15.0	15.2	16.7	14.9	12.7	13.7	21.3	23.0	27.4	12.4	13.9	13.7	19.7	14.0	9.7	8.5	12.5	6.4	12.9	12.7	14.7	7.4	13.4	15.2	13.0	15.5	4.7	8.1	12.0	13.2	15.7	12.4	14.8	13.9	12.4	5.1	20.4	12.7	25.0	16.6	22.4	16.3	9.7	19.8	11.3	22.0	20.1	43.3	25.8	20.7	23.6	26.4	24.2	21.9	23.5	24.4	18.7	17.7	22.5	23.0	22.7	21.1	19.4	14.3	7.0	11.0	9.2	10.9	9.9	6.8	9.2	10.3	8.8	8.2	26.8	20.2	17.6	7.9	4.4	12.2	9.2	20.4	44.2	21.6	8.7	13.7	42.3	33.2	22.4	1.9	8.3	11.2	0.0	26.1	34.3	7.8	7.3	9.3	8.3	29.6	9.5	4.1	6.7	6.7	1.5	10.9	12.4	15.1	29.7	8.8	14.6	25.4	7.0	6.7	12.8	12.2	12.9	7.4	9.1	13.2	3.6	16.5	13.8	12.8	5.9
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367967	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038014, HPA054289"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	7.7	12.1	13.5	8.0	22.8	3.7	12.8	14.6	16.8	15.6	11.5	5.5	13.4	4.6	16.0	15.8	8.6	31.1	11.2	8.4	18.9	11.3	13.9	8.6	8.9	6.0	9.5	11.5	17.0	8.1	18.9	39.9	5.6	15.6	9.6	6.7	9.3	5.9	14.3	5.1	4.9	5.5	17.2	9.5	5.2	8.1	17.2	9.6	11.9	15.9	5.8	7.0	10.0	8.2	8.5	5.2	1.7	7.1	9.1	12.0	4.7	10.5	11.3	12.3	9.6	12.4	12.5	4.4	7.3	11.1	13.3	16.9	6.4	16.0	3.1	13.4	6.5	18.4	7.4	6.9	15.8	21.8	11.0	5.7	5.6	10.8	6.5	8.5	10.2	3.6	9.1	9.6	13.4	18.2	19.2	19.0	9.6	5.3	4.3	13.3	3.4	9.2	7.5	12.1	12.7	11.6	7.2	13.3	6.8	21.6	3.1	13.3	19.2	11.1	3.3	8.2	14.4	11.4	7.4	11.4	8.3	27.5	7.3	17.7	5.2	8.8	6.5	9.1	3.6	8.2	1.4	3.3	1.7	8.3	5.1	10.1	8.5	10.8	8.8	5.2	7.0	9.3	10.6	1.0	9.1	7.1	4.4	12.0	4.7	13.5	22.8	14.6	16.8	18.9	11.3	9.5	11.5	15.6	9.6	6.0	7.5	8.2	29.3	12.8	17.2	4.1	15.3	72.3	15.9	26.2	23.6	6.8	19.9	22.8	19.4	13.7	2.6	0.0	7.9	6.3	18.5	7.6	20.8	10.4	12.0	27.0	16.8	11.1	4.0	7.9	16.7	8.2	8.5	2.8	3.9	18.0	13.9	6.0	19.4	30.7	61.3	19.4	17.5	51.2	20.0	8.9	2.3	14.1	6.6	17.3
NME8	"CILD6, NM23-H8, SPTRX2, TXNDC3"	ENSG00000086288	"NME/NM23 family member 8"	Q8N427	7	37848597-37900401	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 7.9;bone marrow: 13.4;testis: 11.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 33.4;Late spermatids: 14.1"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HMC-1: 2.5;NB-4: 3.7;NTERA-2: 3.5;THP-1: 3.2;U-937: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016416, HPA019259, HPA029572"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"CAB016416: , HPA019259: AB_1858475, HPA029572: "	"unprognostic (7.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-8)"	"unprognostic (5.90e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	0.1	0.0	0.1	0.5	0.1	13.4	0.0	0.0	0.0	0.1	0.1			0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.1	0.1	0.5	0.4	0.4		0.0	0.0	0.0	0.0	0.1		0.1	0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.8	1.9	0.1	11.3			0.0		0.2	0.0	0.0	0.0	7.9	3.8	1.9	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	1.9	1.5	0.7	0.4	0.0	0.0	0.1	1.3	1.5	0.0	0.0	0.7	3.8	0.2	0.0	7.9	0.0	0.8											0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.8	0.0	0.0	0.0	3.0	14.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	0.0	3.8	0.0	0.0
NME9	"NM23-H9, TXL-2, TXNDC6"	ENSG00000181322	"NME/NM23 family member 9"	Q86XW9	3	138261437-138329886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 30.4"	"Cell type enriched"	"Detected in some"	12	"Ciliated cells: 64.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020943, HPA040000, HPA043881"	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712"	"unprognostic (2.71e-5)"	"unprognostic (1.68e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.17e-3)"	1.0	1.7	5.3	1.3	11.3	4.4	1.0	6.2	8.3	1.5	0.8	4.1	3.5	1.1	1.6	3.6	0.8	30.4	1.3	0.9	5.6	8.2	1.7	0.8	4.0	1.1	3.6	3.1	2.5	3.3	1.8	7.5	1.1	10.3	1.7	0.8	0.9	3.4	1.9	4.3	1.8	1.1	1.0	3.6	1.2	1.5	6.0	3.9	0.9	2.3	0.0	1.0	0.8	0.5	0.6	0.6	0.3	0.9	0.3	4.2	0.5	1.1	1.6	1.1	0.5	0.0	0.0	1.7	0.7	0.0	0.2	0.1	0.9	1.9	2.5	1.2	0.0	1.3	1.3	0.2	0.0	0.0	0.5	1.8	2.1	1.6	0.6	0.0	2.7	4.9	0.9	0.0	0.1	0.0	2.9	0.1	3.2	0.6	1.4	0.2	0.4	0.6	2.5	0.7	0.5	1.2	1.0	0.0	0.7	1.7	2.6	3.7	1.0	1.6	0.6	0.4	0.9	0.9	0.1	3.0	0.5	0.8	0.8	0.6	0.9	1.2	1.1	1.0	1.1	0.5	0.1	0.9	0.0	0.5	0.0	4.2	0.2	1.7	0.4	0.3	0.6	2.8	1.2	0.3	0.3	0.2	0.6	0.7	0.5	5.3	11.3	6.2	8.3	5.6	8.2	3.6	3.1	10.3	3.9	0.0	0.3	0.0	0.2	0.0	1.3	1.1	2.5	64.3	3.4	1.8	0.0	0.1	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	2.3	0.0	0.0	5.5	0.5	0.0	0.2	0.0	0.0	0.0
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270465-151290057	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 75.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	12.0	14.2	5.0	18.6	7.1	26.4	14.0	1.3	5.8	8.9	15.0	3.4	11.1	13.2	8.6	10.4	16.1	9.8	14.7	8.7	5.9	3.8	13.0	20.4	18.5	26.9	5.1	2.7	14.8	8.4	2.9	6.5	24.6	6.9	13.6	10.5	5.0	9.8	7.9	5.1	7.3	26.0	13.1	7.7	30.2	10.2	5.3	6.4	36.7	14.9	10.2	14.2	10.4	10.3	10.8	17.0	75.1	26.9	14.3	12.5	14.9	10.9	5.4	0.3	0.0	3.1	8.5	10.7	3.2	7.5	15.4	23.5	1.1	25.0	10.7	11.9	4.8	5.1	6.3	1.1	2.8	3.9	22.7	0.6	30.1	5.6	0.6	13.2	28.5	8.7	5.5	3.8	9.2	2.1	6.8	19.0	11.9	14.9	2.6	2.9	8.4	23.9	42.6	6.3	2.2	8.1	25.8	0.6	9.2	12.7	9.5	1.5	0.0	6.7	7.3	4.1	1.1	1.2	32.5	10.3	2.2	5.0	7.2	4.6	0.4	0.4	0.6	5.3	34.3	2.4	31.6	19.7	21.6	10.8	26.9	12.5	10.8	11.3	10.7	17.0	9.1	9.2	9.4	75.1	14.3	24.4	6.9	9.7	14.9	5.0	7.1	1.3	5.8	5.9	3.8	5.1	2.7	6.9	6.4	23.8	19.8	16.0	18.1	14.8	0.2	3.1	15.3	38.8	27.3	12.2	0.0	62.5	13.3	54.5	2.6	35.8	24.2	0.0	36.0	53.3	19.2	13.1	34.7	16.0	71.3	0.0	17.3	17.2	39.1	0.0	18.1	53.0	1.7	45.9	20.9	5.8	34.1	23.0	13.1	20.9	0.0	6.5	14.7	3.3	1.7	15.6	45.5	40.7	19.5	19.2
NMNAT2	"C1orf15, KIAA0479, PNAT2"	ENSG00000157064	"Nicotinamide nucleotide adenylyltransferase 2"	Q9BZQ4	1	183248237-183418602	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.9"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 30.1;Early spermatids: 50.3;Horizontal cells: 19.1;Late spermatids: 19.5;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 12.9;SCLC-21H: 37.5;SuSa: 12.3;U-2197: 21.9;U-87 MG: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015708, HPA061714"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA015708: , HPA061714: AB_2732669"	"unprognostic (3.70e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.02e-1)"	9.6	7.7	26.2	1.9	34.5	1.0	2.9	53.9	53.5	3.6	2.2	2.0	0.0	1.5	2.5	2.7	1.9	3.8	4.1	19.6	20.6	15.1	1.5	1.1	1.8	1.7	8.6	28.3	1.5	2.9	1.3	17.4	2.0	15.6	1.3	2.1	0.5	1.5	4.1	1.3	1.7	2.0	2.7	4.1	1.2	2.1	8.7	6.3	0.0	7.2	0.0	1.7	1.9	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.2	2.5	0.0	1.5	6.2	2.2	1.6	4.1	0.8	0.2	1.2	2.4	0.0	6.8	0.4	0.7	1.0	0.1	0.0	1.6	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	12.9	0.5	1.0	0.2	5.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.2	4.4	0.0	2.4	0.0	0.1	0.0	2.8	2.0	37.5	2.9	0.3	0.1	0.0	12.3	0.3	0.6	1.4	1.2	0.4	21.9	1.5	0.3	0.0	0.0	17.1	0.1	0.1	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	26.2	34.5	53.9	34.7	20.6	15.1	8.6	28.3	15.6	6.3	0.0	1.0	0.0	0.2	0.7	10.7	30.1	0.0	2.7	3.4	0.0	0.0	0.6	0.0	0.1	50.3	2.9	0.0	0.0	0.0	9.6	0.4	0.1	0.0	0.0	0.5	19.1	0.0	0.0	0.6	19.5	0.0	0.5	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.6	19.4	5.0	0.5	0.2	0.3	1.1	0.0	0.0	0.0
NMRK1	"bA235O14.2, C9orf95, FLJ20559, NRK1"	ENSG00000106733	"Nicotinamide riboside kinase 1"	Q9NWW6	9	75060573-75088217	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.9;Karpas-707: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049795	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA049795: AB_2680886"	"unprognostic (1.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (3.70e-6)"	"unprognostic (3.56e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.64e-2)"	15.5	7.7	11.1	15.9	10.7	6.9	14.3	21.5	14.6	13.2	15.2	5.8	20.1	12.2	8.1	15.6	24.6	9.4	10.9	9.4	10.2	9.7	22.1	40.3	15.4	19.9	10.8	9.7	15.2	30.6	45.8	18.1	19.7	10.2	15.9	10.3	10.9	29.5	17.7	15.0	15.6	26.6	8.3	8.7	18.8	13.6	6.7	8.9	14.4	31.6	11.2	22.0	12.6	14.8	6.7	8.8	7.3	6.7	8.2	24.2	10.1	5.1	1.1	1.5	3.5	12.2	16.5	8.3	7.5	11.8	1.9	3.1	0.0	13.6	3.0	4.5	7.2	3.6	9.0	1.7	5.0	6.0	29.9	1.8	2.1	2.4	2.6	10.9	2.0	0.4	11.4	12.9	3.1	6.4	11.4	13.0	5.2	0.2	36.8	13.2	3.8	1.9	1.8	1.9	19.4	4.7	0.6	13.5	19.3	15.3	9.2	1.0	0.2	3.2	3.3	4.2	10.3	8.5	2.2	8.9	6.5	1.2	5.9	2.0	16.3	13.0	1.8	10.6	2.2	6.6	7.3	2.7	4.5	13.9	2.5	16.7	6.7	24.2	16.0	3.1	3.9	22.1	16.7	5.2	8.2	6.7	8.8	15.4	10.1	11.1	10.7	21.5	14.6	10.2	9.7	10.8	9.7	10.2	8.9	35.7	17.1	17.1	33.3	18.7	8.5	15.1	15.3	20.1	22.7	22.7	7.9	52.7	44.7	25.5	14.0	20.7	33.3	0.0	31.3	65.3	17.5	21.3	1.1	34.4	51.6	11.1	4.1	39.3	19.7	24.5	21.9	10.5	25.3	102.8	28.0	9.6	23.2	24.6	11.7	75.6	7.6	12.9	15.2	6.6	3.8	23.6	38.1	29.9	22.4	26.0
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	45051610-45109016	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.8	32.6	44.9	28.2	37.3	12.0	26.1	34.5	64.3	23.7	24.4	17.2	22.9	23.4	27.3	29.3	26.6	30.9	17.3	26.8	37.7	29.6	28.8	36.6	26.7	27.2	27.7	43.6	29.3	21.8	41.6	23.7	32.7	38.1	23.7	23.1	18.1	34.9	30.1	75.5	28.8	24.8	30.1	36.6	28.2	23.4	26.1	34.0	20.7	29.4	18.6	30.9	25.1	43.3	10.2	18.2	7.6	9.3	7.4	10.0	3.3	17.0	22.6	19.5	17.2	35.3	22.8	20.5	19.0	25.2	37.1	30.6	25.2	14.7	20.5	27.6	26.1	26.6	16.1	33.5	26.6	34.4	52.1	23.4	20.4	15.1	24.8	23.2	26.3	24.6	28.7	24.2	27.5	21.9	19.9	24.8	21.0	32.3	10.4	20.6	14.6	31.9	17.9	18.2	31.4	23.6	21.9	29.1	15.6	29.3	15.8	16.3	14.7	12.0	11.0	17.2	34.8	23.7	20.9	19.9	22.7	17.4	18.2	25.3	16.2	23.0	20.5	24.3	14.8	23.9	6.5	8.1	7.6	7.9	9.3	7.2	10.2	7.8	9.3	6.6	7.6	10.0	7.6	5.3	7.4	6.9	18.2	7.5	3.3	44.9	37.3	34.5	64.3	37.7	29.6	27.7	43.6	38.1	34.0	35.7	35.1	55.6	14.2	12.4	85.1	38.9	94.3	16.0	27.3	66.3	110.0	63.6	66.3	62.0	17.1	41.3	50.2	116.8	61.6	49.6	39.9	11.1	22.0	304.8	40.7	122.3	48.9	77.3	77.9	6.8	50.9	41.1	10.1	108.2	32.8	38.5	58.3	45.6	48.1	45.3	119.2	58.2	14.4	60.6	32.8	12.3	68.4	41.5	52.5	15.0
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313285	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 97.7"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 3284.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 68.8;LHCN-M2: 40.9;RPTEC TERT1: 105.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		15000	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	23.7	1.4	0.6	8.8	0.9	0.1	14.6	0.6	1.7	13.1	8.5	0.7	4.9	0.5	15.8	8.7	12.0	8.3	15.3	8.2	1.6	0.0	4.7	97.7	10.0	3.4	1.1	0.6	11.2	2.0	0.6	2.6	8.6	3.3	9.6	3.3	1.6	3.6	6.7	18.3	8.2	4.3	12.4	1.5	5.8	5.1	7.3	0.6	1.3	5.3	2.2	3.1	10.9	35.3	0.6	0.1	0.7	0.2	0.0	0.9	0.0	0.0	4.8	0.0	4.3	24.8	32.2	0.0	6.1	16.3	9.8	19.5	0.0	6.6	0.0	21.8	12.5	1.3	0.0	0.0	2.2	9.9	0.0	0.0	0.0	7.6	0.0	33.8	0.0	0.0	68.8	23.8	6.9	10.3	8.2	13.5	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	27.4	0.0	105.9	0.0	0.0	0.0	30.7	0.0	0.0	1.5	0.0	0.0	9.5	5.6	22.6	8.7	1.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.2	0.0	0.2	0.1	0.9	0.2	0.0	0.2	0.1	0.6	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.9	0.6	1.7	1.6	0.0	1.1	0.6	3.3	0.6	41.7	380.8	30.2	10.6	92.0	0.5	4.0	76.5	18.7	20.5	76.8	0.0	0.9	8.3	207.6	0.2	191.1	0.0	163.5	133.3	1.9	375.3	11.6	12.8	3284.1	21.8	0.0	5.1	176.1	103.2	1.0	68.7	12.7	91.1	10.0	0.0	0.0	366.0	0.0	12.4	27.9	0.1	0.0	113.1	0.3	0.4	80.5	1.8	46.0	0.0	2.4
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.0"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 303.5;Hepatocytes: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA004829, CAB004975"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		1100000	Mitochondria	Cytosol	"CAB004975: AB_425908, HPA004829: AB_1079495"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	10.8	10.5	11.7	8.3	14.0	7.3	9.1	8.3	19.0	7.6	11.2	7.3	8.8	9.2	7.1	8.8	7.9	5.4	7.1	62.1	10.8	8.2	26.0	48.5	7.2	9.6	9.2	10.3	5.8	12.2	15.6	6.2	5.8	10.0	8.5	12.1	6.7	14.4	7.8	100.0	6.0	8.9	14.7	6.1	6.5	13.6	4.2	6.1	14.0	14.0	32.6	8.7	10.9	6.2	11.4	25.5	13.1	18.5	18.2	19.1	13.5	8.3	6.2	14.3	26.6	16.7	18.6	4.5	8.4	14.4	10.4	9.4	7.1	13.9	8.6	10.5	16.0	11.0	8.0	56.7	2.0	11.0	13.6	15.3	12.4	33.3	8.7	9.6	20.7	18.5	16.0	6.3	5.9	8.5	18.2	20.5	12.5	8.9	34.4	24.7	5.7	22.3	11.2	2.8	0.0	5.6	25.1	33.8	30.8	19.7	7.4	21.1	17.6	30.9	0.4	19.1	3.1	21.6	20.9	11.2	15.2	14.8	6.3	4.1	18.5	19.0	13.2	3.1	27.7	9.8	9.3	14.2	13.1	14.4	18.4	14.8	11.4	15.6	14.5	25.5	10.3	14.6	13.3	2.4	18.2	18.5	9.2	19.1	13.5	11.7	14.0	8.3	19.0	10.8	8.2	9.2	10.3	10.0	6.1	50.6	27.8	20.7	7.7	10.2	17.5	303.5	28.1	24.1	31.8	26.2	33.4	7.2	23.2	10.7	12.2	12.6	17.2	23.3	9.3	2.1	17.9	10.5	23.3	274.2	21.7	6.4	19.1	20.3	31.4	3.4	13.8	18.2	13.5	10.8	24.6	13.2	9.5	11.5	18.0	21.1	11.9	0.0	15.1	2.1	1.2	7.0	1.7	27.7	25.8	7.6
NOB1	"ART-4, MST158, NOB1P, PSMD8BP1"	ENSG00000141101	"NIN1/PSMD8 binding protein 1 homolog"	Q9ULX3	16	69741867-69754940	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041522, HPA049430, HPA067411"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA041522: , HPA049430: AB_2680764, HPA067411: "	"unprognostic (5.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.61e-3)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.21e-5)"	"prognostic unfavorable (8.16e-4)"	"unprognostic (3.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.16e-1)"	18.2	31.6	9.9	14.5	18.0	17.4	18.9	13.4	16.2	18.8	19.4	12.5	12.4	20.3	21.3	15.5	25.4	29.2	19.0	13.3	9.6	9.7	18.4	23.4	13.3	21.3	12.9	7.5	37.5	68.5	13.9	10.1	13.1	13.5	21.5	12.7	13.0	20.4	14.8	26.3	25.1	15.5	18.0	10.1	21.5	20.5	11.6	15.4	23.7	28.9	25.8	29.0	25.6	18.4	21.0	20.3	2.0	15.0	24.5	26.1	17.3	14.8	32.6	7.7	21.8	17.1	27.1	15.3	11.9	16.7	22.4	20.4	36.9	24.5	33.2	18.7	13.2	11.8	22.1	21.1	26.7	13.3	8.3	24.6	12.9	15.4	47.3	30.4	23.8	10.9	34.2	22.8	25.8	33.0	20.9	18.9	20.2	29.4	10.3	11.1	38.9	29.9	47.7	23.6	16.6	19.4	33.2	7.9	41.9	16.6	14.5	20.0	9.9	37.6	13.2	18.6	7.1	14.3	21.6	14.3	15.3	13.9	13.9	19.4	17.0	12.9	58.5	15.3	21.8	16.8	0.1	15.0	2.0	17.6	12.7	24.6	19.4	21.4	16.1	20.3	21.0	23.1	21.0	0.7	24.5	9.5	10.5	26.1	17.3	9.9	18.0	13.4	16.2	9.6	9.7	12.9	7.5	13.5	15.4	3.0	13.1	37.1	60.4	53.2	9.7	4.8	15.3	18.7	46.6	19.2	0.0	58.6	34.9	34.6	8.8	42.1	15.8	23.3	74.6	74.1	39.0	28.3	16.1	13.2	32.4	4.8	9.8	18.4	20.2	5.9	33.9	23.1	20.3	37.9	33.2	10.5	44.9	17.5	40.0	27.6	4.6	25.8	39.2	17.4	28.1	52.1	39.7	37.4	50.6	54.8
NOC4L	"MGC3162, NET49, Noc4, UTP19"	ENSG00000184967	"Nucleolar complex associated 4 homolog"	Q9BVI4	12	132144448-132152473	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053424			Supported	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA053424: AB_2682147"	"unprognostic (9.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.79e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	11.9	10.3	9.0	14.2	11.6	18.8	11.1	11.5	17.2	9.9	9.2	14.1	7.8	14.8	11.5	6.4	12.0	10.7	10.4	8.6	8.0	7.5	11.2	15.6	9.2	13.7	14.7	8.5	13.6	16.8	7.1	10.4	9.7	12.1	9.8	6.9	10.3	16.2	8.8	22.5	15.7	11.9	8.2	9.2	15.5	12.5	28.4	10.6	15.7	10.5	13.2	12.3	9.5	9.5	13.9	18.8	5.9	16.1	7.4	11.4	8.1	12.4	23.1	5.1	8.0	2.6	2.7	26.2	8.6	4.4	10.6	5.8	18.8	5.9	19.1	9.5	4.4	6.3	11.2	9.1	9.4	2.3	7.5	25.0	12.8	7.6	12.3	6.8	14.9	15.0	4.0	6.5	8.3	6.7	4.0	7.4	14.7	21.7	4.4	4.3	14.6	14.2	35.1	15.0	7.3	18.4	18.5	5.7	16.7	5.5	9.2	12.6	10.0	7.3	10.0	6.3	3.1	14.0	9.3	9.8	6.3	16.1	10.1	14.3	11.2	6.9	16.7	9.7	12.9	13.3	2.5	11.8	5.9	11.4	16.1	11.0	13.8	10.6	11.3	15.8	13.9	9.3	8.9	1.7	7.4	12.1	18.8	8.7	8.1	9.0	11.6	11.5	17.2	8.0	7.5	14.7	8.5	12.1	10.6	8.9	7.8	13.0	13.7	19.8	7.9	6.0	25.5	0.0	3.4	3.5	0.0	28.1	6.6	25.9	57.6	11.1	15.2	0.0	28.5	27.4	15.4	9.4	16.1	9.5	22.0	7.9	7.0	11.6	11.0	60.3	13.6	14.1	13.5	13.6	11.1	6.7	23.0	8.6	7.4	16.5	5.0	19.4	14.4	37.9	50.3	18.9	25.5	14.9	16.2	11.9
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015789-139045939	"Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.7"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 8.9;Cone photoreceptor cells: 13.7;Extravillous trophoblasts: 7.7;Syncytiotrophoblasts: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	17.5	3.9	3.3	4.9	8.0	38.7	7.4	3.2	7.3	2.7	3.1	2.7	0.0	2.2	2.8	1.5	4.0	2.5	7.9	5.4	4.9	3.7	6.9	25.8	5.1	3.1	3.0	3.1	1.7	4.4	4.0	4.7	9.3	3.7	2.0	2.8	1.8	10.8	1.4	12.0	3.9	10.5	4.5	2.3	3.2	3.0	4.9	2.6	3.7	2.9	11.8	3.9	3.7	4.6	1.9	1.5	6.3	3.1	1.4	2.4	0.2	4.7	5.5	2.2	4.1	5.0	2.1	13.5	7.1	5.1	10.1	7.3	7.3	2.0	15.8	5.7	5.3	14.3	3.4	11.4	6.2	9.6	7.0	4.6	7.3	3.3	6.4	4.5	10.7	4.3	2.4	3.1	11.2	7.6	2.0	4.4	3.2	13.1	5.2	4.5	5.4	7.3	5.6	7.0	2.1	5.9	6.0	6.4	5.6	6.8	3.1	8.2	5.5	4.5	5.1	4.0	8.9	3.7	8.3	6.6	5.5	7.1	5.2	8.4	4.3	4.0	10.0	5.1	21.2	6.9	1.5	1.4	0.8	2.4	1.5	1.4	1.1	1.1	1.3	0.6	1.9	0.8	1.6	6.3	1.4	3.1	1.5	0.7	0.2	3.3	8.0	3.2	7.3	4.9	3.7	3.0	3.1	3.7	2.6	8.9	0.6	0.0	2.6	0.0	4.7	0.0	2.5	1.4	1.2	0.0	13.7	4.3	1.7	1.9	0.6	0.0	0.3	0.0	0.2	7.7	0.5	2.0	2.3	1.5	1.4	1.6	0.0	0.6	2.2	0.0	0.9	0.7	0.0	0.0	0.1	0.3	1.8	0.0	0.0	3.1	4.6	0.0	0.0	0.9	3.2	0.0	10.1	0.0	0.0	1.7
NOD1	"CARD4, CLR7.1, NLRC1"	ENSG00000106100	"Nucleotide binding oligomerization domain containing 1"	Q9Y239	7	30424527-30478784	"Predicted intracellular proteins"	"Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 10.8;Ito cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074367			Approved	Mitochondria		NA	NA			Mitochondria		"HPA074367: AB_2686683"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (6.62e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (2.64e-1)"	15.2	3.2	3.9	11.1	3.7	6.6	18.3	2.0	2.4	6.5	6.2	4.3	5.0	2.2	8.7	8.9	6.1	7.3	10.1	10.9	2.9	2.1	5.0	2.9	13.8	6.0	3.2	2.2	13.6	4.6	3.8	4.6	13.3	4.7	5.5	4.7	6.4	7.7	7.6	7.2	7.1	6.2	16.3	4.7	12.4	6.9	3.2	3.5	5.1	27.2	6.4	11.1	7.6	6.1	10.9	8.2	13.3	6.2	8.7	9.8	2.4	4.3	2.3	3.2	9.6	2.1	9.9	5.0	3.0	2.1	5.1	6.5	2.0	5.2	6.1	3.6	3.8	5.7	10.1	3.2	5.2	3.5	3.2	2.7	8.6	7.1	2.0	2.6	3.8	6.5	9.1	2.3	3.2	2.8	4.6	16.7	9.3	4.5	2.2	4.6	2.5	5.4	6.8	3.8	4.7	4.1	6.5	3.7	5.5	1.7	3.4	0.6	11.7	3.8	9.9	3.3	4.7	3.3	8.6	7.0	4.5	7.4	5.5	4.1	2.0	6.8	0.2	3.3	13.5	4.6	12.7	3.9	13.3	8.8	5.2	9.8	7.6	6.1	5.7	3.4	10.9	5.6	4.5	3.0	8.7	6.2	8.2	4.6	2.4	3.9	3.7	2.0	2.4	2.9	2.1	3.2	2.2	4.7	3.5	3.0	10.8	0.0	0.4	0.7	0.6	4.0	0.0	4.0	7.9	5.2	0.0	4.5	0.0	1.3	0.0	6.0	2.0	0.0	1.8	2.0	3.4	0.2	2.3	0.8	3.8	0.0	0.0	10.4	4.3	0.0	0.6	4.4	5.0	3.6	5.7	0.9	1.1	0.0	1.8	0.5	0.0	0.0	4.7	0.0	0.5	1.6	1.3	2.9	5.2	0.9
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 5.9;Basal keratinocytes: 5.3;Kupffer cells: 9.7;Macrophages: 13.7;Suprabasal keratinocytes: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.3;eosinophil: 3.9;intermediate monocyte: 9.1;myeloid DC: 15.5;neutrophil: 6.3;non-classical monocyte: 5.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;granulocytes: 6.3;monocytes: 15.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.9;T-47d: 5.7;THP-1: 6.8;U-266/70: 15.7;U-266/84: 6.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	2.6	0.6	0.9	6.2	0.5	13.2	1.7	0.5	1.5	5.7	1.0	0.7	0.9	1.5	1.8	2.6	12.6	1.1	3.7	3.2	1.2	0.5	0.8	1.9	7.6	8.0	1.6	0.0	1.4	0.4	0.0	1.0	2.6	1.4	1.8	1.0	1.2	5.5	0.4	1.4	14.2	1.3	1.9	3.2	4.7	1.4	2.2	0.9	1.0	0.9	12.1	8.3	4.0	10.6	0.0	15.5	6.3	15.3	1.9	1.0	6.8	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.0	5.7	6.8	0.0	0.0	0.0	0.0	0.0	15.7	6.7	0.0	0.2	0.1	0.0	2.0	15.3	3.9	0.2	9.1	0.5	0.0	1.0	0.9	15.5	0.0	0.1	0.3	6.3	1.9	5.8	0.6	0.6	6.8	0.9	0.5	0.5	1.5	1.2	0.5	1.6	0.0	1.4	0.9	0.0	5.9	0.0	0.3	5.3	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.1	0.0	2.4	0.0	1.2	0.0	9.7	0.0	0.0	13.7	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.2	0.7	0.0	0.3
NOL12	"MGC3731, Nop25, RRP17"	ENSG00000273899	"Nucleolar protein 12"	Q9UGY1	22	37681673-37693478	"Predicted intracellular proteins"		"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.1"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003547	Uncertain		Approved	"Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles"		Yes	No			"Nucleoli, Mitotic chromosome"	"Nucleoplasm, Vesicles"	"HPA003547: AB_10602012"	"unprognostic (3.37e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (2.65e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.23e-3)"	"prognostic favorable (9.41e-4)"	"unprognostic (9.96e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.56e-6)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (3.24e-4)"	3.8	11.8	9.3	9.5	10.1	14.6	5.0	13.1	10.6	3.6	6.5	7.9	5.4	8.4	4.1	4.6	7.8	6.2	5.6	7.2	7.7		5.2	4.1	4.8	11.0	8.7	6.4	5.4	5.4	5.4	3.9	6.8	7.2	4.5	6.2	4.4	8.9	4.8	7.9	11.4	7.1	4.5	3.7	8.6	5.8	4.8	9.5	7.2	7.4	7.1	8.0	5.8	5.6	8.1	9.6	31.1	17.1	8.5	11.6	6.4	16.9	15.7	11.7	13.4	3.8	4.0	14.8	8.5	3.9	3.8	4.1	8.8	7.1	14.5	5.1	3.8	4.0	18.5	6.7	22.4	1.3	15.2	24.5	12.3	12.6	20.1	10.3	29.1	18.1	5.9	7.3	15.2	5.9	5.3	7.3	8.6	9.1	13.1	3.3	14.8	15.9	21.7	13.4	7.6	21.2	21.8	7.6	10.9	8.5	6.0	9.5	18.7	9.9	9.1	13.5	1.8	13.0	13.8	10.2	16.2	16.4	11.8	15.6	11.0	13.4	18.7	15.4	21.6	18.9	21.3	14.0	14.2	9.1	14.1	6.5	8.0	8.9	7.9	9.6	8.1	9.1	7.9	31.1	8.5	17.1	7.5	11.6	6.4											3.0	11.7	16.1	10.3	34.7	11.5	3.1	7.6	9.4	7.9	14.0	5.9	16.5	3.3	23.3	77.4	12.6	26.9	0.0	25.4	13.3	12.5	7.3	15.0	4.9	12.1	27.0	12.1	9.8	8.7	31.6	9.2	16.0	20.3	19.0	18.9	9.1	18.7	31.6	10.6	6.4	8.1	12.9	8.2	14.4	24.4	34.8	16.6	16.7	18.4	13.2
NOL3	"ARC, CARD2, MYP, NOP30"	ENSG00000140939	"Nucleolar protein 3"	O60936	16	67170154-67175735	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009208	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009208: AB_634091"	"unprognostic (2.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (5.74e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.48e-2)"	16.3	22.6	13.0	3.2	19.6	1.3	9.4	7.3	14.1	8.4	7.1	10.8	19.7	5.3	7.5	10.5	15.4	7.8	15.7	29.1	11.1	8.3	10.1	12.8	10.1	2.6	15.9	12.3	6.8	12.3	22.8	14.8	8.6	12.7	19.8	6.1	13.8	18.0	13.3	76.1	39.7	5.2	10.6	11.6	3.7	11.1	2.7	15.8	0.6	9.6	27.7	6.3	9.4	9.2	0.0	2.1	1.5	6.8	0.7	3.4	2.5	6.2	10.2	1.7	9.6	8.6	6.5	9.6	5.0	5.4	5.5	3.3	2.2	16.5	0.1	16.8	5.9	1.4	10.5	2.3	7.8	1.3	5.6	3.6	0.2	8.1	3.2	5.4	0.5	1.3	4.0	14.5	4.3	3.1	15.8	2.3	2.2	2.2	6.6	10.3	16.2	0.1	0.8	1.6	5.7	25.2	5.6	3.6	12.4	9.3	1.9	13.6	7.3	21.2	15.4	2.2	2.3	32.8	1.7	5.3	7.3	6.2	7.1	4.3	9.7	3.0	1.7	20.6	1.6	2.4	0.0	6.8	0.0	0.3	0.6	0.1	0.0	3.4	0.3	2.1	0.0	0.0	0.5	1.5	0.7	0.2	2.1	0.0	2.5	13.0	19.6	7.3	14.1	11.1	8.3	15.9	12.3	12.7	15.8	26.8	25.2	2.2	26.4	12.2	16.6	45.2	33.1	8.1	13.6	3.5	15.7	7.0	13.3	54.2	0.9	10.5	15.3	0.0	30.2	9.9	15.1	25.5	2.3	27.7	9.5	52.4	21.5	8.0	5.1	0.4	23.3	3.1	20.3	20.8	17.6	28.3	36.8	10.5	28.3	17.3	46.0	12.9	36.2	0.2	1.1	17.2	9.3	2.2	13.7	21.4
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615327-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	35.8	40.5	45.2	41.4	42.3	44.9	36.6	26.7	38.7	30.5	36.7	25.9	29.2	37.2	35.2	36.7	38.6	33.0	36.6	53.4	39.9	38.4	56.9	58.6	28.8	36.6	41.6	30.2	42.4	42.6	54.0	40.5	45.6	36.8	39.5	32.4	23.1	42.3	35.6	59.3	30.6	46.4	36.7	47.7	45.2	34.8	32.5	40.4	34.3	49.5	36.9	36.0	43.3	56.0	50.7	45.5	38.3	38.0	28.8	49.6	30.9	29.8	15.5	14.6	21.0	11.4	13.2	29.7	27.4	14.9	25.7	24.4	29.4	12.6	38.5	54.3	16.6	31.4	18.5	22.0	20.7	25.2	21.6	36.0	33.1	15.4	49.4	24.5	49.1	26.1	12.4	21.8	23.5	14.5	13.4	16.7	21.7	51.3	10.5	22.2	19.2	27.9	54.5	19.1	17.5	26.6	30.2	20.8	59.2	25.6	9.9	37.2	23.9	16.0	38.8	35.8	19.0	24.1	17.9	25.3	23.7	22.3	24.3	48.1	24.6	47.7	47.0	13.6	29.1	35.8	16.0	30.2	38.3	31.0	35.3	36.6	50.7	45.5	38.3	35.9	41.4	49.6	37.8	14.0	28.8	38.0	45.5	46.9	30.9	45.2	42.3	26.7	38.7	39.9	38.4	41.6	30.2	36.8	40.4	86.4	58.0	93.0	81.6	80.6	62.4	203.3	63.7	148.5	80.8	54.1	21.6	114.5	104.5	133.3	133.2	97.2	61.4	70.0	226.4	127.6	86.4	80.3	87.8	56.9	100.9	46.1	35.6	46.6	45.5	19.9	76.5	83.5	96.2	155.9	59.8	89.8	148.3	72.9	74.6	135.1	46.0	64.7	96.7	142.1	122.5	79.2	129.9	82.8	73.6	94.7
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	15.8	11.5	11.6	14.6	20.0	8.5	13.6	15.9	15.9	15.1	13.2	7.3	12.1	6.4	16.4	11.1	14.1	13.0	9.4	9.4	13.7	8.2	10.6	8.9	9.5	13.6	17.9	8.4	17.5	11.1	25.3	23.6	11.8	13.4	14.0	11.0	5.2	11.0	13.2	15.0	12.9	10.7	14.6	19.5	15.7	10.6	7.7	17.8	18.7	15.2	11.2	15.1	16.3	16.2	13.6	12.2	13.6	14.7	12.6	17.5	6.6	8.1	13.2	6.1	12.3	13.9	11.8	8.4	9.3	7.3	10.0	9.6	4.7	8.5	25.6	8.2	9.8	16.6	16.9	21.8	13.0	11.1	16.0	9.9	18.2	13.2	10.5	9.4	30.3	13.9	12.4	9.6	11.2	15.7	8.2	12.3	7.6	27.6	7.9	11.5	13.1	21.1	10.6	10.3	11.6	12.6	12.8	18.0	10.4	5.2	5.5	11.4	5.6	12.8	11.2	7.8	8.3	4.5	9.6	11.9	9.3	6.0	13.1	9.7	8.0	17.9	13.9	8.6	17.5	11.9	13.6	8.3	11.3	12.5	11.1	17.5	13.6	11.9	12.0	12.2	12.6	14.6	12.5	3.2	12.6	14.7	10.3	13.2	6.6	11.6	20.0	15.9	15.9	13.7	8.2	17.9	8.4	13.4	17.8	17.9	33.1	27.4	15.8	11.6	18.5	25.6	12.7	32.1	23.9	10.4	9.8	16.1	13.3	20.5	9.0	20.2	8.8	23.3	11.2	17.4	13.2	11.2	48.8	9.6	23.0	27.0	8.6	20.3	16.1	6.8	29.7	19.8	10.1	27.1	14.3	13.7	15.3	7.0	22.3	12.4	16.8	6.5	13.4	46.1	37.9	13.9	12.2	15.2	17.9	9.6
NOMO1	PM5	ENSG00000103512	"NODAL modulator 1"	Q15155	16	14833681-14896160	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.0"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.0;Hep G2: 37.3;RPMI-8226: 23.8;SiHa: 43.2"									"CAB025192, HPA046697, HPA061174"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB025192: , HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (3.15e-4)"	4.2	3.3	4.4	10.1	11.1	0.8	4.6	7.9	10.2	2.4	3.7	5.4	1.5	1.4	6.1	3.6	3.4	8.3	2.8	12.9	5.2	6.4	11.3	8.9	4.1	3.4	4.6	10.6	11.7	40.0	1.2	3.3	9.1	6.6	5.9	10.3	2.7	4.1	5.9	12.2	6.9	7.0	9.0	3.5	1.8	5.9	15.0	2.8	1.5	9.9	1.5	2.4	2.6	1.9	1.2	3.8	5.2	4.0	1.4	1.0	1.0	0.3	12.7	16.0	21.0	0.0	1.5	10.4	1.3	3.2	3.9	4.0	0.2	0.9	1.3	1.0	2.9	0.3	0.2	2.9	0.1	4.0	1.9	0.0	1.2	17.0	37.3	13.9	1.8	1.0	0.2	0.2	2.0	2.2	0.4	2.9	0.0	7.2	0.8	18.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	1.5	23.8	0.0	0.7	0.3	11.8	43.2	0.0	0.2	0.8	17.6	0.1	0.4	0.5	0.0	1.8	14.8	0.0	0.6	1.5	0.9	0.7	0.5	5.2	0.6	0.6	0.3	1.2	0.7	0.2	0.3	0.9	0.5	1.2	0.5	0.8	1.6	1.4	4.0	3.8	1.0	1.0	4.4	11.1	7.9	10.2	5.2	6.4	4.6	10.6	6.6	2.8	3.0	8.0	5.2	1.2	5.7	8.3	40.4	2.5	4.0	5.7	10.4	5.9	5.1	0.0	13.8	22.9	7.4	13.6	0.0	25.8	11.0	5.7	1.6	24.1	6.8	5.7	33.4	7.5	8.6	10.4	6.4	2.6	2.6	5.0	6.4	10.8	5.1	26.8	8.6	6.0	8.2	7.1	6.5	7.2	9.8	13.8	5.1	8.0	4.4	11.1	1.3
NOP9	C14orf21	ENSG00000196943	"NOP9 nucleolar protein"	Q86U38	14	24299862-24309124	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000850			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA000850: AB_1078287"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (9.39e-6)"	"unprognostic (7.03e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	12.0	12.9	11.3	11.4	11.4	14.4	10.0	13.3	17.5	11.3	14.4	16.8	9.6	16.5	11.1	10.1	16.6	10.3	13.8	19.4	10.9	10.6	9.7	14.2	9.5	15.1	13.7	10.0	13.3	13.3	20.1	8.9	11.6	10.9	10.8	12.3	13.0	12.5	11.5	29.7	13.5	12.4	12.3	12.3	18.8	10.9	13.0	10.7	11.8	11.2	18.3	14.9	12.1	9.4	1.6	2.1	1.8	5.2	0.4	1.6	1.4	5.0	10.1	8.2	10.3	7.2	6.1	8.2	9.1	6.8	10.7	8.4	7.6	9.0	13.0	5.1	8.2	8.7	13.2	16.3	11.3	11.2	8.2	6.2	9.5	14.0	17.3	5.8	21.8	11.0	6.1	8.8	7.9	7.4	5.8	9.9	7.6	8.1	6.5	7.4	8.7	10.1	8.3	3.7	17.8	13.0	12.7	5.0	8.3	6.6	11.6	8.3	6.4	12.7	14.9	2.8	6.2	6.3	5.8	10.1	7.3	6.0	5.9	8.5	9.1	8.0	9.8	3.9	10.0	5.7	1.4	2.3	1.8	1.5	2.4	1.6	1.2	1.4	0.7	2.1	1.6	1.0	1.0	0.5	0.4	5.2	1.1	1.2	1.4	11.3	11.4	13.3	17.5	10.9	10.6	13.7	10.0	10.9	10.7	3.0	3.5	3.7	3.0	11.1	8.2	0.8	5.1	5.3	9.1	8.7	7.9	5.4	0.0	6.6	2.4	4.1	11.3	23.3	8.7	4.6	4.7	4.7	1.1	16.3	6.5	6.4	10.3	3.7	9.7	0.5	6.1	4.7	0.0	2.8	8.1	3.9	9.7	9.9	4.2	6.5	7.4	6.5	3.1	3.5	6.0	11.8	5.4	3.2	12.1	3.9
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 13.4;skeletal muscle: 36.3"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 7.9;Basal keratinocytes: 3.4;Glandular cells: 2.8;Ito cells: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.3;RH-30: 13.1;RPTEC TERT1: 8.2;U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.5	0.6	3.8	3.5	13.4	0.7	0.6	4.4	4.8	0.7	2.0	1.1	0.0	0.5	0.6	0.7	1.3	0.8	0.5	0.5	2.8	4.4	1.9	0.5	1.4	0.6	2.4	1.6	0.5	1.9	0.4	0.8	0.4	5.9	1.6	0.9	0.6	3.8	0.6	36.3	2.2	0.6	0.8	1.2	0.5	0.5	0.9	3.0	0.0	0.6	0.0	0.5	0.9	0.6	0.9	0.6	2.1	0.5	0.8	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	1.5	0.0	13.1	0.1	8.2	0.1	0.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	2.5	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	2.1	0.5	0.5	0.5	0.4	0.4	0.7	0.4	0.3	0.2	0.9	0.5	0.5	1.9	0.8	0.5	0.6	0.3	0.0	3.8	13.4	4.4	4.8	2.8	4.4	2.4	1.6	5.9	3.0	0.0	0.0	0.0	7.9	3.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.2	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.5	0.0	0.0	0.0	1.0
NOS1AP	"CAPON, KIAA0464"	ENSG00000198929	"Nitric oxide synthase 1 adaptor protein"	O75052	1	162069774-162370475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.1"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 192.4;Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 6.9;HaCaT: 5.2;HEL: 8.3"	"Low region specificity"	"Detected in all"							"CAB018582, HPA030066, HPA055561"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851"	"unprognostic (7.04e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.08e-3)"	2.1	7.9	10.2	1.6	7.0	4.8	6.2	23.1	34.1	2.4	3.7	3.1	7.1	2.7	2.4	1.7	2.2	2.6	7.4	2.3	19.0	10.1	2.9	7.6	2.3	1.4	6.5	13.0	1.6	3.5	2.0	2.7	2.2	5.5	2.5	3.9	2.7	4.6	9.7	1.7	2.4	3.1	2.1	4.4	1.3	3.8	4.0	3.1	0.0	1.6	0.2	1.8	1.8	2.2	0.0	0.1	1.1	0.5	0.0	0.3	0.1	6.9	0.0	3.2	1.9	0.1	0.0	0.5	0.6	0.8	0.9	0.8	1.5	1.7	0.0	4.4	0.2	1.1	5.2	1.1	0.2	0.3	0.1	3.2	8.3	1.2	1.7	0.0	0.0	0.1	0.3	0.2	0.0	0.3	0.9	1.7	1.0	0.6	0.1	0.1	3.6	0.6	0.0	2.4	1.1	3.1	0.1	1.3	0.2	1.5	2.3	2.6	1.8	1.6	0.3	1.2	0.9	1.9	0.4	0.8	0.1	0.8	0.0	1.2	4.7	0.0	0.0	1.1	0.1	0.9	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	10.2	7.0	23.1	21.1	19.0	10.1	6.5	13.0	5.5	3.1	0.0	0.3	0.0	5.3	2.6	8.5	1.9	2.5	1.4	1.2	21.0	192.4	0.0	8.3	0.9	24.7	1.6	3.8	0.0	1.0	0.2	1.2	9.9	0.0	19.5	0.1	63.5	6.4	2.5	0.6	8.0	4.0	0.0	0.0	0.0	7.3	20.7	0.6	5.5	6.7	0.2	2.2	6.5	0.3	1.9	1.3	1.8	0.5	0.0	4.4	6.4
NOSTRIN	MGC20702	ENSG00000163072	"Nitric oxide synthase trafficking"	Q8IVI9	2	168786539-168865514	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 51.2"	"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 61.2;Ito cells: 157.8;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;HEL: 25.9;K-562: 19.5;OE19: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044384, HPA076885"	Approved		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA044384: AB_2678922, HPA076885: "	"unprognostic (4.74e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.02e-6)"	"unprognostic (4.89e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.98e-2)"	27.1	11.6	4.4	7.6	5.6	0.2	17.4	2.7	6.0	20.5	11.0	2.3	10.3	10.4	11.9	12.1	7.8	9.0	20.5	9.8	4.8	4.1	27.9	7.8	19.6	3.5	5.8	3.7	11.2	14.8	2.3	4.2	18.5	7.9	9.4	12.5	2.8	51.2	13.6	7.6	4.2	22.3	9.7	5.1	5.6	16.5	11.2	3.9	0.7	8.5	8.6	2.6	7.6	12.8	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.5	0.0	0.0	0.0	6.8	0.2	0.0	0.0	0.0	4.0	4.3	0.0	2.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	25.9	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.1	0.1	0.7	0.0	2.2	0.9	0.0	0.1	0.1	1.2	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	4.4	5.6	2.7	6.0	4.8	4.1	5.8	3.7	7.9	3.9	8.9	10.1	6.5	0.6	0.9	0.0	3.9	15.3	2.7	5.7	3.5	0.0	14.5	11.6	7.5	21.4	61.2	43.4	0.0	18.9	6.3	2.1	3.0	0.0	0.6	1.3	0.0	10.9	157.8	7.0	42.2	8.1	0.9	23.6	1.0	34.1	2.0	16.3	18.2	5.3	37.6	0.2	71.1	2.2	11.4	1.6	0.4	22.0	0.5	13.9	1.1
NOTCH1	TAN1	ENSG00000148400	"Notch 1"	P46531	9	136494433-136545786	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 41.3;Ito cells: 68.2;Muller glia cells: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;NK-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 25.0;HMC-1: 21.7;hTCEpi: 24.0;MOLT-4: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		NA	NA		8100000	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795"	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	20.0	4.0	10.0	14.5	10.4	14.6	12.8	3.8	18.8	12.8	14.2	19.9	8.2	9.8	11.2	5.1	13.3	9.6	13.1	9.6	10.7	5.8	9.4	7.2	17.4	13.7	11.6	7.5	9.2	17.8	3.7	5.6	8.5	9.3	12.1	5.7	10.4	14.2	11.8	8.2	32.3	10.8	7.7	6.6	20.7	8.6	4.1	9.9	34.8	9.4	10.2	10.9	12.3	22.2	0.6	1.1	8.8	1.0	2.7	1.3	0.9	4.4	7.5	6.2	3.1	0.2	0.5	7.8	2.2	0.6	1.3	0.4	1.1	0.5	6.1	4.7	1.7	1.6	25.0	2.0	10.3	0.2	13.8	1.1	3.4	3.0	0.4	3.4	3.6	21.7	0.4	24.0	1.8	3.8	1.5	8.0	2.7	1.5	1.1	0.9	8.1	38.1	5.8	5.2	3.2	3.4	7.9	5.0	11.2	0.9	3.8	0.0	0.4	3.3	3.5	1.4	1.9	2.1	5.8	11.8	3.3	4.8	3.2	2.4	1.3	1.1	2.4	2.2	2.5	16.9	0.7	1.0	2.8	1.3	0.4	0.8	0.4	0.6	1.0	0.6	0.6	0.4	1.1	8.8	2.7	0.4	1.1	0.4	0.9	10.0	10.4	3.8	11.7	10.7	5.8	11.6	7.5	9.3	9.9	8.9	28.2	13.8	10.6	22.0	0.3	7.3	7.6	0.0	6.8	1.8	2.0	0.7	0.0	4.8	0.3	41.3	4.9	0.0	3.4	1.8	4.8	6.6	34.6	6.8	8.0	1.6	2.4	68.2	10.5	0.0	1.1	17.1	6.8	1.0	11.0	50.6	2.2	7.0	0.7	4.1	1.7	6.5	11.5	0.2	3.2	26.1	0.9	12.9	24.7	14.1
NOTO		ENSG00000214513	"Notochord homeobox"	A8MTQ0	2	73202258-73212513	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034660, HPA063906"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034660: AB_10601974, HPA063906: "						"unprognostic (6.09e-2)"		"unprognostic (9.77e-2)"		"unprognostic (4.84e-2)"				"unprognostic (1.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-2)"		0.2	0.8	0.3	0.6	0.4	2.3	0.3	1.4	0.2	0.1	0.5	0.1	0.1	0.8	0.1	0.6	0.1	0.1	0.4	0.2	0.2	0.6	0.1	0.2	0.3	0.5	0.3	0.1	0.2	0.1	0.0	0.4	0.1	2.4	1.3	0.3	0.6	0.2	0.1	0.5	2.2	2.7	0.1	0.5	0.5	0.5	5.7	0.1	0.7	0.1	0.1	0.1	0.4	0.1	0.8	0.8	2.6	0.8	1.4	1.0	0.3	0.2	0.2	0.4	0.5	0.2	0.3	0.7	0.3	0.0	0.1	0.2	1.1	0.8	0.3	0.2	0.3	0.3	1.1	0.1	0.4	0.5	0.8	0.4	0.5	1.8	0.7	0.0	0.6	1.4	0.2	0.4	0.1	0.0	0.3	0.0	0.5	0.1	1.0	0.0	0.6	0.1	0.4	0.7	0.0	0.5	0.7	0.2	0.3	0.1	0.8	0.9	0.6	1.1	0.8	0.0	0.6	0.7	0.6	1.3	0.8	0.4	0.2	0.7	0.7	0.2	0.8	0.3	1.0	0.2	1.9	0.8	0.3	0.6	0.3	0.9	0.6	0.8	0.5	0.3	0.8	0.8	1.0	2.6	1.4	0.5	0.8	0.5	0.3	0.3	0.4	1.4	0.2	0.2	0.6	0.3	0.1	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 127.4"	"Cell type enriched"	"Detected in some"	47	"Extravillous trophoblasts: 865.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 96.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		59000	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.2	0.1	1.1	0.2	1.2	0.1	0.2	0.3	1.0	0.2	0.2	0.2	0.5	0.6	1.0	1.3	0.3	0.2	0.3	0.3	0.5	0.9	0.8	10.4	1.8	0.2	0.7	0.4	0.2	0.2	0.0	0.2	127.4	0.6	0.4	0.0	0.2	0.3	0.2	4.9	2.4	0.2	0.2	0.3	0.3	0.9	3.0	0.5	0.2	0.2	0.3	0.2	1.3	1.3	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.5	0.6	96.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	15.6	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.9	0.4	1.4	0.5	0.0	1.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	1.2	0.3	1.0	0.5	0.9	0.7	0.4	0.6	0.5	0.0	3.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	865.2	2.3	0.0	0.0	0.9	17.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.8	0.0	18.4	0.0	0.0	0.0
NOVA2	"ANOVA, NOVA3"	ENSG00000104967	"NOVA alternative splicing regulator 2"	Q9UNW9	19	45933734-45973546	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.5"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 50.9;Endothelial cells: 25.9;Horizontal cells: 20.6;Ito cells: 35.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.3;HDLM-2: 8.8;HUVEC TERT2: 14.2;SH-SY5Y: 4.8;TIME: 21.2;U-2 OS: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045607	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"HPA045607: AB_10962628"	"unprognostic (9.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.42e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.31e-2)"	11.8	4.5	23.9	2.7	22.7	1.3	5.7	13.0	33.5	3.9	2.5	7.2	0.0	2.5	5.6	2.7	2.4	3.6	4.2	5.8	17.1	10.9	3.2	2.7	9.4	2.2	7.1	17.3	2.0	2.5	3.3	5.7	9.7	11.1	2.6	2.4	2.5	2.4	3.1	5.5	2.7	2.0	5.7	5.5	2.4	2.5	4.3	8.7	0.0	4.5	0.4	1.8	3.9	3.5	0.0	0.0	0.4	0.1	0.4	0.1	0.0	0.0	0.1	8.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	1.1	0.0	0.0	8.8	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	4.8	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	23.9	22.7	13.0	29.3	17.1	10.9	7.1	17.3	11.1	8.7	0.0	0.0	0.0	0.1	0.6	50.9	3.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.3	25.9	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.4	0.1	20.6	0.0	35.6	2.6	2.4	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.4	0.0	3.1	0.0	0.0	2.3	1.9	0.1	0.0	0.0	0.0	0.3
NOX4	"KOX, KOX-1"	ENSG00000086991	"NADPH oxidase 4"	Q9NPH5	11	89324356-89498187	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"kidney: 65.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 119.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA015475			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015475: AB_1854574"	"unprognostic (2.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.83e-3)"	"unprognostic (8.95e-3)"	"unprognostic (3.80e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.99e-4)"	"unprognostic (9.71e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.03e-3)"	7.5	0.6	0.2	0.6	0.6	0.3	6.5	0.3	0.5	1.2	0.9	1.1	0.4	0.3	7.3	2.5	1.5	0.8	1.3	6.9	0.6	0.2	65.2	0.3	1.2	0.3	0.3	0.2	0.7	1.1	3.8	0.8	1.7	1.0	2.6	0.4	0.8	2.6	0.9	5.1	1.1	0.5	3.5	1.2	0.4	0.4	1.0	0.0	0.0	1.7	1.7	0.4	2.1	1.1	0.4	0.3	1.7	0.3	0.8	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	8.5	15.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.2	4.3	0.3	0.0	34.8	0.1	2.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.4	0.3	0.3	1.7	0.8	0.2	0.3	0.2	0.0	0.2	0.6	0.3	0.5	0.6	0.2	0.3	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	4.1	1.1	0.0	0.0	0.0	10.4	5.9	1.2	13.3	0.0	0.8	1.1	0.0	0.0	0.0	0.6	1.1	0.1	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.7	0.1	0.0	1.1	119.8	19.3	0.0	0.3	0.5	0.1	0.3	2.1	0.0	0.0	0.0
NOXA1	"FLJ25475, NY-CO-31, SDCCAG31"	ENSG00000188747	"NADPH oxidase activator 1"	Q86UR1	9	137423350-137434406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 34.1;Paneth cells: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.6;EFO-21: 9.8;MCF7: 16.2;T-47d: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044781	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA044781: AB_10960532"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.97e-3)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.97e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-2)"	5.1	7.1	8.5	13.9	13.0	3.8	5.9	9.9	11.8	8.9	16.0	7.5	14.5	23.2	8.4	15.7	11.9	8.2	19.7	3.8	7.5	9.7	11.0	9.2	8.6	4.7	5.1	10.1	9.0	17.4	10.4	13.4	2.1	5.2	8.4	5.2	10.0	25.2	11.3	11.6	21.8	22.6	3.9	4.2	7.8	21.1	3.4	4.0	2.5	10.8	8.1	11.3	5.9	6.5	0.4	1.7	0.1	5.5	1.6	1.0	0.4	1.6	4.2	0.1	3.3	0.4	0.0	2.2	0.3	0.5	0.1	0.2	0.7	10.6	0.0	9.8	0.1	0.6	7.1	0.1	0.2	0.0	4.5	3.6	0.0	2.5	1.5	1.0	0.1	2.1	0.3	2.3	0.0	0.1	1.9	0.2	0.0	0.6	0.7	0.0	16.2	0.0	0.9	0.2	4.3	1.4	0.1	0.0	6.2	2.8	3.6	0.9	0.3	0.2	1.7	1.7	0.2	15.9	1.4	1.1	0.2	2.3	2.4	0.3	0.7	0.0	0.0	0.3	0.6	0.5	0.0	1.2	0.1	0.1	1.8	0.5	0.4	0.1	0.0	1.7	0.2	0.4	1.0	0.0	1.6	5.5	0.0	0.0	0.4	8.5	13.0	9.9	11.8	7.5	9.7	5.1	10.1	5.2	4.0	0.0	4.8	0.8	6.7	3.1	8.6	1.0	10.2	4.0	4.5	12.2	7.9	0.2	6.6	6.1	0.0	1.5	34.1	23.3	9.7	0.4	1.0	5.5	2.3	5.7	4.7	3.2	6.4	1.3	3.3	0.0	1.1	5.0	8.5	2.8	19.0	9.6	6.6	28.1	0.7	15.9	7.8	6.5	2.0	4.3	3.6	3.6	0.2	3.2	19.7	5.8
NPAS1	"bHLHe11, MOP5, PASD5"	ENSG00000130751	"Neuronal PAS domain protein 1"	Q99742	19	47019820-47045775	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.2;skin 1: 10.5;stomach 1: 8.0"	"Cell type enhanced"	"Detected in some"	17	"Cone photoreceptor cells: 15.7;Muller glia cells: 5.6;Rod photoreceptor cells: 5.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.2"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"BJ: 8.9;Daudi: 9.1;HEK 293: 10.0;HMC-1: 8.3;NB-4: 15.9;U-266/84: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA043364, HPA072259"		Approved	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043364: , HPA072259: AB_2686500"	"unprognostic (2.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.14e-8)"	"unprognostic (8.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.20e-2)"	0.6	0.6	9.5	1.3	4.1	0.9	1.3	0.4	14.2	0.4	0.9	0.4	0.0	0.5	0.6	0.4	0.8	1.2	0.5	0.9	9.0	5.2	1.2	0.8	0.9	1.7	3.0	4.1	0.4	1.5	0.7	1.1	0.8	5.1	0.6	0.5	3.4	0.7	0.5	0.5	10.5	0.4	0.7	0.8	3.9	8.0	0.8	0.2	0.0	0.6	0.0	1.3	0.5	0.4	2.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.2	0.2	0.4	0.2	0.2	0.0	8.9	0.2	0.1	0.4	0.7	0.5	9.1	2.0	7.2	0.4	0.2	1.9	0.2	0.1	0.6	10.0	0.7	0.8	2.2	0.0	4.8	8.3	0.8	0.4	0.0	0.1	0.5	0.2	1.2	3.1	0.8	1.2	0.7	0.3	15.9	2.2	0.4	1.5	0.8	0.3	0.7	0.5	0.5	0.7	0.6	0.8	0.3	2.1	0.7	1.9	1.5	0.1	0.1	0.9	0.1	0.2	5.0	9.7	1.9	1.1	1.0	6.5	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	9.5	4.1	0.4	14.2	9.0	5.2	3.0	4.1	5.1	0.2	0.0	1.1	0.0	1.2	0.7	0.7	0.8	0.0	2.7	0.0	0.0	15.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	1.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.6	0.8	0.0	0.0	0.5	5.1	0.0	0.3	0.0	2.0	1.9	0.0	0.0	0.5	0.9
NPAS2	"bHLHe9, MOP4, PASD4"	ENSG00000170485	"Neuronal PAS domain protein 2"	Q99743	2	100820152-100996829	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 49.7;Urothelial cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 45.0;PC-3: 34.2;RT4: 27.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019674	Uncertain	Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019674: AB_10601275"	"unprognostic (2.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (5.47e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (3.55e-7)"	"unprognostic (7.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-3)"	6.6	11.5	16.8	8.2	24.8	1.2	10.1	7.6	23.0	11.9	14.4	4.3	1.3	26.7	8.8	4.9	32.4	8.2	13.6	27.3	15.3	6.8	15.9	14.1	5.3	3.6	6.2	14.1	3.3	32.5	1.7	12.7	14.2	10.3	12.2	15.1	6.5	23.7	7.0	12.7	18.5	20.2	17.9	11.0	5.7	19.1	9.9	8.5	0.5	6.3	6.0	13.4	22.4	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	4.0	22.7	0.0	0.2	22.4	9.7	3.3	7.5	22.4	3.1	6.7	0.4	1.8	0.0	9.0	1.2	45.0	0.1	3.3	5.5	3.2	0.2	1.3	0.0	4.0	10.3	10.6	0.0	0.9	8.2	9.0	7.5	12.1	12.6	12.6	2.4	0.1	0.0	2.4	8.1	1.5	0.2	0.4	6.6	34.2	0.1	0.5	0.2	16.0	27.5	0.0	0.4	0.0	1.3	16.8	0.2	0.2	0.2	4.8	2.3	3.1	4.5	3.2	0.0	0.0	0.0	24.5	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.0	1.3	0.0	16.8	24.8	7.6	23.0	15.3	6.8	6.2	14.1	10.3	8.5	0.0	10.7	0.0	7.4	3.4	4.4	13.2	20.4	2.7	10.3	12.2	0.0	0.5	0.0	11.2	49.7	6.5	22.4	0.0	13.3	0.8	5.6	17.5	0.0	12.9	0.1	27.0	8.7	15.4	0.3	7.9	6.6	0.7	3.3	1.0	9.9	3.6	12.8	11.0	4.9	12.1	0.4	0.0	4.4	0.4	1.7	5.6	0.2	0.0	9.9	36.3
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586898	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.7;T-cells: 14.5"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		27000	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	13.4	38.8	17.4	11.2	30.9	26.4	15.8	7.1	25.1	10.1	8.7	65.6	3.4	10.2	11.1	11.7	12.8	8.2	11.2	7.1	23.4	14.3	9.9	10.3	17.8	13.0	46.0	15.4	12.0	7.9	51.8	9.9	18.9	27.7	9.7	8.9	12.0	25.4	10.1	13.7	17.0	12.2	10.9	41.4	11.5	12.0	9.5	38.4	7.0	8.3	5.3	10.7	10.8	10.8	3.6	32.7	3.8	5.8	4.6	14.5	4.1	5.3	10.7	4.6	7.4	15.0	11.6	10.5	9.3	20.2	9.9	21.5	7.1	7.8	4.5	7.2	13.4	33.8	15.0	5.8	16.0	8.8	3.5	4.6	1.6	9.7	16.0	21.4	6.1	7.4	11.1	15.9	20.9	70.4	19.6	9.7	5.2	4.8	12.1	11.1	8.1	2.5	3.6	3.2	6.1	9.6	3.6	7.2	11.2	23.0	13.3	1.9	3.7	11.1	16.2	13.7	7.4	4.0	4.8	12.5	21.0	4.1	8.3	8.0	7.5	23.1	3.1	46.3	5.4	9.4	1.8	4.1	3.8	14.5	3.8	9.8	2.4	5.9	9.9	1.7	3.6	2.7	7.3	3.7	4.6	5.8	32.7	7.7	4.1	17.4	30.9	7.1	25.1	23.4	14.3	46.0	15.4	27.7	38.4	23.8	44.3	6.2	23.3	8.2	5.0	4.4	10.2	0.0	15.9	8.7	17.7	11.6	0.0	9.3	1.1	11.4	11.3	0.0	12.8	6.2	6.5	30.4	10.4	7.9	25.1	3.2	3.5	7.4	9.2	1.4	8.3	17.9	11.8	2.8	4.8	16.2	23.5	14.0	9.9	4.7	12.4	0.0	9.0	12.6	20.4	12.7	19.9	20.3	4.5	51.4
NPDC1	"CAB-, CAB1, DKFZp586J0523"	ENSG00000107281	"Neural proliferation, differentiation and control 1"	Q9NQX5	9	137039470-137046203	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 329.4;Intestinal endocrine cells: 270.4;Ito cells: 337.0;Mucus-secreting cells: 535.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4"	"Lineage enriched"	"Detected in many"	7	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		180000	Nucleoplasm	Cytosol	"HPA008189: AB_1854584"	"unprognostic (6.94e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.84e-2)"	35.4	21.7	33.1	11.9	35.5	4.1	21.6	59.7	65.6	27.8	27.1	18.4	23.8	22.2	26.7	10.8	11.6	25.4	32.3	20.4	34.5	35.3	12.7	5.9	18.9	11.5	25.1	49.0	12.0	28.6	17.2	47.7	20.1	29.5	73.1	13.3	10.6	58.0	35.5	19.0	17.7	23.0	16.4	30.3	32.4	59.6	10.4	14.5	0.8	11.5	8.6	7.2	12.8	20.2	0.1	2.0	0.5	0.4	0.1	13.6	2.6	9.4	11.4	2.8	18.4	6.6	6.8	0.7	20.4	6.4	4.6	1.8	4.6	5.2	9.4	15.5	7.8	1.4	35.7	2.4	5.5	0.5	7.6	11.6	3.8	29.2	3.3	9.5	3.3	0.0	4.7	8.6	2.5	5.0	12.0	11.8	3.8	0.2	0.2	0.9	35.9	0.2	0.3	6.1	30.0	19.0	5.6	0.0	36.0	7.8	6.1	22.7	15.7	5.4	18.2	12.2	1.1	39.3	4.7	20.3	3.4	6.2	24.3	6.2	0.0	0.1	0.3	5.0	0.3	2.9	0.0	0.4	0.5	8.4	0.0	10.7	0.1	13.2	13.6	0.7	0.0	0.3	2.3	0.0	0.1	0.0	2.0	10.4	2.6	33.1	35.5	59.7	65.6	34.5	35.3	25.1	49.0	29.5	14.5	0.0	10.6	4.2	65.4	20.9	88.5	13.4	79.0	2.7	4.5	27.9	15.7	1.0	0.0	43.0	1.0	147.8	41.7	23.3	59.4	1.0	34.3	329.4	0.0	0.8	17.1	58.8	270.4	337.0	25.4	2.5	149.3	6.8	28.7	2.8	535.1	32.8	34.0	79.7	136.9	0.3	54.6	38.8	34.0	2.9	19.1	20.7	1.5	7.7	84.8	89.4
NPEPL1	"bA261P9.2, FLJ11583"	ENSG00000215440	"Aminopeptidase like 1"	Q8NDH3	20	58689131-58719238	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 12.2;classical monocyte: 13.4;eosinophil: 4.9;intermediate monocyte: 8.9;myeloid DC: 8.2;neutrophil: 9.6;non-classical monocyte: 11.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 8.2;granulocytes: 12.2;monocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004986, CAB017025, HPA036356"	Approved		Approved	Nucleoplasm		NA	NA		16000	Nucleoplasm		"CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.87e-9)"	"unprognostic (7.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.73e-4)"	17.2	10.3	9.9	9.7	15.3	15.8	25.0	24.2	10.1	9.6	14.9	10.2	17.2	14.4	11.9	23.5	17.9	12.5	24.5	19.4	10.1	8.6	16.7	11.9	14.5	12.6	12.9	7.2	12.5	15.6	13.6	11.4	11.2	13.1	15.0	4.5	15.7	19.1	17.2	51.8	15.2	13.7	25.8	10.0	16.5	12.8	13.0	9.0	5.6	16.5	20.4	11.8	15.3	20.4	1.0	8.2	12.2	13.4	2.0	2.3	4.1	9.3	13.1	2.4	1.9	5.3	9.8	0.7	3.4	0.3	11.8	6.6	7.5	7.1	0.4	19.6	6.7	0.1	10.1	3.2	4.4	1.1	8.2	2.9	3.1	10.0	3.3	13.4	3.3	5.6	9.6	14.0	4.1	0.0	4.3	9.9	2.6	0.4	1.5	4.6	43.7	1.3	8.8	3.5	5.5	13.7	2.7	1.1	5.1	4.8	6.0	4.4	1.4	9.5	2.6	17.6	1.4	10.2	6.5	10.4	3.0	2.4	5.9	1.8	4.5	1.6	0.3	4.3	6.4	1.2	12.2	13.4	4.9	1.9	8.9	2.3	1.0	1.1	1.3	8.2	0.7	0.7	1.3	9.6	2.0	11.9	0.4	2.3	4.1	9.9	15.3	24.2	10.1	10.1	8.6	12.9	7.2	13.1	9.0	8.9	14.1	0.8	7.2	8.1	14.8	13.3	7.6	14.7	12.5	26.2	23.6	11.6	11.6	13.1	1.3	12.2	10.9	0.0	8.0	6.9	9.0	5.9	2.3	7.3	10.0	7.9	11.5	14.7	15.1	6.4	20.4	9.9	6.8	8.2	9.9	20.9	8.6	15.3	13.8	17.3	8.6	19.4	11.8	2.1	3.3	9.8	7.4	10.1	12.0	4.7
NPFFR2	"GPR74, NPFF2, NPGPR"	ENSG00000056291	"Neuropeptide FF receptor 2"	Q9Y5X5	4	72031804-72148067	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;seminal vesicle: 10.1"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 5.4;Extravillous trophoblasts: 7.3;Horizontal cells: 3.2;Muller glia cells: 4.8;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"GAMG: 22.5;NTERA-2: 7.3;RPTEC TERT1: 9.5;SH-SY5Y: 11.2;U-2 OS: 11.2"	"Region enriched"	"Detected in single"	4	"olfactory region: 5.3"	"Low region specificity"	"Detected in many"			HPA026825			Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Actin filaments"	"HPA026825: AB_10603123"	"unprognostic (1.28e-1)"		"unprognostic (1.05e-2)"		"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.40e-5)"	"unprognostic (5.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-1)"	0.9	0.2	5.5	0.7	2.6	0.2	1.4	0.2	3.5	0.5	0.5	0.0	0.0	0.5	0.1	2.8	0.3	0.8	0.4	0.4	0.9	2.9	0.6	0.2	0.2	0.6	0.5	4.0	0.3	1.2	0.1	1.0	4.6	1.5	3.2	0.9	1.4	0.3	10.1	0.3	0.7	0.5	0.2	0.6	0.5	0.4	1.6	0.0	15.4	1.2	0.0	0.6	2.5	0.7	0.6	0.3	2.3	0.3	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	11.2	0.0	0.0	0.0	1.6	0.0	0.0	1.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.2	1.1	0.8	0.3	0.3	0.2	0.1	5.5	2.6	0.2	3.5	0.9	2.9	0.5	4.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.4	0.1	0.0	0.0	0.2	7.3	1.0	0.0	0.0	0.0	0.9	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	8.1	0.0	0.0	0.0
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: AB_2685505"	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	5.6	4.7	7.3	4.7	11.2	7.2	4.9	6.3	12.0	5.4	3.5	4.9	8.9	4.4	5.2	11.9	3.7	17.4	5.7	3.7	6.6	3.9	4.5	2.5	6.7	4.6	2.8	6.4	7.0	4.9	7.1	17.8	3.7	5.4	4.5	2.9	8.3	4.1	5.7	3.7	9.6	4.5	5.3	3.5	4.6	4.3	11.4	3.7	5.8	14.9	3.7	2.6	4.3	4.5	0.5	0.4	2.6	1.0	0.5	0.8	0.4	7.6	4.2	5.7	4.4	5.1	7.4	4.4	4.0	4.1	5.6	4.4	4.0	6.7	4.0	10.1	4.5	3.8	7.2	2.8	6.8	2.8	4.9	6.5	3.4	7.7	3.6	3.5	6.6	5.2	6.0	3.4	6.6	4.2	3.4	3.9	9.7	6.1	4.3	2.5	5.6	8.0	6.6	1.0	4.0	4.5	6.9	3.6	6.5	2.5	1.0	18.0	5.5	6.3	4.6	6.6	2.6	6.1	7.2	3.5	8.1	3.4	13.4	4.9	5.2	6.9	4.0	3.4	8.4	2.1	2.6	1.0	0.0	0.5	0.2	0.8	0.3	0.5	0.0	0.4	0.5	0.4	0.0	1.4	0.5	0.8	0.3	0.2	0.4	7.3	11.2	6.3	12.0	6.6	3.9	2.8	6.4	5.4	3.7	0.0	0.6	0.0	1.0	3.5	6.4	2.5	5.1	5.3	5.7	3.5	31.4	0.5	1.7	0.8	1.5	2.2	1.6	0.0	1.6	0.4	1.8	1.5	0.0	1.5	1.7	4.8	3.5	1.3	4.3	1.0	3.7	2.6	10.1	1.0	2.3	5.4	1.9	2.6	2.1	1.4	19.4	6.5	2.1	11.2	6.0	4.5	0.9	0.7	1.2	0.9
NPIPA1	"morpheus, NPIP"	ENSG00000183426	"Nuclear pore complex interacting protein family member A1"	Q9UND3	16	14922802-14952060	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 33.1"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 54.9;Early spermatids: 43.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	16	"B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 34.1"									HPA053611	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.82e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.74e-7)"	"unprognostic (2.28e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-5)"	5.1	6.0	5.9	3.8	4.9	4.2	4.8	33.1	8.3	5.0	5.8			1.8	15.6	0.0	3.0	16.3	2.7	4.6	7.0	6.2	6.6	3.0	4.3	5.4	3.7		25.2	4.7	1.1	13.6	3.0		7.8	3.3		2.5	11.7	7.9	16.3	3.0	12.4	3.8	5.0	3.2	6.5			6.1		4.1	5.0	4.0	2.3	0.0	1.7	0.1	0.1	1.3	0.7	0.1	5.3	24.6	9.5	0.0	0.4	4.2	9.3	6.5	8.6	7.7	3.7	5.8	1.5	13.4	12.9	10.3	4.3	11.3	1.3	8.9	4.8	4.3	0.0	8.3	19.6	34.1	11.7	2.8	18.9	18.5	7.2	13.1	5.1	4.1	8.1	1.3	6.5	9.7	11.3	0.0	6.3	0.2	0.0	0.2	4.6	0.1	2.1	13.8	11.3	1.0	9.3	5.0	0.6	10.6	3.1	1.9	10.3	0.8	11.5	0.5	0.2	2.9	3.9	2.8	3.1	0.4	0.7	5.8	1.7	0.0	0.0	0.8	0.0	1.3	2.3	0.3	1.2	0.0	1.3	0.6	0.4	0.0	0.1	0.1	0.0	0.7	0.7											6.0	18.3	0.0	1.1	8.2	7.4	2.0	0.0	54.9	29.6	8.7	5.9	1.8	0.0	5.2	43.7	3.6	2.6	0.0	1.7	1.2	6.2	1.3	20.9	2.9	2.0	6.4	4.7	6.7	5.2	17.6	19.8	4.0	0.0	6.4	4.5	3.0	4.9	3.5	18.0	1.0	4.8	19.4	3.9	12.2	10.4	3.4	1.0	5.0	7.5	0.9
NPIPA2		ENSG00000254852	"Nuclear pore complex interacting protein family member A2"	E9PIF3	16	14748066-14765413	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 11.8"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.5;Club cells: 3.4;granulocytes: 9.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.2;NB-4: 4.1"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"																		1.6	1.2	1.3	1.1	1.5	0.9	1.8	11.8	3.8	0.6	3.2			0.6	1.7	2.7	1.1	2.4	0.8	1.3	1.8	1.5	0.6	0.5	1.6	0.9	1.0		2.6	1.2	2.3	4.1	1.1		2.2	2.6		3.1	1.0	4.2	4.1	1.0	0.8	1.3	0.9	1.6	5.9			1.2		0.8	3.3	1.5	1.6	0.0	0.1	0.1	0.0	0.5	0.0	0.4	0.4	0.3	0.0	0.4	0.3	12.2	1.0	0.5	0.1	0.3	0.4	1.7	0.0	1.1	0.9	0.2	1.4	0.3	0.0	0.1	1.0	0.7	0.8	1.0	0.2	0.4	0.2	2.9	0.1	1.6	1.6	1.2	0.1	0.3	1.6	0.8	0.8	0.2	2.4	1.3	4.1	0.8	0.0	0.5	1.3	0.8	0.2	0.7	0.6	1.1	0.6	0.4	0.7	1.7	1.8	0.0	1.0	0.9	0.4	0.3	0.0	0.5	0.4	0.3	0.3	1.5	0.7	1.0	0.1	0.1	0.0	0.5	0.0	0.3	0.7	0.5	0.1	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0											3.0	4.5	0.0	0.0	2.1	0.0	0.4	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0
NPIPA3		ENSG00000224712	"Nuclear pore complex interacting protein family member A3"	F8WFD2	16	14708944-14726338	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 13.2"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 3.0;Cardiomyocytes: 4.1;Ciliated cells: 4.0"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HSkMC: 5.0;hTERT-RPE1: 7.1;NB-4: 11.2;SK-MEL-30: 16.1"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (1.44e-1)"	"unprognostic (7.83e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.58e-3)"	"unprognostic (4.87e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.71e-2)"	1.3	1.4	1.8	2.3	1.3	1.9	1.2	13.2	5.0	0.8	2.9			0.5	2.4	2.2	1.1	2.8	6.4	1.0	2.2	1.8	1.1	0.8	1.2	1.0	1.1		2.8	1.5	7.2	4.1	1.3		2.3	2.6		1.9	2.9	5.3	3.2	3.4	1.2	1.0	1.0	1.3	1.8			1.4		1.0	1.9	1.6	0.1	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.3	0.0	0.1	1.5	0.5	0.0	0.4	0.4	0.0	2.1	3.5	0.2	1.3	0.8	0.1	0.1	2.3	0.3	0.1	0.0	0.4	0.7	0.4	0.2	0.1	0.5	5.0	0.7	1.3	0.2	7.1	0.1	0.7	0.1	0.3	0.3	1.3	0.0	11.2	0.9	0.0	0.0	0.1	0.0	0.0	3.1	1.0	0.5	0.5	0.0	0.2	16.1	0.7	0.2	0.0	0.5	0.6	0.1	0.0	0.1	0.0	0.2	0.1	1.9	0.1	2.0	1.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	0.3	0.0	0.0	0.5	0.0	4.1	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.2	0.1	0.3	0.0	1.1	0.0	0.1	0.0	1.2	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.6	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.5	0.0
NPIPA5		ENSG00000183793	"Nuclear pore complex interacting protein family member A5"	E9PKD4	16	15363624-15381047	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 25.3"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 13.4;Early spermatids: 15.7;granulocytes: 10.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"THP-1: 15.7"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.19e-4)"	"unprognostic (5.85e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (6.58e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.18e-2)"	"unprognostic (4.02e-2)"	2.0	2.7	4.9	0.8	4.0	3.2	3.3	25.3	6.6	3.2	4.5			2.4	8.0	8.4	4.0	5.8	4.8	4.2	5.5	5.7	1.9	2.5	4.5	2.4	3.6		5.5	4.0	7.6	8.9	1.0		3.3	2.4		1.6	2.5	4.6	13.9	2.1	2.6	2.5	2.7	2.3	8.8			2.9		1.0	2.8	2.5	0.8	0.3	0.1	0.1	1.1	0.7	0.1	0.9	1.4	4.9	0.7	9.3	9.9	0.7	1.9	4.6	6.4	6.6	2.0	0.8	2.1	0.5	4.9	2.0	2.1	1.7	4.9	3.3	3.9	1.9	2.6	5.9	9.8	1.4	0.7	3.7	1.9	8.5	2.5	3.4	2.9	3.4	7.7	2.8	1.5	6.2	1.0	2.1	3.2	6.9	4.0	0.9	0.7	0.7	0.6	5.5	1.9	0.0	0.7	5.5	2.4	6.1	0.6	2.4	15.7	7.8	0.0	2.5	7.6	0.4	4.3	6.0	7.3	0.9	3.8	1.4	0.1	0.1	0.0	0.1	0.0	0.7	0.8	0.4	0.2	0.3	0.4	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.1											0.0	3.0	0.0	0.2	4.2	1.7	2.8	0.0	13.4	3.4	1.8	0.0	0.5	0.0	0.1	15.7	2.1	0.3	0.0	0.2	0.2	7.3	0.3	10.5	1.0	0.3	1.6	0.0	1.3	1.5	2.2	1.4	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	2.7	0.0	5.7	3.9	0.9	4.0	0.2	0.0	0.0	0.1
NPIPA7		ENSG00000214967	"Nuclear pore complex interacting protein family member A7"	E9PJI5	16	16379055-16393954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 3.0;Cardiomyocytes: 13.4;Ciliated cells: 4.0;granulocytes: 5.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"B-cells: 1.7;T-cells: 1.9"	"Cell line enhanced"	"Detected in all"		"HMC-1: 39.4;THP-1: 33.7"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"					"unprognostic (1.17e-2)"													3.6	5.7	3.0	2.8	3.0	3.7	2.9	19.7	4.0	3.2	5.1			3.1	3.7	10.1	5.3	5.5	6.2	1.9	3.8	3.4	4.4	5.9	3.8	5.2	1.7		5.1	8.8	12.4	18.0	3.2		6.1	9.0		6.6	3.2	2.6	13.8	4.2	3.9	1.6	6.3	4.2	6.1			6.8		4.3	4.1	3.3	1.7	0.1	0.2	0.1	0.4	1.9	0.2	3.1	6.9	8.3	3.2	5.0	4.0	5.5	6.5	2.5	7.5	3.9	7.2	5.0	7.9	5.3	6.8	4.6	9.6	5.8	6.7	5.6	2.3	1.7	7.8	21.3	10.5	4.7	2.7	39.4	7.2	26.0	4.1	8.9	9.4	3.8	13.1	4.6	10.2	8.2	13.3	6.3	16.2	5.7	11.4	2.3	9.4	5.6	4.4	12.3	13.4	10.8	5.8	5.2	12.0	5.5	10.7	8.7	33.7	3.3	7.2	3.5	3.2	5.5	2.1	7.7	6.5	4.1	8.7	3.1	0.2	0.1	0.0	1.9	0.0	0.4	1.5	1.2	1.9	0.0	1.7	0.2	0.3	0.0	0.4	0.1	0.1	0.4	0.2											3.0	1.6	0.0	0.0	1.4	0.0	13.4	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0
NPIPA8	LCR16a9	ENSG00000214940	"Nuclear pore complex interacting protein family member A8"	P0DM63	16	18317942-18336736	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1"	"Cell type enhanced"	"Detected in single"	28	"granulocytes: 1.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 18.2;EFO-21: 18.3;HMC-1: 67.5;SCLC-21H: 16.5;THP-1: 18.2"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"					"unprognostic (1.68e-1)"					"unprognostic (3.60e-2)"				"unprognostic (2.81e-1)"				2.6	7.9	2.0	1.3	2.8	3.9	2.3	14.1	10.8	1.4	5.5			0.0	0.6	0.0	0.9	5.1	0.0	2.6	3.4	1.9	1.1	1.0	2.4	1.5	0.5		6.0	1.1	7.6	6.6	4.8		2.3	1.3		1.5	6.5	1.5	4.6	1.7	0.0	0.2	4.4	1.4	2.1			1.6		0.0	3.8	0.5	1.8	0.5	1.7	0.6	0.1	1.1	0.3	0.0	0.7	0.1	0.1	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.1	3.2	18.2	18.3	0.1	0.0	0.0	7.2	2.1	0.0	0.0	0.0	0.0	0.5	0.5	3.0	0.0	67.5	0.1	0.0	0.0	0.0	0.0	1.3	4.4	7.1	0.0	0.0	0.0	0.0	0.0	5.0	7.4	0.0	0.7	11.2	0.5	0.1	0.0	16.5	5.2	0.0	0.1	0.1	3.6	0.0	18.2	0.0	0.3	0.0	0.0	4.1	0.0	0.0	0.0	5.8	5.0	0.4	0.0	0.6	0.0	0.6	0.0	1.1	1.8	0.5	0.2	0.3	0.2	0.7	0.4	1.7	0.1	0.0	0.5	0.0	0.3											0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0
NPIPB11		ENSG00000254206	"Nuclear pore complex interacting protein family member B11"	E5RHQ5	16	29381354-29404029	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 8.9;Early spermatids: 12.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (6.82e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-4)"	"unprognostic (7.41e-2)"	"unprognostic (2.94e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.79e-5)"	2.0	1.0	1.9	3.2	2.5	5.3	1.9	5.9	2.4	1.6	1.8			2.3	2.1	4.2	1.7	2.9	2.1	1.8	2.4	1.9	2.7	3.5	1.9	7.4	1.5		4.4	1.6	0.7	2.3	1.2		2.3	2.0		2.8	0.5	5.1	8.8	3.1	0.9	1.7	5.5	3.2	4.5			2.9		1.0	1.0	1.9	3.1	0.7	1.4	0.5	0.4	1.1	0.2	1.9	1.6	2.9	4.1	2.1	1.7	3.9	1.7	0.8	1.5	0.7	2.1	3.7	12.1	2.8	0.9	0.7	3.3	2.2	2.7	1.6	2.8	3.1	2.6	4.9	3.5	1.1	3.3	6.4	1.0	2.1	1.7	2.3	3.3	0.8	3.2	3.3	3.5	1.4	4.2	2.6	10.3	5.0	1.1	3.5	4.2	1.1	3.7	1.7	1.4	3.7	1.9	0.5	2.6	1.4	9.3	1.4	4.1	3.7	4.0	1.7	2.9	2.4	3.3	2.0	9.9	2.2	4.1	2.9	0.2	0.5	0.1	1.0	0.0	0.2	0.5	0.5	0.8	0.7	3.1	1.1	1.1	1.4	0.4	0.4	0.2	0.0	0.2											8.9	6.4	2.2	0.0	0.0	0.0	1.8	0.0	4.0	4.5	0.0	0.0	0.3	0.0	0.9	12.3	0.6	3.9	0.0	0.7	0.2	0.0	0.1	4.7	0.0	0.3	4.8	6.9	0.0	0.0	4.5	0.3	0.7	0.0	1.0	6.2	0.1	1.5	5.8	0.7	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.3	0.0	4.8	0.0
NPIPB12		ENSG00000169203	"Nuclear pore complex interacting protein family, member B12"		16	29483642-29505999	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 1: 3.0;Club cells: 1.2;granulocytes: 1.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 59.4"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (3.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.28e-7)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.14e-4)"	4.4	2.8	3.2	7.5	4.2	11.3	3.7	10.1	6.3	4.1	5.0			4.4	4.3	7.9	2.9	3.3	4.7	4.3	3.9	3.4	4.7	8.2	5.3	10.8	2.9		5.6	3.8	4.7	5.8	3.5		4.6	4.9		7.8	3.7	8.1	23.7	6.2	3.5	4.0	9.0	4.2	5.3			6.7		5.3	3.1	4.0	9.0	2.2	14.5	3.0	12.6	3.7	0.9	9.3	9.5	7.6	19.8	9.3	5.5	14.4	5.7	1.6	2.9	2.5	8.1	19.5	15.7	10.4	4.6	5.7	12.3	13.0	9.1	3.9	10.1	9.7	11.7	10.9	16.0	8.6	12.6	23.0	8.7	7.2	6.3	6.8	7.4	3.2	8.8	11.7	13.6	4.6	15.5	9.0	59.4	11.8	6.3	6.9	22.0	3.3	15.2	7.0	6.8	8.4	5.8	3.2	14.1	8.2	3.4	6.9	15.9	8.2	19.1	7.2	13.1	10.7	7.5	7.2	15.5	7.8	22.9	8.7	14.5	3.0	1.1	3.7	1.0	0.9	3.4	2.1	2.4	2.0	9.0	2.9	1.9	8.1	12.6	2.3	2.2	1.5	0.9											3.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPIPB13		ENSG00000198064	"Nuclear pore complex interacting protein family, member B13"	A6NJU9	16	30222937-30254510	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 8.8;Ciliated cells: 18.7;Club cells: 13.6;granulocytes: 11.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (7.11e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.58e-2)"	1.8	1.1	1.9	2.3	2.0	6.5	2.3	7.6	3.3	2.3	2.3			1.7	2.4	6.2	2.0	1.9	1.7	1.5	2.4	1.6	1.6	2.3	2.7	4.2	1.5		2.7	1.4	4.8	2.9	1.7		2.8	2.5		2.8	1.7	3.5	9.0	3.3	0.4	1.4	3.9	3.5	1.8			2.8		2.1	1.4	2.2	1.3	0.6	0.8	1.6	1.9	3.2	0.5	3.3	7.8	2.0	6.8	2.0	2.4	3.9	0.6	0.0	0.7	0.3	0.9	4.5	4.7	3.4	1.4	0.7	3.9	4.3	1.9	1.1	2.9	1.7	5.0	8.7	4.1	0.9	6.9	4.4	3.0	2.7	3.0	1.9	1.0	1.3	2.2	2.1	7.2	1.6	7.0	3.0	6.4	2.7	0.7	2.0	6.1	1.0	2.7	2.2	5.5	2.4	2.4	0.9	2.7	1.2	2.9	2.2	1.9	3.4	4.1	3.9	3.6	2.0	2.8	3.2	6.2	3.8	3.0	1.9	0.1	1.6	0.2	3.2	0.4	1.6	0.4	1.3	1.3	0.5	1.3	1.4	0.4	0.8	1.9	1.6	0.6	0.4	0.5											14.9	8.8	0.0	0.0	0.0	0.0	0.0	0.0	18.7	13.6	1.8	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	11.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
NPIPB15	"LOC440348, NPIPL2"	ENSG00000196436	"Nuclear pore complex interacting protein family member B15"	A6NHN6	16	74377878-74392080	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 18.6"	"Group enriched"	"Detected in many"	8	"Early spermatids: 335.7;Late spermatids: 195.5"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	5	"memory B-cell: 4.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"T-47d: 13.5"									"HPA011188, HPA053611"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (2.23e-2)"	"unprognostic (3.48e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.14e-3)"	1.8	1.2	0.8	0.5	1.3	2.9	3.8	4.5	1.5	2.1	6.2			4.1	1.1	0.0	3.0	2.1	2.1	1.1	1.1	0.8	3.1	8.4	2.4	2.6	0.8		1.8	6.1	4.4	5.2	2.7		7.1	11.2		6.1	1.1	3.0	4.1	5.3	1.5	0.9	3.1	4.3	18.6			4.4		2.2	1.4	1.8	4.0	0.2	0.8	0.3	0.6	0.6	0.5	2.8	0.1	2.7	1.6	3.3	2.3	0.6	1.9	2.6	2.1	5.9	1.6	0.1	4.7	0.0	3.7	0.0	5.3	0.0	2.2	1.7	0.0	3.0	0.1	6.2	2.7	1.5	1.9	9.5	3.2	4.8	4.3	3.3	3.2	0.0	0.1	0.4	1.9	1.8	4.3	1.0	0.0	0.6	1.4	0.0	1.0	2.7	3.1	0.0	1.8	3.8	0.0	7.0	0.0	4.5	0.0	13.5	2.2	0.2	2.0	5.6	0.0	1.0	6.5	1.8	1.1	2.7	1.3	1.4	0.0	0.3	0.2	0.6	0.0	0.0	4.0	0.2	0.6	0.2	0.7	0.2	0.0	0.8	0.6	0.1	0.1	0.0	0.5											3.0	5.1	3.7	1.6	1.8	2.8	1.1	7.6	4.0	7.9	7.0	7.9	1.0	0.0	1.2	335.7	2.9	12.4	0.0	3.3	0.9	3.4	5.9	0.0	2.1	1.0	0.0	16.8	3.1	4.0	195.5	10.6	1.2	3.3	1.0	35.4	1.1	2.1	28.1	7.1	0.5	1.7	0.0	2.8	7.2	5.3	2.4	2.1	4.5	15.8	5.5
NPIPB2		ENSG00000234719	"Nuclear pore complex interacting protein family, member B2"	A6NJ64	16	11927373-11976643	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Ciliated cells: 4.0;Collecting duct cells: 1.8;Distal tubular cells: 5.0;granulocytes: 2.3;monocytes: 1.8;Proximal tubular cells: 2.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.5;U-266/70: 22.0"									HPA053611	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (8.80e-2)"	"unprognostic (4.83e-1)"	"unprognostic (5.20e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.89e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.58e-2)"	3.4	3.8	3.8	3.6	5.0	1.8	3.0	4.6	8.2	3.6	2.7	4.9	13.8	3.4	4.9	10.3	1.6	3.3	4.2	2.7	8.2	2.9	4.9	2.3	4.0	4.9	3.0	1.7	4.5	6.6	11.0	3.5	2.4	3.6	3.3	2.9	3.8	6.1	13.2	3.1	6.8	3.9	4.8	3.5	2.7	2.2	17.4	2.4	10.2	6.1	1.8	1.9	2.1	2.8	2.7	2.2	0.7	3.1	3.5	2.7	1.0	0.1	1.4	1.7	1.0	3.7	6.5	2.4	1.9	3.1	0.8	0.4	1.0	1.4	0.9	0.6	1.8	0.3	0.3	1.1	1.4	1.7	0.9	1.5	0.5	1.4	1.5	6.5	0.9	0.4	0.3	3.3	1.8	4.0	0.3	0.2	0.2	0.1	4.2	0.5	2.0	0.2	0.5	0.4	1.1	1.3	1.8	0.1	12.5	0.6	0.8	2.3	0.0	4.3	0.2	0.0	1.7	0.3	2.7	0.4	0.3	0.2	0.4	0.2	22.0	7.1	1.0	2.6	0.3	1.0	0.0	3.1	0.6	1.0	0.2	0.2	2.7	1.7	1.3	2.2	1.6	2.7	0.6	0.7	3.5	0.5	2.2	0.0	1.0	3.8	5.0	4.6	8.2	8.2	2.9	3.0	1.7	3.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.8	0.0	0.6	5.0	0.4	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
NPIPB3	"KIAA0220, NPIPL3"	ENSG00000169246	"Nuclear pore complex interacting protein family member B3"	Q92617	16	21402237-21448567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	10	"Basal keratinocytes: 2.5;Ciliated cells: 2.7;Club cells: 2.3;Melanocytes: 1.7;Suprabasal keratinocytes: 1.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.1"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-5)"	"unprognostic (1.50e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.00e-4)"	7.3	5.0	8.2	8.6	9.8	32.4	8.8	15.5	8.8	6.4	7.6			6.9	5.2	12.4	6.2	6.4	6.8	5.5	9.6	7.2	8.2	9.6	7.9	18.1	6.7		6.7	5.9	4.0	9.5	5.0		9.8	8.2		11.7	5.6	19.7	36.9	9.6	6.1	7.6	14.6	7.1	7.3			9.7		7.9	5.2	6.6	5.3	9.0	6.5	3.6	3.4	5.7	0.4	13.7	12.5	8.6	14.9	11.5	6.6	25.5	9.5	3.4	5.1	5.7	19.3	17.0	20.0	9.6	13.0	6.2	15.7	5.6	14.1	4.7	11.2	7.9	8.8	17.2	54.1	10.4	16.0	16.9	3.5	6.1	12.2	15.6	7.3	6.7	18.2	15.9	26.6	6.9	24.7	16.9	39.2	15.8	7.5	14.7	26.9	8.9	11.8	10.2	8.0	10.9	8.3	5.5	13.1	10.0	16.4	12.9	7.8	11.0	24.2	13.3	2.3	13.8	14.1	9.9	18.1	9.6	14.1	12.7	6.5	3.6	2.6	5.7	2.7	2.3	4.4	3.0	2.9	2.2	5.3	3.9	2.6	3.9	3.4	2.0	9.0	2.0	0.4											0.0	0.0	0.0	0.4	2.5	0.0	0.8	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.1
NPIPB4		ENSG00000185864	"Nuclear pore complex interacting protein family member B4"	C9JG80	16	21834569-21880827	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skin 1: 31.2"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 92.2"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (3.09e-3)"	"unprognostic (3.51e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.04e-8)"	"unprognostic (3.37e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.46e-3)"	5.5	3.7	4.4	7.0	4.6	23.5	6.1	10.4	5.4	5.1	6.5			4.5	5.4	22.4	4.5	5.7	4.9	4.2	5.0	4.0	5.4	6.6	6.0	10.7	3.8		5.9	5.3	3.3	5.4	3.8		6.6	8.2		5.5	3.2	7.1	31.2	8.6	3.5	4.4	10.1	7.3	4.3			7.9		7.5	4.1	5.4	6.3	3.7	4.7	2.5	5.2	2.3	0.3	7.1	9.7	9.3	7.3	6.7	9.7	15.7	8.8	2.7	3.0	4.9	20.6	10.2	13.8	6.8	7.6	2.8	8.2	5.2	7.4	6.0	5.6	4.7	5.5	24.8	27.2	4.5	22.6	14.6	7.2	9.2	8.0	13.3	6.1	6.5	11.3	11.8	12.2	4.5	20.9	8.5	14.2	11.3	2.3	5.4	13.0	5.6	8.0	3.4	7.1	9.4	5.7	5.9	6.8	4.8	9.3	9.0	6.8	14.2	16.0	8.0	7.6	7.6	6.3	5.8	14.7	5.0	10.8	7.4	4.7	2.5	0.7	1.8	1.0	1.3	2.2	2.3	1.1	0.4	6.3	1.8	1.9	3.0	5.2	1.2	3.7	0.6	0.3											3.0	12.6	2.0	1.0	6.8	4.7	1.5	0.0	6.7	10.3	0.0	3.9	0.4	0.0	0.9	92.2	4.2	1.1	0.0	0.5	0.2	5.9	0.4	10.4	1.0	0.6	1.6	1.2	1.8	0.8	13.6	0.3	3.0	0.0	2.8	1.1	1.9	1.2	2.3	0.4	0.0	7.1	0.0	2.9	1.6	0.5	7.3	0.7	2.2	1.7	0.5
NPIPB5		ENSG00000243716	"Nuclear pore complex interacting protein family member B5"	A8MRT5	16	22479121-22536521	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 44.9;Ciliated cells: 54.9;Club cells: 89.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (7.52e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.43e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.90e-10)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.76e-5)"	10.8	7.0	13.4	34.7	12.0	30.6	10.4	18.3	13.4	9.6	10.8	9.6	12.5	7.7	8.6	33.3	7.2	8.4	6.6	8.4	24.1	6.1	8.7	6.1	13.6	19.3	17.5	16.7	9.9	10.1	6.4	8.7	7.2	13.7	10.5	12.1	14.6	12.2	22.9	17.8	54.2	17.1	6.8	9.7	16.3	8.9	10.6	11.8	7.0	14.4	6.8	14.2	8.0	10.0	11.7	7.0	8.3	3.5	4.4	5.9	1.3	10.9	9.6	6.1	7.8	10.4	9.8	14.5	6.7	2.4	4.2	5.3	13.5	18.5	15.1	12.5	8.9	4.0	9.8	14.2	9.6	7.5	18.6	5.2	5.8	25.2	26.0	10.1	31.6	9.8	11.9	7.3	10.3	19.0	7.7	7.4	17.5	16.1	24.6	5.1	18.6	14.0	42.3	17.0	2.0	4.1	15.3	4.4	18.0	7.6	6.4	6.8	5.7	8.3	11.7	5.6	15.1	6.9	10.9	25.2	13.5	6.1	11.2	11.3	13.6	6.4	19.7	5.6	23.0	6.0	6.7	3.5	2.7	5.5	1.7	2.3	8.6	5.2	3.7	2.0	11.7	5.9	4.9	8.3	4.4	3.2	7.0	2.4	1.3	13.4	12.0	18.3	13.4	24.1	6.1	17.5	16.7	13.7	11.8	26.8	44.9	3.7	11.4	12.8	13.0	28.7	2.5	54.9	89.9	5.2	9.8	3.6	0.0	3.1	4.7	11.9	2.6	0.0	1.2	2.3	8.9	9.1	9.3	1.6	3.7	6.4	1.2	6.7	4.6	1.8	9.5	11.0	5.0	9.0	3.0	5.0	4.0	4.9	6.0	0.7	24.7	0.0	17.6	3.0	2.6	10.0	4.9	11.4	3.9	9.2
NPIPB6		ENSG00000198156	"Nuclear pore complex interacting protein family member B6"	E9PJ23	16	28342555-28363508	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"testis: 26.8"	"Group enriched"	"Detected in some"	15	"Early spermatids: 188.9;Late spermatids: 89.0"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	4	"memory B-cell: 3.1;naive B-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"B-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A549: 6.0;BEWO: 5.6;hTCEpi: 5.8;NB-4: 5.8;RPMI-8226: 6.0"									"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (1.99e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-3)"	0.2	0.0	0.9	0.3	1.4	0.5	0.6	1.8	0.9	0.4	0.5			0.3	0.7	1.0	0.1	0.9	0.1	0.1	1.1	0.7	0.1	0.1	0.2	0.4	0.7		1.2	0.2	0.4	0.9	0.2		0.7	0.6		0.2	0.5	0.6	1.8	0.3	0.4	0.9	0.6	0.6	26.8			0.6		0.2	0.2	0.3	3.1	0.1	0.1	0.0	0.1	0.6	0.5	0.2	6.0	2.9	0.6	1.4	0.3	5.6	0.3	0.5	0.1	0.5	0.2	2.4	1.9	0.5	0.2	0.6	0.7	0.3	0.5	0.3	1.3	0.5	1.4	1.1	0.0	0.0	1.7	0.4	1.0	5.8	0.4	1.3	1.0	0.1	3.2	0.2	4.8	0.0	1.4	0.5	5.8	1.6	0.5	0.3	3.1	2.5	6.0	0.1	0.1	0.7	1.3	0.2	0.3	0.6	3.4	1.2	0.4	0.6	0.7	2.3	0.5	0.4	2.2	2.3	0.7	0.2	0.9	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.1	0.6	0.5	0.0	1.8	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.5											0.0	0.6	0.0	0.2	0.5	0.3	0.4	0.0	9.4	1.2	0.0	0.0	0.5	0.0	0.0	188.9	0.1	0.2	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.0	89.0	1.1	0.1	0.0	0.0	0.1	1.0	0.1	0.3	1.8	0.0	0.1	0.0	0.0	4.4	1.1	1.1	1.1	0.0	0.5	0.4
NPIPB7	"LOC440350, NPIPL1"	ENSG00000233232	"Nuclear pore complex interacting protein family member B7"	O75200	16	28456372-28471175	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 14.9"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 117.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.2;hTCEpi: 2.5;U-266/70: 1.6"									"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-1)"		"unprognostic (7.43e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.03e-2)"	0.0	0.0	0.5	0.2	0.9	0.1	0.1	2.3	0.5	0.1	0.3			0.3	0.3	0.3	0.0	0.2	0.1	0.1	0.5	0.8	0.0	0.0	0.2	0.4	0.3		0.5	0.4	0.0	0.0	0.0		0.1	0.5		0.0	0.1	0.0	0.8	0.2	0.1	0.2	0.1	0.1	14.9			0.4		0.1	0.1	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	6.2	0.0	0.2	0.0	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.5	0.4	0.2	0.1	0.0	1.2	0.0	0.1	0.0	0.9	0.1	1.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.4	0.1	0.0	1.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	117.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0
NPIPB8		ENSG00000255524	"Nuclear pore complex interacting protein family member B8"	E9PQR5	16	28637654-28658682	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 14.4"	"Group enriched"	"Detected in some"	12	"Early spermatids: 12.1;Late spermatids: 21.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"hTCEpi: 22.2"									"HPA011188, HPA053611"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (8.28e-2)"				"unprognostic (1.88e-1)"			"unprognostic (1.10e-1)"		"unprognostic (5.78e-2)"			"unprognostic (1.05e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"			0.4	0.7	0.0	0.6	0.3	0.5	0.5	1.6	0.4	0.3	0.9			2.2	0.6	0.7	0.5	0.3	0.1	0.1	0.1	0.0	0.3	1.1	0.6	0.3	0.1		1.1	1.1	0.1	1.3	0.2		1.1	0.4		1.3	0.4	0.9	0.7	2.2	0.2	0.1	0.6	0.7	14.4			1.0		0.4	0.5	0.6	0.6	0.3	0.1	0.1	0.5	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.6	0.3	22.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.1	0.3	0.4	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.5	0.0	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPIPB9		ENSG00000196993	"Nuclear pore complex interacting protein family member B9"	F8W1W9	16	28751787-28772807	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"testis: 13.6"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 5.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 8.0;U-266/70: 6.7"									"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (7.38e-2)"	"unprognostic (6.63e-4)"		"unprognostic (6.63e-2)"	"unprognostic (5.05e-2)"			"unprognostic (5.53e-2)"		"unprognostic (4.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.36e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.71e-2)"	0.6	0.3	1.7	0.9	1.8	1.6	0.4	2.7	1.4	0.4	1.0			0.0	1.1	2.4	0.4	1.5	0.6	0.2	2.2	1.3	0.4	0.4	0.4	1.5	1.7		1.4	0.2	0.5	1.4	0.4		1.2	0.8		0.9	0.9	1.1	2.8	0.8	0.8	2.2	1.1	0.5	13.6			1.7		1.0	0.3	0.7	3.1	0.1	0.5	0.2	1.8	0.7	0.3	0.4	4.0	1.1	0.6	0.5	1.3	3.3	0.0	0.1	0.0	0.0	0.4	2.1	1.6	1.1	0.0	0.5	0.4	0.7	0.2	0.1	0.4	1.9	0.7	0.0	0.8	0.1	2.5	2.7	0.2	8.0	0.6	1.5	0.8	0.0	2.9	0.4	2.5	0.2	3.0	0.9	3.3	1.6	0.2	0.9	3.3	0.0	1.6	0.0	0.4	0.1	0.0	0.2	0.4	0.2	2.2	2.2	1.1	0.0	0.0	2.8	1.9	0.6	6.7	2.9	2.0	0.1	0.9	0.5	0.0	0.2	0.0	0.7	0.0	0.2	3.1	0.4	0.1	0.1	1.2	0.3	0.1	0.5	1.8	0.2	0.0	0.3	0.3											0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	5.3	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0
NPL	"C1orf13, DHDPS1, NPL1"	ENSG00000135838	"N-acetylneuraminate pyruvate lyase"	Q9BXD5	1	182789293-182830384	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.0"	"Cell type enhanced"	"Detected in many"	18	"Cytotrophoblasts: 103.5;Hofbauer cells: 387.9;Ito cells: 109.2;Kupffer cells: 121.2;Syncytiotrophoblasts: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.0"	"Group enriched"	"Detected in many"	36	"granulocytes: 76.0;monocytes: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028345, HPA075808"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		190000	Vesicles	"Plasma membrane"	"HPA028345: AB_10610145, HPA075808: "	"unprognostic (2.43e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (4.41e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.44e-2)"	14.9	6.8	10.9	14.2	12.3	12.4	5.3	3.5	10.2	3.9	5.3	15.0	11.4	2.4	2.5	23.7	8.0	4.1	10.1	4.7	9.2	8.7	37.4	15.4	14.3	20.4	16.0	8.6	2.8	3.2	2.5	2.5	32.9	15.4	4.4	7.4	3.9	5.7	5.8	2.4	6.5	4.8	5.8	15.3	32.1	4.0	4.0	14.4	3.1	3.4	1.3	10.9	11.8	5.5	0.7	1.3	76.0	23.6	0.0	1.3	10.3	2.7	0.5	0.8	0.0	2.4	2.4	0.7	0.9	1.8	1.0	0.5	0.0	1.2	7.3	1.3	0.0	0.0	1.1	1.6	2.0	0.2	0.0	1.2	11.6	0.3	0.1	1.3	4.4	7.0	1.9	7.8	0.2	0.0	0.1	0.1	8.5	8.7	11.7	1.8	0.9	0.2	2.9	9.3	5.7	0.9	1.1	0.6	8.9	0.2	6.1	2.6	3.9	4.2	0.2	3.7	0.9	2.4	7.1	0.2	1.0	2.0	0.6	0.1	8.4	10.1	7.4	2.1	7.8	3.0	3.6	23.6	18.0	1.0	20.8	0.9	0.3	0.8	0.9	1.3	0.7	0.7	0.9	76.0	0.0	16.0	0.2	1.3	10.3	10.9	12.3	3.5	10.2	9.2	8.7	16.0	8.6	15.4	14.4	0.0	5.6	9.1	4.0	5.5	5.1	2.5	2.5	0.0	1.2	7.0	2.0	103.5	16.6	1.0	14.0	2.1	1.3	23.3	2.1	6.6	3.3	1.2	5.7	2.4	387.9	6.4	1.7	109.2	121.2	20.9	0.9	25.3	10.1	21.6	1.1	2.4	1.4	0.0	0.4	55.2	2.4	0.0	2.9	8.6	8.3	6.1	89.7	3.5	0.8	3.9
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	21.7	23.0	15.3	18.7	16.1	22.0	15.4	14.7	24.1	13.2	15.9	18.6	14.2	14.7	18.9	16.3	25.1	14.7	14.4	35.4	16.2	13.5	20.2	28.2	18.4	18.3	16.4	15.5	13.9	18.2	17.8	17.1	25.6	17.2	16.7	13.3	21.0	16.4	14.9	89.8	24.2	16.4	19.4	14.9	22.0	17.6	31.0	13.4	19.7	14.7	17.1	20.6	15.7	16.6	4.6	5.9	5.7	18.1	2.5	4.6	7.8	29.0	38.3	15.3	23.8	18.9	15.7	19.0	24.1	26.9	40.1	37.2	29.0	26.3	21.6	19.4	28.1	29.4	23.6	15.0	20.2	34.9	13.5	19.8	25.0	31.0	25.7	18.1	26.3	31.9	15.5	19.6	37.4	13.4	19.4	40.9	20.2	26.3	32.9	24.2	18.8	35.4	14.3	17.9	14.5	24.2	23.4	24.6	17.6	14.4	28.1	20.5	23.7	30.3	42.3	27.3	30.5	33.1	19.4	29.2	52.7	36.6	28.6	38.6	25.1	17.7	26.6	42.0	17.7	33.8	3.0	18.1	3.9	4.6	4.6	2.8	4.6	3.2	3.6	5.9	3.7	2.9	3.8	5.7	2.5	2.8	4.6	3.0	7.8	15.3	16.1	14.7	24.1	16.2	13.5	16.4	15.5	17.2	13.4	11.9	17.8	16.0	14.4	15.7	22.7	39.6	12.7	8.1	18.2	19.2	27.5	16.5	1.7	17.6	91.1	20.1	26.2	46.7	32.2	17.3	15.5	19.7	3.5	46.4	16.9	19.1	29.2	29.4	24.0	71.7	16.4	19.3	11.8	19.8	15.0	18.4	36.6	20.1	12.0	20.4	35.3	19.4	16.4	22.3	23.3	21.1	31.0	15.0	15.3	23.7
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 28.1;Cone photoreceptor cells: 19.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.1;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.3;HEL: 10.7;Hep G2: 23.7;JURKAT: 7.2;THP-1: 8.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.8	15.6	14.4	0.5	11.4	1.3	2.3	20.4	27.6	1.9	1.4	0.8	0.3	2.4	4.9	1.3	1.4	2.8	2.2	1.5	13.0	13.8	2.9	1.3	2.0	1.0	14.9	15.7	0.8	7.4	40.2	7.8	0.9	7.2	4.7	1.4	3.7	3.1	1.8	0.8	2.0	1.4	4.0	3.0	7.5	2.0	3.1	2.4	0.1	23.2	0.0	0.8	1.4	0.8	0.4	0.0	4.1	0.0	0.0	2.2	0.1	2.9	0.4	0.1	0.2	0.7	0.0	1.2	0.3	0.4	1.9	3.8	1.2	2.8	0.0	0.9	0.0	0.2	13.3	0.3	0.0	1.1	0.1	0.3	10.7	0.7	23.7	2.4	1.4	1.0	0.4	1.8	0.0	0.2	2.9	0.0	7.2	0.3	0.0	0.1	0.0	0.1	2.8	0.6	4.7	0.3	0.2	1.0	0.6	4.4	0.0	2.9	0.2	0.0	0.0	3.5	0.0	0.5	8.4	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	0.0	2.2	0.0	0.9	2.1	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	1.4	0.1	14.4	11.4	20.4	27.6	13.0	13.8	14.9	15.7	7.2	2.4	0.0	1.4	0.5	8.2	0.1	28.1	2.0	2.5	9.4	11.4	0.0	19.6	0.1	3.3	6.3	15.2	0.3	0.4	0.0	7.0	0.2	0.4	3.3	0.0	0.4	3.5	6.4	10.9	2.5	0.0	10.4	0.6	1.2	10.1	1.8	1.5	0.9	5.4	0.0	0.4	9.8	3.9	0.0	1.4	0.5	0.3	1.0	0.2	4.3	0.6	5.8
NPM3		ENSG00000107833	"Nucleophosmin/nucleoplasmin 3"	O75607	10	101781325-101783413	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036295, HPA036296"	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Nucleoli, Actin filaments, Cytosol"		"HPA036295: AB_10671244, HPA036296: AB_10672083"	"unprognostic (3.41e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.58e-2)"	9.8	17.0	14.3	20.9	8.5	17.2	14.3	1.5	16.8	13.3	12.3	2.4	6.2	6.0	15.7	15.0	22.7	11.7	12.4	8.9	9.9	7.3	13.6	13.7	8.8	26.3	7.3	11.4	17.7	39.0	11.3	11.1	12.0	9.1	11.5	15.1	3.7	13.2	7.1	11.7	14.0	8.7	15.0	4.8	14.7	11.0	16.4	7.7	18.5	9.8	23.7	18.8	13.0	13.9	4.5	8.3	0.1	3.7	7.0	10.4	5.7	17.3	22.1	6.6	43.2	15.1	15.9	6.9	9.4	14.4	14.7	12.5	23.6	22.2	28.8	17.6	10.5	8.0	18.7	36.6	40.0	11.6	12.2	38.0	23.1	10.3	37.9	17.0	52.5	16.9	13.7	19.4	20.3	81.4	7.6	19.2	35.5	28.5	16.0	12.0	32.1	21.9	68.4	11.6	24.3	17.0	17.2	34.6	29.2	14.3	8.6	13.5	8.7	5.9	13.8	26.3	8.4	18.0	10.9	7.5	5.8	18.6	8.6	17.4	6.9	7.1	33.1	8.1	48.9	6.0	0.0	2.7	0.0	3.8	3.7	7.0	4.3	6.3	7.2	6.3	4.5	10.4	10.4	0.1	7.0	0.8	8.3	2.6	5.7	14.3	8.5	1.5	16.8	9.9	7.3	7.3	11.4	9.1	7.7	3.0	5.3	14.5	57.6	55.6	1.3	2.9	20.4	4.0	9.1	34.9	0.0	79.7	66.3	48.2	5.3	26.4	2.6	0.0	35.4	70.4	52.3	31.9	16.1	16.1	61.3	0.0	23.3	13.5	17.1	8.8	25.9	36.7	28.7	12.6	30.0	2.2	35.2	3.5	22.3	41.9	1.9	6.5	31.6	40.9	83.0	43.5	50.8	26.6	45.2	53.9
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 125.3"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	5.4	1.6	3.4	2.4	4.4	0.0	8.3	0.7	2.5	13.3	11.0	1.9	4.2	16.4	8.7	11.4	5.7	5.9	19.0	2.5	2.5	2.7	22.7	1.3	34.9	0.9	7.5	2.4	4.1	11.6	0.0	14.6	3.0	2.2	26.3	7.6	16.9	2.8	5.7	2.6	2.1	37.7	4.0	0.9	4.4	4.0	3.0	2.8	3.4	125.3	3.7	2.3	3.7	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	15.2	0.1	0.0	0.0	0.0	7.6	9.9	0.1	0.4	0.1	0.0	0.9	3.8	0.0	0.0	0.0	3.9	0.4	17.2	13.7	0.0	0.0	0.1	1.7	1.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	12.2	0.2	0.7	0.1	0.0	6.2	0.0	0.0	0.1	20.0	0.8	0.9	0.3	0.9	7.4	0.0	2.3	26.8	0.6	0.0	0.3	0.2	0.2	0.6	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	0.7	2.5	2.5	2.7	7.5	2.4	2.2	2.8	172.7	69.4	0.0	4.6	1.6	0.2	2.0	33.1	10.7	97.8	31.4	0.0	2.2	1.7	19.0	11.6	8.0	8.0	0.0	2.1	0.1	0.9	29.6	0.0	0.0	0.3	0.0	15.0	3.1	0.0	11.8	2.3	1.3	5.0	0.0	9.2	0.0	6.3	3.1	0.0	3.0	0.1	0.0	33.5	0.5	1.5	1.0	1.3	0.0	6.9	2.8
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678637-153693992	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 98.4"	"Cell type enriched"	"Detected in many"	10	"Ito cells: 136.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 39.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 60.5"	"Region enriched"	"Detected in many"	5	"olfactory region: 23.0"	"Region enhanced"	"Detected in single"		"olfactory region: 11.1"	HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25.0	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0.0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2.0	2.0	9.0	6.9	3.4	4.6	15.6	2.2	1.2	5.0	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	60.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.0	0.0	7.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0.0	2.5	0.2	0.0	5.8	0.0	0.4	1.3	0.0	4.8	5.1	0.0	0.0	14.0	0.0	0.1	0.0	0.6	8.0	14.2	0.0	0.0	0.0	0.9	3.9	0.4	0.0	1.5	0.2	0.0	0.0	136.2	6.0	7.9	9.5	0.0	0.0	9.0	0.0	0.0	0.7	0.0	3.9	2.8	0.0	0.0	0.9	0.2	0.1	0.9	0.6	0.0	0.0	0.0
NPR3	"ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC"	ENSG00000113389	"Natriuretic peptide receptor 3"	P17342	5	32689070-32791724	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.2"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 44.7;Proximal tubular cells: 133.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 19.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 17.3;fHDF/TERT166: 10.5;HeLa: 37.5;HSkMC: 24.4;U-138 MG: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052702	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA052702: AB_2681922"	"unprognostic (8.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.46e-3)"	"prognostic favorable (5.43e-6)"	"unprognostic (6.00e-4)"	"unprognostic (5.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.38e-2)"	26.9	3.5	0.4	0.4	1.5	1.9	2.7	0.2	0.8	4.5	5.3	0.3	1.4	0.3	4.2	3.3	6.8	2.5	3.9	16.4	0.4	0.5	54.2	7.6	24.2	0.5	0.2	0.8	1.9	0.7	0.3	0.7	5.3	3.1	8.8	0.5	7.3	1.2	18.1	9.5	3.7	1.4	1.8	0.3	4.5	1.0	1.5	0.0	1.1	11.0	13.4	1.4	5.5	4.5	1.4	0.9	7.3	0.6	1.1	1.1	0.2	0.1	1.9	0.1	0.2	1.1	17.3	0.0	4.6	0.9	0.2	0.2	0.0	0.1	0.0	0.1	10.5	0.3	0.0	2.3	0.0	0.5	0.0	0.0	0.2	37.5	0.0	3.4	0.0	0.1	24.4	0.3	1.2	3.3	1.1	0.1	0.0	0.0	0.3	1.5	0.3	0.0	0.2	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	6.3	0.0	0.1	0.1	0.0	0.1	10.3	0.1	0.8	0.1	0.1	0.0	0.0	1.7	0.0	0.1	0.3	0.6	0.4	0.8	0.3	0.5	0.9	0.7	0.5	0.0	1.4	0.9	1.1	7.3	1.1	0.1	0.9	0.4	0.2	0.4	1.5	0.2	0.8	0.4	0.5	0.2	0.8	3.1	0.0	14.9	8.2	0.9	0.0	4.7	3.3	20.6	0.0	6.7	2.3	8.7	0.0	0.0	44.7	0.0	1.1	3.3	0.0	0.0	0.0	0.1	1.5	2.5	3.5	1.5	0.1	3.2	0.0	4.9	0.0	2.2	10.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	12.0	133.6	1.2	6.5	2.7	0.1	0.9	1.1	0.1	0.0	0.0	0.1
NPRL3	"C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11"	ENSG00000103148	"NPR3 like, GATOR1 complex subunit"	Q12980	16	84271-138860	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011741	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA011741: AB_1845577"	"unprognostic (1.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.50e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	11.0	16.8	17.1	10.0	17.1	16.5	9.6	20.5	18.9	11.4	7.4	11.8	9.2	6.9	12.3	6.8	10.0	15.1	6.7	9.8	15.9	6.8	8.4	10.3	8.1	7.9	12.6	20.2	16.1	11.9	21.7	14.9	6.8	13.0	7.5	5.9	8.6	11.3	9.8	22.6	8.2	8.3	8.9	10.4	9.5	9.4	15.7	13.7	5.7	13.2	6.5	7.6	12.5	9.1	4.8	5.5	1.4	5.5	3.4	6.5	3.2	7.0	14.5	6.9	14.0	19.2	10.3	10.9	7.6	9.7	12.6	9.5	22.4	13.0	14.2	12.1	14.2	6.5	7.9	11.8	17.0	7.5	13.7	7.5	19.8	7.9	16.8	18.9	8.1	10.8	12.5	13.2	16.4	14.9	7.5	11.7	10.9	20.3	13.3	11.3	24.5	8.4	4.6	5.0	5.0	9.9	13.2	5.6	20.2	12.2	6.4	15.1	8.1	11.8	13.9	6.7	3.7	11.1	3.6	9.1	15.9	9.0	9.6	6.2	14.8	7.5	19.8	0.5	8.2	7.2	0.1	4.1	1.4	6.0	3.6	6.5	4.2	4.9	4.9	5.3	4.8	5.6	6.4	1.2	3.4	5.5	5.5	5.1	3.2	17.1	17.1	20.5	18.9	15.9	6.8	12.6	20.2	13.0	13.7	11.9	9.4	19.1	15.2	8.4	58.2	7.6	2.5	8.1	5.7	10.4	62.8	19.7	19.9	13.2	26.4	10.8	6.6	93.5	7.9	28.0	13.0	11.6	3.5	9.6	17.4	52.4	9.2	12.3	13.2	60.2	21.0	9.3	11.8	19.0	10.2	23.2	10.7	3.5	18.4	17.0	53.4	6.5	14.6	43.6	33.7	4.8	12.8	16.6	12.8	9.0
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		21000	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	20.8	24.9	49.0	17.8	72.9	6.9	22.5	55.3	84.5	30.3	36.2	11.9	28.1	33.2	52.3	39.9	34.2	35.2	30.5	48.4	43.6	38.3	32.7	18.2	27.2	15.9	30.3	47.8	21.0	23.8	35.9	18.3	30.3	40.0	45.3	36.6	22.7	25.9	54.9	12.1	19.5	39.8	75.3	16.8	16.7	27.1	18.8	20.4	6.3	28.7	18.5	16.6	32.7	25.9	3.0	3.9	19.7	13.3	2.5	4.9	7.3	17.5	31.5	18.2	13.3	37.2	33.6	25.5	40.5	66.5	46.8	41.7	21.4	56.4	10.2	24.2	58.1	58.0	72.9	29.2	33.7	27.0	18.2	19.4	8.1	16.1	19.0	26.4	12.4	22.6	27.4	29.9	30.2	18.3	46.4	24.8	9.2	4.5	11.7	33.4	14.0	5.5	7.6	16.7	22.2	11.3	8.9	20.8	8.6	63.7	26.0	11.1	3.4	39.2	21.9	26.0	47.4	19.8	16.9	27.9	36.4	24.5	20.8	23.5	10.2	19.0	8.8	33.8	19.3	24.8	3.6	10.0	9.5	4.9	13.3	4.0	3.0	2.8	4.4	3.7	2.3	2.9	3.3	19.7	2.5	9.6	3.9	3.0	7.3	49.0	72.9	55.3	84.5	43.6	38.3	30.3	47.8	40.0	20.4	71.5	54.8	7.7	22.7	57.8	76.4	87.0	58.6	87.0	66.0	78.5	47.1	5.7	1.7	17.0	2.8	30.7	78.3	0.0	20.5	7.9	45.4	26.3	26.7	38.2	22.1	36.5	98.8	47.9	71.6	6.6	14.1	37.1	40.5	12.6	77.6	35.4	30.5	49.9	36.0	16.8	47.1	19.4	36.0	8.2	10.4	47.7	5.7	12.5	39.9	25.1
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617297-98629868	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7"	"Group enriched"	"Detected in many"	6	"Peritubular cells: 306.6;Sertoli cells: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 128.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	NA	NA	2490000	320000	"Golgi apparatus, Actin filaments"	Centrosome	"CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621"	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	4.3	24.0	7.1	2.3	8.4	1.0	1.4	0.2	45.6	8.2	3.8	3.2	0.1	1.1	1.8	3.9	2.2	1.5	1.6	3.2	9.2	11.0	0.9	0.9	0.8	0.7	9.4	2.2	1.5	19.5	0.8	71.6	0.8	7.0	2.1	1.4	1.3	1.5	2.2	2.9	4.0	1.3	2.9	2.9	6.1	1.9	20.7	5.0	0.0	1.6	0.1	0.9	1.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	6.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	7.1	8.4	0.2	24.6	9.2	11.0	9.4	2.2	7.0	5.0	0.0	1.1	0.0	0.4	3.4	17.7	2.8	5.1	0.0	2.3	0.0	3.9	0.0	0.0	5.8	9.7	2.9	2.4	0.0	11.0	0.2	6.2	3.2	0.0	0.2	0.4	0.0	15.3	6.2	0.0	19.9	13.0	0.0	11.8	0.0	0.0	0.8	4.7	0.0	306.6	0.0	2.4	148.8	3.8	14.0	40.1	2.6	0.1	0.0	0.4	0.5
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38843982	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 73.6"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"GAMG: 11.4;SCLC-21H: 15.0;SiHa: 11.2;U-87 MG: 43.1"					"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		280000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.3	3.8	39.1	1.8	17.5	0.8	1.9	16.2	73.6	5.8	2.6	4.3	0.5	1.5	5.6	3.3	2.7	6.1	2.0	10.5	57.4	15.2	1.3	0.8	1.7	1.6	5.6	20.7	6.2	3.6	5.9	2.0	0.9	4.5	6.2	1.7	1.0	3.2	5.6	0.9	1.2	1.4	5.7	3.3	2.1	2.0	1.6	4.0	0.0	2.5	0.0	1.6	2.5	1.9	0.3	0.2	0.6	0.2	0.6	2.3	0.4	0.4	2.9	0.1	0.8	6.0	0.6	0.0	1.9	0.4	3.8	1.3	2.9	0.6	0.0	3.5	0.5	11.4	0.4	0.8	0.1	1.3	0.2	1.0	0.0	0.1	4.5	0.6	0.0	0.1	1.9	0.1	3.5	0.0	5.6	0.1	0.0	3.6	0.1	0.1	4.5	0.0	0.2	3.5	1.4	1.0	0.7	0.0	7.0	1.0	8.1	15.0	0.9	11.2	0.0	0.3	0.8	4.8	1.1	0.2	6.9	4.2	0.0	0.3	1.0	0.0	0.0	43.1	8.7	3.5	0.5	0.2	0.1	1.8	0.0	1.3	0.1	1.0	2.3	0.0	0.3	1.5	1.2	0.6	0.6	0.1	0.2	0.0	0.4	39.1	17.5	16.2	49.0	57.4	15.2	5.6	20.7	4.5	4.0	0.0	0.0	0.0	1.9	1.0	5.4	14.2	5.1	2.7	3.4	3.5	2.0	0.0	0.0	5.7	1.6	4.2	0.0	0.0	3.3	0.0	0.8	4.6	0.0	0.2	0.2	0.0	1.7	5.5	0.3	0.4	1.7	0.3	1.7	0.0	0.0	6.5	3.1	0.0	2.1	0.5	3.1	0.0	2.6	0.0	0.8	0.9	0.0	0.0	0.0	3.3
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3028869	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	14	"monocytes: 212.8;Proximal tubular cells: 716.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6500000	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	24.7	45.6	18.2	11.0	17.6	27.2	21.9	44.3	28.1	12.9	11.5	8.9	8.8	15.6	10.4	15.4	12.1	11.2	12.8	38.2	16.0	13.3	82.9	47.0	11.7	17.5	17.0	23.5	13.5	18.4	12.1	9.3	12.1	24.5	12.7	9.0	18.0	24.5	13.5	41.3	20.2	15.5	10.7	11.8	15.3	12.8	7.7	12.5	7.0	11.9	13.9	7.9	10.4	11.0	3.2	16.6	62.1	25.2	7.3	9.3	13.1	12.7	21.6	13.2	29.0	23.3	13.8	14.2	12.4	15.9	11.5	12.9	22.7	4.9	11.2	45.3	21.3	26.9	9.8	13.5	8.6	9.0	26.1	11.5	6.9	26.5	22.7	19.0	6.9	22.1	8.5	10.3	13.9	13.0	16.5	11.1	14.6	39.2	6.7	9.5	28.4	7.9	12.8	17.9	26.9	18.0	14.7	15.7	32.7	17.3	6.8	2.8	5.1	18.8	8.0	39.4	24.7	11.0	4.8	19.1	10.8	4.2	14.4	5.4	14.6	33.1	3.4	12.7	21.0	21.3	5.6	25.2	13.5	9.2	15.7	6.6	3.2	8.3	8.3	16.6	2.1	5.0	5.7	62.1	7.3	13.9	1.7	9.3	13.1	18.2	17.6	44.3	28.1	16.0	13.3	17.0	23.5	24.5	12.5	8.9	17.3	8.1	35.0	31.3	32.4	60.5	50.9	22.7	10.3	24.4	9.8	36.3	137.6	19.8	39.2	32.9	25.6	23.3	55.3	41.3	45.4	32.3	12.8	167.7	66.5	39.7	4.6	20.3	34.6	38.3	33.1	71.3	64.1	212.8	19.0	47.3	40.8	17.3	38.5	716.7	18.8	25.8	46.2	7.0	10.1	36.0	26.1	17.3	20.9	42.3
NR1D2	"BD73, EAR-1r, Hs.37288, HZF2, RVR"	ENSG00000174738	"Nuclear receptor subfamily 1 group D member 2"	Q14995	3	23945260-23980618	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053868, HPA054798"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053868: AB_2682284, HPA054798: AB_2616453"	"unprognostic (8.64e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.47e-7)"	"unprognostic (2.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	15.2	12.5	15.2	7.9	17.1	9.5	15.9	40.9	31.9	21.1	13.3	14.0	20.9	10.0	19.0	11.0	12.2	13.3	11.0	22.5	15.0	13.4	16.8	22.1	10.6	9.6	14.4	16.1	24.3	12.7	41.6	15.8	10.0	16.1	15.1	9.0	16.3	22.2	23.1	35.4	14.2	10.4	15.6	14.6	13.1	10.9	5.6	15.1	5.5	40.7	23.2	10.5	13.0	14.3	2.4	0.9	0.2	2.5	1.1	6.1	1.0	9.9	2.2	5.3	5.0	5.6	6.0	3.3	14.8	19.5	8.2	9.2	1.7	9.8	7.1	5.0	20.7	12.9	6.7	6.6	9.7	17.3	2.5	7.7	1.1	5.3	2.0	11.7	3.7	1.1	8.0	10.3	10.0	25.9	15.4	5.6	4.2	2.5	25.9	6.5	5.7	2.0	1.2	5.7	8.1	11.3	1.8	8.6	4.8	4.6	13.8	5.5	12.2	10.8	6.2	12.8	9.0	5.5	3.3	11.1	21.6	22.0	14.0	16.8	12.7	17.1	3.3	12.3	5.7	12.5	0.0	0.8	0.1	3.3	2.5	6.1	2.4	3.7	3.1	0.9	1.9	2.6	2.6	0.2	1.1	1.4	0.9	2.2	1.0	15.2	17.1	40.9	31.9	15.0	13.4	14.4	16.1	16.1	15.1	11.9	6.9	16.2	30.6	29.7	80.4	32.7	15.3	6.7	17.0	19.2	37.3	8.9	6.6	10.1	8.3	26.1	10.7	0.0	12.9	2.0	40.4	34.0	8.1	27.7	8.5	90.6	27.3	8.6	9.9	9.0	31.7	16.9	27.0	5.4	16.8	58.7	15.8	8.6	40.0	8.8	48.7	32.3	40.9	7.7	10.4	29.4	5.7	18.5	12.4	26.4
NR1H2	"LXR-b, NER, NER-I, RIP15, UNR"	ENSG00000131408	"Nuclear receptor subfamily 1 group H member 2"	P55055	19	50329653-50382982	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005446, HPA056838, HPA070212"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234"	"unprognostic (1.31e-1)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.69e-3)"	30.1	27.5	24.5	24.7	27.5	98.0	24.4	20.6	33.5	25.1	30.9	23.1	25.2	30.9	31.2	23.1	27.9	26.9	28.7	36.8	23.8	19.4	27.1	31.4	28.3	23.3	31.7	25.9	26.5	37.6	22.0	18.6	30.5	28.1	27.9	10.5	23.2	33.8	33.8	76.2	25.3	30.3	29.9	22.9	29.9	26.7	21.2	29.1	20.4	27.1	24.4	21.7	33.2	27.6	34.1	34.2	63.0	37.7	22.3	28.6	32.5	16.1	42.5	4.1	10.4	12.2	12.9	13.3	22.3	19.0	13.2	15.2	8.8	15.7	10.4	20.0	13.4	10.6	15.1	2.6	12.2	3.2	25.8	22.9	9.9	14.3	9.1	23.4	16.4	27.3	13.5	16.7	13.6	9.2	13.4	12.0	8.3	16.2	21.6	7.4	17.9	11.7	13.5	8.3	10.3	36.5	7.0	10.8	18.0	11.4	18.1	4.6	16.2	14.5	18.0	14.0	2.4	12.4	13.7	15.2	17.8	14.5	18.2	19.8	27.1	22.3	7.6	35.5	10.8	17.9	39.1	35.9	63.0	27.7	35.0	27.0	34.1	27.4	25.9	34.2	34.1	28.6	24.9	55.4	22.3	37.7	29.5	24.4	32.5	24.5	27.5	20.6	33.5	23.8	19.4	31.7	25.9	28.1	29.1	26.8	27.8	34.4	74.6	38.1	39.5	23.4	25.5	9.4	7.9	29.6	13.7	57.0	54.7	54.4	5.2	46.6	78.1	0.0	63.6	44.7	33.4	68.0	50.6	17.4	46.9	35.0	20.0	20.9	26.7	6.8	42.0	44.5	57.3	84.8	39.8	39.5	60.4	87.7	50.2	46.2	21.7	38.8	58.5	32.5	30.0	40.0	117.1	47.8	32.6	81.4
NR1H3	"LXR-a, RLD-1"	ENSG00000025434	"Nuclear receptor subfamily 1 group H member 3"	Q13133	11	47248300-47269032	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.2"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 54.2;Hofbauer cells: 54.7;Kupffer cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.9;HSkMC: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036443, CAB037109"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB037109: AB_1840991, HPA036443: AB_10966142"	"unprognostic (2.95e-3)"	"unprognostic (5.31e-3)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (3.56e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.40e-4)"	74.2	9.4	4.8	12.7	6.9	1.2	22.8	7.0	5.5	10.2	17.9	4.4	7.2	23.1	6.7	10.0	6.6	8.1	9.2	8.5	4.0	2.9	10.3	35.7	13.7	29.4	6.8	5.6	7.5	7.8	4.3	3.5	16.1	4.3	10.1	5.9	6.4	7.1	9.0	6.1	5.1	19.0	7.1	3.4	40.2	7.6	13.7	4.1	6.3	9.7	2.6	10.7	10.8	12.9	1.1	4.5	6.5	14.6	6.1	3.8	2.1	1.6	6.8	3.1	3.0	20.9	22.9	14.7	1.7	8.6	2.8	4.4	8.3	21.5	2.9	3.3	1.4	1.0	4.5	3.7	2.9	1.9	2.7	3.0	3.9	9.0	12.4	8.6	1.4	0.5	29.9	1.8	4.4	2.6	4.9	2.4	4.6	4.8	1.2	1.9	7.1	2.7	7.9	3.4	9.1	2.3	4.0	4.2	1.9	2.5	15.3	3.0	1.0	6.1	4.0	5.1	3.2	9.7	3.7	0.6	2.3	3.1	4.5	1.0	6.0	8.7	3.5	4.2	1.8	1.1	6.5	2.9	2.4	1.5	14.6	2.1	1.1	1.7	1.4	4.5	0.9	1.8	1.5	1.5	6.1	4.5	0.8	3.8	2.1	4.8	6.9	7.0	5.5	4.0	2.9	6.8	5.6	4.3	4.1	0.0	9.9	6.1	6.3	3.0	2.1	4.5	22.9	1.4	5.7	5.2	2.0	9.7	10.0	4.4	23.5	12.0	39.9	0.0	7.5	11.4	9.9	3.2	12.7	54.2	54.7	1.6	1.7	21.5	70.5	33.3	8.3	7.9	3.3	6.4	9.7	4.8	4.0	10.5	5.6	19.2	0.9	19.4	6.4	27.2	16.3	2.0	5.5	2.9	12.1	4.1
NR1H4	"FXR, HRR-1, HRR1, RIP14"	ENSG00000012504	"Nuclear receptor subfamily 1 group H member 4"	Q96RI1	12	100473708-100564413	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease mutation, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 109.4"	"Cell type enhanced"	"Detected in some"	15	"Cholangiocytes: 79.0;Distal tubular cells: 36.5;Hepatocytes: 90.4;Proximal tubular cells: 116.5"	"Group enriched"	"Detected in some"	11	"liver cancer: 18.7;renal cancer: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"Hep G2: 18.4;HHSteC: 11.1;RPTEC TERT1: 29.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047699			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047699: AB_10965320"			"unprognostic (1.78e-1)"		"unprognostic (1.81e-1)"		"unprognostic (6.68e-2)"	"unprognostic (2.49e-1)"		"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"		"unprognostic (3.77e-3)"	0.1	11.3	0.1	1.4	0.4	0.0	0.2	0.1	0.2	0.2	5.8	0.4	0.1	11.3	0.1	0.4	0.1	0.1	7.0	0.1	0.1	0.0	25.0	109.4	0.6	2.4	0.1	0.1	7.7	2.7	0.0	2.9	0.2	0.3	0.5	0.4	0.6	0.1	0.1	0.1	0.0	19.5	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	79.0	0.0	0.0	21.0	0.0	0.0	36.5	6.3	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	90.4	0.0	0.0	0.0	14.7	1.9	1.3	0.9	0.0	0.0	0.0	0.1	0.0	0.6	2.9	0.0	116.5	0.0	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.3	0.9
NR1I3	"CAR, CAR1, MB67"	ENSG00000143257	"Nuclear receptor subfamily 1 group I member 3"	Q14994	1	161229666-161238302	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"liver: 63.1"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 124.3"	"Cancer enriched"	"Detected in single"	67	"liver cancer: 17.6"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA051365			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051365: AB_2616454"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.92e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.62e-2)"	0.1	0.0	0.2	0.1	1.9	0.1	0.1	0.1	0.2	0.1	0.7	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	3.5	63.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.3	2.3	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.7	0.3	0.0	0.6	0.3	0.3	0.9	1.1	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	9.4	0.3	1.0	0.6	0.0	0.3	0.6	0.0	0.0	0.0	1.0	0.9	0.0	0.2	2.2	0.0	1.7	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.9	1.2	0.4	0.0	0.8	0.3	0.6	1.7	1.8	1.3	0.9	0.8	0.6	0.0	1.8	2.3	1.4	0.3	2.9	0.4	1.4	2.1	1.2	2.2	0.7	0.7	1.5	0.2	1.5	2.2	1.3	0.5	2.9	0.5	0.7	0.2	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.9	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	20.8	16.0	2.2	1.1	0.6	0.7	0.3	2.5	8.1	9.1	3.5	0.0	0.1	3.3	0.1	1.7	0.3	0.0	0.0	0.0	0.1	0.4	0.4	12.7	124.3	0.3	0.0	0.0	3.1	5.3	1.2	0.3	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.4	28.7	1.7	0.0	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.8
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073703	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898"	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.62e-5)"	11.6	15.8	15.9	11.8	14.7	15.5	12.4	38.3	23.9	12.5	11.2	12.5	12.9	11.2	17.6	20.2	8.3	15.5	11.1	14.8	14.6	9.3	10.3	14.0	14.2	9.9	11.7	15.2	16.3	12.5	16.4	15.4	11.2	13.7	10.7	12.7	14.6	8.0	17.4	19.6	11.0	11.2	15.7	14.2	14.3	10.5	22.2	14.9	12.3	18.0	9.0	10.2	12.3	10.7	4.5	6.2	3.5	4.2	3.5	9.0	3.9	8.1	10.1	16.1	7.6	3.7	6.7	22.9	8.0	5.8	8.0	7.5	8.9	4.6	9.9	2.9	5.3	5.1	8.7	7.9	6.2	6.1	4.3	16.8	12.0	8.2	10.6	8.5	8.0	5.2	7.7	5.1	5.5	6.8	8.9	8.5	12.4	9.1	3.9	9.3	5.4	8.7	18.6	10.9	6.6	17.8	8.4	11.3	5.9	9.0	9.4	8.3	6.6	12.8	5.5	5.9	9.3	9.6	5.1	8.0	6.5	6.4	7.9	4.5	5.7	9.3	9.5	1.6	9.4	3.0	0.5	4.1	3.5	7.1	4.2	9.0	3.7	5.7	6.0	6.2	4.5	7.2	5.0	2.6	3.5	3.7	6.2	3.7	3.9	15.9	14.7	38.3	23.9	14.6	9.3	11.7	15.2	13.7	14.9	32.8	12.5	7.0	12.2	7.3	39.9	16.1	10.2	22.7	1.2	10.4	17.7	12.6	3.3	10.1	14.3	14.6	8.5	0.0	8.2	10.9	11.3	8.0	9.3	10.6	8.3	23.8	6.9	12.9	10.5	3.8	40.6	10.2	13.5	10.8	10.9	14.6	14.3	11.5	28.3	6.8	50.7	6.5	9.8	54.9	23.8	6.5	6.5	10.9	10.9	17.1
NR2E1	"TLL, TLX, XTLL"	ENSG00000112333	"Nuclear receptor subfamily 2 group E member 1"	Q9Y466	6	108166058-108188809	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 19.0"	"Cell type enriched"	"Detected in single"	50	"Muller glia cells: 39.7"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.4;GAMG: 3.0;HEK 293: 2.2;RH-30: 1.6;U-251 MG: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036954, HPA055642"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA036954: AB_10670958, HPA055642: AB_2682871"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"			"unprognostic (1.77e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.00e-1)"	"unprognostic (1.78e-2)"		"unprognostic (7.31e-2)"	"unprognostic (8.64e-2)"	"unprognostic (9.59e-8)"	"unprognostic (2.87e-1)"	"unprognostic (2.49e-1)"		"unprognostic (3.07e-1)"	0.6	1.1	14.5	0.6	16.0	0.8	0.8	0.0	19.0	0.6	0.6	2.8	0.0	0.7	0.6	0.6	0.6	0.6	0.6	0.7	10.8	4.3	0.9	0.6	0.6	0.7	3.5	7.5	0.7	0.7	0.8	0.1	0.7	0.0	0.6	0.6	3.3	1.0	0.6	0.7	0.9	0.6	0.6	0.0	0.7	0.7	0.8	4.1	0.0	0.7	0.0	0.6	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	2.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	14.5	16.0	0.0	10.0	10.8	4.3	3.5	7.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
NR2F1	"COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1"	ENSG00000175745	"Nuclear receptor subfamily 2 group F member 1"	P10589	5	93583224-93594615	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Ito cells: 216.7;Leydig cells: 86.6;Muller glia cells: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 57.1;HHSteC: 43.9;hTERT-RPE1: 38.5;PC-3: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019281, HPA058974"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB019281: , HPA058974: AB_2732629"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.75e-1)"	"unprognostic (7.68e-3)"	"unprognostic (3.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.24e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (1.47e-4)"	15.8	22.9	22.5	5.0	13.7	1.2	9.1	27.4	25.1	31.7	4.6	12.9	10.8	3.3	20.6	24.1	9.4	32.3	30.7	7.2	20.9	13.7	16.4	10.6	18.0	12.7	13.4	23.0	40.4	4.4	1.8	10.3	46.0	14.6	20.5	3.8	44.4	7.2	38.9	1.2	1.6	4.4	14.2	26.7	6.7	12.9	5.9	11.4	0.0	7.5	4.8	4.2	20.9	18.0	0.0	0.0	0.5	0.1	0.2	0.0	0.0	4.7	2.3	57.1	22.6	12.1	3.7	2.7	2.8	1.1	1.7	1.7	0.3	0.8	0.0	0.1	1.1	0.7	1.2	1.4	0.0	0.7	5.8	10.9	2.1	13.8	3.5	43.9	0.4	0.2	17.5	0.0	0.8	0.3	38.5	6.4	0.0	0.0	0.0	5.2	0.0	0.0	0.6	0.0	0.3	47.2	0.6	0.4	0.0	0.3	0.2	5.9	11.9	1.2	0.0	0.1	1.0	0.4	0.8	6.4	9.7	0.4	5.0	6.9	0.0	0.0	0.0	15.9	0.2	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	22.5	13.7	27.4	19.8	20.9	13.7	13.4	23.0	14.6	11.4	0.0	1.7	2.2	0.1	1.1	31.9	15.8	2.5	16.0	5.7	14.0	51.1	0.6	6.6	0.9	1.2	13.7	0.0	0.0	1.4	0.4	39.1	0.4	0.0	3.0	1.0	0.0	0.0	216.7	20.5	2.3	86.6	0.5	0.0	0.0	0.0	68.8	3.2	0.0	9.9	27.4	2.5	12.9	31.6	3.7	2.2	0.5	0.9	0.0	0.0	0.6
NR2F2	"ARP1, COUP-TFII, COUPTFB, NF-E3, SVP40, TFCOUP2"	ENSG00000185551	"Nuclear receptor subfamily 2 group F member 2"	P24468	15	96325938-96340263	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 273.8;Leydig cells: 472.6;Peritubular cells: 573.9;Sertoli cells: 478.6;Smooth muscle cells: 322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058974			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA058974: AB_2732629"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.28e-2)"	30.8	15.0	19.6	13.8	5.3	0.2	81.2	3.7	6.2	85.7	21.9	2.9	22.3	7.0	70.0	32.6	27.7	32.4	50.8	30.1	12.5	8.4	39.8	15.0	25.0	35.4	7.8	3.4	105.1	7.3	12.3	9.6	24.0	7.1	28.6	9.0	30.5	7.7	43.5	18.4	8.3	10.8	27.2	9.8	63.4	26.9	32.5	4.8	1.1	18.5	16.2	7.0	32.6	34.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	31.6	8.2	26.9	16.6	54.6	18.9	9.0	22.9	17.7	23.9	20.5	28.1	32.4	0.0	18.7	11.5	9.5	19.0	4.7	16.4	30.1	0.1	18.3	10.2	10.5	5.0	15.3	7.8	3.8	13.4	5.7	19.8	4.3	28.2	43.8	0.0	27.3	0.0	15.1	21.8	0.0	5.6	0.2	12.3	11.1	0.0	6.6	0.0	52.1	34.6	3.4	0.0	2.5	0.8	3.4	12.4	13.0	0.5	45.1	26.0	8.6	6.0	8.0	0.0	0.0	0.0	14.5	3.9	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	5.3	3.7	6.2	12.5	8.4	7.8	3.4	7.1	4.8	26.8	17.8	0.0	24.0	12.8	5.0	27.9	168.2	26.8	26.1	59.3	23.6	98.0	39.7	17.6	2.2	116.4	17.6	0.0	9.4	41.1	54.4	18.3	0.0	43.3	8.9	3.2	25.3	273.8	17.3	5.8	472.6	7.1	25.3	1.0	36.2	33.9	13.5	17.5	573.9	53.6	13.0	478.6	322.1	4.1	3.6	9.2	29.5	2.9	25.5	16.9
NR4A1	"GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3"	ENSG00000123358	"Nuclear receptor subfamily 4 group A member 1"	P22736	12	52022832-52059507	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 1121.0;granulocytes: 643.7;Smooth muscle cells: 682.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 18.2;non-classical monocyte: 24.4"	"Lineage enriched"	"Detected in many"	13	"monocytes: 24.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 25.8;MCF7: 29.4;SK-BR-3: 28.0;SK-MEL-30: 48.6"	"Group enriched"	"Detected in many"	5	"amygdala: 35.3;basal ganglia: 43.1;cerebral cortex: 77.4;hippocampal formation: 65.3;olfactory region: 79.3"	"Low region specificity"	"Detected in all"			"HPA059742, HPA070142"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA059742: AB_2684119, HPA070142: AB_2732149"	"unprognostic (2.40e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.99e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-2)"	"unprognostic (8.89e-3)"	69.1	111.3	4.0	58.1	12.9	5.7	25.0	5.4	10.9	32.3	23.3	21.1	46.0	5.6	49.8	33.9	28.1	63.3	99.9	76.7	4.8	5.0	17.9	12.1	50.1	8.3	7.5	5.9	177.3	16.1	28.9	51.8	7.6	13.1	88.3	13.8	43.7	66.8	203.2	32.3	23.4	24.3	98.4	6.8	5.1	32.8	11.8	6.4	11.9	34.7	35.8	14.9	71.4	54.5	0.4	1.8	0.2	24.4	0.1	0.2	0.7	1.9	9.7	1.9	3.4	1.4	0.4	7.4	1.8	3.6	1.5	2.1	9.5	1.8	2.0	0.8	3.2	1.4	1.0	5.8	0.8	0.8	0.1	2.0	2.7	25.8	2.6	1.4	1.0	9.1	0.3	1.1	1.4	0.1	1.0	0.4	2.1	2.6	0.5	0.1	29.4	0.7	2.8	5.3	3.0	1.0	0.9	0.3	4.8	0.0	0.7	1.6	4.8	6.0	28.0	48.6	1.3	1.7	3.0	0.0	1.4	4.7	0.9	1.5	16.5	7.8	4.2	1.0	0.8	8.1	0.1	0.6	0.0	0.1	18.2	0.1	0.4	0.0	0.0	1.8	0.4	0.2	0.0	0.2	0.1	24.4	0.1	0.1	0.7	4.0	12.9	5.4	10.9	4.8	5.0	7.5	5.9	13.1	6.4	223.4	1121.0	24.4	132.4	396.0	36.6	7.8	15.3	111.1	143.3	82.0	117.8	62.1	5.0	12.1	16.2	91.9	82.8	0.0	11.1	32.1	293.0	212.1	643.7	7.4	47.6	15.9	331.5	135.7	50.1	4.5	28.1	257.6	352.6	8.2	251.3	24.1	5.1	265.7	22.3	0.7	70.9	122.9	682.6	1.5	12.4	413.3	92.5	20.2	184.5	44.7
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771310	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 112.0;Spermatocytes: 68.9;Spermatogonia: 111.8"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 47.8;CACO-2: 11.0;Hep G2: 10.7;K-562: 14.1;NTERA-2: 17.0;U-266/84: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: AB_2673894, HPA045145: AB_2679233"	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.6	1.0	2.9	1.4	3.4	5.5	1.8	5.8	3.5	0.8	7.9	1.2	1.3	2.5	0.9	1.4	2.2	1.0	0.9	1.0	3.3	1.3	1.9	2.8	1.8	0.7	2.1	2.4	0.6	3.3	1.5	2.2	4.2	2.2	1.7	2.3	1.7	1.5	1.4	1.9	2.6	5.3	0.8	2.3	1.1	0.7	28.2	2.8	0.0	7.3	0.8	1.1	1.3	1.4	0.3	1.0	8.6	1.2	0.1	0.0	0.1	0.5	1.2	6.3	0.8	0.1	0.1	47.8	0.1	0.4	0.3	0.5	11.0	1.2	2.1	0.4	0.0	1.6	1.1	0.6	0.5	0.7	0.5	2.0	1.7	1.8	10.7	0.0	1.0	3.1	0.0	0.6	0.5	0.7	0.1	0.1	0.5	14.1	0.3	0.2	0.2	0.0	1.3	17.0	0.5	0.5	0.5	0.6	0.9	0.2	0.8	0.9	0.3	0.0	0.3	0.4	9.8	1.1	0.5	0.0	0.6	1.3	0.4	0.3	1.4	10.3	1.9	0.3	1.0	0.3	0.1	1.2	2.0	0.0	0.9	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	8.6	0.1	0.6	0.2	0.0	0.1	2.9	3.4	5.8	3.5	3.3	1.3	2.1	2.4	2.2	2.8	0.0	7.7	0.0	15.1	33.2	2.8	1.4	10.2	4.0	4.5	5.2	27.5	30.8	1.7	7.9	43.0	2.7	13.2	0.0	3.1	112.0	3.0	14.2	1.1	5.5	7.1	1.6	4.6	1.3	1.8	22.4	1.1	4.6	8.5	5.4	6.7	8.0	2.3	7.0	1.8	1.9	10.5	0.0	2.1	68.9	111.8	34.8	25.6	0.0	13.0	11.9
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137300482-137302251	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 41.7"	"Group enriched"	"Detected in many"	7	"Basal keratinocytes: 86.2;Suprabasal keratinocytes: 333.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 23.4;HEK 293: 11.8;NTERA-2: 17.2;OE19: 11.5;T-47d: 11.9;TIME: 17.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	7.9	1.6	6.5	8.4	7.8	1.7	13.8	3.9	11.7	5.6	41.7	6.1	1.1	17.1	5.2	1.9	17.4	3.2	26.0	7.1	5.0	6.5	3.2	2.9	7.0	1.8	6.0	3.0	5.6	14.2	3.1	7.1	8.9	7.4	11.8	22.8	5.6	1.9	2.8	4.4	19.7	15.7	4.5	3.2	7.7	8.7	6.0	3.4	2.3	4.2	14.0	14.4	7.6	10.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.5	3.5	4.2	0.0	0.0	1.6	0.1	0.1	0.0	0.0	2.8	1.4	0.0	6.4	0.0	0.1	23.4	6.4	0.2	0.1	0.2	11.8	0.7	1.0	2.6	0.4	0.9	2.3	0.0	1.1	0.0	0.2	0.0	5.3	0.1	6.9	0.1	0.0	7.7	0.1	2.7	17.2	11.5	3.5	4.6	0.7	8.4	0.6	0.2	2.4	4.4	0.7	1.2	0.0	0.7	11.9	1.9	17.1	0.0	0.0	0.1	1.0	0.1	0.1	1.4	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	6.5	7.8	3.9	6.8	5.0	6.5	6.0	3.0	7.4	3.4	0.0	0.0	0.5	2.8	86.2	0.3	2.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	11.7	6.0	10.7	0.0	1.0	0.0	0.6	6.0	0.0	0.0	0.4	0.0	9.8	5.5	0.8	2.9	0.0	0.0	16.9	0.0	15.3	9.4	0.6	31.1	0.4	0.0	2.5	6.5	23.4	0.0	0.8	333.1	0.0	0.0	19.6	5.5
NRBF2	"COPR1, COPR2, DKFZp564C1664, FLJ30395"	ENSG00000148572	"Nuclear receptor binding factor 2"	Q96F24	10	63133247-63155031	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.9"	"Cell type enhanced"	"Detected in many"	8	"Syncytiotrophoblasts: 238.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 100.9"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 100.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021670, HPA059477"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021670: AB_2670803, HPA059477: AB_2684032"	"unprognostic (7.71e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.59e-2)"	15.1	10.0	10.7	16.1	10.2	22.1	21.6	10.9	13.9	12.3	12.3	7.0	9.0	12.4	13.9	9.9	13.9	10.0	13.2	13.6	10.9	9.5	10.6	50.2	19.1	29.4	13.1	8.9	9.2	10.3	6.9	11.5	21.3	11.7	8.7	12.8	6.0	14.8	11.0	46.2	14.6	15.0	10.8	11.7	22.9	10.5	10.0	8.9	16.4	14.2	13.9	14.6	14.6	13.5	7.0	10.0	100.9	13.3	4.3	5.7	7.2	8.9	8.1	8.1	7.4	19.5	30.1	8.1	12.8	21.9	10.3	14.6	17.2	9.6	11.6	6.3	14.3	10.3	7.0	7.9	10.8	14.1	10.4	7.9	8.6	4.2	13.7	25.0	11.3	10.0	27.9	23.2	16.7	41.0	19.3	10.5	7.6	8.7	13.5	13.0	6.6	9.5	20.1	9.4	7.3	33.9	9.3	7.3	6.8	11.8	5.1	4.6	8.0	7.6	14.9	22.2	13.9	9.2	11.3	10.7	7.1	10.5	11.1	13.6	17.0	13.0	14.1	19.9	18.2	5.7	13.8	11.8	22.8	4.5	13.3	4.7	7.0	4.6	4.9	10.0	5.9	5.7	5.3	100.9	4.3	12.5	4.9	5.1	7.2	10.7	10.2	10.9	13.9	10.9	9.5	13.1	8.9	11.7	8.9	3.0	27.1	28.8	40.1	25.5	11.4	6.2	10.2	25.4	19.4	12.2	3.9	45.0	19.9	27.6	5.4	22.2	25.7	0.0	30.6	61.0	36.0	34.9	13.9	47.4	43.7	19.1	15.0	14.7	52.1	5.3	21.6	53.4	43.9	52.3	26.6	14.8	33.1	28.5	20.1	23.0	7.6	19.4	24.5	21.3	67.9	27.9	238.6	37.4	22.2	49.9
NRBP2	DKFZp434P086	ENSG00000185189	"Nuclear receptor binding protein 2"	Q9NSY0	8	143833594-143840974	"Enzymes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.1"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB020944, HPA029051, HPA029052"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB020944: , HPA029051: AB_2672886, HPA029052: AB_10602714"	"unprognostic (1.84e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (3.86e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.04e-1)"	18.5	10.7	21.6	6.8	21.1	1.9	10.0	17.5	32.6	7.6	13.3	47.5	8.7	8.8	11.2	10.0	9.9	14.6	11.3	15.2	23.5	14.9	14.0	18.9	14.9	4.9	30.9	23.6	10.7	10.4	8.4	8.8	6.1	30.2	17.8	6.9	10.1	22.1	15.5	7.6	23.0	9.3	12.3	54.1	7.5	10.1	6.1	27.5	1.0	9.0	3.6	3.8	8.2	7.8	0.5	0.0	0.0	0.4	0.0	1.5	0.3	5.9	7.4	6.7	8.3	10.5	16.2	1.5	12.1	5.3	4.4	6.4	1.7	5.5	0.6	3.2	14.4	3.3	9.5	3.9	4.2	1.7	7.1	2.9	1.1	19.6	3.0	10.8	0.0	2.8	20.7	10.0	2.3	2.2	14.9	6.1	2.1	3.7	7.8	9.3	2.5	0.5	0.3	2.5	6.0	4.1	2.0	6.2	2.7	6.0	2.0	2.4	4.9	15.5	7.9	6.0	4.5	11.3	0.4	14.0	2.6	8.0	12.5	3.9	4.3	0.2	0.1	13.9	2.4	3.5	0.0	0.4	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	21.6	21.1	17.5	21.4	23.5	14.9	30.9	23.6	30.2	27.5	41.7	10.7	0.8	6.0	8.1	14.2	8.1	28.1	5.3	13.6	10.4	13.7	0.7	0.0	4.0	0.3	7.1	5.1	0.0	3.6	0.9	5.8	9.0	0.0	32.1	2.4	15.9	8.6	7.4	4.1	0.0	26.7	3.2	10.1	4.6	8.4	23.2	4.7	3.5	20.1	2.8	10.6	12.9	10.3	1.1	2.3	8.0	0.7	2.9	4.5	3.7
NRCAM	"Bravo, KIAA0343"	ENSG00000091129	"Neuronal cell adhesion molecule"	Q92823	7	108147623-108456717	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.0"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 66.8;Cone photoreceptor cells: 96.2;Muller glia cells: 46.7"	"Cancer enriched"	"Detected in all"	7	"glioma: 57.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive CD8 T-cell: 5.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 26.4;AF22: 25.7;EFO-21: 47.9;HMC-1: 51.2;SH-SY5Y: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012606	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		70000000	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA012606: AB_1854636"	"unprognostic (2.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.42e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.28e-2)"	2.5	28.7	24.5	2.3	23.7	1.2	1.6	16.6	82.0	5.0	1.6	10.5	9.5	1.5	2.6	26.6	1.5	3.7	6.3	1.1	19.1	15.9	5.8	1.3	2.7	1.6	11.8	21.2	2.1	21.5	1.2	14.6	6.4	21.7	1.6	1.6	0.7	2.4	12.1	1.0	1.6	1.5	1.6	10.8	4.2	2.3	2.2	9.9	0.0	4.0	0.0	2.9	1.5	0.8	0.1	0.0	0.3	0.0	0.0	5.5	0.6	0.0	26.4	25.7	0.0	3.1	0.6	0.5	0.1	0.1	0.2	0.4	10.6	0.0	0.0	47.9	0.2	0.4	0.1	0.6	0.4	0.2	0.0	3.4	0.0	0.2	0.2	0.0	0.2	51.2	4.3	0.0	0.0	0.1	0.0	16.5	0.0	0.0	0.2	0.4	9.9	0.1	0.0	3.5	15.7	0.0	0.0	7.5	8.6	5.9	0.0	5.0	31.5	0.3	0.0	0.5	0.9	0.0	0.0	17.5	1.1	0.2	0.0	4.3	0.0	0.1	0.2	0.2	0.0	14.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	5.5	0.0	0.0	0.0	0.0	0.0	0.6	24.5	23.7	16.6	34.7	19.1	15.9	11.8	21.2	21.7	9.9	0.0	0.0	0.0	0.0	0.3	66.8	0.5	2.5	0.0	0.0	5.2	96.2	2.1	3.3	1.3	25.4	0.9	0.0	0.0	10.2	0.2	0.9	0.7	22.0	0.0	0.7	12.7	0.0	2.5	1.5	4.7	0.9	0.0	3.3	1.0	0.0	46.7	5.7	0.0	0.4	2.1	7.9	0.0	0.9	1.0	1.1	0.1	3.7	0.0	0.0	0.0
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 492.5;Late spermatids: 1318.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	16.4	15.9	13.4	15.8	17.5	14.5	11.7	14.7	16.9	12.2	13.7	11.0	9.9	11.2	11.8	12.1	14.4	10.9	10.9	25.7	13.1	13.3	12.4	28.5	12.0	13.6	16.2	10.6	11.7	15.9	19.3	21.4	14.2	15.7	13.8	12.1	9.8	11.9	11.3	96.4	19.1	10.3	13.3	14.0	13.6	11.9	32.3	14.5	19.4	11.7	21.5	15.1	13.0	16.0	13.8	18.5	36.3	19.1	15.8	15.1	16.2	46.9	26.5	26.6	38.1	28.0	43.3	30.9	47.5	41.1	34.6	36.7	18.5	18.6	31.0	25.4	35.7	46.4	27.4	39.0	36.8	43.8	36.7	19.2	37.0	36.0	16.1	28.7	32.3	28.2	34.4	28.2	50.4	46.8	29.8	35.9	33.0	48.7	20.8	43.2	17.2	29.2	11.2	47.2	19.4	28.5	28.6	31.8	34.2	25.5	27.3	25.5	19.2	43.3	34.9	25.7	53.9	23.3	39.3	29.8	30.4	28.2	33.1	40.3	31.1	46.9	29.0	35.9	40.7	34.8	19.3	18.1	26.0	13.7	19.1	13.7	13.8	12.7	15.1	18.5	9.3	12.5	13.4	36.3	15.8	14.5	15.0	14.4	16.2	13.4	17.5	14.7	16.9	13.1	13.3	16.2	10.6	15.7	14.5	32.8	55.9	17.8	35.3	0.0	67.0	0.0	17.8	108.4	63.7	26.2	76.6	47.3	26.6	38.1	492.5	33.3	18.8	70.0	55.1	37.0	33.6	42.0	32.5	52.9	39.9	58.8	17.5	28.3	38.2	1318.0	61.2	53.3	0.0	60.5	26.4	53.0	45.7	14.0	55.5	15.1	68.3	58.2	0.0	37.6	20.9	0.0	69.0	40.6	27.9	33.4
NREP	"C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17"	ENSG00000134986	"Neuronal regeneration related protein"	Q16612	5	111662621-111997464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 149.5"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 82.5;Cytotrophoblasts: 84.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 149.5"	"Group enriched"	"Detected in many"	5	"myeloid DC: 16.0;NK-cell: 4.1;plasmacytoid DC: 16.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 70.3;SH-SY5Y: 76.1"									HPA000545	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA000545: AB_1845721"	"unprognostic (2.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.76e-3)"	4.2	14.4	14.1	5.0	21.9	7.1	6.4	149.5	45.5	8.2	8.5	6.7	4.3	3.5	21.7	4.1	5.2	4.6	16.0	17.2	15.7	10.5	11.7	11.7	6.3	3.3	11.0	21.5	10.4	2.9	1.7	5.0	28.2	27.8	13.1	5.9	16.1	8.3	18.2	39.6	4.7	3.9	13.1	8.0	8.3	5.6	3.0	4.3	34.1	4.7	8.6	3.8	7.4	6.4	0.9	16.2	0.0	2.6	4.1	1.1	1.4	0.1	1.1	70.3	14.9	3.3	7.9	3.3	23.4	13.9	22.2	36.9	0.1	0.4	11.5	7.3	11.3	3.1	0.0	14.6	0.8	11.5	4.6	2.1	9.0	5.9	12.4	4.7	11.9	0.1	7.6	3.7	21.5	7.4	52.5	25.1	13.1	0.1	1.2	23.1	0.2	47.4	8.4	39.8	0.0	5.4	51.0	28.4	3.1	8.5	0.2	16.0	76.1	5.1	0.3	0.5	38.6	2.9	33.1	4.9	27.1	9.1	13.2	2.5	5.6	4.5	14.6	6.0	25.3	5.3	0.0	2.6	0.0	0.0	1.3	0.0	0.9	0.1	0.1	16.0	0.8	0.8	1.1	0.0	4.1	0.6	16.2	0.0	1.4	14.1	21.9	149.5	45.5	15.7	10.5	11.0	21.5	27.8	4.3	6.0	25.0	2.7	1.4	16.1	66.2	29.9	10.2	0.0	9.1	12.2	82.5	84.9	28.2	13.3	2.0	15.7	1.1	0.0	4.9	16.2	34.0	0.8	4.7	8.5	30.5	19.1	20.7	33.7	14.5	0.8	7.8	6.9	13.5	1.8	7.6	12.1	7.6	0.0	21.9	42.5	28.6	12.9	22.3	0.9	11.3	11.0	26.3	4.9	10.7	0.1
NRG1	"GGF, HGL, HRG, NDF, NRG1-IT2"	ENSG00000157168	"Neuregulin 1"	Q02297	8	31639386-32767959	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 35.7;Basal glandular cells: 36.6;Early spermatids: 31.2;Horizontal cells: 27.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"classical monocyte: 22.8"	"Lineage enriched"	"Detected in many"	5	"monocytes: 22.8"	"Cell line enhanced"	"Detected in many"		"A549: 38.0;BJ: 26.0;fHDF/TERT166: 29.1;GAMG: 40.0;HBF TERT88: 25.6;hTEC/SVTERT24-B: 27.3;hTERT-HME1: 28.6"	"Low region specificity"	"Detected in all"							HPA010964	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			Nucleoplasm		"HPA010964: AB_1854641"	"unprognostic (5.76e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.96e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.94e-4)"	"unprognostic (4.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.40e-2)"	"unprognostic (7.83e-2)"	0.7	2.1	4.6	5.0	3.3	1.2	8.8	14.8	8.1	10.6	4.2	0.3	2.1	3.5	2.5	1.1	3.7	2.0	4.8	2.2	4.7	15.4	11.5	23.6	5.7	0.6	6.2	3.5	2.9	0.9	0.8	23.9	0.2	28.3	3.2	5.4	3.6	2.5	1.6	0.2	4.3	5.7	1.1	2.5	1.7	3.1	6.4	0.8	0.2	13.8	7.2	2.2	7.2	3.5	0.0	4.9	0.8	22.8	0.0	0.0	4.6	0.1	38.0	0.6	0.0	0.3	0.7	0.0	26.0	18.4	21.6	16.6	0.0	0.8	0.0	4.8	29.1	40.0	20.5	0.1	10.4	25.6	0.0	0.2	0.5	0.5	0.5	0.1	0.0	0.0	0.3	1.1	27.3	28.6	1.9	12.4	0.0	0.0	0.1	7.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	16.0	1.1	1.1	1.3	1.9	0.0	0.0	2.1	0.0	0.0	9.0	15.0	4.6	23.9	14.5	0.0	0.0	0.2	7.7	0.0	1.8	0.0	22.8	0.2	0.0	2.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.6	4.6	3.3	14.8	8.1	4.7	15.4	6.2	3.5	28.3	0.8	35.7	2.4	0.5	36.6	23.1	11.2	1.7	10.2	4.0	13.6	3.5	7.9	0.0	8.3	1.8	31.2	1.4	0.0	0.0	0.2	0.0	0.7	14.3	1.1	6.6	0.5	27.0	0.0	6.7	16.0	14.6	0.3	1.8	1.7	0.0	0.0	4.8	0.8	0.0	0.4	14.6	3.0	0.0	0.9	1.4	1.0	5.4	0.0	0.0	0.0	5.6
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193"	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	29.0	15.0	10.8	12.6	7.5	19.6	18.4	20.8	10.5	23.1	21.2	6.7	8.5	14.5	16.6	13.4	13.1	18.8	9.0	11.8	9.3	5.8	16.0	22.7	9.3	8.9	5.9	7.3	14.4	15.8	8.3	11.2	16.8	7.2	13.9	15.8	12.7	10.3	7.7	36.5	7.6	30.3	17.3	12.9	17.0	8.4	6.8	7.7	22.1	7.3	12.4	5.9	13.0	14.9	2.6	1.7	0.5	1.4	1.2	5.6	0.7	9.7	20.7	16.3	0.0	8.2	5.3	5.8	11.6	5.2	7.8	5.9	3.8	7.7	0.0	6.6	11.0	3.6	5.1	1.0	6.9	15.7	0.0	4.5	14.7	7.2	11.9	4.9	7.4	3.2	6.5	9.7	8.0	9.4	8.1	5.7	2.2	10.4	8.1	5.1	5.5	3.4	0.0	6.6	3.9	6.2	41.5	12.8	0.3	4.5	16.9	1.4	0.0	9.6	5.1	3.9	13.3	12.4	5.6	9.8	6.3	4.2	9.8	4.7	3.9	0.0	0.0	13.8	0.0	3.2	0.0	1.4	0.5	1.0	0.8	5.6	0.9	1.0	1.1	1.7	2.6	1.7	0.6	0.3	1.2	1.4	1.7	0.5	0.7	10.8	7.5	20.8	10.5	9.3	5.8	5.9	7.3	7.2	7.7	44.7	32.8	11.5	54.8	16.6	33.5	15.3	17.8	18.7	61.4	27.9	47.1	13.0	8.3	20.2	11.9	25.5	34.2	0.0	23.8	109.4	21.7	35.8	29.1	42.3	36.7	20.6	36.1	28.3	37.6	14.4	34.8	26.2	8.5	33.3	38.8	58.9	25.8	40.3	25.5	33.6	60.2	32.3	17.0	9.3	2.3	16.4	11.8	7.7	42.0	78.2
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 48.5"	"Cell type enhanced"	"Detected in some"	16	"Rod photoreceptor cells: 9.2;Sertoli cells: 25.8;Smooth muscle cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	5.1	5.8	3.9	20.1	4.3	3.9	48.5	20.9	6.0	4.2	13.5	1.1	2.9	9.8	9.9	3.0	5.9	7.4	6.2	9.7	7.3	9.2	1.6	2.0	4.6	27.6	5.6	11.7	2.5	0.5	2.6	3.3	11.9	3.2	3.8	4.6	4.3	6.6	5.4	3.2	4.1	6.4	7.2	8.0	3.3	2.6	27.7	0.7	5.9	3.0	3.0	3.8	6.3	2.1	0.8	5.9	1.1	1.1	2.3	0.3	0.8	1.7	2.9	1.7	0.0	0.0	3.6	2.1	0.0	0.0	0.0	4.3	2.1	2.3	0.6	0.0	0.7	1.6	0.0	0.0	0.0	1.6	2.5	3.6	4.5	0.5	0.0	4.4	2.7	0.1	0.0	0.0	0.0	4.4	0.0	2.5	2.0	5.3	0.0	1.8	2.7	2.3	2.9	1.7	0.8	1.7	3.1	1.4	0.0	2.9	2.3	3.3	1.6	2.4	0.5	5.4	1.6	0.8	2.3	1.2	1.5	1.7	3.0	0.9	0.2	3.4	2.9	2.1	1.5	5.9	1.1	0.4	1.7	0.7	0.9	2.1	1.3	1.5	0.7	2.0	2.3	1.0	0.5	1.1	0.4	0.8	0.5	0.3	5.8	20.1	48.5	20.9	9.7	7.3	27.6	5.6	11.9	27.7	0.0	0.6	0.0	0.5	0.1	4.0	1.4	0.0	0.0	0.0	1.8	5.9	0.2	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.1	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	4.9	0.0	9.2	25.8	17.6	0.1	0.2	0.1	0.0	0.0	0.0	0.0
NRIP3	C11orf14	ENSG00000175352	"Nuclear receptor interacting protein 3"	Q9NQ35	11	8980576-9004049	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 11.5;blood: 13.8;bone marrow: 12.7;brain: 28.4;testis: 30.3"	"Group enriched"	"Detected in many"	7	"Early spermatids: 432.1;Horizontal cells: 228.8;Late spermatids: 344.8;Spermatocytes: 110.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 14.4;HMC-1: 26.2;SiHa: 17.0;U-87 MG: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058827, HPA072961"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA058827: AB_2683829, HPA072961: "	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.03e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.88e-3)"	"unprognostic (1.30e-1)"	2.9	11.5	10.0	2.0	19.7	12.7	4.8	27.6	24.7	1.9	1.0	3.1	0.0	1.0	3.9	3.8	1.4	2.1	2.2	1.4	28.4	9.6	1.2	0.7	1.3	1.3	10.5	6.8	0.8	0.8	2.4	0.7	1.3	11.0	1.2	1.2	3.3	1.1	1.4	0.6	0.9	1.0	2.8	4.5	1.0	1.6	30.3	0.8	0.0	1.4	0.0	1.1	1.0	0.3	0.1	0.2	13.8	0.3	0.1	1.0	0.2	0.0	0.4	0.9	0.1	0.4	1.4	0.0	10.2	4.0	8.2	8.7	1.5	0.9	0.0	1.5	2.9	4.9	0.1	2.7	0.2	14.4	0.7	4.0	1.1	0.5	0.1	0.6	12.7	26.2	1.9	0.1	8.5	0.1	8.7	6.6	2.2	2.0	0.1	7.5	0.0	0.6	4.1	3.3	0.0	0.0	0.0	1.4	0.0	0.1	0.6	2.7	0.8	17.0	0.5	2.6	0.7	1.7	1.2	8.3	12.7	6.0	0.7	0.0	0.0	0.0	0.0	24.5	1.5	6.1	13.8	0.1	2.0	0.1	0.3	0.2	0.1	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	10.0	19.7	27.6	19.6	28.4	9.6	10.5	6.8	11.0	0.8	0.0	2.2	0.0	4.8	1.9	6.7	1.2	0.0	0.0	0.0	0.0	9.8	0.4	5.0	0.4	432.1	1.4	0.0	0.0	1.0	0.4	1.2	2.6	15.1	0.0	12.7	228.8	5.1	0.0	1.5	344.8	6.4	5.2	3.3	1.0	0.0	4.1	4.8	0.0	5.3	0.0	9.8	0.0	2.1	110.3	37.3	0.9	0.8	0.0	0.0	3.4
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 42.2;placenta: 64.8"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1"	"Region enriched"	"Detected in single"	28	"cerebellum: 16.0"	"Low region specificity"	"Detected in many"			HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	2.6	12.7	0.4	2.7	0.4	0.0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0.0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0.0	0.3	0.0	42.2	0.5	0.0	2.9	64.8	0.2	22.0	0.1	0.0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0.0	0.0	0.5	3.1	0.3	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.9	0.0	0.0	0.0	1.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	0.0	18.9	0.3	0.0	0.1	0.0	1.0	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	56.0	16.6	0.2	0.9	0.3	0.0	0.0	0.0	7.2	0.5	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.6	1.4	0.0	56.8	0.0	0.0	0.1
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Ito cells: 162.7;monocytes: 389.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.5;HUVEC TERT2: 30.2;TIME: 28.8;U-251 MG: 58.9;U-87 MG: 27.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039980, HPA054974"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA		15000000	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA039980: AB_10795517, HPA054974: AB_2682657"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (7.80e-5)"	24.3	14.5	8.7	11.4	7.4	2.6	7.8	1.2	7.0	34.4	35.4	3.9	8.4	3.5	33.7	4.6	24.8	13.1	25.8	4.4	11.5	8.3	3.4	6.2	15.8	4.9	8.9	3.9	33.0	1.4	2.5	6.6	29.9	9.0	18.6	7.0	27.7	2.6	21.0	2.5	3.3	8.2	44.7	8.6	4.7	17.1	3.4	5.2	2.6	7.3	6.0	3.0	39.3	24.6	1.4	0.5	0.0	1.8	0.0	0.0	0.5	0.7	14.2	9.1	0.0	8.2	2.6	2.7	2.2	4.3	2.8	2.7	13.4	34.5	0.0	3.4	7.1	5.6	5.5	0.4	4.4	4.7	0.0	1.9	0.1	0.6	0.1	22.4	0.0	0.5	19.7	3.4	3.9	3.5	17.4	30.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	11.4	0.0	2.5	0.0	0.5	3.1	5.7	0.0	8.2	0.3	0.3	0.0	20.3	24.3	0.0	0.1	28.8	12.5	0.1	3.2	58.9	0.0	0.0	0.8	27.8	0.0	26.1	0.0	1.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.7	7.4	1.2	3.8	11.5	8.3	8.9	3.9	9.0	5.2	83.4	48.1	3.9	13.9	17.2	25.2	4.8	7.6	64.3	72.8	1.8	0.0	68.2	0.0	2.1	5.6	84.5	0.0	0.0	3.3	4.0	46.3	4.7	3.5	0.9	113.5	0.0	1.2	162.7	27.7	10.2	2.6	22.5	18.6	389.5	0.1	4.3	31.6	0.0	4.6	0.6	2.4	0.0	10.3	1.7	0.7	11.0	21.5	0.7	0.0	44.5
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126122-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 67.2"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 114.4"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.6;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		1.3	6.9	21.5	1.7	27.7	1.7	1.3	5.3	67.2	1.3	1.7	2.1	0.0	1.7	1.5	1.4	1.4	1.3	1.5	1.4	15.3	25.0	1.5	1.4	1.4	1.5	12.4	25.4	1.3	2.6	1.4	12.9	1.3	27.4	1.4	1.7	0.3	1.5	1.3	3.3	1.5	1.6	1.6	6.7	1.5	1.9	1.6	5.0	0.0	1.4	0.0	1.3	1.3	0.1	0.5	0.2	1.8	0.2	0.1	0.3	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.7	0.1	1.7	0.0	0.0	0.3	0.1	0.0	0.1	1.7	0.6	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	2.0	1.3	0.1	0.2	0.3	0.9	0.7	0.2	2.5	0.5	0.2	0.5	0.0	0.0	14.6	11.7	0.0	0.1	0.9	0.2	1.7	3.5	0.2	0.5	0.6	0.1	0.4	0.8	2.3	0.9	0.7	0.0	1.3	1.8	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.3	1.0	0.1	0.2	0.2	0.0	0.0	21.5	27.7	5.3	34.1	15.3	25.0	12.4	25.4	27.4	5.0	0.0	0.0	0.0	0.0	0.0	24.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.9"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	8.4	18.6	34.3	6.0	39.3	0.9	7.2	22.7	70.9	12.8	6.6	11.0	4.9	3.5	12.5	16.0	6.1	13.4	9.3	13.5	31.1	24.9	10.1	1.8	8.7	4.1	17.1	28.5	18.3	10.5	26.5	16.3	10.1	27.8	12.2	6.1	12.8	13.3	16.5	1.4	5.0	3.8	16.3	8.7	5.7	5.3	12.8	6.8	1.3	14.9	2.5	4.2	9.4	4.8	9.4	4.8	1.5	1.1	3.4	3.9	1.5	18.9	23.0	13.9	13.1	18.4	20.6	5.4	12.6	24.3	22.9	23.0	12.6	0.4	0.0	4.4	23.3	16.8	8.3	11.2	1.9	14.6	0.1	11.3	6.8	11.0	24.0	18.6	0.2	1.1	23.3	1.5	16.3	2.7	18.7	15.7	0.1	13.5	12.3	20.0	3.3	0.3	5.8	10.7	0.2	11.9	10.8	7.8	0.9	22.8	0.1	28.4	20.4	15.0	4.4	21.5	9.5	18.4	7.1	10.4	24.5	13.0	0.9	15.3	2.3	0.4	5.1	3.2	0.2	12.9	0.0	1.1	1.5	3.8	0.3	1.1	7.2	1.1	3.9	2.1	9.4	1.6	2.7	0.0	3.4	0.4	4.8	0.9	1.5	34.3	39.3	22.7	70.9	31.1	24.9	17.1	28.5	27.8	6.8	0.0	1.9	0.0	3.1	2.9	24.5	4.0	0.0	2.7	7.9	12.2	2.0	6.1	1.7	11.0	5.5	4.5	1.3	0.0	1.4	5.3	10.8	2.5	4.7	0.4	2.7	15.9	28.3	4.3	1.2	10.0	12.0	1.2	3.3	3.6	2.7	12.3	3.8	1.9	9.9	5.7	12.7	19.4	9.2	21.3	6.6	1.9	3.7	1.0	2.0	2.7
NRTN	NTN	ENSG00000171119	Neurturin	Q99748	19	5823802-5828324	"Disease related genes, Predicted secreted proteins"		"Growth factor"	"Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.3;pancreas: 12.3"	"Cell type enhanced"	"Detected in many"	18	"Cardiomyocytes: 10.8;Cone photoreceptor cells: 11.8;Hepatocytes: 10.6;Rod photoreceptor cells: 43.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.9;T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.2;K-562: 7.1;REH: 18.6;SH-SY5Y: 10.0;U-266/70: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065260			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"		"HPA065260: AB_2685448"	"unprognostic (4.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.96e-2)"	"prognostic favorable (3.86e-4)"	"unprognostic (1.60e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.21e-3)"	"unprognostic (5.60e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.32e-2)"	0.0	3.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	4.9			1.5	0.3	0.6	2.1	0.4	0.5	15.3	0.0	0.0	1.8	7.6	0.0	0.0	0.0		0.0	12.3	0.6	0.3	0.0		1.3	0.0		6.8	1.2	0.0	3.0	1.5	0.9	0.0	0.0	5.0	0.3			0.0		0.0	1.8	1.3	0.7	1.9	0.0	0.1	0.0	1.7	0.3	0.5	0.7	0.8	2.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.9	0.0	0.5	0.1	2.9	0.0	0.0	7.2	5.2	0.0	0.0	2.3	0.9	0.1	1.9	0.1	0.8	0.0	0.0	0.0	0.0	2.5	7.1	0.0	0.0	1.5	0.6	0.7	2.4	1.1	1.8	18.6	2.4	4.3	0.3	0.0	0.5	10.0	0.1	0.9	1.0	0.3	0.3	0.6	0.0	0.0	1.6	0.0	0.0	10.7	2.2	0.5	0.0	1.2	0.7	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.7	0.1	0.4	0.7	0.3	0.3	0.0	0.0	0.0	1.9	1.7	0.3											0.0	2.6	0.0	1.5	1.6	4.7	10.8	2.5	0.0	0.0	3.5	11.8	0.1	3.3	0.2	0.0	0.3	0.0	0.0	0.6	0.0	0.6	1.1	0.0	10.6	0.2	0.0	1.2	4.3	0.0	0.2	0.9	0.0	5.0	0.0	0.0	5.1	1.0	0.0	0.0	0.3	43.6	0.0	0.9	0.3	2.3	4.0	0.1	0.0	0.6	0.9
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269697-38382272	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 85.7;Extravillous trophoblasts: 142.9;monocytes: 86.6;Syncytiotrophoblasts: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	19.2	11.3	31.1	15.8	31.4	36.3	20.1	51.5	37.7	18.5	15.5	16.7	14.0	16.2	16.0	12.5	17.0	16.8	17.0	12.7	24.4	16.6	14.2	11.2	17.9	22.3	25.0	26.8	26.5	16.3	21.0	24.2	22.5	21.9	16.4	18.7	12.3	18.3	17.9	12.3	16.2	17.7	16.0	15.3	17.2	19.7	9.3	25.6	16.7	19.2	6.9	20.4	19.6	23.3	26.7	5.6	26.2	5.1	8.6	18.0	2.9	24.1	13.9	23.9	16.1	16.8	19.3	17.7	20.3	22.4	17.6	20.5	7.4	13.4	28.8	18.7	13.8	17.1	14.6	18.9	16.2	25.2	11.4	11.1	36.7	11.2	8.6	17.2	16.1	13.3	10.3	16.5	15.9	32.4	16.5	20.1	31.9	26.0	19.2	16.7	8.7	47.1	13.7	16.2	18.8	6.6	21.6	26.1	9.1	12.5	18.7	13.5	18.2	16.5	14.5	14.1	16.0	18.2	12.3	19.2	18.3	19.0	27.2	11.9	17.1	20.4	27.8	15.5	16.3	13.2	13.9	5.1	9.1	8.0	2.4	5.3	16.5	12.0	7.1	4.1	26.7	15.0	6.3	26.2	8.6	1.5	5.6	18.0	2.9	31.1	31.4	51.5	37.7	24.4	16.6	25.0	26.8	21.9	25.6	62.5	52.3	0.0	0.0	0.0	0.0	0.0	0.0	62.9	55.7	48.8	0.0	85.7	19.9	60.6	0.0	0.0	0.0	0.0	53.3	142.9	0.0	0.0	8.1	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	86.6	0.0	0.0	50.3	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	109.4	0.0	0.0	0.0
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.4"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 95.1;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 82.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		6900	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	1.9	3.6	11.2	2.7	19.1	1.6	2.6	14.1	35.4	2.5	4.0			1.4	1.9	2.7	3.9	2.2	2.8	1.5	13.9	14.4	3.4	2.5	2.2	3.1	12.6		1.3	3.5	6.5	5.5	2.6		2.8	5.5		2.4	2.1	4.3	2.4	3.2	2.2	3.1	1.6	3.0	3.1			3.6		3.4	3.3	1.0	7.2	15.5	10.4	13.3	6.7	11.1	8.8	6.1	13.6	9.1	0.6	5.4	7.6	7.4	8.4	9.9	8.1	7.9	9.3	0.0	15.0	15.1	18.6	8.4	1.1	10.2	3.1	13.3	5.3	13.4	0.5	9.8	12.8	8.0	0.4	3.3	6.9	4.3	16.4	6.9	4.3	12.7	3.8	10.0	8.2	17.9	12.0	10.0	3.9	5.1	19.1	16.2	7.2	8.8	14.0	9.3	12.8	8.4	9.5	12.4	0.0	5.9	10.1	15.6	18.7	10.3	22.9	8.1	12.1	12.6	17.7	10.1	8.9	6.4	8.1	16.1	10.4	13.3	7.8	8.2	12.1	8.9	6.8	8.2	10.5	15.5	7.2	6.9	8.1	6.0	6.7	12.1	6.2	11.1	8.8											8.9	9.9	12.6	3.2	3.5	95.1	6.2	10.2	4.0	7.9	21.0	82.5	10.9	10.0	10.3	26.6	10.6	25.1	0.0	14.0	12.0	9.3	10.6	9.2	18.7	16.9	41.3	29.3	11.6	27.2	34.0	5.5	15.5	10.1	28.9	27.8	21.3	11.7	14.4	8.1	12.2	82.9	0.0	11.7	28.9	31.3	5.0	15.4	10.9	16.1	7.8
NSMAF	"FAN, GRAMD5"	ENSG00000035681	"Neutral sphingomyelinase activation associated factor"	Q92636	8	58583504-58659844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023067, HPA023148, HPA023151"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA023067: AB_1854653, HPA023148: AB_10670028, HPA023151: AB_1854654"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.86e-3)"	"unprognostic (2.69e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.03e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavorable (4.61e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.69e-1)"	19.3	18.9	13.3	19.2	23.5	8.9	22.7	19.5	14.8	15.2	16.8	11.3	6.0	11.0	17.9	11.5	16.1	12.7	13.1	17.3	12.8	10.9	9.9	6.7	17.7	27.2	13.4	11.7	15.5	20.9	25.6	16.3	15.6	12.9	14.9	17.9	12.7	14.1	15.9	20.3	22.4	16.9	22.3	12.1	20.9	16.8	8.4	11.1	43.8	16.3	11.2	25.0	19.2	17.9	4.8	14.5	15.4	7.2	6.4	8.7	4.5	13.3	13.0	5.9	8.3	22.6	18.4	10.2	10.7	23.9	15.0	14.1	7.2	8.4	16.2	9.0	16.9	15.6	10.7	10.0	8.6	17.1	18.0	5.5	30.3	8.1	8.1	28.7	13.2	21.1	12.4	13.8	10.8	41.6	12.4	14.9	15.0	13.0	11.9	16.9	10.0	27.7	10.7	10.5	10.7	5.1	10.5	8.7	4.6	8.4	10.7	5.5	7.0	9.0	3.4	9.8	8.2	8.3	16.6	13.7	14.9	9.0	19.9	10.9	2.2	1.1	12.8	21.9	10.4	9.4	8.3	7.2	4.8	6.8	5.3	7.0	4.8	7.2	7.1	14.5	4.6	5.1	4.8	15.4	6.4	3.6	5.0	8.7	4.5	13.3	23.5	19.5	14.8	12.8	10.9	13.4	11.7	12.9	11.1	8.9	5.1	13.2	8.6	16.4	8.7	13.7	2.5	2.7	11.4	8.7	3.9	10.5	3.3	6.7	0.2	11.3	6.9	0.0	7.5	7.1	11.3	7.8	27.7	3.4	16.5	30.2	13.8	5.5	29.2	1.5	15.3	27.7	10.1	10.0	8.7	6.0	6.9	7.0	12.0	3.7	5.7	6.5	9.8	1.6	3.2	15.6	7.8	17.3	9.9	8.9
NSMCE1	NSE1	ENSG00000169189	"NSE1 homolog, SMC5-SMC6 complex component"	Q8WV22	16	27224991-27268794	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 274.2;Late spermatids: 281.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041567, HPA043091"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA041567: AB_10964260, HPA043091: AB_10962722"	"unprognostic (6.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	24.0	37.3	26.7	33.3	27.4	16.9	30.1	16.9	27.2	22.2	24.7	31.4	30.8	14.1	23.1	32.5	34.7	36.0	36.7	21.7	24.3	26.3	30.9	37.4	27.1	36.7	31.9	20.9	29.5	45.3	46.7	20.5	21.4	27.1	33.8	21.2	26.0	37.2	31.5	22.5	19.5	23.8	35.4	32.4	20.9	26.2	55.4	19.3	41.5	33.9	25.7	29.3	27.6	20.4	42.0	38.9	31.8	27.7	60.4	41.6	32.6	14.6	21.0	14.4	15.7	23.5	31.6	11.6	15.7	16.0	11.9	12.5	16.3	35.8	28.8	37.7	23.8	12.3	15.8	27.0	47.0	15.5	35.3	18.8	13.3	19.6	31.2	41.0	15.5	10.1	30.9	32.8	30.0	57.4	34.7	16.0	27.6	17.8	9.1	22.0	24.7	20.2	17.2	12.7	24.3	14.5	17.8	17.8	45.1	34.5	9.5	15.3	13.9	10.7	14.9	26.8	18.5	24.6	18.6	9.9	14.5	9.1	16.5	15.0	27.4	19.7	22.2	31.2	15.4	6.2	31.8	27.7	25.0	25.2	24.3	27.8	24.1	36.0	30.6	38.9	42.0	41.6	32.6	9.0	60.4	22.5	37.7	32.8	32.6	26.7	27.4	16.9	27.2	24.3	26.3	31.9	20.9	27.1	19.3	32.8	38.0	33.8	48.8	25.1	13.2	37.8	66.2	91.0	30.7	41.8	2.0	102.9	109.5	65.4	163.4	30.6	55.1	0.0	63.9	52.2	45.2	45.6	274.2	58.2	73.6	12.7	56.4	52.2	49.4	281.7	22.5	40.9	43.9	118.2	57.5	55.3	42.9	45.9	37.4	129.3	13.5	25.8	50.1	91.7	45.8	28.5	53.8	64.8	42.6	44.4
NSUN2	"FLJ20303, Misu, MRT5, TRM4"	ENSG00000037474	"NOP2/Sun RNA methyltransferase family member 2"	Q08J23	5	6599239-6633291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037896	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037896: AB_10670532"	"unprognostic (3.99e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.12e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.70e-2)"	19.0	19.1	11.3	20.4	17.4	16.7	28.1	13.4	16.0	17.4	17.9	20.2	18.2	15.4	21.5	20.6	27.0	19.3	17.1	20.1	12.7	9.7	15.0	34.9	15.0	22.5	13.6	16.5	17.2	18.7	19.5	22.3	18.2	16.1	15.5	21.2	14.3	20.0	15.8	42.3	22.9	20.9	19.1	15.9	23.7	19.9	15.8	13.2	26.7	14.3	17.1	29.5	19.2	17.1	18.1	16.7	15.6	17.3	17.6	22.7	12.7	27.2	23.7	13.9	12.3	8.9	9.9	32.9	21.4	13.0	22.8	19.8	30.8	20.5	47.1	21.9	17.1	28.7	21.0	28.8	24.9	31.0	32.1	23.3	28.0	56.2	17.9	12.8	48.3	22.7	11.3	18.4	25.8	22.6	9.2	16.1	19.8	36.1	17.3	21.1	19.1	26.4	20.9	23.1	18.4	31.0	34.4	14.6	14.5	16.0	30.3	13.3	18.9	52.8	26.8	20.6	18.8	23.4	21.6	18.8	18.2	24.0	18.8	31.8	14.3	26.8	45.2	14.6	38.5	20.9	9.7	14.6	15.6	17.5	17.3	22.7	18.1	18.4	20.7	16.7	16.5	20.4	20.6	2.9	17.6	15.2	16.5	13.0	12.7	11.3	17.4	13.4	16.0	12.7	9.7	13.6	16.5	16.1	13.2	17.9	14.5	12.9	11.7	33.5	5.3	16.1	17.8	17.4	39.8	17.4	13.7	17.1	8.3	18.8	2.2	12.1	10.5	0.0	13.1	17.7	12.1	13.9	19.7	28.4	12.9	3.2	14.3	9.8	22.4	2.2	12.0	14.6	15.1	19.0	15.5	6.8	19.7	14.1	13.4	8.4	6.8	6.5	13.0	13.5	18.7	26.7	19.3	14.1	17.8	12.8
NSUN6	"ARL5B-AS1, FLJ23743, NOPD1"	ENSG00000241058	"NOP2/Sun RNA methyltransferase family member 6"	Q8TEA1	10	18545561-18659285	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 48.7"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 72.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA045902	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA045902: AB_10962354"	"unprognostic (7.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-3)"	"unprognostic (9.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (2.23e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.00e-3)"	5.2	9.8	9.4	8.0	10.3	9.1	8.1	17.8	12.1	8.7	8.2	5.9	13.4	7.2	8.2	10.7	5.7	6.5	5.3	6.3	9.2	8.9	6.0	48.7	4.7	8.7	9.5	6.6	10.2	8.9	8.5	17.7	5.5	7.2	9.3	7.3	3.8	7.0	8.3	3.3	7.6	11.1	9.1	10.8	7.5	7.1	12.3	8.7	10.7	9.3	3.7	8.9	8.0	12.5	9.3	4.5	3.1	8.4	5.5	11.6	2.8	5.7	4.9	13.3	9.8	6.6	9.1	5.8	8.0	2.0	6.7	9.1	9.2	8.8	13.1	3.5	3.1	4.7	8.6	13.4	8.4	8.7	12.7	11.0	13.6	6.4	11.1	6.8	6.1	9.3	7.0	8.2	6.4	4.5	6.7	3.1	15.6	18.8	12.7	6.4	3.2	14.0	7.1	6.8	11.4	3.8	10.0	6.8	13.4	5.0	7.1	7.1	8.8	6.8	7.2	5.4	9.4	4.6	4.9	5.2	5.7	6.6	10.2	5.8	7.9	8.1	14.6	4.0	11.1	3.3	1.4	4.2	3.1	5.4	5.3	8.5	9.3	7.8	6.7	3.3	7.9	9.6	8.1	1.9	5.5	8.4	4.5	11.6	2.8	9.4	10.3	17.8	12.1	9.2	8.9	9.5	6.6	7.2	8.7	8.9	13.7	12.3	15.4	25.4	33.6	6.1	22.9	18.7	17.0	8.7	21.6	8.5	5.0	8.6	13.3	25.1	25.9	0.0	10.9	6.7	13.2	8.6	17.3	72.5	6.4	23.8	13.9	25.8	22.1	11.9	23.9	17.1	11.8	7.2	17.6	18.6	10.1	17.3	15.9	7.9	30.8	12.9	11.1	50.9	20.0	23.3	5.6	20.4	14.5	15.3
NSUN7	FLJ14001	ENSG00000179299	"NOP2/Sun RNA methyltransferase family member 7"	Q8NE18	4	40749897-40809985	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.5"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 48.2;Early spermatids: 34.5;Late spermatids: 53.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.9;CAPAN-2: 8.6;Karpas-707: 6.3;MCF7: 4.1;RPTEC TERT1: 4.2;SuSa: 5.1;T-47d: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA020653	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA020653: AB_1848710"	"unprognostic (2.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.76e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-2)"	0.7	1.2	0.9	2.8	2.0	0.7	5.1	0.2	1.0	3.2	7.0	2.4	7.3	2.3	5.9	9.7	4.5	9.1	5.4	5.5	1.0	1.9	6.6	0.7	8.1	4.2	1.0	0.5	4.6	14.1	7.7	7.5	2.8	2.6	5.7	3.2	4.3	15.2	10.3	0.1	1.9	6.7	2.6	1.8	3.6	3.8	39.5	0.2	2.4	11.9	1.5	5.3	3.7	1.5	1.1	0.0	6.1	0.1	0.0	0.0	0.0	3.9	0.4	1.9	0.0	0.0	0.0	2.9	0.0	0.3	0.2	0.2	1.5	8.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	4.1	0.1	0.0	2.3	0.0	0.5	0.1	0.1	0.0	4.2	1.1	1.0	2.3	0.6	2.7	0.0	5.1	6.3	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.2	1.0	1.0	1.9	1.0	0.5	2.6	0.2	8.9	5.6	0.0	3.3	1.0	0.0	3.7	0.0	48.2	15.9	8.7	0.0	7.5	8.3	4.4	34.5	0.3	2.1	0.0	4.7	2.8	0.5	4.2	0.0	0.0	3.0	0.0	7.9	0.6	0.3	53.6	1.4	0.7	0.0	1.8	5.8	2.0	5.3	0.0	0.0	5.2	0.0	0.0	0.3	22.8	12.4	0.9	3.8	0.5	7.5	4.3
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841197	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.0"	"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.0"					"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"	NA	NA			Mitochondria	Cytosol	"HPA041634: AB_10795597"	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.11e-4)"	4.2	5.4	14.8	3.2	10.5	23.9	5.4	2.7	16.2	12.2	52.0	2.9	9.4	2.0	17.9	8.4	8.9	3.5	2.6	2.2	13.3	5.7	2.2	4.0	2.8	2.3	2.8	11.7	3.8	3.5	1.8	4.2	4.5	10.4	9.8	12.5	3.7	3.9	9.1	7.0	2.8	4.2	32.9	2.1	1.9	6.6	3.5	2.7	0.0	2.9	0.9	2.4	22.4	5.2	4.1	4.9	2.4	1.6	1.5	3.3	0.8	3.3	6.0	3.5	4.0	4.9	3.9	6.5	5.5	3.3	3.9	2.5	4.1	0.9	5.6	1.1	6.5	4.3	3.8	4.9	10.9	5.7	4.1	4.0	7.0	2.2	4.7	2.8	3.7	1.9	3.4	2.4	5.0	22.0	8.0	2.3	2.9	11.0	2.9	8.7	3.0	3.2	6.0	4.3	4.8	6.5	4.5	6.1	2.1	6.2	2.3	4.7	1.9	4.6	5.2	6.5	3.3	2.9	3.5	3.0	3.9	4.7	5.3	11.0	2.6	3.1	4.2	3.7	5.7	5.6	0.8	1.5	0.1	1.7	1.6	3.3	3.5	2.4	1.4	3.8	4.1	2.1	1.8	2.4	1.5	1.0	4.9	0.6	0.8	14.8	10.5	2.7	16.2	13.3	5.7	2.8	11.7	10.4	2.7	0.0	2.9	0.8	17.0	3.9	1.5	2.8	2.5	9.4	2.3	1.8	0.0	4.2	0.0	1.8	8.8	1.6	1.6	0.0	1.8	4.4	3.9	10.0	0.0	4.3	1.7	9.5	39.5	1.3	3.5	7.4	4.6	2.5	0.0	2.8	9.1	0.8	2.3	0.0	7.8	1.5	4.9	0.0	8.0	0.5	3.1	3.9	3.4	0.9	9.0	8.6
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.3	2.8	4.9	0.1	11.2	35.7	0.0	34.5	37.8	17.0	32.0	0.0	53.0	0.0	12.4	30.1	43.8	2.7	0.0	34.7	40.6	0.0	0.0	0.0	0.8	0.6	5.6	0.0	0.0	9.1	0.4	34.7	22.1	93.4	14.1	0.0	0.0	0.1	105.7	0.9	0.0	0.0	0.1	0.9	3.8	0.1	1.1	0.1	36.8	2.4	0.0	0.6	0.4	2.1	11.7	0.2	0.0	0.9	61.2	13.9	0.1	17.5	56.1	2.6	1.6	0.0	95.4	0.0	43.5	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2	0.0	4.3	15.6	1.0	4.6	4.6	0.8	20.4	6.7	6.8	1.8	9.8	0.4	3.3	3.7	0.5	13.5	10.3	0.0	3.7	1.5	16.9	0.9	0.0	29.0	1.3	0.0	0.0	45.4	5.3	0.9	12.0	2.5	6.8	0.0	33.2	5.6	72.9	31.7	24.1	20.6	77.4	0.0	8.0	0.0	0.2	4.3	12.7	2.2	13.8	5.9
NTAN1		ENSG00000157045	"N-terminal asparagine amidase"	Q96AB6	16	15037853-15056079	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051418			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA051418: "	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (4.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	24.2	8.3	11.7	8.1	11.7	11.9	48.2	5.2	12.1	16.1	18.0	5.4	8.6	6.8	14.4	24.5	14.6	10.2	12.2	23.2	8.0	6.0	10.6	16.9	13.5	12.4	7.4	8.0	13.0	13.3	7.6	5.0	7.8	9.8	15.9	15.7	17.9	11.1	7.7	14.4	13.6	9.7	19.8	7.4	13.7	12.9	14.0	6.4	8.1	10.5	12.7	11.7	18.8	19.9	9.4	12.0	31.2	5.7	5.3	12.3	5.2	10.0	7.3	8.8	7.6	11.3	21.8	3.3	12.2	16.6	12.5	21.6	3.4	7.5	6.9	9.7	23.2	9.8	4.2	7.0	14.3	17.5	6.6	9.7	4.0	6.6	18.8	11.6	2.9	2.2	11.3	8.5	12.0	4.6	7.9	28.3	10.3	4.7	7.9	23.2	8.4	5.9	12.3	6.4	11.7	8.2	11.8	12.0	9.3	9.0	13.9	2.7	10.0	5.0	1.8	8.6	17.9	3.3	4.5	15.9	18.1	7.2	7.6	10.7	7.7	15.3	9.1	10.9	6.5	8.2	2.5	4.1	31.2	5.5	5.7	6.5	9.4	7.2	7.3	3.8	6.1	5.9	3.7	1.9	5.3	5.5	12.0	12.3	5.2	11.7	11.7	5.2	12.1	8.0	6.0	7.4	8.0	9.8	6.4	3.0	4.6	27.4	13.7	29.9	5.6	2.5	10.2	4.0	13.6	17.4	9.8	62.9	38.1	42.6	39.3	51.7	10.5	0.0	20.6	15.7	22.3	22.4	8.1	16.4	96.7	23.8	6.4	46.1	47.3	19.7	76.8	45.7	55.6	55.9	8.1	7.8	42.1	11.8	70.7	27.1	7.4	38.8	29.7	26.5	27.7	19.1	47.6	28.4	14.2	19.2
NTF3	NGF2	ENSG00000185652	"Neurotrophin 3"	P20783	12	5432112-5521536	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 29.2"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 26.7;Basal keratinocytes: 16.5;Sertoli cells: 32.3;Smooth muscle cells: 32.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	16	"cerebellum: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;HBF TERT88: 15.0;RT4: 6.8"	"Group enriched"	"Detected in many"	5	"amygdala: 4.1;basal ganglia: 7.4;cerebellum: 12.3;hippocampal formation: 12.3"	"Low region specificity"	"Detected in all"			HPA032001	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA032001: AB_2674106"	"unprognostic (3.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.33e-3)"	"unprognostic (4.66e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.77e-4)"	"unprognostic (4.02e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.06e-3)"	"unprognostic (4.51e-3)"	4.9	2.7	0.5	2.4	0.5	0.0	5.4	29.2	0.6	12.9	4.7	0.3	5.6	2.7	9.2	6.8	5.0	2.2	5.3	4.1	1.7	0.2	4.3	10.4	2.5	1.0	0.7	0.2	16.8	0.4	0.1	1.3	2.7	1.2	8.9	1.5	8.9	4.6	3.7	3.6	3.7	6.6	11.5	0.4	8.5	3.0	3.5	0.0	0.2	1.2	3.9	2.0	10.4	9.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.5	0.0	0.0	0.0	0.0	3.4	9.2	12.1	16.2	0.1	0.2	0.0	5.5	5.7	0.0	2.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.6	3.8	6.8	0.2	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	29.2	0.6	1.7	0.2	0.7	0.2	1.2	0.0	0.0	0.0	0.0	26.7	16.5	0.0	0.6	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	5.2	4.7	0.0	2.4	0.0	0.0	0.0	8.0	0.0	0.0	7.8	0.9	6.8	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	32.3	32.7	0.6	0.7	2.9	0.1	0.0	0.0	3.9
NTF4	"GLC1O, NT-4/5, NTF5"	ENSG00000225950	"Neurotrophin 4"	P34130	19	49061066-49065054	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 24.3"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 28.5;Club cells: 9.1;Cytotrophoblasts: 12.3;Urothelial cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.3;HaCaT: 18.8;HBEC3-KT: 7.0;hTCEpi: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049376			Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA049376: AB_2680735"	"unprognostic (4.15e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.27e-4)"	"unprognostic (1.76e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.90e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.71e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.46e-3)"	0.3	0.0	0.3	0.3	0.3	0.0	3.6	0.3	1.0	2.8	0.3	0.3	5.7	0.0	0.3	8.0	7.1	1.7	0.3	0.3	0.3	0.0	0.3	0.3	3.3	0.3	0.3	0.3	0.3	0.3	0.0	2.3	3.0	0.3	11.9	0.0	0.3	5.7	6.1	11.9	24.3	0.3	1.4	0.3	0.3	0.0	1.3	0.3	1.4	0.9	2.3	2.2	6.2	5.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.2	1.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.0	8.3	0.0	2.1	0.0	0.3	18.8	0.0	7.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	31.0	0.0	1.0	1.9	0.0	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.4	0.1	0.0	2.8	4.9	0.1	0.1	1.1	2.2	0.1	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.0	0.3	0.0	0.3	0.3	0.3	0.3	3.0	0.0	0.0	28.5	6.3	0.0	0.4	0.0	1.4	9.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	3.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	2.8	2.3	0.0	0.0	9.9
NTPCR	"C1orf57, HCR-NTPase, MGC13186"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA028125: AB_10601091, HPA054304: AB_2682443"	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	5.4	9.8	13.2	5.8	14.9	2.5	8.7	14.5	15.9	9.9	8.0	11.1	4.1	5.1	9.6	9.5	8.0	11.3	9.6	10.3	13.3	13.1	8.4	6.1	7.4	6.5	13.7	10.8	12.9	13.4	16.9	8.0	6.3	18.5	8.8	10.3	10.8	10.1	10.0	26.8	9.9	6.8	9.9	12.6	6.3	5.8	11.2	11.0	5.7	13.6	11.1	6.5	7.1	7.4	2.4	1.5	3.3	1.8	1.6	4.3	1.3	2.5	6.2	7.1	3.5	5.3	7.0	0.1	1.7	5.5	5.3	7.2	4.4	3.0	3.9	3.8	3.4	3.0	3.4	4.7	6.3	5.8	2.9	8.9	1.2	3.9	5.6	5.5	2.1	2.4	9.3	12.3	5.1	5.2	5.3	4.3	7.5	3.4	6.1	6.2	1.8	5.5	5.6	7.0	5.1	7.4	3.6	4.6	5.7	7.8	3.1	6.2	10.3	2.4	2.1	2.5	5.6	5.2	4.8	3.2	4.4	3.6	4.8	4.7	6.9	5.6	4.5	5.2	5.2	6.3	1.1	1.6	0.8	2.1	1.8	2.5	1.6	3.0	1.3	1.5	2.4	4.3	3.5	3.3	1.6	1.6	0.6	3.5	1.3	13.2	14.9	14.5	15.9	13.3	13.1	13.7	10.8	18.5	11.0	17.9	19.7	13.4	32.1	17.2	15.2	58.9	28.1	12.0	11.4	24.4	25.5	55.1	79.6	53.6	28.3	24.0	38.0	0.0	56.9	49.7	26.7	31.6	16.1	32.1	37.9	9.5	24.8	26.4	19.2	21.4	18.7	22.0	21.9	33.3	46.4	34.1	37.9	21.0	28.7	60.8	20.0	12.9	24.7	60.2	34.9	20.8	23.5	17.5	61.5	31.6
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 15.8;blood: 32.3;brain: 28.3"	"Group enriched"	"Detected in some"	8	"granulocytes: 56.4;Horizontal cells: 54.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enriched"	"Detected in many"	5	"pons and medulla: 28.3"	"Cell type enriched"	"Detected in single"	127	"basophil: 32.3"	"Lineage enriched"	"Detected in single"	323	"granulocytes: 32.3"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 42.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 8.2"	"Low region specificity"	"Detected in all"			"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		140000	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	1.0	15.8	0.5	0.8	6.0	0.9	0.4	0.0	0.7	0.9	1.1	0.1	0.0	0.8	1.6	2.0	0.7	0.6	2.1	1.5	0.0	1.2	2.9	0.2	1.9	0.3	2.1	0.6	0.3	0.3	0.3	1.1	0.5	28.3	2.2	0.2	3.1	1.2	0.5	0.7	0.2	0.4	1.1	1.2	0.2	1.0	2.4	1.5	0.4	0.3	0.0	0.4	0.7	0.8	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	6.8	0.0	0.0	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.8	9.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	32.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	0.0	0.6	0.0	1.2	2.1	0.6	28.3	1.5	0.0	2.2	0.0	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	56.4	0.0	0.1	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	2.5	0.1	0.0	0.0	0.0	0.0
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027070	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Epilepsy, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;thyroid gland: 63.4"	"Cell type enhanced"	"Detected in many"	12	"Horizontal cells: 228.8;Leydig cells: 96.4;Muller glia cells: 248.1;Sertoli cells: 122.9;Smooth muscle cells: 96.9"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.7;SH-SY5Y: 13.4;SuSa: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346, HPA074873"	Enhanced		Approved	Cytosol		NA	NA		13000000	Cytosol		"CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: "	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	19.8	2.7	66.1	2.0	56.7	1.2	33.2	15.1	133.8	6.4	4.4	27.4	0.0	1.4	3.0	3.3	5.6	3.7	18.7	5.8	61.0	30.7	12.5	2.1	6.3	2.7	32.4	41.4	6.6	18.9	1.6	3.0	2.1	34.1	3.8	3.1	2.0	8.6	11.9	2.0	7.2	1.6	3.0	22.1	6.5	1.4	2.4	34.1	0.0	63.4	2.6	3.4	3.5	3.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	11.7	0.8	0.9	13.4	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	66.1	56.7	15.1	45.6	61.0	30.7	32.4	41.4	34.1	34.1	0.0	0.3	0.0	1.0	50.4	24.4	8.7	0.0	2.7	0.0	8.7	5.9	0.0	23.2	26.5	1.5	4.5	0.0	0.0	0.6	0.1	10.6	0.9	0.0	0.0	0.2	228.8	0.0	5.5	0.0	1.7	96.4	1.2	16.9	1.0	0.0	248.1	0.5	7.2	45.3	7.9	9.1	122.9	96.9	0.7	1.1	21.5	0.0	0.0	5.4	0.8
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 58.9;Early spermatids: 85.5;Late spermatids: 103.3;Sertoli cells: 51.8;Smooth muscle cells: 37.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"U-138 MG: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA		11000000	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245"	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	20.8	7.4	22.0	2.5	28.1	1.5	6.2	30.4	41.8	7.0	4.0	8.4	1.3	2.0	12.4	6.7	3.4	9.5	3.9	5.5	22.0	11.1	5.1	2.0	5.7	3.1	11.2	18.7	5.1	2.9	1.6	7.9	2.8	14.7	6.8	4.7	8.0	11.5	8.7	1.9	2.9	2.5	7.7	13.7	4.1	3.0	13.8	13.7	0.0	2.5	0.7	4.3	7.1	4.8	0.7	0.4	1.3	0.5	0.5	0.8	0.0	0.0	6.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	48.6	0.9	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.1	1.2	0.5	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.1	0.7	0.4	0.4	1.3	0.5	0.1	0.4	0.8	0.0	22.0	28.1	30.4	28.9	22.0	11.1	11.2	18.7	14.7	13.7	0.0	0.0	0.0	5.9	0.5	58.9	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	85.5	0.7	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.9	1.6	0.0	1.8	0.0	103.3	3.1	0.2	0.0	0.0	0.0	8.9	0.0	0.0	25.8	0.0	2.7	51.8	37.7	8.8	1.9	0.1	0.1	0.0	0.0	0.1
NUAK1	"ARK5, KIAA0537, NuaK1"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063340-106140033	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.3;parathyroid gland: 18.6"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 46.0;Endothelial cells: 46.6;Ito cells: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AF22: 23.1;EFO-21: 23.1;RH-30: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"		Yes	No			"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	8.2	1.8	4.2	2.0	13.0	0.0	5.5	9.9	20.1	4.6	1.7	24.3	1.1	1.0	5.8	1.6	1.9	3.6	2.7	11.3	5.1	3.3	2.5	2.4	4.9	1.5	8.7	8.4	3.2	1.2	18.6	1.9	2.5	7.6	3.6	2.2	2.3	1.8	3.7	9.4	11.6	1.5	6.3	5.5	1.1	1.5	1.3	9.3	1.1	1.8	1.1	1.4	3.4	3.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	5.0	3.4	23.1	0.2	9.3	1.0	10.7	5.7	3.9	4.4	3.3	1.7	0.8	0.0	23.1	10.4	1.9	4.8	4.8	4.6	2.1	0.0	1.3	0.0	3.7	1.8	1.9	0.0	0.0	4.8	3.1	2.5	0.8	7.6	8.4	0.0	0.0	16.8	3.1	0.5	0.1	0.2	4.5	0.0	1.4	0.0	33.2	4.0	2.5	5.9	2.7	0.1	2.6	0.8	0.2	15.9	1.2	0.1	6.2	3.8	12.9	1.4	6.8	0.0	0.0	0.3	1.1	0.0	3.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.0	9.9	17.5	5.1	3.3	8.7	8.4	7.6	9.3	0.0	3.7	0.0	32.0	11.9	30.8	46.0	2.5	0.0	5.7	7.0	0.0	0.4	3.3	5.0	0.3	46.6	0.0	23.3	8.3	4.1	9.2	4.4	0.0	10.5	6.1	38.1	0.0	119.1	9.7	1.7	3.7	1.3	10.1	1.0	2.0	1.7	11.7	0.0	2.8	1.4	2.6	0.0	14.4	0.7	5.5	13.9	0.2	0.9	0.9	3.7
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302059-205321791	"Enzymes, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.4"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 31.4;Ductal cells: 40.9;monocytes: 48.7;Mucus-secreting cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.4"	"Group enriched"	"Detected in all"	4	"B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;RPMI-8226: 17.6;RPTEC TERT1: 20.9;SuSa: 24.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	1.4	2.8	0.8	12.5	2.4	8.3	0.9	9.2	1.5	18.9	10.4	3.9	2.4	13.6	2.7	3.8	31.3	3.4	1.3	1.1	1.7	1.0	14.5	3.6	16.2	20.3	5.5	1.5	3.3	13.2	0.1	2.3	7.2	2.0	1.5	7.5	9.8	9.7	2.0	0.7	12.9	15.4	0.9	2.7	10.4	2.0	5.6	2.4	5.5	14.5	20.1	31.7	2.8	24.6	15.3	3.6	42.4	5.6	5.7	10.7	5.4	2.1	11.6	7.1	0.3	0.1	0.3	22.8	2.8	2.9	7.6	3.1	12.2	0.4	3.4	1.7	0.7	12.5	4.2	1.6	4.2	3.3	0.0	0.2	0.0	0.7	2.1	4.9	0.0	0.0	1.3	3.1	4.4	2.6	1.7	0.3	0.0	0.4	0.9	1.4	0.5	0.0	0.0	4.5	1.5	0.3	0.0	0.5	17.6	20.9	0.0	1.1	0.1	0.8	3.3	0.3	24.7	3.3	0.0	0.8	2.7	1.3	0.3	4.3	6.2	0.9	2.1	0.4	0.0	1.0	3.4	5.6	13.2	3.9	4.2	2.8	14.2	4.8	4.6	3.6	15.3	10.7	8.1	42.4	5.7	4.1	1.4	2.8	5.4	0.8	2.4	9.2	1.5	1.7	1.0	5.5	1.5	2.0	2.4	6.0	5.0	9.1	0.8	1.0	0.8	1.4	20.4	2.7	0.0	31.4	0.0	6.5	5.0	40.9	1.7	2.2	20.3	0.0	1.5	27.7	4.0	1.8	0.0	2.9	4.6	0.0	10.4	1.3	11.7	1.2	0.0	6.5	6.8	48.7	40.0	1.7	7.2	2.9	0.0	15.0	0.5	6.5	2.5	0.5	0.9	4.6	3.4	4.5	18.7	0.2
NUBP2	CFD1	ENSG00000095906	"Nucleotide binding protein 2"	Q9Y5Y2	16	1782901-1789191	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041704	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041704: AB_10804006"	"unprognostic (1.94e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.83e-2)"	16.9	22.8	12.9	15.4	12.4	19.5	14.7	16.3	19.8	13.9	15.1	14.9	16.1	21.6	14.1	14.2	20.3	15.6	15.2	13.8	12.0	10.4	16.5	32.3	12.1	18.0	14.4	17.4	14.6	37.6	8.3	13.8	14.7	12.9	17.7	6.4	14.8	26.9	16.3	30.2	17.2	19.1	16.4	12.0	17.9	18.8	14.5	13.2	22.7	19.4	20.7	16.6	15.3	13.6	25.8	44.1	28.8	29.7	25.8	41.3	31.1	9.2	30.3	5.3	15.9	4.3	3.1	17.1	11.3	4.8	6.9	7.9	17.0	14.1	15.0	12.4	2.4	5.2	10.8	3.6	10.2	1.3	12.4	29.1	6.3	22.5	26.8	8.3	9.4	13.0	4.5	9.0	5.4	4.0	4.3	8.7	18.3	15.6	9.6	2.8	34.2	19.0	15.5	14.4	8.7	17.7	25.0	11.5	33.3	5.5	7.1	20.1	23.5	11.2	16.5	11.3	1.5	25.2	11.2	9.6	11.0	14.5	10.9	10.9	22.0	14.0	17.4	6.6	11.9	14.3	25.6	29.1	28.8	34.7	29.7	31.7	24.3	30.9	30.5	30.2	25.8	25.8	24.2	14.4	25.8	28.2	44.1	41.3	31.1	12.9	12.4	16.3	19.8	12.0	10.4	14.4	17.4	12.9	13.2	14.9	25.7	52.2	36.7	31.8	32.4	21.2	45.9	13.4	23.9	29.6	19.6	88.5	56.3	58.2	27.4	31.5	37.8	0.0	64.8	66.3	45.0	34.5	19.7	60.6	55.1	22.3	36.7	27.6	44.1	62.9	33.9	27.6	55.6	48.7	43.9	38.9	54.9	31.6	29.0	50.1	34.0	45.3	42.8	35.1	28.3	36.3	34.6	50.1	53.3	20.0
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712819-205750276	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	25.6	25.3	46.9	17.3	55.5	12.1	31.3	45.0	49.2	33.0	24.2	38.3	18.8	12.5	36.5	27.8	25.3	32.1	22.5	40.6	43.8	35.6	30.9	43.9	20.6	29.4	43.6	47.6	49.1	17.4	50.3	21.0	20.8	32.8	31.9	21.1	21.9	19.0	32.7	43.1	21.7	14.6	42.9	49.1	22.6	17.9	14.2	38.9	35.3	42.5	20.6	24.8	32.0	22.6	7.8	7.4	4.5	4.9	10.7	11.8	4.0	40.6	25.0	67.5	26.6	18.7	25.9	31.8	29.4	30.3	41.3	33.3	13.7	47.0	45.2	17.1	28.6	13.1	30.1	51.2	24.6	47.4	21.6	25.6	29.4	22.1	14.9	13.8	46.1	10.5	20.5	22.3	24.5	42.8	22.2	32.2	29.3	47.1	14.5	32.2	47.0	41.8	23.3	68.9	16.3	18.7	43.7	83.2	25.9	23.1	25.1	28.1	52.0	43.3	34.7	23.5	54.6	53.1	34.8	32.1	31.7	28.2	36.1	51.9	13.4	15.7	36.5	21.8	26.0	42.6	4.5	3.4	3.7	9.9	4.9	9.6	5.8	9.2	8.6	4.7	7.8	11.5	11.8	0.6	10.7	4.0	7.4	5.5	4.0	46.9	55.5	45.0	36.6	43.8	35.6	43.6	47.6	32.8	38.9	199.5	245.2	149.9	252.8	229.2	349.8	365.7	310.8	239.6	291.2	287.9	68.7	230.3	326.6	177.1	41.7	224.6	54.9	233.6	148.6	321.5	312.0	255.4	201.9	550.1	225.1	298.8	172.0	219.1	173.7	32.2	474.1	194.8	165.4	192.0	193.2	516.1	113.3	94.7	456.1	297.2	177.2	310.4	243.6	46.5	115.0	213.3	148.2	154.5	216.0	173.7
NUDCD2	"DKFZp686E10109, NudCL2"	ENSG00000170584	"NudC domain containing 2"	Q8WVJ2	5	163446526-163460140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037384, HPA037385"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA037384: AB_2675447, HPA037385: AB_10673630"	"unprognostic (3.96e-1)"	"unprognostic (3.69e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.85e-2)"	18.3	17.3	19.1	17.4	20.2	14.0	16.6	10.4	21.8	8.5	15.1	23.2	12.7	20.2	12.5	9.7	15.0	14.3	9.9	10.1	19.9	15.1	16.2	20.1	11.8	18.9	27.0	14.5	13.4	24.4	9.6	13.2	14.5	19.3	12.7	9.1	9.3	19.4	10.6	25.7	11.7	18.0	14.1	30.5	16.6	15.9	12.5	20.9	16.9	14.6	11.0	13.4	12.8	11.5	34.3	30.3	14.1	21.6	28.5	36.5	24.4	23.5	12.2	9.3	14.6	5.7	4.2	12.3	9.5	2.8	3.4	5.5	10.9	18.1	13.4	23.0	1.5	15.9	11.9	4.9	5.4	4.1	26.7	13.7	12.4	15.5	9.9	6.2	13.9	14.1	1.5	3.2	3.3	4.8	4.9	3.8	15.3	13.0	16.8	3.5	9.6	20.6	30.7	10.2	7.0	13.5	17.4	15.5	23.8	3.1	5.5	23.7	13.4	15.0	9.7	24.7	5.8	18.6	14.4	8.5	11.8	17.7	13.0	21.8	13.9	23.2	22.6	13.7	24.2	12.3	14.1	18.9	11.8	23.8	21.6	30.3	34.3	34.0	28.4	25.4	24.4	36.5	31.9	2.4	28.5	17.9	30.3	30.0	24.4	19.1	20.2	10.4	18.1	19.9	15.1	27.0	14.5	19.3	20.9	26.8	18.4	48.4	46.7	52.8	29.3	36.7	30.6	41.5	31.8	36.6	21.6	97.0	126.0	54.7	60.9	45.6	19.3	23.3	55.7	43.8	50.3	51.1	30.1	51.3	61.4	9.5	42.1	31.9	41.1	11.4	47.8	38.8	47.2	40.5	42.0	35.3	54.2	28.1	48.1	89.3	36.4	38.8	41.9	69.5	42.8	59.1	47.5	42.4	61.0	48.8
NUDCD3	"KIAA1068, NudCL"	ENSG00000015676	"NudC domain containing 3"	Q8IVD9	7	44379121-44490880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019136, HPA019528, HPA019529"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374"	"unprognostic (3.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.18e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.50e-2)"	8.3	6.3	15.3	5.4	20.8	7.3	7.2	10.9	26.0	7.8	5.8	7.7	6.4	4.0	6.9	7.3	8.0	10.3	6.7	19.5	15.2	13.0	6.0	5.8	7.2	6.2	12.5	16.8	9.3	6.8	12.8	4.7	5.3	10.1	8.4	5.7	6.1	7.1	9.9	18.3	7.0	5.0	8.8	10.1	5.8	5.9	9.9	7.1	4.1	8.1	4.8	6.6	6.3	5.3	4.7	2.8	3.2	3.1	2.5	4.7	3.5	3.1	5.9	4.3	7.8	5.4	4.5	1.7	5.2	5.0	6.0	6.3	4.0	2.2	10.1	3.9	6.7	8.4	3.7	5.9	6.8	3.5	5.8	6.3	2.9	3.6	2.9	5.0	4.8	1.8	4.0	4.6	4.5	5.2	3.6	7.3	3.4	7.2	3.3	4.4	2.8	2.1	4.5	5.5	3.1	7.9	3.3	4.7	3.7	3.4	4.9	4.7	13.5	3.0	5.6	2.3	4.5	4.3	6.9	7.1	4.3	4.4	2.7	4.1	9.2	9.6	5.1	4.5	5.8	7.4	2.0	2.8	3.2	4.6	2.7	4.7	3.5	4.4	3.8	2.6	4.7	4.6	4.0	1.8	2.5	3.1	2.8	4.4	3.5	15.3	20.8	10.9	26.0	15.2	13.0	12.5	16.8	10.1	7.1	11.9	19.2	17.2	11.6	10.1	37.9	38.9	12.7	21.4	13.6	36.6	51.1	17.0	19.9	27.0	56.9	21.1	21.5	0.0	18.7	15.8	15.0	14.2	9.2	28.8	15.6	46.1	16.7	21.5	19.8	67.6	28.1	11.6	15.1	19.8	21.4	25.5	23.6	21.2	26.5	21.3	40.2	32.3	15.5	52.1	13.7	14.2	12.0	15.8	25.0	10.8
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2"	"Group enriched"	"Detected in some"	5	"Ito cells: 54.6;Peritubular cells: 27.3"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 6.2;HAP1: 11.6;HEK 293: 8.6;NTERA-2: 21.3;SH-SY5Y: 4.6;SuSa: 4.4;U-2 OS: 10.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	1.0	2.3	9.3	1.4	10.7	1.8	1.4	6.0	13.1	4.4	2.0	0.9	28.8	1.1	5.5	18.3	1.7	3.4	2.0	0.9	4.9	13.6	3.1	1.9	0.7	0.9	5.3	8.0	19.2	0.6	0.5	4.5	0.5	6.2	17.9	1.3	0.8	1.0	36.3	0.5	1.0	1.2	4.9	1.9	3.1	1.1	27.2	1.2	0.0	0.8	0.0	0.9	2.8	2.9	0.8	0.1	0.0	0.7	2.1	1.0	0.3	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	11.6	0.5	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	21.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.8	1.0	0.0	0.1	0.3	0.0	0.6	0.0	2.1	0.5	0.0	0.0	0.3	9.3	10.7	6.0	11.7	4.9	13.6	5.3	8.0	6.2	1.2	0.0	2.2	0.0	4.6	0.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.4	0.4	2.1	0.0	0.0	0.2	0.0	0.0	54.6	3.4	4.0	5.5	0.0	1.7	0.0	0.0	1.8	0.0	0.0	27.3	0.0	0.4	0.0	1.9	2.4	7.9	0.1	0.3	0.0	0.0	0.0
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496596	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;testis: 35.5"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 13.6;Peritubular cells: 19.4;Smooth muscle cells: 12.7;Spermatocytes: 13.4;Spermatogonia: 11.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.6;NTERA-2: 21.0"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.2	5.4	11.2	1.4	21.9	1.6	2.8	7.4	26.1	3.8	2.6	0.8	4.4	1.7	5.9	4.3	1.9	1.6	2.2	0.8	7.0	17.9	0.9	0.6	0.8	1.1	5.3	12.7	10.0	3.8	0.5	2.8	0.6	5.3	10.1	1.4	0.5	1.3	11.9	0.6	1.7	1.5	5.0	1.8	0.9	0.9	35.5	1.1	3.6	1.0	0.2	1.1	1.7	1.6	0.5	0.4	0.0	0.2	1.9	3.7	1.0	0.0	0.5	10.1	0.0	8.8	11.2	0.0	4.7	1.3	0.2	0.2	0.0	0.0	0.0	0.2	5.7	5.6	0.7	33.6	11.5	0.1	0.0	2.2	0.0	0.0	0.0	4.1	0.0	2.2	6.8	4.6	3.0	11.1	1.9	7.9	10.4	0.0	0.0	9.5	0.2	12.7	0.0	21.0	0.0	8.5	0.0	7.1	0.0	2.1	0.0	0.0	6.6	2.0	0.0	1.8	5.2	0.0	0.0	4.6	2.4	11.1	0.7	0.0	4.4	2.0	7.2	1.5	0.0	0.9	0.0	0.0	0.0	3.7	0.0	1.4	0.5	1.2	1.9	0.4	0.3	0.2	3.1	0.0	1.9	0.2	0.2	0.0	1.0	11.2	21.9	7.4	14.9	7.0	17.9	5.3	12.7	5.3	1.1	0.0	0.0	0.0	4.8	13.6	1.5	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.2	9.4	0.0	0.0	0.0	1.3	0.9	4.1	9.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	10.2	8.1	0.6	5.0	0.0	0.0	0.9	2.2	0.0	19.4	0.0	0.1	0.0	12.7	13.4	11.9	8.0	0.2	0.0	0.0	1.1
NUDT13	DKFZp586P2219	ENSG00000166321	"Nudix hydrolase 13"	Q86X67	10	73110375-73131828	"Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040636	Approved		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA040636: AB_10960360"	"unprognostic (3.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.07e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.96e-2)"	4.3	7.4	3.7	9.9	8.9	5.0	6.3	3.5	5.1	3.4	8.1	7.2	9.5	7.0	6.5	13.8	3.8	4.5	7.0	7.0	5.9	3.0	7.1	12.8	5.1	5.3	7.3	4.5	4.4	7.8	7.4	4.1	3.6	5.8	5.2	4.7	3.7	5.0	8.8	8.6	7.2	5.8	5.2	11.8	5.8	6.0	5.6	7.2	2.4	4.6	2.8	4.8	6.8	3.7	6.2	1.9	2.5	3.4	4.9	3.7	1.1	5.1	3.7	6.0	7.5	3.8	3.2	1.3	4.6	4.1	2.4	2.7	9.7	10.8	2.5	2.3	2.8	3.9	6.1	0.6	4.3	2.4	1.9	10.5	7.0	6.0	5.3	0.3	3.9	2.9	2.3	4.7	3.1	1.7	6.4	1.8	4.6	5.9	4.0	2.4	2.4	2.3	5.6	2.3	3.3	11.9	5.1	1.0	0.2	3.3	2.4	2.7	3.9	2.5	6.2	2.0	2.7	3.4	2.5	3.4	2.1	8.2	0.8	1.7	2.9	3.3	3.4	5.9	7.2	2.0	0.1	2.6	2.5	1.8	2.5	2.1	3.0	1.5	1.6	1.9	6.2	2.3	2.4	1.0	4.9	3.4	0.6	3.7	1.1	3.7	8.9	3.5	5.1	5.9	3.0	7.3	4.5	5.8	7.2	6.0	1.3	2.2	2.3	0.8	1.3	6.2	0.0	6.7	2.3	3.5	3.9	3.0	3.3	1.6	2.6	1.0	1.2	0.0	0.6	0.7	1.3	1.4	0.0	3.2	1.5	0.0	1.2	0.6	1.3	3.4	0.9	1.5	0.0	1.8	1.8	0.8	1.2	2.9	0.7	4.1	1.7	0.0	1.0	3.2	0.5	1.3	0.9	0.0	1.3	0.9
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	18.2	12.6	22.4	5.0	16.0	3.1	14.3	2.5	23.4	6.5	11.0	7.9	5.9	16.7	4.7	11.7	7.1	12.6	9.8	20.9	15.4	13.5	16.7	11.2	12.6	9.4	16.1	14.8	4.0	26.0	4.7	27.6	4.8	11.2	10.5	4.6	14.7	16.7	9.9	28.7	6.2	13.8	3.1	13.2	6.3	12.7	8.9	7.8	3.1	17.9	9.2	5.7	4.9	4.7	5.8	15.1	1.7	27.3	6.1	5.8	8.9	8.2	11.3	1.0	4.4	1.3	1.6	18.1	2.3	3.1	3.8	5.5	8.0	8.8	0.6	11.6	1.2	8.5	10.4	0.5	6.3	0.3	4.3	8.3	1.8	4.9	5.5	9.7	2.2	22.3	2.3	8.0	0.9	0.7	1.6	7.5	4.1	2.8	1.4	1.3	24.0	0.2	0.0	5.9	19.5	15.8	4.3	10.4	4.8	4.1	23.8	15.7	2.3	4.1	0.1	9.6	1.9	8.9	10.7	17.6	6.3	2.8	4.5	2.3	0.7	0.4	1.0	9.3	2.5	2.3	1.7	18.5	0.5	5.8	17.4	3.6	5.8	4.6	3.8	15.1	4.0	4.5	5.2	0.6	6.1	27.3	7.3	2.5	8.9	22.4	16.0	2.5	23.4	15.4	13.5	16.1	14.8	11.2	7.8	11.9	22.0	13.7	80.0	34.6	11.8	47.7	35.7	34.8	5.7	33.2	17.7	39.7	149.2	84.7	2.5	43.4	95.9	0.0	26.5	19.7	19.5	39.7	39.1	21.8	112.1	33.4	35.8	22.7	24.1	8.2	10.6	28.5	43.9	36.9	61.8	28.1	58.1	126.7	3.5	138.7	12.3	0.0	9.5	10.0	28.9	16.7	31.9	15.2	80.1	65.1
NUDT16L1	SDOS	ENSG00000168101	"Nudix hydrolase 16 like 1"	Q9BRJ7	16	4693694-4695859	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044186, HPA063605"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA044186: AB_10968571, HPA063605: AB_2685058"	"unprognostic (1.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (6.81e-2)"	"prognostic favorable (1.02e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.81e-3)"	11.2	21.7	19.3	13.2	22.1	19.3	11.0	25.3	33.1	13.6	20.6	15.9	25.5	21.7	10.4	17.1	14.0	16.5	16.8	31.8	19.7	17.5	20.1	27.2	15.2	18.5	18.3	15.8	13.9	14.8	15.7	19.6	10.5	13.4	19.7	12.2	16.3	16.8	16.3	22.4	10.9	18.6	8.9	16.2	15.9	15.3	13.0	15.9	18.2	21.6	14.2	15.9	10.5	9.8	30.1	40.4	44.9	27.0	28.5	39.6	42.7	7.4	12.3	11.3	15.1	8.5	6.6	10.3	8.9	6.8	10.9	6.9	13.8	6.0	7.8	13.0	10.7	5.5	8.7	12.1	12.2	5.1	11.4	20.4	8.6	10.6	16.6	9.3	12.3	10.2	10.2	11.3	9.1	5.7	7.4	8.0	11.8	15.6	9.8	10.5	29.0	18.4	18.2	17.8	12.5	14.2	25.9	11.9	12.2	13.0	9.3	22.3	16.7	13.0	13.7	5.9	9.2	20.2	28.9	10.3	9.0	13.5	21.1	8.1	17.1	10.1	13.1	5.6	16.5	18.2	23.1	27.0	44.9	27.2	22.5	32.6	28.8	33.3	32.4	24.5	30.1	39.6	33.6	33.3	28.5	24.0	40.4	36.7	42.7	19.3	22.1	25.3	33.1	19.7	17.5	18.3	15.8	13.4	15.9	14.9	19.0	34.7	19.4	12.5	52.0	47.7	12.7	17.4	12.5	40.1	9.8	43.2	92.9	25.8	3.1	23.2	52.5	0.0	27.2	25.3	19.0	19.1	27.6	35.5	35.0	44.5	41.3	15.4	17.0	5.5	29.1	17.5	28.7	51.3	44.4	75.6	24.1	42.1	47.0	80.4	54.6	45.3	22.1	10.9	35.7	14.4	41.1	37.4	46.0	14.6
NUDT17	FLJ34433	ENSG00000186364	"Nudix hydrolase 17"	P0C025	1	145845629-145848953	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 9.0;Spermatogonia: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 5.8;eosinophil: 11.5;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 18.4;granulocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"T-47d: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030145	Approved		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA030145: AB_10603883"	"unprognostic (8.93e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.63e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.07e-3)"	"unprognostic (6.55e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (5.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.96e-1)"	4.6	3.3	8.3	3.9	13.5	6.7	4.9	8.9	10.9	3.8	3.4	5.1	1.5	1.2	4.6	3.1	3.5	7.0	4.4	8.4	6.6	7.7	3.8	2.6	3.4	9.0	5.9	8.1	6.8	6.2	6.2	4.7	2.2	5.4	4.2	2.9	8.0	6.3	5.8	6.7	4.3	3.3	11.1	5.5	6.0	3.3	7.1	2.2	3.5	5.7	3.4	7.7	4.1	3.2	0.9	18.4	11.5	1.8	0.2	1.1	0.7	4.2	3.1	2.9	1.6	1.6	2.4	2.9	2.0	3.4	2.1	3.0	1.9	3.1	6.2	2.2	3.5	0.5	0.8	2.1	1.2	1.4	0.7	3.6	2.4	2.5	2.8	4.7	1.9	8.0	2.5	2.0	1.4	2.4	2.7	4.2	10.1	5.2	5.8	3.8	6.7	2.1	3.6	2.4	2.6	0.3	5.4	1.1	1.9	3.3	1.0	1.4	3.2	1.3	2.6	3.5	3.1	14.5	8.6	2.5	2.5	1.7	1.2	0.8	5.1	2.4	1.5	2.4	2.6	1.9	5.8	0.6	11.5	0.6	1.8	0.4	0.9	0.5	0.3	0.6	0.6	1.1	0.8	0.1	0.2	1.1	18.4	0.5	0.7	8.3	13.5	8.9	10.9	6.6	7.7	5.9	8.1	5.4	2.2	3.0	5.6	0.0	0.9	1.5	1.9	0.4	0.0	2.7	4.5	0.0	0.0	0.4	1.7	1.2	2.9	1.0	0.7	0.0	0.6	0.6	1.9	0.9	2.3	0.6	2.6	0.0	1.2	2.5	0.8	1.3	1.4	1.2	1.7	0.0	0.2	9.0	1.2	0.6	0.4	0.6	3.9	0.0	1.4	6.9	11.7	1.1	0.5	1.3	1.2	0.7
NUDT2	APAH1	ENSG00000164978	"Nudix hydrolase 2"	P50583	9	34329506-34343713	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004684, HPA044903, HPA058623, HPA067639"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877"	"unprognostic (2.74e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.91e-1)"	12.0	18.0	21.6	9.6	21.9	10.2	20.6	14.0	25.5	14.9	14.9	26.0	15.4	12.8	15.7	30.2	14.5	20.5	12.3	16.0	17.3	18.6	10.7	17.5	11.2	12.2	19.5	19.0	28.3	20.9	12.0	19.0	14.1	20.5	16.5	15.3	15.7	16.1	13.0	30.8	13.9	10.1	14.7	20.7	11.3	13.0	8.6	19.1	18.6	3.8	13.2	13.8	14.4	12.1	16.6	15.8	14.3	12.2	14.3	22.2	11.2	23.8	9.8	12.8	4.5	8.8	16.3	9.2	11.5	26.1	13.3	14.0	6.7	11.3	6.6	9.6	14.3	5.1	10.5	11.5	28.4	13.6	24.8	10.3	14.3	18.5	12.6	25.6	11.0	5.9	16.5	18.4	17.2	32.4	18.2	27.5	23.2	4.0	27.1	19.5	14.8	11.4	10.3	7.9	10.6	28.3	14.8	8.0	16.7	13.1	7.8	2.6	10.4	18.7	7.1	10.8	12.0	5.7	11.9	17.7	11.5	10.4	7.5	11.9	6.1	9.9	11.7	14.4	10.6	14.3	14.3	12.2	9.7	11.7	10.3	16.7	16.6	19.2	15.2	15.8	15.0	22.2	19.6	4.5	14.3	10.7	14.7	19.7	11.2	21.6	21.9	14.0	25.5	17.3	18.6	19.5	19.0	20.5	19.1	3.0	5.5	15.9	17.8	25.0	13.1	18.6	43.3	17.4	11.4	15.7	5.9	33.9	74.6	22.6	9.7	21.5	18.6	0.0	34.7	35.6	23.1	17.1	12.7	31.0	32.5	7.9	21.4	30.1	38.4	21.8	25.3	23.9	21.9	32.5	29.1	16.2	26.1	26.9	18.0	39.6	12.8	25.8	23.6	35.8	17.5	27.6	15.8	25.3	31.4	15.7
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392674	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		110000	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	10.5	11.4	38.8	9.3	28.6	8.8	12.6	33.4	40.0	15.4	11.4	16.8	10.3	7.7	11.4	25.9	10.8	15.2	8.5	16.9	33.8	30.0	15.3	10.1	11.2	10.5	29.4	25.6	17.4	9.1	27.9	9.3	8.9	26.1	11.4	9.7	11.2	9.4	15.6	50.7	11.2	8.0	11.2	20.3	13.0	8.4	7.3	21.3	5.4	21.3	8.7	12.1	8.6	9.9	4.5	6.4	12.4	5.9	2.1	3.9	2.6	5.4	4.0	10.8	21.1	7.2	12.2	4.7	4.0	6.7	4.1	3.0	4.8	3.8	19.6	5.4	7.1	2.7	4.6	6.1	10.8	7.7	7.3	7.8	21.6	5.6	10.4	7.2	20.3	11.3	11.0	10.0	5.0	9.4	5.3	11.8	10.2	21.4	7.1	6.6	5.7	14.0	23.8	6.9	16.1	4.0	12.3	8.9	20.4	9.4	11.4	15.2	17.0	8.8	12.5	15.9	3.4	12.5	14.6	12.9	8.3	3.0	7.2	8.6	6.1	14.1	14.4	5.0	20.8	12.9	1.9	5.8	12.4	3.4	5.9	3.9	3.4	3.4	3.2	6.4	4.5	3.2	3.7	4.1	2.1	5.8	3.2	2.4	2.6	38.8	28.6	33.4	40.0	33.8	30.0	29.4	25.6	26.1	21.3	14.9	22.4	43.5	59.4	53.1	115.6	43.3	63.7	46.8	14.8	40.1	111.9	28.0	11.6	15.4	3.0	55.9	18.4	0.0	24.5	26.3	42.3	39.4	12.8	52.1	67.2	160.5	47.2	84.7	91.0	4.0	34.8	58.5	50.6	22.6	24.7	115.6	20.8	19.8	59.4	19.2	125.0	58.2	46.4	44.7	78.0	52.7	16.4	20.1	25.2	59.3
NUDT4	"DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487"	ENSG00000173598	"Nudix hydrolase 4"	Q9NZJ9	12	93377883-93408146	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.7"	"Cell type enhanced"	"Detected in all"	5	"Muller glia cells: 411.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (1.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.25e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.01e-1)"	"unprognostic (8.32e-3)"	17.2	29.7	14.1	14.7	9.5	37.4	20.4	7.0	29.0	15.2	14.7	6.7	17.5	6.5	13.6	24.8	13.7	12.8	40.0	140.7	12.4	12.4	47.9	11.2	11.3	10.9	9.4	13.7	41.9	21.1	16.1	11.9	19.2	13.9	27.1	16.9	25.1	65.2	14.8	40.3	8.1	12.7	13.8	12.6	9.2	13.1	10.6	6.3	14.6	25.5	22.4	8.9	19.6	32.9	6.0	4.1	13.6	3.6	7.6	6.6	2.5	5.8	5.0	9.1	10.2	34.0	14.1	11.5	16.3	13.0	9.4	6.9	46.9	14.6	8.2	3.6	13.0	6.1	7.4	25.5	8.2	14.4	12.5	5.4	30.7	4.4	23.9	32.7	15.9	7.4	30.5	27.5	9.6	21.6	47.1	53.1	14.8	31.1	11.5	10.7	6.0	14.8	15.2	14.4	14.4	12.0	12.4	8.2	8.8	11.2	42.3	7.4	9.5	13.2	25.9	36.5	15.3	18.8	20.8	20.1	8.0	4.7	12.0	10.3	6.5	8.1	12.1	4.2	12.6	24.4	8.2	2.8	13.6	3.9	3.6	6.6	6.0	5.8	3.9	2.6	4.7	6.2	5.8	2.4	7.6	2.9	4.1	5.2	2.5	14.1	9.5	7.0	29.0	12.4	12.4	9.4	13.7	13.9	6.3	17.9	42.6	40.8	110.6	103.7	39.3	226.3	94.3	91.0	31.8	59.3	58.9	156.3	306.7	20.9	78.9	50.0	102.5	327.1	14.7	23.0	86.0	142.6	25.3	48.9	37.7	39.7	146.0	28.8	34.5	17.0	36.2	31.8	101.3	12.6	83.5	411.5	37.2	85.6	43.9	43.1	40.3	71.1	166.9	28.7	7.7	84.6	137.0	29.9	64.3	133.5
NUDT4B	NUDT4P1	ENSG00000177144	"Nudix hydrolase 4B"		1	148748894-148750099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.3;RT4: 21.1"									"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"					"unprognostic (1.24e-1)"									"unprognostic (4.01e-2)"				0.5	1.2		0.0		5.4	0.0		0.0	0.5	0.7			0.7	0.2	0.0	2.0	1.4	5.5	6.5			2.0	0.2	0.0	1.2			4.5	3.0	2.1		1.5		1.4	1.0		5.7	0.0	0.0	0.0	0.5	0.1		0.0	0.1	1.6			1.7		0.1	5.8		0.0	0.3	4.5	0.8	0.2	0.6	0.4	1.6	2.2	0.5	2.6	3.4	3.3	5.0	1.3	3.3	2.4	2.4	23.3	8.5	1.4	0.5	1.7	2.5	2.5	2.8	1.3	1.4	4.8	1.8	3.8	1.4	2.7	3.7	2.8	0.8	5.4	4.5	3.2	2.9	2.1	8.4	1.1	6.9	9.2	2.4	1.4	1.8	0.5	3.0	1.4	2.2	3.4	0.9	5.4	2.0	21.1	1.3	2.1	1.8	3.4	14.4	0.5	6.0	6.0	4.6	3.2	2.0	5.5	3.0	0.8	2.4	1.5	1.6	4.9	9.3	0.0	0.1	4.5	0.0	0.2	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.8	0.0	0.3	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165325-12196144	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA		660000	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	19.6	22.0	17.4	18.6	21.2	13.5	20.2	15.4	21.4	16.7	20.4	16.1	15.2	17.3	10.0	16.5	25.8	16.3	12.1	10.0	16.2	14.3	26.0	57.1	16.8	22.7	21.7	12.8	12.5	16.9	19.1	35.7	19.9	18.5	13.4	24.2	13.2	16.7	19.7	5.1	20.6	15.9	11.6	17.9	22.4	14.1	8.0	21.5	28.2	19.1	16.5	29.5	16.2	18.6	22.4	45.9	50.1	19.5	16.2	37.0	20.4	35.6	26.3	31.5	29.3	30.5	30.2	27.9	26.4	16.9	31.1	33.4	37.7	34.1	35.7	23.0	21.4	19.5	35.9	43.9	40.9	28.7	29.2	42.9	29.7	32.3	55.4	31.8	19.7	20.9	31.7	24.5	33.9	17.3	24.1	39.7	57.2	39.7	24.4	28.3	32.7	36.8	23.1	27.4	57.3	16.4	33.7	11.4	41.4	29.1	12.3	15.2	22.8	32.0	24.7	36.7	38.5	42.3	20.3	24.8	13.3	25.5	37.0	32.3	20.6	36.2	48.0	27.9	25.7	9.8	8.1	19.1	33.5	22.8	19.5	26.2	22.4	24.6	26.8	27.0	18.3	17.0	23.0	50.1	16.2	14.8	45.9	37.0	20.4	17.4	21.2	15.4	21.4	16.2	14.3	21.7	12.8	18.5	21.5	23.8	37.8	33.5	51.1	38.1	19.2	2.8	25.5	60.2	39.8	22.7	15.7	73.5	63.0	74.1	27.1	31.4	34.2	23.3	72.2	127.8	35.8	30.5	31.1	116.5	105.0	20.6	36.8	40.5	41.3	6.6	36.5	39.3	28.7	110.0	34.5	32.9	64.5	28.1	27.3	95.7	22.5	32.3	25.6	20.2	27.5	52.9	48.6	51.7	51.0	40.6
NUDT7		ENSG00000140876	"Nudix hydrolase 7"	P0C024	16	77722492-77742260	"Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.1"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.9;THP-1: 27.9;U-698: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042042	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA042042: AB_10806232"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (5.36e-11)"	"unprognostic (1.19e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.42e-2)"	8.7	19.0	5.4	4.8	8.3	1.4	6.2	4.2	8.6	4.6	8.4	5.7	5.9	7.1	6.2	12.4	8.6	7.1	5.7	24.8	4.8	7.3	14.8	45.1	5.0	6.8	6.3	6.2	5.2	8.5	9.1	4.7	4.2	7.8	6.4	8.3	11.6	5.9	5.3	5.0	6.0	9.4	7.1	7.2	5.5	5.4	6.7	3.5	6.1	19.7	6.5	5.9	6.3	6.0	13.6	7.9	2.5	11.0	2.3	20.6	6.0	1.1	4.0	3.6	2.0	16.9	4.3	3.4	1.0	5.2	1.6	2.1	1.1	5.0	5.8	3.9	3.9	3.8	4.0	2.7	4.3	0.9	1.8	3.7	0.0	0.2	5.3	1.8	3.9	0.8	7.3	5.5	0.9	3.1	0.7	2.7	8.4	4.1	2.5	0.6	10.6	2.0	9.3	3.8	6.9	1.0	4.3	0.4	1.7	8.1	0.0	3.0	2.9	3.7	1.5	3.0	6.5	10.7	27.9	2.1	1.8	0.2	0.8	0.2	0.0	0.0	22.5	7.1	5.0	0.0	2.5	8.5	1.0	9.1	11.0	10.1	8.8	10.8	10.8	6.8	13.6	14.3	9.9	1.4	2.3	10.6	7.9	20.6	6.0	5.4	8.3	4.2	8.6	4.8	7.3	6.3	6.2	7.8	3.5	14.9	5.4	2.2	7.3	8.7	2.6	16.1	28.1	22.7	4.5	14.0	0.0	15.8	49.7	4.9	8.7	6.7	13.4	0.0	8.3	7.4	8.5	3.2	1.1	37.1	5.5	6.4	6.4	4.9	8.3	3.4	5.2	3.0	8.5	0.0	8.1	22.7	4.2	10.5	4.6	35.0	6.1	6.5	9.2	4.8	11.3	12.2	5.6	6.7	14.6	3.3
NUDT8	FLJ41567	ENSG00000167799	"Nudix hydrolase 8"	Q8WV74	11	67627938-67629930	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 96.8;Hepatocytes: 168.1;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 68.5"					"Low region specificity"	"Detected in all"			"HPA041252, HPA041466"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA041252: AB_10794551, HPA041466: AB_10793967"	"unprognostic (8.31e-2)"	"unprognostic (7.26e-3)"	"unprognostic (7.31e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.69e-1)"	"unprognostic (4.12e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.19e-1)"	5.5	2.0	3.0	4.1	4.1	2.1	10.8	4.1	2.7	3.9	8.1	3.5	10.1	10.6	1.7	4.8	22.0	2.4	5.9	32.5	2.6	3.0	16.0	21.4	3.8	4.3	4.9	2.3	2.2	7.7	4.3	1.3	2.5	5.9	4.2	4.2	2.0	28.3	8.2	38.2	12.4	12.2	2.4	4.1	1.9	6.9	1.4	2.3	2.0	13.6	25.0	15.3	1.6	4.7	7.1	11.8	1.0	11.2	8.1	3.4	2.1	10.4	4.2	1.6	2.7	1.5	2.0	2.6	2.2	1.0	0.9	0.9	3.5	2.7	10.9	3.4	1.7	1.3	5.1	1.9	1.3	0.1	10.6	4.6	0.6	1.8	10.6	0.4	3.4	5.3	1.2	2.6	1.1	0.3	0.2	1.9	13.9	3.0	9.8	0.7	17.5	5.7	5.0	0.9	18.4	8.6	3.5	0.8	68.5	2.7	1.8	0.8	1.1	0.5	6.1	2.1	0.6	3.3	1.4	0.5	2.3	3.3	14.9	0.4	7.0	4.6	2.1	1.6	4.7	1.3	0.0	1.0	1.0	3.1	3.9	2.6	3.3	1.8	3.4	4.3	7.1	1.6	1.9	0.0	8.1	11.2	11.8	1.1	2.1	3.0	4.1	4.1	2.7	2.6	3.0	4.9	2.3	5.9	2.3	0.0	6.2	15.0	11.1	10.8	4.3	66.8	17.8	2.7	0.0	27.9	0.0	21.3	71.3	11.4	2.7	7.5	96.8	23.3	20.8	17.7	10.7	20.1	9.2	168.1	7.9	4.8	2.4	9.8	4.7	5.6	4.6	3.0	27.0	2.8	66.6	7.0	11.3	22.4	4.9	147.8	6.0	6.5	11.3	9.1	6.3	22.3	14.5	9.6	56.6	16.3
NUP210L		ENSG00000143552	"Nucleoporin 210 like"	Q5VU65	1	153992685-154155116	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 42.7"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 15.2;Late spermatids: 6.7;Sertoli cells: 6.5;Spermatocytes: 26.5;Spermatogonia: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	43	"MCF7: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047195, HPA064245, HPA066707"	Enhanced		Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.51e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.35e-10)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.09e-2)"	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.1	1.5	0.0	0.0	1.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.4	0.6	0.1	0.0	0.8	0.9	0.4	0.1	0.1	0.1	3.4	0.2	0.1	0.1	42.7	0.0	0.3	0.3	0.0	0.1	1.2	0.1	0.6	0.6	1.8	0.2	0.9	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.8	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.1	0.2	0.6	0.4	0.5	0.0	0.5	0.8	0.3	1.8	0.9	0.0	0.6	0.7	0.0	0.1	0.3	0.1	0.9	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.3	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	6.5	0.1	26.5	5.1	0.5	0.0	0.0	0.0	0.2
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125561-131234670	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 131.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 225.7;Kupffer cells: 255.0;Late spermatids: 282.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 43.7;neutrophil: 131.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 131.5;monocytes: 43.7"	"Cell line enhanced"	"Detected in all"		"K-562: 73.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048789			Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA		100000	Nucleoplasm	"Vesicles, Focal adhesion sites"	"HPA048789: AB_2680521"	"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	16.9	10.3	11.5	13.8	13.9	29.4	12.9	13.0	14.4	10.2	11.4	19.8	10.4	9.0	15.0	13.7	16.1	12.1	10.2	9.7	9.5	8.1	19.0	15.1	11.7	13.3	13.2	8.8	14.2	17.0	16.7	16.9	13.0	11.3	11.1	10.8	15.3	13.0	11.1	15.5	17.5	11.7	11.1	14.3	35.8	12.3	63.7	13.3	27.4	11.8	7.6	16.8	10.7	11.2	1.2	16.8	131.5	43.7	1.2	0.8	17.9	6.8	9.8	8.4	5.0	6.8	6.6	8.8	6.1	6.3	8.0	6.5	8.0	5.0	11.1	4.9	8.4	8.3	15.7	11.3	8.0	7.8	8.0	5.5	6.9	14.0	15.6	6.0	10.8	7.5	7.1	7.4	10.2	8.3	5.1	8.1	7.4	73.0	6.4	8.2	12.8	14.2	16.4	9.1	9.9	8.6	5.0	10.6	11.1	9.2	6.3	7.1	7.4	10.2	9.4	5.3	6.3	12.4	27.0	7.0	14.1	7.9	9.2	9.9	5.6	10.9	10.8	6.9	6.5	8.5	3.5	43.7	17.3	0.7	18.4	0.8	1.2	0.7	0.6	16.8	1.1	0.7	0.7	131.5	1.2	15.0	1.5	0.4	17.9	11.5	13.9	13.0	14.4	9.5	8.1	13.2	8.8	11.3	13.3	17.9	19.9	15.2	9.5	7.7	29.6	24.0	15.3	16.0	15.9	22.7	43.2	10.9	8.3	9.1	225.7	14.6	13.6	0.0	13.1	9.3	11.4	11.4	8.1	11.9	75.5	15.9	19.5	18.4	255.0	282.5	21.6	77.0	10.1	15.4	14.3	14.8	12.0	5.8	19.1	6.7	31.6	6.5	8.1	90.1	44.5	9.5	9.2	11.8	16.3	9.3
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 131.7;Late spermatids: 308.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	8.8	10.9	9.1	13.7	21.4	4.1	15.3	18.9	12.6	9.2	8.6	5.6	5.8	7.3	9.6	9.0	11.7	10.6	9.1	7.9	11.1	6.8	11.9	16.4	9.5	9.3	11.5	5.1	13.1	17.2	8.9	13.1	9.0	8.8	9.3	10.7	7.3	9.7	9.6	9.1	10.9	7.1	10.5	7.6	7.8	9.3	25.8	9.7	19.1	10.3	12.6	12.7	8.0	10.2	8.9	3.8	1.7	6.8	5.9	10.5	5.0	10.0	10.8	16.8	9.9	6.1	5.9	12.2	12.1	9.8	18.3	17.6	19.8	12.2	17.1	11.4	6.4	21.7	8.7	23.1	13.4	29.7	15.3	15.3	16.1	9.0	21.0	4.6	11.6	10.9	4.3	7.1	15.6	14.9	4.1	10.7	10.3	14.5	12.7	13.9	11.7	13.4	13.9	28.6	15.8	33.4	16.5	13.3	12.1	16.9	12.3	14.9	10.4	11.2	13.1	12.7	13.0	8.5	8.1	5.7	14.4	10.2	11.6	13.5	8.5	18.4	18.2	9.8	8.5	19.3	0.0	4.8	1.7	6.1	6.3	10.5	8.9	7.8	7.5	3.8	7.9	9.6	8.4	0.1	5.9	6.8	3.6	7.7	5.0	9.1	21.4	18.9	12.6	11.1	6.8	11.5	5.1	8.8	9.7	8.9	5.0	11.1	14.4	23.1	10.8	4.1	10.2	8.1	14.8	15.7	17.7	18.4	10.0	10.8	131.7	9.3	3.1	23.3	11.1	17.4	12.4	7.0	8.1	11.9	7.4	6.4	3.5	11.6	6.2	308.3	8.9	3.7	20.3	4.6	6.6	10.8	9.6	7.0	7.8	10.1	17.1	12.9	13.2	34.7	19.4	24.0	7.9	8.9	7.4	9.7
NUP37	"FLJ22618, MGC5585"	ENSG00000075188	"Nucleoporin 37"	Q8NFH4	12	102073103-102120124	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056300, HPA073708"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056300: AB_2683092, HPA073708: AB_2686629"	"unprognostic (1.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.72e-4)"	"prognostic unfavorable (7.70e-6)"	"unprognostic (2.48e-3)"	"unprognostic (2.37e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.67e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-1)"	11.1	18.4	6.0	17.5	7.7	12.6	12.8	8.1	7.4	12.4	12.8	8.7	14.9	8.1	13.0	14.7	22.0	12.6	7.8	12.3	5.7	5.4	11.4	8.6	9.0	16.4	6.0	5.1	12.6	11.7	12.6	15.2	17.6	10.6	13.7	16.0	11.2	11.7	9.6	18.0	11.3	14.5	11.4	9.3	16.5	11.5	17.8	6.2	28.4	16.4	18.5	20.8	13.6	11.0	19.4	18.1	30.6	17.2	13.2	26.7	13.0	32.0	23.7	20.9	9.5	17.3	23.0	46.3	20.7	19.5	32.7	22.4	30.2	17.5	21.8	14.8	16.0	22.6	23.8	36.5	32.0	41.1	30.7	20.8	23.4	12.8	27.0	22.1	33.0	7.4	17.7	14.1	25.4	18.9	21.9	26.6	29.1	41.4	8.3	30.2	22.3	24.5	27.4	20.6	30.2	37.9	16.2	29.6	16.5	25.7	24.2	10.9	7.8	15.6	16.8	14.8	24.6	29.4	19.2	8.6	11.8	12.9	16.5	28.3	12.6	23.8	37.4	13.5	27.0	19.7	30.6	14.7	16.4	13.8	17.2	15.0	19.4	16.9	14.0	18.1	17.7	15.3	17.3	4.3	13.2	14.2	15.3	26.7	13.0	6.0	7.7	8.1	7.4	5.7	5.4	6.0	5.1	10.6	6.2	6.0	11.0	22.6	21.0	10.1	7.4	7.9	22.9	28.1	11.4	15.7	7.9	61.2	21.6	20.4	2.3	14.2	9.2	23.3	17.3	79.0	11.7	10.2	7.0	8.6	31.3	3.2	5.8	10.4	14.3	4.0	18.1	16.9	6.8	19.8	15.7	17.6	16.1	10.5	17.7	18.0	17.2	19.4	10.3	50.2	37.0	8.3	33.6	17.3	20.7	10.6
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148515	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	23.7	14.5	13.5	18.2	15.2	28.4	25.7	26.0	17.2	23.1	20.0	14.6	17.9	15.3	22.9	18.2	21.4	22.5	15.1	17.0	12.2	10.8	16.4	20.3	17.8	22.8	20.5	13.1	25.3	19.3	13.3	16.8	22.8	14.9	19.8	19.7	12.2	20.0	24.1	17.8	21.2	18.4	24.7	14.7	23.6	19.2	19.6	20.0	36.1	19.8	18.1	22.1	24.1	21.8	10.0	11.4	7.7	10.0	21.6	16.5	7.5	17.1	6.8	21.8	15.7	18.6	17.8	19.2	17.4	25.1	25.8	26.6	16.0	24.6	26.0	14.7	17.3	14.0	11.6	23.4	19.4	32.4	17.1	13.7	15.7	8.5	15.2	17.6	30.4	19.0	16.2	14.0	20.4	21.7	11.4	22.1	17.1	26.9	16.4	18.6	15.0	32.0	14.3	34.9	20.9	6.1	25.1	34.4	9.9	15.3	16.5	13.2	11.0	16.1	19.1	14.0	17.8	8.1	18.7	14.7	20.8	18.6	24.7	21.1	10.7	3.9	24.8	14.8	17.9	18.2	6.5	7.5	7.7	12.2	9.0	16.5	9.0	12.9	11.7	11.4	10.0	13.8	13.0	3.5	21.6	10.0	8.4	12.5	7.5	13.5	15.2	26.0	17.2	12.2	10.8	20.5	13.1	14.9	20.0	20.8	11.8	23.1	37.0	31.3	13.7	9.9	7.6	18.7	12.5	10.4	19.6	36.3	24.9	18.9	7.9	20.4	11.5	0.0	24.2	38.9	30.9	23.1	23.1	11.9	19.3	7.9	13.8	18.4	18.3	5.6	25.3	17.0	16.9	30.7	18.4	11.8	15.9	21.0	24.4	17.2	19.1	32.3	26.8	38.4	40.1	25.5	32.7	27.7	21.7	29.4
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.1	25.7	15.8	29.1	18.5	19.8	16.1	28.3	21.7	18.2	17.1	21.0	13.4	20.0	24.1	13.7	21.5	22.1	20.9	16.9	14.3	15.1	16.8	27.5	16.2	29.0	15.2	14.2	26.6	18.6	14.0	21.3	24.1	17.4	19.8	17.7	16.2	18.8	20.2	27.1	18.8	20.2	23.3	14.2	26.0	16.4	70.9	17.6	45.5	16.8	17.3	29.6	18.9	19.4	10.7	21.1	6.2	22.3	13.7	16.9	12.5	32.0	30.5	22.6	19.2	7.1	8.1	21.1	24.3	16.7	25.6	25.6	20.6	18.9	36.1	13.4	15.5	17.2	19.1	27.5	16.8	24.8	52.2	29.3	29.0	15.3	19.0	8.6	26.6	28.9	8.3	11.6	16.9	14.1	11.4	18.8	21.7	35.4	35.3	17.5	15.5	48.0	20.3	21.4	29.0	27.2	43.4	26.4	30.7	12.3	24.9	25.3	18.0	23.2	26.5	12.1	16.9	21.5	13.6	14.6	40.3	23.7	13.0	39.4	25.6	69.7	33.2	16.6	23.2	30.0	6.2	20.7	4.2	12.0	22.3	16.9	10.6	12.0	13.2	21.1	10.7	8.2	10.5	3.3	13.7	11.8	18.3	10.7	12.5	15.8	18.5	28.3	21.7	14.3	15.1	15.2	14.2	17.4	17.6	23.8	21.9	40.6	17.0	30.3	10.8	12.6	20.4	24.1	19.4	8.7	5.9	23.7	8.3	21.3	98.8	27.0	16.6	23.3	14.1	38.8	21.5	15.3	22.0	11.0	44.5	60.4	20.7	30.1	34.9	254.9	23.0	47.7	20.3	90.2	22.7	18.3	20.1	23.4	21.5	13.6	15.4	19.4	12.2	71.6	37.3	28.0	18.2	26.6	27.6	12.9
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5420160	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 103.0;Spermatocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	10.8	12.4	8.1	17.2	8.8	13.2	14.1	15.0	9.2	9.0	12.5	6.6	8.1	7.4	10.1	12.2	13.1	10.5	7.7	15.3	8.0	5.6	11.3	25.7	9.1	17.8	6.9	6.9	9.9	11.1	11.9	12.4	10.0	7.5	9.6	14.3	6.9	11.7	12.5	33.4	11.8	12.4	10.2	7.7	20.0	11.4	34.4	8.4	28.9	15.8	10.3	23.1	10.9	10.5	24.2	7.4	3.5	8.6	12.2	10.5	7.4	20.6	22.8	18.4	15.5	8.8	9.0	19.9	15.8	14.2	29.2	26.7	19.5	8.7	37.6	6.5	15.4	16.8	20.9	31.7	18.7	32.5	10.4	21.8	16.4	20.4	14.2	12.4	13.4	17.3	6.7	13.6	21.6	33.3	10.4	19.9	15.1	18.7	9.9	20.3	10.0	20.5	9.2	19.4	19.6	11.5	20.2	20.8	18.0	13.4	9.5	8.0	15.5	19.4	9.4	11.8	15.2	10.5	15.6	12.2	12.4	14.1	13.0	28.8	6.4	8.4	18.6	14.7	15.1	19.1	3.5	4.9	2.2	8.2	7.3	8.1	24.2	9.1	9.8	6.9	23.2	9.5	10.1	0.5	12.2	8.6	7.4	10.5	7.4	8.1	8.8	15.0	9.2	8.0	5.6	6.9	6.9	7.5	8.4	11.9	16.2	36.6	23.6	19.7	12.9	8.9	12.7	13.4	19.4	15.7	15.7	27.0	10.0	20.2	103.0	8.5	8.8	0.0	22.2	20.9	10.1	18.0	7.0	15.8	10.5	9.5	13.2	8.0	4.1	21.6	14.1	11.5	3.3	18.0	9.1	8.9	19.4	14.0	10.3	7.0	10.4	12.9	13.2	115.8	53.5	14.9	30.1	18.1	16.8	38.1
NUPR1	"COM1, p8"	ENSG00000176046	"Nuclear protein 1, transcriptional regulator"	O60356	16	28532708-28539174	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 297.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 11.5;eosinophil: 4.2;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.1;hTCEpi: 84.2;SK-MEL-30: 60.2;T-47d: 35.8;U-87 MG: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006349			Supported	"Nucleoplasm,Cytokinetic bridge"		NA	NA			Nucleoplasm	"Cytokinetic bridge"	"HPA006349: "	"unprognostic (2.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.72e-3)"	"unprognostic (5.77e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.80e-2)"	26.9	38.6	13.1	8.9	20.0	1.7	24.4	13.4	10.1	30.0	28.6	10.4	114.1	4.5	19.9	36.6	31.2	16.5	19.3	16.2	14.8	12.2	19.3	47.1	33.7	7.5	20.5	8.2	41.0	297.9	2.2	5.8	16.1	23.1	46.5	16.5	23.5	89.5	128.3	22.2	27.5	8.9	35.3	23.9	7.6	17.4	18.6	17.6	4.2	146.4	14.4	11.5	47.9	79.1	0.8	0.8	11.5	0.6	1.1	0.5	0.1	0.2	1.6	0.0	13.2	19.7	17.3	10.3	11.5	10.0	0.4	9.3	0.0	0.0	0.0	6.4	17.7	1.1	0.3	0.0	0.3	0.3	0.0	0.5	0.0	0.7	8.3	51.1	0.0	0.0	16.4	84.2	5.4	24.0	12.7	0.0	0.0	0.0	0.5	5.8	2.3	0.0	0.2	0.0	0.0	6.4	0.0	0.0	0.4	0.0	1.1	0.1	0.0	3.3	13.8	60.2	0.2	35.8	1.9	0.0	3.7	9.2	9.8	1.6	0.0	0.0	0.1	32.1	0.0	0.4	11.5	0.6	4.2	0.4	0.4	0.5	0.4	0.4	0.3	0.2	0.8	0.5	0.5	3.1	1.1	0.5	0.8	0.3	0.1	13.1	20.0	13.4	10.1	14.8	12.2	20.5	8.2	23.1	17.6	268.0	266.9	12.9	284.3	281.4	2.7	143.0	84.1	203.4	100.1	307.1	2.0	116.3	18.3	217.4	9.2	223.9	44.6	0.0	489.4	49.3	360.2	373.9	19.7	654.2	297.7	1.6	58.7	232.7	44.1	22.4	489.5	65.6	146.8	10.8	319.6	165.4	272.9	60.4	662.3	199.5	3.2	200.5	420.6	5.8	4.3	464.9	591.9	17.5	358.7	334.3
NUS1	"C6orf68, MGC7199, NgBR, TANGO14"	ENSG00000153989	"NUS1 dehydrodolichyl diphosphate synthase subunit"	Q96E22	6	117675502-117710640	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Angiogenesis, Differentiation, Lipid metabolism"	"Developmental protein, Receptor, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027504	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA027504: AB_10603124"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.26e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	8.4	10.2	14.7	9.3	14.7	7.0	10.0	8.8	13.4	29.6	9.2	6.8	2.0	7.1	9.6	13.5	9.5	8.8	7.1	8.2	12.7	9.9	13.1	17.4	9.5	8.4	16.4	15.7	8.8	28.9	15.0	20.0	10.6	16.2	9.6	9.3	7.1	13.8	14.9	7.9	6.1	14.4	8.5	7.3	9.1	10.6	5.6	12.2	7.2	16.5	3.1	8.7	9.1	18.0	2.4	8.1	3.3	4.9	4.1	4.5	2.3	10.3	7.6	16.4	18.3	16.6	21.8	40.4	18.9	19.7	15.8	18.2	17.2	11.6	24.4	20.6	17.4	20.1	9.4	24.4	18.5	29.5	18.2	22.5	27.9	12.8	30.7	25.6	35.1	16.5	19.0	21.0	17.3	35.4	16.2	16.2	18.3	33.3	21.8	23.6	11.6	16.5	22.4	19.1	14.2	13.9	15.9	11.8	17.5	31.4	10.3	19.5	15.4	11.4	14.8	13.8	19.1	9.4	36.9	14.2	9.8	12.1	15.6	27.1	30.3	22.6	26.0	23.2	27.1	19.5	3.3	3.0	1.8	3.1	3.0	4.5	2.4	3.7	4.1	3.2	2.1	3.1	4.0	0.2	4.1	4.9	8.1	3.4	2.3	14.7	14.7	8.8	13.4	12.7	9.9	16.4	15.7	16.2	12.2	0.0	21.1	21.6	29.1	53.8	14.3	6.1	15.3	10.7	14.8	24.4	9.8	21.6	23.2	19.8	11.9	17.5	19.7	0.0	26.2	41.6	19.7	52.1	31.1	35.9	32.9	14.3	12.6	27.0	29.1	11.8	16.7	32.9	30.4	22.6	26.8	7.5	29.9	21.0	19.1	29.2	8.2	6.5	37.6	21.8	28.8	49.1	48.4	14.1	21.0	80.5
NUTM2A	FAM22A	ENSG00000184923	"NUT family member 2A"	Q8IVF1	10	87225448-87236908	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"eosinophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 14.5"									HPA064635			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA064635: "	"unprognostic (1.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.65e-1)"	3.5	1.8	2.8	0.4	2.5	1.7	1.1	1.5	2.9	1.1	1.8			1.3	1.7	2.1	0.9	1.9	0.8	3.0	3.4	2.2	1.5	1.3	1.6	0.9	2.9		3.0	2.4	2.9	2.0	1.3		2.5	1.0		5.9	0.8	2.3	4.4	2.0	0.7	3.6	1.7	1.8	2.4			2.6		0.2	1.4	1.2	0.4	0.0	1.3	0.2	0.0	0.2	0.2	1.4	0.2	0.7	0.0	1.9	0.9	0.9	0.7	1.8	0.8	0.5	0.2	0.8	1.4	0.1	0.0	0.2	1.4	0.0	1.0	0.1	0.3	1.5	1.7	0.4	0.2	0.7	0.6	14.5	0.5	4.2	1.0	1.2	1.1	0.0	2.5	1.8	0.4	0.2	0.7	1.2	2.5	3.2	0.0	0.5	1.7	0.2	0.0	0.5	0.1	1.8	2.8	0.7	0.6	0.6	0.0	0.3	0.9	1.5	0.0	0.2	0.8	0.1	0.0	0.1	0.7	0.9	1.5	0.0	0.0	0.2	1.3	0.1	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
NUTM2B	"bA119F19.1, FAM22B"	ENSG00000188199	"NUT family member 2B"	A6NNL0	10	79703227-79714681	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 6.2"									HPA064635			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA064635: "	"unprognostic (9.51e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.63e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.32e-2)"	0.9	1.8	2.8	1.6	2.6	3.6	0.6	2.2	3.0	1.1	1.0			0.6	0.9	1.6	0.4	2.3	0.3	2.1	2.8	1.9	1.6	1.1	1.9	1.6	1.7		2.0	2.1	2.2	2.7	0.7		1.6	0.4		3.0	0.7	2.3	2.2	1.2	0.2	1.9	2.0	0.9	4.6			1.1		1.6	0.4	0.7	0.5	0.4	1.0	0.8	0.1	0.1	0.1	1.4	1.4	2.9	2.3	1.0	0.9	1.5	0.6	1.1	0.9	0.9	0.2	3.2	3.2	0.5	0.5	1.3	1.4	0.2	1.4	0.5	2.0	1.2	2.3	0.5	0.8	1.2	1.7	6.2	2.0	1.0	0.4	0.7	2.7	0.0	4.8	3.3	1.8	0.6	2.7	0.4	4.7	3.4	0.0	1.8	0.7	0.5	0.4	1.2	0.4	1.6	3.9	2.1	2.6	3.6	1.1	0.5	3.0	1.7	0.3	0.6	0.5	1.0	0.7	0.2	0.8	0.0	0.3	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.8	0.4	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0
NUTM2D	FAM22D	ENSG00000214562	"NUT family member 2D"	Q5VT03	10	87357668-87370695	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	32	"Cardiomyocytes: 1.0;Cone photoreceptor cells: 3.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 14.4;hTCEpi: 13.3"									HPA064635			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA064635: "	"unprognostic (2.13e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.35e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.32e-1)"	2.3	2.3	4.9	1.6	4.6	2.6	3.0	2.9	5.9	2.8	2.5			2.6	2.3	4.8	2.1	4.3	3.3	4.7	5.5	3.6	3.0	2.9	3.8	2.3	4.9		3.6	6.2	5.5	4.1	3.2		3.6	2.5		4.5	2.5	4.6	6.5	2.1	1.5	5.9	2.9	2.8	3.7			3.8		1.9	2.3	2.1	1.2	0.8	1.0	0.8	0.0	0.9	0.4	4.6	3.3	7.3	0.0	1.9	2.6	1.6	1.3	5.6	2.4	2.8	2.2	2.3	4.0	1.1	2.0	1.3	2.1	0.1	2.7	1.2	2.6	3.0	6.2	0.2	3.2	4.5	4.0	14.4	4.5	13.3	3.1	2.4	4.3	2.4	4.8	6.3	0.9	0.5	4.3	2.7	5.8	4.0	0.9	0.3	3.8	0.4	0.1	2.4	0.9	2.7	4.4	1.4	3.1	1.3	3.1	5.9	2.7	6.4	1.8	1.2	1.7	2.2	4.5	2.6	1.1	1.0	2.3	0.1	0.0	0.8	1.0	0.2	0.8	0.7	0.1	0.2	0.7	0.2	1.2	0.6	0.9	0.3	0.0	0.5	0.8	0.5	0.4											0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NUTM2E	FAM22E	ENSG00000228570	"NUT family member 2E"	B1AL46	10	79841358-79850878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"	16	"Intestinal endocrine cells: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 5.7;NB-4: 4.4;U-266/84: 2.7"									HPA064635			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA064635: "	"unprognostic (2.82e-1)"	"unprognostic (3.95e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.35e-1)"	"unprognostic (4.09e-1)"	0.8	0.2	1.1	0.0	1.3	0.4	0.3	1.6	1.1	0.9	0.4			1.0	0.5	2.9	0.4	1.1	0.3	1.2	1.6	1.2	0.4	0.4	0.7	1.1	0.6		1.3	0.7	0.0	1.5	0.4		0.6	0.4		0.4	0.9	0.1	1.0	0.6	0.6	0.7	0.8	0.7	3.0			1.7		0.0	0.3	0.3	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	1.1	0.2	0.9	0.0	0.0	0.4	0.0	1.3	0.7	0.8	0.2	0.0	0.1	0.0	0.6	0.0	0.6	0.7	0.2	0.0	0.0	0.2	0.3	0.4	0.0	0.3	1.4	5.7	0.4	0.4	0.0	0.4	0.3	0.8	0.4	0.2	0.0	0.0	0.0	1.7	4.4	0.1	0.9	0.3	1.5	0.2	0.0	0.0	0.4	0.2	0.7	0.3	0.5	0.2	0.0	0.0	0.1	0.4	0.2	0.0	0.9	0.0	2.0	2.7	0.4	0.9	1.8	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
NUTM2F	"DKFZp434I1117, FAM22F"	ENSG00000130950	"NUT family member 2F"	A1L443	9	94318196-94328644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	9	"testis: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"NTERA-2: 5.5"									HPA064635			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA064635: "	"unprognostic (1.40e-1)"	"unprognostic (4.93e-3)"	"unprognostic (4.16e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.03e-1)"		"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.72e-3)"	"unprognostic (8.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.14e-1)"		"unprognostic (1.83e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	5.5			0.0		0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NUTM2G	FAM22G	ENSG00000188152	"NUT family member 2G"	Q5VZR2	9	96928310-96940253	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"testis: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 4.6;SiHa: 4.4"									HPA064635			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA064635: "	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.52e-2)"	0.1	0.4	0.1	0.4	0.2	1.9	0.2	0.5	0.2	0.2	0.2			0.2	0.5	0.0	0.7	0.3	0.8	0.2	0.2	0.2	0.4	0.2	0.5	1.1	0.2		0.8	0.6	0.0	0.3	0.4		0.5	0.0		1.4	0.0	2.6	3.1	0.4	0.0	0.4	1.2	0.6	6.2			0.7		0.0	0.4	0.6	1.6	1.2	1.5	0.6	0.0	0.7	0.0	1.6	1.5	1.3	2.2	0.0	0.0	1.6	0.7	0.0	0.0	0.0	4.6	0.6	1.6	0.3	0.0	1.4	2.1	0.0	0.0	0.0	1.1	1.9	1.5	3.7	2.1	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	2.4	1.2	0.0	2.6	0.9	1.8	2.4	1.6	1.1	1.2	1.6	0.2	0.0	1.7	2.0	0.5	4.4	0.5	0.2	0.7	0.4	0.0	1.0	2.5	1.0	0.8	0.9	0.6	0.1	0.9	0.3	0.7	1.1	0.0	0.6	1.5	0.7	0.6	0.0	0.3	0.3	0.5	0.3	1.6	0.3	0.5	0.6	0.0	0.6	1.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NXN	"FLJ12614, NRX"	ENSG00000167693	Nucleoredoxin	Q6DKJ4	17	799313-979770	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Oxidoreductase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 74.7;Urothelial cells: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.7;HHSteC: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023566	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA023566: AB_1854737"	"unprognostic (1.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.05e-3)"	11.9	4.9	5.8	11.5	5.9	1.0	12.8	5.0	5.0	21.7	27.1	4.7	16.9	4.0	21.5	19.2	14.0	13.8	14.5	7.6	6.0	4.2	5.1	3.8	15.8	7.2	3.9	3.1	13.9	23.1	1.1	3.2	10.0	5.6	18.9	3.6	12.3	10.9	19.0	48.9	10.6	8.1	25.8	4.4	2.9	13.0	6.4	4.3	6.0	5.7	17.4	11.8	20.8	26.3	0.9	1.2	1.5	0.2	1.8	1.6	0.3	4.4	6.6	26.1	16.8	1.7	0.3	1.4	14.0	9.3	14.9	23.8	15.6	4.6	0.1	27.0	17.9	3.4	31.7	16.8	26.2	11.8	0.2	9.8	0.0	4.1	13.7	35.0	0.1	0.7	10.6	24.3	1.9	11.7	3.0	13.3	3.6	2.2	0.0	3.9	1.8	0.8	0.3	12.5	13.1	0.4	1.9	0.6	0.1	10.5	6.4	6.7	4.4	6.6	0.0	0.3	16.9	4.7	4.0	0.0	0.3	6.3	0.1	3.9	2.4	1.5	0.1	0.1	0.5	0.2	0.8	0.2	0.1	0.2	0.1	0.1	0.9	0.4	0.2	1.2	0.3	1.6	0.2	1.5	1.8	0.1	1.2	1.4	0.3	5.8	5.9	5.0	5.0	6.0	4.2	3.9	3.1	5.6	4.3	29.8	13.2	0.8	42.2	15.5	1.8	6.3	0.0	10.7	11.4	3.5	31.4	0.4	0.0	3.1	20.4	29.2	0.0	0.0	21.1	0.6	18.8	21.1	1.1	6.7	4.8	4.8	1.7	11.6	0.3	74.7	14.4	3.8	6.8	1.0	0.0	9.6	8.6	0.0	6.7	0.3	16.7	12.9	19.8	10.6	9.1	10.8	0.3	0.0	0.0	52.9
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88535101-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 11.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.6;Proximal tubular cells: 12.2"	"Group enriched"	"Detected in some"	7	"breast cancer: 1.7;endometrial cancer: 4.0;ovarian cancer: 7.2;renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045526	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA045526: AB_10961044"	"prognostic favorable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	7.2	0.4	1.6	1.0	1.6	4.4	3.2	0.6	1.1	6.7	0.5	2.0	0.4	0.6	6.2	9.7	0.8	6.6	0.7	0.5	1.8	2.9	4.4	5.1	0.4	0.4	1.3	1.0	11.7	0.5	0.0	0.7	3.9	1.2	0.8	0.0	2.0	1.4	3.7	1.0	1.3	0.5	0.4	1.8	0.8	0.5	2.2	0.4	0.4	1.2	0.4	0.4	1.2	1.5	1.2	1.1	4.8	1.0	1.7	2.4	0.7	2.0	4.2	1.7	1.5	0.2	1.1	1.2	3.9	1.0	0.5	0.7	0.9	1.3	1.0	1.6	0.4	1.0	2.0	0.6	0.2	1.4	0.6	1.3	1.9	4.0	1.3	0.8	1.2	1.4	0.8	0.3	0.4	0.4	0.6	0.0	1.4	1.3	4.2	1.0	1.0	1.1	1.9	2.1	0.7	0.9	0.8	0.8	1.4	15.3	1.4	1.1	0.7	2.3	1.3	0.7	1.1	1.7	1.0	1.5	1.5	2.9	2.1	0.9	1.4	1.2	1.1	1.3	1.6	1.0	4.8	1.0	2.3	2.1	0.5	2.1	0.8	1.2	2.4	0.3	1.2	2.1	2.4	2.8	1.7	0.5	1.1	2.0	0.7	1.6	1.6	0.6	1.1	1.8	2.9	1.3	1.0	1.2	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.5	8.6	0.0	0.0	0.0	0.2	1.1	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.1	12.2	0.7	0.0	0.8	0.3	0.4	0.1	0.9	0.0	0.0	1.8
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101827392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.6"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 37.8;Horizontal cells: 46.1;Ito cells: 40.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA		7600	Vesicles	Nucleoplasm	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	6.1	4.7	7.2	7.6	16.6	7.8	5.3	6.1	16.2	6.3	5.2	29.5	6.0	2.4	7.9	2.6	4.5	8.2	4.8	12.6	9.8	5.9	3.0	2.5	6.9	10.7	24.0	8.6	5.5	2.6	15.8	6.9	4.7	22.0	6.2	3.4	3.4	4.2	7.5	44.6	2.5	4.9	7.6	9.4	8.7	4.6	5.1	17.2	6.6	5.3	4.1	9.8	7.3	5.0	8.9	11.6	15.9	13.6	6.7	19.5	11.1	7.8	12.0	10.4	3.7	11.2	11.7	2.3	8.7	11.1	10.5	15.3	2.8	0.8	11.5	25.8	9.8	12.7	1.7	11.5	9.4	13.0	14.3	3.6	8.9	7.6	7.4	14.8	7.5	8.3	6.7	1.6	8.7	3.2	13.7	11.3	11.2	1.8	37.8	17.3	4.1	10.0	1.8	5.9	0.4	7.4	4.6	12.6	4.9	7.7	2.0	8.2	9.8	3.7	0.9	6.5	6.5	1.7	10.8	9.8	11.7	13.9	1.3	9.0	18.0	17.8	13.6	10.0	33.3	2.2	6.3	13.6	15.9	12.7	10.4	8.8	8.9	14.2	13.2	11.6	5.8	19.5	15.5	6.9	6.7	9.9	7.4	16.3	11.1	7.2	16.6	6.1	16.2	9.8	5.9	24.0	8.6	22.0	17.2	23.8	6.1	9.7	1.9	3.3	23.7	37.8	5.1	2.7	3.4	0.0	7.9	0.7	0.0	2.6	1.0	11.7	0.0	0.0	2.2	1.2	7.8	0.8	12.7	1.6	6.3	46.1	6.9	40.5	18.4	1.3	8.6	9.5	6.8	10.8	0.5	22.7	2.0	0.0	7.1	0.5	15.7	19.4	7.6	9.3	15.2	2.6	0.6	10.9	0.4	1.0
NXPH3	NPH3	ENSG00000182575	"Neurexophilin 3"	O95157	17	49575858-49583827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"monocytes: 7.2;Muller glia cells: 8.9;Peritubular cells: 13.4;Smooth muscle cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 18.1;BJ: 5.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 61.3"	HPA073819			Approved	"Vesicles,Mitotic spindle"	"Secreted in brain"	NA	NA			Vesicles	"Mitotic spindle"	"HPA073819: "	"unprognostic (2.39e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.59e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-3)"	4.5	2.4	3.2	2.9	7.4	0.3	3.9	23.5	16.4	18.9	8.9	3.4	0.0	1.2	11.3	3.8	4.5	8.0	4.0	5.0	4.7	3.4	0.8	0.4	5.1	1.3	2.7	7.7	9.2	1.6	0.7	7.2	4.1	5.1	11.2	1.6	6.8	6.0	12.3	2.6	2.1	1.7	11.0	1.7	1.2	3.6	3.5	3.2	0.0	1.4	3.9	1.2	15.9	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	18.1	5.7	0.6	0.4	0.2	0.9	0.0	0.0	0.3	0.1	1.2	0.1	0.6	0.2	0.1	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.2	0.1	0.5	0.0	0.0	2.0	0.1	0.0	0.0	0.4	0.3	0.1	0.0	1.9	0.1	0.0	0.0	0.0	0.7	1.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.4	23.5	11.4	4.7	3.4	2.7	7.7	5.1	3.2	0.0	2.2	0.0	0.2	0.3	2.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.9	2.5	0.3	0.0	0.0	0.2	0.0	0.0	1.8	0.3	0.0	4.0	0.0	1.7	7.2	0.0	8.9	0.0	0.0	13.4	0.0	1.1	0.0	12.5	0.1	0.6	1.0	0.1	0.0	0.0	0.1
NYAP1	"C7orf51, FLJ37538, KIAA1486L"	ENSG00000166924	"Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1"	Q6ZVC0	7	100483927-100494799	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.8"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 4.3;Horizontal cells: 12.7;Muller glia cells: 3.8;Peritubular cells: 4.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 10.5;HUVEC TERT2: 5.2;SH-SY5Y: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022251	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA022251: AB_1848915"	"unprognostic (6.59e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.65e-2)"	3.1	6.3	11.8	1.6	15.2	1.3	1.4	15.4	32.8	1.8	1.6	3.8	0.0	1.6	2.8	1.3	1.5	1.9	1.6	1.2	13.2	12.8	1.9	1.1	1.3	1.4	7.4	13.4	5.7	2.1	1.1	10.2	1.7	11.4	2.9	1.4	1.0	2.3	3.2	1.2	1.9	1.8	2.1	3.9	1.6	2.3	9.0	4.4	0.0	1.2	0.0	1.2	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.1	1.8	2.7	1.7	0.3	0.1	1.3	0.2	0.6	0.5	0.2	0.0	1.4	0.4	10.5	0.1	0.8	0.2	0.0	1.8	0.2	0.2	0.4	0.2	2.0	0.0	1.1	1.8	0.0	0.6	0.7	0.4	5.2	0.3	0.7	0.1	0.0	0.4	0.0	0.0	0.8	0.4	0.1	0.1	0.0	0.0	0.1	0.0	1.2	12.7	0.4	0.3	1.2	1.6	0.2	0.0	1.9	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	15.2	15.4	20.6	13.2	12.8	7.4	13.4	11.4	4.4	0.0	0.0	0.0	0.1	0.1	4.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	12.7	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	4.2	0.0	0.7	0.0	0.0	0.9	2.4	0.1	0.0	0.0	0.0	0.0
NYAP2	KIAA1486	ENSG00000144460	"Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2"	Q9P242	2	225399710-225654018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 17.9;pituitary gland: 13.5"	"Cell type enriched"	"Detected in some"	6	"Bipolar cells: 17.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.2;U-2 OS: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045531, HPA056945"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA045531: AB_10960749, HPA056945: "	"unprognostic (2.49e-1)"	"unprognostic (3.34e-1)"		"unprognostic (1.24e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"		"unprognostic (6.13e-3)"		"unprognostic (3.33e-1)"	"unprognostic (2.08e-1)"		"unprognostic (1.32e-8)"	"unprognostic (9.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.27e-1)"	0.8	1.1	10.8	1.0	16.4	1.4	0.7	17.9	11.9	0.6	0.7	0.8	0.0	1.0	0.7	0.7	1.2	0.6	0.8	0.7	8.5	2.5	0.7	0.7	1.9	1.1	2.6	8.5	0.6	0.8	0.6	13.5	0.7	2.5	0.7	0.8	0.0	0.7	0.6	2.6	1.2	0.9	0.6	2.7	0.9	0.8	1.0	2.9	0.0	0.6	0.0	0.8	1.2	0.6	0.5	0.5	2.1	0.3	0.2	0.4	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.7	1.0	2.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.1	0.3	0.2	0.3	0.2	0.4	0.3	0.2	0.1	0.0	0.5	0.3	0.4	1.2	0.2	0.2	0.5	0.1	0.1	10.8	16.4	17.9	11.9	8.5	2.5	2.6	8.5	2.5	2.9	0.0	2.9	0.0	1.1	1.1	17.8	0.3	0.0	0.0	1.2	0.0	2.0	0.2	0.0	0.4	0.4	0.0	0.0	0.0	1.0	0.1	0.4	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.2	0.9	0.1	0.0	0.0	0.8
NYNRIN	"CGIN1, FLJ11811, KIAA1305"	ENSG00000205978	"NYN domain and retroviral integrase containing"	Q9P2P1	14	24398786-24419288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.9"	"Cell type enhanced"	"Detected in many"	5	"Club cells: 12.5;Ito cells: 16.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 26.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.1;HEL: 9.1;HUVEC TERT2: 22.7;RT4: 18.7;TIME: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018945	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA018945: AB_1859538"	"unprognostic (9.41e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.43e-1)"	8.1	2.8	2.1	4.3	2.2	0.2	6.8	26.6	2.6	16.7	7.6	2.5	29.6	2.9	14.6	45.9	11.6	13.4	14.5	5.1	2.2	4.2	6.1	3.6	7.5	2.0	1.8	1.8	28.0	2.9	4.5	4.9	10.5	2.4	9.8	4.1	9.1	5.5	20.2	2.5	9.1	4.5	8.0	1.5	5.2	4.5	7.3	1.4	3.5	7.5	8.5	6.5	8.6	10.2	0.0	1.7	0.0	0.1	0.5	0.1	0.0	0.1	0.0	3.0	0.0	4.1	8.7	0.2	1.4	1.4	0.9	1.1	2.1	9.1	0.2	0.4	5.4	0.1	0.0	4.8	0.1	1.0	0.0	0.5	9.1	1.2	0.2	3.1	0.0	0.0	8.8	0.4	0.6	0.0	1.6	22.7	0.1	1.4	0.0	0.1	0.4	0.0	0.4	1.7	0.6	0.0	1.2	0.0	0.0	0.0	18.7	0.4	6.5	0.0	0.8	0.1	7.6	1.6	1.3	10.9	0.1	5.5	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	2.1	2.2	26.6	2.6	2.2	4.2	1.8	1.8	2.4	1.4	3.0	1.7	0.0	3.9	4.0	0.4	1.7	7.6	1.4	12.5	8.7	0.0	0.9	0.0	3.3	0.7	7.1	1.3	0.0	2.7	0.9	6.6	0.8	0.0	1.8	8.5	0.0	5.2	16.0	5.1	0.0	2.3	0.8	3.3	1.0	8.5	5.3	3.7	3.5	0.4	0.1	0.3	0.0	4.7	0.0	1.1	3.3	0.9	0.0	8.3	3.1
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120210767-120230332	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 187.7;Muller glia cells: 261.4;Urothelial cells: 195.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.6;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.0;Hep G2: 54.7;NB-4: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		65000000	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	16.2	22.5	8.6	6.9	15.4	3.5	24.9	1.2	10.3	18.7	16.8	4.0	8.0	19.4	14.3	17.2	10.7	13.4	20.6	13.7	8.7	1.4	21.5	93.4	5.6	8.1	5.4	6.4	26.2	43.7	2.4	7.4	4.6	3.2	10.3	13.5	18.2	26.5	5.8	3.7	3.0	22.1	11.7	3.3	15.3	9.9	5.5	5.5	1.2	6.8	8.6	3.6	11.2	10.9	0.1	4.6	0.3	6.2	0.0	0.4	1.3	7.0	2.2	8.4	4.2	13.1	14.8	0.5	13.8	14.3	5.6	8.2	2.2	11.0	0.0	35.0	9.3	9.2	7.4	2.3	3.5	2.2	5.1	5.7	5.8	1.4	54.7	11.7	12.8	2.3	18.4	2.1	5.3	14.9	10.8	16.0	3.5	3.7	6.7	1.3	2.6	0.0	36.7	3.4	1.9	11.2	3.3	0.2	6.8	8.4	3.9	0.4	3.0	4.0	4.5	11.4	2.4	1.4	21.3	9.7	12.0	4.4	12.2	1.3	0.2	0.1	0.1	9.2	21.4	4.1	0.0	6.2	0.0	0.2	2.9	0.1	0.1	0.0	0.0	4.6	0.0	0.1	0.4	0.3	0.0	0.6	0.9	0.3	1.3	8.6	15.4	1.2	10.3	8.7	1.4	5.4	6.4	3.2	5.5	0.0	1.1	1.5	19.1	8.4	3.2	3.6	33.1	0.0	2.3	68.0	2.0	1.8	23.2	14.3	0.1	24.8	97.4	23.3	24.3	4.7	46.2	12.2	1.1	187.7	5.5	0.0	21.9	11.1	10.6	0.0	15.5	9.7	15.1	1.8	55.8	261.4	23.5	41.9	4.2	64.1	8.0	51.8	45.3	0.5	6.7	8.9	5.1	3.2	42.0	195.3
OAS2		ENSG00000111335	"2'-5'-oligoadenylate synthetase 2"	P29728	12	112978395-113011723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 14.9;Endothelial cells: 14.3;Hofbauer cells: 15.1;Kupffer cells: 16.2;Macrophages: 15.1;T-cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;SK-MEL-30: 28.2;U-266/70: 26.3;U-266/84: 22.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA003320, CAB024984"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB024984: , HPA003320: "	"unprognostic (2.39e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.64e-3)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-2)"	37.9	3.8	4.0	13.9	5.1	9.0	7.2	1.8	4.9	8.5	4.3	7.5	1.2	4.6	9.0	6.9	13.2	3.9	9.6	6.9	3.8	4.4	8.8	9.9	15.6	24.1	5.0	3.7	3.9	1.9	1.2	2.9	22.2	7.3	6.6	4.7	6.9	32.9	1.8	2.2	2.9	8.8	6.4	7.1	36.6	9.7	2.2	3.0	32.4	9.8	8.2	27.4	13.7	5.4	12.0	12.7	2.0	26.8	15.1	17.4	13.2	0.7	0.1	0.0	0.0	0.4	2.6	0.0	0.1	8.2	72.2	58.9	0.1	1.2	18.2	1.8	1.5	16.2	0.8	0.1	0.2	2.5	4.5	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	1.3	4.1	0.0	0.0	1.1	0.9	0.0	9.5	0.0	0.3	0.5	1.0	0.0	0.1	2.6	3.9	0.0	2.7	0.0	6.5	0.0	0.0	0.7	0.2	28.2	0.0	0.6	1.1	1.8	0.1	0.0	0.3	0.0	26.3	22.6	2.8	0.6	0.9	0.7	2.0	15.9	1.2	13.4	26.8	16.8	12.0	15.4	15.2	12.7	8.9	15.2	11.2	1.8	15.1	26.0	5.3	17.4	13.2	4.0	5.1	1.8	4.9	3.8	4.4	5.0	3.7	7.3	3.0	3.0	8.9	14.9	1.5	1.8	0.0	1.4	0.0	8.1	3.4	1.8	0.0	0.1	0.0	1.0	0.6	14.3	0.3	0.0	1.0	2.1	2.1	2.4	1.1	1.8	15.1	0.0	0.0	11.1	16.2	0.7	0.6	15.1	5.0	3.6	3.1	0.5	2.3	0.2	3.2	0.0	0.1	0.0	1.0	0.0	0.1	1.0	0.1	13.8	0.1	7.7
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938352-112973249	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 64.2;BJ hTERT+ SV40 Large T+ RasG12V: 70.2;GAMG: 31.4"	"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No		21000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	36.9	4.9	5.1	11.2	5.4	18.3	7.0	2.9	5.5	10.5	6.8	5.5	3.2	7.3	10.0	11.8	17.9	4.2	9.4	6.7	4.5	5.3	10.3	7.1	19.9	13.3	5.1	5.1	6.1	3.2	3.3	4.6	19.3	8.7	5.6	6.9	8.9	24.7	3.4	3.3	6.0	9.3	8.3	6.2	22.0	9.5	3.0	3.3	21.3	9.9	6.7	13.5	9.9	8.2	2.6	4.8	10.1	14.7	5.0	3.8	3.9	6.3	9.5	0.0	1.5	0.3	1.4	0.8	1.2	8.3	64.2	70.2	7.2	5.8	0.4	2.3	2.9	31.4	5.5	1.2	7.8	5.4	4.7	0.3	4.9	4.4	2.3	1.2	1.7	2.7	0.5	2.5	9.1	0.5	1.1	3.3	1.3	0.1	1.0	0.8	4.1	2.7	0.9	0.5	11.7	5.6	3.9	3.4	0.1	3.0	17.6	0.2	0.0	5.8	2.2	5.7	0.0	7.6	0.5	2.2	1.7	1.2	1.5	2.6	0.5	19.2	0.1	1.4	4.8	5.2	0.9	7.9	1.6	2.0	8.6	2.5	2.6	3.0	3.0	4.8	1.3	2.2	2.6	10.1	5.0	14.7	0.2	3.8	3.9	5.1	5.4	2.9	5.5	4.5	5.3	5.1	5.1	8.7	3.3	3.0	4.6	2.4	4.8	3.1	0.4	1.7	0.0	0.0	2.3	3.5	0.0	4.0	3.3	10.8	6.1	13.4	4.1	0.0	8.6	15.8	5.4	6.5	1.1	1.5	16.5	0.0	1.7	9.2	4.7	5.9	9.5	6.6	1.7	6.4	6.3	4.4	14.5	4.0	14.2	2.1	0.2	0.0	3.1	0.5	0.2	4.1	1.6	4.6	3.7	25.3
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121019111-121039242	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;bone marrow: 33.1"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 52.2;BJ hTERT+ SV40 Large T+ RasG12V: 26.9;GAMG: 14.8;hTEC/SVTERT24-B: 20.9"	"Not detected"	"Not detected"							HPA001474	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	20.5	0.5	1.0	8.3	1.4	33.1	2.7	0.4	1.9	3.6	5.9	1.7	0.1	1.6	1.7	1.3	4.7	0.6	3.1	2.2	0.7	0.9	4.0	22.6	16.5	1.9	1.3	1.2	1.4	0.4	0.2	0.8	3.6	2.3	2.5	3.0	2.3	3.4	0.3	1.1	0.8	2.0	1.1	1.9	5.2	15.7	2.1	0.6	6.0	3.2	3.7	7.6	2.9	1.5	0.8	3.2	44.5	10.8	6.9	23.6	10.8	1.0	0.2	0.0	0.3	0.4	0.9	0.0	0.1	0.5	52.2	26.9	0.0	5.0	0.3	1.5	0.0	14.8	2.7	0.0	0.3	3.8	9.2	0.0	0.0	5.2	0.0	0.3	0.0	0.7	0.3	0.2	20.9	0.0	0.1	0.1	0.3	0.0	1.8	0.2	0.5	0.0	2.7	0.0	1.8	1.1	0.0	0.1	0.6	0.2	4.9	0.0	0.0	0.4	0.2	8.2	0.0	0.1	0.8	0.0	0.2	0.4	0.6	0.1	2.0	3.7	0.0	7.8	0.4	0.1	4.2	10.3	22.4	20.4	10.8	5.3	0.8	14.1	23.6	3.2	0.3	4.0	15.7	44.5	6.9	7.4	0.1	9.9	10.8	1.0	1.4	0.4	1.9	0.7	0.9	1.3	1.2	2.3	0.6	0.0	6.2	0.0	3.8	1.9	0.0	0.3	0.0	4.0	3.4	0.0	0.0	0.2	0.0	2.7	3.1	2.1	4.2	0.0	3.4	0.6	0.5	1.1	11.5	3.9	12.3	0.0	1.7	0.0	4.0	2.5	0.3	6.8	0.0	4.6	15.9	0.0	7.4	3.5	0.0	0.3	0.0	0.0	2.2	1.9	0.1	0.9	0.1	17.3	1.2	72.1
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 208.5"	"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	13.5	37.1	25.9	9.1	26.7	20.3	33.8	17.2	39.8	24.7	71.9	22.8	33.9	164.0	21.6	15.5	26.1	14.9	16.0	12.7	25.6	29.8	25.6	36.8	11.6	9.3	27.9	30.1	21.8	12.3	12.1	18.0	14.8	37.8	17.9	15.8	13.3	55.2	29.1	13.7	16.3	208.5	22.5	25.5	8.4	17.3	14.6	19.4	4.9	15.9	23.1	15.2	15.5	18.2	10.2	26.5	23.0	23.6	9.6	20.1	16.3	42.0	7.6	5.0	17.9	51.0	49.3	17.1	25.5	52.1	22.8	25.0	19.5	5.5	0.0	18.6	43.0	21.7	44.8	22.8	47.7	24.8	7.4	31.6	47.1	5.3	14.5	26.3	0.0	31.1	32.2	24.6	20.5	24.0	37.8	26.5	8.7	81.0	9.1	31.8	10.9	12.4	2.6	10.0	12.9	10.8	11.6	19.1	11.4	21.8	0.7	10.5	11.2	16.0	42.8	35.9	30.1	14.2	11.6	20.4	13.0	12.2	21.5	15.8	7.8	8.1	11.4	18.0	12.7	6.2	18.6	23.6	20.7	18.5	20.7	20.1	9.6	15.6	19.4	26.5	10.2	19.6	19.1	23.0	9.6	20.8	5.7	14.4	16.3	25.9	26.7	17.2	39.8	25.6	29.8	27.9	30.1	37.8	19.4	17.9	38.8	36.2	123.3	134.4	27.8	14.0	22.9	44.2	75.1	33.2	25.5	97.9	76.3	32.5	16.9	35.8	49.1	303.7	12.0	67.3	125.7	58.3	43.8	69.3	56.5	41.3	41.3	35.6	32.6	9.0	96.4	49.4	81.0	20.8	48.6	32.0	11.7	36.8	112.8	114.0	21.3	77.6	123.8	32.5	27.0	110.2	40.3	40.6	67.9	76.5
OAZ1	"AZI, MGC138338, OAZ"	ENSG00000104904	"Ornithine decarboxylase antizyme 1"	P54368	19	2269509-2273490	"Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009291	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			Vesicles	"Centriolar satellite"	"HPA009291: AB_1079519"	"unprognostic (2.37e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (4.10e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.01e-2)"	50.7	56.5	73.3	47.5	68.2	84.6	67.4	41.5	68.6	27.2	37.8	22.9	31.1	47.8	32.7	33.7	38.6	40.1	34.0	73.7	67.2	53.3	31.8	45.7	50.3	71.4	60.4	52.3	31.2	86.0	11.9	34.6	53.5	39.9	32.1	24.0	27.1	65.6	33.7	137.4	30.4	55.3	37.3	37.0	66.0	41.4	25.0	29.4	31.8	43.8	59.3	40.1	37.2	45.3	69.7	83.1	150.4	136.3	24.4	54.4	160.8	73.1	15.2	11.7	20.1	24.7	39.5	30.5	52.3	36.4	26.5	36.4	21.7	23.7	50.0	28.2	24.3	10.4	21.3	11.5	15.7	17.5	66.4	39.9	38.6	15.2	34.1	25.2	53.8	61.1	26.3	27.6	9.9	15.2	23.9	30.0	18.5	37.4	58.1	29.7	26.7	44.6	56.2	38.6	10.7	27.8	37.1	23.5	65.9	24.1	21.2	27.8	29.4	34.4	31.3	57.5	9.8	26.2	114.5	38.1	18.9	23.2	81.1	54.8	56.7	23.4	61.0	85.7	84.6	28.5	109.3	116.3	134.1	36.1	117.5	36.0	69.7	39.5	38.3	83.1	66.6	36.9	36.4	150.4	24.4	136.3	56.0	54.4	160.8	73.3	68.2	41.5	68.6	67.2	53.3	60.4	52.3	39.9	29.4	339.5	469.8	928.1	928.0	1311.0	338.1	593.5	527.4	441.6	342.4	279.2	100.1	923.2	1042.8	914.1	75.9	534.9	1129.6	817.7	884.4	1236.3	850.7	987.2	688.0	701.2	2052.3	209.7	589.4	454.8	1994.6	195.9	517.2	2135.2	1078.0	2688.9	644.4	226.4	989.3	1304.6	448.7	1061.1	197.0	452.7	966.5	272.6	281.5	1121.8	1407.9	752.7	613.6	1395.6
OAZ2		ENSG00000180304	"Ornithine decarboxylase antizyme 2"	O95190	15	64687573-64703281	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Sertoli cells: 368.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047694	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA047694: AB_2680121"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (2.09e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-1)"	23.2	28.8	47.2	22.6	43.1	13.6	21.9	31.7	46.8	27.6	22.7	36.6	17.2	13.6	28.0	29.0	18.8	29.9	22.6	32.6	41.8	37.6	25.0	42.0	23.5	26.0	41.0	46.3	25.6	14.7	37.1	28.1	35.7	47.8	21.8	17.9	26.5	20.3	25.4	87.5	15.4	13.6	35.1	36.1	32.9	16.6	30.4	47.4	10.8	27.7	29.7	21.0	20.5	17.2	5.4	15.6	72.4	42.1	6.5	5.3	16.0	18.5	17.0	35.7	11.8	25.7	22.4	6.7	21.6	32.7	31.2	27.3	11.5	16.8	16.2	20.1	30.2	23.2	10.1	34.3	19.2	27.5	21.6	13.0	10.6	13.1	8.5	14.6	9.2	34.6	29.2	13.5	15.6	11.1	40.7	29.5	11.5	7.7	8.0	33.4	11.8	6.3	11.4	60.9	10.3	13.7	15.0	20.4	14.1	27.7	14.8	18.8	34.5	8.1	12.3	21.3	46.6	20.5	13.9	17.6	21.2	28.5	10.4	22.9	17.9	26.5	15.4	24.2	19.9	18.9	2.8	23.9	44.1	5.2	42.1	4.4	5.3	4.5	4.3	15.6	5.4	5.3	4.6	72.4	6.5	33.9	8.5	5.1	16.0	47.2	43.1	31.7	46.8	41.8	37.6	41.0	46.3	47.8	47.4	23.8	37.9	45.5	90.9	108.1	94.0	53.7	45.9	46.8	29.6	40.1	98.2	96.4	142.6	95.4	296.9	106.7	17.1	23.3	58.2	58.8	101.1	70.7	100.5	73.7	119.9	69.9	78.6	82.9	98.3	55.8	105.9	126.3	97.8	90.2	27.7	212.4	70.8	29.8	64.0	70.5	149.0	368.7	196.4	123.4	54.7	105.9	57.3	35.4	25.9	61.3
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 180.2;tongue: 48.4"	"Cell type enriched"	"Detected in many"	14	"Cardiomyocytes: 136.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.0"	"Low region specificity"	"Detected in single"							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1.0	0.6	21.2	0.5	0.7	1.6	0.5	1.0	1.0	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1.0	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8.0	4.5	0.2	0.1	5.6	1.5	0.5	1.0	0.9	2.0	2.1	5.7	8.1	0.5	0.6	1.0	0.4	1.1	0.2	2.2	5.1	1.9	16.0	0.0	2.0	1.3	6.1	3.0	1.0	0.4	0.2	5.4	0.4	9.4	5.3	1.3	0.3	5.0	2.1	1.6	8.8	0.8	1.8	8.1	0.1	1.3	4.6	1.5	3.0	9.0	0.2	2.9	1.1	2.4	8.0	3.7	0.7	0.0	9.3	0.2	0.1	4.7	0.9	1.4	0.0	0.8	2.1	0.1	0.4	0.0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1.0	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6	0.0	5.6	0.0	5.9	1.9	3.2	136.5	2.5	1.4	4.5	5.2	9.8	0.1	10.0	2.9	3.8	1.6	0.4	0.0	0.4	0.4	1.5	1.9	6.9	0.5	0.1	0.0	0.0	1.3	0.0	4.0	2.8	0.3	1.7	0.0	1.7	9.7	1.0	0.0	4.2	4.2	2.8	0.0	1.2	0.1	2.5	1.5	1.0	1.8	1.1	3.4
OBSL1	KIAA0657	ENSG00000124006	"Obscurin like 1"	O75147	2	219550729-219571859	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 82.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 829.2;Late spermatids: 1255.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.8;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.7;granulocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.0;SK-BR-3: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036404, HPA036405"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA036404: AB_10670437, HPA036405: AB_2675104"	"unprognostic (2.36e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.27e-3)"	"unprognostic (2.89e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.16e-1)"	10.7	26.9	13.4	7.0	11.5	1.2	11.7	18.0	16.2	17.6	8.7	10.3	10.5	3.8	18.2	23.3	7.3	19.9	14.5	30.7	12.8	8.2	19.6	14.5	9.3	3.4	5.5	10.9	82.2	35.6	23.5	16.6	19.3	11.5	15.1	2.3	19.1	25.5	19.1	21.0	14.8	4.8	10.5	8.8	8.2	10.3	15.5	11.5	0.8	34.1	12.4	2.6	10.1	12.1	0.1	2.7	6.8	0.4	0.1	0.2	0.0	9.5	6.4	11.9	24.7	8.2	6.1	45.0	7.2	10.6	9.2	8.5	5.6	14.9	0.0	15.3	9.8	8.9	9.8	9.2	5.4	1.9	0.0	16.1	20.7	6.2	28.3	6.2	0.5	0.1	16.5	4.5	2.1	3.5	16.4	1.0	0.0	8.5	0.2	6.5	23.6	0.0	5.9	28.2	2.7	6.6	10.6	10.4	0.0	16.6	9.0	5.2	17.8	8.2	43.7	16.4	31.4	4.0	17.9	2.4	9.8	10.6	3.0	2.8	0.0	0.0	0.0	5.7	0.0	9.7	6.8	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.8	0.1	0.4	2.7	0.0	0.0	13.4	11.5	18.0	16.2	12.8	8.2	5.5	10.9	11.5	11.5	8.9	14.8	0.0	19.2	7.4	33.3	45.9	25.5	8.1	10.3	50.6	2.0	55.5	44.7	13.5	829.2	12.0	2.0	0.0	10.7	57.4	14.5	10.9	4.6	13.9	6.6	39.7	19.7	10.4	1.0	1255.6	71.4	3.2	13.5	1.0	3.1	79.6	9.7	2.5	69.6	15.4	9.5	12.9	17.5	239.3	51.1	5.8	72.3	0.0	2.3	7.8
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099358	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.9;skin 1: 12.3"	"Cell type enhanced"	"Detected in some"	24	"Leydig cells: 8.6;Melanocytes: 40.5;Peritubular cells: 13.8"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SH-SY5Y: 5.9;SK-MEL-30: 22.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036402			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.4	0.1	0.9	1.3	4.8	0.0	0.3	0.2	2.9	2.4	0.3	3.6	0.2	0.0	0.4	1.7	2.9	1.6	0.5	0.2	1.3	3.6	0.4	0.4	1.2	3.1	0.3	0.4	0.4	0.2	0.0	1.0	2.9	9.5	0.9	0.2	37.9	1.9	2.7	0.4	12.3	0.2	0.2	0.2	2.0	0.1	2.6	0.2	0.3	7.0	0.5	1.5	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	5.9	0.0	0.0	22.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	4.8	0.2	2.9	1.3	3.6	0.3	0.4	9.5	0.2	0.0	0.0	0.0	0.1	1.8	0.0	0.3	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.6	0.0	40.5	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	1.7	2.9	3.9	0.6	0.1	0.0	0.0	0.1
OCEL1	FLJ22709	ENSG00000099330	"Occludin/ELL domain containing 1"	Q9H607	19	17226204-17229219	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.0"									"HPA042070, HPA043223"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA042070: AB_2677830, HPA043223: "	"unprognostic (6.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.18e-3)"	12.1	14.3	9.2	7.3	7.4	5.9	10.6	7.3	16.5	9.6	18.6	6.2	14.0	20.4	9.7	21.3	8.8	14.7	11.0	9.1	8.3	8.2	23.3	48.1	11.1	7.6	9.9	9.5	12.3	15.9	12.3	6.5	13.0	7.8	13.4	13.7	9.9	11.5	21.7	8.6	5.6	32.2	8.2	8.1	11.8	15.1	4.9	8.1	9.4	20.5	6.8	10.0	9.7	13.6	12.2	18.2	17.2	23.7	11.2	14.4	9.5	5.8	4.4	2.5	2.0	24.0	9.8	6.2	3.6	9.5	2.9	4.9	3.2	6.7	5.0	13.9	5.2	2.5	2.7	3.1	3.7	2.7	4.2	3.7	4.8	4.8	15.4	8.1	1.0	7.4	8.1	3.8	3.6	5.3	9.7	4.0	6.7	3.9	4.8	5.2	4.7	2.4	2.7	3.8	8.3	7.8	2.2	2.1	12.1	12.1	7.7	0.8	3.9	2.2	7.3	6.2	5.1	11.1	4.2	2.5	1.7	2.1	3.7	1.9	13.6	10.2	3.8	6.1	4.4	1.2	17.2	23.7	11.2	8.1	15.7	7.9	12.0	12.2	9.2	18.2	12.2	14.0	8.7	7.5	11.2	12.4	8.0	14.4	9.5	9.2	7.4	7.3	16.5	8.3	8.2	9.9	9.5	7.8	8.1	11.9	5.1	15.2	23.6	5.7	11.6	5.9	30.6	62.9	7.9	19.2	2.0	35.5	51.4	17.4	3.9	15.0	74.1	0.0	24.2	36.0	17.5	26.5	16.1	76.1	23.5	23.8	16.7	21.5	20.4	12.0	26.2	17.1	15.1	10.8	30.2	29.0	21.0	49.1	21.9	112.8	8.2	32.3	13.4	7.7	13.8	5.8	86.3	19.7	25.9	18.2
OCIAD1	"Asrij, FLJ20455, OCIA, TPA018"	ENSG00000109180	"OCIA domain containing 1"	Q9NX40	4	48805212-48861817	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044803	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044803: AB_10961287"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.82e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.10e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.34e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	28.8	43.6	59.9	24.7	73.5	21.8	35.9	55.3	82.2	37.4	37.6	36.1	35.4	33.5	34.1	49.3	28.1	41.6	29.9	47.9	62.7	61.9	57.8	79.0	27.7	32.0	51.4	60.7	40.4	34.6	52.4	53.5	29.0	53.6	34.8	39.6	29.1	34.8	36.4	53.5	23.9	30.1	33.4	51.0	23.7	31.0	23.7	35.1	29.1	55.1	37.2	31.0	31.6	24.0	33.2	35.9	30.7	33.6	41.9	43.2	30.0	25.3	18.6	38.3	26.2	38.0	45.9	29.6	41.5	64.9	42.7	50.1	18.1	72.1	29.4	41.5	36.4	50.3	22.2	36.3	38.4	51.9	24.4	24.3	45.8	18.9	14.7	56.3	47.1	49.6	48.9	56.2	33.5	41.4	50.5	43.7	28.7	50.9	16.5	49.6	17.3	40.4	47.1	31.5	31.6	17.5	28.2	37.2	31.1	82.7	25.6	22.5	41.4	20.4	16.2	45.9	31.9	32.7	41.3	33.0	28.3	32.7	19.4	51.7	42.8	59.3	46.3	34.5	37.8	34.5	17.6	26.0	30.7	30.5	28.5	41.6	33.2	34.7	36.2	32.5	29.3	43.2	37.2	21.2	41.9	33.6	35.9	29.0	30.0	59.9	73.5	55.3	82.2	62.7	61.9	51.4	60.7	53.6	35.1	148.9	102.8	64.1	94.0	70.7	125.5	130.0	91.7	135.1	126.3	115.1	62.8	145.3	116.0	119.6	27.3	96.7	127.3	23.3	111.9	141.2	103.1	99.3	136.5	146.0	135.1	84.2	124.9	116.0	90.1	28.7	122.6	103.2	82.7	75.7	122.7	180.6	107.9	109.4	130.8	136.7	91.1	122.9	84.8	156.2	74.3	66.4	137.8	88.7	125.2	76.6
OCM	OCM1	ENSG00000122543	Oncomodulin	P0CE72	7	5879827-5886362	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.7;brain: 9.5;lymphoid tissue: 5.5"	"Cell type enhanced"	"Detected in some"	13	"Early spermatids: 1.7;Late spermatids: 1.8;Spermatogonia: 1.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.1;PC-3: 1.9;THP-1: 1.5;U-937: 2.2"									"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "	"unprognostic (1.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.90e-4)"	0.1	0.5	9.5	0.7	1.7	1.8	1.6	3.1	1.4	0.2	0.5			0.0	0.2	2.7	0.3	0.3	0.5	0.0	2.0	1.8	0.3	0.1	0.1	5.5	0.9		0.5	0.3	0.0	0.2	0.0		0.2	0.6		0.9	0.8	0.0	2.0	0.7	0.2	0.8	1.4	0.1	2.3			0.6		2.3	0.3	0.1	2.1	0.1	2.0	0.8	0.0	5.7	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.8	0.4	0.6	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.5	0.1	0.0	0.0	1.5	0.0	0.0	0.2	0.5	0.4	0.3	0.3	0.1	0.0	2.2	0.0	0.0	0.8	2.0	1.1	0.5	0.4	0.9	2.8	0.8	0.1	2.1	3.7	1.0	1.6	0.0	0.4	0.0	5.7	1.3											0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0
OCM2		ENSG00000135175	"Oncomodulin 2"	P0CE71	7	97984684-97991169	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"WM-115: 1.7"									"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "																		0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.6		0.0	0.0		0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.4			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OCRL	OCRL1	ENSG00000122126	"OCRL, inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 6.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavorable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	12.1	20.5	10.7	6.0	18.2	5.3	10.8	13.4	23.1	12.7	13.4	10.1	28.8	9.1	15.8	19.7	13.3	12.8	13.8	8.6	13.0	20.5	10.9	11.3	8.6	6.0	12.9	15.1	33.0	12.4	37.3	20.3	13.2	17.8	21.7	14.1	15.3	8.5	27.7	11.4	9.6	9.8	21.5	8.0	6.3	11.4	23.2	6.4	4.3	19.0	5.6	4.1	18.0	9.2	0.4	2.4	0.3	6.6	0.0	0.7	0.7	9.7	11.2	9.3	10.5	16.4	13.7	9.1	14.9	11.9	15.5	14.4	7.5	7.1	0.8	25.7	12.6	18.2	6.1	17.1	11.4	16.1	0.0	11.5	3.0	10.1	7.5	12.2	3.0	0.3	11.4	15.0	15.2	15.1	15.4	11.5	4.5	4.0	7.4	16.0	12.7	2.2	4.2	3.3	12.9	16.7	2.2	9.6	5.8	8.8	10.1	11.3	14.3	7.1	10.1	7.8	12.4	7.2	5.3	9.6	12.6	5.8	13.1	14.8	2.1	1.6	2.0	8.9	11.1	9.9	0.0	2.1	0.0	0.2	2.4	0.7	0.3	0.1	0.1	2.4	0.4	0.6	0.2	0.3	0.0	6.6	0.9	0.1	0.7	10.7	18.2	13.4	23.1	13.0	20.5	12.9	15.1	17.8	6.4	3.0	8.5	0.8	3.1	4.1	9.9	7.9	5.1	4.0	10.3	17.4	5.9	5.1	3.3	4.9	19.5	5.3	13.7	0.0	3.1	4.7	5.1	5.7	0.0	10.9	4.3	12.7	16.8	7.4	10.4	5.9	21.3	4.4	8.5	2.8	11.7	8.6	6.7	10.7	32.2	3.9	6.0	0.0	5.7	6.4	14.0	6.5	4.8	0.0	9.7	6.0
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448504	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 459.5;Late spermatids: 626.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	13.2	8.2	11.6	33.5	11.1	41.8	9.1	7.2	11.8	11.7	17.4	11.5	33.8	8.6	22.9	21.6	16.5	16.5	30.0	33.8	9.7	10.6	31.5	48.7	14.2	42.3	11.3	6.5	29.2	48.7	13.4	35.4	6.9	11.2	26.3	20.7	18.2	11.0	27.2	64.2	9.6	14.9	26.2	10.2	20.4	19.2	54.6	6.3	31.0	16.4	19.8	39.6	16.1	14.6	13.4	10.8	2.4	2.4	1.2	4.4	3.0	19.0	15.3	21.3	25.2	3.8	11.4	49.4	27.6	13.6	26.1	12.1	81.2	8.9	100.7	13.8	16.8	25.2	3.5	65.2	31.3	31.8	38.3	27.2	46.0	26.3	49.5	30.9	77.6	11.0	7.6	8.5	59.0	74.1	13.5	20.9	28.1	76.4	32.8	14.4	12.5	76.8	30.6	38.8	26.5	49.9	54.9	66.9	67.9	15.8	14.0	29.8	25.3	34.6	10.6	13.9	17.1	7.1	34.8	14.6	21.2	43.7	27.3	59.1	15.3	46.3	91.6	19.0	51.5	13.0	0.0	1.3	2.4	2.7	2.4	3.2	13.4	3.8	4.4	3.0	11.0	2.7	4.3	0.5	1.2	1.5	10.8	3.8	3.0	11.6	11.1	7.2	11.8	9.7	10.6	11.3	6.5	11.2	6.3	41.7	217.2	112.6	112.8	51.5	34.5	48.8	71.4	25.4	36.4	38.4	29.5	1.0	61.3	55.5	459.5	35.3	38.6	0.0	23.5	53.1	21.2	276.8	57.7	46.1	43.4	6.4	260.2	11.6	30.9	626.4	14.4	29.0	21.9	12.6	143.2	85.1	24.6	48.9	10.6	101.8	62.6	0.0	40.8	91.4	74.0	76.5	2.9	37.6	120.9	94.9
ODF3L2	"C19orf19, FLJ40059"	ENSG00000181781	"Outer dense fiber of sperm tails 3 like 2"	Q3SX64	19	463346-474983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 12.5;testis: 16.7"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 894.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.5;BEWO: 2.2;EFO-21: 3.1;HMC-1: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA067065, HPA067973"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA067065: , HPA067973: AB_2685937"	"unprognostic (3.75e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.02e-5)"	"unprognostic (3.13e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.99e-1)"	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.3		0.1	0.0		0.0	0.0	12.5	0.0	0.0	0.0	0.3	0.5	0.0	16.7			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	2.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	3.1	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.3	0.0	0.2	1.1	0.0	0.0	0.6	0.1	0.6	1.0	0.1	0.0	0.8	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.5	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	187.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	894.9	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.7	0.0	0.1	6.4	5.2	0.0	0.0	0.0	0.0	0.0
ODR4	"C1orf27, FLJ20505, odr-4, TTG1"	ENSG00000157181	"Odr-4 GPCR localization factor homolog"	Q5SWX8	1	186375838-186421378	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 28.6;Ciliated cells: 28.1;Club cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015988, HPA031352"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA015988: AB_1845644, HPA031352: AB_2673838"	"unprognostic (1.19e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.20e-2)"	11.9	15.9	18.2	7.0	22.9	12.2	13.7	27.7	18.7	13.9	10.3	11.4	16.2	12.5	9.6	16.6	9.5	9.1	10.3	11.8	14.3	11.3	16.1	20.0	10.4	6.1	21.9	14.0	12.1	26.5	44.8	26.5	13.4	16.0	16.1	12.8	9.7	18.3	15.3	10.3	9.5	14.8	9.0	21.3	10.1	12.8	8.1	19.1	9.0	19.0	10.1	6.9	10.4	9.7	4.1	8.6	4.4	11.8	10.6	6.2	4.6	7.5	8.5	9.5	7.5	11.6	11.1	18.0	12.4	7.9	8.1	8.0	16.7	17.5	5.4	14.8	6.1	7.3	19.5	6.9	6.6	7.8	4.7	7.1	5.0	10.9	9.5	10.7	8.3	6.3	8.4	13.5	9.4	15.2	8.5	8.6	5.6	18.9	11.0	9.8	8.0	5.9	8.2	13.1	29.4	2.9	6.7	6.4	14.8	16.0	7.7	6.8	10.6	9.4	20.3	14.4	17.5	17.7	7.2	7.9	11.3	7.1	7.8	11.5	13.4	8.1	8.4	6.3	4.5	10.2	1.5	10.5	2.7	3.8	10.0	5.5	4.1	4.8	5.0	8.6	3.1	6.0	4.6	4.4	10.6	11.8	5.4	6.2	4.6	18.2	22.9	27.7	18.7	14.3	11.3	21.9	14.0	16.0	19.1	26.8	28.6	0.0	0.0	0.0	0.0	0.0	0.0	28.1	54.6	24.4	0.0	20.7	8.3	18.4	0.0	0.0	0.0	0.0	22.2	19.9	0.0	0.0	11.6	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	11.8	0.0	0.0	21.7	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0
OGDHL	FLJ10851	ENSG00000197444	"Oxoglutarate dehydrogenase like"	Q9ULD0	10	49734643-49762379	"Citric acid cycle related proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.9;liver: 48.8"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 28.8;Collecting duct cells: 27.9;Cone photoreceptor cells: 29.5;Distal tubular cells: 77.9;Hepatocytes: 45.6;Horizontal cells: 28.6;Proximal tubular cells: 55.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 44.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.7;RPTEC TERT1: 28.2;SH-SY5Y: 10.6;SK-BR-3: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043716, HPA052497"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA043716: , HPA052497: AB_2681853"	"unprognostic (9.05e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.60e-1)"	"prognostic favorable (1.21e-14)"	"unprognostic (3.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.38e-2)"	0.9	8.1	8.3	1.0	15.3	0.8	0.8	16.2	23.6	1.3	1.3	4.9	2.7	1.4	2.2	1.7	0.9	1.5	1.1	4.1	8.7	13.7	74.9	48.8	0.8	0.9	12.1	11.0	1.9	3.4	23.1	11.7	0.9	23.6	1.8	1.0	8.2	10.3	5.0	0.9	0.8	1.4	1.2	2.9	1.0	1.4	1.9	3.2	0.0	13.0	0.0	1.1	1.4	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.0	13.7	0.0	0.0	1.7	0.0	0.0	0.7	0.1	6.6	1.5	0.0	7.4	0.0	2.2	0.2	4.7	0.1	0.2	0.0	0.3	0.0	0.1	3.3	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.4	0.0	3.4	0.3	0.0	0.0	2.0	5.0	4.5	1.3	0.5	0.6	0.0	0.0	0.0	28.2	0.4	7.8	10.6	0.1	10.4	0.7	4.2	2.9	1.8	0.0	0.0	7.1	0.0	0.4	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	15.3	16.2	23.6	8.7	13.7	12.1	11.0	23.6	3.2	0.0	0.0	1.9	0.5	0.0	28.8	3.2	2.5	0.0	0.0	27.9	29.5	0.0	77.9	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	45.6	0.1	28.6	4.6	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.1	0.0	0.0	55.6	16.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.1
OGFOD3	"C17orf101, FLJ22222"	ENSG00000181396	"2-oxoglutarate and iron dependent oxygenase domain containing 3"	Q6PK18	17	82389223-82418637	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052099	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052099: AB_2681725"	"unprognostic (1.12e-2)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.95e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.02e-1)"	12.9	18.0	7.6	11.3	10.4	10.2	12.1	15.4	13.7	12.0	11.1	14.3	21.8	11.5	14.7	24.9	10.7	15.0	19.0	20.9	7.2	8.5	13.7	16.8	14.4	12.3	9.1	11.9	15.1	30.0	15.3	20.4	12.8	9.0	13.8	6.6	13.9	21.8	22.9	24.4	11.3	11.6	13.4	10.7	10.5	13.0	9.8	8.6	6.9	18.8	17.0	12.8	11.6	12.0	10.1	18.5	3.1	10.3	5.2	10.9	5.2	12.6	15.9	5.3	17.8	10.4	13.2	9.3	13.0	12.1	13.4	13.9	17.0	17.3	8.6	10.4	10.0	13.7	9.5	4.6	10.8	5.6	6.8	14.2	13.3	12.2	21.5	9.3	15.2	15.6	10.5	8.1	6.2	5.4	9.8	14.0	9.7	16.6	6.8	3.9	11.9	10.3	15.8	5.0	13.3	19.4	7.0	10.4	13.2	7.6	11.8	11.6	23.1	22.3	20.4	10.4	4.7	12.1	20.0	10.8	25.4	16.0	9.9	16.4	12.1	1.0	8.2	15.8	8.9	13.1	0.1	10.3	3.1	5.4	9.4	6.1	10.1	7.8	10.9	18.5	8.8	9.4	7.8	1.3	5.2	6.3	9.6	2.9	5.2	7.6	10.4	15.4	13.7	7.2	8.5	9.1	11.9	9.0	8.6	23.8	13.9	24.6	17.8	10.1	21.1	15.3	17.8	8.1	12.5	21.0	9.8	33.4	8.3	22.5	21.6	17.6	23.8	0.0	27.3	50.7	23.5	29.8	9.2	23.5	34.2	28.6	27.6	5.5	19.2	32.5	19.2	14.7	13.5	28.9	21.9	11.9	20.3	31.6	17.7	21.4	14.4	6.5	15.6	10.7	9.1	11.2	26.5	11.7	28.7	25.3
OGFR	7-60	ENSG00000060491	"Opioid growth factor receptor"	Q9NZT2	20	62804835-62814000	"Predicted intracellular proteins"	"Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 13.0;neutrophil: 3.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.0"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA017899	Supported		Approved	Nucleoplasm		NA	NA		11000	Nucleoplasm		"HPA017899: AB_1854774"	"unprognostic (1.33e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (5.19e-4)"	21.8	15.9	25.9	30.4	18.4	33.0	16.8	18.7	34.6	18.2	24.4	13.9	22.1	30.5	17.8	16.3	14.1	17.8	22.4	21.0	23.6	19.3	19.7	38.8	27.4	27.9	14.5	18.1	23.4	23.0	15.1	20.8	22.3	17.5	22.0	11.3	15.1	31.3	18.3	25.6	23.2	29.2	19.5	13.1	38.7	23.4	10.3	16.3	21.0	22.2	12.6	20.2	18.3	29.3	1.6	1.1	13.0	1.8	0.7	1.1	0.4	18.6	12.6	7.7	10.0	7.7	8.6	21.4	11.9	12.5	44.9	19.8	28.5	13.9	23.0	21.9	9.7	22.9	21.8	9.0	14.3	11.0	7.0	14.1	11.2	15.9	25.7	12.7	13.9	26.6	10.7	10.5	10.9	4.6	12.5	9.5	14.2	10.4	11.7	7.1	27.8	28.8	25.4	5.0	9.6	24.5	22.8	13.7	10.1	6.2	10.1	7.7	11.5	16.4	22.6	17.9	7.4	11.4	20.9	12.9	23.8	20.9	18.4	16.8	14.8	4.2	12.3	19.0	14.7	9.1	1.8	1.8	13.0	0.8	1.6	0.5	1.1	1.1	1.0	1.1	1.6	1.1	0.7	3.8	0.7	1.5	0.9	0.6	0.4	25.9	18.4	18.7	34.6	23.6	19.3	14.5	18.1	17.5	16.3	8.9	16.7	30.8	28.9	24.0	59.6	4.1	35.7	6.7	6.8	15.7	88.4	23.2	10.0	31.3	1.7	20.7	32.0	0.0	28.4	42.5	25.4	26.6	0.0	43.1	51.9	41.3	17.2	23.4	71.5	1.9	30.2	39.0	15.1	42.3	24.4	31.6	29.0	31.7	17.7	21.2	39.1	19.4	20.6	1.4	4.1	20.5	23.3	37.0	21.0	27.5
OGFRL1	dJ331H24.1	ENSG00000119900	"Opioid growth factor receptor like 1"	Q5TC84	6	71288803-71308950	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 79.5;Macrophages: 93.2;Muller glia cells: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027122			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA027122: AB_2156775"	"unprognostic (8.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (9.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.58e-3)"	16.9	8.7	20.2	11.3	26.8	16.9	36.0	22.3	33.3	6.7	7.2	29.1	2.8	2.9	8.3	10.7	24.5	5.2	8.3	5.8	30.2	17.6	5.7	4.8	8.5	9.6	27.7	18.3	5.4	6.0	5.8	10.0	9.9	37.8	6.7	4.3	3.3	31.8	10.3	4.1	14.6	5.7	24.1	52.2	11.7	5.4	2.4	29.1	3.2	4.8	4.3	17.8	5.4	9.4	0.7	2.4	12.8	3.0	0.5	0.5	0.6	3.8	1.1	4.1	0.0	11.2	10.3	1.5	17.4	10.8	7.0	7.2	1.4	0.7	23.7	24.0	7.5	6.5	1.9	3.1	12.0	25.0	5.0	2.5	5.2	4.2	0.6	9.1	2.4	1.8	10.3	10.3	5.2	16.4	5.9	5.6	0.0	0.3	1.9	24.1	3.2	0.0	3.8	1.7	1.5	1.0	1.6	12.6	5.4	16.3	0.3	14.1	6.4	5.1	3.2	1.1	6.2	5.5	19.2	8.6	17.3	8.7	1.8	5.7	2.5	0.1	3.1	5.8	16.5	3.0	3.1	3.0	0.1	0.5	2.0	0.5	0.4	0.4	0.5	2.4	0.7	0.1	0.3	12.8	0.5	1.4	0.9	0.2	0.6	20.2	26.8	22.3	27.4	30.2	17.6	27.7	18.3	37.8	29.1	6.0	21.8	14.3	18.0	34.6	15.3	7.8	5.1	1.4	11.4	10.4	23.6	19.2	1.7	12.9	0.4	21.0	0.0	0.0	27.8	10.1	31.4	13.9	5.8	4.0	53.5	36.5	13.8	8.6	79.5	1.1	15.3	93.2	30.4	27.9	2.4	83.6	18.3	0.0	31.1	3.1	5.0	25.8	18.6	0.4	1.1	40.7	15.9	12.1	4.3	14.9
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121179	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 159.5"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 41.2;Horizontal cells: 36.5;Ito cells: 74.3;Leydig cells: 41.1"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	51	"dendritic cells: 5.1;monocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.5;MCF7: 21.5;NTERA-2: 28.6;OE19: 20.3;SCLC-21H: 41.3;SiHa: 34.2;T-47d: 53.0;U-2197: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"	NA	NA		130000000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: AB_2683443"	"unprognostic (6.77e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	7.7	10.0	80.5	5.0	41.5	0.9	4.7	30.9	159.5	7.4	5.4	4.6	0.7	2.5	6.9	26.4	5.0	4.4	3.8	3.9	77.2	19.1	3.4	2.4	4.7	5.2	18.8	36.5	6.2	5.1	3.6	9.9	1.1	13.5	4.8	5.7	0.9	2.6	7.5	6.1	4.5	3.5	6.9	6.1	5.8	3.9	2.8	2.8	0.3	2.7	0.8	7.1	4.1	6.2	0.0	5.1	0.0	5.0	0.0	0.0	0.6	0.0	1.6	3.2	0.0	0.4	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.3	13.1	0.6	0.6	0.0	0.0	3.6	0.2	0.0	25.5	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	21.5	0.1	0.0	28.6	20.3	0.0	0.0	0.0	12.0	0.0	0.0	41.3	5.5	34.2	0.1	2.1	2.2	53.0	0.0	0.0	2.0	4.6	23.1	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	3.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	80.5	41.5	30.9	119.7	77.2	19.1	18.8	36.5	13.5	2.8	0.0	9.3	0.0	2.8	8.7	20.7	5.8	7.6	0.0	3.4	0.0	41.2	0.0	0.0	7.4	5.8	26.1	0.0	0.0	2.3	0.0	8.2	6.1	2.3	0.5	0.3	36.5	2.4	74.3	4.5	8.9	41.1	2.8	20.3	0.0	1.7	32.6	3.6	2.9	27.6	0.0	12.0	0.0	11.7	0.6	3.4	5.5	0.0	0.0	5.5	0.9
OLFM2	"NOE2, OlfC"	ENSG00000105088	"Olfactomedin 2"	O95897	19	9853718-9936552	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.4;skin 1: 60.2"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 111.0;Late spermatids: 38.1;Muller glia cells: 72.1;Suprabasal keratinocytes: 103.3"	"Cancer enhanced"	"Detected in all"		"glioma: 96.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.9"	"Group enriched"	"Detected in many"	27	"granulocytes: 24.9;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.7;ASC diff: 14.9;BJ hTERT+: 11.3;SH-SY5Y: 15.2;U-2 OS: 18.2;WM-115: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049961, HPA057771"	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		2300000	Nucleoplasm		"HPA049961: AB_2680972, HPA057771: AB_2683524"	"unprognostic (1.42e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	20.9	12.2	37.2	2.7	39.7	0.8	5.8	9.1	51.4	4.5	1.9	11.6	0.3	2.1	7.9	3.8	3.9	6.6	4.9	3.9	26.2	21.6	1.8	23.5	3.2	5.0	19.6	17.9	3.5	7.9	1.1	4.4	5.2	15.4	5.2	1.4	3.2	7.1	10.3	1.7	60.2	2.0	5.1	9.0	2.2	1.4	5.2	4.6	16.0	8.4	1.1	3.7	2.6	3.2	0.0	0.0	24.9	0.0	0.6	8.9	1.7	0.0	2.2	1.8	15.7	14.9	9.2	1.0	3.4	11.3	0.8	0.9	0.1	1.5	0.0	1.4	2.5	1.3	0.9	6.0	1.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	2.7	4.8	0.9	0.1	0.1	0.4	0.0	2.9	0.1	0.2	0.0	4.9	0.1	0.1	9.7	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	15.2	0.6	0.0	3.1	6.3	0.6	0.0	0.1	6.6	18.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	15.7	9.6	0.0	24.9	3.5	0.0	3.8	0.0	4.1	3.1	0.0	0.0	8.0	5.1	0.3	0.6	0.0	0.0	8.9	1.7	37.2	39.7	9.1	38.0	26.2	21.6	19.6	17.9	15.4	4.6	0.0	0.0	0.0	4.6	111.0	2.9	0.6	5.1	0.0	0.0	7.0	0.0	0.1	1.7	0.6	6.8	0.5	0.0	0.0	2.0	0.0	9.6	5.0	4.6	16.1	0.2	1.6	1.2	0.6	0.3	38.1	12.7	0.3	16.9	0.0	0.0	72.1	6.6	0.0	9.2	0.0	2.5	0.0	18.7	2.1	9.3	103.3	0.1	7.5	0.0	2.3
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777158-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 12.1;Endothelial cells: 14.2;Fibroblasts: 13.1;Sertoli cells: 12.9;Smooth muscle cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.3;GAMG: 12.1;HeLa: 14.7;hTERT-RPE1: 13.5;WM-115: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	17.3	2.1	1.0	7.4	1.7	0.1	10.9	1.9	3.4	34.2	18.9	3.1	6.3	2.3	29.2	8.3	11.8	4.2	7.6	12.5	1.2	1.0	3.0	0.6	10.3	1.5	2.1	1.5	13.2	3.4	3.6	2.1	5.0	4.0	16.1	4.6	18.9	4.7	9.5	9.8	11.6	5.0	33.7	1.6	23.8	4.0	3.1	0.6	3.7	20.0	11.9	5.0	22.0	10.4	1.4	0.7	2.6	0.9	0.6	0.6	0.4	0.3	5.2	0.4	0.1	6.1	58.3	0.0	0.8	2.9	1.2	1.2	0.0	0.7	0.0	1.5	0.0	12.1	9.7	0.1	0.3	1.4	0.0	0.0	0.0	14.7	0.0	0.3	0.0	0.0	4.1	0.9	3.6	0.5	13.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	0.0	0.5	0.0	3.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	1.5	10.6	1.4	0.1	0.0	1.8	1.9	2.0	0.2	0.7	0.0	0.0	5.6	0.3	22.8	1.9	0.9	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.7	1.4	0.4	0.6	2.6	0.6	0.3	0.6	0.3	0.4	1.0	1.7	1.9	3.4	1.2	1.0	2.1	1.5	4.0	0.6	0.0	2.2	0.0	3.7	10.6	0.5	12.1	0.0	1.4	0.0	0.0	2.0	0.2	0.0	0.1	0.6	14.2	0.0	0.0	0.6	0.2	13.1	1.0	0.0	0.0	0.1	0.0	0.0	3.1	2.4	1.2	2.6	0.5	10.1	0.0	0.0	0.2	0.0	0.0	1.4	0.0	3.9	12.9	28.8	0.2	0.7	7.3	0.0	0.0	0.0	1.6
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023854	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 56.2;Hofbauer cells: 31.7;Kupffer cells: 20.4;Leydig cells: 19.2;Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 8.8;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	10	"monocytes: 8.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;HSkMC: 45.3;RH-30: 34.6"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 45.1"	"Low region specificity"	"Detected in many"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA054136: AB_2682397, HPA062739: AB_2684858"	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	19.6	6.6	1.7	12.8	3.0	0.3	12.3	0.6	4.1	13.0	14.5	2.9	6.5	1.5	14.2	21.8	3.2	9.8	33.7	25.4	2.9	1.6	3.9	1.2	12.8	24.1	2.9	1.2	7.0	2.3	3.2	2.6	27.6	2.2	6.6	2.2	14.5	9.0	6.1	6.1	8.9	5.0	15.1	3.6	22.4	3.4	12.5	2.1	1.9	18.3	13.7	8.5	12.4	7.3	0.0	0.8	0.3	8.8	0.0	0.1	0.2	0.0	0.1	2.6	0.8	8.4	16.0	0.0	0.8	4.1	1.7	4.6	0.0	0.0	0.0	0.1	9.7	1.7	0.0	0.2	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	45.3	0.0	2.0	0.0	0.8	0.2	0.0	0.0	0.4	7.4	0.0	0.0	0.1	0.8	0.0	0.4	0.0	34.6	3.3	0.6	0.0	0.3	0.1	3.4	0.0	0.2	8.0	0.0	0.0	0.0	1.0	0.2	1.5	1.3	0.0	0.0	0.0	9.9	1.0	0.5	0.0	0.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.3	0.0	6.5	0.0	0.0	0.2	1.7	3.0	0.6	4.1	2.9	1.6	2.9	1.2	2.2	2.1	0.0	1.1	0.0	0.0	3.0	0.0	2.5	0.0	0.0	1.2	1.8	0.0	0.2	0.0	0.0	56.2	0.0	0.0	0.0	0.0	0.3	9.3	0.1	1.1	0.0	31.7	0.0	0.0	1.8	20.4	4.5	19.2	9.9	1.7	1.0	0.0	0.9	0.0	0.0	27.6	0.0	0.0	6.5	12.6	1.5	0.9	1.9	0.2	0.0	0.0	0.0
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lung: 46.8;placenta: 53.4"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2"					"Low region specificity"	"Detected in all"			HPA050798			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA	1060000		"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050798: AB_2756318"	"unprognostic (2.30e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (6.34e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.42e-1)"	2.0	1.9	6.0	14.1	10.3	10.6	2.0	1.3	10.2	1.9	0.5	21.3	0.0	0.8	1.0	0.9	0.5	1.2	3.9	1.1	8.5	6.7	6.9	1.8	46.8	0.5	16.4	4.4	0.4	1.6	2.8	1.9	53.4	12.3	1.4	0.7	0.2	2.0	0.7	0.4	0.5	0.8	1.2	28.5	0.6	1.4	2.8	10.5	0.0	1.5	0.0	0.6	4.3	0.4	0.5	5.9	3.3	1.5	0.3	0.3	1.1	1.8	0.1	0.0	0.1	0.0	0.0	4.5	3.1	0.5	2.0	0.7	32.7	0.0	0.4	0.0	4.2	0.1	17.2	0.0	0.1	1.3	0.0	0.0	0.0	1.6	0.0	34.6	0.0	0.0	0.2	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	65.9	26.2	0.0	4.9	7.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	1.5	2.7	0.2	0.2	0.3	0.3	0.3	0.2	5.9	0.5	0.3	0.3	3.3	0.3	0.4	0.8	0.2	1.1	6.0	10.3	1.3	7.4	8.5	6.7	16.4	4.4	12.3	10.5	26.8	30.9	0.0	0.2	1.3	0.4	0.0	2.5	12.0	7.9	0.0	0.0	386.0	0.0	0.0	9.4	1.2	0.0	0.0	0.0	8.5	1.3	0.0	14.0	0.8	209.3	0.0	0.0	0.0	21.9	7.6	0.3	102.1	0.0	36.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	387.3	0.0	0.0	0.0
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	10.2	22.4	13.8	21.5	18.1	9.2	15.8	10.6	14.6	14.5	16.4	14.1	20.1	12.1	15.4	15.1	17.1	15.9	12.1	15.8	12.6	10.0	23.0	23.8	19.1	17.9	16.7	9.6	15.0	18.2	15.7	20.9	8.9	13.0	17.8	16.1	11.3	20.6	22.7	20.9	10.2	16.1	24.2	18.2	17.2	13.9	6.9	19.4	18.4	18.3	14.5	16.4	17.0	20.6	22.5	9.5	18.6	19.5	18.6	22.8	10.2	13.5	5.7	3.8	3.5	19.2	18.0	10.9	5.6	6.1	4.9	6.2	1.6	8.2	30.6	11.9	5.8	17.2	13.9	13.4	13.6	5.8	23.4	7.5	9.5	4.4	6.6	9.5	23.3	6.7	16.9	15.3	4.8	10.0	11.1	4.3	15.3	18.0	9.2	13.4	8.3	7.9	8.3	5.6	20.5	12.4	9.9	12.5	12.8	10.7	9.1	4.0	1.9	11.4	18.8	15.8	18.3	8.5	9.0	2.5	2.5	5.1	12.6	5.8	7.5	9.8	20.1	7.8	18.3	6.2	10.8	9.2	18.6	12.8	14.5	16.5	22.5	15.7	15.0	9.5	21.4	22.8	20.8	10.6	18.6	19.5	5.0	13.9	10.2	13.8	18.1	10.6	14.6	12.6	10.0	16.7	9.6	13.0	19.4	17.9	11.5	14.7	15.7	5.4	7.2	25.0	10.2	54.9	11.4	24.4	11.8	19.1	21.6	7.7	5.0	4.9	6.9	0.0	4.8	7.8	8.6	15.0	5.8	15.5	13.6	1.6	5.8	8.6	10.7	9.7	9.2	10.4	6.8	7.2	15.0	10.0	5.2	10.4	8.1	20.7	19.6	6.5	4.4	11.7	12.1	5.9	15.3	13.8	13.0	17.5
OMD	"osteoadherin, SLRR2C"	ENSG00000127083	Osteomodulin	Q99983	9	92414245-92424461	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Fibroblasts: 27.7;Leydig cells: 90.6;Peritubular cells: 103.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"ASC diff: 12.6;ASC TERT1: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069948			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		14000000	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA069948: AB_2732144"	"unprognostic (1.18e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.31e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.81e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.08e-3)"	14.0	7.9	2.2	1.2	4.3	0.0	14.6	3.7	3.4	20.3	8.3	1.0	8.0	0.8	8.2	19.3	14.0	8.7	8.9	20.2	2.8	1.7	2.9	0.8	12.2	0.8	7.0	5.4	15.3	1.8	1.5	4.2	11.5	6.0	13.6	2.2	14.2	2.3	4.2	2.8	3.5	3.7	13.9	19.3	0.7	5.0	12.8	1.3	0.2	9.2	14.5	3.2	22.1	7.6	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	12.6	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	2.2	4.3	3.7	3.4	2.8	1.7	7.0	5.4	6.0	1.3	0.0	0.0	0.0	0.2	2.4	0.6	1.1	0.0	0.0	1.2	1.8	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.1	27.7	0.1	0.0	0.0	0.3	0.0	0.0	16.5	0.3	1.3	90.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	103.6	0.0	1.3	0.0	3.4	0.2	0.1	2.4	0.0	0.0	0.0	0.1
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435685-57491297	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.6;gallbladder: 60.7;intestine: 18.0"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 910.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 18.7;HeLa: 11.9;RT4: 6.3;SCLC-21H: 9.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.3	0.4	0.3	0.3	18.6	0.2	0.3	3.0	3.7	0.2	16.5	0.0	0.0	15.0	0.3	0.3	0.3	0.2	60.7	0.2	0.5	0.9	0.3	12.8	0.3	0.3	0.5	0.9	0.3	4.3	3.2	5.1	0.2	1.1	0.3	0.3	0.7	0.3	0.3	0.3	0.3	18.0	0.3	0.3	0.3	0.5	0.6	6.6	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	3.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.4	0.0	3.3	0.0	0.1	18.7	3.0	0.7	11.9	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.2	3.6	0.6	0.0	0.4	1.7	0.0	0.1	1.5	0.7	0.0	1.1	0.0	1.6	6.3	9.8	1.6	0.1	0.0	0.2	0.1	0.4	0.7	0.0	1.0	1.3	0.2	0.2	0.3	2.7	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	3.0	3.7	0.5	0.9	0.5	0.9	1.1	6.6	0.0	0.0	0.0	0.2	0.1	3.0	2.6	155.4	0.0	0.0	7.0	13.7	0.0	0.0	69.5	2.0	0.6	0.3	0.0	7.6	0.1	0.0	0.3	0.0	44.2	0.8	910.5	8.5	9.2	0.6	2.8	0.3	0.0	0.0	0.0	0.7	2.9	24.1	3.1	0.0	0.0	4.9	0.0	0.7	1.4	1.7	0.1	0.0	0.0	0.4	0.0
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	26.0	8.4	8.5	9.3	7.5	11.9	9.0	12.7	11.7	13.9	13.6	20.3	8.8	17.3	27.4	11.9	12.7	17.0	14.8	14.3	24.7	20.8	12.0	29.9	7.5	10.2	11.7	24.6	13.8	13.3	12.8	13.4	19.1	8.6	11.7	7.3	12.7	17.0	13.8	20.6	9.5	13.7	11.9	15.0	28.0	12.5	18.7	18.5	10.4	16.3	18.5	11.3	18.9	21.2	13.4	6.8	27.8	19.5	11.7	12.9	9.8	13.8	26.6	15.4	17.8	33.9	14.3	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8	14.9	20.0	20.6	13.8	14.2	17.0	130.0	15.3	16.0	20.5	17.4	29.5	16.2	14.9	14.8	7.2	13.5	20.6	70.0	20.7	12.2	15.9	15.5	18.5	30.2	15.9	20.6	22.4	16.0	23.5	10.2	14.7	21.2	20.3	11.8	20.6	15.7	22.7	7.0	13.8	26.9	21.6	6.5	17.5	11.3	15.0	19.6	15.0	12.8	25.8	19.6
OPA3	"FLJ22187, MGA3"	ENSG00000125741	"OPA3, outer mitochondrial membrane lipid metabolism regulator"	Q9H6K4	19	45527427-45602212	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044881	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA044881: AB_10964052"	"unprognostic (3.37e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (3.14e-3)"	"unprognostic (4.53e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.72e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.30e-12)"	"unprognostic (5.85e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-1)"	21.6	14.8	8.5	9.4	15.9	7.9	21.8	8.5	13.1	6.2	8.9	7.2	5.7	8.4	10.5	7.7	11.3	7.6	9.8	21.8	9.8	9.6	15.9	16.4	19.3	9.7	11.0	4.5	8.9	9.3	23.9	12.3	11.4	18.4	7.9	8.7	12.1	8.2	9.4	19.7	12.5	9.7	10.2	12.4	12.0	9.2	15.7	11.1	5.3	11.8	9.7	9.6	9.5	30.3	6.7	7.8	7.4	13.0	10.9	6.2	4.5	11.5	14.7	5.9	5.9	3.9	4.8	9.0	7.6	7.0	8.1	8.6	6.8	8.3	10.0	5.5	7.5	9.3	9.3	9.9	10.3	7.1	18.1	10.0	15.4	8.2	7.0	7.1	10.8	20.1	7.3	8.1	8.9	9.8	4.7	5.7	6.0	13.1	11.2	5.5	7.1	8.4	4.5	5.2	9.7	10.1	8.5	5.3	5.4	6.3	20.9	4.5	5.3	9.7	8.9	4.1	5.5	5.0	6.2	12.3	6.9	7.9	5.7	12.8	7.6	14.0	8.3	6.7	7.8	10.3	6.0	7.4	3.8	5.3	10.5	5.6	6.7	4.8	4.5	7.8	5.6	6.0	5.9	7.4	10.9	13.0	7.3	6.2	4.5	8.5	15.9	8.5	13.1	9.8	9.6	11.0	4.5	18.4	11.1	11.9	9.4	14.3	16.9	16.7	22.0	21.8	22.9	10.7	9.1	10.4	49.1	23.1	21.6	16.0	12.7	14.1	19.6	0.0	18.5	25.8	9.8	12.5	16.1	19.4	14.5	19.1	13.2	14.1	11.6	15.7	5.8	15.3	13.5	19.0	10.4	13.8	14.0	17.3	6.0	13.4	35.6	0.0	18.6	13.0	14.0	17.1	30.3	13.1	12.1	13.9
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	68042344-68433913	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	5.8	8.2	21.9	2.4	22.6	3.6	7.1	12.3	21.6	9.9	4.9	10.7	3.2	3.5	9.7	4.8	6.1	5.3	4.5	4.1	19.5	9.7	7.0	1.7	6.6	2.0	9.6	12.2	7.1	4.0	6.6	4.8	20.7	9.1	16.2	5.1	7.9	7.2	8.0	7.8	8.6	4.1	6.3	6.2	2.9	5.9	2.9	12.4	0.1	7.2	2.0	2.3	3.9	6.2	2.7	3.3	4.1	1.7	1.7	1.2	0.3	15.1	3.8	2.4	5.9	5.5	5.7	3.9	2.8	3.9	5.3	6.4	2.4	3.1	0.7	10.8	3.4	2.4	4.1	2.1	1.2	8.2	0.4	1.5	3.2	4.3	2.4	1.8	0.8	3.8	3.3	3.9	4.9	4.8	8.9	4.3	0.6	2.1	1.4	3.1	7.8	0.5	0.8	4.6	7.6	3.2	0.4	4.8	0.7	6.9	5.9	0.9	2.3	5.5	7.0	12.4	5.9	4.7	1.3	4.7	3.6	5.8	12.7	3.6	2.1	2.5	0.5	2.8	1.9	2.6	1.1	1.7	0.6	1.2	0.9	1.0	1.3	1.0	0.8	0.7	2.7	1.1	1.2	4.1	1.7	1.2	3.3	0.7	0.3	21.9	22.6	12.3	18.6	19.5	9.7	9.6	12.2	9.1	12.4	14.9	13.4	0.0	4.9	2.9	5.3	3.1	2.5	17.4	7.9	17.4	5.9	18.1	0.0	0.9	1.6	4.5	3.4	0.0	0.7	9.5	11.0	11.1	8.1	0.0	3.9	0.0	4.1	3.7	1.9	0.2	19.5	6.3	8.5	0.0	2.8	18.4	1.0	3.2	11.3	1.6	5.2	0.0	5.1	0.2	1.3	4.4	56.0	0.0	3.4	3.1
OPLAH	"5-Opase, OPLA"	ENSG00000178814	"5-oxoprolinase, ATP-hydrolysing"	O14841	8	144051266-144063965	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 97.1;Late spermatids: 174.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.0;intermediate monocyte: 1.0;neutrophil: 3.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.8;monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.7;BEWO: 14.2;Hep G2: 12.2;PC-3: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026562, HPA028260, HPA052429"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA026562: AB_1854804, HPA028260: AB_10601383, HPA052429: AB_2681830"	"unprognostic (7.89e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (4.03e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.24e-2)"	5.6	5.6	3.3	1.7	3.9	2.3	3.1	4.9	5.3	1.9	7.0	7.0	4.5	11.8	1.6	1.9	5.9	1.3	5.2	16.2	2.5	1.7	10.8	17.2	2.9	2.0	4.5	4.2	2.0	6.0	5.8	1.2	1.3	5.5	3.5	2.0	4.8	9.4	5.6	25.6	5.5	10.4	1.2	4.4	3.7	7.2	49.3	4.9	0.3	1.9	5.4	1.8	2.1	3.3	0.0	0.3	3.8	3.0	0.0	0.1	0.8	2.7	2.7	0.3	22.7	1.0	2.2	14.2	1.3	0.9	0.8	0.5	5.2	5.1	0.0	4.6	2.5	0.0	3.6	0.7	2.0	0.0	0.7	0.0	0.9	4.1	12.2	7.3	0.1	0.0	3.0	9.4	0.9	0.0	0.0	0.1	3.9	3.2	0.0	0.0	3.1	0.2	2.1	1.9	4.2	17.5	0.3	0.0	3.5	2.4	3.3	0.8	0.1	0.0	0.9	0.0	0.3	5.9	3.0	0.1	0.0	3.8	0.0	0.9	0.8	0.9	0.7	0.3	0.7	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	3.8	0.0	0.4	0.0	0.0	0.8	3.3	3.9	4.9	5.3	2.5	1.7	4.5	4.2	5.5	4.9	3.0	2.7	0.8	1.7	1.8	1.0	2.6	5.1	1.4	3.4	8.7	0.0	1.4	10.0	3.5	97.1	0.7	32.0	0.0	2.4	2.2	1.1	1.6	0.0	20.2	2.1	0.0	1.2	3.1	6.0	174.0	2.3	1.7	0.0	1.0	6.3	5.2	3.8	11.2	3.5	11.0	0.0	0.0	1.0	3.5	2.3	1.6	2.1	1.3	10.9	2.0
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772491-128775790	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 11.4;retina: 23.9"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.9	1.8	0.7	3.7	0.9	1.7	0.7	1.0	2.3	0.7	2.2	0.7	0.7	0.5	2.6	0.7	2.4	0.8	4.2	11.4	0.7	0.8	0.7	0.7	0.9	1.0	0.7	1.3	0.7	0.7	0.0	0.7	0.7	0.7	1.4	0.0	23.9	1.1	0.7	1.9	0.9	0.9	0.7	0.7	1.1	1.4	1.1	0.7	0.7	2.3	0.7	0.7	4.3	0.7	0.5	1.2	0.6	1.4	0.0	1.4	0.3	1.7	2.2	5.2	1.7	0.0	0.0	1.5	9.8	0.0	0.0	0.0	5.0	2.1	2.6	1.5	0.0	1.6	1.4	0.0	0.0	0.0	0.3	3.6	1.6	3.0	2.5	0.0	2.0	1.6	0.0	0.0	0.0	0.0	7.0	0.0	1.7	2.2	0.6	1.1	0.7	2.0	3.6	4.7	1.7	3.0	1.0	5.4	3.0	0.0	0.6	0.7	6.9	2.3	5.2	4.4	7.3	0.5	2.0	4.0	10.0	1.0	7.7	8.7	2.1	2.2	1.6	37.6	4.6	9.3	0.0	0.3	0.6	1.4	1.4	0.9	0.2	0.8	1.0	1.2	0.5	0.3	0.9	0.0	0.0	1.0	0.7	0.4	0.3	0.7	0.9	1.0	0.9	0.7	0.8	0.7	1.3	0.7	0.7	0.0	0.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
OPN3	"ECPN, encephalopsin, ERO, NMO-1, PPP1R116"	ENSG00000054277	"Opsin 3"	Q9H1Y3	1	241590102-241677376	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 211.3;Syncytiotrophoblasts: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 35.8"	"Low region specificity"	"Detected in all"							"CAB013682, HPA064443"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013682: , HPA064443: AB_2685267"	"unprognostic (2.41e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.10e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.96e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.13e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.44e-3)"	5.3	4.2	5.1	4.5	8.8	1.7	6.4	1.9	22.1	4.4	9.0	2.4	1.0	2.6	6.2	6.7	7.9	6.7	4.6	3.5	5.2	4.9	6.2	18.1	11.8	8.4	5.0	11.1	6.8	4.2	1.8	6.9	26.4	3.4	2.3	8.0	1.4	4.1	2.3	2.6	4.1	4.4	2.9	3.2	7.8	5.6	4.7	1.7	12.5	9.3	1.7	7.1	6.2	5.1	2.5	12.1	0.9	1.4	0.5	0.5	0.6	2.1	7.0	5.1	0.4	18.8	35.8	3.9	3.7	2.8	2.7	2.7	0.5	5.8	0.3	0.2	4.5	3.0	12.2	1.6	2.6	2.7	7.6	0.4	0.0	1.6	4.3	9.5	1.7	4.0	18.1	7.4	1.6	4.1	18.2	5.4	6.3	3.5	1.0	4.3	1.1	0.6	2.2	13.9	8.9	3.8	2.9	0.3	6.7	18.3	3.1	1.4	5.2	2.4	7.4	2.0	10.8	0.4	6.8	6.5	0.6	0.5	1.0	3.9	2.5	3.9	0.3	2.0	5.7	7.8	0.0	1.1	0.9	0.1	1.4	0.1	2.2	0.2	0.2	2.7	2.5	0.3	0.5	0.3	0.5	1.2	12.1	0.2	0.6	5.1	8.8	1.9	22.1	5.2	4.9	5.0	11.1	3.4	1.7	6.0	4.8	15.9	11.0	13.1	2.3	0.6	15.3	1.4	3.4	12.2	0.0	62.4	11.6	13.0	80.4	5.8	7.3	0.0	8.9	211.3	7.6	6.9	2.3	20.3	25.1	0.0	4.1	6.7	25.6	64.2	10.3	41.2	27.0	30.7	9.0	2.1	20.4	8.2	15.6	15.4	2.1	0.0	9.0	7.7	9.1	10.8	143.5	2.6	8.2	11.6
OR2C3	"OR2C4, OR2C5P, OST742"	ENSG00000196242	"Olfactory receptor family 2 subfamily C member 3"	Q8N628	1	247524677-247536440	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.2;testis: 4.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 1.6;granulocytes: 1.1;Late spermatids: 2.1;Spermatocytes: 2.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	12	"basophil: 4.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	18	"dendritic cells: 1.3;granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8"									HPA058578			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA058578: AB_2683761"									"unprognostic (1.96e-1)"			"unprognostic (7.29e-2)"		"unprognostic (3.45e-2)"	"unprognostic (1.03e-1)"			0.2	0.4	0.1	0.0	0.1	0.1	0.2	0.4	0.1	0.9	0.1			0.0	0.2	0.9	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1		0.3	0.2	1.3	0.1	0.4		0.7	0.0		0.1	0.0	0.5	0.1	0.1	0.4	0.1	0.1	0.1	4.6			0.1		0.0	0.2	0.1	0.0	1.3	4.2	0.0	0.1	0.1	0.0	0.5	0.3	0.6	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.3	1.8	0.6	0.2	0.0	1.1	0.3	0.0	0.1	0.0	0.7	0.5	0.1	0.2	0.1	0.1	0.2	0.5	0.5	0.0	0.1	0.0	0.4	0.1	0.5	1.2	0.7	0.1	0.0	0.4	0.2	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.5	0.6	0.6	0.3	0.7	0.4	1.2	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.5	4.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0
OR6B2	OR6B2P	ENSG00000182083	"Olfactory receptor family 6 subfamily B member 2"	Q6IFH4	2	240028965-240030456	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	6	"testis: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.5"									HPA047529	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA047529: AB_2680077"																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	2.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6B3	"OR6B3P, OR6B3Q"	ENSG00000178586	"Olfactory receptor family 6 subfamily B member 3"	Q8NGW1	2	240045077-240047027	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	6	"brain: 1.6;epididymis: 6.5;testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.2"									HPA047529	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA047529: AB_2680077"																		0.1	0.0	0.8	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0			0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	1.3		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6C6		ENSG00000188324	"Olfactory receptor family 6 subfamily C member 6"	A6NF89	12	55293988-55296569	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;skin 1: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;MCF7: 1.6;THP-1: 1.0"									HPA051090	Uncertain		Approved	"Lipid droplets,Plasma membrane"		NA	NA			"Lipid droplets, Plasma membrane"		"HPA051090: AB_2681341"																		0.0	0.0	0.0	0.4	0.1	1.1	0.1	0.1	0.2	0.5	0.1			0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.1	0.0	0.2		0.1	0.0		0.2	0.0	0.5	1.7	0.0	0.2	0.1	0.1	0.1	0.3			0.0		0.0	0.0	0.0	1.1	1.0	2.3	0.5	0.5	0.6	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.0	0.0	1.1	0.4	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.5	0.8	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.5	0.2	2.3	0.5	0.9	0.6	0.1	0.3	0.6	0.5	0.4	0.1	1.1	0.5	0.6	1.8	0.5	0.3	1.0	0.6	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORAI2	"C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B"	ENSG00000160991	"ORAI calcium release-activated calcium modulator 2"	Q96SN7	7	102433106-102456821	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"B-cells: 169.1;Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 30.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.5;RPMI-8226: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055137, HPA065937"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055137: AB_2682712, HPA065937: AB_2685581"	"unprognostic (5.09e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.07e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (8.49e-5)"	"unprognostic (7.16e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.46e-1)"	6.3	7.2	13.8	28.1	15.8	24.3	8.0	18.6	15.9	4.7	5.7	5.0	5.6	5.6	7.7	6.2	2.7	7.7	6.6	4.1	11.9	17.1	6.9	1.5	6.2	25.9	9.3	4.8	5.0	4.8	13.9	24.8	4.1	10.3	4.3	2.8	4.3	5.1	7.6	1.8	1.6	10.3	4.6	7.0	21.9	7.7	1.8	5.1	9.9	10.9	1.3	20.3	10.0	4.4	14.4	2.5	30.9	2.7	7.4	2.3	2.5	6.4	14.7	5.7	10.9	5.2	5.9	0.4	6.3	7.0	7.0	6.1	8.4	6.8	46.5	17.6	10.7	14.0	2.5	2.2	1.6	2.4	5.0	4.1	6.6	6.9	2.5	7.9	15.8	8.9	5.5	1.1	11.4	1.9	7.3	12.5	6.3	8.2	37.3	5.4	13.5	23.4	7.3	7.1	2.2	6.9	9.6	5.1	45.7	4.1	4.8	9.7	24.2	6.2	2.6	3.4	3.1	3.8	6.2	11.9	16.5	18.4	11.3	8.3	36.4	25.5	34.0	12.3	9.6	8.4	4.9	2.7	30.9	2.0	2.4	2.3	13.3	1.8	1.6	1.6	14.4	1.2	1.4	25.6	7.4	1.4	2.5	0.8	2.5	13.8	15.8	18.6	11.2	11.9	17.1	9.3	4.8	10.3	5.1	3.0	11.1	169.1	8.0	3.5	25.3	2.6	12.7	20.1	15.9	15.7	62.8	1.0	5.0	18.0	2.6	20.1	0.3	0.0	10.3	1.5	12.6	8.4	25.4	0.8	14.7	41.3	16.6	23.4	19.4	4.9	7.5	17.5	10.1	29.7	2.0	11.8	9.9	0.0	9.6	7.9	21.1	0.0	5.9	3.2	9.4	2.8	2.5	25.5	1.3	5.8
ORAI3	"MGC13024, TMEM142C"	ENSG00000175938	"ORAI calcium release-activated calcium modulator 3"	Q9BRQ5	16	30949066-30956461	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015022: AB_1854807"	"unprognostic (1.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.60e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (2.30e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.43e-3)"	"unprognostic (9.17e-3)"	13.4	22.9	5.5	13.0	5.6	12.4	14.8	6.0	8.1	17.0	12.8	9.1	13.3	7.5	12.4	16.9	19.9	13.6	16.5	10.8	4.9	5.1	16.5	39.6	15.4	20.7	5.9	3.6	16.9	14.5	13.5	12.1	14.8	5.8	26.2	7.3	13.3	10.3	15.3	9.4	10.2	9.9	16.4	5.1	20.0	10.4	19.7	5.2	14.2	25.6	6.3	13.7	29.1	15.2	5.1	6.8	17.9	8.5	8.1	2.8	2.2	1.0	5.8	3.0	4.0	26.1	23.5	0.2	3.3	23.0	2.5	6.5	0.5	9.6	1.4	7.8	6.5	10.3	4.7	0.5	6.4	1.7	4.4	1.9	3.7	1.8	5.7	36.5	4.0	11.5	25.2	17.2	4.9	9.7	24.2	4.3	0.8	4.1	7.7	8.2	3.8	0.2	15.0	2.4	3.2	1.6	3.1	2.3	10.8	9.7	2.5	0.7	5.0	3.1	0.9	5.2	7.7	7.3	16.5	3.1	1.9	1.3	4.2	0.7	18.9	1.3	1.1	9.6	9.4	2.9	14.1	6.5	17.9	2.5	6.3	2.8	5.1	1.4	2.0	6.1	4.8	1.7	2.3	10.9	8.1	8.5	6.8	1.9	2.2	5.5	5.6	6.0	8.1	4.9	5.1	5.9	3.6	5.8	5.2	6.0	9.6	31.2	20.7	7.0	1.7	5.6	5.1	8.1	3.4	15.7	2.0	19.6	11.6	14.8	48.3	11.6	5.1	0.0	10.1	2.1	16.0	14.7	6.9	65.7	77.4	33.4	14.5	17.2	29.5	24.4	49.2	21.5	20.3	28.9	12.9	22.3	8.7	16.9	40.7	47.0	3.4	25.8	6.6	24.5	1.5	4.0	3.7	15.0	6.2	19.2
ORAOV1	TAOS1	ENSG00000149716	"Oral cancer overexpressed 1"	Q8WV07	11	69653076-69675416	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062696			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062696: AB_2684837"	"unprognostic (2.15e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.65e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.19e-3)"	11.3	14.8	19.0	14.0	20.2	13.5	12.2	24.0	24.0	11.1	11.3	19.6	14.1	16.0	13.8	33.8	15.6	12.1	9.8	9.4	17.7	13.5	12.6	11.7	11.1	16.3	22.5	16.8	14.5	18.6	12.8	15.7	10.1	16.7	14.1	12.6	11.6	14.4	20.0	15.5	25.4	13.1	15.1	16.2	17.8	13.6	14.7	21.0	9.3	14.1	10.3	15.6	12.4	12.5	8.0	8.0	5.3	9.9	4.1	9.9	4.2	38.2	8.3	5.8	6.7	5.9	5.2	7.1	12.8	7.1	9.8	5.7	13.7	12.5	8.8	6.8	7.7	7.4	15.9	8.1	6.8	12.1	5.1	10.6	9.2	15.5	8.7	9.2	6.8	5.8	6.0	8.8	10.8	11.0	5.7	7.1	8.2	9.3	6.1	9.5	12.7	6.3	13.0	6.2	16.9	16.1	5.9	10.0	7.5	6.4	6.1	7.0	6.4	8.8	6.8	29.7	5.2	10.2	7.3	7.7	10.6	8.7	16.7	10.3	8.2	5.4	6.9	16.6	7.6	9.9	2.3	5.2	3.9	8.8	4.2	6.6	8.0	8.0	5.9	5.5	7.6	9.9	8.7	5.3	4.1	9.9	8.0	8.7	4.2	19.0	20.2	24.0	24.0	17.7	13.5	22.5	16.8	16.7	21.0	20.8	6.4	9.5	9.1	3.9	10.9	2.0	7.6	12.0	2.3	12.2	9.8	6.5	11.6	6.7	2.1	5.9	8.1	0.0	4.8	2.6	6.2	12.3	4.7	2.9	5.7	3.2	12.2	6.2	5.7	0.9	8.6	6.3	3.3	9.0	10.0	13.8	6.6	7.0	10.3	8.7	12.0	6.5	7.3	7.6	10.5	7.3	4.8	7.5	6.8	9.2
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908973-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: AB_2686640"	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	11.7	10.6	8.3	15.9	14.0	9.0	14.0	19.0	14.6	12.6	16.1	11.8	15.1	15.7	18.4	12.9	12.3	10.3	10.7	14.6	9.8	9.2	10.8	9.5	9.5	13.5	8.6	10.4	14.6	14.3	13.7	18.0	14.4	12.9	11.8	12.3	10.3	18.1	22.0	16.1	14.6	16.9	8.9	9.0	14.1	12.1	33.2	6.8	20.3	14.7	12.7	14.2	10.9	11.7	8.1	6.9	5.1	3.6	4.6	8.9	2.2	11.3	8.1	9.0	9.0	3.7	6.3	15.4	11.7	7.3	10.7	10.6	16.6	9.1	7.0	8.5	6.8	12.1	9.2	19.6	13.1	16.2	15.7	18.5	16.4	14.3	20.3	7.3	12.9	11.8	6.0	7.8	10.9	13.4	8.4	12.2	11.9	26.1	8.7	9.3	10.7	17.9	12.2	22.0	10.8	19.2	12.8	9.2	10.4	11.2	9.1	14.5	10.9	10.1	9.0	6.4	18.5	6.5	6.4	9.3	9.4	9.8	8.0	11.6	6.3	14.9	11.6	7.4	12.6	8.8	0.3	3.6	5.1	5.0	1.4	6.3	8.1	6.8	4.7	3.0	7.2	8.9	6.0	1.8	4.6	2.4	6.9	4.6	2.2	8.3	14.0	19.0	14.6	9.8	9.2	8.6	10.4	12.9	6.8	8.9	14.4	7.5	8.0	16.9	14.2	14.9	12.7	14.7	20.5	8.7	23.6	18.1	6.6	8.1	29.1	11.7	9.8	0.0	10.9	15.4	8.0	7.9	10.4	9.0	7.8	6.4	4.1	13.5	6.8	6.2	11.2	5.7	10.1	6.4	13.8	8.7	8.4	7.0	7.8	7.0	14.7	19.4	7.1	63.3	19.6	13.6	9.0	12.9	13.4	6.1
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication, Photosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	12.4	13.7	10.6	9.3	17.9	6.2	16.3	18.7	21.6	12.9	14.2	12.1	9.0	10.1	14.4	17.5	14.1	11.3	8.5	8.2	13.0	12.9	12.6	20.3	10.2	13.7	10.1	11.8	13.8	17.4	10.8	15.9	11.4	17.6	21.5	16.0	14.0	11.8	13.8	10.9	14.8	11.0	14.2	8.6	12.0	12.3	27.3	10.0	20.5	12.6	7.9	15.8	13.4	12.7	14.0	7.2	6.8	7.4	12.5	18.6	8.2	16.3	17.2	10.0	18.0	10.6	10.6	8.9	14.5	13.9	16.4	13.7	11.2	10.7	24.2	12.2	9.0	18.1	15.6	20.0	13.9	19.7	13.1	12.9	8.9	9.8	11.3	14.8	16.8	7.9	10.0	13.3	18.8	17.5	6.9	15.4	13.5	29.0	14.0	13.9	23.2	23.5	17.0	10.7	22.2	18.0	9.8	18.1	24.0	12.6	12.2	13.4	11.3	13.6	27.8	18.6	8.2	9.3	13.0	8.9	14.9	17.5	24.3	18.2	15.5	33.4	31.9	10.7	22.9	18.7	6.8	6.3	4.5	13.1	7.4	17.1	14.0	13.6	15.0	7.2	11.9	17.2	18.6	0.8	12.5	6.0	7.0	11.3	8.2	10.6	17.9	18.7	21.6	13.0	12.9	10.1	11.8	17.6	10.0	3.0	7.4	9.1	2.8	3.9	5.9	4.8	10.2	16.0	7.9	3.5	0.0	18.8	1.7	8.0	4.0	8.0	4.7	0.0	7.7	11.6	5.8	4.1	4.7	8.3	7.7	3.2	5.2	4.9	4.5	4.5	5.8	5.3	1.7	8.2	8.3	2.9	6.4	3.5	7.4	5.7	11.5	0.0	12.3	30.5	22.8	7.4	8.8	9.6	9.1	1.4
ORC6	ORC6L	ENSG00000091651	"Origin recognition complex subunit 6"	Q9Y5N6	16	46689643-46698394	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 84.9;Spermatogonia: 102.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016330, HPA072587"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			Nucleoplasm	"Nucleoli fibrillar center"	"CAB016330: AB_670295, HPA072587: AB_2686537"	"unprognostic (3.47e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.15e-6)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (3.53e-4)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.50e-4)"	"unprognostic (3.97e-2)"	"unprognostic (3.90e-14)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.98e-2)"	0.8	1.4	4.1	8.9	7.0	14.2	1.1	3.8	6.1	1.3	2.8	1.2	1.4	2.7	1.5	1.9	6.7	0.9	1.2	2.3	4.4	3.5	0.8	1.6	1.5	10.6	3.1	4.5	0.9	0.6	0.3	1.2	5.2	2.4	0.8	3.1	0.5	1.4	0.6	0.4	1.9	2.7	1.7	2.9	4.1	1.5	23.1	1.4	12.8	0.9	4.2	10.7	2.6	2.0	4.1	3.4	1.0	2.6	2.8	4.1	2.5	10.9	10.1	16.2	12.6	2.0	2.5	12.0	19.6	7.3	21.7	11.4	14.2	6.7	12.7	10.3	3.7	11.0	11.2	20.8	5.4	18.4	6.5	16.8	10.5	5.4	14.3	2.5	17.2	11.1	0.7	1.0	11.8	6.2	3.5	7.1	11.1	12.7	6.5	13.1	9.6	23.1	21.6	17.9	7.6	27.9	27.9	29.8	12.9	5.3	3.8	19.4	11.5	10.0	11.1	6.8	13.5	5.9	13.7	4.3	20.0	13.6	12.6	18.4	5.0	6.7	44.4	8.5	11.3	15.4	0.0	1.1	1.0	3.5	2.6	1.4	2.7	2.0	2.0	2.2	4.1	2.9	1.4	0.5	2.8	2.5	3.4	4.1	2.5	4.1	7.0	3.8	6.1	4.4	3.5	3.1	4.5	2.4	1.4	3.0	16.4	15.2	2.4	6.0	6.1	3.3	2.5	17.4	9.1	5.2	3.9	22.0	1.7	2.6	9.4	3.0	2.1	0.0	0.6	30.9	9.9	1.7	1.1	8.3	13.2	11.1	1.7	0.0	3.3	6.2	2.6	6.1	32.1	0.0	5.6	2.5	1.6	0.0	3.2	0.7	8.4	0.0	2.2	84.9	102.2	5.3	9.2	4.4	10.3	1.7
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 834.6"	"Cell type enriched"	"Detected in some"	35	"Hepatocytes: 50531.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"					"Cell type enriched"	"Detected in some"	45	"neutrophil: 53.4"	"Lineage enriched"	"Detected in many"	45	"granulocytes: 53.4"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 161.7"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	945000000000	120000000000	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	0.1	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	834.6	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	53.4	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	161.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	14.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	0.0	0.2	0.0	0.0	0.3											3.0	14.9	263.0	0.0	0.0	0.0	0.0	1452.2	0.0	1.2	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	794.3	4.5	0.1	0.0	31.6	0.0	50531.7	0.1	0.0	0.0	844.6	848.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333252	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 404.1"	"Cell type enriched"	"Detected in some"	43	"Hepatocytes: 9578.7"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"					"Cell type enriched"	"Detected in single"	35	"neutrophil: 13.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 13.2"	"Cell line enriched"	"Detected in single"	237	"Hep G2: 136.6"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	61000000000	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	404.1	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	136.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.0	0.1											0.0	8.0	42.8	0.0	0.0	0.0	0.0	224.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.5	0.0	0.0	70.0	5.4	0.0	0.0	2.1	0.0	9578.7	0.0	0.0	0.0	141.2	136.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OSBP	OSBP1	ENSG00000110048	"Oxysterol binding protein"	P22059	11	59574398-59616144	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039227, HPA043625"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039227: AB_2676401, HPA043625: AB_2678587"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"prognostic favorable (2.08e-5)"	"unprognostic (7.80e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.08e-7)"	"unprognostic (1.25e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	15.6	36.6	12.3	10.6	16.3	13.8	16.5	14.7	18.0	16.1	18.8	13.7	35.4	17.3	15.9	19.9	15.9	13.8	19.5	14.7	10.3	11.6	26.3	54.8	12.9	9.7	12.4	12.7	16.6	30.2	31.4	14.7	29.4	17.9	16.1	17.3	12.6	27.7	26.2	32.5	20.9	22.3	15.1	9.5	12.5	19.1	11.3	12.1	18.8	19.6	12.5	13.8	16.7	13.7	4.6	7.9	3.5	3.1	4.0	6.1	2.1	17.7	14.9	11.1	14.9	26.2	24.6	12.2	14.5	18.9	17.5	15.8	16.8	18.1	18.0	19.5	16.7	21.5	18.7	20.4	19.3	19.8	17.3	9.4	12.1	11.6	11.3	28.1	15.4	24.0	18.8	24.1	16.4	43.4	18.3	18.7	16.9	20.7	16.8	15.5	8.2	14.5	11.4	12.6	26.1	14.7	14.1	17.8	12.4	20.8	20.7	13.1	9.3	17.2	21.6	19.8	16.0	30.2	9.9	20.2	15.0	10.5	22.4	9.7	23.5	19.0	18.3	16.9	11.2	12.0	3.5	3.1	2.8	5.9	2.9	5.5	4.6	6.1	4.6	3.2	3.4	5.6	4.7	3.0	4.0	2.5	7.9	2.6	2.1	12.3	16.3	14.7	18.0	10.3	11.6	12.4	12.7	17.9	12.1	23.8	7.0	11.2	14.5	35.1	21.6	29.9	33.1	20.1	17.0	26.2	21.6	11.7	6.6	12.1	7.6	17.2	30.7	0.0	16.0	10.9	16.4	26.0	27.6	56.3	13.4	25.4	28.8	10.4	12.9	10.6	14.7	12.1	13.5	3.6	35.0	16.7	18.6	22.9	18.7	17.9	19.4	6.5	13.7	21.8	13.2	41.4	25.7	10.2	25.1	19.0
OSBP2	"KIAA1664, ORP-4, ORP4, OSBPL1"	ENSG00000184792	"Oxysterol binding protein 2"	Q969R2	22	30693782-30907824	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.1;retina: 45.7"	"Cell type enhanced"	"Detected in many"	24	"Early spermatids: 112.6;Late spermatids: 239.9;Rod photoreceptor cells: 571.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 15.6;HeLa: 55.9;hTERT-HME1: 15.0;SiHa: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021514	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA021514: AB_1854813"	"unprognostic (2.89e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.79e-6)"	"unprognostic (9.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	1.0	8.5	5.7	2.3	11.6	36.1	1.2	17.0	14.4	1.4	1.6	8.5	1.3	6.3	1.9	13.0	3.3	2.0	2.7	10.0	7.7	5.6	2.1	0.7	1.8	1.9	7.1	6.2	1.7	4.9	8.8	14.1	4.0	7.3	2.2	1.7	45.7	2.5	2.4	2.3	4.6	4.6	1.2	6.4	3.4	3.2	19.6	5.5	0.0	2.9	0.3	1.3	4.3	2.2	1.9	1.6	2.5	3.1	2.7	3.2	6.2	2.6	5.8	0.5	2.5	0.4	2.3	0.6	0.5	1.2	1.8	1.9	5.2	1.4	4.6	2.2	0.7	0.6	1.5	2.3	0.2	1.3	2.5	0.7	15.6	55.9	1.0	0.3	0.1	0.9	0.1	6.5	4.6	15.0	0.6	4.6	1.8	9.7	0.2	4.2	2.9	0.4	1.6	1.4	1.2	5.4	1.3	0.2	0.2	0.2	1.0	6.5	2.7	14.9	1.6	0.1	1.2	1.8	0.8	3.3	1.3	7.0	1.2	2.6	1.2	1.7	0.8	5.2	0.0	1.0	0.6	1.8	1.1	1.5	3.1	3.1	1.7	2.9	1.4	1.6	1.9	3.0	3.2	2.5	2.7	2.3	0.7	1.9	6.2	5.7	11.6	17.0	14.4	7.7	5.6	7.1	6.2	7.3	5.5	0.0	1.9	0.0	1.0	4.6	89.3	8.5	0.0	1.4	1.2	1.8	76.6	0.2	1.7	1.4	112.6	1.8	0.4	23.3	1.3	0.2	2.5	1.0	0.0	0.0	0.2	17.5	6.9	0.0	0.0	239.9	2.3	0.2	1.7	0.0	2.3	23.7	0.7	5.8	1.8	0.4	571.4	0.0	1.2	16.2	3.4	8.3	0.2	0.0	1.3	1.6
OSBPL10		ENSG00000144645	"Oxysterol binding protein like 10"	Q9BXB5	3	31657890-32077580	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 39.6"	"Group enriched"	"Detected in many"	13	"Early spermatids: 436.6;Late spermatids: 951.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"memory B-cell: 11.5;naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	22	"B-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 31.5;RPTEC TERT1: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003636			Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA003636: AB_1079529"	"unprognostic (5.28e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (5.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.85e-4)"	11.7	3.5	3.8	8.7	4.3	1.0	6.7	1.4	7.6	8.6	5.6	0.4	5.9	2.5	11.8	6.7	10.0	5.5	16.7	2.9	2.6	2.6	14.5	1.6	4.6	8.2	3.1	3.6	4.1	2.5	1.3	12.0	16.5	2.5	12.8	6.0	8.5	7.3	16.6	2.0	5.5	7.3	39.6	1.2	9.5	4.4	24.0	1.2	0.4	4.3	4.3	15.1	25.2	11.8	11.5	0.1	0.5	0.0	0.0	0.0	0.2	6.2	3.5	0.6	12.5	1.1	2.3	20.9	1.7	1.9	1.6	2.3	8.7	4.5	14.7	16.8	0.4	5.7	3.7	2.7	14.7	1.9	0.1	2.7	0.0	8.7	5.5	0.9	0.0	0.1	2.4	12.4	2.5	31.5	6.1	7.2	0.0	0.0	0.0	6.8	5.1	0.0	0.0	7.9	20.0	9.0	0.1	0.2	0.2	33.2	2.5	0.9	0.1	3.1	5.4	1.7	12.3	3.6	0.0	5.1	2.0	21.5	0.2	8.2	1.4	1.0	14.0	2.9	0.0	12.7	0.2	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	6.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3.8	4.3	1.4	7.6	2.6	2.6	3.1	3.6	2.5	1.2	8.9	3.8	36.5	6.8	9.6	4.8	2.0	5.1	6.7	4.5	7.0	0.0	12.6	8.3	1.9	436.6	17.1	5.7	0.0	4.4	21.8	5.4	16.4	0.0	0.0	2.2	0.0	14.5	20.9	1.2	951.1	10.3	0.9	8.5	1.8	3.5	52.0	10.6	4.5	3.9	20.7	1.7	19.4	9.4	6.5	4.1	10.8	25.3	2.9	7.4	8.6
OSBPL11	"FLJ13012, FLJ13164, ORP-11, ORP11"	ENSG00000144909	"Oxysterol binding protein like 11"	Q9BXB4	3	125528858-125595090	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.9"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039144			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA039144: AB_10794086"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.73e-3)"	"unprognostic (6.38e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.13e-1)"	8.1	5.1	12.6	8.1	16.9	4.7	13.2	5.7	9.7	5.4	7.2	14.1	4.9	5.1	6.1	6.1	6.8	5.0	5.2	5.3	11.0	7.7	6.8	22.4	10.9	11.1	11.2	8.3	4.5	3.8	8.5	5.1	9.0	8.7	4.6	6.6	4.6	5.1	9.7	48.9	6.3	6.0	7.0	10.3	11.4	5.2	7.8	10.9	8.3	5.9	6.0	9.4	6.3	5.3	3.5	11.8	12.8	9.5	1.9	2.2	3.2	13.1	7.1	13.6	7.7	15.5	8.3	17.8	9.9	8.0	12.6	14.5	13.7	4.7	21.7	12.4	8.2	10.4	9.9	15.1	8.7	16.9	5.8	6.5	9.9	8.6	9.1	8.7	7.4	13.6	6.7	10.7	10.5	9.2	5.1	9.1	10.5	10.2	9.9	11.4	7.8	14.7	3.6	18.7	9.7	6.4	13.0	7.9	25.3	10.5	8.2	3.0	8.1	12.2	7.0	10.5	9.8	7.3	3.9	9.4	10.1	9.1	14.6	7.7	6.3	6.6	26.6	7.1	2.6	9.7	10.8	9.3	2.4	1.8	9.5	1.5	3.5	1.0	1.8	11.8	2.7	1.2	1.4	12.8	1.9	7.8	4.5	2.2	3.2	12.6	16.9	5.7	8.4	11.0	7.7	11.2	8.3	8.7	10.9	8.9	11.8	18.6	7.4	8.9	18.9	7.9	5.1	9.4	12.5	8.7	11.8	10.0	5.0	8.2	0.8	9.2	12.6	0.0	6.1	9.0	7.4	5.3	3.5	31.6	22.8	7.9	4.1	11.6	56.9	2.5	6.1	35.7	11.8	13.6	5.2	11.2	8.5	11.9	6.7	8.0	32.0	6.5	8.1	9.1	20.4	13.8	19.3	8.4	6.2	9.6
OSBPL1A	"ORP-1, ORP1, OSBPL1B"	ENSG00000141447	"Oxysterol binding protein like 1A"	Q9BXW6	18	24162044-24397880	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	18	"basophil: 33.7"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 33.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040959, HPA043401"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040959: AB_10964295, HPA043401: AB_10960208"	"unprognostic (1.75e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.53e-2)"	"prognostic favorable (4.98e-13)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.56e-1)"	32.3	14.3	33.3	5.9	28.9	7.0	23.8	6.2	43.1	27.7	13.8	33.9	6.2	10.2	24.4	9.0	15.5	15.2	10.6	24.7	37.6	22.6	21.7	6.6	11.9	5.0	40.6	27.7	14.3	8.3	21.0	8.8	4.2	29.9	12.0	11.5	16.6	23.3	13.9	73.2	8.7	9.8	20.4	49.0	4.8	9.7	6.9	29.0	1.0	14.6	9.9	4.1	12.0	29.7	0.2	1.8	33.7	1.8	0.1	0.4	0.6	15.3	4.6	11.0	20.5	25.8	21.1	10.3	5.7	16.7	5.2	4.3	2.9	16.1	0.0	6.8	10.2	8.3	15.7	4.3	10.0	4.8	0.0	8.1	4.8	3.3	0.0	12.9	12.1	2.5	27.3	14.5	3.9	16.3	22.9	6.5	4.3	0.0	0.1	6.4	6.5	2.7	3.6	9.0	7.9	15.3	0.0	8.8	1.3	1.4	11.3	7.2	7.0	13.4	15.7	18.3	10.8	5.7	8.7	1.4	19.5	4.1	6.2	5.5	0.1	2.1	0.4	9.4	3.5	11.1	33.7	1.8	0.4	0.1	0.9	0.0	0.0	0.4	0.2	1.7	0.2	0.2	0.2	0.7	0.1	0.3	1.8	0.3	0.6	33.3	28.9	6.2	43.1	37.6	22.6	40.6	27.7	29.9	29.0	14.9	16.3	3.2	36.9	17.9	60.0	66.8	28.1	24.1	23.9	19.2	21.6	9.0	54.7	10.3	58.6	58.9	23.8	0.0	6.7	7.0	27.8	29.4	17.3	10.4	24.0	23.8	4.6	33.7	16.4	59.6	39.7	21.9	55.6	1.8	32.2	86.9	8.0	14.8	51.6	55.2	92.0	32.3	45.3	6.7	10.6	8.9	5.4	4.3	8.6	23.1
OSBPL2	"DFNA67, KIAA0772, ORP-2"	ENSG00000130703	"Oxysterol binding protein like 2"	Q9H1P3	20	62231922-62296213	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 38.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 38.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041127, HPA042659"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA041127: AB_10962008, HPA042659: AB_10960683"	"unprognostic (1.00e-3)"	"unprognostic (7.20e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.20e-5)"	"unprognostic (3.86e-2)"	"unprognostic (8.13e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.32e-2)"	12.7	12.7	17.0	13.2	22.7	25.8	17.4	41.6	28.8	15.5	21.2	23.3	16.9	20.0	14.8	16.6	35.0	14.7	20.3	22.0	16.4	16.0	15.4	14.9	13.8	11.6	17.4	15.2	15.1	34.7	26.8	21.3	19.5	24.3	17.0	20.6	15.7	27.3	18.5	16.2	35.1	19.6	20.0	19.1	19.3	24.2	15.2	17.1	14.7	20.0	13.2	19.5	19.8	22.4	6.0	4.0	38.7	4.6	6.5	6.7	4.1	11.4	8.3	9.7	9.0	9.9	9.9	9.2	7.0	13.7	23.5	16.2	29.6	11.8	5.5	18.7	13.8	21.1	20.1	9.3	20.8	13.0	6.6	8.7	14.7	10.3	15.1	9.8	5.6	13.3	9.0	30.7	10.4	11.8	11.1	9.4	14.5	9.5	10.4	6.7	9.5	8.1	9.4	3.1	21.0	7.4	7.6	11.7	7.2	12.0	23.5	12.9	8.4	12.7	24.0	11.9	13.6	15.8	10.1	6.4	11.7	8.7	12.3	8.3	12.2	17.3	8.2	13.1	4.0	7.2	6.0	3.7	13.6	5.5	4.6	5.0	6.0	4.6	5.9	4.0	4.7	4.2	5.0	38.7	6.5	4.0	2.8	6.7	4.1	17.0	22.7	41.6	28.8	16.4	16.0	17.4	15.2	24.3	17.1	14.9	19.4	16.1	18.7	17.9	18.1	54.5	12.7	37.5	22.7	10.4	5.9	12.1	26.6	18.9	17.7	14.6	28.0	23.3	17.5	13.1	10.1	31.4	10.4	10.9	10.8	17.5	15.6	16.0	10.0	12.3	16.1	8.9	8.5	17.2	26.0	18.1	29.1	26.8	12.4	11.2	14.2	12.9	10.3	21.1	13.0	24.3	31.0	15.2	21.1	53.8
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402891	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.4"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 59.0;Ciliated cells: 133.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 2.2;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HEL: 25.0;hTERT-HME1: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	2.4	2.8	9.2	1.9	10.5	0.8	3.2	10.2	18.4	1.9	1.7	3.2	0.2	1.6	1.8	1.7	4.1	2.1	2.2	5.9	7.5	6.3	4.5	8.7	6.3	2.0	4.9	8.0	2.8	2.3	1.2	15.1	1.4	11.3	5.3	2.1	2.5	2.9	2.9	33.4	11.6	5.6	2.6	4.3	2.0	1.7	2.4	4.3	0.0	4.1	6.3	1.7	1.5	2.3	0.2	0.1	2.2	0.0	0.2	1.4	0.6	0.0	0.5	4.4	8.9	3.7	4.1	3.4	7.2	3.8	6.4	7.9	0.7	0.1	0.0	0.3	6.6	3.5	0.1	10.3	5.9	10.9	0.1	5.3	25.0	1.6	0.0	2.4	4.0	0.1	2.7	9.4	14.1	27.4	2.3	3.0	3.2	0.4	3.1	8.4	3.5	0.0	0.0	5.3	0.0	5.3	0.0	9.0	1.6	0.4	0.0	3.4	2.0	3.2	0.9	7.1	5.1	1.2	0.0	5.9	7.4	4.6	4.9	8.4	17.0	6.6	0.0	8.8	0.0	3.4	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.8	0.0	0.2	1.4	0.1	2.2	0.2	0.0	0.1	0.0	0.6	9.2	10.5	10.2	18.4	7.5	6.3	4.9	8.0	11.3	4.3	0.0	4.5	0.0	2.3	11.7	59.0	12.9	7.6	133.8	11.4	0.0	23.6	0.2	1.7	0.6	0.7	1.8	0.3	0.0	0.7	2.5	1.1	1.8	6.9	4.3	2.9	1.6	1.7	0.0	2.2	0.9	0.0	0.9	5.0	0.0	3.8	11.5	0.3	0.0	1.4	5.3	6.6	0.0	5.3	0.0	0.1	18.2	0.1	0.0	0.1	0.5
OSBPL8	"MST120, MSTP120, ORP8, OSBP10"	ENSG00000091039	"Oxysterol binding protein like 8"	Q9BZF1	12	76351797-76559809	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"granulocytes: 242.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001309	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001309: AB_1079530"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-3)"	29.3	11.4	13.9	18.4	41.9	23.1	17.2	13.7	20.2	20.0	11.5	6.8	8.4	7.5	18.5	10.7	20.1	10.4	15.0	19.3	13.4	12.9	30.2	15.2	20.5	22.7	12.1	13.2	14.9	11.2	12.4	16.5	14.4	13.9	16.2	9.7	9.2	15.8	11.1	21.5	22.9	12.6	15.5	14.8	24.9	12.4	12.8	14.7	41.0	11.7	10.6	24.8	18.0	24.5	11.7	15.8	57.2	15.0	9.9	10.9	8.1	12.4	8.0	17.8	12.6	24.8	35.1	11.3	19.2	27.0	12.4	11.3	11.5	5.2	17.5	11.0	22.8	7.7	5.2	13.2	11.1	18.7	14.9	11.7	46.9	7.9	6.8	15.3	29.7	19.1	18.5	21.2	18.4	23.0	22.3	10.6	10.2	32.1	8.1	20.3	8.6	19.8	14.1	8.7	4.5	7.9	10.4	24.3	10.0	9.5	10.6	9.7	10.2	16.4	6.0	11.9	14.6	4.6	18.1	24.8	20.0	10.0	20.6	10.3	8.1	12.7	19.3	7.6	16.7	11.6	27.5	15.0	20.1	9.0	10.8	8.5	11.7	9.6	7.3	13.2	11.6	8.7	7.1	57.2	9.9	11.7	15.8	10.9	8.1	13.9	41.9	13.7	19.9	13.4	12.9	12.1	13.2	13.9	14.7	53.6	69.1	48.0	37.5	103.3	37.1	37.6	20.4	40.2	34.2	48.8	84.4	28.5	51.4	49.5	35.1	65.2	13.0	23.3	47.9	23.5	68.6	48.2	242.1	32.5	69.5	39.7	9.1	50.3	88.2	15.3	60.9	125.5	33.7	85.6	23.5	51.8	73.4	24.6	77.8	126.3	27.5	45.3	89.0	45.6	131.8	108.8	40.3	78.4	14.9	59.7
OSCAR		ENSG00000170909	"Osteoclast associated, immunoglobulin-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 36.7;Kupffer cells: 33.7;Macrophages: 28.2;monocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	34	"classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2"	"Group enriched"	"Detected in many"	75	"dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.6;HHSteC: 9.3;hTERT-HME1: 4.9;NB-4: 5.4;U-937: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		72000000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	4.5	1.0	1.4	3.8	2.8	18.9	1.4	0.4	1.5	1.3	0.9	3.5	0.0	0.4	0.7	1.3	1.2	2.2	2.3	1.1	3.8	1.9	1.0	1.7	40.4	4.7	3.5	0.4	1.2	0.7	0.3	0.5	2.2	4.0	0.8	0.7	1.0	1.3	0.8	0.7	1.9	1.0	2.8	5.6	20.2	1.3	0.6	2.4	1.7	1.0	0.0	1.2	1.7	3.1	0.0	9.4	18.3	20.6	0.0	0.2	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.4	0.0	13.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.3	0.7	0.0	0.0	0.2	0.6	4.9	0.8	0.0	0.1	0.0	0.4	0.1	0.1	0.0	5.4	0.3	0.2	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.6	0.5	16.8	0.0	0.0	20.6	11.7	0.1	12.8	0.0	0.0	0.1	0.2	9.4	0.0	0.0	0.0	18.3	0.0	11.2	0.4	0.1	7.0	1.4	2.8	0.4	1.4	3.8	1.9	3.5	0.4	4.0	2.4	3.0	5.1	0.0	0.5	0.7	0.0	0.3	2.5	6.7	3.4	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.2	1.1	0.0	36.7	0.0	0.0	0.0	33.7	0.0	0.0	28.2	0.0	39.7	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.6	0.1	0.2	0.0	0.0	0.3
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 35.8;testis: 49.9"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 144.6;Early spermatids: 336.5;Spermatocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	3.9	5.3	6.2	1.5	14.0	1.2	6.0	3.6	12.7	6.2	3.6	6.5	7.5	1.8	6.3	14.1	3.2	35.8	5.5	4.7	6.5	8.9	11.9	1.8	6.7	1.3	4.9	5.3	5.9	6.2	15.7	15.7	8.9	7.8	6.4	2.5	6.7	5.3	6.8	2.4	3.4	1.3	5.0	3.2	0.9	3.5	49.9	3.2	1.3	11.1	3.5	2.4	3.2	2.6	0.8	3.8	0.3	1.7	0.3	3.1	0.8	5.2	5.0	6.2	7.1	7.4	7.2	1.1	3.2	7.8	7.9	5.4	0.1	4.6	1.1	6.0	5.7	5.8	4.1	0.2	6.0	5.1	0.9	4.7	0.0	3.3	0.5	9.1	0.6	0.9	8.1	9.8	11.1	4.9	11.5	5.4	5.0	0.1	1.3	6.2	3.7	2.7	1.9	6.3	2.0	2.1	2.9	2.5	0.9	12.9	1.8	16.6	7.3	5.9	2.8	4.1	6.1	6.1	0.9	4.6	5.7	2.1	10.3	5.3	2.3	2.3	0.5	11.0	0.1	3.8	0.0	0.7	0.0	0.9	1.7	0.0	0.4	0.9	0.7	1.8	0.8	2.2	3.1	0.3	0.3	0.2	3.8	2.2	0.8	6.2	14.0	3.6	12.7	6.5	8.9	4.9	5.3	7.8	3.2	8.9	7.5	0.5	6.7	1.3	5.3	4.7	5.1	144.6	19.4	12.2	15.7	9.8	19.9	11.2	336.5	2.4	0.7	0.0	8.1	2.6	4.1	4.3	0.0	1.9	3.8	4.8	4.7	2.5	0.6	35.1	11.5	1.2	3.3	0.0	2.6	12.3	7.9	4.0	8.5	18.1	18.9	0.0	3.3	91.2	18.9	2.8	16.8	0.7	2.6	3.3
OSER1	"C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1"	ENSG00000132823	"Oxidative stress responsive serine rich 1"	Q9NX31	20	44196496-44210791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 722.5;Late spermatids: 1504.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045125	Approved		Approved	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	Yes			"Nucleoli, Nucleoli rim, Nuclear speckles"		"HPA045125: AB_10961629"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (1.18e-1)"	"unprognostic (6.07e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.78e-2)"	"unprognostic (8.01e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.06e-1)"	18.7	11.8	11.9	18.4	13.3	62.5	20.0	17.8	13.3	19.1	17.2	13.0	13.0	15.1	17.5	17.6	23.5	14.2	13.7	16.9	12.4	10.0	15.0	16.3	17.7	16.9	16.3	10.9	21.4	10.9	19.3	12.5	31.7	13.1	22.6	14.1	12.4	17.0	13.2	46.3	22.3	18.9	23.5	16.9	18.2	14.7	47.4	13.3	15.1	19.0	15.4	17.4	29.6	16.7	28.4	14.6	74.3	21.9	15.1	17.6	19.8	20.4	16.0	11.6	9.1	31.1	22.2	13.5	18.9	28.5	29.8	27.4	38.3	21.2	20.5	18.7	17.2	38.8	27.9	13.2	17.4	25.1	6.9	8.6	6.6	34.5	25.9	18.0	11.3	11.0	26.3	29.3	19.5	35.8	15.5	13.5	12.5	9.7	25.3	16.3	30.6	9.1	13.8	10.6	18.7	16.4	12.7	19.7	14.1	14.8	14.0	11.7	11.8	26.9	35.8	23.9	14.3	18.2	10.2	11.8	24.6	18.9	14.6	16.2	17.2	18.4	19.9	17.4	8.5	12.7	50.2	16.8	27.7	12.7	15.7	13.7	28.4	14.8	12.5	14.6	26.9	17.6	15.9	74.3	15.1	21.9	9.5	17.1	19.8	11.9	13.3	17.8	13.3	12.4	10.0	16.3	10.9	13.1	13.3	17.9	28.4	24.4	119.5	230.4	9.6	33.9	17.8	24.1	22.7	12.2	3.9	33.6	31.5	38.1	722.5	31.5	56.3	0.0	32.0	30.4	33.9	80.1	33.4	26.0	38.1	11.1	47.4	17.2	27.0	1504.1	37.7	43.4	72.6	117.2	30.0	23.4	42.0	45.6	33.2	26.2	14.1	19.4	49.5	76.2	55.8	173.4	145.2	35.9	35.3	99.2
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446411-20455105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favorable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	11.2	14.2	13.2	13.1	14.5	10.7	14.4	21.3	18.3	14.3	15.6	18.6	11.6	8.8	16.0	19.2	12.9	13.1	13.6	15.8	13.4	10.2	12.3	22.2	12.4	16.9	13.4	12.5	12.4	12.4	10.6	20.8	13.6	15.5	10.8	14.0	14.5	12.4	18.6	19.6	9.9	12.4	16.8	12.3	18.8	13.6	5.7	15.2	16.2	15.7	9.6	18.7	16.6	11.0	24.5	28.8	23.4	19.1	13.0	14.2	15.7	6.3	10.2	3.3	10.0	5.9	4.0	10.4	5.0	6.5	12.7	12.3	14.0	7.5	13.2	6.5	6.3	5.5	5.5	10.2	10.0	8.0	10.4	13.0	8.3	8.6	18.0	4.3	14.3	11.9	3.1	3.0	15.2	8.1	2.7	8.3	12.0	8.0	7.6	9.9	11.8	14.0	6.2	5.1	18.3	20.3	22.3	6.3	7.4	7.2	7.2	13.2	2.6	8.8	9.3	6.7	2.0	6.2	13.6	3.8	5.3	13.0	6.7	5.9	2.3	12.3	18.0	3.3	22.3	6.4	5.1	19.1	23.4	13.7	17.6	11.9	20.5	14.2	12.0	28.8	24.5	11.3	12.9	8.7	13.0	13.6	12.4	12.9	15.7	13.2	14.5	21.3	18.3	13.4	10.2	13.4	12.5	15.5	15.2	32.8	30.4	31.8	18.6	10.2	35.1	14.5	17.8	25.4	31.8	22.7	35.3	58.5	29.9	21.8	2.7	18.3	27.1	0.0	25.9	38.4	17.9	13.7	24.4	16.6	56.2	9.5	25.8	22.7	27.5	2.5	17.8	30.6	20.3	17.2	21.1	28.4	19.2	31.5	20.1	30.7	52.1	12.9	23.0	5.1	15.6	10.0	38.6	22.5	29.5	13.6
OSGIN1	"BDGI, OKL38"	ENSG00000140961	"Oxidative stress induced growth inhibitor 1"	Q9UJX0	16	83948282-83966332	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 63.5"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 47.5;Enterocytes: 69.2;Hepatocytes: 52.5;Late spermatids: 191.7"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 65.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.5;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"A549: 25.7;Hep G2: 38.6;T-47d: 28.7;WM-115: 24.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA019239			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA019239: AB_1854779"	"unprognostic (8.36e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (3.31e-3)"	"unprognostic (9.14e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.89e-1)"	4.0	9.8	1.7	3.0	6.5	0.8	28.2	0.6	3.7	1.7	17.4	2.1	0.7	18.1	1.3	1.7	5.6	1.8	5.1	6.9	1.3	1.4	13.8	63.5	8.2	1.6	13.4	0.0	3.2	5.2	2.5	1.4	1.2	6.6	2.1	1.8	5.1	2.0	1.7	7.8	1.6	21.3	5.5	13.7	5.4	5.0	5.6	1.9	0.0	5.2	13.5	2.9	6.0	10.6	0.0	1.0	4.5	12.3	0.0	0.0	0.8	1.7	25.7	0.2	1.1	1.6	2.4	2.0	2.9	2.8	2.6	1.0	6.3	9.3	0.0	6.9	2.4	11.9	4.7	1.1	1.9	1.0	0.3	0.3	0.4	5.7	38.6	5.6	0.9	10.1	1.4	1.5	7.0	1.6	1.5	2.6	1.8	2.3	2.5	3.4	11.9	0.3	0.3	0.2	6.2	5.9	0.8	2.6	1.2	1.8	2.2	0.1	0.6	6.2	2.0	12.5	0.7	28.7	1.0	8.9	4.2	6.3	6.1	2.0	1.1	0.4	0.1	14.0	1.3	24.0	0.1	2.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.5	0.0	12.3	0.0	0.0	0.8	1.7	6.5	0.6	3.7	1.3	1.4	13.4	0.0	6.6	1.9	14.9	3.8	0.5	8.2	1.3	0.5	6.9	10.2	1.4	1.2	1.8	0.0	1.2	5.0	10.5	47.5	2.7	69.2	0.0	5.7	0.3	2.1	9.5	1.1	52.5	8.5	0.0	4.1	6.7	8.6	191.7	3.7	3.2	6.8	2.8	7.3	7.5	11.6	10.5	11.3	8.7	0.2	12.9	8.0	1.9	1.0	1.5	1.1	0.0	7.1	5.8
OSGIN2	"C8orf1, hT41"	ENSG00000164823	"Oxidative stress induced growth inhibitor family member 2"	Q9Y236	8	89901859-89927888	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 59.6;Early spermatids: 185.9;Late spermatids: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 17.0"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028515, HPA050595"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA028515: AB_10602014, HPA050595: AB_2681186"	"unprognostic (3.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (3.91e-6)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.25e-2)"	15.2	7.5	12.5	7.8	13.9	40.4	16.8	9.6	17.5	7.6	13.3	26.4	6.0	6.8	26.1	6.1	11.7	8.1	14.2	11.2	14.2	13.4	14.7	16.2	15.7	9.1	13.7	13.0	15.9	7.8	53.5	25.2	6.5	18.2	9.1	8.6	8.3	8.6	7.3	13.2	7.6	8.7	17.1	25.3	9.0	7.5	20.5	14.7	7.1	12.9	8.0	8.9	11.1	8.5	3.0	1.5	17.0	1.4	2.0	2.5	1.3	12.2	12.0	3.0	6.1	6.7	4.9	4.0	8.8	16.9	8.1	7.9	5.6	11.7	8.4	18.0	4.5	10.1	4.5	5.7	6.9	12.7	12.1	4.6	12.8	4.7	3.0	11.4	6.4	8.0	5.7	9.1	9.4	7.8	7.0	9.9	11.1	7.4	15.0	5.8	9.5	11.1	4.3	1.5	12.3	6.4	4.9	4.5	7.2	12.2	9.5	2.8	7.1	6.5	57.5	10.6	5.4	11.7	9.6	6.7	8.9	8.2	7.3	8.0	13.9	11.9	9.2	14.8	7.9	6.2	17.0	1.4	5.8	1.7	0.9	2.4	3.0	2.5	1.5	1.5	1.8	2.1	2.3	10.3	2.0	1.1	1.1	2.5	1.3	12.5	13.9	9.6	17.5	14.2	13.4	13.7	13.0	18.2	14.7	59.6	15.0	11.9	5.9	5.4	7.8	11.6	20.4	10.7	13.6	7.0	2.0	6.5	8.3	12.6	185.9	5.6	2.6	0.0	13.9	6.9	9.4	6.7	16.2	15.8	14.2	3.2	9.2	15.4	18.3	163.7	11.5	10.8	6.8	7.2	4.6	23.0	11.2	3.5	11.7	11.9	5.2	12.9	6.2	12.2	5.9	3.8	1.4	5.3	5.2	5.2
OSMR	OSMRB	ENSG00000145623	"Oncostatin M receptor"	Q99650	5	38845858-38945596	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.4;GAMG: 39.5;HSkMC: 47.5;U-2197: 38.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017278	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA		21000000	Nucleoli		"HPA017278: AB_1854818"	"unprognostic (6.34e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.00e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.96e-6)"	"unprognostic (1.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.75e-2)"	41.1	18.0	7.3	18.7	9.4	0.3	31.0	3.1	9.4	14.1	13.7	2.8	4.6	4.4	14.4	12.9	14.7	14.5	22.4	22.4	5.4	3.5	19.7	23.6	25.7	31.7	9.0	1.3	33.6	10.1	6.6	10.5	40.1	13.3	20.8	8.6	9.2	17.2	11.1	13.0	12.5	8.0	32.5	15.6	23.5	11.5	10.8	6.9	3.6	17.5	10.4	11.3	40.4	43.6	0.6	0.6	1.6	0.4	0.7	0.6	0.1	7.4	9.7	1.6	4.2	17.9	38.4	5.6	12.2	19.4	12.0	16.2	0.0	20.3	0.0	5.8	12.9	39.5	10.4	2.1	15.0	19.5	0.0	1.2	0.5	7.6	7.3	20.3	0.0	0.1	47.5	9.0	27.0	23.1	22.4	1.8	0.0	0.0	0.0	7.5	2.0	0.0	0.0	0.2	1.5	3.2	0.0	0.5	0.0	24.2	2.2	0.0	0.0	27.6	0.0	0.0	2.4	8.4	0.0	2.8	29.4	11.1	38.0	6.5	0.0	0.0	0.0	23.6	0.0	6.3	1.6	0.4	0.4	0.5	0.3	0.2	0.3	0.3	0.1	0.1	0.6	0.4	0.6	1.0	0.7	0.1	0.6	0.2	0.1	7.3	9.4	3.1	9.4	5.4	3.5	9.0	1.3	13.3	6.9	41.7	42.5	0.0	57.8	27.0	0.0	2.8	22.9	9.4	46.6	12.2	0.0	5.3	0.0	43.3	0.5	37.0	0.0	0.0	41.7	6.0	25.9	39.4	1.1	11.3	1.3	0.0	0.0	60.2	9.7	0.4	38.6	1.3	6.8	2.8	0.0	0.8	60.1	0.0	7.1	3.3	0.6	19.4	24.0	0.3	0.6	21.0	14.3	0.5	0.0	57.6
OSR2	FLJ90037	ENSG00000164920	"Odd-skipped related transciption factor 2"	Q8N2R0	8	98944403-98952104	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.9"	"Group enriched"	"Detected in many"	7	"Leydig cells: 726.0;Peritubular cells: 712.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	17	"ASC diff: 113.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052425, HPA063486"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA052425: AB_2681826, HPA063486: AB_2685022"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.73e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-7)"	"unprognostic (1.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.54e-3)"	10.6	2.4	0.5	4.2	0.7	0.0	10.9	0.6	0.5	41.7	3.1	0.5	10.2	0.0	47.9	18.9	4.6	37.6	7.3	1.9	0.5	0.0	1.3	0.5	1.3	2.0	0.8	0.5	36.3	1.4	0.6	1.0	7.7	0.7	20.9	0.8	0.5	1.4	23.7	3.5	6.7	7.4	15.3	0.8	0.5	1.3	27.0	0.6	0.8	1.8	1.8	3.0	6.7	24.1	0.0	0.0	1.0	0.0	0.0	0.6	0.6	6.3	0.9	0.0	0.8	113.9	3.6	0.9	3.5	6.7	2.8	2.8	0.6	0.8	0.0	0.6	5.3	0.1	2.5	0.5	0.9	1.4	0.3	2.6	0.1	0.6	0.3	1.8	0.1	0.1	3.5	2.0	0.4	0.3	0.1	0.0	0.9	0.7	0.0	0.1	2.8	0.5	1.1	0.0	0.5	0.5	2.7	0.3	0.2	0.2	0.5	0.2	0.0	0.3	1.5	0.0	0.0	0.8	1.4	0.0	0.4	0.0	2.8	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.6	0.5	0.5	0.0	0.8	0.5	0.7	0.6	0.0	0.0	0.0	4.2	12.6	0.0	0.6	0.0	0.0	2.3	0.0	0.0	11.1	0.0	0.0	5.0	0.6	1.3	0.0	0.0	96.9	87.0	2.9	0.0	0.0	8.4	0.0	0.0	0.0	0.8	6.4	726.0	1.5	15.1	0.0	1.7	0.0	0.0	0.0	712.8	0.0	0.0	32.3	19.6	3.4	4.7	8.0	20.3	0.0	1.2	0.9
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteopetrosis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Melanocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		130000	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.3	21.9	9.0	18.1	13.5	5.5	16.7	13.7	17.2	14.4	17.8	12.8	9.9	8.4	21.8	10.3	14.1	15.0	13.5	23.2	10.4	16.5	22.0	15.9	17.0	17.2	11.0	10.5	15.6	9.7	11.8	26.0	24.7	20.0	15.4	12.4	29.7	10.8	19.0	18.0	10.4	12.9	24.7	13.1	21.7	14.3	11.1	10.7	13.6	12.4	8.1	13.9	21.0	19.4	10.8	12.4	20.9	28.1	14.5	16.4	16.9	2.1	6.4	7.6	11.1	23.0	7.5	10.9	16.0	16.1	11.7	19.5	3.8	3.6	5.0	13.2	11.1	31.6	4.1	7.5	5.4	18.1	11.5	5.9	10.6	4.1	4.7	17.8	11.6	24.7	10.9	13.6	14.4	11.5	10.8	5.9	5.7	8.3	18.5	18.9	3.0	2.5	2.6	3.0	2.6	4.9	4.1	11.1	2.7	8.4	5.8	0.8	4.5	12.9	3.3	28.5	10.6	3.7	16.9	7.2	10.3	3.8	22.7	22.6	7.1	12.1	4.4	30.4	7.9	22.6	16.8	13.9	15.2	15.0	19.9	16.0	10.8	12.8	16.4	12.4	6.2	12.0	15.0	20.9	14.5	28.1	8.9	15.4	16.9	9.0	13.5	13.7	17.2	10.4	16.5	11.0	10.5	20.0	10.7	8.9	21.3	25.4	14.7	41.4	29.2	18.5	12.7	5.3	6.8	12.2	9.8	18.7	1.7	10.8	3.4	18.0	10.3	0.0	19.8	29.3	16.9	16.3	24.2	12.4	46.3	27.0	4.1	28.8	46.6	2.7	13.3	33.0	143.4	10.8	4.2	24.0	15.6	12.9	26.9	21.0	15.7	25.8	33.9	19.8	19.5	27.1	51.1	27.7	2.9	14.0
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380879	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0"	"Cell type enhanced"	"Detected in some"	24	"Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	4	"amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 5.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.4	0.2	3.5	0.2	4.3	0.1	0.4	0.2	5.8	0.4	2.7	0.0	0.0	0.2	0.5	3.1	0.5	0.5	0.4	9.8	1.0	0.4	13.3	0.1	0.3	0.5	0.5	3.6	0.2	0.7	0.2	21.0	1.4	0.3	0.5	0.3	1.4	0.3	0.5	1.0	0.3	0.6	0.6	0.3	0.4	0.4	0.8	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.5	3.9	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.4	0.5	2.5	0.0	0.2	0.9	0.0	0.1	7.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	0.2	5.8	1.0	0.4	0.5	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74924275-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 20.4;testis: 5.1"	"Cell type enriched"	"Detected in some"	48	"Paneth cells: 508.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.4"	"Cell line enriched"	"Detected in single"	47	"HDLM-2: 15.2"	"Region enriched"	"Detected in single"	13	"olfactory region: 15.6"	"Low region specificity"	"Detected in all"			"HPA024524, HPA053090"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.1	0.0	0.1	2.9	0.1	0.0	0.1	0.1	0.1	0.1	20.4	0.1	0.1	0.2	0.5	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.9	0.1	0.1	0.1	0.1	0.2	11.3	0.2	0.1	0.1	0.0	5.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	508.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.0
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		630000	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	19.8	24.7	41.9	24.1	61.6	32.6	20.8	41.8	101.9	24.3	25.0	31.9	22.3	24.7	21.9	23.6	37.8	34.5	21.6	31.6	46.9	37.8	27.2	27.6	23.0	31.9	33.1	45.4	23.4	23.0	26.0	21.6	30.7	60.4	23.8	24.1	24.2	30.4	27.7	26.7	36.9	26.0	23.1	26.7	25.7	23.9	22.1	21.2	27.8	29.9	24.5	32.8	27.1	22.9	46.0	60.8	56.1	71.3	44.8	64.5	78.2	30.7	55.7	30.7	27.2	20.8	23.0	23.7	18.6	27.6	41.4	30.6	37.4	29.5	16.4	35.3	29.8	36.0	38.6	39.7	46.3	25.7	19.0	30.7	27.4	33.5	47.3	29.2	27.1	30.0	24.4	30.1	31.6	20.2	21.5	39.0	15.3	19.1	18.6	27.7	63.4	29.6	35.9	36.1	26.1	26.5	24.3	12.0	28.1	43.0	45.1	23.3	33.6	21.0	32.3	33.9	22.0	50.1	24.0	28.1	22.1	21.5	29.5	24.4	22.0	13.8	23.6	28.6	17.7	21.1	55.1	56.3	54.3	53.1	71.3	41.4	46.0	49.1	48.6	60.8	41.9	38.4	42.6	56.1	44.8	60.9	42.1	64.5	78.2	41.9	61.6	41.8	101.9	46.9	37.8	33.1	45.4	60.4	21.2	17.9	66.5	50.3	60.6	42.8	41.6	27.7	35.7	62.9	52.4	43.6	37.3	125.6	63.0	73.0	63.0	39.3	99.3	23.3	74.8	89.9	46.6	44.0	46.3	28.0	78.9	28.6	84.2	34.4	55.6	67.0	31.7	66.2	49.0	114.6	62.4	40.9	72.8	56.1	24.1	69.5	48.4	25.8	45.3	45.7	63.7	45.9	162.9	67.3	48.9	63.9
OTUD1	"DUBA7, OTDC1"	ENSG00000165312	"OTU deubiquitinase 1"	Q5VV17	10	23439458-23442390	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.8;tongue: 61.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.3;HaCaT: 23.8;SiHa: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038503, HPA038504"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA038503: AB_2676049, HPA038504: AB_10672712"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.61e-7)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-2)"	11.6	9.2	5.9	8.5	6.9	39.3	14.7	9.7	9.5	13.8	8.8	9.3	6.9	4.9	9.8	10.0	8.2	9.0	9.9	25.9	6.0	5.9	14.7	7.3	26.6	11.0	6.2	6.7	10.9	6.5	12.8	7.8	11.5	5.4	8.0	5.8	9.8	6.4	6.2	60.8	17.5	7.9	7.3	6.5	13.1	16.9	9.9	5.8	8.1	14.9	61.1	12.3	12.7	10.5	3.5	1.0	5.1	4.0	0.2	3.5	0.5	3.0	1.5	1.6	0.7	6.4	3.2	2.1	1.2	2.7	3.0	2.7	0.6	25.3	1.4	2.7	1.6	1.0	23.8	1.7	3.0	2.0	10.7	4.6	0.0	3.7	0.9	5.6	0.2	2.1	3.3	13.2	0.9	4.2	2.6	1.0	1.5	0.3	10.1	1.6	1.5	0.9	0.9	1.2	1.7	0.8	1.5	7.3	1.4	3.9	2.6	0.7	1.7	15.4	2.7	7.0	4.4	1.1	2.2	1.8	1.7	2.4	4.6	0.5	5.0	9.2	0.7	2.6	1.0	0.7	5.1	1.6	2.6	0.8	1.7	1.0	1.9	1.5	0.8	1.0	3.5	1.2	1.7	3.6	0.2	4.0	0.6	3.5	0.5	5.9	6.9	9.7	9.5	6.0	5.9	6.2	6.7	5.4	5.8	62.5	14.4	35.3	7.1	28.4	17.9	124.4	10.2	8.1	4.5	5.2	2.0	2.2	10.0	5.5	7.1	15.7	28.0	0.0	6.1	2.7	16.0	9.2	5.7	7.2	41.9	50.9	5.8	16.5	44.2	4.7	6.1	61.4	32.1	1.8	19.7	27.9	10.6	14.4	12.4	18.8	24.4	6.5	18.9	6.7	2.8	26.7	6.6	10.1	12.6	5.9
OTUD3	"DUBA4, KIAA0459"	ENSG00000169914	"OTU deubiquitinase 3"	Q5T2D3	1	19882513-19912945	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028543, HPA028544"	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA028543: AB_10599302, HPA028544: AB_10602277"	"unprognostic (6.45e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.15e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-2)"	6.5	11.0	15.0	6.9	19.2	11.4	10.0	19.3	23.2	10.6	8.9	6.6	6.4	10.2	14.2	13.0	6.1	8.2	7.2	5.2	12.6	7.3	7.1	4.8	8.5	7.0	9.9	12.5	11.2	7.2	9.3	20.2	5.4	9.0	9.8	8.3	6.9	6.2	9.2	9.2	13.0	9.6	11.9	8.1	7.7	7.3	28.4	9.7	6.0	6.9	2.9	6.3	7.0	7.6	1.7	0.6	0.8	0.4	0.6	2.2	0.3	5.1	1.9	8.7	10.4	3.8	3.3	8.6	5.5	3.2	2.8	2.8	9.1	4.9	8.1	4.5	12.1	2.0	5.0	8.1	3.2	5.5	5.3	10.8	7.8	10.4	6.3	2.1	5.7	7.2	2.7	3.2	4.4	5.7	6.0	3.7	8.3	5.5	3.5	4.8	2.8	4.3	5.7	4.1	4.1	5.1	10.1	22.3	3.0	4.7	5.6	7.7	5.5	3.9	3.2	4.2	8.9	4.8	4.2	4.5	6.8	8.7	7.5	4.7	4.0	3.4	5.0	4.8	7.6	3.1	0.8	0.4	0.1	1.5	0.3	1.4	1.7	1.7	1.4	0.3	1.3	2.2	1.8	0.7	0.6	0.1	0.6	0.9	0.3	15.0	19.2	19.3	23.2	12.6	7.3	9.9	12.5	9.0	9.7	14.9	6.9	3.0	5.2	12.6	13.5	3.6	0.0	10.7	1.2	8.7	15.7	2.3	0.0	4.5	9.9	4.5	3.8	0.0	4.0	4.7	4.2	8.8	1.1	2.1	1.6	25.4	11.5	9.2	1.6	11.5	5.2	3.3	5.0	2.8	6.7	10.2	3.9	5.9	5.6	3.4	16.0	6.5	3.5	19.1	21.2	7.8	2.1	4.4	5.9	3.0
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922028-48958386	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"U-266/70: 187.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	23.5	27.5	32.4	26.8	40.9	38.4	21.9	35.0	52.4	21.3	22.9	28.2	23.4	30.5	25.5	26.8	20.5	25.1	20.9	16.6	29.8	31.3	22.6	24.5	25.2	30.8	25.4	29.8	30.0	25.4	29.6	26.8	23.1	29.4	24.0	17.8	20.4	26.9	27.4	24.4	24.5	29.1	27.1	21.4	34.5	22.3	12.7	24.0	34.8	24.5	14.4	27.2	22.1	22.7	7.8	6.3	8.6	5.1	18.6	7.5	3.5	6.2	9.5	4.4	11.0	7.5	6.8	5.2	5.5	6.5	7.0	7.6	4.7	7.0	7.0	3.6	6.9	6.1	7.7	6.7	5.6	6.5	8.2	8.1	5.3	9.6	5.4	6.4	5.0	5.9	7.5	5.2	7.2	4.9	7.7	5.5	5.8	6.7	11.1	4.9	6.3	7.9	10.9	8.0	2.3	7.5	6.3	6.5	9.1	4.9	5.6	4.3	7.6	7.3	4.7	7.3	10.8	6.3	4.6	7.8	4.6	5.8	12.0	4.5	187.1	46.7	6.7	7.0	7.1	3.1	5.2	3.4	7.0	7.0	5.1	5.8	7.8	5.5	6.0	4.8	6.0	5.2	7.5	8.6	18.6	4.7	6.3	7.0	3.5	32.4	40.9	35.0	52.4	29.8	31.3	25.4	29.8	29.4	24.0	8.9	21.1	23.0	19.4	19.7	31.7	8.5	10.2	17.4	17.0	26.2	25.5	11.3	8.3	13.0	1.5	18.5	26.4	0.0	15.9	12.0	16.5	23.0	6.9	22.9	14.5	27.0	46.2	18.4	24.7	1.5	19.2	19.5	25.3	21.6	26.6	16.0	17.8	15.8	22.3	20.3	25.0	12.9	13.3	5.9	10.9	22.3	25.7	30.9	17.4	22.8
OTUD6A	"DUBA2, FLJ25831, HSHIN6"	ENSG00000189401	"OTU deubiquitinase 6A"	Q7L8S5	X	70062491-70064179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 3.8;testis: 13.6"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 20.9;Spermatogonia: 6.6"	"Cancer enriched"	"Detected in single"	57	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.0;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053304	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA053304: AB_2682107"															"unprognostic (1.58e-1)"			0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	13.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.4	3.8	0.4	0.7	0.6	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.4	1.0	0.5	0.0	0.7	0.8	0.4	0.3	0.2	0.0	0.0	0.5	0.8	0.8	0.0	0.3	0.7	0.3	0.4	0.2	0.3	0.2	0.0	1.1	0.2	0.6	0.0	2.0	0.3	0.9	0.6	0.0	0.2	0.0	0.0	0.0	0.8	0.7	0.6	0.3	0.5	0.2	0.0	0.5	0.1	0.1	0.0	0.2	1.9	0.3	0.5	1.6	0.3	1.5	0.1	0.2	0.2	3.8	0.4	0.3	0.4	0.2	0.4	0.3	0.3	0.2	0.0	0.9	0.3	0.6	2.6	0.7	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.4	0.3	1.1	0.0	0.1	0.0	0.0	0.0	1.2	0.7	0.3	0.5	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	1.9	0.0	0.0	20.9	6.6	0.5	0.2	0.0	0.0	0.3
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU domain containing 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	11.4	11.3	14.6	14.1	18.2	8.9	13.2	13.8	19.6	12.3	11.3	9.9	10.3	9.2	12.1	9.0	13.2	9.1	8.6	14.0	14.9	13.7	11.0	10.5	10.0	13.8	18.5	15.5	12.5	9.9	11.2	14.4	14.9	16.2	11.6	11.3	6.0	9.5	14.8	35.3	11.2	9.1	12.4	19.9	11.3	8.8	11.9	17.4	13.9	11.8	11.0	11.9	11.9	14.0	7.2	12.9	8.8	7.8	7.8	6.8	2.9	16.3	9.4	8.5	6.3	3.8	2.9	8.8	13.0	4.9	12.1	7.9	8.1	10.3	17.3	6.3	6.8	4.9	5.6	17.5	10.6	18.8	13.9	10.7	23.6	9.8	6.1	8.2	12.0	12.5	4.8	5.1	9.7	23.1	7.2	9.8	13.7	23.6	10.9	10.3	8.9	20.1	7.9	4.5	12.5	18.7	9.1	8.1	15.5	9.4	11.8	2.0	7.6	1.2	28.8	12.5	11.5	14.7	5.8	10.0	7.2	10.9	11.0	12.3	10.9	20.7	25.5	10.6	15.1	13.8	8.8	6.5	4.3	5.9	7.8	6.8	7.2	4.8	5.7	8.1	6.8	6.7	5.9	0.9	7.8	5.8	12.9	3.6	2.9	14.6	18.2	13.8	19.6	14.9	13.7	18.5	15.5	16.2	17.4	8.9	9.9	12.4	5.2	20.6	13.1	14.0	10.2	9.4	13.6	1.8	31.4	9.3	8.3	4.7	0.4	7.5	3.1	0.0	4.3	8.3	5.1	4.0	18.4	9.2	7.0	11.1	10.4	9.2	7.5	0.9	8.9	9.4	3.3	8.2	4.2	13.4	5.3	4.2	3.9	6.2	16.7	0.0	7.2	1.9	6.6	15.8	5.6	7.9	5.6	4.7
OTUD7A	"C15orf16, CEZANNE2, OTUD7"	ENSG00000169918	"OTU deubiquitinase 7A"	Q8TE49	15	31475398-31870789	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 20.5;Horizontal cells: 23.8;Spermatogonia: 6.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA044554: AB_10794895"	"unprognostic (3.61e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-11)"	"unprognostic (6.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.79e-1)"	2.6	2.0	12.4	1.7	13.9	5.9	1.5	13.2	17.0	1.8	3.4	16.0	0.0	1.5	1.9	1.9	1.9	2.0	2.3	2.1	10.0	4.6	2.3	1.0	1.5	3.5	20.4	7.1	2.0	2.5	4.6	1.7	0.9	10.5	1.2	3.1	0.7	1.6	2.0	1.8	3.2	2.1	2.9	9.1	2.2	2.3	8.2	17.4	0.0	2.3	0.0	2.4	1.9	1.3	0.1	3.2	0.3	1.4	0.1	0.7	0.4	3.7	4.1	4.5	6.1	0.4	1.3	3.2	2.5	1.3	3.9	2.0	2.5	3.2	2.9	2.2	0.9	2.2	4.6	4.9	2.1	3.2	5.9	6.6	3.7	8.3	2.0	0.3	4.1	5.8	0.0	0.2	3.9	4.3	1.1	3.5	6.4	6.0	5.5	1.8	2.9	3.1	3.9	2.1	4.8	2.0	5.7	3.1	1.4	1.6	3.9	11.0	6.0	3.4	3.0	1.0	2.3	2.5	4.3	2.3	5.4	5.3	3.0	6.3	3.4	2.4	3.0	2.9	5.8	4.5	0.0	0.4	0.3	0.6	0.5	0.3	0.0	0.3	0.7	0.2	0.1	0.2	0.2	0.0	0.1	1.4	3.2	0.0	0.4	12.4	13.9	13.2	13.8	10.0	4.6	20.4	7.1	10.5	17.4	3.0	0.0	0.0	0.6	0.3	20.5	2.2	0.0	0.0	1.2	1.8	2.0	0.0	0.0	0.4	1.0	1.0	0.9	0.0	0.8	0.0	0.7	1.3	0.0	0.8	0.2	23.8	3.5	1.3	0.0	1.1	0.9	0.0	1.7	0.0	1.0	3.7	0.4	0.0	2.5	1.2	2.9	0.0	1.0	4.1	6.1	0.4	0.1	0.0	1.0	0.8
OTULIN	"FAM105B, FLJ34884"	ENSG00000154124	"OTU deubiquitinase with linear linkage specificity"	Q96BN8	5	14664664-14699711	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051074	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			Mitochondria	"Plasma membrane"	"HPA051074: AB_2681334"	"unprognostic (4.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.02e-2)"	10.0	7.4	5.9	22.6	7.8	32.3	8.4	7.2	6.6	8.2	9.3	8.3	8.9	10.7	9.5	7.7	13.8	6.1	10.8	15.5	6.7	4.9	8.5	19.5	11.1	16.0	9.6	2.8	9.1	12.2	7.5	9.8	11.8	7.0	11.1	7.0	7.7	10.6	10.8	16.5	18.1	11.7	8.1	10.5	12.5	7.1	11.5	7.4	15.0	7.8	9.7	19.3	8.5	15.8	3.4	2.9	3.1	3.0	1.0	4.6	0.9	6.4	7.5	7.5	8.5	7.0	7.3	8.3	6.5	4.6	9.3	7.0	10.1	4.8	11.6	12.8	4.2	13.4	7.4	9.3	8.5	6.4	20.0	7.7	8.3	23.9	5.4	6.0	7.9	14.3	4.1	10.5	7.6	6.5	5.1	7.8	9.8	8.2	18.6	6.6	4.0	7.8	6.9	4.6	6.8	8.0	12.1	6.8	4.6	6.0	6.7	3.4	5.6	23.1	5.2	5.0	9.6	5.7	9.1	7.2	12.1	13.7	9.0	8.5	8.4	12.7	13.2	6.9	15.1	6.2	0.4	2.0	3.1	1.0	2.2	3.0	0.9	2.5	3.4	2.9	3.4	1.8	3.9	2.2	1.0	3.0	2.5	4.6	0.9	5.9	7.8	7.2	6.6	6.7	4.9	9.6	2.8	7.0	7.4	3.0	8.6	13.4	20.2	0.0	10.9	13.4	15.3	9.4	7.9	5.2	13.7	13.2	6.6	4.2	7.3	8.7	13.9	0.0	5.0	8.6	4.9	19.7	10.3	32.7	12.3	7.9	9.1	8.0	11.8	2.5	9.8	10.6	0.0	13.6	11.6	13.0	7.1	8.4	6.0	8.9	32.3	0.0	6.2	23.8	30.4	0.0	11.9	15.0	8.9	19.3
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414314-111427777	"Plasma proteins, Predicted intracellular proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 240.9"	"Cell type enhanced"	"Detected in many"	11	"Syncytiotrophoblasts: 14.5"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 7.2;OE19: 9.2;SK-BR-3: 7.4"	"Region enhanced"	"Detected in some"		"cerebellum: 6.6"	"Not detected"	"Not detected"			"HPA031666, HPA062205"	Enhanced		Approved	Vesicles,Microtubules	"Intracellular and membrane"	NA	NA			"Vesicles, Microtubules"		"HPA031666: , HPA062205: AB_2684710"	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favorable (3.93e-5)"	0.4	0.1	0.4	0.4	0.9	0.2	0.4	1.9	1.0	0.7	0.4	0.4	0.4	0.2	9.7	7.1	0.4	240.9	0.4	0.4	0.5	0.5	0.5	1.0	0.4	0.4	0.4	0.4	32.5	0.4	1.5	0.4	0.4	0.4	0.7	0.3	0.4	0.4	0.4	0.4	1.1	0.6	0.4	0.4	0.5	0.2	1.3	0.4	0.6	0.4	0.4	0.4	0.5	0.4	0.8	0.9	0.0	0.5	0.0	1.6	0.2	0.7	0.5	1.4	0.7	2.8	3.1	2.5	0.3	2.0	0.5	1.1	0.8	0.0	1.2	2.6	0.9	0.0	0.8	0.4	0.4	0.8	2.9	7.2	0.4	1.0	3.4	1.0	1.2	3.3	2.8	4.4	0.1	1.6	2.1	0.6	4.9	0.4	2.3	0.2	0.8	0.9	1.7	0.3	9.2	2.6	0.9	0.3	1.0	2.1	5.3	0.9	0.9	0.2	7.4	1.0	3.8	0.5	1.2	1.2	0.3	0.3	3.7	1.0	2.8	0.8	0.6	0.3	2.3	0.3	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.5	0.0	0.9	0.8	1.6	1.2	0.0	0.0	0.5	0.0	0.1	0.2	0.4	0.9	1.9	1.0	0.5	0.5	0.4	0.4	0.4	0.4	0.0	1.4	0.0	1.0	2.7	1.7	0.4	0.0	0.0	0.0	0.0	0.0	5.0	1.7	0.3	2.4	1.5	0.7	0.0	0.0	2.1	0.6	1.2	0.0	3.0	0.5	0.0	0.0	1.3	0.3	4.9	1.4	0.3	0.0	0.0	0.9	0.3	0.1	0.0	1.8	1.7	0.7	0.0	0.9	4.1	0.7	2.8	14.5	0.0	1.7	1.4
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787022-65797219	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.6;tongue: 37.4"	"Cell type enhanced"	"Detected in many"	16	"Syncytiotrophoblasts: 291.8;Urothelial cells: 75.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 10.1;BEWO: 29.1;CACO-2: 7.3;HaCaT: 17.2;RT4: 16.9;SK-BR-3: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003984	Uncertain		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.2	0.1	0.2	3.3	0.3	0.0	2.2	0.4	0.2	7.2	11.5	0.0	3.0	9.6	0.4	0.7	42.6	0.3	4.2	0.1	0.2	0.2	4.7	0.2	1.7	0.0	0.2	0.0	0.1	5.6	5.0	0.2	14.4	0.0	2.3	5.1	1.1	13.9	6.1	0.5	24.1	14.2	0.8	0.2	0.2	0.8	17.3	0.0	0.6	1.8	37.4	25.3	8.3	9.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	7.3	2.7	0.0	0.1	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.8	16.9	0.1	0.0	0.0	13.4	0.1	3.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	3.5	0.0	33.3	23.7	0.0	0.4	10.2	8.1	2.3	3.5	0.0	20.8	0.0	2.2	61.4	0.4	47.4	0.0	3.4	12.0	1.1	21.2	2.3	0.0	1.8	0.0	30.3	0.0	0.0	65.1	1.1	1.3	0.0	0.0	49.6	0.0	3.6	38.6	1.8	4.2	0.0	0.0	0.4	13.7	5.4	50.2	291.8	0.0	42.1	75.8
OVOL2	"bA504H3.3, CHED, CHED1, HOVO2, ZNF339"	ENSG00000125850	"Ovo like zinc finger 2"	Q9BRP0	20	17956979-18059188	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.3;CACO-2: 4.9;CAPAN-2: 8.4;HaCaT: 6.3;OE19: 11.6;SCLC-21H: 9.8;SK-BR-3: 6.5"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 10.5;hippocampal formation: 6.8"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 7.6;hippocampal formation: 5.8"	HPA038531	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038531: AB_10673012"	"unprognostic (2.85e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-4)"	"unprognostic (4.77e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.76e-2)"	0.0	0.0	0.0	3.4	0.0	0.0	3.7	0.0	0.6	3.0	9.8	0.0	18.2	5.0	1.0	3.3	7.6	1.6	8.9	0.0	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.6	8.7	1.0	1.8	2.5	0.0	7.0	2.6	0.0	10.5	14.2	0.1	7.6	8.7	0.5	0.0	0.0	14.7	1.5	0.0	0.3	18.1	5.0	4.4	2.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	4.9	8.4	0.0	1.2	0.0	0.4	6.3	1.5	1.6	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	11.6	0.1	0.0	0.0	2.4	0.1	3.1	9.8	0.0	0.0	6.5	0.1	0.1	3.3	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	6.0	6.7	0.0	9.2	7.3	0.0	0.6	10.2	1.4	7.9	1.8	0.0	1.6	0.0	6.7	14.4	0.0	12.7	0.0	9.7	2.5	0.1	8.2	0.0	0.0	0.1	1.6	3.5	0.0	0.0	3.2	0.3	0.0	0.0	0.0	13.4	0.5	11.5	10.2	0.4	1.2	0.0	0.0	0.1	3.9	0.2	8.5	0.1	0.0	9.7	9.7
OXLD1	"C17orf90, MGC104712"	ENSG00000204237	"Oxidoreductase like domain containing 1"	Q5BKU9	17	81665036-81666635	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 29.7"					"Low region specificity"	"Detected in all"			"HPA056878, HPA057019"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA056878: AB_2683265, HPA057019: AB_2683310"	"unprognostic (1.08e-1)"	"prognostic favorable (2.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-2)"	13.7	12.2	11.0	10.1	11.5	16.0	8.4	6.0	15.1	6.4	12.4	7.0	16.0	14.0	6.5	11.8	10.3	8.7	9.2	11.4	10.2	8.5	9.2	11.9	7.7	9.9	9.6	6.5	4.2	19.6	2.7	4.6	8.2	8.0	8.2	1.9	9.4	27.7	10.8	17.3	12.9	10.3	4.7	7.1	15.1	11.2	18.5	7.1	11.6	10.2	7.2	11.4	7.8	5.6	22.8	23.7	13.3	18.5	25.1	27.9	18.7	8.0	29.7	0.3	7.0	1.9	0.5	5.2	3.2	0.1	0.1	1.1	7.9	7.9	2.4	6.5	0.0	4.3	7.1	0.0	4.6	0.0	4.0	14.6	2.3	13.7	19.2	12.7	1.5	6.1	3.1	3.9	1.7	1.8	0.4	2.9	11.4	3.8	4.2	0.6	19.5	5.8	6.1	3.9	4.1	12.8	4.9	0.2	10.4	1.5	4.4	1.5	6.5	1.6	10.6	14.7	0.1	16.0	9.2	2.1	6.0	4.2	6.6	4.6	10.6	3.7	3.3	8.3	6.2	6.2	12.9	18.5	13.3	19.1	15.1	20.0	19.7	25.9	22.2	17.2	22.8	27.9	21.5	13.1	25.1	15.6	23.7	21.8	18.7	11.0	11.5	6.0	15.1	10.2	8.5	9.6	6.5	8.0	7.1	29.8	17.9	22.7	17.7	7.6	18.5	15.6	35.7	26.8	6.8	22.7	5.9	32.3	61.3	31.9	57.7	14.5	42.4	23.3	41.5	25.7	13.5	32.7	13.9	43.3	38.3	22.3	20.8	20.9	33.7	24.3	30.8	16.8	15.1	37.9	30.8	30.3	38.4	28.8	22.3	52.3	25.8	25.8	12.5	76.4	20.2	7.4	23.3	23.8	30.0	22.2
OXNAD1	MGC15763	ENSG00000154814	"Oxidoreductase NAD binding domain containing 1"	Q96HP4	3	16265160-16350299	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"T-cells: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 33.0"	"Lineage enriched"	"Detected in all"	5	"T-cells: 33.0"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036830, HPA059160"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA036830: AB_2675338, HPA059160: AB_2683936"	"unprognostic (4.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.38e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (1.00e-7)"	"unprognostic (2.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-3)"	"prognostic favorable (7.63e-4)"	8.1	8.8	7.5	14.1	11.1	10.9	8.1	9.1	13.6	5.4	11.4	9.1	7.3	16.3	7.7	4.3	10.8	6.2	7.1	12.0	7.1	5.9	15.5	22.4	6.6	20.7	10.9	7.9	6.9	7.4	6.5	12.4	5.2	9.5	5.4	10.2	6.8	9.4	9.3	18.1	8.2	18.4	4.2	8.9	9.2	9.4	9.3	12.1	8.2	8.0	7.0	16.0	7.8	6.6	1.9	2.2	1.3	2.0	6.4	33.0	7.5	5.6	8.2	5.4	8.5	6.4	5.7	21.1	6.1	4.5	8.4	6.8	11.8	5.7	8.0	3.8	3.8	4.6	4.1	11.1	9.9	8.0	14.6	7.3	11.8	7.0	6.3	6.6	19.0	7.2	4.2	7.4	13.6	6.6	2.6	6.5	8.3	16.1	19.3	3.6	10.0	11.0	10.0	11.5	8.4	9.7	9.9	6.6	14.1	5.7	6.8	3.8	5.4	6.8	11.5	9.4	6.1	7.3	11.0	2.9	5.5	7.0	6.0	9.8	7.0	12.6	13.0	6.5	16.6	7.3	0.0	1.4	1.1	9.0	2.0	11.9	1.9	13.8	9.7	2.2	1.5	33.0	24.4	1.3	6.4	1.8	1.7	7.3	7.5	7.5	11.1	9.1	13.6	7.1	5.9	10.9	7.9	9.5	12.1	0.0	10.4	12.0	4.7	2.2	5.7	12.3	5.1	9.4	3.4	7.0	5.9	9.1	26.6	7.6	32.8	3.5	9.2	0.0	5.5	6.7	4.7	4.5	19.7	18.3	7.5	3.2	2.9	3.7	3.3	24.8	2.8	3.8	5.0	10.8	6.9	5.0	6.3	2.9	1.8	12.6	11.0	6.5	3.4	6.6	10.0	3.0	4.2	39.9	10.3	4.8
OXR1	TLDC3	ENSG00000164830	"Oxidation resistance 1"	Q8N573	8	106359476-106752694	"Predicted intracellular proteins"	"Stress response"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 193.0;Late spermatids: 328.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027375, HPA027380, HPA027395"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA027375: AB_10600087, HPA027380: AB_10601569, HPA027395: AB_10601554"	"unprognostic (8.16e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (6.59e-2)"	"prognostic favorable (5.82e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-1)"	18.3	34.2	20.5	14.1	14.6	9.3	16.8	31.2	50.2	19.0	13.9	7.3	34.8	7.9	16.2	33.4	22.0	13.0	12.6	21.4	23.6	23.0	17.9	21.4	15.0	11.4	22.6	18.8	15.9	10.0	15.0	45.7	9.9	25.9	17.5	12.6	7.2	25.3	30.3	26.4	16.1	10.4	12.7	22.8	15.3	15.2	29.1	14.6	15.5	15.2	17.3	10.5	24.1	21.2	8.7	8.1	20.8	13.3	7.8	12.6	5.5	12.3	4.7	14.0	2.8	20.6	24.9	6.5	10.2	12.0	9.5	12.3	4.1	14.9	12.2	11.8	10.8	5.8	8.8	7.7	8.8	16.1	10.5	8.8	16.8	6.8	7.6	11.1	5.1	9.8	13.8	13.6	10.2	15.3	13.3	10.3	10.4	8.4	46.1	10.6	11.0	15.2	7.2	1.8	17.7	8.4	4.2	11.3	22.8	10.7	15.6	8.4	2.6	4.5	3.1	10.6	6.3	14.8	8.8	7.9	10.7	7.6	9.6	6.4	8.7	5.5	5.2	12.7	1.6	13.0	20.8	6.5	12.4	3.0	12.4	5.0	8.7	5.2	4.7	8.1	5.8	12.6	5.5	3.4	7.8	13.3	5.8	3.7	5.5	20.5	14.6	31.2	50.2	23.6	23.0	22.6	18.8	25.9	14.6	62.5	21.0	29.0	51.7	60.0	77.0	51.5	17.8	56.2	31.8	33.2	55.0	25.1	28.2	13.9	193.0	42.2	23.1	0.0	14.9	16.8	31.9	52.5	30.0	30.4	16.9	25.4	26.4	41.7	33.5	328.3	31.7	33.5	23.6	13.6	28.7	52.4	19.1	31.7	46.0	9.1	123.6	19.4	39.2	143.6	50.3	66.0	59.5	20.8	23.6	78.5
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.4"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 7.4;Ciliated cells: 4.0;Intestinal endocrine cells: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.4;LHCN-M2: 7.7;RH-30: 4.8;U-87 MG: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA028776: AB_2672771, HPA028777: AB_2672772"	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.2	1.6	0.0	0.2	0.2	0.0	0.0	0.9	3.2	0.0	0.0			0.0	0.1	0.0	0.1	0.3	1.1	1.9	0.2	0.8	0.1	0.0	0.2	0.0	0.6		0.3	0.0	0.0	1.6	1.1		0.2	0.0		0.1	1.1	12.4	0.0	0.0	0.0	0.8	2.3	0.1	1.2			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.8	0.3	0.1	0.0	1.0	0.1	1.9	0.8	1.4	0.0	0.0	0.0	1.3	0.5	3.4	1.6	0.0	0.1	0.1	0.3	0.0	2.1	0.8	0.0	3.3	0.0	2.8	0.4	0.0	1.4	0.1	11.4	0.0	0.0	2.3	0.7	7.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.8	0.2	0.0	0.0	0.2	3.6	1.4	0.1	0.6	0.2	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.2	0.0	0.0	13.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0											0.0	1.1	0.0	0.8	0.1	7.4	2.4	0.0	4.0	0.0	1.8	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	2.3	0.0	0.1	1.6	3.4	2.5	0.0	1.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.4	0.0	0.6	0.0	0.0	1.4	0.4	0.1	0.3	0.0	0.0	0.0
P3H1	"GROS1, LEPRE1, LEPRECAN, MGC117314"	ENSG00000117385	"Prolyl 3-hydroxylase 1"	Q32P28	1	42746335-42767084	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 37.3;Extravillous trophoblasts: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 50.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA012113, HPA016980"	Approved		Approved	Nucleoli,Vesicles	"Intracellular and membrane"	NA	NA		13000	Vesicles	Nucleoli	"HPA012113: AB_2668626, HPA016980: AB_2669498"	"unprognostic (3.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.95e-7)"	"unprognostic (5.41e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.60e-3)"	11.9	11.2	7.1	8.6	6.3	5.2	9.7	6.4	5.3	14.0	7.1	6.0	7.7	2.6	13.8	11.1	6.4	8.8	12.1	8.8	3.8	2.9	7.9	19.9	10.8	10.1	6.1	3.3	13.1	6.8	5.8	15.2	36.1	4.6	7.8	5.7	10.5	6.4	6.5	4.3	7.2	6.6	19.7	3.4	13.3	6.6	13.1	4.7	10.2	7.4	5.3	7.8	11.4	8.5	3.1	16.2	11.0	16.2	11.7	7.9	6.1	2.2	5.8	13.1	30.6	30.9	23.7	5.4	26.9	35.1	19.5	33.3	2.9	4.9	3.3	21.6	50.7	7.8	2.0	5.5	6.8	13.4	5.0	7.0	7.9	9.2	8.4	17.9	7.8	9.1	20.1	4.6	19.6	8.4	27.7	27.4	4.8	4.4	4.3	13.0	1.2	5.1	4.5	14.3	1.2	4.2	5.0	19.3	4.5	10.2	1.2	2.7	4.6	16.4	0.4	11.6	23.9	0.9	33.0	22.3	14.6	12.9	11.6	10.6	3.8	4.3	3.0	16.7	10.6	20.2	3.5	13.2	11.0	6.0	14.0	6.4	3.1	4.6	5.1	16.2	2.6	3.9	3.9	1.2	11.7	16.2	7.6	7.9	6.1	7.1	6.3	6.4	5.3	3.8	2.9	6.1	3.3	4.6	4.7	3.0	2.9	4.8	5.7	0.0	10.0	4.2	5.1	1.4	1.2	10.4	23.6	37.3	0.0	10.4	16.8	15.7	0.4	0.0	6.6	47.0	22.9	3.0	1.1	10.6	15.4	14.3	5.8	17.8	6.7	7.5	17.8	8.7	0.0	10.0	2.8	2.6	6.7	2.0	15.2	1.7	20.0	0.0	7.6	21.8	11.1	0.0	14.6	12.5	1.7	3.5
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.5"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7;Alveolar cells type 2: 62.9;Collecting duct cells: 41.8;Ito cells: 44.8;Muller glia cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 20.3"	"Lineage enriched"	"Detected in single"	104	"dendritic cells: 20.3"	"Cell line enhanced"	"Detected in many"		"GAMG: 38.1;HaCaT: 34.0;RPTEC TERT1: 34.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles, Cytosol"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	2.4	22.6	2.9	4.0	3.9	0.2	3.1	0.7	2.2	14.3	11.8	6.2	11.5	1.2	15.0	13.5	8.9	4.6	8.4	3.8	2.8	2.1	74.5	3.5	22.5	3.6	8.1	1.0	11.2	3.9	1.4	6.1	11.0	5.6	19.9	5.3	10.3	2.7	14.3	0.6	8.6	3.6	16.3	7.6	33.7	12.0	2.8	5.3	2.0	1.7	6.3	2.7	5.7	9.8	0.0	20.3	0.1	0.1	0.0	0.0	0.1	14.0	5.6	11.0	0.0	0.2	0.4	13.3	15.0	5.9	2.4	4.0	4.5	5.5	0.0	8.5	2.6	38.1	34.0	0.0	20.1	5.1	0.1	1.9	0.0	3.8	0.0	11.4	0.0	0.1	5.4	6.8	4.8	1.7	23.3	0.4	0.0	0.0	0.1	3.8	0.3	0.0	0.1	3.4	9.4	1.1	0.0	2.2	0.8	34.7	23.7	0.8	0.1	20.4	1.1	8.9	16.9	0.0	0.2	7.5	14.6	5.5	0.1	2.7	1.0	0.0	0.1	3.3	0.0	18.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.1	2.9	3.9	0.7	2.2	2.8	2.1	8.1	1.0	5.6	5.3	44.7	62.9	1.9	7.4	0.0	2.2	1.0	5.1	0.0	5.7	41.8	3.9	30.9	5.0	3.8	14.3	4.5	0.0	0.0	0.7	11.7	2.0	13.7	1.1	0.6	9.1	9.5	0.0	44.8	4.6	11.4	4.4	4.7	0.0	1.0	0.2	49.8	18.0	0.0	0.0	24.5	0.8	0.0	2.7	0.5	0.4	0.0	32.3	0.0	0.0	2.8
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828410-6839851	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;naive CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 17.6"	HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.7	3.1	1.2	2.2	2.6	0.3	3.0	10.7	2.5	12.1	2.7	0.0	7.6	1.1	11.0	8.5	2.5	2.1	5.6	4.4	1.2		1.1	0.4	1.6	1.9	0.0	2.2	9.3	3.6	12.1	7.4	2.5	0.8	5.6	0.5	8.1	5.9	6.5	0.5	1.8	1.7	8.8	0.5	1.0	2.8	2.1	0.1	0.0	3.5	1.2	1.4	5.9	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.8	4.2	7.9	4.9	6.0	0.1	22.1	12.7	7.0	7.7	0.3	0.0	0.0	0.3	8.3	0.2	0.0	2.5	0.2	1.6	0.0	10.6	0.5	2.3	1.0	3.4	0.5	0.0	6.5	0.2	3.4	1.9	15.7	7.4	0.7	2.0	0.0	3.3	0.0	0.0	0.2	15.7	0.0	0.6	0.0	3.9	0.1	0.3	0.0	1.6	6.0	0.0	0.0	2.4	2.1	0.1	0.1	12.9	6.9	10.3	10.6	15.3	0.0	0.1	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.9	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0											0.0	0.0	0.0	3.8	0.0	28.3	9.0	2.5	2.7	3.4	5.2	94.2	0.3	1.7	1.6	0.7	2.3	0.0	0.0	2.3	0.4	7.4	4.6	0.0	0.0	1.2	41.3	1.2	3.7	0.0	1.3	46.1	0.0	0.0	1.8	2.5	4.8	1.9	0.0	36.0	0.3	26.9	6.5	9.2	0.7	0.9	0.0	0.8	0.0	0.4	1.4
P3H4	"LEPREL4, NO55, SC65"	ENSG00000141696	"Prolyl 3-hydroxylase family member 4 (non-enzymatic)"	Q92791	17	41801947-41812604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 4.4;MAIT T-cell: 5.9;memory CD4 T-cell: 2.9;memory CD8 T-cell: 2.8;naive CD4 T-cell: 3.5;naive CD8 T-cell: 4.2;NK-cell: 9.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 9.5;T-cells: 5.9"	"Cell line enriched"	"Detected in many"	12	"OE19: 144.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA022520			Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA022520: "	"unprognostic (9.11e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.69e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (4.48e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.96e-3)"	5.0	13.6	5.4	6.0	5.0	0.5	12.7	7.8	6.2	11.5	8.9	2.9	17.9	8.6	11.9	10.4	5.3	8.3	11.2	9.7	4.3	5.0	7.9	2.7	6.4	6.7	5.5	6.0	12.2	34.5	11.5	11.8	12.8	4.4	10.0	4.3	7.3	10.9	9.5	3.9	7.7	7.6	10.5	3.7	4.4	5.4	3.5	5.9	0.9	20.9	4.5	4.4	7.6	7.1	0.8	0.3	0.0	0.2	9.5	5.9	1.5	1.2	6.6	4.0	10.4	4.3	4.2	3.9	9.7	4.9	3.8	5.2	3.2	1.8	0.2	4.1	8.4	2.9	2.2	3.4	4.7	1.3	2.6	5.4	1.6	6.4	4.3	5.3	0.3	0.5	4.4	1.3	3.3	2.9	8.9	4.7	0.4	0.2	1.6	2.3	4.4	0.0	0.8	2.5	144.7	3.6	3.3	4.4	4.3	2.3	0.3	2.0	4.1	1.8	11.8	4.0	2.6	6.8	1.1	4.9	3.7	5.4	6.7	4.8	1.5	0.3	0.0	5.6	1.5	5.6	0.0	0.2	0.0	4.4	0.0	5.9	0.6	2.9	2.8	0.3	0.8	3.5	4.2	0.0	9.5	0.0	0.0	0.7	1.5	5.4	5.0	7.8	6.2	4.3	5.0	5.5	6.0	4.4	5.9	0.0	8.5	0.0	4.7	0.0	3.4	8.3	7.6	1.4	3.4	5.2	7.9	8.8	6.6	19.2	0.4	6.0	9.1	23.3	5.8	23.2	10.0	7.7	1.1	2.4	2.5	25.4	2.4	12.3	0.6	0.4	19.5	1.0	0.0	1.0	13.6	11.6	8.0	10.5	19.4	4.8	2.5	19.4	3.4	2.5	8.3	0.0	4.5	2.9	11.8	1.8
PA2G4		ENSG00000170515	"Proliferation-associated 2G4"	Q9UQ80	12	56104319-56113907	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB011711, CAB012428, HPA016484"	Supported		Approved	Cytosol		NA	NA		1200000	Cytosol		"CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912"	"unprognostic (5.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.87e-1)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (6.31e-7)"	"unprognostic (4.25e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (4.59e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.67e-2)"	41.1	32.1	26.6	41.4	29.8	52.5	38.5	35.1	38.8	33.7	39.2	31.0	27.1	34.4	36.1	22.4	69.4	31.2	31.9	55.6	26.6	25.5	36.1	51.6	32.6	43.3	26.7	28.0	43.3	44.3	42.8	20.5	39.0	28.2	40.3	44.2	23.6	34.6	33.4	77.3	53.0	31.7	39.4	32.3	46.7	34.4	27.9	23.9	70.8	39.7	57.2	54.0	45.5	39.6	25.5	27.1	13.5	25.1	37.4	48.9	36.0	53.5	47.6	32.7	36.0	15.1	23.0	65.7	56.8	27.2	69.9	39.0	58.2	39.9	107.3	38.2	26.8	20.6	44.2	74.5	63.3	68.3	30.4	63.9	82.4	32.5	49.6	29.6	111.8	30.5	23.2	32.4	60.5	54.7	28.9	42.4	36.7	100.0	49.9	38.2	47.5	86.9	58.4	53.6	33.4	58.5	71.6	59.1	72.7	35.3	40.2	49.1	29.7	37.4	59.1	34.7	25.3	63.8	43.5	33.9	34.1	48.2	39.2	62.6	30.7	42.0	105.1	30.9	67.3	44.2	7.8	23.0	13.5	36.6	25.1	48.9	25.5	38.9	39.4	27.1	22.2	37.6	37.3	3.7	37.4	20.0	26.3	43.3	36.0	26.6	29.8	35.1	38.8	26.6	25.5	26.7	28.0	28.2	23.9	50.6	76.2	104.2	176.7	327.3	53.9	31.3	112.1	121.8	170.6	123.9	17.7	192.6	164.2	166.6	352.5	140.6	87.8	373.8	214.0	240.3	114.2	91.6	164.3	167.1	182.5	31.8	89.5	96.3	99.0	161.4	122.3	128.8	123.2	116.4	123.0	92.6	216.5	94.7	119.2	155.9	42.6	142.3	166.0	162.3	110.4	317.1	161.8	164.1	218.3	201.6
PAAF1	"FLJ11848, Rpn14, WDR71"	ENSG00000175575	"Proteasomal ATPase associated factor 1"	Q9BRP4	11	73876699-73931124	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039952, HPA040020"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039952: AB_10793925, HPA040020: AB_2676802"	"unprognostic (3.13e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.42e-1)"	9.5	12.8	32.4	6.9	30.6	5.2	12.3	18.0	23.2	11.7	8.7	34.4	7.6	7.8	11.5	17.2	10.0	13.9	8.0	9.9	30.5	27.4	16.0	13.8	7.9	7.6	37.4	19.6	17.8	19.8	16.8	10.1	7.7	25.4	14.5	11.5	12.9	9.9	14.5	11.9	12.8	7.8	12.1	38.9	7.1	6.8	18.8	27.0	8.2	13.0	2.1	11.1	7.9	6.3	22.6	19.3	22.1	15.1	16.5	22.6	15.1	5.6	13.1	11.9	9.3	13.0	13.4	6.8	9.7	11.3	15.6	11.1	25.6	4.5	17.1	15.2	9.9	14.5	13.0	14.5	11.7	23.2	12.7	9.0	17.4	12.9	21.0	15.6	16.2	6.7	13.7	18.4	17.0	20.9	12.6	11.7	13.8	21.0	14.7	14.4	11.0	14.3	16.9	5.5	30.0	10.3	13.3	31.9	27.9	11.5	9.8	12.7	14.9	11.5	7.7	30.0	11.7	23.1	9.2	8.4	11.0	7.0	15.5	9.4	18.2	20.4	34.8	7.7	10.6	11.5	22.1	15.1	17.4	16.0	9.5	17.5	22.6	17.5	16.2	19.3	18.8	22.6	19.4	1.3	16.5	3.4	14.0	19.6	15.1	32.4	30.6	18.0	22.3	30.5	27.4	37.4	19.6	25.4	27.0	3.0	12.2	13.7	9.7	4.1	48.0	18.3	12.7	10.7	9.1	15.7	106.0	29.8	11.6	14.3	27.2	7.1	7.7	23.3	12.1	3.2	10.4	7.7	18.5	11.9	16.3	44.5	3.5	11.1	7.3	17.7	15.5	10.4	13.5	16.2	8.0	35.5	8.4	7.0	17.0	42.1	46.1	6.5	13.7	49.6	25.8	7.0	15.3	11.5	10.3	6.5
PABPC1L	"C20orf119, dJ1069P2.3, ePAB, PABPC1L1"	ENSG00000101104	"Poly(A) binding protein cytoplasmic 1 like"	Q4VXU2	20	44910062-44959035	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 17.4;Club cells: 25.0;Collecting duct cells: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Group enriched"	"Detected in many"	5	"B-cells: 3.3;granulocytes: 3.9;T-cells: 1.9"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066650			Approved	"Nuclear bodies,Cytosol"		NA	Yes			Cytosol	"Nuclear bodies"	"HPA066650: AB_2685698"	"unprognostic (4.98e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.92e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (4.00e-15)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (8.84e-4)"	4.7	8.1	9.8	29.3	20.4	14.0	16.0	3.4	6.0	8.4	5.7	6.2	20.4	6.9	8.3	26.1	7.6	9.1	13.0	3.7	8.6	4.2	21.7	29.2	14.6	16.3	5.6	9.3	16.9	29.3	7.7	23.7	5.1	7.1	15.2	6.4	7.6	10.2	14.7	0.9	10.3	10.0	6.2	10.9	12.5	10.0	9.2	6.5	20.3	28.1	6.3	12.9	9.0	12.1	3.3	0.4	3.9	0.5	0.3	1.9	0.1	6.6	8.7	11.7	16.9	4.4	9.4	26.8	14.7	3.0	5.7	7.6	23.7	12.2	8.7	24.8	5.8	9.2	15.5	5.2	13.5	4.7	5.2	10.6	7.0	23.8	21.9	10.1	6.0	2.9	9.9	23.8	12.1	21.5	6.5	1.4	13.5	7.8	12.6	6.8	19.0	7.4	14.3	4.6	6.9	15.3	9.6	2.5	4.6	8.0	8.3	7.3	7.3	5.8	18.3	19.9	15.4	35.8	4.8	4.7	25.5	17.2	11.1	7.0	16.6	16.5	4.4	8.2	2.5	8.4	0.1	0.5	0.1	0.9	0.1	1.9	1.4	0.2	0.7	0.2	3.3	0.3	0.5	3.9	0.3	0.2	0.4	0.5	0.1	9.8	20.4	3.4	6.0	8.6	4.2	5.6	9.3	7.1	6.5	6.0	17.4	0.5	2.5	1.6	0.3	1.4	7.6	12.0	25.0	19.2	0.0	4.5	0.0	2.9	0.4	0.7	1.6	0.0	0.4	3.8	2.3	3.2	3.5	5.0	2.5	0.0	4.1	0.6	0.6	0.0	1.7	2.2	0.0	1.8	2.3	2.4	2.2	3.1	1.8	0.8	1.1	0.0	0.9	0.7	2.1	1.5	3.2	4.4	3.1	2.4
PABPC3	"PABP3, PABPL3, tPABP"	ENSG00000151846	"Poly(A) binding protein cytoplasmic 3"	Q9H361	13	25095868-25099254	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 50.9"	"Group enriched"	"Detected in many"	9	"Early spermatids: 131.2;Late spermatids: 106.4;Spermatocytes: 81.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	14	"U-266/84: 11.7"									"HPA045423, HPA067156"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (2.17e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (5.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.61e-3)"	0.5	0.2	0.2	0.5	0.8	0.2	1.0	0.1	1.1	0.7	0.5	0.1	0.0	0.2	0.2	0.3	0.7	0.2	0.2	0.2	0.3	0.1	0.2	0.2	1.2	2.0	0.2	0.4	0.4	0.3	0.1	0.4	0.2	0.3	0.4	0.2	0.0	0.6	0.9	0.2	0.4	0.5	0.2	0.1	0.4	0.2	50.9	0.0	0.8	0.3	0.0	0.2	0.3	0.4	1.6	1.9	0.5	2.2	1.8	2.5	1.9	0.4	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.5	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.8	0.7	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.8	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.2	0.4	11.7	0.2	0.1	0.3	0.1	0.4	1.4	0.5	0.7	2.1	1.6	1.6	1.7	1.3	1.9	1.3	2.5	2.2	0.5	1.8	2.2	1.1	1.5	1.9	0.2	0.8	0.1	1.1	0.3	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.5	4.6	10.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	131.2	3.6	0.6	0.0	0.3	1.4	3.5	3.4	4.6	0.6	1.4	1.6	4.1	3.1	5.6	106.4	2.8	3.9	5.0	0.0	1.3	1.0	0.1	3.5	4.6	0.8	0.0	6.5	4.1	81.1	4.6	11.3	2.4	2.2	3.3	3.1
PABPN1	"OPMD, PAB2, PABP2"	ENSG00000100836	"Poly(A) binding protein nuclear 1"	Q86U42	14	23321289-23326185	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000637	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553"	"unprognostic (5.11e-3)"	"unprognostic (2.65e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.66e-4)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.25e-3)"	41.1	46.0	67.4	39.8	73.7	57.1	34.0	79.5	80.2	36.1	42.2	39.4	51.2	55.1	55.3	67.7	38.3	43.2	43.4	35.3	64.4	44.7	46.6	47.1	33.2	46.4	62.4	45.8	48.6	35.2	44.8	54.0	40.6	60.3	46.2	52.8	39.4	42.3	45.2	46.6	53.7	55.9	50.2	47.4	46.0	41.4	54.1	69.3	53.5	51.0	29.6	54.6	33.3	46.5	11.4	15.6	13.1	9.8	12.0	9.0	2.8	25.7	28.9	64.0	50.6	30.1	33.8	41.7	26.8	26.5	36.7	35.2	34.6	48.6	46.2	14.4	33.8	41.2	41.0	71.4	37.0	51.1	39.5	27.2	35.7	41.4	89.5	33.7	55.4	49.1	39.3	37.2	27.3	32.2	55.8	40.1	40.1	33.4	36.3	35.0	49.1	58.1	67.8	70.1	32.3	33.1	58.2	24.8	27.9	41.5	53.6	44.3	34.6	34.4	32.0	27.2	45.5	24.2	40.2	33.8	25.7	32.8	25.1	34.0	43.4	30.0	54.9	15.2	45.5	29.8	13.1	9.8	8.9	7.3	7.0	5.9	8.7	7.3	6.3	7.6	11.4	9.0	8.5	11.9	12.0	7.7	15.6	7.9	2.8	67.4	73.7	79.5	80.2	64.4	44.7	62.4	45.8	60.3	69.3	32.8	49.6	74.5	72.7	140.2	113.5	11.8	99.3	25.4	35.2	120.4	137.4	57.9	11.6	47.7	43.5	69.2	70.8	23.3	49.1	55.5	69.1	73.0	23.1	97.3	54.7	73.1	155.0	58.3	81.4	34.5	75.1	76.0	50.6	58.7	95.5	69.4	49.3	88.5	56.3	31.1	80.6	71.1	69.2	26.5	29.2	157.2	52.5	43.6	98.9	93.2
PACRGL	"C4orf28, MGC29898"	ENSG00000163138	"Parkin coregulated like"	Q8N7B6	4	20696282-20752907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 166.5;Late spermatids: 63.0;Spermatocytes: 76.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054666			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA054666: AB_2682564"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.90e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.74e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (4.85e-4)"	7.9	8.7	12.2	10.7	15.6	3.2	16.5	7.8	19.0	9.1	8.9	9.3	14.6	6.6	13.9	15.1	9.6	14.2	10.0	9.5	14.1	12.4	8.7	4.7	7.7	7.3	12.1	12.9	14.0	6.7	9.7	13.7	7.4	10.5	11.2	9.4	8.4	7.7	11.4	10.1	14.3	7.7	13.1	15.1	6.8	7.7	37.3	10.7	4.5	15.8	10.0	6.3	11.1	8.9	4.3	7.0	1.4	4.7	4.1	6.1	2.9	9.0	7.0	12.4	9.4	16.8	15.6	6.0	11.6	9.2	10.7	13.0	6.3	19.3	9.6	7.8	6.6	17.0	4.3	6.9	8.7	18.4	3.0	6.1	6.0	10.6	10.1	8.9	12.4	6.5	10.8	13.0	13.4	12.5	9.9	10.8	8.7	10.4	5.6	9.1	6.5	12.4	11.5	15.7	7.4	10.0	6.6	13.5	5.9	10.7	5.9	20.5	13.5	8.5	4.4	8.7	6.6	8.0	7.0	8.4	10.5	9.7	14.5	16.0	5.7	1.6	8.9	15.3	8.3	18.0	0.0	3.1	1.4	2.7	4.7	6.1	4.3	3.0	2.7	5.3	4.0	4.7	3.0	1.2	4.1	3.7	7.0	3.5	2.9	12.2	15.6	7.8	19.0	14.1	12.4	12.1	12.9	10.5	10.7	8.9	5.4	0.5	9.6	12.0	5.5	5.2	7.6	32.1	9.1	7.0	3.9	4.9	6.6	6.9	166.5	6.7	5.1	0.0	7.9	5.7	9.6	8.5	2.3	2.9	3.7	4.8	8.6	5.5	4.3	63.0	12.0	4.9	5.0	2.8	5.2	8.4	6.7	8.2	11.7	4.2	10.4	12.9	5.5	76.4	32.5	9.3	4.9	2.2	7.6	6.8
PACS1	"FLJ10209, KIAA1175"	ENSG00000175115	"Phosphofurin acidic cluster sorting protein 1"	Q6VY07	11	66070363-66244747	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038914	Approved		Approved	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA038914: AB_10672831"	"unprognostic (7.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.46e-1)"	20.0	14.6	18.0	33.7	23.1	17.7	25.5	33.6	25.5	17.7	16.6	12.5	12.8	10.5	17.4	16.9	19.6	18.1	19.8	33.1	17.3	15.0	17.7	7.4	20.7	42.3	12.8	19.0	26.2	16.7	19.9	16.9	14.6	12.8	21.3	8.5	19.0	66.8	18.8	15.2	16.2	15.1	23.5	11.7	24.0	16.0	28.4	13.6	33.9	21.6	15.6	33.7	21.9	17.7	7.2	1.9	11.2	3.7	2.9	5.8	3.6	16.6	17.6	8.2	5.5	15.8	18.8	9.6	22.6	16.7	16.7	10.4	10.8	13.8	10.5	15.2	39.8	15.5	10.9	6.2	17.1	21.3	16.7	6.9	16.9	15.4	15.5	19.2	2.4	14.0	19.2	8.0	15.1	19.1	31.5	15.6	7.2	6.4	20.7	18.0	31.5	18.0	6.5	3.9	4.6	8.4	12.1	8.4	18.5	11.7	16.8	11.8	13.4	23.6	14.0	11.7	14.0	15.7	3.2	20.6	21.4	9.4	28.6	9.8	10.5	6.7	2.8	18.2	4.0	10.5	5.2	2.0	3.9	5.2	1.5	3.5	4.6	4.9	4.5	1.9	7.2	5.6	5.0	11.2	2.9	3.7	1.2	5.8	3.6	18.0	23.1	33.6	25.5	17.3	15.0	12.8	19.0	12.8	13.6	3.0	4.0	29.6	15.2	9.0	31.1	14.6	10.2	8.1	10.3	12.2	47.1	6.5	5.0	18.0	12.8	13.0	1.3	0.0	54.4	8.1	12.3	21.2	23.1	3.4	11.5	87.4	5.8	23.4	12.3	21.6	17.3	11.0	10.1	36.1	2.7	12.8	46.9	0.0	17.0	12.9	40.9	12.9	9.2	21.3	21.3	8.7	4.8	27.1	2.9	15.9
PACS2	"KIAA0602, PACS1L"	ENSG00000179364	"Phosphofurin acidic cluster sorting protein 2"	Q86VP3	14	105300563-105398147	"Predicted intracellular proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7;skeletal muscle: 63.8"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 92.2;Late spermatids: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077892			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077892: AB_2686865"	"unprognostic (4.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.30e-1)"	15.3	10.8	18.8	7.7	25.5	6.1	13.3	20.5	29.8	8.0	7.7	41.7	6.5	8.4	10.0	8.1	8.9	9.6	8.7	15.1	23.9	18.0	6.8	3.7	9.3	6.1	36.8	13.9	11.8	21.3	10.3	8.1	6.9	26.3	7.6	5.5	6.7	11.8	9.8	63.8	7.2	9.1	8.1	65.7	10.9	7.4	13.4	26.8	2.7	7.1	7.0	4.4	8.3	7.3	0.6	5.4	0.3	4.0	2.1	2.0	0.9	9.3	12.9	12.2	11.5	12.2	11.9	14.5	7.1	8.3	6.1	5.4	5.6	17.8	10.2	12.1	10.8	7.9	10.8	7.4	10.2	4.4	12.7	6.1	4.6	5.1	8.3	16.1	3.8	8.5	13.8	9.8	4.3	10.0	7.8	11.1	10.4	2.9	9.6	5.3	29.3	6.4	5.1	4.7	11.9	10.7	14.4	7.4	6.5	5.2	21.6	27.5	14.6	6.8	6.2	10.6	8.0	15.6	7.1	16.8	9.1	4.2	14.3	7.1	12.7	8.2	3.8	13.9	6.9	8.8	0.0	1.6	0.2	0.9	2.7	1.7	0.2	0.8	1.0	2.7	0.6	0.3	1.0	0.3	2.1	4.0	5.4	2.0	0.9	18.8	25.5	20.5	18.9	23.9	18.0	36.8	13.9	26.3	26.8	8.9	14.3	0.8	6.5	8.0	30.2	17.8	7.6	1.4	13.6	5.2	11.8	3.8	11.6	11.7	47.3	15.8	19.0	0.0	19.9	2.8	11.2	8.4	1.1	7.8	15.0	92.2	12.5	19.6	14.3	63.1	16.1	13.3	25.3	8.2	13.4	14.7	14.0	10.5	15.6	10.5	22.4	6.5	12.7	12.9	11.3	7.3	2.9	5.3	16.6	7.1
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535231	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 81.7"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 70.2;Cone photoreceptor cells: 76.6;Horizontal cells: 65.2;Rod photoreceptor cells: 88.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 15.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 15.0"	"Cell line enhanced"	"Detected in some"		"MCF7: 9.9;RPMI-8226: 11.5;T-47d: 18.3;U-266/84: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	1.5	2.1	42.5	2.4	33.8	2.0	1.4	29.3	81.7	1.5	1.7	2.1	0.0	1.8	1.9	1.5	1.4	2.0	1.7	4.7	32.8	21.9	1.6	1.4	1.5	4.4	14.6	32.9	1.7	6.1	1.4	1.2	1.4	31.6	1.8	1.6	5.5	1.6	1.7	1.5	1.4	1.8	1.5	3.7	2.5	2.4	1.9	4.1	0.0	1.4	0.0	3.4	2.0	0.0	0.0	15.0	0.0	0.0	3.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.1	0.0	9.9	0.6	0.0	2.4	0.1	0.0	0.1	0.0	11.5	0.0	0.3	3.6	0.2	0.0	1.9	0.0	0.4	18.3	2.0	0.0	0.0	0.3	0.0	0.0	3.0	13.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	15.0	0.0	0.1	42.5	33.8	29.3	56.3	32.8	21.9	14.6	32.9	31.6	4.1	0.0	0.0	0.0	0.0	0.0	70.2	4.0	0.0	0.0	0.0	0.0	76.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	1.1	88.6	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0
PACSIN2	SDPII	ENSG00000100266	"Protein kinase C and casein kinase substrate in neurons 2"	Q9UNF0	22	42835412-43015145	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049854, HPA056520"	Enhanced		Supported	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA		83000	"Nuclear speckles, Vesicles, Cytosol"	"Plasma membrane"	"HPA049854: AB_2680915, HPA056520: AB_2683163"	"unprognostic (5.62e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (4.48e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.09e-13)"	"unprognostic (2.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.95e-1)"	20.1	42.0	19.4	19.4	20.7	14.3	22.9	32.3	21.3	18.7	28.4	17.5	21.1	22.5	20.8	18.9	19.3	17.5	33.3	28.0	17.9	19.5	32.5	20.7	25.8	16.9	20.6	15.7	17.4	77.3	14.3	21.5	33.8	32.4	24.6	23.5	26.6	31.7	16.6	23.9	19.4	25.6	25.1	17.8	22.5	27.8	12.6	19.2	13.1	31.0	15.8	18.4	17.7	17.6	4.7	8.3	37.9	12.6	6.7	4.5	5.0	24.7	26.0	21.9	14.0	11.3	12.1	18.0	22.6	13.7	20.5	17.1	27.0	14.6	11.5	19.2	16.7	14.0	17.6	14.3	24.0	13.5	11.7	14.2	18.6	13.3	38.4	16.1	13.1	40.4	11.6	23.8	26.9	11.8	16.7	16.8	10.7	16.0	8.4	17.6	16.2	13.8	20.6	12.1	36.2	11.0	17.0	32.9	7.7	23.5	14.7	14.3	6.4	27.0	18.7	50.7	14.8	13.5	17.4	24.7	15.3	19.5	16.9	13.3	6.3	8.6	12.6	14.6	11.6	33.2	7.9	7.0	17.4	2.8	12.6	3.0	4.2	3.2	2.4	8.3	4.7	3.2	2.4	37.9	6.7	12.1	3.1	4.5	5.0	19.4	20.7	32.3	21.3	17.9	19.5	20.6	15.7	32.4	19.2	65.5	52.9	11.5	38.7	20.6	14.4	20.9	28.1	28.1	35.2	43.6	37.3	28.5	38.1	63.1	2.7	25.4	95.4	0.0	56.4	21.0	22.1	70.2	69.3	19.8	37.7	6.4	23.7	14.1	37.5	4.3	20.1	36.1	79.2	65.9	46.1	7.8	79.7	43.8	21.9	34.2	23.4	90.5	44.3	22.0	26.4	14.8	40.3	17.5	33.5	27.3
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205126-17246005	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 48.7;lymphoid tissue: 60.2"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 12.6;Extravillous trophoblasts: 10.0;Urothelial cells: 3.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.5;EFO-21: 4.6;HaCaT: 2.9;LHCN-M2: 3.6;RPTEC TERT1: 4.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.3	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.1	0.0	4.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	60.2	1.3	6.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.1	9.5	0.0	4.6	0.4	0.4	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	4.9	0.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	12.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	3.8
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Urothelial cells: 6.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.5;RT4: 16.2;T-47d: 12.2;U-87 MG: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	3.2	10.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	6.4	0.0	2.3	0.0	9.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	28.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.5	0.0	1.3	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	16.2	0.0	0.0	0.0	2.4	0.1	0.1	12.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4
PAFAH1B3		ENSG00000079462	"Platelet activating factor acetylhydrolase 1b catalytic subunit 3"	Q15102	19	42297033-42303546	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatogonia: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035639	Uncertain		Approved	"Intermediate filaments"		NA	NA		370000	"Intermediate filaments"		"HPA035639: AB_10670163"	"unprognostic (3.19e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.80e-3)"	4.5	12.8	23.8	10.4	23.2	20.7	12.2	36.4	24.9	17.2	14.6	7.8	8.0	10.9	10.1	11.9	15.5	13.5	9.6	4.6	15.4	25.7	11.7	5.6	5.8	13.6	13.9	13.1	15.4	11.9	8.3	11.8	5.8	12.4	10.3	10.7	11.2	9.8	6.1	10.8	10.6	11.2	6.6	11.7	9.5	11.3	16.3	11.3	37.4	7.8	13.8	15.4	14.6	10.9	19.6	24.6	8.7	13.6	7.8	27.4	10.5	29.3	53.8	33.6	35.9	0.7	1.8	10.4	7.4	10.2	24.3	25.2	17.9	24.7	18.1	9.7	8.9	16.9	10.0	15.2	19.4	10.1	27.4	20.8	21.9	14.4	24.0	5.2	13.9	24.4	5.3	9.0	14.9	7.0	13.5	10.8	39.7	15.4	21.6	17.7	42.9	31.0	10.9	18.6	34.8	0.0	23.0	12.9	16.2	19.7	31.0	38.7	30.3	11.8	23.4	12.3	11.1	29.2	15.9	5.8	20.2	27.4	1.8	19.9	10.3	21.3	15.4	11.3	22.5	17.7	8.7	13.6	7.2	12.1	10.7	16.1	19.6	17.3	13.9	24.6	18.4	23.0	16.0	1.8	7.8	5.4	13.6	27.4	10.5	23.8	23.2	36.4	24.9	15.4	25.7	13.9	13.1	12.4	11.3	14.9	9.1	22.3	37.0	25.0	24.5	1.2	28.1	30.8	15.9	31.4	13.7	30.1	68.0	88.9	12.7	17.1	21.2	23.3	48.0	33.8	21.6	29.7	27.6	7.2	52.3	11.1	56.6	9.2	23.0	16.4	12.7	23.2	43.9	10.8	47.4	24.0	78.6	24.6	8.5	40.4	17.2	0.0	6.2	4.3	212.2	15.6	11.3	17.5	63.6	43.4
PAG1	"CBP, PAG"	ENSG00000076641	"Phosphoprotein membrane anchor with glycosphingolipid microdomains 1"	Q9NWQ8	8	80967810-81112068	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 124.4;Melanocytes: 133.3;Sertoli cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.6;HMC-1: 26.2;SK-MEL-30: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001632, HPA066527"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA001632: AB_1079557, HPA066527: AB_2685685"	"unprognostic (8.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.94e-3)"	5.5	3.8	5.3	20.2	6.1	12.2	4.1	22.3	7.6	2.7	12.3	5.4	2.3	8.6	3.5	2.8	2.9	3.2	12.1	5.5	6.4	4.3	3.2	6.4	20.3	21.2	7.5	4.2	2.6	16.6	0.8	4.2	17.7	7.7	3.9	10.1	10.6	5.0	4.4	3.8	6.2	14.9	3.5	9.9	12.1	5.1	1.4	7.4	15.2	3.4	0.4	15.3	6.2	4.4	2.2	4.1	10.9	13.3	1.6	6.8	2.4	0.0	0.0	2.7	0.1	5.2	5.0	0.1	1.1	8.8	0.5	1.1	0.1	0.0	19.6	0.1	0.3	4.4	0.8	0.0	1.0	0.5	0.5	2.5	11.4	0.2	0.0	5.3	1.8	26.2	2.4	0.7	5.1	4.8	0.5	0.0	3.5	0.1	0.1	8.4	0.1	6.8	0.1	0.2	4.4	0.8	5.2	1.4	0.1	0.9	4.2	0.5	1.0	0.0	0.2	20.3	0.5	0.6	1.9	0.1	0.6	0.3	0.0	0.6	3.2	0.8	7.0	5.6	6.5	4.8	10.9	1.4	1.9	2.6	6.3	6.5	2.2	6.6	4.6	1.8	1.4	5.4	4.0	2.3	1.6	13.3	4.1	6.8	2.4	5.3	6.1	22.3	7.6	6.4	4.3	7.5	4.2	7.7	7.4	0.0	11.3	16.6	3.6	27.9	36.6	12.1	12.7	0.0	18.2	3.5	0.0	0.5	0.0	2.2	3.2	10.5	93.4	0.0	5.7	19.0	22.5	7.3	124.4	8.1	23.3	60.4	3.5	17.2	58.9	1.5	2.3	68.1	133.3	38.7	19.5	45.0	2.3	48.0	7.4	0.3	3.0	122.9	31.9	0.2	0.7	19.7	1.9	59.0	19.2	3.4
PAGE1	"CT16.3, GAGE-9, GAGEB1, PAGE-1"	ENSG00000068985	"PAGE family member 1"	O75459	X	49687450-49695993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	126	"testis: 18.2"	"Cell type enhanced"	"Detected in some"	30	"Sertoli cells: 32.3;Spermatocytes: 65.7;Spermatogonia: 164.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 49.0;Karpas-707: 37.8;U-266/84: 58.3"									HPA003473	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Mitochondria"	"HPA003473: AB_1079558"				"unprognostic (3.00e-1)"										"unprognostic (1.99e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	37.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.7	58.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	5.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	32.3	0.0	65.7	164.4	0.0	0.0	0.0	0.0	0.0
PAGE3	"CT16.6, GAGED1, PAGE-3"	ENSG00000204279	"PAGE family member 3"	Q5JUK9	X	55258412-55264846	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	111	"testis: 11.1"	"Group enriched"	"Detected in some"	54	"Early spermatids: 91.5;Late spermatids: 208.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.0;PC-3: 1.9"									"HPA045032, HPA062248"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA045032: , HPA062248: AB_2684725"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	208.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.8	1.6	0.0	0.0	0.0	0.0	0.0
PAGE4	"CT16.7, GAGEC1, PAGE-4"	ENSG00000101951	"PAGE family member 4"	O60829	X	49829260-49833973	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 129.2;placenta: 199.4;prostate: 58.4"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 11201.2;Syncytiotrophoblasts: 7128.6"	"Group enriched"	"Detected in some"	17	"liver cancer: 14.8;prostate cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;U-266/70: 8.6;U-266/84: 31.4"					"Not detected"	"Not detected"			HPA023880	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA023880: AB_1854930"				"unprognostic (8.56e-2)"			"unprognostic (1.47e-1)"			"unprognostic (1.04e-1)"		"unprognostic (4.82e-3)"			"unprognostic (5.37e-2)"			0.2	0.7	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.6	0.1	0.2	5.7	0.0	6.6	129.2	0.1	6.8	0.1	0.1	0.4	0.5	0.8	0.1	0.2	0.1	0.1	0.2	0.9	0.1	0.0	0.6	199.4	0.2	58.4	0.0	0.1	0.1	9.8	0.8	0.1	0.1	2.4	0.2	0.1	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.6	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.2	0.2	0.4	0.5	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11201.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	341.9	0.2	0.3	0.0	0.0	908.5	0.0	0.0	0.0	0.0	6.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	2.3	0.0	7128.6	0.0	0.0	0.0
PAGE5	"CT16.1, CT16.2, PAGE-5"	ENSG00000158639	"PAGE family member 5"	Q96GU1	X	55220355-55224108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 32.0"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 84.1;Spermatogonia: 158.4"	"Group enriched"	"Detected in many"	6	"liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.5"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.5"	"Group enriched"	"Detected in some"	164	"Karpas-707: 67.1;U-266/84: 141.6"									"HPA052619, HPA055869"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA052619: AB_2681887, HPA055869: "					"unprognostic (4.03e-1)"		"unprognostic (4.51e-2)"	"unprognostic (7.86e-4)"	"unprognostic (1.39e-2)"		"unprognostic (7.21e-2)"		"unprognostic (1.06e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"		"unprognostic (3.44e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	32.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	4.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	141.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	4.5	0.3	3.8	1.6	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.3	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	9.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	6.5	0.0	84.1	158.4	0.1	0.0	0.0	0.0	0.0
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836885-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism"	"Allosteric enzyme, Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 65.1;liver: 220.0"	"Group enriched"	"Detected in some"	8	"Cholangiocytes: 226.7;Hepatocytes: 723.9;Proximal tubular cells: 215.9"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"Hep G2: 72.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		No	NA			"Endoplasmic reticulum, Vesicles"		"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.1	1.3	0.5	0.0	0.5	0.0	0.1	0.2	1.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	20.3	0.1	0.8	0.3	65.1	220.0	0.0	0.0	0.3	0.7	0.1	1.7	0.0	1.6	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	2.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	1.0	0.8	0.3	0.3	0.7	0.8	0.4	0.0	0.0	16.2	0.0	0.0	0.0	0.4	226.7	0.0	0.0	5.2	0.0	0.0	18.3	2.0	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	723.9	0.0	3.2	1.7	14.1	22.2	13.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	215.9	0.1	0.0	0.0	0.7	0.4	0.0	0.0	5.0	0.0	0.0
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464579	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		340000	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	15.5	27.1	21.6	20.4	17.4	21.4	29.3	15.8	20.6	17.5	22.5	18.5	18.4	17.2	19.6	12.6	29.0	19.6	11.4	13.4	16.7	22.6	26.5	63.7	11.3	25.6	26.4	19.2	23.3	27.7	26.2	17.9	24.3	29.8	17.5	30.5	13.1	15.7	16.8	23.8	20.0	16.1	19.4	23.5	19.8	12.8	18.3	15.9	44.9	17.8	26.8	33.1	18.7	18.9	13.7	12.8	3.2	6.4	10.9	14.4	6.7	34.3	25.8	53.3	33.0	11.4	25.9	45.9	29.8	21.6	42.8	42.2	40.9	40.9	79.6	34.7	19.9	23.3	21.3	84.1	43.3	73.4	15.9	29.6	43.2	39.5	45.3	21.9	76.8	19.3	21.9	31.4	45.4	34.3	23.7	35.0	45.7	74.5	29.7	36.8	22.9	88.1	38.5	61.1	66.2	32.3	71.6	22.8	52.3	40.5	24.1	57.3	34.3	29.3	41.0	18.0	45.5	27.1	24.6	18.8	33.9	44.4	33.3	60.8	21.0	18.0	83.7	35.7	56.3	37.3	3.2	3.7	0.3	4.1	6.4	11.8	13.7	11.5	7.3	11.4	8.9	14.4	12.1	0.9	10.9	4.8	12.8	8.3	6.7	21.6	17.4	15.8	20.6	16.7	22.6	26.4	19.2	29.8	15.9	20.8	19.3	31.8	57.8	50.4	26.0	20.9	56.0	21.4	31.8	31.4	5.9	117.2	31.5	30.5	45.8	21.6	14.2	46.7	22.8	137.4	35.6	28.6	20.7	68.6	45.7	27.0	23.8	11.6	15.8	6.6	27.6	17.1	16.9	22.6	34.9	13.2	23.3	7.0	21.9	41.1	22.9	0.0	17.9	39.4	47.7	44.2	45.7	16.0	65.0	44.1
PAIP2B	KIAA1155	ENSG00000124374	"Poly(A) binding protein interacting protein 2B"	Q9ULR5	2	71182739-71227083	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9;pancreas: 47.8;skeletal muscle: 39.4"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 60.6;Hepatocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 13.2;SCLC-21H: 20.5"	"Low region specificity"	"Detected in all"							"HPA046784, HPA072371"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046784: AB_2679804, HPA072371: AB_2686514"	"unprognostic (8.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (8.17e-5)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.96e-12)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.61e-2)"	2.8	2.4	36.3	2.3	28.8	1.8	4.8	11.9	15.7	3.3	4.2	50.9	5.1	4.0	3.5	2.5	6.2	7.4	1.8	17.8	39.5	25.1	9.9	16.6	3.3	2.5	47.7	9.7	11.6	47.8	6.4	2.1	1.4	21.9	5.2	4.2	2.7	29.9	5.6	39.4	15.1	3.2	3.4	44.9	2.7	6.7	2.7	24.6	0.6	11.1	3.5	4.7	2.7	2.3	5.8	4.5	1.0	0.9	1.5	4.6	1.2	2.1	0.5	0.9	3.1	0.3	0.5	3.9	0.3	0.1	0.3	0.1	0.8	0.9	2.7	0.6	0.0	2.1	1.7	5.3	3.1	1.0	1.4	4.3	2.6	0.3	0.1	1.5	0.7	0.2	0.6	2.9	0.1	3.2	0.8	0.5	6.2	4.6	2.7	0.1	2.7	0.8	1.5	2.3	4.9	2.0	0.0	9.2	13.2	1.7	1.4	20.5	1.2	2.3	1.5	0.9	5.0	6.5	0.1	0.1	0.2	1.7	1.7	0.9	5.3	4.5	3.4	0.2	1.0	0.5	1.0	0.7	1.0	2.0	0.9	2.6	4.9	2.8	2.0	0.8	5.8	4.6	4.0	0.5	1.5	0.8	4.5	1.1	1.2	36.3	28.8	11.9	15.7	39.5	25.1	47.7	9.7	21.9	24.6	3.0	5.0	3.0	6.2	6.9	10.8	60.6	15.3	12.0	0.0	7.0	5.9	3.0	18.3	4.1	33.7	3.6	1.1	0.0	35.4	5.9	2.7	8.7	1.1	52.1	1.6	6.4	39.9	4.9	2.2	18.6	4.9	2.1	13.5	3.6	5.9	7.8	16.3	3.5	4.9	43.1	39.1	0.0	3.1	9.3	7.5	17.6	5.3	3.8	7.5	4.7
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		590000	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	28.7	18.9	22.4	27.6	23.5	21.4	56.5	17.4	20.7	19.5	23.0	27.8	17.4	19.0	22.6	19.2	23.4	17.9	20.7	29.0	22.6	22.0	19.5	34.3	35.7	50.2	26.8	13.5	19.9	16.6	30.5	13.0	27.6	22.8	17.7	23.0	12.9	19.6	21.2	34.2	16.3	25.2	23.0	32.1	34.6	18.4	15.9	24.8	44.9	16.9	19.1	31.9	24.1	32.7	6.6	13.7	25.9	12.6	6.6	10.8	7.0	36.0	12.9	18.1	13.3	12.9	17.1	27.0	18.3	15.1	19.9	18.1	30.6	18.5	23.1	52.3	18.4	20.3	18.5	19.2	17.4	30.8	10.4	9.3	34.2	14.9	24.0	26.2	33.2	32.9	13.6	14.3	17.8	37.9	21.1	19.6	25.7	16.4	28.8	19.3	38.0	31.6	17.2	10.8	19.4	19.5	28.9	10.3	20.9	17.4	25.3	10.6	12.1	24.5	17.3	13.8	14.6	60.5	24.1	20.2	16.5	9.2	17.3	26.9	19.6	34.6	56.9	13.7	33.3	15.7	16.5	10.3	24.5	6.3	12.6	8.5	6.4	7.3	7.1	13.7	6.6	5.4	6.3	25.9	6.6	10.8	5.1	10.8	7.0	22.4	23.5	17.4	20.7	22.6	22.0	26.8	13.5	22.8	24.8	74.5	44.7	76.2	49.3	86.5	39.1	56.5	63.7	88.3	47.8	78.5	49.1	41.1	28.2	62.3	49.4	78.8	52.5	0.0	51.3	82.8	47.0	116.6	143.4	125.4	90.3	52.4	43.1	63.3	144.6	51.0	56.4	118.7	32.1	120.0	42.8	58.0	77.2	48.4	42.8	60.3	40.6	38.8	52.3	24.2	41.4	75.4	29.2	71.3	38.3	112.3
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.2;pancreas: 46.5;pituitary gland: 37.2"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 81.5;Leydig cells: 31.7;Peritubular cells: 76.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 4.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.8;HAP1: 8.8;HDLM-2: 11.0;NTERA-2: 8.6;SCLC-21H: 11.2;SH-SY5Y: 7.0;U-2197: 6.8;U-251 MG: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA044791: , HPA060219: AB_2684223"	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	2.0	6.8	17.6	2.5	17.5	1.0	6.4	1.8	24.6	3.7	1.6	0.9	9.1	1.0	6.8	7.6	1.7	3.7	2.6	1.2	26.2	20.8	1.6	1.1	1.8	2.5	7.9	21.9	7.9	46.5	0.9	37.2	1.6	12.9	4.8	1.7	1.4	3.0	7.1	2.4	2.0	1.4	6.1	5.8	2.9	3.0	3.6	1.9	0.0	7.7	0.0	1.7	2.0	1.5	0.1	0.1	0.6	0.1	0.2	4.3	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	9.8	1.0	1.4	0.0	8.8	0.5	1.2	11.0	0.3	0.0	1.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	2.0	5.2	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	8.6	0.0	1.9	0.1	4.0	0.0	0.8	0.0	11.2	7.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.6	4.3	6.8	11.7	0.0	0.1	0.1	1.2	0.0	0.1	0.6	0.1	0.1	0.1	0.0	4.3	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.0	17.6	17.5	1.8	18.5	26.2	20.8	7.9	21.9	12.9	1.9	3.0	1.4	0.0	14.1	0.2	81.5	0.8	12.7	0.0	1.2	0.0	0.0	0.3	0.0	3.0	3.4	2.4	0.0	0.0	11.6	0.3	5.8	1.3	1.1	0.0	0.2	6.4	3.5	0.6	0.3	4.7	31.7	2.0	0.0	1.0	0.0	19.0	7.3	0.0	76.4	0.5	5.5	0.0	0.4	1.1	0.6	1.0	5.6	2.2	0.0	0.9
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537389-9839041	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 30.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"SCLC-21H: 10.2;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.5	5.2	5.7	0.6	11.7	0.5	1.6	30.3	19.6	0.8	0.6	0.8	0.0	0.7	1.0	2.2	1.0	0.7	3.4	0.6	4.0	3.3	1.0	2.3	0.7	0.6	1.6	8.8	0.6	3.5	0.5	2.0	0.6	5.3	1.6	0.6	0.6	1.2	1.6	0.6	1.6	0.6	0.6	1.2	0.6	1.2	1.0	1.7	0.0	0.6	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	3.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	5.7	11.7	30.3	13.6	4.0	3.3	1.6	8.8	5.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40238759-40277487	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 22.2"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 38.8;Suprabasal keratinocytes: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.8;HaCaT: 23.0;hTCEpi: 14.1;SK-BR-3: 7.8"									HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.3	5.3	14.7	0.8	18.4	0.8	2.3	11.3	20.1	3.0	1.3	1.6	2.5	1.4	1.0	1.1	15.8	4.3	1.4	7.9	11.6	5.2	3.4	0.4	2.6	1.0	3.0	10.9	0.6	7.4	12.9	6.4	8.1	2.1	3.6	1.2	0.3	3.4	7.5	3.5	22.2	1.4	0.8	1.2	1.0	3.6	12.8	2.2	0.0	7.4	8.5	5.1	3.0	5.1	1.4	0.7	2.9	0.7	2.0	5.5	1.2	2.7	0.0	0.2	0.1	0.0	0.0	4.4	0.0	0.1	0.6	0.4	14.8	2.0	0.1	2.4	0.0	0.9	23.0	3.3	4.9	0.2	0.1	0.7	0.0	1.9	0.1	0.0	0.1	0.3	0.0	14.1	0.2	3.3	0.2	0.0	3.9	1.1	0.2	0.0	3.2	0.0	0.3	0.4	2.7	2.0	0.2	0.1	1.8	1.1	6.0	5.4	1.3	1.9	7.8	0.2	1.3	0.9	7.2	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.0	0.5	0.4	0.1	2.1	0.7	2.9	5.5	0.3	2.1	1.4	0.5	4.2	0.7	0.5	0.3	1.2	1.3	2.0	0.2	0.5	0.1	1.2	14.7	18.4	11.3	20.1	11.6	5.2	3.0	10.9	2.1	2.2	0.0	3.4	0.0	6.8	8.8	3.9	0.0	7.6	4.0	4.5	5.2	0.0	38.8	11.6	4.0	5.9	0.0	0.0	0.0	3.7	1.2	0.6	4.0	0.0	0.0	3.5	0.0	4.7	0.0	0.3	4.5	1.7	0.3	1.7	0.0	0.8	1.4	2.7	0.0	1.8	0.0	0.0	0.0	0.1	1.6	1.5	16.7	7.6	1.3	1.9	6.8
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497066-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 203.3"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 352.0;Cardiomyocytes: 495.5;Peritubular cells: 375.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"		No	No			"Plasma membrane, Actin filaments"	Cytosol	"CAB070159: AB_1726016, HPA035905: AB_2674854"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.28e-4)"	17.3	8.9	8.5	19.6	7.5	0.1	28.1	2.1	6.7	58.4	71.9	5.7	46.4	6.7	82.2	25.6	84.3	31.3	30.8	95.0	9.2	3.2	12.7	3.6	24.9	17.0	4.6	4.7	28.0	3.0	25.6	3.9	14.0	6.0	71.4	17.9	9.2	11.4	50.9	30.5	8.9	16.8	203.3	6.7	25.8	31.4	14.1	6.9	2.2	12.7	17.2	5.8	140.3	82.7	0.2	2.2	13.6	3.2	0.6	5.1	1.5	17.7	8.7	19.5	12.0	17.9	19.6	27.3	12.1	30.5	10.7	15.2	0.2	1.0	7.7	3.1	5.2	6.5	3.7	11.8	30.8	13.7	16.0	3.6	0.1	25.2	2.2	31.4	0.0	0.2	29.7	19.3	19.1	28.7	25.8	4.5	4.4	0.0	0.1	64.5	0.8	5.1	0.3	5.6	4.5	5.2	1.7	18.0	0.1	1.2	3.5	2.0	10.5	22.8	1.7	1.6	35.4	10.8	0.1	14.5	11.2	42.5	4.7	19.7	10.9	0.1	0.3	9.4	0.2	3.1	13.6	3.2	0.0	5.1	1.9	0.2	0.1	0.6	2.7	2.2	0.2	0.6	2.0	0.8	0.6	1.2	0.2	0.5	1.5	8.5	7.5	2.1	6.7	9.2	3.2	4.6	4.7	6.0	6.9	29.8	10.3	2.4	352.0	83.1	5.7	495.5	28.1	104.4	76.2	41.8	17.7	42.5	1.7	24.0	99.1	28.5	10.3	0.0	44.7	98.6	137.0	124.3	50.8	12.3	21.9	25.4	42.9	68.7	21.6	111.6	120.6	22.6	21.9	88.4	27.7	54.5	57.6	17.3	375.5	14.4	3.4	174.6	188.1	18.6	3.9	43.2	18.7	4.5	24.8	88.9
PALM2		ENSG00000243444	"Paralemmin 2"	Q8IXS6	9	109640788-109946703	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.9;liver: 19.7"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 5.9;Fibroblasts: 5.4;Hepatocytes: 14.7;Intestinal endocrine cells: 7.9;Smooth muscle cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 5.9;RH-30: 20.8"	"Low region specificity"	"Detected in many"							"HPA074153, HPA076866"			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.74e-6)"	"unprognostic (8.39e-2)"	14.8	6.1	8.1	2.0	11.1	1.2	6.7	1.7	17.9	4.3	2.4	9.1	0.0	1.8	4.9	1.7	2.4	3.8	3.0	7.6	6.3	1.8	2.7	19.7	4.8	1.5	5.0	9.7	2.3	2.2	1.4	1.6	3.1	8.4	2.4	2.4	0.0	3.2	1.4	2.5	3.1	2.0	2.2	4.9	1.5	2.2	2.7	8.7	0.0	4.3	0.0	1.4	2.8	2.6	0.5	0.1	1.1	0.2	0.3	0.1	0.0	0.1	0.6	0.5	0.0	0.4	0.9	0.2	0.4	1.2	0.7	1.7	0.3	0.7	0.1	0.1	1.9	4.2	1.8	0.0	0.6	1.3	0.1	1.0	0.0	2.5	0.2	0.0	0.0	0.1	2.0	0.8	5.9	0.9	0.6	0.0	0.0	0.0	0.0	2.5	0.5	0.0	0.0	3.4	0.2	1.3	0.0	20.8	0.4	2.9	0.4	3.9	0.0	5.1	0.2	1.6	0.9	2.0	0.4	0.2	2.1	3.0	0.1	1.7	0.1	0.7	0.1	1.6	0.0	2.4	0.3	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.1	0.0	1.1	0.3	0.1	0.1	0.0	0.0	8.1	11.1	1.7	12.7	6.3	1.8	5.0	9.7	8.4	8.7	0.0	0.3	0.0	0.5	1.1	0.0	5.9	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.3	0.4	0.3	0.0	0.0	0.2	1.5	5.4	0.4	0.0	14.7	0.1	0.0	7.9	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	6.6	0.2	1.0	2.0	0.2	0.0	0.4	0.1
PALM2-AKAP2		ENSG00000157654	"PALM2-AKAP2 readthrough"		9	109780309-110172512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.0;heart muscle: 26.8"	"Group enriched"	"Detected in some"	14	"Alveolar cells type 1: 125.0;granulocytes: 32.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.7;hTEC/SVTERT24-B: 15.1;RH-30: 29.7;U-251 MG: 13.2;WM-115: 17.3"									"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	41.0	2.8	1.6	3.3	1.6	0.1	19.6	0.7	4.7	4.8	2.3	1.5	2.1	1.1	15.2	4.7	2.1	2.5	5.0	26.8	1.8	2.4	2.4	24.8	9.7	1.2	1.9	0.5	5.9	1.1	1.6	1.1	9.2	3.0	3.2	0.6	1.1	2.0	3.6	4.5	1.8	1.0	7.8	1.4	0.5	1.1	1.4	0.9	0.0	3.8	2.5	0.3	5.2	8.9	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	3.3	0.0	15.7	5.6	1.3	5.5	5.4	1.6	3.7	0.0	0.1	0.0	0.5	5.7	6.5	2.0	0.0	1.3	4.6	0.2	1.6	0.0	5.1	0.1	0.1	0.0	0.0	7.1	0.1	15.1	2.4	4.8	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	4.4	0.0	1.4	0.0	29.7	0.0	4.1	0.0	1.8	0.0	2.1	0.2	7.5	4.6	0.6	0.0	0.1	3.4	8.6	0.3	13.2	0.0	0.2	0.0	4.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.6	1.6	0.7	3.0	1.8	2.4	1.9	0.5	3.0	0.9	125.0	5.8	0.0	0.0	0.0	0.0	1.1	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PALM3		ENSG00000187867	"Paralemmin 3"	A6NDB9	19	14053365-14059159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.5;testis: 19.7"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 53.6;Alveolar cells type 2: 36.3;Cholangiocytes: 17.8;Club cells: 18.2;Collecting duct cells: 36.6;Exocrine glandular cells: 24.3;Hepatocytes: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.1;CACO-2: 23.7;HAP1: 19.8;NTERA-2: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052794, HPA056119"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA052794: AB_2681952, HPA056119: AB_2683042"	"unprognostic (3.67e-2)"	"unprognostic (9.08e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.72e-3)"	0.2	0.2	4.3	0.9	1.9	0.0	2.1	3.7	3.6	2.9	0.5	3.2	0.2	2.7	0.4	11.1	0.2	1.5	1.6	0.2	4.2	2.8	12.9	26.5	2.4	0.2	1.7	4.3	0.4	11.7	1.8	0.2	0.7	10.1	1.8	0.2	1.1	6.9	8.0	0.2	0.2	0.8	0.9	2.7	0.2	13.0	19.7	4.9	0.2	6.8	0.2	1.0	3.9	1.9	0.9	0.2	0.0	0.3	0.0	1.8	0.0	1.6	1.5	3.7	22.1	0.3	0.1	4.5	0.4	0.1	1.3	0.6	23.7	0.5	0.0	0.2	0.4	7.0	0.1	19.8	0.0	0.3	0.0	1.3	0.1	0.5	2.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.6	0.1	0.0	4.6	0.0	0.0	3.7	0.2	0.1	14.2	1.8	1.3	0.0	0.0	0.0	0.0	1.9	2.7	3.6	0.1	0.0	0.0	4.0	1.4	0.0	0.2	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.1	0.9	0.8	0.3	0.0	0.1	0.9	1.8	1.8	0.0	0.0	0.1	0.2	0.5	0.0	4.3	1.9	3.7	3.6	4.2	2.8	1.7	4.3	10.1	4.9	53.6	36.3	0.0	0.6	0.0	0.8	0.3	17.8	2.7	18.2	36.6	0.0	0.2	1.7	6.7	0.0	0.0	0.9	0.0	24.3	2.0	1.0	1.4	1.1	31.8	0.1	0.0	1.2	1.3	1.3	0.0	0.9	0.1	1.7	1.8	1.9	0.4	3.8	0.6	2.5	6.8	0.5	0.0	0.0	0.0	6.8	0.0	1.8	0.0	0.6	0.2
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99645943-99694541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.9;skeletal muscle: 106.9"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 153.8;Ciliated cells: 174.0;Endothelial cells: 169.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 43.5;LHCN-M2: 14.0;TIME: 60.9;U-87 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Actin filaments"	"Plasma membrane, Focal adhesion sites"	"HPA017959: AB_1854949, HPA030549: AB_2673518"	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favorable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	84.9	18.6	8.3	6.2	4.3	0.0	46.4	1.1	3.7	17.1	6.5	3.9	4.0	1.3	18.6	10.1	16.2	8.7	5.3	59.0	5.6	3.4	5.1	20.9	10.6	3.4	3.9	3.8	17.4	2.2	4.4	4.7	16.8	19.0	8.1	2.6	7.9	34.0	4.4	106.9	18.0	3.5	12.2	4.1	2.3	2.8	7.5	2.2	2.1	3.4	48.2	6.2	6.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.7	0.1	3.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	7.3	0.0	0.0	0.0	1.1	0.5	0.0	0.0	1.2	43.5	0.0	6.1	0.0	14.0	0.1	0.0	0.0	0.0	0.4	1.9	0.0	10.9	0.0	0.0	2.2	0.2	0.1	0.0	2.8	0.0	0.3	0.6	0.0	60.9	0.0	0.1	4.7	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	4.3	1.1	3.7	5.6	3.4	3.9	3.8	19.0	2.2	6.0	9.3	0.0	9.8	34.2	0.2	153.8	35.7	174.0	45.5	3.5	0.0	0.2	5.0	7.1	73.5	169.5	0.0	0.0	0.2	0.4	4.8	4.7	1.1	55.2	0.5	3.2	1.7	58.9	1.3	7.9	8.6	1.7	23.6	0.0	0.0	54.8	2.5	0.0	22.6	0.0	2.1	0.0	6.1	0.5	0.2	40.7	0.2	0.0	0.0	0.7
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 304.2"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 852.6;Intestinal endocrine cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 75.3;fHDF/TERT166: 96.5;hTERT-RPE1: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA		59000000	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	16.5	24.5	8.2	6.5	16.4	0.8	17.3	6.6	16.5	74.9	14.0	5.4	9.5	5.8	21.3	83.8	11.7	10.6	11.5	304.2	8.8	23.5	13.7	2.1	13.2	5.8	10.0	7.6	17.0	16.4	49.5	18.3	26.3	15.5	13.4	9.5	8.7	53.8	29.4	22.0	8.5	8.5	18.5	4.8	8.9	17.2	7.2	4.6	1.8	21.7	13.2	7.3	15.8	15.3	0.5	2.0	10.1	5.3	16.2	14.1	6.3	14.7	2.2	27.1	12.0	75.3	45.1	10.8	41.8	62.6	12.4	37.8	7.1	19.5	0.0	9.0	96.5	17.5	5.0	1.5	18.4	34.3	1.8	6.1	3.0	8.8	2.3	11.4	0.9	3.3	24.6	7.9	9.1	6.9	78.8	25.5	1.2	0.1	2.0	35.1	3.0	0.0	0.4	4.8	2.6	8.1	1.1	15.1	8.1	47.8	1.7	12.8	8.9	17.8	1.1	10.9	16.6	4.6	0.9	19.6	39.4	10.2	18.4	12.4	4.6	1.1	0.0	45.2	4.1	33.9	1.9	5.3	0.1	14.1	0.9	10.0	0.5	8.5	10.4	2.0	0.3	2.9	4.8	10.1	16.2	1.9	1.1	12.1	6.3	8.2	16.4	6.6	16.5	8.8	23.5	10.0	7.6	15.5	4.6	50.6	28.7	3.7	10.4	25.0	10.9	852.6	0.0	10.7	27.3	57.6	2.0	0.7	6.6	11.6	5.0	54.1	6.8	0.0	18.6	37.1	102.7	20.4	9.2	2.4	5.5	7.9	308.8	70.0	12.0	4.7	55.8	6.7	35.4	5.4	12.6	13.0	34.7	2.9	55.2	41.6	2.8	19.4	47.4	1.6	2.1	20.7	5.6	15.3	6.6	13.1
PANK3	FLJ12899	ENSG00000120137	"Pantothenate kinase 3"	Q9H999	5	168548495-168579600	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 63.0"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 101.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078669	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA078669: "	"unprognostic (1.24e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-3)"	"unprognostic (2.01e-1)"	9.1	16.6	11.6	17.5	10.4	10.5	17.6	22.8	11.9	8.9	23.9	9.0	8.5	28.0	10.2	8.8	12.8	7.8	6.9	7.4	11.7	9.1	13.2	39.2	12.5	8.2	8.4	7.5	10.7	8.8	14.6	11.2	9.4	10.8	9.1	17.9	6.7	11.0	9.6	8.2	11.9	63.0	8.0	10.3	9.6	10.9	10.2	11.0	10.2	10.5	13.4	8.2	9.9	11.6	4.1	2.7	3.5	4.7	0.9	2.5	1.1	13.9	7.9	32.7	17.4	12.3	14.2	13.9	8.4	9.0	11.3	16.7	13.1	13.0	21.6	13.9	11.9	18.3	10.1	22.0	17.0	20.4	20.0	10.6	11.0	7.5	9.7	14.2	14.9	15.0	11.4	23.0	14.2	16.0	8.0	13.3	16.4	10.2	21.9	15.5	7.8	14.8	6.7	14.0	10.9	5.8	10.8	22.4	8.8	14.2	20.8	15.3	32.7	9.7	16.0	23.9	17.2	20.8	18.8	13.6	15.3	21.5	9.0	17.9	15.3	21.0	16.1	9.1	15.2	11.8	3.5	3.2	1.6	1.9	3.8	2.5	4.1	1.9	1.9	2.0	1.6	1.3	2.3	1.3	0.9	4.7	2.7	2.4	1.1	11.6	10.4	22.8	11.8	11.7	9.1	8.4	7.5	10.8	11.0	23.8	17.1	17.4	18.7	30.5	27.4	13.5	22.9	18.7	17.0	24.4	25.5	14.0	8.3	15.1	9.7	23.2	101.4	0.0	17.5	11.9	20.0	29.7	15.0	79.1	19.5	27.0	32.8	17.8	27.0	13.1	15.5	18.7	21.9	10.8	33.0	12.0	18.9	31.7	16.6	19.6	26.0	25.8	31.6	26.0	27.4	49.1	35.0	10.1	35.0	45.2
PANK4	FLJ10782	ENSG00000157881	"Pantothenate kinase 4"	Q9NVE7	1	2508533-2526628	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.1"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 9.0;HDLM-2: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011723, HPA012036, HPA027961"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042"	"unprognostic (1.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.57e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-2)"	5.3	14.4	10.7	17.8	12.6	4.2	5.4	14.9	12.4	5.5	7.1	6.8	4.9	4.2	7.0	4.2	9.8	5.6	9.2	11.8	8.0	5.2	7.2	7.0	6.7	12.5	9.0	6.8	5.7	5.8	4.2	8.3	6.7	7.4	5.8	6.1	8.9	5.6	5.3	43.1	19.0	7.6	9.1	4.4	8.1	6.3	11.0	9.7	9.4	6.8	6.8	7.2	7.2	5.7	4.5	4.8	11.7	6.9	11.4	8.9	5.3	2.5	6.7	2.3	0.0	0.0	2.7	1.6	9.0	0.0	8.2	7.7	0.0	0.0	1.1	3.1	2.5	0.0	3.9	1.9	0.0	1.8	9.4	5.7	0.0	3.9	5.6	2.6	0.0	4.7	0.0	0.0	0.0	0.0	1.2	1.9	1.3	2.5	0.0	2.2	0.0	1.3	0.3	0.0	0.8	2.8	0.0	0.0	1.8	0.0	0.0	2.0	0.0	5.1	1.9	0.0	0.9	0.0	3.4	0.0	0.0	1.9	4.7	2.2	1.3	4.6	6.1	3.0	0.9	0.0	11.7	4.9	4.5	6.2	6.6	5.1	4.5	3.9	6.4	4.8	3.0	7.4	8.0	6.4	11.4	6.9	0.9	8.9	5.3	10.7	12.6	14.9	12.4	8.0	5.2	9.0	6.8	7.4	9.7	6.0	3.2	5.6	4.9	3.7	7.2	22.5	2.5	0.0	2.3	3.5	9.8	6.5	6.6	5.2	1.1	5.2	4.9	0.0	6.0	4.2	7.0	3.2	1.1	7.6	4.6	3.2	2.9	3.7	5.9	0.4	5.5	5.9	5.0	8.2	4.0	4.5	4.7	7.0	8.5	3.6	13.0	19.4	5.9	4.8	5.2	3.9	8.1	8.5	5.0	3.1
PAPD4	"FLJ38499, GLD2, TUT2"	ENSG00000164329	"Poly(A) RNA polymerase D4, non-canonical"	Q6PIY7	5	79612120-79686648	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054468			Approved	Cytosol		No	No			Cytosol		"HPA054468: AB_2682497"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.37e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.67e-3)"	25.4	21.1	15.8	34.4	22.1	42.1	27.9	20.9	30.3	23.8	22.6	24.7	22.7	19.2	34.4	28.1	22.0	20.7	23.3	16.5	16.5	14.6	20.0	25.3	25.6	34.7	19.4	20.2	29.6	21.4	18.0	23.1	25.7	17.2	20.6	23.3	23.8	21.4	28.3	21.0	25.5	25.4	23.1	22.2	37.4	21.0	26.0	21.2	33.8	24.9	21.3	29.3	22.6	21.9	20.2	19.5	22.3	22.1	19.3	29.9	15.7	11.6	8.1	9.1	14.3	15.9	18.5	14.6	14.1	21.7	16.6	26.5	7.2	13.9	21.8	7.4	15.6	19.6	11.2	11.6	15.7	19.0	16.2	10.6	12.4	10.1	11.2	20.7	18.3	17.2	16.3	17.1	11.7	22.0	16.2	14.0	16.0	14.1	16.1	18.2	6.3	20.8	23.6	8.4	8.9	5.8	18.7	9.1	24.3	16.0	16.7	6.0	10.9	11.2	12.3	22.1	15.0	10.5	29.0	12.8	9.0	6.1	8.7	15.6	17.0	14.1	21.6	15.8	19.3	12.5	22.3	19.1	18.6	18.2	22.1	29.9	20.2	19.9	19.9	19.5	16.2	19.3	19.8	17.3	19.3	21.7	10.7	20.2	15.7	15.8	22.1	20.9	30.3	16.5	14.6	19.4	20.2	17.2	21.2	17.9	15.6	14.7	16.3	26.1	21.3	0.0	12.7	24.1	14.8	0.0	21.6	23.1	0.0	0.0	7.5	20.4	16.9	23.3	0.0	18.7	18.8	16.8	20.9	23.2	29.3	31.8	13.8	33.2	52.9	6.6	17.8	36.5	15.1	0.0	17.6	17.1	0.0	20.9	25.1	0.0	33.2	12.9	12.5	24.2	15.0	27.5	28.1	35.0	18.4	20.3
PAPD7	"LAK-1, POLK, POLS, TRF4, TRF4-1"	ENSG00000112941	"Poly(A) RNA polymerase D7, non-canonical"	Q5XG87	5	6713007-6757048	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045487, HPA046742"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA045487: AB_2679346, HPA046742: AB_2679781"	"unprognostic (1.45e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.62e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (8.55e-4)"	13.5	7.9	9.6	13.9	11.1	25.8	16.3	22.7	12.3	15.1	16.6	10.6	14.8	9.5	13.2	8.0	12.2	11.3	11.4	8.6	10.7	7.3	9.7	19.9	13.2	14.1	14.8	5.8	18.5	13.3	13.2	12.2	10.0	9.0	11.6	8.3	10.2	17.0	10.6	10.4	16.7	13.1	13.9	7.9	14.8	10.1	11.1	11.7	25.4	11.3	11.3	11.6	12.5	34.9	1.9	3.8	0.7	0.7	0.5	2.3	0.8	16.5	11.2	13.8	17.0	10.0	9.0	19.9	11.3	14.1	14.1	16.0	11.6	9.3	12.1	8.7	13.8	15.8	12.3	11.3	8.7	13.0	13.6	7.2	6.2	35.5	6.3	6.2	9.3	9.4	6.1	7.6	15.7	10.1	10.4	8.2	9.1	8.3	16.1	11.4	9.1	12.6	12.2	7.5	5.1	8.8	11.5	11.8	3.1	5.6	9.5	13.8	10.5	26.9	13.1	7.7	7.8	7.9	5.1	7.2	16.9	17.8	14.7	15.7	15.4	6.3	10.7	11.0	8.7	10.4	0.0	0.7	0.7	2.1	0.4	2.3	1.9	1.7	1.6	1.2	1.5	1.9	1.7	0.4	0.5	0.6	3.8	1.8	0.8	9.6	11.1	22.7	12.3	10.7	7.3	14.8	5.8	9.0	11.7	6.0	20.8	6.7	8.4	29.1	16.5	0.0	7.6	4.0	9.1	0.0	35.3	4.5	0.0	0.0	9.6	8.2	7.3	0.0	0.0	3.5	14.1	9.6	4.7	13.2	5.8	14.3	4.7	16.0	5.7	2.8	6.1	7.6	3.3	0.0	8.1	7.8	0.0	6.2	8.5	0.0	24.9	0.0	14.7	6.3	4.9	22.6	4.7	6.9	7.6	8.7
PAPLN	MGC50452	ENSG00000100767	"Papilin, proteoglycan like sulfated glycoprotein"	O95428	14	73237497-73274640	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 31.9;Muller glia cells: 21.2;Peritubular cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"neutrophil: 4.4;plasmacytoid DC: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 8.8;granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 13.1;HSkMC: 24.7;hTCEpi: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA048682, HPA053453"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		46000000	Nucleoplasm		"HPA048682: AB_2680492, HPA053453: AB_2682155"	"unprognostic (1.97e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.56e-3)"	"unprognostic (7.42e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.46e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.58e-2)"	9.3	6.1	13.6	11.8	14.8	2.9	11.0	4.1	11.1	10.8	7.0	6.0	3.8	4.1	14.2	19.5	4.6	12.1	8.0	4.8	15.7	3.0	24.9	1.9	7.8	23.3	4.1	9.7	10.9	2.7	1.0	11.1	5.2	5.7	8.1	6.2	14.9	4.7	10.2	1.8	16.2	10.3	8.6	6.0	17.6	7.4	6.5	8.9	5.1	15.3	2.2	16.5	6.8	5.6	1.1	8.8	4.4	0.8	0.5	0.5	0.2	2.0	2.0	0.8	0.3	1.5	1.9	4.6	0.4	0.0	0.1	0.1	2.6	0.6	0.4	2.1	0.0	0.1	3.3	2.1	1.5	0.2	2.3	3.1	0.9	3.2	0.3	13.1	0.3	1.7	24.7	9.1	0.4	1.4	0.1	0.4	1.9	0.6	0.3	0.0	1.0	0.2	2.2	0.5	0.2	0.6	0.3	0.3	2.1	1.8	0.4	0.2	0.4	4.8	5.5	0.9	6.6	0.1	3.7	0.4	0.6	1.9	0.2	0.2	1.1	0.1	0.2	1.1	1.1	0.5	1.1	0.8	0.6	0.4	0.5	0.2	0.7	0.3	0.5	0.2	1.1	0.5	0.5	4.4	0.5	0.4	8.8	0.5	0.2	13.6	14.8	4.1	11.1	15.7	3.0	4.1	9.7	5.7	8.9	0.0	1.6	0.0	0.5	1.8	1.0	1.3	2.5	1.4	5.7	5.2	7.9	0.5	0.0	3.0	0.3	1.1	0.1	0.0	0.0	0.9	6.1	1.7	0.0	0.0	1.2	0.0	0.0	1.8	0.3	1.4	31.9	0.9	1.7	2.8	0.0	21.2	0.4	0.0	41.4	13.4	3.0	6.5	1.0	0.6	0.1	2.6	0.3	0.0	0.9	0.4
PAPOLB	PAPT	ENSG00000218823	"Poly(A) polymerase beta"	Q9NRJ5	7	4857733-4861994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 33.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 67.3;Late spermatids: 69.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"	"Not detected"	"Not detected"							HPA047285			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047285: "					"unprognostic (7.58e-2)"					"unprognostic (1.25e-1)"				"unprognostic (1.68e-2)"	"unprognostic (1.78e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.3	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.3	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.7	0.0	0.5	16.1	2.3	0.6	0.2	0.0	0.0	0.3
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845605	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 406.4"	"Group enriched"	"Detected in many"	7	"Intestinal endocrine cells: 135.4;Muller glia cells: 47.6;Syncytiotrophoblasts: 61.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"	NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.6	0.2	0.2	0.0	3.0	0.8	0.3	5.0	0.6	0.2	0.2	0.0	0.3	0.2	0.2	0.2	1.1	0.2	0.2	0.1	11.6	0.7	0.2	0.2	0.2	0.2	0.2	1.5	0.0	1.2	406.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.3	0.5	0.2	1.0	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.3	4.6	2.2	3.8	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.5	0.5	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.3	1.7	1.4	0.1	0.6	0.3	0.4	0.0	21.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.8	0.3	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	5.2	0.0	0.8	10.0	0.0	1.9	0.0	0.0	0.0	0.2	11.6	0.6	0.0	0.0	0.2	1.2	0.0	135.4	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.2	47.6	1.2	0.0	10.3	0.3	1.1	6.5	0.5	1.2	1.9	0.0	61.9	0.0	0.0	0.0
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720452	"Enzymes, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 50.3;eosinophil: 62.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 62.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	13.5	7.4	24.3	14.4	28.5	11.1	25.2	16.4	32.2	26.6	10.0	45.0	9.4	7.9	25.1	22.8	18.3	24.9	13.3	7.7	31.3	23.9	16.7	5.1	22.0	14.7	29.7	21.9	15.6	24.6	15.6	15.5	8.5	38.2	21.7	12.7	9.5	32.2	14.0	3.3	24.5	8.5	17.0	59.9	9.6	30.4	8.1	25.5	14.7	10.3	11.0	24.6	16.5	13.7	8.5	9.2	62.2	10.2	4.6	6.8	5.8	10.5	9.7	16.4	20.4	20.2	25.5	13.1	13.5	25.4	13.2	17.8	14.8	15.3	16.5	8.6	24.7	10.2	13.3	15.5	26.7	17.1	38.8	11.7	19.3	21.0	33.0	11.1	29.2	33.4	21.1	13.8	15.2	12.5	32.2	29.3	21.1	4.2	32.2	37.0	16.2	23.5	9.0	17.5	11.4	10.8	19.8	25.9	4.7	19.9	14.7	18.6	26.9	14.0	21.1	16.5	21.8	12.5	4.5	17.3	16.6	17.1	11.1	11.3	25.9	17.2	15.4	20.1	22.4	26.0	50.3	8.9	62.2	3.0	9.6	3.5	8.5	4.0	3.4	9.2	4.1	2.5	2.9	9.4	4.6	10.2	1.8	6.8	5.8	24.3	28.5	16.4	32.2	31.3	23.9	29.7	21.9	38.2	25.5	89.3	19.8	21.5	31.5	28.4	13.4	6.5	30.6	113.8	69.4	54.1	9.8	17.1	14.9	29.3	5.2	17.4	7.0	0.0	40.0	37.0	49.8	27.9	41.5	8.1	53.6	28.6	22.5	20.3	50.0	3.7	16.7	46.3	57.3	35.1	18.0	37.3	29.6	7.0	24.1	21.2	13.7	25.8	22.7	16.5	14.3	35.8	7.4	11.8	15.1	20.1
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.2;liver: 49.0"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 223.4;Enterocytes: 147.6;Hepatocytes: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.7;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"BJ: 35.4;fHDF/TERT166: 89.6;HHSteC: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	16.0	59.2	3.5	18.1	6.0	0.3	18.1	1.9	4.3	8.6	25.5	2.2	1.9	9.2	4.0	7.0	3.7	5.3	10.7	9.1	3.9	2.1	9.9	49.0	31.3	15.6	4.4	1.6	10.8	21.2	0.4	1.7	19.0	5.2	3.8	21.2	6.2	6.2	2.0	4.8	1.7	19.4	5.5	3.4	2.9	2.9	3.6	4.3	0.8	7.3	6.2	11.0	5.7	5.3	0.0	2.7	0.8	9.7	0.0	0.1	0.8	3.5	3.7	1.2	0.0	25.7	32.8	0.0	35.4	30.3	21.6	15.6	0.1	0.7	0.0	1.8	89.6	0.6	1.5	2.6	2.5	24.7	0.0	1.9	1.6	2.6	0.0	38.9	0.0	0.7	11.6	0.0	12.4	1.0	26.0	17.9	0.2	0.0	16.7	15.1	13.5	0.0	0.1	1.4	0.8	4.6	0.0	0.0	0.0	22.5	1.6	0.1	0.3	17.2	0.6	0.2	2.5	2.5	0.9	22.4	7.3	4.3	24.7	2.5	0.0	0.1	0.0	3.5	0.0	0.0	0.0	1.4	0.0	0.0	5.3	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	9.7	0.0	0.0	0.8	3.5	6.0	1.9	4.3	3.9	2.1	4.4	1.6	5.2	4.3	223.4	31.0	5.2	0.8	2.1	0.0	3.5	5.1	2.7	14.8	8.7	0.0	0.4	11.6	4.4	0.9	11.3	147.6	0.0	25.2	0.6	18.5	2.7	0.0	93.7	11.5	0.0	12.1	28.8	29.3	0.2	16.1	25.7	1.7	1.8	25.6	1.0	24.6	48.9	4.9	8.4	0.0	12.9	11.3	0.4	0.6	1.1	1.1	1.3	42.4	0.9
PAQR4	FLJ30002	ENSG00000162073	"Progestin and adipoQ receptor family member 4"	Q8N4S7	16	2969245-2973489	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.4;parathyroid gland: 32.8"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"non-classical monocyte: 6.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068394			Approved	Vesicles		NA	Yes			Vesicles		"HPA068394: AB_2685980"	"unprognostic (1.93e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (2.62e-2)"	"unprognostic (7.59e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (3.01e-6)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.06e-3)"	3.1	3.2	14.1	5.2	19.2	10.3	2.3	8.0	26.3	2.4	4.8	49.6	1.3	4.9	1.8	1.0	4.2	3.0	5.5	4.2	24.1	11.7	1.7	1.6	3.9	6.3	30.6	11.1	0.4	6.6	32.8	0.9	2.2	19.1	9.6	4.5	16.8	17.0	1.3	12.3	12.3	4.9	2.8	54.4	3.2	7.4	1.6	20.3	3.6	1.5	3.5	7.8	2.1	1.7	0.5	0.9	0.1	6.7	0.0	0.4	0.5	12.9	11.0	12.5	18.0	2.0	3.7	4.2	4.9	5.9	9.1	8.6	6.6	13.8	12.9	6.7	5.6	6.4	18.2	12.9	7.7	3.8	13.7	5.6	3.9	21.6	8.9	0.2	8.4	14.4	0.9	4.1	4.9	1.3	4.6	5.9	11.0	7.7	35.1	7.7	25.9	12.1	9.0	10.5	19.4	7.5	24.1	16.4	41.6	6.2	4.5	28.6	13.3	18.2	17.6	13.2	1.7	18.9	13.1	3.6	16.0	9.8	7.3	6.9	15.3	10.6	17.2	7.0	11.4	17.5	0.0	1.0	0.1	0.4	0.5	0.0	0.5	0.2	0.1	0.9	0.1	0.0	0.3	0.1	0.0	6.7	0.5	0.1	0.5	14.1	19.2	8.0	21.2	24.1	11.7	30.6	11.1	19.1	20.3	0.0	0.0	2.9	1.4	2.7	14.6	0.8	12.7	10.7	6.8	0.0	55.0	0.7	0.0	4.4	0.5	1.0	2.0	0.0	9.9	7.2	0.8	7.5	2.3	0.0	11.5	6.4	4.1	3.7	9.5	3.0	0.6	4.5	5.0	1.0	5.3	15.7	6.5	2.9	0.0	0.3	145.7	0.0	1.2	1.6	5.2	4.4	0.5	0.0	9.3	0.8
PAQR5	"FLJ20190, MPRG"	ENSG00000137819	"Progestin and adipoQ receptor family member 5"	Q9NXK6	15	69298947-69407780	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.4"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 39.7;Early spermatids: 33.3;granulocytes: 65.8;Late spermatids: 86.2;Proximal tubular cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"A549: 17.5;CAPAN-2: 21.1;fHDF/TERT166: 14.9;HMC-1: 37.0;U-87 MG: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA076729			Approved	Vesicles		NA	NA			Vesicles		"HPA076729: AB_2686813"	"unprognostic (4.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.05e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.47e-14)"	"unprognostic (5.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.16e-4)"	"unprognostic (4.94e-2)"	1.8	15.4	1.9	4.1	2.6	0.7	1.2	1.5	3.1	1.6	12.3	3.0	1.7	1.5	1.1	1.6	9.0	1.0	1.7	1.9	1.8	1.5	41.4	1.0	10.4	0.3	2.0	1.0	0.5	4.8	5.8	0.9	1.0	3.5	1.1	10.8	3.6	1.8	4.2	0.4	3.2	5.2	3.2	3.8	0.2	4.5	1.5	2.2	0.0	0.6	5.7	4.9	2.3	2.6	0.2	0.2	3.5	0.3	0.4	0.7	0.0	5.1	17.5	0.3	0.3	0.7	2.0	0.1	1.6	10.1	2.0	4.3	1.0	21.1	0.0	2.7	14.9	1.7	0.3	5.0	0.2	3.5	0.0	0.7	3.0	2.7	0.3	1.3	0.1	37.0	1.0	0.8	9.0	9.7	2.6	0.0	0.1	0.0	0.3	8.4	0.7	0.0	0.1	1.2	2.7	1.5	0.0	0.3	0.9	7.7	0.4	1.5	0.3	2.7	1.0	1.4	1.0	0.4	1.2	0.2	6.1	2.0	0.5	0.2	0.1	0.1	0.0	15.4	0.0	1.7	3.5	0.3	0.1	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.7	1.3	0.4	0.2	0.2	0.1	0.0	1.9	2.6	1.5	3.1	1.8	1.5	2.0	1.0	3.5	2.2	11.9	21.8	0.0	1.1	0.8	0.5	0.8	22.9	1.4	1.2	19.2	0.0	0.0	39.7	16.0	33.3	0.4	18.4	0.0	0.4	0.0	0.2	0.5	65.8	0.0	3.5	0.0	0.0	0.0	0.3	86.2	0.9	0.9	0.0	0.0	4.8	5.7	1.8	3.5	1.1	33.2	0.0	6.5	0.4	0.3	0.5	1.6	0.1	0.5	11.5	0.7
PAQR7	"MPRA, mSR"	ENSG00000182749	"Progestin and adipoQ receptor family member 7"	Q86WK9	1	25861210-25871253	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"Early spermatids: 346.5;Late spermatids: 1377.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.3;HaCaT: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046936	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046936: AB_2679869"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.47e-1)"	"unprognostic (4.59e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.54e-2)"	1.2	9.5	1.8	0.7	2.3	1.0	1.4	1.8	1.8	2.8	1.6			6.7	4.1	10.2	6.1	6.8	2.1	0.6	1.7	2.6	11.9	1.9	1.6	0.6	2.0		13.2	1.8	3.9	2.1	6.9		2.4	0.4		1.5	8.9	0.2	10.7	5.7	2.9	1.4	3.5	2.3	16.2			1.4		1.0	6.3	4.6	3.2	5.5	10.8	11.7	2.4	1.4	0.8	11.7	2.3	2.4	7.8	2.9	6.2	8.4	7.7	6.9	7.8	7.0	3.9	30.3	0.1	5.5	7.6	2.5	24.9	1.3	13.1	4.7	4.6	1.3	10.0	3.3	4.7	4.9	0.1	1.3	6.3	17.5	5.5	4.1	6.9	2.9	1.1	1.0	0.8	5.7	2.7	0.0	0.7	3.7	1.2	4.0	0.8	0.2	1.4	15.8	9.1	1.2	4.7	12.6	16.5	5.7	3.5	4.7	1.8	3.2	1.3	4.0	4.1	2.1	0.1	0.1	0.5	5.9	0.3	2.6	3.1	5.7	10.8	1.1	10.2	1.1	3.2	0.6	0.8	5.5	1.2	1.0	1.4	2.6	2.4	11.7	0.6	0.2	0.8											0.0	1.9	1.9	4.7	16.1	1.9	1.6	17.8	10.7	6.8	73.3	0.0	36.5	18.3	4.9	346.5	4.5	1.3	0.0	12.5	10.0	7.5	1.0	6.9	4.9	9.2	3.2	4.6	10.4	7.3	1377.7	18.4	5.3	20.3	5.4	1.5	2.0	7.0	3.5	14.2	49.2	0.6	12.9	4.0	11.1	9.1	11.4	29.9	0.9	2.9	2.2
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.2"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 94.7;Mucus-secreting cells: 40.0;Paneth cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 19.4;OE19: 41.1;SuSa: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA064625: AB_2685304"	"prognostic favorable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.40e-4)"	2.4	3.5	25.6	6.6	32.4	1.3	2.2	14.9	31.0	4.2	28.9	35.5	14.2	14.5	4.4	6.7	13.7	5.4	4.9	2.9	27.3	17.5	5.3	1.5	5.8	7.2	48.5	15.8	19.5	2.5	3.7	1.8	5.5	28.2	3.8	28.1	1.9	1.9	28.5	1.1	2.7	25.1	5.2	69.2	4.8	24.1	3.1	36.5	3.1	2.6	0.4	6.0	7.3	3.3	1.0	6.0	2.0	2.6	7.0	16.3	3.2	0.4	0.4	5.2	2.2	3.1	5.1	3.5	1.5	5.8	1.0	2.1	1.9	1.8	0.5	0.5	1.0	2.3	0.2	0.6	2.5	1.6	6.9	0.8	3.1	0.4	19.4	0.8	0.8	0.4	1.4	0.3	0.6	3.7	3.6	5.5	6.1	0.7	3.1	4.0	0.7	2.0	2.8	2.6	41.1	0.2	5.3	0.8	1.2	6.0	1.4	1.9	4.2	0.4	0.1	5.8	17.5	0.1	6.9	2.3	2.0	0.8	0.5	0.9	0.9	1.2	0.7	1.8	8.0	10.3	2.0	2.6	1.3	2.5	0.5	3.8	0.9	7.6	5.2	6.0	1.0	16.3	7.6	0.5	7.0	0.5	3.0	4.7	3.2	25.6	32.4	14.9	22.8	27.3	17.5	48.5	15.8	28.2	36.5	3.0	8.8	0.0	3.2	1.8	1.6	4.6	15.3	0.0	1.2	3.5	7.9	1.4	0.0	3.2	0.4	3.8	94.7	0.0	1.0	2.6	4.7	6.0	4.6	0.0	7.9	0.0	22.1	3.7	16.7	1.0	5.2	3.9	13.5	5.4	40.0	4.5	3.0	55.1	9.6	0.0	3.0	0.0	1.9	11.4	2.9	0.9	0.7	5.9	24.1	7.8
PARD6G	"PAR-6G, PAR6gamma"	ENSG00000178184	"Par-6 family cell polarity regulator gamma"	Q9BYG4	18	80157232-80247546	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.0"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 35.1;Sertoli cells: 19.4;Suprabasal keratinocytes: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 21.6;hTCEpi: 20.1;RT4: 16.1;U-2 OS: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047017	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA047017: AB_2679904"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.80e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.85e-1)"	"unprognostic (2.72e-1)"	2.9	2.2	3.1	4.0	3.1	0.8	8.8	2.0	4.3	15.1	5.0	3.1	8.2	2.1	9.5	6.1	17.3	6.7	4.5	3.0	4.3	4.1	5.5	3.5	2.6	10.4	2.8	2.4	8.9	3.1	2.1	3.7	5.7	3.7	8.8	2.5	4.0	7.0	6.6	2.0	37.0	2.9	8.2	2.6	2.4	2.5	2.4	1.8	6.9	20.7	14.1	11.2	8.4	10.7	0.5	0.5	2.5	0.4	0.6	1.0	0.1	1.7	2.5	10.5	7.8	0.3	0.4	7.6	1.9	0.4	1.7	0.2	0.7	0.7	0.0	0.8	0.8	3.0	7.7	3.7	11.1	1.7	0.3	3.3	0.1	2.0	5.9	0.5	2.2	21.6	3.4	20.1	0.2	1.1	1.3	0.8	2.4	0.7	0.5	2.5	2.8	2.0	0.2	3.1	0.8	3.0	0.0	6.9	0.8	0.3	16.1	4.4	4.5	2.3	1.3	11.0	5.4	1.5	2.0	0.6	3.5	17.4	1.3	0.9	0.5	0.7	0.1	1.1	0.5	6.4	2.5	0.2	0.4	0.3	0.2	0.2	0.3	0.3	1.0	0.2	0.5	0.4	0.5	1.2	0.6	0.4	0.5	0.1	0.1	3.1	3.1	2.0	4.3	4.3	4.1	2.8	2.4	3.7	1.8	3.0	1.1	0.0	12.6	35.1	1.6	2.2	2.5	1.4	1.2	3.5	0.0	0.5	0.0	0.3	0.4	3.1	0.0	0.0	0.2	4.2	5.6	5.4	0.0	1.6	0.7	0.0	0.0	8.0	1.9	0.4	1.7	1.1	11.8	0.0	0.0	2.0	0.9	0.0	1.8	6.3	2.2	19.4	5.8	0.9	4.1	55.8	0.3	2.2	0.5	10.1
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: AB_2682014"	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	4.0	5.6	4.3	4.2	5.4	1.4	5.3	7.8	6.3	4.8	5.1			6.7	4.9	3.0	6.2	4.3	3.6	6.6	4.6	5.9	9.2	5.2	3.5	5.8	4.5		4.7	3.5	8.1	4.7	5.8		4.9	6.1		4.7	5.1	8.1	6.7	5.1	4.7	4.0	5.9	4.7	5.8			4.9		6.9	4.4	4.8	6.9	7.0	12.5	7.7	8.3	9.4	5.5	12.7	10.6	18.6	13.7	9.0	11.2	13.7	12.7	14.0	14.8	14.2	8.5	11.9	9.6	8.3	10.7	6.6	14.4	15.7	8.0	15.9	14.7	14.6	9.8	8.7	9.3	10.2	14.1	8.2	7.2	15.5	12.4	20.5	10.1	9.0	12.7	16.6	8.5	11.1	7.1	15.5	12.7	18.4	7.8	24.3	18.6	21.2	11.1	11.9	8.2	12.9	16.3	10.3	16.4	13.3	18.8	18.8	7.9	9.1	9.2	11.3	9.6	14.2	9.4	14.0	20.5	15.9	15.0	6.7	12.5	6.2	3.0	5.2	5.5	7.9	6.9	7.1	6.7	7.0	6.9	9.4	9.1	3.0	8.3	7.7	5.4	5.5	5.5											8.9	11.7	8.3	4.6	5.5	13.2	23.8	12.7	29.4	12.5	12.2	25.5	6.5	8.3	6.3	3.5	8.3	8.5	23.3	5.6	5.2	6.7	4.0	13.9	9.6	8.2	4.8	6.3	7.4	13.2	3.3	6.9	7.0	3.3	9.0	8.1	8.9	6.7	2.9	7.8	27.7	20.8	0.0	5.5	15.7	12.1	5.3	3.9	7.5	9.7	3.8
PARL	"PRO2207, PSARL, PSARL1, RHBDS1"	ENSG00000175193	"Presenilin associated rhomboid like"	Q9H300	3	183829271-183884933	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019545	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019545: AB_1855796"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.11e-5)"	24.2	20.6	26.2	19.2	30.1	21.2	30.4	22.1	29.6	22.7	29.0	24.4	19.4	21.5	20.2	43.8	21.4	19.6	21.2	30.9	23.1	23.4	27.0	26.7	20.3	26.5	28.4	20.3	20.3	47.5	22.0	20.6	18.5	19.5	22.1	31.3	25.9	35.1	33.4	41.2	22.3	27.0	38.1	19.4	22.3	24.5	22.2	18.9	22.1	20.7	25.4	24.3	23.2	18.2	21.5	45.4	44.3	50.0	21.5	25.9	35.4	32.6	15.5	11.5	9.8	11.2	12.9	23.9	12.3	16.7	23.7	18.6	47.7	17.1	14.6	27.4	15.6	21.3	14.6	18.3	18.9	26.7	20.7	22.5	22.0	10.4	26.1	16.8	21.8	18.6	17.5	24.3	16.6	20.3	11.2	16.8	23.2	12.5	13.6	19.4	35.4	41.6	53.4	30.9	27.4	15.9	18.4	22.5	26.5	22.1	27.3	11.6	16.5	14.6	47.2	30.0	14.7	48.5	41.4	9.8	8.8	19.2	18.2	31.2	27.4	18.5	33.6	16.9	22.2	10.5	27.6	50.0	44.3	19.0	35.4	21.7	21.5	21.6	22.1	45.4	19.9	25.9	21.1	14.5	21.5	26.2	27.0	24.4	35.4	26.2	30.1	22.1	29.6	23.1	23.4	28.4	20.3	19.5	18.9	20.8	26.1	28.3	47.3	27.0	33.9	33.9	20.4	18.7	15.9	29.6	29.5	49.5	99.5	41.8	15.3	30.4	28.2	0.0	73.6	40.6	37.9	39.4	69.2	28.2	68.8	31.8	32.4	30.1	52.8	7.4	26.7	58.0	40.5	60.5	36.5	35.7	49.3	35.1	25.5	71.7	38.7	6.5	49.1	43.3	46.0	26.2	35.2	38.5	49.1	46.1
PARP10	FLJ14464	ENSG00000178685	"Poly(ADP-ribose) polymerase family member 10"	Q53GL7	8	143977153-144012772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA028122, HPA052427"	Approved		Supported	"Nucleoli rim,Golgi apparatus,Cytosol"		No	No			"Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA028122: AB_10601979, HPA052427: AB_2681828"	"unprognostic (9.80e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.63e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.30e-3)"	14.2	18.8	8.8	27.4	9.5	15.7	18.6	5.3	8.7	14.4	16.5	9.3	20.7	20.5	20.3	18.3	15.8	18.0	21.8	6.4	8.9	4.1	20.5	19.1	21.4	23.6	10.4	6.8	22.4	15.3	9.3	14.2	10.4	9.2	17.7	3.8	12.7	27.7	14.9	12.5	14.3	21.8	9.6	8.9	31.1	13.1	15.8	9.8	27.8	15.4	10.4	21.6	8.8	12.9	2.4	16.4	3.2	2.8	1.9	4.6	2.4	8.4	0.8	0.6	1.5	4.2	3.8	4.6	1.4	1.8	9.5	10.7	0.4	14.8	10.5	20.1	4.5	10.9	3.2	0.2	5.0	0.4	23.6	0.0	11.6	4.9	5.3	4.1	4.5	14.0	2.4	5.0	4.7	1.9	1.0	1.4	15.1	0.2	8.4	1.8	10.3	15.7	7.9	0.5	0.1	6.8	14.7	1.7	14.1	3.9	10.7	0.5	0.5	9.8	1.0	18.6	0.2	11.0	6.8	6.5	4.9	7.4	8.2	5.2	14.3	8.4	2.4	7.1	15.3	2.6	0.0	1.9	3.2	4.6	2.8	3.0	1.2	2.2	3.7	2.3	2.4	1.6	2.3	1.1	1.9	2.7	16.4	1.6	2.4	8.8	9.5	5.3	8.7	8.9	4.1	10.4	6.8	9.2	9.8	3.0	6.9	15.7	7.9	6.8	5.9	2.0	7.6	1.4	1.2	8.7	13.7	1.9	1.7	7.6	4.3	7.1	15.1	0.0	4.9	3.0	6.7	4.0	19.5	19.5	10.9	0.0	18.4	11.1	13.9	5.9	14.7	9.2	6.8	30.7	13.6	11.1	6.5	11.2	10.6	20.3	20.2	6.5	8.9	10.0	1.3	4.1	1.1	20.8	12.7	3.3
PARP11	C12orf6	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	7.1	14.5	11.2	8.6	9.2	3.7	8.3	11.0	9.1	6.4	5.4	5.6	4.8	4.9	10.2	7.5	5.0	6.3	5.6	5.1	6.1	5.7	5.7	5.7	6.3	12.8	5.0	5.7	13.1	6.6	10.0	10.4	4.1	7.6	12.0	5.7	7.2	6.6	6.0	4.1	3.9	6.5	7.2	6.1	9.2	4.2	12.8	5.6	16.9	12.3	2.7	12.1	8.3	5.8	10.7	10.2	18.3	10.2	8.2	12.5	7.1	2.3	1.9	12.8	2.0	4.1	6.5	3.6	2.8	4.8	5.0	5.0	7.3	1.8	7.0	1.8	6.2	6.3	2.0	4.2	4.2	8.1	14.1	4.2	10.0	0.0	5.4	4.6	6.7	3.8	5.2	3.3	3.9	11.1	0.0	3.7	13.7	2.6	5.7	7.0	3.3	3.5	2.6	4.7	2.4	0.3	7.1	8.7	1.6	2.3	5.3	0.8	2.9	2.8	2.4	3.6	14.6	0.4	6.1	7.2	4.3	4.3	6.6	3.8	2.7	5.9	9.8	4.1	3.7	1.1	18.3	10.2	10.2	9.2	8.5	12.5	10.7	10.2	6.7	10.2	10.1	11.7	9.4	10.2	8.2	6.4	8.9	4.3	7.1	11.2	9.2	11.0	9.1	6.1	5.7	5.0	5.7	7.6	5.6	8.9	7.4	11.8	4.3	1.6	11.1	3.2	2.5	6.7	2.3	1.8	2.0	3.0	0.0	3.1	60.8	4.5	2.1	0.0	2.6	1.5	4.6	8.0	14.9	3.4	6.2	3.2	3.5	8.0	9.1	25.5	9.8	6.9	1.7	3.6	3.7	6.2	2.9	4.2	8.1	3.3	6.9	6.5	5.1	7.5	8.7	1.6	2.2	10.2	4.3	3.4
PARP12	"FLJ22693, PARP-12, ZC3H1, ZC3HDC1"	ENSG00000059378	"Poly(ADP-ribose) polymerase family member 12"	Q9H0J9	7	140023744-140063721	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003584, HPA063872"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003584: AB_1079568, HPA063872: AB_2685139"	"unprognostic (1.46e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (3.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.01e-2)"	3.1	1.8	1.0	3.7	0.9	6.1	2.5	0.1	0.7	2.1	2.2			4.2	2.8	4.2	2.1	2.5	3.1	1.7	1.0	1.0	3.1	3.0	5.2	3.8	1.0		3.2	2.7	2.5	3.3	3.4		2.8	3.9		4.3	1.4	0.9	8.6	4.4	1.5	1.3	6.0	2.3	5.7			3.2		2.7	1.9	3.1	1.0	1.3	3.4	2.0	2.3	3.3	2.4	3.7	2.3	0.0	0.4	1.1	0.5	3.9	0.6	0.5	4.7	8.0	2.7	3.5	1.7	2.8	1.1	4.8	3.8	1.5	4.4	1.3	4.7	4.7	1.4	1.4	1.8	2.1	0.4	1.4	1.6	2.6	2.0	4.3	3.3	5.0	2.7	4.1	2.3	0.0	2.9	4.5	12.1	0.2	1.8	7.0	2.0	0.0	0.0	2.1	2.3	1.4	0.0	2.4	1.1	3.5	0.6	0.6	0.9	9.6	1.5	2.2	0.5	3.5	0.1	0.1	0.4	0.9	6.0	0.8	0.7	2.0	2.2	2.9	1.7	1.1	0.3	1.9	2.9	1.3	1.0	0.6	1.9	3.4	2.3	1.9	0.7	3.3	2.4											6.0	11.7	6.0	6.5	5.8	3.0	4.2	10.2	5.3	5.7	10.4	2.0	4.5	1.7	10.9	0.6	11.7	32.5	0.0	22.8	16.4	5.3	10.8	19.6	9.6	21.5	0.0	23.1	6.2	10.2	0.4	6.6	13.9	6.8	12.6	13.2	2.6	27.2	25.9	6.7	5.6	2.2	0.0	5.9	28.7	11.9	8.7	1.7	8.7	8.0	9.2
PARP15	"FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577602-122639047	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.9;lymphoid tissue: 40.4"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 12.8;B-cells: 22.9;Ciliated cells: 18.7;granulocytes: 18.5;Hofbauer cells: 6.6;monocytes: 6.4;T-cells: 12.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5"	"Group enriched"	"Detected in many"	6	"B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3"	"Cell line enhanced"	"Detected in some"		"HEL: 10.6;JURKAT: 6.6;REH: 4.9;THP-1: 5.1;TIME: 12.6"					"Not detected"	"Not detected"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	2.4	0.9	0.5	24.5	0.4	9.8	1.3	0.3	0.8	1.2	2.8	1.2	0.5	1.0	1.5	2.3	1.9	1.4	2.8	1.5	0.6	0.5	1.5	1.9	5.6	20.3	0.6	0.6	1.1	2.7	0.0	1.0	1.0	0.6	1.3	2.1	1.8	5.5	0.2	2.6	0.7	22.9	0.9	0.9	40.4	1.7	1.7	0.4	9.4	1.9	1.7	34.8	3.6	1.2	11.9	1.2	1.3	0.6	5.2	9.3	2.7	0.6	0.2	0.5	0.5	0.2	0.3	0.6	0.3	0.2	0.1	0.1	0.3	1.0	0.8	0.6	0.2	0.3	0.6	0.1	0.0	0.0	1.9	0.2	10.6	0.8	0.5	0.2	0.7	0.5	2.2	0.1	0.4	0.2	0.4	2.4	6.6	0.3	2.1	0.0	0.5	3.2	0.7	0.7	0.2	0.3	4.9	0.4	0.6	0.0	1.0	0.8	0.5	0.3	0.2	0.3	0.6	0.8	5.1	12.6	0.4	1.1	0.5	0.4	1.0	0.7	2.4	0.7	0.3	0.2	1.3	0.2	0.1	9.3	0.5	6.5	11.2	5.0	6.4	0.9	11.9	4.3	5.9	0.7	5.2	0.6	1.2	4.5	2.7	0.5	0.4	0.3	0.8	0.6	0.5	0.6	0.6	0.6	0.4	17.9	12.8	22.9	0.0	0.5	0.0	0.4	0.0	18.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	18.5	0.5	6.6	0.0	0.0	2.5	3.5	0.0	0.0	3.2	1.7	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	12.9	0.0	0.0
PARP6	pART17	ENSG00000137817	"Poly(ADP-ribose) polymerase family member 6"	Q2NL67	15	72241181-72272999	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Late spermatids: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026991	Approved		Approved	"Plasma membrane"		Yes	No			"Plasma membrane"		"HPA026991: AB_1854989"	"unprognostic (3.88e-2)"	"prognostic favorable (3.17e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.36e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (8.02e-8)"	"unprognostic (6.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"	13.7	16.6	28.0	12.8	32.4	25.1	26.5	46.6	41.2	15.5	16.2	16.9	18.2	14.1	23.3	23.8	14.0	17.0	20.2	18.4	26.1	22.4	14.3	9.0	15.7	16.8	19.9	21.8	26.3	20.9	20.6	30.8	17.0	19.4	19.3	14.3	14.5	21.3	18.8	23.9	20.3	14.4	19.6	14.2	18.2	18.2	25.1	15.8	9.6	21.7	12.5	15.8	16.3	15.8	4.1	4.0	12.1	5.3	4.3	4.3	2.9	7.3	13.2	13.9	18.1	15.0	12.5	11.3	6.3	9.5	10.4	15.4	8.7	13.3	10.0	3.9	9.5	15.3	9.6	15.3	8.5	6.0	11.9	13.8	14.6	23.1	0.1	12.5	7.5	14.0	16.0	21.0	9.7	26.8	16.4	6.9	16.8	7.4	11.6	8.3	13.3	6.4	13.2	6.4	6.1	0.0	11.9	9.9	7.9	9.6	14.5	39.4	20.9	10.5	8.6	17.1	19.3	10.9	8.7	6.5	13.1	12.0	17.0	9.5	13.1	12.0	10.9	9.4	14.7	9.0	1.7	5.3	12.1	3.8	4.4	2.7	3.3	2.7	4.0	4.0	4.1	4.3	3.2	5.7	4.3	4.9	3.1	4.2	2.9	28.0	32.4	46.6	41.2	26.1	22.4	19.9	21.8	19.4	15.8	20.8	20.5	4.7	8.4	12.8	14.0	14.6	0.0	2.7	15.9	8.7	19.6	5.9	6.6	7.3	49.1	9.8	9.2	0.0	11.2	4.3	9.3	7.6	15.1	4.2	8.1	17.5	16.7	7.4	12.4	137.7	11.5	8.2	15.1	6.4	5.3	7.4	8.1	5.8	9.2	10.3	15.1	6.5	9.5	39.0	8.3	13.8	5.4	7.5	5.6	8.3
PARP8	"FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846522	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"T-cells: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	No			Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: AB_2680667"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (1.12e-4)"	6.2	7.8	8.8	17.1	9.5	33.5	5.3	2.4	18.7	5.6	5.5	3.3	0.6	6.8	5.2	5.4	5.2	7.4	12.3	3.6	12.8	8.0	5.8	4.2	10.9	18.2	4.9	11.0	5.9	7.1	9.8	14.4	5.6	5.4	6.1	4.3	4.1	7.6	4.2	1.7	4.2	14.2	5.4	7.0	20.1	10.2	6.4	2.8	9.9	21.9	1.1	12.3	8.8	7.0	7.1	3.9	13.1	5.9	15.5	32.0	9.5	11.6	0.0	5.4	8.6	1.5	2.6	8.6	1.9	7.0	1.9	5.5	0.3	15.4	6.9	8.2	0.2	19.8	5.8	0.9	5.8	4.5	9.7	7.4	5.1	4.7	0.4	2.8	11.9	0.1	3.3	4.9	3.8	2.7	11.6	0.1	10.9	0.7	4.2	2.6	3.8	14.2	15.0	5.8	0.2	2.8	7.2	11.4	7.9	3.5	5.8	6.0	9.3	6.2	10.2	1.6	8.3	0.4	42.0	0.0	0.4	7.3	0.5	5.7	3.1	0.1	13.4	6.5	3.3	7.9	10.3	5.9	13.1	20.6	1.6	32.0	6.0	16.1	23.0	3.9	7.1	10.0	16.7	12.3	15.5	1.1	1.8	9.5	9.5	8.8	9.5	2.4	18.7	12.8	8.0	4.9	11.0	5.4	2.8	29.8	22.6	12.3	4.8	7.1	13.4	4.5	12.7	21.4	21.6	21.0	0.0	17.5	6.6	11.2	19.7	4.5	6.9	0.0	8.8	5.9	9.1	8.6	13.9	3.6	12.9	6.4	14.5	8.6	28.5	11.4	1.1	17.1	8.5	13.6	3.6	0.5	14.3	7.6	2.8	3.7	2.1	6.5	6.9	5.1	5.5	3.4	20.7	90.6	6.5	13.5
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: AB_2685707"	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.3	13.0	0.9	2.7	14.7	35.1	41.9	4.2	8.9	1.8	6.0	5.4	22.1	8.9	2.3	4.8	7.3	14.0	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.6	4.7	5.0	1.2	7.0	7.5	5.6	0.8	7.5	1.4	3.5	8.9	3.5	0.4	1.6	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.2	1.2	32.4	0.5	3.8	3.1	4.5	1.5	4.4	0.3	1.6	4.7	2.4	3.3	5.2	3.1	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3	38.7	36.9	16.7	9.4	6.4	0.8	5.2	10.2	61.6	44.3	19.2	0.0	4.3	1.7	24.9	1.3	19.0	15.3	0.0	34.9	16.2	11.4	10.4	9.3	43.1	36.1	0.0	10.3	21.5	31.3	2.6	17.0	29.4	6.8	32.5	9.7	14.7	28.4	7.2	22.6	18.9	0.8	19.4	9.6	1.0	0.9	5.8	1.4	12.7	6.6	15.5
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764514	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	6.8	8.4	4.7	4.0	8.2	0.5	6.2	5.2	7.9	6.5	9.0	9.5	8.3	6.0	7.9	7.5	7.0	10.4	4.1	6.6	6.5	4.4	9.6	11.3	4.1	5.8	4.5	5.3	11.5	13.6	7.0	6.6	5.6	4.9	7.1	8.3	5.0	7.2	6.9	8.7	6.7	5.1	4.9	4.3	4.9	6.2	11.5	9.4	8.7	6.7	5.9	5.2	6.0	5.2	7.3	8.9	5.3	11.6	8.1	10.5	6.0	4.7	7.8	5.1	6.7	6.3	5.4	11.5	4.0	5.0	7.2	5.2	9.0	3.1	8.3	6.4	3.6	10.5	7.6	9.2	6.4	5.4	5.3	8.3	8.0	4.8	6.6	9.8	4.6	2.8	5.8	9.8	9.3	8.4	6.2	5.3	9.2	14.0	1.1	5.4	5.0	6.4	6.1	11.8	9.0	10.1	5.0	10.1	9.6	6.1	3.4	5.3	5.4	5.8	7.7	10.5	10.3	4.4	5.9	2.8	5.4	5.6	7.6	5.0	8.2	6.9	3.3	4.0	5.5	3.1	1.5	6.6	5.3	6.4	9.7	7.6	6.1	7.0	6.8	8.9	7.3	10.5	7.0	0.6	8.1	11.6	7.1	9.3	6.0	4.7	8.2	5.2	7.9	6.5	4.4	4.5	5.3	4.9	9.4	0.0	0.6	0.5	0.9	0.6	2.1	1.0	2.5	0.0	1.2	0.0	0.0	5.8	8.3	3.9	6.5	0.0	1.7	0.0	2.4	4.0	0.6	1.1	0.0	1.9	2.6	4.8	0.0	0.0	1.2	5.3	3.4	0.7	0.0	1.0	2.5	2.8	2.1	0.0	2.8	4.5	1.3	0.0	0.4	8.1	10.4	0.9	2.7	0.0	4.3	0.6
PARVB	CGI-56	ENSG00000188677	"Parvin beta"	Q9HBI1	22	43999211-44172949	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.1"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 64.5;Hofbauer cells: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 44.5;RPMI-8226: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062601, HPA072217"	Enhanced		Approved	Cytosol		NA	NA		90000000	Cytosol		"HPA062601: AB_2684803, HPA072217: "	"unprognostic (2.41e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.65e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.05e-3)"	15.9	10.7	6.4	9.7	7.3	16.8	17.4	3.1	8.3	8.0	7.2	3.5	6.3	3.7	8.6	8.7	7.3	6.8	5.3	28.5	5.6	8.8	7.3	7.3	12.6	19.7	8.0	6.3	13.4	4.8	8.6	9.3	10.2	5.8	7.8	4.4	9.3	5.3	7.2	82.1	5.1	6.3	11.9	8.3	15.2	5.4	5.7	4.5	2.3	4.9	22.4	7.9	11.7	26.0	6.3	14.1	4.8	6.4	0.7	2.2	8.3	6.4	7.7	0.1	5.4	8.2	10.4	0.0	9.1	5.6	5.9	4.5	7.9	3.8	0.0	5.0	24.2	4.7	0.2	12.9	0.6	3.3	9.0	8.0	27.6	13.4	0.0	13.6	20.7	24.8	16.1	6.8	4.3	0.0	4.3	44.5	0.1	9.8	18.9	6.4	4.3	0.1	13.7	2.7	5.6	5.3	0.0	0.2	43.4	0.1	0.1	7.0	4.9	2.4	0.4	22.8	0.9	4.5	8.4	27.6	5.4	5.8	8.3	0.9	4.7	4.1	0.2	23.8	6.1	29.8	4.5	6.1	1.4	1.0	6.4	1.6	6.0	1.7	1.4	6.8	6.3	0.4	0.9	4.8	0.7	2.6	14.1	2.2	8.3	6.4	7.3	3.1	8.3	5.6	8.8	8.0	6.3	5.8	4.5	0.0	11.7	29.8	2.6	4.6	9.2	34.8	5.1	6.7	1.2	1.8	15.7	0.9	23.2	1.0	5.5	46.8	0.0	46.7	2.7	8.6	19.0	3.2	64.5	9.8	82.8	6.4	1.2	46.1	44.1	13.6	18.4	40.4	18.6	44.1	0.1	6.7	5.5	0.0	10.3	11.6	13.3	6.5	6.9	1.4	3.2	3.9	1.5	12.8	0.6	1.1
PAWR	"par-4, PAR4"	ENSG00000177425	"Pro-apoptotic WT1 regulator"	Q96IZ0	12	79574979-79691097	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"memory B-cell: 5.0;naive B-cell: 6.2;NK-cell: 2.9"	"Group enriched"	"Detected in many"	8	"B-cells: 6.2;NK-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012640, CAB020779"	Approved		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Actin filaments"	"CAB020779: , HPA012640: AB_1855748"	"unprognostic (2.42e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.77e-3)"	"unprognostic (5.39e-2)"	"unprognostic (9.44e-3)"	"unprognostic (4.21e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.97e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.23e-2)"	10.3	6.1	3.4	16.1	8.9	2.1	16.4	6.2	3.3	27.4	16.6	3.8	20.1	9.4	35.0	19.3	20.8	20.4	20.2	5.6	5.5	3.3	14.4	15.5	14.6	5.0	5.7	2.6	22.1	15.1	14.6	19.0	24.8	5.3	21.8	12.6	7.9	14.3	21.1	2.7	14.5	15.0	31.5	3.6	6.1	10.8	15.4	4.9	6.7	24.5	8.4	8.6	27.5	26.2	6.2	0.3	0.5	0.0	2.9	0.4	0.1	19.8	18.5	3.3	0.1	1.7	0.7	22.2	12.7	3.7	6.4	3.9	22.8	7.6	13.2	23.6	7.0	4.6	22.1	11.6	9.5	9.3	5.4	15.6	0.0	10.6	9.8	9.2	0.2	0.3	1.6	20.3	5.1	29.1	24.1	10.7	5.5	0.7	1.8	7.0	15.1	3.1	0.0	16.1	5.7	10.2	0.0	7.6	8.5	12.3	15.0	9.7	0.0	22.7	12.1	2.0	11.7	10.8	0.1	15.7	9.8	8.8	0.3	8.4	5.9	7.5	9.7	1.6	0.0	4.2	0.5	0.0	0.1	0.1	0.0	0.0	5.0	0.3	0.2	0.3	6.2	0.4	0.4	0.5	2.9	0.0	0.2	0.0	0.1	3.4	8.9	6.2	3.3	5.5	3.3	5.7	2.6	5.3	4.9	74.5	31.8	17.5	137.7	177.7	5.8	14.9	58.6	45.5	73.9	62.8	0.0	46.7	14.9	39.3	50.0	23.5	79.7	0.0	33.3	69.4	22.7	157.7	1.1	50.5	5.6	15.9	66.0	17.8	0.6	75.0	78.6	4.6	16.9	0.0	95.3	2.4	61.3	69.1	85.6	39.3	0.9	84.1	81.4	80.9	61.3	157.1	64.3	7.2	83.0	127.7
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833275-37034185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 21.6;lymphoid tissue: 33.4"	"Cell type enriched"	"Detected in some"	27	"B-cells: 57.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 1.6"	"Group enriched"	"Detected in some"	209	"memory B-cell: 20.1;naive B-cell: 21.6"	"Lineage enriched"	"Detected in single"	216	"B-cells: 21.6"	"Group enriched"	"Detected in some"	8	"Daudi: 21.5;REH: 62.5;U-698: 28.2"	"Region enriched"	"Detected in single"	11	"midbrain: 4.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2"	"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.4	0.2	0.2	33.4	0.2	5.5	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.4	0.2	0.2	0.3	0.5	0.3	0.3	23.2	1.6	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.3	0.3	0.4	2.5	0.0	0.6	0.2	8.7	0.0	0.3	16.5	0.7	0.9	0.0	2.3	0.4	0.2	30.1	1.3	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.1	62.5	0.1	0.1	0.0	0.0	4.4	1.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	0.0	0.2	0.0	0.0	0.0	57.6	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1"	"Group enriched"	"Detected in some"	19	"Basal glandular cells: 7.6;Ciliated cells: 29.4;Club cells: 14.8;Glandular cells: 15.1;Urothelial cells: 10.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.1;HBEC3-KT: 8.1;HDLM-2: 30.7;PC-3: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016239, HPA038462"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB016239: AB_2159984, HPA038462: AB_10672594"	"unprognostic (3.09e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.1	3.7	0.4	0.0	0.0	0.0	0.2	0.1	58.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.0	0.1	0.1	34.6	1.4	0.0	0.1	2.7	0.0	0.1	86.1	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.2	0.2	0.0	11.8	0.5	27.1	33.2	0.4	3.4	0.1	0.0	0.0	0.0	0.0	2.7	0.1	3.5	1.0	0.0	1.7	1.4	2.4	1.3	0.0	0.1	0.0	0.0	0.7	1.1	0.7	0.4	0.0	0.3	8.1	1.2	8.1	0.0	30.7	5.4	0.5	0.5	0.0	0.0	0.0	2.7	0.5	3.8	0.0	1.2	0.0	0.0	3.5	2.0	0.8	0.1	4.6	0.5	0.0	0.1	1.2	13.2	0.0	0.0	0.0	0.0	4.6	2.3	0.0	0.8	4.1	0.9	0.7	3.5	0.0	0.0	0.0	0.5	1.3	0.6	0.0	0.0	3.1	0.4	0.3	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.6	0.8	0.0	0.3	0.0	29.4	14.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.6	15.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.3	0.1	0.0	0.2	10.8
PAXBP1	"C21orf66, fSAP105, GCFC, GCFC1"	ENSG00000159086	"PAX3 and PAX7 binding protein 1"	Q9Y5B6	21	32733899-32771858	"Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003757	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003757: AB_10600796"	"unprognostic (8.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.38e-3)"	"unprognostic (2.54e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.43e-4)"	"prognostic unfavorable (1.50e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	8.9	10.6	11.9	16.6	19.6	42.0	11.6	25.7	20.0	13.5	14.1	11.3	10.1	15.8	16.3	12.4	10.3	11.6	10.1	8.3	11.2	9.7	11.3	10.3	10.1	13.7	22.7	10.0	19.8	12.3	11.6	19.3	13.2	14.7	11.2	12.6	6.9	10.2	10.5	15.2	12.6	12.8	10.8	19.0	11.2	9.5	12.9	19.7	18.5	11.3	5.0	12.3	11.2	18.9	2.2	1.6	0.3	1.3	0.7	3.1	0.4	7.5	6.2	12.5	9.8	4.9	3.9	17.9	5.6	3.6	7.4	5.4	13.0	6.8	9.0	4.4	3.1	5.7	7.7	12.5	5.2	7.7	7.3	10.4	15.5	10.2	9.4	2.4	17.3	9.2	2.1	7.9	8.6	3.8	4.8	4.8	9.5	18.0	8.3	5.4	6.6	11.8	10.1	35.4	8.4	6.3	11.0	11.9	13.1	5.8	7.0	10.3	5.9	8.0	9.3	6.3	8.1	5.9	9.7	4.2	5.5	7.6	6.4	8.7	8.2	10.2	16.7	4.0	15.8	5.5	0.0	1.3	0.3	2.2	0.6	3.1	1.6	2.5	1.9	1.6	2.2	2.7	2.6	0.0	0.7	0.8	1.1	1.4	0.4	11.9	19.6	25.7	20.0	11.2	9.7	22.7	10.0	14.7	19.7	11.9	16.3	9.8	17.0	22.7	51.8	11.5	15.3	28.1	20.5	19.2	58.9	13.9	5.0	6.5	28.6	16.1	13.2	0.0	6.8	10.2	16.4	18.1	11.5	9.9	9.0	20.6	21.2	12.9	11.8	25.3	13.6	15.8	20.3	2.8	15.4	37.6	6.3	12.2	15.9	5.7	78.8	32.3	15.1	24.2	15.5	22.2	14.9	13.1	18.8	22.8
PAXIP1	"CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2"	ENSG00000157212	"PAX interacting protein 1"	Q6ZW49	7	154943687-155003084	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 32.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006694, HPA016950"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA006694: AB_1855011, HPA016950: AB_2669489"	"unprognostic (2.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.30e-1)"	6.0	5.4	5.7	6.2	5.0	9.7	6.3	32.3	5.7	7.8	5.5	5.8	4.5	5.2	6.5	6.7	7.1	5.7	5.0	4.7	6.0	3.4	5.7	6.9	4.7	9.4	5.7	1.4	7.1	8.4	7.2	8.7	7.9	5.6	7.7	5.7	6.9	6.6	5.4	7.1	7.4	6.9	9.3	4.2	6.4	5.9	10.4	6.2	31.2	6.4	4.7	6.9	6.1	5.9	2.2	3.3	1.4	3.1	2.9	6.5	2.5	9.9	8.2	10.9	18.4	4.8	4.0	9.7	4.4	4.7	6.1	7.2	9.0	7.9	13.1	5.6	5.3	12.7	7.9	13.9	7.0	7.6	13.1	10.9	9.9	5.9	7.7	3.4	13.5	13.3	3.8	5.3	6.1	2.5	3.5	5.8	13.3	13.6	8.8	6.1	13.9	28.7	11.3	17.6	9.8	5.6	16.4	11.1	14.2	6.3	8.4	8.7	5.6	11.8	8.8	5.5	10.3	6.7	11.6	2.9	5.1	0.9	7.3	10.6	9.0	5.2	18.0	12.6	16.0	13.8	0.7	2.3	1.4	2.5	2.6	3.8	1.3	4.0	2.9	2.6	2.2	6.5	1.7	1.0	2.9	3.1	3.3	3.2	2.5	5.7	5.0	32.3	5.7	6.0	3.4	5.7	1.4	5.6	6.2	6.0	7.5	6.5	4.7	5.7	18.0	6.1	7.6	4.0	9.1	8.7	9.8	7.4	5.0	3.5	1.5	5.0	4.7	0.0	2.9	6.4	6.0	6.1	2.3	8.9	3.9	3.2	2.4	3.1	4.0	2.7	8.1	3.6	3.3	3.6	8.7	9.3	4.0	2.9	8.9	3.1	12.8	0.0	2.5	15.2	19.9	6.0	5.1	3.9	9.9	3.5
PBDC1	"CXorf26, MGC874"	ENSG00000102390	"Polysaccharide biosynthesis domain containing 1"	Q9BVG4	X	76172936-76178204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003155	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		88000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003155: AB_1078592"	"unprognostic (6.95e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-3)"	"unprognostic (8.82e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.98e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (1.62e-1)"	24.9	25.4	12.7	15.1	14.3	28.9	17.1	15.3	14.9	21.3	31.5	10.0	14.8	28.5	21.3	18.4	26.9	15.1	14.2	14.7	12.5	12.5	36.3	39.1	16.6	17.0	17.6	8.8	23.1	16.1	15.2	22.8	21.9	15.0	22.3	20.9	10.3	18.0	14.3	19.2	19.5	48.9	22.3	22.7	23.8	17.8	8.4	14.6	21.1	22.5	21.2	18.2	20.8	17.6	28.1	24.0	17.0	27.8	27.1	30.6	17.1	12.1	17.7	15.2	10.4	19.5	19.5	13.1	21.6	18.5	19.9	17.2	16.9	16.8	16.6	14.6	21.8	24.8	17.5	25.3	24.2	26.0	12.3	16.0	12.3	9.9	25.3	30.7	36.1	18.1	15.5	19.9	27.2	23.3	12.1	25.3	6.0	17.4	8.3	24.3	14.2	17.0	26.5	42.2	30.2	27.8	14.6	16.0	2.1	29.1	22.5	8.9	11.5	9.5	15.9	0.1	20.5	9.7	13.6	21.7	14.9	14.9	17.7	19.7	14.6	25.8	9.9	16.5	12.7	11.7	6.7	17.6	17.0	30.6	25.6	22.2	28.1	27.5	29.7	22.5	23.7	28.2	26.9	3.3	27.1	27.8	24.0	22.5	17.1	12.7	14.3	15.3	14.9	12.5	12.5	17.6	8.8	15.0	14.6	32.8	23.2	24.8	69.4	47.1	21.4	36.9	33.1	33.5	30.7	38.4	13.7	48.2	41.4	60.7	1.0	28.6	58.6	0.0	54.4	49.7	36.0	52.4	50.7	46.4	62.6	7.9	26.5	19.6	30.5	1.1	44.3	40.9	43.9	80.2	37.2	21.5	53.5	34.8	36.4	66.3	19.3	51.8	41.1	2.3	16.4	61.6	46.0	44.5	46.0	68.1
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809620-27838095	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 19.4;testis: 67.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 218.2;Spermatocytes: 187.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 1.6"	"Group enriched"	"Detected in many"	10	"NK-cells: 2.1;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 61.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	0.6	0.8	0.2	7.7	0.3	3.3	1.3	0.3	0.4	1.1	3.8	0.3	0.2	3.7	0.4	0.6	6.2	0.3	0.8	3.3	0.3	0.2	0.7	0.9	1.2	5.4	0.3	0.2	0.4	0.4	0.0	0.2	2.2	0.3	0.4	4.6	0.2	1.1	0.2	0.4	1.9	3.6	0.9	0.6	1.7	1.7	67.9	0.2	19.4	0.3	4.7	5.3	0.7	1.9	0.1	0.0	0.0	0.0	2.1	1.6	0.5	61.3	20.0	19.7	12.5	1.9	3.5	8.3	28.2	13.4	29.0	24.5	6.9	11.4	32.7	10.0	10.8	32.3	16.3	18.9	9.5	31.9	8.0	10.2	7.8	14.2	10.1	0.1	5.1	11.7	0.9	7.8	13.4	7.2	5.2	14.6	16.2	11.5	22.0	34.2	6.9	19.3	6.0	3.5	16.6	17.4	12.1	27.4	8.8	10.9	9.5	7.8	12.2	10.5	12.4	15.8	5.7	13.0	7.8	8.5	19.1	46.0	24.2	29.9	3.1	8.7	15.1	11.6	9.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	1.6	0.5	0.2	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.9	7.9	0.0	0.3	5.1	0.0	2.3	0.0	0.0	3.1	0.0	0.5	218.2	0.0	1.3	46.7	0.0	40.6	2.9	0.7	0.0	1.0	4.2	0.0	0.0	7.4	1.9	37.5	7.8	0.6	0.0	0.0	4.3	0.0	0.2	0.0	2.8	0.0	0.0	6.5	0.5	187.0	31.0	2.0	5.6	0.0	5.3	0.7
PBLD	"FLJ14767, MAWBP, MAWDBP"	ENSG00000108187	"Phenazine biosynthesis like protein domain containing"	P30039	10	68282660-68333049	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 47.3;kidney: 74.5;liver: 91.4"	"Cell type enhanced"	"Detected in many"	16	"Distal tubular cells: 92.9;Enterocytes: 114.6;Hepatocytes: 159.6;Proximal tubular cells: 362.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA038035, HPA038036"	Enhanced		Approved	Vesicles		NA	NA		420000	Vesicles		"HPA038035: AB_10672470, HPA038036: AB_10675625"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.25e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.68e-2)"	5.0	5.9	3.6	2.4	6.4	2.5	2.9	2.3	8.0	4.1	9.4	11.8	6.8	47.3	4.5	5.1	1.5	2.3	2.9	3.3	3.9	3.1	74.5	91.4	2.3	2.8	6.7	5.6	2.3	17.9	2.4	2.4	7.0	8.4	2.6	8.0	9.4	2.2	6.2	2.3	1.8	39.3	6.5	4.9	1.6	15.0	2.1	6.2	2.5	1.9	4.3	1.6	4.1	1.6	1.7	5.6	6.4	5.8	3.3	2.3	2.5	3.4	6.9	6.7	4.6	6.1	3.5	3.1	13.9	8.8	5.3	5.6	6.3	8.8	3.9	5.4	9.7	2.2	5.3	3.1	3.6	4.6	1.8	5.1	3.1	7.5	5.7	3.0	4.5	3.1	6.2	4.3	3.2	4.0	9.6	3.2	3.7	2.7	8.6	8.3	5.3	4.1	7.9	1.9	2.7	3.0	7.2	8.8	6.4	10.6	5.0	3.9	5.2	9.3	5.4	6.4	1.9	18.7	5.4	10.0	5.3	3.8	2.5	2.2	5.2	3.7	5.7	6.3	2.5	1.3	4.2	5.8	2.9	0.9	2.9	1.8	1.7	1.4	0.9	5.6	1.6	2.3	1.6	6.4	3.3	1.7	2.4	2.3	2.5	3.6	6.4	2.3	8.0	3.9	3.1	6.7	5.6	8.4	6.2	3.0	3.4	6.1	1.7	1.6	4.7	2.8	25.5	17.4	5.7	52.4	9.8	3.1	92.9	5.7	0.8	2.9	114.6	0.0	28.7	2.1	3.3	2.4	1.1	159.6	2.6	9.5	6.9	7.4	7.8	0.0	3.7	4.2	1.7	4.6	34.2	5.0	16.3	35.1	2.8	362.3	16.5	0.0	5.6	1.2	1.4	0.5	2.6	2.2	34.0	3.1
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"HEL: 30.9;NTERA-2: 30.3;SK-BR-3: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	13.2	17.3	14.9	8.3	15.0	1.4	16.4	14.1	17.4	73.4	26.3	11.2	15.9	13.6	67.2	15.3	20.8	35.1	25.8	12.6	10.9	9.7	15.4	4.2	10.4	2.3	11.6	14.6	35.2	29.4	21.3	12.4	9.6	8.1	27.6	9.3	10.2	19.6	25.1	16.8	6.0	14.6	56.8	8.0	5.1	13.9	9.7	8.7	2.7	17.4	8.5	6.6	32.2	24.7	0.0	0.1	2.9	0.0	0.3	0.2	2.5	1.1	22.6	22.3	6.0	15.1	7.3	1.3	9.5	6.1	2.6	1.8	4.3	4.0	0.0	2.0	12.9	1.4	7.9	8.8	2.5	1.0	1.1	9.4	30.9	18.2	0.0	10.0	0.0	7.9	7.2	0.0	1.6	0.7	5.6	0.1	0.0	0.0	0.0	0.7	14.9	0.0	0.1	30.3	1.3	1.1	0.0	7.4	9.0	1.8	13.5	0.8	13.2	10.9	62.4	0.0	21.3	23.7	0.0	0.1	1.3	3.1	8.8	2.7	2.8	21.3	0.0	0.1	0.0	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.1	0.0	2.5	14.9	15.0	14.1	17.4	10.9	9.7	11.6	14.6	8.1	8.7	20.8	15.2	0.9	91.3	20.3	27.6	44.2	91.7	25.4	21.6	31.4	104.1	89.0	28.2	41.5	72.1	39.2	28.0	0.0	58.9	4.5	75.2	44.0	71.4	17.3	8.6	4.8	87.2	60.8	1.6	78.2	59.0	6.8	15.1	1.8	35.4	34.9	31.8	59.6	97.6	49.4	28.8	38.8	62.7	0.9	11.5	24.6	87.5	3.2	39.4	82.1
PBX2	"G17, HOX12, PBX2MHC"	ENSG00000204304	"PBX homeobox 2"	P40425	6	32184741-32190186	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061478	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061478: AB_2684535"	"unprognostic (9.73e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (4.98e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.27e-1)"	15.3	17.7	14.1	14.9	14.8	8.1	12.3	19.3	16.4	17.0	20.8	16.4	36.2	13.7	23.0	39.1	19.7	21.9	19.1	13.6	15.9	10.7	14.8	14.6	26.4	24.0	13.7	10.0	25.0	12.3	10.8	24.3	30.7	12.9	18.4	15.3	15.0	14.6	29.1	17.2	22.0	17.2	22.3	12.2	29.6	22.4	9.9	17.7	17.1	25.6	14.4	20.6	17.4	18.4	0.2	1.8	0.7	0.2	0.0	0.2	0.1	2.3	2.4	12.3	9.5	13.2	16.7	6.9	2.0	4.7	5.4	5.5	3.3	3.7	10.8	12.4	7.2	0.9	6.8	3.8	14.0	5.4	8.0	15.6	8.8	4.3	2.6	11.4	6.1	9.5	22.0	7.7	4.0	11.7	6.7	9.6	17.7	13.3	5.2	2.1	10.7	6.7	13.1	0.1	1.3	1.5	9.0	2.6	12.5	11.8	4.0	4.6	6.4	1.6	3.4	13.4	8.5	8.7	12.6	2.5	4.1	10.6	1.7	2.1	27.7	18.1	13.8	8.7	5.0	6.9	0.0	0.2	0.7	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.0	0.1	1.8	0.0	0.1	14.1	14.8	19.3	16.4	15.9	10.7	13.7	10.0	12.9	17.7	6.0	14.1	14.8	16.4	16.3	17.4	2.4	25.5	2.7	5.7	15.7	7.9	25.3	3.3	14.4	0.6	11.3	9.8	0.0	11.9	23.0	14.3	16.8	15.0	19.2	16.1	25.4	29.2	25.8	34.2	1.8	18.7	18.4	8.5	9.0	15.8	19.8	12.1	14.0	18.4	7.7	4.6	6.5	18.9	0.7	3.4	16.9	39.5	15.0	14.4	15.7
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.7"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 16.1"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 16.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 36.5"	"Region enhanced"	"Detected in all"		"olfactory region: 205.0"	"Region enriched"	"Detected in all"	4	"olfactory region: 287.4"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	8.0	25.0	4.4	16.2	11.6	3.0	10.4	6.6	3.4	16.6	18.9	3.7	6.5	3.1	10.7	10.9	9.1	5.9	22.8	16.1	2.9	6.3	3.4	7.6	9.4	6.1	9.5	3.4	35.0	12.9	86.7	6.8	3.1	13.0	18.8	6.1	7.1	10.5	12.3	3.6	8.2	6.0	21.2	17.6	5.5	10.0	5.1	6.2	6.8	14.7	5.5	3.8	13.3	12.0	1.8	16.1	2.9	1.8	3.8	2.1	1.0	4.7	4.6	20.8	19.2	5.8	9.5	3.7	12.4	7.1	8.7	6.2	5.9	9.4	4.7	1.5	9.9	8.9	3.6	11.7	5.0	17.2	5.0	8.3	4.0	3.5	2.3	7.4	4.4	7.3	4.8	5.7	6.8	4.4	19.2	9.7	3.2	0.2	4.5	17.9	2.5	4.1	2.1	15.3	5.7	3.1	7.7	31.0	0.6	6.6	2.8	11.2	19.4	8.6	1.6	3.8	8.2	7.1	36.5	11.7	17.6	4.8	10.3	23.2	3.2	5.0	4.9	8.4	6.2	9.0	2.9	1.8	2.3	0.9	1.6	1.2	1.4	1.2	1.0	2.1	1.8	2.1	1.0	1.7	3.8	1.3	16.1	1.8	1.0	4.4	11.6	6.6	3.4	2.9	6.3	9.5	3.4	13.0	6.2	8.9	14.7	3.2	9.5	20.1	6.8	52.9	2.5	9.4	13.6	12.2	35.3	0.3	6.6	9.5	11.1	10.8	0.9	0.0	2.2	0.8	11.1	16.7	16.1	9.6	14.6	39.7	11.1	11.1	29.5	8.8	18.4	15.9	6.8	9.0	6.2	8.0	2.8	15.9	10.6	1.5	38.9	0.0	12.0	12.2	7.9	23.1	0.3	7.2	2.3	7.6
PBX4		ENSG00000105717	"PBX homeobox 4"	Q9BYU1	19	19561707-19618916	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 16.9;thyroid gland: 14.4"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 23.3;Spermatogonia: 8.7;T-cells: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdT-cell: 2.8;MAIT T-cell: 3.3;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7;T-reg: 5.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"A-431: 4.0;PC-3: 4.3;RT4: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049859, HPA056469"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA049859: AB_2680918, HPA056469: AB_2797256"	"unprognostic (5.36e-3)"	"prognostic favorable (8.69e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.44e-6)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-2)"	"prognostic favorable (5.94e-7)"	1.0	0.5	2.2	4.5	3.4	1.7	1.0	1.2	1.9	0.9	1.6	0.0	4.6	1.1	0.6	1.3	0.8	1.0	7.1	0.6	2.3	2.5	1.0	0.5	1.8	3.6	0.8	1.2	1.2	0.5	0.7	1.7	1.2	1.5	1.1	1.1	0.7	1.4	2.7	0.5	2.0	1.7	0.5	0.7	1.8	1.7	16.9	0.6	6.1	14.4	0.5	9.6	1.4	0.8	0.3	0.0	0.0	0.1	0.0	5.4	0.8	4.0	0.2	1.9	0.0	0.0	0.0	2.1	0.0	1.6	1.7	1.7	0.0	1.4	0.4	0.9	1.0	1.6	1.6	2.7	0.0	0.7	0.3	0.8	0.0	0.9	0.1	0.3	0.0	1.3	0.5	0.0	0.3	0.0	0.0	0.0	1.8	0.1	0.0	0.3	0.8	1.4	0.1	0.3	2.2	4.3	0.8	0.0	0.0	1.1	5.3	1.2	2.3	1.5	0.2	0.9	0.2	0.8	0.0	0.0	0.0	1.0	2.1	0.8	0.0	1.8	0.3	0.1	0.2	0.0	0.0	0.0	0.0	2.8	0.0	3.3	0.3	2.0	2.9	0.0	0.0	1.8	1.7	0.0	0.0	0.1	0.0	5.4	0.8	2.2	3.4	1.2	1.9	2.3	2.5	0.8	1.2	1.5	0.6	0.0	2.6	0.5	2.2	4.2	0.4	0.4	0.0	2.7	2.3	0.0	0.0	0.0	1.7	0.8	1.6	0.0	0.5	0.0	0.0	1.0	2.6	2.1	0.0	0.0	0.4	0.0	0.0	0.6	0.8	1.1	0.3	0.3	1.7	1.8	2.1	1.1	1.5	0.0	0.7	0.0	0.0	6.5	1.2	23.3	8.7	2.3	0.0	15.0	0.6	2.6
PBXIP1	HPIP	ENSG00000163346	"PBX homeobox interacting protein 1"	Q96AQ6	1	154944076-154956123	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 200.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"Karpas-707: 159.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006949	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA006949: AB_1079572"	"unprognostic (6.17e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (8.94e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (7.19e-4)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.64e-4)"	"unprognostic (1.20e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (3.89e-1)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.26e-3)"	25.3	48.1	35.4	24.9	54.9	13.7	19.9	18.3	31.4	26.8	36.2	26.1	28.1	25.5	28.3	29.8	23.6	22.8	31.1	21.9	46.6	28.6	18.1	13.3	22.6	28.6	41.8	34.4	50.1	17.6	42.4	56.7	21.2	47.8	26.4	14.3	38.6	20.7	48.3	57.2	13.2	28.6	52.6	29.0	27.5	28.1	15.9	33.8	27.9	33.1	22.4	26.8	37.5	25.7	9.2	4.0	42.9	6.6	13.0	46.8	14.4	1.0	2.7	4.3	2.9	15.1	4.7	3.2	3.6	8.0	1.7	3.4	0.7	3.5	4.3	11.6	4.3	2.5	3.8	1.0	2.3	1.2	2.3	1.6	1.0	3.6	2.7	7.0	1.2	12.2	7.1	3.8	2.2	0.4	20.3	6.5	3.4	0.5	159.6	4.3	1.5	2.4	3.8	1.6	2.7	2.0	2.8	6.2	9.5	4.8	2.0	0.7	5.5	4.6	1.4	3.6	8.6	4.5	5.1	6.1	1.7	1.3	1.1	1.1	21.9	18.3	1.0	6.2	1.7	1.3	26.7	2.5	42.9	11.0	3.6	30.4	9.2	29.5	17.2	2.2	5.7	19.7	12.1	23.7	13.0	6.6	4.0	46.8	14.4	35.4	54.9	18.3	31.4	46.6	28.6	41.8	34.4	47.8	33.8	62.5	78.3	31.8	22.2	9.0	23.1	34.4	22.9	26.8	37.5	40.1	15.7	14.6	0.0	37.4	112.5	21.6	20.0	23.3	16.1	20.0	28.9	16.8	49.8	14.3	13.0	1.6	80.4	24.5	16.1	134.8	59.5	13.3	25.3	31.5	22.2	200.0	21.7	25.9	121.3	9.1	6.5	51.8	57.0	2.4	12.9	10.0	22.7	93.7	14.3	12.9
PCBD2	"DCOH2, DCOHM"	ENSG00000132570	"Pterin-4 alpha-carbinolamine dehydratase 2"	Q9H0N5	5	134904906-135007959	"Enzymes, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036428	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036428: AB_10670103"	"unprognostic (3.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.22e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.57e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.50e-1)"	4.9	8.1	5.4	7.0	6.6	6.6	5.3	3.0	4.4	3.9	8.7	6.5	9.4	8.0	6.5	8.4	9.3	4.9	6.9	13.8	5.0	5.3	9.2	9.8	6.5	5.0	5.6	5.2	5.1	12.9	9.6	6.1	4.8	6.8	4.7	6.4	9.6	14.2	7.9	47.0	6.7	12.7	7.6	7.0	5.5	7.1	5.5	5.8	5.3	8.3	13.5	8.1	5.6	5.5	8.2	11.5	7.2	10.1	6.3	6.6	4.3	7.8	7.6	8.1	6.1	5.6	4.8	6.0	6.3	4.9	3.6	3.6	14.2	20.1	9.4	10.6	4.2	7.1	5.3	5.5	6.0	3.3	13.1	3.7	5.3	8.1	8.5	5.4	6.1	3.8	2.6	5.9	3.7	8.7	4.2	4.2	7.3	7.7	14.1	6.3	16.1	6.4	10.4	4.5	10.8	7.4	10.2	7.6	8.3	6.6	6.7	6.1	8.0	9.4	4.9	7.8	7.1	13.7	8.1	4.6	6.9	5.2	6.1	8.0	11.0	15.0	6.4	6.2	7.5	4.5	2.7	10.1	7.2	5.1	6.3	5.0	8.2	6.3	5.3	8.6	8.2	5.4	5.3	3.3	6.3	6.1	11.5	6.6	4.3	5.4	6.6	3.0	4.1	5.0	5.3	5.6	5.2	6.8	5.8	8.9	6.4	4.5	5.6	3.2	12.0	29.7	17.8	10.7	3.4	15.7	11.8	10.5	18.3	14.5	5.4	8.4	17.2	46.7	15.8	21.0	4.9	6.2	5.8	21.7	21.4	22.3	4.1	6.7	5.9	2.5	6.6	9.5	5.0	31.5	8.4	13.5	15.4	3.5	2.1	21.4	46.7	0.0	5.3	5.6	10.4	5.3	8.5	7.5	15.8	7.2
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 151.7;Cone photoreceptor cells: 47.1;Horizontal cells: 109.7;Late spermatids: 60.8;Rod photoreceptor cells: 75.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 47.4;pons and medulla: 23.0"	"Cell type enhanced"	"Detected in many"		"eosinophil: 5.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.9;HDLM-2: 27.2;HSkMC: 20.9;SH-SY5Y: 23.6;U-87 MG: 12.6;U-937: 15.1"	"Region enriched"	"Detected in all"	5	"olfactory region: 280.8"	"Region enhanced"	"Detected in all"		"olfactory region: 184.8"	"HPA030247, HPA073145"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244, HPA073145: "	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	6.5	11.7	6.0	11.2	6.7	12.3	6.3	47.4	12.6	3.8	7.9	7.0	2.2	3.1	9.3	12.4	1.4	3.2	4.4	2.7	6.5	7.3	2.2	1.1	1.8	5.0	6.9	3.7	3.4	3.5	0.6	14.8	2.3	23.0	1.5	3.0	20.2	1.7	1.9	1.1	1.6	4.8	12.3	7.3	11.6	3.4	20.5	6.1	22.6	0.8	0.0	4.6	2.3	1.8	2.9	0.0	5.9	0.4	0.6	1.6	0.5	0.0	0.0	0.2	0.0	6.9	14.9	0.0	0.8	0.2	1.6	0.7	0.0	0.0	0.0	0.3	4.0	1.9	0.0	0.8	0.0	0.2	27.2	0.1	0.0	0.0	0.0	7.0	0.0	0.0	20.9	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.1	0.9	0.3	7.7	1.6	0.4	0.0	1.3	0.0	0.0	1.1	0.0	0.0	2.6	23.6	0.5	0.0	0.0	0.7	0.0	4.2	0.0	0.0	0.0	6.1	0.0	0.3	1.5	0.0	12.6	15.1	0.5	4.4	0.4	5.9	1.6	0.3	0.3	2.9	0.9	0.0	0.0	1.9	1.5	0.2	1.4	0.6	0.2	0.0	0.8	0.5	6.0	6.7	47.4	6.0	6.5	7.3	6.9	3.7	23.0	6.1	0.0	0.0	1.4	0.1	0.2	151.7	2.8	0.0	0.0	1.2	1.8	47.1	0.0	0.0	0.1	29.4	0.5	0.0	0.0	0.2	0.1	1.3	0.9	0.0	0.0	0.4	109.7	2.9	2.5	0.0	60.8	7.8	0.2	3.3	0.0	0.0	29.6	1.4	0.0	12.0	0.0	75.1	0.0	5.3	25.0	12.0	0.0	0.0	0.0	0.0	0.3
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149315-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.0;placenta: 31.1;seminal vesicle: 23.6"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 16.2;Muller glia cells: 8.7;Smooth muscle cells: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 6.9;HUVEC TERT2: 16.1;MOLT-4: 13.4;TIME: 32.0;U-138 MG: 8.6;U-251 MG: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: AB_2686605"	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	1.9	7.6	17.9	1.5	35.5	1.2	1.3	1.7	48.0	3.3	1.5	23.2	4.5	1.3	3.1	1.9	1.6	2.6	1.9	1.8	17.5	12.6	3.7	1.3	2.0	1.2	13.2	16.3	4.1	1.4	1.2	1.7	31.1	13.6	14.7	1.5	1.3	1.8	23.6	1.2	1.3	1.7	2.0	6.8	1.2	1.3	2.9	19.2	0.9	1.5	0.0	1.2	3.6	3.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	5.2	0.0	0.1	0.0	0.0	5.0	2.7	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	16.1	0.0	0.2	0.0	2.4	0.0	13.4	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	32.0	8.6	0.0	0.0	7.3	0.0	0.0	0.0	0.6	0.0	4.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.9	35.5	1.7	27.7	17.5	12.6	13.2	16.3	13.6	19.2	0.0	1.1	0.0	0.2	0.1	16.2	2.0	0.0	0.0	1.2	0.0	0.0	0.7	1.7	0.0	3.3	1.0	0.0	0.0	0.0	0.7	1.6	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.4	0.0	2.3	0.0	4.7	1.8	0.7	0.3	2.4	0.0	0.0	0.4
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631810-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;lymphoid tissue: 32.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 31.0;Endothelial cells: 49.1;Ito cells: 86.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"AF22: 16.2;HEK 293: 10.1;U-87 MG: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA		31000	Cytosol	"Vesicles, Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	2.0	2.4	8.0	2.1	11.2	0.3	0.9	4.6	18.2	2.9	1.2	6.2	0.3	1.1	2.6	1.3	1.7	2.5	3.6	2.3	6.5	12.1	1.6	1.4	13.5	0.9	7.4	4.8	0.8	6.2	2.0	1.0	4.7	4.4	1.2	1.2	1.1	1.0	1.1	1.8	0.6	0.7	2.6	4.4	32.7	1.8	8.9	7.7	0.0	3.4	0.4	0.8	3.4	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.1	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	2.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	1.4	0.0	1.0	0.0	0.0	0.0	6.1	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	11.2	4.6	7.8	6.5	12.1	7.4	4.8	4.4	7.7	0.0	7.0	0.0	0.0	2.4	3.5	4.2	0.0	9.4	15.9	1.8	0.0	0.2	0.0	6.9	31.0	49.1	0.0	0.0	7.0	0.1	1.8	0.3	0.0	0.0	0.5	0.0	0.0	86.5	2.8	11.9	1.7	0.8	10.1	2.8	0.0	2.1	2.1	0.0	1.1	0.0	0.0	6.5	7.6	15.8	10.1	0.9	0.0	0.0	0.0	0.1
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Fibroblasts: 43.4;Leydig cells: 35.1;Peritubular cells: 55.2;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.3;memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 35.8;ASC diff: 43.2;ASC TERT1: 48.1;BJ hTERT+: 21.1;fHDF/TERT166: 34.1;HHSteC: 31.9;HSkMC: 48.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		1200000	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	28.4	3.5	4.2	7.2	4.0	0.0	16.2	2.0	2.7	30.4	13.3	2.1	9.8	6.0	34.0	8.7	11.2	8.6	14.9	8.9	2.7	3.6	5.4	3.0	5.9	2.6	5.2	1.4	14.9	2.4	1.8	3.5	29.0	5.4	23.3	9.5	21.8	6.3	9.5	10.3	5.1	9.0	25.4	5.4	4.0	5.5	9.7	4.0	1.0	8.2	7.7	1.9	17.5	16.3	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	35.8	0.0	43.2	48.1	0.0	6.4	21.1	1.2	1.9	0.0	0.0	0.0	0.0	34.1	0.1	0.0	8.3	0.1	0.6	0.0	0.2	0.0	0.0	0.0	31.9	0.0	0.0	48.9	0.0	2.3	0.9	1.2	0.2	0.1	0.0	0.1	0.6	0.0	0.9	0.0	0.0	0.0	0.6	2.7	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	9.8	0.2	0.0	0.0	16.7	1.0	3.3	0.1	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.2	4.0	2.0	2.7	2.7	3.6	5.2	1.4	5.4	4.0	0.0	0.3	0.0	0.2	3.7	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.2	43.4	0.0	0.0	0.0	2.6	0.0	0.0	4.3	0.0	0.2	35.1	0.0	1.7	0.0	0.0	6.5	0.0	0.0	55.2	0.0	0.1	19.4	8.6	0.7	0.1	2.3	0.7	0.0	0.0	0.0
PCDH19	"EFMR, EIEE9, KIAA1313"	ENSG00000165194	"Protocadherin 19"	Q8TAB3	X	100291644-100410273	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 27.1"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 7.1;Cholangiocytes: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 20.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027533	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA027533: AB_10602043"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.37e-1)"	4.9	1.1	19.8	1.3	10.5	0.7	3.7	1.0	22.5	5.5	4.0	1.9	0.0	1.2	3.8	1.3	2.9	2.2	2.0	1.6	27.1	12.8	1.4	0.9	1.0	1.3	3.7	14.2	3.6	1.1	1.2	2.1	1.0	7.3	1.4	5.5	6.4	2.1	1.6	2.4	3.3	1.8	3.1	3.7	0.8	2.0	2.3	1.0	0.0	1.1	0.7	0.9	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.1	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	3.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	10.5	1.0	22.5	27.1	12.8	3.7	14.2	7.3	1.0	0.0	0.3	0.0	0.0	2.7	7.1	1.4	7.6	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.7	2.8	0.0	0.0	0.0	0.1	1.8	0.4	0.0	0.0	0.1	0.0	1.7	1.3	0.0	1.9	3.1	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.4	0.0	1.6	0.0	0.5	0.0	0.7	1.4	0.0	0.0	0.0	0.0
PCDH20	"FLJ22218, PCDH13"	ENSG00000280165	"Protocadherin 20"	Q8N6Y1	13	61409685-61415522	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;smooth muscle: 12.7"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 3.0;Ciliated cells: 1.4;Melanocytes: 1.7;Mucus-secreting cells: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"RPTEC TERT1: 34.6"									HPA062669			Approved	"Vesicles,Cytokinetic bridge"		NA	NA			Vesicles	"Cytokinetic bridge"	"HPA062669: AB_2732687"	"unprognostic (2.40e-1)"		"unprognostic (1.80e-1)"		"unprognostic (2.45e-1)"		"unprognostic (7.83e-2)"	"unprognostic (6.79e-4)"			"unprognostic (2.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.34e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.12e-1)"		0.3	1.6	6.7	0.4	5.8	0.0	1.3	0.0	13.1	3.5	4.5	0.0	0.2	1.2	4.3	4.3	1.8	0.2	0.9	4.8	13.4		1.2	1.8	4.7	0.0	8.8	3.8	0.3	0.1	0.0	0.7	1.3	6.9	1.5	2.5	0.0	0.7	1.5	0.1	0.5	1.4	12.7	8.4	1.6	1.5	0.4	6.3	0.0	0.3	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	34.6	0.0	0.5	1.3	0.0	2.4	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.1
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 16.5;brain: 47.0"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 324.5;Cardiomyocytes: 94.6;Horizontal cells: 187.5;Muller glia cells: 87.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive B-cell: 16.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 16.5"	"Cell line enhanced"	"Detected in many"		"AF22: 12.6;LHCN-M2: 20.8;TIME: 24.1;U-698: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome		NA	NA		1300000	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	4.5	3.2	18.4	1.1	24.7	4.1	1.5	6.7	47.0	1.8	1.3	7.8	0.0	0.9	1.0	2.1	1.0	1.1	2.4	5.7	15.0	10.0	3.5	2.3	2.3	1.4	21.4	11.0	1.4	2.0	0.7	1.3	0.7	16.6	2.5	1.3	0.0	1.0	5.6	2.0	0.9	1.0	1.2	11.0	1.6	1.7	1.6	18.9	0.7	1.8	0.0	1.4	1.1	0.6	16.5	1.0	2.5	0.0	0.7	0.1	0.2	0.0	9.5	12.6	0.0	3.4	2.6	0.0	1.9	0.1	1.3	0.5	0.0	0.0	2.7	0.0	1.4	0.4	0.0	1.0	0.3	0.6	0.0	5.0	0.1	0.1	0.0	3.3	0.3	0.1	6.3	0.3	1.5	2.5	0.3	1.0	1.1	0.3	0.1	20.8	0.7	5.7	0.0	0.1	0.2	1.2	8.7	0.4	0.0	0.2	0.0	1.6	0.6	0.0	0.1	0.1	0.3	0.0	0.0	24.1	0.7	0.6	2.9	1.0	3.7	0.0	31.7	5.4	0.0	2.5	2.5	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	16.5	0.1	0.1	0.1	0.7	0.0	1.0	0.0	0.2	18.4	24.7	6.7	24.6	15.0	10.0	21.4	11.0	16.6	18.9	17.9	45.8	7.2	2.3	1.6	324.5	94.6	0.0	0.0	7.9	5.2	19.6	0.1	8.3	1.7	3.0	2.9	0.0	0.0	0.0	0.2	8.7	2.6	1.1	3.4	0.2	187.5	60.1	19.0	2.2	2.2	27.3	1.0	10.1	0.0	0.2	87.9	0.2	0.3	13.8	0.6	25.3	6.5	25.0	4.7	5.8	0.3	0.0	1.7	0.4	0.7
PCDHA1		ENSG00000204970	"Protocadherin alpha 1"	Q9Y5I3	5	140786136-141012347	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.1;testis: 3.1"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ito cells: 1.3;Sertoli cells: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"T-47d: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035969	Enhanced		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA			"Plasma membrane"		"HPA035969: AB_10673492"	"unprognostic (2.76e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-4)"	"unprognostic (7.38e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.01e-5)"	"unprognostic (2.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.29e-1)"	0.2	1.5	4.6	0.2	4.4	0.1	0.2	3.3	7.1	0.2	0.3			0.7	0.5	0.1	0.2	0.2	0.4	0.1	5.0	3.7	0.6	0.1	0.2	0.3	3.4		0.2	0.2	1.0	1.4	0.1		0.2	0.2		0.1	0.1	0.1	0.1	0.6	0.2	3.4	0.2	0.3	3.1			0.2		0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.0	0.0	0.2	1.8	0.3	14.4	0.5	0.0	1.6	1.0	0.7	0.1	0.0	0.1	0.0	0.4	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA11	"CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11"	ENSG00000249158	"Protocadherin alpha 11"	Q9Y5I1	5	140868183-141012344	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.3;parathyroid gland: 4.7"	"Cell type enhanced"	"Detected in single"	20	"Bipolar cells: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;EFO-21: 8.8;MCF7: 4.5;T-47d: 6.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077160			Approved	"Vesicles,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Vesicles, Cell Junctions"	"Cytoplasmic bodies"	"HPA077160: AB_2686827"	"unprognostic (1.54e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.98e-3)"		"unprognostic (1.36e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-4)"	"unprognostic (9.91e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.26e-2)"	0.1	0.6	1.0	0.1	1.6	0.0	0.2	7.0	9.3	1.3	0.0			0.0	0.6	0.1	0.0	0.2	1.0	0.0	0.8	1.0	1.2	0.0	0.8	0.0	0.3		0.0	3.3	4.7	1.6	0.0		0.1	0.0		1.3	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	1.6			1.5		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	4.0	16.8	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	8.8	0.0	0.9	0.0	0.2	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.5	0.4	0.0	1.0	0.0	0.1	0.0	4.5	0.0	0.0	3.7	0.8	3.2	0.0	0.0	0.0	0.4	1.9	0.8	2.2	0.0	1.8	0.4	2.4	6.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA12	PCDH-ALPHA12	ENSG00000251664	"Protocadherin alpha 12"	Q9UN75	5	140875302-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 26.8;Bipolar cells: 11.2;Cone photoreceptor cells: 5.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.2;AN3-CA: 4.1;hTCEpi: 6.4;PC-3: 7.8;RT4: 7.7;SH-SY5Y: 4.4"									HPA035812	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA035812: AB_2674796"	"unprognostic (3.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.74e-2)"			"unprognostic (2.24e-2)"		"unprognostic (2.08e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.18e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.97e-2)"	1.0	1.7	0.9	0.3	1.2	0.0	0.9	14.6	3.7	3.5	0.4	1.1	0.0	0.1	1.0	0.5	0.2	1.9	4.3	0.3	1.0	0.7	3.8	1.7	5.7	0.2	0.5	0.8	0.3	2.4	0.9	4.6	0.0	2.3	0.4	0.1	1.5	5.7	0.3	0.1	0.2	0.2	0.6	0.8	0.2	0.3	2.1	0.2	0.0	3.4	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	2.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	2.4	2.6	7.8	0.0	0.0	0.0	0.3	7.7	0.3	4.4	0.0	0.9	0.1	0.5	1.6	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	14.6	3.7	1.0	0.7	0.5	0.8	2.3	0.2	26.8	3.2	0.0	0.0	0.0	11.2	0.4	5.1	0.0	0.0	1.8	5.9	0.0	0.0	0.9	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.3	0.0	0.4	0.2	2.9	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1
PCDHA4	"CNR1, CNRN1, CRNR1, PCDH-ALPHA4"	ENSG00000204967	"Protocadherin alpha 4"	Q9UN74	5	140806929-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 3.0;Ciliated cells: 5.3;granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 9.1;AF22: 8.9;EFO-21: 7.7;T-47d: 7.7"	"Low region specificity"	"Detected in all"							"HPA043180, HPA073478"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"HPA043180: AB_10806381, HPA073478: AB_2686608"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.90e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.00e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.94e-5)"	"unprognostic (5.01e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.29e-3)"	"unprognostic (4.79e-2)"	0.9	0.8	5.1	0.9	6.5	3.2	1.7	12.1	8.7	2.1	1.1	1.6	0.4	0.9	2.3	2.0	0.6	1.6	5.1	1.2	4.5	3.2	2.0	0.6	1.7	1.5	1.9	2.1	1.1	4.1	1.0	1.4	0.7	3.9	1.8	1.1	0.4	1.1	1.3	1.1	2.0	0.9	1.1	3.0	1.1	1.0	1.4	2.4	0.0	1.3	0.1	0.7	1.3	0.8	1.5	1.3	2.0	0.7	0.8	1.1	0.0	0.2	9.1	8.9	0.4	0.1	0.3	0.3	0.2	0.1	0.1	0.1	0.2	1.8	0.3	7.7	0.2	0.4	0.3	0.0	0.1	0.2	0.2	0.2	0.4	0.6	0.3	0.1	0.3	0.5	0.4	2.4	0.2	0.4	0.6	0.5	0.4	0.2	1.2	0.3	0.2	0.2	0.3	2.5	1.9	1.3	0.2	0.2	0.3	0.3	0.4	0.4	3.8	0.1	2.0	0.8	1.6	7.7	0.3	0.9	2.0	1.3	0.7	0.2	0.5	0.2	0.2	0.3	0.4	0.8	1.8	0.7	0.7	1.1	0.4	0.8	0.8	0.8	0.7	0.3	1.5	0.8	1.1	2.0	0.8	0.7	1.3	0.6	0.0	5.1	6.5	12.1	6.6	4.5	3.2	1.9	2.1	3.9	2.4	3.0	1.3	0.0	0.5	0.0	0.9	0.8	0.0	5.3	1.2	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.7	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.3
PCDHA5	"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5"	ENSG00000204965	"Protocadherin alpha 5"	Q9Y5H7	5	140821604-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 13.6"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Horizontal cells: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;EFO-21: 7.5;T-47d: 7.7;WM-115: 2.8"	"Low region specificity"	"Detected in many"							HPA044557	Approved		Approved	"Nuclear speckles,Plasma membrane,Mitochondria"		NA	NA			"Plasma membrane"	"Nuclear speckles, Mitochondria"	"HPA044557: AB_10970597"	"unprognostic (4.95e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (6.25e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-4)"	"unprognostic (9.30e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.17e-5)"	"unprognostic (2.11e-1)"	0.9	1.2	3.4	0.5	3.6	0.6	0.6	13.6	10.2	0.6	0.6	0.4	0.0	0.5	1.2	0.5	0.4	0.5	1.1	0.3	1.6	2.0	1.1	0.4	0.7	0.4	1.3	5.1	0.6	1.2	0.4	2.5	0.4	2.3	0.6	0.5	0.0	0.4	0.4	0.4	0.5	0.5	0.7	1.1	0.4	0.7	0.9	0.1	0.0	0.5	0.0	0.3	0.5	0.2	0.6	0.6	1.6	0.5	0.3	0.3	0.2	0.0	2.6	0.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	1.6	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.1	7.7	0.1	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.5	0.5	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.1	0.6	0.3	0.3	1.6	0.3	0.4	0.6	0.2	0.2	3.4	3.6	13.6	7.2	1.6	2.0	1.3	5.1	2.3	0.1	0.0	2.2	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA6	"CNR2, CNRS2, CRNR2, PCDH-ALPHA6"	ENSG00000081842	"Protocadherin alpha 6"	Q9UN73	5	140827958-141012344	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.7;pituitary gland: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.0;EFO-21: 12.6;hTERT-RPE1: 3.3;U-2 OS: 5.2;WM-115: 7.5"									"HPA059326, HPA078110"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA059326: AB_2683980, HPA078110: AB_2732371"	"unprognostic (1.15e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-4)"	"unprognostic (4.23e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.56e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.55e-2)"	1.1	1.8	2.9	0.8	7.1	0.4	1.6	10.2	10.7	1.9	0.7	2.3	0.0	1.2	2.9	2.3	0.4	1.6	1.6	0.5	3.8	3.8	2.3	0.4	1.1	0.7	4.6	4.1	2.1	3.7	4.7	11.2	0.4	3.6	1.3	0.7	1.6	0.7	0.5	0.4	0.6	1.3	1.4	3.4	0.8	0.7	1.4	3.2	0.0	0.9	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	2.1	1.3	0.2	0.6	0.0	2.0	0.0	5.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.1	10.2	9.6	3.8	3.8	4.6	4.1	3.6	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHAC1		ENSG00000248383	"Protocadherin alpha subfamily C, 1"	Q9H158	5	140926369-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"parathyroid gland: 33.3"	"Cell type enhanced"	"Detected in some"	27	"Alveolar cells type 1: 6.0;Bipolar cells: 1.7;Ciliated cells: 1.4;Rod photoreceptor cells: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.7;EFO-21: 3.7;hTCEpi: 11.3;PC-3: 6.4;SCLC-21H: 5.0"	"Low region specificity"	"Detected in all"							HPA052775			Approved	Nucleoplasm,Nucleoli,Vesicles		No	No			"Nucleoplasm, Nucleoli"	Vesicles	"HPA052775: AB_2681942"	"unprognostic (2.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.29e-2)"	0.3	0.4	0.9	0.3	1.0	0.0	0.0	2.0	2.8	0.4	0.0			0.0	0.2	0.1	0.0	0.0	0.9	0.0	1.0	1.6	0.2	0.1	0.8	1.0	1.1		0.0	1.5	33.3	1.9	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.8			0.8		0.4	0.0	0.0	0.2	0.1	0.5	0.2	0.2	0.1	0.0	0.0	8.7	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	1.1	0.0	0.3	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	11.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	6.4	0.0	0.0	0.0	0.5	0.4	5.0	2.4	0.0	0.7	0.0	1.2	0.5	0.0	0.0	0.6	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.2	0.1	0.0	0.0											6.0	0.3	0.0	0.0	0.0	1.7	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PCDHAC2	PCDH-ALPHA-C2	ENSG00000243232	"Protocadherin alpha subfamily C, 2"	Q9Y5I4	5	140966235-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 14.1;parathyroid gland: 52.5"	"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 2.7;Ito cells: 2.5;Rod photoreceptor cells: 1.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 36.9"									HPA076190			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA076190: AB_2686785"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.31e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.46e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-3)"	1.1	1.7	5.7	1.0	9.2	0.5	0.7	13.6	14.1	1.5	0.9	2.3	0.0	0.7	1.2	0.6	0.6	0.8	3.2	1.2	4.5	5.2	0.9	1.3	2.5	2.2	2.9	6.4	0.7	0.9	52.5	3.1	2.2	3.8	0.9	0.9	2.7	1.1	0.7	0.6	0.6	0.7	1.4	2.0	2.1	1.0	2.4	1.7	0.0	1.6	0.0	1.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.7	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	1.5	0.0	0.7	4.0	0.0	0.0	0.1	0.0	8.4	0.0	0.5	0.0	0.0	0.1	5.5	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	1.3	0.0	0.0	0.0	1.3	0.0	1.6	6.6	0.0	0.0	0.1	0.8	1.4	0.2	0.0	0.7	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.2	13.6	14.1	4.5	5.2	2.9	6.4	3.8	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0
PCDHB1	PCDH-BETA1	ENSG00000171815	"Protocadherin beta 1"	Q9Y5F3	5	141051135-141059344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.9"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 2: 1.4;Basal glandular cells: 1.1;Cardiomyocytes: 2.2;Ciliated cells: 4.0;Club cells: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053921	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA053921: AB_2682310"	"unprognostic (5.54e-2)"	"unprognostic (1.60e-2)"		"unprognostic (9.01e-4)"	"unprognostic (8.65e-2)"			"unprognostic (8.00e-2)"		"unprognostic (7.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-5)"	"unprognostic (3.38e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-4)"	0.1	0.3	0.3	0.1	0.5	1.0	0.1	0.1	0.2	0.5	0.5			0.4	0.1	0.6	0.1	1.8	0.0	0.1	0.4	0.4	0.7	0.1	0.2	0.4	0.2		0.1	1.1	0.7	1.9	0.0		0.1	0.0		0.5	0.0	4.9	0.8	0.5	0.0	0.3	0.3	0.8	1.8			0.3		0.0	0.1	0.1	1.3	0.7	2.5	0.6	1.0	0.6	0.2	0.8	0.4	0.8	1.1	0.2	0.2	1.1	1.1	0.2	0.1	0.1	1.6	1.4	1.1	1.6	0.3	1.1	1.5	0.0	0.1	0.2	0.9	1.2	1.2	1.9	0.7	0.1	1.4	1.2	0.2	0.3	0.2	0.2	1.7	0.2	1.0	0.8	2.6	0.2	1.4	0.7	0.9	1.2	1.2	0.4	1.2	1.0	0.9	0.1	1.0	2.2	0.8	0.1	1.8	1.3	1.2	0.6	0.5	1.2	1.0	0.7	0.8	0.6	1.5	0.6	1.0	1.1	1.1	1.2	2.3	0.6	0.7	0.5	0.4	0.5	0.7	0.5	0.4	0.2	1.3	0.6	0.5	2.5	1.0	0.4	0.7	0.3	0.2											0.0	1.4	0.0	1.1	0.0	0.2	2.2	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6
PCDHB11	"ME2, PCDH-BETA11"	ENSG00000197479	"Protocadherin beta 11"	Q9Y5F2	5	141199582-141203779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 3.0;Bipolar cells: 2.7;Peritubular cells: 3.2;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.2;EFO-21: 11.8;U-2 OS: 4.3"									HPA045042	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045042: AB_2679194"	"unprognostic (1.32e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.47e-3)"	13.6	2.4	2.8	2.0	4.1	1.1	3.4	8.8	5.0	8.6	3.1	1.4	0.0	1.4	4.9	3.4	4.1	3.1	3.1	3.0	1.4	1.8	5.0	1.3	2.9	1.0	1.5	3.7	11.0	12.0	15.8	3.6	2.2	3.0	4.5	1.7	6.8	3.3	3.6	2.0	2.9	1.8	5.1	1.6	2.2	2.9	2.6	1.3	0.0	2.8	2.3	1.1	5.5	4.2	1.2	1.0	2.8	0.9	1.4	0.8	0.1	0.0	0.2	2.5	8.2	0.1	0.3	1.8	0.2	0.8	0.0	0.0	0.0	0.2	0.0	11.8	0.7	0.7	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.2	0.3	0.3	0.0	0.0	1.0	0.1	0.1	0.1	2.0	0.4	0.2	0.0	0.2	0.3	0.0	0.4	0.0	3.2	0.0	0.1	0.3	3.4	0.5	1.8	0.2	1.1	0.4	1.9	0.0	0.5	0.2	4.3	3.3	0.1	0.1	0.1	0.1	2.2	0.2	2.1	2.2	0.9	0.8	0.8	0.5	0.5	0.6	0.6	0.5	0.3	1.2	0.5	0.7	2.8	1.4	0.4	1.0	0.4	0.1	2.8	4.1	8.8	5.0	1.4	1.8	1.5	3.7	3.0	1.3	3.0	0.3	0.0	0.7	0.0	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.0	0.0	1.7	0.0	0.0	1.7	1.1	0.0	3.2	0.5	0.2	6.5	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.6
PCDHB12	PCDH-BETA12	ENSG00000120328	"Protocadherin beta 12"	Q9Y5F1	5	141208697-141212571	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 3.2;Intestinal endocrine cells: 1.7;Melanocytes: 3.3;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.8;ASC diff: 4.7;EFO-21: 5.4;RH-30: 5.8;U-2 OS: 4.4;U-2197: 4.4"									HPA045042	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045042: AB_2679194"	"unprognostic (1.43e-2)"	"unprognostic (3.22e-3)"	"unprognostic (4.18e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.87e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.22e-3)"	"unprognostic (4.97e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.41e-3)"	4.2	2.5	4.4	1.9	5.0	0.4	3.4	9.1	7.5	5.8	3.3	2.5	1.5	1.3	8.0	3.5	1.8	4.9	3.9	3.9	3.1	2.2	2.6	1.5	3.6	0.9	3.0	6.4	8.3	4.0	3.6	13.9	2.0	3.7	4.5	1.8	3.2	1.9	3.9	1.8	1.6	1.7	6.8	3.9	2.6	2.1	3.1	2.7	0.0	1.9	1.2	0.9	3.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.8	4.7	2.7	0.7	0.1	3.4	0.3	0.4	0.0	0.0	0.0	5.4	0.5	2.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	1.2	0.0	0.0	1.3	0.4	0.0	0.0	1.2	1.2	0.3	0.0	0.0	0.1	0.0	1.0	0.9	5.8	0.0	0.0	0.0	2.8	1.6	0.0	0.0	1.0	0.4	3.7	0.8	0.3	0.7	4.4	4.4	0.1	0.0	0.0	0.0	2.8	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	9.1	7.5	3.1	2.2	3.0	6.4	3.7	2.7	0.0	0.6	0.0	0.0	0.3	3.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.3	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.1	0.0	1.7	0.6	0.0	0.0	1.1	0.0	3.3	0.0	0.0	1.4	0.4	0.0	2.5	0.0	0.3	0.0	0.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0
PCDHB14	PCDH-BETA14	ENSG00000120327	"Protocadherin beta 14"	Q9Y5E9	5	141222932-141227759	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 12.7;Horizontal cells: 12.7;Muller glia cells: 8.3;Peritubular cells: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.2;SiHa: 11.4;U-2197: 8.2"	"Low region specificity"	"Detected in all"							"HPA007692, HPA045248"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA007692: AB_2667896, HPA045248: AB_10959599"	"unprognostic (2.57e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.90e-2)"	5.3	5.5	6.6	2.7	9.4	0.9	5.7	9.3	13.9	8.7	5.7	6.8	0.8	1.7	11.5	7.6	5.2	5.3	5.9	6.0	6.8	4.7	3.8	2.9	4.0	1.6	3.8	6.6	6.9	6.0	14.2	14.2	3.7	6.1	6.7	3.2	5.4	4.8	6.3	3.2	10.3	2.2	7.8	4.3	3.1	3.3	3.2	4.0	0.0	3.0	4.3	1.6	7.1	4.9	0.3	0.0	0.7	0.1	0.0	0.3	0.0	0.0	0.0	3.3	6.0	5.4	6.4	0.4	0.5	5.3	0.5	1.6	0.1	1.0	0.2	4.4	1.4	2.8	0.3	0.7	1.0	0.5	0.0	0.1	0.0	1.3	0.1	0.2	0.2	0.2	1.1	4.7	0.1	0.2	4.7	0.6	0.1	0.0	5.7	2.3	0.5	0.4	0.0	0.4	0.0	1.1	3.5	4.0	0.0	0.1	0.2	7.4	14.2	11.4	0.3	1.2	0.5	6.1	0.4	1.7	2.1	1.9	8.2	2.1	0.0	0.1	0.1	4.4	0.1	3.5	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.2	0.3	0.7	0.0	0.0	0.0	0.1	0.0	6.6	9.4	9.3	13.9	6.8	4.7	3.8	6.6	6.1	4.0	0.0	3.7	0.0	0.9	0.3	12.7	2.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	4.4	2.2	0.0	0.0	2.1	0.0	3.5	0.9	0.0	0.9	0.1	12.7	3.4	3.1	0.0	0.5	3.1	0.0	0.0	0.0	0.4	8.3	2.1	0.0	8.1	0.6	1.0	0.0	3.1	1.5	0.1	2.5	0.0	0.0	0.0	0.7
PCDHB15	PCDH-BETA15	ENSG00000113248	"Protocadherin beta 15"	Q9Y5E8	5	141245349-141249365	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 4.2;Early spermatids: 5.6;Horizontal cells: 4.8;Peritubular cells: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 9.3;LHCN-M2: 7.7;WM-115: 7.5"									"HPA007172, CAB026471, HPA074676"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB026471: , HPA007172: AB_1079576, HPA074676: AB_2732263"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	8.6	3.6	7.9	5.5	8.4	0.6	4.0	15.1	17.1	8.5	5.3	8.0	0.3	1.5	12.9	6.0	3.5	7.2	4.7	8.6	5.9	4.1	3.8	2.6	5.4	2.0	4.9	6.0	13.6	5.7	2.7	5.7	3.6	8.9	6.4	2.6	3.7	3.1	5.1	2.9	2.6	2.7	9.1	9.4	5.6	4.8	9.1	7.6	0.0	4.5	4.4	1.6	5.6	5.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.1	9.3	1.2	2.5	2.6	0.1	0.7	1.8	0.1	0.5	0.0	0.5	0.0	1.8	1.4	2.4	0.2	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.3	0.3	0.0	0.0	1.2	2.2	0.1	0.3	2.4	0.4	0.0	0.1	1.7	7.7	0.0	0.0	0.2	2.3	0.0	0.1	0.3	0.6	0.0	0.6	0.0	0.5	1.3	0.3	0.5	2.5	1.3	0.4	0.0	0.0	0.7	1.0	2.9	0.1	0.1	1.2	0.0	1.2	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	8.4	15.1	7.3	5.9	4.1	4.9	6.0	8.9	7.6	0.0	0.0	0.0	0.1	0.1	4.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.7	0.0	0.0	1.3	0.0	0.5	0.1	0.0	0.0	0.1	4.8	0.0	0.0	0.0	2.0	0.6	0.0	1.7	0.0	0.0	1.5	1.0	0.0	3.2	0.3	0.5	0.0	2.0	1.8	0.1	0.5	0.0	0.0	0.0	0.2
PCDHB16	"KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a"	ENSG00000272674	"Protocadherin beta 16"	Q9NRJ7	5	141181399-141186399	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.5"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 13.4;Horizontal cells: 7.9;Muller glia cells: 6.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 12.2;LHCN-M2: 6.5;T-47d: 6.8;U-138 MG: 26.9;U-2197: 7.2;U-87 MG: 6.4"									HPA014668			Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA014668: AB_1855055"	"unprognostic (3.44e-3)"	"unprognostic (4.03e-2)"	"unprognostic (8.14e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.49e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.83e-3)"	3.7	2.6	2.1	1.4	2.7	0.2	2.5	9.7	3.1	8.4	1.1	5.3	0.0	0.4	6.4	6.2	3.3	2.8	2.5	4.5	1.8		2.5	1.0	3.2	0.5	1.7	0.4	9.8	2.6	10.9	17.5	1.5	3.4	6.2	1.1	7.1	2.2	1.1	3.6	1.5	1.1	3.5	2.5	1.1	0.5	2.3	5.0	0.0	3.1	0.0	0.3	6.5	3.3	0.9	1.0	1.4	0.6	0.9	0.8	0.1	0.0	0.0	0.6	12.2	5.5	3.9	0.3	0.5	2.8	0.0	0.2	0.1	0.2	0.0	4.5	0.6	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.1	0.1	0.0	1.1	6.5	0.3	0.0	0.0	0.9	0.0	0.1	0.0	2.3	0.0	0.3	0.1	0.4	1.7	0.2	0.4	2.1	0.3	6.8	0.0	0.3	26.9	1.3	7.2	1.3	0.0	0.0	0.0	6.4	0.0	3.4	0.7	0.5	0.4	0.6	0.5	0.3	0.6	0.5	0.6	0.3	0.9	0.8	0.6	1.4	0.9	0.6	1.0	0.5	0.1											3.0	1.0	0.0	0.0	0.7	13.4	1.2	2.5	0.0	0.0	1.8	0.0	0.0	1.7	0.7	1.0	2.7	0.0	0.0	4.1	0.0	3.8	0.1	0.0	0.0	0.1	7.9	1.7	1.3	0.3	1.1	4.4	0.0	0.0	0.0	0.0	6.3	1.7	0.0	5.3	0.6	1.1	0.0	3.5	4.1	0.0	1.3	0.0	0.0	0.0	0.0
PCDHB2	PCDH-BETA2	ENSG00000112852	"Protocadherin beta 2"	Q9Y5E7	5	141094578-141098703	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	9	"Melanocytes: 3.3;Spermatocytes: 7.1;Spermatogonia: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.7;AN3-CA: 29.4;EFO-21: 16.7;U-138 MG: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007548	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007548: AB_2667859"	"unprognostic (2.94e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.03e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.84e-4)"	7.3	3.0	3.4	1.6	8.6	0.8	5.5	5.7	13.3	3.9	4.4	7.0	0.0	2.1	6.7	2.1	4.0	2.8	4.4	4.3	4.1	1.9	2.9	0.8	6.2	1.0	3.2	5.1	4.3	2.7	0.9	5.3	2.4	4.8	5.9	2.8	4.0	3.8	1.7	1.9	4.3	2.6	4.3	8.4	1.6	1.9	12.1	5.0	0.0	2.8	1.2	0.9	4.4	2.6	0.2	0.2	0.8	0.1	0.5	0.4	0.3	0.2	1.9	13.7	29.4	3.8	1.8	6.3	0.5	2.1	0.0	0.0	0.3	0.1	0.5	16.7	0.9	3.3	0.0	0.6	0.1	0.0	0.2	0.4	0.0	0.0	3.8	0.0	0.0	1.4	0.9	0.0	0.0	0.2	0.6	0.3	1.6	0.4	0.4	4.0	0.1	3.7	0.0	6.0	0.2	3.9	0.0	10.1	0.1	1.5	0.0	7.5	2.1	0.0	1.8	4.3	8.0	8.3	2.4	1.5	12.9	3.9	6.0	1.9	0.2	0.0	0.1	2.8	0.1	7.7	0.5	0.1	0.0	0.4	0.1	0.0	0.1	0.4	0.1	0.0	0.2	0.1	0.2	0.8	0.5	0.1	0.2	0.0	0.3	3.4	8.6	5.7	11.0	4.1	1.9	3.2	5.1	4.8	5.0	0.0	0.3	0.0	0.9	0.7	2.9	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	1.4	1.3	0.0	0.0	0.3	0.0	1.6	0.9	0.0	0.0	0.1	1.6	1.2	0.0	0.0	0.4	1.1	0.0	3.3	0.0	0.2	2.6	0.3	0.0	1.4	0.4	1.2	0.0	0.8	7.1	4.7	0.4	0.0	0.0	0.0	0.4
PCDHB5	"DKFZp586B0217, PCDH-BETA5"	ENSG00000113209	"Protocadherin beta 5"	Q9Y5E4	5	141135218-141138625	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	9	"Early spermatids: 4.5;Spermatocytes: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;GAMG: 8.9;NTERA-2: 11.3;RH-30: 9.0;SCLC-21H: 10.6;SuSa: 14.6;T-47d: 11.2;U-138 MG: 21.0;U-2 OS: 9.4;WM-115: 9.3"					"Low region specificity"	"Detected in all"			"HPA013191, HPA067473"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA013191: AB_1855059, HPA067473: "	"unprognostic (2.21e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-3)"	3.8	4.6	8.1	1.6	10.7	0.7	3.6	7.7	11.0	9.0	2.9	7.9	3.6	1.2	10.4	9.2	2.5	7.5	4.9	4.9	7.9	4.1	6.6	2.3	4.0	1.1	3.6	7.1	14.9	11.2	6.3	7.6	1.6	6.4	7.6	1.4	6.9	5.6	5.9	3.0	1.9	1.5	5.7	5.2	2.2	2.4	6.1	5.9	0.0	6.6	0.7	1.0	4.4	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.6	12.0	0.2	0.9	0.5	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	6.2	0.0	8.9	0.0	6.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.0	2.4	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	9.0	0.0	0.0	0.0	10.6	0.3	0.0	0.1	3.6	14.6	11.2	2.6	0.0	21.0	9.4	3.4	0.0	0.0	0.0	0.0	1.1	0.0	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.1	10.7	7.7	10.5	7.9	4.1	3.6	7.1	6.4	5.9	0.0	0.0	0.0	1.5	0.0	3.7	0.6	2.5	0.0	0.0	1.8	0.0	0.0	0.0	2.4	4.5	0.1	0.0	0.0	3.1	0.0	1.0	0.9	0.0	0.2	0.0	3.2	0.0	0.6	0.0	2.7	2.8	0.0	0.0	0.0	0.0	4.3	3.1	0.0	4.2	0.2	0.7	0.0	1.5	10.3	0.0	0.1	0.0	0.0	0.0	0.6
PCDHB6	PCDH-BETA6	ENSG00000113211	"Protocadherin beta 6"	Q9Y5E3	5	141150022-141153287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 13.4"	"Cell type enriched"	"Detected in some"	7	"Spermatocytes: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.9;SH-SY5Y: 7.2;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029566, HPA075308"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029566: AB_10601385, HPA075308: "	"unprognostic (3.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.65e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.64e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.60e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.52e-2)"	2.5	2.4	3.9	1.0	5.1	0.4	2.5	4.2	8.4	2.3	1.5	2.6	0.0	0.6	4.5	3.7	0.7	2.1	1.4	1.6	3.5	1.9	1.6	1.4	1.7	0.7	2.6	3.6	3.7	1.5	13.4	6.4	1.5	2.9	1.5	0.9	0.7	2.5	1.5	1.4	2.4	1.0	3.0	3.3	1.5	0.9	5.4	3.1	0.0	1.1	1.0	0.7	1.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	16.9	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.2	0.0	0.1	3.6	0.4	5.4	2.2	0.0	0.6	1.3	7.6	0.0	0.0	0.0	0.0	3.9	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.1	4.2	8.4	3.5	1.9	2.6	3.6	2.9	3.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.2	0.0	1.2	9.9	0.1	0.4	0.0	0.0	0.0	0.0
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.0;Bipolar cells: 1.6;Cardiomyocytes: 1.7;Horizontal cells: 3.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 7.0;T-47d: 11.5;WM-115: 5.2"	"Low region specificity"	"Detected in many"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	1.4	1.3	2.7	0.9	11.7	1.0	1.1	6.8	7.9	1.4	1.2	2.7	0.5	1.0	2.8	3.9	1.3	1.1	0.8	3.9	3.5	2.8	1.2	0.5	1.2	1.0	2.5	2.5	2.9	2.5	2.8	6.1	2.3	5.4	1.5	0.9	2.4	1.1	1.0	1.7	1.5	0.6	1.8	2.4	1.1	0.8	2.7	1.1	0.0	1.3	0.6	0.7	1.2	0.9	1.2	0.9	2.7	0.5	0.8	1.0	0.2	0.1	0.4	0.5	1.9	1.2	2.1	0.3	1.7	1.1	0.5	1.0	0.5	0.2	0.5	2.8	1.1	0.9	0.2	0.2	0.3	1.1	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.2	1.8	0.5	0.0	0.7	3.4	0.1	0.3	0.2	0.8	7.0	0.1	0.2	0.8	0.3	0.1	0.3	3.1	2.7	0.3	0.3	0.3	1.8	2.1	0.3	0.9	1.7	0.5	11.5	0.4	0.8	3.3	0.7	1.6	0.4	0.3	1.0	0.2	3.9	0.2	5.2	2.7	0.5	0.5	0.7	0.4	0.4	0.7	0.7	0.5	0.2	1.2	1.0	0.8	1.1	0.8	0.5	0.9	0.6	0.2	2.7	11.7	6.8	6.1	3.5	2.8	2.5	2.5	5.4	1.1	3.0	0.0	0.0	0.0	0.0	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430589-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 3.5;Cardiomyocytes: 1.8;Ito cells: 1.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 7.7;BJ hTERT+: 12.9;fHDF/TERT166: 19.1;HHSteC: 6.3;HSkMC: 14.3;TIME: 6.1"									"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	5.1	12.7	14.8	2.8	18.9	0.7	2.4	4.7	13.8	4.9	1.8	8.6	0.6	1.4	5.4	2.3	3.5	2.7	11.3	6.5	15.7	5.6	3.1	2.8	6.5	1.6	4.7	7.3	6.2	3.6	2.0	2.7	6.5	8.4	3.5	1.7	3.4	1.7	4.9	1.9	5.1	1.5	5.3	8.4	3.7	2.2	1.6	12.4	0.4	3.0	0.6	1.7	4.5	3.6	3.7	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.6	1.2	0.1	7.7	12.9	0.0	0.0	0.0	0.0	0.4	0.0	19.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	14.3	0.0	3.8	0.0	0.0	4.5	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	6.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.8	18.9	4.7	10.4	15.7	5.6	4.7	7.3	8.4	12.4	0.0	0.0	0.0	0.2	0.0	3.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.3	0.1	0.0	0.4	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8"					"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480"	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.8	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.3	0.8	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.0	0.2	0.1	0.3	5.8	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.5	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5	0.0	0.0	0.0	0.1	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 2.4;Cardiomyocytes: 1.1;Horizontal cells: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 11.2;BJ: 3.7;EFO-21: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	4.0	4.5	11.7	1.4	10.5	0.7	2.5	6.9	13.7	4.7	1.3	7.9	0.0	0.7	4.5	3.5	1.5	2.9	3.5	12.2	8.5	5.8	2.5	2.5	2.6	1.0	6.6	7.7	8.6	3.6	1.8	6.3	5.7	8.7	3.0	1.3	4.6	2.9	3.2	1.5	1.9	1.1	3.6	6.0	1.5	1.2	5.2	3.8	0.0	3.3	1.3	1.0	1.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.1	0.2	1.5	0.0	3.7	0.3	0.0	0.1	0.0	0.0	0.1	9.2	0.8	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.1	0.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	10.5	6.9	13.7	8.5	5.8	6.6	7.7	8.7	3.8	0.0	0.0	0.0	0.1	0.0	2.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355025-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.3;BJ: 5.7;HSkMC: 6.0;HUVEC TERT2: 5.7;U-87 MG: 8.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	5.4	4.7	6.5	1.8	8.3	0.5	3.0	8.5	11.2	4.8	2.0	10.4	1.5	1.2	5.0	3.0	1.9	3.4	3.1	4.8	6.3	5.9	2.0	2.7	3.6	0.9	5.6	8.1	5.8	6.7	8.5	3.4	2.8	6.1	4.1	1.4	3.5	4.3	4.2	1.5	1.8	1.2	5.0	5.9	1.3	1.4	2.7	4.0	0.0	2.6	2.7	0.9	2.3	2.5	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	1.0	0.6	4.5	10.3	0.0	5.7	4.6	0.3	1.1	0.0	0.1	1.0	2.0	4.8	1.8	0.1	0.2	0.2	0.6	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.4	6.0	0.2	0.1	0.0	3.5	5.7	0.0	0.2	0.3	2.4	0.8	0.3	0.2	0.2	0.0	0.3	0.3	1.6	0.1	0.3	0.0	0.8	1.7	0.3	0.3	1.1	0.5	2.2	0.0	3.7	2.4	0.7	3.2	0.5	0.2	0.3	0.2	8.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.3	8.5	9.3	6.3	5.9	5.6	8.1	6.1	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"ASC diff: 18.9;ASC TERT1: 7.5"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	4.0	2.7	6.1	1.8	9.1	0.9	3.9	19.1	9.6	9.0	2.7	7.7	4.1	1.0	7.6	3.2	3.3	4.7	4.5	4.9	6.9	4.0	1.5	1.2	3.3	1.3	3.2	3.8	6.6	1.7	3.3	3.7	2.7	4.6	5.6	1.6	4.1	2.5	4.0	1.5	3.0	1.5	4.3	6.3	1.4	1.7	1.7	3.7	0.0	1.8	0.9	1.0	2.5	4.2	0.9	0.8	1.6	0.6	1.9	0.7	0.2	0.0	0.5	0.3	0.1	18.9	7.5	0.0	0.8	0.2	0.1	0.4	0.0	0.0	0.9	0.4	0.3	1.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	1.8	0.2	0.0	0.0	0.4	0.6	0.0	0.1	0.6	0.8	0.3	0.5	0.7	0.1	0.0	0.3	0.9	0.7	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.3	0.3	1.6	0.0	1.0	0.7	0.2	1.0	0.7	0.1	1.0	0.1	0.3	0.2	0.8	1.5	0.6	0.6	0.7	0.3	0.3	0.6	0.6	0.4	0.1	0.9	0.7	0.7	1.6	1.9	0.2	0.8	0.4	0.2	6.1	9.1	19.1	9.6	6.9	4.0	3.2	3.8	4.6	3.7	0.0	0.6	0.0	0.6	0.1	10.6	1.6	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.3	1.1	0.0	0.1	9.5	0.0	1.8	0.3	0.0	3.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	1.8	0.0	1.1	6.5	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373914-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 9.7;Cardiomyocytes: 4.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 5.8;SCLC-21H: 11.2;T-47d: 6.5;WM-115: 14.0"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	4.1	3.8	6.1	2.3	8.4	0.8	2.9	19.6	10.8	7.9	3.4	8.3	2.9	1.0	6.9	4.7	2.6	4.3	3.6	3.7	5.0	4.3	2.8	1.7	3.3	1.4	2.9	4.7	9.7	2.5	2.5	4.5	6.9	3.3	4.0	1.6	5.8	4.1	5.3	2.1	4.7	1.5	6.1	2.8	2.8	1.7	2.2	2.9	0.2	3.8	1.2	1.5	4.6	3.6	1.3	0.7	2.8	0.6	0.5	0.8	0.2	0.1	0.4	3.2	0.5	1.6	5.4	0.1	2.3	0.8	1.2	1.2	0.0	0.2	2.2	3.1	3.7	1.2	0.5	0.1	0.5	0.8	0.0	0.3	0.0	0.3	0.3	0.9	0.1	0.1	5.8	0.4	0.3	0.1	1.1	1.8	0.1	0.3	1.3	0.4	0.5	0.7	1.8	0.3	0.1	0.1	1.5	0.4	0.0	0.4	0.1	11.2	0.9	0.1	0.3	0.7	0.7	6.5	0.1	5.5	0.9	0.4	0.9	0.8	0.4	1.8	0.4	0.9	0.8	14.0	1.8	0.6	0.3	0.8	0.3	0.3	0.8	0.6	0.2	0.1	1.3	0.3	0.5	2.8	0.5	0.3	0.7	0.5	0.2	6.1	8.4	19.6	10.8	5.0	4.3	2.9	4.7	3.3	2.9	0.0	2.1	0.5	0.5	0.0	9.7	4.5	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.0	0.0	1.3	0.1	0.3	0.4	0.0	0.5	0.1	1.6	0.0	1.8	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.9	0.5	0.0	2.1	0.0	1.0	0.0	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.1
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 3.5;Cardiomyocytes: 1.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	1.7	2.0	3.1	1.3	9.0	0.6	2.1	5.3	14.9	3.5	3.0	7.1	2.1	1.0	4.2	4.1	2.2	3.3	1.9	3.0	5.1	3.3	3.2	1.9	2.2	1.0	5.1	6.6	4.7	2.5	4.6	3.4	4.8	5.4	3.7	1.5	5.8	2.6	3.3	1.6	3.8	1.2	3.0	6.3	1.3	1.4	2.1	5.1	0.0	6.6	1.5	1.0	2.4	2.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	1.9	0.0	5.8	9.9	0.0	2.6	17.3	3.5	5.2	0.0	0.0	0.4	4.3	0.5	0.1	0.1	0.0	0.1	2.9	0.0	0.3	0.0	0.4	0.1	1.0	0.0	0.0	4.3	0.1	0.0	0.6	9.3	1.4	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	15.5	0.0	0.1	0.1	3.3	6.8	0.0	5.2	0.1	0.1	2.5	0.0	0.1	1.5	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.0	5.3	7.7	5.1	3.3	5.1	6.6	5.4	5.1	0.0	0.0	0.0	0.4	0.0	3.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 7.1"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 10.4;Cardiomyocytes: 2.5;Horizontal cells: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 2.9;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.6	0.7	0.8	0.7	0.6	2.5	0.7	2.3	2.2	1.2	1.2	1.0	7.1	0.4	2.3	1.5	2.1	0.7	0.9	2.0	1.4	0.5	0.5	0.9	1.1	0.7	0.5	0.4	2.6	0.6	0.2	1.9	1.4	3.5	0.9	0.8	0.4	0.8	0.5	2.2	2.5	1.1	0.7	1.6	0.7	0.7	1.0	1.3	1.1	2.4	0.4	0.6	0.6	1.2	0.7	0.4	2.9	0.4	0.5	0.3	0.1	0.3	0.2	1.1	0.6	1.1	2.6	0.6	2.4	1.5	1.7	0.7	0.2	0.4	1.1	1.0	1.8	0.3	0.4	0.0	0.0	1.3	0.3	0.2	0.3	0.5	0.3	0.1	0.4	0.8	1.4	0.1	0.5	0.1	0.5	0.4	0.2	0.2	0.9	0.2	0.2	0.5	0.7	2.6	0.0	0.1	1.0	0.2	0.1	0.1	0.3	0.7	0.6	0.3	0.9	0.4	2.4	1.2	1.7	2.5	2.6	0.9	0.6	0.2	0.3	0.3	0.4	1.3	0.4	1.3	2.9	0.4	0.5	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.2	0.3	2.8	0.5	0.3	0.4	0.2	0.1	0.8	0.6	2.3	2.2	1.4	0.5	0.5	0.4	3.5	1.3	0.0	1.1	0.0	0.8	0.0	10.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	3.2	0.0	0.6	0.8	0.0	2.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	1.4	0.0	1.7	0.0	0.2	0.6	0.9	0.0	0.0	0.0	0.0	0.4
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 3.7;Club cells: 1.2;Horizontal cells: 3.2;Muller glia cells: 1.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.1;HSkMC: 4.6;hTERT-RPE1: 19.1;TIME: 5.0;U-87 MG: 5.8"					"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	5.6	5.4	12.0	2.6	12.6	0.9	3.7	11.5	17.3	6.9	2.7	11.2	0.1	2.1	7.6	3.9	4.8	6.3	6.5	3.2	10.3	8.5	3.0	2.8	5.0	2.1	9.6	7.1	9.1	3.0	3.8	3.0	3.6	10.9	5.2	2.7	7.7	3.8	7.3	1.9	5.5	2.0	5.9	13.0	3.6	2.9	2.0	5.9	0.0	4.6	1.4	2.5	4.8	3.7	0.5	0.3	1.0	0.5	0.2	1.0	0.0	0.0	0.2	0.7	1.8	0.1	0.3	0.2	0.8	0.0	0.7	0.7	0.3	0.4	1.4	4.1	2.2	0.3	0.1	0.1	0.2	0.8	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.3	4.6	0.2	0.4	0.3	19.1	1.1	0.1	0.1	0.2	0.4	0.4	0.2	0.5	0.2	0.1	0.0	0.2	0.5	0.0	0.2	0.2	0.5	1.2	0.4	0.1	0.6	0.5	1.1	0.5	5.0	0.3	0.3	0.1	2.7	0.2	0.1	0.1	5.8	0.1	1.0	1.0	0.5	0.3	1.0	0.3	0.6	0.3	0.4	0.2	0.1	0.5	0.4	0.7	1.0	0.2	0.2	0.3	0.1	0.0	12.0	12.6	11.5	16.2	10.3	8.5	9.6	7.1	10.9	5.9	0.0	0.0	0.0	0.1	0.2	3.7	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 32.2;pituitary gland: 13.7"	"Group enriched"	"Detected in some"	17	"Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"		Yes	No			"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	2.3	2.7	8.2	1.4	7.5	1.0	2.1	4.3	32.2	2.5	1.4	9.4	0.1	1.2	3.7	2.0	1.7	1.9	2.1	2.2	7.6	5.7	2.1	1.3	2.4	1.2	5.5	5.0	4.1	2.8	1.4	13.7	1.6	7.0	2.5	1.4	2.6	1.7	3.1	1.1	1.4	1.3	3.0	6.9	1.4	1.2	1.5	5.6	0.0	2.5	0.0	1.2	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	2.0	1.8	0.0	14.7	7.7	0.1	1.4	3.6	0.5	0.8	0.2	0.5	0.5	4.7	0.5	3.5	0.6	0.4	0.2	0.5	0.0	0.9	0.0	0.2	1.3	0.2	0.0	0.1	1.2	0.0	0.0	0.0	8.0	0.1	0.0	0.2	0.2	3.3	1.8	0.4	0.3	0.2	0.0	0.0	0.0	2.7	0.1	0.0	0.0	1.1	0.8	0.0	0.9	0.1	1.5	9.6	0.0	1.1	0.2	1.6	1.2	0.0	0.0	2.6	0.3	2.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	7.5	4.3	9.6	7.6	5.7	5.5	5.0	7.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370264-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.5;ASC TERT1: 10.9;TIME: 6.8"									"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802"	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	4.1	1.7	3.3	1.6	6.5	0.5	3.1	3.5	5.6	3.0	3.0	7.2	0.7	0.7	4.9	3.7	3.3	3.3	2.9	4.6	3.3	2.3	2.9	2.0	2.5	3.7	1.9	3.8	5.2	4.2	4.6	5.4	2.3	2.6	2.6	2.2	3.1	6.6	2.6	1.9	3.3	1.4	4.3	2.9	2.4	2.3	1.5	2.8	0.3	3.4	3.2	3.5	2.7	4.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.5	0.3	13.5	10.9	0.2	1.4	2.5	0.9	1.1	0.0	0.0	2.2	0.4	4.3	0.8	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.3	0.1	0.6	0.1	0.0	2.7	0.6	0.2	0.1	0.2	1.2	0.0	0.3	1.0	0.3	0.4	0.7	1.1	0.1	0.0	0.1	1.9	0.7	0.0	0.2	0.1	3.0	0.6	0.0	0.1	0.3	0.4	0.8	0.0	6.8	0.6	0.1	0.7	0.7	0.3	2.1	0.2	0.6	0.6	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	6.5	3.5	5.6	3.3	2.3	1.9	3.8	2.6	2.8	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGC3	"PC-43, PC43, PCDH-GAMMA-C3, PCDH2"	ENSG00000240184	"Protocadherin gamma subfamily C, 3"	Q9UN70	5	141475947-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 99.3"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 6.9;Horizontal cells: 11.1;Muller glia cells: 4.9"	"Group enriched"	"Detected in all"	6	"glioma: 55.0;melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 15.2"	"Lineage enriched"	"Detected in single"	22	"dendritic cells: 15.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.5;ASC TERT1: 41.7;HSkMC: 40.8;U-138 MG: 52.4;WM-115: 78.0"									"HPA008755, HPA010580, HPA077289"	Approved		Approved	"Plasma membrane"		NA	NA		74000	"Plasma membrane"		"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832"	"unprognostic (2.52e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (3.72e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (6.00e-4)"	14.9	15.0	52.8	7.0	49.0	0.5	11.2	30.1	99.3	28.0	8.7	38.9	2.4	3.8	20.6	27.6	12.8	15.7	14.6	11.0	40.2	25.2	7.1	8.0	20.9	4.2	32.0	24.9	16.6	4.4	18.8	7.9	17.7	25.8	17.1	10.2	17.3	8.4	20.1	5.8	18.3	5.6	19.8	28.1	5.3	6.6	4.8	24.1	0.9	5.4	6.4	7.1	8.6	11.1	0.6	15.2	0.0	0.0	0.0	0.1	0.0	2.8	1.6	10.8	2.9	43.5	41.7	0.1	14.2	37.9	7.0	7.6	0.0	2.7	9.4	9.2	24.7	26.5	10.3	1.4	4.4	6.7	0.0	4.3	0.0	0.2	0.2	13.4	0.1	0.3	40.8	6.8	10.6	8.7	25.8	4.7	0.0	0.0	0.3	17.7	5.2	0.2	1.0	0.4	0.1	0.0	6.3	21.9	0.0	3.7	3.0	3.5	15.4	3.8	0.1	23.3	4.0	8.8	13.1	5.7	52.4	2.7	10.2	15.3	0.0	0.1	0.1	12.5	0.0	78.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	15.2	0.0	0.0	52.8	49.0	30.1	38.9	40.2	25.2	32.0	24.9	25.8	24.1	0.0	0.0	0.0	0.4	0.2	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.9	0.6	0.0	0.0	0.2	0.1	0.7	0.3	0.0	0.0	0.2	11.1	0.0	0.6	0.3	0.4	1.1	0.0	0.0	0.0	0.0	4.9	0.5	0.0	0.4	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.5
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489121-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 43.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8"	"Group enriched"	"Detected in many"	5	"amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4"					"HPA008755, HPA010580, HPA076140"	Supported		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	1.0	1.1	7.4	1.1	34.5	0.9	1.1	3.0	43.7	1.1	1.0	2.8	0.0	0.9	1.4	1.3	1.0	1.2	1.2	2.8	11.8	2.8	0.9	0.9	1.1	0.9	2.2	10.0	1.1	1.0	1.0	1.1	1.0	2.3	1.3	1.0	0.0	0.9	1.6	1.6	1.5	0.9	2.0	0.8	1.0	1.0	1.3	1.1	0.0	1.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.7	0.2	0.8	0.6	0.5	0.6	0.0	0.0	0.5	1.6	2.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.5	0.0	5.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.9	0.8	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	8.4	0.1	0.2	0.1	16.0	0.2	0.2	6.8	0.0	0.0	0.0	9.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	34.5	3.0	39.2	11.8	2.8	2.2	10.0	2.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCED1A	"bA12M19.1, C20orf81, FAM113A, FLJ22376"	ENSG00000132635	"PC-esterase domain containing 1A"	Q9H1Q7	20	2835314-2841190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA050816: AB_2681246"	"unprognostic (3.20e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.97e-3)"	18.0	17.3	25.5	21.9	29.1	13.1	14.4	18.7	29.0	17.6	13.4	27.6	18.8	17.1	23.8	20.3	12.6	22.4	23.0	9.7	24.2	17.1	23.1	21.0	16.4	23.5	30.0	20.8	28.4	16.1	38.2	27.0	16.4	25.1	25.4	9.1	21.6	23.7	18.3	6.9	12.7	18.2	15.2	14.5	33.1	20.0	9.4	28.7	14.2	36.0	4.8	16.7	15.8	17.6	9.4	8.2	3.1	7.4	14.2	12.0	6.8	12.5	16.6	16.9	9.3	17.7	24.5	12.2	12.1	13.9	13.0	14.2	11.6	23.2	3.7	8.4	8.2	21.7	20.7	4.0	11.3	6.1	18.2	12.4	14.5	18.4	16.0	14.3	2.8	4.9	32.5	24.1	15.9	21.2	18.7	9.3	18.9	11.4	17.4	9.5	8.7	2.0	18.3	18.6	9.6	9.9	10.0	5.6	7.6	14.6	10.6	15.7	24.2	12.0	15.9	20.8	11.2	20.4	9.8	8.9	12.8	8.8	13.1	5.8	28.7	14.2	1.0	3.1	10.3	15.0	2.9	7.4	3.1	11.0	6.6	10.6	8.6	6.4	9.3	8.2	9.4	12.0	10.6	0.6	14.2	6.1	7.1	4.5	6.8	25.5	29.1	18.7	29.0	24.2	17.1	30.0	20.8	25.1	28.7	14.9	20.3	6.4	10.6	3.5	10.9	4.0	5.1	6.7	10.3	8.7	9.8	4.4	11.6	3.2	0.4	8.3	6.8	0.0	1.8	2.2	8.9	7.3	0.0	11.3	6.1	11.1	8.1	11.6	8.6	2.8	8.3	8.0	1.7	2.8	6.7	9.3	4.1	7.0	2.1	8.4	11.9	6.5	7.6	11.5	7.6	3.1	2.9	11.7	5.4	5.2
PCED1B	"FAM113B, MGC16044"	ENSG00000179715	"PC-esterase domain containing 1B"	Q96HM7	12	47079603-47236662	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 40.2"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 29.9;T-cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 32.7;K-562: 24.4;SK-BR-3: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043901	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA043901: AB_10959888"	"unprognostic (1.71e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.36e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (4.55e-6)"	"unprognostic (4.79e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.74e-2)"	"prognostic favorable (5.36e-5)"	5.7	28.4	4.1	25.9	3.9	7.1	4.4	0.6	3.6	5.1	6.4	5.7	1.2	1.8	7.6	4.6	4.5	6.9	5.8	2.4	2.8	2.3	4.1	2.7	7.8	25.6	3.8	2.9	19.6	2.1	0.6	2.0	3.2	3.7	6.0	2.3	3.3	6.5	2.8	1.0	2.0	8.5	11.7	7.7	20.8	2.9	9.1	3.3	5.7	2.6	1.3	40.2	10.0	4.2	16.5	12.5	1.5	0.8	9.1	32.1	10.9	1.7	32.7	0.8	0.0	0.2	0.0	1.6	1.0	1.8	0.4	0.1	1.6	6.4	5.8	1.8	3.3	0.6	4.7	0.0	4.8	0.0	6.8	0.0	0.2	0.3	0.6	0.7	1.3	0.2	0.1	2.1	0.5	3.7	4.6	1.4	0.4	24.4	5.5	2.3	0.7	0.3	1.1	5.6	4.0	0.4	0.1	0.8	4.0	5.0	2.7	0.2	0.0	2.9	16.3	0.0	1.8	3.0	2.0	0.4	0.1	0.5	0.0	1.1	6.0	4.2	10.6	1.6	4.5	0.2	0.4	0.3	0.8	14.9	0.7	16.9	16.5	17.9	18.8	2.1	10.1	32.1	29.1	1.5	9.1	0.8	12.5	18.9	10.9	4.1	3.9	0.6	3.6	2.8	2.3	3.8	2.9	3.7	3.3	3.0	6.4	11.2	1.0	1.0	2.5	0.4	0.0	1.4	2.3	1.8	0.0	0.5	0.0	3.3	0.7	1.9	0.0	0.0	11.4	7.7	1.6	1.0	1.1	0.0	29.9	0.0	9.8	12.9	3.2	1.1	3.4	2.7	1.7	5.4	1.1	0.8	9.7	0.0	0.7	0.3	0.0	0.0	3.4	0.7	0.2	0.5	1.7	23.3	0.2	2.1
PCF11	KIAA0824	ENSG00000165494	"PCF11 cleavage and polyadenylation factor subunit"	O94913	11	83156988-83187451	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040779			Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA040779: AB_2677133"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (3.74e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.03e-5)"	17.6	15.2	21.8	33.5	23.3	32.1	21.1	29.7	21.3	22.1	19.7	13.6	30.8	14.0	25.6	36.8	21.9	23.4	20.8	14.0	21.7	10.0	15.7	14.5	24.0	25.8	26.6	15.4	28.9	16.1	22.4	32.5	18.9	19.2	25.6	17.9	13.8	22.5	28.5	27.0	32.5	21.2	21.4	20.6	27.2	17.7	20.1	27.4	29.4	23.4	22.5	25.1	24.8	29.3	11.4	6.8	17.5	7.2	13.0	10.5	5.3	11.2	8.1	13.1	11.2	15.8	15.5	10.6	10.8	8.0	10.5	8.0	13.7	11.3	25.4	8.2	7.8	9.9	11.4	19.1	7.4	10.1	18.0	6.5	14.8	10.5	9.6	8.9	17.4	16.6	10.9	14.5	7.9	11.6	14.1	10.5	17.1	17.2	12.4	9.7	12.0	16.3	19.4	13.7	19.3	9.1	15.6	16.6	15.2	9.1	16.8	11.0	12.2	13.2	10.6	10.6	12.7	10.5	12.1	10.8	14.9	7.7	11.0	7.1	11.2	18.7	54.0	6.5	11.6	11.5	12.0	7.2	14.2	10.5	6.9	9.1	11.4	7.4	7.6	6.7	10.4	8.6	8.5	17.5	13.0	5.1	6.8	5.1	5.3	21.8	23.3	29.7	21.3	21.7	10.0	26.6	15.4	19.2	27.4	38.7	59.9	50.4	59.3	47.7	46.6	38.1	30.6	25.4	48.9	43.6	31.4	24.8	21.6	18.2	150.1	49.7	50.2	23.3	15.9	22.0	35.6	61.5	34.8	18.3	32.9	52.4	30.6	53.4	42.5	25.5	55.8	46.3	27.0	28.9	46.6	43.9	16.5	42.1	42.5	12.6	55.5	38.8	61.3	43.2	16.6	54.7	33.0	57.3	41.7	58.5
PCID2	FLJ11305	ENSG00000126226	"PCI domain containing 2"	Q5JVF3	13	113177539-113208715	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069107, HPA073074"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA069107: AB_2686088, HPA073074: AB_2686568"	"unprognostic (2.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (1.73e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.24e-6)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	17.6	22.6	13.7	14.6	16.0	11.3	21.0	33.5	15.9	20.9	18.2	14.6	20.4	10.3	24.0	20.7	15.6	22.5	14.7	31.3	12.8	10.8	15.4	18.1	14.8	19.6	16.9	13.0	30.6	28.6	12.1	37.6	13.4	14.9	20.0	16.3	14.4	21.4	19.3	21.6	15.0	15.2	19.7	13.4	20.1	19.2	43.4	16.5	19.4	25.4	11.6	20.6	18.0	21.2	15.1	9.7	8.1	12.5	7.6	32.4	19.0	21.9	9.3	14.3	12.6	26.3	19.8	10.0	16.9	25.5	23.6	21.9	18.3	20.8	17.6	11.3	22.9	30.0	14.0	22.6	15.3	26.3	15.3	22.3	22.7	24.3	16.1	26.2	38.4	9.3	16.2	17.1	14.8	26.3	19.0	18.6	24.6	17.3	7.2	26.7	10.6	20.4	27.2	14.1	40.6	11.9	18.7	15.9	16.8	21.4	11.1	19.1	11.8	10.5	26.3	19.3	15.1	14.5	47.0	12.0	7.0	25.2	10.1	12.7	11.1	10.3	24.6	24.2	26.2	15.9	8.1	9.6	7.1	27.6	12.5	32.4	15.1	23.6	28.7	9.7	14.2	21.5	22.3	1.5	7.6	11.5	9.2	23.5	19.0	13.7	16.0	33.5	15.9	12.8	10.8	16.9	13.0	14.9	16.5	17.9	11.8	26.0	26.1	19.2	21.0	26.8	15.3	30.8	14.8	14.0	15.7	25.3	23.2	19.0	26.4	26.3	7.9	23.3	12.0	20.4	25.7	26.0	10.4	17.8	18.1	35.0	7.5	15.4	20.8	8.0	38.3	13.8	15.1	26.2	14.1	19.5	17.0	19.5	38.2	18.4	24.9	19.4	28.9	129.6	82.8	21.7	26.0	34.8	19.9	21.4
PCLO	"ACZ, DKFZp779G1236, KIAA0559"	ENSG00000186472	"Piccolo presynaptic cytomatrix protein"	Q9Y6V0	7	82754013-83162930	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 95.6;Cone photoreceptor cells: 123.7;Horizontal cells: 81.0;Intestinal endocrine cells: 57.6;Rod photoreceptor cells: 84.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"REH: 62.4;U-2 OS: 71.7"	"Low region specificity"	"Detected in all"							"HPA015858, HPA029579, CAB079012"	Approved	Supported	Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles, Plasma membrane"		"CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044"	"unprognostic (1.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.79e-6)"	"unprognostic (5.15e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-5)"	"unprognostic (6.62e-5)"	3.1	7.9	8.8	0.8	26.3	0.4	4.7	50.3	19.4	3.2	3.9	1.6	0.4	2.9	1.0	7.3	2.3	2.0	1.9	2.2	9.8	5.7	8.2	0.6	1.8	0.6	4.6	12.6	1.9	4.0	11.4	19.2	1.0	9.1	4.9	3.5	3.6	2.5	5.0	0.6	2.6	2.4	0.7	5.3	1.1	2.9	4.5	4.4	0.0	8.4	0.0	0.8	1.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	1.9	0.1	1.4	0.5	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.4	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.2	1.1	62.4	1.0	0.0	0.4	0.2	1.2	0.8	0.0	0.6	0.1	0.3	0.8	0.1	0.0	0.0	71.7	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.8	26.3	50.3	19.4	9.8	5.7	4.6	12.6	9.1	4.4	8.9	14.1	0.0	8.3	2.3	95.6	24.6	20.4	9.4	18.2	1.8	123.7	0.9	6.6	4.6	9.0	4.1	14.6	0.0	4.4	0.3	0.4	5.3	0.0	0.0	1.3	81.0	57.6	0.0	0.0	5.6	2.6	0.0	0.0	0.0	12.3	17.5	2.5	14.4	6.0	16.7	84.6	0.0	0.3	3.9	13.8	3.0	0.6	0.0	7.7	4.8
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18029944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 451.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Enhanced	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			Centrosome	"Nuclear membrane, Cytosol"	"CAB058695: AB_2665588, HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	19.6	19.0	26.2	26.7	40.4	25.1	25.1	29.2	29.0	25.0	21.1	21.6	22.8	12.4	23.3	27.3	16.4	26.4	17.8	23.0	22.9	18.4	18.8	22.0	19.1	21.1	24.5	24.9	29.1	27.0	42.0	35.8	19.8	26.4	20.2	16.3	16.2	19.4	25.3	63.1	17.6	18.3	26.7	27.2	20.8	17.9	80.0	28.0	40.2	28.2	19.1	20.4	27.0	22.6	11.5	14.9	19.9	7.5	11.2	13.0	4.3	20.6	22.1	34.0	45.0	19.2	20.0	17.6	17.5	21.5	18.7	21.1	14.9	12.4	27.1	12.1	17.4	16.1	15.0	21.7	16.1	31.9	8.9	8.4	46.6	15.6	30.3	21.4	20.4	12.0	17.4	17.2	21.7	24.1	16.4	21.4	28.4	31.4	21.1	22.8	10.3	43.6	33.7	28.0	17.3	6.4	26.3	30.4	9.7	15.5	28.8	26.0	19.6	18.7	10.3	26.8	15.2	16.2	29.7	19.1	17.1	14.0	20.8	14.7	9.0	19.9	24.3	14.4	22.5	17.4	19.9	6.0	14.4	11.5	3.8	12.0	11.1	10.4	13.0	5.9	11.5	11.6	11.6	6.4	11.2	7.5	14.9	10.3	4.3	26.2	40.4	29.2	29.0	22.9	18.4	24.5	24.9	26.4	28.0	119.1	118.7	34.0	55.5	30.0	182.6	220.7	38.2	392.1	177.5	82.0	329.9	42.5	24.9	61.5	377.1	62.9	27.3	70.0	51.3	30.8	46.8	39.6	133.4	45.3	37.2	122.3	68.3	61.4	51.5	176.2	85.4	63.1	52.3	59.5	45.1	137.5	50.9	39.3	91.9	20.6	207.3	122.9	58.7	451.7	165.6	33.4	50.6	87.1	43.7	42.1
PCMTD1	FLJ10883	ENSG00000168300	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1"	Q96MG8	8	51817575-51899186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025696, HPA061444"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA025696: AB_1855077, HPA061444: AB_2684519"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.11e-3)"	22.0	24.1	13.1	18.2	17.1	9.0	41.1	24.3	21.7	22.8	24.4	11.7	33.2	14.8	29.0	24.5	21.6	21.5	22.1	26.1	13.5	12.6	21.5	16.7	29.2	21.0	18.4	11.4	33.3	53.8	57.9	34.2	19.2	15.6	22.8	14.8	15.0	39.8	38.8	45.7	18.0	18.7	38.5	18.9	24.3	19.6	10.4	16.9	27.8	33.6	23.6	15.5	28.4	28.6	16.5	15.4	32.4	12.1	22.3	15.2	10.6	6.5	4.2	14.5	2.6	21.4	20.1	8.3	8.7	15.5	3.7	5.9	1.9	15.1	6.3	12.2	11.6	6.2	16.2	2.5	10.2	6.5	8.0	4.9	7.2	7.5	4.4	28.3	2.6	7.4	19.9	19.5	4.6	12.7	22.7	17.5	9.4	5.5	20.7	5.8	2.7	15.1	6.6	5.6	9.7	1.9	4.7	2.8	8.1	15.1	13.0	9.6	8.1	6.1	8.0	8.7	12.1	7.9	4.0	14.3	3.3	4.4	5.0	3.1	12.6	9.4	2.2	9.9	6.3	4.0	19.6	9.6	22.9	10.2	12.1	12.4	16.2	13.0	12.1	9.7	16.5	15.2	13.4	32.4	22.3	12.1	15.4	13.8	10.6	13.1	17.1	24.3	21.7	13.5	12.6	18.4	11.4	15.6	16.9	107.2	59.0	50.0	62.9	48.0	67.0	80.0	43.3	58.9	44.3	80.3	9.8	30.3	54.7	23.7	3.8	68.6	25.0	46.7	35.1	30.0	62.0	88.3	49.9	30.5	22.5	55.6	44.9	57.1	47.5	4.7	96.4	57.4	67.4	34.3	40.3	112.9	43.4	28.1	112.8	59.7	23.9	38.8	59.7	9.3	14.7	51.8	57.3	41.5	27.0	64.6
PCMTD2	"C20orf36, FLJ10883"	ENSG00000203880	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2"	Q9NV79	20	64255695-64287821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Rod photoreceptor cells: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057849	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA057849: AB_2683544"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.05e-3)"	18.5	22.6	24.2	28.9	24.9	9.7	32.4	49.7	27.3	20.1	14.9	21.1	19.2	14.9	26.0	33.5	15.2	17.2	21.2	26.2	19.8	20.2	22.9	20.2	20.0	25.6	18.5	22.8	38.9	18.1	20.4	21.8	26.3	18.0	19.9	13.6	57.8	20.5	16.9	25.7	42.1	15.7	17.3	19.6	22.1	13.7	17.0	18.2	31.2	19.5	10.5	18.5	17.7	18.1	9.5	7.5	8.3	6.6	14.1	18.1	7.9	10.9	4.0	15.9	12.4	15.4	19.1	15.2	6.8	7.5	9.9	6.1	9.4	17.6	16.4	12.1	8.1	7.8	13.6	8.7	11.0	13.4	3.5	11.9	7.9	17.9	15.7	13.0	8.2	12.1	27.0	15.3	5.2	9.0	17.7	14.3	16.7	14.5	14.8	8.0	7.1	18.8	27.1	11.7	15.2	16.9	15.7	6.3	19.5	15.0	12.7	25.3	29.9	13.0	15.0	17.5	26.0	16.0	16.5	10.4	14.9	5.3	9.5	5.4	18.0	14.6	15.8	9.8	8.7	8.6	7.6	6.6	7.6	8.4	4.5	10.0	8.9	12.5	9.5	7.5	9.5	17.7	12.7	8.3	14.1	4.1	4.7	18.1	7.9	24.2	24.9	49.7	27.3	19.8	20.2	18.5	22.8	18.0	18.2	20.8	21.1	17.1	14.0	18.1	110.9	54.5	20.4	30.8	22.7	27.9	88.4	26.4	19.9	6.5	7.3	34.6	6.7	46.7	7.9	6.2	23.4	15.8	12.7	26.8	12.1	35.0	21.9	52.8	33.3	8.2	39.7	12.8	45.5	5.4	18.1	55.9	9.2	16.7	29.0	18.4	170.0	25.8	19.8	42.9	28.3	18.6	18.3	17.5	14.0	7.8
PCNX1	"KIAA0805, KIAA0995, PCNX, PCNXL1, pecanex"	ENSG00000100731	"Pecanex homolog 1"	Q96RV3	14	70907405-71115382	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 17.4;granulocytes: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053532			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053532: AB_2682180"	"unprognostic (1.96e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.56e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (9.01e-3)"	"unprognostic (2.90e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.37e-2)"	18.2	32.2	14.0	18.8	19.8	20.0	17.4	16.3	21.2	15.7	18.5	14.5	8.8	10.2	18.7	10.3	12.2	14.5	13.2	16.2	11.4	8.1	16.1	14.7	20.2	21.4	14.1	13.1	27.1	12.3	26.3	22.3	11.5	12.0	12.8	10.3	16.8	11.7	12.3	22.8	12.0	18.7	17.1	12.4	22.2	14.1	26.4	13.3	16.4	16.1	10.2	16.7	16.6	17.3	2.3	4.1	11.2	2.0	1.9	10.5	1.6	12.6	8.9	10.3	6.4	17.5	11.8	5.7	13.5	13.6	10.6	14.9	8.8	5.7	9.1	4.7	13.8	8.3	12.7	11.0	10.9	16.1	27.7	4.2	1.7	5.7	9.3	10.6	13.7	4.7	12.1	9.7	10.6	19.1	13.2	10.5	9.4	0.7	13.2	12.2	10.2	6.5	12.5	5.2	5.6	4.9	5.9	11.8	2.7	7.3	9.5	4.3	6.7	10.3	6.2	7.6	11.0	5.5	13.1	12.4	19.6	21.9	6.3	9.7	8.0	4.1	7.6	12.1	11.3	6.8	2.8	2.0	1.8	4.0	1.1	5.5	1.6	6.9	4.1	0.5	2.3	3.0	4.6	11.2	1.9	0.7	4.1	10.5	1.6	14.0	19.8	16.3	21.2	11.4	8.1	14.1	13.1	12.0	13.3	14.9	27.5	0.0	0.0	0.0	0.0	0.0	0.0	17.4	11.4	8.7	0.0	5.1	1.7	7.9	0.0	0.0	0.0	0.0	4.6	5.3	0.0	0.0	14.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	7.2	0.0	0.0	7.4	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0
PCNX2	"FLJ11383, KIAA0435, PCNXL2"	ENSG00000135749	"Pecanex homolog 2"	A6NKB5	1	232983435-233295713	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 29.6"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 8.9;Ciliated cells: 8.1;Club cells: 12.5;Collecting duct cells: 12.2;Distal tubular cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013815, HPA014427"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013815: AB_2236561, HPA014427: AB_1855081"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.27e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	4.7	4.7	11.4	7.5	16.8	4.2	7.7	29.6	23.1	4.9	3.9	6.3	4.2	3.4	6.6	14.0	5.2	9.0	8.1	2.3	11.9	8.2	5.4	1.2	4.7	9.4	8.0	13.1	11.4	5.2	8.6	18.6	2.4	14.3	6.2	4.8	6.0	6.0	8.1	5.6	6.3	5.6	5.2	5.8	5.3	5.8	5.5	5.5	4.0	7.9	3.4	8.8	6.0	5.7	1.5	1.8	0.9	0.9	0.8	3.1	1.1	3.8	9.4	5.1	0.1	8.4	9.2	1.5	2.3	6.8	2.4	4.3	3.0	4.7	8.1	5.5	6.3	9.0	6.4	2.3	6.7	5.7	6.8	6.9	0.1	4.8	0.0	3.8	2.6	1.6	7.0	5.9	4.8	19.1	8.3	4.5	6.1	0.0	4.3	2.4	2.3	7.4	0.2	16.5	3.3	5.7	0.1	1.4	1.1	4.4	6.0	8.8	7.3	3.4	1.5	1.4	3.0	3.4	0.7	1.7	6.8	4.4	7.7	7.6	5.2	5.4	0.1	6.2	3.0	7.8	0.9	0.9	0.4	3.1	0.5	2.4	1.5	2.5	2.9	1.8	1.3	1.1	2.1	0.7	0.8	0.7	0.6	2.7	1.1	11.4	16.8	29.6	23.1	11.9	8.2	8.0	13.1	14.3	5.5	8.9	5.1	0.0	0.0	0.0	0.0	0.0	0.0	8.1	12.5	12.2	0.0	0.3	6.6	5.1	0.0	0.0	0.0	0.0	2.9	1.1	0.0	0.0	1.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.8	0.0	0.0	4.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PCNX3	"FLJ22427, PCNXL3"	ENSG00000197136	"Pecanex homolog 3"	Q9H6A9	11	65615773-65637439	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 8.3;Collecting duct cells: 12.2;Ductal cells: 8.4;Exocrine glandular cells: 7.5;Hofbauer cells: 7.7;Pancreatic endocrine cells: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018084	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA018084: AB_1855083"	"unprognostic (9.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.69e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.82e-1)"	11.0	14.0	11.6	17.0	12.5	20.4	11.8	18.1	16.8	10.3	14.4	13.5	15.6	18.4	16.4	12.6	15.4	13.9	13.6	9.0	11.9	7.1	12.4	18.8	15.1	17.6	12.6	10.6	13.1	18.1	13.9	13.9	16.1	11.7	13.0	7.8	12.1	16.9	13.3	8.2	14.5	18.8	12.1	11.1	18.0	15.3	26.6	11.7	21.6	15.3	8.8	14.2	13.7	10.9	2.6	3.3	6.0	2.5	1.7	3.6	1.3	12.0	18.2	6.7	16.5	5.2	4.1	15.2	8.6	7.5	8.4	6.2	8.7	13.8	8.9	16.7	7.6	11.5	19.9	7.1	9.9	2.5	7.5	12.5	11.6	16.9	7.1	5.9	11.3	14.3	7.7	5.0	8.3	6.6	3.8	8.2	9.5	13.3	7.6	4.9	18.0	9.5	8.8	13.6	5.2	11.7	13.5	6.0	11.6	3.7	19.6	8.3	12.4	9.1	12.1	10.2	3.1	21.2	7.8	11.6	14.7	13.9	12.1	8.6	12.5	7.4	8.0	11.7	5.5	12.8	6.0	2.5	1.5	3.6	1.2	3.0	1.5	2.0	2.1	1.3	2.6	1.5	2.1	3.5	1.7	1.7	3.3	0.8	1.3	11.6	12.5	18.1	16.8	11.9	7.1	12.6	10.6	11.7	11.7	6.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	12.2	0.0	5.6	0.0	8.4	0.0	0.0	0.0	0.0	7.5	4.6	0.0	0.0	4.7	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.6	0.0	0.0	10.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0
PCNX4	"C14orf135, PCNXL4"	ENSG00000126773	"Pecanex homolog 4"	Q63HM2	14	60091911-60169133	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 62.9;Club cells: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002076, HPA003390"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA002076: AB_1078322, HPA003390: AB_2066703"	"unprognostic (2.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (6.84e-5)"	"unprognostic (2.13e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.59e-2)"	12.0	16.5	13.6	14.7	18.2	9.1	14.3	19.4	18.6	18.8	10.2	15.2	14.0	8.2	21.2	13.6	10.4	22.7	14.2	17.8	12.7	13.6	20.6	11.1	12.2	11.0	12.5	12.4	27.4	12.1	26.3	39.8	13.7	16.1	21.3	11.2	17.7	12.7	17.2	15.2	13.0	11.3	16.2	14.5	13.1	10.0	23.0	11.6	24.6	16.5	11.1	11.7	11.6	13.9	7.3	7.7	5.3	8.1	13.4	11.4	5.3	40.1	6.3	12.1	8.2	10.4	12.3	5.4	13.4	22.0	16.1	20.3	6.7	12.2	7.2	5.6	11.2	13.2	5.3	8.1	7.9	27.4	9.1	3.7	11.4	4.6	5.2	22.0	11.8	8.3	9.9	5.5	11.1	18.9	13.0	7.5	16.6	5.8	10.1	25.0	5.3	16.3	4.2	6.2	4.6	8.1	9.5	15.5	2.9	8.9	5.5	9.1	10.7	12.5	4.9	9.7	7.2	10.9	5.2	14.9	33.1	25.3	7.8	10.3	3.3	3.2	9.6	12.6	4.2	16.0	4.8	6.9	5.3	8.7	7.2	11.4	7.3	6.3	7.5	7.0	5.5	7.2	8.0	3.2	13.4	8.1	7.7	6.2	5.3	13.6	18.2	19.4	18.6	12.7	13.6	12.5	12.4	16.1	11.6	14.9	22.2	0.0	0.0	0.0	0.0	0.0	0.0	62.9	35.2	24.4	0.0	14.5	14.9	16.8	0.0	0.0	0.0	0.0	11.2	6.9	0.0	0.0	14.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	18.0	0.0	0.0	15.8	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602177-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 347.3;Leydig cells: 130.0;Smooth muscle cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 85.2;BJ hTERT+: 63.5;HSkMC: 97.7;SH-SY5Y: 68.1;U-138 MG: 39.4;U-2197: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	29.5	16.7	0.6	18.1	1.3	0.0	29.3	1.0	2.0	90.4	11.2	1.6	22.8	2.0	42.1	89.9	23.1	29.6	34.3	47.3	0.7	0.7	14.6	73.0	24.5	51.1	3.7	1.9	38.8	7.9	1.2	11.4	23.8	2.9	49.4	4.5	54.6	16.0	19.8	10.0	16.0	7.4	26.1	6.9	10.5	9.1	20.8	0.5	2.4	17.8	20.1	18.4	28.2	34.0	0.8	1.0	1.6	1.0	1.1	1.1	0.1	0.0	0.0	0.1	0.2	30.1	85.2	0.2	34.9	63.5	15.8	13.9	1.3	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	1.3	0.2	0.2	0.0	0.5	1.7	8.4	0.0	0.2	97.7	0.0	8.3	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.2	7.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	68.1	0.0	0.1	0.1	0.7	0.1	0.0	0.2	39.4	10.9	120.2	0.0	0.0	0.0	0.0	13.7	0.0	6.6	0.0	0.3	1.6	0.5	1.0	1.1	0.8	0.9	0.6	1.0	0.2	0.6	0.3	0.4	1.1	0.8	0.0	0.4	0.1	0.6	1.3	1.0	2.0	0.7	0.7	3.7	1.9	2.9	0.5	8.9	3.2	0.8	2.9	35.5	3.0	15.7	2.5	4.0	5.7	5.2	0.0	13.9	23.2	5.0	10.4	10.5	0.0	0.0	4.5	10.7	347.3	1.6	1.1	16.1	18.8	15.9	1.7	53.4	1.3	18.5	130.0	4.4	30.4	0.0	0.7	10.8	4.7	0.2	47.4	1.9	1.6	32.3	134.4	21.6	14.0	29.0	21.1	7.2	0.4	2.6
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889203	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 55.6"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 99.1;Extravillous trophoblasts: 55.3;Fibroblasts: 87.7;Syncytiotrophoblasts: 202.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;RPMI-8226: 13.5;U-2197: 29.0;U-266/70: 28.7;U-266/84: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	35.2	1.2	1.0	2.0	0.5	5.5	29.0	0.3	0.7	12.4	3.6	0.5	9.1	0.0	3.9	6.0	16.8	2.1	3.8	55.6	1.4	1.2	7.3	7.9	6.9	1.6	0.6	0.7	2.5	0.6	0.1	13.8	20.1	0.4	14.2	2.1	2.5	2.7	3.9	6.3	2.7	1.5	41.6	0.8	1.2	2.0	1.9	0.3	0.0	3.5	6.2	0.9	28.2	30.6	0.0	0.0	1.4	0.2	0.0	0.0	0.3	0.5	4.3	1.4	0.0	25.9	7.2	0.0	0.3	0.1	1.2	1.5	0.2	0.5	0.0	1.2	1.9	6.4	0.0	5.1	0.0	1.4	0.0	8.5	0.9	2.8	0.0	0.0	0.5	0.0	2.9	0.0	2.6	0.7	5.9	0.0	0.7	0.2	0.0	0.5	0.7	1.5	0.4	2.1	0.1	9.0	0.0	3.2	13.5	1.3	0.0	2.7	1.7	6.7	0.0	2.5	1.9	0.0	1.8	0.0	2.3	5.2	29.0	2.1	28.7	13.2	0.0	6.4	0.7	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.5	0.3	0.7	1.4	1.2	0.6	0.7	0.4	0.3	0.0	2.7	0.0	0.5	6.5	13.2	33.1	0.0	0.0	1.2	12.2	23.6	99.1	0.0	0.0	0.5	2.7	0.0	0.0	0.0	55.3	87.7	0.6	1.1	12.1	13.7	6.4	0.0	0.6	0.6	0.6	0.6	2.6	3.3	0.0	0.0	13.7	0.5	0.0	0.0	0.0	11.1	0.0	6.3	8.7	49.4	6.5	202.1	0.0	0.0	0.1
PCP2	"GPSM4, MGC41903"	ENSG00000174788	"Purkinje cell protein 2"	Q8IVA1	19	7631611-7633748	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 45.5;retina: 20.2;testis: 80.7"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 3770.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	14	"cerebellum: 45.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 9.1;Karpas-707: 4.6;NB-4: 18.4"	"Region enriched"	"Detected in some"	43	"cerebellum: 2422.3"	"Region enriched"	"Detected in some"	18	"cerebellum: 135.0"	HPA057428			Approved	"Nuclear speckles,Vesicles"		Yes	NA			"Nuclear speckles"	Vesicles	"HPA057428: AB_2683436"	"prognostic favorable (7.93e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.79e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.70e-2)"	"prognostic favorable (2.76e-5)"	0.5	0.4	0.5	0.5	0.5	1.9	3.3	45.5	0.6	1.0	0.5	0.5	0.5	0.6	0.5	2.0	0.5	1.3	1.2	0.5	0.5	0.0	2.5	1.0	1.2	1.4	0.5	0.5	0.5	1.6	0.3	0.5	0.5	3.2	2.0	0.0	20.2	10.6	1.0	0.5	4.2	0.5	0.5	1.9	1.1	0.9	80.7	0.5	0.5	1.9	0.5	0.6	0.5	0.5	1.0	1.7	2.6	0.3	0.7	1.2	5.2	1.8	0.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	1.7	0.8	1.2	0.0	0.0	1.4	0.0	0.2	0.0	0.8	0.6	2.8	2.5	0.1	0.0	0.3	9.1	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	4.6	0.0	0.3	0.4	18.4	0.4	0.3	0.0	0.8	0.2	0.7	0.9	0.1	0.1	0.0	1.5	1.6	0.0	0.4	4.0	3.4	0.2	0.0	0.6	0.4	0.1	1.6	0.6	0.2	0.0	2.1	0.0	0.0	0.3	0.0	0.9	0.1	1.2	0.4	0.5	0.5	0.5	1.0	0.8	1.0	2.6	0.7	0.0	1.7	0.2	5.2	0.5	0.5	45.5	0.6	0.5	0.0	0.5	0.5	3.2	0.5	0.0	2.9	0.0	0.8	0.7	166.8	0.0	0.0	0.0	2.3	5.2	21.6	0.2	8.3	0.6	765.5	0.0	0.6	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.4	22.3	0.0	0.0	1.2	3770.2	9.8	1.0	1.7	1.8	0.2	24.5	0.5	0.0	12.4	0.3	79.8	19.4	0.0	11.1	6.4	1.0	0.0	1.5	0.5	0.6
PCP4	PEP-19	ENSG00000183036	"Purkinje cell protein 4"	P48539	21	39867317-39929397	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 177.9;seminal vesicle: 234.5"	"Cell type enhanced"	"Detected in many"	23	"Bipolar cells: 431.9;Distal tubular cells: 547.2;Horizontal cells: 1320.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"basal ganglia: 177.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 57.7;SK-BR-3: 9.7;T-47d: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005792	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA005792: AB_1855086"	"unprognostic (6.82e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (5.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (9.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	2.1	11.0	5.6	1.4	177.9	1.0	2.6	15.8	15.8	39.3	10.6	11.4	50.8	1.9	11.4	65.7	38.4	2.9	1.7	1.7	8.3	14.0	9.7	1.0	1.1	1.0	11.6	3.7	1.2	2.1	3.4	1.0	1.3	20.0	60.9	6.9	49.0	1.7	234.5	1.0	1.4	1.5	93.5	3.7	1.5	1.1	1.2	37.5	0.0	39.2	0.0	1.2	65.6	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.5	0.0	0.0	0.0	0.0	57.7	0.0	0.0	0.1	0.1	0.0	9.7	0.0	0.0	18.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	177.9	15.8	15.8	8.3	14.0	11.6	3.7	20.0	37.5	0.0	1.0	0.0	0.5	2.7	431.9	8.1	5.1	0.0	0.0	73.3	58.9	0.2	547.2	0.3	1.1	0.3	0.0	0.0	0.2	0.2	1.5	4.0	0.0	0.0	0.2	1320.5	1.2	0.0	0.0	0.0	8.9	1.9	20.3	0.0	0.0	53.7	1.2	0.0	0.4	219.7	168.9	0.0	3.1	0.5	3.8	5.3	2.4	0.0	0.2	0.9
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258727-161285450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;urinary bladder: 33.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 23.9;Bipolar cells: 34.5;Sertoli cells: 19.4;Urothelial cells: 42.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8"	"Group enriched"	"Detected in all"	5	"basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8"	"Cell type enhanced"	"Detected in single"		"T-reg: 3.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.1"	"Group enriched"	"Detected in some"	6	"RT4: 16.1;T-47d: 10.5"	"Low region specificity"	"Detected in all"							HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"	3.2	1.0	5.7	1.3	67.7	0.6	2.2	4.4	28.9	4.3	4.3	1.4	1.5	2.2	2.2	3.3	16.5	2.1	3.9	1.3	3.9	6.3	1.0	4.3	5.0	0.7	7.8	4.6	2.6	0.5	0.6	21.9	0.9	30.8	5.5	3.2	5.9	1.2	17.8	1.0	2.8	3.3	6.8	7.5	0.8	1.2	2.3	5.3	0.0	1.0	0.0	3.0	33.2	4.1	0.0	0.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	16.1	2.2	0.0	0.0	0.3	0.0	0.2	10.5	0.4	0.2	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.7	67.7	4.4	17.9	3.9	6.3	7.8	4.6	30.8	5.3	3.0	5.4	0.0	23.9	0.0	34.5	0.2	0.0	0.0	7.9	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.2	1.8	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	1.8	0.0	4.1	19.4	9.5	0.2	0.2	0.3	1.5	0.0	0.0	42.7
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831094-48835633	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.9;kidney: 72.9;pituitary gland: 127.7"	"Group enriched"	"Detected in many"	5	"Intestinal endocrine cells: 2932.5;Proximal tubular cells: 1024.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	77	"T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 20.0;PC-3: 50.7;SCLC-21H: 20.1;SH-SY5Y: 18.6;SiHa: 17.6;U-266/84: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	NA	NA		5300000	Vesicles		"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	4.1	27.5	49.1	2.6	72.7	2.1	2.2	15.6	70.3	3.2	9.8	10.8	1.5	12.4	4.4	10.9	2.1	2.3	2.8	2.7	38.5	74.9	72.9	2.1	2.6	2.2	33.5	29.0	2.2	20.0	12.4	127.7	2.3	32.9	4.6	2.7	6.6	2.8	3.1	2.2	2.8	8.5	2.7	18.3	2.4	26.0	3.8	9.8	0.0	2.2	0.0	2.1	2.1	0.5	0.1	0.0	0.0	0.0	0.0	8.2	0.8	0.0	1.8	0.0	5.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.6	0.0	1.4	0.2	0.0	0.3	0.0	0.0	20.0	0.0	0.0	3.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	2.7	0.0	50.7	0.0	0.0	0.1	0.4	0.0	20.1	18.6	17.6	0.0	1.4	0.2	0.0	0.0	0.0	0.0	7.8	0.0	1.6	4.6	23.4	0.1	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.0	3.0	0.0	6.5	6.3	0.0	0.1	2.7	8.2	0.0	0.0	0.0	0.0	2.1	0.8	49.1	72.7	15.6	70.3	38.5	74.9	33.5	29.0	32.9	9.8	0.0	0.0	2.2	1.5	14.1	134.7	1.0	5.1	1.4	0.0	369.9	49.1	0.5	235.4	7.5	11.6	0.5	12.9	0.0	0.6	43.5	6.2	36.6	0.0	0.0	1.5	413.2	2932.5	0.0	0.0	41.9	3.1	2.7	54.0	0.0	16.6	54.9	36.6	411.7	6.7	1024.2	101.7	0.0	16.5	18.2	20.6	10.0	1.6	3.2	10.1	2.6
PCSK2	"NEC2, PC2, SPC2"	ENSG00000125851	"Proprotein convertase subtilisin/kexin type 2"	P16519	20	17226107-17484578	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.0;thyroid gland: 79.5"	"Cell type enhanced"	"Detected in many"	26	"Horizontal cells: 125.5;Melanocytes: 199.1;Muller glia cells: 518.9"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 14.6;thyroid cancer: 65.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	5	"AF22: 36.7;SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049627	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA049627: AB_2680835"	"unprognostic (2.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.84e-2)"		"unprognostic (3.07e-3)"	"unprognostic (4.31e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.26e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-1)"	1.6	35.0	16.3	1.7	20.5	1.3	1.3	7.7	27.8	2.9	4.2	1.6	0.0	6.2	0.9	1.2	2.1	2.0	1.4	3.1	18.0	11.1	1.1	1.0	2.2	0.8	4.1	16.2	11.6	23.7	0.9	1.7	1.5	9.0	1.3	2.8	16.6	2.7	2.3	1.0	16.6	3.3	1.3	5.4	0.9	11.9	4.7	3.8	0.0	79.5	0.0	0.9	1.9	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	20.5	7.7	27.8	18.0	11.1	4.1	16.2	9.0	3.8	0.0	5.3	0.0	0.0	7.2	27.6	0.9	0.0	0.0	1.2	0.0	5.9	0.0	0.0	0.0	76.9	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	125.5	0.0	8.0	0.0	2.7	2.6	0.2	199.1	0.0	0.0	518.9	4.6	0.0	0.0	0.0	11.5	0.0	1.0	0.5	0.2	1.3	0.0	0.0	0.0	0.1
PCTP	STARD2	ENSG00000141179	"Phosphatidylcholine transfer protein"	Q9UKL6	17	55750979-55842830	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.4;liver: 53.2"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.2;Hepatocytes: 64.8;Syncytiotrophoblasts: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.8"	"Low region specificity"	"Detected in all"							HPA022979	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA022979: AB_2671018"	"unprognostic (1.14e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.27e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (9.35e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.93e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.04e-1)"	8.2	5.6	4.9	8.2	8.2	5.1	8.4	3.1	5.3	6.2	11.9	3.0	29.8	9.3	5.2	15.8	6.6	4.9	10.1	12.1	5.1	4.7	17.0	53.2	11.6	7.8	6.2	4.9	5.2	7.5	4.2	5.3	19.4	5.5	7.5	12.7	5.3	7.1	32.1	10.8	4.1	9.8	8.3	5.0	10.0	12.5	8.0	3.9	3.0	5.7	5.8	5.2	8.1	9.9	2.0	12.1	56.4	15.3	6.2	2.7	6.5	8.7	8.1	6.1	2.2	8.2	8.0	15.7	3.4	4.6	5.5	5.4	9.1	11.4	2.4	26.8	5.4	5.1	4.9	3.5	5.8	5.0	38.8	8.2	21.7	2.4	16.9	7.3	8.2	17.2	6.6	7.7	3.2	6.0	6.8	10.6	7.4	15.6	8.8	6.0	7.6	6.5	6.7	6.6	0.0	7.2	3.3	8.8	2.0	5.8	6.5	3.0	6.9	1.7	3.8	14.5	14.0	10.1	14.3	7.7	6.3	4.5	7.0	4.5	24.9	7.8	1.5	5.8	13.6	10.8	15.1	15.3	56.4	2.5	12.6	1.5	2.0	1.6	2.5	12.1	1.4	0.9	2.2	15.9	6.2	13.2	0.9	2.7	6.5	4.9	8.2	3.1	5.3	5.1	4.7	6.2	4.9	5.5	3.9	3.0	7.2	5.1	2.5	0.9	3.8	15.3	17.8	2.7	0.0	8.7	2.0	42.8	10.0	11.2	13.2	7.3	11.8	0.0	12.0	61.2	6.7	1.4	15.0	64.8	19.2	1.6	12.6	9.2	22.6	15.4	15.3	12.6	11.8	10.8	16.2	3.5	8.3	7.0	24.4	30.7	2.2	12.9	10.3	9.8	8.1	1.3	56.2	8.5	14.3	1.7
PCYOX1L	MGC3265	ENSG00000145882	"Prenylcysteine oxidase 1 like"	Q8NBM8	5	149358007-149369653	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 11.1;Rod photoreceptor cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037463, HPA038402"	Approved		Approved	Nucleoplasm,Mitochondria	"Secreted - unknown location"	NA	NA		930000	"Nucleoplasm, Mitochondria"		"HPA037463: AB_10673632, HPA038402: AB_2675997"	"unprognostic (1.34e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.77e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.28e-1)"	4.8	6.6	4.5	7.2	13.5	6.9	4.0	15.9	19.0	6.5	4.4	8.2	2.7	2.3	6.2	2.7	4.6	7.9	5.8	5.2	4.6	8.9	3.7	1.2	4.2	9.6	5.5	9.9	7.9	6.7	27.0	6.4	6.2	13.7	6.4	2.1	9.4	3.4	6.6	1.6	6.6	5.6	6.0	4.6	6.3	5.8	11.5	2.4	5.8	3.3	3.1	7.4	5.0	4.7	1.8	13.5	3.9	9.6	4.5	7.2	4.5	2.1	1.5	2.9	6.3	2.4	1.5	2.1	5.1	1.0	2.5	5.3	0.4	3.5	9.7	15.4	1.6	14.7	4.3	3.2	7.2	0.3	4.7	4.7	4.5	0.0	0.3	7.0	2.9	4.2	6.4	1.2	5.0	4.4	3.4	7.9	8.4	2.6	19.2	0.2	3.4	2.7	4.2	2.7	3.2	9.2	5.2	2.3	25.7	1.0	0.6	5.9	7.7	10.0	3.6	7.9	1.4	9.5	5.5	4.6	2.9	3.1	7.2	2.0	11.3	15.2	5.5	6.1	17.8	7.4	3.0	7.1	3.9	3.0	9.6	4.0	1.8	5.7	2.3	13.5	1.2	6.8	4.7	1.2	4.5	9.1	1.3	7.2	4.5	4.5	13.5	15.9	19.0	4.6	8.9	5.5	9.9	13.7	2.4	8.9	1.7	0.0	1.1	0.9	4.5	4.5	5.1	1.4	2.3	1.8	0.0	4.0	0.0	2.2	2.8	3.8	0.9	0.0	2.1	6.2	2.8	0.7	2.3	0.0	6.4	11.1	0.0	2.5	4.7	1.1	3.1	4.8	1.7	3.6	1.7	6.8	1.7	1.1	2.5	0.3	12.8	0.0	1.2	0.9	3.3	1.4	1.0	2.1	2.2	0.6
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 73.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	24.8	22.2	15.3	19.9	18.7	25.8	18.0	14.2	17.8	13.6	25.3	23.0	21.1	41.1	18.2	18.7	25.2	15.0	19.8	36.0	14.8	13.8	20.2	17.8	18.7	15.6	16.6	14.1	15.6	13.9	16.0	12.1	14.2	20.5	13.3	16.5	14.4	17.1	19.2	45.8	32.8	37.2	19.5	18.3	23.4	18.1	19.4	18.6	13.2	14.8	28.0	19.0	17.6	16.7	7.8	8.7	20.5	9.8	7.9	13.5	4.6	28.7	11.6	8.1	11.9	16.7	18.6	12.3	22.0	15.7	18.9	16.7	28.3	10.5	7.4	73.8	25.2	19.9	22.5	12.9	16.9	16.2	13.4	9.0	21.2	12.2	12.0	15.0	10.2	18.2	15.7	13.0	18.3	13.1	12.2	20.2	6.9	11.8	16.5	18.8	24.3	6.4	5.4	7.0	18.1	17.3	10.6	10.4	11.9	11.6	16.2	8.0	5.9	14.9	25.7	14.3	11.8	37.7	12.8	30.2	15.1	8.4	20.5	29.7	15.3	29.1	13.6	23.1	14.3	18.9	7.5	8.7	9.2	9.6	9.2	8.0	7.8	7.2	10.2	8.7	5.7	4.6	6.8	20.5	7.9	9.8	5.6	13.5	4.6	15.3	18.7	14.2	17.8	14.8	13.8	16.6	14.1	20.5	18.6	14.9	18.8	17.9	8.2	12.9	14.3	58.5	17.8	33.5	15.9	14.0	23.6	10.4	11.6	21.4	63.4	19.5	43.0	0.0	19.9	14.2	13.7	9.7	19.7	31.7	32.6	7.9	21.2	25.2	28.9	52.1	18.4	30.0	18.6	33.3	20.4	11.8	20.8	14.8	26.5	19.4	12.4	25.8	13.7	30.0	10.6	18.7	15.6	22.7	20.5	11.0
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900965-81911464	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 615.4;Late spermatids: 2143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		7000	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	13.6	5.5	13.3	5.7	12.7	5.3	10.4	12.2	17.0	6.5	16.2	13.4	6.4	30.7	5.8	8.6	7.6	12.2	8.0	17.7	14.0	11.8	21.7	46.5	7.2	6.3	13.4	16.0	7.8	11.5	8.2	4.6	6.0	15.9	10.1	8.5	5.8	10.8	6.6	13.5	4.5	26.5	5.0	14.3	4.1	11.5	70.8	11.0	5.6	6.7	6.8	5.8	7.5	4.4	7.3	6.6	2.1	3.5	4.7	8.4	4.0	11.8	6.8	5.5	15.5	27.6	14.5	8.1	8.5	18.4	12.0	14.3	26.7	12.4	4.1	4.7	8.9	22.3	9.8	8.3	15.9	7.0	1.2	6.8	9.0	9.4	61.2	29.5	9.0	7.6	11.9	9.2	10.8	8.4	4.3	11.1	12.7	16.7	8.6	8.9	10.0	10.7	11.1	4.4	41.7	7.3	7.1	5.9	14.7	14.4	22.5	7.0	6.4	6.4	35.5	8.3	11.3	9.8	21.4	7.4	8.9	5.8	6.6	7.0	5.6	2.3	4.0	9.2	12.1	8.7	2.1	3.5	1.2	7.1	3.4	4.6	6.0	8.4	7.2	6.6	7.3	7.0	7.2	1.0	4.7	3.0	6.5	5.0	4.0	13.3	12.7	12.2	17.0	14.0	11.8	13.4	16.0	15.9	11.0	0.0	15.9	13.0	6.8	4.7	11.8	14.9	56.0	10.7	4.5	24.4	0.0	67.4	101.2	15.9	615.4	7.1	65.6	23.3	16.0	30.7	6.8	9.0	9.2	125.6	20.2	15.9	13.4	20.3	10.0	2143.8	25.6	9.3	32.1	21.6	22.6	19.8	17.5	17.3	24.4	119.0	7.1	25.8	11.4	131.3	17.2	5.0	42.4	12.5	30.7	4.5
PDCD2	"RP8, ZMYND7"	ENSG00000071994	"Programmed cell death 2"	Q16342	6	170575295-170584692	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026713, HPA075534"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA026713: AB_1855103, HPA075534: AB_2686754"	"unprognostic (3.80e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	22.8	24.2	18.1	25.4	16.7	20.0	73.3	14.2	20.2	19.6	25.6	12.0	26.6	21.6	23.1	28.5	29.8	23.3	28.3	32.0	17.0	15.6	28.5	33.4	27.5	52.9	16.5	12.8	24.3	53.4	19.9	16.4	21.2	15.4	21.6	26.8	18.0	27.0	32.0	30.8	19.1	26.1	20.7	20.8	30.3	26.3	17.2	10.5	44.3	31.9	28.5	32.9	25.2	22.3	13.8	15.3	9.6	12.3	16.4	17.5	10.6	13.4	9.9	15.0	35.2	21.7	23.9	16.6	16.1	18.5	19.1	21.4	17.7	11.9	24.5	13.1	17.7	25.6	19.4	32.2	26.7	28.1	20.0	35.2	34.7	12.8	32.0	26.4	43.0	23.4	21.7	26.3	24.2	39.3	20.1	26.5	34.1	68.8	16.0	23.3	29.4	29.8	31.1	21.6	43.7	15.2	21.3	11.6	31.7	28.8	8.0	27.7	28.9	18.3	30.0	18.8	17.1	15.2	44.1	20.0	9.4	20.3	22.4	28.4	21.6	25.1	26.6	17.6	42.1	24.0	3.7	11.0	9.6	13.4	10.6	15.7	13.3	15.3	14.1	15.3	13.8	15.2	14.1	4.7	16.4	12.3	14.2	17.5	10.6	18.1	16.7	14.2	20.2	17.0	15.6	16.5	12.8	15.4	10.5	11.9	11.7	52.0	64.7	44.0	33.6	21.0	35.7	14.7	10.3	27.9	11.8	52.7	66.3	54.2	13.5	31.8	31.0	23.3	64.2	59.4	32.4	48.8	16.1	24.6	43.9	15.9	45.3	38.6	37.4	12.9	45.5	39.8	33.7	35.1	39.8	22.3	51.7	35.1	38.2	65.4	32.9	19.4	39.1	28.4	93.3	40.3	39.0	65.7	63.8	68.2
PDCD2L	MGC13096	ENSG00000126249	"Programmed cell death 2 like"	Q9BRP1	19	34404384-34426168	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 28.8;Spermatogonia: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA052181	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA052181: AB_2681751"	"unprognostic (5.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.98e-2)"	6.2	6.6	7.7	7.3	8.9	4.5	6.1	8.8	15.6	5.4	5.8	6.8	6.3	4.6	5.8	6.1	5.8	6.9	6.3	9.3	7.1	7.8	4.5	9.7	4.0	7.1	5.8	6.2	6.9	16.0	4.0	6.8	4.4	5.7	5.7	6.1	5.5	8.9	8.1	26.7	7.4	4.2	5.4	5.8	5.8	7.3	22.9	4.3	6.2	6.1	12.2	7.7	5.3	4.2	9.9	17.4	0.5	3.8	8.5	10.5	4.1	10.5	18.1	2.3	4.4	1.1	2.2	7.2	3.4	2.5	5.7	5.8	16.8	7.8	8.8	15.1	2.0	6.1	3.6	9.2	7.7	5.8	12.9	19.0	8.7	2.8	13.2	7.6	16.7	4.9	2.7	6.8	3.4	11.4	2.3	5.8	14.5	17.2	4.7	5.2	13.5	6.3	6.2	8.9	24.0	18.0	9.6	4.1	13.0	7.4	6.2	13.5	4.7	0.3	11.1	6.1	4.4	4.7	7.0	3.0	3.8	4.7	4.6	11.4	10.4	15.8	16.0	4.7	14.8	3.2	0.0	2.5	0.0	7.3	3.8	10.0	9.9	7.2	7.0	5.1	7.5	10.5	8.0	0.5	8.5	2.3	17.4	8.1	4.1	7.7	8.9	8.8	15.6	7.1	7.8	5.8	6.2	5.7	4.3	3.0	3.7	6.0	8.7	7.2	3.2	4.3	10.2	5.3	3.4	3.5	2.0	6.8	6.6	13.4	17.6	2.9	0.7	0.0	13.2	5.8	4.6	6.0	4.6	3.9	6.6	1.6	11.6	4.3	2.8	2.3	4.9	3.8	3.3	9.0	3.4	5.0	11.7	6.6	6.3	8.0	2.5	0.0	5.6	28.8	36.7	9.4	1.5	7.0	6.8	9.1
PDCD4	H731	ENSG00000150593	"Programmed cell death 4"	Q53EL6	10	110871795-110900006	"Predicted intracellular proteins"	Apoptosis	RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 153.1"	"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 657.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 59.4;U-266/70: 65.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001032, HPA027214, CAB037024"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107"	"unprognostic (4.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.25e-1)"	14.9	9.1	9.4	20.6	9.8	11.8	28.1	15.6	8.1	20.0	46.7	9.1	64.0	18.0	19.1	18.1	40.6	12.3	11.9	8.1	8.4	8.1	6.5	30.6	9.9	13.8	7.8	6.4	27.8	153.1	61.2	30.3	51.4	8.5	18.7	26.1	16.2	81.7	61.7	5.8	37.3	47.1	13.2	8.6	24.0	27.6	10.1	9.5	22.6	55.4	18.8	27.8	15.1	22.7	18.5	12.6	50.9	9.0	26.9	33.1	11.2	5.2	5.1	8.3	8.7	12.4	23.0	4.9	6.1	18.0	3.0	5.2	3.2	13.0	50.2	17.2	8.4	2.3	24.2	5.0	15.5	6.5	43.4	10.0	25.3	29.8	5.3	5.6	12.6	27.6	18.3	49.8	3.1	16.9	13.6	5.6	8.0	6.7	23.8	7.4	13.3	4.6	14.5	2.1	3.7	9.0	2.0	14.8	26.6	4.9	7.3	3.6	15.2	11.7	6.3	21.3	9.2	59.4	23.9	14.3	4.7	3.5	3.4	2.3	65.3	31.6	28.9	4.4	17.6	4.9	50.9	6.1	15.9	18.5	8.3	33.1	18.5	17.1	20.2	7.3	14.3	14.9	18.1	12.0	26.9	9.0	12.6	9.2	11.2	9.4	9.8	15.6	8.1	8.4	8.1	7.8	6.4	8.5	9.5	17.9	50.8	79.3	72.6	118.1	53.9	14.6	22.9	45.5	69.4	24.4	29.5	205.4	29.9	41.5	11.1	69.1	177.9	0.0	89.4	54.3	62.3	50.5	127.3	20.3	49.3	20.6	32.3	79.2	72.9	9.0	134.3	49.5	276.7	41.5	157.6	33.5	61.9	230.3	209.3	20.9	191.1	38.8	44.8	44.6	64.0	144.5	657.3	161.3	172.4	52.3
PDCD5	"MGC9294, TFAR19"	ENSG00000105185	"Programmed cell death 5"	O14737	19	32581068-32587452	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018471	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		31000	Cytosol	Nucleoplasm	"HPA018471: AB_1855108"	"unprognostic (1.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.02e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.54e-2)"	34.1	40.6	42.1	32.3	35.9	18.9	28.9	28.7	33.0	21.2	31.7	16.4	27.0	31.4	22.9	24.8	33.8	21.4	23.1	63.7	33.0	34.2	37.0	52.0	20.6	25.9	32.9	31.9	25.8	47.6	14.7	38.8	29.5	31.0	23.2	27.6	14.7	27.3	24.5	107.4	23.9	27.1	32.1	26.4	26.8	28.0	52.4	23.5	15.2	25.4	42.7	26.6	30.6	31.8	34.6	29.1	11.2	44.8	24.2	49.8	26.9	69.3	86.3	20.8	22.4	35.2	54.4	26.9	51.2	33.0	41.6	35.9	69.9	26.7	37.8	74.8	25.0	38.4	18.6	28.8	39.1	31.9	68.1	46.3	57.1	37.9	41.7	41.9	72.7	23.0	34.5	37.2	28.2	46.4	20.3	27.7	30.0	51.9	41.5	35.0	44.4	32.5	37.8	22.8	54.1	29.3	32.0	32.0	45.7	31.9	18.1	43.9	25.0	48.6	47.4	35.3	15.2	20.7	42.6	42.7	37.4	41.8	40.3	82.5	40.3	57.1	65.7	44.5	66.7	33.0	6.9	23.1	11.2	26.7	34.9	33.9	34.6	42.9	33.0	28.5	25.5	30.4	29.3	3.2	24.2	44.8	29.1	49.8	26.9	42.1	35.9	28.7	33.0	33.0	34.2	32.9	31.9	31.0	23.5	68.5	54.2	33.4	145.9	108.0	36.9	288.5	96.8	120.5	73.9	71.5	25.5	162.5	160.8	234.0	357.7	120.8	81.3	0.0	214.8	167.1	134.8	123.3	46.1	120.1	128.8	47.7	68.5	80.4	43.1	361.1	132.0	84.8	118.1	147.9	102.5	60.5	238.5	74.8	115.6	146.4	36.6	71.1	140.0	373.0	377.8	104.8	119.6	62.3	133.4	113.1
PDCD7	"ES18, HES18"	ENSG00000090470	"Programmed cell death 7"	Q8N8D1	15	65117379-65133836	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 165.8;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 177.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049388	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA049388: AB_2680741"	"unprognostic (7.71e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (8.18e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.29e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.62e-2)"	16.0	16.8	22.4	17.6	26.9	13.1	23.8	43.7	28.5	19.0	19.4	21.3	12.6	14.6	23.8	19.8	23.2	18.6	12.7	14.4	21.0	16.3	13.7	15.6	21.5	19.5	22.9	24.7	26.5	16.6	16.5	15.7	17.4	20.6	17.4	14.3	15.0	14.2	19.0	17.5	16.4	15.4	20.4	17.5	18.7	15.1	27.4	32.1	19.7	18.0	12.7	21.5	18.4	18.6	5.9	4.0	4.0	3.2	7.1	4.5	1.4	8.8	7.4	12.6	13.0	12.7	17.9	7.6	10.2	11.3	12.6	9.7	8.9	9.9	17.1	11.1	8.1	9.4	16.9	32.0	7.3	9.1	10.3	8.6	16.6	6.3	7.8	11.7	22.5	11.2	10.4	11.2	6.9	13.1	12.1	9.9	12.8	21.1	14.0	10.9	6.7	23.6	16.1	15.3	10.3	6.7	20.9	16.2	19.0	7.6	14.2	10.4	12.4	11.4	9.7	14.9	14.4	7.8	18.6	10.1	13.1	12.8	7.5	15.7	25.1	28.6	12.3	11.8	25.0	6.6	4.0	3.2	1.8	4.5	2.6	3.8	4.8	4.3	4.1	2.8	5.9	4.5	4.5	0.8	7.1	2.5	4.0	3.1	1.4	22.4	26.9	43.7	28.5	21.0	16.3	22.9	24.7	20.6	32.1	0.0	11.0	24.3	63.5	33.8	165.8	15.9	15.3	9.4	14.8	27.9	208.1	49.6	24.9	7.2	4.9	27.4	10.0	0.0	7.0	25.2	28.2	37.6	19.6	16.1	20.7	71.5	13.8	16.5	21.8	6.6	53.8	17.5	11.8	5.4	17.4	63.4	6.5	10.5	45.3	17.1	177.0	45.3	24.4	137.9	102.2	34.9	59.7	40.6	21.3	41.6
PDCL	"DKFZp564M1863, PhLP"	ENSG00000136940	"Phosducin like"	Q13371	9	122798389-122828631	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021571, HPA021647, CAB026473"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115"	"unprognostic (3.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-1)"	20.7	14.8	17.5	14.1	21.0	23.8	23.0	20.5	21.9	19.6	15.1	23.7	11.4	13.2	21.5	12.8	18.4	15.9	14.9	14.6	18.4	17.3	13.7	10.1	19.7	17.5	20.2	17.1	15.5	13.0	17.5	13.7	20.6	22.2	17.1	15.9	13.9	21.7	14.7	8.1	15.4	14.7	17.2	22.8	18.4	15.5	12.1	18.8	19.1	17.3	13.3	17.6	15.8	16.4	12.6	14.7	20.6	16.3	16.2	25.3	10.8	9.6	13.3	23.1	8.5	21.0	14.2	12.8	13.5	14.3	12.5	12.9	8.8	12.8	16.1	11.1	16.2	13.8	18.9	14.2	13.3	14.0	15.7	7.2	16.6	17.8	14.7	10.8	14.0	32.9	12.1	9.7	12.3	6.2	11.8	25.7	10.3	16.6	9.5	14.1	14.8	14.9	12.6	16.9	16.6	10.5	15.7	21.9	11.9	15.2	0.0	18.5	16.5	18.3	10.4	8.1	15.8	15.7	9.7	28.0	11.7	13.9	17.0	13.0	7.3	14.6	17.2	10.0	11.3	11.1	20.6	11.9	19.6	13.9	10.4	15.0	11.4	16.7	12.8	12.3	12.6	17.5	15.2	9.8	16.2	16.3	14.7	25.3	10.8	17.5	21.0	20.5	21.9	18.4	17.3	20.2	17.1	22.2	18.8	8.9	8.6	12.8	13.9	21.5	41.4	3.6	10.2	18.7	4.5	19.2	21.6	24.0	8.3	18.4	4.7	30.5	7.9	0.0	15.8	22.8	25.4	15.3	56.5	6.6	22.4	38.1	12.1	26.4	23.7	2.1	21.3	16.0	18.6	41.5	17.7	34.4	14.0	15.9	15.9	11.8	34.6	19.4	22.7	12.0	17.2	20.3	26.7	20.8	12.1	14.0
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.0;kidney: 37.1"	"Group enriched"	"Detected in many"	6	"Distal tubular cells: 157.5;Early spermatids: 314.8;Late spermatids: 455.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"ASC diff: 22.8;HHSteC: 13.5;HSkMC: 28.9"	"Group enriched"	"Detected in many"	6	"amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8"	"Low region specificity"	"Detected in all"			HPA022151	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	7.6	3.9	13.8	3.6	11.5	0.5	4.1	66.0	25.3	11.5	8.8	6.2	1.7	2.6	7.3	6.7	4.7	7.4	18.2	11.8	12.6	4.1	37.1	3.2	3.1	1.8	7.1	15.7	9.2	2.0	1.3	2.3	1.3	6.9	3.8	5.6	3.0	1.8	4.8	2.4	2.1	4.6	11.8	10.1	2.6	4.6	24.6	9.0	0.0	35.1	2.6	1.1	8.3	9.0	0.0	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.1	2.3	0.0	22.8	1.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	3.2	0.0	13.5	0.0	0.0	28.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	3.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	13.8	11.5	66.0	25.3	12.6	4.1	7.1	15.7	6.9	9.0	0.0	1.6	0.0	2.2	1.1	12.6	3.6	0.0	0.0	2.3	26.2	0.0	0.1	157.5	0.3	314.8	5.8	0.0	0.0	0.3	0.0	1.9	2.0	0.0	0.0	0.1	0.0	0.0	8.0	0.0	455.7	13.8	0.2	0.0	0.0	0.6	0.2	0.2	0.0	7.8	1.4	1.1	51.8	47.4	4.4	3.9	1.1	0.0	0.0	0.0	0.7
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32299329	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.6;heart muscle: 56.2"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 55.0;Cardiomyocytes: 112.6;Cone photoreceptor cells: 49.1;Early spermatids: 40.4;Late spermatids: 38.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 15.2;fHDF/TERT166: 49.0;hTERT-RPE1: 15.0;U-251 MG: 26.5;WM-115: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.9	2.7	10.6	3.2	27.7	0.9	5.1	2.4	17.1	1.2	2.7	30.1	0.0	2.3	3.1	6.8	7.4	8.4	2.4	56.2	14.8	7.5	4.0	1.0	5.0	1.4	31.1	12.0	4.9	2.7	1.3	1.3	4.0	16.3	2.9	2.7	7.9	2.6	4.2	1.4	0.9	2.8	10.4	17.1	1.4	3.8	4.2	33.6	0.0	3.9	0.2	1.0	7.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	0.0	0.2	0.1	0.0	15.2	6.2	7.2	5.9	0.0	0.0	0.0	0.0	49.0	0.0	0.4	0.0	0.0	9.3	0.0	0.0	0.4	0.4	0.0	0.0	0.0	10.9	0.6	0.0	1.5	0.1	15.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	7.4	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	8.1	3.0	0.1	26.5	0.0	0.0	0.0	0.7	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	27.7	2.4	17.1	14.8	7.5	31.1	12.0	16.3	33.6	0.0	0.0	0.0	0.8	0.0	55.0	112.6	0.0	4.0	1.2	1.8	49.1	0.0	0.0	5.6	40.4	2.9	0.0	0.0	0.4	0.0	0.0	0.2	8.1	0.0	0.1	3.2	0.0	0.0	0.0	38.3	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	4.4	0.0	2.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20369245-20684381	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.2"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 41.0;Cardiomyocytes: 107.8;Horizontal cells: 49.3;Smooth muscle cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;HEL: 14.6;HeLa: 39.5;HUVEC TERT2: 7.1;SH-SY5Y: 14.8;U-138 MG: 11.4"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"		NA	NA		23000	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	7.1	1.0	1.7	4.7	2.0	0.0	3.8	3.5	1.4	7.8	15.9	1.0	2.0	2.1	7.8	3.5	9.1	4.9	5.5	62.2	1.6	1.4	3.7	1.8	3.9	3.3	1.9	1.1	7.1	6.5	1.0	2.8	13.8	2.7	6.3	9.0	12.0	7.8	4.2	2.0	1.4	21.4	6.0	1.8	2.1	5.5	2.3	0.7	0.0	2.8	1.9	0.9	4.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	7.9	0.0	1.8	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.6	39.5	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.1	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.0	0.0	0.0	2.2	0.0	0.1	14.8	0.0	0.0	0.0	3.5	0.0	0.0	0.2	11.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.0	3.5	1.4	1.6	1.4	1.9	1.1	2.7	0.7	0.0	0.0	0.0	0.1	0.2	41.0	107.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.2	2.2	24.6	0.0	0.4	0.0	3.5	0.5	16.2	0.0	0.5	49.3	4.1	0.6	0.0	0.0	1.4	0.0	1.7	0.0	7.4	2.5	0.5	24.6	0.7	2.6	2.2	6.5	51.8	0.2	0.4	0.3	0.0	0.0	13.9	0.2
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643723-14872044	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	Angiogenesis	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 42.6"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 34.7;Hepatocytes: 50.5;Spermatocytes: 45.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.2"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 5.0;T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 13.6;Karpas-707: 15.7;THP-1: 16.7;U-266/70: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA056111: AB_2683041"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-3)"	42.6	1.0	2.3	12.6	2.2	6.7	17.0	19.2	3.0	2.9	21.8	0.9	0.8	2.2	0.9	1.4	2.6	1.0	6.9	4.7	2.2	2.1	2.4	18.2	10.2	14.1	1.6	1.6	0.9	7.3	0.3	5.1	5.5	1.5	10.7	8.1	1.9	16.5	1.3	0.8	0.9	6.3	9.7	2.1	8.7	3.0	12.5	0.8	7.8	1.2	2.3	7.1	10.5	4.5	0.3	0.4	5.0	1.2	0.1	8.7	1.8	0.0	1.5	3.4	5.5	6.8	0.0	1.3	0.4	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.6	0.0	5.1	0.0	0.0	0.1	11.3	0.1	8.3	10.2	2.4	13.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.0	11.9	15.7	0.0	0.1	2.7	6.6	4.6	1.8	2.5	6.5	1.5	10.3	0.0	1.1	5.2	9.7	1.3	8.8	3.0	1.6	0.0	16.7	0.0	0.0	0.8	0.0	0.0	17.7	5.4	0.4	0.1	2.3	1.0	0.0	0.7	2.9	1.4	0.7	2.9	0.3	4.2	3.2	0.4	0.2	8.7	7.5	5.0	0.1	1.2	0.1	4.2	1.8	2.3	2.2	19.2	3.0	2.2	2.1	1.6	1.6	1.5	0.8	14.9	9.9	1.9	0.8	0.2	0.4	8.2	0.0	6.7	11.4	1.8	0.0	1.0	1.7	0.0	12.4	2.2	2.6	23.3	4.3	1.9	8.5	3.4	34.7	50.5	6.3	0.0	1.2	7.4	14.0	10.1	1.4	12.3	0.0	1.0	13.1	4.5	2.9	17.5	8.5	1.9	0.3	0.0	0.1	45.1	11.1	0.1	2.1	11.7	9.7	0.9
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.2"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 81.5;Horizontal cells: 108.1;monocytes: 104.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 36.6"	"Group enriched"	"Detected in all"	5	"B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.4;HUVEC TERT2: 36.6;NTERA-2: 22.2;SK-MEL-30: 22.0;TIME: 20.4;U-266/84: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	14.9	2.9	21.5	28.4	29.0	48.2	15.0	12.7	31.9	6.4	6.6	39.2	0.7	3.9	6.7	2.1	3.9	3.5	8.1	16.1	20.7	18.8	3.7	8.7	10.0	15.9	36.3	14.2	2.0	1.7	1.7	3.4	13.1	32.2	18.3	8.6	6.6	15.9	10.3	28.2	6.2	8.5	9.5	37.4	18.5	4.2	3.2	36.9	2.3	5.5	5.5	14.7	16.1	3.9	16.1	2.6	36.6	2.8	4.4	13.3	3.7	0.1	7.0	13.8	24.4	0.7	0.7	0.0	4.5	5.3	4.2	5.6	0.0	0.0	2.0	0.1	8.4	0.1	0.0	0.1	0.0	4.2	5.9	0.0	0.1	2.0	0.0	0.5	4.9	0.0	1.4	0.2	2.1	0.1	0.6	36.6	0.0	0.0	1.3	1.8	0.1	0.0	2.8	22.2	0.0	0.3	1.0	2.4	1.3	3.4	0.0	0.1	10.6	0.0	1.2	22.0	1.2	0.1	1.7	20.4	3.3	0.8	1.8	0.7	0.6	19.1	7.5	3.4	5.1	1.4	2.7	2.8	8.4	4.4	2.4	8.4	15.4	8.3	6.2	2.4	16.1	9.4	6.5	36.6	4.4	2.1	2.6	13.3	3.7	21.5	29.0	12.7	24.6	20.7	18.8	36.3	14.2	32.2	36.9	8.9	16.4	50.2	24.5	18.0	35.4	29.1	0.0	2.7	12.5	5.2	0.0	5.2	0.0	0.5	7.9	23.2	0.0	0.0	0.8	1.6	9.3	81.5	14.0	1.6	12.6	108.1	4.1	12.3	25.8	5.6	0.3	42.5	49.0	104.6	1.2	12.2	0.1	0.0	2.5	1.6	3.3	0.0	10.3	0.1	0.7	7.0	4.7	36.2	1.1	5.7
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 28.6"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 141.8;Paneth cells: 179.9;Undifferentiated cells: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.0;Hep G2: 4.0;U-87 MG: 9.0"									"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Cytosol"		NA	NA			"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	2.0	1.3	1.8	1.5	2.8	1.0	2.0	0.8	6.1	4.1	4.4	1.5	3.1	1.5	6.4	6.8	1.3	4.2	5.6	4.2	1.6	1.9	4.1	2.0	4.1	0.5	1.7	5.1	2.0	0.8	0.3	3.5	7.0	2.8	5.8	1.3	2.5	1.3	5.4	13.4	0.6	4.1	3.4	0.7	2.3	5.2	2.6	1.1	0.4	1.2	28.6	0.7	1.8	3.3	1.3	0.6	3.5	0.7	1.0	0.7	0.2	0.1	0.3	0.2	0.3	0.1	0.3	6.0	0.1	0.0	0.2	0.3	1.2	0.2	0.2	0.6	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.4	4.0	0.2	0.2	0.6	0.7	0.1	2.6	0.0	0.5	0.0	0.3	0.9	2.1	0.1	0.4	0.2	0.3	0.2	0.4	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.8	0.3	0.5	0.0	1.6	0.5	0.3	0.0	0.4	0.2	0.7	0.1	1.3	0.6	0.2	9.0	0.2	0.3	3.4	0.7	1.0	0.6	0.4	0.5	0.5	0.5	0.4	0.2	1.3	0.5	0.7	3.5	1.0	0.4	0.6	0.3	0.2	1.8	2.8	0.8	6.1	1.6	1.9	1.7	5.1	2.8	1.1	3.0	8.8	0.0	2.2	4.8	3.0	28.1	5.1	0.0	1.2	0.0	5.9	1.9	0.0	0.0	29.1	3.6	141.8	0.0	0.0	3.5	4.2	1.8	4.6	0.0	0.4	0.0	6.9	1.3	2.2	26.0	0.6	1.1	1.7	0.0	34.4	2.7	0.0	179.9	3.9	0.0	3.3	45.3	13.4	1.9	1.9	3.3	0.9	0.0	66.4	18.4
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 76.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 28.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in many"		"A549: 25.3;AN3-CA: 29.1;HeLa: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.2	1.9	4.4	6.8	8.6	46.2	5.3	4.2	13.0	13.5	18.6	1.4	14.7	4.1	17.1	14.0	10.3	6.6	12.7	15.5	4.5	5.8	12.8	3.4	11.1	3.7	5.2	6.6	5.3	2.9	7.0	9.0	11.8	2.7	18.2	11.2	8.6	24.4	16.5	60.0	5.1	7.5	35.8	5.0	3.8	10.2	2.6	2.8	4.4	6.2	11.3	9.5	20.0	11.2	6.1	0.7	28.1	1.1	0.1	0.8	0.5	0.0	25.3	5.3	29.1	1.0	1.9	4.2	0.6	0.7	1.4	2.1	9.9	0.8	1.9	0.1	0.2	4.3	4.3	0.0	1.1	2.5	1.1	2.9	3.7	41.9	2.1	3.9	1.7	0.2	3.9	0.9	4.0	0.7	0.4	3.0	0.1	0.0	0.6	2.4	1.8	1.4	4.1	1.0	0.7	1.3	0.4	6.7	4.2	6.6	9.5	0.9	3.3	6.7	11.3	5.7	5.0	0.8	3.7	3.4	0.3	0.1	5.0	1.3	1.4	0.0	0.2	4.3	7.0	1.1	2.0	1.1	28.1	0.8	0.0	0.8	6.1	0.7	0.3	0.7	6.1	0.5	0.4	1.5	0.1	0.1	0.0	0.4	0.5	4.4	8.6	4.2	13.0	4.5	5.8	5.2	6.6	2.7	2.8	29.8	76.9	9.1	30.5	9.4	13.6	32.7	10.2	22.7	48.9	40.1	68.7	9.2	10.0	0.5	16.6	12.4	16.7	0.0	1.6	14.8	13.1	46.1	21.9	0.8	4.3	1.6	32.0	14.1	6.0	29.3	1.4	9.4	10.1	4.6	18.4	16.1	5.4	10.5	4.6	17.7	52.1	0.0	5.3	0.5	7.1	7.8	2.6	37.3	10.1	21.1
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494395-119628991	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Peritubular cells: 98.6;Smooth muscle cells: 79.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.6;HHSteC: 35.4;hTERT-RPE1: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		3100000	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	12.3	4.9	2.0	28.2	2.3	0.4	8.1	3.0	2.3	21.3	28.0	1.7	20.1	6.5	17.3	21.4	30.7	10.7	13.3	5.3	2.0	2.8	3.8	1.2	11.4	4.1	2.4	3.4	10.0	7.8	5.1	3.4	8.9	4.4	31.8	11.7	20.2	8.5	23.7	6.8	4.2	15.6	45.6	2.0	2.1	9.1	7.6	1.2	0.9	9.1	8.1	2.2	25.9	15.9	1.5	0.5	1.4	0.4	0.6	2.1	4.2	8.1	0.4	5.7	0.6	2.0	3.0	1.0	5.5	24.6	0.2	0.5	0.5	0.7	0.8	0.2	6.8	1.5	3.0	1.8	0.8	0.7	0.2	3.7	9.1	1.4	0.4	35.4	1.9	0.9	3.3	1.7	0.6	0.0	12.9	0.7	1.9	1.0	1.5	0.8	0.4	2.4	0.3	1.2	0.9	1.4	0.3	2.9	2.1	2.1	2.5	2.2	4.6	6.3	8.0	0.6	4.4	1.4	1.0	1.2	3.2	2.8	1.7	0.7	2.1	1.0	0.7	3.1	0.5	0.4	0.0	0.3	0.0	0.6	0.1	2.1	1.5	1.3	0.4	0.2	1.0	0.6	0.9	1.4	0.6	0.4	0.5	0.4	4.2	2.0	2.3	3.0	2.3	2.0	2.8	2.4	3.4	4.4	1.2	6.0	4.6	0.0	2.3	3.1	8.1	3.5	12.7	1.4	5.7	1.8	13.7	0.2	0.0	12.0	25.6	3.3	6.3	0.0	2.5	0.2	3.8	2.4	1.1	1.0	0.2	4.8	2.4	1.3	0.0	9.4	19.2	0.7	5.0	0.0	10.1	28.4	4.2	9.1	98.6	0.5	5.9	19.4	79.9	2.9	5.5	2.0	0.2	0.0	8.6	1.6
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625584-670782	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.2;retina: 64.2"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 453.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.6	1.9	12.1	4.6	19.1	6.7	3.8	2.3	13.2	2.3	1.3	30.2	1.5	0.8	2.5	3.9	1.4	9.6	3.2	5.2	18.1	10.2	4.6	0.7	4.2	12.0	29.6	9.8	2.6	1.4	9.1	3.2	2.6	14.5	2.5	1.0	64.2	3.5	2.9	0.7	1.8	2.2	2.1	20.2	8.7	2.5	3.6	22.4	4.3	11.4	0.2	8.3	4.1	1.1	16.5	14.1	11.2	5.8	10.2	13.1	7.1	0.0	0.2	0.8	0.4	0.2	0.3	0.2	0.0	0.0	0.5	1.4	0.0	0.1	0.2	8.0	0.2	0.7	0.1	1.7	0.4	0.0	0.1	0.0	0.6	0.2	0.0	4.1	0.1	0.3	0.5	0.1	2.4	0.0	0.5	0.7	11.8	0.1	0.6	0.0	0.2	20.5	0.2	6.5	0.4	0.2	11.1	0.2	0.4	1.4	0.9	14.0	8.2	0.0	0.3	0.1	3.3	0.4	0.0	0.2	0.1	0.8	0.1	0.3	5.4	15.2	0.2	0.2	0.2	0.1	11.2	4.2	0.6	11.5	5.8	10.5	10.0	7.7	7.9	6.6	16.5	12.2	13.1	1.1	10.2	5.6	14.1	11.4	7.1	12.1	19.1	2.3	10.0	18.1	10.2	29.6	9.8	14.5	22.4	3.0	5.3	4.5	1.2	0.3	18.2	3.7	0.0	16.0	5.7	0.0	78.5	0.1	1.7	5.1	0.4	1.8	0.0	0.0	0.6	0.2	0.8	0.9	3.5	0.0	9.2	11.1	1.7	2.5	3.9	0.0	1.4	3.4	3.3	7.2	0.2	20.9	0.7	0.0	1.4	6.7	453.5	0.0	0.2	3.9	2.7	0.3	0.2	7.0	0.1	0.6
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851696-136195574	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 21.0;Endothelial cells: 18.2;Ito cells: 35.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;ASC TERT1: 8.6;EFO-21: 13.4;HeLa: 7.8;HSkMC: 18.7;HUVEC TERT2: 8.7;U-2197: 9.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 112.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.8	4.3	7.3	4.0	21.9	0.8	3.6	1.6	12.8	6.2	4.0	2.3	25.2	3.6	14.2	4.9	2.8	4.2	6.1	7.9	5.1	7.4	9.6	6.4	3.3	2.8	6.4	4.2	22.7	1.6	3.7	8.7	2.2	5.9	6.8	5.0	5.4	5.0	28.5	7.2	1.5	3.7	13.5	5.3	2.3	5.2	2.9	7.1	7.7	8.3	6.1	1.9	10.6	5.1	4.3	2.6	0.6	0.9	0.7	1.8	0.3	0.0	4.5	0.1	0.0	7.3	8.6	0.0	0.4	2.3	1.7	0.9	0.0	0.0	0.0	13.4	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	7.8	0.0	3.1	0.1	0.0	18.7	0.0	3.4	0.0	0.7	8.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.0	0.5	3.2	3.0	0.1	0.1	0.0	0.0	1.5	0.0	1.9	0.0	9.3	0.0	0.1	0.0	0.0	0.5	0.0	0.7	0.2	0.9	0.6	0.2	0.2	0.1	1.5	0.4	0.2	2.6	4.3	1.8	1.0	0.3	0.7	0.1	0.2	0.2	0.3	7.3	21.9	1.6	12.8	5.1	7.4	6.4	4.2	5.9	7.1	0.0	0.3	3.0	0.2	0.3	2.3	8.5	2.5	0.0	0.0	21.0	0.0	0.1	0.0	0.1	0.4	18.2	0.0	0.0	1.5	0.0	3.3	0.3	10.3	4.7	0.3	6.4	7.0	35.0	1.5	0.0	11.2	0.5	0.0	0.0	0.0	13.8	0.1	0.0	7.4	1.2	0.7	12.9	3.1	0.1	0.2	1.3	0.0	0.0	0.0	0.1
PDE8A	HsT19550	ENSG00000073417	"Phosphodiesterase 8A"	O60658	15	84980440-85139145	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 40.2"	"Low region specificity"	"Detected in all"							HPA007722	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA007722: AB_1855130"	"unprognostic (1.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.99e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-2)"	14.3	16.6	14.0	8.5	18.7	2.6	9.8	2.6	14.8	11.4	21.0	35.5	9.1	13.2	9.0	8.2	5.9	8.8	14.3	7.8	17.2	9.8	21.7	26.2	10.5	5.4	23.3	12.1	12.0	12.7	17.6	7.1	10.1	20.1	6.9	19.8	12.6	8.2	9.2	5.6	6.2	11.7	10.7	17.6	6.7	10.8	10.6	25.5	2.2	11.2	4.8	5.0	11.9	10.6	1.3	1.7	1.7	4.5	0.6	3.2	0.6	12.8	21.5	3.7	2.5	15.5	8.2	4.4	8.6	9.6	7.7	8.9	4.8	7.7	2.5	6.8	11.6	9.2	9.1	15.6	6.8	10.4	4.7	9.3	3.4	13.9	6.9	11.2	2.0	5.2	8.2	4.2	9.0	8.7	6.7	9.9	2.9	6.8	8.4	7.0	10.8	1.1	1.9	1.7	4.2	4.0	1.5	3.0	3.6	6.1	40.2	8.5	6.5	8.5	9.4	25.0	4.2	3.0	3.9	7.7	18.1	6.3	6.4	14.1	4.1	7.2	2.8	12.3	8.1	5.1	0.0	2.4	1.7	1.1	2.2	2.1	0.8	1.8	1.9	1.7	1.3	2.2	0.9	0.2	0.6	4.5	0.0	3.2	0.6	14.0	18.7	2.6	14.8	17.2	9.8	23.3	12.1	20.1	25.5	6.0	31.1	9.3	10.7	10.1	13.4	5.2	30.6	10.7	15.9	7.0	11.8	6.3	6.6	8.7	5.6	17.9	20.8	0.0	8.2	5.8	13.3	17.2	20.9	20.8	9.7	9.5	13.9	16.5	12.5	4.1	10.0	16.1	10.1	6.4	17.5	2.5	11.6	31.7	10.6	15.7	32.2	38.8	14.1	22.4	14.5	9.2	3.8	4.8	22.9	22.5
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77429807	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"thyroid gland: 67.7"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 26.4;Cone photoreceptor cells: 51.1;Glandular cells: 41.8;Horizontal cells: 65.2;Muller glia cells: 77.6"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 12.4;HeLa: 28.4;SK-BR-3: 7.6"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	6.8	2.5	9.9	0.7	14.2	0.4	3.8	1.1	16.3	6.3	1.2	2.3	0.3	1.2	11.3	3.2	1.1	10.1	2.1	7.9	8.2	9.2	3.1	1.2	2.2	0.7	5.4	8.3	1.9	4.2	0.3	3.8	13.1	8.6	10.5	0.8	2.0	5.3	7.1	0.4	0.7	1.3	10.3	2.3	0.4	1.5	1.5	5.7	0.3	67.7	0.3	0.7	0.8	1.4	0.2	0.8	1.4	2.3	0.4	0.4	0.1	0.3	3.4	1.4	0.4	1.2	0.0	0.5	1.1	12.4	0.2	0.1	1.4	0.2	0.5	0.2	0.1	0.3	0.9	0.1	0.0	0.2	0.2	1.1	0.7	28.4	0.3	0.0	0.5	0.6	0.5	0.0	0.0	0.0	0.6	0.0	0.6	0.2	0.3	0.0	0.2	0.6	0.7	0.8	0.3	0.1	0.8	1.4	0.7	0.0	0.3	3.8	1.1	1.7	7.6	0.8	1.1	1.6	1.1	0.6	0.4	0.2	0.2	0.6	0.9	0.5	0.6	1.6	0.7	0.4	0.0	0.3	1.4	0.3	2.2	0.1	0.2	0.2	0.3	0.8	0.2	0.4	0.0	0.3	0.4	2.3	0.5	0.1	0.1	9.9	14.2	1.1	16.3	8.2	9.2	5.4	8.3	8.6	5.7	3.0	3.2	0.0	1.6	0.3	11.8	26.4	0.0	0.0	2.3	1.8	51.1	0.0	0.0	1.8	3.6	0.7	0.0	0.0	0.0	0.0	2.3	41.8	1.1	0.0	0.3	65.2	4.7	4.3	0.6	3.0	5.5	0.0	1.7	0.0	0.6	77.6	0.2	0.0	0.0	0.8	4.6	6.5	8.2	0.6	2.1	1.0	0.0	0.0	0.5	2.4
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69328621-69330595	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.2"	"Cell type enhanced"	"Detected in single"	21	"Alveolar cells type 1: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	6.6	7.9	4.8	7.8	4.5	5.3	4.8	3.1	6.9	3.6	7.6	3.8	3.3	7.1	5.3	5.6	8.4	4.4	6.5	3.8	4.6	3.3	14.9	30.2	3.7	7.0	3.0	5.2	5.0	14.2	8.2	3.9	4.9	4.4	5.3	4.1	4.3	12.8	4.6	10.4	6.0	5.2	3.4	2.3	5.0	8.3	3.7	2.0	10.2	7.3	9.2	6.2	3.7	4.0	10.3	3.2	2.5	2.8	1.7	6.9	1.5	9.0	6.1	1.2	2.9	1.8	1.4	10.7	7.6	2.0	5.4	4.7	15.0	6.4	16.7	10.1	2.6	2.5	13.0	3.7	4.0	2.2	4.0	31.0	8.5	5.8	21.4	3.7	11.8	6.8	2.8	7.1	4.8	2.3	0.9	3.1	8.6	20.3	1.9	2.9	11.6	9.2	12.4	7.8	3.3	11.2	21.7	1.9	15.5	4.3	5.7	10.4	8.3	13.1	2.3	6.4	0.5	12.9	3.8	4.7	4.7	8.8	5.4	8.7	15.8	10.5	19.7	3.1	8.8	6.0	0.0	2.8	2.5	1.2	1.6	3.1	4.3	3.9	3.9	3.0	10.3	6.9	2.5	0.0	1.7	1.5	3.2	3.0	1.5	4.8	4.5	3.1	6.9	4.6	3.3	3.0	5.2	4.4	2.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0
PDGFA	"PDGF-A, PDGF1"	ENSG00000197461	"Platelet derived growth factor subunit A"	P04085	7	497258-520296	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.1"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 83.4;Paneth cells: 77.2;Smooth muscle cells: 97.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"WM-115: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005579, HPA065024"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		300000	"Golgi apparatus"		"CAB005579: AB_2161916, HPA065024: "	"unprognostic (2.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.63e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (8.67e-4)"	9.5	6.1	13.1	6.6	20.4	2.1	16.5	9.0	16.6	11.1	14.8	33.4	5.8	16.3	15.5	11.2	8.5	12.1	10.0	14.0	14.9	14.2	10.4	5.4	16.5	8.1	29.8	12.5	6.6	54.7	5.7	6.1	21.5	21.1	14.4	12.7	7.4	16.6	10.2	63.1	10.6	20.3	10.7	26.4	11.8	20.9	4.5	22.7	1.6	6.0	8.6	2.7	11.0	12.7	3.0	3.3	11.6	4.6	5.3	3.6	2.9	5.8	4.0	0.4	5.7	1.1	0.2	13.6	1.3	0.7	1.7	1.2	6.2	6.7	0.1	2.3	1.1	0.7	14.9	0.4	18.1	0.9	3.3	0.6	0.1	3.3	2.2	7.4	0.6	0.7	0.8	7.2	0.8	5.7	2.3	3.3	0.3	0.5	0.8	4.1	7.3	0.8	1.3	10.7	2.3	0.8	2.9	0.4	0.6	2.3	1.4	0.6	0.5	20.1	1.1	3.4	13.4	2.8	0.7	9.7	3.7	10.3	2.1	7.9	0.2	0.3	0.2	3.3	1.8	82.4	11.6	2.6	3.5	2.7	2.9	3.6	3.0	2.7	2.5	2.3	3.0	3.3	3.3	7.6	5.3	4.6	3.3	2.8	2.9	13.1	20.4	9.0	14.5	14.9	14.2	29.8	12.5	21.1	22.7	83.4	11.0	0.0	18.2	24.8	15.7	25.0	5.1	6.7	17.0	14.0	7.9	7.8	5.0	14.2	0.3	19.6	51.1	0.0	46.6	3.8	15.1	23.5	10.4	0.6	1.9	30.2	12.5	22.1	1.5	0.0	2.0	1.6	13.5	1.8	28.3	0.5	52.4	77.2	6.0	8.0	1.9	38.8	97.6	0.2	1.1	8.5	2.4	0.0	20.3	14.5
PDGFB	"SIS, SSV"	ENSG00000100311	"Platelet derived growth factor subunit B"	P01127	22	39223359-39244751	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 22.4;Ito cells: 20.9;Pancreatic endocrine cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 10.8"	"Lineage enriched"	"Detected in single"	12	"T-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"A-431: 13.6;EFO-21: 29.7;HUVEC TERT2: 22.9;SK-BR-3: 22.7;TIME: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011604, HPA011972, CAB018341"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	4390000	98000	Vesicles		"CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134"	"unprognostic (4.96e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.46e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.12e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.03e-1)"	23.5	6.4	10.4	6.4	9.3	0.6	22.5	5.7	13.0	8.3	14.3	12.4	4.2	4.7	10.8	6.5	6.5	5.6	10.8	13.8	9.7	6.1	10.9	3.8	20.8	6.1	14.7	7.3	4.0	8.3	9.2	3.5	37.3	9.6	5.8	3.7	12.1	7.9	8.6	15.2	7.5	6.7	8.9	11.4	5.6	6.2	5.2	10.3	0.8	12.6	8.6	2.3	6.9	5.0	0.0	0.9	0.1	0.4	0.0	10.8	2.3	13.6	1.1	3.6	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	5.4	4.3	0.0	29.7	0.0	1.3	5.1	0.2	1.2	0.0	0.0	0.1	0.3	0.4	1.9	2.0	0.0	7.7	0.0	0.1	0.0	0.2	0.4	22.9	0.0	0.5	2.6	0.8	5.6	0.0	0.0	1.3	3.4	1.4	0.0	0.1	9.2	12.4	0.0	0.1	0.0	0.2	22.7	0.1	2.8	10.3	0.0	28.4	0.0	2.8	0.0	3.1	0.0	0.1	0.1	0.0	0.6	13.1	0.0	0.0	0.0	8.1	0.1	10.8	0.0	4.7	6.1	0.0	0.0	4.1	2.2	0.1	0.0	0.4	0.9	2.4	2.3	10.4	9.3	5.7	13.0	9.7	6.1	14.7	7.3	9.6	10.3	0.0	1.4	0.0	1.1	2.5	0.8	2.8	0.0	1.4	0.0	7.0	0.0	5.6	0.0	12.5	1.1	22.4	0.0	0.0	3.1	5.3	1.3	1.4	0.0	0.8	6.1	0.0	1.7	20.9	1.9	0.0	0.6	8.7	1.7	1.8	0.5	0.3	35.1	0.0	0.0	1.3	0.0	6.5	2.0	0.0	0.2	1.3	3.8	1.3	0.0	0.1
PDGFD	"IEGF, MSTP036, SCDGF-B"	ENSG00000170962	"Platelet derived growth factor D"	Q9GZP0	11	103907186-104164379	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 48.2"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 30.6;Ductal cells: 17.7;Horizontal cells: 25.4;T-cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 7.1;gdT-cell: 13.6;memory CD8 T-cell: 5.8;naive CD8 T-cell: 5.1;NK-cell: 12.6"	"Group enriched"	"Detected in many"	27	"granulocytes: 7.1;NK-cells: 12.6;T-cells: 13.6"	"Group enriched"	"Detected in some"	6	"ASC diff: 56.8;HHSteC: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046183, HPA066271"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		24000	"Golgi apparatus, Vesicles"		"HPA046183: AB_2679573, HPA066271: AB_2685645"	"unprognostic (2.21e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.01e-3)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.57e-3)"	26.1	48.2	1.1	10.1	1.5	0.1	21.2	0.6	1.8	13.8	5.6	1.1	15.0	1.5	9.8	10.2	2.7	5.3	20.6	13.9	0.9	1.9	4.3	1.8	2.3	3.5	0.8	1.6	33.4	32.8	5.0	14.4	8.5	6.4	8.5	4.0	16.7	6.0	16.2	9.8	5.1	2.2	4.0	2.1	2.3	8.6	5.4	0.0	1.1	11.5	4.4	4.6	13.5	10.0	0.4	0.0	7.1	0.0	12.6	13.6	2.9	0.0	3.0	1.6	0.0	56.8	1.7	0.0	0.3	0.3	0.2	0.3	0.0	0.5	2.8	0.5	2.8	2.0	0.1	0.0	0.1	0.1	0.0	1.2	0.0	0.6	0.1	17.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.8	0.0	2.6	0.0	0.0	3.8	0.0	5.4	1.2	0.7	0.0	0.7	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	7.1	13.6	0.0	1.1	0.4	1.5	5.8	0.0	0.0	0.1	5.1	0.2	12.6	0.0	0.0	0.1	2.9	1.1	1.5	0.6	1.8	0.9	1.9	0.8	1.6	6.4	0.0	0.0	0.0	1.7	5.5	2.7	1.0	3.1	30.6	0.0	1.2	5.2	0.0	0.1	0.0	17.7	7.6	7.1	0.0	0.0	3.8	0.1	7.6	1.2	0.0	0.0	0.3	25.4	1.7	3.7	0.3	9.4	0.3	0.0	0.0	1.0	0.7	1.1	3.7	0.0	2.1	0.1	0.3	6.5	2.1	0.3	1.7	1.8	0.0	18.5	0.6	3.1
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229097-54298247	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 81.5"	"Group enriched"	"Detected in many"	9	"Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		150000	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	35.0	12.4	12.6	16.1	7.6	0.9	17.2	2.4	20.1	33.2	19.1	9.2	6.4	9.6	27.6	14.6	21.9	22.5	16.2	15.3	8.9	7.4	22.8	8.4	24.1	26.9	9.2	4.0	81.5	6.8	1.6	2.1	25.1	7.2	18.6	15.2	19.2	8.5	8.3	11.9	7.0	17.4	19.7	8.8	51.6	13.6	19.0	9.3	0.5	11.3	12.8	4.3	35.9	24.6	0.9	0.4	2.5	0.4	0.3	0.8	0.3	0.0	0.0	0.2	0.1	82.8	38.8	0.1	4.3	48.0	0.0	0.1	11.5	0.0	0.1	0.1	33.4	0.1	0.1	3.3	0.0	0.0	0.4	0.1	0.1	0.1	0.2	28.0	0.0	0.0	70.4	0.0	5.5	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	6.7	0.0	0.1	0.0	0.3	0.1	0.0	0.1	15.2	0.5	16.6	0.0	0.0	0.0	0.1	0.4	0.0	0.3	2.5	0.4	0.2	0.5	0.2	0.2	0.6	0.8	0.4	0.0	0.9	0.7	0.4	2.3	0.3	0.3	0.4	0.2	0.3	12.6	7.6	2.4	7.3	8.9	7.4	9.2	4.0	7.2	9.3	0.0	0.3	0.9	0.3	15.1	0.7	4.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	2.9	1.6	3.3	0.0	0.0	5.8	1.2	171.4	0.4	0.0	0.8	2.8	0.0	0.0	38.1	0.6	3.7	416.6	1.6	21.9	8.2	0.0	18.3	12.2	0.0	384.4	0.0	0.4	0.0	13.2	1.1	3.5	13.8	1.1	0.0	0.0	0.8
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113837-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Sertoli cells: 1267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	8	"monocytes: 4.1;T-cells: 2.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 173.0;ASC TERT1: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		35000000	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	61.8	10.4	8.3	11.0	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17.0	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5.0	19.6	9.2	21.5	6.7	1.4	21.4	16.0	7.3	23.6	35.1	0.4	0.1	0.0	4.1	0.0	2.9	0.6	0.0	0.0	1.0	0.0	173.0	59.9	0.4	6.0	25.1	4.2	7.1	0.6	0.0	0.0	0.8	17.3	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.4	24.5	0.0	0.0	27.0	0.0	5.8	0.0	13.5	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.8	2.2	2.9	0.3	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	2.9	0.6	0.0	0.4	0.1	0.8	0.1	0.1	0.0	1.3	0.0	0.0	4.1	0.0	0.0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7	0.0	0.6	0.0	0.5	21.3	5.0	13.4	0.0	1.4	0.0	1.8	3.9	0.6	0.0	0.0	0.8	16.2	0.0	0.0	0.0	1.0	68.8	0.6	0.0	1.5	1.4	0.0	0.0	6.7	0.0	4.7	153.1	2.2	23.6	1.0	0.0	74.9	0.1	0.0	191.6	0.0	1.1	1267.6	273.4	1.1	1.5	13.4	0.7	1.0	0.4	0.9
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.3"	"Cell type enhanced"	"Detected in many"	11	"Fibroblasts: 36.0;Leydig cells: 69.0;Peritubular cells: 66.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AN3-CA: 49.5;BJ hTERT+: 40.1;HSkMC: 21.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA052801: AB_2681956"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	7.7	0.4	0.5	0.1	0.9	0.0	14.3	0.6	0.5	8.0	1.3			0.0	3.6	2.0	0.3	5.8	2.6	1.2	0.3	0.4	0.4	0.3	0.7	0.0	0.4		11.6	1.6	2.3	2.0	1.5		0.9	0.0		1.4	1.1	3.3	1.8	0.6	6.3	0.5	0.2	1.0	0.9			8.3		0.0	0.9	2.0	0.0	0.9	1.4	1.4	0.0	0.0	0.1	0.0	4.5	0.2	49.5	1.5	0.6	3.2	0.9	40.1	1.8	8.0	0.2	0.0	0.0	0.2	0.6	6.0	0.0	2.7	0.2	1.0	0.0	3.0	0.0	1.4	1.0	3.8	0.0	0.0	21.9	0.0	2.2	0.0	0.0	3.3	0.4	0.0	0.6	0.2	3.2	0.0	0.1	2.4	0.2	0.7	0.0	0.0	0.1	0.2	2.9	0.1	0.3	0.3	0.3	0.8	3.0	0.1	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1											0.0	2.2	0.0	0.4	11.7	0.4	2.2	0.0	0.0	3.4	0.0	0.0	14.1	0.0	2.5	19.2	2.7	0.1	0.0	6.4	17.2	36.0	1.7	0.0	0.0	2.7	0.0	1.2	2.5	0.0	3.1	69.0	0.3	10.1	2.8	1.0	1.3	4.9	0.0	66.4	0.0	0.4	0.0	6.1	0.5	1.0	8.7	8.1	0.0	0.2	0.3
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 117.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	13.5	14.9	13.4	8.6	17.2	4.2	10.4	13.9	23.3	9.2	13.3	10.6	9.3	12.2	8.9	8.6	10.9	6.7	7.7	46.1	14.4	12.8	15.0	25.7	7.8	6.8	14.7	14.1	7.7	13.1	14.6	14.7	15.8	22.1	12.0	12.7	8.9	12.4	14.1	70.5	8.8	12.3	11.5	12.0	6.6	13.7	15.7	9.0	5.9	9.1	19.0	8.7	13.0	10.7	12.8	19.5	12.1	21.7	15.0	14.9	9.8	9.1	24.0	13.9	5.5	10.2	12.1	13.6	17.1	14.0	19.4	18.9	31.0	8.5	12.6	11.2	14.4	22.7	17.8	26.9	14.4	19.3	11.3	22.5	11.8	25.3	35.6	22.2	22.3	14.0	12.3	17.9	10.6	14.5	11.2	14.0	10.8	25.3	11.6	15.2	15.6	13.8	13.8	11.3	25.2	14.4	12.1	24.9	10.9	29.0	24.1	14.7	10.7	15.1	22.9	23.4	14.5	25.7	13.8	9.7	14.4	16.2	14.8	18.9	11.1	22.0	15.6	11.3	11.0	14.5	8.6	13.6	12.1	11.5	15.0	10.8	12.8	10.9	9.4	19.5	11.7	13.3	9.6	2.8	15.0	21.7	5.2	14.9	9.8	13.4	17.2	13.9	23.3	14.4	12.8	14.7	14.1	22.1	9.0	32.8	21.1	9.0	18.1	23.1	25.5	117.0	20.4	18.7	19.4	5.2	27.5	53.6	54.7	18.3	35.0	10.9	12.8	23.3	12.6	28.3	19.4	19.1	5.7	22.1	23.1	19.1	8.6	9.8	15.0	31.1	10.0	15.5	20.3	28.9	16.0	18.1	13.9	14.4	12.7	22.7	23.2	0.0	20.9	40.9	33.4	22.2	69.5	10.4	19.0	16.9
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Extravillous trophoblasts: 955.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		53000000	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.20e-4)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	26.9	32.7	16.7	25.0	29.9	19.9	28.7	11.3	16.8	33.4	26.1	13.9	53.7	20.4	30.4	76.1	27.1	25.5	22.4	32.7	14.2	13.9	42.1	118.4	30.4	36.3	17.8	12.7	26.5	141.6	24.9	23.3	39.5	19.0	22.6	30.1	14.6	53.4	45.0	15.7	16.1	28.4	26.5	14.3	35.1	30.9	12.4	19.5	18.1	97.9	20.1	29.7	21.9	30.6	45.2	61.0	52.0	46.2	51.5	52.2	59.7	33.2	36.1	51.7	81.1	66.6	57.6	92.0	80.9	75.1	42.5	57.3	51.2	65.7	54.0	57.0	79.1	82.6	27.3	38.8	67.7	45.7	42.3	30.6	43.8	28.3	83.1	72.1	44.8	32.9	41.5	52.1	41.1	74.2	78.8	95.7	20.5	37.6	116.5	41.9	39.4	17.2	46.5	43.2	108.3	28.6	41.4	52.7	97.8	60.5	40.2	33.2	66.5	31.9	46.8	45.4	70.0	16.5	76.1	47.0	39.9	51.0	35.9	46.7	110.0	67.8	35.0	53.9	56.4	55.8	52.0	44.4	20.5	47.5	46.2	52.2	45.2	37.7	44.7	48.6	33.1	18.4	31.0	8.1	51.5	33.9	61.0	37.7	59.7	16.7	29.9	11.3	16.8	14.2	13.9	17.8	12.7	19.0	19.5	53.6	94.6	111.7	205.7	91.5	66.3	27.4	152.8	108.4	161.5	186.7	27.5	420.2	36.5	263.9	6.1	114.4	100.2	23.3	210.7	955.4	173.7	256.1	129.2	285.4	369.6	39.7	151.3	244.9	137.9	12.1	112.2	137.1	189.0	126.2	149.4	95.2	191.3	100.8	126.9	98.3	45.7	84.1	115.4	95.8	139.7	89.6	463.4	112.4	196.3	240.5
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291024	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 648.1;Enterocytes: 781.7;Paneth cells: 737.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 39.1;memory B-cell: 49.1;naive B-cell: 44.9"	"Group enriched"	"Detected in many"	6	"B-cells: 49.1;granulocytes: 39.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 96.9;HHSteC: 94.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		210000000	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	60.9	6.4	2.9	32.3	3.7	2.7	69.9	3.6	3.7	30.6	78.8	3.0	24.3	27.8	30.0	35.6	48.3	28.0	38.4	107.5	3.0	2.4	19.8	49.0	78.8	91.6	6.3	2.2	23.3	20.5	11.7	6.7	53.0	16.5	34.7	34.7	12.8	34.5	27.4	150.1	26.4	96.3	27.2	8.6	52.9	28.3	14.3	3.6	23.4	76.9	54.9	41.9	65.0	38.9	49.1	6.8	39.1	0.5	1.7	3.2	9.2	34.5	22.3	1.6	0.0	8.2	5.6	36.0	10.6	33.0	27.6	45.4	47.1	53.7	0.0	3.0	28.6	14.0	96.9	11.3	61.3	28.0	0.0	17.5	34.4	6.7	76.3	94.4	0.0	1.8	16.1	32.3	14.0	50.9	29.6	49.3	3.0	7.4	8.8	6.5	6.1	0.1	0.6	3.2	16.7	18.0	29.0	1.3	12.1	14.2	32.9	6.2	2.5	11.4	10.5	0.1	38.8	8.6	15.2	43.4	10.8	2.5	0.0	0.0	4.2	0.0	11.3	11.9	0.0	5.1	0.0	0.5	39.1	2.8	0.1	0.0	49.1	0.5	3.2	6.8	44.9	0.1	2.0	1.7	1.7	0.3	0.7	0.4	9.2	2.9	3.7	3.6	3.7	3.0	2.4	6.3	2.2	16.5	3.6	71.5	92.6	110.2	648.1	325.4	6.5	205.6	201.2	180.7	158.1	48.8	27.5	481.5	13.3	337.3	7.0	238.0	781.7	23.3	152.6	92.5	136.8	121.0	11.6	70.6	44.6	1.6	97.3	328.4	20.6	5.3	4.6	29.4	38.8	5.4	406.4	7.0	203.4	737.0	0.7	62.7	43.8	310.4	177.4	0.5	42.4	173.0	97.8	33.0	340.8	482.4
PDLIM4	RIL	ENSG00000131435	"PDZ and LIM domain 4"	P50479	5	132257671-132273454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 247.7;Glandular cells: 292.2;Urothelial cells: 373.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 27.7;HBEC3-KT: 32.4;HHSteC: 32.2;hTEC/SVTERT24-B: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011912	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA011912: AB_1856277"	"unprognostic (1.36e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.40e-3)"	11.5	5.0	7.1	12.8	13.1	0.6	30.4	2.4	5.9	11.5	32.9	7.4	8.9	5.0	33.4	28.7	27.9	16.2	19.1	21.8	12.2	6.9	6.9	0.6	3.4	8.2	6.5	3.8	15.0	4.8	4.6	10.1	19.8	35.9	17.3	3.7	9.6	19.8	21.9	3.8	21.2	8.7	44.8	23.4	2.8	13.4	6.9	3.8	3.5	4.8	25.2	10.6	22.6	13.8	0.0	0.0	0.0	0.0	1.3	0.0	0.3	13.5	0.0	2.9	0.0	4.1	11.4	1.0	3.9	1.9	3.9	1.3	0.0	1.3	0.1	2.7	20.1	20.0	27.7	0.0	32.4	1.9	0.0	1.4	0.0	0.0	0.6	32.2	0.0	0.0	14.4	2.4	35.6	13.3	14.0	22.2	0.0	5.7	0.0	17.1	0.0	0.0	0.1	1.0	0.0	8.3	0.6	20.0	0.0	8.7	0.0	0.0	12.2	8.8	0.0	0.0	2.4	0.0	1.4	14.0	14.2	15.5	14.8	21.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	7.1	13.1	2.4	5.9	12.2	6.9	6.5	3.8	35.9	3.8	0.0	4.1	0.0	247.7	93.9	0.1	6.3	0.0	65.6	28.4	14.0	2.0	3.0	91.2	100.6	12.4	43.8	1.2	0.0	8.6	10.0	50.7	292.2	4.6	0.0	6.7	0.0	16.1	16.0	0.3	12.8	33.6	5.5	156.9	1.8	8.1	14.8	64.7	23.0	25.8	3.9	0.2	25.8	52.6	9.5	9.2	72.4	19.1	1.3	0.8	373.7
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 71.4;Early spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 39.5;hTERT-RPE1: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	7.9	3.9	8.6	3.6	7.1	13.1	2.8	6.3	7.0	7.4	8.7	4.1	29.6	4.4	21.2	10.0	39.5	17.7	3.6	5.3	11.0	0.4	1.8	2.1	4.9	1.4	8.2	1.0	3.0	8.4	10.5	12.6	20.2	39.3	16.7	4.0	0.7	7.3	9.0	1.9	6.2	3.2	3.9	8.6	5.1	1.5	5.1	0.8	5.1	5.5	0.8	3.7	4.1	0.4	19.3	7.3	1.3	1.2	29.6	9.0	5.8	21.0	7.4	4.1	1.7	3.7	11.5	3.7	7.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8	11.9	5.6	13.4	11.2	11.6	34.7	71.4	22.9	22.7	17.0	15.7	7.9	3.5	5.0	24.3	99.2	14.7	6.0	0.0	11.9	3.2	11.6	13.3	5.8	2.5	5.7	9.5	9.8	14.1	20.8	22.0	10.6	16.2	10.1	2.8	5.2	19.0	22.2	7.0	12.7	8.6	10.6	6.5	12.7	7.2	9.7	9.5	3.7	10.1	8.9	17.0
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	10.7	7.2	7.4	3.7	10.5	3.2	8.7	11.5	16.5	4.9	7.5	10.1	5.7	10.4	7.9	7.2	8.9	7.2	6.0	4.8	7.4	7.1	18.1	16.5	8.6	5.0	9.0	9.4	14.9	13.8	12.0	7.0	7.7	16.0	7.8	8.4	8.5	7.1	6.9	6.3	4.7	6.2	4.6	6.3	4.0	6.7	8.6	8.9	4.6	18.0	4.0	5.9	6.3	5.5	3.3	1.3	1.8	0.4	6.1	6.3	2.0	7.2	8.9	5.5	10.8	14.9	7.7	6.9	3.8	14.8	8.9	13.4	18.1	5.2	10.2	5.5	5.3	8.5	9.3	16.0	8.6	8.6	2.4	8.1	5.1	4.5	11.8	8.1	6.5	9.0	5.8	6.5	12.6	13.1	9.7	3.8	11.5	9.8	7.3	7.9	4.8	12.6	4.7	6.5	4.9	11.3	12.5	7.7	16.0	4.7	7.8	11.1	6.3	12.3	5.0	4.6	4.5	6.7	3.2	3.5	5.4	7.4	3.3	5.6	13.0	12.0	10.1	7.5	5.2	5.4	1.3	0.4	1.8	6.3	0.3	5.2	1.8	3.1	5.1	1.3	3.3	4.5	5.0	1.3	6.1	0.2	0.8	0.9	2.0	7.4	10.5	11.5	16.5	7.4	7.1	9.0	9.4	16.0	8.9	8.9	18.5	5.9	4.3	4.6	7.9	4.5	7.6	1.4	4.5	8.7	13.7	9.1	6.6	2.7	0.1	1.8	5.1	0.0	2.5	1.6	4.2	6.7	5.8	11.5	2.1	4.8	3.5	6.7	0.6	1.9	2.8	0.8	3.3	0.0	4.0	8.4	2.8	5.8	4.2	8.1	6.3	0.0	3.1	4.4	1.3	2.0	3.0	1.9	5.8	7.0
PDPR	PDP3	ENSG00000090857	"Pyruvate dehydrogenase phosphatase regulatory subunit"	Q8NCN5	16	70113626-70162537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048092, HPA070386"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA048092: AB_2680261, HPA070386: AB_2686263"	"unprognostic (8.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.04e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.36e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.24e-2)"	11.9	13.3	12.0	13.3	15.4	14.4	11.6	21.1	16.0	14.0	12.5	23.8	10.4	9.3	18.7	14.5	11.1	12.9	11.7	14.7	9.9	6.7	18.4	7.7	9.8	15.8	10.2	12.6	15.1	13.5	14.2	9.9	10.8	10.7	10.0	12.9	15.4	11.1	17.3	20.9	11.9	13.4	19.7	9.0	14.1	12.0	19.9	10.3	16.0	13.5	9.5	12.6	16.4	10.0	6.0	5.4	5.1	5.0	3.2	7.1	3.1	3.6	10.4	9.8	17.1	17.0	11.5	6.5	5.9	10.5	9.6	7.3	13.0	7.3	7.3	10.3	18.7	8.6	14.2	14.1	12.4	11.3	1.8	4.8	18.7	6.4	8.6	4.8	20.7	15.2	14.9	11.6	13.8	12.5	13.0	10.1	14.0	12.8	3.6	7.9	10.4	12.9	11.3	14.6	2.4	5.1	25.7	10.0	7.9	7.1	8.7	4.5	6.6	16.3	3.1	4.3	13.0	12.9	6.2	5.8	11.1	15.1	9.4	9.3	8.3	9.1	27.5	5.0	7.0	7.1	5.1	4.9	4.5	5.0	5.0	7.1	3.5	3.9	4.8	5.4	6.0	4.8	5.2	4.1	3.2	4.6	5.2	4.3	3.1	12.0	15.4	21.1	16.0	9.9	6.7	10.2	12.6	10.7	10.3	20.8	12.8	7.5	4.2	2.5	19.2	17.7	17.8	20.1	13.6	1.8	29.5	6.2	5.0	4.6	42.6	14.3	8.2	0.0	5.7	6.1	7.4	7.2	17.4	9.8	13.7	30.2	4.7	18.4	16.5	14.2	10.0	11.2	6.8	1.8	10.9	12.4	4.9	3.5	15.6	3.3	21.1	19.4	4.2	7.5	15.6	1.6	4.1	12.2	12.4	4.1
PDRG1	"C20orf126, dJ310O13.3"	ENSG00000088356	"P53 and DNA damage regulated 1"	Q9NUG6	20	31944342-31952092	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047084, HPA063542"	Approved		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA047084: AB_2679925, HPA063542: AB_2685035"	"unprognostic (2.17e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.00e-2)"	7.4	11.1	15.4	7.7	13.2	14.7	11.9	22.8	13.3	8.3	9.1	9.2	31.8	8.6	8.7	14.0	12.1	10.3	6.2	9.5	11.2	10.7	11.1	12.0	7.0	10.9	11.9	13.7	10.2	9.0	43.8	9.8	11.3	13.1	10.7	7.6	8.6	10.7	32.3	19.7	9.5	7.2	8.2	12.8	11.6	8.0	43.1	11.5	7.5	11.3	7.1	12.4	7.7	16.5	22.4	18.6	9.8	12.5	16.6	18.4	11.1	13.5	11.1	6.9	7.6	4.0	2.9	12.8	11.0	6.2	16.5	9.4	40.5	6.8	13.6	8.4	5.1	12.2	8.8	14.5	11.0	13.4	5.0	9.6	19.0	7.9	14.1	10.1	10.8	7.9	3.6	8.1	11.6	12.0	7.0	6.8	14.5	18.9	7.0	6.8	16.4	14.0	12.7	14.2	14.1	23.5	11.0	20.9	7.1	10.7	7.4	16.4	7.9	33.3	10.7	19.9	7.5	18.7	13.3	6.2	13.4	15.8	12.3	13.8	5.2	5.3	14.9	9.0	38.7	8.8	6.9	6.6	9.8	12.7	9.0	12.0	21.5	13.4	13.6	9.8	22.4	18.4	15.9	2.7	16.6	12.5	18.6	12.5	11.1	15.4	13.2	22.8	13.3	11.2	10.7	11.9	13.7	13.1	11.5	17.9	8.9	24.7	14.6	22.7	22.1	13.3	17.8	10.7	5.7	10.4	13.7	39.4	28.2	23.4	7.9	21.0	8.8	0.0	18.3	21.6	23.5	14.3	32.3	7.7	22.6	15.9	21.1	12.3	9.2	13.3	15.0	15.0	11.8	56.9	9.6	18.6	17.9	11.0	15.9	14.0	15.6	25.8	21.2	72.4	37.5	25.0	17.0	15.2	11.5	12.3
PDSS1	"COQ1, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697659-26746798	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 22.4;lymphoid tissue: 31.8"	"Cell type enhanced"	"Detected in many"	5	"Undifferentiated cells: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA038032: AB_10670650, HPA042741: AB_2678139"	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	3.1	2.6	2.4	7.0	3.1	5.6	3.5	5.6	5.1	3.1	18.2	1.5	1.2	20.6	3.8	2.1	8.3	3.4	3.7	4.2	2.2	2.2	8.6	7.2	4.0	7.8	2.1	2.3	2.8	3.8	1.7	2.5	2.8	2.9	2.3	17.0	3.2	3.5	1.8	10.4	2.7	22.4	3.6	3.1	5.7	3.8	3.0	1.6	31.8	2.1	4.7	5.0	2.9	4.0	3.2	5.2	0.9	5.3	0.8	3.4	1.3	7.6	5.9	4.5	8.3	1.5	2.8	6.3	7.1	1.9	10.3	7.0	9.1	4.3	17.4	3.7	3.5	3.9	9.7	14.5	10.8	8.8	7.3	12.1	15.1	5.2	6.6	2.2	10.0	6.0	3.5	4.7	9.6	2.6	1.8	5.4	11.5	13.8	4.6	7.2	12.0	31.5	7.0	9.1	12.3	5.8	14.7	13.0	12.6	6.0	3.6	13.3	8.2	6.8	14.2	7.7	4.9	5.0	11.7	3.4	5.8	9.2	11.8	11.2	1.8	6.7	12.7	5.7	25.5	4.4	0.0	5.3	0.9	0.9	4.1	2.1	0.5	1.8	1.3	5.2	3.2	3.4	1.5	0.3	0.8	2.1	1.4	0.1	1.3	2.4	3.1	5.6	5.1	2.2	2.2	2.1	2.3	2.9	1.6	0.0	0.0	3.7	3.2	6.2	2.8	1.8	7.6	1.4	3.4	3.5	3.9	5.3	6.6	6.6	9.3	2.2	14.7	0.0	3.3	10.1	2.9	2.7	0.0	3.4	7.9	1.6	10.4	3.1	6.8	2.5	2.0	5.1	1.7	2.8	9.8	1.2	4.2	7.0	2.5	17.7	4.7	0.0	3.8	7.0	9.8	2.8	5.3	3.3	23.4	2.5
PDZD8	"bA129M16.2, FLJ34427, PDZK8"	ENSG00000165650	"PDZ domain containing 8"	Q8NEN9	10	117277274-117375467	"Predicted intracellular proteins"	"Host-virus interaction, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.7"	"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 174.2;Late spermatids: 366.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 52.1"	"Low region specificity"	"Detected in all"							"HPA015716, HPA051610"	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Nucleoli fibrillar center"	"Plasma membrane"	"HPA015716: AB_1855162, HPA051610: AB_2681549"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.01e-2)"	8.1	7.8	12.2	5.1	13.3	61.7	8.2	8.7	12.9	9.1	14.8	11.4	32.8	14.0	10.7	15.1	11.4	7.7	10.3	7.0	12.0	10.4	13.5	21.1	7.4	3.7	14.7	7.4	10.1	20.1	18.9	8.6	6.0	12.9	7.3	12.0	6.3	12.4	21.3	6.7	6.6	13.7	7.6	14.8	5.0	10.6	23.2	12.4	8.9	7.5	5.4	4.2	8.0	15.3	1.0	1.7	5.7	2.0	2.5	2.5	0.5	5.2	9.0	3.3	6.3	5.7	5.1	1.8	5.0	4.4	2.3	1.8	4.5	7.0	6.2	4.6	7.6	2.6	7.9	5.7	5.4	4.5	3.9	5.1	52.1	3.7	4.4	4.2	21.7	4.9	5.0	6.4	4.1	12.3	8.5	4.0	5.1	4.7	6.5	5.6	2.1	4.2	2.8	2.6	2.7	8.1	3.4	12.7	2.6	6.7	3.8	2.6	4.2	5.4	2.3	3.9	3.1	1.6	3.2	6.4	3.8	4.2	6.8	8.6	3.5	2.9	4.5	4.7	10.0	3.3	2.7	1.4	5.7	2.2	1.1	2.5	0.9	1.8	1.8	1.7	1.0	1.5	2.0	5.6	2.5	2.0	1.3	0.8	0.5	12.2	13.3	8.7	12.9	12.0	10.4	14.7	7.4	12.9	12.4	11.9	27.8	8.8	17.7	26.4	29.3	16.7	43.3	38.8	25.0	17.4	21.6	8.3	8.3	27.0	174.2	17.8	23.8	23.3	70.7	5.7	19.5	25.1	41.7	45.8	6.8	30.2	32.4	16.5	12.3	366.0	21.9	15.2	21.9	9.0	31.7	24.9	56.7	21.0	26.9	23.1	40.1	25.8	18.9	16.9	29.3	28.2	5.6	18.7	39.0	34.2
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 49.2;kidney: 124.3"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 758.4"	"Group enriched"	"Detected in many"	12	"breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in single"	17	"cerebellum: 10.0"	"Cell type enriched"	"Detected in many"	4	"NK-cell: 7.6"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 7.6"	"Group enriched"	"Detected in some"	4	"RPTEC TERT1: 43.1;T-47d: 112.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.1	0.6	0.2	0.2	0.3	0.0	5.8	10.0	0.2	0.3	16.5	0.2	0.8	13.2	0.3	6.7	0.1	0.1	10.6	0.1	0.2	0.2	124.3	25.7	0.4	0.1	0.3	0.2	0.2	4.2	0.0	0.1	0.9	0.5	0.1	1.3	1.2	0.1	0.1	0.1	0.7	49.2	0.1	0.4	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.0	1.1	0.5	0.2	7.6	1.8	0.5	1.3	0.2	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	18.9	0.1	0.1	0.2	1.1	0.0	0.6	0.0	0.1	0.1	1.8	0.3	0.1	0.4	7.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	1.1	0.1	0.2	0.2	0.2	0.5	0.0	1.3	0.2	43.1	0.0	0.1	1.2	0.3	0.3	0.0	1.2	112.0	0.1	0.1	0.2	0.2	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.1	1.5	0.2	0.6	1.0	0.4	1.8	0.2	1.0	0.4	0.7	0.4	7.6	0.1	1.1	0.1	0.5	0.2	0.3	10.0	0.2	0.2	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.9	0.0	0.1	0.4	0.4	61.1	0.0	0.0	54.1	0.0	0.0	117.7	1.7	8.9	0.0	18.0	0.0	1.6	0.1	0.2	0.1	0.0	45.6	0.2	0.0	6.3	1.8	1.2	5.2	0.0	0.0	0.0	0.0	0.5	0.0	1.8	2.9	0.0	758.4	0.3	0.0	0.3	0.2	0.2	0.0	0.1	0.0	1.0	0.0
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183593-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 281.3"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 4006.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 31.5;RPTEC TERT1: 104.5"	"Not detected"	"Not detected"							HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	2.7	1.2	0.6	2.4	0.6	3.9	4.1	0.6	0.6	9.2	9.1	0.6	0.6	2.2	1.3	4.8	30.4	2.9	23.9	0.7	0.5	0.0	281.3	1.6	7.2	0.5	0.6	0.5	2.3	16.8	0.0	0.6	3.2	0.6	2.1	3.4	0.8	33.9	12.4	0.7	19.9	9.5	0.5	0.5	0.7	9.0	1.4	0.6	1.1	1.0	18.3	18.5	4.1	8.3	0.1	0.5	2.1	1.1	0.2	0.3	42.4	11.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.6	0.0	31.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	104.5	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.1	0.2	0.0	0.5	0.3	42.4	0.6	0.6	0.6	0.6	0.5	0.0	0.6	0.5	0.6	0.6	71.5	39.6	6.7	11.1	12.6	0.0	0.0	359.2	6.7	34.2	221.6	0.0	0.0	351.5	818.0	0.0	1.6	60.9	140.2	656.9	0.0	0.9	37.3	10.4	1.0	0.2	0.0	38.1	2.5	0.3	0.0	3.1	1.5	8.5	21.6	123.8	0.5	959.8	81.8	0.0	4006.8	0.0	0.0	2.3	0.0	0.1	47.2	0.7	1.5	119.5	16.8
PDZRN3	"KIAA1095, LNX3, SEMACAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382433-73624940	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 61.9;Fibroblasts: 24.4;Peritubular cells: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	52	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	52	"dendritic cells: 5.2"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;ASC diff: 28.1;ASC TERT1: 14.8;BJ hTERT+: 20.0;HSkMC: 20.5;U-87 MG: 14.8"	"Group enriched"	"Detected in many"	5	"amygdala: 12.4;basal ganglia: 7.4;cerebral cortex: 17.9;hippocampal formation: 14.5"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	13.0	17.4	11.5	4.8	12.9	0.0	10.3	1.7	26.8	18.7	32.6	4.5	4.6	4.3	29.0	12.4	13.6	11.6	13.1	19.8	9.1	2.5	5.3	0.9	6.3	1.9	3.6	11.2	35.1	2.9	0.3	2.2	8.1	6.8	15.4	6.9	9.7	9.7	14.9	38.3	7.5	10.2	26.3	3.8	1.0	19.3	3.4	2.9	0.2	1.6	5.1	1.1	21.3	18.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	28.1	14.8	0.0	8.0	20.0	2.4	1.5	7.5	0.0	0.0	0.0	10.7	0.3	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.0	4.7	0.0	0.0	20.5	0.0	6.7	0.0	2.9	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.1	2.2	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.8	5.1	0.0	3.7	5.8	4.7	2.2	0.0	0.0	10.1	0.7	11.3	1.0	0.3	0.0	0.1	14.8	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	11.5	12.9	1.7	26.8	9.1	2.5	3.6	11.2	6.8	2.9	0.0	0.0	0.0	9.3	2.2	9.5	61.9	0.0	0.0	0.0	5.2	5.9	0.6	1.7	0.0	0.4	1.3	0.0	0.0	0.4	0.2	24.4	12.7	0.0	0.0	0.7	0.0	20.3	0.0	0.0	0.4	21.6	0.9	15.1	0.0	7.0	20.0	0.4	0.0	26.5	6.3	1.5	0.0	15.5	0.2	4.1	1.6	0.7	0.0	2.3	4.3
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 26.3;Erythroid cells: 23.3;Ito cells: 34.4;Leydig cells: 41.1;Peritubular cells: 33.6;Sertoli cells: 25.8;Smooth muscle cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.1;HBEC3-KT: 13.8;HHSteC: 10.4;HUVEC TERT2: 24.4;TIME: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		35000000	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	18.5	7.1	1.8	3.0	5.1	2.8	29.2	1.2	2.9	16.5	5.8	2.7	6.3	2.3	15.9	10.5	6.6	8.9	10.3	11.1	2.7	1.8	6.8	3.8	12.0	10.1	3.2	2.1	10.6	3.2	1.7	3.9	15.5	3.7	9.6	1.4	15.5	4.1	5.5	11.4	4.4	4.1	9.6	3.1	12.2	4.1	8.1	1.5	0.6	10.5	5.8	2.1	6.7	11.5	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.2	1.3	0.4	0.0	0.0	1.8	0.0	5.4	9.1	2.2	1.3	0.1	0.2	0.0	0.2	4.0	0.2	0.1	0.0	13.8	0.6	0.0	0.0	6.7	0.2	0.3	10.4	0.0	0.0	5.4	0.0	3.1	0.7	0.5	24.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.0	39.2	0.0	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	1.8	5.1	1.2	2.9	2.7	1.8	3.2	2.1	3.7	1.5	0.0	5.6	0.0	0.0	0.8	1.3	5.6	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.1	26.3	0.0	23.3	0.3	0.1	5.1	0.1	1.1	0.0	0.4	0.0	1.7	34.4	1.3	1.9	41.1	0.4	5.0	0.0	1.0	0.3	0.9	0.0	33.6	0.0	0.2	25.8	14.6	0.7	1.1	1.0	0.2	0.0	0.0	0.1
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118135858-118145584	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 260.7"	"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 3140.1;Proximal tubular cells: 3872.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA008819, CAB009906, CAB013493, HPA063904"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		62000000	"Plasma membrane, Cytosol"		"CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708"	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	26.8	207.3	83.0	15.2	82.3	13.5	32.3	63.3	102.7	35.5	50.4	58.0	18.9	75.3	22.9	52.8	24.3	28.5	22.6	57.6	77.6	69.7	132.7	260.7	22.1	16.0	77.8	71.5	43.5	46.2	139.2	30.8	16.5	59.1	35.4	25.4	41.2	43.6	33.1	65.1	20.9	75.4	23.4	79.1	15.3	20.6	22.7	43.5	8.7	94.9	26.1	19.7	20.2	17.8	45.2	37.3	3.0	12.1	20.9	45.3	36.4	32.2	27.6	39.1	40.6	61.7	30.2	60.8	25.7	30.0	40.6	20.9	16.4	11.1	52.0	25.9	38.4	16.2	23.2	57.8	23.9	31.7	13.0	55.3	26.1	31.1	114.3	35.7	47.2	11.4	29.9	39.7	24.0	16.7	46.7	18.8	27.8	43.3	19.4	40.6	38.2	25.7	95.7	37.9	27.1	33.4	50.8	29.1	94.8	49.8	31.5	46.9	36.4	53.4	37.1	50.3	25.0	53.4	32.2	20.4	31.2	17.8	30.5	25.8	19.0	33.7	26.8	36.7	35.4	33.8	0.7	11.0	3.0	26.9	12.1	42.4	45.2	45.3	33.3	33.3	32.5	43.9	35.3	1.2	20.9	10.3	37.3	41.2	36.4	83.0	82.3	63.3	102.7	77.6	69.7	77.8	71.5	59.1	43.5	375.2	339.6	254.0	392.9	282.7	501.7	637.3	598.7	327.9	273.0	743.2	90.3	819.2	3140.1	396.3	35.6	178.6	306.2	116.8	213.3	686.7	314.8	422.6	353.3	1736.5	486.8	681.7	307.9	178.0	167.5	50.5	502.8	218.5	705.2	448.2	324.1	1385.1	201.0	263.6	687.7	3872.6	306.7	362.2	321.6	273.2	133.6	284.3	514.8	194.5	466.9	324.1
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4"	"Group enriched"	"Detected in many"	13	"Cytotrophoblasts: 1669.7;Syncytiotrophoblasts: 2388.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 143.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 95.0;HAP1: 123.3;Hep G2: 95.0;SCLC-21H: 60.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 130.3"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	2.3	67.5	32.0	2.1	143.8	1.4	10.6	25.6	16.8	4.2	2.1	7.4	0.0	1.5	3.3	1.9	2.0	5.1	2.4	1.8	21.0	47.0	4.0	2.0	7.3	2.9	13.1	21.3	27.0	5.4	2.3	102.6	171.4	27.4	2.2	1.9	1.8	4.3	2.2	1.9	1.4	1.6	2.6	14.4	1.8	2.1	19.8	11.1	1.5	5.4	0.0	2.3	1.8	1.0	2.6	0.0	0.0	0.0	2.7	0.7	0.2	2.6	13.4	95.0	40.1	2.0	3.6	5.5	7.3	4.3	5.2	7.1	22.3	4.4	0.2	0.2	8.4	10.8	0.8	123.3	5.2	7.3	0.3	13.0	0.0	15.3	95.0	1.5	15.1	0.0	8.0	1.7	13.0	9.0	4.6	3.1	0.0	0.0	29.8	10.2	0.6	0.0	0.0	43.5	2.2	8.5	5.7	30.4	7.9	23.9	9.9	60.4	3.4	0.0	2.0	7.2	24.9	12.9	0.0	0.0	4.2	0.2	0.5	5.5	8.0	5.3	11.8	9.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.7	0.0	2.6	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.2	32.0	143.8	25.6	14.4	21.0	47.0	13.1	21.3	27.4	11.1	142.9	64.2	2.4	7.4	0.7	70.4	25.2	7.6	16.0	126.3	15.7	7.9	1669.7	54.7	10.7	2.8	2.4	0.0	0.0	4.3	85.1	27.1	7.0	2.3	2.9	150.9	35.0	58.0	2.5	0.0	11.4	8.3	1.4	13.5	0.0	0.7	118.3	4.2	0.0	3.9	10.0	25.7	6.5	12.5	16.4	5.1	0.6	2388.4	0.5	0.1	0.6
PEG3	"KIAA0287, ZKSCAN22, ZNF904, ZSCAN24"	ENSG00000198300	"Paternally expressed 3"	Q9GZU2	19	56810083-56840728	"Predicted intracellular proteins, Transcription factors"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.0;ovary: 106.4;placenta: 49.8"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 267.6;Horizontal cells: 139.8;Peritubular cells: 103.3;Syncytiotrophoblasts: 399.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.3;plasmacytoid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.3"	"Group enriched"	"Detected in some"	5	"BEWO: 32.2;Hep G2: 65.4;RH-30: 22.4"	"Low region specificity"	"Detected in all"							HPA026070	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026070: AB_10603328"	"unprognostic (1.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.48e-5)"	"unprognostic (6.92e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.68e-3)"	2.0	29.8	10.1	1.0	51.0	0.5	4.5	9.8	22.4	4.1	2.4	5.9	0.0	0.7	9.1	2.6	1.7	5.8	1.2	2.3	9.7	9.6	1.8	2.1	1.7	0.7	3.5	16.0	106.4	1.9	7.3	24.6	49.8	21.3	1.8	1.2	0.4	2.3	2.5	1.7	1.8	1.7	4.1	4.8	1.6	2.0	12.3	7.3	0.0	2.7	0.0	2.7	2.6	2.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.1	0.0	22.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	10.1	51.0	9.8	22.4	9.7	9.6	3.5	16.0	21.3	7.3	0.0	5.8	0.0	1.7	4.2	19.4	12.3	2.5	4.0	3.4	1.8	7.9	267.6	1.7	0.7	24.4	2.6	0.0	0.0	0.0	33.5	7.8	1.7	0.0	2.9	29.8	139.8	0.0	4.9	0.6	15.2	54.4	1.0	13.5	0.0	0.0	18.1	0.5	0.0	103.3	0.8	11.8	12.9	7.3	26.9	17.4	2.3	399.0	0.0	0.0	0.7
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144454	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.7"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 199.1;Suprabasal keratinocytes: 190.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 33.9;monocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.8;U-698: 54.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	15.7	5.1	10.0	15.1	20.5	105.7	22.3	15.1	8.9	9.9	14.5	11.0	3.3	9.9	14.5	7.1	26.4	8.0	14.9	11.6	11.3	6.8	6.7	8.6	20.1	16.8	15.6	5.2	4.8	6.2	11.0	14.8	13.7	10.8	7.6	11.8	6.0	12.3	8.5	4.5	17.5	17.3	8.4	15.0	17.8	10.2	7.8	12.8	19.9	6.3	10.2	19.3	14.1	14.8	3.9	2.3	33.9	9.2	1.3	5.0	2.5	1.3	1.0	14.0	9.3	1.6	1.2	3.2	1.8	2.0	1.6	2.6	21.8	1.5	17.9	4.4	0.6	0.6	2.1	4.2	3.9	3.3	4.4	3.3	1.6	0.7	3.5	4.9	1.7	3.2	1.6	3.1	2.4	8.4	1.7	9.2	6.9	1.0	4.5	1.4	0.1	3.8	2.5	9.1	4.1	0.6	4.8	4.8	10.2	6.7	4.0	6.4	9.0	1.3	2.1	4.8	4.5	1.1	1.2	6.5	1.5	2.2	1.5	2.6	10.4	1.0	54.2	0.8	1.6	4.1	5.1	6.5	6.3	0.4	6.1	0.7	3.9	2.2	0.9	2.3	2.4	2.7	1.1	33.9	1.3	9.2	0.2	5.0	2.5	10.0	20.5	15.1	8.8	11.3	6.8	15.6	5.2	10.8	12.8	26.8	45.1	22.4	65.1	199.1	0.9	5.1	10.2	30.8	55.7	5.2	0.0	1.4	1.7	4.5	8.5	42.7	37.0	0.0	23.1	6.5	25.9	43.3	14.0	6.8	19.1	3.2	24.6	36.2	52.6	7.8	1.4	57.1	106.3	13.6	22.2	4.5	18.2	28.1	1.8	7.7	1.8	0.0	48.4	6.1	7.8	190.1	3.3	11.5	27.3	104.0
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301526	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 21.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 19.3;JURKAT: 24.9;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	12.3	3.3	5.2	5.6	4.6	16.5	8.7	21.4	6.5	7.5	9.4	5.4	9.7	11.1	9.3	7.1	4.7	5.9	11.5	3.4	4.6	4.5	9.7	3.1	7.3	4.8	5.2	3.9	16.0	38.9	1.7	5.5	3.3	4.4	8.2	4.2	9.2	7.6	12.4	3.8	6.5	12.6	17.7	5.8	6.6	14.1	10.0	4.2	38.2	4.9	3.4	2.6	13.3	14.9	0.9	2.0	9.0	3.0	0.5	0.8	1.1	0.0	1.8	5.1	0.0	2.8	4.2	0.1	0.7	2.4	0.5	0.0	0.1	0.4	0.1	2.4	1.4	0.0	0.5	3.9	0.0	0.2	1.2	1.4	4.4	7.9	0.0	2.4	0.6	19.3	2.7	0.2	0.0	0.0	2.8	0.9	24.9	3.2	0.0	0.5	0.0	21.6	0.2	8.3	0.0	0.7	10.6	0.3	0.9	2.1	8.7	10.2	0.0	0.4	0.0	5.7	3.3	0.0	3.5	0.3	1.5	2.6	0.4	2.5	0.4	0.0	0.5	2.7	3.0	1.5	1.4	3.0	3.5	0.5	1.6	0.8	0.2	0.6	0.3	2.0	0.9	0.4	0.3	9.0	0.5	1.2	0.5	0.0	1.1	5.2	4.6	21.4	4.4	4.6	4.5	5.2	3.9	4.4	4.2	0.0	7.7	2.7	11.0	12.7	30.0	1.9	7.6	14.7	10.3	12.2	27.5	0.0	3.3	4.4	2.3	10.9	8.4	0.0	12.2	0.1	5.6	7.0	5.7	0.8	1.1	20.6	6.9	11.1	16.5	4.1	15.8	11.1	16.9	2.8	7.4	10.0	8.6	3.7	17.0	8.8	18.5	12.9	22.1	1.4	27.2	15.9	0.1	3.5	3.0	9.7
PELI3	MGC35521	ENSG00000174516	"Pellino E3 ubiquitin protein ligase family member 3"	Q8N2H9	11	66466327-66477337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 20.6;Intestinal endocrine cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033750, HPA038875, HPA062281"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Nucleoplasm, Vesicles"	Nucleoli	"CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735"	"unprognostic (1.15e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.01e-2)"	6.7	9.5	14.5	3.8	17.0	1.8	7.4	19.6	33.1	7.4	8.3	6.7	6.4	4.8	10.3	9.1	10.6	8.2	10.1	7.7	17.4	13.5	4.6	3.2	7.1	4.3	13.0	12.5	15.3	9.9	21.5	8.3	3.8	15.8	11.5	2.9	6.4	10.4	22.3	10.8	11.2	4.7	11.3	6.2	5.0	5.8	6.2	7.8	0.3	8.5	2.7	3.4	9.0	11.8	3.3	3.3	1.3	6.8	1.2	3.1	1.4	15.5	6.6	5.4	4.2	8.6	3.4	4.3	5.0	6.5	4.8	4.1	9.6	3.5	3.9	5.0	5.4	8.6	8.4	3.5	6.3	2.0	7.6	3.1	1.0	5.4	2.8	5.4	0.8	7.6	3.2	7.1	4.9	1.7	7.0	1.0	5.2	1.8	6.1	2.0	9.5	3.2	2.4	3.4	8.2	6.8	10.8	3.9	4.1	2.6	5.0	6.5	3.6	2.5	7.2	17.0	2.4	8.4	4.2	2.7	4.2	6.5	18.3	4.1	5.6	3.2	2.1	8.9	2.5	3.5	1.3	2.5	0.4	2.5	1.8	2.0	2.8	2.1	3.1	3.3	3.3	2.2	1.8	0.1	1.2	6.8	1.0	2.4	1.4	14.5	17.0	19.6	33.1	17.4	13.5	13.0	12.5	15.8	7.8	6.0	1.3	0.0	3.4	1.4	12.1	6.2	2.5	0.0	0.0	0.0	9.8	1.9	1.7	2.7	3.7	2.5	0.0	0.0	2.1	1.7	3.1	2.0	0.0	2.4	2.9	20.6	25.4	1.8	0.6	5.6	6.9	3.2	0.0	2.8	0.5	5.5	1.9	0.8	9.2	2.2	8.5	6.5	4.8	1.9	3.2	0.3	0.2	0.0	0.6	1.6
PELO		ENSG00000152684	"Pelota mRNA surveillance and ribosome rescue factor"	Q9BRX2	5	52787940-52804046	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031458	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA031458: AB_10602141"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.40e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.21e-2)"	28.2	20.5	4.8	16.0	6.6	9.6	15.7	5.7	7.4	13.8	28.9	2.3	17.2	5.9	19.9	15.8	27.8	9.0	17.5	14.1	5.3	6.1	22.4	50.1	35.8	12.9	5.0	2.2	12.2	6.9	7.7	7.3	27.7	4.5	32.5	5.0	7.6	5.9	17.8	13.0	9.1	17.0	65.2	5.0	81.5	8.8	5.5	2.5	1.1	13.6	4.8	4.4	52.9	22.3	4.0	5.3	16.6	5.1	3.6	5.7	3.7	10.9	11.2	5.1	9.0	9.0	6.7	4.5	12.6	14.0	12.4	15.2	11.2	8.5	3.6	22.9	13.6	18.6	9.2	7.4	10.7	10.8	3.8	10.5	4.0	9.7	9.3	27.6	7.5	4.8	8.4	11.0	14.3	11.9	10.7	7.3	5.5	5.0	11.6	10.8	8.5	7.7	4.6	3.8	2.0	12.0	2.7	6.5	10.7	9.0	5.2	8.4	6.5	6.6	8.3	7.3	9.0	7.6	2.7	7.2	7.5	7.3	7.9	15.7	5.0	6.1	4.7	14.4	7.0	6.4	14.7	5.1	6.3	4.5	3.3	5.4	4.0	5.7	5.0	5.3	3.6	4.7	4.4	16.6	3.6	1.9	2.0	4.0	3.7	4.8	6.6	5.7	5.5	5.3	6.1	5.0	2.2	4.5	2.5	8.9	6.1	6.8	43.0	41.7	15.2	11.0	10.2	14.7	13.6	8.7	2.0	30.3	29.9	28.2	46.9	37.2	10.2	0.0	22.4	72.2	44.2	24.6	1.1	17.8	18.1	7.9	9.8	44.8	9.2	3.4	16.4	14.3	6.8	7.2	11.3	13.0	22.6	5.8	11.3	21.8	11.3	84.1	34.0	18.6	13.6	31.2	45.1	17.3	9.4	30.1
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 95.7;liver: 103.5"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 168.4;Peritubular cells: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042375, HPA073930"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol"		NA	NA			"Endoplasmic reticulum, Mitochondria"	"Vesicles, Cytosol"	"HPA042375: AB_10796905, HPA073930: "	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	21.8	7.5	5.6	2.8	6.2	4.2	26.5	2.9	8.1	16.1	6.1	6.4	13.2	7.4	8.7	95.7	5.6	10.5	4.7	5.3	5.3	6.1	8.5	103.5	5.5	6.7	6.3	4.8	7.7	11.4	4.4	5.7	7.1	6.2	7.3	2.2	7.3	12.7	12.9	7.4	7.3	5.8	4.0	6.4	2.8	4.6	19.1	3.2	3.8	9.9	6.3	5.4	3.9	5.2	12.8	17.0	1.6	23.4	15.1	14.4	11.6	14.2	27.3	7.2	18.8	15.4	10.8	10.8	9.1	8.2	12.5	9.9	15.9	9.7	12.5	16.6	9.3	9.4	17.0	10.6	5.5	3.2	9.2	37.0	6.2	14.9	22.8	17.0	5.5	9.3	11.0	11.5	8.3	12.7	4.2	6.7	17.6	5.9	5.3	5.5	27.2	9.8	9.9	10.1	27.3	22.4	9.2	11.6	11.4	10.3	5.3	7.2	17.2	6.5	4.4	16.3	14.5	6.7	2.1	5.8	12.3	12.4	20.5	7.9	7.3	4.9	2.2	11.4	7.7	10.1	1.0	23.4	1.1	10.1	20.8	14.4	12.6	13.2	12.7	17.0	12.8	10.6	11.9	1.6	15.1	14.2	15.5	12.0	11.6	5.6	6.2	2.9	8.1	5.3	6.1	6.3	4.8	6.2	3.2	14.9	13.7	17.0	16.7	16.3	4.4	12.5	12.7	16.0	26.1	26.2	0.0	16.2	14.9	26.3	2.2	18.3	14.6	0.0	33.6	18.8	27.5	23.7	12.7	168.4	21.4	4.8	66.0	9.2	11.1	6.8	87.8	10.8	20.3	1.0	24.8	26.7	26.0	10.5	326.0	21.4	4.8	6.5	30.9	11.1	18.5	15.8	12.2	7.0	22.8	16.6
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521794	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 92.9;kidney: 106.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1020.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		1000000000	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8.0	10.8	9.1	106.0	48.6	11.1	10.6	16.0	7.7	12.6	9.0	9.6	12.5	10.4	13.0	9.2	6.6	13.3	9.6	9.0	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15.0	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.3	36.3	10.7	17.3	45.7	17.6	24.8	11.9	24.4	15.2	17.3	31.6	11.8	5.4	17.8	29.8	11.7	3.5	15.4	9.7	12.5	15.4	15.2	34.7	7.4	32.1	31.3	10.1	42.1	21.7	9.2	13.8	8.6	11.2	20.3	10.7	6.6	15.8	16.5	16.3	7.7	3.4	14.7	26.6	14.8	15.2	14.6	15.0	13.1	35.3	13.2	33.8	22.2	11.0	17.9	9.4	7.6	11.0	16.9	14.7	15.9	19.0	13.7	14.5	21.5	4.8	15.7	14.6	20.9	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16.0	7.7	13.0	11.5	20.8	24.3	20.2	26.1	17.2	33.9	11.7	43.3	26.8	11.4	69.8	3.9	19.3	167.5	63.4	7.6	44.9	37.6	0.0	38.3	59.7	34.6	21.4	55.5	161.7	189.6	58.8	16.6	35.0	46.9	8.9	45.8	63.2	64.1	131.7	14.5	69.3	37.3	28.5	57.0	1020.8	23.8	38.8	38.8	11.4	48.3	17.8	25.4	31.0	16.7	18.0
PER2	KIAA0347	ENSG00000132326	"Period circadian regulator 2"	O15055	2	238244038-238290102	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053136, HPA060510"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053136: , HPA060510: AB_2684298"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.22e-2)"	12.7	3.8	5.1	11.4	10.3	7.8	16.1	16.0	13.4	16.4	8.8	9.2	12.8	5.5	15.4	9.7	15.2	11.8	15.6	6.7	5.8	4.7	4.9	13.7	7.9	4.8	4.7	6.8	14.6	15.7	5.5	11.1	8.4	8.0	12.9	7.1	11.6	23.0	20.7	11.9	20.0	9.1	13.5	4.5	4.9	14.8	19.0	5.3	6.0	9.9	21.3	13.7	11.1	11.3	4.5	4.8	4.1	5.6	3.1	4.5	0.8	1.4	10.1	2.2	3.7	0.1	1.1	7.3	1.0	3.6	1.3	1.3	1.5	5.1	8.8	1.0	2.3	1.4	7.5	2.1	3.0	1.9	2.5	1.5	7.7	5.2	6.9	1.8	11.6	8.2	1.4	7.4	1.6	5.4	1.3	0.7	3.6	3.7	5.6	1.1	6.5	5.7	12.8	3.1	6.5	2.0	13.9	4.9	2.9	1.3	2.9	8.6	1.0	2.5	5.5	1.6	0.7	5.2	7.3	1.8	3.2	3.8	2.5	3.5	6.3	1.4	10.7	6.0	5.1	3.9	4.1	3.7	0.9	2.9	5.6	4.5	4.4	4.5	3.4	3.7	4.5	4.4	4.5	2.9	3.1	5.1	4.8	3.1	0.8	5.1	10.3	16.0	13.4	5.8	4.7	4.7	6.8	8.0	5.3	14.9	26.7	4.2	49.4	65.7	21.5	5.2	20.4	41.5	52.4	26.2	2.0	7.0	6.6	6.4	4.2	9.3	14.6	0.0	9.0	5.4	17.7	14.6	9.2	32.6	3.4	11.1	23.6	8.6	8.9	2.5	10.3	9.3	23.6	1.0	21.2	13.2	7.0	24.3	17.3	3.3	8.0	6.5	25.8	24.7	15.9	74.5	10.9	7.2	24.4	18.4
PET100	C19orf79	ENSG00000229833	"PET100 homolog"	P0DJ07	19	7629737-7631956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 106.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067288			Approved	Mitochondria		NA	NA			Mitochondria		"HPA067288: AB_2732762"	"unprognostic (7.02e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (7.97e-4)"	"unprognostic (4.89e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.66e-2)"	"prognostic favorable (2.44e-4)"	18.7	27.8	24.9	21.3	23.3	42.3	22.9	16.1	27.8	13.2	21.9	9.7	29.3	22.2	13.4	27.4	18.0	11.0	24.0	47.3	31.6	18.3	24.7	36.8	14.9	20.5	19.8	25.3	11.9	24.7	11.0	20.7	18.0	21.0	16.4	16.4	14.7	29.9	30.1	41.1	14.8	18.8	12.9	21.3	18.2	25.6	14.4	12.4	16.4	17.5	29.9	17.5	10.2	13.6	52.6	86.9	106.6	82.2	33.8	60.1	72.1	18.4	16.6	30.5	18.2	14.8	10.7	11.2	15.8	9.1	10.9	10.7	14.8	12.5	12.3	27.9	11.9	13.5	16.4	13.7	14.4	9.0	28.1	27.8	17.6	35.1	23.6	7.4	30.0	16.9	12.1	9.3	7.3	7.7	17.4	15.4	30.3	12.7	47.7	11.4	20.1	32.2	47.2	19.7	21.4	36.3	20.3	17.3	28.6	21.9	22.5	17.0	20.3	21.0	18.9	17.0	19.5	13.8	39.8	16.7	8.6	10.6	17.2	23.5	42.9	33.5	22.4	15.8	23.2	10.2	106.6	82.2	89.2	41.9	63.7	39.0	52.6	48.6	43.8	49.8	51.0	45.4	47.7	77.2	33.8	56.1	86.9	60.1	72.1	24.9	23.3	16.1	27.8	31.6	18.3	19.8	25.3	21.0	12.4	140.0	188.2	119.3	34.8	44.6	49.0	48.4	231.8	145.9	121.7	246.0	21.6	109.5	182.4	187.3	33.6	64.6	254.8	210.2	275.3	108.9	79.7	58.6	101.9	470.9	149.2	17.5	184.1	168.8	266.1	38.0	94.0	169.6	108.0	232.6	239.3	60.6	286.3	280.5	78.1	209.8	67.5	84.1	54.7	111.8	89.1	51.7	149.5	147.2	189.2	40.8
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 60.6;Syncytiotrophoblasts: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: AB_2679539, HPA049231: AB_2680683"	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	14.9	11.6	14.3	12.2	22.3	8.3	13.1	15.7	35.0	11.8	14.8	18.6	8.3	18.0	14.4	10.4	22.6	14.8	12.2	17.8	14.4	16.2	13.3	25.9	13.6	11.6	13.0	16.1	15.7	15.3	13.6	14.2	17.7	22.4	21.9	10.5	14.8	20.0	31.0	22.1	14.6	20.9	10.7	11.1	11.2	12.8	18.7	11.4	11.4	13.5	11.6	17.3	38.7	13.6	4.2	5.0	7.3	3.8	4.2	8.4	3.6	15.6	14.8	12.6	13.8	9.3	8.8	8.2	18.1	15.3	20.2	19.3	15.6	29.1	11.4	18.1	13.8	12.0	18.7	13.1	17.4	9.7	16.0	21.4	14.0	16.1	21.3	14.0	15.8	20.2	10.6	14.1	15.3	14.1	12.1	12.9	15.1	21.9	11.8	9.1	12.9	15.1	20.8	12.9	12.3	17.4	16.4	10.5	16.3	15.9	10.4	15.0	17.2	17.5	14.7	16.3	10.2	13.5	11.4	12.4	14.8	15.6	14.3	15.3	17.0	13.8	22.3	16.2	21.9	15.7	1.9	3.8	7.3	8.4	2.8	5.3	4.2	4.4	6.2	4.7	3.9	5.8	5.2	0.6	4.2	2.5	5.0	5.2	3.6	14.3	22.3	15.7	35.0	14.4	16.2	13.0	16.1	22.4	11.4	8.9	1.3	7.5	12.5	6.4	14.7	6.1	5.1	21.4	2.3	8.7	25.5	40.0	6.6	15.0	2.2	6.0	18.7	0.0	12.7	15.4	7.1	9.7	5.8	48.3	20.4	17.5	8.6	9.8	7.9	2.4	7.5	5.9	11.8	32.5	8.4	13.8	14.7	10.5	5.3	14.8	60.6	6.5	7.2	5.9	12.1	7.0	54.1	8.5	10.5	11.2
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963870-42979220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 73.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	13.0	14.9	12.1	11.5	18.9	9.0	11.5	21.7	19.0	14.7	16.9	14.6	15.3	9.8	11.9	8.8	18.2	23.4	13.0	10.4	12.9	12.1	11.3	18.8	7.4	17.6	17.3	9.1	20.0	73.2	21.3	18.2	10.6	16.0	17.8	8.5	10.8	15.0	12.8	15.2	14.2	24.6	10.5	9.9	12.8	10.6	10.6	17.2	22.3	21.5	6.9	10.9	11.2	12.4	4.3	4.3	4.8	3.2	4.0	6.1	2.5	15.9	7.7	3.9	14.5	14.5	14.0	4.0	2.8	4.4	2.3	4.8	4.8	4.7	6.5	3.9	6.7	9.8	15.1	13.5	14.6	2.4	12.6	7.2	2.1	10.9	2.8	9.8	2.2	4.5	17.4	16.9	9.5	2.6	18.8	11.7	8.9	11.3	6.7	5.0	1.8	5.7	7.2	4.8	36.3	6.7	12.3	6.8	2.6	5.9	4.6	12.2	5.3	2.6	10.4	14.7	6.6	20.5	9.8	6.5	7.4	1.4	3.6	6.4	10.1	8.8	8.9	2.5	11.3	5.9	2.1	3.2	4.8	3.0	2.4	5.4	2.6	4.4	6.1	4.3	4.3	5.5	5.1	2.0	4.0	1.5	2.5	2.1	2.5	12.1	18.9	21.7	19.0	12.9	12.1	17.3	9.1	16.0	17.2	6.0	1.6	2.7	8.8	4.4	14.5	4.5	5.1	5.3	3.4	7.0	2.0	7.7	11.6	2.4	2.2	4.0	12.4	0.0	1.3	5.7	6.4	6.2	0.0	10.5	4.9	20.6	5.2	9.8	6.7	2.2	13.6	2.8	8.5	1.0	7.4	10.6	1.7	7.0	8.9	9.8	6.4	0.0	5.2	7.7	2.8	4.8	6.2	4.4	8.0	5.5
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913937	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.5	17.8	8.1	7.0	8.9	4.0	13.5	7.0	10.7	8.7	8.5	7.9	14.0	6.1	5.5	18.9	9.1	8.9	17.0	14.5	7.2	6.7	16.3	10.0	9.2	4.7	8.9	9.5	6.1	43.6	15.5	10.2	6.7	6.9	11.7	9.2	13.6	15.4	18.9	11.7	12.0	6.6	7.5	9.6	4.7	14.5	19.4	5.4	5.9	11.5	7.5	6.8	6.9	7.0	4.6	5.4	4.3	5.3	2.9	6.9	1.8	4.7	4.6	4.6	6.5	6.0	8.9	2.5	6.6	8.3	7.1	7.5	5.7	5.6	1.7	12.6	7.1	8.6	6.1	3.3	12.3	8.8	4.9	8.0	6.4	4.6	0.8	14.4	8.0	3.7	8.5	13.1	5.1	10.2	8.1	5.3	11.7	11.9	5.1	9.7	11.3	3.5	9.9	4.7	12.6	7.9	4.7	4.7	5.0	15.4	6.4	8.8	12.6	6.1	8.8	8.5	5.4	5.7	10.1	4.0	4.7	2.2	7.3	5.1	7.2	4.7	0.0	3.7	7.3	5.6	0.2	3.0	4.3	2.6	2.5	2.0	4.6	3.4	4.2	5.3	2.9	6.9	4.1	0.5	2.9	5.3	5.4	6.4	1.8	8.1	8.9	7.0	10.7	7.2	6.7	8.9	9.5	6.9	5.4	3.0	6.5	1.5	10.9	10.8	8.2	14.1	5.1	8.1	7.9	10.4	7.9	16.2	51.4	13.6	8.7	5.3	10.7	0.0	19.9	17.5	7.5	13.8	13.9	5.7	10.8	0.0	9.9	6.2	5.4	7.3	8.3	7.2	13.5	15.4	17.9	14.0	15.4	14.0	9.2	27.9	8.5	6.5	9.4	34.9	17.6	15.8	14.3	4.3	17.8	15.3
PFAS	"FGARAT, GATD8, KIAA0361, PURL"	ENSG00000178921	"Phosphoribosylformylglycinamidine synthase"	O15067	17	8247618-8270491	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 28.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022140, HPA022886"	Enhanced		Approved	Vesicles		NA	NA		350000	Vesicles		"HPA022140: AB_1855232, HPA022886: AB_1855233"	"unprognostic (1.90e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (9.19e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.08e-3)"	"unprognostic (9.51e-3)"	"unprognostic (3.63e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.85e-1)"	15.4	15.3	11.4	14.8	13.0	17.5	12.8	14.6	18.5	11.2	12.4	14.0	10.0	9.8	15.1	11.2	13.2	13.5	14.3	9.7	9.0	8.0	13.0	17.0	9.5	18.5	10.7	12.6	16.6	15.7	11.5	9.2	10.7	10.7	11.5	12.2	12.0	10.6	10.6	11.6	13.6	11.5	14.3	7.9	18.0	11.4	17.2	11.1	29.5	12.8	10.8	16.2	10.4	9.5	9.2	7.1	28.2	2.9	2.7	6.5	1.1	5.9	26.5	13.6	20.4	5.0	4.1	15.7	7.7	2.9	14.2	10.8	12.9	5.4	26.5	12.5	4.5	5.0	14.0	31.3	10.0	10.6	12.0	25.6	15.5	25.0	16.1	4.3	12.5	11.5	3.9	2.5	16.4	10.4	4.0	11.7	14.5	20.8	4.0	5.7	9.0	22.1	10.9	22.6	3.3	12.1	33.3	14.1	12.7	6.5	10.0	8.3	12.9	9.5	6.1	8.8	7.6	6.0	5.8	8.2	7.9	10.3	14.4	19.0	4.8	8.5	13.0	8.7	17.8	13.3	9.1	2.9	6.5	4.0	2.5	5.2	7.8	5.2	4.6	2.4	9.2	6.5	5.1	28.2	2.7	1.9	7.1	2.7	1.1	11.4	13.0	14.6	18.5	9.0	8.0	10.7	12.6	10.7	11.1	0.0	6.4	2.2	1.5	2.2	6.5	2.8	2.5	8.1	5.7	3.5	5.9	4.2	0.0	3.0	1.6	2.1	1.0	0.0	2.6	3.2	2.3	1.8	1.1	3.8	4.0	1.6	0.0	3.1	3.0	0.4	4.9	2.2	3.3	6.4	2.0	1.5	1.9	3.6	1.4	2.4	6.4	0.0	1.7	3.9	10.3	1.8	2.6	2.5	5.3	1.3
PFDN1	PFD1	ENSG00000113068	"Prefoldin subunit 1"	O60925	5	140245039-140303121	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006499	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		10000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006499: AB_1079596"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.66e-3)"	"prognostic unfavorable (8.81e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.00e-1)"	36.1	24.8	39.5	18.8	38.8	26.4	25.8	28.5	48.7	23.1	27.0	29.3	15.8	20.9	28.2	29.6	26.8	22.5	18.6	46.7	38.2	34.7	32.7	20.2	24.2	21.6	38.8	35.3	20.6	18.1	26.5	19.9	26.9	45.6	24.3	23.0	19.8	23.1	24.4	69.5	20.9	22.0	32.1	37.1	23.1	19.2	19.6	24.1	23.7	24.4	28.7	25.5	23.0	19.2	38.9	36.3	45.6	46.4	39.5	45.1	37.2	39.1	18.4	32.8	18.9	21.5	22.1	31.7	53.6	26.7	41.2	45.9	39.1	25.1	26.4	54.2	28.5	43.1	14.6	23.8	52.6	48.6	27.9	24.0	23.4	18.8	25.2	25.3	48.1	18.4	23.5	28.0	35.0	36.9	26.7	45.2	31.1	20.9	17.3	34.6	17.5	32.7	33.0	21.7	16.0	27.6	23.2	46.7	19.4	46.0	18.0	18.6	19.6	40.1	35.3	30.6	32.1	24.1	28.5	58.1	29.1	28.9	17.1	47.9	16.9	43.3	68.4	29.4	31.8	33.7	43.2	31.1	45.6	33.4	46.4	35.3	38.9	38.4	38.4	36.3	35.9	38.5	34.6	5.1	39.5	44.1	33.9	45.1	37.2	39.5	38.8	28.5	48.7	38.2	34.7	38.8	35.3	45.6	24.1	62.5	27.0	57.4	56.0	33.8	39.1	71.1	56.0	54.9	56.9	62.8	43.2	99.5	104.5	108.2	2.6	70.9	60.6	70.0	88.5	69.1	54.6	45.1	52.1	56.2	74.9	23.8	44.7	68.2	54.4	9.4	48.3	63.8	70.9	117.2	33.8	53.2	101.0	51.8	49.1	83.4	38.8	64.7	38.1	20.0	47.7	30.6	71.6	50.7	39.3	59.1
PFDN5	"MM-1, PFD5"	ENSG00000123349	"Prefoldin subunit 5"	Q99471	12	53295291-53299450	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008587	Approved		Supported	"Intermediate filaments,Cytosol"		NA	NA		110000	"Intermediate filaments, Cytosol"		"HPA008587: AB_1079597"	"unprognostic (3.56e-3)"	"unprognostic (2.31e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.01e-3)"	75.9	73.7	105.0	82.3	85.4	119.3	142.4	53.8	66.7	97.0	77.1	56.3	102.5	39.7	94.3	156.8	80.3	94.6	91.0	77.0	82.7	76.7	81.8	83.5	64.9	117.2	94.3	69.2	134.5	155.8	49.6	81.2	67.3	63.3	96.1	65.4	60.1	116.4	99.9	87.0	71.6	54.1	108.1	91.0	83.8	64.7	60.5	64.9	60.5	128.1	108.9	101.1	91.8	144.9	163.9	98.0	63.7	127.8	69.4	158.4	329.0	34.6	53.5	51.8	46.6	100.5	139.9	37.8	86.8	118.2	80.9	54.7	48.8	53.4	46.9	52.5	93.3	31.5	31.9	45.0	62.2	78.4	44.3	63.0	42.7	66.1	67.0	64.6	69.4	46.7	133.3	91.4	57.2	44.7	142.1	71.9	57.5	49.8	63.3	80.3	122.5	48.6	103.5	48.8	38.2	82.7	39.6	56.2	55.4	92.3	51.3	43.8	50.0	55.8	49.3	63.0	55.5	64.1	88.7	62.9	45.8	34.9	21.6	38.8	47.5	50.6	69.0	50.2	55.5	41.8	63.7	127.8	46.5	80.9	97.0	110.9	163.9	123.2	97.6	98.0	156.8	158.4	125.9	38.3	69.4	100.2	91.0	95.8	329.0	105.0	85.4	53.8	66.7	82.7	76.7	94.3	69.2	63.3	64.9	244.2	498.3	821.4	978.4	1337.0	168.6	512.1	654.7	603.6	410.6	537.3	96.2	782.3	1197.0	474.2	740.9	714.2	762.1	327.1	835.6	808.8	895.0	782.4	633.6	473.3	1556.7	68.3	634.1	613.9	1908.4	2168.6	878.5	1189.4	1459.3	1100.1	742.2	240.0	653.0	927.0	616.0	1515.7	241.4	543.3	956.8	450.5	191.9	1334.3	732.5	827.4	772.2	931.8
PFDN6	"H2-KE2, HKE2, KE-2, PFD6"	ENSG00000204220	"Prefoldin subunit 6"	O15212	6	33289302-33298401	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043032, HPA048123"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		110000	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA043032: AB_2678278, HPA048123: AB_2680273"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.68e-3)"	12.5	19.1	29.2	15.4	27.8	15.0	15.6	13.2	33.9	12.0	17.7	12.9	13.1	13.8	14.4	22.4	15.1	12.5	11.4	16.2	31.6	24.8	19.1	23.2	10.8	15.7	27.0	31.9	14.5	21.3	15.3	14.6	14.0	20.7	12.5	16.2	8.2	15.8	16.0	43.6	10.8	13.7	13.4	20.7	11.3	12.2	33.1	17.5	10.7	12.2	22.5	18.9	11.8	9.8	6.8	5.0	3.4	7.1	3.9	7.5	4.3	15.0	10.1	7.0	14.5	7.9	6.7	11.5	11.6	5.9	10.1	9.7	9.5	7.5	22.2	14.1	6.5	19.4	11.0	11.5	13.3	15.3	14.9	12.2	19.9	11.2	15.8	8.8	15.2	13.0	6.0	15.3	14.3	10.2	8.0	9.9	13.1	24.2	9.6	10.9	10.3	18.2	16.1	11.7	10.0	8.8	15.7	10.3	22.4	16.4	7.2	16.3	19.7	10.1	26.4	16.7	7.4	15.2	22.0	8.3	7.2	10.7	8.9	19.1	19.3	52.6	24.8	7.0	20.2	10.3	3.2	5.1	3.4	4.1	6.5	4.2	5.9	5.6	7.5	4.9	6.8	3.3	4.6	2.7	3.9	7.1	5.0	5.3	4.3	29.2	27.8	13.2	33.9	31.6	24.8	27.0	31.9	20.7	17.5	23.8	8.3	51.5	39.3	49.5	21.5	17.7	71.4	17.4	17.0	52.4	9.8	107.5	102.8	74.2	74.3	28.8	70.3	0.0	89.2	103.2	41.2	43.0	62.1	64.4	70.1	17.5	48.4	19.0	26.8	30.2	57.2	47.3	67.4	83.0	47.0	38.4	78.6	71.9	46.3	154.1	21.2	38.8	32.0	200.4	54.7	55.8	92.7	37.6	54.6	43.9
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.0"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 36.2;Mucus-secreting cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 21.6;monocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 22.9;U-87 MG: 36.5;WM-115: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA047719: AB_2680129, HPA066058: AB_2685606"	"unprognostic (7.60e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	2.0	2.2	4.0	3.9	4.9	12.7	2.1	6.3	6.3	2.6	17.1	8.6	3.0	17.8	2.1	18.5	6.4	1.5	1.8	1.4	4.2	5.2	3.6	1.7	3.8	6.3	7.4	2.7	3.5	18.9	4.1	5.1	9.5	6.9	3.3	3.5	3.3	2.5	2.0	4.8	3.3	24.0	2.5	5.3	10.0	1.2	26.0	5.2	0.4	1.6	3.6	2.6	4.9	4.2	0.2	2.7	21.6	12.2	0.2	0.5	2.1	5.0	1.5	3.6	3.3	1.2	1.8	7.1	2.5	4.3	5.2	12.6	2.5	1.8	2.2	2.4	1.9	12.4	1.4	1.5	4.4	4.6	1.5	1.2	5.1	3.3	2.7	1.0	0.9	2.3	1.8	6.6	8.3	0.8	22.9	1.2	2.9	1.7	1.9	4.1	1.1	0.3	7.1	2.2	1.0	3.4	0.4	1.7	2.3	2.0	4.7	1.0	2.2	2.7	1.2	9.9	3.7	2.8	2.2	0.3	5.3	2.1	0.6	15.3	8.8	1.9	1.3	36.5	1.8	31.7	0.0	6.5	11.4	0.2	7.3	0.1	0.2	0.3	0.0	2.7	0.1	0.5	0.1	21.6	0.2	12.2	0.3	0.0	2.1	4.0	4.9	6.3	6.3	4.2	5.2	7.4	2.7	6.9	5.2	0.0	2.2	0.0	0.3	2.9	5.0	0.6	0.0	1.4	1.2	0.0	2.0	11.1	0.0	2.0	2.6	0.4	1.7	0.0	1.3	36.2	1.5	0.4	1.1	0.0	5.3	6.4	4.1	1.8	11.0	2.0	0.9	4.4	1.7	0.0	11.8	3.6	2.9	0.3	0.7	0.0	4.3	0.0	0.8	0.5	0.5	1.5	4.6	0.0	1.5	0.0
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 326.0;Horizontal cells: 114.4;Muller glia cells: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.5	27.5	20.0	5.5	23.7	21.8	20.5	14.5	21.0	11.0	52.1	19.6	11.4	12.0	9.7	23.3	23.9	19.3	1.2	12.2	14.8	19.3	0.6	14.7	0.7	8.6	28.3	14.1	18.0	29.7	34.3	23.2	0.8	17.8	26.3	18.8	6.6	18.3	1.2	19.2	9.6	26.5	30.8	15.7	40.0	14.0	9.7	31.9	23.5	14.0	22.2	23.7	22.4	22.5	3.2	20.9	9.5	13.1	13.9	19.7	14.4	38.3	28.5	18.4	1.5	7.9	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8	14.9	5.9	6.8	17.7	6.5	38.0	326.0	17.8	9.4	7.9	21.0	41.2	2.2	56.3	9.4	29.7	15.8	2.2	0.0	2.2	3.5	16.7	6.1	1.1	2.5	3.5	114.4	8.7	9.8	2.7	19.6	28.4	3.2	52.3	18.0	6.2	114.5	3.3	0.0	44.9	25.8	41.0	25.8	26.2	46.8	11.5	4.5	2.1	4.4	12.1	7.6
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 509.4"	"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 4080.6;monocytes: 7018.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB037134, CAB037140"	Enhanced		Approved	Cytosol		NA	NA		1100000000	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	65.2	48.2	24.0	125.4	36.7	118.0	61.3	15.6	25.9	63.8	102.3	33.1	46.7	66.4	97.4	52.9	96.6	67.5	87.8	40.7	22.0	19.6	80.5	137.3	70.5	159.4	37.4	17.3	53.7	37.2	18.3	27.5	82.8	28.5	62.0	68.2	39.3	46.0	52.6	51.6	51.2	96.4	119.4	33.3	138.7	70.4	27.2	30.5	199.3	46.6	65.3	116.3	97.9	54.4	154.4	263.4	356.5	322.9	223.0	288.9	509.4	140.1	169.1	63.5	50.9	32.8	40.9	95.3	119.9	78.8	104.2	79.0	65.4	49.5	101.9	104.3	101.3	63.0	88.6	56.6	122.1	83.9	177.2	111.3	104.3	86.6	84.9	90.0	65.7	248.2	48.5	53.7	80.7	80.5	63.7	93.4	69.8	57.5	74.4	124.7	69.7	125.2	141.8	98.8	60.2	103.9	125.5	85.3	65.6	100.8	75.0	26.0	77.5	80.5	50.5	73.4	55.5	47.3	55.8	114.2	91.1	84.5	68.3	174.1	53.1	53.8	82.1	78.5	79.0	138.3	168.7	216.8	356.5	286.3	278.7	190.1	154.4	236.8	270.9	263.4	135.2	154.8	221.1	255.4	223.0	322.9	212.4	288.9	509.4	24.0	36.7	15.6	25.9	22.0	19.6	37.4	17.3	28.5	30.5	104.2	205.8	866.8	636.2	1604.2	21.1	131.7	501.9	111.1	149.0	703.1	0.0	1882.1	840.6	1770.0	14.2	550.7	1316.6	93.5	1422.2	4080.6	968.1	512.4	473.6	682.9	3613.7	36.5	580.1	689.9	1477.5	18.5	244.2	2021.5	828.4	7018.1	1219.5	67.9	2136.3	1369.2	352.5	1192.8	11.6	498.0	1013.7	95.6	348.1	1322.9	1407.4	2210.4	1246.9	991.4
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Group enriched"	"Detected in many"	13	"Early spermatids: 421.0;Late spermatids: 1332.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 39.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.3	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1	0.0	0.0	0.5	0.2	1.0	4.3	0.0	0.0	0.0	0.0	0.0	9.8	0.0	68.0	0.0	421.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.0	0.0	0.3	1332.7	7.2	0.4	1.7	0.0	0.0	3.8	0.2	0.2	5.6	1.9	4.2	25.8	3.1	30.5	5.6	0.5	0.0	0.0	0.2	0.4
PGAP2	"CWH43-N, FRAG1, MRT21"	ENSG00000148985	"Post-GPI attachment to proteins 2"	Q9UHJ9	11	3797724-3826371	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"GPI-anchor biosynthesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 117.3"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 62.9;Early spermatids: 124.4;Late spermatids: 246.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063099	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA063099: AB_2684940"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.67e-2)"	4.9	9.5	7.6	7.3	8.2	5.2	6.9	5.0	10.6	7.3	12.3	12.4	18.3	10.2	7.4	117.3	20.0	11.1	8.1	9.3	8.0	6.3	8.6	17.1	9.5	8.6	6.9	8.8	7.1	30.8	12.6	9.1	10.7	5.6	10.1	7.9	12.5	14.5	19.6	6.4	25.0	16.7	4.9	8.9	6.6	7.5	17.7	8.4	15.0	14.1	14.6	15.3	7.7	10.4	11.2	8.7	15.9	8.0	8.7	17.0	7.5	12.5	17.2	8.4	7.6	7.5	14.5	13.3	5.2	4.5	7.8	7.0	14.6	22.2	13.6	6.0	3.8	4.6	21.2	13.3	14.5	7.6	16.5	14.5	8.3	7.5	17.9	5.3	10.5	10.9	11.5	20.4	5.6	19.3	5.0	8.7	18.4	17.5	20.3	8.0	18.8	12.9	9.0	15.7	26.7	10.4	20.2	1.0	13.1	14.6	15.2	11.1	11.0	9.4	25.2	5.6	10.3	20.9	4.6	8.2	4.8	4.6	11.4	3.2	12.7	13.9	10.1	6.3	7.2	9.2	1.9	5.8	5.0	8.8	8.0	10.8	11.0	12.6	10.7	8.7	11.2	17.0	11.3	15.9	8.7	8.0	5.9	11.5	7.5	7.6	8.2	5.0	10.6	8.0	6.3	6.9	8.8	5.6	8.4	11.9	8.8	5.1	11.3	28.2	13.3	11.1	10.2	17.4	6.8	12.2	21.6	62.9	1.7	10.5	124.4	10.0	13.1	0.0	18.5	14.0	7.4	10.2	8.1	11.6	13.9	3.2	2.9	3.7	7.0	246.9	8.1	6.1	5.0	11.8	8.5	7.8	12.8	5.8	6.3	7.8	9.1	6.5	7.6	17.7	19.2	25.0	24.5	6.4	20.8	12.4
PGAP3	"CAB2, MGC9753, PER1, PERLD1, PP1498"	ENSG00000161395	"Post-GPI attachment to proteins 3"	Q96FM1	17	39671122-39696797	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"OE19: 133.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016591	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA016591: AB_1855203"	"unprognostic (1.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.57e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.94e-2)"	6.8	8.2	8.9	7.6	14.3	3.4	10.2	6.4	17.3	11.3	19.2	10.0	15.1	12.5	8.3	16.5	16.2	14.0	19.7	9.9	11.3	7.3	13.7	20.7	9.5	6.5	6.3	10.7	9.7	22.7	16.0	10.1	39.2	6.1	11.2	11.7	14.2	16.7	15.6	5.0	16.0	20.7	7.3	5.5	8.1	13.4	9.0	7.3	4.4	20.3	8.7	15.8	8.1	8.9	7.8	5.3	4.0	10.5	9.0	15.1	6.3	0.6	1.6	1.3	1.2	1.4	1.4	1.3	0.7	1.7	1.1	1.0	0.9	4.0	0.6	3.3	1.3	0.3	2.1	0.4	0.4	0.5	1.4	1.3	0.8	0.9	1.5	1.8	2.1	2.2	2.6	2.6	0.5	1.1	1.3	0.3	0.3	0.7	1.6	1.0	1.4	0.4	1.9	1.3	133.7	0.3	0.5	0.8	1.9	1.8	2.0	1.2	0.8	1.9	22.9	1.1	0.1	1.9	2.0	0.5	1.2	1.3	0.6	0.5	1.4	0.3	0.2	1.4	0.8	1.3	2.4	6.7	4.0	15.1	10.5	8.3	7.8	10.6	12.3	5.3	7.6	10.5	10.1	1.7	9.0	3.8	3.6	5.1	6.3	8.9	14.3	6.4	17.3	11.3	7.3	6.3	10.7	6.1	7.3	3.0	12.2	0.0	3.5	3.4	12.1	5.2	12.7	4.0	9.1	14.0	7.9	6.8	1.7	6.0	0.1	4.3	16.0	0.0	9.6	5.2	6.7	4.9	9.2	7.7	4.0	12.7	8.1	4.3	2.7	0.0	2.8	3.5	1.7	1.8	16.3	7.8	5.1	11.5	1.4	3.5	21.6	0.0	2.3	0.7	2.0	2.5	8.7	1.7	13.0	2.5
PGBD1	"dJ874C20.4, HUCEP-4, SCAND4"	ENSG00000137338	"PiggyBac transposable element derived 1"	Q96JS3	6	28281572-28302549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5;plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007267	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007267: AB_1079601"	"unprognostic (2.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.28e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (6.79e-4)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.68e-1)"	6.1	4.5	7.4	3.8	7.2	2.8	8.5	9.6	12.8	6.1	7.4	4.0	1.3	3.0	9.2	6.0	4.5	4.3	4.0	7.0	7.1	6.3	5.9	5.1	5.4	3.1	7.0	7.7	6.0	4.0	6.6	8.6	4.3	5.1	6.0	4.6	4.4	3.8	7.4	4.1	3.0	4.0	11.7	7.0	4.9	4.8	5.2	3.6	8.9	4.0	3.1	3.4	5.2	3.8	1.0	4.4	3.5	0.2	1.2	1.2	0.3	5.1	2.8	9.1	12.9	7.4	5.3	3.0	6.8	4.7	8.6	9.8	3.2	2.2	3.4	4.3	4.6	9.8	2.3	9.9	5.5	11.3	3.7	5.7	6.2	5.8	4.0	3.5	7.7	0.8	4.3	2.6	8.5	2.9	4.9	10.5	6.7	8.0	0.4	9.5	1.5	6.5	9.7	3.4	0.1	5.8	11.2	11.6	0.0	4.3	2.8	6.3	12.1	4.6	0.8	5.1	9.5	2.5	4.8	7.4	12.9	8.6	0.9	10.6	3.3	3.3	4.4	2.9	4.5	6.0	3.5	0.1	0.0	0.6	0.2	0.3	0.5	0.2	1.2	0.7	1.0	0.1	0.5	0.0	1.2	0.1	4.4	0.5	0.3	7.4	7.2	9.6	12.8	7.1	6.3	7.0	7.7	5.1	3.6	6.0	0.6	1.4	2.2	0.2	6.7	7.0	0.0	6.7	0.0	0.0	2.0	0.6	0.0	0.9	0.4	4.2	0.3	0.0	2.3	2.8	1.6	1.0	3.5	0.0	1.4	4.8	1.2	1.8	2.9	0.9	1.7	1.1	3.3	3.6	0.3	4.1	1.2	0.0	3.2	3.7	3.9	0.0	1.4	4.2	7.5	0.3	0.3	0.5	1.0	0.5
PGBD2		ENSG00000185220	"PiggyBac transposable element derived 2"	Q6P3X8	1	248906196-248919946	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3;Syncytiotrophoblasts: 23.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA029888, HPA029889, HPA029890"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002"	"unprognostic (1.06e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.05e-4)"	5.8	7.0	5.0	11.1	6.8	5.7	9.5	10.5	7.7	7.6	7.7	11.9	10.2	8.9	8.6	8.2	11.1	6.8	8.6	4.5	5.1	4.6	7.2	11.8	5.7	10.4	7.4	5.4	10.2	14.7	8.3	5.6	12.7	7.8	9.9	9.9	6.0	10.0	12.8	2.9	12.3	11.9	8.4	5.6	17.3	7.9	13.9	8.6	5.5	12.5	3.9	12.2	7.5	18.2	12.7	8.0	13.9	9.1	7.8	10.9	5.7	4.5	6.2	9.9	5.7	8.8	5.8	12.0	4.4	3.9	7.7	7.3	4.6	6.2	12.0	5.7	4.3	4.4	7.4	5.9	5.5	8.9	7.1	2.8	11.5	9.7	7.0	5.0	5.9	11.3	5.2	5.9	9.1	5.1	6.3	4.4	5.8	18.2	10.5	5.5	8.2	3.3	6.9	9.1	15.5	7.3	14.2	3.1	3.9	4.6	5.9	3.7	6.5	6.3	9.2	7.1	7.0	4.1	11.6	5.3	5.2	5.2	4.6	4.8	10.1	10.0	5.4	5.6	13.2	4.7	13.9	8.8	13.2	9.8	6.2	9.4	12.7	8.6	9.1	8.0	12.6	8.7	10.9	6.5	7.8	9.1	3.8	5.8	5.7	5.0	6.8	10.5	7.7	5.1	4.6	7.4	5.4	7.8	8.6	0.0	9.9	5.0	2.5	4.6	3.0	2.0	2.5	4.0	7.9	5.2	2.0	9.6	1.7	3.8	2.8	4.5	6.4	23.3	2.6	3.5	3.8	2.0	2.3	3.2	2.7	1.6	1.2	3.7	1.5	1.9	2.8	3.1	6.8	3.6	4.3	2.7	1.9	6.5	1.8	2.1	2.5	0.0	3.6	13.0	10.4	5.6	23.2	6.4	4.4	2.1
PGBD4	"FLJ32638, FLJ37497"	ENSG00000182405	"PiggyBac transposable element derived 4"	Q96DM1	15	34102073-34108684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.6"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040896, HPA059823"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA040896: AB_10805831, HPA059823: AB_2684134"	"unprognostic (9.54e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.47e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.70e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.73e-2)"	2.5	3.6	3.9	4.1	8.5	6.7	3.4	5.3	11.1	2.6	2.8	4.8	4.7	3.2	2.6	3.9	3.8	4.6	2.4	4.0	5.4	3.6	3.4	5.3	2.4	5.2	6.0	6.1	3.0	4.6	4.9	6.7	2.5	12.7	3.0	3.4	3.2	3.3	2.6	18.6	4.4	5.1	2.2	4.0	6.0	4.5	7.9	5.8	4.5	3.3	2.0	4.2	3.2	2.7	2.8	1.7	6.4	1.4	1.6	2.6	0.6	2.0	3.6	2.5	4.1	7.4	4.9	1.5	3.1	3.0	2.0	2.5	2.5	2.7	4.1	2.6	2.4	4.0	5.6	1.4	3.6	2.5	4.3	3.8	6.7	6.9	1.8	3.1	2.3	6.1	3.8	4.1	2.6	4.7	3.4	2.2	7.6	4.6	5.0	4.1	1.4	3.7	5.4	1.0	4.1	2.7	5.6	3.4	2.1	2.6	4.2	3.7	3.4	1.6	3.5	1.1	3.1	3.5	3.6	2.5	6.1	3.5	3.2	2.0	5.9	3.8	2.3	5.4	5.2	3.6	6.4	1.4	1.5	1.3	1.2	1.1	1.5	1.7	1.3	0.8	2.8	2.6	2.4	3.2	1.6	0.9	1.7	1.3	0.6	3.9	8.5	5.3	11.1	5.4	3.6	6.0	6.1	12.7	5.8	0.0	2.7	4.9	1.9	0.7	5.3	3.7	2.5	5.3	3.4	0.0	5.9	1.5	8.3	1.1	8.8	1.4	3.2	0.0	0.6	0.6	0.6	1.8	1.1	1.7	1.1	9.5	0.0	4.3	3.5	10.2	1.1	2.1	0.0	1.8	1.8	3.8	1.7	0.9	0.4	0.7	6.1	12.9	0.9	6.0	0.7	0.3	2.7	4.5	1.7	1.4
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 2: 270.0;Cholangiocytes: 150.3;Pancreatic endocrine cells: 843.0"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	7	"monocytes: 1.9"	"Group enriched"	"Detected in some"	11	"Hep G2: 69.6;OE19: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	3.0	249.6	41.7	0.1	0.0	3.3	0.3	16.8	0.1	0.1	0.1	0.1	0.3	139.4	0.0	0.1	0.0	0.1	798.6	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.1	35.9	0.1	0.1	0.1	0.0	0.1	0.1	963.7	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.6	42.3	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	23.8	270.0	0.0	3.1	0.3	0.0	0.2	150.3	5.3	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	117.5	1.0	0.1	95.4	9.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	843.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.4	0.0	0.0	2.6
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 115.1;esophagus: 123.8"	"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 204.0;monocytes: 212.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 115.1;monocytes: 32.0"	"Cell line enhanced"	"Detected in all"		"A549: 181.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		59000000	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	29.8	12.7	10.9	14.2	11.8	85.5	23.7	8.0	19.1	16.0	14.1	13.8	8.1	22.9	6.3	12.5	123.8	8.4	24.9	14.3	10.3	12.1	15.4	23.2	25.6	34.9	12.4	11.4	14.3	8.3	16.2	10.8	17.0	19.3	7.9	12.9	19.7	31.8	6.8	8.5	10.6	25.3	9.5	12.6	27.6	13.4	27.0	7.4	16.8	21.2	68.8	49.9	14.8	26.1	3.9	15.9	115.1	32.0	2.0	3.0	19.0	23.1	181.8	45.3	48.7	69.0	42.7	9.8	15.7	27.8	21.8	29.8	26.6	26.7	22.8	19.4	16.1	29.9	19.7	33.1	28.1	14.7	15.7	28.9	30.8	32.7	55.9	21.0	50.8	34.2	30.4	14.1	34.4	8.5	27.8	51.4	32.0	41.0	20.2	27.8	26.3	41.9	25.5	27.2	31.8	16.0	32.5	41.6	41.9	30.4	12.5	24.4	21.3	13.4	21.3	18.5	31.2	23.5	43.6	48.1	11.5	20.4	13.7	17.3	15.3	27.9	40.8	25.1	55.2	10.3	98.6	32.0	115.1	2.6	15.3	3.0	3.9	2.5	2.4	15.9	2.3	2.4	2.6	38.4	2.0	10.9	11.4	2.4	19.0	10.9	11.8	8.0	19.1	10.3	12.1	12.4	11.4	19.3	7.4	17.9	31.2	16.0	28.9	11.6	7.9	9.5	50.9	17.4	23.9	19.2	17.7	114.8	44.7	45.3	7.1	17.5	32.9	0.0	35.1	31.4	28.8	33.1	24.4	48.2	117.8	1.6	22.4	16.0	204.0	9.8	15.8	88.3	16.9	212.8	23.7	12.9	39.9	25.9	9.9	40.3	16.4	19.4	9.8	33.4	37.9	14.4	68.0	16.0	44.1	66.7
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955784	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 177.3"	"Group enriched"	"Detected in many"	16	"Extravillous trophoblasts: 1478.5;Syncytiotrophoblasts: 1775.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"BEWO: 93.4;HUVEC TERT2: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	No	No	20800		Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	4.3	2.7	1.9	4.4	2.4	0.0	4.3	1.6	3.5	13.1	2.3	2.3	4.0	1.3	2.9	6.3	3.9	9.2	3.4	5.1	2.4	4.1	3.1	2.6	3.6	4.9	2.9	2.0	3.8	1.9	5.4	2.0	177.3	4.6	7.5	1.1	3.5	3.8	6.7	3.3	6.0	4.3	4.6	1.7	1.2	1.7	3.3	2.0	1.4	24.2	4.4	2.9	5.1	5.9	0.7	0.7	1.1	1.0	0.0	2.4	0.2	0.3	0.3	0.3	0.3	0.4	0.0	93.4	0.8	0.8	0.4	0.5	2.2	0.1	0.0	2.0	0.6	0.0	0.1	0.4	4.2	0.3	0.0	0.5	0.0	0.0	2.2	0.3	0.0	2.4	1.1	1.0	1.7	0.4	0.1	44.0	0.0	0.0	0.0	12.4	0.1	0.0	0.1	0.4	0.0	0.7	0.0	11.6	0.0	0.1	0.2	7.0	3.8	0.0	0.1	1.6	5.9	0.0	0.1	8.9	0.0	2.3	0.0	3.7	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	1.1	2.4	1.0	0.0	0.7	0.3	0.7	0.3	0.3	0.6	1.0	0.0	0.0	0.8	0.7	0.5	0.2	1.9	2.4	1.6	2.2	2.4	4.1	2.9	2.0	4.6	2.0	8.9	5.8	0.8	13.0	21.9	0.8	2.8	0.0	1.4	7.9	0.0	13.7	75.1	0.0	0.9	0.1	15.8	0.5	0.0	0.4	1478.5	42.9	3.3	5.8	0.0	33.1	0.0	6.8	7.4	0.3	0.6	12.0	4.5	20.3	0.0	1.1	1.9	0.6	0.2	18.4	0.4	7.5	103.5	62.6	0.2	3.4	17.1	1775.1	0.9	1.7	4.7
PGGT1B	"BGGI, GGTI"	ENSG00000164219	"Protein geranylgeranyltransferase type I subunit beta"	P53609	5	115204012-115262872	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030646	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"	Cytosol	"HPA030646: AB_10602019"	"unprognostic (2.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (7.34e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.15e-2)"	10.5	12.4	7.3	13.3	10.1	10.9	13.9	8.8	22.1	10.8	13.8	7.7	7.9	12.3	9.2	4.6	14.9	7.3	7.0	13.5	9.5	5.9	8.2	13.7	22.2	22.2	10.2	10.0	9.6	10.1	12.0	13.4	7.8	8.2	8.4	15.1	5.7	10.6	8.4	10.2	9.9	10.4	9.5	6.9	10.4	11.0	5.1	10.5	10.2	8.8	9.9	10.1	9.6	10.5	8.0	11.5	21.8	16.7	6.7	6.3	6.4	10.2	11.2	12.8	16.5	7.5	6.3	6.3	12.7	7.5	10.6	11.0	12.2	11.0	20.9	17.3	8.8	11.0	8.0	16.8	16.7	15.9	23.0	9.3	12.0	14.6	9.7	10.0	16.5	17.8	9.4	10.3	10.4	10.9	6.8	10.6	12.4	9.7	8.9	12.1	16.0	14.4	5.5	9.5	11.6	8.7	15.8	17.1	21.2	11.1	19.4	12.5	9.5	15.1	11.5	12.1	8.0	15.4	12.4	12.1	10.9	10.3	7.5	14.8	15.0	16.7	11.0	7.9	17.2	15.1	8.3	12.8	21.8	5.0	16.6	5.6	6.8	5.7	6.3	11.5	8.0	5.4	5.0	13.1	6.7	16.7	10.3	4.9	6.4	7.3	10.1	8.8	22.1	9.5	5.9	10.2	10.0	8.2	10.5	11.9	14.4	20.7	10.2	8.9	22.7	15.7	5.1	25.4	18.2	15.7	45.2	12.3	23.2	17.0	28.4	16.1	17.8	0.0	18.9	11.6	11.7	13.7	23.1	24.5	19.5	22.3	28.9	20.3	18.3	8.1	12.4	23.0	10.1	12.6	23.0	25.4	17.9	21.0	14.5	18.3	111.9	12.9	14.1	11.4	15.6	10.8	11.3	19.1	23.3	17.8
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023065	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.7;bone marrow: 130.1"	"Cell type enhanced"	"Detected in single"	35	"Alveolar cells type 2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"eosinophil: 63.0;neutrophil: 73.7"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 73.7"	"Cell line enhanced"	"Detected in some"		"A549: 7.3;HEK 293: 4.1;HeLa: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045702, HPA070227"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		47000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA045702: AB_10960204, HPA070227: "	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	0.7	0.1	0.2	0.5	0.4	130.1	0.2	0.4	0.2	0.1	0.3	0.3	0.0	0.2	0.1	0.1	0.2	0.4	0.1	10.9	0.2	0.2	0.2	1.5	10.9	1.0	0.2	0.0	0.7	0.2	0.1	1.4	4.1	0.1	0.1	0.1	0.5	0.7	0.1	1.3	0.3	0.2	0.1	0.1	26.9	0.2	0.9	0.0	7.5	1.3	0.0	0.5	0.1	5.5	0.0	0.0	73.7	0.3	0.0	0.0	0.4	0.6	7.3	1.2	0.8	0.0	0.0	2.0	0.6	0.0	0.0	0.0	1.2	0.6	2.0	0.2	0.0	0.6	2.7	0.0	0.0	0.0	1.9	4.1	0.8	3.5	0.3	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.7	0.6	0.0	0.5	0.4	2.2	0.4	0.0	2.7	1.6	0.2	0.2	0.0	2.6	0.8	0.2	0.5	0.1	0.0	0.6	0.3	0.1	0.0	0.1	0.3	0.7	1.1	1.6	1.3	0.8	1.1	1.7	0.1	0.0	0.0	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.3	0.0	0.0	0.4	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 95.8"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 136.1"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7"	"Group enriched"	"Detected in some"	6	"MCF7: 10.9;T-47d: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		160000000000	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0.0	3.6	3.7	2.5	0.6	7.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	136.1	0.3	0.0	0.0	3.1	1.3	2.5	0.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	2.9	0.0	0.0
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell type enhanced"	"Detected in some"	15	"Basal keratinocytes: 1.8;Early spermatids: 1.6;Melanocytes: 1.7;Suprabasal keratinocytes: 3.0"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.2;HDLM-2: 5.3;hTCEpi: 1.7;Karpas-707: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025879			Approved	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Vesicles, Plasma membrane"		"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	5.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.1
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826633-37862937	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1900000	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	11.2	10.8	7.7	11.6	5.9	7.5	13.5	9.8	5.7	14.7	10.3	4.2	6.5	6.1	15.0	7.6	41.3	7.0	11.0	8.3	7.1	4.0	11.1	13.3	7.5	13.2	4.4	5.7	10.0	9.0	9.5	6.4	27.9	10.4	11.1	8.4	6.8	11.0	5.0	2.4	17.7	8.6	12.2	6.9	13.4	9.0	9.0	3.9	17.3	8.8	31.7	22.9	13.6	18.9	4.5	15.3	30.8	13.1	13.2	7.0	7.2	11.7	4.1	6.3	6.7	4.7	5.3	8.3	14.2	8.4	11.7	12.0	7.2	8.6	15.5	7.1	7.7	15.6	6.1	15.3	13.3	29.8	9.9	8.8	17.0	6.9	5.1	10.3	17.8	11.9	7.7	16.1	9.5	8.6	7.3	18.6	13.7	22.1	2.8	10.2	6.2	20.3	21.1	7.3	8.5	6.4	15.5	10.0	6.4	7.2	22.7	13.3	4.5	7.1	10.5	4.9	9.1	9.1	19.2	16.2	8.8	10.8	11.8	28.8	6.3	16.4	17.6	4.6	23.4	14.6	8.0	13.1	30.8	4.9	10.5	5.8	4.5	4.1	5.6	15.3	2.8	4.0	5.0	16.3	13.2	8.0	3.4	7.0	7.2	7.7	5.9	9.8	5.7	7.1	4.0	4.4	5.7	10.4	3.9	0.0	8.0	10.3	13.2	13.1	5.8	4.5	7.6	5.3	4.5	3.5	0.0	26.6	5.0	13.0	0.8	25.5	7.9	0.0	10.4	30.7	6.7	18.4	12.7	7.3	33.4	6.4	6.9	44.8	19.6	0.9	7.8	24.9	5.0	52.3	9.0	345.3	11.4	3.5	9.2	7.4	13.5	12.9	23.7	0.7	0.5	28.1	66.7	12.9	12.3	17.9
PGM2L1	"BM32A, FLJ32029"	ENSG00000165434	"Phosphoglucomutase 2 like 1"	Q6PCE3	11	74330318-74398473	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 48.6"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 76.3;Exocrine glandular cells: 109.6;Pancreatic endocrine cells: 102.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 13.4;LHCN-M2: 16.0;RH-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056995, HPA060948"	Enhanced		Approved	Mitochondria		No	No		64000	Mitochondria		"HPA056995: AB_2683305, HPA060948: AB_2684394"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.28e-3)"	"unprognostic (8.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.16e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.03e-2)"	3.0	4.0	30.6	4.9	19.8	4.0	3.2	6.3	48.6	6.1	4.5	1.3	1.0	2.3	6.1	1.9	2.1	4.7	4.8	1.6	30.1	15.1	2.5	2.1	2.7	4.0	9.7	20.4	1.7	4.4	1.4	4.5	2.1	11.7	3.8	5.1	2.9	3.2	2.5	7.1	1.7	2.6	5.6	2.6	2.5	3.4	2.3	0.3	10.0	4.1	1.3	4.0	5.2	2.6	2.4	1.7	2.5	0.6	3.0	7.5	1.1	2.1	3.0	11.8	2.1	3.6	1.6	0.3	2.8	2.1	2.4	2.7	1.1	5.5	0.2	7.0	1.8	4.3	1.0	2.3	0.5	2.3	0.8	1.2	1.6	1.6	0.9	0.4	1.9	2.6	0.8	0.5	5.5	1.0	2.7	13.4	4.0	2.1	1.5	16.0	0.3	7.6	1.7	2.3	1.6	2.7	2.4	15.4	0.1	6.4	0.4	0.5	2.3	4.5	1.0	2.0	3.4	0.2	0.3	11.1	5.5	5.1	2.2	2.9	2.0	2.9	0.2	0.5	2.7	1.3	2.5	0.6	1.1	2.1	0.6	2.8	2.4	3.5	2.3	0.5	1.8	3.3	1.9	0.7	3.0	0.3	1.7	7.5	1.1	30.6	19.8	6.3	24.4	30.1	15.1	9.7	20.4	11.7	0.3	6.0	5.4	13.7	35.5	6.8	10.1	6.1	12.7	76.3	30.7	8.7	15.7	0.6	5.0	31.7	9.2	20.2	5.3	70.0	109.6	4.7	15.4	55.2	8.1	0.9	4.8	7.9	11.3	20.3	20.4	2.3	2.3	14.4	15.1	3.6	15.9	5.0	102.3	7.0	3.5	3.3	9.9	25.8	11.3	17.6	14.5	4.5	0.1	17.0	18.7	42.9
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		73000	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	15.5	16.7	11.2	10.4	13.7	4.8	12.3	19.1	13.3	15.4	10.1	9.0	30.7	8.9	10.6	26.2	10.3	8.8	14.2	12.2	11.0	8.6	12.2	44.9	13.4	6.3	13.5	9.9	15.5	36.3	9.3	36.2	27.6	18.1	30.9	13.7	7.4	29.2	23.4	5.5	7.5	11.6	11.1	9.7	8.1	14.4	16.8	11.3	4.0	14.9	7.6	8.7	11.1	10.0	8.2	7.4	11.1	6.5	5.3	8.7	3.9	10.1	6.8	13.1	15.6	21.3	22.8	15.2	34.8	25.3	16.9	26.6	17.5	4.8	5.4	7.4	34.8	17.2	6.5	11.9	14.6	32.4	4.0	11.6	6.9	13.3	29.2	24.2	6.7	3.4	14.4	12.1	29.7	37.7	17.1	19.9	3.7	22.5	5.9	18.2	10.6	1.1	4.4	5.8	9.1	9.3	4.7	29.3	3.1	13.1	10.1	5.2	8.2	10.0	9.0	7.0	20.5	7.8	7.5	28.9	11.6	6.4	23.3	18.7	11.5	4.4	3.8	9.1	5.4	18.2	11.1	6.4	3.8	5.0	6.0	6.7	8.2	5.2	6.2	5.5	5.0	8.7	8.2	2.7	5.3	6.5	7.4	3.6	3.9	11.2	13.7	19.1	13.3	11.0	8.6	13.5	9.9	18.1	11.3	26.8	20.1	3.7	21.9	14.1	16.1	5.2	20.4	12.0	28.4	10.4	9.8	27.6	6.6	29.3	40.4	10.8	14.0	23.3	43.3	56.1	40.5	76.0	4.7	30.5	15.6	7.9	15.4	16.5	4.7	15.6	31.1	8.3	10.1	12.6	25.8	25.2	36.6	17.5	17.3	18.1	20.4	6.5	18.6	54.3	31.1	13.7	53.9	7.5	15.5	17.9
PGP		ENSG00000184207	"Phosphoglycolate phosphatase"	A6NDG6	16	2211997-2214807	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.7"	"Cell type enhanced"	"Detected in all"	13	"Cone photoreceptor cells: 380.9;Early spermatids: 399.7;Late spermatids: 977.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043096, HPA046739"	Approved		Approved	"Nuclear bodies"		NA	NA		46000	"Nuclear bodies"		"HPA043096: AB_2678311, HPA046739: AB_2679779"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.50e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.42e-4)"	5.7	7.2	10.9	7.3	12.5	9.2	3.6	31.4	21.4	3.9	6.7	4.8	7.3	7.9	4.7	6.5	3.6	3.7	4.4	15.6	11.4	9.8	6.1	5.5	6.2	7.5	9.6	12.8	2.5	6.6	8.7	6.1	6.9	17.8	5.3	5.3	4.7	6.2	6.8	40.7	5.6	7.5	4.9	6.0	8.0	6.7	23.0	7.4	5.9	8.8	7.9	5.0	4.2	2.6	1.8	1.9	6.1	3.4	0.3	2.2	0.4	9.2	15.2	10.8	10.3	4.5	3.5	20.8	10.9	5.2	10.1	10.4	23.6	11.8	7.1	10.8	5.0	8.2	15.6	7.6	9.3	4.5	9.6	21.1	7.0	23.1	10.6	3.0	12.5	11.7	4.2	4.2	9.4	3.5	3.6	6.5	11.7	12.8	7.5	5.5	25.3	14.1	20.5	14.3	5.7	14.4	23.1	9.4	15.9	8.3	5.9	14.5	8.8	9.7	18.3	7.5	8.1	13.6	14.6	6.4	10.4	13.7	9.3	10.8	17.8	7.7	10.0	3.5	11.1	8.0	0.0	2.3	6.1	2.2	3.4	0.3	0.7	1.3	1.6	1.6	1.8	0.8	1.4	1.4	0.3	3.1	1.9	1.3	0.4	10.9	12.5	31.4	21.4	11.4	9.8	9.6	12.8	17.8	7.4	6.0	8.5	13.4	7.0	20.7	194.2	37.5	12.7	1.4	5.7	38.4	380.9	102.8	49.7	8.0	399.7	21.1	46.4	23.3	12.2	86.7	22.8	21.1	10.3	30.7	50.8	136.7	28.6	19.0	30.8	977.0	23.9	41.2	33.7	8.2	22.2	54.1	10.8	24.6	26.5	28.7	225.9	38.8	21.2	167.9	61.0	27.9	45.5	23.5	34.6	14.4
PGPEP1	"Pcp, PGP, PGP-I, PGPI"	ENSG00000130517	"Pyroglutamyl-peptidase I"	Q9NXJ5	19	18340587-18369950	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035368, HPA055277"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035368: AB_10601388, HPA055277: AB_2682770"	"unprognostic (9.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.95e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.80e-4)"	"unprognostic (2.79e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (4.81e-3)"	"prognostic favorable (3.71e-8)"	"unprognostic (1.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-3)"	11.0	18.6	14.8	10.1	14.9	12.4	10.7	8.1	12.5	13.9	23.3	14.8	25.3	23.6	8.2	16.0	6.3	10.0	16.7	20.6	18.2	15.4	29.9	29.7	9.4	11.4	17.8	7.3	13.2	26.6	15.1	17.1	7.5	12.5	13.4	17.2	13.7	22.8	23.6	25.2	3.6	33.6	12.1	25.5	16.2	15.4	4.2	15.6	8.6	11.5	7.4	7.0	12.8	10.0	3.9	3.3	17.6	6.1	4.3	4.9	3.6	4.7	7.5	6.3	6.3	8.0	6.3	7.7	5.7	8.9	3.9	5.9	5.3	10.2	7.3	9.6	9.3	7.0	1.3	2.4	1.3	2.2	8.6	2.7	8.0	7.5	14.9	11.3	4.7	33.4	6.3	2.8	3.0	0.5	14.2	5.8	12.7	14.6	11.1	3.2	7.6	4.7	3.8	6.4	3.2	2.3	0.0	2.3	6.5	4.2	7.5	2.2	3.5	1.1	0.6	10.1	4.3	2.9	9.5	8.9	4.5	3.1	5.9	2.4	13.8	6.5	4.4	12.1	13.2	4.1	17.6	5.4	7.1	4.9	5.4	2.8	2.0	3.4	4.4	3.3	3.9	4.3	4.0	3.1	4.3	6.1	2.2	3.8	3.6	14.8	14.9	8.1	12.5	18.2	15.4	17.8	7.3	12.5	15.6	8.9	16.7	9.0	10.8	2.1	3.9	17.8	30.6	1.4	6.8	29.6	9.8	15.9	6.6	18.9	0.5	8.0	61.2	0.0	38.9	18.4	7.3	12.7	33.6	67.2	20.3	4.8	37.4	13.5	24.6	0.7	7.2	19.7	15.1	2.8	20.9	6.6	35.6	28.8	19.1	73.1	6.0	6.5	8.0	2.1	4.1	1.0	15.7	15.8	28.1	13.3
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 163.9"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 412.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		6000000	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	25.0	46.0	37.7	11.9	36.9	5.6	60.2	21.8	37.8	36.2	30.5	30.9	42.9	27.0	39.9	71.4	15.0	38.9	20.1	10.0	38.6	50.4	58.7	163.9	15.6	8.8	38.1	29.6	24.7	10.9	23.8	15.5	12.3	35.3	33.5	22.5	22.1	17.5	53.7	5.7	12.5	42.9	22.0	46.9	10.0	18.9	14.2	27.1	6.9	24.7	12.2	7.7	21.3	17.3	3.6	9.9	11.4	11.8	4.8	8.0	28.7	27.3	17.3	34.0	39.1	73.6	35.3	22.1	41.3	48.2	22.0	27.4	20.9	33.6	7.9	45.3	42.8	25.7	21.9	37.1	17.3	29.7	8.4	42.6	8.9	16.6	23.4	12.3	14.5	4.8	36.3	9.8	26.7	13.9	16.3	14.1	9.5	9.3	4.9	25.7	29.2	10.9	10.7	89.1	30.0	29.2	13.0	21.3	11.4	29.0	20.9	31.8	14.2	30.2	50.3	16.2	34.3	11.6	9.3	10.9	15.3	22.6	54.1	38.9	5.2	9.5	8.5	41.9	23.2	29.2	9.2	11.8	11.4	5.5	11.3	7.3	3.6	7.5	8.0	9.9	3.1	7.7	6.3	5.7	4.8	10.0	7.1	7.6	28.7	37.7	36.9	21.8	37.2	38.6	50.4	38.1	29.6	35.3	27.1	116.1	75.0	12.3	114.6	83.6	185.1	15.3	109.5	124.5	78.5	69.8	64.8	71.9	58.0	77.8	2.7	78.8	222.6	23.3	64.6	112.3	104.2	108.1	39.3	412.3	46.0	62.0	55.4	54.6	35.5	4.9	159.3	45.1	97.8	14.4	77.2	101.7	56.7	112.1	170.8	277.5	72.5	103.5	130.8	27.1	70.9	76.7	51.9	21.5	125.9	110.4
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 87.8"	"Low region specificity"	"Detected in all"							"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		64000	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	47.9	29.5	18.3	13.3	20.4	12.8	38.3	17.7	19.3	27.3	46.6	14.8	42.5	46.8	26.1	20.2	32.8	21.1	31.2	27.2	18.4	18.4	36.5	64.7	22.4	13.6	17.4	18.5	24.1	41.6	25.6	34.4	95.6	18.0	29.4	24.8	22.0	29.8	33.4	17.9	46.0	69.1	29.5	16.3	16.7	35.1	19.3	19.2	15.3	33.1	15.7	16.2	35.1	33.8	3.2	6.0	4.7	2.5	2.6	4.8	1.4	23.4	8.6	16.0	12.8	69.4	36.5	16.1	32.2	36.0	23.9	32.0	8.9	24.2	16.5	37.8	41.4	27.8	13.7	14.6	15.9	30.1	9.4	8.4	11.1	22.8	16.9	87.8	16.0	8.3	28.7	32.3	20.0	24.8	55.8	21.4	10.8	18.4	20.9	34.3	7.2	14.8	7.4	12.5	28.5	7.8	11.9	12.8	11.3	35.3	8.3	12.6	12.0	18.0	20.5	18.3	27.5	15.7	7.3	39.6	20.2	16.5	20.7	14.9	24.2	19.6	17.7	22.1	14.4	13.8	4.7	2.5	4.6	3.9	2.1	1.9	3.2	4.8	3.9	1.4	2.7	4.4	4.0	2.2	2.6	1.8	6.0	4.7	1.4	18.3	20.4	17.7	19.3	18.4	18.4	17.4	18.5	18.0	19.2	50.6	34.2	23.8	45.7	89.0	20.4	51.2	48.4	24.1	39.8	41.8	9.8	66.3	24.9	50.1	71.9	50.2	83.0	70.0	64.9	109.7	60.6	46.0	11.5	114.3	31.8	11.1	34.1	27.6	12.7	27.3	42.8	25.2	64.1	18.0	64.6	72.5	60.7	56.1	35.3	99.8	34.3	12.9	59.7	27.7	25.9	97.7	229.9	23.5	49.5	29.8
PHACTR4	"FLJ13171, PPP1R124"	ENSG00000204138	"Phosphatase and actin regulator 4"	Q8IZ21	1	28369582-28500369	"Predicted intracellular proteins"	Neurogenesis	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028985	Approved		Approved	"Plasma membrane,Intermediate filaments,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA028985: AB_10602142"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (9.65e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.26e-2)"	11.0	12.3	10.0	17.2	17.4	11.5	11.6	18.7	15.2	17.2	14.2	16.5	11.7	9.9	22.7	12.1	37.0	15.1	12.6	10.7	11.4	7.9	16.4	18.7	13.8	10.4	15.3	8.9	15.3	15.4	22.3	18.1	11.6	12.1	13.7	15.8	15.4	18.1	10.3	14.9	19.1	15.4	15.7	13.6	14.4	12.1	15.7	18.5	17.8	15.2	18.1	30.0	12.1	20.6	5.3	5.6	4.0	6.3	4.8	7.7	3.4	12.4	8.6	19.3	13.9	4.9	5.5	2.9	9.0	9.2	19.7	20.5	8.2	14.2	12.0	8.2	10.7	12.4	8.9	13.3	9.0	17.7	9.0	7.4	25.0	14.7	12.7	7.4	14.9	28.9	4.9	8.4	12.6	22.3	7.3	25.9	9.3	12.6	8.3	12.5	3.9	10.5	3.7	14.6	6.8	5.9	11.1	18.4	8.9	10.2	11.3	10.2	12.8	20.1	8.3	10.4	8.0	11.2	5.5	16.8	9.6	18.0	6.7	17.3	6.4	9.1	10.1	9.3	12.6	10.1	3.4	4.6	4.0	7.7	4.1	6.8	3.3	5.9	7.2	4.5	5.3	4.0	5.4	3.5	4.8	6.3	5.6	2.7	3.4	10.0	17.4	18.7	15.2	11.4	7.9	15.3	8.9	12.1	18.5	65.5	49.1	30.2	22.5	34.3	33.3	35.0	28.1	81.7	67.1	22.7	19.6	15.0	14.9	29.8	4.7	40.9	48.1	23.3	31.5	14.3	20.1	21.0	45.2	50.0	20.2	22.3	47.4	41.1	23.6	5.9	17.8	29.3	16.9	19.0	49.8	18.4	39.7	31.6	28.0	40.8	37.3	38.8	26.8	48.3	31.1	47.3	12.7	29.4	44.9	29.8
PHF1	"MTF2L2, PCL1, TDRD19C"	ENSG00000112511	"PHD finger protein 1"	O43189	6	33410399-33416453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031038	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031038: AB_10671365"	"unprognostic (1.96e-3)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.43e-3)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (1.72e-4)"	10.7	10.2	12.0	15.5	15.2	23.5	29.0	14.2	12.5	29.7	14.6	9.4	26.4	11.0	18.2	30.7	10.0	16.3	18.3	15.4	13.2	13.3	13.0	10.5	19.7	16.7	16.9	12.0	31.5	24.9	21.1	26.6	7.7	14.6	16.9	6.2	14.6	17.6	28.5	12.9	7.7	12.1	18.9	12.3	18.8	12.7	26.7	12.8	5.0	22.4	9.3	21.3	20.7	29.2	1.5	0.5	3.2	0.4	1.1	4.6	0.9	1.5	2.1	4.8	3.1	2.1	1.2	9.6	3.3	5.2	2.5	2.8	2.9	1.4	0.6	2.0	7.8	16.8	0.5	1.0	1.7	0.6	1.9	1.0	4.5	3.5	1.3	0.4	2.6	11.2	2.5	2.2	4.9	4.4	3.7	1.6	1.6	1.7	3.9	2.0	1.2	0.8	1.6	1.7	0.4	1.5	1.9	0.6	1.6	0.3	2.0	3.2	3.4	1.7	1.8	2.7	0.9	1.3	3.2	3.1	5.0	1.4	2.9	3.5	2.6	4.3	5.2	3.6	2.8	2.9	0.2	0.3	0.7	1.4	0.4	4.6	1.2	2.8	3.5	0.5	1.5	3.3	1.7	3.2	1.1	0.4	0.3	0.9	0.9	12.0	15.2	14.2	12.5	13.2	13.3	16.9	12.0	14.6	12.8	17.9	22.7	25.1	75.0	30.1	69.3	17.0	2.5	12.0	10.3	22.7	35.3	14.3	29.9	11.6	144.2	27.0	13.3	0.0	15.8	11.3	18.6	51.5	69.1	6.2	10.6	42.9	11.5	27.6	8.6	57.2	40.0	15.1	35.4	13.6	13.8	32.4	13.9	11.2	38.5	20.3	62.8	77.6	51.5	61.1	42.1	21.0	31.4	46.8	9.6	66.3
PHF14	KIAA0783	ENSG00000106443	"PHD finger protein 14"	O94880	7	10973336-11169630	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000538, HPA017376"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA000538: AB_1079604, HPA017376: AB_2732420"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.73e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.33e-1)"	12.5	10.9	25.0	12.4	20.4	6.4	18.4	21.4	23.8	14.0	12.7	10.7	7.2	10.3	17.9	11.0	10.6	12.4	12.6	7.7	24.7	22.1	12.2	14.8	11.3	12.0	18.5	15.5	20.2	9.8	18.4	21.4	11.0	20.0	13.9	14.3	7.1	10.0	11.5	9.3	11.3	10.1	14.9	16.2	12.9	13.3	12.0	14.9	31.5	12.7	7.6	12.9	11.9	10.6	3.9	5.8	1.6	2.0	3.4	4.6	0.8	6.7	14.1	20.7	21.4	7.3	7.1	9.9	5.3	4.5	6.5	7.1	12.5	12.2	26.4	9.8	5.0	14.3	9.5	18.4	6.3	7.1	9.5	7.0	13.0	12.5	16.3	6.7	28.8	12.4	6.4	6.8	7.5	13.8	9.0	9.3	10.4	17.2	9.4	7.7	8.7	11.4	12.8	17.3	28.2	10.1	19.3	13.3	8.3	6.7	13.2	18.5	26.0	8.2	28.0	8.9	15.4	14.9	21.2	8.5	9.0	12.0	5.7	10.3	12.1	20.9	18.5	6.3	24.5	21.1	1.6	2.0	1.2	2.9	1.8	2.3	3.9	3.2	3.7	1.2	3.4	4.6	3.8	0.1	3.4	1.6	5.8	4.1	0.8	25.0	20.4	21.4	23.8	24.7	22.1	18.5	15.5	20.0	14.9	38.7	34.5	48.8	62.8	51.1	77.9	19.4	30.6	36.1	53.4	31.4	55.0	57.8	23.2	78.4	17.7	69.7	43.4	0.0	73.0	66.3	61.3	43.8	56.4	39.4	36.4	74.7	88.5	58.9	35.9	9.5	95.3	36.0	35.4	30.7	59.7	49.5	75.4	42.1	110.0	27.0	64.0	51.8	48.4	133.9	124.4	45.8	33.3	30.5	59.7	46.9
PHF20L1	"CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B"	ENSG00000129292	"PHD finger protein 20 like 1"	A8MW92	8	132775358-132848807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025060, HPA028417"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA025060: AB_10599822, HPA028417: AB_10602278"	"unprognostic (9.12e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.83e-2)"	14.5	19.9	15.3	15.7	26.6	27.1	17.6	22.2	22.0	15.7	14.2	12.6	11.7	11.6	17.6	13.0	16.0	12.4	13.6	22.5	15.9	10.5	13.6	16.4	12.9	13.5	11.8	14.8	16.9	12.7	22.4	18.6	15.1	12.9	13.1	12.9	10.0	14.9	14.6	27.0	9.5	12.9	14.5	12.9	15.4	12.8	15.9	13.7	38.9	28.5	9.2	14.7	14.7	16.9	2.4	4.0	14.7	4.3	3.0	3.4	1.6	10.1	10.2	16.7	9.6	13.1	15.7	6.0	14.9	11.7	10.3	10.1	5.7	7.0	11.6	13.1	14.9	8.9	6.0	11.3	7.9	12.8	19.5	8.0	12.5	12.1	4.0	13.8	9.9	8.9	11.7	9.9	10.7	16.0	10.0	11.3	18.6	15.3	18.3	15.3	10.1	32.3	4.4	7.4	11.6	13.6	15.8	11.2	10.0	8.4	8.8	41.5	12.1	9.5	6.8	12.0	7.3	13.3	11.3	14.7	16.7	13.4	10.9	14.2	10.9	14.2	14.9	14.8	17.6	14.8	3.7	4.3	7.5	2.5	2.5	2.5	2.2	2.3	2.9	4.0	2.4	3.4	2.7	14.7	3.0	3.8	3.3	2.6	1.6	15.3	26.6	22.2	22.0	15.9	10.5	11.8	14.8	12.9	13.7	23.8	45.9	43.8	43.6	29.9	53.6	77.9	17.8	29.4	46.6	34.9	41.2	23.1	19.9	33.0	47.6	43.8	33.8	23.3	27.3	24.9	37.5	35.9	58.9	30.1	32.0	50.9	42.0	35.6	44.0	39.6	37.2	48.6	21.9	31.5	24.8	47.4	32.7	24.1	40.3	22.0	52.6	45.3	42.3	61.6	42.6	31.7	37.6	42.1	22.2	54.3
PHF21A	"BHC80, BM-006, KIAA1696"	ENSG00000135365	"PHD finger protein 21A"	Q96BD5	11	45929323-46121178	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 20.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 20.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023253, HPA023580"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023253: , HPA023580: AB_10962727"	"unprognostic (5.30e-3)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (2.59e-8)"	"unprognostic (1.89e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.21e-1)"	14.6	17.9	18.4	19.1	22.2	25.6	12.8	24.9	20.3	16.6	18.9	15.1	9.0	6.9	17.3	11.2	11.7	12.5	13.2	21.4	16.3	10.5	8.1	9.5	20.5	14.4	17.7	10.7	25.2	8.5	27.5	28.7	13.0	13.6	15.6	10.0	14.4	10.0	14.2	15.7	12.8	10.1	17.2	19.4	17.8	10.1	23.5	18.9	18.3	13.1	5.0	14.6	16.7	13.9	3.2	2.8	20.9	5.0	3.6	4.2	2.1	3.7	10.2	19.3	18.6	8.0	12.5	2.6	7.7	13.4	6.7	11.3	2.0	5.9	15.7	5.4	7.5	10.5	4.3	11.7	4.9	6.9	17.5	8.0	9.0	10.1	4.0	9.6	6.3	13.8	11.1	11.4	3.9	11.2	15.7	9.8	10.7	10.6	26.2	7.9	3.6	6.8	10.2	16.6	4.7	6.0	11.5	9.9	5.1	6.7	6.3	12.5	15.6	11.4	5.7	8.0	13.2	10.3	11.8	9.6	11.1	9.0	9.0	6.2	28.0	22.8	10.3	8.7	6.9	8.6	16.5	5.0	2.5	4.2	2.6	3.6	3.2	3.2	3.6	2.8	3.0	2.0	3.4	20.9	3.6	4.2	1.9	3.8	2.1	18.4	22.2	24.9	20.3	16.3	10.5	17.7	10.7	13.6	18.9	11.9	15.3	13.4	8.2	9.2	26.8	20.9	7.6	14.7	10.3	3.5	25.5	3.9	1.7	7.6	6.3	12.5	3.9	0.0	5.5	2.6	11.9	9.3	16.1	4.3	9.0	14.3	22.5	12.3	24.3	6.3	24.2	13.1	10.1	18.0	7.9	9.4	5.0	7.4	13.8	2.9	23.6	12.9	11.6	13.6	11.2	7.8	3.5	14.6	5.8	4.4
PHF21B	"BHC80L, FLJ34161, PHF4"	ENSG00000056487	"PHD finger protein 21B"	Q96EK2	22	44881162-45009999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 12.5;Cone photoreceptor cells: 21.6;Early spermatids: 12.7;Horizontal cells: 27.0;Late spermatids: 30.5;Rod photoreceptor cells: 25.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.2;AN3-CA: 7.3;JURKAT: 6.4;NTERA-2: 5.2;SCLC-21H: 6.4;SH-SY5Y: 28.4;U-2 OS: 6.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053834, HPA074665"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA053834: AB_2682276, HPA074665: "	"unprognostic (1.04e-1)"	"unprognostic (7.76e-2)"		"unprognostic (2.00e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.37e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.02e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.22e-1)"	0.7	3.5	8.4	0.8	7.4	0.5	0.8	3.7	10.9	10.1	0.7	3.6	0.9	0.7	8.6	1.7	1.6	2.3	0.8	1.3	7.8	3.4	2.2	0.5	0.6	0.6	4.7	3.2	5.6	1.8	2.0	17.9	0.6	4.2	4.8	0.6	6.5	0.8	2.1	0.7	0.5	0.7	2.3	4.4	0.6	1.0	8.5	7.3	0.0	3.0	0.0	0.6	0.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	7.3	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	1.5	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.2	0.4	0.0	0.0	6.4	0.0	0.0	0.1	0.6	0.9	0.0	5.2	0.0	0.3	0.0	1.9	0.1	0.0	0.1	6.4	28.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.1	6.4	0.0	0.2	0.3	0.0	3.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	7.4	3.7	7.3	7.8	3.4	4.7	3.2	4.2	7.3	0.0	0.0	0.0	0.8	0.1	12.5	1.3	0.0	1.4	0.0	0.0	21.6	0.0	1.7	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	27.0	0.0	0.0	0.0	30.5	0.6	0.0	0.0	0.0	0.0	4.6	0.1	0.0	1.8	0.0	25.4	0.0	0.0	0.7	3.4	0.0	0.0	0.0	0.0	0.1
PHF3		ENSG00000118482	"PHD finger protein 3"	Q92576	6	63635820-63779336	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024676, HPA025763"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024676: AB_10599736, HPA025763: AB_10600987"	"unprognostic (4.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.37e-1)"	23.7	19.6	17.1	22.9	20.0	33.0	23.5	44.4	19.4	32.6	23.5	9.4	21.9	14.9	22.7	23.4	18.8	16.9	15.9	16.2	19.1	13.3	19.5	26.7	21.0	21.5	20.0	18.5	34.1	17.4	30.3	43.5	23.0	18.7	25.6	17.5	8.5	19.1	21.5	24.5	19.4	19.2	18.1	26.8	21.9	17.1	16.8	24.9	36.3	26.0	12.9	16.9	30.5	26.6	10.3	7.5	16.2	11.5	5.5	12.2	4.5	19.4	9.4	16.3	9.5	16.5	17.5	16.0	12.8	18.4	9.6	13.0	13.0	9.1	23.8	11.1	11.4	14.0	8.6	15.6	13.5	16.2	18.9	12.7	28.5	12.1	20.6	14.7	24.3	11.6	12.6	12.1	13.7	19.7	17.2	11.2	12.8	31.0	22.5	9.8	11.5	10.3	13.0	9.2	12.7	5.8	18.2	14.6	11.3	11.6	11.6	17.5	13.0	15.4	6.9	11.4	18.6	11.9	22.5	15.7	14.9	17.7	11.3	15.2	19.0	19.8	22.8	6.8	19.5	11.4	14.4	6.8	7.3	9.0	8.9	8.9	8.4	8.5	7.0	6.0	10.3	12.2	8.9	16.2	5.5	11.5	7.5	5.9	4.5	17.1	20.0	44.4	19.4	19.1	13.3	20.0	18.5	18.7	24.9	145.9	104.5	56.7	61.6	48.8	64.2	90.4	33.1	103.1	129.7	43.6	45.2	38.2	13.3	36.1	24.3	50.4	43.4	23.3	32.7	26.7	39.3	56.1	97.4	41.4	24.8	47.7	41.3	30.7	43.8	20.2	75.1	40.6	21.9	35.1	41.1	50.4	28.8	39.5	53.4	29.6	63.6	58.2	33.0	87.4	63.1	37.5	26.1	46.8	42.8	35.3
PHF7	"HSPC226, NYD-SP6"	ENSG00000010318	"PHD finger protein 7"	Q9BWX1	3	52410657-52423641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 260.7"	"Group enriched"	"Detected in many"	45	"Early spermatids: 2196.1;Late spermatids: 5962.4;Spermatocytes: 1575.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.1;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA036283, HPA070305"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA036283: AB_10795026, HPA070305: AB_2686248"	"prognostic favorable (7.38e-5)"	"unprognostic (4.57e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (9.44e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.61e-3)"	"unprognostic (7.44e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (2.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.34e-2)"	"unprognostic (6.79e-2)"	0.9	0.6	0.3	0.6	1.5	0.8	0.9	1.0	1.4	0.5	1.0	1.2	0.4	0.7	0.5	2.0	0.6	0.6	0.4	1.9	0.6	0.4	0.6	0.9	0.6	0.5	1.1	0.7	0.4	0.9	0.6	0.5	0.5	0.7	0.7	1.0	1.2	1.0	0.7	1.5	1.0	1.0	0.5	0.9	0.7	0.6	260.7	0.4	1.7	0.5	0.6	0.6	0.9	0.5	6.7	2.6	3.9	2.5	2.2	4.9	1.7	2.0	0.6	1.5	6.4	1.1	1.6	2.7	2.0	2.1	1.6	2.0	1.0	0.8	3.4	0.2	1.5	1.0	1.1	1.1	3.2	2.8	4.1	1.5	3.8	0.4	2.3	1.1	4.2	7.2	0.9	3.6	1.5	3.4	0.5	2.3	7.8	2.3	14.1	1.2	0.9	4.9	1.6	0.7	0.6	4.3	2.2	1.4	4.1	1.7	0.9	1.1	1.2	1.8	0.1	1.6	2.0	0.9	2.1	1.7	2.7	1.9	2.9	4.1	16.7	8.0	2.0	1.1	9.7	1.6	0.7	2.2	3.9	2.1	2.5	2.5	6.7	2.5	3.7	1.1	3.8	1.7	3.5	0.5	2.2	1.4	2.6	4.9	1.7	0.3	1.5	1.0	1.4	0.6	0.4	1.1	0.7	0.7	0.4	3.0	2.9	5.6	4.6	4.0	10.6	7.0	2.5	6.7	0.0	7.0	7.9	3.0	11.6	2.4	2196.1	2.9	8.4	0.0	2.5	1.7	2.9	1.7	6.9	4.0	3.7	12.7	11.1	1.8	4.3	5962.4	71.4	2.6	8.5	2.8	3.3	6.5	3.1	0.0	59.4	5.5	15.7	51.8	3.9	1575.4	63.9	2.6	0.5	4.4	11.8	2.2
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744226	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 99.3"	"Low region specificity"	"Detected in all"							"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		9000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	18.8	1.9	33.3	4.4	32.1	4.4	13.8	7.8	27.2	11.9	5.8	49.7	9.4	4.2	6.1	41.0	16.7	24.5	3.9	5.3	26.7	20.5	14.0	53.2	4.3	5.7	42.0	20.7	17.3	58.2	67.5	5.7	6.4	23.3	24.5	4.7	8.7	62.9	16.4	1.7	35.9	3.0	8.1	28.3	1.9	9.0	8.6	38.1	9.9	15.8	7.3	7.3	7.9	14.1	6.7	3.2	2.9	0.7	1.2	16.5	3.2	13.6	5.6	14.6	35.0	8.4	11.0	27.2	12.3	22.3	17.7	29.3	28.8	2.4	0.0	5.4	33.0	1.9	18.4	27.0	25.7	12.5	0.1	24.6	4.3	19.6	19.9	17.3	27.5	0.1	15.8	43.0	16.9	20.0	9.9	12.7	48.8	7.9	32.6	7.8	53.5	18.4	8.4	36.4	10.6	42.5	16.2	25.3	2.3	1.2	16.2	15.7	14.4	9.0	6.1	99.3	13.9	12.3	47.0	0.1	2.9	15.3	17.9	13.8	26.9	6.7	27.5	35.8	38.5	22.7	2.9	0.7	0.2	2.9	0.2	0.2	6.7	1.8	4.9	3.2	2.7	9.1	16.5	2.0	1.2	0.2	1.8	2.4	3.2	33.3	32.1	7.8	27.2	26.7	20.5	42.0	20.7	23.3	38.1	3.0	9.3	9.7	92.1	46.0	0.8	2.0	84.1	21.4	7.9	19.2	2.0	32.1	114.4	48.9	40.9	3.3	0.2	0.0	120.7	43.3	25.5	86.4	5.7	90.0	8.0	0.0	1.7	2.5	1.3	81.6	62.7	4.8	54.0	19.0	1.1	79.1	39.9	2.5	120.2	80.4	2.9	12.9	16.0	5.2	3.4	67.4	21.2	5.0	1.5	39.9
PHGR1		ENSG00000233041	"Proline, histidine and glycine rich 1"	C9JFL3	15	40351033-40356434	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 308.0;lymphoid tissue: 83.6"	"Cell type enhanced"	"Detected in some"	30	"Enterocytes: 27312.8;Mucus-secreting cells: 5830.8;Paneth cells: 7178.6;Undifferentiated cells: 3711.5"	"Group enriched"	"Detected in many"	16	"colorectal cancer: 248.3;stomach cancer: 94.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 136.7"									HPA068787	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA068787: AB_2686035"	"prognostic favorable (2.05e-4)"		"unprognostic (1.73e-1)"				"unprognostic (5.18e-2)"				"unprognostic (1.18e-1)"	"unprognostic (2.80e-1)"		"unprognostic (1.20e-1)"			"unprognostic (1.27e-2)"	0.3	0.1	0.3	83.6	0.3	0.0	0.6	0.3	0.3	0.3	245.3	0.3	0.3	77.9	0.3	0.3	0.4	0.5	4.1	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.4	32.9	0.3	0.4	0.3	0.3	0.3	308.0	1.3	0.3	0.3	15.1	0.3	0.3	0.3	0.3	0.3	0.3	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	136.7	0.0	0.0	0.0	1.7	0.0	0.2	10.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	193.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27312.8	0.0	0.2	0.0	0.0	1.8	220.4	0.0	0.0	0.0	1865.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5830.8	0.0	2.9	7178.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3711.5	0.9
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Muscle protein"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 57.4"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001081, HPA075355"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001081: AB_1079607, HPA075355: "	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	2.7	10.3	3.8	1.9	7.2	0.7	3.4	3.2	3.5	2.2	2.1	2.0	7.8	1.0	2.7	4.7	4.8	2.8	2.6	5.5	3.0	3.0	2.1	1.8	1.6	1.0	4.2	1.6	5.8	4.2	16.9	14.2	1.8	4.7	4.3	2.5	6.5	6.8	5.1	57.4	2.5	1.3	3.4	3.1	2.3	3.7	3.5	2.7	0.8	6.5	12.6	2.8	3.1	3.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	8.6	12.2	0.7	7.3	4.3	4.1	7.6	1.6	1.5	0.3	0.1	3.5	7.7	0.0	4.9	0.2	8.9	3.4	14.4	5.9	0.4	22.1	14.7	4.0	9.9	3.2	4.5	0.0	0.0	5.5	6.0	1.4	9.9	7.4	8.4	7.3	6.1	0.0	7.9	6.2	6.2	0.4	9.6	14.3	16.3	0.0	0.0	0.0	2.2	4.1	7.6	9.0	7.7	10.1	0.1	9.5	3.6	0.3	4.3	0.0	3.7	1.5	4.2	10.1	9.4	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	7.2	3.2	2.9	3.0	3.0	4.2	1.6	4.7	2.7	0.0	3.0	0.0	4.0	2.2	1.8	5.6	2.5	6.7	2.3	10.4	7.9	0.8	0.0	1.5	0.3	3.5	0.5	0.0	2.2	0.9	0.5	8.7	5.8	1.5	1.3	3.2	2.4	6.2	6.0	0.0	2.8	0.2	1.7	0.0	2.0	1.3	4.4	0.0	8.1	1.1	2.9	0.0	1.3	0.0	0.7	3.0	0.5	0.0	2.4	7.0
PHKA2	"PHK, PYK"	ENSG00000044446	"Phosphorylase kinase regulatory subunit alpha 2"	P46019	X	18892300-18984598	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002912	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA002912: AB_10961321"	"unprognostic (3.90e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.07e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.16e-2)"	"prognostic favorable (2.96e-5)"	9.5	8.6	4.0	9.8	8.3	10.8	7.9	10.9	5.9	8.7	7.7	7.8	4.5	10.1	8.5	5.4	5.8	8.3	10.9	8.6	4.2	3.7	6.2	29.4	5.4	14.1	7.1	3.6	14.5	13.1	8.8	16.9	11.6	6.9	8.3	5.2	9.5	7.4	12.4	6.0	6.9	10.1	4.9	6.6	8.5	6.9	12.4	5.4	29.6	9.2	3.4	9.1	7.2	10.4	3.0	3.2	9.9	5.6	4.2	3.4	2.6	8.4	7.9	4.6	7.7	6.3	5.9	13.0	3.7	3.1	5.4	6.0	8.3	5.5	9.8	2.8	4.7	8.6	7.8	8.3	9.5	5.9	4.9	8.7	11.8	12.3	10.0	4.5	11.0	15.2	9.8	6.4	6.6	9.6	9.0	5.6	10.4	3.9	6.1	3.7	8.6	11.5	18.4	5.7	3.8	8.7	9.2	9.6	10.9	3.5	3.7	4.0	6.2	11.3	11.5	5.0	16.2	14.4	6.4	9.9	7.4	4.3	7.9	5.7	6.0	5.0	7.5	4.2	6.0	4.0	5.1	4.6	9.9	3.2	5.6	3.4	2.5	2.6	2.3	3.2	3.0	3.2	3.0	8.2	4.2	3.6	1.7	3.2	2.6	4.0	8.3	10.9	5.9	4.2	3.7	7.1	3.6	6.9	5.4	8.9	14.6	6.2	5.3	5.8	9.7	19.0	15.3	1.4	4.5	8.7	9.8	14.3	0.0	5.1	4.3	5.8	7.7	23.3	4.4	14.6	5.1	5.9	1.1	44.0	6.8	4.8	4.1	19.0	17.6	4.7	6.9	6.4	5.0	1.0	6.5	23.5	6.5	9.5	7.4	3.9	12.4	0.0	3.4	5.4	7.2	4.1	8.8	4.6	11.9	3.3
PHKB		ENSG00000102893	"Phosphorylase kinase regulatory subunit beta"	Q93100	16	47461123-47701523	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA073380			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA073380: AB_2686598"	"unprognostic (2.87e-3)"	"unprognostic (2.41e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.98e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (3.89e-9)"	"unprognostic (3.56e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (2.53e-2)"	16.9	31.7	11.1	18.1	16.0	11.6	20.6	13.3	16.6	17.2	19.5	16.8	19.5	17.3	22.8	17.6	20.5	12.3	17.0	22.6	11.5	12.4	22.8	16.6	17.0	11.5	14.3	13.0	14.6	21.8	30.0	25.7	17.1	19.9	18.1	19.9	16.1	25.3	21.1	65.6	9.8	24.2	27.0	14.0	17.6	18.5	16.1	10.2	25.2	25.6	23.4	16.3	15.6	15.3	23.1	14.6	12.6	15.6	12.4	11.8	8.7	13.9	20.6	23.7	15.6	16.6	15.8	29.7	16.6	16.1	12.0	6.0	11.2	24.2	16.9	25.1	24.0	9.4	19.8	22.2	25.8	16.9	5.2	11.7	16.0	18.5	37.5	14.8	17.3	19.1	14.1	13.2	8.0	15.1	25.8	23.2	20.8	22.0	10.8	17.2	9.9	16.7	17.1	10.0	23.3	15.8	28.8	29.0	28.5	23.9	12.0	12.5	14.3	27.3	36.6	4.5	27.2	14.0	14.4	25.6	21.8	10.3	11.0	8.7	12.3	9.0	21.9	13.8	11.8	9.0	7.1	15.0	12.6	9.0	13.4	11.8	23.1	9.5	7.3	14.6	23.1	9.5	9.1	7.8	12.4	15.6	10.0	11.0	8.7	11.1	16.0	13.3	16.6	11.5	12.4	14.3	13.0	19.9	10.2	17.9	33.1	36.9	14.7	7.9	32.4	53.8	35.7	20.1	43.3	40.1	94.2	38.8	19.9	17.4	51.2	33.8	39.9	0.0	13.7	21.6	20.6	31.2	17.4	28.1	24.9	22.3	29.3	38.6	50.7	63.4	23.6	27.8	8.5	62.3	34.8	34.7	23.3	20.1	33.6	32.3	71.2	25.8	13.7	50.7	13.0	6.4	28.3	20.3	33.7	23.8
PHLDB1	"FLJ00141, KIAA0638, LL5a"	ENSG00000019144	"Pleckstrin homology like domain family B member 1"	Q86UU1	11	118606440-118658038	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 68.1;Late spermatids: 60.6;Leydig cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 39.2;ASC TERT1: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037959, HPA038448, HPA061506"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			Nucleoplasm	"Mitotic spindle"	"HPA037959: AB_10673651, HPA038448: AB_10697390, HPA061506: AB_2684545"	"unprognostic (7.81e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.36e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.36e-6)"	"unprognostic (7.09e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.44e-1)"	40.5	7.4	19.6	9.5	52.2	0.9	19.0	4.6	30.8	25.0	10.7	87.0	3.6	8.1	22.0	9.6	8.2	18.7	18.5	20.8	22.4	11.8	9.6	2.8	13.7	4.0	47.0	19.9	21.4	18.9	4.9	4.5	20.8	26.9	9.4	5.9	8.0	7.1	14.6	10.0	9.2	8.8	16.0	27.6	10.2	7.9	7.0	51.0	0.0	10.7	5.4	2.3	10.8	11.6	0.5	0.4	2.1	0.3	1.9	0.7	0.1	1.6	2.6	10.5	5.1	39.2	39.8	3.7	7.8	9.6	4.6	2.7	3.9	11.4	0.0	14.7	15.6	6.2	6.6	2.3	16.0	0.7	0.2	1.5	3.0	1.9	1.9	10.1	0.0	5.7	20.7	3.5	6.4	4.4	10.4	13.1	0.2	2.6	0.1	5.9	1.2	0.0	0.1	3.7	0.1	1.3	0.4	2.7	0.2	4.6	2.4	2.4	5.2	19.9	1.7	5.5	4.2	7.3	0.9	16.0	9.5	8.6	4.8	6.2	0.0	0.0	0.0	2.7	0.5	10.7	0.5	0.3	0.4	0.2	0.0	0.3	0.2	0.3	0.7	0.0	0.5	0.7	0.5	2.1	1.9	0.2	0.4	0.2	0.1	19.6	52.2	4.6	30.8	22.4	11.8	47.0	19.9	26.9	51.0	6.0	13.6	0.9	8.3	16.4	3.5	3.9	0.0	0.0	10.3	29.6	0.0	0.9	0.0	9.1	68.1	25.1	16.5	0.0	3.9	1.3	32.9	5.0	1.1	0.6	5.0	3.2	8.1	31.3	3.5	60.6	62.2	7.0	11.8	3.6	21.4	6.7	15.4	28.1	41.8	5.7	1.8	38.8	45.5	7.4	5.8	8.0	1.3	2.2	13.5	2.1
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 48.5;Urothelial cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (4.11e-5)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	2.7	8.5	6.6	11.7	5.9	3.6	6.0	2.1	5.2	8.7	4.8	1.8	7.1	5.8	8.8	6.5	28.4	7.3	15.9	4.5	5.2	2.9	4.8	9.6	4.0	7.8	3.5	5.8	9.5	7.7	6.8	7.9	6.4	3.2	11.7	2.2	6.7	11.1	7.6	9.0	28.7	9.4	7.5	3.0	6.4	5.4	18.7	3.0	12.2	5.7	15.2	23.2	9.3	14.8	4.4	8.1	0.9	3.3	2.6	5.5	2.3	5.3	5.6	2.3	5.8	2.1	4.4	15.2	3.8	3.4	3.8	2.7	5.7	5.6	3.2	12.1	2.3	3.0	6.2	1.7	6.7	0.7	7.5	5.3	3.5	5.3	6.8	5.3	1.3	6.8	3.7	8.5	4.1	2.5	3.0	3.4	8.0	6.2	4.9	1.9	8.3	5.4	0.3	1.4	12.7	4.6	6.4	3.1	2.1	1.8	18.0	0.1	5.1	4.9	10.7	4.6	1.5	7.6	4.5	4.3	2.5	6.6	3.0	3.6	12.6	13.7	3.5	2.3	2.6	4.1	0.3	3.3	0.5	4.0	2.3	2.9	3.7	3.7	3.0	6.9	4.4	5.5	4.8	0.9	2.6	0.2	8.1	3.6	2.3	6.6	5.9	2.1	5.2	5.2	2.9	3.5	5.8	3.2	3.0	0.0	1.7	13.7	24.7	25.8	1.0	1.7	7.6	10.7	2.3	8.7	0.0	18.0	1.7	4.8	7.6	5.0	6.4	0.0	2.1	4.1	8.5	20.4	5.7	9.5	3.2	0.0	2.9	4.9	3.7	7.4	3.4	4.1	5.0	5.4	3.9	3.7	2.4	3.1	3.2	5.5	1.8	6.5	15.5	20.7	5.3	33.5	48.5	6.9	3.3	40.7
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 29.9"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 98.2;Enterocytes: 51.9;Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	No			Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	6.4	4.7	12.5	7.0	10.9	8.1	8.4	17.4	14.9	4.4	16.6	4.6	4.3	15.8	5.8	4.9	2.7	4.7	4.1	4.6	11.7	9.0	5.4	4.9	4.8	5.0	6.2	14.9	7.2	4.9	10.2	7.3	4.3	12.6	4.7	17.8	13.2	2.9	5.7	5.3	3.0	29.9	7.0	7.6	3.9	4.2	10.8	4.7	1.0	9.9	1.1	4.9	4.7	9.8	2.4	2.2	1.2	0.7	3.5	1.5	0.4	4.9	6.5	7.1	7.9	5.7	6.9	4.1	7.4	6.7	10.7	8.8	5.9	1.6	9.8	2.9	12.2	7.7	10.5	10.2	3.8	13.9	3.4	5.5	2.7	5.6	3.9	4.5	2.3	4.3	5.1	2.2	15.2	5.0	4.5	4.0	3.4	2.4	2.7	7.4	10.4	3.2	1.8	5.5	1.5	1.7	5.1	6.2	3.2	5.1	3.8	6.2	3.3	15.9	4.4	2.6	5.7	5.4	1.4	5.5	10.8	7.8	4.5	6.1	6.1	4.3	10.1	6.7	1.9	2.4	0.8	0.5	0.2	1.0	0.7	0.9	2.4	0.8	1.5	0.6	1.6	1.1	0.9	1.2	3.5	0.7	2.2	1.3	0.4	12.5	10.9	17.4	14.9	11.7	9.0	6.2	14.9	12.6	4.7	8.9	2.1	5.2	4.7	8.2	18.7	2.3	0.0	2.7	4.5	3.5	98.2	3.8	0.0	2.4	9.7	3.7	51.9	0.0	2.0	0.3	7.2	5.0	10.3	3.9	1.3	22.3	5.8	3.1	5.4	3.6	4.9	2.2	13.5	2.8	6.7	6.3	2.8	31.6	4.9	4.3	60.3	6.5	5.6	29.1	18.3	8.0	1.1	3.5	7.2	2.1
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase"	Q8TCT1	17	49223362-49230766	"Enzymes, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 80.0;testis: 52.3"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1098.7"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 10.2;pons and medulla: 8.2"	"Group enriched"	"Detected in some"	171	"eosinophil: 30.6;neutrophil: 80.0"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 80.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.6;EFO-21: 5.8;HDLM-2: 6.1;SuSa: 8.9"	"Low region specificity"	"Detected in all"							HPA065025			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	1.1	2.9	1.9	15.3	0.7	1.0	10.2	0.6	0.6	0.2	0.2	2.5	0.9	2.7	0.9	1.3	2.1	1.0	1.7	1.3	1.0	0.9	2.5	2.0	2.1	1.5	1.1	1.0	0.1	0.8	7.6	8.2	0.9	0.0	1.6	0.9	0.5	2.2	1.1	2.6	0.3	1.5	12.6	0.7	52.3	0.1	0.0	0.8	0.1	0.1	1.4	1.3	0.0	0.0	80.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	2.0	0.1	0.2	0.0	0.3	0.4	0.0	0.1	2.7	0.0	8.6	5.8	0.0	3.3	0.0	1.6	0.5	0.1	6.1	0.2	1.2	1.1	0.4	0.0	0.0	1.1	0.4	0.0	0.6	0.0	0.6	0.0	1.1	0.0	0.0	0.6	0.1	0.0	0.4	0.0	0.3	1.6	1.7	3.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	8.9	0.2	0.1	3.5	0.4	2.8	1.9	0.0	0.2	0.3	0.6	2.5	3.3	0.3	0.0	0.1	30.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.0	0.0	0.3	0.0	0.0	0.1	1.1	1.9	1.0	10.2	1.7	1.3	2.1	1.5	8.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	185.3	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.6	0.0	1098.7	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.6	0.0	0.4	0.0	0.0	8.2	3.8	0.0	198.7	0.0	0.0	0.0
PHOSPHO2	MGC22679	ENSG00000144362	"Phosphatase, orphan 2"	Q8TCD6	2	169694454-169701708	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034726, HPA034727"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA034726: AB_10602191, HPA034727: AB_2674302"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (4.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.53e-2)"	8.7	4.0	9.0	5.7	9.7	3.3	14.2	14.2	7.8	8.4	8.2	5.8	6.3	8.2	8.6	5.9	4.6	8.1	6.2	5.7	6.7	5.5	7.5	5.0	4.3	3.6	6.0	9.1	8.2	8.9	10.9	21.3	3.9	7.8	17.4	7.8	6.4	10.5	7.8	6.4	5.2	7.9	6.2	9.7	3.4	6.3	25.4	8.0	5.5	13.0	3.9	3.9	9.1	5.7	8.8	4.6	1.5	1.0	10.5	5.7	1.8	5.7	1.6	4.1	5.6	7.9	2.5	16.3	2.5	1.7	3.9	4.4	5.6	4.4	5.6	5.6	1.9	8.1	4.5	5.5	3.0	3.2	8.3	6.4	5.6	4.9	9.6	5.2	4.5	5.1	4.6	5.8	4.5	6.0	3.3	3.5	8.0	9.2	5.8	2.4	5.3	3.1	5.9	5.6	3.7	2.1	3.2	2.5	4.3	6.2	17.3	17.5	6.0	5.4	2.8	6.0	5.2	7.5	2.8	2.0	4.3	4.1	4.0	2.7	5.6	5.2	5.0	5.1	2.8	4.5	0.0	0.9	1.1	3.9	1.0	5.5	6.8	4.3	3.7	1.0	8.8	5.7	5.6	1.5	10.5	0.9	4.6	4.4	1.8	9.0	9.7	14.2	7.8	6.7	5.5	6.0	9.1	7.8	8.0	3.0	2.2	2.7	9.2	2.3	8.7	2.8	2.5	13.4	1.2	3.5	5.9	8.6	8.3	5.9	91.4	4.5	5.9	0.0	9.9	8.8	3.0	7.0	0.0	2.8	2.5	6.4	14.5	2.5	0.0	23.3	4.4	1.9	3.3	1.0	8.2	5.2	6.7	8.4	4.6	9.8	10.2	0.0	5.1	27.9	11.7	3.8	4.6	4.3	8.1	4.3
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		430000	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	15.8	26.4	31.5	12.1	28.0	11.7	15.3	14.7	27.2	19.2	15.7	18.5	13.7	14.7	11.2	21.7	13.7	21.1	14.2	59.1	22.7	19.3	18.4	12.6	12.1	12.7	27.0	21.0	13.7	46.5	15.6	21.2	14.7	20.8	20.2	11.6	14.1	30.5	22.6	86.0	9.2	16.3	16.9	24.3	10.3	13.4	13.8	18.6	7.5	20.7	19.8	10.4	12.0	9.8	24.9	48.8	3.3	35.4	20.0	24.3	32.1	7.1	52.0	29.7	18.9	19.2	34.9	43.7	16.6	21.2	20.3	18.1	18.9	16.3	15.2	20.2	20.5	24.3	18.9	6.4	37.5	6.4	13.6	13.2	4.8	34.2	41.5	23.9	9.5	19.5	43.5	30.9	11.6	14.0	18.4	26.6	11.9	11.5	14.1	31.4	40.6	13.8	20.0	23.5	47.6	22.4	11.5	13.0	25.1	32.1	11.9	14.6	13.8	17.9	21.0	8.6	14.8	15.9	26.4	21.6	42.5	13.2	11.7	15.3	9.4	9.1	9.3	24.0	6.9	25.4	2.9	35.4	3.3	24.3	34.2	20.9	24.9	21.1	21.9	37.5	16.5	15.0	21.3	1.7	20.0	24.0	48.8	22.9	32.1	31.5	28.0	14.7	27.2	22.7	19.3	27.0	21.0	20.8	18.6	89.3	132.7	80.4	156.2	133.5	37.9	336.8	191.1	136.5	125.1	205.9	21.6	300.5	633.3	164.3	214.6	110.1	411.5	70.0	220.3	372.9	227.8	244.3	120.2	179.9	249.5	63.5	254.7	94.5	103.8	640.4	189.8	148.3	317.2	367.9	241.4	126.9	202.0	354.2	210.0	509.4	53.8	84.1	248.0	93.6	149.9	141.4	220.8	93.5	262.8	160.3
PHTF1	PHTF	ENSG00000116793	"Putative homeodomain transcription factor 1"	Q9UMS5	1	113696831-113759489	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 138.9;Late spermatids: 106.5;Spermatocytes: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059486			Approved	"Nucleoli,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoli	"HPA059486: "	"unprognostic (1.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	6.5	10.4	11.5	7.9	8.6	19.5	11.8	31.6	15.1	7.1	5.4	4.0	7.6	4.5	6.6	9.6	3.4	13.1	8.8	8.2	10.1	12.4	8.9	10.1	10.8	11.9	8.2	12.9	4.0	8.2	15.3	20.9	8.5	10.4	5.8	6.5	8.2	5.2	6.9	5.5	2.4	4.9	8.4	6.4	10.5	8.0	33.8	6.6	3.4	6.1	2.4	7.7	8.1	6.3	3.0	4.5	6.0	2.6	4.3	5.7	1.7	12.8	6.7	19.1	10.1	9.5	8.6	5.0	11.8	15.7	10.6	17.4	7.3	10.4	3.7	16.8	8.2	7.8	7.1	7.2	4.7	12.2	15.2	7.2	8.9	14.1	8.4	7.9	10.9	12.6	7.2	1.3	14.2	3.1	15.4	19.5	0.0	5.3	17.1	12.8	19.0	0.1	11.0	15.1	4.8	10.9	11.5	28.7	7.4	17.0	5.6	13.5	12.4	13.2	6.5	7.0	10.4	2.6	8.9	20.6	8.4	11.6	15.4	11.4	23.9	24.2	6.9	20.6	9.5	22.7	3.0	2.6	4.9	3.0	1.3	2.3	3.0	3.7	3.7	4.5	1.6	0.1	2.6	6.0	4.3	1.7	3.0	5.7	1.7	11.5	8.6	31.6	15.1	10.1	12.4	8.2	12.9	10.4	6.6	6.0	10.9	21.0	6.3	2.2	28.1	7.4	15.3	49.5	10.3	5.2	51.1	17.2	8.3	9.9	138.9	17.6	2.7	23.3	18.2	7.7	11.1	7.1	20.8	7.6	10.9	27.0	18.4	9.2	13.2	106.5	7.5	9.8	5.0	10.8	2.7	5.3	15.5	0.0	8.5	5.4	45.4	0.0	11.4	106.3	31.1	1.5	22.1	18.7	2.9	6.5
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 18.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012312: AB_2668649"	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (5.53e-2)"	7.5	4.5	5.6	15.1	8.6	7.7	5.9	8.7	10.3	7.0	5.9	8.9	5.3	3.2	7.3	4.6	6.4	5.7	7.8	9.1	7.0	5.2	5.4	4.7	6.8	13.7	7.0	6.3	7.4	4.7	27.7	8.2	11.4	9.3	5.9	5.1	4.7	5.7	6.9	67.0	5.5	7.8	8.5	8.2	12.1	4.7	9.1	5.8	9.2	5.7	18.2	15.5	7.9	6.3	6.7	2.1	9.2	18.2	3.8	6.2	2.0	15.2	7.0	9.6	19.5	8.4	9.3	8.0	27.0	24.7	16.2	18.4	11.9	12.4	13.7	2.2	20.9	17.6	12.7	13.7	7.0	23.1	9.2	10.9	5.6	7.7	3.5	9.2	7.4	15.5	5.5	6.7	9.4	14.2	10.4	5.7	7.7	9.1	24.4	17.2	9.6	6.0	4.8	8.7	4.3	8.3	6.1	19.5	11.2	4.4	20.6	9.3	13.0	15.1	17.2	9.8	14.8	18.2	5.8	5.7	27.9	15.0	15.6	15.8	11.5	13.4	17.1	8.8	12.0	24.0	9.2	2.1	3.4	1.5	9.2	3.0	6.7	4.7	1.4	2.1	4.2	1.4	1.5	1.2	3.8	18.2	1.0	6.2	2.0	5.6	8.6	8.7	10.3	7.0	5.2	7.0	6.3	9.3	5.8	6.0	17.5	23.8	17.3	14.2	7.8	21.5	15.3	9.4	9.1	7.0	11.8	11.2	0.0	4.0	10.8	9.0	5.3	0.0	5.8	7.0	14.7	6.5	37.1	4.3	10.4	3.2	5.2	23.4	33.1	4.4	11.2	29.4	10.1	1.8	6.0	4.0	6.0	5.8	12.7	1.8	9.3	12.9	12.8	22.9	32.2	15.6	12.4	35.5	4.5	20.4
PHYHD1	MGC16638	ENSG00000175287	"Phytanoyl-CoA dioxygenase domain containing 1"	Q5SRE7	9	128920895-128942041	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 101.2;Muller glia cells: 104.5;Proximal tubular cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.4;ASC TERT1: 15.3;BEWO: 23.4;HSkMC: 13.1;RPTEC TERT1: 35.3"					"Low region specificity"	"Detected in many"			HPA012115			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA012115: AB_1859448"	"unprognostic (1.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.38e-10)"	"unprognostic (1.10e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.83e-3)"	14.4	11.4	20.3	3.9	15.7	5.9	20.0	8.5	14.0	31.1	8.3	16.3	31.9	2.3	14.2	29.7	16.3	18.5	12.7	14.9	18.4	13.6	25.0	35.9	14.4	5.6	16.9	11.2	24.3	29.9	12.4	6.3	7.3	16.4	16.9	3.2	29.4	29.4	30.2	17.5	25.4	4.3	13.7	25.8	5.5	11.9	9.0	17.7	3.1	30.2	6.6	8.1	9.9	9.8	3.5	13.9	1.1	0.7	2.6	2.5	0.6	0.1	0.2	0.1	0.4	21.4	15.3	23.4	1.6	0.0	1.5	2.7	0.8	0.2	0.3	0.2	1.3	0.1	0.3	0.1	0.1	1.4	0.2	2.4	0.0	3.1	7.7	7.0	0.3	0.3	13.1	0.5	0.2	0.1	0.0	0.1	0.1	0.2	0.5	10.9	0.5	0.2	1.0	7.6	0.1	0.2	9.0	4.3	0.2	35.3	0.3	0.5	0.2	0.2	0.1	0.1	5.4	2.1	0.7	0.5	0.3	1.0	0.3	0.2	0.2	0.4	8.9	0.2	0.2	0.3	1.1	0.6	0.5	1.6	0.7	0.6	3.5	0.8	0.7	1.8	1.2	2.3	2.5	1.1	2.6	0.6	13.9	0.4	0.6	20.3	15.7	8.5	14.0	18.4	13.6	16.9	11.2	16.4	17.7	29.8	26.4	3.6	47.1	19.6	7.5	18.2	10.2	14.7	40.9	31.4	27.5	46.7	101.2	7.6	0.3	4.3	0.0	0.0	13.8	24.1	20.5	15.1	0.0	70.6	8.7	3.2	1.2	38.1	2.2	1.3	63.6	2.5	11.8	0.0	2.6	104.5	17.8	0.0	62.2	114.6	61.9	51.8	14.1	0.9	2.8	21.2	25.9	2.5	1.1	26.5
PHYHIPL	"Em:AC025038.1, KIAA1796"	ENSG00000165443	"Phytanoyl-CoA 2-hydroxylase interacting protein like"	Q96FC7	10	59176590-59247774	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.3"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 131.3;Early spermatids: 143.9;Horizontal cells: 136.7;Late spermatids: 172.3;Muller glia cells: 208.8;Spermatocytes: 91.0"	"Group enriched"	"Detected in many"	5	"glioma: 21.1;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.8;Hep G2: 24.9;SCLC-21H: 4.5;SH-SY5Y: 14.9;SK-BR-3: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038746	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA038746: AB_10673293"	"unprognostic (6.34e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.60e-7)"	"unprognostic (1.29e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	1.9	23.1	22.2	2.0	22.4	1.6	1.8	17.6	70.3	2.1	2.1	25.4	0.4	11.2	2.5	3.8	2.0	2.5	1.8	1.7	20.8	21.4	14.8	2.7	1.7	1.6	28.0	25.0	2.5	5.6	1.6	4.4	10.6	24.8	4.4	2.0	7.6	2.2	4.9	1.6	1.6	11.5	1.7	27.4	1.6	2.2	8.9	31.0	0.0	1.6	0.0	1.6	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	14.9	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	22.4	17.6	32.6	20.8	21.4	28.0	25.0	24.8	31.0	0.0	0.0	0.0	11.5	0.0	131.3	0.4	0.0	0.0	0.0	3.5	11.8	0.9	11.6	0.3	143.9	0.3	0.0	0.0	5.7	0.2	0.2	3.3	0.0	2.1	0.5	136.7	0.0	1.3	0.0	172.3	12.0	0.0	1.7	0.0	0.0	208.8	2.8	0.0	0.4	46.1	49.8	0.0	0.1	91.0	13.2	0.0	41.0	0.0	0.0	3.2
PHYKPL	"AGXT2L2, MGC15875"	ENSG00000175309	"5-phosphohydroxy-L-lysine phospho-lyase"	Q8IUZ5	5	178208497-178232791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036461, HPA063608"	Approved		Approved	Mitochondria		Yes	No		190000	Mitochondria		"HPA036461: AB_10670717, HPA063608: AB_2685059"	"unprognostic (3.29e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (3.82e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-3)"	18.7	13.1	10.5	25.0	10.8	9.8	15.5	8.3	10.9	13.9	24.3	13.4	14.4	15.1	13.5	14.9	10.7	13.6	17.5	15.5	8.9	4.9	18.1	44.4	14.7	16.8	13.7	9.3	13.2	18.0	11.9	11.9	11.8	10.2	12.4	23.9	12.1	12.3	13.7	20.2	7.6	29.8	14.1	10.7	20.2	15.3	16.4	11.7	16.3	16.6	10.5	17.4	14.0	11.8	13.9	32.8	16.7	21.7	10.7	14.0	14.3	5.8	2.4	5.8	2.3	14.7	11.7	8.8	3.7	4.1	4.9	7.9	6.2	7.5	7.6	11.2	11.2	6.2	3.8	5.0	9.4	5.7	15.6	5.0	9.7	9.8	4.4	23.9	5.5	6.3	13.3	9.9	6.2	15.1	10.1	16.3	11.4	7.1	17.7	7.4	8.5	7.7	2.9	1.2	7.3	8.0	5.1	2.8	15.3	8.9	5.3	3.6	3.3	5.8	3.4	6.1	7.1	3.7	4.5	6.6	5.1	4.6	3.3	3.9	11.3	3.1	4.6	1.5	5.9	3.4	6.3	19.5	16.7	10.0	21.7	10.1	13.9	11.3	11.4	25.2	12.6	14.0	11.3	4.4	10.7	21.3	32.8	12.9	14.3	10.5	10.8	8.3	10.9	8.9	4.9	13.7	9.3	10.2	11.7	17.9	14.7	36.2	35.3	9.5	20.4	15.7	33.1	12.0	9.1	22.7	23.6	14.0	16.6	17.9	16.8	22.4	97.5	0.0	16.2	15.1	23.7	24.7	12.7	27.6	27.2	14.3	18.5	22.7	23.8	45.2	39.4	30.7	23.6	63.1	33.9	26.4	14.7	54.6	23.7	31.0	26.5	12.9	16.5	28.6	23.7	9.2	18.4	34.6	33.9	31.3
PI15	P25TI	ENSG00000137558	"Peptidase inhibitor 15"	O43692	8	74824537-74855029	"Predicted secreted proteins"		"Developmental protein, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	23	"Basal glandular cells: 31.8;Glandular cells: 15.4;Urothelial cells: 11.4"	"Group enriched"	"Detected in many"	7	"breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 16.1;SH-SY5Y: 15.9;SK-MEL-30: 21.2;U-266/70: 5.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006593, HPA030057"	Uncertain		Approved	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			Vesicles	Cytosol	"HPA006593: AB_1078568, HPA030057: AB_10602143"	"unprognostic (2.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.63e-14)"	"unprognostic (2.54e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	4.2	1.4	3.7	33.4	6.5	0.2	23.4	0.5	2.2	17.3	8.8	0.0	6.5	0.3	26.5	33.8	1.8	18.5	1.2	18.8	1.3	0.9	2.5	0.4	2.3	4.6	3.5	0.0	28.7	0.5	0.2	0.7	0.4	5.9	21.4	3.3	0.0	1.9	5.2	0.6	0.5	8.3	30.7	6.0	15.2	1.0	2.6	1.7	0.1	0.8	0.9	0.3	7.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	15.9	0.0	0.0	21.2	0.3	0.3	0.4	0.0	0.0	0.3	0.0	0.1	5.5	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	6.5	0.5	2.2	1.3	0.9	3.5	0.0	5.9	1.7	0.0	0.0	0.0	31.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.0	11.4
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Cell type enhanced"	"Detected in many"	21	"Enterocytes: 69.5;Exocrine glandular cells: 290.8;Pancreatic endocrine cells: 135.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"	"Group enriched"	"Detected in some"	5	"EFO-21: 26.6;HaCaT: 32.3;OE19: 29.6;PC-3: 55.0"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA		2100000	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favorable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.84e-6)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavorable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	26.6	0.0	0.3	32.3	0.0	6.6	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.3	5.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	29.6	55.0	0.0	0.2	0.0	6.3	0.1	0.0	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.0	11.3	0.5	5.2	0.1	0.0	0.0	7.6	0.0	13.6	17.4	0.0	0.0	0.0	14.9	0.1	0.1	69.5	0.0	290.8	0.0	0.3	25.8	4.6	0.0	0.1	0.0	16.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.4	0.0	135.9	29.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	33.5	18.7
PI4K2A	"DKFZP761G1923, PI4KII, PIK42A"	ENSG00000155252	"Phosphatidylinositol 4-kinase type 2 alpha"	Q9BTU6	10	97640686-97676434	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB030649, HPA076857"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB030649: , HPA076857: AB_2686817"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (4.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	17.2	23.0	13.8	10.7	21.2	22.8	9.5	16.8	33.8	12.0	9.1	16.8	9.5	10.9	12.8	15.5	18.3	8.9	16.1	15.2	14.5	17.9	14.7	17.1	15.0	11.0	15.9	15.7	10.6	9.5	23.2	15.5	19.9	30.7	10.3	10.2	23.8	10.1	12.7	11.3	15.3	9.9	15.0	9.9	14.4	8.8	14.9	7.5	8.2	12.0	8.8	11.8	13.6	11.2	4.1	3.7	1.1	3.4	1.9	4.0	1.6	12.1	9.2	7.6	13.5	16.3	11.8	6.1	12.2	27.0	19.3	20.5	8.3	12.1	4.4	7.2	15.4	14.2	11.8	8.4	24.3	16.1	5.3	7.2	3.9	6.5	7.5	15.7	3.5	5.6	12.4	20.8	20.2	36.0	21.2	9.8	8.7	6.1	7.3	13.3	6.2	7.7	2.7	4.9	6.3	8.7	3.6	7.9	4.3	13.2	11.4	2.6	8.4	10.3	2.6	15.2	11.2	7.2	5.6	10.8	9.2	6.9	10.9	9.4	6.5	7.6	7.2	17.1	2.1	3.0	0.0	3.4	0.0	4.0	2.3	2.8	4.1	1.7	3.4	3.7	1.9	1.4	2.6	1.1	1.9	1.6	1.7	3.1	1.6	13.8	21.2	16.8	33.8	14.5	17.9	15.9	15.7	30.7	7.5	3.0	4.8	4.7	4.1	11.8	12.9	9.8	10.2	1.4	2.3	5.2	11.8	11.6	3.3	4.0	1.9	5.0	8.3	0.0	4.2	5.3	9.4	4.3	1.1	9.3	32.1	11.1	2.9	3.1	11.0	1.7	4.0	17.5	10.1	22.6	2.5	6.9	5.7	0.0	8.5	6.2	14.2	6.5	5.9	9.1	5.6	12.5	22.7	7.0	2.5	7.1
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		18000	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	7.7	9.2	28.8	10.5	34.2	12.5	6.5	14.1	48.0	9.7	8.8	10.1	4.9	9.1	9.7	6.1	8.3	8.4	8.0	8.5	30.4	19.2	9.0	12.6	9.0	11.2	19.0	25.9	10.2	8.6	25.6	12.5	10.4	19.3	9.8	8.9	10.8	6.8	10.6	7.1	6.6	10.0	13.2	6.8	10.2	9.9	13.1	8.2	17.9	9.9	2.9	10.2	8.4	4.8	5.0	12.5	7.6	5.5	9.1	7.7	2.9	9.9	8.4	7.4	11.1	21.2	12.8	10.6	9.0	13.7	13.3	13.1	6.5	4.2	18.7	5.4	18.1	13.1	8.8	14.0	8.7	8.2	15.9	21.5	19.2	11.3	7.4	10.6	19.0	15.4	11.4	5.5	11.3	6.3	8.7	10.8	5.7	52.4	15.9	10.3	13.7	16.6	6.5	5.8	17.8	8.7	16.7	16.2	3.4	7.4	15.9	18.2	13.3	11.8	13.8	9.4	10.8	11.6	8.7	10.9	24.3	12.6	8.9	7.6	12.2	12.4	14.9	16.0	13.7	10.1	3.1	5.5	7.3	5.1	5.4	4.9	4.6	5.6	6.1	3.6	5.0	5.7	7.7	7.6	9.1	4.6	12.5	5.8	2.9	28.8	34.2	14.1	48.0	30.4	19.2	19.0	25.9	19.3	8.2	11.9	25.4	14.0	5.7	9.0	32.8	25.7	25.5	6.7	9.1	7.0	45.2	15.6	1.7	8.5	30.2	12.8	18.2	0.0	5.5	16.0	10.8	10.3	11.5	15.5	17.4	35.0	18.4	14.7	15.5	19.2	18.4	16.5	10.1	6.4	16.8	22.8	7.1	10.5	22.6	9.1	23.8	25.8	10.5	32.1	28.9	8.5	16.7	13.3	12.7	7.0
PIANP	"C12orf53, DKFZp547D2210, PANP"	ENSG00000139200	"PILR alpha associated neural protein"	Q8IYJ0	12	6693792-6700800	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.7"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 13.9;Horizontal cells: 17.5;Peritubular cells: 13.1"	"Cancer enhanced"	"Detected in many"		"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.9;HAP1: 7.8;hTERT-RPE1: 13.1;NTERA-2: 16.5;SH-SY5Y: 15.6;U-2 OS: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010631	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA010631: AB_10603680"	"unprognostic (1.82e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.30e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	1.5	8.3	28.0	2.2	55.7	1.2	1.5	27.4	52.8	7.2	2.7	2.6	0.5	1.9	11.6	4.1	1.8	2.2	3.3	1.5	19.5	26.2	1.5	1.1	1.5	2.4	11.0	20.9	1.8	1.7	1.2	4.0	1.5	9.0	3.4	2.0	1.7	2.2	8.7	1.3	1.7	2.2	8.1	4.6	1.6	2.1	4.4	8.3	0.0	1.4	0.0	1.7	1.8	2.5	0.3	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.4	5.9	1.1	0.2	0.3	0.2	1.5	7.9	4.1	3.7	0.1	0.2	0.1	0.0	2.8	0.6	0.2	7.8	0.2	2.0	0.2	1.0	0.3	0.2	0.0	0.2	0.3	0.2	1.0	0.0	1.6	0.0	13.1	0.0	2.4	0.0	0.2	0.3	0.2	0.2	0.2	16.5	0.0	0.0	1.1	0.0	0.1	0.1	0.1	2.1	15.6	0.0	0.1	0.0	1.1	0.0	0.0	0.0	4.3	8.7	4.4	1.1	0.2	0.0	0.3	5.8	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.7	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.0	55.7	27.4	27.8	19.5	26.2	11.0	20.9	9.0	8.3	0.0	0.0	0.0	0.0	0.2	13.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	17.5	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	13.1	0.0	3.0	0.0	1.4	0.1	4.5	0.1	0.1	0.0	0.0	0.0
PIAS1	"DDXBP1, GBP, GU/RH-II, ZMIZ3"	ENSG00000033800	"Protein inhibitor of activated STAT 1"	O75925	15	68054179-68198603	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005743, CAB012304"	Supported		Approved	Microtubules		NA	NA			Microtubules		"CAB012304: AB_777265, HPA005743: "	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.28e-2)"	19.5	19.5	15.5	19.9	20.1	26.4	17.4	27.5	20.5	24.3	19.8	12.6	40.3	15.1	25.5	21.5	25.5	22.7	16.6	18.8	15.5	10.5	14.5	13.6	23.2	21.4	13.8	14.4	30.6	16.3	17.6	25.0	16.5	17.3	22.8	14.8	17.6	19.8	44.7	25.1	23.1	19.9	23.0	16.5	21.0	20.9	28.9	14.7	33.4	26.6	12.4	21.8	30.8	23.8	10.7	15.7	37.0	15.5	9.4	12.5	11.9	8.1	11.3	18.3	8.8	11.0	11.4	5.5	12.6	12.8	13.9	15.7	9.3	12.4	15.5	8.6	10.5	8.9	22.9	26.9	6.9	15.1	8.9	10.0	18.6	11.4	10.2	7.2	18.0	15.1	10.2	20.0	9.0	8.2	10.8	9.7	9.0	12.8	11.9	10.6	6.7	14.8	9.2	10.3	9.1	6.4	13.3	17.6	15.1	9.0	10.4	15.3	6.4	8.4	7.8	8.6	17.5	7.0	17.0	8.6	12.1	12.9	6.9	9.2	8.9	11.7	16.8	7.5	19.2	8.9	15.2	15.5	20.6	10.3	12.3	10.7	10.7	10.4	10.8	15.7	10.3	12.5	10.8	37.0	9.4	12.4	8.7	10.8	11.9	15.5	20.1	27.5	20.5	15.5	10.5	13.8	14.4	17.3	14.7	101.3	53.7	28.1	56.5	33.8	55.7	25.8	48.4	26.8	37.5	12.2	100.1	30.4	18.3	23.8	47.5	32.6	26.2	0.0	19.7	15.3	21.3	41.5	54.4	30.5	40.2	46.1	26.5	38.1	77.7	25.1	114.5	46.4	20.3	58.7	30.0	53.1	22.5	20.1	106.8	15.9	59.5	32.3	21.7	54.7	46.0	28.9	30.1	42.6	21.8	53.7
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007646-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 73.5;Late spermatids: 189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010598, HPA076008"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA010598: AB_1079616, HPA076008: "	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	11.0	9.2	12.4	11.1	16.8	8.6	7.6	22.5	15.7	8.8	11.9	16.7	8.1	13.0	9.5	9.2	9.1	8.4	9.7	6.9	9.7	7.1	7.3	12.4	7.8	10.2	18.2	9.3	11.2	16.0	7.1	9.3	12.9	12.6	9.9	5.4	6.5	14.7	8.7	15.2	12.2	11.2	8.0	12.3	12.0	13.9	38.1	15.9	11.0	6.6	6.3	8.3	8.8	9.8	17.9	11.8	20.2	19.1	16.3	17.3	11.3	10.6	7.7	7.2	6.8	3.5	3.2	11.5	6.5	3.6	6.9	6.3	12.0	5.0	8.1	5.9	3.5	7.5	11.2	7.4	5.2	3.0	13.0	11.6	5.8	5.5	9.2	7.3	8.4	10.3	3.7	5.7	6.2	3.8	3.8	8.1	8.5	10.8	11.2	3.3	10.9	15.3	9.9	15.9	5.2	7.1	13.7	7.3	10.6	4.5	6.0	13.2	14.7	9.3	9.1	7.1	5.6	8.4	7.8	5.9	6.9	9.9	14.3	10.1	21.1	15.7	10.3	5.7	10.4	8.4	10.5	14.9	20.2	17.3	16.0	12.2	17.9	12.6	15.9	11.8	15.9	11.1	12.5	16.6	16.3	19.1	11.8	13.4	11.3	12.4	16.8	22.5	15.7	9.7	7.1	18.2	9.3	12.6	15.9	3.0	12.9	7.5	7.0	16.4	17.6	3.0	5.1	13.4	7.9	8.7	11.8	19.8	6.6	16.0	73.5	9.8	12.3	0.0	15.5	13.7	7.1	11.8	6.9	9.3	12.6	25.4	21.2	10.4	9.8	189.7	13.0	8.3	6.8	11.8	14.3	10.4	13.0	5.8	17.3	10.2	21.3	6.5	7.2	35.8	35.3	13.6	30.4	7.5	10.8	7.4
PID1	"FLJ20701, NYGGF4"	ENSG00000153823	"Phosphotyrosine interaction domain containing 1"	Q7Z2X4	2	228850526-229271285	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 116.5;Leydig cells: 81.4;Peritubular cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 23.5;intermediate monocyte: 26.5;myeloid DC: 28.1"	"Group enriched"	"Detected in many"	58	"dendritic cells: 28.1;monocytes: 26.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.4;hTEC/SVTERT24-B: 32.9;LHCN-M2: 21.8;REH: 22.9;RH-30: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036103	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA036103: AB_10602144"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.91e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-6)"	18.9	24.8	21.4	11.3	12.7	2.5	29.6	2.7	34.4	17.8	19.4	3.9	12.1	4.9	13.8	16.0	11.6	15.5	14.1	11.5	13.6	11.7	5.3	52.4	22.8	18.8	15.7	16.7	27.1	11.4	1.8	5.3	20.9	11.9	16.6	18.2	17.9	5.8	13.1	14.6	11.4	13.8	27.8	6.2	15.6	15.6	6.2	6.2	0.1	9.8	8.9	3.4	16.8	50.6	0.0	28.1	0.4	26.5	0.0	0.1	8.1	0.0	0.7	0.0	0.0	21.4	4.1	0.0	3.4	13.1	2.2	2.8	0.2	0.0	0.0	0.1	4.8	6.9	0.6	0.0	0.6	3.0	0.0	0.0	0.0	1.6	0.0	8.8	0.0	0.0	7.7	5.9	32.9	5.4	6.2	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.3	2.8	2.0	22.9	35.0	0.0	0.4	0.0	0.7	0.9	7.3	0.7	0.0	0.3	0.0	0.0	0.0	8.7	3.2	8.1	3.2	0.0	0.0	0.0	11.4	0.0	1.4	0.0	23.5	0.0	0.0	26.5	0.1	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.4	0.0	5.1	0.1	0.1	8.1	21.4	12.7	2.7	15.1	13.6	11.7	15.7	16.7	11.9	6.2	6.0	52.7	1.4	5.0	13.9	3.7	1.9	10.2	4.0	14.8	0.0	0.0	1.3	0.0	2.3	0.1	2.2	40.7	0.0	3.5	27.3	55.1	10.1	5.8	116.5	3.1	0.0	4.7	6.7	36.8	1.1	81.4	58.0	20.3	0.0	13.0	11.8	1.9	20.1	70.7	0.0	1.3	0.0	9.2	0.2	0.5	12.7	4.0	2.2	26.1	1.0
PIDD1	"DKFZp434D229, LRDD, MGC16925, PIDD"	ENSG00000177595	"P53-induced death domain protein 1"	Q9HB75	11	799179-809753	"Predicted intracellular proteins"	Apoptosis	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.9"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 23.0;Spermatogonia: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 21.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB012647, HPA055473, HPA066948"	Supported		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Golgi apparatus, Cytosol"		"CAB012647: , HPA055473: AB_2682827, HPA066948: "	"unprognostic (1.38e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (5.07e-3)"	"prognostic favorable (3.32e-5)"	"unprognostic (7.25e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.17e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.22e-2)"	3.4	3.0	3.3	6.7	3.7	15.0	3.9	7.7	10.0	4.4	4.3	2.2	0.4	7.1	3.2	4.1	6.8	3.3	3.0	2.2	4.7	2.9	2.9	5.6	3.1	7.0	4.4	10.9	2.9	5.6	3.0	2.8	10.1	3.2	5.2	2.0	2.7	6.1	3.5	7.1	7.9	6.5	2.0	5.9	5.3	5.9	5.0	1.9	21.9	3.9	4.3	9.2	3.3	2.8	1.9	3.1	0.1	1.8	0.4	3.3	1.2	4.2	4.9	2.3	4.9	0.5	1.9	21.5	5.9	1.6	2.2	2.9	4.4	8.1	3.5	1.9	0.8	2.0	6.2	1.7	2.4	0.4	6.9	9.9	2.9	3.4	9.1	5.7	3.3	7.5	7.0	4.3	1.1	0.3	0.4	4.0	8.2	3.4	2.6	0.9	1.9	9.2	5.5	3.2	4.5	3.5	15.0	3.4	6.7	0.8	1.5	4.1	5.5	2.5	6.6	1.6	1.4	4.8	5.6	2.2	2.8	6.2	2.0	3.8	8.5	4.8	6.6	3.6	2.7	4.4	0.0	1.7	0.1	1.9	1.8	1.8	1.5	1.4	1.5	3.1	1.9	1.7	1.7	0.0	0.4	1.6	0.8	3.3	1.2	3.3	3.7	7.7	10.0	4.7	2.9	4.4	10.9	3.2	1.9	3.0	9.1	8.1	3.4	0.0	13.1	2.8	7.6	0.0	10.3	3.5	9.8	23.0	1.7	2.5	1.1	2.2	8.6	0.0	4.0	5.2	1.3	3.4	1.1	8.9	4.7	1.6	8.6	1.8	1.9	0.7	6.6	2.8	0.0	1.8	7.9	5.7	3.4	8.0	3.9	3.1	16.2	0.0	1.7	9.2	24.7	0.0	8.1	5.3	8.6	2.6
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11148762	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3"	"Cell type enhanced"	"Detected in some"	10	"Cholangiocytes: 10.2;Ciliated cells: 13.4;Early spermatids: 23.3;Ito cells: 22.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.6;BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 14.9;HeLa: 23.8;U-266/70: 15.2;U-698: 9.9"	"Low region specificity"	"Detected in single"							"HPA015986, HPA031974, HPA040616"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	0.9	0.3	3.1	0.9	2.3	0.0	1.9	0.1	3.6	0.9	3.3			0.0	0.3	1.6	5.8	0.8	5.9	0.0	5.2	2.1	0.9	4.5	7.4	0.5	5.8		0.6	1.7	0.0	0.6	0.0		3.4	1.3		0.0	3.3	0.0	0.8	0.9	1.9	10.3	2.7	1.4	0.9			1.3		0.2	4.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.2	9.6	0.0	0.0	0.0	0.0	0.5	2.8	10.7	14.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.9	0.0	0.3	0.0	23.8	5.6	3.4	0.0	0.0	0.0	0.2	2.7	0.7	0.1	3.3	0.3	0.0	0.2	1.7	0.0	0.1	0.0	3.0	4.1	0.0	0.0	0.0	4.2	0.0	3.3	8.3	0.0	0.1	0.0	0.5	4.5	0.0	2.7	0.0	0.0	3.8	0.2	0.5	15.2	0.1	9.9	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	7.7	0.0	0.4	0.7	0.0	1.4	10.2	13.4	1.2	0.0	0.0	0.0	0.0	0.1	23.3	0.9	0.0	0.0	0.2	0.0	3.1	0.1	4.7	4.5	0.7	0.0	0.0	22.1	4.0	8.6	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.4	0.0	0.4	0.6	0.3	0.0	0.0	0.0
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.57e-4)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	17.3	12.6	11.1	14.3	18.8	8.6	18.0	14.6	15.6	12.9	13.0	17.6	12.8	17.1	19.8	20.2	12.6	13.1	12.7	8.8	8.5	7.5	11.2	18.5	12.5	12.0	14.5	10.7	16.5	16.5	11.9	18.1	10.3	13.6	14.0	14.4	15.5	14.8	16.3	13.4	20.0	15.8	10.1	9.7	12.3	14.8	11.1	13.6	13.7	15.7	11.1	20.4	10.9	12.3	5.2	7.4	5.5	3.7	5.4	9.3	3.3	7.9	11.4	7.7	6.3	11.0	10.4	3.2	4.4	5.3	7.5	13.3	11.6	10.2	3.9	9.1	4.3	4.5	11.6	9.5	5.6	10.7	8.3	24.8	7.7	7.9	13.8	11.8	3.3	5.0	8.8	14.7	13.0	14.8	7.6	8.5	13.1	9.1	5.0	5.9	7.9	6.0	7.7	3.0	15.9	5.9	5.9	6.5	11.2	8.4	4.3	4.1	5.8	4.6	3.3	9.0	20.8	3.5	3.0	5.5	6.8	4.2	4.4	12.5	3.5	0.1	6.3	8.4	8.2	4.2	0.0	3.7	5.5	6.5	3.2	5.6	5.2	8.5	5.0	2.7	4.4	9.3	7.5	0.0	5.4	2.4	7.4	6.7	3.3	11.1	18.8	14.6	15.6	8.5	7.5	14.5	10.7	13.6	13.6	8.9	16.0	3.7	8.0	3.9	11.3	1.7	7.6	10.7	12.5	12.2	9.8	13.3	5.0	5.6	2.1	5.8	6.8	0.0	6.4	6.1	6.0	6.8	4.7	9.4	4.5	6.4	7.5	3.1	2.7	1.9	7.2	5.1	3.3	1.8	10.0	6.7	7.4	7.0	10.6	4.4	12.3	0.0	6.6	13.7	8.3	5.3	8.0	8.7	10.8	8.8
PIGO	"DKFZp434M222, FLJ00135"	ENSG00000165282	"Phosphatidylinositol glycan anchor biosynthesis class O"	Q8TEQ8	9	35088688-35096601	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014905			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA014905: AB_1855369"	"unprognostic (1.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.81e-2)"	9.4	16.6	7.2	8.7	11.7	5.4	11.6	12.6	15.6	10.8	11.5	17.8	15.6	14.1	14.0	13.6	12.6	15.8	13.4	9.5	7.4	6.4	16.1	15.2	10.6	13.8	9.0	10.1	15.9	17.5	47.3	13.4	27.6	11.5	13.1	13.2	18.0	17.5	17.4	7.6	10.0	12.9	10.7	11.0	14.2	13.9	16.5	9.7	11.3	20.0	8.3	13.4	13.6	9.9	7.4	13.7	8.0	8.8	7.1	10.0	4.1	15.9	27.4	7.8	11.2	7.0	7.9	14.0	6.8	11.9	16.5	13.5	10.1	16.3	9.0	12.4	8.1	23.0	11.7	13.1	21.3	10.0	9.9	8.4	5.4	17.9	7.6	13.7	7.3	9.4	9.6	23.6	14.6	24.1	13.1	8.5	13.5	5.9	12.9	13.5	8.8	8.5	8.3	5.0	10.0	11.3	8.9	6.3	9.8	18.1	11.1	6.6	8.9	9.4	23.4	5.3	9.0	17.5	4.8	5.1	12.1	10.7	6.5	12.4	7.9	11.6	3.8	13.1	5.4	15.0	7.0	6.7	8.0	9.2	8.8	9.3	5.0	5.1	10.0	13.7	7.4	6.5	7.6	2.4	7.1	5.9	9.5	7.6	4.1	7.2	11.7	12.6	15.6	7.4	6.4	9.0	10.1	11.5	9.7	3.0	11.5	5.2	4.4	2.3	9.1	2.4	20.4	13.4	7.9	15.7	2.0	17.4	0.0	11.1	0.7	3.1	10.6	0.0	12.1	13.5	3.1	3.6	6.9	11.1	10.0	11.1	2.9	4.9	6.3	1.0	4.0	3.9	3.3	8.2	7.8	14.9	8.2	7.0	2.8	5.6	10.9	6.5	2.5	17.4	7.0	1.8	18.9	7.2	8.5	3.1
PIGP	"DCRC, DSCR5, DSRC"	ENSG00000185808	"Phosphatidylinositol glycan anchor biosynthesis class P"	P57054	21	37059170-37073170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 193.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026921	Uncertain		Approved	Vesicles		Yes	No			Vesicles		"HPA026921: AB_1847874"	"unprognostic (4.47e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.55e-2)"	20.0	30.3	12.3	7.9	13.4	4.2	18.0	6.9	14.3	13.1	13.8	15.6	23.1	9.9	11.7	60.6	12.5	13.9	15.2	27.8	12.3	15.2	19.0	27.4	14.7	9.9	16.1	9.8	15.0	45.4	23.9	28.9	16.2	17.9	21.3	14.3	16.6	22.2	17.4	25.0	7.0	12.8	24.0	24.8	10.1	14.8	19.3	8.4	16.3	20.3	17.3	9.9	17.2	9.2	18.2	16.7	1.7	11.1	8.7	19.3	8.7	9.1	4.4	9.2	5.6	16.7	10.9	6.1	7.4	13.7	6.7	7.6	5.8	19.4	12.6	16.6	11.2	30.3	7.4	7.6	8.4	7.1	13.1	13.2	28.6	5.5	8.0	10.1	8.4	6.3	9.9	16.0	12.1	15.2	15.7	11.5	28.6	17.0	22.6	14.8	6.1	11.2	9.3	7.0	26.2	10.7	11.0	4.7	13.3	16.9	5.1	19.0	11.4	20.9	15.8	28.1	12.8	13.5	18.5	6.0	5.0	2.4	5.8	6.7	30.1	32.7	14.4	14.4	10.8	16.3	0.2	7.1	1.7	11.3	10.4	14.0	18.2	14.5	12.1	11.1	15.3	19.3	16.7	1.0	8.7	11.1	16.7	10.7	8.7	12.3	13.4	6.9	14.3	12.3	15.2	16.1	9.8	17.9	8.4	26.8	36.1	32.3	46.9	29.3	19.4	74.2	43.3	56.2	26.1	41.8	9.8	49.2	76.3	48.2	68.0	32.1	27.7	0.0	62.5	46.0	37.9	46.4	16.1	77.3	60.5	15.9	43.1	32.5	40.6	54.3	63.9	44.6	35.4	37.9	52.5	26.5	65.1	55.4	32.9	92.2	26.6	64.7	43.9	193.5	109.2	23.1	43.7	28.8	53.6	46.5
PIGQ	"GPI1, hGPI1"	ENSG00000007541	"Phosphatidylinositol glycan anchor biosynthesis class Q"	Q9BRB3	16	566995-584136	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039105, HPA039828, HPA061414"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: AB_2684508"	"unprognostic (1.23e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (2.53e-6)"	"unprognostic (2.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	13.9	15.7	12.8	8.7	13.9	48.4	8.4	12.8	20.6	8.4	9.7	11.4	16.7	15.4	10.9	23.3	7.2	10.0	13.6	7.4	10.5	11.1	18.9	12.5	13.0	6.2	9.1	13.2	10.4	29.3	18.1	15.3	8.4	9.4	11.2	4.1	15.4	15.5	17.6	12.4	12.8	8.1	5.5	7.2	10.3	13.6	15.3	8.2	11.8	18.4	4.2	7.9	9.8	6.7	5.6	10.5	5.9	6.0	5.5	5.3	3.9	8.6	13.0	4.6	6.5	3.0	1.8	8.7	9.0	3.5	3.9	4.3	9.1	8.0	4.5	11.8	2.0	3.5	13.8	2.1	4.0	0.8	13.1	19.0	6.9	14.1	6.4	5.8	6.0	6.5	3.3	6.0	6.5	1.3	2.6	3.6	8.5	15.5	2.6	1.3	11.2	11.1	6.9	6.3	1.8	13.4	21.6	3.9	10.5	3.5	3.5	8.4	13.2	10.3	4.7	6.6	1.5	10.7	4.2	8.7	6.6	8.4	7.5	6.3	10.0	2.9	3.6	2.2	3.3	6.5	1.2	4.8	3.0	5.3	5.6	4.6	4.4	4.6	5.1	4.9	5.6	5.1	3.1	5.9	5.5	6.0	10.5	4.2	3.9	12.8	13.9	12.8	20.6	10.5	11.1	9.1	13.2	9.4	8.2	14.9	20.7	3.0	6.7	4.2	12.5	7.3	0.0	17.4	9.1	38.4	3.9	8.9	3.3	16.0	23.2	7.0	20.0	46.7	15.1	7.4	9.1	8.5	8.1	14.3	8.2	9.5	19.4	5.5	7.3	44.6	6.9	7.4	15.1	5.4	11.8	17.5	12.5	9.9	6.7	11.5	12.9	0.0	9.5	27.2	12.6	4.3	4.9	6.9	11.0	3.5
PIGU	"bA346K17.2, CDC91L1, GAB1"	ENSG00000101464	"Phosphatidylinositol glycan anchor biosynthesis class U"	Q9H490	20	34560542-34698790	"Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041706, HPA046766"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041706: AB_2677627, HPA046766: AB_2679794"	"unprognostic (1.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-3)"	"unprognostic (7.94e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.86e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.27e-2)"	"unprognostic (4.21e-3)"	16.8	17.6	18.9	12.9	23.6	10.0	15.2	15.7	26.5	14.7	21.5	43.0	10.8	13.3	21.8	22.8	20.0	28.2	12.7	17.4	21.4	20.2	18.4	16.3	11.3	11.6	21.5	11.9	23.9	16.2	34.4	21.7	17.3	26.9	14.1	24.9	20.1	17.9	15.9	16.4	14.0	14.2	19.6	30.5	11.1	11.5	22.1	18.1	16.5	14.7	15.9	19.5	14.2	15.0	10.0	10.8	9.4	6.3	12.1	15.0	6.7	11.7	15.0	19.1	14.0	12.6	15.2	19.2	12.1	14.5	20.6	18.2	27.7	25.1	15.2	19.8	11.9	26.4	22.0	17.4	22.9	21.0	6.2	9.4	34.2	9.9	31.1	11.7	20.8	8.2	13.4	14.8	11.8	13.5	9.5	14.8	15.0	17.1	13.5	17.4	13.2	17.6	21.2	9.6	26.8	22.7	12.8	24.0	24.3	18.2	11.0	12.3	11.6	22.7	41.2	14.8	11.2	22.7	14.7	8.7	33.9	12.1	18.3	12.1	9.1	12.7	10.1	20.7	21.8	14.6	9.4	4.4	1.9	13.4	6.3	12.2	9.2	12.4	15.0	10.8	10.0	12.7	12.5	0.9	12.1	5.3	10.6	11.2	6.7	18.9	23.6	15.7	26.5	21.4	20.2	21.5	11.9	26.9	18.1	8.9	3.7	1.5	11.9	3.9	8.5	5.2	12.7	26.8	9.1	10.4	15.7	33.8	1.7	16.1	13.6	5.0	10.3	0.0	15.2	23.8	8.0	10.0	8.1	6.7	13.7	1.6	9.8	8.6	5.6	11.0	5.2	3.5	1.7	6.4	13.8	8.1	9.8	21.0	7.4	8.4	9.5	19.4	12.0	31.9	12.2	5.1	17.7	7.0	22.1	7.6
PIGV	FLJ20477	ENSG00000060642	"Phosphatidylinositol glycan anchor biosynthesis class V"	Q9NUD9	1	26787472-26798398	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 65.1;Spermatocytes: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054181			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA054181: "	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (7.60e-7)"	"unprognostic (1.71e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (5.96e-3)"	6.2	14.6	8.1	5.3	8.9	4.6	9.2	6.1	10.3	10.5	7.5	9.9	9.3	7.3	8.3	14.7	8.7	10.6	8.9	4.4	7.2	6.6	10.6	24.6	6.8	5.1	11.6	6.8	9.0	13.5	15.8	13.5	9.3	9.7	11.5	8.4	6.6	9.9	10.6	5.0	10.1	10.7	7.1	7.5	7.2	7.7	31.3	10.0	7.2	20.0	8.2	7.8	9.3	7.6	8.3	9.7	23.5	12.9	18.0	19.1	9.2	9.4	5.7	4.6	4.0	8.9	11.0	3.9	6.5	15.4	6.2	7.6	3.1	19.6	5.6	5.9	8.1	6.9	16.9	2.4	7.6	7.7	9.5	4.0	4.9	7.6	7.8	10.0	8.9	12.1	11.4	31.6	8.5	10.4	13.2	4.7	9.1	8.9	9.0	11.1	5.3	4.4	5.0	6.9	13.9	4.6	3.2	5.3	10.6	9.8	2.4	6.6	3.5	6.4	3.2	6.3	8.3	11.0	4.4	7.8	11.2	4.8	5.4	2.2	3.2	2.1	3.0	9.2	9.5	6.6	23.5	10.3	7.7	13.3	10.1	19.1	7.4	9.0	13.0	9.7	8.3	9.1	11.1	12.5	18.0	12.9	3.8	7.7	9.2	8.1	8.9	6.1	10.3	7.2	6.6	11.6	6.8	9.7	10.0	3.0	5.9	6.7	10.3	3.8	2.9	1.8	2.5	8.1	1.2	7.0	7.9	22.6	6.6	6.3	40.4	5.0	6.1	23.3	4.0	12.3	8.7	6.7	0.0	14.1	8.1	7.9	3.4	7.4	4.7	65.1	6.6	4.0	6.8	10.0	6.5	10.3	4.6	2.9	9.2	7.9	2.7	0.0	5.1	82.9	13.9	3.6	11.8	6.1	9.8	5.8
PIGW	"FLJ37433, Gwt1"	ENSG00000277161	"Phosphatidylinositol glycan anchor biosynthesis class W"	Q7Z7B1	17	36535020-36539310	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023499			Approved	"Plasma membrane"		No	Yes			"Plasma membrane"		"HPA023499: "	"unprognostic (4.96e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.14e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.88e-1)"	3.0	2.4	2.5	4.9	2.9	3.0	4.5	1.8	6.4	2.5	3.8	2.4	0.4	3.3	3.2	4.4	5.7	2.0	2.7	3.5	2.3		6.7	12.0	2.9	4.7	3.6	2.2	4.3	4.8	3.3	6.0	2.6	6.3	2.1	4.8	3.7	3.7	2.8	6.5	5.0	3.9	3.1	3.2	4.3	3.3	3.4	2.2	4.0	4.1	8.1	5.5	2.4	1.2	4.4	6.2	1.1	4.9	4.8	5.8	3.3	7.3	9.7	6.8	6.2	2.9	2.6	8.9	8.9	3.9	8.1	6.7	8.5	7.7	11.0	2.7	4.9	8.9	10.4	11.9	5.0	11.1	6.1	12.6	9.5	6.1	6.8	2.3	19.5	10.5	3.0	5.8	8.9	4.0	1.8	4.5	3.6	16.0	7.0	5.6	5.4	9.6	5.8	9.7	4.3	6.6	8.6	16.0	10.8	4.3	9.7	13.5	10.2	12.7	4.7	6.3	6.4	17.0	3.0	6.1	13.9	16.9	13.4	15.7	5.9	18.6	13.2	3.7	9.9	12.5	1.1	2.8	0.5	3.6	4.2	5.6	2.5	4.7	3.6	6.2	4.4	5.8	5.2	0.9	4.8	4.9	2.9	2.4	3.3											3.0	1.9	1.5	7.4	3.1	2.0	1.2	10.2	2.7	3.4	0.0	0.0	5.2	6.6	4.6	0.1	2.8	1.4	0.0	5.5	5.1	3.7	4.9	0.0	5.3	4.0	3.2	1.2	1.3	2.1	0.2	2.6	2.7	0.0	2.8	3.5	5.6	4.7	3.1	2.1	3.8	2.7	0.0	3.1	2.6	7.3	5.9	3.4	4.3	5.0	4.8
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 34.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029409, HPA073301"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029409: AB_10610280, HPA073301: "	"unprognostic (8.83e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	19.1	13.7	25.1	12.7	25.5	9.3	19.2	16.9	25.8	13.1	15.5	13.1	7.8	12.3	15.2	18.5	16.6	12.6	12.7	13.9	23.2	25.4	18.1	12.5	15.6	27.0	24.8	13.4	10.9	16.0	28.1	18.2	17.7	14.5	18.6	17.1	16.3	12.9	18.5	18.6	12.3	11.8	17.1	21.7	18.4	10.6	9.0	14.2	24.6	15.5	10.6	14.7	13.6	10.7	1.7	3.2	34.5	4.4	3.6	2.1	1.5	22.3	10.2	13.4	9.4	14.2	10.8	7.6	10.1	12.2	12.4	12.9	9.8	14.6	11.0	33.9	10.1	15.4	12.3	11.4	9.6	15.4	10.0	10.6	9.1	7.1	6.6	13.1	10.2	17.0	8.1	15.0	10.0	9.5	9.9	6.7	18.0	6.2	22.1	11.3	20.3	26.3	13.3	6.0	17.8	11.6	14.3	15.8	15.9	12.8	7.5	13.0	14.4	17.0	11.7	13.9	10.5	40.5	9.5	3.5	11.9	5.2	13.0	15.5	27.9	32.1	20.8	10.8	12.6	12.3	15.5	3.0	34.5	1.5	4.4	1.3	1.7	1.4	2.1	3.2	1.7	1.6	1.4	8.6	3.6	4.4	1.4	1.7	1.5	25.1	25.5	16.9	25.8	23.2	25.4	24.8	13.4	14.5	14.2	17.9	21.8	19.9	24.6	15.1	31.0	10.7	20.4	9.4	11.4	27.9	45.2	17.1	29.9	6.9	19.9	15.7	18.7	0.0	4.9	17.4	22.4	27.9	11.5	14.4	17.0	31.8	15.1	17.8	18.3	17.2	25.9	19.4	20.3	10.8	17.7	33.8	5.4	14.4	32.9	29.9	34.6	25.8	19.4	21.4	33.5	13.9	9.7	17.8	26.3	16.3
PIH1D1	"FLJ20643, NOP17"	ENSG00000104872	"PIH1 domain containing 1"	Q9NWS0	19	49446298-49453497	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047258	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047258: AB_10964561"	"unprognostic (2.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	23.1	24.3	29.5	21.1	24.4	22.3	23.7	31.1	36.9	27.3	31.9	25.8	32.9	31.9	23.2	18.1	29.0	30.6	23.0	21.1	25.2	23.2	26.7	41.6	19.2	28.4	23.4	24.7	21.4	36.9	24.4	23.2	27.6	24.8	25.8	22.4	23.0	40.8	27.3	44.7	31.4	27.3	19.9	19.2	25.8	24.9	16.8	23.7	43.6	37.2	34.0	30.6	23.8	24.2	38.6	35.9	49.7	36.4	33.0	52.5	32.6	36.3	18.7	24.1	36.8	11.8	11.0	15.4	14.8	19.5	22.8	35.4	20.0	25.0	24.5	14.0	15.8	5.7	22.3	12.5	27.1	13.4	23.4	24.0	21.9	24.9	25.2	18.3	23.7	33.1	12.8	11.5	16.9	16.0	21.6	21.2	22.3	32.2	21.7	14.3	16.4	26.4	47.0	28.7	32.6	17.9	22.6	27.0	24.6	18.5	29.9	31.2	45.2	15.1	25.8	14.5	12.3	12.3	28.7	12.6	19.2	15.1	7.6	23.1	58.9	46.0	13.4	10.5	25.7	13.4	49.7	36.4	39.3	32.4	34.9	27.4	38.6	36.3	34.4	35.9	34.2	29.5	27.4	4.2	33.0	34.6	34.2	52.5	32.6	29.5	24.4	31.1	36.9	25.2	23.2	23.4	24.7	24.8	23.7	35.7	35.8	57.4	48.9	49.6	17.7	8.7	30.6	46.8	26.1	19.2	17.7	87.9	53.0	65.4	12.8	32.1	42.6	0.0	40.6	102.6	54.6	54.9	51.9	38.6	60.9	22.3	55.2	35.6	35.3	6.2	57.8	45.4	60.8	70.3	50.2	50.7	43.4	63.3	44.2	89.8	19.3	25.8	51.8	33.4	28.1	58.6	78.6	51.7	56.6	56.2
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593312-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 66.5;Kupffer cells: 114.3;Macrophages: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9"	"Group enriched"	"Detected in all"	6	"B-cells: 17.5;monocytes: 38.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.7;NB-4: 17.8;REH: 52.8;THP-1: 26.9;U-698: 33.7;U-937: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	5.8	2.2	2.9	16.8	7.1	14.7	4.8	1.0	3.0	1.4	2.2	3.2	0.0	1.9	1.3	2.3	1.3	2.0	8.5	3.3	3.1	2.4	6.2	38.4	6.0	19.5	5.3	0.5	3.3	16.1	0.3	3.0	10.9	5.1	1.8	2.7	1.6	29.7	0.8	1.1	1.5	6.6	2.4	7.3	32.0	1.9	1.7	4.3	2.0	2.4	0.6	19.2	4.1	2.2	17.5	4.4	4.7	38.9	4.5	4.8	4.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.4	24.7	2.5	0.0	0.4	0.0	5.2	0.0	0.2	13.7	0.9	3.7	0.0	0.4	0.0	10.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.3	17.8	0.2	7.0	0.3	52.8	1.2	5.8	0.0	0.0	1.1	0.6	0.0	0.0	0.3	0.1	0.0	26.9	0.0	0.0	0.8	0.0	0.2	0.2	0.0	33.7	0.0	27.7	0.0	1.7	5.4	3.3	4.8	15.5	1.7	17.5	0.1	1.5	4.4	16.2	0.0	1.2	4.7	4.5	38.9	3.9	0.1	4.2	2.9	7.1	1.0	3.0	3.1	2.4	5.3	0.5	5.1	4.3	3.0	3.8	29.6	0.0	1.3	0.2	2.2	28.1	1.4	3.4	1.8	2.0	0.4	1.7	26.1	3.3	1.4	2.6	0.0	25.2	0.7	1.0	0.5	13.9	66.5	41.2	0.0	1.7	8.0	114.3	0.4	1.1	53.7	5.0	2.8	2.5	0.2	22.8	18.4	2.1	12.8	3.3	0.0	1.7	0.2	0.2	1.0	1.9	27.7	2.9	0.1
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 32.3;Ito cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.3;RT4: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.9	4.5	11.0	16.0	19.3	5.3	11.0	9.1	17.5	7.4	17.0	36.0	9.6	15.5	10.5	5.8	14.6	7.7	14.7	10.7	14.4	9.1	7.6	5.8	18.0	23.9	24.2	11.2	3.9	6.1	4.7	4.3	20.4	14.5	7.3	14.5	6.3	8.0	14.1	20.0	22.6	15.7	11.2	16.2	14.2	20.7	2.4	23.0	31.8	9.8	8.1	23.1	13.1	11.8	7.4	0.3	0.5	0.2	1.6	2.0	0.4	3.2	6.6	5.9	5.4	3.5	0.3	32.3	0.4	1.3	1.3	0.9	3.9	8.7	5.6	1.2	0.7	1.1	8.2	3.5	2.3	0.5	3.4	0.9	0.1	13.1	1.4	0.2	1.9	4.3	0.4	2.5	0.3	0.2	0.5	8.6	5.7	2.0	3.8	0.1	7.3	6.7	5.6	5.4	12.9	4.2	7.3	1.5	1.0	1.6	33.8	6.5	3.6	11.7	16.4	3.8	2.2	7.3	1.0	0.3	0.2	2.1	0.6	0.1	4.1	1.1	7.3	0.2	3.0	0.8	0.1	0.2	0.0	1.2	0.0	1.0	2.9	1.3	0.8	0.3	7.4	0.7	0.6	0.5	1.6	0.0	0.1	2.0	0.4	11.0	19.3	9.1	17.5	14.4	9.1	24.2	11.2	14.5	23.0	0.0	12.6	11.1	1.9	3.4	16.6	6.4	0.0	2.7	4.5	3.5	0.0	3.8	0.0	1.1	0.6	20.0	14.8	0.0	3.0	3.4	4.1	2.2	32.3	3.9	3.3	14.3	9.2	27.0	2.2	0.0	1.1	2.3	3.3	2.8	23.7	2.5	3.3	10.5	7.1	1.9	1.0	0.0	3.1	0.0	1.5	6.9	1.8	2.5	13.2	6.3
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 42.0;HMC-1: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	23.0	10.0	4.3	3.6	3.9	5.3	29.3	5.4	5.2	5.5	5.9	10.7	8.8	9.3	14.8	5.3	10.6	9.9	5.6	8.6	9.9	11.8	6.3	42.0	6.8	6.4	4.0	10.2	66.6	4.5	6.6	3.8	7.8	9.8	8.3	4.5	16.0	6.9	6.9	10.6	5.9	7.2	6.2	17.0	9.4	4.3	4.5	6.6	8.5	12.8	3.7	2.7	15.0	6.5	19.3	13.2	16.3	24.4	8.7	3.5	4.5	7.7	7.6	11.7	7.6	8.5	8.6	9.9	4.9	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7	8.9	14.7	4.7	12.9	16.9	15.4	30.2	12.7	14.7	21.6	17.4	23.6	29.1	5.0	9.4	0.9	8.5	21.3	0.0	16.5	46.3	6.5	23.0	13.9	15.8	13.4	20.6	15.6	11.6	28.8	1.1	3.4	19.7	6.8	14.4	14.9	8.2	15.2	21.8	6.3	18.9	17.9	6.5	6.1	10.7	14.9	20.5	40.0	6.1	12.7	15.3
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651732-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 20.7;granulocytes: 24.3;Kupffer cells: 28.8;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.7;NB-4: 22.4;REH: 23.3;THP-1: 22.5;U-937: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No			Vesicles	"Cytokinetic bridge"	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	4.5	2.1	3.4	34.8	7.1	32.8	2.9	3.3	4.3	3.2	3.3	5.5	0.7	3.1	3.7	3.4	3.5	4.0	6.5	2.9	4.2	3.1	4.6	3.3	8.2	40.3	7.4	1.8	5.3	2.2	2.3	2.2	3.3	4.6	3.2	2.1	3.1	11.2	1.8	0.9	2.0	11.4	2.9	5.3	35.5	3.3	3.0	5.7	23.5	4.1	2.3	36.0	5.8	3.6	8.4	14.5	35.0	15.0	14.5	13.7	16.6	2.7	1.8	0.1	0.5	0.4	0.4	0.2	4.2	8.6	9.2	7.6	0.1	1.1	7.3	1.7	3.3	4.4	0.8	0.7	3.8	5.8	51.7	0.1	0.8	0.4	3.0	1.8	18.8	6.6	1.5	1.6	10.3	3.5	4.0	1.3	5.2	2.6	0.0	5.2	0.2	1.8	22.4	0.8	0.1	0.5	23.3	4.6	0.2	3.9	0.0	0.6	0.5	0.9	1.7	4.1	2.5	0.3	22.5	3.4	2.7	2.8	0.0	3.9	1.7	1.6	10.2	5.9	26.9	1.5	9.6	11.8	21.1	12.9	13.1	13.7	7.8	9.8	11.8	12.5	8.4	12.9	13.4	35.0	14.5	15.0	14.5	7.4	16.6	3.4	7.1	3.3	4.3	4.2	3.1	7.4	1.8	4.6	5.7	8.9	20.7	7.8	1.8	1.3	0.4	2.7	0.0	1.4	1.2	0.0	2.0	0.1	1.7	3.1	2.0	1.6	0.0	0.0	1.8	0.3	1.4	2.5	24.3	0.0	12.5	0.0	0.0	3.7	28.8	1.7	1.1	13.4	3.3	1.0	0.0	2.5	7.7	0.0	1.4	2.9	1.6	6.5	3.8	1.1	2.1	1.0	0.2	30.5	0.1	2.0
PIK3R2	"p85, P85B"	ENSG00000105647	"Phosphoinositide-3-kinase regulatory subunit 2"	O00459	19	18153118-18170540	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Stress response, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 23.3;Undifferentiated cells: 15.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA069291	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA069291: AB_2686109"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.36e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.35e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.00e-2)"	6.4	20.9	27.5	7.2	30.1	10.1	7.2	14.4	36.6	14.5	13.5	11.4	6.7	21.7	13.9	12.0	19.0	17.8	17.2	12.5	33.2	11.5	10.3	10.3	8.4	6.3	10.1	18.1	20.2	13.0	24.3	16.7	10.2	7.9	11.6	10.1	11.4	14.5	11.9	10.9	26.2	16.5	11.1	7.4	7.1	15.9	9.8	11.0	11.3	9.0	9.4	10.4	13.9	11.6	2.5	1.9	3.1	1.8	1.9	3.2	0.8	19.0	9.8	13.4	17.9	17.9	18.0	20.2	15.2	19.2	11.5	8.5	10.0	9.3	15.1	24.2	21.2	8.0	14.3	8.0	16.6	6.4	12.3	29.4	5.7	13.3	23.8	14.3	13.0	7.0	22.5	16.4	7.7	11.8	17.3	2.8	5.5	16.3	5.5	14.1	29.7	8.9	11.1	15.6	15.2	21.9	9.4	18.7	11.5	16.4	14.1	30.1	34.2	14.4	13.9	13.2	8.1	8.9	7.2	5.7	20.5	10.6	25.3	13.5	10.3	13.1	6.8	16.3	19.0	12.9	0.7	1.7	3.1	3.2	1.8	2.0	2.5	1.7	1.5	1.9	2.3	1.6	1.8	1.0	1.9	1.0	1.4	0.3	0.8	27.5	30.1	14.4	36.6	33.2	11.5	10.1	18.1	7.9	11.0	6.0	1.4	0.0	1.2	1.6	5.3	1.1	2.5	0.0	1.2	3.5	3.9	1.4	0.0	5.0	0.2	0.2	8.0	23.3	5.4	2.3	2.2	0.3	2.3	1.0	1.8	9.5	5.8	1.3	6.4	0.0	1.7	1.2	0.0	1.8	11.5	4.5	5.5	2.9	1.8	0.6	3.9	0.0	1.9	0.5	1.5	1.9	1.0	0.0	15.3	0.4
PIK3R3	p55	ENSG00000117461	"Phosphoinositide-3-kinase regulatory subunit 3"	Q92569	1	46040140-46133036	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 44.0;Cone photoreceptor cells: 43.2;Endothelial cells: 43.8;Rod photoreceptor cells: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 8.6;monocytes: 3.1;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"RT4: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005751, HPA071988"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA005751: AB_1855350, HPA071988: AB_2686479"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.32e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (4.88e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.99e-3)"	"unprognostic (2.87e-2)"	"unprognostic (9.74e-2)"	"unprognostic (6.71e-2)"	"unprognostic (8.22e-3)"	33.7	10.9	7.4	7.0	8.2	0.8	24.7	36.4	11.0	16.9	6.3	3.5	9.1	3.3	15.8	11.0	8.4	7.6	10.9	28.7	6.8	8.5	10.4	4.1	20.0	6.0	8.7	3.1	4.6	4.0	18.7	10.2	13.4	10.4	9.0	5.3	13.6	9.4	8.0	14.8	4.6	6.0	12.3	7.1	10.9	7.4	24.0	4.5	5.9	12.7	6.2	5.3	12.3	8.7	0.5	0.6	8.6	3.1	0.1	3.5	0.9	4.7	1.6	21.6	10.9	2.1	0.9	6.9	2.8	2.0	3.7	4.6	0.9	1.4	6.2	8.6	1.1	4.5	2.8	7.5	2.6	2.4	4.8	6.7	3.9	19.4	0.7	0.7	3.5	5.4	2.7	1.5	3.9	1.4	3.6	7.7	14.5	1.4	4.5	5.2	7.2	14.1	2.2	7.6	1.3	4.3	18.2	5.7	7.4	9.3	33.6	15.6	11.3	9.1	24.1	2.6	13.5	6.7	3.2	14.3	4.0	3.7	0.6	2.7	6.4	6.6	3.8	3.1	4.7	2.0	0.0	0.3	8.6	3.3	0.5	3.0	0.5	0.8	2.9	0.0	0.0	0.3	1.9	0.1	0.1	3.1	0.6	3.5	0.9	7.4	8.2	36.4	8.9	6.8	8.5	8.7	3.1	10.4	4.5	0.0	9.6	0.0	3.0	2.3	44.0	17.3	0.0	17.4	5.7	17.4	43.2	4.0	0.0	0.4	8.7	43.8	5.1	0.0	1.0	1.0	4.5	7.4	9.2	0.0	1.4	3.2	7.5	0.0	0.0	12.1	1.1	1.8	5.0	1.0	1.5	30.4	1.3	1.1	7.4	3.4	44.4	0.0	12.5	29.2	28.5	1.6	1.1	1.5	1.7	3.3
PIK3R4	"p150, VPS15"	ENSG00000196455	"Phosphoinositide-3-kinase regulatory subunit 4"	Q99570	3	130678935-130746829	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036032, HPA036033"	Approved		Approved	Vesicles,Microtubules		NA	NA			Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: AB_2674911"	"unprognostic (7.50e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (8.25e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	15.5	16.2	11.6	11.6	15.9	10.6	14.9	14.7	17.2	16.5	13.1	14.9	9.5	10.3	18.8	12.0	12.9	15.6	12.0	12.2	9.7	10.0	14.9	28.2	13.7	12.4	12.0	11.4	17.8	12.0	40.7	20.6	14.4	17.3	14.1	11.6	14.1	14.0	15.4	14.8	16.0	13.4	14.6	12.1	18.5	13.3	14.9	11.8	29.7	18.1	10.2	13.6	16.5	13.9	8.4	9.6	12.0	8.5	11.5	13.7	7.0	14.3	9.1	13.4	9.7	19.9	15.9	9.3	10.7	12.9	14.8	17.2	11.8	12.2	16.9	13.5	10.8	11.8	20.6	22.0	16.6	23.3	10.2	8.2	13.8	10.5	8.2	9.1	20.9	6.9	10.9	12.0	15.8	10.0	9.3	13.7	9.9	16.0	8.6	13.0	12.6	17.1	6.4	16.9	13.0	9.0	12.0	15.6	15.2	9.7	11.8	12.4	9.1	15.4	9.7	10.8	16.5	13.4	9.2	10.8	11.4	9.9	12.8	8.5	10.1	9.1	22.3	12.5	8.0	10.5	12.0	7.2	9.2	9.4	8.4	13.7	8.4	8.6	6.9	9.6	5.7	10.1	9.0	6.0	11.5	8.5	3.4	9.3	7.0	11.6	15.9	14.7	17.2	9.7	10.0	12.0	11.4	17.3	11.8	6.0	5.4	0.0	3.4	3.4	8.2	7.5	15.3	14.7	11.4	10.4	13.7	4.6	1.7	4.1	3.4	6.7	5.3	0.0	5.1	3.1	3.5	3.7	9.2	15.6	5.1	4.8	2.9	8.0	6.7	2.7	8.9	3.8	5.0	5.4	6.2	8.0	5.3	5.8	11.0	4.9	12.0	6.5	3.2	10.8	12.7	3.9	3.5	4.6	5.8	2.5
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802723-8867677	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 12.2"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 8.7;granulocytes: 45.2;Late spermatids: 13.8"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in many"	4	"eosinophil: 32.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 32.1"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 58.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	2.2	0.0	2.1	12.2	5.4	5.3	1.0	0.0	3.7	1.5	1.9	2.5	1.4	3.5	2.6	2.3	1.2	0.4	6.6	2.6	3.1		0.0	0.6	3.4	4.4	2.5	0.0	0.3	0.8	0.3	0.0	1.4	3.2	2.4	1.5	1.4	0.9	0.7	1.0	1.8	5.2	2.2	3.1	6.3	2.3	1.1	2.7	6.9	0.0	0.8	6.4	3.0	3.3	1.3	4.9	32.1	4.3	0.5	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	7.5	0.0	0.0	0.0	0.0	58.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.7	3.4	32.1	0.2	4.3	0.2	1.3	0.0	0.1	4.9	0.1	0.0	0.1	0.5	0.5	3.3	0.0	0.0	1.4											0.0	2.2	0.0	0.0	0.5	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	45.2	0.0	6.3	0.0	0.0	0.0	2.6	13.8	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.5	0.0	0.0
PILRB	"FDFACT1, FDFACT2"	ENSG00000121716	"Paired immunoglobin-like type 2 receptor beta"	Q9UKJ0	7	100352176-100367733	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"testis: 80.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.1;neutrophil: 34.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 51.1;monocytes: 16.8"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 81.3"									HPA026750	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	Yes			Mitochondria		"HPA026750: AB_10670828"	"unprognostic (8.33e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.35e-3)"	10.6	11.3	8.2	11.2	8.2	11.2	10.2	25.2	10.3	9.9	8.2	8.2	8.2	11.4	10.3	12.6	8.2	10.0	8.8	8.2	8.2	5.0	18.6	17.6	8.2	13.2	8.2	8.2	12.1	12.9	19.0	27.6	9.8	8.2	13.6	10.2	8.2	12.0	10.7	12.3	15.8	10.1	8.2	10.5	16.7	9.2	80.1	8.2	8.2	18.3	8.2	11.0	9.9	8.2	0.3	4.3	51.1	16.8	4.0	2.9	4.7	14.0	11.9	13.7	23.7	15.2	3.5	13.3	8.5	3.8	6.1	6.0	8.4	16.4	11.5	16.3	4.4	10.9	15.1	7.5	9.0	4.2	9.4	11.1	10.6	39.9	7.2	3.4	10.6	27.6	4.4	10.6	8.2	16.8	7.6	5.1	17.2	11.3	28.0	4.2	19.0	16.7	55.3	5.9	11.8	6.3	9.8	4.0	11.7	27.5	23.1	12.8	9.2	7.2	81.3	10.1	15.3	14.2	16.5	12.2	21.8	13.9	13.9	11.0	16.9	21.5	13.9	6.1	15.9	12.8	4.1	8.5	51.1	2.9	14.0	1.7	0.1	0.3	1.8	4.3	0.3	0.3	0.7	34.8	4.0	16.8	0.1	0.1	4.7	8.2	8.2	25.2	10.3	8.2	5.0	8.2	8.2	8.2	8.2	35.7	41.6	25.1	19.4	14.0	37.1	1.1	63.7	37.5	42.1	14.0	64.8	10.8	1.7	5.8	13.5	16.4	15.8	0.0	4.9	9.6	8.9	14.5	23.3	62.2	8.5	71.5	28.3	17.8	14.3	9.1	68.4	12.3	18.6	10.0	23.8	26.5	6.4	17.3	48.1	3.4	60.9	25.8	12.0	43.6	9.8	11.8	13.2	66.0	24.8	10.8
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 63.4;lymphoid tissue: 71.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 48.0;B-cells: 109.2;Melanocytes: 89.4;monocytes: 163.3;T-cells: 70.8"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 60.3;Karpas-707: 74.7;RPMI-8226: 73.6;U-266/70: 136.0;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol		NA	NA			Cytosol		"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favorable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	3.6	3.4	4.3	37.2	7.2	30.4	3.4	7.1	7.9	4.5	13.4	2.1	2.2	29.5	2.8	4.3	10.0	5.6	8.3	3.1	5.6	6.7	5.2	5.4	10.6	59.7	3.8	4.6	5.4	3.0	1.0	4.9	2.4	6.7	3.6	17.7	6.1	16.9	4.9	1.5	3.0	19.2	2.2	3.1	71.2	14.7	5.7	1.3	39.4	4.8	3.6	47.9	24.6	3.3	26.0	2.9	46.9	3.0	17.0	63.4	13.2	1.8	1.6	0.8	1.7	0.3	0.2	1.3	1.1	1.4	1.6	1.4	1.4	1.4	8.0	0.5	0.5	0.6	1.1	2.7	1.0	1.5	60.3	2.1	9.7	1.6	1.4	0.7	2.3	6.5	0.6	0.9	1.7	1.0	1.3	0.6	1.0	10.2	74.7	0.9	1.3	0.8	4.8	18.2	0.6	2.5	1.0	0.6	73.6	1.6	0.2	0.6	0.8	1.2	0.8	0.8	4.3	2.1	3.1	0.3	0.4	0.2	0.3	1.1	136.0	120.2	15.3	1.5	2.0	0.4	46.9	1.5	14.3	12.5	1.9	21.2	26.0	34.4	17.6	2.5	15.9	36.9	23.0	38.3	17.0	3.0	2.9	63.4	13.2	4.3	7.2	7.1	7.9	5.6	6.7	3.8	4.6	6.7	1.3	11.9	48.0	109.2	9.5	18.0	2.3	2.0	0.0	14.7	12.5	3.5	2.0	5.3	3.3	2.8	1.4	4.3	4.0	0.0	3.1	5.0	7.5	4.0	22.0	5.4	6.3	11.1	12.6	3.1	9.1	1.4	1.7	18.6	89.4	163.3	6.6	2.3	1.6	3.5	3.9	5.4	2.2	0.0	8.1	2.1	1.5	12.0	2.1	70.8	8.1	3.9
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.4	18.1	19.0	12.9	13.0	10.9	10.1	10.6	12.2	13.0	13.4	9.1	11.5	4.6	31.0	10.9	17.6	11.0	16.8	18.6	16.1	11.7	37.8	7.9	21.6	23.9	7.2	12.5	6.7	7.3	10.3	14.2	4.9	14.7	13.2	14.2	13.3	20.6	9.7	18.7	10.9	21.1	13.5	17.6	16.4	10.9	15.1	13.7	16.5	10.8	12.2	21.7	12.4	5.8	10.9	14.6	9.0	11.5	13.2	5.9	9.1	16.2	7.7	7.1	7.6	7.7	17.0	12.6	6.4	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9	62.5	35.0	52.8	54.1	38.4	26.9	74.7	81.5	84.3	51.2	113.4	7.9	137.4	154.2	102.6	10.6	70.5	117.6	23.3	102.2	92.0	70.9	50.1	55.5	238.7	95.4	27.0	88.9	80.4	73.2	6.2	69.0	61.7	57.3	68.5	76.9	55.6	124.5	101.7	76.4	218.0	33.7	84.1	78.3	14.4	39.1	40.9	100.9	62.3	82.1	54.0
PINLYP		ENSG00000234465	"Phospholipase A2 inhibitor and LY6/PLAUR domain containing"	A6NC86	19	43576800-43583964	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 19.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 17.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 33.8;HMC-1: 22.6;JURKAT: 17.5;REH: 13.7;THP-1: 17.0"									HPA061218	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA061218: AB_2684453"	"unprognostic (6.72e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.60e-2)"	3.6	2.0	5.6	1.8	6.5	1.2	4.0	3.7	2.5	7.4	3.9			0.6	6.8	7.1	5.0	13.1	6.6	4.2	4.4	4.6	7.9	0.3	2.9	2.9	4.2		13.1	0.6	0.0	5.6	1.6		4.5	2.0		2.3	8.1	0.0	2.0	1.7	8.3	2.9	3.0	2.1	1.8			4.0		3.3	2.7	4.4	3.2	17.4	6.6	1.2	0.9	3.3	1.5	0.3	0.1	0.9	0.0	1.6	2.2	0.1	0.4	0.6	0.8	2.1	0.0	0.0	0.0	0.1	8.9	0.8	2.0	0.0	0.0	0.8	0.0	0.1	33.8	0.3	0.0	5.1	0.0	22.6	5.0	0.3	5.1	0.0	2.4	1.4	17.5	0.4	0.4	0.3	0.2	4.0	0.5	0.8	0.0	0.3	13.7	0.1	0.0	0.4	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	17.0	0.6	2.2	0.4	0.0	1.5	0.0	0.0	2.0	7.8	0.0	0.1	6.6	1.2	0.5	2.6	0.8	3.2	1.4	0.8	2.1	1.8	3.2	0.2	3.3	0.0	0.9	0.2	17.4	1.6	1.5											11.9	2.7	1.3	8.9	3.2	5.6	2.2	12.7	17.4	7.9	8.7	5.9	0.4	19.9	1.0	4.7	4.5	0.0	0.0	0.3	0.4	6.7	3.3	0.0	0.0	4.1	6.4	0.0	6.2	0.6	4.2	10.6	1.8	5.0	5.4	0.5	5.5	0.3	0.0	9.2	14.0	3.4	0.0	5.1	2.6	0.9	2.8	0.1	0.0	0.4	6.4
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534849-22714555	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 92.0"	"Cell type enhanced"	"Detected in all"	7	"Erythroid cells: 93.5;Melanocytes: 99.5;T-cells: 152.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		8800000	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: AB_2685490, HPA068771: AB_2686030"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	13.0	7.3	43.8	20.3	63.8	17.3	6.9	6.6	41.4	13.2	7.8	75.5	1.0	5.9	9.9	5.6	9.2	7.2	15.1	5.9	56.0	31.7	7.6	8.3	11.5	33.4	65.7	22.9	4.3	4.9	29.5	4.2	10.5	36.5	4.4	9.0	5.7	3.9	6.3	2.6	4.0	8.1	14.4	92.0	26.6	8.4	5.4	59.8	10.1	5.9	1.0	38.5	11.5	5.8	14.7	12.0	26.3	16.6	38.4	46.7	39.3	8.9	8.8	10.3	3.3	16.5	22.5	7.8	16.6	17.7	9.0	11.1	8.2	14.3	18.7	6.0	33.3	19.8	3.1	8.9	4.6	9.1	41.4	9.3	35.2	6.4	18.1	29.3	6.7	27.6	11.2	4.2	12.2	11.9	13.9	13.3	25.3	19.5	36.6	16.6	3.7	26.9	6.0	4.2	4.3	6.3	10.9	14.7	25.4	13.3	1.7	1.8	4.3	5.3	2.7	26.4	12.2	2.3	11.7	16.0	7.0	10.2	12.8	10.1	23.3	13.1	13.6	18.9	20.5	5.3	16.1	8.8	26.3	34.5	15.6	46.7	14.7	27.5	40.0	11.6	8.6	18.6	34.9	10.9	38.4	16.6	12.0	19.6	39.3	43.8	63.8	6.6	30.3	56.0	31.7	65.7	22.9	36.5	59.8	3.0	7.9	43.2	3.6	15.7	4.1	6.8	15.3	1.4	7.9	17.4	2.0	6.7	10.0	8.7	15.7	24.8	2.6	93.5	9.3	4.0	17.1	5.4	22.0	6.4	27.8	12.7	4.7	68.2	77.2	23.8	15.5	49.0	99.5	85.6	2.8	4.0	16.5	3.5	9.6	9.8	8.1	19.4	21.1	4.1	2.3	14.8	10.4	152.2	2.3	5.5
PIP4K2C	"FLJ22055, PIP5K2C"	ENSG00000166908	"Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma"	Q8TBX8	12	57591174-57603418	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028658	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028658: AB_10601245"	"unprognostic (7.84e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (3.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.06e-6)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.42e-1)"	9.3	13.3	13.9	9.2	25.9	16.7	15.0	18.9	45.5	12.5	17.5	14.6	15.8	11.6	14.2	62.0	20.0	20.0	12.1	10.8	15.4	10.9	26.9	14.4	14.4	9.2	14.3	21.2	12.3	14.9	29.6	13.7	11.1	18.8	16.7	19.4	17.4	18.6	14.6	9.4	18.4	13.3	11.9	12.7	10.7	27.6	25.6	12.1	5.9	17.9	8.5	13.1	14.6	14.1	6.8	5.4	29.7	8.4	9.4	16.1	6.5	19.1	13.5	5.5	6.6	0.0	0.0	17.8	8.0	15.0	14.5	13.5	17.2	27.7	4.1	17.6	9.3	17.9	17.5	9.0	15.7	11.7	6.2	10.1	7.5	6.5	12.1	12.8	6.9	13.5	5.0	26.7	5.5	10.3	17.8	7.3	4.6	9.6	12.6	7.5	18.9	6.2	6.0	10.5	11.7	11.8	0.1	49.9	6.2	15.2	32.8	9.3	11.5	17.2	11.5	10.9	19.4	31.6	6.4	1.6	7.3	10.1	10.7	8.4	9.7	11.3	9.3	14.4	5.9	12.1	29.7	5.2	15.3	16.1	6.2	10.7	5.9	9.9	12.0	5.4	6.8	9.6	11.5	10.2	9.4	8.4	2.3	12.1	6.5	13.9	25.9	18.9	45.5	15.4	10.9	14.3	21.2	18.8	12.1	8.9	7.5	3.0	5.7	11.0	13.1	112.2	15.3	13.4	9.1	33.2	17.7	9.3	18.3	16.2	23.8	3.5	18.0	0.0	17.1	13.6	4.9	9.9	3.5	11.6	7.9	7.9	21.4	9.8	2.9	35.3	6.4	4.1	11.8	8.2	16.1	6.5	28.1	13.6	4.9	10.1	8.3	19.4	6.4	11.9	7.1	11.2	14.5	8.7	8.6	7.1
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705414-69009176	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 103.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 22.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 22.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.8;HEL: 8.9;Hep G2: 7.3;OE19: 39.1;U-266/70: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	4.0	9.5	9.4	8.4	6.5	10.2	4.2	33.4	14.6	5.6	26.9	4.1	10.8	26.1	6.1	2.0	1.2	5.0	7.6	24.6	8.1	11.7	6.1	0.8	12.6	2.1	10.4	6.4	1.4	6.7	21.3	8.5	16.8	32.8	3.3	23.1	28.7	11.6	13.6	3.0	2.4	39.7	2.6	3.7	3.1	19.9	17.6	1.5	0.0	1.6	1.9	3.3	3.5	2.9	3.9	0.9	22.1	0.3	0.0	1.0	0.2	0.0	0.0	23.8	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	8.9	0.2	7.3	0.0	0.5	2.2	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	5.1	0.1	0.6	0.0	0.1	1.2	39.1	0.7	0.7	0.0	0.1	0.1	1.8	0.4	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	9.2	1.7	1.1	0.0	1.6	0.0	3.1	0.3	22.1	0.0	0.0	0.0	3.3	0.2	0.0	0.1	3.9	0.5	0.0	1.2	0.0	0.1	0.9	1.0	0.2	9.4	6.5	33.4	14.6	8.1	11.7	10.4	6.4	32.8	1.5	32.8	27.2	5.2	3.0	0.6	4.6	51.2	5.1	4.0	2.3	5.2	2.0	16.1	23.2	1.3	54.3	3.0	49.9	46.7	12.3	0.7	1.0	2.3	5.7	0.0	3.2	0.0	35.5	1.8	1.3	32.7	2.3	2.2	5.0	0.0	26.7	103.2	5.6	33.1	1.4	0.7	3.1	25.8	46.7	1.2	1.7	0.3	7.3	1.3	23.7	4.3
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	16.1	10.2	20.5	12.8	25.8	4.5	8.0	58.6	46.3	10.7	23.5	8.5	14.8	10.9	19.8	10.0	12.3	12.8	12.7	13.8	22.8	10.7	7.5	3.8	11.5	7.5	11.3	17.1	11.5	17.2	10.0	9.2	13.7	19.0	16.7	6.4	16.9	20.0	33.4	13.5	10.2	11.5	19.2	6.3	15.8	13.6	23.9	8.7	5.3	9.3	3.9	6.0	17.3	19.0	2.5	3.2	3.6	3.0	1.7	2.8	2.0	9.2	8.8	6.9	8.9	13.5	11.0	10.4	17.9	11.3	7.7	6.2	7.8	2.6	3.9	6.9	19.1	8.5	8.2	3.2	5.8	3.2	13.8	5.8	4.4	7.3	6.3	11.3	4.5	13.8	12.2	5.5	6.3	2.4	5.5	13.0	5.9	6.7	7.2	7.2	7.7	5.4	3.3	7.2	3.4	12.2	10.2	5.3	5.3	5.7	8.0	7.0	6.0	9.2	5.0	5.4	9.0	4.0	6.8	28.6	10.8	6.2	38.1	8.3	8.3	6.6	1.7	14.5	9.5	7.7	3.6	2.8	0.0	2.8	2.6	1.2	2.5	2.1	2.0	3.2	1.3	1.0	1.6	2.2	1.7	3.0	2.2	1.4	2.0	20.5	25.8	58.6	46.3	22.8	10.7	11.3	17.1	19.0	8.7	6.0	5.3	5.4	2.8	4.7	40.8	5.5	7.6	2.7	0.0	15.7	35.3	6.2	1.7	6.9	8.4	12.0	7.0	0.0	6.2	6.0	8.5	4.9	1.1	3.6	13.3	28.6	8.1	16.0	11.0	17.7	13.8	10.8	5.0	13.6	9.2	10.5	9.9	7.0	22.6	5.7	26.6	12.9	10.7	19.0	10.4	5.9	13.7	6.4	5.7	3.8
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 177.5;Syncytiotrophoblasts: 204.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 39.6"					"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.27e-5)"	38.3	12.3	9.5	15.1	10.9	20.9	18.5	34.5	12.3	5.9	7.3	6.2	7.4	11.4	9.6	14.4	7.0	10.0	9.5	6.9	6.4	6.9	11.9	8.4	12.9	14.6	8.3	10.1	7.5	10.9	6.0	11.7	38.1	8.6	8.2	3.3	7.7	7.9	7.9	6.4	10.2	8.0	6.2	5.8	16.5	9.7	17.8	7.7	4.2	10.6	5.3	9.8	6.2	7.0	6.9	11.0	28.6	12.9	5.7	6.8	7.9	10.5	9.8	3.0	2.9	9.0	3.5	6.8	8.7	6.9	6.1	6.6	14.1	3.3	6.4	9.3	4.4	8.1	12.0	4.0	7.7	1.0	7.0	8.5	6.7	5.9	11.6	18.8	13.9	17.5	6.5	4.4	10.8	4.7	2.5	5.3	4.5	19.3	3.8	3.4	39.6	6.0	6.0	2.9	7.0	4.1	8.5	3.3	6.4	3.9	9.4	7.3	4.3	5.0	16.3	5.6	2.5	13.4	7.6	10.4	7.7	9.2	4.9	8.0	4.5	6.3	7.9	7.3	9.4	6.1	9.9	12.9	9.3	6.8	9.5	6.5	6.9	4.9	5.7	11.0	6.3	6.7	5.5	28.6	5.7	5.0	5.4	4.7	7.9	9.5	10.9	34.5	12.3	6.4	6.9	8.3	10.1	8.6	7.7	14.9	14.1	13.5	30.6	22.8	22.8	39.5	12.7	4.0	27.3	40.1	19.6	177.5	10.0	26.6	41.3	19.1	11.7	0.0	14.6	14.4	14.5	37.7	17.4	6.6	31.6	17.5	20.1	9.2	32.2	61.8	8.9	19.4	3.3	13.6	11.8	11.0	14.6	8.6	6.7	11.6	25.8	19.4	11.3	16.3	18.1	18.6	204.9	8.7	11.8	36.8
PITPNA	"PITPN, VIB1A"	ENSG00000174238	"Phosphatidylinositol transfer protein alpha"	Q00169	17	1517718-1562816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000528	Uncertain		Approved	Vesicles,Cytosol		NA	NA		100000	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (1.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (7.88e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (1.80e-6)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.81e-3)"	20.2	22.2	31.1	28.1	34.0	38.5	20.8	43.5	54.1	27.5	22.3	21.0	35.0	27.0	29.2	29.8	37.7	33.1	22.2	18.7	30.2	34.2	20.4	22.7	22.5	17.5	34.0	37.5	18.0	17.4	29.3	21.1	31.2	60.7	27.6	27.7	88.0	38.7	33.2	14.3	44.1	42.4	27.0	26.4	21.9	19.7	25.0	18.8	12.4	31.9	15.4	26.8	21.0	23.5	6.4	5.2	12.3	4.0	5.3	7.5	2.5	20.9	23.4	23.9	20.5	26.4	29.4	37.7	23.5	27.4	24.9	18.4	26.9	8.6	27.1	21.3	32.5	15.5	26.4	22.8	23.7	35.1	22.1	23.1	14.5	20.1	12.0	26.3	10.1	18.0	21.2	32.4	25.0	26.5	25.5	42.4	22.4	20.2	15.1	26.7	11.8	25.7	9.2	16.7	34.5	11.4	20.7	9.2	15.2	24.9	24.7	8.6	18.8	27.7	20.5	16.8	25.1	17.5	8.2	38.8	15.4	13.5	44.2	32.0	9.2	15.6	9.2	26.8	15.8	19.5	5.0	3.7	4.6	3.4	4.0	6.4	6.4	5.1	4.6	5.2	4.2	4.8	4.1	12.3	5.3	2.8	4.1	7.5	2.5	31.1	34.0	43.5	54.1	30.2	34.2	34.0	37.5	60.7	18.8	32.8	34.9	20.6	13.7	27.5	27.2	20.1	20.4	12.0	19.4	24.4	7.9	40.9	11.6	13.7	8.5	30.4	46.3	0.0	16.0	40.7	19.5	30.3	18.5	27.0	35.9	38.1	21.2	33.2	25.6	12.5	11.5	25.2	18.6	33.3	28.2	32.9	20.1	20.1	20.5	14.0	14.7	6.5	17.8	33.6	37.7	36.5	100.3	13.1	20.8	25.5
PITPNB	VIB1B	ENSG00000180957	"Phosphatidylinositol transfer protein beta"	P48739	22	27851669-27920134	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000528	Uncertain		Approved	Vesicles,Cytosol		NA	NA		150000	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (9.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.64e-1)"	32.5	22.2	29.6	24.8	29.3	14.8	25.0	20.8	38.0	23.9	37.8	16.2	24.5	17.1	32.9	23.8	42.2	21.7	28.4	31.3	24.7	24.5	20.5	43.8	23.9	24.6	25.7	29.0	24.8	22.3	21.8	26.9	38.1	27.2	26.5	24.6	15.1	20.2	31.2	16.1	23.5	21.2	49.6	22.6	20.6	28.8	14.7	21.1	19.9	20.0	15.2	30.9	45.3	43.3	24.4	17.1	20.4	14.7	17.7	27.2	16.9	30.3	13.2	24.2	18.0	21.5	26.0	18.5	29.5	25.8	32.4	31.4	20.8	14.4	21.0	15.7	28.3	24.0	32.1	34.4	29.4	45.7	35.9	32.5	21.5	21.4	19.0	23.2	48.9	34.9	23.2	28.8	39.1	40.9	21.4	31.4	14.9	30.4	44.0	29.6	16.2	20.7	24.1	18.3	31.8	17.4	26.5	38.2	30.8	26.8	28.9	28.4	35.6	20.2	24.4	23.8	27.0	13.2	17.5	30.8	32.5	47.6	24.6	30.7	18.0	21.1	41.4	27.9	24.3	27.4	20.4	12.8	12.4	22.7	14.7	25.0	24.4	22.2	23.6	17.1	20.8	21.6	21.1	11.6	17.7	13.7	15.4	27.2	16.9	29.6	29.3	20.8	38.0	24.7	24.5	25.7	29.0	27.2	21.1	26.8	29.6	43.6	108.4	85.3	23.7	52.2	28.1	24.1	59.1	29.6	13.7	34.6	31.5	42.4	12.0	54.0	15.5	0.0	43.4	43.6	48.3	61.5	19.8	43.3	24.1	30.2	24.2	31.9	19.6	5.0	29.7	32.9	25.3	69.5	22.6	16.4	50.2	17.5	45.3	23.0	13.1	25.8	124.0	41.7	35.6	71.8	40.6	38.4	19.0	101.1
PITPNC1	"RDGB-BETA, RDGBB, RDGBB1"	ENSG00000154217	"Phosphatidylinositol transfer protein, cytoplasmic 1"	Q9UKF7	17	67377281-67697261	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026563, HPA031250"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA026563: AB_1855409, HPA031250: AB_2673808"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.17e-2)"	"prognostic favorable (4.85e-5)"	"unprognostic (6.57e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-2)"	20.8	10.0	22.9	18.0	31.0	11.3	16.6	18.9	33.5	12.0	7.5	18.7	7.0	4.6	10.7	11.7	11.0	22.4	12.5	11.7	23.4	19.1	17.3	14.3	13.5	24.3	21.4	17.0	16.7	23.3	5.4	12.3	19.0	22.7	11.2	9.1	31.2	18.3	13.1	5.1	5.2	8.1	11.7	14.8	13.9	11.8	5.1	17.8	14.5	10.4	6.0	27.0	12.0	16.8	1.6	1.6	16.1	5.5	7.2	16.4	5.0	5.9	2.3	5.9	11.6	5.2	7.1	6.9	6.7	5.3	1.3	1.0	0.0	8.8	7.3	2.2	6.2	2.2	2.5	10.5	10.1	1.4	13.4	6.1	0.8	9.8	4.8	1.4	1.4	13.8	5.5	4.4	0.8	5.4	0.7	5.1	9.9	0.6	26.6	5.1	12.8	17.0	6.2	10.1	2.8	12.1	21.6	1.3	6.5	12.6	7.2	7.3	19.3	2.6	5.1	6.0	6.6	3.8	7.3	5.1	3.2	1.3	4.0	3.2	17.3	8.6	5.6	20.2	6.0	2.5	1.1	2.5	16.1	16.4	4.0	9.6	1.0	10.7	15.5	1.6	1.6	12.3	13.0	3.1	7.2	5.5	0.4	4.0	5.0	22.9	31.0	18.9	25.3	23.4	19.1	21.4	17.0	22.7	17.8	8.9	0.6	10.0	40.5	4.7	18.6	5.3	20.4	2.7	2.3	0.0	2.0	7.0	18.3	38.5	0.3	48.5	1.3	0.0	43.0	8.8	5.8	29.8	4.7	7.9	12.4	69.9	5.8	17.2	15.8	1.0	4.6	11.0	10.1	19.0	1.3	25.9	36.1	3.5	13.8	12.6	22.1	25.8	21.1	0.5	3.8	3.8	2.9	45.7	2.8	41.1
PITPNM3	"ACKR6, CORD5, NIR1, RDGBA3"	ENSG00000091622	"PITPNM family member 3"	Q9BZ71	17	6451264-6556494	"Disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 16.8;Ito cells: 35.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"neutrophil: 5.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.3;HeLa: 8.8;hTCEpi: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022432, HPA059005"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA022432: AB_2670936, HPA059005: AB_2683876"	"unprognostic (2.97e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.63e-1)"	1.1	2.4	17.9	1.2	18.8	0.5	1.7	18.7	23.0	2.4	4.5	0.7	3.4	1.5	1.9	3.4	9.4	4.3	3.8	0.8	7.2	5.2	1.5	1.6	3.1	0.6	2.9	11.9	24.2	0.9	1.9	0.7	0.6	2.5	2.7	3.6	2.3	1.9	8.3	1.1	14.3	1.4	3.8	0.9	43.3	3.2	2.4	1.5	0.0	2.4	0.7	2.1	1.3	2.5	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.6	0.6	0.4	0.2	0.0	0.1	0.4	0.4	0.1	0.5	0.4	0.3	4.0	0.1	2.1	0.1	1.5	11.3	0.2	2.3	0.2	0.2	0.4	0.1	8.8	0.1	0.6	0.2	0.4	0.1	33.0	0.6	1.9	2.7	0.3	0.4	0.1	0.0	0.3	0.5	0.1	0.1	0.6	2.8	1.6	0.2	1.2	0.0	0.8	0.1	0.3	0.3	5.2	2.4	0.1	0.2	0.8	0.0	0.2	0.3	2.1	0.4	1.3	0.3	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	17.9	18.8	18.7	23.0	7.2	5.2	2.9	11.9	2.5	1.5	3.0	16.8	0.0	1.7	4.5	6.9	2.2	7.6	8.1	9.1	1.8	3.9	0.0	0.0	2.2	3.8	2.7	5.4	0.0	0.5	0.0	0.6	1.5	5.7	0.9	0.1	4.8	1.2	35.0	4.9	1.3	0.6	0.0	0.0	0.0	3.6	0.5	5.9	5.8	0.0	0.0	10.2	0.0	0.5	2.1	1.6	5.1	0.1	0.8	6.0	3.6
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027735-135034813	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8"	"Cell type enhanced"	"Detected in some"	27	"Basal glandular cells: 84.7;Glandular cells: 52.7;Urothelial cells: 214.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.4;HeLa: 33.0;K-562: 32.2;T-47d: 48.1"	"Not detected"	"Not detected"							HPA008743	Approved		Approved	Nucleoli		Yes	No			Nucleoli		"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	0.3	0.3	0.0	4.7	0.0	0.3	0.2	0.0	0.2	14.8	2.8	0.0	0.0	5.6	0.5	1.2	119.4	0.3	1.9	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	32.9	1.3	1.0	8.8	1.1	10.8	33.0	0.2	8.6	0.5	3.2	18.6	0.0	0.2	7.4	0.4	0.0	0.0	0.4	58.8	60.8	18.2	28.9	0.3	0.3	1.4	0.4	0.4	1.1	0.2	17.2	10.6	0.0	14.2	0.6	0.2	4.4	3.4	5.0	1.7	0.6	40.4	10.2	19.4	5.5	0.2	4.2	5.9	2.3	8.3	0.1	0.2	15.0	4.8	33.0	11.1	5.2	1.7	0.0	0.4	6.0	0.0	1.9	0.1	0.0	3.0	32.2	0.0	0.5	5.3	0.1	3.8	0.0	1.5	9.5	5.7	0.3	0.3	0.2	5.4	6.6	0.0	15.1	8.2	0.0	0.1	48.1	1.1	0.6	1.9	4.8	1.0	5.3	0.0	0.0	12.7	2.5	0.1	0.0	1.4	0.3	0.1	0.9	0.3	0.5	0.3	0.6	1.1	0.2	0.3	0.3	1.0	0.7	0.4	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	84.7	1.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.4	0.0	0.3	0.0	0.4	2.0	0.9	52.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.0	0.0	0.3	0.0	9.9	0.3	0.0	0.0	2.0	0.0	1.4	1.4	4.1	5.9	6.4	0.0	0.6	214.7
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;testis: 30.9"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 10.2;Mucus-secreting cells: 7.8;Paneth cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"NB-4: 44.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036587, HPA036588, HPA057508"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	1.9	0.6	1.9	1.9	3.1	17.8	2.7	4.1	1.7	2.2	3.8	1.7	1.7	4.5	2.5	1.7	1.7	2.0	3.6	1.7	1.9	1.7	1.7	1.7	1.7	2.5	1.7	1.7	2.2	8.2	0.2	1.7	2.3	1.7	1.7	5.0	1.7	7.6	2.0	1.7	0.8	4.3	1.7	2.5	2.3	3.6	30.9	1.7	1.7	1.7	1.7	1.8	1.7	1.7	0.0	0.8	0.5	2.4	0.3	1.3	1.0	0.1	0.0	0.2	0.0	3.3	2.2	0.2	0.2	0.1	0.1	0.4	0.3	0.3	0.0	0.2	1.3	0.1	0.0	0.4	0.0	0.1	1.2	0.1	0.1	0.3	0.0	1.3	3.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.2	0.1	44.9	0.0	4.4	0.3	0.1	0.0	0.0	1.0	0.0	0.2	0.1	0.2	0.4	0.2	0.1	0.0	9.9	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.4	0.5	1.0	1.0	0.0	0.0	0.1	0.6	0.8	0.0	1.3	0.4	0.0	0.3	1.0	0.0	0.4	1.0	1.9	3.1	4.1	1.7	1.9	1.7	1.7	1.7	1.7	1.7	0.0	0.3	0.0	0.2	1.1	0.6	1.4	10.2	2.7	2.3	0.0	0.0	3.3	1.7	3.6	2.8	0.5	2.9	0.0	1.8	0.3	0.9	0.4	0.0	0.0	1.5	0.0	0.0	1.3	3.1	1.0	0.3	1.5	0.0	1.0	7.8	0.3	2.7	6.5	1.1	0.6	2.8	0.0	0.8	0.7	1.5	0.1	0.8	0.0	4.7	0.0
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.6	8.8	9.3	7.6	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.1	15.6	9.1	38.6	13.7	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.3	6.7	6.4	7.4	5.3	2.9	1.1	6.7	5.6	0.8	3.6	17.1	8.9	13.2	7.5	11.2	2.5	10.6	8.8	18.7	12.1	11.2	1.9	8.5	20.9	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5	14.9	4.5	5.1	14.7	36.5	16.4	6.3	5.1	2.7	11.4	3.5	7.9	30.0	13.3	20.5	77.4	5.1	0.7	0.0	10.2	12.8	18.9	7.8	4.6	1.7	6.7	4.8	5.2	5.5	3.8	22.6	25.0	4.1	5.0	1.8	2.8	28.6	13.9	1.4	18.4	4.4	5.9	6.5	17.0	0.9	1.0	25.7	17.4	7.9	2.3	17.6
PJVK	DFNB59	ENSG00000204311	Pejvakin	Q0ZLH3	2	178451346-178461409	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.2"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 10.8;Club cells: 3.4;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.5"	"Cell line enhanced"	"Detected in many"		"SuSa: 11.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042621			Approved	Mitochondria		No	No			Mitochondria		"HPA042621: AB_10797503"	"unprognostic (4.01e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.06e-3)"	2.2	1.4	2.5	1.0	3.5	0.7	4.4	1.3	3.7	2.1	1.5	1.2	3.5	0.7	3.5	7.2	2.2	2.6	2.6	1.0	2.7	2.2	2.1	2.2	1.0	1.3	2.8	4.4	7.0	1.0	1.4	3.9	1.0	2.0	2.3	0.9	2.4	2.1	2.7	2.7	3.5	1.3	1.7	2.7	1.0	0.9	35.2	1.3	1.0	2.3	1.7	1.2	1.6	1.2	1.5	6.5	0.6	0.3	0.4	1.3	0.1	0.4	2.7	3.5	2.8	4.7	5.2	1.8	2.2	2.2	2.0	3.1	1.0	4.5	3.1	2.3	1.3	1.6	1.4	2.5	1.4	1.3	1.0	0.9	1.0	3.7	0.6	4.5	0.8	0.2	4.9	3.4	2.2	4.9	5.8	2.3	6.1	0.5	2.0	2.3	0.4	2.9	1.9	4.2	0.3	1.1	3.9	2.6	1.9	3.1	1.4	2.5	2.1	1.0	0.5	0.8	11.0	1.0	0.9	1.5	2.3	0.9	0.7	0.2	6.4	4.0	1.0	1.1	1.7	0.9	0.0	0.3	0.0	0.3	0.2	0.4	0.8	0.4	0.2	0.1	1.5	1.3	0.7	0.6	0.4	0.0	6.5	0.0	0.1	2.5	3.5	1.3	3.7	2.7	2.2	2.8	4.4	2.0	1.3	6.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.8	0.0	0.9	3.3	1.1	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 7.5;testis: 29.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 25.9;Spermatocytes: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.9;U-266/70: 4.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA041903: AB_2677734, HPA043634: AB_2678591"	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.5	1.5	2.0	0.6	2.5	2.2	1.2	1.7	1.9	0.5	0.3	0.7	0.7	0.3	0.5	1.0	0.5	0.4	0.6	1.7	1.0	0.8	0.4	0.3	0.4	1.3	1.2	1.3	0.6	1.1	0.0	1.5	0.2	1.8	0.5	0.1	0.2	0.7	0.0	3.3	0.8	0.3	0.0	0.7	1.0	0.6	29.3	0.4	0.0	1.0	0.0	0.2	0.4	0.6	3.9	3.5	7.5	1.7	1.9	1.9	0.8	1.6	1.2	0.2	0.1	0.4	0.5	1.8	0.6	0.0	0.0	0.0	0.1	3.2	2.3	3.5	0.0	0.1	0.7	0.1	0.0	0.1	1.5	1.1	1.3	4.2	0.1	0.0	0.4	1.8	0.1	0.2	0.0	0.0	0.7	0.6	3.3	1.5	5.9	0.8	0.5	1.1	2.4	0.6	0.1	1.0	0.0	0.1	0.0	0.0	2.3	0.8	0.9	1.5	0.2	0.9	0.7	0.4	0.5	0.5	1.0	1.8	0.7	1.0	4.6	3.4	0.4	2.3	0.7	1.8	7.1	1.7	3.0	1.8	1.2	1.0	2.5	1.6	1.4	0.9	3.9	1.9	1.7	7.5	1.9	1.0	3.5	1.1	0.8	2.0	2.5	1.7	1.9	1.0	0.8	1.2	1.3	1.8	0.4	3.0	2.1	0.5	1.6	1.9	2.3	1.5	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.1	25.9	0.8	0.0	0.0	0.0	0.1	1.3	1.3	1.1	0.2	0.2	3.2	0.0	1.3	0.6	4.7	0.6	0.2	3.3	0.0	0.0	0.9	0.1	0.0	0.4	0.2	3.9	0.0	1.2	19.5	2.2	1.0	0.1	0.7	0.0	0.5
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 8.3;Hepatocytes: 15.1;Late spermatids: 16.6;Proximal tubular cells: 43.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"K-562: 48.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA		2900000	"Golgi apparatus, Cytosol"		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	8.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	"Protein kinase N1"	Q16512	19	14433053-14471867	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003982, CAB010278"	Approved		Approved	"Plasma membrane,Focal adhesion sites,Cytokinetic bridge"		NA	NA			"Plasma membrane"	"Focal adhesion sites, Cytokinetic bridge"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	"unprognostic (3.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.24e-2)"	28.8	19.5	19.1	27.6	26.7	39.6	25.3	21.9	19.2	19.2	26.0	20.9	16.5	10.0	25.4	19.7	16.6	22.2	22.5	38.3	17.1	17.6	17.9	16.3	27.9	42.2	19.5	16.3	21.7	32.3	15.8	18.7	22.7	19.2	22.6	6.9	21.5	22.6	22.7	43.2	7.6	16.9	22.5	19.4	39.7	24.2	21.5	18.9	39.2	17.8	13.8	24.0	22.1	30.5	11.5	17.0	24.1	30.6	13.5	20.7	15.2	37.7	22.5	8.4	17.4	13.6	16.1	13.8	13.6	16.3	14.4	13.8	8.8	21.7	36.1	35.2	23.3	18.0	8.8	13.4	6.0	5.6	29.2	17.4	43.2	14.4	18.6	45.1	17.0	27.1	11.5	4.4	8.7	13.7	16.4	33.4	19.2	19.1	25.1	10.6	15.5	25.5	15.7	15.2	13.7	25.8	34.3	11.5	25.9	7.1	6.2	30.6	43.4	8.4	10.8	22.0	4.2	9.7	29.6	49.9	28.6	12.3	34.6	20.6	33.0	30.0	19.7	18.8	34.1	22.4	15.4	17.3	24.1	20.7	24.2	15.7	10.7	14.0	14.2	17.0	11.5	13.1	14.3	21.3	13.5	30.6	11.1	15.9	15.2	19.1	26.7	21.9	17.3	17.1	17.6	19.5	16.3	19.2	18.9	3.0	2.1	24.5	5.5	3.3	36.7	3.5	25.5	1.4	1.2	33.2	15.7	1.9	1.7	23.7	4.1	29.5	2.6	0.0	25.6	12.9	16.0	10.2	2.3	9.6	49.5	46.1	38.6	51.0	56.2	6.7	18.4	27.1	16.9	29.7	12.0	47.4	49.8	9.5	21.5	12.7	25.3	25.8	16.5	6.3	26.6	2.4	3.1	48.4	6.6	3.2
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.7	9.3	18.5	11.1	12.4	14.1	12.0	14.1	13.0	15.8	16.5	9.9	17.1	9.4	16.8	13.4	19.5	18.8	18.0	10.7	21.7	3.3	13.1	6.9	19.4	8.4	10.9	6.8	2.1	11.6	11.1	12.4	15.0	12.6	18.0	7.5	11.5	6.9	17.0	4.8	7.8	5.9	9.3	9.0	10.9	7.5	28.2	3.8	14.0	46.8	9.0	5.9	21.1	12.2	18.1	14.6	9.1	6.2	16.8	13.5	12.1	17.2	14.7	3.8	3.2	6.4	5.6	6.7	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2	38.7	52.6	24.5	42.6	42.9	83.6	41.1	40.8	45.5	39.8	66.3	84.4	37.5	10.0	51.4	2.1	51.2	79.8	70.0	52.5	29.4	35.1	52.3	15.1	32.6	20.4	62.0	42.5	51.0	34.3	2.9	50.3	29.0	30.4	41.5	55.9	64.3	62.0	87.7	45.3	22.4	151.6	38.8	29.8	35.8	18.8	45.8	31.2	21.0	50.9	118.4
PKN3	"PKNbeta, UTDP4-1"	ENSG00000160447	"Protein kinase N3"	Q6P5Z2	9	128702523-128720918	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 13.4;Extravillous trophoblasts: 5.1;Ito cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 33.4;REH: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045390, HPA058305"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA045390: AB_2679308, HPA058305: AB_2683674"	"unprognostic (4.36e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.73e-3)"	"unprognostic (6.18e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.36e-1)"	11.4	1.8	1.5	6.8	3.8	3.7	10.5	10.1	3.9	4.3	5.8	3.7	4.8	7.7	9.7	2.2	7.1	5.3	10.9	7.3	2.3	1.7	5.0	6.4	8.9	9.1	3.9	1.2	4.0	4.2	3.3	1.4	5.6	4.5	4.2	1.6	4.1	12.9	3.7	7.4	6.7	5.4	4.9	4.4	7.8	7.4	4.3	1.7	9.3	8.1	6.1	5.9	4.4	5.0	0.4	1.0	2.3	0.7	1.0	1.8	0.3	1.4	6.9	5.6	8.5	0.0	0.1	13.9	4.3	1.3	6.3	6.5	0.0	5.0	0.0	4.2	2.3	1.3	9.3	6.8	1.0	1.4	4.3	12.8	8.2	33.4	9.7	1.0	1.0	1.5	0.3	0.3	3.4	0.9	1.3	12.4	2.5	18.6	0.9	1.1	12.8	1.2	4.4	5.2	6.3	2.0	20.3	10.6	1.8	2.6	0.8	0.9	4.2	3.2	1.7	3.2	3.2	6.1	6.6	10.7	0.0	5.3	9.9	3.2	3.1	1.3	2.7	0.8	1.0	3.9	0.0	0.1	1.4	0.9	0.7	1.8	0.2	0.6	0.8	1.0	0.4	0.8	0.1	2.3	1.0	0.2	0.2	1.0	0.3	1.5	3.8	10.1	3.9	2.3	1.7	3.9	1.2	4.5	1.7	0.0	1.3	0.0	1.4	0.9	0.0	1.5	0.0	0.0	2.3	0.0	0.0	1.2	0.0	1.6	0.3	13.4	1.1	0.0	2.3	5.1	0.9	0.9	0.0	0.2	1.5	0.0	0.0	6.2	0.3	0.4	1.4	0.2	0.0	1.8	1.0	0.5	2.6	0.8	0.7	0.3	0.2	0.0	0.8	1.0	3.4	0.9	1.1	1.0	1.4	1.6
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 28.7;Melanocytes: 8.5;Peritubular cells: 16.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 27.2;AN3-CA: 6.8;hTEC/SVTERT24-B: 5.4;LHCN-M2: 8.0;SK-MEL-30: 5.4;WM-115: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		NA	NA			Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	5.8	4.1	10.0	3.3	12.4	0.7	1.7	16.3	25.7	5.1	2.8	3.6	0.2	2.0	5.6	4.7	2.7	9.8	3.4	7.9	7.3	6.9	2.9	1.1	9.6	2.4	5.2	12.3	23.6	6.3	0.9	7.3	12.8	6.9	10.2	2.8	24.3	2.5	8.7	19.5	4.0	2.4	4.6	4.6	3.4	2.5	7.2	3.1	0.0	18.3	8.4	2.2	3.3	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	27.2	6.8	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	4.4	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.4	16.3	25.7	7.3	6.9	5.2	12.3	6.9	3.1	0.0	0.0	0.0	0.0	0.8	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.7	28.7	0.5	0.0	0.0	0.2	0.0	1.4	1.8	0.0	0.0	0.2	7.9	0.0	1.3	0.0	7.4	4.6	0.0	8.5	0.0	0.0	3.3	0.2	0.0	16.6	0.0	0.2	6.5	3.1	0.7	0.1	0.4	0.1	0.0	0.0	0.0
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 80.1;skin 1: 137.6;tongue: 129.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 124.1;Suprabasal keratinocytes: 357.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 295.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 45.1;HBEC3-KT: 27.6;hTCEpi: 98.2;hTERT-HME1: 26.1;PC-3: 37.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		2700000	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	10.1	0.1	0.0	0.1	0.0	0.1	7.0	0.0	0.4	19.7	0.5	0.0	2.5	0.1	1.5	1.9	80.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.6	0.0	6.8	0.1	4.9	10.1	3.9	2.1	137.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	9.2	0.1	129.6	37.2	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	45.1	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.2	1.1	26.1	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	46.2	124.1	6.7	1.3	0.0	0.0	4.5	0.0	2.0	0.0	0.0	0.9	0.0	1.6	0.0	0.0	1.0	0.0	7.1	21.9	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	1.2	3.2	9.4	0.0	0.0	0.0	37.2	0.0	3.9	0.0	0.0	357.5	0.1	0.0	0.0	44.2
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597842-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 14.0;Hepatocytes: 21.7;Peritubular cells: 13.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.9"	"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"	NA	NA			"Nuclear speckles, Cytoplasmic bodies"	Nucleoplasm	"HPA059740: AB_2684118"	"unprognostic (1.35e-1)"	"prognostic favorable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	2.5	0.4	3.8	1.5	4.7	0.2	1.8	1.4	2.5	2.5	1.3	1.7	47.8	0.6	3.2	63.1	0.8	2.7	1.3	5.0	3.6	4.3	9.3	17.2	13.7	6.1	6.0	1.0	0.5	1.8	11.4	1.0	4.4	7.0	6.0	1.2	10.7	1.5	123.8	10.3	0.3	1.9	4.2	7.4	0.5	2.2	2.0	2.5	0.4	5.0	0.4	3.7	2.1	1.3	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	0.3	0.5	0.1	0.0	0.2	0.0	0.0	23.9	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	3.8	4.7	1.4	2.5	3.6	4.3	6.0	1.0	7.0	2.5	0.0	1.7	0.0	0.3	0.6	0.0	1.2	2.5	2.7	1.2	14.0	0.0	0.1	1.7	2.7	5.2	8.7	0.0	0.0	1.9	0.0	0.6	0.3	1.1	21.7	1.6	0.0	1.7	4.9	0.3	2.2	0.3	5.3	1.7	7.2	0.0	0.0	2.2	0.0	13.4	4.9	0.0	0.0	0.3	0.0	0.2	0.5	1.6	0.0	0.0	0.3
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261062	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 96.5;Syncytiotrophoblasts: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	23.8	9.1	9.6	6.6	9.4	5.6	19.7	16.4	16.1	5.4	6.2	10.0	4.7	5.0	7.7	11.2	5.7	7.2	8.5	31.3	7.9	8.6	24.1	11.8	15.9	23.1	7.5	9.2	7.4	6.4	11.3	9.2	24.4	7.7	6.2	5.7	8.5	7.6	5.8	39.9	10.0	5.3	8.2	6.8	16.2	6.2	9.3	6.2	11.3	10.4	6.8	4.9	9.1	5.0	3.7	8.8	9.4	18.2	1.3	4.5	7.7	4.6	5.0	4.0	12.6	19.0	13.9	9.2	11.6	15.5	17.6	14.8	11.6	8.7	8.5	14.6	16.5	13.7	7.3	4.2	5.0	8.1	2.4	6.4	2.4	4.9	9.2	10.2	2.3	12.6	9.5	5.7	17.6	2.8	22.4	10.7	4.2	3.5	4.5	11.3	10.1	3.2	7.0	2.5	4.4	5.7	4.7	5.7	26.3	8.8	4.3	1.3	2.6	15.5	4.7	9.5	3.5	12.1	11.4	8.7	15.4	7.5	19.8	7.2	17.0	14.4	10.3	14.0	6.6	5.9	9.4	14.4	9.3	3.1	16.8	3.2	3.3	3.4	4.5	8.8	3.7	4.5	3.7	0.6	1.3	18.2	7.8	3.2	7.7	9.6	9.4	16.4	16.1	7.9	8.6	7.5	9.2	7.7	6.2	6.0	3.5	0.0	2.1	4.2	12.2	19.7	2.5	1.4	4.5	8.7	7.9	17.6	5.0	8.5	1.7	6.3	4.0	0.0	6.2	7.0	6.9	2.5	15.0	10.9	96.5	36.5	0.0	11.1	32.7	4.5	2.0	16.4	11.8	6.4	6.1	4.3	5.7	4.5	1.4	18.1	5.5	0.0	4.1	3.9	2.2	3.0	42.4	4.3	3.3	1.7
PLA2G4C	cPLA2-gamma	ENSG00000105499	"Phospholipase A2 group IVC"	Q9UP65	19	48047843-48110817	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.8;skeletal muscle: 45.0"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 54.2;Cone photoreceptor cells: 62.8;Muller glia cells: 53.7;Rod photoreceptor cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 8.2;HHSteC: 13.4;TIME: 18.6"	"Not detected"	"Not detected"							HPA043083	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA043083: AB_10795714"	"unprognostic (1.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.01e-2)"	4.0	11.7	8.9	4.2	23.2	0.4	3.0	12.9	14.5	3.4	3.5	23.4	2.0	5.1	6.8	5.2	3.6	4.3	4.6	18.5	10.0	10.0	4.4	3.8	5.9	7.2	31.8	8.5	2.0	4.1	14.8	4.6	4.1	16.9	5.7	2.9	5.4	3.1	6.7	45.0	4.9	6.7	8.1	18.6	8.1	2.4	2.4	17.1	0.7	3.3	7.5	4.3	4.9	2.1	5.4	2.0	0.0	7.9	1.5	0.8	2.0	0.7	1.1	0.0	0.3	5.2	3.0	0.1	1.3	8.2	1.2	3.5	0.0	2.1	0.0	1.8	3.2	2.6	0.2	0.0	0.2	2.0	0.8	0.1	0.0	0.3	1.2	13.4	0.0	1.8	0.6	0.3	0.5	5.4	2.5	5.1	0.0	0.0	7.4	2.0	2.0	0.0	0.1	0.1	0.9	0.1	0.1	1.8	0.7	2.5	0.4	0.8	0.1	1.5	2.6	6.3	4.2	0.7	1.8	18.6	2.3	0.7	2.5	0.9	0.5	1.4	0.2	1.6	0.0	4.4	0.0	3.2	0.0	0.2	7.9	0.6	5.4	0.8	0.0	2.0	1.6	0.0	0.0	0.0	1.5	2.0	1.4	0.2	2.0	8.9	23.2	12.9	14.5	10.0	10.0	31.8	8.5	16.9	17.1	3.0	1.7	0.5	0.8	2.5	54.2	30.9	10.2	0.0	0.0	0.0	62.8	0.1	1.7	7.7	0.2	16.9	1.6	0.0	2.5	0.2	3.8	1.7	0.0	1.0	5.0	31.8	0.0	3.1	0.3	0.0	0.6	2.8	6.8	4.6	1.5	53.7	4.1	0.3	7.4	3.4	133.4	12.9	11.8	0.3	0.5	2.6	0.1	0.0	0.0	0.1
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 30.4;skin 1: 48.1"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 54.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 14.1;RT4: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.1	0.1	0.0	2.5	0.3	0.3	1.8	0.0	0.1	4.5	11.0	0.0	4.7	4.2	0.4	9.7	10.4	0.2	3.1	1.0	0.0	0.0	10.8	0.2	30.4	0.1	0.0	0.0	0.1	0.1	0.7	4.1	0.3	0.0	3.3	2.5	0.0	5.3	2.8	8.6	48.1	12.3	1.1	0.1	0.2	1.6	0.1	0.0	6.2	1.6	14.9	3.4	2.2	6.3	0.6	0.3	0.2	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.4	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.1	0.0	14.1	0.1	0.0	0.0	0.1	0.0	10.6	0.6	0.1	0.0	1.1	0.0	0.1	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	54.9	0.0	3.3	4.8	0.0	3.2	0.0	0.0	0.0	5.2	0.0	1.5	3.3	0.2	0.0	0.0	12.0	0.0	1.2	0.7	0.2	2.7	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	4.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	1.0	0.0	4.3	1.6
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38205690	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 31.8;HMC-1: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	16.2	17.7	15.6	8.5	20.5	13.1	15.6	15.9	26.3	14.8	7.9	36.9	18.5	9.8	16.3	20.5	8.7	21.6	25.3	6.3	19.7	7.2	18.1	8.6	9.0	12.4	19.3	16.7	21.3	12.8	24.2	12.7	6.8	19.5	17.6	6.3	12.9	20.2	17.4	7.4	18.1	8.7	7.8	14.9	12.1	9.5	30.0	23.2	16.3	45.7	4.1	11.3	12.1	11.2	1.8	5.4	4.1	0.9	8.8	5.7	1.9	0.7	2.8	3.0	7.8	10.1	5.0	8.2	0.9	1.0	0.8	1.1	3.1	1.8	5.9	6.6	2.3	1.3	3.6	3.5	1.9	1.0	9.0	13.2	31.8	3.9	3.6	2.8	3.5	20.3	16.3	4.3	2.8	4.5	8.2	1.0	13.0	5.2	10.7	1.5	4.6	6.6	2.1	2.6	2.1	1.8	4.9	1.2	4.5	2.9	7.0	5.8	2.4	1.3	3.1	7.2	4.5	3.3	2.5	1.3	2.6	4.5	1.1	0.6	17.6	3.1	3.1	3.7	4.1	1.6	4.1	0.9	0.4	3.8	0.3	1.9	1.8	3.1	5.7	1.5	1.5	1.4	3.9	3.3	8.8	0.6	5.4	3.7	1.9	15.6	20.5	15.9	26.3	19.7	7.2	19.3	16.7	19.5	23.2	3.0	2.4	4.4	3.6	2.7	9.4	1.5	2.5	5.3	5.7	12.2	3.9	2.5	0.0	1.4	16.1	1.9	11.0	0.0	0.9	2.4	2.1	4.2	0.0	3.4	1.4	14.3	10.9	3.7	1.5	13.7	5.5	1.0	1.7	3.6	6.9	4.5	1.4	11.5	3.5	0.8	7.0	6.5	1.7	23.8	7.5	3.0	4.1	6.9	6.9	1.3
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062610	"Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 46.1"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 31.4;Muller glia cells: 30.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 9.2;ASC TERT1: 12.5;BJ hTERT+: 9.9;hTERT-RPE1: 16.5;TIME: 28.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		99000	Cytosol		"CAB068217: AB_2665660, CAB068218: AB_2665661"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.6	2.1	0.6	2.3	1.1	0.0	9.4	19.5	1.9	11.3	7.0	1.0	2.4	2.4	17.8	4.7	4.7	4.8	6.9	2.7	0.7	1.0	15.0	0.9	2.3	1.8	0.8	0.7	8.7	0.8	14.5	2.6	6.6	3.3	3.3	2.0	7.8	46.1	2.0	0.8	9.6	9.4	5.7	2.5	3.0	1.6	1.3	0.2	0.3	27.6	6.6	5.1	4.5	9.4	0.6	0.6	2.3	0.8	1.0	0.6	0.2	0.1	1.0	0.3	0.0	9.2	12.5	0.0	4.1	9.9	0.8	1.1	0.0	2.1	0.0	0.2	4.3	0.9	2.0	0.0	3.0	0.8	0.0	0.0	0.0	6.9	0.0	0.7	0.0	0.0	5.0	3.3	1.2	1.3	16.5	5.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	7.2	1.3	0.0	1.1	1.6	0.1	28.7	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.5	0.5	0.5	0.6	0.5	0.4	0.3	0.3	0.6	0.6	0.6	2.3	1.0	0.8	0.6	0.4	0.2	0.6	1.1	19.5	1.9	0.7	1.0	0.8	0.7	3.3	0.2	6.0	3.2	0.0	2.2	8.4	0.8	3.6	5.1	6.7	2.3	31.4	0.0	4.3	0.0	0.7	0.0	3.6	2.6	0.0	1.8	1.1	6.7	2.3	1.1	0.0	0.5	15.9	1.2	8.0	0.0	0.9	15.0	0.0	6.8	0.0	6.1	30.3	3.2	5.8	15.6	1.1	1.1	6.5	2.2	0.0	0.6	4.6	1.3	0.0	6.5	2.2
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta specific 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 305.1;Ciliated cells: 487.2;Enterocytes: 398.3;Extravillous trophoblasts: 527.8;Kupffer cells: 319.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 181.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 32.2;CAPAN-2: 93.1;HL-60: 57.7;NB-4: 28.4;RPMI-8226: 41.6;THP-1: 33.5;U-937: 26.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	2.3	1.3	1.7	47.9	5.9	62.0	1.6	0.7	4.1	6.1	44.1	0.6	0.2	14.6	1.0	0.9	34.5	3.1	7.5	2.4	1.4	1.9	1.6	12.4	23.4	51.6	2.5	0.2	1.9	1.2	0.0	1.3	32.3	3.0	2.0	31.4	1.3	9.7	1.0	0.8	0.7	66.5	3.1	5.2	74.8	21.8	0.7	2.7	18.2	1.5	1.4	53.1	3.4	2.5	41.5	181.6	7.0	47.8	77.6	32.9	36.0	32.2	0.2	0.1	0.2	0.0	0.0	5.3	0.8	0.2	2.0	2.5	0.6	93.1	5.4	0.2	9.4	3.2	3.4	0.5	0.2	7.7	0.0	0.1	0.1	6.4	2.7	0.3	57.7	0.3	0.1	0.6	0.3	0.4	0.0	0.1	2.8	0.0	0.4	5.3	0.1	10.9	28.4	0.2	2.5	0.1	1.4	1.9	41.6	0.1	0.9	4.7	0.0	0.2	5.4	0.1	1.7	0.3	33.5	0.2	0.2	6.0	0.1	0.1	0.3	0.0	14.4	0.4	26.6	0.0	2.7	11.0	7.0	32.9	47.8	24.9	41.5	15.7	18.7	10.0	38.4	19.4	22.0	2.4	77.6	25.8	181.6	1.0	36.0	1.7	5.9	0.7	4.1	1.4	1.9	2.5	0.2	3.0	2.7	181.7	50.7	305.1	1.9	0.3	0.0	0.4	2.5	487.2	61.4	0.0	0.0	7.9	0.0	0.0	0.2	1.4	398.3	0.0	3.3	527.8	0.9	0.9	25.5	1.5	20.9	1.6	83.1	171.9	319.5	0.4	0.0	79.4	6.8	1.0	179.6	1.3	57.7	270.0	0.0	0.8	0.1	6.5	0.3	0.2	0.1	0.1	11.9	261.7	36.3	8.4
PLAC8L1		ENSG00000173261	"PLAC8 like 1"	A1L4L8	5	146084386-146104369	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 20.4"	"Group enriched"	"Detected in some"	78	"Early spermatids: 401.3;Late spermatids: 218.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074266			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074266: AB_2686676"	"unprognostic (6.38e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.62e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-6)"	"unprognostic (9.72e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.18e-2)"	0.4	0.1	0.9	0.4	1.0	0.1	1.0	1.6	0.8	0.4	0.4	0.4	0.4	0.0	0.5	0.5	0.4	0.6	0.4	0.4	1.0	1.0	0.4	0.5	0.4	0.4	1.1	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.9	3.1	0.6	0.5	1.9	0.4	0.1	20.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.2	1.3	0.0	0.0	0.0	0.5	0.0	0.9	2.7	2.6	9.8	0.7	1.1	0.6	1.0	0.4	4.2	2.7	0.4	1.2	1.5	2.2	1.1	0.9	0.7	4.0	0.0	3.5	3.2	5.6	2.2	0.9	1.1	0.5	0.9	1.8	0.0	6.3	3.2	2.5	0.5	1.5	3.3	0.2	2.0	1.1	0.0	0.9	2.9	0.5	0.3	3.8	0.9	0.5	0.0	0.3	0.0	2.4	1.2	1.1	0.4	2.3	0.8	0.2	0.9	1.1	0.0	3.7	1.1	1.9	1.2	3.2	1.3	0.8	1.6	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.9	1.0	1.6	0.8	1.0	1.0	1.1	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	401.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.6	0.0	218.3	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.4	0.0	0.2	3.2	1.5	0.0	0.1	0.0	0.1	0.0
PLAG1	ZNF912	ENSG00000181690	"PLAG1 zinc finger"	Q6DJT9	8	56160904-56211324	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 24.0;Horizontal cells: 30.2;Rod photoreceptor cells: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.1;ASC TERT1: 17.5;HSkMC: 12.3;hTERT-HME1: 12.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA072290			Supported	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA072290: AB_2686508"	"unprognostic (1.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.14e-2)"	1.9	3.6	2.4	3.5	2.9	2.1	2.5	11.0	2.7	7.6	3.8	4.1	9.0	3.4	3.4	9.8	2.0	7.5	2.1	6.8	1.9	1.8	3.7	1.2	4.6	6.7	4.8	2.1	11.6	2.2	2.1	17.8	8.0	4.6	5.1	1.6	7.9	7.5	9.2	1.4	3.4	5.5	2.5	6.3	6.2	3.0	5.2	4.5	11.7	3.5	1.5	5.2	4.8	7.0	3.5	0.2	1.1	0.5	0.7	4.6	1.0	1.5	0.0	9.6	0.1	13.1	17.5	3.0	4.3	5.5	2.0	0.9	0.6	5.0	0.2	4.2	2.3	0.5	0.3	2.7	5.7	2.1	0.1	5.9	6.1	0.5	1.4	2.8	2.0	1.9	12.3	3.2	1.1	12.8	5.6	3.8	4.3	2.6	0.1	4.2	0.0	0.5	3.6	2.8	0.4	1.4	4.7	0.7	3.7	2.6	0.5	0.1	0.0	0.1	0.0	0.3	6.8	0.1	1.9	5.7	3.0	3.8	4.8	1.0	1.5	1.1	2.3	3.4	0.7	0.8	1.1	0.1	1.1	0.3	0.1	0.2	3.5	1.0	0.6	0.1	2.0	4.6	4.3	1.0	0.7	0.5	0.2	0.2	1.0	2.4	2.9	11.0	2.7	1.9	1.8	4.8	2.1	4.6	4.5	6.0	2.7	6.2	2.3	0.9	24.0	9.4	2.5	1.4	2.3	5.2	23.6	6.8	0.0	0.6	4.6	3.3	2.1	0.0	1.2	3.6	3.7	2.8	1.1	0.5	4.5	30.2	5.2	19.6	1.3	4.5	14.1	1.9	15.1	0.0	3.0	18.4	1.2	0.9	9.6	0.5	28.0	0.0	0.7	4.3	6.8	0.6	5.9	1.0	1.6	5.3
PLAGL2	ZNF900	ENSG00000126003	"PLAG1 like zinc finger 2"	Q9UPG8	20	32192503-32207791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 46.8;Late spermatids: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 11.7;non-classical monocyte: 20.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 20.7"	"Cell line enhanced"	"Detected in all"		"CACO-2: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005900	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005900: AB_1079629"	"unprognostic (9.40e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.09e-1)"	5.9	5.1	6.1	9.0	7.8	30.2	5.8	10.5	7.7	6.9	10.6	6.8	5.6	11.5	9.6	6.6	17.9	10.9	5.8	5.6	6.2	4.0	7.0	6.1	9.3	9.0	5.8	4.9	11.7	11.6	8.5	12.9	5.4	7.2	7.6	9.2	9.8	10.2	6.7	10.1	10.4	24.8	8.3	4.2	10.4	10.1	33.2	7.4	16.4	7.9	13.7	12.9	6.8	11.4	0.9	1.4	1.4	20.7	0.3	1.0	1.2	7.9	4.6	12.2	4.4	4.6	3.5	7.7	3.1	5.0	6.9	6.3	34.2	4.0	8.2	4.4	3.2	9.7	7.9	15.2	7.3	9.2	4.9	6.8	33.2	3.7	16.4	5.6	14.5	7.4	4.3	6.5	5.5	3.9	3.2	4.9	8.8	11.6	7.5	3.6	4.5	15.9	10.0	5.7	6.1	5.3	10.3	15.8	5.2	2.9	6.1	5.6	6.1	7.8	4.2	6.9	7.4	6.3	17.8	3.7	8.4	9.0	6.0	6.4	20.5	11.3	10.6	4.9	30.7	5.1	1.4	2.1	0.5	0.5	11.7	1.0	0.9	0.6	1.0	1.4	0.6	0.8	0.4	0.6	0.3	20.7	0.3	0.5	1.2	6.1	7.8	10.5	7.7	6.2	4.0	5.8	4.9	7.2	7.4	11.9	19.7	6.6	11.4	6.6	6.9	2.9	2.5	4.0	14.8	1.8	29.5	2.9	3.3	3.2	46.8	3.8	13.1	0.0	4.5	2.6	4.0	10.4	2.3	2.4	5.0	3.2	10.3	4.9	5.1	113.2	2.3	6.6	0.0	1.0	10.4	6.6	5.6	8.6	6.7	2.6	20.2	6.5	2.5	9.4	9.2	10.2	3.4	4.4	13.9	20.2
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42175233-42207724	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 132.2"	"Cell type enhanced"	"Detected in many"	22	"Basal glandular cells: 379.6;Glandular cells: 176.4;granulocytes: 158.4;Urothelial cells: 792.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.9;HMC-1: 55.1;hTERT-RPE1: 61.0;LHCN-M2: 55.7;U-2197: 58.1;WM-115: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	12000	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	19.3	14.9	5.2	12.9	6.8	0.4	13.3	2.2	6.2	24.5	17.1	9.1	19.0	11.2	35.5	28.1	18.1	19.1	18.5	7.3	6.0	5.9	67.6	2.8	15.9	1.9	8.2	3.6	18.4	5.8	132.2	5.1	15.5	9.4	27.4	12.2	39.4	6.1	12.7	5.8	2.0	31.7	23.0	7.0	1.0	14.6	12.2	3.8	0.6	11.2	14.7	7.4	47.9	13.7	0.3	0.1	1.6	0.0	0.0	2.3	0.3	0.5	0.2	4.2	1.0	7.7	10.5	0.1	18.1	32.0	7.7	6.6	0.2	85.9	0.0	0.6	2.3	3.7	1.4	0.0	4.0	15.9	7.9	1.4	0.1	0.1	0.1	37.9	0.0	55.1	10.5	0.0	18.8	0.7	61.0	14.4	0.0	0.5	0.1	55.7	0.0	0.0	0.0	5.6	0.0	7.6	0.0	15.6	0.0	2.5	0.0	0.0	0.9	0.0	0.1	24.6	8.2	0.1	0.0	27.5	1.5	5.7	58.1	1.8	0.0	0.1	0.0	1.2	0.0	115.5	1.6	0.0	0.0	0.3	0.0	1.0	0.3	2.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.3	0.3	5.2	6.8	2.2	6.2	6.0	5.9	8.2	3.6	9.4	3.8	0.0	20.2	2.4	379.6	9.6	4.1	7.6	0.0	5.3	11.4	0.0	3.9	0.5	0.0	0.6	0.8	82.6	0.0	0.0	0.6	1.1	19.9	176.4	158.4	1.0	1.5	1.6	0.0	36.8	0.6	0.8	3.4	7.8	21.9	2.8	0.0	2.0	30.5	0.0	2.5	0.1	3.7	12.9	17.6	0.7	0.4	11.8	0.6	3.8	0.4	792.4
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 56.7"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 29.3;Distal tubular cells: 28.2;Endothelial cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 22.0;Hep G2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		5400	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	5.6	7.0	13.8	4.4	27.7	3.4	5.9	7.5	31.1	6.5	9.9	2.1	20.6	5.5	8.0	10.3	4.5	7.4	6.6	8.6	15.7	9.1	10.0	3.1	4.0	1.6	9.3	14.5	3.2	10.8	56.7	4.6	14.2	5.5	10.4	3.6	1.3	19.7	22.2	9.8	2.3	4.5	12.3	4.0	2.9	5.5	2.6	8.0	4.1	3.1	1.9	1.1	8.6	6.3	0.5	0.8	2.8	3.3	2.4	5.2	0.4	0.0	0.6	2.3	0.1	4.3	8.3	3.2	9.8	6.5	2.6	1.6	22.0	2.4	1.0	4.1	1.9	0.1	0.0	1.8	0.0	1.9	0.0	2.1	0.4	1.6	33.1	1.1	0.5	0.3	0.5	0.4	3.5	0.0	3.3	5.2	6.3	3.3	12.9	0.0	2.9	0.5	1.6	7.4	5.1	3.6	7.0	0.0	5.8	2.0	8.1	8.5	3.6	0.0	2.0	0.4	8.9	9.8	3.2	0.9	8.5	3.8	0.6	6.1	9.7	11.2	16.6	4.3	6.1	14.5	0.8	3.3	2.8	3.6	0.7	5.2	0.2	1.0	1.3	0.4	0.5	0.5	1.1	2.1	2.4	0.4	0.8	0.2	0.4	13.8	27.7	7.5	30.8	15.7	9.1	9.3	14.5	5.5	8.0	0.0	4.3	0.8	17.4	1.6	0.8	29.3	5.1	16.0	3.4	15.7	0.0	1.9	28.2	0.9	7.6	30.5	0.3	0.0	11.3	1.9	7.9	21.8	1.1	2.1	0.7	1.6	0.0	21.5	4.6	3.1	3.1	2.5	6.8	1.0	1.9	16.3	2.4	0.0	3.5	7.9	3.7	0.0	13.0	3.1	4.3	1.5	1.5	5.1	1.2	16.2
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.5;lymphoid tissue: 36.3"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 25.1;granulocytes: 25.5;Hofbauer cells: 26.0;Kupffer cells: 49.0;Macrophages: 28.1;T-cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 31.5;HMC-1: 39.3;THP-1: 11.4;U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	6.3	3.6	8.1	17.6	11.6	30.5	2.9	1.1	7.5	2.9	3.3	16.2	1.7	4.0	2.8	3.2	2.4	4.6	6.5	3.3	6.9	5.1	3.3	4.2	12.5	17.2	12.7	2.4	1.6	2.0	1.3	2.9	4.6	9.3	3.2	5.5	4.1	5.2	2.9	1.3	1.5	10.2	4.8	17.9	36.3	3.6	1.4	10.9	12.2	2.8	1.8	17.6	6.9	2.5	1.0	4.5	8.5	4.3	1.8	3.1	2.0	0.1	0.0	0.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.8	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	6.7	39.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.3	1.7	0.0	0.0	1.8	3.6	0.4	0.0	0.1	5.5	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.0	11.4	4.1	0.0	3.8	0.0	0.0	0.0	0.0	1.5	0.0	21.6	0.0	2.7	4.2	8.5	3.1	4.3	2.0	0.7	1.6	1.6	4.5	1.0	1.6	1.8	6.9	1.8	4.2	1.6	2.9	2.0	8.1	11.6	1.1	7.5	6.9	5.1	12.7	2.4	9.3	10.9	6.0	25.1	3.4	0.1	0.8	0.0	2.8	2.5	6.7	5.7	1.8	0.0	0.4	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.4	1.0	0.0	25.5	0.2	26.0	0.0	0.0	1.8	49.0	0.4	0.3	28.1	3.3	0.0	0.8	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.3	0.2	2.1	0.5	0.3	15.9	1.2	0.0
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251523-64269150	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"intestine: 77.5"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 54.0;Mucus-secreting cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		94000	"Nucleoplasm, Golgi apparatus"		"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	5.8	9.7	6.1	7.0	5.4	3.7	10.9	6.3	5.8	8.6	40.6	3.1	8.8	59.3	9.1	5.9	16.8	7.7	11.8	4.8	5.4	2.6	5.5	3.2	9.1	4.8	3.5	2.2	11.0	4.0	7.6	2.9	11.1	4.8	6.4	7.0	5.0	6.5	6.3	3.8	10.7	77.5	7.0	4.5	7.2	8.0	4.6	5.4	4.2	5.0	8.2	9.3	6.3	8.8	0.3	4.4	0.9	1.4	0.3	0.8	0.4	17.8	10.0	9.9	14.7	10.4	8.0	9.9	14.2	10.8	12.2	7.4	8.8	13.6	1.2	8.6	17.8	10.5	30.8	11.1	13.3	4.2	8.5	6.1	13.9	20.6	6.6	7.2	3.3	9.2	6.7	8.9	13.2	9.8	13.4	17.7	5.4	6.8	1.5	15.4	21.5	4.2	7.0	16.0	22.7	11.0	9.3	22.3	5.2	7.5	18.9	2.6	10.9	21.0	26.5	10.1	6.4	13.9	6.5	30.7	11.3	13.5	25.8	9.1	1.9	0.9	1.4	18.7	8.0	10.4	0.0	1.4	0.2	0.7	1.4	0.8	0.1	0.8	0.7	1.3	0.3	0.4	0.4	0.9	0.3	1.4	4.4	0.2	0.4	6.1	5.4	6.3	5.8	5.4	2.6	3.5	2.2	4.8	5.4	3.0	9.3	0.0	5.1	11.6	1.0	2.6	10.2	0.0	3.4	15.7	0.0	7.8	1.7	6.2	0.9	7.3	54.0	0.0	6.7	14.6	9.3	5.1	5.7	2.6	9.0	3.2	2.4	19.6	12.7	1.1	9.2	11.0	8.5	29.7	41.8	4.3	12.8	23.0	11.7	3.3	0.7	25.8	7.2	2.6	8.7	10.3	12.2	1.3	31.0	7.2
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.9;retina: 40.2;salivary gland: 39.8"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 79.8;Cardiomyocytes: 57.6;Ciliated cells: 56.2;Horizontal cells: 155.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 44.9;pons and medulla: 11.9"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.2;hTERT-HME1: 18.7;LHCN-M2: 30.8;OE19: 17.8;RPTEC TERT1: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	5.5	5.0	2.1	4.5	4.6	0.2	5.6	44.9	5.2	6.0	13.1	2.7	2.4	1.6	12.3	16.2	6.9	10.9	6.2	12.4	2.3	6.6	2.3	0.9	4.4	1.0	4.0	3.3	2.9	1.3	0.5	15.1	4.4	11.9	6.9	12.6	40.2	39.8	7.1	2.5	4.3	3.1	12.3	3.1	1.1	9.7	2.1	2.4	4.3	21.9	4.4	2.0	7.1	8.8	0.0	6.6	0.0	0.0	0.3	0.0	0.0	0.0	6.1	3.1	0.0	0.0	0.1	0.0	13.4	3.8	4.0	2.5	1.2	0.9	0.0	0.2	38.2	14.5	0.0	0.9	2.9	6.0	0.0	1.8	1.6	2.2	0.0	0.6	0.0	0.0	0.9	1.2	5.2	18.7	7.3	0.0	0.0	1.5	0.1	30.8	2.0	0.0	0.0	3.3	17.8	3.9	0.0	0.0	0.2	39.4	2.8	10.2	7.1	0.0	9.2	5.6	4.3	7.8	0.0	0.1	4.3	0.3	0.4	5.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	0.0	2.1	4.6	44.9	5.2	2.3	6.6	4.0	3.3	11.9	2.4	6.0	0.3	0.0	3.6	2.2	79.8	57.6	0.0	56.2	11.4	5.2	0.0	0.0	0.0	0.5	1.0	35.4	2.3	0.0	0.2	0.0	4.8	10.1	0.0	0.0	0.1	155.7	40.4	1.3	0.0	0.4	1.4	0.3	6.8	1.0	35.3	1.9	5.0	7.0	19.4	0.6	5.4	12.9	23.6	1.4	1.3	0.9	0.1	0.0	34.0	1.8
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029762	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;ASC TERT1: 14.3;fHDF/TERT166: 15.8;hTCEpi: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules		NA	NA			Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	10.9	11.3	11.2	5.6	12.1	5.1	8.0	6.0	11.2	11.6	19.3	15.2	7.3	6.6	9.1	7.6	21.9	8.6	8.5	8.0	13.0	6.9	7.8	5.8	9.4	9.3	10.5	11.4	12.8	6.2	4.7	7.3	6.9	15.9	10.6	12.7	8.3	10.9	12.6	4.5	17.0	6.5	12.3	15.5	6.3	6.5	37.3	8.7	7.7	6.6	21.2	12.2	14.6	23.1	1.0	2.6	8.6	2.4	3.7	13.2	5.4	0.6	1.7	5.7	1.6	16.0	14.3	1.8	1.7	6.9	2.7	4.1	0.6	1.4	0.4	0.9	15.8	1.7	9.1	3.0	1.8	0.8	2.5	0.7	0.2	0.9	2.9	9.4	0.0	1.0	11.6	19.6	7.9	1.1	5.9	5.0	1.4	9.6	0.8	5.9	0.7	1.3	0.6	1.5	3.3	1.7	0.5	0.8	2.2	3.1	3.1	0.0	1.6	0.5	7.7	1.9	1.9	1.6	0.7	2.9	1.6	4.1	4.2	0.0	3.5	1.4	0.3	4.1	0.0	0.9	8.6	1.9	0.1	10.2	2.4	11.6	1.0	13.2	9.8	2.6	0.5	7.8	6.1	6.9	3.7	1.4	1.5	11.8	5.4	11.2	12.1	6.0	10.7	13.0	6.9	10.5	11.4	15.9	8.7	3.0	6.9	1.4	11.2	2.5	1.0	3.8	10.2	0.0	4.5	8.7	2.0	1.5	3.3	9.2	1.4	7.4	48.4	0.0	2.6	3.8	6.6	12.4	4.6	3.8	3.5	3.2	4.7	19.6	3.5	2.5	11.8	5.1	1.7	3.6	23.8	14.2	3.3	15.9	13.4	5.0	1.4	6.5	9.1	2.6	3.2	5.1	0.7	8.2	9.4	15.0
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108967-45133354	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 138.0;Paneth cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	5.7	12.0	10.1	4.8	16.5	2.4	6.6	12.2	12.9	5.0	24.9	14.0	2.8	2.9	6.3	6.4	8.9	5.8	9.4	13.1	11.6	6.6	3.6	1.2	4.5	1.7	13.9	11.4	9.9	2.7	1.5	3.0	5.7	19.5	5.8	13.7	10.3	4.7	5.7	63.6	9.9	2.8	12.9	15.0	2.0	17.9	5.4	14.6	0.0	2.3	20.1	2.8	17.5	10.5	1.3	0.9	2.9	1.5	1.3	0.9	0.5	8.4	21.1	1.5	3.1	2.3	5.0	10.7	4.6	10.4	4.3	4.1	5.1	15.5	0.3	16.7	10.8	3.5	19.3	2.4	19.9	1.7	4.2	7.9	0.3	22.2	6.6	11.9	0.4	1.2	5.4	8.0	3.9	5.3	11.0	2.6	0.9	1.8	0.6	4.6	13.2	1.3	1.9	1.8	40.6	20.8	3.0	3.5	0.5	13.6	16.9	0.4	2.7	5.0	8.4	4.5	3.4	17.9	0.9	5.3	2.7	14.8	3.5	5.4	0.8	0.9	0.6	4.4	0.5	2.1	2.3	1.5	2.4	0.9	1.5	0.6	1.0	0.7	0.6	0.5	1.3	0.9	0.8	2.9	1.3	0.3	0.9	0.6	0.5	10.1	16.5	12.2	11.5	11.6	6.6	13.9	11.4	19.5	14.6	11.9	2.2	0.0	10.9	6.8	27.2	23.8	12.7	1.4	2.3	7.0	23.6	2.5	1.7	7.0	12.5	9.2	138.0	0.0	2.9	7.2	8.2	9.8	1.1	0.4	1.5	6.4	4.7	8.6	0.3	3.6	18.4	0.3	3.3	1.0	13.0	6.8	18.3	62.6	31.1	1.7	37.9	6.5	4.2	1.9	6.6	5.0	6.1	0.0	26.3	40.1
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 81.4;Cone photoreceptor cells: 231.7;Rod photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009914, HPA038139, HPA038140"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.6	2.2	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.6	1.9	0.2	1.2	0.6	3.0	0.1	2.0	0.5	4.8	2.8	0.8	1.0	1.1	2.3	1.8	0.4	1.2	0.7	0.2	3.4	0.9	0.8	0.5	4.4	3.0	2.3	21.5	1.0	0.8	0.3	1.3	2.6	0.5	6.1	1.6	1.2	0.7	0.7	0.5	0.8	0.9	4.7	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5	0.0	1.4	0.0	0.2	0.5	81.4	0.8	0.0	0.0	0.0	0.0	231.7	0.1	0.0	0.2	14.2	1.1	0.0	0.0	0.0	12.6	0.6	0.0	0.0	0.0	0.5	7.9	0.0	0.0	0.0	22.0	0.3	0.0	0.0	0.0	0.0	8.8	0.4	0.0	0.0	1.4	181.4	0.0	1.4	2.2	0.8	0.1	0.7	0.0	0.0	0.1
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962693	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.8"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 211.5;Muller glia cells: 142.4;Rod photoreceptor cells: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 40.5;HMC-1: 19.4;REH: 16.5;U-698: 90.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		21000	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	8.4	3.8	3.3	55.8	4.9	14.1	10.7	1.0	2.4	5.6	10.3	5.3	3.1	8.7	11.2	12.2	6.0	4.7	10.1	4.4	3.3	2.8	20.6	8.8	10.7	35.5	5.2	1.8	2.0	3.6	1.0	1.8	4.1	4.5	4.3	3.6	4.6	8.8	2.8	2.0	4.1	17.6	4.6	8.6	33.6	4.2	2.3	4.2	6.3	5.3	2.6	44.6	7.5	7.7	18.8	3.9	26.8	12.2	14.0	1.1	2.3	0.3	0.7	0.1	0.6	0.0	0.0	0.9	0.0	0.1	0.5	0.2	0.2	1.8	40.5	6.9	0.0	1.7	0.9	0.9	0.1	0.3	0.3	0.4	4.8	0.0	0.0	0.3	4.8	19.4	0.0	0.4	0.3	0.2	0.0	0.9	1.8	0.5	3.4	0.1	1.2	0.5	12.1	0.7	0.5	0.2	16.5	0.0	5.2	0.1	0.8	0.3	0.1	1.1	0.3	0.3	0.9	0.7	15.0	0.2	0.0	0.7	0.1	0.1	8.1	13.2	90.0	0.0	6.7	0.3	2.8	4.4	26.8	0.7	5.7	0.3	18.8	0.2	1.1	3.9	17.3	0.3	0.8	24.8	14.0	12.2	2.6	0.1	2.3	3.3	4.9	1.0	2.4	3.3	2.8	5.2	1.8	4.5	4.2	11.9	81.1	49.9	1.4	2.6	211.5	5.2	40.8	10.7	21.6	15.7	98.2	11.2	11.6	2.3	17.0	11.7	1.0	70.0	0.0	1.8	5.8	2.7	38.3	37.2	23.7	95.3	20.6	36.2	45.8	26.9	10.3	15.6	8.5	7.2	0.4	142.4	0.1	5.8	4.6	4.5	205.4	6.5	2.3	4.4	2.9	1.9	9.3	26.2	1.2	4.8
PLCXD1	FLJ11323	ENSG00000182378	"Phosphatidylinositol specific phospholipase C X domain containing 1"	Q9NUJ7	X	276322-303356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.3"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 25.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 53.8"	"Low region specificity"	"Detected in many"							HPA007721	Approved		Approved	Cytosol		NA	Yes			Cytosol		"HPA007721: AB_1079630"	"unprognostic (2.73e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.80e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.82e-14)"	"unprognostic (6.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	7.4	1.5	6.5	5.3	42.3	18.8	8.7	24.6	19.1	8.9	3.7	2.1	2.1	5.3	9.1	2.1	11.4	3.5	5.3	2.8	7.1	4.2	3.1	5.4	3.5	10.0	4.8	3.6	19.3	4.3	2.3	5.5	12.5	29.2	3.5	3.5	2.1	7.0	2.4	4.5	11.6	5.9	2.1	22.2	10.5	17.3	3.6	6.7	2.1	5.1	2.1	5.4	4.7	7.9	5.8	2.9	6.3	11.9	1.8	4.1	2.7	8.8	33.9	8.2	12.3	1.7	1.3	6.5	8.0	0.9	4.3	4.2	13.7	9.6	11.4	5.6	3.5	6.4	2.8	2.0	5.3	2.3	6.8	15.1	53.8	11.0	18.2	5.3	5.5	21.2	7.0	0.7	15.8	1.6	2.9	3.3	18.6	14.0	6.2	3.1	2.8	16.6	8.1	17.4	2.3	6.6	9.4	4.4	16.6	1.3	4.1	8.8	4.7	8.1	4.8	7.4	5.9	9.2	7.7	2.3	5.7	9.1	6.2	8.8	2.1	5.6	26.3	3.7	14.6	6.1	4.3	3.8	6.3	2.8	8.1	3.9	2.3	2.2	3.4	2.9	5.8	2.8	2.7	4.9	1.8	11.9	2.7	4.1	2.7	6.5	42.3	24.6	19.1	7.1	4.2	4.8	3.6	29.2	6.7	8.9	25.9	6.1	8.4	6.2	8.1	2.2	7.6	0.0	2.3	0.0	2.0	8.4	0.0	5.1	0.6	3.9	11.5	0.0	1.6	9.0	3.4	4.9	3.5	6.4	4.8	7.9	2.9	6.2	6.5	0.6	2.3	6.4	0.0	1.0	7.5	2.8	12.0	8.7	3.5	1.4	6.1	12.9	4.1	7.9	18.3	7.5	22.5	4.4	7.4	7.1
PLCXD2	FLJ31579	ENSG00000240891	"Phosphatidylinositol specific phospholipase C X domain containing 2"	Q0VAA5	3	111674676-111846447	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 16.0"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 57.6;Distal tubular cells: 135.9;Hepatocytes: 132.8;Proximal tubular cells: 94.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055947	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055947: AB_2682981"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.23e-7)"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (2.99e-4)"	1.5	1.0	1.9	3.4	5.8	9.6	1.2	5.8	10.9	1.6	2.8	0.4	0.0	6.1	1.0	0.6	1.8	1.2	1.9	1.5	3.6	2.5	2.5	4.1	2.0	5.9	2.9	6.8	1.1	2.3	0.4	4.1	16.0	10.3	1.5	3.6	4.1	2.0	0.7	1.2	1.5	5.9	0.9	2.9	3.5	2.1	4.2	1.1	3.1	3.2	0.5	4.8	1.9	1.6	0.9	7.2	0.6	0.0	2.1	3.6	0.6	3.0	2.7	2.6	1.2	0.1	0.1	0.8	5.3	2.5	5.0	4.4	1.9	1.5	2.2	2.7	0.2	1.6	7.5	1.1	5.1	9.7	0.6	1.3	0.5	5.0	1.7	0.4	0.7	2.6	0.0	1.0	1.6	3.0	4.7	2.8	2.9	0.1	5.4	0.6	0.3	1.5	0.5	0.9	2.0	6.8	1.4	3.8	2.0	2.4	3.1	0.6	4.6	1.1	0.7	1.1	3.1	0.4	0.2	2.6	1.1	6.8	0.5	1.0	6.5	0.9	0.4	0.5	0.4	0.3	0.6	0.0	0.0	3.6	0.0	3.5	0.5	1.9	3.5	0.3	0.9	0.9	2.0	0.2	2.1	0.0	7.2	1.7	0.6	1.9	5.8	5.8	10.9	3.6	2.5	2.9	6.8	10.3	1.1	17.9	2.1	0.5	6.9	0.1	0.7	1.9	28.1	0.0	1.2	57.6	3.9	0.0	135.9	36.1	11.5	0.0	1.3	0.0	43.6	0.0	0.1	3.8	0.0	132.8	0.0	6.4	24.1	0.0	1.6	8.9	0.3	0.0	0.0	0.0	4.9	0.0	45.8	0.0	0.4	94.0	3.7	0.0	0.0	0.5	0.4	0.1	0.0	2.2	1.1	12.2
PLCXD3		ENSG00000182836	"Phosphatidylinositol specific phospholipase C X domain containing 3"	Q63HM9	5	41306954-41510628	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.4;heart muscle: 36.6;ovary: 27.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 124.0;Intestinal endocrine cells: 40.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 33.4"	"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.4;PC-3: 5.6;SH-SY5Y: 26.3;TIME: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046849	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA046849: AB_2679838"	"unprognostic (1.71e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.12e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.15e-3)"	"unprognostic (5.91e-5)"	"unprognostic (5.11e-2)"	"unprognostic (6.75e-2)"	7.0	15.3	6.9	1.2	4.5	0.8	4.5	33.4	6.5	4.5	1.4	2.0	1.4	1.3	1.6	1.7	1.4	2.5	3.4	36.6	4.8	8.1	7.3	2.2	2.0	7.9	4.2	4.2	27.6	4.8	1.3	13.7	0.8	9.0	1.9	1.5	0.5	1.2	2.0	0.9	0.9	1.7	2.1	5.8	0.9	5.9	1.1	2.1	0.0	1.4	0.0	1.0	1.4	6.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.3	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.3	26.3	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	6.9	4.5	33.4	5.5	4.8	8.1	4.2	4.2	9.0	2.1	0.0	0.0	0.0	0.0	0.1	0.4	124.0	7.6	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.7	3.6	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.2	0.1	1.6	40.9	19.6	0.3	2.5	7.2	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.4	9.7	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524696	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 54.8;retina: 37.7"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 6.3;Horizontal cells: 3.2;Late spermatids: 9.5;Leydig cells: 4.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 54.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 4.0;AF22: 14.0;HDLM-2: 6.9;SH-SY5Y: 3.9;U-2 OS: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol		No	No			Mitochondria	"Vesicles, Cytosol"	"HPA028389: AB_10602145, HPA050367: AB_2681105"	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	1.1	5.4	5.0	0.4	3.7	0.4	1.6	54.8	7.6	2.2	0.8	7.7	0.0	0.4	3.5	0.9	1.6	1.8	0.8	0.8	4.4	4.6	1.5	0.5	0.8	3.3	5.4	2.5	6.6	3.1	1.4	7.2	1.5	12.7	2.7	0.6	37.7	2.2	9.3	0.8	0.6	0.5	2.9	6.0	2.2	0.8	4.2	6.2	0.0	1.0	0.0	1.5	0.4	1.0	0.4	0.2	1.0	0.2	0.3	0.4	0.0	0.0	4.0	14.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.2	0.3	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.4	0.3	0.4	1.0	0.3	0.2	0.2	0.2	0.0	5.0	3.7	54.8	5.5	4.4	4.6	5.4	2.5	12.7	6.2	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	9.5	4.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.5	0.0	0.7	0.5	0.2	0.1	0.2	0.0	0.0	0.0
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915147-143976734	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease mutation, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 144.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 73.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Supported	"Intermediate filaments,Focal adhesion sites,Cytosol"		NA	NA		7100000	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	20.9	11.0	15.9	16.5	13.3	27.9	13.1	15.0	20.7	20.7	17.7	14.6	16.7	13.1	20.2	16.8	25.1	18.2	29.0	23.4	18.9	10.7	11.2	10.9	16.6	15.0	9.9	13.0	18.0	14.0	8.8	12.0	24.2	13.2	17.5	9.8	13.0	17.8	14.8	144.9	36.4	24.1	24.7	11.0	16.9	21.4	6.7	12.7	16.3	9.2	44.2	24.5	20.2	19.2	1.5	3.4	0.8	4.1	0.7	2.9	3.2	16.5	52.1	3.3	4.1	6.1	13.6	11.9	24.4	10.8	6.5	3.6	7.2	17.4	1.7	19.0	35.8	11.6	19.8	2.2	34.1	2.6	12.4	1.8	6.3	52.9	5.9	9.7	2.0	5.3	15.7	6.7	17.5	34.2	5.8	7.6	1.5	3.0	5.4	7.5	29.2	1.2	3.4	2.2	5.2	73.4	0.3	9.6	4.5	10.9	30.8	3.5	3.5	41.6	8.9	4.0	4.5	10.8	2.4	24.3	25.2	45.7	22.2	28.9	0.8	0.6	1.2	24.1	2.7	35.8	0.0	4.1	0.2	1.4	3.8	2.8	1.4	2.7	2.0	3.4	1.5	2.0	1.1	0.8	0.7	2.7	2.8	2.9	3.2	15.9	13.3	15.0	17.3	18.9	10.7	9.9	13.0	13.2	12.7	26.8	17.0	14.3	46.9	95.9	11.5	31.5	35.7	18.7	31.8	38.4	23.6	26.8	0.0	34.1	0.9	56.3	142.5	0.0	17.6	23.1	42.0	88.8	8.1	52.0	34.6	28.6	30.9	54.0	64.5	2.4	41.1	45.0	32.1	26.2	69.7	11.4	96.9	52.6	70.4	3.3	9.5	6.5	55.6	0.5	5.7	67.0	57.7	11.5	29.8	96.8
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365173-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0"	"Group enriched"	"Detected in many"	5	"B-cells: 62.6;granulocytes: 59.1;Hofbauer cells: 195.0;Kupffer cells: 185.4;Macrophages: 211.6;monocytes: 179.5;T-cells: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 93.6;HL-60: 21.1;HMC-1: 35.8;NB-4: 31.4;THP-1: 36.6;U-266/84: 24.3;U-698: 24.9;U-937: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		NA	NA		970000000	Nucleoli		"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	27.8	3.6	3.0	21.7	7.7	120.1	4.6	1.0	3.0	1.8	4.2	7.0	0.4	2.4	2.4	7.5	3.5	5.5	4.9	4.9	2.6	2.4	3.8	6.5	17.0	36.6	6.4	0.8	4.3	2.8	0.7	2.0	8.5	5.0	4.0	4.5	2.7	3.5	0.8	2.3	1.7	8.0	5.0	8.6	51.0	3.2	5.7	3.7	8.2	3.8	2.7	25.7	7.3	2.0	22.9	66.9	80.4	50.8	33.2	44.7	65.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.6	0.0	0.0	0.0	21.1	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	10.3	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	1.4	24.3	24.9	0.0	58.0	0.0	24.8	39.7	57.2	44.7	49.2	23.5	22.9	8.2	32.2	32.1	13.5	2.3	25.3	80.4	33.2	50.8	66.9	0.8	65.9	3.0	7.7	1.0	3.0	2.6	2.4	6.4	0.8	5.0	3.7	17.9	30.6	62.6	0.1	5.8	0.0	1.7	0.0	24.1	28.4	1.8	0.0	1.0	0.0	0.1	1.4	3.1	0.0	0.0	0.5	1.3	6.1	0.1	59.1	0.9	195.0	0.0	0.0	4.9	185.4	4.5	0.6	211.6	16.9	179.5	0.0	0.0	0.1	0.0	0.4	0.6	0.0	12.9	2.6	0.9	0.7	5.8	2.2	116.7	0.0	0.1
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Peritubular cells: 50.2;Smooth muscle cells: 103.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.0;ASC TERT1: 19.1;BJ hTERT+ SV40 Large T+ RasG12V: 22.3;SK-MEL-30: 32.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	No			"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: AB_2678249, HPA048473: AB_2680409"	"prognostic favorable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	14.0	10.2	5.0	10.1	7.7	0.3	11.4	4.5	5.5	9.4	14.6	6.1	3.5	4.7	13.2	5.6	8.7	10.2	9.7	19.3	3.9	3.0	9.7	10.8	9.6	5.7	28.9	2.6	22.8	11.4	3.1	13.3	5.2	12.4	9.7	3.4	12.5	6.0	8.1	8.9	5.9	5.1	23.3	13.5	8.0	7.9	6.2	4.4	7.4	12.9	5.8	6.3	11.0	7.3	7.4	2.0	1.4	0.7	1.2	5.3	1.6	3.8	0.2	4.4	28.0	6.5	19.1	3.5	3.0	10.9	12.0	22.3	2.5	1.1	0.1	5.3	4.2	4.7	1.2	1.5	1.5	1.9	0.0	1.5	1.0	0.6	2.8	5.0	0.0	6.4	9.8	1.0	6.9	0.4	4.9	3.5	4.9	4.0	2.3	3.2	2.3	1.3	0.2	0.6	2.5	0.3	0.1	14.0	0.2	3.6	0.0	0.0	4.9	1.3	1.1	32.2	1.1	1.7	1.3	0.5	3.8	3.1	4.9	0.7	12.7	10.5	2.2	4.5	0.3	10.1	0.0	0.6	1.4	3.1	0.7	2.3	3.0	3.0	2.0	0.2	7.4	5.3	4.7	0.3	1.2	0.5	2.0	1.0	1.6	5.0	7.7	4.5	5.5	3.9	3.0	28.9	2.6	12.4	4.4	0.0	18.9	0.0	26.3	8.5	0.7	29.1	5.1	28.1	43.3	7.0	0.0	2.7	1.7	16.3	0.4	6.6	1.0	0.0	4.4	4.2	39.8	15.0	0.0	12.1	2.4	0.0	1.2	5.5	0.3	0.4	38.3	2.8	11.8	1.8	1.0	8.4	6.8	0.0	50.2	9.9	0.7	6.5	103.2	3.5	2.5	8.5	2.4	1.3	1.8	19.6
PLEKHA6	"KIAA0969, PEPP3"	ENSG00000143850	"Pleckstrin homology domain containing A6"	Q9Y2H5	1	204218851-204377665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.1"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 37.9;Cholangiocytes: 35.7;Enterocytes: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 20.3;BEWO: 33.0;CAPAN-2: 27.6;OE19: 27.6;RT4: 22.9;SK-BR-3: 20.4;T-47d: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028152, HPA028157"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cell Junctions"	Vesicles	"HPA028152: AB_10601048, HPA028157: "	"unprognostic (9.81e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.57e-4)"	2.4	4.6	18.2	4.1	27.8	0.4	10.6	60.1	34.5	3.4	23.2	13.4	1.4	18.2	2.6	10.0	13.0	7.4	9.8	11.8	14.2	11.4	20.9	13.9	2.4	0.6	11.5	23.3	2.8	7.6	3.7	17.6	6.3	18.9	9.4	21.9	21.7	5.2	11.2	2.6	2.0	20.8	4.8	19.0	1.9	29.1	2.7	14.2	0.0	2.2	1.3	1.9	7.3	6.1	0.9	1.4	0.1	0.2	0.0	0.4	0.0	20.3	12.8	8.1	0.0	0.1	0.1	33.0	0.7	2.3	0.0	0.1	6.1	27.6	0.1	6.2	0.4	0.1	2.3	0.1	2.2	0.1	0.0	1.3	0.0	5.0	8.7	1.2	0.0	0.0	0.3	6.9	0.0	1.8	2.5	3.6	0.3	0.0	0.0	8.3	9.1	0.0	0.0	2.5	27.6	15.7	0.0	0.0	0.0	8.2	22.9	1.7	16.9	9.2	20.4	0.1	1.8	19.5	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	18.2	27.8	60.1	34.5	14.2	11.4	11.5	23.3	18.9	14.2	0.0	10.4	0.0	4.3	0.1	37.9	13.9	35.7	2.7	1.2	8.7	19.6	5.7	3.3	6.8	6.8	1.1	45.2	0.0	4.5	1.4	2.6	7.3	0.0	18.7	0.7	17.5	16.1	0.6	0.0	2.9	4.9	0.2	0.0	0.0	27.5	0.9	9.4	28.8	3.5	9.1	6.7	0.0	0.2	0.1	0.1	0.5	18.1	0.9	24.0	6.9
PLEKHA8	"FAPP2, MGC3358"	ENSG00000106086	"Pleckstrin homology domain containing A8"	Q96JA3	7	30027404-30130483	"Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072314			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA072314: AB_2686511"	"unprognostic (5.49e-3)"	"unprognostic (8.62e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.07e-2)"	7.3	5.6	9.7	7.2	11.6	3.2	7.5	16.3	13.0	8.5	7.8	8.3	4.8	8.3	8.6	10.0	9.2	5.4	7.7	6.0	8.2	7.5	14.0	6.1	7.1	8.7	9.9	5.8	9.3	9.0	10.5	8.8	21.0	9.9	7.6	8.4	9.1	8.5	9.0	4.8	7.9	9.0	8.7	7.8	5.2	6.9	8.1	9.6	6.9	6.6	1.7	10.2	8.7	8.6	1.2	0.5	2.8	0.9	1.0	1.7	0.3	6.5	4.5	20.6	21.8	5.9	4.7	14.3	4.7	3.8	3.8	5.0	8.5	2.8	15.3	6.5	4.8	9.9	4.8	10.7	5.7	5.4	2.9	7.2	8.8	7.6	7.8	5.1	3.8	3.1	2.3	4.4	5.2	7.4	4.7	8.2	7.5	8.0	5.6	5.4	4.3	7.7	2.7	13.7	3.2	5.1	0.0	5.8	10.3	4.3	5.2	2.7	15.7	5.3	17.2	6.8	19.4	6.0	4.0	6.9	3.4	14.4	3.5	5.5	11.5	20.0	8.9	6.6	2.5	8.0	2.8	0.6	2.5	1.7	0.6	0.9	1.2	1.0	1.1	0.5	0.8	1.2	1.6	0.1	1.0	0.9	0.1	1.0	0.3	9.7	11.6	16.3	13.0	8.2	7.5	9.9	5.8	9.9	9.6	3.0	1.6	4.2	5.3	10.0	14.2	4.1	2.5	0.0	1.2	12.2	23.6	16.1	3.3	9.5	1.5	4.9	6.2	0.0	6.2	15.8	6.2	8.6	4.6	4.0	5.9	9.5	2.4	3.7	2.2	1.1	3.1	4.2	10.1	5.4	4.4	5.8	9.4	23.0	4.6	8.7	19.1	6.5	5.6	8.1	12.2	11.0	16.9	3.3	3.4	8.4
PLEKHG2	"ARHGEF42, CLG, FLJ00018"	ENSG00000090924	"Pleckstrin homology and RhoGEF domain containing G2"	Q9H7P9	19	39412585-39428415	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Leukodystrophy, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017973, HPA048054"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA017973: AB_2669719, HPA048054: AB_2680241"	"unprognostic (3.55e-1)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (3.79e-8)"	"unprognostic (8.01e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	15.7	6.1	2.9	30.8	4.4	14.8	14.2	2.8	4.0	18.7	12.4	3.9	5.6	5.9	20.3	10.1	9.7	12.6	17.6	13.5	3.5	2.6	10.7	5.1	21.4	20.2	4.5	2.2	17.5	4.4	5.8	7.6	17.4	7.4	12.3	3.9	13.6	6.8	15.0	7.1	4.4	9.6	14.1	6.9	24.8	8.8	8.7	3.6	49.3	11.1	9.5	24.6	13.0	10.1	3.9	4.2	2.8	1.8	1.4	4.4	2.7	3.5	17.6	32.2	17.4	3.1	4.1	4.6	9.5	7.5	6.6	5.7	11.3	6.4	6.3	7.0	12.3	5.5	1.2	4.8	8.4	3.5	20.7	4.4	8.1	9.2	5.1	5.3	0.9	10.2	9.3	1.4	7.9	3.8	11.5	8.4	18.2	5.4	7.4	10.5	7.1	10.1	3.2	7.6	3.3	1.7	36.4	3.9	1.9	5.6	6.6	0.8	10.4	2.1	0.8	3.1	11.7	9.5	9.3	10.7	17.3	13.6	6.4	6.0	5.5	1.7	9.1	9.6	3.7	9.5	2.8	1.4	0.4	4.4	0.8	2.6	3.9	2.1	2.5	1.0	3.6	2.8	3.5	2.6	1.4	1.8	4.2	3.9	2.7	2.9	4.4	2.8	4.0	3.5	2.6	4.5	2.2	7.4	3.6	6.0	30.1	7.5	3.2	3.5	0.6	5.6	5.1	2.7	9.1	0.0	0.0	0.7	0.0	5.3	9.7	8.1	2.6	0.0	4.3	2.3	6.4	2.6	2.3	0.8	8.9	0.0	1.2	10.4	12.9	11.7	6.6	11.4	5.0	7.2	2.6	1.2	3.0	2.3	7.8	0.2	2.6	6.5	8.0	2.6	2.2	2.5	0.9	6.7	3.0	1.3
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2"	"Cell line enhanced"	"Detected in many"		"A-431: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"		Yes	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favorable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	12.8	2.9	17.2	7.8	36.9	11.4	19.8	7.3	29.4	15.2	15.9	67.3	9.3	10.2	31.6	9.9	26.4	19.8	17.5	12.5	24.2	12.8	19.5	16.5	8.4	4.0	40.7	21.6	16.8	22.7	17.9	3.7	22.3	19.5	12.3	12.1	13.6	19.6	31.6	5.9	19.6	10.0	20.7	24.5	16.0	11.5	5.1	40.9	1.2	14.5	6.4	5.3	16.6	17.1	0.0	0.7	16.7	1.9	6.4	12.2	2.9	29.0	13.5	11.3	17.1	1.2	0.0	19.7	3.3	3.9	5.2	4.2	14.2	12.9	0.0	5.9	3.1	1.8	28.1	7.6	25.9	1.8	0.0	6.6	12.9	16.7	3.4	1.5	0.4	6.2	1.5	15.0	1.1	9.4	8.7	3.4	0.1	0.0	0.1	1.7	13.7	0.0	11.8	3.8	7.7	14.5	0.1	5.6	2.0	14.3	21.3	3.9	6.9	6.7	10.1	9.7	10.9	11.0	2.9	6.5	2.3	23.4	0.1	4.5	0.0	0.0	0.0	0.2	1.3	4.0	4.5	1.9	11.7	12.2	1.1	8.6	0.0	3.7	5.2	0.7	0.0	0.4	2.7	16.7	6.4	0.7	0.0	1.1	2.9	17.2	36.9	7.3	29.4	24.2	12.8	40.7	21.6	19.5	40.9	3.0	3.8	0.8	15.7	17.2	3.6	6.9	17.8	2.7	3.4	45.4	0.0	6.9	10.0	25.0	0.7	3.0	14.7	0.0	17.7	8.6	8.4	13.8	1.1	9.6	4.4	0.0	33.4	1.8	6.0	0.9	6.9	3.3	5.0	0.0	22.8	11.7	28.1	20.1	24.1	7.0	0.8	25.8	16.5	0.0	1.1	18.7	2.2	5.7	15.0	33.4
PLEKHG4	"ARHGEF44, DKFZP434I216, SCA4"	ENSG00000196155	"Pleckstrin homology and RhoGEF domain containing G4"	Q58EX7	16	67277510-67289499	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"	11	"Spermatocytes: 28.6;Spermatogonia: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA055696			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055696: AB_2682889"	"unprognostic (2.63e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.88e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.06e-3)"	"unprognostic (4.48e-2)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (6.72e-9)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.01e-2)"	5.6	3.5	1.1	3.8	3.9	1.1	7.4	1.0	3.2	4.8	4.5	8.0	3.3	3.6	4.7	5.0	6.1	3.3	6.1	2.2	1.2	1.5	2.2	0.3	4.8	6.8	5.4	2.4	15.2	7.3	0.5	2.6	4.7	3.9	2.2	2.7	9.5	5.7	2.1	1.3	8.2	3.7	2.7	4.7	6.5	2.0	28.2	1.3	5.9	3.4	3.4	5.5	1.6	4.3	0.6	4.0	0.2	0.7	0.4	2.0	1.0	2.5	4.8	0.3	2.8	2.5	23.9	3.7	5.9	7.9	6.0	9.9	13.7	2.3	7.1	17.2	5.4	2.0	0.1	3.6	0.3	4.3	1.2	1.9	14.0	11.3	3.3	7.7	8.3	11.3	17.9	2.8	20.0	0.2	5.0	11.7	23.2	11.2	0.1	0.1	1.9	10.5	2.8	2.2	2.0	5.1	0.0	0.0	7.3	2.8	0.5	1.5	8.8	19.9	1.5	8.1	0.9	1.1	5.9	17.7	2.9	10.5	21.0	0.1	17.0	16.8	6.6	12.1	0.2	3.5	0.0	0.2	0.2	0.8	0.7	1.5	0.6	1.0	1.1	0.3	0.1	2.0	1.2	0.0	0.4	0.3	4.0	1.4	1.0	1.1	3.9	1.0	3.2	1.2	1.5	5.4	2.4	3.9	1.3	3.0	1.6	0.0	0.5	2.5	0.7	2.8	2.5	1.4	5.7	1.8	0.0	0.3	0.0	0.8	1.1	1.5	1.0	0.0	0.3	0.3	3.1	0.5	3.5	0.0	0.7	0.0	1.2	2.5	1.3	2.0	5.8	1.0	0.0	0.0	2.2	2.2	1.0	2.9	1.4	0.0	5.5	6.5	0.9	28.6	22.2	1.1	0.2	3.2	3.2	0.4
PLEKHG4B	KIAA1909	ENSG00000153404	"Pleckstrin homology and RhoGEF domain containing G4B"	Q96PX9	5	92151-189972	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 25.4;Club cells: 19.4;Collecting duct cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 8.5"	"Cell type enriched"	"Detected in single"	21	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 5.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.4;HAP1: 9.3;NTERA-2: 9.6;REH: 21.7;SCLC-21H: 9.7;SH-SY5Y: 8.7;SK-BR-3: 9.2;SuSa: 9.5;T-47d: 13.0"									"HPA036274, HPA058157"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036274: AB_10669668, HPA058157: AB_2683625"	"unprognostic (3.60e-2)"	"unprognostic (8.52e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.59e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (5.96e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.98e-7)"	"unprognostic (1.43e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-3)"	0.1	0.2	1.7	0.3	0.5	1.4	3.9	1.5	0.6	4.4	1.0	3.1	0.0	0.6	3.6	1.0	0.6	3.1	0.0	0.1	1.3	0.9	1.4	0.1	1.3	1.5	0.8	0.0	3.3	2.5	0.2	8.2	7.9	8.5	5.4	0.1	5.1	4.5	1.2	0.4	0.9	0.9	0.7	0.4	0.2	2.1	4.8	1.1	5.2	8.2	0.6	1.6	0.3	0.8	0.0	5.4	0.2	0.0	0.1	0.2	0.0	0.0	0.9	6.9	10.4	0.0	0.0	0.1	0.7	0.2	0.7	1.5	1.2	0.1	0.1	2.3	0.9	0.6	0.4	9.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.2	0.1	0.0	9.6	0.0	0.1	21.7	4.9	5.6	0.8	0.0	9.7	8.7	5.3	9.2	0.0	9.5	13.0	0.0	0.0	0.2	2.6	0.0	0.2	0.1	0.0	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	5.4	0.0	0.0	1.7	0.5	1.5	0.6	1.3	0.9	0.8	0.0	8.5	1.1	0.0	4.3	0.0	2.9	0.3	0.4	1.6	0.0	25.4	19.4	10.4	0.0	4.2	0.0	0.4	0.2	0.0	0.0	0.0	0.2	3.8	0.6	2.5	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.2	5.7	0.3	1.5	0.0	0.0	0.7
PLEKHG5	"GEF720, KIAA0720, Syx, Tech"	ENSG00000171680	"Pleckstrin homology and RhoGEF domain containing G5"	O94827	1	6466092-6520061	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.8;skin 1: 60.0"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 12.9;Suprabasal keratinocytes: 12.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 17.5"	"Group enriched"	"Detected in many"	4	"amygdala: 18.7;basal ganglia: 13.2;cerebral cortex: 26.7;hippocampal formation: 40.2"	"Low region specificity"	"Detected in all"			HPA049570	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049570: AB_2680818"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.50e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.85e-2)"	10.6	9.7	8.7	2.9	6.3	0.7	4.1	59.8	11.6	3.9	3.0	1.2	2.5	3.3	3.8	4.5	7.1	3.9	6.5	5.4	7.7	2.9	2.3	0.8	3.6	2.7	1.8	6.7	2.6	3.1	4.0	15.2	7.6	4.4	3.4	2.8	4.9	4.2	5.3	3.4	60.0	4.3	2.7	1.8	16.9	2.6	2.6	1.4	0.0	2.4	6.5	4.8	2.3	4.4	0.5	0.6	2.1	0.5	0.3	1.0	0.4	4.0	1.1	8.1	4.7	0.8	2.8	1.4	5.5	3.1	1.7	1.0	2.3	8.0	0.1	12.6	1.8	3.1	13.7	0.9	12.0	0.9	7.9	1.6	0.0	5.6	1.4	1.2	0.0	0.7	2.9	6.4	5.9	6.9	10.5	12.3	0.9	0.0	1.0	0.4	3.4	0.1	15.6	2.5	1.2	12.2	0.1	1.0	1.1	4.3	1.3	5.2	14.9	0.6	4.1	0.3	4.1	5.4	0.1	17.5	4.2	3.0	0.0	3.3	0.1	0.0	0.9	4.6	0.0	0.3	1.8	0.5	0.3	0.4	0.4	1.0	0.2	0.8	0.7	0.1	0.5	0.5	0.6	2.1	0.3	0.2	0.6	0.2	0.4	8.7	6.3	59.8	11.6	7.7	2.9	1.8	6.7	4.4	1.4	0.0	1.0	0.0	2.1	6.5	0.6	3.2	2.5	1.4	2.3	3.5	2.0	2.2	0.0	1.1	8.6	4.5	3.3	0.0	1.2	3.3	1.8	1.4	0.0	0.0	4.0	1.6	3.4	5.5	1.2	2.6	1.7	0.0	0.0	0.0	5.2	9.2	3.3	5.8	8.1	0.6	1.5	12.9	1.0	1.9	3.2	12.7	1.6	0.0	2.7	5.5
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.4;placenta: 39.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 64.9;Extravillous trophoblasts: 43.1;Paneth cells: 35.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.9;granulocytes: 2.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 56.1;CACO-2: 17.8;CAPAN-2: 9.8;OE19: 16.9;RT4: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"		NA	NA			"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: AB_2683645"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	7.5	0.2	0.3	8.9	0.7	1.0	15.8	0.3	0.4	4.4	30.3	0.4	1.1	19.4	0.6	1.6	19.9	0.5	6.7	1.2	0.3	0.0	1.1	2.5	1.8	0.3	0.3	0.3	0.6	4.5	1.9	3.3	39.6	0.5	2.6	9.6	0.7	8.8	2.3	0.3	6.7	43.4	0.5	0.3	0.4	5.7	0.5	0.3	0.5	3.4	11.3	8.6	6.8	8.6	0.3	3.9	2.5	0.2	0.1	0.4	0.1	0.2	2.1	0.2	0.0	1.1	0.1	56.1	0.1	0.0	0.1	0.1	17.8	9.8	0.1	0.1	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.2	4.6	16.9	0.3	0.0	0.0	0.1	0.0	18.9	0.1	0.0	0.4	8.4	0.1	4.2	2.7	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.4	2.5	0.1	0.1	3.9	0.1	0.1	0.3	0.7	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3	0.0	0.0	0.0	5.7	4.4	0.0	0.3	5.1	0.0	0.0	1.8	0.0	13.8	0.0	8.3	1.1	0.3	64.9	0.0	1.6	43.1	1.1	6.7	0.0	2.1	2.4	0.0	8.1	0.0	0.0	1.5	2.3	0.0	0.0	0.0	18.6	0.9	2.5	35.4	0.7	0.7	0.0	0.0	3.1	0.2	0.5	6.0	20.0	0.0	20.6	16.8
PLEKHH1	KIAA1200	ENSG00000054690	"Pleckstrin homology, MyTH4 and FERM domain containing H1"	Q9ULM0	14	67533301-67589612	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.0;thyroid gland: 30.2"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 37.3;Mucus-secreting cells: 17.4;Rod photoreceptor cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.0;BEWO: 9.7;RT4: 9.8;SK-MEL-30: 12.1;T-47d: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047707, HPA051964"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA047707: AB_2680126, HPA051964: AB_2681675"	"unprognostic (2.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-2)"	"prognostic favorable (8.03e-5)"	"unprognostic (4.74e-1)"	"unprognostic (9.15e-3)"	"unprognostic (8.43e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.03e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.26e-4)"	1.3	4.5	9.7	1.6	33.7	0.5	2.9	8.6	26.8	3.5	6.8	61.0	2.5	11.6	1.9	8.9	1.6	3.8	2.5	1.1	16.2	8.7	2.7	0.8	1.2	0.6	35.8	16.6	0.6	7.7	10.3	3.3	2.0	26.9	10.7	7.0	5.1	20.3	2.9	1.1	4.1	9.0	1.3	38.1	1.3	6.6	2.3	34.4	0.0	30.2	0.0	0.7	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.2	2.0	10.0	0.2	0.0	9.7	0.0	0.0	0.1	0.1	3.1	1.6	0.0	1.6	0.0	0.9	2.2	3.5	0.8	0.1	0.3	3.5	0.0	1.6	2.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	1.2	3.7	0.0	0.0	7.2	0.0	0.2	3.0	5.7	0.6	0.1	0.3	1.4	1.1	9.8	2.7	2.5	0.8	1.9	12.1	4.9	9.6	2.0	0.0	0.8	3.7	1.0	0.6	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	33.7	8.6	18.1	16.2	8.7	35.8	16.6	26.9	34.4	3.0	8.3	0.0	0.7	0.1	6.9	3.1	2.5	1.4	0.0	8.7	37.3	2.2	3.3	1.8	0.4	0.0	11.9	0.0	3.5	0.3	0.4	3.5	0.0	0.0	0.7	3.2	7.0	0.0	0.8	0.0	0.3	0.8	3.3	0.0	17.4	5.5	2.5	8.6	0.4	1.3	37.9	0.0	0.4	0.4	1.4	1.9	8.9	0.0	16.1	1.0
PLEKHH2	"KIAA2028, PLEKHH1L"	ENSG00000152527	"Pleckstrin homology, MyTH4 and FERM domain containing H2"	Q8IVE3	2	43637273-43767987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 35.7;Collecting duct cells: 62.8;Peritubular cells: 47.4;Sertoli cells: 45.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.3;RPTEC TERT1: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077225			Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA077225: AB_2686828"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.82e-2)"	10.1	2.7	3.7	9.2	6.5	0.3	7.5	5.4	5.6	27.2	8.5	2.9	3.6	4.1	30.0	9.5	5.2	9.8	8.1	3.7	4.2	2.7	8.7	1.8	21.7	3.0	3.4	3.3	19.4	2.5	9.6	1.8	4.2	8.3	7.9	5.0	7.4	3.8	7.8	5.4	6.9	5.7	13.1	9.7	4.7	4.1	4.2	4.0	0.0	4.7	4.7	4.3	11.1	8.6	0.8	0.6	1.4	0.4	0.7	1.0	0.0	0.6	5.2	2.1	0.1	4.3	10.3	0.4	0.7	2.7	1.1	2.8	0.0	1.8	1.3	0.3	0.9	4.5	3.5	0.6	0.8	2.0	0.1	1.5	0.1	0.7	0.2	0.7	0.0	0.7	3.0	0.8	2.6	0.1	1.5	2.3	2.1	4.9	0.2	0.9	1.4	1.0	0.2	1.2	0.8	5.2	0.0	6.2	0.1	8.5	0.3	1.7	0.8	0.5	0.0	5.2	1.6	0.7	0.2	0.2	6.1	1.8	0.3	1.8	1.2	0.3	0.0	2.5	0.0	0.6	0.8	0.4	0.4	0.4	0.2	0.4	0.3	0.7	0.5	0.2	0.8	1.0	0.6	1.4	0.7	0.3	0.6	0.5	0.0	3.7	6.5	5.4	5.6	4.2	2.7	3.4	3.3	8.3	4.0	35.7	8.3	0.5	14.5	7.7	0.7	1.2	10.2	8.1	15.9	62.8	5.9	0.3	5.0	4.0	1.3	2.9	0.0	0.0	1.2	0.3	31.9	6.8	1.1	0.0	0.7	0.0	0.0	3.7	0.3	2.5	33.1	1.1	11.8	0.0	0.0	7.2	4.4	0.0	47.4	2.2	4.1	45.3	15.1	4.3	6.1	7.3	0.5	1.3	0.0	7.2
PLEKHH3	FLJ21019	ENSG00000068137	"Pleckstrin homology, MyTH4 and FERM domain containing H3"	Q7Z736	17	42667914-42676994	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 44.9"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 54.5;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 22.6;T-47d: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046234	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA046234: AB_2679597"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.05e-3)"	"unprognostic (5.95e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.44e-3)"	8.1	7.7	4.0	2.6	4.1	5.1	20.4	9.0	6.1	16.9	6.0	3.3	6.2	4.6	10.0	7.6	13.6	11.0	10.7	6.5	4.4	1.6	4.4	6.6	8.1	1.8	3.9	3.8	14.7	44.9	8.2	6.6	4.4	4.3	10.9	1.8	8.1	9.2	11.3	23.7	10.6	3.4	9.9	6.7	4.0	11.5	8.1	4.1	1.9	5.6	7.3	5.1	10.3	9.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.9	6.3	3.0	4.9	3.8	1.6	5.4	2.6	2.5	2.1	2.0	3.1	3.7	1.0	3.1	3.1	3.5	13.0	2.2	3.5	0.6	5.9	5.0	0.3	12.9	2.6	4.2	0.1	4.4	2.7	5.9	2.7	0.4	2.1	1.4	0.4	7.7	16.3	0.9	12.7	0.3	5.5	1.1	3.6	5.6	1.0	2.9	22.6	0.7	7.9	10.8	11.6	4.0	5.9	5.9	0.7	25.9	5.8	2.1	6.8	6.0	7.5	4.8	18.4	20.5	5.3	4.9	1.5	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.0	4.1	9.0	6.1	4.4	1.6	3.9	3.8	4.3	4.1	11.9	13.3	0.0	17.2	13.9	54.5	9.7	10.2	1.4	5.7	8.7	21.6	9.1	0.0	2.2	7.8	8.1	3.5	70.0	6.6	3.7	10.0	17.2	2.3	10.5	1.8	31.8	7.5	14.1	3.5	1.5	16.4	2.3	15.1	1.0	5.8	16.2	5.3	0.0	21.2	2.0	21.9	25.8	18.9	0.7	12.5	16.3	5.1	0.9	6.8	12.2
PLEKHJ1	FLJ10297	ENSG00000104886	"Pleckstrin homology domain containing J1"	Q9NW61	19	2230084-2237704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 300.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA048989	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA048989: AB_2680590"	"unprognostic (5.11e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.03e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (1.10e-5)"	"prognostic favorable (6.99e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.26e-3)"	13.6	18.0	15.2	30.2	15.6	18.7	15.7	10.1	22.9	9.5	41.3	10.6	12.0	58.9	10.1	15.7	16.8	9.1	30.0	17.9	14.3	11.9	27.5	21.0	18.2	26.1	14.9	14.5	13.6	36.7	5.0	11.0	14.2	15.8	12.1	19.6	9.6	30.4	12.1	43.6	13.9	51.4	11.3	9.3	18.4	35.5	29.0	10.0	18.5	24.3	17.7	16.3	10.2	11.8	47.3	55.9	43.2	34.7	16.9	38.0	30.8	26.4	11.0	20.1	24.4	6.6	8.6	11.9	14.9	7.0	16.0	14.6	28.2	12.5	25.1	12.5	10.2	10.4	20.7	19.1	9.8	4.9	25.6	24.2	13.1	12.2	36.7	10.5	27.9	20.4	12.5	10.2	7.6	6.9	6.4	10.2	22.0	27.7	29.9	11.6	17.5	27.0	24.9	36.1	15.8	15.1	32.4	14.0	30.8	16.3	26.6	50.6	27.9	9.4	17.4	29.3	8.5	23.0	27.8	10.8	6.8	20.5	20.5	16.1	43.8	26.8	28.2	20.3	26.9	8.7	23.8	27.4	43.2	32.8	33.0	28.7	42.5	32.3	34.0	28.4	47.3	26.5	25.7	23.2	16.9	34.7	55.9	38.0	30.8	15.2	15.6	10.1	22.9	14.3	11.9	14.9	14.5	15.8	10.0	35.7	22.6	77.8	44.5	30.9	21.7	37.5	86.6	29.4	15.9	43.6	15.7	77.8	139.3	111.2	53.1	25.1	300.7	0.0	157.2	79.5	36.4	58.9	18.4	42.7	81.8	23.8	51.9	21.5	41.7	91.2	43.7	34.6	28.7	88.4	170.2	26.6	125.6	146.2	33.2	109.9	19.1	32.3	32.5	70.5	91.9	37.3	39.9	29.2	192.0	49.9
PLEKHM3	"DAPR, PLEKHM1L"	ENSG00000178385	"Pleckstrin homology domain containing M3"	Q6ZWE6	2	207821288-208025560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.1;Club cells: 10.3;Cone photoreceptor cells: 11.8;Rod photoreceptor cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035046	Uncertain		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA035046: AB_10603128"	"unprognostic (3.62e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.06e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.86e-4)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.33e-2)"	6.5	10.9	10.0	4.1	11.2	11.1	5.1	11.8	16.8	5.6	5.0	10.6	2.1	3.3	6.2	3.4	4.2	4.5	4.5	6.6	7.3	7.8	5.1	6.8	6.2	4.3	6.2	11.4	9.1	4.8	17.3	7.2	4.6	13.1	6.4	4.9	6.5	5.4	4.8	5.1	5.2	3.9	5.9	8.6	4.9	4.6	5.3	7.5	4.1	10.6	2.3	4.5	4.8	5.4	2.3	1.9	6.7	2.1	2.0	2.7	0.6	1.5	1.3	3.4	1.9	5.6	5.7	5.1	3.1	3.3	2.5	2.3	1.7	1.3	1.3	3.1	3.5	2.4	1.6	3.4	4.4	3.3	2.4	5.3	2.6	4.2	2.7	3.4	2.8	1.5	4.7	5.4	2.8	3.3	3.8	2.6	4.2	1.6	3.6	3.1	0.8	3.4	1.9	3.2	1.1	1.6	2.7	2.8	2.7	1.2	1.7	7.2	3.8	2.8	0.3	3.0	5.7	0.9	2.3	3.7	3.9	2.4	2.4	2.0	4.0	4.7	1.3	4.5	1.7	2.9	3.0	2.1	0.9	2.5	0.8	1.0	2.3	2.3	2.2	1.9	1.7	2.7	2.3	6.7	2.0	1.7	1.9	1.3	0.6	10.0	11.2	11.8	16.8	7.3	7.8	6.2	11.4	13.1	7.5	17.9	17.1	0.0	0.3	0.0	3.0	0.8	2.5	1.4	10.3	1.8	11.8	0.2	0.0	2.5	2.1	0.1	1.1	0.0	3.0	0.4	0.2	0.3	0.0	0.4	0.5	6.4	0.0	0.0	1.2	3.3	0.3	2.5	0.0	7.2	0.0	3.1	3.2	1.4	0.0	3.8	9.9	0.0	0.4	0.2	0.7	0.1	0.1	0.5	0.3	0.0
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966497-975865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 17.5;Glandular cells: 28.7;Pancreatic endocrine cells: 24.5;Suprabasal keratinocytes: 15.2;Urothelial cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 11.3;HaCaT: 19.9;SK-BR-3: 13.6"					"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	0.6	0.0	1.8	0.2	0.4	1.4	0.0	0.1	7.7	0.9	0.0	0.0	0.8	1.1	2.7	31.5	0.3	5.0	0.5	0.3	0.0	2.3	0.8	1.1	0.3	0.0	0.0	0.1	0.5	0.3	0.0	1.5	0.0	3.7	0.2	0.3	5.3	1.2	1.5	31.3	0.7	0.6	0.6	0.5	1.7	0.8	0.0	0.2	0.7	20.2	21.2	6.0	10.6	0.0	0.3	2.0	0.9	2.3	1.1	0.2	11.3	1.2	0.0	0.8	0.0	0.6	1.9	5.3	1.3	3.4	0.8	1.5	8.8	0.0	2.5	2.1	4.5	19.9	0.2	3.3	0.5	3.9	0.8	0.0	3.5	2.3	0.5	0.2	0.1	0.1	2.8	2.2	1.2	2.9	0.3	0.0	0.2	3.2	0.2	6.6	0.0	0.2	0.4	1.6	9.1	0.0	0.0	4.2	3.7	3.4	0.1	0.1	5.9	13.6	0.8	0.3	2.6	0.0	2.4	4.3	1.9	0.4	3.5	2.6	0.1	0.1	5.2	1.9	2.4	0.0	0.9	2.0	0.3	0.3	0.0	0.0	0.5	1.1	0.3	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.6	0.9	17.5	4.0	0.1	0.8	0.0	1.4	1.2	0.0	0.0	5.9	0.0	11.4	0.0	0.6	0.0	0.0	12.2	1.5	0.6	28.7	0.0	0.0	1.0	3.2	0.0	0.0	0.8	0.0	0.0	1.4	1.7	1.8	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	15.2	8.2	2.5	0.0	37.9
PLEKHO2	"DKFZp761K2312, PLEKHQ1, PP1628, pp9099"	ENSG00000241839	"Pleckstrin homology domain containing O2"	Q8TD55	15	64841883-64868007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.9"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 56.4;Ito cells: 42.4;Kupffer cells: 40.1;Muller glia cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 31.3"									HPA040055	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		450000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA040055: AB_10793954"	"unprognostic (4.32e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.85e-3)"	22.1	17.4	12.9	19.9	16.6	29.4	12.4	6.2	9.9	10.3	12.2	11.5	5.2	6.8	11.9	13.3	10.7	13.0	17.4	9.3	13.3	8.0	8.1	8.2	22.4	19.6	10.1	8.7	10.4	5.7	5.1	6.4	22.6	17.2	10.5	5.6	17.0	6.1	10.2	5.9	6.0	9.4	16.9	14.5	57.9	10.2	7.0	11.3	5.1	18.6	6.6	13.8	17.1	14.1	4.0	10.4	30.2	26.6	2.7	5.4	10.3	2.7	1.8	3.5	3.4	31.3	18.0	8.3	8.1	12.2	8.7	8.9	2.2	1.7	7.4	4.3	16.5	8.8	1.0	4.0	3.3	5.1	11.4	1.2	7.4	0.8	2.5	24.1	8.3	11.1	13.0	2.9	10.8	3.5	7.5	12.0	1.5	2.2	26.5	11.5	0.8	1.7	9.0	6.7	1.4	1.7	6.4	8.5	5.3	1.4	1.9	0.3	3.0	3.4	1.2	11.1	6.0	1.2	11.3	15.5	6.7	6.2	6.3	3.3	9.9	15.5	2.5	7.2	10.8	3.9	7.0	14.3	9.2	5.4	20.4	5.0	4.0	3.1	5.0	10.4	2.6	1.3	2.7	30.2	2.7	26.6	1.2	4.1	10.3	12.9	16.6	6.2	9.9	13.3	8.0	10.1	8.7	17.2	11.3	0.0	9.3	8.6	2.1	4.9	0.7	2.6	2.5	1.4	2.3	8.7	0.0	3.3	3.3	2.2	3.2	18.3	0.0	0.0	1.3	4.0	9.3	2.4	18.4	0.8	56.4	0.0	0.0	42.4	40.1	1.8	17.0	30.6	13.5	6.4	0.1	62.2	2.1	0.0	24.1	2.1	3.2	12.9	8.0	0.9	1.9	3.9	5.0	11.5	0.2	3.1
PLEKHS1	"bA211N11.2, C10orf81, FLJ23537"	ENSG00000148735	"Pleckstrin homology domain containing S1"	Q5SXH7	10	113751454-113783429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 152.6;Club cells: 46.6;Exocrine glandular cells: 28.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.7;OE19: 31.9;RT4: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037583			Approved	Vesicles,Centrosome		NA	NA			Centrosome	Vesicles	"HPA037583: AB_10671762"	"unprognostic (2.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.00e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (1.03e-4)"	0.2	0.1	0.2	1.6	0.2	0.0	11.7	0.2	0.2	26.8	18.5	0.2	10.2	17.0	1.0	2.2	0.8	3.4	6.4	0.2	0.2	0.1	0.6	0.2	4.8	0.2	0.2	0.2	1.3	26.6	0.0	1.9	0.3	0.3	3.5	1.8	0.4	53.1	4.9	0.2	0.7	38.8	0.2	0.2	0.2	2.9	1.1	0.2	0.2	0.2	1.3	2.0	0.8	0.2	0.8	0.5	1.3	0.3	0.7	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	31.9	0.0	0.0	2.7	0.0	0.9	10.5	0.0	0.1	0.0	0.9	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.2	2.1	0.1	0.0	0.0	0.0	1.3	0.8	0.1	0.2	0.3	0.1	0.1	0.8	0.2	0.2	0.0	0.5	0.2	0.3	1.3	0.7	0.3	0.5	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2	3.0	2.7	0.0	0.3	0.1	0.0	0.4	0.0	152.6	46.6	0.0	0.0	0.0	0.0	2.8	7.1	0.0	13.8	0.0	28.3	0.0	0.1	2.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.0	1.1	0.0	1.4	0.8	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.3	0.3
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460260	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 147.8;T-47d: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	11.4	3.7	19.6	4.0	40.2	4.4	23.4	1.3	39.4	20.6	5.7	3.7	5.0	5.1	19.2	7.1	17.7	9.5	18.2	28.1	18.8	5.1	6.9	17.6	17.7	3.8	4.2	20.6	11.8	12.6	3.8	3.3	25.9	8.7	8.7	8.7	12.6	22.1	6.2	8.7	20.9	6.1	15.4	2.7	54.7	4.7	19.8	7.4	1.0	8.9	16.6	7.5	14.2	15.5	1.2	2.9	3.0	1.6	10.4	1.2	0.6	16.4	14.9	5.2	0.4	2.7	4.5	2.0	3.5	5.9	11.7	6.8	1.1	14.6	0.0	23.2	12.6	28.5	20.7	0.2	8.1	10.7	0.0	0.4	0.0	6.7	1.2	14.8	0.0	0.4	2.6	11.3	4.5	12.7	147.8	23.5	0.0	0.0	0.5	23.1	6.0	0.0	0.0	0.9	1.6	2.4	0.8	14.3	0.0	30.8	3.3	0.3	0.7	10.8	2.1	9.5	9.7	51.9	0.2	30.0	3.2	8.7	1.4	28.1	0.0	0.0	0.0	2.5	0.0	14.4	3.0	0.7	2.3	0.1	1.6	0.0	1.2	0.7	0.0	2.9	0.9	1.2	0.6	1.9	10.4	0.6	2.0	0.5	0.6	19.6	40.2	1.3	39.4	18.8	5.1	4.2	20.6	8.7	7.4	17.9	18.6	2.7	128.0	125.8	2.8	105.2	22.9	18.7	68.2	17.4	3.9	55.6	8.3	96.4	5.7	109.7	37.3	0.0	69.2	180.6	32.4	45.1	9.2	6.0	13.5	0.0	80.9	51.5	8.9	2.3	11.8	11.2	23.6	5.4	25.3	3.5	71.6	40.7	10.3	2.5	2.7	0.0	79.3	72.4	10.4	90.5	108.6	6.4	24.3	54.0
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 48.9;Erythroid cells: 23.3;Late spermatids: 60.1;Spermatocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.8	5.6	21.1	10.8	0.7	2.1	9.6	11.6	8.2	15.5	16.0	7.8	12.2	16.0	4.3	6.4	12.6	7.8	14.8	9.3	23.9	12.4	6.1	14.5	9.0	7.3	0.2	20.4	17.1	0.6	0.9	14.1	6.5	2.8	11.9	12.3	16.8	21.4	13.0	8.2	31.4	9.1	9.8	12.1	6.4	16.4	14.7	5.5	5.1	7.6	11.6	9.6	7.3	6.7	3.5	9.3	5.4	8.8	5.1	12.2	11.8	8.3	14.4	11.0	12.1	22.8	6.2	15.5	13.5	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0	0.0	1.1	0.8	0.6	1.4	2.1	0.5	0.0	2.7	0.0	1.8	0.0	3.6	0.0	0.6	48.9	0.4	0.0	23.3	0.3	10.4	0.7	0.4	1.1	0.2	3.1	0.0	2.4	0.6	1.0	60.1	2.6	1.6	0.0	1.8	1.9	1.1	0.1	0.0	0.4	0.3	0.7	0.0	0.3	27.0	12.1	0.6	3.2	1.8	2.1	0.9
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291504	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 188.5;Ciliated cells: 167.3;Ductal cells: 295.2;Rod photoreceptor cells: 190.0;Urothelial cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4;MAIT T-cell: 9.4"	"Lineage enriched"	"Detected in single"	52	"T-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"A549: 34.1;CAPAN-2: 37.1;OE19: 63.6"	"Low region specificity"	"Detected in many"							HPA055540	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055540: AB_2682839"	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	1.4	4.7	8.3	5.3	20.9	0.2	17.5	2.0	11.1	30.4	18.2	28.1	13.4	27.5	7.7	4.1	9.1	38.1	31.2	1.5	13.6	7.1	4.7	1.1	3.7	0.8	37.1	6.5	2.4	19.8	0.6	4.1	1.8	16.6	10.7	15.3	6.7	45.8	19.0	0.3	19.0	21.9	3.3	26.0	1.4	22.2	2.2	25.8	0.7	2.2	5.9	5.0	12.1	5.7	0.0	0.1	0.1	0.0	0.0	9.4	0.3	20.0	34.1	0.5	0.0	0.0	0.1	0.0	2.0	0.0	6.3	4.9	9.8	37.1	0.0	21.9	2.9	0.0	11.1	0.0	4.4	2.9	0.2	0.6	0.0	13.7	0.0	7.6	0.0	1.3	1.3	1.9	3.2	4.3	13.9	1.0	0.0	0.1	0.0	0.0	22.8	0.1	0.0	15.2	63.6	0.0	0.0	0.0	0.5	16.0	3.2	4.3	10.2	5.6	9.4	14.7	1.5	12.3	0.6	1.1	13.9	9.2	0.1	14.8	0.1	23.3	16.5	3.9	0.0	11.4	0.0	0.0	0.0	4.4	0.0	9.4	0.0	2.0	2.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	8.3	20.9	2.0	11.1	13.6	7.1	37.1	6.5	16.6	25.8	6.0	6.9	0.0	113.1	0.0	17.7	0.0	188.5	167.3	64.8	21.0	9.8	0.2	3.3	295.2	0.2	3.3	108.1	0.0	125.6	5.1	0.0	71.8	1.1	0.4	0.9	15.9	8.2	0.0	1.3	1.4	0.0	1.3	0.0	4.6	39.9	12.1	100.4	109.1	0.0	1.0	190.0	0.0	0.0	0.3	28.1	0.0	0.7	0.0	113.0	167.4
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120456954-120589855	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 26.5;kidney: 12.6"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 62.8;U-251 MG: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.6	1.7	11.4	1.2	13.6	4.9	3.1	11.6	18.2	3.4	1.2	12.1	1.0	0.7	1.7	2.7	0.9	1.2	11.3	0.7	15.9	17.4	12.6	2.8	0.5	0.6	15.5	6.0	0.6	0.6	0.4	0.5	0.6	26.5	3.0	0.8	0.0	2.0	6.1	0.4	1.7	0.8	1.5	19.1	0.5	1.2	11.1	12.5	0.0	1.5	0.0	0.5	0.8	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.8	1.7	1.0	0.0	1.0	0.0	0.0	8.0	6.3	0.1	0.7	0.1	0.9	1.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	62.8	6.5	0.0	0.7	1.6	0.7	0.0	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.0	3.3	0.0	0.6	0.1	0.5	0.0	0.5	3.5	1.4	0.0	9.0	7.2	4.0	0.3	34.8	0.0	0.0	0.0	6.6	0.0	1.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	13.6	11.6	10.0	15.9	17.4	15.5	6.0	26.5	12.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	12.7	0.0	0.0	3.5	0.0	0.0	6.6	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	2.5	0.0	7.9	17.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	7.4	7.6	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.3
PLPP5	"DPPL1, HTPAP, PPAPDC1B"	ENSG00000147535	"Phospholipid phosphatase 5"	Q8NEB5	8	38263130-38269243	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 77.8"	"Cell type enhanced"	"Detected in many"	4	"Glandular cells: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"memory B-cell: 37.2;naive B-cell: 65.4"	"Lineage enriched"	"Detected in all"	5	"B-cells: 65.4"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055777			Approved	Vesicles		NA	NA			Vesicles		"HPA055777: AB_2682915"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-3)"	"unprognostic (3.66e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (8.72e-5)"	"unprognostic (9.79e-2)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (8.33e-10)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-2)"	5.5	9.3	6.9	11.9	7.9	4.8	8.8	7.5	6.7	11.2	11.5	3.9	33.9	14.4	5.7	30.9	6.6	10.2	21.0	4.6	6.1	6.1	9.6	20.3	7.5	12.0	4.5	5.1	8.4	77.8	4.2	29.9	8.3	6.7	27.9	12.8	16.2	52.0	36.5	2.3	4.7	18.4	5.2	3.5	12.8	16.1	4.6	4.4	3.8	11.9	5.0	14.8	8.0	6.7	65.4	5.3	13.3	3.6	4.3	5.0	3.7	5.5	11.1	6.6	13.5	13.0	12.7	9.1	15.8	19.9	8.1	10.6	5.1	8.5	0.4	13.5	16.3	11.7	6.2	5.4	11.5	6.9	3.5	3.5	9.8	4.7	14.8	22.1	2.8	11.8	9.9	12.0	11.2	14.8	14.3	13.1	13.1	0.4	25.5	9.8	11.4	6.3	4.7	10.0	22.5	3.8	6.9	4.9	51.3	20.2	7.2	5.2	8.0	6.5	10.1	9.2	6.1	21.6	5.5	7.8	5.7	5.0	9.6	4.1	15.8	10.4	1.6	15.8	7.5	9.8	13.3	2.7	4.5	3.0	2.7	5.0	37.2	3.9	3.8	2.5	65.4	2.0	1.9	1.6	4.3	3.6	5.3	3.4	3.7	6.9	7.9	7.5	6.7	6.1	6.1	4.5	5.1	6.7	4.4	8.9	44.0	74.7	61.1	0.0	5.3	0.0	38.2	101.7	39.8	71.5	15.7	39.2	36.5	59.1	22.7	13.5	17.2	0.0	78.1	37.8	35.3	138.3	29.1	20.7	32.8	58.8	43.3	16.5	9.1	6.2	16.4	24.8	0.0	10.0	73.6	37.6	56.5	36.8	8.9	20.3	3.5	12.9	0.0	24.7	4.3	0.0	73.7	17.0	51.4	46.1
PLPP6	"FLJ46512, FLJ90191, PDP1, PPAPDC2"	ENSG00000205808	"Phospholipid phosphatase 6"	Q8IY26	9	4662315-4665258	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 74.5;Late spermatids: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018096	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA018096: AB_1855609"	"unprognostic (2.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.88e-2)"	4.0	8.3	4.4	7.2	6.8	1.1	7.3	11.9	9.7	5.7	9.4	6.2	4.2	10.2	4.9	13.2	9.2	4.1	9.7	3.0	4.9	4.8	6.3	20.0	4.7	8.3	8.6	6.3	4.2	19.2	8.7	5.5	13.1	9.4	16.9	10.0	4.7	10.4	8.5	2.2	8.6	15.4	3.3	4.9	7.1	10.7	8.4	3.4	16.2	7.2	6.9	9.6	7.4	5.5	4.3	5.1	8.5	5.1	4.7	13.0	5.1	3.9	4.1	4.4	5.4	3.6	4.0	4.4	2.7	3.5	2.2	2.5	1.0	2.6	3.8	1.1	2.6	5.5	4.9	3.1	3.8	2.3	47.7	2.9	7.6	3.9	5.4	3.2	2.7	5.7	4.4	3.1	1.7	3.8	2.9	3.3	4.3	1.3	4.0	2.8	4.2	2.5	7.2	4.0	4.0	1.4	2.5	0.0	2.9	3.8	4.5	11.1	5.6	3.2	2.9	1.6	5.7	4.1	6.1	3.8	2.0	1.7	2.6	1.7	0.8	3.0	1.0	3.1	1.9	1.8	8.5	5.1	4.1	4.2	4.4	4.6	3.5	7.4	6.3	5.1	4.3	13.0	9.2	2.1	4.7	4.9	3.9	10.0	5.1	4.4	6.8	11.9	9.7	4.9	4.8	8.6	6.3	9.4	3.4	6.0	2.4	3.4	2.0	0.0	6.8	0.0	5.1	0.0	2.3	1.8	2.0	14.4	1.7	10.9	74.5	1.4	8.5	0.0	12.1	2.1	0.0	7.1	0.0	13.2	5.4	3.2	10.5	4.3	5.3	33.5	2.6	2.2	0.0	1.8	8.4	3.8	8.7	7.4	4.6	2.6	4.3	0.0	0.0	0.6	1.0	0.0	8.7	1.5	6.4	2.6
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.0;skeletal muscle: 107.3"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 16.8;Horizontal cells: 7.9;Leydig cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.0;ASC diff: 11.6;ASC TERT1: 8.8;SCLC-21H: 11.3;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			Vesicles	Nucleoplasm	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	3.6	3.7	3.3	1.7	4.6	1.2	2.8	7.7	8.2	2.3	3.2	4.6	0.0	1.5	2.5	3.1	2.5	2.0	2.3	29.0	3.6	3.9	1.9	1.1	1.5	1.3	3.7	4.2	3.9	1.8	1.1	1.7	1.4	3.7	2.6	1.3	2.0	1.6	2.6	107.3	1.3	1.6	2.9	3.2	1.7	1.4	2.2	3.2	0.0	1.2	22.6	1.2	2.1	1.6	1.3	4.6	0.0	5.2	2.3	0.5	1.9	0.0	0.0	2.2	11.0	11.6	8.8	2.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.3	4.4	2.5	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.5	2.9	0.0	0.0	3.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	11.3	8.7	0.0	0.1	0.0	0.3	0.3	2.7	0.1	0.1	0.8	0.5	0.0	0.0	0.4	0.0	1.9	0.0	1.7	0.0	5.2	0.0	0.0	3.3	0.0	1.0	0.0	0.0	4.6	1.3	0.4	0.5	0.0	2.3	2.8	2.0	0.0	1.9	3.3	4.6	7.7	8.2	3.6	3.9	3.7	4.2	3.7	3.2	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	1.8	2.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.5	7.9	0.0	1.8	0.8	1.3	4.6	0.4	0.0	0.0	0.0	2.3	0.4	0.0	3.5	1.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821977	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6"	"Cell type enhanced"	"Detected in single"	21	"Horizontal cells: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Group enriched"	"Detected in some"	6	"NB-4: 24.1;THP-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.7	0.7	20.5	1.2	30.0	18.2	2.1	0.1	21.3	0.9	0.7	0.7	0.0	0.7	1.3	0.7	0.7	12.6	1.1	0.7	14.4	13.1	0.7	0.7	2.6	0.9	3.9	14.9	1.0	0.7	0.7	0.1	0.8	4.7	0.9	0.7	0.1	0.7	0.8	0.9	0.8	1.0	0.7	1.1	0.9	0.9	3.0	3.1	0.0	0.7	0.0	0.7	0.8	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	5.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.1	0.9	0.0	0.0	0.0	2.1	0.0	0.6	0.0	0.2	1.7	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.4	0.0	24.1	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.1	0.0	0.0	2.7	2.2	51.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	3.9	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	30.0	0.1	21.3	14.4	13.1	3.9	14.9	4.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 18.6;testis: 5.5"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.2;Horizontal cells: 3.2"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 12.3;SH-SY5Y: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: AB_2732631"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavorable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.5	1.8	7.8	0.7	8.7	0.5	0.5	0.8	18.6	1.4	0.6	2.1	0.0	0.7	0.7	0.5	0.6	0.5	0.6	0.5	8.0	6.6	0.7	0.5	0.7	0.5	2.5	4.5	0.6	1.6	0.5	0.3	0.5	3.6	0.6	0.8	1.8	0.5	1.0	0.9	0.6	0.7	0.6	1.0	0.5	0.7	5.5	1.8	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	12.3	0.0	0.0	0.0	0.5	0.1	0.4	22.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	8.7	0.8	11.6	8.0	6.6	2.5	4.5	3.6	1.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.7	0.2	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 13.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 13.1;NK-cells: 4.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		110000000	"Plasma membrane, Cytosol"		"HPA020433: AB_2670440, HPA076083: AB_2686773"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.72e-4)"	"prognostic unfavorable (7.04e-4)"	41.9	11.0	11.8	9.8	12.5	0.2	24.6	3.6	16.7	43.8	14.3	13.9	24.1	6.0	37.4	27.6	54.4	21.5	23.6	18.8	12.2	8.2	40.7	100.5	64.7	6.0	14.7	13.7	44.4	8.9	2.7	4.6	21.9	22.7	21.6	9.2	10.6	16.6	31.4	17.7	38.4	8.2	34.6	14.5	31.6	13.3	14.9	13.0	5.1	64.8	34.7	12.5	38.7	29.0	0.0	13.1	0.4	0.1	4.2	1.5	0.2	28.1	29.0	25.4	7.3	25.7	24.0	38.8	29.4	33.2	28.2	34.2	31.4	23.5	0.1	85.2	24.2	20.9	36.3	26.9	47.9	45.9	0.4	33.7	2.7	36.0	13.1	23.3	0.0	1.4	15.2	23.0	43.6	30.8	45.6	61.1	2.3	0.0	0.0	26.9	8.2	0.0	0.3	33.7	12.2	34.8	0.0	17.0	0.6	33.7	15.3	0.0	5.3	61.8	15.4	12.4	38.4	8.5	0.4	66.8	45.8	7.8	46.6	58.8	1.1	4.1	0.5	20.0	0.1	18.9	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.1	4.2	0.0	13.1	1.5	0.2	11.8	12.5	3.6	16.7	12.2	8.2	14.7	13.7	22.7	13.0	196.5	74.7	2.9	91.8	110.9	0.2	12.5	20.4	13.4	73.9	94.2	0.0	2.1	11.6	57.0	8.6	106.8	2.5	0.0	46.9	97.6	65.4	15.9	0.0	74.6	3.6	0.0	12.7	79.2	6.3	6.5	48.1	4.7	54.0	1.0	5.7	24.0	49.2	4.3	77.8	17.5	1.2	51.8	106.6	1.2	20.9	117.2	3.8	4.3	11.8	92.1
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544864	"Predicted intracellular proteins, Transporters"	"Antiviral defense"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 55.1;BJ hTERT+ SV40 Large T+ RasG12V: 73.3;HHSteC: 50.5;SK-MEL-30: 91.2"									"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Nucleoplasm, Golgi apparatus, Plasma membrane"		"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.9	14.9	11.9	39.7	21.4	27.0	31.1	5.7	19.0	20.9	29.6	7.2	22.1	18.4	19.6	25.7	25.4	19.5	30.8	22.7	16.1	12.7	32.0	36.5	33.8	38.6	17.6	4.9	40.0	26.1	10.3	18.4	25.7	22.1	25.0	28.0	12.6	32.3	34.2	16.4	9.9	24.6	19.4	29.8	46.0	20.5	15.4	14.8	16.4	27.5	14.9	19.5	27.5	48.0	6.5	27.5	26.2	41.2	14.3	8.1	17.6	17.2	6.9	4.4	2.0	6.6	11.2	6.8	5.4	14.8	55.1	73.3	5.5	14.4	1.3	12.9	3.4	43.1	14.2	3.5	5.1	9.3	5.3	3.5	11.1	2.2	4.1	50.5	6.3	5.8	17.8	8.7	6.1	31.1	8.8	8.0	3.2	7.1	17.2	11.2	6.7	4.9	2.4	4.2	11.7	6.2	4.4	4.9	0.4	15.5	4.7	2.7	0.0	6.9	3.4	91.2	6.3	3.4	7.7	4.8	4.4	3.8	9.9	9.0	13.2	2.4	0.0	4.5	4.6	3.8	8.2	41.2	11.0	5.6	40.4	8.1	6.5	3.7	5.0	27.5	4.9	2.6	3.8	26.2	14.3	22.7	7.3	2.1	17.6	11.9	21.4	5.7	19.0	16.1	12.7	17.6	4.9	22.1	14.8	32.8	47.9	22.6	70.0	32.7	0.4	4.0	86.6	81.7	60.3	90.7	0.0	46.8	63.0	225.1	1.5	110.1	67.7	0.0	192.6	100.1	54.5	74.2	26.7	25.9	121.5	0.0	31.9	91.4	84.8	2.2	106.4	157.8	45.5	24.4	60.9	52.6	150.7	102.1	43.2	33.8	1.3	38.8	58.7	0.3	2.2	25.0	37.2	21.3	51.4	160.1
PLSCR2		ENSG00000163746	"Phospholipid scramblase 2"	Q9NRY7	3	146391421-146495991	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 8.1;testis: 16.8"	"Group enriched"	"Detected in some"	25	"Early spermatids: 161.5;Late spermatids: 194.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.9;EFO-21: 2.3;GAMG: 3.7;Karpas-707: 2.5;U-266/70: 2.1"									HPA051352			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA051352: "	"unprognostic (1.11e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.94e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.23e-2)"	0.3	0.3	0.3	1.7	0.3	1.3	0.4	1.0	0.4	0.4	1.5	0.0	1.3	0.2	0.3	8.1	0.6	0.9	1.4	0.3	1.1	0.3	1.4	0.3	1.0	1.8	0.3	0.4	1.0	1.2	0.3	3.2	0.5	1.6	0.4	0.5	0.6	1.4	3.0	0.3	0.3	0.4	0.2	0.8	0.3	0.5	16.8	0.0	0.1	2.5	0.7	0.1	0.3	2.2	0.6	0.5	1.7	1.1	1.3	1.6	0.6	0.0	0.3	0.0	0.0	0.0	1.4	0.2	0.0	0.4	0.6	0.8	0.2	1.9	0.0	2.3	0.0	3.7	0.2	0.3	0.0	0.4	0.1	0.4	0.6	0.8	0.2	0.8	0.0	0.7	0.5	0.5	0.2	0.9	0.6	0.0	0.2	0.3	2.5	0.1	0.0	0.0	0.0	0.5	0.0	1.5	0.2	0.0	0.0	1.5	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.6	0.6	1.3	0.6	0.9	1.4	0.5	0.3	1.4	1.6	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.3	1.0	0.4	1.1	0.3	0.3	0.4	1.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.5	1.4	0.0	7.0	0.0	0.1	1.7	0.8	161.5	0.0	0.0	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.1	0.0	1.7	0.6	0.0	194.1	1.7	0.3	0.0	0.0	0.0	1.0	0.7	0.0	1.4	1.1	0.3	0.0	0.1	4.8	2.3	0.1	0.0	0.0	0.6	0.1
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192339-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 48.7;Fibroblasts: 48.9;Ito cells: 88.4;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.5;ASC TERT1: 19.3;hTERT-RPE1: 24.1;HUVEC TERT2: 19.8;TIME: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	40.5	29.6	19.4	5.9	20.4	1.7	53.3	19.1	23.4	25.1	17.7	14.8	10.8	4.6	21.9	13.9	15.8	28.0	29.4	20.3	23.1	13.8	16.9	43.4	24.2	16.7	13.7	14.6	25.2	13.0	3.8	11.7	35.9	21.8	17.9	16.9	15.9	14.8	18.2	8.7	11.1	9.3	25.0	28.7	18.4	11.0	16.8	16.6	0.9	25.1	8.9	4.5	23.3	28.7	0.0	0.2	0.0	0.2	1.3	0.0	0.5	0.0	3.6	0.6	0.0	24.5	19.3	0.1	4.3	5.9	1.9	4.3	0.4	4.8	0.0	4.8	8.1	1.9	0.5	0.9	0.4	1.1	0.0	0.0	1.9	2.9	0.4	11.2	0.0	0.5	11.7	0.6	4.0	1.2	24.1	19.8	0.0	0.0	0.3	2.9	0.1	0.0	0.0	0.8	1.9	1.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	7.4	0.0	1.4	1.0	0.3	0.2	40.8	4.1	1.0	9.1	0.8	0.1	0.0	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.5	19.4	20.4	19.1	23.4	23.1	13.8	13.7	14.6	21.8	16.6	3.0	10.1	0.0	4.4	9.6	0.3	3.2	17.8	6.7	10.3	3.5	0.0	0.7	0.0	5.0	0.9	48.7	9.1	23.3	10.2	0.2	48.9	3.1	1.1	39.0	0.7	0.0	9.9	88.4	8.6	1.3	39.7	2.5	3.3	0.0	13.5	48.4	5.7	8.6	30.4	16.5	1.3	0.0	25.0	0.7	0.4	7.5	0.7	1.0	6.6	2.2
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351448-17377350	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.3"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 20.4;Endothelial cells: 32.1;Ito cells: 41.7;Melanocytes: 21.9;Suprabasal keratinocytes: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 22.1"	"Cell line enriched"	"Detected in some"	28	"EFO-21: 112.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		53000	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	128.3	9.8	0.8	16.4	0.9	0.0	56.3	0.4	1.5	28.7	29.8	3.2	12.8	20.2	32.0	19.8	27.4	16.6	43.1	18.9	1.1	0.4	33.7	4.6	13.1	34.6	0.9	0.5	14.3	22.9	13.8	16.1	12.6	2.7	26.1	5.2	26.3	16.0	10.4	20.7	11.5	23.7	13.5	1.2	77.8	22.1	9.5	0.7	3.8	88.3	13.9	15.2	30.1	87.7	0.0	22.1	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	22.1	0.0	0.3	0.8	0.9	0.4	1.5	1.1	0.4	0.9	0.5	2.7	0.7	6.0	0.0	0.0	0.7	20.4	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.7	32.1	0.0	0.0	2.3	0.1	5.6	1.4	0.0	0.0	1.4	0.0	0.0	41.7	2.7	0.6	0.0	3.8	21.9	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	10.8	0.4	0.4	14.6	0.1	0.0	0.0	1.7
PLXNA3	"6.3, Plxn3, PLXN4, SEX, XAP-6"	ENSG00000130827	"Plexin A3"	P51805	X	154458281-154477779	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058989			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		58000	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA058989: AB_2683872"	"unprognostic (2.79e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	6.9	7.6	9.8	6.6	9.3	3.5	13.3	25.9	7.4	8.1	6.2	13.8	7.3	7.2	8.6	9.2	5.3	8.3	7.9	6.6	10.5	8.0	5.1	2.5	7.2	7.1	8.7	3.6	16.4	9.9	5.1	35.2	7.4	8.2	9.2	4.8	6.1	13.8	7.5	2.9	19.5	7.2	8.2	8.4	7.0	10.0	5.8	9.8	4.6	9.3	1.8	7.2	6.3	16.4	1.8	0.5	2.7	0.5	2.1	1.0	0.3	8.2	1.6	4.9	12.4	5.2	6.6	6.6	11.8	2.5	2.8	3.8	6.2	3.5	1.5	6.4	12.7	6.6	7.3	4.9	5.7	1.0	0.7	3.7	1.5	19.3	3.4	4.1	0.8	6.9	8.9	4.2	4.1	0.3	9.7	3.1	2.4	3.8	1.3	4.3	10.2	1.4	6.3	1.6	2.6	3.7	5.3	0.4	0.5	3.7	5.5	10.3	5.3	4.4	7.9	2.0	3.6	4.8	1.8	7.8	6.1	5.6	0.6	5.0	0.9	0.1	2.2	11.4	1.1	1.6	2.7	0.5	0.8	0.8	0.4	0.6	1.8	1.0	0.8	0.1	1.2	0.6	0.8	1.4	2.1	0.3	0.5	0.7	0.3	9.8	9.3	25.9	7.4	10.5	8.0	8.7	3.6	8.2	9.8	11.9	11.4	0.9	8.3	7.7	18.3	4.5	2.5	10.7	5.7	10.4	11.8	2.9	0.0	11.1	0.0	3.7	8.0	0.0	5.0	4.9	9.1	8.5	8.1	0.9	7.4	4.8	6.9	3.7	4.3	0.4	10.6	6.4	13.5	7.2	11.4	5.2	13.0	10.5	8.1	0.7	8.9	12.9	6.2	0.2	2.2	6.5	7.8	6.4	7.1	6.5
PLXNA4	"DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B"	ENSG00000221866	"Plexin A4"	Q9HCM2	7	132123332-132648688	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.2;breast: 34.7"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 9.9;Cardiomyocytes: 9.5;Collecting duct cells: 12.2;Cone photoreceptor cells: 15.7;Early spermatids: 9.9;Leydig cells: 13.0;Muller glia cells: 10.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;HMC-1: 10.0;hTERT-RPE1: 12.9;RH-30: 10.7;TIME: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029919, HPA052141, HPA075592"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (5.76e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.42e-3)"	23.2	5.1	8.7	3.5	9.0	1.1	34.7	3.9	15.1	16.2	2.0	1.0	0.8	1.5	2.3	1.0	7.7	3.0	4.2	6.9	9.7	7.2	2.0	1.3	1.8	2.5	4.0	6.6	6.2	1.0	1.0	1.6	6.7	6.6	1.4	2.1	0.7	1.2	2.4	1.7	4.1	1.4	5.1	1.5	2.4	2.8	2.4	1.8	0.0	3.3	0.0	1.3	2.1	9.4	0.0	6.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.0	12.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	10.7	1.1	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.1	0.0	0.0	32.6	3.3	0.1	0.7	0.2	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.0	6.1	0.0	0.0	8.7	9.0	3.9	15.1	9.7	7.2	4.0	6.6	6.6	1.8	0.0	0.0	0.0	0.1	0.6	9.9	9.5	0.0	0.0	0.0	12.2	15.7	0.0	0.0	0.0	9.9	0.7	0.0	0.0	0.0	0.1	5.4	0.2	1.1	0.0	0.1	0.0	1.2	1.8	0.0	5.9	13.0	0.0	6.8	0.0	0.0	10.0	0.4	0.0	6.7	0.3	1.4	0.0	1.4	0.2	0.1	1.1	0.0	0.0	0.0	0.5
PLXNC1	"CD232, VESPR"	ENSG00000136040	"Plexin C1"	O60486	12	94148723-94307675	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.5;retina: 40.6"	"Cell type enhanced"	"Detected in many"	14	"Kupffer cells: 41.4;Macrophages: 32.1;Melanocytes: 91.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 24.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 14.2;monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.3;Karpas-707: 11.9;SK-MEL-30: 19.0;U-266/70: 30.1;U-266/84: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066899			Approved	Mitochondria		NA	NA		82000	Mitochondria		"HPA066899: AB_2685743"	"unprognostic (1.49e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.67e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.33e-3)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.48e-2)"	6.6	7.5	7.1	16.1	6.9	12.6	3.9	16.8	8.6	8.0	5.1	3.1	0.8	3.1	7.3	2.2	4.9	4.3	8.3	4.1	6.3	15.2	3.2	2.0	15.2	43.5	4.5	7.7	13.0	2.3	0.5	6.3	7.5	5.2	4.3	5.4	40.6	3.7	3.7	2.9	6.6	5.0	5.7	4.9	28.6	3.4	12.1	3.3	8.6	3.3	2.7	10.2	9.6	6.5	2.4	2.5	14.2	6.7	0.9	1.7	1.5	0.4	0.2	1.2	0.2	0.7	0.5	0.1	0.6	0.8	0.8	2.4	4.1	0.0	9.8	0.0	0.9	0.7	0.0	15.3	0.6	0.5	6.8	0.3	0.5	0.2	2.7	8.5	2.0	3.4	8.4	0.0	0.9	0.4	1.0	0.0	0.9	0.2	11.9	0.2	0.1	0.4	1.0	2.5	0.1	0.5	1.6	0.4	5.3	0.0	0.7	1.0	0.7	0.1	0.1	19.0	3.1	0.0	1.6	0.3	0.2	1.1	0.1	0.3	30.1	31.3	0.6	0.1	5.3	0.6	0.0	3.0	12.2	1.4	5.2	1.6	2.4	1.6	1.7	2.5	1.4	1.4	1.5	14.2	0.9	6.7	0.9	1.0	1.5	7.1	6.9	16.8	8.6	6.3	15.2	4.5	7.7	5.2	3.3	3.0	3.7	11.2	0.2	5.5	2.1	3.7	2.5	4.0	0.0	0.0	0.0	0.1	1.7	0.2	6.7	1.8	0.2	0.0	0.5	0.1	2.6	0.2	16.1	0.8	19.6	0.0	19.0	9.8	41.4	5.9	1.4	32.1	91.1	19.8	1.6	0.0	0.4	0.0	3.2	3.1	0.6	6.5	1.4	1.5	1.2	1.4	0.1	3.2	1.0	0.1
PMF1		ENSG00000160783	"Polyamine modulated factor 1"	Q6P1K2	1	156212993-156240042	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (1.17e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.62e-2)"	20.6	21.7	18.2	19.8	20.4	40.8	23.3	24.3	23.7	27.4	20.3	26.1	25.2	20.1	25.2	27.5	26.4	20.4	24.4	37.9	16.4	15.5	38.0	32.4	21.3	30.5	23.9	17.4	25.1	28.0	23.6	22.8	35.5	17.1	25.5	18.0	27.6	26.8	20.5	65.7	28.9	20.1	20.9	21.3	29.9	22.8	13.4	22.4	23.6	30.5	48.3	29.5	21.6	22.7	22.8	41.1	26.2	36.5	19.9	31.1	29.0	21.2	26.3	28.4	21.4	5.4	11.2	22.1	11.1	15.7	30.1	25.0	32.2	30.7	19.6	24.2	14.1	10.4	14.3	28.5	18.5	15.5	14.0	33.8	14.5	20.1	28.7	11.2	20.4	20.2	10.1	18.7	13.5	14.3	11.6	22.6	14.4	21.6	22.8	14.5	43.4	21.3	26.4	49.3	31.5	23.4	23.5	15.1	38.8	31.4	16.1	26.0	32.7	18.4	21.2	14.4	21.7	34.5	25.1	13.0	13.0	16.7	14.4	21.7	17.1	17.6	38.5	10.4	19.8	18.0	7.9	36.5	16.4	20.2	25.2	18.1	22.8	19.9	18.8	30.0	21.6	19.4	19.5	26.2	19.9	22.1	41.1	31.1	29.0	18.2	20.4	24.3	23.7	16.4	15.5	23.9	17.4	17.1	22.4	17.9	21.4	70.7	66.4	44.3	11.4	9.7	48.4	6.7	22.7	71.5	11.8	119.8	149.2	81.5	4.4	45.6	19.1	23.3	85.9	94.2	46.0	45.9	43.9	44.8	68.8	7.9	47.1	37.4	37.6	4.2	36.2	38.4	81.0	60.5	42.8	53.7	66.2	42.9	26.5	90.8	23.8	25.8	42.9	14.7	35.1	44.5	131.6	52.3	46.9	60.9
PMF1-BGLAP		ENSG00000260238	"PMF1-BGLAP readthrough"		1	156212982-156243332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 2.7;Distal tubular cells: 3.3;Proximal tubular cells: 2.2;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (8.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.65e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.85e-4)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.36e-1)"	9.8	15.7	16.2	10.3	16.2	12.1	7.8	18.1	14.6	14.6	13.0	13.9	13.4	8.6	13.1	16.3	11.7	15.0	12.9	24.6	14.1	14.2	20.6	17.4	11.0	16.4	12.6	9.0	15.6	15.0	10.4	16.2	19.2	8.8	15.7	7.0	14.8	21.5	13.2	31.8	10.7	10.5	10.9	11.2	14.0	9.5	7.4	11.8	12.5	16.4	26.4	15.8	9.8	11.1	9.8	7.1	10.2	8.9	5.1	10.7	8.1	7.0	7.3	9.7	6.6	2.6	6.8	4.2	6.4	4.2	6.3	5.2	5.4	6.5	6.2	10.8	5.7	2.6	4.9	9.0	8.2	3.2	10.6	15.2	4.3	7.1	10.0	12.4	4.2	7.7	8.3	7.7	5.7	5.0	7.9	5.9	5.7	4.2	10.0	4.4	8.6	3.7	9.0	19.9	4.8	13.4	7.1	3.8	9.1	4.9	3.4	6.7	8.6	4.2	1.7	11.0	8.8	9.9	17.0	6.5	3.1	3.1	3.9	5.7	6.1	7.3	9.4	4.5	5.6	6.2	3.6	8.9	4.4	4.9	5.8	4.8	4.8	7.7	7.1	6.6	9.8	10.7	6.0	10.2	5.1	6.1	7.1	8.4	8.1	16.2	16.2	18.1	12.8	14.1	14.2	12.6	9.0	8.8	11.8	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.4	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.6	0.3	0.0	0.0	0.6	1.2	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	2.2	0.0	6.5	0.0	0.2	0.5	0.0	0.8	0.0	0.5	0.3
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849331	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Club cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 52.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 52.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	14.8	13.1	6.8	15.4	9.0	4.3	13.6	8.2	8.2	11.4	19.4	7.0	11.6	18.9	9.7	13.1	22.7	10.0	13.9	10.7	4.7	2.9	14.6	43.3	11.8	11.2	6.6	4.3	7.8	40.4	7.8	28.3	19.9	6.6	12.0	20.4	8.8	21.2	13.5	12.5	13.2	19.6	9.5	5.7	12.0	15.2	9.7	7.8	7.6	10.0	12.0	22.0	10.5	12.2	2.9	3.5	52.2	4.9	1.6	3.6	3.0	10.8	24.3	5.4	14.1	9.6	15.2	12.0	17.0	20.6	17.1	18.5	18.2	13.5	17.4	7.2	29.7	9.0	15.1	11.0	20.8	17.5	12.9	12.9	5.7	14.7	31.0	18.3	15.2	13.8	22.7	14.8	18.2	16.8	7.9	17.4	10.8	7.8	17.0	11.3	28.5	15.6	14.0	22.9	25.4	15.8	19.8	12.0	34.6	19.0	19.3	10.3	19.3	14.0	30.9	10.2	9.0	20.1	13.4	20.1	12.3	13.9	33.2	16.6	21.0	17.6	21.9	10.3	19.2	16.3	52.2	4.9	0.9	2.5	3.7	3.6	2.9	2.2	3.2	3.5	2.4	2.5	2.4	7.8	1.6	2.3	3.2	1.6	3.0	6.8	9.0	8.2	8.2	4.7	2.9	6.6	4.3	6.6	7.8	14.9	17.9	9.8	6.8	3.4	4.8	2.4	5.1	26.8	46.6	0.0	13.7	7.4	8.3	10.9	0.2	4.5	10.2	23.3	24.6	9.5	5.4	9.5	22.0	11.3	5.1	1.6	7.5	3.7	6.0	0.6	5.8	6.3	1.7	8.2	11.5	2.3	17.8	10.2	2.1	10.0	8.9	0.0	5.2	1.6	3.1	3.6	8.9	5.1	9.2	11.3
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4;seminal vesicle: 38.5"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 16.5;Cone photoreceptor cells: 21.6;Extravillous trophoblasts: 44.0;Rod photoreceptor cells: 19.4;Syncytiotrophoblasts: 41.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17.0	1.0	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0.0	0.5	0.0	0.7	10.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	27.1	0.0	0.0	2.9	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.3	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.2	3.2	0.0	0.1	2.2	0.8	0.3	0.3	0.0	0.2	1.1	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.4	3.7	23.2	19.5	17.0	6.1	15.5	3.8	1.7	0.0	0.0	0.0	0.4	0.6	16.5	2.8	0.0	0.0	0.0	0.0	21.6	8.3	0.0	0.2	0.2	0.3	2.0	0.0	0.3	44.0	0.2	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.4	2.7	4.8	0.0	0.4	0.1	19.4	0.0	0.4	0.5	0.6	0.5	41.4	0.0	0.0	0.9
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99398051-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favorable (1.09e-4)"	24.7	28.5	48.9	28.3	49.8	53.7	29.9	123.3	69.7	35.5	38.3	22.8	39.9	26.7	43.1	58.7	19.8	29.4	22.3	31.0	46.9	17.5	25.5	21.7	26.6	42.2	48.0	29.8	49.3	24.7	34.7	83.9	21.7	41.0	34.1	28.2	24.1	30.8	34.5	39.4	31.9	34.4	31.5	61.0	39.3	28.2	17.4	57.1	32.1	44.7	18.0	30.7	29.5	30.3	18.0	13.1	20.4	7.4	15.6	12.3	2.2	11.1	7.5	40.3	27.6	14.4	21.4	18.7	17.6	9.7	10.5	13.1	13.5	20.2	34.1	11.8	9.9	12.3	17.0	20.2	15.4	21.4	28.0	22.6	19.8	37.4	13.5	10.9	27.4	28.0	21.0	21.9	11.7	15.3	38.3	15.4	18.1	23.0	22.4	13.9	11.1	13.0	31.5	22.5	10.2	7.0	26.3	11.4	12.2	20.7	19.3	16.3	21.6	8.8	11.4	15.1	33.0	15.3	24.2	16.9	10.6	12.6	10.3	15.0	15.6	10.7	31.3	16.0	28.2	12.3	6.9	7.4	6.6	8.6	4.2	8.5	12.0	8.4	6.8	3.3	18.0	12.3	11.8	20.4	15.6	4.8	13.1	7.7	2.2	48.9	49.8	123.3	69.7	46.9	17.5	48.0	29.8	41.0	57.1	172.7	197.8	329.9	282.6	173.4	521.3	112.2	109.5	187.4	202.4	169.3	420.2	132.4	63.0	108.9	13.5	170.1	148.0	70.0	90.8	86.5	187.1	270.2	182.8	89.8	87.1	470.4	237.9	98.8	88.1	13.3	549.4	181.7	158.6	221.0	84.6	269.4	105.3	147.3	414.8	35.6	432.5	245.8	215.3	310.7	171.1	151.8	151.3	236.8	126.4	254.3
PNMA1	MA1	ENSG00000176903	"PNMA family member 1"	Q8ND90	14	73711783-73714372	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003817, HPA015007"	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Focal adhesion sites"	"HPA003817: AB_1079646, HPA015007: AB_1855502"	"unprognostic (2.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (7.49e-5)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.90e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (4.51e-5)"	19.6	18.0	39.1	11.1	42.4	4.7	17.4	30.4	68.2	16.0	19.3	11.2	15.8	8.2	20.5	32.4	13.9	20.9	14.3	13.1	29.6	33.5	16.4	3.1	8.4	12.5	25.8	39.4	31.8	5.7	6.7	20.9	12.3	27.0	29.0	10.1	8.9	4.6	53.4	5.8	4.5	9.1	29.5	19.8	10.1	10.9	38.1	17.3	6.0	11.0	2.5	7.3	14.8	21.2	3.3	3.6	4.0	4.6	4.8	12.8	6.4	15.0	13.7	23.7	17.6	17.9	19.0	9.8	16.0	9.0	14.7	10.8	12.9	9.4	0.3	11.2	19.4	14.0	10.1	18.2	9.5	15.2	14.3	11.2	8.6	11.5	9.6	19.2	4.7	13.7	16.7	11.5	17.5	11.1	29.0	22.1	9.3	7.4	9.6	19.9	37.0	9.4	11.6	7.1	7.8	48.5	14.9	14.8	0.3	19.3	0.4	28.2	21.6	28.2	6.5	12.6	15.0	31.6	8.1	21.3	29.7	23.9	18.0	12.9	8.5	13.1	4.5	29.3	6.8	9.8	2.6	1.7	4.0	8.4	3.3	5.6	2.9	10.8	8.5	3.6	3.3	10.6	9.7	1.6	4.8	4.6	0.6	12.8	6.4	39.1	42.4	30.4	59.9	29.6	33.5	25.8	39.4	27.0	17.3	6.0	4.0	2.4	6.5	3.4	46.6	16.9	0.0	17.4	3.4	14.0	11.8	6.4	13.3	8.4	68.4	12.6	3.1	0.0	5.9	9.3	17.3	7.4	16.1	0.9	13.5	55.6	18.0	22.1	5.4	42.0	30.2	13.2	18.6	19.8	3.7	60.0	19.1	0.0	79.5	17.9	44.9	71.1	44.2	97.4	36.5	3.3	5.0	13.8	1.7	3.1
PNMA8A	"FLJ10781, KIAA1183L, PNMAL1"	ENSG00000182013	"PNMA family member 8A"	Q86V59	19	46466491-46471563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.0"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 20.1;Collecting duct cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.9;K-562: 18.9;LHCN-M2: 19.6;SH-SY5Y: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012956, HPA077702"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA012956: AB_1844328, HPA077702: "	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.76e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.48e-3)"	1.2	17.4	18.6	1.2	26.4	1.1	3.9	24.8	61.0	2.9	1.6	5.1	1.2	1.2	9.7	12.7	1.5	16.7	4.3	10.7	16.6	29.9	7.2	0.9	1.8	0.8	14.1	25.7	13.5	5.0	3.8	14.5	2.4	19.5	7.1	1.1	5.4	4.4	8.1	1.2	1.5	1.3	5.9	8.9	0.9	1.4	16.1	4.4	4.3	11.7	0.0	1.0	1.9	0.7	1.1	1.1	3.0	0.5	0.8	2.6	0.3	0.0	7.4	10.8	10.7	3.2	7.2	2.0	0.7	0.1	1.3	0.7	0.1	0.8	0.0	10.1	0.5	3.8	0.1	17.9	2.9	0.9	0.0	6.7	0.0	0.2	0.2	5.3	0.1	0.1	1.8	3.6	4.5	0.0	1.0	1.0	6.4	18.9	0.1	19.6	0.0	0.1	0.1	9.1	0.0	0.0	0.0	11.9	0.0	4.5	0.0	8.8	17.4	0.0	0.2	0.0	10.4	0.1	0.2	0.6	0.0	0.1	0.1	3.6	0.0	0.0	0.1	0.1	0.0	1.2	3.0	0.5	0.3	0.3	0.3	0.2	1.1	0.3	0.9	0.1	0.7	0.4	2.6	1.3	0.8	0.1	1.1	0.2	0.3	18.6	26.4	24.8	37.2	16.6	29.9	14.1	25.7	19.5	4.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	20.1	3.4	10.4	0.0	0.7	3.3	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157844-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056928			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	18.5	19.2	13.0	17.2	19.0	21.8	15.4	10.0	12.8	10.8	13.1	9.1	10.2	9.9	15.3	15.4	14.9	13.8	13.2	24.5	19.1	9.6	16.6	27.4	12.9	15.0	15.0	11.9	20.0	27.0	13.2	15.7	16.3	13.1	14.4	12.2	8.9	12.7	15.0	48.8	12.4	9.5	15.1	11.7	13.6	13.2	11.4	13.9	9.7	16.6	15.1	15.2	15.8	21.4	14.7	12.6	2.0	13.2	10.6	15.5	14.4	15.1	16.6	7.7	12.6	9.5	7.9	19.3	14.4	9.4	16.3	11.6	31.7	9.0	20.7	12.1	9.5	22.6	13.0	24.7	17.0	25.6	14.4	17.3	20.1	7.9	23.2	14.8	16.0	9.3	10.2	12.6	16.4	18.8	4.7	11.9	13.4	27.7	11.3	14.5	11.1	15.6	15.2	21.6	27.5	18.1	13.3	18.9	22.0	12.4	12.8	13.8	10.2	10.7	13.4	23.1	12.9	9.4	9.0	8.9	18.7	20.2	16.6	39.9	9.1	13.0	32.0	15.4	24.1	25.5	0.4	9.4	1.9	10.1	13.2	15.5	14.7	11.4	11.5	12.6	11.1	13.3	12.2	2.0	10.6	9.4	9.0	11.7	14.4	13.0	19.0	10.0	12.8	19.1	9.6	15.0	11.9	13.1	13.9	14.9	10.4	31.0	31.3	73.8	22.7	10.4	12.7	33.5	46.6	7.0	11.8	34.1	16.6	26.1	20.1	20.3	4.2	0.0	25.8	33.6	22.6	19.3	30.1	14.3	23.5	17.5	16.6	13.5	10.6	4.2	11.5	23.3	11.8	20.8	9.7	13.7	24.7	7.0	15.6	27.9	40.1	6.5	48.7	23.9	42.8	49.1	39.8	20.4	13.6	22.3
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.5	8.3	1.7	4.5	65.2	5.8	11.2	11.3	9.1	7.1	6.3	7.1	10.7	6.3	6.7	8.5	4.4	9.5	2.6	4.7	2.2	8.1	23.1	8.7	3.7	11.3	21.4	6.0	11.0	11.4	6.1	4.7	5.5	7.3	5.8	4.7	7.4	6.4	6.3	6.2	8.0	13.1	5.0	10.8	17.9	7.7	3.8	14.1	7.0	2.4	6.4	8.5	21.0	17.9	6.5	1.1	7.7	6.9	10.4	6.4	5.0	4.1	5.1	24.7	15.2	5.3	16.1	8.5	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5	6.0	16.9	27.0	63.2	39.3	8.8	42.3	63.7	5.3	13.6	48.8	7.9	56.2	28.2	55.9	14.2	38.0	114.0	23.3	57.3	27.0	25.2	72.1	11.5	41.9	27.6	11.1	49.4	84.1	28.5	4.2	44.8	24.9	40.5	27.9	80.0	34.7	98.9	112.2	36.7	37.9	7.5	64.7	32.2	42.2	28.2	36.0	141.7	36.2	41.4	167.2
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.5;LHCN-M2: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.3	13.5	5.5	3.8	4.3	0.4	2.4	1.4	3.3	7.2	3.9	7.1	0.0	2.1	4.0	1.9	3.4	8.4	3.9	2.8	0.0	0.7	0.2	3.2	7.2	6.2	0.0	0.2	4.9	3.1	10.6	0.5	5.7	0.4	0.1	0.0	0.0	15.3	0.6	0.2	0.0	9.2	0.4	0.0	0.0	7.3	0.1	1.5	0.2	1.2	0.1	2.7	1.1	3.8	2.4	4.2	4.6	0.4	1.3	4.1	0.1	0.1	0.0	0.0	0.0	11.6	0.0	4.8	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3	0.0	0.0	0.0	0.5	0.3	37.1	1.1	15.3	0.0	0.0	0.0	17.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.0	42.7	0.6	0.0	1.7	0.6	2.6	0.0	0.3	0.0	1.7	0.0	0.5	1.3	1.5	0.0	0.7	5.0	34.3	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.4
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007522, HPA064773"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA007522: AB_1079649, HPA064773: "	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	12.9	19.7	25.9	25.0	29.3	22.3	17.8	22.1	35.8	10.2	15.9	26.1	10.0	26.3	13.7	6.3	16.4	12.6	14.0	12.0	22.6	19.1	17.1	13.7	30.4	17.6	36.3	19.2	12.5	14.2	15.6	21.6	13.9	29.2	13.4	8.9	15.8	13.7	14.3	27.0	15.3	28.7	14.5	23.5	28.3	12.2	31.3	33.0	7.1	14.7	6.1	8.8	15.9	14.7	3.8	7.3	21.8	19.0	5.0	3.9	4.1	13.2	31.9	6.3	15.2	11.0	16.0	14.5	17.2	17.7	13.4	12.4	7.4	18.3	10.9	29.3	22.2	8.3	17.0	5.3	16.2	6.9	26.6	12.3	7.2	17.0	5.6	12.7	8.0	22.5	13.8	9.4	17.2	10.0	21.3	26.4	13.0	5.9	15.1	11.9	6.2	8.8	10.5	6.9	6.2	29.3	7.1	3.8	12.8	11.9	12.6	8.0	13.9	14.6	6.6	18.7	8.9	5.9	11.5	27.9	16.3	9.6	22.3	18.0	17.9	11.5	4.8	27.4	9.5	15.2	7.9	6.1	21.8	3.5	12.1	3.5	3.8	2.5	3.8	7.3	2.8	2.2	2.9	1.9	5.0	19.0	2.4	3.9	4.1	25.9	29.3	22.1	35.8	22.6	19.1	36.3	19.2	29.2	33.0	6.0	11.8	6.5	2.7	4.2	10.9	8.6	17.8	8.1	6.8	31.4	25.5	14.9	1.7	13.7	60.0	10.8	52.1	0.0	6.1	12.2	4.1	4.5	11.5	19.2	24.9	20.6	16.7	10.4	55.8	82.5	8.9	23.8	8.5	10.0	13.4	10.6	8.4	12.9	7.1	17.0	16.2	0.0	6.2	58.2	10.0	4.8	10.4	10.0	14.0	3.1
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470422-108569666	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	21.5	35.7	29.3	12.4	28.9	51.5	15.0	15.6	27.2	15.4	13.4	9.5	9.3	8.6	13.4	13.7	18.3	9.7	15.9	17.9	23.0	22.1	23.1	24.6	16.7	12.0	20.7	17.5	15.6	10.1	20.7	33.4	25.2	23.2	14.4	11.4	6.0	11.4	13.9	29.8	11.4	10.8	15.3	20.3	19.5	11.1	10.8	21.1	16.1	22.6	13.0	15.3	22.5	12.8	20.0	19.3	16.7	26.8	14.6	12.5	13.7	14.1	6.4	11.3	10.1	25.2	17.4	16.7	13.5	23.8	11.1	18.6	6.1	8.1	7.9	17.1	13.2	22.4	5.4	19.1	8.6	16.9	11.8	5.3	5.4	10.5	4.5	18.4	3.7	11.2	15.7	16.3	14.9	13.8	12.2	15.0	8.9	6.3	22.7	13.8	9.3	8.7	8.9	5.0	8.9	9.1	3.2	11.9	16.7	13.3	18.0	9.4	13.2	12.9	14.0	16.2	14.9	5.9	6.4	12.1	18.3	8.2	27.2	7.4	19.3	19.5	11.7	17.4	5.7	11.8	14.1	19.7	16.7	10.5	21.8	12.5	20.0	10.3	10.3	19.3	18.7	11.2	10.7	16.5	14.6	26.8	7.6	12.5	13.7	29.3	28.9	15.6	27.2	23.0	22.1	20.7	17.5	23.2	21.1	38.7	43.0	28.7	103.5	82.5	61.7	43.5	10.2	81.7	58.0	22.7	17.7	46.4	79.6	26.9	49.7	39.4	25.7	0.0	33.2	30.6	50.6	71.1	70.4	40.3	28.4	30.2	54.7	19.6	49.4	40.1	29.7	48.1	52.3	17.2	16.2	37.9	25.2	14.1	37.1	33.7	29.7	19.4	38.2	17.7	27.4	118.6	108.9	23.5	13.6	109.8
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 53.0;Hepatocytes: 47.2;Proximal tubular cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		150000	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	6.0	13.1	9.9	5.1	13.0	2.9	8.6	8.3	16.5	6.2	7.0	8.6	6.9	8.5	4.2	9.6	8.1	8.4	10.1	10.2	8.7	12.0	26.0	64.7	5.3	7.7	11.2	9.9	8.0	13.7	17.3	7.4	5.8	11.1	6.9	7.4	8.4	8.3	7.1	14.7	5.5	9.6	5.2	7.1	6.8	6.7	6.4	6.0	5.2	14.4	8.2	6.1	5.4	5.2	6.8	12.2	2.4	16.4	7.7	8.2	8.7	17.6	14.6	1.1	2.7	7.5	5.8	0.0	6.0	3.9	6.7	5.8	23.9	13.0	16.8	28.6	5.9	2.7	10.6	9.1	16.3	9.7	20.4	7.8	11.8	6.8	24.8	8.0	10.5	8.2	7.6	12.7	12.4	15.5	6.2	8.7	12.6	11.1	5.8	7.8	13.1	10.6	3.4	2.1	17.5	18.1	9.0	5.1	12.2	18.6	9.1	5.9	4.9	5.5	8.9	5.0	4.3	15.7	3.8	9.1	10.8	6.4	10.8	12.4	13.9	15.3	8.9	8.8	9.1	5.5	2.1	11.0	2.4	6.8	16.4	8.0	6.8	6.2	7.4	12.2	5.7	8.2	7.9	1.1	7.7	10.4	8.9	6.4	8.7	9.9	13.0	8.3	16.5	8.7	12.0	11.2	9.9	11.1	6.0	11.9	15.2	1.5	5.9	1.3	0.7	1.7	22.9	5.3	7.9	12.2	3.9	7.5	53.0	15.3	0.4	3.6	11.0	0.0	13.5	2.0	3.1	7.8	12.7	47.2	15.2	3.2	3.5	4.9	7.0	0.4	9.2	8.5	1.7	8.2	9.9	6.7	13.1	10.5	5.6	75.4	1.7	0.0	1.7	0.7	1.3	1.9	5.3	1.0	13.6	4.8
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 1093.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 54.1;hTCEpi: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: AB_2685684"	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	70.5	58.1	21.3	46.1	28.3	105.4	48.1	30.8	31.8	55.9	51.5	30.3	27.0	23.6	60.3	30.9	45.4	73.6	45.0	48.5	20.8	17.9	32.9	97.9	59.5	87.1	23.1	22.3	83.4	41.3	31.3	29.5	38.8	20.4	56.6	26.0	46.5	35.5	40.8	154.1	49.0	32.4	63.6	31.1	46.9	38.2	35.5	20.8	91.2	38.4	30.8	45.4	113.2	41.0	9.6	7.3	37.5	7.1	6.9	10.4	3.8	2.9	2.8	6.1	10.3	24.8	41.8	4.2	3.8	26.8	7.2	16.9	2.4	8.2	6.4	18.7	4.6	29.6	10.1	3.2	5.8	11.0	8.0	10.0	1.1	16.5	7.7	54.1	5.9	14.8	30.0	57.5	4.8	22.2	27.2	11.8	7.6	0.9	19.7	7.9	2.9	1.5	31.3	1.7	3.3	6.1	7.0	7.4	5.1	16.9	5.2	3.9	11.0	9.9	13.6	10.0	19.0	6.7	29.9	11.2	5.7	3.4	4.0	1.4	31.0	15.1	2.1	11.5	5.1	3.5	10.3	6.6	36.7	7.5	7.1	7.8	8.3	8.9	7.8	4.2	9.6	10.4	10.4	37.5	6.9	6.3	7.3	7.1	3.8	21.3	28.3	30.8	31.8	20.8	17.9	23.1	22.3	20.4	20.8	131.0	125.0	333.4	716.3	860.7	129.0	174.7	124.9	45.5	52.4	85.5	47.1	189.8	198.9	158.1	59.9	195.6	165.4	23.3	206.9	57.7	278.7	681.2	165.7	181.5	204.0	68.3	237.9	148.0	328.8	20.9	446.1	557.5	416.7	926.1	131.7	222.1	145.2	115.8	354.7	216.2	99.3	413.9	840.5	47.0	44.3	1093.4	229.5	380.5	99.7	411.4
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23959109-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	35.6	32.8	21.1	39.3	21.4	39.0	36.8	22.3	21.0	38.6	40.6	17.1	25.9	32.0	37.5	24.4	28.7	24.9	32.7	41.9	20.9	19.4	33.3	21.3	37.2	40.6	21.8	20.2	39.7	25.2	29.2	28.5	36.2	18.6	37.1	30.8	23.8	26.2	30.1	32.8	18.7	38.4	37.9	26.1	34.4	29.3	16.9	18.7	44.6	56.0	23.0	34.4	49.1	35.6	46.8	38.9	69.5	40.5	36.6	48.9	52.8	23.9	9.5	41.9	28.9	28.9	26.6	16.0	26.7	23.8	31.1	25.0	27.7	30.4	65.5	26.2	16.9	11.7	21.4	28.0	23.2	34.6	46.5	18.1	62.2	29.2	29.1	24.7	60.2	28.5	20.0	29.4	25.4	23.8	20.4	29.9	34.0	52.6	36.9	18.2	19.6	37.2	23.0	56.6	22.8	17.8	42.3	27.2	27.8	31.2	25.8	25.1	21.9	23.1	19.9	27.1	32.0	21.6	38.0	23.9	20.1	19.5	19.7	16.9	31.2	35.8	44.7	13.7	58.4	20.6	69.5	40.0	44.0	39.6	40.5	41.3	46.8	43.3	42.6	38.9	46.7	48.9	41.2	26.7	36.6	37.1	27.9	44.6	52.8	21.1	21.4	22.3	21.0	20.9	19.4	21.8	20.2	18.6	18.7	172.7	84.5	75.1	213.3	11.7	31.2	75.8	33.1	101.7	112.6	59.3	17.7	106.7	202.2	72.5	5.4	75.4	113.0	116.8	112.0	88.3	60.2	176.8	73.0	27.6	59.3	19.1	96.3	74.3	66.3	11.0	73.1	84.5	1.7	63.1	76.5	50.4	90.7	85.4	76.4	88.9	24.5	45.3	47.6	22.4	23.0	11.0	118.5	109.3	95.0	217.3
POC1B-GALNT4		ENSG00000259075	"POC1B-GALNT4 readthrough"		12	89519408-89526262	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Ciliated cells: 5.3;Club cells: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.7"									HPA076116			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA076116: AB_2686778"	"unprognostic (4.91e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.77e-6)"	"unprognostic (7.99e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.61e-4)"	"unprognostic (7.65e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.16e-2)"	4.8	3.4	4.1	7.5	6.3	11.4	3.8	6.2	4.9	4.1	4.7	9.0	2.2	7.2	6.0	1.9	4.8	6.0	7.0	4.0	6.1	3.4	6.1	4.5	4.1	5.0	6.8	5.4	4.6	4.4	5.6	4.4	3.3	5.9	4.5	5.7	2.3	6.7	1.7	4.1	3.3	5.3	3.3	5.7	6.0	9.4	7.9	7.5	6.2	4.1	3.0	4.4	5.1	4.1	3.0	2.3	5.7	3.3	2.6	5.5	2.2	1.8	1.6	3.4	15.7	0.5	0.3	0.9	0.7	1.7	2.4	1.7	1.0	1.2	1.3	0.7	1.7	1.8	1.4	3.1	1.0	2.5	3.7	2.1	2.4	1.5	3.1	0.3	2.1	2.8	0.0	1.0	2.5	1.2	2.8	2.1	3.0	1.9	0.8	0.7	1.3	2.0	2.8	1.1	3.6	5.9	2.6	2.3	3.8	1.5	2.2	1.5	2.0	1.8	1.6	1.1	1.1	3.3	2.6	2.0	2.2	1.3	1.1	2.3	1.6	2.4	1.9	1.8	1.9	2.4	3.9	3.0	2.2	3.5	3.0	5.5	1.3	2.3	2.9	2.3	3.0	2.9	2.8	5.7	2.6	3.3	1.6	2.6	2.2	4.1	6.3	6.2	4.9	6.1	3.4	6.8	5.4	5.9	7.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PODXL	"Gp200, PC, PCLP"	ENSG00000128567	"Podocalyxin like"	O00592	7	131500262-131558217	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 82.5;Endothelial cells: 112.3;Rod photoreceptor cells: 186.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 34.6;NTERA-2: 46.7;SuSa: 47.0;TIME: 52.2;U-251 MG: 20.8"									"HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA		43000000	"Plasma membrane, Centriolar satellite"	Vesicles	"CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356"	"unprognostic (1.26e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.28e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.16e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.40e-1)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.56e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.03e-1)"	8.8	4.9	8.2	3.8	8.9	0.8	7.6	4.8	13.5	11.7	5.0	4.6	16.0	2.8	14.5	2.7	4.4	22.1	7.9	19.3	6.7	6.7	30.6	3.0	14.7	2.6	7.2	5.9	6.1	20.4	7.5	4.0	12.5	15.2	4.5	3.7	15.5	9.1	27.8	5.7	3.8	4.8	12.8	8.1	2.9	4.6	3.5	6.6	0.0	14.0	5.2	2.5	6.1	8.3	1.1	0.3	2.2	0.3	0.4	0.8	0.3	4.8	2.3	4.0	1.8	0.1	0.0	0.3	0.6	0.5	1.8	0.7	11.8	7.6	0.0	11.3	34.6	5.2	3.5	3.9	0.0	1.2	0.6	1.9	0.0	14.4	0.1	0.0	0.4	0.3	0.0	0.0	6.2	0.0	0.7	13.9	0.1	1.2	0.2	1.4	1.4	0.0	0.0	46.7	0.6	4.7	2.0	7.0	1.5	0.2	2.1	3.6	0.8	4.2	0.5	0.0	47.0	0.4	0.1	52.2	0.7	2.8	7.1	20.8	0.3	0.4	0.1	2.6	1.9	4.1	0.7	0.3	2.2	0.6	0.2	0.5	0.3	0.5	0.8	0.0	1.1	0.4	0.4	1.1	0.4	0.2	0.3	0.4	0.3	8.2	8.9	4.8	13.5	6.7	6.7	7.2	5.9	15.2	6.6	6.0	13.5	1.9	0.8	4.6	8.2	18.5	0.0	4.0	9.1	26.2	82.5	0.5	0.0	4.1	0.6	112.3	0.7	0.0	15.7	0.3	3.0	2.6	2.3	0.4	0.3	4.8	2.4	44.2	0.8	0.9	4.4	3.2	5.0	1.0	11.0	8.5	29.1	0.0	0.4	0.6	186.1	0.0	4.7	0.2	0.7	2.8	0.6	1.0	1.8	2.0
PODXL2	"endoglycan, PODLX2"	ENSG00000114631	"Podocalyxin like 2"	Q9NZ53	3	127629181-127672809	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 84.6;Horizontal cells: 77.9;Intestinal endocrine cells: 61.0;Late spermatids: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 32.6;SCLC-21H: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024934, HPA042265"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"CAB024934: , HPA042265: AB_2677920"	"unprognostic (2.07e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-3)"	3.0	16.1	19.1	2.6	19.7	1.8	8.1	31.4	42.8	3.0	8.3	9.0	1.6	6.6	4.5	2.5	2.8	4.3	4.4	2.5	22.2	37.3	4.5	1.6	2.1	2.2	21.3	17.5	10.8	12.0	1.2	20.9	1.3	31.5	12.0	7.6	8.7	21.4	2.4	2.8	4.6	6.1	2.0	17.0	2.1	12.2	16.4	7.7	0.6	4.1	1.6	2.7	2.1	0.9	1.6	2.6	0.1	0.8	0.2	2.7	0.7	0.1	3.9	10.8	25.6	0.0	0.0	16.0	1.2	0.0	2.3	0.4	8.0	0.4	9.5	9.7	0.1	3.5	0.0	8.8	0.0	0.2	0.0	18.1	0.2	9.0	8.1	0.3	21.5	22.0	0.4	1.9	0.0	0.0	6.1	0.6	0.0	12.4	0.0	0.8	4.8	0.1	0.0	16.2	2.2	19.1	0.0	0.3	32.6	3.2	1.1	48.6	27.3	11.6	24.8	21.1	1.1	6.3	10.9	0.1	0.0	5.0	0.4	7.5	0.0	0.0	7.4	0.2	14.0	7.1	0.0	0.2	0.0	0.8	0.8	1.1	1.6	2.7	0.7	0.0	1.3	1.3	0.6	0.1	0.2	0.0	2.6	1.7	0.7	19.1	19.7	31.4	33.8	22.2	37.3	21.3	17.5	31.5	7.7	0.0	0.6	0.0	3.7	4.8	84.6	0.4	0.0	1.4	0.0	8.7	29.5	1.9	1.7	5.5	45.3	0.6	8.0	0.0	17.9	3.1	4.6	10.6	1.1	0.5	1.1	77.9	61.0	0.6	0.6	110.3	8.1	0.7	20.3	12.6	18.4	17.7	13.0	18.2	5.3	3.3	35.4	6.5	5.3	18.6	51.7	4.8	1.3	0.0	19.5	2.2
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B, actin binding protein"	Q8WVV4	X	85277396-85379743	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.8;skin 1: 55.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 90.6;Mucus-secreting cells: 54.0;Paneth cells: 51.8;Undifferentiated cells: 38.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.0;naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 6.0"	"Group enriched"	"Detected in some"	5	"OE19: 59.5;RT4: 26.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		430000	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.5	0.4	0.3	9.9	0.3	0.0	3.7	0.4	0.4	7.0	41.8	0.0	0.5	10.9	0.8	1.6	21.4	1.6	10.0	6.3	0.3	0.3	2.5	0.5	1.4	0.4	0.3	0.2	1.0	2.9	0.0	2.5	3.4	0.1	3.9	16.9	0.1	5.6	0.9	0.4	55.6	55.8	0.7	0.4	5.5	7.6	0.4	0.0	0.3	0.7	20.3	9.2	4.9	6.9	6.0	0.0	0.0	0.0	0.0	0.8	0.1	1.2	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	7.8	3.9	1.1	0.0	0.0	7.9	1.7	0.1	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.0	3.0	0.0	0.0	0.0	59.5	0.0	0.0	0.3	0.0	0.0	26.5	0.0	0.0	0.0	2.0	0.0	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.1	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.2	0.1	0.0	0.0	0.3	0.9	4.2	8.0	0.0	13.2	10.2	8.1	11.4	5.2	0.0	2.1	0.0	10.5	0.0	2.2	90.6	0.0	13.4	0.7	0.2	3.2	0.0	0.0	0.2	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	54.0	0.0	17.7	51.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	25.0	4.5	0.0	38.3	17.2
POFUT1	"FUT12, KIAA0180, O-Fuc-T, O-FUT"	ENSG00000101346	"Protein O-fucosyltransferase 1"	Q9H488	20	32207880-32238667	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"monocytes: 16.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054519, HPA059935"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		140000	Centrosome		"HPA054519: AB_2682515, HPA059935: AB_2684171"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-3)"	"unprognostic (8.83e-2)"	"unprognostic (5.51e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-3)"	15.9	13.5	8.2	15.5	8.9	7.4	19.4	6.6	11.3	15.5	20.2	13.1	10.4	16.4	18.1	19.6	13.9	17.4	23.6	20.1	7.5	6.3	18.8	44.6	14.8	22.2	8.8	6.6	18.3	24.6	19.2	11.3	22.4	7.8	16.0	16.0	16.9	13.3	16.0	13.5	13.3	27.5	20.8	7.7	12.4	12.5	16.5	7.0	12.7	20.1	13.9	13.0	15.7	12.6	2.8	3.9	3.3	16.4	1.7	3.3	3.2	15.1	12.2	10.6	11.6	18.3	17.9	19.9	15.8	18.7	26.6	17.5	36.5	20.6	10.3	23.8	17.5	29.6	16.9	10.1	19.5	23.2	5.3	6.4	15.3	11.2	16.5	14.2	13.1	9.8	15.7	15.4	20.1	13.2	11.4	14.8	9.9	11.5	5.9	18.5	7.4	9.0	10.1	5.4	14.7	19.8	7.5	28.2	9.5	8.1	10.1	7.0	8.9	36.1	10.1	13.4	8.5	14.9	15.8	12.8	38.7	14.4	24.1	26.7	7.2	9.2	9.5	23.4	45.7	24.4	3.3	4.4	2.1	2.9	12.8	3.3	2.8	2.6	2.7	3.9	2.4	3.3	2.4	0.9	1.7	16.4	2.9	2.7	3.2	8.2	8.9	6.6	11.3	7.5	6.3	8.8	6.6	7.8	7.0	8.9	7.4	2.2	3.6	2.6	3.3	11.7	10.2	6.7	6.8	7.0	2.0	12.9	1.7	8.7	0.7	6.0	18.8	0.0	8.9	23.4	9.6	5.3	4.7	32.6	9.2	7.9	11.5	14.1	3.3	0.9	9.8	4.3	5.0	4.6	15.0	5.2	7.5	7.0	13.4	4.5	4.1	12.9	5.1	2.3	7.2	1.5	6.4	4.3	17.5	3.5
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693919-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	10.5	5.5	8.0	15.0	10.2	14.3	10.9	12.0	9.6	10.1	9.7	11.8	5.8	5.7	11.2	7.7	10.2	8.9	5.5	9.3	7.8	6.6	6.1	4.9	7.2	12.7	10.3	4.5	12.9	7.3	8.5	8.5	10.7	8.7	7.3	11.0	7.5	7.9	9.3	22.4	9.3	7.5	9.7	13.1	9.0	7.9	5.7	10.0	30.1	7.0	8.5	14.7	9.9	10.6	4.6	2.5	1.2	4.6	2.7	3.8	1.7	14.3	10.7	14.1	11.4	2.6	3.2	3.1	10.7	5.8	11.5	13.2	8.8	7.5	18.3	3.6	4.5	10.3	11.8	26.8	8.6	15.6	9.5	11.4	13.6	20.9	6.6	1.1	17.8	7.3	2.0	1.8	14.3	4.1	2.9	5.9	9.5	12.5	9.3	8.0	9.9	19.3	5.9	13.7	9.6	9.0	17.3	37.0	13.8	4.2	9.4	12.8	7.9	12.6	6.0	5.7	16.3	11.8	5.9	4.6	10.2	7.0	19.4	10.2	5.6	8.1	14.7	5.9	8.5	11.3	0.0	2.0	1.2	3.0	4.6	2.9	4.6	3.4	3.8	2.5	3.2	2.4	2.4	0.6	2.7	1.3	1.6	3.6	1.7	8.0	10.2	12.0	9.6	7.8	6.6	10.3	4.5	8.7	10.0	8.9	6.2	2.2	3.8	2.5	2.9	9.3	0.0	9.4	11.4	1.8	2.0	4.3	3.3	2.8	0.3	3.6	1.5	46.7	2.6	4.3	2.4	2.0	9.2	2.8	3.9	1.6	4.1	3.7	4.3	0.4	5.8	2.4	0.0	1.8	3.7	4.5	1.3	0.0	3.2	1.2	7.2	6.5	3.8	3.4	4.2	1.9	1.9	2.9	4.3	2.2
POLD4	"p12, POLDS"	ENSG00000175482	"DNA polymerase delta 4, accessory subunit"	Q9HCU8	11	67350777-67356972	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 380.3;Paneth cells: 312.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 50.0"									HPA078008			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA078008: "	"unprognostic (7.55e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.36e-2)"	19.0	19.7	6.5	47.0	9.3	19.6	15.0	3.3	8.9	14.9	35.1	11.4	13.6	47.2	13.2	15.6	32.4	10.3	26.9	24.0	6.1	6.1	34.3	90.7	21.3	42.9	10.8	5.2	13.0	26.8	2.7	9.8	23.7	9.1	20.2	9.9	10.0	27.2	13.4	25.7	12.7	56.9	16.5	10.5	30.1	36.2	10.9	8.3	20.6	18.5	19.4	48.9	25.4	17.2	69.6	28.3	49.0	65.8	9.8	24.8	24.3	13.5	37.1	1.0	4.0	5.3	14.4	2.2	16.0	7.6	2.9	3.1	6.2	44.1	35.8	50.0	7.1	12.6	17.4	0.2	15.6	0.2	14.6	1.8	9.0	9.1	7.3	15.2	2.9	40.1	13.2	10.4	7.4	8.1	14.6	11.5	7.1	7.8	11.9	5.9	22.4	3.5	7.0	2.7	28.5	23.7	6.5	8.2	9.7	7.3	9.2	0.3	3.9	8.5	6.3	26.9	3.3	17.4	10.6	24.4	9.9	6.4	23.3	5.4	16.0	4.6	18.7	29.1	7.0	10.6	22.3	30.1	49.0	15.4	35.7	14.1	59.2	17.2	15.3	28.3	69.6	19.5	16.8	29.0	9.8	65.8	22.6	24.8	24.3	6.5	9.3	3.3	8.9	6.1	6.1	10.8	5.2	9.1	8.3	17.9	35.1	43.0	2.4	38.5	2.4	1.9	10.2	6.7	13.6	7.0	5.9	6.8	13.3	122.5	6.2	12.7	380.3	0.0	164.2	8.8	20.6	3.8	68.0	34.7	28.8	3.2	79.8	20.9	36.4	12.5	6.4	71.5	57.3	171.3	167.5	4.0	177.4	312.1	3.5	20.7	4.1	6.5	49.5	1.9	1.7	60.2	10.4	40.5	109.7	3.1
POLDIP2	"DKFZP586F1524, PDIP38"	ENSG00000004142	"DNA polymerase delta interacting protein 2"	Q9Y2S7	17	28347177-28357522	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007700			Approved	Mitochondria		NA	NA			Mitochondria		"HPA007700: AB_2667900"	"unprognostic (5.71e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.39e-2)"	12.5	24.4	15.3	11.2	16.5	10.0	14.4	9.1	20.6	11.2	14.0	11.0	14.1	12.2	9.0	12.1	17.0	11.0	15.2	42.0	14.6	11.1	26.8	50.6	9.2	15.2	13.2	11.5	10.8	26.9	15.5	9.3	10.7	11.8	11.2	14.9	10.6	14.1	13.1	63.5	11.3	15.1	13.8	10.2	13.3	16.4	15.3	7.1	17.0	14.8	22.0	12.5	10.3	8.8	29.3	37.5	24.9	29.5	19.7	29.0	28.6	19.3	36.0	13.1	21.1	20.6	19.8	16.1	20.2	21.5	43.8	31.3	115.5	11.5	35.1	19.8	26.3	22.7	26.0	31.0	21.9	32.6	27.4	33.2	12.4	21.1	24.0	32.3	26.7	15.5	22.5	32.9	30.3	25.0	19.6	24.3	25.0	28.2	20.8	25.8	27.0	30.9	17.1	15.6	33.1	18.4	23.6	28.3	35.6	24.3	18.1	18.9	17.5	36.2	73.4	20.4	21.4	38.5	20.2	20.6	19.7	14.9	22.5	35.9	18.3	21.9	24.3	27.4	18.8	19.7	20.0	29.5	24.9	22.5	28.3	23.0	29.3	23.7	29.0	37.5	20.4	25.9	25.2	12.1	19.7	20.2	25.1	24.9	28.6	15.3	16.5	9.1	20.6	14.6	11.1	13.2	11.5	11.8	7.1	8.9	14.9	31.5	25.9	24.5	23.6	84.4	50.9	4.0	9.1	45.4	3.9	71.3	160.8	71.6	35.4	24.5	60.0	23.3	124.6	81.0	28.2	34.3	11.5	114.6	61.8	27.0	22.5	22.7	29.9	99.3	28.4	29.4	55.6	67.7	37.2	28.7	92.5	28.1	31.1	161.2	15.9	12.9	29.7	58.1	43.2	26.3	68.0	23.5	59.3	34.4
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.6;lymphoid tissue: 17.6"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 23.3;Spermatogonia: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	3.3	2.2	1.5	11.6	2.8	17.6	3.4	1.7	1.6	4.4	4.2	1.1	1.5	2.6	2.8	3.5	9.0	2.4	2.3	1.6	1.0	1.2	2.5	5.1	2.2	5.3	1.1	0.3	2.7	5.0	1.4	2.5	4.1	1.4	2.1	5.2	2.6	2.6	0.7	1.1	3.7	7.7	2.9	2.7	5.4	3.0	5.3	2.4	17.6	1.6	10.3	8.4	2.1	4.2	1.2	0.9	0.7	0.0	3.2	2.7	0.5	17.3	8.9	16.9	7.8	0.8	5.0	8.6	9.9	5.0	15.8	18.3	8.9	13.6	10.8	5.6	5.5	8.5	10.7	16.9	6.1	18.7	12.6	9.3	16.1	9.8	11.0	0.4	19.2	7.0	1.4	0.4	8.6	1.4	2.0	9.1	14.5	14.1	6.9	15.8	15.2	19.5	12.5	9.9	14.2	20.8	16.6	15.5	9.8	5.7	9.8	12.2	7.0	10.0	5.9	3.1	8.5	11.8	6.8	3.2	2.5	18.8	10.5	7.8	5.1	10.3	25.0	4.8	14.2	10.2	0.0	0.0	0.7	0.9	0.0	0.7	1.2	0.9	1.7	0.6	1.2	0.1	0.8	0.0	3.2	0.0	0.9	2.7	0.5	1.5	2.8	1.7	1.6	1.0	1.2	1.1	0.3	1.4	2.4	3.0	0.3	0.8	1.6	4.2	0.8	0.8	0.0	1.4	1.2	0.0	0.0	5.3	0.0	1.2	0.9	0.8	0.8	23.3	1.3	8.5	2.6	1.2	0.0	3.2	4.7	0.0	1.2	6.7	3.7	0.2	1.4	1.2	1.7	1.0	2.0	2.1	0.6	0.0	2.8	0.8	3.3	0.0	1.9	3.0	22.2	3.1	2.9	0.9	2.9	0.8
POLE3	"CHARAC17, CHRAC17, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410672	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	16.9	23.9	18.2	22.0	18.5	56.3	19.3	36.0	25.0	17.0	17.6	15.8	12.5	15.1	18.2	16.5	27.8	17.6	17.0	17.9	16.1	14.8	14.3	29.5	15.8	29.0	15.1	18.5	15.4	20.8	13.1	8.4	21.2	20.0	15.9	20.3	12.4	17.9	16.3	48.3	24.7	17.3	16.9	16.9	26.8	17.2	29.9	15.9	35.0	16.3	27.3	32.4	18.8	16.7	34.9	33.5	34.3	34.4	28.0	44.0	47.7	15.9	19.9	14.0	21.0	8.0	7.2	12.3	21.3	10.9	24.2	19.1	18.4	14.5	58.1	13.3	12.4	14.7	27.4	27.3	23.4	22.4	11.0	16.5	30.1	20.7	18.8	8.6	62.4	18.2	8.1	16.2	21.0	27.0	8.8	16.7	29.6	41.9	32.5	16.7	40.6	42.8	33.6	18.1	34.3	36.1	43.9	58.5	32.6	10.5	15.3	30.5	17.6	31.0	19.6	16.7	8.9	29.3	28.1	13.7	17.9	24.3	22.7	36.4	17.0	55.5	78.3	16.4	36.9	21.4	25.4	34.0	34.3	35.5	34.4	44.0	34.9	34.0	33.7	33.2	33.5	36.9	34.3	7.2	28.0	26.6	33.5	39.0	47.7	18.2	18.5	36.0	25.0	16.1	14.8	15.1	18.5	20.0	15.9	35.7	27.5	46.8	23.7	83.3	13.9	39.7	22.9	46.8	44.3	29.6	5.9	49.3	36.5	26.8	4.0	34.3	14.2	0.0	39.2	47.2	34.7	19.7	54.5	37.2	44.5	12.7	23.6	23.4	27.8	11.5	33.1	54.6	38.8	53.3	31.4	30.3	28.9	10.5	40.0	22.0	17.1	12.9	47.2	27.9	98.5	82.9	29.2	63.4	39.3	18.2
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958492-74970128	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA054979: AB_2682661, HPA071815: AB_2686453"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	19.2	14.5	23.6	15.2	17.3	27.1	21.4	4.4	15.5	18.4	13.4	8.6	7.0	9.0	10.4	9.0	10.0	9.7	13.1	18.1	15.9	10.6	11.6	18.8	10.7	17.0	13.9	12.6	12.8	12.5	2.8	3.9	9.6	12.2	12.0	8.8	13.9	16.2	11.2	28.1	8.1	12.4	14.1	11.7	12.2	12.5	11.0	10.0	5.5	13.1	15.1	10.4	13.9	31.9	14.7	14.7	8.0	22.2	4.4	9.9	12.3	11.8	11.3	1.0	1.0	3.9	8.6	0.0	8.0	10.0	12.9	11.0	15.0	5.3	11.6	6.8	9.1	3.2	5.4	5.4	6.7	15.1	5.3	14.5	9.0	6.5	14.8	14.0	12.7	14.2	8.7	13.1	5.4	11.9	4.0	5.6	1.6	11.0	6.8	9.8	11.5	3.7	35.8	7.9	6.9	21.2	4.5	9.7	9.3	10.7	0.3	3.6	5.4	11.0	4.6	6.4	0.6	3.4	4.1	6.2	2.9	3.3	2.0	7.7	2.4	1.6	4.3	10.5	19.1	14.2	2.3	22.2	8.0	6.3	13.2	7.0	14.7	8.9	7.8	12.9	13.7	9.9	6.9	1.6	4.4	12.4	14.7	8.5	12.3	23.6	17.3	4.4	15.5	15.9	10.6	13.9	12.6	12.2	10.0	23.8	36.0	84.1	81.2	75.1	21.9	40.6	58.6	34.8	21.6	69.8	41.2	124.8	126.0	43.1	10.2	56.2	119.0	23.3	70.2	125.8	83.2	82.4	61.1	123.4	106.6	17.5	11.7	68.7	111.2	19.3	62.2	91.0	92.8	30.7	80.6	78.1	62.4	147.3	51.2	125.5	104.8	77.6	87.3	41.3	86.7	85.4	78.6	69.3	78.6	82.9
POLG2	"HP55, MTPOLB"	ENSG00000256525	"DNA polymerase gamma 2, accessory subunit"	Q9UHN1	17	64477785-64497036	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017030, HPA023202"	Approved		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Nuclear bodies"	Mitochondria	"CAB017030: , HPA023202: AB_1855523"	"unprognostic (1.76e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (4.38e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.17e-3)"	"prognostic unfavorable (6.59e-4)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.82e-2)"	6.7	9.3	5.4	17.5	10.0	8.1	8.2	10.9	8.7	7.7	7.8	7.0	11.1	7.9	10.2	6.8	6.4	7.5	7.9	7.3	5.6	4.4	7.8	7.8	10.4	12.2	10.8	5.2	13.0	9.4	5.0	9.9	6.9	8.7	8.0	5.7	5.8	8.6	11.9	10.7	10.5	8.4	9.3	5.6	11.5	6.9	24.2	7.9	9.8	9.6	5.4	13.3	6.6	11.5	12.2	10.5	6.5	8.2	6.0	12.2	4.4	6.9	8.5	6.1	7.5	5.8	4.7	7.4	4.1	3.9	6.3	5.4	8.8	5.5	12.7	5.0	2.2	6.5	5.7	8.3	3.9	7.9	3.5	9.7	8.6	10.3	8.7	6.5	12.1	9.6	4.7	4.5	5.0	7.5	8.7	4.5	7.7	15.1	4.9	6.1	9.2	12.9	16.1	6.4	7.6	9.5	12.0	20.1	13.4	5.7	2.0	8.6	9.6	3.3	7.4	7.6	9.9	7.3	10.2	5.0	6.8	9.0	5.8	10.7	8.7	5.9	9.6	5.3	11.4	4.7	6.5	5.9	6.5	7.9	3.5	7.5	12.2	8.8	7.6	10.5	12.1	12.2	11.6	1.2	6.0	8.2	4.8	8.4	4.4	5.4	10.0	10.9	8.7	5.6	4.4	10.8	5.2	8.7	7.9	11.9	23.4	11.1	7.7	7.2	4.0	15.7	17.8	5.3	14.8	3.5	0.0	10.9	0.0	4.3	9.2	12.4	11.2	0.0	3.2	12.2	9.9	9.7	12.7	3.8	8.2	6.4	10.5	18.4	7.8	5.0	6.1	6.9	6.8	3.6	13.9	3.0	2.7	16.7	2.8	4.3	8.4	6.5	8.6	52.0	8.2	7.5	3.3	10.2	18.2	4.7
POLI	"RAD30B, RAD3OB"	ENSG00000101751	"DNA polymerase iota"	Q9UNA4	18	54269404-54321266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 68.1;Spermatocytes: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012000, HPA064696"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA012000: AB_1847786, HPA064696: AB_2685325"	"unprognostic (1.64e-1)"	"unprognostic (5.79e-3)"	"unprognostic (9.72e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.99e-2)"	16.5	11.1	10.2	9.5	14.0	5.2	15.8	9.6	14.7	12.9	9.9	13.4	13.7	6.6	13.2	13.1	6.6	10.3	8.3	9.1	8.7	7.6	12.9	6.4	9.0	7.4	10.9	9.0	16.4	11.8	17.6	21.3	17.4	15.3	12.7	7.7	9.6	11.3	14.7	7.2	8.2	7.6	10.9	12.0	8.2	9.0	30.5	10.9	17.3	27.3	1.5	7.0	12.7	10.5	9.9	10.3	10.9	10.7	7.9	12.7	7.1	7.6	2.8	21.0	12.7	7.1	13.9	6.8	6.3	13.6	7.3	12.2	2.1	7.3	3.6	2.1	9.2	7.4	6.3	4.9	7.3	8.2	8.7	2.4	4.5	3.1	5.3	11.6	7.2	3.8	15.1	11.1	6.3	13.3	16.6	15.4	6.0	3.1	10.3	12.2	6.0	5.1	6.4	7.2	2.0	3.1	3.3	4.3	9.0	8.3	10.2	9.9	10.1	4.5	4.0	6.7	14.2	14.7	3.3	7.4	13.8	3.8	2.0	5.2	8.4	1.9	5.2	9.8	6.5	10.0	5.4	10.7	10.9	8.3	5.7	7.7	8.6	8.8	8.6	10.3	9.9	12.7	7.6	6.7	7.9	5.8	8.1	9.8	7.1	10.2	14.0	9.6	14.7	8.7	7.6	10.9	9.0	15.3	10.9	23.8	16.0	4.5	7.9	2.3	15.1	9.5	2.5	24.1	10.3	5.2	9.8	26.3	8.3	7.9	68.1	6.0	2.0	0.0	5.4	14.9	7.1	3.8	12.7	5.8	7.9	3.2	5.8	10.4	8.4	12.8	18.4	6.1	6.8	6.4	4.7	18.8	5.6	2.9	17.0	12.5	20.8	32.3	8.0	70.7	28.2	2.3	23.3	4.4	3.9	2.4
POLM	Tdt-N	ENSG00000122678	"DNA polymerase mu"	Q9NP87	7	44072247-44082540	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058900, HPA066007"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058900: AB_2683848, HPA066007: AB_2685595"	"unprognostic (2.44e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-3)"	10.7	8.7	7.0	18.0	7.1	7.6	12.2	11.9	8.8	13.8	11.2	11.1	11.7	12.2	10.1	12.0	11.7	11.8	11.8	10.8	6.8	4.4	13.0	12.5	10.1	20.9	9.9	7.0	13.8	12.3	10.0	9.0	8.1	8.2	11.8	7.1	12.4	13.5	14.3	11.2	12.0	12.6	8.9	9.0	18.7	12.0	6.8	8.1	30.1	15.4	8.3	17.6	12.4	10.7	5.9	4.8	31.6	2.1	3.5	4.2	1.3	1.1	1.5	1.5	3.5	2.2	2.6	5.0	3.5	4.0	2.7	1.6	1.9	2.6	11.3	3.6	3.0	3.4	3.4	1.6	38.3	1.6	3.9	3.6	1.3	1.6	0.7	3.1	3.5	5.1	4.0	3.7	2.3	2.8	5.6	4.9	11.3	1.6	5.5	2.3	2.6	7.1	3.1	3.3	3.4	8.2	5.7	0.9	4.4	3.0	1.8	1.6	3.0	1.7	7.3	3.7	2.7	4.6	6.0	3.4	1.9	2.8	1.9	5.1	9.0	4.5	8.8	3.5	3.2	4.6	8.6	1.8	5.1	3.3	2.1	3.3	4.0	2.9	3.0	1.6	5.9	4.2	3.4	31.6	3.5	1.6	4.8	2.7	1.3	7.0	7.1	11.9	8.8	6.8	4.4	9.9	7.0	8.2	8.1	3.0	8.5	24.9	9.9	3.9	18.3	5.5	15.3	4.0	9.1	12.2	27.5	10.7	1.7	6.4	0.4	6.4	12.3	0.0	8.2	8.5	5.0	11.9	24.2	8.9	9.0	17.5	5.2	12.9	10.8	0.4	13.0	9.1	10.1	10.0	7.3	7.2	6.9	15.6	9.6	3.8	38.8	0.0	13.0	10.8	11.5	4.4	8.1	14.4	10.1	10.7
POLR1D	"MGC9850, RPA16, RPA9, RPAC2, RPO1-3"	ENSG00000186184	"RNA polymerase I subunit D"	"P0DPB5, P0DPB6"	13	27620742-27744237	"Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 641.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039337	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA039337: AB_10672961"	"unprognostic (1.33e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	30.5	43.8	17.0	35.4	22.1	46.5	36.5	41.2	23.7	34.6	40.8	15.9	34.4	30.9	26.0	29.9	58.9	21.4	32.3	28.5	16.7	14.4	27.3	29.9	32.6	36.5	14.8	20.6	43.6	115.9	16.7	24.3	24.7	15.6	37.4	32.7	20.9	46.2	39.5	38.1	44.8	36.4	41.2	17.4	31.9	41.7	23.7	13.0	50.9	32.3	40.7	40.7	56.8	54.0	29.2	42.7	21.4	39.3	27.9	56.6	26.2	20.0	18.9	21.8	22.3	25.1	45.1	29.3	19.9	34.4	26.4	26.2	30.5	40.9	65.1	15.1	22.4	43.8	31.0	40.1	63.6	31.4	20.1	23.8	46.2	20.6	51.1	37.9	42.0	36.4	40.5	67.3	21.4	40.1	29.7	36.4	37.5	25.2	11.6	25.6	20.8	41.2	51.2	52.5	62.8	20.1	28.4	37.5	29.2	41.6	31.2	37.2	29.2	13.3	26.9	71.8	28.7	16.4	39.2	25.2	11.7	18.3	20.0	21.7	19.1	21.5	36.8	10.2	30.4	22.7	21.4	38.4	17.3	24.9	39.3	32.8	28.4	40.2	31.4	42.7	29.2	43.6	34.2	13.7	27.9	34.2	31.2	56.6	26.2	17.0	22.1	41.2	23.7	16.7	14.4	14.8	20.6	15.6	13.0	83.4	87.9	125.7	260.0	299.0	36.8	61.7	99.3	46.8	102.4	27.9	15.7	139.0	63.0	120.2	371.4	103.0	105.8	70.0	267.5	226.2	97.1	149.2	93.5	69.2	148.4	42.9	119.5	90.9	175.3	641.0	107.9	125.4	75.9	153.3	182.4	43.5	227.4	97.9	74.3	100.6	35.5	77.6	116.0	153.7	85.9	277.2	122.0	126.4	173.3	290.2
POLR2J	"hRPB14, POLR2J1, RPB11, RPB11A, RPB11m"	ENSG00000005075	"RNA polymerase II subunit J"	P52435	7	102473118-102478907	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046970			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046970: AB_2679882"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	19.0	28.1	30.9	16.5	28.9	37.0	52.2	17.9	27.6	20.0	20.6	15.1	22.7	22.2	16.3	27.9	20.0	19.6	27.9	65.7	26.1	25.1	21.0	40.9	21.2	31.9	28.5	17.8	21.7	50.2	16.0	23.4	15.6	22.3	18.4	16.7	19.4	28.2	23.9	75.9	19.1	24.3	28.1	35.9	18.6	20.7	18.1	23.1	20.8	24.9	38.8	18.6	19.9	18.3	42.8	42.3	63.4	40.1	25.5	44.8	38.1	31.5	32.3	22.2	29.2	21.1	16.3	16.3	17.5	18.8	25.8	22.0	29.3	24.7	14.6	33.9	24.4	37.2	17.0	20.5	21.6	15.9	27.2	36.6	14.6	23.2	28.3	25.8	28.2	21.9	21.2	27.1	23.1	13.0	16.9	23.0	31.4	34.1	43.7	21.1	97.3	46.3	50.4	20.5	31.5	41.7	22.1	21.8	43.0	20.6	21.0	18.9	31.5	21.1	40.4	24.9	23.6	18.1	34.6	18.5	29.2	37.2	45.7	34.2	27.0	39.2	37.8	26.0	35.2	33.9	48.3	40.1	63.4	32.1	39.1	30.4	42.8	34.5	35.6	31.3	37.6	29.8	30.0	58.5	25.5	35.5	42.3	44.8	38.1	30.9	28.9	17.9	27.6	26.1	25.1	28.5	17.8	22.3	23.1	32.8	37.7	101.2	100.0	84.3	36.9	165.4	71.4	69.6	36.4	118.7	11.8	175.6	232.1	122.3	40.3	90.9	189.8	140.2	173.5	165.1	101.3	117.4	42.7	165.1	176.1	33.4	98.9	85.3	97.5	33.8	117.6	117.2	135.0	153.3	115.9	97.7	155.7	164.9	104.0	180.9	34.8	51.8	107.2	95.4	243.8	101.5	152.3	76.2	104.4	130.5
POLR2J2	RPB11b1	ENSG00000228049	"RNA polymerase II subunit J2"	Q9GZM3	7	102665368-102671629	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 32.6"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 18.1;RT4: 13.0;U-2 OS: 12.8"									HPA046970			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046970: AB_2679882"																		3.8	3.9	12.0	9.5	10.0	5.4	6.6	10.6	32.6	7.2	4.6	6.5	3.4	7.9	6.9	6.5	4.8	4.6	7.4	4.3	12.5	5.5	5.8	6.1	6.1	7.8	10.1	7.7	9.0	3.7	3.2	6.1	5.7	7.8	4.6	5.2	4.5	11.2	3.4	11.9	9.9	10.3	9.8	9.3	7.5	6.6	3.5	6.2	4.2	5.8	1.3	11.0	4.7	5.1	7.9	6.0	11.3	4.0	2.9	6.5	1.3	2.5	2.2	1.5	1.9	3.4	4.8	3.0	2.8	0.6	1.7	1.8	1.6	5.1	2.6	0.5	1.9	1.0	2.4	1.1	0.7	4.3	1.8	3.0	1.4	3.1	1.0	1.5	6.1	2.8	0.9	0.5	1.3	2.4	0.8	0.6	1.6	2.6	6.6	1.3	1.0	18.1	1.8	1.1	0.9	0.6	2.3	0.4	2.4	1.0	13.0	1.4	1.7	2.4	1.3	1.1	2.4	0.8	1.0	1.0	3.9	12.8	0.6	2.1	2.9	2.1	2.3	1.6	2.7	1.3	11.3	4.0	2.9	5.9	2.3	3.9	5.5	6.0	4.2	1.9	7.9	6.5	5.0	3.2	2.9	3.6	6.0	3.5	1.3	12.0	10.0	10.6	32.6	12.5	5.5	10.1	7.7	7.8	6.2	6.0	1.6	10.0	3.2	1.4	6.1	0.0	2.5	4.0	1.2	8.7	9.8	6.1	5.0	2.9	0.0	3.1	2.9	23.3	0.7	3.5	2.4	2.0	1.1	1.7	3.2	4.8	3.5	5.5	3.2	0.0	8.3	3.8	0.0	8.2	1.9	1.3	1.5	0.0	3.2	2.9	4.1	0.0	2.2	8.6	10.7	1.1	6.5	4.3	2.3	2.7
POLR2J3		ENSG00000168255	"RNA polymerase II subunit J3"		7	102537918-102572653	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 12.3"	"Group enriched"	"Detected in some"	635	"Cytotrophoblasts: 71.6;Extravillous trophoblasts: 52.6;Hofbauer cells: 37.9;Syncytiotrophoblasts: 92.0"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.5"									"HPA011403, HPA046970"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011403: AB_2668503, HPA046970: AB_2679882"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.55e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-2)"	2.8	3.0	0.9	1.7	1.4	2.3	1.9	4.0	4.7	3.1	2.4			3.6	4.5	0.1	2.3	4.9	0.3	1.3	1.1	1.1	2.2	2.8	2.2	1.0	1.5		4.5	1.7	2.9	2.3	1.7		2.5	2.1		4.1	0.2	1.0	5.0	3.5	1.8	1.6	3.9	2.2	0.8			4.0		3.5	4.1	2.2	4.9	5.9	12.3	5.6	4.4	4.4	3.4	8.5	4.1	1.7	0.1	0.2	0.7	0.7	5.1	1.5	3.3	3.8	3.2	2.4	1.2	0.3	0.0	4.8	4.1	2.7	2.1	3.6	21.5	4.7	2.4	3.2	1.0	0.9	3.0	2.2	0.3	1.8	1.7	1.7	6.5	5.2	2.1	2.7	1.5	0.5	6.9	7.5	0.4	0.0	3.0	5.2	0.3	2.9	2.0	0.8	1.1	1.7	0.3	9.4	0.9	5.0	2.1	0.0	1.4	4.2	3.1	8.3	0.0	1.3	0.2	0.6	3.6	5.2	2.4	3.4	9.0	5.6	7.8	3.3	2.0	1.7	4.7	3.1	4.4	5.9	4.9	3.8	3.6	12.3	4.4	3.5	4.3	4.2	3.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.0	0.0	0.0	0.0
POLR2J3		ENSG00000285437	"RNA polymerase II subunit J3"		7	102562133-102572583	"Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 29.2;skeletal muscle: 14.6"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 246.4;Cone photoreceptor cells: 333.8;Rod photoreceptor cells: 291.4"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA046970			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046970: AB_2679882"																		0.5	2.3		1.9		5.5	1.3		5.7	0.0	3.9			2.0	2.7	3.7	1.7	0.0	0.5	0.0			2.9	2.7	0.5	1.9			1.3	0.3	0.0		0.5		0.5	2.0		0.0	0.6	14.6	2.0	1.6	0.0		2.1	1.6	1.2			0.5		1.1	0.5		22.4	26.8	29.2	25.2	16.5	23.5	14.4	14.4	1.8	20.7	18.4	1.1	4.3	7.8	20.3	0.7	4.4	1.3	6.8	11.5	6.7	10.1	3.5	10.7	8.9	2.7	4.8	13.4	0.9	3.1	15.4	26.1	20.2	2.9	25.7	15.2	4.7	6.0	2.4	1.8	12.0	5.9	12.3	13.3	39.1	1.9	7.3	36.5	11.4	6.2	18.4	0.5	17.1	18.6	19.3	5.8	18.4	9.9	14.8	16.1	16.2	14.2	24.5	6.2	14.8	6.5	27.6	12.5	24.2	16.3	17.6	25.9	40.6	15.4	18.1	16.6	26.8	19.9	29.2	17.7	18.0	16.1	22.4	23.5	20.0	17.9	20.2	20.4	19.5	21.1	16.5	25.2	26.8	21.8	14.4											6.0	1.6	68.9	89.5	10.9	246.4	14.3	89.2	9.4	5.7	7.0	333.8	0.0	1.7	0.3	6.1	20.5	47.8	23.3	0.3	0.0	14.6	61.1	13.8	37.1	0.0	168.5	56.1	102.5	57.8	5.0	84.0	10.8	23.6	1.8	38.2	55.9	0.9	59.6	48.4	2.2	291.4	25.8	24.7	93.1	107.3	12.9	0.0	90.0	43.8	82.1
POLR2M	"GCOM1, Gdown, Gdown1, GRINL1A"	ENSG00000255529	"RNA polymerase II subunit M"	"P0CAP2, Q6EEV4"	15	57706629-57782762	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA068141			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068141: AB_2685962"	"unprognostic (3.07e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.80e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.07e-1)"	17.0	16.3	22.9	8.5	26.5	25.2	33.5	15.3	25.1	18.1	11.5	21.0	14.0	9.6	28.0	15.5	12.1	16.1	13.1	22.2	22.7	21.9	15.8	12.0	14.7	19.5	29.9	15.8	27.0	14.8	23.6	12.3	14.4	19.7	21.1	11.5	19.2	12.6	20.5	25.3	11.8	9.6	21.5	25.0	13.2	10.2	10.8	24.0	11.7	19.0	7.1	12.5	18.9	15.1	15.2	14.3	16.2	13.9	22.4	19.5	13.5	9.4	15.9	11.2	28.1	19.6	20.5	10.6	15.7	24.8	16.5	15.7	11.7	7.2	15.2	15.8	10.7	13.7	15.8	12.5	11.8	22.1	15.8	8.5	18.4	12.5	7.4	21.6	17.0	17.6	18.3	19.2	9.3	27.0	18.6	12.7	16.4	18.6	13.3	13.9	6.0	15.4	10.8	18.2	13.0	8.1	15.3	24.8	11.5	12.4	9.5	8.3	14.5	12.0	12.2	18.4	15.3	14.0	24.2	11.6	24.9	20.9	37.3	18.4	15.3	15.7	20.1	15.0	25.5	17.4	16.2	13.9	15.4	15.8	13.5	19.4	15.2	17.2	16.1	14.3	14.7	19.5	17.2	1.6	22.4	11.1	9.9	18.9	13.5	22.9	26.5	15.3	25.1	22.7	21.9	29.9	15.8	19.7	24.0	20.8	7.8	22.9	18.9	14.9	13.6	24.3	10.2	13.4	14.8	24.4	3.9	10.8	21.6	11.0	32.2	19.0	10.3	0.0	13.2	15.2	21.1	25.2	11.6	11.6	15.8	11.1	22.4	17.8	17.8	9.0	20.4	15.3	23.6	13.6	17.7	17.1	17.6	14.0	26.5	13.3	6.5	19.4	28.8	17.9	21.4	12.5	10.1	27.4	19.2	14.5
POLR3B	"FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357658-106510198	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	6.4	14.0	7.1	7.9	14.6	6.5	6.9	8.6	13.6	8.6	7.2	8.2	5.7	6.0	10.1	7.2	14.8	7.7	5.8	8.2	8.9	7.1	9.9	17.5	7.1	11.4	6.2	10.4	11.3	11.9	22.5	17.0	22.9	12.3	8.0	8.3	6.2	8.6	9.9	12.1	15.3	5.7	7.8	6.0	6.4	7.5	9.9	4.7	10.3	8.5	10.2	10.0	7.3	10.1	4.3	4.9	9.8	4.1	3.7	6.3	3.1	11.2	5.3	11.9	5.7	10.6	9.7	16.6	15.9	9.5	11.0	8.5	9.8	3.1	14.4	5.7	9.8	4.1	10.5	13.8	13.5	13.7	11.6	9.2	11.5	7.1	8.3	6.8	18.1	12.4	8.6	9.7	11.0	12.8	7.8	8.1	7.0	16.8	4.7	8.4	8.3	13.1	6.0	12.9	8.2	20.1	8.0	7.1	9.4	6.2	15.4	12.9	7.0	9.7	13.0	9.3	8.3	12.2	5.4	7.8	6.1	7.1	9.8	9.1	5.9	15.0	21.4	3.0	11.2	6.5	9.8	3.9	2.6	4.1	4.1	5.5	4.3	4.5	4.3	4.9	2.6	6.3	3.9	2.6	3.7	4.0	1.8	4.7	3.1	7.1	14.6	8.6	13.6	8.9	7.1	6.2	10.4	12.3	4.7	0.0	8.6	0.0	1.6	1.5	5.6	8.7	2.5	9.4	9.1	5.2	5.9	8.2	1.7	4.3	5.3	2.9	2.7	0.0	4.0	7.9	3.1	1.0	4.7	10.2	2.7	3.2	4.1	3.1	1.2	3.1	3.4	1.7	3.3	0.0	5.7	2.5	3.6	0.0	4.6	2.7	6.8	6.5	2.1	6.7	9.8	2.6	6.2	1.7	4.9	0.8
POLR3F	"RPC39, RPC6"	ENSG00000132664	"RNA polymerase III subunit F"	Q9H1D9	20	18467127-18484643	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049441, HPA050173, HPA072298"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510"	"unprognostic (4.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (8.87e-9)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.98e-3)"	8.6	7.8	8.1	6.0	11.9	4.4	8.0	24.6	15.3	9.9	7.5	8.7	8.5	5.6	11.6	6.5	11.0	9.6	6.7	14.2	8.7	10.1	11.2	7.3	5.9	8.8	7.8	12.9	12.5	7.3	4.5	9.8	8.0	13.9	9.2	6.4	6.7	7.5	7.4	12.0	6.2	5.0	9.0	8.5	6.3	6.7	10.0	7.7	6.3	16.3	7.2	9.1	10.7	6.5	3.1	3.2	1.9	4.5	3.3	6.4	4.1	6.5	6.7	7.0	8.8	5.7	6.9	12.6	9.7	6.8	12.5	9.6	8.4	6.7	5.1	4.1	9.4	8.3	9.0	9.2	8.0	8.2	5.0	7.7	3.7	2.6	3.6	8.1	11.0	6.3	4.4	5.2	18.7	8.6	6.0	5.6	4.5	9.4	4.5	8.6	7.1	9.2	4.7	9.9	6.7	15.3	6.5	15.3	5.6	5.6	2.8	14.6	9.6	7.5	12.6	15.7	4.9	5.8	7.4	5.4	12.9	6.3	9.6	13.6	2.3	15.3	4.0	5.4	5.1	9.3	0.1	2.1	1.9	4.3	4.5	6.4	2.8	3.9	1.2	2.2	3.1	4.1	2.1	0.8	3.3	1.9	3.2	3.4	4.1	8.1	11.9	24.6	15.3	8.7	10.1	7.8	12.9	13.9	7.7	8.9	3.7	5.4	3.0	7.9	17.3	7.3	2.5	12.0	4.5	1.8	9.8	8.6	8.3	7.0	15.9	6.5	2.9	0.0	5.9	10.3	6.7	3.5	5.7	4.5	6.7	11.1	6.4	6.7	7.0	4.1	5.8	6.9	5.0	11.8	3.1	12.5	6.4	0.0	9.6	9.8	17.4	12.9	5.5	17.7	22.0	9.9	6.1	8.5	3.9	2.7
POLR3G	"RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514553	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatogonia: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010109, HPA052658, HPA074330"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	2.7	1.6	7.1	3.6	10.2	4.4	3.8	7.2	7.2	3.7	2.6	6.7	1.4	2.8	2.7	8.4	7.3	2.7	2.4	2.7	7.7	7.7	1.7	4.0	2.9	8.1	10.3	6.1	4.1	4.1	11.1	3.9	3.1	20.2	2.9	3.1	2.6	4.2	1.5	4.4	7.4	2.3	4.2	16.0	3.3	2.1	8.0	8.1	1.0	5.9	8.5	3.2	4.4	4.7	3.9	2.1	6.8	2.8	5.4	3.2	0.8	10.7	6.2	7.4	1.9	2.3	4.1	3.4	5.4	1.7	8.6	7.0	3.6	8.0	29.4	1.8	2.2	8.5	4.5	9.2	8.6	30.8	13.5	8.2	10.8	2.9	5.5	3.9	7.5	2.7	2.7	4.0	14.3	10.9	1.7	10.6	11.7	15.3	2.7	3.1	5.2	7.9	4.7	34.9	1.5	27.7	7.0	3.2	16.6	2.5	1.0	9.4	2.5	2.2	4.1	14.9	3.4	2.2	2.1	12.7	4.7	9.0	6.6	20.3	6.8	17.4	21.7	10.4	10.0	37.3	6.8	0.6	0.3	3.2	0.8	1.6	3.9	1.1	2.0	0.9	2.4	2.4	2.6	1.6	5.4	2.8	2.1	0.5	0.8	7.1	10.2	7.2	7.2	7.7	7.7	10.3	6.1	20.2	8.1	6.0	2.1	0.8	1.2	3.2	2.7	3.4	0.0	2.7	0.0	1.8	7.9	0.7	3.3	2.6	3.0	1.4	0.5	0.0	3.9	5.2	1.5	3.0	6.9	2.4	1.5	3.2	6.4	3.7	0.3	1.0	0.3	0.6	1.7	0.0	1.3	0.6	2.9	2.0	1.1	1.3	0.8	0.0	1.4	7.7	27.4	7.4	0.7	0.0	1.6	0.6
POLR3K	RPC11	ENSG00000161980	"RNA polymerase III subunit K"	Q9Y2Y1	16	46407-53628	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005891	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005891: AB_1079653"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.03e-3)"	"unprognostic (9.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.63e-2)"	7.3	12.4	15.4	16.6	17.6	11.3	8.3	14.3	18.8	8.0	9.1	9.0	11.9	9.8	8.3	9.3	9.8	9.3	7.4	12.0	13.7	15.4	9.1	10.3	7.6	19.6	11.9	15.5	9.1	11.0	12.1	7.5	8.0	9.0	10.0	9.2	5.9	11.1	12.7	21.8	5.7	9.3	8.2	9.8	14.0	9.1	5.7	7.9	13.7	11.5	12.4	18.6	9.9	8.6	39.6	25.3	32.2	18.9	13.5	30.0	18.2	10.8	18.7	11.9	12.3	4.9	3.0	9.5	15.5	4.9	13.8	9.1	24.1	11.7	28.2	11.8	5.4	5.5	10.8	27.7	7.1	9.9	16.9	25.5	20.7	14.0	17.1	3.7	18.6	20.4	3.0	6.3	15.3	7.8	3.2	6.7	12.6	29.5	9.0	8.9	26.9	22.3	12.3	19.5	13.7	17.9	27.1	13.8	29.4	7.8	7.8	17.5	10.3	10.6	19.9	9.1	5.2	11.7	16.8	6.4	8.9	10.9	11.9	18.7	5.8	13.9	55.5	3.8	13.7	13.3	9.0	13.6	32.2	15.8	18.9	16.2	39.6	20.3	18.2	12.4	35.1	18.4	17.2	9.8	13.5	17.3	25.3	30.0	18.2	15.4	17.6	14.3	18.8	13.7	15.4	11.9	15.5	9.0	7.9	3.0	9.9	34.1	17.9	29.7	15.1	25.5	25.5	12.0	7.9	17.4	3.9	34.6	41.4	28.4	0.6	20.3	13.2	0.0	30.5	38.6	19.5	23.0	21.9	26.0	38.9	9.5	17.2	19.0	13.1	0.4	19.5	22.5	21.9	56.9	19.5	12.9	29.0	14.0	15.6	36.1	8.4	12.9	17.5	4.7	15.1	38.6	10.8	27.7	24.8	19.5
POM121C		ENSG00000272391	"POM121 transmembrane nucleoporin C"		7	75416787-75486271	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 64.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043809, HPA049817"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (9.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.00e-2)"	5.5	5.5	6.5	9.9	8.4	11.0	4.5	11.2	7.4	5.9	5.1	5.8	6.5	4.5	7.0	7.5	6.6	5.9	6.0	5.3	6.8		6.9	6.3	5.0	10.3	4.3	4.4	8.4	7.5	7.7	10.1	6.6	5.4	5.4	5.2	9.3	6.5	5.3	5.7	5.5	6.2	6.2	4.6	6.7	5.3	4.6	6.3	13.1	7.0	7.3	12.0	6.6	5.0	3.5	3.4	3.9	1.6	2.7	3.8	1.7	15.8	13.3	18.4	35.2	6.9	7.8	12.1	11.6	10.7	9.5	9.2	15.9	10.3	28.1	4.8	12.6	14.9	14.4	15.6	14.3	15.7	18.9	21.6	13.9	15.3	10.6	9.2	36.8	19.8	6.6	9.1	14.4	10.8	14.0	9.6	11.7	38.9	15.8	15.3	16.0	22.4	18.7	14.6	12.3	15.1	20.2	12.3	14.4	5.2	21.7	20.6	27.0	13.4	21.4	9.4	17.4	18.6	13.1	10.6	23.1	12.5	16.8	23.9	16.9	19.8	34.8	15.0	18.9	21.2	0.6	1.2	1.3	3.8	1.6	3.3	2.6	2.9	1.1	0.9	3.5	1.5	1.9	3.9	2.7	1.0	3.4	0.5	1.7											32.8	22.1	15.2	8.3	16.0	29.4	10.1	30.6	21.4	28.4	12.2	64.8	11.5	5.0	11.7	1.5	15.8	11.4	0.0	14.9	8.4	12.0	18.1	7.0	12.3	10.2	23.8	27.5	12.9	17.3	2.9	16.7	15.5	6.8	7.2	13.8	20.6	15.0	3.5	14.5	8.6	28.6	12.9	12.1	14.0	12.3	16.2	14.2	20.1	16.9	19.0
POMK	"FLJ23356, SgK196"	ENSG00000185900	"Protein-O-mannose kinase"	Q9H5K3	8	43093506-43123434	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 1.4;Club cells: 2.3;Melanocytes: 1.7;monocytes: 1.8;Spermatogonia: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013321	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA013321: AB_2668809"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.10e-2)"	4.7	5.5	9.8	5.6	14.3	12.5	5.1	12.3	18.6	6.9	4.8	8.3	2.2	4.5	6.9	4.4	7.1	6.2	4.8	3.8	7.7	7.0	3.4	4.5	5.5	6.0	4.8	11.1	5.8	9.3	6.3	7.4	6.1	10.5	5.6	5.9	6.1	6.8	4.0	6.2	7.1	5.6	6.4	6.7	7.6	6.8	7.1	7.2	7.5	7.4	3.2	7.4	4.6	5.0	2.6	2.6	6.7	2.9	1.0	3.3	1.3	3.5	7.6	5.8	15.2	2.8	3.5	5.5	2.1	3.2	5.5	4.1	5.5	9.2	5.0	4.7	3.8	2.3	5.9	8.3	6.4	5.4	1.9	1.4	14.0	5.6	2.5	2.0	4.7	7.9	3.8	2.7	7.4	5.3	1.7	5.4	7.1	3.3	14.9	3.7	1.6	10.0	2.0	11.9	2.1	1.0	6.8	6.8	2.9	1.5	9.9	5.6	4.2	9.1	3.2	3.0	4.4	9.8	3.3	7.5	8.4	8.5	8.7	4.2	4.9	8.6	9.4	3.6	3.2	10.0	0.8	2.9	1.9	2.3	2.4	3.3	1.8	1.3	1.3	2.6	2.6	1.8	2.3	6.7	1.0	1.5	2.5	1.1	1.3	9.8	14.3	12.3	18.6	7.7	7.0	4.8	11.1	10.5	7.2	0.0	0.3	0.0	0.1	0.3	1.4	0.3	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	1.8	0.0	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.1	0.4	1.4	0.1	0.5	0.0	0.2	0.1
POMT2	LGMD2N	ENSG00000009830	"Protein O-mannosyltransferase 2"	Q9UKY4	14	77274956-77320884	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003663	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA003663: AB_1079655"	"unprognostic (2.15e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (7.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.94e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.46e-2)"	6.7	10.8	10.4	6.8	11.4	3.8	7.7	12.5	13.3	6.8	6.3	18.0	9.8	4.6	6.9	17.1	5.7	8.7	6.9	7.7	9.3	7.7	8.1	8.3	6.2	3.0	11.7	6.2	7.6	10.6	14.7	16.1	11.4	9.7	7.3	5.8	8.2	10.1	12.3	17.0	4.3	4.6	7.8	8.4	5.2	5.6	30.9	14.4	2.5	11.5	4.9	3.8	5.7	5.0	1.4	1.9	0.8	1.9	0.0	1.7	0.4	10.4	13.4	13.0	14.7	9.3	7.5	10.4	9.2	7.6	13.8	11.8	6.6	9.4	3.1	7.5	8.6	19.1	11.7	6.1	9.2	9.6	4.6	8.3	1.9	6.6	5.4	11.4	2.1	6.3	7.6	9.8	12.9	12.6	9.6	8.0	3.1	4.9	7.3	9.0	20.6	3.6	10.1	3.7	14.5	11.3	3.5	12.7	2.8	14.3	7.7	11.0	10.8	6.0	10.2	7.7	8.9	10.5	4.4	6.6	10.4	16.4	12.0	8.0	4.8	9.4	1.4	5.3	3.2	9.1	0.0	0.4	0.0	1.7	1.9	0.4	1.4	0.0	0.3	0.9	0.2	0.1	0.0	0.8	0.0	0.8	1.9	0.0	0.4	10.4	11.4	12.5	13.3	9.3	7.7	11.7	6.2	9.7	14.4	6.0	3.2	2.2	2.3	2.7	6.5	4.0	5.1	0.0	0.0	1.8	15.7	5.0	0.0	6.6	8.0	2.8	3.9	0.0	6.4	8.6	6.0	3.5	2.3	4.4	4.8	7.9	17.2	3.1	2.4	12.1	1.7	2.2	1.7	3.6	3.0	8.2	5.8	1.9	3.9	3.0	15.0	0.0	3.9	9.8	8.5	1.6	4.8	0.0	2.6	1.4
POMZP3	"POM-ZP3, POM121"	ENSG00000146707	"POM121 and ZP3 fusion"	Q6PJE2	7	76609986-76627261	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 38.3;Late spermatids: 28.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049817	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA049817: AB_2680896"	"unprognostic (2.23e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (4.31e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (4.94e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.99e-2)"	4.0	3.0	4.7	3.4	5.6	6.6	4.5	6.0	5.3	4.7	4.6			2.4	5.8	5.2	3.8	2.8	2.1	3.8	4.7	3.5	4.4	2.2	3.6	3.1	3.5		5.8	4.7	2.0	3.1	1.7		4.5	3.7		4.3	5.1	14.2	5.3	3.0	7.0	4.0	2.5	3.9	9.5			3.9		3.6	4.0	3.9	4.2	3.5	5.7	3.3	3.0	4.8	1.1	1.9	8.1	13.0	16.7	8.6	3.4	1.9	2.9	4.5	2.1	2.7	4.7	3.6	1.2	0.8	2.6	4.6	1.1	3.0	1.3	2.0	4.9	4.6	5.4	4.4	2.7	2.0	2.4	3.6	2.9	5.4	7.2	2.5	1.0	1.3	2.1	2.9	9.4	9.2	2.5	4.2	10.0	5.7	3.0	4.0	1.8	9.5	2.0	1.5	3.0	6.8	12.3	2.5	11.8	4.2	14.4	4.5	3.1	5.0	6.6	0.9	16.4	6.7	2.4	2.1	8.7	1.3	9.7	9.2	1.4	3.3	5.7	2.4	1.5	3.5	2.5	3.9	4.0	3.3	4.2	4.8	2.7	3.8	3.0	1.6	3.5	3.4	1.1											3.0	2.6	3.0	6.4	6.3	4.1	6.0	2.5	4.0	0.0	5.2	11.8	5.7	0.0	1.1	38.3	3.0	4.5	0.0	1.9	3.1	6.0	4.2	5.7	1.7	2.6	3.2	12.5	1.8	4.1	28.3	5.8	3.0	10.1	0.0	2.7	4.6	1.6	4.0	7.4	3.5	5.2	12.9	3.2	22.1	4.1	6.0	8.7	2.2	5.6	8.4
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581398	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA047598: AB_2680096, HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favorable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	16.3	33.8	16.2	25.6	14.4	14.1	23.9	8.7	16.7	18.6	17.5	13.6	24.2	11.8	14.5	27.1	15.9	14.6	19.5	25.8	18.1	13.9	24.1	24.1	18.3	19.7	16.9	15.9	11.7	18.9	25.0	17.5	8.2	14.2	15.6	18.0	15.1	20.9	22.6	13.3	12.7	15.1	19.5	14.4	20.3	15.2	9.0	12.1	24.2	19.8	18.9	19.6	13.7	19.2	32.0	33.5	3.6	19.7	18.2	28.2	22.8	20.1	34.6	12.3	15.0	23.4	12.6	19.6	17.0	11.0	20.8	16.0	29.8	9.3	11.9	25.9	13.6	10.9	21.4	20.6	32.4	18.7	28.1	31.2	14.5	22.6	33.7	16.5	20.4	15.2	15.9	18.7	24.0	11.0	11.7	17.3	28.4	17.7	7.7	20.6	44.4	16.6	18.4	14.7	29.3	29.9	19.5	15.1	32.5	29.1	20.8	9.6	10.6	28.8	8.5	21.9	14.6	39.4	19.7	12.5	10.9	16.3	17.3	18.5	19.9	33.5	21.0	21.2	24.9	17.3	3.6	16.2	3.5	24.7	19.7	22.6	32.0	22.6	23.0	19.0	22.4	28.2	26.8	1.1	18.2	16.7	33.5	21.4	22.8	16.2	14.4	8.7	16.7	18.1	13.9	16.9	15.9	14.2	12.1	11.9	25.1	40.9	40.5	17.4	19.6	53.8	40.8	25.4	37.5	73.3	13.7	49.9	131.0	34.2	1.3	26.7	23.2	23.3	38.8	36.9	22.4	23.7	54.2	46.1	46.0	17.5	21.2	23.9	18.3	2.7	33.4	31.2	47.2	27.1	27.7	54.1	31.5	24.6	35.3	99.7	28.3	19.4	28.8	19.1	33.4	21.7	14.8	37.4	37.5	25.7
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105158280-105179995	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"heart muscle: 23.9;skeletal muscle: 68.9"	"Cell type enhanced"	"Detected in some"	27	"Cardiomyocytes: 40.0;Early spermatids: 75.0;Late spermatids: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.2;LHCN-M2: 11.9;RH-30: 13.4;U-87 MG: 12.0;WM-115: 11.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012514			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.9	0.8	2.2	1.4	4.5	0.6	2.5	0.4	6.8	0.8	1.4	2.1	0.8	0.7	1.3	2.2	2.1	0.7	1.1	23.9	3.7	2.3	0.6	0.6	0.7	0.7	6.1	3.5	0.7	0.6	0.6	3.2	1.2	4.0	1.2	0.6	1.9	1.0	0.8	68.9	0.6	0.6	0.6	3.6	0.6	1.6	3.6	4.0	0.0	0.8	8.8	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.4	0.1	2.4	6.3	0.5	2.4	2.6	4.3	5.2	0.0	1.4	0.0	1.0	4.9	25.2	0.0	1.2	1.1	3.6	0.0	2.6	0.0	0.9	0.0	0.1	0.0	0.0	2.5	0.2	6.9	0.9	1.2	0.3	0.0	2.6	7.3	11.9	0.0	0.0	0.9	2.8	0.0	4.1	0.4	13.4	0.0	0.0	0.0	6.1	11.0	0.0	0.0	8.6	1.5	0.0	4.7	5.4	2.6	0.0	1.7	9.0	0.0	0.0	0.0	12.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.5	0.4	6.8	3.7	2.3	6.1	3.5	4.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	75.0	0.0	0.0	0.0	0.0	1.1	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.6	0.6	0.0	0.0	3.6	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	1.6	1.4	0.0	0.1	0.0	0.0	0.0
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 443.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	12.8	48.2	7.4	7.5	10.8	3.6	15.0	5.3	16.4	11.0	20.8	9.6	32.1	24.9	9.0	8.2	13.4	12.8	9.9	8.4	7.1	7.2	12.0	78.4	13.7	9.9	5.2	10.1	14.4	12.8	12.1	18.5	18.6	7.1	9.3	5.3	10.8	7.8	58.7	13.1	10.0	24.3	7.0	5.2	11.7	9.8	22.4	5.0	8.2	33.3	9.9	8.6	9.8	10.2	5.7	20.6	26.7	18.4	11.2	9.9	13.9	12.8	28.2	12.9	24.0	48.9	18.6	21.6	5.4	17.7	10.2	14.3	21.1	57.3	12.3	5.0	11.7	34.8	6.3	16.9	8.5	4.4	10.5	12.5	5.7	8.3	39.0	34.0	5.7	10.2	38.1	10.7	13.4	9.8	8.2	9.4	6.1	17.0	5.3	9.1	18.9	6.1	10.2	16.1	20.2	16.0	8.8	8.5	13.2	11.5	15.6	13.5	12.9	14.5	74.1	19.5	7.6	21.2	9.6	8.5	9.6	10.6	14.4	10.6	5.2	8.0	8.4	13.6	8.7	12.3	26.7	18.4	25.3	9.9	17.7	8.3	5.4	8.4	9.2	20.6	5.7	8.4	7.1	24.3	11.2	13.0	5.8	8.7	13.9	7.4	10.8	5.3	16.4	7.1	7.2	5.2	10.1	7.1	5.0	35.7	31.2	12.6	24.7	15.1	30.1	9.3	56.0	78.9	37.5	69.8	11.8	88.1	1.7	55.5	13.2	25.3	144.8	0.0	25.7	71.6	24.8	20.8	24.3	443.8	58.9	14.3	19.0	27.6	38.6	6.1	70.2	40.5	11.8	16.2	29.0	33.2	24.3	119.3	105.7	27.5	21.8	64.7	30.9	14.7	32.6	12.8	161.6	20.0	36.8	40.7
PORCN	"DHOF, MG61, por, PORC, PPN"	ENSG00000102312	"Porcupine O-acyltransferase"	Q9H237	X	48508962-48520814	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.3;LHCN-M2: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049215, HPA058413"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA049215: , HPA058413: AB_2683711"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.35e-1)"	4.6	31.4	9.1	4.4	14.1	3.6	4.4	20.0	15.4	12.6	4.6	7.2	12.2	3.4	10.1	3.2	13.9	7.0	6.2	13.4	10.9	9.2	3.3	1.7	5.0	6.6	7.1	8.8	4.9	4.6	6.9	4.1	4.0	8.4	5.0	2.5	7.6	5.8	16.4	5.9	6.8	2.9	6.3	5.5	4.8	5.4	5.4	5.9	2.6	8.5	4.7	5.9	6.5	5.4	4.1	7.2	13.7	5.8	7.8	12.0	4.7	4.4	5.3	1.3	9.3	5.7	3.4	0.5	1.3	2.7	2.0	1.4	0.6	6.8	0.3	5.6	2.8	2.3	6.0	1.9	61.3	0.6	2.8	0.6	0.7	3.2	1.3	8.5	0.7	8.0	4.4	7.2	5.9	12.8	4.8	1.8	2.2	0.3	4.2	21.3	1.2	0.7	0.9	1.7	1.3	3.6	1.3	1.6	6.9	3.4	1.7	1.5	2.3	10.7	2.0	2.0	0.9	2.3	0.3	1.1	5.3	2.8	12.8	2.3	3.7	2.0	0.5	15.3	1.6	3.0	13.7	5.8	7.1	12.0	5.2	9.4	3.7	8.0	10.0	7.2	4.1	5.4	8.1	1.2	7.8	4.2	3.9	5.2	4.7	9.1	14.1	20.0	14.4	10.9	9.2	7.1	8.8	8.4	5.9	6.0	3.2	3.0	4.4	3.5	12.7	2.7	2.5	4.0	4.5	15.7	17.7	0.0	1.7	5.2	0.2	3.5	0.0	0.0	8.6	1.1	4.1	2.3	5.7	1.0	3.1	7.9	5.8	4.9	2.8	0.0	5.2	2.9	3.3	2.8	2.0	9.3	22.6	1.5	3.9	0.7	15.7	6.5	4.7	1.0	3.4	3.3	6.9	6.5	1.2	5.6
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 262.6"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 75.1;SuSa: 71.0;U-138 MG: 96.0;U-2197: 65.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		740000000	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	60.9	2.0	5.3	12.7	4.0	0.0	26.9	0.5	2.7	17.6	14.1	0.6	11.7	0.6	29.0	20.0	16.5	20.3	14.5	34.1	6.2	0.5	47.5	3.0	28.4	19.5	0.5	1.1	21.0	3.1	8.2	1.7	17.3	2.5	12.4	19.7	0.8	10.8	10.2	14.2	46.1	9.6	14.5	1.7	0.7	37.3	21.5	0.1	3.1	8.0	5.5	1.7	23.5	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.2	13.3	8.0	0.0	3.4	0.0	0.8	0.1	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	14.2	0.0	75.1	0.3	2.4	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.1	0.0	0.0	96.0	0.0	65.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.0	0.5	2.7	6.2	0.5	0.5	1.1	2.5	0.1	6.0	18.3	0.0	1.4	262.6	0.0	19.4	0.0	9.4	33.0	0.0	0.0	1.5	0.0	0.0	0.4	27.7	0.0	0.0	0.0	0.2	42.9	0.3	3.5	0.0	3.2	0.0	0.0	16.5	0.0	0.2	6.1	0.2	28.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	62.4	1.1	0.2	42.3	2.9	0.0	0.0	0.0
POU2F1	"OCT1, OTF1"	ENSG00000143190	"POU class 2 homeobox 1"	P14859	1	167220829-167427345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002608, HPA058559, HPA064323"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		No	No			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-3)"	"unprognostic (4.26e-2)"	"unprognostic (5.67e-6)"	"unprognostic (4.47e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.17e-2)"	6.9	5.7	15.5	7.3	11.9	12.6	7.2	36.4	13.8	7.7	6.6	9.5	5.2	4.1	7.5	8.4	5.3	6.5	4.3	5.1	14.5	6.7	7.0	5.8	6.6	8.2	7.7	10.8	8.1	6.1	15.5	8.3	9.6	7.1	6.7	6.8	12.0	5.5	6.5	10.5	8.8	6.6	5.5	6.3	9.3	6.1	10.1	10.9	7.4	6.9	4.9	9.7	7.6	6.2	7.5	5.9	8.6	5.9	1.4	4.4	2.2	6.4	5.2	13.5	4.1	1.6	1.6	5.5	0.8	1.4	1.6	1.6	7.5	3.7	7.3	3.5	1.3	1.5	5.0	8.2	2.5	2.4	2.9	3.1	5.1	3.6	6.1	1.0	5.6	3.4	1.1	1.4	1.8	3.3	2.0	2.1	5.1	5.4	4.2	2.1	3.4	5.1	3.6	15.7	3.5	2.1	7.5	4.9	3.2	2.8	3.6	8.2	6.2	5.0	3.7	3.3	7.1	4.1	6.9	3.4	3.1	4.9	1.9	3.1	4.0	1.8	16.9	1.4	3.4	3.9	8.6	2.3	2.8	4.4	2.7	3.3	7.5	2.3	2.0	2.5	6.8	3.2	2.4	3.3	1.4	5.9	5.9	2.1	2.2	15.5	11.9	36.4	13.8	14.5	6.7	7.7	10.8	7.1	10.9	11.9	12.1	21.9	10.4	11.8	54.9	13.2	12.7	6.7	10.3	19.2	96.2	15.4	5.0	8.8	23.3	16.6	8.5	0.0	10.1	15.3	13.4	14.9	19.6	11.6	11.2	44.5	23.2	11.1	35.6	28.6	23.9	14.6	6.8	23.4	14.3	47.2	12.6	7.0	19.4	6.9	106.3	25.8	11.9	18.5	40.0	9.7	43.3	13.8	13.0	9.7
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.5	0.0	0.0	0.2	0.0	0.0	0.8	0.3	0.6	0.0	0.0	0.1	7.2	0.3	2.7	0.0	0.1	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.2	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.2	0.3	0.1	0.6	0.0	0.0	0.1	0.0	1.9	0.5	0.1	0.1	5.3	0.0	0.9	9.7	0.4	0.8	0.0	0.2	0.4	0.1	0.1	0.1	0.0	1.1	0.2	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	5.1	0.0	9.0	18.5	0.0	0.8	0.0	1.4	2.3	10.4	0.0	1.2	0.0	3.6	1.7	0.0	0.3	0.0	1.2	0.2	0.2	5.0	0.0	0.4	0.1	0.0	2.9	0.0	0.0	3.8	0.0	0.0	5.0	0.0	0.0	0.2	12.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	33.0	6.6	0.0	0.5	10.1
POU5F2	"FLJ25680, SPRM-1"	ENSG00000248483	"POU domain class 5, transcription factor 2"	Q8N7G0	5	93733220-93741637	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 26.8"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 15.9;Rod photoreceptor cells: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"U-2 OS: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA077615	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA077615: "	"unprognostic (1.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.03e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.16e-9)"	"unprognostic (1.87e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-3)"	0.2	0.2	0.2	0.2	0.2	1.2	0.8	0.2	0.9	0.2	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.2	0.2	0.2	0.2	1.4	0.6	0.2	0.2	0.3	0.5	26.8	0.2	0.2	0.5	0.2	0.2	0.2	0.2	2.0	0.5	2.7	0.6	1.1	1.3	0.3	0.4	0.6	1.1	0.5	0.2	0.4	0.5	0.2	0.0	0.3	0.1	0.3	0.5	0.9	0.4	0.2	0.7	0.6	0.9	0.3	0.5	0.6	0.7	0.8	0.7	0.7	0.2	0.8	0.8	0.5	0.7	0.5	0.4	0.5	0.2	0.8	0.6	1.1	0.4	0.4	0.7	1.0	0.7	0.3	0.3	0.5	1.2	0.9	0.2	0.3	1.0	0.9	0.6	0.7	0.2	0.5	0.5	0.7	0.7	0.6	8.5	0.7	0.7	0.8	0.5	0.8	0.5	0.9	0.4	1.4	0.6	0.3	1.0	0.4	1.0	0.8	0.7	0.6	0.1	2.0	0.7	1.1	2.7	1.1	0.4	0.5	1.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	3.0	2.1	3.0	2.1	1.9	10.5	0.4	2.5	1.4	0.0	1.8	5.9	0.7	0.0	1.5	1.7	1.4	1.4	0.0	0.8	0.9	1.4	2.0	8.1	0.8	1.0	15.9	2.9	2.5	1.3	4.5	4.4	2.9	1.7	2.8	0.5	5.4	1.7	0.0	1.4	0.1	15.8	0.0	0.9	6.9	2.3	2.4	0.5	5.4	1.0	2.0
PPA2	FLJ20459	ENSG00000138777	"Pyrophosphatase (inorganic) 2"	Q9H2U2	4	105369077-105474081	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		8300	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	9.2	18.0	18.4	17.2	15.4	24.0	20.6	12.3	17.6	10.2	19.8	9.3	20.3	18.1	13.3	20.7	14.8	10.7	18.7	42.5	15.6	15.3	23.7	21.2	23.1	34.8	17.2	12.1	9.5	25.0	10.4	15.0	9.3	15.4	16.1	16.7	12.6	21.4	26.8	29.6	15.0	16.8	22.8	12.4	12.1	15.0	9.7	10.7	9.4	14.3	28.2	10.6	12.2	9.5	20.0	35.3	14.7	20.8	22.0	17.0	14.6	11.4	5.4	10.6	18.0	6.8	5.4	7.7	6.5	8.5	8.0	5.7	12.1	16.8	9.4	8.6	5.2	6.4	5.7	21.2	10.3	9.4	13.3	7.6	8.4	8.8	11.0	5.3	19.9	8.2	5.2	10.6	5.5	4.3	9.1	7.6	16.5	14.0	13.0	7.2	14.5	17.0	14.4	7.7	22.3	18.5	15.1	6.5	9.3	26.3	8.8	11.0	6.5	4.4	26.6	9.4	6.5	13.9	16.3	4.0	5.7	11.2	6.2	11.2	11.5	14.5	9.8	10.1	10.8	7.7	14.7	15.0	9.7	15.3	20.8	13.3	20.0	16.0	16.2	35.3	16.6	15.5	17.0	6.4	22.0	16.2	17.7	15.9	14.6	18.4	15.4	12.3	17.6	15.6	15.3	17.2	12.1	15.4	10.7	8.9	50.5	30.0	71.8	44.4	30.3	55.7	53.5	57.6	43.3	31.4	15.7	106.7	223.8	100.3	91.0	35.1	73.1	23.3	104.8	78.8	31.9	70.3	43.9	59.7	73.9	20.6	63.1	23.4	36.7	95.8	25.6	65.5	72.6	46.9	86.9	28.4	66.2	97.6	30.4	222.1	16.9	38.8	49.5	16.1	9.4	50.4	70.8	45.8	109.9	75.5
PPAT	"GPAT, PRAT"	ENSG00000128059	"Phosphoribosyl pyrophosphate amidotransferase"	Q06203	4	56393362-56435615	"Enzymes, Predicted intracellular proteins"	"Purine biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036091, HPA036092"	Approved		Approved	"Midbody ring"		Yes	No			"Midbody ring"		"HPA036091: AB_2674936, HPA036092: AB_10603132"	"unprognostic (5.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (1.38e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (1.14e-8)"	"unprognostic (6.74e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.09e-1)"	5.6	10.1	10.8	9.5	11.7	7.3	11.1	11.7	13.7	7.3	6.0	6.9	7.6	6.1	7.4	5.6	8.1	7.1	5.3	4.4	8.9	9.7	9.7	10.3	3.9	12.0	9.7	12.1	12.5	10.8	5.6	6.8	10.3	9.5	6.2	7.7	3.8	9.2	7.6	7.0	6.7	5.1	5.6	9.7	6.3	5.5	13.0	8.9	15.2	9.4	6.4	12.0	7.0	6.6	8.2	3.7	3.3	3.9	11.2	9.5	4.3	8.7	7.3	15.1	7.3	4.9	6.4	12.3	9.8	4.3	8.1	8.7	14.6	10.7	30.8	13.3	4.6	7.5	6.5	29.0	9.8	16.3	8.0	12.9	12.4	9.2	16.1	7.5	24.4	7.8	5.5	7.7	11.5	13.0	5.0	8.5	12.7	31.2	17.1	9.1	7.9	30.1	18.6	20.0	19.9	8.8	25.5	9.9	21.6	13.6	6.2	25.5	12.4	7.8	14.3	8.8	14.8	9.6	5.2	5.9	8.5	14.7	8.5	17.2	12.8	12.8	32.0	9.5	15.6	7.9	3.3	2.0	1.0	4.6	3.1	6.9	8.2	6.3	6.2	2.8	6.3	9.5	8.6	0.5	11.2	3.9	3.7	4.7	4.3	10.8	11.7	11.7	13.7	8.9	9.7	9.7	12.1	9.5	8.9	0.0	5.6	6.7	8.0	27.5	8.3	3.6	5.1	8.1	11.4	3.5	2.0	24.8	8.3	3.7	2.1	7.1	0.5	0.0	2.3	21.1	10.4	5.9	6.9	6.6	6.9	36.5	4.1	8.0	1.8	2.0	7.2	3.4	8.5	1.0	3.7	4.9	2.7	0.0	5.3	9.5	4.5	0.0	10.4	7.7	28.6	27.9	6.4	9.6	8.9	5.3
PPCDC	"FLJ14585, MDS018"	ENSG00000138621	"Phosphopantothenoylcysteine decarboxylase"	Q96CD2	15	75023555-75117462	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 19.9;granulocytes: 40.4;monocytes: 18.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045667	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045667: AB_2679412"	"unprognostic (8.66e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-3)"	10.4	18.5	7.7	11.1	9.3	16.7	14.5	10.8	10.2	8.4	10.8	16.0	15.1	9.4	16.3	13.3	17.5	10.9	12.1	7.8	7.3	7.9	12.5	12.0	13.9	14.0	16.8	5.9	9.2	22.1	14.4	11.3	8.9	11.0	12.0	9.3	15.6	17.5	8.0	10.5	8.3	11.6	6.1	13.6	18.0	10.7	9.7	11.3	7.4	11.0	11.5	16.5	14.2	9.4	4.2	19.9	40.4	18.1	4.5	5.6	4.2	6.0	11.4	4.7	3.7	2.9	2.7	4.1	6.1	2.7	8.3	6.5	6.7	16.5	6.9	11.0	3.0	5.1	6.3	7.7	10.2	4.2	24.3	9.4	12.1	7.1	7.1	8.3	7.0	15.8	3.6	6.8	8.5	13.1	3.3	6.5	10.3	8.1	54.0	5.9	11.7	4.2	10.9	7.6	12.9	5.3	7.1	9.3	14.8	6.2	8.7	11.5	3.3	9.0	12.6	13.2	5.7	15.6	9.1	3.7	8.5	5.9	4.2	10.8	16.5	10.8	11.4	5.2	17.9	9.5	10.9	6.5	40.4	3.4	17.5	5.6	4.2	3.1	3.8	4.9	2.3	3.6	4.3	39.3	4.5	18.1	19.9	3.3	4.2	7.7	9.3	10.8	10.2	7.3	7.9	16.8	5.9	11.0	11.3	14.9	6.9	2.2	6.1	3.4	2.6	3.4	5.1	12.0	3.4	8.7	0.0	14.7	21.6	15.1	0.7	9.8	11.1	0.0	13.4	11.5	7.2	5.7	11.5	4.2	16.7	7.9	4.1	4.9	12.5	2.9	4.0	15.4	13.5	21.6	8.5	3.5	16.2	31.7	4.9	14.9	8.4	6.5	8.2	6.5	16.4	3.4	9.2	13.1	10.0	11.9
PPCS	FLJ11838	ENSG00000127125	"Phosphopantothenoylcysteine synthetase"	Q9HAB8	1	42456117-42473385	"Enzymes, Predicted intracellular proteins"		Ligase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031361, HPA031363"	Approved		Approved	Mitochondria		NA	NA		16000	Mitochondria		"HPA031361: AB_10602150, HPA031363: AB_2673844"	"unprognostic (1.49e-1)"	"unprognostic (6.71e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (2.71e-1)"	"unprognostic (7.79e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.30e-2)"	23.4	36.3	18.9	20.5	21.9	10.7	30.7	12.0	26.0	23.2	32.0	12.4	27.3	25.5	18.2	34.4	31.6	14.5	30.9	22.1	17.8	16.4	41.4	43.9	26.5	28.1	19.3	14.9	19.6	47.0	22.8	16.1	37.6	17.2	27.2	27.3	19.6	36.6	35.0	19.6	21.9	41.0	27.6	18.9	24.4	27.2	13.5	13.4	22.6	31.3	26.0	20.5	24.0	19.4	41.9	44.4	76.1	55.7	42.0	41.0	52.0	22.9	9.6	5.6	8.7	17.4	18.1	20.9	11.6	13.4	15.7	13.9	8.1	28.1	6.9	22.9	14.7	9.1	13.5	3.7	17.6	13.2	18.3	11.1	11.6	10.6	9.6	23.9	11.9	20.6	15.9	31.9	11.0	20.4	19.3	14.5	8.6	4.7	5.0	16.0	13.7	5.8	11.8	6.4	21.2	14.9	6.6	5.7	12.3	34.3	21.7	6.6	7.3	14.2	34.8	36.0	17.0	16.4	52.7	9.1	8.6	11.5	13.1	13.2	16.5	10.3	5.0	3.6	13.8	17.6	58.1	55.7	76.1	30.7	55.1	35.7	41.9	37.0	33.0	44.4	39.9	41.0	34.9	41.2	42.0	51.8	33.2	36.4	52.0	18.9	21.9	12.0	26.0	17.8	16.4	19.3	14.9	17.2	13.4	53.6	69.7	61.9	43.1	20.7	9.2	94.6	86.6	54.9	59.1	61.1	5.9	137.5	336.5	81.6	2.8	50.7	119.1	0.0	120.2	108.8	45.6	37.4	54.4	103.6	97.2	11.1	30.1	43.0	68.9	3.4	56.1	87.5	77.6	111.0	116.6	40.7	82.5	122.6	59.8	254.9	21.8	25.8	44.7	8.4	19.2	31.7	112.6	52.4	93.7	42.7
PPDPF	"C20orf149, dJ697K14.9, exdpf"	ENSG00000125534	"Pancreatic progenitor cell differentiation and proliferation factor"	Q9H3Y8	20	63520724-63522206	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 2540.0;Paneth cells: 2816.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 18.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040929			Approved	Nucleoplasm,Nucleoli,Microtubules		Yes	No			"Nucleoplasm, Microtubules"	Nucleoli	"HPA040929: AB_10794155"	"unprognostic (3.75e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.09e-2)"	63.9	19.9	42.2	46.0	43.0	36.5	38.8	22.3	55.1	54.3	78.6	61.5	43.5	41.3	39.9	46.0	112.6	44.7	67.3	53.2	32.9	31.0	72.1	28.4	56.5	42.8	44.5	34.9	45.6	69.5	15.4	35.0	22.2	48.7	75.3	32.2	58.8	143.7	54.1	116.1	86.2	48.5	61.8	72.0	40.0	120.2	49.0	21.6	28.7	48.0	73.3	87.9	68.6	65.2	5.8	3.4	18.9	4.5	2.4	5.2	3.4	44.6	13.9	9.5	19.2	10.8	18.2	30.7	27.5	8.9	36.0	14.2	25.4	26.9	9.6	37.1	18.3	13.7	47.3	4.8	31.4	5.8	17.1	9.5	3.9	13.0	4.8	29.7	0.0	20.6	17.9	63.4	9.1	12.7	11.9	14.1	12.2	16.1	22.7	13.1	60.8	45.7	0.4	10.3	35.8	80.8	20.9	21.5	19.4	25.7	18.4	32.6	24.9	27.3	44.1	18.9	6.6	63.0	26.2	23.2	30.4	34.6	40.2	22.7	18.1	14.2	6.5	21.5	11.3	19.8	1.9	2.4	18.9	5.2	3.1	4.3	4.6	4.6	4.8	2.9	5.8	4.1	4.5	1.1	2.4	4.5	3.4	5.0	3.4	42.2	43.0	22.3	55.1	32.9	31.0	44.5	34.9	48.7	21.6	291.8	201.0	276.1	613.6	510.4	42.1	61.0	749.1	294.5	174.0	910.7	11.8	432.7	2540.0	793.9	185.5	235.8	2093.0	327.1	669.9	547.6	555.3	988.2	330.2	190.7	548.2	47.7	765.2	266.4	322.1	856.1	344.3	360.7	1130.3	1110.9	1414.5	95.8	744.2	2816.1	271.2	1340.7	49.4	194.1	670.9	133.9	288.9	814.8	346.3	385.8	996.5	1073.4
PPFIBP1	"hSGT2, hSgt2p, L2, SGT2"	ENSG00000110841	"PPFIA binding protein 1"	Q86W92	12	27523431-27695564	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 154.9;Endothelial cells: 139.6;Ito cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 53.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001924	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA001924: AB_1079665"	"unprognostic (5.27e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.11e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.11e-7)"	"unprognostic (8.54e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.09e-2)"	21.3	17.1	15.5	8.0	16.8	2.2	22.6	4.9	25.0	18.3	15.4	13.3	13.0	7.1	28.1	9.3	17.1	16.5	12.2	43.3	17.1	9.0	23.8	15.7	25.0	7.8	13.1	16.4	53.1	13.7	12.7	22.2	34.5	15.3	15.3	11.1	8.1	14.2	18.4	13.7	17.8	10.0	20.5	11.2	16.6	15.1	7.1	13.3	6.2	23.9	14.9	6.2	17.2	18.4	7.0	2.0	1.5	0.6	0.3	1.8	0.6	4.4	8.9	7.3	6.2	12.1	33.8	13.0	16.1	18.1	9.5	13.7	23.4	13.5	3.3	18.8	32.6	12.7	11.1	3.9	14.7	17.1	7.6	2.2	7.4	6.8	3.4	5.3	2.2	4.1	26.2	10.3	27.6	28.4	18.6	32.4	4.5	3.8	3.4	33.7	3.4	2.1	0.6	13.0	6.3	6.9	3.4	18.1	1.2	14.1	9.8	0.6	3.0	8.0	4.3	22.4	53.2	5.5	3.4	31.5	26.8	9.0	14.6	16.4	0.0	0.0	0.2	29.8	3.2	42.2	1.5	0.6	0.3	0.7	0.2	1.4	0.7	1.3	0.7	0.6	7.0	1.3	1.3	1.5	0.3	0.2	2.0	1.8	0.6	15.5	16.8	4.9	25.0	17.1	9.0	13.1	16.4	15.3	13.3	92.3	20.3	24.3	55.3	36.5	2.3	154.9	2.5	9.4	14.8	76.8	3.9	28.5	10.0	37.2	2.6	139.6	7.0	0.0	21.6	18.9	41.3	34.7	3.5	12.7	8.3	42.9	17.9	144.9	21.5	3.1	19.5	6.4	59.1	3.6	14.6	7.5	26.9	14.4	39.6	16.6	1.7	19.4	44.8	1.7	9.1	24.1	76.9	5.9	11.5	75.3
PPFIBP2	Cclp1	ENSG00000166387	"PPFIA binding protein 2"	Q8ND30	11	7513298-7657127	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.8;OE19: 37.0;RT4: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001935, HPA003911"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA001935: AB_1079667, HPA003911: AB_1079666"	"unprognostic (4.14e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.20e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.66e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (5.39e-8)"	"unprognostic (1.78e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.52e-2)"	"prognostic favorable (1.34e-5)"	6.9	6.0	9.2	11.6	13.3	3.1	8.5	6.6	12.9	7.0	13.7	21.4	38.7	12.2	5.7	17.3	17.7	8.4	14.0	6.3	10.0	6.3	17.2	22.1	5.9	6.5	24.0	4.0	8.4	6.0	56.2	3.3	10.0	10.2	12.0	13.3	15.3	34.9	55.9	12.4	20.3	15.4	7.0	10.8	8.0	20.2	18.7	19.3	0.8	17.7	10.2	15.9	20.0	15.3	12.1	7.0	5.4	11.8	2.0	6.1	4.5	0.6	11.9	2.1	1.3	2.9	0.1	29.8	2.7	6.1	1.8	1.7	9.7	1.7	3.3	1.3	1.8	5.8	5.6	8.6	0.8	1.5	1.6	0.8	0.0	0.0	6.1	3.9	7.0	3.2	4.7	2.8	0.0	2.2	0.1	0.5	0.7	0.3	10.0	1.4	6.5	0.0	6.6	13.9	37.0	0.0	1.0	0.0	5.5	0.0	41.4	0.5	4.6	0.3	11.0	7.8	6.0	1.6	5.4	0.1	0.7	1.0	2.3	0.2	4.9	3.6	2.9	0.9	1.6	4.7	2.0	7.9	5.4	2.8	9.4	2.1	12.1	4.4	2.0	7.0	7.1	6.1	4.5	3.8	2.0	11.8	0.5	0.8	4.5	9.2	13.3	6.6	12.9	10.0	6.3	24.0	4.0	10.2	19.3	14.9	9.9	22.3	17.5	4.8	0.0	4.3	10.2	9.4	19.4	14.0	17.7	6.7	8.3	4.4	43.7	2.8	23.1	0.0	8.2	50.5	9.5	11.3	6.9	11.6	6.8	0.0	3.5	1.8	6.0	33.0	4.4	7.2	15.1	18.0	19.2	1.2	7.7	20.7	6.7	13.5	3.1	0.0	6.1	11.9	3.0	8.7	4.0	0.5	15.6	17.4
PPHLN1		ENSG00000134283	"Periphilin 1"	Q8NEY8	12	42238447-42459715	"Predicted intracellular proteins"	"Keratinization, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 85.8"					"Low region specificity"	"Detected in all"			"HPA038902, HPA038903"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA038902: AB_10674844, HPA038903: AB_2676263"	"unprognostic (4.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.28e-7)"	"unprognostic (2.85e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.04e-2)"	25.6	32.4	29.0	37.2	34.2	37.6	27.8	43.0	32.2	24.3	23.7	18.9	27.7	19.2	35.3	27.7	27.0	25.3	24.5	29.0	25.6	28.7	25.2	25.2	23.0	44.3	23.8	35.0	30.6	21.3	20.7	39.9	24.2	26.3	22.6	27.1	21.6	31.1	24.9	32.0	26.1	26.9	28.3	24.6	30.5	23.1	48.4	24.9	51.4	23.1	28.6	47.2	28.1	25.3	25.0	24.1	23.1	14.5	23.7	33.2	12.2	14.7	13.8	16.4	13.6	14.8	16.5	14.5	17.4	19.8	18.3	15.2	22.2	18.7	25.2	22.1	18.5	8.6	13.8	16.8	18.2	22.6	21.6	17.5	39.4	14.2	20.1	15.6	46.4	22.8	19.6	18.7	14.5	14.0	20.9	22.8	22.2	19.2	19.5	20.0	11.3	26.0	28.0	14.2	40.5	13.7	22.2	18.7	23.1	28.5	13.1	11.6	17.1	15.3	12.4	14.9	16.3	18.9	23.3	15.7	10.7	19.1	10.3	14.9	22.5	31.3	40.6	18.1	85.8	7.0	21.0	12.8	23.1	19.3	14.5	23.2	25.0	24.7	25.9	24.1	21.1	22.7	22.6	8.3	23.7	13.4	22.9	33.2	12.2	29.0	34.2	43.0	32.2	25.6	28.7	23.8	35.0	26.3	24.9	38.7	47.5	78.2	56.2	67.3	59.8	29.5	45.9	54.9	54.6	40.1	27.5	73.8	31.5	53.2	175.7	43.2	30.4	23.3	59.6	62.8	45.5	38.3	54.4	29.8	46.7	35.0	32.3	38.1	37.1	48.4	54.1	61.7	60.8	100.0	34.6	43.3	55.2	38.6	49.1	39.8	57.0	51.8	37.6	123.1	54.7	51.7	37.0	76.2	39.2	43.7
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.7	50.0	45.2	102.6	158.3	91.9	39.8	94.9	124.7	75.2	89.4	71.9	73.8	38.0	77.2	147.0	76.4	64.9	82.5	63.8	38.8	24.1	31.1	53.6	55.2	94.1	166.0	53.4	48.5	84.6	68.8	43.8	106.9	93.2	90.8	18.2	37.3	132.4	56.9	63.5	16.3	82.0	39.4	110.7	32.2	31.2	48.0	193.7	78.0	62.0	25.6	40.3	43.5	74.8	69.1	69.6	44.7	163.5	55.8	75.2	62.3	42.0	64.0	71.9	69.6	39.9	70.2	86.1	75.0	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5	116.1	168.3	153.4	361.8	142.3	26.7	0.7	280.2	128.5	194.5	258.2	29.5	546.5	76.3	534.3	16.2	209.5	301.3	70.0	495.6	1107.3	581.4	486.2	176.7	431.7	566.9	42.9	284.9	371.4	213.7	20.8	422.5	284.2	266.6	285.9	313.7	126.6	471.5	326.7	369.5	231.9	33.9	226.4	234.9	37.1	72.8	126.6	935.7	261.7	353.5	357.9
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		35000	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	12.4	17.9	18.1	15.5	19.2	24.2	21.1	20.1	20.2	19.4	16.4	18.4	21.1	12.7	17.2	24.3	25.4	19.1	15.9	17.6	17.5	21.8	15.9	19.4	15.9	23.7	20.0	11.8	31.4	16.7	11.9	17.4	15.5	23.0	19.5	16.6	16.3	13.8	15.8	13.4	14.7	15.7	16.8	23.2	20.2	15.7	18.2	13.0	26.3	23.7	19.4	25.5	28.6	13.6	23.4	21.7	18.7	14.1	20.6	20.6	10.7	8.0	7.1	22.1	9.6	17.3	37.2	7.2	12.8	13.9	14.8	15.0	5.2	15.2	7.7	13.6	13.8	17.4	10.6	7.7	15.6	13.3	16.3	18.5	32.5	19.9	35.1	8.9	31.1	16.5	13.5	15.3	12.1	19.1	25.0	9.8	15.3	25.7	18.9	18.8	12.8	23.9	24.8	13.5	8.1	11.5	9.1	12.4	12.1	19.4	12.4	9.2	8.5	12.9	12.3	20.6	27.1	10.2	14.2	13.4	21.3	12.1	12.6	10.5	20.7	19.6	36.3	16.3	13.9	13.5	18.7	12.7	12.7	12.7	10.8	18.5	23.4	15.6	13.7	21.7	18.9	19.1	20.6	3.0	20.6	14.1	17.9	20.1	10.7	18.1	19.2	20.1	20.2	17.5	21.8	20.0	11.8	23.0	13.0	0.0	11.5	24.3	38.6	28.2	12.5	17.8	17.8	21.4	11.4	15.7	9.8	45.1	48.0	20.2	14.8	15.7	12.9	0.0	14.0	44.2	34.2	17.7	25.4	15.7	41.6	3.2	9.1	16.0	41.1	2.7	33.9	45.8	27.0	23.4	25.0	17.1	18.9	24.6	26.5	45.3	10.5	19.4	29.4	36.5	22.3	40.5	25.7	32.6	29.2	23.7
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.5"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 187.4;Early spermatids: 262.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.5	1.4	5.5	1.1	8.6	0.7	3.6	5.0	4.8	4.6	1.7	7.2	7.4	1.9	3.8	12.7	2.0	36.5	1.7	2.6	6.0	5.4	4.9	1.2	8.9	1.1	3.4	3.2	6.3	4.3	6.6	7.6	1.6	18.3	1.8	1.6	2.6	2.8	5.0	3.9	1.7	1.1	5.4	3.2	1.3	2.3	20.4	5.3	0.0	17.2	1.4	1.1	2.9	2.0	5.1	1.7	2.0	1.3	1.7	1.3	1.1	1.8	1.0	1.2	6.5	10.4	12.9	1.1	0.0	2.3	0.5	0.2	0.1	1.8	0.0	0.5	0.6	0.9	1.2	1.0	0.0	0.3	0.5	0.9	0.5	0.1	0.0	5.2	0.6	0.3	2.7	6.2	0.2	3.9	9.3	0.8	1.4	0.9	0.3	0.4	0.6	0.1	0.6	0.2	4.2	1.3	0.8	0.0	0.6	5.0	0.1	1.5	2.5	0.2	0.3	4.3	0.3	0.5	1.0	0.4	0.1	0.2	1.1	0.2	0.3	0.1	0.1	2.1	0.1	0.4	2.0	1.2	1.2	0.9	1.3	0.9	5.1	1.2	1.1	1.7	3.2	1.1	1.0	1.6	1.7	1.1	1.7	1.3	1.1	5.5	8.6	5.0	4.8	6.0	5.4	3.4	3.2	18.3	5.3	6.0	5.8	0.0	3.5	1.9	2.1	3.3	5.1	187.4	22.7	3.5	2.0	0.5	21.6	1.6	262.5	1.5	0.7	0.0	1.0	0.7	1.7	2.9	0.0	0.0	0.3	1.6	2.9	0.6	0.0	40.8	4.9	0.5	3.3	1.0	1.8	4.9	0.7	0.0	4.9	8.0	11.5	0.0	1.2	52.6	22.0	2.6	0.6	0.5	1.7	1.1
PPIP5K2	"CFAP160, HISPPD1, KIAA0433, VIP2"	ENSG00000145725	"Diphosphoinositol pentakisphosphate kinase 2"	O43314	5	103120149-103212799	"Enzymes, Predicted intracellular proteins"	Hearing	"Kinase, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037895, HPA038442"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA037895: AB_2675724, HPA038442: AB_10673173"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (8.80e-2)"	21.6	20.5	12.6	18.2	18.4	37.9	22.3	30.7	24.2	26.1	23.8	9.7	16.0	14.3	22.6	20.3	17.0	18.5	17.7	16.4	13.2	17.6	21.9	22.6	14.8	20.6	19.5	18.7	26.8	25.5	22.3	40.3	21.6	37.2	18.4	22.1	10.5	17.4	21.7	5.7	16.4	20.2	16.0	19.8	27.7	18.6	13.5	16.2	38.5	20.0	12.9	20.3	16.9	18.2	12.1	15.7	24.3	18.2	10.0	11.2	6.7	9.7	9.5	18.5	21.4	15.0	19.5	16.7	20.2	14.1	12.7	17.5	8.0	16.5	22.9	19.8	20.2	17.9	6.0	16.0	12.1	20.8	18.1	8.4	29.1	17.9	12.7	11.1	25.0	26.4	13.0	9.1	17.9	16.5	11.4	14.1	15.1	30.1	21.1	18.8	8.2	21.6	17.6	20.1	4.3	22.3	20.6	16.5	31.4	13.6	11.2	10.4	13.6	13.9	14.6	13.6	13.6	11.5	17.0	14.1	18.2	8.2	20.2	15.1	13.4	30.4	31.1	10.6	39.8	17.0	23.0	13.4	24.3	8.7	13.8	10.7	12.1	8.4	9.0	15.7	11.3	11.1	11.2	13.0	10.0	18.2	9.3	7.3	6.7	12.6	18.4	30.7	24.2	13.2	17.6	19.5	18.7	37.2	16.2	44.7	17.2	18.1	11.4	12.0	34.2	42.3	20.4	29.4	37.5	15.7	43.2	10.7	5.0	9.7	3.7	21.5	17.0	0.0	14.8	16.5	16.2	12.8	41.7	17.9	26.3	15.9	15.6	14.7	40.6	4.5	27.3	34.8	11.8	16.2	21.5	15.6	13.5	21.0	22.3	17.5	25.9	6.5	14.6	28.9	11.1	13.8	21.7	17.0	25.4	11.4
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 68.5;Collecting duct cells: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.2;HaCaT: 57.0;MCF7: 20.8;SiHa: 30.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		310000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	10.8	0.7	2.2	1.4	0.7	0.2	6.8	0.6	3.0	23.5	2.9	0.2	4.1	1.7	2.6	5.1	126.9	2.9	5.8	1.8	1.8	0.2	3.0	3.3	4.7	0.2	0.0	0.9	1.7	2.8	1.6	2.8	2.9	0.5	4.6	1.0	0.7	24.3	3.3	3.2	30.7	2.0	5.0	0.0	0.2	2.1	1.5	0.0	0.5	7.2	57.8	60.9	5.0	39.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.9	2.5	0.0	0.0	18.7	27.2	9.0	0.0	0.4	0.0	0.1	11.6	17.8	0.1	4.1	0.3	1.0	57.0	0.3	6.8	0.0	0.0	0.4	0.0	13.8	2.0	1.2	0.0	0.0	1.3	6.3	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	1.8	9.2	5.4	0.0	0.0	8.7	13.6	11.1	9.4	0.1	30.5	10.2	0.1	2.8	5.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	3.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.6	3.0	1.8	0.2	0.0	0.9	0.5	0.0	68.5	23.2	0.5	33.9	31.1	7.7	3.5	30.6	12.0	30.7	54.1	5.9	1.6	1.7	15.3	0.6	6.4	4.5	0.0	4.0	1.2	11.0	30.6	0.0	10.9	0.6	1.6	37.8	4.3	0.8	0.2	51.2	1.8	16.9	1.8	3.9	5.3	16.8	5.8	3.9	0.8	11.2	0.0	5.6	3.9	2.9	44.8	1.1	0.7	5.0	47.5
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 362.9;Late spermatids: 423.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		850000	Cytosol	"Plasma membrane"	"HPA029209: AB_2672951"	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	16.2	11.7	13.8	15.0	18.3	64.0	15.1	20.5	28.6	15.5	32.4	13.3	9.4	19.1	17.4	12.7	15.2	10.7	10.8	37.1	13.5	16.1	22.8	26.7	14.6	11.8	15.6	19.1	12.1	13.3	18.2	12.2	15.8	24.3	16.5	19.4	12.3	18.7	13.5	56.1	16.7	25.2	15.0	13.8	11.6	14.9	29.7	12.7	23.4	13.3	11.6	13.4	15.2	16.5	4.0	2.7	8.0	2.1	4.7	4.5	1.9	48.6	11.0	9.6	8.1	14.7	13.6	12.2	13.4	15.7	10.0	9.5	6.2	14.4	29.3	12.8	15.1	7.4	10.8	9.9	13.8	17.5	26.3	5.6	18.0	7.8	9.6	12.3	20.4	12.9	11.5	16.6	11.7	16.0	11.7	9.7	15.0	9.9	23.3	12.1	21.3	26.5	4.8	9.0	9.7	9.3	9.5	22.2	9.4	12.0	23.4	16.3	12.2	13.9	16.3	11.3	9.1	16.4	8.9	13.4	20.8	20.8	9.1	9.5	18.2	10.3	34.3	9.5	8.1	10.5	6.7	1.8	5.1	3.5	1.8	3.8	1.7	2.8	3.1	2.7	4.0	2.2	2.1	8.0	4.7	2.1	1.6	4.5	1.9	13.8	18.3	20.5	28.6	13.5	16.1	15.6	19.1	24.3	12.7	14.9	23.5	24.8	36.4	68.7	40.5	85.1	38.2	9.4	15.9	36.6	60.9	27.7	28.2	22.7	362.9	29.7	97.1	70.0	21.2	20.1	41.4	73.1	26.5	65.2	24.8	55.6	58.3	21.5	27.7	423.8	39.1	33.5	57.3	16.2	52.8	37.7	29.2	66.2	49.1	73.2	62.7	38.8	44.2	46.9	24.8	72.0	61.4	35.5	36.5	38.6
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016745	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	23.7	13.8	31.2	12.2	33.8	24.7	15.2	32.6	25.2	16.3	18.2	26.0	13.6	13.2	15.7	20.4	14.9	12.7	14.3	21.1	29.6	24.6	19.4	27.7	13.4	16.6	34.6	22.4	15.8	20.9	34.6	17.9	12.1	22.9	20.7	19.0	24.3	16.4	16.4	72.0	12.5	14.3	21.1	27.3	16.1	14.8	13.3	34.1	19.1	15.0	13.1	16.8	18.2	15.9	6.5	5.5	11.1	5.0	4.7	9.5	1.6	17.0	15.3	20.4	14.8	25.4	11.9	23.1	13.2	15.3	13.8	12.2	20.5	11.1	18.8	20.8	15.3	11.2	9.3	22.7	8.7	20.4	18.9	8.8	19.8	9.1	14.1	20.6	17.7	16.6	11.4	15.2	10.9	18.6	10.8	11.2	8.8	14.4	20.0	12.3	14.2	17.5	28.5	25.1	15.8	5.2	18.6	22.7	12.6	32.1	17.3	16.4	20.7	11.9	17.9	15.3	31.7	9.7	12.4	10.2	12.1	17.4	10.0	12.7	17.5	11.4	17.6	6.4	29.5	8.7	8.3	3.3	11.1	7.2	4.5	6.2	5.8	6.9	6.1	5.5	6.5	9.5	6.4	9.2	4.7	5.0	5.3	6.2	1.6	31.2	33.8	32.6	24.9	29.6	24.6	34.6	22.4	22.9	34.1	17.9	17.3	29.6	37.1	53.8	47.2	45.6	28.1	5.3	20.5	38.4	60.9	27.6	39.7	35.0	59.2	17.3	39.4	0.0	41.1	24.4	27.3	58.6	26.5	49.9	23.3	101.7	38.6	16.5	48.5	32.9	33.1	41.2	54.0	37.9	27.4	54.4	35.2	40.3	31.8	30.8	128.5	25.8	38.7	33.8	26.0	54.5	54.0	54.2	32.8	45.7
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755869-58985176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 10.7;brain: 36.5;testis: 13.1"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 16.0;Cone photoreceptor cells: 29.5;Early spermatids: 22.1;Horizontal cells: 73.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AF22: 10.2;HAP1: 16.5;MOLT-4: 7.8;SCLC-21H: 7.6;SH-SY5Y: 15.8;THP-1: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.7	10.7	15.0	0.8	7.5	0.7	0.7	11.9	23.3	1.0	0.7	3.6	0.0	0.8	1.1	2.2	0.7	3.3	0.8	2.3	36.5	5.4	1.9	2.4	1.0	0.9	3.2	9.2	1.0	1.7	0.8	3.4	0.6	10.5	3.2	0.7	3.5	0.8	0.7	0.6	0.7	1.0	1.3	2.7	0.8	1.4	13.1	2.0	0.0	0.8	0.0	1.0	0.6	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.5	0.0	0.0	0.8	0.0	0.0	0.8	1.2	0.0	0.0	6.5	0.1	0.1	2.3	0.0	16.5	0.0	0.4	0.1	4.9	0.0	0.1	0.0	1.2	0.5	2.1	0.3	1.3	0.1	0.0	0.5	0.0	4.1	1.6	0.0	0.0	2.9	7.8	0.0	2.9	0.0	0.8	0.0	1.3	0.0	0.0	0.0	7.6	15.8	0.2	0.0	1.0	0.1	0.0	7.0	0.0	0.0	1.9	0.0	2.4	0.0	0.1	4.4	0.3	0.0	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	7.5	11.9	14.0	36.5	5.4	3.2	9.2	10.5	2.0	0.0	0.0	0.0	0.0	0.0	16.0	1.6	0.0	0.0	3.4	0.0	29.5	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.1	73.1	2.9	0.0	0.3	14.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.4	0.0	11.7	0.0	0.0	9.3	2.5	0.0	0.0	0.0	0.0	0.0
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919420-21952837	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ito cells: 61.4;Kupffer cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 36.5;K-562: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		780000	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	25.0	15.6	14.0	21.8	14.3	24.3	18.4	16.9	16.3	18.1	13.2	7.6	12.5	9.6	17.6	9.7	23.6	12.3	13.1	17.0	13.9	14.9	13.2	8.5	21.6	15.1	11.6	10.1	14.4	10.7	8.3	7.7	28.1	14.5	15.6	4.9	11.2	11.2	16.5	15.8	15.5	11.1	15.4	15.5	31.4	10.5	6.7	10.9	6.2	10.9	15.1	10.2	15.8	37.6	0.7	5.5	17.7	13.9	1.7	1.4	2.8	9.2	9.9	6.4	6.2	3.5	6.3	8.1	10.6	6.3	9.4	6.5	4.5	3.7	5.6	13.3	7.4	4.0	11.2	2.8	6.6	3.3	8.0	9.0	21.7	4.6	4.3	5.9	8.0	5.9	5.9	2.0	9.1	4.3	6.7	36.5	5.6	55.2	2.4	12.0	8.6	4.7	6.2	2.7	2.9	10.9	7.1	16.5	1.6	3.2	3.9	2.6	10.0	10.0	3.3	8.6	2.6	4.1	5.6	30.7	11.3	11.5	10.3	10.1	4.7	3.7	6.2	11.4	15.3	21.6	0.0	7.7	3.3	1.0	12.9	0.7	0.7	0.7	0.6	5.5	0.6	0.7	0.8	17.7	1.7	13.9	1.4	1.4	2.8	14.0	14.3	16.9	16.3	13.9	14.9	11.6	10.1	14.5	10.9	6.0	5.9	5.1	4.4	7.2	7.0	13.1	15.3	4.0	3.4	1.8	2.0	13.3	3.3	4.9	1.1	31.9	2.0	0.0	4.3	7.2	7.7	3.9	3.5	5.5	17.5	7.9	5.8	61.4	32.9	1.1	6.6	18.0	6.8	8.2	3.9	3.8	5.6	0.0	6.3	3.4	6.5	6.5	5.7	7.4	10.5	5.0	2.5	5.7	3.8	5.4
PPM1J	"DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ"	ENSG00000155367	"Protein phosphatase, Mg2+/Mn2+ dependent 1J"	Q5JR12	1	112709994-112715477	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.9;skeletal muscle: 45.1;testis: 31.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 105.4;Late spermatids: 189.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 30.9"	"Lineage enriched"	"Detected in many"	17	"dendritic cells: 30.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 20.4"	"Region enriched"	"Detected in some"	8	"olfactory region: 33.6"	"Low region specificity"	"Detected in all"			HPA046045	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA046045: AB_2679516"	"unprognostic (8.68e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.96e-4)"	0.8	2.3	6.4	0.9	4.8	0.8	1.9	7.8	6.8	0.9	0.7	2.1	1.6	0.7	1.4	14.8	3.0	2.4	1.3	5.4	4.3	4.8	1.2	0.7	0.7	2.4	3.7	4.4	1.3	3.8	2.4	1.1	0.8	3.9	1.4	0.7	1.5	2.3	2.3	45.1	13.3	0.6	1.3	1.6	1.3	0.7	31.9	0.7	1.4	1.6	5.3	1.9	1.6	1.5	0.4	30.9	0.0	1.7	0.0	0.0	0.3	2.7	0.1	1.6	1.7	0.8	1.6	1.2	0.3	0.8	0.3	1.0	1.2	0.8	0.4	0.5	0.8	0.9	5.1	1.1	4.8	0.4	0.0	2.8	0.8	0.2	0.2	1.0	0.0	0.2	1.8	3.2	0.9	4.9	1.1	2.2	0.2	1.0	0.0	1.2	2.9	0.0	0.0	1.7	1.5	2.4	0.1	0.2	0.0	2.9	0.1	0.8	0.2	0.6	4.6	1.4	2.4	20.4	0.0	1.2	0.3	3.0	0.0	0.2	0.1	0.0	0.0	2.5	0.6	2.7	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	3.2	0.4	0.0	0.0	0.0	0.0	1.7	30.9	0.0	0.3	6.4	4.8	7.8	6.8	4.3	4.8	3.7	4.4	3.9	0.7	0.0	0.3	0.0	3.5	1.9	3.1	4.8	0.0	0.0	1.2	1.8	9.8	0.9	8.3	2.0	105.4	2.2	0.5	0.0	3.7	1.1	1.3	3.3	0.0	0.0	0.6	0.0	0.0	0.6	0.8	189.5	2.8	1.8	0.0	1.0	0.7	19.0	1.6	3.2	2.5	0.6	8.4	6.5	2.7	2.3	11.5	2.5	0.5	0.0	0.6	2.3
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078907	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 59.9;Cardiomyocytes: 33.6;Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 35.6;U-266/70: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	7.7	8.5	7.4	3.5	11.5	3.3	6.3	15.8	23.2	11.3	7.0	5.5	1.1	3.0	6.2	3.7	8.7	6.1	12.6	9.9	6.3	7.8	8.4	6.0	4.6	1.9	8.0	10.1	3.7	5.4	33.6	26.3	11.5	13.8	9.6	5.9	5.6	18.9	3.7	25.7	7.6	3.6	16.4	4.6	3.4	8.4	2.8	3.7	5.6	14.4	9.6	3.5	16.6	10.8	0.7	1.3	4.9	7.6	1.1	2.6	2.0	1.2	0.8	4.1	2.1	2.4	0.0	2.5	0.2	0.1	0.4	0.1	0.2	0.2	0.2	0.4	0.1	0.9	3.7	3.4	0.2	0.1	35.6	3.6	3.5	3.3	0.4	0.1	2.1	4.1	0.4	1.6	0.1	0.2	0.3	0.2	1.7	0.1	5.6	0.0	1.9	0.8	0.2	2.3	6.5	0.8	4.2	0.7	0.8	0.1	3.8	4.9	4.2	2.0	2.4	0.1	1.4	2.7	2.1	0.2	0.4	0.4	0.3	1.3	35.6	0.1	2.0	0.6	1.8	0.8	0.7	2.3	4.9	2.6	5.5	0.2	0.2	0.6	1.7	1.3	0.7	1.0	1.8	0.2	1.1	7.6	0.8	0.0	2.0	7.4	11.5	15.8	17.9	6.3	7.8	8.0	10.1	13.8	3.7	6.0	2.4	0.0	5.2	7.7	59.9	33.6	10.2	13.4	5.7	1.8	33.4	2.4	0.0	1.5	1.1	2.4	3.8	0.0	3.7	1.6	7.0	6.0	0.0	14.9	5.9	6.4	13.3	0.6	12.4	0.4	4.6	7.2	3.3	2.8	7.6	9.3	1.7	7.0	4.9	3.3	10.1	0.0	11.2	1.5	3.1	7.5	2.2	2.9	4.9	18.0
PPM1M	"FLJ32332, PP2Ceta"	ENSG00000164088	"Protein phosphatase, Mg2+/Mn2+ dependent 1M"	Q96MI6	3	52245793-52250597	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 38.2;Kupffer cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 26.2"									"HPA036905, HPA062291"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA036905: AB_10602818, HPA062291: AB_2684740"	"unprognostic (4.26e-3)"	"prognostic favorable (7.73e-4)"	"unprognostic (2.55e-2)"	"unprognostic (4.85e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"prognostic favorable (6.69e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.37e-2)"	14.3	7.2	13.9	22.7	14.8	16.5	26.3	3.6	9.2	16.9	12.5	4.6	7.8	4.4	13.6	12.0	10.8	11.7	19.4	14.5	8.7	8.5	8.7	4.9	30.1	38.0	5.4	12.3	14.9	5.9	6.9	7.5	8.6	4.9	15.1	6.7	11.0	10.8	12.4	3.1	7.5	8.8	18.1	6.8	22.5	8.3	6.2	5.9	20.5	11.3	9.9	20.5	11.3	13.5	5.0	9.6	19.6	18.6	7.4	15.0	10.1	0.4	2.5	1.5	3.7	22.8	22.8	2.4	5.8	12.5	8.2	6.4	1.4	2.0	4.2	1.7	15.1	4.6	0.7	5.1	1.1	3.3	5.0	1.2	9.6	6.7	1.5	16.7	1.4	9.1	18.8	2.5	9.2	5.8	13.3	10.6	19.5	1.6	7.0	9.6	1.0	6.2	0.4	2.0	1.9	7.0	1.4	0.7	9.2	3.5	1.1	1.1	4.5	4.2	1.0	5.2	3.4	3.6	3.7	7.3	3.1	5.3	1.8	0.7	26.2	4.8	4.5	6.2	2.5	3.8	1.2	15.7	8.5	15.0	12.4	11.7	5.0	11.8	13.8	9.6	3.8	11.1	13.8	19.6	7.4	18.6	5.8	13.2	10.1	13.9	14.8	3.6	9.2	8.7	8.5	5.4	12.3	4.9	5.9	0.0	4.8	11.5	3.9	4.5	1.0	2.0	5.1	1.4	3.4	1.8	0.0	3.0	3.3	1.7	9.9	6.9	0.7	0.0	1.0	5.3	8.2	2.7	5.7	2.4	38.2	1.6	1.2	10.4	40.0	14.2	11.8	24.5	5.0	10.0	0.2	5.1	1.6	1.9	9.2	2.2	0.4	19.4	6.1	0.4	3.6	3.3	1.6	22.0	0.7	1.8
PPME1	PME-1	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171099-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 69.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		16000	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254"	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	9.4	16.1	13.3	6.2	27.6	8.4	9.3	27.4	38.5	11.4	9.2	13.5	9.4	7.1	13.1	16.5	13.5	15.2	8.9	12.8	14.6	18.3	12.3	6.5	8.2	5.5	13.6	18.6	12.4	10.4	69.0	13.6	15.5	22.4	15.1	9.8	9.6	11.9	15.9	21.0	16.2	7.4	13.4	12.7	5.0	8.3	22.9	9.3	8.6	14.9	7.9	8.5	11.4	10.2	7.5	11.3	10.9	9.6	12.2	14.0	8.4	10.1	13.3	9.1	9.6	9.6	7.9	9.0	15.0	9.9	28.4	22.5	29.3	6.8	5.4	10.5	11.1	15.8	17.0	13.5	10.2	26.7	7.6	5.2	8.1	14.5	12.5	19.0	5.9	7.2	7.6	8.4	15.0	6.6	11.1	8.2	7.8	18.8	4.6	49.5	6.7	6.9	6.3	7.2	12.5	10.6	8.2	92.7	8.2	10.7	7.1	12.4	10.7	17.9	8.2	21.0	9.9	15.0	6.1	5.0	11.4	13.6	10.9	11.4	8.7	11.0	9.6	8.4	5.3	9.2	1.3	8.6	10.9	10.8	9.6	13.3	6.9	13.8	12.7	10.8	7.5	14.0	11.2	5.0	12.2	8.5	11.3	9.7	8.4	13.3	27.6	27.4	38.5	14.6	18.3	13.6	18.6	22.4	9.3	26.8	10.9	9.0	17.3	18.0	29.2	15.3	7.6	36.1	30.7	33.2	35.3	10.9	14.9	14.1	36.8	11.4	10.9	70.0	11.8	27.4	13.1	16.6	8.1	7.4	11.8	31.8	24.6	8.0	5.7	10.9	12.7	13.2	3.3	13.6	11.9	15.0	12.8	10.8	23.7	10.1	18.2	6.5	17.0	60.5	41.0	21.8	12.9	10.4	10.7	15.4
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166410-161178013	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030123	Uncertain		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"HPA030123: AB_10603987"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	7.3	14.8	11.6	9.1	12.1	31.7	10.2	23.5	16.5	11.0	9.9	13.2	8.5	6.0	11.7	13.5	7.5	33.2	9.5	9.5	11.5	12.5	12.0	9.1	10.2	11.2	14.2	16.1	13.0	13.1	10.5	12.3	10.1	12.1	11.0	6.7	14.4	11.3	14.6	8.5	15.9	7.1	10.0	10.6	12.0	8.2	6.9	13.7	9.2	11.0	6.1	8.7	8.7	8.2	9.8	11.5	6.9	7.7	12.3	16.7	8.9	7.1	6.6	9.9	6.4	7.5	8.0	3.3	4.9	5.7	6.1	8.1	7.7	6.9	5.6	11.9	3.4	3.1	4.9	7.6	7.9	5.5	3.9	15.0	6.7	14.8	17.6	8.0	2.2	3.7	6.4	8.0	5.9	8.4	9.2	11.5	5.2	19.9	8.7	4.4	6.7	8.9	7.1	7.1	9.0	14.1	10.9	6.8	13.2	11.6	3.1	7.8	12.7	6.0	8.7	9.9	12.5	15.8	10.5	4.0	5.6	6.2	4.9	6.3	15.5	11.3	8.6	5.7	4.9	4.3	6.9	7.7	5.5	12.7	7.7	8.4	9.8	9.8	8.8	11.5	8.6	8.6	8.8	1.6	12.3	5.3	7.2	16.7	8.9	11.6	12.1	23.5	16.5	11.5	12.5	14.2	16.1	12.1	13.7	3.0	13.6	4.5	7.2	10.6	16.2	7.7	7.6	62.9	13.6	7.0	21.6	17.7	18.3	8.8	8.4	9.1	4.9	0.0	4.9	8.3	10.3	3.6	5.8	5.8	8.0	14.3	5.8	8.0	4.3	10.0	9.5	7.9	1.7	10.0	6.5	9.6	6.4	3.6	6.3	14.8	17.3	6.5	6.7	9.6	6.1	13.0	8.7	13.1	7.6	4.7
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398183-67421183	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 177.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8100000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	28.4	35.4	24.2	42.0	32.3	42.1	25.1	19.6	33.4	23.9	39.6	22.1	29.9	33.9	19.6	25.8	59.7	22.8	28.6	33.0	21.8	17.1	43.7	55.0	27.6	49.3	19.9	19.9	20.1	53.3	23.1	21.6	44.0	19.3	27.2	33.2	23.2	49.7	31.1	39.0	34.4	47.3	20.5	21.3	53.7	35.1	15.7	19.4	77.7	38.5	40.5	63.9	25.5	25.7	78.8	76.6	126.2	118.0	68.2	113.9	177.2	45.3	52.4	31.1	45.8	15.5	19.0	31.7	22.5	26.4	45.4	34.5	74.9	54.8	39.1	38.4	34.1	33.8	39.8	35.9	46.8	27.9	41.1	24.4	37.5	24.7	39.2	33.9	47.6	48.5	21.4	31.0	38.6	22.8	21.6	45.5	38.3	34.8	32.4	36.7	103.5	60.3	93.6	51.6	86.5	41.5	42.9	43.0	33.8	44.6	37.6	24.3	40.4	26.1	46.9	69.4	24.3	56.1	33.0	32.4	35.1	35.9	41.3	29.1	32.5	30.1	44.4	42.0	32.7	36.9	81.4	80.1	126.2	88.6	100.5	69.3	78.8	79.8	90.5	76.6	77.0	49.1	69.2	93.3	68.2	118.0	54.4	113.9	177.2	24.2	32.3	19.6	33.4	21.8	17.1	19.9	19.9	19.3	19.4	71.5	93.0	166.0	108.0	88.8	35.0	7.9	117.2	41.5	46.6	82.0	9.8	320.7	180.8	238.7	1.8	77.3	292.4	23.3	272.4	398.0	69.2	127.9	107.3	102.4	338.5	41.3	93.0	87.2	194.1	5.3	45.5	157.2	129.9	390.5	160.1	42.9	250.4	210.5	26.9	236.5	23.6	97.0	60.9	13.0	106.5	106.3	357.3	222.6	164.6	168.4
PPP1R11	"CFAP255, HCG-V, HCGV, TCTE5, Tctex5"	ENSG00000204619	"Protein phosphatase 1 regulatory inhibitor subunit 11"	O60927	6	30066709-30070333	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 93.3"	"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 578.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 18.8;AN3-CA: 25.1;HBEC3-KT: 15.7;HEL: 15.1;JURKAT: 29.4;RPTEC TERT1: 17.5;U-266/84: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043266, HPA060174"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA043266: AB_2678400, HPA060174: AB_2684216"	"unprognostic (2.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-3)"	36.0	18.2	18.5	8.3	21.6	4.4	12.9	9.8	31.7	11.0	27.0	17.3	7.9	33.2	16.0	93.3	26.8	33.7	23.9	16.8	16.6	17.6	18.2	22.6	12.9	13.2	15.5	14.5	26.2	33.1	5.9	8.8	21.1	14.6	13.6	4.6	14.0	20.4	8.8	39.0	37.0	28.6	9.4	13.4	16.0	27.2	18.1	11.4	16.9	20.6	10.9	29.6	15.8	12.4	2.6	2.7	4.4	3.5	0.8	3.2	1.8	18.8	0.0	0.0	25.1	11.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	12.1	0.0	0.0	15.7	0.0	0.0	12.9	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.5	8.2	0.0	0.0	0.0	8.5	0.2	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	16.7	7.3	0.0	0.0	0.0	2.9	2.6	4.4	1.7	3.5	2.0	2.1	1.9	3.1	1.3	2.6	2.7	2.1	2.9	0.8	2.9	2.7	3.2	1.8	18.5	21.6	9.8	31.7	16.6	17.6	15.5	14.5	14.6	11.4	17.9	19.8	58.2	65.2	46.9	29.4	15.0	43.3	24.1	19.4	38.4	5.9	51.3	81.2	116.6	185.3	36.0	115.4	0.0	120.0	106.5	33.8	60.5	77.3	26.0	59.8	12.7	51.5	36.8	38.6	578.9	30.0	49.9	59.1	73.1	76.9	44.8	105.0	77.2	37.8	70.2	30.1	38.8	48.4	51.5	22.6	58.2	62.9	66.0	52.1	78.8
PPP1R12B	"MGC131980, MGC87886, MYPT2, PP1bp55"	ENSG00000077157	"Protein phosphatase 1 regulatory subunit 12B"	O60237	1	202348699-202592706	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 105.2"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 719.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 15.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 15.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024171, HPA024640"	Enhanced		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA024171: AB_1854266, HPA024640: AB_1854265"	"unprognostic (5.24e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.60e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	10.6	2.8	6.9	8.1	9.0	1.8	7.7	13.9	10.5	55.3	62.0	15.0	31.0	5.8	105.2	9.4	37.4	21.9	17.4	83.1	5.8	4.5	5.0	2.9	8.1	4.2	10.1	9.2	18.7	2.3	2.0	4.5	8.4	9.5	36.4	16.3	13.7	5.7	50.3	17.6	5.3	14.1	59.5	7.3	6.9	20.8	3.4	11.1	1.3	5.0	11.2	3.5	35.1	11.4	2.3	1.7	15.9	1.8	0.7	1.7	0.5	2.6	5.3	4.1	3.9	5.8	4.2	6.7	2.1	2.1	2.2	2.1	2.2	4.7	3.0	1.0	3.9	5.3	8.4	6.0	3.2	2.4	3.8	3.7	3.0	7.7	1.4	1.4	6.3	3.4	3.3	3.7	3.1	3.3	11.3	1.8	3.4	4.4	3.5	3.8	2.0	4.7	4.0	2.8	2.9	1.1	3.1	10.5	4.3	1.8	9.6	5.0	3.8	4.0	4.8	2.4	5.6	4.2	2.9	2.3	3.1	1.9	2.3	1.8	5.2	4.8	3.2	2.9	5.2	12.3	1.8	1.8	1.3	1.7	0.9	1.4	1.7	1.1	1.0	1.4	2.3	1.4	1.0	15.9	0.7	1.4	1.7	1.6	0.5	6.9	9.0	13.9	10.5	5.8	4.5	10.1	9.2	9.5	11.1	11.9	17.5	3.7	31.2	15.3	56.6	719.4	12.7	16.0	18.2	12.2	70.7	12.7	10.0	7.2	30.9	9.2	21.3	0.0	11.3	7.2	19.0	16.4	17.4	6.8	7.8	25.4	23.1	20.9	18.5	10.9	11.2	6.0	8.5	1.8	14.0	11.8	6.3	11.5	48.1	4.5	32.3	32.3	105.4	11.9	13.7	9.5	21.3	11.5	30.2	28.9
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256591	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Leydig cells: 315.8;Peritubular cells: 616.7;Sertoli cells: 963.6;Smooth muscle cells: 478.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 46.4;naive B-cell: 42.7;plasmacytoid DC: 39.3"	"Group enriched"	"Detected in many"	29	"B-cells: 46.4;dendritic cells: 39.3"	"Group enriched"	"Detected in some"	4	"A549: 40.6;EFO-21: 35.0;K-562: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518"	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.25e-5)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	45.4	34.9	22.5	15.1	28.7	2.6	20.1	4.4	37.9	21.1	56.1	60.9	16.6	13.9	39.6	10.8	32.6	20.1	31.7	13.0	34.4	19.0	8.9	4.0	21.1	2.8	43.6	19.2	22.7	17.1	1.7	1.6	24.2	28.4	29.7	10.0	4.4	10.4	70.3	13.9	3.5	16.5	79.9	76.0	31.1	22.9	18.7	38.2	0.0	3.3	3.4	2.1	51.6	15.6	46.4	39.3	1.1	0.1	1.4	0.1	3.7	0.0	40.6	0.1	0.0	0.2	0.0	1.7	3.8	0.0	0.0	0.0	3.2	0.0	0.0	35.0	0.2	0.0	0.1	3.5	0.0	0.0	0.5	0.0	7.2	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	16.9	0.1	0.0	0.3	0.0	0.1	1.3	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	2.7	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.1	0.0	46.4	0.0	0.0	6.8	42.7	0.1	0.0	0.3	1.4	0.0	39.3	0.0	3.7	22.5	28.7	4.4	29.7	34.4	19.0	43.6	19.2	28.4	38.2	0.0	1.4	18.2	2.3	8.5	0.3	8.4	0.0	0.0	1.2	0.0	0.0	37.8	0.0	0.4	11.0	30.1	2.0	0.0	9.7	3.1	66.4	2.1	3.5	1.6	8.4	0.0	1.7	207.5	6.3	20.1	315.8	19.1	8.5	111.0	0.1	0.5	2.8	1.1	616.7	0.3	0.9	963.6	478.5	9.1	53.5	6.9	22.1	1.9	0.1	0.7
PPP1R15B	FLJ14744	ENSG00000158615	"Protein phosphatase 1 regulatory subunit 15B"	Q5SWA1	1	204403387-204411791	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"		"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061088			Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA061088: AB_2684426"	"unprognostic (2.91e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (9.52e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.50e-2)"	31.3	15.9	10.1	21.6	14.7	66.4	34.0	17.3	12.9	13.4	16.8	14.2	14.8	13.5	15.7	9.3	19.2	23.0	19.1	13.1	11.8	8.9	14.5	29.1	22.5	18.4	18.7	10.6	18.3	24.3	12.4	12.7	47.7	12.3	14.5	15.1	10.1	39.5	20.7	12.9	16.2	18.6	18.2	15.6	18.7	21.1	9.5	15.3	25.3	17.8	15.9	16.2	18.5	24.2	2.7	5.7	13.9	6.6	3.5	6.2	3.2	12.0	9.6	11.6	9.7	15.0	10.3	46.9	9.9	12.0	13.8	12.5	11.5	17.0	19.9	6.9	12.1	9.6	15.4	17.0	10.1	12.9	15.3	12.2	11.8	23.7	7.4	18.3	20.0	21.2	12.9	13.1	13.5	15.0	9.9	14.9	17.1	18.0	39.7	9.3	11.9	19.0	12.6	19.8	11.1	14.0	13.7	21.0	20.4	13.8	14.8	11.1	17.0	17.9	25.6	20.4	16.3	16.8	20.8	8.3	9.6	13.7	12.3	16.7	27.0	11.9	19.8	8.7	13.8	9.9	10.6	6.2	6.4	4.1	5.8	4.3	2.6	4.0	3.7	5.7	2.7	6.2	4.2	13.9	3.5	6.6	2.4	5.1	3.2	10.1	14.7	17.3	12.9	11.8	8.9	18.7	10.6	12.3	15.3	44.7	35.2	29.4	38.3	65.5	18.3	13.8	25.5	16.0	22.7	17.4	19.6	16.4	3.3	14.5	2.6	31.5	55.1	46.7	20.6	35.7	53.1	38.1	47.4	39.4	29.2	7.9	42.8	25.8	33.5	3.4	12.0	54.4	47.2	37.9	27.4	17.3	27.0	31.6	12.0	12.3	16.9	6.5	54.5	14.4	13.2	56.1	41.2	24.9	19.0	78.0
PPP1R16A	"MGC14333, MYPT3"	ENSG00000160972	"Protein phosphatase 1 regulatory subunit 16A"	Q96I34	8	144477969-144502121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 23.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 167.9;Proximal tubular cells: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 26.1"	"Low region specificity"	"Detected in all"							HPA023755	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA023755: AB_1854268"	"unprognostic (9.63e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.45e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.79e-2)"	3.0	3.8	6.5	3.1	6.8	2.2	3.0	3.3	4.8	3.0	11.1	3.0	3.0	20.5	3.0	3.0	3.0	6.7	3.0	3.0	6.5	4.6	6.5	5.3	3.0	3.0	3.1	3.0	3.0	5.7	4.0	10.2	3.0	3.0	3.4	1.6	3.0	5.4	4.5	3.4	3.7	23.3	3.0	3.0	3.0	7.8	7.4	3.0	3.0	6.8	3.0	3.0	3.0	3.0	2.5	3.2	0.7	4.1	0.7	3.2	2.1	15.8	12.9	2.1	8.2	0.9	1.5	10.6	4.4	2.8	3.4	2.8	3.4	11.4	2.6	11.6	1.6	3.1	10.5	1.1	3.6	0.5	5.3	6.4	3.1	12.5	3.5	2.6	2.2	4.3	1.5	4.9	4.0	1.1	2.2	2.4	4.4	12.3	3.3	1.2	26.1	7.9	10.4	4.0	8.2	16.4	8.3	1.0	5.2	3.1	5.3	6.8	13.1	8.0	7.4	6.6	0.5	17.5	4.8	4.1	3.9	18.4	10.8	8.3	2.2	2.1	0.9	12.6	4.3	3.5	0.0	2.3	0.0	3.2	3.4	2.8	2.5	2.3	2.9	3.2	0.5	1.7	3.1	0.7	0.7	4.1	1.8	1.7	2.1	6.5	6.8	3.3	4.8	6.5	4.6	3.1	3.0	3.0	3.0	3.0	12.5	7.3	31.2	38.4	23.1	75.5	101.9	32.1	17.0	38.4	13.7	6.0	102.8	26.8	8.2	10.5	167.9	0.0	36.4	19.6	9.1	37.1	3.5	156.2	5.4	28.6	49.5	10.4	7.6	9.5	21.0	12.3	8.5	2.8	69.6	87.7	27.8	95.1	14.5	269.6	48.8	6.5	13.3	58.4	27.0	54.1	5.6	6.2	83.9	21.8
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.5"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 175.4;monocytes: 233.6;T-cells: 186.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"eosinophil: 54.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 35.0;U-937: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	17.2	7.1	5.6	24.7	7.9	34.0	16.1	1.7	4.7	12.6	15.9	6.2	4.6	5.3	17.5	7.3	11.5	10.9	13.9	10.1	6.5	3.4	6.1	8.3	20.2	44.9	7.2	1.8	14.9	4.0	2.3	2.9	13.3	6.0	11.2	3.7	7.3	7.9	6.1	6.6	9.5	11.3	13.9	9.8	37.4	9.1	4.9	6.2	48.2	7.8	7.8	23.6	18.2	18.0	4.2	3.4	54.5	4.1	10.2	11.9	5.2	10.0	1.6	6.0	7.2	4.3	11.6	0.2	6.0	7.0	5.3	3.6	1.2	2.0	9.8	5.5	10.5	12.0	6.7	3.0	6.6	2.8	8.2	0.6	23.6	2.9	1.2	3.4	6.1	35.0	7.1	7.7	13.1	11.8	6.3	4.3	16.6	4.3	4.9	6.2	1.1	8.7	12.1	0.0	0.3	0.4	27.8	5.3	8.0	3.1	0.6	0.4	2.0	5.6	2.2	11.1	0.3	1.6	8.4	14.2	21.0	5.3	0.0	14.9	1.8	9.6	12.1	6.0	36.4	24.5	8.1	2.8	54.5	11.7	4.1	8.5	3.1	5.7	11.9	1.8	4.2	4.7	9.0	13.2	10.2	3.0	3.4	9.4	5.2	5.6	7.9	1.7	4.7	6.5	3.4	7.2	1.8	6.0	6.2	3.0	20.7	66.3	25.5	96.9	1.3	2.8	10.2	6.7	4.5	8.7	0.0	2.5	0.0	20.1	23.9	64.4	0.4	0.0	7.1	17.8	32.0	15.2	51.9	7.8	175.4	3.2	1.7	30.7	131.5	14.6	25.6	119.9	37.1	233.6	0.5	0.9	18.0	0.0	21.9	1.3	2.9	25.8	79.5	0.5	1.4	52.1	3.3	186.8	0.4	22.5
PPP1R1C	Inhibitor-1-like	ENSG00000150722	"Protein phosphatase 1 regulatory inhibitor subunit 1C"	Q8WVI7	2	181954241-182131398	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.5;heart muscle: 27.8"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 106.6;Late spermatids: 139.1;Spermatocytes: 41.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;HAP1: 1.2;JURKAT: 1.1;MOLT-4: 2.1;SiHa: 1.3;SuSa: 1.2;U-266/70: 1.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA055043			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA055043: AB_2797251"	"unprognostic (1.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (9.75e-3)"	0.2	0.1	0.7	0.1	3.5	0.1	0.2	3.5	1.8	0.1	0.2	3.0	0.0	0.2	0.2	0.1	0.3	0.2	0.5	27.8	1.5	1.1	0.2	1.2	0.3	0.2	0.8	0.6	0.1	0.6	0.1	0.4	0.2	7.5	1.4	0.2	0.5	0.5	0.2	4.3	0.2	0.7	0.1	2.5	0.2	0.4	0.6	1.3	0.0	0.2	3.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.4	2.1	0.0	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.3	0.2	0.3	1.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.2	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.5	3.5	1.8	1.5	1.1	0.8	0.6	7.5	1.3	11.9	5.4	0.0	0.5	0.2	0.8	34.2	10.2	1.4	11.4	3.5	0.0	2.7	1.7	2.3	106.6	0.0	0.0	0.0	9.8	5.6	0.7	0.1	0.0	17.9	0.5	0.0	5.8	0.0	0.3	139.1	5.5	0.0	3.3	6.4	0.3	6.0	14.6	0.0	0.7	0.5	1.9	0.0	0.5	41.8	2.0	0.3	2.1	0.0	0.7	0.9
PPP1R2	"IPP2, PPP1R2A"	ENSG00000184203	"Protein phosphatase 1 regulatory inhibitor subunit 2"	P41236	3	195514425-195543386	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 363.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 67.5"									"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.13e-1)"	16.4	12.7	19.9	17.7	26.0	45.2	18.3	16.2	22.9	16.1	21.2	11.4	17.4	19.5	18.9	20.7	25.6	15.3	15.8	23.3	18.6	21.7	16.7	13.0	21.7	30.4	16.5	15.4	17.1	12.0	9.5	17.6	16.1	21.2	17.0	16.0	13.7	15.0	19.0	57.1	14.1	22.6	17.7	15.4	24.2	13.9	21.8	7.0	38.1	19.1	25.2	23.5	26.5	15.5	26.0	26.6	63.2	16.9	22.8	50.2	30.1	11.6	2.5	4.3	4.9	7.3	7.8	7.9	7.3	10.6	7.8	6.7	39.5	5.3	4.6	29.2	8.9	8.4	5.2	4.5	7.4	9.6	9.1	8.5	5.3	4.2	13.2	11.3	5.5	5.5	9.5	5.7	5.8	11.8	6.2	6.7	4.9	4.0	9.9	6.8	8.1	9.8	6.2	4.5	14.0	11.8	4.6	7.5	13.7	9.3	8.9	10.2	5.6	8.8	9.7	13.1	8.3	15.3	5.6	7.4	5.0	5.8	8.2	9.9	67.5	29.3	22.1	7.0	10.1	9.7	26.3	16.7	63.2	19.6	16.9	26.9	26.0	41.2	27.0	17.6	23.6	50.2	34.0	39.4	22.8	16.4	26.6	41.7	30.1	19.9	26.0	16.2	22.9	18.6	21.7	16.5	15.4	21.2	7.0	20.8	39.2	125.0	121.2	83.7	47.5	46.2	25.5	66.9	38.7	21.0	55.0	57.7	106.1	61.4	363.0	65.1	53.1	46.7	57.9	34.5	51.3	104.3	109.6	24.6	55.6	49.3	55.0	39.3	59.0	190.1	47.8	82.0	92.8	141.5	44.1	50.2	58.5	55.2	59.8	82.6	79.3	25.8	64.1	239.4	84.1	67.9	86.3	140.6	44.9	143.1
PPP1R21	"CCDC128, FLJ16566, KLRAQ1"	ENSG00000162869	"Protein phosphatase 1 regulatory subunit 21"	Q6ZMI0	2	48440598-48515391	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036791, HPA036792"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036791: AB_10671713, HPA036792: AB_2675317"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (4.59e-6)"	"unprognostic (9.23e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (6.60e-2)"	9.0	10.4	16.4	8.9	18.7	8.1	7.9	16.2	21.6	8.3	8.8	15.0	7.9	7.0	15.8	18.8	11.2	13.5	9.8	8.9	13.2	12.2	25.6	10.4	10.0	10.9	17.7	13.6	12.7	7.3	35.5	11.9	11.3	14.4	10.8	9.8	8.4	6.8	10.2	6.4	9.5	9.0	11.9	12.0	11.0	9.4	8.4	15.9	10.4	19.5	2.4	10.8	12.7	8.8	7.7	5.6	14.1	6.0	3.8	7.9	2.3	13.8	6.7	5.8	7.1	14.5	10.8	15.2	8.2	9.3	5.0	6.1	3.7	8.7	9.4	13.6	11.5	9.8	7.7	4.8	7.4	10.6	12.0	4.1	10.1	5.7	8.9	10.1	4.5	8.1	13.5	6.8	9.1	11.2	12.8	12.7	4.8	4.0	15.8	13.7	7.6	8.6	7.3	14.6	9.9	7.1	7.2	15.5	10.2	10.6	9.2	7.7	4.8	15.2	4.0	14.7	15.9	7.2	7.3	11.3	5.4	6.7	4.8	6.5	11.8	3.3	8.6	8.6	10.1	7.1	14.1	5.4	8.5	4.4	6.0	3.5	5.9	5.2	5.1	5.6	7.7	7.9	6.4	13.0	3.8	5.1	3.5	5.0	2.3	16.4	18.7	16.2	21.6	13.2	12.2	17.7	13.6	14.4	15.9	20.8	13.9	9.9	27.6	9.3	8.6	9.2	7.6	26.8	9.1	24.4	2.0	18.6	5.0	9.1	1.9	11.3	9.5	0.0	7.4	13.6	10.8	14.2	11.5	12.3	28.7	27.0	18.0	12.9	18.0	4.0	11.2	16.4	11.8	19.0	9.6	20.1	9.9	8.6	19.4	45.5	6.2	12.9	17.6	9.1	12.1	12.3	22.7	10.9	8.0	22.7
PPP1R27	"DYSFIP1, toonin"	ENSG00000182676	"Protein phosphatase 1 regulatory subunit 27"	Q86WC6	17	81833492-81835050	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"skeletal muscle: 211.0"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 22.1"	"Cancer enriched"	"Detected in single"	10	"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	23	"HL-60: 63.9;THP-1: 123.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042227, HPA048632"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042227: , HPA048632: AB_2680469"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.98e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.30e-1)"	1.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.7	0.0	0.0	1.7	0.0	211.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	9.6	1.2	0.0	0.0	0.8	0.4	3.2	0.4	0.7	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	123.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.4	0.3	0.3	0.2	0.3	0.4	0.2	0.2	0.3	0.8	0.3	0.4	3.2	0.7	0.3	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	22.1	0.0	2.0	0.0	0.4	2.1	0.2	0.1	0.0	1.0	0.5	0.0	1.2	0.0	0.0	0.5	0.9	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.7	0.7	0.1	1.1	0.0	0.9	0.1
PPP1R2B	"MGC87149, PPP1R2P3"	ENSG00000231989	"PPP1R2 family member B"		5	156850538-156852528	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	33	"testis: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	13	"U-266/84: 5.3"									"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.2	0.3		0.3	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	36.0	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.5	0.4	0.9	0.5	0.5	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.3	0.0	0.1	0.0	0.1	0.5	0.1	0.9	0.2	0.5	0.5	0.5	0.6	0.5	0.4	0.2	1.1	0.5	0.6	0.5	0.2	0.1	0.7	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R35	"C7orf47, MGC22793"	ENSG00000160813	"Protein phosphatase 1 regulatory subunit 35"	Q8TAP8	7	100435282-100436565	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021604, HPA051607"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021604: AB_2670774, HPA051607: AB_2681548"	"unprognostic (2.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.77e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.97e-4)"	5.3	12.0	4.4	12.5	5.6	8.8	5.9	9.7	8.7	9.9	9.6	3.6	7.2	12.8	7.1	6.1	7.4	6.3	7.2	5.4	4.2	4.1	7.4	11.1	5.6	14.4	3.9	7.1	10.6	12.4	7.4	7.9	7.9	4.8	7.7	2.8	7.4	10.6	6.8	7.0	7.7	11.2	6.8	3.6	20.8	8.8	32.2	2.6	20.3	8.6	4.5	10.7	7.6	6.1	4.6	6.8	12.1	2.0	2.7	6.8	2.5	16.0	6.9	4.9	8.6	1.6	1.6	6.3	4.4	4.8	3.7	4.3	2.6	16.5	5.2	7.9	2.6	18.8	5.2	2.5	4.3	0.7	11.4	6.4	5.2	4.9	6.2	6.8	4.5	6.9	3.1	7.7	3.3	5.0	6.0	7.6	18.4	7.4	10.7	4.7	15.3	13.3	21.9	9.6	7.4	9.3	3.6	1.8	15.7	4.8	4.4	4.6	11.5	4.0	28.0	12.7	3.0	8.4	12.9	5.9	5.5	6.5	6.3	11.2	12.4	6.9	6.9	6.1	7.9	11.0	12.1	2.0	4.5	5.2	0.8	5.6	3.5	5.3	6.0	1.7	4.6	3.1	3.0	9.3	2.7	0.5	6.8	6.8	2.5	4.4	5.6	9.7	8.7	4.2	4.1	3.9	7.1	4.8	2.6	14.9	8.1	24.8	32.5	18.7	33.7	1.6	20.4	10.7	2.3	45.4	7.9	56.3	44.7	6.8	7.0	20.0	21.1	0.0	8.7	34.2	11.4	31.9	8.1	13.9	14.4	46.1	17.9	8.0	6.5	4.7	16.7	17.8	16.9	13.6	25.2	25.5	9.8	26.8	8.9	33.9	36.2	12.9	13.3	129.2	24.3	29.2	28.4	28.7	24.7	37.5
PPP1R37	LRRC68	ENSG00000104866	"Protein phosphatase 1 regulatory subunit 37"	O75864	19	45091396-45148077	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"memory B-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"RT4: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041500	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041500: AB_10795122"	"unprognostic (8.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.89e-3)"	"unprognostic (7.72e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.71e-2)"	"prognostic favorable (2.04e-4)"	12.7	19.2	17.3	9.8	17.5	8.1	12.6	27.9	27.2	12.8	13.3	10.4	23.0	20.7	11.6	11.2	13.3	10.1	18.8	11.7	15.9	11.4	13.8	9.3	11.0	8.6	12.9	19.1	10.4	18.2	11.5	28.3	11.1	11.4	13.7	7.0	13.9	25.5	17.0	25.2	19.2	19.2	8.4	10.2	13.1	27.4	16.6	11.2	10.7	14.7	10.3	8.8	18.3	14.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.2	5.0	7.2	6.3	4.3	9.7	9.8	5.7	6.9	7.9	5.9	7.5	3.7	7.1	5.2	6.4	10.7	3.3	7.6	2.0	4.7	8.5	3.2	6.4	7.0	7.9	2.9	5.3	5.5	5.9	6.5	4.2	7.4	5.5	5.0	5.3	2.9	3.7	17.0	6.9	4.5	4.8	9.7	8.0	8.4	5.7	2.6	4.4	35.5	15.3	7.0	8.4	17.7	14.8	2.7	11.3	4.8	8.7	8.2	9.8	4.8	8.6	5.0	3.1	2.7	10.7	3.3	7.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	17.5	27.9	27.2	15.9	11.4	12.9	19.1	11.4	11.2	6.0	4.3	4.7	9.9	6.8	45.1	5.1	15.3	4.0	2.3	3.5	37.3	18.4	6.6	15.9	5.0	6.7	20.3	0.0	8.7	16.3	8.2	8.3	0.0	6.2	15.6	73.1	29.4	9.8	6.5	5.7	11.2	3.0	11.8	4.6	22.2	20.6	10.2	18.1	11.7	14.1	44.4	19.4	8.5	13.4	22.0	8.3	15.3	6.5	22.6	9.7
PPP1R3B	"FLJ14005, GL, PPP1R4"	ENSG00000173281	"Protein phosphatase 1 regulatory subunit 3B"	Q86XI6	8	9136255-9151574	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 66.2;Hepatocytes: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"basophil: 18.0;eosinophil: 7.4;neutrophil: 25.3"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 25.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 26.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA028731	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA028731: AB_10602120"	"unprognostic (4.97e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.08e-7)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (3.33e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	26.6	4.3	1.2	3.2	3.4	4.4	21.4	0.8	1.7	19.7	8.3	1.5	10.3	1.9	22.8	11.0	12.8	6.5	4.3	17.3	1.5	1.4	4.7	58.5	7.8	6.9	3.3	1.0	16.2	4.1	40.7	2.4	18.7	4.7	25.3	4.0	3.3	12.9	15.5	34.8	6.7	4.5	33.7	5.1	5.4	6.3	8.6	2.8	1.6	11.5	6.8	4.5	37.0	21.7	0.8	0.8	25.3	0.7	0.9	1.5	0.6	3.6	1.4	4.1	1.4	10.3	8.8	14.9	1.3	4.4	1.6	2.0	5.5	1.7	1.3	2.2	2.7	9.1	0.6	0.7	1.0	1.7	3.9	0.6	2.2	0.6	0.0	4.6	1.1	9.7	7.2	3.3	1.4	8.3	12.5	26.3	6.5	1.6	3.1	0.6	2.2	5.9	2.0	5.9	8.2	1.2	2.4	5.2	2.2	16.0	14.8	0.0	7.7	2.4	0.1	10.3	6.9	1.9	2.2	18.2	4.8	1.6	0.9	1.7	1.7	3.9	0.0	8.4	3.4	1.4	18.0	0.7	7.4	1.1	0.6	0.9	0.8	1.0	0.6	0.4	0.7	1.5	0.7	25.3	0.9	0.3	0.8	0.7	0.6	1.2	3.4	0.8	1.7	1.5	1.4	3.3	1.0	4.7	2.8	11.9	34.6	3.0	17.9	9.5	3.4	66.2	35.7	48.2	30.7	8.7	5.9	10.1	3.3	8.3	10.4	20.6	8.4	0.0	11.2	25.5	12.1	10.8	32.4	135.4	6.1	6.4	0.0	32.5	10.8	2.7	8.9	13.6	5.0	1.0	8.9	3.5	13.2	3.5	17.0	5.3	13.5	12.9	15.5	1.9	4.7	10.7	15.3	6.4	4.7	1.6
PPP1R3D	PPP1R6	ENSG00000132825	"Protein phosphatase 1 regulatory subunit 3D"	O95685	20	59936668-59940297	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041146	Approved		Approved	Nucleoli,Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"	Nucleoli	"HPA041146: AB_10793870"	"unprognostic (2.50e-3)"	"unprognostic (3.55e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.23e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.48e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (5.71e-2)"	8.2	6.1	9.3	8.2	9.5	9.9	17.2	8.6	9.5	9.1	8.2	6.4	7.1	9.5	9.0	6.5	13.3	7.4	6.5	11.3	8.4	7.8	7.8	2.0	10.0	16.8	9.5	5.4	8.8	17.5	13.3	12.1	9.8	9.3	12.0	5.6	7.6	9.1	11.2	12.9	9.1	10.1	7.1	8.9	11.2	9.6	4.7	6.6	4.0	8.0	8.8	8.9	9.1	8.8	0.7	1.2	6.0	3.5	0.8	1.0	0.4	4.0	2.5	1.7	3.5	3.9	4.1	14.4	5.4	5.8	6.6	3.2	3.9	5.6	1.7	6.7	4.5	4.1	12.0	3.5	3.8	4.3	3.9	2.8	4.5	3.3	2.1	3.6	1.8	12.7	2.9	10.6	2.3	2.0	3.5	3.6	1.1	0.8	0.4	4.2	6.3	1.5	5.9	1.2	7.7	6.0	1.9	0.8	2.6	4.4	6.6	3.3	2.0	6.7	20.3	5.8	3.4	7.4	6.6	3.8	3.9	1.6	4.1	0.8	1.4	3.5	0.4	2.9	6.5	2.4	0.6	1.6	6.0	1.0	0.7	0.9	0.7	0.7	0.8	1.2	0.6	0.9	0.6	4.2	0.8	3.5	0.5	1.0	0.4	9.3	9.5	8.6	9.5	8.4	7.8	9.5	5.4	9.3	6.6	8.9	0.3	2.4	4.4	1.1	6.1	4.7	7.6	4.0	4.5	5.2	2.0	12.2	5.0	1.9	0.3	5.8	4.2	0.0	2.7	3.7	2.6	5.9	5.7	0.2	4.6	12.7	1.7	9.2	8.9	0.0	2.8	3.4	5.0	1.0	3.1	10.3	3.0	6.5	4.2	5.0	10.8	6.5	4.0	0.2	4.3	2.8	4.1	7.5	2.8	7.8
PPP1R3E	FLJ00089	ENSG00000235194	"Protein phosphatase 1 regulatory subunit 3E"	Q9H7J1	14	23295643-23302848	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 61.2;Early spermatids: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 30.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061600	Approved		Approved	"Microtubules,Mitotic spindle,Mitochondria"		Yes	No			"Microtubules, Mitochondria"	"Mitotic spindle"	"HPA061600: AB_2684566"	"unprognostic (3.45e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.89e-5)"	"unprognostic (4.05e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.67e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.12e-2)"	"unprognostic (5.46e-2)"	4.2	7.6	14.5	8.2	22.5	5.5	6.8	27.3	22.9	6.5	5.8	17.5	8.4	9.7	8.2	16.6	4.3	6.5	5.4	4.7	12.4	12.6	9.3	6.9	5.1	13.6	27.0	20.7	11.8	7.1	11.7	14.3	4.4	20.8	9.3	9.6	7.4	6.3	10.4	13.6	16.9	8.8	5.8	21.6	11.0	7.8	11.5	25.9	5.9	13.8	4.9	12.3	5.2	7.0	3.0	1.1	1.6	4.7	0.9	1.7	1.0	0.8	2.2	2.7	1.9	5.2	2.3	1.3	0.9	1.6	1.5	1.3	1.2	4.2	8.0	0.6	1.1	1.6	5.6	1.6	0.8	1.8	2.9	1.6	1.4	4.2	2.8	1.4	1.6	3.3	1.9	3.3	0.9	4.6	2.5	0.7	4.4	1.3	7.3	1.2	1.9	1.5	2.6	0.6	2.6	2.0	2.4	1.8	5.1	0.8	1.8	3.3	0.9	1.3	1.1	0.8	1.4	1.4	0.6	1.2	1.8	1.0	3.1	0.6	30.7	3.2	3.7	1.4	2.9	1.1	0.5	1.3	0.5	1.5	3.9	1.7	3.0	0.5	0.7	1.1	2.3	1.7	1.0	1.6	0.9	4.7	1.0	1.0	1.0	14.5	22.5	27.3	22.9	12.4	12.6	27.0	20.7	20.8	25.9	3.0	3.7	10.8	7.8	4.9	61.2	7.7	2.5	2.7	4.5	19.2	35.3	6.1	5.0	1.8	92.4	6.0	10.7	0.0	2.9	1.6	3.9	5.5	3.5	6.4	6.2	30.2	8.1	8.6	7.8	50.4	25.3	8.2	10.1	1.0	6.4	22.9	2.8	4.8	24.4	5.9	38.7	12.9	2.8	24.7	9.1	8.0	4.3	10.1	8.3	7.8
PPP1R3F	Hb2E	ENSG00000049769	"Protein phosphatase 1 regulatory subunit 3F"	Q6ZSY5	X	49269843-49301461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 35.3;Horizontal cells: 46.1;Rod photoreceptor cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"T-reg: 15.3"	"Lineage enriched"	"Detected in single"	16	"T-cells: 15.3"	"Cell line enhanced"	"Detected in many"		"GAMG: 18.0;HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000244, HPA000918"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA000244: AB_2665949, HPA000918: AB_2268692"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.83e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (5.99e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.55e-1)"	3.0	7.6	15.9	3.7	13.8	2.7	2.3	17.2	21.2	4.3	3.5	7.6	4.5	2.4	4.7	15.9	5.4	6.7	3.6	16.1	16.0	13.1	3.3	2.8	3.4	4.6	12.3	5.4	7.5	2.6	4.4	8.6	2.4	9.1	4.6	1.7	5.3	5.3	6.1	24.0	3.1	3.1	4.1	11.3	5.1	2.9	4.5	7.3	3.5	5.5	1.9	3.0	3.5	4.8	0.4	0.3	0.0	0.9	0.4	15.3	0.5	2.4	5.0	4.4	4.9	6.1	4.4	2.1	2.9	4.5	1.9	3.1	3.5	2.9	2.9	0.6	2.1	18.0	3.9	1.7	1.2	1.0	15.8	5.5	0.3	2.9	0.3	4.0	0.4	1.8	3.0	3.6	2.0	1.6	4.5	0.5	4.0	0.7	1.2	2.3	8.7	1.1	3.9	13.6	0.6	9.5	6.4	3.8	0.9	1.9	1.1	5.2	4.5	1.5	0.5	7.4	9.8	4.5	2.5	2.3	5.5	1.1	4.8	2.1	3.6	4.5	1.9	1.8	6.2	6.9	0.0	0.2	0.0	0.2	0.4	1.0	0.4	3.0	1.0	0.2	0.1	2.4	1.1	0.0	0.4	0.9	0.3	15.3	0.5	15.9	13.8	17.2	19.3	16.0	13.1	12.3	5.4	9.1	7.3	0.0	0.3	0.5	2.5	1.6	35.3	13.7	0.0	2.7	0.0	3.5	7.9	0.8	6.6	0.4	0.1	1.9	0.0	0.0	0.2	0.1	3.0	1.6	0.0	0.8	0.6	46.1	2.9	1.8	0.0	0.4	4.4	0.9	0.0	0.0	0.0	9.7	0.4	0.0	2.8	4.9	15.4	0.0	3.9	0.5	5.6	1.1	1.0	1.5	0.0	2.2
PPP1R7	sds22	ENSG00000115685	"Protein phosphatase 1 regulatory subunit 7"	Q15435	2	241149576-241183652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 735.0;Late spermatids: 1235.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034500, HPA034501"	Supported		Approved	Nucleoli		NA	NA		650000	Nucleoli		"HPA034500: AB_2674192, HPA034501: AB_10670965"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.07e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.23e-1)"	21.5	21.9	39.2	19.4	82.1	22.2	19.7	25.0	40.5	19.0	24.8	16.4	18.8	22.2	18.9	24.8	31.5	32.2	20.5	36.9	31.3	23.3	24.9	28.8	20.4	27.2	23.7	35.2	16.4	22.8	21.9	18.4	17.3	23.5	37.9	25.3	17.6	22.9	22.2	46.4	24.2	22.7	21.3	20.8	17.6	21.8	57.3	29.4	21.2	25.5	26.1	29.6	24.4	25.0	31.4	37.5	48.5	41.0	32.8	53.3	37.4	31.3	19.0	21.6	27.3	42.9	43.1	29.9	34.7	31.8	24.0	34.0	10.3	40.2	16.2	10.4	29.7	36.1	30.9	35.4	32.8	36.9	42.0	34.9	28.3	31.0	40.8	27.7	39.0	29.8	33.2	26.0	28.3	21.0	32.7	35.5	33.4	28.5	24.0	56.0	41.7	34.8	30.1	29.6	50.2	18.2	24.2	56.3	32.7	44.6	31.8	29.4	23.4	18.6	43.8	31.7	25.4	26.1	42.5	34.9	21.8	20.7	40.9	27.9	25.6	15.4	43.8	61.1	41.7	28.6	40.4	39.8	48.5	32.1	40.0	33.7	31.4	38.4	37.7	37.5	28.8	29.8	34.5	31.4	32.8	41.0	22.4	53.3	37.4	39.2	82.1	25.0	40.5	31.3	23.3	23.7	35.2	23.5	29.4	53.6	46.2	73.1	40.9	24.6	40.6	88.8	48.4	119.1	70.5	41.8	15.7	79.0	102.8	76.7	735.0	40.9	60.8	0.0	127.1	78.3	37.5	46.6	56.7	41.4	87.4	30.2	24.6	27.6	40.5	1235.7	47.2	67.7	82.7	65.9	50.2	55.2	81.2	63.3	63.3	96.6	36.4	71.1	54.5	161.9	125.6	33.2	59.8	59.5	47.6	47.3
PPP1R9A	"FLJ20068, KIAA1222, Neurabin-I"	ENSG00000158528	"Protein phosphatase 1 regulatory subunit 9A"	Q9ULJ8	7	94907202-95296415	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 109.7;Rod photoreceptor cells: 85.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.8;NK-cell: 10.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.8;NK-cells: 10.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 10.5;RH-30: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027726, HPA075591"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA027726: AB_1855653, HPA075591: AB_2732296"	"unprognostic (1.05e-1)"	"unprognostic (6.59e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (8.63e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.79e-3)"	2.9	11.7	11.0	1.9	23.5	0.8	8.1	10.9	19.7	5.2	8.7	7.4	7.7	3.0	5.4	9.2	3.2	9.6	4.4	8.2	11.5	9.7	8.2	1.1	6.4	0.9	8.1	13.7	5.0	14.3	16.5	15.5	4.5	12.7	4.2	6.8	5.7	14.2	5.3	6.7	1.1	3.0	5.1	9.1	3.2	6.2	10.0	11.2	0.0	10.9	1.3	1.0	4.2	1.4	1.3	0.3	5.8	0.1	10.9	0.2	0.2	0.0	9.4	6.0	6.7	0.0	0.0	4.8	0.4	0.1	0.9	0.7	5.2	3.1	0.0	8.0	0.4	0.6	0.0	10.5	0.0	1.2	0.0	4.0	9.6	3.8	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.7	4.0	0.1	0.0	4.9	4.3	1.7	0.0	10.5	0.0	9.8	7.8	6.4	6.6	0.0	0.8	1.3	3.9	2.0	0.0	0.0	0.1	3.9	0.1	3.4	6.4	9.2	0.0	0.1	0.0	0.7	5.8	0.0	0.5	0.0	0.0	0.2	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	10.9	0.1	0.3	0.0	0.2	11.0	23.5	10.9	18.3	11.5	9.7	8.1	13.7	12.7	11.2	38.7	49.4	0.0	0.8	0.3	51.3	109.7	7.6	33.5	26.1	45.4	53.0	16.9	3.3	20.0	13.6	2.2	8.8	0.0	6.1	2.0	1.4	8.0	5.7	1.3	1.5	1.6	37.3	8.0	0.0	12.2	2.3	0.4	6.8	0.0	13.4	56.5	7.0	10.5	0.7	6.2	85.0	0.0	3.1	18.2	10.2	0.6	27.7	0.0	16.4	1.0
PPP2R1A	"PP2A-Aalpha, PP2AA, PR65A"	ENSG00000105568	"Protein phosphatase 2 scaffold subunit Aalpha"	P30153	19	52190039-52229533	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Chromosome partition"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018599			Approved	Cytosol		NA	NA		3400000	Cytosol		"CAB018599: AB_628178"	"unprognostic (1.78e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.76e-4)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.19e-2)"	25.3	57.3	60.7	20.5	71.0	18.0	21.4	47.5	82.1	29.6	31.2	26.6	21.5	33.4	26.4	37.9	37.7	47.0	39.9	74.7	70.2	44.8	31.0	29.3	20.0	27.5	44.0	50.9	45.8	24.3	37.8	29.5	24.6	51.0	31.0	29.8	31.0	24.3	35.6	50.6	33.5	25.3	34.5	25.2	20.5	19.8	21.7	18.1	29.0	28.9	35.9	30.6	27.3	23.1	52.8	62.8	51.9	67.2	69.8	56.3	67.8	30.9	52.6	42.0	37.3	34.2	35.8	22.1	26.1	34.2	34.9	30.6	26.4	24.5	27.1	18.8	41.5	19.2	22.4	45.0	39.4	20.3	20.0	121.9	19.9	29.0	29.7	31.3	21.5	19.0	48.0	32.6	32.7	30.1	32.8	33.1	18.2	23.1	19.1	38.7	35.8	30.0	41.0	41.5	31.2	46.5	29.5	24.4	30.3	56.1	51.0	31.7	33.9	32.0	32.0	19.5	28.6	28.9	38.0	31.4	27.7	25.1	13.5	29.8	19.8	29.0	31.8	29.8	21.8	34.9	45.0	55.3	51.9	50.4	67.2	45.8	48.4	45.1	47.1	62.8	52.8	37.7	43.0	33.7	69.8	59.8	39.0	56.3	67.8	60.7	71.0	47.5	82.1	70.2	44.8	44.0	50.9	51.0	18.1	41.7	30.7	69.2	78.9	62.5	111.3	81.8	68.8	52.2	36.4	113.4	23.6	183.6	99.5	195.0	3.8	51.7	133.3	0.0	136.1	214.1	70.0	78.9	68.0	44.8	127.2	136.7	102.6	66.9	55.1	6.8	67.0	47.0	50.6	131.7	108.9	97.9	137.7	175.6	80.2	103.3	48.5	77.6	81.4	14.8	54.1	55.3	152.2	70.3	147.4	93.1
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.9"	"Group enriched"	"Detected in all"	5	"Early spermatids: 249.6;Hepatocytes: 68.4;Late spermatids: 93.2;Spermatocytes: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	31.6	7.2	7.1	7.6	9.8	7.7	13.5	14.8	7.1	7.9	8.2	13.6	5.7	7.7	6.3	5.6	7.9	5.0	7.8	4.6	7.4	5.0	10.3	94.9	5.4	6.2	12.6	3.4	8.7	18.5	5.4	19.4	6.7	9.8	4.6	8.5	6.6	8.8	4.0	6.2	6.7	9.4	5.9	8.7	4.2	11.9	28.6	13.9	10.1	6.1	7.2	9.4	6.0	5.1	11.5	14.7	9.9	11.9	14.1	14.3	12.0	13.0	8.8	12.7	8.6	12.8	6.9	12.8	13.0	9.1	9.7	8.9	29.7	13.8	16.6	9.8	8.4	9.2	12.4	18.8	10.7	12.4	11.5	5.8	16.2	5.2	12.9	6.3	18.9	12.9	7.8	6.5	10.9	8.0	6.8	11.9	17.4	19.6	22.1	10.6	4.2	20.4	7.7	15.6	14.2	9.6	15.7	8.4	20.3	14.4	14.5	4.1	11.3	11.6	10.7	2.1	14.3	12.4	7.1	12.8	11.3	13.7	5.6	8.2	2.3	5.8	60.8	4.0	22.1	14.3	5.4	10.0	9.9	13.7	11.9	13.4	10.4	13.9	12.7	14.7	11.5	12.3	13.1	2.5	14.1	10.7	6.3	14.3	12.0	7.1	9.8	14.8	7.1	7.4	5.0	12.6	3.4	9.8	13.9	17.9	8.0	12.6	9.8	12.7	4.9	3.0	10.2	16.0	6.8	12.2	7.9	11.5	11.6	16.5	249.6	12.3	16.1	23.3	20.0	14.9	9.4	9.7	8.1	68.4	8.4	1.6	15.0	8.6	7.8	93.2	6.1	5.6	8.5	11.8	11.5	9.1	21.0	7.0	7.1	15.9	10.5	12.9	9.5	71.5	18.5	12.8	14.8	7.5	11.5	13.6
PPP2R2A	"B55A, B55alpha, PR52A, PR55A, PR55alpha"	ENSG00000221914	"Protein phosphatase 2 regulatory subunit Balpha"	P63151	8	26291491-26372680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, CAB079289"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB079289: AB_659890, HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.16e-1)"	26.1	14.8	25.1	19.1	30.3	21.2	41.7	23.7	28.0	25.2	18.2	27.9	16.0	23.4	20.5	16.0	50.3	19.1	16.8	24.6	21.2	16.2	21.5	32.0	21.7	17.6	28.9	22.3	22.5	13.3	19.3	18.3	39.4	24.8	20.6	18.4	11.3	24.3	18.3	41.6	31.7	16.2	21.1	22.6	15.9	15.3	19.2	32.1	18.3	21.6	29.1	30.4	21.8	29.9	8.0	4.8	6.5	4.8	7.9	10.1	3.6	18.9	18.4	23.8	17.0	14.9	21.3	25.4	29.6	19.0	27.8	26.7	22.6	14.1	26.2	9.0	15.8	18.3	22.8	28.7	24.0	38.1	11.5	15.1	19.8	18.4	11.9	23.5	11.4	15.4	16.9	34.0	24.0	33.4	18.2	43.2	14.8	27.0	25.5	25.3	12.1	25.9	12.7	31.4	45.1	13.0	18.6	17.8	21.8	17.4	28.7	10.0	13.1	14.2	14.3	23.1	22.9	15.1	10.3	23.2	17.4	21.6	17.7	20.7	9.3	12.1	33.9	20.7	20.8	29.3	3.1	2.3	6.1	4.3	4.4	5.4	8.0	6.0	7.6	4.3	6.8	6.1	7.9	6.5	7.9	4.8	4.8	10.1	3.6	25.1	30.3	23.7	28.0	21.2	16.2	28.9	22.3	24.8	32.1	68.5	57.4	46.7	211.9	121.3	52.2	30.0	30.6	123.1	100.1	14.0	45.2	66.8	41.4	40.1	32.5	64.2	45.3	70.0	28.2	56.0	37.8	125.3	54.3	29.2	32.0	35.0	73.7	52.2	31.3	86.3	43.4	50.2	57.3	42.3	32.7	48.8	45.2	26.2	68.9	36.8	37.6	51.8	57.7	28.9	62.2	125.0	56.0	43.7	33.3	178.5
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 52.2;Late spermatids: 144.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 14.2;A549: 21.0;CAPAN-2: 14.0;GAMG: 34.1;MCF7: 17.3;PC-3: 19.9;SCLC-21H: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291"	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	1.5	6.6	28.2	1.6	33.9	1.1	2.4	17.0	78.4	11.8	1.5	13.8	0.5	1.7	25.3	7.0	25.2	10.5	1.4	1.9	25.8	19.5	1.2	1.1	1.1	1.3	25.6	19.3	1.3	1.7	1.1	5.9	1.1	19.1	5.5	1.4	0.4	1.4	14.4	1.7	28.8	2.0	11.8	32.0	1.3	1.9	4.7	13.5	0.0	1.1	3.9	3.6	1.5	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.2	21.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	9.2	0.0	34.1	6.6	10.3	0.3	0.0	0.0	1.2	0.0	1.4	1.6	0.3	0.0	0.0	3.0	5.5	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.8	17.3	0.0	0.0	1.0	0.3	19.9	0.0	0.0	0.6	0.0	0.0	19.3	3.6	0.6	0.0	0.0	0.6	8.9	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	33.9	17.0	40.2	25.8	19.5	25.6	19.3	19.1	13.5	0.0	0.0	0.0	0.5	13.1	10.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	0.1	0.0	0.0	0.2	0.0	0.2	1.2	0.0	0.0	0.1	3.2	0.0	0.0	0.0	144.3	6.4	0.0	0.0	0.0	0.0	4.1	1.3	0.0	4.2	0.0	2.4	0.0	1.4	1.0	0.9	19.3	0.0	0.0	0.0	0.1
PPP2R2D	"B55D, B55delta, MDS026"	ENSG00000175470	"Protein phosphatase 2 regulatory subunit Bdelta"	Q66LE6	10	131900644-131959834	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042122, HPA042770"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (7.75e-3)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.90e-2)"	4.5	8.1	5.4	4.0	6.6	1.6	11.4	13.5	12.5	3.7	5.2	5.4	2.4	5.3	3.9	5.2	4.2	4.6	4.7	7.9	5.5	4.7	4.9	4.3	5.5	6.0	4.9	5.2	8.5	34.3	9.9	6.3	5.3	4.7	4.8	5.4	4.9	7.8	5.7	11.4	6.8	5.8	6.0	4.4	5.1	4.4	4.4	5.1	6.3	6.1	3.0	4.4	5.6	6.4	0.4	0.0	0.3	0.6	0.1	0.3	0.0	5.2	4.6	2.5	1.5	3.5	2.6	4.1	1.8	3.7	3.5	3.7	3.2	3.6	2.1	1.3	1.9	2.0	9.2	3.7	0.6	3.5	5.4	5.2	3.6	3.9	1.5	0.8	3.2	3.4	0.9	8.4	3.9	5.6	5.7	2.1	2.9	4.7	0.7	3.7	2.1	1.6	8.9	1.8	1.6	4.5	2.1	1.9	0.4	2.8	0.4	2.2	2.9	2.4	1.9	2.0	2.8	1.2	2.9	3.1	1.9	0.7	2.7	9.5	3.2	1.8	2.5	1.7	2.2	0.6	0.0	0.2	0.0	0.2	0.4	0.1	0.4	0.1	0.3	0.0	0.0	0.1	0.3	0.3	0.1	0.6	0.0	0.1	0.0	5.4	6.6	13.5	9.2	5.5	4.7	4.9	5.2	4.7	5.1	17.9	11.0	20.7	31.2	33.2	46.6	33.4	15.3	4.0	11.4	8.7	9.8	9.2	16.6	7.9	7.9	16.9	20.4	0.0	15.3	11.1	13.4	31.3	5.8	18.7	12.5	49.3	10.3	14.1	7.9	5.8	16.1	16.7	11.8	3.6	15.1	24.9	15.7	18.2	19.4	18.8	30.8	25.8	14.4	12.3	14.9	29.6	9.8	10.0	15.6	30.1
PPP2R3A	"PPP2R3, PR130, PR72"	ENSG00000073711	"Protein phosphatase 2 regulatory subunit B''alpha"	Q06190	3	135965673-136147891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 85.6"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 102.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 19.2;BJ hTERT+: 18.8;RPTEC TERT1: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035829, HPA035830, HPA065338"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475"	"unprognostic (3.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.91e-4)"	6.3	3.3	3.4	1.9	6.4	0.7	4.3	1.5	4.9	5.5	6.7	5.2	5.8	1.7	6.8	5.1	5.0	3.0	3.3	27.4	3.9	2.8	31.7	1.2	2.6	0.9	7.0	4.4	3.7	3.8	7.5	3.7	9.0	5.3	3.8	3.5	1.6	7.7	7.8	85.6	10.4	2.5	11.4	6.1	1.2	5.2	4.2	6.5	0.0	2.3	31.6	1.2	6.5	3.9	1.5	1.8	1.7	1.4	1.8	1.5	0.6	19.2	1.1	5.5	2.6	4.5	5.7	6.4	15.1	18.8	7.1	8.9	1.2	1.2	0.0	5.8	15.4	5.1	2.5	2.3	5.3	15.5	0.0	0.7	0.8	0.6	0.0	3.2	0.0	0.8	5.1	4.6	9.1	4.3	7.2	6.8	0.5	0.5	0.0	10.2	3.2	0.1	0.1	3.8	0.2	3.7	0.0	8.1	0.0	25.0	0.7	0.4	3.1	2.4	3.0	5.8	5.2	4.8	0.2	4.4	7.5	4.1	10.1	6.6	0.2	0.5	0.0	5.5	0.4	2.6	1.1	1.2	1.5	0.9	1.4	0.5	0.7	1.0	0.8	1.1	1.5	1.5	1.2	1.7	1.8	1.2	1.8	0.7	0.6	3.4	6.4	1.5	4.9	3.9	2.8	7.0	4.4	5.3	6.5	26.8	22.2	2.7	15.3	23.5	4.1	102.3	0.0	9.4	11.4	52.4	0.0	7.6	18.3	18.1	6.1	8.7	15.8	0.0	8.5	13.2	12.8	12.5	3.5	2.4	2.2	3.2	12.5	5.5	2.1	9.5	22.7	4.6	27.0	14.4	7.9	9.5	12.6	9.9	17.3	37.2	2.2	6.5	11.9	6.6	19.6	29.1	8.7	3.8	7.3	15.3
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333963-386955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 43.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 62.0;Cone photoreceptor cells: 25.5;Spermatogonia: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 15.5;U-698: 24.3"					"Low region specificity"	"Detected in all"			HPA026606			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.90e-5)"	1.8	1.3	8.8	1.1	11.7	3.8	4.8	9.1	8.7	7.6	1.2	0.0	0.0	1.4	6.6	0.7	2.4	2.3	1.4	17.7	12.2	2.9	4.1	1.1	1.5	1.7	15.4	6.2	6.9	2.9	1.5	11.0	8.9	13.0	2.4	0.7	0.0	1.6	1.2	43.5	3.9	1.3	1.6	8.3	1.8	1.8	4.1	15.0	0.0	1.0	0.0	0.9	2.9	2.6	0.1	0.6	2.3	0.1	0.0	1.3	0.1	0.5	5.3	0.7	2.2	0.1	0.2	7.1	5.9	1.5	5.3	6.3	5.3	0.0	0.0	3.2	4.5	0.6	0.0	0.2	0.0	1.4	3.7	4.3	1.2	1.8	0.2	0.0	1.9	2.2	0.1	0.1	0.0	3.2	0.2	0.1	3.2	1.0	0.3	1.2	2.6	9.0	7.8	2.3	0.1	15.5	4.1	3.4	0.3	1.4	1.5	0.0	9.2	0.0	0.9	4.2	4.2	0.0	2.3	0.3	3.1	2.9	0.0	2.0	0.0	0.0	24.3	0.1	2.7	3.9	0.0	0.0	2.3	0.1	0.1	1.3	0.1	0.1	0.0	0.6	0.1	0.3	0.3	0.1	0.0	0.1	0.5	0.0	0.1	8.8	11.7	9.1	8.7	12.2	2.9	15.4	6.2	13.0	15.0	0.0	1.7	0.9	7.8	6.1	11.5	62.0	2.5	2.7	1.2	0.0	25.5	5.6	0.0	2.8	0.5	3.5	1.4	0.0	3.5	5.6	3.0	2.2	0.0	1.0	3.2	6.4	4.6	4.3	2.1	1.5	3.7	5.3	5.0	3.6	3.8	11.2	2.6	0.0	2.8	1.3	19.8	0.0	3.8	12.9	25.5	6.6	3.3	1.9	3.1	3.9
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984499-43012342	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	17.9	14.4	19.7	17.0	31.5	15.1	14.2	28.3	41.0	20.2	24.5	13.7	15.9	31.1	20.7	11.4	18.1	19.0	14.3	22.0	17.7	18.4	15.7	15.8	15.0	16.2	16.6	25.1	20.7	16.5	17.4	11.2	16.6	26.3	18.4	18.6	16.5	13.7	19.2	41.0	17.9	36.4	20.8	11.2	14.4	14.9	27.1	13.1	35.5	13.4	11.1	14.7	19.1	18.5	9.2	12.5	17.9	11.3	11.8	19.7	15.3	24.4	12.9	19.8	25.8	12.3	16.9	11.1	13.6	9.7	27.2	24.1	20.9	6.7	18.3	13.2	16.5	18.8	13.9	26.6	15.6	24.4	15.6	23.1	21.9	16.0	19.6	8.5	15.1	16.1	9.3	10.3	21.7	9.9	15.5	20.7	23.1	22.9	14.2	15.7	10.4	38.8	13.8	8.8	55.4	12.3	27.2	24.5	12.0	8.3	11.6	25.1	16.5	18.4	12.3	14.7	17.1	17.2	14.1	19.6	19.6	18.2	20.5	21.6	14.7	18.5	37.6	7.7	14.1	16.9	14.8	11.3	17.9	16.8	9.8	17.6	9.2	15.3	19.0	11.6	9.0	11.8	14.1	6.9	11.8	7.4	12.5	19.7	15.3	19.7	31.5	28.3	41.0	17.7	18.4	16.6	25.1	26.3	13.1	8.9	7.0	5.2	2.5	7.4	11.6	4.0	5.1	4.0	7.9	7.0	9.8	6.2	5.0	5.8	4.2	6.2	21.7	0.0	6.8	8.7	8.5	2.9	8.1	10.9	8.0	3.2	8.6	8.0	5.9	5.3	8.9	4.2	10.1	6.4	7.6	7.3	7.9	8.4	13.8	3.8	7.5	6.5	8.0	7.5	9.4	8.3	3.8	7.4	9.5	1.7
PPP3CB	"CALNA2, CALNB, CNA2, PP2Bbeta"	ENSG00000107758	"Protein phosphatase 3 catalytic subunit beta"	P16298	10	73436428-73496024	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 133.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008233, HPA008823"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008233: AB_1855661, HPA008823: AB_2668148"	"unprognostic (3.05e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.28e-2)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	17.3	16.1	40.0	11.7	36.3	7.6	22.5	44.5	42.7	13.4	16.1	7.9	9.5	10.1	17.0	15.0	14.0	12.3	12.0	16.7	39.7	20.5	11.9	9.1	9.8	13.1	18.2	40.7	17.2	10.5	19.3	16.8	10.6	21.1	16.8	12.8	9.5	10.4	17.6	133.0	10.9	9.4	23.0	18.1	10.0	10.7	11.6	11.9	8.4	10.1	10.0	14.3	14.1	14.4	4.2	5.7	4.8	3.8	4.5	10.6	2.7	19.1	10.6	19.0	19.6	27.3	37.9	9.1	17.6	24.2	17.3	17.2	6.7	9.8	17.0	5.7	25.4	8.2	10.3	15.3	13.5	24.4	23.8	12.5	7.2	9.6	12.7	16.3	16.0	15.1	26.8	16.3	16.3	21.9	31.9	11.9	14.9	9.0	20.0	34.8	6.0	14.3	14.8	7.7	8.4	31.0	9.6	10.3	8.0	16.8	9.3	10.2	11.8	10.3	25.8	12.9	16.5	19.4	15.5	13.0	13.8	12.7	11.0	23.8	13.4	36.5	11.9	17.1	23.1	7.8	3.2	2.9	4.8	6.2	3.8	7.3	4.2	6.7	6.6	3.0	3.0	5.3	7.9	1.7	4.5	2.3	5.7	10.6	2.7	40.0	36.3	44.5	42.7	39.7	20.5	18.2	40.7	21.1	11.9	3.0	11.0	18.2	26.7	22.8	52.0	42.6	10.2	13.4	11.4	17.4	19.6	17.9	53.0	15.6	5.9	18.3	10.2	0.0	16.6	13.6	21.4	23.8	20.7	12.3	17.9	36.5	40.9	17.2	30.2	7.6	31.1	18.8	25.3	27.1	12.3	32.9	15.6	14.4	27.3	25.6	28.0	6.5	37.1	38.5	44.0	27.6	18.5	15.7	14.4	19.3
PPP3CC	"CALNA3, PP2Bgamma"	ENSG00000120910	"Protein phosphatase 3 catalytic subunit gamma"	P48454	8	22440819-22541142	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023396, CAB024950"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB024950: , HPA023396: AB_1855663"	"unprognostic (7.66e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.64e-2)"	18.0	8.3	6.9	13.7	8.1	15.2	21.1	11.9	12.0	10.3	10.2	10.9	3.7	6.1	13.4	7.8	11.6	9.0	10.7	27.5	7.6	7.3	8.9	8.2	16.5	22.3	7.7	4.9	10.1	9.9	13.7	15.1	12.7	9.9	11.1	7.1	20.7	15.5	6.0	52.4	9.1	9.8	13.5	7.9	14.1	9.5	41.6	6.9	6.8	11.5	13.2	20.0	14.7	11.0	15.5	4.0	6.6	2.9	11.9	16.0	3.9	5.5	4.1	3.6	4.4	9.7	12.1	5.3	7.7	13.6	11.5	12.8	2.3	3.5	21.0	9.5	11.9	19.2	3.9	8.4	7.7	14.7	12.0	4.5	4.5	4.7	6.7	13.1	3.2	7.4	7.3	10.7	7.7	7.9	12.3	9.9	10.3	8.8	28.0	12.8	2.6	7.5	5.3	2.6	5.7	5.6	24.7	8.6	6.9	10.7	5.2	2.6	6.1	5.8	3.4	7.9	7.2	2.3	5.4	10.6	17.9	3.8	27.1	5.9	14.0	16.9	22.0	9.5	4.3	11.8	3.4	1.6	6.6	11.4	2.0	8.7	15.5	12.9	16.0	3.2	13.9	12.4	10.1	0.4	11.9	2.9	4.0	10.1	3.9	6.9	8.1	11.9	12.0	7.6	7.3	7.7	4.9	9.9	6.9	6.0	3.2	39.8	18.1	14.7	9.7	7.0	12.7	2.7	3.4	7.0	45.2	15.0	6.6	12.0	88.7	24.7	7.2	0.0	18.7	19.5	22.6	23.7	3.5	6.8	11.9	3.2	9.9	23.9	11.3	9.4	20.8	18.5	27.0	43.3	3.1	12.3	15.5	9.9	20.1	10.4	50.5	32.3	26.2	71.2	27.9	9.9	11.8	43.6	6.0	23.0
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.2"	"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		43000	"Plasma membrane, Cytosol"		"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	25.8	20.1	43.3	15.9	66.2	32.3	25.7	47.9	78.2	14.8	14.0	7.7	6.9	13.1	16.6	14.2	15.7	10.5	14.7	10.2	56.2	28.7	11.3	29.6	15.5	18.8	23.7	45.1	13.6	9.8	9.4	8.9	18.5	25.4	14.3	14.8	6.8	12.1	16.6	41.7	17.1	12.0	18.5	21.6	16.5	12.6	10.4	16.5	12.7	12.6	7.7	20.1	14.4	13.3	1.0	1.8	6.4	1.4	0.9	1.4	0.9	17.8	15.2	20.6	14.1	14.2	16.5	21.0	25.9	22.1	29.3	25.9	21.9	16.2	24.9	8.9	17.5	20.9	12.1	21.7	18.7	35.8	17.5	15.5	80.8	12.4	20.1	28.1	31.7	27.3	16.6	17.0	22.7	23.3	16.6	19.6	21.1	19.5	28.5	21.3	15.4	26.8	27.9	24.2	15.0	13.0	19.6	27.2	39.6	18.1	19.0	27.2	19.2	14.9	21.2	18.6	14.0	10.0	14.8	20.5	25.3	23.2	19.1	22.3	16.1	17.7	36.9	18.4	33.4	15.8	3.2	1.2	2.9	0.7	0.8	1.4	0.5	0.8	0.5	1.3	1.0	0.9	1.4	6.4	0.9	1.4	1.8	0.9	0.9	43.3	66.2	47.9	78.2	56.2	28.7	23.7	45.1	25.4	16.5	8.9	16.7	16.6	10.6	66.4	21.5	16.1	10.2	2.7	6.8	15.7	49.1	9.8	10.0	5.9	11.6	21.5	14.4	23.3	7.5	14.8	14.0	14.4	19.6	18.5	21.1	11.1	14.6	15.4	42.9	6.5	9.2	22.7	33.7	4.6	14.0	20.4	10.5	10.1	8.1	12.9	86.2	12.9	17.3	2.6	5.3	61.6	10.1	20.3	12.0	16.8
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591615-101595021	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 81.9"	"Group enriched"	"Detected in some"	25	"Early spermatids: 271.7;Late spermatids: 141.7;Spermatocytes: 319.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Low region specificity"	"Detected in single"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA047157: AB_2679960"												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.7	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	6.5	0.0	319.9	3.0	0.0	0.0	0.0	0.0	0.0
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085377	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: AB_2678695"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	24.7	26.6	13.5	26.1	14.1	26.7	18.6	16.0	15.9	19.2	28.4	14.5	20.5	22.5	19.2	28.4	39.1	17.7	31.9	28.5	12.6	12.1	28.9	52.3	27.4	25.3	12.5	12.8	22.5	26.3	23.9	16.2	51.6	11.9	18.3	17.4	18.8	22.0	14.9	26.0	26.1	38.8	15.9	11.9	36.2	22.6	39.0	9.5	59.7	27.1	26.5	37.9	22.2	21.1	19.5	30.3	57.3	28.2	12.4	23.6	12.0	30.8	34.6	23.1	32.2	21.9	18.5	36.0	27.5	30.7	36.2	40.2	30.4	40.3	24.0	35.4	32.4	23.6	25.2	28.6	34.1	21.4	30.1	51.2	16.3	21.5	67.2	33.3	22.9	30.9	26.8	30.2	33.0	21.0	21.7	42.0	31.3	31.8	22.0	27.6	88.9	39.9	41.8	44.0	24.5	18.4	44.7	24.0	41.8	34.2	31.8	22.5	33.3	13.5	40.8	23.5	20.2	37.6	39.0	26.7	21.2	22.3	17.1	21.1	37.8	41.5	28.1	30.2	29.6	25.6	21.4	26.9	57.3	18.3	28.2	13.1	17.0	19.2	20.6	30.3	19.5	17.2	15.2	56.9	12.4	24.5	23.5	23.6	12.0	13.5	14.1	16.0	15.9	12.6	12.1	12.5	12.8	11.9	9.5	47.6	33.1	81.7	96.8	130.7	20.0	9.3	89.2	54.9	23.9	73.3	27.5	268.8	134.3	208.0	127.6	84.2	174.4	0.0	169.7	278.1	71.4	111.6	69.1	85.6	210.3	33.4	120.5	58.9	91.3	98.3	58.1	124.3	75.9	252.5	114.3	41.8	254.7	168.4	49.1	156.3	25.7	71.1	65.1	231.9	141.6	150.8	352.1	111.4	129.3	192.9
PPP4R1	PP4R1	ENSG00000154845	"Protein phosphatase 4 regulatory subunit 1"	Q8TF05	18	9546791-9615240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 23.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040905, HPA041089"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040905: AB_10794869, HPA041089: AB_10805836"	"unprognostic (1.76e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.13e-3)"	"unprognostic (4.15e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	18.0	11.1	9.6	10.7	11.4	16.5	25.1	11.6	12.4	17.7	22.0	13.0	15.5	13.7	16.1	14.5	46.2	13.1	14.3	12.2	9.9	8.9	13.5	12.9	26.7	14.8	9.9	7.8	12.1	20.5	15.9	9.3	28.1	10.3	13.1	12.2	10.1	15.8	13.8	12.8	16.3	25.5	18.1	11.1	15.3	14.4	24.2	11.9	9.4	12.1	28.2	25.3	16.8	21.6	2.5	4.6	23.9	3.9	2.5	3.5	2.0	23.5	16.6	40.3	11.0	8.0	12.2	20.5	23.0	15.5	22.8	22.1	15.1	13.7	11.4	16.9	22.5	19.4	10.1	18.6	34.1	30.9	13.3	7.5	10.8	12.3	10.8	12.5	27.6	16.4	10.8	22.1	19.7	18.7	17.1	26.0	7.7	15.7	10.4	24.6	11.9	19.2	10.6	16.1	32.9	10.5	24.0	24.3	7.1	19.2	33.2	11.8	14.0	27.3	12.3	8.9	27.0	6.7	10.6	27.8	40.3	25.0	20.7	28.2	9.3	12.9	20.8	15.1	11.5	18.2	7.2	3.9	6.7	2.7	3.1	3.5	2.5	2.9	2.7	4.6	1.4	1.0	2.3	23.9	2.5	3.0	1.9	3.0	2.0	9.6	11.4	11.6	12.4	9.9	8.9	9.9	7.8	10.3	11.9	92.3	66.2	7.2	26.1	35.8	18.3	18.2	5.1	53.5	71.7	21.0	9.8	21.9	5.0	21.0	75.8	28.5	19.5	0.0	30.2	13.6	16.7	18.7	3.5	11.5	14.4	31.8	16.7	28.8	16.5	46.4	16.1	14.5	13.5	9.0	14.6	11.2	35.6	10.5	11.0	7.9	20.2	12.9	14.0	13.7	10.7	37.1	19.2	9.5	13.1	57.2
PPP6R2	"dJ579N16.1, KIAA0685, SAP190, SAPS2"	ENSG00000100239	"Protein phosphatase 6 regulatory subunit 2"	O75170	22	50343304-50445090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030656, CAB034919"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB034919: AB_2183817, HPA030656: AB_10602926"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.77e-3)"	16.8	22.1	21.3	19.6	20.7	17.9	32.2	39.0	52.7	13.0	15.8	18.5	20.6	23.1	17.2	13.3	18.6	16.2	17.3	25.6	19.8	18.3	18.7	40.6	19.0	32.8	19.8	22.4	16.8	23.7	19.7	26.7	14.9	19.4	19.8	11.7	20.2	26.3	18.2	47.3	25.8	20.0	21.2	20.4	21.2	22.5	37.8	17.3	21.1	21.1	11.7	18.5	15.6	13.6	9.8	12.3	16.0	10.3	6.4	14.3	8.5	16.2	9.5	15.0	19.0	11.1	11.9	13.5	16.3	17.4	17.4	17.7	8.0	10.1	19.6	8.0	16.0	9.6	13.3	9.2	12.1	6.6	10.1	17.0	10.4	18.4	19.8	14.5	24.5	28.8	17.6	13.1	10.5	5.6	13.8	15.2	16.7	10.6	17.2	12.6	26.3	16.7	17.8	6.2	10.3	11.9	23.6	11.5	12.8	12.8	19.3	9.4	12.7	16.7	26.0	13.1	5.8	9.4	18.7	17.4	16.3	14.8	13.5	10.7	18.5	4.4	17.3	17.0	12.0	22.4	4.0	9.6	6.3	10.8	10.3	12.7	9.5	7.6	11.5	9.8	9.8	7.4	9.5	16.0	6.4	7.4	12.3	14.3	8.5	21.3	20.7	39.0	52.7	19.8	18.3	19.8	22.4	19.4	17.3	20.8	19.4	29.5	12.3	7.8	42.7	15.3	30.6	13.4	13.6	26.2	53.0	14.5	26.6	17.5	58.7	14.3	27.1	0.0	27.9	9.9	9.7	16.4	32.2	48.4	13.8	62.0	25.8	19.6	21.9	27.9	18.1	15.0	10.1	25.2	20.5	22.7	26.7	28.1	18.7	15.3	43.8	25.8	11.2	65.7	42.4	7.4	23.8	20.3	16.2	13.9
PPTC7	TA-PP2C	ENSG00000196850	"PTC7 protein phosphatase homolog"	Q8NI37	12	110533245-110583320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.8"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	10.4	15.3	6.5	10.3	9.6	26.2	10.3	8.3	12.9	9.7	11.8	5.7	4.9	7.5	9.3	4.6	12.6	7.8	8.8	35.3	9.0	9.0	12.6	11.9	13.1	10.9	10.4	6.8	8.9	7.5	13.0	12.7	6.9	15.3	7.7	9.8	8.0	12.9	8.2	53.8	13.4	11.7	13.1	7.4	9.4	8.4	8.2	6.5	16.1	8.0	15.5	13.1	12.4	12.4	2.1	1.4	6.1	1.7	1.7	2.4	0.6	12.2	7.0	6.0	6.3	15.0	13.2	8.6	5.6	7.5	6.2	6.2	7.9	4.8	21.5	5.9	5.5	8.9	11.9	12.0	13.1	12.6	15.6	10.0	19.0	7.5	8.5	14.3	21.0	15.7	11.4	21.6	8.8	25.9	9.3	11.7	15.0	14.1	6.1	10.0	3.1	18.5	18.0	8.5	6.6	13.1	15.5	8.1	13.1	25.7	13.7	9.7	7.6	10.7	14.8	12.4	6.1	7.0	11.3	13.4	5.7	6.1	17.3	9.5	17.8	19.7	24.0	9.6	11.6	11.2	0.1	1.7	1.3	2.3	1.5	2.4	1.3	1.9	1.8	1.3	2.1	2.2	1.9	6.1	1.7	1.1	1.4	1.3	0.6	6.5	9.6	8.3	12.9	9.0	9.0	10.4	6.8	15.3	6.5	20.8	21.2	21.7	47.9	81.6	8.5	96.6	15.3	25.4	22.7	8.7	13.7	6.3	14.9	6.8	29.6	22.2	18.4	23.3	7.1	7.0	37.6	42.4	23.1	24.9	15.0	12.7	16.1	14.7	25.1	17.5	10.6	19.9	32.1	10.0	14.2	3.9	11.1	14.4	9.2	10.5	24.1	12.9	39.1	12.5	22.5	91.1	5.6	20.8	13.8	64.3
PQLC1	FLJ22378	ENSG00000122490	"PQ loop repeat containing 1"	Q8N2U9	18	79902420-79951664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 150.7;Late spermatids: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051666	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051666: AB_2681567"	"unprognostic (6.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.70e-2)"	31.3	12.5	17.4	12.4	16.6	28.3	23.0	12.5	27.0	9.4	16.9	12.3	9.6	8.9	13.4	12.0	20.0	10.8	13.2	13.8	21.3	12.6	16.5	56.7	14.3	14.2	13.0	13.8	9.9	23.8	8.0	8.5	9.5	14.2	10.8	7.1	19.9	21.4	10.1	29.6	19.2	10.0	12.4	7.5	14.0	10.1	22.9	9.7	8.7	25.8	14.4	13.6	11.7	15.8	1.7	7.2	3.8	3.8	2.0	2.5	1.9	16.5	5.7	5.8	11.3	13.1	8.5	8.0	10.9	7.5	8.8	8.3	7.5	9.0	6.9	4.3	9.8	5.1	17.0	8.0	11.6	2.3	21.5	11.7	8.8	8.0	20.2	15.7	20.9	22.3	9.4	11.6	8.0	3.1	4.5	7.5	7.7	3.3	5.7	4.5	12.6	10.3	22.5	1.9	2.2	15.5	18.5	6.1	11.6	5.9	11.9	17.3	7.8	8.2	10.5	12.0	1.6	6.2	23.0	9.4	13.4	13.8	7.1	8.2	3.0	4.6	9.0	10.3	25.5	5.9	0.7	3.8	3.8	1.7	3.8	1.0	1.7	1.7	0.8	4.0	1.5	2.1	2.5	2.5	2.0	3.1	7.2	1.5	1.9	17.4	16.6	12.5	27.0	21.3	12.6	13.0	13.8	14.2	9.7	23.8	16.5	28.9	22.8	35.4	28.8	10.5	15.3	4.0	6.8	5.2	70.7	11.6	1.7	8.6	85.6	20.5	37.1	0.0	12.8	11.6	14.5	23.0	19.5	150.7	31.2	87.4	15.5	18.4	32.9	119.4	18.4	20.5	18.6	7.2	29.7	21.7	13.1	35.1	22.3	16.5	33.4	6.5	19.8	8.6	10.2	44.2	17.4	8.6	26.2	38.7
PQLC2L	C3orf55	ENSG00000174899	"PQ loop repeat containing 2 like"	A1A4F0	3	157543246-157677749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.8;breast: 36.0"	"Cell type enhanced"	"Detected in some"	20	"Collecting duct cells: 21.0;Ductal cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.9;ASC TERT1: 18.8;EFO-21: 12.8;HSkMC: 12.1;hTERT-RPE1: 13.4;LHCN-M2: 17.0"									HPA054395	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	NA			"Nucleoplasm, Nuclear bodies"		"HPA054395: AB_2682473"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.83e-5)"	"unprognostic (2.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.47e-7)"	"unprognostic (1.17e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.56e-3)"	29.8	1.6	0.2	1.8	1.3	0.1	36.0	0.0	0.8	5.3	4.1	0.0	0.0	0.1	1.3	2.0	3.1	1.8	4.3	5.6	0.3	1.2	4.5	0.1	8.4	1.6	0.5	0.1	0.4	1.4	0.1	5.9	2.6	1.3	3.9	1.4	4.6	4.5	1.0	4.8	2.2	1.6	3.4	0.3	0.1	3.8	2.7	0.0	0.0	11.8	3.0	0.5	4.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	0.0	33.9	18.8	0.0	1.7	3.5	0.7	1.0	0.0	2.4	0.0	12.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	2.7	0.0	0.0	12.1	0.6	5.2	0.3	13.4	5.3	0.0	0.3	0.0	17.0	0.1	0.0	0.0	0.1	0.6	3.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.1	0.0	0.0	4.8	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.8	0.3	1.2	0.5	0.1	1.3	0.0	0.0	0.3	0.0	0.6	0.0	0.3	0.3	2.5	1.4	1.2	21.0	0.0	0.0	0.0	5.8	4.2	0.0	0.0	0.0	1.8	0.6	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	4.2	0.3	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.7	0.8	1.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6
PQLC3	"C2orf22, MGC33602"	ENSG00000162976	"PQ loop repeat containing 3"	Q8N755	2	11155198-11178874	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 30.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061607			Approved	Cytosol		NA	NA			Cytosol		"HPA061607: AB_2797264"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.00e-2)"	26.9	21.3	5.1	16.5	6.2	4.2	16.7	2.4	6.2	22.2	14.4	11.3	8.6	5.6	19.7	27.0	18.1	15.4	19.5	14.9	5.4	5.1	20.6	9.8	21.0	26.9	7.9	5.8	20.7	33.3	5.3	5.4	15.5	7.8	18.5	10.5	15.5	14.1	11.2	14.0	9.8	16.5	19.8	13.1	26.3	12.7	12.0	5.7	12.0	17.6	13.0	15.0	15.7	14.7	11.4	36.9	37.0	46.9	14.4	18.4	33.0	3.1	10.8	2.0	6.1	30.8	21.1	7.3	6.6	8.7	3.1	3.7	2.0	12.5	1.1	5.0	12.9	13.6	4.1	3.1	3.4	3.2	20.0	1.6	3.0	1.4	1.3	12.3	1.5	9.3	15.3	11.6	2.0	4.5	6.9	7.0	7.1	2.8	7.0	8.5	14.3	2.2	3.0	4.3	11.2	3.8	2.8	3.3	3.4	11.6	5.4	0.7	3.4	5.6	17.6	12.4	9.3	15.7	5.5	9.9	4.5	1.9	4.8	1.8	12.0	8.7	0.5	11.9	7.1	8.8	15.1	37.3	37.0	18.4	45.7	16.1	11.4	18.2	18.0	36.9	7.7	10.1	13.9	2.3	14.4	46.9	7.1	18.2	33.0	5.1	6.2	2.4	6.2	5.4	5.1	7.9	5.8	7.8	5.7	23.8	6.2	18.0	19.8	22.2	1.7	2.4	20.4	12.0	14.8	50.6	15.7	16.2	8.3	32.7	0.5	17.5	10.7	0.0	56.6	70.6	37.3	19.5	12.7	10.9	53.1	1.6	6.4	38.6	87.8	0.7	43.4	62.1	55.6	84.8	10.7	4.5	41.4	3.5	55.5	11.7	0.9	58.2	38.7	2.1	18.5	20.5	9.4	45.9	11.5	16.9
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722522	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 62.1;prostate: 40.3"	"Group enriched"	"Detected in some"	5	"Intestinal endocrine cells: 873.8;Mucus-secreting cells: 545.9;Undifferentiated cells: 434.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	33	"PC-3: 92.5"									HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047871: AB_2680195"			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.6	2.0	30.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	40.3	62.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	9.9	5.1	0.8	0.0	2.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	92.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.5	0.0	0.2	0.5	0.0	0.4	0.0	0.8	0.1	0.1	2.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	97.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	67.9	0.0	0.0	0.0	0.1	118.0	0.0	0.0	0.0	0.0	873.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	545.9	0.0	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	434.0	46.7
PRAF2	"JM4, Yip6a"	ENSG00000243279	"PRA1 domain family member 2"	O60831	X	49071156-49074071	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 125.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA002859, HPA005504, CAB011655"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340"	"unprognostic (1.50e-1)"	"prognostic favorable (7.42e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (1.66e-6)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.88e-6)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (5.83e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	13.5	17.5	25.0	12.3	26.9	6.7	9.0	18.0	39.7	28.1	11.8	26.3	12.6	6.0	22.1	125.1	7.3	15.6	12.3	12.9	25.3	29.9	12.4	6.9	11.5	11.3	26.1	18.9	20.1	6.2	19.7	31.0	9.8	25.5	12.2	10.0	13.0	7.5	29.4	6.8	7.6	6.6	33.2	23.1	10.9	9.2	17.7	17.0	14.4	13.3	3.8	11.9	12.6	10.7	14.6	6.7	16.4	6.4	16.8	29.4	11.1	4.5	9.6	11.3	14.4	40.6	24.7	1.5	16.4	17.1	11.1	12.3	0.5	1.5	0.4	3.9	35.4	9.2	4.3	0.4	8.9	12.4	8.4	12.8	3.6	12.5	0.4	41.6	2.3	7.1	31.3	7.6	21.1	15.4	23.0	17.0	11.5	0.5	1.3	19.4	8.4	15.1	2.9	6.3	2.2	0.6	8.3	6.2	1.0	16.5	1.3	7.5	18.8	13.7	7.1	9.3	10.3	6.9	1.6	10.3	8.6	11.4	18.4	4.7	20.4	5.1	3.7	20.7	4.2	13.3	16.4	5.9	7.9	18.3	6.4	20.7	14.6	20.1	16.1	6.7	13.6	18.1	19.4	15.4	16.8	4.8	2.6	29.4	11.1	25.0	26.9	18.0	39.7	25.3	29.9	26.1	18.9	25.5	17.0	11.9	7.7	10.0	12.1	6.8	21.7	5.1	12.7	10.7	9.1	10.4	11.8	2.9	10.0	14.9	2.9	30.3	1.3	0.0	5.0	10.4	36.2	8.7	16.1	2.5	5.8	15.9	9.8	23.9	4.6	3.5	35.4	7.7	13.5	3.6	3.4	26.4	4.6	0.0	38.9	15.8	6.7	19.4	40.1	10.7	3.9	6.5	8.1	25.3	1.3	8.1
PRAM1	PML-RAR	ENSG00000133246	"PML-RARA regulated adaptor molecule 1"	Q96QH2	19	8490056-8503112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.8;bone marrow: 70.7;brain: 25.1"	"Group enriched"	"Detected in some"	8	"Hofbauer cells: 29.1;Kupffer cells: 73.2;Macrophages: 49.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 23.6;intermediate monocyte: 28.1;myeloid DC: 16.1;neutrophil: 14.9;non-classical monocyte: 30.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 16.1;granulocytes: 14.9;monocytes: 30.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 9.3;NB-4: 7.3;THP-1: 16.2;U-937: 51.8"					"Low region specificity"	"Detected in all"			"HPA045236, HPA050161"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA045236: AB_2679267, HPA050161: AB_2681036"	"unprognostic (1.68e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.54e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.12e-3)"	4.0	1.5	7.1	9.2	15.5	70.7	1.3	2.7	8.3	2.7	1.2	14.4	0.0	3.0	1.7	1.2	1.4	2.3	2.4	1.5	6.8	3.7	1.3	2.4	12.3	10.2	10.9	3.5	1.7	1.5	1.2	2.1	1.6	10.1	3.7	1.3	1.5	1.5	1.2	1.2	1.9	3.1	2.5	25.1	12.8	1.7	1.3	12.0	1.8	2.0	0.0	1.2	2.3	1.4	0.0	16.1	14.9	30.8	3.1	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	7.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	51.8	0.0	0.8	23.6	0.8	0.0	28.1	0.1	0.0	0.0	0.0	16.1	0.0	0.0	0.1	14.9	3.1	30.8	0.9	0.0	8.9	7.1	15.5	2.7	8.3	6.8	3.7	10.9	3.5	10.1	12.0	6.0	5.3	0.9	0.9	0.3	2.7	0.6	2.5	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	2.3	0.0	29.1	1.6	0.0	3.1	73.2	0.0	0.6	49.9	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.1	1.4	0.0	0.0	0.2	1.3	0.1	0.2	0.0	0.0	0.7
PRAME	"CT130, MAPE"	ENSG00000185686	"Preferentially expressed antigen in melanoma"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 54.3"	"Cell type enriched"	"Detected in some"	8	"Spermatogonia: 241.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"K-562: 143.2"					"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.1	1.7	0.1	0.3	0.3	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.5	0.0	2.8	10.9	0.1	0.2	0.1	0.3	0.2	0.0	0.7	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.0	0.1	0.4	0.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.2	0.0	54.3	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	9.4	0.0	19.8	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	14.2	0.0	0.0	0.0	0.6	0.0	0.0	8.6	2.1	5.0	3.7	0.1	0.0	0.4	27.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	143.2	2.3	0.0	1.2	0.0	0.0	0.0	4.2	0.6	0.8	0.0	0.0	0.0	0.0	0.1	29.4	0.0	0.0	0.0	0.0	4.3	3.5	0.7	0.0	25.8	0.0	0.0	0.4	2.0	0.1	0.0	0.1	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	30.6	5.2	0.0	0.0	5.4	0.0	0.2	0.1	0.0	3.2	0.8	0.3	6.5	0.0	29.8	241.6	0.0	0.0	0.0	0.0	0.0
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966038-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 70.0;Extravillous trophoblasts: 59.0;Spermatocytes: 129.3;Spermatogonia: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 18.9;T-reg: 5.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 18.9;T-cells: 5.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	3.2	2.8	3.5	13.0	3.8	43.3	3.6	12.5	5.8	3.4	9.3	1.6	0.2	6.1	3.5	4.7	15.0	2.6	2.8	3.5	5.1	4.9	2.3	1.9	5.8	9.2	3.4	4.7	3.6	3.8	1.6	1.5	10.4	5.2	2.4	9.9	2.7	3.9	1.0	2.5	9.9	6.6	5.4	3.5	5.8	5.0	44.3	0.8	44.5	1.8	15.3	16.5	3.5	4.9	0.9	2.0	18.9	0.4	2.0	5.8	0.7	32.9	40.2	33.7	22.8	3.5	6.0	18.1	47.4	28.0	52.5	40.3	26.8	32.1	12.5	18.9	30.2	32.5	44.9	38.3	20.3	49.8	23.2	42.5	26.0	52.6	24.6	0.9	12.8	22.5	1.5	2.6	29.8	30.6	11.7	29.4	20.3	21.6	26.9	48.8	28.6	13.1	19.5	13.2	43.1	17.3	13.8	42.0	16.8	23.4	25.0	30.7	24.3	45.1	25.1	16.3	24.3	30.1	25.3	17.6	34.7	30.7	28.6	68.2	8.7	23.1	15.5	15.2	31.8	53.0	18.9	0.4	2.0	0.5	0.0	0.3	0.9	1.0	1.0	1.8	0.4	0.9	0.4	0.2	2.0	0.2	2.0	5.8	0.7	3.5	3.8	12.5	5.8	5.1	4.9	3.4	4.7	5.2	0.8	0.0	1.9	12.3	5.2	14.7	6.8	2.4	0.0	4.0	10.3	3.5	0.0	9.5	0.0	2.9	17.7	3.2	2.0	70.0	2.5	59.0	7.4	5.1	9.2	1.6	17.6	3.2	5.2	9.8	8.6	12.3	3.4	7.0	3.3	9.0	4.5	4.5	1.7	2.6	1.8	0.0	3.5	6.5	10.3	129.3	60.0	12.4	12.2	6.9	7.4	5.4
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	106086320-106109939	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 49.1;T-cells: 100.2;Urothelial cells: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;T-cells: 19.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 68.5;RPMI-8226: 12.8;U-266/70: 25.7;U-266/84: 16.6"	"Region enriched"	"Detected in single"	6	"olfactory region: 4.4"	"Low region specificity"	"Detected in all"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	11.6	1.5	1.6	26.3	3.2	10.4	7.0	5.3	1.6	14.0	16.5	1.9	1.4	5.4	11.6	2.2	33.4	3.8	8.1	2.3	1.9	2.0	3.1	2.4	18.8	33.3	2.1	0.5	4.2	1.8	1.2	2.1	9.0	4.9	3.6	11.0	4.3	10.6	3.0	2.0	8.9	18.2	3.4	7.4	24.2	8.6	3.0	1.5	3.1	7.7	35.7	49.9	12.8	18.0	1.5	0.2	6.8	0.6	2.5	19.3	1.3	0.4	0.1	0.3	0.0	0.5	0.7	0.0	2.3	7.2	0.7	1.3	0.4	2.8	0.6	0.1	4.6	0.1	0.1	0.0	1.1	0.8	6.4	0.0	0.1	1.4	0.0	1.1	0.2	0.5	0.7	3.6	1.0	3.0	0.2	0.9	0.3	0.4	68.5	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.0	12.8	0.6	0.1	0.0	0.0	0.3	0.3	0.0	0.5	0.3	0.7	0.4	1.1	0.6	0.6	2.1	25.7	16.6	1.5	1.6	0.4	0.6	1.2	0.4	5.6	12.6	0.6	19.3	1.5	12.0	11.6	0.2	0.5	1.1	6.8	6.8	2.5	0.1	0.2	15.4	1.3	1.6	3.2	5.3	1.6	1.9	2.0	2.1	0.5	4.9	1.5	0.0	9.0	19.7	8.0	17.3	0.8	1.4	0.0	2.7	7.9	3.5	49.1	0.4	0.0	0.3	0.8	20.4	7.3	23.3	0.2	0.5	5.1	3.1	3.5	1.5	19.3	0.0	1.7	8.0	24.7	0.0	0.0	38.5	35.4	47.7	3.1	0.5	4.8	4.3	1.1	0.1	0.4	0.0	16.4	0.3	1.3	36.3	0.6	100.2	2.5	77.0
PRDM10	"KIAA1231, MGC131802, PFM7"	ENSG00000170325	"PR/SET domain 10"	Q9NQV6	11	129899706-130002835	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026997, HPA061749"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"HPA026997: AB_1855681, HPA061749: "	"unprognostic (4.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.88e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.51e-1)"	5.8	5.4	7.6	7.2	8.9	14.2	8.5	20.3	10.4	7.4	7.8	6.4	5.8	6.6	8.2	6.8	8.4	5.4	5.5	4.6	7.7	6.2	5.0	7.3	6.3	6.9	6.6	6.5	7.3	6.2	9.7	11.2	8.3	6.4	7.1	8.0	5.5	6.7	5.4	12.9	12.1	7.0	6.1	6.3	6.7	7.8	5.6	6.3	14.4	6.5	4.7	9.9	6.2	7.0	8.8	3.3	9.4	3.8	7.1	5.0	1.8	3.0	4.1	5.1	3.4	2.3	2.8	3.4	2.5	3.3	2.1	2.8	4.2	3.3	12.2	3.1	2.9	2.9	4.1	4.3	2.1	3.5	4.7	4.2	8.0	5.0	3.2	1.5	7.2	33.3	2.0	4.8	3.2	2.1	3.3	3.8	3.3	4.4	4.7	3.1	3.6	4.8	3.6	3.9	4.1	3.0	4.5	3.2	1.8	3.1	5.6	5.6	2.9	3.7	4.3	1.2	3.0	3.0	3.0	3.7	5.0	2.3	2.5	3.3	1.2	2.0	16.9	2.2	3.9	4.5	3.9	3.4	8.5	4.5	3.4	4.1	8.8	3.5	3.5	3.3	6.0	5.0	2.4	9.4	7.1	3.8	3.2	4.1	1.8	7.6	8.9	20.3	10.4	7.7	6.2	6.6	6.5	6.4	6.3	3.0	2.4	0.0	1.9	5.5	3.2	2.4	2.5	1.4	1.2	0.0	0.0	1.2	0.0	1.0	2.9	0.6	3.5	0.0	1.0	1.1	2.0	3.2	1.1	1.5	1.3	1.6	1.7	1.3	2.8	2.9	2.3	1.8	0.0	1.0	2.8	0.8	0.8	2.6	1.8	0.7	2.2	0.0	1.4	0.3	0.6	4.4	0.5	1.8	2.3	2.7
PRDM12		ENSG00000130711	"PR/SET domain 12"	Q9H4Q4	9	130664594-130682981	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"brain: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"RH-30: 19.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 11.2"	"Group enriched"	"Detected in some"	33	"basal ganglia: 6.1;hypothalamus: 2.0"	HPA043143	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA043143: AB_10806379"	"unprognostic (3.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.81e-4)"	"unprognostic (7.90e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.01e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.30e-4)"	"unprognostic (1.40e-1)"	0.1	0.7	1.0	0.3	1.5	0.0	0.1	1.1	2.2	0.0	0.1			0.3	0.0	0.9	0.0	0.0	0.0	0.0	1.0	3.7	0.0	0.2	0.0	0.0	0.5		0.0	0.8	0.1	0.2	0.0		0.0	0.3		0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.7			0.0		0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.3	0.2	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.9	0.0	0.8	0.0	0.1	0.1	0.0	19.4	0.5	0.0	0.0	0.9	0.3	0.4	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"	15.2	14.5	26.0	17.2	28.1	64.1	17.2	32.3	44.9	16.2	18.1	19.8	12.6	12.4	18.8	16.4	19.6	14.4	16.4	14.3	19.8	14.5	10.8	9.3	15.6	23.4	18.9	27.8	30.7	12.8	16.0	26.7	15.7	18.0	17.7	13.6	10.3	15.8	18.9	45.2	21.6	16.8	16.8	21.6	16.9	14.2	17.1	17.8	14.4	23.3	11.7	22.7	19.8	19.3	16.0	5.4	9.7	5.1	5.7	5.7	2.5	6.9	4.0	14.4	5.5	11.4	8.8	6.9	9.0	5.5	6.2	7.0	6.2	7.9	21.2	8.0	8.7	5.2	8.6	10.7	5.3	6.9	13.1	7.6	14.2	4.6	2.9	6.3	4.7	12.3	9.3	9.4	6.5	5.5	5.9	6.1	8.4	12.6	24.6	7.7	3.5	7.6	7.5	4.3	5.5	5.3	10.6	7.8	6.3	3.5	7.8	12.5	8.1	7.2	4.6	9.9	9.0	6.5	7.7	10.8	7.9	8.7	7.2	4.9	36.1	24.4	30.4	7.1	11.1	10.2	3.9	4.8	6.8	5.7	3.1	3.8	16.0	4.5	5.2	2.9	12.5	5.2	4.5	9.7	5.7	5.1	5.4	4.1	2.5	26.0	28.1	32.3	44.9	19.8	14.5	18.9	27.8	18.0	17.8	35.7	37.8	66.5	49.3	55.2	46.9	34.7	25.5	53.5	40.9	22.7	43.2	19.3	14.9	15.3	8.6	29.3	23.6	46.7	11.9	11.9	42.7	46.2	39.3	16.4	14.7	66.7	36.4	25.2	38.9	11.6	40.9	37.0	28.7	28.9	18.8	23.0	13.7	14.4	42.5	6.6	36.8	25.8	27.0	41.2	51.7	45.7	15.3	50.4	15.2	52.5
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089121-123194266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7"	"Cell type enhanced"	"Detected in some"	8	"Early spermatids: 2.9;Fibroblasts: 6.0;Late spermatids: 4.1;Melanocytes: 3.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;HEK 293: 9.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA030324	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	1.3	0.3	0.3	0.6	0.3	0.0	1.4	0.4	0.5	1.6	6.7	0.4	0.3	0.4	1.8	0.6	1.2	0.6	19.7	0.9	0.4	0.3	0.6	0.3	10.6	0.0	0.5	0.4	3.8	0.5	0.3	0.5	8.1	3.6	14.1	1.9	0.0	0.3	0.8	0.2	0.4	1.0	29.7	0.8	0.1	1.1	0.5	0.0	0.0	1.4	0.2	0.6	18.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.6	0.9	7.0	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.2	0.5	0.2	0.0	1.4	0.0	0.0	0.3	9.8	2.1	0.9	0.0	2.0	0.0	0.3	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	1.1	0.4	0.1	1.5	0.0	0.0	0.5	0.6	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.4	0.3	0.5	0.4	3.6	0.0	0.0	0.0	0.0	0.1	1.6	0.8	1.1	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.1	2.9	0.5	0.0	0.0	0.2	0.2	6.0	0.1	0.0	0.5	0.7	0.0	0.0	0.0	0.3	4.1	2.0	0.7	3.3	0.0	0.0	0.2	0.1	0.0	1.1	0.3	0.8	0.0	1.4	1.9	1.9	1.1	0.3	0.0	0.0	0.0
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;prostate: 30.9;seminal vesicle: 34.0"	"Cell type enriched"	"Detected in many"	31	"Bipolar cells: 289.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.2;LHCN-M2: 18.2;NB-4: 20.4;SCLC-21H: 44.1"	"Region enhanced"	"Detected in many"		"hippocampal formation: 31.4"	"Group enriched"	"Detected in all"	4	"amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7"	HPA057253			Approved	"Nuclear bodies"		No	NA			"Nuclear bodies"		"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	3.6	3.5	17.6	6.3	10.1	4.4	3.3	3.6	31.0	9.3	8.2	10.9	1.8	2.1	8.2	3.0	2.8	3.7	2.7	1.9	30.9	6.0	1.4	0.9	2.0	6.1	12.3	18.1	5.5	1.1	0.8	4.5	5.6	7.5	30.9	2.6	4.3	1.5	34.0	3.0	2.1	4.4	8.6	15.2	2.5	4.4	1.9	9.0	0.0	1.1	0.0	3.5	9.0	8.2	2.2	0.5	2.1	0.0	0.7	2.4	0.4	0.9	0.0	0.3	0.0	0.9	3.3	0.0	2.5	9.0	1.2	1.4	0.0	0.9	0.0	0.0	3.1	0.8	0.3	0.0	1.0	5.4	3.7	0.8	0.3	0.0	0.0	1.9	3.7	1.1	2.0	0.0	4.9	1.4	12.2	0.1	1.0	0.0	1.6	18.2	0.0	1.7	20.4	0.0	0.0	7.4	0.6	0.0	0.0	0.5	0.1	44.1	6.1	0.1	0.0	0.0	0.0	0.0	1.9	3.8	3.2	0.4	2.3	0.1	0.7	0.0	0.0	7.9	1.8	0.4	0.0	0.0	0.0	1.6	0.0	2.4	0.3	2.1	2.0	0.3	2.2	1.3	0.7	2.1	0.7	0.0	0.5	0.9	0.4	17.6	10.1	3.6	31.0	30.9	6.0	12.3	18.1	7.5	9.0	0.0	0.3	3.5	3.2	0.6	289.0	1.8	0.0	6.7	9.1	1.8	2.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.2	0.1	3.0	2.3	0.0	0.0	0.5	3.2	0.0	0.0	0.0	3.3	2.8	0.7	1.7	1.0	0.0	4.1	0.4	0.0	3.2	0.0	9.2	0.0	1.7	0.4	0.5	0.1	0.1	1.0	0.0	0.6
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45511036-45523047	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004682, HPA007730"	Approved		Approved	Mitochondria		NA	NA		110000000	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.89e-4)"	43.3	58.2	71.0	43.8	57.4	12.0	75.5	31.6	60.0	46.9	51.1	72.2	42.6	78.5	40.8	75.7	136.1	49.7	46.9	84.2	56.5	73.0	121.7	136.5	52.9	51.0	99.1	51.2	43.0	20.4	34.1	34.3	58.3	87.8	42.2	53.0	48.8	53.5	52.2	78.9	46.9	77.6	52.4	98.3	46.5	52.5	25.7	72.6	29.7	130.1	114.3	91.0	49.1	56.3	44.7	50.3	64.4	64.5	20.4	72.3	58.7	64.7	119.4	49.2	62.6	55.9	47.8	105.4	73.7	76.7	80.1	66.6	59.4	28.1	57.2	77.8	79.1	97.3	67.2	106.9	71.3	79.2	44.0	82.6	43.3	168.6	166.0	24.3	50.0	56.7	41.0	53.3	79.4	18.8	44.0	91.7	68.2	79.1	19.8	79.4	52.0	67.1	48.9	154.3	144.4	125.2	118.3	62.1	75.4	143.8	55.9	65.5	32.9	67.6	183.7	4.7	150.5	49.9	40.5	77.9	32.0	72.4	68.4	98.1	13.8	77.4	109.1	52.9	34.8	18.7	64.4	55.6	18.4	28.5	60.6	37.5	44.7	45.5	37.9	50.3	36.2	28.3	31.0	2.4	20.4	64.5	33.5	72.3	58.7	71.0	57.4	31.6	60.0	56.5	73.0	99.1	51.2	87.8	72.6	485.3	206.7	314.1	835.1	539.4	156.1	25.5	438.2	477.8	340.1	586.2	98.2	1056.6	802.4	878.0	14.3	395.3	667.0	116.8	386.1	1465.8	343.6	670.3	319.6	809.1	1307.1	195.5	167.4	307.6	343.8	26.3	461.7	625.9	551.7	763.8	204.7	292.0	608.7	403.3	386.1	1911.4	290.8	304.0	372.5	90.5	393.1	462.1	932.4	124.6	344.7	1354.4
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	52.1	16.0	26.6	29.5	103.2	50.5	22.5	106.5	36.3	44.5	31.6	30.2	35.1	33.9	34.1	87.2	16.4	30.5	34.8	34.3	36.2	29.8	32.1	22.5	27.4	34.1	58.2	23.5	7.4	41.8	34.8	24.4	34.2	28.0	43.6	14.2	50.0	7.0	50.5	10.7	15.9	31.0	58.5	28.7	99.6	19.1	30.8	34.6	66.6	11.9	12.4	23.0	36.7	43.2	24.4	40.0	36.5	33.2	29.3	17.3	19.9	26.2	28.9	10.6	15.7	27.9	20.8	20.5	15.8	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1	163.8	131.5	140.0	350.9	209.2	31.5	477.5	249.7	195.4	161.5	263.5	27.5	589.1	729.5	163.2	193.0	183.6	264.7	256.9	175.5	640.5	290.3	337.6	341.6	875.0	302.1	42.9	136.4	174.3	152.8	441.3	315.2	140.2	173.7	230.0	253.4	390.8	159.2	306.9	391.7	634.8	41.0	181.1	254.2	113.1	58.3	231.0	805.7	161.9	278.6	280.8
PREB	SEC12	ENSG00000138073	"Prolactin regulatory element binding"	Q9HCU5	2	27130756-27134675	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 89.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013582, HPA014133"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013582: AB_1855694, HPA014133: AB_1855695"	"unprognostic (2.32e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.28e-2)"	18.7	17.1	11.4	14.4	12.3	7.9	15.7	13.8	16.9	18.5	15.5	14.9	29.1	13.4	23.6	51.1	15.1	17.6	14.2	19.5	13.8	12.5	21.2	70.1	12.9	15.3	13.0	11.8	27.3	31.5	13.8	17.0	21.5	12.9	16.2	13.2	14.8	42.3	22.4	46.3	11.0	17.3	19.4	11.6	19.8	14.9	15.6	10.1	17.6	19.6	16.3	19.5	15.1	14.2	22.1	35.1	45.8	28.3	28.9	27.0	27.2	15.4	15.5	9.0	14.3	19.6	7.6	16.8	11.2	11.2	16.3	11.5	14.5	9.7	19.2	11.9	11.0	17.6	8.9	17.6	14.0	8.9	14.4	16.1	15.7	7.8	31.3	29.1	17.9	14.9	7.5	17.0	15.3	17.6	8.0	10.5	15.4	11.5	17.3	13.9	17.9	16.6	13.9	9.4	20.0	16.5	15.7	18.1	89.8	10.8	8.2	20.4	11.0	10.8	22.3	16.0	8.4	10.0	30.9	6.2	8.7	12.7	7.5	12.5	38.6	16.1	23.2	14.6	20.5	16.5	28.2	28.3	45.8	24.7	23.4	27.0	22.1	21.1	25.0	29.5	20.1	20.5	21.1	12.0	28.9	24.3	35.1	22.8	27.2	11.4	12.3	13.8	16.9	13.8	12.5	13.0	11.8	12.9	10.1	14.9	10.1	22.3	8.5	16.0	12.0	14.1	20.4	1.4	3.4	19.2	11.8	39.5	29.9	25.3	2.8	9.0	22.4	0.0	31.0	52.2	16.7	13.3	24.1	28.8	33.7	6.4	8.1	13.5	17.2	6.0	21.9	12.8	18.6	16.2	13.2	20.3	27.2	17.5	42.1	21.4	9.6	32.3	19.8	29.8	46.7	15.2	64.8	24.9	17.0	11.2
PRELID2	"FLJ38376, MGC21644"	ENSG00000186314	"PRELI domain containing 2"	Q8N945	5	145471799-145835369	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 31.2"	"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 377.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 15.8;myeloid DC: 5.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 5.2;granulocytes: 15.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042486	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042486: AB_10797498"	"unprognostic (9.45e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-3)"	"unprognostic (2.71e-5)"	"unprognostic (1.96e-3)"	"unprognostic (6.53e-4)"	"unprognostic (6.62e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (9.65e-6)"	"unprognostic (2.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-4)"	"unprognostic (6.42e-3)"	6.6	2.4	1.6	5.3	2.0	3.9	4.4	0.7	2.9	4.9	16.4	2.3	2.8	10.6	5.2	2.9	2.4	3.0	14.5	6.4	1.4	1.4	2.6	2.7	2.4	2.7	2.3	1.1	5.2	15.9	1.3	2.8	0.9	2.0	4.2	16.2	9.2	4.3	2.7	1.3	3.0	31.2	6.2	2.5	2.1	7.8	2.5	1.5	0.8	4.1	2.4	1.9	4.3	11.6	1.8	5.2	15.8	1.9	1.8	2.0	0.9	10.8	3.6	3.4	5.4	0.8	1.9	0.0	3.6	6.3	6.8	9.6	11.6	17.9	0.0	6.2	4.3	15.6	3.3	2.6	8.2	10.1	3.1	4.2	12.5	4.0	6.0	2.1	1.6	13.3	1.1	3.5	7.8	6.9	9.5	7.6	0.0	6.8	5.0	3.3	1.8	0.0	1.9	1.7	12.6	2.4	0.0	0.0	1.7	3.2	1.7	1.5	3.0	4.6	0.6	7.2	1.6	5.5	2.4	7.0	5.9	3.2	10.4	8.1	0.2	0.0	0.0	10.6	0.0	2.4	15.8	1.3	0.4	0.8	1.9	0.4	1.7	1.6	1.2	5.2	1.8	0.2	1.2	0.5	1.8	1.3	0.6	2.0	0.9	1.6	2.0	0.7	2.9	1.4	1.4	2.3	1.1	2.0	1.5	0.0	2.4	1.9	11.1	3.7	19.4	7.7	5.1	2.7	6.8	0.0	377.0	0.1	0.0	11.6	3.4	5.8	91.5	0.0	11.4	2.4	5.3	2.7	17.3	2.1	2.4	4.8	9.2	3.1	2.1	1.0	3.1	4.3	0.0	3.6	27.5	7.5	15.0	48.0	4.2	2.4	47.8	0.0	4.7	0.9	1.0	2.9	0.2	3.2	32.3	8.0
PRELID3B	"C20orf45, dJ543J19.5, SLMO2"	ENSG00000101166	"PRELI domain containing 3B"	Q9Y3B1	20	59033145-59042909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 91.2"	"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 165.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047721	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047721: AB_2680131"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.20e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.96e-2)"	18.6	17.0	14.1	17.0	13.9	13.7	20.4	10.3	14.1	10.0	45.2	8.7	11.2	41.3	9.6	9.6	26.7	8.8	10.3	13.3	12.9	13.4	20.5	30.1	13.5	19.1	15.4	10.0	11.1	24.2	12.7	34.3	28.8	12.3	10.5	30.0	6.1	15.3	12.6	17.2	14.0	91.2	11.6	16.7	19.9	19.3	11.5	12.1	21.4	18.9	25.5	21.2	13.9	14.4	25.8	17.5	26.6	21.0	27.1	27.6	20.2	25.9	12.8	12.5	16.3	9.3	13.2	17.6	19.2	17.1	36.1	19.3	35.7	22.0	41.3	34.0	14.7	27.9	28.4	25.4	30.6	38.0	24.4	15.9	28.6	21.8	7.6	19.8	37.3	26.6	11.7	40.4	20.7	48.3	11.9	11.7	34.3	11.2	18.1	15.4	33.3	42.0	16.6	6.2	42.2	35.6	21.9	28.4	23.4	17.9	22.2	22.6	21.7	30.8	52.4	44.3	9.6	26.5	29.2	13.7	13.1	12.7	23.9	10.1	12.3	17.5	33.4	14.3	18.4	14.6	26.6	13.6	13.5	21.4	17.9	25.9	25.8	26.1	24.0	17.5	18.6	23.6	24.8	11.7	27.1	21.0	14.7	27.6	20.2	14.1	13.9	10.3	14.1	12.9	13.4	15.4	10.0	12.3	12.1	20.8	31.8	13.4	46.7	0.0	8.1	0.0	25.5	41.5	28.4	21.0	5.9	58.5	58.0	57.9	52.0	18.0	96.3	0.0	49.8	92.9	28.8	59.3	15.1	23.2	49.1	11.1	26.9	12.3	34.8	17.4	13.8	30.9	0.0	55.9	65.9	14.3	59.9	56.1	14.9	41.1	6.5	25.8	0.0	62.2	36.7	0.0	103.8	36.2	68.2	165.6
PREX1	"KIAA1415, P-REX1"	ENSG00000124126	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1"	Q8TCU6	20	48624252-48827883	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.7;brain: 35.5"	"Cell type enhanced"	"Detected in many"	11	"Kupffer cells: 81.5;Macrophages: 39.6;T-cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 44.2;SK-BR-3: 46.4;T-47d: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001927	Supported		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001927: AB_1079674"	"unprognostic (8.07e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.47e-2)"	"prognostic favorable (8.56e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.86e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-2)"	10.8	8.1	20.5	25.1	24.9	32.7	12.4	11.4	25.0	9.6	5.1	35.5	0.2	4.6	3.2	2.7	4.8	3.7	9.5	4.9	21.8	15.5	4.1	4.0	17.7	28.3	26.2	12.1	2.2	3.9	5.2	5.8	8.4	17.4	3.9	4.6	7.7	4.0	2.8	4.6	2.7	8.6	5.6	27.6	28.7	6.1	4.5	23.9	2.8	6.7	1.0	15.1	10.3	2.5	2.0	2.1	11.7	2.7	2.1	9.3	2.2	0.6	1.7	22.5	0.0	0.3	1.7	7.8	0.7	1.0	3.2	0.8	0.1	0.0	4.5	14.3	2.0	6.1	0.2	1.1	0.0	2.1	1.0	0.5	0.6	2.5	0.0	1.3	2.4	14.7	1.8	0.0	7.4	0.0	2.2	19.4	2.0	0.0	0.1	4.2	44.2	0.0	6.9	0.9	2.2	1.8	6.6	6.5	2.7	0.1	0.0	4.7	0.7	4.1	46.4	5.1	1.3	41.4	18.9	21.6	1.3	4.6	0.0	1.2	0.2	0.9	5.5	21.0	4.9	6.9	5.2	2.3	2.5	5.0	2.7	3.0	2.0	2.7	4.2	2.1	1.7	0.4	1.5	11.7	2.1	2.3	1.7	9.3	2.2	20.5	24.9	11.4	17.7	21.8	15.5	26.2	12.1	17.4	23.9	3.0	10.0	24.1	0.2	2.3	0.2	2.5	2.5	8.1	4.5	1.8	7.9	0.6	0.0	0.1	2.8	13.4	0.2	0.0	1.1	2.7	6.0	0.8	1.1	1.5	28.2	0.0	1.2	20.3	81.5	2.3	0.9	39.6	8.5	16.2	1.0	17.2	0.2	0.0	0.4	0.0	0.6	0.0	4.7	1.9	10.2	2.0	7.8	41.5	2.9	0.4
PREX2	"DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129"	ENSG00000046889	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2"	Q70Z35	8	67952118-68237030	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 31.5;Endothelial cells: 35.0;Ito cells: 52.8;Muller glia cells: 74.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 12.8;HUVEC TERT2: 17.4;JURKAT: 7.5;NTERA-2: 11.1;RH-30: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015234, HPA075956"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA015234: AB_1847604, HPA075956: AB_2686769"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (6.64e-2)"	18.8	3.0	14.1	3.3	17.9	1.0	8.5	11.4	16.4	10.8	4.4	13.1	3.0	4.3	6.2	4.5	4.4	12.4	7.6	7.6	15.5	8.1	4.1	3.2	9.1	2.4	12.4	10.0	5.2	3.1	3.7	4.4	17.5	17.2	6.3	4.4	2.6	3.0	5.7	4.9	4.4	4.0	6.1	12.7	3.5	4.1	2.7	16.2	0.0	12.1	3.9	2.9	5.9	15.8	1.1	0.3	0.8	0.1	0.2	0.4	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	7.5	0.0	0.0	0.0	0.0	2.6	0.0	11.1	0.0	0.0	0.0	5.0	0.0	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.1	0.1	0.4	0.1	0.2	0.5	0.2	0.2	0.0	1.1	0.2	0.3	0.5	0.2	0.1	0.3	0.0	0.0	14.1	17.9	11.4	13.6	15.5	8.1	12.4	10.0	17.2	16.2	3.0	5.3	0.0	3.2	3.5	24.6	4.4	0.0	1.4	5.7	1.8	2.0	0.0	0.0	0.0	31.5	35.0	0.0	0.0	0.0	0.0	5.5	0.5	1.1	0.4	0.1	4.8	0.0	52.8	3.1	4.9	10.3	0.2	8.5	0.0	0.0	74.9	0.0	0.0	9.9	0.0	3.0	25.8	3.4	0.7	0.7	2.3	0.0	0.0	0.0	1.4
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602775	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease mutation, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 100.3;lymphoid tissue: 38.7"	"Cell type enriched"	"Detected in some"	9	"T-cells: 203.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"gdT-cell: 100.3;MAIT T-cell: 70.9;memory CD8 T-cell: 54.9;naive CD8 T-cell: 36.1;NK-cell: 65.1"	"Group enriched"	"Detected in many"	48	"NK-cells: 65.1;T-cells: 100.3"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 72.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		960000	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	8.8	1.3	0.9	5.5	1.1	15.3	2.4	0.5	0.7	1.7	3.8	0.4	0.2	1.4	4.4	2.9	2.7	1.7	5.3	4.1	0.8	0.9	1.8	6.5	19.6	11.3	2.5	0.3	2.1	1.6	0.0	1.1	3.1	1.2	3.3	0.8	3.9	2.5	3.3	2.6	0.9	5.1	1.2	1.4	38.7	3.1	1.6	0.2	12.7	2.8	1.0	10.3	3.2	1.7	0.4	0.3	1.7	0.2	65.1	100.3	46.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0	0.4	0.0	2.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	100.3	0.1	70.9	0.4	14.6	54.9	0.2	0.2	6.2	36.1	1.7	65.1	0.2	0.3	11.1	46.7	0.9	1.1	0.5	0.7	0.8	0.9	2.5	0.3	1.2	0.2	3.0	22.3	6.5	0.0	0.3	0.0	0.8	0.0	2.7	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.1	8.1	2.1	0.1	0.0	0.0	8.6	5.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.6	0.6	203.1	0.0	0.0
PRICKLE1	"EPM1B, FLJ31937, RILP"	ENSG00000139174	"Prickle planar cell polarity protein 1"	Q96MT3	12	42456757-42590355	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 71.4;Peritubular cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 8.1;naive B-cell: 13.3"	"Lineage enriched"	"Detected in many"	5	"B-cells: 13.3"	"Cell line enriched"	"Detected in many"	18	"HBEC3-KT: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001379, HPA050037"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001379: AB_1855703, HPA050037: "	"unprognostic (2.44e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.29e-4)"	"unprognostic (1.12e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.33e-4)"	9.1	4.1	8.8	6.1	12.6	2.1	17.2	6.6	27.0	16.6	6.1	2.0	5.2	3.4	15.7	8.4	3.2	10.1	17.5	16.4	7.5	5.8	6.4	2.3	11.7	5.4	4.5	10.5	16.3	2.9	2.3	3.9	6.5	5.5	7.1	3.1	11.2	12.6	7.4	4.5	7.2	3.9	16.0	4.4	16.7	3.8	7.2	1.5	0.1	9.9	3.7	4.4	8.6	12.4	13.3	1.7	2.6	1.8	0.6	0.8	0.8	1.1	0.6	2.6	0.0	1.9	2.1	0.1	1.6	0.7	0.4	0.8	0.0	2.4	0.0	4.8	0.2	0.0	0.4	1.8	152.5	0.5	0.0	0.9	2.5	0.1	0.0	0.2	0.0	0.0	3.0	1.1	1.9	0.2	0.2	6.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	8.5	0.0	2.7	0.0	0.1	0.0	3.2	0.1	0.6	0.4	0.0	0.1	0.1	2.2	0.0	5.2	0.4	0.1	2.1	2.1	2.1	0.1	0.0	0.9	0.0	1.6	0.1	1.8	1.8	0.4	0.3	1.0	0.8	8.1	0.3	0.3	1.0	13.3	0.5	0.3	2.6	0.6	0.6	1.7	0.2	0.8	8.8	12.6	6.6	27.0	7.5	5.8	4.5	10.5	5.5	1.5	14.9	5.1	3.7	4.6	2.4	11.8	4.9	20.4	0.0	3.4	1.8	2.0	0.4	0.0	3.7	71.4	5.2	0.0	0.0	2.2	0.2	9.7	0.5	1.1	0.0	0.6	7.9	0.0	14.1	1.2	16.6	9.2	0.0	6.8	0.0	0.0	2.3	2.8	0.0	23.3	2.5	4.0	0.0	3.0	3.0	4.7	1.3	0.6	0.0	0.0	0.6
PRICKLE2	DKFZp686D143	ENSG00000163637	"Prickle planar cell polarity protein 2"	Q7Z3G6	3	64092242-64445476	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 60.9;Ito cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.1;NK-cell: 1.1"	"Group enriched"	"Detected in many"	6	"B-cells: 2.1;NK-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.3;ASC TERT1: 11.4;HSkMC: 16.8;U-87 MG: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035493			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA035493: AB_10696504"	"unprognostic (2.87e-1)"	"unprognostic (4.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.77e-1)"	26.5	4.9	15.2	6.9	14.2	1.3	19.8	2.6	23.0	24.4	20.4	5.2	13.8	3.9	24.8	13.7	11.2	14.3	12.6	7.8	15.7	8.4	6.0	4.9	13.2	1.8	7.0	13.2	12.7	5.5	13.3	8.7	8.1	8.9	11.0	7.1	8.7	6.1	19.9	2.6	5.3	7.4	22.8	6.2	2.7	11.4	2.9	5.5	0.0	9.9	3.6	2.2	14.9	18.2	2.1	0.0	0.2	0.0	1.1	0.1	0.1	0.0	3.4	0.9	0.0	18.3	11.4	0.0	2.5	3.3	2.1	3.1	6.0	0.1	0.0	0.3	2.4	5.6	0.1	0.0	2.3	2.1	2.3	0.1	0.0	0.3	0.0	5.1	0.0	0.0	16.8	3.0	6.1	2.6	6.3	1.3	0.0	0.0	1.3	2.9	3.2	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.1	3.3	8.4	0.9	0.1	0.0	0.6	0.1	6.0	1.2	0.1	0.1	9.0	4.2	2.1	4.9	2.7	0.0	0.5	11.6	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.1	15.2	14.2	2.6	21.6	15.7	8.4	7.0	13.2	8.9	5.5	0.0	10.4	0.0	4.0	5.6	22.7	4.9	2.5	5.3	10.3	3.5	60.9	1.1	0.0	2.2	10.4	5.2	0.0	0.0	0.4	0.3	12.4	0.6	0.0	1.5	3.2	15.9	0.0	33.7	1.5	2.3	9.2	0.9	5.0	0.0	0.4	7.1	0.7	0.0	21.5	5.1	3.6	12.9	10.4	0.4	0.9	2.6	4.1	0.0	1.3	3.0
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780762-41787372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 2.6;Intestinal endocrine cells: 3.4;Rod photoreceptor cells: 3.4;Undifferentiated cells: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 5.3;HeLa: 6.0;hTERT-RPE1: 15.2"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"		NA	NA			"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	4.5	2.2	0.5	3.9	1.2	0.0	8.9	0.0	2.1	6.8	3.0	0.4	5.4	1.8	10.8	4.7	4.1	4.8	5.5	2.1	0.9		2.1	1.6	12.2	0.6	0.6	0.2	2.6	1.0	3.7	1.6	2.5	1.9	5.6	2.6	2.0	2.3	8.4	2.7	1.9	0.4	4.4	0.5	8.8	5.0	1.3	0.2	0.0	5.8	4.4	4.2	3.6	13.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	1.1	3.3	1.7	0.3	2.3	5.3	0.2	0.3	0.0	0.1	1.3	1.2	0.6	2.1	1.4	0.1	2.9	0.0	0.2	0.0	0.4	0.5	0.2	6.0	1.3	0.0	0.0	0.1	2.0	0.3	0.1	0.0	15.2	0.1	0.9	1.8	0.7	0.7	0.9	0.1	0.9	0.4	3.8	0.3	1.9	0.9	0.0	2.1	3.2	0.4	0.7	0.0	3.8	0.3	4.5	0.9	0.9	2.5	1.2	1.3	0.6	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	1.4	1.3	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.6	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	1.7	0.0	0.0	2.5	0.0	3.4	0.0	0.3	1.0	1.4	1.8	0.0	0.0	2.7	1.1
PRIM1		ENSG00000198056	"DNA primase subunit 1"	P49642	12	56731596-56752373	"Predicted intracellular proteins"	"DNA replication, Transcription"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 70.0;Spermatocytes: 38.6;Spermatogonia: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040010	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA040010: AB_10805599"	"unprognostic (3.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (2.40e-8)"	"unprognostic (4.68e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.53e-2)"	5.7	5.2	6.7	9.8	9.3	26.0	10.1	16.0	10.6	6.0	8.2	6.7	5.5	4.5	6.2	4.9	9.6	6.2	3.1	4.0	7.6	4.6	4.5	8.2	5.4	11.1	9.2	4.6	9.7	10.7	7.9	12.3	5.0	7.9	5.2	11.1	5.3	7.0	4.3	6.3	7.9	8.3	6.1	11.8	10.2	6.3	17.0	10.8	28.3	5.1	6.8	13.2	5.6	6.9	8.6	6.3	3.5	6.2	5.3	12.7	4.6	12.2	10.6	14.7	9.0	1.7	2.6	17.3	10.4	8.5	18.5	17.3	11.4	15.8	24.1	8.7	4.8	7.4	12.4	17.7	11.3	20.4	12.0	11.0	31.8	6.8	10.9	0.5	38.9	13.5	1.1	2.1	16.4	7.1	2.8	6.6	28.1	29.9	38.1	10.7	9.1	22.2	14.8	16.3	8.8	13.3	25.0	25.8	20.8	4.4	9.3	15.0	13.3	12.4	6.0	5.6	11.2	19.4	14.9	3.0	9.6	22.8	10.0	13.1	13.9	27.7	13.6	6.0	16.5	12.7	1.4	1.4	3.5	7.8	3.4	9.0	8.6	10.5	7.5	3.4	8.2	12.7	10.0	0.0	5.3	6.2	6.3	9.1	4.6	6.7	9.3	16.0	10.6	7.6	4.6	9.2	4.6	7.9	10.8	6.0	5.0	11.5	11.9	3.4	4.2	2.4	2.5	8.1	6.8	7.0	5.9	7.0	0.0	4.4	5.0	5.8	1.3	70.0	6.4	22.0	3.3	2.7	3.5	4.3	10.3	19.1	1.2	3.7	7.3	2.5	6.6	7.2	3.3	9.0	2.9	5.6	3.4	0.0	4.6	1.6	11.8	12.9	3.9	38.6	82.6	3.4	3.8	10.5	8.5	2.0
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788481	"Predicted membrane proteins"	"Neurotransmitter degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.2"	"Cell type enriched"	"Detected in some"	11	"Muller glia cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.5;Hep G2: 4.8;NTERA-2: 3.0;SCLC-21H: 13.2;SH-SY5Y: 7.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.2"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046671: AB_2679744, HPA060047: AB_2684194"	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	4.6	6.0	4.2	5.9	16.7	0.4	2.4	4.5	8.2	7.7	26.2	21.7	4.2	4.6	7.9	7.9	13.7	10.7	3.3	4.8	5.8	3.3	1.2	0.7	1.0	0.7	20.2	4.0	6.9	1.2	0.6	0.3	2.2	15.5	8.6	7.6	9.9	4.6	10.2	0.7	2.1	11.6	14.9	24.3	0.7	12.1	1.8	14.7	0.0	1.3	0.9	4.4	4.7	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	7.5	0.0	0.0	0.2	0.4	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	13.2	7.5	0.4	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	16.7	4.5	8.2	5.8	3.3	20.2	4.0	15.5	14.7	0.0	0.0	0.0	1.0	0.5	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.4	2.6	0.0	0.0	0.0	0.0	33.7	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.1
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649613-184694963	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Mucus-secreting cells: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 18.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA054372: AB_2682466"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	12.3	12.6	8.3	17.0	11.5	9.1	13.5	14.6	11.0	17.7	14.3	15.4	18.1	6.9	25.4	13.1	12.0	15.1	14.6	12.0	8.0	8.3	8.6	9.9	11.3	10.8	8.4	11.5	18.7	9.0	9.8	14.0	10.8	10.2	14.8	13.2	12.0	11.0	17.9	10.3	10.0	11.2	14.8	14.7	11.9	11.0	8.0	10.2	15.0	12.1	6.4	10.8	16.3	15.9	3.3	2.5	18.6	4.1	3.6	4.9	2.6	9.4	3.8	9.6	11.0	12.8	16.7	6.5	9.2	15.2	16.2	14.3	3.0	9.2	5.4	3.5	7.1	9.3	5.6	7.8	9.8	17.2	10.9	4.0	5.7	5.5	3.6	8.3	4.9	8.5	10.5	8.1	14.8	9.8	9.5	8.5	14.7	11.3	18.7	11.5	3.1	9.4	4.2	3.2	4.3	3.4	8.6	7.0	6.1	8.1	5.7	7.3	9.1	5.7	1.6	10.4	8.0	4.9	8.6	4.5	5.4	7.3	4.4	6.2	9.5	6.8	2.7	8.0	6.3	13.5	7.8	2.0	18.6	3.5	1.9	4.9	3.1	3.2	3.4	2.5	3.3	2.7	2.7	1.0	3.6	4.1	2.2	3.7	2.6	8.3	11.5	14.6	11.0	8.0	8.3	8.4	11.5	10.2	10.2	6.0	7.5	3.7	10.1	8.5	5.8	2.0	10.2	17.4	9.1	5.2	0.0	11.3	5.0	6.4	4.0	4.2	6.1	0.0	4.5	8.4	8.3	4.1	15.0	5.4	8.3	7.9	6.4	8.0	11.8	4.1	11.5	6.1	8.5	6.4	61.4	10.1	3.6	7.0	8.5	4.7	8.2	12.9	7.0	18.0	9.4	8.5	4.1	8.6	8.1	3.3
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 40.2"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 309.5;Rod photoreceptor cells: 106.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3.0	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2.0	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5.0	4.6	2.2	6.0	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0.0	4.0	12.3	0.8	4.4	2.1	0.2	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.7	2.0	0.0	0.7	0.5	2.3	1.8	1.4	2.4	4.2	3.7	4.7	0.0	0.6	0.6	7.4	0.0	7.7	0.0	7.1	0.0	8.5	0.0	6.9	5.2	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.7	0.8	1.9	0.0	0.0	1.0	0.1	0.0	0.0	5.5	0.0	5.4	0.0	0.0	0.0	13.9	1.2	2.0	5.4	5.7	0.1	0.0	6.2	3.2	0.0	0.0	1.5	2.3	2.7	6.2	0.0	0.0	0.0	4.5	0.0	1.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5.0	0.8	8.9	3.7	0.0	5.9	0.8	39.3	309.5	22.9	10.7	15.9	47.1	47.1	0.8	46.4	9.1	2.3	11.7	1.0	0.0	4.1	0.3	3.5	15.6	2.3	6.4	0.1	25.4	13.8	3.7	0.0	1.9	6.4	0.9	5.0	0.0	7.7	16.8	6.7	0.0	27.6	74.2	106.6	6.5	21.2	7.2	2.8	0.4	0.3	0.0	5.2	11.2
PRKAB1		ENSG00000111725	"Protein kinase AMP-activated non-catalytic subunit beta 1"	Q9Y478	12	119667753-119681630	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004247, CAB005058"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB005058: AB_562038, HPA004247: AB_1078149"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.42e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (5.40e-9)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.32e-2)"	16.3	17.2	8.1	16.6	11.9	23.4	13.8	12.5	20.7	16.8	22.8	14.6	6.7	20.4	13.6	13.2	17.9	11.6	19.3	9.2	8.3	7.2	40.1	12.3	21.4	20.6	8.9	9.8	14.2	21.7	11.7	10.8	19.1	11.1	9.7	22.7	20.6	15.3	10.7	12.0	10.6	23.9	12.5	10.5	20.7	25.0	33.4	8.3	20.0	17.5	9.4	16.6	16.3	10.6	26.4	17.4	38.8	19.9	22.1	20.9	18.3	4.7	12.8	10.2	9.6	8.7	7.6	13.4	7.7	10.0	12.6	9.6	13.4	10.9	15.9	10.2	10.5	5.6	6.7	10.2	15.9	11.6	10.2	9.4	24.9	5.6	19.4	15.7	11.5	31.7	11.4	13.5	11.4	15.4	14.2	9.3	23.7	38.0	6.2	9.7	13.1	26.0	12.9	14.3	7.0	14.3	15.1	8.8	9.2	14.3	15.2	8.1	13.8	10.2	3.9	10.5	13.1	12.6	15.1	11.0	7.7	8.2	5.9	7.7	20.0	17.6	11.8	7.6	7.8	11.0	24.8	16.4	38.8	17.2	18.4	20.9	26.4	18.3	18.3	17.4	21.7	19.9	18.6	19.1	22.1	19.9	15.4	19.7	18.3	8.1	11.9	12.5	20.7	8.3	7.2	8.9	9.8	11.1	8.3	44.7	42.5	11.8	5.5	3.0	12.0	4.1	10.2	10.7	17.0	21.0	3.9	15.7	39.7	7.1	1.0	13.5	16.9	0.0	27.0	8.5	8.2	5.6	11.5	5.0	10.3	20.6	18.9	4.3	5.6	1.8	5.2	9.0	3.3	12.6	16.7	11.9	10.0	14.1	6.0	29.4	17.3	6.5	6.0	25.0	9.4	3.8	12.6	10.2	21.5	7.6
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.1"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044342	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044342: AB_10966508"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.59e-3)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (6.78e-7)"	"unprognostic (4.78e-2)"	7.7	7.6	5.6	4.6	7.1	4.7	7.6	13.3	10.9	9.3	24.6	8.9	8.9	19.1	13.0	8.1	10.0	7.4	6.5	15.2	5.6	5.2	6.2	32.6	6.3	3.8	5.9	9.3	8.1	21.0	18.4	6.2	7.5	7.8	10.9	6.9	6.3	5.7	12.6	52.1	9.4	19.1	20.5	8.4	5.7	11.1	6.9	5.5	2.6	5.8	19.9	4.7	19.0	10.3	1.2	1.7	2.9	1.6	5.1	2.5	0.8	3.9	2.2	5.9	4.5	14.0	12.1	21.3	7.5	4.1	5.0	5.5	8.8	7.9	7.2	3.8	5.9	2.9	10.6	6.8	8.4	4.9	2.8	4.7	3.2	7.0	14.2	9.6	3.7	1.4	9.5	16.9	5.2	24.7	7.5	4.9	5.6	4.4	2.9	4.3	4.0	2.7	2.1	12.3	6.8	9.8	4.3	7.9	3.5	3.6	3.2	3.8	7.1	5.6	6.4	26.7	22.0	6.0	4.6	5.6	5.7	12.6	5.2	12.1	4.7	5.1	3.7	5.9	3.3	7.4	2.9	1.2	1.9	1.5	1.2	2.5	1.2	1.6	0.9	1.7	1.1	1.7	1.1	0.3	5.1	1.6	0.8	0.7	0.8	5.6	7.1	13.3	10.9	5.6	5.2	5.9	9.3	7.8	5.5	3.0	1.3	5.0	9.8	14.7	13.2	57.1	25.5	4.0	2.3	17.4	13.7	15.9	1.7	5.0	0.4	6.7	25.7	0.0	6.0	30.8	10.6	4.3	1.1	35.0	5.1	11.1	10.9	6.7	7.3	1.1	8.9	4.1	15.1	9.0	10.7	6.6	7.4	10.1	15.2	4.7	18.6	19.4	21.1	12.4	9.4	12.3	17.2	7.5	8.8	3.9
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1300000	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	25.6	43.4	19.6	17.8	22.7	9.1	34.1	29.1	39.6	20.6	17.5	16.0	16.2	13.4	19.8	15.6	20.9	18.8	16.4	91.6	20.7	29.4	14.7	34.5	16.5	28.2	21.6	27.5	47.0	15.6	20.8	24.6	15.4	26.9	16.6	16.2	18.4	15.5	24.9	92.4	13.4	14.4	29.0	16.2	28.1	13.9	24.4	11.1	15.2	15.7	26.2	14.8	21.1	17.3	1.7	2.4	8.6	5.3	0.7	1.7	1.2	26.2	15.3	34.7	41.3	30.7	32.7	6.3	28.0	25.9	39.8	36.5	18.6	9.4	11.4	22.7	44.3	19.4	17.2	24.4	26.5	37.8	20.7	12.3	20.9	28.9	18.0	26.3	12.9	22.2	31.1	12.8	31.6	11.0	24.6	33.5	18.7	19.6	29.8	40.6	38.9	29.0	9.7	12.4	26.6	34.1	26.2	32.0	26.3	19.4	16.7	27.4	17.5	25.3	15.5	11.5	17.5	22.1	12.5	25.9	47.0	13.1	62.9	26.1	20.6	21.1	16.8	31.5	19.6	17.6	0.3	3.4	0.4	1.7	5.3	0.8	1.7	0.9	1.1	2.4	1.3	1.2	1.7	8.6	0.7	4.6	1.6	0.8	1.2	19.6	22.7	29.1	39.6	20.7	29.4	21.6	27.5	26.9	11.1	6.0	4.3	11.5	6.1	7.8	40.4	110.4	28.1	4.0	2.3	14.0	25.5	5.8	6.6	10.7	25.7	21.6	16.0	0.0	16.2	4.8	14.3	7.3	0.0	30.1	29.0	3.2	16.8	31.9	44.8	12.8	45.5	32.4	13.5	7.2	14.3	24.1	13.5	7.0	48.8	9.6	23.0	19.4	17.3	25.7	6.4	9.8	6.8	7.2	11.4	6.4
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1500000	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	7.0	21.5	40.0	10.5	57.0	6.2	8.0	54.7	85.5	9.4	23.6	16.9	3.9	4.8	8.7	17.6	8.1	5.2	11.5	10.1	43.1	52.1	10.6	9.0	6.9	16.2	38.3	33.5	8.3	11.9	12.2	18.3	5.1	35.5	13.8	22.6	4.9	32.9	12.7	3.2	2.6	6.3	12.6	47.7	14.6	14.2	3.6	25.9	25.5	11.1	1.8	15.3	13.5	4.6	13.5	7.1	17.1	5.4	25.9	27.6	22.0	3.1	6.3	10.1	12.1	11.7	10.3	4.7	15.6	11.9	8.0	7.5	0.1	2.8	16.6	10.8	12.2	14.6	2.2	4.7	5.1	8.5	16.1	2.6	36.5	8.6	1.2	11.5	14.4	0.8	6.1	2.3	7.7	4.3	11.6	36.6	6.2	1.1	9.6	12.9	0.6	18.7	7.6	9.9	0.0	4.4	14.5	15.7	10.0	19.4	11.2	3.3	12.9	8.6	3.3	9.5	7.9	3.0	3.0	32.4	11.1	8.6	11.2	11.8	7.1	8.5	16.7	5.3	15.4	13.8	17.1	2.7	5.8	23.3	3.6	18.7	13.5	17.3	20.6	7.1	10.2	26.4	27.6	1.5	25.9	5.4	4.1	15.9	22.0	40.0	57.0	54.7	58.2	43.1	52.1	38.3	33.5	35.5	25.9	0.0	1.0	20.3	6.7	4.5	44.0	38.9	15.3	4.0	5.7	14.0	33.4	1.4	28.2	6.9	2.4	8.4	61.7	0.0	10.3	1.0	11.0	15.2	57.7	14.8	23.2	44.5	20.8	26.4	52.7	2.6	13.8	32.7	15.1	1.0	61.1	36.9	13.3	28.8	20.5	15.6	30.0	12.9	13.7	5.9	6.9	2.5	0.6	69.2	52.4	6.5
PRKAG1		ENSG00000181929	"Protein kinase AMP-activated non-catalytic subunit gamma 1"	P54619	12	49002274-49019197	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 80.1"	"Low region specificity"	"Detected in all"							HPA077805			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA077805: AB_2686855"	"unprognostic (3.24e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.45e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.49e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (3.40e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.57e-2)"	23.8	30.3	18.5	13.6	18.6	22.6	25.5	14.2	27.0	19.2	18.8	19.6	18.0	13.3	16.0	23.9	26.8	14.1	14.2	39.4	15.2	18.2	27.1	30.8	13.9	14.9	19.7	18.4	18.9	19.6	19.2	22.2	18.9	22.1	19.1	17.0	20.3	18.4	21.0	58.4	21.7	19.8	20.4	15.9	18.7	17.4	19.2	10.7	22.5	22.5	24.9	23.0	23.2	15.7	29.2	41.0	44.0	35.9	40.1	36.9	37.9	18.1	11.3	12.9	20.2	33.0	33.9	7.3	20.0	26.3	20.4	13.1	11.1	16.2	11.7	18.0	23.0	12.1	15.9	9.3	25.8	19.8	13.4	15.4	15.9	17.5	8.9	27.4	21.0	12.5	26.6	20.3	14.8	31.2	27.1	19.6	17.3	12.1	16.8	27.4	11.7	8.7	8.0	7.9	80.1	23.8	4.9	11.4	14.8	27.4	15.3	10.7	13.7	14.2	26.1	30.3	9.4	31.9	11.8	18.2	9.6	13.0	21.9	15.1	27.7	27.0	7.8	23.3	15.1	8.7	41.1	35.9	33.6	31.5	34.2	30.3	29.2	28.4	29.4	41.0	26.4	25.9	26.8	44.0	40.1	33.0	27.6	36.9	37.9	18.5	18.6	14.2	27.0	15.2	18.2	19.7	18.4	22.1	10.7	8.9	24.3	32.2	25.2	17.7	28.4	45.2	15.3	16.0	11.4	34.9	35.3	58.2	64.6	42.7	7.4	19.4	28.4	0.0	40.9	47.6	27.3	19.9	20.8	18.7	46.3	14.3	20.2	30.7	29.3	10.2	33.9	31.8	35.4	65.9	24.8	35.9	39.1	11.5	25.5	49.6	28.2	19.4	26.9	45.8	41.6	22.7	56.1	26.6	29.9	18.7
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556111-151877125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 77.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	12.8	5.5	15.3	8.7	28.8	6.3	9.7	31.1	19.2	8.8	11.5	7.5	9.4	16.7	10.4	10.9	10.8	8.6	12.0	77.2	15.1	13.5	15.4	18.5	8.6	7.7	12.3	14.3	6.8	6.2	6.7	5.1	20.0	18.3	17.5	13.5	7.8	11.9	14.8	21.5	6.9	17.8	32.8	8.5	12.8	13.8	9.7	9.5	2.3	12.6	5.2	7.1	22.4	12.4	7.9	7.8	18.4	6.0	3.1	6.1	3.5	15.5	4.5	3.0	3.6	13.9	11.8	5.4	7.1	6.4	7.7	7.6	2.9	19.9	0.0	11.8	9.5	58.6	5.0	1.9	8.3	12.5	3.7	2.1	4.1	0.5	0.3	20.7	3.1	4.0	5.7	17.8	7.7	8.2	12.8	13.2	4.7	1.4	1.9	23.3	5.8	1.6	2.2	3.1	6.8	13.2	1.5	2.2	3.2	14.7	3.7	13.7	2.1	4.2	7.8	3.1	8.3	2.5	4.1	17.6	1.8	1.5	0.9	4.5	1.4	1.6	0.0	21.9	9.6	17.3	18.4	6.0	10.5	5.1	5.4	3.7	7.9	4.5	4.5	4.3	3.8	4.2	6.1	13.6	3.1	5.4	7.8	2.4	3.5	15.3	28.8	31.1	19.2	15.1	13.5	12.3	14.3	18.3	9.5	6.0	17.5	17.5	32.5	9.4	15.4	84.3	7.6	14.7	13.6	43.6	7.9	2.9	54.7	13.4	39.3	19.4	29.8	0.0	19.9	19.0	16.6	41.6	21.9	55.7	17.5	3.2	12.6	19.6	50.9	26.6	6.9	39.9	15.1	42.3	27.6	18.6	19.6	17.5	7.4	14.7	4.4	12.9	29.1	3.5	19.8	9.5	42.3	26.1	25.4	38.3
PRKAR1A	"CNC1, PRKAR1, TSE1"	ENSG00000108946	"Protein kinase cAMP-dependent type I regulatory subunit alpha"	P10644	17	68511780-68551319	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019378, HPA049979"	Approved		Approved	Cytosol		NA	NA		11000000	Cytosol		"CAB019378: , HPA049979: AB_2680980"	"unprognostic (8.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	47.1	48.0	41.7	34.5	54.8	14.6	38.7	40.4	57.4	48.2	23.8	44.9	31.4	15.1	43.6	37.7	29.6	43.2	37.4	122.7	42.5	52.3	49.2	43.4	47.3	29.5	50.1	43.6	62.5	19.1	107.8	41.9	47.3	57.7	35.6	24.2	32.2	47.5	43.6	99.8	22.8	19.3	39.4	52.8	35.3	25.1	36.9	40.1	28.2	51.8	23.6	29.2	33.8	33.4	11.3	26.9	52.6	28.7	18.5	13.0	22.9	16.6	32.1	41.2	24.6	55.0	62.5	6.2	22.5	46.5	35.2	31.2	12.5	22.5	16.9	15.5	49.1	36.1	13.8	30.4	36.5	50.6	11.4	10.9	26.2	27.9	40.8	39.9	20.0	29.4	44.6	38.0	40.6	34.3	39.6	58.4	14.5	11.8	26.7	42.6	31.6	22.0	10.7	15.2	17.2	21.9	15.4	68.2	18.7	53.4	36.3	15.0	20.3	20.6	37.7	86.7	40.0	29.5	28.3	41.4	49.7	23.7	22.4	20.9	22.3	15.8	25.2	30.1	19.1	30.9	31.1	26.1	46.3	13.0	25.5	13.0	11.3	9.8	11.6	26.9	8.5	8.9	9.8	52.6	18.5	28.7	8.8	12.3	22.9	41.7	54.8	40.4	57.4	42.5	52.3	50.1	43.6	57.7	40.1	137.0	210.8	75.1	77.8	126.8	93.4	608.0	89.2	258.3	168.4	239.0	62.8	66.4	150.9	74.2	287.1	138.4	34.9	23.3	45.5	74.3	135.4	82.7	180.2	101.7	123.8	131.9	131.3	160.2	157.1	53.4	123.7	102.2	182.2	93.8	51.5	115.8	62.1	52.9	179.3	150.9	56.6	84.1	208.1	100.7	40.5	115.2	69.0	106.6	36.6	95.0
PRKCE		ENSG00000171132	"Protein kinase C epsilon"	Q02156	2	45651345-46187990	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 209.3;Late spermatids: 297.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 19.4;TIME: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001948, HPA008236, HPA044496"	Enhanced	Supported	Supported	"Vesicles,Plasma membrane,Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"	"Vesicles, Plasma membrane"	"CAB001948: , HPA008236: , HPA044496: AB_2678959"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (9.61e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (9.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.63e-7)"	"unprognostic (1.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.23e-2)"	5.5	7.4	15.3	7.2	14.2	9.3	8.1	28.8	36.5	6.6	5.5	3.8	5.9	3.6	5.6	4.6	4.7	7.6	4.7	7.7	22.5	10.0	12.8	15.5	17.5	6.9	6.0	15.0	4.1	4.2	16.3	6.0	10.4	9.1	3.6	4.7	3.7	3.6	8.6	7.2	3.0	3.7	6.2	4.4	4.9	4.4	7.2	3.7	1.5	6.5	1.2	5.4	5.0	6.5	5.5	2.2	1.7	1.4	0.9	1.3	0.6	5.4	2.0	2.9	2.9	4.4	5.2	2.3	3.8	7.0	3.2	3.5	0.5	5.4	8.2	3.6	4.0	4.6	1.3	1.8	2.0	4.6	4.9	3.5	0.0	1.4	1.1	5.0	0.6	2.9	4.6	2.3	4.8	3.5	2.7	11.8	1.8	1.1	2.0	3.7	2.8	2.6	0.3	1.0	3.0	1.0	19.4	13.8	8.8	2.9	3.7	2.0	4.4	1.7	5.8	12.5	1.1	4.7	1.9	19.5	6.3	6.6	4.6	3.8	0.0	0.0	6.9	5.2	4.6	6.3	0.0	1.2	1.7	1.0	0.4	1.1	3.6	0.7	0.7	2.2	5.5	1.3	0.4	0.4	0.9	1.4	0.9	0.0	0.6	15.3	14.2	28.8	33.2	22.5	10.0	6.0	15.0	9.1	3.7	6.0	8.6	20.1	6.3	4.4	47.5	9.3	12.7	22.7	27.3	10.4	13.7	0.3	3.3	3.0	209.3	9.9	4.5	0.0	3.3	6.9	8.0	5.7	6.9	7.3	2.6	11.1	7.5	12.3	17.0	297.3	4.9	11.1	13.5	7.2	5.3	7.0	3.0	3.5	5.6	21.3	6.7	12.9	6.6	2.7	2.2	4.3	2.4	4.3	6.2	7.1
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 56.0;Erythroid cells: 70.0;Ito cells: 55.9;T-cells: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6"	"Group enriched"	"Detected in many"	14	"NK-cells: 27.3;T-cells: 35.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 30.4;HUVEC TERT2: 39.9;MOLT-4: 26.5;RT4: 16.8;TIME: 26.1"	"Group enriched"	"Detected in many"	6	"basal ganglia: 25.0;thalamus: 19.5"	"Low region specificity"	"Detected in many"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	17.5	5.4	5.0	21.6	22.0	11.2	14.7	2.8	6.1	13.6	10.3	6.2	6.9	5.1	19.1	7.0	20.1	8.6	12.7	10.1	6.8	4.4	8.1	5.5	24.1	27.6	5.9	2.5	7.1	5.9	8.8	15.5	22.7	7.2	9.8	5.0	9.1	24.7	10.8	9.1	15.9	16.0	10.5	5.7	25.9	6.0	4.3	6.4	54.6	15.1	10.6	34.6	13.2	14.4	0.4	2.2	1.5	0.7	27.3	35.3	17.9	6.4	2.2	0.3	1.7	1.0	0.2	30.4	0.1	0.5	0.3	0.3	0.7	3.8	0.1	4.6	0.0	0.6	4.4	0.2	4.9	0.5	0.8	2.9	0.0	0.7	0.2	0.4	0.0	0.9	0.8	5.1	0.2	3.5	0.4	39.9	12.9	0.0	0.1	2.3	11.7	26.5	0.2	0.5	4.6	3.1	2.2	1.1	0.0	0.0	16.8	1.1	1.9	0.7	5.9	3.6	5.6	5.8	0.5	26.1	0.7	5.2	0.8	0.3	0.5	0.1	0.2	1.1	0.4	1.3	0.1	0.7	0.5	30.0	0.4	23.9	0.4	23.0	35.3	2.2	0.3	28.5	27.6	1.5	27.3	0.2	0.7	18.6	17.9	5.0	22.0	2.8	6.1	6.8	4.4	5.9	2.5	7.2	6.4	6.0	10.7	4.6	15.8	16.7	0.2	3.9	10.2	10.7	18.2	0.0	0.0	23.4	3.3	4.6	25.5	56.0	1.7	70.0	5.9	16.9	3.7	13.1	1.1	1.0	5.6	0.0	11.3	55.9	11.1	3.6	1.7	9.0	15.1	5.4	2.6	9.3	4.4	2.9	6.3	0.8	0.3	0.0	4.1	0.0	2.1	23.3	40.4	137.1	0.7	24.4
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222365-170305981	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	10.3	7.5	11.4	5.9	15.5	2.1	9.5	14.8	16.6	12.5	11.1	7.0	6.0	10.4	13.1	8.4	20.6	15.1	10.5	10.1	9.5	7.7	13.0	6.7	14.8	3.9	5.6	9.4	15.2	7.7	12.4	14.7	9.8	11.0	16.3	12.2	7.3	25.8	12.6	12.7	11.0	11.6	12.5	6.8	6.1	30.2	15.0	5.3	12.6	23.1	8.4	9.9	16.3	13.0	1.9	1.8	1.0	1.3	5.8	4.8	1.4	34.3	8.7	8.8	9.4	7.8	10.9	14.2	8.8	13.0	11.7	12.7	12.7	16.8	10.5	29.1	12.3	16.1	16.1	16.5	17.3	20.1	7.6	10.2	9.7	11.0	7.0	12.4	8.7	4.4	9.8	12.1	10.0	15.7	19.0	9.1	5.8	10.7	8.7	11.7	11.8	12.6	3.4	18.4	36.7	9.7	9.2	13.5	17.3	18.4	10.5	14.0	11.4	19.0	25.0	8.6	13.6	27.5	6.0	9.6	12.2	9.4	11.4	14.5	15.0	14.4	15.0	8.8	6.9	4.7	0.1	1.3	1.0	2.6	1.2	4.0	1.8	3.6	4.8	1.8	1.9	3.9	2.2	0.7	5.8	1.1	1.8	2.3	1.4	11.4	15.5	14.8	16.6	9.5	7.7	5.6	9.4	11.0	5.3	68.5	56.0	2.2	46.0	50.7	15.9	14.9	25.5	22.7	46.6	47.1	13.7	23.8	21.6	13.9	5.5	18.0	21.2	0.0	19.5	22.1	25.6	78.7	8.1	17.8	8.9	14.3	28.2	16.5	20.8	3.6	21.6	10.0	16.9	6.4	28.1	8.1	36.5	17.5	26.9	15.1	9.3	19.4	11.4	12.9	15.1	55.7	17.3	5.7	27.7	69.1
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050470-2185395	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.6;placenta: 93.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 539.8;Syncytiotrophoblasts: 926.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 15.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.2	7.8	15.9	3.0	31.8	1.4	3.9	39.8	43.6	3.2	8.6	17.1	2.3	20.0	1.7	5.5	10.1	6.5	3.1	6.4	15.5	6.4	11.3	6.8	22.3	5.0	12.2	23.6	1.9	8.5	9.8	12.0	93.0	27.3	5.8	7.5	2.6	7.0	3.0	0.4	8.8	18.4	1.2	8.4	6.9	6.1	17.5	13.5	0.6	14.1	0.9	5.0	4.0	4.6	0.4	0.3	15.0	0.3	0.8	2.6	0.3	7.3	4.7	1.7	8.7	0.0	0.0	23.0	0.5	0.2	5.5	0.3	11.9	16.0	0.0	14.6	1.8	4.8	12.9	9.9	12.3	3.9	0.5	11.0	0.0	7.6	15.8	1.6	0.0	5.7	0.3	7.4	0.0	4.2	0.0	0.0	1.9	3.2	0.1	0.1	9.0	0.4	0.0	3.3	20.2	11.4	0.0	0.0	2.5	9.4	7.8	12.0	9.7	6.0	13.4	2.5	14.9	9.4	2.0	0.0	0.0	6.9	0.0	0.0	3.5	0.6	0.1	0.6	0.1	8.3	0.3	0.0	15.0	0.6	0.3	2.6	0.3	1.0	0.6	0.0	0.4	0.8	0.4	1.2	0.8	0.0	0.3	0.8	0.3	15.9	31.8	39.8	43.6	15.5	6.4	12.2	23.6	27.3	13.5	113.2	71.1	0.8	10.2	11.6	22.8	1.2	2.5	21.4	26.1	7.0	3.9	84.1	6.6	10.9	181.6	6.0	56.7	0.0	9.3	48.8	3.1	16.4	8.1	12.5	12.7	58.8	9.8	6.7	1.0	539.8	8.9	3.3	6.8	5.4	22.1	15.6	12.2	31.6	8.1	19.0	21.6	0.0	2.2	15.8	26.8	11.7	926.6	7.7	25.3	11.9
PRKG1	"PGK, PKG, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase, cGMP-dependent, type I"	Q13976	10	50990891-52298350	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 43.8;Late spermatids: 40.9;Peritubular cells: 37.1;Sertoli cells: 38.8;Smooth muscle cells: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"basophil: 8.0"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.6;BJ hTERT+: 15.9;fHDF/TERT166: 13.1;U-138 MG: 9.7;U-87 MG: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		33000	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	8.0	10.9	5.2	6.6	7.3	0.8	6.9	2.8	5.4	19.2	14.4	2.1	6.8	2.9	22.8	10.7	6.0	9.9	12.6	14.8	7.0	4.9	4.4	2.1	19.5	2.6	3.1	4.8	8.9	2.6	13.7	8.4	11.0	4.6	9.5	6.2	6.2	6.4	9.4	24.9	2.8	5.3	28.2	2.7	2.7	5.9	5.0	3.1	0.2	9.2	12.7	1.2	13.4	15.8	0.1	0.1	8.0	0.1	0.3	0.0	0.1	0.0	0.1	1.5	11.6	5.6	5.3	0.0	5.0	15.9	1.6	2.4	0.1	0.8	0.2	0.0	13.1	1.7	0.1	0.0	0.0	1.5	0.0	4.3	0.8	0.3	0.0	4.8	0.0	0.0	6.8	0.0	4.2	0.1	0.4	0.0	0.0	0.0	0.1	4.4	0.1	0.0	0.0	3.3	0.0	2.0	0.0	3.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.1	1.6	0.1	0.0	0.0	9.7	1.7	4.9	2.9	1.2	0.6	0.0	8.6	0.0	2.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.1	5.2	7.3	2.8	5.4	7.0	4.9	3.1	4.8	4.6	3.1	14.9	9.6	0.0	1.4	0.8	6.8	29.7	0.0	1.4	0.0	3.5	0.0	0.8	0.0	1.8	43.8	3.7	2.6	0.0	3.3	0.9	13.0	0.4	4.6	0.0	0.3	0.0	0.0	4.3	0.0	40.9	30.2	0.3	3.3	0.0	4.3	23.0	3.5	11.4	37.1	0.0	1.3	38.8	47.0	0.7	0.6	0.5	1.8	0.0	3.2	0.7
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280836-11281350	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	125	"testis: 747.3"	"Group enriched"	"Detected in some"	154	"Early spermatids: 123959.8;Late spermatids: 465852.4"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Hep G2: 1.1;NB-4: 6.0;U-2197: 4.5;U-698: 2.0"									"HPA055150, HPA059371"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	747.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123959.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	465852.4	1718.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1588.2	0.0	0.0	1138.3	0.0	1916.0	855.6	0.0	0.0	0.0	0.0	0.0
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358563	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	14.8	14.4	15.6	12.7	22.0	11.1	12.9	29.4	20.5	11.4	11.7	20.2	13.9	7.0	18.9	11.9	12.7	18.1	9.3	23.1	14.4	13.1	9.5	12.2	9.7	17.0	11.2	18.7	21.9	14.8	12.0	14.0	11.4	13.3	12.8	7.6	20.8	17.3	16.2	34.0	16.9	9.9	18.5	11.6	12.4	9.9	17.0	13.1	24.4	11.1	12.0	14.9	13.3	10.4	10.8	26.2	9.9	8.5	18.6	18.1	11.5	10.2	16.7	8.0	20.0	7.6	7.2	26.7	10.3	5.6	13.1	10.9	42.3	10.3	21.9	17.4	8.7	4.8	13.4	11.3	10.4	7.3	7.8	16.9	6.5	18.8	19.1	5.5	11.9	10.2	8.0	4.5	10.8	10.2	8.1	7.8	11.4	15.4	1.2	7.1	17.2	14.7	18.5	13.1	10.3	11.4	19.8	11.7	14.8	6.1	9.4	10.9	8.5	34.5	8.7	7.0	6.8	14.5	11.9	9.3	9.3	8.3	11.1	9.2	6.7	12.4	22.5	11.8	12.8	9.6	9.9	7.0	5.9	15.8	8.5	18.1	10.1	10.6	13.9	10.2	10.8	16.1	14.1	0.8	18.6	7.7	26.2	11.7	11.5	15.6	22.0	29.4	20.5	14.4	13.1	11.2	18.7	13.3	13.1	17.9	11.7	10.4	7.4	6.2	20.5	11.8	15.3	14.7	9.1	8.7	51.1	21.8	5.0	11.0	3.4	6.8	24.9	0.0	14.4	6.5	8.0	6.2	6.9	7.5	10.2	28.6	12.7	6.7	5.9	3.2	10.9	8.3	8.5	4.6	27.0	9.4	15.1	26.9	12.4	6.8	16.4	12.9	5.7	6.3	20.0	5.3	9.7	15.2	23.3	9.3
PRMT9	"FLJ46629, PRMT10"	ENSG00000164169	"Protein arginine methyltransferase 9"	Q6P2P2	4	147637785-147684230	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 79.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036844, HPA042537"	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			Microtubules	"Nucleoplasm, Cytosol"	"HPA036844: AB_10672341, HPA042537: AB_2678043"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.30e-2)"	6.0	17.2	6.0	5.2	8.6	12.4	6.9	8.0	8.9	5.6	4.5	4.2	7.9	2.5	8.6	7.6	5.0	7.5	8.4	6.5	5.6	5.0	7.5	5.8	7.6	5.3	5.8	5.3	22.6	7.2	16.3	10.0	5.0	7.1	6.0	4.5	9.8	5.8	11.3	6.7	5.6	4.3	6.1	4.6	4.5	5.9	11.2	3.9	11.6	15.8	2.8	5.4	5.5	5.2	9.6	6.0	10.8	6.1	5.1	10.4	2.7	3.5	2.3	5.7	4.3	4.4	7.6	5.0	3.9	6.3	6.0	6.4	1.8	4.0	12.3	1.8	3.4	3.1	2.5	6.7	3.4	8.3	4.4	3.9	6.8	4.5	3.0	3.3	9.8	3.8	5.2	3.5	3.7	3.3	4.9	5.0	6.2	6.7	7.2	5.1	2.0	8.3	3.9	2.9	3.4	4.3	5.6	4.8	4.5	4.9	2.8	3.5	5.4	6.3	5.0	3.2	3.9	2.1	2.2	4.2	3.9	3.1	4.3	4.3	8.2	6.5	8.1	4.3	6.1	2.8	7.4	6.0	10.8	6.7	6.1	6.5	9.5	8.1	8.2	4.0	9.6	10.4	9.0	4.2	5.1	4.4	6.0	6.8	2.7	6.0	8.6	8.0	8.9	5.6	5.0	5.8	5.3	7.1	3.9	0.0	7.7	61.1	2.9	0.0	54.5	5.5	7.6	2.7	1.2	33.2	106.0	12.1	5.0	5.9	58.8	4.3	5.9	0.0	5.8	8.6	8.5	4.1	34.5	5.7	15.3	47.7	16.7	12.3	31.0	9.5	16.7	14.9	0.0	9.0	4.8	26.9	5.9	3.6	15.9	3.3	79.2	12.9	4.6	29.1	14.0	0.0	12.7	30.5	4.7	1.4
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686236-4701590	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 108.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 108.1"	"Cell line enhanced"	"Detected in many"		"WM-115: 116.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		2200000	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: AB_2678461"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.96e-4)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	24.6	27.3	63.4	14.2	73.1	19.8	30.5	87.5	116.1	42.0	43.4	61.6	8.5	10.6	36.3	17.7	23.0	24.1	31.4	54.1	64.6	48.9	38.5	22.2	22.2	14.7	47.2	65.6	49.6	11.8	20.7	24.9	18.7	71.6	43.8	20.9	34.1	17.1	45.0	21.8	26.7	13.5	40.8	53.1	20.3	18.1	19.1	51.4	2.9	25.6	11.8	16.4	27.0	22.3	4.6	10.5	108.1	11.7	3.6	16.7	10.0	24.6	20.3	4.6	7.2	37.9	23.2	4.1	40.8	58.9	19.8	20.2	6.7	19.1	4.5	9.5	79.5	44.9	57.4	5.1	55.6	37.2	3.7	4.4	0.0	2.3	21.0	46.6	8.0	1.8	21.0	80.2	84.7	66.2	29.2	17.0	3.3	2.4	16.0	22.8	5.5	3.1	4.9	3.8	10.8	30.2	3.8	12.4	4.1	9.9	4.4	5.5	0.8	11.6	16.2	58.0	6.7	3.3	4.2	25.5	32.3	14.8	18.0	33.2	7.4	14.9	15.0	26.0	5.9	116.2	108.1	11.7	0.8	11.9	9.7	16.7	4.2	9.8	9.4	10.5	4.6	5.8	6.8	0.7	3.6	7.6	3.7	11.4	10.0	63.4	73.1	87.5	90.4	64.6	48.9	47.2	65.6	71.6	51.4	74.5	42.1	34.0	181.6	366.5	230.5	189.4	33.1	26.8	70.5	31.4	110.0	6.3	10.0	50.5	4.7	46.7	2.0	0.0	12.7	5.7	171.5	79.9	168.6	29.7	58.0	42.9	28.7	42.4	184.5	8.0	132.6	109.3	160.3	13.6	4.9	133.0	16.9	2.9	159.8	69.9	78.9	12.9	124.6	28.3	4.3	248.5	12.0	52.2	6.9	105.0
PROCA1	MGC39650	ENSG00000167525	"Protein interacting with cyclin A1"	Q8NCQ7	17	28703197-28711854	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 58.8"	"Group enriched"	"Detected in many"	45	"Early spermatids: 1437.9;Late spermatids: 5492.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.3;REH: 12.6"					"Not detected"	"Not detected"			"HPA023648, HPA030218"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Nuclear membrane"	"Golgi apparatus"	"HPA023648: AB_1855726, HPA030218: AB_10601152"	"unprognostic (5.78e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.26e-3)"	"unprognostic (6.90e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.01e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-2)"	1.2	1.1	1.7	1.8	2.6	1.6	1.1	7.8	2.8	2.1	2.0	2.6	2.9	1.8	1.8	1.2	0.9	2.2	1.0	1.0	1.9	2.0	1.8	0.5	1.3	2.6	1.7	2.3	3.1	0.7	0.9	1.2	0.9	3.5	1.2	1.0	4.0	0.8	1.4	2.2	1.3	2.1	1.2	2.4	3.5	1.1	58.8	1.6	1.0	0.7	0.0	1.5	0.9	1.6	3.1	5.0	6.2	3.0	1.1	2.2	1.1	1.1	1.4	4.6	8.6	3.4	2.4	3.1	1.5	0.6	1.1	0.9	1.4	4.2	0.2	0.8	0.8	0.6	3.7	3.6	0.2	0.6	2.1	1.9	3.4	3.4	0.9	0.5	6.4	0.3	1.6	0.4	1.8	0.7	2.6	0.8	2.5	4.1	2.8	0.9	0.9	4.1	12.3	7.1	0.9	0.9	12.6	4.7	0.1	1.3	1.0	2.2	1.9	1.4	0.6	0.5	5.7	7.0	5.4	0.5	0.8	1.4	0.9	0.9	1.5	2.0	1.9	1.3	7.0	1.1	6.2	2.2	6.2	1.1	3.0	0.4	3.1	2.2	0.7	1.4	1.1	1.0	1.8	1.3	1.1	2.5	5.0	1.2	1.1	1.7	2.6	7.8	2.8	1.9	2.0	1.7	2.3	3.5	1.6	0.0	1.4	0.0	1.1	0.9	3.3	5.5	0.0	1.4	2.3	0.0	3.9	0.7	0.0	0.4	1437.9	0.6	1.0	0.0	0.2	1.6	1.8	0.7	15.0	0.0	2.4	3.2	2.4	3.7	4.3	5492.6	23.6	4.3	0.0	1.0	1.1	7.8	0.5	0.0	18.4	0.8	4.6	19.4	1.9	76.2	19.6	0.3	0.6	1.0	1.6	0.3
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.9"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 24.6;Melanocytes: 20.3;Suprabasal keratinocytes: 13.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	10	"OE19: 39.9;RPTEC TERT1: 19.8"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	3.8	2.3	20.8	2.8	19.3	2.0	3.3	9.8	21.3	2.0	3.5	16.2	0.1	13.8	2.3	2.2	8.8	2.4	2.2	4.6	22.2	10.8	9.9	6.6	8.6	2.3	14.9	21.8	2.4	2.2	1.9	1.5	2.4	13.5	2.6	2.6	7.4	2.1	2.4	15.5	13.0	48.9	1.9	12.6	2.2	2.1	3.5	9.8	0.1	4.3	4.1	3.7	2.1	2.3	0.4	0.4	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.4	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.4	39.9	0.0	0.0	0.0	0.2	19.8	0.4	0.0	0.1	0.4	0.6	0.1	2.9	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	20.8	19.3	9.8	21.3	22.2	10.8	14.9	21.8	13.5	9.8	14.9	24.6	0.0	0.2	4.5	0.0	1.6	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.0	0.3	13.2	0.0	0.0	0.4	0.1
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"kidney: 51.2;liver: 49.3"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 140.6;Proximal tubular cells: 216.9"	"Group enriched"	"Detected in some"	50	"liver cancer: 28.1;renal cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"Hep G2: 26.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.7	0.1	0.0	0.3	0.1	0.1	0.0	51.2	49.3	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	3.4	0.0	0.1	0.3	0.3	0.0	0.0	0.0	12.2	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.6	0.1	0.0	0.0	1.3	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	216.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274453-95291308	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 45.9;Collecting duct cells: 31.4;Urothelial cells: 37.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 23.8;CAPAN-2: 42.0;HaCaT: 22.6;hTCEpi: 24.6;MCF7: 18.6;RT4: 25.6;SK-BR-3: 36.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: AB_2685104"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.3	0.2	0.5	2.9	0.6	0.0	9.3	1.1	0.5	11.4	5.2	0.3	22.2	4.4	1.4	22.5	42.6	2.2	37.2	0.5	0.6	0.5	18.8	0.4	1.3	0.3	0.6	0.3	1.5	8.6	8.1	1.5	12.5	0.3	11.6	4.2	0.3	35.6	20.0	1.3	26.7	2.6	2.7	0.7	0.4	11.5	1.8	0.3	1.7	5.7	21.6	22.2	20.0	14.8	0.0	0.2	0.6	0.0	0.0	0.3	0.0	23.8	0.0	0.0	0.2	0.1	0.0	12.1	0.0	0.0	0.1	0.1	0.2	42.0	0.0	0.0	0.0	0.0	22.6	0.0	13.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	24.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	18.6	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	25.6	0.2	0.0	0.0	36.7	0.0	0.3	11.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	0.5	0.6	1.1	0.5	0.6	0.5	0.6	0.3	0.3	0.3	3.0	3.4	0.0	20.8	6.0	0.2	1.4	45.9	6.7	11.4	31.4	3.9	15.3	10.0	12.0	0.4	0.0	2.6	0.0	9.6	2.3	0.8	11.1	0.0	0.0	2.0	0.0	3.5	0.0	0.0	1.1	0.3	0.0	6.8	1.0	10.5	0.0	12.7	7.0	0.7	0.0	0.9	0.0	1.0	0.7	0.0	11.2	9.4	0.0	12.4	37.6
PROSER1	"bA50D16.2, C13orf23, FLJ12661"	ENSG00000120685	"Proline and serine rich 1"	Q86XN7	13	39009866-39038076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034225, HPA055687"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB034225: AB_1564157, HPA055687: AB_2682886"	"unprognostic (6.75e-3)"	"unprognostic (9.56e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.95e-1)"	10.8	9.9	10.6	12.8	13.3	26.8	11.3	22.6	14.3	8.5	13.7	17.4	9.6	12.9	11.9	11.8	14.5	9.2	8.0	8.8	10.7	6.9	12.6	11.3	15.0	15.2	14.8	9.0	10.0	19.0	7.0	19.5	35.4	12.2	13.4	17.3	11.0	17.9	8.3	11.8	18.5	15.0	9.9	16.3	16.6	12.8	19.0	15.0	26.1	14.3	8.2	17.3	10.8	11.2	4.1	4.8	6.0	4.4	7.5	6.4	4.2	7.2	5.6	17.7	12.2	6.1	4.9	28.2	6.9	6.1	6.9	7.5	17.9	11.4	17.0	5.6	6.7	9.4	12.6	19.0	12.4	11.4	25.7	15.6	25.0	6.1	12.3	13.9	26.0	15.5	6.5	15.0	11.0	25.2	4.3	11.3	19.6	12.3	10.3	7.4	12.7	15.8	13.9	26.4	14.4	6.1	16.7	18.8	10.7	7.0	11.4	10.0	11.5	4.8	12.7	10.2	14.4	13.6	15.1	10.3	4.0	6.5	7.9	8.7	9.7	9.9	18.5	6.5	14.5	7.9	6.0	3.4	0.6	5.7	3.2	6.4	4.1	5.5	6.1	4.1	3.1	4.9	5.3	0.9	7.5	4.4	4.8	3.0	4.2	10.6	13.3	22.6	14.3	10.7	6.9	14.8	9.0	12.2	15.0	3.0	15.4	11.2	4.5	6.3	10.5	5.2	2.5	4.0	4.5	0.0	7.9	16.6	1.7	6.4	15.1	7.7	6.3	0.0	11.6	15.4	5.4	9.9	11.5	5.6	9.0	15.9	10.9	6.7	18.3	5.0	6.1	6.5	5.0	4.6	16.0	4.0	13.2	14.4	4.6	2.8	9.3	0.0	3.8	13.4	12.4	6.4	22.4	9.2	13.6	7.4
PROSER3	"C19orf55, FLJ30657"	ENSG00000167595	"Proline and serine rich 3"	Q2NL68	19	35758143-35771028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 84.4;Rod photoreceptor cells: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA058492	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA058492: AB_2683733"	"unprognostic (1.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.74e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.25e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (3.74e-7)"	"unprognostic (8.60e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (9.54e-2)"	4.6	5.2	4.4	7.5	6.8	8.5	5.6	3.9	8.6	6.7	6.0	6.3	7.3	3.5	8.9	7.0	5.6	8.5	6.4	4.9	4.4	3.6	5.0	3.6	6.3	5.4	4.2	4.3	10.3	9.4	7.5	12.8	5.4	5.0	6.2	3.6	8.8	5.8	7.2	3.7	10.5	5.7	9.6	3.5	5.2	7.2	26.2	5.1	13.9	8.7	3.3	6.5	8.3	6.6	3.6	1.7	12.4	2.1	0.9	2.3	0.2	7.8	22.8	8.2	7.9	3.3	3.5	2.6	5.8	6.7	6.4	6.9	6.8	5.5	4.4	6.4	5.5	3.1	4.7	3.5	10.3	4.3	10.5	5.9	6.2	9.6	2.9	2.9	5.0	13.8	4.1	5.9	9.0	8.0	5.1	2.8	5.6	5.4	8.2	5.6	3.9	8.8	2.0	2.2	4.6	3.4	6.6	2.0	3.2	4.2	8.4	8.1	7.2	6.4	4.8	0.9	3.2	7.5	4.3	6.9	6.7	7.3	7.0	6.0	10.4	6.9	3.6	7.2	3.3	4.9	5.8	2.1	4.6	1.4	1.2	2.3	2.5	2.0	1.3	0.5	3.6	1.8	0.7	12.4	0.9	1.2	1.7	1.7	0.2	4.4	6.8	3.9	8.6	4.4	3.6	4.2	4.3	5.0	5.1	8.9	1.0	8.2	9.9	0.0	10.1	1.1	2.5	26.8	3.4	10.4	84.4	6.7	0.0	5.0	29.6	2.1	3.9	0.0	1.6	4.2	7.2	6.1	2.3	1.7	2.5	6.4	9.1	6.7	3.2	16.7	13.3	3.9	0.0	7.2	2.5	6.3	4.6	3.5	3.9	1.1	39.2	6.5	1.0	25.1	4.9	0.0	6.1	9.6	4.4	4.6
PRPF18	hPrp18	ENSG00000165630	"Pre-mRNA processing factor 18"	Q99633	10	13586927-13630868	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037599, HPA047950"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA037599: AB_10795137, HPA047950: AB_2680221"	"unprognostic (5.82e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.63e-1)"	21.7	20.4	22.8	21.1	21.3	40.5	22.6	29.3	22.9	18.5	18.5	15.9	25.3	18.3	20.8	32.1	20.7	15.6	17.1	19.5	17.1	14.8	22.8	23.5	17.9	17.9	17.2	21.4	18.4	19.8	20.1	40.8	20.2	21.6	16.4	20.5	9.8	22.3	28.5	34.1	20.9	20.1	20.9	21.9	17.4	18.6	19.4	22.0	25.6	26.2	16.0	20.7	18.0	21.9	20.0	19.9	30.3	25.0	27.0	25.8	11.6	16.7	12.6	11.2	9.6	15.7	15.4	14.1	19.6	9.8	21.5	20.7	11.9	25.8	14.1	11.1	17.9	9.6	14.0	14.8	16.2	25.0	20.7	14.7	16.4	10.8	9.3	18.8	12.8	19.8	11.8	26.4	18.7	9.2	13.1	20.8	20.6	16.9	19.0	19.5	17.3	23.8	8.8	10.6	16.5	6.3	17.1	13.7	17.4	14.2	7.2	7.9	19.7	15.4	11.1	16.6	14.4	17.2	21.0	17.6	13.4	15.8	21.7	14.6	18.7	20.0	20.1	19.8	16.2	9.1	16.9	20.4	25.9	21.6	18.1	18.6	20.0	19.7	18.5	19.9	18.2	21.0	25.8	30.3	27.0	25.0	17.4	23.6	11.6	22.8	21.3	29.3	22.9	17.1	14.8	17.2	21.4	21.6	22.0	17.9	21.9	26.2	18.8	40.5	13.3	8.1	17.8	34.8	30.7	21.0	9.8	26.7	34.9	26.2	15.5	20.1	20.0	23.3	25.4	33.7	18.6	14.4	25.5	22.9	22.9	20.6	12.1	12.3	20.4	12.0	16.4	20.6	23.6	32.5	18.8	16.0	28.3	28.1	12.4	36.6	19.9	19.4	18.9	113.0	28.5	40.9	34.9	39.2	17.5	21.0
PRPF39	"FLJ11128, FLJ20666"	ENSG00000185246	"Pre-mRNA processing factor 39"	Q86UA1	14	45084099-45116282	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001176	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001176: AB_2171026"	"unprognostic (1.79e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.84e-5)"	"unprognostic (9.51e-3)"	"prognostic unfavorable (6.51e-4)"	"prognostic favorable (8.48e-4)"	"unprognostic (4.34e-3)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (2.99e-4)"	11.9	8.6	15.3	13.3	19.1	12.8	12.4	34.0	21.4	10.5	11.9	11.2	12.6	9.1	14.3	11.6	8.3	13.4	6.4	8.7	12.5	11.5	13.1	10.6	9.1	11.2	14.5	14.4	15.2	9.4	12.9	22.3	9.7	11.4	13.9	8.1	7.0	9.5	13.5	14.2	9.5	11.0	12.2	14.2	10.6	10.1	10.2	15.6	9.5	10.8	6.7	10.4	9.8	13.8	8.7	7.6	7.7	7.4	6.5	11.0	4.9	11.8	9.0	14.8	7.7	9.8	6.7	9.7	11.8	6.6	10.6	10.8	6.2	9.9	9.3	8.4	7.0	7.5	8.7	15.6	10.0	16.2	12.5	8.9	12.6	10.5	9.3	8.0	16.8	6.1	4.4	7.1	6.5	8.2	6.5	8.3	9.8	13.6	11.6	13.4	12.6	16.0	12.2	10.0	11.3	9.4	15.9	14.5	10.5	8.7	12.0	12.4	3.8	9.0	11.3	12.9	9.2	7.0	11.3	10.5	7.0	10.4	7.7	12.7	9.4	16.4	19.2	5.0	11.7	7.4	7.7	4.3	6.6	8.3	7.0	10.8	8.7	7.6	8.2	7.6	8.2	10.0	11.0	3.0	6.5	7.4	3.2	8.7	4.9	15.3	19.1	34.0	21.4	12.5	11.5	14.5	14.4	11.4	15.6	23.8	22.7	8.3	14.7	24.3	18.8	13.7	10.2	6.7	17.0	7.0	13.7	10.3	8.3	7.2	1.2	12.1	8.0	0.0	8.2	9.1	12.7	12.1	15.1	6.6	6.6	15.9	9.2	10.4	5.1	3.3	13.8	10.2	13.5	7.2	8.6	9.4	7.0	5.8	13.8	4.4	22.7	6.5	11.3	10.6	11.8	22.1	10.1	10.2	7.9	8.9
PRPF40B	HYPC	ENSG00000110844	"Pre-mRNA processing factor 40 homolog B"	Q6NWY9	12	49568218-49644666	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 50.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038426, HPA038599"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Aggresome,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Aggresome, Cytosol"	"HPA038426: AB_10674684, HPA038599: AB_10674689"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.50e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.80e-2)"	6.2	12.3	16.6	5.8	12.6	1.5	9.7	15.6	20.3	12.8	8.8	11.7	13.2	5.5	14.7	13.8	8.5	15.2	8.3	16.3	12.6	10.6	12.9	5.5	6.6	4.1	13.3	14.5	22.0	10.3	30.3	17.5	11.8	12.0	11.0	4.9	10.4	14.2	17.9	22.3	13.1	4.7	10.4	9.6	7.3	8.9	25.1	12.9	2.3	19.4	5.5	5.2	9.9	9.1	1.8	1.5	0.0	0.4	3.1	3.5	0.8	5.2	7.6	7.7	7.5	6.4	4.1	7.2	4.3	6.0	4.6	2.3	8.8	11.7	4.2	9.2	5.6	6.5	3.1	4.6	14.8	2.4	3.1	1.8	4.4	2.8	3.1	8.1	1.4	5.9	5.9	12.6	4.6	16.7	9.9	3.6	8.7	2.1	2.3	5.4	4.9	1.0	3.0	3.2	5.9	2.9	3.7	1.2	3.3	9.7	4.8	8.2	9.9	3.4	9.6	5.2	7.4	18.3	4.0	1.5	2.8	11.5	3.7	1.8	5.4	3.0	1.6	8.5	1.1	2.6	0.0	0.4	0.0	2.4	0.3	3.5	1.1	2.3	1.1	0.6	1.8	2.7	2.9	0.0	3.1	0.2	1.5	1.0	0.8	16.6	12.6	15.6	20.3	12.6	10.6	13.3	14.5	12.0	12.9	11.9	16.9	0.5	8.0	3.2	18.1	1.0	5.1	29.4	22.7	17.4	9.8	17.6	6.6	11.1	22.9	3.5	0.7	0.0	9.6	6.1	6.7	4.7	2.3	2.6	4.6	11.1	7.5	8.0	1.0	17.7	10.9	1.4	3.3	8.2	2.7	9.4	7.1	0.0	11.3	4.4	17.6	12.9	7.2	50.8	17.7	5.3	22.1	2.5	4.5	3.9
PRPS1	"CMTX5, DFN2, DFNX1"	ENSG00000147224	"Phosphoribosyl pyrophosphate synthetase 1"	P60891	X	107628424-107651026	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043760, HPA051269"	Uncertain		Approved	Vesicles		NA	NA		140000	Vesicles		"HPA043760: AB_2678656, HPA051269: "	"unprognostic (4.47e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.30e-3)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.25e-2)"	16.8	19.0	18.8	18.7	22.4	33.5	13.0	27.0	30.3	13.5	12.1	20.5	7.0	7.3	16.6	10.4	11.8	17.6	9.6	19.9	19.0	26.5	18.5	45.1	14.9	25.4	21.8	17.5	21.4	17.8	20.0	18.2	10.0	26.9	14.9	12.4	15.0	11.2	12.4	31.2	8.4	10.8	20.0	19.3	19.4	10.8	11.3	13.6	32.3	29.9	11.3	28.6	16.9	10.7	18.2	8.5	12.6	8.7	14.4	22.1	11.6	20.7	30.8	13.7	15.8	7.6	6.0	4.7	61.1	12.7	34.7	29.4	13.3	8.9	34.2	26.4	22.2	24.9	8.5	40.8	12.6	35.7	16.9	25.4	18.2	30.7	17.3	7.0	33.7	13.6	6.8	7.4	21.0	13.8	23.3	11.9	24.7	29.0	41.5	16.0	11.1	22.8	18.2	49.6	17.5	26.7	26.6	22.0	27.5	13.6	11.9	22.6	12.1	30.3	18.3	12.3	26.8	8.4	14.1	7.1	22.6	10.6	24.7	24.2	14.2	23.1	37.4	11.7	36.6	14.1	4.8	5.2	12.6	15.7	8.2	17.6	17.0	19.7	19.3	6.2	18.2	22.1	18.7	3.1	14.4	8.7	8.5	20.1	11.6	18.8	22.4	27.0	30.3	19.0	26.5	21.8	17.5	26.9	13.6	6.0	10.6	39.3	13.5	27.6	29.0	9.5	12.7	30.8	12.5	15.7	3.9	8.6	21.6	12.6	0.6	12.2	1.6	0.0	17.6	10.9	22.4	16.3	25.5	52.0	30.0	14.3	15.5	10.4	11.7	2.6	13.0	19.1	25.3	34.3	5.4	18.6	15.4	3.5	15.9	23.1	12.2	0.0	40.6	3.1	9.7	19.4	1.5	49.0	6.4	8.4
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.1;testis: 109.7"	"Group enriched"	"Detected in many"	21	"Leydig cells: 1325.5;Peritubular cells: 1875.4;Sertoli cells: 614.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051269, HPA067599, CAB070417"	Enhanced		Approved	"Nuclear speckles,Vesicles"		NA	NA			Vesicles	"Nuclear speckles"	"CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869"	"unprognostic (7.50e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	5.4	20.8	4.0	10.2	8.7	6.1	6.1	3.7	11.5	18.7	13.3	5.7	44.4	4.1	17.0	21.7	9.6	9.6	13.2	3.3	4.0	3.5	10.8	9.0	5.4	10.7	2.7	7.7	75.3	19.9	20.1	2.4	3.2	2.9	14.9	10.2	4.4	11.1	138.1	1.5	10.3	6.3	12.2	3.9	7.6	14.3	109.7	3.1	26.2	7.8	5.5	10.9	15.1	10.2	21.9	17.7	10.5	12.5	15.0	22.7	16.7	31.3	20.8	7.2	13.1	8.9	10.6	4.1	15.6	8.6	17.3	16.9	14.7	25.2	9.2	7.1	7.5	14.8	23.8	14.0	17.1	20.4	24.7	30.1	11.3	17.1	13.6	8.3	22.3	11.7	10.2	11.5	12.9	17.1	8.9	7.0	26.8	8.3	12.9	14.6	21.6	34.0	10.3	15.4	25.5	28.1	18.2	31.1	23.5	10.4	26.1	14.0	9.4	18.9	0.7	11.8	10.4	18.8	10.1	6.5	13.7	9.9	49.9	16.6	30.3	11.1	21.9	14.3	11.3	21.4	10.5	12.5	5.6	11.7	12.4	13.6	18.0	17.0	11.1	17.7	21.9	22.7	15.3	5.5	15.0	7.7	12.6	14.0	16.7	4.0	8.7	3.7	11.5	4.0	3.5	2.7	7.7	2.9	3.1	3.0	5.4	25.1	40.7	56.8	0.6	1.6	5.1	21.4	5.7	52.4	0.0	0.6	61.3	17.7	9.4	10.8	8.4	23.3	33.8	5.7	24.8	42.5	27.6	13.9	22.0	0.0	20.9	11.6	18.7	23.3	1325.5	24.5	38.8	20.8	26.7	0.3	28.8	5.8	1875.4	8.7	0.0	614.4	21.7	4.9	5.8	38.1	0.3	29.3	48.2	31.1
PRPSAP1	PAP39	ENSG00000161542	"Phosphoribosyl pyrophosphate synthetase associated protein 1"	Q14558	17	76309486-76384521	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062396			Approved	Cytosol		NA	NA			Cytosol		"HPA062396: AB_2684750"	"unprognostic (1.12e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (3.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.51e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.37e-2)"	18.4	20.5	19.7	14.9	21.3	15.4	27.9	25.7	24.7	16.4	17.3	22.4	16.8	12.9	17.9	22.8	26.1	16.9	14.7	15.4	19.4	22.8	21.0	52.7	23.6	12.8	32.4	20.6	16.3	18.5	27.2	17.1	16.1	27.4	16.5	20.2	22.1	49.2	22.0	11.6	16.9	14.6	18.3	21.1	11.8	16.2	28.1	23.6	12.8	38.3	16.1	19.3	15.0	25.1	16.5	13.1	19.3	15.2	16.7	22.2	11.6	13.8	17.1	20.6	10.1	14.0	12.6	8.1	12.5	17.5	21.1	17.5	12.3	12.0	16.0	6.9	18.7	16.9	8.2	18.5	14.9	21.2	6.2	16.6	11.8	14.0	54.0	17.4	10.0	9.4	13.6	12.2	15.2	13.3	20.6	41.2	16.4	14.2	15.1	13.9	14.8	18.0	9.3	5.2	23.9	15.4	14.8	26.8	11.8	16.1	16.1	11.8	19.3	13.8	14.1	27.9	24.2	22.9	11.8	15.6	24.4	17.9	14.4	15.4	10.2	6.4	11.3	10.8	9.3	10.3	14.4	15.2	19.3	16.2	13.2	17.1	16.5	16.3	15.5	13.1	11.9	14.1	13.6	5.0	16.7	12.3	13.0	22.2	11.6	19.7	21.3	25.7	24.7	19.4	22.8	32.4	20.6	27.4	23.6	0.0	13.9	15.6	34.7	11.6	29.6	15.2	15.3	30.8	13.6	14.0	33.4	41.1	41.4	49.2	21.3	39.3	19.1	0.0	25.7	56.4	18.3	21.4	19.7	33.0	26.4	57.2	15.1	17.8	11.8	20.9	27.0	18.1	30.4	92.0	25.7	119.8	32.0	17.5	43.5	20.7	38.4	58.2	24.7	96.5	84.4	12.8	25.6	24.0	30.4	16.5
PRPSAP2	PAP41	ENSG00000141127	"Phosphoribosyl pyrophosphate synthetase associated protein 2"	O60256	17	18840085-18931287	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 82.5"	"Low region specificity"	"Detected in all"							HPA021881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		28000	"Nucleoplasm, Cytosol"		"HPA021881: AB_1855782"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (4.57e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.08e-2)"	9.5	15.5	18.9	22.7	20.0	16.0	12.7	42.9	23.0	13.6	16.1	27.2	13.7	19.0	16.3	14.6	15.9	16.6	16.6	13.9	20.5	22.0	22.9	16.2	13.7	35.9	23.6	19.4	20.9	16.2	18.5	24.9	10.4	20.2	13.1	19.1	16.2	13.4	13.6	9.8	15.3	16.4	13.5	35.0	14.8	17.0	22.7	22.6	28.1	20.5	10.3	41.1	12.7	13.5	26.0	18.9	17.0	14.7	21.4	29.9	16.7	11.2	12.4	18.0	12.9	7.9	5.0	18.5	8.5	6.6	11.1	10.4	15.5	5.3	28.7	8.7	7.3	11.2	13.7	21.1	10.6	12.2	12.9	16.9	9.0	10.4	12.9	10.9	5.7	8.1	5.7	7.1	14.0	10.8	11.3	10.4	16.2	13.2	4.8	9.9	12.4	12.0	6.7	12.8	22.2	8.2	17.0	29.7	12.7	6.9	7.1	10.6	13.8	12.9	5.1	13.0	82.5	14.2	8.3	6.8	4.6	9.1	15.5	10.4	7.8	9.1	11.9	9.4	8.4	9.4	12.7	13.8	17.0	16.7	14.1	18.5	26.0	21.2	17.1	18.9	24.3	29.9	22.3	5.8	21.4	14.7	13.1	21.1	16.7	18.9	20.0	42.9	20.1	20.5	22.0	23.6	19.4	20.2	22.6	14.9	24.8	27.4	16.5	14.1	35.2	8.6	28.1	30.8	13.6	10.4	27.5	11.2	23.2	20.4	42.2	12.0	14.5	0.0	19.3	30.7	13.4	14.7	45.1	16.3	20.6	15.9	25.4	18.4	14.5	33.2	13.0	15.5	11.8	23.4	21.1	23.3	18.4	11.5	12.7	22.8	31.0	19.4	12.4	47.7	58.0	18.2	11.7	17.5	20.0	13.4
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155499-59204705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 46.7;Extravillous trophoblasts: 19.2;Kupffer cells: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"		Yes	Yes			"Endoplasmic reticulum"		"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	3.2	1.4	2.8	13.8	4.2	14.9	2.0	0.9	2.8	3.1	4.2	2.2	0.7	6.9	2.0	2.1	10.3	1.7	2.1	1.4	3.1	2.3	1.7	1.1	3.4	9.6	3.2	1.6	1.7	1.0	0.2	0.6	4.8	2.0	1.2	5.5	1.2	2.2	0.5	1.3	2.9	4.8	3.2	5.1	7.3	2.5	2.5	2.1	40.8	1.3	7.7	11.7	2.8	3.2	1.4	3.0	2.5	10.6	0.7	2.0	0.8	27.6	13.3	21.0	6.1	0.6	4.9	8.6	17.2	10.8	17.9	14.3	16.4	18.7	17.9	17.6	12.6	14.6	10.2	16.1	17.7	39.3	24.8	10.3	19.7	14.7	11.0	0.2	20.8	8.3	1.1	1.3	19.7	26.2	4.4	20.2	15.0	10.7	19.5	19.1	21.5	20.4	3.7	8.7	13.0	22.5	16.4	31.5	11.5	4.8	7.5	9.1	12.6	14.2	5.2	7.5	10.6	14.0	8.0	13.7	36.8	43.0	18.5	30.6	12.6	24.2	18.0	8.2	11.6	35.9	1.0	2.3	2.5	0.8	5.1	0.3	1.4	0.6	1.0	3.0	0.9	0.6	0.8	2.3	0.7	10.6	1.6	2.0	0.8	2.8	4.2	0.9	2.8	3.1	2.3	3.2	1.6	2.0	2.1	0.0	1.7	7.0	1.9	1.6	2.0	0.8	0.0	0.0	2.3	0.0	0.0	1.8	0.0	0.3	0.5	1.1	0.4	46.7	0.4	19.2	1.6	1.0	2.3	0.0	6.5	1.6	4.7	3.7	13.3	0.2	0.9	5.1	1.7	6.4	2.2	0.8	0.6	0.0	2.1	0.3	2.8	0.0	2.1	3.0	5.1	1.1	1.7	2.5	4.3	1.4
PRR12	KIAA1205	ENSG00000126464	"Proline rich 12"	Q9ULL5	19	49591643-49626439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011959	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA011959: AB_10610286"	"unprognostic (8.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.20e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.40e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.52e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.32e-2)"	"unprognostic (9.65e-3)"	15.3	14.3	17.3	14.6	16.3	11.1	11.3	33.6	21.9	14.0	11.9	12.7	14.7	13.7	17.0	10.1	11.6	14.4	13.7	8.9	16.5	10.7	10.5	6.2	11.7	15.4	11.6	17.3	17.3	12.0	12.0	22.4	10.5	10.3	14.0	5.7	13.2	19.9	25.5	27.7	27.0	13.1	8.6	7.5	21.1	16.7	8.9	14.6	20.0	15.8	7.9	12.3	14.7	15.3	0.5	1.8	0.4	0.5	0.4	0.9	0.4	10.8	16.9	9.3	10.2	4.3	3.8	7.4	6.9	3.4	3.9	3.1	6.4	6.5	11.1	5.9	4.9	3.6	10.1	4.3	6.0	1.2	9.3	12.6	11.3	8.6	6.3	3.0	10.6	17.1	4.8	6.1	4.3	2.9	4.7	4.3	6.9	7.8	6.6	3.4	8.2	12.0	12.9	13.2	5.6	15.8	15.7	7.2	4.1	3.5	13.6	7.4	13.8	10.0	9.4	4.7	3.9	6.6	7.8	10.0	13.5	12.9	5.1	11.2	8.5	9.9	7.6	8.4	6.1	8.2	0.0	0.4	0.0	0.4	0.2	0.8	0.3	0.3	0.9	0.1	0.5	0.3	0.5	0.4	0.4	0.5	1.8	0.3	0.4	17.3	16.3	33.6	21.9	16.5	10.7	11.6	17.3	10.3	14.6	6.0	1.6	4.2	1.3	3.5	7.2	2.6	7.6	2.7	1.2	12.2	3.9	4.5	1.7	3.6	0.6	3.2	5.6	0.0	6.4	2.8	4.0	1.5	10.3	2.4	5.6	4.8	9.8	4.9	7.8	1.1	13.0	2.2	3.3	2.8	7.2	3.5	9.6	7.0	13.8	2.1	3.2	12.9	2.8	2.6	6.1	6.8	0.9	4.4	6.4	1.0
PRR14L	"C22orf30, MGC50372"	ENSG00000183530	"Proline rich 14 like"	Q5THK1	22	31676256-31750140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062645	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062645: AB_2684817"	"unprognostic (2.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.14e-3)"	10.9	10.6	9.8	13.9	12.0	15.1	10.8	18.2	14.0	9.7	11.9	9.9	8.9	8.1	10.0	8.4	14.4	10.4	8.3	9.0	10.1	7.2	8.6	9.8	10.3	12.0	9.4	9.3	13.9	9.7	18.7	21.5	13.5	11.2	8.7	13.6	7.6	11.6	11.9	8.0	13.0	16.4	9.8	10.6	12.8	11.1	11.0	11.8	20.3	10.3	5.8	13.3	11.1	12.1	4.2	4.4	10.0	12.2	3.2	3.8	1.9	9.5	9.3	10.2	10.0	9.4	8.8	10.6	5.2	6.3	8.3	7.8	8.5	3.5	10.9	5.1	10.3	6.2	9.5	19.9	7.9	8.7	14.5	8.4	6.6	7.8	6.7	8.0	20.3	14.3	7.8	8.0	11.5	10.0	7.2	11.5	8.7	9.9	7.3	8.6	9.1	7.1	6.5	11.7	13.8	3.6	10.8	16.3	6.3	6.9	11.0	14.1	8.3	12.3	7.4	6.9	12.6	6.6	8.2	10.9	5.1	10.3	6.7	7.2	11.4	13.4	8.4	7.9	10.0	7.8	9.2	5.3	6.1	3.8	6.4	3.3	3.9	2.3	3.1	3.9	4.2	3.5	3.5	10.0	3.2	12.2	4.4	3.0	1.9	9.8	12.0	18.2	14.0	10.1	7.2	9.4	9.3	11.2	11.8	20.8	16.9	13.0	8.1	6.6	11.4	17.3	15.3	21.4	35.2	10.4	19.6	14.7	8.3	16.4	4.8	9.5	22.2	0.0	14.8	12.9	10.6	11.8	25.5	17.0	12.5	14.3	9.8	12.9	18.1	4.0	13.8	15.1	1.7	15.4	18.6	13.8	18.9	14.0	7.8	9.2	11.0	12.9	7.2	11.6	14.0	8.4	18.5	10.2	16.9	15.9
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 113.1;pancreas: 75.4;thyroid gland: 61.0"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 144.2;Enterocytes: 169.7;Mucus-secreting cells: 103.4;Paneth cells: 199.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.2"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"OE19: 67.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 19.0"	HPA022918	Approved		Approved	Cytosol		No	NA			Cytosol		"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.29e-13)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	0.9	0.2	0.2	13.5	0.2	0.0	10.0	0.2	0.3	3.2	88.7	0.6	22.9	44.9	0.6	8.3	4.9	6.6	21.2	0.3	0.4	0.2	37.3	1.6	20.3	0.2	0.2	0.2	1.9	75.4	0.0	8.5	0.2	2.2	8.1	32.0	0.4	38.7	26.7	0.2	3.7	113.1	0.5	0.2	0.2	27.2	1.3	0.2	0.3	61.0	2.5	5.8	2.1	2.4	1.3	0.5	0.0	0.2	1.2	2.2	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	1.9	0.0	0.1	0.0	0.0	6.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.1	0.1	0.0	67.3	0.2	0.1	0.0	0.4	0.3	0.8	4.0	0.1	0.0	12.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	2.2	0.1	0.0	0.5	0.5	1.3	0.8	0.6	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	2.2	0.2	20.8	13.7	0.0	1.4	0.0	0.0	0.0	73.9	16.0	17.0	15.7	0.0	0.0	144.2	20.3	4.5	0.0	169.7	0.0	32.6	0.0	0.0	25.3	0.0	0.5	0.1	0.0	30.3	0.0	0.0	6.7	1.1	0.0	0.0	1.0	103.4	0.0	11.5	199.8	0.4	24.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	76.5	6.8
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464278-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 13.7;Early spermatids: 13.9;Fibroblasts: 10.5;Horizontal cells: 14.3;Smooth muscle cells: 8.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 24.5;BJ hTERT+: 25.5;fHDF/TERT166: 30.7;HSkMC: 19.7;hTERT-RPE1: 32.1;LHCN-M2: 29.7;U-138 MG: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			Nucleoplasm	"Midbody, Cytosol"	"HPA049254: AB_2680693"	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.6	4.4	4.7	7.0	4.9	0.9	11.3	21.1	7.6	20.3	5.2	2.2	1.8	2.9	15.7	4.6	4.1	5.8	8.2	16.9	4.7	3.8	3.6	1.5	10.0	3.1	2.3	4.9	6.9	2.4	1.8	2.5	12.8	9.6	10.9	6.7	1.4	3.2	3.9	30.4	4.4	4.9	11.6	3.0	4.3	4.3	3.2	1.6	0.0	4.9	14.2	1.8	8.7	23.2	0.5	1.4	0.7	3.2	0.2	0.2	1.0	1.0	0.0	2.5	0.0	7.0	24.5	0.0	11.1	25.5	15.9	12.2	0.0	0.0	0.0	0.0	30.7	2.8	0.0	2.4	0.2	16.8	0.0	0.6	0.0	0.3	0.0	6.7	0.0	0.0	19.7	2.7	4.7	15.0	32.1	0.5	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	1.9	0.0	1.3	0.0	0.0	4.9	0.0	0.0	0.3	2.0	0.0	0.0	0.1	36.7	4.2	1.1	5.7	0.1	0.0	0.0	2.1	0.0	1.2	0.5	3.2	0.2	0.1	1.8	0.1	0.2	0.1	0.0	1.4	0.5	0.1	0.2	0.7	0.2	1.1	0.5	0.1	1.0	4.7	4.9	21.1	7.6	4.7	3.8	2.3	4.9	9.6	1.6	0.0	0.0	0.0	6.4	1.1	2.0	2.5	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.1	13.9	0.1	0.0	0.0	0.0	0.0	10.5	6.0	0.0	0.0	0.5	14.3	0.0	0.6	1.2	7.4	2.6	1.2	1.7	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.5	0.0	8.3	0.6	1.5	0.5	0.5	0.0	0.0	0.5
PRR19	MGC70924	ENSG00000188368	"Proline rich 19"	A6NJB7	19	42302098-42310821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 25.8"	"Group enriched"	"Detected in some"	8	"Early spermatids: 22.2;Late spermatids: 45.8;Spermatocytes: 32.9;Spermatogonia: 25.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA070350			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"HPA070350: AB_2686259"	"unprognostic (2.05e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.02e-2)"	"unprognostic (7.55e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.44e-5)"	"unprognostic (3.57e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-2)"	0.5	1.0	2.2	1.3	5.8	3.5	0.8	2.6	2.9	1.0	0.5	0.7	0.6	0.7	0.8	0.8	1.0	0.9	1.1	0.3	1.8	1.6	0.7	0.9	0.6	0.9	0.9	0.8	0.9	0.5	1.0	0.8	1.2	1.7	0.9	0.5	0.6	1.0	0.8	0.6	1.3	0.8	0.7	1.6	0.7	0.6	25.8	1.0	1.3	0.8	0.3	0.9	0.8	0.5	3.1	2.3	2.8	2.2	2.6	2.9	1.3	3.9	6.1	3.3	4.5	0.2	0.3	3.5	2.3	1.8	5.4	5.1	2.5	3.8	0.7	7.0	1.9	4.0	1.3	1.6	1.7	1.2	2.6	1.5	4.2	3.6	1.5	1.2	1.1	2.6	1.8	2.4	3.5	0.7	1.1	0.9	4.4	2.2	2.0	2.4	9.3	3.9	2.0	3.5	3.7	0.0	1.6	0.6	0.4	1.8	3.4	7.6	3.0	3.2	2.3	0.9	1.1	3.0	1.5	1.2	3.6	5.3	0.9	3.1	0.4	1.4	1.2	3.8	2.9	3.6	2.8	2.2	0.6	2.4	1.8	0.8	3.1	1.7	2.3	2.3	2.2	2.3	1.3	2.4	2.6	0.7	1.5	2.9	1.3	2.2	5.8	2.6	2.9	1.8	1.6	0.9	0.8	1.7	1.0	0.0	0.3	0.0	0.7	0.6	0.4	0.4	0.0	4.0	0.0	0.0	0.0	0.7	1.7	0.9	22.2	0.5	0.4	0.0	1.0	0.6	0.4	0.4	0.0	0.2	0.7	1.6	0.0	0.0	0.0	45.8	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.1	0.5	0.1	0.0	0.6	32.9	25.6	0.6	0.5	0.0	0.5	0.4
PRR22	MGC24975	ENSG00000212123	"Proline rich 22"	Q8IZ63	19	5782960-5784765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"testis: 82.5"	"Group enriched"	"Detected in many"	13	"Early spermatids: 151.0;Late spermatids: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 16.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044157	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA044157: AB_10960694"	"unprognostic (8.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.19e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.42e-3)"	"unprognostic (9.37e-3)"	"unprognostic (4.18e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-3)"	1.1	1.0	1.1	1.7	1.5	2.0	1.1	1.1	1.7	1.1	1.3	1.2	1.1	3.1	1.1	1.1	1.6	2.5	1.1	1.1	1.1	0.7	2.4	4.4	1.1	1.5	1.1	1.1	1.1	2.7	1.0	1.2	1.1	1.1	2.7	0.3	1.1	3.2	1.1	1.1	5.4	3.3	1.1	1.1	2.7	2.4	82.5	1.1	1.1	2.3	1.1	1.1	1.1	1.1	0.2	0.0	0.0	0.2	0.0	0.9	0.1	1.8	3.2	1.4	6.6	0.0	0.2	6.6	1.3	0.6	1.0	1.6	3.2	1.8	2.9	3.7	0.2	0.7	2.4	1.0	1.3	0.2	4.5	10.3	1.4	1.4	1.1	0.6	3.1	16.1	0.8	1.1	1.4	0.4	0.1	0.2	3.6	7.2	0.0	0.8	6.9	3.6	3.8	8.3	0.3	3.3	3.5	1.2	4.6	0.3	2.1	1.8	3.3	0.3	2.4	3.7	0.3	2.8	2.5	1.0	2.5	6.8	8.7	1.6	9.4	7.3	5.6	0.2	6.2	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.9	0.4	0.0	0.0	0.2	0.0	0.0	0.1	1.1	1.5	1.1	1.1	1.1	0.7	1.1	1.1	1.1	1.1	3.0	0.3	0.8	0.4	0.2	5.3	0.3	2.5	0.0	2.3	3.5	0.0	1.9	0.0	0.7	151.0	0.4	2.6	0.0	0.6	0.7	0.8	1.1	0.0	2.1	0.9	4.8	2.4	0.6	1.0	60.2	2.0	0.0	0.0	0.0	2.6	2.2	0.7	1.5	0.4	1.0	5.3	6.5	0.0	8.3	6.6	1.0	1.5	0.0	2.7	0.5
PRR23A		ENSG00000206260	"Proline rich 23A"	A6NEV1	3	139005468-139006268	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	8	"testis: 6.1"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 1.1"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 2.8"									HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.48e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.7	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0
PRR23C	FLJ46210	ENSG00000233701	"Proline rich 23C"	Q6ZRP0	3	139042102-139044892	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 3.4;testis: 4.3"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 3.0;Late spermatids: 1.5;Spermatocytes: 1.4;Spermatogonia: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"									HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.00e-1)"			0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.1	4.3			0.0		0.0	0.0	0.0	1.0	0.4	3.4	0.4	0.8	0.4	0.2	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.9	1.2	0.0	0.3	0.6	0.3	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.3	0.2	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	3.4	0.4	0.6	0.2	0.2	0.2	0.3	0.3	0.1	0.0	1.0	0.3	0.4	2.2	0.8	0.1	0.4	0.3	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.5	0.1	0.0	0.0	0.0	0.0
PRR3	"CAT56, Em:AB014077.1, Em:AB023052.2"	ENSG00000204576	"Proline rich 3"	P79522	6	30556886-30563723	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.0;HAP1: 12.6;JURKAT: 8.8;U-266/84: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064061			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064061: AB_2685185"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.25e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (6.49e-6)"	"prognostic favorable (5.61e-5)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (7.84e-7)"	"unprognostic (2.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.21e-3)"	7.6	5.6	9.7	5.5	7.4	4.0	3.5	15.0	13.8	5.4	4.5	5.6	3.1	2.5	7.3	15.3	3.6	6.2	4.0	3.2	10.1	12.1	4.3	3.8	4.9	6.1	5.9	7.6	13.5	5.4	10.6	8.8	3.4	8.0	4.4	5.3	6.9	2.6	6.9	3.1	6.5	3.4	3.8	4.6	5.0	5.9	8.6	5.7	11.1	4.9	1.7	5.6	6.4	4.0	2.0	2.3	1.5	1.2	1.3	1.9	0.4	0.6	1.6	5.3	10.0	2.6	0.9	0.0	0.0	0.0	0.0	0.0	4.6	0.5	4.6	3.9	0.9	3.5	0.6	12.6	1.0	0.0	2.7	4.5	6.7	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	0.0	0.0	8.8	7.3	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.2	0.0	6.8	2.3	0.6	0.0	0.0	0.0	3.1	0.7	4.0	0.0	0.0	0.0	7.6	8.5	4.4	0.0	2.6	2.9	1.5	1.2	0.3	0.5	0.3	1.0	1.0	1.6	1.2	1.0	2.0	0.9	1.9	1.0	1.3	0.6	2.3	0.0	0.4	9.7	7.4	15.0	13.8	10.1	12.1	5.9	7.6	8.0	5.7	8.9	22.1	16.0	6.3	5.0	9.0	2.4	7.6	14.7	13.6	3.5	13.7	12.1	6.6	4.0	0.6	5.0	7.9	0.0	8.1	6.2	9.1	4.6	11.5	3.9	7.0	6.4	7.5	9.2	6.2	1.8	9.5	7.7	10.1	10.0	7.6	8.0	4.9	5.3	9.6	8.2	18.5	6.5	7.2	8.1	5.9	5.0	8.2	10.2	6.5	3.4
PRR32	CXorf64	ENSG00000183631	"Proline rich 32"	B1ATL7	X	126819764-126821786	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"heart muscle: 8.9;tongue: 26.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"glioma: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"THP-1: 1.3"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 12.0;pons and medulla: 14.2;thalamus: 8.8"	"Low region specificity"	"Detected in many"			HPA048386	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centrosome"		NA	NA			"Plasma membrane"	"Nuclear speckles, Centrosome"	"HPA048386: AB_2680380"					"unprognostic (7.10e-3)"	"unprognostic (7.97e-2)"				"unprognostic (3.79e-1)"						"unprognostic (2.98e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.4	0.0	1.1	3.4	0.0	8.9	0.2	0.1	0.0	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	1.7	0.0	3.1	0.1	0.0	0.3	0.5	0.3	0.0	0.0	0.1	0.0	0.0	26.7	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR36		ENSG00000183248	"Proline rich 36"	Q9H6K5	19	7868719-7874379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.5;pituitary gland: 6.5"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 12.4;Cone photoreceptor cells: 11.8;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 22.3;SCLC-21H: 6.5;SH-SY5Y: 14.6;T-47d: 7.3"					"Low region specificity"	"Detected in all"			HPA062741	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Golgi apparatus"		Yes	No			"Golgi apparatus"	"Nucleoplasm, Nuclear speckles"	"HPA062741: AB_2684860"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (3.56e-1)"	"unprognostic (8.52e-3)"	0.4	2.0	11.8	0.5	11.4	0.3	1.5	12.0	20.5	0.7	0.4	0.8	0.0	0.8	1.2	0.8	0.3	1.1	0.5	0.3	8.0		1.1	0.4	1.3	0.4	0.0	10.6	0.9	3.2	1.6	6.5	0.3	5.5	2.5	0.4	0.5	3.0	1.0	0.3	0.8	0.4	0.4	0.7	0.4	1.4	0.7	1.2	0.0	1.0	0.0	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.7	5.3	4.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	2.3	0.0	1.5	0.0	0.5	0.1	4.1	0.0	0.0	0.0	5.2	0.0	0.2	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	2.6	0.1	0.1	0.0	2.3	0.2	0.2	2.0	0.3	0.4	22.3	0.0	0.2	3.0	4.3	6.5	14.6	0.0	0.2	0.0	0.4	7.3	0.0	0.0	0.0	2.7	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0											0.0	0.0	0.0	0.7	0.0	12.4	0.8	2.5	0.0	0.0	5.2	11.8	0.2	5.0	2.7	5.2	0.0	0.0	0.0	0.8	0.2	0.0	1.8	0.0	0.2	0.1	9.5	3.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	4.2	0.7	0.0	0.0	1.0	4.3	0.0	0.3	0.2	0.7	0.0	0.2	0.0	0.4	1.0
PRR5L	"FLJ14213, PROTOR-2"	ENSG00000135362	"Proline rich 5 like"	Q6MZQ0	11	36296288-36465204	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.1;intestine: 25.7;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 30.1;Paneth cells: 31.7;T-cells: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.6;HMC-1: 27.5;hTERT-HME1: 28.6;SiHa: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070174			Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cytokinetic bridge, Cytosol"		"HPA070174: AB_2686231"	"unprognostic (6.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.71e-8)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.98e-2)"	2.9	1.5	4.2	8.1	15.5	3.1	2.4	1.7	9.5	9.5	25.7	34.1	1.1	2.5	2.6	1.6	1.4	4.9	5.3	1.6	7.2	5.1	3.8	2.3	10.4	6.2	24.9	3.8	11.4	2.0	1.0	2.7	2.8	16.6	2.3	21.4	3.3	6.3	1.6	0.7	1.6	9.3	4.8	22.8	26.1	2.6	1.2	19.7	1.1	3.0	0.2	2.6	3.6	3.6	1.1	4.2	16.9	12.3	4.6	20.1	7.2	0.0	2.8	5.0	0.1	0.7	0.0	0.0	6.0	4.7	12.8	13.2	0.0	0.0	0.0	2.0	7.5	2.9	0.2	1.0	3.1	6.2	2.3	1.7	0.6	16.6	0.0	1.6	0.0	27.5	2.0	4.3	1.2	28.6	12.0	5.3	0.0	0.0	0.0	6.5	1.5	0.3	0.0	0.3	0.0	1.1	1.7	0.5	0.5	13.0	3.1	0.0	0.2	18.9	0.0	1.2	3.3	0.0	0.2	3.7	10.8	3.4	0.0	7.5	0.1	0.0	0.0	4.6	0.6	3.3	16.9	1.1	13.3	20.1	11.8	4.6	0.0	7.2	16.8	1.3	1.1	1.6	10.8	6.5	4.6	12.3	4.2	0.0	7.2	4.2	15.5	1.7	9.5	7.2	5.1	24.9	3.8	16.6	19.7	17.9	6.2	0.0	0.2	0.3	0.0	0.8	2.5	10.7	6.8	7.0	0.0	0.1	1.7	1.2	12.4	4.7	18.8	0.0	2.1	0.1	1.3	0.2	4.7	0.5	7.3	0.0	1.7	14.1	9.5	30.1	0.6	1.5	0.0	3.6	17.0	1.0	2.3	31.7	0.4	0.3	0.3	6.5	1.2	0.4	0.5	0.5	0.2	21.3	13.3	0.3
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 33.1;tongue: 13.0"	"Group enriched"	"Detected in some"	16	"Early spermatids: 3.6;Late spermatids: 8.1;Syncytiotrophoblasts: 7.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SuSa: 20.7"	"Not detected"	"Not detected"							HPA027714	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	1.0	0.0	0.0	0.0	0.0	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.6	0.3	13.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	20.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0
PRRC1	FLJ32875	ENSG00000164244	"Proline rich coiled-coil 1"	Q96M27	5	127517609-127555089	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039212	Supported		Approved	Vesicles		NA	NA		80000	Vesicles		"HPA039212: AB_10794634"	"prognostic unfavorable (9.35e-5)"	"unprognostic (9.01e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.19e-1)"	19.1	22.3	9.2	13.3	10.2	14.3	19.3	12.7	11.0	24.0	23.3	13.0	24.5	19.5	26.5	21.9	23.0	17.6	18.0	17.2	8.5	8.5	26.5	40.0	17.1	21.1	11.3	8.3	25.2	55.7	28.0	38.6	42.3	10.8	18.2	21.9	17.2	47.6	24.5	13.1	21.3	36.7	17.8	12.5	19.4	18.4	18.0	11.9	30.4	23.4	16.7	28.3	21.7	19.7	14.3	13.3	11.5	11.6	10.1	20.7	9.7	13.3	13.7	20.5	15.5	27.8	35.6	24.0	23.6	26.6	21.2	33.5	23.4	15.7	14.9	24.7	37.5	15.9	12.2	15.9	29.3	32.8	20.6	11.1	13.0	13.7	20.2	16.0	11.9	17.1	24.3	21.6	22.4	26.2	19.5	22.5	14.3	11.1	18.4	24.4	15.1	23.4	12.9	11.7	19.3	18.0	9.0	27.1	19.3	16.7	16.9	15.0	11.6	18.5	20.3	17.3	19.6	21.6	15.7	26.5	19.5	14.6	22.6	16.5	15.5	11.5	19.6	23.0	19.2	19.1	11.5	9.9	7.7	16.8	11.6	20.7	14.3	14.0	14.5	13.3	10.2	15.6	13.8	3.0	10.1	10.8	9.0	10.9	9.7	9.2	10.2	12.7	11.0	8.5	8.5	11.3	8.3	10.8	11.9	32.8	18.0	15.6	12.5	13.1	11.7	10.9	28.1	21.4	27.3	26.2	13.7	21.1	11.6	25.8	2.7	18.0	31.5	0.0	26.8	34.3	24.7	29.7	15.1	34.6	19.3	7.9	15.0	31.9	20.9	3.1	31.9	12.0	18.6	8.2	46.4	9.5	26.7	21.0	28.3	20.2	11.7	12.9	23.7	9.8	19.9	16.3	26.4	13.1	28.3	14.2
PRRC2B	"BAT2L, BAT2L1, KIAA0515, LQFBS-1, MGC10526"	ENSG00000130723	"Proline rich coiled-coil 2B"	Q5JSZ5	9	131373636-131500197	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021022, HPA064301"	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA021022: AB_1852324, HPA064301: AB_2685237"	"unprognostic (4.78e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.02e-1)"	"prognostic favorable (5.42e-9)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-2)"	27.4	29.1	43.3	30.3	44.1	30.3	22.1	54.6	56.3	29.4	26.3	32.7	27.3	18.9	33.8	19.7	35.7	36.1	27.5	28.0	39.0	34.1	24.7	18.1	22.5	31.8	26.8	36.8	51.4	30.2	42.0	35.5	23.6	28.9	28.2	15.1	31.8	23.0	29.9	29.4	42.4	23.0	27.2	21.4	27.4	22.2	21.9	26.9	28.1	29.9	18.3	28.1	26.0	29.5	10.3	6.9	4.1	4.5	5.8	7.4	3.0	17.8	34.6	37.0	25.6	28.3	29.2	37.0	18.1	17.7	21.1	17.5	32.4	15.2	30.9	21.4	20.7	24.0	43.0	36.9	15.4	16.0	31.7	19.9	19.2	60.9	14.2	19.1	25.5	25.5	28.6	20.4	22.8	26.6	21.2	24.4	12.4	34.8	23.1	18.9	37.4	21.3	16.5	26.9	17.9	14.2	41.3	37.7	29.7	15.3	28.0	50.0	31.4	43.8	26.7	18.2	24.5	54.1	15.8	35.2	47.4	22.0	20.9	23.6	10.2	25.4	41.5	16.6	13.8	23.4	4.1	4.5	2.7	7.4	1.9	5.5	5.5	4.4	6.6	2.3	10.3	7.2	6.3	3.2	5.8	1.1	6.9	3.6	3.0	43.3	44.1	54.6	54.7	39.0	34.1	26.8	36.8	28.9	26.9	26.8	34.8	28.7	29.5	37.2	106.8	8.4	40.8	36.1	40.9	54.1	72.6	26.9	1.7	29.1	7.3	39.4	18.8	0.0	26.2	28.6	31.7	42.9	26.6	34.7	23.4	138.2	59.8	41.7	40.8	7.8	55.5	20.7	27.0	32.5	26.8	32.1	30.4	14.4	50.2	17.4	66.0	25.8	34.8	7.7	14.5	37.1	19.5	37.3	30.7	40.7
PRRG1	PRGP1	ENSG00000130962	"Proline rich and Gla domain 1"	O14668	X	37349275-37457295	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.4"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078129			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA078129: AB_2686878"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (8.34e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (8.21e-2)"	"prognostic favorable (2.05e-7)"	"unprognostic (1.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.48e-1)"	11.6	5.5	12.0	3.1	22.0	0.7	5.8	2.6	18.7	6.7	5.7	35.9	4.6	4.1	6.2	2.5	5.9	4.0	12.4	8.5	17.9	10.7	14.9	10.7	6.3	2.5	31.0	9.9	6.2	2.6	1.2	2.3	10.6	21.3	5.1	6.0	3.0	3.9	11.6	19.3	3.1	4.3	7.5	43.4	4.0	3.4	2.4	23.7	0.0	11.6	2.9	1.6	5.9	4.5	0.6	0.2	2.6	1.7	0.2	0.4	0.1	15.0	3.4	2.8	2.8	9.4	7.6	1.2	6.4	8.6	2.3	4.0	8.2	9.7	0.0	11.1	5.0	4.3	4.9	7.6	4.8	4.0	0.0	2.4	2.7	3.6	2.8	11.5	0.0	3.5	11.8	4.0	4.5	3.8	4.6	11.9	0.0	1.2	0.0	8.0	1.1	0.0	0.0	3.3	2.4	7.2	0.0	6.2	0.0	39.4	0.7	0.0	0.0	4.7	7.5	2.8	7.7	0.0	1.6	8.5	3.6	2.2	7.0	1.9	0.0	0.0	0.0	3.6	0.0	3.3	2.6	1.7	0.1	0.2	0.5	0.2	0.6	0.1	0.3	0.1	0.4	0.2	0.4	0.8	0.2	0.2	0.2	0.2	0.1	12.0	22.0	2.6	13.9	17.9	10.7	31.0	9.9	21.3	23.7	6.0	3.4	0.0	4.2	10.1	1.8	7.6	12.7	0.0	0.0	31.4	0.0	5.5	6.6	5.9	0.6	16.5	5.6	0.0	2.7	11.7	8.7	5.9	1.1	15.3	3.8	17.5	2.9	14.7	5.1	0.0	4.4	1.4	3.3	1.0	4.8	1.9	12.9	8.0	2.5	7.3	0.2	6.5	5.6	0.9	3.6	5.5	8.7	0.0	4.1	7.4
PRRG2	PRGP2	ENSG00000126460	"Proline rich and Gla domain 2"	O14669	19	49580646-49591015	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 38.8;Paneth cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.7;OE19: 13.8;RT4: 9.0;SK-BR-3: 10.5;T-47d: 11.4;U-266/84: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010702	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA010702: AB_1079693"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (3.82e-9)"	"unprognostic (4.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.68e-2)"	0.9	0.4	0.5	1.1	0.6	0.0	4.8	1.1	1.3	4.0	14.3	0.4	17.5	8.3	1.9	9.6	13.7	3.3	9.8	0.7	0.5	0.4	15.0	12.1	5.2	0.4	0.7	0.4	1.9	13.4	13.8	16.1	8.6	0.7	5.4	5.3	0.7	24.9	14.6	1.2	10.1	23.2	1.4	0.5	1.0	7.1	1.7	0.4	2.1	21.9	9.8	7.8	4.2	4.2	1.2	4.2	2.1	0.9	0.0	1.4	0.4	8.4	0.3	0.2	0.7	1.0	0.0	3.6	0.2	0.0	0.3	0.3	1.7	11.7	0.5	1.3	0.1	0.2	6.8	0.2	6.6	0.3	0.8	0.9	0.4	0.5	0.6	0.7	0.3	0.9	0.7	5.8	0.2	0.2	0.6	2.6	0.7	0.2	0.6	0.0	1.8	0.1	0.7	0.5	13.8	1.1	0.2	0.3	6.6	5.2	9.0	1.9	0.2	1.0	10.5	0.1	0.9	11.4	0.1	0.4	0.7	0.5	0.3	0.1	4.1	13.7	0.4	0.1	0.2	0.3	0.0	0.9	0.4	1.4	0.1	0.7	1.2	0.6	0.6	0.1	0.7	0.8	0.7	2.1	0.0	0.7	4.2	0.6	0.4	0.5	0.6	1.1	1.3	0.5	0.4	0.7	0.4	0.7	0.4	6.0	12.0	1.3	12.1	3.7	1.9	0.8	10.2	4.0	9.1	12.2	2.0	11.6	3.3	27.3	0.7	6.2	38.8	0.0	29.0	5.4	0.8	11.8	2.3	4.9	2.1	4.8	15.5	0.6	3.2	0.0	0.3	2.3	1.7	12.6	13.9	0.8	24.3	31.6	0.0	12.1	3.7	0.0	1.8	0.5	1.5	4.1	10.6	0.8	14.2	12.8
PRRG4	TMG4	ENSG00000135378	"Proline rich and Gla domain 4"	Q9BZD6	11	32829943-32858123	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 110.4;Glandular cells: 119.2;Suprabasal keratinocytes: 123.7;Urothelial cells: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 13.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 31.0;hTCEpi: 16.7;SK-BR-3: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA009040, HPA024566"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA009040: AB_1079694, HPA024566: AB_2237712"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.26e-2)"	1.4	1.4	1.1	3.3	1.7	2.8	7.9	0.7	0.8	7.5	15.7	1.0	13.5	5.3	2.0	5.8	27.6	3.9	5.6	2.1	1.5	1.5	15.7	16.7	10.3	0.5	2.6	0.1	2.0	3.3	1.3	10.6	22.0	1.7	8.9	4.6	2.2	12.7	17.1	1.0	15.4	15.8	1.7	1.7	2.2	3.9	1.0	1.8	3.5	21.0	20.1	12.0	5.6	16.6	0.3	0.5	13.2	2.6	0.3	0.2	0.5	7.4	0.3	0.0	0.1	0.1	0.0	3.2	0.0	3.8	0.9	1.6	3.6	7.4	0.0	0.2	0.0	2.0	31.0	0.8	1.9	0.3	0.2	5.1	1.5	1.1	0.2	0.0	0.6	1.4	0.2	16.7	0.3	0.1	1.3	0.0	0.0	0.0	0.5	0.3	3.4	0.6	3.4	0.3	6.1	0.9	0.0	0.0	0.9	5.7	9.6	1.1	0.1	5.2	13.0	1.6	1.0	9.4	7.3	0.1	0.4	0.5	1.7	0.7	3.4	2.4	0.0	0.9	4.3	1.4	0.7	2.6	0.2	0.1	0.9	0.1	0.1	0.1	0.1	0.5	0.3	0.1	0.2	13.2	0.3	0.8	0.2	0.1	0.5	1.1	1.7	0.7	0.8	1.5	1.5	2.6	0.1	1.7	1.8	26.8	23.1	2.7	81.1	110.4	0.0	0.8	68.8	29.4	19.4	45.4	0.0	20.2	6.6	26.3	0.4	8.2	42.2	0.0	31.9	15.7	6.0	119.2	0.0	42.4	7.6	1.6	13.2	7.4	30.5	0.0	0.3	8.0	11.8	40.5	25.7	0.0	21.2	14.4	1.4	17.0	0.0	6.5	5.2	2.6	3.8	123.7	68.5	2.5	38.2	139.3
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952394	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 23.6;Rod photoreceptor cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;MCF7: 16.1;SK-BR-3: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		18000	"Plasma membrane"	Nucleoplasm	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	1.4	2.9	8.4	1.8	11.9	2.1	2.0	13.4	26.0	2.4	1.4	4.2	0.0	1.0	2.0	2.2	1.7	10.8	1.9	1.6	5.9	3.2	1.5	0.9	1.4	1.8	2.7	8.3	2.9	2.9	24.7	6.9	0.8	11.4	4.0	0.8	1.8	2.0	2.9	1.5	2.5	1.2	1.7	2.3	1.5	1.5	3.9	3.2	1.2	3.4	0.0	2.0	2.1	1.8	1.8	1.5	0.9	0.6	1.7	3.8	1.0	0.2	0.7	2.6	3.4	12.7	1.7	0.8	1.2	2.4	1.5	3.3	0.2	2.4	1.3	0.3	3.0	1.5	0.2	0.9	3.2	0.6	6.8	1.4	0.5	1.3	0.0	1.3	0.3	1.2	3.2	0.2	1.2	0.5	7.1	0.6	4.3	0.7	3.4	1.8	16.1	3.0	0.2	6.2	0.1	1.5	1.8	0.3	1.3	0.7	0.2	4.9	3.2	1.2	24.2	0.4	1.0	6.5	0.3	0.6	0.3	3.5	0.6	0.9	4.4	4.5	0.4	8.0	0.2	0.9	0.9	0.6	0.5	3.3	0.3	3.7	1.6	3.4	3.3	0.2	1.8	3.8	3.5	0.8	1.7	0.4	1.5	0.6	1.0	8.4	11.9	13.4	26.0	5.9	3.2	2.7	8.3	11.4	3.2	0.0	1.3	3.0	3.6	2.4	23.6	2.5	7.6	8.1	1.2	10.4	13.7	0.6	3.3	2.6	3.1	2.8	4.2	0.0	4.4	0.4	4.8	3.6	1.1	2.4	3.1	14.3	10.9	1.8	1.3	2.7	5.2	2.1	1.7	17.2	4.7	9.8	3.2	0.0	2.5	6.2	22.5	0.0	4.7	9.7	5.7	1.9	0.3	4.6	3.6	2.0
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 49.0"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 72.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Peroxisomes, Plasma membrane"	"HPA046373: AB_2679642, HPA052681: AB_2681912"	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	12.1	1.9	2.0	5.9	11.3	49.0	6.8	6.5	3.1	1.6	2.7	0.6	0.0	0.6	0.7	0.5	1.9	1.0	1.1	2.4	1.7	6.2	0.5	0.7	0.8	0.6	1.6	2.4	1.0	0.6	0.8	0.0	0.6	2.9	0.8	0.7	3.4	1.9	1.3	4.2	1.5	0.8	1.0	2.8	1.3	1.6	0.7	1.5	0.7	0.7	1.7	1.0	2.0	3.2	0.0	0.4	0.4	0.4	0.0	1.5	0.4	0.0	0.0	0.1	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.3	0.7	14.1	0.3	0.0	0.0	3.9	0.2	0.3	0.0	0.0	0.1	72.0	0.1	0.0	0.1	0.5	0.0	1.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.5	0.7	0.4	0.0	0.0	0.4	0.0	0.4	2.0	11.3	6.5	3.1	1.7	6.2	1.6	2.4	2.9	1.5	0.0	0.0	0.0	0.0	0.6	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.4	0.3	0.2	0.0	0.0	0.0
PRRX2	"PMX2, PRX2"	ENSG00000167157	"Paired related homeobox 2"	Q99811	9	129665641-129722674	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 24.4;Early spermatids: 53.9;Fibroblasts: 25.4;Smooth muscle cells: 37.7;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.1;BJ: 17.1;BJ hTERT+: 12.2;fHDF/TERT166: 24.6;U-2197: 20.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006607, HPA026808"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA006607: AB_2667623, HPA026808: AB_10603228"	"unprognostic (4.02e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.47e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-10)"	"unprognostic (6.66e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.47e-3)"	8.4	2.1	0.4	2.5	0.4	0.2	7.3	0.2	0.6	15.6	2.4	0.5	3.5	0.7	4.6	5.4	5.3	2.1	2.3	8.6	0.4	0.2	0.6	0.4	2.8	1.8	0.3	0.1	3.2	2.2	0.3	2.8	2.6	1.7	15.1	0.7	12.8	4.6	5.2	6.6	15.8	1.1	10.2	1.2	0.4	1.6	6.7	0.0	0.6	7.9	9.3	6.5	10.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	2.1	8.1	0.0	17.1	12.2	2.2	2.5	0.0	0.0	0.0	6.2	24.6	0.9	0.2	0.5	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	2.6	1.2	3.8	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.8	0.0	0.0	0.9	1.6	0.3	0.0	0.0	5.1	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.6	0.4	0.2	0.3	0.1	1.7	0.0	0.0	0.0	0.0	1.2	24.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	53.9	0.1	0.0	0.0	0.0	0.3	25.4	2.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	2.6	0.0	8.5	0.0	0.0	0.0	0.6	0.0	3.2	0.0	0.0	0.0	37.7	3.2	6.8	26.0	0.3	0.0	0.0	5.0
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1708	"pancreas: 3057.4"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 49265.4"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;OE19: 10.1;RPMI-8226: 5.4;U-2 OS: 3.2;U-266/84: 1.9"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		26000000000	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3057.4	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	1.7	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	0.0	1.9	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	49265.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	208.2	0.0	0.5	2827.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 84.3;Club cells: 46.6;Cytotrophoblasts: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.8;SH-SY5Y: 66.0;THP-1: 29.5"	"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.5	0.0	0.5	0.0	0.0	4.2	0.0	13.7	12.5	2.9	4.9	0.0	5.6	0.0	0.0	20.8	1.5	0.2	9.3	2.8	3.9	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.3	5.3	1.0	3.0	9.6	0.0	0.1	0.0	0.0	2.4	0.0	0.1	2.8	0.6	10.7	0.9	0.0	11.8	0.0	0.0	2.0	1.5	66.0	0.0	0.0	0.8	9.9	0.0	29.5	0.0	5.9	0.8	3.7	2.7	0.3	0.0	0.0	0.3	0.9	3.4	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2	6.0	2.9	0.0	0.8	7.4	0.4	1.2	12.7	84.3	46.6	1.8	0.0	36.7	0.0	0.4	7.1	0.7	9.7	0.0	8.8	2.7	5.6	0.3	6.9	0.0	3.2	0.0	5.1	0.0	0.0	11.8	0.0	1.1	5.0	0.0	2.2	0.0	6.5	8.0	0.0	0.3	0.2	0.0	2.1	8.0	13.8	3.8	10.0	0.0	4.2	4.2
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	708	"pancreas: 6267.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 92348.3"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"					"Group enriched"	"Detected in some"	6	"basophil: 5.6;T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.6;T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"OE19: 11.6;RPMI-8226: 37.4;U-2 OS: 8.1"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		27000000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favorable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.6	6267.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.6	0.0	0.7	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	2.4	0.2	0.0	0.0	0.0	1.1	0.0	11.6	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.5	2.1	0.0	1.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.0	0.0	0.0	0.0	0.0	92348.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	608.7	0.0	0.0	14696.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 21.0;salivary gland: 20.9;testis: 37.5"	"Cell type enhanced"	"Detected in many"	17	"Late spermatids: 257.7;Spermatocytes: 426.2;Spermatogonia: 234.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 10.5;eosinophil: 21.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.4;HEL: 11.6;HeLa: 29.8;K-562: 13.7;U-698: 42.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	27	"basal ganglia: 6.7"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.8	0.0	0.2	0.2	0.2	5.5	1.0	0.4	0.4	1.4	0.4	0.2	1.4	0.2	0.3	0.2	0.8	2.2	2.1	0.2	0.2	0.0	0.2	0.2	2.1	3.3	0.2	0.2	0.3	0.9	1.7	0.2	0.3	0.4	1.8	0.2	0.2	20.9	0.2	0.5	0.4	0.4	0.2	0.2	0.9	0.4	37.5	0.2	0.9	0.2	1.2	1.1	0.3	0.6	0.8	1.4	21.0	2.3	1.0	3.3	1.3	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	11.6	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	5.5	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	10.5	2.3	21.0	2.2	1.6	3.3	0.8	1.1	1.8	0.6	0.6	1.5	2.2	0.2	1.0	0.3	1.4	0.5	1.3	0.2	0.2	0.4	0.4	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	10.2	29.2	1.0	0.0	81.1	0.0	0.0	1.2	0.0	0.0	0.2	0.0	1.1	94.4	0.0	0.2	0.0	0.3	6.3	0.2	21.6	0.0	0.0	11.5	0.0	0.0	0.0	0.0	257.7	6.1	1.8	0.0	0.0	0.9	0.0	0.8	0.0	3.5	0.0	0.0	45.3	1.1	426.2	234.2	0.5	0.1	2.5	1.6	11.1
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852727-2858170	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5"	"Cell type enhanced"	"Detected in many"	18	"Basal glandular cells: 187.4;Pancreatic endocrine cells: 242.0;Urothelial cells: 517.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"cerebellum: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;MCF7: 12.7;RT4: 5.9;SK-BR-3: 13.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			Nucleoplasm		"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.4	0.7	0.0	0.4	0.0	0.6	1.3	1.5	0.4	9.9	1.0	0.0	8.6	1.5	3.0	0.6	40.4	3.0	6.8	0.4	0.0	0.0	2.4	0.7	3.0	0.4	0.0	0.0	0.4	7.5	0.4	1.1	4.3	0.0	5.1	0.6	0.0	13.4	10.6	2.3	1.3	0.4	0.7	0.0	0.4	3.5	0.4	0.0	0.0	1.5	36.5	40.1	5.2	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	13.4	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.0	187.4	20.6	0.0	0.2	33.1	8.1	23.9	15.7	0.0	30.9	1.7	101.8	0.0	0.0	4.2	0.0	86.5	19.4	0.8	63.4	0.0	0.0	2.0	0.0	3.5	0.0	0.0	0.0	0.0	0.9	6.8	1.8	5.3	0.0	242.0	10.5	0.0	0.0	0.0	0.0	1.0	0.0	0.1	24.1	8.8	0.0	5.2	517.3
PRSS27	"CAPH2, MPN"	ENSG00000172382	"Serine protease 27"	Q9BQR3	16	2712418-2720551	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 8.9;Horizontal cells: 11.1;Urothelial cells: 9.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.4;myeloid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.6;SK-BR-3: 22.3;T-47d: 13.1;U-266/70: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB024920, HPA028848"	Approved		Approved	Vesicles	"Secreted to digestive system"	NA	NA			Vesicles		"CAB024920: , HPA028848: "	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-2)"	0.2	0.3	0.1	0.2	0.5	0.2	0.4	0.7	0.4	15.3	0.2	0.1	0.1	0.1	1.2	0.1	94.1	0.3	0.2	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.2	0.1	0.1	10.0	0.3	0.2	1.2	0.1	0.2	0.1	0.2	0.1	0.5	0.1	0.3	0.2	64.5	97.2	0.5	24.0	0.1	1.7	0.2	0.0	0.2	1.4	1.2	0.0	0.2	0.5	1.8	0.3	0.6	5.6	0.0	0.2	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.9	0.0	0.2	1.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.5	0.0	1.7	0.0	0.9	1.3	0.1	0.0	0.8	0.2	0.1	0.1	0.3	0.6	2.7	0.0	22.3	0.5	0.1	13.1	1.5	0.0	0.4	0.0	0.0	0.0	4.6	3.2	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	1.7	0.0	0.3	0.7	0.2	0.2	0.0	0.0	0.0	1.2	0.1	0.5	0.7	0.1	0.1	0.4	0.1	0.1	0.1	0.1	8.9	8.0	0.0	2.4	1.5	5.2	1.1	0.0	5.3	5.7	1.8	3.9	0.5	0.0	1.2	1.5	1.0	0.4	0.0	1.2	0.3	1.1	1.6	3.5	0.8	0.3	11.1	0.0	0.6	0.0	0.4	0.3	1.3	1.7	1.0	0.0	3.2	0.9	0.2	0.0	0.5	4.7	0.0	1.5	2.1	3.8	2.0	2.7	0.0	0.6	9.7
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750466-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"pancreas: 984.9"	"Cell type enhanced"	"Detected in many"	19	"Enterocytes: 998.3;Exocrine glandular cells: 1691.4;Pancreatic endocrine cells: 545.2;Paneth cells: 388.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	82	"basophil: 39.0"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 39.0"	"Group enriched"	"Detected in some"	5	"OE19: 46.2;PC-3: 121.2"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		490000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	0.3	0.3	1.6	1.7	1.5	0.2	0.2	2.8	4.2	0.9	8.2	0.0	0.0	2.8	0.2	0.2	2.9	0.2	4.8	0.4	1.2	0.7	0.3	0.4	0.2	0.2	0.3	1.6	0.7	984.9	0.2	0.1	0.2	2.3	0.2	2.3	0.0	0.6	0.2	0.2	2.0	23.9	0.3	0.2	0.2	0.8	0.3	0.0	0.0	0.2	6.6	3.5	0.2	1.3	0.0	0.1	39.0	0.4	0.1	0.3	0.1	1.7	1.9	0.1	0.0	0.0	0.9	0.0	4.8	1.1	0.5	0.2	4.7	0.4	0.0	0.0	2.1	0.0	2.1	0.0	4.4	1.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.5	15.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	46.2	121.2	0.0	0.0	0.0	0.0	0.2	0.0	12.2	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	39.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	1.5	2.8	4.2	1.2	0.7	0.3	1.6	2.3	0.0	0.0	0.0	2.2	0.2	50.7	0.2	0.9	48.4	0.0	0.0	1.8	0.0	0.0	3.3	13.8	29.4	1.1	998.3	0.0	1691.4	0.0	0.4	7.0	9.2	1.0	0.0	0.0	184.8	1.3	0.3	56.5	1.4	1.2	6.8	10.0	156.0	0.0	545.2	388.3	0.7	6.7	0.0	0.0	3.1	0.5	0.4	117.2	0.1	0.0	282.9	19.5
PRTFDC1	HHGP	ENSG00000099256	"Phosphoribosyl transferase domain containing 1"	Q9NRG1	10	24848607-24952604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0"	"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 7.9"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 7.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 30.1;CAPAN-2: 38.0;HEL: 22.1"									HPA021458	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA021458: AB_1855793"	"unprognostic (2.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (9.49e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.94e-2)"	4.1	18.3	18.1	3.3	18.2	0.6	6.1	6.1	24.0	8.1	7.7	29.0	2.4	13.9	12.9	6.1	4.5	5.9	11.8	8.6	16.8	13.0	4.0	2.2	3.4	2.8	18.1	12.6	17.1	3.6	10.2	11.0	2.3	16.2	6.5	9.2	6.0	7.2	6.9	0.9	1.4	13.2	8.0	22.5	2.3	13.8	1.7	20.7	2.3	3.7	1.1	2.4	6.0	4.6	0.0	0.3	0.1	0.0	7.9	1.1	1.7	7.6	16.5	12.3	5.0	2.0	10.3	0.0	8.1	6.1	5.8	8.0	30.1	38.0	0.0	1.3	9.4	0.4	4.3	14.0	0.0	9.1	0.0	0.6	22.1	3.0	0.0	6.1	0.0	0.0	3.0	0.1	3.1	0.0	5.5	9.1	0.9	7.2	4.2	2.7	0.2	3.4	0.0	8.5	1.3	0.3	3.8	0.0	0.0	5.2	0.2	8.8	0.4	7.7	0.0	0.0	0.3	0.4	1.7	4.9	2.6	6.5	9.4	4.8	0.4	0.0	0.0	6.9	0.0	0.3	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.4	0.5	0.3	0.0	0.1	0.3	0.1	7.9	0.0	0.2	0.0	1.7	18.1	18.2	6.1	15.8	16.8	13.0	18.1	12.6	16.2	20.7	0.0	0.3	0.0	3.7	2.4	10.4	6.9	5.1	1.4	4.5	3.5	2.0	0.5	5.0	4.6	1.0	1.6	4.1	0.0	0.5	4.3	14.2	0.7	0.0	0.0	5.4	6.4	5.2	9.2	1.6	0.8	11.2	0.3	3.3	1.8	4.2	32.0	2.4	2.6	9.2	0.0	15.3	0.0	9.5	2.3	4.1	2.5	0.7	0.0	14.3	0.9
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611546-55743090	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.5;thyroid gland: 23.9"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 180.6;Rod photoreceptor cells: 63.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Group enriched"	"Detected in some"	7	"AF22: 47.4;SuSa: 57.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	1.3	2.2	1.5	1.1	1.8	0.6	2.4	1.2	2.2	4.7	1.4	3.6	1.1	0.7	11.0	4.6	0.7	2.4	1.0	1.3	1.6	1.6	2.6	0.6	5.0	0.6	3.0	2.0	4.5	0.6	6.4	2.7	6.5	4.3	1.4	0.9	16.5	0.9	1.4	3.9	0.6	0.9	2.9	3.5	0.5	1.5	6.5	2.3	0.0	23.9	0.8	0.9	1.2	1.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	1.0	47.4	1.0	0.0	0.0	4.8	0.4	1.4	1.2	1.7	7.9	0.2	0.0	2.0	0.0	1.8	0.0	0.1	0.1	1.7	0.0	2.5	0.3	0.3	3.0	0.3	0.3	0.0	0.1	0.0	0.5	0.8	0.9	0.8	0.0	0.8	0.0	0.7	0.6	0.0	0.0	1.9	0.0	1.1	0.0	7.5	0.0	0.9	0.1	0.6	2.7	0.4	0.6	2.6	57.9	0.2	0.1	0.0	0.6	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	1.8	1.2	2.2	1.6	1.6	3.0	2.0	4.3	2.3	8.9	13.2	0.0	0.0	0.2	9.5	4.6	0.0	0.0	4.5	15.7	180.6	18.0	0.0	0.0	13.5	5.3	0.0	0.0	0.2	4.2	1.9	0.1	0.0	0.0	1.5	0.0	0.0	2.5	0.0	18.8	4.9	0.0	0.0	0.0	0.0	2.8	0.4	0.0	2.5	1.1	63.9	0.0	1.0	7.2	13.4	0.0	5.0	0.0	0.0	0.1
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840960-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 167.3"	"Cell type enhanced"	"Detected in some"	23	"Cholangiocytes: 2.5;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enriched"	"Detected in some"	5	"THP-1: 151.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		120000	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.3	0.2	0.9	0.2	1.0	167.3	0.2	0.0	2.3	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	31.0	0.3	0.6	0.2	1.7	8.1	3.5	0.1	0.1	0.4	0.2	0.2	0.8	4.2	0.8	0.2	0.2	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.0	25.5	0.2	0.2	0.1	35.0	0.9	0.0	0.2	0.2	0.0	0.0	0.0	1.9	0.1	0.0	0.2	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	6.8	0.9	1.0	0.0	2.3	0.3	0.6	0.1	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393768-40413366	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.1;lung: 31.7;retina: 20.6"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 10.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"midbrain: 42.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	21	"midbrain: 24.7"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles, Plasma membrane"		"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	3.4	4.4	4.8	1.0	4.1	1.1	2.7	2.2	5.4	3.0	2.3	1.8	2.8	1.2	3.8	2.0	2.2	3.2	2.4	2.9	4.0	2.2	4.3	0.6	31.7	1.3	42.1	3.7	7.5	5.4	7.3	1.1	6.0	10.3	3.2	0.8	20.6	3.9	4.4	5.4	2.2	1.5	3.3	11.0	1.7	2.4	1.6	3.6	0.0	7.2	6.7	0.9	3.1	2.0	0.3	0.4	0.0	0.3	0.1	1.2	0.2	2.5	2.7	3.3	4.3	2.7	7.0	4.1	2.0	2.3	2.9	2.1	2.3	2.7	0.8	2.6	1.9	1.5	1.3	1.1	1.0	1.0	1.2	1.4	0.5	0.9	0.7	3.2	0.2	3.6	5.0	4.9	1.9	1.6	3.3	1.5	4.5	3.0	0.8	1.5	3.2	1.1	0.8	0.7	5.6	2.5	4.8	2.8	2.4	0.5	1.3	0.3	1.5	3.9	3.4	3.0	1.5	4.9	1.2	2.2	5.9	4.6	2.3	1.2	8.4	7.3	1.1	1.8	1.3	1.3	0.0	0.3	0.0	0.6	0.2	0.2	0.0	0.4	0.6	0.0	0.3	0.3	1.2	0.0	0.1	0.0	0.4	0.3	0.2	4.8	4.1	2.2	5.4	4.0	2.2	42.1	3.7	10.3	3.6	3.0	5.1	0.0	1.0	5.6	0.0	10.8	5.1	0.0	1.2	1.8	0.0	0.8	0.0	0.3	0.0	4.4	0.5	0.0	0.5	0.6	2.5	2.1	0.0	1.0	0.9	0.0	0.0	4.9	1.8	0.0	3.1	1.2	3.3	0.0	0.3	2.7	0.5	0.9	4.2	1.3	0.0	0.0	2.6	0.2	0.7	3.6	2.3	1.3	1.4	0.9
PRY	"PRY1, PTPN13LY"	ENSG00000169789	"PTPN13-like, Y-linked"	O14603	Y	22490397-22514637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"blood: 1.9;epididymis: 2.3;testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	6	"memory CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.1;HDLM-2: 2.3;SK-MEL-30: 1.5"									"HPA046366, HPA059887"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA046366: AB_2679639, HPA059887: "																		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRY2	PTPN13LY2	ENSG00000169807	"PTPN13-like, Y-linked 2"	O14603	Y	22071756-22096007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;testis: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.4;naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 3.6"									"HPA046366, HPA059887"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA046366: AB_2679639, HPA059887: "																		0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.4	0.5		0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5			0.0		0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.5	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSD	"EFA6, EFA6A, KIAA2011, PSD1, TYL"	ENSG00000059915	"Pleckstrin and Sec7 domain containing"	A5PKW4	10	102402617-102421539	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.8"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 51.6;Cone photoreceptor cells: 90.3;Rod photoreceptor cells: 65.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 10.3;MOLT-4: 5.5;SCLC-21H: 9.7;SH-SY5Y: 8.5;U-2 OS: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059237	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA059237: AB_2683954"	"unprognostic (2.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	1.2	9.8	48.7	4.3	59.4	1.6	1.5	8.0	66.8	6.7	21.5	1.7	0.0	6.7	23.9	2.4	3.2	11.1	9.4	1.9	48.7	12.2	1.5	1.4	1.7	1.8	7.6	26.7	5.6	4.7	2.5	13.6	1.8	4.2	6.2	4.4	3.7	1.5	2.2	1.2	2.1	5.8	20.7	1.8	1.5	4.8	4.6	7.0	0.0	1.2	0.0	1.5	11.7	3.0	0.8	0.0	1.1	0.2	0.9	1.3	0.0	0.3	0.1	3.9	3.5	1.4	0.8	0.3	0.3	0.0	0.1	0.0	2.7	0.4	0.3	2.5	0.1	0.3	0.2	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.1	2.2	0.0	0.1	10.3	0.3	0.6	0.1	1.7	0.0	1.4	0.6	0.9	0.0	2.1	5.5	0.3	0.5	0.3	0.0	1.5	0.0	0.1	0.0	0.2	9.7	8.5	0.1	0.1	0.2	0.3	0.6	0.5	0.0	2.9	4.7	0.2	0.0	2.5	0.3	0.1	0.3	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.2	0.3	0.0	0.8	0.3	1.3	1.1	0.9	0.0	0.0	0.0	0.0	48.7	59.4	8.0	41.2	48.7	12.2	7.6	26.7	4.2	7.0	3.0	0.3	0.0	0.2	0.6	51.6	1.2	5.1	0.0	2.3	0.0	90.3	0.2	1.7	0.1	4.1	0.3	0.8	0.0	1.7	0.1	1.7	0.3	0.0	0.5	0.6	12.7	17.2	0.0	0.0	2.0	3.4	0.0	0.0	0.0	0.6	8.6	0.7	0.6	3.9	0.7	65.1	0.0	0.3	3.7	3.4	0.1	0.6	0.0	0.8	0.1
PSD2	"DKFZp761B0514, EFA6C"	ENSG00000146005	"Pleckstrin and Sec7 domain containing 2"	Q9BQI7	5	139795821-139844466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 52.4"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 1.5;Muller glia cells: 2.7;Spermatocytes: 1.4"	"Cancer enriched"	"Detected in single"	43	"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 3.6;SCLC-21H: 2.2;SH-SY5Y: 3.6;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054625			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA054625: "	"unprognostic (3.76e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.12e-3)"	1.3	1.7	21.1	1.3	28.9	1.3	1.7	12.6	52.4	1.9	1.3	15.2	0.0	1.4	1.4	3.6	1.3	1.6	1.3	1.4	16.1	15.2	1.3	1.3	1.3	1.3	18.9	14.4	1.3	1.6	1.3	0.2	1.3	24.7	1.4	1.3	0.0	3.5	1.7	1.4	1.3	1.3	1.4	12.8	1.4	1.3	2.2	17.0	0.0	1.3	0.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.2	0.9	0.1	0.2	0.0	0.0	0.2	0.3	0.9	1.4	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	2.2	3.6	0.0	0.7	0.1	0.3	0.0	0.2	0.0	0.2	1.7	0.0	0.0	1.0	0.0	1.5	1.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	28.9	12.6	17.5	16.1	15.2	18.9	14.4	24.7	17.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0
PSD3	"DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942"	ENSG00000156011	"Pleckstrin and Sec7 domain containing 3"	Q9NYI0	8	18527301-19084730	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.6"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 598.4;Late spermatids: 164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.2;hTERT-RPE1: 22.8;LHCN-M2: 22.0;U-87 MG: 23.6"					"Low region specificity"	"Detected in all"			HPA002455	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Nucleoplasm, Vesicles"	Cytosol	"HPA002455: AB_2666597"	"unprognostic (3.87e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (7.55e-4)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.45e-1)"	2.3	15.5	18.3	2.7	40.5	1.3	5.2	51.6	50.7	11.3	5.7	13.4	2.5	4.2	7.8	3.6	4.8	2.6	6.5	21.8	23.2	9.3	2.1	15.6	4.1	2.2	10.0	27.6	16.0	8.3	9.5	9.6	5.6	10.7	3.7	6.5	5.4	3.2	5.5	1.3	3.9	4.3	5.2	7.4	8.4	8.0	12.7	11.4	0.0	5.4	1.4	3.1	6.1	3.3	3.1	0.6	2.3	1.3	1.9	2.0	0.7	4.9	2.6	11.7	0.0	4.2	26.2	0.6	2.6	4.1	2.4	5.0	1.5	2.0	2.9	1.7	10.7	10.6	0.4	3.4	4.7	4.6	0.0	3.0	0.2	2.0	0.2	7.7	0.0	0.1	6.8	2.9	13.3	2.3	22.8	3.1	0.7	0.3	2.3	22.0	1.7	0.0	0.5	2.3	4.3	6.8	2.3	10.2	1.3	6.1	6.4	5.0	5.6	1.1	0.5	1.8	2.6	0.0	1.1	12.9	7.5	5.2	17.6	2.3	0.2	0.3	6.7	23.6	1.2	2.5	2.3	1.3	1.3	1.0	0.8	1.3	1.6	1.0	0.6	0.5	3.1	0.5	0.6	1.5	1.9	1.1	0.6	2.0	0.7	18.3	40.5	51.6	50.7	23.2	9.3	10.0	27.6	10.7	11.4	3.0	2.4	0.5	11.9	19.5	56.4	111.0	5.1	32.1	13.6	8.7	111.9	2.6	1.7	13.2	598.4	4.9	21.3	0.0	7.4	1.2	30.9	8.6	0.0	36.1	11.0	17.5	5.8	6.2	9.7	164.8	30.8	10.6	1.7	103.6	15.1	80.8	19.5	14.4	50.5	0.2	50.2	12.9	11.5	10.0	15.8	8.7	0.9	0.0	13.0	24.0
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86048373-86088621	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"kidney: 1.9;placenta: 1.2;testis: 2.0"	"Cell type enhanced"	"Detected in single"	35	"Rod photoreceptor cells: 1.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"HEL: 14.3"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome subunit beta 10"	P40306	16	67934502-67937087	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 117.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 36.6;U-266/70: 41.0"									"HPA030224, HPA030225, CAB034384"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		1400000	Cytosol	Vesicles	"CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (5.44e-4)"	11.5	13.0	9.1	24.9	11.8	23.9	11.4	4.0	7.8	8.0	21.6	5.6	8.5	42.4	9.3	9.5	10.6	12.4	16.6	12.0	6.9	4.9	16.9	17.2	19.5	38.3	9.5	5.6	8.7	61.5	0.9	6.9	11.2	8.5	13.5	6.3	5.8	27.9	11.6	6.9	7.0	35.6	7.7	6.5	49.7	23.8	2.5	7.8	39.2	13.1	10.4	20.5	13.2	8.4	50.8	75.2	100.0	98.1	69.1	68.8	117.3	6.0	5.3	0.4	0.8	0.4	3.5	21.3	2.0	8.7	7.0	9.9	2.8	29.5	22.0	3.8	2.7	2.1	8.9	0.1	2.0	0.5	9.7	0.5	7.8	1.8	3.1	12.2	14.5	24.0	5.4	1.2	3.1	0.0	2.2	4.0	5.3	0.7	8.4	2.0	7.5	28.5	14.9	0.3	0.2	2.0	36.6	2.2	30.0	4.8	10.5	0.3	0.4	6.8	12.0	2.6	0.4	2.4	31.5	6.8	4.5	1.2	1.9	2.3	41.0	7.4	14.6	11.1	19.0	9.6	57.1	89.4	67.1	68.8	98.1	50.2	50.8	54.0	57.3	74.6	49.1	45.3	50.1	100.0	69.1	71.4	75.2	60.8	117.3	9.1	11.8	4.0	7.8	6.9	4.9	9.5	5.6	8.5	7.8	20.8	23.2	54.7	11.4	15.2	0.6	1.4	38.2	73.6	15.9	17.4	0.0	24.0	19.9	48.2	11.5	22.9	90.1	23.3	91.6	28.8	24.3	10.7	49.8	10.0	80.6	0.0	15.6	31.3	88.4	25.3	27.9	74.2	45.5	124.4	58.4	1.3	49.6	106.6	19.8	53.7	1.0	19.4	23.4	16.6	6.8	8.7	18.9	122.2	72.8	19.2
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome subunit beta 4"	P28070	1	151399534-151401944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		15000000	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	45.7	64.5	47.4	40.4	49.5	40.2	56.3	39.6	84.0	44.4	44.3	28.5	58.8	41.2	53.5	65.3	55.7	51.2	37.8	66.6	47.0	50.7	57.3	71.9	43.6	81.1	49.2	61.0	52.4	87.0	40.0	45.4	50.9	48.4	42.6	47.5	37.8	46.7	56.1	68.7	45.7	39.7	66.4	55.1	46.6	43.4	31.8	36.3	51.1	46.8	63.3	62.2	58.6	37.7	68.5	106.5	58.6	81.4	72.5	89.0	78.3	52.1	54.7	46.6	55.8	52.8	50.4	64.1	30.8	67.2	89.9	63.1	73.2	70.5	47.5	93.4	51.5	47.8	52.4	47.3	57.9	51.3	66.2	47.8	32.8	41.0	54.7	57.1	45.7	45.2	55.0	55.4	84.4	34.7	45.8	62.7	51.3	53.0	93.0	63.3	139.7	54.8	53.9	119.2	77.4	71.0	52.6	34.1	83.8	73.4	42.7	51.8	61.5	35.8	78.3	103.0	60.3	70.7	72.5	39.7	39.5	42.1	41.9	67.6	92.7	106.1	91.6	58.3	40.7	83.0	54.6	81.4	49.5	63.9	75.2	75.9	68.5	74.9	72.5	96.4	60.8	65.8	68.0	58.6	72.5	56.9	106.5	89.0	78.3	47.4	49.5	39.6	84.0	47.0	50.7	49.2	61.0	48.4	36.3	142.9	125.8	60.3	65.1	68.1	51.9	108.2	81.5	179.3	134.2	68.0	15.7	176.7	87.9	106.1	12.6	85.2	80.0	46.7	168.6	123.7	82.9	62.0	103.4	133.7	108.0	46.1	63.8	90.9	107.2	13.4	96.7	88.1	91.1	226.4	73.7	84.2	122.6	66.6	99.0	122.6	44.8	64.7	80.2	38.6	45.3	66.4	223.6	74.3	80.9	77.2
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome subunit beta 8"	P28062	6	32840717-32844703	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		No	No		3300000	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	17.0	21.9	7.9	34.8	11.7	14.0	14.9	3.6	7.5	10.0	20.8	5.1	8.8	20.1	12.5	15.3	16.6	13.2	23.8	10.6	6.6	5.7	20.9	30.0	29.0	46.3	9.9	5.1	11.3	12.7	3.6	8.2	9.7	8.8	13.5	24.4	9.2	14.6	11.2	5.1	14.7	37.3	11.5	9.0	42.8	19.4	3.9	9.0	32.2	18.7	18.7	29.0	13.9	12.5	28.9	27.4	37.6	33.2	23.3	29.9	52.2	6.4	2.0	0.1	0.0	2.7	7.1	4.4	1.5	10.2	12.5	18.1	0.0	11.4	25.1	4.8	4.1	9.8	4.5	1.4	6.1	3.4	10.3	0.0	11.1	1.3	0.4	15.0	0.2	4.2	8.0	2.8	7.0	2.4	0.4	8.4	5.4	0.3	5.3	3.1	0.0	5.8	6.1	0.0	0.0	1.6	15.6	0.8	12.4	10.2	1.8	0.1	0.1	2.2	5.4	3.4	0.0	2.4	20.5	2.5	3.7	2.0	3.5	0.2	8.9	8.4	5.6	1.3	14.5	4.7	19.4	29.0	37.4	25.5	33.2	22.1	28.9	21.7	26.4	27.4	26.3	15.1	21.6	37.6	23.3	28.6	23.3	29.9	52.2	7.9	11.7	3.6	7.5	6.6	5.7	9.9	5.1	8.8	9.0	35.7	58.8	174.3	61.0	75.0	1.6	6.1	79.0	62.9	45.5	59.3	0.0	1.7	72.9	173.5	0.5	121.7	242.4	0.0	217.6	10.1	57.2	72.3	49.7	67.1	157.1	6.4	63.1	92.1	135.9	0.6	36.2	111.9	54.0	193.0	164.1	32.8	163.9	247.6	28.7	51.6	2.7	38.8	45.7	0.2	1.2	69.5	2.3	193.7	184.0	98.2
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		180000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	27.9	25.9	37.3	24.1	49.3	31.8	26.2	25.6	39.7	25.1	28.2	24.9	21.1	20.3	27.2	26.0	29.4	25.0	21.8	45.7	32.8	28.0	30.7	60.2	21.5	22.8	36.1	27.3	21.0	25.2	31.0	16.8	39.8	28.2	22.6	24.0	21.3	32.1	29.8	134.7	34.8	20.9	30.8	24.3	25.7	24.9	24.0	22.9	33.5	27.1	38.3	28.8	25.5	25.3	39.2	45.1	32.6	54.7	45.0	51.1	61.3	39.2	44.7	43.0	31.6	20.7	22.3	41.9	32.8	48.8	82.5	58.6	39.8	23.0	31.9	20.4	41.2	36.3	39.5	37.6	42.9	37.3	47.4	48.7	30.6	54.7	38.4	26.8	35.6	32.8	24.8	23.2	33.4	37.8	18.3	46.3	33.2	43.3	30.1	50.2	87.5	44.9	45.4	42.1	49.9	54.0	47.6	84.6	27.9	38.4	29.6	31.5	27.2	26.8	37.8	20.6	19.0	46.8	37.2	32.6	47.3	59.9	66.9	83.9	32.7	37.7	36.9	48.9	35.8	59.1	24.4	43.5	32.6	47.9	53.1	43.7	39.2	40.4	43.8	45.1	32.8	35.6	36.2	9.8	45.0	54.7	45.1	51.1	61.3	37.3	49.3	25.6	39.7	32.8	28.0	36.1	27.3	28.2	22.9	53.6	40.7	50.7	95.5	76.6	41.9	207.9	76.5	49.5	45.5	64.6	15.7	229.8	129.3	164.4	108.0	86.3	137.8	116.8	176.4	216.8	106.9	72.7	72.8	141.0	139.1	35.0	61.9	63.8	58.5	158.2	82.0	66.5	94.5	170.5	67.3	81.7	174.0	108.7	94.0	148.2	36.4	116.4	134.6	87.3	61.8	67.5	295.1	69.6	93.3	88.7
PSMC6	p42	ENSG00000100519	"Proteasome 26S subunit, ATPase 6"	P62333	14	52707172-52728587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042823	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		190000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042823: AB_2678188"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.14e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.67e-1)"	30.4	31.1	29.1	23.0	36.8	19.9	30.7	30.1	40.9	26.4	26.4	19.7	29.8	25.6	27.8	27.0	38.0	26.1	19.3	39.7	30.6	28.3	36.1	45.7	21.6	25.7	29.9	35.0	27.8	25.2	26.5	34.7	37.1	44.0	25.5	28.8	14.7	23.4	25.3	73.3	23.0	26.4	29.5	30.1	28.2	24.9	15.5	31.1	30.0	28.6	44.9	32.9	31.6	24.5	37.6	43.1	37.0	40.9	29.8	48.5	40.6	47.1	30.6	36.8	27.3	25.8	27.0	39.8	37.2	35.8	60.4	45.5	38.3	38.8	41.1	46.6	32.2	30.5	36.0	46.8	32.6	63.6	39.4	20.4	30.1	25.2	40.8	31.2	42.6	29.3	20.0	32.6	30.5	30.9	33.0	37.9	20.7	44.7	17.8	44.0	43.2	33.2	29.6	29.7	44.7	42.1	28.4	64.7	18.3	39.8	48.1	26.5	19.7	33.1	20.7	31.7	34.6	42.6	31.2	29.0	33.7	47.3	26.1	38.1	12.6	32.1	46.0	21.8	29.3	30.5	35.8	36.5	37.0	32.1	40.9	37.1	37.6	39.6	34.9	43.1	34.2	38.2	37.3	30.6	29.8	39.9	22.4	48.5	40.6	29.1	36.8	30.1	40.9	30.6	28.3	29.9	35.0	44.0	31.1	65.5	57.0	70.1	126.5	76.5	60.1	71.1	58.6	97.7	95.5	54.1	64.8	139.1	114.4	111.7	19.5	70.0	62.6	46.7	92.7	114.5	84.1	71.0	64.8	74.2	82.7	58.8	67.5	44.2	77.8	18.3	62.2	71.9	75.9	72.1	50.7	62.8	96.7	45.6	61.5	108.8	98.3	71.1	100.0	39.9	74.1	63.0	198.6	69.5	59.8	107.7
PSMD1	"P112, Rpn2, S1"	ENSG00000173692	"Proteasome 26S subunit, non-ATPase 1"	Q99460	2	231056864-231172827	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB021092, HPA036736, HPA036737"	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA		49000	Nucleoplasm	"Actin filaments"	"CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279"	"unprognostic (9.32e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.63e-12)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.70e-3)"	21.9	25.5	21.5	19.0	27.8	14.4	18.4	22.3	29.0	17.3	20.6	16.2	15.3	21.7	24.3	17.6	25.3	16.1	13.0	34.9	31.8	22.1	20.9	27.8	16.8	16.3	20.3	27.2	16.4	10.9	73.9	24.6	28.5	34.0	18.7	23.7	15.0	16.7	21.1	75.5	20.2	17.9	27.2	17.5	18.7	17.4	16.8	17.8	20.6	17.3	23.7	22.3	17.8	16.4	14.3	21.2	23.5	26.7	25.6	21.6	15.4	29.1	31.8	35.9	28.0	37.4	27.0	34.7	38.8	40.5	39.4	40.1	38.6	29.1	22.9	36.7	43.3	41.4	28.1	49.8	36.2	53.8	34.7	26.7	42.4	26.1	44.2	19.3	37.2	36.8	23.2	18.0	42.3	22.5	22.4	46.3	21.0	58.5	17.3	46.6	28.4	29.0	21.4	46.2	29.0	25.5	24.7	55.1	21.9	29.0	30.3	24.0	21.5	31.1	28.1	19.0	38.9	22.3	22.0	43.2	31.4	33.1	37.8	36.8	15.1	22.2	40.8	48.4	28.8	35.8	23.5	19.2	14.6	19.2	25.9	19.0	14.3	18.3	16.9	21.2	12.0	14.9	16.8	10.8	25.6	26.7	12.1	21.6	15.4	21.5	27.8	22.3	27.6	31.8	22.1	20.3	27.2	34.0	17.8	47.6	43.2	20.8	30.2	29.5	45.8	114.2	38.2	77.6	44.3	31.4	39.3	104.8	14.9	66.5	4.9	46.6	49.9	0.0	88.3	83.2	46.2	31.9	100.6	73.7	64.0	85.8	37.8	29.4	37.8	8.1	32.2	38.0	16.9	67.7	24.4	50.0	76.2	24.9	43.2	30.0	51.3	71.1	32.5	124.1	96.9	29.0	140.1	29.8	34.0	35.9
PSMD11	"MGC3844, p44.5, Rpn6, S9"	ENSG00000108671	"Proteasome 26S subunit, non-ATPase 11"	O00231	17	32444261-32483318	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042275, HPA067433"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		78000	"Nucleoplasm, Golgi apparatus"		"HPA042275: AB_10794793, HPA067433: AB_2685838"	"unprognostic (1.16e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (9.39e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.17e-2)"	26.0	22.4	20.7	19.9	22.3	19.9	17.4	22.2	27.1	16.3	19.2	23.8	14.9	19.2	24.2	17.2	28.5	17.6	16.5	24.7	18.3	18.7	21.7	38.2	19.1	19.5	24.4	16.9	19.1	25.8	30.1	19.1	27.5	28.1	18.6	23.7	17.3	19.2	16.7	69.0	25.3	18.8	25.4	19.1	20.0	18.3	22.8	19.8	27.7	19.5	26.9	26.8	18.9	18.9	24.4	30.8	22.8	28.0	30.1	33.1	26.8	35.7	39.7	29.0	31.2	19.7	14.7	31.0	20.4	26.5	45.4	36.9	40.0	32.8	28.1	32.6	22.1	43.7	41.7	33.0	28.4	44.7	14.2	22.5	22.7	20.1	30.9	19.2	26.9	24.4	13.1	15.0	39.4	27.4	14.5	31.8	25.2	43.0	33.0	26.6	22.2	40.2	15.9	39.8	19.3	20.0	25.0	37.6	38.0	22.3	26.9	25.7	17.4	25.9	18.8	20.6	31.4	45.5	12.9	21.8	25.4	29.6	31.3	47.1	18.4	28.7	37.2	36.8	21.1	42.6	22.8	27.4	16.7	28.3	27.1	31.0	24.4	27.7	28.4	30.8	23.7	24.9	26.0	12.6	30.1	28.0	25.1	33.1	26.8	20.7	22.3	22.2	27.1	18.3	18.7	24.4	16.9	28.1	19.8	44.7	26.9	44.2	79.8	112.8	41.5	63.9	50.9	28.1	51.2	24.4	29.5	156.7	68.0	89.4	179.8	49.7	62.9	46.7	93.2	121.7	52.5	82.6	45.0	95.7	80.8	35.0	46.7	49.7	44.8	37.3	45.5	50.2	25.3	80.2	45.1	59.3	94.8	45.6	45.6	82.8	40.8	51.8	72.9	151.9	108.8	102.8	258.4	51.7	51.7	105.7
PSMD12	"p55, Rpn5"	ENSG00000197170	"Proteasome 26S subunit, non-ATPase 12"	O00232	17	67337916-67366627	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023119	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		44000	Microtubules	"Nucleoplasm, Cytosol"	"HPA023119: AB_1855845"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.63e-1)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (1.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	16.4	18.0	16.0	12.3	16.0	11.8	14.1	19.5	26.7	11.7	11.8	8.8	11.5	9.4	12.5	13.3	16.4	9.9	11.4	14.9	17.0	19.7	17.1	31.4	10.8	11.3	23.6	15.3	12.6	17.6	15.7	12.9	13.7	32.5	12.8	13.8	8.1	12.5	11.0	42.3	11.6	10.8	15.7	13.4	12.0	12.4	15.5	11.3	12.7	12.2	18.9	16.7	17.2	19.6	8.8	10.8	12.1	18.1	11.4	14.0	8.9	28.4	17.4	13.8	15.1	10.6	12.9	18.9	20.3	13.0	22.6	20.1	18.0	12.7	16.4	13.1	16.5	17.8	16.9	23.9	20.8	34.0	7.9	17.8	19.1	14.5	18.5	13.8	19.8	11.8	14.2	13.9	21.4	16.9	10.1	22.2	12.7	25.4	9.8	21.2	19.5	18.1	19.2	16.6	13.7	23.1	9.3	35.5	14.7	16.8	23.8	13.2	19.1	15.0	29.4	19.6	17.0	21.0	16.8	22.8	24.1	16.2	18.0	36.6	10.0	15.3	13.9	28.4	21.0	13.8	12.1	10.6	8.8	9.9	17.4	14.0	8.6	13.0	11.1	10.8	8.8	11.7	12.3	7.6	11.4	18.1	7.0	12.1	8.9	16.0	16.0	19.5	26.7	17.0	19.7	23.6	15.3	32.5	11.3	44.7	50.4	33.7	90.9	99.7	41.1	95.7	28.1	60.2	102.4	43.6	23.6	81.6	59.7	68.1	139.8	67.3	22.6	23.3	68.5	68.6	54.6	70.8	48.6	75.5	49.5	87.4	31.6	41.1	43.5	155.9	42.8	55.9	45.5	62.3	25.6	57.8	66.4	21.0	41.4	62.2	40.5	25.8	111.2	105.1	101.1	82.8	102.9	48.5	28.3	110.7
PSMD13	"p40.5, Rpn9"	ENSG00000185627	"Proteasome 26S subunit, non-ATPase 13"	Q9UNM6	11	236546-252984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038691, HPA038692"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA		49000	"Nuclear speckles"	Cytosol	"HPA038691: AB_2676153, HPA038692: AB_10671749"	"unprognostic (1.32e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (2.24e-2)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.76e-5)"	"unprognostic (7.54e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.52e-13)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	24.2	17.9	18.4	20.9	21.3	29.1	28.6	22.1	25.6	24.0	23.6	19.2	20.0	15.6	25.3	20.3	26.8	20.6	19.1	31.8	19.6	20.4	23.4	34.9	23.0	29.8	17.1	19.1	18.1	26.5	15.1	18.0	31.7	21.8	24.0	19.5	16.8	20.9	21.1	56.5	25.5	20.5	21.3	17.0	26.9	18.8	21.2	12.9	32.8	23.3	30.0	27.0	20.5	17.9	20.8	33.5	25.1	32.6	26.4	26.6	39.0	31.1	18.6	22.2	22.9	22.4	20.4	12.8	21.4	30.4	47.0	34.7	16.4	42.1	29.6	20.9	26.1	17.1	29.5	28.0	32.3	37.4	23.8	21.3	13.1	7.2	11.3	25.0	31.9	27.8	18.0	23.2	23.4	20.3	11.5	42.6	21.2	33.1	23.1	35.9	12.3	26.6	19.6	29.7	15.4	27.0	20.6	21.8	20.9	27.5	8.3	18.0	14.2	15.7	16.8	16.6	12.1	10.3	19.8	27.9	13.8	13.2	7.0	25.0	21.0	24.2	38.4	24.8	25.6	22.8	22.2	31.4	20.5	23.5	30.6	26.3	20.8	24.1	23.6	33.5	18.5	21.3	23.3	25.1	26.4	32.6	22.7	26.6	39.0	18.4	21.3	22.1	25.6	19.6	20.4	17.1	19.1	21.8	12.9	44.7	33.8	60.3	44.1	31.8	40.7	42.3	58.6	57.6	36.4	29.6	29.5	145.8	69.6	99.0	33.5	47.1	60.8	23.3	114.2	117.3	41.0	50.8	65.8	52.5	89.1	35.0	46.1	53.4	49.4	36.2	63.6	57.7	43.9	94.6	55.5	65.1	96.7	55.4	56.3	59.8	35.5	84.1	46.4	67.4	79.3	33.9	172.1	62.3	58.8	45.6
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842984	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol		No	No		12000000	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	14.1	20.1	10.2	12.2	16.2	14.7	32.5	20.7	21.8	14.6	12.9	10.2	12.3	10.3	14.8	14.1	17.3	13.8	10.6	12.7	11.7	12.3	11.5	21.0	34.8	23.6	9.8	14.1	16.7	32.2	13.3	11.7	10.5	14.5	16.1	12.5	8.8	15.1	15.7	10.0	16.7	11.2	24.5	9.9	12.3	14.4	11.3	8.1	13.0	12.6	9.2	15.5	14.9	13.5	17.5	14.4	15.2	17.9	14.2	25.2	14.2	13.1	17.1	8.3	15.4	18.6	18.5	9.8	19.5	15.3	18.5	16.9	15.2	8.7	13.4	8.9	19.8	14.6	19.7	0.0	19.2	21.6	12.2	1.9	11.2	23.8	8.4	14.0	3.9	4.2	15.5	12.5	17.9	19.2	9.2	10.7	14.7	41.0	9.0	17.2	16.3	11.9	8.1	12.3	32.1	12.2	11.0	18.1	10.6	17.0	11.6	11.4	7.3	23.6	20.1	9.3	6.5	24.0	9.5	16.5	0.0	10.0	7.7	17.2	5.4	5.4	14.7	11.4	12.9	16.3	15.2	14.9	12.3	17.1	16.5	18.6	17.5	19.9	20.5	14.4	13.2	19.4	15.1	8.1	14.2	17.9	10.5	25.2	14.2	10.2	16.2	20.7	21.8	11.7	12.3	9.8	14.1	14.5	8.1	8.9	14.2	12.8	9.5	11.0	14.0	7.5	12.7	6.7	21.6	8.7	11.8	10.1	10.0	10.8	5.2	10.9	9.5	0.0	11.6	9.5	13.9	12.5	13.9	22.2	10.6	4.8	7.5	16.0	13.9	3.2	12.0	10.6	13.5	7.2	14.3	9.5	13.9	10.8	15.2	12.9	10.4	6.5	15.1	21.1	20.0	11.8	9.2	17.5	9.3	8.4
PSMD8	"HIP6, HYPF, Nin1p, p31, Rpn12, S14"	ENSG00000099341	"Proteasome 26S subunit, non-ATPase 8"	P48556	19	38374536-38383824	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 704.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006702, CAB021101"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"CAB021101: AB_10061018, HPA006702: AB_1079710"	"unprognostic (9.50e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.58e-3)"	"unprognostic (4.84e-2)"	53.0	35.1	30.0	23.9	35.6	32.9	43.0	28.1	49.4	26.5	31.8	25.8	30.1	31.5	30.9	40.9	39.1	32.5	28.0	75.3	32.2	29.3	40.9	71.1	28.8	28.8	27.1	37.0	24.4	48.2	30.6	29.2	56.6	30.0	33.6	32.9	24.6	32.6	29.7	157.1	42.2	33.2	34.5	25.0	27.6	28.9	55.8	21.4	38.1	35.4	50.1	33.9	28.3	27.1	40.4	60.8	32.0	68.1	38.8	65.6	68.7	60.5	96.6	38.1	43.4	62.1	50.0	20.0	44.1	60.2	68.0	71.1	66.2	36.5	42.7	46.1	58.7	41.8	21.1	63.6	54.8	61.5	70.3	42.0	46.4	31.9	40.8	80.4	46.7	41.3	50.4	54.8	58.5	78.0	37.6	53.3	52.0	57.8	48.1	74.7	60.3	44.1	26.3	29.6	89.7	52.8	46.0	61.2	33.9	48.1	50.5	39.9	40.6	45.8	59.3	42.8	37.1	30.9	44.1	39.2	52.0	48.1	54.4	64.6	48.7	56.2	57.0	78.2	48.1	57.7	32.0	55.2	29.2	46.1	59.9	39.1	40.4	40.4	44.2	60.8	37.0	33.6	32.6	20.8	38.8	68.1	42.3	65.6	68.7	30.0	35.6	28.1	49.4	32.2	29.3	27.1	37.0	30.0	21.4	62.5	58.2	119.9	188.9	182.9	97.2	223.0	73.9	99.0	68.2	76.8	51.1	304.9	295.1	231.4	321.4	92.0	206.5	70.0	232.9	276.1	132.4	178.0	91.2	110.9	262.3	73.1	140.2	70.6	89.4	704.4	109.6	143.2	189.0	308.4	120.9	153.3	230.1	154.3	110.7	228.8	89.3	148.8	173.9	203.2	136.5	185.6	476.9	127.8	132.9	185.9
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888731-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		330000	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	25.6	10.7	11.5	12.9	12.1	27.8	18.7	15.3	12.0	9.6	22.1	9.2	14.8	19.5	14.4	13.6	12.3	10.7	12.5	13.9	10.6	11.2	19.2	19.8	12.3	14.8	10.6	9.0	13.0	28.6	4.9	8.3	8.7	12.7	9.5	4.8	9.4	15.3	14.2	28.6	12.4	16.3	15.7	11.6	14.8	24.7	13.6	8.7	13.8	10.9	17.1	9.2	8.2	11.8	24.5	36.7	29.6	26.3	14.9	25.9	27.3	20.5	31.6	2.6	4.8	4.4	4.5	5.5	21.1	6.8	10.6	6.0	23.1	2.5	15.4	17.9	10.8	3.6	8.4	7.5	11.1	6.3	29.6	16.7	12.5	14.7	11.4	11.0	8.8	8.9	8.0	5.3	11.8	4.5	3.8	6.3	9.6	11.2	2.2	6.6	24.1	17.6	6.6	5.5	2.6	24.7	13.4	7.2	9.4	5.1	20.7	5.5	7.7	21.1	3.1	11.3	2.3	9.1	4.4	16.7	10.1	11.6	19.8	14.7	12.0	26.0	22.4	18.1	11.5	9.2	20.3	26.3	29.6	20.9	25.4	16.7	24.5	20.1	18.9	22.2	19.5	15.8	13.6	24.1	14.9	22.0	36.7	25.9	27.3	11.5	12.1	15.3	12.0	10.6	11.2	10.6	9.0	12.7	8.7	44.7	31.8	34.3	9.8	53.8	6.7	7.1	30.6	33.5	38.7	33.2	17.7	25.4	44.7	101.5	24.4	23.2	71.9	93.5	106.1	25.7	39.1	8.6	43.8	24.3	35.7	14.3	44.7	28.8	45.7	8.3	35.1	46.2	52.3	130.8	56.1	12.5	112.4	56.1	36.4	69.8	12.6	38.8	43.4	26.5	32.8	62.6	31.6	49.0	62.2	9.2
PSME1	"IFI5111, PA28alpha"	ENSG00000092010	"Proteasome activator subunit 1"	Q06323	14	24136158-24138967	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 1206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006632	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA		8600000	Cytosol	"Nuclear bodies"	"HPA006632: AB_1079686"	"prognostic favorable (8.87e-5)"	"unprognostic (1.02e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-1)"	"unprognostic (7.04e-2)"	"unprognostic (9.63e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.50e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (1.62e-3)"	37.6	59.1	19.1	64.4	23.0	37.2	59.7	9.9	16.9	34.8	53.9	15.3	47.4	48.2	40.3	50.4	45.4	39.4	53.4	59.1	19.6	17.2	67.7	70.3	61.7	114.2	24.8	17.4	46.7	47.2	26.4	30.6	42.7	21.3	39.2	44.8	28.4	38.0	57.0	38.0	33.7	82.3	45.0	20.4	82.8	38.9	14.5	22.5	70.5	58.4	54.3	52.0	35.8	40.4	68.2	72.2	112.1	93.3	81.2	87.8	132.3	17.7	14.8	11.3	21.6	24.6	28.4	17.3	11.3	37.1	36.4	52.4	9.5	43.3	45.8	8.5	18.9	19.4	25.8	16.0	23.5	24.5	38.2	9.9	20.3	7.3	52.3	54.1	25.8	26.0	24.8	15.2	16.5	14.5	34.7	27.5	29.5	3.1	41.0	14.2	45.1	66.5	31.6	1.0	29.6	25.5	52.9	23.1	32.8	46.0	47.1	7.2	12.8	14.4	37.7	21.9	7.0	24.7	25.4	15.5	10.0	11.8	11.4	16.8	38.2	39.3	21.7	13.7	23.1	16.1	53.2	74.4	89.4	87.0	93.3	87.0	68.2	82.0	82.6	72.2	61.6	59.4	72.7	112.1	81.2	89.4	68.5	87.8	132.3	19.1	23.0	9.9	16.9	19.6	17.2	24.8	17.4	21.3	22.5	193.5	156.8	343.2	204.1	138.9	26.6	52.0	236.9	155.2	184.2	268.7	9.8	343.2	270.2	429.0	2.7	231.5	431.2	116.8	481.9	234.7	186.7	203.3	233.3	201.1	286.2	6.4	182.0	199.5	245.3	8.6	175.2	260.5	178.8	1206.5	304.4	72.8	372.3	455.9	117.4	453.6	19.7	103.5	168.3	2.3	26.2	136.4	254.6	355.3	342.0	230.4
PSME2	PA28beta	ENSG00000100911	"Proteasome activator subunit 2"	Q9UL46	14	24143362-24147570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 120.2"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 1118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA062661			Approved	Nucleoplasm		NA	NA		8000000	Nucleoplasm		"HPA062661: AB_2684825"	"prognostic favorable (1.27e-4)"	"unprognostic (7.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.90e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.07e-3)"	15.4	43.4	14.9	33.9	17.1	16.4	17.1	14.2	14.3	17.5	42.7	9.9	33.5	63.3	17.6	30.2	24.4	17.6	31.3	15.8	13.1	14.7	36.3	64.6	27.5	38.7	13.9	11.0	20.7	26.4	14.6	30.1	25.9	15.3	22.2	35.5	14.3	28.2	36.8	13.6	15.1	102.2	18.6	12.3	61.5	21.4	12.5	13.8	32.7	27.5	27.9	35.9	20.0	18.5	38.8	48.9	20.0	112.2	49.9	45.1	120.2	18.7	19.5	12.6	28.5	9.4	13.7	18.7	11.1	25.9	35.3	44.2	15.1	43.7	25.6	6.5	12.4	36.0	16.9	7.6	19.5	21.2	40.5	6.5	14.9	10.9	60.3	30.4	21.0	22.5	13.6	6.0	24.4	9.9	14.3	17.3	17.1	7.3	32.3	13.5	41.6	41.0	31.0	4.3	31.1	26.5	38.7	19.3	27.9	23.9	44.0	7.7	10.2	20.3	34.6	14.4	7.0	17.7	25.1	13.2	17.6	16.2	8.1	20.2	30.1	39.2	28.4	12.9	23.0	21.9	8.3	60.5	20.0	43.6	112.2	45.1	38.8	43.6	42.8	48.9	29.4	32.8	39.9	19.4	49.9	71.7	35.8	41.7	120.2	14.9	17.1	14.2	14.3	13.1	14.7	13.9	11.0	15.3	13.8	47.6	112.2	196.6	142.5	137.6	37.8	61.3	160.5	129.8	102.4	111.7	21.6	275.9	253.7	303.1	9.6	150.1	574.8	0.0	494.7	240.1	145.1	162.7	140.6	195.6	314.2	27.0	94.0	60.2	127.5	9.7	68.4	275.5	129.9	1118.1	171.6	43.0	283.1	252.6	73.2	281.2	17.2	45.3	111.2	53.1	17.4	122.2	190.9	197.9	289.3	191.8
PSMG2	"CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1"	ENSG00000128789	"Proteasome assembly chaperone 2"	Q969U7	18	12658043-12725740	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 378.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 93.0"	"Low region specificity"	"Detected in all"							"HPA041517, HPA046741"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA041517: AB_2677530, HPA046741: AB_2679780"	"unprognostic (2.28e-2)"	"unprognostic (9.44e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.75e-3)"	37.3	31.0	24.1	25.2	25.2	42.0	37.4	26.2	27.4	30.5	30.3	24.7	20.6	25.6	34.8	39.6	43.4	27.8	39.2	28.5	23.5	23.4	38.7	46.8	30.9	41.8	24.0	18.9	35.7	44.8	9.9	26.4	35.4	23.0	32.5	35.2	24.8	31.9	28.5	29.0	32.2	34.6	38.1	27.0	35.1	31.0	71.6	20.6	49.0	40.3	37.1	41.3	38.1	29.9	28.8	31.2	33.0	40.9	27.6	41.5	33.2	18.0	11.6	13.5	17.5	25.3	37.0	18.0	17.3	28.4	32.6	36.9	19.7	20.3	20.9	14.2	21.0	23.4	11.5	21.9	23.8	28.5	10.8	10.4	11.4	10.5	23.9	24.2	38.7	17.8	29.6	18.9	19.2	26.3	18.8	22.8	16.2	17.0	26.8	25.3	18.0	24.4	53.6	10.6	93.0	13.7	16.7	20.4	29.9	29.3	25.4	16.6	12.7	17.0	20.1	16.3	14.1	17.5	32.5	14.6	36.3	46.6	30.5	20.2	22.4	31.0	24.6	21.3	20.1	14.5	29.0	35.8	33.0	27.5	36.3	32.7	28.8	36.1	31.6	31.2	26.1	33.1	31.0	12.0	27.6	40.9	25.8	41.5	33.2	24.1	25.2	26.2	27.4	23.5	23.4	24.0	18.9	23.0	20.6	47.6	38.4	56.2	83.4	80.8	24.2	29.0	58.6	49.5	38.7	78.5	21.6	169.1	131.0	97.4	378.7	70.5	65.0	0.0	96.8	115.7	101.3	74.8	60.0	52.1	131.4	23.8	65.8	80.4	130.8	85.9	124.3	107.7	69.2	107.4	75.8	51.3	90.0	80.1	91.2	141.7	16.9	84.1	96.6	169.3	251.7	78.7	155.8	80.3	91.4	103.6
PSMG4	"C6orf86, PAC4"	ENSG00000180822	"Proteasome assembly chaperone 4"	Q5JS54	6	3231403-3303373	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067652, HPA074376, HPA075846"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA067652: AB_2685880, HPA074376: , HPA075846: "	"unprognostic (3.13e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.40e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.48e-2)"	13.9	12.7	12.6	13.0	26.1	14.3	16.0	18.5	14.4	15.8	15.1	11.8	11.3	17.3	16.7	23.1	16.9	13.4	18.7	12.9	11.4	14.0	13.1	18.1	11.0	15.2	10.7	12.2	13.8	30.9	8.9	16.2	9.6	10.7	15.5	8.9	13.6	21.0	18.8	36.6	17.9	16.8	18.1	10.6	11.9	17.4	13.3	9.8	13.5	17.2	16.5	14.6	13.1	11.3	25.6	18.5	12.2	20.1	16.2	24.4	13.2	21.5	10.6	6.4	15.7	5.8	8.6	11.0	9.8	7.3	9.4	15.3	8.9	7.5	7.2	26.7	5.8	7.6	10.1	5.3	6.5	6.1	12.2	22.8	5.8	10.9	23.0	6.9	16.7	6.2	7.3	7.3	6.8	10.2	5.4	11.7	14.5	22.5	5.6	5.0	20.6	9.5	31.0	7.8	11.1	20.9	12.8	3.5	40.1	7.4	8.6	27.4	8.0	4.3	6.2	20.9	6.3	7.9	7.5	11.1	8.0	7.6	8.9	9.4	18.2	25.7	13.3	5.6	12.1	10.8	6.2	20.1	12.2	14.8	18.4	17.0	25.3	24.4	17.8	15.5	25.6	24.4	20.9	4.8	16.2	18.1	18.5	20.5	13.2	12.6	26.1	18.5	14.4	11.4	14.0	10.7	12.2	10.7	9.8	20.8	13.9	20.9	23.8	24.7	28.8	18.6	35.7	16.0	19.4	41.8	7.9	32.9	71.3	34.8	24.9	32.9	22.0	0.0	76.0	30.2	26.7	25.6	21.9	55.5	30.7	23.8	21.9	29.4	18.9	9.7	34.2	21.2	28.7	31.5	27.1	15.1	47.9	24.6	21.5	42.5	26.2	45.3	30.9	29.8	76.7	33.4	10.1	20.6	32.0	22.6
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 91.2;Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	7.5	13.4	14.1	5.9	16.6	5.1	11.0	10.1	14.6	5.4	8.0	13.2	11.4	6.9	7.0	9.0	11.0	26.3	10.6	12.8	13.2	12.5	14.7	9.8	5.4	7.4	14.8	10.0	13.9	15.9	7.8	17.1	6.4	11.1	10.6	6.9	6.9	6.8	11.5	6.8	6.4	6.2	8.5	15.2	5.7	8.5	9.1	13.3	10.2	12.2	6.9	8.5	7.1	16.0	7.8	11.9	6.8	8.5	5.3	6.2	5.8	46.9	14.4	8.8	32.9	7.4	10.0	6.1	11.9	7.0	6.6	11.8	12.9	8.2	23.2	8.0	11.0	16.7	9.8	19.5	10.1	6.9	17.6	10.9	6.5	3.9	21.7	15.9	6.5	10.0	12.5	19.0	10.5	12.2	9.4	6.5	22.0	15.5	15.0	10.0	6.3	9.9	15.5	14.1	16.8	20.2	13.0	5.3	13.3	6.3	2.4	16.1	18.6	8.6	5.3	23.8	7.5	15.9	13.7	5.5	5.8	9.2	17.9	10.8	10.4	18.0	26.3	8.3	14.3	18.2	2.2	7.7	6.8	4.2	5.3	3.0	7.2	4.0	5.1	11.9	7.8	6.2	5.5	3.6	5.3	8.5	11.3	5.1	5.8	14.1	16.6	10.1	14.6	13.2	12.5	14.8	10.0	11.1	13.3	3.0	1.0	9.7	8.3	6.1	4.4	9.4	17.8	34.8	9.1	5.2	2.0	11.9	91.2	7.9	131.4	3.6	1.3	0.0	6.8	6.3	5.3	5.3	1.1	7.3	7.9	1.6	4.6	6.7	6.5	38.2	7.8	4.8	6.8	4.6	3.9	41.4	7.8	3.5	5.6	39.1	2.8	12.9	5.7	23.6	26.0	7.4	3.9	5.0	7.5	4.7
PSRC1	DDA3	ENSG00000134222	"Proline and serine rich coiled-coil 1"	Q6PGN9	1	109279556-109283186	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 23.6;Extravillous trophoblasts: 28.6;Peritubular cells: 42.1;Rod photoreceptor cells: 70.6"	"Cancer enhanced"	"Detected in all"		"glioma: 50.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 12.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3"	"Low region specificity"	"Detected in all"			HPA056561			Approved	Nucleoplasm,Cytosol		NA	Yes			Cytosol	Nucleoplasm	"HPA056561: AB_2683175"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.36e-9)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	1.7	2.4	17.1	4.3	21.6	8.3	3.0	3.8	27.3	2.0	4.0	31.2	0.3	5.1	3.0	3.4	6.3	3.2	3.7	2.0	25.9	11.2	1.7	2.6	2.2	4.0	29.8	12.9	3.6	1.4	0.8	1.7	4.8	16.8	4.0	3.3	4.5	2.9	5.9	1.0	6.1	5.3	4.7	30.6	2.3	2.4	8.6	20.7	5.5	2.0	0.4	5.0	2.6	2.3	0.0	5.4	7.3	12.3	0.2	0.7	3.2	18.8	9.8	40.0	19.3	1.6	3.2	11.0	15.0	12.2	20.5	19.7	15.0	7.9	9.6	5.5	7.4	9.6	13.6	21.5	12.3	17.2	3.7	10.4	6.0	13.1	12.2	1.8	6.4	6.9	3.6	1.1	8.1	5.8	7.7	10.0	11.5	13.6	4.4	16.4	17.1	9.7	4.3	16.5	8.7	11.2	15.1	38.5	3.2	6.9	5.0	16.8	9.7	8.4	12.9	15.4	15.2	7.8	6.1	5.1	12.7	21.0	8.9	24.6	3.4	2.2	3.3	10.2	15.3	35.3	0.0	12.3	1.8	0.7	4.8	0.5	0.0	0.7	0.2	5.4	0.0	0.4	0.4	7.3	0.2	2.6	0.0	0.7	3.2	17.1	21.6	3.8	16.4	25.9	11.2	29.8	12.9	16.8	20.7	0.0	3.8	0.0	2.3	1.8	6.5	0.9	2.5	1.4	0.0	1.8	23.6	3.4	0.0	0.9	0.5	0.4	0.5	0.0	0.7	28.6	2.3	0.6	1.1	0.9	9.2	3.2	0.0	1.3	4.0	1.9	5.5	1.6	1.7	0.0	3.2	7.7	0.4	0.0	42.1	2.3	70.6	0.0	2.3	2.7	1.2	1.0	2.4	0.0	2.0	0.7
PSTK	"C10orf89, MGC35392"	ENSG00000179988	"Phosphoseryl-tRNA kinase"	Q8IV42	10	122954381-122997513	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037780, HPA037781"	Approved		Approved	"Nucleoli,Nuclear bodies,Actin filaments"		No	No			"Actin filaments"	"Nucleoli, Nuclear bodies"	"HPA037780: AB_2675662, HPA037781: AB_10670530"	"unprognostic (8.95e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-4)"	"unprognostic (5.21e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (5.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.55e-4)"	2.8	5.6	7.0	2.5	8.8	12.5	8.8	4.3	10.4	5.8	4.3	10.5	4.7	4.6	5.4	11.4	3.7	5.6	3.5	4.7	7.5	7.3	5.5	10.6	2.8	4.0	8.8	8.7	3.8	5.4	4.2	7.2	3.7	9.3	5.6	4.3	3.8	4.3	3.6	6.8	3.8	3.8	5.4	8.7	2.9	3.0	11.1	8.6	2.9	6.8	1.4	3.6	4.8	3.2	6.5	7.4	6.3	5.5	6.6	10.0	6.0	5.4	3.9	2.1	1.0	2.5	4.7	2.6	2.1	5.2	4.6	5.6	5.6	4.9	5.5	5.1	3.8	2.9	3.0	1.0	4.7	5.4	3.0	10.4	3.8	0.9	4.4	6.0	7.7	4.6	5.3	8.1	4.2	8.1	4.3	3.2	5.0	5.2	8.6	6.8	8.2	2.7	4.8	4.7	2.3	5.6	5.5	3.6	5.1	6.9	3.4	2.2	2.4	4.6	5.3	7.7	2.4	2.5	0.6	3.8	3.6	3.4	1.4	5.2	3.2	1.7	7.6	3.3	5.3	1.4	0.0	5.5	6.3	8.9	3.3	10.0	6.5	6.9	8.4	7.4	5.8	9.2	9.4	0.6	6.6	3.9	7.0	4.2	6.0	7.0	8.8	4.3	10.4	7.5	7.3	8.8	8.7	9.3	8.6	8.9	8.2	3.4	4.6	3.9	8.1	4.4	12.7	8.1	4.5	5.2	7.9	6.8	8.3	3.9	20.0	3.1	1.7	0.0	5.6	2.2	4.1	3.4	2.3	5.1	4.2	4.8	4.1	4.3	1.3	2.6	4.9	3.0	5.0	5.4	2.3	8.5	3.4	3.4	5.3	6.4	9.6	0.0	4.7	16.8	13.8	4.1	8.0	5.7	3.8	2.6
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 41.7;Kupffer cells: 40.3;Macrophages: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 38.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 37.7;HMC-1: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		7100000	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.6	3.3	1.8	6.1	3.1	36.9	4.9	0.6	2.1	3.4	3.4	0.9	2.7	2.0	2.7	2.8	4.4	2.9	4.4	4.0	4.5	1.2	3.3	8.6	7.4	11.5	3.4	0.4	3.1	3.9	2.2	3.9	11.6	3.5	5.8	3.0	3.5	4.5	8.8	16.6	5.9	3.1	4.1	4.6	46.7	4.3	1.9	3.2	3.0	1.8	6.5	5.6	4.6	3.0	0.0	8.9	38.1	12.4	0.9	3.9	6.3	1.0	0.0	1.4	0.0	0.3	2.6	7.9	5.6	2.8	2.0	1.7	4.3	1.5	0.0	0.3	1.8	0.0	13.7	7.7	10.6	2.5	0.0	1.2	37.7	1.9	0.0	2.3	2.2	41.9	1.9	13.2	1.9	6.3	1.8	4.0	0.0	9.0	0.0	8.8	1.3	0.3	0.0	0.9	0.0	0.0	0.0	2.9	1.8	4.2	13.8	0.1	0.8	0.9	3.9	0.1	11.4	12.4	4.4	2.9	0.2	3.2	0.3	0.0	0.0	0.1	0.0	0.5	0.0	0.1	20.7	9.0	38.1	3.9	12.4	1.3	0.0	2.3	2.8	8.9	0.0	2.8	3.3	4.9	0.9	11.9	0.3	1.4	6.3	1.8	3.1	0.6	2.1	4.5	1.2	3.4	0.4	3.5	3.2	11.9	15.2	6.9	15.7	12.2	0.6	2.8	2.5	2.7	13.6	0.0	0.0	21.1	3.3	8.8	1.9	2.2	0.4	0.0	3.3	2.5	3.8	21.9	41.7	16.3	12.6	0.0	1.2	10.4	40.3	5.0	2.6	35.6	6.8	6.4	2.6	9.5	20.5	0.0	2.1	2.9	0.2	6.5	6.2	0.5	1.1	8.9	7.3	12.5	2.2	17.0
PTAR1		ENSG00000188647	"Protein prenyltransferase alpha subunit repeat containing 1"	Q7Z6K3	9	69709522-69759959	"Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021248	Uncertain		Approved	"Centriolar satellite,Rods & Rings"		NA	NA			"Centriolar satellite"	"Rods & Rings"	"HPA021248: AB_1855872"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.16e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	16.2	11.2	18.9	13.8	16.8	40.6	18.6	18.7	21.3	17.4	15.8	17.7	13.1	10.2	20.3	11.1	14.8	16.0	13.0	15.8	20.1	8.8	22.2	19.9	19.1	15.9	18.8	12.6	21.5	19.1	27.1	21.5	17.0	14.9	12.4	21.5	17.4	17.8	13.6	23.3	15.8	17.6	15.3	16.5	16.2	13.1	14.9	20.3	38.9	16.2	8.9	14.0	17.4	18.2	4.0	3.4	13.2	6.3	4.8	6.8	2.5	7.8	10.1	13.0	6.5	12.4	15.9	7.5	18.6	13.4	6.4	7.1	3.4	5.3	7.9	9.0	14.7	6.1	12.7	29.9	7.1	14.7	8.1	8.0	13.0	18.0	7.2	12.3	10.9	11.0	9.8	6.7	11.8	17.0	11.5	10.8	13.7	8.2	17.6	16.5	2.1	9.0	3.8	17.2	7.8	7.3	9.3	21.2	5.8	14.7	7.6	9.9	12.1	12.8	5.4	9.6	13.0	3.9	4.9	19.4	16.0	14.7	12.7	15.1	11.8	12.0	5.1	10.8	10.4	28.3	6.8	4.6	6.3	5.2	6.3	4.7	4.0	4.3	3.7	3.4	2.7	4.9	5.3	13.2	4.8	3.5	2.0	6.8	2.5	18.9	16.8	18.7	21.3	20.1	8.8	18.8	12.6	14.9	20.3	32.8	16.3	15.1	16.9	14.8	28.5	15.7	43.3	14.7	13.6	31.4	76.6	15.0	13.3	11.1	12.4	18.8	13.3	0.0	6.8	12.1	14.5	19.6	17.3	29.0	11.0	31.8	10.9	17.8	31.5	16.3	28.7	14.5	30.4	9.0	27.0	28.8	9.6	14.0	21.5	32.4	53.4	25.8	19.1	55.6	8.5	13.4	8.0	20.8	19.9	22.7
PTBP2	"brPTB, nPTB, PTB, PTBLP"	ENSG00000117569	"Polypyrimidine tract binding protein 2"	Q9UKA9	1	96721665-96823738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 48.7;Spermatocytes: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047420	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047420: AB_10962353"	"unprognostic (2.14e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.26e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.31e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.27e-2)"	12.5	10.5	17.1	9.9	21.2	34.4	15.3	22.0	25.8	16.7	26.6	20.0	11.3	7.6	23.6	11.2	12.8	11.9	10.7	7.8	18.8	18.4	12.0	8.1	7.3	9.8	17.9	18.9	14.6	7.3	6.1	22.0	8.1	21.7	16.3	13.0	9.0	7.4	17.3	15.4	8.3	11.0	28.1	18.6	10.3	11.6	35.4	19.9	16.6	14.7	6.8	8.4	21.1	12.8	3.6	1.6	1.4	1.8	4.1	4.2	0.7	3.5	1.9	16.7	8.8	4.0	4.9	9.4	3.2	3.5	5.5	5.1	2.4	3.5	12.2	3.7	2.1	12.1	2.3	10.0	2.6	8.0	2.0	3.0	6.7	5.6	3.1	2.3	3.4	3.5	2.7	1.6	6.9	2.9	4.4	2.7	5.9	4.9	3.3	7.2	1.2	11.0	11.1	10.2	1.4	4.4	6.5	39.6	1.8	5.6	2.0	9.6	9.9	4.1	2.7	4.7	8.7	2.6	7.0	2.6	3.8	7.5	3.1	4.1	2.7	2.0	14.2	1.8	5.5	1.6	0.9	1.4	0.9	2.7	1.7	2.0	3.5	3.5	2.5	0.8	3.6	4.2	2.9	1.4	4.1	1.8	1.6	3.2	0.7	17.1	21.2	22.0	24.7	18.8	18.4	17.9	18.9	21.7	19.9	8.9	11.5	10.8	8.8	12.4	26.4	10.8	5.1	8.1	5.7	19.2	13.7	4.6	11.6	5.9	3.7	14.6	4.0	0.0	4.4	3.6	9.3	8.6	7.0	8.2	2.9	28.6	23.5	8.0	11.3	5.3	8.3	7.7	13.5	6.4	6.2	48.7	4.2	3.5	7.4	6.2	21.7	6.5	27.8	71.4	31.7	6.1	1.7	8.7	4.7	4.8
PTBP3	"DKFZp781I1117, ROD1"	ENSG00000119314	"Polypyrimidine tract binding protein 3"	O95758	9	112217716-112333667	"Predicted intracellular proteins"	"Differentiation, Erythrocyte maturation, mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048374			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048374: AB_2680376"	"unprognostic (6.12e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.38e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.39e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.10e-2)"	22.4	9.4	7.2	24.5	9.2	22.9	26.3	9.5	6.8	17.2	21.7	5.6	18.9	17.7	14.3	18.9	38.4	10.0	17.2	11.6	6.1	8.7	26.8	12.7	25.1	37.2	6.2	4.5	13.0	17.9	9.0	17.8	25.8	6.6	13.8	22.1	9.0	20.2	22.6	8.0	25.0	32.4	12.8	11.4	23.9	20.9	22.6	6.6	41.7	12.6	30.7	38.4	22.1	21.5	7.0	11.8	23.9	9.5	4.3	8.7	4.5	20.0	21.3	8.1	7.0	7.2	7.9	41.5	8.2	6.7	10.1	10.5	24.2	30.1	23.0	9.2	10.6	8.0	28.5	11.2	23.4	13.5	25.6	3.9	23.3	8.8	17.0	9.1	30.5	28.4	8.9	15.9	13.5	18.7	6.4	17.1	17.9	31.1	21.6	11.5	18.7	30.1	8.3	12.8	31.0	7.3	19.6	27.7	11.6	14.9	26.6	10.2	6.5	16.3	21.4	7.9	18.2	25.3	13.8	13.2	8.9	12.2	12.8	10.1	11.1	27.4	20.9	7.7	15.6	8.7	14.2	6.3	11.8	8.4	7.7	8.7	5.5	6.3	6.8	7.2	7.0	5.0	6.0	23.9	4.3	9.5	11.8	6.5	4.5	7.2	9.2	9.5	6.8	6.1	8.7	6.2	4.5	6.6	6.6	26.8	59.3	29.8	34.2	71.2	7.7	6.7	63.7	69.6	70.5	108.2	17.7	29.6	24.9	37.2	53.1	41.4	73.5	46.7	61.6	89.7	27.7	65.8	62.5	27.0	49.5	7.9	86.8	43.6	100.8	105.3	20.1	76.6	27.0	63.1	73.2	3.5	88.0	63.3	17.7	25.4	15.7	19.4	25.9	17.2	19.8	90.8	29.3	57.3	69.2	200.8
PTCD1	KIAA0632	ENSG00000106246	"Pentatricopeptide repeat domain 1"	O75127	7	99416739-99466163	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 22.3"									"HPA020106, HPA047679"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020106: AB_2176551, HPA047679: AB_2680119"	"unprognostic (4.70e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.14e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.10e-3)"	10.3	11.4	9.9	12.0	11.9	21.9	10.6	13.9	16.3	9.4	15.7	5.3	12.0	13.2	12.4	10.6	17.7	12.7	13.2	22.9	10.5	9.1	18.3	29.5	11.5	14.8	9.2	13.1	13.5	19.9	9.3	9.7	9.8	10.7	13.4	7.4	9.1	17.4	13.6	43.8	19.7	18.9	6.4	8.6	15.8	11.6	18.0	7.5	16.0	12.2	30.8	11.3	12.4	10.5	6.2	4.7	4.5	5.0	4.1	8.0	3.2	3.6	7.5	2.6	7.2	2.4	2.0	7.3	5.0	1.9	3.7	2.6	22.3	4.4	7.3	5.9	1.4	6.1	3.9	3.1	4.6	1.3	5.7	8.7	3.7	6.0	5.4	3.8	3.6	7.1	1.6	2.9	3.0	3.0	2.5	1.1	4.7	7.4	5.0	1.8	10.2	6.7	9.6	4.8	3.6	6.3	4.1	3.4	9.0	1.9	3.9	4.8	5.2	5.6	18.8	4.8	3.9	4.0	4.0	2.0	5.6	6.5	10.8	5.4	7.6	6.5	7.8	5.7	5.1	7.6	3.5	4.5	1.8	8.0	5.0	5.2	4.2	5.0	5.2	3.2	6.2	5.9	7.1	4.5	4.1	3.5	4.7	3.3	3.2	9.9	11.9	13.9	16.3	10.5	9.1	9.2	13.1	10.7	7.5	0.0	4.3	11.3	3.5	5.6	7.8	5.5	2.5	8.1	3.4	5.2	9.8	8.1	1.7	4.4	1.0	4.3	3.0	0.0	5.9	4.6	5.0	3.0	12.7	5.9	5.8	7.9	7.0	3.7	1.6	1.5	3.4	4.8	3.3	3.6	5.8	4.6	3.6	3.4	2.8	2.4	8.3	0.0	5.4	6.5	7.1	3.6	4.7	5.7	5.6	2.4
PTCH1	"BCNS, NBCCS, PTCH"	ENSG00000185920	"Patched 1"	Q13635	9	95442980-95517057	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease mutation, Holoprosencephaly, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Late spermatids: 165.3;Leydig cells: 176.9;Peritubular cells: 417.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.8;WM-115: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013717, HPA075072"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB013717: , HPA075072: AB_2686733"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-6)"	"unprognostic (8.63e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.82e-1)"	4.1	3.8	6.7	6.0	9.5	0.7	7.9	21.0	6.4	28.5	12.5	6.1	8.0	7.8	16.2	4.2	3.0	7.4	13.2	2.8	7.0	6.6	4.9	2.2	7.1	4.5	9.5	3.2	5.2	10.8	3.4	4.0	3.7	6.9	6.9	12.3	11.2	6.9	9.5	2.7	4.3	10.9	8.5	5.1	3.8	12.1	14.3	7.9	1.0	6.3	1.9	3.2	11.3	6.9	1.0	0.0	0.0	0.0	0.3	8.9	1.8	5.1	2.5	10.9	6.8	1.6	2.7	6.2	1.0	0.9	1.2	0.7	2.5	2.5	4.1	1.8	1.9	2.3	11.8	6.2	0.8	0.7	4.0	4.1	0.0	2.5	1.1	1.5	0.1	2.3	2.5	1.3	1.1	0.8	2.3	2.2	1.8	3.6	4.8	0.5	1.0	0.0	1.6	15.8	3.7	1.0	0.0	8.3	2.1	0.8	0.7	7.5	3.7	3.7	3.6	1.6	10.6	0.9	1.1	0.5	1.4	7.2	7.3	0.7	9.7	8.4	2.7	2.0	2.0	37.6	0.0	0.0	0.0	8.9	0.0	5.3	1.0	1.7	3.8	0.0	0.3	2.8	3.2	0.0	0.3	0.0	0.0	1.4	1.8	6.7	9.5	21.0	6.4	7.0	6.6	9.5	3.2	6.9	7.9	0.0	5.4	0.9	2.8	3.5	17.4	5.1	10.2	1.4	2.3	0.0	39.3	2.0	5.0	2.5	80.9	3.7	1.3	0.0	3.5	1.6	6.9	5.8	1.1	1.0	0.7	19.1	20.8	3.1	0.8	165.3	176.9	0.8	11.8	0.0	11.2	71.0	2.6	3.5	417.9	1.1	13.5	38.8	4.2	3.3	33.2	3.9	1.1	4.3	5.0	1.1
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47878028-48068689	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3"	"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 1.4;Collecting duct cells: 1.8"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.1;BEWO: 13.5;Hep G2: 22.5;LHCN-M2: 10.7;SuSa: 22.9;TIME: 11.4;WM-115: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	2.1	0.7	4.6	0.1	7.4	0.2	1.3	2.7	11.3	3.8	1.2	0.3	0.0	0.6	1.7	3.7	1.9	3.2	1.4	1.4	2.2	1.3	2.2	2.1	3.1	0.2	1.4	5.5	1.1	1.1	0.4	3.9	1.9	1.8	2.3	1.2	1.6	2.1	6.4	0.6	0.3	0.4	1.9	1.3	0.2	0.5	0.9	0.8	0.0	3.6	0.0	0.3	2.8	1.3	0.4	0.4	0.8	0.2	0.1	0.2	0.0	0.0	0.0	10.1	0.0	1.7	5.0	13.5	1.5	3.2	0.1	0.4	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	22.5	0.5	0.0	0.0	7.4	7.2	0.0	0.1	5.4	1.5	2.3	0.0	0.0	10.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.5	0.0	0.0	0.0	22.9	0.0	0.0	11.4	2.5	1.6	0.0	0.2	0.0	0.0	0.0	3.4	0.0	9.9	0.8	0.1	0.5	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.1	0.2	0.4	0.0	0.0	4.6	7.4	2.7	11.3	2.2	1.3	1.4	5.5	1.8	0.8	0.0	0.6	0.0	0.0	0.1	0.4	0.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PTDSS1	"KIAA0024, PSS1, PSSA"	ENSG00000156471	"Phosphatidylserine synthase 1"	P48651	8	96261715-96336995	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016852	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA016852: AB_1855878"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (1.08e-5)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.55e-2)"	8.2	7.9	8.0	8.1	14.7	10.2	10.4	10.2	15.0	9.7	8.3	5.1	22.5	10.6	8.4	7.8	9.6	7.0	7.9	20.1	8.6	9.9	9.5	12.8	7.8	21.8	7.1	8.0	9.6	12.1	23.2	4.9	10.8	9.6	5.7	7.4	5.2	8.8	29.8	10.1	10.4	8.3	9.0	6.0	11.8	8.1	5.1	3.6	20.7	11.0	7.7	11.8	9.3	6.8	3.6	6.1	9.4	3.7	5.0	4.6	7.8	10.4	8.1	1.4	3.9	2.9	6.1	2.4	7.6	10.5	7.3	5.1	3.0	3.0	17.2	7.0	7.1	1.5	4.3	9.9	7.6	11.4	8.8	7.1	16.9	15.7	1.6	3.0	12.4	5.9	5.1	7.3	10.2	7.2	1.8	4.7	5.3	8.4	8.9	6.6	3.0	9.6	1.9	2.2	3.4	7.6	7.7	7.3	13.0	4.1	8.9	6.1	2.5	2.8	2.5	1.1	1.7	5.9	4.2	8.3	6.6	4.1	4.6	8.7	1.8	9.3	8.4	4.1	13.1	5.4	9.4	3.7	2.1	2.8	2.5	4.0	2.6	4.6	3.4	6.1	3.6	4.0	2.9	1.3	5.0	2.4	1.8	2.6	7.8	8.0	14.7	10.2	15.0	8.6	9.9	7.1	8.0	9.6	3.6	17.9	10.8	40.8	14.5	28.0	8.9	88.9	22.9	2.7	14.8	10.4	9.8	67.1	1.7	16.6	53.9	21.0	13.3	23.3	38.8	47.5	19.7	14.5	32.3	28.4	42.1	4.8	5.2	19.0	42.5	34.9	21.6	30.4	18.6	17.2	15.0	4.8	21.4	5.8	24.4	15.9	4.3	0.0	17.6	10.3	16.6	29.4	67.6	35.2	29.4	13.6
PTER		ENSG00000165983	"Phosphotriesterase related"	Q96BW5	10	16436943-16513745	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 21.6;cerebellum: 8.9;cerebral cortex: 30.8;hippocampal formation: 22.7;hypothalamus: 8.9"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038044, HPA038045"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038044: AB_2675803, HPA038045: AB_10672616"	"unprognostic (5.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.52e-6)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.36e-3)"	11.1	5.4	21.6	10.6	2.9	1.3	8.7	8.9	30.8	6.2	12.1	1.6	14.5	9.2	5.8	8.1	6.9	3.4	3.8	7.8	22.7	8.9	31.3	21.9	9.2	12.6	4.2	1.3	5.3	17.9	11.1	3.4	11.2	3.1	11.3	5.4	6.8	10.6	12.9	6.2	4.0	21.9	5.7	2.6	11.8	9.2	2.9	1.5	17.2	12.0	3.9	9.6	7.7	10.9	15.3	11.7	6.9	16.7	7.6	19.5	9.4	16.1	9.7	0.1	2.9	4.1	8.1	9.7	4.8	0.5	1.8	2.7	8.9	15.3	17.0	4.0	3.2	1.0	7.4	5.5	3.2	2.7	16.6	7.2	15.8	4.6	3.6	4.9	5.1	4.8	5.9	10.4	5.5	0.9	0.0	0.8	15.4	10.8	6.0	2.8	5.4	11.9	5.1	3.9	11.1	2.4	8.9	1.3	8.9	25.5	5.1	12.3	0.8	8.5	2.4	14.0	3.5	5.7	16.2	2.1	0.1	4.3	3.9	0.1	4.5	5.6	18.0	2.0	9.4	6.0	3.5	11.7	6.9	12.7	16.7	13.5	15.3	14.6	12.6	11.7	8.8	11.0	10.9	2.2	7.6	14.5	9.9	19.5	9.4	21.6	2.9	8.9	30.8	22.7	8.9	4.2	1.3	3.1	1.5	26.8	19.9	5.7	12.7	9.7	0.8	22.7	15.3	17.4	28.4	27.9	0.0	17.1	44.7	19.3	0.2	7.1	13.2	0.0	29.9	14.6	7.8	8.8	23.1	21.2	13.0	0.0	11.1	10.4	11.6	0.0	0.9	17.5	8.5	9.0	12.4	13.5	21.4	28.8	0.0	86.8	8.0	6.5	10.3	0.9	6.8	10.8	10.1	12.5	16.8	19.7
PTF1A	"bHLHa29, PTF1-p48"	ENSG00000168267	"Pancreas specific transcription factor, 1a"	Q7RTS3	10	23192327-23194252	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	154	"pancreas: 129.8"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 1.3;Exocrine glandular cells: 4.2;Pancreatic endocrine cells: 1.3;Spermatocytes: 3.3"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"U-2 OS: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB022612			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB022612: "										"unprognostic (2.02e-1)"	"unprognostic (1.85e-1)"			"unprognostic (4.49e-1)"	"unprognostic (1.80e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	129.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.7	0.0	0.0	0.0	0.0	0.0
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 606.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA020631: AB_1855887, HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	9.3	17.0	16.5	9.2	17.8	4.4	7.4	15.3	24.1	7.1	14.8	9.9	7.6	17.7	8.1	9.0	12.6	8.4	10.0	36.4	17.4	14.0	13.2	13.0	5.8	10.2	14.2	11.6	9.2	18.3	11.7	14.3	10.7	10.5	8.0	7.0	13.2	16.2	12.0	73.5	9.3	13.2	5.9	7.0	9.5	14.3	5.8	9.8	9.3	10.5	16.2	13.3	8.5	7.3	5.2	8.2	1.2	6.3	3.7	6.5	2.9	12.7	35.8	4.0	14.8	3.6	3.7	12.2	9.8	5.5	12.4	6.6	26.7	20.0	11.3	15.7	3.9	9.7	33.2	5.8	12.1	1.7	8.1	15.6	5.8	27.1	24.9	11.1	11.7	11.6	5.0	8.8	10.0	6.9	3.8	8.5	12.0	12.8	7.0	4.1	39.5	14.0	22.4	12.8	15.4	29.0	10.6	7.9	28.8	8.4	9.6	20.0	12.0	14.2	22.6	9.5	2.0	20.2	6.3	11.1	12.8	15.8	17.2	17.8	16.2	7.9	11.0	9.7	9.1	11.8	1.2	6.0	1.0	5.6	6.3	6.5	5.2	3.7	5.9	6.7	4.5	4.3	5.1	1.1	3.7	2.8	8.2	4.2	2.9	16.5	17.8	15.3	24.1	17.4	14.0	14.2	11.6	10.5	9.8	14.9	5.4	25.3	29.8	20.4	34.7	606.9	35.7	0.0	6.8	22.7	19.6	69.1	124.3	64.1	1.9	21.1	88.3	0.0	44.8	49.4	20.3	34.0	14.9	33.3	50.6	35.0	43.4	15.4	22.9	3.2	28.4	33.8	54.0	154.1	52.3	18.2	52.2	51.8	20.5	79.0	38.1	19.4	28.3	2.3	56.6	21.5	55.7	21.7	83.1	40.8
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 358.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		580000	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	44.7	41.4	56.0	41.2	55.7	39.6	175.0	44.2	51.7	49.0	51.9	38.1	49.5	46.4	57.7	52.0	52.6	69.8	36.0	46.0	54.6	57.2	52.1	67.1	46.4	62.0	67.0	41.4	82.3	55.1	43.2	49.2	50.3	57.0	60.7	55.3	24.0	36.6	49.4	64.2	37.0	46.7	64.7	72.5	42.7	36.6	39.7	65.1	53.5	72.5	36.7	55.1	72.7	358.9	40.6	36.9	27.3	74.8	29.2	42.5	60.5	81.4	71.0	57.7	34.3	42.5	38.6	87.9	53.4	40.8	68.8	51.4	60.1	85.9	90.3	81.1	45.5	46.3	52.5	108.0	69.7	87.2	66.3	71.9	70.5	44.9	69.5	31.1	83.7	51.2	27.9	51.0	51.9	63.1	65.5	70.7	58.1	113.0	86.5	67.1	50.8	83.1	79.6	98.5	71.9	83.0	72.7	54.4	121.2	60.5	63.8	74.8	43.7	54.5	78.6	46.2	79.6	90.5	70.3	42.3	41.3	48.1	49.5	73.7	36.5	100.4	72.6	45.0	69.1	74.3	27.3	37.5	23.2	32.0	59.0	42.0	40.6	42.5	38.1	36.9	28.5	42.3	36.4	14.8	29.2	74.8	31.3	42.5	60.5	56.0	55.7	44.2	51.7	54.6	57.2	67.0	41.4	57.0	65.1	166.7	121.6	178.4	623.1	343.3	128.5	151.7	150.3	313.2	146.7	179.7	72.6	370.5	316.7	252.0	38.5	189.7	176.9	116.8	186.9	545.4	268.2	456.4	232.8	165.2	311.0	106.5	250.8	168.1	180.7	81.6	221.2	245.7	268.2	312.0	185.6	201.5	190.6	194.6	200.5	268.7	99.7	142.3	307.9	546.1	341.1	330.1	473.4	233.5	241.8	443.4
PTGES3L-AARSD1		ENSG00000108825	"PTGES3L-AARSD1 readthrough"	Q9BTE6	17	42950526-42980528	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 46.6"	"Cell type enhanced"	"Detected in some"	19	"Ciliated cells: 4.0;Club cells: 1.2;granulocytes: 3.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 5.3"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 5.3"	"Cell line enhanced"	"Detected in many"		"RH-30: 6.7;THP-1: 13.2"	"Low region specificity"	"Detected in all"							"HPA021408, HPA022869, HPA023714"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (6.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.34e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.13e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.91e-4)"	"unprognostic (1.83e-1)"	0.7	0.1	0.7	1.2	4.5	1.2	0.5	0.6	1.6	1.5	5.5	0.3	0.1	1.7	4.7	2.4	2.2	1.6	3.6	13.8	0.5	0.7	0.3	0.2	0.6	0.7	0.6	0.8	0.7	0.3	0.4	1.5	0.4	0.4	2.0	3.2	1.6	0.7	3.1	46.6	0.2	1.6	10.6	0.2	0.4	2.4	3.8	0.2	0.5	0.5	14.4	0.8	5.1	1.4	0.1	5.3	0.0	0.0	0.0	0.0	0.4	1.0	0.0	2.7	2.7	0.3	0.0	0.8	2.2	2.0	1.2	1.1	1.7	0.3	0.3	1.7	0.2	0.8	0.0	0.4	1.1	1.9	1.0	0.4	5.6	2.2	4.1	0.0	0.5	4.0	0.1	0.7	1.9	0.1	0.8	0.6	1.8	2.0	0.4	2.2	0.0	1.8	1.4	0.7	3.5	0.5	1.5	6.7	0.7	0.3	0.5	1.3	3.5	1.4	0.5	1.5	3.5	0.9	13.2	0.0	0.9	1.7	0.0	0.7	3.7	1.1	0.4	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.4	0.7	4.5	0.6	1.6	0.5	0.7	0.6	0.8	0.4	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568146	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 88.2"	"Group enriched"	"Detected in many"	8	"Ito cells: 78.5;Leydig cells: 24.7;Peritubular cells: 98.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 17.8;ASC TERT1: 17.9;U-2197: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavorable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (9.99e-5)"	18.2	2.5	0.6	8.0	1.3	0.1	28.3	0.2	1.6	23.3	14.6	0.5	6.5	1.7	36.5	21.7	13.2	32.0	36.3	23.8	0.3	0.5	3.0	3.8	7.5	1.6	0.5	0.9	51.2	1.3	0.2	0.5	1.0	1.0	27.2	3.7	3.2	3.7	4.6	7.0	3.2	4.4	88.2	1.4	0.3	8.7	16.2	0.3	0.0	6.7	5.6	1.7	64.2	36.1	1.0	0.8	2.7	0.6	0.8	0.5	0.1	0.0	0.0	0.7	0.0	17.8	17.9	0.2	0.3	2.1	0.0	0.0	0.0	0.0	0.0	7.1	5.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.3	0.0	0.2	0.0	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.9	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.5	2.7	0.8	0.3	0.8	0.2	0.1	0.6	1.3	0.2	1.6	0.3	0.5	0.5	0.9	1.0	0.3	3.0	2.4	0.0	0.6	3.3	0.8	3.4	0.0	4.0	3.4	3.5	0.0	0.3	0.0	0.4	1.7	3.8	0.0	0.0	0.0	0.1	8.3	0.3	0.0	0.6	0.3	0.0	0.0	78.5	1.5	2.2	24.7	0.7	1.7	0.0	0.0	0.3	0.7	0.0	98.6	0.0	4.6	0.0	2.5	0.7	1.1	4.3	0.2	0.5	0.0	0.6
PTGR2	"FLJ39091, ZADH1"	ENSG00000140043	"Prostaglandin reductase 2"	Q8N8N7	14	73851844-73886827	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 29.0"									HPA001125	Approved		Approved	Vesicles		NA	NA		1000000	Vesicles		"HPA001125: AB_2666207"	"unprognostic (3.82e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.10e-3)"	"unprognostic (6.99e-3)"	"unprognostic (5.96e-1)"	"prognostic favorable (4.55e-12)"	"unprognostic (4.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.24e-2)"	7.4	14.4	16.0	3.4	17.2	1.6	10.9	8.0	13.3	6.2	8.3	15.3	11.9	13.7	5.8	20.3	6.2	13.9	6.4	29.0	15.0	12.2	22.1	20.9	6.6	3.7	15.2	12.6	9.1	6.4	13.8	12.8	3.2	20.4	10.9	6.9	10.1	7.7	8.9	32.4	8.1	9.9	4.9	16.0	4.1	7.0	11.5	17.2	2.0	14.6	9.1	3.4	5.5	7.0	2.2	3.2	8.4	2.4	2.3	4.0	2.3	5.9	8.1	6.7	3.3	5.4	11.8	5.3	2.0	2.8	2.5	3.9	4.6	14.6	0.6	4.8	2.0	5.9	6.0	6.0	4.4	4.7	4.5	2.8	4.1	3.8	2.0	2.7	1.5	1.5	5.5	10.6	3.8	3.1	5.5	1.2	4.2	5.5	1.2	5.6	8.5	4.0	3.9	7.4	8.0	8.1	5.1	2.6	1.0	13.7	5.8	8.9	7.7	5.3	5.7	6.6	6.7	29.0	2.5	1.8	3.8	7.1	2.7	4.4	7.1	3.1	1.9	5.8	3.7	5.0	8.4	2.4	1.8	1.6	0.9	1.2	2.1	2.3	1.2	2.6	2.2	4.0	3.2	2.0	2.3	2.2	3.2	2.1	2.3	16.0	17.2	8.0	13.3	15.0	12.2	15.2	12.6	20.4	17.2	17.9	8.8	0.5	9.0	6.1	9.4	39.0	5.1	41.5	10.3	17.4	13.7	5.6	21.6	10.0	1.9	2.8	10.5	0.0	7.8	1.9	4.1	9.0	3.5	12.5	6.3	31.8	4.6	3.7	5.7	1.5	6.6	4.7	8.5	4.6	11.3	20.3	6.4	13.1	6.3	12.8	20.5	6.5	4.2	29.8	10.9	5.8	3.3	3.3	10.8	5.4
PTHLH	"HHM, PLP, PTHR, PTHRP"	ENSG00000087494	"Parathyroid hormone like hormone"	P12272	12	27958084-27972705	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.6"	"Cell type enhanced"	"Detected in some"	15	"Exocrine glandular cells: 7.9;Melanocytes: 21.9;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"T-reg: 3.0"	"Lineage enriched"	"Detected in single"	30	"T-cells: 3.0"	"Group enriched"	"Detected in some"	4	"HaCaT: 64.7;HBEC3-KT: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035982	Approved	Approved	Supported	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA035982: AB_10794631"	"unprognostic (1.67e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (1.82e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.87e-3)"	2.9	1.0	6.5	3.5	5.3	0.0	20.2	1.4	8.7	11.0	2.3	1.4	2.1	2.4	11.2	2.0	17.0	1.2	45.6	4.0	4.3	3.5	0.4	0.2	1.3	1.1	1.4	4.3	2.6	1.7	0.7	2.3	3.6	3.1	5.5	1.8	2.4	5.3	2.6	0.7	1.5	1.6	13.4	0.8	3.6	1.9	1.3	1.0	0.1	1.4	15.8	3.4	8.0	12.3	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.3	2.2	0.0	0.0	0.6	0.6	0.0	0.0	0.2	0.1	0.2	0.0	1.7	0.0	0.1	0.5	2.1	64.7	0.2	80.0	0.0	1.6	0.3	0.1	0.4	0.0	0.2	0.0	0.1	0.0	4.4	2.0	7.9	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.7	0.0	0.3	0.1	7.7	0.0	0.0	0.0	3.6	0.0	0.4	2.7	0.1	0.0	1.2	0.3	2.0	1.1	17.0	1.0	0.0	2.6	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	6.5	5.3	1.4	6.2	4.3	3.5	1.4	4.3	3.1	1.0	0.0	0.0	0.0	1.1	4.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	4.2	1.3	0.0	0.0	7.9	0.0	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	0.9	0.2	21.9	1.0	0.0	2.2	5.5	0.0	0.0	0.0	0.3	6.5	2.8	0.4	0.1	1.3	0.0	0.0	0.0	0.1
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA		32000	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	22.6	20.4	36.0	14.4	42.3	3.1	19.3	20.5	40.8	24.9	17.9	55.7	23.5	14.5	20.2	29.9	14.6	18.7	18.4	20.0	43.5	23.9	22.3	17.0	21.5	13.0	41.4	31.4	19.4	18.2	33.1	13.0	42.1	30.0	19.2	20.7	11.0	21.9	25.5	17.9	13.5	16.3	21.9	38.0	12.2	17.5	21.2	46.1	2.8	22.5	10.2	14.0	22.2	17.8	8.6	7.2	1.8	3.9	5.2	5.7	4.1	14.5	23.1	32.1	11.5	13.5	14.5	20.7	14.4	20.0	13.4	13.2	10.1	12.0	8.8	32.6	18.3	18.9	17.1	18.8	32.8	20.4	0.1	8.8	19.5	12.8	13.9	18.5	0.0	9.2	9.8	16.2	16.8	23.7	35.4	39.6	12.5	19.6	0.2	17.9	25.2	0.2	0.1	12.4	31.5	25.8	12.9	17.6	0.4	28.4	33.1	12.7	15.9	22.4	7.2	14.5	29.6	17.0	0.3	23.9	13.3	25.0	15.6	16.1	0.0	0.1	0.9	17.2	0.1	17.9	1.8	3.9	0.0	0.3	1.6	0.0	6.8	0.8	0.1	5.3	8.6	5.7	2.0	1.7	5.2	0.9	7.2	0.2	4.1	36.0	42.3	20.5	40.8	43.5	23.9	41.4	31.4	30.0	46.1	29.8	24.9	2.7	51.7	29.7	51.6	26.2	33.1	25.4	20.5	52.4	56.9	27.2	19.9	23.3	34.0	35.8	21.0	0.0	20.0	45.5	28.2	67.2	9.2	14.7	6.8	63.5	24.8	33.7	11.7	33.3	22.2	7.9	23.6	1.0	23.1	41.5	33.4	21.0	20.5	22.6	56.8	97.0	121.7	43.2	62.8	22.6	27.8	1.8	21.0	67.4
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 34.1;Enterocytes: 90.1;Mucus-secreting cells: 39.1;Paneth cells: 65.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 10.6;CAPAN-2: 20.4;HaCaT: 16.6;hTCEpi: 22.5;OE19: 27.4;RT4: 13.0;T-47d: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	10.6	1.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	20.4	0.0	3.6	0.0	0.0	16.6	0.0	0.0	0.0	2.6	0.2	0.0	4.3	0.0	0.0	0.0	3.4	0.0	22.5	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.1	5.9	0.0	0.1	0.1	27.4	7.7	0.0	0.6	0.2	0.0	13.0	0.1	1.1	1.2	4.0	0.0	0.0	12.5	0.8	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.0	0.2	0.2	0.5	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	11.9	34.1	0.0	2.8	5.3	2.0	0.4	12.7	9.4	17.0	0.0	2.0	0.2	0.0	1.4	0.0	0.3	90.1	0.0	1.4	0.1	0.4	1.3	9.2	1.5	0.7	0.0	5.2	0.6	4.1	0.0	0.3	2.8	0.0	0.0	39.1	2.4	10.3	65.1	0.0	0.1	3.9	0.0	0.4	0.2	0.2	13.6	0.1	0.0	18.8	13.8
PTMS	ParaT	ENSG00000159335	Parathymosin	P20962	12	6765516-6770952	"Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.9;eosinophil: 3.3;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.2;granulocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 84.1"									HPA038186	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No		31000	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA038186: AB_10673042"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.55e-2)"	47.0	24.7	45.4	23.5	54.9	7.5	79.3	54.0	40.3	46.0	58.1	7.9	32.4	17.8	71.3	24.9	43.7	36.5	30.8	21.8	31.7	20.0	43.4	155.3	50.7	19.4	11.1	28.6	72.9	18.3	45.8	21.0	26.3	17.9	58.7	19.1	26.6	22.7	58.1	22.6	29.9	24.4	62.5	17.7	20.8	28.3	16.1	15.3	9.5	28.3	29.8	13.0	44.4	81.6	0.1	4.2	12.9	0.3	0.2	1.3	0.3	6.1	27.1	46.7	43.7	25.2	21.2	16.9	26.7	30.0	24.4	21.0	17.2	25.2	2.3	20.1	48.6	20.5	12.9	27.1	24.9	9.7	84.1	36.8	3.0	16.0	5.9	28.6	0.7	7.2	20.1	10.1	17.5	36.2	37.4	27.3	1.2	21.3	6.2	22.2	15.4	1.1	4.9	44.5	13.1	29.4	0.5	12.2	5.1	19.2	1.2	14.3	46.5	29.3	11.0	22.9	34.4	10.0	3.1	37.0	33.6	46.8	4.6	24.4	5.4	2.6	3.2	26.1	2.0	24.5	12.9	0.3	3.3	1.3	0.1	0.6	0.1	0.1	1.2	0.3	0.0	0.0	0.2	1.0	0.2	0.0	4.2	0.5	0.3	45.4	54.9	54.0	40.3	31.7	20.0	11.1	28.6	17.9	15.3	0.0	19.7	44.0	264.1	257.1	332.2	6.9	79.0	10.7	12.5	146.5	188.5	124.4	198.9	34.5	5.5	262.5	134.0	116.8	29.5	354.7	255.9	393.3	54.0	544.5	395.5	109.7	492.9	234.5	56.9	9.0	453.3	138.5	215.9	116.4	209.5	249.7	32.6	106.6	650.6	469.2	250.9	588.6	361.9	5.8	34.1	217.8	136.5	54.3	187.5	139.3
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase, non-receptor type 11"	Q06124	12	112418351-112509913	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		160000	"Nucleoli rim"	"Nucleoplasm, Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	25.4	16.8	38.6	14.4	39.0	17.7	30.8	17.5	39.5	18.3	14.7	26.9	9.9	11.9	19.1	13.3	17.6	11.1	13.1	30.1	38.0	32.2	18.0	23.1	15.1	14.5	45.3	22.5	13.1	14.0	29.3	12.9	16.6	26.2	16.2	13.9	9.4	12.0	20.0	34.0	14.1	11.1	28.0	45.7	10.9	12.8	7.6	32.1	10.9	21.2	8.2	13.7	17.4	15.4	17.3	17.1	22.0	11.8	11.3	15.4	6.3	35.4	33.8	24.7	23.4	36.0	35.2	29.2	43.1	47.0	34.0	25.6	33.7	13.7	37.5	22.5	39.8	21.5	21.2	31.7	38.2	56.5	28.4	26.1	54.5	31.5	18.4	35.9	43.7	34.8	28.4	38.5	36.5	51.9	32.8	28.0	29.0	41.4	13.2	32.8	25.6	30.7	21.3	29.9	34.7	22.2	31.6	36.4	21.5	31.3	39.9	17.2	21.1	41.5	31.8	26.5	26.1	36.6	30.3	34.1	40.0	35.9	23.7	37.6	25.6	42.2	37.5	33.3	30.7	37.3	22.0	11.0	15.0	14.8	9.5	14.1	15.5	13.4	12.1	12.6	17.3	15.4	11.8	10.3	11.3	11.8	17.1	9.8	6.3	38.6	39.0	17.5	39.5	38.0	32.2	45.3	22.5	26.2	32.1	56.6	53.2	13.4	22.8	22.8	27.6	136.3	30.6	20.1	50.0	34.9	15.7	20.0	28.2	34.0	65.9	35.8	17.2	0.0	36.7	21.0	25.9	57.9	26.7	93.6	22.8	12.7	12.6	27.0	32.4	19.0	47.8	23.7	13.5	16.2	19.6	59.0	45.4	20.4	75.0	29.8	21.4	32.3	31.9	7.7	5.3	24.0	29.4	19.8	18.7	65.6
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase, non-receptor type 12"	Q05209	7	77537275-77640071	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1100000	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	29.6	15.1	14.3	20.5	19.6	29.7	25.1	15.7	22.7	20.0	28.9	8.1	13.8	8.8	20.7	9.6	22.0	18.1	19.8	45.6	17.3	12.6	16.9	14.8	34.7	17.4	15.3	13.4	19.0	10.7	12.4	19.8	36.0	18.6	14.1	13.8	9.9	12.8	17.1	17.6	17.6	14.6	23.0	24.0	25.0	14.4	13.9	17.7	9.7	16.7	11.9	12.9	23.2	61.2	2.5	3.9	9.9	4.9	12.8	3.8	2.8	17.2	10.6	25.2	12.8	17.7	18.5	13.5	18.0	23.0	14.2	20.3	5.2	27.0	2.0	5.8	21.0	31.1	12.3	8.4	18.0	28.7	5.0	4.7	10.8	10.7	21.2	17.4	6.1	7.2	15.1	20.1	30.9	39.9	25.5	30.0	0.5	12.9	3.0	45.2	11.8	0.8	17.1	20.3	23.5	12.2	3.6	20.2	1.0	24.4	9.3	3.1	16.7	22.1	20.3	17.5	45.3	9.8	22.5	21.8	30.8	18.6	11.2	33.9	3.1	1.7	5.3	18.1	15.9	53.3	3.7	4.2	6.6	3.6	2.9	1.4	2.5	1.2	2.7	3.9	1.1	0.6	3.8	9.9	12.8	4.9	0.3	1.5	2.8	14.3	19.6	15.7	22.7	17.3	12.6	15.3	13.4	18.6	17.7	65.5	54.6	13.7	41.5	61.1	15.5	35.1	22.9	16.0	46.6	19.2	7.9	34.1	3.3	38.7	2.6	99.1	17.1	0.0	34.2	48.2	53.7	44.4	13.9	19.2	45.4	33.4	11.6	98.8	74.4	5.4	43.1	86.9	33.7	25.2	19.9	63.0	55.1	20.1	44.2	15.8	14.3	64.7	55.6	14.7	57.8	88.7	60.3	26.2	18.0	78.6
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase, non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 152.9;Basal keratinocytes: 97.1;Rod photoreceptor cells: 171.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"AF22: 45.2;RT4: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	10.3	5.9	10.8	2.7	16.9	0.7	9.9	5.7	11.6	15.9	4.1	13.0	7.6	1.2	10.8	21.2	18.7	11.4	6.5	5.3	10.4	5.7	22.1	1.6	18.0	4.3	16.9	7.9	24.1	4.3	26.6	38.3	3.0	14.2	12.0	2.4	39.0	5.9	9.4	1.0	43.0	2.3	8.7	10.3	3.5	3.6	12.2	17.6	1.9	16.9	12.4	11.8	15.7	17.6	0.0	0.5	0.1	4.9	0.1	2.3	0.1	5.1	2.6	45.2	4.4	19.1	16.7	0.0	9.5	19.4	3.6	4.6	0.0	2.6	0.0	2.1	10.5	1.3	17.0	7.8	14.3	7.0	0.1	5.8	4.3	5.6	0.0	2.3	7.5	0.0	10.7	4.6	2.6	8.7	7.6	0.0	0.0	0.0	7.4	0.0	2.3	0.6	2.7	10.3	0.0	1.9	1.5	0.0	0.0	13.8	21.5	2.6	3.8	2.8	6.3	5.2	7.6	3.7	0.2	0.0	3.5	2.7	0.0	1.2	7.7	0.0	0.0	3.7	0.0	1.5	0.0	0.2	0.0	0.2	3.0	2.3	0.0	2.2	0.3	0.5	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.1	0.1	10.8	16.9	5.7	11.6	10.4	5.7	16.9	7.9	14.2	17.6	44.7	152.9	0.0	21.0	97.1	9.8	1.7	10.2	32.1	75.1	45.4	86.4	0.2	3.3	4.3	20.2	2.2	0.0	0.0	3.0	0.1	20.2	12.1	4.7	0.0	0.2	1.6	4.6	1.8	2.2	14.8	42.3	5.7	18.6	0.0	0.5	14.1	4.3	3.5	30.8	9.2	171.6	12.9	12.5	24.4	21.6	86.9	0.2	4.4	0.2	45.5
PTPN18	BDP1	ENSG00000072135	"Protein tyrosine phosphatase, non-receptor type 18"	Q99952	2	130356007-130375409	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012174, HPA053367"	Uncertain		Approved	"Intermediate filaments"		NA	NA		550000	"Intermediate filaments"		"CAB012174: AB_2173224, HPA053367: AB_2732579"	"unprognostic (3.11e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.85e-3)"	12.8	7.1	11.0	16.7	13.5	18.9	22.3	26.8	13.7	15.3	22.8	6.6	25.7	16.6	9.3	11.0	11.3	13.3	21.3	7.5	9.8	8.5	13.9	19.2	16.9	29.2	8.4	9.5	7.8	28.9	6.4	11.0	9.4	6.9	17.8	19.3	7.9	18.5	24.0	11.0	6.9	28.8	10.5	9.1	37.7	16.0	3.3	9.1	1.6	13.0	7.1	35.5	11.0	10.7	7.6	7.4	6.2	17.1	2.8	6.6	10.2	5.8	3.9	1.6	7.9	9.9	6.8	16.4	3.0	2.7	3.9	4.4	7.8	9.0	21.9	3.0	7.3	1.8	6.7	6.9	6.8	3.8	9.9	3.8	7.9	4.7	9.2	5.1	7.7	21.5	8.0	5.6	4.3	5.9	0.8	7.4	4.9	7.4	16.7	7.4	11.4	1.4	13.4	1.6	12.6	4.3	13.3	4.6	29.6	7.7	3.6	10.1	2.6	5.3	19.0	8.7	1.6	6.6	11.4	6.9	5.6	6.3	3.0	2.8	2.6	0.7	21.1	8.5	7.0	6.0	6.2	7.8	6.1	6.6	10.8	4.1	7.6	4.4	6.3	6.7	4.5	2.7	5.4	4.9	2.8	17.1	7.4	5.6	10.2	11.0	13.5	26.8	13.7	9.8	8.5	8.4	9.5	6.9	9.1	26.8	22.9	49.5	26.1	5.8	13.5	8.1	20.4	18.7	12.5	34.9	3.9	12.1	46.4	16.6	0.7	21.5	49.1	0.0	39.9	25.3	13.3	43.8	35.7	18.1	76.6	9.5	46.7	17.2	79.3	0.9	17.5	52.8	32.1	16.2	50.4	12.4	23.4	56.1	10.6	25.1	10.0	19.4	19.8	3.0	4.1	5.1	9.6	39.8	38.3	27.6
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase, non-receptor type 21"	Q16825	14	88465778-88554733	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 53.6;Syncytiotrophoblasts: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 23.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus, Centriolar satellite"	"CAB011468: AB_442979, HPA073999: AB_2732247"	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favorable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.5	4.7	5.3	8.6	7.3	0.0	13.2	4.4	5.8	10.7	8.7	10.7	7.4	4.9	10.6	10.7	8.9	8.3	12.7	17.4	7.4	4.2	8.1	6.0	15.3	1.6	6.6	4.2	15.8	7.8	10.6	3.9	15.6	6.4	11.9	6.5	12.6	6.5	10.5	8.8	24.2	10.5	15.7	7.3	3.7	7.4	15.2	6.5	0.8	16.0	8.4	3.1	12.0	26.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	3.6	2.9	7.7	3.0	8.2	7.2	8.0	9.8	7.5	5.8	8.1	5.2	6.6	0.0	2.4	12.4	5.2	3.4	1.1	3.4	8.5	0.2	1.7	0.0	3.2	2.1	9.2	0.0	0.1	4.7	6.8	4.8	5.8	7.5	4.7	0.0	1.1	0.1	14.8	3.0	0.0	0.1	2.2	3.9	5.6	0.0	23.1	0.0	5.0	2.6	0.5	9.0	5.6	14.1	3.2	6.8	6.9	1.5	9.2	10.8	8.5	4.4	6.7	0.3	1.2	0.0	4.0	0.1	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.3	4.4	5.8	7.4	4.2	6.6	4.2	6.4	6.5	53.6	5.9	0.0	4.0	9.3	7.3	31.1	5.1	9.4	7.9	7.0	33.4	7.6	0.0	4.4	12.7	4.5	9.3	0.0	7.2	4.4	9.3	7.8	2.3	9.0	1.6	1.6	4.6	7.4	1.2	3.5	15.8	0.7	0.0	0.0	14.6	4.9	8.2	5.8	25.5	3.3	9.0	0.0	8.5	12.1	6.1	10.5	85.2	0.0	4.6	4.7
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6"	"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	33.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.1	0.0	4.7	0.0	0.0	0.1	13.3	10.5	3.0	0.0	1.4	0.1	2.7	5.2	8.4	0.0	7.7	5.1	0.1	9.4	7.5	0.0	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.4	8.0	0.1	0.1	0.2	14.4	3.0	18.0	5.5	13.6	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4	0.0	9.2	29.6	0.2	2.3	0.4	0.5	0.0	4.0	0.0	1.8	2.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.5	0.2	0.9	0.2	26.6	0.6	7.1	0.0	0.0	0.6	19.2	0.6	0.0	20.5	3.3	1.8	1.0	0.0	0.6	0.0	0.0	0.0	0.4	12.9	0.9	0.3	0.2	2.4	0.1	65.4	1.7	0.2
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase, non-receptor type 4"	P29074	2	119759631-119983818	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 53.9;Cone photoreceptor cells: 98.2;Horizontal cells: 152.6;Rod photoreceptor cells: 80.5;T-cells: 90.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"NK-cells: 12.2;T-cells: 19.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	6.8	6.9	10.0	5.9	12.2	7.3	7.2	37.4	16.9	9.6	5.5	7.2	5.2	8.1	7.2	6.6	6.9	8.9	6.3	8.9	10.2	8.4	12.0	6.6	8.0	7.9	7.3	13.1	8.9	6.3	11.6	16.3	4.1	8.3	6.2	4.0	7.1	7.9	6.6	11.2	5.8	5.5	4.7	7.3	9.2	8.9	7.7	6.5	18.9	22.5	6.8	6.5	5.3	5.8	0.5	0.3	0.9	0.4	12.2	19.3	4.7	7.4	4.4	5.8	7.7	5.2	5.4	9.9	3.4	9.6	1.9	5.3	6.6	11.6	5.4	8.2	3.8	5.8	6.6	4.5	5.3	5.2	12.6	3.8	3.7	4.2	6.2	3.5	3.8	2.8	4.9	10.0	9.0	4.1	6.6	8.5	5.5	6.4	5.5	5.1	5.7	5.2	4.4	7.6	4.2	7.2	3.6	10.0	7.6	7.0	10.2	7.6	9.4	4.7	6.0	3.9	5.1	2.9	2.4	10.6	0.3	6.7	2.3	4.1	9.5	13.2	6.8	5.1	0.2	3.2	0.2	0.2	0.9	19.3	0.3	15.6	0.5	9.6	15.1	0.3	0.5	3.2	11.0	0.7	12.2	0.4	0.3	5.6	4.7	10.0	12.2	37.4	16.9	10.2	8.4	7.3	13.1	8.3	6.5	3.0	10.5	14.0	12.8	7.2	53.9	13.9	10.2	6.7	6.8	15.7	98.2	8.5	6.6	6.1	3.8	12.8	8.1	0.0	6.3	9.0	7.6	8.7	11.5	9.0	3.6	152.6	8.7	13.5	5.6	7.1	16.1	5.3	8.5	7.2	7.8	23.6	5.5	10.1	13.4	10.4	80.5	0.0	5.0	21.2	20.6	5.8	3.1	90.0	10.6	7.8
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase, non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 70.0"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 2.4;Distal tubular cells: 1.7;Endothelial cells: 2.4"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 70.0"	"Cell type enriched"	"Detected in single"	9	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HMC-1: 3.7;NTERA-2: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	2.5	1.6	16.3	1.1	70.0	1.1	1.2	0.9	47.5	1.5	1.1	0.4	0.0	1.1	1.2	1.0	1.3	1.7	1.4	4.3	9.1	8.6	1.1	0.9	2.7	1.1	3.5	16.0	2.5	1.2	1.5	0.5	0.9	6.1	1.6	1.4	0.0	1.3	1.7	1.8	1.0	1.4	1.4	2.1	1.3	1.3	3.4	9.3	0.0	1.2	0.0	1.0	1.5	0.3	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	5.8	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	70.0	0.9	25.1	9.1	8.6	3.5	16.0	6.1	9.3	0.0	0.0	0.0	0.0	0.1	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase, non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;lymphoid tissue: 63.7"	"Group enriched"	"Detected in many"	5	"B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basal ganglia: 9.4;thalamus: 2.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2"	"Region enriched"	"Detected in single"	10	"basal ganglia: 5.5"	"Region enriched"	"Detected in all"	4	"basal ganglia: 10.9"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	2.6	3.1	0.5	27.1	9.4	24.5	0.6	0.4	0.5	0.6	2.3	0.6	0.0	3.0	0.7	0.6	1.7	0.8	2.9	0.5	0.6	0.8	1.1	0.9	3.2	16.5	1.2	0.2	0.6	0.6	0.0	0.7	0.4	0.8	1.3	1.9	0.7	5.3	0.3	0.4	0.6	3.7	0.9	1.6	15.4	1.4	12.7	2.9	63.7	0.9	0.6	24.8	2.9	0.8	2.6	2.6	17.0	1.1	9.9	10.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	16.7	0.0	0.0	0.0	36.3	48.9	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.7	1.5	0.0	0.0	4.9	15.8	0.0	0.0	0.0	0.7	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	7.4	1.8	10.5	0.0	26.2	0.0	11.5	1.1	17.0	10.6	1.1	9.5	1.9	7.1	10.5	2.0	2.6	5.3	6.4	7.1	9.9	0.4	2.6	9.0	2.8	0.5	9.4	0.4	0.5	0.6	0.8	1.2	0.2	0.8	2.9	3.0	9.0	40.6	1.0	2.1	2.4	0.7	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.2	0.4	2.9	0.0	0.0	0.0	0.1	1.7	0.5	137.4	0.5	15.6	0.0	0.0	4.9	6.2	1.3	4.9	23.4	8.5	9.0	0.0	5.6	0.1	0.0	2.1	0.6	4.4	0.0	0.9	0.9	0.4	2.0	0.7	156.8	0.0	0.5
PTPN9	MEG2	ENSG00000169410	"Protein tyrosine phosphatase, non-receptor type 9"	P43378	15	75463251-75579289	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041922	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041922: AB_10795269"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.25e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.49e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.39e-1)"	16.8	12.8	15.0	11.8	17.7	9.2	15.7	11.1	20.0	17.4	22.4	10.5	12.0	17.0	18.9	16.4	10.9	16.4	13.5	12.2	13.1	14.6	17.9	14.0	16.0	12.6	11.6	12.4	16.0	12.3	16.6	12.5	18.9	13.2	16.9	19.5	18.4	14.6	21.9	6.8	11.8	30.6	17.6	15.6	15.6	13.4	8.7	7.5	16.3	34.4	8.0	13.9	14.7	15.3	3.3	5.9	4.6	5.7	6.7	7.2	2.9	9.2	11.2	17.5	11.6	13.1	14.5	5.7	14.0	21.7	17.7	16.1	6.7	14.1	15.0	11.3	23.7	14.2	14.1	37.6	16.0	17.9	18.6	9.5	8.4	8.0	7.1	19.7	12.8	13.0	18.7	16.8	14.1	22.2	18.1	14.8	10.0	5.6	5.5	19.9	6.1	9.0	12.0	16.0	8.4	5.7	17.8	8.7	4.1	22.3	15.1	6.9	14.3	19.8	11.0	21.4	17.5	5.7	22.0	17.0	17.0	5.5	11.1	14.8	8.1	8.4	14.0	9.9	19.4	16.6	4.6	4.3	4.2	7.2	5.7	5.7	3.3	5.0	6.1	5.9	2.3	2.1	3.9	0.7	6.7	5.4	3.9	3.1	2.9	15.0	17.7	11.1	20.0	13.1	14.6	11.6	12.4	13.2	7.5	6.0	12.0	13.4	6.8	3.0	11.0	3.1	10.2	8.1	9.1	10.4	7.9	13.9	13.3	9.2	2.4	8.0	20.3	0.0	8.6	3.5	11.9	8.9	15.0	9.9	16.4	3.2	6.9	22.1	18.1	3.5	11.5	20.8	6.8	16.2	12.2	5.4	14.2	10.5	25.8	8.4	17.5	12.9	8.6	5.2	7.0	2.9	8.5	12.9	12.1	12.7
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase, receptor type A"	P18433	20	2864184-3039076	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		21000	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	21.9	18.5	55.6	14.3	48.6	16.4	23.3	44.5	56.0	29.7	19.7	37.5	9.4	14.7	26.3	18.7	22.7	26.5	21.3	14.0	45.9	41.1	22.1	13.5	21.6	16.9	38.0	46.7	28.6	14.9	41.5	23.4	29.0	52.5	23.5	20.0	18.5	16.7	21.8	8.2	21.0	15.3	25.7	52.6	17.9	16.3	27.4	30.4	20.6	32.4	8.5	20.4	22.9	19.2	7.7	5.7	7.9	6.7	6.2	11.0	3.7	21.0	12.9	37.2	11.4	41.2	75.1	7.9	15.8	31.0	19.6	24.1	15.3	29.2	13.8	12.5	21.2	19.8	22.6	15.0	22.6	22.2	21.3	9.6	19.6	5.4	19.4	14.7	19.7	9.3	33.5	23.5	16.2	17.1	24.2	27.1	19.9	19.7	17.7	19.4	8.6	22.7	22.3	14.3	18.9	10.3	17.4	18.0	17.2	16.7	16.3	20.6	19.7	15.3	26.1	23.5	16.9	16.3	16.9	19.4	17.6	8.7	19.5	13.9	13.0	18.0	18.2	8.1	18.7	16.4	7.9	4.8	7.5	11.0	4.8	9.0	7.7	7.4	7.9	3.7	5.1	7.4	9.0	6.0	6.2	6.7	5.7	8.1	3.7	55.6	48.6	44.5	56.0	45.9	41.1	38.0	46.7	52.5	30.4	20.8	16.3	29.4	29.9	14.1	87.6	6.5	45.9	17.4	27.3	43.6	29.5	25.3	23.2	13.3	11.8	26.9	31.5	23.3	13.4	35.4	36.1	29.8	23.0	28.0	33.5	66.7	42.6	43.6	35.2	12.5	55.8	21.8	35.4	10.8	27.0	77.3	13.8	25.8	46.0	19.2	55.1	38.8	26.4	51.2	75.4	15.1	27.3	39.5	26.2	27.6
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase, receptor type B"	P23467	12	70515866-70637440	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 113.4;Ito cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 3.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 11.3;hTERT-RPE1: 9.1;HUVEC TERT2: 28.0;TIME: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		6700000	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	23.5	7.0	4.5	5.5	7.0	0.1	22.9	3.6	6.1	11.3	8.0	4.3	7.1	5.3	17.1	8.5	5.8	8.2	11.4	17.6	6.2	5.1	18.7	12.0	39.9	3.3	6.9	4.6	5.5	4.4	4.9	5.7	23.3	7.8	6.1	8.2	16.0	3.6	7.1	11.8	4.7	7.4	13.3	7.3	22.9	5.2	3.7	4.3	0.7	14.0	12.2	2.6	6.5	14.7	3.5	0.1	0.2	0.0	0.4	0.3	0.2	1.9	0.1	0.8	0.1	0.0	0.0	0.4	0.4	1.9	1.0	2.4	0.0	1.5	0.7	11.3	0.3	0.1	6.9	0.1	0.3	3.6	0.6	0.3	0.1	0.8	0.5	0.1	0.3	0.0	0.0	0.3	2.8	0.0	9.1	28.0	0.0	1.5	0.5	0.6	0.0	0.0	0.0	1.0	1.9	0.4	0.0	0.7	0.4	5.2	0.8	0.0	0.4	0.7	0.0	1.6	0.2	0.0	0.6	40.9	0.4	0.4	0.1	2.4	0.5	0.4	0.3	0.2	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	4.5	7.0	3.6	6.1	6.2	5.1	6.9	4.6	7.8	4.3	0.0	19.9	13.7	0.8	3.3	5.4	9.2	17.8	0.0	1.2	3.5	0.0	0.0	0.0	1.4	4.3	113.4	4.3	46.7	0.8	0.0	1.9	0.6	23.3	2.0	0.3	4.8	0.0	448.7	26.3	2.5	1.1	2.0	5.0	0.0	4.8	0.3	7.2	14.4	0.0	0.0	0.8	0.0	0.9	0.7	0.5	1.4	0.0	1.7	5.2	0.6
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase, receptor type D"	P23468	9	8314246-10612723	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 37.5"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 110.1;Intestinal endocrine cells: 34.0;Muller glia cells: 44.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.5;HAP1: 5.1;HSkMC: 8.0;NTERA-2: 5.7;RH-30: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2500000	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.6	1.7	19.7	1.5	19.2	1.1	1.1	27.9	32.1	5.6	5.4	21.7	0.2	4.0	3.6	1.8	1.5	3.6	2.6	3.0	18.0	13.5	11.4	4.2	3.4	0.9	17.9	22.3	12.7	1.7	37.5	4.4	9.4	15.1	3.3	5.3	1.9	1.1	2.0	1.0	1.2	4.6	2.8	29.7	1.4	1.7	2.5	18.5	0.0	3.2	0.0	1.0	2.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	23.5	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	2.6	4.8	0.6	0.0	0.0	0.0	0.2	8.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	5.7	0.0	1.5	2.9	8.7	0.0	2.1	0.0	4.0	0.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.7	19.2	27.9	32.1	18.0	13.5	17.9	22.3	15.1	18.5	0.0	2.7	0.0	0.2	0.5	110.1	4.6	25.5	0.0	2.3	5.2	15.7	0.3	0.0	2.5	13.0	0.4	10.1	0.0	0.0	0.1	7.6	1.7	0.0	12.8	1.0	4.8	34.0	1.3	0.6	3.7	14.7	0.0	0.0	0.0	14.3	44.7	0.3	3.5	0.0	22.3	7.4	0.0	3.7	1.1	1.1	0.6	0.2	0.0	5.2	0.0
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase, receptor type E"	P23469	10	127907061-128085855	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 91.0"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 141.1;Macrophages: 249.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 91.0;plasmacytoid DC: 65.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.8;HUVEC TERT2: 19.8;NB-4: 14.9;TIME: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	16.8	18.5	12.5	24.0	12.5	39.5	11.0	7.4	15.3	4.8	9.2	14.5	1.6	9.6	5.1	8.1	8.8	6.2	10.7	12.3	15.0	12.2	4.4	4.8	22.5	20.0	12.5	6.5	4.3	3.1	3.4	6.5	8.0	9.8	4.5	9.8	4.8	7.0	3.1	1.9	4.9	12.7	7.7	14.3	26.4	7.7	4.3	10.9	11.4	6.6	6.1	12.2	10.0	5.0	1.2	65.7	91.0	25.5	4.0	5.4	4.9	1.9	0.4	0.2	0.0	1.2	0.2	3.6	0.0	0.0	0.8	1.7	0.8	12.0	1.5	1.3	1.0	2.6	1.1	1.0	5.7	0.3	1.8	0.9	0.1	0.7	0.0	2.0	7.4	5.6	0.4	3.3	2.9	5.9	18.8	19.8	4.9	0.0	0.9	1.2	1.8	2.2	14.9	0.1	2.1	0.7	8.8	1.2	2.9	3.3	8.5	0.0	1.2	3.4	0.6	0.1	0.9	0.3	9.4	37.4	0.8	0.8	3.7	4.1	0.4	0.6	2.1	5.5	5.8	0.0	17.4	25.5	19.3	5.4	9.0	3.2	0.9	2.4	3.6	13.3	1.2	1.7	2.9	91.0	4.0	6.8	65.7	3.5	4.9	12.5	12.5	7.4	12.7	15.0	12.2	12.5	6.5	9.8	10.9	77.4	67.6	24.7	47.2	52.9	2.6	15.1	5.1	9.4	33.0	3.5	0.0	33.6	0.0	4.3	1.6	49.4	12.3	0.0	4.0	40.5	9.9	8.3	30.1	1.3	53.6	0.0	6.4	46.1	141.1	1.7	0.6	249.1	23.6	4.6	14.4	0.0	28.7	11.5	0.4	1.9	0.8	0.0	8.1	0.5	1.4	56.6	14.2	52.4	10.2	34.4
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase, receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 261.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 54.6;SK-BR-3: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		95000000	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	37.1	5.5	22.4	10.4	18.1	0.9	30.7	6.8	19.5	14.2	34.3	16.8	34.4	30.7	12.3	33.4	41.4	32.2	20.0	6.3	17.2	15.0	12.0	45.6	15.7	5.8	17.2	18.5	10.4	25.3	17.5	10.3	38.1	16.1	30.9	23.1	5.9	41.9	23.6	2.9	46.8	35.5	16.8	11.2	2.0	21.8	4.3	15.8	4.6	12.5	11.7	14.9	21.4	21.3	0.9	0.0	0.2	0.0	0.0	0.0	0.7	31.0	14.9	9.7	11.5	2.2	0.1	54.6	17.8	7.1	14.7	12.6	15.8	42.3	0.0	5.0	7.8	11.9	24.3	11.3	39.2	17.9	0.3	14.1	0.1	10.2	14.3	6.9	0.2	0.2	2.3	22.6	21.2	35.2	18.6	21.9	1.5	4.7	1.4	5.4	17.9	0.2	0.2	14.8	17.2	4.1	10.8	17.3	0.7	5.7	46.9	14.6	5.4	17.7	62.4	2.3	26.9	18.1	3.3	17.1	0.3	23.6	1.5	23.7	0.6	0.5	0.0	1.4	0.7	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	22.4	18.1	6.8	19.5	17.2	15.0	17.2	18.5	16.1	15.8	145.9	89.7	2.2	43.9	55.8	11.0	4.0	152.8	81.7	63.7	82.0	41.2	48.4	0.0	138.1	4.0	7.0	185.3	0.0	104.8	261.2	17.9	82.4	4.7	141.8	12.4	174.8	96.9	9.2	4.3	6.9	6.4	5.4	11.8	4.6	152.5	28.3	148.7	95.1	6.7	13.9	28.0	0.0	11.0	8.0	34.8	79.8	55.4	2.2	124.5	65.3
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase, receptor type G"	P23470	3	61561569-62297613	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 91.5;Horizontal cells: 146.2;Ito cells: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 36.2;HSkMC: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"		NA	NA		520000000	"Plasma membrane"		"HPA000546: , HPA064237: AB_2685221"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	22.2	18.0	12.9	10.1	10.7	1.2	26.1	8.1	16.4	17.2	13.9	5.2	12.0	5.6	15.8	19.0	6.4	13.1	15.7	12.4	24.5	9.9	20.2	8.2	38.9	10.2	8.3	10.5	16.6	6.0	58.6	11.9	13.1	15.1	11.3	8.9	23.3	7.9	17.2	19.2	6.6	8.4	17.4	12.7	9.2	8.7	11.4	5.0	0.1	21.7	7.0	3.2	10.0	14.6	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	11.7	0.0	36.2	18.5	5.7	7.2	11.8	7.7	10.4	5.4	0.2	0.2	4.2	8.5	6.1	0.1	5.6	5.6	12.2	0.6	3.2	0.5	0.0	6.2	12.2	3.0	0.0	26.8	2.3	10.9	13.2	2.5	8.3	0.8	0.0	7.2	6.9	3.1	0.0	0.0	7.2	0.0	0.0	4.7	3.6	0.2	7.9	3.3	0.9	1.9	1.7	0.0	2.8	5.0	0.0	0.1	18.9	10.8	10.3	17.2	6.0	2.3	2.6	0.0	8.2	1.3	13.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	12.9	10.7	8.1	16.4	24.5	9.9	8.3	10.5	15.1	5.0	11.9	25.9	0.8	5.2	8.1	91.5	10.4	7.6	2.7	5.7	21.0	5.9	7.6	5.0	7.9	2.9	41.3	11.0	0.0	1.6	0.6	33.6	7.0	0.0	26.0	15.0	146.2	23.6	89.0	2.2	2.5	61.5	1.8	16.9	1.0	7.6	38.3	4.5	7.0	53.4	13.3	4.8	71.1	52.3	1.0	6.1	4.3	10.5	0.9	11.0	2.2
PTPRH	SAP-1	ENSG00000080031	"Protein tyrosine phosphatase, receptor type H"	Q9HD43	19	55181248-55209506	"Enzymes, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in many"	18	"Enterocytes: 106.7;Paneth cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 9.1;K-562: 10.6;OE19: 22.4;SK-MEL-30: 15.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042300			Approved	Mitochondria		NA	NA			Mitochondria		"HPA042300: AB_10796900"	"unprognostic (1.87e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.57e-3)"	"unprognostic (5.01e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-11)"	"unprognostic (4.08e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.57e-1)"	0.5	8.9	0.5	5.2	0.7	0.0	0.5	0.5	1.0	0.7	39.9	0.6	0.5	30.1	0.5	0.5	0.6	0.0	29.6	0.5	1.3	1.6	0.6	7.8	0.6	0.5	3.0	0.5	0.6	2.8	0.0	3.0	0.6	0.5	1.0	9.6	0.6	0.5	0.5	0.5	0.0	84.3	0.7	6.9	21.2	10.2	0.5	0.5	0.5	0.5	1.0	0.8	1.1	2.4	0.0	0.7	0.0	1.5	0.0	0.0	0.0	4.9	3.0	0.0	1.2	1.0	2.7	0.0	0.1	2.7	0.5	1.1	1.3	7.0	0.0	0.2	0.5	6.2	0.0	0.0	0.0	0.6	0.0	0.1	0.4	0.1	3.5	9.1	0.0	3.6	0.7	2.2	1.7	2.7	0.3	0.1	0.0	10.6	0.5	0.0	0.0	0.0	0.2	0.0	22.4	7.2	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.0	3.1	15.9	0.0	0.0	1.4	0.0	0.7	1.1	0.3	0.0	0.0	2.6	0.0	0.8	0.1	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.7	0.5	0.5	1.3	1.6	3.0	0.5	0.5	0.5	0.0	0.0	0.0	2.4	1.5	0.0	0.6	20.4	0.0	0.0	1.8	0.0	0.0	0.0	11.7	0.0	0.2	106.7	0.0	22.9	0.0	0.2	3.1	0.0	5.1	0.2	15.9	4.6	1.3	0.0	0.0	0.0	0.8	0.0	1.0	14.0	0.2	20.1	38.6	0.0	0.0	0.3	0.0	0.4	0.0	0.2	1.0	0.1	0.0	15.6	17.9
PTPRM	"hR-PTPu, PTPRL1, RPTPU"	ENSG00000173482	"Protein tyrosine phosphatase, receptor type M"	P28827	18	7566782-8406861	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Endothelial cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 7.2"	"Group enriched"	"Detected in many"	50	"dendritic cells: 2.7;T-cells: 7.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003891, CAB022442, CAB022443"	Supported		Approved	"Plasma membrane"		NA	NA		76000000	"Plasma membrane"		"CAB022442: , CAB022443: , HPA003891: AB_2667073"	"unprognostic (2.59e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (1.07e-4)"	31.4	14.1	9.5	6.3	22.2	0.6	23.6	10.4	17.2	11.0	13.6	6.2	28.1	4.7	15.4	10.9	8.1	13.6	18.1	33.5	10.5	15.0	16.9	6.5	22.0	7.8	8.5	12.0	15.7	7.6	16.3	21.9	18.3	23.2	10.6	6.6	18.3	7.4	21.8	26.0	7.3	8.7	14.1	9.3	12.1	11.0	12.2	9.1	2.9	31.1	7.3	6.3	18.6	25.3	0.0	2.7	0.0	0.0	0.0	7.2	1.4	1.5	11.4	5.5	0.0	35.1	24.4	13.3	14.0	12.3	9.4	14.0	10.4	2.4	0.0	13.8	16.7	0.2	0.1	0.0	4.9	13.1	0.1	2.5	0.0	7.6	5.0	10.0	0.0	0.1	27.6	10.3	5.2	14.9	18.1	9.4	0.0	0.0	4.8	7.5	0.2	4.5	0.1	0.9	3.3	2.5	0.1	4.7	21.1	23.1	19.6	0.5	3.0	0.4	0.0	11.7	9.1	0.0	0.0	9.7	19.4	12.2	9.2	2.4	0.4	0.1	0.0	16.6	0.0	3.6	0.0	0.0	0.0	4.5	0.0	1.8	0.0	6.0	7.2	0.1	0.0	1.7	3.1	0.0	0.0	0.0	2.7	1.0	1.4	9.5	22.2	10.4	17.2	10.5	15.0	8.5	12.0	23.2	9.1	41.7	29.0	0.9	6.8	5.4	24.2	24.1	17.8	22.7	9.1	5.2	2.0	10.4	1.7	15.5	24.0	47.4	0.5	0.0	7.1	2.7	10.2	7.0	2.3	20.2	8.2	0.0	1.7	38.1	8.0	34.9	2.6	5.2	28.7	1.0	1.3	2.8	12.6	0.3	4.9	11.3	1.9	6.5	8.0	3.6	9.8	2.5	10.5	2.5	0.8	5.4
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase, receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.6;pancreas: 28.9;pituitary gland: 43.4"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 48.9;Cone photoreceptor cells: 56.9;Horizontal cells: 92.2;Intestinal endocrine cells: 45.2;Rod photoreceptor cells: 31.1"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-2 OS: 20.3;U-87 MG: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	1.7	22.3	19.3	4.7	35.7	1.7	1.3	17.3	89.6	1.2	2.4	2.5	0.0	2.5	1.5	1.2	1.5	1.3	1.5	1.4	21.6	40.1	1.5	1.2	1.4	1.3	14.4	19.8	1.3	28.9	1.2	43.4	1.4	22.0	1.4	1.9	3.1	1.2	1.3	1.2	2.0	2.5	2.4	3.5	1.3	6.0	1.4	2.1	0.0	1.5	0.0	1.2	2.7	0.0	0.1	0.3	0.2	0.0	0.0	0.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.5	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.2	75.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	3.7	19.3	35.7	17.3	54.0	21.6	40.1	14.4	19.8	22.0	2.1	0.0	0.0	0.0	0.1	0.1	48.9	1.7	0.0	0.0	0.0	0.0	56.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	92.2	45.2	0.0	0.0	0.2	0.3	0.0	1.7	0.0	0.0	4.1	4.3	0.0	0.0	0.0	31.1	0.0	0.3	2.2	2.3	0.1	0.0	0.0	0.0	0.0
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase, receptor type N2"	Q92932	7	157539056-158587788	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;pancreas: 51.3"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 84.3;Intestinal endocrine cells: 126.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 15.6;HDLM-2: 22.0;NB-4: 22.6;SCLC-21H: 12.5;SH-SY5Y: 12.7;THP-1: 11.1;U-87 MG: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	2.1	10.5	20.1	1.7	33.9	1.0	1.1	6.2	40.6	1.7	4.6	2.9	0.0	5.1	2.0	2.9	1.5	6.9	4.7	1.9	18.2	21.3	2.0	1.2	3.1	2.1	11.3	22.3	5.8	51.3	0.5	20.0	1.5	10.3	10.2	3.7	1.5	3.4	2.6	0.8	0.7	4.2	1.6	5.3	7.7	24.2	2.2	5.2	0.0	5.6	0.3	1.7	2.8	0.6	3.4	1.3	14.8	1.1	1.5	3.5	1.1	0.0	0.2	15.6	1.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.6	0.2	3.7	0.0	0.4	0.0	0.0	22.0	0.2	0.0	0.0	2.5	0.6	0.0	0.0	1.1	0.2	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.0	0.2	6.5	22.6	3.1	5.5	0.8	0.0	0.7	0.1	0.0	0.0	12.5	12.7	0.0	0.0	0.0	0.0	0.0	11.1	3.3	5.1	1.9	0.0	0.4	0.1	0.0	0.0	15.4	9.2	3.7	8.7	1.1	1.6	0.9	0.1	0.3	2.3	1.5	1.1	1.3	3.4	1.4	0.9	14.8	1.5	0.0	0.2	3.5	1.1	20.1	33.9	6.2	40.6	18.2	21.3	11.3	22.3	10.3	5.2	3.0	11.7	10.4	12.5	2.1	31.6	2.2	7.6	84.3	13.6	38.4	9.8	0.4	29.9	15.8	35.1	23.3	4.5	0.0	11.7	0.4	3.9	21.1	18.5	0.8	34.3	11.1	126.1	41.1	11.0	13.1	11.5	6.0	11.8	3.6	39.6	40.1	6.1	5.8	18.4	3.5	6.3	25.8	5.1	41.6	11.7	1.3	0.6	10.0	7.2	22.5
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase, receptor type Q"		12	80402178-80680271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 12.6;urinary bladder: 19.2"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 14.9;Club cells: 7.9;Early spermatids: 7.0;Late spermatids: 3.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	24	"basal ganglia: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.4;BJ: 6.2;HBF TERT88: 4.4;RH-30: 4.9;RT4: 5.4;SiHa: 3.1;U-2197: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol		No	NA			Cytosol		"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	4.6	0.2	0.3	1.0	12.6	0.0	5.2	0.2	0.3	1.7	1.3	0.0	1.6	0.0	0.5	4.7	1.6	4.1	0.5	1.3	0.4	0.5	6.5	0.2	5.4	2.1	0.2	0.0	0.9	0.6	0.0	1.1	6.4	0.0	6.5	0.0	0.0	0.4	0.5	0.5	0.3	0.2	4.0	0.2	0.2	0.2	5.8	0.0	0.0	3.9	0.0	0.6	19.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	6.2	1.3	1.9	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.9	0.0	0.8	0.2	0.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	5.4	0.0	0.0	3.1	0.1	0.0	0.3	0.3	0.0	0.0	0.5	0.1	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.6	0.2	0.3	0.4	0.5	0.2	0.0	0.0	0.0	14.9	0.6	0.0	1.5	0.0	0.0	1.7	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Cell type enhanced"	"Detected in some"	17	"Club cells: 27.3;Horizontal cells: 62.0;Muller glia cells: 107.0"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 94.3;NTERA-2: 26.3;WM-115: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	1.1	0.0	0.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6	0.0	1.0	0.0	5.6	22.3	14.1	0.8	0.0	17.4	27.3	0.0	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.1	0.0	0.0	0.1	62.0	0.0	0.0	0.0	0.4	0.3	0.0	18.6	0.0	0.0	107.0	0.6	0.0	0.0	0.0	6.2	0.0	0.4	0.0	0.2	18.7	0.2	0.0	0.0	7.4
PTRHD1	"C2orf79, LOC391356"	ENSG00000184924	"Peptidyl-tRNA hydrolase domain containing 1"	Q6GMV3	2	24789734-24793382	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019951	Approved		Approved	Nucleoplasm		NA	NA		55000	Nucleoplasm		"HPA019951: AB_1853109"	"unprognostic (1.28e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.99e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	8.2	20.0	19.4	10.8	16.2	20.4	13.3	4.6	13.0	6.7	13.6	8.5	7.8	16.1	5.6	11.9	12.7	8.2	10.2	15.8	15.6	14.4	11.3	16.0	9.2	17.6	16.9	8.8	8.5	28.1	2.7	8.4	12.2	10.4	11.0	9.4	7.6	25.9	7.5	30.1	10.3	15.0	5.6	15.5	10.4	11.7	25.2	6.9	17.5	15.6	19.9	12.9	8.3	8.4	29.1	44.1	8.2	27.9	14.5	23.7	26.1	8.2	19.7	6.4	2.8	3.6	8.1	11.0	6.0	5.7	7.9	5.1	19.4	7.8	6.9	2.5	6.4	4.9	5.5	5.3	5.6	2.6	9.3	35.5	12.4	9.5	21.1	7.5	10.1	11.7	7.7	4.6	3.7	4.1	6.3	7.3	6.3	12.4	5.5	5.8	17.9	8.3	18.9	13.4	5.0	11.9	6.8	19.5	11.4	9.2	15.4	10.0	15.4	6.6	8.9	7.7	3.1	8.6	7.8	12.0	6.7	10.5	3.2	5.0	4.3	13.3	7.4	6.3	6.4	4.5	8.2	27.9	5.9	16.6	19.0	8.5	29.1	16.4	14.5	42.9	22.1	15.3	17.8	3.2	14.5	13.7	44.1	23.7	26.1	19.4	16.2	4.6	13.0	15.6	14.4	16.9	8.8	10.4	6.9	47.6	55.7	79.8	66.2	106.5	9.2	71.1	66.2	88.3	51.2	62.8	5.9	158.8	97.8	80.3	89.5	45.2	101.8	0.0	123.7	124.1	73.0	66.7	40.4	82.2	114.7	1.6	84.6	51.0	98.7	121.2	43.7	98.5	64.1	162.3	129.2	35.2	108.6	131.0	37.4	119.9	11.8	71.1	48.3	75.3	38.1	124.0	140.3	64.8	148.8	111.1
PTS	PTPS	ENSG00000150787	"6-pyruvoyltetrahydropterin synthase"	Q03393	11	112226365-112269955	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001481	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA001481: AB_1079716"	"unprognostic (2.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.66e-3)"	"unprognostic (8.38e-3)"	"unprognostic (4.58e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.65e-1)"	6.7	37.1	13.9	6.3	16.6	12.2	13.9	8.9	16.5	10.4	12.7	10.2	6.1	10.7	9.3	20.3	17.9	8.2	14.7	11.6	11.8	28.9	21.9	40.7	5.6	10.4	23.5	14.3	6.7	11.9	12.1	21.5	12.1	18.8	14.9	14.4	9.9	10.9	11.4	11.7	11.5	10.9	12.4	16.8	5.1	18.8	6.7	9.8	3.6	16.3	13.2	7.7	9.3	16.1	6.3	6.8	1.9	5.5	3.4	5.9	2.9	10.4	11.0	12.0	5.1	8.6	10.3	15.9	31.1	14.2	17.1	18.1	24.8	10.5	11.1	23.8	18.2	22.9	15.1	17.0	20.0	18.5	9.0	14.3	2.8	17.0	20.2	27.2	6.8	1.5	17.9	28.3	16.3	19.3	13.2	12.8	9.5	10.6	6.0	10.7	11.5	5.2	9.0	9.0	19.4	21.7	3.5	2.4	15.9	36.6	15.0	13.6	13.7	17.5	17.1	9.7	40.8	12.8	6.1	16.1	16.8	18.3	20.0	24.4	4.2	8.3	26.5	11.6	7.2	17.4	0.9	2.1	1.9	3.8	2.3	3.8	5.5	5.0	4.7	3.6	6.3	3.5	4.5	1.0	3.4	5.5	6.8	5.9	2.9	13.9	16.6	8.9	16.5	11.8	28.9	23.5	14.3	18.8	9.8	17.9	24.5	24.0	66.3	109.0	14.8	83.9	56.0	54.9	21.6	52.4	0.0	48.3	179.1	80.8	4.1	41.9	57.6	23.3	68.2	99.5	46.6	67.1	19.7	115.0	33.0	9.5	76.7	34.4	17.3	6.9	13.6	30.6	25.3	34.3	50.0	26.2	90.3	66.6	24.4	114.8	16.5	25.8	69.5	15.8	93.0	114.6	58.8	33.1	39.6	98.4
PTTG1	"EAP1, HPTTG, PTTG, securin, TUTR1"	ENSG00000164611	"Pituitary tumor-transforming 1"	O95997	5	160421822-160428744	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.5;testis: 100.1"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 470.4;Erythroid cells: 654.1;Spermatocytes: 278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.5"	"Lineage enriched"	"Detected in all"	7	"T-cells: 54.5"	"Low cell line specificity"	"Detected in all"											"CAB008373, HPA008890, HPA045034"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			Cytosol	Nucleoli	"CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.46e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (7.50e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.35e-2)"	1.5	1.7	2.1	16.2	5.5	34.1	2.9	1.4	4.6	3.8	8.2	1.0	0.7	5.8	1.3	2.6	24.1	1.0	1.9	2.3	5.1	2.7	1.7	1.4	3.8	19.2	1.5	2.2	1.1	1.2	0.2	2.0	5.0	2.2	1.6	11.3	1.5	4.5	1.1	1.2	8.7	5.8	4.5	1.4	7.5	3.4	100.1	1.0	29.8	23.9	23.2	35.1	3.3	7.2	8.1	6.1	2.4	2.1	3.3	54.5	4.7	45.7	23.8	53.8	38.5	9.1	9.0	16.8	24.3	55.7	64.6	70.8	46.0	40.3	50.0	21.7	27.6	74.3	24.0	33.4	67.6	92.7	57.1	30.3	26.4	32.2	27.7	1.8	23.9	23.2	4.2	11.3	43.8	26.6	19.8	45.5	33.5	21.1	39.0	66.3	21.5	28.6	58.8	27.1	37.7	34.6	26.7	63.3	42.9	32.9	9.3	33.5	21.3	35.1	21.4	72.2	45.5	43.7	26.2	19.4	29.2	39.1	22.8	70.9	33.6	29.9	57.2	31.5	41.4	51.7	1.9	0.7	2.4	7.0	2.1	2.5	8.1	14.4	16.2	6.1	5.5	3.6	8.9	0.8	3.3	1.4	5.8	54.5	4.7	2.1	5.5	1.4	4.6	5.1	2.7	1.5	2.2	2.2	1.0	6.0	15.5	20.5	54.1	220.3	1.3	4.9	7.6	1.4	11.4	5.2	0.0	50.4	3.3	4.0	470.4	10.3	6.3	654.1	4.5	163.8	37.7	15.3	38.0	2.9	72.7	0.0	5.8	17.8	20.0	39.3	10.3	35.9	82.7	39.7	15.4	2.7	3.5	9.1	7.4	1.2	0.7	6.5	35.3	278.1	72.8	136.5	26.7	44.5	34.5	30.7
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960435-37961125	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.8"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 4.1;Early spermatids: 3.1;Spermatocytes: 1.9;Suprabasal keratinocytes: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4;T-reg: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;MOLT-4: 3.1;U-698: 2.1"									"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	1.0	0.4	0.9	5.2	1.2	5.0	0.5	2.2	2.4	1.1	3.9	0.2	0.0	0.0	1.6	2.2	3.3	1.8	1.5	2.5	1.0	0.4	0.7	0.5	0.9	1.0	0.7	0.4	1.2	1.0	1.4	0.4	1.8	0.3	0.8	0.7	0.0	0.2	1.4	1.9	0.6	3.1	2.0	0.9	2.3	1.0	5.3	0.0	15.8	1.3	7.5	7.3	1.8	0.7	0.4	0.0	1.4	0.4	0.0	1.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	3.1	0.5	0.0	0.0	0.0	0.7	0.5	0.9	0.0	0.5	0.3	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	1.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	1.4	0.0	0.0	0.0	1.0	0.1	0.9	1.2	2.2	2.4	1.0	0.4	0.7	0.4	0.3	0.0	0.0	0.0	1.4	0.5	4.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.7	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.2	2.5	0.0	0.0	0.0	0.3
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell type enhanced"	"Detected in some"	10	"Ductal cells: 6.0;Fibroblasts: 10.1;Macrophages: 5.9;Melanocytes: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.4;ASC TERT1: 125.2;BJ hTERT+: 82.2;HHSteC: 160.8;HSkMC: 167.5;hTEC/SVTERT24-B: 88.5;TIME: 119.2;U-2197: 111.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1090000	310000	"Plasma membrane"		"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	52.1	0.0	86.4	125.2	0.0	9.0	82.2	3.9	4.2	0.0	0.5	0.0	32.1	10.6	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	160.8	0.1	0.0	167.5	0.0	88.5	30.1	7.7	18.2	0.0	0.0	0.0	26.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	119.2	17.7	0.8	111.1	1.5	0.0	0.0	0.0	3.7	0.4	5.0	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2	0.0	1.7	0.0	1.1	1.4	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	6.0	1.9	2.0	0.0	0.0	0.0	0.0	10.1	0.4	0.0	0.0	2.6	0.0	0.0	3.1	4.6	0.8	0.3	5.9	13.5	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	0.0	4.2	0.0	0.4	0.9	0.2	0.0	0.0	0.1
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 11.8;Early spermatids: 11.1;Horizontal cells: 19.1;Late spermatids: 16.8;Muller glia cells: 11.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.7;JURKAT: 6.1;NTERA-2: 6.8;SH-SY5Y: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: AB_2680145"	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	1.3	1.9	11.0	1.2	10.3	0.6	0.9	14.7	13.5	2.4	1.0	2.4	0.5	1.0	5.6	2.6	1.5	1.6	3.0	1.6	9.4	6.2	1.7	0.7	1.4	1.3	4.9	7.3	1.6	0.7	0.6	3.9	1.5	6.2	1.9	1.1	1.7	1.6	2.6	1.0	0.9	1.0	5.0	4.5	2.5	1.3	8.1	6.4	0.0	0.8	0.0	1.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.1	0.0	0.0	0.2	0.4	0.7	1.8	0.0	0.0	0.2	0.0	0.0	3.0	0.0	2.9	0.0	1.0	0.0	4.4	1.6	0.0	0.2	0.0	0.0	0.2	1.3	0.0	1.3	0.0	1.0	4.3	6.1	0.4	0.5	0.2	0.0	0.9	0.0	6.8	0.0	0.3	2.2	1.2	0.0	0.0	0.0	1.2	8.2	0.0	0.0	0.0	3.3	0.0	0.0	2.6	2.9	3.7	0.0	0.4	0.3	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.3	14.7	8.9	9.4	6.2	4.9	7.3	6.2	6.4	0.0	0.0	0.0	0.0	0.0	11.8	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	11.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	16.8	0.6	0.0	0.0	0.0	0.0	11.3	0.0	0.0	1.4	0.0	1.8	0.0	0.3	1.7	1.1	0.0	0.0	0.0	0.0	0.0
PUS10	"CCDC139, FLJ32312"	ENSG00000162927	"Pseudouridylate synthase 10"	Q3MIT2	2	60940222-61018259	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044736, HPA049582"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Nucleoplasm, Nuclear bodies, Mitochondria"		"HPA044736: AB_2679066, HPA049582: AB_2680824"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.15e-3)"	7.0	8.7	7.4	5.0	7.3	3.9	7.3	6.8	7.9	4.8	10.0	5.1	3.0	9.2	7.7	9.1	5.0	5.4	6.4	4.6	6.5	6.9	8.5	17.6	6.3	6.5	8.5	4.6	6.8	7.2	6.3	10.3	4.2	5.9	6.6	6.0	6.7	6.2	3.9	6.7	4.3	19.8	3.6	7.1	5.9	4.2	7.8	8.0	9.1	10.4	4.1	8.3	4.4	4.4	5.2	4.9	9.8	6.9	4.8	4.3	1.8	2.7	1.6	4.5	7.7	4.0	4.4	5.2	5.7	5.3	5.6	5.3	4.3	3.9	8.7	5.9	3.2	5.2	3.0	5.1	4.6	6.8	8.8	2.5	7.9	2.1	13.4	7.1	8.7	5.0	5.2	5.4	3.9	9.5	6.9	7.0	8.7	8.1	6.1	3.8	2.5	6.9	7.0	4.1	2.1	3.0	6.8	6.0	4.4	3.2	5.3	2.6	3.6	4.5	8.0	9.1	3.2	3.1	5.6	5.3	5.4	4.2	3.5	4.1	7.4	3.2	18.6	4.6	5.2	6.0	9.8	1.9	2.0	3.9	2.2	4.3	5.2	2.5	2.6	1.6	3.2	3.0	3.4	4.1	4.8	6.9	4.9	1.5	1.8	7.4	7.3	6.8	7.9	6.5	6.9	8.5	4.6	5.9	8.0	0.0	11.0	1.9	2.2	2.2	6.8	4.2	0.0	10.7	3.4	3.5	0.0	5.2	6.6	2.6	1.5	3.9	16.5	0.0	4.4	3.8	2.8	2.9	0.0	11.6	5.3	1.6	1.2	6.2	5.1	1.1	2.8	3.2	1.7	10.8	2.0	6.5	4.3	2.9	1.4	5.1	6.3	6.5	2.1	7.1	10.9	1.9	10.4	5.7	3.3	4.3
PUS3	FKSG32	ENSG00000110060	"Pseudouridylate synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: AB_2685126"	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.6	8.8	5.9	7.4	7.7	2.3	8.7	9.0	8.4	7.4	9.2	3.6	4.6	9.9	8.4	8.6	8.1	6.4	5.9	7.6	8.0	6.4	9.6	36.6	6.1	11.0	8.7	7.2	7.7	17.9	8.2	21.1	7.6	7.7	10.4	7.4	5.4	10.6	5.1	15.2	8.2	11.5	13.9	9.7	8.9	9.3	5.3	7.3	9.6	12.4	10.6	9.2	11.1	7.3	13.0	8.8	9.9	12.3	13.0	16.5	7.1	3.5	4.3	13.2	14.7	13.5	17.2	6.3	11.7	9.8	6.7	7.5	13.9	13.3	17.9	19.4	5.2	9.8	12.2	21.3	10.9	6.8	15.2	10.3	18.4	5.4	10.0	14.3	11.5	5.4	13.6	13.1	8.0	17.1	9.9	12.3	13.5	18.7	9.3	7.2	2.1	12.8	12.3	11.4	26.3	8.4	2.5	12.0	10.1	11.0	5.6	15.3	13.6	8.0	11.2	6.4	9.9	24.0	7.5	8.3	14.2	5.8	6.7	9.6	7.0	10.5	18.8	3.8	18.6	9.7	9.9	9.7	7.8	13.0	9.4	15.2	13.0	12.8	12.5	8.8	12.2	16.5	15.6	3.7	13.0	12.3	7.8	12.9	7.1	5.9	7.7	9.0	8.4	8.0	6.4	8.7	7.2	7.7	7.3	8.9	8.6	9.0	9.4	11.4	9.1	5.2	15.3	8.1	14.8	5.2	27.5	7.4	5.0	12.3	5.9	7.7	4.2	23.3	23.5	10.6	5.6	7.1	12.7	28.8	7.2	4.8	4.6	7.4	3.2	4.3	7.2	5.4	1.7	3.6	3.9	8.9	13.5	3.5	7.4	14.6	10.4	6.5	11.0	4.6	6.9	10.3	11.7	7.5	6.0	9.3
PUS7	FLJ20485	ENSG00000091127	"Pseudouridylate synthase 7 (putative)"	Q96PZ0	7	105439661-105522267	"Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024116	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024116: AB_1848754"	"unprognostic (3.07e-1)"	"unprognostic (1.52e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (4.89e-6)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (7.58e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (1.03e-8)"	"unprognostic (2.76e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (4.90e-2)"	12.7	6.9	7.7	13.0	12.5	5.8	14.1	12.2	12.9	10.2	9.6	8.5	4.6	7.0	11.4	5.6	14.7	9.8	6.0	9.4	8.3	7.0	7.5	11.8	8.8	8.3	12.3	8.0	10.0	11.9	17.0	8.1	9.8	11.4	8.6	11.6	5.3	9.3	11.0	19.5	13.3	6.3	13.2	9.0	5.4	8.0	8.5	13.8	4.3	14.6	13.5	10.0	8.0	11.0	5.9	3.3	0.4	5.0	2.7	5.4	2.0	15.4	10.4	9.2	14.2	6.6	7.8	10.0	7.7	6.7	13.8	11.8	13.7	5.9	9.0	12.9	7.9	11.7	12.0	17.4	9.2	21.4	6.4	13.3	13.7	8.8	12.4	8.2	21.1	4.9	7.7	10.1	11.6	14.7	4.8	13.7	8.0	30.7	7.3	8.7	20.5	23.2	16.5	22.3	18.3	12.2	14.5	14.9	38.5	14.2	11.7	15.0	14.8	15.3	24.9	9.5	11.1	9.0	4.3	8.4	19.3	13.3	24.2	16.1	5.7	10.9	25.7	6.5	17.7	16.0	0.0	2.1	0.4	2.6	5.0	5.4	5.9	3.5	2.8	3.3	3.6	2.9	3.8	0.2	2.7	4.2	0.1	2.2	2.0	7.7	12.5	12.2	12.9	8.3	7.0	12.3	8.0	11.4	13.8	6.0	7.0	1.5	6.8	11.8	4.1	3.1	0.0	5.3	7.9	1.8	2.0	4.0	1.7	6.5	0.9	6.0	0.9	0.0	6.2	7.8	5.1	7.2	11.5	3.9	3.7	0.0	6.9	3.7	1.3	1.2	3.7	3.5	0.0	5.4	3.4	1.5	6.0	2.9	1.8	4.4	2.9	0.0	10.8	1.4	10.9	8.5	2.9	0.7	6.0	6.4
PUS7L	DKFZP434G1415	ENSG00000129317	"Pseudouridylate synthase 7 like"	Q9H0K6	12	43718993-43758817	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056203, HPA058750"	Uncertain		Approved	"Nucleoli,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoli	"HPA056203: AB_2683064, HPA058750: AB_2683807"	"unprognostic (3.41e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	8.0	7.0	14.9	9.1	18.5	6.1	10.6	20.3	16.6	9.2	7.3	3.7	8.3	7.3	7.3	7.9	9.7	6.1	7.7	6.9	14.2	9.0	9.3	7.9	5.4	10.4	8.3	12.6	10.2	9.5	12.7	21.7	7.7	11.5	8.3	9.1	2.7	8.4	9.4	6.1	7.2	7.6	6.3	12.1	9.2	7.6	5.6	11.3	13.0	11.6	6.1	11.3	8.6	8.3	6.6	5.2	8.6	4.3	5.1	6.9	3.4	6.4	4.9	4.3	2.5	3.0	10.8	7.7	5.6	4.8	7.6	5.9	17.4	4.7	14.9	7.2	6.9	4.4	5.9	6.2	5.7	13.1	4.6	3.9	10.9	5.5	6.5	3.7	17.4	7.1	4.5	4.3	7.9	8.3	7.1	5.5	8.8	18.9	6.6	17.7	2.6	8.9	4.5	7.9	0.0	5.2	8.5	10.2	8.9	3.3	5.0	7.3	2.4	7.0	7.6	3.0	5.4	9.0	4.9	4.0	7.8	5.1	9.0	8.9	5.8	9.9	15.1	7.2	28.8	2.6	8.6	4.3	4.8	5.0	3.8	6.2	4.4	5.4	5.3	4.4	6.6	4.8	6.9	3.1	5.1	3.1	5.2	2.1	3.4	14.9	18.5	20.3	16.6	14.2	9.0	8.3	12.6	11.5	11.3	8.9	12.1	29.0	16.6	10.3	66.3	11.7	12.7	5.3	14.8	24.4	64.8	29.4	34.9	17.4	1.7	17.6	11.0	0.0	20.2	20.3	20.3	16.9	16.2	18.3	17.8	41.3	18.6	17.2	23.4	2.1	18.7	16.6	11.8	12.6	22.4	37.1	15.1	14.0	25.1	17.7	103.5	19.4	16.6	23.6	34.3	9.7	20.3	25.4	28.5	8.7
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 125.0;parathyroid gland: 137.5"	"Group enriched"	"Detected in some"	10	"Distal tubular cells: 543.8;Horizontal cells: 1442.9"	"Group enriched"	"Detected in many"	10	"breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3"	"Region enhanced"	"Detected in all"		"cerebellum: 125.0"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.4"	"Cell line enriched"	"Detected in single"	198	"RPMI-8226: 134.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 2377.5"	"Low region specificity"	"Detected in all"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		No	NA			Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB002515: AB_563948, HPA048536: AB_2680433"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.9	0.8	1.2	0.9	3.9	0.8	4.3	125.0	47.2	0.8	0.8	6.6	0.0	0.8	1.1	0.9	0.8	0.8	0.9	0.8	4.5	9.4	16.7	1.8	1.2	1.2	28.6	2.5	0.8	0.8	137.5	0.2	1.2	22.9	0.9	0.9	27.3	1.2	1.0	5.0	0.8	0.8	0.9	12.6	1.2	0.9	1.1	1.2	0.0	0.9	0.0	1.4	1.2	1.0	0.0	0.5	3.4	0.4	0.0	0.3	12.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	134.1	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.5	0.3	12.2	1.2	3.9	125.0	47.2	4.5	9.4	28.6	2.5	22.9	1.2	0.0	0.0	0.0	0.0	0.0	39.1	0.2	0.0	0.0	0.0	36.6	9.8	0.2	543.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.5	0.0	40.7	1442.9	0.0	40.5	3.7	0.0	0.6	0.9	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.8	104.1	0.0	0.0	0.0	0.6	0.0	0.3	1.0	0.0	0.0
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"Poliovirus receptor"	P15151	19	44643798-44663583	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 65.6"	"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"TIME: 53.4"									"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA		940000000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.90e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (2.75e-4)"	10.0	13.9	7.4	7.5	8.1	4.7	9.2	11.0	11.0	6.5	10.6	6.5	4.1	13.7	11.3	5.7	6.6	8.8	9.2	23.5	5.8	10.0	10.6	65.6	14.8	2.4	6.0	6.5	10.4	15.9	9.9	20.7	15.5	9.7	10.4	7.7	6.6	8.5	6.9	19.8	5.5	13.0	11.1	7.0	4.8	12.3	6.0	7.2	2.3	8.5	10.8	3.7	8.3	6.7	0.0	5.6	1.2	8.1	0.6	0.4	2.2	21.8	15.3	1.5	6.1	1.9	2.3	2.6	36.9	10.3	12.1	13.9	8.9	9.3	0.0	21.2	10.7	21.2	14.4	5.2	14.0	8.1	2.6	10.1	3.9	9.6	6.0	12.9	1.5	8.4	2.9	6.9	10.7	21.0	12.1	13.1	2.3	1.8	0.0	5.6	1.9	1.3	1.3	3.4	7.4	11.3	0.0	7.0	2.0	26.0	6.7	6.6	7.7	23.4	14.7	5.2	1.7	8.3	3.7	53.4	14.7	18.1	10.8	28.8	0.0	2.1	0.0	11.7	7.5	8.3	0.0	6.4	0.0	0.2	6.6	0.0	0.0	0.0	0.4	5.6	0.0	0.2	0.1	1.2	0.6	8.1	0.5	0.0	2.2	7.4	8.1	11.0	11.0	5.8	10.0	6.0	6.5	9.7	7.2	14.9	28.0	4.5	12.8	3.2	6.9	11.2	20.4	2.7	18.2	1.8	2.0	2.4	3.3	43.0	8.5	13.5	11.9	0.0	30.3	30.1	5.4	11.3	1.1	36.5	7.4	1.6	12.6	7.4	9.2	10.2	5.2	7.8	1.7	25.2	9.7	1.3	48.8	14.4	14.9	2.8	3.3	0.0	17.8	3.4	1.5	4.8	0.8	0.0	10.6	6.5
PVRIG	"C7orf15, CD112R, MGC2463"	ENSG00000213413	"PVR related immunoglobulin domain containing"	Q6DKI7	7	100218241-100221490	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 51.7;lymphoid tissue: 21.0"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 1.1;granulocytes: 2.3;Horizontal cells: 3.2;T-cells: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	32	"gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8"	"Group enriched"	"Detected in many"	37	"B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7"	"Group enriched"	"Detected in some"	26	"Daudi: 36.9;JURKAT: 21.8;MOLT-4: 40.2;U-698: 11.9"					"Low region specificity"	"Detected in all"			HPA047497	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Nucleoli, Endoplasmic reticulum"		"HPA047497: AB_2680069"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.13e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.71e-3)"	0.5	0.1	0.4	5.6	0.7	1.2	0.4	0.4	1.1	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.0	0.5	0.9	0.9	15.9	0.4	0.4	0.6	0.5	0.0	0.4	0.4	0.8	0.4	0.0	0.4	0.7	0.4	2.0	0.0	8.9	0.4	0.4	21.0	1.4	0.6	0.4	18.0	0.5	0.4	4.2	1.0	0.4	24.8	0.2	1.0	0.1	42.9	51.7	17.5	0.1	0.8	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.1	0.0	0.1	40.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.1	0.1	0.0	43.5	0.1	51.7	24.8	28.9	42.9	0.1	19.3	32.6	32.2	1.0	42.9	0.1	0.2	22.8	17.5	0.4	0.7	0.4	0.4	0.4	0.0	0.4	0.4	0.8	0.4	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0
PWP1	IEF-SSP-9502	ENSG00000136045	"PWP1 homolog, endonuclein"	Q13610	12	107685732-107713167	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038708			Approved	"Nucleoli rim,Golgi apparatus"		Yes	No			"Nucleoli rim"	"Golgi apparatus"	"HPA038708: AB_2676163"	"unprognostic (7.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.65e-4)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.10e-2)"	33.2	25.4	29.4	29.3	32.2	27.9	35.1	32.9	38.7	25.6	29.2	20.3	26.1	17.9	32.9	26.8	33.9	27.5	21.1	18.7	32.9	25.3	31.5	32.3	22.0	29.6	22.9	38.6	35.2	31.1	31.6	23.0	29.8	37.6	27.1	27.5	16.6	26.0	30.5	43.5	32.7	24.2	33.6	33.3	28.7	27.0	36.3	22.1	32.5	27.1	26.8	36.5	30.0	28.1	31.7	21.6	10.9	14.7	18.8	23.8	12.7	24.0	30.3	18.4	17.5	25.9	28.5	24.4	25.4	28.9	36.2	30.7	30.4	11.5	37.3	13.8	39.3	24.5	21.2	24.9	26.8	35.9	18.6	28.4	28.3	18.6	35.3	26.7	34.2	20.4	25.6	24.8	33.3	30.0	28.5	42.2	23.1	37.2	10.5	38.6	26.6	24.0	33.9	22.0	22.3	49.7	19.8	21.7	34.7	22.5	34.2	20.9	16.8	20.8	15.1	34.9	24.3	26.6	17.1	32.9	27.6	14.0	22.3	28.8	15.1	20.8	29.3	12.3	19.1	24.1	10.9	9.8	7.1	20.2	12.4	18.6	31.7	20.2	21.2	15.9	28.5	17.3	23.8	3.1	18.8	14.7	21.6	21.5	12.7	29.4	32.2	32.9	38.7	32.9	25.3	22.9	38.6	37.6	22.1	38.7	30.2	62.6	43.1	42.9	46.5	20.1	22.9	50.9	46.6	26.2	35.3	58.8	49.7	58.1	7.9	42.1	17.6	23.3	54.3	62.1	45.9	25.8	55.5	39.8	41.3	31.8	20.2	38.6	30.2	5.4	46.6	39.1	28.7	101.0	30.3	47.0	55.3	17.5	41.4	59.8	40.3	25.8	36.0	110.6	70.9	43.4	38.2	41.5	32.1	37.3
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2, small subunit processome component"	Q15269	21	44107290-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 9.5;Smooth muscle cells: 13.4;Suprabasal keratinocytes: 7.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 31.0;Daudi: 26.8"									HPA024573	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	6.1	6.1	11.3	7.7	14.6	3.6	6.3	9.7	12.8	4.0	9.0	9.6	2.4	4.4	7.8	9.2	8.2	5.9	4.8	4.6	6.8	4.8	6.9	8.7	5.0	7.9	15.4	5.7	5.0	12.8	1.4	4.0	7.6	8.9	8.1	1.8	4.9	8.2	5.2	8.0	14.7	5.6	2.2	6.4	8.8	10.6	5.3	17.2	3.6	4.8	8.6	16.8	5.0	5.7	6.8	2.6	2.9	4.3	3.4	6.9	5.0	1.2	0.4	0.3	1.2	3.6	3.6	9.3	12.0	6.3	16.0	10.8	31.0	0.5	26.8	0.4	0.0	0.9	1.4	0.5	9.1	9.2	6.6	19.4	3.2	5.6	7.2	2.3	2.4	0.9	0.3	0.0	11.1	0.0	2.8	0.5	11.4	10.2	10.8	5.3	0.4	0.1	0.7	0.3	0.7	1.2	1.5	0.1	13.9	0.0	0.4	9.4	1.6	0.6	1.0	7.5	4.6	0.0	1.0	6.1	6.5	1.1	14.4	1.4	14.5	17.3	1.2	0.4	2.9	9.2	0.2	2.2	2.9	6.0	3.1	6.6	6.8	4.9	6.9	1.6	4.1	4.9	6.1	1.2	3.4	4.3	2.6	3.5	5.0	11.3	14.6	9.7	12.8	6.8	4.8	15.4	5.7	8.9	17.2	0.0	1.3	0.5	0.1	9.5	0.1	3.4	0.0	1.4	2.3	0.0	0.0	0.1	1.7	0.0	0.1	1.4	2.6	0.0	0.0	1.2	1.0	0.7	0.0	0.0	1.7	0.0	2.4	3.1	5.4	0.0	1.1	0.0	1.7	0.0	4.7	0.2	0.0	3.2	0.0	0.0	0.2	0.0	13.4	0.6	1.7	7.4	0.6	2.9	4.7	0.0
PWWP2A	KIAA1935	ENSG00000170234	"PWWP domain containing 2A"	Q96N64	5	160061801-160119423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Cell type enhanced"	"Detected in all"	5	"Bipolar cells: 94.1;Horizontal cells: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046733, HPA058233"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA046733: AB_2679777, HPA058233: AB_2683647"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.24e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.51e-4)"	8.4	9.3	9.5	12.7	22.3	11.9	9.1	52.7	16.0	14.4	13.6	19.9	5.3	9.6	10.8	7.2	8.7	9.5	8.1	7.4	15.9	8.8	10.3	8.6	9.8	12.0	25.2	8.9	10.5	10.5	10.6	15.1	11.2	17.0	11.9	14.7	10.3	8.8	8.4	7.0	14.7	10.6	9.3	13.8	12.5	11.8	6.3	21.3	18.6	9.8	5.8	11.4	10.7	10.1	6.0	2.9	6.0	4.4	1.1	4.9	0.9	10.7	5.2	13.5	11.5	15.1	11.8	19.1	8.6	7.0	7.7	7.9	16.8	21.0	17.4	13.2	6.6	12.6	7.8	11.7	13.5	12.7	18.0	13.0	12.5	9.6	8.6	11.5	12.5	9.5	8.4	6.7	15.5	11.8	17.3	12.3	9.9	9.5	11.3	13.0	9.0	10.7	12.2	15.9	9.2	6.7	16.9	12.0	11.1	9.4	7.7	15.9	11.1	14.5	14.7	15.6	11.5	11.3	13.9	16.4	13.5	9.3	10.0	16.7	13.0	11.6	15.5	8.8	12.7	13.2	6.0	4.4	2.4	2.8	2.0	2.2	6.0	3.0	3.3	2.9	3.7	4.9	2.7	5.0	1.1	2.6	2.7	2.5	0.9	9.5	22.3	52.7	16.0	15.9	8.8	25.2	8.9	17.0	21.3	8.9	14.8	18.5	12.5	28.3	94.1	10.6	10.2	14.7	17.0	19.2	68.7	11.2	14.9	11.6	1.5	15.3	18.4	23.3	9.6	10.5	16.2	15.6	23.1	7.6	7.8	89.0	31.6	12.9	11.0	2.1	51.8	14.6	10.1	12.6	19.4	22.7	13.1	14.4	36.0	5.8	50.6	25.8	22.6	9.7	17.2	22.6	7.8	17.3	20.4	11.2
PXDC1	C6orf145	ENSG00000168994	"PX domain containing 1"	Q5TGL8	6	3722614-3752026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 79.6"	"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 93.5;Extravillous trophoblasts: 114.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 4.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019246			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA019246: AB_2670113"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (2.82e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.84e-1)"	26.3	5.5	5.9	5.9	6.5	0.4	30.6	3.2	6.6	11.1	10.3	6.4	5.3	10.7	10.1	14.4	13.9	8.3	18.5	10.8	6.5	4.4	13.4	79.6	14.2	5.8	7.5	3.1	6.2	10.0	3.4	4.3	32.9	6.2	9.1	3.1	7.5	12.3	8.1	11.9	11.7	16.9	20.6	7.0	6.1	8.9	3.9	6.9	1.0	16.8	11.5	5.8	14.9	21.0	4.2	0.3	0.5	0.0	0.0	0.9	0.3	11.7	5.0	8.2	5.5	26.0	19.7	26.4	21.4	16.5	18.3	14.2	8.3	2.3	0.0	13.9	35.0	13.5	8.8	1.6	5.9	8.7	11.9	1.6	0.0	3.6	7.4	43.5	0.0	0.0	17.8	19.4	11.3	24.4	15.1	20.0	0.8	0.0	1.5	14.3	0.7	0.0	0.1	0.3	2.3	6.0	0.6	4.4	0.4	6.9	9.9	0.9	0.4	14.2	14.6	28.7	11.4	1.2	0.7	20.8	15.5	6.6	6.0	14.5	0.0	0.0	0.0	3.5	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.3	4.2	0.1	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.3	5.9	6.5	3.2	6.6	6.5	4.4	7.5	3.1	6.2	6.9	44.7	10.4	4.2	93.5	42.8	0.4	6.9	15.3	5.3	12.5	7.0	0.0	26.6	10.0	30.2	0.4	37.0	1.3	0.0	44.5	114.0	36.1	45.1	3.5	57.1	21.2	0.0	0.0	36.2	9.1	0.2	21.0	17.8	23.6	37.9	0.8	14.3	55.0	0.0	17.0	16.8	0.7	0.0	31.6	0.5	3.8	29.0	65.6	2.9	0.0	38.2
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426126	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 81.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Approved		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favorable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	9.3	9.4	20.7	17.0	51.4	33.6	7.6	22.6	31.4	28.9	8.9	81.1	2.4	6.3	14.2	5.3	6.6	8.0	9.6	7.5	33.7	19.9	10.4	5.7	8.2	23.8	68.6	23.4	11.1	8.5	13.7	6.1	17.5	43.9	6.0	6.4	4.4	8.8	7.7	7.6	7.5	7.7	11.8	55.9	13.5	8.3	6.7	56.6	3.7	40.3	2.5	26.1	9.8	13.1	31.3	18.8	31.8	22.5	8.7	11.2	13.4	4.3	2.5	1.9	3.5	26.9	23.9	5.7	6.9	14.7	6.7	9.4	1.2	0.9	22.8	1.6	11.7	9.7	1.3	6.0	4.4	7.1	5.7	3.8	3.9	3.1	1.7	31.4	33.9	6.9	20.4	10.6	8.4	14.6	23.6	5.9	14.6	4.8	7.5	12.0	1.6	7.4	35.0	2.3	1.3	6.3	12.8	3.3	4.1	4.2	2.4	1.7	1.2	4.7	3.4	5.5	3.6	11.5	35.1	6.0	8.4	3.5	15.9	7.3	5.9	5.8	22.7	12.1	48.2	3.5	14.6	20.1	29.4	11.2	16.2	9.9	29.0	8.1	9.4	18.8	31.3	7.1	8.4	31.8	8.7	22.5	13.5	8.7	13.4	20.7	51.4	22.6	31.4	33.7	19.9	68.6	23.4	43.9	56.6	8.9	4.6	34.0	4.9	12.6	29.2	11.8	7.6	8.1	6.8	22.7	19.6	13.3	28.2	5.9	60.8	14.3	6.3	23.3	5.0	6.5	30.9	6.4	19.6	6.8	12.0	19.1	7.5	18.4	24.8	27.6	28.4	16.3	16.9	8.2	5.2	29.3	3.5	3.5	23.7	9.1	20.8	19.4	15.5	14.0	19.4	11.4	29.4	15.9	4.4	3.2
PXMP4	PMP24	ENSG00000101417	"Peroxisomal membrane protein 4"	Q9Y6I8	20	33702754-33720319	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.6;SK-BR-3: 35.9;T-47d: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050077	Approved		Approved	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			Peroxisomes	"Nucleoli fibrillar center"	"HPA050077: AB_2681006"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.53e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.03e-10)"	"unprognostic (3.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.20e-1)"	6.2	20.0	6.4	5.4	10.0	3.9	15.6	4.7	12.6	7.8	7.8	12.5	16.9	10.1	7.1	7.1	10.0	8.0	9.1	7.9	6.7	5.3	6.7	13.4	27.5	9.3	6.1	9.2	9.2	9.5	24.4	5.3	5.0	6.5	11.5	7.5	10.8	27.6	13.2	9.9	14.4	11.8	7.1	7.6	6.4	9.0	4.2	5.9	8.4	19.0	6.9	5.9	10.6	9.0	6.2	6.2	12.0	21.9	5.8	8.5	5.5	1.2	5.6	1.6	5.6	2.8	4.1	4.0	4.0	2.2	3.1	1.4	19.6	6.2	0.0	7.8	3.4	7.7	5.9	4.2	4.7	2.2	1.6	1.6	6.4	4.8	0.1	2.6	0.3	4.9	3.1	5.1	4.3	1.4	1.6	2.0	2.0	3.5	4.1	2.2	12.0	5.8	4.5	0.2	9.9	0.0	3.1	7.7	0.7	2.0	4.1	5.1	2.6	11.3	35.9	3.6	0.9	30.3	2.1	4.0	2.3	2.6	5.7	3.7	2.6	5.8	0.1	4.4	2.1	3.8	1.4	8.0	12.0	8.1	14.9	8.5	5.5	8.3	8.1	6.2	6.2	6.3	8.5	2.1	5.8	21.9	3.8	5.7	5.5	6.4	10.0	4.7	12.6	6.7	5.3	6.1	9.2	6.5	5.9	17.9	61.7	5.2	4.0	1.4	9.9	11.3	12.7	6.7	21.6	17.4	13.7	10.3	8.3	7.1	24.5	6.6	15.1	0.0	8.6	20.0	6.1	4.1	3.5	27.9	13.0	4.8	4.1	8.6	6.7	30.4	9.8	5.0	3.3	4.6	10.9	15.3	6.3	10.5	10.6	7.7	10.2	6.5	4.2	2.3	8.9	2.0	3.7	3.5	12.4	3.5
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 49.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"		NA	NA			"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: AB_2681436"	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (1.09e-4)"	"prognostic unfavorable (3.72e-5)"	"prognostic unfavorable (7.12e-5)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	35.4	26.2	17.9	26.7	16.5	31.6	45.9	15.5	18.6	25.0	29.0	12.4	31.7	25.6	27.6	30.9	16.0	29.8	31.8	26.2	18.0	7.6	27.6	13.1	35.8	42.9	15.7	8.1	14.8	16.3	17.6	13.9	34.0	15.8	24.9	23.5	24.7	22.1	40.1	98.5	19.7	34.7	44.4	20.3	34.0	20.6	19.8	14.4	9.9	26.7	22.8	11.6	30.1	45.7	0.5	7.6	49.5	12.3	14.4	26.3	14.5	33.2	16.5	5.9	5.9	11.9	31.0	40.1	28.2	24.6	23.0	12.1	19.2	21.0	2.3	18.5	28.6	22.3	23.8	4.1	51.4	18.4	1.8	3.7	0.4	12.2	6.9	17.2	0.5	0.7	15.1	33.6	24.0	27.4	26.0	40.8	6.2	5.9	3.8	44.9	22.1	2.0	0.7	8.4	14.5	57.5	4.9	9.8	2.0	23.6	32.0	9.7	2.9	25.3	7.8	15.2	14.5	19.2	2.7	53.7	16.0	17.5	19.9	33.5	4.0	2.2	0.8	46.0	5.0	31.2	9.8	12.3	13.4	26.3	4.4	14.2	0.5	12.1	17.2	7.6	0.4	9.6	12.8	49.5	14.4	0.2	1.2	9.1	14.5	17.9	16.5	15.5	18.6	18.0	7.6	15.7	8.1	15.8	14.4	53.6	30.4	3.0	29.8	37.5	7.1	11.5	25.5	28.1	35.2	40.1	31.4	31.3	16.6	30.3	1.2	56.8	59.3	0.0	34.6	124.5	18.0	29.6	17.4	15.3	29.4	11.1	52.5	57.1	49.0	1.6	22.5	13.7	25.3	10.0	49.9	6.9	56.8	50.3	17.7	11.6	30.4	6.5	10.5	3.8	8.0	16.9	20.9	28.7	28.4	33.9
PYCR2	P5CR2	ENSG00000143811	"Pyrroline-5-carboxylate reductase 2"	Q96C36	1	225919877-225924340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA056873	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA056873: AB_2683263"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	21.4	37.2	25.7	24.0	28.2	29.5	17.2	14.3	38.2	21.8	17.4	40.0	25.8	16.1	25.3	20.0	17.7	33.2	24.6	38.0	27.9	28.3	23.4	35.0	22.0	30.3	34.0	30.8	34.5	29.0	26.6	29.8	22.2	29.5	22.4	13.7	21.5	26.3	32.1	36.0	15.3	16.7	22.3	38.4	25.9	20.1	17.6	24.7	35.0	19.2	20.0	23.5	24.6	16.2	19.3	25.9	16.4	12.7	28.3	36.1	18.1	16.9	14.0	8.6	14.4	9.7	10.1	18.1	17.9	11.2	12.2	10.9	18.3	14.1	29.8	38.5	13.1	9.6	19.6	12.3	14.1	7.0	35.8	25.6	28.5	14.6	18.3	15.1	25.0	46.8	9.7	17.8	13.8	15.9	10.9	11.6	25.0	41.1	20.0	12.3	13.9	31.4	28.4	47.9	26.7	19.5	28.2	19.2	61.8	15.8	13.5	10.8	14.0	14.9	11.9	37.4	7.2	15.3	47.9	9.7	9.6	11.5	20.3	24.6	32.0	35.1	29.5	15.1	19.1	26.5	15.1	8.7	16.4	21.1	12.7	22.2	15.9	20.6	19.5	13.6	19.3	36.1	29.2	6.0	28.3	10.8	25.9	18.6	18.1	25.7	28.2	14.3	38.2	27.9	28.3	34.0	30.8	29.5	24.7	17.9	21.4	27.4	51.9	13.2	13.0	38.6	15.3	60.2	17.0	33.2	13.7	79.6	41.4	44.2	5.9	22.9	13.5	46.7	30.3	34.9	22.5	33.6	38.1	16.3	35.3	12.7	25.4	19.0	20.8	5.6	35.4	21.2	32.1	65.9	14.1	38.4	25.0	13.9	35.3	24.0	36.1	25.8	18.9	33.6	40.3	11.2	34.9	45.7	13.6	34.4
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248069-25298014	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 101.9"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 93.8;Enterocytes: 83.8;Peritubular cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 71.7;SK-MEL-30: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		NA	NA		16000000	Cytosol		"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.37e-4)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.43e-4)"	19.0	11.3	24.2	12.1	22.9	6.1	28.4	38.3	34.8	14.3	47.0	21.5	19.0	12.5	15.9	13.8	49.6	14.1	21.1	72.5	21.1	21.3	13.5	4.4	14.8	8.1	22.9	24.7	11.9	9.7	8.0	18.2	6.2	28.0	42.2	33.8	11.0	58.4	52.0	5.0	23.9	13.1	101.9	17.8	8.2	24.1	14.5	17.4	9.5	21.1	8.4	10.3	56.7	14.8	4.5	11.2	5.2	16.8	8.1	10.6	16.0	5.3	38.3	6.9	6.7	17.7	33.4	5.1	10.8	14.2	9.1	7.7	8.6	6.6	6.3	12.8	14.4	17.1	21.5	7.8	28.8	5.0	3.5	4.8	5.1	3.1	14.7	21.0	7.5	7.1	19.4	27.0	23.1	34.3	11.3	11.6	4.0	2.7	16.1	12.7	14.8	7.5	5.8	6.2	6.5	71.7	5.7	12.6	8.4	49.9	9.8	10.4	6.5	7.4	13.0	89.9	5.7	9.1	4.8	25.5	10.8	6.6	11.5	22.0	6.2	9.6	2.4	12.1	5.9	58.7	2.6	10.2	5.2	8.5	15.5	8.3	4.5	6.8	7.5	11.2	4.2	8.8	10.6	2.5	8.1	16.8	5.5	7.5	16.0	24.2	22.9	38.3	34.8	21.1	21.3	22.9	24.7	28.0	17.4	8.9	28.8	2.2	18.7	10.5	23.6	93.8	15.3	9.4	9.1	24.4	35.3	5.9	10.0	15.4	2.4	10.8	83.8	0.0	14.5	5.7	9.1	20.1	5.8	5.9	10.0	17.5	27.1	8.6	15.2	6.8	25.3	11.0	33.7	18.0	47.4	20.4	19.1	57.9	81.3	9.9	9.4	0.0	17.6	1.7	4.9	8.8	3.7	12.8	52.1	7.1
PYGO1		ENSG00000171016	"Pygopus family PHD finger 1"	Q9Y3Y4	15	55538890-55588947	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 26.6"	"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 11.3;Spermatocytes: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-698: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042248	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042248: AB_10794272"	"unprognostic (5.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-6)"	"unprognostic (3.36e-4)"	"unprognostic (4.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.80e-2)"	3.0	3.8	3.8	1.6	8.2	0.6	3.1	10.1	5.1	10.8	5.1	2.8	8.2	0.9	9.8	5.8	3.3	4.2	3.9	2.6	5.2	4.3	1.8	0.6	3.2	1.0	4.2	2.8	14.2	2.3	26.6	6.9	3.2	5.0	7.9	1.9	5.5	1.9	9.4	18.7	1.5	1.8	7.9	5.2	0.8	2.8	6.0	3.2	0.0	10.1	5.7	1.0	7.6	9.2	0.6	0.2	0.9	0.2	0.3	0.4	0.0	2.8	5.1	8.9	4.7	3.4	7.7	3.7	6.1	6.7	4.8	5.6	3.4	0.0	0.0	1.8	3.9	6.8	0.0	9.1	0.0	6.2	0.0	3.1	1.3	1.4	0.3	4.9	4.9	0.0	4.1	4.7	4.3	0.7	4.9	2.5	0.7	0.1	0.0	7.6	0.1	0.2	0.0	2.4	0.6	2.6	0.0	11.4	0.0	1.5	2.0	4.9	5.8	5.5	0.0	4.2	1.3	1.7	1.5	0.0	12.1	5.5	0.2	7.1	0.1	0.1	25.9	3.8	0.0	2.8	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.3	0.0	0.0	0.6	0.3	0.4	0.9	0.3	0.1	0.2	0.1	0.0	3.8	8.2	10.1	2.8	5.2	4.3	4.2	2.8	5.0	3.2	8.9	4.6	0.0	4.1	1.4	4.9	3.9	0.0	2.7	3.4	8.7	0.0	0.9	0.0	0.3	1.7	0.7	0.0	0.0	0.0	0.1	6.6	4.8	0.0	0.0	0.4	0.0	0.0	0.6	0.6	1.9	9.2	0.8	6.8	0.0	0.0	6.3	0.8	0.0	11.3	0.0	3.1	0.0	4.1	10.7	2.1	0.6	0.2	0.0	0.0	0.5
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977054	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.4;lymphoid tissue: 23.3"	"Cell type enriched"	"Detected in some"	11	"T-cells: 126.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 33.4;MAIT T-cell: 19.1;memory CD4 T-cell: 14.2;memory CD8 T-cell: 25.2;naive CD8 T-cell: 16.0;NK-cell: 11.4;T-reg: 21.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.4;T-cells: 33.4"	"Cell line enriched"	"Detected in some"	6	"U-698: 33.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	4.0	0.6	0.5	20.1	0.5	3.9	2.1	0.4	0.4	2.0	2.7	0.2	0.3	1.2	2.2	1.4	1.7	1.6	3.2	1.2	0.6	0.5	1.8	2.6	11.7	18.8	0.7	0.0	1.6	0.8	0.0	0.8	1.7	0.4	2.6	1.8	1.2	3.4	1.2	0.7	0.9	7.8	0.4	1.3	20.7	2.0	1.0	0.0	6.6	2.5	1.9	23.3	5.7	1.6	4.9	0.1	1.2	0.1	11.4	33.4	6.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	33.1	0.0	5.1	0.0	0.4	0.1	0.1	33.4	0.1	19.1	4.9	14.2	25.2	0.1	2.4	4.8	16.0	1.2	11.4	0.1	0.1	21.0	6.0	0.5	0.5	0.4	0.4	0.6	0.5	0.7	0.0	0.4	0.0	11.9	3.2	9.5	0.7	0.3	0.2	0.3	0.0	9.4	3.4	3.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.1	0.4	2.3	1.3	2.1	0.0	0.0	3.1	4.3	0.0	0.0	1.4	1.7	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.1	0.5	0.1	126.8	0.0	0.3
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No			"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	17.5	21.4	16.2	21.2	14.8	13.2	20.3	16.3	17.1	15.2	21.2	14.2	27.1	21.8	16.1	30.8	46.7	16.3	21.5	13.6	14.0	14.7	19.4	31.3	14.4	28.6	14.7	14.0	13.3	24.8	15.3	19.8	21.5	12.8	20.7	21.5	18.3	22.9	24.5	18.2	27.2	29.9	16.3	13.2	25.5	15.8	21.1	14.1	26.3	22.5	31.2	39.1	16.5	19.9	29.5	35.9	21.6	27.2	14.4	53.6	24.1	17.5	14.1	20.6	11.4	12.5	16.3	33.8	13.0	15.7	12.3	10.4	20.5	21.0	22.1	19.8	12.5	5.7	13.9	15.8	27.8	9.9	17.0	11.8	18.0	12.0	25.2	15.3	20.8	16.5	14.7	17.9	13.8	20.8	15.6	13.0	9.9	15.3	24.6	14.4	26.5	13.3	37.2	35.9	20.1	7.3	12.0	8.2	25.3	25.2	25.0	13.9	16.0	16.6	22.3	11.6	20.0	27.1	44.1	10.1	7.4	10.5	11.5	9.4	13.0	19.7	34.1	12.7	14.5	11.6	3.9	24.5	21.6	18.7	27.2	22.9	29.5	34.0	26.1	35.9	25.2	22.6	22.6	5.8	14.4	18.5	19.6	53.6	24.1	16.2	14.8	16.3	17.1	14.0	14.7	14.7	14.0	12.8	14.1	17.9	15.9	15.9	26.4	0.0	13.6	0.0	28.1	30.8	26.1	22.7	7.9	72.4	66.3	34.7	9.6	12.4	38.3	23.3	44.0	61.6	11.5	34.5	17.4	32.7	48.8	6.4	7.0	19.0	44.8	7.4	21.6	40.2	0.0	146.1	41.7	34.7	43.4	37.0	22.3	44.1	10.6	12.9	0.0	18.1	24.3	0.0	51.8	37.4	37.7	28.0
PYROXD1	"DKFZp762G094, FLJ22028"	ENSG00000121350	"Pyridine nucleotide-disulphide oxidoreductase domain 1"	Q8WU10	12	21437615-21471252	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038319, HPA038320"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA038319: AB_10669522, HPA038320: AB_2675956"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.70e-4)"	12.7	10.8	6.2	8.5	7.6	7.5	10.4	9.4	10.1	12.2	22.2	5.1	11.7	13.6	9.3	11.2	18.1	8.2	9.2	10.3	6.2	7.6	22.7	32.3	8.3	11.2	8.9	7.5	11.2	15.7	8.8	7.9	9.0	10.6	10.2	11.4	7.6	14.3	13.0	18.9	9.7	26.1	17.2	11.5	9.1	12.3	7.5	6.5	6.8	15.8	12.7	8.1	10.2	8.1	3.0	2.6	2.1	5.8	3.8	5.2	2.1	6.6	2.5	3.8	4.2	2.8	5.2	8.9	10.3	4.9	3.9	3.0	3.2	6.3	7.2	4.4	7.8	3.3	8.3	4.2	8.2	4.4	8.5	3.6	8.5	6.9	4.0	13.1	12.5	8.9	8.5	10.0	2.4	10.7	5.0	5.7	7.8	3.9	3.1	7.8	4.1	5.8	17.3	6.5	5.7	4.7	1.0	8.3	8.0	12.1	6.7	1.2	9.6	4.9	9.0	18.9	5.7	10.7	15.0	7.5	4.7	4.5	9.7	9.5	4.6	3.2	9.1	18.9	9.4	5.5	2.1	2.0	1.3	4.5	3.3	4.8	3.0	5.0	5.2	1.9	2.5	4.2	4.3	0.9	3.8	5.8	2.6	3.8	2.1	6.2	7.6	9.4	10.1	6.2	7.6	8.9	7.5	10.6	6.5	11.9	27.9	6.5	9.0	6.0	20.9	10.1	33.1	36.1	13.6	26.2	23.6	13.5	19.9	20.0	137.0	7.4	34.4	0.0	29.0	10.4	7.3	9.6	24.3	20.2	14.5	7.9	19.7	5.5	19.0	22.8	9.8	17.9	5.0	6.4	19.5	13.3	36.1	23.0	6.0	31.1	27.2	12.9	9.2	26.7	19.0	6.8	16.2	18.3	19.9	11.1
PYROXD2	"C10orf33, FLJ23849"	ENSG00000119943	"Pyridine nucleotide-disulphide oxidoreductase domain 2"	Q8N2H3	10	98383565-98415184	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.8"	"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 50.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 28.6;U-937: 18.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037566, HPA037567, HPA067394"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832"	"unprognostic (2.35e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic favorable (3.37e-4)"	11.0	15.5	5.1	9.0	7.0	2.7	9.2	2.6	6.3	12.2	6.5	12.0	14.2	2.5	8.3	15.5	4.1	11.6	13.1	9.5	5.3	3.8	6.7	11.7	8.6	2.9	12.6	3.0	11.5	4.3	7.5	6.0	5.0	9.6	12.9	5.8	12.5	26.9	11.3	9.6	3.2	4.1	12.2	8.1	5.2	5.5	3.7	10.7	4.3	9.2	2.3	3.0	11.9	6.9	0.0	0.5	50.8	0.0	11.3	1.8	0.4	2.1	5.3	3.0	0.1	4.7	9.5	1.1	3.5	10.9	2.0	3.8	0.0	7.4	0.0	6.3	3.7	0.5	1.0	0.9	1.2	2.1	0.2	0.8	4.3	8.8	0.4	6.1	0.0	10.0	5.6	1.6	1.6	1.9	28.6	1.5	2.0	0.1	0.1	3.0	6.5	0.1	10.2	0.9	4.1	1.8	1.3	1.1	0.0	2.9	3.3	0.2	0.1	3.8	0.5	2.6	4.3	3.1	4.8	2.0	0.0	2.3	0.6	3.4	0.7	0.4	0.0	3.5	18.7	0.3	1.1	0.0	50.8	1.8	0.0	0.4	0.0	0.6	1.5	0.5	0.0	0.3	1.1	0.1	11.3	0.0	0.1	0.1	0.4	5.1	7.0	2.6	6.3	5.3	3.8	12.6	3.0	9.6	10.7	8.9	3.2	0.0	5.5	0.5	0.0	8.1	0.0	13.4	6.8	1.8	0.0	4.5	6.6	2.1	0.2	3.1	2.0	0.0	2.2	3.3	4.6	2.8	2.3	2.4	7.5	0.0	1.2	4.3	3.8	0.2	3.1	2.5	1.7	1.0	4.9	3.1	1.1	0.0	3.5	7.3	0.8	6.5	4.2	2.6	1.5	0.5	1.5	4.4	6.0	8.4
PYURF	PreY	ENSG00000145337	"PIGY upstream reading frame"	Q96I23	4	88520985-88523813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036455	Uncertain		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA036455: AB_10673388"	"unprognostic (8.25e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	40.4	48.3	47.3	29.2	43.9	44.2	63.2	28.2	43.4	40.6	38.4	31.2	35.2	35.8	47.4	56.4	40.9	41.0	36.4	62.5	45.4	45.1	48.7	59.1	33.5	43.1	47.6	35.3	44.9	61.8	40.7	42.6	39.0	43.2	42.7	37.7	31.6	48.6	42.9	54.0	37.1	37.5	44.7	51.4	36.9	33.8	28.5	38.4	28.3	47.7	40.5	33.0	41.7	51.4	45.3	50.8	35.0	43.3	47.3	54.1	74.3	29.4	9.9	19.9	23.6	40.3	41.5	13.5	21.8	30.7	27.4	23.2	7.7	23.5	0.1	24.6	30.8	18.6	12.7	18.0	27.4	34.6	36.0	31.3	32.7	13.2	29.3	30.6	54.0	21.1	28.6	41.5	17.6	36.1	26.0	44.7	10.2	36.7	33.2	39.5	22.3	32.8	33.1	16.7	34.5	19.1	33.5	18.6	34.3	22.5	16.7	24.1	23.6	27.6	25.3	57.4	20.6	11.7	27.2	30.4	29.2	26.9	28.4	20.0	23.6	19.1	3.6	25.6	27.5	32.0	30.9	43.3	35.0	45.0	42.0	50.2	45.3	52.0	48.5	50.8	35.5	54.1	51.6	8.6	47.3	41.0	31.9	51.8	74.3	47.3	43.9	28.2	43.4	45.4	45.1	47.6	35.3	43.2	38.4	47.6	58.8	74.6	136.8	204.7	28.0	4.5	68.8	84.3	85.3	82.0	9.8	205.8	243.7	96.5	35.0	121.7	71.5	23.3	113.5	97.9	127.4	138.8	102.8	109.9	125.1	25.4	110.1	92.7	113.8	79.3	116.5	112.4	330.7	100.0	88.2	79.4	90.7	113.1	112.8	171.4	25.3	58.2	140.4	100.3	65.3	252.6	137.1	99.2	113.0	120.5
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.1;liver: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 298.8;Muller glia cells: 301.8;Proximal tubular cells: 369.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		NA	NA		1800000	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	22.5	25.9	67.8	3.4	111.9	4.4	7.4	16.0	54.1	5.7	7.5	56.3	2.6	9.1	5.5	12.5	5.2	6.4	6.3	15.0	80.7	58.2	36.1	64.8	8.0	3.7	114.1	36.7	6.7	10.3	13.7	6.2	4.1	82.5	10.3	5.9	2.6	12.4	7.5	34.2	4.6	8.1	6.4	93.6	4.8	9.1	4.1	94.7	0.7	7.7	2.8	4.4	4.5	2.6	7.5	42.5	1.0	21.9	9.9	15.0	12.3	11.6	22.8	9.0	12.5	21.9	11.1	15.9	16.6	7.0	15.5	13.6	18.2	15.4	4.3	10.7	9.2	17.3	6.6	12.8	18.8	9.7	13.1	2.6	11.8	11.8	43.0	13.2	15.3	1.1	13.7	11.9	9.7	13.4	8.3	7.8	11.0	12.6	9.9	16.6	6.0	22.8	24.6	15.3	11.0	15.4	9.5	6.9	17.2	16.0	6.4	17.1	21.8	11.0	1.8	47.2	10.3	5.0	5.9	13.5	9.0	16.1	8.9	13.2	15.4	24.0	30.2	18.0	13.5	14.9	0.0	14.4	1.0	12.3	21.9	11.1	7.5	13.3	12.8	18.0	6.2	15.0	12.9	0.4	9.9	16.3	42.5	6.9	12.3	67.8	111.9	16.0	54.1	80.7	58.2	114.1	36.7	82.5	94.7	26.8	26.9	18.2	16.6	17.7	34.9	59.2	38.2	4.0	14.8	36.6	7.9	65.3	92.9	37.2	0.8	17.8	14.2	0.0	20.5	28.8	26.3	26.4	25.3	298.8	69.8	77.9	167.4	25.8	34.9	3.3	21.0	26.9	145.1	20.8	22.6	301.8	17.0	7.0	35.7	369.1	26.6	25.8	26.4	3.3	60.7	14.1	15.3	16.7	36.6	11.1
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37344574-37373322	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6;blood: 137.6"	"Group enriched"	"Detected in many"	6	"Intestinal endocrine cells: 208.4;Melanocytes: 501.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 137.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 137.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.9;SCLC-21H: 24.3;SK-MEL-30: 81.6;U-266/84: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	3.2	77.6	4.3	5.4	5.8	17.0	6.4	1.2	11.6	9.2	11.3	2.2	1.5	2.2	6.2	43.7	2.4	1.9	5.5	2.9	6.7	17.9	12.4	1.3	6.1	7.4	3.9	5.0	1.4	5.5	9.6	31.6	7.8	5.9	3.5	4.2	21.2	14.7	2.8	4.0	14.2	2.3	3.4	3.0	8.5	3.4	2.6	0.5	2.3	1.8	4.4	4.8	7.0	2.9	0.2	10.7	137.6	29.7	0.0	0.0	12.1	0.1	8.0	0.0	0.0	1.1	2.7	0.0	1.1	17.9	1.3	2.1	0.5	1.4	0.0	0.6	6.0	15.2	0.0	0.5	0.0	2.1	0.1	15.6	3.6	0.0	1.5	0.1	0.5	0.0	1.5	0.0	9.9	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	8.8	2.2	24.3	0.0	1.3	0.0	81.6	1.6	0.1	0.6	3.8	0.0	0.0	0.0	0.1	3.1	63.8	0.0	5.5	0.0	0.0	0.6	29.7	0.2	0.0	3.4	0.0	0.2	0.0	0.0	10.7	0.1	0.0	0.0	137.6	0.0	0.3	0.2	0.0	12.1	4.3	5.8	1.2	11.6	6.7	17.9	3.9	5.0	5.9	0.5	3.0	2.9	8.2	9.7	34.7	10.9	1.1	2.5	1.4	0.0	21.0	2.0	0.5	1.7	45.4	0.4	7.3	2.0	0.0	2.1	4.3	11.0	9.5	55.3	0.2	21.3	41.3	208.4	22.7	29.2	2.2	2.8	35.6	501.0	10.8	5.8	1.2	25.4	1.9	22.3	4.7	2.9	12.9	15.5	2.1	0.6	12.7	3.9	1.9	6.9	5.5
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29679008-29698699	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.2"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 349.5;Extravillous trophoblasts: 260.2;Hepatocytes: 304.1;Proximal tubular cells: 417.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.6;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 98.7;Hep G2: 41.2"									"HPA011887, HPA076010"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		230000	Vesicles		"HPA011887: AB_2668555, HPA076010: "	"prognostic unfavorable (5.10e-5)"	"unprognostic (2.00e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (1.44e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-2)"	3.2	36.4	6.1	3.0	5.2	1.1	2.4	1.6	5.8	17.9	10.8	4.4	43.3	20.0	12.7	44.3	1.3	14.9	4.9	11.3	4.9	7.5	40.1	61.2	4.7	2.9	7.9	7.5	15.3	22.9	6.1	2.6	24.3	10.0	4.4	5.2	12.6	15.0	19.4	1.5	1.6	24.1	4.7	6.4	5.3	2.7	3.1	2.6	3.7	2.2	0.3	2.1	5.9	5.1	0.1	4.6	1.2	7.7	0.5	1.4	2.2	0.1	0.2	9.4	10.3	1.6	3.9	23.1	0.9	0.9	1.5	1.9	23.6	16.8	0.4	98.7	1.8	1.5	0.1	3.2	0.1	0.8	0.1	2.1	4.8	0.3	41.2	9.0	0.7	2.0	12.3	0.2	0.8	0.0	2.3	0.0	4.6	12.1	0.5	0.0	22.9	3.0	16.8	28.7	0.5	0.0	13.3	2.8	9.3	8.6	0.7	7.6	15.4	0.0	26.8	19.8	16.1	20.0	21.5	0.1	0.4	3.9	0.1	0.0	0.3	0.7	3.1	0.7	1.7	1.5	0.0	3.7	0.4	1.3	4.7	1.4	0.1	0.9	1.0	4.6	0.1	0.1	0.7	1.2	0.5	7.7	2.6	0.8	2.2	6.1	5.2	1.6	5.8	4.9	7.5	7.9	7.5	10.0	2.6	8.9	22.7	18.6	9.6	3.2	1.5	34.8	7.6	0.0	0.0	61.1	0.0	349.5	43.1	0.9	0.0	2.8	125.5	0.0	48.0	260.2	17.5	2.9	4.7	304.1	118.1	6.4	27.2	11.1	13.0	0.0	27.0	12.3	40.5	5.4	45.2	20.3	17.4	77.2	25.5	417.3	3.5	6.5	11.3	0.5	2.5	1.8	180.3	6.4	95.6	6.4
QRICH2	DKFZP434P0316	ENSG00000129646	"Glutamine rich 2"	Q9H0J4	17	76274049-76307998	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 27.4"	"Cell type enhanced"	"Detected in some"	21	"Cholangiocytes: 7.6;Early spermatids: 25.8;Late spermatids: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA052219	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA052219: AB_2681766"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.82e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-3)"	0.9	0.8	1.2	0.9	2.2	1.9	0.9	5.7	2.0	0.9	0.9	0.9	0.9	0.3	0.9	1.0	1.0	1.2	0.9	0.9	1.4	2.0	0.9	1.1	1.1	0.9	1.4	0.9	0.9	1.3	0.6	0.9	1.4	0.9	0.9	0.8	0.9	5.6	0.9	1.4	1.7	0.9	0.9	1.2	0.9	0.3	27.4	0.9	0.9	3.0	0.9	0.9	0.9	0.9	0.9	0.0	0.0	0.1	0.3	0.4	0.3	1.2	2.5	4.8	5.4	2.6	2.4	2.2	2.2	0.5	1.7	0.5	1.3	0.5	6.5	0.9	1.4	1.3	0.5	6.3	1.1	2.1	1.8	3.8	0.6	1.7	5.8	1.4	0.9	3.0	2.1	1.0	1.9	0.1	3.3	2.1	2.0	3.5	1.3	0.6	3.8	3.4	0.8	1.9	1.6	5.2	7.6	3.9	0.2	0.9	2.3	4.4	4.4	1.1	0.6	2.6	4.9	2.0	2.7	2.1	1.4	5.1	6.8	2.6	1.8	1.7	0.6	1.5	3.8	1.6	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.2	2.2	5.7	2.0	1.4	2.0	1.4	0.9	0.9	0.9	0.0	0.0	0.0	0.3	0.1	0.5	1.6	7.6	0.0	0.0	1.8	0.0	0.6	0.0	0.7	25.8	0.6	0.3	0.0	0.0	0.9	0.2	0.3	0.0	0.8	0.2	1.6	0.0	0.0	0.3	5.8	0.9	0.0	1.7	1.0	0.5	1.5	0.5	0.0	0.7	0.4	1.8	0.0	0.6	2.1	1.1	0.3	0.3	0.0	0.4	0.3
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 32.6;naive B-cell: 26.1"	"Lineage enriched"	"Detected in all"	7	"B-cells: 32.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome		NA	NA			Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	9.8	10.8	12.4	17.0	14.7	8.5	15.6	10.1	15.6	7.6	11.7	10.1	11.9	11.3	9.5	10.8	10.3	8.5	8.3	13.9	10.4	9.1	15.5	12.5	7.7	21.0	15.8	8.3	10.2	10.8	10.9	11.9	8.7	9.9	8.3	13.7	7.5	10.6	12.5	35.7	8.8	14.8	8.8	11.9	16.7	11.0	10.6	13.7	13.8	13.7	14.6	21.3	8.9	8.6	32.6	4.0	1.6	4.5	2.6	3.1	2.2	6.2	6.5	9.0	13.0	5.8	7.3	12.7	7.1	7.4	9.6	9.6	7.5	5.2	20.9	6.6	7.9	9.9	11.1	13.3	8.6	12.1	9.9	10.2	10.1	6.9	7.8	9.1	22.9	9.1	7.2	13.5	10.2	15.1	7.3	6.8	13.2	18.4	6.8	7.9	7.0	7.3	11.2	9.3	10.9	7.6	20.1	11.5	5.3	10.4	7.2	7.8	8.0	5.7	13.4	10.5	8.2	8.7	17.8	6.6	6.8	5.6	7.2	11.0	4.0	5.6	12.2	9.3	15.6	10.0	1.6	2.4	0.4	2.6	3.6	2.5	32.6	2.9	2.2	4.0	26.1	2.7	2.6	0.7	2.6	4.5	3.2	3.1	2.2	12.4	14.7	10.1	15.6	10.4	9.1	15.8	8.3	9.9	13.7	17.9	8.4	62.4	6.4	3.5	14.2	24.6	10.2	26.8	7.9	10.4	15.7	18.2	14.9	13.3	10.4	10.4	10.5	0.0	15.9	19.4	7.2	6.4	17.4	13.0	11.3	3.2	16.7	8.0	13.2	4.5	7.8	9.0	8.5	14.4	10.5	9.4	12.8	7.0	8.5	14.6	18.7	0.0	6.6	20.7	12.0	4.6	10.3	11.4	19.0	8.4
QSER1	FLJ21924	ENSG00000060749	"Glutamine and serine rich 1"	Q2KHR3	11	32893178-32993316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005682	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005682: AB_1855985"	"unprognostic (2.94e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (7.94e-5)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-2)"	10.8	8.3	13.6	9.1	11.3	8.3	22.0	21.3	14.9	13.1	8.7	9.8	9.5	5.4	13.8	13.1	15.9	11.2	8.9	10.0	12.5	7.1	9.3	9.5	9.1	8.2	13.1	10.9	21.4	15.6	16.5	11.4	9.0	11.5	11.5	9.2	10.9	16.7	9.7	9.8	20.1	7.9	10.4	11.5	10.1	9.3	14.2	12.8	14.2	14.2	14.0	10.1	11.8	24.8	2.0	2.2	0.3	2.4	1.7	1.1	0.4	11.4	14.2	16.6	15.3	6.5	12.6	8.0	10.0	9.0	7.3	9.0	12.3	5.4	12.0	6.5	12.1	12.2	14.9	15.2	9.0	15.6	5.1	9.8	11.2	13.7	10.2	4.9	13.5	6.1	6.1	9.6	9.3	15.1	8.9	10.0	7.0	17.1	5.4	11.4	10.2	6.5	5.4	17.6	7.1	8.7	10.8	32.8	5.0	7.5	12.6	8.7	12.4	18.9	10.1	6.3	12.8	10.4	7.1	9.8	17.8	17.9	31.9	21.4	3.7	5.0	12.6	11.5	6.4	11.4	0.0	1.2	0.3	1.1	2.4	0.5	2.0	0.7	1.0	1.1	0.9	0.6	0.7	0.0	1.7	0.6	2.2	0.2	0.4	13.6	11.3	21.3	14.9	12.5	7.1	13.1	10.9	11.5	12.8	17.9	12.0	7.3	8.6	24.7	16.5	26.8	12.7	13.4	19.4	7.0	13.7	10.6	3.3	8.1	11.1	13.5	4.2	0.0	10.3	10.6	16.9	9.2	3.5	9.0	12.2	9.5	0.0	13.5	16.4	7.6	22.7	13.3	15.1	1.8	11.0	11.8	10.0	11.6	19.8	6.9	14.1	6.5	12.0	19.7	19.1	24.1	3.5	4.3	10.4	11.1
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154834-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 172.2"	"Cell type enriched"	"Detected in many"	8	"Extravillous trophoblasts: 1528.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 197.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056243			Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		3200000000	"Golgi apparatus"	Vesicles	"HPA056243: AB_2683077"	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	15.9	18.7	8.0	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9.0	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28.0	24.5	12.1	20.6	19.4	18.4	12.3	19.0	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8.0	7.1	11.4	42.1	6.0	1.4	18.0	18.4	38.1	71.7	44.9	45.4	38.4	27.1	0.7	13.6	0.6	27.9	35.9	5.3	9.2	1.7	12.1	18.8	2.5	2.7	1.3	3.5	1.8	197.7	4.6	13.0	20.3	5.5	40.9	49.1	50.6	56.5	3.1	1.9	6.6	25.2	7.3	0.9	8.6	4.9	29.2	17.3	1.8	3.3	1.1	6.3	12.0	5.2	5.3	13.1	17.9	8.7	3.4	3.2	21.9	66.5	48.1	18.9	32.2	37.9	4.8	7.9	1.1	18.3	14.8	14.4	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5.0	19.2	1.8	4.4	4.3	20.4	8.0	13.1	3.9	5.5	11.4	8.0	9.5	7.3	13.6	10.1	9.0	8.5	9.1	13.4	9.1	53.6	87.2	7.8	26.2	12.2	9.8	43.7	68.8	14.7	43.3	68.0	23.6	13.2	0.0	189.3	48.3	38.6	47.7	0.0	114.6	1528.4	54.2	30.1	25.3	1.5	63.8	6.4	44.4	101.9	45.4	16.5	164.5	43.6	42.2	44.1	163.8	43.9	172.2	143.8	66.8	9.5	6.5	32.3	17.5	20.9	25.4	8.7	129.1	15.0	96.4	58.0
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245841	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		5700000	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.2	8.0	8.4	15.9	14.1	16.0	7.3	30.3	10.6	5.8	5.8	9.4	8.9	6.0	8.1	13.2	5.6	8.1	5.5	7.0	7.6	7.1	7.0	9.2	6.5	19.1	11.0	6.7	9.4	21.7	12.1	29.2	5.8	9.6	6.1	6.7	7.9	6.5	4.9	5.1	12.4	10.3	8.1	7.1	14.6	7.6	11.7	10.1	8.3	12.1	6.0	16.7	5.4	6.4	3.4	0.8	1.6	0.3	0.4	0.8	0.2	7.0	17.1	14.2	18.8	8.0	9.8	17.9	8.9	10.0	17.5	16.1	12.7	15.3	10.8	14.8	12.0	32.2	22.8	16.8	12.9	14.2	15.9	8.4	5.8	28.3	14.0	11.4	17.2	8.9	7.8	13.2	17.3	21.1	7.7	12.8	11.4	14.0	29.3	9.2	11.9	6.3	11.5	16.8	21.2	10.9	11.8	18.5	17.7	6.0	6.3	15.2	11.5	14.1	11.2	7.5	9.7	8.0	10.1	7.3	21.3	15.4	17.4	20.3	10.4	13.8	23.8	14.2	9.1	19.8	1.6	0.3	0.7	0.5	0.0	0.8	1.9	0.6	0.2	0.1	3.4	0.2	0.4	0.1	0.4	0.0	0.8	0.3	0.2	8.4	14.1	30.3	10.6	7.6	7.1	11.0	6.7	9.6	10.1	8.9	6.4	6.9	2.5	5.0	16.1	3.1	0.0	8.1	5.7	5.2	17.7	1.2	1.7	3.3	4.9	7.0	1.1	0.0	3.4	2.5	4.7	4.8	1.1	3.4	2.0	4.8	15.6	2.5	4.8	4.7	5.5	2.7	0.0	1.0	4.9	2.8	3.5	0.0	6.7	1.9	8.2	6.5	5.7	16.8	26.4	10.0	0.8	3.1	3.4	3.3
QTRT1	TGT	ENSG00000213339	"Queuine tRNA-ribosyltransferase catalytic subunit 1"	Q9BXR0	19	10701430-10713437	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 232.5;Paneth cells: 244.4;Undifferentiated cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042695, HPA048651, HPA049440"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042695: AB_2678119, HPA048651: AB_2680477, HPA049440: AB_2680767"	"unprognostic (6.19e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.76e-3)"	"unprognostic (3.88e-1)"	"unprognostic (4.81e-3)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	14.0	18.4	20.6	13.4	29.1	14.2	11.5	18.0	21.3	11.3	14.5	13.3	19.4	12.8	15.3	11.6	14.6	15.8	13.5	19.5	19.7	13.1	11.8	18.9	8.4	13.5	22.9	19.3	22.1	33.9	5.8	12.0	9.8	19.9	13.7	6.6	10.5	26.6	12.7	20.5	12.6	14.2	13.3	12.7	11.5	12.5	5.0	22.2	5.3	19.0	11.9	10.3	12.0	10.3	19.6	19.1	0.9	14.4	18.5	18.8	10.4	17.2	13.9	6.6	19.3	7.0	8.4	8.7	8.8	7.9	10.3	10.2	11.1	6.6	19.5	21.7	5.0	6.2	11.6	6.0	10.6	3.4	11.5	8.4	12.8	5.6	23.3	12.1	19.0	11.3	12.4	9.1	6.7	9.9	4.7	10.5	10.8	14.1	22.4	5.1	26.9	16.3	23.7	17.5	10.8	21.5	17.2	8.8	30.1	8.4	11.1	21.5	9.3	13.5	14.8	11.5	2.9	9.5	8.0	8.1	15.9	8.9	25.4	20.5	24.7	19.0	9.5	8.6	23.1	19.2	0.9	8.3	0.2	15.1	14.4	18.8	19.6	16.3	13.1	16.4	19.0	17.5	13.9	0.6	18.5	7.3	19.1	17.7	10.4	20.6	29.1	18.0	21.3	19.7	13.1	22.9	19.3	19.9	22.2	0.0	5.0	26.7	54.7	56.6	36.4	5.6	28.1	12.0	5.7	54.1	47.1	41.0	54.7	20.6	1.3	27.0	191.9	70.0	23.8	30.6	33.2	38.0	16.1	26.7	26.1	85.8	185.1	16.5	20.2	1.1	46.9	9.6	47.2	7.2	232.5	24.4	15.1	244.4	35.3	58.5	54.3	19.4	30.3	12.1	28.9	36.6	23.5	26.2	247.9	33.9
QTRT2	"FLJ12960, QTRTD1"	ENSG00000151576	"Queuine tRNA-ribosyltransferase accessory subunit 2"	Q9H974	3	114005833-114088422	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.9;Club cells: 19.4;granulocytes: 14.0;monocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036827, HPA036828"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA036827: AB_2675336, HPA036828: AB_10696788"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.41e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-3)"	17.1	13.9	8.7	12.4	10.4	13.3	14.1	6.4	10.3	11.0	11.2	14.9	7.9	10.4	16.1	9.2	13.7	13.1	13.6	7.5	6.7	6.7	15.8	15.7	12.2	14.9	11.0	7.6	12.6	15.3	10.7	16.9	11.6	9.4	11.2	12.5	17.7	11.8	9.8	7.5	12.4	12.9	10.8	11.3	19.9	10.7	14.1	10.0	17.3	13.2	10.9	21.6	11.6	10.9	13.9	15.8	5.3	12.9	6.4	6.6	5.0	13.4	14.0	11.7	12.9	5.2	6.4	11.1	7.1	4.5	12.1	11.2	13.3	9.8	25.1	10.4	6.5	14.5	13.5	22.7	10.7	16.0	4.7	10.2	11.3	8.4	9.4	7.4	20.4	10.6	5.0	9.7	11.0	15.7	4.9	12.5	11.7	11.8	9.0	6.8	10.7	17.1	8.0	22.4	19.2	15.4	15.5	8.2	13.5	9.5	9.3	16.0	7.6	10.3	10.2	13.0	10.2	11.3	10.4	8.2	10.6	11.6	4.1	13.7	6.4	9.2	35.1	9.3	15.2	21.3	0.3	12.4	2.9	5.6	12.9	5.3	13.9	4.8	5.5	15.8	9.5	6.6	5.3	5.3	6.4	9.1	6.6	5.9	5.0	8.7	10.4	6.4	10.3	6.7	6.7	11.0	7.6	9.4	10.0	17.9	16.9	0.0	0.0	0.0	0.0	0.0	0.0	8.1	19.4	3.5	0.0	9.4	1.7	13.8	0.0	0.0	0.0	0.0	10.8	8.6	0.0	0.0	14.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	14.4	0.0	0.0	12.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
R3HCC1	DKFZp564N123	ENSG00000104679	"R3H domain and coiled-coil containing 1"	Q9Y3T6	8	23270120-23296279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023073, HPA023153"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			Cytosol	Nucleoplasm	"HPA023073: AB_1855987, HPA023153: AB_2237834"	"unprognostic (5.80e-2)"	"unprognostic (4.70e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (7.46e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.02e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (7.65e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.43e-1)"	14.8	14.2	21.4	14.8	20.9	18.4	24.6	16.5	36.3	13.9	18.4	26.0	14.8	14.5	16.4	18.2	12.5	17.9	16.4	23.8	21.5	16.9	13.2	16.6	18.8	15.9	30.1	16.3	22.1	50.3	16.0	14.7	10.4	20.7	14.8	12.0	15.3	24.8	20.7	36.6	16.3	14.4	18.3	33.7	13.0	16.9	17.4	21.4	15.8	13.6	14.7	13.9	12.9	12.6	28.5	29.7	41.6	27.1	29.7	36.5	25.7	21.2	26.7	21.5	20.8	9.2	12.5	14.6	14.0	13.6	24.1	17.6	18.5	10.0	21.5	15.0	17.3	16.5	16.0	22.6	26.2	16.3	13.7	22.2	20.0	18.4	15.5	21.8	13.6	15.0	14.8	20.8	20.6	9.7	17.8	18.4	24.4	23.1	18.2	14.1	17.4	30.7	22.8	17.1	23.0	19.5	21.0	26.2	12.8	11.5	23.4	27.5	23.7	16.0	19.1	22.9	15.4	17.4	16.4	15.6	22.2	18.5	18.4	28.6	13.4	11.9	22.1	17.2	19.1	27.4	17.8	27.1	41.6	36.5	22.6	31.5	28.5	29.6	30.4	29.7	21.0	23.2	26.6	16.6	29.7	24.2	27.7	30.5	25.7	21.4	20.9	16.5	36.3	21.5	16.9	30.1	16.3	20.7	21.4	23.8	14.3	5.2	14.0	13.3	22.4	21.3	17.8	24.1	10.3	5.2	25.5	16.1	48.0	25.7	28.8	17.9	24.9	0.0	43.9	18.7	27.2	9.6	22.0	17.3	25.7	17.5	18.4	12.9	13.7	72.6	16.4	14.0	20.3	15.4	21.3	35.2	32.4	19.2	20.5	24.7	93.2	12.9	29.3	43.5	32.0	14.2	6.4	20.0	22.8	9.9
R3HCC1L	"C10orf28, GIDRP86, PSORT"	ENSG00000166024	"R3H domain and coiled-coil containing 1 like"	Q7Z5L2	10	98134624-98244897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037367	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA037367: AB_10696930"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-2)"	14.5	8.2	9.5	14.9	12.9	19.1	13.0	16.4	11.4	11.1	12.9	8.9	10.3	8.0	11.4	13.0	12.0	8.0	7.7	8.1	10.2	6.2	9.6	10.8	10.9	13.8	11.9	5.4	9.3	10.1	15.6	20.7	14.4	11.8	13.7	13.1	12.9	12.0	9.5	10.0	14.1	15.0	10.1	16.7	13.2	9.4	25.2	12.5	17.1	11.0	6.9	15.7	11.5	16.0	10.2	6.0	18.6	12.9	10.2	13.9	5.5	10.6	7.0	10.7	9.4	9.2	9.8	8.9	12.1	16.9	11.9	13.2	9.5	7.7	15.1	6.5	7.2	6.7	12.2	10.7	7.3	13.5	11.3	7.3	8.9	5.5	10.6	11.3	12.1	10.9	8.9	8.4	10.4	15.5	10.5	7.6	9.5	7.7	9.4	9.2	10.2	9.5	12.6	7.7	5.1	9.2	9.8	12.2	6.1	8.6	6.3	3.7	7.9	6.2	4.6	23.6	14.3	8.3	7.7	8.4	8.0	8.5	8.9	9.0	9.6	10.1	25.8	11.4	12.7	5.8	10.7	6.9	18.6	9.9	9.4	8.8	10.2	10.2	10.0	5.3	9.5	9.0	8.8	8.5	10.2	12.9	6.0	13.9	5.5	9.5	12.9	16.4	11.4	10.2	6.2	11.9	5.4	11.8	12.5	14.9	13.7	6.5	4.8	3.0	6.2	7.7	10.2	17.4	7.9	7.0	5.9	7.9	5.0	6.5	18.2	6.2	10.2	0.0	6.0	8.3	4.5	5.3	16.2	3.9	6.2	4.8	5.8	3.1	9.8	9.4	4.9	9.1	11.8	10.0	10.6	6.2	7.5	5.8	5.3	2.9	13.3	0.0	5.1	40.0	22.6	3.3	10.9	7.5	7.6	7.1
R3HDM1	"KIAA0029, R3HDM"	ENSG00000048991	"R3H domain containing 1"	Q15032	2	135531455-135725270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030936			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA030936: AB_10670835"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-3)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (5.83e-7)"	"unprognostic (1.16e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.47e-1)"	6.5	6.4	23.2	8.3	27.8	13.4	5.3	22.2	57.6	6.7	7.5	4.5	2.4	4.5	6.9	6.6	6.2	5.5	6.3	5.3	17.9	15.5	6.0	6.2	5.0	11.0	11.5	32.7	5.3	8.4	20.1	13.2	4.2	7.7	5.4	10.3	4.3	4.3	6.1	13.5	5.3	5.6	8.6	7.9	6.6	5.4	14.3	7.6	14.2	8.7	3.6	13.2	8.4	4.3	6.5	12.7	3.5	8.4	9.6	9.6	5.0	20.2	12.5	17.7	20.4	9.5	13.0	10.4	12.7	13.4	12.9	14.1	22.3	14.1	32.2	10.2	18.1	9.4	9.2	23.0	23.7	22.6	20.2	11.6	26.0	15.9	22.2	11.4	22.1	16.8	12.2	10.6	22.6	29.1	11.7	20.6	35.2	26.8	27.7	14.7	20.9	38.3	15.2	13.6	15.2	14.7	22.8	12.2	19.3	12.8	17.9	18.1	14.1	20.5	8.4	9.2	16.1	11.3	11.9	15.0	11.9	11.9	15.0	16.0	22.2	30.4	30.3	13.5	18.2	15.2	3.5	7.8	3.0	6.1	8.4	5.8	6.5	6.6	9.1	11.2	4.4	6.4	7.2	1.0	9.6	7.1	12.7	9.6	5.0	23.2	27.8	22.2	57.6	17.9	15.5	11.5	32.7	7.7	7.6	6.0	1.9	14.1	5.9	7.0	44.7	14.0	12.7	4.0	18.2	7.0	19.6	6.4	16.6	7.5	37.1	12.0	3.8	23.3	6.5	8.3	7.5	7.5	17.4	10.2	10.6	25.4	22.0	13.5	20.0	33.7	12.7	14.2	6.8	10.8	9.7	8.7	7.2	3.5	10.6	9.0	38.8	0.0	8.6	22.3	25.1	8.4	2.6	13.8	10.3	5.2
R3HDM4	"C19orf22, MGC16353"	ENSG00000198858	"R3H domain containing 4"	Q96D70	19	896503-913245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 93.1"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 93.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043025, HPA048638"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043025: AB_2678275, HPA048638: AB_2680472"	"unprognostic (9.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (7.33e-6)"	"unprognostic (4.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.74e-2)"	15.4	11.7	23.3	33.2	19.5	57.7	15.4	12.7	26.6	15.9	16.5	16.3	10.0	17.1	15.3	13.2	33.0	15.7	20.1	12.5	20.2	11.9	18.8	24.1	22.7	43.3	14.8	11.9	19.2	34.9	10.0	16.2	18.5	12.8	17.7	12.6	15.5	24.2	14.5	21.6	22.4	18.0	13.4	10.3	41.1	24.1	8.1	12.5	31.9	14.6	19.6	43.0	20.6	19.0	6.4	2.2	93.1	2.0	1.2	7.7	3.8	17.8	10.5	11.2	15.2	7.1	12.7	18.5	12.2	9.7	12.3	10.9	11.1	15.4	13.0	10.1	13.7	2.6	16.4	6.5	14.4	5.6	19.8	13.7	17.8	9.2	19.4	21.5	9.7	31.6	16.8	27.9	7.9	16.8	11.3	14.1	15.5	32.9	26.5	11.4	32.0	13.9	18.7	14.5	21.8	17.3	13.7	5.4	24.6	20.3	18.8	19.8	19.2	10.7	23.7	19.9	9.0	20.9	23.6	14.2	22.5	12.5	26.1	12.0	29.5	15.4	18.9	14.3	14.1	19.5	14.6	2.0	16.2	2.5	1.5	3.9	6.4	5.0	3.4	2.2	3.8	4.8	3.3	93.1	1.2	2.0	0.9	7.7	3.8	23.3	19.5	12.7	26.6	20.2	11.9	14.8	11.9	12.8	12.5	17.9	28.7	41.0	33.3	31.1	15.9	6.0	20.4	12.0	13.6	17.4	7.9	34.5	6.6	39.6	0.9	18.0	18.6	23.3	47.7	40.0	23.1	40.7	23.1	10.5	23.7	27.0	31.4	12.9	21.9	1.7	10.3	25.3	23.6	54.1	28.0	6.0	48.9	26.9	11.0	13.6	10.4	25.8	23.1	0.7	3.9	27.7	57.7	29.8	20.7	65.5
RAB11B	H-YPT3	ENSG00000185236	"RAB11B, member RAS oncogene family"	Q15907	19	8389981-8404434	"Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054396			Approved	"Vesicles,Centriolar satellite"		NA	NA			"Vesicles, Centriolar satellite"		"HPA054396: AB_2682474"	"unprognostic (5.81e-3)"	"prognostic favorable (2.08e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.58e-5)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.29e-3)"	41.1	38.7	38.1	34.3	51.9	36.5	32.5	43.7	89.0	27.9	29.3	70.8	27.6	46.1	31.0	26.8	38.8	31.0	31.7	56.7	39.6	37.5	40.6	35.9	32.3	32.3	43.6	34.4	35.1	60.5	27.6	35.3	37.9	62.2	32.9	15.0	40.1	57.8	32.7	47.8	40.7	46.4	26.4	48.4	42.9	45.8	25.9	38.5	30.8	71.1	22.1	28.0	33.2	27.1	20.8	28.2	45.6	24.5	24.9	23.8	16.6	22.1	29.3	21.1	19.4	10.8	10.7	15.6	13.2	9.1	10.0	10.5	19.2	18.7	13.0	37.4	11.1	13.2	17.4	7.1	18.9	3.2	25.8	34.2	13.8	24.5	23.7	10.4	16.1	25.9	14.9	12.5	10.8	7.2	12.8	12.4	17.8	14.5	34.9	10.2	21.2	27.2	76.7	29.6	10.6	26.6	18.1	14.0	21.8	10.3	32.8	22.8	29.3	16.3	13.6	16.9	8.8	17.2	18.2	23.8	37.7	21.7	28.9	20.9	36.1	23.9	15.3	28.1	18.1	25.2	19.9	20.8	45.6	22.6	21.1	15.7	19.1	20.6	23.8	21.8	20.8	20.0	18.6	32.1	24.9	24.5	28.2	19.8	16.6	38.1	51.9	43.7	89.0	39.6	37.5	43.6	34.4	62.2	38.5	17.9	21.7	62.4	69.6	55.2	59.7	15.3	53.5	34.8	12.5	90.7	13.7	131.9	107.8	81.0	25.9	59.8	123.3	70.0	83.2	137.8	70.8	71.6	29.9	54.2	94.9	63.5	110.0	67.5	62.1	27.6	80.0	52.9	67.4	93.8	87.3	89.1	70.0	108.7	71.8	86.1	25.3	90.5	75.4	59.7	27.9	60.6	175.5	66.0	81.3	83.6
RAB11FIP2	"KIAA0941, nRip11, Rab11-FIP2"	ENSG00000107560	"RAB11 family interacting protein 2"	Q7L804	10	118004916-118046603	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037726	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA037726: AB_10672390"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.17e-1)"	8.8	7.1	11.8	6.4	21.6	12.0	7.2	13.3	19.9	11.4	9.7	7.9	19.0	3.8	23.0	29.8	6.8	12.9	8.6	7.2	10.5	7.1	12.8	5.6	7.7	8.5	8.0	12.9	10.7	7.0	8.6	6.6	8.3	11.5	12.7	5.3	6.9	6.2	27.2	6.5	6.3	6.7	20.0	7.5	7.7	15.5	8.6	8.8	10.0	11.8	3.8	5.6	10.5	13.7	2.3	2.6	1.9	1.2	0.9	2.3	0.4	5.2	6.8	5.7	7.2	9.5	12.2	6.1	10.6	12.3	6.5	6.8	5.5	5.7	10.9	8.5	10.7	4.8	3.7	7.9	4.6	10.1	2.8	8.3	3.9	7.0	3.8	13.8	7.2	4.3	11.9	8.9	9.2	20.3	8.7	4.0	7.1	2.8	9.4	8.4	1.9	5.4	5.4	4.8	2.4	4.8	4.8	20.2	3.6	9.7	4.2	1.3	10.6	7.4	3.0	12.9	7.2	2.3	6.8	5.8	8.8	7.1	10.3	10.4	6.8	5.7	7.1	9.0	12.4	5.4	1.5	1.2	1.4	1.5	0.8	1.4	2.2	1.2	1.5	0.6	2.3	2.3	1.3	1.9	0.9	0.7	2.6	0.6	0.4	11.8	21.6	13.3	19.9	10.5	7.1	8.0	12.9	11.5	8.8	53.6	29.8	9.1	7.7	9.2	29.2	23.6	22.9	6.7	6.8	40.1	27.5	9.0	6.6	10.6	13.5	12.8	4.1	0.0	16.2	7.0	22.4	9.2	3.5	7.7	9.7	36.5	13.9	11.6	25.1	5.0	31.1	14.4	21.9	10.0	6.4	24.9	16.4	5.9	26.9	15.6	29.1	25.8	19.8	10.9	20.9	8.3	4.3	8.6	5.8	5.4
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425619-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.5"	"Cell type enriched"	"Detected in many"	14	"Proximal tubular cells: 333.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No			"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	10.2	13.4	19.3	7.5	16.9	8.7	7.3	29.7	27.4	11.5	10.6	12.2	9.0	13.4	11.9	11.0	8.2	9.5	11.3	14.0	18.7	12.1	70.5	12.2	10.5	8.1	12.0	18.0	13.4	22.2	22.4	14.6	10.0	10.6	11.5	5.4	9.9	13.2	12.6	23.5	12.2	14.6	10.8	8.9	10.2	7.6	13.5	11.9	5.7	8.6	7.4	5.3	9.7	16.6	1.1	0.8	0.1	0.1	0.1	1.5	0.6	4.4	10.2	9.8	8.6	14.5	9.5	8.5	8.5	8.0	7.8	5.6	7.5	2.1	12.3	10.0	12.4	6.9	4.6	6.1	9.0	2.7	9.1	8.7	5.5	9.5	21.7	15.5	5.5	6.9	9.1	6.2	8.0	7.0	9.1	11.9	8.5	2.8	4.9	9.8	13.7	8.9	10.9	8.2	3.2	4.2	18.5	7.8	3.2	7.8	2.7	10.2	9.5	8.7	10.7	5.4	3.5	5.9	10.2	19.2	11.4	7.6	10.6	5.6	6.8	5.3	14.5	4.3	3.9	8.4	0.0	0.1	0.0	1.5	0.0	1.3	0.8	0.9	0.7	0.5	1.1	0.6	0.3	0.1	0.1	0.0	0.8	0.0	0.6	19.3	16.9	29.7	27.4	18.7	12.1	12.0	18.0	10.6	11.9	3.0	1.7	3.4	0.4	3.3	8.2	11.7	7.6	4.0	6.8	5.2	5.9	0.8	23.2	1.4	1.0	2.5	6.4	0.0	1.0	0.1	2.3	1.1	1.1	14.1	0.7	20.6	2.9	19.6	5.1	1.6	0.6	1.2	0.0	0.0	2.7	6.1	1.6	1.7	1.8	333.9	7.1	6.5	2.1	2.7	3.0	1.9	0.7	2.6	4.1	0.3
RAB12		ENSG00000206418	"RAB12, member RAS oncogene family"	Q6IQ22	18	8609445-8639381	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040727	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA040727: AB_10794858"	"unprognostic (7.92e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.11e-2)"	20.0	16.0	18.0	10.2	18.3	7.2	15.6	23.5	22.1	17.2	16.8	13.8	9.2	7.3	18.5	12.3	17.3	13.4	11.2	45.6	16.2	16.2	18.4	20.7	15.8	12.5	13.7	17.8	19.0	7.5	10.4	12.7	17.6	15.3	15.3	10.5	13.7	10.1	18.6	96.4	18.1	10.3	25.4	12.2	16.3	10.8	8.3	10.6	7.7	12.1	21.2	11.9	19.4	20.2	3.2	4.1	7.7	5.1	3.9	3.1	1.3	11.6	6.9	8.1	8.5	24.2	20.6	4.5	15.9	21.9	18.2	21.4	9.4	10.8	4.0	15.5	19.0	13.6	7.4	9.4	17.0	22.1	1.6	7.6	3.4	7.4	9.8	22.5	4.5	3.6	20.3	24.1	13.3	17.1	18.8	21.9	3.6	5.2	5.8	17.6	12.6	5.1	4.5	5.2	40.4	6.6	3.6	19.7	3.8	17.7	15.7	13.5	9.6	12.1	16.5	19.9	12.0	4.8	6.9	18.3	21.1	12.3	21.0	24.1	3.9	2.2	3.4	15.8	4.2	13.4	7.7	2.2	2.4	2.1	3.6	3.0	3.2	2.3	2.5	1.8	3.0	3.1	3.0	4.1	3.9	5.1	4.1	2.5	1.3	18.0	18.3	23.5	22.1	16.2	16.2	13.7	17.8	15.3	10.6	11.9	17.1	3.4	1.7	5.8	14.8	87.9	2.5	10.7	13.6	3.5	5.9	1.4	3.3	2.0	0.0	7.4	1.6	0.0	1.2	1.1	5.0	3.2	5.8	15.3	1.5	11.1	5.2	19.6	13.9	0.0	3.1	6.9	3.3	2.8	2.8	14.3	2.5	0.0	4.2	4.9	6.7	0.0	5.2	1.0	1.5	7.3	0.9	2.5	2.3	3.5
RAB15		ENSG00000139998	"RAB15, member RAS oncogene family"	P59190	14	64945814-64973226	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.4"	"Cell type enhanced"	"Detected in many"	6	"Mucus-secreting cells: 31.6"	"Cancer enhanced"	"Detected in all"		"testis cancer: 83.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 5.2"	"Cell line enhanced"	"Detected in many"		"HAP1: 38.0;RH-30: 45.4;RT4: 33.2;SK-BR-3: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041177	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			"Vesicles, Centriolar satellite"		"HPA041177: AB_10794547"	"unprognostic (9.80e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.82e-2)"	2.3	4.0	16.7	4.2	19.2	0.6	6.3	40.4	32.9	5.7	9.9	2.2	3.2	9.1	2.4	4.5	1.8	1.9	4.7	14.1	21.2	10.8	7.5	11.4	4.3	2.6	7.8	12.6	1.4	5.6	16.2	4.0	11.9	10.2	4.3	15.4	1.9	27.2	3.8	3.9	2.8	9.6	8.6	4.2	1.2	5.3	1.0	2.5	2.4	2.9	0.6	2.2	13.4	1.8	0.0	5.2	0.0	0.1	0.8	0.7	0.1	3.0	16.5	6.1	6.0	1.4	1.9	17.1	1.9	2.7	4.0	3.6	7.7	8.4	0.1	1.1	4.8	1.9	3.2	38.0	0.3	2.9	1.0	1.8	3.5	0.3	6.7	0.2	0.1	2.2	1.3	0.7	1.7	0.3	1.0	12.6	8.6	0.1	0.5	7.1	17.6	4.2	3.2	13.6	18.9	2.4	5.2	45.4	0.2	4.7	33.2	19.6	3.8	1.0	34.8	4.4	7.4	9.8	3.3	3.1	3.5	15.0	1.6	2.4	0.1	0.1	1.6	0.7	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.1	5.2	0.3	0.1	16.7	19.2	40.4	32.9	21.2	10.8	7.8	12.6	10.2	2.5	6.0	3.8	0.0	3.0	2.3	0.4	20.1	2.5	1.4	5.7	15.7	0.0	20.0	3.3	7.2	0.4	2.1	3.5	0.0	10.4	13.7	2.1	5.0	1.1	8.7	2.4	11.1	1.2	4.9	0.0	0.4	0.3	0.9	0.0	1.8	31.6	2.0	12.0	3.5	1.4	3.7	2.7	0.0	3.3	0.5	0.3	1.0	15.0	0.5	12.0	9.1
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;stomach 1: 36.6"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 200.3;granulocytes: 234.0;Late spermatids: 149.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.6;NK-cell: 5.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.0;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"HEL: 20.9;hTCEpi: 16.0;hTERT-HME1: 19.4;U-87 MG: 56.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		37000000	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	1.1	2.4	13.8	2.3	11.3	1.0	10.8	0.8	30.0	4.5	4.4	0.3	0.0	4.5	1.1	0.7	17.0	1.3	9.8	0.9	12.0	7.9	0.8	1.4	6.2	0.7	4.6	18.4	0.7	5.3	1.3	3.6	2.4	8.6	18.0	4.8	0.0	12.8	3.3	0.6	13.2	4.3	1.1	2.1	1.8	36.6	4.8	0.4	0.1	0.7	13.9	5.9	6.8	7.1	0.0	0.0	1.1	0.0	5.0	4.6	3.4	2.5	7.4	0.2	0.0	0.5	6.8	0.0	0.5	4.5	0.6	0.4	0.0	2.9	0.4	0.0	1.3	5.8	4.9	0.0	3.0	0.1	0.0	0.2	20.9	1.8	0.0	0.9	1.1	2.3	5.4	16.0	8.8	19.4	7.3	0.2	0.1	0.0	1.3	5.5	2.5	0.0	2.4	0.1	4.6	5.0	0.0	0.0	0.1	1.4	9.6	0.0	3.6	0.7	4.5	0.0	0.0	2.8	0.1	0.1	6.5	0.2	3.3	0.6	0.1	0.0	0.0	56.8	11.9	0.3	1.1	0.0	0.2	4.6	0.0	1.1	0.0	1.5	2.3	0.0	0.0	0.6	2.3	0.5	5.0	0.0	0.0	0.0	3.4	13.8	11.3	0.8	30.0	12.0	7.9	4.6	18.4	8.6	0.4	44.7	32.8	0.0	6.7	22.8	1.7	0.4	15.3	6.7	21.6	5.2	2.0	5.4	1.7	5.2	200.3	0.7	3.1	0.0	35.6	4.0	2.5	73.1	234.0	0.8	0.6	6.4	4.1	3.1	0.8	149.0	2.0	2.4	6.8	1.8	17.2	1.3	24.0	17.5	0.4	0.0	0.4	6.5	1.3	2.2	1.2	43.0	2.4	20.1	8.1	27.8
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543693-146554965	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 26.5"	"Group enriched"	"Detected in many"	40	"dendritic cells: 16.0;granulocytes: 26.5;monocytes: 17.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA025731	Approved		Approved	Cytosol		NA	NA		330000	Cytosol		"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favorable (1.56e-4)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	18.4	9.0	5.2	11.0	4.9	57.8	29.9	1.1	4.4	8.4	14.6	6.6	6.3	6.7	14.8	12.8	10.2	10.2	11.2	15.3	5.2	3.0	10.7	23.0	16.5	26.4	6.2	3.5	11.0	7.4	1.5	2.8	5.9	7.4	12.5	14.9	11.3	10.1	6.9	6.3	10.2	9.0	28.2	7.5	29.4	10.6	20.8	5.5	10.4	5.8	7.0	5.6	15.6	15.2	0.0	16.0	26.5	17.3	0.5	0.0	4.9	12.0	6.4	7.5	12.5	11.4	19.4	0.0	23.5	26.1	32.2	53.6	3.9	6.0	0.0	8.6	24.7	35.8	16.0	0.4	15.1	43.5	0.0	5.8	15.3	16.1	14.1	49.6	21.1	22.7	17.1	25.4	18.4	26.2	16.9	20.8	0.0	2.9	0.0	17.5	2.8	9.6	11.5	0.9	0.0	12.4	0.0	8.0	0.1	12.6	8.4	0.0	9.9	27.5	3.3	40.5	6.9	6.4	17.2	16.6	9.8	13.4	25.7	28.5	0.0	1.7	0.0	22.5	15.9	13.2	26.5	17.3	2.9	0.0	7.7	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	6.3	0.5	5.3	0.8	0.0	4.9	5.2	4.9	1.1	4.4	5.2	3.0	6.2	3.5	7.4	5.5	44.7	6.5	5.3	93.5	47.6	1.4	1.4	48.4	2.7	9.1	10.4	3.9	1.7	21.6	146.0	64.9	29.2	39.3	0.0	90.9	5.3	38.7	32.5	57.6	67.1	193.4	0.0	57.7	31.9	182.0	123.7	22.7	98.6	160.3	72.1	30.8	9.1	140.5	43.2	24.1	61.7	1.3	19.4	20.6	31.1	12.3	16.7	2.6	5.7	62.4	55.7
RAB36		ENSG00000100228	"RAB36, member RAS oncogene family"	O95755	22	23145326-23164350	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 38.2"	"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 53.5;Late spermatids: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 12.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 12.7"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 17.8;U-266/84: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059631			Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA059631: "	"unprognostic (2.74e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.02e-3)"	"unprognostic (5.56e-3)"	"prognostic favorable (4.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-1)"	2.4	5.9	7.6	2.0	11.9	1.3	3.5	2.7	14.1	6.5	2.8	6.8	9.3	1.4	5.4	12.7	3.0	38.2	6.6	1.9	7.7	8.4	8.2	0.8	6.1	1.7	4.5	9.3	8.1	4.3	1.9	16.6	7.0	5.8	5.1	1.8	4.8	4.6	11.2	1.2	1.9	1.5	4.9	2.6	1.9	2.7	12.8	3.1	0.0	20.7	1.2	1.9	3.6	2.1	1.0	0.3	12.7	0.6	1.7	0.7	0.3	5.6	6.6	5.1	7.7	1.2	2.5	2.1	3.2	6.5	7.1	2.7	0.4	0.0	0.0	3.5	4.2	4.0	7.1	0.2	3.7	2.3	0.0	3.0	0.0	0.2	0.6	3.0	0.0	0.9	3.2	1.4	6.6	1.3	4.7	1.0	0.0	0.3	5.8	0.3	4.5	0.0	0.1	0.6	3.7	1.8	0.0	0.0	17.8	9.2	1.0	12.6	5.5	0.3	2.8	1.6	0.4	0.0	0.6	0.5	0.9	2.2	2.5	4.6	12.6	17.5	0.0	6.5	0.0	4.2	0.3	0.6	0.0	0.7	0.3	0.4	1.0	0.1	0.2	0.3	0.3	0.5	0.4	12.7	1.7	0.3	0.0	0.1	0.3	7.6	11.9	2.7	14.1	7.7	8.4	4.5	9.3	5.8	3.1	0.0	2.7	0.8	0.6	0.5	0.6	0.8	5.1	53.5	9.1	1.8	5.9	5.3	5.0	2.8	10.0	0.1	0.0	0.0	0.2	0.3	1.0	0.4	1.1	0.0	0.3	1.6	6.4	0.6	1.2	16.9	3.1	0.0	1.7	0.0	0.5	3.2	0.1	0.0	2.8	7.8	0.5	0.0	0.8	1.9	1.6	0.1	2.4	0.0	0.0	0.3
RAB3A		ENSG00000105649	"RAB3A, member RAS oncogene family"	P20336	19	18196784-18204074	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 114.7"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 94.1;Distal tubular cells: 33.2;Horizontal cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 13.8;SCLC-21H: 25.3;SH-SY5Y: 12.1;U-2197: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, CAB009949, CAB078998"	Enhanced	Supported	Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731"	"unprognostic (1.82e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (6.14e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.14e-2)"	2.3	13.0	32.3	2.6	50.5	2.0	2.0	39.1	114.7	2.8	3.1	6.3	0.0	3.6	2.7	2.6	2.4	3.2	2.8	17.0	40.8	32.7	4.1	2.2	2.5	2.4	31.5	35.6	8.0	2.3	5.0	7.5	2.4	38.2	3.8	2.8	5.8	4.2	4.4	7.5	2.5	3.0	2.9	7.0	2.5	2.5	2.2	4.8	0.0	2.9	0.1	2.1	2.9	0.7	4.6	6.0	5.1	3.0	0.7	4.2	2.6	0.9	1.0	2.4	3.2	3.8	1.0	1.4	2.1	1.2	1.4	1.9	0.9	0.6	3.4	2.3	1.7	1.3	2.7	11.0	1.3	0.7	0.7	3.5	1.3	4.0	3.8	1.0	2.3	4.2	3.2	1.3	0.8	0.4	2.8	0.4	4.2	0.7	1.2	1.3	3.2	5.1	0.6	1.9	2.8	13.8	3.6	0.2	2.8	1.5	0.5	25.3	12.1	1.0	4.4	2.4	1.0	0.9	0.4	0.4	1.3	0.9	17.5	1.2	2.1	4.6	0.8	3.3	1.7	1.1	0.0	3.0	3.8	3.0	2.2	4.0	4.6	3.2	3.0	6.0	2.2	4.1	4.2	5.1	0.7	2.7	5.5	1.8	2.6	32.3	50.5	39.1	95.0	40.8	32.7	31.5	35.6	38.2	4.8	0.0	0.0	0.9	2.1	2.9	94.1	1.1	2.5	0.0	0.0	15.7	7.9	1.4	33.2	2.1	2.4	1.4	1.4	0.0	0.8	3.6	3.9	1.4	0.0	1.5	4.3	87.4	9.2	3.1	1.6	0.0	4.0	4.3	10.1	2.8	2.3	11.3	0.8	2.0	5.3	6.3	28.8	0.0	8.6	0.3	2.8	4.3	1.5	2.2	3.7	1.4
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990764	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;placenta: 37.6;prostate: 20.0"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 137.0;Alveolar cells type 2: 101.3;Intestinal endocrine cells: 282.2"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 44.6;BJ hTERT+: 17.3;fHDF/TERT166: 16.1;HBF TERT88: 15.3;TIME: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.4	5.8	16.6	1.4	8.5	0.8	1.8	2.0	13.8	0.4	3.1	0.9	0.0	1.6	0.5	0.8	0.5	0.7	2.7	0.4	9.9	15.8	1.4	1.3	0.5	0.5	4.5	9.3	3.2	2.1	0.4	13.7	37.6	18.2	20.0	4.4	0.1	0.8	0.6	1.0	3.7	1.9	0.9	1.4	0.5	2.7	0.8	1.3	0.0	0.5	0.0	0.6	0.6	0.4	1.1	0.8	2.1	0.5	0.5	0.4	0.0	0.6	3.0	0.4	0.5	0.1	0.8	0.0	44.6	17.3	9.0	4.4	3.6	1.3	0.2	0.7	16.1	1.3	0.0	5.5	4.6	15.3	0.0	0.4	0.0	0.2	1.2	0.7	0.0	0.0	0.4	0.1	14.9	3.4	5.6	2.8	0.4	0.1	0.1	9.9	0.1	0.0	0.0	7.2	0.8	0.4	0.1	0.0	0.0	1.4	0.2	1.5	0.4	0.0	0.1	0.0	9.3	0.0	0.1	34.6	8.8	3.2	0.1	14.5	0.0	0.2	0.1	8.0	0.0	0.3	1.1	0.5	0.3	0.4	0.3	0.3	0.6	0.3	0.4	0.1	1.1	0.4	0.4	2.1	0.5	0.5	0.8	0.2	0.0	16.6	8.5	2.0	13.8	9.9	15.8	4.5	9.3	18.2	1.3	137.0	101.3	0.9	5.2	2.2	2.4	0.6	15.3	52.2	51.2	0.0	2.0	0.6	3.3	4.0	1.9	0.5	1.3	0.0	15.3	0.2	0.9	19.1	7.0	0.4	0.3	0.0	282.2	0.0	2.6	1.0	0.6	0.9	1.7	1.0	6.1	24.2	59.3	0.3	1.1	0.0	3.5	0.0	0.4	1.9	4.8	1.3	3.3	0.7	1.5	2.6
RAB3C		ENSG00000152932	"RAB3C, member RAS oncogene family"	Q96E17	5	58582221-58859394	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 13.6;brain: 47.4;pituitary gland: 14.1"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 35.2;Early spermatids: 17.4;Intestinal endocrine cells: 55.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEL: 3.5;NB-4: 2.2;SCLC-21H: 14.6;SH-SY5Y: 5.3"	"Low region specificity"	"Detected in all"							"HPA003160, HPA048156"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA003160: AB_1079731, HPA048156: AB_2680291"	"unprognostic (1.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.52e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.70e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.61e-3)"	2.5	13.6	19.8	2.5	36.1	1.1	1.3	7.7	47.4	1.3	1.8	2.1	0.0	3.1	2.1	1.0	1.3	1.3	1.9	1.1	22.9	23.6	1.2	1.2	1.2	1.3	14.5	23.6	1.2	3.3	1.4	14.1	1.2	25.6	1.1	2.1	0.0	1.1	1.1	1.1	1.1	3.3	2.0	3.2	1.0	2.3	1.3	4.1	0.0	1.1	0.0	1.4	1.7	0.4	0.3	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.8	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.6	5.3	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.8	36.1	7.7	32.4	22.9	23.6	14.5	23.6	25.6	4.1	0.0	1.1	0.0	0.0	0.1	35.2	0.6	0.0	0.0	0.0	0.0	3.9	0.0	3.3	0.1	17.4	3.3	0.0	0.0	8.4	0.7	0.2	0.0	2.3	0.4	0.1	3.2	55.3	6.7	0.0	7.7	0.9	0.0	1.7	0.0	0.3	1.5	6.4	0.0	0.7	0.0	6.8	12.9	0.0	2.5	1.7	0.1	0.0	0.0	0.0	0.0
RAB3D	"D2-2, GOV, RAB16, RAD3D"	ENSG00000105514	"RAB3D, member RAS oncogene family"	O95716	19	11322046-11346270	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 49.1;Suprabasal keratinocytes: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 44.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.6;Karpas-707: 20.7;MCF7: 23.8;SK-BR-3: 31.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB018067, HPA063283"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB018067: AB_606903, HPA063283: AB_2684976"	"unprognostic (4.71e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.99e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (4.17e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.34e-1)"	6.3	3.8	6.4	4.6	8.2	13.2	10.8	7.1	11.9	13.5	7.7	5.0	12.0	7.2	7.9	7.7	30.2	8.0	10.3	9.0	8.1	6.4	10.6	21.6	7.9	8.3	5.3	6.7	7.4	54.7	5.1	5.4	6.4	6.1	15.0	7.8	9.9	22.8	11.0	5.2	42.4	5.7	7.9	4.3	9.2	16.6	5.6	4.1	5.4	14.4	12.0	9.4	8.1	13.3	0.6	9.3	44.6	22.5	0.4	1.5	5.9	0.6	6.3	2.0	8.0	3.3	5.7	0.4	0.5	1.7	1.1	1.2	2.2	0.2	0.2	7.3	3.8	2.1	8.6	3.4	5.3	1.0	3.4	0.5	2.5	2.8	2.5	2.0	1.3	6.1	2.4	21.6	0.9	2.3	3.0	9.2	1.9	0.9	20.7	0.3	23.8	0.9	3.0	1.7	12.6	6.5	0.9	0.0	7.0	10.0	6.3	2.2	4.3	1.9	31.1	4.0	2.9	18.5	15.4	3.5	1.1	0.3	5.2	0.1	7.1	9.0	1.4	3.8	8.3	1.2	26.0	22.5	23.9	0.9	13.5	1.5	0.6	0.9	0.7	9.3	0.6	0.6	0.7	44.6	0.4	9.9	0.2	1.5	5.9	6.4	8.2	7.1	11.9	8.1	6.4	5.3	6.7	6.1	4.1	6.0	18.8	0.8	4.8	14.0	0.6	2.0	7.6	0.0	10.3	14.0	0.0	6.0	10.0	4.4	0.4	7.0	2.1	0.0	21.7	5.0	6.8	10.4	12.7	1.1	8.3	0.0	17.9	13.5	49.1	0.0	4.0	6.3	8.5	0.0	27.4	3.3	14.1	3.5	4.6	1.0	0.4	6.5	7.2	0.0	2.7	33.1	8.7	6.9	15.7	3.3
RAB3GAP1	"KIAA0066, RAB3GAP, RAB3GAP130, WARBM1"	ENSG00000115839	"RAB3 GTPase activating protein catalytic subunit 1"	Q15042	2	135052265-135176394	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034494, HPA034495"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034494: AB_2674188, HPA034495: AB_10670158"	"unprognostic (1.02e-2)"	"unprognostic (2.43e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.15e-1)"	24.1	18.4	22.1	20.8	32.9	27.3	21.8	27.1	37.2	25.1	24.0	21.2	20.0	15.7	42.2	27.0	26.1	20.1	18.3	28.4	21.4	29.1	20.1	16.9	18.6	19.7	24.5	28.1	31.3	29.4	31.7	50.0	33.0	34.5	26.0	24.0	23.2	37.3	25.4	37.4	25.1	19.4	26.4	26.0	17.5	22.7	19.6	21.3	28.8	26.2	20.9	24.6	25.2	24.8	9.1	5.4	9.3	7.1	3.6	10.7	2.4	19.6	8.0	14.2	11.6	27.9	23.8	13.1	30.3	25.0	24.1	23.9	17.7	16.2	29.3	18.8	30.9	9.2	16.7	14.9	27.9	29.5	13.9	15.1	14.5	10.2	15.4	19.5	17.9	15.9	20.7	37.0	22.1	40.2	21.8	17.4	13.4	18.8	17.1	21.9	11.6	9.1	7.0	10.8	11.9	13.5	15.8	18.2	12.2	14.2	17.6	11.4	9.0	20.5	12.3	14.3	12.9	10.8	13.1	20.9	24.5	18.7	10.5	12.6	12.2	6.8	22.1	16.0	10.9	13.6	9.3	5.0	7.6	2.0	6.7	1.8	7.0	5.0	2.8	5.4	9.1	10.7	5.3	2.0	3.6	7.1	2.9	6.5	2.4	22.1	32.9	27.1	37.2	21.4	29.1	24.5	28.1	34.5	21.3	23.8	26.1	28.6	33.7	26.9	27.2	50.9	43.3	33.5	35.2	29.6	47.1	19.8	10.0	18.0	25.6	25.5	29.6	23.3	23.1	14.0	23.7	41.6	45.1	21.5	19.7	28.6	33.3	27.0	20.9	19.3	28.4	29.1	21.9	17.2	33.0	18.1	30.5	20.1	33.6	17.0	32.0	45.3	27.8	34.5	21.1	26.0	32.7	11.4	20.3	42.6
RAB3GAP2	"DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69"	ENSG00000118873	"RAB3 GTPase activating non-catalytic protein subunit 2"	Q9H2M9	1	220148293-220272454	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cataract, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026273, HPA027299"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA026273: AB_1856007, HPA027299: AB_1856008"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.76e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	16.7	16.2	14.9	19.6	18.7	14.3	17.8	24.2	22.4	15.6	13.5	14.3	13.9	12.2	16.8	14.9	15.6	12.8	12.8	15.3	16.5	18.8	18.9	15.6	14.3	18.2	17.1	15.6	16.2	14.5	35.6	28.3	19.8	21.9	14.2	13.5	11.6	15.6	15.8	19.9	13.1	15.0	14.9	15.2	14.9	14.5	10.1	15.5	26.1	20.5	11.9	21.7	16.0	15.8	7.1	5.2	12.3	5.1	3.6	8.9	4.6	13.9	10.6	12.9	9.7	14.8	17.7	14.6	14.4	13.7	13.0	15.4	9.7	11.6	17.3	10.2	13.8	9.8	13.3	13.3	11.0	15.1	14.5	8.7	13.5	14.1	9.1	19.6	19.3	13.9	14.0	12.6	12.6	19.7	14.6	11.8	7.6	23.3	11.3	14.6	3.9	14.8	6.8	27.7	7.5	6.3	8.1	17.8	15.4	11.1	11.5	12.9	15.6	14.9	14.5	23.3	14.5	15.2	18.4	17.1	14.3	6.7	9.8	15.3	10.0	12.1	15.3	12.2	16.3	16.7	12.3	3.9	7.5	7.1	4.9	8.6	7.1	7.0	8.9	5.2	5.5	6.3	7.4	2.5	3.6	5.1	3.3	8.0	4.6	14.9	18.7	24.2	22.4	16.5	18.8	17.1	15.6	21.9	15.5	38.7	21.6	17.1	12.0	10.3	54.4	31.3	22.9	12.0	23.9	24.4	64.8	15.7	5.0	16.3	2.6	17.6	16.9	0.0	14.3	11.2	17.7	17.2	18.5	20.3	21.2	39.7	34.0	25.8	29.8	1.6	16.7	20.6	13.5	16.2	20.3	46.1	17.6	14.0	24.4	14.5	51.3	6.5	14.4	15.6	11.8	8.5	19.3	19.3	18.8	11.3
RAB3IL1	GRAB	ENSG00000167994	"RAB3A interacting protein like 1"	Q8TBN0	11	61897301-61920269	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 103.3;Erythroid cells: 46.7;Hofbauer cells: 50.1;Late spermatids: 98.4;Leydig cells: 52.0;Peritubular cells: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 18.0;HHSteC: 18.7;K-562: 20.2;RPMI-8226: 20.9;U-2197: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039723	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA039723: AB_10795406"	"unprognostic (1.62e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (1.97e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (7.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.59e-3)"	24.1	7.1	8.2	6.8	8.0	12.9	13.3	4.0	6.5	18.5	7.8	6.8	4.5	4.3	18.0	9.5	7.2	13.3	10.0	11.2	8.2	3.4	10.0	7.4	6.2	5.9	10.1	3.8	28.6	3.2	6.1	5.4	14.0	8.7	11.9	2.6	13.4	6.7	5.1	9.1	8.5	5.0	8.5	7.7	22.7	5.4	22.1	6.9	6.6	8.8	6.5	2.4	13.4	26.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	3.2	6.9	0.2	3.5	13.4	9.9	0.7	2.6	6.7	3.9	2.7	0.9	0.7	0.0	4.9	3.9	18.0	1.7	4.6	0.2	0.7	0.0	1.0	6.5	2.5	3.3	18.7	0.2	0.1	5.6	3.4	2.0	4.4	0.6	0.4	3.4	20.2	0.2	2.2	5.8	0.0	0.0	2.0	0.6	6.9	0.3	0.9	20.9	0.3	0.3	0.2	2.4	1.6	1.4	11.9	1.1	1.0	0.7	0.5	14.5	6.5	27.5	1.1	0.2	0.9	0.0	2.8	7.5	6.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.2	8.0	4.0	6.2	8.2	3.4	10.1	3.8	8.7	6.9	0.0	0.0	0.5	0.9	4.5	0.0	1.7	0.0	0.0	1.2	1.8	0.0	1.2	1.7	1.9	103.3	3.6	0.0	46.7	0.8	1.6	15.6	1.3	0.0	0.9	50.1	1.6	0.0	22.7	12.1	98.4	52.0	2.9	8.5	0.0	0.0	6.0	1.7	0.0	42.5	9.7	7.6	0.0	5.7	0.7	8.3	3.4	1.1	0.0	0.0	0.1
RAB3IP	"FLJ22548, RABIN3, RABIN8"	ENSG00000127328	"RAB3A interacting protein"	Q96QF0	12	69738681-69823204	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Bipolar cells: 217.9;Early spermatids: 250.3;Late spermatids: 317.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 52.8"					"Low region specificity"	"Detected in all"			HPA039794	Uncertain		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA039794: AB_10960557"	"unprognostic (4.38e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.68e-13)"	"unprognostic (6.17e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.37e-1)"	3.4	10.2	15.9	6.2	17.2	13.7	12.3	49.7	17.9	5.2	12.9	14.0	8.2	11.9	3.5	28.5	6.0	9.3	9.6	11.2	15.8	11.3	29.9	10.2	9.1	7.7	15.0	11.2	3.2	15.0	15.9	24.4	7.3	25.9	13.2	14.1	22.4	9.9	12.0	7.7	8.6	13.4	3.1	14.9	5.6	11.1	42.6	12.1	8.7	9.6	2.6	9.1	5.5	7.6	10.2	5.9	7.4	5.7	7.6	12.4	5.0	14.9	8.1	4.7	8.1	2.4	1.1	14.7	1.5	3.4	5.9	8.2	23.7	6.8	11.9	4.9	0.8	7.8	11.5	4.6	8.0	10.4	17.2	8.7	8.4	3.1	11.2	2.3	9.4	5.4	2.5	8.3	5.4	18.8	6.1	8.6	14.7	4.0	10.7	3.4	16.2	9.3	4.4	12.7	15.7	9.0	11.4	7.4	12.4	19.6	18.7	19.0	3.5	5.5	9.6	2.2	21.3	17.1	3.9	2.4	2.5	6.7	1.0	6.6	4.9	19.5	52.8	5.9	6.2	4.0	1.9	5.7	7.3	4.8	2.0	9.5	10.2	8.5	7.7	5.9	9.1	10.8	10.3	7.4	7.6	2.3	5.5	12.4	5.0	15.9	17.2	49.7	15.5	15.8	11.3	15.0	11.2	25.9	12.1	56.6	41.9	9.8	44.6	20.9	217.9	43.6	81.5	42.8	54.6	48.8	104.1	18.8	31.5	58.7	250.3	9.0	33.9	23.3	27.6	7.0	6.9	68.5	2.3	15.6	3.1	27.0	39.2	4.3	1.8	317.8	4.0	6.1	5.0	18.0	32.4	97.7	42.5	31.6	3.5	65.3	93.1	6.5	4.9	48.1	25.3	26.1	7.1	7.9	41.7	65.8
RAB40B	"RAR, SEC4L"	ENSG00000141542	"RAB40B, member RAS oncogene family"	Q12829	17	82654973-82698728	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.3;OE19: 25.4"									HPA076172			Approved	Vesicles		NA	NA			Vesicles		"HPA076172: "	"unprognostic (2.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.34e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (2.95e-6)"	"unprognostic (1.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (9.83e-3)"	6.3	7.5	29.7	2.1	43.4	1.0	6.5	9.3	34.2	6.2	12.5	38.3	1.5	7.3	6.5	15.0	5.0	5.8	5.3	13.4	25.8	13.7	15.9	6.4	5.3	2.1	21.3	17.0	8.6	5.0	5.3	5.9	3.3	19.8	8.7	7.9	2.2	8.0	5.9	29.6	8.5	5.3	4.4	28.7	4.0	16.7	3.0	23.2	0.0	4.3	3.9	2.5	4.6	3.4	3.5	10.0	2.1	4.5	2.8	2.6	1.0	4.5	7.4	2.3	6.8	5.7	7.2	3.3	5.0	1.4	3.2	1.0	2.4	1.2	0.6	10.1	5.0	2.0	8.3	4.3	4.0	2.8	0.3	21.3	1.8	7.6	6.7	2.8	0.5	2.0	6.1	6.6	1.8	1.4	3.1	2.9	4.5	5.2	0.6	4.3	6.0	1.7	3.9	0.4	25.4	9.8	4.2	5.9	3.8	11.1	8.4	12.5	7.9	3.6	3.2	6.8	10.9	6.9	3.7	5.9	9.0	2.7	9.3	4.1	3.6	2.8	6.4	2.1	1.2	1.5	2.1	0.7	0.1	1.6	1.9	2.2	3.5	2.0	2.6	1.2	1.3	2.5	1.3	0.3	2.8	4.5	10.0	2.6	1.0	29.7	43.4	9.3	26.8	25.8	13.7	21.3	17.0	19.8	23.2	8.9	9.1	4.5	25.1	26.7	9.9	28.0	22.9	5.3	4.5	14.0	0.0	2.2	69.6	16.8	27.4	14.3	30.2	0.0	7.8	4.3	23.5	40.6	1.1	17.1	5.4	31.8	20.2	18.4	1.9	20.4	18.7	6.0	45.5	1.8	41.7	7.4	8.8	25.9	17.3	54.3	11.0	25.8	15.6	1.6	11.5	25.5	1.0	7.5	36.0	61.2
RAB40C	"RARL, RASL8C"	ENSG00000197562	"RAB40C, member RAS oncogene family"	Q96S21	16	589357-629272	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 39.9"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA076172			Approved	Vesicles		NA	NA			Vesicles		"HPA076172: "	"unprognostic (8.04e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.00e-3)"	6.8	4.3	9.1	4.8	15.2	5.8	5.3	18.1	29.9	5.2	9.1	5.9	5.3	14.1	6.2	6.5	11.0	7.6	5.1	7.6	9.7	6.5	6.3	5.3	7.7	4.2	6.6	13.2	8.5	39.9	5.7	12.2	7.2	7.5	7.9	5.0	3.3	14.5	7.2	10.5	25.7	14.1	8.0	4.6	4.7	12.6	6.1	6.1	8.7	5.3	4.3	6.0	8.8	7.6	1.3	1.7	14.0	3.0	0.9	2.2	1.2	5.9	12.9	7.6	10.6	4.4	5.5	10.2	8.0	3.8	6.5	5.3	11.5	10.9	6.9	8.7	4.7	5.7	13.6	4.6	6.6	1.3	7.2	7.9	3.8	8.6	8.1	7.8	7.9	7.2	4.6	14.5	5.2	5.4	4.6	5.3	8.2	8.6	7.1	2.8	17.5	7.3	13.9	8.9	10.5	7.7	11.9	5.5	10.8	3.7	8.6	10.4	8.4	8.8	19.4	7.4	3.7	14.2	15.3	6.5	6.9	9.8	9.1	4.7	6.9	6.6	8.4	4.5	10.5	7.1	1.1	3.0	14.0	0.4	1.8	2.2	1.3	1.5	1.7	1.7	0.9	1.1	0.8	5.3	0.9	0.9	0.7	0.6	1.2	9.1	15.2	18.1	29.9	9.7	6.5	6.6	13.2	7.5	6.1	8.9	14.9	0.9	9.0	15.5	10.4	4.1	2.5	4.0	6.8	10.4	7.9	21.2	6.6	5.9	3.3	4.4	25.8	0.0	10.8	12.8	4.7	8.7	6.9	13.2	8.2	15.9	10.4	8.6	6.5	4.1	4.6	3.8	6.8	3.6	16.3	7.5	9.0	19.9	6.0	6.8	2.7	0.0	5.2	14.2	10.0	27.1	47.5	4.4	15.8	7.4
RAB42	MGC45806	ENSG00000188060	"RAB42, member RAS oncogene family"	Q8N4Z0	1	28592200-28595443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Cell type enriched"	"Detected in some"	7	"Hofbauer cells: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.6;Hep G2: 15.5;HSkMC: 11.0;REH: 8.5"									HPA050290			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA050290: AB_2681075"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.00e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.07e-3)"	4.3	1.2	0.8	1.8	1.6	0.4	3.2	0.8	1.6	3.7	2.3	0.8	0.8	1.8	3.1	4.1	1.5	1.4	2.4	1.3	1.6	0.5	1.5	3.2	3.4	14.3	1.2	0.8	1.4	0.8	5.0	0.8	6.2	1.2	3.3	2.5	1.7	4.2	0.8	1.5	0.9	2.3	1.8	5.5	5.9	1.6	3.0	0.8	3.4	1.0	0.8	4.4	4.1	1.8	0.7	0.7	1.2	0.9	2.4	0.5	0.1	0.1	1.2	1.0	0.0	4.6	10.6	0.0	0.7	4.4	4.6	6.1	2.2	1.5	0.2	2.9	5.0	0.4	0.1	4.5	0.0	3.0	0.1	0.1	0.4	7.1	15.5	1.8	1.2	0.0	11.0	0.2	2.8	0.0	0.4	1.4	0.1	0.2	0.1	0.9	0.0	0.2	2.4	5.4	0.1	0.0	8.5	0.0	1.8	1.8	0.0	0.3	2.1	4.2	0.1	0.0	0.7	0.1	2.0	0.7	0.0	1.4	4.6	0.1	0.4	2.8	0.2	0.2	4.5	0.1	1.2	0.9	0.2	0.3	0.4	0.3	0.6	0.2	0.2	0.7	0.7	0.5	0.4	0.9	2.4	0.8	0.4	0.1	0.1	0.8	1.6	0.8	1.6	1.6	0.5	1.2	0.8	1.2	0.8	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	1.2	0.0	0.0	0.5	0.0	6.9	4.0	0.1	0.0	0.0	0.0	0.6	2.3	0.2	0.0	0.0	74.2	0.0	0.0	2.5	2.9	10.0	1.4	4.4	0.0	1.8	0.0	0.9	1.9	0.3	0.0	0.3	0.9	0.0	0.9	1.5	1.9	0.4	0.3	0.0	0.0	0.1
RAB43	"ISY1, RAB11B, RAB41"	ENSG00000172780	"RAB43, member RAS oncogene family"	Q86YS6	3	129087569-129122801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 73.9"	"Cell type enhanced"	"Detected in single"	13	"Club cells: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.3;T-cells: 3.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046840, HPA060085"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA046840: , HPA060085: AB_2684199"	"unprognostic (3.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	5.4	6.2	3.9	8.0	3.3	14.6	5.3	6.0	3.6	6.4	7.0	3.2	7.2	5.8	5.4	6.8	4.1	5.3	12.0	3.8	2.8	2.0	9.1	73.9	11.4	12.1	2.7	1.6	7.8	7.4	2.5	8.0	4.7	3.7	7.3	1.7	7.7	7.4	4.7	1.9	3.0	5.9	4.9	2.7	9.9	5.7	5.2	2.1	17.3	17.1	2.6	13.6	6.6	6.0	1.3	1.1	13.3	1.6	1.5	3.5	1.3	15.6	4.3	1.0	4.1	2.0	0.9	6.2	5.4	3.6	3.1	2.6	6.7	6.7	0.4	12.6	4.0	4.2	6.6	0.4	6.2	0.7	7.9	4.2	1.0	0.7	8.7	19.4	3.6	9.3	5.3	3.8	1.6	0.4	1.3	6.2	9.4	1.7	7.9	4.3	6.6	3.5	6.9	5.0	3.6	7.0	7.5	2.3	4.5	10.1	13.3	0.3	1.9	2.4	5.0	10.0	1.7	2.1	3.8	8.9	6.9	4.9	5.6	2.0	12.4	6.5	2.4	6.2	0.7	7.4	0.5	1.5	2.6	1.9	1.6	0.9	0.6	1.8	1.5	0.7	1.3	3.5	3.0	13.3	1.5	0.7	1.1	2.7	1.3	3.9	3.3	6.0	3.6	2.8	2.0	2.7	1.6	3.7	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0
RAB6A	RAB6	ENSG00000175582	"RAB6A, member RAS oncogene family"	P20340	11	73675638-73761137	"Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009936, HPA059131"	Approved		Approved	"Golgi apparatus"		NA	NA		7200000	"Golgi apparatus"		"CAB009936: AB_2175466, HPA059131: AB_2683916"	"unprognostic (2.84e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (1.79e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (8.67e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.36e-1)"	25.7	27.3	50.7	18.5	52.6	12.1	21.7	46.1	64.7	25.8	24.1	30.7	16.1	26.5	25.5	20.4	37.4	20.7	21.1	35.7	50.2	50.5	29.0	36.5	25.0	15.1	46.0	30.7	25.3	18.0	27.3	16.0	33.2	76.4	24.7	26.6	19.1	19.2	25.7	35.0	20.8	31.6	29.6	40.8	19.9	20.1	12.7	27.4	15.0	37.4	16.7	21.4	29.0	23.8	17.6	19.8	62.0	27.1	23.9	28.5	29.5	20.7	16.0	26.3	17.0	34.8	39.5	35.8	32.4	31.0	28.1	25.5	31.0	36.7	17.7	35.5	42.0	23.7	23.6	16.6	33.1	35.5	20.3	6.5	28.9	17.8	26.1	29.7	18.7	28.9	29.1	62.4	28.1	41.6	31.0	33.0	18.5	16.8	28.1	32.9	23.3	19.9	13.0	10.6	46.4	15.5	15.4	48.6	32.3	34.3	34.9	20.6	18.1	33.4	34.9	72.3	27.0	27.0	17.3	40.7	29.0	15.1	49.4	13.8	18.7	21.4	37.0	12.0	15.6	26.2	62.0	25.7	40.5	28.5	27.1	25.6	17.6	24.0	25.1	19.8	15.3	18.1	21.3	20.2	23.9	26.3	10.5	26.1	29.5	50.7	52.6	46.1	64.7	50.2	50.5	46.0	30.7	76.4	27.4	29.8	44.8	43.1	42.2	74.1	46.8	58.5	30.6	30.8	25.0	64.6	82.5	84.3	36.5	59.0	6.8	82.4	79.7	23.3	43.5	131.1	64.6	49.3	47.4	60.1	56.8	38.1	49.8	67.5	53.7	5.9	48.9	55.5	69.2	76.7	55.6	49.5	60.9	48.7	58.0	43.7	44.5	25.8	63.8	31.4	33.5	98.5	145.2	58.6	44.1	59.1
RAB6B		ENSG00000154917	"RAB6B, member RAS oncogene family"	Q9NRW1	3	133824239-133895836	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 86.5;parathyroid gland: 33.1"	"Cell type enhanced"	"Detected in many"	17	"Cardiomyocytes: 26.9;Erythroid cells: 93.5;Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 10.5"	"Lineage enriched"	"Detected in single"	54	"T-cells: 10.5"	"Cell line enriched"	"Detected in many"	4	"HEL: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017713, HPA059131"	Uncertain		Approved	"Golgi apparatus"		NA	NA		11000000	"Golgi apparatus"		"CAB017713: , HPA059131: AB_2683916"	"unprognostic (2.87e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (3.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.80e-2)"	"prognostic favorable (3.97e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.05e-3)"	5.3	8.4	38.2	2.6	26.1	7.0	2.3	18.4	86.5	2.8	3.1	4.1	2.7	2.5	2.6	2.3	3.6	11.5	2.9	14.4	29.2	29.1	3.6	1.1	2.1	2.8	25.6	43.6	2.2	3.8	33.1	4.4	2.0	26.9	2.7	2.3	3.4	6.8	5.0	2.4	1.5	1.9	6.1	12.1	4.6	4.3	3.5	7.0	0.0	4.3	0.0	2.2	1.6	1.0	0.1	0.1	0.0	0.0	0.1	10.5	1.1	0.0	0.9	1.8	4.7	3.3	3.4	0.1	1.0	1.9	2.3	0.2	0.5	0.4	0.0	2.1	0.7	6.7	0.1	4.3	0.1	1.1	0.0	3.3	70.8	1.0	0.1	0.4	0.4	2.8	1.0	0.9	0.3	0.0	0.0	0.9	2.6	16.5	0.2	0.3	1.6	0.2	6.5	5.8	3.3	0.8	0.0	0.1	0.7	1.2	0.4	15.3	3.3	1.4	1.3	8.3	7.5	5.2	3.0	1.1	2.1	5.1	1.0	1.7	1.8	0.4	0.1	0.2	0.1	1.7	0.0	0.0	0.0	1.0	0.0	10.5	0.1	0.2	2.5	0.1	0.1	0.2	0.6	0.0	0.1	0.0	0.1	0.1	1.1	38.2	26.1	18.4	54.0	29.2	29.1	25.6	43.6	26.9	7.0	0.0	0.0	0.0	1.7	1.1	6.9	26.9	2.5	10.7	3.4	1.8	2.0	0.2	3.3	2.4	0.1	2.4	0.0	93.5	1.2	0.5	4.0	2.1	0.0	0.0	0.2	63.5	0.0	3.1	0.3	0.0	1.7	0.0	1.7	0.0	0.0	6.6	3.6	0.0	6.3	0.8	17.4	0.0	9.2	0.5	3.8	1.3	0.2	1.0	0.0	0.6
RAB6D	"RAB6CL, WTH3DI"	ENSG00000233087	"RAB6D, member RAS oncogene family"		2	131361111-131364142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 13.4"	"Cell type enriched"	"Detected in single"	27	"Ciliated cells: 2.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.3"					"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 6.4;OE19: 2.6;REH: 2.5;U-2 OS: 2.5"									HPA059131	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA059131: AB_2683916"	"unprognostic (4.19e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.08e-1)"	"unprognostic (4.79e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.12e-1)"	0.0	0.0		0.0		0.0	0.0		1.1	0.0	1.1			0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	13.4		0.0		1.9	1.0		0.0	0.0	0.0	0.0	0.8	0.0		0.0	0.0	1.0			0.0		0.0	0.0		0.2	0.3	1.4	0.4	0.5	0.5	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	6.4	0.1	0.9	2.6	0.0	2.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	2.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.4	0.3	0.5	0.4	0.4	0.4	0.1	0.5	0.3	0.3	0.2	0.5	0.4	0.2	0.5	0.4	0.1	0.5	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAB8A	"MEL, RAB8"	ENSG00000167461	"RAB8A, member RAS oncogene family"	P61006	19	16111629-16134234	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041945			Supported	"Nucleoplasm,Plasma membrane"		No	No		16000000	"Nucleoplasm, Plasma membrane"		"HPA041945: "	"unprognostic (1.10e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (6.60e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (9.99e-2)"	23.4	22.8	15.6	24.5	14.1	32.5	15.9	16.6	13.6	18.2	23.1	18.5	15.0	37.6	17.2	11.8	22.9	18.0	17.1	10.6	13.6	11.2	24.8	57.8	19.3	24.9	14.2	8.4	23.3	24.7	8.8	15.5	30.9	13.6	16.3	20.1	16.5	27.4	14.7	5.2	22.3	56.2	14.1	16.7	43.4	20.1	15.9	14.7	33.4	18.5	12.7	36.1	19.7	17.9	34.3	45.4	55.2	81.1	39.0	31.8	75.5	29.0	19.6	16.2	13.6	13.2	11.7	25.4	17.7	15.3	23.6	24.8	22.4	33.6	20.1	20.2	17.3	20.6	19.3	21.7	21.8	15.0	41.2	12.7	42.1	18.3	23.0	15.1	36.5	42.0	12.1	11.3	22.2	9.7	12.7	19.3	20.7	19.5	30.7	18.7	33.5	30.4	32.0	20.3	34.9	31.6	34.6	17.8	35.6	17.4	22.3	15.0	14.8	17.9	21.2	11.2	10.9	17.2	13.6	19.1	19.8	12.9	38.6	30.1	16.7	34.3	30.3	19.1	36.5	21.4	36.0	50.6	55.2	31.8	69.8	28.4	34.3	28.4	28.6	45.4	31.8	22.5	26.5	53.8	39.0	81.1	32.5	26.6	75.5	15.6	14.1	16.6	13.6	13.6	11.2	14.2	8.4	13.6	14.7	23.8	26.1	58.8	41.8	42.4	14.1	2.8	17.8	45.5	23.9	29.6	13.7	78.7	69.6	59.2	24.1	29.5	105.7	0.0	45.1	81.2	38.0	31.1	46.3	44.5	79.7	6.4	29.1	23.9	36.3	12.6	25.6	79.9	32.1	147.9	48.7	29.6	58.4	77.2	23.3	44.7	12.2	32.3	24.7	24.4	19.0	45.9	66.6	64.7	40.4	32.5
RABAC1	"PRA1, PRAF1, YIP3"	ENSG00000105404	"Rab acceptor 1"	Q9UI14	19	41956681-41959390	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019320, HPA029171"	Supported		Approved	"Nuclear membrane,Nucleoli fibrillar center"		NA	NA			"Nuclear membrane"	"Nucleoli fibrillar center"	"CAB019320: , HPA029171: AB_10602121"	"unprognostic (7.70e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.45e-2)"	44.2	45.4	42.3	36.7	42.5	29.6	43.5	30.9	53.1	43.6	40.5	32.0	45.3	47.8	46.8	32.4	36.2	30.4	39.8	32.2	39.5	45.9	46.0	92.3	35.7	53.0	44.7	33.4	37.5	88.1	18.5	48.6	51.0	39.9	33.8	19.1	23.3	68.8	40.5	52.2	31.6	43.4	32.0	38.4	32.2	60.6	28.3	31.9	38.8	56.1	28.7	32.4	31.4	47.5	54.5	59.6	114.0	58.1	33.2	57.2	64.1	17.3	47.7	6.9	17.9	47.0	27.0	9.1	51.7	27.4	12.7	17.9	8.4	11.4	50.2	26.8	30.6	7.3	13.0	4.2	16.2	5.3	18.5	28.0	7.3	14.0	14.5	25.2	6.4	20.3	26.2	16.2	8.6	6.3	16.6	17.7	14.2	3.2	65.4	11.7	26.7	11.2	5.8	8.4	24.9	31.0	15.3	14.8	9.7	12.1	13.0	12.7	18.5	13.6	29.6	12.5	5.6	11.1	5.4	34.3	22.8	15.1	22.1	7.4	58.2	19.4	17.4	33.0	12.0	24.5	86.2	58.1	76.4	57.2	30.5	48.1	54.5	52.0	49.8	33.8	49.9	35.3	47.6	114.0	33.2	29.6	59.6	55.8	64.1	42.3	42.5	30.9	53.1	39.5	45.9	44.7	33.4	39.9	31.9	119.1	107.6	134.8	132.5	110.7	54.7	56.9	175.8	84.3	81.9	172.7	15.7	168.6	116.0	298.8	157.9	238.6	301.1	23.3	264.4	410.9	312.7	240.5	140.7	234.8	161.0	54.0	187.1	255.9	127.0	499.8	284.2	161.6	384.6	285.9	338.7	137.5	343.3	280.5	236.2	262.8	46.9	226.4	277.1	222.3	127.0	119.2	227.2	151.3	250.8	152.9
RABGEF1	"rabex-5, RABEX5"	ENSG00000154710	"RAB guanine nucleotide exchange factor 1"	Q9UJ41	7	66682164-66811464	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001407			Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA001407: AB_1856024"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (3.77e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.64e-4)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.55e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	18.4	15.2	13.0	14.7	14.4	59.2	12.0	22.4	16.8	16.9	14.1	12.6	9.4	9.1	16.4	9.5	20.6	12.0	13.5	10.8	13.5	15.6	14.9	17.2	10.5	10.6	12.8	12.1	14.7	13.2	13.3	10.2	18.8	13.5	13.1	11.0	13.8	10.6	16.1	12.1	21.9	15.5	15.3	11.9	15.3	11.9	21.5	9.8	13.1	22.3	20.7	18.2	19.1	16.3	15.7	10.4	18.1	13.5	15.4	10.9	7.6	20.6	6.2	5.4	9.1	14.7	20.6	5.4	18.2	23.3	19.2	18.3	5.8	13.4	10.1	7.1	26.3	14.1	8.7	7.4	9.8	26.8	6.9	5.9	5.4	7.3	5.7	11.7	9.2	7.7	10.2	12.7	24.7	27.4	15.9	5.0	6.9	9.9	7.4	19.0	10.4	6.2	12.9	7.1	9.6	9.0	5.5	9.4	7.6	16.8	9.5	6.2	9.7	8.4	18.6	9.8	9.4	10.7	5.8	6.5	31.2	6.5	19.1	14.2	9.6	12.5	12.0	14.4	10.3	9.9	18.1	7.8	9.4	8.6	6.9	9.3	11.2	8.1	10.9	7.3	15.7	8.8	8.2	15.1	15.4	13.5	10.4	6.7	7.6	13.0	14.4	22.4	16.8	13.5	15.6	12.8	12.1	13.5	9.8	11.9	13.8	5.2	6.5	3.7	9.7	4.2	0.0	20.1	18.2	5.2	15.7	3.2	10.0	4.5	4.1	5.8	5.9	0.0	4.8	3.0	5.1	10.1	13.9	5.9	4.2	7.9	17.2	4.9	12.3	1.8	5.5	9.3	1.7	5.4	5.1	4.8	12.5	14.0	8.9	4.0	16.7	0.0	7.3	6.6	6.4	5.8	11.3	2.5	4.7	11.1
RABGGTB		ENSG00000137955	"Rab geranylgeranyltransferase beta subunit"	P53611	1	75786197-75795079	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026585, HPA027167, HPA030793"	Approved	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA026585: AB_1856026, HPA027167: AB_1856027, HPA030793: "	"unprognostic (4.83e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (9.80e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.05e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.89e-1)"	19.4	31.8	20.2	25.3	20.1	8.7	23.5	25.8	24.2	19.4	18.8	16.8	14.8	18.6	20.9	14.1	15.7	15.6	12.0	27.2	19.1	20.4	40.7	35.8	17.4	13.1	26.3	14.8	18.5	33.2	12.3	26.4	17.3	20.5	15.6	16.2	13.7	25.0	15.8	33.5	9.5	14.5	13.1	29.4	19.0	14.3	11.9	18.0	21.3	17.3	21.6	34.4	12.4	13.3	10.6	12.8	7.6	11.5	6.3	10.7	4.4	17.1	9.8	17.8	6.9	22.3	25.7	10.3	23.4	17.4	22.5	18.0	22.1	4.2	14.4	23.9	12.9	38.2	10.6	43.3	18.8	31.7	14.9	11.6	12.4	16.4	37.3	27.7	16.6	7.6	17.1	42.6	20.0	23.2	33.3	18.3	15.4	20.7	15.0	25.1	7.4	14.0	19.8	14.1	12.9	16.8	11.5	26.2	6.6	17.1	9.4	9.6	9.3	5.3	30.2	54.2	15.8	5.9	17.1	17.6	14.2	16.1	33.3	44.7	10.1	29.5	10.3	16.4	13.5	6.2	7.6	7.7	4.5	8.8	11.5	10.3	10.6	8.9	8.1	12.8	7.1	10.5	10.7	1.3	6.3	8.0	12.0	8.0	4.4	20.2	20.1	25.8	24.2	19.1	20.4	26.3	14.8	20.5	18.0	32.8	40.6	61.9	46.8	113.4	22.5	59.6	66.2	22.7	33.0	26.2	19.6	39.2	87.9	38.3	1.3	35.0	39.3	0.0	44.7	50.2	57.6	54.1	71.3	68.3	56.4	30.2	86.2	29.4	47.6	3.6	30.0	61.3	55.6	48.7	49.0	26.6	40.5	35.1	31.5	127.1	22.2	6.5	65.0	15.4	14.3	125.0	44.7	48.9	56.6	68.1
RABIF	"mss4, RASGRF3"	ENSG00000183155	"RAB interacting factor"	P47224	1	202878957-202889135	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 2502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027715, HPA054936"	Approved		Approved	"Microtubules,Cytokinetic bridge"		NA	NA			"Microtubules, Cytokinetic bridge"		"HPA027715: AB_10602151, HPA054936: AB_2732590"	"unprognostic (4.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.62e-3)"	"prognostic favorable (5.64e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.23e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.47e-1)"	7.1	7.0	13.4	10.3	13.8	14.0	7.9	11.5	17.9	8.9	10.4	10.9	3.1	9.9	6.3	8.2	13.8	6.2	8.4	6.7	12.7	15.4	11.2	10.9	8.9	11.7	13.4	10.4	4.0	5.7	6.0	9.2	11.2	14.5	8.6	11.7	6.6	7.9	6.8	7.4	10.6	12.0	9.3	18.2	10.2	7.0	30.2	10.6	8.9	6.3	8.8	15.8	9.4	7.5	15.7	17.7	31.1	21.0	14.9	18.7	15.6	12.4	13.5	9.6	11.0	15.2	11.7	10.6	13.9	7.7	14.4	13.5	9.3	10.9	10.3	6.9	11.0	9.9	11.8	7.6	8.8	10.9	12.2	14.1	8.5	11.1	9.7	12.3	11.6	14.8	9.7	12.7	18.1	4.7	7.2	18.9	13.4	13.4	11.4	14.0	20.8	12.9	12.6	7.8	9.8	16.7	9.3	13.0	14.1	14.7	13.0	13.7	12.0	12.0	21.2	10.7	12.5	13.7	8.5	14.5	10.1	9.3	4.6	12.2	6.0	13.2	11.0	9.9	10.8	9.3	24.1	20.0	27.6	18.3	21.0	13.3	15.7	17.4	17.2	17.7	15.5	15.9	16.7	31.1	14.9	18.8	16.9	18.7	15.6	13.4	13.8	11.5	17.9	12.7	15.4	13.4	10.4	14.5	10.6	0.0	15.7	22.8	29.0	48.2	4.6	9.3	7.6	9.4	7.9	12.2	2.0	43.7	13.3	34.0	555.0	24.8	30.4	0.0	46.5	41.5	19.7	25.2	12.7	28.9	36.9	1.6	22.4	16.0	37.6	2502.1	26.2	34.4	50.6	48.7	12.4	10.8	58.5	31.6	28.3	47.7	5.7	12.9	27.6	68.8	55.8	45.4	66.0	26.1	13.4	37.3
RABL2A		ENSG00000144134	"RAB, member of RAS oncogene family like 2A"	Q9UBK7	2	113627229-113643396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.3"	"Cell type enriched"	"Detected in many"	6	"Ciliated cells: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.2"									"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome		NA	NA			Centrosome	Vesicles	"HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770"	"unprognostic (7.76e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.77e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.78e-3)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.19e-5)"	2.2	1.7	6.0	5.9	9.5	1.7	3.3	6.3	20.9	4.3	3.4	4.2	0.4	2.4	4.7	9.0	2.7	29.3	2.8	3.3	7.0	6.0	3.5	3.4	12.9	1.8	4.0	7.5	7.4	2.6	1.2	6.3	1.6	6.4	3.8	2.0	3.8	5.2	12.2	2.2	2.1	2.2	3.6	4.8	2.7	2.1	4.8	4.3	2.0	5.5	2.0	3.1	2.1	2.7	8.8	9.8	2.5	7.6	12.2	10.4	5.5	2.6	4.3	6.0	4.8	5.0	7.3	4.6	2.4	2.0	3.5	2.5	3.8	1.6	3.7	10.4	0.8	2.5	2.7	3.0	0.3	2.3	5.1	5.8	1.8	0.1	0.5	4.1	0.8	1.3	2.6	5.2	0.7	1.5	5.1	2.5	5.5	1.7	0.9	2.1	2.1	12.2	0.9	3.3	2.2	1.5	2.3	2.3	1.6	2.4	0.6	2.5	8.5	2.3	2.6	2.2	1.9	0.5	3.5	0.6	0.5	0.8	0.9	1.7	3.6	3.8	0.8	7.1	2.7	1.2	0.0	4.8	2.5	7.1	7.6	7.7	8.8	10.4	7.2	7.5	8.0	8.6	6.8	0.5	12.2	7.2	9.8	5.0	5.5	6.0	9.5	6.3	20.9	7.0	6.0	4.0	7.5	6.4	4.3	8.9	7.2	7.5	4.3	3.9	7.0	4.0	0.0	119.1	12.5	7.0	9.8	2.8	11.6	6.7	9.4	3.0	5.2	0.0	2.7	2.2	7.3	3.0	11.5	3.9	3.1	15.9	6.9	6.7	2.8	9.8	7.5	4.6	6.8	6.4	3.7	6.5	4.0	3.5	6.7	5.0	17.6	0.0	6.6	20.4	8.3	4.3	2.1	5.7	4.3	3.4
RABL2B		ENSG00000079974	"RAB, member of RAS oncogene family like 2B"	Q9UNT1	22	50767501-50783663	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 59.0"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 167.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome		NA	NA			Centrosome	Vesicles	"HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.86e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (4.58e-5)"	"unprognostic (3.14e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.37e-3)"	8.2	8.2	12.4	11.1	22.1	8.1	12.9	19.7	21.2	13.0	8.4	12.7	12.6	7.9	13.9	59.0	8.1	41.9	9.4	5.8	13.1	15.3	10.6	7.0	14.4	13.3	9.9	16.5	17.8	9.6	10.9	16.7	7.4	14.3	10.0	11.0	9.5	9.5	11.6	5.1	13.8	8.6	10.2	9.5	11.5	9.1	12.2	14.5	12.6	17.9	3.5	12.3	9.4	9.2	13.6	13.2	9.2	19.4	10.8	16.8	10.3	13.3	12.1	20.8	16.2	23.3	18.6	15.2	10.0	11.1	8.1	11.1	3.4	11.8	8.6	8.9	14.3	13.2	17.5	9.4	11.7	8.8	7.4	13.4	7.4	20.9	8.8	9.7	20.9	8.0	15.8	16.0	10.6	13.4	24.1	9.0	15.5	5.6	10.9	16.1	16.8	10.4	9.2	7.9	8.2	9.1	17.6	12.0	9.0	15.7	13.3	8.9	16.2	12.2	10.8	7.5	15.0	10.7	6.5	13.8	7.8	15.6	6.6	6.7	9.2	4.2	4.2	14.7	5.2	10.9	1.0	10.9	9.2	16.8	17.4	12.2	11.2	13.0	13.7	11.6	13.6	15.2	14.7	4.3	10.8	19.4	13.2	13.0	10.3	12.4	22.1	19.7	21.2	13.1	15.3	9.9	16.5	14.3	14.5	11.9	11.2	10.4	10.3	4.7	14.6	3.6	12.7	167.3	29.6	21.0	29.5	10.4	11.6	17.3	17.0	7.3	7.8	0.0	9.5	9.3	8.5	7.5	3.5	6.4	10.7	15.9	5.2	5.5	10.1	16.3	13.0	8.5	16.9	15.4	7.2	12.9	9.0	3.5	10.3	12.2	37.4	6.5	10.3	27.4	27.0	5.0	5.6	15.8	10.1	6.3
RABL3	MGC23920	ENSG00000144840	"RAB, member of RAS oncogene family like 3"	Q5HYI8	3	120686681-120742993	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Cone photoreceptor cells: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035150, HPA035151"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035150: AB_2674493, HPA035151: AB_10601154"	"unprognostic (1.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.78e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (2.33e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.65e-1)"	21.5	26.7	16.5	9.3	19.5	8.8	14.8	15.7	19.9	12.2	14.1	16.6	13.6	10.6	11.8	12.2	16.6	11.0	9.9	11.9	14.6	16.6	19.7	20.5	10.3	10.3	19.2	16.2	18.7	13.9	23.3	14.7	13.4	20.9	14.4	15.1	12.8	11.2	14.9	19.6	10.3	13.0	11.6	22.5	11.3	11.4	8.2	14.0	11.2	22.9	12.6	11.8	13.8	11.9	7.8	11.4	5.7	11.8	13.1	10.9	5.6	16.6	12.9	11.6	3.7	12.6	17.1	9.7	15.0	11.3	8.7	8.1	8.8	6.9	13.5	7.8	13.2	13.7	6.8	11.7	8.2	16.5	11.3	5.5	13.7	9.2	11.3	8.1	24.0	8.7	8.9	15.8	7.4	8.9	11.6	13.0	8.8	11.1	9.1	11.4	14.4	18.4	6.3	7.1	18.9	7.7	8.6	14.2	7.5	11.4	7.5	5.5	7.4	7.1	6.4	8.3	4.7	11.8	15.7	17.7	6.7	6.0	4.9	15.7	6.7	6.3	11.4	19.0	23.8	8.2	5.6	5.8	4.2	10.9	11.8	9.0	7.8	9.7	10.3	10.7	6.8	9.3	10.8	5.7	13.1	6.6	11.4	10.3	5.6	16.5	19.5	15.7	19.9	14.6	16.6	19.2	16.2	20.9	14.0	8.9	9.4	9.3	14.5	5.7	16.9	11.6	20.4	17.4	14.8	8.7	110.0	11.8	6.6	14.2	16.2	11.9	9.8	0.0	13.9	15.5	8.2	11.6	8.1	14.7	12.8	7.9	5.2	4.3	8.3	6.9	5.5	9.5	10.1	10.8	12.2	15.7	13.4	13.6	5.6	20.3	18.0	0.0	5.9	9.7	7.5	9.7	18.4	6.9	10.2	13.1
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	20.8	17.7	31.0	21.6	42.8	32.9	17.9	43.6	41.4	12.5	25.1	18.0	14.8	29.4	13.7	14.6	17.9	12.8	22.2	29.4	28.2	22.2	17.1	7.3	17.2	18.5	22.7	21.6	13.9	39.6	17.4	23.3	16.0	16.7	24.3	16.6	13.1	24.8	16.9	98.6	21.5	29.4	15.6	20.6	20.0	24.5	16.5	17.2	20.9	13.9	22.6	13.9	13.8	19.9	4.7	4.1	2.9	5.7	6.1	5.2	1.4	19.2	25.6	18.4	21.5	7.5	8.5	48.4	17.5	11.3	17.0	12.5	28.5	20.5	27.3	11.0	13.6	17.9	42.3	20.4	15.5	5.8	28.4	26.3	16.7	32.0	33.3	13.6	30.9	21.5	9.4	16.0	10.5	11.7	10.4	17.7	23.6	36.3	13.4	11.6	38.5	33.0	21.4	34.4	23.7	22.1	43.3	22.0	26.6	11.2	17.2	60.6	25.1	30.9	36.3	21.6	10.2	31.2	31.2	21.3	22.1	19.2	23.2	28.3	11.5	13.1	22.2	18.5	15.1	20.6	1.2	4.8	2.9	3.7	5.7	3.8	4.5	3.9	3.6	3.3	4.7	3.2	4.1	2.3	6.1	2.0	4.1	5.2	1.4	31.0	42.8	43.6	41.4	28.2	22.2	22.7	21.6	16.7	17.2	26.8	48.3	8.9	15.4	16.0	37.2	29.1	0.0	8.1	7.9	24.4	19.6	20.7	26.6	28.0	10.1	16.9	100.2	0.0	49.7	27.9	22.0	31.8	15.0	0.0	27.4	36.5	49.8	0.0	0.0	10.9	18.1	26.0	38.8	26.2	55.1	18.1	55.1	51.0	25.1	38.5	38.3	0.0	17.3	15.4	26.4	16.9	23.7	12.9	57.2	21.6
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374523-6403977	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		44000000	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: AB_2680167"	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (1.74e-5)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	45.2	35.0	71.0	28.4	64.0	24.4	46.5	42.1	93.0	48.7	58.9	75.5	22.5	51.6	48.7	49.5	93.4	47.2	40.0	48.4	73.8	59.8	47.8	42.9	45.6	38.3	76.7	60.9	45.1	29.2	51.0	25.2	55.8	54.9	40.5	64.0	37.2	43.3	48.9	57.4	58.6	49.8	57.3	88.2	35.0	49.7	28.1	47.1	41.3	40.9	42.8	50.7	52.2	54.0	11.0	32.0	49.1	31.9	7.3	11.8	10.7	75.1	34.1	35.3	38.3	41.9	53.5	21.1	42.4	52.1	56.6	57.7	33.5	71.1	21.2	27.5	59.1	58.6	53.6	37.6	51.4	72.5	9.9	31.2	21.3	27.6	24.1	50.4	19.2	17.4	35.6	46.0	40.7	45.7	43.1	49.8	21.0	38.0	16.8	60.9	54.8	10.5	45.2	63.2	38.3	40.9	18.7	35.9	31.1	72.7	47.7	26.8	45.1	29.9	109.6	34.0	42.1	61.8	57.8	52.2	37.2	56.0	45.5	48.9	12.8	14.0	20.0	34.3	36.7	70.4	7.6	31.9	16.4	7.2	22.2	4.5	11.0	8.1	9.2	32.0	11.0	9.8	6.5	49.1	7.3	22.1	18.2	11.8	10.7	71.0	64.0	42.1	93.0	73.8	59.8	76.7	60.9	54.9	47.1	137.0	112.5	192.8	745.4	829.8	84.3	183.1	481.6	92.3	104.6	338.5	23.6	691.3	454.3	121.1	58.5	522.9	706.2	303.7	149.3	914.8	466.9	1152.5	132.3	288.4	738.1	138.2	323.2	535.2	736.9	43.7	441.0	745.3	435.3	408.4	531.5	280.9	231.2	471.0	444.5	611.5	54.4	472.1	495.6	210.1	328.6	1004.1	707.0	194.1	436.1	1582.5
RAD51AP1	PIR51	ENSG00000111247	"RAD51 associated protein 1"	Q96B01	12	4538798-4560048	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 33.7;Erythroid cells: 46.7;Extravillous trophoblasts: 30.1;Hofbauer cells: 34.3;Late spermatids: 50.0;Spermatocytes: 35.8;Spermatogonia: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051499			Approved	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA051499: AB_2681508"	"unprognostic (1.03e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (6.30e-2)"	"unprognostic (5.25e-3)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.29e-3)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.44e-15)"	"unprognostic (2.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.88e-2)"	"unprognostic (3.75e-2)"	3.0	2.0	1.7	9.2	3.6	15.4	2.7	4.5	2.6	1.8	5.4	1.4	3.8	5.4	1.5	3.2	7.6	1.1	2.2	1.9	1.5	1.2	1.7	1.7	2.6	8.8	2.1	1.7	1.5	1.2	0.5	1.2	4.2	1.8	1.7	7.1	1.5	2.8	1.0	1.2	3.2	6.2	1.9	2.9	5.8	2.9	9.2	2.5	29.8	1.4	4.7	8.2	2.1	3.1	4.5	9.7	0.9	3.1	1.9	1.5	0.9	13.0	4.6	16.5	8.2	1.0	2.1	19.3	17.2	7.6	19.2	25.4	12.5	12.7	17.1	2.5	3.7	9.0	8.3	11.4	5.1	29.5	13.4	9.7	21.5	8.0	8.6	0.2	19.5	10.9	0.4	0.5	11.5	11.2	2.7	7.7	11.8	13.4	19.7	12.1	4.7	15.9	7.1	40.1	12.7	5.2	16.0	19.8	6.7	5.8	6.5	5.5	6.1	12.8	10.0	4.1	17.4	4.0	11.4	3.4	13.1	13.4	14.1	18.3	3.0	3.4	32.7	4.9	14.1	10.5	0.0	0.8	0.9	0.2	3.1	0.8	4.2	0.6	1.5	0.6	4.5	0.2	0.4	0.0	1.9	2.7	9.7	1.4	0.9	1.7	3.6	4.5	2.6	1.5	1.2	2.1	1.7	1.8	2.5	0.0	0.3	7.5	1.7	4.6	3.0	1.2	2.5	0.0	5.7	0.0	3.9	6.8	0.0	2.0	33.7	0.7	1.3	46.7	2.3	30.1	2.9	1.1	1.1	1.0	34.3	0.0	2.4	1.8	4.7	50.0	1.1	6.6	0.0	10.8	2.8	2.6	1.1	0.0	1.4	1.2	4.9	0.0	1.9	35.8	29.9	2.3	3.9	3.8	7.7	0.9
RAD51B	"hREC2, R51H2, RAD51L1, REC2"	ENSG00000182185	"RAD51 paralog B"	O15315	14	67819779-68730218	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB016191, HPA051869"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"CAB016191: AB_2238209, HPA051869: AB_2681644"	"unprognostic (9.10e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.47e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.13e-3)"	5.1	4.9	4.2	4.6	10.1	9.2	8.2	2.0	5.6	8.2	4.3	11.6	11.2	1.7	10.8	13.8	7.0	6.0	6.4	3.4	5.6	3.2	4.3	3.2	5.0	6.6	9.2	4.0	10.0	5.7	8.0	10.0	8.0	7.5	7.0	4.0	9.4	18.7	3.8	2.4	7.1	5.8	6.7	7.3	6.9	3.7	3.4	7.3	12.6	4.9	4.6	12.1	7.7	8.3	13.6	6.6	14.0	5.9	7.8	10.1	4.8	12.2	4.9	5.4	3.3	5.1	8.7	3.4	6.2	4.8	6.9	8.9	3.4	16.7	15.2	4.1	3.8	8.0	11.1	3.4	10.0	9.5	6.7	3.5	7.2	4.4	2.7	2.7	6.1	7.3	4.4	7.7	7.9	8.4	3.2	6.2	11.3	5.8	7.1	5.6	9.6	11.8	2.1	3.2	11.9	4.9	13.4	6.5	5.5	5.4	3.5	3.7	2.4	5.0	1.8	10.8	6.7	8.4	5.5	1.6	8.5	8.2	6.6	5.1	3.4	3.5	12.0	4.7	10.7	4.8	14.0	5.9	5.4	8.6	4.7	7.1	13.6	8.2	9.2	6.5	11.5	10.1	9.7	0.7	7.8	4.5	6.6	9.1	4.8	4.2	10.1	2.0	5.6	5.6	3.2	9.2	4.0	7.5	7.3	0.0	0.6	3.9	4.8	6.0	1.3	1.5	0.0	1.4	2.3	1.8	7.9	4.8	3.3	1.8	1.5	3.6	1.4	0.0	1.2	5.5	2.5	3.4	4.6	0.6	5.7	1.6	4.6	0.6	4.3	1.3	3.4	3.6	8.5	10.0	2.7	5.1	1.1	0.0	4.2	1.6	5.9	0.0	2.0	3.8	3.2	6.0	3.3	2.5	1.3	3.1
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 79.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: AB_2679250"	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	11.1	22.7	22.1	10.1	20.8	19.4	15.4	20.8	31.0	12.3	13.7	16.0	11.1	7.3	14.3	23.1	13.2	11.8	10.9	24.9	20.2	17.4	13.7	13.9	8.9	19.6	17.2	21.4	13.4	11.2	20.0	18.3	15.1	28.9	18.3	15.0	13.2	10.6	12.7	15.5	10.3	9.6	14.4	14.0	14.4	13.2	18.9	12.7	23.8	12.6	11.7	18.6	12.6	11.8	14.4	13.0	18.8	11.3	11.2	21.7	9.2	15.7	18.3	11.3	12.4	6.2	5.3	25.8	8.6	4.0	11.6	14.8	7.8	10.2	9.3	12.8	5.9	15.3	6.0	15.1	12.2	21.6	22.6	31.3	13.1	20.6	29.4	6.1	16.8	11.7	3.2	11.0	12.9	10.5	6.2	12.9	15.6	20.3	12.8	9.9	79.0	23.8	23.4	3.0	10.5	17.0	15.3	17.9	17.5	7.0	9.9	14.0	13.0	6.9	3.4	13.0	3.0	10.2	17.8	4.1	9.8	26.0	8.8	10.5	12.0	44.5	27.2	9.9	16.6	11.2	18.8	7.5	9.8	13.7	11.3	13.3	14.1	15.0	14.9	13.0	14.4	16.4	15.4	4.6	11.2	9.8	11.7	21.7	9.2	22.1	20.8	20.8	31.0	20.2	17.4	17.2	21.4	28.9	12.7	17.9	11.5	15.2	17.6	10.5	14.6	54.1	10.2	10.7	13.6	15.7	5.9	46.3	49.7	22.6	78.9	14.9	4.2	70.0	16.3	78.6	13.4	14.4	23.0	12.5	29.2	15.9	6.4	14.1	13.4	51.1	16.1	22.9	23.6	22.6	13.1	21.7	12.0	10.5	14.5	19.5	23.0	32.3	22.1	113.9	80.6	9.4	30.3	21.3	12.5	8.4
RAD52		ENSG00000002016	"RAD52 homolog, DNA repair protein"	P43351	12	912077-990053	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028957			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA028957: AB_2672842"	"unprognostic (4.53e-1)"	"unprognostic (8.08e-3)"	"unprognostic (4.68e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-1)"	"prognostic unfavorable (2.22e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.74e-2)"	7.4	8.5	12.4	8.1	15.1	5.0	10.0	18.8	15.9	12.6	11.7	14.5	13.6	9.4	12.5	14.2	8.2	11.0	9.0	7.8	14.3	7.3	9.9	10.5	6.9	8.9	15.0	9.6	17.6	11.4	9.6	15.6	8.5	15.0	10.5	11.7	9.5	8.4	11.0	16.5	14.9	10.4	12.8	17.0	10.3	8.8	6.8	20.9	9.4	14.6	4.3	9.7	9.7	13.3	7.0	9.6	7.4	3.8	4.0	6.0	1.4	3.1	12.2	9.5	10.7	10.4	7.8	10.2	6.3	5.9	7.0	7.0	11.7	11.2	10.0	2.0	6.3	6.1	9.4	7.2	4.2	6.2	13.4	6.4	11.1	11.7	8.1	5.9	11.9	3.4	4.5	7.5	7.4	22.7	14.0	5.9	9.8	7.4	5.7	6.7	6.6	8.1	11.9	12.4	7.9	7.9	8.3	9.3	3.7	7.3	5.7	3.4	3.9	8.1	8.8	4.5	14.6	8.2	5.8	5.8	9.8	11.9	7.7	6.6	2.2	3.4	10.4	5.1	5.0	3.6	7.4	3.4	2.0	4.6	2.9	6.0	4.8	4.9	4.0	4.4	7.0	5.7	5.2	2.8	4.0	3.8	9.6	4.4	1.4	12.4	15.1	18.8	15.9	14.3	7.3	15.0	9.6	15.0	20.9	3.0	5.1	0.0	1.1	1.5	3.7	3.1	0.0	1.4	4.5	3.5	2.0	3.6	1.7	1.9	3.2	3.0	4.0	0.0	1.4	2.2	2.2	1.3	5.7	2.1	2.3	3.2	1.7	0.6	1.0	4.5	0.6	2.2	0.0	2.8	2.3	1.9	0.6	2.9	0.7	1.4	2.3	6.5	3.1	4.6	4.1	0.9	1.7	1.3	2.9	0.9
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.4	4.1	3.3	3.5	4.3	5.2	4.1	7.8	4.3	3.6	4.4			2.2	5.3	4.6	3.6	3.9	2.5	3.1	3.4	3.5	3.4	8.8	4.2	3.8	3.4		5.6	5.0	5.3	3.9	4.9		3.8	3.5		3.7	4.2	7.3	4.6	4.1	4.3	4.1	4.7	4.4	4.7			4.2		5.2	3.8	3.5	6.9	5.2	6.5	7.1	6.3	8.3	4.0	5.6	4.4	11.4	11.2	6.4	4.6	6.0	4.8	6.8	6.6	6.3	7.8	3.3	14.8	1.4	8.4	6.9	4.4	17.9	6.0	8.2	7.8	4.0	12.7	9.5	5.1	5.8	14.1	7.6	5.2	4.8	10.1	9.8	4.2	7.3	12.9	8.3	8.1	5.2	4.3	12.6	6.4	9.0	2.8	4.8	5.8	8.8	2.0	3.3	7.3	4.7	8.9	7.6	7.3	4.9	7.2	4.7	8.5	9.5	7.0	8.0	7.1	9.3	8.7	8.8	15.0	7.5	8.0	8.8	6.5	4.8	4.7	8.1	6.0	8.3	4.3	7.1	6.6	5.2	6.9	4.7	5.4	2.2	6.3	7.1	5.2	6.3	4.0											8.9	11.8	9.0	6.6	8.1	33.3	9.7	10.2	10.7	7.9	8.7	29.5	13.5	1.7	8.3	6.1	11.1	4.2	0.0	9.0	7.3	8.0	8.9	17.4	20.7	7.7	44.5	15.6	11.1	11.4	1.9	14.1	6.8	13.5	4.6	6.8	10.4	10.2	6.2	15.9	3.4	31.5	12.9	9.2	37.2	39.4	7.9	24.8	9.6	7.0	9.8
RADIL	"FLJ10324, KIAA1849, RASIP2"	ENSG00000157927	"Rap associating with DIL domain"	Q96JH8	7	4797055-4883719	"Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;testis: 18.5"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 12.7;Spermatocytes: 18.2;Spermatogonia: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.7;HEK 293: 6.0;NTERA-2: 6.8;SCLC-21H: 9.5;SH-SY5Y: 20.6;U-2197: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051776	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA051776: AB_2681605"	"unprognostic (6.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.89e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-4)"	"unprognostic (5.10e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.28e-3)"	7.5	2.4	4.3	0.8	4.6	0.5	3.7	29.9	9.9	5.9	3.3	3.3	0.7	0.8	6.1	1.4	1.7	6.4	2.1	7.8	4.1	4.0	1.1	0.7	7.5	0.6	3.4	4.4	1.6	2.5	1.5	3.3	7.2	7.5	2.1	1.1	2.7	1.1	4.3	4.5	1.2	1.8	3.1	4.3	1.0	1.4	18.5	4.0	0.0	2.8	0.6	0.7	2.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.8	7.7	0.2	1.9	0.0	0.9	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.8	1.1	0.0	3.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.7	4.1	0.0	0.4	2.1	0.0	0.0	6.8	0.0	1.3	5.0	0.2	0.0	0.0	0.0	9.5	20.6	0.1	0.0	0.0	1.6	3.0	0.6	0.0	0.0	0.0	5.5	1.5	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.6	29.9	9.9	4.1	4.0	3.4	4.4	7.5	4.0	3.0	1.0	0.0	0.0	0.7	0.5	1.7	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.6	1.3	0.0	0.0	1.6	0.0	2.4	0.4	0.0	0.0	0.1	12.7	0.0	0.0	0.0	4.1	3.1	0.0	6.8	0.0	0.1	3.3	0.3	0.0	3.5	0.0	0.5	6.5	3.6	18.2	9.7	0.5	0.1	0.0	0.0	0.0
RAE1	Mnrp41	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351010-57379211	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA048795: AB_2680523"	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	9.2	10.0	9.4	11.1	15.2	28.6	12.0	18.1	18.3	9.5	9.7	11.5	9.3	8.0	13.0	13.9	14.0	12.2	7.9	8.1	9.8	11.0	9.2	10.7	7.1	12.5	8.1	12.6	12.1	9.1	12.3	13.7	13.5	10.4	9.2	11.4	9.4	8.9	11.0	9.6	14.8	8.8	11.3	7.3	12.1	8.6	64.8	8.3	19.4	11.7	11.5	17.3	10.0	11.5	17.0	16.6	39.1	21.5	11.8	20.2	17.8	12.8	15.9	15.8	9.0	9.6	8.8	14.4	10.4	14.7	51.4	19.9	50.4	10.3	20.6	14.6	15.0	19.6	17.1	29.7	25.6	42.4	6.2	13.4	14.1	14.2	22.3	18.0	16.9	12.7	12.9	23.1	22.1	24.8	8.6	15.5	14.1	24.7	10.0	16.1	34.7	25.2	14.8	10.0	24.5	28.0	14.1	15.4	13.7	12.0	13.5	17.3	14.3	17.7	40.4	18.2	12.9	22.0	14.8	9.0	21.9	19.7	12.9	17.3	10.9	23.3	23.5	15.3	10.5	10.9	9.1	21.5	39.1	15.6	18.1	18.9	17.0	15.2	15.5	16.6	16.3	20.2	18.4	19.4	11.8	17.9	12.6	12.9	17.8	9.4	15.2	18.1	18.3	9.8	11.0	8.1	12.6	10.4	8.3	17.9	14.7	22.4	14.7	15.2	14.6	8.5	12.7	21.4	12.5	17.4	13.7	44.8	23.2	28.2	84.3	14.2	7.9	23.3	12.5	32.5	15.6	10.5	36.9	11.3	33.3	3.2	6.3	10.4	63.2	48.9	20.1	28.8	10.1	27.1	13.0	17.6	17.6	20.4	21.2	16.6	15.0	19.4	15.0	94.3	78.1	18.3	58.9	21.5	18.0	14.9
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.2;tongue: 18.4"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 4.2;Basal keratinocytes: 2.7;Melanocytes: 3.3;Urothelial cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 23.4;hTCEpi: 18.7;SiHa: 9.2;U-87 MG: 7.6"									HPA062673			Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA062673: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.5	10.0	0.3	0.6	0.3	0.0	2.5	0.2	1.0	5.6	0.6	0.5	1.4	0.2	0.8	4.3	21.2	0.5	1.2	0.9	0.4	0.2	2.3	0.2	1.3	0.1	0.3	0.1	1.9	0.1	0.1	1.2	0.1	0.5	2.9	0.1	0.8	3.9	2.2	0.4	4.3	0.5	1.8	0.9	0.2	0.6	0.5	0.2	0.2	0.7	18.4	10.7	2.8	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	1.0	0.0	1.3	1.9	1.8	0.0	0.6	2.4	1.1	1.5	0.0	1.2	0.0	0.5	1.3	1.1	2.0	0.7	4.1	0.8	0.2	1.3	0.4	23.4	0.0	0.5	0.0	0.0	2.7	18.7	2.8	1.3	1.3	0.4	0.6	0.2	0.2	0.4	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.8	2.5	0.3	0.2	9.2	0.4	0.0	0.1	0.3	0.3	1.3	0.5	0.4	1.1	0.6	0.0	0.0	0.0	7.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.0	0.4	0.2	0.3	0.1	0.5	0.2	0.0	0.0	0.0	4.2	2.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	9.5
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12583601-12664226	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 53.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 53.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002640, CAB019291"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB019291: , HPA002640: AB_1856047"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.17e-3)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-2)"	19.5	15.6	15.1	14.7	17.1	32.2	17.5	35.2	18.9	19.9	20.3	21.1	19.6	18.4	24.9	15.7	24.6	18.6	20.2	39.3	15.3	11.0	21.7	36.2	19.7	15.7	16.0	13.4	24.9	31.3	30.7	16.9	24.8	14.3	18.8	19.2	25.0	18.3	18.4	79.7	23.9	29.6	23.7	13.8	22.1	23.7	16.7	17.8	27.7	26.9	27.9	26.1	20.5	20.4	6.6	9.3	53.9	9.9	8.5	8.6	7.7	15.4	17.8	27.1	21.0	23.6	19.1	54.6	23.6	40.0	31.3	35.5	13.9	12.8	16.2	11.3	36.5	16.9	9.9	28.5	20.9	32.6	28.3	22.4	21.8	21.4	12.9	23.9	21.2	20.7	17.6	21.2	32.2	26.1	21.6	22.4	24.9	15.8	42.6	30.1	26.4	27.2	15.7	27.6	19.3	24.2	22.0	23.8	20.4	18.7	23.4	8.5	17.8	19.3	18.7	12.5	22.0	31.0	28.1	16.0	21.5	20.5	18.0	26.2	33.2	52.9	34.9	18.5	24.8	22.8	11.3	9.7	18.4	7.4	9.9	7.5	6.6	7.3	7.2	9.3	6.3	7.5	7.6	53.9	8.5	9.6	4.2	8.6	7.7	15.1	17.1	35.2	18.9	15.3	11.0	16.0	13.4	14.3	17.8	20.8	36.5	39.7	31.1	30.6	51.6	25.8	28.1	25.4	21.6	26.2	62.8	34.3	11.6	22.9	7.1	29.1	32.5	0.0	32.0	39.8	32.9	38.2	33.5	36.5	25.2	41.3	28.2	31.3	36.8	3.4	36.2	34.2	25.3	29.7	29.6	32.1	28.8	34.8	38.9	15.7	84.2	32.3	33.0	17.7	27.4	38.0	52.1	38.3	29.5	36.9
RAG2		ENSG00000175097	"Recombination activating 2"	P55895	11	36575574-36598279	"Disease related genes, Predicted intracellular proteins"	"DNA recombination"	"Chromatin regulator"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 165.8"	"Cell type enriched"	"Detected in single"	6	"Early spermatids: 1.4"	"Cancer enriched"	"Detected in single"	21	"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 14.0;MOLT-4: 15.6;REH: 62.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065704			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065704: AB_2732737"				"unprognostic (4.30e-2)"					"unprognostic (9.09e-2)"	"unprognostic (1.21e-1)"		"unprognostic (1.77e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.68e-3)"		0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	165.8	24.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	62.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RAI14	"DKFZp564G013, KIAA1334, NORPEG, RAI13"	ENSG00000039560	"Retinoic acid induced 14"	Q9P0K7	5	34656237-34832627	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 64.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 166.4;Early spermatids: 198.0;Late spermatids: 250.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036949, HPA036950"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Actin filaments, Cytosol"	"HPA036949: AB_10670568, HPA036950: AB_10669721"	"unprognostic (7.63e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.75e-2)"	"unprognostic (5.49e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (9.75e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.81e-2)"	"unprognostic (4.34e-2)"	5.6	4.5	3.9	8.3	5.9	0.5	5.1	4.4	3.2	23.3	9.1	5.5	14.1	2.5	29.2	8.2	8.8	6.8	8.8	3.6	4.4	3.5	7.7	11.2	10.4	5.1	6.9	1.5	9.5	4.8	6.4	2.7	64.4	5.6	10.4	4.0	8.2	8.4	10.8	2.0	7.6	3.6	34.7	17.0	21.2	6.0	26.6	5.7	2.1	6.7	2.7	3.8	22.5	14.9	0.8	0.6	2.5	0.8	2.5	3.3	0.3	2.7	10.8	12.5	8.3	6.7	23.5	16.0	32.7	26.4	18.9	19.0	8.2	3.5	0.6	13.1	16.0	20.7	1.8	14.2	24.1	41.1	0.0	6.8	4.5	10.2	5.0	20.8	0.1	0.4	21.9	7.6	33.9	27.1	31.2	59.9	1.0	6.3	0.2	24.6	2.2	0.4	0.1	9.7	1.6	10.5	3.9	19.1	0.1	22.0	15.6	3.3	1.8	19.3	2.9	8.8	19.1	3.3	0.5	38.5	30.8	16.5	7.5	14.2	0.7	0.0	0.0	26.0	0.0	11.9	2.5	0.8	0.3	3.3	0.3	0.4	0.5	1.0	0.2	0.2	0.8	0.3	0.6	1.6	2.5	0.1	0.6	0.1	0.3	3.9	5.9	4.4	3.2	4.4	3.5	6.9	1.5	5.6	5.7	98.3	166.4	1.7	20.2	10.6	1.9	3.3	5.1	24.1	95.5	33.2	64.8	23.9	6.6	30.0	198.0	51.8	3.2	0.0	24.7	59.3	26.2	11.8	3.5	21.9	6.5	14.3	1.7	16.5	2.4	250.8	66.7	4.2	5.0	1.8	0.8	18.5	39.1	1.9	29.7	18.0	4.7	0.0	17.3	8.1	12.4	13.8	130.6	2.5	2.3	63.1
RAI2		ENSG00000131831	"Retinoic acid induced 2"	Q9Y5P3	X	17800049-17861337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 45.5;Peritubular cells: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 1.5;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 5.1"	"Cell line enriched"	"Detected in some"	10	"ASC diff: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051054	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA051054: AB_2681328"	"unprognostic (3.45e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (3.39e-14)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.80e-2)"	23.6	9.7	2.5	10.1	4.0	0.0	28.5	4.0	4.9	41.0	13.7	1.7	15.0	3.5	29.6	17.8	12.2	27.9	21.2	16.1	2.4	2.7	9.4	1.9	14.5	12.9	2.4	1.8	32.7	7.7	4.6	11.1	7.1	2.9	28.3	4.5	10.7	6.6	18.7	7.2	8.3	8.8	20.4	2.7	2.4	12.0	16.2	2.1	2.0	15.1	6.3	5.9	24.2	53.6	0.0	0.0	0.0	0.0	0.4	5.1	0.4	0.0	0.0	0.1	0.0	49.6	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.5	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.5	5.1	0.0	0.4	0.0	0.0	0.0	0.4	2.5	4.0	4.0	4.9	2.4	2.7	2.4	1.8	2.9	2.1	11.9	5.0	0.0	8.6	3.7	13.8	11.2	7.6	8.1	1.2	21.0	0.0	0.0	5.0	6.8	0.2	14.6	0.3	0.0	8.8	0.1	13.2	11.3	0.0	0.0	0.4	25.4	26.5	9.8	0.0	1.1	45.5	0.0	5.0	1.0	0.0	13.7	4.1	0.0	66.4	1.6	2.8	0.0	6.2	0.5	1.1	2.5	0.0	0.0	0.0	4.8
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538116	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Collecting duct cells: 455.4;Extravillous trophoblasts: 356.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	10	"neutrophil: 55.1"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.1"	"Cell line enhanced"	"Detected in all"		"OE19: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	NA			Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: AB_2679738"	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	19.7	14.6	23.2	14.8	24.3	17.9	19.1	27.1	27.2	17.1	20.7	14.0	54.7	12.5	15.9	16.7	33.7	17.5	13.7	21.4	24.7	19.6	30.6	14.2	15.1	14.6	23.1	13.7	18.8	10.4	19.8	15.3	28.8	19.6	24.3	17.4	9.8	17.6	44.8	24.3	47.5	13.4	22.7	20.6	19.3	17.4	8.5	23.1	15.4	15.7	23.4	16.4	24.3	26.3	2.5	5.5	55.1	4.5	4.3	3.2	1.2	18.4	12.4	11.1	12.5	12.8	20.1	14.7	22.3	12.1	11.4	12.3	13.8	18.3	23.5	16.3	20.4	16.3	10.6	15.3	16.7	14.4	23.3	14.8	12.4	11.5	10.2	10.4	36.4	14.4	14.0	16.8	16.0	16.0	15.4	19.3	20.7	17.7	21.7	18.1	14.6	21.8	16.0	8.6	74.7	12.7	29.5	19.8	17.2	15.8	25.7	14.9	12.2	19.3	16.9	9.9	17.8	10.5	16.9	23.0	34.1	26.2	23.6	26.5	13.4	13.3	25.4	14.8	17.3	12.8	3.1	2.8	4.3	3.2	2.9	2.7	2.5	2.7	2.6	2.4	2.4	2.3	2.9	55.1	4.3	4.5	5.5	1.7	1.2	23.2	24.3	27.1	27.2	24.7	19.6	23.1	13.7	19.6	23.1	53.6	33.1	41.7	69.2	138.9	39.0	58.4	94.3	28.1	45.5	455.4	27.5	88.3	104.5	97.1	10.8	89.6	83.8	93.5	79.0	356.6	77.0	126.4	39.3	76.9	61.7	49.3	71.2	62.0	61.6	4.2	67.3	70.3	55.6	119.0	76.9	41.2	124.5	79.5	82.0	81.7	31.3	64.7	79.6	48.8	70.5	212.0	37.3	67.5	84.5	98.4
RALGAPA1	"DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1"	ENSG00000174373	"Ral GTPase activating protein catalytic alpha subunit 1"	Q6GYQ0	14	35538352-35809304	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 371.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000851	Approved		Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"HPA000851: AB_1078945"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.90e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.46e-1)"	13.9	21.8	19.5	13.1	25.6	8.3	22.5	31.7	28.3	20.2	18.3	23.2	13.6	10.7	21.0	19.2	15.1	15.0	13.0	11.7	21.8	22.2	17.1	13.9	13.4	11.7	21.5	17.9	28.1	15.4	43.6	42.6	10.1	28.1	20.4	20.2	14.2	15.0	15.2	15.9	27.0	13.8	17.5	23.6	11.6	14.1	13.7	21.3	14.9	21.3	12.2	13.0	15.0	19.2	1.6	1.5	0.1	1.1	2.3	3.3	0.5	5.7	6.7	9.1	8.0	13.8	10.7	5.8	4.3	4.8	5.4	5.1	4.2	5.1	5.7	6.4	5.7	7.6	9.5	10.8	8.3	5.5	12.2	4.7	5.2	8.7	20.2	7.2	8.7	8.5	7.7	15.0	4.8	12.1	9.1	7.6	11.5	5.0	14.5	5.0	9.2	6.6	4.1	3.9	14.3	10.8	5.3	6.4	3.4	10.9	9.2	8.5	13.8	9.2	15.4	7.4	9.1	14.7	4.3	6.9	5.5	4.1	6.2	5.3	11.8	10.7	7.3	2.6	5.7	5.9	0.0	0.6	0.1	2.4	1.1	3.3	1.6	2.5	3.1	1.1	1.3	1.8	2.5	0.1	2.3	0.9	1.5	2.7	0.5	19.5	25.6	31.7	26.0	21.8	22.2	21.5	17.9	28.1	21.3	14.9	25.7	18.7	22.2	33.9	87.3	18.1	17.8	18.7	31.8	22.7	371.1	9.0	0.0	11.1	12.0	26.1	25.2	0.0	13.7	4.6	28.2	31.9	54.1	13.9	8.1	49.3	29.9	16.0	7.8	4.7	31.7	16.0	18.6	13.6	22.7	37.9	12.8	28.1	27.3	8.2	125.6	38.8	34.0	37.1	36.6	40.4	12.7	20.0	26.9	23.1
RALGAPA2	"AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2"	ENSG00000188559	"Ral GTPase activating protein catalytic alpha subunit 2"	Q2PPJ7	20	20389552-20712488	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 47.7;SCLC-21H: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042707, HPA043622"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042707: AB_2678124, HPA043622: AB_2678585"	"unprognostic (7.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (3.77e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.33e-2)"	26.5	7.0	7.3	9.9	8.1	19.4	16.9	11.4	8.7	10.6	12.7	9.6	14.9	10.5	15.2	9.6	8.9	10.7	13.0	7.8	8.3	4.2	11.0	26.4	26.5	13.0	10.8	4.4	8.0	18.5	14.1	20.9	18.5	7.4	13.2	13.5	8.2	22.6	12.8	26.0	15.3	10.0	9.6	8.4	8.2	18.1	8.6	9.3	8.2	23.2	6.0	10.2	13.9	15.7	1.7	2.0	7.0	2.1	2.6	2.4	0.6	3.5	2.3	4.7	2.5	2.4	1.9	5.3	0.9	0.9	1.2	1.5	1.9	4.9	1.6	3.1	1.4	5.1	3.7	4.9	4.0	2.2	7.1	2.4	5.4	1.2	3.3	0.9	6.9	3.2	1.7	3.1	1.9	0.9	2.0	6.7	7.5	1.1	3.0	1.8	2.3	2.6	9.2	2.0	11.3	2.1	3.8	3.2	2.2	4.1	47.7	26.7	2.3	3.6	2.6	3.0	4.7	1.8	6.6	1.7	1.9	1.8	1.4	1.3	1.7	1.2	0.7	1.6	4.5	2.6	5.9	2.1	6.0	1.7	0.7	2.4	1.4	1.1	1.6	1.0	1.7	2.1	1.5	7.0	2.6	1.6	2.0	1.4	0.6	7.3	8.1	11.4	8.7	8.3	4.2	10.8	4.4	7.4	9.3	6.0	34.4	5.2	8.3	9.4	35.1	8.9	48.4	26.8	14.8	14.0	25.5	7.9	1.7	18.0	18.9	55.4	19.6	0.0	21.5	4.6	5.2	14.5	8.1	37.6	10.2	49.3	23.6	58.3	18.1	6.4	1.7	8.1	8.5	4.6	24.1	10.1	20.9	21.0	6.3	9.2	13.0	12.9	6.2	8.6	10.7	14.4	9.4	9.6	26.2	25.0
RALGAPB	"DKFZp781M2411, KIAA1219, RalGAPbeta"	ENSG00000170471	"Ral GTPase activating protein non-catalytic beta subunit"	Q86X10	20	38472816-38578861	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051454	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA051454: AB_2681490"	"unprognostic (1.06e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (7.25e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	18.0	19.4	13.9	16.9	22.2	14.3	21.6	28.1	25.4	17.5	16.6	21.2	14.9	15.6	25.3	17.6	18.7	15.3	14.3	15.3	14.3	15.2	19.7	11.6	15.6	14.6	15.5	13.5	17.4	15.5	39.2	34.9	21.5	19.9	19.7	17.8	18.6	17.1	17.9	21.3	19.7	22.3	17.2	13.6	18.5	16.5	25.4	16.2	32.1	24.0	12.3	22.9	22.4	15.5	3.3	3.6	6.1	3.4	5.6	4.8	1.5	13.2	12.5	13.1	9.6	12.6	14.7	13.9	10.9	12.8	13.7	13.5	22.5	10.1	12.5	10.5	12.7	20.2	15.8	12.2	16.6	19.4	7.1	5.2	19.1	11.3	12.8	12.0	15.4	10.2	10.4	21.6	16.1	17.8	10.9	17.8	10.8	13.9	12.5	13.1	8.7	17.6	6.5	9.6	13.2	16.4	10.2	18.7	8.3	9.1	24.9	13.8	15.2	24.1	32.7	20.3	15.7	18.9	8.0	21.0	27.8	11.1	15.6	11.0	14.6	17.9	11.4	20.1	7.6	12.2	3.1	2.3	6.1	3.3	1.8	4.6	3.3	4.8	4.3	3.6	3.0	4.1	3.5	4.6	5.6	3.4	2.4	1.9	1.5	13.9	22.2	28.1	25.4	14.3	15.2	15.5	13.5	19.9	16.2	20.8	17.9	1.4	6.7	12.4	22.8	17.3	15.3	13.4	15.9	29.6	25.5	8.5	3.3	8.5	8.7	14.7	22.3	0.0	8.0	6.5	11.4	16.1	16.1	9.7	8.5	19.1	12.1	18.4	17.0	6.3	15.5	11.0	10.1	6.4	16.1	12.6	12.6	17.8	17.7	7.9	14.9	12.9	10.8	20.7	20.2	15.7	12.7	11.7	13.7	12.4
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912114	"FDA approved drug targets, Predicted membrane proteins"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 91.6;pancreas: 94.7"	"Cell type enhanced"	"Detected in many"	18	"Exocrine glandular cells: 240.1;monocytes: 755.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	16	"NK-cell: 30.0"	"Lineage enriched"	"Detected in many"	16	"NK-cells: 30.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.1;HDLM-2: 37.9;PC-3: 44.2;SH-SY5Y: 55.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA057814: AB_2683536"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.61e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.46e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.08e-3)"	3.5	13.8	22.4	9.4	23.9	1.2	1.6	7.8	22.5	34.1	38.8	9.9	8.9	24.9	91.6	21.7	8.9	29.1	19.0	61.7	19.6	15.4	3.1	13.4	3.1	3.3	18.0	12.7	8.4	94.7	1.0	1.6	4.5	14.6	25.5	3.5	1.5	1.5	25.1	62.4	2.4	14.4	51.8	19.5	2.4	14.2	4.3	17.1	0.0	1.1	5.4	2.0	18.3	14.0	0.1	0.4	0.2	0.0	30.0	1.8	1.4	7.9	0.0	0.1	0.0	3.4	5.3	0.3	0.5	0.9	0.5	0.4	0.0	13.1	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.0	37.9	1.0	0.0	0.0	0.2	10.7	0.0	0.0	4.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.7	0.0	0.3	0.1	0.0	44.2	0.0	0.4	0.2	0.0	0.0	0.4	55.7	0.8	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.2	0.1	0.2	30.0	0.0	0.0	0.0	1.4	22.4	23.9	7.8	15.3	19.6	15.4	18.0	12.7	14.6	17.1	0.0	1.0	0.5	11.4	10.3	2.1	136.4	91.7	14.7	9.1	10.4	0.0	2.1	0.0	55.5	0.2	4.2	4.9	0.0	240.1	7.5	28.8	73.7	1.1	137.8	18.7	1.6	110.7	51.5	4.0	0.4	7.8	6.3	60.8	755.6	26.2	3.3	79.4	4.0	10.6	0.0	2.3	6.5	86.3	0.0	4.9	5.1	1.9	3.2	6.6	3.8
RAMP2		ENSG00000131477	"Receptor activity modifying protein 2"	O60895	17	42758447-42763041	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 348.5;Ito cells: 252.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 47.1;EFO-21: 31.4;HUVEC TERT2: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052020			Approved	Vesicles		NA	NA			Vesicles		"HPA052020: AB_2681697"	"unprognostic (8.64e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-1)"	48.6	7.1	8.6	7.6	9.6	0.2	43.4	3.4	15.4	35.1	9.7	10.8	6.1	5.2	49.5	24.2	19.5	17.0	20.4	23.9	9.6	8.5	18.8	14.6	51.5	17.3	13.8	7.7	17.3	9.6	5.6	6.1	56.1	12.5	24.9	9.1	71.1	12.8	12.2	16.2	15.6	11.5	30.9	8.8	15.6	9.2	10.9	3.0	3.9	20.0	30.1	11.7	13.2	23.1	0.0	6.4	0.0	0.1	0.0	0.3	0.0	0.0	0.4	1.9	0.0	47.1	2.4	1.5	0.3	0.7	3.9	1.9	4.3	0.0	0.0	31.4	1.1	0.2	0.0	1.8	0.0	3.3	0.0	0.0	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.0	0.6	0.1	1.3	14.1	0.5	0.0	0.1	0.2	0.0	0.2	0.3	9.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.9	3.9	1.1	0.0	6.4	1.9	0.4	1.2	2.6	7.6	2.8	0.2	0.9	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.3	0.0	8.6	9.6	3.4	15.4	9.6	8.5	13.8	7.7	12.5	3.0	0.0	10.1	5.1	4.4	30.6	0.1	1.7	0.0	0.0	1.2	3.5	0.0	1.0	3.3	0.7	1.1	348.5	0.0	0.0	0.6	1.2	42.9	4.5	0.0	0.9	2.8	0.0	4.1	252.3	12.4	3.1	35.9	3.2	21.9	4.6	0.0	8.9	0.0	0.0	20.5	0.4	1.6	6.5	9.5	11.2	60.0	24.1	1.3	2.5	0.0	4.1
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.3"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 76.6;Late spermatids: 31.1;Spermatocytes: 27.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nuclear membrane,Nuclear bodies,Cytosol"		Yes	No			"Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	1.6	4.9	1.3	1.8	2.1	0.8	1.8	10.4	3.6	1.8	2.0	2.9	1.1	1.5	5.3	2.8	1.0	2.2	2.7	1.5	1.4	2.2	2.4	1.8	4.1	2.4	1.5	1.7	1.8	7.2	3.6	9.4	5.0	5.3	2.4	2.3	5.4	5.1	2.7	1.0	1.1	2.6	2.4	3.1	1.0	2.5	16.3	0.4	0.1	4.7	0.1	1.4	1.5	1.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.1	5.5	4.5	1.5	0.5	3.4	4.0	1.8	2.9	1.7	2.3	0.0	0.1	3.3	3.8	0.0	0.0	0.0	1.7	5.8	0.0	4.3	1.1	2.2	0.0	1.6	0.0	0.0	4.5	0.3	0.3	0.0	0.3	2.6	0.0	0.4	0.0	1.6	2.8	0.0	0.0	0.4	0.8	0.5	0.0	3.6	0.0	0.9	1.4	0.3	2.0	0.0	5.5	2.8	2.5	0.9	1.5	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	2.1	10.4	3.6	1.4	2.2	1.5	1.7	5.3	0.4	8.9	1.3	0.0	5.2	0.2	20.8	1.4	5.1	0.0	2.3	0.0	13.7	8.7	0.0	6.3	76.6	2.8	2.8	0.0	1.2	2.7	2.6	5.1	0.0	1.3	1.6	0.0	5.2	3.1	1.2	31.1	2.6	0.0	1.7	1.8	3.3	5.6	3.6	3.5	2.8	0.7	24.1	0.0	2.2	27.1	24.0	0.0	2.1	0.0	4.5	6.1
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.3;thyroid gland: 72.5"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 66.1;Distal tubular cells: 61.3;Horizontal cells: 87.4;Mucus-secreting cells: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A549: 16.5;OE19: 57.5;SCLC-21H: 19.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 286.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.9	38.2	30.2	1.9	89.3	1.1	3.1	27.1	40.1	4.7	10.5	5.7	0.0	6.9	1.7	1.8	2.9	3.0	13.4	2.7	17.8	12.9	33.2	10.3	7.8	1.2	8.6	20.6	1.6	49.3	7.1	8.2	5.8	14.6	7.4	9.4	2.4	43.9	1.2	0.7	2.1	11.6	1.1	3.2	0.9	28.4	2.1	14.2	0.0	72.5	0.9	1.6	2.5	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.3	2.1	16.5	0.1	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	2.3	0.0	1.7	0.0	11.1	2.8	1.6	0.1	0.0	0.3	0.8	0.7	1.5	7.7	0.2	0.0	2.4	0.1	1.1	0.0	0.0	0.0	0.0	8.0	10.2	0.4	0.0	5.5	2.6	0.2	1.0	57.5	2.5	1.5	0.4	0.3	3.8	1.2	19.2	3.4	2.7	10.0	3.2	0.7	1.0	1.8	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	30.2	89.3	27.1	30.4	17.8	12.9	8.6	20.6	14.6	14.2	8.9	21.1	0.5	0.9	1.1	66.1	3.3	25.5	0.0	6.8	14.0	0.0	0.1	61.3	10.9	0.6	0.0	4.2	23.3	24.6	1.1	0.6	8.3	0.0	5.6	0.2	87.4	6.4	0.0	0.8	0.0	0.0	0.7	15.1	1.0	97.4	10.0	20.3	10.2	0.0	10.2	6.2	0.0	0.4	1.0	3.4	1.0	1.3	0.0	6.9	1.1
RAP1GAP2	"GARNL4, KIAA1039"	ENSG00000132359	"RAP1 GTPase activating protein 2"	Q684P5	17	2755705-3037739	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.5;pancreas: 26.0"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 31.4;Horizontal cells: 35.0;Intestinal endocrine cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022148, HPA022896"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA		110000	"Nuclear membrane, Cytosol"		"HPA022148: AB_1849474, HPA022896: AB_1849476"	"unprognostic (1.85e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.52e-5)"	"unprognostic (1.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (3.44e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.50e-2)"	1.2	4.6	6.7	2.9	13.5	16.8	3.1	27.5	22.9	2.7	5.3	2.2	0.0	5.9	3.7	1.0	2.5	5.8	2.7	9.9	6.5	6.3	3.9	0.7	3.4	3.4	4.3	16.4	3.3	26.0	4.5	8.0	3.3	15.8	2.6	5.6	2.6	9.0	3.5	0.8	2.7	5.5	2.3	4.3	3.2	15.4	2.3	3.1	1.6	2.1	0.3	3.0	1.6	2.2	0.5	3.0	7.2	6.3	2.9	5.2	2.0	4.5	5.7	1.1	4.7	0.0	0.0	9.4	6.1	2.9	0.8	0.7	12.5	2.0	1.7	1.7	0.8	8.0	6.3	3.7	11.5	0.2	0.0	4.0	2.1	8.0	5.6	1.1	0.4	2.3	0.3	10.0	3.2	8.3	4.3	0.1	2.1	11.8	0.8	0.0	5.1	1.7	1.1	6.8	2.2	5.5	7.6	4.0	4.4	3.5	2.3	12.7	30.9	8.9	9.2	4.0	4.6	4.6	1.3	1.4	5.4	8.6	0.9	5.2	0.0	0.0	0.7	0.3	3.9	8.7	1.5	2.3	3.3	5.2	4.7	2.0	0.5	1.7	3.7	1.8	0.4	0.3	1.9	7.2	2.9	6.3	3.0	1.6	2.0	6.7	13.5	27.5	22.9	6.5	6.3	4.3	16.4	15.8	3.1	6.0	4.5	1.3	5.8	1.8	13.0	14.2	7.6	4.0	2.3	12.2	31.4	5.9	8.3	5.3	3.4	1.4	6.8	0.0	10.5	4.8	2.9	11.6	5.8	0.4	2.9	35.0	46.3	2.5	13.9	5.4	1.7	3.9	3.3	1.0	20.7	2.0	11.4	21.0	1.4	0.6	4.7	0.0	2.8	0.4	3.0	0.4	2.9	4.3	12.1	9.6
RAPGEF3	"bcm910, cAMP-GEFI, EPAC"	ENSG00000079337	"Rap guanine nucleotide exchange factor 3"	O95398	12	47734367-47771040	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 66.3;Endothelial cells: 26.0;Proximal tubular cells: 32.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 22.3;HUVEC TERT2: 9.5;NB-4: 10.9;RPTEC TERT1: 10.7;TIME: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004386, HPA040365, HPA043518"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524"	"unprognostic (2.12e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (6.67e-7)"	"unprognostic (9.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.61e-3)"	"unprognostic (3.38e-2)"	26.5	2.8	18.2	3.0	19.7	1.9	22.1	3.9	23.0	12.7	4.8	28.8	19.4	4.7	10.6	11.9	10.4	15.9	13.7	15.9	20.7	7.3	22.8	1.6	6.9	4.7	24.2	14.9	30.9	5.4	4.9	3.0	9.8	19.1	7.1	3.2	3.3	20.5	16.9	10.6	6.9	4.8	6.0	12.0	10.9	6.3	2.5	27.4	0.0	27.3	4.8	2.7	8.6	11.5	1.1	0.6	0.5	0.7	0.0	1.2	0.4	1.8	0.5	0.6	1.9	0.2	1.9	0.6	1.4	1.1	0.5	0.3	0.2	4.7	0.1	22.3	2.3	0.9	1.9	0.7	3.4	0.3	2.3	0.3	0.2	1.7	0.1	0.1	0.3	0.2	0.7	0.3	1.0	0.6	2.9	9.5	0.4	0.1	2.4	0.4	1.2	0.0	10.9	0.5	0.7	3.0	0.3	0.1	0.8	10.7	2.0	0.2	0.3	0.2	1.3	0.3	0.7	5.1	0.4	9.5	5.6	0.9	1.2	0.4	1.0	0.3	0.1	3.4	2.3	0.6	0.0	0.7	0.0	0.1	0.4	0.6	0.5	0.1	1.2	0.3	1.1	0.2	0.3	0.5	0.0	0.5	0.6	0.4	0.4	18.2	19.7	3.9	23.0	20.7	7.3	24.2	14.9	19.1	27.4	0.0	13.2	0.0	3.9	2.4	0.6	10.6	0.0	2.7	3.4	66.3	0.0	0.2	6.6	0.7	0.9	26.0	0.4	0.0	0.6	0.3	4.1	6.6	3.5	0.0	0.8	0.0	0.0	18.4	0.3	2.1	22.5	1.5	5.0	0.0	5.5	1.2	3.5	2.9	8.1	32.2	0.3	6.5	2.1	0.6	0.8	2.9	0.2	0.0	0.4	18.0
RAPGEF4	"cAMP-GEFII, CGEF2"	ENSG00000091428	"Rap guanine nucleotide exchange factor 4"	Q8WZA2	2	172735274-173052893	"Predicted intracellular proteins"	Exocytosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.6;brain: 70.9"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 43.2;Endothelial cells: 30.4;Ito cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 68.3;basal ganglia: 31.5;cerebral cortex: 55.3;hippocampal formation: 70.9;olfactory region: 23.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 18.0;SCLC-21H: 7.0;U-266/70: 9.3;U-266/84: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004388, HPA028968"	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"CAB004388: AB_670916, HPA028968: AB_2672846"	"unprognostic (1.87e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.98e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.93e-1)"	3.3	29.6	68.3	1.6	31.5	0.6	5.2	10.9	55.3	4.9	1.5	5.4	1.0	2.1	6.6	2.7	2.3	2.9	3.7	5.7	70.9	10.2	3.8	24.6	5.4	1.7	10.0	23.8	9.7	2.0	3.2	2.4	2.3	8.6	3.5	1.7	11.3	1.7	2.9	1.4	10.6	1.8	4.3	2.9	0.9	5.4	3.7	11.5	0.0	4.3	0.9	1.8	4.2	1.2	0.4	0.6	1.4	0.6	0.6	0.7	0.1	0.1	0.1	2.7	0.4	0.0	0.2	0.1	0.9	0.5	0.1	0.2	0.0	3.1	0.0	0.2	0.0	0.2	0.5	2.3	0.6	0.3	0.1	4.8	0.4	2.3	0.0	0.0	3.0	0.8	0.0	0.7	0.0	0.0	2.7	2.9	1.3	0.0	18.0	0.1	0.0	0.2	0.2	0.3	1.5	0.3	0.0	0.6	0.0	0.0	5.4	7.0	2.6	0.1	0.1	0.9	1.4	0.1	0.1	0.8	0.1	0.3	0.0	0.2	9.3	18.0	0.0	0.3	0.1	0.2	1.4	0.4	0.4	0.3	0.4	0.6	0.4	0.4	0.3	0.3	0.4	0.6	0.7	1.0	0.6	0.6	0.6	0.3	0.1	68.3	31.5	10.9	55.3	70.9	10.2	10.0	23.8	8.6	11.5	3.0	3.2	0.9	1.0	5.5	2.5	6.7	0.0	0.0	0.0	0.0	43.2	0.1	0.0	0.6	2.1	30.4	0.0	0.0	2.3	0.0	0.9	0.5	0.0	9.9	0.1	1.6	7.5	23.9	1.9	1.1	4.0	0.0	3.3	0.0	0.2	1.2	2.4	0.0	1.4	0.0	8.9	0.0	1.4	0.5	2.0	3.3	0.1	0.0	0.0	0.6
RAPGEF6	"PDZ-GEF2, PDZGEF2, RA-GEF-2"	ENSG00000158987	"Rap guanine nucleotide exchange factor 6"	Q8TEU7	5	131423921-131635236	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037982, HPA037983"	Approved		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: AB_2675769"	"unprognostic (1.86e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.72e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.81e-4)"	7.2	7.3	8.4	15.2	11.2	15.7	9.9	34.1	12.7	7.2	6.7	13.7	6.1	5.0	6.9	5.9	6.5	6.1	7.7	6.6	9.4	10.5	6.2	8.4	9.5	24.6	13.1	9.0	8.6	6.2	12.5	9.5	8.0	17.1	7.2	7.8	5.4	6.9	7.9	6.9	8.1	7.3	6.9	10.9	11.3	6.5	19.7	14.5	21.2	7.1	5.5	22.0	7.7	7.2	5.4	1.6	8.7	2.0	5.3	14.2	5.4	7.0	5.1	7.2	6.7	3.8	4.3	6.9	7.8	6.2	6.7	10.1	9.3	5.0	16.5	5.2	5.2	10.3	5.7	10.0	8.2	13.6	8.0	5.5	10.4	7.4	5.0	3.1	7.2	11.0	3.1	3.9	9.7	9.5	4.7	5.9	9.3	5.9	10.0	5.9	3.6	7.4	5.8	3.1	3.9	3.8	11.1	10.4	8.7	4.8	5.5	24.9	5.7	8.1	3.7	9.7	8.2	5.2	6.3	5.7	8.9	6.3	7.1	8.9	5.8	6.9	17.9	5.1	9.5	7.5	1.4	1.7	6.3	6.3	2.0	10.7	4.5	8.5	6.8	1.4	5.4	14.2	10.1	8.7	5.3	1.5	1.6	9.6	5.4	8.4	11.2	34.1	12.7	9.4	10.5	13.1	9.0	17.1	14.5	11.9	16.2	5.3	4.7	14.1	10.0	3.6	0.0	8.1	7.9	7.0	19.6	4.9	1.7	3.6	30.7	3.8	3.6	0.0	2.4	2.9	7.4	5.7	2.3	4.4	6.6	1.6	13.3	8.0	11.4	13.2	4.0	11.2	13.5	7.2	7.8	4.2	3.8	5.8	4.9	1.9	8.8	0.0	5.1	11.6	10.6	15.3	5.8	14.4	6.8	4.7
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7;skin 1: 87.1"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 40.4;Enterocytes: 66.1;Paneth cells: 46.5;Suprabasal keratinocytes: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 39.0;hTCEpi: 19.5;T-47d: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Nucleoplasm, Microtubules"	"Cytokinetic bridge"	"HPA022895: AB_1856071"	"prognostic favorable (8.43e-4)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	1.5	1.3	15.9	2.7	17.2	1.8	4.1	8.2	22.7	8.9	19.5	1.8	0.9	18.8	1.6	4.3	37.7	2.9	5.9	1.1	11.2	6.2	0.6	1.7	1.6	1.1	2.8	20.2	0.8	1.6	0.8	2.7	1.2	5.5	3.4	17.7	1.3	5.7	3.2	4.6	87.1	15.5	2.0	1.9	1.4	12.6	2.4	2.9	0.2	0.9	13.3	10.7	6.5	19.4	0.1	0.9	2.9	0.4	0.0	0.6	0.0	2.1	1.1	5.8	4.3	0.6	1.4	2.8	0.8	0.6	1.1	1.3	2.4	3.1	1.7	0.8	1.1	1.0	39.0	1.1	1.3	1.6	3.1	2.9	1.0	1.3	2.4	0.7	2.1	3.6	1.6	19.5	1.2	0.5	1.7	1.7	5.8	0.7	1.2	0.8	6.0	1.9	2.5	1.8	10.7	1.1	3.6	0.7	1.0	0.7	11.4	11.2	2.3	1.3	13.2	0.5	5.1	34.1	1.6	3.3	1.4	2.9	1.5	1.3	1.9	1.8	1.4	3.3	1.3	1.7	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.4	0.4	0.9	0.0	0.1	0.2	2.9	0.0	0.4	0.2	0.0	0.0	15.9	17.2	8.2	22.7	11.2	6.2	2.8	20.2	5.5	2.9	0.0	0.6	0.8	9.6	40.4	2.1	1.6	20.4	0.0	1.2	1.8	5.9	0.1	0.0	0.5	2.4	1.6	66.1	0.0	0.7	0.2	1.0	5.0	5.7	3.8	0.5	1.6	4.7	4.9	0.8	1.4	3.1	1.6	5.0	1.8	32.6	2.8	1.2	46.5	3.5	0.0	4.6	0.0	1.4	11.5	10.4	84.8	0.6	0.0	32.3	31.9
RAPH1	"ALS2CR18, ALS2CR9, KIAA1681"	ENSG00000173166	"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1"	Q70E73	2	203394345-203535410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 68.3;Ito cells: 89.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.8;non-classical monocyte: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA016744, HPA020027"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nuclear bodies, Plasma membrane"	Cytosol	"HPA016744: AB_1844781, HPA020027: AB_1844782"	"unprognostic (9.78e-2)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.79e-1)"	11.0	6.1	7.3	6.3	7.6	2.7	17.6	8.4	12.7	9.8	7.9	3.7	6.8	6.9	6.8	8.4	9.2	6.3	12.5	8.3	5.2	5.0	8.2	51.1	17.2	6.8	4.2	8.4	3.6	5.8	4.0	9.9	11.1	6.0	7.2	6.7	8.5	11.2	4.4	8.3	10.2	10.2	7.1	4.8	26.7	7.8	7.9	3.1	1.7	25.8	7.9	5.6	9.6	8.7	0.0	1.1	0.0	2.8	1.1	0.6	0.3	5.5	3.8	8.1	4.6	6.4	8.3	7.2	7.7	5.7	8.0	10.2	17.7	5.9	0.0	1.9	11.7	5.9	2.7	4.2	6.6	16.8	1.1	2.4	0.0	9.2	3.1	16.0	0.0	0.1	11.5	5.6	14.7	15.5	8.8	12.5	0.8	0.4	4.3	16.0	3.1	0.0	0.0	4.8	2.8	4.9	0.1	11.5	3.1	5.8	17.9	2.8	3.8	5.3	5.1	6.4	11.2	2.8	0.2	14.8	19.8	6.4	9.4	8.1	2.0	3.4	0.0	16.3	0.1	4.4	0.0	0.8	0.0	0.2	2.8	0.6	0.0	0.5	0.1	1.1	0.0	0.4	0.1	0.0	1.1	2.6	0.1	0.5	0.3	7.3	7.6	8.4	12.7	5.2	5.0	4.2	8.4	6.0	3.1	14.9	6.7	2.2	16.6	43.6	9.3	0.8	15.3	5.3	10.3	14.0	13.7	7.1	6.6	5.8	10.1	18.9	21.2	0.0	8.0	5.9	19.4	17.6	1.1	68.3	15.3	9.5	2.4	89.0	14.9	3.2	4.4	15.9	11.8	2.8	7.2	20.0	14.3	14.0	4.6	2.4	4.6	19.4	16.1	15.7	10.4	35.8	9.2	1.8	11.2	19.1
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437757-47449178	"Disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"skeletal muscle: 45.3;tongue: 14.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 10.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"RH-30: 72.9"	"Low region specificity"	"Detected in single"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	1.7	0.8	0.2	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	2.7	0.7	0.1	0.1	1.4	0.4	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.4	0.0	0.3	0.8	0.0	45.3	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.4	14.8	0.4	0.0	0.0	0.2	0.1	2.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.7	0.0	2.6	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.3	10.0	0.0	0.0	0.0	1.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309192-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 26.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 63.9;SK-BR-3: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058282, HPA071548"			Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Actin filaments, Cytosol"	"HPA058282: AB_2683666, HPA071548: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	27.6	13.5	5.0	18.6	7.6	32.3	23.7	11.5	15.2	30.2	29.6	5.0	16.8	18.0	23.8	23.9	17.3	23.3	30.2	24.3	5.9	6.1	14.6	24.0	32.0	23.4	4.6	7.8	50.0	9.3	7.4	18.1	16.6	6.5	22.9	8.5	26.8	12.1	32.7	43.1	14.3	31.6	18.6	3.7	31.1	14.3	21.8	2.9	9.7	16.3	15.4	20.2	31.5	20.3	1.0	6.1	26.6	9.3	2.5	2.6	1.9	5.1	12.1	3.6	6.1	7.1	10.9	3.6	4.2	6.4	6.2	4.0	8.3	4.4	2.7	6.6	9.5	5.7	15.0	4.1	10.0	3.6	20.5	6.1	7.8	6.1	8.1	11.4	2.8	24.7	15.3	2.9	6.6	8.4	23.7	9.2	2.4	4.9	6.0	7.0	63.9	1.8	9.5	3.1	4.7	3.8	3.6	21.3	10.3	3.6	4.1	1.5	12.4	9.0	40.6	12.4	3.6	38.2	11.2	10.7	7.8	13.3	13.6	4.6	14.4	4.8	2.3	13.1	5.5	23.0	8.7	4.2	15.7	1.6	6.9	2.6	1.0	1.7	1.7	6.1	0.9	0.8	1.3	26.6	2.5	9.3	1.8	1.4	1.9	5.0	7.6	11.5	15.2	5.9	6.1	4.6	7.8	6.5	2.9	3.0	9.5	5.6	22.6	17.3	24.2	3.2	10.2	4.0	2.3	7.0	5.9	1.9	11.6	14.3	58.0	20.4	52.7	0.0	16.9	5.1	23.8	11.2	34.6	22.8	11.3	3.2	9.2	22.7	35.4	50.8	38.6	37.4	27.0	0.0	14.2	9.3	16.8	24.6	21.5	11.8	8.2	32.3	33.0	2.9	6.9	16.6	4.3	11.5	13.2	19.2
RARRES1	"LXNL, TIG1"	ENSG00000118849	"Retinoic acid receptor responder 1"	P49788	3	158696892-158732696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 105.0;vagina: 111.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 153.1;Glandular cells: 151.9;Paneth cells: 100.4;Urothelial cells: 237.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"CAPAN-2: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003892	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA003892: AB_1856079"	"unprognostic (5.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.09e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.88e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	49.4	6.1	0.4	26.5	0.5	0.0	54.5	0.3	0.4	18.5	29.9	0.6	10.0	2.1	6.8	24.2	11.5	40.6	8.3	105.0	0.6	0.3	26.8	2.7	13.4	13.3	0.5	0.5	75.5	3.9	0.0	19.7	1.6	2.0	46.2	15.7	19.4	49.0	17.9	10.5	3.3	9.3	20.7	2.4	3.2	6.6	19.0	0.2	1.0	31.5	1.7	5.9	39.6	111.3	1.0	1.2	0.0	0.9	0.2	0.7	0.1	2.5	0.8	0.0	0.1	0.5	1.6	0.0	0.2	0.7	0.1	0.2	0.1	162.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	17.8	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.2	2.2	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.4	1.0	0.7	0.3	0.0	0.2	0.9	1.2	0.3	0.1	0.4	0.5	0.3	0.4	0.6	0.3	0.5	0.5	2.0	0.2	0.0	1.1	0.0	153.1	0.5	0.4	0.8	7.6	28.1	30.7	14.0	0.0	2.4	0.0	8.0	19.5	1.6	68.0	0.0	4.2	0.6	13.4	151.9	29.9	3.8	10.7	0.0	35.9	16.5	1.5	25.5	10.0	2.9	5.0	0.0	75.6	3.4	1.6	100.4	1.1	18.7	0.4	0.0	1.0	2.3	0.5	0.4	9.5	0.0	69.1	237.5
RARS	DALRD1	ENSG00000113643	"Arginyl-tRNA synthetase"	P54136	5	168486445-168519299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	21.8	26.3	16.0	18.3	15.3	6.2	22.6	17.1	18.4	21.2	29.4	9.1	20.4	33.3	22.9	21.4	34.7	19.5	14.4	21.7	19.8	12.3	29.8	33.5	18.7	18.6	13.9	15.2	21.3	33.0	19.9	34.5	30.3	15.8	18.9	27.4	15.5	34.0	15.4	27.8	27.9	48.7	21.5	14.5	22.1	24.4	17.2	11.8	20.5	21.5	32.3	23.7	22.4	22.6	11.1	21.8	5.2	17.7	16.8	16.3	11.7	27.2	32.4	24.0	26.6	33.2	38.1	41.3	40.2	34.6	41.9	49.0	55.0	29.8	29.0	33.0	38.2	43.1	26.5	31.4	54.1	54.7	30.1	21.6	19.5	29.5	34.5	28.8	46.0	20.8	29.2	28.9	45.6	21.9	25.8	33.5	15.9	29.1	14.7	44.8	25.2	19.1	18.3	39.4	24.0	22.1	8.4	35.0	27.6	37.3	31.1	22.9	28.2	30.7	35.5	41.5	30.5	32.3	19.3	33.2	30.4	27.9	23.4	46.8	14.7	26.9	29.8	33.1	32.9	28.8	3.4	14.4	5.2	12.5	17.7	14.3	11.1	12.6	13.3	21.8	6.6	15.6	16.3	4.0	16.8	16.4	10.3	12.8	11.7	16.0	15.3	17.1	18.4	19.8	12.3	13.9	15.2	15.8	11.8	53.6	32.3	25.1	37.6	26.3	25.0	43.6	35.7	46.8	39.8	24.4	25.5	88.8	14.9	80.1	16.6	27.5	40.6	23.3	83.1	79.2	34.8	24.5	26.6	31.4	51.1	12.7	12.6	33.2	24.6	11.6	23.0	35.0	27.0	72.1	36.7	22.7	61.2	38.7	23.0	36.0	22.7	19.4	28.9	27.7	42.2	31.1	70.5	20.1	44.8	35.2
RARS2	"DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL"	ENSG00000146282	"Arginyl-tRNA synthetase 2, mitochondrial"	Q5T160	6	87514378-87590003	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039987, HPA042645"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039987: AB_2676786, HPA042645: AB_2678097"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.16e-3)"	27.0	44.1	13.3	21.1	15.9	16.0	22.9	24.0	17.3	25.1	21.4	18.6	25.2	17.5	35.5	25.5	20.4	21.1	19.2	21.5	14.4	12.8	23.7	32.1	20.5	24.4	17.3	14.2	22.2	30.1	20.5	36.9	28.3	17.2	20.7	23.1	24.0	23.5	27.7	23.0	20.4	30.5	24.7	16.8	21.1	20.5	23.9	13.6	28.0	21.2	20.5	27.3	24.3	20.2	16.7	18.9	22.8	20.2	18.1	28.8	16.2	10.1	10.1	24.3	26.4	24.7	27.0	17.3	24.4	29.2	16.9	21.5	19.4	11.4	12.9	14.5	25.0	17.1	14.2	20.4	14.0	24.0	9.5	19.3	13.3	12.8	30.8	31.1	15.7	11.5	26.9	13.6	14.2	18.1	23.7	22.2	13.6	30.7	12.8	24.9	18.7	5.1	16.7	15.8	21.8	10.9	10.3	24.5	11.3	20.8	21.4	22.0	29.7	12.8	6.4	17.1	21.4	11.9	24.0	15.1	11.2	9.0	12.3	20.1	13.6	22.8	10.7	17.6	16.6	19.4	15.9	19.1	22.8	18.1	19.3	21.3	16.7	23.4	17.0	16.7	16.2	23.0	19.1	11.6	18.1	20.2	18.9	28.8	16.2	13.3	15.9	24.0	17.3	14.4	12.8	17.3	14.2	17.2	13.6	17.9	14.1	14.5	30.7	15.3	13.2	19.7	7.6	20.1	26.1	10.4	19.6	27.0	38.1	25.7	69.3	24.2	16.2	0.0	41.3	37.9	29.7	24.9	17.4	13.2	18.2	6.4	8.6	22.7	14.8	27.7	23.6	14.2	18.6	22.6	23.2	12.1	29.9	21.8	22.6	23.7	15.6	25.8	24.7	38.7	31.1	15.7	33.1	21.8	24.1	29.1
RASA2	GAP1M	ENSG00000155903	"RAS p21 protein activator 2"	Q15283	3	141487047-141615342	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035374, HPA035375"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA035374: AB_10602122, HPA035375: AB_2674596"	"unprognostic (1.85e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.36e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.23e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (7.62e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.34e-5)"	12.0	7.4	11.1	25.2	10.6	26.8	14.4	20.8	12.2	13.4	12.7	7.9	7.7	7.7	19.1	11.2	11.6	11.3	9.9	7.4	8.7	9.9	9.3	7.5	14.4	27.1	8.2	7.8	16.2	8.7	9.2	15.0	12.2	8.7	10.5	10.8	11.4	13.2	9.4	6.1	15.7	12.9	12.3	11.2	21.4	8.2	6.7	7.8	25.4	10.1	7.3	23.6	11.8	14.0	10.5	3.4	14.4	5.9	11.5	17.7	5.8	16.0	3.0	6.5	4.9	7.2	8.9	9.3	11.7	23.1	7.6	9.4	6.9	5.3	10.3	8.1	10.1	7.3	6.7	4.6	5.0	13.9	5.5	4.5	5.5	2.4	2.5	3.8	10.4	14.5	5.2	4.6	6.9	8.2	9.2	9.6	8.9	4.9	13.4	7.5	2.3	13.6	8.6	7.5	5.4	2.2	5.1	11.0	12.7	7.5	5.8	2.3	4.7	9.3	8.3	8.5	7.1	4.1	7.9	8.0	9.0	4.1	12.4	5.2	21.9	6.4	13.9	7.8	7.2	4.4	7.7	3.7	3.8	11.9	3.7	11.7	7.0	10.6	11.9	3.4	10.5	17.7	13.5	14.4	11.5	5.9	2.6	9.7	5.8	11.1	10.6	20.8	12.2	8.7	9.9	8.2	7.8	8.7	7.8	41.7	23.4	14.6	30.7	19.2	15.7	6.1	10.2	12.0	21.6	12.2	35.3	15.3	1.7	15.2	84.9	16.3	12.7	23.3	14.3	6.1	14.4	45.5	30.1	8.7	10.8	28.6	15.1	15.4	26.9	4.6	12.7	26.0	11.8	7.2	16.3	17.5	21.7	16.1	13.4	7.0	56.0	6.5	21.5	14.2	13.9	24.0	11.0	50.3	15.9	49.5
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616757	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 58.0"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 65.5;Intestinal endocrine cells: 69.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 27.6"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	5.5	2.3	4.2	2.5	2.6	1.6	4.4	2.7	4.7	4.9	4.0			3.6	6.3	1.8	1.9	3.6	1.9	1.5	3.6	3.0	3.3	0.2	2.7	3.6	1.9		4.1	2.1	6.8	3.7	4.0		3.3	1.6		2.0	5.6	58.0	5.4	4.3	3.2	1.2	4.1	2.2	0.6			2.2		2.4	3.9	4.7	3.6	11.3	2.2	9.4	1.5	3.7	3.1	0.7	1.2	9.2	1.9	1.7	4.7	0.3	9.4	4.8	3.2	3.3	3.8	2.7	7.2	7.0	14.3	0.3	9.2	0.4	0.1	2.4	1.3	2.4	2.0	3.7	0.9	1.8	1.3	2.7	4.4	1.1	0.8	0.4	12.3	1.6	4.9	3.2	10.6	0.7	3.7	7.2	5.0	0.7	5.0	4.8	9.9	2.0	10.3	0.3	3.5	9.0	18.8	1.7	2.2	1.2	6.1	1.9	3.6	2.3	27.6	13.4	3.1	2.4	16.8	10.3	6.2	3.4	3.0	3.4	0.4	8.4	0.3	1.9	9.4	3.7	2.8	3.2	2.2	11.3	3.6	3.4	2.4	2.2	1.5	1.2	9.8	3.5	3.1											11.9	10.4	6.0	4.5	3.4	65.5	0.6	2.5	6.7	7.9	3.5	15.7	0.2	11.6	1.1	0.4	10.8	6.2	0.0	0.6	0.1	2.3	0.9	1.1	0.8	5.8	27.0	69.0	3.7	8.0	0.0	7.8	16.2	1.7	2.8	12.1	5.8	1.4	2.9	7.4	7.5	11.0	12.9	7.2	2.1	2.3	3.0	0.3	5.0	1.9	2.7
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102482445-102517781	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 47.4"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 2.3;Cardiomyocytes: 4.0;Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 6.2;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 9.1;SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.2"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	2.9	1.1	2.3	1.4	1.2	0.0	2.1	0.5	4.4	3.2	2.4			2.5	4.1	0.0	0.6	1.5	1.3	0.5	1.8	2.0	0.9	0.1	0.8	1.3	1.1		2.2	0.9	0.0	1.1	1.7		1.5	0.0		0.7	3.7	47.4	1.8	3.0	0.5	0.5	1.9	0.8	0.2			0.3		0.2	1.4	2.3	0.1	6.2	0.0	3.7	0.0	0.2	1.8	0.2	0.9	3.2	0.2	0.5	1.9	0.1	5.7	3.1	1.2	2.9	0.2	0.4	2.2	6.4	6.6	0.5	7.7	0.0	0.0	0.0	0.2	0.7	0.3	1.7	0.5	0.0	0.0	0.2	2.1	0.3	0.0	0.0	9.1	0.8	0.1	0.6	8.1	0.7	2.2	0.0	1.1	0.0	0.3	0.9	2.3	1.1	3.6	0.0	0.8	2.2	11.8	0.9	0.2	0.2	2.2	0.2	1.6	1.0	16.5	14.2	1.3	0.5	2.7	1.9	0.2	1.9	0.4	2.6	0.0	3.7	0.0	0.2	3.7	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.6	3.9	0.0	1.8											0.0	1.1	0.5	0.2	0.3	2.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.4	0.0	0.3	0.0	0.3	0.7	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.1	0.4	0.0	0.9	0.2	0.0	1.0	0.1	0.5	0.0	0.1
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 64.0"	"Cell type enriched"	"Detected in many"	9	"Collecting duct cells: 34.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.5;EFO-21: 11.1;REH: 12.3;RPMI-8226: 27.4;RPTEC TERT1: 10.9;U-698: 23.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7"	HPA041650	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.9	10.4	8.6	2.5	11.2	1.2	1.6	0.4	18.2	2.5	2.1	18.8	3.7	1.2	0.9	0.9	16.9	2.2	1.8	0.8	11.8	4.9	7.4	0.9	0.9	1.7	7.3	10.9	0.8	1.4	64.0	3.9	1.0	4.0	0.9	1.7	0.0	22.4	7.4	0.8	8.0	1.1	0.9	1.8	1.0	9.6	1.1	8.4	0.0	8.0	6.0	5.0	1.0	3.7	0.4	0.2	1.3	0.2	0.3	1.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	8.5	11.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.3	0.0	0.0	0.3	3.0	0.0	12.3	0.0	27.4	10.9	0.0	0.3	0.0	0.0	4.1	0.0	0.0	1.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	1.3	0.2	0.1	0.1	0.0	1.6	0.2	0.9	0.4	0.0	0.4	1.2	0.5	0.4	0.3	0.0	0.2	0.4	0.3	8.6	11.2	0.4	18.2	11.8	4.9	7.3	10.9	4.0	8.4	0.0	0.0	0.5	0.0	0.5	0.5	3.5	2.5	0.0	0.0	34.9	0.0	1.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	2.1	1.7	1.8	4.1	2.3	3.0	3.5	0.0	3.9	0.0	0.0	0.1	0.0	0.3	1.0	1.0	0.0	2.3	0.4
RASAL2	nGAP	ENSG00000075391	"RAS protein activator like 2"	Q9UJF2	1	178094141-178484147	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 143.3;Rod photoreceptor cells: 179.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018805, HPA020453"	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA018805: AB_1856085, HPA020453: AB_1856086"	"unprognostic (5.55e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.05e-4)"	13.5	3.8	4.2	2.8	5.1	0.4	7.1	2.7	8.5	9.5	4.2	3.7	4.2	2.4	10.9	5.5	24.4	5.8	9.0	15.5	3.8	5.9	7.1	2.7	9.2	1.5	4.0	6.5	6.3	5.0	6.1	6.7	21.2	5.6	5.0	4.3	10.7	9.6	4.5	8.3	7.5	3.3	7.1	3.8	2.9	3.7	9.0	2.7	0.0	5.0	13.1	4.8	5.6	13.2	2.1	0.5	1.4	0.6	0.3	0.1	0.0	16.3	5.4	7.1	2.3	4.8	6.5	9.9	8.2	8.0	7.0	5.3	8.6	8.7	0.0	13.7	8.0	11.5	13.8	5.7	13.1	6.5	0.0	3.1	0.0	5.7	3.4	5.7	2.3	0.3	20.4	2.6	8.3	30.0	7.3	6.3	0.0	0.5	0.0	9.7	1.7	0.0	1.9	5.3	3.1	1.0	0.1	2.9	0.0	3.8	2.2	5.5	2.7	6.4	5.0	5.0	6.3	5.8	2.6	11.9	9.3	9.5	9.7	10.9	3.6	0.0	0.0	7.3	1.2	6.6	1.4	0.4	0.1	0.1	0.3	0.0	0.6	0.0	0.0	0.2	2.1	0.1	0.1	0.8	0.3	0.6	0.5	0.0	0.0	4.2	5.1	2.7	7.1	3.8	5.9	4.0	6.5	5.6	2.7	71.5	11.7	1.4	7.8	14.2	47.0	33.2	17.8	37.5	14.8	15.7	143.3	11.6	5.0	19.0	12.3	41.2	5.2	0.0	10.9	12.1	14.7	18.7	7.0	5.4	15.0	79.4	32.7	43.0	2.5	5.1	18.1	13.1	3.3	12.6	14.6	22.8	23.0	2.9	21.5	5.7	179.6	64.7	27.8	28.6	32.2	21.1	35.0	0.7	12.8	29.3
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464571	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.9"	"Group enriched"	"Detected in many"	5	"B-cells: 38.9;granulocytes: 39.2;T-cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 14.4;HEL: 11.9;HMC-1: 23.1;Karpas-707: 25.7;NB-4: 13.1;RPMI-8226: 10.9;TIME: 17.1;U-937: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	2.8	2.1	3.1	19.2	3.8	16.7	1.7	0.5	1.9	1.4	3.4	4.6	0.7	3.6	1.7	1.1	3.0	1.9	4.5	1.1	4.1	1.8	3.3	2.8	8.0	23.5	4.5	1.3	0.9	1.3	0.3	1.4	0.8	3.7	2.3	1.9	1.5	7.5	1.1	0.7	1.2	14.5	0.9	5.1	29.9	4.0	0.6	4.6	27.3	3.1	1.6	28.9	4.5	2.0	2.9	3.2	8.8	9.3	8.9	16.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	11.9	0.0	0.0	0.2	9.5	23.1	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	25.7	0.0	0.1	5.0	13.1	0.0	0.0	0.0	1.4	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	17.1	0.0	0.0	0.0	0.0	0.2	4.6	7.0	0.0	16.1	0.0	4.3	1.7	8.8	14.9	3.4	8.9	2.2	9.5	16.4	2.6	2.9	8.0	9.6	2.5	8.9	9.3	3.2	6.4	3.5	3.1	3.8	0.5	1.9	4.1	1.8	4.5	1.3	3.7	4.6	3.0	9.3	38.9	0.0	0.2	0.0	2.2	0.0	8.1	2.3	0.0	0.0	0.1	0.0	0.1	0.4	2.9	0.0	0.0	0.5	0.2	0.9	0.1	39.2	3.9	9.8	0.0	0.0	4.3	9.2	0.6	0.0	7.4	0.0	2.8	0.0	0.1	0.3	0.0	1.1	0.8	0.0	0.0	0.5	0.4	0.3	0.5	0.3	62.3	0.0	0.1
RASD1	"AGS1, DEXRAS1"	ENSG00000108551	"Ras related dexamethasone induced 1"	Q9Y272	17	17494437-17496395	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Mucus-secreting cells: 239.8;Muller glia cells: 245.0;Peritubular cells: 441.6;Sertoli cells: 556.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	47	"plasmacytoid DC: 48.0"	"Lineage enriched"	"Detected in many"	47	"dendritic cells: 48.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 34.4;HSkMC: 8.4;REH: 32.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 77.3;hippocampal formation: 60.2;thalamus: 58.1"	"Low region specificity"	"Detected in all"			HPA047896	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA047896: AB_10960535"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	79.6	24.3	14.0	6.2	23.2	8.3	30.4	11.6	32.0	49.1	7.1	8.5	18.6	5.9	19.9	17.1	10.9	11.6	11.8	20.1	14.7	15.5	30.2	85.9	5.6	3.7	10.0	22.5	33.5	17.5	7.2	81.3	2.6	22.2	17.8	6.9	6.6	49.4	51.8	37.2	9.1	6.1	4.3	19.6	12.2	6.1	13.8	8.9	9.1	37.7	9.2	2.5	6.2	5.5	0.0	48.0	0.0	1.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	34.4	1.9	0.1	0.4	0.6	0.0	0.1	1.4	0.0	0.0	3.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	3.8	0.2	0.0	0.1	8.4	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	3.4	6.2	0.6	0.7	0.6	2.1	32.9	0.0	0.0	0.7	0.0	6.2	0.2	0.5	0.4	7.2	1.0	0.0	0.0	1.9	0.0	0.3	0.2	0.1	7.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	48.0	0.0	0.3	14.0	23.2	11.6	32.0	14.7	15.5	10.0	22.5	22.2	8.9	26.8	30.8	3.7	47.7	15.2	21.5	61.3	12.7	8.1	40.9	141.3	3.9	2.5	11.6	55.0	2.1	17.5	18.7	0.0	1.1	2.2	69.9	113.7	8.1	13.2	3.4	6.4	213.7	10.4	3.7	4.2	101.5	8.8	28.7	3.6	239.8	245.0	13.9	15.8	441.6	3.8	20.0	556.2	153.3	1.6	1.6	11.5	5.6	6.9	22.1	20.7
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540868-35554001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.0;seminal vesicle: 25.2"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5"	"Region enriched"	"Detected in many"	8	"basal ganglia: 527.8"	"Region enriched"	"Detected in all"	8	"basal ganglia: 265.8"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.6	7.9	8.6	2.5	71.0	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5.0	0.8	0.5	1.5	0.6	3.4	8.0	0.8	1.0	0.9	1.0	0.4	2.1	9.6	4.4	3.5	4.0	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0.0	1.4	0.1	1.4	3.8	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.8	0.0	0.5	0.0	0.0	0.1	0.7	0.2	1.1	0.9	0.1	0.5	0.0	0.2	2.4	4.3	0.1	0.2	0.0	1.0	0.0	0.7	0.0	0.1	0.0	1.4	0.0	0.0	0.2	3.3	2.2	0.3	13.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	1.3	0.0	0.9	0.0	0.0	2.0	0.3	2.2	7.6	0.0	0.2	0.6	0.2	0.1	1.8	4.4	0.2	0.8	1.9	0.6	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.6	71.0	1.8	23.5	4.1	5.0	3.4	8.0	2.1	15.3	0.0	0.0	0.0	0.2	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.2	0.7	0.0	0.1	45.3	4.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1
RASGEF1A	"CG4853, FLJ37817"	ENSG00000198915	"RasGEF domain family member 1A"	Q8N9B8	10	43194535-43266919	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.6;brain: 18.3"	"Cell type enhanced"	"Detected in some"	5	"Collecting duct cells: 3.5;Spermatogonia: 3.4;T-cells: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 13.2;SCLC-21H: 12.8;SK-BR-3: 11.6;T-47d: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035593	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035593: AB_10602083"	"prognostic favorable (1.86e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.11e-7)"	"unprognostic (2.88e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.83e-2)"	1.1	2.3	13.1	1.6	16.2	16.6	4.4	11.0	18.3	2.1	0.9	4.0	0.0	1.2	1.6	0.7	1.5	3.4	3.0	1.5	12.3	10.6	1.4	0.4	1.8	6.0	7.2	8.7	1.8	4.8	10.7	3.3	1.1	7.2	1.7	0.7	2.3	4.6	2.6	1.1	0.9	0.8	1.7	3.5	3.5	1.0	3.1	4.1	0.0	1.2	0.2	4.6	2.2	1.9	2.1	5.8	10.4	0.6	7.1	3.6	1.1	7.5	6.5	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.2	4.2	6.6	7.1	0.6	0.0	0.1	1.0	6.2	0.0	0.0	5.1	0.0	0.1	0.3	3.1	0.0	2.5	1.6	7.2	0.6	0.0	0.0	0.0	0.3	13.2	0.0	0.0	1.5	0.0	0.1	0.6	3.3	0.0	0.0	0.0	0.2	0.5	3.6	12.8	0.0	0.0	11.6	0.1	6.1	12.7	0.1	0.0	0.0	2.9	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	6.6	3.6	0.6	1.3	0.2	0.9	2.6	3.3	2.1	0.3	1.8	10.4	7.1	0.4	5.8	0.0	1.1	13.1	16.2	11.0	17.8	12.3	10.6	7.2	8.7	7.2	4.1	0.0	0.0	2.2	0.2	0.5	0.7	2.0	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.3	1.1	0.4	0.0	0.0	1.2	0.9	0.4	0.6	0.0	0.0	1.0	1.6	0.0	1.8	0.3	0.4	0.0	1.5	0.0	1.0	0.0	0.0	2.5	0.0	0.0	0.5	0.3	0.0	0.5	0.6	3.4	0.3	0.2	2.9	0.8	0.0
RASGEF1B	"FLJ31695, GPIG4"	ENSG00000138670	"RasGEF domain family member 1B"	Q0VAM2	4	81426393-82044244	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 7.7;memory B-cell: 6.4;naive B-cell: 8.8;non-classical monocyte: 12.4;plasmacytoid DC: 18.0"	"Group enriched"	"Detected in many"	5	"B-cells: 8.8;dendritic cells: 18.0;monocytes: 12.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 12.0;Daudi: 15.4;Karpas-707: 10.4;NTERA-2: 7.1;OE19: 8.5;SCLC-21H: 6.9;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044574	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044574: AB_10794292"	"unprognostic (3.24e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (4.42e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-2)"	"prognostic favorable (4.21e-6)"	"unprognostic (4.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.04e-2)"	11.7	5.3	12.2	8.4	18.9	22.2	14.3	3.5	8.4	7.6	8.0	10.0	2.6	10.8	3.0	9.9	10.9	6.6	10.1	4.9	6.2	8.2	9.4	32.8	19.1	9.2	13.0	3.5	3.3	2.5	1.7	12.6	10.3	38.3	3.8	6.0	6.1	9.7	4.2	3.5	20.3	10.7	5.0	8.7	13.2	12.2	1.9	19.3	8.0	3.9	4.7	8.5	4.8	5.6	8.8	18.0	0.8	12.4	2.5	2.0	0.7	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	12.0	0.3	15.4	0.0	0.0	0.1	0.3	1.0	0.1	0.0	0.1	2.2	1.2	1.0	0.5	0.5	0.3	0.7	0.2	0.5	0.0	0.5	0.1	0.0	2.6	0.2	10.4	0.0	0.5	5.0	0.5	7.1	8.5	3.2	1.5	0.1	5.8	0.5	0.2	6.9	0.1	0.0	2.1	0.0	7.3	1.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.0	4.7	1.1	0.2	0.1	0.4	2.1	0.2	1.4	7.7	1.5	6.4	1.1	1.1	1.7	8.8	2.0	1.9	0.8	2.5	12.4	18.0	0.3	0.7	12.2	18.9	3.5	8.4	6.2	8.2	13.0	3.5	38.3	19.3	26.8	22.3	27.4	6.7	52.3	9.9	8.1	15.3	44.2	12.5	14.0	35.3	26.8	11.6	2.8	0.4	8.7	10.4	0.0	3.5	2.1	12.4	11.0	104.0	39.5	37.5	3.2	25.7	51.5	43.3	1.1	0.9	59.7	59.1	1.0	6.8	0.8	2.4	5.1	1.8	7.7	4.4	0.0	15.9	0.7	0.2	49.4	9.4	7.5	6.5	6.5
RASGEF1C	FLJ35841	ENSG00000146090	"RasGEF domain family member 1C"	Q8N431	5	180100791-180209153	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 27.4;testis: 7.1"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 2.5;Late spermatids: 3.2;Spermatocytes: 5.5;Syncytiotrophoblasts: 1.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;HEK 293: 2.8;MCF7: 3.9;SCLC-21H: 12.6;U-2 OS: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028242	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA028242: AB_10602294"	"unprognostic (2.21e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.75e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-4)"	"unprognostic (5.89e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-2)"	1.1	1.1	7.0	1.1	5.4	0.6	1.4	27.4	22.0	1.4	2.3	9.2	0.0	0.8	0.6	0.8	1.2	1.7	1.2	1.5	4.5	2.8	0.6	0.6	0.6	0.6	5.1	4.9	0.8	0.9	0.8	0.2	0.8	7.7	0.8	1.1	0.4	3.0	2.7	0.7	1.1	1.4	1.0	8.3	0.7	0.8	7.1	4.7	0.0	2.1	0.0	0.6	0.8	0.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.2	0.0	3.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.6	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	7.0	5.4	27.4	11.1	4.5	2.8	5.1	4.9	7.7	4.7	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	5.5	0.9	0.0	1.6	0.0	0.0	0.0
RASGRP3	"CalDAG-GEFIII, GRP3, KIAA0846"	ENSG00000152689	"RAS guanyl releasing protein 3"	Q8IV61	2	33436324-33564750	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.4;skeletal muscle: 28.7"	"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 50.6;Ito cells: 52.2;Urothelial cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 11.4;memory B-cell: 10.4;naive B-cell: 13.4"	"Group enriched"	"Detected in many"	16	"B-cells: 13.4;granulocytes: 11.4"	"Group enriched"	"Detected in some"	6	"Daudi: 29.9;HEL: 31.6;U-266/70: 49.5;U-266/84: 18.9;U-698: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058937			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA058937: AB_2683858"	"unprognostic (2.64e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.82e-2)"	7.8	2.6	9.4	13.6	13.3	3.2	4.9	2.0	9.6	3.1	3.5	35.0	0.0	5.7	2.6	1.3	2.0	2.1	5.0	24.3	13.4	8.8	5.1	4.1	5.8	19.8	25.2	5.5	1.6	3.7	9.3	3.1	8.2	19.9	2.1	5.3	6.7	5.4	1.7	28.7	2.3	4.5	3.7	42.4	10.1	5.4	1.3	26.3	1.9	6.7	5.0	25.0	5.4	2.1	13.4	0.2	11.4	0.1	0.2	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	1.5	4.5	0.8	0.2	29.9	0.1	0.2	0.3	0.0	0.0	0.0	0.4	3.1	0.3	31.6	0.2	0.0	0.4	0.1	4.3	0.0	0.0	0.0	0.0	0.6	1.8	0.3	0.1	1.6	0.6	0.0	0.2	2.3	0.1	0.2	0.0	0.0	1.4	0.0	0.3	1.9	0.2	0.0	0.0	0.1	1.4	0.0	0.0	0.2	0.5	0.1	0.1	0.1	0.2	49.5	18.9	13.2	0.0	0.1	0.1	11.4	0.0	0.0	0.3	0.0	0.4	10.4	0.5	0.5	0.2	13.4	0.7	0.2	0.0	0.2	0.1	0.0	0.7	0.9	9.4	13.3	2.0	9.6	13.4	8.8	25.2	5.5	19.9	26.3	0.0	8.0	43.4	28.1	4.7	1.2	45.2	0.0	4.0	5.7	5.2	0.0	0.4	10.0	14.6	1.0	50.6	0.0	0.0	47.5	1.1	3.9	22.2	18.4	4.4	38.6	0.0	0.0	52.2	7.2	0.6	0.9	10.2	38.8	22.6	0.0	0.3	44.4	0.0	1.8	9.8	1.1	0.0	3.8	0.9	2.3	3.1	0.5	4.4	0.0	57.1
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 10.9;granulocytes: 26.5;Hofbauer cells: 12.0;Kupffer cells: 34.4;Macrophages: 11.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEL: 19.4;HMC-1: 19.4;U-937: 5.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	4.5	1.8	2.4	8.0	3.3	23.3	5.4	0.7	1.8	1.8	1.7	2.8	0.1	1.4	1.6	2.9	1.6	2.6	3.4	6.2	2.0	1.3	1.5	1.8	11.8	23.1	3.4	0.2	1.1	1.6	0.5	0.9	3.0	1.8	1.7	1.2	1.7	1.6	0.8	1.5	1.4	2.4	2.7	4.2	19.2	1.9	0.8	2.4	0.5	1.0	0.2	1.0	2.6	3.1	0.1	5.2	22.4	9.5	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	19.4	0.0	0.0	0.0	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	6.0	7.1	10.6	0.0	8.5	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.0	22.4	0.0	9.5	0.4	0.7	2.1	2.4	3.3	0.7	1.8	2.0	1.3	3.4	0.2	1.8	2.4	0.0	1.1	0.0	0.0	0.7	0.0	10.9	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	26.5	0.0	12.0	0.0	0.0	1.8	34.4	0.0	0.0	11.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1
RASL10B	"RRP17, VTS58635"	ENSG00000270885	"RAS like family 10 member B"	Q96S79	17	35731649-35743521	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 24.6;skeletal muscle: 26.7"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 12.2;Early spermatids: 9.3;Horizontal cells: 6.4;Late spermatids: 25.1;Muller glia cells: 17.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 14.1;HHSteC: 16.1;HSkMC: 11.7;NTERA-2: 24.1;REH: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046842, HPA057092"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA046842: AB_2679835, HPA057092: AB_2683332"	"unprognostic (5.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.38e-6)"	"unprognostic (8.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-6)"	"unprognostic (2.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.60e-3)"	12.8	0.9	6.3	0.3	9.1	0.2	2.8	0.3	12.3	1.8	0.3	1.0	24.6	0.8	1.3	0.8	0.3	3.9	0.8	10.9	4.7		1.0	1.1	0.4	0.2	0.0	2.8	2.5	4.7	2.5	1.1	2.8	6.3	0.9	0.2	1.1	12.6	15.2	26.7	0.3	0.9	0.9	0.6	0.2	0.3	1.6	2.5	0.0	0.9	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	3.6	0.0	0.6	0.4	1.1	0.7	0.4	2.5	2.1	4.6	0.0	0.0	0.4	0.1	0.0	0.0	14.1	0.0	0.8	0.0	4.6	0.0	2.3	5.2	16.1	0.0	0.0	11.7	0.9	0.8	0.0	2.0	0.0	7.6	3.0	0.0	0.2	0.2	6.4	0.0	24.1	0.0	0.0	11.7	6.5	10.4	0.0	0.0	10.8	10.5	0.7	0.2	0.9	11.0	1.3	0.7	0.0	1.2	8.7	0.0	0.3	0.0	0.0	2.9	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.4	0.1	2.9	12.2	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.9	9.3	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	3.0	0.2	6.4	0.0	0.0	0.3	25.1	2.0	0.0	0.0	0.0	0.0	17.6	0.5	0.0	2.8	0.0	1.1	0.0	1.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1
RASL11A		ENSG00000122035	"RAS like family 11 member A"	Q6T310	13	27270327-27273690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 18.7;Sertoli cells: 32.3;Smooth muscle cells: 45.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.5"	"Group enriched"	"Detected in many"	5	"B-cells: 4.5;granulocytes: 3.3;monocytes: 2.9"	"Cell line enriched"	"Detected in many"	4	"ASC diff: 43.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004859, HPA053296"	Supported		Approved	"Nuclear bodies"		Yes	No			"Nuclear bodies"		"HPA004859: AB_2667270, HPA053296: AB_2682106"	"unprognostic (1.59e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (3.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.34e-1)"	18.9	5.0	2.3	8.1	9.8	3.3	36.4	5.9	5.8	11.6	15.7	7.3	4.3	13.1	14.1	10.4	9.7	14.1	6.5	9.4	4.7	2.1	17.1	30.0	11.6	26.7	3.3	1.2	13.7	3.2	1.4	7.2	5.2	3.6	15.9	20.7	8.1	6.6	10.4	4.9	6.1	24.4	28.5	3.3	17.7	8.9	8.7	5.3	0.9	7.6	3.9	16.4	16.8	27.5	4.5	0.6	3.3	2.9	0.4	0.7	0.2	0.3	1.2	0.3	0.6	43.1	4.4	0.2	1.8	1.9	0.1	0.1	7.8	0.8	0.4	0.6	1.4	1.0	0.2	2.2	0.8	0.1	1.7	8.9	1.7	0.2	0.5	7.0	0.5	0.7	4.7	0.7	0.1	0.1	1.7	0.6	0.7	0.2	0.0	0.0	0.8	0.0	2.3	1.2	7.7	10.0	0.5	0.0	0.2	1.5	5.8	0.8	0.2	0.7	3.2	0.2	1.1	0.2	0.7	0.3	0.1	0.4	2.9	0.3	0.1	0.0	0.0	0.3	1.9	0.1	1.2	2.0	0.8	0.0	0.4	0.0	0.1	0.0	0.1	0.6	4.5	0.2	0.7	3.3	0.4	2.9	0.1	0.0	0.2	2.3	9.8	5.9	5.8	4.7	2.1	3.3	1.2	3.6	5.3	14.9	9.1	0.0	2.4	4.0	0.0	1.1	0.0	18.7	14.8	7.0	0.0	0.6	3.3	1.0	0.0	1.2	6.3	0.0	2.0	0.1	1.9	1.0	0.0	0.0	1.1	0.0	0.0	1.8	0.6	0.0	0.3	3.5	1.7	1.0	5.2	0.0	0.6	11.5	1.4	1.1	0.0	32.3	45.0	0.0	0.0	3.9	0.7	0.0	6.0	0.9
RASL11B		ENSG00000128045	"RAS like family 11 member B"	Q9BPW5	4	52862290-52866835	"Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 38.0"	"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 31.4;Cytotrophoblasts: 80.5;Extravillous trophoblasts: 60.5;Peritubular cells: 64.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.9;CACO-2: 7.7;NTERA-2: 10.5;RPTEC TERT1: 6.6;SH-SY5Y: 26.8;SuSa: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057803	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA057803: AB_2683533"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.72e-2)"	"unprognostic (7.20e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.00e-6)"	"unprognostic (1.10e-1)"	1.1	1.6	9.2	0.6	3.8	0.2	0.7	9.8	11.5	2.2	0.4	0.1	12.5	0.1	5.3	2.7	0.3	2.9	2.4	12.4	2.7	1.9	8.5	0.5	0.7	0.7	0.7	5.5	38.0	0.8	19.9	0.4	8.8	0.4	2.2	0.3	1.3	0.8	20.2	0.3	2.0	0.5	1.9	0.5	15.2	2.5	3.9	0.0	0.0	0.6	0.0	1.0	1.2	2.8	0.2	0.9	0.0	0.1	2.2	1.3	0.2	0.2	0.0	3.9	0.0	3.5	1.6	9.9	0.1	0.0	0.2	0.0	7.7	0.0	0.0	0.3	0.0	0.1	0.0	0.5	2.3	0.0	0.0	0.9	0.3	0.0	0.0	0.7	0.0	0.3	1.7	4.1	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.8	0.7	0.0	10.5	0.8	0.1	0.0	4.5	0.0	6.6	1.0	2.2	26.8	0.1	1.7	0.8	6.9	0.9	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.9	0.0	2.2	0.0	0.9	0.0	0.2	9.2	3.8	9.8	11.5	2.7	1.9	0.7	5.5	0.4	0.0	6.0	0.0	0.0	1.2	0.8	3.5	4.1	0.0	0.0	2.3	31.4	0.0	80.5	0.0	1.1	0.3	0.7	0.5	0.0	0.5	60.5	7.3	0.5	0.0	0.0	6.9	0.0	0.0	1.3	0.0	1.5	22.5	0.0	0.0	1.0	0.5	2.0	0.6	3.5	64.3	0.0	1.1	0.0	3.8	2.1	8.1	0.4	19.3	0.0	0.5	0.2
RASSF10		ENSG00000189431	"Ras association domain family member 10"	A6NK89	11	13009577-13012106	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.3"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 13.4;Distal tubular cells: 21.6;Pancreatic endocrine cells: 6.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 9.5;CAPAN-2: 8.5;HaCaT: 13.1;HMC-1: 6.5;RPTEC TERT1: 13.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040406			Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA040406: AB_2732485"	"unprognostic (6.71e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.41e-3)"	"unprognostic (6.25e-3)"	"prognostic favorable (2.76e-4)"		"unprognostic (3.43e-3)"	"unprognostic (8.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.65e-2)"	0.2	0.0	0.4	0.2	1.0	0.0	3.9	0.0	1.7	1.1	1.4	1.0	0.0	1.8	0.0	1.3	9.3	5.2	2.5	0.2	1.0		4.7	0.0	1.8	0.0	0.0	0.6	1.2	0.0	3.8	0.1	0.0	0.6	1.6	0.5	0.4	8.0	0.1	0.8	4.1	0.6	0.0	0.1	0.0	5.6	2.4	1.0	1.1	0.1	8.1	7.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	9.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.5	0.0	0.6	0.0	0.3	13.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.4	0.0	1.3	0.0	0.0	13.3	1.4	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	3.2	0.0	3.8	0.0	0.0	0.8	0.0	13.4	4.5	1.8	0.0	0.1	21.6	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	1.1	0.0	0.1	0.0	2.4	0.6	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.5	6.7	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	5.3	3.5
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823645	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.1"	"Cell type enhanced"	"Detected in many"	9	"Kupffer cells: 93.0;monocytes: 117.2;Peritubular cells: 140.7;Rod photoreceptor cells: 154.5"	"Cancer enhanced"	"Detected in all"		"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.6;BEWO: 20.6;Daudi: 21.0;HL-60: 24.6;NB-4: 31.8;U-937: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: AB_2681386"	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	8.3	5.1	26.5	21.5	26.9	38.6	3.6	10.2	45.8	14.9	4.1	59.5	0.1	2.7	13.0	11.6	5.2	9.8	7.8	2.4	33.2	22.4	2.0	3.0	10.1	26.2	54.7	8.7	3.5	1.7	0.7	2.6	4.5	39.7	3.9	5.0	19.8	2.0	4.8	1.2	2.2	5.7	18.6	106.1	14.9	3.3	9.9	27.3	4.7	2.5	0.6	34.2	10.7	2.7	7.9	14.1	42.1	17.9	2.4	4.7	10.6	0.0	4.9	12.1	19.6	0.1	0.0	20.6	1.2	3.4	0.2	0.0	1.1	0.0	21.0	1.9	1.0	0.4	0.0	1.7	0.0	0.3	7.5	0.7	13.7	0.0	0.2	0.0	24.6	14.0	0.0	0.0	0.4	0.0	0.4	8.0	2.4	0.0	8.3	0.0	0.0	3.6	31.8	2.7	0.0	0.4	5.6	1.3	8.0	0.0	9.7	0.1	0.9	0.0	0.3	0.6	2.7	0.0	15.7	0.2	0.5	2.6	0.2	1.5	0.1	1.9	12.9	0.1	39.2	0.1	21.1	17.9	29.5	2.4	15.4	4.7	7.9	3.9	3.3	14.1	5.3	2.6	2.1	42.1	2.4	16.8	9.4	3.4	10.6	26.5	26.9	10.2	19.3	33.2	22.4	54.7	8.7	39.7	27.3	0.0	14.9	27.7	0.0	4.1	37.9	1.6	2.5	0.0	3.4	0.0	25.5	2.4	1.7	1.0	5.0	12.7	0.0	0.0	0.8	4.8	8.2	0.8	51.0	0.8	24.8	6.4	0.0	16.0	93.0	15.3	30.8	38.0	8.5	117.2	0.0	12.7	0.4	0.0	140.7	0.2	154.5	0.0	3.3	0.7	0.6	2.3	1.1	10.2	0.0	0.9
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697567	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 44.4"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 44.4"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	22.4	13.8	4.2	24.0	4.5	5.9	48.4	2.5	4.5	15.3	64.1	6.5	21.6	8.3	18.5	12.5	27.0	9.4	30.1	37.4	4.6	4.4	5.8	6.4	19.4	22.2	7.4	2.9	13.6	10.0	1.0	4.3	16.0	7.6	26.5	17.8	14.1	18.9	21.2	16.0	5.0	18.0	80.1	10.8	25.7	25.6	6.9	5.5	7.6	5.3	6.3	14.5	57.4	30.9	5.5	3.2	44.4	6.6	4.1	7.9	0.9	9.8	11.1	3.5	6.8	3.8	5.6	21.6	4.3	22.4	5.8	6.9	7.9	10.5	15.5	9.2	3.1	7.0	4.3	10.7	4.5	7.1	12.7	4.1	10.1	4.9	9.0	10.5	10.7	7.1	3.7	3.9	13.3	9.9	17.1	24.7	7.5	5.4	7.7	6.8	9.3	7.0	7.0	7.8	23.4	6.7	11.3	11.4	6.5	7.6	12.0	8.0	8.4	7.2	1.4	51.3	8.9	6.3	6.8	35.6	4.8	5.8	4.9	4.6	7.2	7.6	10.1	5.7	9.4	13.7	5.9	6.6	4.2	5.1	6.3	4.2	5.5	7.6	5.6	3.2	3.7	7.7	7.9	44.4	4.1	5.9	3.0	7.7	0.9	4.2	4.5	2.5	4.5	4.6	4.4	7.4	2.9	7.6	5.5	3.0	19.1	15.9	14.0	14.4	0.0	43.1	30.6	2.7	9.1	5.2	0.0	27.0	0.0	11.5	0.3	26.6	22.5	46.7	18.3	14.0	12.2	23.2	5.8	3.9	22.4	0.0	25.3	16.5	63.0	0.4	2.3	34.1	45.5	33.3	14.0	2.5	20.7	15.3	13.4	1.1	0.0	12.9	28.9	0.6	24.9	10.5	16.5	26.7	15.2	21.6
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 128.5;monocytes: 389.5;Muller glia cells: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 28.5;monocytes: 28.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.5;RH-30: 54.6;RPMI-8226: 17.8;U-937: 27.9;WM-115: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	23.4	5.9	16.7	17.0	25.5	6.0	8.4	12.5	36.5	3.6	8.2	26.7	12.1	11.2	2.6	14.9	4.3	3.3	9.0	29.1	16.6	15.1	37.2	10.5	9.7	14.1	34.5	9.7	3.0	11.5	2.2	8.4	10.4	19.4	4.5	5.3	8.4	14.0	9.9	7.6	2.9	10.8	7.0	21.8	12.6	4.3	5.7	31.5	1.2	23.0	2.9	7.4	8.3	3.9	0.0	28.5	0.9	28.3	2.2	3.0	13.8	0.4	0.1	2.0	3.9	6.1	0.3	1.4	0.2	0.3	0.6	1.2	1.6	0.2	0.0	0.7	0.2	1.3	0.0	0.8	0.9	0.9	12.2	0.0	0.0	0.0	12.7	6.5	0.8	0.0	4.5	0.0	0.6	0.0	3.7	0.9	0.5	0.0	21.5	0.9	0.0	0.9	13.9	0.4	0.0	0.4	2.6	54.6	17.8	0.1	0.3	0.3	0.3	0.0	0.1	0.6	3.7	0.3	10.6	0.2	0.1	1.2	1.0	2.1	0.2	0.2	0.0	6.4	27.9	18.1	0.0	28.3	0.0	3.0	21.7	0.0	0.0	0.2	1.3	28.5	0.0	0.2	1.0	0.9	2.2	11.5	0.7	0.1	13.8	16.7	25.5	12.5	18.2	16.6	15.1	34.5	9.7	19.4	31.5	17.9	15.0	4.7	1.2	3.3	17.2	38.7	38.2	6.7	10.3	15.7	3.9	0.9	14.9	40.8	1.2	4.7	11.8	0.0	3.4	1.1	7.0	1.3	1.1	15.5	128.5	35.0	11.1	8.0	63.6	3.2	9.8	81.9	8.5	389.5	8.7	247.8	4.1	14.0	2.1	98.2	13.3	25.8	17.6	0.3	0.9	1.5	2.2	6.4	16.6	0.5
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 77.9"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 70.5;Intestinal endocrine cells: 115.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	8	"memory B-cell: 6.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 6.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.3;hTERT-HME1: 9.7;RPTEC TERT1: 10.4;RT4: 30.0;U-266/70: 8.9;U-698: 26.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.5	0.3	0.3	12.9	0.3	0.0	4.8	0.3	0.3	1.8	12.1	0.4	3.7	5.8	0.4	3.7	3.7	1.3	7.7	0.3	0.3	0.5	13.4	1.2	4.2	3.0	0.3	0.1	1.8	11.3	0.0	2.2	11.2	1.1	6.4	7.8	0.4	5.1	6.3	0.4	3.1	23.2	2.1	0.5	0.6	21.5	0.9	0.1	77.9	3.3	2.0	8.2	11.0	2.5	6.4	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	5.2	32.3	0.5	0.0	0.1	1.6	0.0	2.6	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.7	0.1	0.0	0.0	0.2	10.4	30.0	1.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	26.4	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	6.4	0.4	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.5	0.3	0.1	1.1	0.1	11.9	3.2	3.2	34.4	8.8	0.0	1.1	25.5	37.5	40.9	7.0	0.0	42.9	14.9	16.0	0.2	0.1	49.3	0.0	70.5	17.2	0.7	17.9	1.1	3.9	3.9	0.0	115.4	0.0	0.8	0.0	0.0	0.7	1.7	1.0	48.1	14.3	57.4	59.6	0.0	32.3	0.4	0.0	1.0	0.0	0.0	1.3	39.5	0.0	16.8	36.0
RASSF8	"C12orf2, HoJ-1"	ENSG00000123094	"Ras association domain family member 8"	Q8NHQ8	12	25959029-26079892	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 534.5;Horizontal cells: 406.8;Late spermatids: 509.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038163, HPA038164"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA038163: AB_2675874, HPA038164: AB_10672621"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.58e-2)"	9.8	14.1	14.6	6.4	14.0	1.3	14.6	8.0	10.4	20.9	12.7	10.3	7.0	2.5	23.9	10.5	6.7	10.0	14.6	11.9	16.0	8.5	19.7	5.2	12.5	2.2	15.1	8.0	26.3	5.2	4.3	16.1	10.6	14.8	14.2	4.6	14.7	4.4	12.7	12.0	3.3	4.4	17.3	19.9	5.0	7.0	44.7	13.6	0.3	9.7	5.2	2.2	10.1	18.8	0.6	4.1	0.9	0.3	1.4	0.6	0.1	3.3	2.7	11.8	1.4	18.3	20.8	16.4	18.2	26.7	7.7	8.5	5.8	1.0	0.2	14.4	19.6	8.6	1.3	2.5	2.1	9.9	1.2	3.4	0.6	6.7	0.3	9.1	2.0	0.1	12.3	2.1	17.1	11.5	12.0	9.2	4.2	0.6	2.4	8.9	4.5	2.4	0.4	11.7	0.0	25.2	3.1	11.4	0.1	4.7	5.0	0.5	8.5	9.6	0.1	8.9	10.7	1.7	1.7	10.8	15.3	7.9	38.7	13.6	1.0	0.7	0.3	14.1	0.2	21.4	0.7	0.3	0.2	0.6	0.1	0.2	0.3	0.2	0.2	0.0	0.6	0.3	0.2	0.9	1.4	0.1	4.1	0.1	0.1	14.6	14.0	8.0	10.4	16.0	8.5	15.1	8.0	14.8	13.6	35.7	16.5	0.0	33.0	6.9	12.8	30.8	17.8	1.4	12.5	21.0	9.8	8.1	11.6	7.5	534.5	18.0	0.0	0.0	3.6	14.5	30.9	26.1	1.1	6.7	4.5	406.8	0.0	9.8	1.8	509.0	16.7	7.4	13.5	0.0	0.0	27.8	4.4	0.0	14.2	17.4	9.6	12.9	18.6	20.9	8.9	4.6	3.8	0.0	0.0	12.6
RAVER2	"FLJ10770, KIAA1579"	ENSG00000162437	"Ribonucleoprotein, PTB binding 2"	Q9HCJ3	1	64745095-64833232	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 31.0;Mucus-secreting cells: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 7.8"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045785	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045785: AB_10964058"	"unprognostic (8.02e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (5.14e-6)"	"unprognostic (1.74e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-2)"	5.2	9.6	13.2	9.2	14.0	7.8	9.0	17.4	9.3	11.5	21.8	7.2	13.9	22.3	9.1	5.9	10.8	7.5	15.2	17.1	13.4	8.1	7.5	1.7	7.9	1.9	8.6	6.1	8.2	7.3	15.2	27.7	6.9	9.1	12.0	25.7	12.6	15.3	15.1	18.5	6.5	41.4	9.1	9.5	4.6	11.8	2.6	7.4	7.0	7.2	10.7	6.8	8.4	8.4	0.2	0.9	7.8	0.1	0.2	0.4	0.0	10.3	3.2	9.9	10.7	1.8	1.5	2.7	2.3	4.2	4.8	5.4	8.5	4.6	0.0	5.4	2.4	10.8	7.9	10.0	6.9	5.8	0.0	11.1	12.6	8.6	7.6	3.4	16.9	0.1	4.5	6.4	0.3	4.9	11.1	7.8	10.6	2.7	10.5	0.4	3.8	5.6	3.5	12.2	8.2	8.6	19.3	15.5	4.2	5.1	7.8	7.4	16.7	10.4	0.0	10.1	9.7	8.1	2.7	2.9	4.4	7.2	4.4	8.1	8.0	9.0	4.4	2.7	0.0	4.1	7.8	0.1	0.1	0.2	0.0	0.4	0.2	0.2	0.1	0.9	0.1	0.1	0.1	0.0	0.2	0.0	0.4	0.1	0.0	13.2	14.0	17.4	9.3	13.4	8.1	8.6	6.1	9.1	7.4	6.0	9.1	0.0	5.5	7.1	5.8	21.8	10.2	5.3	11.4	1.8	13.7	0.1	0.0	2.5	6.3	6.9	31.0	0.0	4.5	0.3	5.3	5.9	1.1	0.0	0.5	0.0	17.3	4.3	4.0	10.7	6.1	0.7	3.3	0.0	30.2	24.7	3.0	14.4	7.8	1.6	3.5	0.0	8.1	1.2	0.9	5.1	0.2	1.5	25.1	6.3
RBFA	"C18orf22, FLJ21172, HsT169"	ENSG00000101546	"Ribosome binding factor A"	Q8N0V3	18	80034358-80046397	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040485, HPA041479"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA040485: AB_10795368, HPA041479: AB_10795697"	"unprognostic (5.31e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.00e-3)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (2.98e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.82e-1)"	"unprognostic (5.00e-3)"	19.4	21.0	11.3	14.4	15.8	16.7	30.9	20.4	17.3	12.1	12.5	15.9	10.0	14.8	13.6	14.3	17.7	11.4	12.9	13.8	10.6	8.6	14.5	36.9	11.0	18.5	12.5	14.2	12.3	20.0	12.5	9.7	12.6	12.7	11.8	12.7	11.3	13.4	12.3	21.3	18.6	11.1	18.3	13.8	13.2	12.1	13.8	12.8	9.9	11.6	18.6	15.7	14.0	14.2	10.7	8.3	0.3	10.1	7.5	11.7	5.7	14.3	16.2	11.4	10.5	11.6	13.8	14.8	12.3	7.8	18.1	16.3	9.4	12.7	30.3	4.6	11.0	12.4	13.6	12.7	15.8	14.5	11.0	13.2	18.0	11.7	24.9	8.9	28.4	8.9	13.2	15.4	12.0	17.3	6.4	15.1	19.2	9.6	18.9	11.0	13.8	28.2	19.6	11.9	9.7	16.1	19.0	10.6	37.0	17.3	16.9	19.7	11.9	11.0	13.1	8.3	10.3	9.5	14.3	10.3	20.6	19.2	3.0	13.2	7.0	12.1	25.3	11.9	24.7	11.7	0.0	5.1	0.0	7.5	7.0	11.7	10.7	7.6	7.3	8.3	8.3	8.4	7.9	0.3	7.5	10.1	6.5	5.8	5.7	11.3	15.8	20.4	17.3	10.6	8.6	12.5	14.2	12.7	12.8	29.8	7.5	26.0	20.9	16.5	12.9	9.2	12.7	17.4	25.0	26.2	17.7	41.8	26.6	23.9	14.1	14.8	9.2	0.0	21.0	42.0	21.6	15.3	12.7	36.5	21.9	30.2	20.1	14.1	6.7	12.1	17.5	17.6	32.1	7.2	20.5	9.5	20.1	2.9	17.3	34.6	21.4	19.4	20.8	28.3	58.3	20.6	20.8	10.1	22.1	13.9
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713338	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 81.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	15	"RH-30: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746, HPA075862"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		No	No			Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: , HPA075862: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		1.2	2.4	19.9	1.5	33.0	1.6	1.3	31.5	57.2	1.4	1.9	1.9	0.0	1.3	1.3	5.0	2.0	2.2	1.3	17.6	16.4	6.7	1.5	1.3	1.2	1.2	3.7	21.7	1.4	1.3	1.2	0.5	1.3	13.5	2.6	1.7	0.0	1.7	4.9	67.6	1.5	1.4	1.2	3.5	1.2	1.4	1.7	5.6	0.0	1.3	9.7	1.2	1.5	0.3	1.7	0.7	3.1	0.7	1.2	1.4	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	25.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	2.4	0.6	2.0	1.1	0.3	0.7	1.0	0.9	0.8	0.3	1.7	1.4	1.0	3.1	1.2	0.7	0.7	1.0	0.0	19.9	33.0	31.5	34.3	16.4	6.7	3.7	21.7	13.5	5.6	0.0	0.3	0.0	0.0	0.0	2.3	81.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	1.1	0.0	1.7	1.0	0.4	7.1	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0
RBFOX2	"FOX-2, HNRBP2, HRNBP2, RBM9"	ENSG00000100320	"RNA binding fox-1 homolog 2"	O43251	22	35738736-36028425	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006240, HPA075862"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006240: AB_1079750, HPA075862: "	"unprognostic (3.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.08e-2)"	14.0	11.6	25.7	7.6	30.5	0.4	12.7	58.4	37.2	26.4	23.2	7.4	11.2	7.9	38.5	13.8	22.9	20.4	16.7	20.8	19.6	15.9	10.2	10.6	12.7	3.7	12.0	26.3	43.3	9.3	20.5	20.6	21.3	22.8	18.3	13.6	9.7	10.3	20.5	40.7	12.6	10.6	32.6	9.7	5.4	13.3	10.4	10.1	1.8	18.7	5.7	5.3	18.1	15.9	0.0	0.7	0.0	0.0	0.1	3.1	0.1	15.1	9.9	32.3	18.9	20.3	34.2	13.3	28.4	38.1	21.2	23.3	18.9	6.5	9.7	13.7	32.2	12.4	14.7	11.7	13.0	27.1	7.7	13.5	5.4	8.8	7.0	6.1	1.5	4.1	24.8	16.8	20.2	23.0	19.3	25.7	2.4	4.1	1.2	23.2	5.9	1.5	0.8	12.6	5.7	13.7	2.3	28.7	2.2	14.6	17.0	10.0	37.9	32.4	5.1	10.0	17.1	6.0	1.8	31.7	30.3	17.9	17.9	13.1	1.1	3.1	12.0	14.2	2.2	17.1	0.0	0.0	0.0	1.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.1	25.7	30.5	58.4	37.2	19.6	15.9	12.0	26.3	22.8	10.1	62.5	32.6	0.5	41.3	33.0	3.3	54.1	25.5	14.7	33.0	26.2	0.0	50.4	29.9	47.1	14.6	43.8	18.4	0.0	27.9	74.6	68.9	41.7	2.3	20.9	8.6	111.2	54.8	32.5	1.3	5.4	73.6	3.3	15.1	4.6	22.3	15.4	54.8	2.9	87.7	14.0	5.9	51.8	71.0	35.7	22.7	29.5	24.3	2.5	23.4	50.4
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781364-27891098	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 57.6;Proximal tubular cells: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.5;RPTEC TERT1: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	14.4	22.2	2.5	2.4	5.2	4.1	2.2	2.1	4.1	2.6	3.0	1.7	4.9	12.4	4.7	4.7	3.1	7.4	10.7	3.5	3.7	4.3	15.1	22.6	10.4	0.8	3.0	2.4	24.2	2.4	3.5	10.3	6.2	12.3	6.9	2.4	2.2	1.4	16.8	7.6	1.0	11.8	3.8	4.7	1.7	1.6	4.8	1.4	0.3	4.5	2.8	1.1	4.8	12.0	5.8	5.1	5.6	3.8	4.9	6.5	3.4	3.1	2.1	0.3	0.4	0.4	0.7	2.1	0.8	0.6	0.4	0.6	4.8	1.5	1.1	10.5	1.7	1.5	1.3	0.2	1.0	0.8	0.4	0.2	0.1	0.5	4.1	1.6	0.9	0.2	1.0	1.7	2.7	3.7	0.7	0.6	1.9	0.1	1.3	2.0	4.1	0.7	2.3	0.0	2.1	1.7	0.9	0.2	0.7	22.1	0.2	0.9	1.2	2.9	4.0	1.7	1.1	1.8	4.6	0.2	0.7	0.5	1.9	1.2	6.7	7.9	2.1	1.9	3.1	0.1	5.6	3.8	1.9	3.0	1.6	6.1	5.8	4.0	6.5	5.1	4.6	4.2	3.6	5.6	4.9	0.8	0.8	5.8	3.4	2.5	5.2	2.1	4.1	3.7	4.3	3.0	2.4	12.3	1.4	6.0	5.3	1.9	2.8	1.8	10.3	6.4	2.5	57.6	7.9	17.4	3.9	3.3	39.7	9.3	26.8	4.1	18.8	0.0	11.1	1.1	1.9	1.1	2.3	25.3	5.5	7.9	3.5	1.8	1.8	21.9	1.4	7.2	1.7	2.8	3.2	12.1	7.7	7.0	2.5	88.0	18.7	0.0	2.1	15.4	14.5	1.4	1.3	5.0	6.4	1.7
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491649	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 410.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	No			"Nucleoplasm, Nucleoli rim, Mitotic chromosome"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	27.8	20.6	15.7	22.2	20.0	11.1	25.5	24.1	18.7	26.3	23.7	24.7	25.6	15.4	30.0	20.2	21.5	25.1	19.5	19.9	15.5	11.7	23.8	34.2	24.0	31.6	25.8	13.7	29.3	30.7	55.3	22.6	12.4	15.8	28.2	18.9	20.2	26.2	30.5	28.3	20.8	24.6	26.1	17.9	27.2	24.9	28.6	22.8	54.4	31.0	10.3	31.6	36.5	26.8	9.1	8.0	20.2	9.8	26.2	35.1	24.5	12.6	8.6	11.6	10.7	30.3	29.3	5.4	9.3	13.3	11.7	4.0	5.6	16.0	18.6	14.2	15.8	11.0	16.0	8.7	14.5	18.6	6.6	12.0	8.3	8.8	10.4	13.1	11.6	26.2	18.6	17.8	7.9	11.4	23.5	18.0	20.6	6.8	11.7	13.0	3.7	23.0	15.6	4.7	14.4	7.9	16.8	21.1	21.3	11.4	13.0	9.4	7.9	21.2	9.3	9.1	10.1	12.1	15.2	14.9	14.5	7.7	11.9	6.9	17.9	10.6	21.8	18.0	14.5	9.9	16.4	8.2	20.2	21.2	5.9	23.7	8.7	23.8	24.3	8.0	9.1	35.1	29.6	15.7	26.2	9.8	4.9	17.5	24.5	15.7	20.0	24.1	18.7	15.5	11.7	25.8	13.7	15.8	22.8	38.7	83.1	23.6	26.7	20.5	27.2	10.1	40.8	42.8	43.3	26.2	19.6	4.5	14.9	10.6	410.5	23.6	18.8	0.0	8.9	12.0	22.6	37.9	53.2	40.8	10.1	33.4	19.0	33.2	46.3	128.8	38.9	26.4	10.1	23.4	31.9	37.2	10.2	10.5	40.3	21.4	22.5	38.8	24.7	118.2	42.4	24.1	3.4	79.1	23.7	30.9
RBM12B		ENSG00000183808	"RNA binding motif protein 12B"	Q8IXT5	8	93729356-93741017	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 41.2;Horizontal cells: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024398, HPA053050"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024398: AB_1856109, HPA053050: AB_2682026"	"unprognostic (4.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.15e-2)"	"unprognostic (4.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.62e-2)"	10.0	10.6	14.1	15.5	14.5	9.3	13.2	22.9	15.1	18.1	10.8	16.2	11.0	10.1	24.3	11.4	11.4	13.6	9.5	14.8	12.3	7.3	10.7	10.0	12.3	20.6	13.3	12.3	28.0	11.4	15.3	21.1	14.8	11.7	15.2	10.8	13.4	15.3	10.2	12.6	9.4	13.1	16.6	14.5	14.3	11.8	18.9	14.2	22.0	18.1	7.4	18.2	13.2	16.6	3.4	3.9	13.4	3.2	3.7	6.1	2.7	12.5	9.5	24.4	17.3	6.0	11.6	11.9	10.6	7.9	12.1	12.8	7.1	17.2	22.1	16.9	5.9	12.9	12.9	21.1	5.6	13.7	15.6	10.9	28.7	22.2	6.1	7.1	10.6	14.6	7.5	7.3	7.9	7.9	8.1	8.1	13.2	23.5	18.6	10.7	7.3	19.7	8.4	0.1	9.5	10.2	14.6	17.3	7.3	6.2	10.8	16.1	12.7	11.4	3.6	8.9	17.5	13.8	8.2	15.8	11.4	17.2	8.2	10.8	21.8	16.0	18.8	8.1	15.2	19.0	13.4	3.0	5.8	3.5	2.9	5.0	2.2	4.4	3.4	3.1	3.4	6.1	5.0	4.5	3.7	3.2	3.9	4.9	2.7	14.1	14.5	22.9	15.1	12.3	7.3	13.3	12.3	11.7	14.2	6.0	7.2	8.6	7.2	3.5	28.2	11.2	12.7	12.0	4.5	12.2	41.2	6.5	3.3	5.2	0.8	10.3	4.1	0.0	4.0	3.9	7.2	7.5	0.0	6.4	3.9	42.9	15.1	12.3	11.5	0.9	11.5	6.7	5.0	10.0	8.2	19.2	6.1	6.6	9.6	4.1	29.5	19.4	7.2	18.6	8.9	3.8	3.3	10.2	7.3	4.1
RBM14-RBM4		ENSG00000248643	"RBM14-RBM4 readthrough"		11	66616626-66646469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Ciliated cells: 6.7;Club cells: 9.1;Cone photoreceptor cells: 3.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.3;SK-MEL-30: 7.0"									HPA047849	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047849: AB_2680180"	"unprognostic (2.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-4)"	"unprognostic (3.92e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.77e-4)"	"unprognostic (5.74e-7)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.10e-2)"	7.3	5.9	5.7	7.4	7.7	13.9	5.0	12.3	8.2	5.4	7.5	6.9	7.5	2.8	8.1	11.4	6.4	4.9	7.1	12.2	5.9	5.4	6.2	14.7	6.3	6.4	8.5	4.9	6.0	7.9	2.8	9.1	5.9	5.5	7.6	4.8	7.5	5.8	5.8	9.3	4.0	6.3	7.3	5.3	7.5	7.7	11.9	6.5	13.2	7.2	4.9	9.2	6.7	5.7	8.6	10.8	7.5	6.4	4.3	5.4	4.4	2.1	1.5	0.8	1.8	1.6	0.2	1.1	1.1	0.5	2.1	0.4	3.5	0.6	0.7	1.2	0.2	1.7	3.7	1.4	0.4	0.5	0.0	0.7	3.3	1.3	2.4	0.6	1.8	1.7	0.0	0.3	0.9	0.2	0.5	0.0	0.6	4.7	1.5	1.1	3.8	2.6	12.3	1.2	2.2	4.7	1.8	5.2	0.6	0.4	2.3	2.6	0.9	0.6	1.7	7.0	0.4	0.8	1.3	0.0	2.7	2.6	1.7	1.5	0.2	0.7	1.6	0.9	1.2	0.8	6.4	6.4	7.5	5.4	5.6	3.8	8.6	3.6	4.1	6.7	8.0	1.3	3.1	3.5	4.3	5.3	10.8	2.3	4.4	5.7	7.7	12.3	8.2	5.9	5.4	8.5	4.9	5.5	6.5	0.0	0.6	0.0	0.5	0.0	0.9	0.0	0.0	6.7	9.1	0.0	3.9	0.4	0.0	0.4	1.4	0.4	0.0	0.0	0.2	0.3	0.2	0.6	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.1	0.7	0.0	0.0	0.7	0.9	0.1	0.9	0.0	0.2	0.7
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237624-122264839	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA057281: AB_2683394, HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favorable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	12.8	14.8	16.5	9.1	16.5	15.1	24.6	18.1	20.3	14.4	13.4	10.5	13.7	10.4	13.6	16.2	11.8	11.6	11.7	27.2	16.7	18.6	17.3	12.2	10.7	10.9	17.8	13.2	15.1	13.7	16.0	18.2	16.2	16.3	17.2	12.6	8.2	12.6	13.9	29.4	10.1	10.8	13.2	16.0	12.4	12.3	7.6	15.0	11.9	15.3	13.5	11.1	13.0	14.4	8.7	9.5	16.0	13.0	7.7	10.0	8.2	5.8	6.1	8.4	9.2	12.4	15.4	7.3	13.3	10.9	9.1	8.5	7.0	5.8	10.2	5.8	8.6	10.1	13.7	13.1	13.8	11.5	10.4	5.9	7.6	10.2	5.9	14.0	15.1	10.5	13.1	15.7	9.6	19.6	9.2	13.1	8.3	10.4	8.0	13.6	6.3	7.8	9.3	6.5	19.8	10.2	7.0	17.4	13.8	12.7	6.6	17.6	9.3	10.0	14.1	15.0	6.9	8.2	8.6	7.2	8.6	4.9	13.7	13.0	11.7	21.5	8.5	14.1	9.4	10.2	6.8	9.2	16.0	10.0	10.5	9.6	8.7	8.9	9.7	9.5	6.0	9.3	9.7	9.7	7.7	13.0	6.9	9.1	8.2	16.5	16.5	18.1	20.3	16.7	18.6	17.8	13.2	16.3	15.0	29.8	10.9	16.7	9.8	19.3	11.8	46.6	7.6	17.4	13.6	24.4	2.0	28.1	23.2	20.9	61.1	24.8	12.3	0.0	14.0	35.6	16.0	18.9	17.3	13.7	24.5	3.2	18.9	13.5	21.4	54.6	12.4	16.2	18.6	10.0	16.7	15.8	18.5	13.9	15.9	18.9	11.6	19.4	23.1	10.1	19.4	22.6	47.6	17.3	13.6	14.1
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644397-110839469	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.9;skeletal muscle: 20.9"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 137.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.7;HEL: 4.8;K-562: 4.6;RH-30: 15.7;SH-SY5Y: 14.6;SuSa: 5.0;T-47d: 8.8"	"Region enhanced"	"Detected in some"		"olfactory region: 4.6"	"Not detected"	"Not detected"			"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		Yes	No			"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.7	0.1	0.4	0.6	1.9	0.1	2.2	0.5	1.5	0.9	2.6	1.3	0.0	0.2	2.5	7.5	3.6	1.9	2.3	45.9	0.6	0.2	1.1	0.1	0.5	0.1	0.3	1.3	2.4	13.7	0.9	1.2	1.4	1.4	1.0	0.5	4.3	6.3	0.7	20.9	0.7	1.0	2.1	0.6	0.1	0.6	0.9	1.4	0.0	0.7	3.4	0.5	1.8	3.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.1	0.0	0.0	2.3	5.7	4.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	15.7	0.0	0.0	0.0	0.1	14.6	0.1	0.0	0.6	5.0	8.8	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.9	0.5	1.5	0.6	0.2	0.3	1.3	1.4	1.4	0.0	0.0	0.0	0.2	0.1	1.3	137.1	0.0	17.4	0.0	0.0	2.0	1.0	1.7	0.0	0.7	0.6	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.4	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	12.7	1.4	2.3	6.5	1.9	0.0	0.5	0.0	2.6	0.0	0.0	0.1
RBM23	"CAPERbeta, FLJ10482, RNPC4"	ENSG00000100461	"RNA binding motif protein 23"	Q86U06	14	22893206-22919184	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004144	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Intermediate filaments"	Nucleoplasm	"HPA004144: AB_1079747"	"unprognostic (5.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-1)"	"prognostic favorable (8.06e-9)"	"unprognostic (4.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.81e-1)"	18.7	26.9	22.0	22.1	29.3	28.1	24.8	33.7	35.7	28.6	22.5	26.9	25.9	18.3	35.0	24.7	25.9	36.9	24.2	20.3	19.9	24.2	27.8	27.0	25.2	25.0	19.7	23.7	40.8	23.2	56.6	37.5	43.9	23.9	27.2	25.7	35.4	25.3	25.8	18.0	22.3	24.8	28.2	22.6	32.7	25.3	23.5	26.7	44.0	42.4	19.7	31.2	24.8	34.9	14.0	17.8	49.9	17.2	20.5	14.3	9.8	20.1	31.9	32.6	17.0	17.9	15.4	13.6	22.1	30.4	43.1	33.9	14.4	24.8	33.8	17.5	20.5	20.7	28.7	36.5	18.6	35.2	26.5	30.1	15.9	24.9	1.1	28.2	30.5	26.2	19.7	25.8	24.8	16.5	24.1	24.0	17.0	20.0	22.0	21.1	25.7	33.3	13.7	14.5	30.8	30.0	28.8	27.0	20.5	16.8	28.6	22.5	25.2	33.2	25.8	14.0	22.4	19.0	18.1	22.2	7.5	12.8	17.9	20.4	20.9	26.7	31.9	12.5	17.6	26.7	11.3	17.2	17.6	14.3	13.3	9.8	10.8	10.2	12.3	17.8	14.0	12.5	10.9	49.9	20.5	16.4	9.3	10.4	9.8	22.0	29.3	33.7	35.7	19.9	24.2	19.7	23.7	23.9	26.7	41.7	38.7	72.9	41.5	16.4	60.7	21.2	58.6	76.3	47.8	31.4	110.0	43.5	38.1	32.4	6.9	35.1	49.3	46.7	29.6	40.1	28.0	24.3	68.2	30.6	27.8	47.7	62.8	44.8	37.7	8.2	32.8	36.7	15.1	54.1	33.4	44.2	29.7	35.3	26.5	21.4	123.6	32.3	32.8	39.7	58.7	18.3	84.8	83.0	31.8	22.7
RBM26	"ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17"	ENSG00000139746	"RNA binding motif protein 26"	Q5T8P6	13	79311824-79406477	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040252	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA040252: AB_10672895"	"unprognostic (5.55e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (5.87e-6)"	"unprognostic (8.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic favorable (8.20e-4)"	18.0	23.7	25.1	23.2	35.2	28.0	22.9	47.3	30.2	22.1	16.4	21.9	18.4	16.0	25.2	25.8	18.2	21.4	15.5	15.6	23.7	17.7	14.7	17.4	18.7	32.4	24.7	18.5	30.5	24.8	20.3	34.4	20.9	25.5	19.5	19.8	16.2	20.0	17.7	20.9	27.9	23.5	18.6	23.4	29.1	20.4	25.1	27.8	37.0	22.9	15.2	28.9	17.6	18.2	9.4	4.3	6.0	3.3	3.7	7.5	1.6	20.6	11.1	27.4	13.9	12.3	13.1	15.0	14.2	12.0	14.8	15.4	14.8	17.7	31.1	11.7	10.5	9.7	19.8	20.5	14.0	21.6	18.7	21.9	24.0	24.7	13.4	9.7	44.6	19.1	8.8	11.7	15.1	21.3	13.6	15.5	19.4	18.1	10.4	16.5	6.9	27.0	23.6	17.0	18.6	6.6	27.3	22.8	16.4	13.7	11.9	20.9	14.1	12.2	14.8	8.7	17.4	13.3	37.2	14.6	12.7	12.6	10.1	14.4	15.1	13.2	38.7	20.5	25.0	15.0	6.0	2.4	4.4	5.0	3.3	5.2	6.2	5.0	4.7	1.4	9.4	7.5	6.6	3.3	3.7	2.4	4.3	5.2	1.6	25.1	35.2	47.3	30.2	23.7	17.7	24.7	18.5	25.5	27.8	53.6	68.6	40.2	32.3	30.8	65.0	37.4	33.1	34.8	39.8	24.4	68.7	27.9	8.3	21.3	39.0	42.9	27.1	0.0	22.4	26.3	29.4	32.5	54.3	37.2	27.8	54.0	47.1	55.9	55.1	20.7	60.1	36.7	15.1	22.6	36.8	44.7	23.5	31.6	44.6	15.7	67.1	51.8	20.6	81.3	79.1	31.0	19.2	40.7	37.5	30.2
RBM27	"ARRS1, KIAA1311, Psc1, ZC3H20"	ENSG00000091009	"RNA binding motif protein 27"	Q9P2N5	5	146203600-146289132	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035944, HPA036422"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035944: AB_10670672, HPA036422: AB_10669987"	"unprognostic (8.18e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (4.73e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.67e-3)"	"unprognostic (4.09e-3)"	17.1	11.7	14.4	19.0	18.1	28.8	16.3	21.2	18.3	16.0	17.4	11.3	13.0	12.7	18.0	14.4	15.8	14.8	11.1	14.4	13.6	11.3	14.1	17.8	13.5	18.2	13.2	14.6	20.1	12.7	18.7	15.3	15.5	14.4	15.1	14.6	11.6	15.5	12.1	23.4	15.1	15.9	19.2	13.7	15.1	14.4	16.4	13.9	26.4	18.9	14.3	18.6	18.6	16.3	5.2	4.3	5.1	4.7	6.0	6.6	2.4	10.2	8.4	10.9	17.5	9.5	9.1	12.6	7.6	8.7	11.2	12.4	14.7	13.3	21.8	6.0	8.6	15.5	10.7	16.2	17.6	20.0	16.6	7.2	15.0	9.5	10.1	10.4	23.3	17.4	8.5	9.2	12.1	21.5	8.6	10.0	10.4	16.3	13.2	10.6	9.3	16.8	11.7	15.0	11.3	9.6	15.2	17.0	14.9	11.3	11.5	13.7	9.4	15.7	15.3	12.1	11.6	18.0	12.8	9.5	12.1	12.8	8.9	12.3	12.7	12.0	25.8	9.0	17.1	11.2	4.9	2.8	5.1	5.0	4.3	5.7	4.5	5.0	5.7	3.6	5.2	6.6	5.2	4.2	6.0	4.7	4.3	4.9	2.4	14.4	18.1	21.2	18.3	13.6	11.3	13.2	14.6	14.4	13.9	14.9	14.5	12.7	7.9	58.7	10.4	15.9	5.1	26.8	21.6	14.0	9.8	7.8	1.7	6.8	23.3	15.1	7.5	0.0	5.9	6.5	22.2	13.0	20.9	11.3	9.6	14.3	10.4	10.4	22.7	3.6	10.6	18.7	18.6	4.6	15.7	6.6	9.0	7.0	13.8	5.3	8.5	0.0	26.4	27.3	11.1	54.3	8.1	12.5	12.6	19.6
RBM33	"DKFZp434D1319, DKFZp686F102, MGC20460, PRR8"	ENSG00000184863	"RNA binding motif protein 33"	Q96EV2	7	155644451-155781485	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019232, HPA021497, HPA021768"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019232: AB_1856121, HPA021497: AB_2176261, HPA021768: AB_1856123"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (3.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.89e-2)"	"unprognostic (8.90e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.29e-4)"	16.8	14.1	18.6	24.5	20.9	65.0	16.2	46.1	27.6	14.8	15.1	24.1	13.4	17.2	16.3	21.9	16.4	11.9	14.1	13.2	16.3	12.5	15.6	21.0	19.8	21.1	22.8	14.9	19.3	20.5	14.3	29.1	13.2	16.4	15.7	16.2	13.8	15.9	13.6	33.0	26.9	20.8	14.0	25.5	21.4	17.1	16.0	20.8	28.5	17.3	10.2	19.7	13.8	18.7	5.7	5.7	23.9	6.8	5.0	5.6	2.5	16.8	19.8	12.4	11.5	6.6	8.8	12.6	10.6	7.5	6.5	9.6	18.0	16.1	18.6	14.4	7.8	17.9	12.1	11.3	8.9	8.8	17.6	16.3	17.7	20.7	11.7	7.4	24.9	17.9	8.5	10.6	10.5	15.0	9.7	11.5	20.9	22.5	15.4	9.3	16.2	25.6	21.6	13.4	11.3	13.0	20.7	13.9	15.3	9.5	18.1	12.8	13.1	17.8	12.0	10.0	9.8	9.0	13.2	13.5	11.2	6.7	20.1	14.1	27.3	20.6	27.7	18.4	16.6	14.3	16.3	6.8	13.7	4.5	6.3	3.6	5.7	4.5	5.4	5.6	5.3	4.1	5.2	23.9	5.0	4.9	5.7	5.6	2.5	18.6	20.9	46.1	27.6	16.3	12.5	22.8	14.9	16.4	20.8	29.8	28.4	44.1	18.2	17.4	54.2	25.2	12.7	17.4	12.5	3.5	78.5	15.9	6.6	16.4	18.4	20.7	29.0	23.3	15.5	14.0	14.9	26.2	37.1	25.1	14.0	125.5	25.2	16.0	26.6	29.8	24.2	26.3	11.8	30.7	25.7	29.4	19.7	26.2	16.6	13.8	96.9	12.9	19.6	29.3	22.4	20.6	21.9	32.0	21.8	22.2
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161457	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Nucleoplasm, Mitotic chromosome"	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	15.8	10.5	17.2	16.4	18.1	30.6	14.8	15.5	22.3	11.0	13.5	10.6	7.0	16.7	10.9	15.2	15.4	9.9	11.3	15.2	13.4	11.6	19.4	14.2	11.5	20.0	16.9	9.9	13.9	13.5	6.6	24.9	14.7	20.9	13.5	12.6	7.6	18.3	11.2	22.2	17.9	17.6	10.9	17.9	14.6	13.1	28.8	17.3	17.5	14.7	10.9	17.1	14.1	16.0	34.2	27.2	38.0	19.2	25.3	35.5	22.7	12.0	9.1	9.5	12.1	7.2	13.0	23.6	12.8	8.9	11.5	11.1	12.3	13.8	20.8	13.9	7.7	9.2	18.1	11.3	11.7	11.1	18.8	18.4	15.6	6.5	8.5	14.4	24.6	15.3	11.4	13.5	10.7	7.4	10.6	9.2	20.8	22.1	10.7	14.5	6.9	21.4	21.2	27.6	16.6	6.5	20.1	10.5	24.0	11.9	9.2	11.8	21.5	17.7	11.3	28.9	6.9	24.6	26.8	9.6	11.7	10.2	16.1	25.6	13.0	21.0	22.0	13.7	16.5	18.2	38.0	16.9	20.4	23.7	19.2	28.2	34.2	27.3	30.4	17.2	26.3	26.0	29.9	8.2	25.3	19.1	27.2	35.5	22.7	17.2	18.1	15.5	22.3	13.4	11.6	16.9	9.9	20.9	17.3	17.9	10.9	5.1	5.4	2.9	3.3	2.6	5.1	16.0	11.4	3.5	9.8	5.2	5.0	5.6	5.6	3.5	3.6	0.0	5.4	3.7	3.5	4.5	22.0	3.0	2.9	0.0	7.5	5.5	6.8	4.4	3.7	4.3	3.3	9.0	2.6	4.1	7.1	2.9	5.3	7.9	4.9	0.0	5.2	6.1	5.3	3.3	5.1	11.4	3.7	5.7
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"		NA	NA			"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	41.4	44.1	37.5	41.5	41.4	120.8	38.5	57.5	41.8	43.4	35.0	30.7	46.3	29.5	51.9	34.3	42.8	35.3	40.7	40.2	35.8	29.9	39.2	32.4	40.4	41.8	41.1	31.4	52.3	35.6	40.9	71.5	45.2	37.4	39.2	27.0	28.9	37.1	46.0	44.1	32.1	30.6	40.2	43.0	38.4	33.5	22.9	46.4	52.4	40.7	28.2	40.5	39.9	46.1	27.6	32.5	88.9	25.1	24.2	22.5	16.8	28.9	26.9	27.9	24.7	22.1	25.1	30.6	38.9	19.5	25.4	23.9	38.8	26.8	39.9	30.3	15.0	23.7	27.4	41.5	24.6	29.3	26.8	29.7	53.2	27.2	44.9	25.0	48.9	33.3	10.2	42.7	21.3	24.1	25.2	23.6	19.8	54.8	35.7	21.7	25.1	56.9	35.3	33.8	30.4	32.3	34.8	44.5	30.1	23.0	20.9	27.2	23.7	30.4	38.7	33.9	45.7	26.1	34.5	27.2	33.1	28.3	30.6	34.9	23.0	46.6	58.7	22.7	39.4	24.2	41.2	25.1	38.2	22.5	22.1	22.1	25.3	19.8	20.7	22.4	27.6	18.9	18.0	88.9	24.2	19.4	32.5	22.1	16.8	37.5	41.4	57.5	41.8	35.8	29.9	41.1	31.4	37.4	46.4	217.4	272.9	286.2	469.4	547.4	245.5	170.5	147.7	277.1	246.9	190.1	298.4	332.4	160.8	177.8	36.1	270.2	247.4	93.5	161.5	312.9	353.4	410.0	503.4	165.1	177.4	208.2	283.3	159.0	179.4	26.2	243.1	231.7	256.4	248.9	177.6	221.0	173.7	189.4	201.5	125.5	372.3	161.7	294.1	267.2	236.8	513.0	469.7	366.7	196.0	480.8
RBM4	"LARK, RBM4A, ZCCHC21, ZCRB3A"	ENSG00000173933	"RNA binding motif protein 4"	Q9BWF3	11	66638617-66666682	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042174, HPA047849"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (8.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.07e-3)"	41.6	50.3	37.1	34.4	37.2	57.5	38.3	55.5	43.9	40.6	39.1	35.5	43.4	33.9	42.2	48.3	44.5	37.4	33.6	33.0	32.1	31.0	40.9	37.2	34.3	44.7	30.1	32.7	51.1	63.9	44.9	41.5	42.5	31.1	42.7	33.2	41.3	54.6	33.2	40.8	37.4	36.2	36.7	26.9	48.5	42.1	47.3	32.2	68.2	59.5	37.9	48.7	36.5	37.2	51.4	45.0	61.7	51.9	57.5	72.7	54.3	26.9	35.7	54.3	30.6	20.0	21.7	33.0	28.5	23.1	30.1	21.6	59.5	35.2	34.9	39.4	28.5	27.1	30.1	57.9	33.9	32.3	34.6	30.2	47.5	36.6	35.5	39.6	32.4	20.7	31.8	29.5	34.6	49.1	30.7	39.8	34.4	37.3	25.8	31.3	55.8	53.3	33.4	68.2	52.8	39.4	50.0	50.9	38.6	39.8	43.7	45.8	32.9	50.2	36.9	79.8	38.3	70.0	32.7	40.4	31.4	27.7	19.4	23.0	32.5	33.9	56.4	25.1	25.6	44.9	61.7	45.7	48.6	56.8	46.8	51.0	48.0	59.0	61.8	45.0	51.4	63.8	63.5	53.6	57.5	51.9	40.6	72.7	54.3	37.1	37.2	55.5	43.9	32.1	31.0	30.1	32.7	31.1	32.2	26.8	35.6	27.0	53.2	15.9	54.4	4.1	12.7	41.5	33.0	19.2	88.4	31.8	13.3	19.9	32.7	23.2	24.5	23.3	20.1	24.9	21.1	36.2	35.8	8.5	12.6	58.8	33.4	19.0	14.3	5.2	25.3	23.5	18.6	25.2	13.9	15.1	17.3	18.2	19.1	8.1	77.2	19.4	25.8	24.7	32.8	19.4	36.6	42.7	18.0	55.6
RBM41	FLJ11016	ENSG00000089682	"RNA binding motif protein 41"	Q96IZ5	X	107064420-107118823	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042881	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA042881: AB_10794536"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.92e-1)"	10.0	10.3	9.2	9.1	10.8	5.0	9.5	23.7	14.2	13.4	11.9	10.1	8.2	12.7	12.2	11.5	11.1	12.4	7.6	8.8	8.7	6.8	11.8	13.7	8.3	8.9	9.7	9.4	9.7	10.6	21.0	14.1	12.0	11.6	10.8	11.2	9.0	10.7	9.0	14.6	11.6	15.5	11.2	14.2	11.5	8.2	15.6	12.8	12.2	15.7	8.0	9.9	12.4	9.8	6.3	4.8	10.6	7.0	8.6	6.3	3.4	14.4	11.6	7.5	6.0	5.0	8.7	8.7	8.6	8.5	6.3	8.6	7.7	12.1	7.9	16.3	6.2	11.1	12.0	10.8	8.0	9.7	9.8	16.0	9.7	21.0	9.4	5.6	9.8	7.6	6.1	15.9	7.7	7.7	8.9	9.5	7.5	16.7	11.1	7.6	7.0	8.3	5.6	11.0	8.0	13.3	6.7	6.3	6.8	9.4	9.2	6.2	9.8	10.7	7.7	6.9	10.7	7.1	5.1	9.2	8.9	5.2	10.5	6.7	5.2	9.6	8.9	5.0	4.5	6.6	10.6	7.0	10.6	6.3	3.7	3.9	6.3	5.5	6.3	4.7	6.3	4.1	2.8	1.0	8.6	3.7	4.8	4.9	3.4	9.2	10.8	23.7	14.2	8.7	6.8	9.7	9.4	11.6	12.8	11.9	14.2	10.3	5.1	4.6	20.6	20.4	7.6	14.7	6.8	7.0	25.5	7.0	1.7	12.0	4.0	5.8	11.8	23.3	6.9	4.6	6.2	5.2	12.7	7.8	5.7	11.1	7.5	6.2	7.9	1.3	13.3	10.5	5.0	6.4	9.0	10.5	10.6	10.5	11.0	6.9	20.7	0.0	9.5	6.8	7.2	6.5	3.8	10.1	11.0	5.5
RBM42	MGC10433	ENSG00000126254	"RNA binding motif protein 42"	Q9BTD8	19	35629030-35637686	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 321.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043671	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043671: AB_10794890"	"unprognostic (4.77e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.26e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.33e-2)"	26.0	22.0	16.6	20.3	16.0	29.2	23.6	12.1	23.4	20.4	27.3	22.6	18.8	24.2	25.5	21.8	25.5	18.3	23.6	24.9	13.7	12.0	22.2	33.3	19.3	19.2	15.7	17.6	27.6	17.7	20.7	15.0	41.3	16.0	19.5	9.9	15.9	25.1	24.6	44.6	31.5	24.7	18.6	18.1	25.4	22.0	23.7	16.0	41.1	25.8	21.9	21.3	21.2	22.4	43.6	49.1	61.3	48.9	38.9	45.6	33.9	32.4	51.2	11.4	15.5	10.4	8.3	31.2	22.4	12.4	26.4	20.8	30.2	21.2	18.1	41.0	14.2	14.3	13.4	13.1	15.7	7.7	46.8	23.5	25.0	17.1	24.6	27.1	22.0	24.1	11.7	12.6	19.4	10.7	8.4	14.4	19.1	25.9	14.9	11.9	37.0	27.9	29.1	13.1	29.5	21.1	30.5	15.6	18.0	12.5	15.1	15.0	21.8	25.4	21.0	17.0	6.6	16.7	34.7	22.0	18.9	25.8	24.9	38.9	36.5	38.4	27.9	18.2	21.0	26.3	46.1	42.1	61.3	45.6	48.9	39.3	41.0	37.9	45.5	49.1	43.6	34.2	37.7	38.6	38.9	45.4	45.4	41.9	33.9	16.6	16.0	12.1	23.4	13.7	12.0	15.7	17.6	16.0	16.0	35.7	21.1	26.7	41.9	46.0	19.2	12.0	50.9	26.8	28.4	50.6	11.8	174.8	63.0	68.5	26.2	42.7	70.6	0.0	78.3	85.4	48.9	29.9	50.7	27.6	78.2	9.5	50.1	48.5	29.8	12.0	53.8	45.9	50.6	83.8	42.6	43.4	64.2	45.6	59.4	63.4	13.9	51.8	59.0	62.6	56.9	38.0	321.4	45.9	48.9	38.9
RBM43	"C2orf38, FLJ45645"	ENSG00000184898	"RNA binding motif protein 43"	Q6ZSC3	2	151247940-151261879	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.2;HSkMC: 16.4"	"Low region specificity"	"Detected in all"							HPA038204	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA038204: AB_10669520"	"unprognostic (3.50e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.94e-2)"	10.7	14.8	5.2	7.6	6.4	6.0	7.9	1.6	4.9	14.4	8.1	5.4	7.4	3.1	14.6	14.6	8.4	13.6	7.2	4.4	6.0	4.8	7.8	7.0	14.3	13.6	4.5	5.3	17.6	6.8	8.7	7.8	6.0	4.3	14.4	4.7	14.3	6.2	8.9	4.5	6.2	6.3	11.5	5.6	8.4	5.9	6.5	4.1	11.0	13.4	3.6	6.9	20.5	6.6	3.2	1.1	5.9	4.6	5.3	4.9	1.2	2.9	1.9	3.1	4.1	8.3	18.2	2.0	3.4	7.8	4.3	6.3	0.1	4.9	2.3	1.3	6.1	2.3	1.5	0.9	3.9	2.2	3.4	2.1	5.5	0.7	0.2	8.1	6.7	1.9	16.4	4.4	3.4	2.6	6.5	9.1	2.5	2.2	2.6	5.8	2.9	3.8	3.2	1.1	0.0	3.6	2.6	3.5	1.3	7.3	2.5	1.1	3.6	3.3	2.4	6.4	0.5	3.5	4.4	5.1	3.2	2.9	2.8	1.4	0.9	0.6	0.0	8.5	2.7	1.9	1.9	1.7	5.9	2.8	2.1	4.6	2.8	3.9	3.5	1.1	3.2	4.9	3.4	2.0	5.3	4.6	0.5	1.9	1.2	5.2	6.4	1.6	4.9	6.0	4.8	4.5	5.3	4.3	4.1	3.0	6.2	4.7	2.3	3.0	7.5	2.1	15.3	32.1	6.8	17.4	0.0	5.6	23.2	4.9	2.3	9.0	2.9	0.0	5.1	3.3	8.7	3.3	3.5	8.6	4.7	6.4	5.8	15.4	11.3	1.1	25.9	4.8	3.3	8.2	6.9	21.7	3.8	5.3	27.3	8.8	0.9	0.0	5.7	0.7	3.2	2.8	1.1	5.9	4.3	2.0
RBM46	"CT68, MGC27016"	ENSG00000151962	"RNA binding motif protein 46"	Q8TBY0	4	154781213-154828813	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"testis: 34.5"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 74.4;Spermatogonia: 75.5"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 2.7;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079488			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA079488: "	"unprognostic (4.79e-1)"				"unprognostic (1.14e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.99e-7)"	"unprognostic (4.86e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.27e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	34.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	74.4	75.5	0.0	0.0	0.0	0.0	0.0
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 42.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 11.3;granulocytes: 42.4;monocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"A549: 16.8;BEWO: 50.3;CAPAN-2: 22.1;SK-BR-3: 16.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA006347	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	8.2	33.6	1.9	8.2	2.4	2.6	10.9	0.8	1.2	5.4	22.9	3.3	28.7	24.1	2.6	15.4	27.3	5.3	12.7	4.0	2.4	1.1	37.0	16.1	14.5	11.3	3.0	0.3	4.6	19.2	8.0	2.9	27.2	6.6	13.2	17.3	9.2	60.8	36.0	0.9	6.0	42.8	2.2	4.1	15.0	22.2	7.1	2.2	1.6	31.5	13.7	20.6	7.8	9.7	2.0	11.3	42.4	14.2	0.1	0.1	4.8	11.6	16.8	0.0	0.5	0.0	0.0	50.3	0.3	0.3	0.1	0.1	9.8	22.1	0.0	8.8	0.3	0.9	4.6	0.3	3.3	0.1	0.0	2.8	0.0	1.2	2.7	0.2	0.1	0.1	0.2	2.0	0.0	0.0	0.3	0.0	0.0	0.6	2.5	0.0	6.6	0.0	0.3	5.1	16.3	0.9	0.0	0.0	13.0	15.5	14.8	0.5	0.1	6.6	16.8	0.1	3.8	7.4	3.1	0.0	0.1	0.6	0.1	0.3	8.9	13.2	1.4	1.5	1.4	0.0	0.1	14.2	0.1	0.0	10.9	0.1	2.0	0.0	0.0	11.3	1.2	0.1	0.0	42.4	0.1	8.1	4.6	0.0	4.8	1.9	2.4	0.8	1.2	2.4	1.1	3.0	0.3	6.6	2.2	74.5	109.6	29.8	66.4	52.3	0.0	2.0	63.7	107.1	92.1	106.4	0.0	84.5	54.7	73.9	0.9	3.4	253.2	0.0	99.6	71.8	8.3	174.3	6.9	117.3	81.1	1.6	116.9	35.0	113.3	1.5	2.3	85.9	35.4	57.7	177.9	0.4	94.8	165.8	1.1	114.0	0.0	0.0	3.1	1.9	11.4	65.9	219.6	0.0	144.7	244.6
RBM4B	"MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B"	ENSG00000173914	"RNA binding motif protein 4B"	Q9BQ04	11	66664998-66677921	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042174, HPA047849"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.71e-2)"	7.1	12.3	17.6	9.6	17.3	4.0	10.2	35.9	19.3	13.4	10.0	22.8	13.5	9.3	19.0	20.2	10.1	18.3	9.8	9.2	17.5	17.4	9.9	9.8	8.8	13.8	15.4	16.2	29.8	11.8	15.7	25.6	12.2	17.3	14.6	11.5	14.5	14.1	15.0	13.9	17.4	10.3	14.0	16.4	11.8	9.8	17.0	18.7	8.5	12.3	7.6	15.5	11.3	11.5	21.8	11.4	26.8	15.1	13.2	12.5	8.4	13.1	13.2	29.1	24.2	14.3	14.7	9.8	12.7	12.7	14.2	14.6	18.5	13.9	14.7	18.2	16.0	13.9	17.2	19.1	17.5	15.1	14.2	13.0	16.0	16.6	19.7	10.5	16.2	15.8	15.3	12.0	14.5	12.4	16.3	13.7	12.0	12.1	14.8	19.1	21.2	10.0	12.5	17.3	29.7	17.8	20.6	23.2	15.1	12.9	13.3	17.9	16.4	15.1	7.8	28.3	19.5	20.8	15.4	12.6	15.7	16.2	15.3	11.3	7.3	12.3	15.1	14.5	11.5	13.8	12.7	9.6	26.8	10.8	14.1	10.4	21.8	10.1	10.4	11.4	18.6	12.5	9.2	6.1	13.2	15.1	9.4	7.4	8.4	17.6	17.3	35.9	19.3	17.5	17.4	15.4	16.2	17.3	18.7	11.9	5.1	15.9	14.0	7.1	35.5	4.5	7.6	21.4	10.3	17.4	31.4	32.2	10.0	12.0	21.2	7.0	8.5	0.0	5.0	14.2	17.8	7.3	9.2	7.4	11.1	23.8	18.4	6.7	8.7	36.0	17.0	8.2	15.1	9.0	8.6	21.8	5.3	7.4	12.7	11.2	56.8	6.5	11.3	42.1	40.0	6.1	18.5	13.4	10.3	4.3
RBM6	"3G2, DEF-3, DEF3, g16, NY-LU-12"	ENSG00000004534	"RNA binding motif protein 6"	P78332	3	49940007-50100045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026272, HPA027164"	Enhanced		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA026272: AB_1847592, HPA027164: AB_1847593"	"unprognostic (3.81e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (7.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.13e-5)"	24.4	30.2	30.2	51.3	37.1	30.0	25.1	49.4	41.1	31.2	31.0	28.9	38.5	30.3	51.4	34.3	21.8	28.8	32.6	25.3	32.1	19.8	29.2	30.6	26.8	39.8	38.1	26.0	42.6	35.9	41.9	36.9	21.9	30.5	40.1	29.8	25.6	28.1	38.3	25.3	35.9	32.4	36.7	40.9	42.6	28.0	29.7	38.0	24.9	32.6	21.9	35.9	25.1	36.6	12.8	9.9	14.7	8.6	7.3	15.6	5.9	9.7	6.2	25.4	16.9	26.0	14.3	9.0	16.5	14.3	14.6	15.4	10.7	11.1	50.1	9.7	16.4	14.9	8.1	21.7	14.5	18.6	20.1	8.1	23.2	14.2	13.9	14.8	24.4	24.1	13.3	18.0	16.5	18.6	27.0	18.4	13.1	19.0	12.6	13.9	9.3	22.9	36.2	20.3	12.1	11.4	8.8	10.9	12.8	14.4	19.0	10.1	18.2	15.1	10.9	10.3	23.6	8.5	19.3	17.0	14.6	17.4	11.9	16.7	17.4	41.2	30.2	8.4	20.5	14.3	14.7	8.6	5.0	15.6	4.7	12.1	12.8	10.2	8.5	8.8	11.9	10.5	11.5	6.1	7.3	7.7	9.9	6.7	5.9	30.2	37.1	49.4	41.1	32.1	19.8	38.1	26.0	30.5	38.0	53.6	75.9	98.3	36.2	48.0	117.7	27.5	35.7	52.2	50.0	59.3	96.2	29.5	10.0	26.7	26.1	51.5	48.5	23.3	24.1	24.9	50.1	43.0	40.6	28.4	24.2	87.4	45.4	47.3	59.4	17.2	60.7	54.9	57.3	40.5	32.6	52.2	32.6	31.6	57.0	10.3	141.3	45.3	50.9	108.1	28.1	39.5	30.3	54.2	31.0	31.9
RBMS2	SCR3	ENSG00000076067	"RNA binding motif single stranded interacting protein 2"	Q15434	12	56521929-56596196	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039225, HPA058784"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA039225: AB_10963056, HPA058784: AB_2683819"	"unprognostic (1.35e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.63e-2)"	24.5	7.2	5.7	5.8	10.0	3.6	31.3	8.5	8.7	12.2	9.9	6.0	6.1	4.7	17.5	11.9	9.3	10.4	10.4	19.3	8.6	5.1	12.4	4.4	53.1	8.0	7.5	5.2	12.6	7.5	11.5	12.1	24.8	11.4	9.6	9.6	14.3	10.3	9.8	9.3	7.5	7.5	12.9	19.2	13.2	8.0	4.8	7.4	2.7	16.5	8.1	5.3	11.7	19.2	1.1	4.9	3.0	8.3	2.1	2.3	1.5	11.7	9.8	4.2	6.1	10.4	10.0	4.3	14.9	15.4	11.5	10.1	7.7	20.9	0.2	17.8	15.1	4.5	8.5	3.9	23.7	12.9	3.9	3.1	1.4	7.6	2.3	6.7	1.7	2.8	8.9	6.0	11.9	14.1	13.4	21.1	2.5	0.7	2.9	19.4	1.5	1.6	1.9	2.5	0.0	3.6	0.9	4.7	0.2	14.2	2.8	0.4	3.2	17.3	6.3	2.1	9.9	6.7	3.1	32.2	7.2	15.3	3.9	3.5	2.6	1.1	0.8	2.6	0.4	10.0	1.0	8.3	2.6	1.6	2.6	1.7	0.6	0.7	2.3	4.9	1.1	1.8	1.2	3.0	2.1	0.6	1.3	0.9	1.5	5.7	10.0	8.5	8.7	8.6	5.1	7.5	5.2	11.4	7.4	38.7	15.6	0.0	8.0	3.3	4.1	6.7	15.3	6.7	17.0	12.2	9.8	17.8	1.7	19.9	9.7	41.2	4.1	0.0	14.6	31.2	7.2	11.1	8.1	1.0	9.3	7.9	5.2	47.9	21.6	17.0	16.1	7.3	0.0	2.8	6.9	6.1	28.5	11.2	23.3	9.1	1.6	25.8	8.3	0.7	1.1	1.8	19.8	0.9	6.6	11.5
RBMS3		ENSG00000144642	"RNA binding motif single stranded interacting protein 3"	Q6XE24	3	28574791-30010391	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 110.2;Ito cells: 119.7;Leydig cells: 147.9;Peritubular cells: 104.0;Sertoli cells: 109.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 7.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 14.5;HHSteC: 14.2;WM-115: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034719	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034719: AB_10670172"	"unprognostic (8.39e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.25e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.24e-4)"	16.5	10.3	4.8	3.2	5.6	0.1	9.9	1.6	4.2	10.6	6.6	2.6	7.9	1.7	5.6	9.3	6.0	6.7	8.5	16.5	5.1	2.4	6.2	4.4	12.3	5.6	5.1	3.4	13.3	2.5	10.8	4.8	12.3	8.5	8.4	3.3	10.0	4.6	13.5	9.7	3.3	3.6	13.7	8.6	7.4	4.6	4.9	4.7	3.7	18.6	5.5	2.0	9.3	8.9	0.2	7.3	0.0	0.0	0.0	0.8	0.1	1.4	0.1	7.0	0.1	13.4	8.8	0.0	3.7	2.4	4.0	4.9	0.0	0.2	0.0	4.0	14.5	1.1	0.1	0.4	2.8	7.9	0.0	0.5	3.9	5.4	0.0	14.2	0.0	0.0	8.4	1.7	7.1	8.4	5.8	5.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.2	0.0	0.3	0.2	5.2	0.0	1.5	0.0	0.0	13.4	9.0	0.0	0.4	3.3	0.0	0.0	11.7	7.9	7.3	9.2	7.6	0.0	0.0	0.5	1.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	7.3	0.6	0.1	4.8	5.6	1.6	4.2	5.1	2.4	5.1	3.4	8.5	4.7	110.2	19.7	0.0	23.2	7.3	0.4	14.5	25.5	12.0	29.6	8.7	0.0	14.0	0.0	4.0	20.0	46.7	0.0	0.0	1.1	3.7	69.8	5.7	4.7	0.9	2.5	0.0	0.0	119.7	23.9	14.8	147.9	3.8	6.8	1.0	0.0	0.0	0.6	0.0	104.0	2.6	0.0	109.9	52.6	0.9	1.1	6.4	8.0	1.9	0.0	3.3
RBMX	"hnRNP-G, HNRNPG, RNMX"	ENSG00000147274	"RNA binding motif protein, X-linked"	P38159	X	136848004-136880764	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057707	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057707: AB_2683508"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (5.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.64e-3)"	31.0	25.0	30.6	57.1	41.1	48.0	40.6	28.7	33.0	44.2	28.3	32.5	32.7	24.6	45.9	31.7	26.7	38.9	22.1	31.4	26.5	18.0	25.6	20.9	34.4	64.6	34.0	29.3	81.9	39.1	30.1	30.1	25.3	30.5	28.4	33.4	27.5	29.9	29.4	50.0	27.6	27.3	43.0	44.2	27.4	30.1	23.6	29.2	70.1	31.5	34.4	44.8	36.1	33.4	47.1	41.9	25.0	44.9	39.4	60.7	62.9	40.4	44.2	81.1	36.0	20.3	34.4	47.3	40.4	44.0	56.0	59.5	47.2	40.7	73.7	41.8	28.8	35.2	27.1	86.0	42.2	64.9	31.8	40.5	56.4	43.6	50.3	17.8	61.4	51.9	28.2	20.5	43.5	61.1	43.1	45.1	69.9	50.6	37.8	45.5	51.5	89.7	41.5	51.5	43.3	37.1	74.6	54.3	45.5	41.5	48.5	47.4	51.3	32.2	29.2	37.4	50.1	33.5	41.5	28.6	31.8	34.5	21.9	51.4	27.1	36.2	78.0	22.6	44.9	43.3	25.0	37.5	20.8	36.4	44.9	50.3	47.1	47.4	43.1	41.9	45.0	60.7	49.6	6.0	39.4	39.2	25.4	46.8	62.9	30.6	41.1	28.7	33.0	26.5	18.0	34.0	29.3	30.5	29.2	104.2	138.2	258.8	161.8	135.0	109.2	87.6	155.4	174.0	208.1	83.7	90.3	148.4	131.0	128.6	6.7	123.5	81.3	233.6	127.9	222.2	130.2	86.5	255.9	103.0	103.4	87.4	194.8	214.2	240.2	4.3	159.0	111.5	91.1	117.2	164.5	89.1	96.1	94.7	125.2	73.8	131.7	90.5	161.3	27.3	77.1	107.0	93.3	214.2	203.4	130.2
RBMX2	"CGI-79, Snu17"	ENSG00000134597	"RNA binding motif protein, X-linked 2"	Q9Y388	X	130401969-130413343	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026609	Approved		Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane"	Nucleoli	"HPA026609: AB_1846601"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.04e-4)"	"prognostic favorable (9.15e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.44e-9)"	"unprognostic (1.06e-1)"	"unprognostic (4.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.63e-3)"	19.4	16.7	22.3	16.7	20.0	17.1	25.0	22.7	22.9	25.1	19.9	18.9	19.1	17.0	29.4	29.5	18.7	19.8	18.8	17.8	21.0	18.7	17.7	21.1	16.9	21.2	18.6	22.1	28.2	21.9	17.9	24.4	17.3	21.0	23.0	20.0	16.3	20.5	23.7	21.0	21.4	15.9	23.0	18.9	21.1	18.4	10.8	19.0	26.4	23.0	17.9	26.7	27.2	20.2	12.6	10.5	11.0	9.5	9.4	19.3	5.4	14.0	14.7	14.7	15.2	14.7	27.6	15.0	13.2	13.5	15.0	16.4	10.9	17.2	13.5	31.7	10.0	19.8	15.2	23.5	12.2	21.9	12.3	20.9	12.1	13.5	11.4	13.3	18.7	14.4	20.0	17.4	16.8	23.4	21.8	16.8	16.8	10.5	11.8	16.7	24.4	21.4	23.3	11.1	24.6	23.9	16.6	14.6	18.2	15.2	11.2	17.2	20.6	8.3	17.7	23.2	12.5	11.5	13.8	10.9	12.1	9.9	28.2	27.4	15.7	17.0	19.2	14.8	30.5	15.3	11.0	9.4	10.8	11.1	9.5	11.1	12.4	13.8	14.0	7.8	12.6	15.1	14.2	8.0	9.4	9.4	10.5	19.3	5.4	22.3	20.0	22.7	22.9	21.0	18.7	18.6	22.1	21.0	19.0	17.9	14.7	30.6	27.8	28.5	21.4	20.3	25.5	29.4	45.5	10.4	9.8	28.5	13.3	28.8	2.9	30.2	14.2	0.0	30.8	34.2	26.7	22.1	34.6	23.6	30.5	15.9	39.0	35.0	46.7	3.5	30.0	32.5	27.0	31.5	21.9	19.8	26.5	17.5	41.4	32.3	10.4	32.3	30.7	16.5	47.3	26.0	21.6	32.0	27.7	20.3
RBMXL1	KAT3	ENSG00000213516	"RNA binding motif protein, X-linked like 1"	Q96E39	1	88979456-88992960	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057707	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057707: AB_2683508"	"prognostic favorable (7.60e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	13.3	9.8	18.5	11.7	15.3	23.8	13.4	12.0	18.0	18.2	12.2	15.3	9.7	9.8	18.5	16.2	20.9	16.7	11.5	14.0	17.1	15.2	17.4	18.3	13.0	13.5	17.1	17.0	22.8	14.5	25.0	14.1	16.7	17.9	16.3	9.5	14.8	11.8	14.3	8.9	12.1	12.2	16.9	17.4	14.4	13.9	14.2	13.0	11.7	16.2	10.1	14.0	19.3	12.4	8.8	8.6	12.3	10.1	6.3	10.8	8.4	10.7	3.2	9.2	12.0	10.9	11.1	17.6	4.6	10.7	9.4	11.1	5.3	7.3	9.1	9.2	5.5	21.9	6.3	17.4	11.5	10.5	8.3	7.7	10.8	11.2	7.0	6.3	8.5	5.9	6.4	6.7	8.4	7.5	4.1	6.0	6.5	15.0	6.0	5.6	4.0	9.0	4.4	16.9	7.0	7.3	8.3	22.6	4.5	6.2	12.5	6.7	10.3	5.0	11.3	11.6	12.9	8.2	8.9	4.4	6.1	12.5	7.1	7.8	9.5	8.9	9.4	4.3	5.2	5.6	2.5	6.6	5.9	6.9	8.9	9.3	6.7	9.7	7.3	8.6	8.8	10.8	6.6	12.3	6.3	10.1	4.4	7.6	8.4	18.5	15.3	12.0	18.0	17.1	15.2	17.1	17.0	17.9	13.0	32.8	34.6	13.7	48.3	27.2	18.9	17.1	20.4	24.1	29.6	12.2	13.7	25.6	3.3	7.6	1.2	18.0	9.7	0.0	7.6	24.9	16.5	19.0	33.5	28.7	10.2	23.8	27.6	14.1	21.3	1.5	15.8	13.8	20.3	19.0	9.4	26.1	8.1	5.8	14.2	4.3	16.8	6.5	23.1	10.1	15.4	21.2	28.5	20.8	10.5	30.8
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 161.0;pancreas: 107.4;retina: 85.3"	"Group enriched"	"Detected in many"	7	"Ductal cells: 920.8;Exocrine glandular cells: 932.2;Ito cells: 319.8;Pancreatic endocrine cells: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 136.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 56.8"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	1.9	43.1	6.5	3.3	11.3	0.1	7.5	5.1	7.8	7.8	3.2	11.5	8.4	4.5	26.8	11.3	3.3	58.4	42.7	7.5	7.7	8.1	3.7	20.1	4.9	6.5	10.4	4.9	161.0	107.4	4.3	26.2	20.6	31.5	9.8	2.1	85.3	4.7	6.4	1.8	2.9	4.8	17.5	8.7	4.7	2.8	12.9	4.3	0.9	3.3	2.6	2.0	7.7	7.2	0.5	0.5	2.1	0.9	0.7	0.4	0.2	1.2	0.3	1.1	26.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.0	8.7	0.0	0.4	0.0	6.1	0.1	0.0	0.0	0.7	0.0	0.4	11.2	25.8	0.0	0.0	0.4	0.0	0.0	0.0	26.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	5.2	0.0	0.0	0.0	3.2	136.6	5.6	0.0	0.0	2.3	0.5	0.1	0.0	0.0	20.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.9	0.8	0.4	0.8	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	2.1	0.7	0.5	0.5	0.1	0.2	6.5	11.3	5.1	7.8	7.7	8.1	10.4	4.9	31.5	4.3	29.8	5.1	10.5	43.6	15.7	12.3	15.5	63.7	5.3	12.5	22.7	2.0	2.6	11.6	920.8	3.9	54.2	0.0	0.0	932.2	6.9	95.1	21.2	0.0	6.6	16.2	3.2	41.3	319.8	11.5	8.3	25.0	2.8	8.5	23.4	0.5	79.7	450.0	0.0	4.2	2.7	7.0	25.8	22.5	2.3	4.1	30.6	3.2	2.5	0.8	27.7
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	198	"intestine: 333.2"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 8.9;Collecting duct cells: 12.2;Cone photoreceptor cells: 7.9;Enterocytes: 17.1;Pancreatic endocrine cells: 9.4;Paneth cells: 14.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 41.9"	"Region enriched"	"Detected in single"	4	"basal ganglia: 4.6"	"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		96000	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	130.1	0.0	0.0	221.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	1.6	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	333.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	41.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.2	5.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	8.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	12.2	7.9	0.0	0.0	0.5	0.0	0.0	17.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	9.4	14.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7123684-7128942	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 2221.9"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 1.3;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HEL: 7.0;Hep G2: 15.6;K-562: 32.0"					"Low region specificity"	"Detected in all"			HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favorable (3.68e-4)"	1.5	2.6	0.3	18.2	0.3	0.7	1.3	0.6	0.3	2.8	1.7	0.1	2.3	1.4	5.3	13.3	2.3	1.5	3.6	2.3	0.3	0.3	99.9	74.2	3.6	54.3	0.2	0.0	3.5	1.3	0.2	1.6	0.1	0.1	2.6	1.6	0.7	5.9	3.3	0.4	0.7	4.4	1.8	0.2	44.3	1.2	1.2	0.0	6.2	2.0	0.7	10.1	2.3	1.4	0.1	0.0	1.3	0.0	0.0	2.4	0.1	1.8	3.2	0.0	1.0	0.0	0.0	0.7	1.2	0.0	0.0	0.2	1.7	2.0	1.1	0.5	0.0	0.2	2.3	0.1	0.0	0.0	2.8	0.0	7.0	5.0	15.6	0.0	0.4	2.0	0.3	0.1	0.0	0.0	3.2	0.0	1.1	32.0	1.5	0.0	0.0	0.1	0.4	0.4	0.0	0.1	0.4	0.0	0.1	0.1	2.7	0.1	0.3	2.8	1.1	0.0	0.9	0.6	1.1	1.1	1.3	1.3	3.7	0.5	0.6	0.2	0.2	0.9	1.5	0.2	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.4	0.1	0.3	0.3	0.6	0.3	0.3	0.3	0.2	0.0	0.1	0.0	0.0	1.1	1.4	0.4	1.3	1.2	0.0	2.5	1.4	0.0	76.8	0.0	0.0	298.4	0.2	3.2	9.0	0.0	0.0	0.4	0.0	0.9	0.4	0.0	302.4	0.1	4.8	0.0	10.4	6.4	5.4	2.3	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.4	2221.9	1.6	0.0	1.0	0.2	0.4	1.9	0.0	2.1	0.0	0.3
RC3H1	"KIAA2025, RNF198, roquin, RP5-1198E17.5"	ENSG00000135870	"Ring finger and CCCH-type domains 1"	Q5TC82	1	173931214-174022297	"Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027428, HPA027434, HPA027448"	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683"	"unprognostic (6.91e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.43e-3)"	"unprognostic (6.83e-3)"	10.4	7.8	11.8	8.0	10.3	32.6	10.6	26.7	14.0	9.9	10.3	12.3	8.3	6.9	10.9	8.4	11.8	9.4	8.1	9.0	11.9	7.4	8.1	11.2	11.3	8.8	10.4	7.1	10.8	9.8	10.2	14.6	9.1	12.4	8.7	8.6	13.3	9.0	7.6	19.1	14.0	10.6	8.4	9.3	13.6	9.1	9.7	9.0	15.2	9.9	7.7	13.6	8.4	9.8	2.8	1.6	10.4	3.9	2.3	2.7	1.1	7.3	10.2	5.7	8.8	10.8	8.4	7.8	5.0	7.2	5.8	5.1	9.4	8.2	10.4	9.0	8.1	4.5	7.1	8.5	7.1	8.2	7.2	2.1	9.0	7.6	7.8	6.6	11.7	10.5	8.0	5.5	8.4	5.7	5.4	8.9	5.1	10.2	6.4	7.0	5.5	7.0	10.6	9.8	6.8	1.1	7.7	10.2	7.6	10.3	14.2	6.8	6.1	9.5	12.3	4.8	10.0	8.2	11.9	12.9	7.6	7.6	6.5	6.4	8.0	8.1	13.4	5.1	5.3	7.6	4.5	3.2	4.0	2.0	3.2	2.1	2.1	1.9	2.3	1.6	2.8	2.7	2.3	10.4	2.3	3.9	1.3	1.5	1.1	11.8	10.3	26.7	14.0	11.9	7.4	10.4	7.1	12.4	9.0	38.7	30.9	19.0	14.5	30.6	34.5	22.4	22.9	25.4	19.4	22.7	76.6	8.9	8.3	21.9	9.1	26.3	25.0	0.0	16.3	6.7	36.9	24.8	15.1	29.4	10.0	36.5	32.8	33.7	35.2	6.7	14.7	18.5	28.7	19.8	27.4	25.7	19.9	17.5	9.9	8.1	44.8	19.4	26.8	35.6	11.7	35.8	9.7	30.5	23.4	26.1
RCAN1	DSCR1	ENSG00000159200	"Regulator of calcineurin 1"	P53805	21	34513142-34615142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 220.2"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 195.4;Hepatocytes: 146.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"SK-MEL-30: 156.7;WM-115: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037218, HPA068436"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB037218: AB_2179743, HPA068436: "	"unprognostic (3.83e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.27e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.60e-3)"	21.5	7.9	22.2	15.8	25.8	2.8	20.7	14.8	19.6	29.3	12.2	27.7	3.2	10.6	10.6	7.4	10.1	4.2	18.8	18.6	22.4	22.4	27.1	77.3	15.0	7.5	27.2	11.1	5.0	20.3	220.2	11.2	30.4	18.1	8.9	13.3	12.6	6.9	5.9	10.9	9.7	13.5	15.4	41.3	5.2	13.1	3.7	19.4	19.9	19.8	12.2	6.9	19.8	6.9	1.6	5.2	8.0	3.9	0.2	1.9	0.9	5.8	1.1	6.0	3.8	3.3	2.0	3.7	21.9	22.6	9.0	9.0	6.6	5.6	0.1	1.0	12.7	17.9	0.5	4.3	4.4	12.2	3.3	2.6	1.1	2.0	3.1	12.8	1.8	3.7	5.3	4.0	10.7	7.5	2.2	2.9	4.0	2.2	5.7	5.9	2.8	17.4	1.4	3.4	5.8	2.9	6.6	4.7	2.7	2.8	10.1	2.9	1.2	16.0	10.4	156.7	5.7	14.0	3.1	3.2	30.5	3.1	5.0	5.3	5.0	3.1	1.0	10.0	5.4	102.2	0.0	2.0	8.0	1.3	3.4	1.9	1.6	1.6	1.2	2.7	1.2	0.7	1.3	1.0	0.2	3.9	5.2	1.8	0.9	22.2	25.8	14.8	19.6	22.4	22.4	27.2	11.1	18.1	19.4	89.3	64.0	6.7	17.3	84.0	14.8	21.4	22.9	16.0	17.0	195.4	25.5	6.3	18.3	67.7	38.0	57.3	62.2	0.0	16.3	10.7	35.7	12.5	8.1	146.7	46.2	3.2	3.5	25.2	24.5	9.6	6.6	30.2	54.0	38.7	22.2	10.6	25.9	38.4	9.2	96.4	6.7	0.0	82.6	11.9	2.3	69.4	9.3	5.2	8.4	34.1
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 229.0;Muller glia cells: 167.3;Sertoli cells: 97.0;Smooth muscle cells: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	43	"T-cells: 4.8"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 25.3;HDLM-2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	13.7	7.2	13.2	4.3	33.4	0.8	5.9	19.5	51.8	10.9	10.6	13.4	2.3	5.5	7.3	27.6	13.9	7.8	18.0	98.8	14.7	24.2	17.5	4.0	8.3	2.6	38.3	27.1	13.5	6.2	47.7	6.7	1.1	60.3	13.8	12.2	27.9	5.5	14.9	29.3	5.9	7.7	14.2	17.0	4.1	14.0	3.5	11.0	0.0	10.8	14.4	4.1	15.9	8.8	0.0	0.0	0.1	0.1	0.0	4.8	0.8	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.4	6.1	0.4	0.0	0.0	0.0	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	50.9	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.1	0.2	0.1	5.6	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.6	4.8	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.0	0.0	0.8	13.2	33.4	19.5	51.8	14.7	24.2	38.3	27.1	60.3	11.0	6.0	4.3	0.8	3.8	5.6	19.4	229.0	2.5	0.0	0.0	3.5	3.9	0.0	59.7	5.8	22.0	10.8	0.0	0.0	2.1	0.0	5.6	1.7	0.0	0.2	0.1	28.6	24.1	0.0	0.3	11.0	27.0	1.8	30.4	0.0	0.3	167.3	4.3	0.0	47.4	1.4	8.0	97.0	159.7	0.7	0.9	6.5	0.0	0.0	0.1	1.1
RCAN3	DSCR1L2	ENSG00000117602	"RCAN family member 3"	Q9UKA8	1	24502351-24541040	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.0"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 73.6;Intestinal endocrine cells: 78.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 37.0"	"Group enriched"	"Detected in many"	4	"MAIT T-cell: 5.6;memory CD4 T-cell: 14.0;memory CD8 T-cell: 5.0;naive CD4 T-cell: 19.2;naive CD8 T-cell: 9.9;T-reg: 19.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 19.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034533, HPA064289"	Enhanced		Approved	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA034533: AB_10601481, HPA064289: AB_2685232"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.41e-3)"	"unprognostic (3.66e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.52e-3)"	"unprognostic (9.83e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.71e-2)"	3.2	1.5	2.7	15.8	4.0	4.7	7.6	37.0	3.7	3.9	5.0	7.6	3.2	5.2	3.2	7.7	12.6	11.2	6.5	3.1	3.3	7.8	5.3	2.1	8.1	27.2	5.5	1.9	2.0	15.0	5.5	15.0	7.0	7.6	27.7	5.2	6.1	17.4	4.8	1.6	10.0	6.7	2.6	7.9	7.9	13.2	2.6	2.9	17.2	11.7	8.6	23.2	6.0	6.3	2.8	1.5	1.4	0.9	1.9	19.2	4.2	10.5	8.3	0.1	2.6	2.3	5.3	9.6	7.2	3.9	5.7	5.4	2.4	14.1	7.9	6.6	12.1	4.2	10.0	7.5	9.1	6.2	7.6	4.5	0.8	2.2	7.2	1.4	2.6	7.0	1.9	6.8	1.9	3.0	5.0	1.2	9.9	1.1	0.3	2.6	3.5	6.9	4.0	11.1	8.2	6.1	2.8	0.1	0.2	4.3	9.1	22.6	5.6	5.7	7.5	22.2	5.2	7.7	5.4	8.2	6.8	8.2	0.4	4.9	10.7	12.8	10.1	2.8	10.8	7.9	1.4	0.9	1.1	0.7	0.5	5.6	2.6	14.0	5.0	1.5	2.8	19.2	9.9	0.3	1.9	0.2	1.1	19.2	4.2	2.7	4.0	37.0	3.7	3.3	7.8	5.5	1.9	7.6	2.9	17.9	14.1	12.6	24.9	12.6	37.2	5.9	15.3	73.6	18.2	19.2	60.9	2.9	11.6	18.2	0.9	7.5	6.5	0.0	24.5	9.2	6.2	52.5	16.1	1.1	8.7	23.8	78.8	7.4	7.9	0.0	1.7	18.6	28.7	34.3	13.5	9.4	32.0	11.2	1.1	0.7	32.8	0.0	8.1	0.5	12.8	19.1	4.5	35.7	11.0	21.8
RCBTB1	"CLLD7, CLLL7, FLJ10716"	ENSG00000136144	"RCC1 and BTB domain containing protein 1"	Q8NDN9	13	49531946-49585583	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 41.7;Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 37.8;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056783			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056783: AB_2683234"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.52e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.17e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.49e-2)"	7.4	17.6	16.9	6.5	19.7	8.8	10.3	9.4	16.9	7.0	5.0	27.5	21.3	4.5	12.2	15.1	4.1	9.6	7.0	11.1	18.3	16.5	13.7	6.2	9.3	9.4	26.5	11.2	5.8	8.2	30.9	15.3	9.2	15.8	8.4	6.3	15.1	6.0	14.6	5.0	5.8	5.6	10.8	22.7	9.9	7.4	6.4	22.3	10.9	32.0	4.1	7.7	8.5	6.5	4.6	7.4	15.3	8.1	2.5	8.7	3.2	3.0	7.1	15.8	14.2	21.1	18.4	9.2	11.8	11.8	8.9	9.2	6.0	7.8	10.5	2.6	9.7	7.8	4.4	11.7	18.1	15.5	15.3	9.0	12.5	5.7	15.3	25.3	10.0	10.0	16.3	11.2	7.4	11.9	11.8	15.5	20.8	5.5	4.6	17.9	2.8	14.4	5.8	16.4	10.4	4.4	18.8	11.9	6.6	11.2	8.5	8.3	11.0	6.0	4.6	11.7	13.9	6.2	7.3	10.8	6.7	5.4	14.0	5.7	4.7	5.7	17.1	6.0	10.0	9.4	15.3	5.8	6.1	2.9	7.2	3.4	4.6	4.8	2.3	7.4	3.2	3.0	2.8	2.9	2.5	8.1	1.0	8.7	3.2	16.9	19.7	9.4	14.3	18.3	16.5	26.5	11.2	15.8	22.3	41.7	9.6	6.5	2.3	3.3	8.3	14.8	12.7	16.0	14.8	1.8	60.9	2.5	6.6	6.4	0.3	7.4	0.7	0.0	4.3	2.5	3.5	4.2	2.3	7.3	7.5	9.5	15.5	5.5	12.0	0.4	3.1	8.4	8.5	7.2	2.5	5.8	4.9	0.0	5.3	7.9	37.8	38.8	7.1	1.7	3.6	2.0	0.9	4.9	1.9	1.8
RCBTB2	CHC1L	ENSG00000136161	"RCC1 and BTB domain containing protein 2"	O95199	13	48488959-48533256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	9	"MOLT-4: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040242	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA040242: AB_10795362"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.98e-1)"	15.8	10.6	9.1	10.3	8.9	3.8	9.7	7.3	12.1	14.2	7.3	19.0	15.2	4.3	22.3	11.1	11.9	11.7	10.5	11.6	9.0	8.6	14.8	8.0	8.8	8.5	15.8	6.2	18.0	6.1	4.7	25.8	14.9	11.4	14.6	7.0	20.0	27.4	18.5	6.1	4.6	6.1	11.9	16.3	14.9	8.0	5.8	12.8	4.4	23.9	6.9	10.6	10.3	11.3	0.5	13.1	25.9	19.0	6.7	7.3	9.1	0.4	0.3	6.5	0.4	5.1	4.5	0.0	1.9	2.4	1.1	0.8	0.2	0.4	1.3	1.4	3.0	0.7	0.8	0.9	0.7	1.3	1.6	1.2	3.4	0.9	0.3	1.9	1.5	2.1	4.6	1.9	1.5	0.7	2.7	3.5	8.7	0.2	2.0	4.1	0.1	78.3	4.4	3.5	0.1	1.0	6.6	0.6	5.6	2.2	1.0	1.4	1.2	1.5	0.3	2.3	2.8	0.1	3.9	3.0	1.3	0.6	0.3	0.7	0.1	0.1	1.5	0.7	3.5	2.5	2.2	19.0	2.1	7.1	13.7	4.3	0.5	6.0	7.3	13.1	0.5	3.6	5.4	25.9	6.7	12.0	0.2	7.1	9.1	9.1	8.9	7.3	9.7	9.0	8.6	15.8	6.2	11.4	12.8	3.0	3.5	7.8	10.6	5.5	1.2	11.8	5.1	2.7	9.1	5.2	2.0	1.2	6.6	0.7	5.6	17.6	0.7	0.0	0.7	1.1	8.7	5.6	8.1	4.7	22.1	1.6	7.9	25.8	30.3	5.9	8.6	30.1	8.5	16.2	2.0	31.9	1.1	0.9	13.4	9.6	3.7	12.9	7.6	10.1	3.2	5.0	0.8	20.8	2.0	6.8
RCC1L	WBSCR16	ENSG00000274523	"RCC1 like"	Q96I51	7	75027122-75074228	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.4"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 50.0;Distal tubular cells: 41.4;Extravillous trophoblasts: 33.6;monocytes: 29.7;Syncytiotrophoblasts: 45.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052184, HPA060643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA052184: AB_2681752, HPA060643: AB_2684335"	"unprognostic (9.73e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (8.91e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-1)"	7.4	8.5	4.4	7.0	5.1	4.2	3.3	4.3	5.6	5.8	6.4	7.0	7.2	6.4	5.0	4.8	7.4	4.8	7.7	11.5	3.7		7.9	12.0	3.9	5.5	5.6	4.0	7.1	9.1	4.9	3.3	6.5	3.8	7.2	3.2	7.3	7.8	6.4	33.4	4.3	6.0	9.5	2.3	6.8	4.8	5.4	5.7	3.6	8.7	8.4	6.8	5.8	7.7	6.8	5.5	4.8	4.9	6.7	9.2	2.6	15.3	23.5	12.4	21.1	8.9	7.3	17.2	15.0	10.8	12.9	10.6	23.7	18.9	16.3	6.9	12.1	16.9	18.2	10.5	10.0	5.4	17.9	16.7	12.0	15.7	22.1	12.6	19.2	19.5	9.0	8.3	11.2	9.1	8.7	11.4	3.5	38.4	10.6	9.9	32.6	0.9	29.1	29.0	18.6	18.5	9.3	10.1	34.0	11.2	14.0	13.5	20.2	20.1	42.6	18.3	9.1	30.0	20.1	12.8	17.1	14.3	15.2	19.5	11.9	9.4	25.6	13.1	20.4	22.5	4.8	3.8	2.2	7.3	4.9	5.7	5.7	7.8	6.4	5.3	6.8	7.5	9.2	1.4	6.7	3.5	5.5	5.9	2.6											0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.5	21.0	0.0	50.0	41.4	21.1	0.0	0.0	0.0	0.0	17.7	33.6	0.0	0.0	4.7	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	29.7	0.0	0.0	16.6	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.89e-5)"	8.8	12.1	15.7	9.9	20.1	15.6	17.8	20.7	16.8	10.2	12.7	9.8	8.7	9.0	11.0	7.5	8.4	12.9	7.2	17.6	14.1	16.2	17.1	12.5	10.4	12.2	15.9	15.7	16.2	10.6	14.9	13.0	10.5	17.1	12.0	14.2	7.7	12.3	11.3	29.7	5.9	9.2	12.4	16.7	12.2	10.3	13.4	15.4	14.9	20.3	8.0	12.7	9.7	12.1	4.4	7.4	18.9	8.8	4.6	7.4	4.3	6.1	3.2	9.5	8.9	10.0	8.8	5.4	4.1	9.7	8.6	10.2	8.7	7.6	10.2	7.9	5.9	8.5	3.7	24.1	7.3	13.1	8.3	7.9	13.2	6.0	11.1	8.6	17.8	7.3	8.1	9.2	9.9	9.3	10.4	17.3	13.3	12.2	10.4	20.0	9.9	16.3	7.2	15.8	16.8	5.6	8.8	22.4	8.7	13.4	10.5	14.7	8.1	6.8	16.0	17.7	10.9	9.0	8.1	6.8	5.7	5.6	5.0	6.9	11.1	7.9	14.5	6.9	12.7	8.9	18.9	8.8	8.5	4.3	5.2	7.4	4.4	5.3	5.0	7.4	2.2	3.9	5.5	3.7	4.6	4.7	3.8	5.2	4.3	15.7	20.1	20.7	16.8	14.1	16.2	15.9	15.7	17.1	15.4	17.9	6.4	18.7	28.1	36.1	36.0	49.4	12.7	6.7	7.9	22.7	19.6	28.8	58.0	26.3	26.2	18.6	15.4	0.0	19.8	19.5	23.5	31.2	4.7	21.3	16.6	22.3	13.3	23.9	33.0	39.2	20.8	22.4	27.0	14.4	23.7	22.1	21.3	24.6	23.7	44.0	19.0	32.3	22.7	60.0	42.9	27.0	28.3	34.8	27.1	23.7
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792869-4885917	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"liver: 108.1;pancreas: 37.5"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HDLM-2: 35.1;HEL: 90.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071308: AB_2686384"	"prognostic favorable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	15.9	6.8	4.2	6.7	5.9	17.2	12.9	5.5	6.3	5.6	3.8	6.2	6.3	2.4	5.5	5.4	5.5	5.6	3.8	3.7	4.1	3.6	5.7	108.1	6.9	9.1	5.8	4.2	9.0	37.5	3.8	5.1	6.8	5.6	3.6	4.2	4.5	4.8	9.1	10.9	10.5	4.1	5.2	7.1	5.0	5.2	6.8	5.6	5.7	4.5	8.1	7.2	5.3	6.8	10.4	6.8	12.9	2.3	10.8	9.1	3.5	5.6	6.7	2.6	4.1	3.9	2.6	6.8	2.6	2.9	5.0	4.2	3.4	3.3	10.9	1.9	2.4	5.6	3.6	11.9	8.0	5.8	35.1	6.1	90.1	8.1	6.7	5.6	8.1	7.3	5.8	4.6	4.8	7.4	2.7	4.9	8.0	9.2	7.1	3.0	7.3	6.6	14.0	8.9	6.8	2.7	8.2	3.4	5.7	6.1	6.4	7.4	6.1	3.4	5.0	3.9	5.3	4.7	9.6	3.4	3.0	3.3	4.1	8.2	2.9	8.2	11.7	5.4	5.0	1.9	12.9	1.5	3.8	5.6	2.3	6.8	8.0	6.6	7.6	4.0	10.4	8.9	9.1	0.6	10.8	1.2	6.8	5.5	3.5	4.2	5.9	5.5	6.3	4.1	3.6	5.8	4.2	5.6	5.6	6.0	5.0	10.0	14.8	22.7	4.8	10.1	5.1	16.0	6.8	3.5	0.0	33.2	21.6	11.0	59.1	7.7	2.2	0.0	9.9	10.9	10.3	6.4	13.9	135.7	15.5	4.8	2.9	16.0	8.8	39.4	21.3	5.8	3.3	15.4	6.4	7.8	9.2	2.9	35.3	12.1	6.5	12.9	14.6	17.7	19.5	18.4	29.6	10.1	7.2	12.6
RCOR2		ENSG00000167771	"REST corepressor 2"	Q8IZ40	11	63911221-63916844	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.6"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.1;NTERA-2: 23.4;SCLC-21H: 36.7;SH-SY5Y: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021638	Uncertain		Approved	Nucleoplasm,Vesicles,Midbody		Yes	NA			Nucleoplasm	"Vesicles, Midbody"	"HPA021638: AB_10960885"	"unprognostic (1.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.33e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.06e-3)"	0.8	1.4	3.3	0.7	8.0	0.3	0.7	9.3	16.6	3.0	1.4	3.4	0.0	2.0	3.5	2.6	1.2	3.7	1.6	5.9	4.0	2.6	0.7	0.4	1.0	0.3	2.4	3.8	5.2	1.4	3.2	5.0	1.8	1.8	1.7	1.7	3.3	2.3	1.7	3.1	0.6	1.6	2.5	2.2	0.5	1.2	7.0	2.5	4.1	0.6	0.6	0.3	2.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	18.1	1.2	0.3	1.5	5.4	0.1	0.3	0.2	0.6	0.7	0.1	0.1	0.2	0.4	0.3	0.2	7.9	0.0	0.2	0.2	1.0	0.2	0.1	5.8	3.0	0.0	0.1	1.8	0.0	0.3	0.0	0.0	0.1	2.4	0.9	0.0	0.0	1.6	1.6	6.4	23.4	2.3	0.0	5.8	1.0	0.5	0.0	0.0	36.7	24.4	0.1	1.6	0.9	4.6	1.3	2.2	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	8.0	9.3	11.0	4.0	2.6	2.4	3.8	1.8	2.5	0.0	0.0	0.0	0.0	0.0	15.7	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.2	3.7	0.5	0.0	0.0	0.0	0.2	3.2	1.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.9	0.3	0.0	0.4	0.0	2.1	0.0	0.2	0.7	2.6	0.3	0.7	0.0	1.1	0.0
RCSD1	"CapZIP, MGC21854, MK2S4"	ENSG00000198771	"RCSD domain containing 1"	Q6JBY9	1	167630093-167706249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.4;lymphoid tissue: 70.8;skeletal muscle: 52.3"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 128.0;Kupffer cells: 116.2;monocytes: 64.1;Sertoli cells: 77.6;T-cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 48.3;REH: 48.5;RPMI-8226: 33.1;THP-1: 25.5;U-266/70: 32.4;U-698: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016597, HPA073490"	Enhanced		Approved	"Plasma membrane"		NA	NA		150000	"Plasma membrane"		"HPA016597: AB_2669397, HPA073490: "	"unprognostic (2.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.65e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.97e-2)"	8.5	2.9	3.5	33.3	4.8	19.2	7.3	1.2	3.1	3.0	8.4	3.6	1.3	3.6	2.7	5.4	4.1	3.1	8.8	18.4	3.9	3.6	4.2	3.7	9.0	45.6	5.1	2.2	2.5	1.5	0.8	2.0	7.0	3.1	3.7	5.0	3.1	6.5	2.5	52.3	2.3	20.1	7.4	6.9	40.6	4.9	3.7	3.4	70.8	4.8	12.7	29.2	7.4	4.5	51.0	22.1	56.4	38.2	26.6	27.8	26.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.3	0.0	0.0	0.0	8.3	0.9	0.1	0.0	0.1	0.0	0.0	0.0	19.7	15.5	14.2	6.5	0.0	15.3	11.9	0.4	0.0	0.0	48.5	0.2	33.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	25.5	0.1	0.0	0.1	0.0	0.0	32.4	9.6	31.8	0.0	15.8	0.0	48.4	38.2	56.4	15.2	25.1	18.3	45.6	19.8	18.9	22.1	51.0	17.2	15.9	38.5	26.6	24.1	12.8	27.8	26.3	3.5	4.8	1.2	3.1	3.9	3.6	5.1	2.2	3.1	3.4	3.0	10.7	128.0	1.2	1.0	0.6	40.7	0.0	0.0	5.7	1.8	0.0	0.4	0.0	0.1	0.4	17.9	0.0	0.0	0.0	0.2	3.1	0.7	12.8	1.7	37.5	0.0	0.0	27.0	116.2	1.5	0.9	47.2	5.0	64.1	0.0	0.0	0.1	0.0	0.4	0.3	0.7	77.6	21.5	0.0	0.1	1.5	1.0	84.1	0.0	0.3
RD3L	"TDRD9-AS1, TDRD9AS1"	ENSG00000227729	"Retinal degeneration 3-like"	P0DJH9	14	103940426-103942308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	16	"heart muscle: 32.6"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 69.7;Cardiomyocytes: 39.9;Cone photoreceptor cells: 27.5;Horizontal cells: 25.4;Rod photoreceptor cells: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.1"	"Region enhanced"	"Detected in single"		"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			HPA067971	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA067971: AB_2685935"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.1	0.2	0.0	1.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	39.9	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Syncytiotrophoblasts: 175.4;Urothelial cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favorable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.4	6.8	4.0	6.0	6.6	5.5	4.2	8.7	9.4	7.5	8.3	3.5	9.0	5.1	5.0	5.0	17.6	4.2	7.1	11.4	3.0	5.4	8.8	7.5	5.6	5.1	4.7	5.2	3.8	10.7	8.8	6.1	34.0	10.0	5.7	4.0	6.4	11.6	13.1	9.4	18.0	6.9	5.2	2.2	6.8	9.5	4.4	3.0	2.1	7.2	8.6	8.9	8.5	10.2	7.4	6.0	5.4	6.7	6.1	8.5	3.5	3.1	3.6	0.6	1.9	0.4	0.4	5.8	2.9	0.3	2.1	1.5	5.4	3.6	1.8	2.4	0.7	0.4	3.2	3.8	2.3	0.2	1.6	10.1	2.0	4.7	3.7	0.9	4.8	1.4	1.3	0.9	1.9	1.4	0.7	2.8	1.6	4.0	1.0	0.7	5.2	0.8	3.1	0.8	6.9	4.7	2.5	1.0	10.0	1.3	5.5	2.2	2.7	2.8	8.0	3.6	0.6	3.9	4.7	2.9	0.3	1.1	0.2	3.9	2.0	3.6	2.2	1.5	3.4	2.0	4.1	4.1	5.4	8.5	6.7	7.7	6.1	7.0	7.7	4.5	7.4	8.4	6.8	2.6	6.1	5.9	6.0	5.7	3.5	4.0	6.6	8.7	9.4	3.0	5.4	4.7	5.2	10.0	3.0	14.9	16.2	5.1	19.9	9.5	17.3	22.2	28.1	6.7	11.4	14.0	39.3	30.2	10.0	12.3	18.5	6.5	27.1	0.0	5.7	26.9	6.0	23.1	8.1	6.0	9.9	23.8	11.5	16.5	4.1	11.2	3.4	5.0	6.8	1.8	19.8	10.0	11.4	26.2	3.2	3.4	27.0	6.5	5.1	1.4	9.6	15.3	175.4	8.7	21.9	72.9
RDH8	"PRRDH, SDR28C2"	ENSG00000080511	"Retinol dehydrogenase 8 (all-trans)"		19	10013249-10022279	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"retina: 29.4"	"Cell type enhanced"	"Detected in some"	28	"Bipolar cells: 33.9;Cone photoreceptor cells: 51.1;Early spermatids: 58.4;Rod photoreceptor cells: 203.6"	"Group enriched"	"Detected in some"	8	"melanoma: 2.2;stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.9;SK-MEL-30: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064473			Approved	"Nucleoplasm,Midbody ring,Cytosol"		NA	NA			Nucleoplasm	"Midbody ring, Cytosol"	"HPA064473: "			"unprognostic (4.12e-1)"		"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.98e-3)"		"unprognostic (4.58e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-1)"			"unprognostic (1.02e-1)"	"unprognostic (3.86e-1)"		"unprognostic (2.63e-1)"	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.9	0.8	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	0.3	0.0	0.0	0.0	0.0	51.1	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.4	0.0	203.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
REC8	"kleisin-alpha, REC8L1, Rec8p"	ENSG00000100918	"REC8 meiotic recombination protein"	O95072	14	24171853-24180257	"Plasma proteins, Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 30.4"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 48.2;Early spermatids: 113.3;Late spermatids: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 6.7;HHSteC: 5.7;MOLT-4: 6.9;SH-SY5Y: 30.2;SuSa: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031727, HPA031729"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031727: AB_10602920, HPA031729: AB_10669915"	"prognostic favorable (2.19e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (5.57e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.40e-3)"	2.8	4.6	3.1	2.9	4.6	8.2	1.5	20.3	6.1	3.0	2.7	5.2	9.9	2.0	3.3	3.0	1.5	17.4	30.4	1.6	3.8	3.8	6.3	1.7	3.6	4.0	3.8	5.4	2.2	1.7	0.9	21.4	1.0	10.8	3.2	0.9	8.0	2.1	10.3	1.3	1.4	2.2	3.7	5.1	4.2	8.5	13.3	3.4	22.3	2.0	0.0	4.4	1.7	1.7	2.1	6.2	10.7	6.3	3.3	6.9	1.3	0.0	0.1	6.7	0.0	0.2	0.3	0.3	0.3	0.3	0.6	0.5	0.0	0.7	0.1	0.0	0.0	0.4	0.3	0.2	0.0	0.4	0.6	0.1	0.2	0.3	0.0	5.7	0.1	0.9	3.1	0.3	0.2	0.0	2.6	1.2	0.2	0.0	0.9	0.0	0.1	6.9	1.1	2.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.1	30.2	0.0	0.0	0.2	17.5	0.1	0.2	0.2	0.0	0.1	0.2	0.0	1.1	0.3	0.1	0.0	0.1	0.1	2.6	0.1	10.7	6.1	1.2	6.9	2.1	2.2	3.3	3.8	1.6	1.0	3.1	0.1	3.3	6.3	6.2	3.5	1.3	3.1	4.6	20.3	6.1	3.8	3.8	3.8	5.4	10.8	3.4	11.9	13.3	7.0	4.4	1.6	15.5	1.7	22.9	48.2	13.6	26.2	0.0	1.1	5.0	2.2	113.3	4.1	3.5	0.0	2.4	2.8	2.4	1.0	3.5	2.5	2.0	6.4	4.6	4.3	5.9	57.2	4.4	5.6	1.7	1.0	2.3	23.8	3.6	0.0	2.8	23.3	1.6	0.0	1.4	1.9	37.5	1.8	0.3	8.7	1.7	1.8
REEP2	"C5orf19, SGC32445, SPG72, Yip2d"	ENSG00000132563	"Receptor accessory protein 2"	Q9BRK0	5	138439017-138446969	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.9"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 50.6;Cone photoreceptor cells: 66.8;Horizontal cells: 46.1;Rod photoreceptor cells: 59.8"	"Cancer enriched"	"Detected in many"	9	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.0;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.9;SCLC-21H: 17.6;SH-SY5Y: 19.8;U-87 MG: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031813, HPA076571"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA031813: AB_2674054, HPA076571: "	"prognostic favorable (7.83e-5)"	"unprognostic (1.11e-2)"	"unprognostic (3.97e-6)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (5.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.93e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.13e-3)"	5.2	10.9	27.2	3.4	27.2	1.2	2.0	37.0	58.9	3.0	4.4	5.9	0.4	2.8	3.7	2.6	5.6	2.8	3.6	10.5	29.3	32.1	1.6	1.0	1.5	1.4	27.9	19.6	3.5	2.9	2.8	13.9	1.6	25.8	6.1	3.3	7.9	2.1	9.9	15.6	2.0	3.1	13.6	9.7	1.2	2.2	4.5	6.3	0.0	1.4	0.5	1.5	4.1	1.1	0.0	1.0	0.0	0.0	0.0	3.2	0.3	0.2	3.1	12.0	41.9	1.8	4.7	0.0	3.6	1.7	4.9	5.7	2.2	0.4	0.0	0.6	4.4	0.1	0.2	11.4	2.3	3.8	1.2	10.1	0.0	0.8	5.4	4.4	0.0	0.0	1.5	0.1	2.8	0.2	8.9	1.0	11.7	0.0	3.0	1.6	1.8	1.0	0.7	7.4	0.0	0.1	4.0	1.1	0.0	0.9	0.0	17.6	19.8	1.2	0.0	3.0	3.2	1.1	0.4	0.1	2.8	2.9	2.7	6.7	7.8	4.9	0.3	15.8	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	3.2	0.3	27.2	27.2	37.0	35.6	29.3	32.1	27.9	19.6	25.8	6.3	0.0	0.0	0.0	0.8	0.6	50.6	8.7	0.0	0.0	0.0	1.8	66.8	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.1	46.1	4.6	0.6	0.0	4.7	0.0	0.0	0.0	0.0	0.0	16.1	0.1	0.0	2.5	0.2	59.8	0.0	3.4	0.4	3.0	0.4	0.0	0.0	0.0	0.1
REEP4	"C8orf20, FLJ22246, FLJ22277, PP432, Yip2c"	ENSG00000168476	"Receptor accessory protein 4"	Q9H6H4	8	22138020-22141951	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 93.5;Syncytiotrophoblasts: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042683	Approved		Approved	Cytosol		No	Yes			Cytosol		"HPA042683: AB_2571730"	"unprognostic (2.38e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.88e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.65e-2)"	6.3	4.3	3.9	9.2	6.2	18.1	22.9	2.3	4.3	12.8	11.9	6.9	4.0	8.4	5.6	5.4	39.8	5.5	11.1	4.5	3.4	2.9	5.2	6.4	18.0	16.5	7.2	2.5	4.9	11.0	3.2	5.6	35.8	5.7	9.2	8.8	4.5	11.0	6.0	3.0	43.1	8.6	5.2	7.5	19.9	12.3	19.1	6.8	14.5	10.8	20.4	24.9	12.4	20.8	4.4	17.7	25.9	23.6	9.8	10.9	10.2	12.3	25.7	8.3	13.0	3.6	3.6	14.7	11.1	6.3	14.6	13.3	14.8	12.6	15.1	14.6	6.1	12.9	32.0	9.9	19.2	7.5	8.4	11.3	16.2	13.6	15.1	3.9	7.4	25.1	3.3	37.1	11.1	9.4	4.7	8.9	18.4	12.7	52.8	7.5	19.0	19.1	26.9	12.0	18.9	16.1	10.8	6.9	30.9	6.6	13.3	6.7	12.3	9.0	10.5	16.0	5.8	20.8	11.3	9.1	9.7	15.8	21.6	15.6	12.1	9.1	9.9	10.9	16.8	19.2	17.7	23.6	25.9	10.9	23.0	8.5	4.4	9.6	9.1	17.7	2.2	4.5	5.9	6.8	9.8	15.3	6.9	6.1	10.2	3.9	6.2	2.3	4.3	3.4	2.9	7.2	2.5	5.7	6.8	3.0	8.6	6.7	15.8	24.8	5.4	1.4	7.6	2.7	5.7	12.2	2.0	42.2	0.0	21.3	7.0	6.7	17.0	93.5	13.4	42.8	9.8	4.1	10.3	4.9	49.9	0.0	16.7	13.5	40.7	7.4	8.3	23.4	3.3	11.8	28.1	2.1	18.6	28.6	7.8	1.8	1.6	12.9	10.3	28.2	16.8	34.4	78.7	13.1	29.0	18.3
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"intestine: 354.2;pancreas: 502.4"	"Cell type enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 8841.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.4;EFO-21: 11.8;HDLM-2: 10.9;NB-4: 12.2;RPMI-8226: 15.7;SH-SY5Y: 10.2;U-2 OS: 19.4;U-251 MG: 7.2;U-266/84: 10.2"									"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA		22000000	Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				0.2	0.4	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0.0	1.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.1	0.2	0.0	0.0	0.0	15.7	0.0	0.0	1.2	10.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.4	3.8	7.2	0.0	10.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.8	4.3	0.0	5.2	0.0	1666.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	97.4	19.1	0.0	8841.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
REG3G	"LPPM429, PAP1B, UNQ429"	ENSG00000143954	"Regenerating family member 3 gamma"	Q6UW15	2	79025686-79028505	"Predicted secreted proteins"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 262.6"	"Group enriched"	"Detected in some"	25	"Exocrine glandular cells: 161.0;Pancreatic endocrine cells: 87.4"	"Cancer enriched"	"Detected in many"	13	"pancreatic cancer: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.0;RPMI-8226: 1.0;SK-MEL-30: 3.1;U-2 OS: 1.6;U-266/84: 1.3"									"HPA047894, HPA048334, HPA060705"	Uncertain		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"									"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"		"unprognostic (8.82e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.64e-2)"			0.1	3.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.8	0.6	0.1	61.1	0.1	0.0	0.1	0.1	0.1	0.0	7.1	0.1	0.1	0.1	0.1	0.1	0.1	262.6	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	2.8	0.3	0.1	0.1	0.0	19.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	1.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.0	0.0	0.0	161.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.6	0.0	0.0	1.0	0.0	0.0	87.4	0.0	0.7	2.4	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0
RELL1		ENSG00000181826	"RELT like 1"	Q8IUW5	4	37590800-37686376	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.2;TIME: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013377	Approved		Supported	"Plasma membrane,Microtubules"		NA	NA			"Plasma membrane, Microtubules"		"HPA013377: AB_1844403"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.71e-2)"	21.1	3.0	5.5	6.2	9.7	28.8	19.3	6.4	6.5	8.4	10.4	6.5	2.8	7.2	8.3	7.8	9.8	7.3	9.7	12.1	5.1	5.0	4.9	5.5	10.4	14.6	9.1	2.1	8.9	4.0	2.6	3.2	20.7	17.9	6.2	7.5	8.1	5.3	5.0	10.1	11.5	8.6	11.1	28.2	10.9	14.7	4.1	5.3	6.0	18.1	9.6	6.6	15.6	13.3	0.1	3.2	16.1	4.0	0.9	1.7	1.3	2.9	3.8	9.2	6.5	6.4	5.3	7.3	5.2	5.4	4.6	5.8	11.6	3.6	0.6	4.0	4.8	6.7	2.8	3.0	5.5	7.2	0.0	1.5	1.2	3.2	9.9	3.8	4.3	3.0	7.2	4.5	5.6	5.6	1.8	18.3	2.3	2.2	3.0	3.4	2.4	4.5	2.3	1.8	3.1	1.1	1.6	33.2	1.5	4.5	4.3	2.0	5.7	4.8	3.6	4.6	1.9	12.3	1.5	21.8	9.3	5.4	7.0	5.8	1.5	1.6	4.9	8.4	6.8	7.0	0.0	4.0	2.5	1.3	0.8	1.2	0.1	1.2	1.1	1.6	0.0	1.1	1.7	16.1	0.9	0.5	3.2	1.1	1.3	5.5	9.7	6.4	6.5	5.1	5.0	9.1	2.1	17.9	5.3	8.9	1.9	2.4	1.2	3.0	0.4	1.7	10.2	4.0	5.7	0.0	0.0	1.0	0.0	2.6	5.2	6.4	5.1	0.0	7.3	3.0	2.1	2.3	2.3	0.8	2.3	3.2	1.2	8.0	2.8	4.0	3.4	3.1	1.7	2.8	1.1	4.9	9.3	1.9	5.6	0.0	1.5	12.9	2.8	1.2	0.1	4.1	4.3	5.7	0.6	3.8
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471784-103989516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein, Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 73.4;liver: 35.8"	"Cell type enriched"	"Detected in some"	15	"Ito cells: 182.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Region enriched"	"Detected in many"	11	"cerebellum: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 34.4;PC-3: 7.0;SCLC-21H: 8.4;SH-SY5Y: 9.1;TIME: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077891			Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		59000000	"Golgi apparatus"	Vesicles	"HPA077891: "	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	2.7	5.9	5.7	1.2	5.3	0.5	6.3	73.4	6.7	2.9	2.1	0.8	0.0	1.1	1.0	3.0	1.7	4.4	1.9	3.2	5.7	5.3	1.2	35.8	1.6	7.9	1.8	2.5	1.3	1.0	0.3	0.8	0.4	5.1	1.2	2.1	10.6	1.1	2.1	0.4	1.1	1.9	2.4	3.2	1.1	0.8	1.5	0.0	0.0	2.6	1.7	0.9	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	2.4	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	1.4	0.0	0.0	0.0	8.4	9.1	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	5.3	73.4	6.7	5.7	5.3	1.8	2.5	5.1	0.0	0.0	0.0	0.0	0.0	0.6	11.3	3.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	2.6	0.0	0.0	1.0	0.1	2.4	0.3	0.0	2.4	0.2	0.0	0.0	182.3	9.4	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.1	0.5	0.2	0.0	0.0	0.0
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: AB_2673269"	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	9.5	9.4	18.9	11.5	22.0	15.5	18.4	25.9	25.5	12.9	12.9	14.8	15.3	11.7	17.5	32.5	20.9	14.6	14.0	17.7	17.7	17.6	12.1	23.1	11.5	13.3	15.1	19.4	17.0	13.9	32.8	28.3	14.0	20.0	13.6	13.7	13.6	21.6	13.4	12.1	22.6	12.2	16.3	10.8	15.8	12.4	27.7	11.7	30.7	13.9	13.5	18.4	14.7	14.3	4.6	6.2	8.0	7.5	5.2	6.9	2.0	12.8	10.1	19.4	24.2	11.0	19.7	21.2	12.5	13.8	14.7	17.8	24.0	11.2	15.5	10.6	17.4	17.5	15.1	22.0	18.9	19.6	16.5	19.0	13.1	6.1	14.5	16.6	41.2	21.2	16.0	15.5	26.9	32.7	14.0	15.1	23.1	17.4	16.0	18.8	21.7	23.3	22.6	18.5	16.5	9.7	27.4	11.9	8.8	12.1	19.5	17.4	17.2	11.5	17.7	16.5	29.9	8.4	28.5	14.7	8.2	13.7	22.2	17.1	15.8	14.3	21.8	9.8	17.0	12.0	8.0	2.3	3.2	4.2	6.5	6.9	4.6	5.4	5.8	3.4	3.4	5.5	6.5	1.5	5.2	7.5	6.2	5.4	2.0	18.9	22.0	25.9	25.5	17.7	17.6	15.1	19.4	20.0	11.7	17.9	6.1	13.7	10.2	11.8	11.3	25.0	12.7	17.4	13.6	5.2	15.7	22.4	6.6	7.0	9.2	9.3	8.3	0.0	6.1	24.3	8.0	9.3	16.1	34.5	11.5	12.7	5.8	17.2	21.9	5.1	6.6	11.5	5.0	3.6	14.7	32.3	7.5	10.5	8.1	6.9	14.7	19.4	7.6	35.6	32.8	13.0	23.9	20.0	14.5	15.4
RERGL	FLJ22655	ENSG00000111404	"RERG like"	Q9H628	12	18080869-18320107	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	32	"Sertoli cells: 161.7;Smooth muscle cells: 159.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	719	"REH: 72.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA041740	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041740: AB_10795694"	"unprognostic (3.53e-2)"	"unprognostic (7.03e-4)"	"unprognostic (6.29e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"		"unprognostic (5.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.66e-2)"	22.4	4.0	5.4	3.2	8.3	0.0	13.0	1.8	8.9	33.4	10.3	4.3	3.5	2.1	16.5	29.2	8.7	19.6	17.3	4.7	7.5	6.1	12.8	0.9	3.1	0.9	9.4	6.0	11.3	1.0	0.8	0.7	0.3	9.0	12.6	12.3	1.6	2.1	14.1	7.7	5.6	6.3	11.8	6.2	1.1	3.9	11.7	4.2	0.4	7.0	8.0	1.1	8.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	8.3	1.8	8.9	7.5	6.1	9.4	6.0	9.0	4.2	0.0	0.0	0.0	0.1	3.9	0.0	3.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	1.9	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.1	0.0	1.4	0.4	0.0	161.7	159.4	0.1	0.7	2.0	0.1	0.0	0.0	0.3
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077027-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 63.9"	"Cell type enriched"	"Detected in some"	44	"Horizontal cells: 74.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;monocytes: 6.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"midbrain: 95.5"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		260000	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9.0	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1.0	1.2	1.5	5.8	1.0	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2.0	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2.0	0.0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0.0	6.7	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	11.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	91.8	0.0	0.0	0.0	0.1	1.3	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9.0	1.5	5.8	17.5	1.2	16.8	0.0	0.0	0.3	0.0	0.5	0.2	0.1	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	1.7	1.0	1.2	1.1	0.8	0.1	74.7	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.4	1.1	0.5	0.0	0.0	0.0	0.1
RETREG2	"C2orf17, FAM134A, MAG-2, MGC3035"	ENSG00000144567	"Reticulophagy regulator family member 2"	Q8NC44	2	219176225-219185479	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 43.6;Ductal cells: 36.6;Exocrine glandular cells: 41.9;Extravillous trophoblasts: 32.2;Hofbauer cells: 31.4;Pancreatic endocrine cells: 35.3;Proximal tubular cells: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011170, HPA011844"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA011170: AB_1845713, HPA011844: AB_2668544"	"unprognostic (2.63e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (7.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (8.74e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.45e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.70e-2)"	14.8	22.4	27.8	14.8	34.2	23.8	22.3	38.5	56.9	20.9	20.0	24.1	20.0	18.6	19.9	28.8	18.7	23.8	18.9	10.8	28.2	28.7	31.2	24.0	17.4	18.1	26.6	35.7	32.7	29.5	38.0	20.2	16.6	26.7	18.4	23.5	20.0	20.7	19.1	10.6	19.5	18.1	20.7	21.5	17.4	17.6	61.4	16.5	15.1	28.0	12.8	19.7	18.6	24.7	6.8	5.8	21.1	7.3	4.2	8.7	2.9	12.5	13.4	11.6	17.5	44.0	18.7	12.3	15.4	26.7	18.8	16.4	13.4	21.7	10.3	15.5	29.0	38.7	16.3	13.9	13.8	20.8	14.4	11.6	13.7	18.6	22.1	25.3	14.8	19.0	20.2	36.2	21.1	20.4	32.5	16.9	11.2	9.4	23.8	26.0	18.5	8.9	16.1	8.5	16.1	15.7	11.4	12.8	8.3	15.5	14.8	16.6	17.1	9.9	19.2	36.4	18.9	16.0	16.5	13.3	21.1	11.4	29.8	11.5	24.1	13.7	11.6	22.1	14.8	11.6	8.5	5.7	5.3	8.5	7.3	7.8	6.8	7.0	8.7	3.8	5.8	6.4	8.1	21.1	4.2	6.6	5.8	8.1	2.9	27.8	34.2	38.5	56.9	28.2	28.7	26.6	35.7	26.7	16.5	14.9	13.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	11.4	43.6	0.0	25.1	18.3	36.6	0.0	0.0	0.0	0.0	41.9	32.2	0.0	0.0	4.7	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	19.8	0.0	0.0	35.3	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	0.0
RETREG3	"DKFZp686B1036, FAM134C, FLJ33806"	ENSG00000141699	"Reticulophagy regulator family member 3"	Q86VR2	17	42579513-42610623	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 28.0;Collecting duct cells: 29.6;Exocrine glandular cells: 21.8;Pancreatic endocrine cells: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016492	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA016492: AB_1853027"	"unprognostic (6.79e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (5.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.43e-2)"	23.2	17.4	11.9	15.8	15.6	5.8	16.3	23.1	21.9	17.0	18.8	13.2	15.5	13.1	25.4	20.9	21.6	15.0	20.8	10.0	11.2	12.3	16.0	28.7	16.2	19.0	11.3	9.8	17.4	43.2	19.6	16.5	29.4	13.7	19.4	16.1	32.5	24.6	14.1	18.5	31.1	17.5	15.7	7.8	24.0	17.1	27.2	8.5	29.9	17.8	16.7	26.3	14.8	17.1	14.1	7.8	22.6	11.4	13.7	27.8	16.6	6.6	20.6	9.0	14.7	23.3	13.0	13.0	9.5	12.9	11.3	13.3	9.7	14.3	14.6	13.4	15.4	11.6	26.0	11.6	14.2	11.0	15.6	11.1	5.9	12.6	17.2	16.0	10.1	15.3	19.8	19.6	12.4	12.6	12.6	12.1	10.8	12.1	14.5	8.9	11.5	14.8	14.8	5.7	12.5	5.1	8.1	14.1	14.9	12.9	21.4	16.3	11.2	10.2	8.3	14.4	17.4	23.7	7.9	15.3	12.3	7.6	12.1	9.0	25.1	29.8	13.0	11.2	6.5	9.3	22.6	8.0	17.7	24.2	10.0	21.2	13.0	20.0	23.0	7.8	14.1	19.8	22.2	7.2	13.7	11.4	7.7	27.8	16.6	11.9	15.6	23.1	21.9	11.2	12.3	11.3	9.8	13.7	8.5	23.8	28.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	11.4	29.6	0.0	17.6	6.6	15.5	0.0	0.0	0.0	0.0	21.8	13.6	0.0	0.0	7.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	12.6	0.0	0.0	25.9	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0
REV1	REV1L	ENSG00000135945	"REV1, DNA directed polymerase"	Q9UBZ9	2	99400475-99490035	"Predicted intracellular proteins"	"DNA damage, DNA repair, DNA synthesis"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044534, HPA051036"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA044534: AB_2678975, HPA051036: AB_2681319"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-3)"	12.0	15.5	11.0	15.8	16.9	7.8	14.5	32.5	15.6	14.1	10.4	12.2	13.4	7.6	18.3	23.1	13.7	14.8	10.3	14.4	10.1	9.1	11.3	12.4	14.1	12.2	10.5	11.3	16.5	11.1	13.7	16.7	9.1	10.8	14.9	12.1	14.1	12.1	16.2	17.8	12.9	14.3	15.4	10.5	11.2	10.1	11.8	11.1	10.1	13.3	12.8	15.7	16.0	18.2	1.6	1.1	0.4	0.6	1.3	3.3	0.6	7.0	1.8	11.3	4.3	8.9	8.8	12.3	8.0	9.7	9.1	10.5	4.0	6.7	14.3	6.4	8.1	9.6	9.8	8.4	10.3	14.3	6.6	6.8	7.4	6.5	9.1	10.0	9.2	15.3	8.5	12.6	8.1	12.0	10.2	11.6	7.3	8.5	4.9	10.0	4.5	9.6	16.8	8.2	4.5	5.9	15.4	8.6	6.1	11.2	11.9	7.5	7.9	7.2	5.8	10.1	12.8	6.0	13.4	8.8	10.9	9.2	4.5	5.1	6.6	6.8	11.6	4.4	11.9	8.3	0.0	0.6	0.2	1.3	0.6	0.8	0.4	1.8	1.6	1.1	1.6	3.3	2.8	0.4	1.3	0.5	0.6	1.1	0.6	11.0	16.9	32.5	15.6	10.1	9.1	10.5	11.3	10.8	11.1	65.5	45.7	19.7	49.2	42.8	81.5	48.1	5.1	32.1	45.5	21.0	37.3	27.9	5.0	16.0	21.1	28.7	23.3	70.0	16.0	16.9	25.3	37.2	24.3	12.9	16.6	77.9	16.8	22.7	13.8	17.5	25.0	25.0	18.6	25.2	16.6	40.2	13.4	21.0	43.5	9.8	61.1	25.8	21.2	56.7	48.5	31.0	29.4	19.7	17.7	53.5
REV3L	"POLZ, REV3"	ENSG00000009413	"REV3 like, DNA directed polymerase zeta catalytic subunit"	O60673	6	111299028-111483715	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.2;ASC TERT1: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064853, HPA069382"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064853: AB_2685369, HPA069382: AB_2686134"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.59e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-3)"	21.0	7.1	7.8	8.8	7.3	7.3	15.1	26.0	7.6	31.7	11.0	5.8	14.1	5.4	34.5	18.5	7.6	12.2	7.4	7.1	6.5	6.1	6.5	6.4	10.8	6.3	5.4	5.8	11.3	8.1	7.8	15.1	10.2	6.8	11.4	7.4	8.3	6.9	16.3	17.1	8.2	7.0	18.0	6.9	7.1	8.6	10.3	6.7	10.2	9.2	7.2	5.5	18.3	16.2	5.1	2.8	6.0	2.9	1.7	4.6	1.0	4.7	3.0	5.8	8.8	40.2	30.6	6.4	6.7	11.1	3.7	6.1	5.3	2.9	10.4	4.9	9.7	5.8	4.9	8.5	3.7	6.3	6.1	4.7	6.9	7.6	7.1	5.6	7.2	4.2	19.5	3.4	6.8	10.7	6.4	6.8	5.4	8.8	6.6	7.1	4.4	8.5	1.5	2.0	2.4	5.0	5.5	6.4	3.4	2.8	5.9	7.7	6.1	8.4	3.1	7.2	4.7	3.8	7.8	7.8	5.6	5.2	26.0	7.6	7.0	8.1	9.3	5.4	5.6	7.3	1.9	1.7	3.3	3.3	1.3	4.6	2.8	2.5	3.0	1.7	5.1	1.6	2.8	6.0	1.7	2.9	2.8	1.9	1.0	7.8	7.3	26.0	7.2	6.5	6.1	5.4	5.8	6.8	6.7	44.7	73.8	34.3	19.1	27.1	106.3	31.0	12.7	56.2	45.5	19.2	53.0	18.3	3.3	13.5	30.3	42.0	13.4	0.0	9.9	10.9	62.7	15.8	45.1	12.5	10.9	33.4	57.4	19.0	18.3	11.9	46.6	44.7	20.3	15.4	14.8	74.6	10.1	13.5	36.7	9.2	58.5	38.8	60.6	40.2	68.7	23.5	27.6	22.4	17.7	6.7
REX1BD	"C19orf60, FLJ20850, FLJ30108, FLJ34606, FLJ37391"	ENSG00000006015	"Required for excision 1-B domain containing"	Q96EN9	19	18588685-18592336	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.1"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 114.3;Distal tubular cells: 131.0;Hofbauer cells: 225.5;Proximal tubular cells: 163.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 25.6;EFO-21: 24.1;PC-3: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043414	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA043414: AB_10797141"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (8.47e-4)"	29.8	12.6	21.2	15.2	18.2	13.1	9.9	20.7	21.6	9.8	18.3	10.3	17.5	13.0	10.8	13.9	8.7	8.4	11.5	17.6	18.0	16.6	17.7	25.4	11.5	8.5	16.6	18.0	11.9	15.9	5.0	8.3	8.6	14.4	15.8	4.7	8.5	22.2	14.3	100.1	9.7	17.8	8.7	12.3	25.8	24.1	5.2	11.4	7.4	7.4	14.0	8.8	8.1	9.9	44.5	51.8	50.5	55.2	32.5	57.0	49.0	6.8	8.3	0.7	1.3	1.2	1.0	25.6	7.2	1.1	1.7	2.0	1.5	7.9	7.1	24.1	1.3	0.4	5.0	0.3	1.6	0.4	7.7	17.2	4.6	3.1	3.9	1.4	4.0	11.5	2.2	1.6	0.8	0.4	0.6	2.1	3.2	5.8	2.1	0.8	11.4	7.4	6.5	11.2	3.5	35.6	8.1	2.1	18.0	2.4	6.2	3.5	13.3	3.3	3.3	8.0	0.3	1.8	3.4	7.1	0.8	7.3	9.9	4.2	20.5	6.4	4.1	6.8	7.2	3.3	28.1	55.2	50.5	55.7	47.3	56.8	44.5	57.0	49.9	51.8	34.3	52.6	49.1	31.6	32.5	43.7	44.8	45.1	49.0	21.2	18.2	20.7	21.6	18.0	16.6	16.6	18.0	14.4	11.4	26.8	38.7	0.0	0.0	0.0	0.0	0.0	0.0	36.1	38.7	73.3	0.0	114.3	131.0	66.1	0.0	0.0	0.0	0.0	99.8	112.7	0.0	0.0	38.4	0.0	225.5	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	101.8	0.0	0.0	75.0	0.0	0.0	163.2	0.0	0.0	0.0	0.0	0.0	0.0	55.6	0.0	0.0	0.0
REXO2	"CGI-114, DKFZP566E144, SFN"	ENSG00000076043	"RNA exonuclease 2"	Q9Y3B8	11	114439386-114450279	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038450, HPA038451"	Enhanced		Supported	"Nucleoli,Focal adhesion sites,Mitochondria"		NA	NA		390000	Mitochondria	"Nucleoli, Focal adhesion sites"	"HPA038450: AB_10672516, HPA038451: AB_10697391"	"unprognostic (3.26e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (6.84e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (6.70e-4)"	21.8	31.1	13.5	15.8	14.2	16.2	30.0	14.9	12.6	31.4	36.0	11.2	24.0	8.4	38.4	24.8	33.5	17.7	23.9	64.3	13.3	10.5	35.7	28.6	20.1	13.9	17.0	13.1	28.5	27.7	61.2	24.9	45.0	15.3	32.0	17.7	11.6	61.6	22.8	27.8	22.7	15.8	44.6	15.7	18.6	31.5	29.6	14.5	9.9	20.0	25.2	15.2	34.9	40.6	15.5	28.6	19.0	7.9	18.1	30.5	12.2	27.8	16.2	6.3	16.9	50.7	53.8	15.0	47.3	37.0	23.9	30.5	42.6	47.7	15.3	47.7	41.7	36.3	17.8	14.1	41.8	39.5	14.9	10.9	16.9	22.4	26.5	66.7	12.3	5.4	37.2	40.1	30.2	32.1	42.0	42.7	15.9	31.2	9.4	53.5	6.6	8.9	15.5	19.4	22.3	28.7	7.9	20.6	55.8	34.2	22.7	11.2	7.0	21.7	16.8	19.9	27.5	34.1	6.5	40.4	30.8	36.8	23.7	28.9	7.4	8.8	25.9	21.2	29.1	16.4	19.0	6.0	8.8	14.3	7.9	16.5	15.5	21.6	17.9	7.8	11.7	19.9	16.1	1.5	18.1	7.9	28.6	30.5	12.2	13.5	14.2	14.9	12.6	13.3	10.5	17.0	13.1	15.3	14.5	98.3	49.6	36.3	126.2	123.4	12.0	342.7	43.3	89.7	68.2	90.7	2.0	149.0	235.4	121.0	59.3	101.2	22.2	93.5	62.0	153.2	153.3	156.6	32.2	67.6	83.4	4.8	77.7	89.6	17.6	35.4	195.1	39.5	229.5	53.3	64.2	27.2	110.2	31.6	166.2	264.0	6.7	51.8	115.4	227.9	71.1	142.2	225.1	37.4	70.7	116.6
REXO5	NEF-sp	ENSG00000005189	"RNA exonuclease 5"	Q96IC2	16	20806429-20849668	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"blood: 33.9;testis: 119.4"	"Cell type enhanced"	"Detected in some"	7	"Ciliated cells: 2.7;Club cells: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.9;monocytes: 2.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	15	"basophil: 33.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 33.9"	"Cell line enhanced"	"Detected in many"		"K-562: 24.4;U-266/70: 25.2"					"Low region specificity"	"Detected in all"			"HPA040755, HPA040868, HPA066145"	Approved		Approved	"Nuclear membrane,Nucleoli,Endoplasmic reticulum"		NA	NA			"Nuclear membrane"	"Nucleoli, Endoplasmic reticulum"	"HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: "	"unprognostic (2.39e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.42e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-2)"	0.8	0.7	0.7	1.4	1.9	2.6	1.0	1.0	1.0	0.4	0.6	0.6	0.2	0.7	0.9	0.8	0.6	1.1	0.7	1.1	0.6	0.5	0.5	0.5	0.6	0.7	0.4	1.2	0.8	0.6	3.3	0.4	0.4	0.6	1.4	0.8	0.7	0.8	0.7	0.4	0.6	0.6	0.7	0.3	0.3	1.6	119.4	0.4	4.1	0.3	0.5	0.9	0.8	0.6	0.0	0.3	33.9	0.2	0.8	0.7	0.1	6.4	3.6	5.7	2.5	2.3	4.8	1.9	4.3	4.8	4.8	5.3	2.7	5.6	3.9	6.9	3.6	3.3	3.2	4.3	1.9	5.0	4.1	3.1	6.5	5.4	3.7	0.5	9.6	9.5	2.2	0.8	5.6	7.3	2.1	1.6	0.0	24.4	17.5	11.7	8.3	1.5	7.2	3.1	2.5	3.7	7.8	10.8	7.0	1.4	2.2	5.1	5.7	4.0	5.5	1.4	1.7	9.3	8.2	0.8	3.5	3.2	4.7	5.1	25.2	17.0	1.5	7.4	12.4	3.4	33.9	0.2	2.2	0.1	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.7	0.1	0.7	1.9	1.0	1.0	0.6	0.5	0.4	1.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.0	1.3	2.0	0.0	0.0	1.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	11.0	9.5	16.1	15.8	15.4	23.0	15.3	13.9	16.6	10.1	12.8	10.0	5.0	8.6	10.0	9.4	17.9	10.1	9.0	9.1	12.1	9.1	10.1	23.0	10.6	20.4	12.3	14.0	11.7	15.1	10.9	8.6	17.5	15.1	11.0	15.0	8.9	12.2	8.1	16.5	18.8	10.0	12.7	14.8	14.2	12.2	13.5	14.0	22.1	10.4	14.7	28.5	9.9	11.6	22.4	18.7	27.5	24.2	24.8	13.6	15.8	22.9	17.9	20.9	20.7	4.3	5.1	9.6	13.5	14.9	27.5	33.2	19.8	21.4	21.7	3.8	9.5	26.1	15.8	17.0	22.6	28.6	15.5	29.5	13.2	24.9	14.7	3.4	19.8	8.2	5.1	5.1	25.9	17.9	6.0	14.7	20.9	27.4	13.4	21.1	27.1	19.7	38.6	23.8	36.5	15.1	29.5	23.2	27.1	14.7	18.6	17.0	21.6	16.0	30.3	11.0	26.9	21.9	18.3	5.7	27.3	18.1	21.0	30.1	8.2	10.6	37.7	13.8	30.7	28.3	19.5	22.0	15.6	11.4	24.2	11.7	19.0	9.9	10.4	18.7	22.4	12.6	9.5	27.5	24.8	22.4	10.0	13.6	15.8	16.1	15.4	13.9	16.6	12.1	9.1	12.3	14.0	15.1	14.0	11.9	12.0	15.3	19.1	21.2	14.1	5.0	10.2	9.4	15.9	5.2	2.0	51.5	5.0	14.8	2.2	11.7	9.9	0.0	16.7	50.3	12.7	9.4	22.0	13.1	32.8	3.2	4.6	11.6	12.7	1.8	8.1	24.0	20.3	34.3	7.8	12.8	12.3	5.8	10.3	7.8	8.7	6.5	15.1	23.6	52.6	14.9	38.6	23.6	15.6	12.4
RFC3	"MGC5276, RFC38"	ENSG00000133119	"Replication factor C subunit 3"	P40938	13	33818049-33966558	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 32.4;Spermatogonia: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 70.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030149	Approved		Supported	Nucleoplasm,Vesicles		No	No			"Nucleoplasm, Vesicles"		"HPA030149: AB_10602921"	"unprognostic (3.86e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.02e-3)"	"unprognostic (4.49e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.86e-1)"	8.0	17.7	5.7	19.1	7.2	14.4	10.9	19.9	10.2	7.9	7.5	5.6	5.9	6.9	11.6	8.9	10.3	7.0	6.5	6.2	5.2	5.5	5.4	6.2	6.6	19.1	4.7	5.6	9.6	7.6	3.7	5.9	14.2	8.6	5.7	10.3	7.0	7.8	4.6	6.1	7.5	7.0	6.6	5.6	11.8	6.3	17.8	3.7	34.7	6.1	9.7	19.2	5.2	7.0	8.2	7.9	8.5	7.5	3.3	8.3	4.1	11.6	11.7	22.3	18.0	1.7	2.7	12.1	16.2	7.5	21.9	19.0	15.3	18.1	43.8	6.9	6.3	13.4	18.0	28.2	11.5	29.6	16.8	16.8	25.3	13.6	16.6	1.9	30.6	12.2	2.6	1.5	18.8	13.0	3.6	7.2	15.9	17.6	11.1	13.1	13.6	25.8	14.6	26.2	25.1	10.2	9.7	26.0	10.0	6.5	10.5	11.6	20.4	12.2	16.5	8.5	12.7	13.3	17.0	3.8	11.5	12.9	14.6	17.2	6.2	8.5	70.2	8.3	18.1	22.0	1.6	5.7	8.5	4.5	7.5	4.9	8.2	5.5	4.7	7.9	7.8	7.4	6.3	1.3	3.3	6.5	3.3	8.3	4.1	5.7	7.2	19.9	10.2	5.2	5.5	4.7	5.6	8.6	3.7	8.9	3.8	9.7	6.5	10.9	14.0	7.4	2.5	4.0	10.3	3.5	7.9	18.1	3.3	4.6	7.0	5.8	0.4	0.0	7.7	32.4	6.6	2.9	1.1	5.4	10.2	7.9	5.8	8.6	7.3	5.0	5.8	5.0	8.5	6.4	4.3	5.7	3.9	0.0	4.2	3.5	11.3	6.5	3.8	25.0	43.9	6.0	13.7	4.6	4.5	1.4
RFC5	RFC36	ENSG00000111445	"Replication factor C subunit 5"	P40937	12	118013588-118033130	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041037	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041037: AB_10805834"	"unprognostic (9.63e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (5.12e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.06e-1)"	9.4	9.3	9.8	15.1	10.7	30.3	11.7	14.4	12.5	11.4	11.0	10.2	12.6	10.2	12.9	10.8	14.3	12.2	8.4	6.7	15.2	6.5	9.3	13.9	8.4	16.0	7.0	10.1	18.7	12.3	7.3	11.4	9.1	11.0	8.7	14.5	8.5	9.9	12.6	7.3	11.2	11.5	9.0	9.3	11.1	9.8	16.4	9.3	33.4	12.0	11.2	17.0	12.6	10.8	12.9	8.8	14.2	10.4	9.1	14.1	7.9	19.5	21.4	21.0	11.7	5.2	6.1	23.0	14.8	10.1	28.7	21.5	22.0	8.5	23.1	10.5	7.6	17.6	18.8	28.9	14.5	27.1	16.2	24.1	18.1	16.8	14.4	3.1	28.3	13.8	3.2	4.8	21.6	6.9	12.3	11.9	28.5	24.1	8.4	13.4	21.4	35.6	21.4	15.9	11.8	19.7	26.7	25.8	22.0	12.4	17.8	28.2	12.3	25.5	7.1	9.1	12.8	26.3	10.9	5.5	15.4	17.3	21.0	27.8	14.3	18.5	28.3	14.8	20.4	26.1	14.2	6.2	3.9	11.2	10.4	10.0	12.9	13.7	9.8	8.8	11.1	10.7	9.3	6.1	9.1	5.8	7.6	14.1	7.9	9.8	10.7	14.4	12.5	15.2	6.5	7.0	10.1	11.0	9.3	0.0	3.5	0.0	7.8	7.4	3.7	2.6	2.5	17.4	4.5	8.7	2.0	12.7	8.3	7.5	1.3	4.1	2.5	46.7	5.6	22.1	4.3	2.5	5.7	5.8	8.0	1.6	4.1	4.3	2.6	1.7	3.7	4.1	0.0	2.8	5.6	7.8	3.4	3.5	7.8	4.6	6.3	0.0	5.2	12.6	9.3	4.6	7.4	6.9	10.8	1.8
RFESD		ENSG00000175449	"Rieske Fe-S domain containing"	Q8TAC1	5	95646754-95684773	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.3"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 163.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 3.7;NK-cells: 5.0;T-cells: 12.7"	"Cell line enhanced"	"Detected in many"		"HEL: 21.2;K-562: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016546	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016546: AB_630417"	"unprognostic (1.15e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.09e-1)"	2.4	3.8	2.8	2.8	5.5	28.3	8.6	4.9	5.1	3.5	2.6	3.1	3.3	1.8	3.1	6.2	3.4	2.8	1.9	5.4	3.8	3.1	3.4	4.4	3.7	3.8	4.5	4.1	4.2	10.7	6.9	9.7	2.9	5.5	4.5	2.2	2.8	8.1	4.9	6.8	9.7	2.3	2.1	8.6	3.7	3.4	16.0	3.9	8.6	4.5	1.4	4.1	3.3	2.9	3.7	1.6	0.3	0.9	5.0	12.7	2.8	1.8	2.9	0.5	1.8	1.9	3.4	0.0	1.0	1.5	1.6	1.7	2.3	2.0	3.0	2.1	0.8	3.9	2.7	2.0	1.5	1.8	4.4	1.7	21.2	2.9	0.8	2.3	1.9	2.2	1.5	2.9	2.1	1.9	1.5	1.6	8.9	39.4	2.3	2.6	1.2	6.2	8.4	2.3	0.8	2.7	3.0	0.3	1.3	0.6	1.1	2.8	2.0	2.8	1.3	0.0	0.2	1.4	1.0	0.8	2.1	1.6	1.5	1.7	2.1	5.0	2.3	1.8	2.3	1.1	0.0	0.7	0.3	3.5	0.9	9.4	3.7	8.5	6.0	1.5	2.9	12.7	7.2	0.0	5.0	0.8	1.6	4.9	2.8	2.8	5.5	4.9	5.1	3.8	3.1	4.5	4.1	5.5	3.9	11.9	3.5	4.5	3.7	2.9	2.2	8.3	0.0	6.7	5.7	1.8	0.0	2.9	1.7	2.0	11.8	1.1	0.1	163.5	1.5	10.4	1.9	1.5	3.5	1.6	3.3	1.6	0.0	2.5	1.0	6.3	1.7	0.8	0.0	3.6	1.0	2.7	2.1	0.0	1.1	2.1	1.2	6.5	1.1	39.4	10.8	5.9	1.7	2.2	1.3	2.5
RFFL	"CARP-2, CARP2, fring, rififylin, RNF189, RNF34L"	ENSG00000092871	"Ring finger and FYVE like domain containing E3 ubiquitin protein ligase"	Q8WZ73	17	35005990-35089319	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.3;Karpas-707: 38.5"									"CAB008096, HPA017910, HPA019492"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190"	"unprognostic (2.59e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.73e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.26e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.36e-1)"	5.8	6.1	11.1	9.9	22.9	22.1	6.7	4.4	15.7	6.7	14.6	56.8	5.9	14.8	6.9	5.3	21.6	5.4	11.5	5.8	14.4	10.5	15.4	25.0	6.8	8.9	32.1	7.3	5.2	10.1	8.3	4.9	6.5	30.7	10.7	12.6	4.5	9.6	7.0	12.2	5.2	11.9	7.3	32.1	9.9	13.4	15.7	27.5	13.1	23.0	5.4	15.0	10.2	9.2	4.2	5.2	26.8	7.6	6.7	14.5	7.1	7.9	15.0	4.0	5.6	6.6	9.4	2.1	5.2	8.5	5.4	6.5	5.1	15.8	2.3	6.6	6.6	11.5	11.2	6.2	10.1	7.5	41.3	4.3	12.4	4.0	12.5	5.6	8.0	7.4	6.3	6.0	8.1	14.3	7.2	5.2	7.2	5.8	38.5	4.8	2.5	1.8	7.1	4.7	15.6	9.0	5.5	6.4	13.9	8.0	15.9	4.4	5.5	3.3	3.5	3.2	8.9	5.3	8.8	10.3	3.2	5.6	3.1	8.4	14.4	12.1	3.7	12.3	5.6	2.8	11.3	7.6	16.3	8.8	4.6	10.6	4.2	9.9	8.3	5.2	4.1	8.5	7.5	26.8	6.7	4.1	0.6	14.5	7.1	11.1	22.9	4.4	15.7	14.4	10.5	32.1	7.3	30.7	27.5	38.7	30.1	16.1	9.1	5.4	10.1	1.0	17.8	10.7	23.9	0.0	13.7	7.5	1.7	6.4	36.4	5.8	22.2	0.0	13.0	1.3	8.0	22.0	24.3	26.6	6.5	6.4	14.5	11.6	15.7	81.0	2.8	14.9	1.7	16.2	20.7	19.9	13.9	17.3	4.2	16.8	31.7	6.5	5.1	11.8	9.1	5.4	4.2	20.1	16.1	33.9
RFK	"FLJ11149, RIFK"	ENSG00000135002	"Riboflavin kinase"	Q969G6	9	76385517-76394517	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023259, CAB033887, HPA057163"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357"	"unprognostic (1.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	8.1	15.4	24.8	9.8	31.0	15.2	8.7	15.3	27.7	8.9	22.1	5.7	6.2	23.9	9.5	14.3	9.4	10.0	14.5	11.4	33.0	33.5	19.4	23.6	8.8	7.4	22.8	13.2	10.8	11.9	10.3	16.5	26.0	28.3	9.6	16.8	13.3	9.1	7.6	10.3	3.8	39.3	8.5	10.2	8.2	20.3	12.2	8.0	8.1	14.4	5.7	11.6	9.2	7.3	4.9	9.6	3.8	16.3	6.8	6.7	7.8	9.8	10.6	6.5	8.4	9.7	9.7	19.6	11.5	8.5	8.3	6.5	3.7	6.1	16.1	13.7	8.2	15.2	10.7	8.8	7.4	16.6	4.8	8.6	5.1	14.8	12.0	17.6	16.8	12.2	6.5	13.6	9.9	10.9	9.3	26.7	13.9	13.5	13.4	16.5	9.2	21.6	6.2	8.4	22.9	11.3	12.1	8.6	4.1	38.0	4.9	16.6	6.1	12.3	17.3	10.1	8.8	4.4	9.3	16.7	8.8	15.9	18.9	16.1	14.6	14.5	5.6	14.5	15.1	12.0	3.8	8.1	2.8	4.4	16.0	6.7	4.9	6.5	5.2	9.6	4.0	6.3	6.0	1.2	6.8	16.3	3.6	6.1	7.8	24.8	31.0	15.3	27.7	33.0	33.5	22.8	13.2	28.3	8.0	14.9	8.6	15.2	14.2	40.3	49.7	29.9	28.1	26.8	19.4	40.1	19.6	37.4	51.4	55.2	161.1	40.7	67.5	70.0	168.8	297.5	21.6	23.6	11.5	32.1	30.7	11.1	27.1	62.6	51.2	78.7	20.4	25.3	28.7	12.6	24.6	39.5	147.1	66.6	61.2	98.3	23.1	0.0	23.6	85.0	58.5	35.4	103.3	20.8	29.9	24.0
RFLNA	"Cfm2, FAM101A, FLJ44614, RefilinA"	ENSG00000178882	"Refilin A"	Q6ZTI6	12	123973241-124316024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"stomach 1: 118.3"	"Cell type enriched"	"Detected in some"	24	"Pancreatic endocrine cells: 66.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 9.0;HUVEC TERT2: 12.8;LHCN-M2: 22.4;OE19: 23.3;RH-30: 7.3"					"Low region specificity"	"Detected in all"			"HPA058911, HPA078021"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA058911: AB_2683853, HPA078021: AB_2732368"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.78e-4)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (8.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-8)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	5.5	3.0	6.4	5.2	8.6	2.6	8.2	10.8	6.6	11.7	20.9	9.7	7.0	19.5	4.8	4.8	3.0	5.5	3.7	5.1	6.3	6.3	5.4	5.3	3.2	2.8	9.8	5.2	5.2	7.6	2.7	9.4	3.4	9.0	6.3	15.4	6.3	8.7	5.4	8.5	4.2	20.7	3.4	8.3	2.8	118.3	2.7	8.3	1.9	9.6	2.3	2.8	3.3	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.3	0.0	0.0	0.3	0.3	1.1	0.8	0.0	0.1	3.1	0.1	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.0	9.0	0.0	0.5	12.8	1.3	0.0	0.0	22.4	0.0	0.0	0.0	1.9	23.3	0.0	0.0	7.3	0.1	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.4	8.6	10.8	6.6	6.3	6.3	9.8	5.2	9.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 48.4;bone marrow: 40.9"	"Cell type enhanced"	"Detected in some"	25	"Alveolar cells type 2: 5.5;Hofbauer cells: 30.7;monocytes: 10.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 48.4"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 48.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 28.0;HMC-1: 67.5;NB-4: 21.5;U-937: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	6.8	1.6	1.9	4.1	2.3	40.9	5.6	1.1	1.5	2.6	4.9			1.8	4.2	2.2	1.1	2.1	2.7	3.7	2.1	1.5	2.7	1.7	5.2	2.9	1.8		1.8	1.0	0.8	1.3	6.3		3.6	1.1		1.2	1.7	2.8	1.9	3.2	3.6	2.3	4.1	3.2	0.9			3.0		2.7	4.5	1.4	0.0	2.5	48.4	2.1	0.5	3.0	1.0	8.8	2.3	1.2	5.6	4.0	2.9	6.3	14.5	6.3	4.8	2.3	0.1	0.3	0.0	0.3	28.0	2.1	0.8	3.3	0.3	4.4	0.0	1.9	0.4	0.4	0.6	5.9	3.2	67.5	1.6	0.1	1.5	0.6	1.8	4.8	1.4	1.3	0.1	5.4	0.1	0.1	21.5	2.6	0.2	0.0	0.9	2.6	0.0	0.8	0.0	0.1	13.2	5.8	0.0	5.1	4.7	0.1	10.1	0.9	3.7	3.4	2.2	0.0	2.1	2.2	0.0	0.0	18.7	5.8	48.4	2.1	21.6	1.8	1.4	1.8	0.0	1.8	1.5	0.6	0.0	3.0	2.7	10.2	0.5	1.8	2.5	1.1	1.0											0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.4	1.8	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	1.1	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	10.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Approved	Nucleoplasm		No	No		450000	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: AB_2673989"	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	19.5	13.0	13.8	9.3	13.3	11.7	43.8	14.3	13.8	11.4	11.8	9.0	22.7	14.9	13.5	20.9	13.4	16.3	17.0	12.2	11.6	8.7	12.5	34.5	16.7	10.1	11.2	8.0	19.7	26.6	4.1	10.7	8.2	9.9	11.8	4.8	10.6	27.3	20.4	32.6	13.3	12.7	12.9	8.5	8.9	13.2	12.8	10.6	5.7	12.6	10.5	7.6	12.4	12.8	3.4	3.4	4.3	5.0	0.4	6.3	1.5	9.5	9.5	2.8	9.6	7.2	6.3	12.3	8.9	5.2	4.3	3.4	5.8	6.8	2.2	6.4	14.1	8.8	5.3	1.9	7.7	0.9	2.9	10.0	3.2	2.3	23.6	35.5	1.2	7.1	11.5	5.2	7.3	12.5	8.4	8.0	7.5	4.0	8.4	3.4	11.7	7.1	3.3	2.8	6.4	10.0	5.0	3.4	5.0	4.8	5.8	5.0	12.4	3.4	5.8	26.3	3.2	16.1	6.8	3.0	6.8	9.2	6.4	4.8	11.3	2.1	2.3	8.5	2.0	5.8	2.3	5.0	4.3	4.1	1.4	1.5	2.5	2.8	4.3	3.4	3.4	2.8	1.9	2.0	0.4	1.5	2.7	6.3	1.5	13.8	13.3	14.3	13.8	11.6	8.7	11.2	8.0	9.9	10.6	6.0	11.3	5.2	11.2	8.7	28.3	10.0	7.6	4.0	3.4	22.7	23.6	4.8	6.6	7.0	2.9	9.2	17.1	0.0	12.8	2.8	17.9	13.2	1.1	42.9	8.3	11.1	10.9	17.8	9.7	8.5	20.1	6.1	10.1	2.8	13.3	30.4	11.9	17.3	18.7	28.9	24.4	0.0	7.0	17.9	3.1	8.9	3.1	7.5	11.1	7.0
RFPL1	RNF78	ENSG00000128250	"Ret finger protein like 1"	O75677	22	29438583-29442455	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 20.4"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 6.5;Ito cells: 12.9;Kupffer cells: 2.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.2;HMC-1: 4.3;Karpas-707: 4.7;SH-SY5Y: 5.8;SiHa: 2.8;THP-1: 5.3"									"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA048320: AB_2680356, HPA072380: AB_2686515"		"unprognostic (4.54e-1)"				"unprognostic (6.63e-8)"						"unprognostic (3.14e-3)"			"unprognostic (1.89e-1)"			0.0	3.3	0.2	0.1	0.7	0.0	0.0	0.4	20.4	0.2	0.0			0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	1.9	0.0	0.1	0.4		2.8	0.0	0.0	0.6	0.0		3.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	4.5			0.0		0.0	0.0	0.4	1.6	0.9	0.0	1.8	0.0	1.2	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	11.2	0.7	0.0	1.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	5.8	2.8	0.0	0.0	0.3	0.0	5.3	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.2	1.2	0.8	0.0	0.6	1.0	0.9	1.6	0.1	1.1	0.0	0.0	1.8	0.0	1.2	0.5											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFPL2	RNF79	ENSG00000128253	"Ret finger protein like 2"	O75678	22	32190435-32203477	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 7.9;prostate: 10.8"	"Cell type enriched"	"Detected in single"	4	"Glandular cells: 3.1"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 5.6"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;OE19: 1.1;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2"									"HPA046608, HPA048320, HPA072380"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515"	"unprognostic (3.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.29e-2)"	"unprognostic (9.66e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.64e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.04e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.62e-7)"	"unprognostic (3.50e-2)"	0.1	0.3	2.3	0.2	3.9	1.1	0.1	2.7	7.9	0.1	0.1			0.2	0.1	0.1	0.3	0.1	0.1	0.1	3.1	5.6	0.2	0.5	0.1	0.4	1.9		0.1	0.1	0.1	0.0	0.1		10.8	0.1		0.1	0.1	0.1	0.4	0.2	0.1	0.4	0.2	0.2	0.2			0.2		0.1	0.1	0.0	0.0	0.5	0.0	0.8	0.0	1.2	0.2	0.0	2.5	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.4	0.0	0.3	0.0	1.1	0.0	1.0	0.1	0.0	0.0	0.2	1.8	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	0.8	0.0	1.2	1.2	0.5	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2											0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFPL3	RNF120	ENSG00000128276	"Ret finger protein like 3"	O75679	22	32354885-32361161	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	21	"testis: 23.4"	"Cell type enriched"	"Detected in single"	7	"Early spermatids: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;NB-4: 4.8;U-266/70: 5.6;U-266/84: 5.5"									"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA048320: AB_2680356, HPA072380: AB_2686515"	"unprognostic (1.63e-1)"				"unprognostic (9.90e-2)"			"unprognostic (1.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.32e-2)"		0.0	0.0	0.3	0.0	0.3	1.0	0.0	0.7	0.4	0.2	0.0			0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.4	0.2		0.6	0.5	0.0	0.2	0.0		0.3	0.0		0.4	0.0	0.3	1.1	0.2	0.0	0.1	0.5	0.0	23.4			0.0		0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	1.1	0.2	0.1	0.8	2.4	0.7	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.3	2.4	1.1	0.1	0.1	0.0	1.5	0.5	0.0	0.0	0.0	0.0	1.4	0.0	1.8	0.1	1.8	0.0	0.9	1.4	4.8	0.2	0.3	0.1	2.4	0.5	0.6	0.0	0.4	1.8	0.5	0.1	0.4	1.3	0.6	0.0	0.4	0.0	0.0	0.9	0.4	0.0	5.6	5.5	0.1	0.1	1.7	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"classical monocyte: 12.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 12.7"	"Cell line enriched"	"Detected in some"	17	"U-2 OS: 44.7"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA046368: AB_2679640"							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0	0.0	5.2	0.0	0.1	0.2	0.0	0.0	0.0	0.4	7.1	0.0	0.8	0.0		0.1	0.4	0.0	0.1	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.4	3.8			0.0		0.1	0.0	0.0	0.0	3.8	1.7	12.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	44.7	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	12.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	1.7	0.0	0.8	0.0	0.0	2.8											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769141-55773179	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.5;monocytes: 5.4"	"Cell line enriched"	"Detected in some"	24	"U-2 OS: 24.8"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA046368: AB_2679640"															"unprognostic (8.87e-2)"			0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1			0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.0	0.0	0.3	3.0	0.0	0.4	0.0		0.6	0.7	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.3	0.0	0.1	2.3	0.2	1.5			0.3		0.0	0.3	0.0	0.0	2.5	0.4	5.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
RFT1	CDG1N	ENSG00000163933	"RFT1 homolog"	Q96AA3	3	53088483-53130462	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA060327, HPA069022"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA060327: AB_2684253, HPA069022: AB_2732126"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.54e-2)"	12.9	19.1	10.8	13.8	14.7	7.2	13.2	11.0	19.2	11.9	11.7	17.0	9.6	10.2	16.2	14.0	16.9	13.0	11.0	12.4	10.2	7.4	10.1	17.7	11.6	15.3	10.5	10.5	15.5	43.7	15.4	9.4	13.8	10.6	11.0	13.8	13.4	18.6	11.3	7.0	13.4	10.5	11.6	11.5	14.5	12.8	23.8	11.1	16.8	15.2	9.1	16.3	12.5	12.1	16.5	27.5	25.9	23.1	11.7	14.5	13.6	16.2	15.4	10.6	16.9	12.5	13.3	22.1	14.8	13.9	25.9	23.7	15.2	32.1	21.5	9.3	14.2	24.4	17.5	23.9	24.2	23.0	20.2	10.5	21.2	11.2	15.0	21.9	19.3	12.5	14.0	20.5	34.8	25.2	11.5	16.4	22.6	11.1	19.7	17.0	16.5	18.1	11.4	21.2	28.4	20.3	7.5	10.2	32.6	14.3	11.0	6.0	8.2	18.3	13.5	13.3	12.0	10.1	27.6	10.8	24.1	15.6	16.4	29.0	12.5	15.0	16.3	17.2	24.8	25.1	25.9	23.1	9.9	13.3	22.4	13.4	12.2	12.5	13.6	24.1	16.5	14.5	14.5	7.7	11.7	15.5	27.5	10.9	13.6	10.8	14.7	11.0	19.2	10.2	7.4	10.5	10.5	10.6	11.1	3.0	3.0	0.8	9.0	4.4	3.9	5.9	10.2	5.3	4.5	8.7	3.9	35.2	1.7	14.2	1.0	5.8	4.3	0.0	18.4	27.2	7.5	7.0	2.3	9.5	19.8	4.8	2.4	10.4	8.7	1.4	8.1	4.7	6.8	10.8	6.7	4.9	11.3	10.2	5.6	4.8	6.1	0.0	2.8	9.3	9.6	3.8	20.3	6.4	10.0	6.4
RFX1	EF-C	ENSG00000132005	"Regulatory factor X1"	P22670	19	13961538-14007039	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 122.1;Late spermatids: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048722, HPA052966"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048722: AB_2680500, HPA052966: "	"unprognostic (6.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (5.45e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.56e-2)"	7.4	7.4	13.1	8.7	13.1	9.8	7.0	36.2	19.3	10.3	6.0	6.2	10.2	10.6	8.0	4.6	8.0	8.5	6.3	7.0	11.7	5.9	7.9	8.6	7.0	7.2	8.6	9.5	10.2	12.5	11.9	18.9	8.0	9.5	8.5	3.1	9.8	12.7	12.4	11.0	7.0	9.2	4.4	6.8	12.0	11.2	21.0	10.8	11.6	10.9	3.4	9.3	6.8	13.6	3.9	3.5	10.8	3.5	3.4	2.0	1.1	6.2	6.3	3.4	4.1	2.1	2.6	10.3	3.5	2.3	4.0	3.5	6.5	6.3	3.5	7.0	1.8	3.5	8.2	2.5	2.5	1.4	3.5	14.1	4.0	7.1	5.8	3.9	4.1	8.6	1.9	2.7	3.6	2.1	3.6	3.2	3.1	10.2	4.0	2.1	9.5	7.4	8.9	7.7	3.4	9.7	6.5	3.5	5.0	4.0	3.4	14.2	7.5	6.0	5.3	4.8	1.9	5.6	4.3	3.7	7.1	5.8	7.7	5.9	9.4	4.2	2.4	5.6	4.0	6.2	0.7	3.5	1.6	1.4	1.1	1.3	2.9	1.6	1.5	1.7	3.9	1.7	2.0	10.8	3.4	2.0	3.5	1.0	1.1	13.1	13.1	36.2	19.3	11.7	5.9	8.6	9.5	9.5	10.8	14.9	9.9	15.9	8.0	4.9	27.9	7.7	5.1	1.4	12.5	21.0	33.4	8.2	8.3	8.7	122.1	9.8	14.9	0.0	8.4	10.4	9.6	6.2	11.5	14.4	9.2	22.3	16.0	13.5	17.5	79.7	23.9	8.5	1.7	3.6	14.5	13.8	9.3	12.5	26.2	6.7	47.6	12.9	6.1	31.2	17.5	6.6	15.9	15.3	12.7	5.6
RFX2	FLJ14226	ENSG00000087903	"Regulatory factor X2"	P48378	19	5993164-6199572	"Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 51.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 120.5;Early spermatids: 120.3;Late spermatids: 146.0;Spermatocytes: 95.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"neutrophil: 18.3"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.3;SCLC-21H: 20.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048969	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA048969: AB_2680577"	"unprognostic (1.31e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.07e-1)"	6.7	2.0	8.4	5.3	9.4	8.6	6.4	8.3	7.0	6.9	11.3	7.2	0.7	4.1	15.7	7.0	9.0	22.0	6.4	5.4	9.5	3.6	1.9	2.5	10.0	2.1	4.4	4.0	7.2	5.3	2.9	12.9	2.2	9.9	4.1	2.6	3.1	2.4	3.3	2.5	6.6	5.7	14.8	9.0	2.1	5.9	51.5	7.5	4.1	3.0	12.1	3.1	8.7	5.3	0.3	1.6	18.3	2.0	0.5	0.5	0.6	4.0	3.3	5.3	10.3	2.8	1.6	3.1	2.6	3.6	2.2	3.5	1.4	5.1	4.6	2.8	3.4	4.8	6.4	1.3	5.2	3.0	1.1	0.8	7.2	3.3	1.4	3.2	3.1	16.3	1.9	4.5	4.9	2.6	2.7	3.3	6.4	4.6	0.2	2.2	2.0	6.2	4.3	1.4	5.6	2.0	1.7	3.2	0.5	2.8	7.9	20.1	2.5	2.5	2.0	1.4	0.6	3.4	3.5	4.8	0.9	4.6	3.6	2.6	6.7	2.2	2.6	2.8	11.6	1.9	0.0	2.0	0.8	0.1	0.4	0.0	0.3	0.4	0.3	1.6	0.1	0.4	0.5	18.3	0.5	1.1	0.0	0.0	0.6	8.4	9.4	8.3	7.0	9.5	3.6	4.4	4.0	9.9	7.5	23.8	40.1	2.2	23.8	23.5	3.3	7.2	15.3	120.5	40.9	3.5	2.0	5.2	3.3	3.9	120.3	9.9	3.0	0.0	1.5	5.4	9.7	5.5	44.0	2.0	7.0	0.0	13.2	6.7	8.7	146.0	7.5	13.6	6.8	5.4	4.4	5.5	2.3	1.5	3.9	1.5	3.6	25.8	14.6	95.0	13.0	19.3	4.7	4.9	5.2	17.3
RFX3		ENSG00000080298	"Regulatory factor X3"	P48380	9	3218297-3526004	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1;testis: 36.5"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 140.5;Early spermatids: 159.1;Intestinal endocrine cells: 135.5;Late spermatids: 86.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 22.4;HDLM-2: 13.2;SCLC-21H: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035689	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA035689: AB_10671224"	"prognostic favorable (1.47e-4)"	"unprognostic (8.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.49e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.52e-1)"	"unprognostic (8.89e-3)"	5.2	4.6	17.9	7.6	14.9	11.4	6.7	35.1	19.5	6.9	4.7	6.9	5.0	5.0	6.8	6.3	3.8	22.0	5.2	4.0	12.8	7.5	5.0	4.1	7.2	6.7	6.0	11.9	7.0	5.4	9.0	21.7	5.8	9.9	6.1	5.6	4.2	4.7	4.6	5.7	4.4	5.0	4.0	12.5	5.7	6.6	36.5	11.0	12.7	5.7	2.9	7.5	4.5	7.8	8.3	4.6	8.9	4.8	5.3	9.3	3.2	2.0	2.7	22.4	5.4	0.9	1.0	2.2	0.8	2.4	1.9	1.4	0.8	2.6	3.2	0.9	1.1	1.6	1.1	5.5	2.3	3.4	13.2	1.5	6.0	3.0	1.8	1.1	1.2	0.8	1.4	1.1	2.3	3.8	3.8	3.3	4.2	1.1	3.3	2.0	1.6	3.8	4.4	5.9	1.7	1.2	4.0	1.5	0.8	3.1	1.6	12.0	5.3	1.3	0.6	2.0	4.6	1.1	3.2	2.0	1.4	3.3	0.7	1.3	1.1	0.5	6.4	1.6	1.4	1.5	3.5	3.2	6.2	8.8	4.8	5.4	6.3	8.1	7.2	3.1	8.3	5.7	7.0	8.9	5.3	1.4	4.6	9.3	3.2	17.9	14.9	35.1	19.5	12.8	7.5	6.0	11.9	9.9	11.0	6.0	7.7	6.2	7.4	4.4	22.0	4.9	0.0	140.5	34.2	3.5	23.6	1.6	0.0	3.1	159.1	13.5	2.5	0.0	2.2	2.1	4.3	9.6	5.8	0.9	2.7	36.5	135.5	11.6	6.9	86.4	6.6	6.2	1.7	1.0	9.2	13.8	3.2	5.8	7.1	1.7	25.2	0.0	10.3	10.2	2.5	5.5	1.1	6.7	5.5	3.3
RFX4		ENSG00000111783	"Regulatory factor X4"	Q33E94	12	106582907-106762803	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 43.9;testis: 70.5"	"Cell type enhanced"	"Detected in some"	31	"Early spermatids: 34.1;Late spermatids: 23.0;Spermatocytes: 99.6"	"Cancer enriched"	"Detected in single"	54	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.2;NK-cell: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	14	"AF22: 33.3"	"Low region specificity"	"Detected in all"							HPA050527	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050527: AB_2681158"	"unprognostic (3.67e-1)"		"unprognostic (4.86e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.97e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.46e-2)"		1.3	1.2	13.8	1.2	14.5	1.2	1.2	7.6	20.6	1.2	1.2	21.0	0.0	1.2	1.2	1.3	1.2	1.3	1.3	1.3	15.7	9.9	1.3	1.2	1.3	1.3	12.0	8.6	1.2	1.4	1.2	8.0	1.2	20.6	1.4	1.2	0.0	1.2	1.3	1.2	1.2	1.3	1.2	43.9	1.2	1.3	70.5	13.7	0.0	1.4	0.0	1.2	1.2	0.1	0.5	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.2	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	13.8	14.5	7.6	13.6	15.7	9.9	12.0	8.6	20.6	13.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	99.6	3.1	0.0	0.0	0.0	0.0	0.0
RFX7	"FLJ12994, RFXDC2"	ENSG00000181827	"Regulatory factor X7"	Q2KHR2	15	56087280-56243266	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035462	Supported		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA035462: AB_10602152"	"unprognostic (2.36e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.24e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	6.6	6.6	4.2	4.1	7.1	6.7	5.0	28.2	11.7	4.4	3.5	8.6	3.0	4.3	4.4	4.9	5.1	4.1	3.1	4.2	4.7	3.6	4.4	4.2	4.1	7.1	4.5	8.3	4.7	6.3	7.1	10.6	4.1	8.1	3.9	3.9	2.7	5.3	7.1	13.7	9.8	4.6	4.1	6.4	6.0	4.1	6.0	6.8	15.4	4.2	3.7	7.2	4.9	4.8	1.3	1.5	4.6	0.8	1.4	2.6	0.5	3.9	6.1	14.6	11.1	6.3	7.2	3.8	2.9	4.1	3.9	6.2	4.3	2.9	11.1	4.8	4.3	3.3	10.1	8.8	5.6	5.3	5.9	3.5	13.1	8.3	9.3	6.5	10.6	2.3	5.9	13.3	3.5	8.8	6.9	7.0	11.3	6.1	5.8	6.6	4.6	8.9	4.3	6.9	3.2	2.3	9.9	9.4	10.1	5.7	10.1	8.1	10.2	3.7	4.3	5.2	11.1	3.3	8.6	5.8	10.7	5.4	2.7	6.3	5.5	5.2	12.6	3.8	11.4	4.7	4.6	0.5	0.9	1.2	0.8	1.6	1.2	1.8	1.9	0.9	1.3	1.0	1.3	0.0	1.4	0.4	1.5	2.6	0.5	4.2	7.1	28.2	11.7	4.7	3.6	4.5	8.3	8.1	6.8	6.0	11.2	5.4	4.2	11.8	15.8	5.3	2.5	6.7	4.5	7.0	9.8	3.5	3.3	3.0	16.3	6.2	3.0	23.3	4.0	1.2	5.4	5.4	11.6	7.6	4.7	15.9	4.6	8.0	11.3	9.1	6.1	5.6	5.0	1.8	5.6	4.1	3.0	6.5	9.9	3.7	7.4	0.0	3.6	6.6	5.8	15.4	1.4	6.4	6.2	5.1
RFX8	FLJ42986	ENSG00000196460	"RFX family member 8, lacking RFX DNA binding domain"	Q6ZV50	2	101397361-101474703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 14.4;Late spermatids: 6.0;Spermatocytes: 4.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	12	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;hTEC/SVTERT24-B: 15.7;LHCN-M2: 7.5;U-87 MG: 10.4;U-937: 4.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059745			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA059745: AB_2684120"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.56e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-5)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	2.1	0.6	0.4	0.8	0.7	10.0	7.5	0.2	2.3	0.9	0.5	0.8	1.3	0.4	0.7	1.7	0.7	0.2	1.0	0.8	0.4	0.9	0.6	0.7	0.7	0.9	0.7	1.6	0.7	0.6	1.0	2.2	0.9	1.6	0.5	0.1	0.8	0.9	0.1	0.5	1.4	0.3	0.8	0.8	0.4	0.4	2.6	0.0	7.8	1.5	0.0	0.3	0.6	2.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	2.0	1.4	1.4	1.4	0.0	3.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.1	0.0	15.7	0.1	0.0	0.0	0.5	0.0	0.0	7.5	0.0	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	1.9	2.8	0.0	0.0	0.0	10.4	4.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	2.3	0.4	0.9	0.7	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.8	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.5	4.7	0.7	0.0	1.1	0.0	0.0	0.1
RFXAP		ENSG00000133111	"Regulatory factor X associated protein"	O00287	13	36819224-36829104	"Disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	SCID	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032035			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA032035: AB_2674120"	"unprognostic (2.03e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.14e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.15e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.94e-1)"	"prognostic favorable (4.18e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (2.81e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.99e-3)"	8.5	6.7	15.0	8.8	14.4	9.2	9.0	31.8	15.6	12.7	9.5	12.3	8.4	5.7	13.1	10.2	5.8	10.9	7.7	6.4	13.0	9.1	6.2	5.0	8.1	11.5	13.3	10.8	13.9	9.3	11.9	14.2	7.0	11.3	10.3	8.1	9.8	8.8	11.3	8.1	6.5	8.7	11.1	10.5	9.1	7.9	11.7	14.5	19.7	11.2	4.6	9.8	8.0	8.1	1.4	1.9	2.4	0.6	0.7	1.3	0.0	4.5	1.1	6.6	9.3	2.5	3.4	4.3	3.7	3.9	7.0	4.3	3.2	3.7	19.9	3.1	3.3	6.2	4.2	6.8	2.2	7.9	14.8	11.3	9.5	5.0	6.2	4.5	17.4	7.0	3.1	4.1	3.4	2.6	2.0	5.2	15.3	5.4	4.0	2.1	2.2	17.3	12.5	7.1	3.9	2.0	15.2	12.3	6.0	3.0	2.8	5.4	6.8	3.6	2.4	2.8	4.2	2.4	10.4	4.0	1.8	3.9	6.3	3.3	3.8	3.1	15.0	5.1	12.1	2.8	0.0	0.1	2.4	1.0	0.0	0.8	1.4	0.6	1.1	0.1	0.5	0.7	1.3	0.0	0.7	0.6	1.9	1.1	0.0	15.0	14.4	31.8	15.6	13.0	9.1	13.3	10.8	11.3	14.5	3.0	3.8	3.9	2.8	3.2	14.7	2.4	2.5	1.4	2.3	3.5	2.0	5.2	13.3	2.8	3.1	4.5	2.0	0.0	4.7	2.8	9.3	1.5	10.3	2.4	2.7	22.3	6.9	8.6	1.6	2.9	10.3	5.0	6.8	2.8	2.4	21.6	2.7	2.9	10.3	1.2	16.3	6.5	6.4	14.6	23.3	1.8	1.0	12.8	4.0	0.7
RGL1	RGL	ENSG00000143344	"Ral guanine nucleotide dissociation stimulator like 1"	Q9NZL6	1	183636085-183928531	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 46.1;Kupffer cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.6;HSkMC: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019788	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA019788: AB_1856215"	"unprognostic (3.08e-1)"	"unprognostic (5.25e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.49e-5)"	"prognostic favorable (4.32e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.88e-2)"	22.1	15.7	22.1	16.9	24.8	1.5	19.7	14.2	23.2	18.1	9.9	25.5	8.8	7.9	17.4	11.5	9.9	14.4	20.3	15.0	21.5	15.0	25.7	14.3	18.4	17.4	18.2	16.3	18.7	6.3	10.5	9.7	14.2	19.1	12.5	11.9	21.0	7.8	11.1	3.0	8.4	9.4	19.8	19.6	37.5	7.6	13.0	20.4	1.7	9.1	2.9	8.9	18.1	12.6	0.0	2.4	0.2	5.2	0.0	1.1	1.2	0.1	0.7	13.7	2.1	18.6	8.6	13.9	6.3	10.6	2.9	3.6	6.1	0.4	0.1	5.9	4.4	2.2	0.3	0.9	1.6	2.8	0.2	1.0	0.1	1.4	6.2	5.0	0.2	0.7	29.2	0.3	7.3	1.7	13.7	10.6	1.4	0.0	10.1	6.0	0.0	1.4	0.1	4.9	0.4	0.4	11.8	0.9	12.0	0.8	3.8	1.7	4.1	1.9	2.1	1.0	4.6	0.1	0.1	7.7	4.1	1.6	12.8	3.4	1.0	0.2	0.0	4.3	0.1	11.3	0.0	2.1	0.0	0.2	5.2	0.4	0.0	0.8	0.0	2.4	0.0	1.1	0.6	0.2	0.0	1.8	0.0	0.6	1.2	22.1	24.8	14.2	21.9	21.5	15.0	18.2	16.3	19.1	20.4	8.9	10.5	2.2	2.1	7.2	2.4	7.5	5.1	16.0	11.4	5.2	0.0	3.9	5.0	2.6	10.2	13.6	2.1	0.0	0.8	1.7	10.8	3.3	3.5	2.1	33.6	7.9	0.0	46.1	85.8	11.8	12.0	15.6	5.0	1.0	0.8	26.6	0.8	0.0	19.4	23.7	1.9	25.8	4.7	1.6	2.7	4.1	4.3	0.5	0.4	1.4
RGL2	"HKE1.5, KE1.5, RAB2L"	ENSG00000237441	"Ral guanine nucleotide dissociation stimulator like 2"	O15211	6	33291654-33299324	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 4.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047039, HPA053444"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047039: AB_2732538, HPA053444: AB_2682153"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-2)"	12.1	9.2	6.7	10.0	8.4	4.5	6.8	9.4	8.4	8.6	7.0	7.1	15.3	6.7	8.9	9.5	6.5	8.3	9.9	9.1	7.2	3.2	7.5	4.2	9.9	7.2	7.5	4.8	10.7	6.6	4.9	17.1	7.7	8.6	7.5	4.2	7.5	6.8	13.3	19.9	4.6	6.6	6.3	4.9	19.0	7.1	6.4	6.6	4.6	12.8	4.5	6.8	7.5	10.7	0.5	0.7	4.2	0.9	0.7	0.4	0.8	3.6	1.0	4.1	2.1	0.6	0.4	2.0	1.7	1.0	0.5	0.7	0.5	0.9	1.2	6.1	0.3	2.0	0.8	0.8	0.5	0.3	3.0	2.1	2.5	1.0	0.9	0.5	1.8	3.9	0.8	0.5	1.6	0.3	2.6	1.1	1.5	3.1	0.9	0.3	0.7	1.2	2.6	0.1	0.5	1.8	1.2	2.3	1.3	0.8	0.7	3.5	3.4	1.2	2.2	5.2	1.1	1.8	2.1	3.2	2.0	2.9	1.3	4.6	5.1	2.9	3.2	0.6	1.3	3.5	1.6	0.8	2.0	0.4	0.9	0.4	0.5	0.3	0.4	0.7	0.5	0.2	0.3	4.2	0.7	0.2	0.0	0.3	0.8	6.7	8.4	9.4	8.4	7.2	3.2	7.5	4.8	8.6	6.6	14.9	40.4	15.9	31.8	25.2	27.7	22.9	12.7	21.4	30.7	21.0	21.6	22.8	11.6	19.0	3.9	54.2	6.1	0.0	12.7	34.3	17.5	39.0	10.5	10.4	26.5	30.2	27.4	61.4	25.6	10.3	15.5	20.5	16.9	10.8	10.4	20.9	17.4	22.9	13.8	9.7	29.6	25.8	21.7	27.8	16.2	21.2	85.5	20.8	8.3	35.6
RGL4	Rgr	ENSG00000159496	"Ral guanine nucleotide dissociation stimulator like 4"	Q8IZJ4	22	23688136-23699176	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.3;bone marrow: 55.8"	"Cell type enriched"	"Detected in some"	7	"T-cells: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"neutrophil: 81.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 81.3"	"Group enriched"	"Detected in many"	5	"MOLT-4: 15.1;U-937: 35.7"									HPA035979	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA			Centrosome		"HPA035979: AB_10673227"	"unprognostic (1.48e-4)"	"unprognostic (2.75e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.93e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.11e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-3)"	1.6	1.0	0.5	9.8	0.6	55.8	0.6	1.0	0.8	0.4	1.0	0.2	0.0	1.3	1.0	1.0	1.1	1.2	1.8	10.8	0.5	0.5	0.8	1.5	6.7	19.9	0.6	0.0	1.4	1.0	0.0	0.7	0.8	0.5	0.5	0.2	0.4	2.2	0.0	0.8	1.9	4.1	0.0	0.6	21.6	0.9	18.4	0.3	11.1	1.0	0.3	8.9	1.1	3.6	0.9	0.8	81.3	12.0	4.8	17.8	5.8	0.9	0.3	3.5	1.5	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.7	0.6	1.1	0.3	0.0	0.6	1.7	0.0	0.0	0.0	1.1	2.2	0.5	1.2	0.2	0.0	1.9	2.3	0.0	0.0	0.0	0.0	1.8	0.0	1.2	1.2	1.8	0.0	0.5	15.1	2.1	0.2	0.3	0.4	5.4	1.2	0.8	0.0	1.0	1.1	1.7	1.0	2.2	0.3	2.0	0.7	1.2	1.5	2.0	1.2	1.3	0.6	3.2	0.5	0.8	1.1	35.7	0.9	11.8	0.4	58.6	9.5	2.9	9.8	0.9	12.4	10.9	0.8	0.7	17.8	15.9	81.3	4.8	12.0	0.1	17.0	5.8	0.5	0.6	1.0	0.5	0.5	0.5	0.6	0.0	0.5	0.3	0.0	7.9	5.0	0.0	0.8	0.5	0.4	0.0	0.0	2.3	0.0	2.0	0.0	0.0	1.9	4.4	0.0	0.0	0.0	1.5	0.1	0.2	0.0	1.1	0.0	0.1	1.6	0.0	0.0	0.8	0.4	0.0	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.3	0.0	53.2	0.0	0.0
RGMA	"RGM, RGMa"	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0;skeletal muscle: 85.5"	"Group enriched"	"Detected in many"	5	"Leydig cells: 110.1;Peritubular cells: 110.0;Spermatogonia: 37.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 31.0;BEWO: 9.1;MOLT-4: 9.2;NTERA-2: 13.9;REH: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		1400000	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	12.2	3.3	17.4	17.6	24.7	1.8	9.3	11.0	59.0	21.0	22.2	22.2	0.9	9.1	21.8	9.4	23.1	12.1	9.5	7.7	19.3	16.2	2.3	1.6	2.8	3.1	23.0	12.8	16.6	9.1	1.9	2.1	2.5	30.9	5.5	6.5	2.3	16.2	7.0	85.5	4.9	12.3	46.9	36.8	2.2	26.6	15.8	23.1	0.2	2.9	12.2	5.6	4.1	8.8	1.3	0.7	1.7	1.0	0.7	0.5	0.2	1.2	0.2	31.0	0.5	6.5	3.6	9.1	0.2	0.0	0.0	0.0	0.3	0.4	0.1	0.1	0.2	0.0	2.0	5.2	0.1	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.1	0.1	3.8	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.6	9.2	0.1	13.9	0.0	0.0	8.0	7.1	0.0	0.0	0.3	3.3	1.8	0.3	0.1	0.0	1.7	2.5	1.6	0.1	0.0	6.7	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.8	1.4	0.7	0.6	0.4	1.0	0.3	0.6	0.5	0.5	0.1	1.3	0.4	0.5	1.7	0.7	0.4	0.7	0.3	0.2	17.4	24.7	11.0	21.3	19.3	16.2	23.0	12.8	30.9	23.1	0.0	1.0	0.0	15.6	4.8	0.2	3.2	0.0	1.4	2.3	0.0	2.0	3.8	0.0	4.7	0.8	1.1	0.0	0.0	0.6	1.0	7.4	13.3	0.0	0.0	1.8	0.0	0.0	3.1	3.7	2.6	110.1	1.1	3.3	0.0	0.0	4.1	0.6	0.0	110.0	0.0	1.1	12.9	12.3	0.7	37.2	2.5	2.1	0.7	0.0	12.0
RGMB	"DRAGON, FLJ90406"	ENSG00000174136	"Repulsive guidance molecule BMP co-receptor b"	Q6NW40	5	98768650-98798643	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 51.6;Mucus-secreting cells: 39.5;Undifferentiated cells: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.3"	"Group enriched"	"Detected in many"	12	"B-cells: 4.1;T-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"BJ: 68.4;fHDF/TERT166: 37.5;HBF TERT88: 48.5;LHCN-M2: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016993			Approved	Nucleoplasm		NA	NA		150000	Nucleoplasm		"HPA016993: AB_1856216"	"unprognostic (1.50e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-3)"	8.3	7.2	14.0	9.9	11.7	0.8	14.4	18.0	23.9	8.8	19.7	5.6	9.9	19.0	8.4	5.7	17.7	10.1	8.9	8.8	9.8	14.4	3.9	6.6	10.8	4.1	7.2	13.3	20.1	15.4	9.0	12.3	5.1	11.5	19.2	28.5	6.8	18.4	15.6	23.1	28.1	22.9	10.6	11.6	6.2	34.5	13.3	5.6	1.0	13.5	7.2	7.7	9.7	15.7	4.1	0.1	0.5	0.2	0.3	8.3	1.6	1.8	1.3	19.1	1.7	5.7	9.9	2.6	68.4	30.5	30.5	21.6	0.9	0.8	1.0	2.9	37.5	2.3	1.8	2.2	5.9	48.5	3.4	2.8	0.0	1.6	1.1	2.8	0.1	0.0	8.1	2.0	19.9	6.1	8.2	5.5	3.2	0.0	0.8	35.6	1.7	0.0	0.0	1.5	0.7	4.4	2.8	11.7	1.8	1.1	1.8	8.3	4.2	0.9	2.1	3.2	0.9	1.7	0.0	13.5	19.4	4.0	12.4	31.0	1.8	2.2	1.4	7.3	0.0	4.2	0.0	0.0	0.2	0.3	0.2	1.4	3.1	3.9	1.3	0.1	4.1	8.3	3.9	0.5	0.3	0.0	0.0	5.3	1.6	14.0	11.7	18.0	21.5	9.8	14.4	7.2	13.3	11.5	5.6	14.9	2.6	4.2	12.8	27.5	4.9	13.0	5.1	2.7	1.2	8.7	15.7	3.8	1.7	4.6	51.6	7.4	7.8	0.0	4.5	4.7	13.2	10.6	0.0	7.5	1.7	0.0	20.9	8.6	1.3	12.3	8.3	2.1	11.8	1.0	39.5	1.3	6.6	10.5	6.7	1.2	3.6	0.0	18.6	4.9	12.6	21.3	1.5	0.0	50.0	15.9
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 51.0;liver: 118.8"	"Cell type enhanced"	"Detected in many"	13	"Distal tubular cells: 49.7;Hepatocytes: 141.5;Muller glia cells: 48.0;Peritubular cells: 65.4;Proximal tubular cells: 86.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 16.5;fHDF/TERT166: 5.3;Hep G2: 24.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103, HPA029104"	Enhanced		Approved	Cytosol		NA	NA		47000	Cytosol		"HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: "	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	2.6	51.0	6.7	0.6	6.5	0.4	1.5	8.4	6.2	2.8	1.9	6.2	2.5	4.5	2.3	6.1	1.5	1.7	2.0	4.5	6.1	4.2	17.6	118.8	4.9	0.7	5.9	4.5	7.5	12.7	6.2	2.5	4.2	5.0	4.8	1.1	8.4	7.5	6.3	3.8	0.6	4.6	4.9	4.4	1.1	2.9	1.5	5.2	0.0	6.5	1.6	0.6	2.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.3	0.6	0.0	0.0	16.5	0.0	0.0	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.6	0.8	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.7	6.5	8.4	6.2	6.1	4.2	5.9	4.5	5.0	5.2	6.0	2.2	0.0	2.9	0.5	10.2	25.8	7.6	2.7	1.2	14.0	0.0	0.1	49.7	8.4	0.4	1.8	0.0	0.0	7.9	0.1	7.5	0.9	0.0	141.5	0.1	4.8	4.6	6.2	4.0	0.6	23.0	0.0	1.7	0.0	0.0	48.0	7.8	0.0	65.4	86.9	1.9	12.9	8.0	0.2	0.2	0.3	0.2	0.0	0.3	1.1
RGPD1	RGP1	ENSG00000187627	"RANBP2-like and GRIP domain containing 1"	P0DJD0	2	86907953-87013976	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.4;placenta: 8.0;testis: 17.7"	"Cell type enhanced"	"Detected in some"	17	"Cardiomyocytes: 1.6;Early spermatids: 1.9;granulocytes: 3.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.8;MOLT-4: 13.2;NTERA-2: 4.0;RPMI-8226: 2.9;SuSa: 7.7"									"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (8.24e-2)"	"unprognostic (6.05e-2)"		"unprognostic (6.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.06e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.80e-1)"		"unprognostic (2.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.88e-5)"	"unprognostic (2.23e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.99e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	10.4	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.1	0.2		0.2	1.7	1.1	4.8	8.0		0.0	0.0		0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.3	0.3	17.7			0.2		0.5	0.0	0.1	1.3	0.0	0.1	0.0	1.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	13.2	0.2	4.0	0.2	0.0	0.1	0.1	2.9	0.0	0.0	0.1	0.8	0.2	0.0	0.0	7.7	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.1	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.7	0.0	0.2	0.1	0.8	0.0	1.1	0.0	0.0	0.1	0.1											0.0	0.3	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0
RGPD2	"RANBP2L2, RGP2"	ENSG00000185304	"RANBP2-like and GRIP domain containing 2"	P0DJD1	2	87755955-87825952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 11.3;testis: 12.3"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 5.7;Early spermatids: 4.3;Late spermatids: 2.3;Spermatocytes: 2.3"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	4	"T-reg: 11.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 11.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.7;JURKAT: 5.2;MOLT-4: 12.2;NTERA-2: 5.3;SuSa: 15.5;THP-1: 4.9"									"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (4.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.83e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.59e-1)"	0.7	2.1	0.1	0.6	0.2	7.1	0.8	1.3	0.3	4.6	0.8			1.2	1.1	0.0	0.3	2.4	0.0	0.5	0.0	0.2	0.4	0.8	1.2	1.3	0.1		1.7	6.3	0.1	2.7	7.5		0.6	0.1		0.8	0.1	0.6	0.6	1.8	0.0	0.1	0.9	1.7	12.3			0.9		1.6	0.3	0.9	0.9	0.0	0.5	0.1	0.0	11.3	0.4	0.0	0.0	0.6	0.0	0.0	0.0	10.7	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.1	0.1	2.5	0.2	0.0	0.1	0.0	5.2	3.7	0.3	0.0	0.4	12.2	0.0	5.3	2.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	2.7	4.3	0.1	0.0	15.5	0.0	4.9	0.1	0.8	0.1	0.0	0.0	2.4	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.4	0.9	2.7	0.5	0.0	0.9	1.4	0.2	0.4	0.0	0.0	0.0	11.3	0.4											0.0	0.6	0.0	0.0	0.1	0.2	5.7	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.1	4.3	0.0	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	2.3	0.4	0.0	0.8	0.0	0.0	0.0
RGPD3	RGP3	ENSG00000153165	"RANBP2-like and GRIP domain containing 3"	A6NKT7	2	106391290-106468376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 11.6"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 14.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 3.3;MOLT-4: 10.3;RPMI-8226: 3.3"									"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.44e-1)"	"unprognostic (4.74e-3)"	"unprognostic (5.05e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.34e-1)"	0.2	0.1	0.3	0.0	0.5	0.4	0.4	0.3	0.9	0.2	0.0			0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.4	1.4	0.7	0.1	0.1	0.6		0.2	0.2	0.7	0.7	0.2		0.2	0.0		0.0	0.3	0.0	0.3	0.1	0.1	0.4	0.7	0.1	11.6			0.1		0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	1.2	0.2	0.4	0.5	0.5	0.4	0.3	0.5	0.1	0.4	0.5	0.4	0.3	0.5	0.0	0.0	0.1	0.4	1.4	0.3	1.2	0.1	0.7	0.3	0.1	3.3	0.3	0.6	0.3	0.1	0.1	0.1	0.3	1.1	0.4	0.4	0.3	0.7	0.6	0.0	0.5	0.2	10.3	0.1	0.4	0.0	0.1	0.0	0.1	3.3	0.1	0.6	0.5	0.1	0.4	0.0	0.2	0.3	0.1	0.3	0.2	0.3	0.2	0.6	0.5	0.7	0.6	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.3	0.1	0.6	0.5	0.0	0.1	0.7	0.2	0.0	0.0	0.2	0.2	1.2	0.2											0.0	1.4	0.0	0.0	0.1	0.0	1.7	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	2.1	0.0	0.0	0.0	0.0	0.0
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.2"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 118.6;Suprabasal keratinocytes: 96.1;Urothelial cells: 169.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: AB_2682555, HPA067421: AB_2685836"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	4.7	4.4	20.7	4.1	22.0	2.3	4.4	10.2	37.2	5.4	2.9	10.2	1.5	5.3	6.4	5.6	13.5	7.5	4.4	4.7	13.4	5.6	4.4	6.7	6.5	3.4	12.3	16.3	8.9	3.1	3.1	6.1	4.1	9.4	6.8	2.2	3.1	6.5	5.7	6.8	20.6	4.6	3.0	18.9	4.1	3.2	5.5	9.9	4.3	3.8	3.4	3.6	5.5	7.9	1.0	1.5	1.6	3.9	0.4	1.3	0.7	4.0	5.1	10.3	7.4	3.5	2.7	4.3	4.3	3.5	4.5	3.3	4.1	2.4	1.0	2.7	3.8	6.6	3.9	2.0	13.9	1.5	0.1	1.6	0.4	2.9	10.0	3.1	0.3	5.7	2.3	9.5	2.3	3.2	4.1	9.9	3.6	4.7	0.2	4.1	3.4	0.7	10.8	4.9	2.3	4.9	10.2	4.0	3.3	2.3	12.0	11.7	12.0	2.7	1.9	9.1	2.6	4.7	6.9	7.4	8.8	5.8	1.8	4.6	5.1	4.0	2.3	5.1	6.0	6.2	1.0	1.2	0.3	0.9	3.9	0.3	0.2	0.8	0.5	1.5	1.0	1.3	0.5	1.6	0.4	3.7	0.8	0.6	0.7	20.7	22.0	10.2	37.2	13.4	5.6	12.3	16.3	9.4	9.9	6.0	8.3	0.5	118.6	75.0	19.0	7.5	15.3	29.4	20.5	5.2	27.5	5.3	3.3	9.0	3.8	21.1	5.1	0.0	9.2	1.0	10.0	34.2	13.9	22.7	19.8	9.5	14.3	25.8	6.1	4.2	13.8	19.0	16.9	5.4	9.9	38.9	11.1	0.0	7.4	18.1	18.7	0.0	8.8	20.2	14.9	96.1	5.6	4.5	8.0	169.4
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357837-177372601	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.9;brain: 76.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 61.1;Proximal tubular cells: 68.0;Suprabasal keratinocytes: 100.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 76.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.7;HMC-1: 36.4;NB-4: 16.0;RPMI-8226: 21.0"	"Group enriched"	"Detected in many"	11	"amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5"	"Low region specificity"	"Detected in all"			"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"		No	No			Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: AB_2679836, HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	1.9	1.5	7.7	12.5	76.1	17.5	1.3	0.4	8.8	1.7	2.6	1.9	0.6	5.1	1.3	1.4	3.2	6.6	3.4	0.7	17.1	1.9	2.1	6.9	4.3	15.5	2.5	3.6	0.8	1.5	0.1	0.9	1.0	0.8	1.2	0.5	0.7	5.2	1.8	1.6	3.5	5.7	1.2	0.7	12.8	3.7	0.7	4.4	24.2	4.3	1.7	12.9	4.9	1.6	9.2	12.2	43.9	12.3	6.5	20.7	12.4	1.9	0.4	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.2	1.2	3.8	4.8	2.7	0.0	0.4	3.9	0.0	1.2	0.0	40.7	0.1	7.5	0.1	1.5	0.2	5.8	36.4	0.6	0.3	0.2	0.2	0.0	0.2	5.5	1.3	9.8	0.0	0.1	7.8	16.0	0.6	1.9	1.0	3.6	0.0	21.0	0.4	0.1	0.1	0.7	0.0	0.1	3.0	0.0	1.3	9.2	0.3	0.0	0.7	0.0	3.5	5.2	2.5	2.1	0.6	11.0	0.9	18.6	12.3	43.9	20.5	11.4	20.7	9.2	19.1	18.7	12.2	8.0	16.0	14.3	43.0	6.5	11.6	5.4	18.2	12.4	7.7	76.1	0.4	8.8	17.1	1.9	2.5	3.6	0.8	4.4	6.0	4.1	20.7	25.0	61.1	0.4	1.6	40.8	14.7	4.5	10.4	2.0	3.2	26.6	10.5	0.5	6.0	7.5	0.0	14.4	8.2	5.3	12.3	24.3	55.7	21.0	0.0	4.6	7.4	13.7	0.8	2.6	16.9	20.3	0.0	5.3	8.0	12.8	14.4	2.1	68.0	1.9	0.0	5.1	0.0	15.1	100.6	2.7	40.0	3.3	13.7
RGS16	"A28-RGS14, RGS-r"	ENSG00000143333	"Regulator of G protein signaling 16"	O15492	1	182598623-182604408	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"thyroid gland: 67.5"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 519.8;Smooth muscle cells: 484.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.0;NB-4: 17.6;SCLC-21H: 33.4;U-266/70: 37.8;U-698: 47.2"	"Region enriched"	"Detected in many"	5	"thalamus: 87.4"	"Group enriched"	"Detected in many"	6	"midbrain: 92.1;pons and medulla: 72.2;thalamus: 126.3"	"HPA053250, HPA055824"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA053250: AB_2682090, HPA055824: AB_2682934"	"unprognostic (4.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.07e-3)"	"unprognostic (5.39e-2)"	17.8	7.5	4.5	18.6	9.8	3.0	5.2	3.3	9.9	2.4	6.4	20.7	7.2	2.3	2.6	3.7	4.5	8.0	10.8	3.6	7.4	12.3	6.7	6.8	13.3	10.8	12.0	1.3	2.9	4.3	6.0	28.1	7.9	16.5	3.7	4.1	9.1	3.3	40.8	5.2	3.0	3.5	8.0	25.0	6.1	5.1	1.2	10.7	0.3	67.5	16.2	4.9	6.1	4.2	5.8	11.5	2.2	0.9	3.4	5.4	1.4	0.2	0.0	1.9	0.0	0.3	0.0	14.8	0.0	0.5	0.0	0.0	0.0	0.1	32.0	0.1	0.0	0.0	0.1	3.5	0.3	0.0	3.6	2.6	3.3	0.3	0.0	0.5	5.3	2.9	0.7	5.4	0.0	0.2	0.0	0.0	1.1	0.1	5.6	0.0	3.5	0.1	17.6	10.3	0.2	1.0	0.0	10.6	7.6	0.0	1.5	33.4	3.5	0.0	2.7	0.0	2.0	1.1	4.2	0.0	0.1	0.7	0.9	1.6	37.8	1.7	47.2	0.1	3.4	1.7	2.2	0.4	0.7	0.4	0.5	0.8	5.8	5.4	0.6	0.6	2.3	2.5	0.8	1.4	3.4	0.9	11.5	3.2	1.4	4.5	9.8	3.3	9.9	7.4	12.3	12.0	1.3	16.5	10.7	125.0	148.7	13.4	6.7	73.2	519.8	16.5	0.0	4.0	31.8	8.7	17.7	6.1	0.0	1.6	0.4	67.1	1.3	23.3	2.0	125.4	54.3	12.1	72.5	1.0	15.6	30.2	48.3	25.8	3.7	0.0	0.3	13.9	77.6	20.8	3.8	129.8	2.8	0.9	0.4	0.3	30.5	64.7	484.2	0.0	1.5	55.2	28.8	5.7	1.9	9.0
RGS17	"RGS-17, RGSZ2"	ENSG00000091844	"Regulator of G protein signaling 17"	Q9UGC6	6	153004459-153131249	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 17.3;Ductal cells: 11.7;Intestinal endocrine cells: 40.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.9;GAMG: 11.0;hTERT-HME1: 14.0;LHCN-M2: 13.9;RH-30: 10.0;U-87 MG: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022276, HPA056493"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA022276: AB_10794628, HPA056493: AB_2683152"	"unprognostic (2.77e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.33e-2)"	"unprognostic (5.96e-12)"	"unprognostic (2.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	3.0	1.3	14.2	1.5	12.5	3.3	1.4	16.8	10.1	7.1	1.5	1.2	0.0	1.7	2.2	1.1	3.2	1.3	5.9	1.0	8.1	7.3	0.9	0.6	1.4	1.6	3.2	7.8	2.7	4.4	0.3	7.2	0.6	7.9	5.2	2.0	0.2	1.5	1.6	0.6	1.9	1.8	1.4	4.1	1.2	4.3	3.3	3.0	0.3	8.9	0.0	0.6	3.7	1.5	0.5	0.4	1.4	0.3	2.1	1.6	0.2	0.0	4.3	3.2	0.1	1.5	12.9	0.1	0.3	1.4	1.0	2.7	0.0	0.3	0.2	0.3	0.7	11.0	0.2	3.0	3.2	1.5	0.2	0.3	0.5	0.3	0.1	3.5	0.2	1.5	5.4	0.0	5.5	14.0	3.1	6.4	1.2	0.1	0.2	13.9	2.3	0.1	0.3	2.2	0.1	3.5	0.1	10.0	0.1	4.0	1.3	2.2	5.8	0.1	0.0	0.0	0.5	0.0	0.2	3.2	2.2	2.7	2.7	3.9	0.2	0.0	0.1	11.8	0.1	3.0	1.4	0.3	0.4	1.6	0.2	0.2	0.2	0.9	0.6	0.2	0.5	0.3	0.9	1.1	2.1	0.3	0.4	0.2	0.2	14.2	12.5	16.8	10.1	8.1	7.3	3.2	7.8	7.9	3.0	0.0	0.0	0.0	0.6	0.2	17.3	0.8	5.1	4.0	5.7	0.0	0.0	0.1	0.0	11.7	0.1	1.0	0.0	0.0	0.3	0.2	2.0	5.9	10.5	0.0	0.3	3.2	40.3	0.0	0.6	0.4	2.8	0.4	0.0	0.0	0.0	2.2	2.2	0.9	8.5	0.0	3.4	0.0	1.7	0.9	3.2	0.0	0.2	2.1	0.1	7.3
RGS18	RGS13	ENSG00000150681	"Regulator of G protein signaling 18"	Q9NS28	1	192158457-192185815	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 66.0;lymphoid tissue: 37.3"	"Cell type enhanced"	"Detected in some"	26	"granulocytes: 24.3;Kupffer cells: 118.0;Macrophages: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 66.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 66.0"	"Group enriched"	"Detected in some"	5	"HEL: 29.3;HL-60: 22.4;NB-4: 21.1;U-937: 19.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028727, HPA045780"	Uncertain		Approved	"Golgi apparatus"		NA	NA		380000	"Golgi apparatus"		"HPA028727: AB_2797219, HPA045780: AB_10962728"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.30e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.81e-4)"	"unprognostic (1.73e-2)"	"unprognostic (9.91e-2)"	3.9	1.9	4.8	11.4	4.6	9.9	1.8	0.9	3.1	2.0	2.2	1.0	0.0	2.3	1.1	2.3	2.0	2.2	4.5	7.5	3.6	2.5	2.7	4.2	16.1	23.0	4.9	0.8	1.6	1.2	0.0	1.2	3.8	4.2	1.8	2.3	0.6	1.6	0.8	0.9	0.9	4.8	2.3	9.2	37.3	1.4	1.3	4.4	3.0	1.3	0.4	3.5	4.6	1.3	0.0	9.8	66.0	14.9	0.1	1.3	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	27.4	9.8	66.0	0.1	12.9	1.3	0.0	0.1	0.2	9.8	0.0	0.0	0.0	32.4	0.1	14.9	2.3	0.0	16.4	4.8	4.6	0.9	3.1	3.6	2.5	4.9	0.8	4.2	4.4	6.0	0.0	2.2	0.0	0.2	0.0	0.4	0.0	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	24.3	0.4	7.6	0.0	0.0	0.6	118.0	0.2	0.3	42.4	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	12.9	0.0	0.1	0.2	0.1	0.1	7.1	0.0	0.0
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	Autophagy	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 95.0;bone marrow: 36.7;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 73.1;Hofbauer cells: 121.6;Kupffer cells: 93.5;Macrophages: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 49.8;NB-4: 39.2;THP-1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cell Junctions"	"Nucleoli fibrillar center"	"HPA056384: AB_2732602, HPA069984: AB_2732145"	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	7.0	4.8	6.0	19.0	7.5	36.7	12.7	2.5	5.0	3.3	3.5	6.8	1.9	5.5	2.9	2.9	4.4	4.1	4.5	5.1	5.4	4.9	4.0	7.2	10.4	27.2	9.1	2.6	2.7	3.9	0.8	2.6	5.6	5.7	3.9	1.8	2.2	6.1	2.2	1.6	4.3	10.6	3.2	7.1	43.1	5.7	2.8	7.2	15.2	3.7	1.2	19.5	6.1	3.6	17.3	29.9	95.0	55.5	9.1	13.8	22.0	4.9	7.5	2.1	3.9	0.9	1.6	3.7	3.1	2.2	6.5	2.7	11.1	6.8	8.7	8.7	1.9	6.9	4.8	2.2	4.0	1.5	4.2	4.1	12.4	3.8	4.5	1.3	25.2	49.8	1.1	2.4	2.7	0.9	1.3	4.2	5.8	4.7	4.6	1.9	8.8	18.6	39.2	2.2	4.2	9.6	15.7	1.3	6.2	1.8	2.4	4.1	3.9	3.2	2.0	4.1	1.1	2.6	33.3	4.4	6.1	3.1	1.0	3.0	2.9	2.2	10.5	3.4	19.3	4.0	33.1	35.5	95.0	13.4	50.4	13.8	17.3	12.7	12.7	29.9	17.1	8.9	9.2	79.6	9.1	55.5	17.1	13.5	22.0	6.0	7.5	2.5	5.0	5.4	4.9	9.1	2.6	5.7	7.2	3.0	5.5	73.1	4.9	8.7	0.0	2.2	0.0	2.7	4.5	1.8	0.0	2.6	0.0	10.2	0.3	15.2	0.0	23.3	12.7	7.2	6.4	7.3	47.4	0.6	121.6	0.0	0.0	12.3	93.5	0.4	4.0	101.1	5.0	24.4	0.5	0.5	12.8	3.4	1.1	1.7	0.0	12.9	7.2	0.2	6.8	7.9	1.5	48.0	0.8	7.5
RGS22	"CT145, DKFZP434I092, PRTD-NY2"	ENSG00000132554	"Regulator of G protein signaling 22"	Q8NE09	8	99960936-100131268	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 519.1;Late spermatids: 1277.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.0;HL-60: 3.2;HMC-1: 2.2;RPMI-8226: 4.2;SCLC-21H: 1.8;U-2 OS: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053026			Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Actin filaments, Cytosol"	"HPA053026: "	"unprognostic (3.04e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.47e-5)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.98e-5)"	"unprognostic (3.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.25e-3)"	"unprognostic (8.36e-4)"	2.8	1.0	1.8	0.3	2.5	0.3	1.0	0.4	1.4	2.0	0.5	3.4	2.0	0.2	2.9	6.8	0.5	8.5	1.2	0.7	2.6	1.7	0.4	0.3	3.9	0.5	0.9	1.6	6.5	0.6	0.2	10.9	0.6	9.0	2.3	0.3	0.9	0.4	2.2	0.4	0.7	0.5	1.5	1.7	0.3	0.5	43.3	1.3	0.0	0.5	0.0	0.5	0.8	0.8	0.6	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	3.2	2.2	1.2	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.6	0.4	0.0	0.3	0.3	1.3	4.2	0.5	0.3	1.8	0.2	0.0	0.0	0.0	0.9	0.3	0.8	0.0	0.0	2.8	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.1	1.8	2.5	0.4	1.4	2.6	1.7	0.9	1.6	9.0	1.3	0.0	0.0	0.0	0.0	1.9	1.3	0.6	0.0	91.0	21.6	0.0	0.0	0.1	0.0	0.0	519.1	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1277.1	121.7	0.5	0.0	0.0	0.0	9.3	0.0	0.0	59.1	0.0	0.2	0.0	0.9	64.9	7.4	1.8	0.7	0.0	0.0	0.0
RGS4	SCZD9	ENSG00000117152	"Regulator of G protein signaling 4"	P49798	1	163068775-163076802	"Disease related genes, Predicted intracellular proteins"		"Signal transduction inhibitor"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 88.0"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 10.1;Intestinal endocrine cells: 49.4;Muller glia cells: 14.1;Smooth muscle cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 91.6;LHCN-M2: 36.1;SH-SY5Y: 71.9;TIME: 146.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030802			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA030802: AB_10602295"	"unprognostic (1.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.02e-2)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.97e-4)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.30e-2)"	2.9	20.9	9.1	2.1	45.3	0.5	1.4	1.1	88.0	4.0	1.7	1.0	0.0	2.9	4.8	1.4	6.3	4.9	11.2	4.7	13.9	10.1	1.5	2.6	2.1	2.3	12.1	36.2	1.1	2.7	1.2	6.2	1.3	16.0	3.3	1.8	1.0	0.9	3.9	0.7	0.6	1.6	3.0	1.9	1.5	3.7	2.1	2.1	0.0	1.5	0.2	0.7	2.8	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	3.5	18.5	0.0	12.5	13.6	1.8	4.8	0.0	0.0	0.0	5.5	8.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.0	19.7	2.4	91.6	19.1	0.0	0.0	0.0	36.1	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	71.9	0.0	0.0	0.0	0.7	0.0	0.0	146.6	14.9	0.7	2.9	20.7	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.1	45.3	1.1	78.8	13.9	10.1	12.1	36.2	16.0	2.1	0.0	0.0	0.0	0.8	0.2	0.2	0.5	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	10.1	0.5	0.0	0.0	0.2	0.0	1.7	0.5	0.0	0.0	0.4	0.0	49.4	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	14.1	4.1	0.0	0.0	0.0	1.6	0.0	10.3	0.0	0.2	0.3	0.1	0.0	0.0	0.1
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775515-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.5;brain: 38.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 19.9;Horizontal cells: 58.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.2;HaCaT: 6.9;hTERT-HME1: 8.4;RH-30: 7.4;SH-SY5Y: 6.5;U-2 OS: 7.4;U-251 MG: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.7	11.5	9.1	0.8	18.3	0.7	0.9	27.6	38.1	0.9	0.8	1.6	1.7	1.0	1.0	0.8	0.9	0.7	1.3	0.7	11.5	8.3	4.2	0.8	0.9	1.1	3.6	8.9	1.3	1.4	0.7	2.8	0.7	4.7	0.8	0.9	1.3	0.7	1.4	0.7	0.9	0.9	0.7	1.4	1.0	4.6	7.8	1.8	0.0	0.7	0.0	1.0	0.7	0.1	0.7	3.6	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.9	0.0	2.7	5.3	7.2	0.5	0.0	0.0	0.0	0.4	3.7	4.0	6.9	0.0	0.1	3.6	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.4	0.5	0.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.9	0.3	0.2	0.0	7.4	0.0	0.0	0.0	6.0	6.5	0.4	0.3	0.3	0.2	0.0	0.0	2.8	0.0	7.4	0.4	8.0	0.0	4.3	0.0	1.1	0.0	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	9.1	18.3	27.6	20.7	11.5	8.3	3.6	8.9	4.7	1.8	0.0	0.0	0.8	0.0	0.0	19.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	58.8	6.9	0.6	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	2.0	0.0	0.0	6.4	9.3	0.0	0.0	0.0	0.0	0.0
RGS7BP	R7BP	ENSG00000186479	"Regulator of G protein signaling 7 binding protein"	Q6MZT1	5	64506257-64612312	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.1"	"Cell type enhanced"	"Detected in some"	14	"Ito cells: 20.3;Leydig cells: 6.6;Peritubular cells: 13.1;Sertoli cells: 6.5;Smooth muscle cells: 7.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039600	Approved		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039600: AB_2676591"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.81e-3)"	"unprognostic (1.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.50e-3)"	2.8	4.7	10.2	1.1	22.6	0.4	1.1	10.4	31.1	6.0	1.3	1.5	0.5	1.6	3.7	5.7	2.7	10.9	2.7	3.7	10.8	4.3	3.3	1.7	2.2	0.8	4.0	16.0	3.8	0.8	0.7	1.7	0.4	8.2	7.8	1.4	1.8	2.7	10.9	0.7	1.0	1.7	2.3	1.9	1.3	1.5	1.5	6.7	0.0	1.0	0.0	0.6	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	22.6	10.4	25.1	10.8	4.3	4.0	16.0	8.2	6.7	0.0	0.0	0.0	0.1	0.0	4.3	1.8	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	0.0	1.3	6.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	13.1	0.0	1.7	6.5	7.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"basal ganglia: 47.3"	"Group enriched"	"Detected in many"	6	"gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	74	"NK-cells: 3.7;T-cells: 11.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 23.2;HEL: 9.5"	"Region enriched"	"Detected in many"	9	"basal ganglia: 222.4"	"Region enriched"	"Detected in all"	9	"basal ganglia: 79.8"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: AB_2668943"	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	1.1	1.9	3.3	4.4	47.3	1.0	2.3	4.1	8.9	3.4	5.2	7.2	2.7	3.3	4.2	7.2	4.1	9.5	3.9	1.3	5.4	7.4	2.0	5.0	5.9	5.3	3.5	3.7	6.7	3.7	7.3	7.9	3.0	4.5	8.6	3.4	24.1	3.2	9.2	1.6	1.5	3.6	4.0	3.4	4.3	3.7	1.7	6.6	0.4	4.2	0.5	7.5	5.1	2.4	0.0	0.0	0.0	0.0	3.7	11.0	1.4	0.2	0.0	1.1	0.1	0.1	0.2	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.7	1.6	0.0	0.0	0.1	0.0	0.1	0.2	23.2	0.5	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.0	0.0	2.8	0.0	1.0	7.4	0.0	0.0	0.0	3.6	0.0	3.7	0.0	0.0	0.0	1.4	3.3	47.3	4.1	4.5	5.4	7.4	3.5	3.7	4.5	6.6	3.0	1.0	0.0	0.9	0.3	21.5	0.4	0.0	1.4	2.3	1.8	306.3	0.0	3.3	6.8	0.6	0.3	0.0	0.0	2.8	0.1	2.3	0.2	0.0	0.0	0.1	49.3	57.3	1.8	0.0	1.7	0.9	3.2	1.7	33.3	2.2	27.8	3.9	0.0	4.6	8.1	472.2	0.0	0.9	0.0	0.4	0.1	0.1	9.2	0.4	0.1
RGS9BP	"FLJ45744, PERRS, R9AP, RGS9"	ENSG00000186326	"Regulator of G protein signaling 9 binding protein"	Q6ZS82	19	32675407-32678300	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 38.3;skeletal muscle: 15.8"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 30.8;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 70.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 6.8"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;memory CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 10.7;HMC-1: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049791	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA049791: AB_2680884"	"unprognostic (2.82e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.20e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.34e-2)"	0.4	0.5	0.8	0.3	1.1	0.3	0.4	0.2	0.7	0.3	0.4	1.4	0.2	0.4	0.3	0.6	1.1	0.4	0.3	6.7	1.0	0.8	0.9	0.3	0.9	0.3	1.1	0.3	0.3	0.4	0.4	0.6	0.4	6.8	1.3	0.3	38.3	0.5	0.6	15.8	0.6	0.3	7.4	1.3	0.4	0.4	0.9	0.9	0.1	0.4	4.3	0.3	2.3	1.0	0.0	0.3	0.0	0.9	0.5	1.5	0.0	0.2	0.2	0.0	0.9	0.5	0.2	0.5	0.0	0.5	0.4	0.2	0.2	0.3	0.4	0.5	0.1	0.5	0.1	1.8	0.1	0.1	0.5	0.2	10.7	0.3	0.0	0.2	0.3	2.8	0.0	0.5	0.0	0.4	0.2	0.0	0.1	0.9	1.5	0.2	0.5	0.0	1.7	0.0	0.1	2.0	0.2	0.4	0.2	0.0	0.1	0.4	0.1	0.0	1.1	0.1	0.0	1.1	0.5	0.0	0.5	0.7	0.2	0.3	0.6	0.7	0.1	0.3	0.6	0.8	0.0	0.3	0.0	1.4	0.9	0.0	0.0	0.2	1.5	0.3	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.8	1.1	0.2	0.7	1.0	0.8	1.1	0.3	6.8	0.9	0.0	0.0	0.0	0.1	0.0	30.8	3.9	0.0	0.0	0.0	1.8	53.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.6	0.0	0.6	0.8	0.9	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.4	70.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605158-49636884	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 54.1"	"Cell type enriched"	"Detected in some"	50	"Erythroid cells: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"HEL: 87.8;K-562: 86.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				1.2	0.2	0.0	1.1	0.5	54.1	3.2	0.0	0.1	2.3	1.0	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0.0	0.0	0.1	0.7	3.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0.0	0.2	0.5	0.4	0.1	0.9	0.1	0.0	4.5	0.6	0.2	0.0	1.7	1.8	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	116.8	0.2	0.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RHBDD3	"C22orf3, PTAG"	ENSG00000100263	"Rhomboid domain containing 3"	Q9Y3P4	22	29259852-29268209	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043979	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA043979: AB_10960539"	"unprognostic (9.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.67e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.11e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.42e-3)"	9.6	16.2	9.0	6.8	10.0	7.9	4.9	13.0	10.1	6.7	7.9	8.1	15.8	14.0	8.8	12.7	6.2	9.0	8.2	7.3	8.9	10.3	7.7	16.4	5.6	8.6	9.2	6.7	6.2	15.4	5.5	11.7	10.9	8.9	11.5	2.7	11.4	10.9	14.2	12.1	7.6	9.7	5.3	8.7	8.2	8.4	17.6	6.9	7.1	8.9	3.5	4.5	5.3	4.1	2.4	13.2	2.2	5.7	3.8	4.7	3.1	3.1	5.3	3.1	8.9	1.0	1.7	17.3	2.0	2.8	2.6	3.2	4.7	7.2	9.0	9.0	2.0	1.5	10.0	1.8	1.6	0.3	11.5	14.4	3.2	4.2	6.0	11.2	7.3	8.3	4.8	4.5	1.1	3.1	1.8	3.5	3.7	3.8	5.9	1.8	6.4	4.6	11.0	14.1	2.0	6.2	8.2	5.6	10.1	1.1	3.3	6.7	3.5	7.1	7.5	8.2	0.8	5.0	6.1	4.9	7.0	3.1	2.9	3.0	14.7	4.4	10.4	2.9	3.1	5.8	0.0	5.7	2.2	3.2	4.7	3.8	2.4	3.1	4.7	5.6	1.3	2.4	3.3	1.8	3.8	4.5	13.2	4.6	3.1	9.0	10.0	13.0	10.1	8.9	10.3	9.2	6.7	8.9	6.9	6.0	6.5	0.0	9.0	5.5	17.8	7.9	12.7	6.7	4.5	14.0	5.9	37.5	0.0	14.8	6.6	7.4	21.0	0.0	17.4	15.1	14.2	14.3	0.0	13.9	22.3	15.9	8.1	16.0	11.4	5.6	13.0	6.6	6.8	10.8	10.2	13.3	12.1	17.3	11.3	5.7	21.4	6.5	7.2	26.8	25.8	5.3	32.0	7.2	14.5	8.0
RHBDL1	"RHBDL, RRP"	ENSG00000103269	"Rhomboid like 1"	O75783	16	675666-678268	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 12.0;Cone photoreceptor cells: 11.8;Horizontal cells: 14.3;Rod photoreceptor cells: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 3.4"	"Group enriched"	"Detected in many"	20	"B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 9.3;MCF7: 9.8;U-266/70: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030359, HPA030360, HPA046593"	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711"	"prognostic favorable (8.12e-4)"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.63e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.49e-2)"	1.7	6.3	10.0	1.1	8.3	2.3	0.7	21.3	14.5	1.3	2.2	1.3	2.2	5.8	1.3	1.7	1.1	1.0	1.2	2.4	8.4	9.9	3.9	1.2	0.8	1.1	5.5	7.2	0.9	6.2	2.2	4.4	1.1	4.6	1.5	1.1	1.5	6.1	2.6	0.8	3.1	5.9	0.7	2.2	0.6	4.5	2.2	1.9	0.7	0.6	0.6	0.5	0.8	0.5	2.2	0.1	0.0	0.0	1.3	3.4	0.7	1.8	2.3	1.3	2.0	1.0	2.7	6.9	0.8	1.3	0.4	0.1	4.8	1.3	0.7	1.6	0.5	0.2	1.2	0.1	0.4	0.0	1.7	8.7	1.0	9.3	1.9	1.0	1.7	1.3	1.8	3.3	0.3	0.0	1.0	0.1	3.1	1.3	1.3	0.1	9.8	0.4	4.7	1.3	2.5	0.7	8.3	1.2	1.8	0.1	1.6	1.7	2.3	1.0	0.5	2.2	0.9	3.6	4.9	0.5	2.8	2.6	0.9	0.6	11.9	1.6	2.3	1.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	0.3	0.0	0.5	0.5	0.2	0.0	1.3	0.0	0.1	1.2	0.7	10.0	8.3	21.3	14.5	8.4	9.9	5.5	7.2	4.6	1.9	0.0	0.0	0.0	4.2	1.9	12.0	0.8	0.0	8.1	1.2	0.0	11.8	0.2	0.0	0.7	2.0	0.0	3.9	0.0	0.5	0.2	0.9	1.4	0.0	0.8	0.3	14.3	2.4	0.6	1.2	1.1	1.4	0.0	0.0	0.0	4.5	2.0	1.0	3.6	2.5	7.4	35.2	0.0	0.5	0.7	2.1	1.6	0.2	0.0	4.7	1.6
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein (gene/pseudogene)"	Q9H310	1	156369212-156385219	"Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 23.2;kidney: 16.9;ovary: 5.9"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in some"	15	"cerebellum: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0"					"Low region specificity"	"Detected in all"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	23.2	0.1	0.3	0.3	0.0	1.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.1	0.1	16.9	3.3	0.1	0.0	0.1	0.1	5.9	0.2	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.4	0.1	1.0	0.3	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	1.1	1.2	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.2	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	21.0	0.0	0.0	16.6	0.3	10.7	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	4.3	0.1	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	1.0	0.0	1.1	0.1	0.0	0.4	0.9	0.0	0.0	0.0	2.2	0.4	0.4	0.0	0.0	0.0	0.0
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.0;bone marrow: 16.5;salivary gland: 7.1"	"Cell type enriched"	"Detected in some"	20	"Erythroid cells: 23.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.0"	"Group enriched"	"Detected in some"	6	"HEL: 28.2;K-562: 8.7"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.3	0.3	0.3	0.5	0.5	16.5	0.3	1.5	1.4	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.4	0.9	0.3	0.2	0.3	0.3	2.5	0.8	0.3	0.3	0.9	0.3	0.1	0.4	0.3	1.1	0.5	0.0	0.3	7.1	0.3	4.1	2.5	0.4	0.3	0.4	1.8	0.3	0.5	0.3	0.3	0.4	2.3	0.3	0.3	0.3	2.0	0.6	10.0	1.4	1.4	1.4	1.2	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	28.2	0.7	0.2	0.0	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	8.7	0.7	0.0	0.1	0.2	0.2	3.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.2	0.1	0.1	0.2	0.5	0.4	0.5	0.2	0.4	0.1	0.3	0.1	0.1	0.5	0.2	0.1	4.9	1.4	2.8	1.0	0.6	1.1	1.3	1.3	0.8	0.2	2.0	1.4	1.3	10.0	1.4	0.8	0.6	0.9	1.2	0.3	0.5	1.5	1.4	0.3	0.2	0.3	0.3	1.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	23.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.9;skeletal muscle: 63.5"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 127.6;Horizontal cells: 316.2;Syncytiotrophoblasts: 252.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;NK-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.6	9.8	2.7	2.0	5.8	0.5	4.5	0.8	5.0	8.8	4.7	7.2	16.5	3.4	10.2	4.9	1.9	6.8	6.3	6.6	3.7	2.5	20.5	3.4	5.4	1.4	6.7	2.3	6.9	6.0	7.4	2.2	50.9	4.6	4.9	2.6	13.3	1.4	20.3	63.5	1.9	3.5	7.7	3.8	7.4	11.7	8.5	5.7	0.6	2.3	5.2	0.9	5.0	5.2	0.5	1.6	0.7	0.6	1.3	0.0	1.3	0.1	6.2	9.5	0.0	4.5	4.0	0.0	2.7	2.5	2.3	3.5	0.3	0.1	0.0	11.7	14.5	1.1	0.1	2.8	0.8	2.7	0.0	2.5	0.5	4.5	34.5	4.9	0.7	0.2	5.7	1.6	1.4	1.4	8.8	10.8	2.0	5.1	0.0	10.1	0.2	2.6	0.0	4.1	0.1	4.1	2.3	13.3	3.2	7.5	0.3	2.6	10.2	3.3	3.6	3.6	6.2	0.7	1.2	9.6	4.4	11.7	0.1	3.0	0.0	0.0	0.0	2.2	2.0	2.4	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.7	1.3	0.6	0.0	0.0	1.3	2.7	5.8	0.8	5.0	3.7	2.5	6.7	2.3	4.6	5.7	14.9	8.3	0.0	0.8	1.5	2.7	24.9	2.5	12.0	3.4	1.8	127.6	49.5	1.7	3.2	49.1	7.1	0.6	0.0	13.6	3.6	9.0	1.0	0.0	1.8	10.1	316.2	7.9	16.5	12.3	26.5	7.5	3.2	1.7	0.0	6.7	20.9	14.1	3.4	4.6	30.1	26.0	6.5	4.1	1.6	1.0	1.3	252.8	0.0	2.3	0.2
RHOBTB2	"DBC2, KIAA0717"	ENSG00000008853	"Rho related BTB domain containing 2"	Q9BYZ6	8	22987417-23020199	"Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 59.6;Alveolar cells type 2: 57.6;Bipolar cells: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 31.8;hTCEpi: 28.3;RT4: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060938	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA060938: AB_2684391"	"unprognostic (2.67e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.43e-1)"	5.9	7.4	14.8	6.4	33.2	2.0	5.3	5.1	36.9	4.4	8.1	7.2	24.4	7.7	6.3	5.2	4.6	6.6	6.0	17.6	14.0	9.1	6.0	1.9	31.0	12.2	9.8	14.4	15.9	7.2	5.8	9.0	10.0	8.0	5.7	2.5	11.2	5.6	22.6	10.9	3.5	19.7	6.1	4.0	10.4	6.9	7.0	6.5	5.5	14.9	2.8	14.5	13.7	3.4	7.8	2.9	4.5	1.6	4.4	2.8	1.1	2.5	4.9	4.0	6.4	4.9	3.4	5.4	3.5	4.6	5.5	4.1	12.7	2.5	31.8	5.3	5.0	7.1	5.0	1.9	19.5	2.6	2.7	1.1	3.4	6.7	3.5	2.3	2.0	7.1	4.4	28.3	5.7	2.9	3.8	3.9	2.3	0.8	3.1	3.6	7.3	1.3	3.2	4.2	7.3	3.5	1.7	6.4	2.1	3.9	47.6	2.6	4.8	2.6	8.1	5.3	3.1	1.5	5.2	4.8	6.9	5.0	12.3	3.9	8.0	7.7	11.4	6.7	2.9	5.3	4.5	1.0	1.3	2.8	1.6	1.9	7.8	0.8	1.3	1.0	7.1	1.1	1.1	0.2	4.4	1.6	2.9	1.4	1.1	14.8	33.2	5.1	36.9	14.0	9.1	9.8	14.4	8.0	6.5	59.6	57.6	5.2	2.3	2.6	30.1	10.1	5.1	4.0	14.8	7.0	3.9	12.8	1.7	1.5	0.5	4.0	0.7	0.0	3.3	6.5	4.6	1.0	4.6	0.8	12.1	15.9	5.8	8.0	2.2	0.2	5.8	4.3	1.7	1.0	3.4	6.0	3.5	0.2	6.0	3.7	5.8	0.0	3.7	0.9	1.7	0.5	4.7	2.2	0.4	0.6
RHOF	"ARHF, FLJ20247, RIF"	ENSG00000139725	"Ras homolog family member F, filopodia associated"	Q9HBH0	12	121777754-121803403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 150.8;monocytes: 394.1;Pancreatic endocrine cells: 113.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;HDLM-2: 52.6;PC-3: 36.9;RPTEC TERT1: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045912, HPA076019"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		58000	"Nucleoplasm, Golgi apparatus"		"HPA045912: , HPA076019: AB_2732299"	"unprognostic (1.26e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-5)"	"unprognostic (1.38e-3)"	"unprognostic (2.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.14e-1)"	5.0	13.8	13.3	19.2	15.6	29.3	5.8	53.2	19.3	16.5	17.8	8.9	15.9	24.7	12.7	17.5	13.7	10.9	10.3	13.5	13.8	9.8	16.4	6.9	18.7	28.6	20.2	8.7	8.8	7.5	9.1	14.7	4.7	14.2	8.3	14.1	12.4	9.6	12.1	8.5	7.3	26.5	9.9	11.2	28.4	20.9	9.0	18.9	27.2	18.3	6.2	24.4	14.2	10.2	17.4	24.2	13.4	21.0	18.5	32.9	13.6	16.4	19.1	3.6	4.2	1.2	1.9	1.6	1.7	1.5	0.7	1.3	7.7	37.5	1.6	12.7	1.7	0.4	2.3	6.3	9.8	0.6	52.6	2.1	8.8	12.9	7.2	2.9	9.8	7.3	2.5	2.1	1.6	0.8	6.4	5.0	12.4	1.5	2.7	0.4	10.5	13.7	14.8	3.0	3.8	36.9	7.2	0.2	2.9	29.8	1.4	2.9	2.4	9.9	1.3	0.7	1.6	5.6	4.3	6.1	1.2	11.4	3.6	0.4	3.8	1.9	5.0	1.5	11.2	0.7	6.2	3.5	13.4	32.9	11.1	31.0	17.4	26.0	28.1	10.9	14.8	20.1	24.5	7.7	18.5	21.0	24.2	27.3	13.6	13.3	15.6	53.2	19.3	13.8	9.8	20.2	8.7	14.2	18.9	35.7	12.5	61.8	1.6	7.7	7.4	1.2	20.4	13.4	12.5	22.7	0.0	1.7	34.9	38.6	18.0	2.0	150.8	0.0	50.1	3.3	7.8	3.4	19.7	4.0	13.6	0.0	6.4	12.3	10.0	46.1	3.7	30.7	20.3	394.1	21.3	4.0	113.8	31.6	2.1	12.4	9.1	6.5	2.2	20.9	2.6	11.5	4.6	105.8	7.6	6.4
RHOH	"ARHH, RhoH, TTF"	ENSG00000168421	"Ras homolog family member H"	Q15669	4	40191053-40246967	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.8;lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	5	"B-cells: 118.6;granulocytes: 136.5;Melanocytes: 54.0;T-cells: 125.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 34.9;HMC-1: 26.8;JURKAT: 35.1;MOLT-4: 48.5;U-266/70: 18.8;U-266/84: 15.1;U-698: 32.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030345, HPA061314"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA030345: AB_10601607, HPA061314: "	"unprognostic (4.00e-2)"	"unprognostic (1.83e-4)"	"unprognostic (1.24e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.31e-6)"	"unprognostic (2.96e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.44e-2)"	1.8	0.6	0.6	33.8	1.1	21.7	5.2	0.4	0.4	1.3	2.4	0.5	0.4	1.6	2.0	0.9	2.5	1.5	4.1	1.1	0.6	0.7	1.6	1.7	4.8	43.2	0.8	0.2	0.7	0.8	0.0	0.9	0.3	0.8	2.1	2.0	1.0	7.8	0.6	0.5	1.2	15.1	0.7	1.2	33.1	2.7	0.7	0.6	94.7	1.6	1.9	41.0	5.1	1.5	41.2	4.7	32.2	0.2	12.3	54.8	21.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.2	0.0	0.0	0.0	5.7	26.8	0.4	0.0	0.0	0.0	0.0	0.0	35.1	0.4	0.3	0.0	0.0	48.5	3.6	0.6	0.0	0.1	5.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.1	0.1	0.0	0.1	0.0	0.0	18.8	15.1	32.2	0.0	1.2	0.0	32.2	0.2	29.6	21.6	0.1	19.4	30.5	34.6	29.1	0.3	41.2	54.8	43.3	1.6	12.3	0.2	4.7	47.0	21.1	0.6	1.1	0.4	0.4	0.6	0.7	0.8	0.2	0.8	0.6	3.0	16.4	118.6	1.4	6.4	0.0	0.8	2.5	1.4	4.5	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.0	23.3	0.0	0.1	4.1	1.1	136.5	0.0	2.2	0.0	0.0	1.8	4.6	0.0	0.0	12.1	54.0	10.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	6.0	0.2	125.8	0.0	1.8
RHOJ	"ARHJ, FLJ14445, RASL7B, TCL"	ENSG00000126785	"Ras homolog family member J"	Q9H4E5	14	63204114-63293219	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	18	"Endothelial cells: 65.7;Ito cells: 34.4;Peritubular cells: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 15.6;HUVEC TERT2: 90.5;TIME: 24.0;WM-115: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003050	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003050: AB_1079812"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (3.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-3)"	17.0	2.9	11.4	6.4	12.0	0.2	14.3	7.3	15.8	15.1	12.0	3.4	7.9	5.8	22.8	14.7	12.4	15.6	20.0	13.0	11.3	4.6	7.3	4.0	18.6	7.0	8.0	9.8	11.9	3.6	3.3	6.5	7.3	6.8	15.9	8.8	14.8	7.2	11.8	5.8	6.0	8.4	25.3	5.4	9.4	9.4	4.7	8.5	0.0	13.1	13.9	3.9	16.9	9.2	1.2	0.9	2.6	0.8	1.4	0.6	0.1	0.0	0.0	15.6	0.0	0.0	0.0	0.0	2.5	10.5	0.9	1.5	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	8.9	90.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	24.0	0.0	0.2	0.2	1.4	0.0	0.0	0.0	0.0	0.0	26.0	1.0	0.8	0.6	0.5	0.4	0.3	0.7	0.4	0.4	0.2	1.2	0.6	0.6	2.6	1.4	0.2	0.9	0.2	0.1	11.4	12.0	7.3	15.8	11.3	4.6	8.0	9.8	6.8	8.5	0.0	2.2	0.0	0.2	5.3	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.4	0.4	65.7	0.0	0.0	0.7	0.0	11.6	0.5	0.0	0.0	0.1	0.0	0.0	34.4	1.0	0.5	10.9	1.7	3.3	0.0	0.0	9.1	0.1	0.0	15.2	0.0	0.2	6.5	8.0	0.1	0.4	4.3	0.1	0.0	0.0	0.5
RHOQ	"ARHQ, RASL7A, TC10"	ENSG00000119729	"Ras homolog family member Q"	P17081	2	46541806-46583121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 155.1;Horizontal cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 63.1;ASC TERT1: 49.4;SK-MEL-30: 53.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044938			Approved	Vesicles,Cytosol		No	No			"Vesicles, Cytosol"		"HPA044938: AB_2679149"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (2.01e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.52e-2)"	43.3	13.1	20.9	14.1	19.4	4.9	16.7	6.5	15.1	16.4	16.6	12.7	11.7	4.9	15.5	32.9	9.8	13.8	15.0	65.2	16.8	13.0	13.9	6.0	14.2	10.0	19.5	14.9	16.0	12.9	20.4	8.2	13.8	20.4	14.6	6.9	16.0	9.6	19.2	63.8	7.2	8.9	19.3	15.4	13.2	9.3	6.3	13.4	8.0	18.0	17.2	9.1	17.7	12.1	3.9	2.9	8.9	4.8	0.7	0.8	1.3	4.2	4.4	7.3	10.2	63.1	49.4	1.0	12.1	30.6	5.9	9.3	2.1	1.3	10.3	13.2	21.4	20.5	1.7	7.6	3.6	10.8	3.5	5.2	2.4	3.3	7.1	30.9	3.0	3.7	43.7	6.2	7.8	8.4	14.5	7.0	0.9	4.1	17.1	12.7	2.9	2.4	5.5	7.6	3.1	5.5	1.6	13.3	3.5	8.0	8.2	5.8	18.9	4.4	6.0	53.6	12.7	3.3	7.1	4.8	19.3	18.1	18.9	4.9	17.6	6.3	10.8	28.2	7.6	6.8	2.7	4.6	7.8	0.7	4.8	0.6	3.4	0.4	0.8	2.9	3.9	0.1	0.6	8.9	0.7	3.4	1.3	0.6	1.3	20.9	19.4	6.5	15.1	16.8	13.0	19.5	14.9	20.4	13.4	53.6	21.9	25.1	25.9	19.9	21.3	155.1	17.8	13.4	21.6	19.2	9.8	9.5	14.9	18.9	11.1	26.2	0.1	0.0	27.2	2.8	51.4	36.9	11.5	9.0	39.2	114.4	5.8	18.4	69.5	9.0	32.8	63.6	40.5	19.0	2.2	43.0	24.6	0.0	40.0	23.0	22.3	45.3	57.7	1.7	2.9	17.2	21.6	14.4	0.9	26.7
RHOXF2	"CT107, PEPP-2, PEPP2, THG1"	ENSG00000131721	"Rhox homeobox family member 2"	Q9BQY4	X	120158561-120165630	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 23.0"	"Group enriched"	"Detected in some"	60	"Spermatocytes: 5.2;Spermatogonia: 6.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 10.1;K-562: 62.2;NB-4: 46.0;THP-1: 17.3;U-266/84: 27.6"									"HPA003314, CAB020794"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB020794: , HPA003314: AB_1855193"					"unprognostic (1.60e-1)"										"unprognostic (5.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	1.0	0.5	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.2	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.2	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	1.0	0.3	0.4	0.4	0.4	0.4	0.2	0.3	0.2	0.2	0.3	0.3	0.4	0.7	1.1	0.5	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	6.8	0.0	0.0	0.0	0.0	0.0
RHOXF2B		ENSG00000203989	"Rhox homeobox family member 2B"	P0C7M4	X	120070672-120077705	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"blood: 2.6;testis: 9.4"	"Cell type enriched"	"Detected in single"	20	"Spermatogonia: 2.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	348	"HL-60: 47.1;K-562: 47.2;NB-4: 76.4"									HPA003314	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA003314: AB_1855193"																		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.2	0.0	9.4			0.0		0.0	0.0	0.0	1.0	1.6	2.6	1.3	1.7	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	76.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.7	0.8	0.5	0.9	1.0	0.7	0.5	0.7	0.7	1.0	0.7	0.7	1.4	1.7	1.3	1.6	0.5	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0
RHPN1	"KIAA1929, ODF5, RHPN"	ENSG00000158106	"Rhophilin Rho GTPase binding protein 1"	Q8TCX5	8	143368887-143384220	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 22.7;Collecting duct cells: 36.6;Cone photoreceptor cells: 29.5;Rod photoreceptor cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 17.0;MOLT-4: 15.3;RPMI-8226: 11.3;T-47d: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024288, HPA024671"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024288: AB_1856274, HPA024671: AB_1856275"	"unprognostic (2.04e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.12e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-2)"	3.3	3.2	17.9	3.6	11.9	5.9	4.0	2.5	14.3	5.7	2.6	10.8	6.2	1.2	1.1	6.2	1.9	8.0	3.7	1.3	19.4	9.7	9.7	0.9	4.0	4.0	9.0	9.4	0.8	7.8	10.3	14.8	1.4	10.9	3.2	1.3	2.0	6.6	7.2	0.8	5.3	1.9	1.7	8.3	5.6	5.2	2.7	14.1	15.4	14.9	0.5	2.5	2.4	1.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	1.7	3.0	0.7	2.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	1.2	0.1	6.1	0.0	0.1	0.7	0.0	0.0	0.0	0.3	2.7	0.0	1.9	0.1	0.2	0.1	1.9	0.0	0.5	0.0	0.0	0.5	0.6	7.2	0.6	3.7	0.0	17.0	15.3	1.5	1.1	3.5	8.3	4.2	0.0	11.3	2.8	2.8	4.5	1.7	0.9	5.1	1.0	0.0	27.7	0.0	0.0	0.0	3.2	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.3	0.3	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	11.9	2.5	12.7	19.4	9.7	9.0	9.4	10.9	14.1	6.0	6.9	0.8	2.4	2.3	2.5	0.8	5.1	22.7	4.5	36.6	29.5	1.3	10.0	8.7	4.3	3.6	0.0	0.0	2.4	0.2	1.1	3.3	0.0	0.8	2.8	6.4	21.8	2.5	2.2	7.2	0.3	1.1	6.8	1.8	2.3	11.4	3.3	0.0	1.4	12.9	23.5	0.0	0.7	6.0	7.3	1.3	1.6	3.2	3.0	2.6
RIBC1	FLJ32783	ENSG00000158423	"RIB43A domain with coiled-coils 1"	Q8N443	X	53422690-53431120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 12.7;fallopian tube: 24.5;testis: 37.6"	"Cell type enhanced"	"Detected in many"	26	"Ciliated cells: 92.3;Early spermatids: 217.1;Late spermatids: 387.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 8.4;T-47d: 11.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001150			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA001150: AB_2666211"	"unprognostic (1.08e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.39e-3)"	"unprognostic (9.88e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	0.6	2.9	2.0	1.3	3.7	0.4	1.3	0.5	1.4	1.8	0.7	5.3	0.8	0.7	2.1	5.4	1.1	24.5	1.4	1.1	2.5	3.0	2.3	0.3	2.9	0.6	1.3	1.4	5.5	1.6	1.9	5.0	0.5	12.7	1.1	0.4	2.4	1.9	1.5	0.5	1.0	0.7	0.5	1.4	0.6	0.7	37.6	1.2	0.3	3.1	0.2	0.5	0.8	0.5	1.5	1.0	2.9	1.5	3.7	2.3	1.1	1.9	5.2	2.0	1.4	0.7	1.3	1.2	0.5	0.3	1.1	1.0	2.0	3.1	1.9	3.5	0.2	3.5	3.6	0.5	1.1	1.5	1.1	3.3	1.1	8.4	0.9	0.3	1.1	2.0	0.4	0.4	3.1	0.7	2.6	0.9	1.5	0.8	2.3	0.7	1.3	2.2	1.0	2.5	0.9	1.4	1.6	1.4	1.5	3.0	1.0	4.5	0.8	5.1	1.9	1.2	6.5	11.6	0.5	0.6	0.5	2.6	1.5	0.7	2.4	1.6	1.1	2.1	0.4	0.9	0.0	0.7	0.0	0.3	1.2	2.3	0.2	0.9	1.9	1.0	1.5	0.4	0.4	2.9	3.7	1.5	0.8	1.9	1.1	2.0	3.7	0.5	1.4	2.5	3.0	1.3	1.4	12.7	1.2	0.0	0.3	0.0	1.4	1.1	2.3	0.8	2.5	92.3	7.9	0.0	3.9	0.5	1.7	1.1	217.1	0.6	0.0	0.0	0.2	0.3	0.6	0.7	2.3	0.5	0.1	1.6	1.2	0.0	0.3	387.5	2.3	0.4	1.7	0.0	0.0	2.6	0.5	0.0	1.8	5.0	9.1	0.0	0.2	10.9	6.1	0.6	0.3	0.0	0.2	0.5
RIC8A	"synembryn, synembryn-A"	ENSG00000177963	"RIC8 guanine nucleotide exchange factor A"	Q9NPQ8	11	207511-215113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041491, CAB046012"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB046012: AB_11129402, HPA041491: AB_2677510"	"unprognostic (3.93e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.13e-3)"	"unprognostic (8.70e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.63e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.60e-1)"	30.9	30.2	31.4	27.1	35.4	28.8	27.5	27.8	51.7	29.3	31.4	25.9	32.5	24.1	35.8	36.6	36.5	35.4	33.2	31.9	27.0	25.5	33.9	39.5	28.4	28.7	23.8	30.0	35.1	38.0	34.9	30.2	43.7	27.4	29.8	26.1	33.2	29.4	36.1	22.5	32.2	35.1	41.3	21.2	32.5	28.4	40.3	18.6	43.9	33.2	24.9	33.3	33.3	27.3	31.3	20.7	40.2	26.6	31.9	40.1	37.2	51.4	25.1	20.4	20.3	28.1	23.2	14.2	37.3	30.1	51.1	35.5	21.6	36.6	20.6	15.6	56.4	38.8	28.0	23.2	39.5	28.6	24.8	23.2	11.6	17.8	19.9	22.7	19.3	38.8	25.3	35.0	31.6	28.7	26.4	25.0	22.0	19.8	20.1	39.1	20.8	23.0	15.4	18.6	21.9	31.2	21.7	20.2	14.0	29.6	13.6	21.3	19.2	28.9	32.7	19.9	20.6	23.1	15.6	28.0	33.9	29.9	12.4	34.6	22.3	33.0	19.8	33.4	17.6	25.3	27.5	19.7	40.2	40.1	23.0	39.3	31.3	35.9	34.6	20.7	27.2	31.1	31.4	28.8	31.9	26.6	17.0	29.8	37.2	31.4	35.4	27.8	51.7	27.0	25.5	23.8	30.0	27.4	18.6	14.9	19.7	27.6	17.9	15.8	27.4	23.6	22.9	14.7	18.2	24.4	9.8	34.7	23.2	48.4	11.7	22.4	23.8	23.3	38.3	50.5	25.4	17.7	17.3	14.7	40.7	30.2	19.4	23.4	24.1	12.3	28.4	15.8	27.0	47.7	15.8	41.3	55.2	21.0	37.4	18.6	28.2	19.4	27.4	85.8	53.0	16.9	27.1	34.1	21.0	14.8
RIC8B	"FLJ10620, hSyn, RIC8"	ENSG00000111785	"RIC8 guanine nucleotide exchange factor B"	Q9NVN3	12	106774595-106889316	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039970, HPA042746"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039970: , HPA042746: AB_2678143"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.87e-3)"	"unprognostic (5.43e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	7.4	6.4	10.9	6.0	32.3	1.7	6.1	13.0	12.7	8.0	6.3	5.1	11.5	4.3	7.9	6.4	4.6	8.2	8.1	9.9	6.6	7.5	10.5	6.9	5.3	3.3	6.5	6.7	8.7	6.2	20.4	13.1	5.3	8.2	6.6	5.6	7.5	4.2	12.5	8.3	3.1	4.2	9.4	5.8	5.4	4.4	5.1	17.2	8.7	13.4	0.9	4.1	5.9	7.2	1.1	3.6	3.3	4.0	2.4	6.0	2.8	2.8	8.9	16.9	6.8	8.1	10.2	2.0	9.6	7.6	8.7	8.0	2.9	2.3	1.7	6.6	5.7	3.4	5.0	6.8	3.8	10.3	20.1	8.4	6.2	4.6	3.9	6.8	6.5	4.4	5.7	4.2	6.2	2.9	10.1	7.9	6.3	3.6	0.1	7.6	2.3	6.3	5.9	8.6	4.5	9.0	5.6	9.9	5.6	7.1	3.3	12.4	8.0	6.7	4.3	5.0	6.7	3.8	4.7	7.6	6.9	3.8	4.6	6.6	5.1	10.6	0.1	3.3	3.9	10.2	2.3	4.0	3.3	5.1	2.0	6.0	1.1	2.9	2.6	3.6	0.6	2.2	2.3	1.7	2.4	1.8	2.2	3.1	2.8	10.9	32.3	13.0	12.7	6.6	7.5	6.5	6.7	8.2	17.2	6.0	5.6	3.9	3.8	3.0	12.6	27.4	20.4	10.7	5.7	3.5	9.8	5.8	6.6	17.9	4.6	10.0	6.2	0.0	3.5	3.1	6.5	1.8	8.1	7.3	3.1	6.4	17.9	16.5	7.1	4.0	11.8	4.7	6.8	1.0	7.2	5.7	5.5	3.5	18.0	5.9	42.2	12.9	7.2	16.2	9.2	2.5	1.1	7.5	6.2	1.0
RICTOR	"AVO3, KIAA1999, MGC39830, PIA"	ENSG00000164327	"RPTOR independent companion of MTOR complex 2"	Q6R327	5	38937919-39074408	"Predicted intracellular proteins"	"Host-virus interaction"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 192.4;Rod photoreceptor cells: 174.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 22.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 22.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037802, HPA037803"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA037802: AB_10672286, HPA037803: AB_2675676"	"unprognostic (2.25e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-2)"	15.4	10.0	12.4	14.2	15.7	35.5	16.4	25.6	20.1	14.7	12.7	18.8	9.8	9.4	17.7	12.7	10.8	12.7	11.0	16.1	13.6	9.8	12.7	13.2	18.7	17.7	20.0	10.1	18.0	12.7	14.3	20.0	21.6	24.1	12.1	11.8	10.0	12.9	9.7	22.1	15.2	15.3	17.9	16.3	16.4	12.4	15.2	21.4	31.6	15.1	8.3	15.3	17.1	14.4	3.5	3.6	22.2	2.2	2.5	4.6	0.5	4.7	8.6	6.3	6.3	8.1	9.3	9.3	6.6	15.4	7.3	7.4	5.2	8.6	7.8	2.5	6.5	11.1	7.8	5.5	7.2	8.8	6.8	4.9	9.1	20.5	6.3	5.2	7.6	12.2	7.9	5.4	9.0	9.9	7.2	12.0	6.4	7.4	15.0	4.9	2.5	7.8	12.8	4.0	2.5	6.7	6.3	11.3	6.8	6.0	7.9	5.4	3.7	17.2	6.4	8.9	6.2	4.5	8.4	10.2	14.9	7.2	6.0	4.9	6.7	4.1	7.8	6.3	10.3	5.4	6.1	1.0	5.6	3.7	1.0	3.0	2.6	3.7	3.2	1.0	3.5	3.9	4.6	22.2	2.5	2.2	3.6	2.2	0.5	12.4	15.7	25.6	20.1	13.6	9.8	20.0	10.1	24.1	21.4	59.6	45.8	63.3	35.5	43.4	67.6	32.3	28.1	14.7	25.0	26.2	192.4	33.1	0.0	20.7	1.7	43.5	22.5	23.3	13.7	15.3	41.7	48.0	32.3	32.1	16.9	49.3	41.9	46.6	42.1	3.2	44.0	44.8	32.1	30.7	25.5	31.6	22.7	22.6	30.4	11.3	174.9	12.9	23.1	37.5	29.4	39.4	80.7	76.2	19.0	39.4
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 43.4;pituitary gland: 29.2"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 113.8;Early spermatids: 62.9;Intestinal endocrine cells: 44.4;Late spermatids: 46.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 6.6;SCLC-21H: 3.6;SH-SY5Y: 7.1;SK-BR-3: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.5	2.7	4.0	0.5	9.3	0.5	1.1	0.5	5.6	1.6	1.1	0.8	1.2	0.6	2.1	6.1	0.7	43.4	0.9	0.5	4.6	5.1	0.6	0.5	3.1	0.5	2.5	5.2	2.6	1.2	1.1	29.2	0.5	3.6	1.0	1.3	1.2	0.5	1.9	0.5	0.6	0.8	1.1	0.5	0.5	2.0	14.7	2.1	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	7.1	0.0	11.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.3	0.5	5.6	4.6	5.1	2.5	5.2	3.6	2.1	17.9	1.0	0.0	0.0	0.0	6.7	14.0	0.0	113.8	15.9	5.2	15.7	0.0	3.3	3.1	62.9	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.1	0.0	44.4	0.0	0.0	46.5	0.6	0.3	3.3	0.0	2.0	0.8	0.2	0.0	1.4	2.2	2.7	0.0	1.0	14.9	7.8	0.0	0.0	0.0	0.8	0.0
RILPL1	FLJ39378	ENSG00000188026	"Rab interacting lysosomal protein like 1"	Q5EBL4	12	123470054-123533718	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041314	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041314: AB_10795587"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.81e-1)"	6.1	5.7	9.9	3.5	12.3	3.0	3.7	5.2	11.3	4.8	4.7	12.6	4.4	2.1	6.6	5.0	4.8	5.0	4.3	43.8	9.6	7.5	3.8	3.0	5.5	2.3	21.1	5.8	7.2	3.2	5.7	3.6	7.1	11.1	6.2	2.2	4.9	8.0	7.8	66.2	6.2	2.7	9.8	14.4	3.8	3.0	2.9	15.1	0.3	8.2	9.7	1.9	4.7	5.3	1.6	1.2	4.6	1.2	1.2	2.0	0.7	5.9	8.4	7.6	5.9	8.6	8.1	8.0	10.8	6.1	5.9	5.3	5.2	1.4	0.3	5.4	10.5	4.3	6.5	5.6	5.2	2.4	6.1	10.3	0.8	5.4	7.6	15.1	0.3	2.3	9.2	10.3	6.6	9.6	14.8	6.0	1.1	4.7	0.4	5.9	9.9	0.6	1.9	5.6	1.7	8.9	1.0	4.2	0.3	4.2	6.3	1.2	7.1	5.8	5.1	12.9	4.4	6.7	0.2	11.8	7.8	3.9	11.2	6.8	1.3	0.6	0.2	8.0	0.1	4.8	1.4	1.0	0.7	0.9	0.5	0.8	0.9	1.0	0.8	0.3	1.6	2.0	1.6	4.6	1.2	1.2	1.2	0.9	0.7	9.9	12.3	5.2	9.9	9.6	7.5	21.1	5.8	11.1	15.1	35.7	13.2	0.0	4.3	4.0	13.4	9.2	5.1	5.3	11.4	10.4	5.9	7.9	1.7	1.8	1.3	4.6	0.0	0.0	1.8	5.2	5.6	3.2	1.1	1.3	4.4	22.3	0.0	10.4	1.3	0.9	14.4	1.0	5.0	1.0	1.0	20.0	2.1	0.0	7.8	1.8	6.2	6.5	6.1	0.9	2.3	3.3	7.8	1.3	0.5	2.6
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 19.7;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 72.5;Rod photoreceptor cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"B-cells: 2.7"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 17.6;SH-SY5Y: 34.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041494: , HPA044114: AB_2678815"	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.9	11.9	14.1	1.1	13.0	0.6	0.6	1.1	24.7	6.1	1.5	1.6	0.0	2.5	2.5	2.4	0.8	6.6	1.1	0.4	15.3	11.0	2.8	0.6	0.7	0.5	5.6	12.9	2.1	2.3	49.1	42.7	0.4	4.9	1.3	1.8	4.1	0.6	1.4	0.5	2.4	2.3	2.3	5.6	1.1	5.2	2.3	1.6	0.0	0.9	0.0	0.5	0.8	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.2	4.2	0.0	0.0	17.6	34.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	13.0	1.1	24.7	15.3	11.0	5.6	12.9	4.9	1.6	0.0	0.0	0.0	0.0	1.8	19.7	0.8	0.0	1.4	0.0	0.0	29.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	9.5	72.5	0.0	0.0	1.7	0.9	0.0	0.0	0.0	1.2	3.1	0.1	0.0	0.7	0.0	13.7	0.0	0.0	1.1	1.2	0.5	0.0	0.0	0.6	0.0
RIMKLB	"FAM80B, KIAA1238, NAAGS, NAAGS-I"	ENSG00000166532	"Ribosomal modification protein rimK like family member B"	Q9ULI2	12	8681600-8783095	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 171.4;Late spermatids: 230.6;Syncytiotrophoblasts: 114.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 31.2;U-698: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059552			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA059552: "	"unprognostic (5.29e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-5)"	"unprognostic (2.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.52e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.99e-1)"	22.5	10.7	15.9	10.7	19.2	15.8	20.1	23.3	21.2	18.1	17.6	16.4	11.2	5.1	35.9	18.2	10.4	25.4	12.5	10.7	17.6	12.8	9.2	3.2	13.9	7.6	10.2	19.0	22.7	7.3	36.2	10.1	21.2	19.9	11.7	6.5	18.0	9.0	13.5	9.5	8.8	8.7	25.5	14.0	11.5	7.7	27.8	12.1	13.6	15.6	4.8	6.4	11.8	18.4	4.0	1.3	5.3	2.9	2.8	3.9	2.5	1.2	7.1	16.5	17.5	2.2	2.0	23.5	6.9	3.3	5.8	4.0	0.6	7.5	10.3	6.5	4.5	6.5	2.6	8.3	9.2	6.5	0.1	5.1	4.8	20.1	0.0	2.6	1.4	4.9	4.3	4.1	5.5	9.6	4.0	7.5	8.7	6.6	0.0	3.6	4.3	9.5	0.6	19.4	0.0	0.4	14.9	22.5	0.0	8.9	3.6	0.5	10.8	7.6	9.8	6.7	31.2	2.1	4.7	14.1	6.1	20.4	3.2	2.2	0.1	0.0	52.5	5.3	0.9	4.2	5.3	2.9	1.2	2.4	1.1	3.0	2.2	2.4	3.5	1.2	4.0	3.9	1.5	0.7	2.8	1.4	1.3	0.1	2.5	15.9	19.2	23.3	19.5	17.6	12.8	10.2	19.0	19.9	12.1	26.8	40.5	5.0	21.6	13.5	20.8	13.7	10.2	41.5	35.2	12.2	0.0	49.9	13.3	12.1	171.4	30.3	2.0	23.3	2.6	14.1	23.7	15.5	11.5	0.0	16.2	12.7	8.6	20.3	7.5	230.6	21.6	7.7	32.1	1.0	2.5	35.5	5.6	2.9	29.0	7.9	3.1	12.9	22.8	49.1	26.8	11.7	114.2	5.1	1.0	15.0
RIMS2	"KIAA0751, OBOE, RAB3IP3, RIM2"	ENSG00000176406	"Regulating synaptic membrane exocytosis 2"	Q9UQ26	8	103500748-104256094	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 51.1;brain: 28.7"	"Group enriched"	"Detected in many"	10	"Bipolar cells: 397.4;Cone photoreceptor cells: 665.6;Rod photoreceptor cells: 1047.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 6.0;Daudi: 11.7;RT4: 8.4;SCLC-21H: 20.8;SuSa: 8.3"	"Low region specificity"	"Detected in all"							"HPA046538, HPA066498, CAB079049"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB079049: , HPA046538: , HPA066498: AB_2685678"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (8.01e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.67e-5)"	"unprognostic (8.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	0.9	51.1	15.8	1.0	21.8	1.1	1.8	14.5	28.7	8.5	0.9	0.5	0.9	1.2	1.4	1.7	1.0	6.3	1.7	0.9	10.3	4.9	1.1	0.9	1.0	1.1	3.1	17.5	2.8	1.6	0.9	12.4	1.1	8.6	2.8	1.0	5.8	1.0	1.8	1.0	1.0	1.4	2.0	4.0	0.9	1.7	3.9	8.7	0.0	2.9	0.0	1.0	1.5	1.6	0.7	0.7	2.9	0.6	1.6	0.6	0.2	3.7	0.0	6.0	0.0	0.0	0.0	0.0	0.4	0.3	1.1	1.4	0.1	0.3	11.7	0.1	0.0	1.2	0.3	1.8	0.7	1.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.9	2.1	0.0	1.3	0.1	0.5	0.0	0.5	0.8	0.0	4.6	0.0	0.6	0.0	0.0	0.0	0.0	8.4	20.8	5.1	0.0	0.1	0.5	8.3	0.3	0.2	0.0	0.0	5.6	0.1	0.1	1.5	0.0	0.1	0.4	0.2	0.2	2.7	0.6	0.6	0.6	0.3	0.4	0.4	0.3	0.4	0.1	0.7	0.3	0.5	2.9	1.6	0.4	0.7	0.3	0.2	15.8	21.8	14.5	28.7	10.3	4.9	3.1	17.5	8.6	8.7	26.8	32.3	0.0	1.6	0.2	397.4	0.7	2.5	18.7	29.6	0.0	665.6	0.5	1.7	0.0	29.0	0.5	0.0	0.0	0.0	0.2	0.8	4.9	15.1	0.0	0.2	63.5	8.1	0.6	0.3	13.5	66.7	0.4	1.7	0.0	0.2	71.8	0.4	0.0	27.6	0.1	1047.7	0.0	0.3	15.3	9.9	0.4	0.1	0.5	0.0	0.9
RIMS3	"NIM3, RIM3"	ENSG00000117016	"Regulating synaptic membrane exocytosis 3"	Q9UJD0	1	40620679-40665657	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.7"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 10.7;Late spermatids: 23.5;Muller glia cells: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 1.8;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 4.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.3;JURKAT: 13.2;SH-SY5Y: 17.7;U-87 MG: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055285			Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA055285: AB_2682771"	"unprognostic (3.51e-3)"	"unprognostic (7.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-4)"	"unprognostic (3.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.19e-2)"	1.3	7.2	13.6	2.2	19.2	3.7	3.1	21.5	47.7	1.4	3.4	3.4	0.0	1.1	3.0	2.2	2.9	2.1	1.3	1.5	7.8	17.4	1.4	0.7	3.1	2.0	7.4	22.3	2.5	1.1	4.0	0.5	3.8	4.9	3.2	3.8	2.0	2.0	4.1	0.6	2.7	1.7	4.8	3.4	1.7	2.5	3.1	4.4	0.7	2.8	0.0	2.8	1.7	1.0	0.1	4.6	0.1	0.3	0.1	1.8	0.1	1.9	0.7	2.9	3.1	0.1	0.0	0.4	0.0	0.0	0.5	0.6	0.3	0.6	37.3	0.0	0.0	1.4	0.3	1.9	0.3	0.3	6.4	0.9	2.1	0.2	1.0	0.1	0.3	1.7	0.0	1.5	0.1	0.1	0.1	0.1	13.2	1.8	1.4	0.0	3.4	5.5	0.2	1.8	0.3	0.2	2.5	2.6	6.9	0.5	0.5	10.0	17.7	0.4	1.8	1.2	4.0	0.4	10.4	0.0	0.3	3.0	0.0	0.5	0.3	2.7	8.2	16.3	0.6	0.3	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.5	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	4.6	0.4	0.1	13.6	19.2	21.5	47.7	7.8	17.4	7.4	22.3	4.9	4.4	6.0	0.0	0.0	0.2	0.5	6.3	1.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	10.7	0.1	1.7	0.0	1.3	0.1	0.3	0.4	1.1	0.0	2.4	4.8	0.0	0.0	2.1	23.5	0.0	1.1	0.0	1.0	1.9	12.8	2.3	0.8	0.7	0.3	0.6	0.0	2.2	3.3	1.1	0.1	0.2	0.0	0.6	0.1
RIMS4	"C20orf190, dJ781B1.3"	ENSG00000101098	"Regulating synaptic membrane exocytosis 4"	Q9H426	20	44751808-44810338	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.8;testis: 14.6"	"Cell type enhanced"	"Detected in some"	19	"Horizontal cells: 36.5;Peritubular cells: 12.4;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 13.1;MCF7: 8.8;SCLC-21H: 27.1;SH-SY5Y: 13.9;SiHa: 9.4;U-2 OS: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060928	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060928: AB_2684387"	"unprognostic (1.54e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-2)"		"unprognostic (4.63e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.60e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.94e-2)"	1.0	2.1	13.8	0.8	23.3	0.4	1.2	9.6	23.8	11.8	1.2	0.2	0.0	0.6	3.2	2.2	1.3	11.9	1.4	0.6	14.1	7.5	0.6	0.5	1.7	0.6	4.9	8.8	9.5	0.6	0.5	6.0	0.6	4.1	3.2	1.2	1.0	2.0	1.8	1.8	0.5	0.7	4.3	1.3	0.5	2.3	14.6	2.6	0.0	7.5	0.9	1.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	1.3	0.0	13.1	0.1	0.0	0.0	5.5	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	8.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.1	13.9	9.4	0.0	0.1	0.4	4.1	0.4	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	23.3	9.6	19.0	14.1	7.5	4.9	8.8	4.1	2.6	0.0	0.0	0.0	0.0	0.2	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	36.5	1.7	0.0	0.0	2.4	6.6	0.0	0.0	0.0	0.7	0.8	0.1	0.0	12.4	0.0	0.7	25.8	0.0	0.7	4.1	0.1	0.0	0.0	0.0	0.0
RIN1		ENSG00000174791	"Ras and Rab interactor 1"	Q13671	11	66330242-66336840	"Predicted intracellular proteins, RAS pathway related proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 31.5"	"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.7;non-classical monocyte: 19.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 19.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.7;PC-3: 20.1;U-2197: 29.3"	"Group enriched"	"Detected in many"	6	"amygdala: 37.2;basal ganglia: 37.4;cerebral cortex: 29.2;hippocampal formation: 35.3;olfactory region: 16.6"	"Group enriched"	"Detected in many"	6	"amygdala: 9.1;basal ganglia: 17.1;cerebral cortex: 8.2;hippocampal formation: 12.4;olfactory region: 9.1"	HPA035491	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA035491: AB_10601608"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (9.34e-7)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.46e-1)"	4.9	5.1	11.1	7.1	22.7	3.9	3.4	13.0	13.5	5.9	5.2	1.5	2.4	8.0	4.2	2.3	15.8	5.8	8.7	3.3	9.7	2.3	2.3	2.7	3.8	5.4	1.4	5.8	4.8	6.6	1.5	5.0	4.5	2.2	4.7	3.6	2.5	4.8	3.5	10.3	31.5	5.8	2.8	0.8	4.6	11.1	2.8	2.5	0.0	1.5	8.7	8.6	3.4	7.0	0.1	3.3	0.0	19.1	0.0	1.5	2.0	1.6	4.5	1.3	2.8	1.6	8.8	1.0	10.1	9.2	7.8	3.8	2.8	5.1	0.3	5.1	7.3	3.2	10.7	0.0	13.6	1.0	0.5	0.0	0.4	4.3	2.4	3.0	0.1	4.7	8.5	26.7	7.9	4.7	9.7	1.6	0.3	0.2	0.1	3.4	0.3	0.1	11.5	0.6	2.1	20.1	0.1	3.9	0.0	2.3	1.7	10.0	2.7	2.6	1.3	13.8	0.4	0.9	0.8	4.4	12.5	7.4	29.3	2.5	0.2	0.5	0.0	17.4	2.7	5.0	0.0	4.3	0.0	0.2	9.7	1.5	0.1	1.0	0.3	3.3	0.0	1.1	0.5	0.0	0.0	19.1	0.0	0.1	2.0	11.1	22.7	13.0	13.5	9.7	2.3	1.4	5.8	2.2	2.5	0.0	0.3	0.0	7.8	11.8	3.3	0.8	2.5	1.4	1.2	0.0	0.0	0.6	0.0	2.4	0.3	2.9	8.6	0.0	6.1	4.3	5.1	1.9	4.6	0.0	4.3	0.0	2.9	4.9	9.5	1.0	4.0	4.2	1.7	1.0	5.2	0.5	6.7	7.0	1.8	0.0	0.9	0.0	1.4	1.6	0.9	13.2	0.2	1.3	6.6	6.3
RIN2	RASSF4	ENSG00000132669	"Ras and Rab interactor 2"	Q8WYP3	20	19886521-20002457	"Disease related genes, Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 81.6;Ito cells: 94.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.2;granulocytes: 2.2;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034641	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Nucleoli, Golgi apparatus"	"HPA034641: AB_10671230"	"unprognostic (8.23e-3)"	"unprognostic (8.09e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.27e-2)"	"prognostic favorable (8.34e-6)"	"unprognostic (3.10e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.02e-3)"	"unprognostic (3.63e-2)"	19.2	6.7	9.9	6.1	8.7	4.0	24.4	4.3	10.2	11.7	21.6	9.5	7.6	10.5	12.7	6.6	11.1	9.7	14.7	13.7	10.0	6.2	12.2	4.6	26.8	4.3	8.3	4.4	12.7	5.1	4.2	4.9	16.7	9.3	8.0	10.4	16.5	12.0	11.3	10.9	6.6	23.4	13.2	7.7	17.5	6.5	3.5	9.9	0.3	13.1	5.5	3.7	9.9	15.6	0.3	1.2	2.2	3.3	0.1	0.3	0.4	3.4	11.4	2.1	6.8	12.5	7.7	7.1	2.8	11.8	3.0	1.7	5.4	3.1	0.0	12.4	7.1	5.7	12.7	0.1	18.1	3.3	1.4	0.0	0.0	2.0	0.4	2.8	0.0	0.0	11.2	3.1	5.7	6.3	6.8	16.2	0.0	0.0	0.2	9.0	2.5	0.0	0.2	0.3	1.6	25.3	0.1	7.6	1.8	3.9	4.9	1.8	0.4	2.7	11.2	0.0	2.2	1.0	0.9	17.5	6.3	1.4	3.7	4.7	0.0	0.0	0.0	4.0	0.0	1.0	0.6	3.3	0.2	0.2	2.7	0.2	0.2	0.2	0.2	1.2	0.3	0.3	0.3	2.2	0.1	2.8	0.6	0.1	0.4	9.9	8.7	4.3	10.2	10.0	6.2	8.3	4.4	9.3	9.9	59.6	13.7	4.7	21.9	37.3	5.7	26.6	10.2	13.4	15.9	29.6	7.9	3.8	36.5	15.5	0.6	37.6	17.0	0.0	30.1	5.9	38.6	19.7	0.0	3.8	81.6	6.4	13.8	94.5	62.1	0.8	17.8	36.0	20.3	4.6	16.1	26.2	24.4	7.0	14.5	34.2	0.7	0.0	17.4	0.0	0.1	47.2	5.9	2.5	18.9	24.1
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208495-33212722	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	26.7	22.6	17.8	15.9	21.3	12.0	14.6	27.6	24.2	22.2	17.6	22.0	21.0	18.2	31.9	17.3	14.5	18.8	21.4	14.4	17.3	18.2	19.3	21.6	16.8	14.5	24.0	15.4	25.0	18.3	24.0	34.0	14.9	17.0	21.8	7.6	20.0	19.0	20.5	18.0	21.7	19.5	22.9	18.5	23.2	24.1	16.9	20.8	25.5	29.3	13.1	14.3	13.9	17.1	1.2	2.2	0.8	1.5	0.2	2.2	0.2	4.2	3.6	4.2	4.1	4.3	1.4	9.8	11.2	6.8	4.6	4.7	3.8	3.2	7.0	4.7	4.5	5.8	7.7	3.6	3.4	3.2	8.6	2.9	8.4	5.9	7.2	9.7	4.8	6.9	0.0	3.4	4.1	7.6	3.6	1.7	3.8	12.1	5.4	4.8	0.0	0.3	3.7	1.9	3.1	4.6	4.5	7.0	7.7	5.0	3.7	8.4	5.2	4.0	4.3	11.6	1.1	5.0	8.4	2.3	5.1	3.8	0.0	9.2	6.1	6.2	6.7	3.8	4.4	3.1	0.0	1.5	0.8	2.2	0.4	0.4	1.1	0.7	1.0	0.7	1.2	1.7	0.9	0.3	0.2	0.5	2.2	0.4	0.2	17.8	21.3	27.6	24.2	17.3	18.2	24.0	15.4	17.0	20.8	0.0	22.7	20.1	35.5	24.5	30.5	21.4	17.8	17.4	14.8	21.0	15.7	36.0	13.3	28.6	21.1	23.2	23.3	0.0	30.3	27.6	28.0	27.3	19.6	30.5	26.3	23.8	29.4	30.7	29.6	13.2	37.2	20.0	16.9	20.8	19.8	38.3	26.5	21.0	28.0	26.9	18.0	25.8	22.7	32.9	18.8	26.7	52.7	25.4	21.0	24.7
RINL	FLJ45909	ENSG00000187994	"Ras and Rab interactor like"	Q6ZS11	19	38867834-38878279	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"T-cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 17.3;Karpas-707: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042083, HPA042103"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Nucleoplasm, Vesicles"		"HPA042083: AB_10793977, HPA042103: AB_10797380"	"unprognostic (1.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (7.38e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.05e-2)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.40e-3)"	5.5	3.7	6.3	10.2	10.3	5.4	10.4	6.5	5.8	2.6	3.9	4.2	6.2	3.4	1.8	2.4	5.3	4.6	6.1	3.9	5.1	6.4	5.0	6.0	7.0	20.4	5.5	3.8	1.7	17.4	4.9	5.7	3.3	5.5	2.6	3.5	5.9	7.9	4.5	3.0	3.2	6.3	2.6	4.5	13.0	6.1	1.4	3.5	7.6	6.4	3.1	15.7	4.3	2.9	16.6	12.3	3.1	2.1	4.1	8.7	2.9	0.0	1.4	0.4	0.2	0.6	0.3	2.6	0.3	0.2	0.3	0.4	2.3	7.0	7.9	3.7	0.4	0.1	0.2	1.3	3.0	0.4	1.7	0.8	9.8	2.0	5.0	1.7	5.5	17.3	1.6	0.6	0.9	0.6	0.3	3.5	6.1	2.0	20.3	0.0	1.2	1.7	3.9	0.6	4.1	0.3	1.1	0.1	5.9	1.9	0.2	2.6	1.1	3.2	5.2	2.8	0.4	0.6	6.7	2.2	0.1	1.5	0.4	0.0	8.7	7.2	6.2	0.6	3.1	0.4	3.1	0.9	1.5	8.7	2.1	5.5	12.4	5.8	6.3	1.6	16.6	4.6	5.4	2.8	4.1	2.0	12.3	6.1	2.9	6.3	10.3	6.5	5.8	5.1	6.4	5.5	3.8	5.5	3.5	3.0	7.7	15.2	4.6	2.9	3.2	3.0	12.7	1.4	1.2	3.5	7.9	11.3	6.6	5.6	0.4	6.8	0.0	0.0	6.2	5.5	3.8	2.2	15.0	5.4	7.9	0.0	6.9	8.6	5.9	0.4	2.8	5.0	10.1	10.8	0.3	4.8	4.8	1.7	2.5	8.1	10.5	0.0	1.9	2.9	1.8	3.3	3.4	24.5	1.0	3.0
RINT1	"FLJ11785, RINT-1"	ENSG00000135249	"RAD50 interactor 1"	Q6NUQ1	7	105532085-105567677	"Predicted intracellular proteins"	"Cell cycle, ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019875, HPA031646"	Approved		Approved	"Golgi apparatus"		Yes	No			"Golgi apparatus"		"HPA019875: AB_1856283, HPA031646: AB_2673975"	"unprognostic (1.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (1.76e-1)"	12.2	13.6	9.0	13.0	12.4	13.8	12.8	17.8	15.0	12.7	10.5	8.9	11.9	13.6	13.4	8.4	17.7	11.9	9.1	11.8	16.2	8.1	12.9	14.5	11.3	15.5	10.2	12.0	15.0	24.7	14.7	17.9	11.9	13.3	10.7	11.3	9.9	14.7	11.8	35.1	14.5	11.6	9.7	12.3	12.0	12.7	15.1	10.1	15.5	13.3	10.5	17.8	13.1	13.6	9.9	5.5	4.2	5.5	8.0	12.0	6.4	12.8	11.1	5.4	11.5	8.4	11.5	7.0	12.5	8.4	12.5	14.3	12.2	7.0	14.4	14.4	10.7	13.1	9.0	10.5	9.3	16.3	7.5	11.9	8.0	12.4	8.1	6.1	17.4	8.4	6.8	6.4	13.2	7.1	8.0	13.4	7.2	17.5	9.3	13.3	21.0	12.7	9.1	11.6	8.8	10.8	7.2	9.7	20.6	4.8	10.8	9.8	10.4	13.4	20.5	7.1	8.5	9.1	5.7	9.5	14.3	10.6	39.2	14.1	19.4	26.0	28.0	9.6	14.3	16.1	4.2	3.8	4.0	6.9	5.5	12.0	9.9	10.1	9.2	5.5	7.4	9.7	9.0	0.4	8.0	4.3	4.1	9.6	6.4	9.0	12.4	17.8	15.0	16.2	8.1	10.2	12.0	13.3	10.1	3.0	9.8	8.8	8.4	6.0	5.2	8.7	2.5	21.4	7.9	3.5	7.9	9.6	8.3	6.8	5.3	5.1	5.1	0.0	5.5	8.8	7.2	5.1	9.3	4.2	6.5	6.4	5.2	3.7	4.9	4.5	8.1	3.8	5.0	4.6	5.6	6.6	6.0	3.5	9.2	5.3	8.9	6.5	5.7	23.3	12.4	6.8	10.1	7.0	6.9	7.4
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183260	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	22.2	20.1	14.8	17.1	17.5	24.4	19.7	26.3	18.6	19.1	17.0	8.9	14.0	17.3	17.5	17.1	17.0	15.0	10.7	19.6	15.7	13.4	21.0	23.6	13.3	17.6	20.0	11.1	20.7	21.5	15.1	37.5	15.8	19.7	19.5	17.3	10.3	18.7	16.6	24.9	13.3	20.2	16.3	20.7	22.5	16.4	14.8	18.6	25.8	21.7	20.7	17.4	20.7	21.0	15.2	17.8	9.4	18.7	17.8	24.1	13.5	8.8	10.4	9.7	18.8	12.8	14.0	15.5	22.3	13.8	15.8	21.0	14.2	15.6	19.6	25.4	10.0	24.9	10.5	16.5	13.0	21.7	13.8	9.1	9.8	20.1	19.8	11.5	18.6	13.8	9.2	10.2	19.3	19.6	12.1	12.8	14.6	14.8	12.7	18.1	14.8	21.8	22.3	11.5	5.3	11.2	24.5	18.9	28.8	12.4	8.1	12.1	9.0	13.5	14.1	15.4	15.1	14.7	17.8	13.7	20.3	14.1	16.1	24.3	12.5	16.2	44.0	12.1	19.1	18.5	7.0	16.0	9.4	16.3	18.7	22.3	15.2	20.7	17.8	17.8	11.0	22.5	24.1	3.2	17.8	13.4	17.8	18.5	13.5	14.8	17.5	26.3	18.6	15.7	13.4	20.0	11.1	19.7	18.6	8.9	10.9	13.0	14.3	23.5	16.4	15.9	12.7	10.7	11.4	7.0	11.8	16.7	14.9	14.2	1.1	14.0	7.0	0.0	13.1	19.4	15.8	9.9	27.6	7.8	15.9	12.7	9.2	6.2	11.0	1.8	12.4	11.5	5.0	13.6	11.2	12.3	10.5	10.5	15.2	12.2	17.2	6.5	21.7	20.7	20.2	16.6	14.5	14.4	12.1	11.4
RIOK3	SUDD	ENSG00000101782	"RIO kinase 3"	O14730	18	23452823-23486603	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	"unprognostic (7.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.71e-2)"	10.1	8.7	6.9	11.7	7.7	52.4	10.9	8.9	10.1	14.7	21.4	8.5	5.9	15.6	8.8	9.3	41.0	7.8	10.7	11.5	6.1	5.5	10.5	19.9	10.1	10.7	9.1	6.2	7.6	10.7	7.5	11.6	21.4	11.6	6.8	14.7	6.0	14.9	7.0	40.0	13.3	36.5	15.2	10.5	8.9	12.9	22.7	7.6	11.1	7.3	16.0	16.5	13.7	21.5	11.7	11.0	21.7	21.5	8.3	11.2	10.0	14.8	5.8	6.1	7.9	11.1	12.4	11.0	14.9	11.0	10.6	10.2	6.7	16.1	10.3	19.6	16.6	10.8	19.5	10.3	17.0	16.4	10.2	4.3	9.6	10.9	8.4	27.8	27.0	8.4	14.8	32.4	18.8	26.0	12.1	14.7	6.5	13.9	13.0	15.9	7.9	9.3	4.4	5.6	21.7	11.7	10.5	12.7	12.5	12.1	19.5	14.2	10.2	19.1	8.7	10.9	15.9	7.7	14.6	23.1	17.5	4.4	7.7	9.6	23.5	19.7	15.3	10.3	12.5	13.1	21.7	13.5	8.0	9.1	19.6	6.9	8.2	7.6	7.9	11.0	11.7	6.1	6.9	9.3	8.3	21.5	5.1	11.2	10.0	6.9	7.7	8.9	10.1	6.1	5.5	9.1	6.2	11.6	7.6	74.5	51.9	21.7	78.2	107.0	43.0	61.7	43.3	56.2	67.1	24.4	53.0	38.5	21.6	40.3	191.3	39.6	193.3	116.8	45.8	56.7	46.6	92.4	61.2	72.5	37.1	27.0	60.3	33.7	55.0	227.3	20.8	49.5	40.5	47.7	85.9	17.1	98.8	75.8	28.3	40.3	43.8	6.5	38.7	23.6	9.5	125.6	73.9	34.1	42.3	194.9
RIPOR1	"FAM65A, FLJ13725"	ENSG00000039523	"RHO family interacting cell polarization regulator 1"	Q6ZS17	16	67518418-67546788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 23.1;Ductal cells: 13.7;Hofbauer cells: 25.5;Pancreatic endocrine cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 8.2;eosinophil: 6.4;intermediate monocyte: 12.0;memory B-cell: 12.3;myeloid DC: 7.6;naive B-cell: 8.1;neutrophil: 4.9;non-classical monocyte: 10.4;plasmacytoid DC: 10.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005923	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA005923: AB_1078809"	"unprognostic (7.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.82e-8)"	"unprognostic (8.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.46e-2)"	26.6	16.7	21.2	20.8	28.5	21.9	23.7	31.8	35.1	18.8	16.6	13.1	8.4	8.7	24.2	11.4	15.1	17.6	20.4	35.6	21.2	15.8	30.8	11.7	27.8	17.6	12.8	18.6	20.6	22.4	20.4	14.4	27.9	16.9	15.7	7.6	27.1	15.8	20.7	24.3	12.1	15.6	24.0	10.0	37.5	13.4	11.6	12.5	6.7	19.0	13.1	16.2	17.0	22.6	12.3	10.8	6.4	12.0	1.1	1.4	3.7	15.7	13.4	6.1	9.5	15.4	13.9	13.4	16.8	16.7	19.5	16.3	27.5	11.7	2.1	23.6	28.8	9.9	9.0	12.1	15.2	12.6	6.9	6.2	20.9	18.4	6.2	17.3	1.6	10.6	13.7	7.1	26.2	17.8	13.9	20.5	3.8	2.3	2.4	14.4	17.2	4.9	5.2	1.6	3.0	10.8	16.8	10.9	11.2	14.9	8.1	4.5	12.0	31.3	5.3	10.6	6.2	11.3	3.9	35.5	22.3	13.1	18.7	11.6	3.4	2.3	6.5	14.8	4.0	11.8	0.0	8.2	6.4	1.0	12.0	1.4	12.3	0.8	0.4	7.6	8.1	0.6	0.5	4.9	1.1	10.4	10.8	0.5	3.7	21.2	28.5	31.8	35.1	21.2	15.8	12.8	18.6	16.9	12.5	14.9	23.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	7.0	0.0	0.5	0.0	13.7	0.0	0.0	0.0	0.0	10.8	1.1	0.0	0.0	9.3	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	7.2	0.0	0.0	25.5	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0
RIPOR3	"C20orf175, C20orf176, dJ530I15.2, dJ530I15.3, FAM65C"	ENSG00000042062	"RIPOR family member 3"	Q96MK2	20	50586108-50691528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 3.0;Collecting duct cells: 3.5;monocytes: 3.6;Proximal tubular cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.9;ASC TERT1: 9.3;HEL: 29.1;HSkMC: 18.3;K-562: 16.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051823, HPA054759"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051823: AB_2681626, HPA054759: AB_2682596"	"unprognostic (7.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.66e-5)"	"unprognostic (4.96e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.98e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.58e-2)"	18.9	11.8	4.6	4.2	8.1	22.8	8.1	3.0	5.3	18.6	6.4	2.9	2.4	3.3	14.1	5.7	5.8	13.5	4.3	5.7	4.3	1.1	15.1	7.7	2.9	9.1	5.1	0.9	5.1	2.1	1.5	5.5	2.7	5.2	5.4	2.2	6.3	4.3	1.1	11.7	3.0	5.8	5.8	3.8	4.2	3.2	6.4	6.3	2.7	4.2	2.5	2.6	6.6	24.6	1.1	0.7	1.9	0.3	0.1	1.1	1.0	0.0	0.0	0.5	0.0	19.9	9.3	0.0	0.0	6.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.1	2.3	0.0	0.0	18.3	0.0	0.5	0.0	0.0	0.0	0.0	16.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.7	0.0	0.0	2.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	1.4	0.1	1.9	1.1	0.3	0.0	1.1	0.8	0.4	0.1	0.8	0.8	0.4	1.1	0.1	0.2	0.7	0.3	1.0	4.6	8.1	3.0	5.3	4.3	1.1	5.1	0.9	5.2	6.3	3.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.5	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221751	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"retina: 164.1"	"Cell type enriched"	"Detected in some"	43	"Muller glia cells: 2424.2"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Group enriched"	"Detected in many"	4	"amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7"	"Group enriched"	"Detected in some"	7	"basophil: 3.3;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Cell line enriched"	"Detected in single"	48	"SK-MEL-30: 21.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1.0	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.0	3.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	6.9	10.6	0.6	7.0	3.7	1.3	1.6	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	37.3	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	2424.2	0.0	0.0	0.0	0.0	56.9	0.0	0.0	0.1	0.0	0.0	16.7	0.0	0.0	0.0
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"Rearranged L-myc fusion"	Q13129	1	40161373-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	14.8	8.1	12.6	11.3	12.6	44.5	13.9	20.8	17.1	12.4	11.1	11.6	7.1	8.6	14.1	8.6	12.4	9.9	11.2	12.3	11.0	8.3	8.7	12.7	12.8	11.8	12.8	11.8	14.6	9.4	12.5	15.1	11.9	15.4	13.2	9.2	10.2	9.4	9.9	13.4	17.7	9.9	14.3	14.1	10.1	9.3	15.9	11.8	14.9	10.0	8.4	13.5	18.1	14.8	4.1	3.5	10.1	4.1	4.1	4.9	2.4	12.4	4.8	9.5	9.9	8.5	6.9	11.3	4.7	7.0	8.1	10.8	9.7	6.6	12.4	6.2	6.0	6.1	11.8	11.9	8.2	14.8	5.8	8.1	10.2	5.9	5.9	6.7	8.4	6.2	6.8	8.7	8.6	9.8	9.7	5.5	6.9	15.5	7.7	7.4	3.9	7.1	5.1	12.6	4.6	5.6	5.6	15.6	7.2	5.2	12.6	6.8	9.5	8.7	11.7	8.3	15.4	5.5	30.8	4.7	9.6	10.2	7.8	8.7	7.0	6.6	11.7	8.3	7.9	5.9	10.1	2.8	5.5	3.7	3.9	4.9	4.1	3.7	3.8	3.5	4.1	4.8	4.0	6.3	4.1	4.1	1.6	3.3	2.4	12.6	12.6	20.8	17.1	11.0	8.3	12.8	11.8	15.4	11.8	29.8	10.8	22.4	42.2	58.3	17.2	13.4	5.1	30.8	30.7	3.5	15.7	6.9	5.0	10.9	32.9	23.3	8.4	0.0	5.9	8.0	34.2	25.7	26.5	8.3	8.5	25.4	19.4	16.0	13.9	4.9	8.3	16.8	16.9	10.0	7.8	17.0	9.3	14.0	7.4	5.7	15.8	12.9	27.8	26.5	20.0	53.3	14.4	14.1	6.7	27.2
RMDN1	"CGI-90, FAM82B, FLJ20665, RMD1"	ENSG00000176623	"Regulator of microtubule dynamics 1"	Q96DB5	8	86468257-86514357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026495	Approved		Supported	"Actin filaments,Centrosome"		NA	NA			Centrosome	"Actin filaments"	"HPA026495: AB_1848414"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (8.51e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.71e-3)"	"unprognostic (3.47e-1)"	20.4	20.1	19.0	19.5	18.4	12.2	16.9	10.8	13.3	13.8	22.5	13.9	7.7	16.3	11.6	13.3	21.1	12.4	14.2	44.3	17.6	16.7	35.0	32.5	21.0	23.6	22.2	10.7	11.6	13.0	14.5	15.6	12.7	19.1	12.6	17.2	13.6	12.2	18.9	45.2	18.5	29.0	17.7	23.1	19.2	16.9	14.4	15.3	25.6	29.3	27.1	18.0	14.3	11.2	17.8	22.1	38.6	27.9	15.5	18.0	12.6	21.2	9.2	10.8	6.1	21.3	35.1	13.2	15.6	14.1	12.4	12.2	10.9	13.7	25.4	13.3	13.0	11.6	20.7	13.8	15.6	14.9	21.6	10.9	13.3	10.9	27.3	11.5	6.0	0.3	19.0	14.8	16.6	25.7	22.3	27.9	15.1	14.0	14.0	19.7	19.2	21.2	2.8	5.5	37.3	23.2	12.1	15.2	26.1	14.7	13.4	5.1	11.4	12.9	51.6	22.0	12.0	29.0	11.3	15.1	13.9	22.6	17.6	9.4	18.2	15.0	19.7	18.1	9.7	18.8	5.6	17.1	38.6	12.3	21.6	14.3	17.8	12.8	14.4	19.5	12.3	10.6	13.7	6.8	15.5	27.9	22.1	18.0	12.6	19.0	18.4	10.8	12.5	17.6	16.7	22.2	10.7	19.1	15.3	38.7	30.0	8.2	11.9	11.9	13.3	104.4	28.1	37.5	44.3	19.2	15.7	37.2	41.4	36.4	68.7	24.1	20.2	0.0	46.2	44.7	20.4	7.5	1.1	52.1	48.2	19.1	9.8	20.3	43.0	59.6	12.0	27.5	15.1	44.1	20.5	25.6	40.0	14.0	8.5	46.4	20.2	0.0	18.6	44.1	30.4	13.6	23.8	19.2	26.4	9.7
RMDN2	"FAM82A, FAM82A1, FLJ32954, RMD2"	ENSG00000115841	"Regulator of microtubule dynamics 2"	Q96LZ7	2	37923187-38067142	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 38.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 207.9;Late spermatids: 131.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 17.7"									"HPA034705, HPA034706"	Enhanced		Supported	"Golgi apparatus,Mitotic spindle,Cytosol"		Yes	No			"Mitotic spindle, Cytosol"	"Golgi apparatus"	"HPA034705: AB_2674292, HPA034706: AB_10696362"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.34e-1)"	4.6	38.4	6.1	8.7	6.8	1.9	8.9	6.2	8.2	6.3	9.7	1.8	5.9	6.8	7.0	9.2	3.7	4.3	5.5	4.6	5.9	3.5	6.6	24.0	8.2	3.3	3.2	5.1	3.2	4.2	3.2	8.6	3.1	4.6	8.1	8.7	5.2	5.7	10.2	5.0	2.9	14.7	7.7	4.8	14.1	4.6	15.6	4.0	2.1	4.7	3.6	2.1	4.3	9.0	7.5	6.0	4.8	8.0	6.3	6.1	2.3	3.4	3.9	2.7	1.7	12.1	12.4	1.6	7.3	9.3	3.6	3.8	1.0	11.4	2.4	3.2	10.8	2.3	3.9	0.9	4.9	4.6	4.7	2.7	4.0	1.6	3.4	6.3	0.0	4.1	17.7	3.8	5.0	0.7	6.1	2.0	1.2	4.8	2.0	6.5	1.3	0.8	4.1	5.2	6.6	3.9	0.0	0.7	0.4	9.5	3.1	2.1	7.9	5.7	0.6	6.4	2.3	1.2	5.5	2.8	5.1	5.4	2.7	2.8	3.9	6.8	4.8	6.0	0.9	5.1	0.0	4.9	1.0	4.0	8.0	6.1	7.5	1.9	2.5	3.3	5.0	2.0	4.3	4.8	6.3	6.1	6.0	0.2	2.3	6.1	6.8	6.2	8.2	5.9	3.5	3.2	5.1	4.6	4.0	26.8	23.5	5.4	7.2	2.2	3.7	3.6	7.6	13.4	27.3	5.2	2.0	1.7	6.6	4.2	207.9	3.6	21.2	0.0	3.4	0.8	7.3	2.5	15.1	12.9	4.4	4.8	4.6	3.7	6.5	131.8	8.6	4.4	5.0	1.8	11.2	5.8	2.4	7.0	5.6	5.9	2.2	6.5	3.9	3.9	3.7	2.0	0.7	3.8	15.9	2.0
RMND5A	"FLJ13910, GID2, GID2A, p44CTLH, RMD5"	ENSG00000153561	"Required for meiotic nuclear division 5 homolog A"	Q9H871	2	86720173-86778041	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046795, HPA060843"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046795: AB_10963573, HPA060843: AB_2684378"	"unprognostic (4.54e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.32e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.56e-1)"	9.8	7.0	11.1	6.5	11.7	15.6	10.1	47.3	19.2	9.0	11.8	8.4	6.8	9.7	11.3	8.4	19.7	8.1	8.9	23.1	12.5	8.5	11.2	25.6	6.9	12.6	9.3	10.0	9.0	9.9	15.8	7.6	9.6	7.0	8.4	13.1	10.3	12.0	7.1	34.2	13.4	9.0	12.0	11.2	8.0	7.2	5.5	5.5	24.1	7.9	10.6	8.1	9.2	12.0	4.6	6.4	20.7	8.7	6.0	8.8	5.1	8.1	4.4	7.8	4.6	10.4	4.6	16.1	3.2	2.7	4.3	4.9	16.1	8.8	28.5	10.0	2.9	5.0	9.8	19.7	6.8	6.7	8.2	15.1	25.1	9.7	14.5	10.5	18.2	8.3	7.0	13.6	4.5	15.8	4.9	7.4	21.2	15.8	16.4	3.4	5.3	16.7	15.6	13.2	9.8	5.7	20.1	24.1	17.9	8.9	9.8	14.5	11.2	7.3	14.8	11.8	11.5	7.4	15.8	7.1	3.0	5.8	5.4	5.0	7.4	7.7	19.6	2.5	22.1	3.4	20.7	8.7	5.4	6.0	6.8	7.1	3.2	4.6	6.7	6.4	4.6	6.4	8.8	19.0	6.0	7.9	5.1	3.1	5.1	11.1	11.7	47.3	19.2	12.5	8.5	9.3	10.0	7.0	5.5	11.9	12.8	15.0	18.5	37.3	19.8	71.8	17.8	18.7	6.8	10.4	5.9	17.5	19.9	11.7	8.4	19.2	33.8	70.0	12.3	16.0	17.9	26.5	8.1	55.5	13.7	22.3	37.9	19.0	33.6	4.7	17.8	17.1	30.4	8.2	48.6	14.1	19.1	31.7	16.3	23.8	15.2	6.5	18.6	16.6	26.7	47.9	20.6	18.5	24.4	21.7
RMND5B	"FLJ22318, GID2, GID2B"	ENSG00000145916	"Required for meiotic nuclear division 5 homolog B"	Q96G75	5	178130996-178150565	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 149.7;Late spermatids: 317.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047778	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047778: AB_2680153"	"unprognostic (2.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (7.66e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.22e-8)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.43e-2)"	"unprognostic (5.78e-2)"	12.2	12.6	11.6	7.3	13.7	7.7	9.7	10.4	18.8	11.4	11.8	16.2	9.1	9.0	16.2	11.8	36.7	12.8	12.5	17.2	11.4	9.0	11.3	13.1	11.5	11.1	14.5	16.7	11.8	16.9	12.8	15.7	11.3	13.0	12.2	8.2	16.1	15.8	11.9	23.4	18.0	11.7	18.7	9.1	10.5	12.0	42.0	9.2	11.2	14.3	13.0	18.2	11.5	14.0	13.2	8.5	22.4	13.8	2.2	12.8	7.2	6.4	10.9	7.5	18.1	9.7	1.0	22.4	5.4	6.1	7.9	9.5	12.8	9.6	14.1	10.8	4.0	9.1	9.0	7.4	11.3	3.1	39.5	9.9	14.4	13.0	6.7	10.3	6.9	5.4	2.0	9.1	5.5	9.4	4.9	8.2	4.9	12.0	10.0	2.6	56.9	5.0	4.2	9.6	8.6	6.8	6.2	5.4	9.7	7.3	10.5	7.7	10.8	7.2	24.8	12.6	6.4	17.3	10.0	5.6	4.8	7.1	4.4	6.7	14.5	13.4	11.6	6.0	7.0	6.5	9.2	9.7	22.4	4.2	11.2	1.8	11.1	8.5	4.8	5.7	13.2	12.8	7.6	6.8	2.2	13.8	8.5	12.5	7.2	11.6	13.7	10.4	18.8	11.4	9.0	14.5	16.7	13.0	9.2	11.9	5.8	15.6	17.3	8.5	46.1	20.9	20.4	4.0	5.7	29.6	49.1	27.9	19.9	17.7	149.7	10.6	18.7	46.7	16.6	24.1	15.3	18.0	4.7	11.9	18.8	46.1	8.6	14.7	10.7	317.0	26.7	11.0	6.8	24.4	13.7	29.1	16.2	13.6	23.7	16.5	53.1	12.9	14.2	79.2	34.1	11.7	37.2	10.0	16.2	17.6
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20803278	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"pancreas: 809.6"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 863.6;Alveolar cells type 2: 748.9;Hofbauer cells: 1257.5;Ito cells: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.0;myeloid DC: 16.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 16.1;monocytes: 8.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 74.4;OE19: 16.9;RT4: 29.1;TIME: 38.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1500000000	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	79.2	48.4	28.7	12.0	38.5	1.6	59.7	4.0	32.2	21.3	33.7	57.8	63.6	16.8	13.6	49.1	19.3	24.3	37.5	70.3	41.2	21.6	33.8	8.6	94.3	23.5	39.0	16.0	19.2	809.6	6.7	4.1	79.0	25.1	23.0	39.8	106.4	15.9	35.6	31.7	10.8	20.6	26.6	52.3	34.5	87.9	86.5	27.1	7.8	11.2	14.3	7.2	29.0	10.9	0.0	16.1	1.3	8.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	74.4	0.0	7.2	0.1	0.0	0.0	0.0	0.5	0.3	16.9	0.0	0.0	0.0	0.3	0.0	29.1	0.3	0.3	0.0	0.2	0.0	0.5	0.0	0.0	38.7	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.0	0.0	1.0	1.3	8.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	2.0	28.7	38.5	4.0	32.2	41.2	21.6	39.0	16.0	25.1	27.1	863.6	748.9	16.1	0.9	31.6	0.0	58.9	40.8	58.9	295.7	15.7	0.0	12.0	0.0	8.2	17.6	308.3	107.7	0.0	270.1	10.2	30.9	1.4	23.3	4.9	1257.5	1.6	46.9	532.2	311.7	43.1	29.7	100.6	38.8	4.6	398.3	0.8	308.4	78.7	10.3	0.3	1.8	97.0	15.6	7.0	5.3	24.6	21.6	7.5	165.1	1.7
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3544793-3558616	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034817, HPA043037"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA034817: , HPA043037: AB_2678280"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	16.6	12.8	10.1	14.5	15.4	14.7	16.1	11.0	13.1	9.7	12.1	11.4	10.8	11.8	13.3	14.0	14.1	10.0	11.0	18.5	13.1	10.3	10.9	17.0	11.2	18.3	12.9	11.4	10.1	15.1	10.5	10.8	11.5	12.3	11.2	12.6	9.5	11.2	16.0	35.3	11.3	11.3	17.7	11.9	12.4	11.8	13.8	12.5	10.9	10.1	10.3	14.5	12.8	11.8	16.6	15.9	7.4	12.8	17.2	14.6	10.8	8.8	20.6	7.1	12.1	7.5	7.8	15.9	14.5	12.6	12.4	10.0	15.7	10.7	17.0	15.7	13.0	17.8	9.7	11.9	11.8	9.9	12.7	7.8	14.7	12.2	26.3	14.2	19.1	13.9	6.9	9.9	13.4	15.8	5.4	10.9	27.2	20.0	17.0	12.7	17.5	11.3	10.7	13.8	17.7	15.4	13.8	11.7	17.8	7.5	15.6	12.0	15.7	12.3	8.6	12.1	6.9	7.3	7.3	11.2	16.4	11.2	13.0	20.1	25.2	34.1	28.4	15.3	14.4	21.4	2.8	11.5	7.4	14.5	12.8	14.6	16.6	12.7	13.6	14.2	13.8	12.9	12.5	3.2	17.2	11.1	15.9	11.2	10.8	10.1	15.4	11.0	13.1	13.1	10.3	12.9	11.4	12.3	12.5	20.8	5.8	33.5	22.9	6.6	24.6	21.5	10.2	13.4	6.8	3.5	19.6	27.2	31.5	32.0	2.8	17.3	13.6	0.0	42.6	35.7	17.7	24.8	27.6	15.3	27.4	33.4	14.5	14.1	16.4	2.3	12.7	15.4	10.1	37.9	11.2	16.4	36.8	7.0	24.8	20.1	17.0	19.4	19.0	18.4	29.0	10.7	30.6	16.0	14.7	29.8
RNASEH2C	"AGS3, AYP1"	ENSG00000172922	"Ribonuclease H2 subunit C"	Q8TDP1	11	65714005-65720947	"Disease related genes, Predicted intracellular proteins"			"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065375	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065375: AB_2685481"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	10.3	18.0	16.6	16.6	17.9	29.9	16.2	33.3	21.2	13.4	18.9	13.5	19.8	15.6	19.1	12.6	8.8	15.7	16.0	25.8	14.8	11.4	14.5	10.0	10.6	22.6	20.1	9.6	24.7	17.0	19.7	22.2	10.0	14.5	20.2	7.9	14.6	13.0	22.4	10.9	20.4	14.3	11.5	11.0	25.0	13.6	7.3	19.1	20.0	14.2	12.0	14.4	14.6	17.1	12.6	20.1	3.6	13.5	9.4	10.3	9.4	5.1	6.2	8.5	6.0	7.3	3.4	3.6	3.4	2.4	9.9	7.9	6.5	8.2	10.6	4.0	3.7	12.8	8.4	6.4	5.0	6.5	8.9	18.1	9.4	18.6	3.4	0.7	1.5	10.4	3.7	1.7	8.5	2.6	5.4	4.0	10.9	4.7	13.1	3.7	8.6	17.7	11.9	5.4	2.7	9.0	16.2	4.9	16.6	2.6	3.5	10.9	8.7	1.8	6.8	3.3	2.5	9.9	5.1	3.6	10.0	8.1	7.3	4.7	13.0	4.0	2.3	13.9	8.2	8.5	2.7	13.5	3.6	10.3	9.2	10.2	11.7	6.8	7.6	8.5	12.6	8.6	6.8	2.8	9.4	6.9	20.1	6.7	9.4	16.6	17.9	33.3	16.3	14.8	11.4	20.1	9.6	14.5	19.1	23.8	32.8	96.1	92.8	28.0	25.3	54.6	91.7	34.8	23.9	64.6	7.9	68.7	89.5	55.7	29.6	77.7	75.9	140.2	40.5	92.5	63.1	75.9	64.6	90.4	112.4	22.3	123.3	101.3	90.4	104.8	125.7	55.3	60.8	65.9	45.1	30.6	48.8	66.2	94.0	205.6	23.2	109.9	87.2	53.0	71.1	32.2	173.9	62.3	50.2	83.3
RND1	"ARHS, Rho6, RHOS"	ENSG00000172602	"Rho family GTPase 1"	Q92730	12	48857145-48865898	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.8;liver: 50.6"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 2: 240.1;Ductal cells: 153.1;Exocrine glandular cells: 130.1;Pancreatic endocrine cells: 223.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"SK-BR-3: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077800			Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	NA			"Vesicles, Plasma membrane, Actin filaments"		"HPA077800: AB_2686854"	"unprognostic (5.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (8.38e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.35e-3)"	2.9	1.3	9.9	2.6	15.0	2.0	2.8	2.6	21.8	1.4	2.8	1.4	0.2	2.6	4.4	1.5	1.8	1.1	13.3	2.5	7.4	7.6	1.8	50.6	12.3	1.4	7.1	8.6	0.9	2.0	3.2	3.2	1.6	8.6	3.7	2.3	1.0	4.0	1.5	0.6	0.6	2.3	2.6	5.6	0.9	6.1	0.8	2.3	0.0	5.5	2.1	2.4	6.9	2.0	1.7	1.7	0.0	0.0	0.5	1.6	0.2	0.6	4.3	2.1	1.2	0.4	0.0	0.3	0.0	0.2	0.6	0.7	2.7	0.9	3.3	0.8	0.0	0.2	0.0	1.7	0.1	0.4	1.0	1.0	0.4	0.0	1.6	0.2	1.0	0.6	0.0	0.1	0.3	0.4	0.0	1.1	2.2	0.1	3.3	0.0	5.5	0.4	0.2	5.1	7.4	0.2	1.0	0.2	1.5	0.6	0.8	0.0	0.6	0.1	39.2	0.1	5.4	3.8	0.1	0.2	0.0	0.4	0.0	0.5	1.7	2.8	5.9	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.6	1.7	0.2	0.1	1.7	1.1	0.7	0.1	0.0	0.5	0.0	0.0	0.4	0.2	9.9	15.0	2.6	20.4	7.4	7.6	7.1	8.6	8.6	2.3	26.8	240.1	2.4	4.0	10.2	2.7	3.6	12.7	9.4	33.0	1.8	7.9	0.9	0.0	153.1	0.4	18.8	10.5	0.0	130.1	0.6	5.6	18.5	14.0	9.6	1.0	0.0	30.2	1.8	0.3	0.0	0.0	10.2	13.5	10.8	4.1	3.2	223.3	14.0	0.4	1.3	3.3	0.0	18.6	0.7	1.7	9.3	1.3	5.0	3.1	7.3
RNF10	"KIAA0262, RIE2"	ENSG00000022840	"Ring finger protein 10"	Q8N5U6	12	120533480-120577594	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052643	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA052643: AB_2681897"	"unprognostic (1.54e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.58e-2)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (5.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.40e-1)"	26.2	37.7	32.6	23.0	34.5	64.3	64.2	33.4	44.0	27.7	30.5	25.3	30.1	23.8	24.1	41.4	40.2	22.5	32.2	79.6	32.4	27.0	36.0	37.9	43.8	44.8	27.2	27.0	25.2	34.0	36.0	27.0	26.5	21.9	25.2	27.7	23.8	26.6	33.8	118.9	26.6	29.5	32.1	26.9	29.0	28.1	46.0	23.5	23.9	25.7	45.0	27.0	28.4	51.7	11.3	17.7	49.7	15.2	13.1	17.2	14.0	29.9	39.7	19.5	31.0	38.3	30.4	23.1	28.2	32.2	23.5	25.1	32.7	13.9	35.6	25.9	46.6	18.4	20.7	35.7	38.3	33.6	34.9	20.0	36.3	22.2	33.6	51.5	32.5	25.7	30.9	44.4	33.0	45.4	40.9	47.5	26.9	36.1	24.7	35.2	34.5	21.4	35.8	29.6	28.0	39.6	19.2	25.1	50.8	46.5	61.7	19.2	20.9	39.3	25.4	21.6	28.3	40.9	18.9	37.7	17.1	19.2	27.3	18.2	21.4	38.2	25.2	28.4	22.2	18.3	41.0	15.2	49.7	14.3	13.2	15.5	11.3	14.1	16.3	17.7	10.0	12.8	12.8	35.1	13.1	14.8	9.1	17.2	14.0	32.6	34.5	33.4	44.0	32.4	27.0	27.2	27.0	21.9	23.5	23.8	27.5	42.7	46.5	55.1	36.2	82.7	25.5	8.1	20.5	45.4	21.6	51.8	139.3	44.1	48.0	40.9	63.6	23.3	51.0	58.9	41.3	56.3	36.8	39.4	32.6	52.4	47.3	42.4	43.0	33.1	52.6	32.9	54.0	43.3	45.8	30.4	52.5	56.8	51.6	53.3	50.7	51.8	51.4	131.6	55.8	57.5	93.5	44.8	40.1	68.6
RNF112	"BFP, ZNF179"	ENSG00000128482	"Ring finger protein 112"	Q9ULX5	17	19411125-19417276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 47.5"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 3.2;Fibroblasts: 3.0;Muller glia cells: 7.7;Peritubular cells: 3.5;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in some"	8	"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;fHDF/TERT166: 4.8;SCLC-21H: 4.8;SH-SY5Y: 8.4;U-87 MG: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015970	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA015970: AB_1859103"	"unprognostic (1.16e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.43e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-9)"	"unprognostic (1.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.24e-1)"	2.5	8.1	11.3	2.3	15.9	0.6	1.8	47.5	29.1	1.2	3.6	1.4	0.0	2.9	2.0	6.9	1.1	1.5	4.4	2.3	12.4	8.2	1.2	0.7	1.7	1.4	3.9	14.1	1.3	0.8	0.5	1.9	1.1	3.1	10.2	4.4	1.6	1.3	3.5	2.1	1.9	3.6	3.5	2.9	1.7	2.1	2.0	3.7	0.0	0.9	0.0	0.8	2.8	1.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	4.2	0.1	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	3.4	0.0	0.0	1.7	0.2	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.1	0.1	0.2	0.0	0.0	4.8	8.4	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	27.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	15.9	47.5	15.9	12.4	8.2	3.9	14.1	3.1	3.7	0.0	0.0	0.0	0.0	0.9	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	3.5	0.0	0.4	6.5	1.5	1.1	0.7	0.9	0.2	0.0	0.1	0.1
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953892	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1239.3;Late spermatids: 628.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 110.4"	"Low region specificity"	"Detected in all"							HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.36e-2)"	23.2	21.3	24.4	18.3	25.7	31.2	20.6	26.7	23.1	24.0	29.7	32.6	21.1	29.5	20.3	23.4	20.2	23.6	20.1	21.9	23.0	25.3	30.3	31.6	24.4	24.0	28.3	19.4	28.4	36.8	16.1	21.6	40.6	23.7	24.5	21.3	27.1	27.8	24.1	43.8	15.2	33.9	17.6	29.3	36.3	24.2	101.9	24.1	28.3	37.9	20.0	24.1	22.6	25.0	28.5	32.5	43.4	44.6	23.7	29.4	34.9	15.9	15.7	8.1	8.5	16.7	11.5	23.8	14.3	16.2	29.6	12.6	46.6	13.1	7.7	28.6	7.5	18.1	12.8	12.0	14.4	10.3	14.0	8.8	9.8	10.5	32.7	14.7	17.8	11.8	10.0	13.3	11.3	7.8	10.1	7.0	13.4	18.4	9.1	8.6	53.8	14.9	18.5	8.3	12.5	22.6	16.3	8.5	14.0	15.6	13.0	12.4	8.9	17.5	110.4	22.1	6.9	29.4	16.6	9.2	26.8	12.5	14.0	16.4	18.7	19.5	14.7	15.2	11.6	14.8	38.5	42.5	35.7	22.0	39.2	24.6	28.2	24.6	22.4	32.5	28.5	29.4	23.7	43.4	23.7	44.6	26.7	28.8	34.9	24.4	25.7	26.7	23.1	23.0	25.3	28.3	19.4	23.7	24.1	44.7	50.1	53.6	105.2	95.2	25.2	37.5	28.1	32.1	28.4	66.3	11.8	79.1	61.3	83.5	1239.3	54.7	64.9	23.3	88.7	65.1	64.6	89.9	43.9	57.8	95.3	38.1	58.0	44.8	69.1	628.0	65.3	62.5	67.4	101.0	68.6	36.1	81.0	69.1	56.3	87.7	19.7	38.8	75.9	206.1	156.2	76.2	104.4	48.0	73.6	96.0
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824077	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	7.2	5.2	6.8	4.8	6.8	6.4	7.7	16.2	7.0	6.3	3.4	4.6	5.7	3.5	8.9	5.0	5.8	4.3	4.8	23.5	5.8		5.6	5.1	3.9	5.6	4.7	6.2	4.7	4.5	5.8	5.9	3.5	5.2	6.5	3.8	7.3	3.6	5.6	27.6	3.8	3.1	10.9	4.5	4.2	3.8	3.4	4.5	6.0	5.0	5.4	4.5	4.1	6.3	2.7	2.4	9.0	2.2	3.2	3.2	1.4	11.3	4.7	5.8	4.3	10.7	14.0	4.7	8.6	16.0	6.4	7.8	5.1	4.1	8.0	9.8	12.2	6.3	8.0	6.4	5.9	6.9	8.0	4.2	6.4	6.1	4.7	6.7	9.9	14.8	8.1	5.2	6.4	7.8	7.3	8.1	6.3	6.3	13.1	11.5	8.6	7.2	6.3	7.3	7.2	10.0	7.0	5.8	6.6	12.4	3.8	5.9	8.1	7.0	8.6	6.4	7.5	9.5	9.5	10.0	9.3	7.3	5.6	9.1	11.0	10.4	8.4	4.7	6.7	5.9	9.0	2.2	3.2	3.2	1.5	2.7	2.7	2.2	3.2	1.8	2.4	2.3	3.1	1.7	3.2	1.6	2.4	2.0	1.4											14.9	29.8	29.4	28.9	18.3	96.0	134.9	25.5	24.1	26.1	17.4	108.0	23.1	28.2	34.8	52.4	66.1	14.0	23.3	69.3	24.5	48.2	51.0	31.1	28.7	32.3	77.9	26.0	66.3	32.6	18.4	36.5	29.9	37.1	88.4	19.7	66.7	49.7	20.9	76.0	37.2	104.3	58.2	49.2	78.7	54.1	15.7	16.6	66.0	23.8	32.8
RNF121	FLJ11099	ENSG00000137522	"Ring finger protein 121"	Q9H920	11	71928701-71997597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046041	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA046041: AB_10965850"	"unprognostic (1.36e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.72e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.70e-1)"	9.8	14.1	18.5	14.0	14.9	6.5	14.1	18.5	16.6	12.6	13.0	12.4	22.4	18.5	17.9	26.3	10.6	14.3	10.8	13.1	11.7	11.7	20.2	16.9	9.4	8.9	12.4	13.4	15.0	15.6	24.1	19.4	18.9	12.1	13.5	13.1	15.7	18.0	19.5	19.2	11.8	18.7	14.1	10.1	10.1	12.8	16.3	13.6	8.9	15.6	8.1	15.3	11.9	10.4	5.9	6.9	8.8	5.5	5.6	7.0	5.1	4.9	10.8	11.1	8.2	10.8	8.5	7.8	9.2	9.9	14.6	15.4	21.0	11.0	4.6	8.1	10.3	14.2	11.7	12.2	11.1	15.8	6.6	7.1	7.7	10.5	10.3	8.0	6.7	6.6	8.0	9.9	15.8	9.5	15.8	26.0	7.3	11.6	4.9	12.8	11.2	4.5	7.7	7.7	22.5	11.0	5.8	23.5	4.3	16.5	9.7	7.9	8.5	11.9	10.2	16.7	12.3	11.8	4.9	16.1	10.4	9.8	6.9	7.7	6.0	5.4	5.2	9.0	4.4	9.1	8.8	4.1	4.0	5.6	5.5	7.0	5.9	4.7	4.5	3.9	2.2	5.3	5.9	2.1	5.6	3.9	6.9	3.9	5.1	18.5	14.9	18.5	16.6	11.7	11.7	12.4	13.4	12.1	13.6	6.0	14.0	12.6	8.9	7.8	15.3	7.9	12.7	6.7	4.5	19.2	19.6	28.1	6.6	23.5	3.1	4.9	16.2	23.3	28.0	22.0	10.8	9.4	6.9	12.1	12.5	9.5	9.2	8.0	5.7	2.0	12.0	10.2	10.1	17.2	10.4	17.5	24.0	9.9	11.7	16.5	17.5	19.4	9.0	21.6	17.7	5.1	26.0	12.8	8.3	8.2
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689499-49721529	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA065983: AB_2685592, HPA071879: AB_2686468"	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	5.3	8.0	7.7	8.0	10.4	17.5	5.0	13.8	13.6	5.2	6.8	6.2	7.8	12.7	6.4	8.0	7.5	6.4	7.0	12.9	8.5	6.8	8.4	21.8	5.7	6.1	7.3	6.6	5.1	7.7	8.9	8.4	7.3	6.6	7.3	4.8	7.6	6.9	6.7	81.2	7.7	12.5	6.2	6.7	7.6	6.9	8.8	7.8	8.3	6.2	12.0	9.1	6.6	4.8	11.3	12.7	11.8	10.9	7.7	11.4	5.3	6.7	9.6	11.4	11.8	17.4	10.8	12.3	8.8	11.7	11.3	12.6	10.2	11.7	16.5	8.1	12.6	10.0	8.5	8.6	13.3	7.9	10.9	11.8	13.4	18.9	22.3	17.4	13.0	14.6	13.6	13.1	10.6	12.3	11.2	11.6	16.8	14.1	14.3	9.5	10.1	13.7	21.1	6.3	8.5	15.5	6.5	7.0	17.0	15.4	11.5	7.8	15.7	12.2	10.8	13.4	6.7	11.1	23.4	12.0	9.9	12.1	8.9	10.9	19.5	19.1	6.6	14.1	16.5	14.9	11.8	10.9	7.9	11.4	9.5	6.8	9.8	7.2	6.8	8.6	11.3	8.7	8.2	6.3	7.7	9.7	12.7	5.5	5.3	7.7	10.4	13.8	13.6	8.5	6.8	7.3	6.6	6.6	7.8	8.9	4.0	4.4	2.4	2.1	8.6	1.0	20.4	1.4	4.5	3.5	3.9	5.6	5.0	4.9	10.6	3.6	13.1	0.0	4.8	3.6	4.9	4.4	6.9	23.8	4.8	6.4	6.4	9.8	9.9	12.6	6.9	3.2	3.3	4.6	5.9	3.5	6.0	7.0	5.3	8.5	8.2	0.0	4.9	8.7	9.1	2.6	7.1	2.9	6.3	3.7
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663277	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	14.2	14.2	13.4	17.0	13.7	18.7	14.5	12.2	24.7	9.8	16.0	14.8	7.4	24.3	10.4	9.2	19.8	9.5	13.1	14.2	13.1	10.2	11.6	27.9	10.4	19.9	11.4	11.6	12.1	22.4	5.9	10.0	14.1	12.3	10.0	6.3	10.1	13.2	9.3	50.3	21.9	20.3	9.9	10.0	18.6	21.0	33.6	9.3	16.1	8.6	19.5	18.6	13.1	11.2	15.9	13.6	7.5	13.8	17.1	17.3	9.2	25.9	8.6	7.3	10.3	1.7	2.4	12.5	13.6	5.2	7.9	7.5	17.4	9.1	21.5	8.9	5.7	3.1	17.4	4.4	10.2	2.2	14.2	31.8	10.9	9.0	14.4	6.6	21.6	16.1	4.1	8.1	6.5	5.1	3.2	7.2	17.7	21.9	21.7	4.1	20.9	22.1	10.1	19.5	5.5	17.0	16.1	6.3	33.8	6.0	14.5	17.4	13.6	10.3	13.6	13.9	2.6	8.7	17.0	9.4	14.4	10.4	21.1	23.3	38.3	19.0	25.2	18.3	12.7	14.8	0.6	9.8	7.5	17.3	11.5	14.2	15.9	15.7	16.7	12.4	15.6	12.2	11.4	2.2	17.1	13.8	13.6	16.8	9.2	13.4	13.7	12.2	24.7	13.1	10.2	11.4	11.6	12.3	9.3	11.9	6.1	54.8	41.2	122.5	31.3	24.2	15.3	12.0	10.3	8.7	15.7	58.6	46.4	55.4	113.7	26.1	51.9	0.0	66.1	118.3	35.3	49.3	14.9	20.2	38.3	30.2	20.8	20.3	27.6	18.2	19.8	38.3	40.5	56.9	34.2	27.0	95.1	54.9	18.4	25.6	22.0	58.2	45.0	118.2	66.8	126.6	73.7	55.3	49.7	76.9
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812708-149962139	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	24.0	21.3	30.6	19.0	39.4	9.8	28.5	19.9	30.4	19.0	17.7	39.9	16.2	14.3	16.8	33.7	16.8	15.9	20.4	16.4	40.5	29.7	35.8	39.2	31.7	19.6	60.9	26.8	18.1	19.6	23.5	14.9	32.4	40.7	25.5	20.3	19.5	36.1	20.9	18.0	18.4	16.3	20.4	102.2	25.5	17.0	12.5	51.2	13.3	32.1	18.8	15.9	21.4	16.5	8.8	15.7	72.4	31.5	7.8	8.5	14.6	19.7	12.3	8.3	9.5	32.8	20.1	13.9	10.9	28.2	10.6	15.8	10.8	28.4	8.2	16.0	13.4	19.5	18.8	11.1	14.0	14.9	10.0	8.1	9.9	5.7	10.5	21.8	10.6	14.1	21.2	26.6	8.9	24.2	12.8	11.7	7.9	3.1	16.7	9.4	11.1	7.6	7.0	5.5	19.1	9.6	5.5	8.9	34.8	20.5	9.2	4.4	12.7	9.0	13.6	35.2	6.8	25.9	11.2	12.2	14.4	5.8	15.2	7.0	28.4	18.7	16.9	12.1	9.9	7.7	12.9	20.3	16.6	6.8	25.2	8.5	8.8	7.6	7.6	15.7	8.3	7.3	7.5	72.4	7.8	31.5	11.2	8.3	14.6	30.6	39.4	19.9	29.2	40.5	29.7	60.9	26.8	40.7	51.2	101.3	59.5	39.3	61.2	65.4	43.7	25.6	38.2	34.8	61.4	45.4	27.5	86.4	36.5	54.3	2.2	62.6	27.6	0.0	62.0	65.2	68.3	63.5	58.9	46.6	172.6	20.6	19.4	77.3	168.9	4.7	70.5	155.4	97.8	42.3	26.4	85.9	48.5	29.6	82.7	59.8	32.2	90.5	50.9	19.7	29.6	63.2	43.8	51.0	24.3	45.5
RNF135	MGC13061	ENSG00000181481	"Ring finger protein 135"	Q8IUD6	17	30968785-30999911	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021576, HPA052404"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA021576: AB_1856331, HPA052404: AB_2681817"	"unprognostic (1.13e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (6.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.47e-1)"	18.2	11.6	6.5	15.9	7.1	7.1	28.8	6.4	6.1	16.3	22.2	7.2	16.5	9.7	15.7	16.8	18.4	11.8	14.4	7.4	7.1	4.8	19.5	6.0	19.0	28.0	6.8	2.5	15.1	11.7	15.0	5.9	19.2	6.3	18.1	13.2	13.6	13.3	14.8	7.5	21.4	16.7	13.9	6.1	22.7	10.0	8.8	4.8	6.0	25.0	12.7	18.8	13.0	19.1	11.8	18.4	21.7	25.1	5.4	5.3	9.7	5.9	12.4	0.7	12.3	17.0	13.5	10.5	4.7	7.1	4.6	4.1	0.0	4.5	4.8	7.0	9.0	8.2	7.6	6.1	5.8	3.7	4.6	2.6	2.3	3.7	0.0	11.9	6.0	5.2	13.4	30.6	4.9	15.9	7.8	7.3	0.0	0.0	16.4	7.4	7.9	0.0	6.1	5.0	11.5	6.7	12.6	0.0	17.6	6.4	8.5	4.6	0.2	6.8	2.9	6.8	8.3	18.8	9.3	6.4	0.0	1.6	7.5	5.3	0.2	0.5	3.4	8.2	10.4	6.3	9.1	24.0	12.1	5.3	21.8	2.9	11.8	2.8	2.7	18.4	11.2	1.5	2.7	21.7	5.4	25.1	6.6	3.8	9.7	6.5	7.1	6.4	6.1	7.1	4.8	6.8	2.5	6.3	4.8	3.0	5.1	6.5	11.6	8.2	0.0	3.2	7.6	4.0	2.3	10.4	0.0	38.0	24.9	8.1	0.3	10.8	20.4	0.0	16.3	30.0	10.8	9.4	1.1	2.4	45.6	0.0	4.7	28.8	64.6	0.6	15.5	22.7	15.1	36.1	11.5	3.2	9.9	11.5	14.5	34.9	0.6	25.8	12.0	0.4	0.9	12.8	36.5	8.6	15.2	9.8
RNF138	"NARF, STRIN"	ENSG00000134758	"Ring finger protein 138"	Q8WVD3	18	32091855-32131561	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4"	"Group enriched"	"Detected in many"	16	"Early spermatids: 845.1;Late spermatids: 2984.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041101			Approved	Mitochondria		NA	NA			Mitochondria		"HPA041101: AB_10805837"	"unprognostic (2.37e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.90e-1)"	8.2	5.0	6.5	11.0	7.4	40.4	7.7	9.9	7.1	6.5	11.0	9.0	5.8	8.0	7.5	6.3	7.4	9.7	7.1	5.0	6.8	6.4	5.9	10.1	7.6	17.9	10.6	6.3	9.0	7.8	5.6	8.7	7.2	6.7	6.5	10.0	4.5	6.9	4.9	5.1	5.6	11.2	5.6	9.1	14.3	6.6	73.4	8.1	28.3	7.0	5.7	9.9	6.1	6.8	14.4	24.3	25.7	24.9	16.4	43.8	24.2	9.1	5.4	22.4	11.1	2.9	6.1	12.7	9.3	5.3	11.7	13.6	6.4	6.4	22.0	11.7	6.1	7.6	9.5	11.7	10.5	16.0	12.2	19.6	17.3	7.0	7.8	11.5	47.6	15.4	5.9	10.6	12.9	18.4	6.8	11.9	19.7	23.8	9.0	7.5	8.7	32.1	21.3	25.0	15.8	7.5	33.2	14.1	12.6	10.7	6.8	25.4	12.7	12.5	7.2	9.7	10.7	4.7	20.1	9.1	14.1	10.3	3.4	10.4	15.0	19.9	38.1	7.7	26.6	13.8	8.0	24.9	24.0	10.5	18.6	13.4	14.0	22.9	14.8	24.3	14.4	43.8	27.9	25.7	16.4	15.3	10.5	16.7	24.2	6.5	7.4	9.9	7.1	6.8	6.4	10.6	6.3	6.7	8.1	14.9	22.4	13.8	29.1	61.6	6.1	6.7	25.5	16.0	18.2	15.7	0.0	25.9	14.9	15.3	845.1	21.2	16.7	0.0	16.0	16.6	21.4	26.1	22.0	14.7	21.1	7.9	28.7	20.3	27.6	2984.7	27.3	30.7	25.3	10.8	21.0	8.0	10.5	20.1	20.8	10.7	4.8	32.3	25.9	118.9	102.4	45.7	7.4	27.7	27.0	31.8
RNF141	"ZFP26, ZNF230"	ENSG00000110315	"Ring finger protein 141"	Q8WVD5	11	10511678-10541230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 903.9;Late spermatids: 383.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 63.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018133	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA018133: AB_1859142"	"unprognostic (7.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.88e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-2)"	14.0	17.6	27.9	14.8	39.0	10.0	15.8	10.2	28.8	10.9	10.0	44.4	6.0	12.5	8.2	11.8	33.7	9.7	8.4	12.8	30.1	23.6	14.2	12.4	12.3	9.4	44.7	18.7	6.5	8.2	19.4	9.5	8.5	33.7	13.6	9.9	7.3	20.6	8.8	23.9	24.2	17.5	7.8	56.2	15.1	12.3	42.2	39.3	7.7	13.3	12.8	15.4	10.6	12.9	19.1	8.2	43.5	29.2	2.4	4.2	8.6	17.7	9.3	12.9	7.8	19.7	19.2	9.5	12.1	9.5	4.6	5.6	13.9	63.6	7.3	11.2	9.3	8.3	12.8	5.5	13.9	7.1	8.0	7.4	5.0	5.9	7.2	7.6	7.9	6.0	12.6	16.2	2.5	15.3	17.0	12.4	9.4	13.5	6.9	11.5	7.4	7.8	2.9	6.5	11.4	5.2	10.0	5.8	8.0	7.4	19.2	4.0	8.5	11.7	13.7	7.5	11.3	8.8	4.2	13.1	11.6	7.2	9.5	3.7	3.1	5.9	8.2	14.2	11.2	13.9	8.5	15.0	25.2	2.5	29.2	4.2	19.1	2.9	2.4	8.2	18.4	3.3	2.2	43.5	2.4	27.0	7.6	3.4	8.6	27.9	39.0	10.2	28.4	30.1	23.6	44.7	18.7	33.7	39.3	17.9	42.2	20.1	35.2	36.2	18.2	41.6	17.8	22.7	11.4	19.2	11.8	11.7	34.9	17.4	903.9	18.9	19.7	0.0	21.5	12.7	11.6	45.2	12.7	24.5	34.2	35.0	20.2	22.1	101.8	383.0	18.1	24.1	18.6	27.9	29.7	19.0	35.2	5.8	18.4	25.6	11.0	6.5	13.7	68.5	25.8	35.0	15.0	10.4	22.5	62.0
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	13.3	20.1	23.9	15.6	23.0	7.1	24.1	30.2	27.3	11.3	11.7	5.7	5.3	4.7	12.6	13.6	26.7	11.4	20.8	16.8	22.0	8.4	8.2	6.1	30.7	36.3	17.5	9.7	14.1	6.0	26.9	29.0	21.9	18.5	11.8	12.6	10.2	17.8	14.8	5.5	14.9	11.0	13.8	12.4	12.7	11.2	7.9	18.0	12.4	14.3	8.0	19.6	19.3	15.7	8.9	2.7	14.4	2.6	2.1	6.2	1.3	20.3	20.1	31.0	37.2	32.8	14.6	6.0	16.3	28.5	15.1	24.6	6.9	16.9	7.0	29.4	14.3	28.8	26.7	24.4	21.5	26.7	28.8	8.7	14.7	22.9	5.7	14.1	9.7	14.1	9.0	38.9	14.1	20.7	21.2	14.8	17.1	14.6	27.1	14.2	0.5	11.0	3.0	13.4	6.4	10.3	14.7	13.5	14.0	20.2	7.0	11.3	20.9	16.5	17.7	26.8	22.1	12.4	8.9	15.8	17.0	15.6	13.6	28.9	6.0	8.3	6.5	19.8	12.1	36.3	2.8	2.6	14.4	3.2	2.5	3.7	8.9	4.7	3.8	1.9	4.4	6.2	4.3	9.7	2.1	2.2	2.7	5.7	1.3	23.9	23.0	30.2	27.3	22.0	8.4	17.5	9.7	18.5	18.0	104.2	213.5	76.8	93.4	109.1	103.7	10.0	79.0	48.2	106.9	34.9	55.0	2.7	16.6	63.7	22.1	50.7	48.5	46.7	99.7	20.5	58.0	100.6	68.1	16.3	39.0	108.1	52.0	127.7	90.9	29.9	42.8	54.8	62.4	223.6	41.8	63.1	90.1	51.8	48.8	8.4	48.6	45.3	49.5	14.9	33.0	86.9	9.2	73.0	57.2	150.2
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.8	24.9	9.7	18.9	30.3	10.1	14.6	9.1	8.4	10.0	13.4	15.4	15.9	7.1	7.9	8.9	14.8	11.5	6.9	12.7	8.4	12.7	24.6	7.5	9.1	21.7	18.7	11.4	22.8	23.4	17.7	10.0	13.7	9.9	22.3	10.6	7.4	13.6	9.7	3.4	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.2	7.4	10.5	11.6	16.5	7.1	26.1	20.8	17.9	5.9	18.5	13.3	14.3	8.8	6.6	13.7	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7	32.8	24.8	20.8	11.4	15.8	34.0	33.0	38.2	20.1	7.9	8.7	3.9	25.1	34.9	24.3	40.1	34.9	12.8	0.0	14.1	22.7	38.1	21.4	21.9	25.2	22.8	28.6	19.7	28.3	67.8	33.7	64.5	25.0	43.9	24.4	11.5	36.1	15.1	13.9	62.6	42.1	18.1	32.3	33.5	44.7	12.2	17.6	32.2	28.7	10.9	14.1
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 123.7"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 255.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 123.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 123.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.91e-4)"	20.3	13.4	7.9	29.0	10.9	32.9	13.5	7.9	10.8	12.5	16.6	10.8	11.4	12.3	11.3	12.8	28.9	14.3	14.5	12.1	9.5	9.4	15.1	19.6	24.5	47.4	13.7	6.2	14.3	21.1	14.3	10.6	19.4	11.2	11.1	12.0	12.8	15.8	8.1	8.8	20.2	16.8	9.6	13.9	65.0	13.8	15.2	9.7	17.0	12.7	13.1	24.4	14.9	17.2	2.1	9.3	123.7	21.3	2.3	9.0	9.9	9.7	5.8	4.4	5.5	16.5	16.6	25.7	12.1	15.9	16.4	18.5	14.5	25.8	2.9	14.7	11.9	21.7	19.9	6.2	12.3	15.3	8.4	8.5	6.0	5.1	24.5	22.1	6.5	9.8	15.1	20.3	19.4	12.9	12.6	29.8	6.4	5.3	9.1	16.4	8.3	8.7	6.5	3.0	13.2	10.5	5.7	7.3	11.2	19.3	23.9	5.8	4.3	7.3	18.1	17.5	5.0	4.9	8.8	19.7	8.3	4.7	12.4	2.6	18.4	10.8	0.1	2.7	9.1	6.1	5.8	13.0	14.8	8.2	20.4	7.4	2.1	7.3	8.1	4.8	1.5	5.1	5.3	123.7	2.3	21.3	9.3	9.0	9.9	7.9	10.9	7.9	10.8	9.5	9.4	13.7	6.2	11.2	9.7	44.7	56.9	34.7	63.4	68.3	20.3	10.6	48.4	24.1	23.9	52.4	53.0	48.5	1.7	48.9	61.2	33.8	33.9	0.0	36.5	60.6	44.7	62.7	37.1	38.9	76.7	7.9	8.2	28.8	255.2	27.7	28.4	171.2	38.8	16.2	35.9	11.9	49.2	36.6	18.4	25.1	19.7	58.2	44.3	31.2	36.2	80.0	107.1	69.8	31.9	137.0
RNF151		ENSG00000179580	"Ring finger protein 151"	Q2KHN1	16	1966823-1968975	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"testis: 64.1"	"Group enriched"	"Detected in some"	131	"Early spermatids: 2032.5;Late spermatids: 1079.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"T-reg: 2.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055054			Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles, Vesicles"	"HPA055054: "	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.39e-3)"	"unprognostic (4.63e-1)"	"unprognostic (1.98e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.43e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.2	0.6	1.2	0.6	0.0	0.0	0.9	0.3	0.0	0.0	0.3	0.6	0.0	1.6	0.2	0.5	0.0	2.0	0.0	0.0	0.0	0.2	2.0	0.4	1.7	1.6	0.0	0.6	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.0	1.2	0.0	1.6	0.8	0.3	0.9	0.0	0.0	2.5	0.0	0.0	0.8	0.1	0.0	0.6	0.3	0.2	1.4	0.0	0.0	1.1	1.1	0.7	0.8	0.2	0.9	1.4	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2032.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1079.9	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	6.5	0.1	11.9	5.1	0.0	0.0	0.0	0.0	0.0
RNF157	KIAA1917	ENSG00000141576	"Ring finger protein 157"	Q96PX1	17	76142453-76240373	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;skeletal muscle: 52.2;testis: 24.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 118.6;Cone photoreceptor cells: 178.7;Horizontal cells: 170.0;Rod photoreceptor cells: 66.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.5;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.3;U-266/70: 22.4;U-266/84: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021854, HPA021991, HPA023922"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202"	"unprognostic (4.21e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.02e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-1)"	10.5	3.5	21.0	3.4	19.4	2.3	2.5	10.7	36.5	1.5	7.6	8.0	0.4	8.2	1.9	3.6	1.5	2.4	1.8	3.6	26.4	15.5	5.1	1.4	1.4	4.5	19.7	12.0	1.4	3.6	8.8	2.7	2.1	25.3	1.8	6.6	6.8	1.9	2.0	52.2	1.5	7.3	2.2	11.3	3.0	2.4	24.7	5.9	0.0	3.8	1.5	2.8	1.5	0.5	0.7	0.4	2.5	0.3	1.1	8.5	1.4	0.1	3.4	12.7	4.6	4.0	2.0	5.9	0.1	3.9	0.8	0.4	1.4	1.4	0.0	1.8	0.3	3.1	0.1	11.2	0.0	0.7	42.3	3.8	0.0	1.2	1.9	0.6	0.5	4.8	1.1	0.0	1.5	0.0	0.7	0.1	2.1	6.6	0.1	1.6	3.4	1.8	0.3	2.1	2.3	9.0	0.0	0.1	0.0	1.5	1.3	2.2	10.5	2.3	0.0	5.0	3.0	0.3	2.1	0.0	0.8	1.1	6.2	3.9	22.4	18.0	0.0	0.3	0.0	6.4	2.5	0.3	0.4	2.3	0.2	4.9	0.3	5.1	4.0	0.2	0.7	8.5	5.5	1.7	1.1	0.3	0.4	2.1	1.4	21.0	19.4	10.7	36.5	26.4	15.5	19.7	12.0	25.3	5.9	3.0	3.5	1.5	0.7	1.8	118.6	8.4	15.3	0.0	2.3	1.8	178.7	0.6	0.0	1.5	22.3	4.4	12.7	0.0	1.0	0.4	1.5	0.8	0.0	4.3	0.3	170.0	2.4	0.6	0.6	21.5	10.6	2.3	1.7	0.0	3.4	34.2	0.1	2.5	13.1	8.2	66.3	0.0	1.0	21.9	22.5	1.9	0.2	12.7	11.0	1.0
RNF165	"ARKL2, RNF111L2"	ENSG00000141622	"Ring finger protein 165"	Q6ZSG1	18	46326809-46463140	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 28.6"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 36.3;Cone photoreceptor cells: 94.2;Horizontal cells: 76.3;Rod photoreceptor cells: 51.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;HaCaT: 7.0;HeLa: 6.9;RPMI-8226: 6.7;SCLC-21H: 13.2;SH-SY5Y: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041615, HPA047798"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA041615: AB_2677582, HPA047798: AB_2680158"	"unprognostic (6.46e-3)"	"unprognostic (7.25e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-5)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-5)"	"unprognostic (3.53e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	1.9	1.7	9.9	1.0	9.5	0.9	2.1	28.6	13.8	1.0	0.8	1.7	1.7	0.4	1.0	8.4	2.7	3.0	1.0	2.5	6.1	4.4	2.3	8.3	1.0	0.9	2.2	7.2	0.5	1.0	13.1	4.8	0.8	2.0	3.6	0.6	2.7	1.4	3.9	3.6	3.5	1.0	0.7	1.7	5.3	0.7	1.3	1.0	1.7	8.8	1.2	1.3	1.2	1.0	0.0	1.5	0.5	0.0	3.9	1.1	0.0	1.5	0.1	12.7	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	7.0	0.5	1.0	0.0	0.0	1.0	0.1	6.9	0.0	0.0	2.9	0.0	0.0	0.8	0.0	0.0	0.3	0.0	2.2	0.0	0.2	0.0	0.0	2.3	1.0	1.7	0.3	1.2	2.4	0.5	6.7	0.8	2.1	13.2	15.0	2.3	0.0	0.0	0.9	0.3	0.6	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	4.1	0.4	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.9	0.0	1.5	0.0	0.0	9.9	9.5	28.6	13.8	6.1	4.4	2.2	7.2	2.0	1.0	3.0	1.7	0.0	8.3	2.4	36.3	7.9	0.0	0.0	3.4	0.0	94.2	0.1	3.3	0.0	2.7	1.9	0.0	0.0	0.0	0.2	1.5	1.7	0.0	5.7	0.1	76.3	0.0	0.6	0.8	3.1	2.3	0.0	1.7	0.0	0.0	3.7	0.1	0.0	3.9	0.0	51.7	0.0	0.8	0.5	0.5	1.8	0.2	2.9	0.0	1.6
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696495-88706421	"Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.9"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 37.7;Macrophages: 37.5;T-cells: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 44.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	9.2	8.1	9.2	22.8	8.9	63.9	10.5	13.7	15.3	6.7	7.2	11.2	3.7	12.0	8.1	8.3	6.4	9.1	12.3	10.0	8.6	7.3	9.6	9.7	20.8	30.5	8.9	6.5	9.7	11.4	5.3	8.5	7.5	8.4	8.9	4.9	11.0	12.1	6.0	14.8	8.2	16.0	8.3	11.1	47.2	10.9	9.2	9.1	21.6	8.8	7.8	23.8	9.7	6.7	2.0	11.8	28.7	12.5	5.5	17.1	9.7	4.2	6.8	5.3	8.4	2.6	2.2	10.1	4.3	2.8	5.1	2.3	4.6	2.7	5.1	5.6	2.5	2.9	4.7	3.1	2.8	2.0	2.6	9.2	6.9	5.0	7.7	6.9	6.8	8.8	2.6	2.7	4.0	3.3	2.8	5.3	8.7	11.5	3.8	2.1	8.3	15.9	44.6	8.7	1.8	9.1	14.9	3.3	13.2	2.3	1.9	4.9	5.5	9.8	2.0	5.3	2.7	5.8	23.3	7.3	3.8	5.7	5.7	5.1	8.6	5.0	12.4	3.4	25.9	5.3	3.0	12.5	28.7	17.1	9.1	14.8	2.0	10.4	14.8	11.8	1.9	8.7	12.5	20.4	5.5	10.5	7.3	10.5	9.7	9.2	8.9	13.7	15.3	8.6	7.3	8.9	6.5	8.4	9.1	8.9	5.1	15.7	4.7	4.2	10.1	2.4	7.6	1.4	3.4	7.0	5.9	7.4	8.3	5.2	1.1	8.0	2.0	0.0	8.0	7.5	8.2	3.6	20.7	4.0	34.7	7.9	4.7	10.4	37.7	1.8	8.6	37.5	10.1	11.8	2.7	8.9	4.6	0.0	7.4	5.6	8.6	6.5	7.1	9.4	8.6	5.1	3.1	66.8	4.1	1.3
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	30.5	45.9	45.8	32.1	47.0	40.7	38.3	37.9	67.9	44.3	43.5	54.6	49.2	42.7	43.1	55.8	51.6	44.0	47.4	40.1	43.1	39.9	44.1	84.1	35.6	38.7	43.7	43.6	42.6	52.4	52.8	40.7	49.0	41.2	43.6	46.7	38.5	49.1	51.7	56.5	51.6	51.1	42.4	46.4	47.1	42.7	42.0	33.1	53.9	55.1	47.3	47.6	48.1	40.7	25.6	18.2	54.4	26.7	27.6	53.0	37.9	24.2	35.2	15.3	18.8	37.8	18.9	22.9	15.0	21.0	31.7	25.1	24.5	11.2	17.9	29.2	24.8	15.8	37.3	26.6	29.2	23.7	17.3	42.8	30.6	44.4	24.1	28.6	14.4	64.6	22.1	46.1	33.0	31.4	19.9	20.4	26.7	11.9	61.3	25.3	17.3	22.7	17.9	18.3	25.7	22.6	15.7	15.3	22.3	36.5	20.4	12.1	15.0	13.8	23.7	20.0	22.4	22.6	14.7	12.5	19.0	12.6	17.0	28.5	20.4	20.6	5.9	26.1	20.8	19.8	22.4	21.4	54.4	53.0	22.6	41.1	25.6	40.6	52.7	18.2	24.0	28.5	42.3	52.1	27.6	26.7	18.0	37.7	37.9	45.8	47.0	37.9	67.9	43.1	39.9	43.7	43.6	41.2	33.1	0.0	3.8	37.8	33.1	60.9	40.7	13.4	66.2	2.7	2.3	47.1	19.6	101.9	48.0	68.5	41.4	35.8	73.2	46.7	58.4	102.1	39.8	31.4	13.9	83.9	52.2	17.5	30.5	38.1	36.1	68.6	45.1	42.0	37.1	57.7	40.4	45.0	52.7	40.3	50.5	53.1	25.5	38.8	27.8	111.1	83.5	72.8	104.7	90.0	54.4	39.3
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165844-64372869	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 54.0"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 31.9;Muller glia cells: 32.9;Sertoli cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favorable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	8.1	8.1	9.9	3.1	12.8	1.6	6.3	6.0	13.0	10.1	7.1	5.5	20.1	3.4	12.7	11.8	6.9	8.1	7.3	10.4	7.4	10.6	12.4	7.2	6.1	3.4	9.4	9.3	12.0	6.6	54.0	16.1	2.0	10.7	11.5	3.0	11.3	7.3	16.4	4.4	6.6	3.2	15.0	11.0	5.1	5.0	8.1	7.1	0.0	20.6	2.5	2.4	10.9	7.9	2.4	1.0	4.2	1.8	2.0	4.2	0.3	0.0	0.1	1.3	0.0	0.0	0.0	0.3	1.1	0.5	1.1	0.6	0.0	0.1	0.0	0.1	0.8	0.6	0.2	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.1	2.7	0.0	0.1	5.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.5	0.0	1.3	0.1	3.3	25.4	1.9	0.3	0.3	0.1	0.0	0.3	0.0	1.7	1.3	0.1	0.1	0.0	3.2	0.1	2.9	0.0	0.0	0.0	0.5	0.0	3.6	3.0	1.8	4.2	1.9	0.6	2.5	1.4	3.0	3.2	0.6	2.4	4.2	3.9	2.6	2.0	0.8	1.0	1.8	0.3	9.9	12.8	6.0	11.7	7.4	10.6	9.4	9.3	10.7	7.1	14.9	10.5	0.0	6.5	4.0	16.5	9.6	12.7	2.7	7.9	15.7	13.7	0.0	6.6	4.5	3.7	5.6	0.0	0.0	2.3	0.1	2.5	5.0	0.0	5.4	0.1	11.1	1.2	12.3	1.2	5.5	31.9	0.2	5.0	0.0	1.6	32.9	2.8	0.6	23.7	14.3	17.3	38.8	17.9	15.4	9.7	6.5	0.0	0.0	0.1	3.8
RNF181	HSPC238	ENSG00000168894	"Ring finger protein 181"	Q9P0P0	2	85595725-85597613	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046112, HPA062121"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046112: AB_2679542, HPA062121: AB_2684687"	"unprognostic (3.79e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (3.24e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.49e-2)"	32.9	41.5	42.2	26.4	36.2	32.8	40.4	19.0	38.7	34.4	40.5	33.0	36.0	34.5	28.1	44.5	40.2	33.3	34.8	52.4	34.5	32.9	57.8	85.1	36.0	33.1	41.2	29.3	31.6	85.1	21.8	20.2	50.7	36.0	34.2	35.4	32.1	42.1	45.7	47.0	30.4	46.5	33.2	42.2	37.2	35.7	36.3	31.3	31.0	43.7	39.2	42.6	43.8	29.4	53.2	80.2	78.6	94.7	39.3	54.4	83.3	32.7	33.2	25.9	28.1	26.4	32.8	41.8	27.7	54.6	59.1	56.3	50.6	34.8	31.2	54.5	41.1	56.1	30.7	22.3	44.3	63.6	35.6	27.5	23.7	17.2	60.8	46.5	26.2	32.5	34.2	59.0	39.4	65.9	45.5	49.1	29.4	27.8	32.5	79.8	52.5	24.7	61.1	18.0	43.3	50.2	26.5	54.4	44.4	55.2	30.5	15.5	20.4	23.4	34.1	45.5	32.5	33.8	34.9	42.4	29.0	20.7	58.0	39.5	45.4	37.8	39.1	45.4	39.7	25.5	40.4	94.7	71.6	40.7	69.3	37.7	53.2	42.6	39.1	71.0	44.3	36.7	36.8	78.6	39.3	51.8	80.2	54.4	83.3	42.2	36.2	19.0	38.7	34.5	32.9	41.2	29.3	36.0	31.3	137.0	86.2	115.3	81.4	103.8	25.0	99.1	145.2	88.3	91.0	143.1	2.0	196.4	353.1	216.8	308.0	104.6	151.4	70.0	252.2	207.3	131.6	104.1	100.4	194.3	230.7	17.5	67.4	87.8	155.3	193.3	81.7	162.9	161.9	198.4	101.4	48.2	256.8	175.4	73.6	513.2	19.4	58.2	121.5	89.5	30.4	103.6	185.0	97.2	90.7	92.8
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980302	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 12.9;brain: 17.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.5;Horizontal cells: 14.3;Muller glia cells: 15.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 37.0;RPTEC TERT1: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.2	0.7	7.6	0.6	6.2	12.9	1.2	16.6	17.6	1.2	0.7	7.5	2.0	0.8	1.6	2.5	1.0	2.7	0.9	1.0	11.0	7.3	2.6	0.5	5.7	0.8	6.8	8.5	1.1	3.6	0.5	2.0	2.9	14.3	0.9	0.6	2.2	1.9	4.7	0.9	0.8	1.1	1.0	5.1	0.5	0.6	7.0	2.9	0.0	3.0	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.8	5.3	0.0	1.8	2.3	0.3	2.7	3.7	7.5	7.3	0.1	0.0	0.0	0.0	2.9	8.2	0.0	6.2	0.0	13.8	0.0	2.0	0.1	37.0	0.0	0.0	0.0	0.0	1.2	0.0	11.6	0.1	8.7	0.1	1.5	0.2	0.0	5.2	0.0	0.0	0.9	3.0	0.0	10.3	1.5	1.3	0.4	29.7	0.0	6.4	6.1	0.2	0.0	10.4	2.0	0.0	1.0	2.8	9.2	2.0	0.1	6.1	0.0	0.0	0.0	6.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.2	16.6	12.1	11.0	7.3	6.8	8.5	14.3	2.9	0.0	0.0	0.0	0.0	0.2	16.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	14.3	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	15.3	0.1	0.0	0.0	0.5	1.2	6.5	0.8	3.0	1.9	0.0	0.2	0.0	0.0	0.0
RNF19B	"FLJ90005, IBRDC3"	ENSG00000116514	"Ring finger protein 19B"	Q6ZMZ0	1	32936445-32964685	"Enzymes, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 54.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in all"		"Daudi: 39.3;Karpas-707: 47.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049587, HPA063640"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA049587: AB_2680826, HPA063640: "	"unprognostic (2.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.39e-4)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (8.78e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.23e-2)"	8.6	11.3	8.0	13.1	10.5	36.4	12.0	14.1	14.1	9.9	13.2	10.1	4.8	14.1	10.8	6.9	23.3	7.9	10.1	8.5	6.0	7.2	12.0	6.5	13.8	12.9	9.6	9.3	7.1	7.0	6.4	5.7	9.4	10.2	7.4	15.3	9.0	10.8	5.7	10.2	13.6	15.5	10.6	8.0	9.0	7.4	54.7	8.3	6.8	8.2	11.1	16.7	11.3	12.8	1.3	1.3	16.1	2.0	0.8	1.6	0.7	6.7	5.2	4.5	4.1	2.7	3.9	30.0	3.1	3.8	5.7	6.1	6.1	20.3	39.3	5.5	4.1	7.0	9.7	5.5	7.5	5.2	14.4	3.6	3.4	4.1	6.1	8.8	5.2	7.2	3.1	14.0	12.5	15.4	6.6	11.9	3.9	4.2	47.3	5.5	2.2	3.4	6.4	7.2	7.7	5.9	4.6	6.4	4.0	4.4	9.8	7.1	3.6	10.0	3.4	22.4	11.5	2.9	7.6	13.0	3.1	4.3	7.8	5.4	11.3	5.7	13.9	4.5	5.3	4.6	5.3	2.0	3.5	1.6	1.8	1.2	1.2	1.4	0.8	1.3	1.3	0.4	0.6	16.1	0.8	1.5	0.6	1.5	0.7	8.0	10.5	14.1	14.1	6.0	7.2	9.6	9.3	10.2	8.3	11.9	4.1	1.9	20.3	41.0	4.4	12.0	15.3	6.7	2.3	7.0	2.0	11.0	1.7	9.3	30.1	8.7	34.3	0.0	9.9	5.4	7.1	22.8	4.6	3.4	12.6	3.2	10.9	3.7	20.2	18.4	2.0	28.7	5.0	43.3	16.5	2.0	19.2	17.5	3.5	7.1	7.4	0.0	5.4	29.3	12.6	28.4	6.2	3.2	10.5	35.3
RNF207	"C1orf188, FLJ32096, FLJ46380"	ENSG00000158286	"Ring finger protein 207"	Q6ZRF8	1	6205475-6221299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 24.2"	"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 28.2;Urothelial cells: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.8;HaCaT: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028378, HPA042535"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA028378: AB_10601157, HPA042535: AB_2678042"	"unprognostic (5.53e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	1.6	2.1	0.6	6.6	1.5	0.3	1.9	5.6	1.8	5.7	5.8	0.9	13.3	2.8	3.6	3.8	4.4	4.7	6.6	24.2	0.7	2.1	5.9	4.3	2.0	2.2	0.7	0.2	3.3	5.3	3.3	4.0	9.2	0.9	7.7	2.4	10.6	6.1	16.6	2.5	1.1	8.2	7.6	1.2	1.9	3.5	1.2	0.6	1.4	6.4	2.8	8.7	5.0	5.0	0.0	0.0	0.0	2.7	0.0	0.3	0.1	2.3	4.5	0.4	3.2	0.2	0.4	2.9	1.5	1.1	0.3	0.4	2.3	17.8	0.3	1.2	1.2	0.0	7.6	0.4	1.1	0.1	2.4	1.8	0.1	5.5	2.3	1.5	1.8	0.1	1.3	0.3	0.0	0.0	4.4	0.1	0.4	0.6	3.9	0.1	1.7	0.2	0.3	0.2	0.4	4.1	0.0	0.8	3.2	2.6	4.0	0.5	1.2	2.4	1.6	1.1	0.8	2.9	0.1	0.5	0.0	0.7	0.5	0.0	3.8	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.2	0.1	0.6	1.5	5.6	1.8	0.7	2.1	0.7	0.2	0.9	0.6	8.9	3.8	0.5	28.2	0.2	3.0	14.6	12.7	4.0	15.9	17.4	2.0	11.4	0.0	13.4	0.7	0.7	6.8	0.0	8.6	5.7	3.7	17.2	0.0	3.4	1.0	3.2	3.5	1.8	0.0	0.0	0.0	1.7	0.0	3.6	9.2	6.5	12.5	2.9	1.1	1.9	18.7	6.5	5.0	0.1	2.3	0.4	4.7	0.5	6.0	32.3
RNF214	DKFZp547C195	ENSG00000167257	"Ring finger protein 214"	Q8ND24	11	117232625-117286445	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 17.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.3;T-cells: 17.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039332	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA039332: AB_10671874"	"unprognostic (7.36e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.06e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	12.9	14.0	13.3	10.5	18.5	11.8	12.3	19.7	21.3	15.4	11.2	22.3	11.7	11.0	17.6	11.8	10.1	11.5	9.6	11.3	13.9	11.3	11.1	12.7	11.6	12.1	14.9	17.4	17.1	28.0	21.5	16.3	12.8	16.6	10.8	12.1	16.8	13.4	13.3	18.4	10.9	10.7	22.2	17.7	12.5	12.9	22.3	14.9	10.9	15.5	11.1	13.6	13.3	12.6	1.8	2.2	4.3	2.1	0.9	17.2	1.3	6.5	8.3	18.7	11.0	9.9	11.2	9.6	12.6	10.5	11.3	12.1	13.1	16.8	9.0	18.5	13.1	11.7	9.7	20.6	9.4	14.2	15.0	5.5	27.8	7.2	9.9	19.0	14.7	10.6	9.0	11.1	14.1	20.9	15.5	14.1	16.0	16.5	9.4	13.8	5.3	11.0	13.1	10.0	11.3	7.1	11.9	12.8	12.1	11.4	11.8	11.6	13.0	13.4	8.7	6.2	15.4	16.2	11.2	13.9	11.2	9.6	7.4	8.6	5.4	4.3	11.2	4.7	11.8	14.6	4.3	2.1	2.2	2.1	2.0	1.2	1.8	7.2	3.6	1.7	1.7	1.9	1.9	0.9	0.9	1.8	2.2	17.2	1.3	13.3	18.5	19.7	21.3	13.9	11.3	14.9	17.4	16.6	14.9	23.8	13.7	8.9	8.0	4.4	21.8	10.1	5.1	13.4	18.2	5.2	9.8	11.8	8.3	10.9	35.5	8.4	8.7	0.0	11.1	11.0	7.3	6.1	4.7	7.4	11.0	12.7	8.6	6.2	7.8	16.5	9.5	9.3	8.5	12.6	7.8	16.7	8.7	8.4	12.0	7.8	39.9	12.9	10.3	49.2	49.3	4.4	16.2	8.4	8.6	5.0
RNF215		ENSG00000099999	"Ring finger protein 215"	Q9Y6U7	22	30368811-30421771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 12.9;Cone photoreceptor cells: 11.8;Muller glia cells: 10.3;Rod photoreceptor cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029427, HPA056498"	Approved		Approved	Nucleoli,Microtubules		NA	NA			Microtubules	Nucleoli	"HPA029427: AB_2732447, HPA056498: AB_2683154"	"unprognostic (1.24e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.67e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (6.37e-10)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	9.8	7.1	17.5	7.3	12.6	8.0	8.0	20.7	24.5	10.1	7.8	7.3	11.9	10.4	14.0	13.0	6.4	10.6	13.3	7.7	11.3	14.4	8.5	8.0	6.9	6.5	10.4	15.2	10.8	15.4	12.6	7.9	9.0	10.7	12.3	5.2	11.2	8.8	11.8	7.4	7.9	5.5	10.9	8.1	8.8	6.9	10.0	5.5	2.2	10.3	1.6	5.0	7.9	8.0	4.8	3.5	3.5	2.1	6.1	4.8	0.9	4.3	9.0	9.5	15.4	9.3	9.8	9.4	7.4	6.7	7.4	4.6	2.5	4.8	1.7	13.4	6.0	14.1	5.4	5.8	8.5	6.0	10.0	7.0	3.0	9.8	3.2	12.9	2.2	12.2	13.3	10.5	12.8	6.9	24.5	8.7	4.6	2.5	8.3	8.8	6.9	1.6	5.4	3.0	6.2	10.1	7.8	5.5	6.8	9.7	6.6	4.2	10.7	7.4	5.5	5.5	9.1	5.0	2.5	12.0	20.2	9.0	5.8	4.3	8.8	2.2	2.3	11.8	1.7	7.8	1.9	2.1	3.5	2.5	1.9	2.5	2.7	2.6	2.0	1.1	4.8	4.8	4.3	1.6	6.1	1.7	3.5	1.3	0.9	17.5	12.6	20.7	24.5	11.3	14.4	10.4	15.2	10.7	5.5	3.0	3.8	0.0	1.2	0.2	12.9	1.7	0.0	0.0	3.4	0.0	11.8	1.4	0.0	1.3	0.6	1.4	0.5	0.0	1.2	1.2	1.6	1.1	0.0	1.7	1.5	7.9	0.0	4.3	1.9	0.2	0.9	0.6	1.7	2.8	0.6	10.3	1.5	0.0	1.1	0.8	12.8	6.5	1.0	1.9	0.9	0.1	1.4	0.0	0.6	1.0
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 118.7;Late spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.3	15.4	12.7	21.6	15.2	13.1	8.7	15.3	16.1	15.9	14.8	11.1	8.2	12.5	7.9	17.1	27.6	10.3	13.1	10.8	13.0	7.8	11.4	9.7	9.3	11.2	18.1	15.8	16.6	13.5	13.8	12.2	14.9	13.2	12.6	12.2	19.3	8.8	17.6	22.0	5.9	25.2	17.4	8.1	12.9	15.1	17.9	7.0	9.5	12.1	9.7	15.4	9.7	24.3	8.7	14.9	9.6	16.2	13.6	16.1	29.1	16.4	13.8	7.2	5.3	10.2	12.1	14.7	25.6	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3	6.0	19.2	11.0	16.6	14.7	36.2	25.7	5.1	13.4	14.8	12.2	49.1	11.9	21.6	15.1	118.7	24.8	10.2	0.0	12.0	11.1	20.5	16.4	18.5	13.4	19.2	27.0	5.8	23.9	19.0	171.4	34.5	23.8	11.8	33.3	12.5	35.8	13.1	3.5	28.3	10.6	49.0	25.8	22.7	96.9	99.0	14.2	12.7	23.0	10.8	13.1
RNF219	"C13orf7, FLJ13449"	ENSG00000152193	"Ring finger protein 219"	Q5W0B1	13	78614291-78659179	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034785, HPA034786"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034785: AB_10601496, HPA034786: AB_2674331"	"unprognostic (2.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (6.87e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-2)"	17.6	7.7	10.7	8.9	15.5	3.4	10.6	24.2	16.3	11.9	8.0	4.7	7.3	7.4	11.3	7.8	8.7	9.1	7.1	10.6	10.7	10.3	7.6	6.7	8.0	13.9	11.9	12.1	12.3	6.6	5.0	11.5	12.2	12.7	10.2	8.5	4.0	7.1	10.1	8.7	8.5	8.7	12.7	13.4	13.6	6.8	21.7	13.4	21.8	9.5	8.5	16.7	12.8	9.2	10.5	7.0	8.2	10.6	12.3	13.3	7.8	11.2	4.4	19.4	11.3	6.8	6.6	8.8	9.4	7.1	9.3	11.7	8.7	8.4	19.0	4.6	5.9	6.1	11.2	15.2	7.4	16.4	11.8	11.1	29.0	5.7	7.7	5.7	28.0	9.1	6.3	8.3	7.7	8.4	5.3	7.6	9.7	7.5	2.6	12.1	3.1	17.0	9.5	0.0	12.0	4.9	19.9	15.9	7.3	6.3	6.0	14.1	7.9	6.5	8.3	7.0	11.5	4.2	22.6	6.2	8.1	7.4	5.3	7.8	2.7	3.1	18.3	13.0	17.1	8.7	4.8	6.0	8.2	9.5	9.7	11.3	10.5	10.7	11.6	7.0	10.1	13.3	11.9	2.0	12.3	10.6	5.9	10.4	7.8	10.7	15.5	24.2	16.3	10.7	10.3	11.9	12.1	12.7	13.4	14.9	3.0	8.0	7.0	7.4	10.5	18.7	10.2	12.0	10.3	8.7	5.9	13.2	5.0	9.1	22.1	14.3	2.7	0.0	3.9	10.1	8.0	5.7	9.3	5.7	8.1	9.5	4.7	12.3	10.6	11.0	13.6	12.8	11.8	7.2	4.7	9.6	7.1	2.9	9.9	7.6	8.0	0.0	5.2	23.9	51.1	10.0	4.2	9.5	7.1	5.8
RNF220	"C1orf164, FLJ10597"	ENSG00000187147	"Ring finger protein 220"	Q5VTB9	1	44405194-44651724	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 37.2"	"Low region specificity"	"Detected in all"							"HPA027577, HPA027578"	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA027577: AB_2672339, HPA027578: AB_10601482"	"unprognostic (3.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.46e-2)"	9.8	7.4	20.9	9.6	38.5	12.7	6.7	12.6	40.1	5.4	9.2	40.7	2.7	10.7	8.0	8.8	6.0	9.3	4.5	9.2	33.4	20.9	7.4	5.1	7.4	7.6	49.8	19.8	9.5	8.1	7.0	5.7	8.7	25.8	7.7	5.9	4.2	9.3	7.1	28.4	8.7	8.8	8.0	57.4	7.9	7.6	7.0	49.6	5.0	7.3	4.6	8.0	7.9	5.6	3.6	6.6	2.8	2.3	1.9	4.3	1.4	6.1	2.9	12.6	4.2	4.9	4.5	9.4	7.2	6.7	5.6	8.3	5.0	6.1	11.9	6.4	5.8	8.0	4.0	14.0	5.9	7.6	14.7	12.5	16.3	9.1	8.4	7.9	11.5	8.4	4.9	13.6	6.2	10.0	4.6	3.2	6.3	12.0	5.9	3.5	4.2	11.3	8.7	13.7	6.7	6.6	9.6	7.4	8.5	3.6	3.8	5.7	7.0	6.1	4.3	8.7	4.6	3.2	20.4	4.9	6.0	6.4	5.6	13.3	13.5	12.9	8.5	4.9	37.2	3.5	2.4	2.3	2.8	3.2	1.8	2.4	2.4	1.0	4.3	3.4	3.6	1.9	1.7	1.5	1.9	1.3	6.6	3.2	1.4	20.9	38.5	12.6	30.8	33.4	20.9	49.8	19.8	25.8	49.6	8.9	12.0	15.9	12.3	13.5	23.6	19.4	25.5	4.0	9.1	22.7	23.6	15.6	14.9	16.5	7.9	16.1	22.2	46.7	24.8	20.6	12.8	18.6	10.4	25.9	22.1	22.3	17.3	15.4	25.1	11.8	17.8	12.8	11.8	15.4	22.6	13.2	19.6	20.1	13.1	27.9	17.0	6.5	9.9	27.4	27.9	15.3	8.5	20.0	25.2	12.7
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663864-218672411	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Actin filaments"	"HPA036420: AB_2675114, HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	13.4	12.7	13.9	11.1	16.1	6.2	13.7	13.4	27.6	17.3	13.3	17.1	9.8	4.3	16.6	16.2	12.2	16.8	11.8	17.2	13.1	16.5	13.7	15.6	11.9	12.1	12.1	11.6	17.8	13.0	19.3	14.8	17.7	15.4	14.7	9.0	15.3	13.6	17.9	16.9	15.7	10.3	16.0	10.0	12.9	11.8	18.4	9.1	15.3	16.8	12.7	16.8	14.0	11.8	13.3	8.2	23.3	11.2	14.8	15.0	13.9	5.9	7.6	6.9	8.0	10.6	6.5	7.5	6.8	17.1	23.4	21.8	12.7	4.0	4.0	5.4	14.3	12.9	5.4	8.0	13.3	10.2	4.3	10.9	5.4	5.6	12.0	13.0	4.8	5.9	14.3	12.4	21.2	14.3	6.5	12.7	15.4	9.1	6.2	15.0	17.0	5.4	5.9	11.0	4.9	8.7	7.6	4.4	5.8	14.3	6.4	7.0	7.9	5.2	5.9	10.1	5.0	7.0	8.8	7.3	13.3	6.3	5.2	9.6	5.4	4.2	6.7	11.2	6.0	8.0	23.3	10.6	14.9	13.9	10.3	12.6	11.9	13.7	13.6	8.2	13.3	15.0	11.7	8.9	14.8	11.2	7.4	11.5	13.9	13.9	16.1	13.4	27.6	13.1	16.5	12.1	11.6	15.4	9.1	0.0	0.3	4.7	4.6	5.6	7.4	3.1	5.1	5.3	2.3	1.8	7.9	11.1	13.3	10.5	10.3	5.9	6.4	0.0	11.4	8.1	7.2	3.0	6.9	6.4	11.3	4.8	1.2	9.2	5.9	3.4	6.6	4.6	8.5	10.0	4.9	7.0	10.2	8.6	12.0	11.5	4.5	25.8	6.1	14.4	11.9	5.9	8.4	10.1	4.8	3.9
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337313	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.73e-4)"	19.0	21.5	13.6	15.4	21.6	25.6	16.9	18.4	38.9	19.8	22.0	17.6	14.5	20.3	31.2	15.6	26.0	24.4	19.8	15.1	17.1	13.8	22.3	28.7	17.3	17.5	15.0	16.6	25.6	18.5	31.4	14.3	27.5	27.2	19.2	18.2	20.2	20.0	28.5	17.6	19.8	21.4	27.0	14.3	19.8	24.3	27.6	13.0	26.7	20.6	14.0	21.1	25.8	18.1	13.8	14.2	7.1	15.5	9.8	16.7	16.2	15.7	17.5	16.4	19.3	16.2	12.8	17.4	17.2	18.6	20.1	15.9	29.5	33.2	14.0	23.8	20.4	30.5	28.8	23.2	25.9	12.6	16.6	12.8	36.8	8.2	24.3	12.4	15.4	15.3	13.3	13.3	25.0	22.6	13.2	15.2	21.7	17.8	22.0	13.8	34.5	14.1	16.0	16.4	18.3	22.4	14.7	16.8	11.1	12.3	11.5	11.7	11.3	13.9	17.6	4.6	16.5	39.9	12.9	10.0	24.3	16.2	12.7	15.6	5.3	8.6	0.1	8.1	26.1	18.9	7.1	15.5	3.9	16.7	14.5	11.0	9.0	12.7	14.5	14.2	13.8	14.5	12.4	1.1	9.8	14.1	8.1	6.6	16.2	13.6	21.6	18.4	38.9	17.1	13.8	15.0	16.6	27.2	13.0	3.0	6.5	9.0	12.0	6.2	9.1	0.5	28.1	2.7	7.9	10.4	2.0	31.3	5.0	17.7	3.4	7.5	10.0	0.0	15.0	54.3	13.5	11.2	7.0	19.8	18.0	4.8	13.2	8.6	9.9	4.9	13.0	8.8	1.7	12.6	10.2	9.7	11.8	10.2	16.6	10.3	7.6	6.5	10.3	12.2	8.3	7.4	20.4	9.6	14.5	8.6
RNF31	"FLJ10111, FLJ23501, HOIP, Paul, ZIBRA"	ENSG00000092098	"Ring finger protein 31"	Q96EP0	14	24146683-24160661	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 5.8;Club cells: 5.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009063, HPA048745"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB009063: AB_2127706, HPA048745: AB_2680509"	"unprognostic (3.58e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	14.4	18.5	11.7	21.5	17.4	20.0	15.1	20.0	26.4	17.7	17.3	18.4	19.9	13.4	22.4	22.3	15.4	17.4	17.2	14.5	10.7	9.8	17.2	14.8	15.3	19.3	11.0	18.0	20.6	23.6	20.0	19.2	18.7	13.4	16.4	14.1	16.9	19.6	23.1	39.5	29.1	16.1	19.7	9.1	27.3	16.5	21.8	11.0	33.6	17.4	13.1	24.9	16.3	13.5	2.4	4.6	3.8	3.7	2.5	4.8	1.3	4.5	10.6	9.9	12.2	6.7	7.0	20.1	7.9	11.7	15.6	12.5	9.6	11.5	9.0	5.0	11.3	9.2	7.8	5.6	11.3	9.3	9.4	4.2	8.4	10.8	21.0	11.1	14.1	15.0	12.8	9.7	7.1	11.1	9.7	9.9	7.5	4.9	11.9	6.9	14.1	13.3	8.3	5.3	7.9	11.6	8.9	7.3	5.7	7.9	18.8	8.8	11.0	7.3	19.3	9.6	9.0	6.8	10.4	9.7	11.0	8.4	8.0	7.4	16.0	14.1	8.8	4.1	5.6	10.2	0.0	2.1	1.5	1.9	3.7	4.8	2.4	1.9	2.1	1.8	1.1	2.3	1.3	3.8	2.5	2.1	4.6	3.0	1.3	11.7	17.4	20.0	26.4	10.7	9.8	11.0	18.0	13.4	11.0	0.0	5.8	0.5	0.2	0.6	0.7	0.2	0.0	1.4	5.7	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.3	0.4	0.2	0.0	0.6	0.3	0.0	0.0	0.6	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.7	0.0	0.1	0.7	0.4	0.6	0.5	0.8	0.0	0.3
RNF39	"HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.3;skin 1: 26.4"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 43.3;Glandular cells: 56.0;Urothelial cells: 159.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"OE19: 8.8;U-266/84: 6.7"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 8.0;hippocampal formation: 4.2"	"Group enriched"	"Detected in some"	5	"cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"		NA	NA			"Vesicles, Plasma membrane, Centrosome"		"CAB019278: , HPA047115: AB_2679938"	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	0.3	0.2	0.1	0.3	0.3	0.4	5.1	0.3	0.9	7.3	0.7	0.0	1.1	0.9	0.8	0.3	28.3	0.8	1.1	0.2	0.2	0.1	0.3	0.3	3.6	0.3	0.2	0.0	0.6	2.3	0.4	0.4	9.7	0.3	8.1	0.4	0.6	10.2	0.6	0.4	26.4	0.4	1.0	0.2	0.2	4.3	0.8	0.0	0.3	0.4	10.1	11.7	7.8	12.4	0.0	0.0	1.3	0.0	0.2	0.0	0.0	2.4	0.0	0.6	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	1.4	0.0	1.2	0.0	0.4	2.2	1.0	0.2	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.1	1.4	0.0	1.8	0.6	0.5	0.0	0.8	0.0	1.1	0.0	8.8	0.0	0.3	0.3	0.0	1.6	0.3	0.2	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.4	0.5	0.0	0.2	1.6	6.7	0.6	0.5	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.2	0.1	0.2	0.0	0.3	0.0	3.0	2.4	0.0	43.3	15.9	0.5	0.3	5.1	1.4	3.4	0.0	0.0	0.0	0.0	5.5	0.4	0.0	0.4	0.0	2.9	0.0	0.4	56.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	1.0	1.7	0.0	14.8	0.0	1.1	0.0	0.5	0.0	0.9	0.0	0.2	20.8	0.6	0.0	0.5	159.5
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202175-56221933	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	22.2	17.6	18.6	11.8	30.2	12.0	14.3	30.9	47.1	16.2	15.0	16.9	12.3	8.5	16.4	9.7	16.5	17.7	18.0	22.6	17.3	22.4	14.1	10.5	16.5	14.8	15.3	18.2	17.0	16.0	17.9	16.7	14.6	25.3	25.2	13.6	14.6	10.5	15.6	21.2	10.1	10.8	20.3	11.8	13.5	12.2	10.1	12.1	11.3	20.5	10.1	17.0	16.2	11.5	24.6	13.1	41.1	11.5	13.4	12.5	12.3	7.5	11.6	12.6	20.0	26.5	19.3	9.4	25.3	25.1	22.8	18.6	14.2	9.9	14.6	13.5	21.4	7.6	8.7	17.0	12.2	16.6	15.3	9.3	19.6	8.3	8.1	55.6	21.4	21.4	24.6	28.7	19.0	33.6	30.1	22.1	12.4	13.9	15.0	12.6	12.2	12.2	9.6	15.2	7.6	13.6	13.3	9.1	8.8	12.1	11.1	23.1	14.0	22.1	12.7	20.0	13.2	17.8	25.2	13.3	11.5	12.3	14.8	9.8	10.8	12.4	13.3	13.7	12.9	13.7	21.0	11.5	41.1	12.5	11.4	11.2	22.7	10.6	10.9	13.1	24.6	11.0	11.2	15.8	13.4	11.2	10.2	12.1	12.3	18.6	30.2	30.9	47.1	17.3	22.4	15.3	18.2	25.3	12.1	41.7	26.4	27.0	18.8	10.6	26.2	20.1	25.5	24.1	25.0	15.7	21.6	13.2	14.9	14.3	78.7	16.4	9.3	23.3	18.6	14.4	14.9	30.9	24.4	14.9	17.6	27.0	19.5	22.1	29.2	38.0	21.3	21.9	6.8	21.6	13.2	23.9	17.8	16.1	24.4	15.8	16.9	25.8	21.4	9.9	12.2	14.4	14.1	15.0	13.6	16.9
RNF44	KIAA1100	ENSG00000146083	"Ring finger protein 44"	Q7L0R7	5	176526697-176538025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 100.6;Late spermatids: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038981	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038981: AB_10674846"	"unprognostic (1.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.57e-7)"	"unprognostic (1.50e-1)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (1.61e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.15e-2)"	10.8	12.7	16.5	27.1	17.7	38.5	12.4	27.1	21.6	10.3	14.8	14.3	7.3	20.5	12.6	10.0	17.0	12.1	12.4	10.0	15.7	10.9	15.2	9.3	14.1	34.9	14.6	13.7	17.8	16.0	10.3	11.0	20.6	13.4	12.8	13.5	11.1	15.9	10.8	10.2	20.5	22.2	8.6	14.5	38.1	16.4	14.5	16.1	43.3	17.3	7.5	24.1	14.1	13.3	4.1	1.9	9.4	3.1	3.3	5.5	2.6	3.7	8.6	13.8	12.8	2.7	2.3	37.0	2.2	1.9	1.4	1.9	13.0	8.3	7.2	13.6	1.2	6.7	10.2	6.1	13.1	1.7	27.7	10.8	7.6	7.3	12.0	3.5	8.8	10.6	4.4	10.6	1.6	5.0	4.8	4.0	14.0	8.5	10.8	2.0	13.0	20.5	19.9	18.2	4.9	10.6	8.4	3.6	10.3	5.0	8.8	17.0	20.7	3.3	9.1	12.5	9.5	10.0	17.8	6.6	3.7	5.6	3.0	4.0	13.8	10.3	9.8	1.8	18.3	4.8	0.0	2.7	4.7	5.5	3.1	4.1	3.5	4.2	4.6	1.8	4.1	4.2	5.0	9.4	3.3	2.5	1.9	5.0	2.6	16.5	17.7	27.1	21.6	15.7	10.9	14.6	13.7	13.4	16.1	11.9	29.4	27.6	8.3	35.7	14.8	11.0	17.8	8.1	15.9	12.2	9.8	8.2	6.6	10.2	100.6	18.0	25.7	0.0	13.9	10.1	10.4	14.5	15.1	8.7	13.1	27.0	39.1	15.4	41.2	305.8	18.4	19.0	5.0	7.2	38.5	8.8	18.6	20.1	11.7	8.4	7.7	6.5	7.2	3.4	10.0	43.3	10.1	35.5	34.0	12.3
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353972-37394738	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.7"					"Low region specificity"	"Detected in all"			"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	8.0	11.7	13.1	8.2	17.8	8.9	11.5	25.7	18.7	9.2	9.5	10.6	6.8	6.9	13.5	5.7	18.3	12.0	8.8	17.6	13.4	14.8	11.8	7.5	10.8	8.3	12.0	16.0	13.2	6.5	11.9	16.4	10.2	13.7	8.6	8.2	8.0	10.2	11.9	15.2	9.9	8.4	10.7	9.6	7.7	7.6	19.8	13.8	6.6	8.0	9.4	13.3	12.9	15.2	8.8	8.3	2.6	8.1	7.6	10.8	5.5	6.6	4.0	9.7	11.5	7.8	11.3	2.8	6.9	8.6	13.2	14.5	6.0	3.7	8.3	4.2	6.7	11.4	6.3	13.5	8.8	13.8	8.7	13.1	14.2	7.0	8.9	4.5	7.6	10.5	5.6	8.5	7.8	9.1	8.1	12.6	9.8	9.6	2.9	7.5	4.4	9.1	9.4	6.7	3.4	5.3	7.2	8.9	5.7	6.7	4.7	19.1	6.4	5.2	5.9	9.5	6.6	5.3	7.4	5.7	8.7	7.7	8.2	10.2	8.6	11.3	40.7	4.2	10.8	10.0	1.0	4.6	2.6	10.8	6.0	10.0	8.8	8.1	10.2	8.3	6.0	7.1	9.4	0.6	7.6	8.1	3.6	9.3	5.5	13.1	17.8	25.7	18.7	13.4	14.8	12.0	16.0	13.7	13.8	17.9	23.4	13.0	21.7	16.3	26.0	28.3	10.2	28.1	15.9	24.4	37.3	20.9	13.3	20.8	35.2	15.8	8.6	0.0	16.6	21.6	23.9	20.0	27.7	14.7	15.4	47.7	21.4	22.1	14.2	20.2	24.7	13.8	10.1	20.8	16.1	21.5	23.6	15.6	29.0	16.8	29.6	12.9	16.4	43.0	33.1	19.3	4.9	15.8	16.2	17.0
RNFT1	PTD016	ENSG00000189050	"Ring finger protein, transmembrane 1"	Q5M7Z0	17	59952240-59964761	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.5"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 175.4;Spermatocytes: 283.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA013739			Approved	Nucleoli		NA	NA			Nucleoli		"HPA013739: AB_1856382"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (3.04e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.45e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.60e-1)"	7.9	6.2	2.8	5.3	4.3	3.8	4.2	5.1	3.7	3.1	4.0	2.4	3.7	5.3	2.7	8.1	4.6	3.2	3.1	4.1	3.1	2.2	4.7	12.0	5.0	4.4	2.9	3.1	3.5	7.5	4.7	6.1	4.4	3.4	4.5	4.8	4.2	5.1	3.0	6.7	2.7	7.6	3.0	3.4	4.1	3.9	45.5	3.0	5.9	6.1	4.3	6.0	5.1	3.7	9.5	10.1	20.2	17.1	8.9	7.7	7.9	4.8	2.2	2.3	3.1	7.6	5.7	4.5	6.2	3.3	4.9	6.0	6.9	1.9	7.2	10.4	5.2	11.1	5.6	7.3	4.7	8.5	6.8	7.9	6.1	5.8	6.2	5.7	9.4	9.4	6.3	2.5	4.6	2.0	2.5	4.9	1.7	17.4	4.5	4.1	6.3	3.8	4.5	0.9	6.6	5.1	5.2	17.5	4.2	3.9	3.5	1.4	2.7	8.9	2.2	12.4	3.2	10.3	17.9	3.5	9.5	8.4	5.5	5.3	6.5	18.1	4.3	6.6	5.3	4.7	17.3	11.8	20.2	5.6	13.9	7.7	9.5	5.2	6.3	10.1	6.1	6.8	6.1	5.7	8.9	17.1	6.7	6.5	7.9	2.8	4.3	5.1	3.7	3.1	2.2	2.9	3.1	3.4	3.0	0.0	6.1	15.9	13.3	10.1	7.7	5.6	2.5	16.0	6.8	8.7	19.6	29.6	5.0	12.0	175.4	7.8	14.4	0.0	12.5	30.4	15.3	14.5	18.5	27.2	40.4	17.5	4.1	11.6	25.1	60.1	8.3	27.8	16.9	36.9	7.6	4.5	12.5	19.3	11.0	8.6	6.8	19.4	8.6	283.8	42.4	8.4	24.1	16.0	10.1	7.2
RNFT2	"FLJ14627, TMEM118"	ENSG00000135119	"Ring finger protein, transmembrane 2"	Q96EX2	12	116738178-116853631	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.3;Cone photoreceptor cells: 15.7;Early spermatids: 40.0;Late spermatids: 40.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064161	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA064161: AB_2685202"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.14e-5)"	"unprognostic (8.62e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.36e-3)"	"unprognostic (4.01e-4)"	1.7	3.2	8.8	2.6	15.1	3.5	1.4	13.6	21.0	1.5	1.6	6.6	0.0	2.0	1.5	4.3	1.5	1.5	1.6	1.4	9.9	12.1	2.0	1.0	1.5	4.1	9.7	9.8	1.7	1.4	2.6	7.5	2.9	19.0	1.2	1.7	3.6	2.6	1.2	2.1	2.7	1.8	1.4	6.2	2.9	1.9	7.0	3.4	2.5	2.1	0.0	4.4	1.2	0.4	4.3	2.2	4.0	1.1	2.8	3.1	0.9	1.5	9.2	4.8	15.6	0.2	0.0	8.0	0.6	0.7	1.9	1.7	3.6	1.8	8.1	2.3	0.1	2.4	1.9	10.2	0.7	1.9	7.6	5.1	1.5	7.4	4.9	2.1	0.6	4.7	0.2	0.2	3.2	1.0	1.6	0.3	5.7	6.2	2.9	0.2	7.8	7.8	1.9	4.8	2.0	1.8	5.1	2.7	4.1	3.7	1.9	7.4	6.7	2.3	1.2	2.2	3.3	7.3	1.8	0.5	1.3	5.3	3.1	3.1	3.7	12.2	8.4	5.9	0.8	1.0	4.0	1.1	1.3	2.0	0.7	0.6	4.3	1.8	1.4	0.6	3.3	2.9	3.1	3.4	2.8	0.8	2.2	1.1	0.9	8.8	15.1	13.6	20.9	9.9	12.1	9.7	9.8	19.0	3.4	0.0	0.3	0.0	0.2	0.0	15.3	0.8	2.5	1.4	0.0	7.0	15.7	2.7	0.0	0.8	40.0	2.1	0.4	0.0	0.2	2.3	0.6	0.3	0.0	0.0	1.8	9.5	4.1	0.0	2.2	40.6	0.6	1.0	1.7	1.0	0.4	6.9	0.7	0.0	1.4	0.8	8.9	0.0	0.4	2.6	3.6	0.0	1.4	0.0	0.6	0.1
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88610272-88963721	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	9.1	12.1	10.2	19.6	12.2	14.2	9.9	18.5	13.1	10.0	8.1	8.7	7.0	7.4	11.1	7.2	12.5	8.7	7.2	9.6	10.5	16.0	9.4	11.8	9.4	26.3	9.8	6.4	10.4	6.6	12.1	23.1	11.6	11.1	9.8	9.8	9.4	8.4	11.6	10.5	9.0	10.7	10.7	10.7	14.3	7.5	15.0	10.4	28.0	10.0	7.8	28.2	10.9	13.8	18.6	4.4	5.7	4.6	8.0	8.4	4.3	5.7	8.8	13.7	17.5	8.1	8.5	8.2	13.2	8.6	10.7	13.6	10.0	4.4	14.9	10.8	9.4	14.2	7.2	16.0	10.6	19.7	20.2	12.5	19.3	7.9	8.0	6.6	20.7	11.0	5.4	9.3	11.1	10.8	9.2	9.4	8.2	19.1	12.0	15.8	7.6	9.1	14.8	8.2	9.5	7.7	18.0	21.2	8.4	9.6	8.9	8.1	11.6	10.9	6.6	7.2	13.6	7.1	20.8	7.5	8.7	8.0	9.8	17.7	10.9	19.0	8.4	12.8	15.5	15.8	3.5	3.0	5.7	6.4	4.6	6.4	18.6	7.2	7.9	4.4	16.8	8.2	8.4	2.5	8.0	3.9	3.1	6.7	4.3	10.2	12.2	18.5	13.1	10.5	16.0	9.8	6.4	11.1	10.4	0.0	18.1	34.7	7.8	7.3	19.8	9.2	2.5	13.4	18.2	12.2	37.3	8.7	0.0	5.7	4.9	4.7	5.9	0.0	4.3	8.0	7.1	6.8	8.1	8.6	6.7	14.3	8.7	6.2	7.5	3.6	5.5	9.8	3.3	6.4	5.7	8.7	5.6	3.5	7.4	5.8	43.3	6.5	7.5	19.9	21.7	7.5	9.8	13.8	6.3	5.8
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		6600000	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	18.5	22.0	6.4	14.9	8.2	9.5	16.7	9.2	11.0	17.8	34.2	13.5	21.2	31.1	17.4	18.7	33.2	19.2	21.8	11.5	6.1	4.6	22.5	18.3	21.5	14.1	7.0	5.4	18.0	19.5	11.6	10.4	26.3	9.0	18.4	26.8	16.4	25.1	13.6	10.0	18.3	66.6	12.8	8.1	22.7	15.7	21.2	6.0	13.9	28.4	19.1	24.7	17.6	17.5	2.3	12.1	12.3	17.0	1.6	3.1	2.2	19.1	20.9	12.5	18.7	20.4	19.2	31.4	14.8	28.8	18.6	21.0	15.0	24.6	4.2	19.1	26.1	11.5	34.9	15.9	29.0	13.0	11.4	20.5	10.5	10.0	14.0	17.4	26.7	37.1	17.5	30.0	16.6	19.1	23.1	33.4	10.4	23.8	6.2	18.8	17.5	3.6	11.4	17.6	30.6	10.4	14.0	17.6	29.6	38.6	17.5	14.4	12.2	36.7	45.8	14.8	25.3	34.8	15.2	23.8	8.7	11.8	8.5	18.0	13.9	11.2	3.8	8.7	22.7	17.4	10.8	9.2	12.3	1.9	15.7	2.6	1.6	2.0	2.2	12.1	2.3	1.8	2.1	6.7	1.6	17.0	4.5	3.1	2.2	6.4	8.2	9.2	11.0	6.1	4.6	7.0	5.4	9.0	6.0	8.9	19.2	23.6	35.3	25.5	11.5	9.0	43.3	13.4	15.9	24.4	9.8	99.1	16.6	59.5	4.4	20.4	152.6	0.0	44.9	74.5	19.0	29.0	15.0	46.6	92.1	11.1	43.1	27.0	67.5	3.8	23.6	48.7	23.6	85.6	66.6	10.8	41.4	81.6	21.5	50.1	7.7	25.8	18.6	15.7	8.2	18.9	73.2	17.5	73.0	31.8
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036772, HPA036773"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA036772: AB_10670848, HPA036773: "	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (7.43e-4)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	17.2	13.7	10.1	13.7	8.8	17.2	48.4	7.2	10.5	11.0	21.0	9.5	11.8	18.6	8.0	8.9	22.1	8.0	22.3	28.3	9.2	6.0	18.2	26.7	32.2	54.1	12.9	8.2	7.1	40.0	7.7	4.3	10.1	8.1	14.9	9.1	7.0	21.5	13.5	26.5	22.5	31.0	11.4	9.7	25.7	20.0	5.9	7.6	23.1	8.8	16.7	12.1	14.4	18.8	7.0	7.6	22.4	9.1	7.6	12.4	5.4	6.9	11.7	2.6	6.9	9.6	10.0	8.9	4.5	11.2	5.0	6.3	3.2	20.6	2.0	2.3	11.3	7.1	7.6	2.9	8.4	0.5	12.2	4.0	4.6	3.8	18.9	24.1	3.0	8.4	11.8	13.6	2.6	5.2	8.1	17.3	8.0	3.4	13.6	3.4	9.8	3.7	11.3	3.4	13.6	4.7	7.9	3.9	16.9	20.5	9.6	2.4	5.2	3.0	10.4	20.3	3.1	7.3	13.8	11.8	5.5	5.7	7.6	5.1	12.9	1.9	2.3	11.3	8.4	8.2	5.8	9.1	22.4	12.4	7.8	10.6	7.0	9.6	11.1	6.4	6.8	5.4	8.1	16.0	7.6	7.6	7.6	11.1	5.4	10.1	8.8	7.2	10.5	9.2	6.0	12.9	8.2	8.1	7.6	20.8	28.4	28.0	12.0	6.9	6.3	30.7	15.3	2.7	10.3	12.2	0.0	6.1	14.9	22.4	2.6	17.8	92.4	0.0	42.5	5.7	9.9	19.0	33.5	37.6	38.2	3.2	25.3	28.3	58.8	3.7	8.1	30.5	21.9	22.6	46.2	12.2	47.4	37.7	12.7	26.5	6.2	12.9	16.5	0.9	8.3	8.2	4.2	40.6	33.1	19.2
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 34.7;Horizontal cells: 49.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 15.2;HEL: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013371	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA		660000	"Nucleoplasm, Centriolar satellite"		"HPA013371: AB_1856391"	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	1.1	3.3	6.4	0.8	13.8	0.3	1.1	19.0	26.1	3.6	1.3	2.2	0.0	0.9	2.9	0.8	6.2	0.4	3.1	1.0	6.3	6.5	2.5	1.8	12.3	1.8	9.6	5.5	9.4	2.2	6.8	2.1	6.4	9.9	1.9	0.8	4.8	2.1	7.8	0.4	3.0	1.2	1.9	7.8	3.6	1.1	4.5	3.6	3.6	0.4	4.2	3.0	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.0	4.3	0.0	0.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.0	41.7	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	4.7	0.0	0.0	0.5	2.7	6.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	13.8	19.0	11.3	6.3	6.5	9.6	5.5	9.9	3.6	0.0	0.3	0.0	1.5	1.5	34.7	1.9	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.1	49.3	0.0	4.3	0.0	1.7	2.8	0.0	0.0	0.0	1.4	0.9	0.3	0.0	5.6	0.0	4.4	0.0	0.8	0.2	0.7	1.0	0.1	0.0	0.0	0.1
ROBO3	"FLJ21044, HGPPS, HGPS, RBIG1"	ENSG00000154134	"Roundabout guidance receptor 3"	Q96MS0	11	124865386-124881470	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.1"	"Cell type enhanced"	"Detected in many"	11	"Muller glia cells: 42.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"AF22: 20.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Low region specificity"	"Detected in all"			HPA071053			Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA071053: "	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.95e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.75e-8)"	"unprognostic (7.27e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-3)"	2.4	1.5	1.5	0.5	1.4	1.3	1.7	0.5	3.1	0.8	0.9	0.5	0.5	1.9	1.8	20.1	0.5	2.1	0.5	1.5	1.5	0.6	0.7	0.5	1.7	0.8	1.1	1.1	7.4	0.5	0.2	0.5	1.5	1.0	1.0	0.2	1.0	1.7	0.5	2.6	0.2	2.2	4.5	0.7	3.0	0.8	1.0	0.5	0.8	1.1	0.5	0.5	0.5	1.0	0.0	1.3	1.4	0.3	0.0	0.8	0.0	0.0	0.0	20.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.5	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.8	1.1	0.0	1.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.3	0.4	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.3	0.8	0.0	1.5	1.4	0.5	2.7	1.5	0.6	1.1	1.1	1.0	0.5	0.0	5.3	0.0	13.5	2.6	0.6	2.8	0.0	0.0	5.7	12.2	0.0	0.1	0.0	6.6	0.2	10.3	1.1	0.0	0.7	0.1	7.6	6.0	9.2	0.0	1.5	0.0	3.4	4.9	2.1	0.0	12.4	8.5	3.3	1.8	0.9	42.6	1.1	2.9	7.8	0.4	1.7	0.0	4.9	3.2	5.9	0.9	0.1	1.7	2.3	5.6
ROBO4	"ECSM4, FLJ20798, MRB"	ENSG00000154133	"Roundabout guidance receptor 4"	Q8WZ75	11	124883691-124898500	"Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Endothelial cells: 62.4;Ito cells: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 64.9;TIME: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065212			Approved	"Plasma membrane"		NA	NA		340000000	"Plasma membrane"		"HPA065212: AB_2685434"	"unprognostic (2.86e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.15e-2)"	33.3	4.5	4.0	5.6	4.5	0.6	21.6	2.0	5.5	11.1	4.4	4.3	3.7	2.8	10.8	7.8	5.3	7.7	8.5	15.5	4.9	3.0	10.6	6.5	24.9	5.8	4.7	2.8	5.9	3.5	3.8	3.8	23.6	5.5	6.0	1.8	9.2	2.9	4.5	12.5	4.5	4.7	8.4	3.6	33.3	4.3	3.9	3.3	1.0	11.6	9.8	2.5	6.2	5.9	0.0	1.2	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	6.2	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.7	0.1	64.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.2	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.0	4.5	2.0	5.5	4.9	3.0	4.7	2.8	5.5	3.3	0.0	6.2	2.4	0.6	1.9	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	62.4	0.0	0.0	0.2	0.0	1.1	0.2	2.3	0.6	0.1	0.0	0.0	172.5	9.1	0.9	4.0	2.0	1.7	0.0	0.0	1.4	0.1	0.0	1.1	0.0	3.6	0.0	0.8	0.0	0.1	1.1	0.0	0.0	0.0	0.1
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615120	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 108.1"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 2384.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 17.9;U-266/84: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028910, HPA073279"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA028910: AB_2672824, HPA073279: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	9.4	4.6	16.3	2.3	15.0	0.9	3.6	5.7	18.8	4.9	3.1	5.1	3.3	2.0	3.8	5.7	4.7	7.4	5.2	2.7	14.7	9.2	2.4	3.2	3.0	2.3	18.1	4.7	13.2	3.2	4.8	2.1	1.6	8.7	3.8	3.0	108.1	2.5	5.9	2.2	3.7	1.7	6.3	21.6	2.5	2.4	3.7	7.7	0.7	3.0	2.2	2.6	3.1	9.2	1.1	0.8	0.8	1.2	5.6	3.2	1.4	2.1	1.2	2.2	4.6	3.2	15.7	0.4	1.4	2.5	3.1	2.0	0.6	3.6	2.0	10.0	8.1	1.3	2.8	1.0	2.8	0.8	3.6	1.8	1.8	5.4	2.6	9.3	0.7	0.6	17.9	4.1	3.2	6.4	10.5	4.8	0.9	2.7	4.6	6.2	5.4	1.1	1.5	0.5	1.1	3.3	1.1	1.8	12.8	3.4	1.2	2.3	3.4	3.5	4.1	1.6	0.3	5.6	0.9	5.4	5.1	1.9	6.0	1.6	2.1	18.8	1.6	9.5	2.1	1.0	0.0	1.2	0.8	0.9	0.3	2.4	0.7	3.2	0.8	0.6	1.1	1.5	1.8	0.4	5.6	1.1	0.8	0.9	1.4	16.3	15.0	5.7	8.4	14.7	9.2	18.1	4.7	8.7	7.7	0.0	4.1	0.0	4.4	3.3	268.3	2.4	0.0	2.7	1.2	5.2	559.6	0.8	1.7	1.3	2.1	8.0	1.6	0.0	2.7	0.2	3.5	2.6	1.1	0.6	1.0	162.1	4.1	11.1	1.8	5.9	17.5	1.0	3.3	1.0	2.8	315.6	1.7	3.4	5.3	4.0	2384.7	0.0	3.4	0.9	2.7	0.9	0.6	0.0	2.9	2.0
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774022-64181498	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 31.2"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 47.6;Intestinal endocrine cells: 20.6;Leydig cells: 25.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 13.0"	"Group enriched"	"Detected in some"	5	"NK-cell: 3.3;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.8;ASC TERT1: 24.8;CACO-2: 16.9;HHSteC: 18.8;HSkMC: 20.3;NTERA-2: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057016			Approved	Microtubules	"Intracellular and membrane"	NA	NA		2800000	Microtubules		"HPA057016: "	"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	5.5	1.7	1.3	3.5	2.7	0.4	3.4	13.0	2.8	16.7	8.8	2.2	4.4	2.0	14.2	5.0	4.9	5.5	10.7	10.6	1.3	1.1	3.6	0.8	9.7	1.1	1.0	2.4	8.3	9.8	31.2	3.6	2.9	3.0	10.9	3.9	7.9	2.8	6.3	2.1	4.5	4.1	17.8	1.1	3.1	9.2	2.7	0.9	1.8	1.5	4.6	2.1	10.2	8.8	0.4	1.1	0.1	0.1	3.3	0.1	0.0	7.1	5.6	2.8	0.4	19.8	24.8	1.9	1.4	3.9	0.8	2.0	16.9	2.3	0.1	3.2	3.3	1.4	1.5	0.0	1.3	0.5	0.0	1.8	0.0	0.7	0.2	18.8	0.0	0.0	20.3	5.2	10.4	12.2	4.0	0.3	0.2	0.0	0.1	5.2	0.1	0.1	0.0	20.6	5.2	2.8	0.1	0.1	4.4	4.1	0.1	1.6	6.6	0.4	0.1	2.9	10.0	0.0	0.0	3.9	1.6	2.9	11.0	2.9	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	3.3	0.1	1.1	0.0	0.0	1.3	2.7	13.0	2.8	1.3	1.1	1.0	2.4	3.0	0.9	47.6	8.0	0.0	1.8	3.4	1.7	8.5	2.5	1.4	2.3	1.8	0.0	0.2	0.0	5.3	7.8	1.3	0.0	0.0	13.4	0.7	7.6	1.5	0.0	0.0	5.8	0.0	20.6	1.3	0.0	4.7	25.6	0.0	3.3	0.0	2.3	4.9	10.7	0.0	13.8	2.8	0.0	6.5	12.0	0.7	1.2	4.0	0.2	0.0	2.6	0.9
RORB	"NR1F2, ROR-BETA, RZRB"	ENSG00000198963	"RAR related orphan receptor B"	Q92753	9	74497365-74693177	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;cervix, uterine: 20.8"	"Group enriched"	"Detected in many"	5	"Horizontal cells: 1322.1;Muller glia cells: 409.4"	"Group enriched"	"Detected in some"	5	"glioma: 2.1;prostate cancer: 2.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HHSteC: 18.3;HSkMC: 10.1;JURKAT: 18.1;MOLT-4: 5.1;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008393	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008393: AB_1079830"	"unprognostic (6.89e-3)"	"unprognostic (4.06e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.81e-8)"	"unprognostic (5.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.00e-2)"	3.1	7.9	8.3	1.2	11.1	1.0	1.4	1.8	35.5	20.8	1.3	2.1	2.2	1.1	8.9	0.9	1.7	1.5	4.5	3.9	5.6	7.0	2.0	1.0	2.0	0.9	4.1	18.7	1.4	1.1	1.1	4.0	10.6	6.1	10.5	1.6	18.7	1.2	11.7	0.9	1.3	1.1	1.7	6.7	1.0	1.6	2.0	3.7	2.2	1.5	0.0	1.5	2.3	2.2	0.2	0.2	1.8	0.2	0.6	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.5	10.1	0.0	0.0	0.0	0.0	0.0	18.1	0.0	2.8	0.0	0.1	5.1	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.4	2.5	0.0	1.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.6	1.8	0.6	0.1	0.2	0.0	0.0	8.3	11.1	1.8	35.5	5.6	7.0	4.1	18.7	6.1	3.7	0.0	3.7	0.0	0.6	1.4	160.1	11.7	0.0	1.4	0.0	0.0	113.9	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.0	0.4	5.4	2.3	1.1	0.0	0.6	1322.1	0.0	1.3	0.0	0.5	0.0	1.3	1.7	0.0	0.0	409.4	0.1	0.0	0.0	5.7	181.1	0.0	3.1	0.5	0.1	0.4	0.1	0.8	0.0	0.8
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117288300-117425855	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 38.6;lung: 20.2"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 56.7"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 7.4;olfactory region: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"GAMG: 16.3;HSkMC: 8.7;hTCEpi: 18.1;LHCN-M2: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.3	0.2	0.2	0.0	0.4	0.0	0.2	0.2	7.4	0.2	0.4	0.0	7.9	0.0	0.2	38.6	0.2	0.2	0.0	0.2	0.2	0.2	0.4	0.2	20.2	0.0	0.2	2.5	0.2	0.2	0.0	0.3	0.7	0.0	0.2	0.3	0.0	0.2	2.3	0.2	0.7	0.3	0.0	0.2	0.2	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.7	18.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.6	0.0	2.2	1.4	0.1	1.7	0.0	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	7.4	0.2	0.2	0.2	2.5	0.0	0.0	14.9	56.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RP9	PAP-1	ENSG00000164610	"RP9, pre-mRNA splicing factor"	Q8TA86	7	33094797-33109401	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: AB_2681233"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"	10.1	13.8	11.7	9.4	16.0	20.7	14.9	17.1	16.0	10.9	12.2	13.0	7.0	10.3	14.6	18.8	8.1	10.0	10.7	19.2	11.1	10.1	11.4	11.5	9.7	19.4	17.4	8.6	14.2	16.9	10.4	14.2	11.7	11.0	14.0	11.8	12.8	15.0	14.4	34.7	10.7	12.5	15.7	11.8	17.2	10.5	15.2	12.6	13.6	15.6	9.0	18.2	13.4	16.0	34.1	11.7	8.1	5.0	5.9	8.4	3.3	9.9	14.3	15.1	17.2	9.6	9.0	7.2	12.7	10.9	14.7	11.8	12.7	7.3	12.6	8.4	10.5	18.1	10.0	18.3	10.9	19.0	5.7	11.4	9.2	11.3	11.8	16.9	12.3	6.5	9.0	10.3	16.7	33.1	12.0	12.0	13.5	16.5	11.6	14.7	20.6	13.2	33.8	12.7	13.3	10.3	13.3	13.1	8.4	10.6	9.6	14.6	20.0	8.9	20.0	21.7	18.7	10.5	17.1	9.6	14.6	20.5	12.9	20.6	18.9	17.1	25.1	10.3	17.6	28.2	6.4	5.0	8.1	6.6	3.6	6.1	22.0	7.0	7.4	5.3	34.1	8.4	7.8	0.9	5.9	4.6	11.7	5.9	3.3	11.7	16.0	17.1	16.0	11.1	10.1	17.4	8.6	11.0	12.6	11.9	8.5	17.4	13.8	18.7	16.3	32.5	12.7	10.7	11.4	14.0	13.7	16.9	18.3	14.1	3.5	21.7	10.5	0.0	13.7	16.3	19.4	11.5	3.5	15.1	16.0	7.9	9.8	14.7	7.6	2.7	16.7	9.9	21.9	9.0	16.4	15.8	13.4	5.8	15.2	13.5	12.9	25.8	20.2	33.0	48.0	15.7	8.7	11.8	18.0	10.7
RPAIN	"hRIP, MGC4189, RIP"	ENSG00000129197	"RPA interacting protein"	Q86UA6	17	5419641-5432876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023924, HPA031526"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA023924: AB_10601890, HPA031526: AB_10601555"	"unprognostic (1.68e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (5.20e-4)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.00e-3)"	12.4	19.5	24.4	12.1	26.4	14.9	22.1	18.3	24.0	14.6	13.4	12.1	18.4	12.1	13.8	21.6	11.9	17.0	12.2	25.4	20.2	21.0	17.1	19.3	11.5	12.8	18.0	24.9	17.4	15.8	10.9	25.5	12.0	19.7	14.5	14.6	12.9	11.9	14.0	41.6	12.3	9.5	13.5	17.5	10.5	14.6	11.4	18.9	16.2	12.1	15.8	15.0	12.2	10.5	25.3	19.3	22.3	13.4	12.1	24.7	13.0	8.6	19.4	20.3	16.6	15.4	11.7	8.8	8.7	16.6	19.3	17.3	11.4	3.1	10.4	12.3	5.6	13.6	9.2	26.2	8.3	16.7	10.7	19.0	8.1	9.5	14.4	19.9	10.4	18.7	10.0	17.0	11.7	23.8	23.1	17.0	34.3	8.6	6.7	10.5	7.4	23.9	19.0	10.4	10.6	9.9	11.5	14.6	9.2	14.2	10.1	13.5	24.0	7.9	6.2	22.5	15.6	9.0	14.5	8.3	6.0	8.2	4.9	16.8	6.6	10.9	10.4	8.9	10.7	9.1	11.2	13.4	22.3	12.5	12.0	15.8	25.3	17.0	16.2	12.8	21.4	20.4	18.2	2.4	12.1	10.5	19.3	24.7	13.0	24.4	26.4	18.3	24.0	20.2	21.0	18.0	24.9	19.7	18.9	65.5	50.7	59.6	66.4	56.1	44.3	29.4	56.0	84.3	62.6	38.4	49.1	68.2	87.9	61.5	70.6	39.1	37.3	70.0	50.2	37.9	52.2	69.0	59.1	35.8	48.9	44.5	105.7	37.4	42.9	8.5	65.6	45.6	45.5	56.9	46.6	59.2	64.8	60.0	67.5	60.9	56.8	71.1	54.6	90.7	27.9	65.5	49.9	57.9	50.1	82.7
RPAP1	"DKFZP727M111, FLJ12732, KIAA1403, MGC858"	ENSG00000103932	"RNA polymerase II associated protein 1"	Q9BWH6	15	41517176-41544269	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041739	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041739: AB_2677647"	"unprognostic (8.83e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (4.30e-3)"	10.1	10.2	12.8	8.5	12.4	4.7	8.1	7.8	15.6	7.8	10.2	12.6	7.9	8.5	10.7	6.0	12.3	10.4	6.9	9.5	10.9	6.1	6.7	10.8	7.3	9.8	12.3	10.1	12.4	9.4	12.9	9.4	8.7	11.9	9.4	7.1	9.5	9.8	9.2	27.0	10.3	8.0	10.1	8.0	9.1	9.4	12.6	11.8	11.2	8.3	7.9	10.7	11.2	8.4	5.9	4.5	0.0	5.9	4.9	7.2	3.3	7.2	8.7	11.9	12.5	10.0	7.3	10.1	7.2	6.2	9.3	9.1	23.5	6.6	5.7	11.9	8.0	15.0	17.2	21.4	10.5	8.0	10.0	10.4	10.7	12.1	10.3	6.3	8.8	6.8	7.4	13.3	11.0	7.7	6.3	10.4	13.0	25.0	6.5	8.6	4.6	9.5	5.4	21.0	11.2	8.1	17.2	10.3	6.1	4.1	17.1	10.9	14.6	9.2	9.6	4.9	10.8	15.9	11.0	9.4	14.7	9.6	14.6	11.5	11.0	30.1	6.4	10.4	9.6	13.8	0.0	2.6	0.0	7.2	3.5	6.6	4.8	4.3	4.5	4.5	5.9	6.1	5.3	0.0	4.9	5.9	2.9	4.4	3.3	12.8	12.4	7.8	15.6	10.9	6.1	12.3	10.1	11.9	11.8	3.0	4.8	9.1	3.8	2.5	9.4	8.1	2.5	5.3	4.5	5.2	11.8	5.6	1.7	4.8	1.1	4.6	3.5	0.0	4.7	5.3	4.1	4.9	2.3	8.1	4.2	15.9	2.4	3.7	4.0	1.3	3.4	3.3	1.7	6.4	5.6	4.8	4.8	0.0	8.9	2.4	7.0	0.0	3.8	11.2	9.8	3.6	2.3	6.9	6.6	2.7
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022259	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	19.4	26.9	20.6	16.7	28.0	14.6	22.6	26.4	27.7	18.7	19.7	23.3	20.7	17.4	27.8	21.5	24.0	17.6	17.3	17.2	21.1	21.0	26.7	23.3	19.4	21.6	21.7	21.7	22.9	14.1	14.8	41.9	24.4	18.6	20.5	26.6	18.9	18.3	27.9	12.3	17.2	16.0	27.1	25.8	15.6	19.8	11.9	19.7	23.5	25.2	14.5	23.2	24.1	20.2	8.6	28.9	8.0	20.5	30.5	10.7	11.3	20.6	26.8	17.4	17.5	28.3	27.4	29.9	27.2	21.8	25.9	34.8	38.5	31.7	13.9	17.9	21.0	35.1	20.3	25.6	29.0	39.6	16.7	18.1	25.8	39.3	35.9	38.6	27.3	19.9	19.2	28.9	29.7	38.7	23.6	33.7	13.9	25.9	19.4	21.2	32.9	14.8	23.8	25.5	41.7	19.6	18.7	20.8	19.9	29.9	30.9	20.9	12.0	23.0	22.5	18.2	32.8	19.4	31.4	27.6	34.8	23.2	16.9	25.1	11.7	14.8	29.9	25.2	27.0	22.5	6.9	17.3	8.0	10.2	20.5	8.9	8.6	8.0	9.6	28.9	8.4	10.7	9.6	1.7	30.5	13.7	10.6	10.7	11.3	20.6	28.0	26.4	27.7	21.1	21.0	21.7	21.7	18.6	19.7	6.0	6.9	14.7	13.5	14.7	12.5	5.3	7.6	13.4	19.4	17.4	19.6	32.4	26.6	20.5	8.8	11.9	12.3	23.3	15.1	36.8	15.5	12.1	5.8	15.5	33.1	9.5	9.8	17.2	17.6	9.3	10.3	20.4	13.5	16.2	14.2	8.2	17.4	14.0	13.8	37.0	12.9	6.5	14.1	16.4	16.1	17.8	21.4	11.4	18.9	12.0
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;brain: 1.2;pituitary gland: 1.2"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 2.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NB-4: 1.1"									"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.1	0.1	1.0	0.3	0.1	0.1	1.2	0.2	0.0	0.0			0.3	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.4	0.1		0.0	0.8	0.0	1.2	0.2		0.1	0.0		0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.2			0.1		0.1	0.0	0.0	0.4	1.0	0.3	0.7	1.4	0.6	0.2	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.4	0.7	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.3	1.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.2	1.1	0.7	0.2	0.0	0.0	0.1	0.3	0.5	0.2	0.3	0.1	0.3	0.4	0.2	0.1	0.1	0.4	0.0	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.7	0.4	0.1	0.3	0.7	0.2	0.5	0.7	0.5	0.4	0.4	0.3	1.0	0.4	0.5	0.6	0.0	1.4	0.4	0.3	0.4	0.2											0.0	0.0	0.0	0.1	0.1	2.9	1.5	0.0	0.0	1.2	0.0	7.9	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.2	0.3	0.3	0.0	0.7	0.0
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 83.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	21.1	17.1	13.9	14.1	19.2	15.4	20.7	16.7	17.3	14.5	13.8	9.0	10.3	10.3	15.4	12.1	19.2	15.8	14.4	19.6	16.5	11.0	18.8	30.7	12.2	15.3	16.8	11.3	20.9	25.9	13.7	21.6	15.5	19.3	15.5	14.1	9.5	14.0	11.5	46.3	16.7	10.6	19.8	17.4	16.3	14.2	18.1	18.7	10.0	20.4	29.3	15.8	22.1	15.1	10.3	9.3	0.8	7.7	11.1	12.4	6.1	8.0	3.9	4.4	17.4	7.7	12.1	11.6	11.6	6.9	10.3	10.3	15.7	5.9	19.0	11.1	5.8	15.3	9.2	14.6	11.0	23.4	8.0	13.4	12.4	4.9	9.1	9.3	18.8	6.0	7.3	8.8	14.3	29.3	6.9	8.2	8.8	33.0	10.5	12.9	7.8	13.9	19.8	12.8	13.1	7.1	13.3	8.4	13.5	9.9	8.1	7.5	9.7	5.1	6.8	19.1	6.6	6.2	16.1	5.3	8.5	7.5	83.2	31.0	4.5	7.0	23.7	11.3	23.8	17.1	0.3	6.9	0.8	5.9	7.7	12.4	10.3	8.4	7.7	8.1	7.8	11.1	10.5	0.2	11.1	4.9	9.3	7.3	6.1	13.9	19.2	16.7	17.3	16.5	11.0	16.8	11.3	19.3	18.7	17.9	26.9	21.2	94.7	69.6	12.6	61.4	45.9	61.6	63.7	17.4	0.0	40.8	58.0	40.9	72.5	33.0	12.0	0.0	41.1	44.2	40.8	42.1	44.0	66.6	48.0	17.5	10.9	22.7	27.3	20.4	31.9	26.8	35.4	18.0	26.8	18.6	37.2	21.0	25.5	70.4	8.2	12.9	35.4	37.2	27.3	58.0	28.9	17.9	32.7	65.4
RPGRIP1L	"CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134"	ENSG00000103494	"RPGRIP1 like"	Q68CZ1	16	53598153-53703938	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.8"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 109.7;Spermatocytes: 38.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039405, HPA040530"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039405: AB_10794636, HPA040530: AB_2677023"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.92e-4)"	"unprognostic (5.95e-2)"	3.0	6.5	8.0	3.8	13.8	2.7	6.1	5.3	12.7	6.3	3.3	2.4	6.8	2.4	7.3	7.8	3.9	11.7	4.9	3.3	9.1	9.9	5.5	2.2	3.5	3.1	5.9	13.2	6.5	3.2	18.5	25.8	3.8	9.0	5.2	3.5	1.7	3.4	5.3	2.3	3.6	2.0	6.3	3.5	1.9	3.5	20.9	4.7	3.1	7.6	2.3	3.1	4.4	3.6	4.9	2.0	1.8	1.0	2.1	5.6	1.3	9.1	11.3	10.2	9.4	12.3	12.0	4.5	10.2	6.7	9.5	2.7	6.2	7.4	6.1	7.4	10.4	6.4	10.6	8.5	9.7	16.9	3.7	5.9	2.2	9.6	6.2	5.1	5.5	4.2	7.5	6.0	10.6	6.6	10.4	7.1	8.5	5.6	3.5	14.0	3.5	9.0	3.9	6.5	3.2	5.4	15.4	14.0	7.3	12.3	2.4	17.8	6.7	12.6	5.3	4.6	6.5	8.0	4.4	6.4	10.4	7.4	8.5	9.0	4.6	5.3	10.8	15.7	3.3	6.1	1.7	0.9	1.1	3.6	1.0	3.5	3.2	2.6	3.3	0.8	4.9	2.6	5.6	1.8	2.1	1.0	2.0	2.1	1.3	8.0	13.8	5.3	12.7	9.1	9.9	5.9	13.2	9.0	4.7	6.0	3.7	3.2	2.8	4.0	5.1	7.3	0.0	109.7	19.4	10.4	7.9	4.6	14.9	6.5	13.1	2.5	0.1	0.0	2.7	6.2	9.3	1.4	6.9	3.8	2.4	3.2	0.0	3.7	1.2	9.0	4.4	2.8	1.7	2.8	3.8	6.1	3.5	0.0	6.0	14.2	8.4	6.5	4.1	38.1	11.0	4.6	1.4	1.0	3.8	2.1
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691644-88750935	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 210.0;Syncytiotrophoblasts: 188.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		4100000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: AB_2683563"	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	12.9	8.8	6.6	15.6	7.0	43.0	12.1	11.1	6.4	8.1	12.7	6.1	11.0	12.4	11.1	7.3	18.3	8.5	14.0	10.9	5.0	4.9	6.8	6.2	9.0	16.2	7.2	3.8	11.7	26.5	3.6	11.4	26.1	6.5	8.8	13.4	6.0	12.6	8.5	17.6	9.2	12.7	7.7	5.1	15.4	10.4	8.9	7.6	30.7	9.6	10.5	19.3	8.1	11.8	18.5	14.1	21.4	12.5	13.3	22.4	11.6	8.5	5.0	10.2	8.1	7.2	7.4	22.4	4.8	4.5	7.9	5.4	17.8	11.4	43.7	10.4	5.5	10.9	5.2	12.7	4.0	12.5	20.7	16.5	17.5	3.2	17.6	7.3	32.0	12.9	6.8	3.4	7.0	11.0	3.9	11.1	23.4	18.7	7.6	7.4	13.4	35.1	28.1	9.2	28.4	8.3	18.4	12.1	10.7	6.5	13.8	7.3	8.3	5.7	7.4	11.0	5.8	4.0	13.2	6.3	4.7	12.4	15.4	13.6	5.9	4.8	43.8	4.8	29.1	6.7	5.5	9.7	21.4	11.1	9.8	14.2	18.5	15.5	16.4	14.1	15.4	22.4	18.4	2.3	13.3	12.5	6.8	12.6	11.6	6.6	7.0	11.1	6.4	5.0	4.9	7.2	3.8	6.5	7.6	11.9	10.4	45.3	15.3	33.2	8.7	11.4	15.3	2.7	3.4	19.2	2.0	210.0	8.3	13.5	6.8	26.6	15.2	70.0	30.1	69.7	29.7	21.6	21.8	5.9	38.8	12.7	18.4	17.8	15.5	2.6	18.4	22.5	38.8	25.2	24.7	4.3	21.4	28.1	17.7	12.9	5.1	19.4	18.0	25.3	32.5	35.8	188.7	37.3	56.2	35.5
RPL10L		ENSG00000165496	"Ribosomal protein L10 like"	Q96L21	14	46651010-46651821	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"testis: 45.5"	"Cell type enhanced"	"Detected in many"	29	"Early spermatids: 439.0;Late spermatids: 154.0;Spermatocytes: 85.2"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 6.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	45	"U-2 OS: 30.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011311	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA011311: AB_1856431"	"unprognostic (7.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.70e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.3	0.6	0.4	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.4	0.3	0.5	1.0	0.6	0.8	0.2	0.7	0.9	0.9	0.0	0.4	0.2	0.4	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	8.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	439.0	0.6	0.2	0.0	0.0	0.2	1.7	5.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	154.0	5.8	2.0	10.1	0.0	1.8	0.0	0.0	0.0	2.1	0.0	0.0	6.5	4.7	85.2	11.5	16.4	0.2	0.0	2.3	2.6
RPL11	L11	ENSG00000142676	"Ribosomal protein L11"	P62913	1	23691742-23696835	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA002734, HPA074839"	Approved		Approved	Vesicles		NA	NA		720000	Vesicles		"HPA002734: AB_1079838, HPA074839: AB_2686717"	"prognostic favorable (2.55e-4)"	"unprognostic (3.98e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.70e-2)"	"unprognostic (4.51e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (5.93e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.90e-1)"	75.0	46.8	35.1	71.4	74.9	65.8	175.9	33.4	41.1	100.3	69.1	32.9	50.5	30.3	130.0	112.0	87.8	95.9	65.4	79.9	56.0	26.2	56.2	78.8	78.7	222.2	39.5	46.6	148.2	311.5	47.6	43.4	48.3	78.6	85.2	97.7	43.2	204.8	66.6	84.2	92.1	58.0	103.4	47.0	72.3	77.5	52.9	23.2	65.5	91.9	92.2	169.3	73.7	115.4	178.7	93.6	43.4	72.4	79.3	199.1	235.2	38.0	62.3	75.1	38.3	129.0	183.1	26.4	25.6	108.5	98.3	73.5	112.5	43.0	79.4	28.5	87.3	39.9	32.6	94.3	126.9	110.1	28.1	126.3	37.1	213.7	148.6	96.6	62.4	30.5	177.8	188.0	82.8	149.5	121.0	103.9	139.6	42.8	43.0	104.1	118.0	36.2	99.8	18.8	124.7	71.4	46.1	36.5	75.5	110.8	68.1	29.7	36.2	20.1	42.0	74.2	67.9	30.9	77.7	31.1	24.1	33.0	40.5	32.3	39.6	35.8	55.6	30.4	89.3	27.5	43.4	72.4	22.0	73.6	63.2	125.4	178.7	150.1	107.5	93.6	157.3	199.1	146.6	11.6	79.3	49.8	93.2	109.4	235.2	35.1	74.9	33.4	41.1	56.0	26.2	39.5	46.6	78.6	23.2	1095.8	1949.2	5840.5	6304.6	5888.0	338.2	523.0	3003.8	1172.4	1937.0	1067.8	145.3	4113.3	4073.5	2275.3	832.2	3353.1	1873.9	1261.4	5801.9	6645.9	3301.0	4731.7	1987.6	2712.5	3407.9	195.5	2079.9	2711.8	3936.0	1676.5	4261.5	5099.8	3564.8	4184.1	3270.1	600.2	3952.7	3415.8	1958.1	3600.3	474.8	1390.5	3246.9	514.6	525.9	6987.2	3890.4	3666.1	4664.7	6181.0
RPL12	L12	ENSG00000197958	"Ribosomal protein L12"	P30050	9	127447674-127451405	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003403	Approved		Approved	"Golgi apparatus"		NA	NA		520000	"Golgi apparatus"		"HPA003403: AB_1856432"	"unprognostic (5.89e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (4.98e-2)"	"unprognostic (3.05e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.80e-2)"	68.0	44.4	34.5	55.7	38.5	81.6	103.5	23.4	35.9	80.3	56.3	26.3	48.3	35.0	54.4	82.8	71.4	79.4	59.0	40.1	28.9	22.1	54.2	68.9	48.6	108.3	29.2	26.8	118.6	174.8	16.1	34.3	40.0	28.7	57.2	49.7	34.1	88.8	68.4	116.2	88.3	54.0	63.7	38.8	82.7	52.3	35.6	38.7	63.9	58.4	102.4	82.0	83.6	77.0	173.9	97.8	17.7	60.5	76.2	152.2	157.1	64.9	60.1	66.5	133.3	128.1	287.8	102.5	58.3	159.1	104.9	82.4	129.4	68.0	124.4	79.4	99.1	52.7	78.7	84.0	135.7	72.1	62.6	77.2	72.8	81.8	117.2	272.5	111.2	78.7	312.4	271.5	73.5	280.2	209.2	141.6	78.0	98.1	106.3	130.3	224.0	104.7	171.9	97.2	193.6	112.6	89.6	127.7	134.5	154.0	65.8	58.7	85.5	43.8	147.8	180.9	82.0	121.3	154.4	79.2	39.6	70.8	67.8	114.6	55.4	67.9	127.1	41.1	106.7	60.1	17.7	58.0	16.5	67.8	60.5	125.9	173.9	127.1	92.4	97.8	171.9	152.2	126.5	7.5	76.2	58.0	89.5	109.6	157.1	34.5	38.5	23.4	35.9	28.9	22.1	29.2	26.8	28.7	38.7	646.2	1503.7	5061.0	4045.1	5372.0	160.0	370.4	2430.6	770.9	1642.4	1207.3	80.5	2922.1	3451.8	1765.9	255.9	2512.6	1491.9	1168.1	6162.0	4789.2	2566.4	3026.3	1780.6	2248.3	2994.4	90.6	2015.9	2955.6	5097.2	446.3	5005.1	4147.9	3416.3	2961.2	3509.9	262.9	3860.9	2195.4	2246.6	3878.9	223.2	970.2	2259.3	323.0	463.1	6086.7	3114.7	2449.3	4507.2	4205.0
RPL13A	"L13A, TSTA1"	ENSG00000142541	"Ribosomal protein L13a"	P40429	19	49487554-49492308	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038751	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA038751: AB_10962004"	"unprognostic (2.35e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.81e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.87e-1)"	85.4	87.0	45.7	114.3	46.9	132.5	106.4	38.9	41.2	103.8	145.5	38.8	89.2	84.1	129.4	80.7	117.7	83.5	119.9	112.5	37.2	31.2	65.4	113.9	71.8	265.3	41.5	37.0	203.8	334.9	21.8	54.2	76.7	44.1	114.3	46.8	65.4	169.0	95.4	216.0	122.9	77.0	121.1	44.2	121.4	87.8	54.5	27.8	124.0	119.8	147.0	115.0	112.7	196.5	284.6	144.9	40.5	81.3	148.0	268.3	354.3	120.1	147.8	70.3	205.2	134.2	212.6	83.8	105.2	130.3	75.9	82.4	125.3	92.4	304.9	84.7	78.6	31.8	79.7	87.6	152.2	45.0	85.4	206.5	153.9	96.2	178.5	163.5	231.1	122.4	245.8	254.2	53.8	182.8	168.6	122.3	107.9	132.5	115.1	87.3	104.5	161.5	234.8	135.9	114.9	133.0	157.1	160.5	132.9	103.1	204.3	120.6	158.6	54.9	244.9	232.4	58.8	108.0	266.7	150.6	95.8	103.4	59.4	138.5	116.5	157.9	137.6	59.9	158.5	87.8	40.5	81.3	20.7	132.2	70.3	194.3	284.6	226.2	180.3	126.7	264.8	268.3	212.3	13.6	148.0	60.4	144.9	165.3	354.3	45.7	46.9	38.9	41.2	37.2	31.2	41.5	37.0	44.1	27.8	1503.7	1729.8	9229.7	10612.9	10289.3	512.1	472.1	3870.0	2000.9	3534.0	1509.2	202.2	6720.7	4604.1	3662.2	243.1	4976.1	2426.8	1868.9	11119.9	8860.9	5735.6	8516.9	2404.2	3758.5	5124.9	208.2	3836.4	4121.8	6096.6	467.8	8451.2	6154.9	5402.0	6444.6	6340.8	679.2	7721.8	5811.0	4166.9	5142.4	507.0	2612.9	6508.5	432.4	584.7	12485.0	7026.2	7155.4	9081.3	10590.2
RPL18	L18	ENSG00000063177	"Ribosomal protein L18"	Q07020	19	48615328-48619536	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"NB-4: 559.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046572	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		100000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA046572: AB_2679705"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.27e-2)"	56.2	57.3	50.3	79.1	40.8	122.4	84.9	35.2	51.1	89.8	76.6	44.8	60.8	66.1	100.6	56.1	129.6	78.2	99.2	43.4	38.3	33.1	56.4	101.9	62.1	194.1	40.3	27.0	206.5	260.5	19.8	57.1	74.8	26.8	100.5	39.6	54.6	136.7	62.3	78.8	108.6	60.5	69.1	39.7	88.7	64.0	45.8	28.6	114.9	115.8	116.5	122.2	91.2	90.5	137.1	84.5	19.0	57.5	71.1	144.1	148.6	58.3	91.0	33.5	58.2	34.2	67.5	49.0	26.8	44.7	55.7	46.9	82.1	54.3	85.4	28.2	25.6	21.1	48.4	30.4	61.0	21.2	36.4	105.9	30.9	42.6	78.4	69.2	43.0	48.3	79.5	89.5	29.8	40.2	40.8	54.7	62.6	43.6	75.3	34.9	74.1	67.6	559.5	53.4	76.1	45.4	70.8	27.0	77.4	45.0	72.2	47.7	62.1	24.2	85.4	81.0	16.2	48.0	83.8	31.2	41.3	45.9	25.6	61.5	62.6	72.9	50.9	26.0	66.4	48.6	19.0	57.5	12.2	65.7	47.6	115.3	130.3	116.4	88.1	79.2	137.1	144.1	113.9	8.6	71.1	37.3	84.5	89.6	148.6	50.3	40.8	35.2	51.1	38.3	33.1	40.3	27.0	26.8	28.6	550.9	838.5	3591.6	3815.8	3969.4	373.7	225.2	1370.7	546.0	953.2	671.7	135.5	3294.6	1175.5	1414.5	62.6	1818.4	1578.0	724.2	3930.9	4507.0	2016.4	3365.3	983.1	1161.9	1943.0	127.1	1609.4	1403.2	2086.4	135.2	3008.2	2285.6	2161.1	2417.6	2644.1	668.4	2833.8	2163.8	1372.2	1352.6	310.0	1015.4	2447.3	225.6	356.8	4859.7	3460.6	2407.5	3173.8	4275.2
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859876-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 430.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055259	Approved		Approved	Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"		"HPA055259: AB_2682764"	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	48.8	33.8	24.9	42.2	43.0	85.7	53.6	27.8	61.1	49.9	46.0	26.5	28.1	40.4	47.8	36.4	65.5	56.5	38.9	31.5	22.6	16.2	50.0	85.9	34.8	83.7	22.3	26.1	109.2	106.6	9.3	30.5	46.9	30.9	41.8	26.8	30.4	99.8	31.6	157.7	90.1	43.3	36.6	21.9	57.6	50.1	67.3	17.6	59.5	65.3	107.9	54.0	45.0	57.1	395.8	193.6	24.8	110.7	126.0	278.4	430.5	126.2	98.3	65.7	92.6	98.7	162.7	166.5	77.5	98.5	102.6	97.9	135.7	127.1	191.0	179.7	66.7	41.0	95.2	77.4	165.0	35.9	97.6	208.7	89.2	94.6	154.5	171.0	128.3	97.8	203.0	217.6	56.7	122.3	106.8	112.2	157.6	113.3	123.9	64.7	196.8	173.5	169.5	154.6	142.0	151.7	156.2	69.7	226.4	93.6	120.2	95.2	142.9	27.5	192.0	239.8	33.9	91.2	249.4	85.9	63.6	74.1	126.9	129.9	166.2	151.1	123.3	83.5	205.4	78.8	24.8	110.4	16.5	134.8	110.7	234.6	368.3	232.2	167.1	166.6	395.8	278.4	212.5	11.3	126.0	85.6	193.6	195.9	430.5	24.9	43.0	27.8	61.1	22.6	16.2	22.3	26.1	30.9	17.6	482.4	926.8	6413.8	4901.3	7713.4	240.4	390.4	1829.3	614.3	1162.5	875.9	119.8	4308.9	2022.7	2828.9	39.6	2919.7	1766.7	1097.9	7783.8	7254.8	3471.5	4168.2	1383.3	2046.3	2960.9	123.9	1772.7	2331.9	4202.4	100.2	3856.5	5199.5	4502.8	5216.5	3612.2	346.7	5814.1	2767.0	1530.2	2592.2	347.7	1235.3	4175.6	138.6	661.5	9733.7	3896.6	4323.4	4712.9	6201.7
RPL22	"EAP, L22"	ENSG00000116251	"Ribosomal protein L22"	P35268	1	6181269-6209389	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068294			Approved	Nucleoplasm,Nucleoli		NA	NA		320000	Nucleoli	Nucleoplasm	"HPA068294: AB_2732781"	"unprognostic (3.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.98e-1)"	75.5	71.5	54.3	79.7	42.8	124.7	75.0	46.7	39.5	95.8	73.9	39.2	53.9	66.5	133.6	63.9	103.9	59.1	61.8	50.8	47.4	38.6	58.8	90.2	55.3	142.6	50.6	39.7	163.1	154.8	30.4	57.0	49.8	37.4	90.8	46.4	57.0	140.3	66.8	114.0	79.7	62.6	106.6	58.3	79.1	62.0	38.2	35.0	95.3	91.0	112.8	81.1	101.5	91.9	75.6	62.3	11.0	38.9	42.2	98.8	73.9	89.4	25.5	54.4	55.5	38.3	60.3	43.0	78.2	31.5	28.8	24.6	50.6	77.8	138.9	64.4	28.9	19.9	51.8	40.8	40.6	38.0	68.0	66.5	135.0	58.1	62.8	38.0	178.6	54.2	53.1	33.7	25.6	53.1	59.6	35.9	39.0	111.2	84.2	33.0	39.5	78.0	145.7	33.8	59.9	56.7	75.3	112.8	107.6	42.1	31.1	75.2	69.0	63.6	184.4	143.1	49.3	59.3	141.6	87.7	41.1	45.3	54.2	73.4	67.7	92.9	210.2	27.2	184.7	25.4	11.0	38.9	8.8	38.0	34.3	66.9	75.6	71.1	52.3	59.8	72.4	98.8	78.1	2.9	42.2	27.8	62.3	54.0	73.9	54.3	42.8	46.7	39.5	47.4	38.6	50.6	39.7	37.4	35.0	413.9	647.4	2117.2	1742.6	1617.7	195.0	241.8	1080.3	472.4	833.7	554.8	123.7	1561.4	1614.8	1042.5	368.7	1236.7	707.2	537.3	1569.0	2352.9	1052.3	1320.4	878.8	1234.2	1317.3	133.5	877.3	1218.4	1697.8	247.8	1877.2	1676.9	1020.7	1556.4	1647.3	322.2	1580.5	1090.7	1160.1	1724.2	283.7	763.2	1114.2	317.0	420.5	1692.2	1548.7	1448.0	2302.5	1714.3
RPL22L1		ENSG00000163584	"Ribosomal protein L22 like 1"	Q6P5R6	3	170864875-170870483	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 101.9"	"Low region specificity"	"Detected in all"							"HPA048060, HPA056207, HPA068294"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (5.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.96e-2)"	17.2	14.6	8.9	28.1	9.5	36.0	21.5	6.0	9.3	14.3	15.7	5.3	6.6	8.4	12.2	12.3	33.6	15.3	11.8	11.3	7.4	8.5	11.4	64.3	18.8	31.4	10.1	5.7	18.6	71.6	1.9	12.1	10.5	10.7	14.7	15.7	6.4	15.7	14.0	17.7	19.4	13.7	12.2	11.5	37.5	17.4	9.7	8.9	17.9	15.2	32.5	27.8	18.9	15.9	24.1	24.2	1.9	7.6	13.1	13.8	3.5	15.8	17.9	5.8	67.6	17.3	101.9	17.8	16.1	37.2	13.1	8.5	7.6	3.7	49.0	3.7	15.0	41.1	4.1	14.4	41.1	7.3	2.9	2.6	4.4	2.2	17.1	70.0	9.0	6.5	74.0	84.0	4.1	44.6	20.5	44.5	27.2	3.1	3.1	71.8	20.1	65.7	5.1	90.9	6.1	3.2	88.2	2.1	7.5	32.5	35.3	0.9	4.9	1.6	8.1	7.0	3.3	11.3	8.0	20.6	2.5	19.3	5.0	22.4	5.0	3.5	7.8	45.9	5.5	52.1	1.0	4.8	1.9	6.8	5.7	13.8	24.1	10.0	9.0	5.1	17.9	6.7	7.4	1.0	13.1	7.6	24.2	6.3	3.5	8.9	9.5	6.0	8.1	7.4	8.5	10.1	5.7	10.7	8.9	8.9	36.6	274.9	201.6	175.5	13.0	14.5	53.5	57.6	92.1	19.2	3.9	84.0	56.3	132.5	30.8	89.5	76.2	23.3	199.7	252.2	105.2	161.6	105.0	90.9	170.2	7.9	138.8	87.8	140.5	29.1	129.2	89.6	74.2	57.7	130.6	34.1	350.4	115.2	83.8	69.0	18.4	45.3	94.8	47.6	26.2	216.6	82.3	126.9	150.6	274.6
RPL23A	L23A	ENSG00000198242	"Ribosomal protein L23a"	P62750	17	28719393-28724359	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 261.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA051754, HPA077474"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		15000	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA051754: AB_2681593, HPA077474: AB_2686841"	"unprognostic (1.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (3.91e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.68e-1)"	49.1	38.5	48.6	43.3	62.1	67.9	87.0	40.6	75.5	63.8	47.0	27.3	48.5	34.8	53.2	44.0	56.5	64.1	35.1	48.8	56.6	28.7	39.5	93.2	62.3	108.0	42.6	39.6	142.1	63.3	21.4	45.3	51.0	40.5	44.9	48.8	27.6	61.3	41.7	64.9	70.5	44.6	39.8	63.4	59.1	47.8	108.1	35.7	56.1	44.4	78.8	84.9	51.1	61.0	261.4	139.2	30.6	75.3	142.1	254.7	206.1	59.4	121.4	73.5	91.1	97.3	156.9	71.6	55.8	98.0	94.6	80.0	123.5	57.7	134.5	52.6	77.5	49.4	81.4	96.7	124.6	98.1	71.1	267.4	64.2	119.3	131.4	88.7	133.4	67.3	152.5	160.5	75.3	119.1	137.4	102.4	62.4	83.4	91.3	94.6	98.2	148.9	176.0	69.9	152.8	74.0	88.2	132.7	158.9	102.5	121.5	75.9	88.6	39.6	288.0	125.0	107.5	143.2	156.7	60.7	52.1	74.2	60.6	98.7	113.9	105.2	78.5	82.6	73.8	57.4	30.6	66.3	19.4	156.5	75.3	232.3	261.4	227.4	203.4	108.7	227.4	254.7	229.5	9.4	142.1	59.6	139.2	154.0	206.1	48.6	62.1	40.6	75.5	56.6	28.7	42.6	39.6	40.5	35.7	801.0	1123.4	5775.1	4513.0	4612.6	216.8	263.3	2257.3	837.9	1637.9	820.0	66.8	3852.2	2612.9	1885.1	774.8	2545.4	1436.7	1541.8	4018.0	5653.9	2983.4	3636.7	1439.5	1994.3	2312.0	154.1	1776.5	2366.9	2960.5	235.1	4219.8	3481.8	2908.6	3701.6	2998.1	414.4	2891.2	3114.2	2224.7	2308.4	257.2	1681.6	3269.7	698.0	548.5	5416.5	4120.8	3800.4	4030.5	4740.6
RPL26	L26	ENSG00000161970	"Ribosomal protein L26"	P61254	17	8377516-8383250	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 586.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030449, CAB037301"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"CAB037301: AB_796168, HPA030449: AB_10602125"	"unprognostic (2.02e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.38e-1)"	122.5	64.5	70.2	102.5	49.8	132.2	170.4	44.4	52.4	127.6	131.6	34.8	68.1	53.1	76.4	97.0	161.2	87.6	98.6	68.1	54.8	42.5	100.6	138.3	97.5	117.5	61.6	32.6	183.0	586.0	32.2	41.1	82.2	47.7	129.0	84.0	41.5	95.3	87.4	170.8	106.3	98.6	103.6	62.9	129.0	75.9	53.0	45.1	104.9	131.6	145.8	107.9	154.7	127.6	154.9	120.8	25.1	92.1	93.0	158.2	165.0	103.5	95.3	93.8	111.0	177.2	291.8	91.7	90.0	133.9	122.3	92.4	100.7	53.4	181.0	103.5	106.6	50.0	115.1	119.2	184.4	144.0	67.6	214.8	70.6	105.2	116.1	207.2	104.9	91.7	248.7	369.2	101.2	304.3	172.0	150.5	104.1	79.9	54.6	128.4	71.3	115.6	143.5	88.1	108.9	63.3	115.5	95.3	112.6	164.3	77.9	39.0	83.3	48.5	90.6	208.1	86.7	92.7	140.5	94.3	49.5	61.8	68.2	157.5	43.9	51.2	79.1	81.0	149.3	73.3	25.1	92.1	18.2	89.9	78.3	130.5	154.9	134.3	116.8	120.8	140.1	158.2	136.0	10.9	93.0	69.5	104.5	111.3	165.0	70.2	49.8	44.4	52.4	54.8	42.5	61.6	32.6	47.7	45.1	833.7	960.0	5357.4	2721.4	4954.5	234.8	252.2	2797.5	959.6	1909.7	952.6	125.7	3974.4	3344.0	2212.2	695.5	2535.1	1389.0	1425.0	4263.0	6092.8	2980.6	2437.9	1777.7	2307.8	2989.4	128.7	2198.5	2802.7	4762.9	1400.7	4423.2	3635.2	3033.3	3719.6	3654.9	300.8	3633.9	3236.9	2028.4	4497.4	340.9	1487.5	2382.4	569.4	578.1	6200.9	3820.5	3284.3	5356.2	2887.4
RPL30	L30	ENSG00000156482	"Ribosomal protein L30"	P62888	8	98024851-98046469	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002651	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		52000	"Endoplasmic reticulum, Cytosol"		"HPA002651: AB_1079842"	"unprognostic (3.28e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.97e-3)"	146.2	68.8	77.6	75.4	56.2	153.1	195.1	54.3	62.0	158.8	123.2	64.1	96.3	57.5	146.1	120.3	164.9	126.6	113.5	147.3	64.5	53.1	75.7	140.6	121.2	383.2	78.6	46.4	284.8	344.3	44.6	62.1	97.5	49.3	154.7	96.3	66.2	172.7	131.4	191.2	144.8	90.1	164.3	85.2	146.6	96.3	79.5	58.7	168.1	170.4	102.5	176.5	153.6	197.4	180.4	94.5	42.1	70.0	94.2	238.2	179.6	140.6	96.6	104.1	99.8	150.1	278.4	100.3	83.1	145.4	140.3	123.3	106.6	133.1	184.2	217.7	118.6	61.8	92.4	129.6	154.4	146.2	72.6	108.3	160.4	96.7	139.7	221.0	85.4	80.2	236.1	245.3	103.9	298.2	166.0	144.0	163.1	114.4	122.2	119.0	187.2	199.2	160.3	93.1	345.6	140.4	107.9	79.3	169.4	114.4	130.8	150.5	128.9	48.1	120.3	189.7	109.9	158.4	203.3	80.0	55.0	59.1	81.9	99.4	129.0	104.4	150.8	77.2	174.8	80.2	42.1	70.0	31.6	104.4	63.1	154.1	180.4	181.2	138.9	94.5	171.7	238.2	186.0	26.3	94.2	55.6	94.0	117.8	179.6	77.6	56.2	54.3	62.0	64.5	53.1	78.6	46.4	49.3	58.7	792.1	1260.6	3527.5	3700.2	3367.9	233.0	62.5	1253.5	748.2	1387.6	526.9	131.6	2248.9	1518.6	1338.6	1083.1	1770.9	1274.6	771.0	3239.9	3233.6	1966.2	2865.1	1485.8	1753.3	1997.4	136.7	1584.7	1633.3	2339.1	2033.5	4049.5	3046.8	1886.1	2374.3	2539.3	588.0	2447.0	2198.9	2259.0	2091.2	300.7	1384.1	2144.4	839.5	561.5	3649.2	2426.7	3150.2	3341.5	3592.2
RPL32	L32	ENSG00000144713	"Ribosomal protein L32"	P62910	3	12834485-12841588	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 406.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047501, HPA051994"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		140000	"Endoplasmic reticulum, Cytosol"		"HPA047501: AB_2680070, HPA051994: AB_2681686"	"unprognostic (6.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.44e-2)"	80.5	42.2	62.9	55.4	44.5	106.7	109.0	33.2	50.8	101.5	58.9	34.9	38.3	37.3	63.1	91.5	94.8	82.3	49.5	53.5	46.5	36.5	68.4	132.9	63.7	117.4	50.1	41.1	167.0	406.2	20.4	38.6	48.6	32.8	62.6	68.4	41.8	67.9	43.3	121.4	90.5	48.6	78.0	48.4	77.7	52.0	55.9	30.7	103.9	66.9	87.7	121.5	91.2	68.9	230.3	119.2	38.8	86.1	104.4	281.7	293.2	74.3	89.4	78.1	99.5	122.9	220.1	258.1	61.4	114.5	129.9	89.1	118.1	76.3	129.7	56.2	88.2	42.7	46.7	88.5	127.7	106.9	59.8	148.2	75.4	113.4	127.6	183.7	121.4	76.5	197.5	278.9	99.1	191.7	128.7	113.3	95.8	92.5	120.7	106.1	224.3	136.5	209.9	131.5	107.3	169.8	109.0	70.2	168.9	131.2	123.8	49.6	99.3	41.4	111.2	132.1	73.0	162.7	234.2	65.3	56.4	72.1	74.0	112.7	81.6	128.1	226.8	71.8	174.4	83.9	38.8	86.1	22.9	99.1	66.7	178.3	230.3	197.2	143.1	119.2	214.7	281.7	213.1	12.7	104.4	53.6	118.2	147.0	293.2	62.9	44.5	33.2	50.8	46.5	36.5	50.1	41.1	32.8	30.7	994.6	1705.3	6619.8	6646.5	8194.1	323.1	436.2	2817.8	1037.3	2033.7	1385.3	157.1	4359.8	3864.6	2400.6	1607.7	4582.5	1755.3	1822.2	5640.8	6521.8	3945.6	4507.1	2255.6	2952.6	3734.4	170.0	2220.9	3848.6	5359.1	5126.5	6169.0	6114.9	4595.6	3626.7	4532.6	595.4	4264.1	3517.5	2818.3	4510.9	491.8	1933.8	4140.6	977.2	891.7	9583.4	4079.8	4680.5	6188.5	6735.9
RPL35	L35	ENSG00000136942	"Ribosomal protein L35"	P42766	9	124857880-124861981	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA006047	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA006047: AB_1856443"	"unprognostic (1.16e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.58e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	91.6	70.1	81.9	116.6	59.2	178.1	156.1	49.2	55.6	109.3	118.5	45.8	86.8	63.0	95.1	98.9	158.5	98.4	89.9	97.0	60.2	55.0	77.5	140.3	89.1	228.4	65.9	48.1	189.1	492.3	25.7	67.0	71.8	45.8	118.3	56.6	63.9	150.9	98.5	247.1	142.7	75.6	131.5	60.8	113.4	78.2	60.5	46.0	113.3	128.4	154.6	130.1	125.5	176.4	201.4	172.2	31.1	82.2	105.1	165.8	281.7	92.1	144.0	81.7	112.1	89.4	189.6	112.2	72.8	117.7	151.9	103.7	237.6	91.4	138.3	75.8	81.0	90.8	178.8	94.8	159.3	55.8	84.6	164.0	55.9	195.6	153.5	159.7	124.3	74.8	174.5	249.4	89.8	159.9	83.9	111.5	132.0	119.8	175.6	113.8	299.6	146.3	285.2	153.2	277.3	177.6	125.0	126.1	307.8	130.3	109.5	110.7	89.9	66.1	156.8	147.5	42.4	159.3	205.3	57.1	67.8	71.7	117.5	147.7	99.1	230.7	206.2	95.2	131.0	113.8	28.5	82.2	31.1	116.6	72.1	155.1	201.4	156.5	133.8	121.0	189.4	165.8	143.9	10.8	105.1	58.8	172.2	122.6	281.7	81.9	59.2	49.2	55.6	60.2	55.0	65.9	48.1	45.8	46.0	592.6	1127.4	4054.2	3642.8	4892.3	209.9	654.8	1602.5	592.9	1178.4	1076.5	80.5	2511.2	2289.6	1953.2	1188.8	2070.4	1494.7	1448.3	5315.3	3981.0	2376.0	2324.3	1249.1	2646.1	2485.0	103.3	1248.3	1951.4	2954.3	3494.2	2571.6	3157.2	2675.7	2877.4	2738.3	357.7	3375.0	1946.4	1208.2	2550.5	284.6	976.6	2381.7	761.7	853.4	6349.1	2061.3	2553.9	3546.1	3372.3
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396154	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Undifferentiated cells: 3155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: AB_2685164, HPA077586: AB_2686846"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	62.9	40.7	50.7	81.5	53.8	139.8	136.1	27.7	46.8	65.3	71.0	25.1	53.4	45.6	67.5	71.4	77.1	59.0	60.6	54.9	43.1	31.1	47.3	60.1	43.4	190.1	42.1	50.6	165.3	171.4	15.0	35.1	44.7	41.8	55.9	68.3	26.1	158.1	71.5	125.7	96.5	54.1	65.5	44.6	67.9	54.6	26.3	32.6	60.8	69.3	118.6	104.0	71.9	74.0	162.9	113.2	13.7	74.2	86.7	175.5	199.2	121.6	65.9	101.2	49.8	124.8	224.0	64.8	93.8	102.9	123.1	188.1	78.0	62.6	235.8	93.9	77.8	75.9	82.2	151.3	131.4	128.3	83.0	166.0	109.0	116.2	71.9	179.5	198.3	105.1	212.5	248.1	99.7	184.9	165.2	113.8	103.1	131.7	126.8	99.1	175.3	91.8	236.6	134.6	252.8	134.0	86.2	221.6	184.8	112.5	50.8	68.0	135.7	87.6	98.4	167.8	84.2	47.5	224.4	105.0	36.6	89.6	101.0	95.0	108.0	154.1	186.4	45.0	295.6	39.0	12.5	74.2	13.7	86.6	73.6	140.3	162.9	162.3	120.6	111.4	134.0	175.5	156.7	7.2	86.7	70.4	113.2	84.9	199.2	50.7	53.8	27.7	46.8	43.1	31.1	42.1	50.6	41.8	32.6	408.0	871.7	1431.2	350.0	815.0	25.3	12.6	713.4	501.9	1443.4	165.7	13.7	675.4	368.1	934.6	6.2	708.2	731.9	397.1	2614.9	904.3	568.3	225.8	1204.1	656.9	533.8	14.3	1058.9	1162.0	2037.4	20.4	977.8	917.6	497.7	1450.9	2170.9	77.3	2295.7	1329.1	393.5	579.9	33.5	232.8	598.3	23.3	110.3	980.8	628.4	1100.0	3155.0	282.8
RPL36A-HNRNPH2		ENSG00000257529	"RPL36A-HNRNPH2 readthrough"		X	101391011-101412297	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 2: 29.9;Ciliated cells: 33.5;Club cells: 53.4;granulocytes: 25.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 14.8"									HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (3.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"		"unprognostic (4.65e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.04e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-1)"	6.7	6.0	3.7	8.5	5.0	7.2	6.1	15.3	5.2	5.9	9.9	1.4	4.9	1.5	6.7	7.2	6.9	4.5	5.8	5.1	3.7	5.4	4.3	5.8	4.5	22.1	4.6	4.6	12.7	19.7	1.5	3.6	4.2	3.5	5.2	4.5	1.5	18.1	7.2	14.0	5.3	4.4	6.4	5.0	6.5	4.3	2.5	2.3	5.9	6.9	13.1	6.2	7.3	7.5	16.2	19.8	13.6	16.1	10.6	14.3	22.4	3.7	0.0	5.1	1.0	2.3	5.2	1.7	14.8	0.7	3.0	2.2	0.0	2.2	3.5	4.6	2.1	0.2	0.4	4.4	0.6	1.0	4.4	1.7	4.1	2.7	1.3	4.0	3.6	1.7	5.6	2.8	1.6	1.1	3.8	1.8	2.2	1.4	4.3	4.0	0.6	5.7	2.3	0.4	1.9	2.0	7.2	5.3	2.8	1.3	0.6	3.2	4.6	1.8	1.6	1.8	1.3	1.8	2.0	2.1	0.5	2.8	2.5	2.6	3.7	6.4	1.2	1.4	3.5	3.1	7.5	14.9	13.6	13.1	16.1	11.5	16.2	12.3	12.4	19.8	15.4	14.3	13.6	4.7	10.6	9.9	10.7	9.0	22.4	3.7	5.0	15.3	5.2	3.7	5.4	4.6	4.6	3.5	2.3	11.9	29.9	0.0	0.0	0.0	0.0	0.0	0.0	33.5	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPL36AL	RPL36A	ENSG00000165502	"Ribosomal protein L36a like"	Q969Q0	14	49618519-49620685	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	Yes			"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (1.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.00e-1)"	60.3	55.8	45.9	46.5	40.9	68.2	66.5	35.9	37.7	69.3	74.3	29.2	56.6	52.1	54.9	102.1	61.8	45.9	31.5	48.2	38.0	34.4	69.9	139.2	54.8	63.6	45.3	34.1	105.3	131.9	35.7	62.0	56.9	40.3	62.9	50.5	30.8	85.2	68.6	82.4	40.8	99.8	71.1	48.0	78.8	61.8	36.7	41.8	65.4	72.5	67.6	71.0	87.6	63.9	105.8	112.7	119.5	66.7	84.5	132.0	139.8	73.4	55.4	40.1	23.2	57.7	79.8	23.5	60.7	67.1	56.9	64.5	57.6	50.9	96.9	57.9	50.2	40.1	53.0	34.0	51.8	66.6	33.2	39.2	60.7	58.5	74.3	73.1	96.9	52.2	81.6	79.4	43.5	58.8	67.6	72.0	43.8	38.5	86.3	43.7	94.8	57.0	87.0	22.5	52.9	57.0	36.1	63.1	51.9	86.3	111.8	35.1	21.7	53.4	42.4	60.8	39.8	91.8	53.9	55.4	35.7	56.8	46.4	46.7	52.6	53.7	97.8	25.8	43.9	33.9	119.5	66.7	99.6	98.6	63.2	132.0	105.8	129.3	123.0	68.7	79.9	120.7	112.6	74.0	84.5	55.9	112.7	118.2	139.8	45.9	40.9	35.9	37.7	38.0	34.4	45.3	34.1	40.3	41.8	285.9	358.6	508.2	1190.5	840.1	106.5	561.0	550.3	325.2	378.7	296.6	23.6	568.2	843.9	636.4	440.5	541.3	862.9	397.1	1188.0	608.8	559.0	968.4	688.3	743.7	689.7	76.3	351.4	449.9	649.0	160.8	672.0	707.1	799.7	1234.5	570.5	159.8	1112.3	813.6	502.0	790.1	95.2	478.6	799.2	285.3	135.9	733.7	431.8	698.8	483.1	1226.2
RPL37A	L37A	ENSG00000197756	"Ribosomal protein L37a"	P61513	2	216498189-216579180	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065327	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA065327: AB_2685469"	"unprognostic (9.94e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.84e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.67e-1)"	115.0	109.4	130.0	114.9	104.2	153.1	252.9	78.4	82.8	134.5	129.9	66.0	80.5	79.8	188.5	123.9	154.9	131.5	90.7	154.0	91.2	81.7	81.0	116.7	100.7	283.5	108.6	91.0	281.8	423.2	47.3	84.3	74.1	89.0	134.7	115.2	77.9	265.7	107.8	307.2	159.0	76.6	171.8	98.6	97.6	99.0	130.3	60.1	117.2	123.7	186.1	154.7	137.2	195.1	215.6	197.7	39.6	103.3	119.1	222.5	229.2	81.9	70.2	152.5	102.6	159.6	281.3	113.4	111.8	150.3	114.2	97.7	177.9	80.1	90.7	157.1	137.3	122.8	86.3	144.1	164.9	118.2	103.1	152.7	148.1	127.2	251.1	273.3	162.6	93.3	304.6	347.5	98.7	279.0	313.3	157.3	180.8	115.3	133.2	147.6	165.4	154.1	334.9	176.5	183.8	80.3	112.0	114.6	110.4	159.0	144.6	99.1	111.5	41.3	129.4	254.7	226.8	81.9	281.6	105.4	82.7	90.3	80.9	122.2	141.7	199.6	173.0	92.2	114.0	83.5	39.6	103.3	24.2	122.9	77.1	168.0	215.2	190.4	151.9	143.0	215.6	222.5	198.2	13.5	119.1	63.9	197.7	136.5	229.2	130.0	104.2	78.4	82.8	91.2	81.7	108.6	91.0	89.0	60.1	1113.6	1605.4	4470.7	2849.7	4385.4	480.1	1288.8	2771.9	1195.1	2353.3	1200.4	174.7	2558.5	2674.2	2235.0	3158.6	2255.3	1994.6	1401.6	7324.8	4423.3	2457.1	2614.9	2050.5	4095.4	2673.7	189.1	2525.5	3209.1	4083.5	6452.6	5314.9	2718.4	2706.1	2655.6	4289.5	857.5	5221.5	4229.5	2791.1	2456.8	499.9	1972.6	2514.2	2077.9	1466.6	6429.9	2683.3	2745.2	5422.7	2918.7
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 115.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 7.8;Karpas-707: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049136	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049136: AB_2680648"	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	1.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	1.4	0.0	0.1	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.8	0.0	148.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	36.7	2.1	0.0	0.0	1.8	1.7	4.9	1.5	0.9	1.4	0.5	2.1	2.5	0.6	2.3	0.1	0.1	1.5	1.0	0.0	0.1	0.0	7.8	4.2	1.3	1.4	0.0	1.9	2.1	0.2	0.2	0.0	1.0	1.3	0.8	1.7	2.7	0.0	0.5	0.9	0.2	0.3	0.2	0.2	1.5	0.0	1.4	0.8	5.8	0.1	1.3	1.6	1.9	1.3	2.3	5.0	0.7	0.7	1.8	0.3	0.8	3.4	1.0	1.0	2.8	1.2	1.5	1.4	1.1	1.2	1.2	2.9	1.6	0.8	2.5	1.2	1.2	1.7	0.6	0.4	1.6	1.5	1.3	1.4	1.1	0.9	1.4	1.1	1.2	0.5	1.8	1.2	1.4	4.9	0.9	1.0	1.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	115.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.3	0.4	0.0	0.0	0.0	0.4
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034600	Uncertain		Supported	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"		Yes	No		830000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	63.6	33.4	37.0	59.0	40.4	70.6	88.2	34.5	42.2	73.6	60.5	33.5	42.3	18.8	67.3	49.8	81.3	65.7	39.4	38.8	31.7	26.4	53.2	84.5	46.1	103.9	35.1	26.3	139.1	159.9	33.1	42.0	52.0	34.1	67.6	50.9	35.9	66.2	51.0	87.2	77.1	36.4	67.3	47.9	60.3	46.3	42.8	20.0	81.3	66.1	91.7	102.8	74.2	55.9	72.5	58.7	5.9	40.9	45.0	97.0	135.7	45.1	91.1	38.6	64.9	173.7	316.0	68.1	55.1	113.9	85.4	66.3	100.7	79.3	178.9	62.9	131.3	40.4	82.2	275.6	213.2	94.6	49.4	165.2	109.6	81.7	83.7	244.9	114.8	54.9	310.0	278.0	92.8	371.0	105.2	136.6	84.9	100.3	70.4	127.7	74.5	76.4	51.1	84.4	100.9	65.3	85.8	88.0	173.6	117.4	89.7	68.6	71.7	34.0	96.8	136.2	84.5	71.5	166.0	80.0	44.7	67.5	41.5	87.6	69.2	107.3	119.6	55.0	154.6	50.2	3.5	40.9	5.9	38.2	36.2	71.1	72.5	74.6	53.7	58.7	60.5	97.0	75.7	2.7	45.0	33.5	37.4	57.0	135.7	37.0	40.4	34.5	42.2	31.7	26.4	35.1	26.3	34.1	20.0	419.9	882.0	1803.2	2287.0	2152.7	118.6	357.6	588.5	738.8	1063.5	324.5	76.6	1844.2	1399.3	929.4	510.9	791.2	291.1	327.1	1855.6	3103.9	1180.5	1227.4	901.9	616.8	1082.4	38.1	731.3	578.2	1045.6	1022.7	1235.2	1320.8	1032.5	1779.1	995.5	130.7	1271.8	480.5	936.2	1212.4	111.6	452.7	1291.3	308.9	412.0	2258.1	2005.7	1400.6	1218.5	2270.0
RPL6	"L6, TAXREB107, TXREB1"	ENSG00000089009	"Ribosomal protein L6"	Q02878	12	112405190-112418838	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060903, HPA068418"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No		270000	"Microtubules, Cytokinetic bridge"		"HPA060903: AB_2732653, HPA068418: AB_2685987"	"unprognostic (5.95e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.90e-2)"	63.6	60.2	58.0	55.5	72.9	102.2	94.0	42.0	87.8	63.8	65.1	39.4	50.5	39.8	68.9	83.2	86.5	64.9	38.9	45.8	50.0	38.7	78.8	111.9	45.2	84.5	45.3	72.6	149.8	113.7	39.3	78.7	69.2	91.1	56.9	63.5	32.9	81.5	51.8	73.6	80.0	50.9	52.5	46.0	68.0	67.6	60.0	42.3	71.2	62.9	122.7	106.4	61.9	68.1	164.0	158.0	28.3	98.8	125.5	191.9	287.6	96.8	91.9	112.6	115.3	141.0	233.0	150.7	95.4	133.0	125.3	72.1	143.4	61.2	210.8	81.1	99.0	48.9	95.1	120.0	163.7	125.6	83.0	152.8	113.7	81.5	127.5	148.3	202.3	88.5	215.9	228.2	95.4	219.9	232.6	140.2	137.2	149.1	57.7	143.8	129.3	145.9	325.6	159.2	204.3	106.7	134.6	123.8	202.3	155.2	159.0	105.8	137.1	66.2	175.7	159.0	106.3	184.6	206.9	84.3	63.1	77.5	80.8	104.6	79.9	124.0	169.1	81.6	146.2	94.3	28.3	98.8	20.9	114.5	84.1	189.8	164.0	174.1	147.8	136.0	145.4	191.9	162.2	12.7	125.5	73.3	158.0	137.8	287.6	58.0	72.9	42.0	87.8	50.0	38.7	45.3	72.6	91.1	42.3	741.5	1203.3	3176.6	3335.4	2794.0	249.2	237.4	1470.0	906.1	1552.6	603.7	129.6	2560.4	2967.7	1798.1	320.1	2016.2	774.2	724.2	2637.8	3961.8	1779.3	2297.0	1229.7	1338.0	1682.0	114.4	1334.9	1475.6	2186.3	568.6	2638.6	2337.5	1801.7	2647.6	1649.3	361.1	2447.2	1150.3	1494.6	2579.4	298.4	911.9	2153.7	404.1	478.4	3190.6	2566.3	2157.3	2203.0	3047.7
RPL7	"humL7-1, L7"	ENSG00000147604	"Ribosomal protein L7"	P18124	8	73290267-73295789	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 536.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 638.4"									HPA058373	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		170000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA058373: AB_2683694"	"unprognostic (3.75e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.31e-1)"	54.7	36.5	54.6	37.9	49.3	67.6	86.9	55.9	54.1	57.5	46.2	36.4	41.0	33.6	54.9	50.6	59.5	50.6	26.5	36.7	32.1	22.0	46.4	67.6	40.3	53.3	55.9	20.5	125.8	87.5	22.9	67.7	33.4	55.0	43.6	44.9	44.1	51.8	36.6	61.9	72.7	37.0	49.5	46.9	46.5	51.2	135.1	54.9	33.7	42.6	69.0	66.6	50.8	58.5	338.1	231.5	66.1	171.7	205.0	464.0	536.3	99.7	72.5	78.0	93.8	159.2	204.1	76.7	109.7	88.2	75.0	59.2	87.2	104.6	296.9	89.8	88.4	51.2	95.8	102.9	140.1	117.1	79.8	85.4	162.5	94.9	89.7	95.7	114.5	83.4	191.0	165.6	69.4	217.2	138.4	121.5	100.9	144.9	112.7	106.4	84.7	181.7	175.2	90.9	182.4	78.0	122.9	89.3	115.7	116.9	100.1	108.0	78.7	51.5	638.4	153.6	67.0	161.3	150.6	114.0	57.7	88.3	73.3	101.3	65.2	92.3	191.6	60.3	142.3	94.7	66.1	171.7	41.1	179.1	138.9	322.3	338.1	314.4	232.5	231.5	282.6	464.0	327.0	22.3	205.0	118.6	192.4	237.0	536.3	54.6	49.3	55.9	54.1	32.1	22.0	55.9	20.5	55.0	54.9	759.3	1377.6	4083.1	8227.6	7155.0	251.0	580.3	2023.0	1007.8	1723.2	1244.0	117.8	3979.6	4725.1	2246.6	1393.0	2953.4	897.4	1004.5	4388.5	6073.2	3431.1	4195.6	1418.7	1830.9	2853.5	89.0	1556.2	2090.7	3232.1	609.0	3931.9	3610.7	3514.2	2982.9	2652.3	679.5	3206.0	2051.6	2172.0	4500.4	280.8	1435.8	4545.3	828.4	372.8	8292.9	4080.0	3000.7	4416.0	6170.5
RPL7A	"L7A, SURF3, TRUP"	ENSG00000148303	"Ribosomal protein L7a"	P62424	9	133348214-133351426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046794			Approved	Nucleoli,Vesicles		NA	NA		160000	Nucleoli	Vesicles	"HPA046794: AB_2732534"	"unprognostic (5.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.07e-3)"	"unprognostic (4.17e-3)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (1.98e-1)"	"unprognostic (8.88e-2)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.89e-2)"	58.8	72.8	34.9	64.0	39.6	78.6	96.3	33.1	43.2	70.1	66.6	27.6	66.9	38.9	137.4	81.5	96.0	94.8	74.4	48.2	29.5	25.7	51.0	59.3	48.1	159.6	32.7	45.2	164.9	193.1	29.1	50.6	42.4	34.1	90.1	67.6	47.3	204.8	70.0	85.2	91.9	48.6	91.0	35.5	68.1	61.4	78.2	24.0	80.5	77.9	70.1	93.2	75.1	109.7	79.7	56.4	12.1	35.8	50.2	80.4	94.0	44.6	68.0	77.7	77.3	136.7	227.0	74.2	56.3	115.3	101.6	56.7	103.3	58.9	140.1	34.8	98.1	54.9	109.5	114.8	135.3	82.0	59.4	65.0	49.3	101.1	100.4	90.7	116.6	58.4	228.3	202.5	73.4	127.5	165.7	128.9	98.9	94.2	73.9	116.6	151.6	90.4	122.1	84.4	200.3	67.1	79.6	97.5	178.2	130.8	57.2	73.0	64.5	46.1	118.7	71.9	67.4	129.4	123.6	70.3	67.1	48.3	60.3	66.7	28.9	57.5	86.1	52.4	81.5	52.1	12.1	35.8	7.7	52.2	33.6	77.3	79.7	71.2	64.3	56.4	71.8	80.4	73.5	5.5	50.2	29.3	56.1	54.6	94.0	34.9	39.6	33.1	43.2	29.5	25.7	32.7	45.2	34.1	24.0	482.4	687.0	2813.3	3757.7	2882.1	278.7	355.9	1538.8	477.8	915.6	567.0	135.5	3181.9	1798.9	1584.8	1644.9	1944.8	1276.3	864.3	3823.0	4356.2	1751.6	3047.6	827.3	1030.7	2186.7	123.9	1445.6	1391.5	1793.3	3226.4	3459.6	1682.6	1434.0	2247.1	2534.7	429.4	2742.5	1749.9	1813.9	2011.8	362.0	950.7	1790.0	984.2	735.4	3479.5	2766.0	1939.0	3532.0	4275.0
RPL7L1	dJ475N16.4	ENSG00000146223	"Ribosomal protein L7 like 1"	Q6DKI1	6	42879618-42889925	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046049, HPA050478"			Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA046049: AB_10964167, HPA050478: AB_2681138"	"unprognostic (1.03e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.58e-2)"	17.5	22.1	19.9	14.4	27.5	9.0	19.9	20.5	35.9	14.8	14.2	16.9	16.4	11.9	15.7	17.4	18.9	17.2	10.2	14.4	17.6	16.5	18.8	23.5	11.9	16.5	14.9	20.4	17.4	16.9	22.9	22.4	15.1	17.9	17.0	17.0	13.2	17.4	14.4	19.9	16.3	12.8	16.5	13.9	15.4	13.7	33.0	14.5	25.1	17.8	15.6	20.3	13.7	13.3	15.4	12.5	10.2	13.6	16.4	18.6	10.6	31.3	10.0	17.8	28.5	16.8	21.7	12.1	25.1	18.3	24.4	20.2	24.8	12.0	47.2	22.8	21.1	19.9	15.1	40.4	30.6	40.6	24.7	30.4	25.1	14.1	22.4	18.5	38.7	19.5	22.2	23.5	32.0	31.0	16.6	23.9	20.9	48.5	16.3	22.2	23.1	22.0	25.2	17.9	96.5	14.8	25.3	20.0	29.9	19.0	19.9	34.1	20.8	21.5	16.5	26.4	14.7	22.1	37.5	22.8	23.7	19.8	18.7	43.3	20.6	32.1	71.8	13.2	36.8	24.6	5.6	11.4	10.2	14.9	13.6	18.6	13.3	14.6	15.5	10.8	15.4	15.5	14.9	2.6	16.4	11.9	12.5	12.0	10.6	19.9	27.5	20.5	35.9	17.6	16.5	14.9	20.4	17.9	14.5	71.5	90.2	79.6	70.6	50.7	62.2	36.8	43.3	96.4	85.3	40.1	31.4	75.2	72.9	77.0	9.5	60.8	22.6	93.5	57.9	63.9	52.5	52.0	48.7	57.8	46.3	68.3	90.5	48.5	37.5	8.6	73.4	44.1	28.7	74.9	39.6	69.6	70.8	31.6	67.1	57.2	58.0	51.8	56.9	40.4	84.8	52.7	66.9	64.5	43.4	52.0
RPLP2	"D11S2243E, LP2, MGC71408, P2, RPP2"	ENSG00000177600	"Ribosomal protein lateral stalk subunit P2"	P05387	11	809647-812880	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 318.8"	"Low region specificity"	"Detected in all"							HPA053635	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		730000	Mitochondria		"HPA053635: AB_2682212"	"unprognostic (6.98e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-2)"	165.8	66.1	52.7	134.4	47.8	132.4	240.5	28.0	42.6	110.3	108.3	43.2	78.6	82.6	103.7	95.7	160.7	76.7	99.1	129.1	45.8	37.0	67.4	118.5	103.2	499.1	51.9	28.5	190.5	241.9	20.4	49.2	75.3	35.9	118.4	70.3	53.1	154.6	97.8	160.3	125.6	95.7	108.6	52.4	176.3	75.7	60.0	32.4	207.7	111.3	106.1	155.0	136.0	190.6	232.5	127.3	27.8	82.7	82.7	233.6	233.4	79.6	85.0	46.1	63.1	65.4	69.0	64.9	47.9	32.7	52.6	42.7	131.8	67.3	101.6	35.5	43.9	46.0	76.6	53.4	75.0	25.9	47.0	318.8	51.8	72.3	190.7	74.4	99.2	59.1	89.1	113.5	21.2	67.1	75.2	53.0	96.2	92.4	68.5	36.4	98.5	92.1	160.8	100.6	138.3	225.4	106.2	42.7	112.8	51.3	62.9	62.6	92.3	31.2	98.7	109.5	40.6	36.8	134.5	51.4	33.3	43.3	29.4	61.8	116.0	93.1	99.1	54.1	76.5	39.7	27.8	82.7	27.2	100.7	65.2	140.1	232.5	189.1	142.1	94.0	222.8	233.6	178.0	11.9	82.7	51.5	127.3	106.4	233.4	52.7	47.8	28.0	42.6	45.8	37.0	51.9	28.5	35.9	32.4	991.6	1490.9	7641.0	5455.0	5430.4	205.9	564.1	2489.2	1006.5	1874.5	1519.7	74.6	4512.3	2196.7	2810.0	1146.6	3224.8	2324.9	2733.2	6455.7	6707.6	3165.9	4519.9	1638.7	2939.5	3968.0	138.2	2281.0	3329.3	4720.2	2348.5	5919.8	5263.8	2832.5	3803.6	5348.0	406.2	4700.1	3847.1	2652.5	3432.0	167.5	1959.6	3005.2	957.2	2076.7	6894.6	4884.8	5234.3	6955.8	5526.4
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306247-58324695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	7.1	8.5	8.3	5.7	12.9	5.3	7.1	15.8	10.7	6.6	8.6	5.9	6.6	10.2	8.2	7.8	8.5	7.4	6.2	11.8	7.2	6.8	11.2	15.0	5.6	7.6	6.5	9.9	8.4	11.9	10.8	9.4	6.0	7.2	7.4	8.2	9.0	8.5	7.0	53.5	7.4	9.1	11.7	5.5	7.7	7.7	9.1	5.9	6.3	8.1	18.5	8.5	7.2	7.0	4.6	6.6	4.7	9.8	9.8	6.4	3.5	10.1	8.1	9.4	7.5	7.9	8.5	10.4	8.6	9.3	12.4	14.0	12.3	6.7	12.2	2.0	11.5	10.8	6.2	14.1	12.8	12.1	8.5	7.4	11.6	9.7	6.7	7.7	19.9	9.7	9.3	12.4	14.7	14.1	6.2	9.7	15.0	9.9	8.7	12.0	5.5	13.5	7.0	12.3	8.4	15.4	5.5	7.4	11.8	9.0	14.6	5.9	10.5	8.1	9.7	11.6	6.8	9.3	9.6	8.8	9.4	10.5	9.9	16.3	13.0	22.3	17.6	10.7	14.0	6.6	3.0	5.7	4.7	4.2	4.9	5.6	4.1	5.5	5.8	6.6	4.6	6.4	6.2	2.6	9.8	9.8	6.2	3.0	3.5	8.3	12.9	15.8	10.7	7.2	6.8	6.5	9.9	7.2	5.9	8.9	11.0	7.0	7.1	27.7	24.7	26.6	5.1	8.1	5.7	3.5	23.6	7.2	10.0	5.3	0.7	7.2	11.7	0.0	5.3	5.2	8.4	6.9	3.5	17.9	5.4	17.5	9.2	12.3	11.4	0.9	11.5	9.5	21.9	8.2	12.5	12.9	6.2	3.5	9.2	10.1	28.1	0.0	20.5	8.6	13.5	37.6	8.6	7.0	13.4	6.2
RPP25	FLJ20374	ENSG00000178718	"Ribonuclease P and MRP subunit p25"	Q9BUL9	15	74954416-74957464	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 79.4;Hofbauer cells: 60.4;Rod photoreceptor cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.7;monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 18.6;SCLC-21H: 17.1;SK-MEL-30: 25.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046900	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA046900: AB_10962049"	"unprognostic (9.36e-2)"	"unprognostic (7.17e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (7.18e-2)"	"unprognostic (5.73e-3)"	"unprognostic (5.50e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.50e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.53e-1)"	3.9	7.3	3.0	1.9	4.6	0.0	2.2	3.2	14.0	3.4	6.7	3.7	1.2	6.0	1.7	1.3	3.3	1.8	3.7	2.5	2.5	6.8	2.6	1.9	5.1	2.7	8.0	5.1	12.0	4.9	9.0	2.8	6.1	10.6	2.1	4.1	3.2	2.4	1.3	1.9	2.1	4.6	2.0	7.9	6.2	5.6	1.9	1.8	3.1	4.9	2.6	2.5	4.1	2.4	2.3	16.7	0.3	6.4	0.3	2.7	1.4	8.9	6.8	1.7	0.0	0.6	0.4	2.9	1.7	2.0	0.5	0.4	9.2	8.2	0.0	7.9	1.7	0.5	2.7	5.3	0.3	0.1	3.3	0.2	0.0	7.9	0.2	18.6	0.0	5.3	2.4	0.2	3.4	0.0	0.3	7.9	2.3	6.0	0.0	1.7	3.4	1.4	2.4	8.2	15.7	2.7	0.0	0.0	6.0	1.6	0.1	17.1	12.8	12.8	11.3	25.6	0.9	2.2	7.1	1.8	0.0	0.7	1.6	0.0	0.1	0.0	0.0	0.9	13.9	10.0	0.0	3.3	0.0	1.5	6.4	0.9	2.3	1.1	1.3	3.3	1.9	2.7	2.1	0.3	0.3	4.8	16.7	0.4	1.4	3.0	4.6	3.2	14.0	2.5	6.8	8.0	5.1	10.6	1.8	3.0	0.6	4.5	6.4	9.7	79.4	1.5	10.2	0.0	1.2	8.7	3.9	1.7	11.6	11.4	0.3	5.8	17.2	0.0	16.7	3.9	18.6	13.1	0.0	1.0	60.4	20.6	9.8	36.8	12.1	0.9	36.5	7.9	13.5	22.6	9.4	7.8	15.6	15.8	28.3	12.8	56.0	12.9	10.3	0.5	7.0	10.0	1.9	2.5	18.4	8.7
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871716-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	24.2	19.0	20.9	16.8	20.3	27.2	22.3	26.0	24.0	18.9	19.0	16.2	16.3	11.5	25.2	18.6	23.8	19.2	16.0	26.6	19.8	16.8	20.6	18.4	17.1	23.2	18.5	20.4	23.9	17.7	37.7	23.6	23.6	19.3	18.8	19.3	18.7	19.2	16.5	35.9	23.5	16.4	20.6	19.2	21.3	19.2	32.0	21.6	31.2	18.1	24.0	26.3	21.7	18.9	19.4	22.2	16.2	19.5	14.2	20.3	16.2	28.6	19.1	20.0	24.1	13.0	14.1	7.1	20.5	18.5	34.4	36.1	32.2	23.1	16.9	15.7	13.0	22.4	20.1	26.6	18.2	35.5	27.1	18.3	11.4	12.2	25.4	12.4	23.0	14.4	11.5	11.9	25.9	29.4	14.5	19.4	15.6	22.6	15.5	22.7	17.7	26.6	31.3	12.4	16.3	21.7	14.9	17.1	17.8	12.9	13.6	10.9	10.9	12.0	8.7	24.1	19.2	23.5	14.6	11.0	17.2	17.2	9.7	42.3	10.5	26.8	36.3	21.5	12.5	13.1	4.3	19.5	16.2	17.1	18.7	18.6	19.4	19.6	18.7	22.2	16.7	17.0	18.5	2.2	14.2	15.3	20.7	20.3	16.2	20.9	20.3	26.0	24.0	19.8	16.8	18.5	20.4	19.3	21.6	29.8	20.0	24.7	27.9	30.6	18.6	39.9	22.9	17.4	20.5	14.0	17.7	50.9	26.6	34.6	73.2	18.4	8.7	0.0	30.3	55.9	20.4	16.0	23.1	12.4	49.9	15.9	19.0	20.3	22.6	37.3	26.7	27.6	21.9	32.5	17.8	20.3	27.7	14.0	27.6	27.1	20.1	38.8	28.1	53.2	47.3	29.6	28.3	27.3	17.5	21.8
RPP40	"bA428J1.3, RNASEP1"	ENSG00000124787	"Ribonuclease P/MRP subunit p40"	O75818	6	4994732-5004063	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035685, HPA035686"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035685: AB_2674734, HPA035686: AB_10670153"	"unprognostic (2.93e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.10e-6)"	"unprognostic (8.00e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (7.54e-8)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.19e-1)"	6.9	16.8	10.8	7.2	10.7	6.7	11.1	3.5	11.9	6.0	5.5	4.2	6.3	4.6	6.1	6.6	11.9	5.5	4.7	5.5	10.0	8.8	5.6	10.8	3.9	10.1	9.9	5.8	6.2	7.8	5.2	8.6	5.6	9.1	5.3	5.3	1.5	4.0	6.7	7.7	9.8	3.6	7.5	5.3	6.8	4.3	10.5	8.0	6.1	5.6	13.0	8.3	9.1	6.9	7.8	12.3	0.0	11.1	7.9	8.4	5.0	6.4	10.8	3.4	9.7	6.4	8.1	10.9	6.4	3.2	12.3	9.8	14.7	5.0	14.0	28.3	6.6	16.9	6.9	7.0	9.9	11.2	5.3	14.2	8.8	7.0	19.9	7.5	11.3	5.0	6.3	8.5	12.2	12.2	2.7	12.0	12.9	13.9	2.8	8.9	18.4	5.7	19.5	5.7	7.7	17.6	12.2	6.5	25.6	6.2	7.0	12.3	3.6	6.0	5.8	6.4	9.5	10.5	9.4	5.7	16.2	10.9	10.9	14.5	5.0	21.1	11.0	3.0	19.0	8.3	0.0	6.9	0.0	3.4	11.1	5.0	7.8	5.9	4.1	12.3	6.5	8.1	7.2	0.0	7.9	3.5	5.9	8.4	5.0	10.8	10.7	3.5	11.9	10.0	8.8	9.9	5.8	9.1	8.0	0.0	0.6	4.5	7.0	11.0	0.2	3.6	0.0	5.3	4.5	1.8	0.0	11.1	10.0	8.1	5.5	7.0	0.4	0.0	8.1	10.7	6.0	3.1	0.0	5.8	9.9	0.0	2.9	6.7	2.1	2.1	5.2	3.4	8.5	1.8	3.1	1.3	3.9	2.3	4.6	11.7	0.2	0.0	7.2	11.4	26.8	12.9	8.0	1.9	6.8	7.0
RPRD1A	"FLJ10656, HsT3101, P15RS"	ENSG00000141425	"Regulation of nuclear pre-mRNA domain containing 1A"	Q96P16	18	35984387-36067576	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 88.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 215.3;Late spermatids: 274.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040602	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA040602: AB_10673137"	"unprognostic (2.06e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.92e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.95e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.30e-1)"	16.8	27.0	32.1	12.0	32.0	7.8	19.0	28.5	36.9	16.9	18.1	22.8	26.3	14.4	20.0	88.6	18.4	19.7	14.4	21.3	30.2	27.6	20.8	16.5	14.5	13.8	27.5	31.3	19.3	17.6	20.2	24.0	13.7	30.2	23.3	16.1	13.2	20.2	23.4	36.1	15.3	13.5	21.2	27.8	16.0	14.9	20.3	23.5	10.2	24.4	11.1	14.3	20.6	20.1	8.6	10.7	5.0	8.4	9.3	7.6	4.3	12.1	13.4	22.9	24.3	12.6	14.8	14.3	22.0	21.6	12.8	18.1	3.6	13.5	17.0	23.2	15.9	6.8	20.3	25.3	22.1	18.2	15.1	14.5	18.1	20.2	14.3	22.2	30.0	9.8	11.3	29.6	12.1	34.7	16.1	18.2	20.4	16.2	18.7	16.3	15.1	16.0	12.8	18.4	6.3	9.7	13.4	7.3	27.2	19.5	26.2	40.0	33.7	18.3	10.2	18.7	19.5	14.0	21.7	22.1	13.4	8.4	7.1	17.8	21.2	29.2	17.7	13.6	25.0	13.4	0.9	6.3	3.0	4.4	8.4	6.5	7.5	5.8	5.0	10.7	8.6	7.6	5.8	5.0	9.3	5.5	7.4	3.1	4.3	32.1	32.0	28.5	36.9	30.2	27.6	27.5	31.3	30.2	23.5	29.8	16.5	47.2	28.5	30.6	50.7	32.9	15.3	13.4	13.6	33.2	29.5	13.9	23.2	18.7	215.3	21.0	12.2	0.0	17.2	14.7	15.0	35.2	12.7	22.1	8.8	35.0	27.6	19.6	16.8	274.1	20.4	15.7	28.7	5.4	18.5	29.4	17.3	23.7	21.5	21.4	49.7	12.9	26.9	34.1	37.7	33.4	12.2	20.1	19.5	29.4
RPRD2	"FLJ32145, HSPC099, KIAA0460"	ENSG00000163125	"Regulation of nuclear pre-mRNA domain containing 2"	Q5VT52	1	150363091-150476566	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061693	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		91000	"Nucleoplasm, Vesicles"		"HPA061693: AB_2684587"	"unprognostic (1.68e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.38e-1)"	14.0	16.9	16.8	12.0	21.6	13.2	14.0	40.1	22.1	20.2	17.9	21.4	16.6	11.5	21.0	16.4	17.0	24.2	12.2	14.1	16.3	14.1	18.3	12.5	14.0	13.8	16.3	14.1	34.2	17.9	27.5	29.4	10.7	15.2	18.3	16.3	19.8	14.5	19.2	28.5	15.6	13.9	20.1	13.8	16.7	14.2	16.2	17.4	25.6	25.4	10.4	17.3	21.6	17.1	8.0	4.2	6.0	8.6	5.1	9.1	2.5	15.8	12.1	16.1	16.2	16.7	14.2	15.2	11.5	13.7	12.7	12.5	10.4	19.5	25.1	13.2	14.0	7.1	17.6	22.5	17.1	13.9	11.5	9.5	14.4	14.3	12.5	12.0	21.5	17.8	15.0	13.0	17.7	23.4	14.1	15.6	15.4	14.0	27.4	12.8	22.8	18.9	7.0	20.1	20.0	13.7	17.4	11.9	25.3	18.6	14.6	17.1	17.3	23.5	20.0	15.2	15.0	15.8	19.2	14.3	11.8	12.2	9.8	16.2	16.8	18.4	19.0	11.7	16.2	11.5	6.0	3.6	4.4	8.1	2.4	7.4	7.6	7.6	6.4	3.5	8.0	8.9	8.8	2.0	5.1	8.6	4.2	9.1	2.5	16.8	21.6	40.1	22.1	16.3	14.1	16.3	14.1	15.2	17.4	17.9	20.4	25.7	8.7	13.7	32.3	23.0	17.8	20.1	27.3	31.4	15.7	11.8	6.6	11.0	7.2	20.1	14.2	0.0	11.2	7.3	13.6	13.3	17.3	22.2	12.7	11.1	24.8	25.8	16.8	3.2	35.1	10.1	10.1	10.8	22.5	25.1	12.3	14.0	37.4	22.1	27.5	32.3	12.7	21.8	23.4	12.8	8.4	23.6	23.4	9.9
RPS10	"MGC88819, S10"	ENSG00000124614	"Ribosomal protein S10"	P46783	6	34417454-34426125	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047268, HPA048084"	Approved		Approved	Cytosol		NA	NA		170000	Cytosol		"HPA047268: AB_2680007, HPA048084: AB_2680255"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (4.98e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.45e-1)"	84.5	76.6	68.1	142.7	49.5	158.8	142.0	35.9	54.3	130.3	132.7	48.2	97.2	65.1	149.8	103.9	169.7	113.6	74.7	84.9	51.3	44.1	80.7	122.5	96.3	180.1	54.8	31.9	189.4	323.2	20.3	59.1	88.0	39.5	129.7	64.5	59.4	248.9	75.5	153.2	131.9	76.4	105.6	49.4	132.5	85.3	66.7	41.0	110.5	151.0	158.8	127.4	127.1	169.7	150.1	105.0	31.6	61.5	83.1	176.2	227.6	98.7	64.0	66.6	151.0	114.8	169.3	110.1	81.5	112.8	134.7	97.5	155.2	50.5	190.9	84.5	90.2	68.8	74.6	124.3	139.4	81.2	80.1	221.5	85.4	70.6	147.1	158.8	135.0	91.9	187.0	243.0	94.3	179.1	119.1	117.5	108.6	145.6	96.8	100.6	154.1	109.7	202.9	100.4	244.7	94.4	104.1	78.0	180.1	101.2	109.3	111.4	68.2	58.6	98.8	225.6	65.5	128.4	346.0	80.6	60.8	77.8	69.1	132.3	80.2	178.5	160.0	33.1	175.6	109.0	31.6	61.5	18.8	78.9	50.6	116.3	150.1	136.2	111.1	88.7	147.7	176.2	136.7	13.6	83.1	47.2	105.0	90.2	227.6	68.1	49.5	35.9	54.3	51.3	44.1	54.8	31.9	39.5	41.0	333.5	603.3	2152.2	474.9	1201.0	51.9	57.2	950.3	406.9	664.3	249.5	27.5	1272.5	507.3	1182.8	376.5	678.3	1089.4	654.1	2086.5	1615.5	676.8	419.9	573.0	927.7	904.0	49.3	1185.7	891.2	1556.1	890.1	786.1	881.2	600.6	1996.4	2188.6	195.4	1807.7	1595.7	444.1	950.3	80.4	258.7	675.6	285.7	224.9	1448.4	1216.1	1389.4	2844.5	431.7
RPS10-NUDT3		ENSG00000270800	"RPS10-NUDT3 readthrough"		6	34284887-34426071	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 46.7;Ciliated cells: 21.4;Club cells: 35.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 21.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.2"	"Low cell line specificity"	"Detected in all"											"HPA047027, HPA047268, HPA048084, HPA055953"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA047268: AB_2680007, HPA048084: AB_2680255, HPA055953: AB_2682984"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.28e-2)"	"unprognostic (6.85e-2)"		"unprognostic (8.95e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.17e-8)"	"unprognostic (5.80e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.42e-1)"	14.5	10.9	28.0	24.9	21.7	35.6	12.1	9.9	25.4	22.6	23.0	7.3	16.4	9.5	26.2	17.7	29.9	10.0	12.2	20.8	23.7	23.2	13.4	21.1	16.3	31.8	25.2	4.3	33.2	58.4	5.3	7.6	18.8	5.7	22.5	7.7	9.4	44.6	12.4	49.4	6.4	12.9	18.0	17.2	23.0	14.4	23.4	6.0	18.9	26.4	27.9	22.0	22.0	29.9	3.7	4.7	21.2	4.8	2.9	2.3	2.1	9.6	2.9	8.1	14.4	6.0	4.1	8.4	6.7	3.4	5.1	5.3	3.2	4.5	9.3	13.0	4.2	12.1	6.2	11.1	3.5	6.4	7.6	4.9	16.6	6.0	10.2	1.2	15.9	21.2	1.6	7.3	7.3	15.3	7.0	5.0	10.3	16.2	12.6	6.3	8.4	18.1	9.2	4.5	18.7	1.7	10.1	6.8	5.3	5.0	10.4	12.6	4.1	4.7	5.3	17.7	5.1	7.9	33.5	3.9	7.7	12.7	3.9	10.2	6.7	9.2	15.2	1.0	9.6	12.6	6.9	3.9	21.2	2.1	4.8	2.1	3.7	2.3	2.0	4.7	3.5	2.3	1.9	3.1	2.9	4.1	3.3	2.2	2.1	28.0	21.7	9.9	25.4	23.7	23.2	25.2	4.3	5.7	6.0	32.8	46.7	0.0	0.1	0.7	0.0	0.0	0.0	21.4	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1
RPS11	S11	ENSG00000142534	"Ribosomal protein S11"	P62280	19	49496365-49499689	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049719	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA049719: AB_2680860"	"unprognostic (1.49e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (5.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-3)"	103.0	76.8	80.6	187.8	68.7	161.8	165.7	50.4	75.3	138.6	134.1	43.2	105.8	67.0	149.4	132.4	142.8	132.3	133.0	135.9	63.2	53.5	84.3	105.7	101.9	354.2	71.5	64.2	242.4	490.0	41.7	89.7	72.2	63.4	116.6	103.4	72.7	193.2	104.0	223.4	140.8	88.1	198.4	69.9	132.6	96.3	67.2	48.3	137.3	119.0	190.7	169.5	145.6	230.6	232.4	173.3	45.1	96.7	91.3	161.6	231.8	109.9	171.4	130.3	201.2	188.4	285.3	87.3	93.6	185.0	133.4	127.9	118.7	91.9	269.9	58.4	127.4	58.2	74.2	153.6	185.5	131.5	115.1	266.6	163.2	112.8	170.5	176.0	288.2	121.3	283.0	302.6	89.1	229.4	226.9	192.4	166.1	161.1	143.9	143.9	122.9	134.5	217.1	120.3	276.2	176.8	129.7	165.0	143.5	191.4	259.9	139.2	185.8	63.7	214.8	139.2	132.5	69.8	299.8	110.2	106.0	95.2	51.4	123.1	144.1	219.0	191.9	44.1	198.6	90.3	45.1	96.7	29.9	95.6	82.8	127.6	232.4	137.5	110.9	144.1	221.1	161.6	135.7	25.9	91.3	70.6	173.3	109.8	231.8	80.6	68.7	50.4	75.3	63.2	53.5	71.5	64.2	63.4	48.3	777.2	1364.0	2990.9	2041.9	2385.3	290.8	613.7	1123.6	1019.8	1465.0	450.1	135.5	1657.4	1031.2	1067.3	717.3	1435.9	1074.1	934.5	2445.2	2866.6	1515.8	1592.1	1273.2	1366.5	1658.3	89.0	1443.9	1317.9	2294.0	1350.9	2974.6	2278.1	1459.3	1700.6	2280.4	469.1	1978.0	1439.5	1446.5	1386.6	340.6	860.2	1282.2	599.4	586.0	2983.4	1970.5	1736.0	2339.2	2255.1
RPS12	S12	ENSG00000112306	"Ribosomal protein S12"	P25398	6	132814441-132817564	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006124, HPA006365"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		280000	Cytosol	"Golgi apparatus, Vesicles"	"HPA006124: AB_1856460, HPA006365: AB_2667570"	"unprognostic (6.58e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.66e-2)"	95.6	65.1	66.4	169.3	53.2	199.6	187.3	49.6	66.9	98.4	83.8	42.5	93.7	73.1	106.1	99.2	129.4	88.0	113.7	152.2	56.1	44.6	78.0	108.8	182.0	515.8	67.8	42.0	222.2	403.5	23.2	46.3	87.7	44.5	94.4	82.1	56.5	220.6	71.5	100.5	153.8	79.5	162.6	71.8	122.9	85.4	62.6	52.5	139.6	116.7	155.1	130.9	109.7	196.8	159.2	101.3	17.4	54.3	70.9	211.8	222.0	67.7	51.5	80.0	124.2	154.6	196.5	95.1	86.4	116.5	91.9	89.0	105.9	65.1	150.2	119.9	110.5	47.7	66.1	86.9	144.7	84.4	98.3	111.8	102.3	67.6	149.5	173.3	287.6	80.0	210.4	237.3	79.4	281.5	158.1	120.7	124.0	167.5	99.9	111.6	138.2	121.1	167.6	98.7	116.1	84.2	137.2	64.0	95.1	122.2	70.5	68.2	55.6	29.1	187.4	231.2	79.8	79.4	292.9	105.0	39.3	112.7	131.6	159.4	150.1	122.2	111.9	129.8	163.5	56.0	17.4	54.3	7.8	95.6	50.7	147.0	159.2	168.0	123.1	73.4	139.3	211.8	174.2	5.7	70.9	40.7	101.3	90.8	222.0	66.4	53.2	49.6	66.9	56.1	44.6	67.8	42.0	44.5	52.5	1542.4	2505.6	7624.6	6638.1	7352.8	495.9	774.7	3589.8	892.7	2634.3	1174.2	168.9	6440.4	3876.2	3101.2	589.5	3918.9	1905.6	3387.3	6989.0	7823.6	3608.9	7408.3	1688.4	3952.6	5017.5	200.2	2756.2	3903.9	5319.7	1401.7	5625.0	4474.4	3735.1	4011.8	6131.1	754.9	6107.0	3738.4	2810.9	3874.6	503.2	1591.0	3387.1	860.2	1688.1	9189.4	6602.5	5004.5	7735.2	7372.2
RPS13	S13	ENSG00000110700	"Ribosomal protein S13"	P62277	11	17074389-17077787	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005985	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA		56000	"Endoplasmic reticulum"		"HPA005985: AB_10960703"	"unprognostic (7.74e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	119.9	51.1	49.0	80.4	40.3	120.2	120.6	36.0	38.8	129.2	91.3	49.0	52.0	54.5	74.1	70.7	143.1	74.2	83.1	70.5	43.4	38.8	84.9	133.7	97.3	151.2	55.4	26.2	190.8	234.2	29.2	47.8	98.5	34.9	117.2	66.3	57.4	101.7	67.9	203.5	102.6	91.0	90.2	60.3	115.0	75.8	82.1	39.3	146.2	118.0	132.0	127.4	135.4	87.4	166.8	139.3	20.7	103.6	72.0	204.5	216.1	108.5	77.6	77.5	65.0	133.0	202.2	87.1	75.9	93.9	106.5	86.5	121.3	134.6	158.9	53.6	81.1	72.2	79.9	107.0	115.4	106.3	68.4	230.5	71.2	81.1	126.0	161.1	146.3	74.7	156.5	186.8	45.7	181.3	125.0	122.6	103.4	102.3	89.2	101.5	100.2	115.8	193.0	90.8	138.3	153.0	111.2	111.4	98.6	102.1	118.0	64.0	110.7	37.0	140.7	170.4	78.4	63.3	218.2	82.4	51.4	89.8	119.6	94.8	64.7	131.9	123.3	59.7	117.7	68.2	20.7	103.6	15.3	64.2	77.2	126.1	166.8	135.3	93.8	132.8	152.0	204.5	151.5	10.6	72.0	60.9	139.3	94.0	216.1	49.0	40.3	36.0	38.8	43.4	38.8	55.4	26.2	34.9	39.3	860.5	1324.4	3859.3	3661.0	4056.8	255.9	720.6	1864.9	1102.8	1633.3	631.6	98.2	3330.4	2470.2	1793.4	1053.3	2297.1	956.0	817.7	3950.3	4558.3	2409.4	2957.7	1429.6	1826.7	2531.3	85.8	1317.4	1933.5	3782.3	1414.9	3288.7	3755.9	2068.4	3014.5	2386.6	599.7	2990.2	2142.8	1668.1	2743.0	320.5	860.2	2530.8	433.3	316.8	4762.2	3753.8	2537.2	3057.2	3744.2
RPS15	"MGC111130, RIG, S15"	ENSG00000115268	"Ribosomal protein S15"	P62841	19	1438358-1440494	"Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA054510, HPA057793"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		170000	"Endoplasmic reticulum, Cytosol"		"HPA054510: AB_2682510, HPA057793: AB_2683528"	"unprognostic (4.47e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.08e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.33e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-2)"	61.7	61.2	63.0	67.5	51.4	123.6	74.2	46.0	87.5	56.2	66.4	46.1	41.2	69.0	73.6	52.3	80.9	61.2	73.7	72.1	50.4	40.5	64.8	103.7	43.0	95.3	52.1	52.6	144.8	136.0	21.6	59.3	60.9	45.2	66.9	37.1	61.2	123.7	53.2	154.9	102.4	67.6	51.8	51.0	76.2	63.5	60.8	24.9	70.7	74.2	127.6	82.9	47.6	70.9	237.3	149.5	48.6	106.7	103.8	218.1	269.2	103.9	111.1	48.8	66.4	45.8	66.8	84.2	54.5	43.5	65.4	51.2	178.1	36.8	129.0	49.0	35.0	23.1	66.3	47.6	67.5	25.7	107.3	248.7	42.2	101.7	168.2	48.5	107.3	80.6	82.0	81.6	44.2	43.4	63.5	57.5	118.1	85.6	185.9	40.8	182.9	88.7	144.3	110.5	83.3	142.8	92.4	58.3	168.5	59.4	114.5	78.7	93.4	46.0	79.3	156.2	27.1	60.6	144.8	58.0	55.4	63.4	110.4	120.2	161.5	159.8	125.4	55.0	98.1	63.3	48.6	106.7	44.5	116.2	89.5	160.8	237.3	179.3	146.1	149.5	222.5	218.1	177.4	21.6	103.8	68.2	124.2	162.9	269.2	63.0	51.4	46.0	87.5	50.4	40.5	52.1	52.6	45.2	24.9	845.7	1291.0	5528.5	5609.3	8137.2	413.6	279.6	2101.9	934.2	1767.5	1455.1	164.9	3608.1	3294.2	1842.6	725.7	3005.1	2262.4	2453.0	4593.9	5682.0	3308.9	4379.3	1687.8	2548.8	3281.3	144.6	1742.9	2587.2	4363.2	2200.3	3679.4	4495.5	4398.2	3907.2	3542.4	728.2	3370.7	3075.6	1974.7	3966.5	432.6	1319.4	2967.7	790.1	989.9	11039.2	3219.2	4153.4	4441.6	5090.7
RPS17	"MGC72007, RPS17L, RPS17L1, RPS17L2, S17"	ENSG00000182774	"Ribosomal protein S17"	P08708	15	82536750-82540564	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 149.0"					"Low region specificity"	"Detected in all"			HPA055060	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		39000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA055060: AB_2682686"	"unprognostic (3.37e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.83e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.31e-1)"	40.1	37.3	23.9	41.5	28.0	78.5	93.7	20.5	39.7	41.3	35.4	18.0	32.7	12.0	34.4	69.6	58.2	48.5	36.3	36.2	24.9	16.0	33.0	56.8	30.4	75.5	22.2	22.4	100.0	160.7	8.0	28.1	28.7	29.1	32.2	54.1	21.2	64.2	38.1	47.5	60.8	33.0	54.2	26.6	40.9	38.1	29.3	19.2	36.1	38.5	85.2	82.2	34.1	55.8	42.1	34.6	12.5	19.7	26.5	48.5	63.4	10.4	75.5	24.4	15.8	41.3	57.4	18.9	5.7	10.6	18.1	16.6	107.6	34.5	14.9	10.7	23.1	32.1	33.1	58.8	58.3	32.6	9.1	149.0	2.6	78.0	72.2	56.4	13.2	14.4	73.9	107.7	22.3	76.5	48.5	38.3	39.2	10.2	39.9	27.8	84.1	16.9	46.6	36.7	67.8	60.3	11.4	6.2	26.8	53.9	95.3	17.8	11.5	2.3	32.0	31.5	42.3	38.9	40.7	9.9	28.2	20.6	17.4	12.6	12.0	18.6	13.0	23.1	34.1	15.4	12.5	19.7	4.5	16.6	17.2	43.6	39.9	41.3	26.8	27.2	42.1	48.5	42.4	2.5	26.5	14.8	34.6	23.7	63.4	23.9	28.0	20.5	39.7	24.9	16.0	22.2	22.4	29.1	19.2	756.3	1289.8	2965.8	4861.9	38.4	77.5	373.2	1826.7	922.1	1902.9	167.5	47.1	3046.0	462.6	1389.5	55.8	1090.9	569.4	1962.4	2604.1	5603.8	1698.1	3804.0	863.8	2556.7	2408.0	39.7	929.1	1950.1	2775.5	119.3	4074.2	1038.9	28.7	2043.3	2571.6	141.3	2469.3	1560.6	1761.1	737.0	85.0	1164.2	222.0	396.6	646.1	55.8	2855.8	2041.0	4254.9	4758.2
RPS2	"LLREP3, S2"	ENSG00000140988	"Ribosomal protein S2"	P15880	16	1962052-1964860	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 284.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055133	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		140000	"Endoplasmic reticulum, Cytosol"		"HPA055133: AB_2682708"	"unprognostic (2.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (7.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (3.04e-7)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.47e-1)"	46.1	41.0	28.0	101.8	40.4	97.6	65.9	34.7	30.7	48.2	47.0	22.2	28.8	39.9	45.7	27.1	100.7	61.7	55.7	38.2	19.5	16.0	34.2	107.4	71.1	104.2	36.6	18.6	112.6	284.3	9.6	32.2	45.4	30.1	43.6	32.5	18.3	53.6	28.9	67.3	78.3	47.5	25.8	22.4	131.9	47.8	18.9	28.1	115.2	50.3	114.5	78.3	51.6	77.6	137.5	69.0	18.2	44.9	53.6	125.4	54.7	82.1	119.4	69.2	222.4	100.5	248.0	122.5	56.4	135.8	148.3	105.4	212.5	57.6	157.7	90.4	97.6	49.6	103.4	99.8	189.4	55.8	99.4	197.5	53.2	133.2	190.4	245.5	124.7	87.7	331.0	271.7	123.9	206.3	151.2	143.8	142.6	108.6	89.6	102.3	381.5	156.5	218.6	219.8	106.7	107.9	191.9	112.1	188.6	135.4	78.3	124.1	112.7	55.3	173.7	133.8	63.0	117.1	219.0	65.6	80.0	105.5	19.2	118.1	34.9	57.3	200.7	43.1	108.1	100.4	4.9	37.6	18.2	50.7	44.9	84.6	137.5	99.9	78.4	68.7	117.9	125.4	93.8	7.6	53.6	36.0	69.0	68.1	54.7	28.0	40.4	34.7	30.7	19.5	16.0	36.6	18.6	30.1	28.1	482.4	958.5	7786.3	8744.5	10604.5	334.0	200.5	2094.2	638.4	1375.2	863.7	176.7	7309.9	2722.3	3301.1	203.5	3456.8	1531.9	1775.4	9857.9	13493.6	4843.2	5941.0	994.5	1678.5	5355.9	262.2	2031.1	2492.1	3769.8	337.5	3898.8	5677.6	4852.0	6570.0	4025.4	405.5	5646.9	1494.2	1481.1	1482.6	356.9	1235.3	5926.4	173.6	2431.8	13172.5	6844.1	5004.5	6746.1	10161.2
RPS27	"MPS-1, MPS1, S27"	ENSG00000177954	"Ribosomal protein S27"	P42677	1	153990755-153992155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 778.4;lymphoid tissue: 769.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066851			Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: AB_2685737"	"prognostic favorable (9.69e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.05e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.86e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.81e-2)"	120.7	72.5	74.9	188.7	118.6	186.7	268.2	51.3	91.4	172.5	114.2	35.9	136.4	58.1	169.0	135.6	107.5	129.0	144.1	176.5	59.6	50.1	98.6	102.5	167.8	769.0	92.1	76.0	317.8	227.2	44.6	91.5	67.5	71.2	117.6	113.6	63.5	248.2	116.1	243.8	160.1	115.9	254.3	65.6	159.3	111.5	119.0	81.9	118.2	113.0	224.0	270.9	162.9	286.0	720.2	296.5	132.9	139.9	324.1	750.5	778.4	103.7	121.7	160.9	87.6	378.8	373.5	99.8	125.8	301.7	169.5	153.2	243.8	114.7	236.3	105.7	181.5	56.5	104.6	141.7	208.3	143.3	114.7	182.7	93.1	161.4	158.1	251.1	206.9	122.8	362.6	409.8	134.8	248.4	252.8	138.9	197.5	113.6	128.5	160.9	260.8	222.5	131.0	194.8	347.8	177.5	142.6	117.8	183.8	156.6	210.3	85.5	190.7	72.1	254.0	218.7	229.1	141.6	415.8	82.0	58.6	97.1	93.4	125.7	258.2	263.2	286.4	101.7	116.2	80.3	132.9	139.9	68.1	393.0	138.9	473.7	720.2	594.4	502.0	179.5	637.3	750.5	579.6	32.4	324.1	127.0	296.5	397.8	778.4	74.9	118.6	51.3	91.4	59.6	50.1	92.1	76.0	71.2	81.9	2045.7	3610.2	12664.6	4456.3	11098.6	390.9	812.1	5699.4	2137.4	3923.0	2044.8	182.6	5213.2	3755.2	3414.7	2254.7	2990.8	2165.3	4461.9	9085.2	5382.4	5444.6	3827.3	4020.8	6408.4	3759.0	181.1	2910.0	5208.2	8634.5	6446.8	6571.4	6944.5	5609.6	8769.4	6097.0	734.9	5926.8	6112.7	3330.7	4371.1	465.9	2690.5	3231.1	1566.2	1451.5	12519.6	5337.4	8309.1	7958.0	4025.9
RPS28	S28	ENSG00000233927	"Ribosomal protein S28"	P62857	19	8321158-8323340	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047132	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047132: AB_10962147"	"unprognostic (3.47e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (3.09e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.81e-2)"	20.3	19.0	24.1	19.2	22.0	45.2	29.7	23.4	38.9	18.2	16.9	8.2	16.3	23.5	20.4	17.5	32.5	23.1	17.4	35.6	15.1	14.5	18.7	45.0	17.5	35.8	18.4	23.1	49.5	71.9	6.4	17.7	17.0	22.4	20.4	8.6	21.1	42.4	12.2	40.7	36.3	20.7	16.3	13.7	29.3	20.9	48.6	11.2	22.2	25.0	35.9	17.7	21.9	33.5	30.3	26.5	5.3	16.6	11.1	30.8	38.4	33.6	13.7	12.4	28.2	18.0	27.2	19.7	22.1	20.4	25.8	21.1	18.5	14.8	50.6	27.3	12.9	11.0	25.8	16.5	38.0	3.7	30.6	109.9	24.4	14.9	18.4	32.5	28.0	27.2	43.6	44.0	18.7	16.9	16.1	23.7	39.7	34.1	57.7	11.4	21.1	42.7	99.6	37.3	19.6	83.8	30.5	13.4	53.5	17.0	16.2	24.0	23.4	15.9	29.6	39.3	4.2	22.4	47.4	29.6	21.4	18.2	41.3	36.8	67.4	35.4	34.4	22.6	53.9	14.3	5.3	16.6	3.5	16.9	10.6	22.8	30.3	27.1	19.7	15.8	26.8	30.8	21.4	2.6	11.1	9.8	26.5	16.4	38.4	24.1	22.0	23.4	38.9	15.1	14.5	18.4	23.1	22.4	11.2	1354.9	2501.9	6198.1	3612.6	7018.3	462.3	334.0	2894.3	1209.9	2587.6	1271.9	278.8	3255.4	2826.8	2557.8	200.6	2505.3	1869.9	1728.7	6319.3	3886.7	2995.5	2958.6	1841.3	4636.2	3871.6	252.6	2554.9	3833.9	4924.3	397.0	3625.0	3606.8	3342.1	4294.1	4940.9	645.3	4721.1	3391.2	1546.1	3475.5	503.9	1067.2	2167.5	225.8	948.4	9504.9	3550.0	3573.0	6794.8	3480.6
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	14.9	9.1	13.3	15.7	17.1	13.2	7.6	37.6	22.7	7.7	12.4	13.1	5.8	14.0	11.0	6.9	18.5	8.1	10.5	7.8	10.9	10.1	8.7	9.6	10.9	15.0	16.7	9.9	6.5	9.2	5.7	4.7	16.6	9.8	8.3	8.4	10.0	10.9	8.9	16.3	17.3	15.4	9.8	11.5	22.2	18.3	3.3	13.5	7.6	6.7	16.7	16.4	9.7	8.8	0.5	12.6	1.4	3.0	0.3	1.0	2.1	28.1	15.8	2.3	5.7	5.1	4.8	32.6	15.0	7.9	11.8	5.8	15.6	14.8	2.9	17.5	8.6	15.0	26.1	2.7	12.2	5.8	8.9	5.3	6.6	13.5	7.9	5.1	6.7	12.4	4.7	11.5	10.0	8.2	4.2	7.1	5.4	2.7	4.1	5.9	25.8	6.0	10.5	2.5	10.9	33.3	11.8	9.4	9.4	8.1	13.0	3.4	2.7	15.5	9.5	13.0	3.4	11.1	8.3	14.1	16.1	20.2	29.0	13.3	4.9	3.8	2.9	10.6	7.7	8.1	1.1	3.0	1.4	0.9	2.4	1.0	0.5	0.7	0.7	2.7	0.4	0.4	0.4	0.2	0.3	1.4	12.6	0.6	2.1	13.3	17.1	37.6	22.7	10.9	10.1	16.7	9.9	9.8	13.5	3.0	4.0	5.7	4.6	10.8	6.3	11.8	5.1	0.0	1.2	3.5	3.9	60.8	5.0	13.7	0.2	7.4	17.0	0.0	21.8	31.5	9.1	7.1	19.5	6.4	26.9	7.9	8.1	11.6	29.2	0.7	10.3	15.3	8.5	12.6	11.6	3.1	40.7	10.7	6.3	7.3	2.0	0.0	9.2	0.7	7.2	9.4	39.0	8.7	13.9	8.5
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84187907	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.7	2.9	5.9	1.0	12.2	0.0	2.3	4.7	5.1	3.1	4.5	1.1	20.7	1.7	2.7	4.0	1.5	4.0	1.9	1.2	5.1	2.9	9.2	0.9	0.8	0.2	1.5	3.3	4.9	3.4	13.5	9.1	0.5	4.4	4.3	3.7	1.5	3.0	15.0	1.4	2.3	2.0	1.7	1.0	0.6	2.4	2.6	2.7	0.8	14.5	0.9	0.6	3.3	2.3	1.2	0.8	2.4	0.5	0.7	2.8	0.1	0.0	3.7	3.6	0.0	3.4	3.4	0.0	7.7	4.1	3.4	2.9	2.8	3.0	0.0	0.0	4.1	0.0	0.1	9.1	6.1	8.1	0.0	4.6	0.0	0.1	0.0	3.1	0.0	0.0	1.9	0.0	0.0	3.8	3.8	0.8	0.0	0.0	0.2	2.7	0.0	1.3	0.1	11.0	0.0	11.9	0.0	14.6	0.0	0.6	8.5	0.0	11.7	0.0	4.2	0.0	5.2	2.0	0.0	0.0	0.1	4.4	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	2.4	0.4	0.5	0.5	0.3	0.4	1.2	0.4	0.7	0.8	0.6	0.4	0.4	1.1	0.7	0.5	0.4	2.8	0.1	5.9	12.2	4.7	5.1	5.1	2.9	1.5	3.3	4.4	2.7	8.9	2.4	2.0	4.4	0.2	19.9	2.0	12.7	6.7	3.4	17.4	23.6	2.1	1.7	0.4	0.4	0.6	3.4	0.0	1.1	0.6	0.3	7.4	0.0	1.5	0.2	1.6	24.0	1.3	0.0	0.0	4.0	0.0	0.0	0.0	5.0	2.8	1.3	2.9	5.6	3.3	18.2	0.0	0.6	3.7	6.3	0.4	1.9	0.0	5.3	4.2
RPS6KL1	MGC11287	ENSG00000198208	"Ribosomal protein S6 kinase like 1"	Q9Y6S9	14	74903954-74923396	"Enzymes, Predicted intracellular proteins"		"Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 67.9;Cone photoreceptor cells: 78.5;Horizontal cells: 38.1;Rod photoreceptor cells: 72.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	26	"B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.0;SCLC-21H: 24.9;SK-BR-3: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027451, HPA027794"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027451: AB_10599304, HPA027794: AB_10602098"	"unprognostic (2.71e-2)"	"unprognostic (9.33e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.49e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.52e-2)"	4.2	7.5	14.7	2.3	13.6	4.2	5.7	18.2	29.1	2.1	4.8	9.0	2.2	3.8	5.1	8.8	5.3	2.5	3.7	10.2	14.3	13.7	2.3	2.1	2.5	2.5	11.1	15.3	1.5	6.7	4.0	10.6	1.4	8.4	2.8	5.6	5.9	3.2	5.4	12.7	1.2	2.8	6.9	8.8	1.7	2.0	11.4	6.8	0.0	3.8	1.2	2.5	1.9	0.8	2.0	5.4	0.1	0.0	0.0	2.0	0.1	2.3	0.3	1.0	3.8	0.1	0.0	4.5	0.4	0.2	1.8	0.5	5.6	1.6	0.0	3.5	0.7	0.5	0.3	1.8	0.3	2.4	0.0	0.8	1.9	0.8	4.2	4.7	2.2	13.0	0.3	3.2	2.0	0.0	0.0	5.9	0.0	2.7	0.7	0.1	7.6	0.0	0.8	0.8	0.7	3.7	1.8	0.0	7.2	1.8	0.0	24.9	3.0	0.3	14.4	2.4	2.0	1.4	1.5	4.0	0.1	0.2	3.1	0.0	10.1	5.3	5.3	1.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	2.0	0.4	0.1	0.0	0.4	1.9	2.0	0.1	0.0	0.0	5.4	0.0	0.1	14.7	13.6	18.2	18.2	14.3	13.7	11.1	15.3	8.4	6.8	0.0	0.0	0.0	1.8	0.7	67.9	5.1	0.0	5.3	0.0	3.5	78.5	1.4	1.7	1.2	6.5	2.6	2.0	0.0	5.3	1.1	1.0	1.6	0.0	2.1	3.0	38.1	6.4	1.3	0.0	5.6	2.0	1.2	3.3	0.0	1.5	4.0	3.1	1.5	2.5	0.8	72.2	6.5	2.7	22.3	15.8	1.1	1.1	1.3	2.5	1.3
RPS7	S7	ENSG00000171863	"Ribosomal protein S7"	P62081	2	3575205-3580919	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056586	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	Yes		1000000	"Endoplasmic reticulum, Cytosol"		"HPA056586: AB_2683179"	"unprognostic (3.28e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (6.41e-2)"	"unprognostic (6.02e-3)"	"unprognostic (7.08e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (1.34e-8)"	"unprognostic (3.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	54.0	42.1	41.7	57.4	47.8	91.9	112.1	35.1	52.6	57.9	54.4	22.5	35.3	38.3	49.4	70.5	75.2	60.6	80.9	42.7	35.6	28.9	88.1	184.7	40.5	73.8	35.4	49.9	128.7	94.3	19.0	42.3	56.0	46.5	49.6	61.0	27.5	61.1	46.8	96.7	74.9	53.8	46.2	35.2	74.2	55.7	120.7	30.3	59.0	49.0	129.1	89.6	54.8	62.3	124.7	91.6	22.4	53.7	83.8	117.9	145.9	62.6	61.4	94.7	101.7	94.2	206.7	155.5	76.2	133.1	126.8	74.0	106.1	99.2	209.9	127.4	88.0	88.2	69.2	107.0	123.7	112.2	65.7	144.3	76.6	45.1	152.7	227.3	132.6	79.8	173.5	186.7	78.6	171.0	137.4	148.1	194.4	118.2	106.7	128.2	84.5	146.9	296.0	139.7	189.1	95.4	117.4	96.6	186.7	143.2	77.2	108.0	162.4	40.3	155.3	231.8	83.4	85.4	192.4	69.1	76.4	50.2	52.5	122.0	119.8	218.3	205.7	80.3	159.9	85.0	22.4	53.7	19.9	74.4	47.3	109.5	124.7	107.1	94.6	91.6	107.1	117.9	103.2	11.4	83.8	44.3	87.8	90.6	145.9	41.7	47.8	35.1	52.6	35.6	28.9	35.4	49.9	46.5	30.3	461.6	611.6	3582.6	3530.2	3485.1	365.6	144.4	1480.3	812.4	1235.2	614.1	306.3	3079.2	2208.3	1634.1	1148.8	1674.5	681.7	724.2	2971.3	4852.3	1818.6	2622.1	1119.4	1214.5	2053.4	133.5	1202.6	1662.2	2169.7	372.0	2710.8	2469.9	1898.0	2610.5	1831.6	516.1	2628.7	1420.3	1643.8	3007.3	556.0	1429.3	2159.8	1061.8	775.2	4415.0	3108.3	2545.2	2502.1	3299.7
RPUSD1	"C16orf40, MGC19600, RLUCL"	ENSG00000007376	"RNA pseudouridylate synthase domain containing 1"	Q9UJJ7	16	784974-788397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041144, HPA041938"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cell Junctions, Cytosol"	"HPA041144: AB_10794265, HPA041938: AB_10795601"	"unprognostic (1.51e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.07e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.25e-2)"	"unprognostic (8.07e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-1)"	9.5	9.7	12.0	16.5	14.8	20.9	10.4	15.3	23.8	7.4	11.2	9.4	6.2	17.6	10.5	14.0	13.9	8.6	11.2	8.1	12.7	10.4	10.7	13.4	8.2	18.2	9.5	11.3	10.0	15.3	9.9	8.9	8.2	11.2	11.3	5.1	10.9	19.8	10.5	11.1	16.8	12.8	8.3	7.0	17.4	15.1	6.2	9.2	15.5	8.5	15.1	15.6	10.8	10.7	17.3	23.1	17.7	19.9	18.0	20.4	15.8	10.6	12.6	3.1	14.0	2.7	3.2	14.4	8.9	5.1	11.7	8.5	29.3	10.1	14.9	9.7	4.2	8.2	18.3	7.1	9.0	2.1	13.5	29.0	7.3	19.3	10.5	4.4	13.5	12.4	4.8	8.7	10.1	2.7	3.4	8.0	8.8	17.1	6.7	4.0	33.8	16.8	14.1	15.8	4.9	21.8	30.0	8.3	30.6	4.2	6.6	16.3	11.7	10.2	16.8	9.8	1.9	8.6	16.9	9.0	11.7	15.2	12.2	12.8	10.8	10.8	17.1	5.6	10.6	9.5	17.5	19.9	17.7	18.3	18.0	18.1	14.9	15.5	20.4	23.1	17.3	16.2	16.3	12.7	18.0	17.4	21.2	18.7	15.8	12.0	14.8	15.3	23.8	12.7	10.4	9.5	11.3	11.2	9.2	3.0	3.5	18.7	3.5	14.2	38.1	3.3	2.5	2.7	0.0	8.7	2.0	17.7	6.6	13.7	0.4	6.8	18.6	0.0	23.3	22.4	8.9	4.4	0.0	4.0	17.2	1.6	12.7	10.4	1.6	1.4	6.4	7.9	13.5	23.4	11.0	7.8	22.5	14.0	6.0	8.1	3.3	12.9	5.6	4.2	12.0	14.6	12.2	10.2	16.7	4.7
RPUSD2	"C15orf19, C18B11, FLJ31409"	ENSG00000166133	"RNA pseudouridylate synthase domain containing 2"	Q8IZ73	15	40569300-40574943	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042079, HPA042194"	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Nucleoplasm, Microtubules"		"HPA042079: AB_10794643, HPA042194: AB_10794416"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.63e-7)"	"unprognostic (7.27e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.75e-2)"	6.6	9.8	7.8	7.7	15.3	14.2	9.3	7.7	14.6	7.7	9.3	7.7	8.1	8.3	10.9	9.9	9.9	8.5	6.4	11.4	7.6	7.4	7.0	12.2	6.5	10.6	6.8	8.8	11.0	9.8	6.9	7.5	7.5	8.4	8.5	7.3	7.7	13.3	8.9	19.8	10.6	8.8	6.5	5.0	11.0	7.9	7.9	6.6	13.7	10.4	10.5	10.5	8.2	6.3	20.1	8.9	2.9	8.9	17.8	16.0	8.1	7.7	8.8	7.5	12.4	6.5	4.9	14.2	7.0	8.3	12.1	9.6	10.8	4.9	7.5	10.1	8.0	11.0	21.1	17.3	12.2	6.9	8.6	11.8	13.2	12.2	12.7	9.7	10.9	9.5	6.9	11.5	7.9	10.9	5.6	7.4	12.3	16.1	8.9	5.9	9.5	13.0	13.8	9.6	11.3	9.6	16.7	8.3	11.4	7.7	6.8	8.6	9.9	9.4	10.7	5.6	6.5	10.2	15.0	4.6	8.3	9.7	10.6	7.9	9.2	18.3	20.0	7.2	17.2	6.4	0.0	3.5	2.9	13.5	4.1	12.4	15.6	13.3	14.3	6.8	20.1	16.0	13.3	0.4	17.8	8.9	8.9	13.6	8.1	7.8	15.3	7.7	14.6	7.6	7.4	6.8	8.8	8.4	6.6	6.0	1.6	5.9	11.3	9.4	12.1	7.0	5.1	10.7	3.4	7.0	15.7	13.5	21.6	7.6	1.6	4.6	3.2	0.0	9.4	7.0	7.1	7.4	4.6	7.8	6.1	17.5	12.7	3.7	1.2	1.5	6.6	3.5	3.3	3.6	5.3	14.0	5.4	3.5	9.6	9.9	14.7	12.9	7.6	5.5	17.0	9.4	4.7	8.4	8.3	7.9
RPUSD3	MGC29784	ENSG00000156990	"RNA pseudouridylate synthase domain containing 3"	Q6P087	3	9837849-9844602	"Predicted intracellular proteins"	"mRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037551, HPA037552"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037551: AB_2675538, HPA037552: AB_10672600"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.83e-2)"	10.8	18.9	19.5	11.8	25.9	17.0	13.2	21.1	26.5	11.1	14.9	12.9	9.8	16.0	14.0	14.4	19.3	13.9	14.0	20.7	17.2	17.0	16.9	19.5	11.8	14.3	14.4	16.5	14.7	17.5	24.1	17.0	15.2	17.4	13.3	15.6	14.6	12.5	17.5	43.3	18.6	11.9	15.6	10.6	13.2	13.6	36.3	16.4	16.5	15.3	13.9	18.7	15.0	12.2	23.7	22.2	12.4	24.7	37.0	29.7	19.0	9.0	13.5	10.3	6.6	17.4	12.9	77.2	7.8	11.2	13.0	13.8	11.8	9.3	15.6	9.8	8.6	19.2	7.7	22.9	14.0	10.4	12.0	24.0	20.8	12.1	12.6	13.6	12.7	13.2	15.8	19.5	15.1	17.6	10.7	17.1	21.1	15.3	10.9	12.8	21.3	17.3	23.3	11.2	13.2	20.3	12.3	8.5	26.1	14.3	6.8	8.0	6.7	9.8	12.6	21.5	15.5	21.5	13.8	10.1	5.2	9.4	9.1	11.4	16.2	19.3	20.5	11.0	24.2	12.0	12.4	24.7	11.9	22.6	17.6	22.9	23.7	21.2	21.1	22.2	20.0	24.2	21.5	6.0	37.0	12.0	21.3	29.7	19.0	19.5	25.9	21.1	26.5	17.2	17.0	14.4	16.5	17.4	16.4	17.9	8.1	21.6	19.2	7.1	24.2	21.4	12.7	13.4	14.8	14.0	19.6	38.5	39.7	26.0	63.8	13.4	18.8	0.0	27.6	39.4	12.4	15.6	20.7	24.1	33.7	11.1	12.7	23.4	14.3	42.6	19.8	16.7	15.1	26.2	14.4	16.9	22.0	14.4	20.1	35.2	21.2	6.5	18.6	105.6	21.0	11.2	14.4	25.9	26.2	10.1
RRAD	"RAD, REM3"	ENSG00000166592	"RRAD, Ras related glycolysis inhibitor and calcium channel regulator"	P55042	16	66921679-66925644	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 246.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 183.7;Cardiomyocytes: 231.4;Sertoli cells: 109.9;Smooth muscle cells: 182.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HDLM-2: 62.2;U-87 MG: 18.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA041755	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA041755: AB_2677655"	"unprognostic (1.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-3)"	"unprognostic (3.46e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.80e-3)"	7.3	2.1	0.4	2.4	2.7	1.3	5.0	1.2	1.7	4.7	2.0	3.2	1.8	1.2	3.3	8.5	20.4	6.3	4.1	61.2	0.7	0.6	5.6	0.8	6.3	1.3	1.5	0.8	4.7	0.7	1.0	2.0	10.7	4.6	4.2	0.4	3.9	4.3	1.4	246.0	2.2	1.2	5.7	1.7	0.8	1.7	2.3	1.2	0.3	3.9	14.7	4.3	4.5	5.7	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	2.8	0.0	0.0	0.0	0.3	0.1	1.6	0.1	0.2	1.4	0.7	1.9	0.0	1.6	0.1	0.5	0.1	0.0	0.1	0.2	62.2	0.1	0.0	0.0	0.7	2.8	0.0	0.2	0.8	0.3	5.0	0.0	1.2	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.2	1.5	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.1	2.0	0.0	0.1	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	2.7	1.2	1.0	0.7	0.6	1.5	0.8	4.6	1.2	65.5	183.7	3.5	1.9	8.4	12.5	231.4	0.0	83.0	19.4	64.6	9.8	1.0	19.9	33.7	1.5	14.0	4.9	0.0	2.7	2.7	26.9	9.8	33.5	0.0	1.3	1.6	10.2	1.3	1.5	0.4	0.6	14.2	21.9	1.0	2.7	1.5	34.5	1.7	4.9	5.8	3.0	109.9	182.3	1.7	1.9	8.8	4.7	2.2	3.0	2.6
RRAGA	"FIP-1, RAGA"	ENSG00000155876	"Ras related GTP binding A"	Q7L523	9	19049395-19050983	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003734	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA003734: AB_1079851"	"unprognostic (6.30e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (6.74e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.05e-1)"	39.0	39.0	38.0	21.5	44.9	14.6	33.8	40.1	67.7	36.9	30.4	39.0	39.8	21.8	45.9	46.6	33.7	43.6	28.6	48.3	39.5	46.5	39.0	38.3	27.7	28.4	38.0	41.7	50.2	26.9	38.4	33.3	40.1	43.4	35.7	26.9	25.1	29.5	45.3	57.1	31.6	24.9	47.9	34.3	25.5	27.1	26.1	31.6	27.0	34.3	32.6	26.2	37.3	28.1	20.9	30.9	54.1	38.5	29.5	36.6	35.1	26.4	21.9	18.1	18.7	65.3	41.7	12.5	26.7	32.1	23.3	28.8	8.3	8.2	5.2	14.8	44.9	21.1	10.1	15.4	25.2	24.8	22.5	17.3	33.7	31.4	32.1	42.9	4.6	12.8	36.8	24.5	19.9	13.6	32.3	27.7	8.7	7.6	7.7	48.3	16.7	12.7	27.4	10.0	13.8	16.9	9.9	11.8	7.5	35.4	23.2	14.9	18.6	14.6	13.3	13.7	17.1	17.1	12.6	21.5	28.4	10.9	20.1	19.8	5.4	8.8	11.9	31.2	7.1	10.2	48.3	32.5	54.1	30.5	35.9	29.7	19.6	31.6	30.1	30.9	20.9	29.4	28.8	22.8	29.5	38.5	22.3	36.6	35.1	38.0	44.9	40.1	67.7	39.5	46.5	38.0	41.7	43.4	31.6	23.8	23.0	18.6	97.4	54.3	46.9	41.1	33.1	32.1	29.6	50.6	17.7	116.6	89.5	84.2	48.5	65.8	37.1	23.3	54.0	84.8	68.5	44.0	32.4	61.0	57.2	46.1	16.8	74.9	33.1	18.5	86.9	36.2	54.0	56.9	29.0	87.9	46.5	37.4	96.9	104.9	34.2	32.3	57.3	91.9	17.2	51.8	101.5	38.3	32.9	74.5
RRAGB		ENSG00000083750	"Ras related GTP binding B"	Q5VZM2	X	55717739-55758774	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003734	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA003734: AB_1079851"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.31e-5)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (3.64e-6)"	"unprognostic (8.89e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	11.8	14.8	18.8	8.6	25.8	7.1	14.7	21.2	22.2	14.7	11.4	11.5	11.7	7.1	18.7	36.3	9.2	20.6	12.9	14.5	19.0	24.5	16.0	7.9	10.8	7.5	19.6	20.7	22.8	8.4	21.4	23.7	11.1	17.6	16.6	9.7	12.9	8.9	18.8	13.6	12.0	8.7	17.1	15.8	10.7	9.9	8.9	17.4	7.3	22.6	8.3	8.4	12.3	14.9	12.2	9.1	8.7	8.3	7.7	10.4	5.1	5.8	4.4	5.1	3.9	17.5	17.0	1.3	5.1	9.7	4.5	6.1	2.3	3.9	1.7	37.3	7.0	3.8	3.8	4.6	2.7	4.4	2.8	6.2	2.6	5.6	5.3	12.9	4.1	4.1	19.8	11.3	3.4	4.2	18.8	6.1	4.5	3.5	4.2	7.8	4.2	2.2	5.4	5.3	1.5	7.1	8.3	5.7	4.9	7.2	7.5	5.2	4.5	7.0	2.2	7.7	13.5	6.6	4.2	3.4	5.4	2.7	5.3	2.7	5.7	7.7	3.3	4.4	8.6	2.5	8.7	6.1	5.2	6.9	8.3	10.0	8.9	8.7	9.4	9.1	12.2	10.4	10.0	1.8	7.7	4.7	5.8	9.6	5.1	18.8	25.8	21.2	22.0	19.0	24.5	19.6	20.7	17.6	17.4	11.9	19.5	1.4	13.0	7.7	18.7	13.4	2.5	9.4	5.7	17.4	13.7	5.8	23.2	7.7	1.3	11.3	4.9	0.0	4.3	4.3	11.0	8.1	16.2	2.4	6.3	19.1	4.1	7.4	4.3	2.4	9.2	7.9	5.0	8.2	4.9	24.9	4.1	6.0	14.5	16.5	28.6	0.0	11.8	5.2	11.4	6.8	4.0	7.5	6.0	7.1
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364636-89412270	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 118.0;Distal tubular cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.3;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 28.2;SCLC-21H: 14.8;U-266/70: 35.7;U-266/84: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Nucleoplasm	"Vesicles, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	8.1	8.4	9.2	2.6	12.8	8.9	8.8	22.4	16.3	8.7	3.3	7.9	3.1	2.2	2.1	6.6	12.8	11.9	3.7	29.9	8.6	7.4	21.8	5.0	6.4	2.8	8.5	7.9	2.2	6.4	16.0	11.5	3.4	10.7	5.9	2.4	12.8	38.7	4.2	60.0	5.5	2.1	7.5	12.6	4.4	2.3	6.1	9.2	4.1	23.3	13.9	5.2	9.2	9.3	0.1	0.7	6.3	3.9	0.1	0.6	0.3	0.0	0.7	1.9	1.4	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.7	0.0	10.0	0.0	10.7	0.0	0.0	0.0	5.3	2.4	0.0	0.0	0.8	7.1	8.5	0.2	0.6	0.0	0.0	0.0	0.0	7.4	0.2	28.2	0.0	0.7	3.4	3.5	1.6	0.0	0.7	7.1	10.3	0.1	2.6	0.2	14.8	0.8	0.2	1.0	12.0	0.6	0.3	5.6	0.0	0.8	1.2	5.1	1.3	35.7	16.5	0.0	2.7	5.4	0.8	3.9	1.2	2.6	0.0	1.1	0.1	0.1	0.4	0.0	0.7	0.0	0.3	0.6	6.3	0.1	3.9	0.6	0.0	0.3	9.2	12.8	22.4	9.1	8.6	7.4	8.5	7.9	10.7	9.2	8.9	11.8	7.5	12.1	14.3	18.0	118.0	15.3	13.4	5.7	14.0	29.5	0.4	99.5	14.2	15.2	3.6	0.0	0.0	14.9	1.2	6.0	29.7	4.6	8.6	46.1	44.5	1.2	3.1	19.9	10.4	2.8	8.5	37.1	5.4	0.3	18.0	12.3	0.0	3.9	15.6	14.2	0.0	6.6	8.4	25.7	19.7	0.6	1.5	0.0	25.7
RRAS	R-Ras	ENSG00000126458	"RAS related"	P10301	19	49635292-49640201	"Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 13.8;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010160, HPA060364, CAB069439"	Uncertain		Approved	Vesicles		NA	NA		23000	Vesicles		"CAB010160: AB_2180086, CAB069439: AB_1622637, HPA060364: AB_2684264"	"unprognostic (9.23e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (8.54e-2)"	"unprognostic (4.55e-3)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (2.16e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (1.54e-9)"	"unprognostic (6.13e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.74e-2)"	40.9	14.9	6.3	16.0	7.0	1.7	35.2	2.9	7.3	45.2	48.8	7.0	50.6	14.5	55.3	27.0	53.2	35.2	44.9	56.5	6.2	4.8	24.5	13.7	37.8	12.6	7.0	8.0	28.0	9.0	1.7	6.9	39.2	8.5	62.7	8.8	24.9	19.9	62.1	19.2	11.1	29.4	72.5	6.2	25.1	28.7	23.3	5.8	3.4	26.8	19.1	13.8	79.6	39.4	1.1	2.5	0.1	15.9	0.3	1.2	1.4	15.9	19.8	2.5	5.1	44.4	49.6	0.7	21.2	30.1	10.3	13.6	2.7	27.0	1.0	11.1	31.1	15.1	10.7	1.4	21.7	4.2	6.5	1.1	1.9	6.5	1.6	41.3	0.1	4.1	34.9	19.3	13.0	10.4	44.1	26.3	0.7	1.2	7.9	18.3	6.3	0.0	1.8	0.5	13.7	16.1	1.5	6.2	2.9	22.3	3.2	0.0	2.3	8.3	7.4	1.3	6.9	10.6	1.5	37.4	30.5	12.2	5.3	6.0	5.9	2.4	0.2	31.7	1.2	9.5	0.0	3.8	0.1	0.4	13.8	0.4	1.1	1.1	0.4	2.5	0.3	1.2	0.3	0.0	0.3	15.9	0.7	0.4	1.4	6.3	7.0	2.9	7.3	6.2	4.8	7.0	8.0	8.5	5.8	35.7	6.4	6.5	44.4	26.3	1.5	49.0	38.2	2.7	11.4	48.8	2.0	3.7	8.3	56.9	0.7	46.0	50.1	0.0	48.8	30.8	57.9	44.2	10.3	4.5	28.8	4.8	9.8	62.0	27.6	3.0	55.8	15.7	25.3	39.7	19.1	33.8	104.3	13.9	71.5	8.6	1.3	77.6	123.5	0.9	4.7	16.8	5.9	7.0	13.2	46.3
RRAS2	TC21	ENSG00000133818	"RAS related 2"	P62070	11	14277926-14364506	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 12.3"	"Group enriched"	"Detected in many"	5	"B-cells: 12.3;NK-cells: 3.5;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB010420, HPA050942"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB010420: AB_2253855, HPA050942: AB_2681285"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (7.80e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.50e-2)"	"unprognostic (4.15e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	22.3	11.8	8.3	27.5	7.8	2.3	22.6	9.5	7.0	14.1	16.9	6.4	7.8	11.9	16.2	9.8	13.5	11.1	12.9	29.8	8.7	8.1	25.6	33.0	18.1	15.2	6.5	7.6	16.6	18.5	13.5	7.4	50.8	8.4	16.7	11.0	14.5	15.1	12.9	31.4	9.2	37.7	31.4	7.6	17.6	13.7	21.0	5.2	11.3	26.2	14.4	20.8	27.3	15.0	12.3	0.4	1.5	0.0	3.5	6.2	0.9	15.3	6.7	6.4	5.6	22.9	22.4	9.5	54.3	28.4	46.9	59.6	13.5	19.2	17.7	9.1	36.4	15.2	17.7	10.8	19.4	47.3	15.7	10.5	1.1	4.0	10.7	24.5	0.0	0.1	23.7	36.8	18.7	60.1	19.3	23.3	4.3	7.7	0.0	40.7	7.4	3.7	0.9	18.2	3.1	6.3	3.7	21.2	0.3	24.0	8.5	1.7	3.3	13.1	8.4	7.4	22.6	5.4	1.1	53.1	25.4	14.1	48.7	14.7	0.0	0.0	8.3	10.2	0.0	5.1	1.5	0.0	0.0	6.2	0.0	2.6	12.3	1.1	3.2	0.0	6.9	0.6	2.5	0.4	3.5	0.0	0.4	0.0	0.9	8.3	7.8	9.5	7.0	8.7	8.1	6.5	7.6	8.4	5.2	17.9	17.6	46.8	50.4	61.6	5.2	23.2	43.3	10.7	18.2	17.4	0.0	32.7	19.9	40.3	48.4	18.0	39.6	0.0	16.1	49.9	26.8	69.2	9.2	27.6	6.9	12.7	18.3	12.9	1.6	34.5	15.3	2.5	25.3	2.8	16.6	18.6	42.0	25.9	10.6	70.4	10.3	19.4	21.2	34.6	41.4	43.5	24.3	26.6	19.6	64.4
RRNAD1	"C1orf66, CGI-41, METTL25B"	ENSG00000143303	"Ribosomal RNA adenine dimethylase domain containing 1"	Q96FB5	1	156728442-156736960	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047426	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047426: AB_2680041"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.03e-3)"	14.1	19.4	12.4	22.6	19.0	8.7	19.1	15.3	18.8	17.6	25.7	20.8	31.2	22.5	20.3	22.9	18.4	24.4	20.2	12.5	13.3	10.9	15.9	25.8	14.5	14.4	19.9	14.5	24.5	29.2	24.3	18.8	20.5	16.1	21.8	14.8	20.2	22.5	24.5	21.9	23.9	26.6	12.9	14.7	18.5	19.3	25.9	17.7	11.9	30.3	13.5	15.9	21.7	27.9	4.9	5.9	7.0	4.0	6.5	8.6	2.9	5.9	11.8	8.8	8.6	23.7	10.9	13.4	4.5	13.9	7.8	5.9	6.4	27.6	10.2	13.6	7.1	11.0	25.6	12.2	10.6	3.2	20.2	10.3	6.1	11.2	4.7	14.9	9.1	16.8	16.8	20.4	7.8	14.9	9.3	6.5	9.2	14.6	23.1	4.1	14.4	4.6	10.7	10.1	26.0	3.7	7.6	5.8	23.6	9.3	6.5	11.4	16.5	8.0	16.5	9.8	14.0	21.8	19.6	6.3	4.9	6.0	7.5	6.0	26.9	26.3	12.6	5.4	10.3	5.8	6.7	3.3	4.7	6.8	2.5	6.9	3.4	6.6	4.8	5.9	4.9	5.3	6.0	7.0	6.5	4.0	2.2	8.6	2.9	12.4	19.0	15.3	18.8	13.3	10.9	19.9	14.5	16.1	17.7	6.0	10.8	9.7	21.1	9.0	9.9	6.1	20.4	6.7	10.3	3.5	11.8	21.2	8.3	10.3	44.1	11.3	18.0	0.0	11.6	14.3	9.4	17.5	4.7	18.5	9.6	7.9	9.2	9.2	10.2	10.3	10.3	6.6	8.5	9.0	16.6	20.3	9.4	17.5	8.9	11.6	11.6	12.9	6.2	15.8	22.8	10.0	27.1	8.3	16.5	15.9
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.9	21.4	5.7	12.3	4.4	5.2	12.5	10.1	6.1	10.5	8.2	23.2	14.8	17.6	13.2	6.4	9.4	20.6	15.6	11.7	7.1	9.6	18.7	13.6	8.0	18.0	7.3	21.1	17.9	5.4	16.6	25.8	23.9	11.9	5.9	9.9	19.4	11.8	5.9	20.8	14.3	13.6	24.5	8.5	14.5	15.7	7.8	17.4	7.3	8.9	7.7	16.4	8.1	7.8	10.1	4.6	18.8	11.0	7.7	7.1	12.2	15.8	31.9	24.2	21.0	20.7	10.1	27.2	7.5	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1	32.8	39.8	13.7	10.9	20.8	6.2	9.5	7.6	25.4	34.2	14.0	39.3	4.4	0.0	9.1	5.6	6.7	3.9	0.0	7.4	5.9	7.6	10.1	39.4	6.8	10.4	4.8	20.6	4.9	10.8	3.6	3.4	8.4	6.8	1.0	7.2	2.2	7.8	5.1	2.5	6.8	12.3	0.0	6.1	9.9	18.4	17.1	7.7	4.4	7.8	12.4
RRP15	"CGI-115, KIAA0507"	ENSG00000067533	"Ribosomal RNA processing 15 homolog"	Q9Y3B9	1	218285287-218337983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024639	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria"		Yes	No			"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Mitochondria"	"HPA024639: AB_1844368"	"unprognostic (2.68e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.65e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-2)"	10.3	7.2	8.9	8.0	9.9	8.5	11.6	11.6	10.4	8.4	8.0	5.5	5.4	5.3	10.1	7.1	8.7	8.9	5.0	11.4	8.6	6.3	9.3	10.7	7.5	8.3	8.0	5.0	9.8	8.4	12.1	10.0	8.7	8.6	7.8	7.2	5.8	7.9	6.4	33.5	8.5	6.8	11.8	9.4	10.3	7.6	6.3	9.0	6.5	8.9	10.5	8.3	8.5	9.4	5.1	3.3	0.6	2.4	3.1	5.7	1.6	8.1	6.1	6.8	4.9	5.0	7.0	5.9	8.3	6.3	8.8	6.4	11.9	7.5	11.8	11.5	6.4	5.9	7.4	11.6	11.0	14.7	4.7	8.7	9.1	5.8	6.6	10.3	14.1	5.0	4.8	6.8	11.4	15.3	3.9	5.6	5.5	18.6	3.9	9.8	7.5	9.3	6.9	13.6	6.5	12.8	6.6	4.2	11.6	7.0	7.6	8.0	11.5	7.1	13.3	12.2	8.5	9.5	10.2	7.9	7.1	6.6	12.5	15.4	4.7	7.2	12.2	8.1	6.9	11.2	0.6	1.6	0.2	3.5	2.4	4.8	4.7	4.2	2.9	2.4	5.1	5.7	5.5	0.5	3.1	2.1	3.3	2.5	1.6	8.9	9.9	11.6	10.4	8.6	6.3	8.0	5.0	8.6	9.0	29.8	25.5	31.5	28.8	58.0	29.7	58.0	17.8	13.4	30.7	34.9	9.8	32.1	23.2	30.7	5.9	26.0	2.9	0.0	44.6	48.1	26.3	14.3	30.1	37.6	29.3	25.4	11.6	19.0	13.3	2.7	34.8	25.8	20.3	17.2	18.6	20.3	31.8	2.9	23.3	23.5	21.8	25.8	28.8	46.4	75.7	41.7	15.1	22.4	25.7	22.8
RRP7A	"CGI-96, Rrp7"	ENSG00000189306	"Ribosomal RNA processing 7 homolog A"	Q9Y3A4	22	42509968-42519802	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001586, HPA046768"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA001586: AB_1078506, HPA046768: AB_2679796"	"unprognostic (8.46e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.96e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.73e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.53e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	10.4	12.9	19.9	15.4	26.6	16.5	13.5	18.5	20.9	12.8	12.2	15.1	9.4	10.2	12.0	47.3	15.1	18.9	12.0	11.1	17.5	14.8	14.0	18.1	11.3	21.5	14.8	9.3	21.2	12.0	16.6	10.3	17.7	17.4	17.8	10.8	12.6	15.2	14.6	13.5	14.9	13.3	11.9	11.7	15.6	12.0	11.2	18.6	17.4	11.6	8.7	16.4	10.7	11.0	26.2	30.5	17.4	27.5	15.2	18.4	20.3	13.0	18.4	10.1	11.9	6.5	4.3	20.5	11.1	6.7	14.4	12.2	23.4	7.5	21.8	5.7	7.9	8.0	14.5	11.6	15.5	6.2	5.5	23.7	11.8	12.8	12.6	6.2	28.3	10.2	5.5	7.8	19.5	9.9	5.2	8.7	11.7	16.6	6.3	8.5	26.5	27.2	11.6	8.4	10.4	13.4	47.4	10.4	9.6	7.5	16.0	5.5	3.9	8.2	23.6	10.8	5.4	9.6	12.8	6.5	11.0	14.2	8.4	11.3	9.7	7.2	25.6	9.2	10.9	15.8	10.0	23.5	17.4	18.4	26.4	17.7	20.5	16.1	16.8	18.1	26.2	17.7	16.5	4.7	15.2	27.5	30.5	13.5	20.3	19.9	26.6	18.5	20.9	17.5	14.8	14.8	9.3	17.4	18.6	20.8	35.8	52.9	72.3	38.9	26.5	14.2	25.5	34.8	33.0	21.0	15.7	80.7	14.9	65.2	48.5	37.9	36.0	23.3	23.4	117.3	32.9	62.0	46.2	29.2	83.7	25.4	25.3	31.3	37.8	94.1	20.4	49.8	32.1	146.1	29.9	22.2	58.6	42.1	17.3	34.2	28.7	6.5	26.9	30.9	22.8	33.1	100.7	41.5	40.0	87.7
RSAD1	FLJ11164	ENSG00000136444	"Radical S-adenosyl methionine domain containing 1"	Q9HA92	17	50478800-50485975	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA022436, HPA022967, HPA024459"	Approved		Approved	"Nucleoli,Mitotic chromosome,Mitochondria"		NA	NA			Mitochondria	"Nucleoli, Mitotic chromosome"	"HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: "	"unprognostic (8.21e-2)"	"unprognostic (4.11e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-2)"	13.5	22.2	16.1	16.8	23.9	8.9	14.1	32.2	20.3	16.8	13.1	12.7	13.5	13.9	13.8	15.1	8.8	12.9	13.6	25.7	13.7	11.6	18.5	28.2	14.0	16.6	19.0	13.7	20.9	46.0	20.3	12.9	10.1	16.3	12.8	14.9	12.6	21.4	14.0	37.0	13.5	12.0	13.7	23.6	16.7	16.0	8.8	19.1	11.6	15.8	20.9	14.0	11.7	12.4	7.4	5.8	3.8	4.6	6.7	10.9	5.1	5.7	19.7	9.5	15.6	16.3	13.3	3.4	10.2	9.9	13.1	11.1	19.5	7.4	15.7	22.6	7.1	13.0	5.5	10.7	14.2	11.3	17.3	19.5	21.1	8.8	18.9	11.4	12.7	14.9	9.7	15.7	8.7	16.9	10.9	12.7	38.8	16.3	15.0	10.9	13.5	21.2	9.3	3.8	24.6	21.3	8.7	10.9	14.2	15.8	8.8	5.2	17.8	2.6	12.2	13.1	12.6	18.4	13.0	8.9	13.7	14.6	10.4	11.9	23.5	16.4	6.1	10.3	18.2	9.5	1.1	4.1	3.8	9.5	4.6	9.9	5.1	8.2	9.4	5.1	7.4	10.9	10.5	0.0	6.7	4.3	5.8	6.2	5.1	16.1	23.9	32.2	20.3	13.7	11.6	19.0	13.7	16.3	19.1	3.0	12.5	11.2	4.6	9.0	12.3	23.6	12.7	1.4	6.8	15.7	2.0	15.8	19.9	10.9	7.3	13.7	8.7	0.0	25.4	9.6	10.3	5.5	3.5	15.8	14.2	7.9	24.2	6.7	7.8	5.4	14.4	9.6	16.9	10.8	12.6	30.7	11.1	3.5	10.3	8.7	7.4	12.9	12.4	8.4	21.2	8.7	8.5	13.1	13.0	2.8
RSAD2	"cig5, vig1, viperin"	ENSG00000134321	"Radical S-adenosyl methionine domain containing 2"	Q8WXG1	2	6865806-6898239	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"		Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 31.8"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 32.8;Ciliated cells: 17.4;granulocytes: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 24.3"	"Group enriched"	"Detected in some"	5	"BJ hTERT+ SV40 Large T+: 31.1;BJ hTERT+ SV40 Large T+ RasG12V: 48.0;HMC-1: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA041160, HPA049409"	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA041160: AB_10795489, HPA049409: AB_2680751"	"unprognostic (8.91e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (3.27e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-3)"	"unprognostic (9.47e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.79e-1)"	31.8	3.1	4.8	10.1	8.7	12.5	4.1	1.1	7.8	7.2	5.6	4.7	2.1	3.4	4.8	7.8	2.9	5.5	6.2	5.3	5.3	5.8	6.1	3.6	15.3	7.7	4.8	5.6	3.5	2.1	1.2	6.2	10.1	12.5	3.7	3.1	7.5	20.2	2.5	5.5	1.0	4.9	5.2	6.1	10.8	7.2	2.3	2.0	11.5	10.2	3.5	2.8	4.0	2.0	0.4	2.7	24.3	5.1	1.6	3.2	2.2	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	31.1	48.0	0.0	1.0	0.5	0.0	0.0	5.3	0.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	22.4	0.0	0.0	2.1	0.0	0.0	0.0	1.3	0.5	0.4	0.0	0.0	2.8	0.6	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	0.1	14.6	3.6	24.3	1.8	5.1	2.2	0.2	1.9	1.7	2.7	0.4	3.2	2.4	14.4	1.6	4.5	0.2	0.9	2.2	4.8	8.7	1.1	7.8	5.3	5.8	4.8	5.6	12.5	2.0	32.8	4.6	0.0	2.8	0.5	0.2	2.5	5.1	17.4	3.4	0.0	2.0	0.6	0.0	3.3	0.9	9.1	2.5	0.0	5.3	0.7	1.5	3.3	23.1	0.4	7.8	0.0	8.6	11.1	2.4	0.4	1.4	7.4	0.0	2.8	1.6	6.2	5.4	0.3	2.1	0.0	0.6	0.0	3.1	0.2	0.4	0.3	2.4	2.2	0.4	6.3
RSBN1	"FLJ11220, ROSBIN"	ENSG00000081019	"Round spermatid basic protein 1"	Q5VWQ0	1	113761832-113812476	"Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042124, HPA049484"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA042124: AB_10794644, HPA049484: AB_2680787"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-3)"	10.4	8.4	8.6	9.4	14.6	35.8	10.3	23.9	12.0	17.0	14.4	6.9	8.1	7.7	13.4	8.6	9.7	10.9	8.4	8.1	8.9	9.1	10.4	7.9	11.5	11.8	8.1	7.3	18.3	13.3	17.6	15.1	8.2	8.4	11.5	10.9	9.6	10.1	10.7	17.1	10.7	10.9	11.5	7.2	12.8	8.8	12.4	10.0	22.6	11.8	5.7	12.7	16.6	10.7	20.7	16.4	25.7	9.2	14.3	20.8	7.3	11.9	3.4	11.8	7.0	7.0	8.1	5.7	4.2	9.2	8.7	9.1	4.0	3.6	10.5	6.8	5.2	4.0	5.3	8.3	5.2	14.2	10.1	6.0	7.9	3.7	4.6	5.3	14.8	8.5	6.1	5.7	7.4	7.1	7.4	6.8	11.8	11.9	6.6	6.3	12.2	11.8	8.8	9.9	3.8	5.9	21.6	11.5	5.4	5.2	5.2	11.9	9.5	8.1	8.0	7.2	6.2	3.9	10.0	8.1	7.8	8.5	11.6	6.9	8.8	6.6	13.3	8.1	9.1	13.0	25.7	9.2	14.6	18.6	6.9	18.8	18.3	20.1	17.1	7.6	20.7	20.8	16.9	17.9	14.3	7.5	16.4	17.4	7.3	8.6	14.6	23.9	12.0	8.9	9.1	8.1	7.3	8.4	10.0	32.8	16.1	30.8	35.7	66.3	83.2	16.9	15.3	29.4	29.6	24.4	62.8	21.1	16.6	17.4	15.1	40.5	36.7	23.3	22.6	20.3	33.4	36.6	34.7	17.0	17.1	92.2	47.3	27.0	20.5	4.0	46.6	26.3	38.8	34.3	43.1	59.4	19.0	44.2	46.7	12.8	100.8	38.8	50.9	94.3	33.0	57.0	26.3	58.9	38.5	36.5
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696443-77783022	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 337.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	12.9	10.6	15.0	22.1	14.6	9.5	15.5	28.7	17.0	22.8	23.5	8.9	12.1	11.1	17.2	13.6	15.0	14.2	13.4	10.6	12.4	10.3	12.0	14.9	15.7	18.2	11.1	11.0	19.2	14.9	19.5	16.2	12.2	11.8	18.8	15.1	13.9	14.0	15.4	13.6	11.7	14.9	18.0	11.0	20.7	14.3	29.8	13.8	34.5	21.1	6.7	18.0	23.6	28.2	7.2	7.0	31.5	4.0	3.0	5.2	1.2	9.0	7.0	11.7	20.5	8.2	10.5	5.7	6.7	7.3	9.6	11.0	8.6	16.2	18.6	2.6	6.9	12.1	7.9	15.8	8.7	13.8	10.1	8.5	14.8	11.0	8.4	6.9	18.1	14.0	7.5	6.4	8.8	9.7	7.3	7.9	12.4	20.1	19.6	9.9	10.4	15.5	18.3	8.3	11.7	6.3	16.2	11.7	19.5	6.0	11.9	13.8	14.4	10.2	18.6	7.3	12.4	11.3	9.7	7.5	14.4	13.3	8.6	10.2	8.8	9.3	29.9	6.8	16.9	9.4	9.1	4.0	6.4	5.2	2.9	3.9	5.4	4.5	3.8	2.2	7.2	4.3	4.7	31.5	3.0	3.2	7.0	4.5	1.2	15.0	14.6	28.7	17.0	12.4	10.3	11.1	11.0	11.8	13.8	53.6	44.7	77.1	91.4	69.9	234.2	15.9	38.2	69.6	80.8	52.4	221.9	45.1	33.2	32.4	254.3	67.5	45.0	0.0	43.8	30.0	64.1	42.7	68.2	48.3	38.0	149.4	74.4	43.0	41.9	50.1	94.0	54.7	60.8	45.1	68.1	88.8	31.9	58.5	112.4	18.0	337.1	71.1	85.6	98.9	156.4	65.7	32.4	99.1	57.8	72.2
RSG1	"C1orf89, MGC10731"	ENSG00000132881	"REM2 and RAB like small GTPase 1"	Q9BU20	1	16231700-16237162	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 3.5;granulocytes: 4.6;Spermatocytes: 3.7;Spermatogonia: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028453	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028453: AB_10601692"	"unprognostic (7.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.45e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	3.2	7.5	14.2	3.7	17.1	5.8	3.3	3.7	9.8	6.0	3.7	3.9	12.6	4.2	5.6	3.2	8.9	11.8	3.8	7.9	10.4	12.0	5.3	3.6	3.2	4.5	9.3	10.5	10.1	8.3	7.9	8.0	4.1	10.4	5.4	3.3	5.7	8.0	7.5	2.1	7.4	3.6	6.1	7.9	5.9	6.6	6.7	7.5	1.7	11.6	0.3	4.0	5.9	3.0	3.2	2.2	4.0	3.5	2.9	6.2	1.4	4.0	11.0	3.4	11.1	2.3	4.2	3.1	4.5	2.9	3.7	1.6	4.0	6.2	8.7	9.2	2.5	7.3	3.3	6.1	5.9	0.4	13.1	5.1	4.3	9.6	0.8	5.7	2.9	7.9	2.2	5.1	4.3	3.9	3.7	3.5	6.7	15.6	3.4	3.0	5.0	3.1	2.1	0.8	4.3	4.3	7.8	0.4	7.0	3.3	2.5	8.2	5.5	1.8	2.8	4.1	2.6	8.4	2.7	3.5	1.1	1.8	2.2	1.5	9.4	3.5	5.0	3.0	6.3	6.2	0.0	1.2	4.0	5.0	3.5	6.2	3.0	3.1	1.4	2.2	3.2	3.0	2.4	1.1	2.9	2.2	0.7	3.2	1.4	14.2	17.1	3.7	9.8	10.4	12.0	9.3	10.5	10.4	7.5	0.0	3.5	0.5	1.5	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.7	0.0	0.0	0.8	0.7	2.0	0.0	0.0	2.0	0.7	1.0	4.6	0.8	2.1	0.0	1.2	0.6	1.3	0.9	1.1	0.0	1.7	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	3.7	0.3	0.9	0.0	1.2	0.5
RSPH3	"dJ111C20.1, RSHL2, RSP3"	ENSG00000130363	"Radial spoke head 3 homolog"	Q86UC2	6	158972871-159000187	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 113.8;Early spermatids: 110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039109, HPA040230"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"HPA039109: AB_10794423, HPA040230: AB_10796119"	"unprognostic (6.18e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	4.9	9.0	7.1	3.8	9.8	3.1	6.2	6.3	12.7	6.8	8.2	7.0	14.3	11.3	7.4	12.8	15.5	10.7	6.0	6.6	8.0	6.8	10.7	5.4	8.5	2.6	4.8	10.6	7.3	8.6	25.9	14.4	5.5	10.4	8.9	6.5	5.5	10.3	14.9	3.8	7.6	12.2	6.6	6.0	3.9	7.5	24.3	7.0	2.1	12.8	5.1	3.9	9.1	8.4	2.3	5.8	13.0	7.7	1.8	1.8	1.6	9.8	5.1	2.3	5.4	5.4	6.9	2.9	7.0	8.2	2.8	3.7	2.0	6.0	2.1	6.5	7.5	7.6	7.5	1.5	6.6	3.1	4.8	4.4	2.7	5.0	3.4	5.2	2.5	1.9	8.5	11.8	4.5	8.9	10.7	2.7	2.7	3.1	3.4	4.6	5.6	1.5	3.1	1.5	4.3	3.4	2.4	0.4	2.1	8.8	3.2	3.5	4.4	13.2	4.4	2.5	2.9	5.4	6.2	6.4	2.9	7.4	5.6	3.8	3.6	6.9	1.8	12.4	3.3	4.6	0.7	5.2	0.6	0.8	3.6	1.8	1.3	1.2	1.6	5.4	2.3	1.0	1.4	13.0	1.8	7.7	5.8	1.4	1.6	7.1	9.8	6.3	12.7	8.0	6.8	4.8	10.6	10.4	7.0	23.8	13.2	0.5	14.8	6.5	12.2	15.9	15.3	113.8	25.0	21.0	33.4	9.0	11.6	12.7	110.2	5.8	27.3	0.0	9.0	8.8	8.9	17.9	2.3	7.5	9.2	3.2	12.6	6.7	10.3	47.9	13.0	11.6	6.8	1.0	18.0	13.4	10.9	14.4	16.6	16.5	29.6	6.5	6.1	45.3	8.7	7.8	4.9	8.7	10.0	19.7
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head 4 homolog A"	Q5TD94	6	116616479-116632985	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7"	"Cell type enriched"	"Detected in many"	10	"Ciliated cells: 365.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.4;pons and medulla: 19.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 7.6;U-266/84: 5.5"	"Low region specificity"	"Detected in many"							"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.5	0.7	1.8	0.5	9.4	0.9	0.7	1.2	0.9	2.2	0.4	10.2	0.4	0.5	1.9	13.3	0.4	35.9	0.8	0.5	3.0	3.3	0.7	0.4	11.1	0.5	0.5	1.1	13.7	0.6	2.8	16.7	0.3	19.8	0.6	0.4	0.2	0.4	0.5	1.0	0.6	0.4	0.6	0.7	1.0	0.8	6.6	1.8	0.0	1.0	0.0	0.5	0.4	0.1	0.8	0.1	1.3	0.2	0.2	1.0	0.0	0.1	0.2	1.4	3.2	0.1	0.1	0.3	0.4	0.8	0.6	0.8	0.7	1.1	1.0	0.3	0.1	1.2	0.2	0.3	0.6	0.6	0.8	1.1	0.4	0.5	1.2	0.0	0.8	1.1	0.4	0.2	1.0	0.2	0.1	0.0	0.9	0.2	0.1	0.6	0.2	0.7	0.1	0.6	0.1	0.1	0.8	1.6	7.6	3.2	0.4	2.8	1.2	0.2	0.2	0.5	0.3	0.5	0.6	0.5	0.4	0.7	0.5	0.5	0.5	5.5	0.4	0.1	0.4	0.5	1.3	0.2	0.8	1.0	0.1	0.1	0.4	0.3	0.0	0.0	0.8	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	1.8	9.4	1.2	0.7	3.0	3.3	0.5	1.1	19.8	1.8	3.0	4.3	0.0	0.0	0.0	3.0	0.4	0.0	365.4	35.2	0.0	2.0	0.0	1.7	0.4	18.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	2.3	0.0	0.1	1.6	0.0	2.5	0.0	8.7	0.3	0.0	1.7	0.0	0.0	1.7	0.2	0.0	0.0	0.0	3.2	0.0	0.4	4.4	1.5	0.1	0.2	0.0	0.0	0.0
RSPO1	"FLJ40906, RSPONDIN"	ENSG00000169218	"R-spondin 1"	Q2MKA7	1	37611350-37634923	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 17.3;endometrium 1: 26.6"	"Cell type enhanced"	"Detected in some"	18	"Fibroblasts: 4.7;Melanocytes: 1.7;Smooth muscle cells: 4.1"	"Cancer enriched"	"Detected in some"	13	"ovarian cancer: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 1.8;NTERA-2: 4.6;THP-1: 4.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046154, HPA062923"	Uncertain		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA046154: AB_10964912, HPA062923: "	"unprognostic (1.50e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.99e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.75e-6)"		"unprognostic (1.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.13e-2)"		"unprognostic (1.93e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-2)"	5.0	0.1	0.2	1.9	0.3	0.0	5.8	0.5	0.6	17.3	2.1	0.2	0.2	0.6	26.6	3.0	1.8	15.8	12.2	0.4	0.2	0.0	0.7	0.2	4.5	1.9	0.2	0.2	7.5	1.6	0.0	0.2	1.3	0.4	3.0	0.2	2.3	1.5	1.4	0.2	4.0	3.1	10.9	0.2	0.7	2.0	1.0	0.2	0.2	0.2	1.3	6.1	1.3	8.8	0.4	0.3	0.7	0.5	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	4.7	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.7	0.2	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.7	0.0	0.5	0.3	0.3	0.0	0.2	0.3	0.5	0.6	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0
RSRC1	"BM-011, MGC12197, SFRS21, SRrp53"	ENSG00000174891	"Arginine and serine rich coiled-coil 1"	Q96IZ7	3	158105855-158545730	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044792	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA044792: AB_10794502"	"unprognostic (1.06e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (7.40e-5)"	"unprognostic (5.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.84e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.48e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.15e-1)"	26.2	24.4	23.8	16.6	25.6	18.7	23.0	43.0	32.3	22.6	17.3	17.7	12.2	12.3	19.4	19.2	18.2	14.6	14.7	20.1	23.8	27.0	22.1	23.1	13.2	17.9	26.5	22.5	18.8	21.5	22.8	28.2	16.5	31.9	19.3	20.7	12.5	16.7	21.5	22.8	15.4	14.3	20.7	33.7	19.5	16.4	14.8	23.2	24.0	24.1	13.3	19.9	19.6	16.2	24.5	33.8	17.6	21.6	9.4	15.7	6.6	31.6	15.2	12.0	15.4	28.5	20.0	15.7	15.9	13.9	18.2	20.2	21.1	24.3	30.4	29.7	19.4	20.2	14.2	22.3	14.3	27.1	46.1	19.0	31.4	13.4	17.2	4.5	26.6	20.3	14.4	13.8	14.2	12.7	19.5	8.5	18.0	18.3	22.9	13.8	25.9	20.7	17.9	10.0	21.5	14.7	24.4	20.5	37.0	13.4	10.5	20.8	23.6	17.6	12.1	19.6	13.5	27.6	23.1	9.4	22.7	13.7	29.4	31.3	19.3	20.6	32.6	23.2	36.3	27.9	17.6	19.8	10.3	14.8	21.6	15.6	24.5	15.7	14.8	11.9	24.1	14.9	15.7	13.7	9.4	19.9	33.8	12.5	6.6	23.8	25.6	43.0	32.3	23.8	27.0	26.5	22.5	31.9	23.2	29.8	20.2	41.2	28.8	33.2	75.7	40.1	53.5	38.8	22.7	78.5	31.4	31.3	63.0	45.2	33.4	29.6	17.7	46.7	52.3	44.9	43.5	26.6	73.0	63.5	34.6	60.4	31.7	32.5	42.4	6.6	42.8	58.5	42.2	45.1	40.3	59.2	39.6	28.1	33.6	44.6	92.1	19.4	39.1	31.6	37.3	24.0	24.7	37.0	28.1	24.0
RSRC2	FLJ11021	ENSG00000111011	"Arginine and serine rich coiled-coil 2"	Q7L4I2	12	122503458-122527000	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040070, HPA048183"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA040070: AB_10673430, HPA048183: AB_2680302"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-2)"	18.5	19.4	24.8	20.2	31.9	82.6	20.1	34.9	45.9	19.3	21.0	16.0	19.9	14.3	21.4	21.4	26.9	19.6	21.0	20.2	28.9	21.4	20.6	18.2	19.1	23.0	24.9	24.1	25.2	19.0	11.3	43.2	20.6	28.1	20.0	18.6	10.7	19.1	21.3	36.8	18.7	19.2	20.4	45.1	18.6	16.0	20.7	29.4	21.1	23.5	17.7	15.7	25.0	28.0	24.6	16.3	22.3	18.4	16.4	19.3	9.8	11.8	14.4	13.6	5.7	10.8	7.0	9.8	22.1	7.1	9.5	5.4	20.1	5.0	13.5	18.8	7.6	5.6	7.7	14.9	6.2	9.3	12.8	13.8	23.7	17.4	21.5	6.0	20.3	14.4	8.8	7.3	8.1	13.8	11.9	6.7	5.9	15.0	8.5	8.3	9.5	14.7	15.2	11.2	10.0	11.8	11.2	12.3	8.8	12.3	22.4	11.0	9.9	17.2	5.8	12.1	14.0	9.3	7.5	10.0	9.7	11.8	10.7	12.1	9.7	22.6	21.9	6.1	11.8	5.4	19.8	16.6	22.3	16.4	13.5	13.9	22.8	15.0	13.3	16.3	24.6	19.3	15.2	17.7	16.4	18.4	15.4	19.0	9.8	24.8	31.9	34.9	45.9	28.9	21.4	24.9	24.1	28.1	29.4	80.4	89.6	138.1	368.8	179.7	109.7	83.7	94.3	141.8	109.2	89.0	74.6	125.3	165.8	92.9	188.3	119.6	104.7	46.7	84.2	129.5	131.9	177.4	209.2	101.1	82.4	141.4	149.8	73.6	78.5	80.0	111.0	114.7	119.8	97.4	81.2	130.5	83.8	101.7	99.3	86.6	122.3	122.9	136.3	196.1	162.4	163.4	234.2	162.4	74.8	247.2
RSRP1	"C1orf63, DJ465N24.2.1"	ENSG00000117616	"Arginine and serine rich protein 1"	Q9BUV0	1	25242237-25338213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 353.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058992, HPA067651"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058992: AB_2683873, HPA067651: AB_2685879"	"unprognostic (1.03e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.81e-2)"	"unprognostic (5.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.73e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.87e-2)"	"prognostic favorable (2.91e-5)"	11.3	55.9	13.2	23.7	20.6	21.3	9.4	18.3	16.7	48.3	13.4	17.8	44.2	10.4	19.2	26.0	15.6	14.7	30.3	16.5	16.8	13.6	19.4	17.5	16.3	11.0	31.0	15.6	20.2	22.8	6.7	25.0	17.0	18.6	21.4	6.4	12.7	36.7	36.6	9.9	16.9	12.6	12.0	25.9	15.0	17.3	14.0	21.5	23.1	17.5	10.5	20.9	12.2	21.1	7.7	18.6	39.2	18.0	10.0	10.5	7.7	3.4	9.7	1.5	1.3	8.4	2.2	3.3	3.4	1.3	4.8	5.1	7.5	4.0	2.8	12.3	0.9	1.5	5.6	7.5	0.8	1.3	6.9	5.1	11.2	10.8	9.0	2.4	4.9	5.7	0.8	4.6	1.9	0.2	2.8	2.9	3.7	8.7	27.6	1.3	4.1	1.3	9.4	5.4	7.0	5.6	4.1	3.8	4.1	3.3	0.2	4.7	1.3	2.5	1.7	2.0	0.8	2.0	5.0	4.0	3.0	2.4	2.8	2.1	15.1	13.5	3.1	2.3	12.4	2.2	36.5	18.0	25.5	7.9	11.4	8.2	7.4	8.2	6.4	18.6	7.7	7.9	5.2	39.2	10.0	14.9	11.8	10.5	7.7	13.2	20.6	18.3	16.7	16.8	13.6	31.0	15.6	18.6	21.5	56.6	75.6	125.0	203.5	0.0	95.1	40.3	40.8	108.4	69.4	89.0	133.5	64.6	18.3	33.2	24.1	69.8	353.7	23.3	18.8	45.9	62.1	147.7	216.6	15.7	55.8	79.4	125.4	61.4	67.3	10.1	129.8	97.5	0.0	83.0	125.1	79.6	32.5	277.0	84.8	7.9	146.7	122.9	31.5	64.2	96.5	0.0	101.4	148.1	107.4	174.4
RSU1	"FLJ31034, RSP-1"	ENSG00000148484	"Ras suppressor protein 1"	Q15404	10	16590611-16817528	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA025927	Uncertain		Approved	Vesicles		NA	NA		210000000	Vesicles		"HPA025927: AB_10610420"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.30e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.53e-2)"	34.3	11.9	11.3	18.5	11.0	18.1	27.3	11.2	9.9	24.6	26.9	13.0	11.7	8.9	33.5	15.9	29.3	21.3	17.3	19.5	11.3	12.4	29.4	19.5	20.4	16.0	13.7	7.4	27.2	36.9	9.2	6.4	48.1	10.2	22.5	18.3	13.0	15.1	21.7	12.7	15.1	15.9	37.2	13.7	30.3	18.3	9.7	11.8	19.6	17.1	16.0	20.3	31.9	20.8	12.2	23.7	17.4	17.7	20.4	23.6	29.8	9.5	6.7	5.5	32.3	29.5	30.5	6.7	23.9	10.3	16.9	18.2	6.2	8.9	9.6	3.8	32.4	8.9	8.5	6.6	12.6	18.1	14.2	5.4	30.1	4.3	5.9	13.0	4.6	17.5	15.0	13.3	15.8	5.0	15.0	17.2	10.1	4.8	6.6	22.5	6.2	10.4	8.2	5.7	14.0	3.8	6.9	7.4	6.4	15.9	3.5	2.2	4.3	11.9	7.8	11.7	10.3	2.7	12.0	21.1	14.2	5.0	17.8	12.2	5.8	7.0	8.3	18.8	13.1	6.1	17.4	14.7	15.0	18.2	17.7	20.3	11.6	20.8	19.4	23.7	12.2	15.5	19.3	10.4	20.4	16.4	17.7	23.6	29.8	11.3	11.0	11.2	9.4	11.3	12.4	13.7	7.4	10.2	11.8	32.8	20.3	26.9	25.5	32.5	1.4	35.0	33.1	38.8	22.7	40.1	2.0	108.0	58.0	66.2	80.6	63.2	17.4	23.3	103.9	65.2	65.8	16.0	33.5	27.2	107.3	3.2	6.9	62.0	57.4	127.5	36.5	65.6	57.3	119.0	20.6	5.6	69.9	14.4	64.3	41.3	14.1	64.7	122.6	3.9	21.5	37.4	80.4	48.9	23.4	21.8
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 17.3;pituitary gland: 25.8;retina: 57.0"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7;neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.2;SH-SY5Y: 5.4;U-266/84: 21.1;U-87 MG: 4.8"					"Not detected"	"Not detected"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Endoplasmic reticulum"		"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.3	6.9	10.2	0.5	3.4	0.9	0.3	2.7	17.3	0.2	0.9	0.4	0.0	1.0	0.3	1.5	0.3	0.3	0.4	0.3	7.3	5.1	0.2	0.4	0.5	0.4	2.8	2.8	0.3	2.5	0.2	25.8	0.3	4.0	0.4	0.9	57.0	0.3	0.3	0.3	0.5	1.0	0.6	1.0	0.4	2.5	3.5	0.0	7.0	0.4	0.0	0.4	0.3	0.0	0.3	0.2	1.8	0.2	0.4	0.2	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.1	0.9	0.9	0.0	0.6	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.9	0.0	0.1	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	1.2	2.7	0.0	0.1	0.0	0.0	0.9	0.7	1.1	0.7	0.1	1.0	0.0	0.0	8.2	5.4	0.1	0.1	0.4	0.4	2.7	0.7	0.0	0.8	1.0	0.7	0.1	1.2	21.1	4.0	4.8	0.0	0.0	1.7	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	1.8	0.4	0.2	0.2	0.1	0.0	10.2	3.4	2.7	8.6	7.3	5.1	2.8	2.8	4.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	1.4	0.0	0.0	0.0	0.0	329.9	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	45.9	0.1	0.0	0.0	0.0	289.4	0.0	0.0	11.5	5.1	0.0	0.0	0.0	0.0	0.0
RTCB	"C22orf28, FAAP, HSPC117"	ENSG00000100220	"RNA 2',3'-cyclic phosphate and 5'-OH ligase"	Q9Y3I0	22	32387582-32412255	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000535, HPA001103"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		43000	Nucleoplasm	"Vesicles, Cytosol"	"HPA000535: AB_2666021, HPA001103: AB_1078351"	"unprognostic (1.84e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (4.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	26.4	30.1	20.1	20.4	29.7	15.1	29.2	22.9	34.5	25.7	35.6	35.2	32.7	51.6	29.7	25.8	30.8	26.9	22.9	26.4	19.6	24.6	42.4	55.1	23.1	22.7	29.1	26.2	29.0	29.4	38.4	29.9	33.7	36.7	27.0	42.3	27.1	29.9	28.6	40.9	46.6	61.7	31.8	24.4	29.3	29.7	30.8	25.5	32.0	32.7	30.1	46.6	26.5	24.2	44.6	51.5	29.0	47.7	37.0	40.5	44.0	32.2	29.0	36.4	27.3	31.9	23.8	29.0	28.3	34.1	45.3	43.1	37.6	13.2	8.0	19.0	33.0	27.9	22.0	41.6	41.1	58.7	40.4	41.8	22.8	24.6	34.1	22.0	53.3	20.9	23.4	27.3	44.8	43.6	25.0	40.7	22.6	27.0	22.8	33.0	26.9	22.6	18.5	20.8	37.5	26.6	35.2	39.3	41.2	31.1	28.1	37.6	20.8	30.7	19.9	35.9	40.0	21.8	20.7	30.6	25.0	36.9	21.7	27.1	15.9	12.7	28.9	25.9	24.2	32.6	29.0	43.5	27.4	31.7	47.7	35.5	44.6	33.3	33.0	51.5	43.6	39.9	34.6	4.3	37.0	35.5	28.9	40.5	44.0	20.1	29.7	22.9	34.5	19.6	24.6	29.1	26.2	36.7	25.5	29.8	30.2	40.2	48.9	53.8	50.9	32.3	48.4	37.5	22.7	33.2	19.6	98.9	56.3	89.0	3.8	37.9	93.2	0.0	84.1	74.7	40.4	51.2	42.6	54.7	75.2	49.3	44.9	35.0	41.7	7.0	32.5	40.0	28.7	107.4	50.3	61.1	82.4	59.7	44.9	108.7	48.0	25.8	37.2	57.2	58.8	66.5	81.8	30.9	51.3	61.4
RTEL1	"bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL"	ENSG00000258366	"Regulator of telomere elongation helicase 1"	Q9NZ71	20	63657810-63696253	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA020622, HPA067329, HPA078328"			Approved	"Nuclear speckles,Nuclear bodies"		NA	NA			"Nuclear speckles, Nuclear bodies"		"HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380"	"unprognostic (3.63e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.27e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.30e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.50e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.84e-2)"	8.4	14.3	9.4	11.5	12.4	14.2	7.9	25.6	11.8	9.1	11.1	11.2	10.9	9.8	15.4	7.4	7.0	9.5	9.3	6.2	8.0	6.9	7.1	7.2	8.9	7.8	7.5	12.1	10.6	17.8	7.2	18.2	9.8	8.2	10.2	4.8	10.2	12.9	10.2	10.2	8.2	10.1	8.8	4.4	11.6	10.4	17.6	8.9	9.1	11.9	4.9	9.5	9.3	9.0	1.7	3.6	0.0	3.3	0.4	3.0	2.4	5.3	7.3	5.2	10.1	1.1	1.2	9.7	11.0	2.9	17.2	4.5	14.5	4.5	7.1	5.7	3.3	6.5	9.9	3.6	7.2	4.1	3.5	7.3	8.8	12.6	13.8	3.8	8.6	16.1	1.5	4.0	4.2	5.3	3.3	5.8	12.7	10.8	6.8	3.8	5.7	13.3	11.1	5.1	4.5	15.3	10.7	4.9	7.3	2.8	6.5	10.4	6.3	6.1	18.0	1.4	2.5	4.7	9.7	7.7	19.5	6.4	6.7	8.4	6.3	2.6	4.5	4.7	6.1	6.7	0.0	2.7	0.0	3.0	3.3	1.6	0.9	1.7	2.0	3.6	1.7	2.9	1.1	0.0	0.4	2.6	3.2	1.4	2.4	9.4	12.4	25.6	11.8	8.0	6.9	7.5	12.1	8.2	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006714	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	20.4	27.8	27.6	21.6	33.8	34.3	20.4	40.5	34.5	23.7	22.5	14.3	17.6	16.9	25.7	18.4	22.4	18.5	18.4	24.8	26.5	21.4	17.6	19.6	17.2	23.0	17.0	35.1	27.7	15.2	37.0	20.3	36.9	27.2	22.0	20.6	15.4	19.5	23.2	55.2	24.8	20.7	24.7	14.9	23.5	19.0	25.4	13.5	25.3	26.7	15.6	21.6	27.8	20.2	8.0	7.4	11.6	4.3	8.6	5.7	1.4	15.3	10.1	33.4	27.1	19.0	22.6	15.8	20.6	23.2	28.3	23.7	19.7	9.8	14.6	16.7	21.5	12.6	27.4	19.3	17.1	24.3	22.2	18.0	30.7	22.9	14.7	13.3	27.3	18.0	16.2	17.4	15.1	15.3	21.1	22.7	26.8	23.3	17.0	23.1	11.7	26.1	16.9	18.0	19.2	13.9	28.4	26.1	13.9	18.4	33.1	17.2	22.8	18.5	23.7	9.3	19.0	19.4	26.5	18.6	27.8	17.7	27.6	22.5	19.7	30.3	24.3	20.0	26.1	16.9	5.9	4.3	8.4	4.8	2.8	4.4	8.0	4.7	4.1	3.0	6.5	5.7	4.7	11.6	8.6	3.3	7.4	5.4	1.4	27.6	33.8	40.5	34.5	26.5	21.4	17.0	35.1	27.2	13.5	119.1	70.9	118.3	89.5	128.8	209.3	81.2	112.1	69.6	75.1	116.9	88.4	138.6	139.3	89.0	242.0	101.3	97.3	116.8	95.9	97.3	120.4	91.4	89.0	170.3	83.7	139.8	84.2	119.7	72.1	267.8	134.3	89.8	102.9	103.6	107.1	106.0	103.7	94.8	150.3	100.0	188.1	84.1	92.0	109.4	66.6	142.4	183.4	97.8	106.5	90.9
RTF2	"C20orf43, CDAO5, HSPC164, RTFDC1"	ENSG00000022277	"Replication termination factor 2"	Q9BY42	20	56468585-56519449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 133.3;Distal tubular cells: 132.6;monocytes: 160.5;Syncytiotrophoblasts: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053986	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053986: AB_2682333"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (8.90e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.48e-3)"	33.4	34.2	43.5	29.1	43.9	52.6	28.9	27.4	48.7	28.8	29.4	53.0	20.1	28.0	31.4	24.1	30.5	31.6	23.2	38.7	40.6	35.6	31.8	30.3	24.2	29.7	49.6	35.7	35.2	27.5	26.0	29.3	30.5	46.6	28.5	26.0	26.0	25.8	31.7	74.6	27.9	29.8	34.1	59.7	30.2	25.3	29.1	45.2	31.4	29.1	28.9	34.4	29.0	23.9	20.0	35.1	91.6	31.8	29.4	23.0	33.2	28.9	20.8	21.1	20.6	26.4	23.6	19.6	45.2	34.2	65.3	37.5	42.4	28.1	24.8	53.7	36.6	32.1	32.5	21.1	34.8	45.2	11.6	16.4	31.0	22.8	32.8	30.3	44.1	42.9	20.9	36.2	29.1	25.3	27.8	28.0	26.6	24.0	26.0	32.0	55.3	36.9	37.6	15.6	41.1	39.7	25.4	57.5	32.7	27.2	19.1	21.8	23.7	47.5	80.6	42.5	16.3	37.3	42.1	30.0	55.9	36.2	30.4	36.5	21.7	24.9	35.3	44.0	30.1	30.4	39.2	31.8	84.1	20.9	29.6	17.6	18.6	18.0	20.3	35.1	20.0	20.5	18.8	91.6	29.4	28.8	29.9	23.0	33.2	43.5	43.9	27.4	48.7	40.6	35.6	49.6	35.7	46.6	45.2	47.6	50.4	0.0	0.0	0.0	0.0	0.0	0.0	62.9	62.6	62.8	0.0	133.3	132.6	81.8	0.0	0.0	0.0	0.0	83.7	92.1	0.0	0.0	83.7	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.0	160.5	0.0	0.0	80.1	0.0	0.0	106.9	0.0	0.0	0.0	0.0	0.0	0.0	153.0	0.0	0.0	0.0
RTKN	B5	ENSG00000114993	Rhotekin	Q9BST9	2	74425836-74442422	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030259	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA030259: AB_10601484"	"unprognostic (4.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.43e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-3)"	3.2	4.9	17.1	3.9	24.2	0.4	7.1	3.9	23.6	5.6	8.7	29.7	7.3	21.2	5.1	4.0	8.0	9.0	9.7	7.2	22.2	13.7	27.0	39.0	6.3	1.9	34.8	7.7	3.6	16.3	12.8	5.3	7.9	17.2	6.5	8.8	6.0	17.3	7.0	7.5	21.1	16.4	4.4	36.3	2.2	6.0	1.4	29.4	1.9	7.4	5.3	4.3	3.1	5.6	1.7	9.7	0.0	0.0	3.1	0.4	0.6	16.8	5.2	6.7	19.8	4.1	4.8	29.0	2.6	3.3	3.8	2.8	26.2	9.4	0.1	7.5	2.5	4.7	23.2	2.5	16.9	1.8	3.3	10.9	4.0	0.9	33.0	2.5	0.0	0.0	2.9	13.5	3.3	10.8	7.0	1.9	0.2	2.0	0.1	5.6	12.0	0.6	3.3	7.3	24.5	10.5	3.7	21.0	2.5	18.6	0.1	6.8	6.5	7.2	28.1	14.9	6.5	15.7	1.5	0.2	7.2	5.0	3.2	3.5	1.7	1.1	0.6	6.9	0.0	6.7	0.0	0.0	0.0	0.4	0.0	0.3	1.1	0.2	0.3	0.9	1.7	0.0	0.1	0.0	3.1	0.0	9.7	0.0	0.6	17.1	24.2	3.9	14.9	22.2	13.7	34.8	7.7	17.2	29.4	8.9	10.2	1.7	19.9	17.7	0.0	2.5	17.8	2.7	17.0	10.4	2.0	38.3	18.3	38.6	0.8	7.0	35.9	0.0	17.8	4.0	10.3	22.4	1.1	34.6	8.2	0.0	29.6	3.1	2.6	0.4	11.8	0.0	27.0	1.0	15.4	5.8	24.3	31.6	8.1	43.3	0.4	6.5	3.4	1.1	3.4	18.9	27.9	2.9	21.8	14.5
RTKN2	"bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1"	ENSG00000182010	"Rhotekin 2"	Q8IZC4	10	62183035-62268707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lung: 67.6"	"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 1628.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	7	"T-reg: 15.4"	"Lineage enriched"	"Detected in single"	47	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"A-431: 25.5;HaCaT: 20.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037946, HPA038446"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA037946: AB_10795398, HPA038446: AB_10796218"	"unprognostic (2.33e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-3)"	"unprognostic (6.66e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.48e-4)"	"unprognostic (3.70e-11)"	"unprognostic (3.95e-2)"	"unprognostic (9.34e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.55e-1)"	0.3	0.1	0.7	1.8	0.8	0.5	0.7	0.1	1.6	1.5	1.1	0.0	0.1	0.7	0.6	0.1	7.1	0.2	0.4	0.2	0.5	0.2	0.5	0.2	67.6	2.3	0.2	0.5	0.3	0.2	0.2	0.8	0.7	0.1	0.7	1.2	0.1	1.6	0.1	0.1	0.7	1.1	0.3	0.2	0.8	0.7	5.3	0.1	6.9	0.8	1.3	4.1	0.7	3.0	0.3	0.2	0.3	0.1	0.2	15.4	0.2	25.5	1.4	13.7	6.3	0.0	0.1	3.3	3.7	4.3	4.2	6.7	10.6	5.1	0.1	1.6	1.4	4.3	20.5	7.6	0.6	4.4	3.6	5.2	4.2	3.1	4.4	0.0	5.7	3.3	0.2	0.3	5.2	0.5	2.3	0.6	6.8	0.2	0.2	5.6	3.2	11.0	7.3	5.8	3.8	5.2	9.5	14.6	0.0	2.7	11.1	7.5	8.6	2.4	8.6	3.5	4.2	7.8	3.1	0.0	1.9	12.5	0.1	9.3	0.1	0.0	9.8	2.5	0.0	3.0	0.1	0.1	0.1	1.3	0.0	0.1	0.1	2.1	0.4	0.0	0.3	0.8	0.3	0.3	0.2	0.1	0.2	15.4	0.2	0.7	0.8	0.1	1.6	0.5	0.2	0.2	0.5	0.1	0.1	1628.8	44.5	0.9	8.3	4.1	0.6	0.4	0.0	4.0	15.9	0.0	0.0	3.0	0.0	1.4	376.8	0.1	0.4	0.0	1.4	4.9	2.5	7.0	3.5	0.0	2.1	0.0	1.7	1.8	0.6	65.6	2.0	2.2	1.7	0.0	5.9	0.4	9.1	0.0	1.8	1.4	0.5	0.0	1.9	21.3	23.6	1.6	1.7	12.7	3.3	87.2
RTL1	"HUR1, Mar1, MART1, PEG11, SIRH2"	ENSG00000254656	"Retrotransposon Gag like 1"	A6NKG5	14	100880655-100884847	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 5.0;brain: 7.6;placenta: 8.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"melanoma: 1.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"SH-SY5Y: 121.1"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.1"					"HPA066979, HPA077601"	Enhanced		Approved	Cytosol		No	NA			Cytosol		"HPA066979: AB_2685759, HPA077601: "					"unprognostic (1.61e-1)"					"unprognostic (3.30e-1)"	"unprognostic (1.26e-1)"			"unprognostic (1.42e-3)"	"unprognostic (2.10e-1)"			0.0	5.0	0.2	0.0	0.9	0.0	0.0	0.5	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.6	0.0	0.0	0.0	0.0	1.8		1.3	0.1	0.0	0.3	8.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656069-78659328	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;GAMG: 3.2;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4"									"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737"	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	2.6			0.2	2.5	0.2	0.5	0.4	0.5	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.2	0.2	0.0	0.0	0.0		0.2	0.5		0.7	0.0	0.1	0.3	1.1	2.7	0.0	0.0	3.2	0.0			0.1		0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	2.4	2.6	0.0	0.0	0.0	0.1	4.0	3.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.6	0.0	0.6	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.0	0.1	1.4	0.2	3.4	0.2	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"kidney: 3.5;liver: 4.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.8;SuSa: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.5	4.7	0.0	0.0	0.7		0.0	0.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2			0.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL5	"KIAA2001, Mar5, Mart5, RGAG4, SIRH8"	ENSG00000242732	"Retrotransposon Gag like 5"	Q5HYW3	X	72127110-72131901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.2;Ciliated cells: 4.0;Club cells: 3.4;Distal tubular cells: 1.7;granulocytes: 2.3;Hofbauer cells: 3.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;AN3-CA: 6.3;SCLC-21H: 7.6;SH-SY5Y: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003652	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003652: AB_1079805"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (4.23e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	5.4	7.2	7.0	2.7	12.5	1.9	7.7	22.7	14.2	4.9	4.5	3.5	6.2	2.8	9.6	10.1	2.6	4.9	6.0	4.0	10.3	8.9	4.4	4.2	5.5	2.4	5.2	11.2	10.5	1.1	7.4	16.3	5.2	6.3	5.7	3.0	3.0	3.7	6.9	2.3	2.1	3.2	6.7	9.5	2.7	5.4	12.4	4.8	0.0	11.7	0.8	2.0	5.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	5.6	6.3	1.5	1.8	0.3	2.1	0.8	0.3	0.9	0.4	0.0	0.0	0.9	0.4	1.0	0.0	1.1	0.1	1.1	0.0	0.8	0.2	0.1	0.0	0.1	0.0	0.7	3.4	0.1	0.9	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.6	10.6	0.4	0.0	0.0	2.4	0.2	0.0	0.7	0.8	0.7	1.4	0.0	0.1	0.0	0.0	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	12.5	22.7	14.2	10.3	8.9	5.2	11.2	6.3	4.8	3.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RTL6	"dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3"	ENSG00000188636	"Retrotransposon Gag like 6"	Q6ICC9	22	44492572-44498298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	10	"Ciliated cells: 13.4;Collecting duct cells: 12.2;Ductal cells: 6.3;Exocrine glandular cells: 5.6;Pancreatic endocrine cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005697	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA005697: AB_1079244"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	11.6	14.1	19.3	7.7	17.4	3.2	10.2	16.2	30.0	13.6	12.2	14.7	15.2	9.7	17.8	14.2	9.4	19.1	12.4	16.7	17.1	16.1	10.9	4.9	10.4	6.3	16.9	11.4	22.6	12.1	18.9	9.9	5.9	11.9	11.5	10.4	9.2	7.7	16.3	15.5	3.7	9.2	19.0	16.5	7.9	10.7	12.6	9.5	14.4	11.6	7.2	5.3	11.8	10.2	0.2	1.1	0.1	1.4	0.9	4.5	2.1	7.0	9.8	12.7	16.9	10.0	8.1	3.3	9.3	11.1	13.1	10.4	3.2	4.2	0.0	5.9	17.4	9.9	6.1	8.5	9.2	8.2	3.3	16.7	0.0	18.9	0.0	12.4	0.9	4.7	8.8	9.0	12.0	9.3	18.0	11.7	11.3	3.9	0.0	8.9	12.4	22.3	2.0	7.8	7.8	10.5	6.1	6.7	0.0	11.3	8.2	13.7	16.0	15.2	7.4	9.4	6.4	7.4	9.9	12.0	10.3	14.0	13.6	7.4	4.4	1.7	0.0	15.4	2.3	15.4	0.0	1.4	0.1	4.3	0.6	4.5	0.0	2.5	3.6	1.1	0.2	1.0	2.5	0.0	0.9	0.8	0.1	0.4	2.1	19.3	17.4	16.2	27.8	17.1	16.1	16.9	11.4	11.9	9.5	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	13.4	4.5	12.2	0.0	2.2	0.0	6.3	0.0	0.0	0.0	0.0	5.6	2.6	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.8	0.0	0.0	6.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870966	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 144.6"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 227.2"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9"	"Group enriched"	"Detected in many"	15	"dendritic cells: 7.9;monocytes: 4.6"	"Group enriched"	"Detected in some"	4	"HEL: 23.2;SCLC-21H: 28.7;SH-SY5Y: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		140000	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	6.3	8.3	27.4	6.1	46.3	1.6	3.0	98.5	144.6	2.6	2.9	11.0	0.0	2.7	2.1	1.6	2.3	8.6	4.4	1.9	32.3	50.7	2.3	1.9	4.8	2.7	21.3	45.9	1.7	3.6	19.2	10.3	2.7	35.1	5.0	3.0	1.2	2.3	2.6	1.6	2.3	3.4	2.7	12.1	10.6	3.6	2.6	10.5	0.0	2.7	0.0	2.3	2.5	0.9	0.0	7.9	0.4	4.6	0.0	0.0	1.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.8	23.2	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	28.7	46.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.1	0.0	2.1	0.0	0.0	0.0	7.7	1.6	0.2	0.0	4.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	1.0	27.4	46.3	98.5	94.7	32.3	50.7	21.3	45.9	35.1	10.5	0.0	0.6	0.0	0.4	4.2	26.8	0.8	2.5	1.4	1.2	0.0	23.6	0.8	0.0	0.0	13.2	0.5	0.2	0.0	0.0	0.7	2.1	6.2	0.0	0.4	15.8	227.2	51.9	0.0	15.9	14.4	2.6	24.4	10.1	1.8	0.0	13.1	2.2	0.0	1.1	0.3	29.4	0.0	2.1	2.1	2.5	5.6	2.1	0.0	0.2	0.3
RTN2	"NSP2, NSPL1, SPG12"	ENSG00000125744	"Reticulon 2"	O75298	19	45485289-45497061	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"skeletal muscle: 155.7;tongue: 43.2"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 109.9;Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 9.1;eosinophil: 3.5;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 23.6;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034941, HPA034948"	Approved		Approved	"Nuclear speckles"		NA	NA		16000	"Nuclear speckles"		"HPA034941: AB_10671358, HPA034948: AB_2674375"	"unprognostic (3.08e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (4.34e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.03e-1)"	3.4	3.1	6.9	1.9	9.0	1.3	3.4	5.9	10.4	2.5	4.2	1.0	3.7	1.8	3.4	6.7	5.4	2.0	3.5	5.4	7.4	4.8	1.4	1.7	2.6	2.2	4.8	3.7	1.0	2.5	2.2	1.6	11.4	4.6	5.1	1.6	2.6	6.5	4.8	155.7	2.6	1.8	3.3	1.4	2.6	1.9	1.2	1.0	0.0	1.8	43.2	3.5	4.2	1.5	0.1	2.4	9.1	0.5	0.3	0.0	0.5	1.9	2.7	4.6	3.6	7.9	9.8	9.1	4.4	10.7	2.8	5.4	5.4	1.7	1.7	6.2	4.8	2.3	3.7	3.0	2.1	0.8	4.0	4.4	11.8	2.0	4.0	3.4	0.7	13.5	10.7	1.1	1.2	2.2	4.9	5.1	0.4	6.4	3.3	8.3	1.5	0.0	2.2	3.4	8.8	3.5	2.0	23.6	9.4	1.6	23.4	13.0	12.5	0.9	21.7	6.8	4.5	17.1	4.7	4.5	7.9	2.4	0.2	0.9	1.9	4.4	3.9	2.1	2.7	4.0	9.1	0.2	3.5	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.3	0.5	2.4	0.0	0.5	6.9	9.0	5.9	10.4	7.4	4.8	4.8	3.7	4.6	1.0	3.0	7.2	0.0	21.5	5.7	8.9	3.9	5.1	1.4	2.3	3.5	5.9	109.9	0.0	16.6	0.0	10.8	0.3	0.0	6.1	125.7	7.6	19.7	16.1	2.4	23.2	22.3	10.9	20.9	10.0	0.0	5.2	10.6	21.9	10.0	2.0	8.5	9.1	0.0	6.3	0.1	10.6	12.9	10.0	0.4	3.0	3.0	100.5	0.0	0.4	19.5
RTN4R	NOGOR	ENSG00000040608	"Reticulon 4 receptor"	Q9BZR6	22	20241415-20283246	"Disease related genes, Predicted membrane proteins"		Receptor	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.0;brain: 33.2"	"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 12.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 20.5;REH: 28.8;SCLC-21H: 17.6;SK-MEL-30: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB012443			Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		1300000	"Plasma membrane, Focal adhesion sites"	"Actin filaments"	"CAB012443: "	"unprognostic (1.28e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.07e-1)"	0.8	1.1	10.9	1.2	7.0	1.3	0.7	33.2	24.6	0.8	1.7	1.2	0.3	3.9	4.9	0.5	0.9	1.3	0.6	1.4	8.8	3.1	0.9	4.0	1.7	1.1	1.4	6.8	1.1	2.7	0.6	1.6	1.1	4.9	1.2	0.6	0.7	1.3	1.2	0.8	5.2	1.8	0.7	2.8	5.9	2.3	1.1	0.5	0.1	1.1	0.4	0.7	0.7	0.7	0.1	1.3	0.0	0.0	0.7	12.0	1.7	4.2	2.0	1.3	3.0	0.0	0.0	0.7	0.4	0.0	0.3	0.1	3.2	1.2	0.2	1.4	0.0	2.1	6.9	0.8	1.8	0.0	0.1	7.4	0.1	1.8	0.4	0.7	0.1	0.2	0.0	2.3	0.0	0.2	0.0	0.0	2.0	0.2	0.2	0.0	5.9	2.2	20.5	4.8	1.2	3.7	28.8	0.0	0.2	0.2	1.8	17.6	2.8	2.0	1.5	13.7	0.3	1.7	0.6	0.0	0.2	8.2	0.0	0.1	0.0	0.5	0.5	0.2	4.2	0.0	0.0	0.0	0.0	5.1	0.0	12.0	0.0	4.5	5.1	0.2	0.1	2.7	5.7	0.0	0.7	0.0	1.3	3.1	1.7	10.9	7.0	33.2	20.1	8.8	3.1	1.4	6.8	4.9	0.5	3.0	0.0	0.0	3.6	4.5	5.3	1.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	2.4	2.0	1.4	1.3	0.0	3.7	4.3	0.5	3.1	0.0	0.9	1.3	6.4	0.0	0.6	0.0	0.0	0.3	0.0	1.7	1.0	1.4	9.8	2.4	0.0	0.0	0.0	4.8	0.0	0.6	0.0	1.3	4.8	0.0	1.0	1.6	2.6
RTN4RL1	"DKFZp547J144, NgR3, NGRH2"	ENSG00000185924	"Reticulon 4 receptor like 1"	Q86UN2	17	1934677-2025345	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.3"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 17.9;Cone photoreceptor cells: 35.3;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.8;HaCaT: 10.8;hTCEpi: 10.3;T-47d: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044428	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Midbody"	"Intracellular and membrane"	NA	NA			"Actin filaments"	"Nucleoplasm, Plasma membrane, Midbody"	"HPA044428: AB_10963229"	"unprognostic (5.23e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.97e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.32e-3)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.15e-2)"	8.3	5.0	6.8	1.2	8.0	0.6	7.0	4.6	19.3	3.4	1.3	0.6	7.2	0.8	1.9	1.0	1.4	3.6	2.9	2.7	9.6	2.7	2.6	3.2	3.9	0.8	1.3	7.9	1.6	3.8	2.0	6.5	1.3	0.7	6.1	0.8	8.4	9.8	5.3	3.9	11.3	1.2	1.2	1.0	2.7	1.2	1.3	0.1	0.0	1.5	0.8	0.9	1.4	3.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.4	1.6	1.8	2.5	2.1	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.1	10.8	0.2	10.8	4.7	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.3	0.0	3.7	0.0	0.0	2.6	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.3	0.8	0.3	1.2	0.0	0.0	2.3	0.1	0.3	0.8	1.8	0.3	13.5	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	8.0	4.6	19.3	9.6	2.7	1.3	7.9	0.7	0.1	0.0	2.1	0.0	0.2	2.4	17.9	2.6	0.0	2.7	2.3	3.5	35.3	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	2.1	1.4	31.8	0.0	6.7	0.0	0.9	0.0	0.0	3.3	0.0	0.0	1.5	0.1	0.0	0.0	0.0	10.0	0.0	0.5	0.0	0.1	2.5	0.0	0.0	0.0	0.2
RTTN	DKFZP434G145	ENSG00000176225	Rotatin	Q86VV8	18	70003031-70205945	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 15.9;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041343, HPA041967, HPA075089"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA041343: AB_10794409, HPA041967: AB_10796790, HPA075089: "	"unprognostic (1.76e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.25e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	5.5	6.2	6.2	8.1	13.0	12.9	8.0	12.3	8.0	8.0	5.2	26.5	4.0	5.6	12.1	6.1	4.7	6.0	5.9	8.3	7.2	6.4	8.9	9.0	6.3	8.5	14.2	5.9	11.0	8.4	13.0	7.0	6.8	12.8	5.5	6.2	13.9	5.2	6.4	5.9	6.0	6.1	7.5	12.4	7.9	5.4	14.3	12.5	20.4	5.2	5.5	13.0	5.0	6.8	2.5	1.3	0.6	0.9	1.5	3.1	0.5	3.5	5.4	8.4	2.0	1.2	1.4	3.1	6.4	2.9	5.8	5.7	2.4	2.1	2.9	0.9	3.7	5.6	3.9	5.4	9.3	9.3	11.1	2.8	3.3	5.4	2.2	0.8	5.0	3.4	1.2	10.2	6.4	19.9	2.4	3.3	4.9	3.2	6.8	5.1	1.2	5.6	1.8	1.4	0.7	4.2	4.7	7.3	2.8	0.8	2.4	3.0	3.8	3.5	1.6	2.2	5.1	2.3	3.6	3.3	7.5	2.0	2.4	4.7	3.1	2.9	6.5	4.5	3.4	4.8	0.6	0.9	0.6	1.1	0.2	1.9	2.5	2.1	1.3	0.4	1.7	3.1	1.9	0.4	1.5	0.3	1.3	1.3	0.5	6.2	13.0	12.3	8.0	7.2	6.4	14.2	5.9	12.8	12.5	0.0	11.3	1.9	1.4	1.3	7.0	4.5	0.0	0.0	6.8	0.0	0.0	3.2	0.0	1.0	4.8	2.3	2.0	0.0	1.4	1.6	2.3	1.0	4.7	3.4	2.0	15.9	0.0	1.8	1.0	2.6	2.0	2.6	0.0	0.0	1.6	2.9	1.5	3.1	1.8	2.7	9.6	12.9	2.3	9.2	6.5	1.5	2.5	2.2	1.7	1.8
RUBCN	"KIAA0226, rubicon, rundataxin"	ENSG00000145016	"RUN and cysteine rich domain containing beclin 1 interacting protein"	Q92622	3	197671393-197749727	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Endocytosis, Immunity, Phagocytosis"		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050908, HPA054497"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA050908: , HPA054497: AB_2682507"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.91e-5)"	"unprognostic (1.99e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.23e-1)"	10.7	8.4	19.3	15.5	24.0	10.7	6.8	30.0	24.6	7.9	9.8	12.4	6.4	10.7	9.1	6.5	14.5	7.7	10.4	10.3	18.1	18.8	7.8	5.7	12.4	19.8	14.6	19.4	14.0	11.0	13.3	16.6	8.5	18.3	7.4	8.8	8.3	7.1	11.2	9.7	11.7	12.0	11.4	15.1	22.3	11.3	22.0	15.8	7.9	7.4	7.0	22.3	9.6	8.0	7.8	14.7	12.8	4.1	1.5	4.4	1.2	15.1	3.5	4.3	8.6	7.5	4.3	4.4	7.0	4.6	8.4	7.2	6.3	4.2	17.4	13.8	7.6	8.3	8.3	7.9	3.8	6.9	4.4	7.0	10.6	6.1	2.3	4.3	6.0	8.9	3.5	5.0	7.4	8.8	3.9	5.1	7.4	5.8	43.4	5.6	12.2	7.2	3.8	3.6	4.5	11.7	7.2	4.3	10.8	4.9	6.6	17.3	4.1	5.1	10.0	5.6	2.9	14.8	3.9	6.9	5.1	4.9	13.9	9.3	20.6	16.5	13.2	6.7	11.1	4.4	0.6	2.4	12.8	3.6	3.5	2.3	6.6	3.0	4.4	1.4	7.8	2.2	3.0	2.7	1.5	4.1	14.7	3.6	1.2	19.3	24.0	30.0	24.6	18.1	18.8	14.6	19.4	18.3	15.8	6.0	12.8	22.8	4.6	0.0	17.7	0.0	2.5	1.4	7.9	12.2	17.7	1.5	1.7	5.8	13.1	4.7	3.8	23.3	5.5	3.0	2.7	6.2	2.3	3.9	7.7	20.6	0.0	11.1	12.6	11.4	4.6	8.5	0.0	105.6	3.6	15.3	6.3	0.0	6.0	2.2	13.7	6.5	0.0	21.4	15.6	0.0	5.4	6.9	3.1	10.0
RUBCNL	"C13orf18, FLJ21562, KIAA0226L"	ENSG00000102445	"RUN and cysteine rich domain containing beclin 1 interacting protein like"	Q9H714	13	46342000-46438190	"Predicted intracellular proteins"	"Autophagy, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.1;lymphoid tissue: 24.0"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 2: 9.6;Club cells: 4.5;Hofbauer cells: 13.4"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"memory B-cell: 29.9;naive B-cell: 31.1;neutrophil: 31.1;plasmacytoid DC: 22.5"	"Group enriched"	"Detected in many"	17	"B-cells: 31.1;dendritic cells: 22.5;granulocytes: 31.1"	"Group enriched"	"Detected in some"	5	"Daudi: 40.0;U-698: 66.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favorable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"	3.7	1.6	4.5	21.2	4.3	15.0	5.7	2.9	3.6	5.5	8.1	2.9	1.3	1.5	3.0	3.2	1.0	2.0	3.8	1.5	3.4	3.7	1.5	1.7	5.5	20.2	4.5	2.7	0.9	1.2	0.1	2.7	3.3	5.2	2.2	11.2	3.0	6.5	1.8	0.8	2.7	14.9	2.8	8.8	24.0	1.6	15.9	3.7	10.1	2.2	0.2	21.7	2.9	2.0	31.1	22.5	31.1	1.6	0.3	0.0	1.2	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	1.5	0.0	40.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.4	11.5	0.1	1.6	0.0	0.0	0.8	0.0	0.1	0.0	0.6	2.3	0.0	9.2	0.0	0.0	0.3	0.0	0.1	0.2	9.2	66.1	0.4	0.1	0.0	0.0	1.0	0.0	0.0	1.6	0.0	29.9	0.0	0.0	1.0	31.1	0.0	0.0	31.1	0.3	0.9	22.5	0.0	1.2	4.5	4.3	2.9	3.6	3.4	3.7	4.5	2.7	5.2	3.7	3.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	2.3	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550558-179610026	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		9600	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	20.9	27.9	19.7	24.7	22.4	21.1	36.9	22.4	18.9	18.2	20.2	16.9	27.9	16.9	22.5	16.9	25.9	18.8	20.7	14.8	19.7	14.8	23.9	17.5	20.8	23.1	18.8	17.1	19.4	19.8	22.6	21.5	17.3	19.7	20.9	15.5	16.4	21.2	18.3	26.7	24.2	18.8	17.5	14.7	27.9	18.6	12.2	20.5	20.1	27.3	14.1	20.1	20.7	34.3	3.2	3.4	7.9	4.5	1.2	2.9	21.5	7.2	12.0	6.4	8.4	12.4	10.3	7.3	12.9	9.2	7.7	9.0	11.6	17.0	11.8	7.4	15.7	8.9	6.7	11.7	16.9	9.1	37.3	8.8	20.6	9.2	8.3	12.7	11.4	11.3	10.3	9.3	5.1	14.9	13.5	8.3	6.7	8.3	11.3	6.9	22.0	12.1	7.9	6.8	7.9	5.6	10.9	4.6	10.9	12.8	11.9	6.4	9.2	18.9	12.3	6.7	8.5	9.8	14.0	10.0	10.2	3.4	5.4	10.1	7.0	10.8	21.2	9.3	20.7	9.3	7.4	3.4	7.9	1.7	3.6	1.0	2.7	2.0	1.7	3.0	3.2	1.4	1.8	5.9	1.2	4.5	3.4	2.9	21.5	19.7	22.4	22.4	18.9	19.7	14.8	18.8	17.1	19.7	20.5	32.8	25.0	14.2	10.0	9.2	9.7	19.3	20.4	38.8	31.8	14.0	19.6	18.9	8.3	18.0	5.6	17.8	13.0	0.0	12.5	12.9	13.5	12.4	28.9	12.4	28.1	11.1	10.4	8.0	29.4	3.2	21.3	26.8	10.1	38.7	17.2	13.6	18.3	18.1	25.5	25.0	11.0	6.5	16.5	10.9	7.4	9.9	17.7	13.8	13.4	8.1
RUFY2	"FLJ10063, KIAA1537, RABIP4R, ZFYVE13"	ENSG00000204130	"RUN and FYVE domain containing 2"	Q8WXA3	10	68341107-68407294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039792	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039792: AB_10673363"	"unprognostic (1.23e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.40e-2)"	8.1	7.0	15.5	5.4	16.3	2.6	10.1	34.3	28.7	9.6	6.6	14.8	6.4	4.9	12.1	7.7	8.1	8.9	7.6	6.5	16.9	16.2	8.3	3.2	7.8	5.2	19.1	11.6	15.0	6.9	11.3	11.9	8.3	16.5	10.0	7.9	5.2	6.2	8.3	6.3	6.9	5.7	10.4	32.8	6.4	7.3	5.8	16.3	5.7	9.7	4.8	5.9	8.6	6.4	2.1	1.0	2.3	1.7	6.5	3.0	0.7	9.9	3.6	5.8	7.4	7.9	12.7	3.6	8.6	10.8	9.5	9.7	5.3	9.0	2.9	6.3	13.5	4.4	6.9	2.6	9.2	9.6	1.4	5.9	1.8	2.8	2.6	8.6	2.3	1.2	10.3	9.9	10.9	11.0	13.5	9.8	2.5	3.8	4.8	9.4	4.0	2.3	3.1	2.6	2.9	10.1	3.1	5.2	1.7	8.6	5.7	7.1	6.9	6.0	7.7	4.9	8.0	11.5	3.0	11.4	11.3	8.4	6.4	11.6	5.1	2.6	1.6	10.3	2.6	4.4	1.5	1.0	2.3	1.7	1.4	1.7	1.7	2.2	2.3	0.6	2.1	2.5	3.0	1.2	6.5	1.7	1.0	0.6	0.7	15.5	16.3	34.3	17.7	16.9	16.2	19.1	11.6	16.5	16.3	29.8	10.8	8.3	14.6	6.0	31.0	10.0	0.0	25.4	27.3	24.4	56.9	7.4	1.7	13.7	6.1	20.2	6.2	0.0	11.2	5.0	13.0	12.8	7.0	5.5	5.7	30.2	9.8	20.3	7.8	4.1	22.5	10.9	11.8	10.8	10.9	21.7	13.4	3.5	16.6	8.1	63.6	12.9	14.2	8.4	26.5	7.0	8.0	8.7	6.9	9.5
RUNDC1	DKFZp761H0421	ENSG00000198863	"RUN domain containing 1"	Q96C34	17	42980565-42993690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023726	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA023726: AB_2184078"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.39e-2)"	"prognostic favorable (6.93e-5)"	"unprognostic (9.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.77e-3)"	7.3	11.0	23.4	8.7	23.1	8.4	14.7	18.6	24.6	13.0	12.9	7.9	12.2	9.0	12.3	17.9	9.0	20.9	9.5	8.7	17.2	13.0	12.1	6.6	9.6	9.3	9.2	16.9	7.7	14.2	17.7	17.2	6.7	12.2	17.9	11.0	8.9	11.1	12.9	14.5	9.1	10.0	12.3	7.5	10.7	13.9	11.9	12.5	9.6	14.5	4.4	10.4	12.7	8.1	5.6	7.5	10.0	5.2	1.4	2.6	1.2	11.3	20.0	8.1	10.9	13.9	8.4	8.7	11.0	11.5	15.8	11.9	12.6	6.6	7.7	10.0	10.9	10.8	14.3	10.3	11.1	17.7	8.6	16.3	5.1	11.3	12.0	8.9	11.0	11.0	6.2	13.7	14.0	9.3	12.7	8.4	8.5	9.8	4.9	9.1	8.3	13.6	7.9	9.1	16.3	12.7	9.9	11.4	7.6	13.3	15.3	11.8	11.0	8.7	8.3	9.1	12.5	16.0	12.4	6.9	14.5	9.0	8.5	13.1	11.7	11.2	6.7	10.3	5.9	9.0	5.0	3.3	10.0	1.9	5.2	2.4	4.6	2.3	1.6	2.5	5.6	2.3	2.5	7.6	1.4	3.6	7.5	2.6	1.2	23.4	23.1	18.6	24.6	17.2	13.0	9.2	16.9	12.2	12.5	41.7	48.0	16.4	9.9	13.4	18.8	12.2	20.4	20.1	22.7	5.2	21.6	8.9	18.3	10.8	7.7	6.6	17.5	0.0	8.4	6.0	6.8	16.2	10.5	5.8	7.2	36.5	18.4	8.0	7.9	2.5	9.2	11.3	3.3	10.0	13.2	14.5	8.7	17.5	13.4	10.3	33.5	19.4	8.1	19.7	13.6	12.8	4.6	11.4	13.6	14.4
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"Runt related transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.5;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"	17	"B-cells: 38.9;granulocytes: 46.0;Macrophages: 35.5;Melanocytes: 43.9;monocytes: 68.5;T-cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.5;Karpas-707: 53.2;SK-MEL-30: 29.5;U-266/70: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.0	1.1	0.9	25.4	1.1	31.5	3.4	0.5	1.0	11.9	8.0	1.2	0.3	2.5	1.7	1.4	3.5	1.7	6.2	1.3	0.9	1.1	2.2	2.3	11.7	28.8	2.8	0.7	1.3	1.0	0.0	1.0	1.3	1.8	2.3	2.3	2.8	6.5	2.2	2.2	9.5	13.7	1.3	1.8	30.6	2.7	2.1	0.8	14.2	1.8	3.1	47.6	8.9	2.2	4.5	1.0	4.3	4.6	18.1	15.1	3.1	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	6.3	6.2	5.4	0.0	0.1	3.7	0.0	0.2	39.5	0.6	0.1	0.6	0.0	0.0	1.4	13.7	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	53.2	0.0	0.0	0.4	12.2	0.2	0.0	1.0	0.0	0.0	7.4	0.0	0.1	1.2	0.0	2.4	0.0	29.5	1.0	0.0	8.5	0.0	0.0	0.6	0.0	0.1	18.4	12.8	6.0	0.0	13.8	1.5	0.4	0.7	4.3	15.1	3.0	8.1	4.5	5.7	13.2	0.9	3.8	2.8	10.3	0.9	18.1	4.6	1.0	5.7	3.1	0.9	1.1	0.5	1.0	0.9	1.1	2.8	0.7	1.8	0.8	0.0	5.1	38.9	0.7	6.8	0.0	2.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.2	0.1	1.2	0.7	46.0	0.8	4.9	0.0	0.0	1.8	17.0	0.8	0.0	35.5	43.9	68.5	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	4.7	0.2	2.7	5.1	0.2	144.9	0.0	0.4
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193379-83198932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	5.0	10.1	8.5	3.4	10.4	1.0	5.4	11.8	14.6	5.6	4.0	5.9	11.6	4.2	5.7	15.9	3.1	6.5	7.6	7.2	9.4	11.0	7.5	8.1	4.8	3.9	6.5	11.7	7.0	13.4	7.4	9.8	4.2	11.6	19.2	4.3	3.7	16.4	11.3	4.1	3.4	4.0	5.5	4.8	4.1	5.3	14.5	3.9	1.7	10.4	3.1	4.4	5.2	2.8	3.7	6.8	0.7	3.9	0.8	4.6	2.1	2.2	2.0	4.7	8.9	5.7	4.2	3.3	5.0	10.7	3.8	4.6	2.9	1.2	1.7	4.1	6.1	8.7	2.2	3.9	3.0	5.9	2.0	4.0	2.0	3.0	6.4	8.8	0.5	1.6	5.4	5.0	4.8	10.0	12.5	7.0	4.8	3.1	3.0	4.6	3.1	0.7	1.5	1.6	2.0	2.0	2.5	9.7	1.0	7.9	2.5	1.7	5.8	3.0	4.9	4.5	7.1	3.0	3.0	7.4	2.7	1.7	3.7	2.2	6.7	2.7	1.0	3.1	0.8	3.1	0.5	1.8	0.0	2.4	1.6	3.9	3.7	3.6	3.6	2.0	2.2	4.6	4.5	0.7	0.8	3.9	6.8	4.0	2.1	8.5	10.4	11.8	14.6	9.4	11.0	6.5	11.7	11.6	3.9	0.0	7.9	5.2	3.2	3.3	5.6	5.0	5.1	4.0	0.0	1.8	0.0	6.8	5.0	7.7	27.1	2.9	2.6	0.0	8.0	2.7	5.8	7.9	0.0	4.4	4.3	1.6	5.2	4.3	1.3	11.7	8.3	2.3	8.5	3.6	4.7	8.4	6.2	3.4	5.6	9.3	4.1	6.5	5.0	20.7	7.2	2.0	4.8	2.5	2.6	2.1
RWDD4	"FAM28A, MGC10198, RWDD4A"	ENSG00000182552	"RWD domain containing 4"	Q6NW29	4	183639635-183659225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036501, HPA036502"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA036501: AB_2675159, HPA036502: AB_10670800"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (1.01e-6)"	"unprognostic (6.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.65e-2)"	11.0	37.4	8.3	9.3	8.2	8.5	14.8	10.0	7.5	10.0	11.6	8.1	10.6	7.6	9.7	12.1	16.0	9.7	11.6	15.7	7.8	9.1	17.6	13.3	10.3	9.9	8.4	6.1	28.6	17.9	7.1	28.4	10.3	8.1	12.2	8.5	8.9	25.6	13.6	30.7	8.2	11.2	10.4	8.4	11.4	9.5	12.3	7.7	10.6	17.1	17.7	10.5	13.2	13.7	7.4	8.5	11.8	9.7	11.4	9.9	6.4	13.3	7.8	12.0	14.7	19.3	20.5	9.1	16.9	13.5	21.4	13.6	5.0	17.6	20.2	4.0	13.8	10.3	6.3	16.6	15.8	22.6	13.4	7.4	14.6	9.2	12.8	13.7	22.4	11.1	13.3	16.5	11.7	13.1	16.6	16.0	15.9	13.9	26.4	22.3	5.6	22.9	18.9	8.0	5.1	10.2	16.0	9.3	12.8	20.9	6.5	11.5	16.2	15.9	18.7	14.6	9.6	9.4	13.6	11.6	9.0	4.4	9.6	13.0	8.9	6.6	6.9	16.9	16.6	12.7	6.0	6.1	11.8	8.6	8.2	8.4	7.4	7.8	8.1	8.0	5.2	7.4	7.7	5.3	11.4	9.7	8.5	9.9	6.4	8.3	8.2	10.0	7.5	7.8	9.1	8.4	6.1	8.1	7.7	20.8	15.0	21.6	28.9	29.9	17.0	9.4	28.1	29.4	20.5	17.4	5.9	22.5	63.0	27.5	5.6	26.2	14.0	0.0	67.9	34.3	27.8	53.7	35.7	29.7	32.4	9.5	20.8	19.0	31.4	7.3	68.4	22.4	54.0	30.7	25.4	27.0	45.6	10.5	66.4	98.2	21.6	19.4	33.3	39.5	54.4	31.0	22.7	26.1	24.3	39.9
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 186.8;Kupffer cells: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.9;non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.9;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HaCaT: 27.4;RT4: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	18.5	10.1	9.9	10.4	6.7	19.6	36.8	4.6	9.8	11.0	9.3	4.9	8.1	14.0	10.1	6.1	24.2	9.3	12.9	14.2	9.0	3.7	11.7	49.3	12.8	10.4	6.0	7.0	11.7	20.6	8.0	10.7	9.6	9.4	9.7	2.0	9.5	9.3	9.7	45.8	19.0	15.2	10.6	9.5	11.5	8.8	5.9	8.1	1.5	13.6	18.3	5.9	16.0	23.7	0.1	1.7	14.9	12.3	1.3	1.1	1.8	5.6	15.8	2.0	5.0	3.6	3.3	24.3	3.0	3.5	4.4	2.5	8.8	8.8	0.0	8.3	4.4	3.8	27.4	0.7	10.7	0.2	8.0	2.0	0.0	19.3	13.3	4.6	6.6	2.4	5.4	4.6	5.5	2.6	0.6	3.7	0.9	10.9	0.5	1.0	15.1	0.5	1.4	3.8	4.1	5.5	2.9	7.5	10.9	0.2	24.4	4.5	2.0	9.6	9.2	2.4	0.1	12.8	9.0	4.8	5.4	6.5	5.7	2.7	0.7	0.0	0.1	4.1	6.7	3.5	1.1	5.2	2.8	1.1	9.3	0.0	0.1	0.7	0.7	1.7	0.0	0.2	0.9	14.9	1.3	12.3	0.1	0.9	1.8	9.9	6.7	4.6	9.8	9.0	3.7	6.0	7.0	9.4	8.1	29.8	22.2	2.2	14.1	30.7	3.8	30.8	79.0	8.1	21.6	8.7	23.6	24.3	1.7	11.9	4.5	17.5	46.7	23.3	12.2	27.0	17.3	15.8	1.1	186.8	29.1	31.8	9.2	72.4	115.8	14.1	30.0	27.5	11.8	5.4	24.8	42.2	14.1	34.5	19.8	16.2	21.2	19.4	17.9	0.7	12.3	40.9	20.0	13.1	23.9	26.0
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400917-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8"	"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 23.6;Melanocytes: 27.0;Muller glia cells: 9.1;Sertoli cells: 12.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 29.0"	"Region enriched"	"Detected in many"	5	"basal ganglia: 89.8"	"Low region specificity"	"Detected in all"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	1.9	3.9	5.4	1.0	14.9	0.6	1.0	0.3	5.9	4.0	2.5	5.3	0.6	1.3	1.8	1.3	1.7	3.6	1.2	5.8	7.5	8.9	0.7	0.8	3.4	0.8	4.1	4.3	1.7	2.7	0.8	29.8	1.3	14.1	1.1	2.7	13.5	1.9	2.1	44.8	2.9	2.0	1.8	8.9	1.0	1.1	1.5	5.4	0.0	1.1	2.5	0.6	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	29.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	14.9	0.3	5.9	7.5	8.9	4.1	4.3	14.1	5.4	0.0	0.0	0.0	0.0	0.6	0.3	2.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.9	4.6	0.0	27.0	0.0	0.0	9.1	0.1	0.0	2.1	0.0	4.0	12.9	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RXYLT1	"HP10481, TMEM5"	ENSG00000118600	"Ribitol xylosyltransferase 1"	Q9Y2B1	12	63779803-63809558	"Disease related genes, Predicted intracellular proteins"		Transferase	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 25.4;Distal tubular cells: 31.5;Exocrine glandular cells: 26.6;Extravillous trophoblasts: 28.9;Syncytiotrophoblasts: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064014			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA064014: AB_2685176"	"unprognostic (1.19e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.33e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	9.7	19.6	10.3	9.8	11.3	5.7	14.7	8.2	13.6	10.3	9.3	10.6	11.3	7.8	9.2	20.8	9.6	10.9	9.6	21.1	9.8	11.4	15.2	20.1	11.9	14.8	10.7	8.0	17.4	33.4	20.2	19.0	10.5	9.5	12.1	10.1	12.4	17.0	14.5	14.7	11.1	8.2	12.2	13.1	10.6	8.1	16.1	9.0	9.1	17.2	10.7	9.7	11.8	8.1	6.6	7.2	1.8	3.6	4.7	7.0	2.2	7.7	14.3	10.1	8.5	8.8	11.9	11.7	8.7	12.6	13.0	8.6	5.2	7.4	16.6	15.1	9.1	10.5	7.1	12.2	11.1	15.5	17.3	12.4	9.0	4.0	8.2	13.4	13.7	7.9	10.6	11.1	12.6	16.4	12.1	7.2	12.5	10.1	14.2	19.6	12.4	7.4	5.7	6.1	7.1	18.2	7.5	11.7	8.9	12.4	10.2	25.0	4.3	9.1	6.9	17.2	6.6	14.7	6.9	8.3	11.6	12.0	7.2	11.9	9.4	13.5	11.6	7.9	8.3	15.3	1.2	3.1	1.8	4.0	2.9	6.9	6.6	4.4	4.8	3.0	4.2	5.9	4.8	0.6	4.7	3.6	7.2	7.0	2.2	10.3	11.3	8.2	13.6	9.8	11.4	10.7	8.0	9.5	9.0	8.9	5.9	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.4	15.7	0.0	21.6	31.5	19.6	0.0	0.0	0.0	0.0	26.6	28.9	0.0	0.0	7.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	14.4	0.0	0.0	17.5	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0
RYK	"D3S3195, JTK5, JTK5A, RYK1"	ENSG00000163785	"Receptor-like tyrosine kinase"		3	134065303-134250744	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034117, HPA045503, HPA075430"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293"	"unprognostic (7.84e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.85e-2)"	23.8	13.2	8.5	12.1	9.3	6.3	27.5	10.6	9.5	26.5	19.3	12.7	18.2	8.8	25.8	19.1	21.1	16.7	15.8	17.1	8.1	6.7	12.9	12.7	12.4	9.1	10.8	7.3	39.7	17.7	14.1	17.9	18.8	8.6	26.9	12.1	16.4	15.2	21.5	15.3	15.5	13.3	28.6	8.4	13.8	14.3	20.3	10.0	13.6	23.2	11.4	15.2	27.5	31.9	2.8	0.7	6.7	1.6	3.1	4.3	1.1	26.0	6.9	21.9	16.7	28.2	30.1	16.9	17.3	40.2	23.1	26.0	21.9	20.0	5.1	28.8	21.2	22.2	24.4	15.5	21.8	33.1	8.5	7.0	13.5	7.5	14.0	22.1	6.5	11.9	19.9	25.7	14.3	28.8	25.3	19.3	9.0	4.7	2.5	22.6	12.4	9.1	8.5	18.4	21.7	8.3	4.5	16.8	10.7	18.9	19.3	10.7	15.9	21.0	15.3	26.2	14.7	19.1	11.9	14.2	19.2	17.4	20.0	13.9	1.1	1.3	2.8	12.2	11.0	13.5	6.7	1.6	3.1	2.5	1.6	2.9	1.5	4.2	3.0	0.7	2.8	4.3	3.4	0.6	3.1	1.6	0.0	1.0	1.1	8.5	9.3	10.6	9.5	8.1	6.7	10.8	7.3	8.6	10.0	11.9	24.7	11.9	30.3	36.7	18.8	28.1	22.9	5.3	22.7	41.8	27.5	16.4	0.0	14.3	7.9	26.0	12.7	0.0	18.1	11.9	35.7	30.8	17.3	17.4	9.7	12.7	13.4	39.9	17.7	4.0	30.8	14.0	13.5	10.0	21.0	26.7	18.6	17.3	30.8	8.1	37.2	45.3	26.4	27.0	33.8	33.2	9.0	12.5	20.0	36.3
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433699-38587564	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 231.0"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 46.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;monocytes: 6.3"	"Cell line enhanced"	"Detected in some"		"A549: 5.7;HaCaT: 14.0;hTCEpi: 5.7;RH-30: 11.5;SiHa: 22.8;U-2 OS: 9.6"	"Low region specificity"	"Detected in some"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: AB_2683121"	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	5.3	0.7	3.0	0.6	1.9	0.4	0.6	2.7	1.7	0.6	0.4	2.7	0.0	0.4	0.4	6.7	3.0	0.6	0.5	0.4	1.8	4.0	0.5	0.4	0.7	0.6	1.5	1.3	0.4	0.4	0.3	0.3	0.6	1.9	0.9	0.4	0.4	2.2	0.6	231.0	2.4	0.5	0.4	1.1	0.6	0.5	1.6	1.9	0.0	1.6	55.1	3.2	0.6	0.5	0.7	5.3	0.1	6.3	0.0	0.6	0.6	0.0	5.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.3	0.3	4.8	0.0	0.0	14.0	0.2	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.4	1.3	5.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.0	0.0	11.5	1.1	0.6	0.0	0.0	1.1	22.8	0.0	0.0	0.4	0.5	4.3	0.0	0.0	9.6	0.2	0.0	0.3	1.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.4	3.2	0.5	0.4	0.3	0.6	5.3	0.7	0.0	0.0	0.1	0.0	6.3	0.0	0.6	0.6	3.0	1.9	2.7	1.7	1.8	4.0	1.5	1.3	1.9	1.9	0.0	0.6	0.0	3.4	10.1	4.1	3.4	0.0	0.0	0.0	0.0	2.0	0.1	5.0	0.1	5.2	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	7.1	1.6	0.0	0.6	1.9	4.7	2.8	4.5	0.0	0.0	0.0	46.0	0.0	0.0	1.8	0.0	1.5	0.0	0.3	5.5	6.9	4.1	0.2	0.0	0.0	0.1
RYR3		ENSG00000198838	"Ryanodine receptor 3"	Q15413	15	33310945-33866121	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 28.8;skeletal muscle: 26.8"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 14.6;granulocytes: 13.9;Horizontal cells: 65.2;Late spermatids: 25.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;RH-30: 10.6;RPTEC TERT1: 5.0;SuSa: 4.8"	"Low region specificity"	"Detected in many"							HPA062004			Approved	Vesicles		NA	NA			Vesicles		"HPA062004: AB_2797267"	"unprognostic (5.85e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.03e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.10e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	1.8	2.0	9.9	1.1	15.4	2.5	2.9	4.9	12.4	2.8	4.5	6.0	0.2	1.5	10.2	1.0	2.7	3.9	1.6	1.0	13.3	3.5	1.2	0.9	1.2	0.9	5.6	6.9	1.7	0.8	28.8	1.2	1.0	10.7	1.8	2.9	0.6	1.4	3.9	26.8	1.2	1.3	7.4	5.9	1.4	1.6	1.6	7.9	0.0	1.1	1.5	1.4	2.1	2.6	0.1	0.0	4.0	0.0	0.0	0.1	0.0	0.3	7.0	1.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.1	0.4	0.6	0.0	2.3	0.2	0.0	0.0	0.0	0.4	0.2	1.4	0.2	0.0	0.0	1.0	0.7	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.4	2.6	0.0	0.4	0.2	0.3	1.1	0.4	0.1	0.5	10.6	0.2	5.0	0.5	0.1	0.5	0.8	0.0	0.2	4.8	0.1	0.3	0.9	0.2	0.1	0.0	0.7	0.3	1.2	0.7	0.5	2.3	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	15.4	4.9	12.4	13.3	3.5	5.6	6.9	10.7	7.9	0.0	0.6	0.0	0.0	0.3	2.4	1.7	0.0	10.7	1.2	0.0	0.0	0.5	0.0	0.0	14.6	0.7	0.0	0.0	0.0	0.6	0.3	0.0	13.9	0.0	0.8	65.2	0.0	0.0	0.0	25.1	0.3	0.4	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.3	0.7	0.0	0.3	0.0	1.0	0.5	0.1	0.0	0.0	0.0
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 465.5;skeletal muscle: 423.5"	"Cell type enhanced"	"Detected in many"	22	"Collecting duct cells: 146.5;Distal tubular cells: 137.6;Hofbauer cells: 149.3;Melanocytes: 323.9;Proximal tubular cells: 712.0"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Hep G2: 43.7;SK-MEL-30: 149.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		240000	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	27.7	3.2	70.0	2.8	67.3	2.2	14.3	4.1	42.5	2.0	2.4	47.3	0.0	3.5	2.6	8.5	14.1	8.8	2.6	465.5	44.9	42.9	20.0	2.6	2.4	2.5	85.0	30.7	2.2	4.5	2.0	4.3	4.5	31.4	6.3	2.1	4.3	99.3	3.7	423.5	4.0	2.9	2.1	87.7	2.4	3.3	2.8	31.8	0.0	29.0	57.6	4.7	2.9	0.1	0.6	0.6	2.1	1.0	0.3	0.5	0.5	0.7	0.3	0.5	4.6	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.9	0.4	0.5	19.6	0.0	0.2	1.1	0.0	0.0	0.0	0.5	0.4	1.0	0.6	43.7	0.0	0.3	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	3.5	0.5	0.0	1.2	0.1	0.5	0.2	0.5	0.4	3.1	0.4	1.1	0.8	1.7	0.7	0.2	0.3	1.4	149.9	1.4	4.5	2.3	0.4	0.4	0.3	0.3	0.4	0.7	0.7	0.7	0.3	0.8	0.2	2.1	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.5	0.0	0.6	0.3	0.0	0.0	0.3	1.0	0.6	0.0	0.5	70.0	67.3	4.1	42.5	44.9	42.9	85.0	30.7	31.4	31.8	0.0	0.0	0.0	1.1	8.7	0.6	57.3	5.1	0.0	0.0	146.5	2.0	0.9	137.6	0.7	0.5	2.1	0.9	0.0	3.4	0.8	2.3	1.2	0.0	3.2	149.3	0.0	1.7	13.5	0.6	1.5	6.1	1.3	323.9	0.0	2.2	60.1	1.1	0.0	8.5	712.0	2.2	0.0	2.1	0.9	0.7	1.9	2.9	0.0	1.5	0.6
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151994390	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 148.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4"	"Cell line enhanced"	"Detected in many"		"OE19: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		230000	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	36.7	19.9	7.3	12.1	9.4	4.5	30.7	7.3	10.7	19.0	42.3	8.4	7.3	23.4	7.3	10.1	87.1	8.5	10.7	16.7	7.3	4.4	19.1	10.2	33.5	7.3	7.3	7.3	11.5	7.3	1.6	7.3	18.7	11.1	8.5	49.8	9.5	21.1	7.3	7.3	21.8	21.7	14.0	9.6	7.3	8.6	61.4	7.3	7.3	7.3	22.1	13.6	8.1	37.7	17.8	148.1	21.4	89.2	25.9	85.4	74.8	63.5	65.2	0.2	13.5	73.8	98.4	48.6	36.0	48.7	32.3	32.8	117.1	88.5	0.0	35.0	62.8	38.3	111.1	18.5	140.1	30.1	11.4	5.3	7.7	29.7	27.4	26.4	2.9	6.7	25.5	118.1	35.2	40.5	29.0	71.4	4.2	0.1	0.1	42.9	55.1	0.5	18.6	8.8	273.2	72.5	0.0	12.6	1.2	136.1	18.9	0.5	0.5	58.8	21.1	27.4	77.4	46.6	7.4	75.8	15.5	38.8	73.4	25.1	1.7	0.3	10.9	91.1	2.6	54.2	21.4	89.2	21.0	33.3	54.4	35.2	17.8	52.6	42.3	148.1	8.6	19.6	29.5	3.2	25.9	46.5	24.2	85.4	74.8	7.3	9.4	7.3	10.7	7.3	4.4	7.3	7.3	11.1	7.3	2373.2	509.0	165.5	824.9	1416.6	10.1	91.6	634.4	507.3	913.4	902.0	3.9	1028.8	1291.5	1817.5	320.0	1052.4	1898.6	46.7	1882.2	473.9	2108.7	1493.1	280.8	168.1	1060.4	15.9	1037.0	742.7	952.8	225.8	599.2	1623.9	1548.8	1432.9	1679.7	14.1	2865.9	3115.1	60.8	287.0	25.8	142.3	345.1	12.6	80.7	1085.7	314.3	441.6	1750.5	1802.8
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 714.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.4;NK-cells: 19.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 94.7;SuSa: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	38.2	20.9	49.6	13.8	48.3	1.2	61.8	11.5	28.2	39.1	32.3	25.0	13.9	9.4	23.5	25.0	19.9	34.5	32.0	56.3	30.3	32.0	28.0	20.2	23.3	12.7	54.2	32.7	29.9	13.9	45.9	9.7	21.6	37.7	23.0	19.3	21.1	19.8	21.7	73.8	14.1	13.7	27.2	38.9	13.7	11.9	10.3	28.5	2.4	79.0	28.2	14.6	21.1	16.0	2.6	8.4	3.0	1.5	19.4	0.9	0.8	21.1	17.7	20.5	13.0	18.1	53.1	7.4	29.4	46.6	17.8	20.5	17.2	23.6	0.5	55.9	49.8	2.6	20.2	8.5	18.2	15.8	0.0	7.9	1.3	22.2	14.6	12.0	0.6	4.6	42.7	6.9	15.9	17.2	52.5	40.2	0.1	6.8	0.0	55.3	74.9	0.0	0.3	16.5	18.2	53.5	3.3	21.2	0.1	94.7	16.2	6.3	0.2	62.8	32.4	63.5	111.1	26.4	0.7	56.9	12.3	6.9	16.4	35.3	0.2	0.5	0.9	22.0	0.3	7.2	3.0	1.5	0.1	0.3	0.7	0.6	2.6	0.3	0.2	5.0	1.6	0.5	0.3	0.2	19.4	0.9	8.4	0.9	0.8	49.6	48.3	11.5	28.2	30.3	32.0	54.2	32.7	37.7	28.5	26.8	88.4	17.1	154.8	98.1	2.0	108.1	175.8	60.2	93.3	441.4	0.0	118.0	210.5	277.9	6.5	300.3	126.3	46.7	281.2	170.7	294.9	188.4	23.1	34.1	128.8	0.0	119.8	371.4	32.4	21.5	714.6	43.9	226.0	20.8	107.7	97.5	336.0	115.8	295.2	330.9	5.7	0.0	84.3	7.5	18.3	66.1	62.5	8.6	64.8	157.7
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.0;tongue: 189.3"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 2079.3;Enterocytes: 1153.1;Suprabasal keratinocytes: 3157.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 61.0;HaCaT: 84.7;HBEC3-KT: 120.1;hTCEpi: 179.0;OE19: 129.5;SK-BR-3: 126.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		110000	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	0.6	0.0	0.6	4.3	0.6	0.0	6.4	0.6	0.6	38.0	19.2	0.6	3.9	21.4	5.7	2.6	256.0	1.2	7.9	0.6	0.6	0.0	2.4	1.2	7.5	0.6	0.6	0.6	0.7	4.6	6.6	0.8	1.4	0.7	1.9	19.6	0.7	41.8	3.1	0.6	41.4	23.8	1.0	0.6	0.6	9.4	0.9	0.6	8.9	9.6	189.3	71.0	2.2	79.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.6	11.1	0.0	0.1	0.0	0.0	84.7	0.0	120.1	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	179.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	129.5	0.1	0.0	0.0	0.2	0.6	4.0	0.0	0.0	0.1	126.4	0.1	3.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.7	0.6	56.6	133.0	0.5	298.4	2079.3	0.0	4.4	214.0	18.7	91.0	33.2	0.0	0.6	41.4	164.9	0.0	0.2	1153.1	0.0	59.6	1.7	22.4	341.3	28.7	5.8	0.3	0.0	147.3	1.3	0.0	0.0	0.0	5.3	229.5	3.6	470.4	0.0	202.6	775.0	0.0	3.1	0.0	0.0	33.3	0.0	0.0	3157.3	0.2	0.7	410.3	819.7
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 223.9;tongue: 102.1"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 744.7;Glandular cells: 697.0;Pancreatic endocrine cells: 790.1;Suprabasal keratinocytes: 794.3;Urothelial cells: 1359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 2.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 117.9;SK-BR-3: 142.9"	"Low region specificity"	"Detected in all"							HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		92000	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	20.1	5.5	9.3	8.0	7.2	0.0	11.9	3.4	8.3	37.2	21.1	8.3	3.2	16.2	8.7	7.2	223.9	7.6	18.2	9.5	6.7	5.4	14.3	27.0	18.3	7.5	7.1	5.7	15.3	4.1	6.5	3.3	14.9	7.2	9.3	14.5	5.1	35.5	5.4	9.8	43.1	31.2	10.6	5.9	13.4	10.6	12.3	4.6	3.2	11.3	102.1	87.5	11.3	51.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	56.4	27.2	1.4	3.2	9.4	35.7	3.7	32.3	29.7	26.6	23.6	25.5	31.6	0.0	51.9	48.3	6.0	41.5	0.0	72.5	15.6	0.1	0.0	0.0	23.7	7.5	10.8	0.0	0.0	16.9	69.7	64.4	50.7	34.8	117.9	0.0	0.6	0.0	58.5	75.0	0.0	0.1	6.0	100.1	73.6	0.0	16.4	0.1	100.2	20.3	0.0	0.1	23.8	142.9	4.7	12.9	44.4	0.3	63.2	16.0	25.6	15.4	73.0	0.0	0.2	0.1	47.6	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	7.2	3.4	8.3	6.7	5.4	7.1	5.7	7.2	4.6	35.7	18.0	15.1	744.7	563.0	0.4	29.7	119.8	26.8	103.5	102.9	2.0	12.3	61.3	584.7	3.2	283.5	336.2	0.0	172.2	7.2	105.8	697.0	19.5	109.5	4.7	0.0	133.3	333.3	22.5	10.0	62.2	11.1	106.3	12.6	178.6	38.3	790.1	294.7	57.7	126.7	1.8	6.5	41.5	1.7	1.2	794.3	6.9	12.8	201.3	1359.9
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Cell type enhanced"	"Detected in many"	20	"Basal glandular cells: 2667.8;Basal keratinocytes: 10183.7;Suprabasal keratinocytes: 3170.0;Urothelial cells: 4604.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 671.5;RT4: 262.5"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		130000	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	25.4	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.5	0.5	0.5	63.2	0.0	671.5	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	89.4	0.7	102.0	0.7	0.4	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.6	4.9	0.0	16.0	0.0	15.9	262.5	0.5	0.0	1.1	0.1	0.2	0.2	0.1	0.1	0.1	0.4	22.2	2.9	8.6	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4	8.9	15.9	2.2	2667.8	10183.7	0.0	2.0	2.5	307.9	1714.1	207.6	0.0	0.1	1039.5	26.2	3.0	3.6	1.3	0.0	24.2	0.9	117.2	609.3	16.2	0.0	1.8	0.0	1.7	0.6	1.5	3.8	0.6	38.5	720.4	9.0	1.7	1.0	390.7	2.9	0.7	9.8	0.0	0.0	213.2	0.2	2.3	3170.0	0.2	1.3	1.5	4604.3
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 7.6;thyroid gland: 9.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.5;Distal tubular cells: 3.3;Extravillous trophoblasts: 7.2"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"OE19: 24.3;PC-3: 7.1;RPTEC TERT1: 8.6;RT4: 14.2;SCLC-21H: 12.7"	"Region enriched"	"Detected in single"	85	"olfactory region: 1210.8"	"Region enriched"	"Detected in single"	30	"olfactory region: 16.8"	HPA064184			Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.5	0.1	0.8	2.4	0.2	0.9	0.4	0.2	0.9	0.6	0.3	0.2	0.2	2.3	1.0	0.2	1.3	0.7	1.6	0.2	0.4	0.1	2.3	0.2	3.0	4.6	0.2	0.2	0.2	0.2	0.0	0.4	1.1	0.2	1.5	0.0	0.2	3.8	0.2	0.2	6.0	0.5	0.2	0.2	1.1	1.9	0.2	0.2	1.6	9.1	0.2	2.6	1.8	0.6	0.9	4.6	2.3	1.2	0.0	7.6	1.2	1.5	4.1	0.0	0.0	0.4	0.3	0.3	0.7	0.9	0.5	1.0	0.4	3.0	0.0	2.7	1.5	0.3	1.2	0.1	0.7	0.6	0.3	0.0	1.9	1.5	0.1	0.3	0.0	2.5	0.0	0.8	2.0	0.6	0.3	0.4	0.0	0.5	0.1	2.2	0.1	0.3	0.9	0.1	24.3	7.1	0.0	1.3	0.7	8.6	14.2	12.7	0.0	0.1	6.5	0.6	1.2	0.0	0.4	0.3	0.1	0.9	1.9	1.2	0.0	0.6	0.0	0.4	0.5	0.2	0.0	1.2	2.3	2.0	0.2	7.6	0.9	4.2	2.2	2.8	0.5	2.4	1.1	1.9	0.0	0.6	4.6	6.1	1.2	0.8	0.2	0.2	0.9	0.4	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.2	7.2	0.7	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.2	0.0	0.0	0.4
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598962-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 342.0"	"Cell type enhanced"	"Detected in some"	16	"Kupffer cells: 25.7;Macrophages: 53.7;Melanocytes: 94.5;monocytes: 55.9"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 78.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 78.0"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 82.9;WM-115: 163.0"	"Low region specificity"	"Detected in all"							"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		120000	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	67.7	14.0	60.9	5.6	51.0	2.0	13.2	39.4	151.2	5.2	9.1	101.0	3.0	4.7	1.5	7.6	8.6	2.1	8.3	6.6	74.6	65.4	1.5	1.6	2.9	9.8	152.0	36.5	2.4	3.0	1.1	3.1	1.4	90.3	3.0	8.3	7.4	10.1	15.3	1.3	5.7	7.5	4.3	342.0	5.7	4.3	1.5	46.4	0.0	1.3	1.8	10.8	8.2	1.6	0.1	3.4	0.7	1.9	11.0	78.0	10.6	0.1	0.0	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	82.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	1.0	163.0	0.0	0.1	0.0	78.0	1.8	22.4	0.0	0.2	14.5	3.4	0.1	0.6	33.3	0.7	11.0	1.9	0.8	0.0	10.6	60.9	51.0	39.4	37.6	74.6	65.4	152.0	36.5	90.3	46.4	3.0	7.4	0.9	0.2	14.9	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.2	7.6	0.0	0.0	4.9	25.7	0.4	5.2	53.7	94.5	55.9	0.0	9.7	0.1	0.0	0.0	0.0	4.0	0.0	2.1	0.0	0.1	11.0	0.1	0.5	0.0	0.1
S100G	"CABP1, CABP9K, CALB3"	ENSG00000169906	"S100 calcium binding protein G"	P29377	X	16650158-16654670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"intestine: 74.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"breast cancer: 4.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.1;PC-3: 2.2;RPMI-8226: 7.0;SH-SY5Y: 1.3"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in many"			"CAB017688, HPA028920, HPA055873"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB017688: AB_1119899, HPA028920: , HPA055873: AB_2682952"	"unprognostic (2.68e-2)"									"unprognostic (2.78e-1)"				"unprognostic (9.88e-3)"				0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	18.0	0.0	0.0	74.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	7.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SAC3D1	"HSU79266, SHD1"	ENSG00000168061	"SAC3 domain containing 1"		11	65040901-65044828	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"testis: 26.3"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 67.9;Late spermatids: 96.5;Spermatocytes: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042677	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA042677: AB_10797506"	"unprognostic (1.35e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.00e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (9.67e-6)"	"unprognostic (4.11e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (2.97e-3)"	"unprognostic (5.71e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.49e-1)"	6.3	6.1	5.1	5.1	5.8	7.1	10.9	7.1	8.4	3.7	7.7	3.0	5.0	5.8	4.3	4.2	5.1	4.0	6.4	4.2	4.8	4.5	3.7	6.6	4.7	4.4	5.1	3.0	3.2	8.6	2.6	4.1	3.0	6.5	4.2	3.5	1.4	6.7	5.7	12.4	6.4	3.9	4.9	4.4	4.5	5.0	26.3	4.6	16.2	3.3	6.2	4.8	3.6	4.6	2.3	3.6	0.4	3.6	0.1	2.7	0.8	18.7	11.1	7.7	7.3	4.1	2.9	4.8	12.2	3.2	9.4	7.9	7.9	4.9	10.0	8.5	4.7	10.2	10.4	6.3	8.9	1.3	12.4	10.4	7.9	7.2	14.1	3.0	5.3	2.9	0.8	8.0	7.2	3.2	2.3	3.3	11.4	11.0	5.6	3.2	10.3	8.3	21.7	2.5	6.7	22.6	6.2	5.5	11.0	4.0	4.3	9.5	7.9	9.3	10.3	6.8	2.2	8.1	7.6	3.2	4.5	13.7	14.6	7.8	13.4	9.4	7.5	2.7	7.0	2.0	0.0	3.1	0.4	1.6	2.6	1.5	2.3	1.9	1.2	1.5	2.2	2.7	1.8	0.3	0.1	3.6	3.6	2.2	0.8	5.1	5.8	7.1	8.4	4.8	4.5	5.1	3.0	6.5	4.6	3.0	0.3	5.2	5.1	7.7	6.8	5.2	5.1	1.4	1.2	8.7	0.0	15.5	6.6	1.8	67.9	5.8	14.6	0.0	1.4	37.0	8.9	8.3	5.7	13.1	25.4	4.8	6.9	4.3	16.1	96.5	16.4	8.3	10.1	2.8	12.1	12.7	2.3	11.9	13.1	10.3	6.9	0.0	8.2	199.6	43.9	6.8	5.6	9.6	20.7	3.1
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745424	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		8400000	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	18.4	24.9	22.0	18.9	23.3	14.9	18.2	23.3	26.3	19.0	19.4	16.4	21.2	18.9	22.6	19.3	17.0	18.1	16.6	15.6	21.8	22.8	31.9	22.7	23.2	19.9	20.5	24.9	15.7	18.3	25.1	31.9	21.2	28.7	21.1	20.1	17.7	20.0	18.2	12.7	14.7	20.4	17.0	22.2	20.9	20.5	11.0	19.6	26.8	35.8	8.5	19.7	20.9	20.9	5.8	13.7	13.4	8.7	30.1	14.9	13.4	11.0	8.3	15.5	8.6	26.4	18.1	11.9	17.0	18.1	16.0	13.8	11.0	9.0	18.1	9.8	16.3	20.3	8.7	19.1	11.5	20.6	11.4	11.6	18.6	13.6	10.6	14.2	27.9	22.8	11.9	18.2	16.2	12.5	13.1	10.9	17.6	20.4	18.7	26.2	5.4	23.7	15.3	16.6	12.2	17.0	6.2	8.1	17.0	17.5	16.2	6.1	14.7	11.7	15.5	17.9	16.4	11.6	27.0	12.3	14.6	8.1	14.7	17.5	10.7	26.1	12.9	17.0	43.1	14.5	4.3	8.7	13.4	13.6	7.0	14.9	5.8	9.8	13.6	13.7	5.3	10.1	13.1	7.1	30.1	6.0	5.7	8.2	13.4	22.0	23.3	23.3	26.3	21.8	22.8	20.5	24.9	28.7	19.6	26.8	31.2	19.3	7.8	17.4	22.6	14.0	17.8	10.7	13.6	7.0	29.5	17.8	16.6	9.1	1.3	13.5	15.8	0.0	8.7	9.5	15.3	14.3	16.2	13.1	21.0	31.8	11.5	14.7	19.1	2.4	15.5	17.3	16.9	18.0	8.8	14.1	10.7	17.3	21.5	16.5	21.4	6.5	12.0	10.1	10.9	15.2	15.3	41.7	10.3	8.9
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: AB_2681266"	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.12e-4)"	25.7	29.6	31.0	29.6	33.7	35.4	17.4	50.8	46.2	27.4	21.6	28.4	23.1	25.8	30.2	27.4	15.7	26.8	19.4	21.0	30.3	24.6	32.2	20.0	18.2	26.8	30.5	26.5	42.8	24.2	31.0	38.4	17.3	28.6	28.4	20.9	21.3	23.6	34.8	38.1	18.9	25.7	24.8	43.4	29.4	20.1	23.4	34.3	23.5	26.9	11.1	25.2	24.1	32.7	11.4	9.3	24.3	9.5	6.4	13.3	5.6	17.8	23.3	17.0	12.5	16.7	10.8	19.8	17.0	9.3	10.7	10.1	29.7	13.0	34.2	15.6	8.5	8.7	16.5	20.7	10.6	17.7	23.7	22.1	26.0	23.7	23.0	9.7	21.7	24.5	10.7	11.3	15.6	12.1	10.6	10.4	12.4	24.9	17.3	12.6	20.0	25.9	20.7	29.0	14.0	24.7	32.9	14.7	19.0	12.0	30.6	16.0	14.9	22.6	10.4	13.7	11.4	15.4	13.4	16.4	13.2	13.8	16.5	23.2	23.0	20.5	24.8	13.6	18.9	21.6	24.3	9.5	15.8	11.9	8.2	13.3	10.3	10.5	9.2	8.3	11.4	11.7	9.1	18.3	6.4	8.5	9.3	9.5	5.6	31.0	33.7	50.8	46.2	30.3	24.6	30.5	26.5	28.6	34.3	38.7	42.6	34.8	47.8	41.4	64.3	26.8	12.7	65.6	37.5	31.4	70.7	37.5	19.9	41.3	5.9	42.1	42.8	23.3	38.9	37.8	33.4	47.8	39.5	21.3	27.2	41.3	41.2	22.7	23.2	5.1	67.0	39.7	25.3	49.5	33.1	83.1	36.3	42.1	61.9	50.7	79.7	45.3	49.5	61.2	74.7	36.6	27.0	50.7	37.9	44.8
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;kidney: 26.8;liver: 32.0"	"Group enriched"	"Detected in some"	14	"Cholangiocytes: 7.6;Collecting duct cells: 8.7;Cone photoreceptor cells: 23.6;Distal tubular cells: 10.0;Hepatocytes: 27.2;Proximal tubular cells: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 15.2;BJ hTERT+: 12.9;NTERA-2: 24.6;RPTEC TERT1: 20.9;U-87 MG: 24.1"	"Region enriched"	"Detected in many"	5	"olfactory region: 64.6"	"Low region specificity"	"Detected in many"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.8	0.7	12.2	1.2	14.5	0.7	0.9	1.7	18.9	16.1	3.1	31.9	0.0	1.6	17.8	1.5	0.8	10.4	1.1	1.2	13.6	5.5	26.8	32.0	0.6	0.6	21.8	9.1	5.2	1.6	0.9	4.3	4.3	17.6	1.3	3.2	0.0	0.9	2.3	0.6	0.7	1.4	9.4	19.7	0.7	3.0	2.2	19.4	0.0	23.7	0.0	0.6	2.2	4.8	1.0	1.9	2.3	3.1	0.1	1.1	1.1	0.0	0.8	15.2	0.1	0.4	0.3	0.0	5.0	12.9	0.3	0.7	0.0	0.0	0.0	5.8	7.1	4.5	0.0	9.4	0.0	0.4	0.0	5.7	0.0	0.0	9.1	0.3	0.0	4.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	1.8	0.9	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	24.1	0.0	5.0	0.6	3.1	2.3	0.7	2.0	0.7	1.0	1.0	0.9	1.9	0.8	0.6	0.6	1.8	0.1	1.5	1.9	1.1	1.1	12.2	14.5	1.7	10.3	13.6	5.5	21.8	9.1	17.6	19.4	0.0	0.0	0.0	0.0	0.2	0.0	1.1	7.6	0.0	0.0	8.7	23.6	0.0	10.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	27.2	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	16.7	0.2	0.0	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.1
SALL2	"Hsal2, KIAA0360, ZNF795"	ENSG00000165821	"Spalt like transcription factor 2"	Q9Y467	14	21521081-21537216	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9;parathyroid gland: 36.0"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 14.3;Cone photoreceptor cells: 7.9;Horizontal cells: 12.7;Muller glia cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"AF22: 46.7;NTERA-2: 35.3;SCLC-21H: 15.9;SuSa: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004162	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA004162: AB_2667155"	"unprognostic (5.73e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	2.6	4.7	11.5	1.6	12.7	0.5	5.3	30.9	21.9	7.5	4.5	10.4	2.9	2.3	10.5	6.0	3.5	11.6	4.0	3.7	11.7	8.9	4.2	1.7	4.8	1.9	7.4	9.3	19.5	3.7	36.0	10.9	1.5	13.5	5.8	2.4	4.3	3.3	10.0	2.1	2.2	3.1	10.5	9.5	2.1	3.2	1.9	11.4	3.7	12.0	0.1	1.9	4.6	4.8	0.3	1.7	0.0	0.0	0.5	3.8	0.6	0.0	0.8	46.7	11.6	0.8	0.7	0.0	1.1	1.5	3.7	3.1	0.8	0.7	0.0	1.0	1.3	1.4	0.1	11.4	1.2	4.3	0.7	6.4	0.0	0.4	1.0	1.4	0.0	0.0	3.1	0.3	1.5	0.0	8.1	0.9	5.0	7.6	0.0	2.9	0.8	7.2	0.0	35.3	0.0	0.2	6.8	1.1	0.0	3.4	4.9	15.9	8.9	0.0	0.2	0.1	15.3	4.6	0.1	0.0	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	1.0	0.1	1.5	1.2	0.2	0.3	1.8	3.8	0.0	0.5	0.0	1.7	1.6	0.6	11.5	12.7	30.9	14.3	11.7	8.9	7.4	9.3	13.5	11.4	3.0	2.2	0.0	0.4	0.6	14.3	0.8	2.5	0.0	2.3	5.2	7.9	0.1	1.7	1.6	0.2	0.2	0.0	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.1	12.7	0.0	1.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	11.0	0.5	0.0	5.6	1.0	2.8	0.0	1.4	0.0	0.2	0.5	0.1	0.0	0.0	0.1
SAMD1		ENSG00000141858	"Sterile alpha motif domain containing 1"		19	14087840-14091036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041662, HPA049059"	Uncertain		Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			Cytosol	Mitochondria	"HPA041662: AB_2677605, HPA049059: AB_2680616"	"unprognostic (2.93e-2)"	"prognostic favorable (7.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (7.98e-5)"	"prognostic favorable (8.31e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.45e-1)"	16.0	9.5	23.5	17.4	20.2	19.6	47.9	17.2	21.2	15.3	21.3	19.7	12.2	20.6	14.7	9.8	18.2	14.0	12.8	16.8	21.2	17.9	13.1	11.1	15.9	20.1	20.9	10.3	14.5	20.3	7.2	7.3	11.3	16.5	12.7	15.5	7.8	15.4	16.1	27.2	25.9	21.5	12.4	21.3	18.0	16.7	11.4	16.1	79.1	14.8	10.8	17.9	12.9	20.5	3.5	2.3	4.5	2.9	8.0	2.7	1.5	22.8	17.4	15.4	21.7	9.7	9.9	23.5	12.6	3.0	12.9	10.4	13.1	11.3	39.9	17.2	8.1	6.1	18.6	16.8	9.4	6.5	26.7	13.8	17.4	23.1	23.6	8.6	10.2	10.9	6.9	15.6	8.9	3.0	12.5	7.6	25.6	21.1	10.9	7.4	34.4	21.7	40.3	31.6	16.7	15.5	29.6	13.6	28.6	10.9	11.1	28.3	28.3	11.1	15.1	8.4	8.7	9.5	22.0	8.2	22.6	20.8	22.6	15.9	20.7	17.8	32.9	13.5	28.0	9.1	0.3	2.9	4.5	1.7	0.9	2.0	3.5	1.9	2.0	2.3	2.1	2.7	2.0	0.5	8.0	1.0	1.8	2.1	1.5	23.5	20.2	17.2	19.6	21.2	17.9	20.9	10.3	16.5	16.1	3.0	7.9	9.7	3.5	10.2	27.7	10.1	20.4	2.7	2.3	10.4	5.9	1.6	1.7	9.4	0.3	9.0	29.0	23.3	9.6	7.2	8.0	6.8	8.1	13.5	13.4	49.3	23.8	14.7	17.4	0.5	17.8	9.4	10.1	9.0	25.3	18.6	10.9	17.3	17.7	5.0	8.6	12.9	8.4	0.7	16.2	15.1	1.5	4.9	24.7	3.9
SAMD10	C20orf136	ENSG00000130590	"Sterile alpha motif domain containing 10"	Q9BYL1	20	63974113-63980008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040973	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040973: AB_10794258"	"unprognostic (5.89e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.94e-3)"	2.4	2.8	6.4	6.1	14.5	3.4	5.4	25.7	10.4	2.3	4.4	1.6	9.2	7.3	1.4	3.0	10.3	4.7	8.8	3.2	5.5	5.0	6.5	4.4	3.6	10.1	3.5	3.5	0.5	5.6	5.3	3.3	3.3	3.2	4.8	3.7	2.7	9.7	6.5	1.7	9.3	6.8	1.5	1.9	5.7	10.2	3.2	2.4	5.7	3.1	2.7	12.3	5.4	4.2	2.9	1.0	0.6	0.4	1.0	6.2	1.6	5.9	0.0	2.0	0.2	0.5	0.6	0.1	1.9	1.6	3.9	1.8	5.7	11.6	0.4	4.0	0.9	0.2	8.1	1.9	2.4	2.0	12.1	4.0	2.0	5.9	8.6	0.8	10.0	16.2	0.5	4.4	2.1	0.3	2.9	1.8	4.3	4.8	4.9	0.7	4.5	4.5	9.3	3.2	8.5	9.2	6.3	0.1	10.5	6.4	10.5	2.2	4.7	1.3	11.3	2.4	0.8	7.6	5.0	1.7	1.2	2.8	0.0	0.3	1.0	0.7	3.3	3.8	8.1	1.1	0.0	0.2	0.6	4.9	0.2	2.7	2.9	3.3	2.9	0.6	1.3	5.6	6.2	0.0	1.0	0.4	1.0	2.5	1.6	6.4	14.5	25.7	10.4	5.5	5.0	3.5	3.5	3.2	2.4	3.0	0.0	2.2	2.2	0.9	6.1	2.0	0.0	2.7	1.2	8.7	2.0	2.3	1.7	3.4	0.0	1.0	2.6	0.0	3.0	0.4	0.3	2.6	0.0	0.6	1.1	0.0	4.7	2.5	1.5	0.0	0.0	0.7	1.7	2.8	4.2	2.7	5.2	1.9	0.0	3.1	2.6	0.0	0.8	0.5	1.3	1.6	2.3	4.4	2.2	3.4
SAMD11	MGC45873	ENSG00000187634	"Sterile alpha motif domain containing 11"	Q96NU1	1	923928-944581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 235.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"NK-cell: 4.7"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 4.7"	"Group enriched"	"Detected in many"	4	"HEK 293: 38.7;HeLa: 42.9;SCLC-21H: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA030110			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA030110: "	"unprognostic (9.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.18e-1)"	2.1	10.0	2.4	5.0	3.0	1.0	1.6	1.6	4.7	4.4	3.0	7.2	2.5	5.1	9.5	7.4	4.2	13.6	4.5	8.5	5.7	4.0	10.0	2.9	2.4	2.1	6.9	2.0	5.9	1.8	0.6	21.9	0.6	5.9	12.4	1.4	16.9	2.4	22.1	1.4	0.3	5.6	6.0	8.8	11.7	5.5	2.7	5.1	0.3	4.6	0.6	0.5	7.2	22.8	0.3	0.0	0.0	0.2	4.7	0.4	0.0	0.1	2.7	0.0	2.5	0.1	0.0	0.9	4.2	0.2	0.2	0.1	0.1	0.8	0.0	8.1	8.7	2.2	5.5	2.7	0.0	0.0	0.3	38.7	0.0	42.9	0.1	0.7	0.0	0.3	1.6	0.0	0.0	0.0	4.3	0.0	0.1	1.4	0.0	0.0	2.9	0.0	0.0	1.6	0.1	0.3	0.2	0.6	2.2	0.4	0.0	28.0	8.6	8.8	4.2	0.0	2.6	4.9	0.2	0.5	1.4	6.4	0.1	0.9	0.5	0.0	0.1	1.8	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.3	0.2	0.2	0.0	0.1	0.1	0.4	0.0	4.7	0.1	0.0	0.0	0.0	2.4	3.0	1.6	4.7	5.7	4.0	6.9	2.0	5.9	5.1	0.0	2.6	0.0	0.1	0.3	16.4	0.8	0.0	0.0	3.4	3.5	27.5	0.2	0.0	0.5	2.2	0.8	0.0	0.0	0.3	0.6	2.3	2.5	0.0	0.0	0.2	33.4	25.4	6.7	0.3	7.9	0.9	0.0	0.0	0.0	0.0	15.0	2.6	0.2	3.9	0.2	235.2	0.0	1.4	0.9	16.6	0.5	0.1	0.0	0.0	0.3
SAMD12	FLJ39458	ENSG00000177570	"Sterile alpha motif domain containing 12"	Q8N8I0	8	118189459-118621995	"Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 104.2;Alveolar cells type 2: 67.7;Ciliated cells: 112.4;Club cells: 92.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 6.8;dendritic cells: 4.3;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 23.6;U-266/70: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024634	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA024634: AB_1856549"	"unprognostic (6.96e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (3.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.35e-3)"	2.1	3.0	14.1	3.1	16.2	1.1	5.0	13.8	20.2	4.6	6.9	7.7	8.9	7.1	2.7	8.0	9.7	8.8	6.7	10.8	10.8	7.0	8.3	4.0	6.2	2.3	9.6	13.7	2.1	4.7	12.7	20.8	0.9	13.7	6.3	8.1	2.6	5.7	12.8	2.0	2.3	4.8	1.9	10.9	4.2	9.5	3.2	8.6	0.7	15.8	2.5	4.5	10.8	3.0	6.8	4.3	0.2	0.0	1.1	3.7	0.9	7.5	0.3	0.6	0.0	0.0	0.0	2.0	3.5	5.5	6.3	3.3	1.7	7.1	10.5	0.7	4.3	1.6	1.8	2.4	4.1	9.2	0.2	0.8	0.1	4.7	0.0	0.0	0.0	0.3	0.2	1.3	4.6	0.7	1.6	0.2	5.9	0.0	6.2	3.2	1.9	2.2	0.0	1.0	6.7	1.2	0.0	0.0	7.3	2.8	11.4	3.3	0.0	2.3	23.6	0.3	1.9	1.7	0.0	0.0	0.1	3.1	1.4	0.8	12.1	9.9	0.8	1.4	0.0	1.3	0.1	0.0	0.0	0.6	0.0	3.7	6.8	2.6	1.7	0.3	2.9	3.7	1.8	0.2	1.1	0.0	4.3	2.4	0.9	14.1	16.2	13.8	20.2	10.8	7.0	9.6	13.7	13.7	8.6	104.2	67.7	0.5	8.7	1.4	16.8	9.4	15.3	112.4	92.1	27.9	41.2	0.0	16.6	9.9	4.9	4.0	7.3	0.0	10.9	0.1	0.5	3.4	52.3	3.2	0.1	28.6	13.7	3.7	0.0	3.8	0.3	0.9	6.8	1.0	9.8	3.4	10.8	0.0	0.4	14.0	26.5	0.0	1.0	0.5	1.9	1.5	0.0	2.5	11.1	10.8
SAMD13		ENSG00000203943	"Sterile alpha motif domain containing 13"	Q5VXD3	1	84298366-84389957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.4"	"Cell type enhanced"	"Detected in many"	10	"Mucus-secreting cells: 19.6;Paneth cells: 35.1;Spermatocytes: 20.4;Undifferentiated cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 11.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 10.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058929	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA058929: AB_2683855"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.55e-2)"	"prognostic favorable (1.14e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.65e-6)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.98e-7)"	"unprognostic (3.99e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.56e-3)"	1.2	5.2	4.9	1.0	12.9	2.1	2.0	9.1	5.8	1.5	16.6	7.4	0.6	2.6	1.8	4.5	1.1	3.7	1.4	1.7	4.8	2.3	1.7	0.4	0.7	0.8	7.9	6.5	0.5	2.3	1.0	2.3	0.5	4.5	3.4	19.4	0.4	13.6	1.9	7.6	1.2	3.0	2.1	5.1	1.5	5.6	12.4	8.5	3.5	8.6	2.0	0.4	2.7	0.7	0.6	1.4	11.2	0.8	0.7	0.5	0.3	0.7	2.5	1.2	4.0	4.3	4.3	2.7	0.3	0.3	0.3	0.3	0.2	4.0	4.2	7.5	0.2	0.8	0.8	0.4	1.3	0.6	2.2	2.1	1.5	1.8	0.3	1.1	4.8	0.1	1.5	1.9	0.1	1.2	3.0	10.1	9.5	0.6	1.2	1.2	1.2	6.2	0.6	4.0	3.2	2.6	0.7	3.1	1.6	7.9	2.7	1.6	6.2	0.1	0.2	9.2	1.7	1.2	4.5	1.6	1.4	0.4	0.4	1.1	3.2	0.6	7.2	0.5	4.3	1.2	11.2	0.4	0.0	0.1	0.8	0.3	0.2	0.1	0.1	0.9	0.6	0.5	0.5	0.2	0.7	0.3	1.4	0.0	0.3	4.9	12.9	9.1	5.8	4.8	2.3	7.9	6.5	4.5	8.5	0.0	1.1	0.0	0.6	0.3	1.0	1.2	5.1	1.4	1.2	1.8	0.0	3.4	5.0	1.3	3.9	1.3	6.2	0.0	0.6	0.6	2.0	2.8	5.7	0.0	1.4	0.0	10.9	1.8	1.6	3.1	1.7	0.9	8.5	0.0	19.6	2.6	0.9	35.1	2.5	2.2	0.0	0.0	0.1	20.4	2.0	0.3	0.7	0.0	16.6	1.3
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50129882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 45.8"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 42.7;Horizontal cells: 11.1;Intestinal endocrine cells: 12.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.9;HEL: 6.9;HMC-1: 23.2;SH-SY5Y: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: AB_2681662"	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	2.8	3.8	18.3	3.9	19.5	2.0	1.0	45.8	18.5	2.4	2.2	3.1	1.1	2.0	3.2	4.3	1.6	1.3	2.2	1.5	15.4	10.3	2.9	1.7	5.4	2.2	7.9	16.1	1.7	1.5	2.9	2.1	3.9	10.9	3.9	1.8	4.3	1.3	4.0	6.1	1.6	2.6	2.8	6.8	3.0	3.2	4.6	6.9	0.0	1.3	0.0	3.2	2.2	0.9	0.0	0.0	2.3	0.0	0.3	0.0	0.4	0.0	0.1	4.0	0.0	1.1	0.2	0.0	2.5	0.9	0.0	0.0	0.5	0.0	0.1	3.7	1.0	0.0	0.1	0.2	0.0	0.1	10.9	0.1	6.9	0.2	0.0	0.6	0.0	23.2	0.3	0.0	0.0	0.0	0.4	0.6	0.0	0.2	0.3	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	10.9	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.4	1.4	0.3	0.0	0.2	0.0	0.0	2.0	0.0	0.8	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	18.3	19.5	45.8	18.5	15.4	10.3	7.9	16.1	10.9	6.9	0.0	0.3	0.0	0.1	0.3	42.7	1.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.2	2.1	2.9	0.0	0.0	0.3	0.1	1.4	0.1	2.3	0.0	0.1	11.1	12.2	4.9	0.3	1.9	1.4	0.8	0.0	2.8	0.0	1.4	0.3	0.0	3.2	0.8	3.1	0.0	2.2	1.4	1.1	0.1	0.3	0.0	0.0	0.0
SAMD15	"C14orf174, FAM15A, FLJ35963"	ENSG00000100583	"Sterile alpha motif domain containing 15"	Q9P1V8	14	77376689-77391497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 29.1;testis: 22.1"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 65.6;Cone photoreceptor cells: 58.9;Early spermatids: 61.5;Late spermatids: 75.0;Rod photoreceptor cells: 75.7;Spermatocytes: 45.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 10.8"					"Low region specificity"	"Detected in many"			"HPA030673, HPA030677"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			"Nucleoplasm, Nuclear membrane, Nucleoli"		"HPA030673: AB_10600655, HPA030677: AB_10599938"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.83e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.76e-2)"	0.8	1.3	5.3	0.5	6.7	0.9	1.5	0.8	3.3	1.2	0.7	2.2	3.1	0.6	1.5	7.5	0.7	6.2	1.5	0.6	3.7	2.9	6.0	0.6	1.8	1.9	1.4	3.1	3.2	2.7	5.2	29.1	0.5	7.9	1.3	0.5	4.4	0.8	1.1	0.5	0.8	0.6	0.6	1.5	0.7	0.7	22.1	2.3	0.1	6.9	0.0	1.8	1.9	0.7	0.6	0.2	2.3	0.5	0.6	0.4	0.1	3.6	4.9	1.9	4.1	0.5	2.1	1.8	1.5	1.3	4.0	3.6	3.5	3.3	4.0	1.6	1.5	3.5	3.5	1.4	2.0	5.5	0.3	0.7	0.6	1.4	0.9	0.2	0.7	4.3	2.0	1.3	3.4	0.4	1.7	2.7	2.0	0.4	1.2	1.6	10.8	0.9	0.4	0.8	0.9	1.6	1.7	1.9	0.2	6.9	2.0	4.3	2.7	5.1	0.8	0.7	0.8	6.4	1.2	1.0	3.7	2.2	3.9	1.9	0.7	3.3	2.6	4.7	0.2	1.9	0.7	0.5	1.2	0.2	0.1	0.1	0.2	0.2	0.1	0.2	0.6	0.3	0.4	2.3	0.6	0.5	0.1	0.4	0.1	5.3	6.7	0.8	3.3	3.7	2.9	1.4	3.1	7.9	2.3	0.0	0.0	0.0	0.4	0.2	9.7	0.8	2.5	65.6	2.3	0.0	58.9	0.2	1.7	2.4	61.5	0.3	0.0	0.0	0.6	0.2	0.6	0.5	0.0	0.0	0.1	3.2	3.5	0.0	0.0	75.0	1.4	0.0	0.0	0.0	0.0	4.8	1.0	0.0	0.0	3.4	75.7	0.0	0.3	45.6	6.0	0.0	0.2	0.0	0.0	0.1
SAMD4A	"DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA"	ENSG00000020577	"Sterile alpha motif domain containing 4A"	Q9UPU9	14	54567097-54793315	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 48.7;testis: 44.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 1164.1;Late spermatids: 1577.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.9;non-classical monocyte: 3.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043061, HPA065309"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"HPA043061: AB_2678299, HPA065309: AB_2685462"	"unprognostic (1.46e-1)"	"unprognostic (8.10e-3)"	"unprognostic (9.66e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	7.5	2.9	7.8	9.0	6.0	0.5	4.0	5.6	7.0	8.9	10.1	8.0	3.0	2.3	11.1	5.5	5.4	4.2	6.5	28.2	5.5	7.3	2.5	7.6	6.4	2.9	10.6	5.2	2.1	4.1	4.8	2.0	6.0	10.8	7.7	3.3	3.4	2.4	6.3	48.7	2.6	3.3	23.8	26.5	4.6	3.9	44.6	6.1	0.7	2.4	1.3	4.8	15.9	5.8	0.9	2.6	0.0	3.9	0.0	0.4	0.8	17.0	1.7	3.4	1.7	7.2	11.4	6.3	14.9	21.3	11.8	12.0	17.5	4.1	1.0	7.6	20.6	5.2	11.8	3.3	7.4	16.6	9.7	1.6	0.0	2.0	3.6	4.1	0.0	0.1	6.4	2.5	8.5	12.6	3.3	9.2	0.0	1.3	0.0	5.5	1.1	0.2	0.0	1.7	0.1	4.1	0.5	6.8	0.0	5.5	5.5	0.5	5.6	2.3	2.9	7.7	7.2	11.2	0.2	18.6	14.0	23.1	3.4	4.6	0.1	0.0	0.0	4.0	0.3	4.5	0.0	2.3	0.0	0.0	3.9	0.0	0.3	0.0	0.0	2.6	0.9	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.8	7.8	6.0	5.6	5.7	5.5	7.3	10.6	5.2	10.8	6.1	23.8	1.0	3.2	34.8	35.1	0.5	244.5	12.7	0.0	5.7	17.4	7.9	7.5	3.3	8.2	1164.1	32.1	4.2	0.0	6.7	1.7	65.1	37.0	22.0	48.2	10.0	9.5	5.8	12.3	13.0	1577.3	13.6	11.7	23.6	0.0	1.3	1.0	14.6	5.8	22.3	19.2	4.2	12.9	48.5	12.7	7.2	21.2	1.6	1.0	1.3	37.6
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.6;lymphoid tissue: 35.4"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 59.6;T-cells: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 29.4;GAMG: 28.8"					"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	9.6	4.0	2.3	9.2	2.4	5.2	2.6	1.0	1.6	9.3	6.8	0.6	0.9	4.3	2.8	3.0	34.6	2.7	4.3	2.5	1.3	1.5	6.3	3.5	7.8	10.8	2.5	1.1	6.3	2.3	0.1	6.4	11.3	3.1	5.3	7.0	0.7	5.7	1.6	2.4	1.5	12.7	2.2	2.5	21.7	6.3	2.5	1.7	35.4	3.3	9.9	9.5	4.8	9.7	5.5	3.0	15.6	9.8	7.4	7.6	2.6	11.7	1.5	0.4	0.1	5.3	6.8	0.1	4.6	19.3	22.2	29.4	0.0	13.1	4.9	7.3	11.4	28.8	13.9	0.0	4.2	7.5	16.8	0.5	7.2	7.9	0.0	2.4	8.0	10.0	3.0	6.1	7.3	2.0	1.2	3.3	5.5	0.5	12.3	4.6	0.0	11.9	6.6	0.0	0.0	3.3	3.9	3.9	5.6	0.1	1.5	1.9	0.2	3.6	1.4	3.8	0.0	0.4	3.9	14.2	5.2	1.9	15.5	2.5	7.4	1.4	4.6	5.4	4.7	5.1	15.6	3.6	12.7	7.6	7.0	7.3	5.0	5.9	6.5	3.0	5.5	6.3	5.7	15.5	7.4	9.8	2.1	7.2	2.6	2.3	2.4	1.0	1.6	1.3	1.5	2.5	1.1	3.1	1.7	8.9	3.0	23.2	7.5	2.1	1.6	0.9	2.5	20.1	9.1	14.0	0.0	1.5	0.0	20.9	0.0	24.8	12.1	0.0	10.8	4.6	8.3	6.6	41.7	1.0	10.7	6.4	2.9	8.0	24.0	0.2	14.1	26.3	3.3	13.6	20.9	2.0	32.1	59.6	11.7	2.1	0.0	12.9	9.2	0.2	0.0	1.6	0.3	50.7	3.3	25.5
SAMD9L	"C7orf6, FLJ39885, KIAA2005"	ENSG00000177409	"Sterile alpha motif domain containing 9 like"	Q8IVG5	7	93130055-93148369	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 71.3;Paneth cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 21.0;GAMG: 17.0;HDLM-2: 18.6;Karpas-707: 50.1"	"Low region specificity"	"Detected in all"							"HPA019461, HPA019465, HPA019488"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA019461: AB_1856555, HPA019465: AB_2183384, HPA019488: AB_1856557"	"unprognostic (6.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.03e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.22e-1)"	25.1	6.8	6.0	16.5	7.9	5.9	7.1	5.1	5.7	10.0	6.7	3.3	3.2	7.4	5.9	11.4	8.8	7.0	9.4	5.5	5.7	3.3	9.1	3.7	14.8	17.3	4.5	5.9	11.1	3.9	1.2	6.4	11.3	7.4	8.8	7.7	4.2	8.1	4.5	3.6	2.6	13.2	5.8	6.5	28.4	9.3	3.9	6.0	26.7	11.7	5.5	10.3	9.1	7.8	11.2	4.5	21.7	9.7	5.9	10.1	2.4	2.6	0.1	0.0	0.1	3.6	7.4	0.0	2.3	9.7	13.2	21.0	0.0	6.0	1.7	2.9	6.2	17.0	1.1	0.0	0.8	2.1	18.6	0.0	1.6	0.6	0.0	2.9	3.4	2.6	2.8	0.3	2.6	0.4	2.4	5.7	2.6	0.0	50.1	5.5	0.0	5.5	3.1	0.2	0.0	0.6	2.3	0.8	4.0	0.7	0.2	0.0	0.1	0.4	0.0	3.6	0.0	0.1	1.8	13.2	3.9	0.8	11.3	1.4	13.9	4.6	0.5	4.1	3.1	3.8	14.3	4.9	11.4	10.1	9.7	8.9	11.2	5.8	7.4	4.5	7.9	3.3	5.7	21.7	5.9	8.9	3.3	8.2	2.4	6.0	7.9	5.1	5.7	5.7	3.3	4.5	5.9	7.4	6.0	32.8	9.1	23.1	2.1	2.1	0.0	1.2	5.1	17.4	7.9	10.4	0.0	0.3	8.3	10.9	0.0	20.7	2.6	0.0	5.3	0.7	7.6	2.8	33.5	0.0	23.8	0.0	1.2	23.9	18.6	0.7	8.9	22.7	6.8	71.3	8.4	16.3	9.9	51.8	11.0	3.3	0.0	6.5	5.6	0.2	0.0	1.9	0.1	28.7	2.4	7.3
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36889773-36951901	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 131.6;Kupffer cells: 243.3;Macrophages: 175.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 46.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 58.1;BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		100000	Nucleoplasm	"Plasma membrane"	"HPA047072: AB_2679921"	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	54.3	18.6	8.7	31.8	13.0	9.9	35.9	4.9	9.7	14.5	21.2	9.0	8.7	15.8	13.5	20.2	24.1	33.4	15.3	25.4	8.7	6.0	12.5	12.4	25.7	48.3	14.5	4.9	22.1	18.1	4.9	22.4	13.7	10.2	14.0	13.2	11.6	14.7	9.7	9.2	11.4	20.6	21.3	13.7	40.7	19.2	15.1	15.0	9.7	14.9	10.7	18.5	23.2	50.2	0.4	46.7	2.8	23.4	6.0	10.9	19.1	3.9	1.5	0.7	1.5	58.1	11.0	0.7	2.3	4.2	24.6	26.4	4.9	1.3	8.3	3.3	1.6	15.0	3.0	6.1	2.9	5.2	2.4	2.0	0.4	2.1	2.6	5.1	4.7	1.5	13.5	0.1	8.6	0.2	1.4	3.2	0.0	1.5	2.0	0.5	1.2	0.0	1.8	0.7	2.4	3.2	0.2	4.0	3.2	0.9	0.6	3.0	0.4	3.0	1.1	2.9	0.2	1.4	7.6	0.8	1.9	2.1	2.0	3.4	1.2	3.0	3.5	1.6	0.4	0.6	0.2	19.4	0.6	6.1	23.4	5.6	0.4	6.9	6.4	46.7	0.4	8.5	6.3	2.8	6.0	20.4	11.0	10.9	19.1	8.7	13.0	4.9	9.7	8.7	6.0	14.5	4.9	10.2	15.0	26.8	30.5	23.8	1.9	5.7	5.3	16.9	25.5	83.0	53.4	1.8	3.9	2.5	0.0	9.3	2.3	36.5	1.1	0.0	8.6	2.8	23.4	2.7	11.6	17.4	131.6	6.4	5.8	47.9	243.3	2.3	76.2	175.7	5.0	16.2	4.3	30.6	11.1	20.1	90.5	1.2	2.6	58.2	29.8	5.1	5.4	5.1	2.4	54.9	4.5	4.7
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 1107.2;monocytes: 1399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 53.6;eosinophil: 49.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 60.9;K-562: 72.4;Karpas-707: 31.6"	"Region enriched"	"Detected in some"	7	"olfactory region: 25.4"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	14.4	3.9	5.8	33.0	10.4	72.1	4.2	1.1	5.1	2.9	4.7	4.9	0.0	3.1	3.4	4.6	4.1	6.8	10.1	5.1	4.4	3.4	5.9	7.2	27.9	28.3	11.1	1.4	3.3	2.3	1.0	2.7	6.7	6.7	4.1	7.0	3.4	3.4	1.2	1.6	1.9	13.6	4.7	17.5	43.6	5.0	2.4	7.1	12.6	2.6	2.8	16.7	11.8	4.5	6.5	5.6	53.6	17.3	3.7	12.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.1	0.0	60.9	0.0	0.0	0.0	7.1	2.9	0.0	0.0	0.0	9.0	2.4	0.8	1.1	72.4	31.6	0.0	0.0	3.4	8.7	0.0	0.0	0.0	5.9	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	7.9	0.0	0.0	0.0	0.0	13.6	0.1	0.0	0.3	4.6	0.0	53.6	8.8	49.9	5.3	11.6	3.6	6.5	10.3	7.8	5.6	2.6	6.6	4.6	11.0	3.7	17.3	0.2	12.9	6.8	5.8	10.4	1.1	5.1	4.4	3.4	11.1	1.4	6.7	7.1	20.8	87.5	39.7	0.8	13.9	54.7	1.2	2.5	14.7	20.5	34.9	0.0	0.4	0.0	0.4	0.0	7.1	0.0	23.3	5.4	0.5	6.2	0.4	1107.2	0.9	57.4	0.0	0.0	3.1	159.2	0.0	0.6	220.5	20.3	1399.5	0.1	1.5	0.6	0.0	0.0	0.4	4.2	0.0	3.3	0.0	0.0	11.5	0.5	120.4	0.0	0.7
SAP25	FLJ00248	ENSG00000205307	"Sin3A associated protein 25"	Q8TEE9	7	100572228-100573820	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 50.2"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 19.4;Cone photoreceptor cells: 66.8;Horizontal cells: 20.6;Rod photoreceptor cells: 58.2;Spermatocytes: 18.4;Spermatogonia: 71.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.8;NB-4: 28.2;OE19: 47.3;U-937: 11.0"									HPA062610			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA062610: AB_2684806"	"unprognostic (1.70e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.09e-5)"	"unprognostic (6.89e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.96e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.52e-6)"	"unprognostic (7.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-3)"	2.4	2.5	2.0	9.5	2.5	15.2	2.0	5.0	2.6	3.1	2.3	2.3	2.0	3.5	2.2	2.7	2.0	2.5	2.6	2.0	2.4	1.2	5.1	2.0	4.7	15.2	2.0	2.0	7.9	2.0	0.5	4.8	2.8	2.3	3.2	0.6	2.0	5.2	3.6	2.0	3.3	6.7	2.0	3.0	19.6	2.6	50.2	2.0	2.0	5.7	2.0	4.5	2.0	2.2	0.2	1.2	3.8	1.9	0.0	0.9	0.2	1.5	0.5	1.1	0.6	0.1	0.1	2.7	1.3	0.2	0.8	0.3	1.3	1.6	0.8	0.7	0.0	0.1	1.7	0.2	0.4	0.1	1.5	1.0	1.5	1.1	0.4	0.2	1.7	12.8	0.3	0.8	0.4	0.1	0.6	0.2	3.3	1.8	3.2	0.1	3.6	3.1	28.2	1.8	47.3	0.6	6.7	0.4	1.2	0.1	0.5	0.7	2.1	0.1	1.5	1.7	1.3	2.3	6.4	1.4	1.2	2.5	1.1	1.1	5.4	1.3	0.6	0.3	11.0	1.2	2.2	0.8	0.0	0.9	1.9	0.2	0.2	0.5	0.1	0.2	0.2	0.6	0.8	3.8	0.0	0.7	1.2	0.0	0.2	2.0	2.5	5.0	2.6	2.4	1.2	2.0	2.0	2.3	2.0	0.0	5.5	1.9	1.3	0.0	19.4	0.0	2.5	0.0	2.3	0.0	66.8	2.1	0.0	1.6	1.4	0.0	1.3	0.0	0.6	0.5	0.8	2.2	1.1	1.1	2.9	20.6	0.0	1.8	9.4	3.4	3.1	4.5	0.0	3.6	2.6	9.2	1.5	1.9	1.1	0.2	58.2	6.5	0.0	18.4	71.9	0.0	3.0	4.9	1.5	1.4
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762799-31764851	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"retina: 8.8;skin 1: 14.7"	"Cell type enriched"	"Detected in single"	27	"Ciliated cells: 2.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.3;JURKAT: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071699			Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA071699: AB_2686433"	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	0.8	0.3	0.7	1.6	1.0	4.8	1.8	0.7	1.3	2.0	1.0	1.3	0.7	0.2	1.2	0.8	0.7	1.8	2.5	0.7	0.7	0.8	3.2	0.9	1.4	2.5	1.9	0.7	1.6	0.7	0.2	2.9	3.3	3.9	2.6	1.1	8.8	0.7	1.6	0.7	14.7	1.5	0.7	3.1	2.1	0.8	1.2	0.7	0.7	0.7	0.7	0.7	0.8	0.7	0.0	0.5	0.2	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.5	0.4	0.8	0.8	0.4	0.2	0.2	0.0	2.8	1.0	0.8	0.1	0.2	0.0	1.6	0.0	0.7	0.1	0.0	3.1	3.8	7.3	1.0	0.2	0.3	0.1	0.2	0.0	1.1	1.4	0.3	0.5	6.4	0.4	1.1	0.0	3.7	2.8	2.3	0.0	0.3	0.8	0.4	0.9	0.0	0.6	0.7	1.2	0.6	0.3	0.7	0.4	0.9	0.3	0.0	0.2	0.1	2.9	0.0	0.3	2.1	2.0	2.0	0.2	2.7	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.7	1.0	0.7	1.3	0.7	0.8	1.9	0.7	3.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SAR1B	SARA2	ENSG00000152700	"Secretion associated Ras related GTPase 1B"	Q9Y6B6	5	134601144-134649271	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 296.4;Hepatocytes: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, HPA048368"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (6.14e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.32e-2)"	"prognostic favorable (7.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (6.59e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.87e-2)"	15.0	24.4	14.4	9.2	16.4	9.0	15.0	11.2	17.4	11.7	20.9	23.2	20.5	26.7	8.2	15.8	19.0	7.7	11.6	17.9	15.1	12.7	23.2	78.8	9.6	9.4	26.7	12.1	9.7	17.5	27.9	27.3	11.6	19.7	16.0	15.3	10.9	19.1	16.8	68.6	8.5	45.1	10.8	26.5	11.4	16.6	23.9	20.1	8.6	13.8	30.2	12.9	12.2	10.4	22.0	28.9	23.9	33.2	14.5	33.4	29.3	17.0	14.9	11.1	25.5	35.3	17.2	15.1	28.8	24.8	26.0	40.1	25.2	24.3	9.4	24.5	29.5	36.2	15.9	19.2	27.9	33.8	21.8	11.2	9.9	25.5	24.0	29.0	8.4	13.8	19.2	17.9	30.2	25.8	13.2	19.5	12.6	13.0	22.0	26.5	25.3	11.2	12.9	3.7	21.0	10.5	9.9	19.3	20.7	18.9	28.7	11.3	5.2	20.3	11.1	20.8	15.4	22.7	10.6	15.6	22.7	13.7	20.5	21.5	27.9	61.2	17.1	17.5	16.6	24.8	9.8	32.0	23.9	20.5	31.1	25.1	22.0	23.7	23.6	28.9	13.3	21.1	20.7	11.7	14.5	33.2	19.7	33.4	29.3	14.4	16.4	11.2	17.4	15.1	12.7	26.7	12.1	19.7	20.1	29.8	28.8	28.3	36.3	33.4	28.9	69.9	63.7	46.8	36.4	54.1	39.3	30.5	48.0	41.7	296.4	30.0	96.1	0.0	72.9	33.5	40.9	74.8	25.5	238.0	47.2	31.8	26.6	38.6	54.8	51.0	33.9	46.0	60.8	30.7	50.3	41.1	59.5	28.8	42.1	102.9	37.4	19.4	43.4	103.0	38.3	44.7	96.3	37.4	42.9	76.5
SARAF	"MGC8721, TMEM66"	ENSG00000133872	"Store-operated calcium entry associated regulatory factor"	Q96BY9	8	30063012-30083208	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040400			Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA		17000	"Endoplasmic reticulum"	"Rods & Rings"	"HPA040400: AB_2676962"	"unprognostic (1.11e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.86e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.03e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-1)"	30.7	80.7	58.1	37.3	69.0	57.8	62.1	45.8	89.0	40.9	32.8	35.8	49.3	26.9	35.0	65.9	20.2	42.9	39.5	34.3	57.5	80.9	38.7	67.0	39.1	77.7	59.1	49.8	60.6	67.8	44.6	48.9	61.6	53.4	45.6	28.1	26.1	69.4	45.5	29.7	18.4	30.7	30.4	62.4	36.4	38.7	21.3	35.4	50.3	50.0	16.0	36.0	35.4	37.3	36.9	30.2	96.2	36.9	29.0	99.7	91.0	21.6	15.4	19.6	13.0	33.6	23.4	14.9	26.8	38.5	23.3	30.2	8.3	24.3	14.7	39.4	29.1	22.5	19.2	19.7	22.2	19.2	7.8	14.3	20.1	11.0	10.7	33.8	6.4	24.0	36.5	41.8	26.2	21.6	37.6	32.4	28.0	23.5	31.4	17.6	8.2	23.5	10.6	17.4	39.9	16.7	19.0	13.0	20.2	32.4	8.8	8.5	30.2	23.4	23.3	30.0	16.0	20.1	13.5	23.0	15.6	44.8	7.1	8.8	22.2	20.2	13.3	38.7	17.5	25.3	96.2	30.1	50.8	41.3	28.9	45.2	27.0	59.4	47.5	30.2	36.9	99.7	67.4	58.4	29.0	36.9	25.1	53.5	91.0	58.1	69.0	45.8	89.0	57.5	80.9	59.1	49.8	53.4	35.4	157.8	151.5	175.3	315.5	0.0	275.4	116.6	183.4	389.5	151.2	200.7	115.8	212.5	107.8	306.4	503.5	140.5	151.8	23.3	314.8	218.5	186.1	398.0	205.8	225.0	268.6	131.9	111.2	216.7	320.6	650.1	202.5	236.8	0.0	172.3	165.1	296.0	289.2	188.4	276.5	210.5	171.0	174.6	120.5	100.9	125.1	0.0	231.6	276.7	147.8	245.7
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 25.3;liver: 52.8;pancreas: 39.4"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 94.3"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.1;Hep G2: 18.7;JURKAT: 8.3;MOLT-4: 13.5;RH-30: 11.6;RPMI-8226: 23.4;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	0.5	1.1	1.7	1.0	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2.0	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0.0	0.1	0.9	11.1	0.0	0.3	1.5	0.1	0.4	0.5	0.7	0.2	0.1	0.0	1.5	0.2	1.4	0.0	0.0	0.2	0.4	0.0	0.2	1.5	0.0	18.7	1.2	0.0	0.2	2.6	0.0	1.3	0.0	0.3	0.1	8.3	0.0	0.2	7.0	1.9	13.5	1.4	1.7	1.0	0.1	0.9	11.6	23.4	0.0	0.1	1.0	9.3	0.0	0.3	2.3	0.5	1.5	0.1	0.0	2.1	2.0	0.2	0.0	0.1	0.0	0.8	1.3	0.8	0.0	0.1	0.1	0.1	0.4	0.0	1.0	0.0	4.1	1.0	0.0	0.4	8.4	1.5	0.6	0.1	0.0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8	0.0	3.4	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	1.0	0.2	1.1	94.3	0.1	0.0	1.2	2.5	2.4	0.2	4.4	0.2	0.0	0.0	0.0	2.1	0.2	0.0	2.8	14.7	0.2	0.0	1.0	0.1	0.9	0.1	0.0	2.9	0.0	0.1
SARM1	"KIAA0524, SAMD2, SARM"	ENSG00000004139	"Sterile alpha and TIR motif containing 1"	Q6SZW1	17	28364356-28404049	"Predicted intracellular proteins"	"Differentiation, Immunity, Innate immunity, Neurogenesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 25.2;Cone photoreceptor cells: 27.5;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024359, HPA024759"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA024359: AB_1856582, HPA024759: AB_1856581"	"unprognostic (1.40e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-4)"	"unprognostic (6.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.62e-4)"	4.3	14.6	9.5	6.9	8.6	2.6	6.0	14.4	9.4	5.4	4.2	6.5	11.2	15.3	7.5	8.9	3.7	7.0	4.5	4.6	6.8	4.4	4.6	8.7	6.2	12.3	4.8	7.6	6.3	13.1	8.0	11.7	2.8	5.4	6.8	4.9	6.1	5.0	11.7	4.0	4.8	9.8	7.7	6.6	7.2	5.8	3.5	4.5	0.9	5.9	2.4	4.4	4.7	5.1	1.3	1.2	0.7	2.4	1.5	2.4	0.8	0.1	2.4	3.1	4.0	2.3	1.6	0.5	1.7	3.3	3.7	2.4	26.0	0.4	0.5	0.1	2.4	2.2	1.1	2.2	0.1	3.1	5.5	1.5	0.0	3.7	0.6	1.7	0.0	1.6	1.1	0.1	1.7	0.5	3.5	0.1	0.8	0.1	2.0	1.0	2.2	0.3	0.0	2.2	0.5	0.2	0.9	2.6	0.6	1.2	1.8	8.2	7.6	7.4	1.1	2.9	1.4	0.3	0.6	0.3	3.3	0.4	1.2	2.4	3.3	2.2	0.5	3.5	0.2	1.7	0.7	0.7	0.1	1.2	1.2	1.1	0.8	1.7	1.8	1.2	1.3	1.1	1.8	0.6	1.5	2.4	0.4	2.4	0.8	9.5	8.6	14.4	7.7	6.8	4.4	4.8	7.6	5.4	4.5	3.0	3.4	0.0	1.9	0.8	25.2	0.8	7.6	5.3	6.8	3.5	27.5	0.5	3.3	3.4	5.8	1.6	4.5	0.0	9.3	0.6	2.3	2.2	4.6	2.0	1.4	20.6	9.1	2.5	8.2	2.0	3.1	2.1	3.3	1.8	3.6	4.7	3.5	2.9	1.4	4.6	16.3	6.5	1.7	0.2	0.4	0.5	0.5	3.2	3.9	0.9
SARS2	"FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS"	ENSG00000104835	"Seryl-tRNA synthetase 2, mitochondrial"	Q9NP81	19	38915266-38930896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 34.4;Late spermatids: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA052730, HPA056957"	Approved		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"	"unprognostic (3.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.62e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.69e-2)"	5.8	16.5	9.9	7.2	12.8	11.1	7.4	10.7	20.4	8.0	9.2	11.3	11.4	12.3	9.0	9.4	12.9	11.5	8.2	12.3	8.3	8.6	13.4	20.6	6.3	11.0	10.9	7.8	9.5	14.4	11.2	11.4	10.7	15.0	11.0	8.5	11.8	13.6	9.9	15.5	15.6	9.9	8.1	7.2	11.3	11.1	8.8	11.5	11.4	13.8	9.5	12.6	11.0	8.3	6.3	12.7	0.4	7.2	6.5	8.0	4.3	5.7	17.4	7.0	4.1	2.9	6.0	9.6	4.0	5.5	9.5	7.5	14.2	7.1	6.5	5.8	5.7	3.8	5.4	7.3	11.4	2.4	5.5	9.4	12.9	7.5	12.2	6.9	11.0	12.9	9.1	6.2	6.2	4.3	4.7	6.7	10.5	11.1	6.4	4.8	12.2	8.3	10.0	7.1	9.0	3.5	12.0	6.3	7.1	10.1	13.9	12.0	7.6	5.4	14.5	3.6	2.7	7.4	7.4	4.3	5.9	6.8	4.6	3.9	4.7	2.7	5.1	3.8	7.7	4.9	0.0	4.1	0.4	8.0	7.2	6.4	6.3	5.9	8.0	12.7	5.7	4.3	4.9	0.3	6.5	6.4	5.0	6.6	4.3	9.9	12.8	10.7	20.4	8.3	8.6	10.9	7.8	15.0	11.5	6.0	6.4	9.5	3.4	3.8	7.2	8.1	10.2	4.0	4.5	5.2	7.9	34.4	13.3	13.2	10.2	3.2	5.1	0.0	11.2	19.0	5.1	2.3	5.7	8.1	11.2	4.8	10.9	6.2	6.2	42.6	4.4	3.5	3.3	6.4	7.1	2.9	7.8	3.5	4.6	5.6	13.4	0.0	2.1	1.5	7.2	3.6	24.4	6.9	16.6	2.6
SASH1	"dJ323M4.1, KIAA0790, SH3D6A"	ENSG00000111961	"SAM and SH3 domain containing 1"	O94885	6	148272304-148552050	"Predicted intracellular proteins"			"Disease mutation, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 97.4;Muller glia cells: 93.7;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 2.9;intermediate monocyte: 5.5;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	32	"monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.2;ASC TERT1: 22.8;HUVEC TERT2: 21.8;WM-115: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029947, HPA029949"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029947: AB_10598915, HPA029949: AB_10602280"	"unprognostic (9.71e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.79e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.53e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.54e-1)"	41.4	5.4	19.6	5.3	21.7	0.7	25.7	9.9	28.1	16.8	9.2	22.2	4.4	5.6	11.2	9.3	35.6	10.0	15.6	13.2	21.9	14.2	13.5	7.7	16.7	4.7	26.3	11.4	5.3	7.7	15.0	3.5	23.5	22.8	9.8	8.3	9.2	12.2	8.1	10.6	17.5	6.7	13.2	28.6	10.3	6.0	4.8	22.3	0.2	30.9	10.4	8.2	13.2	17.9	0.0	0.0	0.1	5.5	0.0	0.1	0.6	1.3	0.8	6.9	2.3	60.2	22.8	1.1	7.9	19.1	6.0	9.2	1.7	1.6	0.0	4.2	21.1	3.0	1.6	2.1	1.9	5.0	0.0	1.5	0.0	3.9	1.6	1.8	0.0	0.4	10.6	1.9	9.0	2.4	2.4	21.8	0.0	0.1	0.0	5.6	1.5	0.0	0.0	2.0	0.7	1.1	0.0	5.0	0.0	4.4	4.3	0.2	0.0	2.4	8.9	6.2	1.8	0.7	3.9	18.9	5.9	1.2	18.6	1.7	0.0	0.0	0.0	9.4	0.0	27.8	0.1	2.9	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.6	19.6	21.7	9.9	17.9	21.9	14.2	26.3	11.4	22.8	22.3	14.9	20.8	0.8	6.3	36.5	12.5	18.3	7.6	14.7	21.6	43.6	5.9	16.4	6.6	2.2	0.5	97.4	2.5	0.0	2.1	55.4	26.8	6.2	2.3	6.6	8.1	3.2	4.6	63.8	31.8	1.1	17.0	12.1	40.5	0.0	4.5	93.7	1.2	2.9	26.5	12.2	3.9	77.6	64.3	0.3	4.5	28.9	27.3	0.0	6.4	5.7
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779979-129795201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3"	"Cell type enhanced"	"Detected in some"	12	"B-cells: 45.6;Hofbauer cells: 45.7;Kupffer cells: 59.2;T-cells: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 43.6;JURKAT: 31.2;MOLT-4: 31.1;NB-4: 23.7;REH: 23.3;U-698: 39.8;U-937: 30.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	7.8	3.4	2.8	34.6	5.2	33.2	2.7	0.7	2.2	2.0	3.3	4.0	0.2	3.9	1.9	2.1	2.9	3.4	3.6	2.0	3.3	2.4	3.3	3.0	10.6	38.2	5.2	1.1	1.3	1.8	0.2	1.8	2.5	4.2	2.7	3.5	1.6	7.8	0.8	0.9	1.1	18.8	2.4	6.2	55.7	4.2	0.8	4.0	85.3	2.5	2.0	38.6	7.0	2.0	22.0	27.6	53.7	44.2	33.4	46.9	61.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.0	3.7	0.0	0.0	31.1	23.7	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.1	0.0	0.0	0.0	8.8	39.8	0.0	30.9	0.0	7.9	29.4	53.7	46.9	44.1	38.7	19.1	26.7	43.1	27.6	22.0	19.3	30.0	29.1	33.4	44.2	12.7	32.3	61.8	2.8	5.2	0.7	2.2	3.3	2.4	5.2	1.1	4.2	4.0	0.0	5.1	45.6	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.5	0.4	0.0	21.9	0.9	45.7	0.0	0.0	3.7	59.2	0.0	0.3	20.3	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.5	75.2	0.0	0.0
SASS6	"DKFZp761A078, FLJ22097, SAS-6, SAS6"	ENSG00000156876	"SAS-6 centriolar assembly protein"	Q6UVJ0	1	100083563-100132955	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 71.0;Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028187	Uncertain		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	Cytosol	"HPA028187: AB_10602220"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.76e-8)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.54e-1)"	6.2	3.8	3.8	6.1	5.4	10.9	5.9	17.8	6.9	6.4	6.1	5.0	8.3	6.4	4.8	5.5	6.2	4.3	2.5	3.2	5.4	3.5	3.3	3.5	3.3	8.5	5.5	3.3	5.3	4.2	10.2	12.0	5.9	5.8	6.9	6.4	3.1	5.1	4.8	3.8	4.5	7.0	4.9	6.2	7.3	4.6	15.0	6.9	17.1	4.6	5.0	7.7	4.5	4.8	5.1	1.4	8.1	2.3	2.3	3.6	1.4	11.4	3.9	9.4	9.1	1.1	2.0	13.7	7.2	3.5	9.6	11.4	6.0	6.2	12.3	6.3	2.9	5.5	10.6	12.7	4.4	12.9	6.8	12.8	10.4	8.3	7.7	0.6	17.6	10.6	1.0	2.1	7.9	7.0	2.0	5.0	9.1	16.8	12.1	4.4	3.4	15.7	8.5	12.2	7.8	7.8	11.3	18.4	6.4	4.5	5.3	6.7	10.0	7.2	11.7	6.0	6.9	5.8	10.7	2.4	6.6	8.4	7.7	10.2	6.1	12.4	17.2	5.5	11.7	3.7	8.1	1.2	4.8	3.5	2.3	3.6	5.1	3.4	2.9	1.4	3.9	3.1	3.0	3.5	2.3	1.7	1.4	3.1	1.4	3.8	5.4	17.8	6.9	5.4	3.5	5.5	3.3	5.8	6.9	0.0	2.9	10.4	2.1	3.5	17.2	2.4	5.1	6.7	5.7	1.8	15.7	8.3	1.7	6.0	11.7	4.7	1.6	0.0	4.9	17.1	5.2	3.5	5.7	2.9	8.1	7.9	4.1	6.7	5.0	4.0	7.5	4.9	1.7	5.4	4.1	10.9	5.1	2.9	10.3	3.7	21.0	0.0	4.7	71.0	34.5	3.6	4.2	6.4	6.3	1.7
SATL1		ENSG00000184788	"Spermidine/spermine N1-acetyl transferase like 1"	Q86VE3	X	85092287-85243961	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 11.7;Ciliated cells: 17.4;Club cells: 12.5;Late spermatids: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HAP1: 3.5;HEL: 1.2;RH-30: 1.5;SH-SY5Y: 1.4;SuSa: 1.0"									HPA060369	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA060369: AB_2684265"					"unprognostic (1.77e-1)"	"unprognostic (2.06e-1)"				"unprognostic (4.69e-3)"			"unprognostic (7.88e-2)"					0.3	2.7	2.9	0.4	2.6	0.4	0.4	5.4	4.6	0.4	0.4	0.2	0.0	0.3	0.4	0.3	0.3	0.4	0.3	0.5	2.2	2.0	1.1	0.4	0.3	0.3	1.1	2.7	0.4	0.3	0.3	7.2	0.4	2.2	0.5	0.4	0.0	0.4	0.3	0.7	0.6	0.3	0.3	1.4	0.4	0.3	4.8	0.4	0.0	0.4	0.2	0.3	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	3.5	0.0	0.0	0.0	0.6	1.2	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.0	0.1	0.5	1.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.6	5.4	4.6	2.2	2.0	1.1	2.7	2.2	0.4	11.9	11.7	0.0	0.0	0.0	0.0	0.0	0.0	17.4	12.5	0.0	0.0	0.0	3.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SAXO2	"DKFZp666G057, FAM154B"	ENSG00000188659	"Stabilizer of axonemal microtubules 2"	Q658L1	15	82262810-82284930	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 46.8"	"Cell type enhanced"	"Detected in many"	28	"Ciliated cells: 370.7;Early spermatids: 61.6;Late spermatids: 100.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 12.3;K-562: 11.2;SCLC-21H: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040487, HPA040833"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA040487: AB_10796457, HPA040833: AB_10796561"	"unprognostic (3.03e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.13e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.87e-2)"	0.9	1.3	4.1	1.3	5.4	0.7	2.8	4.4	5.3	2.7	1.2	3.5	5.0	0.9	2.1	14.8	0.7	46.8	1.9	1.4	5.5	2.8	2.3	1.1	9.1	1.1	3.1	2.8	9.2	2.6	4.7	11.5	0.7	5.6	2.4	1.8	1.6	2.3	3.0	1.2	1.9	1.6	0.9	2.3	1.3	2.3	18.0	3.7	1.0	3.1	0.1	1.6	1.0	1.2	6.7	1.3	5.3	0.2	3.2	2.7	0.5	1.6	2.2	1.3	4.9	1.1	2.2	0.6	0.5	0.4	0.9	1.8	0.2	2.7	1.6	1.2	0.0	2.6	12.3	2.1	1.8	2.1	1.1	8.0	0.6	3.8	0.0	0.1	0.4	0.5	1.5	2.6	1.7	1.4	2.8	1.9	3.4	11.2	0.9	1.2	1.1	0.6	0.0	3.2	0.6	0.9	1.5	0.6	1.0	0.9	1.1	9.4	1.5	1.3	0.0	1.7	0.8	4.7	0.5	0.2	2.4	1.4	5.0	0.9	2.6	2.8	1.0	2.3	0.6	1.6	0.0	0.1	5.3	1.1	0.0	1.4	2.5	0.4	2.7	0.1	6.7	1.8	0.8	0.1	3.2	0.2	1.3	0.1	0.5	4.1	5.4	4.4	5.3	5.5	2.8	3.1	2.8	5.6	3.7	0.0	2.4	0.0	1.7	0.0	2.6	1.1	2.5	370.7	44.3	3.5	3.9	0.4	1.7	0.4	61.6	0.5	0.0	0.0	0.4	0.4	0.2	1.8	1.1	0.0	0.1	0.0	2.4	0.0	0.0	100.5	2.3	0.0	0.0	0.0	2.1	3.3	0.3	0.0	2.1	3.5	4.9	6.5	0.1	40.5	7.2	0.0	0.2	0.0	0.6	1.2
SBF2	"CMT4B2, DENND7B, KIAA1766, MTMR13"	ENSG00000133812	"SET binding factor 2"	Q86WG5	11	9778667-10294207	"Disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050933	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA050933: AB_2681280"	"unprognostic (2.26e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.36e-2)"	"unprognostic (5.55e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (3.66e-5)"	"unprognostic (3.72e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.11e-2)"	26.2	12.7	19.8	8.9	22.5	6.1	17.9	26.7	17.4	23.6	15.6	18.4	13.2	9.8	19.1	14.2	16.9	15.3	14.9	13.7	16.3	12.3	20.8	13.8	13.8	8.7	14.6	12.0	26.8	8.0	33.9	23.2	20.5	13.7	16.8	15.3	15.6	14.7	17.7	8.8	13.2	11.1	22.0	16.1	12.4	13.3	15.3	19.1	7.8	24.0	9.1	9.2	20.2	25.5	0.6	1.0	3.9	3.9	0.9	0.6	0.5	6.7	6.1	9.6	6.8	12.9	17.2	49.3	5.3	9.6	6.3	8.9	4.0	8.3	2.6	2.8	9.3	9.2	4.5	5.7	4.3	11.0	2.7	4.1	1.0	4.4	5.4	5.2	2.4	3.6	8.7	5.8	3.3	12.3	9.6	10.2	5.6	2.2	2.5	7.4	2.0	3.5	0.7	4.1	6.1	6.1	3.3	6.7	3.4	5.6	6.1	3.2	7.1	7.3	10.2	4.5	5.2	3.0	1.7	11.1	11.3	5.6	11.2	4.3	0.9	1.9	3.7	8.4	1.2	7.9	0.0	1.9	0.1	0.2	1.8	0.6	0.3	0.2	0.4	1.0	0.6	0.3	0.1	3.9	0.9	3.9	0.4	0.2	0.5	19.8	22.5	26.7	17.4	16.3	12.3	14.6	12.0	13.7	19.1	41.7	103.3	8.8	32.8	22.7	31.5	23.8	15.3	38.8	31.8	15.7	70.7	11.6	3.3	11.0	12.7	38.3	13.8	0.0	7.5	10.5	31.5	47.0	19.8	14.7	16.3	35.0	42.1	51.0	51.2	6.2	47.2	31.9	28.7	15.4	17.1	13.0	10.9	21.8	25.5	9.8	76.6	25.8	28.8	16.8	16.8	26.8	11.6	34.6	17.2	43.4
SBK3	SgK110	ENSG00000231274	"SH3 domain binding kinase family member 3"	P0C264	19	55540656-55545543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 24.2"	"Cell type enriched"	"Detected in single"	25	"Cardiomyocytes: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.4;CACO-2: 3.3;CAPAN-2: 5.6;NTERA-2: 2.5;RH-30: 4.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA078322			Approved	Mitochondria		NA	NA			Mitochondria		"HPA078322: AB_2732379"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.47e-5)"	"unprognostic (4.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-1)"	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0			0.2	0.0	0.0	1.7	0.0	0.1	24.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.8	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	3.3	5.6	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.0	0.0	2.5	0.1	0.6	0.2	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	1.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SBNO1	"FLJ10701, FLJ10833, MOP3, Sno"	ENSG00000139697	"Strawberry notch homolog 1"	A3KN83	12	123289109-123364843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.1"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 294.5;Spermatogonia: 190.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042388	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042388: AB_10795704"	"unprognostic (1.61e-2)"	"unprognostic (9.61e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.61e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-2)"	7.6	7.6	12.9	9.8	12.2	21.4	9.0	24.3	15.9	9.4	8.6	6.4	6.9	7.4	10.9	6.4	10.7	9.3	6.4	7.5	11.3	9.2	9.5	11.0	7.4	12.7	12.1	10.9	10.4	9.5	13.7	15.6	11.8	12.2	10.2	9.5	5.3	7.2	9.1	11.2	8.6	10.1	10.0	9.7	9.4	8.7	57.1	12.3	19.5	14.6	4.8	12.0	8.6	10.4	11.6	8.1	13.8	13.5	7.9	14.7	6.7	11.3	22.1	8.9	16.5	12.7	9.9	18.5	10.4	10.4	9.3	7.8	15.6	7.4	24.5	12.5	11.9	10.4	13.5	18.8	11.6	15.4	18.0	7.1	23.8	13.8	12.6	6.5	29.0	20.7	7.8	9.2	13.0	12.8	10.1	9.1	13.6	29.2	8.0	16.0	11.5	16.0	11.7	13.5	9.8	11.5	17.2	13.0	12.6	7.2	29.6	15.1	6.4	18.1	12.8	9.6	10.9	22.2	10.1	12.0	12.6	16.0	14.9	9.2	8.1	17.2	31.3	7.2	17.3	14.2	8.3	8.2	10.9	12.6	9.6	14.7	11.6	12.2	12.5	8.1	9.7	12.0	12.9	13.8	7.9	13.5	7.6	9.4	6.7	12.9	12.2	24.3	15.9	11.3	9.2	12.1	10.9	12.2	12.3	26.8	18.8	38.5	40.3	56.2	86.0	31.1	22.9	37.5	33.0	34.9	74.6	55.8	19.9	28.9	42.5	25.9	21.1	0.0	23.7	43.8	36.7	29.8	28.8	23.6	23.9	60.4	38.6	28.3	35.1	26.7	23.6	31.9	32.1	54.1	22.7	48.9	30.2	17.5	57.0	23.2	55.9	25.8	44.2	294.5	190.1	53.6	88.7	42.7	36.6	41.3
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 105.1;skin 1: 241.3;tongue: 338.1"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 889.6"	"Group enriched"	"Detected in many"	9	"cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 20.2;ASC TERT1: 35.2;HSkMC: 47.6;U-2197: 16.3;U-87 MG: 38.5"					"Low region specificity"	"Detected in some"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	NA	NA		62000000	Vesicles		"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	0.3	0.0	0.2	0.2	1.6	0.1	11.2	0.2	0.2	65.1	0.2	0.2	0.2	0.0	3.5	0.2	105.1	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.0	0.2	26.8	0.2	1.3	241.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.8	0.2	338.1	51.7	0.4	51.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	20.2	35.2	0.0	1.6	2.2	0.7	0.2	0.0	0.0	0.0	0.3	1.4	0.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	47.6	2.6	9.5	2.3	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	5.9	1.2	16.3	0.4	0.1	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	79.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	13.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	889.6	0.2	0.0	0.0	0.1
SBSPON	"C8orf84, RPESP"	ENSG00000164764	"Somatomedin B and thrombospondin type 1 domain containing"	Q8IVN8	8	73064540-73124088	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 66.7;urinary bladder: 47.9"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 40.1;Muller glia cells: 43.4;Peritubular cells: 25.1;Smooth muscle cells: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 10.0;RPTEC TERT1: 18.1;SuSa: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029595	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		19000	Vesicles		"HPA029595: AB_10600763"	"prognostic favorable (7.18e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.25e-2)"	6.7	3.0	0.6	1.7	0.7	0.3	6.7	2.6	0.7	6.5	4.2	2.9	16.5	0.8	4.9	18.1	9.6	8.2	3.0	3.5	1.1	0.8	14.4	0.6	5.0	2.4	2.5	0.9	9.0	1.2	0.0	1.7	9.3	5.4	19.4	1.1	4.3	4.3	25.4	1.1	1.8	2.6	66.7	15.7	1.1	9.9	5.6	0.7	0.1	3.2	2.5	0.9	47.9	7.6	0.9	1.2	1.1	0.4	1.5	0.8	0.3	0.3	0.2	0.5	0.6	0.0	0.0	1.4	10.0	0.0	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.3	0.0	0.0	0.4	0.3	1.0	0.5	0.2	0.2	0.2	0.0	18.1	0.1	0.6	0.5	1.1	0.4	0.1	3.6	0.2	0.1	0.5	0.2	1.7	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.2	0.7	0.4	0.4	0.6	0.0	0.1	0.4	0.6	0.7	0.1	0.9	0.4	0.8	1.1	1.5	0.4	1.2	0.2	0.3	0.6	0.7	2.6	0.7	1.1	0.8	2.5	0.9	5.4	0.7	8.9	0.0	0.0	4.1	1.1	2.6	1.1	7.6	0.0	0.0	40.1	2.0	0.2	1.7	1.0	5.8	1.5	0.0	0.0	0.0	0.2	14.3	1.6	0.0	0.0	0.4	0.0	0.0	0.6	0.0	1.6	11.2	0.0	3.3	0.0	0.0	43.4	0.8	0.0	25.1	0.7	1.8	6.5	30.8	10.3	2.1	1.1	0.3	0.0	0.0	0.3
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292453-121308694	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 143.5"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 117.3;Ito cells: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	10.9	15.3	16.9	5.5	18.4	2.7	23.3	10.4	26.9	9.4	9.4	17.8	24.5	17.4	6.8	30.1	19.5	7.2	7.4	9.4	18.7	19.6	19.7	143.5	10.1	5.5	20.8	17.8	7.8	8.9	17.5	14.7	6.3	40.8	40.3	8.6	8.2	9.5	24.0	3.9	7.7	13.4	7.6	43.4	4.1	8.8	9.7	16.0	3.7	10.4	8.2	8.1	14.0	14.6	6.0	9.8	7.5	6.3	6.8	10.0	3.8	6.8	3.4	51.8	11.0	20.1	17.5	7.3	7.7	14.5	5.2	9.2	21.6	25.5	6.5	24.4	8.4	41.5	25.7	16.1	19.5	5.1	3.2	22.0	9.6	22.6	17.2	16.4	6.0	3.3	14.3	16.0	16.4	16.9	4.4	7.8	6.4	6.2	9.4	24.0	7.1	2.4	7.9	16.1	19.8	11.0	3.4	13.0	5.5	36.5	30.8	13.7	7.7	17.7	4.0	10.1	36.2	16.2	10.4	14.9	5.0	8.1	8.8	3.6	1.8	2.9	8.7	1.9	13.4	8.6	7.5	4.8	1.2	5.0	6.3	8.5	6.0	6.8	6.0	8.5	6.0	10.0	9.5	0.4	6.8	4.5	9.8	6.9	3.8	16.9	18.4	10.4	26.9	18.7	19.6	20.8	17.8	40.8	16.0	17.9	26.4	26.2	53.7	8.7	21.9	17.8	15.3	14.7	18.2	19.2	29.5	13.8	5.0	17.3	2.2	8.4	23.5	0.0	25.4	14.2	17.3	59.7	17.3	117.3	17.9	22.3	13.8	163.9	25.6	1.0	17.8	15.1	18.6	22.6	12.7	40.5	14.5	11.4	15.9	14.6	29.6	12.9	16.7	6.0	13.0	13.6	15.6	21.7	11.9	45.5
SCAF1	"FLJ00034, SR-A1"	ENSG00000126461	"SR-related CTD associated factor 1"	Q9H7N4	19	49642125-49658642	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046828, HPA054593"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046828: AB_10961907, HPA054593: AB_2682536"	"unprognostic (1.16e-1)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.18e-2)"	21.6	15.6	22.2	17.0	30.5	14.4	12.9	24.9	48.3	14.1	15.0	27.0	7.4	18.2	18.9	7.4	27.2	24.0	17.2	21.3	21.4	18.9	12.4	13.9	13.9	17.7	17.5	21.6	24.1	21.1	13.7	17.5	18.4	26.1	15.0	8.6	14.1	20.8	11.8	28.4	18.5	17.0	14.6	14.8	20.2	17.0	15.9	15.7	19.7	18.4	8.4	13.1	16.9	13.6	5.1	5.1	7.8	2.9	1.9	4.2	3.2	26.5	46.7	12.8	21.1	6.1	5.8	15.6	20.1	6.6	9.4	8.0	25.3	16.6	15.5	13.8	7.4	14.3	20.5	9.2	12.3	2.8	23.9	26.2	17.4	23.1	12.6	10.5	16.5	17.3	9.7	7.8	11.3	8.0	9.2	7.6	6.4	22.4	16.0	7.4	17.1	16.5	8.8	16.3	12.1	28.0	20.5	17.8	16.0	6.2	38.5	19.1	20.9	20.7	21.9	7.4	8.2	15.2	9.2	20.8	34.4	19.9	12.2	29.4	22.7	33.7	14.8	20.7	10.5	19.4	4.0	2.9	2.7	4.2	2.5	2.7	5.1	2.4	2.8	2.3	4.7	2.2	2.4	7.8	1.9	2.2	5.1	0.5	3.2	22.2	30.5	24.9	48.3	21.4	18.9	17.5	21.6	26.1	15.7	6.0	0.0	14.5	7.4	10.8	11.9	2.4	12.7	0.0	0.0	21.0	3.9	12.5	6.6	11.8	26.1	4.5	25.6	0.0	11.2	11.6	9.9	10.2	5.7	14.4	12.3	9.5	13.8	17.8	9.2	73.7	20.4	6.3	10.1	10.8	18.1	9.9	13.8	17.6	22.3	11.2	6.9	12.9	8.2	13.7	19.2	10.5	18.4	8.9	17.2	10.2
SCAI	"C9orf126, FLJ36664, NET40"	ENSG00000173611	"Suppressor of cancer cell invasion"	Q8N9R8	9	124942608-125143506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 34.4"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 65.5;Cone photoreceptor cells: 188.5;Rod photoreceptor cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020632	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA020632: AB_1845804"	"unprognostic (1.93e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-3)"	4.5	6.5	9.5	6.4	14.3	6.8	5.4	9.5	19.1	5.0	4.5	3.5	3.1	3.3	5.9	4.6	4.1	6.1	3.7	3.7	7.1	7.9	4.4	3.8	8.5	7.2	4.6	12.0	7.6	4.6	5.7	4.6	2.7	4.8	5.5	5.0	12.4	3.7	3.3	4.2	6.6	4.0	4.0	4.0	5.0	4.4	5.2	5.1	34.4	5.3	2.1	6.2	4.2	4.5	2.9	3.1	1.5	1.7	2.5	2.6	1.3	3.7	2.9	3.9	3.7	2.2	5.3	6.5	2.3	4.9	2.5	3.6	3.7	3.6	6.7	1.8	2.3	3.0	6.3	5.0	2.6	5.2	4.7	1.8	4.4	5.3	3.2	3.0	4.7	3.4	2.0	2.3	3.9	2.6	4.3	3.6	12.2	6.2	7.9	3.8	4.0	14.9	3.2	3.8	7.2	3.2	9.4	6.2	5.8	1.7	5.1	4.0	2.5	5.5	3.1	2.9	4.4	7.6	2.1	3.7	2.3	4.3	3.8	4.0	4.4	8.3	6.4	2.8	3.8	3.4	0.8	1.2	0.2	1.1	1.7	1.2	2.0	1.9	1.3	0.8	2.9	2.6	1.8	1.5	2.5	0.6	3.1	2.6	1.3	9.5	14.3	9.5	17.0	7.1	7.9	4.6	12.0	4.8	5.1	65.5	23.3	13.0	7.7	2.5	39.5	3.9	17.8	9.4	12.5	17.4	188.5	5.6	1.7	3.0	9.2	6.8	5.0	0.0	1.8	4.3	5.4	6.4	4.7	7.6	3.5	15.9	12.6	13.5	5.6	4.1	8.9	3.2	3.3	1.8	7.1	32.7	2.2	6.6	5.6	1.9	114.6	0.0	3.8	27.2	20.4	3.8	2.2	8.7	8.6	3.7
SCAMP1	SCAMP37	ENSG00000085365	"Secretory carrier membrane protein 1"	O15126	5	78360583-78479071	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044753, CAB079009"		Supported	Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Nucleoplasm, Vesicles, Cell Junctions"		"CAB079009: , HPA044753: "	"unprognostic (8.25e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.34e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (8.44e-3)"	"unprognostic (7.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.99e-2)"	7.5	8.3	9.2	4.0	19.3	2.4	10.0	12.8	19.5	8.4	6.4	5.4	9.9	5.3	8.7	9.3	8.6	10.7	6.4	8.0	15.8		10.4	6.2	5.9	3.9	6.5	15.8	8.8	8.8	17.5	14.6	7.6	14.6	12.2	7.3	7.6	10.6	11.0	4.7	5.8	5.3	9.1	9.0	3.9	9.6	4.5	7.1	4.1	14.2	3.8	3.7	8.8	6.3	7.9	14.9	15.3	15.8	10.0	9.9	7.4	12.5	9.9	9.9	30.6	13.7	17.7	15.6	11.6	16.9	9.6	21.9	3.7	23.5	18.5	13.1	16.9	27.5	10.2	14.0	21.8	17.2	6.5	13.3	8.5	7.9	7.6	8.8	5.4	6.6	11.6	20.2	10.9	17.3	24.2	14.6	10.4	3.2	13.3	18.2	14.7	9.3	11.5	8.0	5.4	10.2	11.4	16.3	21.1	17.5	14.9	28.1	17.1	10.7	15.2	10.9	10.5	21.1	9.8	14.9	10.6	7.9	11.7	9.7	9.3	11.2	11.5	20.7	20.3	8.8	15.3	11.4	12.8	8.2	12.6	9.9	7.9	9.4	9.8	14.9	6.6	7.8	6.8	7.0	10.0	15.8	4.6	9.1	7.4											23.8	19.0	6.7	28.6	34.8	72.3	33.0	20.4	71.0	26.1	38.4	66.8	10.4	11.6	22.7	31.3	27.8	11.7	23.3	26.3	21.3	31.0	36.1	11.5	13.9	16.8	30.2	34.0	22.1	30.5	12.1	18.7	22.7	28.7	6.4	33.6	43.2	26.4	11.5	26.9	20.5	63.0	12.9	25.0	17.0	20.4	39.5	8.8	13.8	17.0	25.0
SCAMP4	FLJ33847	ENSG00000227500	"Secretory carrier membrane protein 4"	Q969E2	19	1905214-1926013	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043284	Approved		Approved	"Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles"	"Lipid droplets, Plasma membrane"	"HPA043284: AB_10806501"	"unprognostic (1.60e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (2.58e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.92e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.03e-1)"	17.3	16.5	17.1	16.0	21.7	10.2	18.4	16.5	28.2	19.5	13.2	46.3	21.1	19.3	16.3	20.4	22.0	37.2	19.4	8.5	19.3	19.5	19.9	21.5	19.3	13.9	22.1	14.6	23.7	28.0	12.7	23.2	24.2	27.6	19.5	9.8	21.4	41.1	21.4	9.1	19.2	18.9	12.1	42.1	17.2	21.8	15.9	20.3	10.3	23.8	10.6	18.2	15.7	13.9	6.4	14.2	2.5	5.9	7.1	5.0	3.7	23.1	23.1	10.6	25.7	21.3	13.3	12.6	15.0	14.0	16.5	20.1	18.8	22.3	9.5	14.7	12.0	9.4	27.7	10.0	15.3	6.1	15.0	9.0	6.6	8.2	18.0	27.3	6.6	10.2	20.3	9.7	14.3	8.7	13.5	11.2	10.6	15.0	10.8	9.5	27.8	8.8	12.8	17.3	12.0	7.8	11.0	7.7	14.4	20.3	20.6	15.0	19.8	9.5	22.9	12.6	7.7	22.4	17.3	11.9	20.3	14.1	36.3	15.8	26.3	25.9	8.5	26.9	11.1	13.0	1.9	5.2	2.0	5.0	5.9	2.7	6.4	3.5	3.2	5.7	4.6	2.1	3.7	2.5	7.1	5.0	14.2	2.7	3.7	17.1	21.7	16.5	28.2	19.3	19.5	22.1	14.6	27.6	20.3	8.9	8.2	23.1	21.9	15.1	18.6	2.2	17.8	10.7	5.7	47.1	70.7	33.6	6.6	18.8	0.6	14.4	42.4	23.3	11.0	30.8	21.6	30.1	17.3	10.4	33.3	20.6	18.0	14.7	18.8	0.4	20.1	12.3	20.3	15.4	27.2	30.6	13.6	20.1	16.3	9.0	49.3	0.0	10.8	16.3	29.8	17.7	49.3	13.3	21.0	23.3
SCAND1	"RAZ1, SDP1"	ENSG00000171222	"SCAN domain containing 1"	P57086	20	35953617-35959472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 56.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071335			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA071335: "	"unprognostic (3.88e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.15e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.48e-2)"	38.7	31.8	23.5	25.4	22.0	50.3	21.6	13.7	37.7	18.1	30.3	12.3	22.4	45.3	19.3	32.8	21.0	17.0	27.1	19.8	21.6	22.7	30.7	39.6	18.0	26.5	21.0	18.4	19.8	30.7	8.8	21.2	16.9	14.5	26.8	7.2	19.1	36.2	27.8	50.7	19.5	35.4	15.4	16.5	31.9	40.6	23.8	13.4	34.8	26.8	26.2	15.9	14.8	17.3	42.0	60.9	70.6	61.6	30.4	47.2	43.2	13.1	9.8	3.9	7.4	2.0	2.4	24.7	9.2	3.7	4.0	4.7	9.0	9.8	10.2	23.9	1.5	5.0	12.4	0.8	4.3	0.5	3.6	21.9	25.2	5.3	19.3	7.1	7.9	10.4	4.3	3.5	3.3	0.7	2.2	6.5	10.4	10.9	8.2	2.4	13.3	22.1	56.0	13.0	4.9	38.7	16.8	11.9	16.6	3.9	5.2	19.0	28.1	15.2	24.2	20.4	0.5	16.5	15.0	12.9	13.6	12.2	13.1	9.0	24.5	12.0	14.4	15.8	8.5	10.5	70.6	61.6	57.3	35.1	40.9	27.7	36.6	35.0	30.9	45.8	42.0	29.7	29.0	53.3	30.4	39.6	60.9	47.2	43.2	23.5	22.0	13.7	37.7	21.6	22.7	21.0	18.4	14.5	13.4	29.8	61.8	122.1	143.1	53.2	63.9	37.9	122.3	99.0	58.0	157.1	41.2	128.1	263.6	209.3	325.6	135.4	382.5	140.2	293.5	148.6	101.5	133.3	68.1	259.8	180.5	49.3	270.0	173.1	196.2	55.7	109.9	114.4	99.5	165.1	166.0	123.3	251.1	354.2	94.0	414.6	67.4	109.9	81.1	93.9	35.3	65.6	137.0	117.1	137.4	182.1
SCAPER	"Zfp291, ZNF291"	ENSG00000140386	"S-phase cyclin A associated protein in the ER"	Q9BY12	15	76347904-76905444	"Predicted intracellular proteins"			"Disease mutation, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 237.6;Rod photoreceptor cells: 661.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046253, HPA048077"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	No			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA046253: AB_2679600, HPA048077: "	"unprognostic (3.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.69e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.89e-3)"	9.0	10.9	17.0	9.3	15.6	8.8	9.4	26.0	20.7	10.3	8.3	10.7	9.8	8.9	10.0	10.8	12.1	9.0	7.5	17.8	15.9	17.2	12.6	9.9	8.4	7.1	17.3	13.2	16.8	10.9	24.1	36.3	24.6	15.6	9.9	6.3	7.7	9.7	9.5	17.9	9.8	8.3	10.4	20.6	7.5	7.9	25.7	14.7	12.6	16.3	8.7	7.7	9.4	9.5	13.2	6.6	20.4	4.6	12.0	14.3	2.8	5.0	4.7	6.6	3.8	3.3	6.2	5.5	7.0	4.9	3.2	4.6	5.0	4.1	5.1	6.1	2.3	8.6	5.5	15.5	2.9	4.8	11.9	7.6	2.7	5.7	2.4	4.3	7.2	6.4	5.1	5.2	3.8	6.2	7.0	4.3	10.5	3.8	14.6	5.5	2.1	7.0	2.2	2.0	4.7	2.8	6.4	10.5	1.8	2.9	5.2	15.7	7.6	9.2	3.2	7.5	8.4	4.8	6.0	5.2	7.4	6.9	3.5	6.0	8.9	18.6	7.6	4.3	9.1	4.9	20.4	4.6	11.5	8.6	2.5	9.8	11.0	8.7	7.6	2.5	13.2	14.3	9.1	7.7	12.0	2.9	6.6	6.6	2.8	17.0	15.6	26.0	17.1	15.9	17.2	17.3	13.2	15.6	14.7	92.3	52.8	16.4	22.9	18.3	84.2	167.4	15.3	16.0	40.9	12.2	237.6	23.7	1.7	11.6	45.9	22.0	20.2	0.0	5.1	9.4	13.4	12.1	20.9	7.9	11.7	73.1	15.5	19.0	11.0	17.8	19.0	10.3	10.1	3.6	7.7	46.4	5.9	11.6	18.0	5.7	661.5	19.4	11.7	121.4	69.5	16.4	43.5	21.2	12.4	19.7
SCARB1	"CD36L1, CLA-1, CLA1, SR-BI, SRB1"	ENSG00000073060	"Scavenger receptor class B member 1"	Q8WTV0	12	124776856-124882668	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 173.1;liver: 93.7;placenta: 65.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 24.9;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066285, CAB070124, HPA072449"	Enhanced		Approved	"Vesicles,Lysosomes,Rods & Rings"		NA	NA			Vesicles	"Lysosomes, Rods & Rings"	"CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201"	"unprognostic (9.70e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.21e-3)"	"prognostic unfavorable (1.83e-5)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (3.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"	21.2	173.1	7.9	3.5	21.4	1.8	25.0	4.3	10.1	4.7	28.6	13.4	1.1	8.8	4.3	3.5	2.8	4.7	8.0	3.2	7.4	5.1	2.2	93.7	5.8	5.3	6.3	5.1	14.3	2.9	3.3	4.4	65.9	9.4	4.3	4.9	10.7	8.6	2.3	3.0	6.3	21.3	4.4	5.7	5.0	2.7	7.7	11.4	0.5	4.0	1.1	5.6	3.6	10.0	3.1	24.9	1.2	6.5	0.2	0.4	2.5	9.3	22.6	7.4	29.1	4.9	10.5	0.0	6.6	7.5	8.2	5.2	27.0	29.9	27.0	19.0	4.4	13.4	14.2	18.8	44.3	3.9	12.9	18.9	7.6	22.4	43.5	16.6	13.0	6.6	17.9	9.0	15.6	11.1	14.0	22.3	4.9	14.3	11.6	1.5	18.5	4.0	17.4	6.7	11.6	23.4	16.9	5.9	53.9	0.7	13.1	13.9	5.4	35.8	48.4	33.5	4.5	27.1	14.7	2.1	1.3	8.8	6.6	10.1	2.7	1.1	4.4	5.3	15.8	12.8	0.0	6.5	0.0	0.2	3.7	0.2	3.1	0.1	0.4	8.2	1.7	0.1	0.1	1.2	0.2	0.5	24.9	0.0	2.5	7.9	21.4	4.3	10.1	7.4	5.1	6.3	5.1	9.4	11.4	3.0	2.4	18.5	3.1	4.9	5.0	4.8	12.7	4.0	1.2	3.5	27.5	8.8	3.3	5.1	13.9	11.2	9.2	23.3	6.6	9.3	5.9	10.5	1.1	105.2	42.5	15.9	10.3	15.4	14.0	10.8	8.3	10.1	45.5	5.4	14.0	52.5	5.9	14.2	4.9	2.4	7.4	0.0	2.1	27.8	1.7	2.8	36.3	2.5	8.8	3.8
SCARB2	"CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII"	ENSG00000138760	"Scavenger receptor class B member 2"	Q14108	4	76158733-76234536	"Disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 18.3;granulocytes: 6.2;monocytes: 15.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 88.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015415, HPA018014"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB015415: AB_831511, HPA018014: AB_1852881"	"prognostic unfavorable (2.82e-5)"	"unprognostic (2.73e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.89e-2)"	33.6	20.6	30.7	13.0	32.9	4.1	34.1	22.9	42.8	40.1	34.9	63.7	21.4	22.7	26.8	37.0	20.3	24.9	34.5	29.7	35.7	30.3	29.0	51.6	43.8	21.7	43.9	31.6	37.0	32.3	47.5	14.5	41.0	44.1	44.2	32.7	23.1	40.3	34.1	54.3	16.5	27.6	24.4	70.5	26.7	36.1	16.1	40.7	6.2	39.2	16.5	10.8	31.7	40.3	2.6	18.3	6.2	15.3	0.7	3.0	3.6	5.7	4.6	7.2	13.9	88.2	43.1	6.1	19.3	44.4	16.9	31.4	8.2	15.9	0.0	15.3	41.3	16.3	4.9	5.1	12.0	17.9	24.8	5.8	0.5	4.2	3.9	21.6	3.0	2.0	31.9	12.1	17.9	10.3	39.3	30.2	1.5	2.7	29.2	26.0	8.8	0.2	0.6	1.7	17.1	4.5	3.6	14.7	4.9	11.9	3.8	17.1	17.7	16.5	11.5	16.7	9.4	5.2	3.0	19.9	17.1	8.6	14.1	6.0	27.1	17.0	0.0	19.9	3.9	25.2	6.2	8.8	2.1	1.8	15.3	1.9	2.6	1.5	1.1	5.2	2.0	1.8	3.0	1.5	0.7	14.7	18.3	1.8	3.6	30.7	32.9	22.9	41.1	35.7	30.3	43.9	31.6	44.1	40.7	163.8	38.3	16.4	69.4	21.3	92.5	50.2	96.8	45.5	37.5	94.2	56.9	29.5	6.6	100.8	5.0	72.9	82.1	0.0	63.0	42.1	60.9	149.5	3.5	90.6	138.6	57.2	98.3	91.4	117.9	2.9	42.0	58.7	64.1	26.2	73.9	73.8	79.5	66.0	62.6	27.2	69.7	90.5	54.8	3.4	13.2	29.5	49.7	10.5	48.8	82.4
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724047-246768137	"Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 95.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 1022.4;Spermatocytes: 461.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	17	"basophil: 95.3"	"Lineage enriched"	"Detected in all"	22	"granulocytes: 95.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 53.5"	"Low region specificity"	"Detected in all"							"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		NA	NA		2100000	Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	14.1	25.8	15.7	6.4	17.5	13.4	11.3	11.3	20.5	10.9	11.7	24.7	8.5	15.1	12.0	8.5	4.8	14.4	9.7	15.8	15.6	19.8	23.0	67.3	9.3	7.3	26.1	15.0	10.6	12.7	15.0	12.7	14.1	21.7	18.1	12.2	7.3	7.4	16.7	23.9	10.7	15.3	10.8	62.1	5.1	12.4	65.1	17.5	8.5	18.2	7.3	4.8	25.0	13.2	1.4	2.3	95.3	3.2	4.2	3.0	2.1	13.1	12.8	9.4	5.6	11.3	14.2	0.1	10.3	14.4	17.4	14.6	7.8	37.0	7.0	13.5	11.8	9.7	4.3	7.9	3.0	17.9	9.7	2.9	11.8	11.7	15.6	10.6	22.9	10.2	9.5	1.4	11.8	1.2	16.5	18.6	14.7	14.7	0.0	17.3	3.1	23.8	29.1	14.1	7.1	10.2	20.1	12.1	0.0	53.5	30.9	10.7	12.0	13.9	0.6	9.1	5.2	10.4	23.9	12.1	8.1	7.2	19.6	26.5	34.7	11.9	4.1	13.8	31.3	10.6	95.3	3.2	5.5	2.5	2.8	3.0	1.4	0.7	2.1	1.3	1.1	1.0	3.0	0.8	4.2	1.8	2.3	0.5	2.1	15.7	17.5	11.3	20.5	15.6	19.8	26.1	15.0	21.7	17.5	6.0	11.5	8.0	36.7	26.8	29.6	33.1	50.9	52.2	17.0	144.8	17.7	28.0	26.6	57.2	1022.4	20.2	47.9	0.0	61.3	13.6	42.0	76.7	57.5	163.4	83.3	6.4	43.0	21.5	44.3	154.3	44.0	20.4	45.5	15.4	25.1	52.2	56.6	28.1	44.6	51.6	30.6	19.4	27.8	461.4	68.6	59.8	70.7	16.7	53.2	149.1
SCFD1	"C14orf163, KIAA0917, RA410, SLY1, STXBP1L2"	ENSG00000092108	"Sec1 family domain containing 1"	Q8WVM8	14	30622112-30735812	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003579	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		59000	Nucleoplasm	Cytosol	"HPA003579: AB_1079872"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.32e-2)"	22.4	22.7	20.6	17.6	29.7	15.5	21.7	21.9	28.1	27.7	20.0	12.6	19.3	17.1	20.5	23.3	25.9	19.0	13.4	20.9	19.2	17.8	24.5	33.9	18.8	16.6	16.5	19.4	21.8	33.8	28.5	68.5	29.4	26.0	20.3	21.9	14.5	34.5	22.3	24.7	15.7	22.0	19.6	15.6	20.4	18.8	18.8	17.1	24.4	31.0	18.0	19.0	17.2	22.3	14.3	16.3	18.8	17.2	19.4	15.9	9.2	24.4	10.6	13.6	9.0	22.4	25.3	19.8	18.3	25.5	27.0	32.1	17.2	18.5	13.5	8.8	28.9	12.0	14.2	16.7	19.3	31.5	18.9	9.2	9.3	14.9	58.0	28.1	17.4	12.1	18.8	14.8	16.6	28.3	19.2	18.3	8.5	15.3	25.8	26.6	28.8	10.7	10.1	13.0	24.3	18.7	9.4	14.9	16.3	21.8	21.2	14.2	11.9	17.7	17.7	18.1	14.4	25.9	13.0	14.7	18.7	14.4	15.6	15.2	17.8	16.6	18.5	8.8	13.5	19.4	18.8	13.4	15.6	9.6	14.4	12.4	14.3	11.1	12.0	16.3	12.3	10.5	10.7	4.3	19.4	17.2	13.3	15.9	9.2	20.6	29.7	21.9	28.1	19.2	17.8	16.5	19.4	26.0	17.1	47.6	25.3	39.5	46.3	22.1	34.1	32.1	20.4	52.2	36.4	24.4	41.2	55.2	54.7	40.9	20.1	30.2	26.5	23.3	44.2	52.3	39.9	39.2	51.0	18.5	40.8	28.6	45.3	22.1	24.6	13.2	35.6	40.1	35.4	67.7	33.2	29.7	37.5	25.9	37.8	30.5	39.0	12.9	31.2	66.2	51.7	21.3	69.5	39.9	24.8	40.0
SCFD2	"FLJ39514, STXBP1L1"	ENSG00000184178	"Sec1 family domain containing 2"	Q8WU76	4	52872982-53366075	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036526, HPA036527"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036526: AB_10673499, HPA036527: AB_2675175"	"unprognostic (1.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.81e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.51e-2)"	13.7	19.4	11.0	15.8	15.1	12.5	13.7	7.8	17.6	12.9	11.7	16.2	6.5	10.5	14.2	9.0	16.7	9.9	10.0	11.9	11.5	13.2	13.6	17.2	10.4	12.7	15.7	9.3	13.2	18.3	11.4	15.3	11.2	16.4	8.7	11.8	10.5	13.0	10.4	13.8	13.5	10.7	14.2	13.2	12.7	10.6	5.1	12.4	16.2	10.1	10.2	19.3	10.4	12.1	6.5	15.9	1.4	9.7	13.9	9.5	9.1	6.6	6.2	3.6	8.3	11.9	12.1	4.4	15.5	11.7	5.4	4.6	4.4	8.6	12.7	12.0	29.5	5.7	4.2	11.5	13.5	10.4	3.9	6.7	7.1	6.6	5.3	5.6	8.4	13.1	8.3	8.2	10.4	4.1	5.2	9.1	3.4	12.0	7.4	9.2	7.7	12.4	5.4	2.1	19.1	7.8	7.7	3.3	13.4	6.0	4.5	10.3	5.8	3.5	13.1	6.9	4.3	5.1	4.1	8.4	11.8	7.5	13.3	11.3	8.7	4.7	15.0	8.0	10.5	33.5	0.0	5.6	1.4	7.8	9.7	7.8	6.5	6.4	8.8	15.9	5.7	9.5	8.6	1.2	13.9	9.3	10.3	5.5	9.1	11.0	15.1	7.8	16.9	11.5	13.2	15.7	9.3	16.4	12.4	0.0	1.9	7.5	4.6	3.3	3.3	2.8	15.3	5.3	0.0	3.5	5.9	6.7	1.7	3.5	1.8	3.0	2.2	0.0	4.5	6.2	5.1	2.5	12.7	5.3	4.7	4.8	1.2	3.1	2.7	1.7	6.1	3.9	5.0	0.0	3.0	3.8	2.2	2.9	5.3	5.4	3.2	0.0	3.1	4.3	3.2	4.6	3.5	4.4	4.0	1.8
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602503	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 124.4;Intestinal endocrine cells: 272.8"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 25.5;HSkMC: 21.8;hTERT-RPE1: 21.8;SCLC-21H: 22.2;SH-SY5Y: 9.7;WM-115: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		54000	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	3.5	133.0	13.3	11.0	94.1	0.9	0.9	5.6	55.9	1.4	5.4	5.8	0.0	17.3	2.1	0.9	1.0	0.8	2.2	1.4	10.5	79.4	1.0	0.8	1.9	0.9	21.7	11.0	1.3	10.7	1.1	76.5	1.1	57.7	2.1	5.5	1.5	0.9	1.3	0.8	1.0	8.0	5.2	10.3	0.8	8.0	0.9	5.0	0.0	3.1	0.0	0.8	1.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.8	4.0	1.1	25.5	0.1	0.2	0.9	1.8	4.7	0.2	0.4	0.0	0.4	0.3	2.9	0.1	0.1	0.0	2.4	0.0	0.2	0.0	0.2	0.0	0.3	0.3	2.1	21.8	0.1	2.7	0.9	21.8	0.0	0.0	0.1	0.2	2.3	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	22.2	9.7	0.0	0.2	1.1	0.8	0.0	0.0	0.0	2.5	1.0	0.1	1.6	0.0	0.0	0.1	0.7	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.3	94.1	5.6	23.0	10.5	79.4	21.7	11.0	57.7	5.0	6.0	0.0	0.0	0.2	0.0	124.4	0.2	0.0	1.4	2.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	0.0	0.0	0.1	7.9	272.8	1.3	0.8	0.0	0.6	0.0	1.7	0.0	0.7	11.9	24.2	2.9	0.4	0.0	12.7	0.0	0.5	0.1	0.2	0.1	0.1	0.0	0.3	0.6
SCGB2A1	"LPHC, MGB2, MGC71973, UGB3"	ENSG00000124939	"Secretoglobin family 2A member 1"	O75556	11	62208668-62213939	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 191.8;epididymis: 135.9"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 61.1;Ciliated cells: 107.1;Glandular cells: 36.8;Intestinal endocrine cells: 35.6;Mucus-secreting cells: 60.0"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 971.9;ovarian cancer: 208.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 14.0"									HPA034584	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA034584: AB_10602221"	"unprognostic (7.73e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (1.22e-4)"	"prognostic favorable (1.54e-8)"		"unprognostic (2.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.87e-3)"	"prognostic favorable (6.36e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.35e-1)"	0.2	0.0	0.2	0.5	0.2	0.0	6.8	0.2	0.3	191.8	1.0	0.3	20.8	0.0	40.8	135.9	1.0	28.7	2.5	0.4	0.2	0.3	1.2	0.4	0.9	0.2	0.2	0.3	5.6	2.2	0.0	1.5	0.7	0.5	1.2	1.3	0.2	18.8	1.4	0.2	2.3	0.3	0.2	0.2	0.2	4.3	4.5	0.2	0.3	0.8	1.1	3.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.1	0.0	1.1	0.2	0.0	2.6	0.6	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.5	0.2	0.0	3.7	0.0	4.1	0.1	0.0	0.0	61.1	107.1	11.4	15.7	0.0	0.1	3.3	4.8	0.0	0.0	2.6	0.0	4.7	0.0	0.0	36.8	0.0	0.0	3.7	0.0	35.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	60.0	0.0	14.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.4	3.9
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 11.3;Horizontal cells: 14.3"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	58	"dendritic cells: 9.7;granulocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;AN3-CA: 17.3;HUVEC TERT2: 20.5;NTERA-2: 10.5;SH-SY5Y: 59.6"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	3.9	30.1	1.5	22.0	2.0	1.9	23.9	55.0	3.7	3.6	21.1	0.0	2.2	4.7	2.0	4.2	3.4	3.0	65.9	29.6	17.9	3.5	1.9	3.1	1.7	22.8	24.1	1.8	1.6	1.4	6.0	10.3	15.6	6.2	2.3	0.7	2.9	2.6	54.5	1.4	1.9	5.9	28.9	5.1	2.0	2.7	24.3	0.0	2.0	7.6	1.6	1.9	0.6	0.0	9.7	3.1	0.0	0.1	0.0	0.1	0.0	0.0	9.5	17.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.4	0.1	4.0	0.1	20.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	59.6	0.0	0.0	0.0	2.6	0.0	1.0	3.7	0.2	0.5	0.1	0.8	0.7	0.0	0.0	0.2	0.7	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.1	30.1	22.0	23.9	28.9	29.6	17.9	22.8	24.1	15.6	24.3	6.0	1.7	0.0	4.6	0.3	4.2	11.3	0.0	4.0	3.4	3.5	2.0	1.0	0.0	0.2	0.0	4.6	0.0	0.0	0.2	0.4	0.6	0.5	0.0	0.5	0.2	14.3	0.0	1.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	4.9	0.9	0.0	0.0	0.7	0.5	0.0	1.8	0.0	0.4	0.5	0.7	0.0	0.0	1.4
SCMH1	Scml3	ENSG00000010803	"Scm polycomb group protein homolog 1"	Q96GD3	1	41027200-41242154	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048898, HPA053292"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA048898: , HPA053292: AB_2797246"	"unprognostic (6.02e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (5.80e-4)"	12.5	13.1	14.7	18.2	15.3	11.2	21.3	15.9	13.9	15.8	27.9	6.7	23.4	9.0	21.4	16.7	11.1	16.5	17.2	27.2	12.6	8.8	14.8	9.5	11.4	10.5	7.6	12.5	24.8	30.2	26.5	23.0	7.8	10.7	22.7	12.6	16.8	19.2	23.8	28.4	8.4	12.7	36.9	7.4	8.7	18.5	26.6	6.7	11.3	14.3	11.1	8.3	22.7	25.7	4.3	7.6	2.2	2.2	2.9	4.2	1.7	9.0	6.1	14.5	13.3	6.7	12.7	0.0	7.3	12.8	12.3	12.8	5.8	11.7	16.6	5.6	13.2	10.3	2.3	11.2	9.8	10.6	11.4	8.5	7.7	8.2	14.4	29.0	16.5	12.8	13.8	10.0	8.1	19.8	14.9	12.3	20.7	7.2	12.9	12.0	4.9	16.5	14.3	13.3	7.7	6.5	18.3	15.2	9.8	9.8	11.4	10.2	11.0	12.7	10.2	10.5	10.3	9.0	42.5	9.0	12.9	10.1	7.9	13.3	13.2	7.4	18.1	8.1	14.8	11.7	1.3	1.2	2.2	3.3	2.2	4.2	4.3	3.9	3.1	3.7	2.1	2.9	2.4	0.0	2.9	0.5	7.6	2.7	1.7	14.7	15.3	15.9	13.9	12.6	8.8	7.6	12.5	10.7	6.7	8.9	6.7	8.0	23.8	6.0	13.8	13.5	10.2	4.0	7.9	12.2	15.7	6.7	1.7	8.8	7.2	6.8	7.8	0.0	18.3	2.6	8.0	20.7	4.7	4.7	5.2	7.9	8.1	6.7	4.8	9.4	15.3	3.1	8.5	2.8	6.2	6.0	11.3	3.5	17.0	11.5	13.5	19.4	8.0	50.0	28.6	3.1	4.0	4.8	11.7	11.9
SCML1		ENSG00000047634	"Scm polycomb group protein like 1"	Q9UN30	X	17737449-17754988	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 214.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 17.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 39.9"									"HPA035270, HPA035271, HPA061397"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035270: AB_10672860, HPA035271: AB_10602795, HPA061397: AB_2684503"	"unprognostic (6.36e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-3)"	12.6	12.1	5.9	6.7	6.2	3.1	9.6	5.5	7.7	9.6	10.7	6.7	13.5	8.8	10.4	8.3	6.8	7.2	6.2	7.2	6.4	4.6	7.8	30.4	11.9	8.2	5.1	4.1	19.6	7.4	4.1	8.8	10.9	9.5	8.5	8.3	12.7	7.1	15.0	19.5	6.2	8.5	11.1	8.0	7.9	6.0	35.4	4.3	6.3	5.2	7.3	6.1	11.5	7.6	3.5	2.2	0.8	3.2	8.0	17.1	2.1	10.2	2.8	8.8	3.0	8.4	11.1	1.0	10.0	9.7	11.1	14.2	5.8	4.7	0.0	4.4	6.9	7.2	5.9	11.5	7.1	16.5	0.0	22.7	0.8	8.0	11.3	11.3	0.0	5.5	7.4	6.5	14.6	10.9	2.4	0.1	4.0	1.6	0.0	10.1	3.2	0.0	0.0	1.4	7.6	11.1	0.0	4.6	4.6	4.4	2.5	1.8	2.3	4.6	0.0	3.8	5.3	1.6	0.2	5.2	10.7	4.4	39.9	6.5	6.2	5.6	0.0	8.7	0.9	3.0	0.0	1.1	0.7	0.2	2.9	0.2	1.3	2.9	0.3	2.2	3.5	17.1	8.0	0.8	8.0	3.2	0.5	0.4	2.1	5.9	6.2	5.5	7.7	6.4	4.6	5.1	4.1	9.5	4.3	17.9	22.6	10.3	31.8	84.3	54.6	21.8	5.1	8.1	17.0	15.7	64.8	4.1	8.3	4.9	20.6	22.7	19.6	0.0	7.6	1.9	35.3	28.9	10.4	52.5	16.1	36.5	10.9	14.1	12.9	14.8	55.0	17.0	27.0	3.6	17.7	32.4	4.8	21.6	32.2	4.4	85.4	51.8	45.3	214.3	49.6	99.6	4.7	5.7	32.0	23.7
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239314-18354727	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Spermatocytes: 22.8;Spermatogonia: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 7.0"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 20.0;REH: 17.8"					"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: AB_2685333"	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	2.4	7.7	3.1	2.1	4.1	8.6	3.1	3.4	3.8	3.7	3.7	3.7	2.0	2.1	4.9	2.5	2.3	2.9	2.8	2.0	2.3	2.0	1.5	2.6	1.3	2.0	3.6	0.5	9.5	3.9	3.2	8.0	7.1	2.3	2.9	2.3	3.6	10.0	2.2	2.0	3.4	2.0	6.5	2.2	2.3	1.7	19.0	4.2	12.5	4.3	2.3	2.1	2.7	4.2	0.8	7.0	0.2	0.2	0.9	0.7	0.2	0.9	3.3	11.8	3.0	0.9	1.5	3.5	2.0	1.4	4.0	4.5	4.8	0.7	0.0	0.4	0.9	2.9	0.0	16.5	0.2	4.9	0.0	13.5	0.0	3.0	2.1	0.5	10.3	2.7	0.6	0.6	2.9	3.4	1.0	0.2	10.5	7.7	0.0	2.8	1.5	16.5	5.5	20.0	0.3	4.2	17.8	5.9	2.4	0.0	0.2	7.2	8.4	3.5	3.3	0.0	13.6	4.2	4.6	0.3	3.6	2.6	8.0	1.8	0.0	9.4	16.6	1.2	7.1	2.7	0.0	0.2	0.2	0.7	0.2	0.7	0.2	0.3	0.2	0.9	0.8	0.2	0.1	0.2	0.9	0.1	7.0	0.0	0.2	3.1	4.1	3.4	3.8	2.3	2.0	3.6	0.5	2.3	4.2	0.0	0.3	0.8	1.0	3.2	2.2	1.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.3	1.3	0.7	0.0	0.9	1.5	6.4	1.2	0.0	0.0	1.1	1.7	0.0	0.0	0.0	0.5	2.1	0.3	0.0	1.1	0.6	3.6	0.0	0.4	22.8	28.0	3.6	0.3	0.0	1.2	0.3
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107704104-107824317	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.3;lymphoid tissue: 24.6"	"Group enriched"	"Detected in many"	21	"Early spermatids: 71.9;Late spermatids: 104.1;T-cells: 35.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"gdT-cell: 19.5;MAIT T-cell: 18.0;memory CD4 T-cell: 27.3;memory CD8 T-cell: 24.3;naive CD4 T-cell: 26.9;naive CD8 T-cell: 23.9;NK-cell: 17.6"	"Group enriched"	"Detected in many"	5	"NK-cells: 17.6;T-cells: 27.3"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 37.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA063326, HPA065958"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063326: AB_2684986, HPA065958: AB_2685587"	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	1.3	0.6	0.5	13.9	0.6	2.7	1.4	0.3	0.5	1.2	5.4	0.3	0.3	10.1	0.9	4.9	1.3	1.2	2.4	0.6	1.7	0.9	1.7	2.7	3.2	24.6	0.4	0.0	0.7	1.4	0.0	3.9	0.3	0.5	1.2	2.1	1.6	5.7	0.0	0.3	0.9	12.4	0.4	0.9	11.5	2.4	10.4	0.2	23.9	1.5	1.3	24.5	2.3	1.3	4.5	0.3	3.6	0.1	17.6	27.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	2.1	19.5	0.0	18.0	4.5	27.3	24.3	0.0	3.5	26.9	23.9	3.6	17.6	0.1	0.3	2.6	9.4	0.5	0.6	0.3	0.5	1.7	0.9	0.4	0.0	0.5	0.2	0.0	0.0	0.9	0.0	1.3	0.0	0.8	0.0	1.4	0.0	0.0	0.0	1.0	0.0	0.6	71.9	0.3	1.0	0.0	0.0	0.0	0.6	0.0	1.1	1.7	0.2	1.6	0.0	1.3	0.0	104.1	0.9	0.8	3.3	1.0	1.6	0.0	0.1	0.3	0.7	0.0	0.0	0.0	1.0	1.1	0.5	0.1	0.1	35.9	2.9	0.0
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 33.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 26.9;Bipolar cells: 33.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 11.6;Hep G2: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	1.1	1.3	5.2	1.1	13.6	1.0	1.1	10.3	26.6	1.1	1.1	2.3	0.0	1.0	1.1	1.1	1.0	6.8	1.0	1.1	6.9	8.3	1.1	1.1	5.6	1.0	5.7	9.7	1.0	1.0	1.1	2.9	1.2	33.9	1.1	1.1	0.3	1.0	1.0	1.2	1.1	1.1	1.1	3.6	1.1	1.1	1.4	4.2	0.0	1.1	0.0	1.0	1.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	11.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.2	13.6	10.3	26.6	6.9	8.3	5.7	9.7	33.9	4.2	6.0	26.9	0.0	0.0	0.0	33.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SCN3B	HSA243396	ENSG00000166257	"Sodium voltage-gated channel beta subunit 3"	Q9NY72	11	123629187-123655244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 70.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 15.3;Early spermatids: 12.8;Horizontal cells: 19.1;Late spermatids: 24.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 9.6;RH-30: 4.3;SCLC-21H: 9.5;SH-SY5Y: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041707			Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA041707: AB_2732493"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.13e-4)"	"unprognostic (3.93e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.29e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.34e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.16e-4)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.43e-2)"	2.2	8.5	17.7	1.5	23.5	1.3	2.0	2.8	70.3	1.6	1.5	1.2	0.0	1.6	1.5	1.5	1.5	1.8	1.4	1.9	26.2	13.2	1.6	1.0	1.4	1.2	5.2	18.8	1.7	1.9	3.9	12.6	1.1	3.8	1.8	1.6	3.7	1.2	1.4	5.8	1.7	1.5	2.1	1.5	1.3	1.4	2.2	1.2	0.0	3.7	0.0	1.2	1.1	0.4	1.2	1.3	2.7	0.6	1.1	0.8	0.1	0.0	0.2	0.3	0.2	0.1	0.1	0.3	0.2	0.3	0.0	0.0	3.0	0.1	0.3	1.5	0.4	3.1	0.2	1.0	0.1	0.2	0.1	0.6	0.0	0.5	0.3	0.1	0.0	0.6	0.4	9.6	0.1	0.1	0.0	0.3	0.3	0.4	0.5	0.0	0.1	0.1	0.2	0.8	0.3	0.1	0.2	4.3	0.0	0.0	0.2	9.5	7.2	0.6	0.1	0.0	1.0	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.6	0.6	0.5	0.6	0.4	0.4	0.7	0.7	0.7	0.3	1.2	0.5	0.8	2.7	1.1	0.5	1.3	0.4	0.1	17.7	23.5	2.8	39.5	26.2	13.2	5.2	18.8	3.8	1.2	0.0	0.3	0.0	0.8	5.0	15.3	1.4	0.0	0.0	0.0	1.8	5.9	0.1	0.0	0.3	12.8	8.7	0.0	0.0	0.9	0.1	1.1	1.0	0.0	0.0	0.2	19.1	4.1	0.6	0.0	24.3	0.0	0.5	0.0	0.0	0.0	8.3	0.4	0.0	0.4	0.1	5.9	6.5	0.7	0.3	1.5	4.8	0.0	0.0	0.0	0.4
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 53.7"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 3.4;Ito cells: 3.1;Late spermatids: 2.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"					"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Group enriched"	"Detected in some"	11	"REH: 10.1;RH-30: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	5.9	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.3	0.3	0.0		0.1	0.0		0.5	0.0	53.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4			1.6		0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	10.1	31.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 66.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 22.0;RH-30: 18.3"	"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.9	0.9	2.7	0.0	0.4	0.0	1.2	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	1.7	3.6	0.4	0.0	0.0	22.0	1.1	0.0	0.0	2.0	0.0	0.0	0.0	18.3	0.0	0.0	2.4	0.3	2.4	0.0	0.0	0.0	0.7	0.0	0.0	4.4	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	3.1	66.1	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.3	0.9	0.0	0.0	0.0	0.0	1.0
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 27.6;pituitary gland: 9.7"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 13.7;Cone photoreceptor cells: 9.8;Intestinal endocrine cells: 10.9;Rod photoreceptor cells: 10.5;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 12.0;ASC TERT1: 12.7;BJ hTERT+: 11.2;WM-115: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	1.1	3.0	9.1	1.5	18.1	1.9	1.9	16.7	27.6	1.0	2.0	1.6	0.0	1.1	1.5	2.0	0.9	1.1	2.5	0.9	12.6	4.5	1.9	4.3	1.0	1.3	3.2	13.7	1.8	3.2	1.5	9.7	0.9	14.8	1.8	2.5	0.9	1.7	1.2	1.0	1.1	1.2	1.0	2.2	1.7	2.7	3.8	1.6	0.0	1.7	0.0	1.2	1.0	0.6	0.4	0.2	0.0	0.0	0.0	1.0	0.0	1.4	1.0	12.0	0.1	1.6	12.7	0.2	6.8	11.2	7.9	7.3	2.0	1.4	0.3	1.6	8.9	3.5	0.0	1.9	0.0	9.3	1.2	0.6	0.1	0.1	0.2	0.1	0.2	0.9	1.7	0.0	5.2	1.1	3.1	8.4	2.8	0.1	0.1	4.9	0.8	2.0	0.1	4.1	0.7	3.8	0.0	0.6	0.0	0.0	0.4	4.8	2.0	3.5	1.8	0.2	1.8	0.3	0.1	2.2	7.7	5.1	2.8	4.3	0.1	0.1	0.0	1.5	1.6	11.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	1.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	9.1	18.1	16.7	25.0	12.6	4.5	3.2	13.7	14.8	1.6	0.0	0.0	0.0	0.4	0.0	13.7	1.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.2	0.0	3.4	0.0	4.8	10.9	1.3	0.0	0.2	0.0	0.0	0.0	0.0	1.3	5.3	0.5	0.0	0.7	0.5	10.5	0.0	0.3	1.9	10.0	0.0	0.0	0.0	0.6	0.1
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 27.7;Hofbauer cells: 50.6;Intestinal endocrine cells: 31.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 18.6"	"Cell line enhanced"	"Detected in many"		"BJ: 17.2;BJ hTERT+: 12.8;HHSteC: 14.8;hTERT-RPE1: 12.0"	"Region enriched"	"Detected in some"	5	"hypothalamus: 10.9"	"Low region specificity"	"Detected in all"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	6.6	4.2	3.8	2.8	9.1	4.2	2.7	0.9	4.4	1.8	10.2	0.5	0.1	1.4	0.9	3.8	2.6	1.2	5.8	2.9	2.8	15.9	4.8	8.3	4.5	3.5	4.1	2.3	2.1	4.8	0.6	11.3	9.2	7.3	2.0	7.0	1.7	1.8	1.9	0.9	1.8	4.2	5.2	2.5	12.4	1.7	16.2	0.4	10.3	1.4	1.9	1.2	3.6	1.8	0.0	18.6	0.7	0.1	0.4	0.0	0.0	0.0	1.9	0.1	0.0	7.4	6.5	0.0	17.2	12.8	4.0	1.3	0.5	0.0	0.0	0.0	2.1	0.2	0.0	4.9	0.6	6.6	0.0	1.6	1.3	1.5	1.4	14.8	0.0	0.0	0.4	0.2	6.8	1.3	12.0	0.8	0.9	4.3	5.0	0.6	0.0	2.6	0.0	1.5	0.0	0.5	0.7	2.5	6.5	1.8	7.2	0.8	7.2	0.0	0.0	0.3	3.8	0.2	0.0	0.0	0.0	1.1	0.1	0.3	0.1	0.0	0.0	2.5	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.4	0.1	18.6	0.0	0.0	3.8	9.1	0.9	4.4	2.8	15.9	4.1	2.3	7.3	0.4	11.9	18.4	0.9	0.2	0.9	0.2	1.6	5.1	4.0	7.9	5.2	0.0	0.2	3.3	14.9	1.7	2.2	11.3	0.0	27.7	0.4	1.2	0.2	3.5	6.0	50.6	0.0	31.7	20.3	1.5	1.9	1.1	4.3	3.3	0.0	14.6	1.3	18.8	8.6	0.0	12.2	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.0	10.7	0.1
SCNM1	MGC3180	ENSG00000163156	"Sodium channel modifier 1"	Q9BWG6	1	151156664-151170297	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052439, HPA054324"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052439: AB_2681834, HPA054324: AB_2682451"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (2.17e-13)"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.71e-2)"	20.5	15.5	22.2	21.1	21.1	32.9	16.2	17.0	20.0	15.3	16.8	21.0	8.0	16.3	18.4	15.0	19.4	16.5	15.5	16.5	19.8	17.1	19.5	19.8	16.1	34.0	22.9	14.9	16.8	13.5	10.3	12.1	23.6	20.2	17.3	14.7	20.3	16.2	15.2	47.9	21.7	20.5	18.0	22.3	41.8	14.6	14.4	19.4	40.9	16.1	20.1	27.2	21.6	15.6	28.2	61.4	50.9	45.3	28.8	30.1	37.8	13.1	9.2	10.3	12.1	14.5	10.9	17.4	10.4	12.1	25.4	19.9	20.1	12.9	21.0	17.0	11.2	6.6	17.8	12.0	9.6	12.4	13.2	13.3	18.1	13.2	12.8	21.0	24.0	17.8	11.4	18.7	17.8	16.0	11.9	15.3	14.7	14.4	16.1	12.4	32.4	17.0	37.3	26.2	20.5	14.4	23.3	12.4	26.0	13.6	8.8	12.8	20.6	11.8	19.2	23.3	13.4	17.8	77.1	11.2	12.2	11.4	12.6	22.1	20.9	28.4	32.8	12.7	25.5	15.6	50.9	45.3	45.6	20.4	33.7	19.3	28.2	24.8	23.0	60.2	24.7	22.9	19.9	45.7	28.8	21.0	61.4	30.1	37.8	22.2	21.1	17.0	20.0	19.8	17.1	22.9	14.9	20.2	19.4	3.0	17.5	25.9	17.5	23.7	17.9	26.6	12.7	24.1	21.6	27.9	17.7	31.2	46.4	32.0	24.9	23.7	24.2	46.7	27.7	28.6	28.9	12.3	39.3	11.0	62.2	7.9	13.8	18.4	58.4	19.2	28.7	54.1	20.3	52.3	15.5	22.0	32.8	28.1	20.1	28.3	14.5	32.3	33.0	22.8	13.5	15.9	23.0	46.7	16.8	19.6
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 gamma subunit"	P51170	16	23182715-23216883	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.9;salivary gland: 26.8"	"Cell type enhanced"	"Detected in some"	29	"Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	7	"hTCEpi: 31.4;RT4: 14.2"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.8"	"Low region specificity"	"Detected in all"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	1.1	0.3	0.6	0.2	0.0	0.4	2.5	9.7	0.4	14.0	5.5	0.0	4.8	0.2	3.2	1.7	10.3	0.5	0.2	0.2	1.5	0.0	42.9	0.2	15.6	0.2	0.0	0.3	0.2	3.8	0.2	6.5	0.7	0.7	10.2	1.1	0.0	26.8	12.8	2.2	6.6	0.2	0.3	0.3	0.2	6.9	0.3	0.0	1.5	25.5	3.3	3.9	1.7	11.3	0.3	0.3	1.8	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	1.8	0.2	0.1	0.3	0.1	0.0	0.6	0.0	9.7	0.4	1.5	0.0	0.0	0.3	0.7	0.0	17.9	3.4	0.0	4.0	0.3	0.0	0.8	0.0	2.7	21.6	85.5	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4
SCO2	"MYP6, SCO1L"	ENSG00000130489	"SCO2, cytochrome c oxidase assembly protein"	O43819	22	50523568-50525606	"Disease related genes, Predicted membrane proteins"		Chaperone	"Cardiomyopathy, Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	296	"Cytotrophoblasts: 22.9;Extravillous trophoblasts: 29.8;Hofbauer cells: 52.1;Syncytiotrophoblasts: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046943, HPA056254"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046943: AB_2732536, HPA056254: AB_2683080"	"unprognostic (8.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.51e-2)"	13.0	11.6	8.8	20.6	9.0	27.9	16.6	15.2	14.7	8.1	25.1	4.5	7.9	21.6	7.4	9.0	19.7	22.9	10.1	19.7	8.8	10.9	21.3	28.0	14.9	12.3	7.4	11.3	8.0	18.4	2.6	8.9	10.0	7.2	7.7	6.6	5.5	22.1	4.6	9.9	14.3	18.8	8.1	8.0	13.9	8.9	8.4	5.0	6.9	12.2	13.8	14.1	10.1	6.9	17.4	23.8	7.0	7.9	11.7	22.1	15.1	15.0	14.3	6.9	9.2	6.8	9.3	10.4	10.2	8.2	13.5	11.8	17.6	8.5	20.4	7.9	8.0	8.6	17.9	7.0	11.8	2.4	5.8	38.3	6.5	22.0	23.1	15.8	17.2	12.7	13.8	17.9	6.9	5.9	5.7	8.9	6.1	7.3	27.9	5.7	28.1	8.5	34.6	7.1	11.0	23.6	14.1	8.8	22.9	10.2	10.6	10.4	12.8	11.5	32.7	23.4	3.2	12.7	16.5	10.7	11.8	11.4	13.2	11.1	13.3	6.7	9.1	16.1	13.3	10.0	5.2	6.3	2.9	22.1	7.3	20.9	17.4	18.6	21.8	10.6	15.4	14.6	17.0	7.0	11.7	7.9	23.8	15.4	15.1	8.8	9.0	15.2	14.7	8.8	10.9	7.4	11.3	7.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.0	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
SCO2		ENSG00000284194	"SCO2, cytochrome c oxidase assembly protein"		22	50523568-50526439	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 13.0"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 107.9;Paneth cells: 129.8;Suprabasal keratinocytes: 86.4"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 13.6"									"HPA046943, HPA056254"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046943: AB_2732536, HPA056254: AB_2683080"																		2.4	1.1	0.7	6.3	0.6	13.0	6.7	0.6	1.2	1.5	2.3	0.0	1.1	0.6	0.6	0.7	4.6	0.8	2.4	4.3	0.1		2.8	4.2	3.7	9.3	0.4	0.0	1.2	0.8	0.0	0.0	0.9	0.6	1.6	0.5	0.1	4.2	0.2	0.7	1.8	3.5	1.6	1.7	5.7	1.9	0.4	0.6	10.6	1.0	1.4	2.6	1.6	0.7	10.3	17.6	10.4	12.6	4.0	10.3	10.7	4.0	2.8	0.1	2.6	0.0	0.5	2.3	2.8	1.9	2.5	1.9	0.4	3.8	7.0	2.0	0.9	1.4	2.5	1.0	0.0	0.0	1.3	10.7	3.6	0.7	0.4	4.9	9.4	2.9	3.3	1.2	1.3	0.5	0.8	0.5	0.0	4.5	9.5	1.4	1.5	1.1	9.9	1.4	0.2	4.1	6.5	0.8	13.6	1.8	1.1	0.6	2.4	1.2	0.4	9.6	0.3	1.4	7.3	3.2	1.7	3.7	2.9	2.4	8.1	2.5	9.7	4.0	2.1	1.7	8.4	12.6	8.7	7.2	7.3	8.7	10.3	9.4	7.8	17.6	8.9	6.9	5.5	10.4	4.0	6.8	12.6	10.3	10.7											3.0	2.4	30.9	16.7	76.1	6.2	14.5	22.9	1.4	2.3	0.0	2.0	0.0	0.0	0.0	13.8	19.1	107.9	0.0	0.0	0.0	13.8	24.3	16.1	48.9	0.0	11.1	24.8	19.0	25.2	16.0	15.3	20.8	40.5	0.0	50.5	4.2	0.1	129.8	10.3	0.0	6.9	0.0	21.5	12.0	26.6	86.4	0.0	15.0	77.7	19.3
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 356.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	16.2	26.6	49.3	9.7	45.0	4.5	27.7	36.3	57.1	17.7	16.1	25.0	15.0	16.5	18.8	32.2	20.4	17.3	15.3	38.3	47.1	66.9	38.6	27.9	13.7	9.7	59.7	32.5	16.6	19.0	29.6	30.5	18.5	74.5	24.2	19.2	15.0	17.9	20.1	13.5	11.0	16.0	19.9	61.8	9.9	19.6	11.1	25.0	6.0	26.0	13.0	11.8	14.8	11.8	18.8	14.3	18.5	12.4	19.2	27.9	19.2	14.8	10.1	27.9	14.5	25.0	34.7	20.0	24.4	23.8	19.7	22.2	6.7	22.2	6.1	21.8	25.0	18.2	6.4	16.9	34.7	30.1	21.0	12.1	9.6	5.2	15.9	22.1	19.3	12.2	23.1	47.0	17.5	19.8	38.3	26.3	18.0	14.8	18.2	34.4	9.8	23.9	11.7	8.7	13.1	17.5	14.7	11.7	9.0	57.9	13.7	19.6	20.5	16.5	24.9	26.8	25.9	18.1	11.9	20.0	30.2	17.6	24.8	23.7	27.9	47.7	16.3	35.1	8.8	29.5	18.5	9.0	11.7	15.7	12.4	20.1	18.8	19.0	15.5	11.2	15.2	27.9	21.4	5.2	19.2	12.0	14.3	16.6	19.2	49.3	45.0	36.3	57.1	47.1	66.9	59.7	32.5	74.5	25.0	44.7	38.0	35.7	59.8	54.3	131.0	122.4	43.3	54.9	37.5	120.4	21.6	120.6	271.9	89.4	356.8	55.2	50.3	0.0	99.5	67.4	61.2	77.2	35.8	56.1	42.7	162.1	36.2	44.2	22.2	56.1	55.5	40.5	131.6	45.9	40.9	160.2	87.9	28.8	62.2	179.9	63.0	45.3	62.8	39.4	51.3	49.4	74.4	27.3	40.9	46.3
SCPEP1	RISC	ENSG00000121064	"Serine carboxypeptidase 1"	Q9HB40	17	56978105-57006768	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 113.9"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 80.9;U-266/70: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039102, HPA057200"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"		"HPA039102: AB_10673605, HPA057200: AB_2683365"	"unprognostic (5.83e-3)"	"unprognostic (7.43e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	29.5	54.1	14.7	12.6	10.2	17.8	25.8	8.8	14.8	21.5	17.6	12.8	50.1	8.8	17.5	24.1	25.9	14.6	20.7	25.0	10.2	11.8	24.8	8.7	25.6	24.5	12.2	14.3	19.9	9.4	113.9	13.6	7.6	14.2	24.6	9.5	13.4	31.5	37.6	6.4	17.8	15.9	23.2	13.9	22.3	20.8	7.7	10.8	2.4	62.7	14.1	25.3	24.7	20.8	14.1	23.4	60.8	44.8	4.6	3.0	20.3	9.7	6.0	9.3	8.6	80.9	18.1	5.2	4.7	23.7	8.3	16.6	2.8	6.2	13.2	27.6	11.2	14.4	9.5	4.4	21.2	8.8	17.7	7.7	3.9	6.0	1.6	18.5	8.1	40.3	21.9	9.1	10.7	8.3	7.7	13.8	5.0	1.1	47.3	11.9	4.2	3.6	20.2	4.2	3.0	8.7	5.1	11.4	8.5	1.8	30.2	2.9	7.2	11.9	9.0	7.0	11.2	4.0	20.7	7.4	25.2	6.7	14.8	5.3	53.4	39.1	7.2	17.6	5.8	6.9	0.3	44.8	60.8	3.0	27.1	1.9	12.9	2.1	1.9	23.4	14.1	2.9	2.9	7.3	4.6	25.3	4.5	2.5	20.3	14.7	10.2	8.8	14.8	10.2	11.8	12.2	14.3	14.2	10.8	41.7	48.6	36.6	158.5	21.1	14.6	27.4	12.7	200.8	135.4	90.7	15.7	8.4	16.6	13.6	0.9	22.1	2.6	23.3	6.1	13.6	64.4	62.4	8.1	19.2	144.9	9.5	23.4	64.4	136.9	1.1	59.5	105.4	23.6	80.2	3.1	27.2	6.2	1.5	64.0	24.5	16.3	51.8	42.2	3.2	7.9	17.3	9.3	20.8	3.5	121.2
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribbled planar cell polarity protein"	Q14160	8	143790920-143815379	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	13.0	6.1	15.1	10.8	12.2	9.4	15.9	10.1	13.9	15.1	18.4	17.5	9.8	14.8	9.4	5.9	36.6	11.6	11.9	8.0	12.2	7.7	10.2	13.6	11.5	12.9	13.5	12.8	10.9	17.2	11.2	9.6	9.5	11.8	10.9	7.6	7.5	22.9	11.2	36.8	33.3	16.3	11.2	9.7	11.2	17.0	10.1	16.4	14.0	9.1	11.9	9.6	11.6	17.8	0.6	0.5	0.2	0.4	0.2	1.5	0.6	18.6	15.1	6.9	8.8	2.5	3.3	11.7	10.5	3.0	4.9	4.1	6.6	12.2	7.4	12.8	3.1	2.8	19.5	3.7	14.1	0.9	8.2	20.8	10.3	13.0	11.6	5.7	4.3	5.8	2.8	13.7	4.7	4.1	2.2	5.3	8.1	13.0	2.6	3.7	37.2	11.1	9.2	5.2	11.6	19.2	13.4	6.4	8.2	2.5	18.8	15.1	11.1	11.9	13.1	11.1	2.2	16.5	10.3	10.2	5.4	22.4	9.5	14.7	9.3	9.1	7.5	5.5	4.3	8.4	0.1	0.1	0.1	0.6	0.4	1.5	0.6	0.4	1.2	0.5	0.4	0.4	0.4	0.2	0.2	0.1	0.2	0.4	0.6	15.1	12.2	10.1	13.9	12.2	7.7	13.5	12.8	11.8	16.4	0.0	6.9	6.9	4.2	7.6	11.1	10.8	15.3	1.4	1.2	14.0	13.7	8.9	3.3	7.5	1.2	6.0	18.4	23.3	8.1	5.3	5.1	8.0	0.0	7.5	5.5	4.8	13.3	4.3	6.3	0.4	8.3	4.6	8.5	4.6	19.5	11.9	9.9	20.1	9.2	4.3	14.0	12.9	4.2	7.9	9.2	9.4	4.2	5.1	19.5	5.9
SCRN1	KIAA0193	ENSG00000136193	"Secernin 1"	Q12765	7	29920103-29990289	"Enzymes, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.8"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 65.2;Muller glia cells: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 69.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024517	Enhanced		Approved	Cytosol		No	No		110000	Cytosol		"HPA024517: AB_2184811"	"prognostic unfavorable (8.32e-4)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (2.60e-4)"	6.8	14.8	32.0	6.3	31.5	3.6	7.6	62.8	55.4	12.4	8.1	23.2	4.5	3.4	13.3	8.8	10.0	13.9	8.5	9.8	26.6	30.7	12.8	1.5	8.3	6.7	42.7	26.6	17.5	18.5	42.9	12.1	8.0	26.3	15.0	5.6	7.8	8.4	20.2	1.0	5.7	5.0	17.7	42.9	5.2	7.1	11.4	23.3	8.2	7.1	1.5	10.6	9.4	5.8	10.4	7.8	6.9	16.7	4.8	8.1	2.2	21.8	15.8	25.8	10.4	18.3	28.2	0.1	20.4	27.4	22.2	24.0	18.2	17.4	2.7	18.2	26.1	49.4	9.9	29.3	8.7	32.5	0.1	6.1	9.0	10.6	11.7	23.4	0.0	0.1	23.5	12.6	20.1	10.8	30.3	20.4	5.9	0.1	7.1	31.2	12.3	3.1	0.0	23.5	0.0	17.0	0.0	27.5	0.2	15.5	10.8	9.4	22.4	21.1	13.7	23.6	33.9	18.5	1.4	22.5	28.9	24.9	0.3	25.8	2.3	35.4	0.2	13.6	0.1	69.6	2.2	2.3	6.9	0.6	10.2	8.1	10.4	0.1	0.8	7.7	5.0	0.6	1.0	0.4	4.8	16.7	7.8	0.0	2.2	32.0	31.5	62.8	43.1	26.6	30.7	42.7	26.6	26.3	23.3	26.8	13.1	8.2	9.7	2.7	63.5	12.6	20.4	21.4	22.7	31.4	43.2	0.3	13.3	18.8	49.3	5.8	0.0	0.0	21.5	1.6	7.7	14.1	8.1	0.5	4.8	65.2	11.6	2.5	10.0	48.7	12.7	10.6	6.8	4.6	0.9	76.1	21.8	17.3	19.8	1.8	39.0	6.5	8.5	2.3	12.3	1.5	0.8	4.3	1.0	17.0
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841333	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		350000	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.83e-4)"	43.4	10.3	8.3	14.2	14.1	6.7	20.8	17.7	13.1	10.6	17.3	11.2	23.6	25.1	11.4	18.1	8.9	15.4	13.3	17.9	8.6	8.9	29.3	17.4	8.3	8.7	8.1	9.6	11.8	25.3	11.4	14.5	7.8	10.5	13.6	6.1	14.8	20.1	19.2	20.0	10.9	20.1	9.7	7.3	15.0	9.8	4.0	10.9	8.5	18.1	9.0	11.0	10.7	10.0	16.9	19.2	25.9	13.4	16.5	22.1	10.8	12.0	19.2	5.3	5.1	15.7	12.2	16.3	6.1	12.5	9.4	9.6	14.4	14.4	6.7	12.3	3.2	5.0	6.6	1.7	10.7	3.2	15.9	13.2	6.8	14.1	12.4	5.6	3.2	5.4	11.7	8.1	5.7	4.5	14.0	10.5	16.2	2.3	7.6	12.8	10.9	10.7	5.6	2.7	5.2	7.6	14.3	4.0	26.9	7.4	5.5	4.1	17.2	3.4	7.3	8.0	3.8	16.6	6.4	4.8	8.6	9.2	2.4	2.8	31.5	4.1	3.1	23.3	5.7	1.9	12.3	12.8	25.9	16.9	13.4	16.3	16.9	14.0	16.4	16.3	15.6	22.1	12.2	3.2	16.5	6.5	19.2	13.9	10.8	8.3	14.1	17.7	13.1	8.6	8.9	8.1	9.6	10.5	10.9	35.7	25.1	11.2	25.9	14.0	11.3	19.8	12.7	26.8	14.8	15.7	9.8	38.7	63.0	22.9	2.8	20.3	52.0	0.0	53.1	8.3	23.5	18.8	16.1	25.3	19.4	19.1	21.5	23.9	8.1	2.1	30.8	12.7	40.5	11.8	30.3	26.6	27.6	34.5	15.6	296.5	15.6	6.5	17.0	5.2	14.9	10.0	28.3	26.1	34.7	16.9
SCRN3	FLJ23142	ENSG00000144306	"Secernin 3"	Q0VDG4	2	174395730-174429575	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034689, HPA034690"	Approved		Approved	Vesicles,Cytosol		NA	NA		9300	"Vesicles, Cytosol"		"HPA034689: AB_2674282, HPA034690: AB_10670574"	"unprognostic (5.39e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	12.4	15.9	19.2	7.6	18.4	3.7	11.4	13.2	27.0	8.4	10.4	16.7	12.5	15.4	10.3	10.1	14.2	9.1	9.4	21.2	20.2	20.0	17.4	18.0	10.1	10.5	23.5	21.1	11.7	12.1	26.6	20.6	10.9	25.9	13.4	11.3	8.7	10.6	12.3	30.3	11.5	11.5	11.8	27.9	9.3	10.2	8.4	20.2	10.4	17.3	6.2	9.5	11.2	9.1	9.9	6.9	18.5	4.6	5.5	7.5	2.2	9.1	5.6	14.6	13.5	11.3	12.8	8.2	14.1	10.9	10.9	13.0	5.5	6.7	1.7	9.3	13.9	8.3	9.1	11.2	12.1	14.1	19.8	10.1	17.0	12.3	4.3	17.1	12.9	9.0	14.4	15.2	20.1	14.8	12.2	12.5	9.5	11.2	6.6	14.8	10.2	10.7	12.6	7.1	20.1	23.9	5.3	15.3	10.0	12.2	9.4	9.5	26.7	9.7	9.6	17.7	16.6	12.9	12.5	9.2	12.7	6.6	14.9	11.8	17.6	18.2	0.2	13.8	6.4	12.7	4.8	4.6	1.9	4.6	2.7	3.3	7.0	4.7	4.3	4.3	9.9	7.5	5.9	18.5	5.5	3.6	6.9	4.8	2.2	19.2	18.4	13.2	27.0	20.2	20.0	23.5	21.1	25.9	20.2	8.9	10.4	3.7	9.8	3.2	12.8	20.6	7.6	13.4	7.9	8.7	9.8	9.3	11.6	7.8	2.2	4.9	6.3	0.0	8.6	5.9	6.3	5.6	8.1	8.3	7.8	17.5	5.8	10.4	6.9	2.3	4.4	4.9	3.3	3.6	6.5	22.0	9.9	3.5	6.3	9.8	14.7	0.0	6.2	18.1	5.2	4.3	5.7	2.5	6.4	10.1
SCRT2	ZNF898B	ENSG00000215397	"Scratch family transcriptional repressor 2"	Q9NQ03	20	661596-676179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 17.9;retina: 6.1"	"Cell type enriched"	"Detected in some"	51	"Horizontal cells: 57.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.0"	"Group enriched"	"Detected in many"	4	"cerebellum: 8.8;cerebral cortex: 17.9"	"Cell type enriched"	"Detected in single"	25	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.4"	"Group enriched"	"Detected in some"	5	"Karpas-707: 4.0;NTERA-2: 3.7;RPMI-8226: 8.1;SCLC-21H: 3.9;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA067697			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067697: AB_2685890"					"unprognostic (9.71e-2)"					"unprognostic (2.03e-1)"	"unprognostic (6.97e-2)"			"unprognostic (9.70e-2)"	"unprognostic (1.70e-1)"			0.3	0.3	0.7	0.3	0.7	0.3	0.3	8.8	17.9	0.3	0.3	0.6	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.6	0.3	0.3	0.3	0.3	1.9	0.0	0.3	1.3	0.3	0.0	0.4	3.2	0.3	0.3	6.1	0.3	0.3	0.3	0.3	0.3	0.3	1.1	0.6	0.3	0.7	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	8.1	0.0	0.0	3.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	8.8	17.9	0.7	0.6	1.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35214419-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.0"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 9.5;Intestinal endocrine cells: 10.4;Rod photoreceptor cells: 6.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 10.6;ASC diff: 32.4;ASC TERT1: 43.5;HSkMC: 20.3;hTEC/SVTERT24-B: 12.4;U-138 MG: 12.1;WM-115: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1890000	110000	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.06e-3)"	1.6	2.6	0.5	1.1	0.4	0.2	0.3	0.3	0.7	1.6	3.3	0.0	2.8	0.2	1.3	7.0	1.5	0.7	0.7	6.4	0.3	0.5	2.3	0.2	1.3	0.2	0.4	0.6	0.9	0.2	0.3	1.6	0.9	0.6	7.0	1.1	6.8	1.1	5.3	0.8	0.7	0.8	13.8	0.6	0.3	1.2	1.7	0.0	0.0	38.0	0.3	0.3	11.4	2.5	1.1	1.6	2.5	0.7	1.1	1.1	0.1	0.0	0.0	10.6	0.1	32.4	43.5	0.1	2.6	1.3	0.0	0.0	0.2	0.0	0.0	0.4	6.2	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.3	0.0	12.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.3	0.7	4.4	0.2	0.0	0.6	12.1	0.5	0.0	0.1	0.0	0.0	0.0	1.9	0.0	10.2	1.4	0.7	1.3	1.1	0.5	0.3	0.8	0.7	0.3	0.1	1.1	0.8	0.8	2.5	1.1	0.5	1.6	0.8	0.1	0.5	0.4	0.3	0.7	0.3	0.5	0.4	0.6	0.6	0.0	0.0	1.1	0.0	0.2	0.0	2.5	3.3	0.0	1.4	3.4	1.8	2.0	0.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	1.0	0.1	1.1	0.0	0.3	9.5	10.4	0.0	1.2	2.2	0.9	0.0	1.7	0.0	0.0	2.0	0.1	0.0	3.5	0.0	6.1	0.0	4.7	0.2	1.9	0.0	0.6	0.0	0.0	0.1
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	17.0	17.9	19.6	16.5	30.2	7.3	21.5	17.6	26.7	19.9	17.9	9.6	14.0	14.0	26.2	23.2	19.5	18.9	10.6	16.4	18.2	15.4	21.9	23.9	14.6	22.8	16.4	19.1	22.7	26.9	20.4	30.6	17.5	22.6	18.5	18.6	9.4	18.3	20.8	32.3	19.6	16.1	24.9	16.2	23.5	18.1	24.1	19.9	21.5	25.8	17.1	22.9	21.3	17.5	13.2	10.3	5.6	16.8	15.4	17.8	10.5	14.6	5.9	14.6	19.5	17.4	15.7	15.3	20.8	18.1	17.4	15.2	18.2	21.0	23.0	15.7	19.0	16.7	15.1	22.2	20.1	21.9	20.2	11.7	19.6	13.1	15.0	16.4	33.3	22.4	13.7	22.8	18.4	20.3	10.8	15.2	15.7	35.1	19.0	17.8	16.2	33.7	11.8	23.7	23.7	9.0	20.5	27.5	19.3	16.6	16.4	22.1	18.4	14.2	29.0	23.5	16.6	13.3	19.6	14.3	18.8	19.0	22.4	17.3	17.5	18.2	31.4	21.1	15.1	23.2	5.6	9.9	2.7	14.2	12.7	17.7	12.1	17.4	16.1	10.3	13.2	17.8	14.9	1.6	15.4	16.8	9.0	14.7	10.5	19.6	30.2	17.6	26.7	18.2	15.4	16.4	19.1	22.6	19.9	17.9	26.7	35.6	21.5	24.5	19.7	10.6	15.3	33.5	50.0	21.0	5.9	26.9	29.9	34.3	86.0	21.1	13.9	0.0	21.5	26.1	23.2	22.2	48.5	20.5	32.6	12.7	21.9	16.0	23.5	81.4	23.6	29.5	23.6	39.7	22.8	22.4	28.9	22.9	31.1	37.2	19.7	19.4	24.5	58.5	94.3	29.0	20.9	32.0	26.0	19.7
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	31.4	17.6	5.6	14.0	1.5	0.2	17.7	8.8	8.5	8.2	7.0	3.7	19.2	0.0	3.2	6.2	4.5	31.1	2.4	62.1	5.5	0.1	1.6	0.0	1.6	18.8	1.3	1.3	0.1	0.8	57.5	7.4	17.6	11.5	0.9	0.0	0.7	12.3	4.4	18.8	0.0	0.3	5.0	24.0	34.2	0.6	2.0	23.8	10.6	47.2	1.6	13.1	6.6	44.8	2.0	2.3	4.4	0.3	1.3	32.7	10.5	1.2	59.2	61.4	129.2	0.1	9.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4	86.4	91.4	3.0	135.6	101.2	0.1	0.8	298.1	2.7	63.7	40.1	0.0	2.4	26.6	54.9	0.0	1.1	102.7	23.3	19.0	43.0	9.7	42.4	5.8	520.4	2.2	20.6	10.4	6.7	9.6	0.0	0.6	5.4	20.3	1.0	72.0	0.0	67.3	73.7	1.1	68.3	0.0	0.0	7.1	0.7	12.8	200.1	209.7	4.4	66.5	356.0
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493351-96611780	"CD markers, Predicted membrane proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.1;thyroid gland: 111.2"	"Cell type enhanced"	"Detected in many"	5	"Fibroblasts: 194.4;Hepatocytes: 184.9;Smooth muscle cells: 188.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.9"	"Cell line enhanced"	"Detected in many"		"AF22: 102.6;EFO-21: 48.2;fHDF/TERT166: 44.4;RPTEC TERT1: 53.6;U-138 MG: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA044416"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB025123: , HPA044416: AB_2678934"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.23e-1)"	43.2	9.9	13.9	9.1	16.9	2.5	17.0	12.7	8.4	43.4	18.7	7.3	21.2	5.8	21.9	15.3	13.3	21.0	15.0	19.1	12.0	12.6	23.9	115.1	14.4	4.4	9.7	9.3	45.9	16.8	1.6	24.0	31.3	10.7	25.9	10.7	51.4	6.3	28.1	9.4	6.5	9.6	34.3	9.5	7.5	11.9	8.7	9.3	0.5	111.2	13.8	3.5	35.9	26.3	0.0	1.3	13.9	1.9	0.0	0.2	0.5	0.0	0.0	102.6	0.0	37.1	34.7	0.1	14.8	17.6	8.6	9.6	3.0	0.0	0.0	48.2	44.4	1.2	0.0	17.7	0.2	7.4	0.0	6.9	0.0	9.9	37.7	1.2	0.2	0.4	13.3	0.4	19.5	0.5	33.3	0.3	0.0	9.7	0.0	3.6	0.8	0.0	2.5	10.8	0.0	0.1	0.1	16.1	0.3	53.6	8.7	3.0	8.0	0.0	0.0	0.7	35.9	4.4	11.4	8.0	49.7	15.2	0.2	8.2	0.9	0.0	0.1	15.8	0.0	15.5	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	13.9	0.0	0.1	0.0	0.0	0.5	13.9	16.9	12.7	8.4	12.0	12.6	9.7	9.3	10.7	9.3	53.6	30.2	4.7	67.2	47.9	22.0	25.8	33.1	5.3	3.4	54.1	11.8	1.8	24.9	11.7	25.6	10.2	0.1	23.3	13.2	2.0	194.4	44.9	1.1	184.9	114.7	4.8	3.4	20.3	22.0	14.5	48.6	87.0	59.1	118.2	0.5	18.4	12.7	0.0	98.6	44.8	10.2	32.3	188.5	3.2	57.1	34.4	3.2	3.2	1.2	14.5
SDC3	"N-syndecan, SYND3"	ENSG00000162512	"Syndecan 3"	O75056	1	30869467-30908761	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Collecting duct cells: 45.4;Kupffer cells: 157.7;Late spermatids: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 52.5;WM-115: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017087, CAB025786, HPA048085"	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256"	"unprognostic (1.42e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.83e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (9.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (6.45e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.46e-1)"	17.9	48.8	35.4	11.6	44.7	1.9	9.2	10.4	53.1	20.4	20.8	21.7	10.9	6.9	25.6	7.1	9.8	13.7	15.9	11.1	26.8	32.2	4.7	11.5	12.0	15.4	36.1	16.4	6.2	4.4	6.1	5.4	9.7	34.1	14.8	8.1	8.2	8.6	29.2	17.7	5.7	9.1	33.1	28.3	45.3	9.3	2.4	15.5	2.6	5.5	1.7	4.2	14.4	6.0	1.2	1.0	3.2	2.5	2.1	1.2	0.9	2.7	2.0	16.3	7.6	12.6	3.0	3.2	6.8	9.7	3.2	2.0	0.3	2.5	0.2	17.3	19.0	4.6	3.7	1.7	1.5	2.1	1.4	1.4	0.0	0.8	0.4	12.1	0.0	1.8	7.3	7.5	0.2	3.2	17.9	4.0	0.7	1.3	0.2	6.2	2.9	0.1	0.1	8.3	1.9	2.4	0.1	15.6	0.6	4.0	2.9	6.4	4.1	8.6	1.2	52.5	10.9	1.2	1.2	4.4	4.0	6.9	0.5	1.5	0.0	0.1	0.2	0.4	0.0	73.1	3.2	1.3	1.0	0.8	2.5	1.2	0.8	0.8	0.9	0.9	1.2	1.0	1.0	2.5	2.1	1.8	1.0	0.9	0.9	35.4	44.7	10.4	29.5	26.8	32.2	36.1	16.4	34.1	15.5	0.0	2.1	0.8	2.8	2.3	8.1	3.2	15.3	0.0	2.3	45.4	0.0	2.1	0.0	9.0	17.7	8.7	0.0	0.0	2.6	2.8	10.0	6.9	0.0	0.2	13.2	0.0	2.9	28.8	157.7	63.3	2.0	2.2	18.6	5.4	0.9	1.5	6.1	0.6	7.4	0.3	25.6	0.0	5.6	0.7	0.4	1.9	3.0	0.0	1.2	3.7
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.1"	"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 450.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 75.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA			"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (7.42e-2)"	15.9	26.2	19.9	15.7	24.3	3.5	40.5	6.9	20.1	20.4	24.8	19.2	9.0	13.3	17.6	14.7	42.4	27.4	26.2	19.5	19.8	12.1	56.6	141.1	56.7	4.8	23.5	20.5	14.7	36.6	6.2	12.5	23.0	30.9	19.5	22.3	21.8	47.6	17.5	25.5	45.5	13.8	38.7	23.0	9.0	46.9	33.7	15.7	2.0	26.5	25.2	23.5	34.4	16.4	0.7	2.8	2.0	3.1	1.4	8.1	1.2	23.0	3.0	1.6	0.1	41.2	25.4	71.1	29.5	40.3	33.5	24.0	35.1	58.9	0.0	13.2	37.1	33.8	30.0	1.2	75.0	40.8	6.6	1.1	0.7	2.4	13.7	44.9	0.1	1.2	34.1	50.4	13.8	33.8	18.6	4.4	0.5	1.1	0.0	19.2	22.9	0.0	2.0	3.0	20.1	9.3	0.0	14.9	0.0	55.0	30.8	0.6	2.3	40.6	25.2	7.2	19.6	18.2	1.4	8.2	25.6	21.3	2.5	19.0	1.2	0.9	0.1	40.2	2.3	15.2	2.0	3.1	0.7	1.3	1.1	4.1	0.6	4.1	1.6	2.8	0.7	0.9	1.1	1.6	1.4	1.1	2.5	8.1	1.2	19.9	24.3	6.9	20.1	19.8	12.1	23.5	20.5	30.9	15.7	271.0	364.7	7.8	299.2	332.0	10.3	49.5	201.2	113.8	195.7	179.7	11.8	27.4	54.7	239.6	0.5	9.0	87.8	0.0	450.4	202.4	50.9	254.2	12.8	232.3	18.5	0.0	52.9	14.7	15.1	2.9	3.7	36.5	72.6	56.9	103.4	8.5	443.3	93.4	4.9	128.2	23.3	0.0	42.6	0.9	2.8	413.3	56.3	18.8	79.5	364.0
SDF2		ENSG00000132581	"Stromal cell derived factor 2"	Q99470	17	28648356-28662189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042799			Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA042799: AB_10794533"	"unprognostic (3.91e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.77e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.28e-3)"	"unprognostic (3.20e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-2)"	13.3	31.8	15.4	10.9	14.9	8.8	17.1	11.2	13.9	17.9	15.8	13.3	26.1	9.6	14.5	28.3	14.4	16.9	14.8	13.3	11.4	13.4	20.1	22.5	14.2	8.8	18.8	11.5	19.9	18.9	10.1	18.9	21.3	16.2	19.1	11.3	11.5	20.7	16.0	13.1	10.2	14.2	14.7	11.4	15.0	13.8	9.5	14.2	11.3	25.2	13.9	14.7	12.8	15.0	11.5	15.3	45.5	12.3	15.1	16.9	13.0	7.4	19.0	8.7	7.4	37.2	10.7	8.0	23.3	15.9	14.6	17.3	10.5	6.9	4.0	21.1	20.6	19.3	14.3	11.2	7.3	10.6	23.1	13.7	6.9	8.9	9.7	11.5	4.0	8.9	21.2	9.8	13.2	3.5	14.1	13.3	4.3	7.1	8.9	16.7	11.0	7.5	8.6	5.9	18.4	7.1	5.4	15.5	8.6	14.0	9.1	6.3	6.9	16.5	12.8	12.0	15.7	15.1	4.6	17.1	7.4	9.8	9.7	13.1	10.2	15.8	5.5	11.8	5.4	11.3	36.3	12.3	30.5	16.9	9.8	15.5	11.5	13.2	16.3	7.7	10.7	12.5	14.9	45.5	15.1	9.4	15.3	16.6	13.0	15.4	14.9	11.2	13.9	11.4	13.4	18.8	11.5	16.2	14.2	23.8	20.0	36.3	50.6	30.2	25.2	10.1	28.1	20.1	26.1	40.1	23.6	110.1	24.9	68.3	3.7	43.0	68.9	23.3	41.5	92.5	54.1	49.7	20.7	42.3	50.3	12.7	54.9	41.1	39.2	2.2	70.5	41.1	35.4	46.9	44.8	47.8	62.2	84.2	62.6	44.7	26.1	71.1	33.0	25.9	29.9	33.0	176.4	60.9	41.1	70.8
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		780000	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.7	30.4	12.5	20.4	21.6	16.2	34.0	14.5	18.4	25.0	25.5	32.9	25.6	23.2	45.8	16.5	18.9	24.3	22.1	29.6	14.8	49.4	20.2	11.8	84.1	42.8	13.4	14.7	15.4	16.1	19.0	18.6	9.9	19.9	27.0	16.6	19.0	19.3	11.7	28.7	19.4	39.7	4.3	20.5	38.6	25.1	18.2	45.0	53.1	24.9	13.8	7.9	68.2	44.1	17.9	8.1	26.7	18.6	19.5	18.5	18.2	11.0	11.9	20.6	8.8	17.1	17.9	21.2	11.7	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8	32.8	63.8	52.9	58.0	54.4	45.7	238.2	76.5	58.9	40.9	71.5	96.2	94.1	121.0	78.8	32.8	37.6	207.8	0.0	39.4	87.2	53.2	29.4	42.7	135.6	60.4	95.3	45.6	43.0	39.1	20.2	63.3	43.9	86.0	78.5	75.8	40.3	44.9	92.8	52.3	129.8	77.8	77.6	45.0	66.5	55.1	31.5	129.4	59.9	128.8	78.3
SDHAF1	LYRM8	ENSG00000205138	"Succinate dehydrogenase complex assembly factor 1"	A6NFY7	19	35995199-35996315	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064277			Approved	Mitochondria		NA	NA			Mitochondria		"HPA064277: AB_2685231"	"unprognostic (2.01e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.47e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.59e-2)"	11.2	15.7	13.5	11.1	14.7	7.3	14.0	24.5	23.4	14.0	16.7	17.0	13.1	25.0	12.4	13.1	14.8	12.1	11.9	11.1	14.8	13.7	14.4	23.5	10.4	17.6	19.0	10.3	13.6	24.5	11.2	15.1	10.5	12.5	13.9	10.0	9.9	23.7	13.8	17.4	12.4	20.6	15.3	14.3	15.0	16.8	7.7	14.4	14.4	21.9	12.6	11.2	15.8	14.0	31.5	28.5	33.4	26.4	32.7	33.2	20.9	5.9	15.7	4.7	10.8	4.6	5.9	8.1	5.8	6.3	6.4	7.4	11.2	4.6	11.2	11.4	3.8	4.3	6.0	6.1	3.3	3.1	20.9	14.4	4.9	6.5	14.6	5.6	5.8	8.2	5.1	10.7	3.9	4.2	2.5	3.5	11.8	15.1	12.2	2.8	14.6	11.1	11.5	7.2	19.7	7.6	12.2	5.2	12.5	6.1	7.7	18.4	13.7	9.4	15.4	9.9	4.0	8.8	9.9	4.6	7.3	11.0	6.9	8.8	16.6	7.6	13.0	6.4	11.3	6.5	23.3	22.1	33.4	27.5	24.3	29.4	27.6	29.4	26.5	22.7	31.5	33.2	27.8	12.1	32.7	26.4	28.5	30.2	20.9	13.5	14.7	24.5	23.4	14.8	13.7	19.0	10.3	12.5	14.4	6.0	2.6	23.0	10.5	26.7	20.4	8.1	10.2	0.0	1.2	17.4	5.9	20.4	23.2	18.6	20.9	18.2	23.8	0.0	25.7	29.5	18.8	16.9	4.6	19.6	19.5	17.5	27.6	16.5	20.2	5.1	21.3	15.6	23.6	27.1	29.0	15.0	19.4	32.5	27.6	23.7	11.9	25.8	11.9	9.8	14.1	36.4	19.3	29.4	31.0	14.4
SDHAF3	"ACN9, DC11, LYRM10, Sdh7"	ENSG00000196636	"Succinate dehydrogenase complex assembly factor 3"	Q9NRP4	7	97116590-97181763	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 126.0;Proximal tubular cells: 122.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020515, HPA020523"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020515: , HPA020523: AB_2670464"	"unprognostic (3.94e-2)"	"unprognostic (9.11e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.61e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.34e-1)"	"unprognostic (8.45e-2)"	8.2	16.0	11.8	11.6	12.0	11.4	9.6	5.4	15.5	6.7	12.3	7.9	11.1	15.2	8.3	11.8	12.0	8.8	12.5	22.0	11.3	12.8	17.6	20.1	10.2	14.6	12.9	11.5	7.4	16.2	5.8	13.7	5.8	16.6	8.4	12.8	9.4	16.8	12.4	18.3	9.7	13.2	9.8	15.7	11.5	12.1	14.9	9.6	15.6	14.6	11.2	8.7	9.6	7.9	12.0	25.9	11.3	8.7	6.4	15.0	12.2	7.4	6.1	3.2	20.7	2.0	1.7	3.2	2.3	1.5	2.4	4.1	1.1	6.0	12.1	7.6	2.1	3.6	2.7	7.9	6.6	5.3	8.7	11.1	8.3	6.2	11.2	3.7	17.3	3.3	3.6	4.1	4.3	5.8	1.7	2.2	10.0	21.5	0.3	4.9	0.0	20.3	24.4	7.0	11.2	6.7	4.2	2.9	17.5	3.1	5.5	15.5	8.1	8.9	11.7	10.4	5.8	0.1	4.7	3.6	0.9	11.6	19.0	2.3	7.1	17.0	32.3	3.4	30.6	11.8	5.4	6.9	2.7	9.1	8.7	12.1	12.0	11.6	14.3	9.5	9.8	15.0	14.9	11.3	6.4	8.2	25.9	10.2	12.2	11.8	12.0	5.4	15.5	11.3	12.8	12.9	11.5	16.6	9.6	17.9	8.4	34.0	19.4	0.0	13.1	32.7	25.5	29.4	12.5	24.4	3.9	33.2	126.0	25.1	89.5	10.1	4.6	0.0	33.8	22.6	9.5	17.7	4.7	49.5	26.9	9.5	12.9	17.8	19.4	10.2	21.0	16.4	0.0	4.6	30.6	28.6	20.6	35.1	23.3	122.5	16.9	32.3	12.2	18.4	51.7	0.0	8.0	25.9	48.7	19.2
SDHAF4	"C6orf57, Sdh8"	ENSG00000154079	"Succinate dehydrogenase complex assembly factor 4"	Q5VUM1	6	70566917-70589569	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031824	Supported		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			Mitochondria	Nucleoplasm	"HPA031824: AB_10602113"	"unprognostic (8.72e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (2.45e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.94e-2)"	13.4	14.5	18.1	6.5	20.1	6.1	14.3	15.7	25.7	8.3	9.5	7.9	10.3	7.9	9.0	14.6	9.8	16.0	8.5	17.6	18.0	21.2	14.9	10.7	8.4	10.6	14.7	17.4	9.7	14.2	10.5	18.3	10.2	15.5	10.6	10.6	11.1	9.7	8.9	30.5	9.7	7.9	8.8	13.0	6.9	8.8	7.3	9.7	7.4	11.5	10.2	7.8	8.1	6.9	10.5	13.4	9.1	10.5	9.6	9.3	6.2	10.0	3.3	14.3	8.8	7.3	10.9	2.8	5.4	4.2	2.6	4.0	2.9	8.5	6.9	10.4	2.8	6.4	1.8	4.9	4.8	3.9	14.4	3.3	4.8	1.4	2.9	12.4	4.7	3.8	7.8	15.4	2.0	11.8	9.2	6.5	11.6	3.2	10.7	8.6	6.9	4.2	11.7	6.8	5.1	3.3	4.7	9.7	8.0	11.4	3.3	13.2	9.6	3.2	1.6	6.8	6.4	7.3	12.2	4.8	2.7	2.1	2.2	5.8	5.0	3.4	2.2	3.0	11.2	6.4	6.0	10.5	9.1	7.7	9.2	8.0	8.7	8.5	9.0	11.3	10.5	9.3	8.5	7.1	9.6	9.5	13.4	9.1	6.2	18.1	20.1	15.7	25.7	18.0	21.2	14.7	17.4	15.5	9.7	11.9	15.2	2.2	7.2	0.0	7.5	17.6	7.6	25.4	10.3	7.0	7.9	8.8	19.9	8.0	4.0	5.2	3.3	0.0	10.1	7.4	5.1	7.1	4.7	11.3	9.1	17.5	3.5	3.7	4.1	2.2	11.5	8.5	0.0	12.6	6.6	9.9	9.8	3.5	6.3	11.8	5.8	12.9	3.1	10.7	5.3	0.0	4.2	4.4	6.4	6.9
SDK1	FLJ31425	ENSG00000146555	"Sidekick cell adhesion molecule 1"	Q7Z5N4	7	3301448-4269000	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 99.7;Late spermatids: 120.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	28	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 7.9;BEWO: 9.8;RPTEC TERT1: 8.2;RT4: 10.2;SuSa: 9.9;U-2 OS: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011392	Approved		Approved	Cytosol		NA	NA		2700000	Cytosol		"HPA011392: AB_1856648"	"unprognostic (2.39e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.37e-1)"	5.8	1.1	2.2	6.1	1.7	1.4	5.8	0.9	3.1	16.6	6.2	1.4	6.8	1.8	6.1	10.9	2.9	4.5	4.8	1.9	3.4	2.2	3.9	0.7	7.0	8.7	1.6	1.4	4.3	22.4	1.5	6.3	2.9	2.1	6.9	2.4	5.6	2.6	9.4	1.8	2.9	4.2	16.5	1.9	16.3	3.6	7.7	1.9	1.8	1.5	3.6	3.4	9.5	13.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.0	1.7	7.9	0.0	0.0	0.0	9.8	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.3	0.0	3.1	0.1	0.8	0.0	0.2	0.0	4.6	0.0	0.3	0.2	3.9	0.0	0.0	1.6	0.0	0.3	0.5	0.0	0.6	0.1	0.0	0.0	3.9	2.0	0.0	0.0	2.7	0.1	0.0	5.6	5.5	0.0	8.2	10.2	4.9	7.2	0.0	0.0	0.0	9.9	0.0	2.5	0.2	0.0	12.3	0.0	3.4	0.0	0.0	0.0	0.0	1.6	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.9	3.1	3.4	2.2	1.6	1.4	2.1	1.9	0.0	4.0	0.0	0.4	1.1	10.0	20.4	2.5	9.4	7.9	5.2	0.0	2.3	0.0	1.0	99.7	0.6	0.0	0.0	4.7	0.8	4.1	0.6	0.0	0.0	0.5	1.6	4.7	1.3	0.0	120.8	1.7	0.5	5.0	0.0	0.5	0.3	3.5	0.0	5.3	1.4	0.7	6.5	2.1	6.6	5.1	0.4	1.6	0.0	0.0	0.3
SDK2	"FLJ10832, KIAA1514"	ENSG00000069188	"Sidekick cell adhesion molecule 2"	Q58EX2	17	73334384-73644089	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 13.6"	"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 14.2;Horizontal cells: 19.1;Intestinal endocrine cells: 14.3;Late spermatids: 15.3;Spermatocytes: 12.4;Syncytiotrophoblasts: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.7;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	5	"B-cells: 2.7;dendritic cells: 2.3"	"Cell line enhanced"	"Detected in some"		"AF22: 14.7;BEWO: 12.1;RPMI-8226: 4.8;SuSa: 8.1;U-2 OS: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014725			Approved	Nucleoplasm		NA	NA		2000000	Nucleoplasm		"HPA014725: AB_2183303"	"unprognostic (7.22e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.62e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (7.69e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.64e-2)"	0.4	0.6	2.1	5.3	1.2	0.7	2.6	0.5	2.7	8.9	0.5	0.6	0.0	0.0	3.1	5.1	0.9	3.5	1.4	3.5	1.7	4.1	1.1	0.5	4.2	4.8	1.6	0.0	0.8	0.4	0.0	1.9	3.7	1.9	2.6	0.3	2.2	2.0	1.4	0.4	0.5	0.5	0.3	3.0	3.6	0.6	13.6	0.0	0.1	1.8	1.1	2.9	0.7	7.2	2.7	2.3	0.0	0.0	0.2	0.5	0.0	0.0	2.1	14.7	4.2	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	3.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.5	0.0	4.8	0.0	0.0	3.3	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	4.4	1.8	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	2.7	0.5	0.4	0.0	0.2	0.0	2.3	0.0	0.0	2.1	1.2	0.5	2.5	1.7	4.1	1.6	0.0	1.9	0.0	0.0	2.4	4.5	3.7	0.8	3.5	2.0	0.0	0.0	2.3	0.0	0.0	3.8	0.0	0.2	10.9	0.3	0.0	0.0	0.2	14.2	1.9	2.3	1.1	0.0	0.6	19.1	14.3	0.0	0.0	15.3	0.6	0.0	1.7	1.8	0.2	7.8	0.0	0.0	0.0	0.0	0.6	0.0	0.9	12.4	3.5	0.1	14.9	0.0	0.0	0.3
SDR39U1	"C14orf124, HCDI"	ENSG00000100445	"Short chain dehydrogenase/reductase family 39U member 1"	Q9NRG7	14	24439766-24442905	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044294, HPA075356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044294: AB_10961400, HPA075356: "	"unprognostic (2.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.87e-3)"	"prognostic favorable (2.34e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.32e-2)"	19.5	29.3	21.6	12.4	24.1	21.4	15.6	47.7	26.9	13.9	13.5	23.0	17.1	14.8	16.3	16.5	12.0	19.6	10.4	37.1	21.7	18.5	22.2	18.6	11.8	17.0	32.5	19.6	19.2	22.3	17.2	27.9	12.9	22.0	17.2	8.7	19.5	31.1	21.9	64.2	16.2	14.9	13.9	18.8	22.4	16.5	15.2	29.8	13.3	18.0	17.0	12.2	13.9	14.7	25.8	30.6	17.2	19.5	27.5	24.5	15.6	10.6	17.7	12.6	14.8	17.6	13.5	12.9	6.3	7.9	13.1	15.2	13.7	13.3	14.4	15.6	6.4	10.1	18.7	11.2	14.1	5.7	19.6	19.7	12.6	13.2	34.9	8.6	11.5	12.7	15.0	17.1	9.4	13.6	13.5	13.9	32.6	11.3	12.3	12.8	18.6	18.9	18.6	12.1	15.0	16.5	24.3	6.5	10.1	23.0	13.4	22.0	19.1	15.5	27.7	13.6	7.9	19.1	17.0	7.4	4.1	13.8	11.9	7.8	21.2	13.3	17.3	10.8	14.7	10.9	17.2	19.5	11.5	21.9	11.6	21.0	25.8	16.6	17.1	21.9	25.2	23.7	24.5	6.0	27.5	9.5	30.6	19.3	15.6	21.6	24.1	47.7	26.9	21.7	18.5	32.5	19.6	22.0	29.8	26.8	20.8	26.1	35.9	23.6	34.7	0.2	35.7	17.4	26.1	38.4	11.8	43.4	102.8	23.4	11.6	31.5	17.8	46.7	17.5	20.7	25.9	23.5	34.7	34.4	25.8	27.0	26.5	16.5	18.1	19.8	30.5	19.8	40.5	15.4	21.6	56.9	16.4	11.5	29.7	56.4	36.7	0.0	31.9	63.7	13.0	23.8	46.9	27.7	21.3	26.3
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 276.9"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 317.5;Hofbauer cells: 211.0;monocytes: 169.5"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"myeloid DC: 12.8"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 12.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.5;SK-BR-3: 3.4"	"Low region specificity"	"Detected in single"							HPA039230	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	0.9	0.9	2.2	1.4	5.9	0.5	0.4	0.6	2.1	0.5	0.9	0.8	0.0	0.7	0.4	0.2	0.2	0.2	1.4	0.2	1.7	2.5	0.2	276.9	0.6	0.6	4.2	0.7	0.3	0.4	0.1	0.0	1.0	2.8	0.3	0.8	1.3	0.3	0.2	0.2	0.2	0.7	0.3	1.3	0.5	0.9	0.3	0.8	0.1	0.3	0.0	0.3	0.8	0.0	0.0	12.8	0.6	0.8	0.2	0.0	0.3	0.0	0.4	0.2	1.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.2	0.4	2.3	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.5	1.3	0.6	0.6	0.1	0.8	5.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.6	0.0	1.4	0.1	0.4	0.8	0.0	0.9	0.0	0.8	0.1	0.2	0.6	0.1	0.1	1.6	3.4	0.7	0.1	1.2	1.7	0.6	0.0	0.9	1.1	0.3	0.7	0.4	0.2	1.1	0.8	0.3	0.1	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.6	0.2	0.1	1.3	0.0	0.3	2.2	5.9	0.6	1.6	1.7	2.5	4.2	0.7	2.8	0.8	0.0	1.1	21.2	0.2	2.2	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.3	0.0	23.3	0.3	0.7	0.8	0.2	0.0	317.5	211.0	0.0	0.0	10.4	27.7	0.0	0.0	55.6	1.7	169.5	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	2.8	2.1	3.3	0.0	0.0
SDSL	"cSDH, SDS-RS1"	ENSG00000139410	"Serine dehydratase like"	Q96GA7	12	113422237-113438276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.2"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 118.4;Hofbauer cells: 93.1;monocytes: 174.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 13.2;monocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.6;MCF7: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005740	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA005740: AB_10601486"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (8.58e-4)"	"unprognostic (2.93e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.33e-2)"	3.1	15.3	4.2	3.8	5.1	1.4	2.8	1.5	7.1	2.6	7.1	5.5	6.2	10.0	2.5	9.7	1.3	4.6	5.2	7.2	3.6	6.1	15.5	53.2	2.8	2.8	9.5	4.2	4.6	15.3	5.0	7.6	3.1	7.8	4.2	5.0	4.6	4.9	4.5	2.1	0.7	7.8	2.9	8.8	3.0	5.2	7.0	2.6	1.5	20.3	1.3	1.6	4.0	1.5	1.1	13.2	0.3	7.1	1.3	0.2	1.7	3.6	14.2	2.0	6.0	0.4	0.9	1.4	2.1	0.5	2.2	1.9	6.1	3.8	0.2	10.7	3.4	6.2	3.7	0.9	4.8	0.8	8.6	3.6	9.1	3.4	2.6	12.0	1.1	22.6	1.9	6.8	5.5	8.2	2.6	3.3	0.0	7.1	2.8	2.7	38.7	0.0	4.5	2.1	3.9	6.1	0.0	3.0	6.8	5.9	4.4	0.6	0.2	8.8	10.0	8.5	1.9	12.3	10.4	3.0	2.7	5.3	12.1	1.8	0.6	0.5	0.1	11.6	3.7	3.3	0.1	6.5	0.0	0.0	7.1	0.0	1.1	0.0	0.0	13.2	0.1	0.0	0.0	0.3	1.3	0.9	12.8	0.2	1.7	4.2	5.1	1.5	7.1	3.6	6.1	9.5	4.2	7.8	2.6	0.0	6.1	8.6	2.1	0.8	0.2	15.7	25.5	0.0	0.0	27.9	2.0	11.4	66.3	30.4	0.4	2.9	43.5	23.3	17.7	2.6	3.8	6.0	43.8	118.4	93.1	3.2	30.5	4.9	12.3	1.1	2.6	14.9	3.3	174.9	28.9	19.5	17.4	40.3	5.3	76.8	1.5	0.0	5.7	0.0	0.2	0.5	6.1	4.3	25.5	4.3
SEC11A	"SEC11L1, sid2895, SPC18, SPCS4A"	ENSG00000140612	"SEC11 homolog A, signal peptidase complex subunit"	P67812	15	84669538-84716716	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047533			Approved	"Nuclear membrane,Golgi apparatus"		NA	NA		7400000	"Nuclear membrane"	"Golgi apparatus"	"HPA047533: AB_2680078"	"unprognostic (8.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.19e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.99e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.89e-2)"	65.5	43.6	18.7	23.3	17.3	36.4	42.6	11.2	15.5	44.4	38.5	23.0	38.8	20.7	41.8	57.9	40.3	27.3	33.2	30.8	18.7	18.4	56.5	68.2	44.7	41.1	24.7	12.6	55.7	70.9	21.2	41.7	46.0	18.4	44.4	28.0	28.5	43.5	36.2	51.9	23.3	33.3	39.7	31.5	38.4	29.5	28.2	19.7	33.2	74.6	39.3	32.1	49.8	37.8	29.1	44.3	32.6	48.4	34.3	45.9	46.3	23.7	51.3	37.9	58.6	48.1	60.0	29.1	38.0	44.3	31.2	37.4	54.9	59.0	11.8	25.0	46.7	36.9	51.9	52.5	31.9	34.0	29.0	38.8	34.5	58.5	51.6	41.7	25.9	39.1	41.3	40.1	21.5	34.9	50.9	44.1	15.5	34.2	31.8	42.1	55.7	10.6	56.4	40.3	36.1	22.1	13.3	49.0	38.5	70.2	66.7	18.6	41.8	31.6	35.4	85.5	59.4	34.5	60.3	30.0	31.7	23.8	27.0	46.2	31.2	59.2	16.7	34.4	45.7	24.7	20.7	43.8	24.1	28.4	47.3	28.5	29.1	35.4	30.4	43.8	26.6	30.2	30.9	32.6	34.3	48.4	44.3	45.9	46.3	18.7	17.3	11.2	15.5	18.7	18.4	24.7	12.6	18.4	19.7	83.4	82.6	129.4	146.5	95.1	26.0	57.2	214.0	68.3	101.2	122.1	21.6	264.5	202.2	211.7	36.2	236.3	103.8	23.3	215.7	493.0	216.8	157.8	217.7	143.3	324.9	19.1	151.1	167.6	353.0	67.9	277.3	291.4	150.1	267.9	172.8	64.3	169.6	103.7	156.3	255.0	33.2	168.1	121.7	176.8	142.9	104.8	255.7	159.2	214.9	195.4
SEC11C	"SEC11L3, SPC21, SPCS4C"	ENSG00000166562	"SEC11 homolog C, signal peptidase complex subunit"	Q9BY50	18	59139477-59158836	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 132.6"	"Cell type enhanced"	"Detected in all"	5	"Glandular cells: 405.9;Muller glia cells: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 59.5;Karpas-707: 64.1;RPMI-8226: 129.8;U-266/70: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026816, HPA047533"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Nuclear membrane"	"Golgi apparatus"	"HPA026816: AB_10602089, HPA047533: AB_2680078"	"unprognostic (1.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.15e-1)"	5.9	18.4	30.1	18.6	29.7	11.3	16.0	14.9	25.2	12.2	18.7	24.4	27.8	27.5	9.1	58.0	10.7	9.2	11.1	7.2	27.7	33.9	19.0	66.8	13.0	22.0	41.8	21.3	7.0	96.8	14.6	46.6	8.1	27.1	48.8	16.4	10.0	132.6	34.1	4.3	7.9	21.1	6.6	51.3	23.6	28.4	6.4	25.3	7.3	35.9	8.6	23.4	18.9	5.9	33.6	50.0	10.6	17.6	17.3	34.4	32.6	8.8	10.7	5.8	9.0	3.6	0.6	7.4	8.0	6.9	9.9	6.0	7.5	4.8	20.3	12.7	4.8	7.3	9.5	9.1	6.0	5.7	59.5	12.5	6.5	7.4	22.9	10.8	21.5	9.9	2.0	14.4	6.1	16.6	2.1	3.2	8.7	7.5	64.1	3.5	10.4	8.8	8.6	5.9	14.7	6.6	8.0	5.7	129.8	6.4	7.4	27.1	10.8	4.8	19.5	27.1	3.3	8.8	15.8	2.6	12.0	5.0	4.2	9.6	65.4	48.1	19.9	12.0	14.6	14.7	10.6	13.1	9.4	25.9	15.5	33.1	33.6	27.3	25.2	13.5	17.4	14.3	19.5	2.0	17.3	17.6	50.0	34.4	32.6	30.1	29.7	14.9	25.2	27.7	33.9	41.8	21.3	27.1	25.3	26.8	96.0	46.9	40.1	29.0	63.6	51.8	132.5	95.0	89.9	57.6	47.1	59.9	74.6	117.2	35.1	52.2	73.8	23.3	229.6	80.5	24.9	405.9	46.2	201.1	102.0	47.7	325.7	35.6	28.2	14.8	11.5	58.2	243.0	32.5	93.2	440.4	146.8	74.8	21.5	86.0	65.5	6.5	40.9	97.2	84.1	39.6	125.2	74.3	75.9	57.4
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77086716-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Ito cells: 287.8;Late spermatids: 570.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 71.8"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 71.8"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 92.7;TIME: 57.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	40.8	34.0	25.4	25.3	39.1	33.4	40.6	42.3	33.2	27.7	11.1	21.9	12.2	13.3	15.8	18.9	18.8	15.9	21.2	18.2	27.0	19.5	25.1	15.8	38.4	25.8	31.6	20.6	12.6	18.3	17.3	18.6	49.3	22.5	10.8	10.5	24.2	21.4	12.9	51.0	11.9	12.2	16.2	25.8	33.9	18.4	35.4	24.4	10.0	24.0	14.4	26.0	15.7	14.7	2.4	2.3	71.8	6.2	1.5	2.0	1.9	11.9	8.7	15.5	23.8	6.5	8.0	5.5	10.9	9.4	12.8	11.2	11.6	7.8	32.0	22.0	15.0	15.8	4.6	6.9	10.6	16.7	5.9	6.2	16.7	6.8	15.1	11.1	3.4	7.8	11.3	4.3	10.7	11.2	17.1	92.7	3.9	10.2	27.1	18.1	6.1	5.9	4.4	5.6	5.2	7.9	4.5	24.9	23.7	21.9	4.8	11.9	9.3	12.0	6.4	6.7	14.9	5.3	3.7	57.9	14.6	13.7	7.9	7.7	15.5	12.1	16.8	6.3	3.5	4.3	4.2	3.2	9.2	0.7	5.5	0.6	2.4	0.7	0.5	2.3	1.2	0.8	0.5	71.8	1.5	6.2	0.8	2.0	1.9	25.4	39.1	42.3	33.2	27.0	19.5	31.6	20.6	22.5	24.4	38.7	24.7	57.3	18.3	26.1	28.1	14.2	15.3	62.9	25.0	26.2	17.7	8.9	84.6	15.6	199.7	196.1	10.7	23.3	18.0	9.4	22.0	33.6	32.5	9.4	43.6	35.0	18.9	287.8	111.7	570.5	24.5	46.3	33.7	53.3	13.7	19.7	30.2	13.5	16.3	18.1	16.8	38.8	18.7	27.0	43.4	26.6	11.1	35.5	10.7	33.3
SEC14L4	"dJ130H16.5, TAP3"	ENSG00000133488	"SEC14 like lipid binding 4"	Q9UDX3	22	30488913-30505711	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 35.8;testis: 13.4"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.6;Cholangiocytes: 15.3;Hepatocytes: 13.9;Muller glia cells: 8.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 3.1;neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.1"	"Cell line enriched"	"Detected in some"	4	"BEWO: 29.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.0"	HPA069748			Approved	Centrosome		NA	NA		44000	Centrosome		"HPA069748: AB_2686187"	"unprognostic (6.98e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.06e-8)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.98e-2)"	0.1	1.1	0.1	0.1	0.1	6.7	0.1	0.2	0.4	0.4	0.2	0.1	0.1	0.0	0.1	1.0	0.3	0.2	0.4	0.1	0.1	0.1	0.3	35.8	8.5	0.1	0.1	0.1	0.2	0.2	6.7	0.2	0.3	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.5	0.4	13.4	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.7	0.5	3.1	0.4	0.4	0.4	0.1	1.7	5.6	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	3.1	0.4	0.4	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.4	2.6	0.4	0.3	0.5	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	20.8	8.6	0.0	0.5	0.1	0.1	0.6	15.3	1.4	2.3	1.8	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.2	0.2	0.4	1.1	13.9	0.1	1.6	0.0	0.6	0.3	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.6
SEC14L6		ENSG00000214491	"SEC14 like lipid binding 6"	B5MCN3	22	30522799-30546682	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 15.4;parathyroid gland: 20.9"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.0;Club cells: 6.8;Collecting duct cells: 12.2;Muller glia cells: 14.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.6"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"K-562: 11.2;RPTEC TERT1: 21.1;SiHa: 6.2"									HPA067695			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067695: AB_2685889"	"unprognostic (3.49e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.25e-2)"	"unprognostic (8.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.02e-2)"	0.7	0.7	3.3	0.0	3.6	1.1	2.4	1.1	2.1	2.3	0.0			0.1	2.0	15.4	0.0	0.9	2.8	0.0	2.4	3.4	7.2	0.0	7.9	0.0	4.0		1.7	3.5	20.9	1.8	0.0		1.0	0.0		0.0	1.6	0.0	7.3	0.0	1.3	3.9	0.0	0.6	3.8			0.0		0.1	0.1	0.0	1.2	0.9	2.7	0.8	1.9	2.2	0.3	0.2	0.1	0.9	0.3	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.2	0.5	0.3	1.1	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	2.8	0.3	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.7	0.0	0.1	11.2	0.2	0.0	0.4	0.1	0.4	0.5	0.0	0.1	0.2	0.0	0.1	21.1	0.2	0.2	0.1	6.2	0.1	0.0	0.2	1.7	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.3	0.1	1.9	0.8	0.7	0.6	0.6	1.6	0.7	0.5	0.5	0.2	1.2	0.6	0.9	2.7	1.9	0.7	0.9	2.2	0.3											11.9	8.0	0.0	0.3	0.1	0.0	0.3	5.1	0.0	6.8	12.2	0.0	0.0	1.7	5.1	0.0	0.4	0.0	0.0	0.7	0.0	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	14.0	1.9	0.0	0.7	2.6	0.3	0.0	0.1	0.5	0.2	0.0	0.1	0.0	0.0	0.1
SEC16B	"LZTR2, PGPR-p117, RGPR, Sec16S"	ENSG00000120341	"SEC16 homolog B, endoplasmic reticulum export factor"	Q96JE7	1	177923956-177984303	"Predicted intracellular proteins"	"ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 43.4;liver: 47.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 57.2;Late spermatids: 36.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.5;CAPAN-2: 9.0;EFO-21: 6.9;HDLM-2: 6.9;Karpas-707: 6.1;RPMI-8226: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054292, HPA072913"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Actin filaments"		NA	NA			"Endoplasmic reticulum, Plasma membrane"	"Actin filaments"	"HPA054292: AB_2682439, HPA072913: AB_2732213"	"unprognostic (2.31e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.34e-4)"	"unprognostic (6.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	1.4	1.8	1.1	3.2	0.9	0.0	1.5	0.9	2.3	1.7	19.6	0.9	0.9	14.3	1.3	0.9	0.9	1.6	2.5	2.2	0.9	0.4	2.5	47.4	0.9	0.9	0.9	0.9	1.8	4.8	0.1	1.4	0.9	1.0	0.9	1.6	0.9	1.4	0.9	3.9	0.9	43.4	0.9	0.9	2.7	4.0	0.9	0.9	0.9	1.4	0.9	1.0	0.9	1.0	0.0	0.7	0.0	0.7	0.0	0.0	0.2	2.3	1.9	0.1	1.9	2.5	8.5	0.1	1.9	0.6	0.1	0.9	1.3	9.0	0.8	6.9	1.5	0.1	0.0	0.5	0.2	0.1	6.9	0.1	0.0	0.0	4.2	0.2	0.1	0.0	5.0	0.6	0.3	0.1	0.2	2.7	0.0	0.0	6.1	4.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	7.8	0.1	0.2	0.8	1.6	0.1	0.2	1.0	0.0	0.1	1.6	0.9	1.3	0.2	0.8	0.0	2.0	0.8	0.1	3.4	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.1	0.9	0.9	2.3	0.9	0.4	0.9	0.9	1.0	0.9	0.0	1.3	0.5	0.2	0.2	1.0	0.4	10.2	2.7	2.3	1.8	2.0	0.3	0.0	0.4	9.0	1.4	1.0	0.0	1.0	0.0	0.8	0.1	1.1	57.2	0.6	11.1	3.5	4.3	2.7	36.6	2.3	0.6	1.7	0.0	4.4	0.8	1.2	3.7	1.1	1.7	4.3	0.0	1.4	0.3	0.9	0.9	0.0	0.0	4.3	0.1
SEC22C	"MGC13261, MGC5373, SEC22L3"	ENSG00000093183	"SEC22 homolog C, vesicle trafficking protein"	Q9BRL7	3	42547969-42601080	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031242			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA031242: "	"unprognostic (1.68e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.35e-7)"	"unprognostic (2.59e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-3)"	25.3	20.9	27.6	13.4	30.5	28.0	28.8	19.0	30.5	24.1	21.1	32.8	17.4	28.4	26.2	25.8	16.4	22.2	17.4	22.6	27.5	25.4	22.5	14.1	24.6	18.9	34.7	24.6	29.0	26.6	23.8	23.7	17.7	27.6	36.4	14.5	25.7	23.3	25.1	15.4	14.5	31.6	24.9	49.2	15.8	20.7	32.0	25.6	14.5	23.5	11.8	15.2	18.4	17.6	11.5	10.3	18.8	10.7	9.9	19.4	9.2	12.3	11.6	16.2	14.5	32.5	30.7	4.5	22.4	20.7	21.5	22.7	8.2	18.4	12.0	9.2	23.2	15.5	6.6	12.5	18.9	19.4	16.7	14.2	18.7	19.6	9.3	25.7	10.3	19.2	18.2	23.2	26.9	28.7	20.6	24.5	19.3	18.5	21.1	21.1	8.0	12.3	9.5	10.2	6.8	17.3	6.3	11.5	10.5	17.7	10.1	9.5	13.7	17.1	12.6	15.7	12.4	24.5	9.6	22.3	19.6	15.6	29.7	21.7	17.8	26.9	11.3	21.3	13.2	18.2	8.7	10.7	18.8	13.7	7.7	19.4	11.5	17.7	16.1	9.9	9.8	15.2	13.4	6.0	9.9	8.0	10.3	14.2	9.2	27.6	30.5	19.0	30.5	27.5	25.4	34.7	24.6	27.6	25.6	23.8	25.9	19.9	14.3	13.4	15.4	16.9	25.5	18.7	18.2	10.4	27.5	18.6	34.9	26.6	32.1	31.2	4.2	70.0	28.5	17.2	32.7	23.5	48.5	10.6	28.2	25.4	8.6	27.6	18.3	9.9	30.2	19.3	38.8	45.1	4.4	31.0	23.7	0.0	40.3	22.3	31.8	38.8	31.4	75.8	54.1	8.9	8.8	28.7	6.7	5.4
SEC23A		ENSG00000100934	"Sec23 homolog A, coat complex II component"	Q15436	14	39031919-39109646	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		54000	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: AB_2686223"	"unprognostic (2.40e-1)"	"prognostic unfavorable (5.75e-4)"	"prognostic favorable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.69e-4)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	23.9	23.5	10.2	16.8	19.1	7.1	22.1	18.6	20.6	21.4	29.6	8.4	14.0	30.2	30.0	16.8	20.3	19.0	17.2	26.5	11.0	14.8	14.4	55.7	13.5	15.5	12.5	12.8	24.3	8.5	4.7	17.2	15.5	19.8	18.6	18.6	16.2	9.8	31.0	31.7	9.6	38.3	52.8	8.3	11.8	16.9	12.3	6.9	12.9	11.8	11.3	11.3	31.9	18.9	15.6	19.8	38.1	21.6	26.0	26.1	17.9	10.8	20.5	17.9	15.8	32.7	37.6	5.4	43.8	37.9	31.2	39.0	20.5	9.2	2.6	10.7	61.1	13.0	8.7	22.4	17.7	45.7	8.3	7.7	4.5	16.3	66.5	25.0	7.5	6.9	28.7	9.5	21.6	16.0	24.2	26.1	6.0	3.3	6.3	24.3	10.1	6.7	3.1	4.0	16.8	19.6	9.8	24.6	3.9	16.4	16.5	1.9	4.3	30.4	9.0	9.7	15.2	11.1	2.3	29.1	16.6	12.7	24.1	11.0	6.1	7.5	12.3	11.2	6.4	15.8	38.1	21.6	24.2	18.2	18.6	26.1	15.6	23.0	23.4	19.8	14.5	24.2	19.6	19.6	26.0	16.3	17.4	24.0	17.9	10.2	19.1	18.6	20.6	11.0	14.8	12.5	12.8	19.8	6.9	14.9	30.6	32.3	28.2	23.0	39.5	49.2	15.3	2.7	17.0	29.6	64.8	13.2	6.6	7.8	13.7	33.8	75.3	0.0	4.8	35.6	56.3	32.7	27.6	112.9	22.6	28.6	23.5	113.0	33.6	13.4	69.3	27.2	23.6	14.4	25.3	17.0	13.0	30.0	67.1	31.8	52.0	38.8	60.4	16.7	14.3	21.0	20.7	29.8	20.9	29.1
SEC24A		ENSG00000113615	"SEC24 homolog A, COPII coat complex component"	O95486	5	134648789-134727823	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038901, HPA056825"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli fibrillar center, Vesicles"		"HPA038901: AB_10674843, HPA056825: AB_2683249"	"unprognostic (9.10e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.18e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.37e-3)"	"unprognostic (8.97e-2)"	12.5	18.6	7.8	12.9	8.8	15.2	19.9	10.9	8.9	12.9	19.7	6.7	17.7	20.8	12.4	11.0	18.1	9.6	11.9	11.6	7.2	6.7	10.5	43.5	12.7	19.8	6.6	5.8	11.7	18.1	16.6	25.1	22.2	9.7	10.9	13.2	9.8	27.2	25.6	19.7	10.1	33.1	10.8	10.2	14.2	15.4	7.4	7.3	10.7	12.8	11.5	14.3	14.7	12.3	5.6	6.1	8.1	5.8	4.8	7.2	3.0	11.1	6.3	12.0	9.2	18.0	18.3	13.0	17.3	21.5	13.9	24.2	23.5	6.8	8.4	11.8	20.1	14.8	6.4	15.0	13.4	24.4	10.2	7.1	7.1	9.9	17.4	12.8	8.3	14.3	11.3	7.7	13.4	9.9	12.2	12.7	5.9	9.6	13.0	13.9	6.0	7.9	6.1	7.8	10.3	4.0	8.1	10.7	9.8	9.2	8.9	5.1	5.2	11.2	5.4	13.8	22.0	9.5	7.0	13.7	11.6	4.4	14.6	10.3	23.1	20.2	13.9	13.6	8.9	22.0	8.1	4.9	3.5	4.2	5.8	7.2	5.6	4.6	4.2	6.1	3.7	4.4	5.0	3.0	4.8	5.7	4.1	4.2	3.0	7.8	8.8	10.9	8.9	7.2	6.7	6.6	5.8	9.7	7.3	6.0	6.7	8.2	12.6	28.3	7.6	5.1	12.7	6.7	13.6	3.5	11.8	8.9	5.0	5.3	8.2	7.9	23.6	0.0	11.6	13.7	15.1	22.2	12.7	51.2	10.2	12.7	9.1	17.2	14.6	3.1	7.8	10.5	13.5	5.4	16.8	6.0	13.2	11.5	12.7	10.5	7.3	6.5	11.3	8.8	8.1	28.2	19.0	7.7	12.4	27.6
SEC24B		ENSG00000138802	"SEC24 homolog B, COPII coat complex component"	O95487	4	109433772-109540896	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038181	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA038181: AB_10672472"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	25.5	20.2	15.8	18.3	16.5	26.6	34.5	26.9	18.9	21.4	20.0	16.8	19.9	15.5	26.2	19.2	22.6	18.9	18.7	20.5	14.2	12.1	18.9	49.5	20.4	17.8	15.7	11.8	24.9	20.4	30.7	27.7	22.3	15.1	19.1	18.3	22.5	20.2	28.3	37.0	25.8	17.4	25.5	14.8	17.4	18.0	12.1	16.7	31.7	20.8	18.3	21.9	24.9	31.1	13.9	15.7	14.6	13.7	15.7	16.1	10.6	12.1	11.1	17.7	13.2	21.5	21.6	10.1	15.9	19.5	13.6	12.1	10.1	14.1	11.3	8.4	24.1	11.7	10.3	19.7	15.9	20.1	13.8	9.8	11.7	10.2	11.1	14.5	15.4	13.8	21.2	20.4	15.5	18.8	19.3	20.0	11.7	17.8	10.3	20.0	9.9	22.3	7.2	6.7	15.1	9.0	14.5	15.6	6.5	16.5	15.2	12.5	10.0	12.3	26.2	9.4	19.0	7.7	6.0	18.4	16.0	10.7	13.9	11.3	10.0	12.5	10.8	14.2	6.2	12.8	8.2	12.3	14.6	12.3	13.7	13.7	13.9	13.7	12.8	15.7	11.6	16.1	13.2	12.3	15.7	13.2	6.2	11.9	10.6	15.8	16.5	26.9	18.9	14.2	12.1	15.7	11.8	15.1	16.7	23.8	12.5	8.6	17.6	31.5	21.9	25.7	17.8	13.4	17.0	5.2	5.9	10.9	5.0	8.9	3.3	20.2	15.4	23.3	11.2	7.7	14.2	18.4	10.5	24.5	10.7	15.9	15.0	17.8	22.5	5.9	19.0	12.9	16.9	3.6	15.3	19.7	10.8	15.6	20.5	8.4	20.7	12.9	15.0	13.0	13.6	32.0	13.5	12.5	13.2	27.8
SEC24D	KIAA0755	ENSG00000150961	"SEC24 homolog D, COPII coat complex component"	O94855	4	118722823-118838683	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041626, HPA053486"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041626: AB_10796348, HPA053486: AB_2682166"	"unprognostic (9.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (3.42e-6)"	"unprognostic (1.09e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	14.7	10.6	3.1	12.5	4.0	7.3	13.9	6.4	6.1	26.8	25.2	2.9	27.9	18.0	25.4	24.6	11.5	16.6	18.6	16.7	4.0	4.0	11.1	65.5	17.9	11.4	3.8	4.7	21.9	32.4	6.1	37.0	33.8	3.8	16.9	16.2	10.1	23.0	38.0	6.5	8.1	41.8	20.2	4.0	19.3	14.3	9.3	2.4	7.6	21.1	8.6	17.0	24.0	15.9	1.8	5.9	15.7	7.0	5.2	6.8	2.4	7.6	4.1	9.5	7.6	27.2	36.4	6.7	32.8	36.6	16.9	20.2	4.3	5.7	6.0	4.7	52.4	8.7	2.6	5.2	10.4	18.3	5.0	2.8	6.7	6.4	18.3	27.7	17.3	12.5	21.6	5.9	14.8	24.4	30.1	27.8	4.2	1.7	18.6	26.4	5.3	8.4	5.2	8.9	17.3	6.6	5.2	6.9	10.5	15.0	3.8	5.6	11.3	4.6	23.9	3.9	14.5	3.3	14.1	30.1	13.2	4.2	18.8	7.4	14.4	5.2	10.1	28.6	11.1	18.2	5.9	5.5	15.7	3.4	6.2	6.8	1.8	3.5	4.8	5.9	1.4	2.3	2.9	5.1	5.2	7.0	3.1	4.5	2.4	3.1	4.0	6.4	6.1	4.0	4.0	3.8	4.7	3.8	2.4	3.0	11.7	11.9	13.0	18.7	3.8	3.4	20.4	10.7	18.2	14.0	0.0	20.2	0.0	8.9	73.3	15.7	24.8	0.0	22.1	49.1	54.0	27.5	8.1	60.6	24.7	1.6	39.6	27.6	37.6	64.8	42.3	20.7	16.9	8.2	58.7	1.2	15.6	14.0	36.0	3.1	2.9	25.8	43.4	10.9	6.6	15.4	37.6	10.0	13.6	16.6
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818661-82901166	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		22000	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	41.3	40.6	22.5	28.0	29.2	30.6	34.5	27.4	30.6	46.4	36.0	26.4	39.2	35.7	53.6	50.2	37.7	34.8	36.1	42.8	23.7	23.8	47.3	57.8	33.9	26.6	25.3	25.3	67.1	79.1	42.7	62.7	54.1	36.0	37.2	38.1	32.6	47.8	46.0	38.7	34.1	51.4	46.2	24.5	28.4	35.9	23.3	23.3	35.7	50.0	31.0	39.5	47.1	37.6	29.4	34.6	34.8	36.0	40.5	40.0	30.5	25.1	11.4	33.1	23.3	59.0	73.6	24.1	46.9	52.7	26.5	32.8	19.8	32.4	32.7	20.7	93.6	15.3	12.1	32.6	31.0	36.6	33.3	13.0	19.9	19.7	51.7	58.7	21.3	25.4	70.4	39.5	40.3	46.4	45.7	42.8	14.8	30.3	32.5	47.0	22.0	28.0	17.2	22.6	26.9	10.5	20.9	17.9	24.2	42.6	14.5	21.4	23.8	18.7	32.5	30.3	35.2	25.3	24.1	43.7	34.8	18.1	30.5	29.4	24.4	10.4	44.9	34.8	25.7	39.9	34.8	31.1	23.3	32.6	34.8	40.0	29.4	29.2	31.8	34.6	24.4	29.3	28.0	9.5	40.5	36.0	28.9	24.0	30.5	22.5	29.2	27.4	30.6	23.7	23.8	25.3	25.3	36.0	23.3	98.3	74.0	44.9	45.0	53.8	48.4	69.9	50.9	80.3	120.6	45.4	51.1	47.9	23.2	54.7	22.3	50.3	62.5	23.3	61.8	70.7	94.4	74.7	70.7	86.8	41.3	39.7	36.8	58.3	42.7	13.0	128.9	48.4	49.0	43.3	90.1	43.6	63.6	38.6	118.5	55.5	61.5	51.8	81.2	28.3	33.4	64.7	68.2	34.8	46.5	74.0
SEC62	"Dtrp1, HTP1, TLOC1"	ENSG00000008952	"SEC62 homolog, preprotein translocation factor"	Q99442	3	169966635-169998373	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014059, HPA061450"	Approved		Approved	"Endoplasmic reticulum,Intermediate filaments"		NA	NA			"Endoplasmic reticulum"	"Intermediate filaments"	"HPA014059: AB_1858029, HPA061450: AB_2684524"	"unprognostic (8.15e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-1)"	33.2	30.8	43.1	18.8	46.0	27.3	22.5	30.3	51.7	28.7	26.6	19.7	33.1	19.6	26.1	47.7	25.5	18.7	20.2	21.0	41.7	40.7	41.7	65.7	25.7	19.5	53.2	25.9	31.9	39.5	37.3	34.7	37.8	53.9	34.0	19.9	10.5	39.7	30.8	22.1	11.2	24.4	32.5	55.1	35.3	30.1	16.3	40.2	17.6	42.3	12.2	21.8	43.7	28.3	38.5	14.9	25.0	15.5	12.7	23.6	11.0	34.3	24.2	19.1	16.8	57.2	30.3	12.0	44.1	32.5	20.6	21.5	25.8	36.3	38.7	49.3	31.5	34.4	32.9	23.4	21.3	32.4	30.2	22.7	26.8	15.1	25.9	41.6	27.1	17.6	30.2	20.5	22.6	22.1	28.3	20.3	12.0	16.4	37.5	24.4	28.7	14.2	14.4	19.5	27.6	15.9	19.1	27.6	52.1	29.5	22.1	19.6	18.5	36.1	39.7	30.1	19.2	59.4	25.0	27.0	29.3	13.3	24.4	35.5	43.5	32.6	60.5	30.7	21.2	27.3	6.4	14.1	25.0	19.4	15.5	22.2	33.2	18.4	19.4	13.0	38.5	23.6	20.9	22.2	12.7	11.6	14.9	16.0	11.0	43.1	46.0	30.3	51.7	41.7	40.7	53.2	25.9	53.9	40.2	220.3	262.7	342.9	200.0	226.0	367.3	496.5	300.7	294.5	280.9	645.6	261.1	203.3	165.8	224.9	14.0	313.8	139.0	771.0	299.5	183.3	350.0	241.8	280.2	977.5	192.3	427.5	250.7	386.1	211.1	22.8	518.6	248.1	264.9	296.6	208.7	387.4	260.2	190.0	409.4	320.7	346.7	291.1	249.2	173.4	114.7	150.7	363.1	201.5	162.6	151.0
SECISBP2L	KIAA0256	ENSG00000138593	"SECIS binding protein 2 like"	Q93073	15	48988476-49046563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.1"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 183.4;Syncytiotrophoblasts: 594.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039875	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039875: AB_10673365"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-3)"	"unprognostic (9.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (5.65e-8)"	"unprognostic (1.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.28e-1)"	13.2	12.6	30.1	8.5	32.2	14.4	14.3	18.1	38.0	15.2	10.8	40.7	12.1	7.2	14.1	17.4	13.2	14.4	11.1	11.1	38.4	23.8	19.3	13.9	27.3	9.5	38.8	24.8	15.5	10.9	42.0	12.7	29.4	36.7	16.3	9.2	8.1	30.8	14.8	10.1	8.3	8.5	11.5	66.1	10.6	13.6	9.9	35.6	6.7	18.2	6.7	9.8	10.8	10.3	14.7	8.1	14.6	6.0	7.8	11.1	4.0	4.7	5.1	11.5	9.6	16.4	12.7	6.8	16.8	14.1	14.3	17.7	5.7	4.3	3.3	8.0	12.8	15.0	4.0	14.4	4.2	16.9	19.2	3.5	9.5	7.4	4.5	8.6	5.2	10.8	10.0	5.5	12.2	6.9	15.2	13.5	8.0	5.7	8.5	16.5	2.0	5.4	5.0	4.1	3.1	4.6	5.5	12.6	13.0	18.4	10.2	2.0	7.8	10.9	20.0	15.9	20.4	5.8	6.1	16.2	12.5	6.0	11.8	7.8	7.0	12.4	6.0	9.9	7.6	16.6	9.3	5.1	14.6	9.0	4.9	8.5	12.2	8.1	6.1	3.6	14.7	11.1	8.7	9.2	7.8	6.0	8.1	5.8	4.0	30.1	32.2	18.1	31.5	38.4	23.8	38.8	24.8	36.7	35.6	107.2	183.4	25.3	14.0	13.2	33.9	35.8	15.3	99.0	61.4	31.4	25.5	71.2	13.3	23.4	8.2	29.2	20.7	0.0	16.3	30.7	28.0	30.9	31.3	22.1	23.2	54.0	9.2	26.4	13.7	6.9	31.1	18.1	43.9	28.9	14.2	35.2	29.3	14.0	34.3	32.1	25.4	6.5	21.7	17.4	27.8	11.8	594.9	17.5	9.9	31.0
SELENOF	SEP15	ENSG00000183291	"Selenoprotein F"		1	86862445-86914424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 217.7;Extravillous trophoblasts: 290.7;Hofbauer cells: 216.8;Syncytiotrophoblasts: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054937			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No			Nucleoli	Cytosol	"HPA054937: AB_2682642"	"unprognostic (6.15e-2)"	"unprognostic (6.98e-3)"	"prognostic favorable (6.53e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.65e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.34e-2)"	41.5	48.9	34.7	32.4	33.2	27.1	41.4	20.4	33.9	44.3	37.0	28.9	42.7	32.9	34.9	62.0	36.9	36.8	36.1	31.4	33.4	35.8	68.4	85.3	47.8	45.4	36.0	25.1	47.6	38.5	20.6	46.9	65.6	34.3	41.5	37.4	30.8	35.8	33.7	22.0	21.7	51.1	30.2	45.0	58.7	32.3	36.4	29.0	57.0	100.7	22.8	33.7	40.0	29.7	68.9	57.5	44.3	41.8	26.8	41.3	51.1	39.1	26.9	22.5	24.8	73.7	87.7	36.8	49.4	56.6	46.5	47.4	38.0	47.7	48.4	63.4	43.8	40.3	24.7	25.4	27.5	54.9	45.1	35.9	49.2	25.7	35.9	46.6	64.3	33.6	56.3	43.6	30.9	46.7	37.9	39.1	40.2	45.5	50.6	45.1	17.6	46.7	43.3	33.0	40.7	37.2	39.1	41.6	47.2	64.5	40.5	29.2	24.2	49.2	44.9	65.1	21.5	19.6	56.1	40.8	34.1	25.4	65.6	53.9	30.5	30.9	49.5	19.9	53.2	39.9	44.3	40.0	36.8	32.8	38.4	41.3	56.7	35.8	34.7	39.0	68.9	37.1	37.5	36.7	26.8	41.8	57.5	38.3	51.1	34.7	33.2	20.4	33.9	33.4	35.8	36.0	25.1	34.3	29.0	110.2	143.1	0.0	0.0	0.0	0.0	0.0	0.0	128.5	137.6	102.9	0.0	217.7	63.0	187.2	0.0	0.0	0.0	0.0	170.1	290.7	0.0	0.0	59.3	0.0	216.8	0.0	0.0	0.0	0.0	0.0	0.0	83.2	0.0	111.8	0.0	0.0	167.0	0.0	0.0	129.7	0.0	0.0	0.0	0.0	0.0	0.0	263.6	0.0	0.0	0.0
SELENOH	"C11orf31, SELH"	ENSG00000211450	"Selenoprotein H"	Q8IZQ5	11	57741250-57743554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 376.4;Hofbauer cells: 352.0;Proximal tubular cells: 359.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048362	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA048362: AB_2680370"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.60e-1)"	27.5	49.3	34.8	35.6	49.9	36.2	30.4	17.0	52.5	23.6	30.6	14.8	23.3	38.5	22.1	38.1	36.3	26.9	28.7	32.7	29.7	31.9	33.8	49.5	26.4	40.1	29.3	40.0	28.4	41.5	9.7	30.7	28.9	22.2	32.8	16.2	22.8	48.2	26.0	52.7	21.1	37.8	15.5	19.5	49.3	36.8	30.8	18.7	44.4	43.2	25.4	35.5	21.6	23.3	61.7	83.7	39.6	71.7	29.9	53.1	71.6	32.3	23.7	25.6	14.7	3.9	12.5	4.7	13.1	11.1	11.2	6.6	6.4	16.4	15.6	36.6	7.2	10.4	14.4	11.9	15.9	7.5	22.7	25.7	20.7	15.1	15.6	23.0	30.5	40.6	13.2	13.5	13.2	12.4	16.8	19.5	22.5	19.7	14.8	13.3	31.1	26.3	46.9	45.4	10.5	31.1	33.6	24.7	29.7	10.7	15.1	13.8	28.1	11.5	10.8	33.6	15.8	29.7	22.9	19.4	12.7	28.0	25.0	18.9	74.4	53.4	10.3	27.4	24.3	30.1	39.6	71.7	34.5	29.9	71.0	28.2	59.7	39.7	31.3	71.2	61.7	53.1	37.6	5.4	29.9	65.4	83.7	29.4	71.6	34.8	49.9	17.0	52.5	29.7	31.9	29.3	40.0	22.2	18.7	154.9	129.2	0.0	0.0	0.0	0.0	0.0	0.0	262.3	136.5	143.1	0.0	264.9	376.4	215.3	0.0	0.0	0.0	0.0	273.6	236.1	0.0	0.0	123.2	0.0	352.0	0.0	0.0	0.0	0.0	0.0	0.0	84.9	0.0	178.5	0.0	0.0	265.5	0.0	0.0	359.8	0.0	0.0	0.0	0.0	0.0	0.0	123.1	0.0	0.0	0.0
SELENOK	SELK	ENSG00000113811	"Selenoprotein K"	Q9Y6D0	3	53884410-53891988	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 244.0;Pancreatic endocrine cells: 237.2;Proximal tubular cells: 306.1;Syncytiotrophoblasts: 292.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 78.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 78.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008196	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008196: AB_1856665"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.85e-1)"	"prognostic favorable (7.18e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.56e-3)"	20.4	33.5	29.2	19.0	30.2	38.8	24.1	19.7	21.7	18.9	20.5	20.9	28.3	17.3	15.8	49.4	15.0	16.3	17.1	43.2	25.3	26.2	27.6	38.5	18.0	15.1	32.8	16.8	24.8	72.6	20.0	33.0	18.4	27.9	19.3	22.1	27.3	34.2	20.6	41.0	11.5	20.4	16.7	30.1	16.9	18.4	16.8	27.4	8.7	37.7	18.6	20.3	20.2	18.7	12.4	13.4	78.6	10.9	9.9	15.2	15.4	8.8	6.0	13.1	9.7	20.3	12.4	15.5	12.7	14.8	15.1	18.6	13.4	13.6	13.3	5.7	8.2	18.8	5.5	14.6	8.5	13.9	23.3	20.8	8.3	27.0	31.7	18.0	10.9	20.0	7.1	15.1	10.9	14.8	10.2	13.6	9.5	8.0	36.1	14.6	10.0	7.0	13.4	13.6	10.8	22.6	4.6	8.2	24.8	18.8	15.4	7.1	20.5	8.1	12.1	12.6	16.0	7.9	18.0	8.6	10.2	11.8	25.4	17.9	24.9	29.2	11.7	15.4	14.3	15.3	78.6	8.9	21.9	15.2	9.4	14.6	12.4	14.1	15.1	7.5	9.9	12.3	14.1	19.6	9.9	10.9	13.4	14.3	15.4	29.2	30.2	19.7	21.6	25.3	26.2	32.8	16.8	27.9	27.4	125.0	114.9	0.0	0.0	0.0	0.0	0.0	0.0	99.0	99.0	141.3	0.0	144.5	160.8	244.0	0.0	0.0	0.0	0.0	174.6	157.8	0.0	0.0	218.6	0.0	145.4	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	130.8	0.0	0.0	237.2	0.0	0.0	306.1	0.0	0.0	0.0	0.0	0.0	0.0	292.8	0.0	0.0	0.0
SELENOM	"SELM, SEPM"	ENSG00000198832	"Selenoprotein M"	Q8WWX9	22	31104772-31120069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 293.1;Distal tubular cells: 261.9;Exocrine glandular cells: 512.5;Pancreatic endocrine cells: 240.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 23.0;MAIT T-cell: 29.7;memory B-cell: 32.4;memory CD4 T-cell: 38.3;memory CD8 T-cell: 27.4;naive B-cell: 24.2;naive CD4 T-cell: 51.6;naive CD8 T-cell: 30.4;T-reg: 34.7"	"Group enriched"	"Detected in all"	6	"B-cells: 32.4;T-cells: 51.6"	"Cell line enhanced"	"Detected in many"		"BJ: 40.4;BJ hTERT+: 38.8;HHSteC: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008667, HPA019601"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		110000	"Nucleoplasm, Cytosol"		"CAB008667: AB_1622762, HPA019601: AB_1856666"	"unprognostic (5.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.51e-3)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.19e-2)"	35.9	19.5	19.8	31.3	20.6	2.4	33.4	13.5	20.8	83.5	66.2	9.1	38.3	22.0	67.5	34.2	53.4	46.1	67.2	25.5	19.1	20.6	19.2	6.6	18.2	35.1	20.7	11.7	49.9	38.1	18.1	27.2	22.1	15.9	59.5	10.7	41.4	57.3	89.1	29.4	11.6	24.0	76.2	14.1	18.2	35.2	21.9	8.8	1.4	45.7	12.2	12.8	92.5	36.1	32.4	1.3	2.4	7.5	7.5	51.6	21.9	3.2	6.8	2.0	11.4	19.1	22.4	22.3	40.4	38.8	18.8	13.7	0.2	0.5	0.4	8.4	23.7	8.5	0.3	1.8	2.4	1.3	1.8	6.8	0.7	2.1	3.4	51.1	0.0	3.5	21.8	7.3	8.9	3.4	9.0	2.4	0.6	0.6	3.9	4.7	1.7	0.1	0.4	2.6	3.0	7.3	0.0	0.0	4.6	2.9	0.0	4.4	9.7	12.6	11.2	0.1	0.7	15.5	0.2	8.2	5.7	16.1	21.1	0.0	3.6	1.6	0.2	22.8	0.0	3.6	2.4	2.2	0.9	23.0	3.8	29.7	32.4	38.3	27.4	1.3	24.2	51.6	30.4	1.6	7.5	7.5	0.4	34.7	21.9	19.8	20.6	13.5	20.8	19.1	20.6	20.7	11.7	15.9	8.8	50.6	112.8	0.0	0.0	0.0	0.0	0.0	0.0	37.5	59.1	293.1	0.0	11.2	261.9	97.3	0.0	0.0	0.0	0.0	512.5	132.0	0.0	0.0	27.9	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	74.9	0.0	0.0	240.3	0.0	0.0	109.7	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0
SEM1	"C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1"	ENSG00000127922	"SEM1, 26S proteasome complex subunit"	"P60896, Q6ZVN7"	7	96481626-96709891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 543.9;Exocrine glandular cells: 464.8;Extravillous trophoblasts: 599.1;Syncytiotrophoblasts: 729.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020429, HPA072648"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA020429: AB_1859527, HPA072648: AB_2686543"	"unprognostic (5.41e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.52e-4)"	"unprognostic (4.55e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (8.00e-5)"	44.1	58.5	33.3	38.6	48.7	23.1	29.0	25.0	36.3	29.6	48.4	16.8	44.0	41.5	33.5	44.1	45.4	24.0	29.5	69.9	34.8	27.9	34.7	91.6	24.3	28.2	31.7	31.8	45.7	43.6	14.8	51.2	63.5	32.2	32.2	27.8	22.0	43.4	34.5	109.5	34.2	39.0	42.1	43.8	25.0	40.0	52.5	28.8	28.8	28.7	61.8	28.0	31.5	34.0	50.6	94.9	36.7	65.7	42.0	79.0	48.9	63.4	37.5	52.3	54.3	22.4	19.5	28.2	51.9	25.5	21.9	27.4	33.9	52.8	41.9	129.0	25.2	67.7	32.9	43.7	35.0	31.1	48.7	33.0	50.2	55.2	52.6	20.5	74.2	37.6	24.8	27.5	32.7	33.5	34.3	29.2	50.4	65.0	51.8	22.2	80.4	83.8	105.3	70.7	64.4	34.3	32.6	67.4	49.5	31.0	63.2	43.1	54.5	96.9	81.4	52.8	83.8	23.2	56.6	60.0	43.2	75.2	79.8	64.7	32.6	87.4	121.2	47.2	65.6	59.4	36.7	61.3	15.8	45.5	65.7	43.2	50.6	59.3	53.1	86.3	45.3	46.9	47.2	4.1	42.0	55.4	94.9	79.0	48.9	33.3	48.7	25.0	36.3	34.8	27.9	31.7	31.8	32.2	28.8	160.8	197.7	0.0	0.0	0.0	0.0	0.0	0.0	274.4	190.0	232.1	0.0	543.9	349.8	309.5	0.0	0.0	0.0	0.0	464.8	599.1	0.0	0.0	94.2	0.0	339.5	0.0	0.0	0.0	0.0	0.0	0.0	130.5	0.0	421.2	0.0	0.0	446.5	0.0	0.0	414.8	0.0	0.0	0.0	0.0	0.0	0.0	729.5	0.0	0.0	0.0
SEMA3A	"coll-1, Hsema-I, SEMA1, SEMAD, SemD"	ENSG00000075213	"Semaphorin 3A"	Q14563	7	83955777-84492724	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 24.5"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 18.7;Club cells: 20.5;Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 65.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	15	"monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 42.8;BJ: 33.3;fHDF/TERT166: 36.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029447, HPA052235"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA029447: AB_10602302, HPA052235: AB_2681770"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.51e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-2)"	"unprognostic (6.18e-12)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.47e-4)"	9.6	1.1	2.9	5.2	14.6	0.3	3.7	1.0	6.0	7.4	17.8	1.4	0.7	2.3	1.5	3.3	8.6	3.5	8.6	3.7	2.0	2.1	1.3	1.1	4.9	12.9	1.6	6.5	1.4	1.0	1.3	12.0	14.7	11.1	5.0	8.7	8.2	1.5	0.8	1.0	2.7	5.3	24.5	3.3	17.9	5.4	1.8	1.8	0.0	4.2	1.4	2.4	11.9	2.1	0.0	0.2	0.0	4.7	0.3	0.3	0.0	3.7	10.2	42.8	0.0	1.3	1.0	2.8	33.3	19.6	2.8	1.7	3.6	10.0	0.0	1.6	36.2	0.3	18.5	0.1	7.9	3.9	0.0	1.4	0.0	1.9	0.0	1.1	0.8	0.0	1.3	0.0	6.0	1.4	8.7	10.4	0.0	0.0	0.0	1.1	0.2	0.0	0.0	16.0	0.1	3.7	0.7	18.2	1.0	6.2	0.2	3.3	1.7	0.2	0.0	0.3	7.1	0.2	0.3	5.8	3.7	3.9	10.7	4.8	2.5	1.7	0.0	3.8	1.4	7.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	4.7	0.0	0.0	0.0	2.9	14.6	1.0	6.0	2.0	2.1	1.6	6.5	11.1	1.8	3.0	1.7	0.0	0.0	0.8	10.3	4.1	0.0	18.7	20.5	0.0	43.2	0.3	0.0	0.0	0.1	2.7	0.0	0.0	1.8	0.1	4.7	0.3	1.1	0.0	1.0	3.2	0.0	0.6	0.3	0.0	2.3	0.0	1.7	0.0	0.0	16.0	3.2	0.0	0.0	0.0	65.3	0.0	1.0	1.6	1.7	1.1	0.2	0.0	0.0	0.3
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 109.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"basophil: 25.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 49.5;hTERT-RPE1: 43.2;RT4: 45.2;T-47d: 51.2;U-2197: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA			"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	27.1	4.1	3.7	11.9	5.6	0.2	25.1	1.2	6.8	37.0	31.7	7.6	21.6	4.3	26.9	25.1	20.0	7.1	16.4	12.4	5.2	6.1	5.8	1.1	12.3	0.3	13.1	3.0	23.5	1.5	0.0	4.1	5.9	25.5	29.6	14.1	27.4	13.6	19.7	7.3	9.7	10.6	48.8	8.5	8.9	13.3	11.6	6.0	0.2	2.5	15.2	1.5	35.5	14.5	0.0	2.0	25.8	3.2	0.0	0.0	0.8	1.1	14.6	30.4	0.1	6.8	16.5	0.0	9.9	11.4	5.0	6.4	2.3	27.6	0.0	0.4	3.3	49.5	5.9	0.1	8.9	8.2	0.0	3.0	1.8	13.1	0.1	8.2	0.1	0.0	7.2	5.9	12.4	12.2	43.2	0.0	0.0	0.1	0.0	8.4	21.1	0.0	0.0	0.2	4.1	2.3	0.0	14.7	0.2	26.3	45.2	0.1	15.7	27.8	7.2	1.7	13.5	51.2	0.0	23.8	27.5	12.6	66.4	17.4	0.2	0.0	0.0	10.4	0.0	27.2	25.8	3.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	1.0	1.8	0.0	0.8	3.7	5.6	1.2	6.8	5.2	6.1	13.1	3.0	25.5	6.0	8.9	12.8	0.0	33.4	23.5	0.0	35.1	0.0	109.7	19.4	7.0	5.9	0.3	1.7	3.6	0.4	3.5	25.9	0.0	5.8	0.5	25.3	36.0	4.7	0.0	9.3	0.0	5.8	1.3	2.6	1.7	7.2	8.6	52.3	4.6	16.2	1.3	40.1	15.8	49.1	0.1	0.3	0.0	16.2	0.3	0.2	16.6	0.2	0.0	23.4	52.9
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.8;thyroid gland: 33.0"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 137.5;Leydig cells: 48.6;Peritubular cells: 58.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"amygdala: 17.1"	"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 17.0;HaCaT: 17.3;TIME: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	NA	NA		77000	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	4.1	2.2	17.1	1.9	2.3	0.1	4.3	0.8	2.8	4.6	2.9	1.8	2.5	1.4	1.9	7.4	1.3	3.9	1.4	2.0	3.6	2.7	3.0	1.0	3.6	6.1	2.4	3.1	4.1	0.8	0.4	1.5	0.6	5.4	6.2	2.6	2.6	5.6	2.9	0.7	2.1	2.7	3.2	4.8	33.8	2.4	4.3	2.5	0.0	33.0	0.6	1.1	4.7	3.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.3	4.6	5.0	5.4	2.6	0.0	0.0	0.0	1.4	17.0	0.1	17.3	1.9	0.0	3.6	0.0	3.5	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	6.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	4.5	1.2	5.5	4.0	1.7	0.0	0.1	0.6	0.0	0.0	0.2	8.9	0.2	0.0	26.5	0.0	1.7	0.2	0.0	3.3	1.9	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.1	2.3	0.8	2.2	3.6	2.7	2.4	3.1	5.4	2.5	0.0	3.5	0.8	2.3	3.2	1.5	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	137.5	5.2	0.0	0.0	0.2	0.0	6.7	7.1	2.3	0.0	0.9	1.6	25.4	1.8	0.0	14.9	48.6	0.8	11.8	0.0	0.0	0.9	0.0	0.0	58.7	4.5	4.1	0.0	2.1	0.7	0.7	2.0	0.0	0.0	0.1	0.4
SEMA3E	"coll-5, KIAA0331, M-SemaK, SEMAH"	ENSG00000170381	"Semaphorin 3E"	O15041	7	83363238-83649113	"Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 163.8;Alveolar cells type 2: 146.0;Ciliated cells: 62.9;Club cells: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.0;SK-BR-3: 20.6;U-2 OS: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029419, HPA063804"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA029419: AB_10602090, HPA063804: AB_2685127"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.82e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (9.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-6)"	"unprognostic (1.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	4.0	1.1	2.4	1.0	12.2	0.6	7.8	2.0	12.2	5.5	6.4	1.9	0.5	2.2	5.4	1.4	4.7	2.3	6.5	0.9	4.0	4.7	1.0	1.0	6.1	0.6	5.9	6.4	0.9	9.6	0.7	1.4	1.1	5.1	15.0	4.9	2.4	6.2	9.1	1.0	2.2	3.6	10.3	6.6	0.7	3.8	0.9	3.1	0.9	2.2	0.5	0.8	9.8	3.3	0.5	0.3	1.4	0.6	0.7	0.5	0.2	0.2	1.1	0.2	0.0	0.5	3.3	0.0	0.0	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	3.5	0.0	1.4	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.9	0.0	0.0	0.5	0.5	1.2	0.0	2.1	0.0	0.0	0.8	0.1	0.0	0.0	20.6	0.0	3.6	1.6	0.0	0.0	0.8	7.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	1.4	0.3	0.5	0.3	0.3	0.5	0.3	0.4	0.3	0.3	0.5	0.5	0.5	0.8	0.7	0.6	0.3	0.3	0.2	2.4	12.2	2.0	8.7	4.0	4.7	5.9	6.4	5.1	3.1	163.8	146.0	0.0	1.0	1.0	41.8	1.2	17.8	62.9	75.1	1.8	0.0	0.7	0.0	4.2	0.9	0.5	0.0	0.0	1.0	0.2	2.1	3.6	22.1	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.9	1.1	1.7	1.8	0.0	39.8	4.4	0.0	0.0	0.1	2.7	0.0	1.0	0.3	0.4	0.4	0.2	0.0	0.0	1.1
SEMA4B	"KIAA1745, MGC131831, SEMAC, SemC"	ENSG00000185033	"Semaphorin 4B"		15	90160604-90229679	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0"	"Group enriched"	"Detected in many"	5	"B-cells: 14.7;granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 52.8;RPTEC TERT1: 32.7;RT4: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013372	Approved		Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA013372: AB_1856670"	"unprognostic (3.33e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.09e-2)"	7.0	19.8	13.1	13.7	16.7	7.1	13.6	9.1	13.1	16.2	21.7	9.4	18.2	24.0	9.0	12.3	56.7	16.3	20.3	13.8	13.3	7.6	18.6	32.1	11.6	10.0	13.4	11.1	17.0	19.8	9.4	10.8	14.6	15.4	18.1	10.0	15.4	21.3	15.7	4.0	29.0	22.2	13.5	18.8	16.3	22.4	8.3	14.8	12.8	32.7	15.5	27.2	31.6	24.6	14.7	0.9	4.0	2.0	0.3	0.7	1.0	5.9	16.2	1.2	3.8	1.1	0.8	8.9	1.8	4.0	2.3	2.4	1.9	52.8	4.2	20.4	1.3	13.3	28.3	1.0	26.3	1.9	24.0	3.4	5.5	4.0	2.6	4.5	0.6	2.5	3.2	11.5	2.5	5.2	9.6	2.5	1.2	2.6	6.7	1.2	4.4	1.5	2.3	5.5	13.2	14.9	1.8	0.9	9.2	32.7	35.5	3.9	3.9	6.4	10.4	2.4	2.8	7.2	1.7	5.7	1.8	3.4	3.8	4.1	9.7	11.8	2.1	17.4	4.5	1.8	0.0	2.0	0.3	0.7	1.2	0.5	14.7	0.5	0.4	0.9	11.8	0.4	0.5	4.0	0.3	2.0	0.1	0.1	1.0	13.1	16.7	9.1	13.1	13.3	7.6	13.4	11.1	15.4	14.8	14.9	22.7	19.3	32.9	57.8	2.9	5.5	10.2	17.4	40.9	15.7	23.6	11.3	3.3	21.9	0.9	4.5	26.4	0.0	31.3	69.5	4.8	31.7	0.0	11.5	10.7	15.9	4.1	4.3	5.1	0.7	12.0	6.0	5.0	1.0	13.0	31.5	34.3	19.0	11.3	3.3	45.7	19.4	15.5	0.3	3.2	49.9	10.4	4.4	14.9	45.4
SEMA4F	"SEMAM, SEMAW"	ENSG00000135622	"Ssemaphorin 4F"	O95754	2	74654228-74683853	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 11.8;Horizontal cells: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064095, HPA065969"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			Nucleoplasm	"Plasma membrane, Centrosome"	"HPA064095: AB_2732710, HPA065969: AB_2685590"	"unprognostic (9.69e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (5.94e-5)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.74e-6)"	"unprognostic (2.60e-2)"	"unprognostic (8.08e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (4.69e-2)"	8.1	5.1	15.5	3.5	15.5	1.3	5.7	12.9	21.3	5.2	3.8	3.3	2.3	1.9	6.6	6.7	2.7	5.6	3.5	4.9	17.2	12.2	4.8	2.1	8.1	5.1	5.3	16.5	9.1	4.6	13.7	10.2	3.5	7.8	5.2	4.2	3.6	5.0	5.7	3.0	4.9	3.0	7.0	5.7	4.7	4.3	7.2	3.8	2.9	4.7	1.3	4.9	3.5	4.7	2.8	0.2	1.4	0.4	2.5	5.6	2.1	6.5	4.4	4.8	6.8	7.8	4.4	3.0	4.5	9.4	8.2	7.6	1.8	3.8	2.2	4.9	7.2	19.8	1.9	7.0	7.7	9.1	5.7	5.9	3.8	1.8	3.6	2.8	0.8	6.1	4.0	6.7	5.5	2.9	18.7	3.5	5.0	0.2	0.1	4.8	1.9	3.5	0.7	2.6	3.7	4.3	0.0	6.2	0.0	6.4	3.0	3.0	7.2	6.6	2.7	8.2	6.0	3.2	0.5	3.8	14.1	6.8	3.4	8.2	5.3	5.2	0.3	17.2	0.3	7.5	0.5	0.2	1.4	5.6	0.1	3.2	2.8	3.0	4.9	0.2	2.1	3.3	3.9	0.8	2.5	0.4	0.1	2.2	2.1	15.5	15.5	12.9	21.3	17.2	12.2	5.3	16.5	7.8	3.8	0.0	6.2	0.0	1.5	0.3	8.8	1.4	10.2	1.4	7.9	5.2	11.8	0.7	1.7	2.0	3.1	1.6	0.4	0.0	1.4	2.0	1.2	1.5	2.3	0.6	0.7	11.1	6.9	2.5	0.0	2.4	0.9	0.7	0.0	1.8	0.7	4.1	2.7	0.9	1.4	0.2	5.7	6.5	0.4	3.1	9.8	0.4	0.3	2.5	1.0	1.1
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443616-116574934	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.2"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 93.0;Horizontal cells: 130.3;Ito cells: 160.2;Syncytiotrophoblasts: 291.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 12.9;HAP1: 15.1;NTERA-2: 33.8;SuSa: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"		NA	NA		180000	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	12.7	37.4	12.6	4.9	34.7	3.6	10.6	18.7	26.5	6.9	19.6	31.2	0.8	19.2	6.1	3.4	3.9	6.2	12.8	5.0	17.2	12.9	6.1	6.0	17.8	4.5	35.9	13.9	13.1	10.3	2.2	4.4	30.2	32.2	6.6	17.5	2.6	15.1	3.2	7.6	5.6	24.0	6.3	48.2	8.2	5.4	6.6	31.4	0.5	6.7	1.6	2.7	4.6	5.9	1.6	0.7	0.1	0.4	0.0	1.3	0.0	0.1	0.0	10.9	12.9	0.0	0.0	11.3	0.2	0.1	0.0	0.0	0.6	0.4	0.4	0.5	0.1	0.2	0.1	15.1	0.0	0.0	0.4	2.2	0.2	0.2	3.6	0.1	0.1	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.1	33.8	0.0	0.1	1.9	7.1	0.5	5.6	9.7	3.0	1.1	0.0	0.2	5.8	68.7	4.2	0.7	0.2	1.0	0.9	0.1	0.4	0.2	0.1	0.2	0.1	0.5	4.0	0.0	0.4	0.0	1.2	0.0	0.1	1.6	1.3	0.0	0.3	1.2	0.4	0.5	0.1	0.0	0.2	0.7	0.1	0.0	12.6	34.7	18.7	24.0	17.2	12.9	35.9	13.9	32.2	31.4	0.0	1.1	0.8	0.7	5.8	8.1	6.7	48.4	0.0	0.0	14.0	2.0	93.0	0.0	26.5	9.7	56.5	45.5	0.0	1.1	3.7	16.0	1.5	0.0	0.6	10.8	130.3	26.9	160.2	15.5	1.4	6.1	1.3	23.6	0.0	31.1	5.1	2.5	42.1	1.8	3.7	3.2	0.0	6.2	0.5	1.4	3.6	291.1	1.3	32.4	0.5
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 124.1;tongue: 43.4"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 15.3;Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 11.9;HUVEC TERT2: 20.9;TIME: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		290000	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	3.2	1.9	2.3	1.5	3.0	1.3	3.4	16.8	5.8	4.2	2.6	1.5	0.8	6.7	4.1	3.5	3.2	2.9	3.9	12.7	2.3	3.5	3.0	3.3	1.9	3.4	1.7	3.3	4.8	1.7	1.7	4.3	1.6	2.7	2.8	1.6	3.4	3.1	1.9	124.1	3.4	5.2	3.6	1.1	1.3	1.6	15.0	0.6	0.5	1.3	43.4	2.9	2.2	3.6	0.9	0.6	0.7	0.0	0.1	1.4	0.2	0.8	0.8	11.9	4.6	5.1	1.7	1.1	0.8	0.4	0.8	1.1	0.2	0.5	0.5	3.4	2.7	1.7	1.2	1.1	0.4	0.7	1.0	3.5	6.2	0.5	1.0	0.7	0.1	2.3	2.9	1.4	1.0	0.5	2.4	20.9	3.4	0.5	0.6	2.0	0.4	1.0	0.8	5.4	0.1	1.4	7.4	2.6	0.3	0.4	0.3	6.1	7.9	1.1	0.5	1.0	3.1	1.3	1.0	9.7	2.0	2.9	3.0	0.4	5.0	0.9	5.1	0.5	0.2	0.7	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.6	0.3	0.2	2.3	3.0	16.8	5.8	2.3	3.5	1.7	3.3	2.7	0.6	0.0	3.2	1.7	0.8	1.4	4.2	15.3	2.5	0.0	1.2	0.0	19.6	0.2	0.0	0.3	0.5	3.1	0.3	0.0	0.4	0.4	2.1	0.5	0.0	2.4	0.3	6.4	0.0	4.9	1.6	2.1	5.2	0.0	1.7	0.0	0.0	1.7	0.4	0.0	2.5	2.7	6.9	0.0	2.0	2.8	1.1	0.9	0.1	0.0	0.2	0.5
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.8;placenta: 36.7"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 47.6;Cone photoreceptor cells: 108.0;Enterocytes: 37.0;Horizontal cells: 74.7"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 13.4;SCLC-21H: 11.9;SH-SY5Y: 11.0;SuSa: 13.2;U-266/70: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		480000	"Plasma membrane"	"Golgi apparatus"	"HPA043109: AB_10793941"	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.3	1.9	10.3	3.7	16.7	0.8	5.3	5.4	17.1	5.3	14.7	15.3	4.3	18.9	2.1	2.9	2.0	5.2	4.0	8.3	10.3	11.2	14.2	3.0	8.2	2.2	14.0	13.6	25.0	14.8	16.2	6.1	36.7	15.9	4.8	12.0	10.0	4.4	8.5	15.6	3.1	40.8	3.4	12.7	2.5	3.4	2.6	11.0	0.2	6.3	1.5	1.1	3.1	9.6	0.5	0.0	1.9	0.6	0.0	0.8	0.0	0.0	0.0	2.2	0.0	1.3	1.1	0.2	0.5	13.4	0.3	0.0	0.3	0.1	1.8	0.0	3.4	0.0	7.0	2.8	0.9	0.0	0.9	1.6	0.0	4.1	0.0	3.6	0.0	0.1	1.0	7.3	0.0	0.4	0.0	0.9	4.8	0.1	2.9	0.4	0.7	2.2	0.5	4.2	0.0	0.0	1.3	0.0	2.0	1.0	0.9	11.9	11.0	0.1	0.9	3.7	13.2	0.4	0.0	0.0	6.2	0.3	0.2	0.0	8.8	0.0	2.0	1.6	0.2	1.6	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.0	10.3	16.7	5.4	17.1	10.3	11.2	14.0	13.6	15.9	11.0	47.6	1.0	0.0	4.0	1.8	3.3	9.4	0.0	0.0	3.4	10.4	108.0	14.7	5.0	1.0	0.1	6.7	37.0	0.0	0.2	1.2	6.7	0.9	3.5	0.8	2.3	74.7	16.7	4.9	0.0	0.0	21.6	0.0	8.5	0.0	2.6	14.3	0.4	6.0	12.7	0.2	2.0	0.0	12.2	0.7	5.1	1.0	3.9	0.0	9.8	1.4
SENP1		ENSG00000079387	"SUMO1/sentrin specific peptidase 1"	Q9P0U3	12	48042898-48106308	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011765, HPA046491"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA011765: AB_1079907, HPA046491: AB_2679672"	"unprognostic (2.66e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.20e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-1)"	5.7	3.3	3.0	9.0	4.0	8.4	5.2	5.3	3.2	5.5	4.9	3.8	3.5	3.4	6.2	4.3	5.7	5.2	3.8	3.6	2.7	3.3	3.8	3.9	4.3	7.3	3.0	2.3	6.2	4.4	6.1	11.4	8.1	3.0	4.4	4.7	5.1	20.0	4.7	6.8	6.6	4.5	5.8	4.3	6.4	4.5	60.2	3.6	15.0	5.2	4.8	8.3	5.7	6.3	5.3	3.8	7.1	2.6	3.8	5.5	2.3	7.1	9.2	11.5	8.6	3.4	5.1	8.5	7.7	8.6	13.2	10.8	11.3	11.6	19.4	6.7	7.0	5.2	7.0	14.2	6.8	13.5	17.6	6.4	17.0	8.9	5.4	5.7	15.8	11.5	4.1	5.6	11.9	10.6	5.9	6.9	13.2	14.9	9.3	6.8	5.7	19.7	5.0	10.5	4.9	7.0	18.7	12.1	9.5	3.6	8.8	12.1	8.3	11.1	6.8	4.5	6.8	10.7	7.6	6.3	11.2	10.1	6.5	8.1	9.6	15.5	19.0	6.9	36.8	5.1	2.0	1.8	7.1	4.3	2.6	5.5	2.4	4.2	3.9	3.3	5.3	3.6	4.1	3.8	3.8	2.0	3.8	5.0	2.3	3.0	4.0	5.3	3.2	2.7	3.3	3.0	2.3	3.0	3.6	8.9	6.2	5.6	4.2	3.3	8.2	2.1	7.6	5.3	10.3	3.5	3.9	3.1	3.3	3.0	10.2	6.3	2.5	0.0	5.6	2.8	3.7	3.6	5.8	6.6	3.8	14.3	3.4	7.4	10.0	3.3	5.8	4.8	1.7	5.4	3.7	4.8	4.5	2.0	6.3	3.4	8.3	0.0	3.1	64.4	24.9	5.4	2.3	4.4	3.6	3.0
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO1/sentrin specific peptidase 6"	Q9GZR1	6	75601509-75718278	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.9	20.0	24.3	21.8	24.5	27.1	25.9	35.0	24.3	32.5	27.7	23.5	24.9	16.8	37.7	21.2	21.0	27.4	21.5	20.0	22.8	19.8	24.1	22.5	22.5	21.1	29.6	20.3	38.7	21.8	40.1	44.2	26.8	27.0	27.7	21.8	23.0	20.4	25.7	27.8	22.0	24.1	43.0	27.2	24.7	21.3	26.1	28.6	28.5	34.8	15.8	23.9	27.1	34.0	9.9	10.9	19.4	13.1	9.8	11.2	5.5	10.9	11.5	26.2	18.7	20.4	27.2	19.5	19.8	22.1	16.8	21.0	15.8	10.6	18.6	18.8	22.8	19.8	14.1	24.6	13.2	26.0	27.4	21.3	28.2	13.9	14.7	28.4	24.5	20.8	21.0	22.1	15.7	35.1	20.4	27.7	15.6	34.1	20.7	20.5	13.4	9.7	13.2	15.9	14.8	9.8	18.3	13.8	27.2	17.9	16.4	22.9	23.7	16.9	15.0	17.2	22.0	13.5	23.4	23.1	15.0	16.4	7.7	20.4	23.8	23.6	14.9	7.5	23.4	15.8	5.2	7.4	19.4	7.7	7.9	11.2	9.3	7.8	10.2	8.7	9.9	11.2	9.9	14.7	9.8	13.1	10.9	6.5	5.5	24.3	24.5	35.0	24.3	22.8	19.8	29.6	20.3	27.0	28.6	62.5	112.5	47.7	47.5	41.3	58.8	66.9	35.7	56.2	105.8	27.9	86.4	28.4	14.9	28.8	30.6	40.8	33.0	0.0	28.8	23.6	46.3	54.5	61.4	29.8	25.4	57.2	26.5	36.8	38.9	28.6	65.6	37.8	33.7	39.7	33.3	61.0	28.0	24.6	59.4	24.5	62.7	25.8	62.7	116.1	58.3	42.3	34.4	34.8	39.8	53.1
SENP7		ENSG00000138468	"SUMO1/sentrin specific peptidase 7"	Q9BQF6	3	101324205-101513241	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027259, HPA071998"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Centrosome, Cytosol"	"HPA027259: AB_1856679, HPA071998: "	"unprognostic (1.50e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.38e-3)"	"unprognostic (9.25e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.08e-3)"	"unprognostic (3.27e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.23e-2)"	17.0	9.0	11.0	19.1	14.5	19.5	16.5	35.5	19.5	21.7	13.1	11.8	8.2	6.4	24.3	15.2	11.9	18.6	12.8	10.0	13.2	9.1	10.5	7.7	11.5	19.0	12.9	10.8	27.9	15.9	22.4	24.4	17.0	18.7	15.1	10.0	9.2	10.2	11.1	11.1	18.6	13.8	16.0	17.3	14.1	13.6	7.9	16.8	32.1	16.0	9.4	15.4	17.2	14.0	6.8	3.2	24.5	4.1	6.2	7.6	3.8	7.0	4.8	23.6	13.0	4.5	6.9	4.3	4.1	3.0	6.8	8.5	3.1	6.6	5.4	6.4	3.9	6.3	7.1	7.3	3.7	13.8	10.1	2.2	9.8	3.7	4.2	3.7	5.7	9.7	5.3	6.8	3.4	7.8	6.2	9.8	10.7	8.1	14.0	6.4	4.6	10.4	6.6	4.8	3.7	5.1	11.6	6.3	4.9	8.2	4.1	9.1	7.0	3.8	3.9	5.1	12.7	6.3	7.6	8.0	9.5	5.9	3.2	4.0	9.9	5.9	12.8	3.3	7.6	7.7	24.5	4.1	3.8	4.2	3.6	5.2	4.2	5.6	4.2	3.2	6.8	7.6	5.1	12.6	6.2	3.8	2.8	4.5	3.8	11.0	14.5	35.5	19.5	13.2	9.1	12.9	10.8	18.7	16.8	14.9	26.4	9.5	7.3	8.0	47.4	19.3	5.1	38.8	25.0	15.7	19.6	5.0	5.0	6.0	2.1	22.9	5.6	0.0	4.5	2.2	13.9	6.7	34.8	9.6	6.7	49.3	12.6	42.4	22.1	2.5	17.0	11.6	10.1	1.8	6.3	20.1	6.1	2.9	18.4	6.7	33.6	45.3	9.9	20.4	17.1	8.7	2.1	22.4	4.9	3.9
SENP8	"DEN1, HsT17512, NEDP1, PRSC2"	ENSG00000166192	"SUMO/sentrin peptidase family member, NEDD8 specific"	Q96LD8	15	72114258-72143688	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 71.2;Late spermatids: 177.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036273	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA036273: AB_10669985"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.85e-4)"	"unprognostic (5.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.46e-12)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.54e-2)"	2.5	4.8	6.4	3.4	8.1	5.0	4.4	5.7	8.0	4.0	4.0	3.9	6.4	3.8	3.9	6.7	4.8	5.1	4.2	7.7	7.3	6.9	9.3	5.0	3.3	3.1	6.2	7.7	5.3	6.2	3.9	12.7	3.7	8.0	5.9	4.3	4.2	5.6	6.6	11.0	3.5	3.3	4.2	5.0	3.1	4.3	26.5	4.3	2.2	12.0	4.5	2.7	4.9	3.0	3.0	5.7	2.1	5.6	7.1	3.7	2.1	1.9	3.3	6.4	5.0	7.7	9.3	3.6	5.0	3.2	3.1	2.8	2.7	4.6	1.9	7.5	3.2	5.4	4.6	9.8	7.8	4.5	2.1	5.3	3.1	4.6	2.2	5.4	3.6	1.7	4.5	7.9	1.9	8.5	4.0	2.8	5.9	4.6	3.7	7.2	4.9	3.7	4.8	5.1	4.5	3.3	2.4	5.4	4.1	8.0	3.4	7.8	2.6	5.3	4.4	5.3	8.0	6.8	2.8	2.9	6.2	2.3	10.2	2.6	3.0	3.6	2.3	2.9	5.0	4.4	2.1	1.9	1.4	1.6	3.9	2.3	3.0	2.8	2.5	5.7	1.4	3.1	3.7	0.7	7.1	5.6	1.7	2.1	2.1	6.4	8.1	5.7	8.0	7.3	6.9	6.2	7.7	8.0	4.3	6.0	4.0	0.0	2.0	0.2	4.0	5.2	2.5	8.1	5.7	1.8	3.9	6.1	11.6	2.8	71.2	0.9	1.6	0.0	1.6	3.1	2.1	1.4	0.0	1.0	1.9	1.6	1.2	1.8	1.5	177.0	1.7	2.1	0.0	4.6	1.3	7.2	1.4	1.9	1.1	5.7	3.2	0.0	0.5	10.4	11.4	0.4	6.5	0.5	2.1	0.9
SEPHS2	"SPS2, SPS2b"	ENSG00000179918	"Selenophosphate synthetase 2"	Q99611	16	30443631-30446181	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.8;liver: 111.2"	"Cell type enhanced"	"Detected in many"	11	"Distal tubular cells: 326.6;Proximal tubular cells: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 96.4"	"Low region specificity"	"Detected in all"							HPA047931	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA047931: AB_2680216"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.86e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.35e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-2)"	9.0	9.0	4.9	6.9	6.4	4.0	6.7	6.3	8.4	5.3	25.6	5.2	5.5	26.6	7.6	6.1	6.0	6.1	12.6	5.3	5.2	5.1	32.8	111.2	5.8	7.6	5.5	3.8	5.2	10.0	7.3	6.4	7.5	7.7	6.6	13.1	6.2	10.6	4.7	11.1	5.5	52.8	4.9	4.4	10.5	12.1	3.0	4.6	14.1	11.9	6.4	9.5	8.1	4.4	14.6	15.3	20.5	13.7	23.2	18.9	8.9	14.8	13.4	4.8	16.5	14.7	9.4	12.5	10.3	12.7	10.1	12.6	8.3	11.4	21.3	15.9	10.9	9.2	8.3	8.8	9.4	10.3	13.6	27.2	21.3	7.3	39.0	18.6	11.8	96.4	11.9	20.1	9.5	17.7	6.4	9.2	15.8	17.2	13.9	8.9	21.9	17.7	24.4	11.8	11.2	10.2	17.3	8.3	16.3	12.5	13.4	10.1	8.7	8.8	25.8	33.4	10.0	22.6	39.5	7.7	10.6	7.5	10.2	6.2	12.0	19.2	11.1	9.2	22.1	11.8	6.1	12.9	20.5	11.2	11.2	17.1	12.4	15.9	16.1	15.3	14.6	18.9	12.9	12.9	23.2	13.7	10.9	15.1	8.9	4.9	6.4	6.3	8.4	5.2	5.1	5.5	3.8	7.7	4.6	41.7	32.3	26.8	1.1	33.3	0.8	46.2	0.0	21.4	21.6	61.1	0.0	1.1	326.6	80.1	0.0	17.5	13.1	0.0	72.7	0.9	24.9	1.7	30.1	6.7	1.2	0.0	34.0	0.6	2.4	0.0	0.0	34.5	42.2	64.1	1.1	0.2	55.5	3.5	0.0	285.3	0.8	0.0	54.6	0.7	0.7	37.3	1.0	20.8	1.4	0.6
SEPSECS	"SLA, SLA/LP"	ENSG00000109618	"Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase"	Q9HD40	4	25120014-25160442	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"RNA-binding, Transferase, tRNA-binding"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.2"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070409			Approved	Vesicles		NA	NA			Vesicles		"HPA070409: AB_2686265"	"unprognostic (1.83e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.37e-3)"	"unprognostic (5.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.82e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-3)"	7.0	6.1	3.8	8.5	6.4	11.8	7.4	5.4	6.0	5.3	13.5	7.8	8.9	11.8	6.7	9.6	5.3	6.5	8.9	5.6	4.8	3.6	10.5	34.2	9.4	9.7	7.2	4.9	8.5	11.3	7.3	5.1	4.4	5.4	4.7	7.8	5.2	6.2	9.2	5.5	10.9	15.3	3.7	7.0	7.5	7.4	8.9	6.8	12.3	7.7	4.8	8.0	6.8	5.5	5.7	5.9	3.2	4.0	3.4	5.5	2.2	2.9	1.6	6.2	3.3	5.7	7.9	5.4	3.0	4.1	3.4	3.4	1.3	7.2	5.4	3.0	3.4	3.8	3.6	4.8	3.6	3.8	2.7	1.6	6.6	5.6	2.6	6.4	5.8	8.7	7.4	5.7	2.5	5.6	5.2	3.6	12.2	10.4	5.5	2.7	1.7	9.3	16.3	2.9	2.4	6.1	4.8	7.4	4.8	4.7	3.1	4.7	4.4	2.7	2.2	5.2	4.6	4.2	5.6	3.7	5.2	2.7	1.6	2.9	8.6	9.6	6.0	3.2	9.6	3.1	2.4	4.0	2.2	3.6	3.4	3.5	3.4	4.5	4.9	3.4	5.7	4.6	5.5	3.2	3.4	2.4	5.9	2.6	2.2	3.8	6.4	5.4	6.0	4.8	3.6	7.2	4.9	5.4	6.8	0.0	7.4	4.1	1.5	2.2	2.6	3.9	25.5	9.4	3.4	15.7	0.0	4.7	6.6	4.2	17.7	6.3	8.5	0.0	4.1	3.2	4.0	2.3	3.5	35.0	5.4	4.8	5.8	6.7	6.9	13.0	3.1	5.8	3.3	6.4	6.4	3.1	4.6	7.0	6.0	17.4	2.2	0.0	1.8	13.4	18.5	2.9	4.9	4.9	7.3	1.1
SEPT1	"DIFF6, PNUTL3"	ENSG00000180096	"Septin 1"		16	30378133-30395991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	11	"blood: 54.4;lymphoid tissue: 89.8"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 61.6;T-cells: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 17.7;JURKAT: 23.1;MOLT-4: 30.1;REH: 17.9;U-266/70: 10.4;U-266/84: 15.1;U-698: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041566, HPA060339, HPA073635"	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA041566: AB_10794671, HPA060339: , HPA073635: "	"unprognostic (3.65e-3)"	"prognostic favorable (9.72e-5)"	"unprognostic (5.06e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.32e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (2.08e-1)"	"prognostic favorable (7.24e-5)"	"unprognostic (1.24e-2)"	"unprognostic (6.52e-3)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.72e-2)"	1.1	0.8	0.8	20.1	1.6	0.3	0.7	1.1	0.6	1.5	2.8	0.2	0.1	3.9	1.2	0.8	2.0	1.4	1.4	0.8	0.7	0.6	1.2	0.9	3.7	16.0	0.9	0.1	1.5	1.0	0.2	0.5	0.4	0.3	0.8	0.0	0.9	6.6	0.6	0.4	0.9	6.2	0.4	0.7	16.7	3.6	0.4	0.2	89.8	0.9	1.7	32.9	0.9	0.9	28.2	43.5	16.1	0.4	34.4	54.4	38.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.4	0.0	0.0	0.1	0.0	2.3	0.5	0.1	0.0	0.0	0.0	0.3	0.0	23.1	0.1	8.0	0.0	0.0	30.1	0.6	0.0	0.0	0.3	17.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.4	15.1	10.4	0.2	3.3	0.0	16.1	0.4	15.3	54.4	0.3	41.9	28.2	49.5	49.3	1.5	27.6	46.6	46.9	1.4	34.4	0.2	43.5	50.7	38.1	0.8	1.6	1.1	0.6	0.7	0.6	0.9	0.1	0.3	0.2	0.0	12.7	61.6	0.0	23.1	18.4	1.2	17.8	0.0	6.8	15.7	7.9	9.6	31.5	0.0	0.6	4.1	10.9	0.0	0.0	3.4	8.9	0.0	12.7	22.9	8.1	17.5	16.7	6.7	17.3	1.3	44.0	10.3	32.1	0.0	15.6	14.8	0.0	9.9	29.4	44.4	14.7	12.9	0.7	0.5	1.1	19.4	4.1	135.7	17.8	0.0
SEPT11	FLJ10849	ENSG00000138758	"Septin 11"	Q9NVA2	4	76949703-77040384	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 227.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Approved		Approved	Cytosol		NA	NA		6500000	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (1.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (5.70e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	39.9	6.4	25.0	12.1	36.6	3.2	28.0	24.8	49.7	21.1	22.8	9.9	7.8	10.1	16.7	12.2	10.9	11.1	21.8	14.6	17.2	13.7	25.5	16.0	18.8	10.3	11.4	27.1	10.2	10.4	7.8	5.7	39.1	14.3	12.3	19.5	7.9	8.5	13.1	17.4	6.7	16.2	19.2	10.5	11.6	11.5	4.5	13.9	2.7	10.1	5.9	10.3	15.9	16.8	2.7	12.0	18.2	3.8	21.2	6.9	3.7	12.9	5.3	51.0	45.2	30.5	24.4	14.7	75.7	58.5	17.2	24.3	9.6	9.6	0.3	15.8	91.1	8.1	5.5	16.8	11.2	26.8	16.9	5.6	25.5	7.1	6.9	26.7	13.7	10.9	30.9	5.3	24.9	9.3	13.7	25.8	5.2	10.5	7.2	50.6	7.5	18.0	0.4	17.1	10.6	2.7	21.2	58.0	1.5	9.7	14.2	17.5	13.1	14.7	8.4	12.0	34.2	7.6	5.5	28.0	57.8	17.3	28.3	13.9	4.4	3.5	0.1	22.0	1.5	11.6	6.6	1.4	18.2	5.1	1.2	3.1	2.0	5.8	6.9	4.5	2.7	2.2	5.9	0.4	21.2	3.8	12.0	3.2	3.7	25.0	36.6	24.8	49.7	17.2	13.7	11.4	27.1	14.3	13.9	14.9	13.2	17.5	0.0	20.4	51.2	11.2	15.3	36.1	21.6	82.0	23.6	74.7	33.2	0.0	3.4	49.3	65.6	46.7	0.0	227.1	109.2	0.0	81.0	42.3	44.8	58.8	35.2	60.8	13.0	3.1	99.5	34.0	28.7	0.0	49.9	32.4	0.0	56.1	112.8	45.9	25.0	135.8	45.3	1.4	8.1	13.4	50.6	27.4	62.6	0.0
SEPT2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		8800000	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	64.2	46.4	76.5	42.9	69.9	29.1	58.7	34.9	61.8	69.3	48.4	85.2	57.4	37.8	59.5	59.8	46.8	48.2	54.0	56.2	65.8	55.4	64.6	31.4	51.2	51.3	76.5	52.7	63.4	73.0	56.6	56.3	58.9	60.7	53.7	53.3	48.8	43.6	64.7	39.5	32.0	42.2	81.8	100.8	51.5	45.6	67.7	57.2	36.2	64.2	39.0	47.5	56.5	42.6	25.5	51.2	38.5	50.5	51.3	36.9	59.4	32.3	29.2	79.5	52.0	74.1	80.8	41.2	71.7	70.7	46.1	58.7	16.4	35.2	13.2	17.1	82.0	25.0	28.8	51.9	48.5	75.9	33.2	36.9	52.9	29.2	60.1	45.3	50.3	32.4	71.9	31.8	38.4	37.1	52.9	80.2	33.8	47.2	19.3	67.8	23.3	29.8	30.8	57.9	29.2	21.4	29.5	100.0	27.8	68.4	49.6	57.1	38.4	49.7	34.3	47.3	59.1	20.6	45.5	75.8	56.5	24.0	54.5	42.4	38.2	33.2	46.4	48.6	30.8	78.1	38.5	46.0	26.3	30.3	50.5	36.9	25.5	29.6	31.2	51.2	21.6	26.2	27.4	16.3	51.3	37.2	38.6	29.5	59.4	76.5	69.9	34.9	52.3	65.8	55.4	76.5	52.7	60.7	57.2	142.9	106.2	90.8	0.0	77.2	51.5	114.7	71.4	117.8	135.4	89.0	70.7	118.8	114.4	0.0	157.8	127.2	51.6	46.7	0.0	159.0	147.1	0.0	333.1	52.1	119.3	54.0	85.8	135.1	100.6	140.6	121.7	111.3	82.7	0.0	73.4	155.1	0.0	79.8	174.6	96.3	58.2	109.9	144.2	131.8	84.2	80.8	116.3	82.9	87.9	0.0
SEPT3	SEP3	ENSG00000100167	"Septin 3"	Q9UH03	22	41969475-41998221	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 101.6"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 17.5;Early spermatids: 10.9;Extravillous trophoblasts: 21.5;Horizontal cells: 14.3;Late spermatids: 20.4"	"Cancer enhanced"	"Detected in many"		"glioma: 24.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.2;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 13.8;SCLC-21H: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003548, CAB017633"	Supported	Supported	Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Nucleoplasm, Plasma membrane"	"Actin filaments"	"CAB017633: AB_2301476, HPA003548: AB_1079908"	"unprognostic (2.10e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.67e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	1.3	4.4	31.3	1.4	26.9	1.3	2.0	35.9	101.6	1.4	1.5	5.6	0.0	1.4	1.4	2.2	1.3	1.2	1.5	1.2	28.9	17.2	1.4	1.2	1.7	1.5	13.2	24.3	1.2	2.0	10.7	1.0	4.9	13.4	2.1	1.5	1.0	1.3	1.2	1.2	2.2	1.4	1.4	7.3	1.3	1.5	2.4	5.3	0.0	1.7	0.0	1.5	1.4	0.1	0.3	1.2	2.1	0.0	0.1	0.2	0.0	0.7	0.8	13.8	10.3	0.1	0.0	6.9	0.1	0.1	0.9	0.4	0.2	1.6	11.1	0.4	0.1	5.9	0.0	7.2	0.0	0.3	4.6	2.3	0.0	0.2	0.0	0.1	0.0	0.5	0.1	0.5	0.0	0.0	0.0	0.0	6.2	0.0	1.7	0.0	1.2	1.8	0.1	9.4	0.1	0.3	8.9	0.0	0.6	0.0	1.3	37.2	7.7	5.5	0.0	9.1	1.4	1.3	3.3	0.0	0.0	4.9	0.4	0.5	7.3	6.4	0.1	0.1	4.5	1.4	2.1	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.0	1.2	0.0	0.2	0.1	0.0	0.1	0.0	0.9	0.2	0.0	31.3	26.9	35.9	42.1	28.9	17.2	13.2	24.3	13.4	5.3	0.0	0.0	0.0	0.0	0.3	17.5	0.4	0.0	0.0	2.3	0.0	3.9	1.5	0.0	0.0	10.9	0.0	0.0	0.0	0.0	21.5	0.1	0.0	0.0	0.0	1.4	14.3	1.2	0.0	0.0	20.4	0.3	0.3	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.6	0.3	4.6	0.0	0.0	0.0
SEPT5	"H5, HCDCREL-1, PNUTL1"	ENSG00000184702	"Septin 5"	Q99719	22	19714464-19724224	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.2;parathyroid gland: 86.4"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 9.2;Late spermatids: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"eosinophil: 11.9;neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	46	"granulocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"K-562: 67.2;THP-1: 21.5"									"CAB016120, HPA029095, HPA063885"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		1600000	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.87e-6)"	"unprognostic (3.39e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.30e-2)"	4.2	6.4	60.7	2.3	62.9	12.5	5.1	31.2	86.2	12.2	3.0	5.5	1.1	2.2	7.4	17.0	15.0	14.1	5.5	50.9	52.9	14.6	2.0	1.1	3.7	3.0	12.4	38.7	9.0	5.5	86.4	11.1	4.4	14.9	4.3	2.7	5.3	3.6	4.0	2.8	42.9	2.5	6.4	3.6	2.2	3.4	6.2	9.5	1.9	6.7	4.1	3.1	3.5	5.6	0.0	0.2	11.9	0.1	0.0	0.2	6.3	0.1	3.1	12.2	18.9	1.2	4.0	0.1	4.7	5.9	5.3	3.1	0.2	1.6	0.4	1.8	10.4	7.8	1.7	8.9	1.7	2.7	3.2	1.1	0.2	0.6	0.0	4.9	0.2	13.0	5.3	2.2	1.7	0.7	1.5	2.2	6.7	67.2	0.2	8.3	1.2	1.3	7.5	1.6	0.3	3.3	13.6	0.4	2.1	0.3	0.4	19.6	16.0	0.7	1.0	0.8	3.2	4.9	21.5	0.8	14.0	18.8	0.6	0.9	1.3	0.0	0.1	1.7	0.6	4.5	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	4.4	0.0	0.0	0.2	0.0	6.3	60.7	62.9	31.2	86.2	52.9	14.6	12.4	38.7	14.9	9.5	0.0	3.4	0.0	0.0	0.8	4.8	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	9.2	0.5	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.1	3.2	5.1	1.3	0.0	35.9	2.6	0.0	3.3	0.0	0.0	1.9	0.0	0.0	3.2	0.0	0.3	0.0	7.2	2.3	2.7	7.0	0.0	0.0	0.0	0.0
SEPT6	"KIAA0128, MGC16619, MGC20339, SEP2, SEPT2"	ENSG00000125354	"Septin 6"	Q14141	X	119615724-119693370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 145.4"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 130.4;Horizontal cells: 100.1;T-cells: 146.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 52.7;MOLT-4: 56.0;REH: 51.6;SH-SY5Y: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Supported		Approved	Cytosol		NA	NA		10000000	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (6.35e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.24e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.60e-2)"	5.1	39.1	6.9	34.0	6.5	20.6	5.6	23.6	13.1	6.1	22.5	3.8	5.6	5.4	6.7	7.2	9.5	7.3	9.9	8.8	6.7	17.2	8.2	9.8	7.0	42.9	9.5	6.9	6.0	2.2	3.4	5.5	14.1	13.3	6.5	7.3	8.4	12.4	16.7	2.3	3.8	17.6	9.3	5.4	31.8	9.5	24.7	3.3	145.4	4.3	4.5	43.8	9.8	5.3	24.3	22.6	13.0	12.9	27.5	38.5	16.8	1.2	1.9	7.5	13.4	0.7	1.5	10.6	3.6	8.1	6.2	10.8	0.6	2.8	24.9	2.9	4.6	6.5	0.7	11.7	2.3	4.3	15.2	2.7	11.0	4.0	4.4	1.8	12.4	5.8	2.8	0.5	4.9	0.1	2.6	9.0	52.7	8.1	13.4	3.6	0.9	56.0	7.0	7.9	0.3	6.0	51.6	6.2	20.1	6.6	1.3	3.3	78.6	9.5	3.5	4.0	8.4	4.7	6.4	5.6	1.7	3.5	5.4	0.9	6.7	2.6	33.0	0.1	13.2	1.2	9.8	5.6	13.0	22.3	9.4	23.3	24.3	28.4	25.6	12.0	22.9	30.5	26.0	4.4	27.5	12.9	22.6	38.5	16.8	6.9	6.5	23.6	13.1	6.7	17.2	9.5	6.9	13.3	3.3	8.9	16.2	130.4	0.0	6.4	23.2	7.3	2.5	13.4	9.1	21.0	45.2	40.1	46.4	0.0	2.3	21.7	1.2	0.0	0.0	43.9	20.5	0.0	41.6	14.7	47.3	100.1	7.5	25.8	33.0	6.5	31.1	58.0	15.1	0.0	2.6	32.6	0.0	2.9	71.8	1.1	34.4	25.8	7.4	1.4	9.8	6.0	35.9	146.6	5.3	0.0
SEPT7	"CDC10, CDC3, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 1164.8;Sertoli cells: 802.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Enhanced	"Nucleoli,Actin filaments,Midbody,Cytosol"		Yes	No		16000000	"Actin filaments"	"Nucleoli, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	35.5	28.5	89.0	26.8	77.8	31.9	29.5	41.9	81.5	35.1	28.7	54.3	11.5	15.7	37.8	36.2	31.7	25.4	34.2	47.5	86.4	58.1	24.3	21.5	28.3	38.8	79.6	66.2	42.8	11.2	22.9	31.9	41.0	72.0	28.4	28.2	9.6	14.9	29.9	21.7	29.1	20.1	42.6	76.8	29.5	18.1	19.3	98.2	33.0	22.6	17.3	41.4	36.9	24.0	40.4	24.0	47.3	24.8	69.1	56.8	48.6	36.1	17.4	44.5	29.2	50.2	51.9	22.8	46.7	43.1	39.9	34.4	27.0	28.1	34.3	31.7	47.5	53.6	27.5	31.4	31.1	57.0	23.4	16.5	27.6	24.4	14.6	29.3	33.2	30.5	33.6	24.4	31.3	30.9	41.8	41.5	27.1	21.6	27.1	64.7	16.9	33.5	55.8	47.7	33.9	24.7	34.6	42.4	19.7	38.6	27.0	23.9	42.0	32.6	42.0	27.9	76.2	31.0	36.8	35.0	40.3	47.8	24.7	51.4	32.0	29.1	86.5	25.7	55.6	85.0	47.3	20.7	34.9	55.4	24.0	56.8	40.4	39.6	50.5	24.0	37.4	35.6	44.9	39.3	69.1	24.8	17.2	34.2	48.6	89.0	77.8	41.9	81.5	86.4	58.1	79.6	66.2	72.0	98.2	142.9	97.9	186.4	0.0	141.0	199.4	207.8	40.8	222.1	184.2	129.1	43.2	148.6	127.6	0.0	342.3	214.2	64.6	23.3	0.0	161.3	239.6	0.0	368.3	69.5	168.4	1164.8	58.6	187.2	128.6	256.8	324.7	171.1	178.8	0.0	61.0	328.2	0.0	106.6	426.0	108.1	113.7	802.0	509.2	101.6	233.2	140.9	103.9	294.1	77.5	0.0
SEPT8	"KIAA0202, SEP2"	ENSG00000164402	"Septin 8"	Q92599	5	132750817-132807241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 150.3"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 154.1;Muller glia cells: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005665, HPA036534"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	NA			Cytosol	"Actin filaments"	"HPA005665: AB_1079910, HPA036534: AB_2797226"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.86e-2)"	"unprognostic (4.30e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.70e-1)"	9.5	8.4	43.1	7.0	49.4	2.9	7.1	27.8	74.9	9.3	10.2	66.8	5.2	10.7	6.7	8.2	13.4	7.0	10.7	13.1	56.3	37.0	9.2	4.3	8.4	5.6	76.1	29.3	10.9	9.4	15.9	5.0	18.5	45.8	8.1	11.5	7.9	13.6	9.3	4.1	20.4	10.5	9.0	150.3	5.9	11.0	2.9	64.1	1.5	9.5	5.2	7.5	18.3	6.2	0.8	2.4	1.1	2.0	0.3	5.2	1.7	17.0	8.3	11.9	24.4	16.7	16.4	39.3	18.5	17.8	17.6	21.6	14.5	12.4	0.1	16.5	17.8	10.5	13.3	22.4	30.3	19.5	21.9	16.1	16.8	10.5	12.4	12.2	5.9	24.4	11.8	9.8	8.1	11.6	17.3	24.4	14.9	25.6	3.3	9.4	16.3	19.1	5.5	6.3	10.4	5.4	17.6	14.0	1.4	10.3	44.2	16.0	10.0	15.7	3.6	10.4	36.2	32.1	7.8	25.4	19.7	12.9	4.8	13.1	4.6	4.3	0.6	12.5	8.8	14.7	1.1	2.0	0.0	4.1	1.1	4.2	0.8	3.4	5.2	2.4	0.3	0.9	2.2	0.0	0.3	0.5	0.0	3.6	1.7	43.1	49.4	27.8	44.6	56.3	37.0	76.1	29.3	45.8	64.1	11.9	6.7	1.4	0.0	8.9	15.4	15.7	15.3	5.3	6.8	47.1	13.7	26.2	11.6	0.0	1.1	15.7	16.8	0.0	0.0	9.8	22.2	0.0	12.7	6.7	10.4	154.1	11.6	16.5	4.3	1.5	14.4	7.2	15.1	0.0	16.9	82.2	0.0	20.3	19.4	9.4	18.4	45.3	25.0	4.7	4.8	15.1	8.5	6.9	17.2	0.0
SERF1B	"FAM2B, H4F5C"	ENSG00000205572	"Small EDRK-rich factor 1B"	O75920	5	70025247-70043113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 1: 8.9;Cardiomyocytes: 34.7;Ciliated cells: 9.4"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.2;SiHa: 39.6;SK-MEL-30: 26.3;WM-115: 21.0"									HPA075271			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA075271: AB_2686740"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.52e-1)"	3.7	2.4	7.6	1.6	8.3	2.6	2.6	5.7	10.4	2.9	3.4			0.9	3.2	22.7	5.0	1.6	4.7	3.1	6.6	6.7	8.4	1.6	3.5	3.2	7.5		2.5	3.9	11.6	4.0	2.0		4.7	3.9		7.8	5.1	4.1	2.7	2.6	10.3	5.5	3.9	5.7	20.5			4.9		1.4	7.9	3.0	7.0	6.4	10.9	4.5	5.7	8.7	1.8	11.8	0.3	1.7	2.3	8.6	6.5	8.5	3.4	6.2	2.2	1.9	0.3	1.2	1.1	24.2	5.3	1.4	3.3	0.9	0.7	3.7	2.9	0.4	6.5	0.4	0.6	0.5	0.7	1.1	0.4	12.9	0.7	0.1	6.6	0.6	0.3	0.4	1.6	0.2	0.1	11.1	6.8	1.7	0.0	0.2	1.2	6.7	4.9	1.3	0.5	8.7	6.4	39.6	1.8	26.3	0.7	17.5	3.2	18.8	10.2	0.7	0.4	0.6	0.7	1.2	9.1	0.6	0.0	21.0	0.3	0.9	10.9	6.4	3.0	6.9	6.0	8.2	5.8	3.5	7.0	8.7	5.8	2.5	5.7	4.5	6.4	5.8	1.8											8.9	2.1	0.0	0.5	0.3	0.0	34.7	0.0	9.4	5.7	0.0	2.0	0.0	1.7	0.2	1.6	0.5	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	1.2	0.0	0.4	0.7	0.4	0.5	0.0	0.0	0.2	0.4
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443354-122471822	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	49.0	62.0	72.0	21.6	74.5	31.4	39.6	67.3	96.4	40.4	25.1	61.5	17.0	23.9	36.7	27.8	23.8	27.0	31.6	39.1	75.5	78.4	48.7	58.1	38.9	20.6	91.6	57.7	42.7	24.4	56.4	32.9	47.0	109.2	36.0	25.2	29.7	22.5	37.8	37.4	20.5	27.2	35.4	120.6	28.4	23.1	15.6	57.5	12.9	50.8	13.0	18.7	33.2	22.8	10.0	12.6	44.1	20.4	17.7	20.7	17.4	7.4	9.2	23.3	21.3	88.4	48.6	12.4	39.2	49.2	21.5	33.4	10.7	20.2	5.0	30.9	44.1	24.7	14.9	13.7	16.9	32.3	15.9	16.3	14.1	15.7	19.5	39.6	14.1	28.2	50.4	33.3	26.7	37.0	49.6	18.5	13.2	14.0	28.5	44.4	8.5	6.3	9.4	7.5	11.7	11.7	7.8	11.5	12.0	46.2	13.1	12.2	22.1	17.3	19.3	26.5	21.6	13.3	19.9	37.7	25.9	11.3	21.2	20.3	21.6	24.1	6.6	34.3	11.5	30.2	44.1	15.0	31.4	16.8	18.8	18.1	10.0	17.6	16.2	12.6	8.7	20.7	17.9	38.9	17.7	20.4	9.9	18.6	17.4	72.0	74.5	67.3	86.9	75.5	78.4	91.6	57.7	109.2	57.5	140.0	86.4	39.7	67.4	58.7	103.2	138.9	89.2	52.2	54.6	73.3	66.8	48.9	8.3	55.1	2.4	116.4	66.3	46.7	42.2	46.7	95.4	88.7	119.2	115.6	64.9	130.3	81.1	105.6	142.0	5.6	117.3	84.8	89.4	25.2	36.8	98.4	63.7	38.6	123.4	38.5	56.5	58.2	75.4	17.9	19.6	65.5	100.1	71.3	29.3	78.2
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.9"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 546.6;Enterocytes: 427.6;Pancreatic endocrine cells: 386.0;Syncytiotrophoblasts: 373.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 12.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.3;HaCaT: 53.9;HBEC3-KT: 85.2;hTCEpi: 48.5;RT4: 58.3;SK-BR-3: 48.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favorable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (2.11e-4)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	2.0	6.6	0.6	13.5	1.2	1.1	12.1	0.8	0.8	17.3	32.9	0.8	52.1	27.4	3.7	26.5	32.5	4.3	34.4	2.0	1.0	0.6	57.5	113.9	10.3	7.1	1.8	0.5	1.7	12.9	5.7	5.1	33.9	1.4	17.0	12.8	5.0	58.6	74.4	20.2	14.2	73.0	6.7	1.2	1.7	20.7	3.5	0.8	5.7	13.1	12.7	19.1	31.1	19.9	0.2	12.0	2.3	2.7	0.0	0.0	0.5	13.0	3.1	2.7	8.9	6.0	8.1	7.6	25.2	18.7	1.6	2.0	4.7	47.3	8.6	33.2	23.6	2.0	53.9	0.3	85.2	0.3	0.8	2.0	0.0	2.7	2.4	6.8	0.0	10.1	7.4	48.5	10.4	22.9	7.2	1.0	1.0	0.3	0.0	2.8	2.1	0.3	0.3	2.8	26.1	6.6	0.0	5.4	2.9	9.0	58.3	1.2	6.7	6.4	48.8	1.0	1.4	28.5	1.5	6.2	0.4	2.1	0.2	0.5	0.4	0.3	0.4	0.2	0.2	2.1	0.0	2.7	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	12.0	0.0	0.5	0.6	1.2	0.8	0.8	1.0	0.6	1.8	0.5	1.4	0.8	14.9	6.2	0.5	97.8	11.0	0.0	0.6	127.4	8.1	21.6	111.7	0.0	323.0	61.3	546.6	3.9	4.4	427.6	0.0	288.5	86.2	3.3	137.4	0.0	45.6	43.7	0.0	111.9	8.6	7.6	6.6	2.0	6.8	38.8	83.8	168.4	0.6	386.0	170.9	0.0	57.4	0.0	0.0	1.4	0.6	3.6	18.4	373.5	0.0	116.2	257.8
SERP1	"FLJ43424, RAMP4"	ENSG00000120742	"Stress associated endoplasmic reticulum protein 1"	Q9Y6X1	3	150541994-150603228	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 122.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (8.81e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.78e-1)"	24.5	34.2	23.1	22.4	22.6	25.4	38.0	12.5	18.4	38.6	26.7	15.6	59.9	21.4	20.2	56.7	29.6	28.1	25.1	15.1	17.4	16.5	27.7	93.6	38.1	47.8	17.5	15.6	31.5	137.6	21.1	33.0	33.2	14.7	32.9	23.8	15.6	103.1	58.9	9.7	18.1	33.5	15.6	18.9	42.9	38.4	17.8	16.0	38.4	51.3	17.3	33.6	31.2	29.8	49.6	67.9	76.4	89.1	36.8	68.2	90.5	33.1	7.1	10.9	8.2	16.0	18.8	25.0	23.7	15.3	13.0	15.3	18.5	14.6	26.8	45.8	17.1	10.8	16.2	17.6	12.2	17.3	16.5	15.2	28.4	6.2	18.7	31.3	25.6	19.1	11.2	22.0	7.5	37.7	14.2	15.1	18.3	13.8	37.9	11.0	14.3	21.6	22.3	20.4	21.0	18.5	28.2	8.3	83.3	15.7	10.7	18.8	16.0	9.1	20.1	35.9	13.7	17.7	25.1	14.6	6.2	11.4	13.3	18.2	122.2	34.9	36.0	11.3	25.2	5.7	62.2	88.3	76.4	52.9	81.8	68.2	49.6	56.9	53.3	67.5	47.9	56.7	52.1	64.4	36.8	89.1	67.9	54.3	90.5	23.1	22.6	12.5	18.4	17.4	16.5	17.5	15.6	14.7	16.0	62.5	139.6	390.1	556.3	477.8	73.3	37.8	160.5	156.6	144.5	164.0	55.0	242.2	310.0	207.9	287.5	159.5	300.1	0.0	263.4	394.7	208.5	631.9	219.9	431.3	345.7	39.7	243.7	217.3	540.1	505.4	203.4	389.3	330.7	232.6	361.6	114.7	332.1	414.1	178.9	241.5	64.5	109.9	173.1	132.7	83.4	518.0	790.1	279.9	304.6	899.5
SERP2	"bA269C23.1, C13orf21"	ENSG00000151778	"Stress associated endoplasmic reticulum protein family member 2"	Q8N6R1	13	44373665-44397714	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 40.7"	"Group enriched"	"Detected in many"	13	"Early spermatids: 499.5;Late spermatids: 180.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 5.9;SH-SY5Y: 8.3;U-2197: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (6.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	1.7	3.2	30.0	2.0	34.1	0.8	4.0	14.3	40.7	2.7	2.3	3.9	1.3	4.2	4.8	12.4	1.7	3.0	1.8	14.6	24.8	20.9	2.6	1.8	2.0	2.3	19.0	15.6	5.9	2.8	1.9	2.4	1.2	10.1	4.1	2.1	2.0	2.0	5.8	1.4	1.4	3.2	3.4	10.4	1.1	2.4	15.3	6.4	1.2	2.1	0.4	2.1	1.4	1.0	0.0	0.0	6.0	0.0	1.3	0.3	0.2	0.0	0.0	3.4	0.0	0.5	2.9	0.0	0.6	1.0	3.7	2.5	0.0	0.0	0.0	2.9	2.7	0.0	0.1	0.0	0.0	3.6	0.0	0.1	0.6	0.0	0.2	3.2	0.1	0.0	0.4	0.0	2.6	0.0	0.7	0.5	0.0	0.0	0.0	5.9	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.9	8.3	0.0	0.4	0.0	0.8	0.0	0.0	0.7	0.0	0.2	7.6	0.0	0.0	0.2	0.0	1.7	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	30.0	34.1	14.3	37.2	24.8	20.9	19.0	15.6	10.1	6.4	0.0	1.0	0.0	3.9	1.5	18.6	13.2	7.6	0.0	1.2	8.7	13.7	2.4	14.9	9.3	499.5	2.7	2.9	0.0	11.6	2.3	6.0	5.6	18.4	5.6	0.2	14.3	13.8	2.5	0.0	180.5	12.0	0.6	11.8	1.0	1.9	14.7	4.4	1.7	18.0	5.8	15.3	25.8	5.6	7.9	11.3	0.9	1.7	5.0	2.5	1.4
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280455-94293271	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	223	"liver: 169.5"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 200.2"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	5900000000	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	169.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.1	0.1	0.2	0.0	0.6	0.3	2.1	0.8	0.8	0.8	0.5	0.6	0.6	1.0	0.9	2.6	0.6	2.3	0.4	0.4	0.2	0.3	2.4	0.6	1.5	0.9	1.5	2.1	0.7	21.2	0.5	1.7	1.2	0.7	0.5	0.3	0.8	1.2	1.1	1.1	0.6	1.4	1.1	0.3	1.4	1.1	0.9	0.2	0.6	1.0	1.1	0.9	0.6	0.7	1.0	0.9	0.5	0.5	0.2	1.2	1.5	0.9	0.6	0.8	0.4	0.7	0.6	1.2	0.5	1.0	1.0	1.9	0.5	0.7	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.2	0.4	2.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	200.2	0.0	0.0	6.3	4.3	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661963	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 141.8;Club cells: 465.2;Urothelial cells: 238.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 186.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;HaCaT: 9.1;HBEC3-KT: 2.2;SiHa: 5.6;U-2197: 11.6"									"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000000	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavorable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.7	0.2	0.2	0.2	0.0	3.8	0.2	140.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	5.4	0.2	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	1.1	0.0	0.2	13.0	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.2	21.3	3.1	13.1	80.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.2	9.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	10.3	0.0	15.8	0.0	0.0	0.0	0.0	141.8	465.2	0.0	0.0	0.0	0.0	3.7	24.6	0.0	0.0	0.0	7.4	0.0	0.0	36.6	2.3	0.0	0.1	0.0	0.0	0.0	0.0	33.0	1.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	238.3
SERPINB6	"CAP, DFNB91, PI6, PTI"	ENSG00000124570	"Serpin family B member 6"	P35237	6	2948159-2972165	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 821.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009668, HPA012736"	Enhanced		Approved	Centrosome		NA	NA		5100000	Centrosome		"HPA009668: AB_1079919, HPA012736: AB_1856729"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.63e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (3.51e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	31.6	38.8	21.1	23.5	34.8	17.3	29.6	13.4	20.8	31.8	44.6	35.2	38.1	54.9	30.3	30.3	36.0	35.9	42.4	58.7	21.1	21.3	32.4	20.1	36.2	45.3	33.7	20.4	45.3	85.3	26.5	23.7	38.5	28.5	37.8	30.9	32.6	23.4	32.6	51.0	12.0	85.5	36.6	32.4	41.4	29.9	55.5	28.9	5.9	32.6	34.2	23.7	31.7	24.5	8.4	30.8	34.2	31.3	23.6	18.6	24.0	30.4	20.0	6.6	27.3	17.9	40.0	20.4	28.5	34.6	22.6	26.4	7.0	22.1	0.2	32.9	32.2	25.8	46.3	18.3	29.0	21.2	40.0	8.3	17.9	23.9	11.8	31.4	0.3	10.9	23.0	20.3	21.5	5.6	39.6	53.5	0.2	23.2	0.5	40.2	21.6	0.2	0.3	3.9	34.7	38.5	2.0	12.3	25.6	28.5	7.4	0.4	16.9	23.4	3.5	31.6	25.6	15.4	14.6	38.2	23.1	8.5	51.3	19.2	0.6	0.1	0.6	17.8	18.0	23.7	13.9	31.3	34.2	16.8	30.4	8.3	8.4	9.5	11.1	30.8	6.9	11.3	18.6	2.8	23.6	24.6	3.1	1.3	24.0	21.1	34.8	13.4	20.8	21.1	21.3	33.7	20.4	28.5	28.9	47.6	66.6	38.9	56.1	18.2	24.1	116.6	30.6	123.1	58.0	71.5	19.6	135.2	84.6	164.5	478.1	107.4	297.6	0.0	298.9	268.0	77.3	94.3	101.6	31.0	159.4	28.6	70.0	185.4	162.5	821.7	77.1	104.2	60.8	173.1	110.7	143.7	252.9	244.7	79.9	156.8	48.0	77.6	110.5	190.3	30.0	23.1	135.0	42.4	162.8	77.4
SERPINB7	MEGSIN	ENSG00000166396	"Serpin family B member 7"	O75635	18	63752935-63805376	"Disease related genes, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 70.6;Ductal cells: 49.1;Extravillous trophoblasts: 68.8;Pancreatic endocrine cells: 169.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 46.7;fHDF/TERT166: 32.9;HaCaT: 80.4;HBEC3-KT: 25.6;HBF TERT88: 44.7;hTERT-HME1: 26.0;U-138 MG: 44.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024200	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Endoplasmic reticulum"	Mitochondria	"HPA024200: AB_1856730"	"unprognostic (8.66e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.03e-4)"	"unprognostic (9.11e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-3)"	0.2	0.0	0.1	0.1	0.1	0.0	6.6	0.1	0.1	2.0	0.2	0.0	0.0	0.0	0.5	0.0	2.6	0.1	1.3	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	54.6	0.1	0.0	0.1	0.0	0.3	0.3	0.0	6.7	0.1	22.6	16.7	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.7	0.0	46.7	9.4	7.1	5.3	0.0	0.2	0.0	0.0	32.9	12.4	80.4	0.0	25.6	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.6	1.1	26.0	0.3	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	44.0	1.6	0.9	4.4	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	70.6	0.0	0.0	0.0	1.4	1.2	0.0	0.0	1.2	0.0	49.1	0.0	0.0	0.0	0.0	7.8	68.8	1.1	2.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.3	2.8	0.0	0.0	169.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	19.2	5.1	0.0	0.0	2.5
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63969925-64019779	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.6"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 37.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	12.4	7.4	2.9	9.3	4.2	16.0	6.1	1.3	5.5	7.7	7.4	7.1	0.0	3.7	4.1	4.3	20.6	3.7	13.7	4.5	3.1	3.3	7.1	23.7	8.2	10.1	4.7	4.0	8.1	4.2	1.1	5.0	9.5	7.4	4.2	6.1	3.4	8.1	2.1	4.5	36.6	8.7	4.4	6.0	9.8	4.2	2.9	3.5	4.2	5.0	17.5	11.3	9.6	11.0	5.1	25.3	5.9	20.5	2.1	4.2	5.0	7.6	1.5	1.3	9.4	4.7	6.6	0.6	24.7	24.0	15.7	15.7	0.3	3.4	0.1	9.1	14.7	7.7	12.4	0.2	15.6	22.5	10.5	0.3	0.0	2.9	0.8	10.7	37.9	3.3	6.3	13.6	21.1	6.9	10.2	16.6	1.6	0.2	4.4	10.8	0.6	0.6	4.2	0.5	1.3	7.6	0.5	3.4	0.6	7.0	8.7	0.7	0.7	4.9	0.7	9.1	1.1	0.3	14.3	25.8	24.0	5.1	2.9	9.9	1.9	0.3	0.0	24.6	22.1	20.6	1.1	20.5	0.8	3.8	16.1	3.4	3.6	3.1	2.3	25.3	5.1	1.7	2.6	5.9	2.1	8.0	13.7	4.2	5.0	2.9	4.2	1.3	5.5	3.1	3.3	4.7	4.0	7.4	3.5	3.0	11.7	4.7	24.0	36.5	0.2	1.2	7.6	6.7	12.5	0.0	0.0	2.9	0.0	27.3	0.6	8.8	8.1	0.0	16.7	4.1	9.3	12.1	4.6	10.4	15.0	0.0	1.7	4.9	24.1	1.1	0.9	25.5	15.1	16.2	3.1	1.6	29.4	2.0	0.0	1.6	0.2	0.0	8.6	2.3	1.0	42.3	26.2	3.9	2.8	32.4
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887266-2903280	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.0;lymphoid tissue: 39.6"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 116.9;monocytes: 105.6;Syncytiotrophoblasts: 226.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 59.1;SuSa: 62.4;U-698: 25.4"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		4900000	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	5.6	5.1	3.3	15.9	4.1	7.2	2.6	3.6	6.7	3.9	2.1	4.4	1.3	1.7	1.9	1.9	4.6	4.1	5.3	4.9	3.4	3.6	2.5	7.6	13.7	39.6	4.8	3.9	3.8	1.3	4.7	4.9	24.5	4.7	2.6	2.9	3.5	7.5	1.3	2.0	1.0	5.5	2.4	7.1	14.4	2.0	4.4	2.0	6.4	4.2	2.1	18.9	3.4	3.8	10.3	6.4	2.9	38.0	18.8	17.9	12.3	0.0	2.5	0.0	0.0	0.1	0.0	59.1	0.5	0.1	0.6	0.9	0.7	4.8	9.6	6.0	0.5	0.0	0.0	7.1	0.0	0.5	3.1	0.7	0.9	0.9	1.4	3.4	0.0	0.0	2.7	0.0	1.0	0.0	0.0	12.9	0.8	4.4	0.1	0.4	0.2	0.0	0.0	8.2	0.0	0.0	0.9	0.0	0.1	0.4	0.0	0.4	0.1	5.8	0.0	0.0	62.4	0.0	0.1	13.4	0.0	0.1	0.0	0.0	0.0	12.1	25.4	0.0	0.0	0.0	1.7	18.3	0.1	17.9	38.0	14.7	8.3	13.0	16.8	6.1	10.3	12.1	17.5	2.9	18.8	22.0	6.4	13.0	12.3	3.3	4.1	3.6	6.7	3.4	3.6	4.8	3.9	4.7	2.0	17.9	24.9	31.6	1.9	31.4	1.5	4.2	2.5	13.4	14.8	5.2	0.0	62.3	0.0	14.4	0.9	42.0	1.6	0.0	0.2	116.9	44.8	2.2	45.1	6.8	16.6	7.9	14.9	60.2	47.5	2.5	4.0	98.8	84.4	105.6	3.1	4.8	6.2	5.8	16.6	1.4	2.9	12.9	18.1	0.5	2.2	32.2	226.0	48.4	3.5	7.4
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20773879-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 170.8"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 223.1"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 64.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		94000000000	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.6	0.9	0.3	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	170.8	0.3	0.0	0.0	0.7	0.3	0.0	3.6	0.1	0.2	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	1.9	2.7	0.7	0.4	1.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	64.2	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	5.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	4.4	0.0	0.4	0.0	1.0	0.2	1.7	0.4	0.5	0.6	0.1	1.9	0.9	0.7	0.7	1.3	0.2	2.7	0.7	0.1	0.0	2.3	0.6	0.9	0.0	0.0	0.0	0.7	2.6	0.5	0.0	13.7	0.0	0.0	0.0	0.0	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.7	0.0	1.1	223.1	0.1	0.0	0.0	4.9	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127089-101139266	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 253.6"	"Cell type enhanced"	"Detected in many"	22	"Pancreatic endocrine cells: 138.9;Syncytiotrophoblasts: 545.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"NK-cell: 10.8"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"BJ: 142.8;HUVEC TERT2: 165.7;LHCN-M2: 160.0;TIME: 409.8;U-138 MG: 195.1;U-251 MG: 171.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"	No	No	142000000	14000000	Cytosol		"CAB068501: AB_1642775, HPA050039: AB_2680997"	"unprognostic (5.02e-2)"	"prognostic unfavorable (5.01e-4)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.88e-8)"	"prognostic unfavorable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.51e-4)"	45.5	14.0	1.1	16.7	1.8	0.1	11.4	0.5	1.5	13.3	7.0	3.4	3.3	1.2	6.6	14.4	6.8	9.3	69.6	29.2	1.5	0.6	7.8	65.3	56.3	3.3	4.1	1.8	19.7	24.7	1.4	2.6	253.6	5.9	7.6	0.9	2.3	2.4	6.2	12.4	4.1	2.3	13.5	4.1	5.8	6.6	8.6	2.2	0.6	11.3	3.7	2.8	71.7	18.1	0.2	0.4	0.5	0.2	10.8	0.3	1.0	3.0	2.6	0.0	0.2	32.7	65.2	3.7	142.8	27.0	72.1	63.0	0.3	0.2	0.1	34.2	45.4	99.7	0.7	0.0	11.0	74.4	0.1	0.0	0.0	0.2	2.4	65.8	0.0	0.1	25.5	4.4	110.5	58.1	39.1	165.7	0.0	0.2	0.1	160.0	0.0	0.0	0.0	0.7	0.0	1.7	0.0	0.2	0.1	0.2	1.2	0.0	0.0	11.7	3.2	0.3	18.0	0.1	0.4	409.8	195.1	8.5	66.4	171.5	0.0	0.1	0.1	48.7	0.0	1.8	0.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.1	0.2	10.8	0.0	0.4	0.0	1.0	1.1	1.8	0.5	1.5	1.5	0.6	4.1	1.8	5.9	2.2	0.0	11.4	0.0	30.0	35.5	0.4	1.9	7.6	8.1	7.9	5.2	0.0	34.4	0.0	22.9	0.0	53.9	0.0	0.0	3.8	35.1	24.7	5.4	10.3	90.0	15.2	0.0	5.1	60.2	4.7	0.4	16.4	7.5	6.8	1.8	0.0	0.3	138.9	0.0	11.3	0.0	0.2	38.8	16.5	0.0	0.0	21.7	545.0	0.7	0.0	5.9
SERTAD1	"SEI1, TRIP-Br1"	ENSG00000197019	"SERTA domain containing 1"	Q9UHV2	19	40421592-40426025	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063323			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA063323: AB_2684984"	"unprognostic (2.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.08e-3)"	17.3	10.6	5.7	11.3	6.2	30.4	9.6	4.4	9.0	11.4	10.8	5.3	5.3	7.9	10.7	4.4	18.2	13.1	16.1	13.8	8.0	5.4	10.3	14.3	20.8	7.9	8.1	2.8	10.3	17.3	2.8	7.3	19.5	10.3	15.3	3.9	5.8	10.0	6.8	11.4	10.9	13.7	8.4	6.3	8.9	14.2	5.5	8.6	6.6	19.1	23.7	10.0	10.5	18.9	10.6	20.2	14.4	17.2	12.1	10.5	9.7	11.5	13.7	2.0	4.8	5.5	3.9	5.3	18.6	5.7	10.1	10.0	6.1	9.5	2.3	8.9	6.2	2.9	4.7	1.6	16.8	3.1	6.3	3.4	2.0	3.3	5.1	6.3	0.7	7.3	6.4	10.4	11.0	2.0	4.9	5.7	2.0	4.2	3.7	9.1	17.3	1.0	3.8	1.5	8.3	9.2	1.4	3.1	5.8	5.3	8.2	0.6	0.9	9.8	9.2	9.0	2.3	9.1	1.9	10.4	10.1	11.3	8.1	12.4	5.4	2.2	3.0	14.1	3.0	4.7	14.4	17.2	11.0	8.1	14.9	4.8	10.4	8.0	7.6	20.2	10.6	9.4	6.5	13.9	12.1	14.0	18.4	10.5	9.7	5.7	6.2	4.4	9.0	8.0	5.4	8.1	2.8	10.3	8.6	68.5	63.2	28.7	142.2	112.1	4.5	72.2	20.4	30.8	36.4	29.6	0.0	38.7	19.9	48.9	1.2	96.6	151.4	0.0	54.3	48.2	93.6	137.2	134.6	12.5	49.7	3.2	101.7	70.6	24.6	3.1	15.3	63.6	89.4	41.5	87.8	14.0	62.1	119.3	10.3	15.0	1.7	38.8	145.2	1.0	4.9	114.0	108.9	37.4	53.7	97.0
SERTAD3	RBT1	ENSG00000167565	"SERTA domain containing 3"	Q9UJW9	19	40440844-40444705	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068262			Approved	Nucleoli		NA	NA			Nucleoli		"HPA068262: AB_2685965"	"unprognostic (1.56e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.50e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-3)"	28.3	13.0	5.7	16.8	7.1	10.8	18.6	3.7	6.9	29.3	31.5	13.0	22.0	12.3	24.6	22.2	29.6	18.8	24.9	21.1	5.8	5.7	21.4	19.6	23.6	12.3	8.8	4.5	33.1	8.0	8.8	14.1	49.1	6.6	24.8	14.2	13.6	15.7	25.1	32.1	13.5	25.2	18.9	7.9	21.4	18.6	16.6	6.8	7.8	25.6	24.2	17.3	31.8	18.3	14.4	24.8	28.7	20.6	7.8	7.7	12.2	15.5	30.2	10.6	13.8	11.9	18.3	14.7	12.7	17.2	18.2	15.8	10.9	12.2	7.6	5.7	16.4	11.1	5.7	10.7	12.4	10.3	8.5	4.7	5.0	9.9	9.3	14.1	1.2	16.1	16.1	17.1	11.3	8.2	14.8	14.8	3.5	15.0	5.1	14.4	23.3	3.1	6.1	5.6	13.5	7.4	4.6	6.5	6.2	14.4	12.3	1.5	6.6	10.8	18.9	9.5	17.0	16.5	12.6	12.3	15.6	12.5	12.0	10.0	8.7	4.6	6.5	12.4	5.5	6.9	12.2	20.6	22.0	7.1	20.4	7.1	14.4	7.7	7.6	23.0	12.7	5.7	6.8	28.7	7.8	17.1	24.8	6.0	12.2	5.7	7.1	3.7	6.9	5.8	5.7	8.8	4.5	6.6	6.8	8.9	11.8	24.9	34.2	41.0	3.3	9.2	10.2	9.4	5.7	22.7	3.9	75.5	26.6	27.3	5.4	27.8	37.4	0.0	26.8	74.2	58.2	42.4	20.7	6.0	31.4	3.2	47.1	31.9	20.3	5.1	26.4	36.8	32.1	30.7	43.9	19.3	27.7	44.4	28.7	18.2	0.5	58.2	28.6	11.4	13.0	37.6	156.8	15.0	27.5	37.6
SESN2	"DKFZp761M0212, HI95, SES2, SEST2"	ENSG00000130766	"Sestrin 2"	P58004	1	28259527-28282491	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 23.1;SK-MEL-30: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018191	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA018191: AB_1856750"	"unprognostic (7.05e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (8.97e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	9.2	7.7	7.0	6.8	6.7	32.0	7.6	6.1	11.1	6.1	9.6	3.5	4.6	14.3	7.2	4.0	15.2	6.2	7.6	4.3	4.5	6.1	12.5	18.4	7.7	4.1	8.4	4.5	22.4	10.4	7.5	5.4	9.3	7.6	5.2	8.3	6.9	14.5	4.6	5.8	4.9	12.6	6.2	10.9	5.8	7.2	9.2	4.3	4.8	7.0	4.2	9.7	7.3	14.9	1.9	2.8	6.2	2.7	3.9	9.6	2.5	2.6	1.4	3.5	5.8	5.7	4.5	19.2	5.1	4.7	3.1	3.7	2.0	1.9	3.0	2.1	2.3	3.5	2.6	4.1	3.6	2.2	2.7	3.8	1.2	2.0	3.4	18.8	4.5	6.8	14.3	23.1	8.4	20.1	1.4	3.4	7.1	7.1	14.5	2.9	1.5	1.6	1.2	2.8	1.2	2.9	2.5	0.9	6.6	2.1	4.5	1.2	1.3	1.4	1.2	27.9	4.0	3.2	6.4	1.9	1.6	4.9	3.6	3.1	18.8	4.7	4.7	3.7	4.6	3.5	0.0	2.3	1.9	9.6	1.9	4.7	1.9	3.4	4.6	2.4	1.4	2.1	4.3	6.2	3.9	2.7	2.8	3.9	2.5	7.0	6.7	6.1	11.1	4.5	6.1	8.4	4.5	7.6	4.3	0.0	5.3	7.3	16.1	15.0	12.1	6.1	7.6	1.4	1.2	7.0	7.9	25.1	3.3	20.3	2.0	5.8	23.8	0.0	14.6	17.0	10.4	12.6	4.6	18.8	11.7	0.0	12.6	8.0	3.3	2.7	2.3	10.9	6.8	7.2	10.7	5.8	23.7	11.5	3.2	20.7	7.4	0.0	21.9	4.7	3.3	10.9	56.0	12.8	11.5	19.1
SESN3	"MGC29667, SEST3"	ENSG00000149212	"Sestrin 3"	P58005	11	95165513-95232541	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 511.2;Late spermatids: 396.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;ASC TERT1: 21.5;SuSa: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037935			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037935: AB_10670534"	"unprognostic (2.72e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.09e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.34e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.42e-2)"	7.3	14.2	22.3	10.4	38.6	11.9	11.6	10.2	20.8	10.3	6.8	11.1	3.3	5.2	9.3	11.7	7.6	7.0	9.9	5.1	15.9	12.9	8.7	6.0	7.2	17.3	12.6	12.0	18.4	3.3	27.7	10.7	6.6	13.9	8.5	5.4	19.7	9.1	4.8	5.4	8.4	10.6	7.6	11.6	12.7	3.9	41.6	14.1	11.3	17.3	4.0	18.3	10.0	7.7	4.2	1.1	1.0	3.5	0.8	4.5	0.8	0.0	0.4	11.6	0.0	19.6	21.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	3.0	1.4	0.0	0.5	2.3	7.0	5.0	0.0	2.5	3.6	1.5	6.1	0.4	0.3	1.3	0.2	11.8	8.8	0.0	2.6	3.6	0.4	1.8	0.1	0.5	0.9	0.0	0.9	3.5	4.7	0.0	0.5	2.2	0.7	0.2	2.6	7.6	1.5	3.2	0.1	0.1	0.6	47.8	0.0	4.3	0.1	1.3	3.0	0.2	0.4	0.1	0.0	0.4	0.5	1.6	2.8	1.0	0.8	0.6	0.7	1.7	0.8	4.2	2.3	1.3	0.7	2.7	4.5	1.7	0.8	0.8	3.5	1.1	4.0	0.8	22.3	38.6	10.2	20.8	15.9	12.9	12.6	12.0	13.9	14.1	23.8	6.4	52.8	25.9	20.5	48.2	7.5	0.0	2.7	14.8	33.2	21.6	0.8	1.7	4.1	511.2	29.0	9.7	23.3	2.0	0.3	22.8	17.2	6.9	4.9	19.2	0.0	7.0	28.3	40.6	396.5	37.7	20.8	30.4	114.6	14.1	93.1	1.9	5.8	82.0	14.6	12.5	6.5	24.7	35.4	8.3	10.9	1.4	15.2	16.3	9.1
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2"	Q9BYW2	3	47016429-47163967	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	13.2	10.5	12.2	15.2	15.4	20.0	11.7	22.4	16.4	13.4	14.0	9.1	12.9	9.5	15.8	7.5	10.8	11.4	8.7	8.8	10.6	6.8	11.4	10.3	10.4	11.8	11.7	9.5	16.0	13.4	21.4	16.3	10.7	11.3	12.4	10.9	7.7	12.7	14.8	27.6	12.5	11.5	11.9	9.8	13.8	10.4	12.8	12.8	23.2	15.8	5.5	12.8	16.1	15.5	4.8	2.6	6.0	2.3	7.1	3.9	1.0	11.6	9.2	15.4	7.9	9.3	10.7	6.5	10.7	10.4	12.6	11.5	9.7	7.6	25.7	6.7	14.8	12.3	7.1	16.7	10.2	17.1	14.7	6.6	26.4	15.3	7.5	7.0	19.7	15.3	9.2	9.9	12.4	15.4	10.2	11.6	13.3	16.9	9.7	10.3	6.1	14.5	2.6	11.7	5.6	7.7	9.6	15.0	13.3	6.4	15.3	6.7	10.6	18.1	7.1	6.7	11.5	7.5	14.7	14.8	13.9	10.4	11.8	17.1	12.5	13.9	26.0	8.0	11.3	8.1	2.4	2.2	5.2	3.9	2.3	2.4	3.7	2.4	3.0	2.5	4.8	3.5	3.0	6.0	7.1	1.9	2.6	1.0	1.0	12.2	15.4	22.4	16.4	10.6	6.8	11.7	9.5	11.3	12.8	44.7	53.3	20.6	20.5	29.7	33.4	58.5	22.9	66.9	80.8	10.4	39.3	16.3	10.0	17.4	24.0	29.3	26.5	0.0	19.3	10.1	20.8	25.9	55.6	26.7	14.3	25.4	21.2	23.4	27.2	20.8	28.1	21.6	16.9	20.8	27.8	21.7	20.0	17.5	31.1	9.3	37.0	12.9	21.7	78.1	18.9	31.1	15.4	27.7	24.8	34.2
SETD3	"C14orf154, FLJ23027"	ENSG00000183576	"SET domain containing 3"	Q86TU7	14	99397746-99480889	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003591, HPA003639"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003591: AB_1079930, HPA003639: AB_1079931"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-1)"	"prognostic favorable (1.89e-15)"	"unprognostic (6.81e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-3)"	17.1	12.5	24.7	13.3	26.8	9.2	16.6	14.6	23.8	14.3	22.7	18.7	26.9	16.2	14.2	39.6	16.9	21.7	13.4	34.1	24.1	17.9	43.4	21.0	16.7	11.9	23.7	13.9	11.7	16.9	17.4	14.5	19.4	18.4	16.9	17.6	16.2	24.9	20.2	68.7	14.1	16.5	26.0	25.3	13.7	15.4	39.1	15.3	11.5	25.6	20.3	10.9	24.0	21.4	9.2	18.6	19.9	17.4	16.0	18.2	11.3	13.8	15.9	12.0	11.4	14.0	15.8	42.8	17.5	13.4	18.4	18.9	15.3	23.5	13.6	14.4	19.7	14.5	18.0	14.7	19.7	29.4	13.3	7.8	12.3	10.3	14.0	17.5	18.5	18.6	11.0	26.0	16.3	23.9	13.9	22.8	20.5	9.7	20.6	20.3	25.9	19.2	20.1	7.1	34.6	18.1	11.7	24.6	11.2	26.4	17.1	21.5	10.0	15.7	16.4	13.4	22.8	22.2	16.2	20.1	8.3	11.5	55.9	13.3	14.7	16.7	14.7	15.7	18.5	12.6	6.4	15.0	19.9	15.5	17.4	18.2	9.2	13.4	14.5	18.6	7.6	11.2	13.9	9.4	16.0	14.8	11.7	9.7	11.3	24.7	26.8	14.6	23.8	24.1	17.9	23.7	13.9	18.4	15.3	23.8	35.6	13.7	15.9	21.6	24.5	76.3	25.5	34.8	29.6	24.4	25.5	52.8	28.2	21.0	146.2	23.8	28.2	0.0	24.3	35.0	18.6	20.9	31.3	24.9	31.6	17.5	20.8	15.4	28.0	98.0	17.5	26.8	10.1	16.2	24.4	39.5	20.0	21.0	19.8	84.0	33.4	6.5	22.0	89.9	86.5	28.2	25.1	20.3	27.1	17.3
SETD4	"C21orf18, C21orf27"	ENSG00000185917	"SET domain containing 4"	Q9NVD3	21	36034541-36079389	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024073, HPA035405"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024073: AB_1856755, HPA035405: AB_2674612"	"unprognostic (4.23e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.05e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.17e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.28e-2)"	10.9	12.1	14.4	10.6	19.4	10.2	12.4	19.8	20.8	11.5	12.9	22.0	13.8	15.1	14.7	15.8	14.1	14.9	10.6	13.4	13.6	13.6	12.6	9.1	11.2	10.6	21.0	14.0	13.8	10.5	18.0	17.2	11.9	18.9	13.2	13.0	14.2	12.7	11.3	11.6	18.0	18.0	15.1	14.5	11.1	13.1	28.9	21.7	10.9	13.5	8.6	16.3	12.3	13.4	17.1	17.4	11.9	14.2	10.9	13.4	8.4	9.4	6.7	10.2	13.0	5.1	6.2	16.6	12.6	11.1	13.0	8.8	14.1	8.7	5.1	8.9	5.7	10.1	7.2	7.6	7.5	11.4	9.1	9.2	13.9	10.7	8.8	12.3	13.1	8.0	6.4	12.8	8.9	11.4	7.4	9.7	7.1	18.0	9.6	8.0	9.9	8.7	19.0	21.3	8.1	8.6	13.1	7.5	12.6	14.3	6.8	8.4	13.5	12.8	14.0	12.8	9.3	12.2	11.1	8.1	11.4	4.3	7.1	11.5	15.2	22.0	8.0	12.0	18.2	9.8	6.7	14.2	11.9	9.8	11.0	10.8	17.1	12.1	10.3	16.2	13.9	8.9	10.3	10.7	10.9	10.5	17.4	13.4	8.4	14.4	19.4	19.8	20.8	13.6	13.6	21.0	14.0	18.9	21.7	8.9	6.5	11.6	9.8	10.8	12.3	8.5	2.5	21.4	10.3	8.7	29.5	13.8	5.0	10.7	28.5	7.0	8.4	0.0	7.2	7.7	9.3	9.5	10.5	4.7	8.9	3.2	3.5	8.6	7.1	5.3	8.9	4.8	10.1	7.2	9.9	8.6	8.5	7.0	9.6	7.4	19.5	6.5	7.2	44.6	18.5	8.0	7.9	5.1	10.0	9.6
SETD9	"C5orf35, MGC33648"	ENSG00000155542	"SET domain containing 9"	Q8NE22	5	56909260-56925532	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 23.8"	"Group enriched"	"Detected in many"	6	"Early spermatids: 523.2;Late spermatids: 284.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA049936			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049936: "	"unprognostic (1.13e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.37e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	7.2	2.6	2.3	1.2	4.4	2.4	11.1	1.4	5.2	2.6	4.4	4.7	4.6	4.4	2.7	2.5	2.4	1.9	2.1	7.0	2.1	2.4	5.4	8.8	2.4	5.3	5.3	3.8	2.6	7.3	2.4	2.0	2.6	3.7	4.3	3.3	2.8	5.3	1.2	4.1	1.9	5.2	4.4	3.6	1.8	2.7	23.8	3.2	1.1	4.4	3.4	2.0	2.9	8.1	1.1	2.0	4.3	3.0	1.6	2.9	0.8	4.9	1.8	3.0	3.8	4.6	2.6	5.2	1.4	2.2	2.4	6.1	4.5	5.7	4.5	7.0	2.1	3.1	4.6	3.2	1.8	6.3	3.2	6.7	1.2	1.5	3.7	1.8	1.4	4.3	1.2	2.5	2.2	3.2	3.6	3.9	1.9	3.7	3.3	5.5	7.1	0.7	3.5	4.7	0.0	7.2	4.6	1.9	6.0	2.6	1.7	3.4	5.4	1.2	3.5	5.9	2.0	5.5	3.4	4.2	1.6	7.3	4.6	3.1	3.3	9.5	7.4	2.2	1.3	0.7	1.4	2.3	4.3	1.4	2.0	1.3	0.5	1.6	0.4	2.0	1.1	0.5	0.6	2.7	1.6	3.0	0.8	2.9	0.8	2.3	4.4	1.4	5.2	2.1	2.4	5.3	3.8	3.7	3.2	3.0	2.4	10.3	12.8	15.5	3.0	14.8	10.2	5.3	1.2	7.0	0.0	13.2	48.0	13.9	523.2	6.8	19.6	0.0	15.2	17.3	15.0	18.2	14.9	24.6	13.3	0.0	17.7	9.8	13.9	284.0	9.5	15.7	27.0	11.8	9.2	2.8	8.6	17.5	5.3	36.6	2.9	0.0	10.2	63.8	8.4	13.4	12.0	8.9	12.0	16.4
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	16.9	15.4	9.5	21.2	15.9	16.9	17.7	21.6	18.2	18.6	15.4	25.2	18.6	13.0	22.8	18.9	15.6	16.8	14.0	10.9	9.6	8.5	13.3	12.7	15.6	20.7	15.3	13.2	23.9	17.6	21.0	15.4	18.4	13.7	14.9	16.8	20.6	16.1	18.5	20.0	18.0	17.1	17.9	13.7	21.9	15.0	33.5	14.2	24.5	18.6	12.0	20.7	18.6	16.3	11.2	12.8	6.9	14.9	7.6	9.1	5.3	5.9	6.9	10.0	6.6	4.8	6.4	16.7	4.9	5.7	7.1	6.1	4.6	8.2	11.6	6.8	5.4	2.8	7.4	9.3	5.3	5.6	5.6	11.5	6.6	7.1	5.3	6.8	11.6	6.3	8.4	5.9	5.8	9.5	7.2	8.3	7.5	11.0	9.5	5.0	11.4	8.0	6.8	13.7	8.3	5.5	9.3	6.5	8.6	5.4	6.8	7.3	13.3	7.5	8.8	5.9	12.6	9.5	15.7	5.6	4.1	4.3	4.5	6.8	9.9	10.6	90.6	4.3	4.1	4.0	6.8	10.7	6.9	8.3	14.9	8.7	8.7	7.4	9.1	12.8	11.2	8.3	8.3	6.5	7.6	10.6	8.6	4.7	5.3	9.5	15.9	21.6	18.2	9.6	8.5	15.3	13.2	13.7	14.2	6.0	12.3	5.3	7.2	4.8	10.9	4.1	5.1	9.4	6.8	7.0	17.7	11.4	3.3	6.6	23.5	6.9	6.2	0.0	5.0	7.2	4.9	6.2	7.0	6.2	8.8	6.4	3.5	10.4	14.2	21.8	9.5	10.4	1.7	7.2	10.3	6.3	7.3	10.7	9.2	5.4	10.1	6.5	5.9	22.4	14.5	4.4	8.4	7.0	9.3	6.4
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated 2"	Q96T68	13	49444374-49495003	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"CAB012190: AB_2186195, HPA071677: AB_2686430"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favorable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	10.2	14.5	9.8	20.5	10.8	9.5	14.1	14.4	12.3	13.0	12.4	8.3	13.6	7.8	13.1	11.6	9.8	9.9	9.7	12.7	8.2	6.9	12.4	11.0	16.3	19.0	7.2	11.1	21.0	15.0	10.8	15.8	7.8	9.5	13.6	11.9	13.5	11.7	10.9	5.5	9.6	11.4	11.3	8.4	19.0	10.7	18.1	8.7	17.3	14.6	3.7	16.6	11.9	10.3	8.4	7.4	4.7	5.4	7.8	10.2	4.5	2.0	1.4	4.3	4.4	6.1	6.9	2.2	5.9	7.4	5.3	5.0	8.7	5.0	25.7	1.2	3.8	4.0	4.2	4.5	4.0	5.2	5.8	3.9	8.9	3.9	5.2	8.6	13.5	5.1	5.3	7.4	4.0	13.4	5.8	4.5	8.3	3.9	3.6	4.8	1.8	5.1	10.1	2.2	5.5	3.4	10.0	5.4	5.4	4.9	1.9	2.2	2.6	2.6	3.7	12.6	3.9	3.1	11.8	2.7	5.1	1.8	6.8	2.4	4.3	6.0	13.6	1.6	11.0	2.3	4.1	4.1	4.7	6.9	5.4	5.8	8.4	7.1	7.1	7.4	8.1	10.2	7.6	1.4	7.8	4.3	5.2	9.4	4.5	9.8	10.8	14.4	12.3	8.2	6.9	7.2	11.1	9.5	8.7	26.8	14.1	32.7	5.3	6.2	12.6	22.4	10.2	13.4	10.3	5.2	25.5	4.8	8.3	3.3	14.7	8.2	6.9	0.0	3.8	2.9	5.1	3.0	5.8	5.9	15.9	12.7	11.1	5.5	19.0	11.1	9.2	17.4	13.5	10.0	6.2	10.8	3.1	2.9	7.8	3.4	29.6	0.0	5.2	18.2	11.8	5.3	2.4	19.1	8.5	2.0
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354985	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	20.3	12.3	13.0	23.5	15.0	14.0	16.1	16.7	14.8	14.7	16.0	11.2	14.5	9.9	18.3	15.2	13.2	17.5	12.3	13.8	13.0	8.3	12.5	15.8	18.5	23.5	19.8	12.6	15.8	11.0	24.0	24.6	13.4	16.9	13.8	12.6	8.6	16.2	16.1	18.4	15.2	19.4	16.9	20.6	25.7	13.2	34.5	18.1	26.3	31.6	10.8	24.0	18.8	16.3	8.0	5.5	16.9	5.0	5.3	6.5	2.3	9.1	12.3	14.2	15.3	18.3	22.3	8.5	12.2	13.7	9.9	9.3	12.9	10.5	15.6	6.0	22.7	24.4	18.8	14.2	10.5	10.9	14.8	6.1	16.3	13.8	11.2	17.2	25.0	19.9	15.6	16.6	16.9	15.1	12.2	15.9	11.1	18.9	12.6	11.4	13.2	15.4	9.6	15.2	15.5	9.6	14.7	20.6	10.4	11.0	12.0	8.9	13.6	20.1	8.9	11.1	19.7	12.3	12.9	18.1	20.8	9.0	13.9	11.6	7.7	13.0	24.2	9.5	10.0	11.1	7.7	4.9	4.8	6.1	4.5	6.5	6.2	4.6	4.6	3.6	8.0	5.0	4.3	16.9	5.3	5.0	5.5	3.4	2.3	13.0	15.0	16.7	14.8	13.0	8.3	19.8	12.6	16.9	18.1	56.6	43.7	27.4	25.9	26.9	29.3	49.2	20.4	54.9	56.9	19.2	27.5	11.5	3.3	17.7	5.9	43.4	27.4	0.0	12.7	8.9	28.8	33.6	55.6	30.4	24.7	63.5	13.9	58.3	69.1	10.9	28.4	39.3	11.8	16.2	27.3	24.6	20.3	19.8	33.9	18.0	28.0	12.9	22.7	47.4	38.0	29.4	7.9	39.9	17.1	38.1
SEZ6L		ENSG00000100095	"Seizure related 6 homolog like"	Q9BYH1	22	26169474-26383597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 60.8"	"Cell type enriched"	"Detected in some"	6	"Horizontal cells: 20.6"	"Group enriched"	"Detected in some"	6	"glioma: 14.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	73	"dendritic cells: 7.2;monocytes: 7.4"	"Group enriched"	"Detected in some"	7	"SCLC-21H: 30.8;SH-SY5Y: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045135			Approved	Vesicles		NA	NA		2400000	Vesicles		"HPA045135: AB_2732518"	"unprognostic (1.01e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-6)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.18e-1)"	1.2	12.5	26.4	1.6	11.3	1.3	1.1	20.1	60.8	2.4	1.3	4.3	0.0	1.5	1.1	1.1	1.1	1.1	1.2	2.5	39.1	23.6	1.1	1.1	1.3	1.1	11.2	25.5	1.1	2.7	1.0	3.8	1.1	15.0	1.3	1.4	0.0	1.3	1.2	1.1	1.2	1.6	1.4	5.3	1.3	2.9	1.4	5.4	0.0	1.2	0.0	1.1	1.2	0.2	0.0	7.2	0.0	7.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	8.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.5	26.4	11.3	20.1	29.3	39.1	23.6	11.2	25.5	15.0	5.4	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	20.6	0.0	0.0	0.0	0.7	0.6	0.7	0.0	3.6	0.0	0.5	1.0	0.0	0.4	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
SF3A2	"Prp11, PRPF11, SAP62, SF3a66"	ENSG00000104897	"Splicing factor 3a subunit 2"	Q15428	19	2236504-2248679	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042843, HPA049439"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042843: AB_2678199, HPA049439: AB_2680766"	"unprognostic (5.29e-2)"	"prognostic favorable (7.16e-4)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (3.09e-3)"	"unprognostic (9.19e-2)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.73e-2)"	21.1	12.0	12.1	27.1	16.6	35.7	21.3	25.7	22.3	29.2	19.7	20.5	13.2	29.7	32.5	18.2	22.4	23.7	19.5	13.8	10.9	9.0	15.7	13.5	17.4	28.7	13.5	13.1	39.3	25.1	7.5	17.7	24.9	12.1	22.9	7.0	18.4	29.9	21.6	24.8	36.0	26.0	22.8	12.8	27.9	21.0	45.3	14.6	54.2	19.6	20.3	27.0	30.3	24.2	3.4	4.2	9.3	4.3	2.1	5.5	2.8	26.0	11.5	15.9	15.8	4.6	6.9	27.5	9.0	8.4	14.6	14.1	16.8	9.1	28.4	10.7	7.4	9.6	20.9	15.4	11.7	3.2	21.8	23.5	18.2	11.4	13.7	12.4	22.6	23.6	9.7	10.5	12.6	9.9	7.5	14.3	22.7	21.5	26.9	5.4	14.2	29.5	22.0	31.2	10.5	9.6	49.9	9.0	24.7	6.2	7.6	19.5	32.3	13.8	10.7	11.6	7.1	14.9	26.0	14.2	15.2	16.7	31.6	28.7	30.0	29.6	28.5	11.1	17.7	15.0	1.2	2.9	9.3	5.1	4.3	3.5	2.8	3.9	5.5	2.9	3.4	3.5	3.1	2.9	2.1	2.8	4.2	4.6	2.8	12.1	16.6	25.7	19.6	10.9	9.0	13.5	13.1	12.1	14.6	3.0	5.0	30.0	23.2	34.7	6.8	2.0	7.6	1.4	4.5	10.4	3.9	57.9	21.6	20.6	52.3	20.2	18.8	0.0	8.2	72.3	27.1	10.2	16.1	3.8	28.9	7.9	12.6	28.8	21.4	70.4	42.6	20.0	30.4	18.0	20.0	5.2	9.4	21.6	30.1	16.5	11.9	12.9	17.1	53.5	60.0	22.1	49.3	50.8	23.3	18.2
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990921	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: AB_2674130"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	7.0	6.4	5.3	6.3	5.9	13.6	7.6	7.4	5.5	6.3	6.5			4.3	9.4	8.7	6.8	7.7	4.1	4.3	4.8	4.9	5.9	6.2	6.1	8.4	5.3		8.7	6.7	6.4	5.7	5.6		6.1	7.2		5.9	7.2	15.3	7.7	5.9	7.7	4.3	7.9	6.2	5.8			6.3		10.3	6.2	6.1	23.6	19.0	10.6	20.6	18.7	27.8	20.6	15.9	12.2	22.1	18.8	13.8	12.8	26.7	15.6	14.3	27.5	22.3	20.0	17.0	30.4	13.7	15.2	10.7	13.8	28.0	22.8	33.8	13.9	27.3	38.6	19.5	17.3	12.7	46.9	18.7	12.1	16.0	28.4	18.8	12.6	19.0	23.7	34.0	12.0	19.8	10.7	24.7	27.1	54.5	16.6	19.0	29.5	37.9	21.9	12.6	16.7	19.3	14.3	20.0	9.3	16.5	20.6	11.0	18.6	17.0	14.4	15.8	13.2	30.9	11.5	16.3	31.0	13.9	43.2	17.9	10.6	15.3	9.8	21.8	18.9	21.2	20.4	25.8	22.0	19.0	23.6	27.8	23.6	2.0	18.7	20.6	11.8	26.3	20.6											47.6	31.2	43.1	32.7	42.0	34.1	19.8	7.6	28.1	44.3	21.0	21.6	48.1	33.2	40.0	18.5	30.6	15.5	0.0	33.5	56.8	32.4	19.1	40.5	20.8	45.1	25.4	15.0	21.5	25.3	10.0	36.8	36.9	37.1	107.4	22.3	37.9	31.9	7.0	50.9	23.7	34.2	38.8	34.7	116.5	59.6	36.5	27.6	38.9	28.3	25.9
SF3B4	"Hsh49, SAP49, SF3b49"	ENSG00000143368	"Splicing factor 3b subunit 4"	Q15427	1	149923317-149928344	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028578, HPA064660"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA028578: AB_10601601, HPA064660: AB_2685314"	"unprognostic (2.43e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.74e-7)"	"unprognostic (9.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	26.7	26.1	14.0	21.1	26.2	32.8	22.2	18.3	33.5	29.1	31.8	28.6	18.3	21.0	36.7	24.6	31.9	29.2	24.3	15.7	13.8	13.3	28.9	26.3	21.4	22.0	16.1	11.3	45.0	23.2	31.1	20.3	41.1	18.1	27.4	28.0	27.6	24.2	27.0	15.2	30.5	27.5	28.3	13.2	30.6	23.5	43.7	14.8	57.7	30.9	24.6	41.5	27.4	23.3	35.7	36.7	53.9	48.7	43.9	41.9	27.3	31.4	26.3	30.5	22.5	17.9	14.3	34.2	29.7	25.9	39.6	31.9	28.6	25.0	31.5	18.9	31.9	24.2	33.5	36.6	31.6	43.1	17.8	20.8	30.1	17.7	22.4	24.9	38.2	36.9	16.1	27.8	38.5	22.1	15.5	21.5	27.0	23.1	26.4	42.3	82.7	42.6	26.8	43.7	41.9	28.5	32.5	28.0	31.7	30.3	30.8	17.0	31.7	26.4	32.2	18.7	39.0	47.3	38.0	17.6	33.8	37.4	27.6	46.5	36.8	55.5	37.7	27.0	28.1	31.0	29.0	35.8	53.9	39.0	46.5	40.1	35.7	37.2	41.9	31.1	31.7	35.2	33.1	48.4	43.9	48.7	36.7	41.2	27.3	14.0	26.2	18.3	33.5	13.8	13.3	16.1	11.3	18.1	14.8	14.9	12.0	26.4	39.1	48.1	20.2	3.1	7.6	46.8	20.5	22.7	3.9	68.7	51.4	55.7	52.0	20.0	32.7	23.3	45.2	64.5	34.9	20.8	38.1	13.9	46.6	7.9	25.0	13.5	21.3	6.6	41.7	30.8	23.6	67.7	33.6	24.6	48.6	31.9	27.6	31.1	14.9	45.3	36.3	52.7	55.6	44.8	79.2	34.8	33.6	41.1
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261958-41309497	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 175.8;Leydig cells: 535.6;Peritubular cells: 122.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 270.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"	Yes	No		1600000	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: AB_2685376"	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (3.12e-4)"	20.1	3.4	4.6	2.4	7.5	0.3	73.2	10.8	5.6	58.4	6.1	15.2	8.0	3.0	35.6	19.3	9.7	25.9	15.5	43.9	7.8	2.5	30.6	1.5	1.8	0.9	4.5	6.7	12.5	1.5	0.6	0.7	9.9	24.1	12.8	7.8	19.3	73.2	27.1	1.9	20.8	5.4	21.4	2.8	5.0	11.0	11.1	13.7	0.0	3.3	18.4	5.1	10.9	41.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	6.3	0.1	5.7	0.3	1.2	10.9	57.4	16.6	15.8	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.8	4.4	23.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.0	21.4	1.6	1.6	270.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	17.1	0.0	0.0	0.0	1.3	0.0	35.3	0.0	0.3	1.5	0.4	0.0	3.3	23.2	0.0	0.1	0.1	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	7.5	10.8	5.6	7.8	2.5	4.5	6.7	24.1	13.7	0.0	0.0	0.0	104.7	10.0	1.5	175.8	0.0	0.0	1.2	59.3	2.0	0.7	68.0	3.1	4.8	6.7	0.0	0.0	0.0	55.3	47.0	19.9	0.0	0.0	1.7	1.6	0.0	15.4	0.0	13.0	535.6	1.4	94.5	0.0	0.0	51.5	0.1	0.0	122.4	3.5	1.5	0.0	4.1	1.6	20.6	4.8	0.7	0.0	0.0	8.5
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780592-153789120	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 102.5"	"Group enriched"	"Detected in some"	15	"Basal keratinocytes: 102.6;Fibroblasts: 163.9;Melanocytes: 113.1;Smooth muscle cells: 47.4;Suprabasal keratinocytes: 92.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 53.5;ASC diff: 20.3;HSkMC: 33.5;NTERA-2: 74.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA			"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	42.9	4.0	3.4	17.6	1.7	0.2	70.0	1.3	8.0	10.9	20.6	11.3	18.2	4.4	6.4	64.4	51.5	18.5	74.9	42.2	8.5	1.2	1.9	0.2	21.3	2.6	2.8	5.6	7.9	22.5	1.6	23.2	0.3	4.6	33.4	10.8	8.4	23.9	19.5	2.5	26.1	13.7	72.3	5.4	0.3	11.4	13.2	5.0	0.3	29.1	29.4	6.8	102.5	37.4	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	53.5	0.0	20.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	1.7	1.3	5.7	8.5	1.2	2.8	5.6	4.6	5.0	3.0	1.1	0.0	0.6	102.6	0.0	0.3	0.0	5.3	3.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	163.9	0.3	1.1	0.0	3.3	0.0	0.0	0.0	0.0	0.2	3.7	2.2	113.1	1.0	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	47.4	0.0	0.2	92.6	0.1	0.0	0.0	1.0
SFSWAP	"SFRS8, SWAP"	ENSG00000061936	"Splicing factor SWAP"	Q12872	12	131711081-131799737	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039362, HPA040063"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039362: AB_10794089, HPA040063: AB_10795413"	"unprognostic (1.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (7.50e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	20.2	15.0	17.7	23.2	24.0	47.1	17.9	31.1	23.8	16.6	15.7	31.1	11.6	20.4	25.7	15.1	15.7	15.7	16.5	11.9	20.5	15.9	15.7	12.3	16.4	20.7	27.0	17.2	21.4	19.8	19.5	18.0	16.6	16.6	14.7	9.9	16.9	22.1	15.5	27.4	30.0	19.0	17.3	21.1	23.7	18.4	17.5	26.4	21.9	17.1	15.9	16.8	16.7	20.5	6.6	11.0	8.5	6.4	8.4	5.5	2.6	13.8	12.5	8.9	9.4	7.1	5.9	20.0	10.8	7.5	12.8	8.8	12.2	6.7	17.1	10.1	8.0	6.6	13.0	12.5	9.9	7.5	5.2	19.7	15.5	6.8	14.2	7.6	19.9	15.3	6.7	11.4	11.5	14.0	10.2	7.9	13.3	21.4	6.8	5.7	17.4	16.7	30.3	23.2	7.5	20.9	19.6	9.0	13.4	7.3	10.2	14.0	15.8	10.2	8.6	12.8	7.3	12.4	15.6	10.1	10.6	14.0	8.2	12.0	19.5	21.2	17.2	10.5	13.7	14.2	3.0	6.4	2.6	5.2	4.4	5.0	3.5	4.6	4.2	4.5	6.6	4.9	5.5	8.5	8.4	5.0	11.0	3.8	2.6	17.7	24.0	31.1	23.8	20.5	15.9	27.0	17.2	16.6	26.4	68.5	35.6	23.8	31.0	34.6	46.7	18.0	30.6	41.5	52.4	14.0	62.8	26.1	0.0	18.1	18.1	30.8	17.4	0.0	22.9	26.0	25.5	26.3	36.9	13.9	19.7	39.7	20.7	21.5	25.9	9.6	27.9	25.3	21.9	30.7	20.8	35.2	22.5	16.7	28.0	9.9	59.1	45.3	25.8	31.1	42.7	40.9	36.5	37.1	19.3	46.4
SFT2D1	"C6orf83, MGC19825, pRGR1"	ENSG00000198818	"SFT2 domain containing 1"	Q8WV19	6	166319728-166342591	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014677	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA014677: AB_2238986"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.47e-4)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (4.20e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.75e-2)"	21.1	24.6	33.6	21.7	31.8	16.4	24.5	15.6	25.0	20.2	27.9	43.4	23.4	23.5	14.7	37.0	19.6	18.8	18.6	15.6	34.9	26.2	27.6	12.5	27.2	23.9	43.9	18.6	18.3	32.6	13.4	11.8	25.9	27.8	27.3	26.8	15.0	38.0	19.4	11.2	12.5	24.9	16.0	61.2	24.6	27.6	18.3	32.8	20.6	24.9	15.3	23.7	17.1	16.1	25.5	57.6	50.1	30.1	14.9	21.7	24.2	13.3	13.0	10.7	22.4	19.6	17.5	16.8	20.8	17.9	14.7	22.3	27.1	27.5	11.8	15.9	17.0	25.7	16.3	15.6	17.1	22.5	16.3	28.5	13.9	11.0	38.2	17.7	35.2	28.3	16.4	20.4	16.9	14.8	21.2	7.8	19.6	25.7	11.9	22.6	21.5	10.3	60.1	10.5	39.9	12.8	7.3	12.3	27.5	36.0	13.9	2.0	9.3	14.2	23.2	18.5	12.6	12.6	63.7	7.3	9.2	17.7	24.3	21.5	11.4	8.2	12.9	19.5	22.2	22.4	29.5	28.5	34.7	18.1	28.1	11.3	25.5	14.7	15.1	30.4	21.2	15.9	15.9	50.1	14.9	30.1	57.6	21.7	24.2	33.6	31.8	15.6	25.0	34.9	26.2	43.9	18.6	27.8	32.8	38.7	55.2	94.6	100.0	76.8	8.2	23.0	58.6	44.2	44.3	102.9	0.0	131.5	76.3	136.4	33.1	53.4	86.8	23.3	110.4	203.9	98.4	175.7	146.5	20.8	187.8	14.3	27.6	63.3	172.6	14.5	78.9	142.4	94.5	228.2	114.9	23.5	133.8	128.7	44.6	126.0	8.4	84.1	53.6	137.2	79.4	89.8	109.7	82.0	105.5	178.5
SFXN2	SLC56A2	ENSG00000156398	"Sideroflexin 2"	Q96NB2	10	102714538-102743492	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 31.4;Proximal tubular cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018150, HPA026834"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA018150: AB_1856790, HPA026834: AB_1856791"	"unprognostic (1.70e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.98e-3)"	"prognostic favorable (2.28e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.77e-2)"	"prognostic favorable (6.52e-4)"	2.4	3.1	2.3	5.1	5.8	3.8	4.0	2.9	3.5	3.3	4.4	3.7	6.3	3.7	4.8	8.3	2.9	6.0	3.5	1.8	2.4	1.9	24.2	13.7	3.0	10.1	2.8	1.4	8.4	8.1	11.0	9.2	4.7	3.1	4.1	4.3	7.3	17.5	6.4	1.5	2.6	3.3	1.7	1.7	3.3	4.9	2.2	2.5	15.3	7.1	2.0	6.8	3.0	2.3	5.6	3.2	2.5	1.2	3.3	6.3	1.4	3.0	1.5	2.7	2.8	1.0	0.7	3.8	1.0	0.4	1.4	0.7	5.2	1.4	6.6	2.0	0.9	0.7	2.3	0.5	3.5	0.8	1.1	2.1	9.6	2.9	3.2	0.4	5.4	0.8	0.8	0.5	1.3	1.4	1.0	1.2	5.7	4.3	3.1	0.8	2.9	7.9	1.8	1.6	2.9	0.7	4.0	3.3	0.9	1.3	2.4	2.0	2.1	0.9	2.3	0.4	1.1	28.7	1.2	0.9	1.1	3.3	1.4	2.3	3.4	4.5	5.7	1.3	6.6	0.8	2.5	1.2	0.4	3.7	0.5	3.5	1.6	3.9	3.9	1.5	5.6	6.3	5.3	2.5	3.3	0.9	3.2	3.8	1.4	2.3	5.8	2.9	3.5	2.4	1.9	2.8	1.4	3.1	2.5	0.0	8.5	1.5	2.5	0.8	5.0	2.4	0.0	0.0	2.3	1.8	31.4	6.7	8.3	1.7	0.8	1.4	2.0	0.0	2.5	3.0	1.1	3.6	0.0	13.4	7.6	0.0	3.5	5.5	5.6	0.0	2.0	1.6	0.0	1.0	3.4	0.9	1.6	0.0	1.4	24.5	14.4	0.0	1.9	1.2	1.2	1.1	3.8	0.8	7.2	1.0
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.3;liver: 31.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 100.9;Late spermatids: 111.2;Muller glia cells: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	4.0	10.1	26.1	4.9	24.6	12.8	3.1	10.1	28.3	3.4	6.6	12.9	3.7	7.6	3.2	18.4	2.7	5.2	4.4	3.6	25.3	12.7	12.7	31.4	3.7	3.6	16.0	18.6	2.9	2.7	3.4	3.1	4.5	14.9	5.2	6.8	2.6	2.1	5.4	6.3	3.2	7.3	4.5	9.6	5.2	5.1	2.9	13.3	1.6	4.3	1.7	3.7	5.0	2.1	3.0	4.2	6.4	8.9	5.8	1.3	2.1	3.4	7.4	11.8	9.1	2.8	1.9	4.3	7.0	4.0	11.2	5.9	11.4	8.9	2.1	7.3	7.3	8.1	3.0	9.1	10.1	5.3	8.5	5.9	8.6	7.3	14.9	3.6	4.3	9.4	4.9	2.8	7.8	0.9	4.0	6.5	2.6	7.4	1.8	3.0	6.7	1.2	6.6	14.5	6.7	4.7	8.1	9.7	2.6	6.5	8.2	7.6	2.1	6.5	3.3	2.7	6.7	1.7	2.2	4.7	3.4	11.2	4.8	8.0	3.0	2.9	2.5	11.7	8.1	4.0	4.8	8.9	4.2	0.9	3.9	1.3	1.6	0.5	1.0	4.2	3.0	0.6	0.8	6.4	5.8	4.3	2.9	1.0	2.1	26.1	24.6	10.1	26.3	25.3	12.7	16.0	18.6	14.9	13.3	0.0	4.1	8.8	4.0	4.1	24.0	5.4	5.1	0.0	4.5	34.9	31.4	7.6	3.3	4.4	100.9	6.0	15.1	23.3	7.9	1.9	7.5	2.9	0.0	53.3	10.6	19.1	13.2	8.6	4.0	111.2	9.8	7.0	8.5	10.0	5.8	76.6	6.2	5.3	10.6	20.2	38.4	12.9	7.7	7.9	13.0	8.2	3.5	5.7	6.8	1.6
SGCB	"A3b, LGMD2E, SGC"	ENSG00000163069	"Sarcoglycan beta"	Q16585	4	52020706-52038482	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011422, HPA058656"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA011422: AB_1856795, HPA058656: AB_2683790"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.53e-6)"	"unprognostic (3.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (7.61e-4)"	17.7	13.2	17.6	5.4	19.0	0.5	8.8	18.6	20.7	14.9	18.3	17.5	3.7	7.7	17.1	7.0	13.2	11.5	11.6	32.4	16.5	14.5	20.5	6.4	9.0	3.4	20.4	12.9	12.6	4.0	29.9	17.5	13.9	17.9	15.4	9.9	7.9	7.8	17.0	54.1	4.4	8.7	21.8	24.7	6.3	9.0	9.2	20.3	0.9	7.9	10.4	2.8	13.5	11.8	4.3	1.7	0.9	2.0	0.5	6.6	2.0	3.4	4.2	8.9	3.3	34.4	26.0	3.2	19.7	25.3	11.1	11.7	1.1	4.7	0.9	3.8	25.8	17.2	1.7	6.6	7.2	11.9	5.7	2.5	0.0	4.0	2.1	14.1	2.0	1.1	28.5	5.1	9.6	5.6	29.1	14.5	3.4	0.0	0.0	23.6	1.3	4.5	0.0	3.2	1.4	6.5	0.0	4.7	0.0	9.3	1.2	5.2	9.1	12.5	0.6	4.3	10.4	1.6	1.2	14.7	16.5	5.5	7.7	17.4	4.8	6.1	1.7	12.1	0.7	18.8	0.4	2.0	0.1	3.9	0.8	3.7	4.3	4.6	4.1	0.9	3.6	3.3	4.1	0.9	0.5	0.6	1.7	6.6	2.0	17.6	19.0	18.6	17.5	16.5	14.5	20.4	12.9	17.9	20.3	29.8	12.5	7.0	23.0	11.8	22.7	71.9	20.4	18.7	12.5	12.2	5.9	4.3	1.7	23.7	46.3	25.1	15.9	0.0	46.3	44.3	51.2	9.7	2.3	14.3	2.6	27.0	15.6	35.0	2.2	132.8	35.9	5.1	25.3	1.8	2.6	22.7	35.3	3.5	85.9	54.8	13.4	45.3	63.4	9.8	15.8	9.3	5.3	7.5	11.3	12.3
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;T-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"		Yes	No		50000	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: AB_2686713"	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	22.4	35.7	16.9	7.5	19.0	0.6	23.2	23.6	18.5	22.5	20.5	16.8	14.0	5.3	23.6	16.8	11.1	17.1	19.0	19.3	17.7	14.3	12.9	8.9	17.3	9.0	21.5	12.9	59.3	12.9	8.7	23.1	31.9	15.0	15.6	9.7	11.2	11.9	22.7	6.1	3.5	8.0	28.1	20.9	15.8	11.2	13.2	17.5	2.9	15.4	6.9	4.4	22.7	16.1	9.2	0.3	0.6	0.1	1.4	2.9	0.5	3.7	11.9	12.0	19.4	19.2	36.0	2.1	14.3	29.0	12.2	18.6	7.4	22.5	3.5	20.4	25.3	25.5	2.5	18.1	6.4	16.7	0.6	9.8	0.3	11.7	8.0	15.0	1.1	0.0	29.1	8.9	18.0	23.5	33.3	8.6	0.0	0.0	28.4	14.2	11.8	0.0	0.0	9.2	2.2	9.4	5.4	14.9	7.5	23.8	3.7	7.6	6.1	0.0	15.9	18.2	14.6	5.5	0.1	0.0	38.8	13.0	3.6	22.1	14.7	18.3	4.3	14.4	0.0	21.8	0.6	0.1	0.1	2.9	0.1	1.2	6.4	0.9	1.4	0.1	9.2	0.3	1.0	0.5	1.4	0.1	0.3	0.2	0.5	16.9	19.0	23.6	18.5	17.7	14.3	21.5	12.9	15.0	17.5	65.5	26.6	5.2	18.8	4.4	16.7	15.1	17.8	22.7	43.3	19.2	3.9	75.6	5.0	31.9	1.1	15.0	0.0	0.0	3.9	20.1	52.5	6.3	2.3	7.2	5.5	19.1	1.2	44.8	4.8	1.9	69.9	2.3	49.0	0.0	0.0	27.8	2.8	0.0	54.8	14.7	28.3	84.1	46.2	9.1	3.4	3.4	69.2	0.9	0.0	2.0
SGF29	"CCDC101, FLJ32446, TDRD29"	ENSG00000176476	"SAGA complex associated factor 29"	Q96ES7	16	28553915-28591790	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 187.5;Late spermatids: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA052590, HPA053608"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoli	Nucleoplasm	"HPA052590: AB_2681875, HPA053608: AB_2682205"	"unprognostic (1.38e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.42e-3)"	11.1	11.4	7.9	11.8	12.5	9.9	15.5	20.9	11.0	19.5	17.1	10.6	16.9	11.6	21.4	10.2	9.0	17.6	11.1	10.7	7.9	6.8	9.8	12.9	11.1	17.2	16.5	7.1	31.5	17.7	8.6	9.4	8.4	10.8	13.1	6.9	12.1	14.8	20.0	36.1	12.2	13.4	21.4	13.4	11.6	13.5	35.6	14.4	17.6	19.5	9.0	10.4	17.1	25.1	25.4	27.6	18.8	18.2	19.5	36.1	20.4	7.0	12.0	9.2	6.0	6.4	6.3	16.8	4.8	5.4	12.6	11.9	13.8	6.4	21.3	12.0	3.7	7.6	8.3	7.0	8.4	3.6	6.8	13.3	13.2	7.4	18.3	15.6	11.8	14.9	6.7	11.5	7.5	7.6	6.8	4.7	13.6	11.1	10.9	4.4	23.6	13.4	23.2	12.7	5.2	11.7	21.0	6.0	18.5	6.3	10.7	14.9	6.9	7.4	14.2	7.9	3.7	11.7	9.8	3.3	8.7	7.4	5.0	8.3	12.7	18.4	12.4	6.2	20.1	7.0	5.0	18.2	18.8	22.3	15.6	26.9	22.2	31.2	27.2	18.3	25.4	36.1	27.8	5.6	19.5	12.5	27.6	29.6	20.4	7.9	12.5	20.9	11.0	7.9	6.8	16.5	7.1	10.8	14.4	14.9	11.8	6.7	16.2	0.0	6.1	0.0	5.1	12.0	13.6	17.4	13.7	15.2	8.3	9.9	187.5	3.6	9.3	0.0	11.3	10.4	9.5	6.7	5.8	14.3	12.7	0.0	3.5	6.2	12.9	270.5	28.4	12.1	0.0	11.8	9.2	11.2	11.3	12.2	20.5	18.8	13.9	19.4	0.0	8.4	19.2	0.0	17.6	13.1	14.0	11.1
SGIP1	DKFZp761D221	ENSG00000118473	"SH3 domain GRB2 like endophilin interacting protein 1"	Q9BQI5	1	66533383-66748299	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 91.2;Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 347.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 17.0;BJ hTERT+: 22.0;fHDF/TERT166: 13.9;hTERT-RPE1: 9.2;RPTEC TERT1: 16.2;SH-SY5Y: 8.8;U-138 MG: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017963	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA017963: AB_10964882"	"unprognostic (1.74e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.48e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.63e-2)"	6.2	7.5	19.6	3.8	30.2	1.3	2.7	26.2	36.5	7.5	2.7	11.4	1.3	3.4	17.1	8.0	5.2	4.7	8.1	6.8	22.9	12.4	14.0	1.7	9.6	2.0	10.8	26.3	3.6	1.2	1.9	7.0	3.9	26.4	5.4	3.4	5.8	3.5	9.1	3.2	1.7	3.2	7.0	11.3	1.4	5.1	7.4	14.9	0.0	8.0	0.8	1.5	6.1	5.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.4	0.0	17.0	22.0	1.3	2.0	0.0	0.0	0.0	0.0	13.9	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.6	0.2	0.0	3.9	0.0	0.0	2.4	0.0	1.3	0.0	9.2	6.4	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.4	8.8	0.0	0.0	0.0	0.3	0.0	0.6	1.1	16.1	0.0	0.4	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	19.6	30.2	26.2	35.0	22.9	12.4	10.8	26.3	26.4	14.9	0.0	0.0	0.0	0.2	0.9	91.2	1.6	2.5	0.0	0.0	8.7	329.9	0.0	6.6	0.3	0.5	11.1	0.0	0.0	0.0	0.0	4.1	0.4	9.3	0.0	0.2	69.9	0.0	0.6	0.0	0.5	2.0	0.0	10.1	0.0	0.0	55.4	0.0	0.0	10.6	0.0	347.4	12.9	52.6	0.0	0.0	0.9	0.2	0.0	0.0	0.3
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66667596-66862022	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006699, HPA027146"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favorable (5.52e-6)"	"prognostic favorable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	6.5	5.9	13.9	8.7	20.9	7.7	23.9	9.8	14.8	12.0	10.0	24.0	8.7	8.6	8.0	10.3	7.6	7.8	7.8	5.4	16.1	10.2	14.9	13.6	9.9	8.5	28.8	9.3	9.8	15.6	29.2	14.8	5.9	14.6	7.8	10.7	17.2	7.0	7.7	6.1	12.4	10.8	6.0	32.8	8.2	7.2	8.9	21.9	8.3	17.3	4.3	6.8	6.1	8.0	5.8	13.8	21.4	15.7	6.9	13.3	8.0	11.6	3.0	0.5	1.9	3.5	7.0	6.5	7.4	7.1	4.1	4.3	5.3	7.8	8.8	1.8	8.1	11.0	3.8	6.1	4.3	5.1	4.9	10.3	7.9	2.2	5.2	3.5	7.1	9.4	3.3	3.9	1.9	6.8	3.8	6.5	7.0	1.5	4.2	7.7	1.8	5.6	4.4	1.7	6.7	4.1	9.8	4.4	5.9	5.4	2.6	2.5	2.0	3.3	5.0	11.2	5.2	23.5	14.2	7.7	3.9	3.4	3.3	2.8	5.2	10.1	10.1	4.5	12.0	4.0	21.4	15.7	6.2	8.1	9.3	13.3	3.7	8.4	8.5	13.8	5.8	9.0	6.9	2.5	6.9	4.4	7.7	5.3	8.0	13.9	20.9	9.8	14.8	16.1	10.2	28.8	9.3	14.6	21.9	6.0	22.6	7.8	5.6	11.7	1.7	5.6	7.6	16.0	11.4	10.4	17.7	7.0	13.3	5.8	0.6	9.8	10.5	0.0	15.8	1.2	4.5	8.9	14.0	18.3	21.3	0.0	15.5	17.2	34.8	1.1	3.7	32.9	8.5	45.1	7.0	3.5	12.1	9.7	7.4	30.7	1.6	0.0	3.1	4.1	11.3	13.8	4.0	15.8	8.2	4.7
SGK494		ENSG00000167524	"Uncharacterized serine/threonine-protein kinase SgK494"		17	28607964-28614200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 89.8;Rod photoreceptor cells: 106.4;Spermatocytes: 85.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: AB_2679710"	"unprognostic (1.83e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.33e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.62e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.45e-5)"	"unprognostic (1.20e-7)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-3)"	1.6	4.7	10.3	3.5	25.3	10.6	2.3	17.8	25.8	1.9	1.8	0.9	0.4	0.7	2.0	4.5	1.3	2.4	0.8	2.1	8.6	3.7	5.6	1.6	3.2	3.3	2.5	10.7	3.7	1.3	2.0	5.6	3.1	11.2	2.3	4.0	6.3	1.9	3.2	3.8	6.3	2.3	1.9	2.9	3.4	1.3	8.5	4.1	0.1	2.5	0.1	3.5	1.9	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	5.1	6.1	5.7	1.9	2.5	4.4	0.8	0.3	2.1	1.9	6.1	0.7	7.0	0.9	2.8	3.1	3.1	4.5	2.4	2.7	3.9	6.7	7.3	4.0	3.6	0.2	9.8	5.2	1.2	7.3	7.4	4.2	1.7	2.3	9.7	7.0	0.6	1.3	7.1	2.4	6.5	6.1	3.2	0.9	7.1	8.7	4.6	1.2	6.7	3.7	3.5	4.3	2.4	3.6	8.6	3.6	5.5	3.0	4.1	3.5	4.1	5.0	3.8	3.6	8.5	3.0	7.1	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	25.3	17.8	25.8	8.6	3.7	2.5	10.7	11.2	4.1	0.0	1.3	5.2	5.5	0.0	89.8	0.3	10.2	0.0	1.2	5.2	21.6	5.6	0.0	2.0	10.6	2.9	4.2	0.0	1.3	2.0	1.0	5.8	0.0	5.8	3.6	33.4	1.2	8.6	5.7	2.2	2.0	3.2	0.0	3.6	2.7	6.8	1.9	7.0	1.8	1.4	106.4	0.0	0.3	85.6	14.7	0.0	20.7	5.0	3.2	3.4
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"		10	50305586-50625163	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	14.7	19.6	16.9	12.3	19.4	17.6	13.2	17.5	20.1	15.8	12.8	24.0	11.9	11.7	12.5	18.1	13.7	14.8	13.6	16.6	18.2	14.6	17.9	23.5	18.6	11.6	22.9	14.0	16.9	19.1	64.6	22.9	20.7	18.6	17.6	10.7	15.5	19.8	15.8	13.2	25.6	13.7	15.2	31.7	13.6	12.8	9.6	24.9	11.4	21.5	8.7	14.9	15.2	21.3	5.3	3.7	20.1	6.7	7.6	11.0	4.2	16.1	7.7	2.3	5.0	8.2	10.8	10.5	10.8	10.9	7.6	7.2	6.4	16.8	12.0	6.3	14.1	6.9	10.3	5.3	11.3	8.0	10.4	5.6	17.2	10.3	4.8	9.5	3.9	4.3	6.9	13.3	10.1	12.4	4.9	10.7	4.4	33.1	18.0	8.1	6.8	1.7	2.2	5.1	7.4	7.4	2.9	10.3	4.6	11.1	17.1	3.4	2.7	7.9	7.9	4.1	6.6	11.9	1.5	14.9	8.3	10.1	7.9	7.9	6.1	4.8	3.4	10.3	6.5	6.7	2.4	6.7	20.1	3.7	3.4	8.2	5.3	4.9	5.4	3.7	5.0	6.8	4.3	12.5	7.6	2.7	2.3	11.0	4.2	16.9	19.4	17.5	20.1	18.2	14.6	22.9	14.0	18.6	24.9	41.7	27.0	11.0	24.2	48.3	16.3	20.6	7.6	25.4	38.7	27.9	3.9	8.7	13.3	15.3	12.1	17.0	9.3	23.3	18.7	6.6	21.6	31.8	19.7	14.5	23.8	4.8	14.3	20.9	40.7	21.3	15.0	16.6	11.8	5.4	11.2	16.5	10.7	3.5	9.9	7.9	35.9	0.0	15.5	8.1	1.9	72.9	4.1	10.7	11.5	23.2
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200583782	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.6;lymphoid tissue: 25.7;testis: 27.9"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 14.7;Club cells: 11.4;Extravillous trophoblasts: 24.6;granulocytes: 10.5;Hofbauer cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: AB_2677149"	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	5.3	1.7	1.5	8.6	2.3	5.3	3.5	4.0	3.1	1.6	2.7	0.7	0.3	2.1	1.6	1.0	3.7	1.6	1.3	1.4	1.9	1.5	1.8	1.0	1.9	6.5	2.7	3.7	2.2	1.2	1.1	0.9	2.2	3.2	1.4	2.9	0.1	1.7	1.5	1.0	2.0	2.8	1.7	3.5	3.9	1.7	27.9	2.3	25.7	1.5	4.1	7.0	2.0	1.8	3.8	2.1	12.6	1.9	2.4	4.2	1.4	15.7	7.4	17.9	8.0	2.4	3.9	11.1	18.1	7.6	15.6	15.7	11.4	10.7	10.3	8.5	8.6	16.5	11.8	15.7	9.4	26.7	20.6	7.8	19.4	10.7	8.1	0.7	20.2	15.7	1.5	1.1	15.7	8.1	3.8	13.8	14.7	14.9	15.2	29.5	7.0	16.2	8.3	12.7	11.2	18.5	12.8	23.6	9.4	6.5	6.2	10.5	7.2	13.3	6.5	7.9	15.1	6.9	11.9	8.3	16.4	16.3	15.0	15.8	6.9	14.4	22.4	10.3	13.6	23.4	12.6	1.8	5.1	2.8	1.7	1.9	3.0	3.2	2.8	1.0	3.8	2.4	3.0	1.3	2.4	1.9	2.1	4.2	1.4	1.5	2.3	4.0	3.1	1.9	1.5	2.7	3.7	3.2	2.3	3.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	14.7	11.4	0.0	0.0	3.2	3.3	3.1	0.0	0.0	0.0	0.0	2.3	24.6	0.0	0.0	10.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.8	0.0	0.0	2.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
SGSM2	"KIAA0397, RUTBC1"	ENSG00000141258	"Small G protein signaling modulator 2"	O43147	17	2337498-2381058	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 8.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021641, HPA024553"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA021641: AB_2188702, HPA024553: AB_1856512"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.84e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (9.00e-6)"	"unprognostic (2.78e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-2)"	11.1	15.3	51.8	13.3	45.8	17.3	15.9	14.4	43.7	11.6	12.1	12.6	14.9	10.8	13.3	38.6	16.5	12.7	15.1	12.3	43.2	24.9	12.6	6.6	14.7	15.4	13.9	34.8	11.3	14.8	25.4	30.7	11.1	18.9	20.6	7.4	13.6	23.0	18.1	13.4	23.0	13.0	14.2	13.7	16.6	14.2	10.0	17.6	9.4	15.7	6.0	10.8	16.1	10.9	0.6	0.9	8.6	0.4	1.3	2.1	0.7	10.2	15.9	14.5	20.2	8.3	10.0	21.6	8.9	10.5	12.4	12.6	15.9	19.8	4.9	9.7	12.9	4.6	14.5	8.9	10.5	4.3	7.2	18.2	8.7	24.0	16.8	7.1	5.1	13.1	10.7	7.0	12.6	7.3	18.0	12.8	13.6	5.1	7.5	7.4	21.8	11.0	6.9	7.1	7.4	7.0	24.2	7.4	4.0	15.9	21.6	7.1	16.7	11.1	8.4	6.7	9.5	21.7	6.2	14.9	10.0	11.4	14.6	11.7	6.2	0.9	4.5	8.7	6.8	8.7	8.6	0.4	2.1	1.7	0.3	1.5	0.1	0.7	1.0	0.7	0.6	2.1	1.1	0.2	1.3	0.0	0.9	1.0	0.7	51.8	45.8	14.4	43.7	43.2	24.9	13.9	34.8	18.9	17.6	6.0	24.8	3.4	7.1	6.1	54.4	12.4	10.2	6.7	15.9	12.2	127.6	11.8	0.0	5.5	14.7	11.9	6.4	0.0	3.9	7.6	9.1	14.0	19.7	6.8	6.6	28.6	13.3	16.0	6.9	25.3	7.5	8.2	5.0	2.8	9.9	11.7	5.4	3.5	11.3	3.4	55.1	19.4	5.7	3.0	6.7	6.8	11.8	7.5	8.0	11.5
SGTA	SGT	ENSG00000104969	"Small glutamine rich tetratricopeptide repeat containing alpha"	O43765	19	2754714-2783371	"Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056309	Approved		Approved	Nucleoplasm		NA	NA		20000	Nucleoplasm		"HPA056309: AB_2683096"	"unprognostic (2.31e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.99e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.58e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.04e-1)"	19.1	18.6	28.6	16.7	28.8	27.3	15.7	25.8	44.4	17.3	19.3	46.8	21.1	26.8	18.7	18.9	23.9	23.9	16.0	44.6	30.6	24.7	21.6	29.5	15.6	18.9	28.8	27.0	30.2	41.8	14.9	23.9	30.4	27.0	20.4	11.4	22.2	31.9	22.4	62.9	16.2	24.0	18.4	35.7	20.9	19.6	28.9	21.0	33.2	25.0	18.6	15.9	16.6	19.7	16.4	22.5	22.9	29.7	19.6	23.1	19.0	28.4	23.5	21.5	20.6	8.9	9.3	17.9	19.3	13.9	29.7	25.5	37.3	12.9	26.7	15.6	15.0	17.8	20.4	27.2	30.2	11.7	0.1	24.2	15.1	12.3	27.3	21.3	20.6	17.4	15.4	16.2	22.3	20.0	11.7	19.9	22.7	39.1	22.4	14.8	17.3	31.6	22.5	37.3	19.3	22.7	39.7	19.5	30.2	15.9	17.7	40.3	31.2	14.8	21.2	27.5	10.0	25.1	24.8	16.6	19.2	19.8	36.6	34.6	39.0	38.7	32.0	24.7	43.0	29.6	13.4	21.1	20.6	18.5	26.0	21.0	16.4	19.4	20.1	22.5	15.0	15.7	15.4	22.9	19.6	29.7	19.4	23.1	19.0	28.6	28.8	25.8	44.4	30.6	24.7	28.8	27.0	27.0	21.0	8.9	20.7	20.8	21.0	21.1	40.9	41.9	17.8	4.0	10.3	17.4	23.6	45.8	29.9	34.2	66.8	24.8	37.6	0.0	38.9	44.3	23.5	22.7	27.7	21.5	33.6	36.5	30.9	12.9	22.5	34.2	20.4	20.3	18.6	38.7	27.5	40.1	31.5	38.6	25.8	21.7	40.8	12.9	22.8	31.7	20.6	21.5	77.6	17.5	30.2	26.4
SH2B1	"FLJ30542, SH2B"	ENSG00000178188	"SH2B adaptor protein 1"	Q9NRF2	16	28846600-28874212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060663, HPA076175"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060663: , HPA076175: AB_2686782"	"unprognostic (3.60e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.27e-3)"	"unprognostic (6.10e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.38e-4)"	"unprognostic (1.39e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.60e-4)"	18.1	29.5	31.5	22.2	32.0	24.6	19.7	45.0	42.3	23.3	24.1	27.7	32.7	33.6	26.0	21.6	19.4	25.7	22.0	23.6	26.0	22.9	27.0	18.2	18.9	26.0	30.1	36.2	39.7	27.1	50.6	33.1	15.4	25.5	25.4	21.6	29.1	35.3	32.6	37.7	29.5	32.0	20.3	22.2	28.9	21.7	19.9	28.0	17.0	33.1	18.8	18.2	20.9	21.2	4.7	4.7	7.1	3.4	1.7	5.3	2.0	12.9	19.1	14.7	18.9	15.5	13.2	12.3	13.6	7.7	10.8	11.7	12.9	22.1	12.1	19.2	10.9	9.3	20.8	9.6	15.1	6.1	15.6	12.4	10.7	44.1	19.6	11.8	10.7	10.3	18.4	12.4	15.0	6.1	18.4	12.3	12.5	17.0	17.8	14.1	17.8	16.0	16.0	19.0	6.8	7.8	27.2	8.8	20.1	12.4	9.9	16.9	22.8	6.5	19.2	9.9	9.2	15.1	11.6	17.3	12.4	10.5	10.8	10.2	33.9	16.7	13.3	19.3	18.9	12.4	7.1	3.4	2.0	5.3	2.8	5.1	3.9	4.3	3.7	3.0	4.7	3.4	3.1	6.0	1.7	2.7	4.7	4.5	2.0	31.5	32.0	45.0	42.3	26.0	22.9	30.1	36.2	25.5	28.0	6.0	10.7	9.8	15.5	9.6	24.3	15.8	15.3	9.4	14.8	21.0	31.4	13.5	13.3	8.1	1.8	11.7	24.4	0.0	11.3	6.7	11.9	10.3	5.8	4.9	10.7	27.0	26.6	11.1	7.6	3.4	20.4	10.0	3.3	10.8	22.2	16.9	10.5	22.1	22.3	7.0	26.8	25.8	12.2	9.3	11.3	9.7	11.4	10.2	26.5	9.5
SH2B2	APS	ENSG00000160999	"SH2B adaptor protein 2"		7	102285091-102321711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 37.8"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 20.7;Extravillous trophoblasts: 58.6;Syncytiotrophoblasts: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 5.2;neutrophil: 3.9"	"Group enriched"	"Detected in many"	5	"B-cells: 5.2;granulocytes: 3.9;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.5;Karpas-707: 22.9;RPMI-8226: 16.8;U-266/70: 21.3;U-266/84: 37.3;U-698: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051131	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051131: AB_2681354"	"unprognostic (2.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.99e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.02e-3)"	"unprognostic (3.42e-2)"	5.5	1.3	4.2	11.8	5.1	3.9	2.4	6.5	4.3	2.9	2.0	1.3	0.0	3.1	3.3	1.1	2.3	2.9	2.2	1.7	2.7	5.0	3.2	1.1	9.2	12.6	3.6	1.5	2.2	2.6	1.9	1.9	5.7	4.3	2.9	1.1	0.9	2.0	1.5	37.8	2.4	3.5	1.9	5.0	16.7	2.9	2.2	4.1	0.6	2.8	2.6	10.4	3.1	3.9	5.2	0.7	3.9	3.3	0.0	0.2	0.1	1.3	1.0	1.1	2.4	0.2	0.1	10.4	0.4	0.1	0.3	0.2	0.3	0.2	23.5	2.4	0.1	1.0	1.3	0.2	0.3	0.1	2.9	1.0	0.0	0.6	0.2	0.2	0.1	0.8	0.2	0.3	0.2	0.0	0.4	0.0	0.6	0.1	22.9	0.4	2.5	0.1	4.1	2.6	0.8	4.3	2.9	1.2	16.8	0.8	0.3	1.2	4.3	0.8	2.1	0.5	0.9	0.3	3.0	0.0	0.4	2.4	4.1	0.4	21.3	37.3	31.7	1.5	0.8	0.5	0.0	0.6	0.0	0.2	3.3	0.0	1.4	0.0	0.0	0.7	5.2	0.0	0.0	3.9	0.0	1.3	0.0	0.0	0.1	4.2	5.1	6.5	2.9	2.7	5.0	3.6	1.5	4.3	4.1	0.0	0.0	20.7	2.1	2.3	5.9	1.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.1	0.3	3.5	0.0	0.0	0.0	58.6	1.8	2.8	0.0	0.8	7.1	4.8	1.7	1.3	7.1	0.7	0.6	6.4	6.8	0.0	0.6	8.5	0.1	0.0	0.4	10.3	1.4	0.0	2.5	0.9	12.6	1.4	48.6	0.0	1.2	1.8
SH2B3	"IDDM20, LNK"	ENSG00000111252	"SH2B adaptor protein 3"	Q9UQQ2	12	111405948-111451623	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 49.7;Kupffer cells: 110.0;Macrophages: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 32.3;hTEC/SVTERT24-B: 37.0;U-87 MG: 56.2;WM-115: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005483	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005483: AB_1079260"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.65e-2)"	"unprognostic (8.17e-3)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (2.86e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.24e-2)"	17.6	9.0	7.9	13.7	7.9	34.4	19.8	3.8	9.3	8.9	7.5	7.2	3.1	5.3	8.0	7.1	5.6	7.5	12.7	15.3	5.8	5.5	9.2	12.5	17.6	27.8	6.6	4.0	8.2	11.0	4.7	7.6	16.1	5.2	8.4	9.3	8.7	5.0	4.2	10.2	3.6	10.3	9.1	7.8	31.7	5.5	13.3	6.8	9.5	10.2	3.2	11.8	10.0	5.8	1.8	6.1	3.8	10.3	2.3	1.7	1.9	2.3	1.4	1.8	1.9	6.4	9.6	1.2	7.5	20.6	5.7	6.2	2.1	1.3	3.9	5.4	11.4	19.5	0.4	1.4	4.3	9.4	3.3	0.7	13.4	0.6	1.5	6.3	5.8	32.3	5.7	1.0	37.0	3.3	12.8	30.9	3.3	9.6	1.6	20.9	0.8	2.4	11.7	2.8	0.6	5.4	2.4	4.2	2.5	2.7	0.9	1.2	1.3	1.3	0.1	10.7	1.7	0.9	8.4	23.9	5.3	3.0	4.5	12.1	3.6	3.8	4.5	56.2	4.2	42.8	1.1	4.3	1.5	1.6	10.3	1.4	1.8	1.4	1.7	5.9	0.7	1.0	1.3	3.8	2.3	7.6	6.1	0.5	1.9	7.9	7.9	3.8	9.3	5.8	5.5	6.6	4.0	5.2	6.8	3.0	31.9	11.5	1.3	6.1	4.1	14.9	5.1	0.0	2.3	1.8	2.0	0.4	1.7	3.1	9.6	32.1	3.8	0.0	7.5	1.1	9.8	2.4	37.0	9.4	35.5	3.2	3.4	49.7	110.0	4.0	2.6	49.7	15.1	34.3	2.6	0.9	6.9	7.0	3.9	1.4	3.1	0.0	17.6	9.4	4.0	3.6	0.8	11.8	1.7	0.8
SH2D3A	NSP1	ENSG00000125731	"SH2 domain containing 3A"	Q9BRG2	19	6752160-6767588	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 105.7;Urothelial cells: 79.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 18.8;HaCaT: 16.2;HBEC3-KT: 31.1;SK-BR-3: 15.7"					"Not detected"	"Not detected"			"HPA035722, HPA064382"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		NA	NA			Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA035722: AB_10670024, HPA064382: AB_2685251"	"unprognostic (3.32e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.63e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.21e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (7.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.81e-3)"	0.5	0.2	0.4	9.2	0.9	1.9	5.3	0.6	0.5	4.7	19.7	0.5	8.7	10.9	3.8	6.7	20.0	3.0	15.8	0.4	0.4	0.0	9.6	1.7	13.4	5.4	0.6	0.4	1.1	18.8	4.9	3.4	14.3	0.9	11.0	4.3	1.6	24.0	13.3	0.8	15.3	18.0	2.2	1.0	3.8	11.0	2.5	0.4	5.0	10.9	11.0	17.2	9.0	9.4	5.6	0.4	0.0	0.1	1.9	9.2	1.0	18.8	2.7	0.0	0.1	0.0	0.0	9.3	0.1	0.0	0.0	0.0	6.8	14.6	2.9	8.6	0.0	0.0	16.2	1.1	31.1	0.0	1.4	2.7	0.1	2.3	1.0	0.0	0.2	4.0	0.0	13.0	0.0	3.2	0.4	0.0	6.6	3.1	7.2	0.0	6.6	1.4	0.0	0.7	10.2	5.3	0.5	0.0	11.5	5.6	12.0	0.0	0.0	1.1	15.7	0.0	0.4	10.4	0.1	0.3	0.3	1.1	0.2	0.1	6.2	6.7	3.6	0.1	2.0	0.1	0.0	0.0	0.0	3.0	0.1	5.2	3.9	6.8	6.2	0.1	5.6	9.2	4.7	0.0	1.9	0.1	0.4	3.3	1.0	0.4	0.9	0.6	0.5	0.4	0.0	0.6	0.4	0.9	0.4	17.9	13.9	36.4	105.7	27.2	3.5	1.7	30.6	17.4	30.7	38.4	9.8	19.1	1.7	53.7	0.9	2.6	48.5	23.3	31.9	46.8	3.3	55.3	5.7	2.6	3.1	0.0	11.6	1.8	0.0	0.0	0.6	4.3	3.3	5.4	27.1	0.8	56.0	66.2	0.0	9.1	4.5	0.0	2.1	7.5	8.9	34.9	9.0	13.8	21.5	79.6
SH2D5		ENSG00000189410	"SH2 domain containing 5"	Q6ZV89	1	20719732-20732837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 19.5;placenta: 14.8;testis: 9.4"	"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 4.2;Suprabasal keratinocytes: 1.9;Syncytiotrophoblasts: 4.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.3;hTERT-HME1: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030182			Approved	Cytosol		NA	NA			Cytosol		"HPA030182: AB_10670431"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.80e-6)"	"unprognostic (1.11e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-2)"	0.4	0.9	4.5	1.3	19.5	0.4	0.3	0.5	19.2	0.6	0.5	0.3	0.0	1.2	1.4	0.3	0.5	0.5	0.6	0.3	3.9	4.1	0.4	0.3	0.4	0.3	1.5	7.3	1.7	0.3	0.6	0.1	14.8	2.1	0.5	0.3	0.0	0.4	1.8	0.3	0.6	0.5	1.2	0.3	0.4	0.6	9.4	0.7	0.0	2.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.7	3.9	0.8	0.0	0.0	0.0	0.1	4.6	6.6	4.6	3.1	1.6	1.6	0.0	1.2	1.4	10.0	0.4	3.3	25.3	1.9	0.0	1.7	0.0	0.5	1.2	3.8	0.0	0.0	0.2	5.3	8.6	32.4	1.6	0.1	0.8	0.0	0.0	1.9	0.9	0.5	0.0	1.5	0.5	5.0	0.1	0.1	0.2	4.8	0.6	1.5	0.2	0.3	0.1	1.5	0.7	0.0	0.0	0.0	5.6	9.9	8.3	2.2	0.0	0.0	0.4	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	19.5	0.5	12.3	3.9	4.1	1.5	7.3	2.1	0.7	0.0	0.0	0.0	1.0	4.2	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.9	1.9	4.2	0.0	0.0	0.3
SH2D7	LOC646892	ENSG00000183476	"SH2 domain containing 7"	A6NKC9	15	78077808-78104909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	7	"testis: 37.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 17.9;Late spermatids: 23.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.1;AN3-CA: 2.8;BEWO: 2.6;HEK 293: 2.0;SCLC-21H: 2.4;SH-SY5Y: 4.4;SuSa: 2.3"					"Low region specificity"	"Detected in all"			"HPA051320, HPA058382, HPA076728"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA051320: AB_2681439, HPA058382: , HPA076728: "	"unprognostic (1.22e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	0.1	0.2	0.6	0.5	0.4	0.0	0.1	0.5	0.5	0.1	4.3	0.1	0.1	5.0	0.1	0.1	0.1	0.0	1.0	0.2	0.4	0.4	0.1	0.1	0.6	0.1	0.3	0.1	0.1	0.3	0.0	0.2	0.3	0.1	0.2	0.5	0.2	0.2	0.1	0.1	0.1	4.2	0.1	0.3	0.1	0.3	37.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	2.1	2.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	1.5	0.1	0.0	1.1	1.4	0.0	0.0	0.4	2.4	4.4	0.4	0.6	0.2	2.3	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.5	0.5	0.4	0.4	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	2.5	0.0	0.0	0.0
SH3BGR	21-GARP	ENSG00000185437	"SH3 domain binding glutamate rich protein"	P55822	21	39445855-39515506	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 219.7"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 161.5;Early spermatids: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 15.6;U-87 MG: 48.5"	"Group enriched"	"Detected in many"	5	"cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7"	"Low region specificity"	"Detected in all"			"CAB003685, HPA030690"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB003685: AB_425682, HPA030690: AB_2673570"	"unprognostic (3.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.68e-3)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.75e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.16e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-2)"	2.4	5.2	7.2	1.2	7.3	0.9	2.9	1.1	4.3	2.9	6.1	3.0	2.0	1.9	2.1	6.6	5.3	2.1	5.0	30.0	6.6	5.4	3.2	2.8	1.5	0.9	7.5	5.0	1.8	2.8	2.1	4.5	1.1	6.1	5.8	2.0	1.2	3.2	5.2	219.7	0.9	1.4	12.4	7.9	1.2	2.9	3.7	5.9	0.1	3.9	41.5	2.2	7.3	8.6	2.7	11.5	2.6	1.7	2.8	4.0	1.2	1.1	1.3	1.7	2.5	3.8	4.4	0.5	2.0	0.9	0.9	0.7	0.7	2.2	3.4	5.2	5.1	7.0	0.1	0.9	1.5	1.4	2.0	3.5	3.4	0.6	1.4	7.7	1.2	0.7	3.6	6.3	3.2	6.4	3.2	1.0	6.5	2.6	4.4	3.6	4.1	2.2	2.0	1.7	2.9	2.9	3.6	6.5	2.1	4.7	0.8	5.0	2.1	3.0	2.4	3.1	1.6	9.2	0.6	0.8	2.6	0.3	1.5	3.8	15.6	3.3	3.4	48.5	3.0	3.3	2.3	0.7	0.0	1.2	1.7	3.1	2.7	1.1	1.8	1.9	1.4	4.0	3.0	2.6	2.8	1.7	11.5	0.7	1.2	7.2	7.3	1.1	4.3	6.6	5.4	7.5	5.0	6.1	5.9	3.0	3.8	0.9	6.0	2.4	2.1	161.5	5.1	5.3	2.3	5.2	3.9	3.1	39.7	3.5	91.7	1.8	1.3	0.0	19.1	1.3	3.5	3.4	4.6	6.4	2.2	4.8	1.2	1.8	2.1	20.4	2.0	1.3	11.8	1.8	1.9	14.0	5.8	1.9	5.3	11.9	6.1	6.5	27.4	23.3	21.1	1.5	1.6	1.9	3.2	4.8
SH3BGRL	MGC117402	ENSG00000131171	"SH3 domain binding glutamate rich protein like"	O75368	X	81201943-81298547	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051248	Approved		Approved	Vesicles		NA	NA		14000000	Vesicles		"HPA051248: AB_2681405"	"unprognostic (3.02e-3)"	"unprognostic (4.25e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.73e-1)"	46.5	35.9	48.6	32.9	40.4	43.2	51.5	11.7	40.4	60.0	70.4	27.3	43.5	25.0	66.2	45.0	49.3	45.0	43.1	24.2	42.4	46.3	41.4	17.6	37.7	46.3	56.7	29.0	40.1	23.1	29.7	59.8	24.3	40.7	55.6	32.1	27.8	34.8	88.1	9.7	19.1	33.6	77.4	67.1	52.7	41.0	26.7	36.0	46.5	33.4	21.4	34.8	81.7	34.9	31.5	41.1	83.4	71.1	23.2	32.6	51.1	0.1	7.0	25.5	29.2	33.6	45.8	1.7	15.6	29.8	5.7	11.8	2.2	21.5	20.9	13.5	22.8	8.1	3.8	18.0	11.2	9.2	17.7	6.3	27.7	11.7	1.3	8.1	19.4	54.5	26.5	8.1	8.1	7.2	44.7	25.2	14.3	9.5	52.0	31.3	9.4	20.2	25.3	20.0	0.2	11.3	18.6	11.6	11.0	29.6	9.6	0.0	11.3	0.0	0.7	14.1	17.7	8.5	59.4	25.5	16.0	6.4	14.6	6.4	12.1	10.4	19.2	18.3	39.9	11.8	83.4	49.5	71.9	17.6	63.9	19.0	31.5	22.3	20.7	41.1	26.0	20.7	21.6	17.1	23.2	71.1	19.4	32.6	51.1	48.6	40.4	11.7	40.4	42.4	46.3	56.7	29.0	40.7	36.0	104.2	80.1	174.5	109.6	112.2	11.1	20.3	56.0	127.2	88.7	115.1	0.0	5.3	291.8	67.6	4.3	119.6	42.3	93.5	66.7	4.3	136.2	89.9	212.7	17.1	382.1	4.8	89.6	135.1	328.5	9.4	161.4	380.8	140.0	336.4	72.7	101.9	45.7	107.8	295.2	151.2	8.1	258.7	350.5	1.6	6.8	104.5	4.8	147.1	66.1	120.4
SH3BGRL3		ENSG00000142669	"SH3 domain binding glutamate rich protein like 3"	Q9H299	1	26279176-26281522	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 309.8"	"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 2380.9;Urothelial cells: 2379.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 134.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030848, HPA076219"	Enhanced		Approved	"Nuclear bodies"		NA	NA		73000000	"Nuclear bodies"		"HPA030848: AB_10602398, HPA076219: AB_2686787"	"unprognostic (4.97e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (2.17e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.43e-2)"	97.7	26.9	37.3	82.0	37.2	80.9	33.5	11.3	43.2	33.6	65.8	32.3	19.1	31.9	22.9	124.4	84.0	22.9	42.9	31.3	34.6	32.3	36.6	35.1	58.7	98.4	40.5	19.9	26.8	33.6	7.5	22.2	39.9	31.1	23.9	78.2	21.6	36.3	18.3	16.2	51.8	41.3	34.8	32.6	101.4	40.8	13.7	19.3	80.5	26.6	66.0	95.0	41.1	41.5	75.1	184.4	237.0	211.4	68.2	155.1	309.8	28.8	11.2	11.9	15.8	37.8	94.2	1.8	49.5	58.7	44.2	29.2	8.4	26.2	6.0	18.2	92.5	16.5	10.8	5.5	47.2	33.3	10.3	4.1	51.0	10.7	8.7	28.7	15.9	87.2	38.9	27.4	45.7	36.3	67.9	52.9	13.4	5.3	25.6	80.4	13.0	11.1	25.8	13.2	25.0	73.5	19.7	13.4	9.2	35.9	9.8	7.2	11.3	18.2	20.3	21.9	13.6	3.7	26.6	79.5	62.9	22.6	91.7	24.1	8.1	12.4	5.7	134.9	42.2	31.3	107.5	211.4	188.4	143.1	191.7	106.2	75.1	127.2	140.7	184.4	66.0	55.5	108.8	237.0	68.2	180.6	96.8	155.1	309.8	37.3	37.2	11.3	43.2	34.6	32.3	40.5	19.9	31.1	19.3	89.3	227.2	487.6	666.7	874.2	12.9	5.3	206.4	127.2	135.4	349.0	3.9	99.7	265.2	1062.3	13.2	348.4	756.2	70.0	895.1	379.2	363.5	911.1	977.5	102.7	2380.9	15.9	325.9	311.8	2032.0	36.2	128.9	1759.5	738.9	502.3	1235.8	41.9	1651.6	517.4	152.4	317.2	12.4	148.8	259.2	6.6	24.7	925.4	189.9	897.8	380.7	2379.6
SH3BP1	ARHGAP43	ENSG00000100092	"SH3 domain binding protein 1"	Q9Y3L3	22	37634654-37656119	"Predicted intracellular proteins"	Phagocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"T-cells: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 20.3;HMC-1: 20.9;NB-4: 21.2"									HPA000757	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA000757: AB_1079951"	"unprognostic (7.81e-3)"	"unprognostic (7.91e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.78e-1)"	"prognostic unfavorable (3.48e-7)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.37e-2)"	"unprognostic (8.48e-3)"	4.1	3.0	3.2	17.9	4.5	12.8	2.6	5.0	5.7	7.9	12.0	3.6	2.0	20.6	2.6	3.6	25.1	3.2	4.2	2.2	2.9	2.1	2.8	2.2	6.2	11.7	3.1	2.9	4.3	2.2	1.9	1.8	9.1	3.2	5.7	5.0	2.7	7.0	2.6	1.1	16.8	18.2	2.4	4.2	19.9	5.1	3.8	4.1	15.4	2.0	15.2	23.4	9.8	13.5	0.6	2.1	7.3	5.9	1.6	2.8	1.1	10.0	0.5	1.7	1.4	0.4	1.7	14.2	1.6	2.8	2.7	3.0	2.6	1.0	5.7	1.4	1.0	0.9	20.3	0.8	11.0	1.1	17.7	6.6	8.0	0.3	3.6	1.4	11.5	20.9	2.1	2.7	3.4	0.4	2.3	0.4	2.8	2.7	2.1	0.2	5.4	1.4	21.2	3.5	5.9	1.6	7.3	1.5	4.9	0.3	10.7	1.9	4.8	0.5	2.4	8.4	1.8	3.0	10.2	0.5	1.0	5.4	0.3	0.1	15.0	5.3	4.4	1.4	11.9	5.7	3.2	2.7	7.3	2.0	3.2	2.2	0.6	2.2	2.2	1.4	0.3	1.4	2.8	1.8	1.6	5.9	2.1	2.1	1.1	3.2	4.5	5.0	5.7	2.9	2.1	3.1	2.9	3.2	4.1	0.0	11.1	18.4	16.5	16.9	0.2	0.8	5.1	4.0	0.0	0.0	2.0	41.3	0.0	2.3	0.3	1.1	41.3	0.0	4.0	37.2	3.9	5.0	13.9	0.0	43.7	7.9	4.1	4.3	24.1	0.0	4.6	26.8	5.0	26.2	28.9	2.7	2.0	35.1	1.8	0.2	0.4	0.0	1.9	2.8	3.9	13.4	31.4	48.5	20.0	36.7
SH3BP2	"CRBM, RES4-23"	ENSG00000087266	"SH3 domain binding protein 2"	P78314	4	2793023-2841098	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 83.9;Suprabasal keratinocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036790	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA036790: AB_10671712"	"unprognostic (7.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (5.42e-6)"	"prognostic unfavorable (9.52e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.41e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.67e-4)"	17.5	7.0	9.7	20.4	14.5	30.2	13.1	6.1	10.1	9.0	11.6	9.8	7.5	8.9	7.9	18.7	10.8	8.7	9.5	9.9	9.3	8.8	26.3	18.3	20.2	18.5	12.0	3.5	8.8	10.1	3.6	7.6	20.8	15.4	8.4	7.4	11.6	9.3	7.8	11.0	31.2	14.2	8.9	14.5	46.8	10.8	5.0	12.2	5.2	8.0	6.9	17.4	11.6	10.9	4.4	8.6	16.7	21.9	3.8	7.0	5.4	5.3	3.2	3.7	5.2	3.1	7.9	3.5	8.5	7.0	6.6	5.9	2.3	16.7	8.4	9.7	7.1	5.5	2.5	0.2	5.6	4.0	4.3	3.4	19.7	6.6	2.7	10.3	8.1	13.9	14.9	5.3	3.7	3.3	7.2	14.4	7.5	1.1	19.5	7.8	4.3	1.2	9.7	6.0	11.5	6.3	0.4	3.4	3.6	11.2	8.4	11.3	8.4	6.2	5.9	4.2	3.5	9.0	13.5	18.3	6.4	4.9	2.3	6.3	8.2	3.8	1.7	7.5	21.9	6.8	1.8	10.5	6.7	7.0	18.6	4.4	1.4	1.9	4.6	8.6	4.4	1.0	2.7	16.7	3.8	21.9	3.5	3.5	5.4	9.7	14.5	6.1	10.1	9.3	8.8	12.0	3.5	15.4	12.2	3.0	4.3	12.4	8.1	33.9	0.8	6.1	7.6	2.7	9.1	38.4	0.0	0.9	3.3	6.3	7.4	27.2	19.0	0.0	19.1	1.2	11.3	12.4	9.2	40.4	43.6	0.0	9.8	39.9	83.9	5.8	12.7	47.9	18.6	7.2	13.3	30.8	21.0	23.4	9.6	30.1	5.1	38.8	17.5	1.6	3.4	72.9	3.5	17.3	12.1	17.0
SH3BP5L	KIAA1720	ENSG00000175137	"SH3 binding domain protein 5 like"	Q7L8J4	1	248810446-248826633	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038067, HPA038068"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA038067: AB_2675814, HPA038068: AB_10670651"	"unprognostic (2.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (4.41e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.99e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.66e-2)"	4.1	5.0	5.3	4.0	4.8	3.0	3.3	10.3	8.7	4.1	4.9			6.2	4.9	2.5	7.2	4.7	3.3	6.5	5.5	4.0	4.1	4.5	3.9	4.2	4.2		3.9	4.2	5.9	2.4	5.0		3.9	2.9		5.1	5.7	13.6	8.0	5.6	4.3	5.0	5.4	4.3	3.6			3.6		4.0	4.1	3.7	1.1	1.2	6.2	1.8	0.4	1.5	1.0	10.0	6.3	8.4	9.6	12.0	8.1	11.0	22.7	7.8	13.3	10.1	6.1	8.9	5.0	13.8	19.0	3.3	10.8	7.9	9.7	6.4	11.5	2.8	8.2	6.8	4.9	7.3	8.9	9.9	6.6	10.5	14.7	5.6	9.4	8.8	9.5	14.0	5.3	8.9	3.3	8.4	6.1	14.7	11.2	16.2	9.6	5.9	10.2	9.1	4.5	9.7	13.4	7.0	8.7	7.5	6.6	9.4	18.4	12.1	16.4	7.0	6.6	34.5	13.2	14.7	4.5	12.2	10.3	6.9	5.5	1.8	5.4	1.1	1.0	1.1	0.5	1.5	0.9	1.2	1.1	0.5	0.4	6.2	0.4	0.4	0.8	0.2	1.0											0.0	1.3	3.0	1.7	4.0	8.1	8.9	2.5	0.0	0.0	10.4	0.0	7.5	1.7	7.2	1.1	3.1	12.6	0.0	5.1	4.0	5.1	3.0	0.0	7.4	5.2	7.9	7.5	4.3	5.7	0.4	4.0	3.7	3.3	5.4	7.2	3.7	8.3	8.7	5.3	5.8	3.3	0.0	3.3	8.0	6.0	4.1	9.5	5.2	5.2	2.7
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579082-17797129	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 83.0"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 74.6;Cone photoreceptor cells: 21.6;Late spermatids: 36.0;Rod photoreceptor cells: 24.1"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.7;HeLa: 13.8;JURKAT: 12.1;RT4: 26.7;SCLC-21H: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	1.1	1.2	16.7	1.1	17.3	1.0	1.1	68.4	83.0	3.1	1.5	1.6	0.0	1.2	2.8	2.1	1.4	2.6	1.1	4.1	17.1	11.3	13.7	1.1	1.9	1.0	9.1	22.2	2.5	3.4	1.2	6.6	1.0	12.8	2.5	1.6	1.6	1.0	1.1	1.1	1.1	1.5	2.4	6.3	1.1	4.5	5.8	2.2	0.0	2.2	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	4.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.7	0.0	13.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.5	0.0	0.0	0.0	0.0	26.7	17.3	0.0	0.2	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.0	0.2	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	17.3	68.4	41.1	17.1	11.3	9.1	22.2	12.8	2.2	0.0	0.0	0.0	0.3	0.1	74.6	1.6	0.0	0.0	0.0	7.0	21.6	0.0	10.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	12.7	5.1	0.0	0.0	36.0	1.1	0.0	0.0	0.0	0.7	6.5	0.3	0.0	0.4	18.3	24.1	0.0	0.1	2.1	2.5	0.0	0.1	0.0	0.2	0.4
SH3GL3	"CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13"	ENSG00000140600	"SH3 domain containing GRB2 like 3, endophilin A3"	Q99963	15	83447228-83618743	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 30.3;testis: 31.6"	"Group enriched"	"Detected in many"	10	"Early spermatids: 502.6;Late spermatids: 937.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 21.8;HEK 293: 10.8;K-562: 17.0;RH-30: 6.7;SuSa: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039381, HPA077877"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039381: AB_10794635, HPA077877: AB_2686863"	"unprognostic (1.10e-3)"	"unprognostic (6.62e-2)"		"unprognostic (4.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.01e-2)"		"unprognostic (2.37e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.43e-6)"	"unprognostic (4.42e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.78e-4)"	1.1	1.3	12.5	1.1	26.6	1.4	1.3	6.3	30.3	1.2	1.1	28.2	0.0	1.2	1.8	2.0	2.9	3.5	1.1	1.2	14.2	9.9	2.3	1.1	4.1	1.3	25.5	14.6	1.2	1.0	1.1	0.7	1.8	17.6	1.7	1.2	0.0	1.0	1.8	1.0	1.6	1.2	1.2	16.7	1.1	1.2	31.6	26.0	1.2	1.2	0.5	1.9	1.6	0.7	0.4	0.7	0.7	0.3	0.0	0.4	0.3	0.0	0.0	1.8	1.3	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	21.8	1.3	0.0	0.0	10.8	3.2	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	4.5	17.0	0.0	0.0	0.6	1.3	0.0	2.6	0.0	0.8	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	9.5	0.0	0.0	0.3	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.3	0.7	0.0	0.1	0.7	0.2	0.3	12.5	26.6	6.3	18.5	14.2	9.9	25.5	14.6	17.6	26.0	8.9	1.7	0.0	1.3	0.8	4.1	0.4	0.0	1.4	0.0	3.5	0.0	0.6	0.0	0.4	502.6	0.0	0.0	0.0	0.0	1.0	0.4	0.2	0.0	0.0	0.3	73.1	0.0	0.0	0.0	937.4	8.6	0.0	1.7	0.0	0.0	2.5	0.5	0.0	3.9	0.0	1.1	0.0	0.2	9.5	6.8	0.1	0.6	0.0	0.0	0.1
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cytotrophoblasts: 90.7;Syncytiotrophoblasts: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 63.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favorable (4.28e-4)"	9.3	18.8	36.9	11.7	27.0	30.4	16.6	31.3	47.2	15.8	16.4	33.0	43.7	25.7	14.4	14.2	29.5	21.0	13.6	14.8	34.2	24.4	15.8	6.6	14.9	13.6	28.8	37.9	20.0	35.9	29.1	26.8	45.2	26.3	21.3	10.1	13.4	30.0	33.8	19.4	46.6	20.4	16.6	30.9	14.9	25.8	7.8	24.1	16.9	16.4	15.0	15.8	27.8	18.1	7.7	7.6	6.6	4.6	5.0	4.9	2.8	13.4	11.4	5.6	7.6	3.4	4.3	16.8	4.7	10.7	9.4	8.6	7.1	23.3	14.2	3.7	8.3	7.2	33.2	1.7	10.2	2.7	9.1	7.7	3.6	18.2	6.2	7.1	3.2	8.7	3.1	11.7	4.8	4.3	10.3	7.8	18.8	4.8	19.0	4.7	33.1	18.2	8.5	5.0	22.8	8.0	37.1	10.6	63.5	10.4	16.3	17.7	14.3	6.8	17.8	7.3	4.9	25.5	4.8	7.1	4.4	7.5	11.1	10.3	18.5	9.0	9.0	10.1	4.0	2.3	4.4	3.3	6.6	4.1	1.6	4.9	7.7	4.7	3.8	2.7	3.8	3.4	3.0	2.7	5.0	4.6	7.6	3.9	2.8	36.9	27.0	31.3	47.2	34.2	24.4	28.8	37.9	26.3	24.1	14.9	30.8	10.4	24.5	18.4	20.3	9.0	12.7	5.3	19.4	45.4	7.9	90.7	13.3	12.2	8.2	11.3	41.2	23.3	22.8	15.3	16.4	24.4	5.8	7.8	17.9	44.5	24.3	11.6	11.6	14.9	17.5	9.8	13.5	4.6	31.4	26.6	19.7	49.9	19.1	6.2	15.6	12.9	16.5	6.1	6.6	46.9	125.1	10.4	29.9	48.9
SH3PXD2B	"FLJ20831, KIAA1295"	ENSG00000174705	"SH3 and PX domains 2B"	A1X283	5	172325000-172454523	"Disease related genes, Predicted intracellular proteins"	Differentiation		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 28.3;Leydig cells: 36.8;Peritubular cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"classical monocyte: 1.3;myeloid DC: 1.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 1.7;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 37.5;ASC TERT1: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036471	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA036471: AB_10670799"	"unprognostic (3.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.84e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (5.38e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (8.45e-4)"	26.9	17.8	6.9	12.4	10.1	0.7	28.0	13.3	8.7	28.0	10.0	16.6	13.4	3.1	26.4	19.6	12.3	14.6	21.4	5.8	7.6	4.1	2.8	2.6	13.2	11.4	16.0	4.5	18.1	7.9	16.7	4.3	10.2	10.9	10.6	6.9	15.9	14.8	16.8	5.1	15.0	8.2	25.8	10.0	7.7	11.1	10.9	9.6	1.8	6.5	4.3	4.2	17.0	14.9	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.3	5.4	20.1	13.2	37.5	31.8	17.1	3.2	11.2	2.1	4.2	1.5	0.5	0.0	4.4	12.5	6.4	3.0	7.1	3.7	2.0	0.3	1.3	0.0	5.1	1.0	12.1	0.0	14.1	20.3	5.8	8.6	2.5	2.0	14.4	1.4	0.0	0.1	9.1	1.1	0.0	1.7	7.7	3.0	1.2	6.3	3.2	1.8	2.2	0.5	1.7	11.3	2.2	1.4	4.1	6.6	0.5	0.8	15.4	13.0	5.2	7.9	1.4	0.0	0.0	0.0	8.8	0.8	10.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	10.1	13.3	8.4	7.6	4.1	16.0	4.5	10.9	9.6	0.0	0.6	0.0	2.8	9.0	0.6	1.6	7.6	0.0	2.3	0.0	0.0	3.9	0.0	8.4	0.8	5.8	0.3	0.0	13.8	28.3	12.8	5.6	0.0	2.0	2.7	1.6	2.4	2.5	19.6	1.3	36.8	8.6	13.5	1.0	1.8	4.5	18.6	0.0	25.5	1.4	0.2	12.9	10.5	0.7	4.1	7.0	1.8	0.0	2.8	5.0
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094256-169271105	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;monocytes: 8.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	15.2	4.8	13.8	7.2	11.8	3.7	11.1	2.5	12.7	7.5	17.2	15.9	10.8	15.7	6.8	7.2	7.1	6.9	19.7	7.8	17.8	9.3	14.6	9.6	11.3	3.7	13.0	10.9	11.9	12.0	5.2	7.8	8.6	10.3	17.2	16.0	10.7	20.9	10.7	16.2	6.8	17.2	8.8	11.7	4.5	27.6	7.0	11.3	0.9	23.1	7.6	5.5	9.4	6.3	0.4	3.4	0.0	8.5	0.3	0.0	0.7	7.3	6.1	5.6	16.1	6.0	7.6	7.2	20.5	9.9	15.2	7.1	6.1	8.9	0.0	1.0	21.2	4.1	4.9	4.5	8.0	16.9	0.0	2.6	4.3	14.0	3.2	13.7	1.5	0.1	4.5	4.4	13.0	10.4	19.4	9.4	1.6	0.0	0.0	14.1	3.0	1.5	1.4	2.8	9.5	5.3	2.2	1.8	0.3	7.0	5.8	4.2	5.1	5.1	8.0	2.0	2.5	2.6	0.6	8.4	7.2	5.6	12.0	7.2	0.5	0.0	0.0	8.2	1.5	8.6	0.0	1.4	0.0	0.0	5.9	0.0	0.4	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.3	8.5	0.2	0.0	0.7	13.8	11.8	2.5	12.7	17.8	9.3	13.0	10.9	10.3	11.3	59.6	33.6	6.2	32.4	30.5	2.1	5.2	45.9	34.8	45.5	26.2	0.0	9.8	10.0	35.2	4.4	11.2	52.9	0.0	55.1	19.0	14.9	71.6	10.3	7.6	6.5	0.0	30.1	8.6	6.5	3.1	11.2	7.5	3.3	1.8	26.8	11.3	54.5	27.9	11.3	13.3	0.9	64.7	42.1	2.3	7.5	11.0	11.0	0.0	28.8	55.9
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 36.2;Kupffer cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.3;MOLT-4: 26.5;SK-MEL-30: 15.2;U-2197: 11.5"	"Low region specificity"	"Detected in many"							"HPA038132, HPA056807"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: AB_2683239"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	16.8	4.2	3.7	12.7	7.6	7.5	8.5	0.9	4.0	5.7	3.2	8.6	3.3	1.9	3.2	7.9	9.7	3.9	10.0	4.5	6.6	3.5	19.9	11.2	10.1	14.2	7.4	1.0	2.8	8.6	1.1	3.3	5.8	7.2	5.9	2.4	6.4	5.9	6.0	2.0	3.3	5.6	4.1	9.6	17.0	9.6	1.7	5.8	24.4	5.6	3.8	14.5	9.9	6.3	6.5	14.5	1.0	8.6	0.4	2.0	2.6	2.2	3.5	0.1	0.0	0.0	0.4	2.6	0.2	0.2	0.3	0.5	1.8	1.3	3.1	3.0	0.0	0.5	1.3	0.0	6.6	0.0	8.1	0.1	0.0	2.8	2.9	2.6	0.0	0.4	0.1	8.2	0.1	6.7	0.2	15.3	2.0	0.4	4.3	0.3	2.5	26.5	2.1	0.1	1.3	2.9	1.7	0.9	0.9	0.3	0.4	0.2	1.4	1.0	0.3	15.2	1.0	0.0	0.5	6.2	0.0	1.8	11.5	0.2	0.1	0.6	2.7	0.1	1.2	2.0	0.0	7.5	1.0	0.7	6.9	0.7	4.2	1.5	0.9	6.2	6.5	0.7	0.6	0.2	0.4	8.6	14.5	2.0	2.6	3.7	7.6	0.9	4.0	6.6	3.5	7.4	1.0	7.2	5.8	0.0	8.0	7.4	10.1	0.7	0.8	2.8	7.6	1.4	3.4	24.4	0.0	1.8	6.6	3.2	0.5	6.9	0.2	0.0	4.8	2.7	1.7	4.0	17.3	7.3	19.3	22.3	1.2	36.2	27.9	1.0	0.6	18.1	0.0	5.4	0.9	18.4	7.4	2.9	0.7	12.5	0.6	0.0	2.1	0.0	0.0	0.5	2.5	6.9	1.2	15.7
SH3TC2	"CMT4C, KIAA1985"	ENSG00000169247	"SH3 domain and tetratricopeptide repeats 2"	Q8TF17	5	148923639-149063163	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.1;placenta: 22.7;testis: 14.4"	"Cell type enhanced"	"Detected in many"	14	"Rod photoreceptor cells: 24.7;Syncytiotrophoblasts: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 6.2;RT4: 9.9;SK-MEL-30: 8.9;WM-115: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037683, HPA037684"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA037683: AB_2675608, HPA037684: AB_10672603"	"unprognostic (6.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.18e-2)"	"unprognostic (4.53e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.40e-1)"	1.3	0.8	3.3	0.8	15.4	1.2	1.4	0.9	8.6	2.2	1.0	32.1	0.0	0.6	1.0	1.7	2.0	1.3	1.3	3.7	6.0	3.0	0.6	0.7	1.0	0.7	22.7	4.6	0.6	0.5	0.8	0.5	22.7	12.0	0.9	1.8	0.0	1.4	1.4	1.5	1.1	0.7	1.3	12.9	1.0	0.7	14.4	15.6	0.0	0.8	0.0	1.0	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.7	0.2	0.0	0.0	0.0	0.1	0.1	2.9	1.3	0.5	0.2	6.2	5.1	0.0	5.6	0.3	1.7	4.3	0.0	4.1	0.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.4	2.0	1.8	1.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	3.1	5.7	0.0	3.9	0.0	2.1	9.9	0.0	0.0	0.0	0.3	8.9	0.2	0.0	0.0	0.3	0.2	1.1	0.2	3.5	0.0	0.0	0.0	0.2	1.3	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	15.4	0.9	8.6	6.0	3.0	22.7	4.6	12.0	15.6	3.0	5.9	0.0	0.6	0.8	1.1	1.7	2.5	1.4	4.5	0.0	3.9	0.7	0.0	0.7	4.8	1.4	0.0	0.0	0.2	0.2	0.9	1.0	2.3	0.0	0.3	0.0	0.0	1.3	2.4	1.5	0.3	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	24.7	0.0	0.4	1.4	0.8	0.6	10.0	0.0	0.0	2.6
SH3YL1	"DKFZP586F1318, Ray"	ENSG00000035115	"SH3 and SYLF domain containing 1"	Q96HL8	2	217730-266398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 94.7"	"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 402.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030926, HPA030927"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030926: AB_10670148, HPA030927: AB_10669874"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-3)"	3.6	11.7	10.3	8.7	10.1	2.6	16.0	8.7	9.7	9.6	12.9	8.6	16.1	9.8	7.9	12.4	17.4	12.8	22.9	4.1	10.5	8.0	42.5	3.8	14.9	10.4	10.9	11.8	9.9	94.7	13.9	20.7	11.4	7.9	17.7	15.8	7.3	35.3	26.9	3.2	21.5	32.1	7.6	13.1	5.5	23.6	6.0	8.2	5.7	22.5	15.3	14.4	18.0	9.5	7.2	3.3	14.0	2.3	12.4	20.6	5.2	3.6	0.7	4.1	1.8	5.6	5.3	2.7	4.7	5.3	1.8	1.8	9.9	13.9	0.1	2.3	4.1	1.2	15.5	1.0	20.3	1.7	3.1	0.7	0.9	1.1	3.1	4.5	0.4	1.2	5.9	21.0	1.0	3.4	8.8	2.6	5.1	0.2	0.6	3.6	10.7	3.9	2.0	1.3	65.8	0.8	1.8	1.2	0.2	12.6	21.0	1.7	2.8	0.7	19.6	3.3	5.7	13.4	3.1	1.9	0.9	0.2	5.2	2.0	0.5	0.0	0.3	9.0	6.2	3.0	14.0	1.3	1.0	2.6	1.6	8.4	7.2	13.3	6.7	3.3	5.5	20.6	11.9	0.8	12.4	2.3	2.9	16.2	5.2	10.3	10.1	8.7	9.7	10.5	8.0	10.9	11.8	7.9	8.2	53.6	103.8	28.7	161.2	73.5	18.5	5.7	280.2	57.6	78.5	96.0	21.6	132.4	247.1	104.8	113.4	15.7	68.8	0.0	125.5	61.0	27.7	132.4	15.1	6.8	23.1	25.4	47.1	18.4	6.9	92.8	33.9	14.8	69.2	14.4	79.9	7.7	99.4	91.2	38.5	402.5	8.7	25.8	18.6	61.2	23.6	100.7	206.5	17.5	106.3	210.4
SHANK3	"KIAA1650, prosap2, PSAP2, SPANK-2"	ENSG00000251322	"SH3 and multiple ankyrin repeat domains 3"		22	50674415-50733298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 32.4"	"Cell type enriched"	"Detected in some"	5	"Ito cells: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.4;TIME: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003446	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA003446: AB_1079958"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.09e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-1)"	9.5	5.4	23.5	1.3	26.1	2.6	8.7	13.0	32.4	3.5	2.0	2.4	0.1	5.2	3.8	3.4	2.5	2.8	1.1	4.4	21.6	2.4	2.9	5.1	5.3	2.9	2.5	18.1	1.6	7.6	7.9	1.0	1.7	2.6	1.9	1.9	0.6	8.5	3.4	3.6	3.1	6.6	1.5	2.0	12.3	1.3	3.4	6.4	0.2	4.1	1.4	2.6	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	0.6	2.9	0.5	0.5	0.0	0.6	0.0	0.2	0.0	0.6	1.7	0.0	1.2	0.2	1.7	0.6	0.9	0.4	0.0	0.0	0.0	6.4	0.4	1.7	1.5	0.8	0.3	1.6	1.1	0.1	0.3	0.1	2.0	0.7	0.1	0.1	0.1	0.9	0.5	0.2	1.3	0.7	1.8	1.7	0.0	0.7	0.3	0.5	1.3	1.9	1.7	0.0	0.8	0.4	0.3	0.4	10.2	0.2	1.7	0.7	0.4	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	26.1	13.0	32.4	21.6	2.4	2.5	18.1	2.6	6.4	0.0	1.4	0.0	0.0	0.2	0.5	19.6	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.8	16.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	5.6	0.3	0.0	2.4	90.2	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.4	0.7	0.0	0.0	0.9	0.2	0.4	0.3	0.0	0.0	0.0	0.3
SHARPIN	"DKFZP434N1923, SIPL1"	ENSG00000179526	"SHANK associated RH domain interactor"	Q9H0F6	8	144098633-144108124	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 99.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 302.5;Late spermatids: 974.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024825, HPA044453"	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA024825: , HPA044453: AB_10962490"	"unprognostic (4.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.00e-1)"	12.0	14.5	15.8	7.9	11.7	13.2	10.9	9.0	15.3	11.3	12.3	13.7	17.3	11.5	11.4	14.7	11.4	12.9	10.3	14.7	14.0	8.9	14.1	25.7	10.0	9.3	14.6	11.3	11.9	14.0	11.7	10.2	9.6	13.3	12.2	7.2	10.5	16.8	11.8	25.5	13.5	10.7	9.4	9.2	12.5	12.0	99.4	12.3	6.1	10.9	10.8	7.1	10.1	9.5	12.7	22.4	26.1	21.2	17.3	22.1	11.0	8.7	12.8	7.2	5.6	11.7	12.0	8.3	8.1	9.6	10.8	10.8	9.0	14.1	3.8	14.9	9.8	6.3	10.0	3.5	12.2	3.1	11.3	9.6	9.5	14.6	10.7	20.7	3.3	8.8	13.5	20.2	9.1	10.3	13.3	11.5	12.2	6.3	8.9	9.9	14.3	11.2	9.4	2.9	18.4	46.6	7.8	5.4	12.6	11.4	10.0	7.3	11.3	13.9	21.0	13.3	6.1	22.0	12.2	9.7	8.5	13.5	12.1	10.9	11.0	8.3	5.0	12.4	8.1	6.7	12.5	18.1	26.1	16.7	21.2	18.6	12.7	16.6	22.1	16.6	12.3	13.8	15.0	9.3	17.3	18.4	22.4	16.5	11.0	15.8	11.7	9.0	15.3	14.0	8.9	14.6	11.3	13.3	12.3	8.9	17.8	26.6	26.7	21.3	23.2	18.2	17.8	4.0	9.1	33.2	3.9	48.0	101.2	49.2	302.5	33.1	72.2	0.0	43.4	40.8	41.3	29.5	12.7	33.1	51.8	46.1	34.0	30.7	32.4	974.5	45.5	32.9	43.9	73.9	40.9	35.3	67.6	63.1	41.1	69.5	24.9	51.8	34.4	141.6	64.2	28.2	36.0	45.7	50.7	29.1
SHB		ENSG00000107338	"SH2 domain containing adaptor protein B"	Q15464	9	37919134-38069211	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 74.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	71	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"OE19: 35.0"									"CAB010161, HPA049911, HPA052108"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Nucleoplasm, Cytoplasmic bodies"	"CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730"	"unprognostic (4.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.96e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-1)"	8.6	5.6	7.5	5.3	15.9	7.2	8.0	1.4	12.5	8.2	8.4	16.1	3.2	10.1	6.1	5.6	19.6	5.9	29.4	20.2	8.9	5.0	13.6	34.2	11.6	3.1	17.9	5.3	5.6	17.8	13.7	13.1	7.7	12.6	12.9	7.0	7.6	18.9	11.3	6.4	13.0	9.5	11.9	7.6	6.7	14.1	3.5	16.3	2.7	7.7	10.3	11.1	10.7	11.9	0.0	0.0	8.1	0.0	0.0	0.1	0.0	8.1	12.9	1.4	0.2	1.5	3.6	2.3	9.0	11.0	6.3	4.9	3.0	5.7	0.0	10.9	7.7	14.6	7.8	5.1	13.3	4.4	6.9	10.3	0.0	4.5	9.5	10.0	0.4	0.4	3.2	4.2	9.9	7.6	14.7	6.4	1.3	3.2	2.7	7.3	5.5	1.0	0.4	3.4	35.0	12.3	0.4	3.8	0.4	13.1	2.9	13.9	11.1	1.2	9.8	2.2	11.5	6.2	0.5	7.9	2.9	10.6	1.5	14.3	0.8	0.3	0.1	17.4	0.8	2.8	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	15.9	1.4	12.5	8.9	5.0	17.9	5.3	12.6	16.3	6.0	6.4	0.5	74.8	18.1	0.3	8.1	35.7	2.7	6.8	21.0	7.9	8.6	13.3	14.6	1.8	9.8	10.5	0.0	17.2	1.0	5.7	35.8	0.0	19.8	5.2	0.0	7.5	5.5	1.3	3.4	0.6	2.1	6.8	0.0	10.6	2.0	17.9	8.6	0.4	18.2	1.4	0.0	4.7	0.5	6.8	29.6	3.3	0.0	7.4	45.7
SHC2	"SCK, SHCB, SLI"	ENSG00000129946	"SHC adaptor protein 2"	P98077	19	416583-460996	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 44.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 51.6;Horizontal cells: 46.1;Ito cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.6;HHSteC: 6.5;SCLC-21H: 14.1;SH-SY5Y: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006136	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA006136: AB_1856827"	"unprognostic (2.54e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.53e-4)"	"unprognostic (4.45e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.86e-2)"	"unprognostic (4.43e-2)"	9.8	11.3	18.5	2.7	15.1	1.0	6.8	5.0	17.6	7.9	6.3	10.2	3.7	8.9	11.7	5.9	2.6	8.1	14.6	7.9	15.7	15.2	3.8	20.6	6.5	2.8	15.2	11.3	5.1	44.8	7.8	18.6	10.7	15.6	13.7	1.4	9.9	19.5	8.2	3.4	8.5	6.2	4.7	9.6	11.5	10.5	6.0	15.0	0.0	9.7	0.7	1.3	3.8	6.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.7	0.5	2.8	0.3	0.0	0.0	0.5	0.0	5.6	0.0	1.4	0.4	1.3	0.0	0.0	1.2	1.8	0.0	0.0	3.0	6.5	0.0	2.1	0.3	0.0	0.0	0.0	2.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	2.1	0.0	14.1	12.7	0.0	0.0	0.0	2.7	0.3	2.1	0.0	0.6	3.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.5	15.1	5.0	17.6	15.7	15.2	15.2	11.3	15.6	15.0	6.0	12.0	0.0	1.8	1.6	4.3	7.7	20.4	0.0	0.0	0.0	2.0	0.1	0.0	20.6	1.9	11.9	0.0	0.0	32.6	0.1	4.3	12.6	0.0	51.6	0.8	46.1	8.1	57.7	6.5	6.0	8.3	0.5	8.5	1.8	3.4	28.9	30.9	0.0	10.6	0.3	2.7	0.0	5.0	15.4	8.2	2.8	0.0	1.7	0.1	3.3
SHC4	"RaLP, SHCD"	ENSG00000185634	"SHC adaptor protein 4"	Q6S5L8	15	48823735-48963444	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7;testis: 19.5"	"Cell type enhanced"	"Detected in some"	7	"Ciliated cells: 4.0;Ductal cells: 4.1;Melanocytes: 6.8;Spermatocytes: 6.0"	"Cancer enhanced"	"Detected in some"		"melanoma: 9.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.6;SK-MEL-30: 17.9;WM-115: 15.3"	"Low region specificity"	"Detected in all"							HPA074146			Approved	Cytosol		NA	NA			Cytosol		"HPA074146: AB_2686667"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-5)"	"unprognostic (9.84e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.36e-2)"	1.5	2.3	9.0	2.3	24.8	0.7	3.7	2.0	15.8	2.5	2.5	18.9	0.3	1.1	1.3	2.5	1.5	1.9	3.2	6.6	11.2	6.2	1.2	0.8	1.2	1.1	25.7	9.4	1.6	0.9	0.7	1.1	1.3	13.2	1.3	1.6	1.7	4.8	3.3	2.0	1.3	1.1	1.9	16.2	0.9	1.0	19.5	23.8	0.0	1.1	0.0	0.8	1.7	0.9	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.3	0.9	9.6	0.4	1.3	0.0	1.4	2.7	0.6	1.1	0.0	0.2	0.1	2.4	0.5	0.1	0.0	0.2	0.4	0.8	1.9	0.1	0.6	0.0	0.0	1.0	0.0	0.1	1.8	0.0	1.2	0.1	1.2	0.1	0.9	0.0	0.2	1.3	1.5	0.3	0.2	0.1	0.0	3.5	0.2	2.5	0.3	2.0	0.4	0.5	0.7	0.2	0.1	17.9	0.9	0.0	0.1	0.0	0.8	0.4	0.6	1.0	0.7	0.1	0.0	0.8	0.5	15.3	0.2	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	24.8	2.0	13.4	11.2	6.2	25.7	9.4	13.2	23.8	0.0	0.0	0.0	0.0	0.2	0.5	1.8	0.0	4.0	2.3	0.0	0.0	0.6	0.0	4.1	2.2	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.0	3.6	1.1	0.0	6.8	0.0	0.0	2.7	0.1	0.0	3.2	0.0	0.7	0.0	0.2	6.0	2.8	0.3	0.7	0.0	0.0	0.0
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46580554-46621626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 24.1;Spermatocytes: 27.0;Spermatogonia: 30.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	1.5	0.8	1.0	17.3	3.0	18.9	0.9	2.4	1.3	0.8	2.2	0.6	0.3	1.3	1.5	2.0	5.7	0.4	1.1	1.5	1.0	0.7	5.0	0.3	1.7	11.2	0.7	0.7	1.2	0.3	0.2	0.8	2.8	0.7	0.9	2.5	0.3	2.6	0.3	1.4	3.8	2.3	1.9	1.1	9.9	1.4	14.1	0.9	22.9	0.6	3.0	12.9	2.0	1.6	4.6	2.0	1.8	5.4	0.3	3.4	2.1	15.3	16.4	6.2	7.5	1.3	3.2	8.6	31.4	12.4	30.7	14.3	7.8	10.1	13.5	14.2	14.3	12.4	10.2	13.6	10.2	38.0	8.6	9.1	14.8	12.4	13.2	0.0	13.0	18.9	0.6	0.6	22.5	9.2	3.0	16.0	7.1	6.1	14.3	33.3	10.2	11.6	10.8	4.8	7.2	17.5	21.2	41.6	21.6	6.3	4.8	2.6	3.4	21.7	11.5	4.9	5.6	6.3	10.7	9.2	22.5	14.6	21.7	24.9	11.3	14.9	21.6	10.3	14.0	22.6	0.3	0.8	1.8	0.5	1.3	0.1	4.6	0.8	0.4	1.2	1.9	0.1	0.3	0.8	0.3	5.4	2.0	3.4	2.1	1.0	3.0	2.4	1.3	1.0	0.7	0.7	0.7	0.7	0.9	0.0	1.4	0.0	0.5	1.4	0.2	1.4	2.5	0.0	2.3	0.0	0.0	3.1	0.0	0.3	6.4	0.3	0.4	0.0	0.0	24.1	1.0	0.4	0.0	0.0	10.7	0.0	0.0	2.5	2.9	1.5	0.6	3.9	1.7	2.8	0.2	1.0	0.1	0.0	0.4	0.0	0.3	0.0	0.5	27.0	30.1	0.5	3.1	0.7	0.6	0.9
SHF		ENSG00000138606	"Src homology 2 domain containing F"	Q7M4L6	15	45167214-45201175	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 84.3"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 46.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 84.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 50.7;SH-SY5Y: 22.6"	"Region enriched"	"Detected in all"	5	"cerebellum: 269.9"					HPA057381			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057381: AB_2683423"	"unprognostic (4.05e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.83e-2)"	2.9	19.3	6.9	3.3	10.4	0.6	3.3	84.3	14.5	7.3	6.3	3.9	2.2	10.5	8.5	4.0	4.1	6.2	5.3	4.5	5.9	7.2	1.8	18.9	2.9	1.8	4.5	6.7	20.5	2.5	2.5	3.5	1.5	7.1	5.3	4.4	6.3	5.3	5.2	2.6	6.5	7.9	6.3	5.2	2.3	2.9	4.1	3.2	1.6	4.9	2.4	1.8	5.8	5.5	3.3	2.6	2.5	1.9	5.1	4.2	1.5	0.0	0.6	10.0	0.3	0.7	0.4	4.7	1.2	0.8	2.8	4.0	1.4	4.7	0.5	4.0	1.7	2.7	0.8	3.8	0.3	1.3	0.8	1.7	0.3	0.9	9.8	0.4	0.0	3.3	0.9	0.2	0.3	0.0	2.1	2.1	4.9	1.9	0.2	3.9	1.6	2.1	0.3	3.9	1.8	0.2	6.0	7.9	0.2	0.9	0.2	50.7	22.6	0.3	0.3	0.2	3.2	0.5	0.9	0.1	0.3	4.3	0.3	0.1	0.4	0.3	0.4	0.1	0.2	1.5	0.3	1.9	1.2	3.8	1.7	4.2	2.4	1.6	2.4	1.8	3.3	2.2	1.7	2.5	5.1	1.7	2.6	0.3	1.5	6.9	10.4	84.3	12.1	5.9	7.2	4.5	6.7	7.1	3.2	0.0	1.1	0.0	4.9	3.2	46.9	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.9	6.1	3.7	4.2	0.0	1.1	0.4	3.0	2.5	2.3	9.7	0.6	9.5	12.5	3.7	1.0	9.8	4.0	2.8	8.5	0.0	8.6	5.7	0.5	5.8	3.9	1.0	4.5	6.5	5.0	4.7	2.7	2.3	0.6	0.7	4.5	7.1
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26051031	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 9.6;Basal glandular cells: 8.8;Urothelial cells: 18.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 18.9;JURKAT: 13.2;LHCN-M2: 13.2;NTERA-2: 9.6;RH-30: 30.7;U-2197: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.3	0.0	0.7	0.0	2.0	0.0	12.9	0.0	0.5	1.5	0.0			0.4	0.0	7.9	0.0	0.0	0.3	0.0	2.0	0.6	3.0	0.0	3.7	0.1	1.1		0.0	0.0	0.0	1.7	0.0		0.4	0.0		1.9	0.0	10.2	1.0	0.3	0.0	3.5	0.0	1.6	0.9			20.8		0.3	0.0	0.0	0.8	0.6	2.2	1.1	1.0	5.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.2	2.5	1.0	0.0	0.0	1.2	18.9	0.7	13.2	0.0	0.0	13.2	0.7	1.3	0.3	9.6	5.5	4.8	0.0	30.7	0.1	1.2	4.3	0.3	0.0	0.2	0.0	3.4	2.0	0.4	0.1	1.0	0.0	0.5	19.2	4.2	0.0	0.0	0.0	0.0	0.0	2.6	2.2	0.4	1.7	0.6	0.7	1.0	0.6	1.7	0.7	0.3	0.8	3.9	5.6	1.6	1.0	1.1	0.6	0.7	0.4											0.0	9.6	0.0	8.8	4.7	0.0	0.4	0.0	1.4	0.0	3.5	0.0	0.2	0.0	4.0	1.5	1.2	0.0	0.0	0.2	0.3	0.7	2.4	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.7	0.0	0.2	1.7	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	1.2	0.3	3.6	1.5	0.1	0.0	0.0	18.2
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397839-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 30.0"	"Group enriched"	"Detected in some"	9	"Distal tubular cells: 36.5;Ito cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"memory B-cell: 2.1;naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.4"	"Group enriched"	"Detected in some"	7	"AN3-CA: 70.7;PC-3: 41.0"	"Region enriched"	"Detected in single"	24	"olfactory region: 63.3"	"Low region specificity"	"Detected in some"			HPA054754			Approved	"Lipid droplets,Cytosol"		NA	NA			Cytosol	"Lipid droplets"	"HPA054754: AB_2682593"	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.5	2.1	1.0	2.3	3.5	0.1	1.8	0.7	1.3	0.9	5.0	0.1	2.9	2.9	0.3	6.2	8.6	0.4	4.2	12.9	0.9	1.5	30.0	1.0	4.7	15.4	8.3	0.7	1.4	0.3	0.1	0.5	0.2	3.3	2.6	4.1	0.3	1.2	1.5	3.4	0.4	8.4	10.7	1.0	0.6	3.5	2.0	2.2	0.0	4.6	2.6	1.1	6.8	4.7	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	41.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	3.5	0.7	1.3	0.9	1.5	8.3	0.7	3.3	2.2	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	3.5	0.0	0.0	36.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	23.9	0.8	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241263-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;cervix, uterine: 22.4"	"Group enriched"	"Detected in some"	4	"Late spermatids: 9.9;Peritubular cells: 27.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 34.1"	"Low region specificity"	"Detected in many"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	2.2	0.7	5.8	0.6	5.5	0.2	1.2	9.8	7.5	22.4	0.9	2.5	1.9	0.4	4.2	2.4	0.9	1.7	0.5	1.1	12.1	9.9	2.5	0.2	1.5	0.2	11.8	2.9	0.6	1.4	6.0	0.0	0.3	13.6	5.9	0.8	0.8	0.2	10.1	1.0	0.5	0.4	1.2	9.6	0.2	6.0	2.9	2.1	0.0	0.7	0.0	0.2	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	9.8	4.9	12.1	9.9	11.8	2.9	13.6	2.1	0.0	0.0	0.0	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	9.9	4.6	0.0	1.7	0.0	0.0	0.4	0.0	0.0	27.3	0.0	0.1	0.0	0.1	0.5	1.9	0.1	0.0	0.0	0.0	0.1
SHISA7		ENSG00000187902	"Shisa family member 7"	A6NL88	19	55428740-55442863	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 24.9"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 1.8;Horizontal cells: 1.6"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 6.7;HMC-1: 7.0;THP-1: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058935	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA058935: AB_2683857"	"unprognostic (3.98e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"		"unprognostic (3.08e-1)"	"unprognostic (4.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.87e-7)"	"unprognostic (7.53e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.04e-1)"	0.7	1.7	11.3	0.7	16.7	2.6	0.7	4.0	24.9	0.7	0.8	7.2	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.7	11.2	8.2	0.7	0.7	0.7	0.7	8.3	3.1	0.7	0.8	0.7	2.4	0.7	5.5	0.7	0.8	0.0	0.7	0.7	0.7	0.8	0.8	0.7	4.0	0.7	0.8	2.2	14.6	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	6.7	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	1.2	0.6	0.0	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	16.7	4.0	10.9	11.2	8.2	8.3	3.1	5.5	14.6	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
SHISA9		ENSG00000237515	"Shisa family member 9"	B4DS77	16	12901620-13240413	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.3;Ciliated cells: 21.4;Club cells: 12.5;granulocytes: 10.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"EFO-21: 29.8;LHCN-M2: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072399			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA072399: AB_2686517"	"unprognostic (1.88e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.69e-5)"	"unprognostic (2.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.90e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	1.2	4.8	17.2	1.6	23.5	2.7	1.3	0.9	21.3	0.9	3.4	3.6	0.4	1.6	1.1	2.3	1.2	0.7	0.9	1.3	10.2	6.7	3.4	1.4	0.7	1.0	3.3	12.6	1.1	1.3	0.6	1.9	1.0	10.2	6.9	1.8	0.6	1.7	1.4	4.2	1.9	1.7	1.2	2.1	1.0	1.3	1.6	4.0	0.0	3.5	0.0	0.8	0.8	0.9	2.0	1.2	3.9	0.9	1.2	0.9	0.0	0.6	0.3	0.5	0.5	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.3	0.5	0.5	29.8	0.1	0.6	0.5	0.1	0.1	0.1	0.5	0.2	0.7	0.6	0.3	0.0	0.5	0.8	0.9	0.0	0.1	2.1	0.3	0.1	0.5	0.4	1.2	24.2	3.3	0.4	0.7	6.4	0.5	0.3	0.6	0.4	0.3	6.6	1.1	6.4	0.5	0.3	1.0	0.4	3.1	0.8	0.4	0.4	0.6	3.9	0.6	0.4	1.2	1.2	0.6	0.4	0.2	0.8	3.9	0.9	0.4	0.8	0.5	0.6	1.1	0.7	0.8	0.3	2.0	0.9	0.8	3.2	1.2	0.7	1.2	0.7	0.0	17.2	23.5	0.9	18.8	10.2	6.7	3.3	12.6	10.2	4.0	23.8	15.3	0.0	0.5	0.1	0.6	0.8	0.0	21.4	12.5	1.8	0.0	0.0	1.7	0.7	3.8	0.3	0.0	0.0	0.0	0.0	0.2	1.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.2	0.0	0.0	0.0	0.5	0.1	2.9	0.0	0.9	0.3	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.3	0.5
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243667-44312851	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9"	"Cell type enriched"	"Detected in single"	4	"Ciliated cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SiHa: 17.0;U-2197: 38.7;U-87 MG: 22.5;WM-115: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol		No	No			"Vesicles, Cytosol"		"HPA051178: AB_2681374"	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	0.7	1.3	13.8	1.3	3.6	0.0	0.5	1.6	13.0	22.5	7.7	0.5	6.9	1.4	34.2	4.5	1.5	1.9	2.3	0.5	5.4	9.1	0.5	0.5	0.6	0.5	3.6	0.5	1.7	0.6	0.1	0.8	5.7	0.5	5.8	1.5	0.5	0.5	8.9	0.5	0.4	0.8	31.9	0.5	0.5	0.5	1.5	0.5	0.5	0.5	0.5	0.5	11.9	3.3	0.0	0.1	0.7	0.0	0.2	0.1	0.0	0.0	0.1	1.7	0.6	0.0	0.0	0.0	0.4	1.1	1.1	0.6	0.0	0.0	0.0	0.0	1.0	7.0	0.0	2.3	0.1	0.1	0.0	1.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.9	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.2	0.0	17.0	0.0	0.1	0.2	0.0	0.1	0.0	6.4	1.0	38.7	0.2	0.0	0.0	0.0	22.5	0.0	12.9	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	13.8	3.6	1.6	11.8	5.4	9.1	3.6	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHKBP1	"PP203, Sb1"	ENSG00000160410	"SH3KBP1 binding protein 1"	Q8TBC3	19	40576851-40591399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 81.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041887	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA041887: AB_10794639"	"unprognostic (1.26e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.52e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.64e-2)"	12.1	13.0	9.8	25.4	15.2	40.1	19.5	2.7	11.3	12.1	10.7	11.7	9.0	12.7	14.1	12.1	17.8	13.4	12.2	10.7	7.5	5.2	16.5	14.7	20.0	53.5	17.8	5.9	11.4	14.6	9.9	9.2	11.7	11.0	13.6	7.4	9.0	12.7	10.3	5.8	12.1	17.0	11.8	11.1	51.8	15.2	7.5	15.1	33.9	14.0	11.1	25.3	14.4	13.5	14.9	28.4	81.8	40.7	12.2	19.3	30.6	23.1	36.0	7.2	10.2	6.3	7.1	13.7	9.1	13.6	14.2	19.6	15.7	16.0	24.5	18.0	14.2	12.1	10.2	9.3	17.2	6.7	37.7	22.2	17.8	9.8	10.5	13.7	16.6	51.0	11.6	12.5	13.0	8.2	10.4	20.6	28.0	9.9	20.6	10.8	20.4	17.0	23.4	5.2	21.0	13.4	30.7	9.4	18.3	11.7	19.1	6.0	14.0	13.9	7.7	8.1	7.3	12.1	27.5	15.5	14.3	18.9	22.3	17.9	19.4	9.2	16.5	23.0	19.6	12.7	35.8	37.1	37.0	14.3	36.0	11.6	14.9	13.8	14.6	28.4	13.1	8.2	9.4	81.8	12.2	40.7	8.5	19.3	30.6	9.8	15.2	2.7	11.3	7.5	5.2	17.8	5.9	11.0	15.1	11.9	24.0	64.1	17.4	7.6	2.2	3.5	2.5	8.1	14.8	27.9	5.9	20.8	24.9	36.5	7.3	22.4	28.0	0.0	34.0	44.6	14.1	13.1	51.8	11.3	69.2	3.2	21.9	22.7	78.8	12.5	13.6	55.0	21.9	80.2	16.2	6.0	31.1	31.6	11.7	23.2	1.5	0.0	12.3	1.8	18.8	8.5	24.7	51.1	18.9	18.8
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229327-57234935	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 212.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Supported	Microtubules,Mitochondria		NA	NA		160000	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavorable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	13.0	13.5	5.9	15.0	7.1	12.6	9.5	9.6	9.5	10.5	11.5	6.1	5.0	13.4	10.2	8.5	22.1	8.6	10.3	11.0	6.5	5.4	15.5	103.1	11.8	18.7	8.7	4.6	17.9	38.9	4.5	8.1	16.8	6.5	10.3	9.4	7.1	44.6	5.7	16.5	13.7	11.5	9.9	7.6	23.5	13.4	5.4	6.3	26.1	13.2	19.0	25.6	11.2	13.8	33.6	14.5	6.5	11.7	9.7	48.7	12.3	25.1	11.7	11.8	31.2	9.3	14.3	23.4	13.6	22.2	18.3	16.8	16.7	12.2	46.6	22.6	16.8	7.6	16.1	21.3	22.2	9.9	26.0	19.0	19.2	7.2	11.8	68.7	31.7	17.0	18.3	32.2	14.7	49.2	16.6	18.1	24.8	20.0	44.3	13.8	16.5	25.2	17.4	10.1	10.1	19.0	17.0	212.4	43.1	9.1	11.6	25.3	12.1	7.1	16.8	49.3	4.5	22.8	39.0	11.4	7.4	15.1	9.6	18.5	59.5	32.5	39.5	16.0	29.6	13.3	6.5	9.8	5.9	6.9	11.7	8.0	33.6	12.1	7.4	14.5	32.4	5.3	5.4	0.5	9.7	7.5	4.8	48.7	12.3	5.9	7.1	9.6	9.5	6.5	5.4	8.7	4.6	6.5	6.3	8.9	13.1	58.9	19.1	30.8	6.2	7.5	20.4	9.4	12.5	3.5	0.0	53.0	11.6	41.7	0.4	13.5	11.0	46.7	41.3	42.8	21.6	14.9	28.8	158.5	43.3	7.9	9.2	20.3	38.1	0.2	16.7	22.7	37.1	27.1	21.6	42.4	40.1	21.0	15.2	48.7	4.9	6.5	22.6	2.1	7.2	28.4	31.2	26.2	37.7	17.6
SHOC2	"KIAA0862, SOC-2, SOC2, SUR-8, SUR8"	ENSG00000108061	"SHOC2, leucine rich repeat scaffold protein"	Q9UQ13	10	110919547-111013667	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009164, HPA048134"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA009164: AB_1079960, HPA048134: "	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.97e-3)"	"unprognostic (8.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.67e-1)"	22.9	13.2	22.3	17.2	32.4	31.2	18.0	24.9	25.2	19.3	16.7	8.9	12.1	12.5	17.3	17.4	19.1	14.1	15.8	14.6	19.0	24.8	20.9	18.2	16.8	20.9	22.3	20.1	21.9	15.7	26.5	33.4	17.9	17.7	18.1	17.0	9.8	13.9	14.4	21.7	15.8	24.2	25.0	23.3	23.2	13.9	26.7	17.7	29.4	21.5	9.4	23.3	23.7	17.1	16.4	11.3	34.6	13.7	9.8	9.6	11.2	11.4	7.2	9.2	15.4	21.1	21.6	5.9	14.0	20.9	13.1	15.9	6.5	10.3	24.9	7.0	25.0	8.1	9.7	11.1	10.0	19.1	13.5	6.6	11.3	11.2	6.3	15.4	19.2	20.4	23.9	15.9	15.1	28.5	17.9	13.2	8.8	7.0	17.8	18.5	6.1	9.4	15.4	5.7	6.1	7.5	13.6	18.5	7.0	13.7	7.8	4.8	9.6	12.2	6.1	13.6	11.0	31.2	16.4	13.3	10.6	9.4	13.3	9.5	16.5	16.8	39.9	12.6	19.9	7.5	20.9	12.0	16.7	7.0	13.7	8.4	16.4	8.3	8.1	11.3	13.0	8.8	8.5	34.6	9.8	13.5	8.1	9.6	11.2	22.3	32.4	24.9	25.2	19.0	24.8	22.3	20.1	17.7	17.7	50.6	40.8	46.7	30.7	49.6	25.8	74.4	40.8	61.6	47.8	29.6	15.7	18.3	54.7	41.5	33.1	58.5	52.5	46.7	51.5	19.5	32.4	33.4	70.6	59.6	26.2	28.6	25.2	48.5	70.5	69.4	60.7	61.5	47.2	51.3	31.7	24.7	51.5	29.4	76.0	48.4	31.4	71.1	53.3	95.1	56.7	61.1	50.7	52.9	26.9	47.7
SHOX	"GCFX, PHOG, SHOXY, SS"	ENSG00000185960	"Short stature homeobox"	O15266	X	624344-659411	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;breast: 13.9"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 1.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"BJ: 19.5;BJ hTERT+: 9.0"									"HPA035141, HPA060931"			Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA035141: AB_2674489, HPA060931: AB_2684388"	"unprognostic (7.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.82e-2)"			"unprognostic (2.45e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.67e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.38e-1)"	3.8	1.0	0.3	0.7	0.3	3.0	13.9	1.8	0.8	0.3	0.4	0.2	0.2	1.4	0.3	0.6	0.3	0.4	0.4	0.4	0.7	0.3	0.3	0.3	0.3	0.6	0.3	1.4	0.3	0.9	0.0	0.3	4.8	6.3	0.8	0.3	0.2	1.4	0.2	2.8	1.4	1.0	0.2	0.4	1.6	0.4	0.4	0.2	0.2	0.5	0.2	0.2	0.3	0.3	2.2	1.9	5.5	1.8	2.5	1.5	0.8	0.1	0.2	0.1	0.2	0.2	0.1	3.2	19.5	9.0	2.9	3.2	0.3	0.3	0.3	0.1	0.4	0.8	0.3	0.2	0.0	1.0	0.2	0.1	0.1	1.3	0.1	0.1	0.1	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.1	0.3	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.6	0.0	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.3	0.1	0.2	0.1	5.5	1.8	1.8	1.4	1.1	1.5	1.6	1.1	1.2	0.5	2.2	1.5	1.5	5.2	2.5	1.5	1.9	1.0	0.8	0.3	0.3	1.8	0.4	0.7	0.3	0.3	1.4	6.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
SHPK	"CARKL, SHK"	ENSG00000197417	Sedoheptulokinase	Q9UHJ6	17	3608262-3636322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024361, HPA064939"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA		150000	"Nucleoplasm, Nuclear speckles"		"HPA024361: AB_1846030, HPA064939: AB_2685388"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	8.9	12.9	7.6	6.2	10.6	5.9	8.9	17.3	12.3	8.8	14.1	14.9	8.8	18.5	10.7	6.1	11.6	7.6	5.3	5.9	7.0	5.5	14.3	26.7	6.3	5.3	12.0	4.5	10.2	13.7	11.8	6.2	8.6	9.8	7.4	8.6	12.3	8.9	9.4	7.5	12.1	22.8	5.1	6.7	6.1	9.7	5.2	13.0	7.7	7.7	4.0	7.6	7.5	9.6	5.2	7.1	5.1	4.8	6.4	7.5	5.4	5.3	10.9	11.6	7.4	4.8	4.9	6.4	3.6	3.2	7.0	4.2	18.7	5.0	6.3	8.0	6.9	6.6	10.4	15.4	11.6	5.1	10.1	15.0	6.9	9.3	13.4	5.8	5.9	9.8	8.2	5.6	7.8	5.3	6.0	13.2	5.0	9.1	8.1	6.8	9.5	7.6	4.6	5.8	12.3	7.3	10.5	6.1	10.1	10.0	6.9	3.3	8.9	13.1	12.1	3.6	7.4	10.8	3.5	9.4	10.8	5.1	10.3	8.7	2.7	3.5	4.2	11.7	5.4	5.4	3.3	4.7	5.1	4.6	4.8	4.7	5.2	4.2	3.7	6.5	4.0	7.5	4.7	0.9	6.4	4.1	7.1	3.6	5.4	7.6	10.6	17.3	12.3	7.0	5.5	12.0	4.5	9.8	13.0	0.0	2.7	1.5	0.8	0.0	5.4	0.8	7.6	1.4	1.2	5.2	15.7	8.1	1.7	2.9	0.4	2.2	10.5	0.0	4.1	8.6	0.9	1.9	0.0	14.8	6.9	14.3	3.4	1.8	1.3	0.0	3.7	2.5	0.0	3.6	5.9	3.1	4.3	5.8	2.5	6.5	15.6	0.0	0.8	0.6	1.2	0.4	4.7	1.0	5.5	1.7
SHPRH	"bA545I5.2, FLJ90837, KIAA2023"	ENSG00000146414	"SNF2 histone linker PHD RING helicase"	Q149N8	6	145864245-145964423	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Helicase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 175.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034854, HPA044852"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA034854: AB_10964488, HPA044852: "	"unprognostic (3.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (5.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.01e-1)"	10.9	7.3	8.3	11.0	10.0	5.5	10.4	38.0	11.5	10.6	8.0	4.5	10.8	6.0	14.1	9.2	8.5	9.8	6.7	7.2	7.2	4.2	8.4	6.5	7.1	9.0	7.6	5.9	18.8	8.7	11.4	19.7	6.6	8.5	8.3	7.4	7.3	10.2	13.7	11.4	13.9	8.2	11.0	10.3	8.8	8.5	10.7	8.7	8.4	12.5	7.2	8.0	10.7	11.5	6.7	4.8	4.4	2.4	3.4	4.3	1.2	3.0	2.3	11.7	6.8	5.4	5.8	5.6	3.6	2.9	4.5	5.8	5.3	2.1	10.6	4.5	2.7	3.5	5.2	7.1	5.1	5.9	4.7	8.1	10.7	5.3	4.4	4.0	22.4	6.7	4.0	5.9	4.2	6.2	4.4	4.8	7.6	14.8	6.0	3.8	2.7	14.4	8.3	7.8	5.0	4.1	10.4	18.1	3.6	6.1	3.0	9.6	6.7	6.4	5.9	4.0	8.4	3.1	10.8	5.3	2.9	5.4	5.6	4.2	4.9	7.0	12.7	3.0	9.6	4.4	1.6	2.3	4.4	4.3	2.4	3.7	3.9	3.6	2.9	2.7	6.7	4.1	3.3	0.1	3.4	2.4	4.8	3.3	1.2	8.3	10.0	38.0	11.5	7.2	4.2	7.6	5.9	8.5	8.7	26.8	18.9	20.8	15.3	18.8	113.2	15.9	17.8	12.0	23.9	21.0	198.3	12.7	6.6	15.4	8.3	19.7	10.0	0.0	11.1	5.8	14.4	13.4	12.7	14.8	10.2	89.0	18.5	14.1	21.8	5.1	46.9	15.5	13.5	15.4	14.3	57.4	13.0	10.5	32.2	4.5	175.4	71.1	21.7	76.9	67.5	17.2	5.5	20.3	15.0	9.6
SHROOM1	"APXL2, KIAA1960"	ENSG00000164403	"Shroom family member 1"	Q2M3G4	5	132822141-132830898	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.7;urinary bladder: 37.8"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 81.2;Hepatocytes: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"RT4: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037690, HPA037691"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA037690: AB_2675613, HPA037691: AB_2675614"	"unprognostic (2.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.22e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.26e-3)"	5.5	2.4	8.2	2.9	13.5	0.7	3.5	8.3	9.6	4.2	12.0	26.3	23.8	6.5	6.4	2.7	2.2	3.8	7.2	2.4	9.5	5.3	3.2	42.7	4.6	1.0	23.8	7.9	2.6	6.7	7.6	3.1	12.4	12.3	35.9	11.9	8.8	6.3	17.0	1.8	1.5	10.0	4.9	13.8	1.3	10.5	1.3	20.5	0.0	3.0	0.6	1.0	37.8	11.6	0.1	0.2	0.7	3.7	0.3	0.1	0.6	6.8	4.2	0.7	0.6	1.2	3.5	7.5	7.0	6.4	5.9	6.6	9.0	4.7	1.2	10.1	4.0	3.1	0.7	2.5	4.7	3.6	7.0	8.0	0.2	6.5	8.2	3.6	0.5	2.5	1.5	2.5	4.1	2.6	4.1	3.9	0.1	5.5	6.7	5.0	3.6	0.2	3.1	1.1	5.4	5.8	0.4	0.0	0.6	1.0	19.6	4.8	1.2	6.9	0.6	3.8	4.0	4.2	2.4	3.7	6.8	9.2	1.0	9.0	7.3	5.1	0.1	6.7	0.0	2.1	0.5	3.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.6	8.2	13.5	8.3	9.6	9.5	5.3	23.8	7.9	12.3	20.5	23.8	27.8	1.5	12.6	1.1	2.3	2.0	33.1	12.0	17.0	8.7	9.8	4.7	1.7	5.9	0.6	9.3	81.2	0.0	9.3	3.9	4.2	47.7	8.1	58.6	5.7	15.9	21.9	12.9	10.5	0.9	4.4	4.0	0.0	0.0	27.1	20.3	6.7	35.1	4.6	2.1	12.0	25.8	3.6	8.4	4.1	1.8	2.4	2.2	27.4	13.9
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786456-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Cone photoreceptor cells: 45.2;Peritubular cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RT4: 12.8;SuSa: 13.4;WM-115: 15.6"	"Low region specificity"	"Detected in many"							HPA051646	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		No	No			"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: AB_2681562"	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	1.3	3.6	6.8	1.3	7.7	0.5	2.5	2.8	17.0	4.7	3.2	3.7	4.6	1.8	3.3	5.8	7.2	3.6	6.3	1.5	7.4	5.5	5.3	7.6	8.1	1.0	5.7	9.1	13.8	7.2	5.5	6.1	14.3	5.8	10.6	3.0	3.6	6.0	5.8	0.7	7.9	1.4	2.1	7.9	1.7	2.6	5.8	2.5	1.8	3.1	3.4	3.4	6.4	4.3	0.0	0.9	1.1	0.0	0.0	0.2	0.0	4.0	0.5	7.5	1.0	0.4	1.2	4.2	0.4	1.3	1.6	2.6	4.9	0.0	0.0	1.4	1.0	0.3	3.2	3.8	10.7	1.9	0.0	2.9	0.0	0.0	0.8	2.5	0.0	5.1	0.2	7.5	12.3	0.5	2.7	9.2	0.0	0.0	0.0	2.6	4.3	0.0	0.0	6.6	0.0	0.0	0.0	8.3	0.0	7.0	12.8	1.1	0.6	0.3	0.1	12.0	13.4	4.4	0.2	4.3	12.0	1.5	0.0	0.4	0.0	0.0	0.0	7.9	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	6.8	7.7	2.8	17.0	7.4	5.5	5.7	9.1	5.8	2.5	0.0	1.0	0.0	2.7	1.6	5.1	3.1	5.1	1.4	2.3	3.5	45.2	7.7	3.3	2.7	0.5	5.8	0.3	0.0	0.0	1.0	0.5	5.4	0.0	4.9	0.5	1.6	1.2	11.6	0.6	0.0	3.4	0.0	0.0	0.0	0.5	1.8	1.5	0.0	78.1	0.9	17.7	0.0	0.9	0.0	1.3	1.8	1.7	0.5	0.4	4.8
SHROOM4	KIAA1202	ENSG00000158352	"Shroom family member 4"	Q9ULL8	X	50591647-50814302	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 27.3"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.2;Endothelial cells: 36.5;Ito cells: 31.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.1;HUVEC TERT2: 23.3;RH-30: 4.5;RPTEC TERT1: 5.0;TIME: 8.7;WM-115: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010089, HPA010565"	Uncertain		Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Nucleoplasm, Vesicles"	"HPA010089: , HPA010565: AB_1079961"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (7.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	13.1	3.5	5.9	3.6	12.1	2.4	10.1	1.9	7.7	6.4	2.9	27.3	1.6	2.4	6.8	3.6	5.2	4.3	5.7	8.5	8.3	4.8	9.7	1.9	21.4	1.9	15.9	6.5	2.5	1.9	3.6	3.7	15.3	13.0	3.6	3.0	4.8	3.5	3.7	6.0	3.2	2.6	7.4	19.7	2.1	2.4	1.5	15.8	0.0	6.3	6.7	2.1	4.8	4.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.5	0.1	0.0	6.1	0.8	0.0	0.6	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.5	0.0	5.0	2.2	0.1	0.0	0.0	0.8	1.3	3.3	0.0	0.1	8.7	0.0	0.0	0.0	0.6	0.4	0.0	0.0	1.2	0.2	4.5	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	12.1	1.9	7.7	8.3	4.8	15.9	6.5	13.0	15.8	23.8	15.2	0.0	1.7	3.2	0.1	2.5	0.0	2.7	2.3	5.2	0.0	0.4	3.3	0.6	0.0	36.5	0.3	0.0	0.2	2.3	1.9	0.8	3.5	1.0	0.5	0.0	2.9	31.3	3.8	0.0	1.1	1.5	0.0	0.0	2.3	2.8	1.3	0.0	1.1	2.6	0.3	0.0	1.4	0.0	0.9	2.8	0.2	0.0	2.6	1.4
SHTN1	"KIAA1598, shootin-1, shootin1"	ENSG00000187164	"Shootin 1"	A0MZ66	10	116881482-117126586	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9"	"Group enriched"	"Detected in many"	43	"dendritic cells: 13.2;monocytes: 14.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037942, HPA037943"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA037942: AB_2675748, HPA037943: AB_10671637"	"unprognostic (1.00e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.08e-6)"	3.5	6.5	51.5	6.8	50.1	1.6	8.7	9.8	34.1	5.5	7.0	42.3	0.3	6.7	4.4	8.4	5.4	5.2	6.5	2.6	58.9	37.0	7.8	12.1	9.8	4.5	67.8	22.7	6.8	10.9	18.6	20.4	5.4	36.3	7.3	8.6	2.0	9.9	3.0	0.9	9.6	7.8	3.8	67.4	7.0	9.0	9.9	54.5	0.4	11.9	1.4	4.1	4.0	2.4	0.0	13.2	0.3	14.0	0.0	0.2	3.5	15.8	8.9	0.9	1.9	0.0	0.0	8.9	1.3	3.5	2.7	5.2	10.0	10.5	0.0	2.7	4.9	8.1	8.2	7.1	6.0	2.8	0.0	7.4	0.0	9.4	6.2	1.2	2.8	2.5	0.4	5.3	2.7	5.2	7.2	6.6	4.3	4.3	0.0	1.9	6.3	0.0	0.1	3.4	3.0	6.0	0.0	12.0	3.5	7.4	2.2	9.9	3.9	10.7	15.6	9.7	10.9	12.5	2.5	11.3	0.9	6.7	0.0	7.8	1.7	0.0	0.0	4.9	0.0	4.9	0.0	14.0	0.1	0.0	8.8	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.3	0.0	4.0	8.9	0.2	3.5	51.5	50.1	9.8	30.2	58.9	37.0	67.8	22.7	36.3	54.5	71.5	33.1	2.4	13.5	0.0	78.9	3.4	28.1	33.5	43.3	22.7	58.9	35.1	18.3	40.5	5.8	1.3	14.6	0.0	45.7	25.7	3.1	31.7	2.3	42.7	35.4	46.1	16.4	3.1	79.2	9.0	10.3	62.9	0.0	91.0	20.8	13.1	41.7	50.9	4.9	44.5	55.6	12.9	3.5	17.4	41.4	0.0	16.7	0.0	17.7	11.9
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 102.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	20.6	11.4	11.9	11.0	13.5	19.2	25.5	15.5	16.6	14.6	13.1	15.0	6.5	12.8	16.8	13.4	12.7	12.9	12.9	11.4	12.6	11.6	12.1	17.5	13.9	10.0	12.8	11.6	16.7	11.4	13.1	9.1	102.6	14.1	14.2	12.2	32.1	13.2	12.1	17.0	16.6	16.0	18.6	12.7	11.3	12.5	17.9	13.0	17.5	14.5	9.3	11.5	15.9	14.8	12.6	8.3	21.9	5.2	5.3	6.1	3.5	8.6	7.8	16.9	15.1	14.6	12.8	17.3	8.1	11.0	12.1	5.9	5.9	11.3	11.2	9.0	10.2	8.4	10.1	11.6	11.8	14.9	4.5	9.4	6.0	6.1	15.4	20.4	5.9	9.3	15.3	21.3	7.0	16.4	13.5	10.1	10.5	9.7	10.7	9.8	5.9	15.9	12.1	20.6	9.6	12.1	18.6	25.4	11.8	11.2	10.9	19.3	17.1	24.0	12.0	20.7	15.2	7.6	13.7	10.7	12.9	11.7	7.0	8.6	14.0	5.8	20.6	9.6	7.4	11.6	6.9	5.2	21.9	2.7	2.2	3.0	12.6	3.0	4.2	8.3	12.1	6.1	4.5	2.9	5.3	1.3	7.9	1.6	3.5	11.9	13.5	15.5	16.6	12.6	11.6	12.8	11.6	14.1	13.0	11.9	11.9	16.4	51.3	76.1	18.3	12.0	10.2	9.4	10.3	15.7	7.9	161.7	26.6	21.4	60.8	27.0	18.8	0.0	19.9	25.3	52.6	43.7	4.6	19.5	29.5	33.4	21.7	28.8	18.3	53.9	21.0	23.2	47.2	38.7	18.3	30.7	19.2	14.4	18.4	21.1	16.5	19.4	37.1	68.6	47.5	66.1	624.0	13.4	16.7	38.7
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741127-150763477	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 325.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	9.6	48.0	7.6	11.8	10.3	22.7	23.5	10.9	17.2	30.0	10.5	8.4	20.3	7.9	23.5	13.9	28.8	14.9	11.0	10.7	7.2	7.3	8.4	35.5	11.8	19.1	9.9	7.5	19.0	14.6	6.4	8.1	31.4	7.9	18.8	9.2	8.3	11.2	21.7	8.3	19.3	9.5	17.4	9.4	16.9	12.0	8.7	8.6	23.6	11.4	10.6	25.1	22.7	25.6	3.0	3.1	10.0	2.7	1.6	3.6	1.1	16.9	4.2	3.3	6.6	11.3	8.5	13.3	7.1	8.2	8.6	10.4	8.6	7.6	9.4	10.4	7.3	7.2	10.5	8.8	6.3	8.1	7.9	6.3	18.5	5.1	28.4	16.2	10.2	5.5	7.7	14.7	5.1	11.7	6.8	6.6	18.6	4.6	37.4	5.3	20.3	18.6	5.2	10.7	15.8	8.4	13.7	7.1	33.9	5.4	5.9	12.7	6.0	5.3	5.0	12.5	7.8	33.4	15.4	4.6	5.9	5.3	12.8	9.5	44.5	16.9	13.2	5.6	14.7	3.0	9.5	2.7	10.0	2.1	1.5	3.2	2.5	3.6	3.2	2.4	3.0	1.9	1.9	5.9	1.6	1.5	3.1	2.0	1.1	7.6	10.3	10.9	17.2	7.2	7.3	9.9	7.5	7.9	8.6	6.0	3.7	47.8	71.4	130.4	40.0	14.9	15.3	17.4	7.9	21.0	35.3	144.9	11.6	5.6	2.0	9.2	26.2	46.7	5.7	18.3	47.9	44.4	10.3	47.4	28.4	33.4	36.8	16.5	64.5	1.5	40.9	27.9	42.2	16.2	31.8	33.5	8.9	10.5	29.0	13.0	2.2	12.9	39.1	0.5	6.6	124.5	325.6	52.4	29.9	65.9
SIGIRR	"IL-1R8, TIR8"	ENSG00000185187	"Single Ig and TIR domain containing"	Q6IA17	11	405716-417455	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 67.0"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 346.4;Proximal tubular cells: 462.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023188	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"		"HPA023188: AB_1856856"	"unprognostic (6.21e-3)"	"prognostic favorable (7.44e-5)"	"unprognostic (7.30e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (6.85e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (1.00e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (1.54e-5)"	11.0	3.2	11.8	19.3	12.3	18.1	17.7	2.4	12.3	10.7	16.9	11.2	16.2	18.6	11.0	14.5	13.7	16.3	12.8	12.9	11.1	10.1	29.4	67.0	14.9	25.6	11.7	8.5	9.6	22.7	10.0	7.3	6.2	15.6	14.2	9.2	15.2	22.1	13.4	6.4	4.5	20.4	11.2	17.7	28.7	17.7	7.4	10.2	12.4	15.4	8.8	18.0	11.3	13.3	11.4	12.9	17.4	16.7	27.8	38.9	22.8	7.9	21.8	1.3	7.6	1.2	6.5	16.0	1.2	1.8	3.7	3.3	10.0	50.0	2.2	5.9	6.9	0.4	11.5	3.5	4.1	0.6	6.8	13.2	4.3	4.3	0.2	4.0	3.6	7.6	3.5	0.8	0.6	0.5	2.1	10.6	8.7	4.4	0.1	1.0	26.7	10.5	12.3	7.9	16.2	11.9	13.6	0.0	7.8	2.6	5.4	13.5	6.6	0.1	7.4	9.5	3.5	9.4	3.0	12.3	1.2	1.5	1.8	0.0	2.7	4.6	5.5	5.0	8.4	4.2	17.4	13.0	11.2	38.9	13.9	30.9	11.4	32.5	33.7	12.9	8.6	29.8	28.9	7.0	27.8	16.7	4.9	29.9	22.8	11.8	12.3	2.4	12.3	11.1	10.1	11.7	8.5	15.6	10.2	26.8	33.8	47.6	28.4	14.4	8.9	15.9	56.0	56.2	20.5	52.4	11.8	14.2	53.0	49.0	1.0	55.6	127.0	0.0	64.0	7.7	36.0	31.6	40.3	346.4	43.4	25.4	75.7	73.6	54.3	2.9	29.1	39.7	81.0	27.1	78.4	65.1	64.4	129.8	28.0	462.2	18.5	25.8	33.1	7.0	66.2	11.2	8.5	121.8	72.6	38.0
SIGLEC15	"CD33L3, HsT1361"	ENSG00000197046	"Sialic acid binding Ig like lectin 15"	Q6ZMC9	18	45825512-45844080	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 5.9"	"Cell type enhanced"	"Detected in some"	16	"Hofbauer cells: 8.2;Pancreatic endocrine cells: 2.1;Urothelial cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 5.9;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	40	"dendritic cells: 2.1;monocytes: 5.9"	"Group enriched"	"Detected in some"	7	"PC-3: 8.7;U-87 MG: 26.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053509			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA053509: "	"unprognostic (3.89e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (9.14e-5)"	1.1	0.3	0.1	4.3	0.1	0.0	3.0	0.2	0.1	2.1	0.2	0.0	0.0	1.6	0.3	0.0	0.3	0.3	3.4	1.9	0.1	0.1	0.5	1.4	2.0	0.9	0.1	0.0	0.5	0.2	0.0	0.1	1.1	0.0	1.1	0.1	0.1	0.2	0.2	0.7	0.3	2.5	3.2	0.1	3.7	0.9	0.3	0.0	1.2	0.2	0.0	2.6	4.2	0.2	0.0	2.1	0.0	5.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	8.7	0.9	0.1	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.4	0.0	0.0	0.0	26.3	0.6	0.0	0.0	5.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.4	0.0	0.0	0.2	0.0	0.5	0.7	0.0	0.0	8.2	1.6	0.0	1.8	1.8	0.0	0.0	1.3	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	2.2
SIGLEC6	"CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6"	ENSG00000105492	"Sialic acid binding Ig like lectin 6"	O43699	19	51519525-51531856	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"placenta: 87.4"	"Group enriched"	"Detected in some"	12	"Cytotrophoblasts: 56.9;granulocytes: 52.1;Syncytiotrophoblasts: 157.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.5;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	33	"B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 103.0"									"HPA008945, HPA009084, HPA018198"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868"	"unprognostic (1.97e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (9.31e-3)"		"unprognostic (8.46e-4)"	"unprognostic (2.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.57e-3)"	1.8	0.0	0.0	5.6	0.0	0.1	0.8	0.0	0.1	1.2	1.7	0.0	0.3	0.9	2.0	1.2	1.5	0.5	8.6	0.4	0.0	0.0	0.4	0.1	4.2	1.5	0.0	0.0	0.1	0.3	0.1	0.1	87.4	0.0	3.7	1.5	0.5	1.4	1.0	0.2	1.3	6.0	3.1	0.0	1.3	1.7	1.0	0.0	0.3	0.2	1.0	2.6	2.2	1.9	6.5	6.8	2.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.2	103.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.1	0.0	6.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	52.1	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.8	0.0	0.0	0.0
SIGLEC7	"CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2"	ENSG00000168995	"Sialic acid binding Ig like lectin 7"	Q9Y286	19	51142299-51153526	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 51.5;lymphoid tissue: 29.4"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 29.4;Kupffer cells: 51.3;Macrophages: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"Karpas-707: 31.5;RPMI-8226: 18.3;U-937: 19.4"									HPA075513			Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000	"Plasma membrane"	Vesicles	"HPA075513: "	"unprognostic (3.14e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.27e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.26e-2)"	6.9	3.7	1.6	10.0	5.8	3.7	3.0	0.3	2.2	0.9	1.6	1.0	0.6	1.4	0.9	2.1	1.1	1.8	2.4	1.9	0.8	1.0	2.8	9.8	4.7	18.4	3.3	0.0	1.3	0.9	0.2	0.9	5.9	2.9	1.0	2.3	0.7	2.3	0.2	0.4	0.5	2.3	3.5	3.3	29.4	1.1	1.8	2.5	0.7	1.0	0.0	2.1	3.2	1.7	0.6	14.9	51.5	32.0	20.0	4.4	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	19.4	0.0	0.5	32.0	51.5	2.5	23.0	4.4	0.6	0.0	1.1	14.9	0.0	0.0	1.0	26.8	20.0	9.1	0.6	0.0	15.8	1.6	5.8	0.3	2.2	0.8	1.0	3.3	0.0	2.9	2.5	0.0	2.1	1.4	0.0	0.1	0.0	0.0	0.0	1.4	1.2	1.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.6	29.4	0.0	0.0	7.4	51.3	0.0	1.4	24.5	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.0
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427189	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skin 1: 34.5"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 2: 112.3;Basal keratinocytes: 268.2;Melanocytes: 91.1;Suprabasal keratinocytes: 369.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	10	"B-cells: 2.0;dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.9;HeLa: 28.1;hTCEpi: 21.8;LHCN-M2: 21.9;U-266/84: 15.9"									"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB023801: , HPA038211: AB_2675894, HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	8.8	2.3	3.0	3.6	3.0	5.9	7.5	3.0	3.0	13.5	3.0	3.0	3.0	0.0	3.0	3.0	12.9	5.5	10.7	7.1	3.0	0.8	3.0	12.3	5.4	3.0	3.0	3.0	13.7	7.3	3.5	5.7	8.2	3.0	3.9	0.1	3.0	4.6	9.8	5.0	34.5	3.0	3.3	3.0	4.0	5.3	3.0	3.0	3.0	3.9	3.0	3.0	10.5	6.1	2.0	1.6	0.0	0.1	0.0	0.1	0.1	0.5	1.7	2.0	0.0	0.1	0.8	0.8	0.9	0.3	1.7	1.3	2.4	0.0	2.5	0.7	0.2	9.5	11.2	1.6	16.9	1.0	0.1	0.5	0.7	28.1	0.9	2.3	0.7	0.1	1.0	21.8	0.4	5.2	9.9	0.3	0.0	0.1	0.5	21.9	0.1	0.4	1.7	0.8	0.0	1.5	0.0	0.3	2.5	1.9	6.3	0.0	0.0	11.0	1.9	0.4	0.3	1.1	0.3	3.7	0.4	2.0	0.1	0.0	4.3	15.9	0.5	4.7	2.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	3.0	3.0	3.0	3.0	3.0	0.8	3.0	3.0	3.0	3.0	26.8	112.3	2.4	0.6	268.2	0.2	9.3	7.6	9.4	17.0	12.2	0.0	0.5	0.0	2.8	0.0	2.2	14.2	0.0	1.8	1.0	5.2	0.4	18.5	7.8	1.7	0.0	26.6	1.8	3.7	0.0	0.0	4.0	91.1	2.8	15.1	0.5	5.0	23.0	0.0	0.0	0.1	0.0	10.8	0.0	0.5	369.5	2.1	1.3	18.6	1.0
SIK1B		ENSG00000275993	"Salt inducible kinase 1B (putative)"		21	6111134-6123739	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 19.8;Ciliated cells: 16.0;Club cells: 6.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	6	"B-cells: 1.6;dendritic cells: 5.0;monocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.6;hTERT-RPE1: 38.8;Karpas-707: 39.0;LHCN-M2: 26.8;SiHa: 28.1"									"HPA038211, HPA078064"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038211: AB_2675894, HPA078064: "	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.62e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.69e-3)"	"unprognostic (7.41e-2)"	9.7	13.7	0.4	3.0	1.7	8.4	5.2	0.4	3.1	2.9	3.0	1.3	4.6	0.9	3.1	1.9	6.8	1.0	15.5	6.2	1.5		1.7	12.3	8.5	1.2	1.8	0.6	10.2	11.2	1.6	2.2	3.2	2.6	5.1	2.3	7.6	3.9	14.3	9.1	2.9	6.1	1.7	2.1	2.0	5.0	1.7	1.0	1.0	0.9	5.6	3.2	7.1	2.7	1.6	5.0	0.0	1.7	0.3	0.5	0.1	3.0	15.1	1.1	0.9	0.2	0.1	2.7	0.3	0.2	0.6	0.3	16.8	2.2	1.0	0.5	0.0	2.4	0.3	1.8	0.0	0.2	2.7	0.5	2.3	28.6	3.2	1.0	0.3	0.2	0.4	13.3	1.5	8.7	38.8	0.6	0.4	0.9	39.0	26.8	1.4	0.3	0.7	1.6	2.7	1.7	0.6	6.9	4.5	1.5	5.1	1.4	0.7	28.1	1.8	1.5	0.8	0.3	1.2	0.7	0.4	1.5	0.6	6.2	5.4	11.7	0.5	4.3	1.0	1.8	0.0	0.1	0.0	0.1	0.8	0.5	1.6	0.0	0.1	0.7	1.6	0.1	0.1	0.0	0.3	1.7	5.0	0.0	0.1											23.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	16.0	6.8	1.8	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	5.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
SIK2	"DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2"	ENSG00000170145	"Salt inducible kinase 2"	Q9H0K1	11	111602391-111730853	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 62.8;Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016026, HPA071049"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear speckles, Intermediate filaments, Cytosol"	"HPA016026: AB_1857321, HPA071049: "	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.17e-9)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.13e-2)"	32.8	10.7	10.1	6.6	17.2	4.0	22.5	10.6	17.3	10.0	9.9	15.1	5.2	7.7	9.5	7.0	7.9	9.7	12.7	14.5	10.5	10.3	14.6	24.4	13.6	5.4	9.7	9.9	16.4	37.8	22.0	28.6	7.5	11.9	8.4	8.3	14.9	15.4	8.6	35.1	8.7	7.7	8.7	9.6	5.8	19.6	4.2	13.0	4.4	11.1	7.9	5.8	8.6	10.0	2.2	2.7	2.8	3.6	2.2	3.5	2.1	5.9	4.0	7.0	7.5	34.8	10.3	4.1	5.2	7.5	4.0	4.6	13.4	6.4	4.7	7.3	6.1	4.7	8.4	5.4	3.9	5.2	3.5	2.3	5.1	3.5	6.6	7.5	4.9	3.3	10.0	5.8	5.8	7.6	8.0	4.7	4.7	4.7	6.9	6.2	2.8	5.1	4.5	2.4	5.0	3.9	6.9	7.4	5.6	8.9	5.4	3.3	7.7	7.7	3.1	3.1	6.6	7.7	4.0	6.5	8.8	5.3	5.6	7.1	2.0	1.5	9.9	2.8	7.0	5.9	1.1	3.3	2.8	3.5	3.6	1.9	2.0	2.5	2.5	2.7	2.2	1.4	2.0	1.4	2.2	2.9	1.5	2.4	2.1	10.1	17.2	10.6	16.4	10.5	10.3	9.7	9.9	11.9	13.0	17.9	32.3	9.1	6.7	13.1	14.4	16.6	22.9	13.4	11.4	15.7	62.8	3.5	5.0	7.1	12.4	18.0	9.5	46.7	6.7	4.1	14.4	5.8	9.2	34.2	4.8	30.2	17.3	9.8	12.4	9.7	10.6	8.6	18.6	2.8	10.2	13.3	9.2	8.6	13.8	20.7	60.3	0.0	13.7	3.2	5.9	10.5	4.3	7.4	9.9	6.5
SIKE1	"FLJ21168, SIKE"	ENSG00000052723	"Suppressor of IKBKE 1"	Q9BRV8	1	114769479-114780685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024177, HPA025726"	Supported		Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Vesicles	"HPA024177: AB_1848798, HPA025726: AB_1848800"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.52e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.05e-1)"	18.3	15.4	14.5	17.4	15.9	15.3	16.4	23.5	16.3	18.3	17.3	14.5	14.2	16.7	17.2	13.4	18.1	14.3	13.4	20.3	14.2	15.1	24.4	22.2	12.3	19.7	21.1	11.2	17.2	17.5	15.4	22.5	17.1	23.2	15.2	17.3	9.3	17.2	13.9	21.1	21.9	17.5	16.4	19.2	20.6	14.5	11.8	17.9	26.0	19.3	17.1	21.2	17.2	14.2	8.1	9.8	12.3	7.6	9.2	10.3	5.3	8.5	2.4	11.4	10.8	13.7	10.9	12.2	7.1	6.7	10.4	14.1	7.5	4.5	16.0	7.0	6.0	4.5	8.3	12.5	8.5	14.1	10.8	7.3	8.8	7.6	7.7	13.0	10.0	7.2	10.7	9.8	7.5	12.1	6.5	9.3	12.6	13.4	10.3	7.9	38.1	17.5	9.0	25.7	4.8	7.4	10.5	23.4	8.1	7.6	7.8	8.7	9.7	11.2	11.0	12.8	10.6	6.6	33.5	6.5	8.7	11.5	14.5	9.9	8.7	7.5	15.7	12.4	15.2	18.7	12.3	6.0	7.4	8.6	6.4	10.3	7.9	8.0	7.4	7.8	8.1	9.3	9.9	4.0	9.2	7.6	9.8	6.2	5.3	14.5	15.9	23.5	16.3	14.2	15.1	21.1	11.2	23.2	17.9	23.8	11.3	20.5	20.8	28.3	9.9	37.2	20.4	8.1	13.6	29.6	9.8	26.2	43.1	24.9	28.0	21.2	22.5	0.0	22.3	29.0	22.4	24.9	19.6	33.5	24.5	7.9	17.9	24.5	15.8	47.2	26.2	19.8	21.9	18.0	20.8	14.1	27.5	20.1	18.7	46.0	14.7	19.4	21.7	28.6	31.3	31.9	30.1	30.9	19.8	19.5
SIM1	bHLHe14	ENSG00000112246	"Single-minded family bHLH transcription factor 1"	P81133	6	100385015-100464929	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 19.2;Distal tubular cells: 6.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Region enriched"	"Detected in single"	21	"hypothalamus: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.0;BJ: 12.8;BJ hTERT+: 18.7;BJ hTERT+ SV40 Large T+: 5.8;HDLM-2: 5.5;RPTEC TERT1: 14.7"	"Region enriched"	"Detected in single"	7	"hypothalamus: 6.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.6;hypothalamus: 5.2"	HPA024385			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favorable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			5.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	13.2	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	2.2	21.6	0.5	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	17.5	4.7	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	8.0	0.0	12.8	18.7	5.8	5.4	0.0	0.0	0.0	0.0	4.0	1.2	0.0	0.0	0.0	4.9	5.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	6.6	3.0	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	1.6	0.0	0.4	0.0	0.0	0.0	0.0
SIMC1	"C5orf25, FLJ44216, OOMA1, PLEIAD"	ENSG00000170085	"SUMO interacting motifs containing 1"	Q8NDZ2	5	176238367-176345991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 29.3;testis: 41.5"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037889, HPA037890"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA037889: AB_2675720, HPA037890: AB_2675721"	"unprognostic (1.15e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (2.32e-6)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.20e-2)"	3.1	15.1	5.4	5.0	3.9	2.0	3.3	10.2	5.4	7.5	4.5	2.0	2.9	3.9	8.0	6.8	3.1	9.3	5.3	2.0	6.2	4.4	1.8	5.1	3.1	3.5	2.5	3.0	29.3	3.4	4.2	7.6	3.3	3.4	6.1	4.9	4.0	3.8	4.7	5.5	2.3	5.1	6.2	3.0	5.5	5.1	41.5	3.7	4.5	2.1	2.7	3.4	4.4	5.4	7.1	8.1	10.5	5.3	10.8	6.3	3.5	1.8	5.0	16.3	13.0	8.5	8.4	8.2	6.9	6.8	7.2	9.0	17.5	5.4	0.0	8.6	8.0	14.8	1.7	17.6	12.3	9.0	3.1	13.1	8.8	3.3	2.2	19.1	9.6	6.8	5.6	5.1	4.8	8.7	5.3	6.7	3.2	22.0	8.5	8.5	8.6	9.4	7.6	5.9	2.3	5.5	14.0	10.8	12.1	4.8	3.7	10.7	11.6	7.6	1.1	6.6	5.9	4.4	18.4	4.7	8.8	4.7	8.0	5.9	2.1	2.4	13.8	3.5	6.4	5.0	7.0	5.3	10.5	5.2	5.2	6.3	7.1	6.3	4.0	8.1	6.9	5.3	4.1	0.7	10.8	4.0	3.9	4.1	3.5	5.4	3.9	10.2	5.4	6.2	4.4	2.5	3.0	3.4	3.7	8.9	3.5	2.7	4.8	2.6	15.3	3.1	2.5	2.7	3.4	1.8	3.9	0.2	1.7	3.2	27.6	2.1	5.3	0.0	3.2	2.1	4.3	3.7	0.0	7.5	2.0	17.5	12.7	4.9	4.1	9.8	27.6	2.8	5.0	4.6	9.3	5.8	4.1	7.0	32.5	2.1	4.5	32.3	5.3	64.2	24.7	2.3	0.7	5.0	8.9	2.6
SIN3B	KIAA0700	ENSG00000127511	"SIN3 transcription regulator family member B"	O75182	19	16829400-16880353	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Peritubular cells: 62.6;Syncytiotrophoblasts: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050329	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA050329: AB_2681089"	"unprognostic (2.71e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (4.37e-4)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (1.18e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	19.1	17.9	22.2	17.2	28.1	9.8	21.5	25.1	38.6	24.4	16.0	20.8	50.0	12.8	37.5	21.5	14.5	23.3	17.3	15.7	24.2	20.8	15.9	9.8	21.7	20.8	16.5	30.4	32.5	16.2	60.8	17.7	53.2	24.8	22.7	11.0	15.5	20.2	54.7	17.1	22.7	17.7	26.5	14.8	25.1	13.7	30.2	13.4	9.3	22.5	9.6	15.8	17.2	22.2	4.8	2.6	6.1	6.7	1.9	2.0	2.3	14.7	7.9	13.4	17.2	11.1	10.2	42.4	12.6	10.4	17.5	15.6	19.4	13.9	13.3	14.1	14.5	14.8	12.7	11.1	11.3	16.2	13.8	20.0	14.2	17.3	8.8	14.6	8.3	11.5	16.8	14.9	11.7	10.1	13.9	15.8	10.7	11.5	8.2	12.2	17.7	11.2	13.4	16.6	7.7	25.4	14.9	12.3	8.7	9.9	12.6	9.9	12.4	15.9	12.3	9.9	18.8	8.6	7.8	20.7	17.0	10.4	24.5	14.0	11.8	8.6	13.3	11.8	10.9	12.6	0.1	6.7	6.1	1.8	6.0	1.2	4.8	1.7	2.0	2.1	3.8	2.0	1.4	3.3	1.9	5.3	2.6	0.5	2.3	22.2	28.1	25.1	38.6	24.2	20.8	16.5	30.4	24.8	13.4	20.8	14.8	10.7	8.6	7.0	18.1	6.9	2.5	5.3	7.9	3.5	13.7	17.1	3.3	9.2	7.9	11.7	4.7	0.0	7.4	24.5	8.6	10.0	4.7	5.6	15.1	9.5	4.7	8.0	13.0	18.2	46.9	6.6	5.0	10.0	7.9	8.7	12.5	3.5	62.6	4.5	15.7	6.5	6.6	9.3	10.4	7.0	104.5	6.4	5.8	11.2
SINHCAF	"C12orf14, FAM60A, TERA"	ENSG00000139146	"SIN3-HDAC complex associated factor"	Q9NP50	12	31280584-31327058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 108.4;Club cells: 103.5;Extravillous trophoblasts: 98.9;monocytes: 269.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 83.1"	"Low region specificity"	"Detected in all"							"HPA038167, HPA057585"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038167: AB_10675629, HPA057585: AB_2732615"	"unprognostic (2.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.75e-2)"	13.1	6.5	1.6	21.4	5.1	7.9	11.1	4.5	1.9	25.4	15.8	3.4	15.8	6.7	28.3	16.8	19.8	14.6	8.4	5.6	2.9	1.8	16.6	3.3	17.0	22.5	3.4	0.9	18.5	19.6	7.6	19.6	18.9	5.2	18.6	8.3	6.0	16.3	20.1	3.2	12.7	17.0	11.7	3.8	18.5	7.0	13.6	3.7	39.0	14.9	12.3	27.3	19.3	13.6	22.8	28.3	7.9	8.0	19.0	15.1	10.4	3.4	5.1	17.2	3.4	1.0	2.1	31.9	1.8	1.3	3.5	4.7	13.7	9.0	11.9	14.6	0.5	3.8	6.2	14.4	6.9	6.9	12.6	6.4	8.2	3.5	8.5	4.3	13.3	8.0	1.9	10.8	3.0	14.7	6.9	8.1	14.2	11.3	4.6	1.5	2.6	23.8	9.8	83.1	10.7	2.8	20.2	8.2	10.2	7.9	10.3	24.0	16.2	4.2	7.6	9.9	39.4	3.2	7.9	8.9	0.8	5.2	0.4	5.9	5.3	7.6	24.0	2.4	5.1	4.6	7.9	4.8	7.5	8.8	5.8	10.3	22.8	12.3	10.4	10.4	17.9	15.1	11.8	1.5	19.0	8.0	28.3	5.8	10.4	1.6	5.1	4.5	1.9	2.9	1.8	3.4	0.9	5.2	3.7	71.5	30.2	0.0	0.0	0.0	0.0	0.0	0.0	108.4	103.5	43.6	0.0	63.7	69.6	61.6	0.0	0.0	0.0	0.0	37.9	98.9	0.0	0.0	10.5	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	269.7	0.0	0.0	47.6	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638097-65650930	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: AB_2676716"	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	10.5	9.1	7.5	27.1	12.0	29.8	10.0	2.6	8.7	8.9	10.8	9.4	2.9	7.7	10.9	3.0	7.6	9.0	9.9	8.0	8.4	4.6	9.5	7.8	17.6	33.2	11.5	4.7	7.7	4.6	2.7	4.2	11.9	10.3	8.6	3.9	8.2	8.7	6.8	5.4	4.2	17.2	9.0	14.3	47.1	8.1	3.0	10.5	25.3	7.7	4.6	32.7	8.5	7.8	6.6	2.8	14.1	5.2	5.8	7.4	3.0	0.7	6.2	4.5	9.6	2.6	5.5	10.6	7.2	6.1	5.6	5.5	1.9	6.9	9.9	16.2	3.5	0.2	3.6	1.6	2.4	1.9	10.7	4.0	24.2	9.2	3.4	4.7	9.8	10.5	5.6	1.1	7.8	1.0	5.6	16.4	10.4	13.7	4.6	2.8	2.7	3.9	16.7	3.0	2.5	5.8	17.8	2.5	8.8	2.1	0.5	1.7	10.3	3.5	6.1	14.6	4.3	4.6	15.1	23.0	6.9	14.1	7.6	1.4	6.9	5.4	22.3	9.5	15.6	20.1	4.0	4.1	10.2	7.4	4.8	5.5	5.3	3.7	4.8	2.8	6.6	2.9	4.4	14.1	5.8	5.2	2.7	3.5	3.0	7.5	12.0	2.6	8.7	8.4	4.6	11.5	4.7	10.3	10.5	6.0	6.9	45.9	21.9	6.1	1.7	3.7	25.5	0.0	2.3	22.7	0.0	7.8	31.5	18.4	2.6	16.8	17.3	23.3	13.0	17.8	8.2	22.9	6.9	19.8	31.9	4.8	20.2	39.9	38.3	5.4	7.5	26.7	10.1	10.8	11.7	4.8	23.9	11.5	12.4	14.6	1.6	12.9	14.0	0.7	17.9	9.7	11.3	33.2	11.4	27.8
SIPA1L2	KIAA1389	ENSG00000116991	"Signal induced proliferation associated 1 like 2"	Q9P2F8	1	232397965-232561558	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 54.1;Cone photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 33.8;NTERA-2: 27.1;WM-115: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024181, HPA027224"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Golgi apparatus"		No	NA			"Nuclear bodies"	"Nuclear membrane, Golgi apparatus"	"HPA024181: AB_1856886, HPA027224: AB_2672165"	"unprognostic (2.34e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.98e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.57e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.84e-3)"	"unprognostic (3.45e-3)"	4.1	1.1	3.6	2.9	3.3	2.1	3.4	0.3	7.6	3.2	8.9			1.6	1.9	1.0	8.7	1.2	4.4	16.2	3.1	3.9	1.6	2.4	6.5	0.8	6.5		6.7	1.4	3.9	3.2	10.0		2.9	10.5		3.3	2.3	2.5	3.3	3.3	3.7	3.0	4.5	2.0	3.4			3.4		1.1	4.7	5.7	0.0	1.2	4.3	1.2	2.0	2.4	0.2	0.0	3.6	33.8	0.2	0.2	0.0	14.6	0.6	1.2	1.5	1.1	1.4	0.0	2.8	6.8	12.7	1.4	0.8	6.9	1.1	1.4	0.0	6.4	0.0	3.3	0.0	3.1	0.4	3.6	1.9	4.7	0.3	3.0	0.0	7.8	12.4	0.0	0.0	0.8	1.5	3.6	0.3	27.1	0.1	5.4	0.0	0.0	1.7	4.3	5.3	1.8	5.9	11.3	0.3	4.6	8.1	0.7	0.4	2.7	4.0	0.0	8.7	1.4	3.2	0.0	0.0	5.0	3.1	22.9	0.0	0.6	0.0	0.2	1.2	2.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	4.3	2.0	0.9	1.2	0.0	0.2											6.0	2.6	0.5	7.6	7.8	24.4	54.1	12.7	5.3	5.7	3.5	49.1	4.0	0.0	5.3	9.5	18.6	16.4	0.0	0.5	6.1	12.6	14.3	1.1	3.0	8.9	4.8	6.9	1.3	12.9	7.6	0.9	11.0	13.5	5.4	30.2	10.8	1.2	35.1	1.8	0.2	35.3	0.0	19.8	3.4	26.0	6.5	12.4	1.0	21.2	15.9
SIRPB2	"dJ776F14.2, PTPN1L, PTPNS1L3"	ENSG00000196209	"Signal regulatory protein beta 2"	Q5JXA9	20	1470741-1491587	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.5;lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in some"	24	"Hofbauer cells: 4.4;Kupffer cells: 18.9;Macrophages: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"classical monocyte: 19.8;eosinophil: 12.3;intermediate monocyte: 12.8;myeloid DC: 8.8;neutrophil: 29.5;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	194	"dendritic cells: 8.8;granulocytes: 29.5;monocytes: 19.8"	"Cell line enhanced"	"Detected in some"		"A-431: 5.3;HBEC3-KT: 4.5;HMC-1: 9.3;hTCEpi: 10.0;HUVEC TERT2: 5.0;THP-1: 8.8;TIME: 4.4;U-937: 9.4"					"Low region specificity"	"Detected in all"			"HPA011548, HPA048032"	Uncertain		Approved	"Nuclear bodies"		NA	NA		100000	"Nuclear bodies"		"HPA011548: AB_2668514, HPA048032: AB_2680236"	"unprognostic (3.22e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.50e-5)"	"unprognostic (3.59e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	8.1	4.2	5.8	15.8	11.0	8.1	5.2	0.8	6.5	2.8	2.4	3.3	0.0	1.3	1.9	4.5	2.6	3.1	5.2	2.7	5.9	3.1	2.6	2.5	9.5	17.3	9.2	1.7	1.4	1.6	0.7	1.4	10.0	7.9	1.8	2.5	2.4	2.8	1.0	1.2	1.5	3.3	5.5	13.1	21.2	2.0	1.8	9.1	1.0	1.7	0.3	4.3	6.4	3.9	0.0	8.8	29.5	19.8	0.0	0.0	6.4	5.3	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	1.3	0.0	4.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.2	9.3	0.0	10.0	0.0	0.2	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	8.8	4.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	9.4	0.1	1.2	19.8	12.3	0.0	12.8	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	29.5	0.0	9.7	0.3	0.0	6.4	5.8	11.0	0.8	6.5	5.9	3.1	9.2	1.7	7.9	9.1	0.0	0.6	0.5	0.7	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.4	1.1	0.0	4.4	0.0	0.0	0.6	18.9	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.5
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884669-67918390	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	17.2	32.3	12.6	21.1	17.8	17.0	18.1	22.6	14.5	24.2	20.5	15.7	14.0	9.2	19.0	12.7	12.7	15.1	15.2	14.7	14.1	10.4	13.9	17.3	12.6	16.1	17.0	10.1	26.6	14.4	16.4	13.3	14.7	12.1	21.7	12.5	12.1	12.3	16.1	19.9	12.9	15.0	21.0	17.7	13.5	13.2	25.4	16.3	28.1	15.2	9.3	14.7	21.6	37.5	4.9	3.9	3.8	3.5	3.6	7.1	1.8	8.3	9.6	15.2	16.9	14.5	11.2	9.5	11.6	12.0	16.0	14.3	10.5	7.2	17.6	6.3	7.7	10.0	6.7	18.8	3.9	17.2	9.4	10.9	9.3	7.2	8.2	13.3	10.0	7.2	10.3	9.4	9.6	16.6	17.2	6.4	10.1	11.8	9.6	11.6	6.7	9.3	13.9	18.8	5.4	15.3	16.9	12.0	6.9	7.5	5.2	9.8	13.5	21.3	14.1	14.7	13.7	10.2	9.3	5.3	12.5	11.6	11.0	11.2	8.1	9.6	34.9	6.4	15.2	5.1	3.8	2.4	3.2	3.4	3.0	4.9	4.9	3.7	4.7	3.9	3.3	7.1	4.2	3.1	3.6	3.5	3.5	2.9	1.8	12.6	17.8	22.6	14.5	14.1	10.4	17.0	10.1	12.1	16.3	17.9	6.1	10.4	16.4	34.8	11.7	27.0	15.3	1.4	9.1	5.2	25.5	5.7	5.0	3.9	171.4	12.8	17.4	23.3	4.7	4.3	17.6	23.9	11.5	14.8	7.8	11.1	41.1	14.1	20.9	29.0	16.4	13.5	15.1	1.8	16.9	7.0	6.4	10.5	18.4	6.3	13.4	0.0	38.2	20.6	15.4	41.5	10.4	13.8	12.4	14.9
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.6;skeletal muscle: 108.7"	"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 174.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"	Nucleoplasm	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	14.1	11.0	30.2	8.1	36.0	10.7	9.1	14.3	38.8	11.0	8.4	78.1	4.0	9.3	9.7	7.8	17.1	12.9	10.7	20.3	36.9	23.5	9.0	12.0	10.8	8.8	52.3	20.5	17.3	9.5	10.1	6.2	7.7	40.8	9.8	7.6	5.8	14.9	11.2	108.7	13.7	9.3	12.8	86.6	9.9	9.0	7.9	46.3	3.2	10.1	23.4	8.9	10.6	7.1	13.2	21.5	28.0	33.0	16.6	23.5	22.1	8.2	5.2	4.4	11.1	25.6	17.6	3.0	6.1	10.9	9.5	12.3	9.3	5.3	2.9	13.3	11.3	7.3	4.5	8.1	13.1	5.8	13.2	8.4	5.6	5.9	5.6	18.1	3.9	12.4	18.4	15.8	7.8	9.4	11.8	16.7	9.4	5.2	22.9	14.5	4.7	7.8	3.0	0.7	14.1	7.3	10.4	12.6	8.0	7.7	7.4	11.3	5.1	7.1	9.5	6.7	3.9	4.3	10.1	15.8	12.9	2.8	19.9	9.0	9.4	4.5	6.6	10.3	9.8	11.9	19.5	27.3	28.0	23.5	33.0	14.6	12.2	11.4	16.1	21.1	13.2	7.5	12.5	20.7	16.6	25.8	21.5	15.5	22.1	30.2	36.0	14.3	38.8	36.9	23.5	52.3	20.5	40.8	46.3	14.9	20.8	11.4	27.5	45.8	26.8	30.8	7.6	29.4	20.5	12.2	33.4	28.9	31.5	27.0	174.5	26.3	34.2	23.3	15.3	12.8	23.1	19.4	25.3	16.2	56.7	28.6	16.8	23.9	33.7	57.6	28.7	34.2	43.9	14.4	20.4	20.6	21.1	18.6	38.5	23.3	27.0	19.4	35.0	12.7	5.9	52.6	35.4	43.6	15.8	22.6
SIX2		ENSG00000170577	"SIX homeobox 2"	Q9NPC8	2	45005161-45009430	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 23.3;skeletal muscle: 21.0"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 2.2;Exocrine glandular cells: 1.9;Melanocytes: 1.7;Pancreatic endocrine cells: 1.2;Smooth muscle cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.9;LHCN-M2: 22.0;RH-30: 15.1;SCLC-21H: 25.8;U-2197: 16.7;U-698: 19.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056958			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA056958: AB_2683287"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.09e-6)"	"unprognostic (1.28e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.53e-9)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.05e-1)"	5.8	0.2	0.2	0.2	0.4	0.1	3.4	0.5	0.4	13.3	0.4	0.2	0.0	0.1	1.1	0.8	0.8	0.1	0.1	0.8	0.1	0.0	0.4	0.1	0.3	0.2	0.9	1.8	0.3	4.6	5.7	13.5	0.3	1.4	5.2	0.1	9.3	23.3	1.3	21.0	0.3	0.1	0.4	0.8	0.1	7.4	1.1	0.0	3.9	0.7	4.0	0.8	1.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	6.3	23.9	0.0	0.1	1.1	0.4	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.0	2.2	3.9	0.2	0.0	1.2	0.0	7.7	0.0	0.0	0.0	2.1	1.1	0.0	4.9	0.0	0.1	0.7	0.2	0.1	0.0	22.0	0.8	0.0	1.3	0.2	0.0	4.8	0.0	15.1	0.0	0.0	1.2	25.8	0.2	3.3	0.1	0.0	0.2	0.1	1.9	0.3	0.4	1.3	16.7	0.0	0.5	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.1	0.0	0.9	1.8	1.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.1	0.6	0.0	0.0	0.0	0.1
SIX3	HPE2	ENSG00000138083	"SIX homeobox 3"	O95343	2	44941898-44946077	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5"	"Group enriched"	"Detected in some"	18	"Bipolar cells: 197.9;Horizontal cells: 174.8;Muller glia cells: 357.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 40.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 34.3;SCLC-21H: 31.9;SH-SY5Y: 12.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 38.7"	HPA067988			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067988: AB_2685939"	"unprognostic (1.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-2)"		"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.73e-2)"	0.4	0.4	3.7	0.5	40.2	0.5	0.5	0.7	0.7	1.5	0.4	1.5	0.0	0.5	0.4	0.4	0.5	0.4	0.5	0.4	1.6	7.2	0.4	0.4	0.5	0.5	1.1	2.7	0.4	1.0	32.1	30.9	0.4	0.1	0.4	0.4	66.5	0.4	0.4	1.1	0.5	0.4	0.4	0.0	0.4	0.5	0.8	6.5	0.0	0.4	0.0	0.4	0.4	0.0	1.1	1.1	4.5	2.2	1.9	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.3	0.0	5.9	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	34.3	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	31.9	12.7	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.6	1.2	1.0	1.1	1.7	1.1	1.1	0.8	0.8	1.1	1.3	1.4	1.7	1.9	2.2	1.1	1.3	0.7	3.7	40.2	0.7	0.7	1.6	7.2	1.1	2.7	0.1	6.5	0.0	0.0	0.0	0.0	0.0	197.9	0.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	174.8	1.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	357.8	0.0	0.0	0.0	0.6	13.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
SIX4	AREC3	ENSG00000100625	"SIX homeobox 4"	Q9UIU6	14	60709528-60724348	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.4;salivary gland: 16.4;skeletal muscle: 19.3"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 9.2;Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Glandular cells: 15.2;Urothelial cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 20.7;hTERT-RPE1: 15.9;RH-30: 21.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA031794	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031794: AB_10602928"	"unprognostic (2.23e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.63e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.08e-1)"	2.0	1.5	0.9	0.6	0.9	0.3	4.8	4.3	4.5	3.3	0.7	0.1	3.3	0.4	1.6	1.3	0.5	3.5	1.1	1.5	1.0	1.0	1.4	0.5	2.1	0.2	1.0	2.2	2.9	3.3	20.4	6.3	2.1	3.6	4.0	0.3	0.8	16.4	2.7	19.3	0.5	0.5	0.9	1.8	0.3	2.0	0.7	1.1	0.8	3.9	2.4	1.4	1.7	14.3	0.2	0.1	1.0	0.1	0.3	0.2	0.0	20.7	1.5	1.2	5.6	4.9	6.2	9.8	4.7	7.1	1.4	2.0	1.0	6.6	0.0	3.1	2.3	1.4	7.9	5.6	3.8	3.3	1.6	4.6	0.6	2.1	1.4	1.6	2.1	0.2	2.9	1.8	1.3	6.6	15.9	1.2	0.4	4.1	0.0	7.2	5.2	0.0	0.2	3.6	0.1	8.9	1.3	21.0	0.0	2.5	11.9	3.4	0.3	3.0	4.7	1.2	2.0	6.4	0.1	4.1	4.4	9.7	2.9	4.2	1.4	0.0	0.0	1.5	0.0	0.8	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.9	0.9	4.3	4.5	1.0	1.0	1.0	2.2	3.6	1.1	3.0	0.3	0.0	9.2	0.3	0.2	1.6	0.0	20.1	6.8	1.8	19.6	4.7	0.0	0.1	0.0	0.3	0.0	0.0	0.9	3.3	1.9	15.2	1.1	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.3	0.1	1.7	0.0	0.0	1.7	2.7	0.0	1.4	0.3	0.4	0.0	0.3	0.1	0.9	0.5	2.6	0.0	0.0	10.5
SIX6	"OPTX2, Six9"	ENSG00000184302	"SIX homeobox 6"	O95475	14	60508951-60512850	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cataract, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 43.3"	"Cell type enhanced"	"Detected in some"	33	"Cone photoreceptor cells: 27.5;Horizontal cells: 46.1;Muller glia cells: 158.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.0"	"Region enriched"	"Detected in single"	8	"hypothalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"JURKAT: 9.3;MOLT-4: 29.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"hypothalamus: 2.5"	HPA001403	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001403: AB_1079993"					"unprognostic (2.76e-1)"				"unprognostic (6.14e-2)"			"unprognostic (8.18e-2)"			"unprognostic (5.75e-2)"			0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.4	0.0	10.6	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	29.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.8	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176602	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 41.6;testis: 12.6"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 19.6;Spermatocytes: 18.7;Spermatogonia: 13.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 2.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Supported	"Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Mitotic spindle, Centrosome"	Cytosol	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.8	0.6	0.6	6.4	0.6	6.2	0.9	0.4	1.6	0.8	2.8	0.3	0.0	1.1	1.0	0.8	5.1	0.2	0.3	0.4	0.8	0.5	0.8	0.5	1.0	6.1	0.6	0.3	0.5	0.4	0.0	0.6	2.6	0.8	0.4	4.0	0.2	0.9	0.0	0.5	2.4	3.1	1.1	0.5	2.6	1.4	12.6	0.3	41.6	0.3	5.7	6.4	0.5	1.4	0.4	0.2	0.3	0.3	1.9	2.3	0.6	11.3	6.0	10.8	9.1	0.0	2.3	8.5	15.3	6.5	19.4	13.2	9.8	12.2	15.5	4.6	8.4	8.3	10.7	14.4	6.2	21.2	13.3	7.4	20.6	3.9	5.6	0.0	16.0	8.0	0.4	0.4	15.5	5.2	1.8	9.4	13.2	10.7	6.6	12.8	8.8	24.3	14.4	12.5	17.2	11.2	16.0	23.2	7.2	4.3	4.4	13.8	5.1	5.1	8.0	3.2	7.5	7.1	12.3	3.8	7.7	11.1	7.1	18.4	4.0	8.5	15.6	1.9	12.5	22.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.8	1.4	0.2	0.0	0.8	0.3	0.0	1.9	0.3	0.0	2.3	0.6	0.6	0.6	0.4	1.6	0.8	0.5	0.6	0.3	0.8	0.3	0.0	0.0	2.2	0.5	1.8	0.0	0.6	0.0	2.7	2.3	0.0	0.0	1.3	0.0	0.9	5.1	0.8	0.2	0.0	1.2	19.6	0.8	0.4	0.0	0.2	4.6	0.0	0.0	2.5	1.9	6.0	1.4	2.2	0.0	1.0	0.3	0.2	0.6	0.9	1.1	0.3	0.0	0.0	0.9	18.7	13.5	2.5	1.8	1.0	2.7	0.1
SKAP1	"SCAP1, SKAP55"	ENSG00000141293	"Src kinase associated phosphoprotein 1"	Q86WV1	17	48133440-48430275	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.9;lymphoid tissue: 52.1"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 48.5;granulocytes: 113.6;Late spermatids: 118.7;T-cells: 123.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.3;HDLM-2: 9.9;HMC-1: 8.5;JURKAT: 14.5;Karpas-707: 10.5;RPMI-8226: 12.4;RPTEC TERT1: 15.4;U-266/70: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002969, CAB025882, CAB055513"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"CAB025882: , CAB055513: , HPA002969: AB_1079870"	"prognostic favorable (5.07e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.14e-4)"	1.9	9.4	0.5	28.0	0.6	2.9	4.5	0.4	0.6	5.9	3.8	0.6	10.9	1.1	2.2	10.6	2.1	8.0	6.2	2.1	1.3	1.1	12.9	2.0	5.2	20.0	0.7	0.4	2.4	2.8	11.6	17.5	0.7	1.2	3.0	2.4	1.6	10.2	7.4	0.5	1.2	6.1	1.2	1.9	11.7	2.2	7.8	0.6	52.1	1.8	1.3	27.7	5.1	4.3	11.9	0.1	2.1	0.2	22.3	50.9	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	19.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.2	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	10.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	15.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	9.6	6.8	0.0	0.0	0.0	0.0	2.1	0.1	0.3	35.9	0.0	30.1	2.8	29.6	32.2	0.1	11.9	26.1	28.9	0.7	22.3	0.2	0.1	50.9	22.3	0.5	0.6	0.4	0.6	1.3	1.1	0.7	0.4	1.2	0.6	3.0	14.6	10.4	0.1	1.8	0.0	0.6	0.0	2.7	5.7	8.7	0.0	0.1	39.7	0.2	48.5	1.6	0.3	0.0	1.6	0.1	1.3	0.3	113.6	25.1	0.2	0.0	1.2	6.2	3.7	118.7	1.4	1.7	1.7	0.0	0.6	2.0	1.5	0.0	0.7	1.1	0.3	6.5	0.3	34.8	4.1	1.1	0.2	123.7	0.1	0.4
SKIDA1	"C10orf140, FLJ45187"	ENSG00000180592	"SKI/DACH domain containing 1"		10	21513478-21526368	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"thyroid gland: 9.6"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 13.7;Early spermatids: 13.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 23.1;AN3-CA: 5.9;BEWO: 10.7;SH-SY5Y: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039208, HPA040439"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA039208: AB_10795034, HPA040439: AB_10796122"	"unprognostic (5.36e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.45e-4)"	"unprognostic (9.97e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.93e-2)"	"unprognostic (3.38e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.20e-2)"	"unprognostic (8.52e-3)"	0.9	1.9	1.9	0.4	3.3	1.7	2.2	3.1	5.9	1.3	1.7	0.0	0.0	0.3	1.0	1.0	0.9	1.7	0.6	5.5	2.5	1.8	4.1	4.3	1.0	0.3	1.4	3.4	4.2	1.5	7.3	1.8	2.5	3.0	1.1	0.6	4.1	2.6	2.0	0.5	2.9	0.5	1.0	1.2	0.4	0.6	4.6	0.3	0.9	9.6	0.7	0.3	1.1	1.1	0.6	0.5	1.5	0.6	0.5	0.3	0.1	0.4	1.0	23.1	5.9	0.5	0.2	10.7	0.5	0.3	0.0	0.0	2.1	0.1	0.2	0.9	0.3	0.1	1.4	2.1	0.4	0.0	0.0	2.6	0.1	1.0	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.7	0.2	0.4	0.1	0.2	0.1	0.9	0.7	0.1	1.4	0.0	0.0	0.3	0.7	0.0	0.4	0.6	2.5	5.3	0.8	4.0	0.1	2.0	0.4	4.6	0.3	0.2	0.7	0.2	0.5	0.1	0.0	0.3	1.4	0.0	0.2	1.5	0.3	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.3	0.6	0.3	0.3	1.3	0.5	0.6	0.5	0.2	0.1	1.9	3.3	3.1	5.9	2.5	1.8	1.4	3.4	3.0	0.3	0.0	1.0	0.0	0.8	1.3	13.7	5.2	5.1	0.0	2.3	1.8	0.0	4.6	6.6	0.1	13.5	3.5	0.0	0.0	0.6	3.1	1.7	0.6	1.1	8.9	2.4	1.6	0.0	3.1	1.5	6.6	1.4	0.0	0.0	0.0	0.0	6.8	0.5	0.0	2.1	5.1	4.0	6.5	0.6	4.8	3.2	1.6	2.9	0.0	0.0	0.2
SKIL	"SNO, SnoA, SnoN"	ENSG00000136603	"SKI like proto-oncogene"	P12757	3	170357678-170396835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"granulocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008472, HPA014233"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008472: AB_1856933, HPA014233: "	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (2.94e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.34e-1)"	16.2	15.0	10.5	21.1	14.7	22.8	12.4	5.0	18.2	14.0	11.8	12.2	13.4	15.9	17.1	12.7	14.4	12.0	26.8	21.7	11.2	11.4	15.0	18.0	23.8	15.2	11.6	10.6	17.8	11.4	9.6	21.1	26.6	16.0	15.8	11.7	14.8	14.2	17.0	19.5	10.3	28.0	13.5	17.3	12.6	17.9	14.4	8.3	14.0	18.9	13.5	21.1	15.3	16.3	5.7	2.9	5.4	11.3	3.2	2.6	2.3	8.3	10.3	6.9	4.4	8.9	3.9	12.7	8.4	5.8	5.8	4.6	2.1	18.1	10.4	27.0	7.6	9.9	19.2	4.2	3.9	9.3	17.9	4.1	13.8	10.0	4.5	7.7	5.8	7.6	6.7	3.8	8.5	6.6	19.4	14.7	1.0	6.1	11.7	12.2	8.9	2.4	1.8	26.9	9.3	3.6	5.7	23.2	2.1	8.8	13.2	5.1	6.3	20.9	21.3	4.4	14.6	14.2	6.3	28.1	16.9	15.8	14.3	15.6	15.7	7.3	19.9	6.4	3.0	7.8	3.4	4.3	2.0	1.6	9.8	2.3	4.6	1.4	2.1	2.9	5.7	2.5	2.6	5.4	3.2	11.3	2.0	0.5	2.3	10.5	14.7	5.0	18.2	11.2	11.4	11.6	10.6	16.0	8.3	68.5	62.7	31.1	75.8	64.6	24.9	9.5	10.2	92.3	77.3	33.2	51.1	7.8	13.3	46.2	69.5	57.1	35.2	0.0	98.8	47.2	82.2	47.0	200.8	27.0	26.1	50.9	22.8	70.6	59.0	24.0	35.1	68.2	33.7	39.7	42.7	11.8	128.3	18.2	64.0	35.6	30.1	25.8	66.2	51.9	26.9	83.9	34.4	25.5	13.8	127.8
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959080-31969755	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 19.2"	"Low region specificity"	"Detected in all"							"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	14.5	32.8	12.4	19.4	15.2	19.0	11.3	15.4	20.2	11.6	12.6	16.0	10.6	36.7	12.5	37.4	14.8	11.7	10.3	12.3	10.7	8.2	12.6	27.8	17.9	13.9	12.3	10.1	13.6	13.1	3.8	21.6	11.3	12.7	17.2	11.1	14.6	11.5	14.3	17.1	14.3	15.7	17.8	10.6	21.7	22.7	10.7	13.7	17.4	14.9	7.5	15.0	13.6	10.7	2.2	2.3	1.1	4.3	0.4	3.2	1.2	0.3	8.1	7.2	0.7	2.1	4.1	8.3	5.8	3.4	4.4	7.6	0.4	0.1	0.3	12.6	8.6	6.9	5.8	0.0	10.0	3.5	8.3	15.9	0.0	0.5	0.7	0.0	0.3	0.4	10.3	8.8	0.1	0.1	6.0	0.0	9.7	0.1	7.2	0.0	0.5	0.5	0.7	10.2	0.0	0.1	1.1	0.1	0.5	2.3	0.1	0.3	0.4	9.3	0.1	5.0	6.3	0.4	7.8	6.6	8.6	2.9	10.3	0.2	16.0	19.2	3.4	12.3	0.4	0.3	1.0	1.3	0.3	2.4	4.3	1.6	1.5	2.2	1.6	2.3	2.2	3.2	2.6	1.1	0.4	2.9	0.6	0.2	1.2	12.4	15.2	15.4	20.2	10.7	8.2	12.3	10.1	12.7	13.7	14.9	9.9	13.0	4.1	2.5	5.7	6.7	2.5	10.7	4.5	7.0	7.9	10.4	1.7	8.8	2.3	5.8	20.0	0.0	7.4	6.8	3.9	7.1	8.1	15.3	8.2	0.0	12.1	9.2	4.7	1.6	8.6	4.6	6.8	8.2	12.1	6.3	7.9	14.0	5.6	5.1	7.8	0.0	5.0	3.9	8.3	3.1	10.4	7.7	9.0	4.2
SKP1	"EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L"	ENSG00000113558	"S-phase kinase associated protein 1"	P63208	5	134148935-134177038	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB012982, HPA053745, HPA058134"	Approved		Supported	Nucleoplasm,Cytosol		No	No		600000	Nucleoplasm	Cytosol	"CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.40e-1)"	63.7	90.2	101.8	35.1	113.6	59.2	110.3	109.3	152.1	94.0	70.5	78.8	55.7	43.6	73.9	99.3	72.9	84.5	64.4	116.0	112.7	100.7	113.8	83.5	52.8	52.3	109.9	121.7	98.4	44.6	116.8	81.4	83.1	114.2	84.8	69.1	68.5	54.7	113.4	141.7	59.9	55.2	82.3	106.3	47.0	58.8	69.3	79.7	57.5	108.0	82.1	60.9	71.8	58.2	113.5	78.4	136.3	90.7	96.4	157.1	209.1	67.3	52.7	78.5	105.5	121.7	99.4	56.0	78.6	100.0	92.4	95.7	80.8	65.8	49.9	118.0	105.9	105.7	37.7	78.4	118.8	107.7	45.6	55.5	39.3	82.7	57.4	57.4	30.2	48.9	85.0	95.8	80.9	64.1	115.4	98.7	64.7	47.4	44.1	138.1	53.3	65.0	32.4	45.5	64.4	56.7	36.0	84.0	61.1	103.1	75.9	64.3	50.4	106.6	27.3	71.7	106.8	79.0	47.3	74.1	59.7	37.1	62.3	79.6	27.5	45.7	74.2	83.1	57.9	64.6	132.3	83.2	136.3	91.3	78.3	102.0	113.5	131.3	111.8	78.4	99.8	157.1	123.5	78.0	96.4	90.7	69.6	130.2	209.1	101.8	113.6	109.3	152.1	112.7	100.7	109.9	121.7	114.2	79.7	265.0	270.4	263.0	830.1	598.8	220.4	653.1	438.2	570.2	337.8	563.5	68.7	766.8	1437.4	561.3	416.1	363.7	459.0	490.6	329.5	626.8	509.6	661.6	327.0	354.9	416.6	211.4	341.7	300.8	284.1	774.4	556.9	378.1	681.6	669.9	301.7	518.2	333.4	550.6	670.0	1023.7	167.2	498.0	623.8	684.9	643.7	564.2	1126.5	371.9	336.9	686.2
SLA	"hSLAP, SLA1, SLAP, SLAP-1"	ENSG00000155926	"Src like adaptor"	Q13239	8	133036724-133103054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 61.6;lymphoid tissue: 152.5"	"Cell type enhanced"	"Detected in many"	14	"Hofbauer cells: 59.4;Kupffer cells: 193.1;Macrophages: 141.0;T-cells: 117.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 14.1;JURKAT: 59.1;Karpas-707: 37.9;U-266/84: 21.3;U-937: 14.9"	"Group enriched"	"Detected in many"	5	"amygdala: 14.8;basal ganglia: 9.9;cerebellum: 44.5;cerebral cortex: 11.2;hippocampal formation: 11.6"	"Low region specificity"	"Detected in all"			"HPA012296, HPA074192"	Enhanced		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA012296: AB_1856946, HPA074192: AB_2686673"	"unprognostic (1.19e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.73e-3)"	"unprognostic (6.07e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.65e-1)"	6.8	3.6	2.5	21.3	2.7	24.0	2.6	1.6	3.3	2.7	2.2	1.5	1.7	1.6	2.1	1.6	2.4	3.2	5.3	2.6	2.8	1.7	3.2	3.5	11.2	18.2	2.5	2.7	1.7	1.4	0.0	1.4	3.4	2.0	2.1	1.7	1.5	4.0	1.4	1.6	1.3	8.4	2.8	4.1	33.3	2.5	1.6	1.4	152.5	9.2	2.1	18.3	4.3	1.6	11.2	18.4	61.6	31.7	29.2	27.5	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	1.7	14.1	0.2	0.0	0.1	0.0	0.0	0.0	59.1	0.0	37.9	0.0	0.0	10.0	2.4	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	4.6	0.0	0.0	0.1	0.0	0.0	2.0	21.3	0.0	0.2	14.9	0.0	0.1	24.3	45.0	21.2	28.1	26.7	9.5	19.5	21.1	18.4	11.2	18.6	18.9	61.6	29.2	31.7	1.4	27.5	29.6	2.5	2.7	1.6	3.3	2.8	1.7	2.5	2.7	2.0	1.4	8.9	25.0	32.9	0.3	1.9	7.0	2.0	2.5	9.4	19.4	0.0	0.0	0.4	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.7	2.3	0.1	34.8	1.7	59.4	0.0	0.0	11.1	193.1	0.9	0.3	141.0	5.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	6.5	0.9	0.0	0.0	2.4	0.1	117.6	0.0	0.1
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646216	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.7;lymphoid tissue: 36.5"	"Cell type enriched"	"Detected in some"	8	"T-cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"gdT-cell: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9"	"Group enriched"	"Detected in some"	7	"HEL: 41.9;JURKAT: 24.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	2.3	0.8	0.7	15.1	0.8	11.3	1.3	1.5	0.5	1.5	3.9	0.2	2.3	2.8	2.0	1.1	1.7	1.4	4.8	1.6	0.7	0.7	1.5	1.9	6.9	17.1	0.7	0.0	1.6	0.8	0.0	1.1	1.6	0.8	1.5	1.8	1.8	6.3	0.4	0.9	0.7	7.5	1.5	1.1	15.9	2.5	1.0	0.3	36.5	1.5	1.1	18.4	3.8	1.3	0.2	21.7	2.3	0.3	16.5	14.9	11.6	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.2	1.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.1	0.0	0.1	4.9	3.5	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.5	0.0	0.8	0.2	1.6	13.9	0.3	11.7	0.2	11.5	12.9	0.1	0.1	10.8	14.5	2.3	16.5	0.0	21.7	14.9	11.6	0.7	0.8	1.5	0.5	0.7	0.7	0.7	0.0	0.8	0.3	0.0	3.8	0.0	0.1	0.3	0.2	0.3	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.1	0.0	0.2	0.0	0.0	1.3	1.5	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	0.1	0.1	31.9	0.1	0.3
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.6;lymphoid tissue: 51.9"	"Cell type enhanced"	"Detected in some"	15	"B-cells: 8.3;Early spermatids: 9.3;Late spermatids: 16.5;T-cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 33.3;U-698: 49.0"									"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA051363: AB_2681454, HPA051903: AB_2681658"	"prognostic favorable (9.42e-4)"	"prognostic favorable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favorable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favorable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"	3.9	0.8	0.4	21.0	0.4	1.2	1.0	0.4	0.4	1.1	3.8	0.3	0.4	1.1	1.0	0.6	2.3	1.6	2.8	1.2	0.4	0.4	2.1	1.6	4.7	51.9	0.6	0.4	0.6	0.8	0.0	0.6	1.7	0.7	1.4	1.5	1.5	5.6	1.0	0.5	0.7	11.9	0.4	0.8	29.6	2.3	0.9	0.2	12.9	1.8	0.6	30.4	4.1	1.3	15.2	0.3	8.4	1.0	15.9	28.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.0	0.0	8.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.2	49.0	0.0	0.2	0.0	2.5	0.1	8.4	22.9	0.3	15.8	14.7	14.6	28.6	0.1	15.2	8.2	16.4	1.0	15.9	1.0	0.3	16.8	7.4	0.4	0.4	0.4	0.4	0.4	0.4	0.6	0.4	0.7	0.2	0.0	2.2	8.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.8	0.9	0.0	0.0	3.7	3.8	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	20.8	0.0	0.0
SLAMF7	"19A, CD319, CRACC, CS1"	ENSG00000026751	"SLAM family member 7"	Q9NQ25	1	160739057-160754821	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.9;lymphoid tissue: 45.0"	"Cell type enriched"	"Detected in many"	5	"monocytes: 204.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"U-266/70: 80.7"					"Low region specificity"	"Detected in all"			"CAB015445, HPA055945, HPA061654"	Enhanced		Approved	Vesicles		NA	NA		620000	Vesicles		"CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.46e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.57e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-2)"	5.5	1.0	0.7	28.6	0.7	2.3	3.4	0.6	0.7	4.1	11.9	0.2	0.4	11.1	1.9	1.3	6.7	1.6	6.2	1.0	0.7	0.7	2.4	3.1	10.2	24.6	0.8	0.4	2.5	2.2	0.0	0.9	1.3	0.6	1.8	10.2	2.9	15.1	4.8	0.9	2.0	15.8	0.8	1.2	45.0	11.0	1.5	0.4	5.9	2.1	4.2	38.7	11.5	2.6	3.7	27.4	1.1	14.9	17.3	32.9	8.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	2.2	0.0	0.7	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	80.7	6.8	0.0	2.2	0.0	0.0	0.0	1.6	0.3	32.9	11.0	25.4	3.7	3.5	22.4	7.2	0.6	1.1	13.6	1.1	17.3	14.9	27.4	0.0	8.7	0.7	0.7	0.6	0.7	0.7	0.7	0.8	0.4	0.6	0.4	8.9	8.9	20.2	1.4	0.7	0.0	0.8	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	23.3	2.3	0.1	1.1	1.8	8.1	0.0	8.9	0.0	0.0	0.6	6.0	0.0	0.0	12.8	18.6	204.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.2	39.5	0.0	3.0
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	9	"basophil: 51.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 51.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favorable (4.53e-4)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	14.5	14.6	3.6	11.6	5.1	22.5	13.4	5.0	8.1	21.5	15.3	8.1	16.3	10.6	25.0	36.1	22.8	15.4	21.1	19.5	6.0	4.6	17.7	6.7	16.3	14.0	5.8	6.2	32.3	25.7	6.1	12.7	40.1	7.6	23.7	6.4	12.4	11.7	13.3	13.7	26.2	13.6	20.1	5.3	13.1	12.6	11.6	4.7	12.6	15.7	23.3	18.6	23.3	18.3	1.6	2.7	51.2	1.7	2.2	3.8	1.8	24.9	10.7	2.9	14.6	10.1	11.0	19.0	18.6	11.4	12.6	12.7	9.5	12.1	19.0	35.4	17.8	16.8	21.5	9.4	9.5	3.4	12.3	4.4	5.9	14.1	7.5	18.6	7.0	9.6	13.7	10.9	11.7	6.3	11.3	8.6	3.3	6.6	18.7	8.2	33.1	3.8	6.3	2.2	12.2	20.8	6.1	7.7	14.4	9.5	9.3	2.6	4.7	11.7	21.3	4.9	3.5	6.8	5.6	11.3	15.0	9.4	34.8	23.5	13.4	12.9	19.6	16.0	14.7	7.7	51.2	1.3	5.6	3.8	1.7	2.9	1.6	2.6	2.8	1.1	1.6	1.9	1.8	1.7	2.2	1.5	2.7	1.8	1.8	3.6	5.1	5.0	8.1	6.0	4.6	5.8	6.2	7.6	4.7	3.0	6.5	11.7	23.8	20.0	2.0	3.6	7.6	4.0	3.4	17.4	5.9	42.9	6.6	15.3	2.4	14.3	14.4	0.0	17.0	52.6	23.3	12.1	12.7	1.6	17.2	3.2	9.8	18.4	7.8	1.0	25.0	10.5	3.3	16.2	14.0	2.3	15.9	15.3	12.4	7.7	1.6	6.5	22.6	1.2	2.7	24.3	86.2	17.5	10.6	24.7
SLC10A5		ENSG00000253598	"Solute carrier family 10 member 5"	Q5PT55	8	81693607-81696174	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.1;liver: 10.3"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 6.7;Enterocytes: 5.2;Intestinal endocrine cells: 3.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025966	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA025966: AB_1856959"	"unprognostic (6.42e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.71e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.82e-7)"	0.0	0.3	0.9	0.1	2.3	0.0	0.2	5.1	1.8	0.3	2.5			2.9	0.3	0.9	0.2	0.3	1.4	0.1	0.9	2.1	1.8	10.3	0.3	0.0	0.8		0.4	1.0	0.3	1.9	0.0		0.5	3.5		0.3	0.2	0.1	0.4	3.5	0.2	0.3	0.3	3.4	0.0			0.8		0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.7	0.3	0.9	0.9	0.7	1.4	0.7	0.9	0.4	0.3	0.5	0.4	0.5	0.9	1.3	0.2	0.2	0.9	1.1	0.8	1.3	0.7	2.4	1.8	2.6	1.4	0.4	0.1	0.3	0.4	2.2	0.7	1.7	1.5	0.4	0.6	1.6	1.2	1.3	0.7	0.5	1.2	0.4	6.5	0.5	0.3	0.3	0.6	1.2	3.1	2.1	0.9	0.7	0.6	0.3	0.5	1.6	0.6	0.9	1.1	1.5	1.4	1.4	1.5	2.2	0.1	1.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	6.7	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	5.2	0.0	1.0	0.1	0.0	0.2	0.0	2.1	0.0	0.0	3.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.5	1.7	0.0	1.8	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.0	0.4
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.6;lymphoid tissue: 23.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.8;HMC-1: 3.7;NB-4: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	13.5	4.7	4.3	14.9	13.3	11.6	2.6	0.6	9.3	1.7	1.8	4.6	0.0	1.3	1.3	2.1	1.4	4.1	3.0	6.5	15.0	2.6	2.1	3.2	37.6	19.9	17.1	0.7	2.4	3.3	1.2	1.9	6.2	11.3	1.7	1.0	1.7	2.0	1.2	2.0	1.0	1.2	4.6	18.1	23.8	1.7	2.4	10.3	0.0	1.8	0.2	1.0	7.1	1.3	0.4	2.4	6.0	7.9	0.2	0.4	2.6	0.3	0.7	0.0	0.4	0.1	0.1	0.9	0.0	0.0	0.1	0.2	1.0	2.1	0.2	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.7	0.1	3.8	0.6	0.7	0.1	0.0	3.7	0.3	0.1	0.0	0.2	0.3	0.0	1.2	1.0	0.7	0.1	1.3	0.2	3.1	0.0	0.6	0.2	0.2	0.6	0.4	0.1	0.3	0.8	0.2	0.5	0.4	0.4	0.2	0.3	1.1	0.3	0.7	0.4	0.2	0.0	0.3	0.3	0.7	0.2	0.4	0.4	0.3	7.9	0.6	0.4	5.8	0.3	0.1	0.2	0.2	2.4	0.4	0.4	0.3	6.0	0.2	7.0	0.2	0.2	2.6	4.3	13.3	0.6	9.3	15.0	2.6	17.1	0.7	11.3	10.3	20.8	52.4	3.0	3.9	0.8	3.6	6.3	5.1	17.4	22.7	8.7	0.0	1.6	8.3	0.8	1.2	4.7	1.2	0.0	1.8	7.2	2.4	5.7	24.3	4.7	110.2	1.6	1.2	8.6	163.4	0.4	2.0	201.4	1.7	1.0	4.0	7.6	0.6	0.9	0.7	6.8	3.0	19.4	5.0	0.5	1.7	0.9	6.8	1.7	2.2	2.7
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"kidney: 143.2"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 177.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 1.9;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.9"	"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.0	0.0	0.3	0.0	1.0	0.0	0.0	1.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	143.2	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.1	0.0	0.0	0.3	1.0	1.4	1.5	0.1	0.3	0.3	0.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	36.6	0.0	0.0	177.4	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A2	"BSC, BSC2, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189688	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 50.7;salivary gland: 61.2"	"Cell type enhanced"	"Detected in many"	8	"Glandular cells: 203.2;Mucus-secreting cells: 402.7;Undifferentiated cells: 269.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 54.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA020130: AB_1854502, HPA063697: AB_2685094"	"unprognostic (4.61e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (8.60e-4)"	"unprognostic (3.99e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.95e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.88e-3)"	5.5	11.0	10.8	9.4	24.1	2.7	26.2	11.4	18.1	5.1	28.5	37.2	0.0	24.6	5.7	1.9	3.8	4.1	50.7	4.1	15.5	9.9	4.5	2.9	6.5	3.5	36.1	13.5	5.6	5.3	11.2	5.5	3.3	30.0	14.8	36.3	8.5	61.2	2.1	8.5	23.0	28.8	6.6	27.7	2.9	36.3	5.5	26.7	2.0	5.6	6.8	18.3	4.2	3.6	3.6	9.8	0.5	1.2	3.6	3.0	0.4	4.8	24.1	24.8	9.6	6.2	4.0	5.1	4.5	3.4	3.2	3.4	9.6	7.7	7.2	6.1	3.9	2.9	14.7	4.7	5.2	5.0	7.2	5.9	2.0	4.3	1.4	1.9	2.6	3.6	4.2	1.9	7.2	4.3	2.4	5.3	3.1	3.3	4.9	5.0	5.1	4.6	2.2	2.9	55.9	7.9	2.5	7.0	2.9	3.8	16.5	4.4	2.8	9.1	4.0	3.5	2.8	2.2	1.3	8.8	8.1	5.4	6.1	5.7	4.1	3.7	8.0	4.2	1.5	6.5	0.5	0.7	0.2	1.9	1.2	3.0	2.7	1.8	2.3	0.9	3.6	2.0	2.7	0.3	3.6	0.8	9.8	1.6	0.4	10.8	24.1	11.4	18.1	15.5	9.9	36.1	13.5	30.0	26.7	14.9	37.4	13.4	18.3	20.4	45.1	14.0	99.3	10.7	38.7	31.4	119.8	0.9	1.7	45.3	45.7	23.6	29.9	0.0	41.4	2.1	14.8	203.2	18.4	7.4	3.6	76.3	71.5	6.7	7.3	70.8	79.1	10.2	194.0	0.0	402.7	27.8	49.2	77.2	27.3	9.6	76.9	71.1	24.5	27.0	21.5	26.2	1.1	12.1	269.5	16.9
SLC12A4	KCC1	ENSG00000124067	"Solute carrier family 12 member 4"	Q9UP95	16	67943474-67969601	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041138	Approved		Approved	Endosomes		NA	NA			Endosomes		"HPA041138: AB_10794544"	"unprognostic (5.07e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.26e-1)"	16.6	18.3	9.2	8.0	8.8	3.1	26.5	7.0	12.7	19.4	16.5	20.1	12.0	5.1	20.7	9.7	11.8	13.8	15.5	24.4	12.2	5.2	10.7	17.1	19.5	6.6	11.4	8.2	14.2	11.9	30.1	8.1	32.6	18.1	17.8	4.3	23.0	10.5	20.7	14.6	16.9	8.6	27.4	10.0	10.2	10.9	17.6	9.8	8.8	21.0	9.1	8.4	16.5	16.6	1.0	2.4	8.3	5.4	2.7	1.6	1.6	5.0	6.8	5.3	10.0	17.6	15.5	28.6	15.6	16.2	13.5	11.8	13.6	8.2	1.8	7.7	21.5	7.5	9.3	2.5	19.3	10.2	1.8	2.0	1.3	8.9	14.9	20.0	0.1	6.4	17.1	12.7	18.1	6.6	15.8	8.3	3.4	4.1	1.5	18.5	0.8	1.9	5.1	4.0	1.5	3.6	2.0	10.0	1.6	7.4	4.4	0.0	3.2	29.7	1.8	2.6	13.8	14.2	2.0	11.2	19.3	13.7	8.5	6.7	9.3	2.3	3.0	11.2	1.4	16.6	8.3	3.9	2.0	1.5	5.4	1.0	0.4	0.9	0.9	2.4	1.0	0.8	0.7	1.4	2.7	3.8	1.1	1.6	1.6	9.2	8.8	7.0	8.6	12.2	5.2	11.4	8.2	18.1	9.8	14.9	7.8	2.2	12.2	9.0	1.0	25.6	2.5	6.7	10.3	14.0	0.0	24.6	0.0	10.9	2.1	14.3	0.0	0.0	7.1	13.5	13.6	12.7	1.1	7.5	6.9	0.0	0.0	14.1	4.6	1.3	18.4	4.4	10.1	16.2	0.0	21.0	12.7	0.0	34.3	3.4	0.8	38.8	27.6	9.7	6.6	4.5	53.1	1.5	0.0	8.6
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229996-34338060	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 9.4;neutrophil: 18.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 18.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 27.2"					"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	8.7	5.8	7.4	12.4	11.1	27.5	7.0	10.2	14.1	14.7	8.0	12.7	3.6	8.3	6.3	8.7	24.9	4.7	6.3	6.9	6.8	6.9	18.6	4.9	11.5	10.9	9.9	8.4	5.8	5.1	5.4	10.9	5.2	12.5	5.0	7.4	9.7	9.3	4.9	10.5	8.6	10.2	6.0	9.2	11.1	8.0	38.5	10.9	18.2	10.6	8.2	13.6	8.2	21.2	2.0	1.0	18.5	1.4	0.6	2.3	0.7	2.6	3.2	2.0	2.9	6.5	7.6	1.4	4.0	9.3	3.1	4.5	1.8	4.4	1.9	3.7	4.2	2.8	27.2	4.8	3.3	3.7	0.7	3.2	14.6	8.2	4.2	4.0	8.7	16.0	4.4	5.8	9.1	18.4	7.0	9.4	5.2	3.2	4.3	4.2	0.9	0.9	6.9	1.5	2.3	3.5	4.4	3.5	1.8	3.5	6.8	4.4	3.2	4.4	0.1	0.9	4.7	1.9	3.0	5.8	3.6	2.6	12.4	0.9	3.8	4.1	1.2	4.3	6.5	1.5	9.4	1.1	2.3	0.5	1.4	0.3	1.2	0.8	0.7	0.7	2.0	1.3	1.1	18.5	0.6	0.6	1.0	2.3	0.7	7.4	11.1	10.2	14.1	6.8	6.9	9.9	8.4	12.5	10.9	20.8	18.9	18.2	3.9	1.0	12.8	7.4	5.1	5.3	5.7	5.2	80.5	2.5	0.0	4.2	9.2	16.3	10.3	0.0	4.1	1.3	2.0	4.8	4.7	6.7	11.9	7.9	6.4	14.1	38.6	5.3	7.5	14.4	0.0	1.0	7.3	8.0	8.7	12.7	8.1	17.8	54.2	19.4	2.0	38.5	20.4	0.6	0.9	12.8	6.0	20.5
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;thyroid gland: 20.5"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 22.7;granulocytes: 18.4;Mucus-secreting cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.2;OE19: 17.3;U-2197: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031123	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.1	1.1	11.1	0.7	19.4	0.0	2.0	0.8	7.0	1.2	3.0	1.7	0.4	4.9	0.4	2.9	3.5	1.7	8.1	0.5	3.8	1.2	2.1	5.7	1.9	0.4	1.0	3.6	0.5	9.0	8.2	1.9	2.2	8.6	2.5	4.1	6.2	10.0	0.4	1.8	1.0	3.4	0.4	1.3	0.4	3.8	4.6	2.0	0.4	20.5	0.4	0.7	1.9	1.7	0.2	0.2	1.8	0.5	0.0	0.2	0.0	8.2	0.0	1.4	0.0	1.7	2.4	4.1	0.4	1.0	0.4	0.9	10.7	3.9	0.0	1.0	3.7	1.4	5.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	18.2	0.0	0.6	4.7	5.0	1.4	0.5	9.7	0.0	0.0	0.0	0.3	0.6	2.2	0.0	0.0	5.7	17.3	0.4	0.0	0.1	0.0	4.2	0.6	2.4	0.0	4.8	5.1	0.1	0.6	9.1	0.2	0.1	0.1	0.7	35.3	0.0	0.1	1.0	2.7	1.7	0.0	0.7	1.8	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	19.4	0.8	7.0	3.8	1.2	1.0	3.6	8.6	2.0	0.0	0.3	0.0	1.1	0.9	0.0	1.0	0.0	0.0	1.2	22.7	0.0	0.3	0.0	3.9	0.2	0.0	2.0	0.0	2.9	6.2	1.3	5.0	18.4	6.4	0.8	0.0	5.2	0.0	0.0	0.0	0.0	0.6	0.0	3.6	28.6	0.0	4.3	2.9	0.0	1.1	0.0	0.0	0.3	0.7	0.4	0.3	2.5	0.0	5.0	0.9
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684713-6713567	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	65	"liver: 150.4;salivary gland: 153.9"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 374.3"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	61	"Hep G2: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	0.8	1.0	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0.0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0.0	0.0	0.0	7.0	0.6	0.5	0.2	0.6	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	23.3	0.4	0.1	0.0	0.3	0.0	374.3	0.0	0.0	0.0	15.4	21.0	0.0	0.6	0.3	0.0	0.0	0.0	7.4	9.8	0.0	0.0	0.0	1.4	0.0	0.0	0.9	1.5	0.4	0.1	0.0	0.0	0.2
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752654	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 134.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 30.1;SK-BR-3: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	51.7	0.2	0.3	42.7	1.9	2.2	0.9	0.1	16.6	0.1	0.1	0.1	6.3	8.2	0.2	0.1	0.1	0.1	0.2	7.1	4.3	0.3	1.0	0.3	0.9	0.5	0.2	0.3	0.3	0.1	9.9	134.9	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.7	0.4	0.5	1.9	1.1	1.1	2.3	0.7	1.2	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.9	30.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	6.8	0.0	0.0	0.0	1.7	1.7	0.6	0.1	0.3	0.0	29.9	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.7	0.9	0.3	0.8	0.8	0.7	0.7	0.2	1.1	0.9	0.8	2.2	1.2	0.4	1.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.4	30.6	1.4	2.3	1.8	0.0	0.0	1.7	9.1	0.0	0.0	51.2	0.0	0.7	0.0	0.0	0.8	0.0	29.9	0.1	0.0	3.5	0.6	0.3	0.0	0.0	0.0	1.7	0.0	1.7	0.0	2.9	5.8	0.0	9.8	0.0	0.0	0.2	0.0	0.2	0.6	0.1	0.0	1.7	0.3
SLC15A4	"PHT1, PTR4"	ENSG00000139370	"Solute carrier family 15 member 4"	Q8N697	12	128793191-128823983	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 67.3;Late spermatids: 84.4;Muller glia cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016713	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016713: AB_1856978"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (5.14e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.56e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.57e-1)"	12.7	7.0	6.6	11.4	7.3	17.6	10.7	8.7	10.2	11.6	8.8	16.0	4.2	5.4	17.2	5.7	9.1	12.3	10.0	9.8	8.4	5.0	8.1	20.4	10.9	14.8	13.8	6.6	10.4	8.2	8.4	6.2	8.8	9.7	7.4	5.4	16.1	8.4	8.8	35.1	9.7	8.2	12.2	10.2	12.2	7.9	27.8	10.1	29.7	9.1	7.3	17.8	11.9	10.5	2.0	20.1	12.1	2.4	4.2	5.0	1.7	6.2	10.3	2.6	5.7	23.4	15.2	9.7	10.9	9.2	7.9	9.0	4.6	9.1	22.8	5.7	9.5	7.9	7.1	7.2	6.7	8.6	11.1	6.6	3.1	6.2	8.2	24.4	10.5	3.3	9.8	12.4	6.5	17.2	23.5	5.4	4.6	5.1	14.4	16.0	4.3	5.4	2.7	9.3	6.8	6.0	4.6	5.7	8.8	15.2	8.0	4.7	3.9	4.4	8.4	11.6	7.4	11.3	2.9	8.1	8.7	4.9	4.3	6.6	4.8	10.6	10.5	11.7	7.4	0.1	0.0	1.8	4.4	5.0	2.4	2.5	1.9	0.9	2.9	1.1	2.0	1.0	2.5	12.1	4.2	1.0	20.1	0.4	1.7	6.6	7.3	8.7	10.2	8.4	5.0	13.8	6.6	9.7	10.1	17.9	10.1	9.7	6.1	9.2	10.3	8.3	5.1	0.0	6.8	21.0	11.8	4.5	1.7	21.0	67.3	4.8	5.5	0.0	9.4	4.8	9.8	7.2	11.5	16.3	18.7	14.3	10.4	13.5	21.5	84.4	11.5	18.6	23.6	19.0	4.3	87.4	19.6	4.9	12.7	3.7	15.6	6.5	9.2	8.0	10.6	8.0	3.3	19.2	6.1	6.0
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.1;skeletal muscle: 33.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 26.2;Melanocytes: 42.2"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 29.4;HEK 293: 12.7;RPMI-8226: 24.2"	"Low region specificity"	"Detected in many"							HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	7.6	4.9	1.8	2.4	5.4	0.4	1.1	9.5	2.0	0.8	4.8	1.7	1.7	7.6	0.7	1.6	0.7	1.1	1.0	2.8	1.8	1.0	8.1	9.8	6.1	1.8	0.8	0.5	1.2	25.1	8.9	1.5	17.4	5.6	1.2	1.3	3.6	3.5	6.0	33.4	12.1	6.0	0.8	1.0	2.7	3.9	3.5	0.8	19.6	2.2	1.5	0.9	4.4	1.4	0.5	0.3	0.8	0.2	0.3	4.7	0.3	0.6	0.6	0.2	1.3	0.0	0.0	2.4	0.0	0.1	0.5	0.8	5.1	0.2	4.1	0.9	0.1	1.4	0.0	29.4	0.0	0.5	0.1	12.7	4.7	0.3	4.8	0.0	5.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.8	0.1	0.0	2.0	6.2	0.7	9.0	0.1	1.9	3.5	4.3	24.2	0.0	0.4	6.8	2.1	0.1	0.6	1.1	2.3	1.2	0.8	0.0	0.1	1.1	0.3	1.6	2.0	0.0	1.1	0.2	3.8	0.5	0.8	0.2	0.1	0.2	0.2	0.2	0.2	1.1	0.3	0.0	0.5	4.7	4.0	0.8	0.3	0.1	0.3	4.0	0.3	1.8	5.4	9.5	2.0	1.8	1.0	0.8	0.5	5.6	0.8	8.9	26.2	0.9	10.0	8.7	6.2	7.7	0.0	1.4	5.7	5.2	2.0	1.1	1.7	0.1	7.2	0.7	3.9	0.0	11.1	1.7	2.5	2.8	1.1	19.7	20.5	1.6	6.3	5.5	13.5	5.2	0.0	14.3	42.2	1.0	2.8	1.7	3.1	0.0	0.0	15.2	0.6	0.0	1.0	9.8	9.8	12.9	1.0	0.5	5.0	0.9
SLC16A12	MCT12	ENSG00000152779	"Solute carrier family 16 member 12"		10	89430299-89556641	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 28.0;kidney: 55.6"	"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 25.0;Peritubular cells: 25.1;Proximal tubular cells: 55.2"	"Cancer enriched"	"Detected in many"	10	"renal cancer: 18.0"	"Region enriched"	"Detected in many"	6	"pons and medulla: 11.7"	"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.8;HSkMC: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037587			Approved	Mitochondria		NA	NA			Mitochondria		"HPA037587: AB_2732475"	"unprognostic (5.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (4.50e-12)"	"unprognostic (3.84e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.84e-3)"	2.3	1.3	1.0	0.1	0.7	0.0	2.4	1.3	0.6	4.9	1.6	2.6	6.2	0.1	2.0	28.0	0.5	2.2	0.1	4.0	1.8	0.8	55.6	1.0	3.3	0.1	0.8	0.3	1.8	13.3	0.0	5.0	5.9	11.7	1.4	0.1	16.3	0.9	7.9	4.4	1.1	0.8	0.5	0.6	0.1	1.7	2.4	0.3	0.0	3.8	0.7	0.0	1.8	1.5	0.7	0.5	1.8	0.3	0.9	0.3	0.0	0.2	0.0	0.1	0.1	3.0	22.8	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.1	3.7	0.0	0.0	8.1	0.2	1.1	1.4	1.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.8	0.0	2.7	0.1	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.0	0.7	0.2	0.3	0.8	0.9	0.1	0.5	0.0	0.0	1.0	0.7	1.3	0.6	1.8	0.8	0.8	0.3	11.7	0.3	3.0	3.8	0.0	1.5	0.0	0.0	2.0	2.5	8.1	4.5	14.0	0.0	14.3	13.3	0.0	3.0	1.1	0.0	0.0	3.7	0.6	1.1	0.8	1.1	1.7	1.1	3.2	17.4	0.6	0.0	3.0	25.0	1.0	0.0	0.0	0.0	0.0	3.5	0.0	25.1	55.2	0.3	12.9	1.4	0.1	0.2	0.3	7.6	0.0	0.0	1.4
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036075-7040121	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 55.9"	"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 5.2;Hepatocytes: 6.8;T-cells: 4.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 16.9;GAMG: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	2.5	1.3	1.4	3.5	0.8	0.2	1.6	1.5	1.0	1.8	4.9	0.7	1.2	8.0	1.1	1.4	5.0	1.5	3.2	1.3	1.2	0.7	12.0	55.9	2.9	7.6	0.8	0.5	1.7	2.8	2.7	1.0	3.3	0.7	1.5	1.3	1.8	3.5	1.5	0.5	4.5	10.2	0.7	0.6	4.8	1.6	0.7	0.3	3.6	3.0	2.4	5.8	1.8	2.4	6.8	2.8	2.4	2.2	2.7	3.9	1.3	9.5	16.9	4.0	2.4	2.5	1.4	1.7	1.0	2.5	2.2	5.0	5.4	10.7	6.1	1.6	1.5	20.0	15.0	3.1	5.2	0.9	7.5	2.1	2.5	1.3	13.0	2.8	0.8	5.8	1.6	6.0	3.3	2.7	2.9	8.9	5.5	2.8	1.7	2.3	4.7	3.6	1.5	1.6	4.9	1.3	1.7	1.4	1.0	2.1	2.7	0.1	1.1	3.0	1.7	1.3	6.2	4.6	1.3	3.3	1.4	3.3	2.3	1.4	3.0	6.3	0.3	4.1	2.2	0.6	0.0	2.0	2.2	3.2	1.9	2.3	2.3	2.9	3.9	2.1	6.8	3.1	2.9	2.4	2.7	2.2	2.8	3.0	1.3	1.4	0.8	1.5	1.0	1.2	0.7	0.8	0.5	0.7	0.3	0.0	1.0	2.2	0.7	0.5	0.1	0.3	0.0	1.4	0.0	5.2	0.0	1.6	0.0	0.8	0.0	1.8	1.5	0.0	0.2	0.4	0.4	0.7	3.5	6.8	0.4	3.2	0.0	2.5	0.3	0.0	0.9	1.7	0.0	1.0	0.3	0.9	0.5	0.0	0.0	1.0	0.4	0.0	0.4	0.0	0.0	1.4	2.1	4.3	0.4	0.9
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034974-230068999	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 4.5;Suprabasal keratinocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 12.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 16.7;Karpas-707: 11.5;REH: 14.3;RPMI-8226: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	5.4	5.2	7.0	2.2	11.1	6.6	4.0	14.4	16.2	6.5	4.6	3.2	1.1	1.3	4.9	3.2	5.3	4.1	3.6	3.0	6.9	8.2	1.7	2.5	2.5	1.6	6.2	8.2	10.2	1.1	12.4	1.9	1.6	6.7	5.9	5.0	12.0	20.5	4.7	1.3	13.4	1.6	4.9	4.4	10.1	1.8	2.0	1.3	1.1	2.0	3.4	3.3	3.8	4.8	0.4	0.5	12.0	0.0	0.1	0.4	0.1	2.1	1.3	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.4	3.7	1.1	0.1	0.0	6.3	0.1	2.5	0.0	0.2	16.7	0.0	0.4	2.9	0.0	0.0	3.1	0.1	3.4	0.0	11.5	0.2	0.0	1.6	2.1	0.8	0.2	2.0	14.3	0.0	12.9	4.4	1.9	4.8	1.5	3.5	0.0	0.1	0.0	5.7	1.5	0.0	0.0	0.9	2.4	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.4	0.0	0.3	0.4	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	7.0	11.1	14.4	16.2	6.9	8.2	6.2	8.2	6.7	1.3	0.0	0.0	0.0	0.6	2.3	2.9	3.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	4.5	0.0	0.0	0.5	0.0	0.8	0.8	0.0	1.0	0.1	3.2	3.5	3.1	0.3	0.0	1.1	0.0	1.7	0.0	0.0	1.8	0.7	0.0	2.8	0.5	1.1	0.0	1.0	0.2	0.2	4.1	0.2	0.0	1.6	0.2
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421461-74533917	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.6"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 50.8;Peritubular cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BJ: 34.4;GAMG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA072719: AB_2686552"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (3.16e-4)"	13.5	24.4	10.9	5.4	12.2	0.7	4.9	5.9	14.3	9.9	5.5	8.4	1.8	4.1	9.4	2.7	5.2	6.7	10.5	10.7	8.0	5.9	9.4	43.6	6.0	1.6	4.2	8.0	14.7	6.6	12.7	12.6	10.0	8.2	9.2	2.6	11.1	5.8	7.0	3.5	2.2	3.0	7.6	4.1	1.9	4.2	1.8	5.1	6.4	13.6	4.3	3.0	5.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.2	4.0	2.9	16.6	7.9	4.2	0.0	34.4	10.6	14.0	8.0	0.0	0.3	0.0	0.5	13.3	27.0	0.6	0.4	14.6	8.2	2.3	1.3	0.0	0.0	0.0	0.6	0.0	0.0	6.2	3.5	7.2	8.5	5.3	0.0	0.0	0.0	0.0	3.2	0.0	0.2	1.0	11.0	0.0	3.0	6.6	7.9	0.0	6.9	0.0	0.7	5.1	3.8	19.3	0.1	1.0	0.2	0.4	0.0	13.6	3.6	14.9	17.1	0.0	0.0	0.0	15.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	12.2	5.9	14.3	8.0	5.9	4.2	8.0	8.2	5.1	0.0	1.1	0.0	3.2	0.7	4.5	3.5	5.1	4.0	3.4	3.5	0.0	4.2	3.3	3.7	0.0	2.7	0.0	0.0	2.1	2.7	4.8	3.2	2.3	50.8	0.8	3.2	8.1	2.5	1.5	0.0	14.1	0.0	3.3	1.0	0.0	6.1	3.1	0.0	19.4	5.4	1.1	12.9	5.6	0.1	0.0	1.1	1.7	0.0	0.0	4.8
SLC16A3	"MCT3, MCT4"	ENSG00000141526	"Solute carrier family 16 member 3"	O15427	17	82228397-82261129	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 1393.3;Syncytiotrophoblasts: 626.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB017490, HPA021451"	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear membrane"	"CAB017490: AB_2189333, HPA021451: AB_1853663"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-3)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (1.19e-7)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.71e-7)"	"unprognostic (2.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.36e-2)"	10.4	4.8	3.9	16.9	5.2	11.2	8.8	1.0	5.2	8.0	10.5	3.8	1.7	8.0	4.8	4.7	12.4	5.0	10.4	7.4	4.1	3.8	10.9	3.7	19.0	14.2	9.6	0.6	8.3	3.9	1.4	3.6	36.7	8.4	6.9	4.3	42.9	8.1	4.8	81.2	2.1	8.0	4.5	8.0	17.3	13.9	12.7	6.9	3.9	8.7	7.3	11.0	13.0	7.4	3.7	10.3	40.4	12.4	9.9	6.2	5.4	11.5	5.8	0.1	0.1	2.6	8.3	11.5	48.2	29.7	34.3	38.9	2.7	30.2	0.1	38.0	34.0	29.7	4.1	4.1	69.9	14.4	20.7	0.2	22.0	42.9	50.4	44.2	32.3	27.2	17.1	10.3	23.0	10.6	45.1	18.6	0.4	0.1	6.8	29.7	3.1	0.3	31.8	0.4	4.8	47.0	0.1	0.5	7.6	18.1	0.5	0.7	0.3	46.4	41.3	0.6	4.8	6.0	27.2	32.2	68.4	1.1	1.0	50.3	22.1	0.3	1.0	33.5	20.4	0.6	17.5	12.4	34.6	4.1	11.7	6.2	3.7	3.5	4.6	10.3	2.8	1.8	2.2	40.4	9.9	11.8	6.1	3.0	5.4	3.9	5.2	1.0	5.2	4.1	3.8	9.6	0.6	8.4	6.9	8.9	12.7	14.3	34.8	5.8	9.7	4.8	7.6	14.7	14.8	54.1	3.9	56.0	0.0	116.4	3.0	22.8	93.3	0.0	16.0	1393.3	24.4	12.4	75.9	0.8	262.7	120.8	20.1	17.2	103.7	2.7	2.8	101.0	13.5	232.6	23.8	21.4	199.4	84.2	3.5	3.8	7.4	0.0	14.7	1.6	7.1	5.8	626.2	40.6	16.6	118.3
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362848-110391082	"Predicted membrane proteins"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.4;placenta: 76.5"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 68.0;Proximal tubular cells: 176.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.0"	"Group enriched"	"Detected in many"	4	"B-cells: 5.0;granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	3.8	2.4	1.9	2.1	2.8	0.6	3.4	2.3	1.7	2.7	4.5	2.9	2.7	4.7	2.3	11.9	4.3	2.4	9.6	4.0	2.6	2.1	61.4	7.9	6.1	1.4	2.7	1.4	21.3	0.8	0.5	3.5	76.5	6.9	3.7	0.9	17.3	1.9	3.2	1.1	0.8	14.0	1.8	3.6	2.0	2.5	4.0	1.8	0.0	8.0	1.3	1.3	3.1	3.0	5.0	0.1	1.3	0.6	0.0	0.7	0.3	0.2	5.5	1.2	1.8	4.0	7.8	11.6	3.0	11.7	1.0	2.9	1.7	17.3	0.3	3.3	9.4	0.1	0.3	0.0	1.1	1.1	0.3	1.4	0.3	1.1	1.7	11.6	0.3	0.3	5.7	0.1	1.7	0.1	25.2	2.4	0.4	0.2	0.6	1.9	0.5	0.2	0.3	0.3	0.0	0.2	0.1	0.8	0.1	2.0	0.2	0.7	0.4	0.3	5.6	17.8	5.6	0.3	0.0	0.2	0.7	0.4	0.2	0.8	0.3	0.0	0.9	0.6	0.2	3.2	0.0	0.6	0.3	0.5	0.2	0.2	5.0	0.6	0.1	0.1	1.0	0.6	0.7	1.3	0.0	0.2	0.0	0.2	0.3	1.9	2.8	2.3	1.7	2.6	2.1	2.7	1.4	6.9	1.8	11.9	17.3	3.2	5.2	2.7	11.1	1.1	15.3	0.0	5.7	68.0	5.9	28.5	3.3	2.9	0.4	4.4	1.3	23.3	0.8	29.3	13.9	2.7	4.7	4.5	3.7	3.2	3.4	3.1	1.0	1.1	16.7	0.8	10.1	1.0	0.9	2.3	1.3	0.2	11.0	176.8	17.7	0.0	5.2	3.0	2.0	3.1	29.4	4.6	0.5	5.0
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.5"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 21.6;Kupffer cells: 17.4;Rod photoreceptor cells: 39.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	13	"SK-MEL-30: 107.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA054459: AB_2682494, HPA066328: AB_2685660"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	7.8	3.4	3.0	6.6	6.3	8.1	6.2	3.7	6.2	2.2	0.8	3.1	9.8	0.9	2.8	32.5	12.4	1.5	1.6	1.4	3.2	4.2	0.9	1.4	9.7	4.6	4.7	1.4	1.8	1.2	0.4	2.4	2.4	6.9	0.8	1.0	13.0	3.5	11.0	10.3	4.2	1.2	0.9	2.7	6.3	1.1	2.2	0.9	1.5	3.3	6.6	7.9	3.7	3.3	0.6	2.7	8.5	4.7	1.1	2.9	1.2	0.4	0.3	0.1	0.1	0.1	0.1	3.1	0.1	3.9	0.3	0.2	0.1	0.5	3.5	0.3	0.0	0.0	0.1	0.6	0.0	0.1	1.0	0.2	0.2	0.4	4.5	0.7	1.2	0.2	0.1	0.0	0.2	0.2	0.3	0.1	0.5	0.2	0.8	0.0	3.9	1.6	0.7	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.3	0.8	0.0	0.1	2.1	107.0	0.8	3.1	0.7	0.5	1.2	0.2	0.1	0.3	0.8	3.1	3.2	8.1	0.9	0.5	1.1	4.7	0.3	2.9	4.4	1.5	0.6	1.2	2.3	2.7	0.3	0.8	1.6	8.5	1.1	2.2	0.6	2.6	1.2	3.0	6.3	3.7	6.2	3.2	4.2	4.7	1.4	6.9	0.9	0.0	4.5	0.8	0.1	0.2	4.8	0.6	0.0	2.7	6.8	8.7	21.6	0.1	0.0	0.0	0.5	0.9	0.0	0.0	0.0	8.6	0.9	0.2	1.1	0.0	5.5	0.0	0.0	1.3	17.4	0.0	0.0	12.8	10.1	1.0	0.0	5.8	0.0	0.0	1.8	0.2	39.6	0.0	0.1	1.6	0.4	0.4	0.3	5.7	0.0	0.0
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 70.9"	"Cell type enhanced"	"Detected in some"	9	"Leydig cells: 4.0;Melanocytes: 5.0;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;RT4: 4.5;SiHa: 6.5;T-47d: 7.8;U-266/70: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075017	Enhanced		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA			"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	1.6	2.6	1.9	0.8	5.1	1.2	0.8	0.8	3.3	0.8	0.8	0.8	0.8	0.5	1.3	0.8	1.1	1.2	2.7	2.9	2.7	2.9	0.8	0.8	0.8	0.9	2.8	0.8	0.8	2.1	0.0	2.6	0.8	1.3	4.0	0.0	70.9	10.0	0.8	1.9	4.2	0.8	0.8	3.7	1.8	2.3	2.0	0.8	0.8	0.9	0.8	0.8	1.6	0.8	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.4	0.7	1.2	0.2	0.0	0.0	6.1	0.5	0.0	0.0	0.0	1.3	3.5	0.4	1.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.9	0.3	1.0	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	1.6	0.0	4.0	0.0	0.0	1.4	0.1	0.1	2.0	0.0	0.0	0.0	4.5	2.0	0.3	6.5	0.3	1.0	0.6	7.8	0.2	0.0	0.0	3.6	0.3	0.0	11.5	1.6	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	5.1	0.8	1.2	2.7	2.9	2.8	0.8	1.3	0.8	0.0	0.0	0.0	0.5	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	0.0	0.0	1.3	0.3	1.6	4.0	0.0	5.0	0.0	0.0	0.9	0.2	0.0	2.1	0.0	0.5	0.0	0.9	0.9	4.1	0.6	0.0	0.0	0.0	0.1
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650761-59736002	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 58.0;kidney: 70.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 218.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	0.7	58.0	5.7	2.0	4.6	0.7	0.9	9.9	4.4	8.2	4.6	9.6	1.6	0.3	12.6	2.2	5.3	8.6	3.3	1.4	10.0	2.6	70.9	1.1	0.6	0.8	6.7	5.5	13.4	1.3	11.8	6.4	0.2	8.2	3.2	6.4	5.2	1.6	4.2	9.2	0.5	0.8	3.0	6.0	14.3	2.4	3.4	6.5	0.0	11.2	4.4	3.1	0.9	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	4.2	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.7	8.7	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.1	1.8	0.0	0.4	0.1	0.0	2.3	0.1	0.3	4.4	6.1	0.1	0.4	3.3	2.3	0.0	16.4	1.6	7.5	2.7	0.2	5.7	0.0	0.2	2.8	7.9	0.1	0.3	0.0	8.8	2.8	3.6	2.6	0.4	0.9	0.1	8.3	0.0	0.0	0.0	0.0	14.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.7	4.6	9.9	4.3	10.0	2.6	6.7	5.5	8.2	6.5	0.0	0.0	0.0	1.1	0.1	4.7	2.8	0.0	4.0	9.1	7.0	0.0	0.0	21.6	0.7	0.1	0.0	17.7	0.0	0.0	0.8	1.2	12.7	0.0	0.0	0.1	3.2	19.3	0.0	10.5	0.4	12.7	0.0	3.3	1.0	15.5	11.2	0.2	30.3	11.3	218.2	0.8	0.0	2.8	0.3	0.1	0.1	0.0	0.0	12.8	5.7
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782897-25832059	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	56	"kidney: 67.6;liver: 17.9"	"Cell type enriched"	"Detected in some"	4	"Proximal tubular cells: 44.6"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	389	"RPTEC TERT1: 38.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050513			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	67.6	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	44.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73654155	"Disease related genes, Predicted membrane proteins"	"Amino-acid transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 155.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.7;ASC TERT1: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	7.2	5.8	6.4	2.9	6.8	2.9	9.6	6.3	6.8	4.9	7.8	4.7	12.5	6.5	5.1	17.2	5.0	3.4	6.2	6.2	4.5	6.7	24.3	13.2	7.6	4.9	5.0	4.5	3.4	8.7	155.6	9.3	12.6	6.7	6.9	8.6	6.6	15.5	8.6	3.5	4.8	12.9	4.6	5.9	4.3	6.0	4.1	4.7	3.0	30.5	2.6	7.1	5.9	4.3	5.2	9.9	12.4	10.6	12.0	9.4	6.0	2.8	3.8	3.9	6.2	41.7	31.1	5.2	9.3	23.5	2.5	8.9	2.5	6.9	2.6	4.5	13.1	5.9	5.0	5.4	2.3	4.5	1.8	6.3	1.1	2.1	5.9	8.4	2.1	4.4	14.2	3.5	5.7	4.0	10.7	6.4	3.5	2.7	2.9	8.8	1.9	0.8	1.2	2.8	11.9	2.3	1.9	4.8	11.1	6.6	7.9	1.5	2.7	1.9	5.6	5.4	6.0	2.5	13.2	9.3	1.2	1.1	5.0	2.2	8.2	11.4	0.7	4.2	4.6	3.7	12.4	10.6	4.2	8.5	9.7	8.3	5.2	9.4	8.1	9.9	3.7	7.8	8.6	7.4	12.0	6.0	7.4	8.2	6.0	6.4	6.8	6.3	6.8	4.5	6.7	5.0	4.5	6.7	4.7	20.8	20.2	7.8	12.1	8.5	7.8	5.3	15.3	14.7	9.1	48.8	27.5	14.4	3.3	12.2	27.9	15.0	21.9	0.0	11.9	12.0	22.1	30.0	13.9	31.0	53.7	0.0	11.6	25.8	26.5	32.1	6.9	22.4	10.1	7.2	42.3	7.3	16.7	17.5	10.6	30.8	24.7	0.0	8.0	11.1	2.3	9.8	19.1	7.9	15.0	18.6
SLC17A9	"C20orf59, FLJ23412, VNUT"	ENSG00000101194	"Solute carrier family 17 member 9"	Q9BYT1	20	62952647-62969585	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Exocytosis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 42.7"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 28.5;Hepatocytes: 35.4;Hofbauer cells: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 16.0;CACO-2: 14.8;Hep G2: 30.7;NB-4: 16.5;RPMI-8226: 15.9;U-937: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047470			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047470: AB_2680060"	"unprognostic (2.65e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-3)"	"unprognostic (5.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (2.78e-15)"	"unprognostic (6.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	4.2	1.3	1.6	11.4	3.4	11.9	2.2	0.4	1.4	1.9	4.8	0.6	0.1	6.4	1.7	1.2	1.5	2.1	7.3	1.5	1.5	0.7	1.5	42.7	5.7	6.6	4.8	0.0	1.9	3.4	0.0	2.5	1.9	3.4	1.6	3.8	1.1	3.6	1.2	3.4	0.9	3.9	1.4	3.9	10.5	10.7	0.8	2.9	0.5	1.4	0.5	11.8	5.6	2.4	4.0	4.2	0.0	2.7	7.3	1.3	1.2	0.0	0.0	0.0	0.1	0.1	1.3	0.0	16.0	4.6	5.3	8.4	14.8	0.0	11.5	0.0	12.8	0.0	0.0	2.3	0.0	1.2	0.0	0.0	5.0	0.4	30.7	3.6	9.0	0.0	1.2	0.0	6.3	0.0	0.0	3.4	0.0	0.0	6.7	0.0	0.0	0.3	16.5	0.0	5.7	0.0	11.9	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	1.1	0.0	0.0	0.5	0.0	2.3	0.1	6.2	0.0	19.4	0.0	0.0	1.6	0.0	1.3	2.7	0.9	4.0	0.0	0.6	4.2	3.2	0.0	0.6	0.0	7.3	0.6	0.0	0.1	1.2	1.6	3.4	0.4	1.4	1.5	0.7	4.8	0.0	3.4	2.9	0.0	0.6	28.5	0.0	0.8	0.2	1.2	12.7	0.0	1.2	0.0	0.0	0.3	0.0	0.2	0.6	0.7	1.6	0.0	0.3	0.6	5.8	0.5	4.7	35.4	16.2	0.0	2.9	2.5	4.0	0.0	1.1	9.1	5.0	1.0	7.7	0.0	1.1	0.0	0.7	0.0	0.0	0.0	3.1	0.3	0.9	1.0	0.7	4.1	9.1	0.4
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132798553	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 48.4;Hofbauer cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029747, HPA049659"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA029747: AB_10600797, HPA049659: AB_2680843"	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favorable (3.55e-4)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.3	7.3	26.2	6.0	21.9	4.5	11.0	13.1	20.6	9.4	9.5	18.8	3.1	14.4	7.0	7.8	10.7	10.1	11.5	4.2	21.6	15.8	11.8	6.0	5.7	7.2	19.5	10.8	7.4	7.8	13.0	6.9	15.5	17.0	5.0	11.4	7.4	11.7	4.9	4.8	10.5	10.4	5.8	21.7	7.0	14.9	2.3	16.3	8.3	10.1	5.9	8.6	10.6	5.5	7.5	15.6	0.6	11.3	2.8	9.4	6.5	4.0	3.8	6.5	0.0	0.8	2.4	4.0	1.4	4.5	2.9	9.3	8.4	8.3	0.1	5.8	0.9	5.1	11.3	8.8	9.9	2.3	5.9	16.6	2.1	7.0	10.2	5.0	1.9	0.2	6.5	9.5	4.6	10.0	5.9	9.3	13.2	23.7	1.6	2.4	5.7	6.1	0.2	8.6	9.0	5.4	9.8	7.1	6.6	24.1	7.1	13.1	0.0	7.8	15.5	12.4	3.9	5.3	0.0	4.3	1.3	3.4	1.3	3.8	5.1	0.4	0.2	7.1	0.2	1.0	0.0	11.3	0.5	3.7	2.5	6.7	5.5	5.7	5.2	15.6	7.5	8.2	5.6	0.6	2.8	0.2	12.1	9.4	6.5	26.2	21.9	13.1	20.6	21.6	15.8	19.5	10.8	17.0	16.3	0.0	6.2	5.9	8.2	9.0	4.1	2.6	48.4	12.0	10.3	26.2	2.0	41.0	8.3	26.3	0.1	5.1	3.9	0.0	13.2	16.4	5.1	7.2	0.0	11.9	51.1	0.0	15.6	22.1	19.4	0.0	6.4	7.8	13.5	2.8	11.9	8.5	15.1	3.5	4.2	5.0	3.3	0.0	3.3	0.2	0.4	9.5	23.8	4.9	16.6	11.5
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45544411	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 133.1;Syncytiotrophoblasts: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 37.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 37.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	9.0	7.8	7.1	8.2	13.5	10.5	12.5	9.6	8.9	5.0	9.7	6.0	9.4	31.2	4.3	4.6	2.3	4.6	3.5	3.2	7.1	6.1	4.7	14.1	13.9	14.1	8.7	4.4	8.1	5.4	1.8	3.5	32.9	11.5	4.7	2.0	17.8	6.0	3.5	3.5	6.1	16.5	2.3	5.9	11.7	5.7	3.4	3.4	11.8	9.6	2.8	4.1	3.1	3.1	0.9	4.9	37.6	6.4	0.4	1.1	2.4	10.6	9.7	1.9	7.9	0.6	0.8	15.9	5.0	0.8	4.6	2.9	22.4	9.9	9.9	9.9	1.2	3.9	5.5	3.9	3.6	1.1	9.1	19.3	20.8	5.2	15.5	2.7	13.5	3.2	1.0	2.8	4.9	1.6	1.3	3.8	10.6	24.8	4.3	1.6	11.9	18.3	12.6	11.4	4.7	11.3	25.0	2.2	28.7	2.1	6.4	11.8	10.4	5.6	9.3	4.3	2.7	7.0	16.0	4.6	6.0	7.5	1.6	8.1	1.8	6.6	9.0	2.7	22.1	4.8	0.6	6.4	8.5	0.3	6.0	1.1	0.9	0.5	0.7	4.9	0.3	0.8	0.5	37.6	0.4	3.7	1.5	1.0	2.4	7.1	13.5	9.6	8.9	7.1	6.1	8.7	4.4	11.5	3.4	44.7	4.6	0.8	1.7	2.2	18.0	2.4	2.5	1.4	10.3	0.0	0.0	133.1	0.0	7.8	3.3	2.8	9.3	0.0	4.2	16.2	2.9	3.6	1.1	10.9	24.0	7.9	0.0	1.8	11.6	3.2	6.1	5.9	3.3	0.0	3.1	8.6	6.8	5.3	10.6	1.9	3.6	0.0	3.8	1.2	4.1	1.4	303.1	2.2	7.6	0.9
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169486003	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.7"	"Cell type enhanced"	"Detected in many"	12	"Suprabasal keratinocytes: 44.2;Syncytiotrophoblasts: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favorable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	23.1	11.1	1.9	5.3	4.4	4.8	14.2	7.4	6.1	5.9	5.4	2.8	2.7	2.1	5.0	9.0	7.5	10.0	17.5	14.8	2.7	2.1	8.6	23.4	9.2	3.1	2.8	1.7	10.3	14.4	6.8	16.3	22.1	4.7	9.4	2.8	16.4	10.4	4.6	75.7	7.5	6.6	11.3	3.7	1.8	9.4	7.3	1.8	3.6	7.9	21.6	3.9	10.4	9.8	1.4	1.9	3.0	4.6	2.6	3.3	0.7	4.5	3.2	7.3	5.7	22.8	8.4	16.2	3.6	2.7	3.0	4.2	13.1	4.8	4.0	4.2	2.4	5.5	4.9	8.8	5.4	3.3	11.5	8.2	3.8	10.4	11.9	12.4	9.6	3.8	9.9	7.9	4.8	12.3	4.2	4.4	7.1	15.4	2.6	5.0	3.0	4.9	4.3	16.6	8.8	4.9	0.0	15.8	4.6	7.9	9.7	6.4	8.6	5.0	8.7	17.8	8.7	5.5	6.3	3.7	3.6	5.0	4.4	7.1	3.6	3.3	1.3	5.3	3.7	4.7	0.0	1.7	3.0	0.9	0.7	3.3	1.4	1.1	2.1	1.9	1.2	3.1	3.0	1.1	2.6	4.6	0.7	1.0	0.7	1.9	4.4	7.4	6.1	2.7	2.1	2.8	1.7	4.7	1.8	8.9	17.1	0.9	13.6	26.3	4.7	24.0	7.6	13.4	11.4	5.2	2.0	19.6	0.0	7.1	4.4	2.3	6.3	0.0	4.6	3.0	20.6	10.4	10.3	23.1	6.2	6.4	8.6	0.6	3.7	0.4	6.4	5.7	20.3	0.0	4.4	2.6	8.2	5.7	4.6	1.8	4.7	0.0	9.4	3.4	3.4	44.2	130.8	1.5	4.7	21.3
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718031	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.2;breast: 78.2;placenta: 27.5"	"Group enriched"	"Detected in many"	8	"Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	48.2	0.6	2.2	1.8	2.4	1.2	78.2	1.5	1.9	0.5	6.1	1.0	0.5	7.7	0.6	0.4	0.6	0.6	8.9	1.9	2.3	2.4	2.1	16.0	5.6	1.3	3.0	0.7	0.9	1.3	0.2	0.3	27.5	2.6	0.5	1.6	0.7	0.9	0.2	0.7	1.6	4.5	0.5	2.6	0.5	0.5	0.6	1.5	0.0	0.5	0.4	0.4	1.0	2.3	2.6	1.8	8.6	1.8	4.3	1.1	0.4	0.3	1.6	0.3	1.0	14.3	0.4	7.4	0.1	0.2	0.3	0.6	18.7	0.5	0.4	0.2	0.1	4.6	0.5	0.5	0.5	0.8	0.1	1.2	0.1	1.0	0.8	1.7	0.2	0.2	3.3	0.4	0.1	0.9	0.3	0.0	0.3	0.2	0.9	0.0	1.8	0.1	0.7	3.2	0.6	0.3	0.3	0.2	0.2	0.2	0.3	1.1	0.1	0.6	2.1	0.5	2.7	0.3	0.2	0.5	0.5	0.5	4.2	0.4	0.2	0.1	0.7	1.4	0.3	0.5	8.6	1.8	1.7	1.0	1.2	0.6	1.6	0.8	0.9	0.4	2.6	1.0	1.1	6.1	4.3	1.1	1.8	0.4	0.4	2.2	2.4	1.5	1.9	2.3	2.4	3.0	0.7	2.6	1.5	8.9	3.2	0.0	0.4	0.0	2.9	0.3	0.0	0.0	0.0	1.8	0.0	45.5	1.7	1.7	0.3	0.5	6.4	0.0	0.0	7.0	0.9	0.3	0.0	11.4	4.6	0.0	1.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.8	0.6	0.0	0.0	2.2	0.1	0.0	1.0	0.0	0.1	0.0	134.3	0.0	5.6	0.3
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36606355-36688334	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 188.6"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 579.8"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	39	"dendritic cells: 3.4;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0.0	2.1	2.8	2.3	7.2	5.4	5.9	12.0	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4.0	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3.0	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0.0	2.6	0.7	4.5	4.8	1.2	0.0	3.4	0.0	4.3	0.0	0.0	0.8	0.4	0.1	21.5	1.9	2.2	6.0	13.8	0.0	0.0	0.8	1.9	34.7	1.7	0.0	10.5	0.3	0.3	26.3	6.3	2.8	0.9	0.3	12.9	0.0	0.1	0.0	0.4	0.4	0.1	11.1	13.0	5.3	2.2	0.4	0.0	0.4	0.0	0.1	3.6	0.0	0.0	0.1	2.5	0.0	2.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	2.1	6.3	0.3	10.5	0.0	1.0	0.0	1.9	3.2	0.0	7.6	0.0	0.0	0.0	8.8	14.5	4.9	0.0	4.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6	3.0	0.3	0.5	10.4	9.5	7.7	33.9	0.0	5.3	1.2	0.0	2.0	25.3	0.0	0.4	0.6	1.1	0.0	0.0	0.0	13.5	11.8	3.2	0.0	0.2	38.2	3.2	0.0	1.3	63.4	1.9	4.0	11.0	6.8	3.6	0.0	579.8	0.3	0.0	0.0	0.0	11.3	6.5	4.7	0.2	0.1	6.1	7.7	0.0	0.0	3.3
SLC20A1	"Glvr-1, GLVR1, PiT-1"	ENSG00000144136	"Solute carrier family 20 member 1"	Q8WUM9	2	112645857-112663827	"Predicted membrane proteins, Transporters"	"Host-virus interaction, Phosphate transport, Symport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 198.3;Enterocytes: 165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 87.9;U-87 MG: 85.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019279, HPA035834"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB019279: , HPA035834: AB_2674809"	"unprognostic (1.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (6.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-3)"	23.4	9.9	11.9	38.8	16.0	51.3	18.9	25.6	29.1	9.4	42.7	10.6	4.7	12.3	11.7	8.6	11.0	12.2	22.7	17.0	12.0	12.3	16.3	40.2	23.1	27.6	13.5	16.8	7.7	25.7	7.4	13.3	59.8	20.6	15.3	19.1	17.8	10.4	12.2	25.6	10.2	21.8	13.1	15.5	23.8	13.8	13.3	9.1	19.0	12.8	9.5	22.4	21.6	14.4	3.8	17.9	12.3	25.2	19.9	27.1	13.0	10.9	9.0	11.8	9.5	9.0	22.1	9.1	29.6	35.5	13.2	17.2	13.7	27.1	19.9	16.4	11.0	51.3	11.5	12.9	22.5	19.4	10.9	13.2	16.9	9.2	13.0	13.4	9.6	30.0	11.2	8.9	46.6	32.7	87.9	16.8	8.6	31.3	20.9	57.2	4.3	13.1	37.4	19.8	5.1	24.4	12.4	10.6	5.6	19.1	50.8	10.8	10.2	14.9	9.1	20.4	5.5	9.3	6.9	36.4	24.3	16.0	8.4	22.9	8.7	22.4	16.7	85.5	9.3	29.3	3.8	14.5	12.3	24.2	25.2	27.1	3.8	10.4	17.4	10.9	2.1	8.3	13.1	6.1	19.9	14.7	17.9	6.0	13.0	11.9	16.0	25.6	29.1	12.0	12.3	13.5	16.8	20.6	9.1	11.9	32.9	31.8	53.3	100.2	60.0	31.1	22.9	36.1	31.8	8.7	198.3	36.6	11.6	14.7	0.9	44.4	165.9	23.3	12.2	11.8	33.2	30.0	24.3	49.9	25.2	19.1	34.2	46.1	48.3	2.0	3.4	60.3	25.3	8.2	39.4	21.5	21.0	83.4	4.6	3.8	74.9	0.0	22.1	4.8	17.4	54.1	62.1	52.4	51.1	43.9
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Predicted membrane proteins"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 28.2;Erythroid cells: 23.3;Late spermatids: 23.1;Spermatocytes: 35.7"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 9.5"	"Group enriched"	"Detected in many"	66	"dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5"	"Group enriched"	"Detected in some"	18	"NB-4: 9.8;REH: 9.0;THP-1: 31.3;U-937: 18.4"					"Low region specificity"	"Detected in all"			HPA036902	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	3.5	0.2	0.2	0.4	0.2	16.0	0.2	0.1	0.2	0.1	0.7	0.0	0.0	0.0	4.9	0.8	0.1	0.3	0.7	0.1	0.2	0.1	1.1	0.3	1.6	0.0	0.2	0.0	0.9	0.1	9.6	0.1	0.3	0.2	0.2	0.0	0.0	0.6	0.0	0.2	0.3	0.1	1.6	0.2	0.8	0.2	26.4	0.0	2.2	0.1	0.8	0.1	0.1	0.1	0.0	5.1	5.0	9.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	18.4	0.0	5.0	9.5	1.6	0.0	2.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	23.3	0.0	0.1	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.2	23.1	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	35.7	0.2	0.4	0.0	0.0	0.0	0.0
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887780-2903740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.1;kidney: 13.4;liver: 13.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 89.5;Paneth cells: 107.4;Proximal tubular cells: 73.1;Syncytiotrophoblasts: 67.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 9.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;CAPAN-2: 7.0;MCF7: 13.2;OE19: 6.7;SK-MEL-30: 24.5;WM-115: 11.0"									HPA068288	Enhanced		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA068288: AB_2685969"	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	1.4	0.3	0.2	6.0	0.7	0.0	0.6	0.2	2.2	0.5	13.7	0.6	0.2	12.8	0.8	1.2	1.1	0.4	4.9	0.3	0.2	0.3	13.4	13.6	0.6	0.2	1.3	1.5	0.4	0.2	0.0	0.3	2.0	1.6	0.7	9.8	0.2	4.2	0.2	0.4	1.0	20.1	0.6	1.6	0.8	1.4	0.6	0.4	0.2	0.3	1.6	0.3	0.5	0.9	0.0	4.9	5.2	9.1	0.5	0.6	2.7	0.8	7.1	0.1	0.3	0.0	0.0	0.7	0.4	0.3	0.0	0.2	1.6	7.0	0.0	0.6	0.0	0.4	0.4	0.0	0.2	0.0	0.3	0.1	0.0	0.6	4.1	0.5	0.0	0.1	0.1	0.2	0.0	0.4	0.2	0.2	0.4	0.0	0.7	0.0	13.2	0.0	0.3	0.1	6.7	0.3	0.2	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.3	24.5	0.1	0.0	0.7	1.4	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.2	1.9	11.0	5.2	9.1	1.6	0.3	5.1	0.1	0.0	0.1	0.3	4.9	0.0	0.0	0.1	2.2	0.5	3.5	0.0	0.6	2.7	0.2	0.7	0.2	2.2	0.2	0.3	1.3	1.5	1.6	0.4	0.0	0.3	1.3	1.1	0.5	0.0	0.1	2.5	0.0	0.0	7.0	0.0	16.4	8.3	0.8	0.0	0.0	89.5	0.0	0.7	8.2	0.8	1.4	1.1	18.4	15.6	0.0	8.7	1.8	4.1	0.0	0.3	5.4	3.3	3.6	25.4	0.0	1.5	107.4	0.0	73.1	0.0	0.0	0.6	0.0	0.2	1.0	67.5	0.0	23.7	2.3
SLC22A23	"C6orf85, FLJ22174"	ENSG00000137266	"Solute carrier family 22 member 23"	A1A5C7	6	3268962-3457022	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 73.9;Late spermatids: 171.9;Mucus-secreting cells: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014697	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA014697: AB_1844371"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (5.16e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.53e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (8.91e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	7.4	2.2	9.0	4.6	16.2	8.1	9.3	8.4	14.8	5.6	17.4	30.8	3.4	19.6	3.6	11.8	16.8	11.3	7.5	2.2	11.0	8.1	6.9	12.6	8.0	3.9	28.6	8.7	3.0	14.9	14.8	6.5	8.3	17.8	14.2	14.4	5.7	10.0	2.8	5.9	14.9	20.3	3.0	17.5	4.6	26.0	7.2	21.0	5.2	4.1	9.8	9.9	3.8	9.9	0.1	0.7	0.8	0.3	0.3	1.4	1.9	2.4	5.6	12.5	13.9	4.4	5.0	16.0	0.4	0.1	0.7	0.3	12.5	0.4	0.6	1.4	2.7	11.1	3.6	2.5	6.6	0.2	2.0	7.7	5.8	2.1	11.0	0.6	0.3	0.4	1.2	13.0	12.1	0.6	2.6	0.4	3.2	5.2	3.3	0.4	2.9	0.5	1.4	4.3	13.7	2.3	1.3	0.8	9.9	0.0	15.3	1.4	0.2	3.3	4.8	4.1	13.3	18.5	0.1	3.1	7.3	2.3	9.4	1.5	7.5	0.1	0.2	12.8	0.4	4.4	0.0	0.3	0.0	0.4	0.0	0.2	0.0	1.0	0.4	0.2	0.1	1.4	0.9	0.8	0.3	0.2	0.7	0.0	1.9	9.0	16.2	8.4	14.8	11.0	8.1	28.6	8.7	17.8	21.0	6.0	13.7	0.5	4.2	10.3	7.9	2.4	10.2	33.5	17.0	5.2	7.9	12.2	0.0	2.5	73.9	8.4	29.0	23.3	7.0	0.9	1.4	19.2	0.0	10.0	9.8	0.0	4.1	6.7	8.0	171.9	1.7	2.0	3.3	10.8	52.1	9.1	5.7	14.4	0.7	2.4	3.4	0.0	0.9	2.1	1.1	11.0	7.7	1.0	22.6	3.9
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348268-160452581	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 98.6"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 62.8;Hepatocytes: 56.3;Leydig cells: 31.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 17.6;HeLa: 23.6;Hep G2: 14.7;hTERT-RPE1: 6.2;OE19: 7.5;RPTEC TERT1: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	4.1	6.9	1.0	2.1	1.3	0.0	5.2	1.8	0.9	7.6	4.1	0.9	4.1	0.2	14.2	11.8	4.1	9.0	9.0	1.1	1.2	1.3	2.4	15.2	12.7	9.7	2.2	0.9	10.3	1.3	0.0	0.9	17.8	1.9	18.9	0.6	0.9	34.5	23.0	98.6	5.1	2.7	10.8	4.4	0.3	2.9	3.4	0.6	0.4	3.4	5.7	2.1	3.2	7.3	0.0	0.0	0.8	0.0	0.1	1.5	0.0	0.0	17.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.2	0.0	0.0	0.0	23.6	14.7	0.8	0.0	0.0	0.5	4.5	2.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	7.5	4.9	0.0	0.0	0.0	9.0	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.0	1.0	1.3	1.8	0.9	1.2	1.3	2.2	0.9	1.9	0.6	14.9	62.8	0.0	0.3	4.1	0.0	1.6	5.1	1.4	10.3	0.0	0.0	0.4	5.0	9.1	0.4	0.3	0.7	0.0	2.5	0.2	11.0	3.4	2.3	56.3	0.6	0.0	0.0	0.0	0.6	0.9	31.4	1.5	3.3	0.0	0.4	0.0	33.9	0.0	23.0	2.1	0.0	0.0	11.4	0.2	0.1	5.8	0.3	0.0	0.4	0.7
SLC22A4	"DFNB60, MGC34546, OCTN1"	ENSG00000197208	"Solute carrier family 22 member 4"	Q9H015	5	132294443-132344206	"Disease related genes, Predicted membrane proteins"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Ciliated cells: 89.7;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 23.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.1;U-138 MG: 14.9"	"Region enhanced"	"Detected in all"		"cerebellum: 72.4"	"Low region specificity"	"Detected in all"			"CAB015468, HPA036974"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB015468: , HPA036974: AB_2732474"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.42e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.17e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.06e-2)"	2.7	4.1	3.5	3.8	5.0	22.4	3.1	3.1	4.7	2.4	5.9	4.4	1.8	4.6	2.1	3.2	0.8	14.7	2.6	3.0	3.9	4.9	15.4	1.6	7.2	3.8	3.2	2.0	5.0	1.0	7.7	6.9	6.8	12.6	5.4	3.1	13.8	2.6	4.1	9.2	1.7	18.1	1.5	9.9	7.7	2.2	0.9	2.7	0.5	1.0	2.7	0.8	2.5	2.2	0.0	1.7	23.0	3.5	0.0	0.0	0.6	1.1	1.7	0.1	0.4	0.8	0.6	0.5	7.6	35.1	5.9	6.1	0.7	1.9	0.3	2.1	4.4	4.4	1.9	0.0	1.2	4.1	1.4	0.2	0.1	3.3	0.1	0.6	2.3	0.0	1.4	0.2	3.2	3.0	2.1	2.5	0.2	3.0	4.0	4.5	0.6	0.0	5.4	0.2	0.1	1.9	0.0	0.4	0.2	0.9	0.1	0.5	0.2	8.3	0.5	0.2	0.2	0.3	1.4	3.1	14.9	1.4	5.8	1.9	0.0	1.5	0.0	4.4	2.7	1.7	0.0	3.5	3.5	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	23.0	0.0	0.2	0.2	0.0	0.6	3.5	5.0	3.1	4.7	3.9	4.9	3.2	2.0	12.6	2.7	3.0	0.0	0.0	1.0	0.7	1.6	0.8	2.5	89.7	13.6	0.0	0.0	0.6	0.0	3.2	0.0	2.1	5.3	70.0	0.3	1.6	1.4	2.2	0.0	0.0	4.2	3.2	1.2	0.6	1.5	0.0	0.6	4.3	0.0	0.0	0.4	1.5	1.2	1.4	0.0	4.9	0.3	0.0	1.0	0.4	0.2	0.4	2.1	0.0	1.1	0.9
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369752-132395614	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.3;skeletal muscle: 93.6"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 22.3;SiHa: 23.0"									HPA063062			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063062: AB_2684934"	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favorable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	3.0	4.7	4.0	1.9	4.9	0.6	4.4	9.0	4.2	4.4	10.6	3.6	15.0	11.8	3.6	12.6	2.5	7.4	5.2	7.2	3.8	3.8	42.3	4.5	2.3	1.5	3.5	3.2	3.9	5.2	17.9	8.5	8.1	3.9	8.2	8.3	5.9	4.2	21.8	93.6	3.5	19.6	2.9	3.8	1.7	4.4	2.5	2.7	1.0	5.0	3.2	2.4	3.9	3.2	1.4	6.4	0.4	4.1	1.5	4.0	2.1	3.6	8.7	0.5	7.0	2.8	1.3	12.1	1.6	1.8	2.8	3.9	6.4	7.5	1.7	3.8	1.6	8.1	8.7	5.8	4.3	3.3	2.2	7.1	0.9	22.3	2.9	4.7	1.4	1.5	1.3	8.1	1.9	9.9	4.8	0.7	3.2	4.0	1.1	2.6	6.2	2.1	1.4	0.6	6.3	3.8	0.8	0.0	9.4	8.4	9.1	3.0	2.1	23.0	18.0	4.4	1.9	8.3	1.8	0.4	0.5	2.5	5.9	2.0	3.8	7.4	0.1	1.8	3.6	1.6	0.0	4.1	0.0	2.6	2.2	2.8	1.4	2.4	3.1	6.4	1.4	2.6	3.0	0.4	1.5	0.7	0.6	4.0	2.1	4.0	4.9	9.0	4.2	3.8	3.8	3.5	3.2	3.9	2.7	8.9	5.1	2.7	5.9	6.8	6.5	5.2	20.4	6.7	3.4	15.7	11.8	16.6	1.7	8.8	1.4	3.0	46.4	0.0	4.5	4.8	4.0	12.8	0.0	5.9	4.0	9.5	6.9	1.3	8.7	2.3	6.1	2.6	5.0	0.0	12.6	8.7	5.4	25.9	3.9	23.2	7.4	0.0	1.9	7.2	2.5	5.5	6.9	2.9	16.1	7.8
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"intestine: 36.5;kidney: 32.4"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 6.7;Proximal tubular cells: 8.9"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 9.0;U-266/70: 6.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.3"	"Not detected"	"Not detected"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	0.4	0.0	0.3	2.3	0.3	0.0	0.5	0.3	0.5	0.8	14.9	0.3	0.3	5.3	1.1	0.3	0.9	0.5	0.3	0.3	0.3	0.0	32.4	3.1	0.7	0.3	0.3	0.3	1.0	0.4	0.5	0.3	0.5	0.3	1.4	0.8	0.3	0.4	0.3	0.3	1.1	36.5	0.3	0.3	0.4	0.5	0.3	0.3	0.3	1.3	0.3	0.4	0.6	1.3	0.8	0.0	0.0	0.8	0.0	0.5	0.0	0.9	0.4	0.2	1.1	4.0	2.2	0.8	2.2	0.6	0.4	1.3	2.4	1.6	0.5	0.8	1.5	0.1	3.2	0.7	0.3	0.6	1.9	1.8	2.1	1.9	0.2	0.7	0.2	0.9	0.7	9.0	0.9	2.9	3.6	1.2	1.2	0.3	0.9	0.6	0.3	0.1	1.0	0.0	0.8	0.2	0.5	0.6	0.8	3.1	3.7	0.5	1.0	0.2	0.0	2.4	1.1	0.9	1.1	2.6	2.1	1.4	2.2	0.7	6.6	0.3	2.9	0.6	0.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	2.0	1.1	1.3	0.8	0.3	2.5	0.0	0.0	1.8	0.0	0.2	1.7	0.2	0.0	0.7	6.7	0.0	0.0	0.1	0.6	1.4	0.0	0.5	0.2	0.0	1.7	0.6	0.3	0.0	1.4	0.4	1.7	1.0	2.8	1.9	0.2	3.1	1.1	8.9	0.1	0.0	0.8	0.0	0.1	1.4	0.3	0.0	1.6	0.7
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision"		"Congenital stationary night blindness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"retina: 91.1"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 301.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA039370	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	6.2	5.3	4.5	7.7	5.0	2.6	9.3	7.0	3.4	8.9	5.0	5.6	7.5	3.7	10.6	12.2	4.2	9.0	6.2	4.1	4.7	4.1	7.9	4.7	12.0	6.0	5.3	2.6	9.7	6.6	6.5	6.1	8.9	4.0	6.0	4.1	91.1	6.4	8.3	3.8	8.5	4.5	5.0	6.8	7.8	4.2	10.8	3.2	6.9	9.0	4.6	4.8	6.0	5.3	3.8	2.6	4.7	1.5	2.3	1.8	0.4	1.5	3.1	3.3	3.0	5.0	8.4	4.1	3.9	4.2	3.8	2.5	1.4	6.6	2.1	12.9	3.7	1.3	4.2	3.9	4.2	2.3	2.1	2.9	4.6	2.3	6.8	7.2	3.0	6.3	7.1	6.2	2.1	12.8	5.4	6.6	4.9	4.8	7.2	6.2	6.4	1.9	2.8	4.3	13.5	1.2	2.0	1.0	1.4	5.8	6.0	1.6	2.3	1.0	2.9	8.0	4.8	6.2	4.2	9.4	3.9	3.9	1.5	2.6	2.9	5.2	2.5	4.1	6.5	3.3	4.7	1.5	2.1	1.4	1.3	1.8	1.4	1.5	1.2	1.1	3.8	1.1	1.5	1.7	2.3	0.6	2.6	0.3	0.4	4.5	5.0	7.0	3.4	4.7	4.1	5.3	2.6	4.0	3.2	6.0	3.2	1.4	1.2	1.3	26.9	1.9	0.0	4.0	5.7	0.0	25.5	3.3	0.0	1.1	1.1	7.0	2.8	0.0	1.1	2.0	1.5	1.1	2.3	1.5	1.7	19.1	1.7	4.3	2.2	1.8	2.8	1.5	1.7	0.0	2.2	23.4	1.7	0.0	2.1	0.5	301.7	0.0	1.4	10.4	6.4	0.9	2.1	0.8	2.1	0.8
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212646-19722937	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 18.2;granulocytes: 26.5;Late spermatids: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	53	"basophil: 7.1;eosinophil: 3.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 7.1"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	7.0	2.5	10.9	4.6	11.0	1.0	3.6	7.4	9.2	17.6	8.9	5.5	7.0	2.9	26.3	19.0	15.3	17.2	14.5	1.7	27.1	12.0	1.2	0.6	6.2	1.5	4.5	3.4	14.8	1.2	7.9	1.6	3.0	5.3	8.5	4.1	5.5	6.1	13.8	26.4	5.2	4.4	21.7	2.9	1.7	2.7	1.7	3.1	0.9	2.5	11.0	4.9	8.1	20.7	0.0	0.0	7.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	6.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.2	0.0	0.0	0.4	0.0	41.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.8	0.0	0.3	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.9	11.0	7.4	6.5	27.1	12.0	4.5	3.4	5.3	3.1	3.0	0.6	0.0	1.0	1.0	9.4	0.4	0.0	0.0	2.3	1.8	0.0	5.4	0.0	0.0	18.2	0.1	0.0	0.0	0.0	0.3	1.5	0.7	26.5	0.0	0.6	1.6	7.5	0.6	0.0	14.9	3.4	0.0	0.0	0.0	2.6	2.9	0.1	0.9	3.9	0.0	1.4	0.0	3.1	0.5	0.4	3.6	2.9	0.0	0.6	2.7
SLC24A4	NCKX4	ENSG00000140090	"Solute carrier family 24 member 4"	Q8NFF2	14	92322581-92501483	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.6;brain: 28.1"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 223.9;Cone photoreceptor cells: 188.5"	"Group enriched"	"Detected in some"	5	"glioma: 0.5;melanoma: 0.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.7;SCLC-21H: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063206			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA063206: "	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.58e-2)"	1.8	1.0	4.9	3.8	6.0	8.6	0.6	1.1	11.7	0.8	0.9	9.6	6.3	0.9	0.6	0.7	0.8	0.8	1.9	0.9	4.7	3.2	0.5	0.7	2.3	2.7	10.8	4.7	1.0	0.6	0.5	1.8	1.2	28.1	0.7	1.0	4.6	0.7	1.2	2.4	0.8	1.2	1.4	14.2	5.0	0.9	2.9	5.7	0.0	0.6	0.0	1.4	1.5	0.8	0.1	2.3	1.3	11.6	0.2	0.2	2.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.6	2.7	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.7	0.4	0.4	0.2	0.0	0.2	0.3	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.1	0.6	0.0	0.4	0.0	0.3	1.1	0.0	0.3	0.1	0.1	0.3	0.0	0.3	5.2	0.0	0.2	0.2	0.5	0.1	0.3	1.2	0.6	0.2	1.5	0.3	0.1	0.4	0.1	0.1	0.2	0.3	0.3	0.2	7.9	0.0	0.0	11.6	0.2	0.0	0.0	0.0	2.3	0.1	0.0	0.0	1.3	0.2	9.4	0.4	0.0	2.0	4.9	6.0	1.1	7.3	4.7	3.2	10.8	4.7	28.1	5.7	0.0	3.4	0.0	0.1	0.0	223.9	1.2	0.0	1.4	0.0	0.0	188.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	3.5	0.0	0.0	1.8	26.6	4.6	0.3	4.0	0.0	0.0	0.0	2.1	0.1	0.0	0.4	0.0	8.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1
SLC25A14	"BMCP1, UCP5"	ENSG00000102078	"Solute carrier family 25 member 14"	O95258	X	130339888-130373361	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060316			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA060316: AB_2684251"	"unprognostic (1.65e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.36e-3)"	"unprognostic (8.92e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.95e-3)"	"prognostic favorable (1.78e-4)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.52e-6)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (1.39e-5)"	3.1	9.3	9.2	3.4	18.3	3.7	5.5	13.6	20.6	4.8	3.8	6.1	4.2	2.2	6.7	11.0	4.3	9.7	4.6	7.7	8.7	15.8	5.2	4.1	4.6	4.1	7.3	11.4	6.8	4.5	5.6	15.0	3.6	11.2	5.1	4.1	5.7	5.1	6.7	3.4	4.7	3.6	7.7	5.3	3.5	4.8	10.2	4.2	4.2	5.7	4.6	5.3	3.1	3.8	7.5	9.3	8.7	7.2	8.1	9.5	4.9	6.9	9.1	6.5	4.8	4.4	4.2	3.5	5.2	7.0	10.2	10.2	3.6	4.2	4.7	18.2	7.0	12.5	3.9	9.4	3.9	10.1	6.0	11.9	1.5	8.4	8.5	6.2	5.9	2.8	3.9	4.7	12.8	3.9	6.0	5.6	6.6	4.1	6.7	16.1	10.6	6.2	8.3	5.5	7.5	15.0	5.3	8.5	9.4	5.9	3.0	8.2	7.3	5.5	5.6	8.8	4.5	3.6	3.3	3.7	5.5	3.6	12.5	10.5	6.3	16.1	4.1	10.0	7.3	4.9	5.8	7.2	5.2	6.4	5.8	7.8	7.5	5.4	6.1	7.5	4.6	4.2	7.0	8.7	8.1	5.2	9.3	9.5	4.9	9.2	18.3	13.6	15.6	8.7	15.8	7.3	11.4	11.2	4.2	6.0	2.1	8.3	6.8	8.9	8.8	3.2	7.6	26.8	1.2	3.5	2.0	8.0	14.9	9.4	9.0	4.4	3.8	0.0	7.9	7.3	6.0	4.1	3.5	3.8	4.6	6.4	8.6	4.9	3.3	5.1	4.6	5.1	8.5	2.8	4.0	8.5	7.5	4.5	7.8	8.3	12.7	6.5	6.2	21.6	39.2	7.3	4.5	7.0	5.2	4.7
SLC25A16	"D10S105E, GDA, HGT.1, ML7"	ENSG00000122912	"Solute carrier family 25 member 16"	P16260	10	68477999-68527474	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036243, HPA044580"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036243: AB_2675019, HPA044580: AB_10962723"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.44e-3)"	18.7	8.0	6.4	5.5	8.9	7.0	15.5	9.6	13.5	5.1	6.9	8.1	4.8	8.1	7.7	7.8	5.9	5.4	8.8	5.9	8.4	7.3	12.0	22.6	10.2	9.2	7.8	8.6	6.3	21.1	6.9	7.3	7.1	9.2	17.3	6.4	8.5	15.0	6.6	9.4	6.5	11.0	8.4	6.3	6.4	9.4	3.5	6.6	6.4	7.8	4.8	7.7	6.4	5.4	3.2	2.9	5.0	2.7	2.4	2.5	1.2	3.0	1.2	3.5	4.8	4.7	5.7	3.8	4.1	4.5	2.7	2.9	7.1	2.0	3.2	3.0	8.1	1.4	1.8	11.0	2.1	6.8	2.4	6.8	1.7	3.2	3.1	5.8	5.4	3.8	4.9	5.4	5.0	7.1	4.0	2.2	2.9	1.9	5.4	5.6	2.8	3.1	3.9	0.8	0.8	15.9	1.7	2.5	1.0	7.3	9.8	2.5	2.0	5.9	5.8	4.6	2.5	3.2	2.2	9.5	4.1	5.3	6.6	4.7	5.5	2.9	5.2	3.9	4.5	1.8	4.0	2.7	2.7	1.7	1.9	1.6	1.7	1.6	1.4	1.8	3.2	1.6	2.5	5.0	2.4	1.5	2.9	1.7	1.2	6.4	8.9	9.6	13.5	8.4	7.3	7.8	8.6	9.2	6.6	41.7	20.2	6.9	5.6	5.7	16.9	8.0	15.3	13.4	7.9	12.2	37.3	14.4	10.0	6.6	7.7	5.8	13.8	0.0	16.7	23.1	7.2	16.0	8.1	35.0	9.4	19.1	14.5	14.7	7.2	9.2	2.8	5.8	1.7	3.6	7.8	8.5	12.2	7.0	7.4	19.2	31.5	0.0	8.9	4.1	2.5	5.9	50.0	4.3	7.4	8.6
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563439-17590994	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 13.1;brain: 49.0;liver: 50.0"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;BEWO: 12.9"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	13.1	2.2	33.2	1.5	28.0	1.2	2.7	7.5	49.0	1.4	1.4	13.3	0.0	1.5	1.7	1.4	1.5	1.7	2.1	2.3	33.3	15.7	1.8	50.0	1.5	1.5	25.6	19.1	1.9	1.8	1.7	0.0	1.3	17.8	4.8	1.3	0.0	1.6	1.6	2.5	1.4	1.4	1.8	14.9	1.9	1.5	3.4	21.6	0.0	1.5	0.0	1.3	1.4	0.0	0.4	0.4	2.1	0.6	0.0	0.5	0.1	0.5	0.9	3.4	0.6	5.7	0.0	12.9	0.4	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.0	3.7	1.1	0.1	0.0	0.0	0.4	1.4	0.5	0.4	0.8	2.3	0.5	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.6	0.4	0.0	0.6	0.1	0.8	2.9	1.3	2.1	4.2	1.2	0.0	0.1	0.6	1.2	0.5	0.4	0.6	1.0	2.6	3.7	1.4	0.2	0.2	0.5	0.3	0.4	1.4	1.7	0.0	2.7	0.3	0.5	0.0	0.4	2.1	0.4	0.6	0.0	0.4	0.5	0.1	0.3	0.2	0.1	0.3	0.5	0.0	0.2	0.4	0.1	0.1	33.2	28.0	7.5	25.7	33.3	15.7	25.6	19.1	17.8	21.6	26.8	15.9	0.0	0.2	0.0	0.5	1.4	0.0	28.1	12.5	0.0	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.5	4.6	5.8	67.6	0.2	0.0	0.0	2.5	4.6	0.6	0.9	0.7	0.0	0.0	0.0	1.4	0.0	0.0	2.5	0.6	3.2	0.0	0.0	2.7	4.8	0.1	1.5	0.0	0.0	0.1
SLC25A25	"KIAA1896, MCSC, PCSCL"	ENSG00000148339	"Solute carrier family 25 member 25"	Q6KCM7	9	128068201-128109245	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020381	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Vesicles, Mitochondria"		"HPA020381: AB_1857037"	"unprognostic (4.62e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (4.65e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.42e-2)"	29.2	15.8	7.3	8.1	12.8	5.5	10.6	8.8	20.0	14.4	7.2	6.3	20.0	7.9	14.6	8.2	22.7	17.5	31.6	5.6	7.6	9.0	9.5	48.4	12.4	6.7	7.5	8.0	13.6	52.6	12.1	19.0	7.6	15.0	8.5	5.5	13.6	7.6	63.5	31.3	9.5	10.0	17.3	8.7	7.8	10.5	7.3	5.3	5.4	10.8	20.2	9.7	8.6	9.6	2.9	4.6	3.8	8.4	1.5	7.6	3.9	5.7	6.1	8.6	12.4	6.5	5.6	5.7	12.0	11.2	10.1	6.7	10.9	6.1	7.5	3.7	5.5	5.6	10.3	6.8	3.9	3.8	8.7	5.6	4.3	12.2	6.5	10.4	5.0	10.0	7.2	3.8	9.9	7.3	3.3	6.8	12.6	15.6	16.2	6.3	13.9	8.7	5.1	8.7	18.7	9.5	8.7	7.4	15.7	3.9	6.0	21.4	9.2	12.6	8.1	16.7	3.5	8.9	2.9	4.3	11.5	6.8	8.6	11.8	14.2	24.8	8.0	7.8	2.7	9.4	3.8	2.3	1.2	4.8	7.3	2.4	1.7	5.3	4.8	4.6	2.9	4.5	7.6	0.4	1.5	8.4	1.5	3.9	3.9	7.3	12.8	8.8	20.0	7.6	9.0	7.5	8.0	15.0	5.3	20.8	41.7	5.2	37.8	23.2	18.1	2.0	33.1	21.4	9.1	19.2	119.8	8.5	10.0	10.3	0.3	33.7	36.7	23.3	10.0	10.4	16.9	26.9	8.1	58.9	8.4	17.5	49.5	19.0	13.3	0.6	8.6	18.9	20.3	18.0	17.3	12.8	10.0	28.1	7.8	8.6	65.5	19.4	63.4	4.1	8.6	37.6	19.2	8.7	15.3	47.7
SLC25A30		ENSG00000174032	"Solute carrier family 25 member 30"	Q5SVS4	13	45393316-45418455	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 38.0;skeletal muscle: 43.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 39.7;Hepatocytes: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045260			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045260: AB_10962505"	"unprognostic (9.23e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.91e-8)"	"unprognostic (2.24e-1)"	"unprognostic (5.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.19e-3)"	7.7	6.3	6.2	4.7	5.7	5.3	7.1	3.6	6.3	6.5	4.2	2.1	9.7	2.5	7.7	7.2	5.3	3.9	4.5	38.0	5.8	3.8	24.6	19.5	5.9	9.3	5.4	4.3	10.8	7.5	2.4	5.7	3.4	8.1	8.0	3.5	9.5	6.8	9.1	43.1	4.4	3.5	9.4	7.6	6.1	4.0	5.0	4.9	1.2	6.5	6.7	4.4	6.6	9.0	1.6	5.3	4.3	3.4	1.7	2.7	1.1	2.3	5.1	3.0	13.1	15.4	9.8	1.0	10.9	6.4	9.5	5.7	5.3	6.3	0.0	9.6	11.1	7.0	4.5	7.0	11.0	11.3	7.6	5.7	8.6	3.3	14.1	9.1	12.3	11.7	6.4	7.5	13.9	10.4	11.2	16.4	8.7	5.2	0.0	19.1	2.7	4.5	8.5	4.5	2.7	6.5	11.2	5.1	4.5	20.5	1.9	0.6	3.1	6.1	9.4	8.7	5.5	7.3	16.6	6.0	8.9	5.1	9.8	7.5	2.3	4.5	0.1	9.7	11.7	13.6	0.0	2.8	4.3	2.2	3.4	1.5	1.6	2.2	2.2	4.0	1.5	2.7	1.2	0.0	1.7	1.5	5.3	0.8	1.1	6.2	5.7	3.6	6.3	5.8	3.8	5.4	4.3	8.1	4.9	6.0	2.1	1.5	1.9	11.4	1.7	39.7	10.2	0.0	1.2	14.0	3.9	0.7	19.9	2.2	7.6	4.1	1.4	0.0	1.2	0.8	2.2	2.8	4.7	38.9	3.7	0.0	2.4	7.4	10.0	2.3	4.6	5.9	5.0	6.4	3.9	0.8	2.4	0.0	6.0	22.1	1.1	6.5	2.2	0.0	1.4	5.4	0.5	4.4	3.3	1.1
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736405-15741396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 38.8;skeletal muscle: 22.2"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 16.0;Paneth cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 10.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria		NA	NA			Mitochondria		"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.5	2.4	1.2	0.9	1.9	2.8	0.7	10.4	1.8	1.1	25.9	0.8	0.5	13.5	1.7	1.4	1.6	1.3	3.6	13.3	1.5	1.2	7.3	3.9	1.1	1.1	0.7	1.8	2.4	18.6	0.6	2.1	1.2	1.5	1.1	1.9	3.7	11.1	0.8	22.2	0.8	38.8	1.0	1.1	1.9	1.4	2.3	1.2	0.5	1.9	11.0	1.9	0.7	1.1	0.7	0.5	2.0	0.5	2.2	4.1	1.1	0.7	0.5	3.5	1.6	1.7	0.7	1.5	0.5	0.3	0.8	0.6	1.4	1.9	0.9	0.8	0.7	1.8	0.7	0.6	0.6	0.8	1.2	0.7	1.5	1.1	0.5	0.6	0.4	2.2	0.8	2.7	1.0	0.5	2.2	0.4	4.6	0.6	3.2	0.6	1.8	3.7	2.0	2.9	0.4	1.0	1.9	3.1	1.0	0.3	0.1	0.7	2.8	0.8	1.0	7.4	3.4	1.9	2.5	1.7	1.7	2.2	2.3	0.6	3.8	3.5	0.7	0.6	2.2	1.4	1.2	0.5	0.4	1.4	0.2	3.1	0.5	3.0	2.0	0.2	0.7	4.1	2.3	2.0	2.2	0.2	0.5	1.3	1.1	1.2	1.9	10.4	1.8	1.5	1.2	0.7	1.8	1.5	1.2	0.0	0.0	0.0	0.3	0.2	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.7	16.0	0.0	0.2	0.2	0.7	0.3	0.0	2.1	1.2	3.2	3.4	2.5	2.6	0.4	0.9	0.1	0.0	1.8	2.4	1.7	0.2	5.3	0.4	3.0	1.4	0.0	0.9	0.5	0.6	0.1	1.1	0.0	4.1	0.4
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295343	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.4"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA051720: AB_2681584"	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.91e-5)"	6.8	8.2	4.0	10.2	8.3	7.4	8.1	2.6	6.0	13.0	7.2	11.1	18.2	8.3	14.1	11.6	5.3	8.6	7.5	4.4	8.2	3.7	14.4	4.4	7.2	8.2	8.9	5.2	3.4	9.6	6.6	12.9	44.4	9.2	8.2	7.9	11.3	6.2	24.9	3.4	4.2	7.2	6.0	9.7	9.4	9.8	20.2	7.2	9.0	9.1	4.1	7.1	7.2	4.6	3.8	7.2	9.0	11.1	3.2	5.6	2.9	4.5	12.5	2.1	9.4	7.2	2.8	5.2	2.9	2.7	3.3	3.6	1.5	11.7	5.2	3.1	3.4	6.7	10.1	2.7	3.6	1.8	2.8	3.3	4.4	9.2	1.8	2.7	0.5	11.9	5.9	2.1	6.2	1.1	2.3	5.1	6.1	1.2	1.8	2.7	2.5	4.7	2.4	0.7	3.1	4.2	5.1	1.5	2.3	2.5	11.6	1.1	2.8	8.6	5.2	3.7	2.3	11.6	3.3	6.7	2.2	1.7	5.3	2.5	4.0	2.4	1.8	5.7	7.8	5.6	4.5	7.3	9.0	5.5	11.1	4.3	2.6	4.8	5.6	7.2	3.8	1.7	3.5	1.4	3.2	7.8	3.6	4.9	2.9	4.0	8.3	2.6	6.0	8.2	3.7	8.9	5.2	9.2	7.2	0.0	4.8	5.4	1.5	0.7	3.7	1.2	2.5	0.0	1.2	10.4	7.9	7.3	10.0	2.4	2.4	2.2	2.5	0.0	6.2	2.0	1.3	1.8	4.7	2.4	5.9	1.6	8.6	2.5	3.7	3.6	1.4	2.7	0.0	8.2	2.7	6.8	2.6	3.1	1.1	5.7	8.9	0.0	0.7	27.9	0.7	0.3	14.5	3.8	3.0	1.1
SLC25A36	"FLJ10618, PNC2"	ENSG00000114120	"Solute carrier family 25 member 36"	Q96CQ1	3	140941830-140979933	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027036	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoplasm	"HPA027036: AB_1857048"	"unprognostic (4.12e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (1.55e-4)"	20.2	16.9	14.9	13.4	20.5	36.5	25.2	18.7	31.3	23.5	19.4	18.3	17.3	22.3	25.6	37.3	12.2	25.1	13.7	29.5	15.9	19.0	29.0	3.1	22.4	18.6	15.6	16.7	32.6	33.9	29.7	26.3	19.1	21.6	20.6	14.8	21.1	17.5	17.7	60.6	16.2	17.2	20.4	18.5	14.1	23.6	24.4	12.2	15.4	23.7	15.1	12.7	20.7	18.5	17.0	14.9	15.7	13.1	18.1	16.6	10.9	23.8	5.4	17.5	14.3	16.1	20.6	22.1	9.0	11.5	10.1	14.3	14.9	11.4	19.9	22.4	7.6	14.5	16.0	21.2	8.8	20.7	15.2	17.2	16.4	13.0	9.4	24.2	23.4	10.2	23.2	29.6	7.4	22.7	22.7	10.6	14.7	8.7	12.9	14.7	10.3	13.9	16.1	17.4	5.9	10.1	15.1	15.6	28.2	11.9	8.2	11.3	18.5	12.2	22.2	39.1	16.0	15.4	13.3	10.7	14.1	7.9	24.9	8.6	26.2	17.0	23.2	18.2	9.8	6.9	10.5	10.4	15.7	11.4	13.1	13.3	17.0	11.7	12.5	14.9	16.0	16.6	15.7	1.8	18.1	13.1	10.9	10.2	10.9	14.9	20.5	18.7	31.3	15.9	19.0	15.6	16.7	21.6	12.2	92.3	107.7	22.2	58.2	60.7	96.5	82.2	38.2	133.8	62.6	68.0	125.7	48.2	54.7	22.9	5.0	40.0	22.6	0.0	33.6	33.4	49.8	72.0	63.6	0.4	22.8	87.4	57.0	29.4	35.2	11.5	55.3	36.5	54.0	29.7	27.0	70.1	26.8	17.5	55.9	52.8	122.5	58.2	54.2	29.3	61.1	47.6	41.3	41.1	40.3	64.7
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528805-23575463	"Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.8"	"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 3550.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 28.9"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"HEL: 47.7;hTERT-RPE1: 27.9"	"Low region specificity"	"Detected in all"							HPA045680	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8.0	15.0	8.6	1.9	9.0	5.9	5.7	13.9	33.0	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.8	4.2	4.5	4.1	5.9	7.3	6.6	3.0	3.9	2.2	2.5	4.1	8.2	6.2	3.7	2.5	14.5	4.9	4.1	8.2	3.0	1.0	2.2	47.7	7.0	1.4	4.9	2.7	1.9	6.2	8.0	4.8	4.8	27.9	3.4	5.0	10.5	3.1	3.5	1.6	3.2	11.3	2.3	4.7	3.3	3.3	2.2	2.4	6.8	2.1	1.4	1.9	4.1	6.4	3.0	4.4	1.8	4.1	5.5	10.9	1.6	6.4	5.8	2.5	0.9	3.9	10.2	6.5	6.8	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6	35.7	79.2	39.5	104.8	82.9	35.3	31.5	48.4	21.4	84.2	73.3	64.8	32.1	13.3	81.9	645.6	82.4	66.7	3550.9	197.4	63.8	90.2	258.9	35.8	34.3	36.1	6.4	19.5	100.7	50.6	772.4	48.6	101.8	65.8	8.2	33.2	41.6	177.5	34.5	35.0	24.5	60.7	19.4	95.7	12.5	47.1	47.0	15.3	22.7	43.1	139.3
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399060-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035188, HPA078530"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035188: AB_10602400, HPA078530: "	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	12.7	3.0	4.4	11.1	3.7	1.3	11.8	5.9	3.8	8.9	12.3	4.3	5.6	12.8	8.0	7.3	23.5	5.8	6.3	6.0	5.1	3.4	11.4	11.3	10.4	9.5	3.8	2.7	7.8	15.6	4.0	3.0	7.3	5.8	8.5	14.2	7.4	12.8	4.4	6.3	14.0	13.3	7.7	8.2	9.0	7.9	4.3	4.3	1.9	5.7	9.6	16.2	8.9	12.9	4.3	6.3	0.2	10.7	6.6	3.2	1.4	13.6	10.1	0.7	4.0	14.0	21.2	5.4	7.5	9.6	6.1	5.9	5.2	6.9	1.5	4.6	21.0	18.4	10.1	7.9	7.1	5.5	11.8	2.4	4.9	3.3	7.0	8.7	4.6	5.2	8.7	12.6	10.1	8.5	8.7	7.5	2.7	0.9	7.3	7.0	24.4	0.0	6.5	4.6	7.2	15.9	1.2	0.0	2.0	10.1	4.7	0.6	0.0	10.2	21.6	12.0	3.4	3.8	4.6	10.4	10.0	2.9	10.8	11.6	0.1	5.7	3.3	10.0	7.7	8.8	0.0	3.4	0.2	1.0	5.1	1.8	4.3	2.0	3.2	6.3	3.6	1.1	1.9	0.0	6.6	10.7	1.6	1.6	1.4	4.4	3.7	5.9	3.8	5.1	3.4	3.8	2.7	5.8	4.3	6.0	8.9	6.0	5.9	6.9	0.1	1.4	0.0	1.4	6.8	3.5	0.0	8.9	8.3	3.6	0.0	7.3	16.9	0.0	7.9	6.7	9.3	3.1	8.1	4.9	9.7	0.0	7.0	6.2	6.5	0.0	7.5	9.9	10.1	11.8	10.3	0.0	12.1	8.6	5.3	7.0	0.1	0.0	13.3	0.4	2.2	12.2	5.7	7.2	10.3	5.1
SLC25A44	"FLJ90431, KIAA0446"	ENSG00000160785	"Solute carrier family 25 member 44"	Q96H78	1	156193932-156212796	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 115.9;Late spermatids: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065411			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA065411: AB_2685486"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (2.49e-4)"	"unprognostic (3.37e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.37e-1)"	14.3	9.0	15.9	9.3	23.1	10.2	8.9	18.6	31.9	9.1	10.4	19.7	6.6	16.8	8.1	11.1	9.0	7.8	10.7	10.6	16.1	16.7	25.9	31.2	10.6	8.7	14.4	18.1	7.1	8.3	17.7	10.9	7.8	22.5	8.7	11.1	9.3	7.0	9.5	12.8	9.1	13.9	10.8	13.5	13.3	8.4	8.9	12.1	10.6	9.7	6.0	11.2	9.7	7.9	3.7	6.3	33.8	9.1	4.2	4.9	5.6	10.3	17.7	8.7	11.5	19.0	10.3	6.8	11.1	16.4	20.3	16.6	17.3	9.4	8.2	9.8	16.6	11.0	15.5	31.7	13.1	18.0	9.4	10.6	7.5	11.3	10.4	14.5	9.7	13.8	14.4	11.5	20.5	12.4	9.8	16.4	10.2	7.8	13.6	13.9	18.6	10.1	6.9	20.5	19.8	18.4	6.5	8.8	14.0	26.5	12.3	13.6	18.3	13.0	23.6	14.8	16.0	17.8	15.9	13.2	11.7	9.9	13.1	13.2	14.0	10.6	12.5	12.9	10.2	11.5	6.5	8.4	8.7	4.7	9.1	4.9	3.7	3.8	4.4	6.3	2.4	3.1	3.7	33.8	4.2	7.1	2.8	3.3	5.6	15.9	23.1	18.6	31.9	16.1	16.7	14.4	18.1	22.5	12.1	11.9	24.8	12.3	4.8	24.6	12.6	30.7	7.6	4.0	14.8	8.7	19.6	4.3	5.0	5.4	115.9	11.7	9.2	0.0	4.9	3.3	17.9	6.1	4.7	29.8	6.5	19.1	5.8	10.4	8.6	71.2	6.6	12.2	11.8	1.8	8.5	7.2	4.9	5.8	5.3	13.9	8.8	19.4	12.2	9.1	7.7	29.7	6.9	7.5	7.5	6.3
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 60.5"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 32.2;T-cells: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA050821	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050821: AB_2681249"	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	2.2	1.8	2.1	4.0	2.3	3.1	3.2	1.0	2.6	1.7	4.5	4.0	4.7	4.1	1.0	5.4	1.5	1.3	1.3	2.8	2.5	1.1	3.9	7.7	5.3	9.4	1.8	2.3	1.3	60.5	4.2	4.7	1.2	2.3	2.5	1.2	3.5	5.0	1.3	4.1	2.0	11.0	1.5	2.3	9.6	1.9	2.4	2.0	5.8	9.0	2.8	8.2	1.9	1.7	10.8	19.2	6.0	10.1	13.5	11.4	2.5	0.3	4.7	0.2	6.9	1.3	0.6	3.5	0.8	2.1	0.4	0.4	1.0	2.2	4.1	3.9	1.9	1.8	0.6	0.5	0.3	0.0	13.8	1.0	4.5	2.5	0.3	0.8	1.4	4.8	1.6	0.1	0.5	0.4	0.4	0.7	8.0	0.6	18.7	0.7	1.5	3.3	0.1	0.3	0.2	2.2	6.1	0.9	13.6	0.7	0.0	2.3	3.1	1.4	3.7	0.7	0.4	1.9	0.7	1.3	0.5	1.8	4.5	0.3	7.8	4.9	1.2	1.4	1.0	2.7	6.0	5.5	3.9	7.9	9.0	8.4	8.9	7.0	7.5	5.7	10.8	11.4	8.5	3.3	13.5	10.1	19.2	6.3	2.5	2.1	2.3	1.0	2.6	2.5	1.1	1.8	2.3	2.3	2.0	0.0	3.5	32.2	5.2	2.5	9.0	5.5	10.2	17.4	4.5	12.2	0.0	1.4	0.0	4.9	5.2	2.9	23.9	0.0	4.7	1.0	3.3	7.8	4.6	12.1	6.3	6.4	6.4	7.4	7.0	3.3	6.4	13.8	5.0	18.0	12.9	7.7	4.3	8.6	3.5	6.2	0.3	6.5	2.5	2.3	0.2	1.8	1.3	35.9	7.4	3.5
SLC25A48	"FLJ44862, HDMCP"	ENSG00000145832	"Solute carrier family 25 member 48"	Q6ZT89	5	135579202-135889770	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 22.4;kidney: 11.7;skeletal muscle: 12.8"	"Cell type enhanced"	"Detected in some"	26	"Distal tubular cells: 8.3;Enterocytes: 4.5;Proximal tubular cells: 27.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.0;HEK 293: 4.2;HEL: 4.1;RPMI-8226: 3.7;SCLC-21H: 3.9;U-2 OS: 5.1"									HPA014674	Uncertain		Approved	"Intermediate filaments,Actin filaments"		NA	NA			"Intermediate filaments"	"Actin filaments"	"HPA014674: AB_1859512"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	1.0	0.8	10.8	1.0	13.0	0.9	1.6	1.3	18.8	0.9	2.0	10.3	0.0	2.0	1.0	0.7	1.3	0.7	0.9	0.9	11.9	8.1	11.7	1.3	0.7	1.0	22.4	4.1	0.7	3.3	0.8	0.4	1.1	5.6	1.3	1.8	0.0	3.5	0.6	12.8	3.2	4.1	0.7	5.4	0.9	0.8	1.2	15.2	0.0	1.0	0.5	0.7	0.8	0.3	0.6	1.0	2.1	1.0	0.8	0.7	0.2	0.4	0.3	0.1	0.3	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.4	0.7	0.1	0.4	0.0	0.1	0.5	5.0	0.0	0.0	0.7	4.2	4.1	0.6	0.8	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.1	0.0	0.0	1.7	0.8	0.0	0.1	0.1	0.0	3.7	0.3	0.6	3.9	0.4	0.7	0.5	1.0	1.3	1.8	0.6	0.5	0.4	5.1	0.3	0.2	1.7	0.5	0.2	0.4	0.4	0.3	2.1	0.3	0.7	0.5	0.5	0.6	0.5	0.5	0.4	0.3	0.6	0.6	0.7	1.5	0.8	1.0	1.0	0.5	0.2	10.8	13.0	1.3	9.9	11.9	8.1	22.4	4.1	5.6	15.2	0.0	0.0	0.0	0.0	2.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.8	0.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.2	0.1	2.9	0.0	27.1	0.1	0.0	0.0	0.1	0.5	0.6	0.1	0.0	1.6	0.1
SLC25A51	"CG7943, MCART1, MGC14836"	ENSG00000122696	"Solute carrier family 25 member 51"	Q9H1U9	9	37879400-37904353	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 74.4;Late spermatids: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (5.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (6.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (8.27e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (2.08e-2)"	17.6	9.1	11.7	9.9	12.9	21.2	27.6	11.3	14.2	12.0	10.7	12.0	10.8	15.3	10.3	10.2	12.6	8.1	10.7	11.5	12.9	9.3	13.3	9.7	14.6	10.8	11.9	14.9	11.0	16.7	20.6	12.8	9.7	11.9	10.5	9.0	8.2	13.3	8.4	15.9	11.7	13.4	12.2	11.4	12.6	9.7	18.8	12.4	14.4	9.8	7.6	12.9	9.1	10.2	3.1	1.4	13.4	3.9	2.1	3.6	1.1	8.2	6.6	5.1	8.0	24.5	10.7	5.2	7.0	7.3	6.1	8.9	8.6	3.6	17.4	4.1	16.6	8.6	4.1	13.6	9.9	11.8	11.9	4.2	5.3	18.2	12.0	13.8	8.3	7.8	10.7	11.6	9.1	11.7	9.7	11.0	16.7	11.6	13.9	13.0	4.7	10.0	1.9	6.3	8.5	4.8	7.0	6.8	10.7	6.1	6.0	10.7	6.9	5.6	6.8	4.0	9.0	3.7	9.1	11.9	10.3	12.1	4.8	8.7	5.3	11.2	12.2	13.5	6.1	8.5	13.4	1.9	3.2	2.1	3.9	3.6	3.1	2.3	3.0	1.4	2.2	2.2	2.5	1.5	2.1	1.6	0.6	3.4	1.1	11.7	12.9	11.3	14.2	12.9	9.3	11.9	14.9	11.9	12.4	8.9	0.6	4.2	5.0	4.1	4.3	5.7	2.5	1.4	2.3	1.8	3.9	3.2	14.9	8.3	74.4	3.4	5.1	0.0	6.3	11.8	4.2	3.9	3.5	3.2	10.5	1.6	3.5	0.6	5.9	125.5	3.4	5.0	1.7	9.0	4.2	3.4	7.2	7.0	3.9	13.4	3.4	0.0	3.1	10.2	10.3	5.1	3.3	3.2	3.5	3.4
SLC25A52	MCART2	ENSG00000141437	"Solute carrier family 25 member 52"		18	31759562-31760880	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	17	"testis: 18.2"	"Group enriched"	"Detected in some"	10	"Early spermatids: 41.8;Late spermatids: 77.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.5"									"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (8.97e-2)"	"unprognostic (4.85e-2)"			"unprognostic (2.93e-1)"	"unprognostic (4.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.30e-4)"	"unprognostic (7.15e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.3	0.4	0.4	0.0	0.8	0.4	0.5	1.3	0.4	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.3	1.2	0.5	0.0	0.4	1.1	0.0	0.3	0.2	0.5	0.0	0.9	2.5	0.6	0.0	1.5	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.9	0.7	1.0	0.0	0.0	1.3	0.1	0.3	0.3	0.0	1.1	0.9	0.0	0.0	0.4	0.7	1.5	0.8	1.0	0.2	0.1	0.6	1.7	1.3	0.6	0.6	0.5	0.7	1.3	1.5	0.7	0.8	0.6	1.2	0.8	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.4	0.4	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.9	0.0	0.0	0.0	0.0	0.0
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.1;liver: 45.4"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 3.3;Hepatocytes: 9.0;Proximal tubular cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 13.3;HMC-1: 9.1;T-47d: 9.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.1	6.5	1.4	1.7	1.7	1.5	1.6	4.6	2.7	1.3	7.4	1.1	1.1	6.5	1.4	1.9	1.1	1.1	2.6	1.1	1.4	1.5	17.1	45.4	1.1	1.7	1.1	1.1	1.6	4.0	0.0	2.1	1.1	1.1	1.8	0.0	1.1	4.2	1.1	1.5	3.1	10.5	1.1	1.1	2.4	4.0	1.1	1.1	1.1	2.0	1.1	1.1	1.1	1.1	0.4	0.3	7.0	0.6	1.1	1.8	0.7	1.3	2.3	0.0	1.8	0.2	0.4	4.2	1.9	0.1	0.0	0.0	4.5	2.6	0.7	2.3	0.0	1.8	1.3	0.1	0.0	0.0	2.6	0.9	3.4	3.1	13.3	0.2	2.1	9.1	0.6	0.2	0.1	0.0	1.0	0.3	2.9	3.5	0.0	0.4	2.9	1.3	3.6	1.0	1.7	7.2	7.3	0.0	0.3	0.7	5.1	0.2	1.4	0.5	0.2	1.2	0.4	9.2	1.4	2.1	4.8	1.0	4.8	1.3	7.0	3.2	1.2	1.7	4.4	2.1	7.0	0.6	0.4	0.4	0.3	0.8	0.4	1.2	0.9	0.2	0.1	0.8	1.8	0.0	1.1	0.3	0.3	1.6	0.7	1.4	1.7	4.6	1.6	1.4	1.5	1.1	1.1	1.1	1.1	0.0	0.6	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	1.3	0.0	0.3	3.3	0.2	0.1	1.1	9.0	0.6	0.0	0.0	1.3	0.3	0.0	0.9	0.0	1.7	0.0	0.6	0.2	0.6	0.2	0.4	8.5	0.1	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.6	0.1
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	9.9	30.9	10.2	10.2	19.3	16.3	8.4	9.1	18.0	11.6	8.2	12.6	14.1	8.7	11.6	14.6	6.9	9.2	10.0	5.1	9.4	30.5	12.4	6.9	12.8	14.3	10.5	17.4	18.3	7.9	14.9	25.6	21.1	17.2	11.8	5.1	15.6	12.2	14.8	6.5	13.1	11.9	11.6	9.3	17.3	7.3	4.8	7.3	1.8	18.1	4.9	6.7	9.8	14.1	0.4	1.3	0.1	2.3	0.1	4.9	1.9	0.5	8.2	9.7	7.5	4.9	3.6	11.2	4.7	5.9	10.6	6.6	9.4	1.7	0.1	9.6	4.9	7.7	3.1	5.4	3.5	4.2	11.2	9.7	0.0	10.4	8.7	12.9	0.0	1.5	6.6	5.7	5.1	2.3	1.0	8.9	1.9	4.0	11.9	6.2	7.7	0.4	0.2	4.3	2.3	8.0	0.4	1.0	4.3	9.6	9.0	3.8	11.9	4.7	11.8	12.2	15.8	14.1	0.2	6.6	8.6	5.0	7.3	0.5	13.5	5.1	1.3	4.4	0.0	6.8	0.0	2.3	0.0	1.8	0.9	2.6	0.4	3.2	2.6	1.3	0.2	4.9	2.0	0.1	0.1	0.3	0.0	4.0	1.9	10.2	19.3	9.1	18.0	9.4	30.5	10.5	17.4	17.2	7.3	6.0	12.0	0.9	9.3	4.0	28.0	2.0	0.0	2.7	5.7	12.2	55.0	12.2	1.7	6.3	0.4	14.1	3.9	0.0	5.3	7.0	8.2	9.4	1.1	2.0	14.0	3.2	9.8	6.2	5.9	0.2	15.8	8.3	3.3	2.8	2.5	21.0	3.9	3.5	11.7	4.8	37.6	32.3	4.7	0.2	1.5	4.1	21.7	5.7	2.8	5.2
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960737-149993455	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 81.9"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 676.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.2;RPTEC TERT1: 55.5;TIME: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA041957: AB_10795646, HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	8.5	15.6	2.6	23.2	3.7	1.3	4.7	6.3	2.3	3.8	81.9	3.0	29.4	5.4	4.8	14.2	8.3	3.1	2.6	3.1	2.5	2.6	3.8	1.6	6.8	5.3	3.7	2.3	5.1	2.9	21.4	11.1	16.9	7.6	6.1	75.0	4.9	27.9	36.7	11.2	6.0	13.4	4.3	5.5	3.0	2.4	2.8	3.0	5.2	2.7	4.4	13.0	4.1	2.8	1.6	1.7	7.0	3.3	2.5	3.0	1.1	3.3	3.0	3.8	6.2	4.6	3.3	0.9	3.1	2.8	2.5	3.1	15.7	1.8	2.5	24.2	3.3	6.1	2.4	3.6	7.3	4.6	2.0	2.3	3.2	2.4	1.8	3.5	5.9	5.5	3.6	4.3	4.2	5.5	6.3	6.0	3.2	0.8	2.6	10.6	1.0	2.2	3.1	1.2	1.1	4.8	3.3	5.9	1.3	55.5	14.7	1.1	2.9	5.5	1.3	9.4	3.1	2.6	3.5	28.5	5.9	4.4	5.1	3.7	1.8	2.4	1.5	5.4	7.2	8.4	7.0	1.1	0.8	2.5	0.8	3.0	1.3	1.5	2.1	1.7	1.6	2.1	2.2	1.0	2.5	3.3	1.7	2.6	1.1	2.6	3.7	6.3	2.3	2.5	2.6	3.7	2.3	7.6	3.0	41.7	13.7	7.5	12.5	4.0	16.1	6.7	7.6	6.7	14.8	31.4	15.7	160.9	1.7	5.2	17.7	15.3	151.8	0.0	8.6	5.2	16.0	21.5	87.8	2.4	26.4	6.4	20.3	16.5	13.8	9.9	16.1	12.2	86.0	16.2	37.7	15.0	9.4	147.9	11.7	4.4	80.3	0.0	10.2	9.2	10.2	4.4	676.5	9.6	53.2	4.9
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 108.4"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 51.6;Cardiomyocytes: 25.8;Proximal tubular cells: 10.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.6;Hep G2: 4.7;OE19: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.1	6.4	0.1	0.1	0.0	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.1	0.1	0.0	0.1	108.4	0.1	0.1	1.9	0.1	0.1	0.1	0.1	17.8	0.1	0.1	0.2	0.4	1.1	2.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	51.6	0.0	0.0	0.0	0.0	25.8	0.0	4.0	4.5	1.8	0.0	0.0	1.7	2.9	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
SLC27A1	"ACSVL5, FATP, FATP1, FLJ00336, MGC71751"	ENSG00000130304	"Solute carrier family 27 member 1"	Q6PCB7	19	17468769-17506168	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.6;SK-MEL-30: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076520			Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Plasma membrane"	"Mitochondria, Cytosol"	"HPA076520: AB_2732311"	"unprognostic (1.48e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	14.5	14.3	13.1	5.2	13.9	2.0	9.3	20.1	19.3	11.8	6.4	44.1	10.1	4.6	8.9	6.4	5.9	14.7	11.0	18.3	12.9	10.0	5.2	5.2	8.5	6.7	22.0	17.2	23.2	14.5	26.1	9.8	7.5	16.1	11.0	2.6	9.6	26.7	13.0	24.2	13.7	3.7	5.5	13.4	7.1	10.9	9.6	19.3	1.3	9.9	4.7	5.3	6.9	8.8	0.5	7.4	0.3	9.9	1.7	3.2	4.6	3.6	1.8	2.5	6.1	17.6	9.8	2.1	2.6	7.0	3.0	4.5	0.2	11.3	1.2	5.0	4.4	2.8	4.4	0.2	4.1	0.7	1.4	0.8	0.7	0.2	1.3	3.4	0.3	4.0	9.0	2.9	3.0	1.2	12.5	2.0	2.4	0.4	0.7	1.9	1.5	2.0	2.9	0.7	3.6	3.2	2.8	2.0	0.8	1.9	1.1	0.8	1.8	1.8	0.9	29.1	1.6	3.2	0.9	1.2	5.9	3.9	4.7	1.8	2.5	1.8	0.4	6.1	3.2	4.1	0.0	9.9	0.3	1.7	4.7	3.2	0.5	1.2	2.1	7.2	0.3	1.6	2.1	0.0	1.7	1.8	7.4	0.7	4.6	13.1	13.9	20.1	19.3	12.9	10.0	22.0	17.2	16.1	19.3	3.0	14.0	1.5	14.9	6.0	8.2	16.7	10.2	4.0	9.1	8.7	25.5	3.7	1.7	9.3	0.7	4.7	0.1	0.0	4.1	14.7	9.7	10.3	2.3	5.8	24.7	6.4	5.2	9.2	20.6	1.7	19.8	9.1	8.5	5.4	2.6	9.7	4.9	0.0	11.0	2.7	17.6	6.5	5.2	8.1	4.3	4.0	1.9	6.1	1.3	7.0
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340646-128361470	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 56.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	7.7	7.1	9.9	7.0	13.6	2.5	4.9	9.4	26.5	6.5	25.7	15.8	5.2	54.0	6.6	5.6	26.1	4.4	9.8	7.7	11.6	15.9	17.7	20.8	5.8	5.0	14.8	9.6	5.6	11.3	9.8	5.4	5.8	21.9	5.7	8.3	6.7	7.5	7.3	6.7	24.3	56.1	8.1	11.6	5.1	8.6	13.2	7.9	6.8	12.7	15.2	14.9	8.5	9.5	3.7	7.2	2.6	6.2	1.9	8.1	3.3	10.2	20.1	10.3	13.2	15.7	4.8	11.8	8.7	5.5	10.1	7.3	14.4	10.1	9.6	7.0	9.3	12.1	35.2	12.4	10.0	3.1	9.6	19.1	5.7	17.7	12.5	8.5	10.5	9.2	6.3	13.7	10.4	8.3	4.5	11.4	13.0	13.5	6.7	9.2	25.2	12.4	10.1	4.6	23.2	32.0	15.2	10.1	17.8	17.2	15.5	17.9	9.8	14.5	26.7	9.5	5.4	13.3	4.0	16.7	12.1	11.8	13.2	10.7	6.0	8.5	3.1	12.3	6.3	13.6	0.0	4.1	2.6	8.1	5.6	6.1	3.7	5.2	6.4	7.2	1.7	4.1	4.3	1.6	1.9	6.2	6.4	3.6	3.3	9.9	13.6	9.4	26.5	11.6	15.9	14.8	9.6	21.9	7.9	0.0	1.4	3.0	1.2	2.5	9.3	2.8	7.6	1.4	0.0	8.7	11.8	4.9	1.7	12.4	2.2	3.3	75.1	0.0	13.8	5.7	3.8	2.4	9.2	15.5	9.9	7.9	12.6	4.9	7.1	3.6	1.1	2.9	1.7	12.6	14.0	4.8	20.8	31.7	3.9	8.1	6.2	6.5	2.7	8.8	6.9	5.4	4.3	1.7	12.4	2.6
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.2"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 22.4;Cytotrophoblasts: 39.8;Extravillous trophoblasts: 30.2;Muller glia cells: 39.4;Syncytiotrophoblasts: 23.0"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"BEWO: 31.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.5	23.2	6.3	0.5	6.8	0.3	2.9	0.6	2.8	4.1	0.9	8.2	0.0	0.6	4.2	0.5	7.2	19.5	2.7	20.6	3.2	3.3	0.2	0.3	0.9	0.4	10.4	0.0	9.7	0.3	0.2	7.7	19.6	13.3	3.7	1.8	1.7	3.9	0.4	0.5	2.2	1.1	1.0	12.7	0.3	0.6	11.3	15.1	5.4	3.9	8.7	5.5	1.5	3.2	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	31.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.6	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	2.4	0.0	2.2	1.5	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.2	3.1	0.0	3.7	0.0	2.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	6.8	0.6	2.8	3.2	3.3	10.4	0.0	13.3	15.1	0.0	0.0	0.0	1.0	2.9	0.0	22.4	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	6.2	0.0	0.0	0.0	0.0	30.2	0.9	0.1	0.0	0.0	3.4	3.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.0	0.6	23.0	0.0	0.0	0.0
SLC29A4	"ENT4, FLJ34923"	ENSG00000164638	"Solute carrier family 29 member 4"	Q7RTT9	7	5274369-5306870	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.7"	"Group enriched"	"Detected in many"	8	"Horizontal cells: 158.9;Intestinal endocrine cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.5;SH-SY5Y: 35.6;U-2 OS: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052829			Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Microtubules, Cytokinetic bridge"		"HPA052829: AB_2681967"	"unprognostic (6.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.49e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.60e-2)"	35.7	8.3	7.6	2.5	6.4	0.8	6.5	4.2	9.7	2.0	2.5	2.0	0.3	4.5	2.4	5.3	1.3	4.2	1.8	1.7	9.4	15.7	3.4	3.8	1.2	1.8	12.2	5.4	3.2	13.0	0.5	1.6	0.8	7.0	3.0	2.0	11.5	1.1	1.0	2.1	1.4	5.4	2.0	3.1	1.1	7.1	1.3	1.1	0.3	4.3	0.3	0.7	2.3	0.5	1.3	1.1	4.3	1.1	4.3	1.3	0.3	0.0	10.6	6.3	24.5	0.3	0.1	1.2	0.9	0.0	0.8	0.4	6.0	0.2	0.0	1.2	0.9	4.1	0.1	2.4	0.2	0.2	0.0	1.3	0.1	0.3	8.7	1.9	0.1	1.5	0.8	8.2	0.1	0.4	1.5	0.7	2.2	1.7	0.1	0.6	5.2	0.9	0.4	8.0	0.7	0.6	4.0	1.0	0.9	1.6	0.2	4.2	35.6	0.6	2.2	0.4	5.7	2.7	2.8	0.3	8.8	12.3	0.8	0.2	0.5	0.0	0.0	1.1	0.3	3.9	2.0	1.1	0.6	0.8	0.5	1.3	0.7	0.5	0.7	0.4	1.3	0.7	0.9	4.3	4.3	0.5	1.1	0.3	0.3	7.6	6.4	4.2	9.7	9.4	15.7	12.2	5.4	7.0	1.1	3.0	0.3	0.0	0.2	0.1	1.8	2.3	0.0	1.4	0.0	0.0	15.7	0.2	0.0	4.3	0.0	0.0	1.3	0.0	0.2	0.2	1.1	2.2	0.0	0.6	0.4	158.9	98.9	0.0	0.0	0.4	0.3	0.0	0.0	0.0	2.2	4.4	1.9	0.0	0.4	0.0	1.3	0.0	0.9	0.3	6.0	0.3	0.2	0.0	0.6	0.0
SLC2A13	HMIT	ENSG00000151229	"Solute carrier family 2 member 13"	Q96QE2	12	39755021-40106089	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.7;parathyroid gland: 43.0"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 87.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006584, HPA061679"	Enhanced		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA006584: AB_1849755, HPA061679: "	"unprognostic (1.66e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.16e-2)"	3.8	7.2	9.8	3.3	18.0	1.2	3.0	4.0	27.7	13.0	7.4	2.8	0.3	6.0	5.9	5.3	3.7	2.9	4.0	4.9	8.2	14.1	10.7	6.2	3.7	1.9	14.9	11.0	3.1	5.0	43.0	11.1	4.6	4.8	3.0	6.8	2.4	4.2	2.6	1.2	2.1	8.3	4.7	2.7	2.3	5.6	2.0	4.1	0.6	2.2	0.9	1.4	3.9	3.9	2.0	0.1	1.5	0.5	0.6	0.9	0.0	0.6	3.6	2.6	1.2	18.5	7.7	5.3	5.8	4.1	2.6	3.4	0.0	1.7	2.2	4.3	4.6	3.6	0.3	1.8	1.8	2.2	1.9	5.4	1.7	9.1	1.3	2.9	4.9	2.9	3.8	1.7	1.2	2.2	1.5	1.2	2.2	0.7	5.7	5.9	0.6	0.7	4.1	2.9	0.0	2.5	0.0	4.0	1.2	4.8	2.2	3.3	3.4	2.3	4.5	1.5	4.1	2.5	4.3	1.1	3.5	1.3	12.4	3.4	4.5	0.1	1.4	6.4	2.8	2.2	0.0	0.5	1.5	0.4	0.2	0.3	0.1	0.4	0.9	0.0	2.0	0.2	0.5	0.8	0.6	0.1	0.1	0.1	0.0	9.8	18.0	4.0	19.8	8.2	14.1	14.9	11.0	4.8	4.1	8.9	17.1	4.7	1.7	3.7	4.3	3.5	10.2	5.3	2.3	8.7	0.0	5.0	0.0	4.3	2.5	5.2	35.1	0.0	10.9	2.1	7.1	2.7	10.3	8.5	7.2	87.4	19.5	8.0	7.9	2.1	21.3	7.4	15.1	6.4	21.3	2.0	8.7	29.4	7.1	6.4	1.3	6.5	6.1	0.9	1.9	4.5	3.1	4.4	11.1	1.4
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 52.4"	"Cell type enriched"	"Detected in many"	7	"Spermatocytes: 60.6"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2"									HPA006539	Supported		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.4	3.1	0.1	0.1	0.6	3.0	0.4	0.1	0.2	0.4	0.4	0.3	0.1	0.0	0.3	0.8	0.8	0.1	0.3	0.1	0.2	0.3	0.1	2.0	0.2	0.2	0.1	0.1	2.7	7.4	0.0	0.6	0.5	0.3	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0.0	52.4	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.6	0.4	6.9	0.7	1.3	1.7	0.2	0.0	0.3	0.3	0.2	0.2	0.6	12.6	0.0	0.0	0.0	0.2	20.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.1	0.5	5.3	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.9	0.1	0.0	0.1	0.1	0.1	2.3	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.0	25.2	0.0	1.3	0.3	0.1	0.5	0.3	0.1	0.1	0.1	0.2	0.3	0.0	0.3	5.5	0.7	1.8	1.0	0.2	1.2	0.5	1.0	0.8	0.4	0.6	0.7	0.9	6.9	1.3	0.2	0.3	1.7	0.2	0.1	0.6	0.1	0.2	0.2	0.3	0.1	0.1	0.3	0.2	0.0	0.6	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	3.7	2.3	0.0	0.0	1.3	0.9	1.9	0.0	9.2	0.4	0.2	0.0	0.0	8.0	4.4	0.9	0.3	3.1	1.7	0.0	0.0	0.0	0.5	5.8	2.5	0.0	0.4	0.0	4.2	60.6	2.7	0.1	0.3	3.2	0.0	0.0
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936275	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 166.3"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 462.0"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 30.2;neutrophil: 55.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 55.6"	"Group enriched"	"Detected in many"	5	"BEWO: 143.6;CACO-2: 154.0;SuSa: 113.9"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		NA	NA		33000000	"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.36e-8)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	48.8	10.0	9.5	25.2	10.5	166.3	26.4	13.1	24.3	9.4	10.0	6.8	1.8	4.2	10.3	8.2	13.2	8.0	25.6	22.8	10.8	13.6	10.3	14.1	32.4	12.8	13.3	3.3	18.8	6.1	6.9	10.9	43.9	13.7	15.0	6.9	14.8	3.8	3.9	13.6	7.4	5.8	18.7	15.4	16.4	7.0	10.6	12.5	3.3	15.7	7.0	13.6	51.8	10.5	1.8	2.4	55.6	4.6	3.6	6.4	3.5	0.0	0.7	6.6	2.5	2.4	8.5	143.6	2.3	2.5	2.3	5.4	154.0	1.0	0.1	0.0	1.6	3.2	0.0	0.2	0.3	4.2	4.5	0.1	8.9	0.6	20.2	6.7	3.2	13.0	3.5	0.2	6.1	2.8	5.4	2.1	0.7	4.1	2.1	2.1	0.0	0.2	3.4	29.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.0	113.9	0.0	0.4	2.1	2.9	1.5	5.6	0.2	0.0	6.2	0.4	8.5	1.5	1.5	30.2	4.6	7.0	6.4	0.5	5.3	1.8	4.4	4.9	2.4	1.7	2.8	3.8	55.6	3.6	0.2	0.1	5.8	3.5	9.5	10.5	13.1	13.3	10.8	13.6	13.3	3.3	13.7	12.5	134.0	147.7	116.7	2.9	115.1	27.9	8.4	7.6	18.7	48.9	3.5	58.9	41.5	0.0	0.2	2.4	227.7	0.0	0.0	0.0	218.4	149.1	3.8	462.0	1.0	97.9	4.8	1.2	85.3	85.8	1.9	9.5	229.2	173.7	1.0	0.0	19.2	0.8	0.2	7.4	1.2	68.8	116.4	236.4	1.4	0.6	71.6	93.1	133.8	0.0	2.8
SLC2A4RG	"GEF, HDBP1, Si-1-2, Si-1-2-19"	ENSG00000125520	"SLC2A4 regulator"	Q9NR83	20	63739861-63743505	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 90.0;Proximal tubular cells: 114.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in single"	4	"T-cells: 3.1"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063050			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA063050: AB_2684930"	"unprognostic (2.89e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.07e-3)"	"unprognostic (6.48e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.22e-1)"	30.9	10.5	6.3	7.4	6.1	13.0	16.4	5.4	7.5	19.3	14.2	6.7	18.9	5.2	11.7	17.9	25.1	10.1	19.6	19.3	5.2	4.4	19.3	37.5	10.6	18.6	5.8	4.2	25.1	17.3	5.1	6.9	9.4	6.3	23.4	2.6	16.1	14.7	15.0	71.0	20.2	9.1	29.4	5.0	14.4	11.3	13.2	3.3	6.1	9.3	19.9	16.2	19.3	11.6	0.0	0.7	0.5	0.2	0.6	3.1	0.0	17.8	12.2	5.4	9.1	4.0	10.1	7.3	11.7	9.5	25.6	9.0	22.1	31.3	2.3	19.6	5.8	9.1	18.5	1.8	13.7	2.8	10.8	5.9	2.2	9.3	12.9	11.9	7.7	6.4	10.9	18.3	5.0	5.7	5.8	7.2	3.3	8.6	3.6	8.8	21.6	4.6	16.4	2.7	12.8	34.8	21.5	11.7	8.6	8.5	4.9	7.3	13.6	24.0	14.0	3.1	1.3	32.8	29.1	6.9	33.8	13.9	20.5	9.4	9.8	14.2	5.4	14.9	6.8	8.8	0.0	0.1	0.5	2.0	0.0	0.8	0.0	3.1	1.8	0.3	0.0	3.0	1.9	0.0	0.6	0.2	0.7	1.8	0.0	6.3	6.1	5.4	7.5	5.2	4.4	5.8	4.2	6.3	3.3	8.9	20.5	8.2	28.4	21.8	10.7	18.2	17.8	4.0	9.1	40.1	9.8	26.5	66.3	6.8	5.2	19.2	10.5	23.3	9.2	14.2	34.0	13.4	3.5	90.0	12.4	9.5	2.4	15.4	14.2	3.3	26.7	8.6	3.3	14.4	18.8	22.3	13.9	9.3	32.5	114.1	6.5	32.3	17.6	0.9	5.6	33.1	7.2	22.3	14.5	10.1
SLC2A8	"GLUT8, GLUTX1"	ENSG00000136856	"Solute carrier family 2 member 8"	Q9NY64	9	127397138-127408424	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 119.6;Late spermatids: 229.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 33.8"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 33.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 46.6;Hep G2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011935	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA011935: AB_1849760"	"unprognostic (6.49e-2)"	"prognostic favorable (2.57e-6)"	"unprognostic (9.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (9.86e-6)"	"unprognostic (1.70e-1)"	"prognostic favorable (6.55e-6)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.04e-3)"	10.9	24.5	11.4	13.3	11.3	3.5	10.4	15.0	15.2	9.0	19.8	11.7	37.0	17.7	9.5	17.4	8.7	6.0	9.4	9.8	10.4	9.3	8.7	25.7	8.1	7.3	12.5	10.2	6.7	12.1	5.7	5.5	13.2	8.7	18.5	6.5	12.5	9.4	28.3	22.6	11.6	17.0	44.1	10.3	11.3	13.1	30.6	9.3	1.2	9.1	6.9	4.3	42.4	9.1	2.4	33.8	6.9	5.6	1.2	6.3	2.0	1.8	7.2	3.2	7.2	0.0	0.0	10.2	2.8	1.9	4.5	2.7	46.6	1.7	2.8	6.4	1.5	7.2	9.7	3.9	4.5	1.1	2.6	6.2	0.4	5.7	27.5	4.2	0.0	3.0	0.1	4.2	0.4	1.8	2.2	3.5	3.9	2.9	6.3	1.8	13.1	0.0	0.0	5.2	10.2	11.3	1.0	4.5	7.8	4.2	19.3	5.4	3.7	6.7	11.5	2.5	4.3	7.4	1.6	3.0	0.0	4.7	0.3	6.2	19.5	18.2	4.2	3.1	0.0	3.4	0.0	3.0	6.9	4.9	5.6	3.5	2.3	1.6	3.3	4.6	2.4	0.3	1.2	0.2	1.2	5.1	33.8	6.3	2.0	11.4	11.3	15.0	15.2	10.4	9.3	12.5	10.2	8.7	9.3	8.9	9.6	5.4	6.1	9.8	11.1	6.1	7.6	5.3	4.5	5.2	9.8	66.2	13.3	12.0	119.6	7.4	15.1	23.3	14.7	10.8	11.6	11.0	6.9	23.6	59.6	6.4	11.6	12.9	12.4	229.4	10.0	8.2	25.3	8.2	13.3	14.9	15.9	21.5	11.0	12.2	7.7	12.9	8.1	38.0	10.9	9.3	56.3	6.9	15.6	5.5
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046133	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 78.0;placenta: 20.0"	"Cell type enhanced"	"Detected in many"	16	"Cytotrophoblasts: 23.2;Exocrine glandular cells: 18.5;Proximal tubular cells: 27.2;Syncytiotrophoblasts: 71.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"BEWO: 4.7;RPTEC TERT1: 10.6;WM-115: 6.5"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Not detected"	"Not detected"			HPA017979			Approved	Vesicles		NA	NA			Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	0.7	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.0	1.3	1.1	0.1	0.1	4.0	2.2	0.1	0.1	10.4	0.1	0.2	0.1	0.1	0.1	0.1	78.0	0.1	0.1	20.0	0.1	0.3	0.0	2.0	1.0	1.4	1.7	0.4	0.6	0.1	0.1	0.1	0.1	0.4	0.1	0.1	12.8	0.2	0.1	0.5	0.1	1.5	1.1	3.1	1.0	1.5	0.9	0.4	0.2	0.2	0.2	1.0	0.3	0.1	4.7	0.4	0.2	0.1	0.1	0.9	1.0	0.2	0.9	0.1	0.2	0.9	0.2	0.3	0.1	0.6	0.3	0.6	0.7	0.1	0.1	0.6	0.7	0.0	0.2	0.1	0.1	0.3	0.0	0.3	0.6	1.5	0.1	0.8	0.5	0.9	0.8	0.4	0.2	0.3	0.7	0.7	10.6	0.4	0.9	0.5	0.6	1.1	0.4	1.6	0.7	0.5	0.6	0.7	1.2	0.6	0.3	1.1	0.6	0.8	0.5	0.6	6.5	3.1	1.0	0.4	0.9	0.4	0.5	0.7	0.6	0.8	0.2	1.5	0.6	0.8	3.1	1.5	0.5	1.1	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.0	4.0	0.0	0.7	0.3	2.4	5.1	15.3	0.0	0.0	8.7	0.0	23.2	5.0	6.8	0.0	0.5	0.4	0.0	18.5	2.4	0.6	0.6	4.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	1.8	0.1	0.5	5.4	0.0	0.0	27.2	1.8	6.5	0.9	0.2	0.4	0.6	71.2	0.0	0.6	0.7
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.7;epididymis: 41.0;testis: 19.5"	"Group enriched"	"Detected in some"	18	"Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9"	"Group enriched"	"Detected in many"	5	"amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6"	"Group enriched"	"Detected in many"	7	"amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.5	1.9	15.8	0.5	11.4	0.5	0.4	0.4	28.7	0.5	0.5	0.0	1.9	0.4	0.5	41.0	0.4	0.7	0.4	5.0	10.2	0.8	0.4	0.5	0.5	0.8	1.1	12.1	0.5	0.4	0.6	0.4	0.4	1.6	0.6	0.5	0.7	0.4	0.9	0.4	0.4	0.5	0.5	0.7	0.5	0.4	19.5	0.0	0.0	0.4	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.0	1.5	0.0	0.2	0.1	0.0	0.0	1.0	1.0	0.3	0.4	0.0	0.0	0.0	8.0	0.2	8.8	0.0	0.2	0.0	1.0	5.0	0.2	11.7	0.2	0.1	2.0	0.0	0.0	0.5	0.0	0.1	0.7	2.4	1.4	0.0	0.1	3.8	0.0	0.3	1.5	0.2	0.0	19.0	9.9	1.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.2	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	15.8	11.4	0.4	28.7	10.2	0.8	1.1	12.1	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	29.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.3	18.7	9.4	0.1	0.1	0.0	0.0	0.0
SLC30A5	"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1"	ENSG00000145740	"Solute carrier family 30 member 5"	Q8TAD4	5	69093646-69131069	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035373	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035373: AB_10794630"	"unprognostic (9.81e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	19.4	22.1	14.4	19.4	15.7	13.3	29.7	14.9	18.5	25.0	20.9	13.2	33.7	19.7	24.3	32.4	20.5	20.3	23.5	25.4	14.5	15.4	28.6	39.2	24.3	23.7	15.5	13.1	25.4	50.5	29.6	38.1	34.3	13.9	24.5	19.8	17.6	36.8	35.3	17.1	21.2	25.0	18.1	13.2	20.1	20.3	18.1	12.7	22.1	33.5	18.8	19.6	18.2	28.9	8.3	13.2	12.4	6.9	5.6	9.1	3.3	15.7	12.2	11.4	20.0	30.1	23.2	36.2	25.0	22.7	15.8	24.2	11.2	19.8	20.9	31.9	17.0	27.7	17.0	15.8	18.9	26.8	24.9	18.2	23.3	15.4	18.3	24.2	14.6	26.0	15.6	25.1	16.2	19.4	22.2	15.3	14.5	14.0	25.0	20.1	19.9	19.2	30.4	12.9	10.7	14.0	15.4	14.5	37.7	23.6	14.8	20.4	16.2	19.8	19.9	33.9	16.6	19.2	32.5	13.9	10.3	13.4	25.7	24.7	22.7	27.9	16.3	20.3	26.6	25.4	12.4	6.7	10.7	6.1	6.8	6.5	8.3	9.1	8.9	8.4	6.3	8.4	7.1	5.9	5.6	6.9	13.2	6.1	3.3	14.4	15.7	14.9	18.5	14.5	15.4	15.5	13.1	13.9	12.7	17.9	15.5	9.0	22.6	16.7	13.9	26.2	12.7	14.7	14.8	24.4	21.6	35.4	24.9	18.8	5.2	16.6	12.3	23.3	23.5	60.9	24.0	28.7	41.4	17.4	19.6	7.9	12.7	19.0	17.3	6.7	22.5	16.4	13.5	12.6	24.9	13.4	17.8	21.0	20.8	16.1	22.6	25.8	20.9	9.9	14.9	18.7	43.1	20.3	21.7	24.2
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150942-113164137	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 60.2;salivary gland: 125.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 80.2;Kupffer cells: 82.1;Macrophages: 93.6;monocytes: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.2;hTCEpi: 33.7;hTERT-HME1: 23.1;LHCN-M2: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	15.7	8.0	10.0	8.1	20.5	7.0	8.5	3.2	15.0	3.0	8.4	45.1	27.1	5.2	2.0	6.0	4.6	3.0	4.5	3.4	18.2	9.4	9.8	11.2	10.0	6.2	34.3	10.5	2.8	7.8	17.9	1.2	10.2	22.3	2.1	4.4	1.0	125.5	21.8	6.7	18.5	9.9	3.8	48.5	14.1	4.5	5.4	26.2	1.2	2.8	2.9	5.8	3.9	4.1	0.3	21.2	54.5	60.2	0.2	1.2	13.4	5.5	2.5	1.4	2.0	22.2	9.1	4.8	4.2	5.4	5.1	4.9	1.8	1.7	0.3	0.8	3.5	8.3	20.6	2.0	12.0	4.8	2.8	0.8	0.3	1.2	2.9	8.5	2.2	1.2	10.2	33.7	11.9	23.1	2.7	2.7	2.7	1.6	3.0	26.6	5.3	2.1	1.3	0.7	2.8	2.3	0.4	20.1	0.4	1.7	3.4	1.3	2.2	5.8	17.8	1.7	1.2	6.4	2.0	2.5	2.8	1.9	9.2	3.6	1.9	3.9	0.2	8.8	2.9	2.8	0.8	36.6	3.6	0.9	50.5	1.2	0.2	1.0	1.0	21.2	0.3	0.8	0.8	54.5	0.2	60.2	0.5	0.6	13.4	10.0	20.5	3.2	15.0	18.2	9.4	34.3	10.5	22.3	26.2	8.9	8.6	18.0	5.3	33.0	6.9	0.4	2.5	10.7	5.7	1.8	33.4	80.2	3.3	10.7	2.3	6.7	17.4	0.0	6.6	5.8	13.3	7.9	0.0	18.7	55.9	6.4	3.4	17.2	82.1	2.0	14.7	93.6	0.0	89.2	3.2	8.2	13.8	7.0	8.9	17.4	9.1	19.4	8.9	30.6	5.1	33.5	36.0	8.3	3.5	4.2
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042430, HPA060345"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042430: AB_10806238, HPA060345: AB_2732647"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	11.3	17.3	6.5	9.9	8.6	3.1	12.1	9.4	9.4	18.8	13.1	10.5	29.9	11.3	14.0	22.9	11.8	12.3	11.5	12.9	7.8	6.7	19.4	38.3	12.8	13.6	9.4	5.6	13.6	42.4	18.8	24.6	13.9	8.9	15.0	10.5	9.2	26.6	33.9	7.0	9.4	15.2	10.4	8.2	11.9	12.4	8.9	8.8	14.9	26.1	5.8	10.7	10.2	11.6	6.0	16.7	12.1	8.3	6.9	10.8	6.0	14.9	10.4	5.4	6.7	20.0	17.3	10.2	11.2	15.0	13.6	13.4	5.9	16.0	7.7	18.1	9.1	14.2	12.7	9.3	11.0	15.4	10.9	9.6	8.0	5.0	11.6	29.0	8.8	7.1	13.8	22.1	7.2	28.1	15.2	14.9	7.3	6.4	18.6	12.2	9.5	3.5	5.2	5.2	12.6	10.0	4.0	6.0	23.1	13.9	9.5	6.3	5.2	9.4	21.9	19.9	8.0	6.9	11.2	15.4	8.0	4.0	14.7	11.7	21.9	7.7	8.1	11.5	7.2	11.4	12.1	8.3	6.0	9.4	6.5	10.8	6.0	6.8	7.4	10.7	4.1	6.5	6.3	1.8	6.9	6.3	16.7	6.1	6.0	6.5	8.6	9.4	9.4	7.8	6.7	9.4	5.6	8.9	8.8	20.8	20.6	11.9	10.4	7.9	16.4	21.8	22.9	21.4	18.2	10.4	25.5	15.7	5.0	13.3	10.1	11.3	14.8	0.0	13.5	23.4	14.7	16.8	11.5	43.1	17.3	17.5	12.0	18.4	16.2	9.1	17.3	15.9	11.8	14.4	14.7	17.2	15.0	3.5	20.1	15.5	19.9	12.9	17.2	17.2	7.2	8.3	31.5	15.8	12.1	9.1
SLC35A4		ENSG00000176087	"Solute carrier family 35 member A4"	"L0R6Q1, Q96G79"	5	140564456-140569103	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062210			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA062210: AB_2684712"	"unprognostic (3.01e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.56e-5)"	"unprognostic (2.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.55e-1)"	22.0	30.4	12.3	18.6	17.1	8.4	19.6	14.0	21.8	18.2	25.5	24.9	22.6	19.2	18.2	19.8	30.3	20.6	26.0	25.7	13.1	10.3	35.1	39.2	23.1	22.5	16.0	11.1	19.0	28.3	28.2	14.9	24.6	19.4	20.4	26.5	20.5	32.6	15.9	54.3	28.3	30.6	19.8	13.0	28.5	21.7	30.5	15.3	26.0	29.2	28.0	27.5	18.3	18.0	15.4	32.8	15.8	36.9	26.9	27.6	32.4	15.5	46.7	18.7	35.2	25.7	16.1	27.9	22.7	15.3	27.7	29.2	56.5	18.0	46.0	28.1	21.3	32.3	17.2	0.0	33.1	23.8	55.9	25.6	34.4	45.6	0.2	18.3	33.6	26.0	21.3	25.9	27.5	24.7	13.0	23.7	22.8	26.6	46.5	27.4	28.8	35.0	14.6	12.7	22.4	23.9	26.1	37.9	39.9	20.7	30.8	20.9	27.9	28.7	47.8	22.3	19.2	39.7	14.4	27.7	24.9	17.4	24.7	25.4	19.3	45.3	19.3	18.4	38.0	28.9	7.5	26.9	15.8	27.6	36.9	26.3	14.3	22.1	24.7	32.8	15.4	25.9	23.0	9.9	26.9	33.3	12.0	14.7	32.4	12.3	17.1	14.0	21.8	13.1	10.3	16.0	11.1	19.4	15.3	11.9	24.8	21.9	20.2	9.3	12.2	23.8	43.3	6.7	17.0	15.7	3.9	26.8	38.1	28.1	58.7	14.7	37.1	0.0	30.4	42.8	19.5	22.2	20.7	19.5	28.5	12.7	24.2	27.6	21.1	94.4	11.5	15.8	16.9	31.5	27.2	20.3	31.1	21.0	11.7	31.1	8.5	32.3	12.6	5.4	16.4	10.2	25.5	20.3	28.7	29.1
SLC35A5	FLJ20730	ENSG00000138459	"Solute carrier family 35 member A5"	Q9BS91	3	112561709-112585577	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035519, HPA057964"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035519: AB_10601487, HPA057964: AB_2683566"	"unprognostic (7.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.60e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.42e-1)"	13.4	17.7	19.4	11.2	22.1	4.4	13.0	14.2	24.1	15.0	13.6	32.7	9.7	14.9	15.2	15.0	13.0	13.3	13.8	9.6	22.9	22.0	18.2	18.0	12.8	12.4	37.8	19.5	16.9	12.6	17.9	17.6	17.2	27.5	14.8	14.8	14.4	11.7	13.4	5.5	8.0	15.5	14.1	42.9	12.7	12.5	15.4	26.6	11.6	23.8	6.4	13.1	13.2	10.4	12.0	15.2	15.7	20.1	5.2	11.5	7.8	11.3	10.3	17.6	10.7	23.1	22.0	10.2	18.5	13.5	16.0	18.3	7.6	13.0	10.3	15.9	16.2	18.1	14.3	12.8	8.9	20.1	7.7	6.3	12.9	9.9	6.7	19.1	11.5	12.4	19.1	17.8	14.1	8.7	20.1	14.2	7.9	7.4	12.7	21.9	4.0	8.7	7.3	11.9	13.0	11.0	7.7	6.6	10.6	19.7	8.5	10.3	14.0	12.0	5.9	21.0	12.7	7.9	8.1	15.9	23.3	12.8	5.0	8.5	8.9	12.8	17.9	17.3	9.6	17.0	8.4	12.6	15.7	8.9	19.8	8.3	12.0	8.5	7.0	15.2	11.5	11.5	9.4	11.2	5.2	20.1	7.2	8.4	7.8	19.4	22.1	14.2	24.1	22.9	22.0	37.8	19.5	27.5	26.6	3.0	8.5	10.0	7.0	5.7	12.3	4.7	10.2	5.3	6.8	14.0	0.0	30.6	8.3	6.8	94.9	12.4	12.4	0.0	6.7	20.1	15.1	7.4	13.9	10.2	15.8	35.0	7.5	12.9	19.1	17.6	15.8	9.1	25.3	11.8	10.7	18.5	6.5	12.9	16.3	12.3	14.0	25.8	9.9	15.4	10.0	5.8	24.9	10.9	8.5	2.7
SLC35B1	UGTREL1	ENSG00000121073	"Solute carrier family 35 member B1"	P78383	17	49700943-49709014	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048655, HPA057418"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA048655: AB_2680481, HPA057418: AB_2683432"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.36e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.17e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (5.69e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-2)"	8.5	8.3	8.4	7.4	11.8	8.0	10.7	8.2	14.0	9.3	13.0	9.3	9.2	13.7	7.6	26.5	9.4	9.9	7.3	15.8	8.6	9.2	16.0	46.7	10.1	16.0	9.8	7.9	7.5	22.3	13.5	13.2	12.4	9.9	7.4	13.1	8.4	22.4	12.7	33.7	9.2	27.3	8.0	8.1	10.2	9.3	9.1	7.1	6.5	19.7	13.8	10.8	9.9	6.7	6.6	25.0	8.1	15.1	7.0	9.5	7.9	13.6	22.9	17.2	27.0	15.8	9.9	19.5	14.5	23.6	30.9	24.8	47.3	16.0	9.5	34.0	20.1	18.6	10.2	27.1	17.3	33.9	11.6	19.8	12.0	15.1	27.7	27.6	22.5	11.4	10.1	19.0	22.2	27.8	7.9	19.0	15.6	11.7	27.4	21.2	27.8	16.5	14.6	7.6	25.6	25.9	11.1	18.6	25.7	15.1	14.5	14.9	19.1	8.5	6.8	9.9	19.3	21.8	15.4	8.1	23.6	10.5	25.2	19.0	14.5	23.8	14.2	15.4	17.1	20.6	8.1	15.1	5.0	9.5	13.5	6.9	6.6	6.5	8.9	16.7	3.6	6.6	6.0	6.7	7.0	9.1	25.0	7.4	7.9	8.4	11.8	8.2	14.0	8.6	9.2	9.8	7.9	9.9	7.1	14.9	27.2	30.7	36.3	19.8	25.8	35.5	20.4	30.8	31.8	26.2	33.4	49.1	29.9	55.6	40.4	35.0	41.9	0.0	89.2	91.8	36.1	53.6	41.5	49.5	66.9	20.6	48.6	22.7	21.3	11.3	27.9	37.0	35.4	45.9	30.5	41.4	64.2	27.5	19.4	37.9	30.4	12.9	15.3	44.2	33.8	22.0	67.3	35.2	36.0	37.4
SLC35B2	UGTrel4	ENSG00000157593	"Solute carrier family 35 member B2"	Q8TB61	6	44254096-44257890	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029638	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA029638: AB_10602402"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	18.0	28.2	14.8	12.6	15.0	10.7	17.7	16.2	24.8	18.3	18.9	35.8	19.0	13.0	22.6	23.4	14.3	18.6	27.1	17.7	15.2	10.9	32.3	35.5	16.1	12.9	17.1	14.6	16.7	38.1	27.4	11.1	26.1	19.8	19.0	20.2	23.8	49.6	20.4	17.5	15.6	16.4	20.5	24.7	18.4	20.6	16.3	18.7	12.2	19.3	17.8	17.6	19.6	14.3	12.9	14.4	21.8	8.6	10.8	21.1	10.2	23.1	13.3	16.7	32.0	27.5	29.1	12.2	25.4	42.1	25.0	30.8	11.7	21.6	5.2	22.9	31.4	26.9	22.1	11.4	28.6	17.6	15.3	14.7	10.4	10.5	13.9	25.7	22.2	17.0	29.8	30.1	23.0	11.3	34.6	18.3	11.9	14.9	22.4	29.9	27.2	8.2	18.6	7.4	69.9	15.5	8.2	10.8	26.4	27.0	17.2	20.8	20.0	12.5	13.9	28.6	10.9	25.8	20.4	18.1	19.7	13.1	19.6	22.1	17.3	19.7	12.1	26.3	17.7	40.0	21.8	8.6	13.2	21.1	6.5	17.8	12.9	11.9	16.1	7.7	7.7	11.0	14.2	0.7	10.8	2.3	14.4	9.6	10.2	14.8	15.0	16.2	24.8	15.2	10.9	17.1	14.6	19.8	18.7	6.0	11.5	22.3	25.5	11.9	9.7	6.7	43.3	5.3	11.4	26.2	2.0	50.8	11.6	69.2	0.4	9.8	13.7	0.0	64.7	44.1	30.6	27.0	34.6	15.3	32.9	9.5	18.9	16.0	9.9	1.2	21.6	10.0	50.6	32.5	20.3	42.2	56.9	27.4	18.7	11.5	12.5	0.0	16.7	15.2	67.3	12.2	29.4	13.1	29.9	18.4
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	16.8	25.9	19.4	26.7	24.0	25.6	17.5	30.3	25.0	19.1	19.3	22.8	21.3	22.0	19.2	20.9	23.4	24.3	20.2	13.5	19.0	12.9	20.7	26.7	17.4	22.9	19.9	13.6	21.0	30.5	18.0	23.7	29.8	17.7	23.6	12.2	28.9	30.9	17.3	13.4	25.6	20.7	15.8	19.3	26.1	21.6	19.6	23.3	19.7	23.0	13.5	23.4	19.1	19.3	17.4	42.9	26.8	21.9	18.3	28.3	23.5	14.3	17.4	8.1	6.4	11.3	10.9	15.0	7.8	14.9	8.8	10.5	24.3	22.9	9.6	26.8	9.3	11.9	20.3	4.6	17.7	3.3	7.8	13.6	8.5	10.6	19.4	21.5	11.0	10.1	15.7	22.7	12.5	14.6	9.7	7.3	10.6	13.3	17.7	6.5	34.8	7.8	16.5	10.5	15.4	16.9	7.3	8.7	18.6	11.1	14.2	12.0	16.6	7.3	38.1	24.4	5.2	22.5	19.3	7.0	22.7	14.5	11.4	12.4	23.7	19.4	9.9	25.7	12.6	10.1	19.0	21.9	26.8	23.8	21.5	22.2	17.4	24.4	24.0	23.9	16.9	28.3	25.5	19.5	18.3	16.7	42.9	22.1	23.5	19.4	24.0	30.3	25.0	19.0	12.9	19.9	13.6	17.7	23.3	14.9	15.5	28.6	25.7	12.8	31.2	5.9	17.8	12.0	18.2	26.2	39.3	80.2	11.6	34.0	4.6	13.5	26.5	0.0	53.8	43.9	23.9	32.4	14.9	23.7	33.9	17.5	20.2	28.3	19.1	4.3	17.8	17.0	20.3	45.1	31.2	21.9	31.3	30.6	18.0	15.4	29.4	19.4	14.4	15.6	21.0	14.4	66.2	25.9	27.7	28.5
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922264-136925639	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;retina: 16.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Group enriched"	"Detected in some"	4	"basal ganglia: 9.9;hypothalamus: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 18.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 26.6;olfactory region: 10.4"	"Region enriched"	"Detected in many"	6	"basal ganglia: 24.4"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.1	4.9	0.0	0.4	9.9	1.2	0.1	0.0	0.4	2.0	0.4	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	0.4	0.0	4.8	4.0	0.0	2.1	0.0	1.7	0.0	0.8	1.2	0.0	0.0	0.1	0.5	4.3	0.6	16.4	0.2	0.1	0.0	0.2	1.3	0.3	0.0	0.2	3.2	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	18.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	9.9	0.0	0.4	0.0	4.8	1.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1
SLC35E2	KIAA0447	ENSG00000215790	"Solute carrier family 35 member E2"	P0CK97	1	1724838-1745999	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 22.1;Ciliated cells: 10.7;Club cells: 11.4;Horizontal cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA006118, HPA062711"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA006118: , HPA062711: AB_2684844"	"unprognostic (3.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-4)"	"unprognostic (9.52e-4)"	"unprognostic (6.57e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.87e-4)"	3.0	4.1	8.0	5.2	5.1	0.6	3.0	9.8	6.2	4.0	3.0	2.9	1.6	4.9	6.0	10.5	4.5	5.8	7.6	3.0	5.0	3.5	2.5	2.4	4.8	11.6	4.4	4.7	5.5	3.5	6.9	5.9	3.5	4.0	3.6	5.4	3.6	9.1	1.6	4.7	6.4	4.8	3.7	3.7	6.8	6.2	6.2	5.5	5.5	3.5	3.8	4.3	4.3	7.7	5.0	5.2	6.4	3.4	3.1	6.5	3.2	1.6	1.6	5.4	11.5	11.2	11.0	3.6	7.4	15.3	7.0	9.0	4.6	15.1	4.9	1.3	1.7	1.7	7.5	1.4	2.9	7.6	6.8	1.7	6.4	7.5	1.2	2.3	1.3	7.2	8.8	3.7	1.2	6.3	5.8	2.1	9.2	2.1	2.2	1.3	1.2	1.9	3.2	1.0	0.9	1.9	3.7	5.0	1.0	7.4	5.3	15.2	3.1	2.2	9.2	8.8	1.3	17.9	3.6	9.6	7.3	1.5	2.2	0.4	3.0	0.4	1.6	5.2	3.9	1.2	6.4	3.4	2.1	5.5	2.6	6.5	4.5	4.8	5.3	1.5	5.0	5.5	4.8	4.0	3.1	1.6	5.2	4.5	3.2	8.0	5.1	9.8	6.2	5.0	3.5	4.4	4.7	4.0	5.5	26.8	22.1	0.0	0.5	0.5	5.1	0.0	2.5	10.7	11.4	0.0	2.0	0.8	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.4	1.0	0.4	2.3	0.8	0.6	12.7	0.0	1.8	0.6	0.0	2.8	0.3	0.0	0.0	0.7	1.2	0.0	0.0	3.2	0.0	3.9	0.0	0.0	0.7	1.3	1.5	0.2	4.9	1.2	0.4
SLC35E4		ENSG00000100036	"Solute carrier family 35 member E4"	Q6ICL7	22	30635652-30669016	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 20.2;testis: 22.5"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 93.5;Late spermatids: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.0;U-2197: 14.5;U-87 MG: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049558	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA049558: AB_2680817"	"unprognostic (2.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-4)"	"unprognostic (5.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-7)"	"unprognostic (2.77e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.05e-3)"	4.0	2.5	5.6	3.3	11.8	3.4	2.6	4.0	11.4	2.7	5.9	8.1	2.1	2.7	4.2	3.5	4.5	3.1	2.9	5.6	5.2	4.7	2.0	1.1	2.4	2.1	13.0	6.3	2.8	4.1	3.1	2.8	1.6	6.6	2.9	4.2	2.4	2.6	3.5	20.2	7.3	2.5	3.5	2.6	2.4	3.8	22.5	10.1	0.0	2.0	6.6	2.1	3.6	7.6	0.7	3.6	1.6	2.8	2.1	3.2	0.9	6.5	2.9	1.1	2.2	3.0	7.7	0.6	4.3	3.8	3.0	2.8	0.2	1.8	0.4	2.3	4.4	4.2	4.2	1.9	2.5	1.5	15.0	2.1	0.1	2.1	0.2	4.3	0.3	1.8	2.4	1.1	11.9	3.7	4.7	10.1	0.5	0.6	2.0	4.6	1.9	0.2	1.3	1.3	1.9	10.9	1.2	2.2	0.2	1.4	0.5	6.0	2.3	4.4	1.9	2.1	0.5	1.3	0.5	13.4	12.7	4.0	14.5	4.1	0.6	0.5	0.2	15.5	0.2	3.3	1.6	2.1	0.3	0.9	2.8	1.4	0.3	2.1	3.2	3.6	0.7	2.1	1.7	0.8	2.1	2.2	1.0	2.3	0.9	5.6	11.8	4.0	11.4	5.2	4.7	13.0	6.3	6.6	10.1	0.0	1.0	0.9	2.0	12.9	8.8	1.6	0.0	8.1	1.2	1.8	21.6	0.0	0.0	3.2	93.5	4.9	2.6	0.0	2.1	0.4	3.7	1.5	1.1	0.0	1.7	11.1	2.4	4.9	0.3	68.4	3.1	4.5	3.3	2.8	2.6	17.3	1.9	5.7	3.5	0.3	9.3	0.0	4.1	21.8	3.4	16.7	0.1	2.5	4.4	1.4
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907526-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 41.9"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9"	"Group enriched"	"Detected in some"	16	"glioma: 15.1;melanoma: 3.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"AF22: 23.9;WM-115: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	2.8	2.7	13.8	2.1	14.5	0.9	1.2	3.6	41.9	1.7	3.5	4.3	0.0	1.6	2.7	5.5	1.8	1.5	1.8	5.3	10.4	10.2	1.7	1.0	1.1	1.0	9.3	15.3	1.4	1.4	1.0	0.6	1.0	5.6	2.3	2.3	2.6	1.7	2.9	1.2	1.6	1.8	2.6	4.1	1.6	1.4	1.8	5.6	0.0	1.8	0.0	1.0	1.4	2.6	0.2	0.6	1.0	0.1	0.3	0.9	0.1	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.2	0.0	2.9	3.4	0.0	0.0	0.1	0.0	40.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.0	0.3	0.0	0.6	0.0	0.1	13.8	14.5	3.6	17.4	10.4	10.2	9.3	15.3	5.6	5.6	0.0	0.0	0.0	0.0	0.3	11.0	4.3	0.0	0.0	2.3	0.0	2.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.1	15.9	0.0	0.0	0.0	17.4	0.6	0.0	13.5	0.0	0.0	27.9	0.0	0.0	1.1	0.0	1.8	0.0	0.7	0.9	1.2	0.0	0.0	0.0	0.0	0.0
SLC35F2	FLJ13018	ENSG00000110660	"Solute carrier family 35 member F2"	Q8IXU6	11	107790991-107928293	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 43.2"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 40.9;Suprabasal keratinocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 54.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048185, HPA050695, HPA060150"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA048185: AB_2680304, HPA050695: AB_2681217, HPA060150: "	"unprognostic (7.73e-2)"	"unprognostic (3.28e-3)"	"unprognostic (8.37e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (6.22e-2)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	3.0	2.5	2.4	7.4	2.2	1.3	2.7	2.1	2.4	7.4	8.1	1.8	3.8	8.4	2.6	4.8	5.0	6.2	5.9	2.4	3.7	2.6	5.6	2.0	4.0	7.7	2.4	2.2	3.4	3.4	0.3	2.6	9.7	1.9	10.6	9.8	5.2	43.2	2.7	2.3	8.5	7.4	1.8	4.2	2.7	2.8	3.7	2.3	1.8	3.2	6.7	6.9	3.4	3.7	9.3	5.9	0.5	0.2	2.9	11.2	1.6	8.5	5.6	0.6	7.9	4.7	7.0	8.1	2.0	1.1	5.3	6.8	24.2	9.0	14.2	20.3	5.9	28.6	17.9	11.3	18.1	10.5	11.8	10.4	7.9	5.5	10.0	7.7	18.5	4.0	4.8	10.5	17.5	37.9	15.9	27.6	11.3	20.7	5.9	3.7	5.1	7.6	17.8	6.0	18.9	54.7	15.5	7.2	18.6	28.3	7.8	13.8	5.8	6.4	14.9	3.9	7.9	11.0	3.9	20.5	9.7	16.1	0.2	20.4	15.4	17.4	15.6	6.2	5.9	6.3	0.1	0.2	0.0	2.8	0.1	7.3	9.3	4.8	4.9	5.9	6.1	1.8	2.5	0.5	2.9	0.0	0.3	11.2	1.6	2.4	2.2	2.1	2.4	3.7	2.6	2.4	2.2	1.9	2.3	8.9	1.0	11.1	30.1	40.9	1.1	0.5	0.0	0.0	15.9	3.5	11.8	0.7	3.3	10.1	0.3	5.8	14.0	0.0	7.2	13.5	5.1	19.0	2.3	0.0	5.0	0.0	5.8	0.0	0.8	0.9	0.9	3.9	21.9	6.4	10.2	1.3	17.0	10.5	2.5	5.5	7.5	6.5	4.1	0.3	4.9	44.0	3.8	2.5	22.6	15.2
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904933-234324516	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in some"	9	"Basal glandular cells: 2.4;Distal tubular cells: 3.3;Exocrine glandular cells: 3.0;Glandular cells: 1.7;Intestinal endocrine cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	49	"plasmacytoid DC: 7.1"	"Lineage enriched"	"Detected in single"	69	"dendritic cells: 7.1"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA051327: AB_2681443, HPA061582: AB_2684563"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.8	3.5	4.6	1.3	26.0	0.7	6.8	25.1	16.7	1.4	0.8	0.5	0.0	0.8	1.0	2.5	1.6	1.7	0.8	0.6	5.4	4.6	1.6	0.6	1.2	2.4	4.8	6.6	0.6	3.6	4.6	2.8	0.7	4.1	2.0	0.8	0.0	6.6	1.1	1.1	0.8	0.9	1.1	4.8	1.0	2.5	1.1	4.3	0.5	1.9	0.3	1.9	0.8	0.6	0.0	7.1	0.0	0.1	0.0	0.0	0.0	1.4	3.9	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.1	0.3	0.0	3.6	0.0	49.4	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.4	0.0	0.0	0.0	3.6	0.0	2.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	4.6	26.0	25.1	11.6	5.4	4.6	4.8	6.6	4.1	4.3	0.0	0.0	0.0	2.4	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.6	0.0	0.0	0.0	3.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.7	1.3	0.1	0.0	0.0	0.0	0.0
SLC35F4	"C14orf36, FLJ37712"	ENSG00000151812	"Solute carrier family 35 member F4"	A4IF30	14	57563922-57982194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 29.5;seminal vesicle: 10.5"	"Cell type enhanced"	"Detected in some"	24	"Cone photoreceptor cells: 3.9;Early spermatids: 5.9;Peritubular cells: 2.8;Rod photoreceptor cells: 14.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 4.5;U-87 MG: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043853	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA043853: AB_10963083"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-4)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-2)"		"unprognostic (1.38e-1)"		"unprognostic (1.76e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.03e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (9.23e-2)"	0.1	0.1	1.2	0.1	4.9	0.1	0.1	29.5	1.1	1.0	0.2	0.1	0.5	0.2	1.5	0.2	0.1	0.2	0.5	0.1	0.9	2.2	0.4	0.1	0.1	0.1	0.8	1.2	0.3	0.1	0.1	0.2	0.1	2.9	3.5	0.1	2.4	0.1	10.5	0.1	0.1	0.4	1.1	1.3	0.1	0.1	2.7	0.7	0.0	2.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.9	29.5	1.1	0.9	2.2	0.8	1.2	2.9	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	2.8	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35F6	"ANT2BP, C2orf18, FLJ20555, TANGO9"	ENSG00000213699	"Solute carrier family 35 member F6"	Q8N357	2	26764284-26781231	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 48.6;Karpas-707: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034655	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA034655: AB_10696359"	"unprognostic (2.26e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.11e-4)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-2)"	37.3	24.1	9.7	10.5	11.7	6.5	42.2	8.3	15.6	17.9	14.5	16.0	12.4	10.4	14.1	14.0	25.2	12.5	14.4	15.0	10.4	11.6	37.4	25.4	15.3	22.0	12.3	9.3	20.4	12.6	13.1	12.2	26.6	11.9	15.3	9.0	13.8	16.7	14.2	16.7	30.9	14.7	15.4	11.4	14.8	16.3	11.7	9.1	10.5	24.1	20.4	15.5	13.8	18.2	3.1	7.1	7.8	19.0	8.6	8.8	5.9	8.3	14.7	4.5	11.4	15.5	7.0	6.9	4.7	7.3	6.1	5.6	9.2	16.0	2.2	8.0	6.6	15.1	10.4	6.4	9.5	4.3	3.8	3.1	2.5	5.6	7.7	48.6	2.7	12.8	11.1	9.8	6.9	23.2	2.8	7.1	3.4	4.7	42.8	6.1	13.5	3.4	2.4	2.5	6.0	3.9	3.0	12.9	3.5	16.2	6.7	3.4	4.5	8.0	13.1	8.5	3.9	4.9	2.8	6.4	8.0	8.5	10.9	5.2	8.3	10.4	4.3	8.6	4.6	7.2	7.0	12.0	5.3	8.8	16.5	5.0	3.1	6.1	8.0	7.1	2.5	4.2	6.0	7.8	8.6	19.0	5.5	3.8	5.9	9.7	11.7	8.3	15.6	10.4	11.6	12.3	9.3	11.9	9.1	11.9	8.0	6.7	11.8	15.0	17.3	11.2	25.5	5.3	7.9	31.4	5.9	22.1	6.6	29.6	1.5	19.2	18.8	0.0	33.5	20.1	22.4	12.8	1.1	19.2	46.2	14.3	8.7	28.8	43.7	1.1	17.0	26.4	27.0	10.8	8.7	18.9	38.9	9.1	11.3	49.9	9.7	25.8	29.9	3.7	6.5	22.5	31.8	13.8	9.7	10.6
SLC36A4	"FLJ38932, PAT4"	ENSG00000180773	"Solute carrier family 36 member 4"	Q6YBV0	11	93144171-93197964	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017887	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017887: AB_2190238"	"unprognostic (1.23e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.04e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.45e-3)"	"unprognostic (4.20e-2)"	8.0	11.0	16.0	12.6	19.3	24.1	6.5	20.7	20.2	8.0	7.3	8.7	2.1	3.0	10.4	3.6	7.8	6.2	8.4	9.2	14.2	14.8	13.7	11.0	8.2	7.0	16.8	10.3	8.6	8.0	8.0	17.2	8.7	17.6	7.5	9.4	5.4	5.4	9.1	3.4	5.9	4.2	11.5	20.0	5.7	6.4	6.0	13.4	5.6	12.7	2.3	9.2	8.6	7.7	1.6	2.9	8.1	7.7	0.8	2.6	1.8	5.1	9.3	19.0	3.8	6.7	13.7	10.7	9.0	15.0	13.4	16.3	7.4	17.0	6.3	5.2	8.3	7.0	6.4	5.8	3.3	12.3	10.5	6.8	7.2	19.5	4.9	5.3	18.1	10.8	6.6	10.4	7.7	4.9	6.3	7.1	9.0	0.6	0.1	13.6	1.3	7.9	13.7	7.6	2.0	9.4	3.6	11.3	2.6	4.5	7.7	17.6	22.9	13.1	5.1	3.2	14.5	9.3	5.3	7.9	25.3	7.8	14.9	13.0	2.6	5.2	0.0	5.7	7.6	13.0	0.2	7.7	8.1	1.3	3.9	1.8	1.3	1.0	1.6	2.9	1.6	2.6	1.7	2.5	0.8	2.5	1.1	0.8	1.8	16.0	19.3	20.7	20.2	14.2	14.8	16.8	10.3	17.6	13.4	11.9	8.6	18.2	35.2	27.2	21.1	7.7	12.7	21.4	6.8	19.2	21.6	9.5	29.9	19.1	1.7	18.0	0.7	0.0	37.9	21.2	11.6	37.1	4.6	6.4	13.1	25.4	26.5	10.4	59.0	3.1	16.7	44.6	20.3	10.0	17.4	13.3	27.9	5.8	14.5	12.3	23.0	6.5	17.6	6.2	2.7	28.0	13.6	10.7	4.3	23.7
SLC37A4	"G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d"	ENSG00000137700	"Solute carrier family 37 member 4"		11	119024114-119030906	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"liver: 42.2"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 183.4;Hepatocytes: 134.8;Muller glia cells: 96.7;Proximal tubular cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.4;HEK 293: 17.3;Hep G2: 21.6;MCF7: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038939, HPA038940"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038939: AB_2676279, HPA038940: AB_2676280"	"unprognostic (4.77e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.34e-2)"	"unprognostic (5.39e-2)"	2.1	3.7	4.8	4.8	3.7	1.4	3.7	7.8	5.9	1.7	5.0	2.7	13.6	26.0	2.6	15.9	2.5	4.0	6.9	4.6	3.7	4.9	29.6	42.2	3.3	4.7	3.7	3.1	3.3	15.5	5.9	2.2	3.3	2.3	4.3	5.3	3.0	4.6	13.6	27.7	2.0	6.7	1.9	3.1	3.4	1.8	4.5	1.4	2.9	3.3	3.3	2.4	1.7	2.3	1.2	0.7	2.7	3.7	2.0	4.1	1.2	0.4	7.2	2.6	1.9	4.7	1.9	1.5	0.2	5.9	1.6	4.1	16.4	1.2	1.8	4.0	2.3	3.4	0.4	1.1	8.2	2.5	2.1	17.3	5.4	1.6	21.6	1.7	3.1	0.9	0.0	2.3	0.8	4.4	6.6	5.4	0.4	2.1	4.8	2.7	15.1	0.1	6.9	0.1	1.6	8.6	4.4	0.0	8.5	1.8	7.6	3.3	3.3	0.0	0.4	2.7	3.5	3.2	2.3	0.0	0.0	2.6	0.1	2.8	0.8	1.3	0.5	0.7	7.9	0.7	0.0	1.9	2.7	3.3	3.7	2.8	1.2	1.9	4.1	0.7	1.1	1.6	2.3	0.0	2.0	1.5	0.2	2.1	1.2	4.8	3.7	7.8	5.9	3.7	4.9	3.7	3.1	2.3	1.4	3.0	5.6	6.7	7.2	1.5	6.4	3.6	183.4	8.1	4.5	15.7	0.0	22.4	26.6	25.4	9.2	6.3	26.5	23.3	22.1	16.5	3.7	9.0	0.0	134.8	24.5	15.9	23.7	21.5	9.1	1.9	8.9	7.0	3.3	16.2	17.5	96.7	18.6	24.6	9.9	134.4	11.0	0.0	4.1	7.1	22.6	2.4	12.7	4.6	37.7	5.1
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 107.8"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 86.1;Cone photoreceptor cells: 176.7;Hepatocytes: 93.4;Muller glia cells: 75.9;Rod photoreceptor cells: 112.3"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"					"Cell type enhanced"	"Detected in some"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Hep G2: 32.4;SCLC-21H: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA031871: AB_2674080"	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	0.7	0.3	3.4	0.3	5.2	0.5	0.7	2.4	10.5	0.3	0.3	10.3	0.0	0.7	0.4	0.4	0.6	0.4	0.4	2.0	4.1		1.5	107.8	0.3	0.4	3.4	4.0	2.4	11.6	1.8	0.7	0.6	7.8	0.4	0.3	22.2	0.9	0.3	10.4	0.5	0.4	0.3	4.7	0.3	0.9	0.7	5.2	0.0	0.6	1.9	0.4	0.3	0.0	1.1	1.0	5.6	0.8	1.5	0.8	0.2	0.0	0.0	0.8	4.9	0.0	0.0	1.3	0.0	0.0	0.9	0.4	2.9	0.1	0.1	0.8	0.0	0.2	0.0	1.3	0.0	0.6	0.1	0.4	0.0	0.6	32.4	0.1	0.3	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.5	0.1	0.0	0.4	0.3	0.0	0.1	0.2	10.8	0.9	0.5	0.1	0.0	1.5	1.3	0.2	0.0	0.2	0.9	0.0	0.7	0.3	0.0	0.1	0.1	0.2	0.1	5.6	0.8	0.9	0.6	0.2	0.4	0.7	0.5	0.4	0.2	1.1	0.6	0.8	3.3	1.5	0.2	1.0	0.4	0.2											0.0	0.0	1.9	0.1	0.0	86.1	2.8	15.3	0.0	0.0	0.0	176.7	0.2	0.0	0.7	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	93.4	0.1	7.9	3.4	0.0	3.3	0.0	2.0	0.0	0.0	1.0	0.0	75.9	0.8	0.0	0.4	1.4	112.3	0.0	0.0	1.0	1.8	0.0	1.1	0.0	0.0	0.0
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470256	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 87.7"	"Cell type enhanced"	"Detected in many"	14	"Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 35.6;HBEC3-KT: 54.3;HeLa: 53.5;hTCEpi: 40.4;Karpas-707: 47.8;RPMI-8226: 87.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	1.5	0.9	5.3	4.7	7.1	17.3	0.9	3.5	11.6	4.0	4.9	7.7	0.1	5.1	1.8	1.3	3.7	2.0	1.5	2.4	6.9	5.7	0.7	0.4	9.4	3.3	7.0	2.7	3.7	87.7	0.4	0.4	2.8	14.6	5.1	6.4	1.5	4.4	3.7	0.4	8.0	3.5	2.8	7.3	4.8	4.5	0.5	4.6	2.4	7.9	3.6	3.4	4.8	3.1	7.4	8.3	0.3	0.4	5.4	16.2	5.7	23.0	0.0	0.0	0.2	0.4	2.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	24.2	0.0	10.2	0.0	35.6	27.6	54.3	0.0	7.7	0.0	13.1	53.5	16.6	4.0	26.8	0.0	3.8	40.4	0.5	0.1	0.0	0.4	5.9	24.1	47.8	5.4	0.0	5.8	9.3	12.5	0.0	0.1	21.3	0.1	87.9	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.1	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	8.7	0.2	0.1	0.1	0.0	0.2	0.2	11.5	0.4	16.2	7.4	12.6	10.8	1.5	4.7	6.0	7.7	0.3	5.4	0.0	8.3	13.0	5.7	5.3	7.1	3.5	11.6	6.9	5.7	7.0	2.7	14.6	4.6	0.0	1.1	0.8	1.6	23.7	0.6	0.4	0.0	1.4	0.0	5.2	17.7	0.1	0.0	4.9	0.4	3.1	2.3	23.3	67.4	0.4	5.6	0.9	4.6	0.4	2.5	0.0	0.0	0.0	0.0	0.7	2.3	1.1	8.5	2.8	12.3	0.0	93.7	3.5	1.1	0.0	0.2	0.0	1.0	0.0	0.0	7.4	0.0	8.5	19.1	0.9
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 130.6;Hofbauer cells: 89.9;Late spermatids: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"		NA	NA			"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	26.1	16.9	8.3	6.7	16.6	4.0	11.4	9.7	14.0	8.1	7.1	5.2	5.5	4.5	10.0	20.5	5.0	8.4	14.4	5.4	8.8	8.6	16.9	9.2	12.2	9.6	8.6	10.9	9.9	6.1	23.8	21.5	13.7	14.3	8.1	10.1	10.9	11.7	6.4	4.1	4.6	5.6	8.0	7.6	10.8	6.4	10.9	6.5	8.8	9.7	7.1	7.2	11.6	8.1	2.4	5.2	0.2	8.6	0.7	5.2	3.4	7.1	10.0	3.2	5.9	33.9	12.3	2.2	5.4	16.2	5.1	4.8	2.5	19.6	1.7	9.3	4.9	10.8	6.3	3.1	5.5	4.8	2.4	1.4	3.0	4.1	6.5	11.1	1.5	5.8	9.7	2.3	5.0	5.9	21.1	6.8	2.7	4.1	3.7	17.9	4.0	2.7	3.9	2.0	4.3	6.6	0.5	9.5	5.5	15.0	4.0	1.5	1.2	4.5	3.3	8.7	4.7	4.7	2.6	7.2	8.0	3.4	9.3	3.0	0.7	2.1	0.6	16.4	1.3	6.3	0.0	8.4	0.1	2.2	8.6	2.6	2.4	4.0	2.9	4.4	2.2	3.3	4.3	0.2	0.7	5.4	5.2	5.2	3.4	8.3	16.6	9.7	14.0	8.8	8.6	8.6	10.9	14.3	6.5	20.8	4.1	2.7	10.8	4.6	18.5	2.8	5.1	34.8	5.7	5.2	21.6	5.0	1.7	4.1	130.6	6.7	2.2	0.0	2.5	7.9	8.5	6.5	5.8	4.0	89.9	4.8	4.1	3.7	20.7	97.9	10.0	19.2	5.0	1.8	2.3	14.2	6.0	2.0	5.6	16.8	25.0	0.0	6.6	15.1	10.6	2.5	5.6	4.4	2.8	5.9
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58685104	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 273.8;Late spermatids: 600.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041777	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782"	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	7.0	11.1	10.6	6.7	10.0	2.7	7.2	7.7	13.7	6.2	5.3	10.6	6.8	4.8	6.0	7.4	6.0	4.2	6.5	13.8	7.2	7.2	7.4	12.1	5.2	4.3	6.1	11.0	4.7	5.0	16.9	10.2	8.4	8.3	5.2	6.9	8.9	6.1	5.6	9.6	5.3	4.9	8.5	5.8	10.3	5.4	27.1	6.6	4.2	8.0	8.1	5.1	6.5	6.3	2.8	6.1	2.5	8.6	2.3	5.2	6.6	4.4	7.0	6.9	10.6	14.4	8.7	13.0	10.5	12.2	14.8	10.3	6.5	6.9	2.8	6.0	14.6	11.9	10.8	6.6	7.3	8.8	1.8	6.0	3.2	5.8	10.5	21.9	6.6	9.2	17.4	15.4	10.3	6.8	8.0	15.1	6.7	9.4	4.3	10.7	5.3	2.6	3.9	7.5	4.7	10.4	9.6	7.5	7.6	6.5	10.2	5.1	7.7	15.8	10.8	4.6	9.7	5.1	2.8	11.8	8.1	6.2	14.0	3.1	6.3	4.1	3.2	11.0	4.0	6.0	0.2	8.6	2.5	5.2	8.4	3.1	1.9	3.3	3.8	6.1	2.8	2.7	2.9	0.8	2.3	7.5	2.1	2.2	6.6	10.6	10.0	7.7	13.7	7.2	7.2	6.1	11.0	8.3	6.6	3.0	4.1	0.5	3.9	3.4	9.7	11.2	2.5	4.0	3.4	10.4	11.8	7.3	3.3	12.6	273.8	4.7	3.9	0.0	7.4	7.9	5.7	3.0	1.1	8.5	31.3	15.9	12.6	8.6	8.6	600.3	8.9	7.1	8.5	2.8	3.6	8.0	10.5	3.5	8.1	4.6	7.1	6.5	5.1	6.2	6.1	3.8	12.8	1.8	5.1	2.7
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.0;thyroid gland: 39.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		49000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	6.6	10.9	16.0	6.0	24.8	3.7	6.2	10.8	41.0	9.8	3.8	4.2	4.9	3.6	9.4	3.3	3.5	8.5	7.6	4.7	15.0	11.2	7.8	2.1	6.3	6.5	8.5	24.4	7.4	5.7	5.8	5.7	10.7	15.7	16.7	4.0	1.4	4.8	6.5	3.3	5.7	5.7	6.7	10.2	14.4	4.3	7.9	6.2	10.6	39.9	1.7	6.4	6.1	4.9	9.4	18.4	19.3	2.7	11.0	4.6	1.5	2.9	9.9	18.9	5.2	3.7	8.8	9.8	13.7	6.7	6.6	3.3	14.8	10.6	4.1	20.9	7.8	5.1	4.2	11.5	12.6	8.4	2.1	8.6	4.6	15.4	12.1	4.1	16.8	1.9	5.2	1.8	7.3	8.4	23.4	14.8	4.2	13.3	5.8	10.6	2.8	4.8	5.2	22.0	17.2	7.8	11.3	6.6	10.2	28.8	4.9	7.3	10.0	13.7	28.0	7.2	34.5	4.5	10.5	14.5	12.1	14.0	7.9	7.1	2.0	1.2	2.4	9.7	7.9	12.2	19.3	2.7	1.9	4.5	2.5	3.5	6.8	4.0	3.7	3.3	9.4	3.5	4.6	0.5	11.0	1.8	18.4	3.9	1.5	16.0	24.8	10.8	39.7	15.0	11.2	8.5	24.4	15.7	6.2	3.0	10.9	18.2	9.3	22.8	21.9	7.3	7.6	6.7	29.6	34.9	7.9	41.3	1.7	17.6	23.2	27.0	2.9	23.3	9.5	54.8	20.3	18.5	12.7	2.5	21.6	7.9	15.0	24.5	18.1	11.5	17.5	29.7	6.8	8.2	5.1	15.6	17.5	2.9	17.7	14.9	19.9	12.9	13.8	47.8	27.0	17.9	19.6	21.5	4.5	6.4
SLC39A11	C17orf26	ENSG00000133195	"Solute carrier family 39 member 11"	Q8N1S5	17	72645949-73092712	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 49.0;Mucus-secreting cells: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021455			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021455: AB_2670710"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.85e-2)"	10.4	7.4	12.4	7.8	17.9	10.7	10.8	5.3	14.4	9.3	13.3	19.8	6.6	11.5	4.8	9.6	13.0	5.6	8.6	4.2	13.3	6.3	7.9	21.9	8.2	4.8	27.8	6.6	2.8	23.8	3.1	3.8	7.0	15.3	5.3	13.8	6.7	16.6	5.2	3.7	11.2	12.7	5.7	15.7	6.5	27.6	4.1	22.5	6.0	20.6	3.6	8.6	8.3	7.6	6.0	14.9	9.8	16.2	8.7	6.9	6.3	4.3	7.9	0.9	3.8	6.9	5.6	5.4	4.6	4.1	2.1	2.9	2.9	19.7	5.4	4.8	4.7	3.4	3.7	1.3	2.3	3.3	5.8	2.8	5.0	2.1	3.4	4.1	5.3	48.4	4.8	4.5	4.4	2.6	2.3	2.2	2.8	2.6	6.8	2.7	6.1	3.4	11.6	0.7	13.3	3.4	2.3	3.6	4.5	3.5	4.5	2.2	3.1	2.5	18.7	2.8	3.9	12.8	7.4	1.8	4.2	4.0	3.6	2.8	5.5	2.5	3.8	6.9	10.8	2.4	5.5	16.2	9.8	6.9	15.4	4.6	6.0	5.3	5.2	14.9	3.9	3.8	5.2	2.5	8.7	11.9	10.5	6.5	6.3	12.4	17.9	5.3	14.4	13.3	6.3	27.8	6.6	15.3	22.5	0.0	4.6	3.7	4.4	3.9	2.3	2.0	7.6	6.7	7.9	3.5	0.0	4.7	0.0	6.8	19.2	3.6	19.9	23.3	12.3	14.7	3.6	5.1	29.9	25.0	25.0	4.8	8.1	4.3	15.5	49.0	3.7	7.6	10.1	15.4	73.3	3.9	8.3	20.4	3.2	9.8	1.5	12.9	6.1	1.9	2.5	3.9	4.1	3.2	14.7	6.3
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367249-22434129	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport, Zinc transport"		"Disease mutation, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 135.5;pancreas: 77.2"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 491.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 66.5"	"Low region specificity"	"Detected in all"							"HPA016508, HPA056732"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA		950000	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"		"HPA016508: AB_1857148, HPA056732: "	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favorable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	15.0	16.1	2.6	7.7	5.4	0.1	45.5	2.4	6.1	3.6	13.7	1.9	2.8	31.6	6.7	2.8	3.9	5.6	9.8	41.1	2.8	2.4	10.4	135.5	4.8	5.3	3.7	1.9	10.6	77.2	3.0	6.4	4.0	9.2	5.1	11.4	4.1	20.2	4.4	46.1	4.4	18.2	14.1	4.7	2.3	16.2	5.9	2.8	0.7	25.1	2.1	1.4	11.3	19.0	5.0	1.8	2.5	0.5	2.9	8.7	3.9	10.4	13.9	3.9	7.8	14.0	11.8	8.5	15.0	66.5	23.5	37.1	46.2	9.9	10.4	8.5	17.6	61.2	11.5	19.2	18.7	38.8	10.8	11.0	8.3	11.1	46.5	33.3	5.7	9.1	12.5	15.3	41.6	29.1	11.9	10.4	7.5	7.2	10.7	11.9	4.8	8.6	3.6	23.7	16.6	10.7	12.3	7.3	22.2	8.6	4.5	6.6	10.3	15.3	6.6	31.0	8.7	5.2	8.3	5.7	29.2	14.9	18.4	15.4	6.2	5.6	13.6	41.3	7.6	17.0	0.0	0.5	2.5	8.3	0.1	8.7	5.0	4.8	6.3	1.8	2.6	5.7	7.6	0.2	2.9	0.1	0.8	3.8	3.9	2.6	5.4	2.4	6.1	2.8	2.4	3.7	1.9	9.2	2.8	3.0	4.8	3.7	8.8	29.7	7.1	50.1	50.9	0.0	3.4	7.0	2.0	0.2	1.7	48.7	0.4	31.6	63.6	0.0	63.9	2.1	30.9	17.2	0.0	491.4	1.5	46.1	32.0	31.9	15.9	1.8	22.2	1.6	42.2	4.6	51.4	4.6	55.6	28.8	39.3	21.4	7.4	0.0	46.7	0.0	2.4	18.3	0.5	4.9	33.7	9.8
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Predicted membrane proteins"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8"	"Cell type enriched"	"Detected in some"	4	"Muller glia cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"HaCaT: 23.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA			"Plasma membrane"	"Cytoplasmic bodies"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	1.3	0.3	0.4	5.6	1.2	0.0	44.3	0.0	0.8	0.0	13.0	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.2	1.0	0.2	8.5	0.8	0.4	2.7	50.6	0.1	23.8	0.1	0.2	0.1	0.1	0.0	0.1	0.0	1.3	0.1	6.1	3.3	1.2	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.8	4.2
SLC39A3	ZIP3	ENSG00000141873	"Solute carrier family 39 member 3"	Q9BRY0	19	2732204-2740152	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 234.7;Late spermatids: 338.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042139, HPA058526"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA042139: AB_10793875, HPA058526: AB_2683743"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.75e-3)"	"unprognostic (9.22e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.80e-2)"	11.1	15.5	13.3	8.3	18.0	23.9	13.3	10.6	28.0	12.7	10.8	14.0	8.3	10.2	14.3	19.5	10.5	14.6	10.5	11.7	14.4	13.0	11.0	23.6	9.0	11.7	11.5	12.9	11.0	11.9	17.8	15.5	10.6	14.9	10.8	8.8	10.7	12.4	11.7	11.2	8.1	9.4	14.0	11.1	12.9	9.3	50.1	8.8	13.0	12.5	6.8	9.4	14.2	7.8	24.4	38.0	29.6	17.5	13.1	17.5	15.4	11.9	9.7	7.3	18.0	15.2	10.4	7.4	8.7	10.3	16.1	16.5	10.5	7.8	7.4	5.6	14.9	12.8	9.7	11.2	11.6	10.1	0.0	8.0	32.5	7.2	10.5	16.8	26.9	47.6	9.3	18.8	11.9	9.8	5.8	8.2	13.9	35.6	33.1	10.8	7.7	13.2	20.2	7.8	10.6	12.9	17.5	4.8	22.0	7.6	9.3	10.1	9.2	7.6	5.4	18.1	4.9	9.5	35.3	5.0	11.3	6.2	17.5	12.6	9.0	14.1	7.0	8.5	90.6	13.4	16.4	17.5	29.6	17.5	16.1	15.4	24.4	15.4	14.9	23.4	24.4	12.9	14.5	7.8	13.1	15.5	38.0	9.7	15.4	13.3	18.0	10.6	28.0	14.4	13.0	11.5	12.9	14.9	8.8	3.0	3.2	33.4	14.3	9.2	19.5	6.7	28.1	5.3	5.7	7.0	7.9	32.9	14.9	40.6	234.7	14.4	18.4	70.0	53.8	46.9	22.6	24.4	25.3	27.7	57.4	46.1	23.1	17.2	18.1	338.5	19.8	24.6	23.6	28.9	16.6	28.8	36.0	20.3	26.2	18.0	15.4	25.8	15.1	118.7	27.5	8.5	22.1	20.0	23.4	14.6
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 77.8;liver: 38.2;pancreas: 101.1"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 110.0;Enterocytes: 260.0;Hepatocytes: 140.6;Mucus-secreting cells: 92.0;Paneth cells: 142.5;Proximal tubular cells: 149.4;Undifferentiated cells: 142.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	51	"CACO-2: 22.8;Hep G2: 32.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.2	0.1	0.2	4.1	0.2	0.0	0.2	0.2	0.2	0.2	40.5	0.2	0.2	48.6	0.2	2.3	0.2	0.1	5.9	0.2	0.2	0.1	22.5	38.2	0.2	0.2	0.2	0.2	0.2	101.1	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.2	0.2	0.2	0.1	77.8	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	22.8	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	32.9	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	2.2	0.0	0.6	0.6	0.2	12.7	0.0	0.0	3.5	110.0	0.0	16.6	0.3	0.4	0.1	260.0	0.0	17.7	0.0	0.1	0.1	0.0	140.6	0.1	0.0	24.3	2.5	1.3	0.0	0.0	0.0	0.0	1.0	92.0	0.5	12.1	142.5	0.0	149.4	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	142.6	0.0
SLC39A9	FLJ11274	ENSG00000029364	"Solute carrier family 39 member 9"	Q9NUM3	14	69398015-69462388	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007921, HPA075390"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007921: AB_1080007, HPA075390: AB_2686748"	"unprognostic (2.37e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	15.8	22.2	19.5	11.3	19.2	8.8	24.8	15.0	26.3	19.5	25.5	22.4	20.6	20.8	19.1	25.6	22.3	16.5	16.7	14.5	18.9	19.1	31.2	52.9	15.7	13.0	17.8	13.7	16.3	28.0	24.5	24.6	29.7	17.1	19.4	22.7	17.0	65.2	24.2	7.7	16.7	27.8	16.3	19.3	16.3	19.8	17.4	14.1	18.3	22.4	13.7	19.2	14.5	14.6	9.9	17.2	12.5	14.8	9.2	12.5	9.2	29.4	23.2	14.9	15.0	25.6	19.9	13.4	18.1	21.0	15.5	17.9	17.4	27.9	24.0	13.2	20.9	7.9	24.3	16.2	17.0	19.6	16.2	8.7	15.2	13.2	13.2	19.2	11.2	21.6	16.0	27.2	14.2	21.4	16.6	16.2	20.4	11.6	24.0	18.0	16.4	16.7	12.1	11.9	24.7	16.5	16.9	21.0	15.6	20.9	32.2	15.3	25.1	17.5	30.6	10.5	12.0	43.0	18.3	17.2	28.4	20.3	11.8	12.3	26.4	14.7	18.5	26.8	12.8	23.1	11.9	14.8	12.5	11.7	14.1	12.5	9.9	10.2	11.5	17.2	7.7	10.3	11.2	12.0	9.2	13.0	8.3	7.4	9.2	19.5	19.2	15.0	26.3	18.9	19.1	17.8	13.7	17.1	14.1	17.9	13.0	13.7	6.6	10.8	7.2	7.0	20.4	12.0	10.3	15.7	5.9	12.4	5.0	12.6	13.3	14.6	36.8	0.0	21.6	13.5	14.1	18.8	11.5	62.5	14.0	9.5	28.3	23.4	21.5	15.1	12.0	9.3	6.8	10.0	31.8	10.4	22.1	20.1	12.0	14.6	11.0	6.5	12.9	11.8	6.4	10.9	14.9	8.2	22.3	12.4
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 66.0;kidney: 191.5;pancreas: 36.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 256.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	17	"RPTEC TERT1: 49.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.2	0.1	0.2	0.7	0.2	0.0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0.0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66.0	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4.0	1.3	2.0	1.3	1.6	2.7	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.9	0.2	0.0	0.1	0.2	49.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.1	1.3	1.3	1.0	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4.0	2.5	2.7	2.0	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1	3.0	1.0	1.5	0.2	0.0	12.5	0.3	63.7	0.0	0.0	40.1	9.8	0.0	53.0	18.3	10.9	0.0	32.7	0.0	12.6	0.0	0.2	1.4	0.0	2.8	0.1	20.6	0.0	0.6	0.0	3.3	1.1	0.0	0.0	2.8	3.8	1.6	3.4	7.2	0.4	256.0	11.9	0.0	0.1	0.7	0.3	0.1	0.1	0.0	8.0	0.5
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789093-205813748	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 78.1;pancreas: 36.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 157.4;Cone photoreceptor cells: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	6.0	7.2	6.2	4.0	7.3	3.3	3.4	9.0	8.3	3.6	3.9	10.8	4.0	1.6	5.0	5.9	3.8	7.3	4.7	78.1	7.2	3.8	6.1	1.2	5.3	4.5	7.8	4.9	7.5	36.8	5.8	3.6	2.6	6.9	5.1	1.5	5.8	2.8	4.8	26.5	2.6	2.7	4.0	8.5	3.3	6.6	11.6	7.3	2.1	11.2	11.9	4.5	5.2	5.0	1.8	0.0	0.1	0.3	1.0	4.6	2.0	10.8	9.6	6.1	9.7	7.6	7.5	8.3	11.2	11.0	11.4	10.1	4.8	6.2	15.7	7.1	10.2	9.5	11.3	5.9	8.2	3.9	28.8	9.0	3.8	9.5	0.7	7.3	0.0	11.0	9.5	6.9	13.0	9.3	9.5	7.0	12.8	7.0	6.6	9.1	6.7	7.0	1.1	7.2	2.9	4.4	8.3	18.3	3.8	2.6	13.5	5.1	6.5	8.6	7.7	7.0	5.3	5.5	4.0	8.7	13.6	8.8	12.4	11.6	22.0	14.6	5.2	10.6	5.0	8.4	0.0	0.1	0.1	3.6	0.3	4.6	1.5	3.4	3.4	0.0	1.8	3.2	3.3	0.0	1.0	0.0	0.0	3.3	2.0	6.2	7.3	9.0	8.3	7.2	3.8	7.8	4.9	6.9	7.3	3.0	16.5	12.6	19.3	18.4	12.9	157.4	10.2	9.4	12.5	0.0	47.1	1.7	1.7	8.2	1.5	20.4	0.0	0.0	9.4	12.7	8.0	15.4	6.9	1.8	2.7	17.5	5.8	4.3	2.2	1.7	9.2	3.2	8.5	0.0	0.8	18.0	8.8	0.6	8.9	13.7	21.3	0.0	19.4	6.8	15.0	15.8	2.6	8.5	1.0	20.0
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515786	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 27.0;liver: 91.8;pancreas: 100.5"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 40.8;Hepatocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 23.8;NB-4: 28.3;U-937: 27.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (7.30e-2)"	4.7	3.3	0.8	2.2	0.8	9.3	7.4	0.7	1.3	6.0	4.8	0.9	3.9	2.5	5.0	6.8	4.1	3.3	27.0	3.2	0.7	0.6	3.4	91.8	2.9	3.3	0.8	1.1	6.5	100.5	0.1	1.3	1.8	0.7	6.2	2.8	11.4	14.9	2.1	7.5	5.6	2.6	7.0	0.9	2.5	7.6	3.1	0.7	0.8	7.4	2.9	3.1	7.6	3.5	3.1	8.2	8.1	6.0	6.9	11.1	5.2	0.4	0.6	0.7	8.0	10.5	7.7	0.1	4.2	5.4	1.2	3.1	2.5	1.1	23.0	1.1	3.1	1.5	0.3	7.1	0.4	1.5	1.1	1.8	11.8	0.2	23.8	13.8	20.7	2.9	9.7	1.7	2.0	9.3	2.9	5.3	13.8	16.5	4.3	1.5	0.8	0.1	28.3	2.6	10.4	5.4	19.7	3.9	10.2	0.2	0.0	9.4	1.4	0.7	0.1	9.2	0.2	0.6	10.5	2.1	1.2	2.9	10.6	0.6	4.8	1.5	13.5	0.6	27.3	1.6	8.1	6.0	0.7	11.1	2.4	9.5	3.1	5.2	8.0	8.2	1.7	5.1	7.2	0.5	6.9	0.1	1.9	9.1	5.2	0.8	0.8	0.7	1.3	0.7	0.6	0.8	1.1	0.7	0.7	0.0	8.2	0.8	1.6	6.3	5.0	4.9	40.8	1.4	1.2	0.0	0.0	0.1	3.3	2.5	22.9	4.6	0.9	23.3	30.5	0.4	5.4	1.9	3.5	109.6	6.1	0.0	5.8	14.7	7.6	11.8	14.4	1.8	5.0	0.0	6.1	0.0	18.0	0.0	7.4	0.0	0.3	6.5	6.2	0.5	0.4	3.1	0.1	6.4	9.8	0.9
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 149.9;thyroid gland: 69.0"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4"	"Region enriched"	"Detected in many"	4	"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Nucleoplasm, Plasma membrane"	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	32.3	6.3	2.5	12.4	4.3	18.8	16.8	2.2	3.0	11.9	9.6	3.6	2.4	2.7	10.1	6.5	12.6	8.9	11.4	12.5	3.1	1.5	4.2	149.9	16.5	8.8	4.0	1.8	16.0	7.2	1.2	1.8	5.1	3.4	11.6	4.2	9.4	12.2	3.1	15.4	11.0	6.2	10.3	4.7	11.6	6.9	6.8	2.3	10.4	69.0	11.5	13.8	20.3	15.4	2.7	23.6	6.1	36.8	1.1	7.8	14.0	40.0	0.0	2.3	0.0	7.8	11.5	0.1	3.1	13.3	4.6	7.9	0.0	8.8	23.1	1.4	7.3	2.4	23.1	6.7	4.1	9.3	0.1	0.0	36.0	13.7	0.0	15.9	71.0	62.7	34.5	0.1	44.6	0.5	3.3	12.9	10.7	41.1	22.4	17.8	0.0	14.9	45.6	3.5	0.0	0.7	30.9	0.4	80.1	11.0	0.0	5.5	0.0	8.8	0.2	37.4	0.2	3.4	10.8	6.8	0.2	12.0	30.4	8.7	0.0	0.1	5.8	27.5	25.8	76.4	3.2	28.8	6.1	5.7	34.5	6.5	2.7	4.0	7.8	23.6	2.0	3.1	3.2	2.5	1.1	36.8	23.6	6.9	14.0	2.5	4.3	2.2	3.0	3.1	1.5	4.0	1.8	3.4	2.3	14.9	41.4	4.5	6.7	41.6	0.5	2.8	30.6	5.3	34.2	1.8	0.0	0.5	0.0	47.0	1.0	23.3	0.0	0.0	5.5	2.2	20.2	3.4	63.7	53.8	71.5	0.0	0.0	11.6	17.3	1.4	9.2	55.1	28.7	0.0	0.5	0.9	10.9	0.0	11.7	0.0	0.0	64.7	18.4	1.0	0.2	15.4	0.7	15.0	0.6	2.5
SLC44A1	"CD92, CDw92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 111.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 73.5;ASC TERT1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		270000	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	8.7	7.4	40.0	6.4	48.8	5.3	14.6	7.2	37.0	9.9	26.7	69.5	10.2	12.0	8.8	18.4	10.1	8.5	11.0	6.9	50.0	29.6	12.0	20.3	9.8	4.6	64.3	21.3	8.0	8.0	20.5	3.9	12.3	38.2	6.6	26.9	4.6	6.0	14.8	4.8	11.4	14.0	9.5	111.6	4.8	18.9	2.3	59.4	2.3	24.0	5.1	7.9	12.4	7.9	2.4	3.7	2.5	5.4	8.7	1.8	1.6	6.9	5.8	1.6	1.9	73.5	58.1	5.0	5.8	15.3	3.8	5.1	6.2	18.5	9.2	3.0	22.0	4.3	13.8	4.7	8.4	6.5	8.0	3.8	11.5	4.1	7.7	4.9	2.2	5.9	32.2	6.9	7.3	6.6	9.8	12.0	4.8	0.3	19.2	4.3	9.8	9.1	2.6	8.9	12.3	5.6	1.9	6.1	6.9	5.2	16.3	7.7	3.0	8.2	9.1	8.2	9.9	9.0	6.9	10.2	3.8	3.4	4.1	4.2	14.8	9.8	6.9	7.4	5.0	5.0	2.5	5.4	1.1	1.1	2.1	0.8	2.0	1.2	0.8	3.7	2.4	1.8	0.6	1.0	8.7	1.2	1.3	1.1	1.6	40.0	48.8	7.2	29.8	50.0	29.6	64.3	21.3	38.2	59.4	32.8	21.6	15.9	31.4	62.7	7.6	9.3	56.0	14.7	9.1	101.2	221.9	44.4	3.3	16.4	2.4	38.4	140.4	0.0	31.4	7.9	49.9	25.3	98.1	132.6	20.0	6.4	151.0	54.0	50.8	2.9	101.8	39.6	70.9	122.6	158.5	6.7	33.4	123.8	75.0	23.3	44.8	38.8	27.0	1.4	1.7	65.0	59.0	15.3	134.8	29.5
SLC44A2	CTL2	ENSG00000129353	"Solute carrier family 44 member 2"	Q8IWA5	19	10602457-10644559	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 210.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 62.3;SK-BR-3: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003228, HPA070799"	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA		78000	"Vesicles, Cell Junctions"		"HPA003228: AB_1080009, HPA070799: AB_2686314"	"unprognostic (6.35e-3)"	"unprognostic (5.75e-2)"	"unprognostic (4.34e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.61e-2)"	29.3	14.2	25.1	21.4	28.3	23.4	31.6	24.2	33.9	24.7	23.0	40.7	21.7	10.5	21.0	17.3	31.8	24.8	24.9	29.1	21.2	17.9	29.4	9.1	39.4	46.7	26.1	18.4	14.2	16.5	21.6	8.6	114.9	31.8	19.9	20.3	36.6	22.1	28.8	51.6	29.0	19.1	19.3	37.5	49.4	44.0	51.6	21.2	30.4	26.9	26.4	39.2	29.0	26.3	19.0	17.8	86.0	45.9	13.1	21.8	22.8	62.3	1.5	14.0	8.3	21.2	13.1	39.9	13.6	33.4	22.4	26.5	14.0	29.9	12.6	18.2	37.6	2.7	48.3	2.1	10.4	14.5	0.3	1.8	8.0	7.9	0.5	23.5	0.1	6.8	14.1	13.9	8.4	7.4	18.3	17.1	5.9	3.8	2.1	34.0	45.9	6.6	6.1	4.9	18.5	5.6	14.2	19.9	0.5	7.3	33.2	1.3	8.4	10.7	60.1	1.5	15.2	23.4	0.6	15.6	10.1	3.6	12.0	3.4	0.8	1.4	12.4	2.5	5.6	11.2	22.9	7.2	39.3	21.8	19.6	17.2	17.7	15.1	16.5	3.7	19.0	16.5	16.8	86.0	13.1	45.9	17.8	16.5	22.8	25.1	28.3	24.2	33.9	21.2	17.9	26.1	18.4	31.8	21.2	50.6	29.0	40.2	16.9	8.7	11.9	32.2	20.4	16.0	39.8	87.2	13.7	107.9	1.7	38.7	130.7	26.0	27.4	46.7	39.5	210.6	15.5	11.6	19.7	0.9	32.0	3.2	9.2	66.9	28.0	20.6	35.9	7.7	5.0	4.6	17.2	33.6	29.3	37.4	53.0	3.8	2.9	58.2	18.6	3.0	2.7	7.4	78.1	41.7	20.9	16.5
SLC44A5	"CTL5, MGC34032"	ENSG00000137968	"Solute carrier family 44 member 5"	Q8NCS7	1	75202131-75611116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 63.4;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 7.2;RPTEC TERT1: 7.1;SH-SY5Y: 11.1;SuSa: 11.8;TIME: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047455, HPA051011"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA047455: AB_2680054, HPA051011: AB_2681309"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (1.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.30e-1)"	1.0	0.4	2.4	1.0	1.5	0.0	6.3	1.0	3.6	1.0	1.8	1.0	1.0	0.9	1.0	1.0	7.7	3.7	1.0	2.2	2.8	2.8	2.0	1.0	1.0	1.0	2.3	1.0	1.0	1.8	5.6	3.7	3.8	1.0	1.0	2.9	1.0	1.6	1.0	1.5	11.3	1.0	1.0	1.0	1.0	1.3	32.6	1.0	1.0	1.0	1.0	1.8	2.2	1.9	3.2	0.3	0.6	0.3	0.5	1.1	0.3	0.2	0.2	4.5	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	2.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.5	0.6	1.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.4	2.4	2.6	0.0	0.0	1.7	0.0	4.5	2.9	0.6	0.0	0.0	2.1	7.1	4.8	1.0	11.1	0.0	4.6	0.0	11.8	0.2	0.0	13.7	0.4	1.2	0.0	1.4	2.0	1.9	3.0	0.2	0.0	0.7	0.4	0.3	0.2	0.4	0.1	0.9	3.2	0.8	1.1	0.1	2.4	0.6	0.4	0.6	0.5	0.2	0.3	0.6	0.3	2.4	1.5	1.0	3.4	2.8	2.8	2.3	1.0	1.0	1.0	0.0	0.6	0.0	0.6	1.6	3.7	0.6	0.0	2.7	1.2	0.0	0.0	6.8	0.0	0.1	63.4	0.4	0.4	0.0	0.8	3.2	0.2	0.8	0.0	0.0	1.0	0.0	2.4	3.1	0.0	27.3	0.9	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.2	5.8	3.2	0.0	0.2	3.1
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680459	"Cancer-related genes, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 115.0"	"Group enriched"	"Detected in many"	11	"Glandular cells: 50.8;granulocytes: 117.6"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	226	"basophil: 22.6"	"Lineage enriched"	"Detected in single"	226	"granulocytes: 22.6"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 141.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.33e-5)"	0.8	1.5	2.5	1.5	6.2	0.7	0.8	0.4	5.8	1.9	2.1	19.0	0.0	2.1	0.9	0.6	0.9	1.1	1.8	0.7	4.2	2.0	1.1	4.0	1.7	1.6	13.2	1.6	1.0	0.7	0.5	1.9	0.6	7.2	115.0	1.6	0.2	0.9	0.7	2.2	0.9	2.1	0.8	12.4	5.0	6.4	1.4	11.1	0.0	0.5	0.7	0.7	1.5	0.4	0.0	0.0	22.6	0.0	0.0	0.0	0.2	1.5	0.5	0.4	0.4	0.0	0.0	0.3	0.2	0.0	0.5	0.4	1.1	2.9	0.4	0.7	0.0	0.5	0.5	0.2	0.5	0.0	0.6	0.4	4.7	0.1	0.3	0.3	0.8	141.5	0.0	0.1	0.3	0.0	0.3	1.6	0.7	0.7	0.2	0.2	0.3	0.1	1.3	2.0	2.7	1.7	0.1	0.7	0.2	0.6	2.2	0.2	0.5	0.2	3.5	0.6	0.4	0.8	0.2	1.5	0.2	1.6	0.5	1.1	0.0	0.1	0.0	0.3	0.2	1.1	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	6.2	0.4	5.8	4.2	2.0	13.2	1.6	7.2	11.1	0.0	5.6	1.3	1.1	0.0	0.2	1.7	5.1	2.7	1.2	1.8	0.0	0.4	0.0	1.8	0.1	0.6	3.4	0.0	0.5	0.1	0.6	50.8	117.6	4.9	2.0	0.0	0.0	0.0	0.6	0.0	1.7	0.9	0.0	1.0	7.4	0.2	2.4	7.0	1.4	1.8	0.0	6.5	1.0	0.0	1.5	0.1	0.0	0.0	4.4	0.8
SLC45A4	KIAA1126	ENSG00000022567	"Solute carrier family 45 member 4"	Q5BKX6	8	141207166-141308305	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 32.9;Collecting duct cells: 47.1;Cone photoreceptor cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 9.4;neutrophil: 8.6"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.6;OE19: 23.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023154	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA023154: AB_2191204"	"unprognostic (7.79e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.73e-6)"	"unprognostic (8.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.40e-2)"	5.6	3.9	6.9	7.6	7.0	10.2	4.3	10.0	19.1	14.2	6.6	2.7	8.5	5.4	6.7	8.9	5.0	11.6	6.9	9.3	8.2	5.9	12.2	1.6	10.1	7.6	5.1	8.4	5.0	14.2	5.4	20.6	17.8	11.5	9.5	3.9	11.4	15.6	16.3	6.4	7.4	6.0	4.3	3.0	6.8	24.4	28.5	2.9	6.6	8.7	1.8	6.4	7.8	4.4	0.0	0.4	9.4	0.1	0.2	0.5	0.1	3.7	8.6	3.1	4.9	0.2	0.2	13.8	2.1	1.3	1.9	1.5	5.4	10.0	0.8	9.4	0.8	2.7	3.1	1.7	1.0	0.9	5.9	2.5	2.4	2.5	0.0	1.5	0.9	15.6	0.7	1.4	1.5	0.8	0.4	1.3	4.0	4.6	0.6	0.5	9.2	8.4	1.9	4.1	23.2	3.5	2.6	0.2	2.4	6.8	6.8	4.9	3.9	2.3	0.8	3.6	2.2	1.6	5.6	0.7	0.0	2.1	3.3	4.1	3.1	9.9	1.0	1.9	3.7	3.6	1.3	0.1	9.4	0.2	0.1	0.2	0.0	0.2	0.5	0.1	0.0	0.2	0.2	8.6	0.2	0.1	0.4	0.2	0.1	6.9	7.0	10.0	19.1	8.2	5.9	5.1	8.4	11.5	2.9	8.9	10.1	0.0	5.7	2.4	32.9	11.1	10.2	17.4	6.8	47.1	51.1	7.1	0.0	6.2	9.5	1.4	9.5	0.0	2.4	0.6	2.0	6.0	1.1	0.0	5.6	3.2	2.4	0.6	2.7	4.1	2.0	2.7	3.3	0.0	6.3	2.8	5.6	5.8	2.1	3.3	9.3	0.0	2.1	4.2	1.9	2.0	13.6	1.5	3.3	9.5
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 62.9;liver: 50.0"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 58.8;Hepatocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 20.5;T-47d: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favorable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	6.9	14.2	3.8	5.9	5.7	1.4	6.4	7.6	6.5	8.3	19.6	6.9	2.8	24.0	5.2	7.4	3.1	4.1	12.7	8.1	4.2	4.2	10.4	50.0	6.0	11.4	4.7	3.9	5.0	5.5	4.2	18.2	5.0	6.6	5.3	10.1	17.4	10.3	5.6	8.2	4.0	62.9	4.5	5.1	11.6	4.8	9.3	3.7	11.8	6.8	3.0	6.9	6.1	4.7	9.1	10.4	22.6	15.9	5.6	11.2	7.4	0.0	2.0	0.0	5.5	4.5	1.8	0.1	2.0	11.1	2.2	3.2	0.1	4.7	3.8	3.7	2.8	8.4	0.4	2.5	1.0	3.3	2.8	4.9	2.5	0.0	0.0	8.4	0.0	3.3	7.2	2.1	3.3	5.4	2.2	4.0	11.3	2.7	0.0	10.5	2.0	6.2	0.4	0.2	5.6	1.7	2.6	9.9	0.1	20.5	0.6	0.9	0.3	0.0	10.2	4.0	2.4	15.0	3.3	1.5	1.1	2.1	0.3	11.7	3.1	1.5	0.5	0.6	0.0	2.0	22.6	8.0	3.0	9.8	11.5	8.4	6.6	7.9	9.6	10.4	9.1	11.2	10.6	8.2	5.6	15.9	9.7	9.2	7.4	3.8	5.7	7.6	6.5	4.2	4.2	4.7	3.9	6.6	3.7	0.0	4.8	5.1	0.0	1.6	22.0	7.7	17.8	10.7	1.2	8.7	7.9	0.5	1.7	11.8	3.0	8.9	58.8	0.0	4.9	0.2	5.4	0.6	24.4	50.6	9.7	20.6	3.5	19.6	25.4	1.7	1.4	14.5	6.8	4.6	7.0	14.1	3.8	5.8	2.1	8.4	9.5	0.0	2.8	2.3	0.5	1.5	0.6	10.0	10.0	0.1
SLC4A1AP	"HLC3, kanadaptin"	ENSG00000163798	"Solute carrier family 4 member 1 adaptor protein"	Q9BWU0	2	27663471-27694976	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 127.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036679	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA036679: AB_2675244"	"unprognostic (5.63e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.21e-1)"	"unprognostic (7.89e-3)"	"prognostic unfavorable (3.76e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.79e-4)"	12.3	16.1	18.8	14.2	27.0	12.7	13.9	27.4	29.0	11.5	11.3	15.8	8.7	11.6	12.8	12.2	14.2	12.3	9.8	18.6	17.9	19.6	15.3	15.0	12.8	14.6	17.0	20.5	15.2	13.3	23.8	16.0	14.5	29.1	12.6	12.3	9.0	12.4	12.1	26.0	15.1	12.0	12.5	15.4	13.1	12.5	29.9	16.8	16.1	14.6	14.9	15.1	11.1	11.0	16.7	13.3	40.8	17.9	22.5	19.5	14.1	22.0	12.9	13.0	12.1	13.4	12.4	19.1	18.4	12.7	19.4	15.9	18.8	16.2	14.0	17.1	14.7	20.5	15.8	20.8	14.2	17.4	19.4	17.0	16.1	13.5	20.6	16.4	22.9	15.4	11.1	18.1	19.3	18.3	16.3	19.7	13.8	23.2	15.3	17.8	13.4	15.4	22.5	13.1	14.6	12.7	12.8	28.5	16.1	19.9	10.3	14.2	14.0	14.3	19.6	17.6	13.8	11.8	15.1	19.9	18.1	16.4	12.5	21.4	25.3	35.7	44.8	19.6	18.5	14.4	40.8	17.7	24.2	17.6	16.9	17.4	13.5	16.1	15.3	13.3	16.7	19.5	16.5	16.5	22.5	17.9	10.7	17.1	14.1	18.8	27.0	27.4	29.0	17.9	19.6	17.0	20.5	29.1	16.8	29.8	21.6	5.2	11.5	10.5	20.1	26.0	12.7	22.7	29.6	17.4	17.7	21.1	5.0	23.4	23.8	18.3	9.7	0.0	31.5	17.0	12.3	7.8	37.0	14.0	21.3	23.8	15.6	12.9	15.8	3.1	16.1	13.3	16.9	27.1	10.6	21.0	27.1	8.6	18.0	12.6	20.2	32.3	10.0	127.5	65.0	10.5	20.4	15.0	8.5	7.6
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 76.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.9	52.8	10.4	21.4	10.4	6.1	23.8	19.4	10.5	15.9	13.8	30.0	25.6	9.6	42.6	9.2	23.4	15.7	10.6	9.4	2.9	27.6	15.8	12.6	25.7	15.2	17.0	6.5	40.6	8.9	8.3	18.0	4.6	17.1	8.8	13.6	38.9	8.1	12.3	30.6	18.6	11.2	24.7	21.5	19.6	14.7	5.7	11.2	13.0	12.1	8.6	31.2	17.7	33.5	16.5	8.2	13.8	12.8	19.0	21.4	10.9	21.0	28.5	8.8	11.8	5.4	32.7	16.3	42.9	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5	8.9	10.9	6.7	4.5	9.8	7.9	3.6	17.8	1.4	2.3	19.2	23.6	28.5	14.9	31.0	0.6	9.8	17.3	0.0	30.9	9.0	16.2	5.0	48.3	31.4	23.1	14.3	26.5	14.7	15.1	1.3	12.7	9.9	25.3	9.0	11.1	22.3	39.3	14.0	18.7	18.9	8.8	12.9	15.5	3.2	7.7	6.0	76.5	8.3	18.9	3.1
SLC4A3	"AE3, SLC2C"	ENSG00000114923	"Solute carrier family 4 member 3"	P48751	2	219627327-219641980	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 103.6;ovary: 30.2"	"Group enriched"	"Detected in many"	17	"Cardiomyocytes: 201.0;Horizontal cells: 527.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"myeloid DC: 2.3;plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063498			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063498: AB_2685025"	"unprognostic (9.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (8.92e-4)"	"unprognostic (1.77e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.12e-4)"	1.8	5.4	11.8	1.6	22.5	1.2	2.0	8.8	22.0	2.8	1.3	3.0	0.4	1.4	3.4	2.6	2.9	2.7	2.3	103.6	10.4	8.2	1.6	1.0	1.3	1.4	6.5	9.0	30.2	2.7	4.5	9.9	2.5	24.1	4.2	1.1	4.9	3.1	4.3	1.2	1.6	1.3	3.1	1.6	2.6	1.4	4.2	3.5	0.0	1.5	0.0	1.3	1.6	0.9	0.0	8.9	0.0	0.1	0.0	0.0	0.0	6.2	0.2	2.2	6.5	0.4	0.4	4.4	3.9	4.1	5.3	3.8	4.5	3.6	0.0	1.5	1.4	9.2	3.6	1.1	7.1	1.6	0.0	1.0	0.0	0.0	0.1	1.1	0.1	0.3	3.1	6.7	0.0	2.1	13.4	0.0	0.0	0.2	0.0	1.5	2.1	0.0	0.0	3.6	0.2	5.3	0.0	0.0	0.0	3.6	1.5	1.3	6.4	2.5	6.8	3.3	7.5	0.6	1.6	0.0	3.3	5.8	0.0	3.1	0.0	0.0	0.0	2.7	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	11.8	22.5	8.8	22.0	10.4	8.2	6.5	9.0	24.1	3.5	0.0	0.0	0.0	0.6	0.2	8.9	201.0	0.0	0.0	1.2	1.8	0.0	10.5	1.7	2.8	2.0	0.1	0.0	0.0	1.5	2.5	2.2	0.3	0.0	0.0	1.6	527.6	0.0	0.0	0.0	11.9	14.1	1.1	0.0	1.0	0.0	7.0	1.3	0.0	21.2	0.3	6.7	6.5	1.4	0.5	1.1	0.6	11.6	0.0	0.0	0.0
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 48.5"	"Group enriched"	"Detected in many"	10	"Cone photoreceptor cells: 691.1;Rod photoreceptor cells: 667.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	14.5	5.0	3.2	10.5	4.6	3.3	17.0	4.0	4.8	10.8	38.2	5.0	8.8	48.5	8.1	12.6	8.4	6.5	12.5	9.3	5.0	3.8	15.3	3.7	9.3	10.3	4.8	1.9	9.0	3.3	2.4	4.4	5.6	4.5	10.3	6.9	20.0	8.3	8.4	5.6	5.6	43.4	18.2	5.8	9.7	7.8	6.1	5.5	6.8	6.3	14.7	15.5	15.0	14.9	1.8	2.0	0.1	0.9	2.4	3.9	0.7	5.9	11.1	10.0	4.6	4.7	8.4	7.1	20.2	9.4	7.8	6.1	3.0	3.1	13.5	1.7	7.8	7.5	2.6	9.5	9.8	12.4	11.4	3.1	6.2	7.6	3.2	8.1	14.0	5.4	6.7	4.3	11.8	38.2	16.5	12.8	8.9	4.1	4.8	16.0	2.1	13.9	3.2	6.6	0.7	11.0	9.5	7.9	2.7	18.3	4.2	2.5	6.3	9.2	6.8	3.1	8.9	15.5	5.4	8.9	18.4	5.1	12.7	15.6	1.8	1.9	7.7	16.1	9.9	8.4	0.0	0.5	0.0	3.0	0.6	2.0	1.2	3.8	3.9	1.4	1.8	1.5	2.7	0.1	2.4	0.9	2.0	3.2	0.7	3.2	4.6	4.0	4.8	5.0	3.8	4.8	1.9	4.5	5.5	0.0	12.8	13.2	28.2	26.1	65.7	18.7	15.3	5.3	25.0	59.3	691.1	4.5	8.3	13.6	6.7	25.3	5.8	0.0	6.2	23.0	30.2	41.3	23.1	5.9	16.9	6.4	36.7	14.7	33.1	5.9	8.3	36.7	33.7	20.8	50.6	45.2	13.6	12.7	9.2	10.5	667.4	38.8	32.8	32.4	21.7	26.8	6.8	33.0	12.2	33.6
SLC4A8	NBC3	ENSG00000050438	"Solute carrier family 4 member 8"	Q2Y0W8	12	51391317-51515763	"Predicted membrane proteins"	"Anion exchange, Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;pituitary gland: 20.0;testis: 15.3"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 85.2;Cone photoreceptor cells: 168.9;Horizontal cells: 109.7;Spermatocytes: 91.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.6;HMC-1: 12.4;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077895			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077895: "	"unprognostic (4.01e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.72e-4)"	"unprognostic (3.13e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.60e-6)"	"unprognostic (1.35e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.47e-1)"	1.0	6.5	5.8	2.2	13.3	1.7	3.1	9.2	22.9	2.7	1.1	9.8	0.0	1.4	1.2	5.4	0.7	3.7	1.1	1.0	10.9	5.6	3.2	0.8	2.8	3.0	6.0	9.3	7.3	2.4	1.0	20.0	1.0	28.6	1.4	1.4	2.2	1.5	1.7	0.8	1.0	2.0	1.1	4.7	2.2	3.0	15.3	5.1	0.0	0.8	0.0	2.7	1.0	0.7	1.1	2.6	3.4	3.1	1.7	1.7	0.7	0.2	0.8	9.9	0.1	0.4	0.5	17.6	2.7	4.5	4.4	2.8	5.8	0.2	3.6	0.4	3.6	2.4	0.1	3.9	0.2	4.1	0.7	0.5	1.8	0.3	0.0	0.0	0.6	12.4	0.1	0.2	2.2	0.5	2.6	5.1	1.6	0.1	6.4	2.2	2.1	5.2	1.1	4.3	1.1	2.9	0.1	0.0	0.0	0.5	0.1	13.2	8.9	1.0	1.4	0.0	3.2	1.6	0.4	4.7	2.8	1.5	0.2	3.4	3.2	1.0	0.2	3.9	0.5	0.4	1.3	2.1	3.4	1.7	1.4	0.4	0.6	0.6	1.6	2.6	1.1	0.6	1.0	2.3	1.7	3.1	1.0	0.3	0.7	5.8	13.3	9.2	22.9	10.9	5.6	6.0	9.3	28.6	5.1	0.0	8.3	0.5	0.6	0.0	85.2	1.7	0.0	38.8	9.1	1.8	168.9	1.0	6.6	0.1	48.8	1.1	0.3	0.0	1.2	4.3	0.5	1.0	7.0	0.0	2.1	109.7	5.8	0.6	1.2	22.8	2.6	3.3	1.7	0.0	0.2	13.6	0.1	2.9	3.5	0.8	18.4	0.0	0.8	91.6	6.4	0.1	0.3	2.5	0.0	1.0
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 beta subunit"	Q86UW2	15	65045370-65053396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 85.0"	"Cell type enriched"	"Detected in many"	6	"Enterocytes: 518.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 16.9;EFO-21: 11.3;Hep G2: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA			Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	0.4	3.8	0.6	0.0	0.4	0.4	0.8	14.0	34.9	0.4	0.4	28.1	0.9	3.3	0.4	1.0	0.5	0.4	0.5	0.6	7.5	2.4	1.6	0.4	0.6	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.8	9.5	0.4	0.4	0.8	0.4	0.1	85.0	0.4	0.4	0.4	0.2	4.1	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.7	0.1	0.0	0.5	0.3	0.0	1.4	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	16.9	0.0	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	14.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.3	0.7	0.0	0.1	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.5	0.6	0.6	0.4	0.4	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.0	2.5	10.7	0.0	0.0	0.0	0.0	11.6	0.0	48.8	0.0	518.3	0.0	0.0	0.0	0.0	0.0	4.6	1.5	0.1	0.0	1.7	0.6	0.0	9.7	0.3	0.0	0.0	0.0	7.7	0.0	0.0	84.2	0.0	54.0	0.0	6.5	0.0	1.5	0.4	0.0	0.1	0.0	19.7	0.0
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043032-32113029	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 274.9"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 27.0"	"Region enriched"	"Detected in single"	26	"cerebellum: 8.6"	"Not detected"	"Not detected"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.2	0.0	0.2	1.3	0.2	0.0	1.5	0.2	0.2	2.2	181.5	0.2	2.9	95.5	0.3	0.8	1.9	0.0	14.1	24.5	0.2	0.0	1.0	0.9	0.3	0.2	0.2	0.2	0.2	0.4	0.0	1.0	0.2	0.2	0.8	1.6	0.2	5.7	3.5	0.2	4.6	274.9	0.2	0.2	0.7	1.2	0.8	0.2	0.2	0.2	3.5	1.5	0.2	2.0	0.3	0.1	0.6	0.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	27.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.8	0.6	0.0	111.5	117.2	0.0	4.5	0.0	0.0	0.0	0.0	2.4	40.8	0.0	26.1	0.0	1.2	0.0	0.2	19.7	0.0	0.0	0.0	0.0	24.5	0.0	0.0	54.9	1.1	0.0	0.0	0.0	8.7	0.0	0.6	14.7	1.4	1.9	0.0	0.0	0.0	4.2	0.5	4.8	0.0	0.0	19.6	4.8
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Predicted membrane proteins"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 48.0;intestine: 21.8"	"Group enriched"	"Detected in some"	4	"Enterocytes: 1.7;Paneth cells: 2.9;Proximal tubular cells: 5.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 18.9;Karpas-707: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.6	0.6	4.3	0.6	21.8	0.5	2.8	1.9	11.2	0.6	1.7	29.7	0.0	10.9	0.6	0.5	0.5	0.6	1.4	0.7	12.1	7.4	9.9	1.0	0.6	0.7	48.0	2.4	0.6	0.5	0.5	0.2	0.5	18.3	0.6	0.8	0.0	0.6	0.8	0.7	0.5	21.8	0.5	34.7	0.6	0.6	0.8	22.9	0.0	0.6	0.0	0.7	0.6	0.1	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.3	21.8	1.9	8.0	12.1	7.4	48.0	2.4	18.3	22.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	5.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.0;placenta: 51.7"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 69.3;SK-BR-3: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	20.9	4.6	5.0	7.6	8.5	8.5	15.9	7.9	8.1	4.0	6.4	5.6	6.4	10.9	7.4	36.7	5.5	5.9	6.3	3.5	5.3	5.7	5.9	64.0	6.0	6.4	7.0	8.1	5.6	6.0	4.5	4.2	51.7	7.1	4.8	6.6	5.6	6.7	10.6	7.9	4.6	7.6	4.9	4.4	4.8	4.8	17.5	6.1	5.8	5.1	4.3	13.0	4.6	10.1	6.8	10.0	2.0	9.0	6.3	10.4	5.8	16.7	17.4	11.1	14.6	10.3	3.7	69.3	6.1	4.1	9.3	6.4	25.6	6.0	11.6	9.3	3.3	10.1	9.4	23.7	7.0	6.5	9.0	13.9	20.6	7.4	39.2	12.2	26.4	10.8	12.9	6.0	11.4	8.9	2.6	8.3	9.5	30.1	4.8	5.9	34.4	8.9	12.9	32.0	19.4	6.4	15.1	13.1	16.8	5.3	16.1	9.4	13.9	6.6	74.6	8.8	11.3	16.6	5.7	3.8	10.3	14.1	6.2	16.3	8.0	18.3	18.5	5.6	18.6	14.4	0.1	6.5	2.0	8.5	7.3	10.4	6.8	8.3	8.2	9.7	6.7	8.5	10.1	0.3	6.3	9.0	10.0	8.2	5.8	5.0	8.5	7.9	8.1	5.3	5.7	7.0	8.1	7.1	6.1	0.0	4.1	13.4	6.8	7.1	4.5	5.9	7.6	4.0	2.3	7.0	3.9	98.8	1.7	9.6	11.6	3.8	6.0	0.0	7.0	89.2	5.4	7.1	0.0	36.0	19.5	11.1	5.2	7.4	10.0	25.3	6.6	6.5	0.0	78.5	6.8	3.9	6.2	2.9	13.1	3.6	3.4	12.9	5.9	31.1	18.5	5.5	190.6	7.5	13.3	6.4
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 45.1"	"Group enriched"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Group enriched"	"Detected in some"	13	"basal ganglia: 13.8;pons and medulla: 45.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"RT4: 8.9;SCLC-21H: 2.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 26.3"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA			"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.3	2.4	0.1	1.6	13.8	0.0	0.3	0.1	0.4	3.3	5.2	0.1	0.3	2.3	1.6	0.7	1.0	0.2	0.5	1.2	0.2	2.2	0.9	0.2	0.9	0.0	0.3	0.5	0.8	0.5	0.0	0.1	0.0	45.1	0.8	2.5	1.0	0.9	4.2	0.1	0.1	2.5	3.1	10.0	0.1	1.7	0.3	0.8	0.0	4.0	0.3	0.1	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	0.1	0.4	0.2	2.2	0.3	0.5	45.1	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 77.3"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 20.8;Early spermatids: 5.8;granulocytes: 4.6;Late spermatids: 7.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	33.0	0.1	0.8	26.0	0.1	7.2	0.1	0.2	2.2	0.1	0.0	0.0	3.1	4.9	2.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	1.0	77.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	1.0	0.0	0.0	0.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	1.7	0.4	5.8	0.0	0.7	0.0	0.2	0.0	0.0	0.1	4.6	4.5	0.1	0.0	0.0	0.0	1.2	7.9	0.3	0.0	0.0	0.0	0.6	0.0	0.1	1.1	0.4	3.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0
SLC6A12	BGT-1	ENSG00000111181	"Solute carrier family 6 member 12"	P48065	12	190077-214570	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 22.1;liver: 59.3"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 43.6;Hepatocytes: 17.4;monocytes: 17.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	57	"classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6"	"Group enriched"	"Detected in many"	51	"dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.4;RPTEC TERT1: 17.0;SuSa: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034973	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA034973: AB_10610427"	"unprognostic (3.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (2.70e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-4)"	"unprognostic (3.35e-1)"	"unprognostic (4.31e-4)"	0.6	0.8	6.3	1.3	12.9	0.6	0.8	6.6	14.7	0.9	1.0	4.3	0.0	3.7	1.3	5.6	0.5	3.0	1.2	0.7	7.2	4.6	22.1	59.3	2.2	0.8	8.1	4.9	0.7	1.3	0.6	0.3	0.9	9.4	0.6	1.8	0.2	0.6	0.5	0.5	0.7	1.1	1.2	3.1	0.8	2.3	1.6	8.8	0.0	4.5	0.0	0.7	0.9	0.2	0.0	2.9	3.7	8.6	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.0	0.1	0.0	0.5	0.0	0.0	0.1	3.7	0.3	0.5	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	6.6	0.0	0.0	6.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.7	0.0	8.6	0.0	0.0	1.9	6.3	12.9	6.6	14.7	7.2	4.6	8.1	4.9	9.4	8.8	0.0	0.3	0.9	0.0	0.1	0.0	0.4	0.0	0.0	0.0	43.6	0.0	0.0	1.7	0.0	3.6	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	17.4	2.4	0.0	0.0	1.3	0.3	3.4	0.6	1.8	0.0	17.2	1.2	6.3	0.0	0.0	0.0	6.8	0.2	6.5	0.0	0.5	1.7	0.4	0.7	0.0	0.8	0.0
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.8;Hep G2: 8.2;OE19: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	3.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0											20.8	100.3	0.0	0.1	0.1	0.0	0.2	0.0	10.7	33.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.2	0.0	28.5	0.0	0.0	5.2	3.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.1	0.0	101.5	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.0	3.2
SLC6A15	"FLJ10316, hv7-3, NTT73, SBAT1, V7-3"	ENSG00000072041	"Solute carrier family 6 member 15"	Q9H2J7	12	84859488-84913615	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 18.0;Horizontal cells: 11.1;Melanocytes: 30.4;Rod photoreceptor cells: 10.2"	"Cancer enhanced"	"Detected in some"		"melanoma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 31.1;ASC TERT1: 19.2;hTERT-HME1: 43.9;SCLC-21H: 30.0;SK-MEL-30: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008609	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA008609: AB_1857190"	"unprognostic (1.01e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.65e-6)"	"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"unprognostic (7.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.69e-4)"	"unprognostic (2.57e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-3)"	1.4	4.5	18.0	2.2	16.2	1.0	2.3	17.8	31.0	1.7	2.2	5.4	0.0	1.4	2.8	1.1	6.7	1.2	1.3	1.0	10.9	18.2	1.5	1.0	1.3	1.1	10.3	16.9	2.1	1.0	1.0	5.6	8.9	14.7	1.8	1.8	9.2	1.4	1.5	1.0	4.9	2.1	1.6	4.9	1.1	1.3	3.6	12.8	0.0	2.0	1.8	1.8	1.1	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	3.6	0.0	31.1	19.2	0.0	0.0	6.5	0.5	0.3	0.0	0.0	0.0	0.0	0.2	4.1	0.4	0.0	8.3	0.0	0.0	9.5	0.0	1.5	0.0	11.5	0.0	0.2	10.7	16.0	4.2	43.9	8.5	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	7.8	0.0	9.9	22.1	0.1	0.0	0.0	0.0	4.7	2.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	16.2	17.8	18.6	10.9	18.2	10.3	16.9	14.7	12.8	0.0	0.0	0.0	0.0	2.4	18.0	0.4	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.1	11.1	0.0	0.0	0.0	0.2	0.0	0.0	30.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.2	0.0	0.2	0.1	0.4	0.5	0.2	0.0	0.0	0.0
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150486-110202202	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 53.5"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 2.1;Melanocytes: 10.1;Rod photoreceptor cells: 3.6"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008043, HPA008044"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008043: , HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	1.4	7.8	9.3	1.2	18.3	1.1	1.3	21.8	53.5	1.0	1.1	2.3	0.0	1.0	1.0	2.1	1.3	1.0	1.1	1.0	11.2	14.9	2.1	0.9	1.0	0.9	6.0	16.2	1.0	2.6	1.0	12.4	1.8	19.5	1.0	1.0	2.6	1.2	1.0	1.0	7.6	1.1	1.1	1.8	1.0	1.8	2.4	0.7	0.0	1.3	0.0	0.9	1.0	0.1	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.3	0.4	1.7	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.6	4.8	1.5	28.3	0.8	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	5.7	0.0	2.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	9.3	18.3	21.8	37.3	11.2	14.9	6.0	16.2	19.5	0.7	0.0	0.0	0.0	0.0	0.5	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	3.6	0.0	0.4	0.0	1.1	0.4	0.1	0.0	0.0	0.0
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.4;placenta: 41.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 107.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 8.2"	"Region enriched"	"Detected in single"	32	"pons and medulla: 23.1"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	2.4	20.4	0.3	0.1	0.1	0.0	1.8	0.1	0.3	3.2	0.3	0.3	0.1	0.0	4.5	7.2	0.8	0.4	0.4	0.1	0.1	0.0	0.4	1.0	0.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	41.8	9.7	0.5	0.1	0.1	1.6	1.7	0.1	11.4	0.4	1.0	0.2	0.1	0.2	8.3	0.2	0.1	0.2	0.9	0.5	0.5	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	107.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	9.7	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	6.9	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.4	4.7	0.0	0.0	0.0
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392790-1445430	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 48.4"	"Cell type enriched"	"Detected in single"	5	"Alveolar cells type 2: 2.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 25.7"	"Region enriched"	"Detected in some"	47	"midbrain: 48.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8"	"Group enriched"	"Detected in some"	8	"midbrain: 96.4;thalamus: 31.8"	"Region enriched"	"Detected in single"	138	"midbrain: 362.2"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles		NA	NA			Vesicles		"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484"	"unprognostic (2.25e-4)"	"unprognostic (2.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-5)"	"unprognostic (9.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.40e-7)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.74e-2)"	0.2	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.3	1.1	0.8	0.1	0.8	0.6	0.1	0.0	0.6	0.3	0.0	3.4	0.0	48.4	0.0	1.5	0.0	0.0	0.0	0.1	1.0	0.7	0.0	1.7	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.8	0.0	2.4	2.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.0	0.1	3.8	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.6	48.4	0.0	1.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 76.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 33.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.2"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.2	25.9	5.7	18.0	16.5	46.4	8.1	11.1	12.2	11.3	9.5	8.7	3.6	8.5	14.5	4.4	7.0	7.0	14.5	23.2	5.6	4.6	16.6	2.3	18.6	12.9	18.0	7.6	31.3	2.8	3.8	9.6	18.0	13.3	5.0	4.1	76.4	15.7	7.7	26.6	16.8	22.2	8.2	11.1	20.3	14.0	4.0	12.6	6.2	10.4	11.3	11.2	8.8	6.1	1.6	1.9	33.2	6.9	0.7	3.9	2.3	4.6	17.3	6.2	4.7	8.1	2.5	12.8	7.0	27.8	8.3	6.1	6.3	8.0	13.5	6.4	11.0	12.0	3.7	4.2	5.7	7.4	1.5	5.2	12.8	22.7	9.4	0.2	3.5	27.8	1.3	1.7	7.6	2.0	7.2	9.0	6.3	7.1	2.7	7.3	4.9	9.8	6.8	9.6	6.5	5.0	7.0	7.4	21.1	45.5	9.7	11.5	4.1	5.2	2.8	1.5	24.4	10.7	1.9	22.7	10.6	5.7	2.6	5.0	3.0	3.4	5.0	24.7	6.9	32.4	2.5	5.1	5.0	1.3	4.2	0.7	1.6	1.4	1.7	1.9	0.9	0.2	0.3	33.2	0.7	6.9	0.7	3.9	2.3	5.7	16.5	11.1	12.2	5.6	4.6	18.0	7.6	13.3	12.6	6.0	22.1	4.7	11.2	43.8	102.1	3.6	2.5	12.0	12.5	19.2	538.0	2.2	0.0	9.6	17.0	16.1	0.7	0.0	7.1	12.8	16.4	5.5	12.7	0.4	26.7	9.5	13.8	11.6	62.5	13.3	16.1	47.4	16.9	129.0	2.9	28.2	21.5	2.9	16.3	26.3	502.9	0.0	8.2	0.5	1.5	20.8	4.2	22.4	1.2	10.6
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2;skin 1: 38.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 26.6;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.9;hTCEpi: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	2.9	22.8	8.8	4.6	18.3	8.6	5.4	5.5	14.3	6.0	7.9	38.1	2.6	2.5	6.2	1.5	16.5	9.6	4.9	1.3	9.9	10.0	2.0	4.9	5.6	1.4	29.5	4.5	4.0	7.8	2.1	1.0	1.7	26.8	2.6	6.2	24.0	7.9	6.1	1.3	38.2	5.6	8.9	42.2	1.1	3.5	1.2	26.3	0.0	4.9	7.2	4.3	6.6	10.9	0.2	0.0	0.2	0.1	0.0	1.4	0.2	7.3	5.5	2.7	7.0	4.4	1.5	6.2	5.9	15.9	9.6	11.9	1.8	2.9	0.1	0.6	16.3	0.0	23.9	4.2	4.7	1.9	0.0	0.7	6.5	13.1	2.1	20.2	1.4	0.3	4.5	41.9	4.7	11.2	6.0	0.2	4.7	5.0	18.8	0.4	4.0	1.0	0.0	2.1	2.8	7.4	0.8	0.0	8.4	0.9	0.8	1.7	1.6	3.0	13.7	2.7	0.7	3.6	3.9	0.1	1.1	4.5	0.9	3.0	20.8	14.3	1.6	3.6	0.0	1.4	0.0	0.0	0.2	0.4	0.1	0.2	0.2	0.4	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	8.8	18.3	5.5	9.4	9.9	10.0	29.5	4.5	26.8	26.3	0.0	1.3	0.9	0.7	6.6	26.6	0.6	5.1	8.1	0.0	1.8	15.7	0.4	0.0	3.2	5.8	0.4	9.8	70.0	7.9	0.7	0.9	1.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.4	1.4	0.0	3.3	1.8	2.9	1.2	4.2	2.0	1.4	1.0	10.2	6.5	6.3	0.0	0.4	11.3	0.5	0.0	1.3	2.5
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2"	"Cell type enhanced"	"Detected in many"	13	"Glandular cells: 37.7;monocytes: 90.2;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.6;TIME: 31.4;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles		NA	NA			Vesicles		"HPA064215: AB_2685213"	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	1.1	0.9	16.3	4.7	15.8	2.2	1.5	8.2	26.0	2.4	2.0	17.9	0.0	1.5	1.3	13.4	3.3	8.9	3.8	2.5	17.4	6.9	0.9	0.9	2.3	1.5	12.6	16.8	1.7	5.4	1.0	1.2	2.1	17.2	2.0	2.8	0.3	1.6	1.0	0.8	1.9	1.4	1.0	27.2	1.4	9.2	2.2	14.0	0.0	8.9	6.0	2.2	4.0	0.8	0.1	3.8	0.4	0.0	0.1	0.0	0.0	1.6	13.8	6.2	4.8	1.3	1.7	1.7	7.6	5.3	1.7	4.0	1.5	5.8	3.1	10.0	26.5	9.4	2.2	3.3	6.5	7.4	5.9	0.7	2.2	13.1	3.4	20.6	5.8	2.1	4.1	28.6	4.9	22.1	2.6	21.6	3.2	3.0	8.2	9.1	1.2	0.8	0.5	1.2	8.1	3.9	0.9	2.0	3.6	1.0	6.6	2.5	0.5	3.3	0.9	11.7	1.4	1.5	12.4	31.4	2.3	6.5	3.4	6.0	6.9	3.1	3.2	3.9	3.2	46.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	3.8	0.0	0.0	16.3	15.8	8.2	15.9	17.4	6.9	12.6	16.8	17.2	14.0	0.0	5.9	3.7	7.0	4.0	4.0	3.6	2.5	1.4	3.4	0.0	2.0	2.2	0.0	3.6	2.1	1.6	1.1	0.0	21.4	0.5	1.0	37.7	4.6	0.4	0.5	1.6	25.9	3.7	0.0	0.4	2.3	9.0	5.0	90.2	5.4	48.4	27.4	1.1	2.1	0.0	1.9	0.0	1.0	0.7	0.7	2.8	0.9	0.0	1.3	11.1
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 31.5;Horizontal cells: 27.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.3	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	1.8	0.0	0.1	1.3	0.8	0.2	0.1	0.0	0.2	7.2	0.0	0.0	0.2	1.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	7.2	2.1	0.0	0.1	0.0	0.3	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3	3.0	2.1	0.0	0.3	0.3	31.5	0.8	0.0	5.3	4.5	0.0	2.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.5	0.2	2.3	1.0	0.0	27.0	1.7	0.0	0.0	0.4	2.0	0.9	3.3	0.0	0.0	1.8	0.1	0.0	2.5	0.0	3.9	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869488	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 71.2"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 70.0;granulocytes: 68.9;Intestinal endocrine cells: 82.6;Smooth muscle cells: 85.8;Syncytiotrophoblasts: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 15.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 108.7;hTCEpi: 186.8;MCF7: 101.2;SiHa: 153.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA052673: AB_2681909, HPA056077: AB_2683031"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	8.2	3.2	18.3	14.7	24.5	71.2	4.3	15.9	45.8	7.9	4.6	16.7	8.9	6.2	5.3	30.4	38.7	3.3	6.4	8.2	19.8	22.1	3.6	9.7	3.8	11.1	23.9	9.6	5.1	12.1	1.5	9.0	28.4	23.4	4.3	3.4	34.9	11.5	15.4	11.2	10.7	5.7	4.8	17.7	6.4	12.7	34.9	19.8	3.7	4.2	16.7	15.0	11.5	7.7	0.5	15.9	0.6	0.0	0.2	1.4	0.4	14.9	56.6	1.1	15.9	0.4	0.9	40.8	12.0	4.3	7.3	4.7	36.9	21.4	13.7	10.6	15.2	2.5	67.4	11.7	108.7	5.1	14.3	5.9	11.2	53.1	26.4	17.1	10.4	20.7	3.0	186.8	9.0	66.8	2.4	1.4	48.5	16.7	15.3	5.8	101.2	12.5	15.3	5.2	9.4	13.8	12.2	4.3	20.9	8.1	1.2	9.1	3.6	153.4	30.7	32.9	10.8	14.1	13.8	1.1	2.6	17.1	10.6	9.3	20.0	16.3	59.1	10.1	25.9	24.4	0.6	0.0	0.0	1.0	0.0	1.2	0.5	0.5	0.8	0.3	0.0	0.1	0.4	0.1	0.2	0.0	15.9	1.4	0.4	18.3	24.5	15.9	28.1	19.8	22.1	23.9	9.6	23.4	19.8	0.0	1.1	16.4	11.1	65.1	12.7	2.8	2.5	0.0	0.0	1.8	15.7	12.4	0.0	16.8	0.8	4.3	1.7	70.0	8.0	28.4	10.4	13.9	68.9	14.5	8.2	9.5	82.6	2.5	3.5	4.0	1.7	6.6	37.1	2.8	2.8	13.3	19.5	0.2	1.4	0.5	50.1	0.0	85.8	1.7	2.5	32.9	89.8	8.6	1.6	26.1
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.8"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 38.7;Syncytiotrophoblasts: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050713	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA050713: AB_2681218"	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.84e-4)"	25.9	7.6	5.4	12.9	6.7	6.9	18.7	9.0	8.0	5.3	7.1	3.4	6.7	3.6	5.5	14.0	4.0	7.1	4.7	13.1	5.3	3.3	5.4	2.3	9.8	16.3	3.3	4.6	3.0	3.2	2.5	11.1	16.3	5.4	6.6	10.8	9.0	5.8	5.1	58.8	8.4	9.4	8.3	3.4	9.4	5.3	5.2	3.7	31.8	15.0	8.0	19.6	5.7	8.0	7.2	16.2	5.9	3.6	6.7	12.6	1.7	9.4	9.7	7.2	7.7	21.4	12.8	20.3	11.1	8.1	16.6	13.9	41.3	7.2	18.8	8.8	14.2	4.8	14.5	14.0	13.9	18.1	3.8	10.0	10.0	19.1	13.1	3.9	11.8	9.1	8.6	12.2	12.9	6.5	5.3	11.1	9.8	14.7	3.4	9.0	5.1	15.3	8.2	5.4	6.4	3.5	19.5	4.5	15.8	5.8	8.3	10.6	5.8	32.1	9.0	3.8	6.3	13.5	6.4	16.3	11.0	8.4	9.2	13.9	7.2	13.5	21.5	7.0	8.7	7.4	2.5	3.6	3.0	4.9	1.7	6.1	6.6	7.3	4.6	3.4	7.2	12.6	7.4	5.9	6.7	1.4	16.2	3.1	1.7	5.4	6.7	9.0	8.0	5.3	3.3	3.3	4.6	5.4	3.7	38.7	16.8	11.1	8.0	17.4	3.7	17.3	0.0	8.1	3.4	17.4	35.3	20.4	0.0	3.0	4.0	9.0	4.2	0.0	3.4	1.6	10.5	3.0	4.6	1.3	12.0	9.5	2.4	7.4	6.7	14.6	5.5	7.5	10.1	3.6	8.9	2.1	4.1	6.2	3.5	0.3	2.6	0.0	7.3	14.2	9.4	19.2	40.0	17.5	6.9	2.3
SLC7A6OS	FLJ13291	ENSG00000103061	"Solute carrier family 7 member 6 opposite strand"	Q96CW6	16	68284503-68310946	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041533	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041533: AB_10794298"	"unprognostic (1.43e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.44e-4)"	"unprognostic (2.05e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	19.8	14.1	15.7	16.1	20.0	20.1	17.4	29.1	18.2	13.2	13.1	20.2	10.9	13.9	15.5	18.0	12.4	13.4	10.7	16.5	14.6	11.7	13.4	9.3	13.8	24.7	19.8	14.2	17.0	14.7	18.8	13.1	15.9	18.1	13.4	13.4	14.2	14.1	15.0	24.5	15.5	16.3	12.3	17.4	20.3	13.7	12.2	24.5	17.0	15.7	8.7	19.8	14.0	21.6	13.3	11.2	21.8	13.3	12.7	14.9	10.6	8.1	8.4	12.3	9.2	7.2	9.9	14.1	10.3	6.0	12.3	10.9	21.2	11.8	14.3	9.5	6.9	7.8	14.8	11.5	8.8	11.2	5.3	7.0	9.5	13.3	17.4	9.3	13.4	10.4	7.6	9.8	10.1	16.4	11.0	9.2	12.4	14.6	6.4	11.2	12.2	17.3	13.6	8.8	9.4	7.2	20.5	7.6	17.5	7.8	10.8	13.0	9.5	19.8	4.6	11.6	10.0	12.4	12.4	13.5	9.9	8.5	9.6	8.2	15.9	12.8	21.3	10.2	16.2	10.1	21.5	11.4	21.8	13.4	13.3	14.9	13.1	13.4	12.0	8.7	13.3	14.5	11.4	10.3	12.7	10.8	11.2	13.3	10.6	15.7	20.0	29.1	18.2	14.6	11.7	19.8	14.2	18.1	24.5	8.9	4.6	16.6	10.7	8.1	22.0	0.8	12.7	14.7	6.8	12.2	33.4	19.6	14.9	11.0	2.5	10.8	7.4	0.0	9.8	9.6	8.7	9.1	13.9	5.8	18.3	15.9	13.3	11.6	16.3	1.3	14.7	10.8	11.8	21.6	7.5	26.5	13.1	7.0	15.2	6.9	22.8	0.0	9.5	12.5	18.9	5.8	18.4	20.2	8.8	12.3
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 67.7"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 601.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 25.2"	"Cell line enhanced"	"Detected in many"		"BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	3.9	2.9	7.7	4.4	14.3	1.4	2.0	3.5	15.3	5.5	7.3	1.8	7.1	3.3	12.2	3.9	4.0	3.9	5.3	67.7	7.7	6.6	11.0	2.2	3.7	2.5	5.2	8.2	2.1	1.5	1.1	1.9	6.8	7.6	12.2	3.4	1.0	1.5	17.2	1.5	2.1	3.6	20.5	2.8	4.4	2.5	1.4	2.5	0.1	1.6	0.0	1.3	9.8	2.8	0.0	2.4	25.2	6.0	0.0	0.0	0.5	1.5	1.2	1.1	0.1	1.7	3.6	0.0	15.4	6.0	5.1	3.3	0.0	2.5	0.0	1.2	37.3	5.5	0.6	0.3	2.5	5.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	5.9	10.9	2.3	0.4	0.0	0.0	0.2	6.5	0.0	0.4	0.0	0.8	0.1	2.1	4.1	8.1	0.0	1.8	0.2	1.7	0.3	0.0	0.0	0.0	5.6	0.0	0.3	5.2	4.8	0.1	0.0	1.6	0.8	0.0	0.0	0.8	0.9	0.7	0.0	4.9	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	25.2	0.0	6.0	0.1	0.0	0.5	7.7	14.3	3.5	15.3	7.7	6.6	5.2	8.2	7.6	2.5	3.0	3.2	2.9	0.0	1.1	50.8	601.5	2.5	0.0	1.2	33.2	3.9	0.4	0.0	0.0	0.8	3.3	0.0	0.0	0.0	1.4	4.8	0.1	0.0	0.0	28.3	0.0	0.0	20.3	56.6	0.7	0.0	46.7	1.7	1.0	0.6	35.9	0.1	0.0	7.8	0.1	6.9	12.9	19.6	0.2	0.4	2.8	0.9	0.0	0.0	0.0
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748652-74769353	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 372.3;Proximal tubular cells: 352.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 78.7;SK-BR-3: 64.2;T-47d: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		9600000	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	5.4	33.3	19.8	9.9	23.3	22.6	15.2	21.9	15.1	12.5	30.6	15.2	35.9	57.6	5.4	12.0	74.3	20.5	30.8	5.6	14.2	8.8	36.1	64.9	8.6	13.5	14.3	14.0	5.0	26.5	12.5	4.9	8.3	12.8	10.1	13.4	22.9	41.8	23.3	1.5	11.2	73.3	3.1	12.1	13.8	14.8	5.4	14.1	18.4	5.6	24.3	30.3	7.1	20.3	9.8	14.3	72.7	24.8	45.1	70.4	44.3	13.9	11.5	5.7	5.9	3.5	2.5	25.9	3.3	3.1	8.6	8.4	36.0	8.4	3.0	3.4	7.1	4.6	20.1	9.8	6.5	4.1	3.7	9.4	23.0	31.1	47.9	7.1	15.0	15.6	2.1	3.6	6.8	2.9	18.0	7.1	9.2	7.3	16.5	13.2	78.7	35.3	33.7	5.1	39.5	6.8	3.8	6.5	13.9	11.9	10.0	4.9	6.5	3.5	64.2	7.2	16.6	124.2	12.0	2.3	2.7	7.8	6.3	5.5	28.6	12.9	5.6	4.3	20.0	1.5	72.7	14.1	65.3	70.4	20.6	46.6	9.8	43.2	59.3	13.7	8.6	25.5	45.2	50.3	45.1	24.8	14.3	47.0	44.3	19.8	23.3	21.9	15.1	14.2	8.8	14.3	14.0	12.8	14.1	6.0	18.8	36.3	18.8	41.0	1.9	14.9	206.4	41.5	14.8	29.6	3.9	67.4	56.3	154.8	9.9	11.7	372.3	0.0	86.0	43.0	16.6	31.5	24.3	159.6	66.7	4.8	18.0	4.9	23.7	8.2	8.1	24.4	27.0	7.2	41.8	82.0	78.1	101.7	39.3	352.2	4.7	6.5	14.4	6.0	20.7	50.2	93.3	101.5	27.5	31.5
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473303-102533972	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9"	"Cell type enriched"	"Detected in some"	8	"Collecting duct cells: 24.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.9;OE19: 11.4;RT4: 7.1"	"Group enriched"	"Detected in some"	18	"hippocampal formation: 11.6;olfactory region: 8.3"	"Not detected"	"Not detected"			HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.3	0.0	1.1	0.1	0.0	1.3	0.1	23.2	0.2	0.1	0.1	12.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	3.7	2.4	0.7	0.2	0.2	0.0	0.1	0.1	33.9	0.3	0.0	0.2	0.1	0.5	0.4	0.6	0.2	1.5	0.9	1.8	0.8	1.2	1.2	0.1	0.2	0.2	0.2	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.4	0.1	2.4	0.0	0.3	0.3	0.0	0.0	0.0	3.9	0.1	0.2	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.9	0.0	0.4	0.1	0.1	1.1	11.4	0.4	0.2	0.5	0.3	0.0	7.1	0.2	0.2	0.1	0.4	0.0	0.3	0.2	0.1	0.5	0.4	1.1	0.7	0.2	0.2	0.2	0.0	0.5	0.1	0.1	1.6	0.7	1.1	1.2	0.6	0.8	0.8	0.9	0.9	0.5	1.5	1.0	1.2	1.8	1.2	0.8	0.9	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	3.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	2.7	1.2	24.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 25.5;Exocrine glandular cells: 60.7;Hepatocytes: 33.1;Pancreatic endocrine cells: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.3	7.9	8.8	6.3	13.3	5.3	5.5	16.5	24.5	5.6	5.0	5.2	0.4	2.0	8.5	4.2	4.7	5.9	9.8	5.5	8.9	12.5	1.9	45.6	3.3	7.2	10.3	13.4	8.0	2.4	1.2	8.8	5.2	20.8	5.6	3.9	8.3	2.1	6.7	4.5	3.7	3.0	9.8	9.8	4.6	5.7	4.8	4.7	2.5	2.6	1.8	6.9	5.5	8.5	5.6	1.7	0.0	0.1	12.2	6.3	1.8	2.6	1.3	3.1	6.5	15.7	13.1	0.0	12.0	4.8	2.0	1.9	1.3	1.7	16.9	2.1	13.9	2.7	0.8	7.1	5.0	2.8	14.8	4.9	16.9	4.2	12.2	8.4	11.8	5.3	11.5	6.8	4.2	14.7	6.7	8.6	4.8	5.7	12.4	6.2	1.0	9.5	7.3	2.4	0.0	3.8	0.0	3.4	7.4	5.8	1.0	10.8	9.7	5.4	1.4	3.5	0.9	1.5	7.9	10.5	4.5	2.7	7.0	4.1	10.6	7.6	12.3	5.3	10.4	1.7	0.0	0.1	0.0	5.1	0.0	6.3	5.6	5.6	4.5	0.9	3.6	3.4	4.2	0.0	12.2	0.1	1.7	2.4	1.8	8.8	13.3	16.5	21.2	8.9	12.5	10.3	13.4	20.8	4.7	0.0	0.3	6.5	2.6	4.2	8.9	2.4	7.6	0.0	1.2	0.0	25.5	0.3	0.0	5.5	10.6	8.7	0.0	0.0	60.7	2.0	8.8	2.0	1.1	33.1	1.3	7.9	2.9	4.3	1.5	5.0	5.2	2.3	10.1	6.4	0.6	0.6	60.5	0.0	4.9	1.0	2.0	6.5	10.5	1.8	4.3	3.3	0.2	4.6	0.0	0.9
SLC9C2	"MGC43026, SLC9A11"	ENSG00000162753	"Solute carrier family 9 member C2 (putative)"	Q5TAH2	1	173500464-173603094	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 24.9"	"Cell type enhanced"	"Detected in some"	13	"Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.7"	"Group enriched"	"Detected in some"	4	"BEWO: 1.8;THP-1: 3.7"					"Low region specificity"	"Detected in all"			"HPA059122, HPA079529"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA059122: , HPA079529: "	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"		"unprognostic (8.52e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-6)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.81e-1)"	0.4	0.1	0.3	0.0	1.3	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.5	0.0	0.1	0.4	0.0	1.7	0.0	0.1	0.5	0.3	0.2	0.0	0.4	0.1	0.0	0.4	0.8	0.3	0.1	0.4	0.5	0.5	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.3	1.0	0.3	24.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	1.3	0.0	1.6	0.5	0.3	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.3	0.0	5.9	0.1	0.0	0.0	4.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.1	0.0	0.0	0.0
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296549	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 55.9"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 38.8;Proximal tubular cells: 28.3"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.1;RPTEC TERT1: 45.9;U-937: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.4	0.3	0.7	0.7	5.4	0.3	0.2	1.8	0.3	1.9	0.0	5.2	1.4	0.2	0.6	0.3	0.3	1.6	1.1	0.3	0.4	55.9	5.2	11.0	0.2	0.3	1.0	0.3	0.9	0.0	0.7	0.1	0.2	0.4	0.5	0.0	3.2	11.8	0.3	0.6	2.1	0.0	0.3	1.6	0.4	1.3	0.0	1.5	1.0	0.3	0.1	0.7	1.1	0.1	0.4	10.0	1.1	2.6	4.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.5	45.9	0.0	0.3	0.2	0.0	0.1	0.0	1.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	11.6	0.0	7.9	1.1	7.5	4.3	0.0	0.4	0.0	0.7	2.3	0.4	0.1	0.2	1.5	10.0	2.6	0.0	0.3	0.0	1.0	0.3	0.7	0.2	1.8	0.3	0.4	0.3	1.0	0.2	0.0	6.0	38.8	0.0	0.1	0.0	0.0	0.3	0.0	4.0	6.8	5.2	0.0	0.0	1.7	0.2	8.3	0.0	1.2	0.0	0.7	0.0	0.0	0.0	5.7	5.5	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	28.3	0.0	0.0	0.0	1.7	0.7	0.0	0.0	2.2	1.2	0.3
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667047-69835064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 12.4;Cardiomyocytes: 13.6;Glandular cells: 10.0;Intestinal endocrine cells: 15.0;monocytes: 36.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.0;NTERA-2: 6.0;RPMI-8226: 5.7;SCLC-21H: 6.5;U-266/70: 3.5"	"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory region: 8.2"					HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.7	0.2	0.5	1.5	0.7	1.5	0.2	0.1	0.8	0.3	0.4	0.1	0.0	0.4	0.5	1.5	1.0	0.5	0.4	21.4	0.7	0.7	0.2	0.4	0.3	4.1	0.3	0.3	0.2	0.7	0.0	4.7	0.0	0.5	4.2	0.7	0.6	0.9	0.0	13.9	0.3	0.7	0.2	0.2	0.8	0.3	0.4	0.0	9.5	0.5	16.2	1.7	0.9	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.0	0.0	0.0	2.4	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	6.0	0.0	0.9	1.0	0.9	5.7	0.1	0.0	6.5	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	0.1	1.2	3.5	0.6	0.0	0.3	0.0	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.0	1.7	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.7	0.1	0.7	0.7	0.7	0.3	0.3	0.5	0.0	3.0	0.0	1.9	1.1	0.2	12.4	13.6	0.0	0.0	1.2	0.0	2.0	0.0	0.0	1.5	0.4	0.7	0.0	0.0	1.2	0.0	0.6	10.0	0.0	0.0	0.1	1.6	15.0	0.0	0.0	0.4	0.0	0.3	0.0	36.9	1.6	0.3	2.4	0.0	0.0	0.0	0.2	0.0	1.0	0.9	1.7	0.4	0.0	0.0	0.9	0.7
SLF1	"ANKRD32, BRCTD1, BRCTx, DKFZp564C0469, DKFZp761C121"	ENSG00000133302	"SMC5-SMC6 complex localization factor 1"	Q9BQI6	5	94618347-94739436	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 104.0;Spermatogonia: 128.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"HeLa: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040793, HPA054213"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040793: AB_10796560, HPA054213: AB_2682419"	"unprognostic (7.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-5)"	"unprognostic (1.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-6)"	"unprognostic (3.27e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.32e-2)"	3.4	3.6	9.8	4.5	14.1	6.3	4.0	17.6	14.7	3.4	4.0	2.1	2.7	4.3	3.7	3.3	3.7	4.8	4.6	4.7	6.1	6.2	3.8	3.1	3.4	6.5	3.1	9.8	6.3	4.7	3.3	7.9	3.4	5.3	3.0	5.2	1.7	3.4	3.1	3.4	7.8	6.7	3.3	5.1	5.9	3.2	14.8	4.8	9.2	4.0	3.4	5.2	3.5	3.4	5.3	1.9	10.8	1.9	1.5	4.6	1.0	3.0	4.1	5.8	5.4	1.8	2.3	3.7	4.8	2.5	5.6	7.8	2.1	4.3	4.9	3.2	1.4	6.9	4.3	4.7	3.9	7.6	1.7	3.9	3.3	34.8	1.8	0.5	1.7	3.7	1.1	1.1	4.9	2.2	1.8	2.3	3.0	3.5	3.0	4.8	2.8	4.6	2.2	6.0	1.7	2.2	2.8	6.5	5.4	1.8	2.4	5.9	5.9	5.9	2.5	2.0	4.8	3.4	4.8	1.6	2.7	3.7	3.8	6.3	2.3	4.7	4.0	4.1	4.8	5.3	1.0	1.9	1.1	2.6	1.5	1.4	3.1	3.9	4.6	1.2	5.3	1.8	2.4	10.8	1.5	1.2	1.9	2.2	1.0	9.8	14.1	17.6	14.7	6.1	6.2	3.1	9.8	5.3	4.8	3.0	5.4	20.2	5.1	0.0	24.2	0.0	2.5	37.5	13.6	5.2	25.5	12.2	1.7	6.4	6.2	7.1	4.2	46.7	6.1	12.5	3.2	2.7	14.0	5.8	6.9	19.1	2.4	10.4	5.4	6.7	5.2	5.1	0.0	4.6	5.4	6.5	7.5	5.5	5.6	9.1	31.0	0.0	0.0	104.0	128.8	0.0	5.1	21.7	5.2	1.6
SLF2	"C10orf6, FAM178A, FLJ10512, FLJ25012"	ENSG00000119906	"SMC5-SMC6 complex localization factor 2"	Q8IX21	10	100912569-100965136	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Leydig cells: 100.1;Peritubular cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038499, HPA057568"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA038499: AB_10672520, HPA057568: AB_2683471"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	9.8	20.2	19.5	17.1	26.6	12.1	11.3	21.4	21.4	12.2	10.7	22.0	13.0	9.4	20.9	56.1	9.4	17.3	9.6	11.6	17.8	14.2	10.9	10.2	11.6	15.6	29.4	17.3	29.4	12.3	11.6	26.8	17.4	18.3	14.5	12.1	7.8	10.3	16.0	17.9	15.1	11.5	12.9	22.7	22.0	9.9	26.7	31.3	14.7	11.3	10.5	13.2	10.8	19.9	13.8	9.5	8.6	8.9	10.9	14.0	5.6	9.9	8.2	12.1	12.5	6.4	8.7	4.6	10.5	7.4	9.9	12.0	5.9	6.9	9.2	6.5	4.4	7.3	10.1	8.3	3.5	12.0	10.4	6.6	8.5	5.5	11.6	4.6	10.9	10.2	4.0	5.1	7.6	8.1	9.9	6.3	5.9	6.0	9.1	14.4	6.6	7.3	6.0	5.4	3.8	6.1	7.2	59.5	3.2	3.9	5.1	2.6	5.2	6.6	1.8	12.1	6.0	10.5	4.0	8.1	11.6	9.7	7.2	12.0	7.4	10.9	7.6	7.9	12.6	6.0	6.8	8.9	8.6	14.0	8.8	12.2	11.1	10.8	11.5	6.5	13.8	12.0	10.6	4.6	10.9	8.8	9.5	9.8	5.6	19.5	26.6	21.4	21.4	17.8	14.2	29.4	17.3	18.3	31.3	23.8	13.9	5.3	7.4	0.0	33.7	0.0	2.5	25.4	15.9	24.4	23.6	14.6	11.6	8.2	6.9	15.7	3.8	0.0	6.8	5.6	11.3	9.9	22.1	13.2	15.4	36.5	11.7	31.3	15.3	3.2	100.1	11.9	0.0	4.6	13.3	23.8	6.6	10.5	99.3	5.8	29.7	19.4	0.0	29.3	40.5	0.0	4.2	17.5	8.7	5.4
SLFN13	FLJ31952	ENSG00000154760	"Schlafen family member 13"	Q68D06	17	35435096-35448837	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 50.6"	"Cell type enhanced"	"Detected in many"	22	"Cholangiocytes: 22.9;Ciliated cells: 81.7;Club cells: 18.2;T-cells: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 14.7;HL-60: 46.9;Karpas-707: 13.7;REH: 26.9;U-266/70: 23.7"									"HPA022532, HPA023064"	Uncertain		Approved	"Cytokinetic bridge"		Yes	No			"Cytokinetic bridge"		"HPA022532: AB_1856615, HPA023064: AB_1856616"	"unprognostic (1.11e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	3.0	1.0	1.1	6.4	1.7	11.8	4.8	0.5	1.0	5.2	6.5	2.6	4.8	4.0	5.6	6.0	6.5	12.4	6.1	1.8	1.3	0.7	5.1	1.7	5.2	4.8	0.9	0.5	2.7	2.0	14.3	3.2	1.2	2.0	2.4	3.1	0.9	50.6	2.0	1.4	1.5	5.7	1.8	1.5	11.3	5.7	1.5	1.1	24.8	12.7	5.4	12.9	2.0	2.0	1.4	0.4	6.5	0.5	8.1	1.9	0.5	0.0	2.5	5.1	0.0	0.1	0.5	0.0	0.6	0.1	2.5	4.0	0.0	0.0	0.0	14.7	0.4	0.1	4.3	0.5	1.8	2.8	1.4	0.8	13.4	2.2	0.0	0.2	46.9	0.4	0.1	0.2	1.3	0.0	0.0	0.8	0.1	0.0	13.7	0.0	0.0	0.3	10.2	2.5	0.0	0.0	26.9	0.1	1.3	4.3	12.4	0.0	0.0	0.0	2.3	0.1	0.3	3.6	7.5	0.1	0.0	0.7	3.8	0.2	23.7	3.2	0.0	0.0	7.5	0.3	5.0	0.4	6.5	1.9	0.5	1.5	1.4	0.9	1.0	0.4	1.3	0.8	0.6	1.4	8.1	0.2	0.1	0.7	0.5	1.1	1.7	0.5	1.0	1.3	0.7	0.9	0.5	2.0	1.1	0.0	3.0	2.2	3.1	0.9	0.0	0.6	22.9	81.7	18.2	5.2	0.0	0.4	1.7	1.1	0.1	0.7	0.5	0.0	0.3	0.2	0.8	1.0	3.5	0.4	1.3	0.0	2.9	3.1	0.6	0.0	0.9	1.6	0.0	1.8	2.7	0.2	1.1	0.0	0.4	0.8	0.1	0.0	0.6	0.2	0.1	1.0	0.0	15.7	3.9	1.0
SLFN5	MGC19764	ENSG00000166750	"Schlafen family member 5"	Q08AF3	17	35243036-35273655	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 96.4;T-cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 11.1;MAIT T-cell: 13.7;memory CD4 T-cell: 13.6;memory CD8 T-cell: 12.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 13.7;NK-cell: 16.8;T-reg: 27.8"	"Group enriched"	"Detected in many"	7	"NK-cells: 16.8;T-cells: 27.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 33.8;hTERT-HME1: 45.1"	"Low region specificity"	"Detected in all"							HPA017760	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA017760: AB_2189993"	"unprognostic (3.43e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.48e-1)"	32.9	12.8	2.8	21.2	2.6	2.8	11.5	1.7	3.0	18.9	7.7	6.6	25.3	4.0	13.6	7.7	10.0	9.3	8.3	6.4	3.6	2.8	5.9	4.0	18.6	20.9	4.8	1.2	10.7	5.0	4.5	3.2	9.9	6.0	15.9	5.0	7.9	15.4	43.1	27.5	5.0	8.5	10.9	6.1	25.3	7.6	3.8	2.2	51.4	7.6	7.2	22.3	17.0	8.5	0.7	1.4	1.9	3.0	16.8	27.8	7.1	6.1	3.2	0.4	0.5	9.2	16.3	1.2	16.1	25.5	13.5	15.1	0.0	4.0	0.7	10.4	15.9	3.6	26.0	0.3	7.2	9.5	0.1	0.5	0.1	3.3	0.3	33.8	0.4	0.1	18.5	18.4	10.3	45.1	8.1	6.1	6.4	0.0	9.3	9.4	0.5	7.5	0.3	0.5	1.3	2.4	0.0	5.4	0.0	3.5	15.3	1.0	0.0	1.8	1.7	28.7	1.9	10.7	0.2	24.1	5.4	2.1	3.9	3.6	1.7	0.1	0.1	15.9	0.0	7.7	1.9	1.7	1.1	11.1	2.7	13.7	0.4	13.6	12.6	1.4	0.7	17.0	13.7	0.7	16.8	3.0	0.5	27.8	7.1	2.8	2.6	1.7	3.0	3.6	2.8	4.8	1.2	6.0	2.2	56.6	61.3	2.2	22.6	4.0	0.9	7.8	25.5	96.4	69.4	17.4	0.0	0.2	1.7	58.0	1.5	67.1	1.4	0.0	33.7	1.5	15.3	77.2	57.9	3.9	12.1	6.4	1.2	57.1	21.5	0.0	6.9	15.8	11.8	45.1	4.5	5.8	62.6	2.9	1.4	1.3	4.3	12.9	17.3	0.4	1.9	3.4	0.2	91.8	0.4	70.5
SLFNL1	FLJ23878	ENSG00000171790	"Schlafen like 1"	Q499Z3	1	41015597-41023237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 49.7"	"Group enriched"	"Detected in some"	83	"Early spermatids: 200.0;Late spermatids: 500.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054956			Approved	Cytosol		NA	NA			Cytosol		"HPA054956: AB_2682649"	"unprognostic (7.01e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.11e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.40e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-4)"	"unprognostic (2.70e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.43e-1)"	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.3	0.2	0.4	0.2	0.2	0.2	0.5	2.6	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.8	1.9	0.2	0.2	0.2	0.6	0.3	0.1	0.3	0.2	0.2	0.6	0.0	0.2	3.4	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.1	49.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	1.3	0.0	0.0	0.7	0.0	1.0	1.6	0.7	1.1	0.0	0.3	4.9	2.1	0.1	0.0	0.1	10.2	1.0	1.8	1.8	0.1	0.3	1.8	0.1	0.0	0.0	1.3	3.0	1.3	2.4	1.3	0.7	1.9	1.2	0.2	0.2	0.1	0.0	0.5	0.2	1.5	1.1	2.2	0.1	0.9	1.1	2.0	1.9	0.2	2.6	2.5	1.3	1.1	0.0	2.8	1.3	0.6	0.4	0.9	0.8	0.9	0.6	1.2	0.8	2.0	2.4	1.0	1.5	1.1	0.6	2.3	0.3	2.2	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.4	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	3.2	0.0	0.1	0.2	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	200.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	500.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	4.2	2.4	0.1	0.0	0.0	0.0	0.0
SLIT1	"MEGF4, SLIL1, Slit-1, slit1, SLIT3"	ENSG00000187122	"Slit guidance ligand 1"	O75093	10	96998038-97185920	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 44.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 27.2;Late spermatids: 15.4"	"Group enriched"	"Detected in many"	10	"glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	10	"JURKAT: 12.4;MOLT-4: 41.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006879			Approved	"Plasma membrane"	"Secreted in brain"	NA	NA			"Plasma membrane"		"HPA006879: AB_1078197"	"unprognostic (2.72e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.43e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.39e-3)"	1.2	0.8	13.4	0.9	16.1	0.9	0.8	0.4	44.3	0.8	0.9	0.5	0.0	0.9	0.8	0.7	0.8	1.0	0.8	0.8	13.9	10.5	0.8	0.7	1.0	0.9	4.6	13.2	0.8	1.4	0.8	8.0	0.8	2.2	1.1	0.8	0.3	0.8	0.7	0.9	0.8	0.9	0.8	1.4	0.9	1.1	2.0	0.3	3.3	3.6	0.0	0.9	0.8	0.0	0.0	1.6	0.4	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.3	0.0	0.1	41.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.4	1.6	0.0	0.2	13.4	16.1	0.4	24.8	13.9	10.5	4.6	13.2	2.2	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.7	0.0	0.3	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.1
SLITRK3	KIAA0848	ENSG00000121871	"SLIT and NTRK like family member 3"	O94933	3	165186720-165197109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;liver: 12.8"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 4.5;Hepatocytes: 2.4"	"Cancer enriched"	"Detected in single"	22	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.6;HAP1: 5.5;Karpas-707: 1.6;SCLC-21H: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017636, HPA048042"	Enhanced		Approved	Mitochondria		No	NA		1400000	Mitochondria		"HPA017636: AB_1857232, HPA048042: AB_2732542"	"unprognostic (8.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.08e-2)"		"unprognostic (1.96e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-1)"		"unprognostic (6.74e-3)"	"unprognostic (5.03e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.03e-4)"	0.6	0.6	7.4	2.0	12.0	0.4	0.5	10.6	17.4	9.9	3.0	1.5	0.3	1.1	12.1	2.0	7.6	12.6	0.8	1.0	13.2	5.5	0.6	12.8	0.9	0.5	3.7	6.5	2.5	0.4	0.4	0.3	0.4	4.2	3.3	3.1	0.3	0.8	9.6	0.9	0.5	1.5	6.2	2.3	0.4	0.8	1.0	2.4	0.0	0.6	0.0	0.5	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	12.0	10.6	15.7	13.2	5.5	3.7	6.5	4.2	2.4	0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 11.5;Horizontal cells: 20.6;Muller glia cells: 6.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;HeLa: 5.5;hTERT-RPE1: 5.1;U-138 MG: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013843	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA013843: AB_1857233"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.3	3.3	0.1	6.8	0.1	0.2	3.1	9.2	0.4	0.2			0.0	0.1	1.0	0.2	6.7	0.1	0.1	4.8	4.2	0.0	0.0	0.2	0.1	2.6		0.6	0.8	0.0	0.0	0.0		1.8	0.3		7.4	3.1	0.2	0.2	0.0	0.0	1.0	0.1	0.5	0.2			2.0		0.3	0.0	0.4	0.7	1.4	1.6	0.3	1.4	0.4	0.1	0.0	1.2	11.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	2.9	0.0	0.0	0.0	2.0	1.3	5.5	0.0	0.8	0.0	0.0	2.5	0.2	0.0	1.0	5.1	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	2.7	0.0	1.4	1.0	0.3	0.2	0.4	0.0	1.7	0.3	0.0	0.3	0.0	0.0	0.8	2.6	0.0	3.9	0.0	0.0	0.6	1.7	0.0	0.0	3.5	0.1	1.1	1.1	0.3	0.4	0.4	0.2	0.4	0.4	0.4	0.3	0.1	0.7	0.4	0.3	1.6	1.4	0.3	1.4	0.2	0.1											0.0	0.6	0.0	1.7	0.1	11.5	1.6	0.0	2.7	0.0	0.0	3.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.1	1.1	0.0	0.0	20.6	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	1.5	6.5	0.0	0.0	4.6	0.0	1.6	0.0	0.1	5.0	0.1	0.0	0.0	0.0	0.0	0.9
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967201-104029233	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 181.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		17000	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	15.2	11.2	13.7	11.0	36.7	14.6	16.1	16.7	13.1	16.6	19.0	9.9	10.9	9.1	17.0	12.1	40.2	12.1	13.6	17.2	10.6	7.1	14.9	12.2	17.1	10.1	11.2	13.4	17.2	12.5	22.6	13.1	17.4	12.8	19.3	13.6	11.4	19.8	12.7	19.3	16.6	15.5	29.8	13.0	12.1	15.7	10.2	12.8	12.0	15.8	21.6	12.5	24.9	23.6	1.4	2.2	6.5	1.4	1.3	3.6	0.7	21.6	12.7	15.1	10.8	16.4	22.9	6.4	13.5	18.0	10.1	9.5	8.0	23.3	11.5	8.5	13.9	8.6	23.6	8.0	17.1	14.8	9.2	11.0	11.7	10.4	6.7	12.3	13.9	10.1	11.7	22.5	13.6	39.9	14.1	18.1	7.5	14.6	8.0	13.2	7.5	9.7	7.7	3.7	14.0	8.1	9.5	18.6	6.0	13.2	25.0	3.5	6.2	11.7	11.4	11.2	8.0	5.9	10.1	27.3	7.4	7.8	13.6	15.8	9.7	11.8	7.3	11.0	18.8	4.7	1.2	1.4	3.3	3.6	1.2	3.6	1.1	2.2	2.2	1.2	1.4	1.5	2.5	6.5	1.3	1.0	2.2	1.4	0.7	13.7	36.7	16.7	13.1	10.6	7.1	11.2	13.4	12.8	12.8	166.7	108.1	23.8	57.3	50.6	27.3	89.7	28.1	66.9	138.8	41.8	23.6	27.8	3.3	28.4	6.3	53.4	45.3	23.3	46.5	11.5	39.3	60.5	32.5	21.7	17.3	23.8	17.7	41.7	24.0	11.0	43.1	31.1	8.5	37.9	31.8	23.4	61.5	54.9	59.4	11.3	24.1	6.5	34.9	42.3	39.1	59.8	43.8	21.8	29.4	181.1
SLMAP	"KIAA1601, SLAP"	ENSG00000163681	"Sarcolemma associated protein"	Q14BN4	3	57755450-57929168	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 133.6;urinary bladder: 114.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 272.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002357, HPA002358"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		12000	"Endoplasmic reticulum"		"HPA002357: AB_1080023, HPA002358: AB_1080021"	"unprognostic (3.70e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.82e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.58e-6)"	"unprognostic (8.18e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.08e-2)"	10.6	10.7	7.0	22.4	11.1	7.4	12.0	10.2	7.2	26.5	50.3	5.8	24.7	9.8	43.0	19.5	44.0	21.3	15.0	58.2	6.5	5.6	8.0	7.8	8.0	7.2	6.9	6.0	21.4	5.8	16.0	8.0	7.7	6.8	47.8	12.2	8.7	8.6	37.7	26.1	9.4	23.3	133.6	6.0	7.2	27.2	14.9	6.8	11.2	11.1	12.1	6.3	114.2	26.4	5.9	5.1	15.8	5.5	7.1	5.9	4.5	22.1	12.5	10.7	15.4	16.1	16.2	14.6	20.5	21.2	14.4	13.9	30.0	33.0	14.9	9.8	16.3	25.8	12.2	19.1	27.3	18.9	16.4	10.9	25.8	17.7	23.5	15.7	25.5	14.4	11.7	21.9	17.7	33.0	18.6	16.4	15.1	21.0	13.5	14.7	7.2	17.4	13.1	16.1	16.1	24.3	7.2	11.7	14.8	29.4	24.2	6.1	7.2	26.7	20.3	12.6	14.7	11.0	16.2	19.4	15.9	12.7	20.1	26.5	15.7	26.7	20.3	14.3	22.3	14.9	7.5	5.5	15.8	5.9	3.6	4.9	5.9	4.6	5.0	5.1	4.5	5.4	5.5	13.4	7.1	3.6	2.9	5.1	4.5	7.0	11.1	10.2	7.2	6.5	5.6	6.9	6.0	6.8	6.8	35.7	34.1	6.2	37.6	81.7	24.0	272.3	33.1	29.4	29.6	31.4	47.1	15.6	16.6	39.8	28.6	23.2	38.0	0.0	29.8	10.7	23.5	70.4	3.5	20.3	13.9	30.2	13.8	16.0	19.4	17.7	30.2	18.8	27.0	11.8	24.3	98.5	46.3	29.2	67.5	24.5	32.2	51.8	116.9	81.2	26.8	64.1	13.6	23.0	23.4	106.8
SLN	"MGC12301, MGC125854, MGC125855"	ENSG00000170290	Sarcolipin	O00631	11	107707378-107719693	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 446.6"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 248.9;Muller glia cells: 330.7"	"Group enriched"	"Detected in many"	13	"glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HSkMC: 6.0;Karpas-707: 2.8;PC-3: 2.7;SuSa: 6.2;U-2 OS: 2.7"	"Region enriched"	"Detected in some"	5	"basal ganglia: 19.0"	"Not detected"	"Not detected"			CAB011628			Approved	Microtubules		NA	NA			Microtubules		"CAB011628: AB_2195046"	"unprognostic (6.85e-2)"	"unprognostic (6.18e-8)"	"unprognostic (2.60e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.12e-3)"		"unprognostic (5.28e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.52e-9)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.09e-4)"	"unprognostic (3.77e-2)"	4.8	0.5	0.2	0.0	1.9	0.0	0.1	0.4	1.0	0.0	0.2	0.0	0.0	0.0	0.0	5.3	9.1	0.1	0.0	72.9	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	2.3	0.0	0.4	4.3	0.0	446.6	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.9	40.1	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.1	0.6	1.1	0.1	0.2	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.3	0.3	6.0	0.0	0.8	0.0	0.4	0.0	0.0	0.1	2.8	0.0	0.4	0.3	0.4	0.1	0.1	2.7	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	0.0	2.7	0.0	0.2	1.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.9	0.4	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.7	248.9	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	7.3	0.0	0.0	0.0	0.4	1.7	0.5	0.0	0.0	0.0	0.3	3.2	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	330.7	0.2	0.0	0.4	0.1	14.1	0.0	0.4	0.0	0.0	1.3	4.8	0.0	0.0	0.0
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 1679.4;Alveolar cells type 2: 2934.9;Basal glandular cells: 1025.0;Cholangiocytes: 1719.7;Ciliated cells: 2255.1;Club cells: 3002.8;Collecting duct cells: 3252.2;Urothelial cells: 2991.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"pons and medulla: 4.7"	"Cell type enriched"	"Detected in single"	90	"neutrophil: 68.8"	"Lineage enriched"	"Detected in single"	90	"granulocytes: 68.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 157.0;hTCEpi: 184.3;OE19: 67.0;SiHa: 55.2;THP-1: 46.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	26400000	2600000	"Golgi apparatus"		"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	9.2	0.4	0.0	2.4	0.0	10.0	10.0	0.1	0.2	934.9	3.4	0.1	268.3	0.2	11.9	5.5	51.3	23.3	19.6	3.5	0.0	0.0	17.3	20.1	81.5	1.3	0.3	0.4	5.5	5.4	0.1	25.9	1.4	4.7	13.4	3.6	2.0	480.2	548.7	41.3	9.6	0.7	3.9	0.9	0.7	5.2	7.1	0.0	2.3	2.0	86.2	53.0	17.7	24.0	0.0	0.1	68.8	0.7	0.0	0.0	1.1	0.4	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	28.4	0.0	157.0	0.0	2.1	11.7	0.0	5.6	0.0	0.7	0.0	0.0	21.0	0.0	30.3	0.0	0.0	0.8	184.3	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	67.0	10.7	0.0	0.0	0.0	32.0	1.2	0.0	0.0	55.2	11.8	0.1	0.0	0.2	46.6	0.0	0.0	0.7	0.1	0.0	0.1	0.7	0.4	0.0	2.8	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	68.8	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.4	4.7	0.0	1679.4	2934.9	5.2	1025.0	89.4	0.0	0.9	1719.7	2255.1	3002.8	3252.2	0.0	1.3	0.0	285.2	390.2	5.3	69.3	23.3	231.9	0.9	101.8	495.3	70.9	353.5	5.8	0.0	192.4	19.6	6.7	55.8	23.6	30.6	37.1	9.0	72.4	0.0	552.6	410.1	0.0	1.1	0.0	0.0	22.7	1.0	1.6	121.5	1.7	5.3	161.1	2991.2
SLX1A	GIYD1	ENSG00000132207	"SLX1 homolog A, structure-specific endonuclease subunit"	Q9BQ83	16	30193887-30197561	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.2;intestine: 26.0"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 10.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 44.5"									HPA047038	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047038: AB_2679913"	"unprognostic (3.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-1)"		"unprognostic (1.26e-6)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.86e-1)"	3.4	5.2	2.9	7.7	1.7	7.7	3.7	0.7	1.9	2.0	8.2			26.0	1.6	0.0	5.4	1.0	2.7	4.2	2.7	2.5	7.1	13.1	3.5	5.4	3.0		0.5	6.7	0.9	2.3	2.9		1.8	2.6		2.9	1.5	4.9	3.1	19.6	1.5	2.8	9.5	12.6	0.3			2.1		3.7	3.7	1.9	19.4	35.8	41.6	44.2	17.7	30.6	26.4	15.5	9.8	3.6	3.9	1.0	0.8	22.1	3.5	3.3	1.4	1.4	2.0	11.2	6.4	14.2	2.2	3.9	12.4	1.0	1.8	1.6	11.5	11.3	6.6	3.3	19.3	2.2	7.9	18.1	0.9	3.0	1.2	1.7	2.9	1.3	2.4	5.8	12.4	1.3	15.7	10.2	27.3	11.3	7.2	6.6	30.1	0.6	34.3	3.4	5.0	7.1	19.1	0.0	30.5	7.2	1.2	5.4	6.8	0.0	9.4	10.7	9.3	5.2	44.5	17.1	5.9	10.4	8.2	6.4	5.8	44.2	41.6	23.5	40.9	16.7	19.4	17.6	19.1	35.8	18.1	8.8	14.9	16.1	17.7	32.5	18.3	30.6	26.4											0.0	0.6	0.0	0.9	0.6	0.7	2.0	0.0	0.0	0.0	3.5	0.0	5.1	0.0	5.4	0.2	1.6	4.9	0.0	10.4	1.8	1.5	0.8	0.0	2.5	2.5	0.0	3.5	1.8	7.5	0.0	0.9	3.3	6.8	2.8	3.6	0.2	7.8	5.8	0.0	2.4	0.2	0.0	2.3	0.3	0.4	1.9	3.4	3.8	4.0	0.4
SLX1B	"GIYD2, MGC5178"	ENSG00000181625	"SLX1 homolog B, structure-specific endonuclease subunit"	Q9BQ83	16	29454501-29458219	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.5"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 10.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA047038	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047038: AB_2679913"	"unprognostic (2.93e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.51e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.44e-1)"	"unprognostic (5.25e-3)"	4.6	2.9	0.2	3.9	0.5	8.8	4.9	2.0	2.7	5.6	6.6			14.1	5.4	2.7	3.0	4.4	1.1	2.2	0.4	0.5	3.3	11.1	5.7	3.0	0.6		4.2	3.1	3.4	2.2	5.4		4.0	4.6		8.0	5.4	11.2	5.7	13.4	2.9	1.8	6.3	4.7	0.0			6.1		6.6	5.7	3.9	3.2	20.8	26.5	24.7	3.7	6.5	6.7	6.8	5.9	15.4	0.7	3.2	4.6	21.2	6.4	15.0	14.6	12.4	1.6	10.5	17.3	5.6	4.5	2.3	2.6	5.7	9.2	3.5	1.0	4.3	7.1	3.1	9.2	9.9	7.2	2.9	6.1	6.6	9.6	6.5	9.2	16.2	20.4	3.7	7.1	6.8	9.7	1.3	7.2	1.3	15.4	8.6	7.0	12.2	15.5	12.3	4.2	2.5	14.8	2.7	30.2	1.4	2.4	1.4	4.1	10.8	4.9	1.5	2.9	1.1	3.2	20.1	11.0	5.4	5.5	2.1	3.3	24.7	26.5	2.8	20.7	0.8	3.2	2.5	2.8	20.8	2.5	1.2	1.6	14.8	3.7	11.9	1.2	6.5	6.7											0.0	0.3	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.1	1.0	0.0	1.3	0.6	0.4	0.2	0.0	0.5	1.0	0.0	0.0	0.6	1.2	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.8	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.9	0.1	0.1
SLX4IP	"C20orf94, dJ1099D15.3"	ENSG00000149346	"SLX4 interacting protein"	Q5VYV7	20	10435303-10636829	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046372	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046372: AB_2679641"	"unprognostic (4.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.56e-3)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (6.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.55e-2)"	4.9	6.4	4.7	7.1	8.1	4.2	5.9	6.6	7.9	5.5	5.7	9.9	9.1	5.1	5.2	13.1	7.2	6.1	5.2	4.2	5.3	5.4	6.7	6.9	5.7	5.5	7.3	4.1	5.2	8.4	13.8	25.4	4.4	6.8	5.6	6.4	9.5	6.2	6.4	9.9	9.6	5.8	3.0	6.1	6.2	6.1	6.1	7.7	11.2	7.2	3.9	9.1	6.4	6.0	3.9	5.6	2.5	4.4	3.7	4.0	1.3	3.8	7.3	3.7	10.0	2.2	2.9	3.1	1.9	2.2	3.1	3.3	5.4	4.9	6.0	3.2	2.3	4.3	7.6	5.5	5.7	4.9	0.0	2.1	5.5	2.5	7.3	3.6	5.9	3.3	4.0	5.0	3.8	7.6	4.0	3.0	5.4	4.4	5.3	3.7	3.2	8.8	8.7	6.6	4.6	2.5	6.4	9.7	5.4	4.5	3.8	6.6	5.0	5.6	8.9	5.7	5.4	9.7	3.1	4.4	2.5	5.2	3.1	2.2	5.5	12.5	7.7	1.9	5.7	4.3	0.7	2.9	1.2	2.3	3.8	3.8	3.6	3.3	2.7	3.5	3.9	3.4	2.7	2.5	3.7	4.4	5.6	4.0	1.3	4.7	8.1	6.6	7.9	5.3	5.4	7.3	4.1	6.8	7.7	6.0	5.4	3.0	4.5	0.6	11.2	3.2	10.2	4.0	10.3	1.8	15.7	9.2	10.0	7.0	1.6	1.9	5.9	0.0	3.5	6.9	4.1	4.1	8.1	5.7	7.0	9.5	9.8	6.7	3.5	2.9	4.6	3.1	5.0	10.8	6.3	11.0	3.9	7.4	4.2	8.4	18.4	0.0	5.3	7.4	9.6	1.4	5.5	5.3	6.8	4.7
SMAD4	"DPC4, MADH4"	ENSG00000141646	"SMAD family member 4"	Q13485	18	51028394-51085045	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019154	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA019154: AB_1853480"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.00e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (4.40e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	25.6	17.5	16.0	14.0	16.7	11.4	24.9	29.7	16.0	27.9	22.6	17.9	21.3	15.1	28.2	18.8	21.7	20.5	17.5	19.6	15.3	11.5	21.0	22.0	20.1	16.0	17.2	13.3	30.5	25.0	30.0	28.9	30.6	14.2	27.8	17.4	18.4	23.1	22.8	39.7	18.2	23.4	27.6	13.9	21.7	19.3	17.6	18.4	38.8	35.0	13.9	18.1	29.0	24.1	3.6	3.6	3.4	1.8	2.9	4.7	1.3	8.5	11.4	30.9	8.9	12.8	19.8	17.4	15.1	16.6	20.3	25.5	7.0	2.0	14.3	4.5	13.0	10.4	14.2	17.3	6.8	21.6	12.4	9.8	9.9	11.4	8.0	12.7	17.2	7.8	8.9	11.5	10.0	14.7	19.6	14.7	7.3	11.1	13.2	12.0	4.5	10.2	5.0	16.1	4.6	7.1	13.3	15.7	14.0	9.7	3.7	19.1	11.3	14.1	2.6	9.4	13.7	7.0	10.0	11.0	17.2	8.0	4.3	10.0	19.9	13.8	12.4	11.2	6.7	11.3	0.8	1.8	1.8	3.2	1.1	3.7	2.2	3.3	2.6	3.6	3.6	4.0	4.7	3.4	2.9	1.3	2.9	4.3	1.3	16.0	16.7	29.7	16.0	15.3	11.5	17.2	13.3	14.2	18.4	20.8	23.2	11.8	18.4	22.8	13.2	33.5	40.8	16.0	19.4	21.0	19.6	15.5	10.0	16.2	7.3	23.2	15.6	0.0	10.8	16.8	23.8	31.7	4.6	40.0	13.2	14.3	38.1	23.9	26.1	11.4	30.8	16.7	27.0	5.4	33.8	18.9	18.1	24.3	28.7	18.5	20.8	25.8	29.2	13.9	16.2	23.8	10.5	13.8	26.2	22.5
SMAP1	"FLJ13159, SMAP-1"	ENSG00000112305	"Small ArfGAP 1"	Q8IYB5	6	70667776-70862015	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 261.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030574	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA030574: AB_10601589"	"unprognostic (1.55e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.22e-1)"	18.7	14.8	19.9	17.8	25.1	15.1	15.3	20.7	30.2	14.4	25.2	14.5	18.5	24.5	16.2	17.7	29.3	10.5	16.3	20.5	20.5	18.6	14.1	17.2	14.4	18.3	19.2	18.1	15.2	33.9	27.1	11.5	14.8	25.0	17.2	27.0	13.0	18.6	15.2	32.6	21.0	29.6	18.7	15.7	14.8	20.7	29.6	13.0	26.6	20.0	17.5	20.1	18.9	16.6	12.5	11.7	24.0	15.5	20.2	21.9	16.3	26.7	8.5	13.5	16.4	12.5	16.5	21.8	12.0	13.8	10.1	9.9	12.6	8.0	14.0	13.1	14.7	14.6	8.5	12.7	12.8	17.2	16.1	17.7	15.5	8.0	10.6	8.4	11.3	13.2	10.8	14.9	11.3	13.8	19.0	15.8	7.4	14.7	17.2	15.8	15.7	8.4	13.8	9.9	14.2	9.9	16.0	50.1	23.1	18.2	16.5	18.9	13.5	7.7	11.0	7.6	12.0	14.5	17.1	15.1	8.2	14.1	5.3	10.6	16.0	14.3	7.2	6.2	13.3	11.2	24.0	13.7	14.6	16.3	15.0	18.5	12.5	21.9	18.6	11.7	11.1	11.2	14.4	19.3	20.2	15.5	11.5	20.5	16.3	19.9	25.1	20.7	30.2	20.5	18.6	19.2	18.1	25.0	13.0	35.7	32.5	47.6	31.8	59.4	49.5	34.1	66.2	16.0	30.7	36.6	35.3	22.2	46.4	68.3	261.7	39.6	88.7	0.0	131.9	35.0	39.4	71.6	48.4	36.8	51.8	52.4	40.2	63.3	52.2	208.7	46.9	47.5	30.4	54.1	58.5	64.5	87.9	63.4	62.9	42.1	36.2	64.7	46.2	64.2	85.5	67.5	26.5	51.7	60.3	38.6
SMARCA1	"hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI"	ENSG00000102038	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1"	P28370	X	129446501-129523500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003335, HPA064712"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA003335: AB_1080024, HPA064712: AB_2685332"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.03e-4)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.33e-2)"	10.4	44.6	14.5	5.0	15.2	0.4	11.8	12.0	12.0	17.1	11.4	7.7	25.5	3.9	15.8	31.4	9.6	12.0	12.3	19.3	13.9	17.9	13.9	34.1	9.2	2.5	13.1	8.4	42.2	9.0	34.8	29.9	21.0	14.6	23.8	4.3	9.7	9.8	42.9	8.7	4.6	4.8	17.7	14.0	6.9	10.0	33.0	13.1	2.0	26.0	6.8	2.6	16.8	15.3	0.3	0.8	0.0	0.0	1.6	4.3	0.5	6.6	15.0	31.0	20.2	22.6	20.5	10.7	13.7	39.6	20.4	23.2	5.2	23.9	0.0	21.3	25.7	24.0	6.4	19.2	8.0	23.0	0.0	3.6	0.0	13.6	28.1	9.9	0.0	0.0	25.6	2.3	14.6	2.8	31.2	14.9	3.7	3.4	1.6	22.0	0.0	0.1	0.0	12.4	2.6	8.6	0.0	16.7	0.0	20.1	8.2	7.4	20.4	1.9	0.2	3.4	22.8	13.8	0.1	10.3	13.7	7.0	8.9	7.4	0.0	0.0	0.0	12.1	0.0	8.4	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.0	0.0	0.3	4.3	1.3	0.0	1.6	0.0	0.8	0.0	0.5	14.5	15.2	12.0	12.0	13.9	17.9	13.1	8.4	14.6	13.1	89.3	46.5	1.3	28.2	20.7	25.6	68.0	12.7	60.2	68.2	38.4	43.2	40.5	24.9	23.4	2.0	21.1	0.0	23.3	10.5	11.6	49.7	20.5	2.3	52.9	11.7	87.4	16.1	17.2	2.5	8.2	132.3	3.6	27.0	10.0	1.1	49.1	12.6	0.0	118.1	31.1	13.3	64.7	30.1	12.6	6.1	10.3	48.9	0.0	1.0	24.8
SMARCD1	"BAF60A, CRACD1, Rsc6p"	ENSG00000066117	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1"	Q96GM5	12	50084972-50100712	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004101	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA004101: AB_1080026"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (3.62e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	21.3	24.5	16.4	22.6	22.7	29.9	21.3	27.8	28.2	19.8	19.9	29.5	17.6	18.8	23.6	23.4	23.3	19.9	18.2	15.6	16.3	13.8	25.1	18.3	19.4	26.1	15.7	20.4	24.7	19.6	44.3	17.8	24.7	18.8	20.4	22.4	20.3	21.4	25.9	16.6	19.7	24.0	23.8	18.5	28.1	17.4	34.4	14.9	64.3	24.3	17.9	36.7	19.3	18.2	6.0	6.7	4.4	3.4	3.1	6.9	2.3	8.1	13.8	40.7	23.5	12.7	12.0	20.2	10.1	18.0	29.9	17.5	37.7	12.8	31.8	15.3	19.4	13.6	10.5	34.3	26.7	25.9	24.6	25.3	31.4	13.9	21.8	15.1	27.7	12.6	12.1	17.9	17.7	32.0	20.1	35.2	34.0	26.5	19.8	15.1	19.1	40.2	14.9	50.8	12.5	22.6	48.3	10.6	27.8	17.0	19.1	21.9	36.6	21.3	10.9	42.5	31.6	24.5	23.3	21.1	15.4	17.3	9.7	20.7	27.9	24.5	28.3	12.5	11.2	17.4	4.4	2.3	4.1	6.1	2.1	5.8	6.0	3.3	3.9	3.6	5.6	2.1	6.9	1.1	3.1	3.4	6.7	5.0	2.3	16.4	22.7	27.8	28.2	16.3	13.8	15.7	20.4	18.8	14.9	0.0	8.1	33.4	17.8	14.7	31.0	5.7	15.3	9.4	25.0	26.2	19.6	17.5	44.7	25.2	3.2	21.0	17.7	0.0	24.9	16.2	12.9	16.7	16.1	12.7	15.1	25.4	29.9	14.1	10.7	6.6	15.3	11.0	16.9	34.3	18.6	26.7	27.6	14.0	15.2	30.4	26.0	32.3	13.3	21.9	31.5	17.1	9.3	16.0	15.7	14.4
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 35.4"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 487.9;Spermatogonia: 418.0"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.2;EFO-21: 4.4;SiHa: 19.1;U-266/70: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.2	0.0	0.5	0.0	9.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.0	19.1	0.1	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.0	0.3	2.0	0.0	0.2	0.7	0.4	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	63.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	28.8	5.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.2	0.0	1.0	97.0	0.0	487.9	418.0	0.0	0.7	0.0	0.0	0.1
SMCHD1	"FSHD2, KIAA0650"	ENSG00000101596	"Structural maintenance of chromosomes flexible hinge domain containing 1"	A6NHR9	18	2655738-2805017	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Hydrolase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 30.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 30.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039441	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA039441: AB_10671042"	"unprognostic (2.99e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (1.32e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.63e-2)"	19.8	8.1	9.1	29.9	11.1	35.6	17.2	18.0	11.3	21.9	17.3	8.2	16.0	13.7	19.2	12.3	12.4	15.6	13.3	12.6	8.3	8.0	9.3	10.2	21.5	31.3	12.7	8.6	20.0	21.2	15.9	14.8	16.2	9.4	15.6	15.3	11.6	14.0	14.0	12.9	10.8	23.7	23.1	9.8	32.0	14.0	13.7	11.5	34.4	12.1	9.6	22.1	25.7	23.5	4.1	1.2	30.3	1.2	1.1	3.2	0.5	10.9	5.0	17.0	10.6	7.3	10.7	12.2	11.0	7.9	10.5	13.4	9.3	3.6	23.7	4.9	9.8	11.8	6.0	13.7	6.3	16.6	4.8	7.1	14.8	9.8	8.9	8.2	42.4	11.6	7.0	5.8	13.3	11.0	8.1	8.6	11.9	17.2	14.8	10.0	3.9	17.7	10.9	6.8	5.9	5.8	14.5	13.8	10.4	6.5	16.9	14.0	8.8	14.9	5.0	8.6	9.9	3.7	18.1	8.1	13.0	18.0	17.6	20.2	9.0	13.5	21.7	8.4	7.9	11.3	1.9	1.2	3.1	1.9	0.8	1.4	2.9	2.5	2.2	0.4	4.1	3.2	2.0	30.3	1.1	1.1	1.2	2.5	0.5	9.1	11.1	18.0	11.3	8.3	8.0	12.7	8.6	9.4	11.5	41.7	46.8	107.2	33.5	24.2	88.8	43.9	12.7	22.7	35.2	17.4	94.2	30.4	5.0	20.1	88.0	41.1	49.1	23.3	16.7	19.9	31.9	43.1	38.3	13.9	17.4	93.8	21.8	28.8	68.9	26.8	38.9	61.6	28.7	64.1	29.6	37.0	20.6	59.6	35.7	6.3	91.7	38.8	36.3	85.4	79.0	21.8	39.2	79.1	25.5	40.9
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	8.7	12.3	20.3	14.6	18.0	15.3	19.9	19.5	17.9	15.2	12.9	10.2	14.7	11.0	13.0	20.2	16.4	15.7	10.7	21.3	15.8	16.2	14.1	18.4	10.1	14.4	16.3	12.4	23.2	21.6	11.3	12.9	9.8	9.9	16.4	12.1	15.5	37.0	15.9	26.4	10.4	18.0	9.8	13.3	10.6	12.9	10.9	7.9	15.2	23.4	18.7	16.1	14.9	16.9	5.4	5.0	2.3	3.5	2.9	5.9	3.0	2.2	1.5	3.1	3.7	5.7	4.1	2.4	0.8	4.1	5.1	4.4	2.9	2.2	5.8	1.0	4.3	1.4	2.6	4.0	4.3	3.3	1.5	6.6	1.9	3.2	4.1	7.1	3.5	2.5	3.2	7.3	2.0	4.3	2.9	5.0	2.1	3.1	5.1	3.5	5.9	4.9	5.3	1.1	5.7	3.3	4.3	2.7	8.4	6.4	2.6	3.8	2.5	2.0	4.6	5.0	1.6	3.9	3.8	2.0	2.2	2.4	1.9	1.5	3.5	3.8	6.9	3.3	3.4	1.6	2.3	3.5	1.6	2.7	1.7	3.7	3.7	5.4	2.8	5.0	5.4	5.9	3.9	0.3	2.9	2.5	3.8	3.0	3.0	20.3	18.0	19.5	17.9	15.8	16.2	16.3	12.4	9.9	7.9	77.4	85.3	270.8	168.6	148.1	59.5	296.6	234.4	179.3	92.1	193.7	19.6	251.6	485.7	138.8	92.3	121.8	346.2	0.0	174.6	167.3	105.2	269.9	91.0	309.5	220.1	52.4	331.5	110.5	164.5	80.6	175.2	186.8	200.8	116.4	276.7	86.2	148.7	295.1	140.0	446.7	82.0	122.9	137.7	196.7	54.5	239.6	258.2	167.5	271.3	230.0
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7, nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	14.6	14.3	20.7	17.1	25.3	30.9	17.6	35.8	29.3	17.6	18.1	19.9	6.6	16.8	16.6	13.6	19.1	22.1	12.9	20.0	17.8	14.8	18.2	18.7	15.6	19.7	16.0	23.1	22.7	18.7	25.9	20.2	18.7	15.9	15.1	20.4	15.9	17.2	14.5	19.2	20.5	17.8	15.2	14.4	18.9	18.3	52.1	15.1	31.6	19.9	12.7	23.9	14.5	22.3	9.3	11.7	11.2	9.6	9.5	10.3	8.0	21.5	13.1	19.0	14.8	13.0	12.3	31.7	13.3	24.5	14.8	11.3	19.4	16.9	30.4	15.3	16.4	13.5	23.4	25.5	19.7	17.6	13.5	11.2	24.6	14.2	15.7	13.2	32.1	15.7	11.2	18.1	20.3	47.1	12.1	16.2	16.9	30.4	21.5	15.3	21.8	22.5	14.2	32.9	25.8	7.5	14.3	21.3	23.7	11.4	20.2	25.6	20.0	20.5	29.1	15.8	33.9	29.0	13.1	15.4	16.8	17.5	16.6	18.8	23.6	27.6	25.2	13.7	18.2	17.9	3.1	9.3	9.5	9.7	9.6	8.9	9.3	8.8	9.5	10.7	8.5	9.9	10.3	11.2	9.5	5.0	11.7	7.8	8.0	20.7	25.3	35.8	29.3	17.8	14.8	16.0	23.1	15.9	15.1	20.8	19.4	14.9	8.8	24.0	22.5	27.4	20.4	21.4	19.4	26.2	29.5	9.9	8.3	11.4	52.6	24.5	30.7	0.0	13.5	13.1	10.8	13.7	20.9	41.4	11.4	28.6	33.1	24.5	36.2	38.5	14.1	24.4	10.1	4.6	20.4	9.3	13.7	20.3	11.7	10.6	18.0	38.8	16.5	37.0	19.6	23.5	9.0	15.3	16.3	17.0
SMG8	"C17orf71, FLJ10587, FLJ23205"	ENSG00000167447	"SMG8, nonsense mediated mRNA decay factor"	Q8ND04	17	59209400-59215247	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 5.3;granulocytes: 5.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024841	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024841: AB_10600790"	"unprognostic (2.68e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-3)"	"unprognostic (9.91e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.75e-1)"	14.7	17.9	11.9	9.4	15.1	15.0	13.8	14.5	19.8	12.9	9.6	15.4	14.8	9.2	15.9	11.7	13.9	14.1	8.1	11.5	11.3	13.2	11.6	12.5	9.9	13.6	12.3	13.3	19.0	11.4	13.8	12.8	18.5	16.1	11.7	9.7	13.2	12.7	11.9	13.7	13.3	11.3	11.8	9.8	15.9	11.9	18.3	11.6	24.2	13.3	9.0	15.5	12.0	9.2	7.8	10.8	15.3	17.8	7.0	7.9	6.2	10.5	15.0	11.9	11.8	14.9	12.6	16.0	15.3	15.8	21.6	18.8	10.1	9.4	15.5	24.1	14.6	16.9	12.8	18.9	14.3	20.9	20.5	18.0	17.7	8.7	14.5	17.1	17.2	15.4	16.4	17.7	15.7	11.8	14.4	14.1	9.9	21.4	8.2	14.8	23.4	16.7	8.0	11.6	15.3	14.7	11.2	17.6	14.6	10.2	7.6	10.4	17.0	10.7	5.9	12.7	15.5	18.1	12.2	13.5	8.2	18.7	8.8	13.7	16.5	22.9	18.2	10.4	9.2	13.3	15.3	14.2	6.6	6.7	17.8	7.9	7.8	6.2	6.3	10.8	4.8	6.3	5.6	3.4	7.0	17.6	3.6	5.8	6.2	11.9	15.1	14.5	19.8	11.3	13.2	12.3	13.3	16.1	11.6	3.0	1.6	0.0	0.2	0.6	0.6	0.8	0.0	5.3	2.3	0.0	0.0	0.9	0.0	2.4	0.2	0.5	1.0	0.0	2.3	0.8	0.4	0.2	5.7	0.8	0.7	3.2	1.7	1.3	1.6	0.0	0.9	0.4	0.0	2.8	0.7	0.7	3.0	3.5	0.7	0.5	0.8	0.0	0.4	1.1	0.9	0.5	1.1	1.0	1.2	0.3
SMG9	"C19orf61, FLJ12886"	ENSG00000105771	"SMG9, nonsense mediated mRNA decay factor"	Q9H0W8	19	43727992-43754990	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 79.9;Late spermatids: 263.1;Syncytiotrophoblasts: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041763, HPA042096"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA041763: AB_2677659, HPA042096: AB_2677845"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.71e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.24e-3)"	"unprognostic (3.88e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (8.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (8.09e-4)"	10.0	14.6	18.1	16.9	24.5	12.4	14.9	25.0	24.8	13.2	12.0	21.6	11.5	13.4	11.6	13.8	11.2	10.9	11.7	9.4	16.5	15.6	10.2	8.5	11.9	19.3	36.0	14.2	10.2	8.1	14.9	14.2	16.6	23.1	14.7	11.0	9.2	14.0	12.7	9.1	12.3	11.7	13.9	20.4	17.1	14.2	40.9	29.6	13.2	10.8	4.1	19.3	11.1	12.0	9.2	8.0	3.6	12.2	4.6	8.3	10.7	12.5	13.9	10.2	6.5	7.1	10.2	6.8	18.0	10.8	20.1	15.2	9.7	16.7	13.8	8.8	12.3	6.9	5.5	11.8	10.0	13.2	10.5	6.7	24.7	9.9	6.4	8.3	18.6	13.6	5.4	8.6	14.6	15.7	17.0	8.1	12.8	18.5	12.3	9.3	8.9	19.7	5.2	4.9	24.2	9.4	10.5	8.4	6.1	10.7	10.3	17.0	8.4	18.7	14.3	10.6	8.5	8.6	10.3	9.8	31.6	18.5	11.6	13.7	6.0	12.8	16.5	9.5	14.3	25.6	1.0	6.1	3.6	6.3	9.0	5.6	9.2	6.4	5.3	8.0	6.7	8.3	5.7	1.5	4.6	12.2	7.0	4.6	10.7	18.1	24.5	25.0	24.8	16.5	15.6	36.0	14.2	23.1	29.6	29.8	8.8	13.4	13.4	8.2	12.2	3.6	5.1	8.1	3.4	8.7	3.9	39.8	1.7	10.4	79.9	8.0	8.1	0.0	7.6	12.2	8.3	12.6	9.2	2.6	18.5	12.7	4.1	9.2	8.2	263.1	12.0	10.7	10.1	21.6	8.3	5.6	10.0	5.8	11.3	5.7	9.1	6.5	4.7	16.3	15.8	6.1	79.8	10.0	9.0	8.8
SMIM11A	"C21orf51, FAM165B, SMIM11"	ENSG00000205670	"Small integral membrane protein 11A"	P58511	21	34375480-34407866	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 3.0;Ciliated cells: 4.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051321	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA051321: AB_2681440"	"unprognostic (2.62e-2)"	"unprognostic (4.28e-2)"			"unprognostic (1.27e-1)"		"unprognostic (5.86e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.04e-1)"		"unprognostic (4.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"		"unprognostic (8.84e-2)"	"unprognostic (4.83e-3)"	2.1	6.7	7.8	1.4	7.4	1.0	5.0	4.4	9.5	2.9	4.1			2.2	4.3	6.0	1.4	6.3	4.8	8.8	6.9	6.1	5.1	4.5	5.0	3.3	6.7		5.0	3.8	5.2	4.1	2.4		3.7	6.2		4.8	2.9	16.4	2.6	4.6	3.7	6.5	3.7	17.0	1.7			12.1		5.0	4.3	2.2	4.6	6.5	6.3	4.8	3.4	11.8	3.6	7.7	8.9	0.0	6.0	6.3	5.3	0.0	0.0	4.7	5.8	6.1	6.2	7.6	14.8	4.3	0.4	10.2	5.7	0.0	0.1	8.5	27.3	17.1	3.2	0.0	3.6	4.8	3.9	7.3	0.1	9.1	0.0	4.9	5.9	10.3	9.3	13.7	12.5	3.7	5.7	2.2	3.8	12.6	13.9	17.6	4.9	7.2	20.8	2.6	2.4	5.3	10.5	0.1	8.7	12.4	4.5	15.8	5.1	0.0	14.3	1.7	4.1	10.3	10.6	13.0	5.2	4.4	6.9	7.0	0.3	3.0	6.3	1.8	4.8	2.7	4.6	3.4	5.0	6.5	2.5	4.6	2.5	0.7	3.4	1.2	1.2	11.8	3.6											3.0	1.6	0.0	0.3	0.0	0.2	0.0	0.0	4.0	1.2	0.0	0.0	0.3	1.7	1.1	0.4	0.0	0.0	0.0	0.6	0.3	0.0	0.3	0.0	1.1	0.6	0.0	1.2	1.3	0.3	0.0	0.0	1.3	0.0	0.0	0.9	0.2	0.9	0.0	0.4	1.4	0.4	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.7	0.1
SMIM11B		ENSG00000273590	"Small integral membrane protein 11B"	Q8TCY0	21	7744962-7777853	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 19.7"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 14.9;Ciliated cells: 20.1;Club cells: 7.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051321	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA051321: AB_2681440"					"unprognostic (1.99e-1)"					"unprognostic (1.78e-1)"				"unprognostic (1.35e-1)"				2.2	1.9		1.4		1.4	2.5		0.6	1.8	1.0			2.3	2.8	4.9	1.5	0.3	1.1	5.8			4.0	4.0	0.3	2.2			3.4	0.9	0.0		0.2		1.8	0.0		1.1	2.1	5.4	0.8	0.7	0.9		0.8	1.7	0.0			1.1		0.4	1.2		19.7	11.2	10.3	11.6	9.5	17.6	10.5	14.3	0.5	8.6	17.5	13.2	16.2	10.4	8.0	11.5	5.7	6.5	0.5	4.0	12.4	4.8	11.3	9.4	2.1	16.2	12.7	2.5	4.6	9.5	20.3	10.7	8.3	13.8	22.0	8.9	16.1	9.1	6.4	10.7	9.7	3.6	10.2	23.5	20.6	7.5	5.9	10.5	16.6	12.7	10.5	0.1	9.6	5.3	17.8	18.2	3.4	15.7	0.8	16.3	7.6	13.1	5.9	6.7	6.9	9.4	0.4	6.7	3.6	2.4	10.5	9.1	19.2	11.7	29.0	9.2	5.0	11.6	10.3	14.1	8.7	16.1	16.0	14.7	14.8	11.2	19.7	17.6	15.7	3.1	9.5	9.1	10.8	13.9	10.5											14.9	3.5	0.0	0.5	0.0	0.8	0.0	0.0	20.1	7.9	0.0	0.0	0.2	3.3	0.4	0.2	0.0	0.1	0.0	0.3	0.2	0.0	0.2	4.7	0.4	0.4	0.0	0.0	0.6	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	1.0	0.1	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.4	0.3
SMIM12	"C1orf212, FLJ90372"	ENSG00000163866	"Small integral membrane protein 12"	Q96EX1	1	34712737-34859816	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065331	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA065331: AB_2685470"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (7.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.52e-2)"	26.6	28.8	16.4	19.0	21.9	16.0	21.0	14.2	27.1	12.2	22.6	14.2	12.4	22.6	14.8	15.5	22.4	13.9	15.7	25.5	15.6	21.7	31.7	61.5	17.1	21.4	19.0	18.7	13.3	25.5	10.9	15.3	19.3	19.8	11.3	21.8	15.4	17.3	16.8	32.2	15.7	23.1	23.9	13.8	19.2	17.0	13.7	13.1	20.3	18.1	20.1	20.1	15.7	16.8	25.7	38.5	54.4	35.1	25.5	36.6	35.3	21.7	16.7	18.8	13.6	24.6	19.4	13.0	23.7	20.7	30.7	26.6	16.8	27.8	22.9	21.4	24.3	24.2	22.0	23.8	31.8	23.6	27.8	16.7	40.7	26.8	20.0	22.9	44.3	24.1	29.4	31.2	33.2	27.0	11.1	31.2	20.0	28.9	31.3	27.0	15.8	21.4	22.9	30.3	17.1	21.8	18.3	18.4	29.8	27.1	22.9	18.0	14.2	22.0	20.8	33.3	24.7	14.1	12.6	29.3	21.1	21.6	32.2	27.8	17.6	24.2	23.2	19.8	26.5	13.8	36.4	34.7	54.4	31.1	35.1	36.6	25.4	29.2	33.9	38.5	25.7	24.4	31.4	22.8	25.5	28.0	27.6	32.5	35.3	16.4	21.9	14.2	27.1	15.6	21.7	19.0	18.7	19.8	13.1	23.8	12.5	54.1	17.0	60.7	14.8	28.3	56.0	26.8	17.0	21.0	9.8	43.4	72.9	68.9	51.5	46.6	46.3	70.0	73.0	49.7	30.1	24.0	23.1	74.6	73.0	19.1	20.9	44.2	34.6	23.8	13.8	47.4	37.1	111.8	21.6	21.4	68.8	33.2	21.9	69.5	14.5	12.9	67.9	35.2	22.7	66.0	48.5	47.4	34.9	38.3
SMIM13	C6orf228	ENSG00000224531	"Small integral membrane protein 13"	P0DJ93	6	11094033-11138733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.4"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 66.6;Syncytiotrophoblasts: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065706	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Nucleoplasm, Nuclear membrane, Golgi apparatus"		"HPA065706: AB_2685539"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.04e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.45e-2)"	5.7	4.2	7.5	2.8	13.0	2.0	4.5	13.3	26.4	4.3	3.2	7.7	1.1	3.1	4.6	3.2	8.5	3.0	3.7	5.7	6.5	2.8	3.9	8.7	5.2	2.3	9.5	8.3	3.8	3.2	7.6	2.8	11.4	14.3	4.3	3.3	2.8	5.3	4.6	9.1	13.7	3.9	4.7	4.9	5.1	3.4	9.4	8.1	1.7	3.9	2.1	2.6	3.3	4.9	0.5	2.4	1.3	0.4	1.2	1.0	0.4	5.7	5.0	7.8	6.5	8.1	9.2	8.1	16.2	7.0	8.4	9.4	6.6	1.9	7.3	22.1	5.2	8.3	5.1	16.1	5.7	15.1	4.0	11.7	7.5	5.6	5.2	10.8	13.9	1.8	11.0	15.9	8.6	11.3	6.6	8.8	6.6	10.6	3.0	15.8	3.2	5.9	8.1	3.6	3.9	4.4	7.9	14.3	10.1	5.1	4.6	18.1	10.0	3.4	11.2	18.9	11.3	2.7	5.8	12.5	12.7	9.2	5.2	10.8	5.6	18.7	10.4	3.0	5.9	19.4	1.3	0.3	0.3	1.0	0.4	0.8	0.5	0.4	0.5	0.6	0.3	0.1	0.9	0.1	1.2	0.3	2.4	0.6	0.4	7.5	13.0	13.3	19.6	6.5	2.8	9.5	8.3	14.3	8.1	11.9	1.0	11.2	14.5	66.6	17.0	10.5	5.1	1.4	2.3	10.4	19.6	24.9	3.3	4.9	6.3	10.5	4.0	0.0	6.5	30.2	12.4	11.5	10.4	20.8	12.3	28.6	3.5	7.4	5.3	3.8	2.6	9.5	15.1	4.6	6.9	7.1	7.9	3.5	3.9	6.6	13.9	0.0	10.3	11.3	17.0	34.5	54.5	6.9	7.4	14.0
SMIM17		ENSG00000268182	"Small integral membrane protein 17"	P0DL12	19	56643145-56655766	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in many"	6	"brain: 26.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in some"		"AF22: 5.4;HEK 293: 5.3;RH-30: 4.2;SCLC-21H: 4.9"									"HPA071857, HPA071861"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA071857: AB_2686461, HPA071861: AB_2686462"	"unprognostic (1.32e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (9.02e-3)"	"unprognostic (3.46e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.71e-3)"	"unprognostic (7.51e-3)"	1.8	1.2	7.0	0.6	10.4	0.8	2.4	4.5	17.3	0.9	1.1	0.9	0.0	1.0	2.2	4.8	1.2	1.5	1.0	1.7	6.0	13.8	1.3	0.8	1.3	0.7	5.9	7.7	1.8	1.2	0.5	2.2	1.1	26.5	1.7	1.2	0.4	1.3	2.6	1.1	1.9	0.7	1.4	2.7	1.0	0.7	1.6	0.1	0.0	1.1	0.0	0.8	0.5	0.5	0.0	1.4	0.0	0.4	0.0	0.0	0.1	0.3	0.0	5.4	1.5	1.2	0.9	1.1	0.7	0.6	1.3	0.3	0.0	0.2	0.4	0.8	0.3	0.5	0.3	0.1	0.4	0.7	0.0	5.3	3.1	0.6	0.8	0.8	2.5	0.4	1.7	0.7	0.0	1.5	1.1	0.5	2.9	0.1	0.0	1.1	0.0	2.8	0.4	0.0	0.0	0.6	1.5	4.2	0.1	0.7	0.0	4.9	1.0	1.3	0.1	0.8	0.9	0.0	0.8	0.8	1.9	0.2	0.5	0.5	0.3	0.8	1.3	0.6	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	10.4	4.5	17.3	6.0	13.8	5.9	7.7	26.5	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM19	C8orf40	ENSG00000176209	"Small integral membrane protein 19"	Q96E16	8	42541155-42555193	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011145, HPA074830"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA011145: AB_1078360, HPA074830: "	"unprognostic (2.12e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (7.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (1.74e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.70e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-3)"	23.7	26.9	20.2	19.2	17.2	12.7	31.2	21.1	23.9	17.5	23.2	12.4	25.2	14.0	16.1	39.3	23.2	27.3	27.9	41.9	18.2	15.6	35.6	61.9	22.1	23.4	17.4	16.5	21.5	40.2	18.0	12.8	16.0	13.6	17.7	16.7	17.7	42.7	20.4	50.6	19.8	31.3	26.6	17.2	18.0	19.5	26.4	9.8	21.4	34.9	30.8	15.8	26.5	13.2	28.1	41.4	25.7	17.0	29.7	29.2	15.2	13.4	10.0	22.0	18.9	13.5	16.1	7.0	10.4	14.4	8.6	10.2	2.4	30.1	14.8	4.4	8.8	20.8	9.7	11.4	6.8	8.9	11.8	9.5	12.6	6.8	5.3	27.6	8.8	3.2	13.2	5.9	7.1	23.0	16.6	7.7	17.6	9.9	34.1	8.5	13.1	6.4	13.4	26.0	31.6	6.9	7.3	15.7	24.9	21.6	10.0	4.6	16.9	10.7	11.6	31.5	12.4	24.5	16.9	9.6	5.4	4.6	14.7	6.8	32.5	17.9	19.5	22.8	14.3	14.2	25.7	17.0	11.5	19.3	12.4	23.2	28.1	24.9	23.5	25.1	27.5	23.9	22.9	6.0	29.7	10.3	41.4	29.2	15.2	20.2	17.2	21.1	23.9	18.2	15.6	17.4	16.5	13.6	9.8	20.8	35.8	32.7	56.6	40.6	24.7	70.6	53.5	119.1	50.0	31.4	5.9	73.7	170.8	60.6	134.0	42.9	36.0	23.3	111.2	54.1	58.6	43.9	39.3	132.8	69.1	22.3	15.6	37.4	37.1	52.2	63.9	47.1	87.7	68.5	72.2	41.5	70.1	73.6	55.9	175.5	10.3	25.8	44.8	48.8	35.6	43.3	39.5	44.9	75.4	48.0
SMIM20	"C4orf52, MITRAC7, PNX"	ENSG00000250317	"Small integral membrane protein 20"	Q8N5G0	4	25861830-25929874	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016552	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA016552: AB_1859536"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.86e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (5.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.12e-3)"	14.9	20.5	21.8	15.6	26.7	7.1	25.0	11.4	28.0	12.9	16.4	8.3	12.8	24.1	13.7	46.4	11.9	15.1	22.5	33.7	17.9	16.2	27.1	22.7	18.5	26.0	19.2	14.3	19.5	50.0	8.7	10.0	9.5	22.8	13.6	16.1	11.3	20.4	15.7	51.3	6.9	23.8	24.0	22.6	12.7	18.8	17.7	13.5	9.3	21.3	15.3	14.5	14.5	15.9	27.1	21.4	13.3	20.3	18.1	31.1	18.2	12.9	10.9	14.6	14.1	16.2	35.4	19.6	12.7	15.4	10.9	14.0	9.6	23.1	21.4	22.1	14.0	22.7	3.8	17.0	16.2	15.3	12.1	13.5	12.3	7.9	18.3	27.6	14.6	8.2	25.0	32.6	13.9	21.2	21.4	8.4	14.5	19.7	7.0	13.4	8.3	15.8	24.9	27.6	17.3	16.3	13.1	19.1	13.7	24.3	9.5	18.9	17.6	8.1	5.7	27.9	16.8	11.8	20.9	13.9	11.9	14.1	13.3	16.1	13.8	11.3	22.4	18.0	15.6	15.0	13.3	18.2	8.4	15.7	20.3	20.5	27.1	22.7	19.7	20.5	26.8	31.1	24.7	9.2	18.1	15.2	21.4	23.2	18.2	21.8	26.7	11.4	28.0	17.9	16.2	19.2	14.3	22.8	13.5	8.9	35.3	39.7	30.7	19.5	7.0	54.2	58.6	29.4	35.2	34.9	7.9	53.4	111.0	55.9	8.3	17.8	60.0	0.0	54.3	51.6	39.2	34.0	10.4	52.1	61.7	1.6	18.6	19.0	49.0	18.9	34.8	47.0	42.2	36.1	53.7	55.6	48.1	35.1	45.3	134.2	16.1	71.1	36.2	42.9	40.5	16.9	36.6	25.9	63.5	25.3
SMIM22		ENSG00000267795	"Small integral membrane protein 22"	K7EJ46	16	4788397-4796491	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.3"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 1586.1;Mucus-secreting cells: 1138.7;Paneth cells: 989.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"CAPAN-2: 68.7;OE19: 58.6;RT4: 25.3;SCLC-21H: 17.9;SK-BR-3: 51.6"	"Not detected"	"Not detected"							HPA077331			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA077331: AB_2686834"	"unprognostic (6.55e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.69e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.73e-3)"	0.8	0.0	0.8	14.4	0.8	0.2	10.9	0.8	0.8	10.8	47.0	0.9	37.8	27.5	2.5	12.1	2.6	18.0	28.1	0.8	0.8	0.0	6.2	0.9	6.8	0.8	0.8	0.8	2.8	36.2	0.0	12.1	4.1	0.8	10.2	28.1	0.8	42.2	35.3	0.8	2.2	54.3	1.7	0.8	0.8	41.7	27.2	0.8	1.0	0.9	2.8	4.5	18.5	3.6	1.9	1.5	3.9	1.3	0.9	1.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	68.7	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.1	0.2	58.6	0.0	0.1	0.1	5.8	0.3	25.3	17.9	0.3	0.1	51.6	0.0	0.1	4.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.1	3.9	1.3	1.6	1.3	0.5	0.6	0.7	1.3	0.6	0.3	1.9	1.6	0.7	3.3	0.9	0.6	1.5	0.9	0.3	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	0.8	0.8	44.7	91.2	2.2	16.6	1.9	3.3	0.4	239.5	456.4	104.6	237.3	0.0	3.6	21.6	209.7	33.3	0.4	1586.1	0.0	336.4	0.4	0.3	47.7	18.4	0.0	0.3	1.6	452.3	0.0	0.0	89.0	0.6	2.7	21.9	9.0	1138.7	0.5	428.0	989.0	1.1	55.8	4.1	0.0	0.2	15.1	0.4	1.9	3.1	0.0	572.8	123.6
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480542	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 160.8;intestine: 204.2;kidney: 76.9"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 1384.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 78.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7"	"Low region specificity"	"Detected in many"							"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.1	0.7	0.6	0.9	7.0	0.3	0.2	2.2	0.2	137.0	0.4	2.4	71.4	0.2	160.8	0.3	0.3	46.7	0.3	0.4	0.5	76.9	7.2	0.3	0.3	0.4	0.6	0.3	1.6	0.0	0.9	0.2	0.3	0.3	2.0	0.2	0.3	0.4	0.2	0.3	204.2	0.2	0.6	0.4	24.8	1.2	0.3	8.8	0.2	0.2	0.2	0.2	0.2	3.2	2.4	3.0	0.0	8.6	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	42.4	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.2	31.7	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	30.2	4.2	0.0	50.3	0.0	16.6	0.0	1.1	0.4	0.0	0.4	0.6	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.7	0.0	23.7	0.0	3.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.1	0.6	0.7	1.7	0.0	8.6	0.0	2.4	2.1	1.1	0.7	0.9	0.2	2.2	0.4	0.5	0.4	0.6	0.3	0.3	0.0	0.0	1.7	0.1	0.0	12.1	0.2	229.3	0.0	0.0	55.8	25.5	0.0	202.2	3.9	5.0	0.0	64.6	23.3	11.3	0.1	0.0	0.3	1.1	8.5	0.1	0.0	133.5	0.6	0.8	11.2	0.3	0.0	0.0	1.0	34.7	2.7	11.1	51.8	0.0	1384.0	32.6	0.0	0.0	0.7	0.4	0.0	0.0	1.0	35.7	0.2
SMIM26	"LINC00493, LOC388789"	ENSG00000232388	"Small integral membrane protein 26"	A0A096LP01	20	18567347-18569563	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 330.0;Proximal tubular cells: 358.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA068733			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA068733: AB_2686024"	"unprognostic (1.20e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (7.84e-5)"	6.8	13.2	8.4	6.8	11.6	9.9	15.6	9.2	13.2	8.8	8.8	5.0	11.9	8.6	9.0	20.4	9.3	11.2	10.8	15.0	9.2		13.2	16.4	6.7	13.4	9.2	10.9	17.2	29.4	6.9	10.6	7.4	14.7	9.5	9.7	6.9	16.8	15.7	32.3	7.7	10.9	11.7	8.9	6.2	8.3	5.4	10.8	7.7	12.0	18.7	9.6	11.4	12.6	49.2	52.0	75.1	42.9	29.6	49.8	37.5	23.6	30.7	23.0	24.2	21.3	29.3	27.3	17.7	20.9	20.5	23.5	19.0	27.3	23.4	20.3	18.9	36.9	26.0	21.7	28.8	23.3	10.0	27.5	31.1	14.3	62.5	40.8	20.4	23.9	24.9	38.5	23.2	37.5	35.7	30.7	29.0	22.8	22.0	25.3	29.0	24.0	56.3	13.3	44.5	37.2	15.7	27.3	32.0	45.9	23.7	23.2	24.7	18.5	35.8	68.1	21.3	26.2	30.1	16.0	14.5	15.3	17.9	18.5	21.4	51.7	26.0	13.1	13.2	10.9	34.8	42.9	32.2	33.2	36.2	34.7	49.2	45.0	37.6	52.0	45.1	49.8	46.7	75.1	29.6	33.3	48.6	45.4	37.5											119.1	61.5	0.0	0.0	0.0	0.0	0.0	0.0	160.6	66.0	162.3	0.0	177.5	330.0	123.9	0.0	0.0	0.0	0.0	185.9	113.7	0.0	0.0	32.5	0.0	161.8	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	115.4	0.0	0.0	172.0	0.0	0.0	358.7	0.0	0.0	0.0	0.0	0.0	0.0	173.9	0.0	0.0	0.0
SMIM3	"C5orf62, MSTP150, NID67"	ENSG00000256235	"Small integral membrane protein 3"	Q9BZL3	5	150777946-150796734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 24.4;blood: 22.3;bone marrow: 11.4;pancreas: 45.7"	"Cell type enhanced"	"Detected in many"	8	"granulocytes: 87.8;Sertoli cells: 135.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 64.2;ASC TERT1: 31.4;LHCN-M2: 29.1;U-87 MG: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075345			Approved	Vesicles		NA	NA			Vesicles		"HPA075345: AB_2686744"	"unprognostic (2.33e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.45e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.05e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.46e-3)"	"prognostic unfavorable (1.15e-8)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-3)"	24.4	5.4	6.1	3.3	5.6	11.4	3.9	3.3	6.2	2.2	3.1	1.8	0.7	1.3	3.0	2.9	2.2	3.0	3.3	3.4	2.6	1.2	2.9	1.1	3.6	0.7	3.0	1.0	3.2	45.7	1.2	1.8	6.4	6.2	3.2	2.3	1.3	1.8	3.3	2.5	2.2	3.9	3.7	2.6	1.9	2.9	1.7	4.3	1.8	2.7	0.7	0.7	3.8	1.8	0.3	18.4	22.3	13.3	3.6	7.2	11.6	2.0	0.6	1.1	9.4	64.2	31.4	2.4	8.0	17.2	2.9	11.9	3.1	5.4	0.0	0.4	8.2	2.0	1.6	1.8	1.7	4.4	0.0	0.5	2.9	0.4	1.4	11.4	2.9	21.2	26.3	3.6	8.3	3.8	19.3	0.9	7.2	0.8	0.0	29.1	1.5	4.1	4.0	0.5	1.6	1.9	2.3	0.1	0.0	3.1	1.5	0.2	0.7	1.1	0.1	2.3	1.3	3.9	18.1	1.5	13.2	2.4	10.3	4.1	0.0	0.0	0.0	47.7	11.1	1.6	17.9	13.3	22.3	7.2	5.3	4.3	0.3	5.1	4.9	6.2	0.0	5.0	4.3	13.9	3.6	4.8	18.4	0.7	11.6	6.1	5.6	3.3	6.2	2.6	1.2	3.0	1.0	6.2	4.3	6.0	10.4	0.5	56.6	0.0	0.7	6.6	10.2	0.0	4.5	7.0	0.0	7.7	11.6	6.6	0.6	6.7	2.3	0.0	28.1	4.8	19.3	11.1	87.8	0.4	39.0	0.0	4.6	12.9	26.7	0.6	13.0	15.3	0.0	34.3	34.3	42.1	14.9	0.0	34.6	7.1	0.7	135.8	63.1	0.0	0.5	0.0	6.8	10.2	6.2	43.2
SMIM4	C3orf78	ENSG00000168273	"Small integral membrane protein 4"	Q8WVI0	3	52534013-52579237	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 90.6"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 211.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047771	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA047771: AB_2680150"	"unprognostic (3.76e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.89e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.25e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (6.35e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (8.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-2)"	11.1	47.3	6.8	9.3	12.0	4.1	15.9	10.3	13.4	6.0	8.7	3.2	16.0	7.5	5.2	16.3	5.5	5.0	13.0	90.6	8.4	6.1	12.2	9.3	21.7	26.5	8.5	6.9	19.1	28.3	6.2	22.1	4.1	17.4	10.6	6.7	10.5	25.8	19.1	66.8	6.7	7.9	17.0	9.1	5.7	8.5	14.1	7.6	1.8	17.3	30.8	5.3	7.0	5.3	13.7	26.2	8.8	24.7	11.0	16.9	10.4	23.0	8.1	9.5	24.0	11.2	5.8	19.4	10.5	4.9	12.1	10.6	9.9	6.2	10.0	4.8	4.4	12.2	12.2	3.1	8.4	4.9	6.6	24.6	9.4	23.2	19.9	17.0	11.1	13.1	12.5	5.2	10.2	7.4	6.6	11.0	11.0	12.4	15.0	8.1	10.0	10.3	15.6	16.1	12.7	17.3	7.1	9.1	19.7	6.7	10.1	10.3	13.0	20.5	6.8	19.8	5.6	7.0	9.4	9.7	6.7	22.0	31.6	21.3	17.5	19.0	21.9	36.8	20.9	9.2	3.5	24.7	8.8	10.8	18.7	10.5	13.7	15.6	13.2	26.2	12.5	16.9	15.2	0.9	11.0	7.5	14.0	14.9	10.4	6.8	12.0	10.3	13.4	8.4	6.1	8.5	6.9	17.4	7.6	44.7	44.8	30.4	29.5	24.2	16.1	211.3	61.1	62.9	77.3	50.6	11.8	35.0	180.8	36.8	15.8	36.5	60.3	0.0	74.3	16.7	27.7	17.7	56.7	143.5	98.6	3.2	76.2	60.8	84.6	8.0	60.1	52.8	35.4	17.2	57.4	43.6	50.1	28.1	95.1	134.6	12.7	45.3	51.1	7.7	15.8	30.2	23.1	25.9	67.6	18.2
SMIM5	C17orf109	ENSG00000204323	"Small integral membrane protein 5"	Q71RC9	17	75633434-75641404	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.2"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 118.7;Distal tubular cells: 77.9;Erythroid cells: 233.6;Urothelial cells: 102.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	51	"plasmacytoid DC: 54.2"	"Lineage enriched"	"Detected in many"	51	"dendritic cells: 54.2"	"Cell line enhanced"	"Detected in some"		"HEL: 3.1;MCF7: 14.3;OE19: 3.8;SK-BR-3: 6.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA065332, HPA071268"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA065332: AB_2685471, HPA071268: AB_2686377"	"unprognostic (6.97e-2)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.29e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (2.64e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.58e-1)"	0.4	0.6	2.1	1.8	10.7	9.9	1.4	1.1	7.5	4.0	4.4	23.5	2.1	9.8	0.7	0.8	14.3	5.5	4.7	5.1	3.7	2.2	13.6	0.5	2.5	1.1	8.8	4.8	1.3	1.1	0.4	1.1	1.9	16.9	1.9	2.8	2.5	8.4	2.2	0.4	7.8	9.5	2.1	10.1	2.4	11.0	0.9	8.9	0.4	9.3	0.9	3.6	4.4	7.3	0.0	54.2	1.0	0.0	0.0	0.0	4.0	2.5	1.7	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.2	3.1	0.4	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.2	14.3	0.1	0.1	0.1	3.8	0.2	0.4	0.5	0.1	0.0	2.8	1.2	0.1	0.0	6.4	0.0	0.5	0.9	0.2	0.1	0.3	0.2	0.1	0.2	0.3	0.0	0.1	0.1	0.7	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	54.2	0.0	4.0	2.1	10.7	1.1	7.5	3.7	2.2	8.8	4.8	16.9	8.9	8.9	6.5	0.0	6.3	1.0	1.2	19.3	10.2	25.4	2.3	118.7	2.0	1.2	77.9	1.8	0.1	1.3	13.2	233.6	0.5	4.2	2.4	6.1	0.0	0.0	0.6	0.0	13.8	2.5	0.0	0.0	0.6	0.6	6.8	0.0	8.2	3.2	6.4	10.5	1.4	0.8	1.8	0.0	0.4	0.5	0.4	7.3	27.5	1.3	1.7	102.7
SMIM6	C17orf110	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647977	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 508.7;Late spermatids: 1038.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 22.0"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 22.0"	"Cell line enhanced"	"Detected in some"		"A549: 12.6;CACO-2: 4.1;EFO-21: 9.8;HEL: 7.1;OE19: 11.6;RPTEC TERT1: 4.5"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.2	0.1	2.4	0.6	4.1	0.6	0.1	0.6	6.1	1.8	5.3	12.3	3.2	7.9	0.9	2.2	0.2	19.1	15.8	0.1	4.0	2.1	13.5	5.2	1.8	0.3	5.3	4.1	0.4	7.3	1.7	0.1	0.4	5.4	0.3	5.5	0.1	0.2	2.9	0.1	0.2	9.4	0.0	9.1	0.2	26.5	20.6	3.1	0.0	0.1	0.2	0.2	1.1	0.8	0.0	22.0	0.0	0.0	0.4	0.0	0.2	0.7	12.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.1	3.9	0.0	9.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	7.1	0.3	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.4	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.2	4.5	2.1	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	22.0	0.0	0.2	2.4	4.1	0.6	6.1	4.0	2.1	5.3	4.1	5.4	3.1	3.0	1.9	0.8	3.2	0.1	0.0	0.0	30.6	44.2	6.8	33.2	0.0	0.0	116.0	27.9	508.7	0.1	26.2	0.0	14.7	2.6	0.2	1.8	0.0	5.4	0.6	0.0	189.1	0.0	0.0	1038.8	6.1	1.0	0.0	2.8	36.2	0.0	37.4	84.2	1.8	15.7	0.0	6.5	0.1	4.9	2.1	0.0	3.4	0.0	3.1	8.4
SMIM7	"C19orf42, MGC2747"	ENSG00000214046	"Small integral membrane protein 7"	Q9BQ49	19	16630751-16660442	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043127	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA043127: AB_10806378"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.64e-2)"	24.6	26.2	20.5	16.9	27.1	12.0	25.5	30.0	32.1	23.4	19.1	28.1	30.4	18.8	25.7	43.2	19.7	23.2	20.1	21.8	19.6	19.7	28.8	32.4	20.1	21.1	22.1	21.2	31.7	39.6	29.8	23.0	28.6	22.7	27.2	26.0	29.2	40.6	25.9	19.6	22.9	20.0	22.3	26.7	23.3	23.1	22.4	15.8	20.6	34.1	18.1	22.7	19.3	23.0	21.8	31.0	15.4	30.4	15.2	17.7	16.5	18.9	13.0	16.0	12.6	22.9	19.7	13.2	17.0	16.3	15.5	13.6	12.0	25.0	12.9	23.9	17.2	15.4	13.5	14.3	19.5	17.7	12.1	12.2	12.6	11.9	11.9	8.9	18.3	16.6	14.2	12.2	13.0	13.9	14.3	15.6	11.0	17.0	19.6	19.8	28.8	12.3	16.8	13.7	30.3	19.6	13.8	11.3	12.2	15.4	20.2	5.8	14.4	13.1	11.8	15.9	8.9	17.9	26.9	12.1	16.5	11.7	42.8	27.2	17.5	24.9	17.3	18.0	24.0	20.0	14.4	30.4	15.4	17.7	26.5	14.4	21.8	17.3	15.7	23.8	21.3	16.8	15.9	14.2	15.2	28.0	31.0	17.6	16.5	20.5	27.1	30.0	32.1	19.6	19.7	22.1	21.2	22.7	15.8	62.5	60.5	87.1	54.8	30.3	69.0	32.3	45.9	45.5	45.5	54.1	90.3	122.2	109.5	72.5	10.8	49.4	63.9	23.3	74.9	85.4	64.1	63.4	49.6	76.9	99.9	60.4	70.0	64.4	77.0	15.6	82.3	59.6	45.5	96.4	58.9	84.5	74.9	77.2	78.1	97.6	112.1	71.1	57.0	86.0	82.7	31.2	130.8	47.3	55.5	45.2
SMIM8	"C6orf162, dJ102H19.2, DKFZP586E1923"	ENSG00000111850	"Small integral membrane protein 8"	Q96KF7	6	87322583-87399749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007401, HPA067453"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA007401: AB_1078357, HPA067453: AB_2685844"	"unprognostic (2.54e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.86e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.01e-1)"	7.8	9.0	13.3	6.3	14.6	9.0	9.1	15.6	15.6	7.4	8.3	7.6	8.5	8.8	11.4	12.2	6.5	7.1	4.7	10.3	17.9	12.5	10.4	12.0	5.6	9.1	12.0	10.8	10.5	8.0	6.1	19.2	5.8	11.9	7.9	8.1	7.8	7.2	7.3	16.2	5.4	7.9	11.3	10.2	6.5	6.3	7.4	8.0	11.0	7.5	4.7	6.5	6.5	8.7	16.0	8.9	13.4	8.4	7.7	18.7	8.5	4.3	3.9	8.0	13.8	4.7	5.3	3.5	4.9	3.8	4.2	8.0	2.7	4.1	9.0	5.9	4.9	7.2	5.5	6.3	3.7	8.0	8.0	6.9	13.1	4.4	5.3	4.4	13.6	4.8	5.0	5.1	4.2	4.5	4.7	5.9	11.6	14.7	15.2	4.6	3.3	8.2	10.9	4.9	6.5	6.0	13.2	11.9	5.1	5.3	4.3	13.7	5.7	7.2	4.3	7.8	7.7	3.9	13.8	5.7	2.2	6.3	9.3	4.7	6.8	11.0	5.9	7.1	6.6	6.5	5.2	8.1	13.1	10.7	7.7	10.6	16.0	12.6	12.8	8.9	10.4	18.7	16.2	13.4	7.7	8.4	7.5	15.5	8.5	13.3	14.6	15.6	15.6	17.9	12.5	12.0	10.8	11.9	8.0	11.9	4.3	15.9	17.9	12.2	25.0	38.9	12.7	13.4	12.5	22.7	35.3	14.8	38.1	8.8	15.3	13.4	7.7	0.0	9.1	10.5	15.1	10.1	4.7	12.1	12.7	35.0	8.2	19.0	14.6	12.1	14.7	12.8	8.5	10.8	9.5	23.3	6.9	14.0	19.4	18.3	23.0	25.8	12.5	18.9	21.6	12.9	12.5	13.1	17.6	10.7
SMKR1		ENSG00000240204	"Small lysine rich protein 1"	H3BMG3	7	129502479-129512932	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"testis: 65.7"	"Group enriched"	"Detected in many"	36	"Early spermatids: 1715.8;Late spermatids: 4654.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 2.9;NK-cells: 1.3;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 12.8;SCLC-21H: 22.5"					"Low region specificity"	"Detected in all"			HPA078358			Approved	Nucleoli		NA	NA			Nucleoli		"HPA078358: AB_2686883"	"unprognostic (5.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.67e-2)"	0.3	1.0	3.1	0.5	6.3	0.3	1.5	0.8	3.3	0.6	0.3	0.1	0.0	0.5	0.4	1.7	0.4	4.6	0.4	0.2	2.7	2.2	0.7	0.2	0.5	0.7	1.1	2.7	0.3	2.6	2.9	2.7	0.9	1.0	0.5	0.4	0.0	0.3	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.5	65.7	0.7	0.0	0.7	0.1	0.7	0.2	0.0	2.9	0.0	0.2	0.0	1.3	3.7	0.4	8.8	8.6	0.2	7.5	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	2.3	0.0	0.8	0.5	4.9	1.1	1.5	0.0	1.1	8.2	0.9	0.0	1.7	0.0	1.6	0.1	5.7	0.0	3.8	2.3	1.6	1.0	0.3	5.3	0.5	0.2	0.4	12.8	1.6	0.8	1.1	2.3	7.7	0.8	0.0	1.9	3.2	0.0	22.5	6.1	6.4	0.7	0.5	1.5	2.0	1.1	0.1	0.0	0.2	5.0	1.9	2.2	2.8	0.1	3.1	0.3	0.6	0.0	0.0	0.0	3.7	0.0	1.7	2.9	0.7	1.9	0.0	1.5	1.5	1.4	0.2	1.3	0.0	0.0	0.0	0.4	3.1	6.3	0.8	3.3	2.7	2.2	1.1	2.7	1.0	0.7	3.0	0.0	0.0	2.1	0.1	1.4	0.0	0.0	8.1	1.2	5.2	0.0	0.0	8.3	1.7	1715.8	0.1	0.0	0.0	5.3	0.2	0.6	1.0	0.0	0.0	0.1	0.0	8.6	0.6	0.0	4654.0	34.8	0.0	1.7	1.0	0.0	1.0	3.1	0.0	25.8	1.1	0.2	0.0	0.0	89.2	28.0	0.3	0.1	5.0	0.0	0.7
SMOC1		ENSG00000198732	"SPARC related modular calcium binding 1"	Q9H4F8	14	69854131-70032366	"Disease related genes, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;liver: 48.0"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 78.8;Peritubular cells: 125.2;Syncytiotrophoblasts: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	50	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in some"		"AF22: 19.8;HeLa: 54.5;HSkMC: 16.0;SiHa: 32.1;SK-BR-3: 14.1;U-266/70: 20.3;U-87 MG: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004153, CAB034427"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		27000	"Plasma membrane"		"CAB034427: AB_2193382, HPA004153: AB_1080035"	"unprognostic (3.31e-1)"	"unprognostic (2.17e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.09e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	7.4	10.7	23.0	1.4	10.8	1.1	2.9	5.2	62.2	8.6	2.2	32.0	19.4	3.0	2.2	10.3	1.3	7.1	1.5	4.7	22.6	16.2	2.1	48.0	1.4	1.8	23.8	8.5	1.8	26.4	1.1	2.4	9.0	21.7	42.9	2.0	14.7	3.6	35.8	8.7	1.2	2.3	1.9	15.0	19.5	3.5	24.7	16.9	0.0	2.9	0.6	1.5	1.7	3.6	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	19.8	0.0	4.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	7.7	0.0	54.5	8.0	0.0	0.0	0.0	16.0	4.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.1	32.1	14.1	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.0	0.0	20.3	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	23.0	10.8	5.2	11.2	22.6	16.2	23.8	8.5	21.7	16.9	0.0	0.0	0.9	0.0	0.2	1.5	1.7	10.2	1.4	0.0	0.0	15.7	18.5	0.0	0.2	4.1	1.3	0.0	0.0	1.9	0.8	4.2	0.0	0.0	78.8	2.5	0.0	15.0	2.5	2.7	13.2	7.2	0.0	0.0	0.0	0.0	0.2	5.8	0.0	125.2	0.0	0.2	0.0	0.7	1.5	3.3	0.4	33.6	0.0	0.0	0.0
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 48.0;Pancreatic endocrine cells: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1;neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 35.5;Karpas-707: 60.7;RPTEC TERT1: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA047117: AB_2679940, HPA060198: AB_2684220"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.33e-6)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	3.5	3.1	26.0	4.1	22.7	24.2	3.4	10.1	29.0	9.6	6.7	23.5	17.6	9.5	10.2	6.9	6.1	4.7	14.0	2.9	28.8	16.2	3.8	4.4	2.1	4.0	25.1	16.5	9.2	28.9	8.7	6.0	5.7	20.7	8.1	1.4	6.5	10.6	10.2	2.5	7.8	7.1	3.9	25.9	2.9	7.4	3.9	24.1	0.3	3.9	3.4	2.6	5.3	5.2	0.1	2.1	3.5	0.9	0.2	0.2	15.3	3.2	35.5	2.5	1.8	1.7	2.6	4.5	4.6	8.9	3.4	2.3	14.6	8.9	0.0	1.5	4.2	5.5	6.5	2.0	2.2	1.4	0.0	1.1	6.2	1.1	14.8	10.9	1.2	2.5	9.8	4.0	7.1	3.0	4.1	6.0	5.0	1.3	60.7	2.0	1.0	2.3	3.5	3.1	3.1	4.9	2.0	3.1	8.4	28.0	2.4	0.5	2.1	8.6	1.0	15.9	1.3	0.1	1.5	7.1	3.9	3.7	0.7	3.6	2.8	0.4	0.0	3.2	1.5	3.0	0.0	0.9	0.1	0.0	0.4	0.0	0.1	0.2	0.2	2.1	0.0	0.0	0.0	3.5	0.2	0.1	1.0	0.0	15.3	26.0	22.7	10.1	17.6	28.8	16.2	25.1	16.5	20.7	24.1	0.0	0.3	1.5	9.5	11.2	0.5	1.4	12.7	1.4	4.5	10.4	0.0	0.3	0.0	48.0	3.1	5.6	2.1	23.3	26.4	0.6	9.5	12.1	5.7	2.0	16.2	0.0	5.8	14.1	3.4	5.6	13.6	10.4	8.5	36.9	2.1	28.2	84.5	0.8	12.7	1.4	1.3	0.0	8.1	4.2	4.9	9.3	0.2	0.0	2.9	8.8
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440763-109443919	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 151.6;Late spermatids: 248.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.0	6.8	4.2	20.2	4.9	8.5	8.5	5.4	6.4	9.0	12.6	9.8	16.4	10.5	6.1	16.0	17.2	17.4	12.6	5.1	4.9	3.7	10.2	7.8	8.4	9.4	4.7	4.2	6.7	15.5	17.9	8.8	19.5	4.8	10.1	10.2	8.4	16.6	11.9	3.3	16.9	15.4	7.8	4.3	10.1	11.1	35.1	4.7	18.3	10.5	13.5	23.0	6.3	10.1	18.3	13.4	9.3	7.8	6.2	8.0	5.3	8.9	10.4	5.5	8.6	9.7	5.3	18.3	3.0	11.2	7.6	7.2	9.8	7.3	4.9	6.4	6.4	16.0	11.5	5.5	13.2	4.6	6.2	14.2	5.7	10.7	6.0	8.1	6.2	6.7	5.6	15.3	6.7	13.3	8.5	6.9	8.7	11.0	8.7	3.7	12.9	10.0	13.5	1.5	11.9	5.0	7.1	2.6	5.3	13.7	15.3	7.2	6.0	5.7	17.9	13.5	4.6	5.7	12.0	4.4	3.4	4.9	2.7	11.2	5.9	1.5	3.1	6.6	6.0	6.0	5.7	7.8	9.3	6.6	7.5	7.3	12.8	7.4	8.0	10.2	18.3	5.6	5.7	2.3	6.2	6.6	13.4	7.2	5.3	4.2	4.9	5.4	6.4	4.9	3.7	4.7	4.2	4.8	4.7	11.9	7.4	4.2	8.5	8.8	1.3	2.0	12.7	58.9	7.9	12.2	3.9	8.2	1.7	14.7	151.6	3.8	27.2	0.0	17.1	16.1	6.0	12.7	0.0	3.2	8.5	0.0	8.1	4.3	6.6	248.2	8.6	10.8	8.5	11.8	21.2	2.3	13.7	24.6	8.5	7.9	5.2	12.9	2.8	36.6	10.6	16.3	14.2	4.9	13.8	13.7
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	13.2	16.1	12.4	17.1	20.7	39.1	14.8	22.1	25.1	19.9	15.8	31.4	15.3	15.5	22.5	14.1	19.3	19.5	12.7	13.4	13.2	16.0	14.3	18.5	14.7	20.5	21.3	12.2	22.2	22.2	24.1	31.2	24.3	19.5	16.3	16.7	17.7	17.1	15.2	17.0	17.5	15.2	18.3	16.0	16.4	14.5	23.6	21.6	27.9	22.8	19.6	27.1	16.9	16.6	10.5	9.8	14.5	11.4	11.7	15.2	9.7	32.0	15.8	20.0	14.8	10.3	7.6	26.1	17.1	12.7	25.2	21.1	45.8	16.5	20.9	15.2	17.1	14.4	18.2	25.5	22.6	17.5	27.7	24.7	23.5	17.0	36.3	8.8	26.2	15.0	8.8	15.2	28.3	11.3	9.3	14.5	20.9	29.2	17.0	14.1	17.3	27.4	13.2	30.7	13.7	21.1	29.1	15.2	22.7	10.7	15.2	27.8	15.6	16.8	20.6	7.5	11.6	14.0	11.5	11.2	21.6	21.0	14.1	20.0	14.8	16.6	28.1	19.5	15.0	15.3	1.8	9.3	14.5	13.9	11.4	15.2	9.5	10.4	12.4	9.8	10.5	10.2	11.4	4.5	11.7	8.0	6.4	9.4	9.7	12.4	20.7	22.1	25.1	13.2	16.0	21.3	12.2	19.5	21.6	3.0	9.9	10.2	9.1	13.4	20.0	3.2	5.1	6.7	6.8	7.0	11.8	19.8	8.3	8.1	17.4	7.4	7.1	0.0	10.5	21.1	10.3	8.6	5.8	13.5	12.1	14.3	12.6	9.8	9.4	32.6	13.6	6.5	15.1	5.4	12.5	7.8	11.0	9.1	17.3	5.6	15.1	0.0	8.0	24.0	22.0	18.1	13.0	12.8	12.1	7.9
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 208.6;Proximal tubular cells: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		22000000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.8	15.9	4.0	8.3	5.4	8.1	24.9	9.7	9.9	35.3	46.7	3.8	8.0	19.2	10.0	9.8	9.6	5.1	8.5	11.9	4.5	4.1	20.1	36.9	13.0	29.1	4.7	5.6	6.2	24.6	16.1	7.0	23.2	6.5	19.6	28.5	7.6	9.5	13.7	56.1	32.1	63.6	10.9	4.9	37.7	13.1	3.8	3.2	3.3	7.2	18.0	7.6	18.7	24.3	0.1	0.4	31.2	3.2	0.0	0.0	0.5	0.1	1.2	3.0	1.4	22.3	10.1	9.6	5.0	13.5	1.5	3.3	1.6	1.3	0.0	0.7	3.1	4.1	2.4	0.8	2.5	1.3	0.0	2.6	1.1	5.1	4.2	14.3	0.0	0.0	12.3	18.3	1.4	2.7	6.0	2.7	0.0	1.8	0.0	6.2	4.4	0.0	0.1	0.5	28.0	3.9	0.0	5.3	0.1	7.4	2.0	2.2	0.0	0.7	9.1	12.7	2.0	1.5	0.7	5.2	3.0	1.7	0.3	3.2	0.0	0.0	0.0	4.3	2.3	6.7	31.2	1.7	0.4	0.0	1.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.5	4.0	5.4	9.7	9.9	4.5	4.1	4.7	5.6	6.5	3.2	3.0	16.2	2.2	20.4	47.7	2.8	3.6	22.9	5.3	3.4	5.2	3.9	117.9	48.0	19.1	0.1	5.8	208.6	0.0	22.5	35.4	27.9	13.5	9.3	67.1	54.3	3.2	46.8	24.5	86.5	1.1	14.4	9.9	33.7	1.0	51.3	11.4	17.1	87.7	13.4	122.4	5.9	12.9	8.3	0.9	3.9	66.5	96.2	4.3	33.0	12.8
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 24.4;Enterocytes: 33.4;Pancreatic endocrine cells: 24.8;Paneth cells: 43.2;Undifferentiated cells: 29.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.1;CAPAN-2: 17.8;NTERA-2: 13.7;RPMI-8226: 14.3;SK-BR-3: 23.0;T-47d: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		330000	Cytosol	"Golgi apparatus"	"HPA030561: AB_10604095"	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.6	1.2	0.0	0.1	0.0	0.0	23.1	0.0	0.5	0.3	1.7	5.9	17.8	0.8	4.2	0.0	0.3	2.9	1.9	1.6	0.3	0.0	11.8	3.8	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.5	0.2	0.5	0.5	0.1	0.5	0.2	0.0	9.3	0.0	0.4	13.7	2.0	2.1	0.2	0.1	14.3	12.4	4.6	11.9	0.2	0.0	23.0	0.6	2.5	16.6	0.7	0.0	0.0	3.9	0.0	0.0	0.1	6.0	0.3	0.4	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3	8.9	13.2	2.2	2.4	0.1	0.0	0.3	2.5	4.0	15.9	8.7	0.0	2.2	0.0	24.4	0.2	0.1	33.4	0.0	19.9	0.1	0.0	5.5	0.0	0.0	0.3	0.0	19.7	0.6	0.0	0.0	0.0	0.8	0.0	0.0	23.2	0.0	24.8	43.2	0.0	6.7	0.0	0.0	0.8	0.0	0.1	0.1	6.4	1.3	29.8	2.5
SMPX	"DFN6, DFNX4"	ENSG00000091482	"Small muscle protein, X-linked"	Q9UHP9	X	21705972-21758163	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5"	"Cell type enriched"	"Detected in single"	2069	"Cardiomyocytes: 810.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"GAMG: 22.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA077360			Approved	"Plasma membrane"		NA	NA		45000	"Plasma membrane"		"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	1.4	0.0	0.1	0.6	0.1	0.0	0.2	0.6	0.9	0.1	4.0	0.0	0.0	0.1	0.1	4.7	4.0	0.1	0.1	108.8	0.1	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.5	0.0	3.6	0.1	155.8	0.0	0.9	1.8	0.1	0.0	1.5	0.1	0.0	0.0	1.0	74.5	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.9	0.1	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	810.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0
SMS	"MRSR, SPMSY, SpS, SRS"	ENSG00000102172	"Spermine synthase"	P52788	X	21940573-21994835	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Polyamine biosynthesis"	Transferase	"FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 588.3;Distal tubular cells: 515.6;Syncytiotrophoblasts: 727.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029849, HPA029852"	Approved		Approved	"Nuclear bodies,Cytosol"		No	No		26000	"Nuclear bodies"	Cytosol	"HPA029849: AB_10602072, HPA029852: AB_10611521"	"unprognostic (2.51e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (7.49e-4)"	"prognostic unfavorable (7.79e-8)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (7.85e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"	21.7	48.1	29.7	18.7	25.0	18.6	28.4	36.6	35.4	20.8	23.1	8.1	26.0	23.5	20.8	31.3	19.2	13.3	20.9	26.3	22.3	25.0	55.1	19.5	17.6	18.5	25.6	28.5	42.4	16.7	13.6	19.2	63.6	24.2	61.3	24.4	15.7	20.7	20.6	18.0	9.7	25.1	36.8	17.4	18.9	18.8	18.4	11.0	19.6	27.6	11.7	20.8	28.2	16.5	13.2	19.4	37.0	25.7	11.7	20.3	12.3	83.0	21.3	36.2	13.8	9.6	16.3	11.2	22.8	13.6	35.0	33.6	26.3	27.2	30.2	7.9	23.2	96.8	18.3	35.5	41.6	69.4	13.9	16.6	15.6	25.6	18.7	17.7	30.2	13.7	10.7	12.7	36.0	67.7	25.5	33.5	12.2	33.2	4.2	47.8	17.7	22.2	30.2	61.5	18.8	31.6	22.2	24.9	22.9	46.7	11.8	17.3	14.0	18.2	23.4	60.0	96.2	21.1	12.6	29.6	25.4	25.6	52.7	37.0	3.2	6.5	17.9	49.6	13.4	35.2	2.9	21.4	37.0	7.6	22.1	9.4	13.2	12.0	13.2	19.4	8.3	7.9	9.3	21.1	11.7	25.7	4.0	20.3	12.3	29.7	25.0	36.6	35.4	22.3	25.0	25.6	28.5	24.2	11.0	23.8	21.6	43.8	142.7	58.5	33.8	30.5	48.4	48.2	55.7	104.7	11.8	588.3	515.6	219.3	1.6	38.1	67.1	0.0	132.3	261.4	79.8	237.6	39.3	44.0	322.1	20.6	56.6	52.8	131.4	3.6	88.3	123.6	87.7	344.5	84.4	32.3	142.0	65.4	97.2	354.3	33.3	64.7	46.4	5.9	214.2	44.3	727.3	67.0	102.6	134.1
SMU1	"BWD, FLJ10805, fSAP57, SMU-1"	ENSG00000122692	"SMU1, DNA replication regulator and spliceosomal factor"	Q2TAY7	9	33041764-33076659	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019708	Supported		Approved	Vesicles		NA	NA		16000	Vesicles		"HPA019708: AB_1857300"	"unprognostic (2.20e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (4.98e-3)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.67e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.96e-2)"	25.0	20.0	21.7	17.0	22.2	23.3	20.7	29.6	24.5	22.2	18.0	28.3	17.4	14.5	28.3	21.2	18.1	20.6	15.0	17.1	21.3	21.2	19.5	21.9	17.0	19.7	22.1	18.1	26.3	18.7	30.3	26.6	18.2	24.2	21.1	19.1	20.2	20.5	21.0	22.9	21.9	19.6	23.6	23.5	21.0	16.9	16.0	19.5	31.1	24.1	16.5	24.6	20.8	17.7	14.4	21.2	20.7	17.5	12.9	16.5	10.4	16.0	12.7	15.3	13.3	16.7	12.8	12.0	12.6	11.4	17.3	17.2	12.9	6.8	20.4	9.3	15.6	9.4	9.9	19.6	15.1	19.3	23.3	9.4	15.3	22.0	15.0	14.5	26.4	14.5	13.3	17.3	15.9	11.4	13.0	14.4	14.3	14.1	13.1	14.4	7.4	20.6	28.3	21.1	12.1	13.6	17.7	12.7	11.0	13.1	12.1	13.1	11.4	17.0	12.3	7.9	12.5	11.9	9.7	15.4	11.1	12.4	16.1	14.6	5.9	10.8	24.1	12.4	12.5	7.9	20.7	14.9	11.6	14.1	16.0	15.0	14.4	16.0	13.2	16.6	13.7	16.3	16.5	8.7	12.9	17.5	21.2	13.2	10.4	21.7	22.2	29.6	24.5	21.3	21.2	22.1	18.1	24.2	19.5	23.8	28.9	28.1	39.6	47.7	26.6	25.4	28.1	54.9	39.8	19.2	35.3	29.5	18.3	29.2	19.4	33.7	15.9	0.0	21.2	30.4	26.9	27.7	37.1	26.6	27.4	22.3	27.0	23.4	26.4	4.7	30.0	32.1	21.9	31.5	18.7	36.8	23.2	18.4	24.4	25.3	37.1	19.4	32.4	27.7	31.8	50.3	48.3	29.4	20.4	33.1
SMUG1	"FDG, HMUDG, UNG3"	ENSG00000123415	"Single-strand-selective monofunctional uracil-DNA glycosylase 1"	Q53HV7	12	54121277-54189008	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026804, HPA065892"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA026804: , HPA065892: "	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.58e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.73e-1)"	9.5	15.2	17.3	7.0	16.4	4.9	15.5	13.2	16.1	9.8	11.1	11.7	13.5	9.2	9.5	24.1	19.2	14.2	9.2	10.7	15.0	7.8	13.8	23.5	7.8	17.0	11.5	15.0	10.3	23.6	8.3	11.5	14.9	14.4	11.9	10.5	14.2	16.2	10.9	13.6	16.4	16.2	9.2	10.4	11.2	15.2	12.1	14.1	12.6	12.4	6.1	13.1	10.0	9.8	24.2	23.8	38.0	25.0	13.0	20.8	17.0	13.1	24.3	9.6	9.9	17.8	13.9	16.2	10.2	13.4	16.1	14.7	24.3	29.5	7.9	26.2	14.7	15.1	17.3	6.7	26.9	10.4	8.2	14.1	11.8	19.4	17.3	21.3	7.9	14.7	15.9	42.0	18.9	18.8	17.6	12.9	14.1	19.6	17.3	17.6	25.4	9.8	15.4	11.9	22.6	22.0	7.2	9.8	14.2	19.9	19.4	14.3	17.0	11.7	20.2	17.9	20.3	31.5	14.9	6.2	10.8	12.0	9.7	11.6	16.2	12.7	5.3	15.7	6.2	16.3	38.0	25.0	28.7	15.8	19.7	15.7	24.2	15.6	17.0	21.1	18.8	14.1	14.1	24.5	13.0	15.8	23.8	20.8	17.0	17.3	16.4	13.2	16.1	15.0	7.8	11.5	15.0	14.4	14.1	6.0	13.6	25.1	12.2	6.6	9.3	17.5	17.8	29.4	11.4	24.4	7.9	73.8	51.4	31.2	3.9	10.8	34.2	0.0	34.9	84.6	11.8	15.7	2.3	42.7	39.7	6.4	11.1	16.5	16.8	8.1	17.3	14.0	5.0	41.5	23.4	10.0	39.3	24.6	16.6	49.7	9.3	32.3	9.6	25.1	29.2	9.2	83.6	15.0	23.3	16.5
SMURF1	KIAA1625	ENSG00000198742	"SMAD specific E3 ubiquitin protein ligase 1"	Q9HCE7	7	99027438-99144100	"Enzymes, Predicted intracellular proteins"	"Differentiation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019671, HPA055245"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA019671: , HPA055245: AB_2682757"	"unprognostic (2.21e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.62e-2)"	15.0	11.1	8.7	10.5	15.0	23.8	12.4	12.1	16.5	11.8	10.9	20.9	6.9	9.5	11.6	5.7	19.3	10.2	12.5	7.9	9.3	8.4	10.3	10.1	16.0	8.1	15.4	9.4	19.6	22.5	9.0	15.1	15.4	14.9	11.7	10.6	14.3	13.4	9.6	10.7	17.3	10.3	9.8	10.6	9.1	19.5	26.0	11.8	6.6	7.8	6.6	12.7	11.5	13.3	1.2	1.2	2.4	1.9	1.0	2.1	0.6	13.7	7.9	6.4	4.5	5.1	5.4	9.6	7.7	7.4	6.3	5.9	3.9	11.4	4.3	8.4	7.2	13.9	7.5	3.5	10.0	6.5	3.2	3.0	2.3	4.6	3.8	4.8	2.6	5.7	4.8	6.9	9.9	11.5	9.6	5.9	4.2	6.9	7.6	5.8	11.2	4.5	5.4	7.5	7.6	8.5	4.3	6.0	2.6	6.9	11.4	2.8	6.4	7.4	9.8	6.8	11.8	3.1	5.0	8.7	10.0	10.3	17.8	15.4	6.8	4.6	4.5	5.0	5.2	15.4	2.0	1.4	2.3	1.3	1.5	1.6	0.9	2.1	1.3	1.1	1.2	1.2	1.0	2.4	1.0	1.9	1.2	2.0	0.6	8.7	15.0	12.1	16.5	9.3	8.4	15.4	9.4	14.9	11.8	17.9	28.0	5.2	20.4	23.0	25.8	3.9	20.4	20.1	20.5	12.2	7.9	6.1	1.7	13.9	3.7	10.8	7.8	0.0	13.9	8.0	10.1	31.9	2.3	6.7	5.7	25.4	10.9	7.4	3.1	5.3	5.8	8.5	8.5	4.6	8.7	3.7	25.0	10.5	13.1	4.4	6.9	6.5	15.5	41.5	1.0	19.3	17.6	2.5	7.8	65.2
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 75.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 109.6;Cytotrophoblasts: 142.7;Early spermatids: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	"Intermediate filaments,Mitochondria,Cytosol"		NA	NA			Cytosol	"Intermediate filaments, Mitochondria"	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	5.9	5.7	8.8	5.6	7.3	2.7	10.0	5.0	23.9	4.9	4.7	2.1	3.1	4.8	3.8	6.7	7.3	10.4	4.5	75.7	7.0	8.4	7.7	9.7	8.1	8.0	5.3	10.0	4.7	7.8	2.9	7.5	10.6	6.9	4.6	5.8	3.1	6.2	3.0	29.5	4.3	4.7	3.8	4.7	6.2	6.2	8.9	2.2	8.0	7.8	5.1	5.6	5.2	4.0	9.3	5.5	8.1	5.9	17.6	14.5	7.3	24.5	7.1	9.7	6.8	10.0	17.5	41.3	13.9	11.5	17.6	20.0	28.0	21.0	12.7	14.3	15.7	9.6	11.6	9.2	25.8	17.1	10.6	10.7	4.1	12.0	22.3	9.0	17.8	2.9	18.7	14.6	12.2	9.7	12.2	12.7	12.2	12.9	3.2	15.7	12.8	12.4	11.2	8.7	14.4	9.7	7.7	23.5	10.8	17.4	18.0	9.6	22.4	10.8	38.9	28.6	23.3	30.3	11.9	14.6	13.7	20.2	7.5	21.5	13.1	4.9	14.6	17.8	14.2	15.6	6.7	5.9	8.1	9.5	3.2	11.2	9.3	14.5	12.7	5.5	4.8	12.7	11.6	0.6	17.6	1.2	3.8	14.5	7.3	8.8	7.3	5.0	23.9	7.0	8.4	5.3	10.0	6.9	2.2	17.9	11.9	11.2	14.0	18.3	3.8	109.6	22.9	48.2	12.5	3.5	0.0	142.7	26.6	32.4	113.6	10.8	12.7	0.0	17.4	93.2	12.2	8.9	3.5	15.5	33.9	14.3	4.1	22.1	17.4	93.5	10.9	9.9	15.1	10.8	15.2	15.2	22.5	10.5	3.5	27.8	4.6	12.9	15.7	15.2	43.7	15.7	71.9	12.8	20.8	7.6
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 108.5;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 95.1;K-562: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	6.0	12.0	9.9	9.7	16.2	7.6	10.6	25.9	14.7	8.9	6.5	6.4	3.7	4.5	8.7	21.8	6.1	10.0	7.7	5.8	10.3	12.0	8.9	5.5	9.2	6.3	12.0	10.2	8.0	7.2	6.7	11.9	4.6	15.3	6.8	8.3	9.5	5.3	5.9	9.5	6.7	5.2	7.6	6.8	5.3	6.1	10.5	8.1	7.5	18.8	3.6	9.3	8.3	6.6	11.3	5.9	8.3	3.4	19.4	12.9	8.7	4.7	2.9	4.2	3.6	4.8	6.6	4.2	6.7	5.0	7.9	17.8	3.7	5.5	7.7	5.4	6.2	4.9	3.1	3.8	7.5	26.5	4.0	3.9	4.5	4.3	4.5	9.0	4.6	95.1	17.7	1.8	10.4	6.7	6.0	5.4	5.5	35.9	2.7	7.7	1.6	8.7	8.8	3.7	6.6	4.7	8.1	5.1	11.2	5.7	6.9	10.0	4.8	3.1	0.4	6.1	4.7	3.9	7.8	4.1	3.8	2.6	2.7	7.9	13.6	3.7	4.0	7.3	6.3	4.4	8.1	3.4	8.3	10.5	3.0	10.8	11.3	11.1	12.8	5.9	11.1	12.3	12.9	2.4	19.4	3.3	3.8	11.8	8.7	9.9	16.2	25.9	14.7	10.3	12.0	12.0	10.2	15.3	8.1	6.0	27.8	5.3	13.2	10.9	5.8	7.7	2.5	44.2	13.6	12.2	21.6	7.8	13.3	20.6	46.2	11.7	4.2	0.0	28.1	33.5	15.4	5.4	108.5	4.2	10.3	9.5	24.1	9.2	3.8	74.1	10.3	6.0	11.8	1.8	8.3	9.1	16.5	2.9	16.3	14.6	13.9	0.0	15.1	17.3	24.7	10.0	6.1	13.6	9.2	6.4
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	10.6	10.0	8.6	13.8	9.6	4.8	11.0	16.3	11.8	9.9	10.8	9.6	9.6	11.5	15.3	8.7	6.3	10.1	7.1	11.0	6.3	6.1	6.1	7.4	8.5	10.4	7.4	6.7	15.5	21.7	5.4	11.3	7.7	9.2	10.1	8.3	10.7	14.1	15.5	19.3	10.6	12.9	10.0	9.2	10.0	7.6	9.2	8.2	12.8	9.1	5.6	12.2	10.8	12.8	6.1	6.3	11.5	4.3	4.1	7.9	3.0	6.0	11.4	11.5	8.2	7.9	5.4	13.4	9.9	5.7	10.5	10.9	18.1	5.2	16.2	6.7	4.0	7.1	11.8	10.9	6.4	13.2	4.6	11.0	5.9	12.1	4.9	3.9	6.0	5.8	3.8	5.8	10.8	9.6	5.4	5.2	14.0	6.2	6.3	8.2	3.7	10.9	4.2	5.2	7.2	5.6	13.6	5.8	4.1	4.2	7.4	4.7	6.5	9.2	3.8	9.5	9.8	5.5	3.7	5.0	10.3	5.3	8.6	8.5	4.4	5.9	5.8	5.8	5.3	10.1	11.5	3.6	3.2	7.9	4.3	6.5	6.1	4.6	5.0	2.1	3.8	5.3	7.6	2.1	4.1	3.3	6.3	4.8	3.0	8.6	9.6	16.3	11.8	6.3	6.1	7.4	6.7	9.2	8.2	6.0	26.7	8.5	8.1	4.4	19.2	4.5	7.6	17.4	17.0	7.0	31.4	7.8	1.7	4.6	19.6	9.0	8.1	0.0	2.9	8.7	10.3	5.9	7.0	5.9	11.2	25.4	3.5	19.6	13.7	5.1	25.0	14.5	5.0	15.4	4.2	7.0	3.2	0.0	23.3	2.2	19.3	45.3	21.7	13.3	14.9	5.8	6.8	7.5	5.0	3.1
SMYD5	"NN8-4AG, RAI15, RRG1, ZMYND23"	ENSG00000135632	"SMYD family member 5"	Q6GMV2	2	73214222-73227237	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015514, HPA049002"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA015514: AB_2669205, HPA049002: AB_2680595"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.66e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.58e-7)"	"unprognostic (1.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.40e-1)"	13.9	16.5	16.9	14.9	23.6	11.2	20.1	18.3	24.5	14.5	11.3	18.5	16.0	8.3	16.2	23.0	17.0	22.7	9.4	19.1	16.4	18.2	15.9	19.0	10.6	18.3	15.3	15.0	33.4	27.1	22.6	13.9	15.2	15.7	13.4	13.2	17.1	13.4	16.4	16.4	15.0	10.3	16.8	13.1	14.7	9.7	15.7	14.5	9.4	16.4	13.2	17.2	12.4	17.6	6.8	3.2	0.0	4.1	4.2	12.0	4.3	11.7	22.8	13.6	13.0	10.0	14.8	23.2	11.3	11.5	22.0	13.6	29.1	12.1	21.0	10.6	19.0	26.5	12.1	21.0	24.4	20.0	12.7	14.8	20.3	9.2	31.8	13.5	19.9	8.4	12.4	15.8	20.1	24.2	9.8	13.3	16.9	21.4	10.2	13.9	16.5	18.6	13.1	21.2	24.8	18.2	12.5	25.6	17.3	14.4	17.1	8.8	13.2	10.3	15.4	13.0	13.0	12.6	7.1	9.1	15.2	23.9	18.4	18.5	11.2	8.3	18.7	17.1	17.2	12.1	0.0	1.3	0.0	5.5	3.8	12.0	6.5	7.6	7.3	3.2	6.8	7.7	8.3	0.0	4.2	4.1	3.0	3.1	4.3	16.9	23.6	18.3	24.5	16.4	18.2	15.3	15.0	15.7	14.5	3.0	6.4	5.1	3.6	4.5	8.5	6.9	2.5	0.0	5.7	5.2	3.9	7.7	1.7	8.2	0.5	4.3	0.9	0.0	7.6	8.1	3.3	2.3	6.9	4.7	5.2	4.8	0.0	2.5	1.6	2.5	2.6	2.0	5.0	5.4	4.0	3.5	5.0	0.0	2.8	6.8	5.6	6.5	3.1	6.5	10.8	3.0	4.0	2.5	5.0	3.0
SNAI2	"SLUG, SLUGH, SLUGH1, SNAIL2"	ENSG00000019549	"Snail family transcriptional repressor 2"	O43623	8	48917604-48921740	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Deafness, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Basal glandular cells: 113.7;Basal keratinocytes: 144.6;Fibroblasts: 122.9;Ito cells: 49.1;Leydig cells: 68.1;Melanocytes: 82.7;Peritubular cells: 63.3;Sertoli cells: 51.8;Smooth muscle cells: 149.4;Suprabasal keratinocytes: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.8;ASC TERT1: 57.5;HSkMC: 42.4;hTERT-HME1: 39.6;LHCN-M2: 52.5;U-138 MG: 48.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB011671	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011671: AB_777968"	"unprognostic (3.52e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.83e-4)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (4.69e-8)"	"unprognostic (1.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.16e-4)"	13.9	6.1	1.0	13.7	1.4	0.0	60.3	4.8	1.8	52.9	7.8	2.0	14.4	2.2	31.3	17.3	15.6	20.7	12.8	12.5	1.0	0.8	17.8	4.8	6.7	14.2	1.9	1.6	27.6	5.8	1.2	2.5	11.5	3.4	34.4	4.6	20.5	11.0	18.8	6.1	21.7	6.3	21.7	3.9	10.6	5.5	9.0	0.9	4.7	6.0	11.6	8.2	22.4	37.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.7	0.1	9.4	0.0	55.8	57.5	0.0	8.7	14.9	8.7	11.9	0.0	3.8	0.0	0.0	10.9	13.0	6.5	0.0	25.6	9.6	0.0	0.1	0.0	2.0	0.0	19.7	0.0	0.0	42.4	26.9	7.3	39.6	1.2	0.2	0.0	0.0	4.0	52.5	0.0	0.0	0.0	0.4	0.0	7.4	0.0	26.6	0.0	0.0	1.5	1.1	0.8	0.7	0.0	13.6	4.4	0.0	0.0	2.3	48.1	1.6	8.0	4.4	0.0	0.0	0.8	16.8	0.0	16.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	4.8	1.8	1.0	0.8	1.9	1.6	3.4	0.9	0.0	0.0	0.0	113.7	144.6	1.1	0.8	0.0	0.0	9.1	0.0	0.0	1.5	0.0	3.4	0.5	9.0	0.0	0.0	2.1	0.4	122.9	18.4	0.0	5.5	1.4	0.0	0.0	49.1	1.0	0.6	68.1	0.8	82.7	0.0	0.0	0.0	5.1	0.0	63.3	0.0	0.1	51.8	149.4	0.2	0.2	129.4	1.8	0.0	0.0	11.1
SNAI3	"SMUC, Zfp293, ZNF293"	ENSG00000185669	"Snail family transcriptional repressor 3"	Q3KNW1	16	88677682-88686493	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;skeletal muscle: 33.9"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 8.0;granulocytes: 9.2;Hofbauer cells: 7.0;Kupffer cells: 14.2;Macrophages: 10.3;T-cells: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NB-4: 14.7;RPMI-8226: 23.2"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected"	"Not detected"			HPA071127			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071127: AB_2686346"	"unprognostic (1.03e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.19e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.09e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.47e-2)"	0.9	0.8	2.4	6.3	2.3	2.3	0.8	1.9	2.9	1.3	3.4	2.1	0.2	2.2	0.8	1.3	1.3	1.4	2.6	2.4	2.5	1.7	1.3	1.0	5.3	4.5	3.1	0.8	1.5	6.1	2.1	1.0	0.9	2.2	1.6	0.8	1.4	3.6	0.7	33.9	1.1	4.6	1.1	2.4	9.2	3.5	2.1	2.2	2.1	3.0	9.5	13.0	2.7	2.4	4.6	9.2	25.5	7.7	0.5	11.6	5.4	0.2	0.8	0.2	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	2.9	0.2	1.9	0.5	0.0	0.7	0.6	0.2	0.2	0.0	0.3	1.1	0.9	0.1	0.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	1.7	3.6	0.0	2.6	0.1	14.7	0.3	0.3	0.3	3.2	0.2	23.2	0.0	0.4	1.4	0.2	0.6	0.0	0.2	0.4	1.0	1.8	0.3	0.1	0.9	0.2	0.0	0.6	3.3	3.3	0.2	4.0	0.4	2.8	7.7	25.5	6.1	2.9	10.9	4.6	9.9	5.7	9.2	3.8	6.1	3.8	17.1	0.5	0.7	6.5	11.6	5.4	2.4	2.3	1.9	2.4	2.5	1.7	3.1	0.8	2.2	2.2	3.0	0.0	8.0	0.1	0.5	0.2	2.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.1	9.2	0.0	7.0	0.0	0.0	0.6	14.2	0.0	0.0	10.3	5.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.8	0.0	1.1	0.3	0.1	10.9	0.0	0.0
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10218830-10307418	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 356.9"	"Cell type enhanced"	"Detected in many"	23	"Bipolar cells: 497.2;Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 186.3"	"Group enriched"	"Detected in many"	6	"glioma: 28.9;pancreatic cancer: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"Karpas-707: 11.0;SCLC-21H: 36.6;SH-SY5Y: 21.8;U-87 MG: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.64e-3)"	"unprognostic (7.26e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-7)"	"unprognostic (6.86e-3)"	"unprognostic (5.87e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-2)"	2.2	16.4	81.0	3.3	60.0	2.1	3.4	202.9	356.9	2.2	2.8	3.4	3.7	3.2	4.6	6.4	2.2	4.0	2.8	2.4	86.5	37.1	2.5	2.3	2.6	2.2	46.7	65.2	3.7	4.1	2.1	5.5	2.3	97.7	3.1	2.8	4.0	2.2	11.9	2.1	2.2	3.3	4.7	13.9	2.1	4.3	3.2	7.4	0.0	2.3	0.0	2.2	2.6	0.1	0.0	1.6	0.7	0.0	0.0	0.6	0.3	0.0	2.1	1.8	0.0	0.2	0.0	0.0	0.9	0.0	2.2	0.6	0.0	0.0	0.0	2.0	0.0	1.6	0.4	0.2	0.0	4.5	0.2	0.1	0.0	3.0	0.3	1.6	0.0	0.2	2.1	0.0	1.8	0.0	5.0	0.0	1.3	0.0	11.0	0.7	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.4	0.0	36.6	21.8	0.3	0.0	0.0	1.1	0.0	2.9	0.0	2.3	3.1	0.0	1.0	0.0	5.6	0.0	26.3	0.0	2.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.3	81.0	60.0	202.9	163.5	86.5	37.1	46.7	65.2	97.7	7.4	0.0	0.0	0.0	1.7	0.7	497.2	0.4	7.6	0.0	0.0	0.0	100.1	0.0	0.0	0.1	16.5	0.6	0.0	0.0	0.0	0.1	1.0	0.5	0.0	0.0	0.1	62.0	41.6	0.0	0.0	56.7	15.8	0.2	1.7	0.0	0.0	42.9	1.6	0.2	64.7	1.4	186.3	0.0	1.0	0.9	0.3	0.6	0.0	0.0	0.0	0.0
SNAP47	"C1orf142, SNAP-47, SVAP1"	ENSG00000143740	"Synaptosome associated protein 47"	Q5SQN1	1	227728539-227781231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028167	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA028167: AB_10603032"	"unprognostic (3.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-1)"	7.4	23.8	21.2	10.8	27.8	6.7	16.2	21.2	29.0	12.4	10.0	10.7	6.9	8.3	21.3	13.4	10.8	15.7	9.8	30.7	21.0	15.1	11.9	14.7	10.0	13.5	12.9	17.4	29.5	17.1	20.7	15.8	16.2	11.6	11.3	8.5	12.6	14.8	10.4	20.4	11.2	8.0	16.6	8.4	9.0	9.2	25.5	11.4	11.6	15.6	9.2	11.9	11.5	9.9	15.4	14.7	20.2	15.1	18.2	29.8	14.7	17.3	24.1	15.2	14.5	18.7	14.7	19.5	11.3	18.1	18.5	15.5	15.9	16.1	12.5	20.7	18.2	14.9	19.1	19.3	21.4	15.9	24.5	34.2	10.7	17.0	10.8	11.5	15.5	9.8	16.8	17.8	24.0	12.9	16.3	15.5	15.1	19.4	12.9	19.1	11.4	15.6	14.8	24.2	22.9	35.0	17.6	17.1	19.3	13.4	15.9	30.2	17.8	17.4	24.6	17.0	16.6	29.8	15.0	11.6	17.6	21.2	16.9	27.5	16.3	11.8	15.2	16.0	12.1	22.4	10.1	13.0	20.2	19.2	12.4	18.4	15.4	21.8	22.0	14.3	13.9	18.6	17.0	4.7	18.2	15.1	14.7	29.8	14.7	21.2	27.8	21.2	29.0	21.0	15.1	12.9	17.4	11.6	11.4	6.0	12.5	22.7	14.5	11.8	28.6	10.1	12.7	9.4	11.4	14.0	25.5	21.8	29.9	17.7	39.1	9.0	8.9	0.0	15.7	23.8	13.7	11.9	5.7	11.6	14.4	39.7	15.5	9.2	6.7	71.2	23.9	6.4	11.8	23.4	7.5	28.1	14.4	0.0	19.4	14.6	31.0	12.9	10.3	24.5	23.0	13.4	23.0	22.0	9.5	8.4
SNAPC2	"PTFdelta, SNAP45"	ENSG00000104976	"Small nuclear RNA activating complex polypeptide 2"	Q13487	19	7920316-7923250	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049843, HPA077597"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049843: AB_2680910, HPA077597: AB_2732354"	"unprognostic (4.56e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.78e-2)"	12.5	15.1	11.0	14.2	17.1	20.3	12.0	19.3	19.8	30.8	20.0	13.2	11.9	14.2	32.4	11.8	20.3	21.8	12.1	12.1	11.7	11.6	15.6	11.1	12.3	12.4	10.6	13.6	24.2	15.1	12.0	16.5	13.6	12.2	24.8	6.0	10.8	18.0	27.0	8.1	16.4	11.3	22.8	9.1	14.8	11.9	28.7	12.3	18.3	17.5	10.4	11.4	29.9	16.1	11.5	20.1	14.7	20.9	17.7	15.5	10.4	9.1	10.7	5.1	19.7	7.0	15.1	4.6	9.7	10.5	9.7	8.8	4.9	8.0	7.9	12.2	11.4	7.7	11.3	3.5	7.3	2.8	10.1	9.0	11.0	4.7	6.9	12.8	6.8	18.3	12.3	11.3	11.4	7.0	7.9	11.0	8.4	10.8	13.3	5.9	8.1	8.7	19.5	6.4	4.7	23.8	10.4	5.0	7.8	8.9	3.2	6.0	13.4	5.0	5.5	21.8	2.3	8.9	7.5	14.1	32.8	11.6	30.6	12.1	12.7	20.8	4.8	20.5	14.3	10.3	4.5	16.4	14.7	13.7	20.9	13.7	11.5	11.7	11.8	20.1	11.0	12.2	12.2	2.4	17.7	20.7	13.3	15.5	10.4	11.0	17.1	19.3	19.8	11.7	11.6	10.6	13.6	12.2	12.3	3.0	3.0	13.5	18.0	21.6	7.9	2.6	7.6	0.0	3.4	10.4	0.0	10.4	14.9	20.2	1.4	15.7	11.6	0.0	21.1	18.3	26.1	27.3	18.4	4.7	26.0	22.3	11.5	11.6	20.4	5.2	12.7	24.4	18.6	41.5	10.5	5.7	22.2	3.5	13.4	12.9	5.4	12.9	30.3	8.6	21.2	21.2	8.2	21.9	12.0	19.5
SNAPC3	"MGC132011, MGC33124, PTFbeta, SNAP50"	ENSG00000164975	"Small nuclear RNA activating complex polypeptide 3"	Q92966	9	15422704-15465953	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 98.3;Late spermatids: 162.5;Spermatocytes: 125.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053145, HPA066031"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA053145: AB_2682055, HPA066031: AB_2685600"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.93e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.09e-2)"	9.8	18.5	18.7	10.3	21.1	4.6	10.4	26.3	21.2	17.9	13.2	10.4	10.3	11.6	16.5	15.5	12.6	10.8	10.8	17.5	18.0	14.0	12.3	8.6	10.0	11.2	15.2	16.3	17.4	11.1	12.8	18.4	16.7	21.8	13.3	14.6	9.6	10.5	11.3	19.3	13.7	14.2	12.8	15.2	12.8	10.5	14.7	15.9	11.9	11.3	6.8	10.8	12.9	15.1	12.2	7.7	5.0	21.2	5.0	8.2	5.5	3.9	5.1	10.8	4.1	8.7	9.1	6.3	6.2	2.8	3.7	4.4	2.4	1.7	2.8	2.4	3.9	5.2	2.4	5.7	2.9	4.6	13.1	6.7	10.1	10.8	3.3	4.3	2.2	7.8	5.9	5.9	2.6	3.0	15.7	6.8	6.7	2.8	4.6	8.4	1.2	2.7	7.2	3.4	3.0	13.5	5.5	1.3	1.5	6.4	2.4	11.6	8.2	2.1	1.9	1.4	9.9	4.6	4.6	5.6	6.2	2.5	2.6	7.9	6.1	7.3	3.5	4.0	3.0	2.8	3.4	10.1	5.0	5.7	16.7	5.5	9.9	5.7	5.1	7.7	12.2	8.2	7.9	1.2	5.0	21.2	6.3	7.9	5.5	18.7	21.1	26.3	21.2	18.0	14.0	15.2	16.3	21.8	15.9	17.9	11.0	17.8	12.4	8.5	19.2	37.1	5.1	13.4	5.7	19.2	29.5	10.6	11.6	16.6	98.3	16.4	21.6	0.0	8.2	10.8	16.4	10.3	17.3	12.4	13.8	33.4	14.5	19.0	22.1	162.5	31.4	10.0	18.6	17.2	14.1	15.1	11.3	27.7	28.7	24.2	17.8	12.9	21.7	125.8	27.9	10.5	8.1	17.1	16.2	10.2
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046627, HPA073243"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.8	5.8	7.6	9.5	15.4	12.7	7.6	20.1	19.4	8.0	6.6	10.9	8.7	9.5	9.9	10.1	6.6	14.5	9.2	6.3	10.1	8.0	8.6	11.5	8.0	10.8	7.7	10.1	11.2	17.8	13.4	13.3	6.7	10.4	9.1	7.2	11.8	10.8	8.5	7.2	13.5	7.8	8.0	8.2	11.7	8.1	20.0	10.2	11.2	10.0	5.7	10.2	9.4	7.1	3.4	1.7	3.7	1.6	2.3	2.6	0.6	6.1	7.2	7.4	10.3	4.8	9.4	13.7	8.0	5.4	8.5	6.8	16.5	5.7	9.5	5.8	6.3	5.9	20.0	9.0	10.4	5.1	13.3	14.1	6.4	18.3	7.8	4.3	13.5	7.7	7.4	8.7	7.3	7.0	7.4	7.5	7.9	13.1	7.1	5.9	13.8	7.8	15.2	15.4	9.8	9.5	12.8	7.5	13.5	4.9	11.2	21.5	15.0	8.1	13.4	4.3	6.7	13.7	7.9	10.6	8.8	8.0	15.7	11.4	4.4	5.1	7.7	6.1	6.3	5.1	0.0	1.6	1.3	2.6	1.3	1.2	2.0	1.1	1.1	0.6	3.4	0.9	0.7	3.7	2.3	0.5	1.7	0.9	0.6	7.6	15.4	20.1	19.4	10.1	8.0	7.7	10.1	10.4	10.2	6.0	7.0	2.9	1.9	4.7	7.5	3.2	2.5	17.4	3.4	3.5	2.0	2.4	0.0	5.9	2.6	3.6	3.6	23.3	3.8	1.7	2.7	2.2	1.1	6.4	2.8	3.2	5.1	5.5	1.6	1.5	4.6	2.8	0.0	1.0	5.2	4.8	5.3	6.0	4.6	4.2	11.5	0.0	2.3	8.6	8.8	5.9	1.1	3.2	5.6	2.8
SNAPIN	"BLOC1S7, BORCS3, SNAPAP"	ENSG00000143553	"SNAP associated protein"	O95295	1	153658654-153661830	"Predicted intracellular proteins, Transporters"	"Exocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046974	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA		15000	"Golgi apparatus"	Nucleoli	"HPA046974: AB_10962506"	"unprognostic (3.65e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.31e-3)"	"unprognostic (4.89e-2)"	21.8	32.5	20.2	14.5	25.9	8.4	30.2	12.1	26.3	17.5	19.2	18.5	17.2	9.1	19.7	25.0	20.7	20.4	21.4	38.1	17.4	17.7	21.8	22.1	15.7	26.1	21.6	17.8	17.9	22.9	18.0	10.8	14.5	20.5	17.9	14.7	15.6	14.1	22.6	56.9	16.1	13.2	24.9	22.1	19.4	16.0	16.5	20.8	18.1	19.9	29.8	21.7	19.6	13.9	42.4	50.8	44.6	49.9	35.4	42.8	42.8	20.1	24.8	21.1	12.7	27.0	18.1	13.6	17.1	19.0	24.3	18.5	17.6	16.2	14.5	34.6	17.4	11.9	27.0	17.3	22.3	17.0	19.3	23.9	16.0	19.1	8.4	27.9	15.7	10.2	21.7	16.7	18.1	20.7	24.5	22.7	17.0	13.6	11.2	24.3	32.6	17.9	9.2	11.4	31.7	26.7	17.1	18.4	38.3	26.8	19.4	16.1	28.2	19.7	22.9	22.4	20.7	34.8	16.8	20.0	11.3	17.3	22.4	16.0	27.3	29.8	22.1	21.6	9.9	14.7	27.6	49.9	44.6	30.9	49.1	35.0	42.4	31.4	31.0	50.8	36.9	34.8	31.8	10.4	35.4	39.0	38.1	42.8	42.8	20.2	25.9	12.1	26.3	17.4	17.7	21.6	17.8	20.5	20.8	17.9	17.6	24.3	31.9	18.3	13.6	35.0	22.9	36.1	22.7	27.9	7.9	54.7	63.0	60.4	5.7	30.1	18.8	0.0	57.1	40.8	26.9	29.4	30.0	25.5	77.8	20.6	13.3	31.9	48.5	18.5	28.4	40.8	25.3	91.0	20.8	57.6	41.2	25.7	46.7	60.8	17.2	45.3	38.2	29.6	39.2	20.6	61.7	26.6	25.6	33.4
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.9;breast: 19.6"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 5.0;Pancreatic endocrine cells: 9.1;Proximal tubular cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 6.3"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 36.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA052824	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA052824: AB_2681964"	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.4	1.5	4.8	0.8	6.4	1.5	19.6	2.8	9.0	0.3	2.4	9.3	0.0	2.7	0.7	2.0	0.3	0.4	0.3	0.4	8.8	7.8	1.2	2.1	1.3	1.7	11.9	7.0	0.5	4.2	0.7	0.3	0.9	9.1	3.0	1.1	0.0	3.2	0.6	2.8	10.8	2.0	0.6	27.9	1.4	1.3	6.2	7.4	0.0	0.9	0.0	0.5	0.5	0.0	0.0	0.0	6.3	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.9	0.6	1.0	1.5	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.4	0.1	0.3	0.3	0.0	0.0	0.0	0.4	1.3	0.3	0.2	36.4	0.5	0.0	1.1	0.0	0.9	0.2	0.5	0.4	1.0	0.4	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	1.4	0.2	0.3	0.2	0.0	0.5	0.1	0.5	0.2	0.0	1.3	0.6	0.0	1.6	0.5	0.1	0.5	0.5	0.4	2.4	2.5	0.1	0.0	0.8	0.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.4	2.8	9.0	8.8	7.8	11.9	7.0	9.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.5	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 86.5;Sertoli cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 51.9;TIME: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	31.5	8.8	9.8	13.1	14.4	41.0	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11.0	11.0	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18.0	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17.0	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3.0	20.9	5.5	8.1	10.7	6.5	3.3	2.0	3.8	3.6	11.3	4.0	3.6	3.6	6.1	3.9	3.8	2.8	4.8	5.3	2.8	4.5	2.6	2.1	4.4	7.7	4.1	6.0	3.6	6.0	3.8	3.2	5.9	6.7	6.7	4.5	5.3	4.4	7.5	4.0	51.9	6.1	2.6	6.1	3.5	1.7	6.8	5.9	4.2	1.8	9.3	4.7	2.8	5.5	10.1	5.7	2.7	5.6	3.1	3.3	4.3	3.4	2.3	8.6	30.2	3.4	3.5	3.9	4.1	9.9	7.1	4.5	2.4	8.1	4.9	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3.0	3.2	10.1	10.1	20.9	8.1	5.0	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11.0	11.0	11.4	10.6	22.5	7.2	29.8	30.3	12.9	9.7	46.9	49.8	14.5	22.9	16.0	18.2	15.7	15.7	6.3	10.0	9.2	40.0	52.3	28.4	0.0	7.8	2.7	11.8	9.9	13.9	21.3	11.3	28.6	10.4	86.5	27.6	4.9	11.5	16.6	21.9	4.6	8.9	15.6	8.4	8.2	11.0	10.4	17.2	122.9	26.4	10.7	15.7	44.8	6.9	41.7	8.5	15.4
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53010-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.9;skeletal muscle: 63.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: AB_2677353, HPA044248: AB_2678873"	"unprognostic (7.87e-2)"	"prognostic favorable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	7.1	10.1	31.4	11.5	25.4	15.6	7.4	15.7	31.2	7.1	9.7	6.8	5.4	7.2	6.6	9.6	8.8	8.8	6.3	28.7	25.0	22.6	11.7	16.4	5.4	16.4	28.1	20.3	10.9	10.8	7.7	10.8	4.9	24.7	9.8	10.1	7.5	12.6	8.4	63.7	4.3	6.4	8.6	13.5	6.6	10.2	6.4	7.7	9.4	9.4	11.0	16.4	6.8	4.8	18.0	56.9	23.2	9.9	5.2	6.5	5.7	11.6	26.5	14.7	17.1	5.3	6.3	7.2	9.9	6.4	22.2	18.8	35.6	11.4	37.0	11.8	8.1	11.9	12.0	26.9	18.2	17.1	13.3	20.9	21.4	37.0	35.6	5.6	39.1	25.5	8.0	6.5	19.7	5.5	4.8	11.9	22.4	32.0	8.8	12.6	55.2	20.5	16.3	17.6	20.8	13.0	33.1	15.7	44.2	11.7	8.2	16.2	10.5	22.3	29.0	4.8	15.1	18.7	19.1	9.3	9.8	12.3	12.6	15.8	9.2	21.7	57.4	5.2	21.0	15.0	2.8	6.6	23.2	4.0	9.9	5.0	17.5	4.2	4.9	12.8	18.0	4.5	4.5	4.5	5.2	8.5	56.9	6.5	5.7	31.4	25.4	15.7	31.2	25.0	22.6	28.1	20.3	24.7	7.7	11.9	11.0	47.7	21.4	16.6	18.1	96.8	15.3	44.2	9.1	31.4	3.9	47.2	132.6	34.7	1.7	16.8	21.9	23.3	44.3	49.4	26.3	35.5	4.6	52.5	99.3	11.1	42.3	11.6	18.6	4.5	19.8	52.0	59.1	138.9	29.1	45.5	30.9	42.9	28.0	74.2	12.0	6.5	32.0	32.0	47.5	19.2	21.9	20.1	45.1	16.3
SNRNP27	"RY1, U4/U6.U5-27K"	ENSG00000124380	"Small nuclear ribonucleoprotein U4/U6.U5 subunit 27"	Q8WVK2	2	69893560-69905575	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034541	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034541: AB_10602408"	"unprognostic (2.24e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.89e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	20.4	24.3	35.1	15.8	28.0	25.9	19.3	25.4	27.3	14.4	12.9	18.3	12.7	12.6	17.2	19.2	13.7	13.7	15.3	27.2	27.5	28.4	17.5	16.9	13.8	20.8	28.7	23.2	16.5	12.7	18.7	26.5	20.6	22.7	17.6	15.0	12.1	14.4	14.4	73.7	14.1	14.6	16.4	31.4	15.1	12.7	9.8	21.9	15.1	18.9	12.3	18.7	15.4	20.1	24.1	26.6	23.6	16.9	19.4	19.7	14.9	10.7	5.8	19.4	12.1	17.2	18.8	15.8	14.8	17.0	20.0	16.4	12.4	12.1	10.7	12.6	11.4	21.4	6.3	12.4	5.8	26.1	12.7	13.3	13.3	6.0	16.0	16.0	16.0	23.5	13.3	14.2	13.5	11.7	17.2	15.6	17.0	17.5	19.2	26.4	5.8	22.6	29.1	14.9	11.6	6.5	18.0	16.5	11.8	23.0	7.0	20.3	16.4	11.1	12.3	16.4	15.5	11.0	13.6	9.9	15.3	20.7	20.8	22.2	11.9	11.4	17.8	13.7	19.8	28.2	22.5	16.9	23.6	16.3	14.8	17.0	24.1	17.7	15.6	13.7	21.0	19.7	19.3	9.0	19.4	14.7	26.6	18.8	14.9	35.1	28.0	25.4	27.3	27.5	28.4	28.7	23.2	22.7	21.9	50.6	38.3	74.4	35.1	43.6	30.5	52.0	45.9	54.9	34.2	59.3	13.7	41.3	63.0	54.7	23.4	36.9	31.8	23.3	47.8	49.9	48.9	30.4	56.8	71.5	49.6	22.3	37.4	52.8	53.1	8.5	47.5	52.7	35.4	43.3	39.6	35.8	50.5	42.1	54.5	41.9	29.5	38.8	46.7	71.9	58.1	40.3	43.9	49.8	34.9	32.9
SNRPB2	"Msl1, U2B''"	ENSG00000125870	"Small nuclear ribonucleoprotein polypeptide B2"	P08579	20	16729961-16742563	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 82.5"					"Low region specificity"	"Detected in all"			"HPA050814, HPA076104"	Supported		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA050814: AB_2681245, HPA076104: AB_2732301"	"unprognostic (4.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.45e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (4.23e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.77e-1)"	27.1	29.4	30.8	29.9	31.5	46.6	32.4	23.2	33.3	25.1	28.6	18.3	19.5	24.7	33.5	37.9	25.4	28.2	22.8	30.9	31.0	29.7	45.4	30.2	24.7	39.9	28.7	33.0	33.4	21.5	19.7	41.9	35.2	25.5	25.9	28.1	16.9	23.0	25.5	34.7	18.4	30.1	31.8	30.8	36.0	27.0	24.3	28.3	40.8	33.1	31.1	35.7	34.1	22.7	21.2	29.8	29.0	24.5	19.8	30.6	18.1	16.2	16.0	21.1	13.1	10.6	13.3	23.5	16.1	13.5	17.6	17.3	18.3	18.4	26.1	12.6	13.7	26.9	15.3	16.6	18.8	25.2	8.5	13.9	24.1	5.3	33.7	12.4	28.1	16.6	13.2	12.6	16.0	12.6	13.1	16.4	17.9	19.8	11.9	17.9	16.9	32.1	34.1	18.8	82.5	21.5	18.5	25.3	18.3	17.0	11.0	11.2	32.1	11.9	32.9	79.2	16.3	20.8	23.0	13.9	16.1	16.0	14.4	26.4	10.5	21.5	29.1	7.6	16.8	34.7	26.5	19.5	29.0	19.3	24.3	24.8	21.2	24.5	21.8	20.5	19.6	21.5	23.5	8.4	19.8	24.5	29.8	30.6	18.1	30.8	31.5	23.2	33.3	31.0	29.7	28.7	33.0	25.5	28.3	41.7	50.5	143.6	137.9	79.1	29.0	59.3	107.0	71.0	58.0	89.0	0.0	243.3	182.4	155.3	65.1	101.3	71.8	70.0	147.1	239.3	108.5	97.4	130.4	123.8	197.4	46.1	89.6	143.6	159.1	15.7	159.9	140.9	104.6	180.3	95.5	72.9	145.9	94.3	146.3	288.9	20.2	97.0	116.0	149.2	137.1	83.9	315.1	173.0	100.5	144.0
SNRPG	Sm-G	ENSG00000143977	"Small nuclear ribonucleoprotein polypeptide G"	P62308	2	70281362-70293771	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064152, HPA067814"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064152: AB_2685199, HPA067814: AB_2685903"	"unprognostic (6.42e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (4.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.41e-2)"	24.8	40.2	22.8	36.4	26.4	40.3	34.8	16.7	23.1	21.1	34.3	14.3	29.0	25.5	25.4	42.8	40.3	19.5	28.5	33.6	24.0	18.6	35.2	38.9	25.5	36.3	30.5	25.0	22.7	37.7	10.0	29.5	36.1	27.4	22.8	32.8	16.7	38.9	33.2	57.3	17.6	26.0	24.6	34.0	33.8	26.1	33.9	27.9	33.8	28.8	42.2	36.6	22.1	47.3	51.2	69.6	43.1	55.0	33.2	57.2	63.6	48.9	51.4	53.0	30.6	19.1	20.6	47.6	32.2	28.9	42.5	39.6	88.6	32.7	44.0	24.5	25.0	52.2	32.5	52.1	44.4	45.7	40.7	51.0	58.4	35.1	109.4	25.4	73.6	41.9	18.3	25.2	40.0	39.8	17.4	42.7	38.0	77.8	32.5	33.4	58.3	63.8	118.2	57.0	60.5	42.9	43.5	65.2	51.6	60.5	45.7	30.5	27.2	29.8	25.6	35.5	33.7	25.7	60.1	29.3	30.5	58.6	31.9	64.2	25.5	26.5	90.0	27.4	63.3	33.1	31.0	43.8	43.1	40.4	55.0	40.7	51.2	56.0	46.3	51.0	40.9	45.6	53.7	21.9	33.2	54.9	69.6	57.2	63.6	22.8	26.4	16.7	23.1	24.0	18.6	30.5	25.0	27.4	27.9	187.6	179.7	207.0	263.9	265.7	86.8	143.2	165.6	295.8	176.3	191.9	31.4	575.2	452.6	350.1	21.6	194.3	190.4	163.5	341.1	649.7	230.3	272.1	204.8	326.8	339.5	62.0	179.0	173.1	183.0	38.3	162.8	237.5	212.6	352.5	202.6	251.2	356.9	212.7	149.6	501.2	70.3	181.1	181.0	261.1	342.4	278.2	436.2	244.5	250.8	301.5
SNRPN	"HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN"	ENSG00000128739	"Small nuclear ribonucleoprotein polypeptide N"	P63162	15	24823637-24978723	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 388.0;Horizontal cells: 314.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 117.7;SuSa: 79.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003482, HPA067842"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (9.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.59e-2)"	"prognostic favorable (8.93e-8)"	"unprognostic (4.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.74e-2)"	7.9	35.1	62.2	7.8	73.4	5.6	13.0	65.6	74.7	21.4	9.4	18.4	14.2	6.5	11.6	64.8	8.0	22.8	25.9	84.7	55.9	68.3	35.8	12.4	13.0	14.9	51.3	47.4	28.4	20.3	49.8	42.8	6.5	51.6	33.0	6.4	17.3	22.4	29.1	34.9	6.3	7.9	10.9	31.9	13.3	10.3	9.6	21.3	9.9	55.5	6.8	14.1	12.9	7.8	48.6	71.0	23.6	9.6	36.3	73.7	67.3	0.1	21.5	39.4	27.0	23.3	10.6	0.1	7.1	14.6	4.7	8.7	19.9	10.2	0.0	14.0	17.1	7.2	4.0	0.0	20.9	2.7	11.8	0.0	13.0	13.8	21.3	27.6	15.5	11.7	20.1	8.9	10.3	12.2	31.9	14.0	27.7	3.5	0.0	26.9	0.0	31.0	0.2	117.7	0.0	9.1	16.2	14.9	0.0	25.4	32.3	23.3	22.3	0.1	0.5	25.2	79.9	13.9	39.9	9.4	11.9	12.2	0.0	4.2	33.2	17.8	20.4	10.0	10.6	8.9	23.6	9.3	13.7	44.6	9.5	49.9	48.6	55.2	50.6	8.7	45.1	73.7	60.6	2.5	36.3	9.6	71.0	55.4	67.3	62.2	73.4	65.6	74.7	55.9	68.3	51.3	47.4	51.6	21.3	8.9	39.2	89.8	86.5	1.9	173.2	156.1	188.5	45.5	38.7	169.3	49.1	1.2	388.0	144.4	79.6	44.3	9.8	0.0	71.7	1.1	38.2	150.5	61.2	26.3	51.9	314.6	137.0	52.8	26.7	74.6	71.7	25.3	0.0	55.1	35.3	123.5	61.4	31.3	109.6	212.5	75.0	51.8	47.2	58.4	44.8	1.5	1.4	76.2	21.6	54.7
SNTB2	"D16S2531E, EST25263, SNT2B2, SNT3, SNTL"	ENSG00000168807	"Syntrophin beta 2"	Q13425	16	69187129-69309052	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 187.1;Rod photoreceptor cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001394			Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA001394: AB_1080170"	"unprognostic (4.86e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-3)"	"unprognostic (6.46e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.88e-1)"	20.7	8.4	5.8	10.2	7.9	3.8	13.4	5.3	9.4	22.9	12.2	4.5	13.3	5.5	17.8	10.9	16.1	13.0	10.4	8.6	4.8	3.2	14.1	5.8	12.7	7.2	4.8	4.8	13.9	6.6	31.9	7.2	7.4	5.3	16.7	7.8	26.0	8.3	8.4	8.8	12.7	9.6	15.7	5.0	8.6	9.3	10.5	4.0	6.4	22.8	6.8	7.5	18.3	20.2	1.0	0.6	3.0	1.0	2.6	3.7	0.9	4.0	6.2	4.3	3.4	16.0	21.6	5.3	8.0	11.2	6.3	7.0	6.1	3.7	5.1	4.9	9.3	3.3	7.4	5.8	3.9	8.2	2.2	3.2	2.2	6.1	5.2	5.3	0.1	3.4	15.4	2.9	10.3	4.2	6.6	18.8	1.4	1.3	8.0	7.6	4.6	1.7	0.7	2.9	2.4	5.0	10.1	3.8	9.5	3.3	6.2	1.6	3.6	24.5	3.5	2.5	3.4	4.1	0.3	14.6	11.9	5.7	8.3	7.4	1.8	2.8	5.8	7.6	0.8	5.4	1.1	1.0	1.0	3.2	1.0	3.3	1.0	1.6	1.8	0.6	0.8	1.0	3.7	3.0	2.6	1.0	0.4	1.6	0.9	5.8	7.9	5.3	9.4	4.8	3.2	4.8	4.8	5.3	4.0	17.9	9.4	7.8	23.9	33.8	22.9	6.5	2.5	5.3	7.9	26.2	39.3	8.1	3.3	9.2	20.9	65.9	17.4	0.0	21.0	7.0	31.2	42.1	1.1	9.7	6.1	4.8	9.9	84.7	22.9	21.8	54.7	10.1	28.7	1.8	17.0	187.1	14.1	24.6	61.2	27.4	126.8	6.5	39.2	22.7	8.3	33.9	3.1	21.0	16.8	25.9
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	30.5	23.4	20.3	24.0	24.8	59.5	28.3	32.1	26.2	26.1	27.6	29.6	21.5	24.6	32.5	24.3	29.1	25.4	20.5	26.3	20.6	18.3	23.5	25.3	24.8	31.5	23.9	26.7	32.1	26.5	19.8	31.6	32.3	26.8	29.8	24.9	22.3	23.4	17.6	41.8	33.3	30.7	30.8	23.7	32.3	24.2	36.3	24.3	37.5	34.1	24.2	30.4	33.0	25.0	32.5	38.2	47.8	44.1	47.6	47.1	35.5	39.3	29.1	30.0	31.8	24.7	27.9	34.9	27.1	23.9	29.8	27.6	28.9	36.2	38.5	24.8	20.1	22.7	38.8	35.9	25.7	40.7	30.6	28.4	31.1	26.3	28.9	35.5	21.7	36.9	21.4	34.5	27.0	37.4	32.5	28.9	37.0	44.4	28.9	22.8	40.3	38.6	36.9	33.5	44.5	39.3	41.8	38.8	26.4	27.7	36.5	32.3	34.9	37.3	33.0	37.3	32.2	47.3	41.8	30.6	32.8	37.5	29.5	32.3	28.7	40.6	42.8	29.7	35.0	36.1	42.0	38.0	47.8	32.1	40.6	36.0	30.9	36.2	36.3	38.2	32.5	38.3	36.0	36.1	47.6	44.1	22.7	47.1	35.5	20.3	24.8	32.1	26.2	20.6	18.3	23.9	26.7	26.8	24.3	86.4	43.0	62.2	66.5	50.3	55.1	46.0	43.3	109.7	79.6	50.6	33.4	68.5	64.6	65.3	25.3	65.0	31.6	46.7	61.0	83.4	54.9	37.6	88.0	26.6	66.2	36.5	41.9	45.4	48.4	16.5	72.2	71.0	37.1	92.0	37.1	67.4	58.2	45.0	69.6	39.6	63.7	64.7	69.5	252.6	138.5	47.4	91.2	73.9	40.5	62.2
SNX10		ENSG00000086300	"Sorting nexin 10"	Q9Y5X0	7	26291895-26374329	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;brain: 39.0;liver: 37.4"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 242.1;Hofbauer cells: 146.8;Kupffer cells: 156.1;Macrophages: 186.4;Muller glia cells: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 67.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.2;U-937: 22.3;WM-115: 77.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015605, HPA064782"	Approved		Supported	Nucleoplasm,Nucleoli,Microtubules		NA	NA			"Nucleoplasm, Microtubules"	Nucleoli	"HPA015605: AB_1857342, HPA064782: AB_2685349"	"unprognostic (6.42e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.87e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.50e-1)"	17.7	8.7	20.2	18.6	17.9	20.9	6.7	13.2	39.0	2.9	3.3	2.1	0.1	2.5	5.4	0.8	1.8	1.9	5.2	1.3	22.2	32.7	21.3	37.4	22.4	18.0	27.8	20.8	1.0	5.0	0.6	3.0	8.9	36.2	2.2	3.9	1.8	1.4	1.5	0.9	1.0	3.6	5.4	15.4	22.1	2.3	3.0	2.1	3.8	1.9	0.1	13.6	6.3	1.8	16.3	20.1	67.6	30.9	9.0	5.6	11.6	13.9	1.3	0.0	2.6	0.0	0.0	15.2	0.0	1.0	0.0	0.0	0.1	4.7	6.1	11.0	0.0	9.6	0.4	3.5	0.9	0.0	8.4	3.3	0.6	0.1	9.2	0.0	13.0	2.3	0.1	1.4	0.0	1.1	0.0	0.2	7.9	0.3	0.0	0.0	2.4	5.4	13.7	4.0	0.1	1.3	0.0	0.0	0.3	27.2	3.0	6.0	1.8	3.0	2.2	15.8	5.0	4.0	18.6	0.0	0.0	3.3	0.0	3.4	4.7	3.7	4.1	0.1	22.3	77.5	8.2	29.2	0.7	4.0	30.9	3.8	16.3	2.8	3.4	20.1	14.5	1.5	2.6	67.6	9.0	30.1	7.4	5.6	11.6	20.2	17.9	13.2	39.0	22.2	32.7	27.8	20.8	36.2	2.1	3.0	17.1	49.9	1.0	4.7	17.7	1.6	20.4	1.4	7.9	22.7	2.0	11.6	242.1	51.3	0.9	5.6	2.6	23.3	23.5	64.7	3.6	2.8	31.1	90.6	146.8	33.4	9.1	2.5	156.1	0.7	1.1	186.4	8.5	49.5	2.5	262.3	22.1	0.0	0.0	123.2	20.4	0.0	3.3	1.6	28.0	2.6	24.0	38.8	9.7	0.9
SNX11		ENSG00000002919	"Sorting nexin 11"	Q9Y5W9	17	48103357-48123074	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044787, HPA054660"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA044787: AB_10795988, HPA054660: AB_2682560"	"unprognostic (1.75e-1)"	"unprognostic (6.86e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.22e-3)"	"unprognostic (9.02e-3)"	"unprognostic (2.70e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.89e-2)"	16.8	12.1	15.1	18.7	23.5	21.0	11.9	12.9	19.5	8.8	13.8	20.2	11.0	9.2	11.6	16.6	19.6	10.4	10.2	12.5	16.2	15.4	16.0	14.4	12.8	21.5	17.2	15.0	9.7	12.3	12.1	13.7	14.9	13.7	12.5	14.0	13.7	15.6	11.3	12.3	11.5	12.2	17.5	18.1	25.5	12.6	11.5	17.0	15.0	21.3	12.2	28.9	14.2	11.3	9.8	11.7	39.8	21.0	6.6	8.4	9.2	12.1	15.4	12.9	12.5	11.7	5.1	14.7	12.4	9.0	17.0	18.4	22.9	10.8	13.0	16.5	14.8	9.9	10.3	12.2	12.9	17.3	29.8	15.4	17.8	9.5	11.0	12.7	20.1	13.4	8.4	14.5	15.1	14.8	10.4	14.6	12.3	11.2	12.2	11.0	11.3	12.6	15.5	7.5	13.8	13.2	7.5	22.4	14.1	10.8	12.1	9.3	17.8	8.4	6.0	22.5	16.5	12.3	15.6	11.3	17.3	10.8	11.9	15.7	20.9	30.1	14.6	12.6	9.8	11.2	11.4	14.5	13.9	8.4	18.1	6.1	9.8	4.7	5.9	11.7	9.4	4.1	6.6	39.8	6.6	21.0	5.5	4.2	9.2	15.1	23.5	12.9	19.5	16.2	15.4	17.2	15.0	13.7	17.0	6.0	1.3	10.7	4.5	5.4	8.5	4.3	0.0	1.4	2.3	15.7	2.0	9.1	5.0	10.6	1.5	5.8	9.7	0.0	13.2	9.3	5.8	5.9	2.3	6.2	16.9	14.3	14.3	4.9	17.7	1.6	4.9	8.1	5.0	50.5	7.6	11.1	13.8	3.5	6.3	6.3	9.2	12.9	4.2	7.7	23.6	4.4	13.7	5.1	6.3	5.4
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	23.4	25.9	19.9	16.0	21.9	16.6	26.7	25.2	30.1	20.1	23.3	16.1	17.8	17.7	23.8	37.0	17.1	17.8	17.4	17.4	19.5	24.2	33.2	41.0	23.8	17.7	21.6	18.0	17.9	27.7	27.2	35.5	29.6	30.8	21.1	22.2	19.9	17.7	20.2	9.6	17.1	31.0	15.8	20.7	24.6	26.8	49.1	17.1	16.1	26.1	11.2	18.2	22.6	15.1	8.9	16.4	20.0	24.1	13.4	13.3	8.9	15.0	9.2	15.1	22.1	34.5	25.4	15.8	19.3	26.7	15.2	23.5	16.6	25.5	19.8	23.9	24.8	29.7	20.4	10.3	19.9	24.1	17.5	6.1	21.6	12.8	24.8	28.5	20.2	22.5	22.1	15.1	17.7	18.0	28.2	27.0	7.8	21.9	17.2	32.9	17.5	1.2	38.7	6.1	23.6	10.4	8.1	30.8	9.4	37.0	27.9	6.6	15.1	11.8	26.1	17.9	20.9	16.2	36.3	24.0	12.0	7.5	15.0	20.0	17.3	27.4	7.3	24.7	23.9	24.2	18.1	13.6	20.0	13.3	20.3	10.0	8.9	9.0	11.9	16.4	8.8	8.2	10.3	6.3	13.4	24.1	4.8	10.2	8.9	19.9	21.9	25.2	30.1	19.5	24.2	21.6	18.0	30.8	17.1	86.4	38.0	17.1	16.6	13.1	35.5	12.3	17.8	32.1	28.4	21.0	53.0	44.7	5.0	28.9	45.3	24.0	24.4	0.0	36.5	25.9	25.0	15.8	30.1	26.6	31.1	14.3	30.6	27.6	34.8	10.7	18.1	25.4	27.0	39.7	28.0	32.8	30.0	24.6	27.6	23.7	39.0	19.4	21.6	165.5	8.4	12.9	47.3	25.3	25.3	15.2
SNX18	"SH3PX2, SH3PXD3B, SNAG1"	ENSG00000178996	"Sorting nexin 18"	Q96RF0	5	54517759-54546585	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 68.7;Kupffer cells: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037800	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA037800: AB_10672465"	"unprognostic (2.22e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.81e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (6.79e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	16.2	9.0	10.1	9.2	13.5	50.3	17.8	5.8	9.9	13.0	12.1	20.3	13.8	8.1	14.7	7.6	11.4	11.5	11.8	13.1	10.3	9.0	11.6	13.9	12.1	18.7	18.3	7.0	23.8	8.1	17.4	5.3	18.4	12.7	14.5	5.2	10.9	11.4	13.9	7.7	9.6	8.8	12.5	23.3	26.0	11.7	13.5	15.0	6.7	15.0	5.4	6.6	15.1	26.2	1.2	4.2	6.7	6.1	1.7	1.3	0.6	4.0	3.3	5.3	6.0	12.4	13.4	28.9	6.7	17.0	3.5	5.9	4.1	7.5	0.1	11.3	10.4	6.5	3.8	5.0	6.6	4.5	2.2	3.7	1.2	2.2	2.5	20.8	2.2	1.2	21.0	8.0	4.8	5.0	6.3	7.4	3.0	2.1	28.1	6.1	3.8	2.1	2.5	2.6	1.6	3.5	5.6	2.9	6.4	3.4	11.8	6.6	3.9	5.6	6.5	7.3	8.5	7.7	3.7	2.5	13.3	6.7	9.8	7.1	19.1	18.4	1.1	5.1	5.3	13.7	0.0	1.6	0.2	1.3	2.6	0.3	1.2	0.6	0.8	1.9	1.2	0.3	1.0	6.7	1.7	6.1	4.2	0.3	0.6	10.1	13.5	5.8	7.9	10.3	9.0	18.3	7.0	12.7	15.0	50.6	23.2	7.5	4.0	8.8	9.2	12.4	5.1	16.0	14.8	21.0	68.7	21.3	13.3	11.9	0.3	12.0	3.6	0.0	13.2	25.8	15.4	5.3	5.7	23.3	34.9	4.8	5.8	40.5	73.9	1.7	13.0	34.5	10.1	8.2	8.5	10.3	12.6	6.6	16.6	5.8	43.9	0.0	36.8	2.4	8.9	10.3	6.9	14.1	9.6	12.2
SNX19	"CHET8, KIAA0254"	ENSG00000120451	"Sorting nexin 19"	Q92543	11	130875436-130916509	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013447	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA013447: AB_1857347"	"unprognostic (8.79e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	22.3	23.1	24.0	16.9	30.6	10.0	17.2	18.0	38.0	17.1	23.8	35.6	25.3	17.1	22.9	32.5	17.9	19.8	20.4	22.6	22.8	22.2	24.1	25.6	17.5	15.3	31.0	15.3	20.6	26.6	32.9	28.5	18.5	28.0	21.7	22.2	23.7	23.1	27.2	26.4	19.0	17.8	26.0	30.8	18.5	22.3	36.2	28.2	24.6	31.1	12.1	18.1	23.0	16.4	5.9	5.4	11.3	6.6	3.6	6.2	5.2	6.7	7.5	9.6	13.4	29.0	20.4	6.4	18.0	21.4	9.1	9.5	8.4	13.0	6.4	12.6	19.9	20.3	12.3	1.4	12.9	11.7	10.3	5.8	11.7	7.4	0.0	21.0	0.0	9.1	23.2	16.0	9.3	10.2	18.8	11.1	8.8	10.3	0.0	19.4	4.9	9.4	7.7	2.9	16.8	9.5	7.2	9.1	3.7	9.9	12.2	9.4	8.8	7.7	12.4	6.1	7.8	22.0	7.3	14.7	12.8	9.5	10.5	10.5	2.2	0.0	0.0	5.3	7.7	14.6	11.3	6.0	4.4	4.8	6.4	6.2	5.9	4.7	5.7	5.3	4.4	5.6	4.4	3.6	3.6	6.6	5.4	4.1	5.2	24.0	30.6	18.0	38.0	22.8	22.2	31.0	15.3	28.0	28.2	23.8	6.4	10.9	5.9	3.5	22.7	17.9	22.9	14.7	13.6	22.7	9.8	7.7	8.3	10.2	23.3	9.3	11.8	0.0	14.0	4.7	7.4	8.7	18.4	18.8	8.9	15.9	10.9	15.4	11.9	35.0	12.7	10.3	3.3	2.8	10.6	21.3	13.4	11.4	14.9	8.7	37.1	12.9	8.3	31.9	11.5	3.8	11.7	6.5	8.5	9.1
SNX21	"C20orf161, dJ337O18.4, SNX-L"	ENSG00000124104	"Sorting nexin family member 21"	Q969T3	20	45833810-45843275	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Fibroblasts: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 3.9;classical monocyte: 2.9;eosinophil: 7.3;intermediate monocyte: 5.0;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.3;monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 16.4;PC-3: 20.0;U-87 MG: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046359	Approved		Approved	"Vesicles,Centriolar satellite"		NA	NA			"Vesicles, Centriolar satellite"		"HPA046359: AB_10963216"	"unprognostic (1.97e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.18e-1)"	25.4	21.0	10.0	4.4	9.8	1.9	14.1	10.3	18.3	18.8	8.4	8.6	10.3	10.0	17.6	13.8	11.3	14.3	15.3	9.1	7.5	6.4	8.9	5.2	9.5	2.7	7.9	7.5	19.1	4.2	5.5	6.9	6.9	8.8	14.1	2.9	13.6	10.2	11.2	43.4	35.2	6.1	19.8	7.6	6.6	9.3	7.2	6.4	0.0	6.0	14.9	3.7	15.4	12.0	0.2	0.3	7.3	5.0	0.0	1.0	0.7	3.6	4.7	0.8	6.8	3.8	3.5	3.3	4.8	4.3	5.2	3.9	3.4	2.8	0.0	16.4	4.8	3.9	4.8	0.1	3.8	0.5	0.4	0.6	0.1	2.3	3.2	2.9	0.0	1.1	2.6	2.2	4.6	0.2	1.2	3.2	0.4	0.0	0.0	1.7	9.2	0.0	0.3	1.2	0.6	20.0	0.0	0.6	0.0	1.6	0.6	0.8	7.4	10.7	10.2	5.7	0.3	6.6	0.9	3.5	7.6	5.9	14.2	4.3	0.0	0.5	0.2	18.1	0.0	4.0	3.9	2.9	7.3	0.0	5.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	3.3	0.1	1.0	0.7	10.0	9.8	10.3	18.3	7.5	6.4	7.9	7.5	8.8	6.4	8.9	8.8	0.0	5.8	9.0	12.7	4.5	5.1	6.7	12.5	5.2	7.9	4.1	21.6	8.5	3.7	7.7	10.7	0.0	10.3	4.6	37.9	3.2	0.0	3.0	4.2	14.3	8.6	8.6	5.9	11.4	18.1	5.8	10.1	0.0	8.7	12.7	7.0	4.2	15.9	11.7	12.5	6.5	18.9	0.9	1.9	19.8	2.1	1.5	7.2	2.7
SNX22	FLJ13952	ENSG00000157734	"Sorting nexin 22"	Q96L94	15	64151715-64157481	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;thyroid gland: 41.1"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 140.2"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 6.6;naive B-cell: 11.5"	"Lineage enriched"	"Detected in many"	9	"B-cells: 11.5"	"Cell line enriched"	"Detected in some"	4	"Daudi: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038470			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA038470: AB_10673174"	"prognostic favorable (2.89e-5)"	"unprognostic (8.93e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.74e-2)"	1.1	1.5	11.9	7.6	8.9	10.2	1.2	3.4	16.5	0.7	1.1	23.2	11.8	1.5	1.2	3.5	0.9	0.8	1.3	7.9	13.4	9.0	1.1	1.9	4.7	11.4	13.7	8.1	1.3	1.6	0.4	2.2	1.0	12.3	3.0	0.7	0.0	3.6	8.4	0.7	2.0	2.2	0.9	17.0	6.1	2.1	1.0	6.6	1.6	41.1	0.0	13.3	2.1	0.3	11.5	1.2	0.0	0.2	0.1	0.1	1.6	0.2	0.4	0.9	0.8	0.1	0.0	0.7	0.8	0.0	0.0	0.2	0.4	0.9	19.9	0.5	0.1	0.5	0.4	1.7	0.0	0.0	0.1	2.4	0.4	2.2	2.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.6	3.3	0.0	1.2	0.2	0.0	1.4	0.5	0.3	4.1	0.3	1.2	0.8	0.8	4.6	0.9	0.2	0.7	0.0	0.8	2.0	0.0	0.0	1.1	1.4	0.3	0.5	4.3	1.8	4.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.2	11.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.6	11.9	8.9	3.4	9.3	13.4	9.0	13.7	8.1	12.3	6.6	26.8	9.1	15.2	1.7	1.3	0.8	14.2	0.0	0.0	1.2	0.0	3.9	2.7	0.0	0.4	1.1	0.7	0.7	140.2	3.2	6.1	3.6	3.9	2.3	3.4	4.0	0.0	0.0	2.5	2.2	1.7	0.6	2.7	3.3	1.8	0.8	0.5	1.8	0.0	0.4	1.8	1.8	0.0	1.0	1.1	1.2	2.5	3.3	2.1	0.6	1.4
SNX24	SBBI31	ENSG00000064652	"Sorting nexin 24"	Q9Y343	5	122843439-123029354	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 70.2;Late spermatids: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044566, HPA073934"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA044566: AB_10797034, HPA073934: AB_2686644"	"unprognostic (2.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (7.93e-6)"	"unprognostic (2.31e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.42e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.69e-2)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.50e-2)"	6.7	7.2	10.7	5.2	13.8	3.3	6.5	6.2	14.9	7.3	9.0	20.4	5.9	12.6	9.5	10.4	31.2	6.5	8.9	9.7	11.5	11.1	17.1	11.4	14.2	4.6	25.1	8.9	5.9	8.9	20.9	15.8	24.2	19.7	5.5	10.7	8.2	11.0	5.8	7.2	13.5	14.5	9.5	38.3	6.4	13.1	6.9	16.4	1.0	15.4	12.9	8.2	8.1	11.3	0.7	1.3	0.1	5.9	2.5	2.5	1.2	13.1	6.1	9.6	6.5	3.6	9.4	19.7	11.8	11.1	13.8	17.8	8.3	12.4	0.0	10.1	11.6	13.5	2.7	6.1	15.0	21.0	7.2	3.7	1.9	5.6	11.8	18.2	0.1	2.3	7.8	22.3	6.9	26.9	11.9	6.7	2.2	2.4	11.1	10.3	11.7	0.3	0.4	3.9	2.4	3.7	1.6	15.4	6.7	19.8	8.1	5.9	7.0	11.2	8.3	12.4	13.0	14.9	4.2	5.5	14.9	11.6	5.8	18.8	3.9	5.1	1.9	12.6	0.2	30.2	0.0	2.8	0.0	1.2	5.4	0.7	0.7	1.3	1.0	1.3	0.6	0.5	0.3	0.1	2.5	5.9	0.3	2.5	1.2	10.7	13.8	6.2	14.9	11.5	11.1	25.1	8.9	19.7	16.4	41.7	21.1	0.0	6.8	9.3	15.5	13.0	17.8	9.4	1.2	19.2	5.9	40.1	29.9	12.8	70.2	6.0	22.2	0.0	10.3	47.6	9.4	7.1	0.0	10.4	57.5	11.1	1.2	8.0	37.6	69.6	8.3	11.0	3.3	18.0	6.0	9.6	16.8	2.9	8.9	30.6	16.5	12.9	6.6	4.4	7.5	14.6	33.2	2.9	6.9	8.0
SNX27	"KIAA0488, MGC20471, MY014"	ENSG00000143376	"Sorting nexin family member 27"	Q96L92	1	151612006-151699091	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045816			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045816: "	"unprognostic (3.35e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.04e-1)"	10.9	12.5	21.5	12.5	28.6	13.4	12.6	25.0	27.7	14.8	15.9	23.4	13.5	9.1	12.1	16.2	12.1	13.9	11.5	12.1	23.0	21.3	24.2	12.8	13.6	10.4	23.7	19.2	17.2	10.0	26.0	14.8	17.5	20.3	14.8	13.0	13.1	9.7	20.6	25.6	16.0	10.1	21.3	23.1	17.0	11.2	12.8	18.7	8.8	12.8	7.7	10.8	17.4	21.7	2.5	8.4	20.3	18.6	1.7	3.6	7.3	5.9	8.9	9.5	11.9	15.0	11.1	21.1	3.2	6.7	5.7	6.2	7.2	8.0	5.7	7.1	5.2	6.2	7.5	12.1	6.5	7.2	8.1	4.5	9.1	5.2	8.1	10.0	10.8	6.3	8.8	4.9	6.5	7.5	5.8	6.4	9.1	5.5	35.1	7.5	10.7	6.4	7.5	16.7	11.8	5.8	6.7	9.2	7.3	8.9	9.0	9.5	8.1	8.7	16.2	6.2	10.7	10.4	9.2	8.5	8.1	5.5	8.4	6.7	7.4	7.4	11.5	9.7	7.0	9.0	9.5	18.6	2.6	2.6	16.1	3.6	1.8	3.2	2.3	8.4	2.5	3.1	2.5	20.3	1.7	16.9	2.1	2.5	7.3	21.5	28.6	25.0	24.6	23.0	21.3	23.7	19.2	20.3	18.7	11.9	21.9	11.2	13.8	18.8	42.4	25.5	20.4	8.1	15.9	27.9	25.5	40.5	21.6	21.5	23.7	16.1	12.3	23.3	18.3	18.4	17.5	15.0	3.5	17.9	37.8	38.1	18.0	22.7	76.7	6.6	28.1	28.6	28.7	32.5	15.2	22.7	21.5	10.5	37.4	51.8	27.3	32.3	19.4	41.7	29.4	21.7	87.6	12.9	15.8	13.2
SNX29	"FLJ12363, RUNDC2A"	ENSG00000048471	"Sorting nexin 29"	Q8TEQ0	16	11976737-12574289	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 333.8;Early spermatids: 117.2;Horizontal cells: 87.4;Late spermatids: 346.9;Rod photoreceptor cells: 256.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"naive B-cell: 19.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008889, HPA062810"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoli, Cytosol"	"HPA008889: AB_1079856, HPA062810: "	"unprognostic (2.50e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.82e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.08e-2)"	"prognostic favorable (1.38e-7)"	"unprognostic (3.85e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (1.03e-4)"	11.4	5.5	8.2	9.8	14.4	10.7	8.3	13.2	11.9	9.4	6.7	22.7	5.2	3.3	9.6	9.1	9.9	11.1	6.4	6.6	9.0	8.1	24.5	3.6	8.7	14.8	13.7	9.1	13.7	4.8	32.1	16.1	10.0	14.4	5.4	4.9	15.4	6.9	6.8	11.7	8.2	5.8	12.2	18.5	10.8	6.1	16.9	13.1	12.5	8.6	4.9	19.2	9.8	7.4	19.2	5.8	3.0	5.7	1.0	4.3	1.4	3.1	1.8	2.8	2.3	16.9	13.9	3.7	6.8	18.7	2.8	3.1	0.3	3.6	11.7	9.1	10.5	1.8	2.7	1.8	4.3	4.1	4.5	1.9	1.5	1.6	4.0	3.2	1.6	4.3	12.7	2.8	4.1	1.8	4.2	4.9	3.9	2.4	3.3	2.8	4.2	3.1	1.9	1.6	2.0	1.7	7.0	3.6	9.4	12.5	2.9	3.4	2.8	7.7	4.6	1.6	2.5	2.6	2.0	7.4	5.0	2.0	3.7	1.3	19.2	14.6	7.3	9.2	1.8	3.1	3.0	5.7	1.2	1.7	3.7	2.1	8.3	3.6	2.2	2.0	19.2	4.3	3.1	2.0	1.0	1.8	5.8	3.1	1.4	8.2	14.4	13.2	11.9	9.0	8.1	13.7	9.1	14.4	13.1	11.9	19.3	51.4	5.6	13.6	52.7	9.5	5.1	16.0	13.6	15.7	333.8	15.9	18.3	3.8	117.2	11.2	3.4	0.0	2.5	4.2	17.2	3.4	41.5	5.0	24.8	87.4	12.6	16.5	21.8	346.9	19.8	27.4	11.8	11.8	3.6	21.7	5.8	3.5	14.5	32.0	256.7	6.5	10.8	21.5	7.6	13.6	14.3	9.6	3.3	4.6
SNX30	ATG24A	ENSG00000148158	"Sorting nexin family member 30"	Q5VWJ9	9	112750838-112881671	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 65.1;Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019346	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli, Cytosol"		"HPA019346: AB_2286395"	"unprognostic (1.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (4.48e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-2)"	4.9	4.4	12.2	7.7	12.6	8.3	7.7	18.1	18.5	10.9	11.1	25.6	3.6	7.9	6.4	4.1	5.3	3.8	5.4	3.4	14.2	12.0	23.7	5.2	23.4	8.8	14.8	12.8	6.9	5.2	6.9	6.3	5.1	14.7	4.1	11.7	4.9	7.1	4.3	2.6	5.7	8.9	7.5	20.3	7.4	4.7	12.7	11.8	2.3	3.1	2.6	8.7	5.4	4.6	0.7	4.2	1.5	5.1	0.8	1.7	1.6	6.0	3.8	6.6	5.2	8.3	7.6	5.5	5.2	10.9	4.4	4.2	13.5	1.4	10.1	4.4	13.4	7.9	7.2	7.9	3.1	6.9	3.2	3.7	3.1	3.4	5.4	6.0	3.1	5.6	6.2	4.3	6.8	5.1	11.2	3.8	2.6	4.8	5.8	5.9	4.2	2.0	3.6	7.2	9.8	4.0	4.3	15.4	2.6	8.6	10.6	9.8	3.1	6.8	9.4	13.0	7.0	7.0	5.6	4.2	6.6	7.0	19.3	4.4	15.1	13.9	4.8	8.5	2.9	12.8	0.0	5.1	1.5	0.8	2.0	1.7	0.0	0.8	1.0	4.2	0.7	0.7	0.6	0.7	0.8	2.1	0.7	1.6	1.6	12.2	12.6	18.1	18.5	14.2	12.0	14.8	12.8	14.7	11.8	6.0	65.1	0.0	1.9	7.2	5.7	3.8	5.1	1.4	9.1	5.2	9.8	0.4	5.0	2.1	5.3	3.0	12.4	46.7	2.8	1.6	5.7	3.1	6.9	5.9	11.9	7.9	4.6	12.3	19.7	6.3	5.2	12.5	20.3	1.0	9.7	2.6	3.4	17.3	7.4	33.2	2.7	0.0	1.4	5.5	10.5	9.7	0.3	3.8	8.6	5.4
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572882-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 73.9"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	50	"RT4: 42.9"	"Region enriched"	"Detected in single"	5	"thalamus: 2.9"	"Region enhanced"	"Detected in single"		"olfactory region: 3.1"	"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.5	0.0	0.6	0.1	0.7	0.1	0.4	0.6	2.3	1.7	0.3	0.3	0.1	0.2	0.3	0.2	6.2	0.3	0.9	1.8	0.8	0.7	0.3	0.4	0.3	0.3	0.9	0.3	0.3	0.2	0.1	0.2	0.1	0.6	13.8	0.1	0.4	1.4	0.1	1.0	0.5	0.1	7.4	0.8	0.1	0.6	3.3	0.5	0.1	0.4	2.6	21.4	25.4	16.0	1.1	0.3	3.0	0.5	1.6	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	2.5	0.5	0.2	0.3	0.2	0.1	1.1	0.1	0.2	0.2	0.5	0.1	0.3	3.0	1.6	0.0	0.3	0.0	0.0	0.6	0.7	0.6	0.3	0.8	0.7	0.9	0.3	0.6	0.5	0.0	0.0	0.0	3.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	73.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.4	0.4	0.4	0.0	0.0	0.0	1.0
SNX7		ENSG00000162627	"Sorting nexin 7"	Q9UNH6	1	98661701-98760500	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037419, HPA054338"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"		"HPA037419: AB_10671754, HPA054338: AB_2682454"	"unprognostic (3.19e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.10e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (9.59e-7)"	"unprognostic (1.53e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.77e-1)"	19.2	13.6	12.0	8.2	11.3	0.2	22.4	3.1	9.8	18.6	24.7	9.7	12.5	19.4	18.7	18.7	17.7	13.5	15.4	18.0	12.0	15.6	22.1	13.0	9.6	4.7	13.6	9.3	13.8	13.7	14.7	13.2	13.9	15.6	17.7	25.4	6.6	15.0	14.8	5.8	11.5	27.2	21.8	17.3	6.4	13.9	14.7	12.7	2.0	13.9	10.3	7.4	18.7	21.9	0.6	0.3	0.0	1.4	0.0	0.3	0.3	16.3	8.9	5.4	7.3	19.2	30.4	3.0	10.4	19.1	15.7	20.5	5.1	6.2	0.0	13.6	25.6	12.9	4.7	5.6	14.8	15.7	0.0	10.9	0.0	14.1	8.8	11.3	0.0	0.0	15.2	16.0	12.9	5.7	17.8	21.8	0.2	0.0	0.0	24.7	3.3	0.1	0.0	5.1	6.5	12.8	0.0	12.1	0.0	15.6	13.2	2.7	32.1	13.9	13.2	7.5	9.4	0.0	0.6	14.9	15.4	8.6	11.9	21.0	0.0	0.0	0.0	21.8	0.0	7.4	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	12.0	11.3	3.1	9.8	12.0	15.6	13.6	9.3	15.6	12.7	17.9	4.1	0.5	35.3	13.1	0.2	45.7	12.7	20.1	4.5	22.7	0.0	25.2	31.5	40.0	13.7	15.7	27.6	0.0	71.6	28.2	36.3	18.9	1.1	10.6	10.1	3.2	20.2	8.6	1.6	16.0	31.7	10.8	33.7	64.9	25.3	10.1	46.0	20.1	49.5	51.2	0.2	32.3	47.5	3.3	10.5	14.3	11.8	0.0	44.8	39.6
SOBP	FLJ10159	ENSG00000112320	"Sine oculis binding protein homolog"	A7XYQ1	6	107489958-107660167	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 68.3;Horizontal cells: 87.4;Late spermatids: 46.7;Peritubular cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 3.0;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	14	"B-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"AF22: 11.0;AN3-CA: 14.2;ASC diff: 13.5;HDLM-2: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029242	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029242: AB_10603340"	"unprognostic (7.11e-2)"	"unprognostic (1.35e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.84e-2)"	"unprognostic (5.35e-3)"	"prognostic favorable (1.55e-5)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-3)"	7.6	12.0	19.3	4.4	15.6	1.3	3.6	15.1	30.2	12.7	12.8	11.0	2.5	3.7	9.0	5.5	5.6	6.2	7.6	17.0	18.0	12.4	5.8	3.6	5.0	2.9	12.5	14.9	21.6	3.9	10.9	12.0	6.1	9.6	13.0	4.2	7.4	21.1	7.0	22.1	1.5	3.4	14.3	9.6	4.7	5.6	9.1	11.1	1.0	6.1	4.1	3.3	14.8	8.0	4.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	11.0	14.2	13.5	5.2	1.3	0.1	0.0	0.3	0.6	0.0	0.0	5.8	0.4	0.0	1.0	0.0	7.3	0.2	0.2	9.3	6.9	0.7	0.0	6.8	1.8	3.0	0.6	5.4	0.0	5.3	0.0	1.1	4.4	2.7	0.0	0.3	0.0	2.9	1.4	0.3	2.6	0.2	0.9	3.3	1.4	0.0	0.0	0.2	3.6	5.9	1.3	0.0	0.1	0.5	0.5	2.1	0.1	3.5	1.2	6.0	0.5	2.8	0.5	3.8	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.2	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	19.3	15.6	15.1	20.6	18.0	12.4	12.5	14.9	9.6	11.1	3.0	9.8	8.5	8.9	0.5	36.8	20.2	28.1	16.0	5.7	22.7	0.0	0.1	0.0	1.9	68.3	2.8	0.0	0.0	0.2	0.6	7.3	8.4	0.0	0.6	2.3	87.4	10.4	3.7	7.4	46.7	41.7	1.6	3.3	0.0	0.0	6.9	0.5	0.0	46.0	9.8	9.8	25.8	16.1	3.0	2.2	0.6	0.1	0.0	0.0	0.7
SOCS1	"Cish1, JAB, SOCS-1, SSI-1, TIP3"	ENSG00000185338	"Suppressor of cytokine signaling 1"	O15524	16	11254405-11256200	"Cancer-related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.3;lymphoid tissue: 58.3"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 63.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 15.2"	"Cell type enhanced"	"Detected in many"		"basophil: 12.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"HDLM-2: 48.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010355, HPA074108"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"CAB010355: AB_2193144, HPA074108: AB_2686661"	"unprognostic (4.50e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.31e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.67e-1)"	10.9	2.8	0.7	19.2	1.5	13.9	37.9	15.2	1.1	15.8	6.3	0.3	2.2	3.3	4.9	7.6	5.6	4.2	11.0	3.6	0.6	1.0	11.1	42.3	9.6	25.8	0.8	0.0	9.3	3.8	0.7	16.8	9.3	2.4	5.3	1.8	3.2	3.7	3.9	2.3	6.0	11.0	6.5	1.1	14.7	6.6	7.1	0.4	58.3	5.1	4.8	14.7	5.4	8.3	4.4	1.3	12.9	0.1	5.5	2.7	0.4	1.2	0.2	0.5	0.1	1.6	0.2	1.9	1.0	7.5	0.4	0.6	0.3	0.2	2.9	2.2	0.4	1.4	0.5	0.2	0.1	0.1	48.3	0.3	0.8	0.0	3.9	0.7	0.0	8.9	0.7	0.1	1.0	0.1	0.2	0.1	0.3	6.4	0.8	0.0	1.1	3.2	1.8	5.4	0.0	0.8	0.3	0.3	0.3	0.5	0.2	0.7	0.1	0.2	1.7	0.5	1.5	0.0	0.4	0.0	0.6	3.2	0.4	0.6	0.2	0.2	4.5	1.2	0.3	0.6	12.9	0.1	8.8	2.2	0.0	2.0	1.4	2.5	2.7	0.0	4.4	2.7	2.5	0.3	5.5	0.0	1.3	2.6	0.4	0.7	1.5	15.2	0.6	0.6	1.0	0.8	0.0	2.4	0.4	0.0	4.1	11.5	14.7	10.9	1.9	9.2	5.1	2.7	0.0	48.8	5.9	21.5	19.9	11.3	40.7	3.6	23.6	0.0	7.3	4.3	30.9	5.9	54.0	2.4	4.0	0.0	25.0	10.4	6.5	17.6	6.6	8.4	28.7	24.4	12.9	7.4	6.9	9.1	39.3	7.0	4.2	0.0	16.5	0.9	2.0	5.9	48.3	63.1	6.6	10.8
SOCS2	"CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2"	ENSG00000120833	"Suppressor of cytokine signaling 2"	O14508	12	93569814-93583487	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 123.3;monocytes: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 45.5"	"Lineage enhanced"	"Detected in many"		"granulocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 39.4;K-562: 31.9;REH: 75.7;THP-1: 32.6"	"Low region specificity"	"Detected in all"							CAB010356	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB010356: AB_2239660"	"unprognostic (4.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.35e-3)"	"prognostic favorable (8.17e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.09e-2)"	25.2	14.3	2.6	5.1	4.1	3.6	39.6	2.3	4.3	37.9	14.2	2.4	23.1	4.3	38.8	21.4	7.7	15.0	15.5	12.4	4.9	3.1	14.6	28.2	22.7	12.3	3.3	1.4	14.1	7.1	18.7	26.7	21.9	11.0	33.5	6.9	7.0	4.9	32.5	12.0	3.7	10.7	36.9	3.3	4.3	12.3	10.3	2.9	12.7	12.7	7.1	4.3	15.6	21.3	0.8	0.6	45.5	0.1	8.2	11.5	5.1	0.8	1.0	4.0	3.5	2.3	4.1	4.5	4.9	17.9	3.5	1.6	39.4	1.8	0.2	0.1	4.5	1.0	9.1	20.7	1.4	4.1	15.8	0.5	3.2	0.1	0.5	3.3	1.0	6.8	6.7	1.2	4.1	5.5	0.3	0.5	2.0	31.9	0.6	0.5	0.4	0.2	1.4	11.2	0.7	1.6	75.7	0.0	0.8	1.0	1.6	6.8	8.1	1.6	2.7	12.6	4.0	0.0	32.6	0.5	10.6	0.2	0.0	2.7	0.4	0.2	0.2	0.2	2.4	6.7	45.5	0.0	2.2	8.4	0.1	11.5	0.1	10.5	7.7	0.0	0.8	10.7	6.3	0.3	8.2	0.1	0.6	6.0	5.1	2.6	4.1	2.3	4.3	4.9	3.1	3.3	1.4	11.0	2.9	8.9	64.9	0.0	42.5	16.0	3.8	4.4	0.0	4.0	31.8	21.0	3.9	28.9	53.0	10.2	7.0	46.6	15.5	0.0	32.8	4.5	32.4	113.6	23.1	9.7	11.0	65.2	7.9	123.3	11.9	14.7	84.8	9.2	16.9	188.4	14.6	1.3	9.3	17.5	95.1	17.2	0.7	77.6	40.1	2.6	7.9	9.3	29.3	13.8	15.6	25.7
SOCS3	"CIS3, Cish3, SOCS-3, SSI-3"	ENSG00000184557	"Suppressor of cytokine signaling 3"	O14543	17	78356778-78360077	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 259.3;Smooth muscle cells: 425.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.6;T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.9;HSkMC: 25.4;U-266/70: 25.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB012220, HPA068569"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB012220: AB_443287, HPA068569: AB_2686008"	"prognostic favorable (4.80e-4)"	"unprognostic (2.67e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (9.34e-9)"	"unprognostic (1.08e-2)"	"unprognostic (8.80e-2)"	"unprognostic (7.59e-3)"	"unprognostic (8.40e-2)"	94.9	16.8	6.3	42.5	21.4	33.9	25.7	3.0	12.8	27.6	26.6	5.6	1.9	6.2	13.9	9.2	22.7	88.0	59.6	23.5	11.4	5.1	13.5	30.4	52.1	30.2	13.9	0.1	31.2	14.5	13.9	13.4	23.5	38.0	20.8	9.2	10.3	9.2	6.7	26.0	12.1	15.6	39.0	29.6	36.7	32.2	12.1	8.7	5.6	14.2	40.9	10.3	38.1	41.1	0.0	1.3	11.6	1.3	0.4	4.3	0.6	2.0	3.3	2.4	1.3	0.9	15.5	6.5	10.4	9.5	10.9	4.6	2.1	1.4	0.0	2.2	2.4	6.9	0.6	0.5	1.0	4.3	49.9	0.3	1.9	7.3	0.4	5.0	0.0	0.9	25.4	0.8	8.4	3.2	6.6	4.7	0.1	5.5	19.6	5.0	1.0	1.0	0.3	1.7	0.3	4.3	0.0	12.5	0.3	17.3	2.0	0.1	1.5	3.1	0.8	0.4	9.5	0.9	0.4	2.7	21.5	6.1	7.5	6.0	25.9	14.5	0.0	17.6	0.2	1.4	0.0	1.3	0.3	1.0	0.1	2.6	0.0	2.8	1.2	1.3	0.0	4.3	0.8	11.6	0.4	0.0	1.2	1.6	0.6	6.3	21.4	3.0	12.8	11.4	5.1	13.9	0.1	38.0	8.7	44.7	145.2	37.8	106.0	146.0	1.0	23.1	5.1	20.1	55.7	36.6	2.0	8.0	5.0	34.0	0.6	259.3	21.3	0.0	34.0	41.1	225.0	61.7	33.7	14.4	86.4	0.0	31.8	133.8	82.4	0.2	72.5	182.0	81.0	48.7	21.3	2.0	36.2	24.3	2.1	6.8	1.6	12.9	425.2	0.5	0.2	116.2	51.9	47.9	36.7	70.2
SOCS4	SOCS7	ENSG00000180008	"Suppressor of cytokine signaling 4"	Q8WXH5	14	55027230-55049488	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013478, HPA057961"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB013478: , HPA057961: AB_2683564"	"unprognostic (7.18e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.74e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.82e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.13e-1)"	14.5	11.1	12.5	16.0	21.2	12.7	12.2	12.6	19.1	11.4	12.0	14.0	8.7	11.1	13.6	9.3	13.2	13.9	15.0	13.9	15.5	10.9	17.6	10.6	16.7	18.0	22.6	10.5	12.6	10.2	12.8	18.5	12.4	17.0	11.7	12.8	7.2	11.9	10.3	12.3	10.5	13.2	17.5	29.6	16.4	15.1	9.5	19.6	16.2	15.3	6.5	16.0	16.1	18.9	3.8	4.1	4.5	5.8	6.0	4.9	2.0	10.8	9.4	12.8	15.0	8.4	9.8	10.2	12.7	9.4	8.1	13.4	7.7	11.7	16.4	9.0	9.5	7.8	15.2	17.4	10.3	19.0	16.8	7.0	9.7	12.2	4.6	8.6	11.1	17.2	7.8	10.7	14.6	10.7	9.0	14.6	16.5	5.8	16.5	14.7	10.8	16.6	8.1	10.1	8.7	10.2	15.4	20.0	6.3	11.6	12.0	17.1	14.7	12.8	7.7	12.1	12.2	10.8	8.2	14.8	20.9	21.1	10.2	10.8	5.9	6.3	15.8	13.5	9.0	16.0	1.7	4.2	4.5	3.2	4.9	4.9	3.0	4.0	3.0	3.1	3.8	2.2	2.4	2.6	6.0	5.8	4.1	3.6	2.0	12.5	21.2	12.6	19.1	15.5	10.9	22.6	10.5	17.0	19.6	6.0	11.3	20.6	7.6	21.3	13.1	17.3	7.6	18.7	20.5	14.0	19.6	4.4	11.6	8.1	3.7	15.8	11.5	0.0	7.6	4.8	10.8	6.5	31.3	7.8	6.6	35.0	19.5	15.4	10.4	1.5	6.6	12.4	3.3	15.4	7.9	14.5	11.8	7.2	9.6	11.3	14.5	0.0	20.0	15.1	11.3	20.3	4.1	15.2	6.9	7.9
SOCS5	"CIS6, Cish5, CISH6, KIAA0671, SOCS-5"	ENSG00000171150	"Suppressor of cytokine signaling 5"	O75159	2	46698952-46763129	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 45.7;fHDF/TERT166: 44.5;U-138 MG: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020884, CAB025510"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025510: , HPA020884: AB_1857356"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (4.52e-2)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	12.2	10.1	16.9	5.6	24.9	6.2	21.3	26.4	14.9	13.6	9.4	6.3	7.6	4.8	14.0	8.8	8.2	9.6	11.2	11.2	11.9	8.1	9.1	6.3	10.1	9.9	9.1	10.8	23.8	6.0	14.8	9.0	6.9	11.8	9.9	6.5	5.8	9.3	13.0	8.8	6.9	6.8	13.6	10.8	8.1	7.2	9.5	8.8	10.9	9.8	5.0	6.1	9.4	9.0	4.8	1.3	6.3	3.7	2.3	3.3	1.6	5.2	4.0	3.5	5.1	11.2	16.2	4.3	24.7	45.7	12.1	7.1	3.8	2.6	2.7	4.8	44.5	3.7	2.6	3.8	3.9	15.4	2.6	3.5	4.2	3.7	4.5	7.0	2.4	4.7	12.8	5.9	10.3	4.1	13.5	4.1	1.1	3.6	2.9	7.7	1.8	2.1	3.9	3.9	5.5	3.3	2.8	5.9	3.4	4.9	4.0	2.7	7.5	6.0	4.0	4.6	3.5	1.6	3.5	4.6	30.2	6.8	10.0	4.8	3.7	2.2	2.3	13.8	4.8	9.3	1.2	1.1	6.3	2.4	1.0	3.0	4.5	1.5	1.6	1.2	4.8	2.7	3.3	1.1	2.3	3.7	1.3	2.5	1.6	16.9	24.9	26.4	14.9	11.9	8.1	9.1	10.8	11.8	8.8	3.0	6.7	6.0	6.3	14.7	12.1	13.6	15.3	5.3	9.1	3.5	21.6	3.1	5.0	6.3	8.5	22.4	6.3	0.0	5.9	1.9	12.1	8.8	16.2	6.4	4.0	17.5	10.4	20.3	6.3	5.1	16.1	7.2	6.8	6.4	7.6	8.9	5.5	7.0	15.9	6.3	5.3	12.9	17.9	11.9	15.6	12.7	2.3	4.4	6.0	4.8
SOCS6	"CIS4, Cish4, HSPC060, SOCS4, SSI4, STAI4, STATI4"	ENSG00000170677	"Suppressor of cytokine signaling 6"	O14544	18	70288901-70330200	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.0;myeloid DC: 6.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							CAB010189	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB010189: AB_661195"	"unprognostic (1.76e-3)"	"unprognostic (6.83e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.80e-2)"	9.1	8.8	12.7	5.1	16.3	10.2	12.8	13.8	11.6	15.0	14.6	20.1	9.8	14.1	12.9	6.7	17.7	11.8	12.6	9.8	12.8	7.8	8.9	26.1	8.8	2.8	21.4	10.1	10.6	12.4	18.1	7.2	21.1	14.9	8.7	13.5	14.3	17.3	7.8	17.7	8.4	20.4	13.3	20.3	4.2	12.7	6.1	18.0	2.5	10.8	10.3	7.5	10.6	11.8	0.5	6.3	4.6	6.0	1.5	1.1	1.7	10.2	22.6	9.6	6.6	9.2	10.8	10.8	22.0	13.6	13.4	10.2	8.4	17.4	1.1	2.0	20.4	16.3	12.1	7.0	7.2	13.1	0.0	4.2	7.7	8.0	12.9	10.9	4.1	8.7	8.7	8.7	11.6	9.8	13.4	6.7	0.9	4.5	5.3	9.1	4.9	3.6	3.1	6.2	6.5	9.7	4.2	9.3	1.9	8.3	8.4	4.5	11.1	11.3	12.6	10.2	7.3	3.7	7.3	8.2	14.8	7.5	3.0	8.8	0.0	0.0	2.8	16.5	0.3	9.9	0.0	6.0	4.6	0.4	1.2	0.2	0.5	0.8	0.1	6.3	0.0	1.1	0.6	0.0	1.5	0.1	0.6	0.0	1.7	12.7	16.3	13.8	11.6	12.8	7.8	21.4	10.1	14.9	18.0	23.8	13.4	1.3	12.4	10.4	10.4	18.0	22.9	24.1	29.6	10.4	5.9	20.5	10.0	16.1	1.1	12.2	38.4	0.0	16.2	12.8	12.9	15.0	30.1	27.7	21.4	35.0	28.3	8.6	5.7	1.8	10.6	14.7	25.3	8.2	25.7	6.5	22.4	23.7	12.0	17.4	4.7	0.0	11.3	1.2	11.3	10.5	57.2	2.2	23.0	30.4
SOCS7	"NAP4, NCKAP4"	ENSG00000274211	"Suppressor of cytokine signaling 7"	O14512	17	38352228-38405593	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9;testis: 19.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 232.7;Late spermatids: 410.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004475	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA004475: AB_2667194"	"prognostic unfavorable (7.49e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.62e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.88e-1)"	2.4	1.9	6.1	2.5	6.7	2.1	3.2	22.9	7.8	2.6	2.3	3.5	3.3	2.2	3.6	4.2	3.5	3.2	2.3	2.7	5.1		2.4	0.9	2.6	1.8	3.3	5.1	5.1	9.1	5.1	0.9	2.2	2.9	3.1	2.7	2.9	3.6	3.2	6.0	5.2	2.1	3.6	1.4	1.7	1.4	19.7	4.3	4.7	5.2	1.8	2.8	2.4	2.4	0.8	1.0	0.2	0.9	0.7	2.6	0.3	8.9	10.1	11.3	8.8	6.4	5.4	9.4	3.9	3.4	4.8	3.9	7.9	2.7	6.1	6.0	6.2	6.8	6.0	9.6	2.8	6.1	11.4	8.6	6.5	11.4	8.2	2.2	14.2	11.2	3.3	11.3	5.0	6.9	6.0	4.0	3.2	5.3	4.2	5.9	4.9	12.2	9.4	3.7	9.8	1.6	12.2	19.0	5.6	3.2	11.0	20.0	10.9	9.7	6.3	6.9	10.0	11.7	8.0	4.0	4.8	4.3	8.6	12.0	14.7	10.2	9.0	6.4	7.2	9.7	0.2	0.9	0.1	2.1	0.5	2.6	0.8	0.7	0.3	0.4	0.7	0.4	0.6	0.2	0.7	0.5	1.0	1.1	0.3											14.9	8.5	0.8	6.0	0.7	43.1	19.2	2.5	9.4	14.8	1.8	27.5	7.8	1.7	5.2	232.7	3.6	3.6	0.0	5.6	4.0	4.3	6.6	0.0	7.8	2.8	33.4	4.7	7.4	7.0	410.0	9.8	2.2	1.7	2.8	6.1	12.0	5.6	7.0	8.5	2.2	16.6	0.0	2.6	58.3	22.2	0.6	6.8	6.9	6.3	6.8
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777442-36863686	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.5"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"	NA	Yes			"Nucleoli, Cytosol"		"HPA043992: AB_2678762"	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.2	11.4	10.8	4.5	10.6	1.4	6.0	55.5	12.5	11.3	8.3	20.5	7.2	2.5	8.8	5.3	7.2	9.4	9.9	6.7	9.9	7.5	4.7	1.3	6.1	3.0	12.7	8.9	12.6	3.7	11.5	4.4	7.9	8.7	10.7	3.9	6.7	4.4	12.3	2.9	11.0	4.6	14.1	7.9	5.3	5.3	14.8	14.7	0.9	16.0	4.7	4.1	8.0	10.5	1.0	2.1	1.4	0.7	0.7	0.2	0.2	7.5	10.3	12.5	13.5	7.3	6.7	3.3	6.6	7.2	9.5	5.6	4.1	1.2	3.3	2.5	11.6	8.2	10.2	10.0	6.2	10.0	0.5	2.0	5.4	9.6	5.4	3.8	1.2	5.3	3.8	7.6	9.0	6.4	4.1	6.1	3.7	3.8	0.7	10.3	7.3	3.8	2.8	3.2	0.8	8.0	9.0	11.7	1.3	5.5	2.3	15.0	9.4	13.8	15.2	4.4	5.8	19.3	8.1	9.3	23.8	4.6	11.6	14.4	1.4	0.3	3.4	10.1	1.6	15.0	1.4	0.7	0.2	0.1	0.4	0.2	1.0	0.1	0.1	0.4	1.0	0.2	0.2	1.4	0.7	0.3	2.1	0.1	0.2	10.8	10.6	55.5	12.0	9.9	7.5	12.7	8.9	8.7	14.7	0.0	2.6	1.4	4.8	11.2	18.8	12.1	0.0	2.7	7.9	19.2	35.3	12.5	1.7	3.4	0.4	10.5	1.7	0.0	1.3	8.6	11.0	5.2	10.4	0.2	8.5	22.3	5.8	9.8	5.3	1.5	11.2	6.0	5.0	1.0	1.3	19.4	1.8	0.0	17.7	1.2	3.7	12.9	11.3	0.7	1.0	14.1	2.7	1.0	2.5	2.5
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;pituitary gland: 11.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 1.4;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.5;SCLC-21H: 24.3;SH-SY5Y: 13.9"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.8	2.8	5.0	1.8	5.3	0.4	0.4	11.4	15.3	1.0	0.8	3.7	0.0	0.5	2.1	0.2	2.0	1.0	1.9	0.8	4.2	4.5	0.6	0.6	1.7	0.8	6.7	5.0	3.3	1.7	0.2	11.9	1.2	7.9	1.1	0.6	0.7	1.1	0.5	0.3	1.0	1.9	0.6	11.4	1.4	3.9	1.8	4.3	0.0	1.9	0.0	0.3	1.6	0.8	0.3	0.2	0.0	0.0	0.0	2.3	0.0	0.2	3.3	7.5	1.1	0.0	0.6	0.3	0.7	0.9	0.9	2.4	0.2	0.3	0.4	0.2	0.1	6.2	0.0	0.8	0.0	0.7	0.7	0.1	0.6	0.0	0.1	0.0	0.2	0.1	1.2	0.0	3.7	0.0	0.8	0.0	1.1	0.3	0.2	0.5	0.5	4.9	0.0	3.4	0.0	0.8	0.4	1.8	0.0	0.1	0.0	24.3	13.9	0.0	0.0	0.2	0.9	0.0	0.3	0.2	6.0	1.2	0.4	1.7	0.2	0.1	0.1	4.5	1.1	5.9	0.0	0.0	0.0	0.3	0.0	0.4	0.3	2.3	0.8	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.0	5.3	11.4	8.2	4.2	4.5	6.7	5.0	7.9	4.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0
SOHLH1	"bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2"	ENSG00000165643	"Spermatogenesis and oogenesis specific basic helix-loop-helix 1"	Q5JUK2	9	135693407-135699528	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 21.1;testis: 21.5"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 82.1"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CACO-2: 14.8;U-266/84: 22.8"									HPA059439			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA059439: AB_2684017"	"unprognostic (2.93e-1)"			"unprognostic (1.23e-3)"	"unprognostic (9.85e-3)"	"unprognostic (2.84e-2)"		"unprognostic (3.55e-1)"		"unprognostic (2.59e-3)"				"unprognostic (4.98e-3)"	"unprognostic (2.17e-1)"		"unprognostic (1.63e-1)"	0.2	0.1	4.4	0.2	3.2	0.1	0.2	1.7	21.1	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.1	0.2	0.2	9.4	1.4	0.2	0.2	0.2	0.2	2.0	0.2	0.3	0.2	0.3	1.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.4	0.2	0.2	21.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	3.2	1.7	21.1	9.4	1.4	2.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	8.0	82.1	0.0	0.0	0.0	0.0	0.0
SORBS3	"SCAM-1, SH3D4, vinexin"	ENSG00000120896	"Sorbin and SH3 domain containing 3"	O60504	8	22544986-22575788	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 147.7;Late spermatids: 378.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015849	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA		6600	Cytosol	"Focal adhesion sites"	"HPA015849: AB_1857365"	"unprognostic (6.15e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.88e-4)"	"unprognostic (4.21e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.53e-5)"	52.2	22.6	25.0	16.8	23.2	3.3	56.5	31.4	27.0	49.3	28.9	21.9	19.2	19.6	40.6	32.0	27.5	33.8	42.8	32.8	27.3	12.8	28.1	41.8	38.9	28.7	21.3	18.0	49.0	21.7	27.0	24.1	43.3	22.8	38.0	23.7	45.8	36.6	34.5	29.5	32.0	34.5	41.9	24.1	28.6	20.4	36.0	21.2	3.4	29.7	36.2	15.7	38.4	44.7	0.8	5.6	0.4	3.2	4.0	17.4	3.3	22.6	28.6	15.6	17.6	25.4	33.9	16.0	23.3	36.2	27.3	17.0	28.9	10.2	0.2	15.9	36.3	11.0	19.5	23.4	21.3	14.2	15.9	10.2	1.9	16.1	13.2	28.9	0.2	0.1	21.3	15.9	9.5	14.0	30.5	21.1	12.1	4.9	0.7	19.4	8.9	1.9	0.7	5.5	3.9	12.0	21.7	10.6	2.1	12.4	4.4	0.9	14.1	11.4	2.8	14.4	17.1	4.7	8.1	32.8	24.3	17.4	17.7	16.4	0.4	0.6	3.0	14.2	5.4	16.4	0.0	1.6	0.4	8.6	3.2	17.4	0.6	9.4	9.9	5.6	0.8	9.7	5.6	0.4	4.0	0.7	1.9	0.4	3.3	25.0	23.2	31.4	27.0	27.3	12.8	21.3	18.0	22.8	21.2	17.9	4.5	3.0	20.1	26.0	2.0	8.0	25.5	9.4	11.4	12.2	0.0	21.8	8.3	18.5	147.7	38.9	46.6	0.0	16.9	25.1	46.3	33.6	17.3	37.5	30.7	4.8	14.0	75.5	27.9	378.2	56.7	18.7	23.6	1.8	35.7	20.2	20.5	48.2	55.2	20.3	3.1	58.2	68.3	5.5	6.1	18.6	17.2	14.1	25.3	21.6
SORCS1	sorCS1	ENSG00000108018	"Sortilin related VPS10 domain containing receptor 1"	Q8WY21	10	106573663-107164534	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 18.5"	"Cell type enriched"	"Detected in some"	4	"Muller glia cells: 59.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"intermediate monocyte: 2.4"	"Lineage enriched"	"Detected in single"	24	"monocytes: 2.4"	"Group enriched"	"Detected in some"	12	"RH-30: 33.9;SH-SY5Y: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011948	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA011948: AB_1857366"	"unprognostic (5.86e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.82e-3)"	"unprognostic (5.81e-2)"	"unprognostic (6.48e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-4)"	1.4	5.8	6.0	4.5	14.1	0.4	1.8	0.5	13.2	2.2	10.7	1.1	1.9	1.4	2.1	1.2	2.0	3.2	2.8	4.2	2.6	4.7	8.0	0.5	0.5	1.9	2.1	6.6	1.2	3.0	0.6	1.2	0.4	3.3	2.7	3.6	6.5	2.4	4.9	0.8	2.3	4.5	2.7	2.1	1.7	3.4	2.3	2.7	0.2	18.5	1.1	2.7	4.7	3.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	33.9	0.0	0.0	0.0	0.0	44.4	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	14.1	0.5	11.3	2.6	4.7	2.1	6.6	3.3	2.7	0.0	0.3	0.0	0.0	0.6	1.8	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	14.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.3	3.4	0.0	0.0	1.7	0.0	0.0	59.3	0.1	0.0	0.4	2.2	1.7	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1"	"Cell type enhanced"	"Detected in many"	19	"Bipolar cells: 66.5;Muller glia cells: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;HaCaT: 16.6;HMC-1: 12.5;RPMI-8226: 7.4;SiHa: 12.0;THP-1: 7.0;U-937: 7.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061916			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA061916: AB_2684636"	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	4.9	2.6	12.0	6.4	16.6	3.3	1.8	4.8	22.4	13.8	4.0	32.1	3.2	3.1	6.0	8.2	4.7	3.5	7.1	3.2	10.7	6.9	7.4	5.2	8.3	2.0	9.9	11.2	7.4	1.7	0.8	2.7	0.9	11.2	7.5	2.6	7.5	2.6	5.3	2.4	1.9	4.2	11.5	11.2	1.3	1.9	3.4	11.3	0.8	6.2	2.2	2.7	5.2	3.7	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.9	1.1	0.2	0.1	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.5	0.0	6.6	4.2	1.1	16.6	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.2	0.1	0.0	12.5	0.2	3.7	5.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.7	0.0	1.3	7.4	0.2	0.0	0.7	0.6	12.0	0.0	0.0	0.7	0.0	7.0	0.0	4.3	1.3	0.0	0.1	0.0	0.0	0.0	1.4	7.3	0.2	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	12.0	16.6	4.8	17.7	10.7	6.9	9.9	11.2	11.2	11.3	3.0	13.7	0.0	0.2	0.1	66.5	2.0	0.0	2.7	7.9	5.2	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.2	0.2	1.6	0.0	0.0	0.3	10.2	11.8	0.3	1.7	0.0	0.0	31.9	0.7	0.0	7.4	0.7	2.4	0.0	0.5	0.1	0.1	0.4	0.0	0.0	0.0	0.4
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023104-45077185	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"	17	"Hepatocytes: 654.8;Proximal tubular cells: 226.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 72.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 36.4"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 36.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		430000	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.4	10.2	3.0	1.5	3.2	1.0	7.1	3.1	3.8	66.3	5.5	6.2	39.2	2.6	2.6	3.2	6.7	3.5	3.9	3.4	3.0	3.0	20.9	98.4	1.6	2.2	4.2	2.3	1.6	7.3	1.2	1.8	0.5	5.0	48.5	3.8	2.3	7.6	46.7	1.4	8.0	8.7	2.0	5.0	2.4	5.6	2.5	3.9	3.1	116.3	3.8	3.5	4.2	4.4	1.6	2.4	36.4	2.7	0.4	1.0	1.3	15.6	13.8	3.5	11.3	3.0	5.3	3.7	4.3	3.0	9.9	8.4	11.5	8.6	2.0	9.8	5.3	10.7	23.6	18.1	16.4	7.9	34.0	11.2	15.7	18.1	25.3	2.3	27.3	26.4	6.8	12.5	5.7	9.1	4.8	9.3	24.2	17.6	5.6	9.3	6.3	16.5	14.8	13.5	26.5	14.7	0.0	22.8	7.6	7.2	15.3	24.8	13.0	8.9	14.0	6.6	3.9	20.2	11.2	8.3	7.9	7.0	17.6	10.4	1.0	6.9	2.0	12.8	24.1	20.6	5.0	2.7	36.4	0.6	2.5	1.0	1.2	0.6	0.8	2.4	1.6	0.5	0.6	1.4	0.4	2.5	1.3	0.6	1.3	3.0	3.2	3.1	3.8	3.0	3.0	4.2	2.3	5.0	3.9	0.0	1.9	16.8	20.6	6.9	9.5	2.8	38.2	28.1	28.4	31.4	0.0	1.0	24.9	52.5	26.1	3.8	9.1	0.0	118.4	3.9	5.8	134.4	8.1	654.8	14.4	3.2	81.4	20.9	21.2	17.1	3.4	8.2	15.1	8.2	29.3	6.8	90.9	13.3	5.6	226.9	3.6	0.0	9.2	6.5	2.5	17.8	0.8	6.4	32.6	87.8
SOS1	"GF1, GINGF, HGF"	ENSG00000115904	"SOS Ras/Rac guanine nucleotide exchange factor 1"	Q07889	2	38981396-39124345	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005396	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB005396: AB_2270724"	"unprognostic (6.68e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-2)"	25.9	13.2	19.2	18.8	18.1	12.0	26.1	33.3	18.6	18.6	21.9	12.1	15.3	18.3	19.1	14.6	17.4	17.0	18.1	16.4	17.9	14.1	14.6	15.2	19.9	19.9	18.2	14.0	28.1	13.0	33.5	21.7	21.5	17.8	18.4	16.8	14.6	15.9	18.1	26.2	15.0	23.1	22.3	14.6	16.2	20.1	12.7	20.1	23.1	19.4	12.9	21.8	25.1	22.0	3.2	1.4	3.2	2.0	6.2	4.6	0.9	9.9	6.1	9.6	6.8	13.0	15.5	10.0	6.3	7.8	5.0	4.8	6.6	6.0	14.5	4.3	8.2	7.8	6.0	11.2	5.7	9.4	14.5	5.0	22.4	5.3	9.1	5.3	7.1	57.0	9.5	9.2	6.8	6.7	8.6	7.9	3.3	9.5	6.8	6.4	5.4	7.6	6.6	6.0	12.3	4.4	8.6	8.6	4.2	5.3	8.1	9.3	9.3	7.5	13.5	7.8	8.3	4.3	3.8	8.8	8.4	6.8	6.6	6.2	8.1	8.2	7.6	6.7	7.1	5.0	0.0	1.2	3.2	3.2	1.8	4.6	3.2	3.3	3.3	1.0	2.4	3.7	3.4	1.4	6.2	2.0	1.4	1.9	0.9	19.2	18.1	33.3	18.6	17.9	14.1	18.2	14.0	17.8	20.1	14.9	31.1	14.3	12.7	18.4	17.6	28.1	17.8	21.4	19.4	8.7	9.8	7.5	1.7	8.3	24.4	32.8	15.5	0.0	10.3	6.5	15.3	19.0	3.5	14.8	9.1	7.9	11.5	10.4	14.6	4.9	21.0	14.4	6.8	8.2	17.7	15.7	10.1	10.5	20.5	10.0	11.2	6.5	11.2	7.6	5.3	22.1	8.7	22.3	16.4	25.8
SOS2		ENSG00000100485	"SOS Ras/Rho guanine nucleotide exchange factor 2"	Q07890	14	50117120-50231558	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004577, HPA047368, HPA052689"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB004577: AB_628270, HPA047368: AB_2680014, HPA052689: AB_2681917"	"unprognostic (7.99e-2)"	"unprognostic (6.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (8.48e-8)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.57e-2)"	16.0	12.9	16.9	10.5	17.8	25.2	13.4	15.8	14.5	12.9	20.1	19.8	23.4	15.5	14.9	17.3	12.7	11.2	11.4	15.3	17.7	13.4	18.4	9.4	12.5	15.6	19.9	9.8	11.8	11.6	38.6	20.5	30.1	15.1	13.0	13.0	11.1	14.3	14.7	37.1	13.0	26.7	18.3	23.1	17.0	12.1	19.2	16.8	14.7	18.7	14.6	10.3	15.3	15.0	1.2	2.1	8.5	2.8	2.4	1.8	0.6	9.6	7.1	14.6	9.7	11.2	12.3	6.9	8.7	9.7	6.6	8.3	3.1	12.9	10.2	7.9	11.1	11.5	8.9	7.8	6.6	11.8	17.0	2.9	10.2	5.6	5.4	12.4	12.0	11.0	12.7	16.3	6.2	14.4	16.8	14.2	8.5	7.8	25.6	15.8	8.0	9.9	9.5	4.5	7.3	6.3	10.7	20.3	7.6	10.7	9.2	10.6	12.4	9.7	11.5	11.4	11.0	12.7	14.7	15.5	18.3	12.0	8.2	5.6	18.1	19.6	12.6	4.7	6.7	10.7	8.5	1.8	4.1	1.8	1.4	1.5	0.9	1.1	1.3	1.2	1.2	1.3	1.2	7.2	2.4	2.8	2.1	0.1	0.6	16.9	17.8	15.8	14.5	17.7	13.4	19.9	9.8	15.1	16.8	8.9	19.9	1.9	15.2	31.7	16.1	38.0	20.4	14.7	19.4	17.4	15.7	6.4	6.6	10.3	9.6	23.3	24.9	0.0	9.2	6.6	14.1	24.6	19.7	11.9	8.1	23.8	19.5	18.4	30.6	5.6	11.5	17.9	16.9	1.8	18.1	18.5	11.9	22.9	12.7	12.7	22.5	19.4	17.6	38.0	6.9	34.6	10.9	17.3	11.7	28.4
SOWAHB	ANKRD56	ENSG00000186212	"Sosondowah ankyrin repeat domain family member B"	A6NEL2	4	76894928-76898147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.3"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 1.4;Distal tubular cells: 1.7;Urothelial cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;BEWO: 8.8;CACO-2: 4.2;OE19: 6.7;RT4: 18.9;T-47d: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036809, HPA036810"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA036809: AB_10672479, HPA036810: AB_2675327"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.73e-3)"	0.3	0.6	1.2	2.1	1.1	0.0	0.9	0.5	7.9	1.7	6.9	0.2	7.4	5.1	0.3	0.7	9.7	0.9	4.3	0.2	1.0	1.1	6.9	16.3	1.6	0.0	0.7	2.0	0.2	7.3	5.6	0.9	0.6	1.4	2.2	5.8	0.3	11.1	2.7	0.2	2.2	12.6	0.0	0.4	0.2	4.2	0.2	0.2	0.0	3.9	2.3	4.9	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	4.2	2.6	0.0	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.5	18.9	0.1	0.0	0.0	1.4	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.5	7.9	1.0	1.1	0.7	2.0	1.4	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2
SOWAHC	"ANKRD57, C2orf26, FLJ21870"	ENSG00000198142	"Sosondowah ankyrin repeat domain family member C"	Q53LP3	2	109614334-109618990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 131.1;Suprabasal keratinocytes: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.9;hTCEpi: 18.6;RT4: 23.6"	"Low region specificity"	"Detected in all"							HPA056131	Enhanced		Approved	Cytosol		No	No			Cytosol		"HPA056131: AB_2683047"	"unprognostic (6.76e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (5.11e-3)"	"prognostic favorable (3.56e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.54e-2)"	4.9	2.7	2.7	3.7	2.7	0.1	6.5	0.8	2.3	8.9	11.8	3.5	5.3	3.3	3.7	6.4	30.4	3.6	7.2	2.2	2.5	3.2	11.5	35.4	5.1	3.7	5.7	0.8	9.2	4.1	4.1	2.2	20.7	3.6	9.8	5.9	3.9	8.1	6.3	1.1	14.4	17.9	7.8	5.7	3.6	4.4	7.8	2.8	3.2	5.3	30.4	15.9	11.5	10.5	0.8	0.5	1.3	2.3	0.5	1.1	0.5	6.7	1.3	3.9	2.1	2.0	3.3	12.8	14.8	8.7	2.6	2.7	6.0	2.1	0.0	6.1	2.2	4.9	6.4	0.9	9.7	2.8	55.9	6.5	0.0	3.0	8.5	1.8	0.0	1.7	1.7	18.6	5.6	4.0	2.2	0.6	0.0	0.1	0.0	1.9	2.2	0.0	0.6	2.8	6.2	5.9	0.0	0.8	0.1	3.9	23.6	4.9	2.1	5.0	0.9	3.9	4.0	1.9	0.1	0.9	2.1	7.9	1.2	1.0	1.9	1.8	0.0	2.4	0.2	4.7	1.3	2.3	0.3	0.3	0.9	0.4	0.8	0.7	0.3	0.2	0.6	0.5	0.7	1.2	0.5	0.8	0.5	1.1	0.5	2.7	2.7	0.8	2.3	2.5	3.2	5.7	0.8	3.6	2.8	14.9	9.8	3.0	32.5	131.1	10.3	4.2	20.4	2.7	12.5	12.2	9.8	3.1	3.3	14.2	38.3	6.8	30.2	0.0	6.2	25.3	12.3	14.5	0.0	44.5	6.9	0.0	15.0	7.4	7.2	8.5	10.9	6.1	18.6	1.8	27.8	8.0	11.7	40.3	14.2	17.4	18.6	12.9	15.3	10.4	6.9	174.3	8.4	1.5	31.7	73.5
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 185.8;Suprabasal keratinocytes: 148.4;Urothelial cells: 76.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Group enriched"	"Detected in some"	7	"A-431: 41.8;HaCaT: 47.0;HBEC3-KT: 18.8;hTCEpi: 18.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"		Yes	NA			Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	41.8	1.0	0.6	0.3	0.0	0.1	3.2	0.5	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	0.1	47.0	0.0	18.8	0.1	1.1	1.3	0.1	0.5	0.1	0.0	0.1	0.9	0.0	18.6	0.2	4.2	1.3	0.0	0.8	0.9	0.3	0.0	0.3	0.2	0.5	1.3	0.1	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	1.9	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.5	0.6	1.5	0.6	1.1	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0	0.0	0.0	0.0	39.1	185.8	11.0	2.8	0.0	10.7	5.7	1.8	13.7	0.3	1.7	0.0	0.1	1.6	0.2	0.0	0.4	1.5	6.1	15.1	0.0	0.0	0.4	9.5	1.2	1.8	2.7	0.6	29.1	1.1	25.3	1.8	0.0	33.2	0.3	0.0	34.6	0.0	6.2	32.3	8.9	0.4	8.7	148.4	0.9	0.0	0.2	76.9
SOX17		ENSG00000164736	"SRY-box 17"	Q9H6I2	8	54457935-54460888	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	23	"Endothelial cells: 80.4;Ito cells: 39.3;Melanocytes: 18.6"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 122.8;ovarian cancer: 96.2;testis cancer: 25.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"EFO-21: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025594, HPA068399"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025594: , HPA068399: AB_2685981"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.76e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.98e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.88e-1)"	26.7	2.0	1.2	9.1	1.8	0.6	31.3	0.6	2.9	25.7	7.9	1.5	1.0	1.4	23.9	7.1	11.6	23.1	20.2	20.6	1.5	1.3	3.0	2.2	8.7	1.5	2.0	1.0	13.0	1.5	1.7	1.5	9.9	2.3	7.6	1.6	3.6	2.4	3.0	13.3	3.1	3.3	5.9	1.8	15.7	3.7	5.8	0.4	0.8	3.6	6.2	1.3	12.3	5.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.6	2.9	1.5	1.3	2.0	1.0	2.3	0.4	0.0	0.0	0.0	0.1	12.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	80.4	0.0	0.0	0.2	0.1	1.0	0.6	0.0	0.0	0.1	0.0	0.0	39.3	1.6	1.5	2.3	0.0	18.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.4	0.6	11.8	0.0	0.0	0.0	1.5
SOX18		ENSG00000203883	"SRY-box 18"	P35713	20	64047582-64049641	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 53.3"	"Group enriched"	"Detected in many"	15	"Endothelial cells: 106.0;Ito cells: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 15.5;NB-4: 25.5;REH: 6.1;TIME: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA073703			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073703: AB_2686628"	"unprognostic (2.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.63e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.40e-2)"	53.3	6.2	3.1	9.9	5.0	1.8	27.5	2.5	5.2	18.3	9.4	3.1	4.3	7.4	26.0	10.0	16.4	15.0	15.8	29.7	3.2	3.1	10.1	6.8	29.3	17.7	4.8	2.3	11.2	3.6	4.6	3.2	12.4	6.1	12.3	2.7	13.1	8.1	5.8	20.3	7.9	7.2	7.0	3.4	13.7	7.2	6.9	1.2	2.9	13.8	20.5	5.8	8.4	18.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.8	0.0	2.1	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	15.5	0.0	2.6	0.0	0.0	0.5	0.0	25.5	0.1	0.0	0.2	6.1	0.0	0.4	0.0	1.0	0.4	0.5	0.2	0.0	0.3	0.0	0.4	1.2	7.0	0.1	2.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.0	2.5	5.2	3.2	3.1	4.8	2.3	6.1	1.2	0.0	1.1	3.4	0.1	0.9	0.8	6.2	2.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	8.8	106.0	0.0	0.0	0.0	0.0	0.9	0.2	4.6	0.2	0.1	0.0	0.0	165.7	8.9	2.1	1.1	0.8	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	1.0	1.8	1.5	1.0	0.2	0.0	0.0	0.4
SOX21	SOX25	ENSG00000125285	"SRY-box 21"	Q9Y651	13	94709622-94712399	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.2;skin 1: 18.3;stomach 1: 38.7"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 4.7;Suprabasal keratinocytes: 8.0"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 42.6;NTERA-2: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048337, HPA064084"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048337: AB_2732547, HPA064084: AB_2685187"	"unprognostic (3.33e-1)"	"prognostic favorable (7.60e-4)"		"unprognostic (7.96e-2)"	"prognostic favorable (8.79e-5)"	"unprognostic (1.54e-2)"	"unprognostic (3.87e-1)"	"unprognostic (9.02e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	0.6	0.6	11.0	0.7	10.1	0.6	1.5	2.5	13.2	0.7	0.6	7.5	0.0	0.6	0.7	0.6	8.3	0.7	0.7	0.6	10.9	5.5	0.6	0.6	0.8	0.6	6.0	8.2	0.6	0.6	0.6	0.1	0.6	5.8	1.2	0.6	0.0	1.7	0.6	0.7	18.3	0.6	0.7	6.1	0.6	38.7	0.8	9.8	0.0	0.7	1.0	4.3	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	3.3	6.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.1	2.5	12.3	10.9	5.5	6.0	8.2	5.8	9.8	0.0	0.0	0.0	1.2	4.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.0	0.0	0.0	0.0	0.7
SOX7		ENSG00000171056	"SRY-box 7"	Q9BT81	8	10723768-10730512	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.2"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 57.2;Basal keratinocytes: 54.4;Endothelial cells: 70.1;Ito cells: 42.4;Suprabasal keratinocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.4;hTCEpi: 17.4;HUVEC TERT2: 20.3;TIME: 5.4"	"Low region specificity"	"Detected in many"							HPA009065	Approved		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.45e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.41e-3)"	"unprognostic (4.84e-3)"	17.4	1.8	3.5	3.4	3.3	0.7	7.0	1.7	4.2	16.0	3.4	2.1	1.0	0.8	7.1	6.8	19.7	3.0	6.1	12.5	2.6	2.2	3.0	7.4	37.2	2.9	2.6	1.5	2.6	4.5	2.7	4.2	26.4	3.6	5.8	2.2	7.6	7.1	5.0	12.5	11.7	2.1	4.2	3.0	2.2	2.2	1.9	3.2	0.6	4.7	22.7	14.5	8.8	23.1	1.9	0.3	0.8	0.4	0.2	1.2	0.1	4.5	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.5	9.4	2.8	3.4	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.1	17.4	0.0	3.6	0.0	20.3	0.0	0.4	0.2	0.0	0.1	0.1	0.1	1.3	0.7	2.6	0.9	0.0	0.0	0.0	1.7	0.5	2.7	1.7	0.0	0.0	1.2	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.5	0.4	0.1	0.2	0.2	1.2	1.9	0.3	0.1	0.1	0.3	0.2	0.4	0.8	0.2	0.1	0.3	0.1	0.1	3.5	3.3	1.7	4.2	2.6	2.2	2.6	1.5	3.6	3.2	0.0	18.1	2.7	57.2	54.4	1.1	2.8	2.5	2.7	3.4	0.0	3.9	4.1	0.0	0.1	0.2	70.1	0.0	0.0	0.2	0.2	2.8	12.5	3.5	4.5	0.5	0.0	0.0	42.4	1.5	0.0	0.9	1.1	3.3	0.0	0.1	0.5	0.2	0.0	0.4	0.0	2.4	0.0	4.1	2.6	1.5	35.5	10.4	0.0	0.4	20.7
SP140	"LYSP100-A, LYSP100-B"	ENSG00000079263	"SP140 nuclear body protein"	Q13342	2	230203110-230313215	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.2;lymphoid tissue: 46.8"	"Group enriched"	"Detected in many"	4	"B-cells: 77.6;Erythroid cells: 23.3;T-cells: 44.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 36.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 18.0;HDLM-2: 30.1;Karpas-707: 15.0;RPMI-8226: 9.3"									"HPA006162, HPA067493"	Enhanced		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center"	Mitochondria	"HPA006162: AB_1857403, HPA067493: AB_2685851"	"unprognostic (8.15e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-3)"	"unprognostic (5.72e-4)"	"unprognostic (5.66e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.20e-9)"	"unprognostic (9.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.30e-3)"	1.9	0.8	0.9	39.1	1.1	2.9	1.1	0.5	0.7	0.7	2.3	0.5	0.0	1.4	0.6	0.9	3.5	0.8	1.4	0.8	0.9	1.0	1.1	1.1	6.3	26.9	1.4	0.0	0.7	0.4	0.0	0.9	0.6	0.6	1.0	2.0	1.0	8.9	0.1	0.3	0.7	13.1	0.3	2.0	34.9	2.3	1.3	0.7	4.0	1.3	1.7	46.8	4.8	0.9	36.2	3.0	12.6	3.6	5.1	10.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	18.0	0.0	0.0	3.1	0.0	0.0	0.0	1.1	30.1	0.0	0.0	0.0	0.4	0.1	2.5	0.1	0.3	0.0	0.3	0.4	0.2	0.0	0.1	0.0	15.0	0.3	0.0	0.0	0.8	0.8	0.0	0.0	0.0	1.7	9.3	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.8	0.0	0.0	5.5	2.2	0.6	1.3	0.4	0.0	0.0	1.3	4.1	9.0	2.6	10.0	36.2	9.0	9.7	3.0	25.1	4.6	6.1	12.6	5.1	3.6	0.2	7.8	3.6	0.9	1.1	0.5	0.7	0.9	1.0	1.4	0.0	0.6	0.7	0.0	2.9	77.6	0.0	0.8	0.7	0.4	0.0	2.7	1.2	0.0	7.9	0.1	0.0	0.0	10.8	0.6	0.0	23.3	0.0	0.1	0.9	0.1	0.0	0.8	10.0	0.0	0.0	3.1	6.3	3.0	0.0	10.1	6.8	10.0	0.0	0.5	0.2	0.0	1.1	0.3	1.6	0.0	0.4	1.4	0.4	1.0	0.2	44.0	0.0	0.1
SP140L		ENSG00000185404	"SP140 nuclear body protein like"	Q9H930	2	230327184-230403732	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA055864	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055864: AB_2682949"	"unprognostic (1.44e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.70e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (5.09e-10)"	"unprognostic (9.15e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-3)"	11.0	10.5	2.2	24.3	4.6	9.6	9.3	1.0	2.8	11.2	10.0	4.3	8.7	8.5	12.5	12.0	8.4	7.7	9.7	6.0	3.3	2.2	7.7	14.5	12.3	19.3	4.8	1.4	12.3	5.1	1.9	6.1	10.8	4.8	9.1	7.5	5.1	16.0	12.5	5.4	3.5	16.2	9.4	6.7	25.0	6.8	2.8	4.3	15.7	6.3	6.4	22.7	10.5	16.0	21.0	5.1	11.2	7.1	14.5	13.4	6.0	7.7	1.4	1.8	5.6	9.7	10.6	10.3	11.5	13.3	9.7	15.4	0.8	9.0	5.9	12.1	8.9	17.0	1.4	0.0	8.4	15.9	15.4	0.0	10.4	6.2	5.7	18.2	8.5	12.0	8.7	4.5	14.0	9.4	8.1	14.1	9.1	2.5	5.6	17.4	4.2	12.7	11.9	6.5	5.3	4.0	4.5	17.1	4.7	8.8	9.8	0.3	1.8	2.8	5.8	6.4	12.1	8.5	9.2	15.4	8.6	6.3	4.9	8.7	8.2	5.0	8.4	11.4	8.7	15.0	11.2	4.9	2.4	10.4	6.5	12.5	16.9	9.5	8.3	5.1	21.0	13.4	12.0	5.0	14.5	7.1	2.1	5.8	6.0	2.2	4.6	1.0	2.8	3.3	2.2	4.8	1.4	4.8	4.3	29.8	32.3	27.9	13.3	1.6	2.9	3.6	12.7	33.5	21.6	15.7	17.7	8.2	0.0	18.2	11.1	25.1	11.3	0.0	15.9	13.8	7.0	8.3	39.5	8.2	17.4	0.0	3.5	11.1	13.7	3.2	4.0	14.8	5.0	6.4	7.9	2.0	17.5	21.0	7.8	2.9	1.9	6.5	6.9	0.5	1.4	2.3	10.0	28.7	6.6	18.4
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	18.8	15.0	16.9	21.9	20.5	19.1	21.0	28.5	23.4	17.3	16.3	26.9	12.5	16.9	20.5	16.2	19.9	18.3	14.9	20.2	13.8	11.8	17.2	13.3	17.4	22.3	14.1	13.0	20.5	19.7	31.0	14.5	21.4	18.5	16.2	15.8	26.9	18.7	18.2	30.2	19.2	20.8	16.6	17.6	22.2	16.5	23.2	16.3	31.9	21.7	16.0	28.3	18.9	18.0	8.3	6.3	14.3	9.3	12.7	11.5	7.8	16.5	19.2	13.2	11.1	6.5	6.1	12.6	9.8	7.2	10.2	9.2	20.9	8.4	14.4	8.8	12.8	10.3	12.8	9.2	8.5	10.7	20.9	12.9	14.6	12.9	10.8	6.1	13.0	17.3	8.8	10.1	11.9	11.3	7.2	9.6	13.4	15.8	24.6	9.8	22.5	32.1	8.2	5.9	15.0	12.8	14.6	18.1	9.0	7.1	26.9	13.2	15.8	8.5	9.1	9.7	8.5	13.1	12.4	15.8	17.9	9.6	12.4	15.0	21.9	24.2	12.9	9.7	8.8	14.4	14.3	8.0	12.1	11.5	9.3	10.1	7.0	8.8	10.7	6.3	8.3	10.2	10.3	14.3	12.7	8.1	6.1	8.8	7.8	16.9	20.5	28.5	23.4	13.8	11.8	14.1	13.0	18.5	16.3	8.9	21.6	8.3	13.7	5.6	8.4	8.3	2.5	12.0	5.7	10.4	0.0	9.2	13.3	5.9	7.9	10.0	7.7	0.0	6.7	7.7	6.0	10.4	12.7	5.8	7.8	11.1	15.0	5.5	8.5	7.5	9.8	9.2	8.5	7.2	8.9	11.3	5.4	11.5	3.2	5.9	5.9	6.5	7.8	9.1	7.2	6.6	17.2	12.5	7.3	14.5
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428034-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: AB_2676959"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	5.8	4.7	7.9	8.9	11.0	10.2	6.3	25.9	9.5	8.6	4.4	6.4	3.8	3.1	9.2	5.8	4.1	7.8	4.6	6.5	8.3	6.1	5.4	3.4	6.0	11.7	8.6	6.9	19.8	5.2	17.1	11.8	3.7	6.7	7.3	4.3	6.0	5.0	5.7	10.5	5.0	5.6	5.3	6.8	9.1	4.9	6.0	10.0	27.0	13.1	4.8	11.2	6.8	6.3	5.4	1.5	7.2	1.8	3.5	8.3	3.1	2.2	1.7	5.1	8.1	1.5	1.0	1.5	2.3	1.7	2.7	3.7	3.5	2.7	9.2	1.4	1.5	7.2	2.8	7.5	2.2	5.3	2.7	2.8	4.8	3.3	1.5	1.1	4.0	5.7	1.1	1.9	2.9	3.3	1.4	5.4	6.7	6.0	7.0	2.2	1.0	9.3	2.9	12.3	4.3	2.1	20.9	8.7	3.3	0.9	1.6	6.6	8.2	5.3	2.4	1.8	5.1	2.6	2.9	2.3	4.4	5.5	2.7	4.2	9.3	7.3	14.4	2.5	6.4	6.1	4.3	0.8	7.2	6.8	0.9	8.3	3.7	6.4	6.6	0.9	5.4	7.6	7.1	1.9	3.5	1.8	1.5	7.6	3.1	7.9	11.0	25.9	9.5	8.3	6.1	8.6	6.9	6.7	10.0	3.0	7.0	5.0	11.4	11.2	15.9	7.6	10.2	1.4	7.9	0.0	7.9	1.0	0.0	1.7	5.5	5.8	1.1	0.0	1.8	1.0	6.1	7.1	4.7	4.0	1.5	17.5	10.3	11.6	6.5	4.1	5.2	5.9	6.8	2.8	1.8	9.8	1.4	8.6	6.3	1.4	18.8	0.0	4.1	7.9	8.3	9.7	1.3	14.6	2.8	4.3
SP5		ENSG00000204335	"Sp5 transcription factor"	Q6BEB4	2	170715351-170718078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 3.3;Fibroblasts: 2.3;Mucus-secreting cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 51.7"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Group enriched"	"Detected in many"	4	"cerebellum: 5.3;hippocampal formation: 1.2;olfactory region: 5.8;thalamus: 3.6"	HPA074123			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA074123: AB_2686664"	"unprognostic (1.16e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.77e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-8)"	"unprognostic (8.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.17e-1)"	8.7	1.8	0.5	2.5	0.6	0.1	7.4	1.6	1.0	11.4	3.9	1.4	3.2	3.1	7.2	3.0	1.9	3.0	5.1	0.8	0.6	1.4	0.8	5.9	4.6	3.1	0.2	0.8	1.5	0.5	0.1	0.1	2.1	0.4	7.2	1.0	3.8	2.1	0.9	0.7	6.6	3.1	3.1	0.1	0.2	7.3	2.4	0.0	0.2	0.1	0.8	6.5	3.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.9	0.0	0.0	0.2	0.0	0.2	0.6	0.1	0.0	0.0	1.5	0.1	0.2	0.0	51.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.6	1.0	0.6	1.4	0.2	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.7	0.0	2.8	0.0	0.0	0.0	1.8	0.0	0.9	3.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.3	0.1	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.9	0.0
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 45.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"		Yes	No			Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.4	0.0	0.0	0.0	0.0	45.4	0.2	0.2	0.9	0.2	9.5	0.9	0.0	0.3	0.0	0.6	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	0.1	0.1	2.2	0.0	0.0	0.8	0.0	0.0	0.0	3.9	0.8	0.0	0.0	0.0	0.2	5.7	1.4	0.0	0.0	5.8	0.0	8.7	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	45.5	0.0	0.7	0.0	0.3	6.9	0.0	0.7	1.6	0.3	1.6	0.0	0.0	3.6	0.0	1.7	1.3	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.0	1.3	2.9	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.6	82.6	0.0	2.7	5.1
SP8		ENSG00000164651	"Sp8 transcription factor"	Q8IXZ3	7	20782283-20786886	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"prostate: 14.3"	"Cell type enhanced"	"Detected in some"	16	"Basal glandular cells: 2.9;Glandular cells: 2.4;Spermatocytes: 1.2;Spermatogonia: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HUVEC TERT2: 5.9;NTERA-2: 12.2;PC-3: 20.6"	"Group enriched"	"Detected in some"	13	"basal ganglia: 15.7;olfactory region: 66.8"	"Region enriched"	"Detected in some"	11	"olfactory region: 72.4"	HPA054006	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054006: AB_2682340"		"unprognostic (1.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-4)"		"unprognostic (3.46e-1)"	"unprognostic (5.49e-1)"	"unprognostic (1.73e-2)"		"unprognostic (2.42e-2)"		"unprognostic (3.38e-1)"	"unprognostic (7.44e-2)"			0.1	0.1	2.3	0.1	2.8	0.1	0.2	0.1	3.2	0.3	0.3	1.9	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.5	0.3	0.1	0.2	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.2	0.7	14.3	0.1	0.0	0.1	0.1	0.1	2.4	0.8	0.1	0.2	0.2	0.3	0.5	0.7	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	1.1	0.0	0.0	0.0	4.3	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	12.2	0.1	20.6	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	2.6	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.8	0.1	3.2	2.4	0.5	0.1	1.7	0.7	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.7
SP9	ZNF990	ENSG00000217236	"Sp9 transcription factor"	P0CG40	2	174334946-174338492	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.4;fallopian tube: 5.1;skin 1: 4.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.0;fHDF/TERT166: 6.8;HEK 293: 2.8;THP-1: 14.4"	"Group enriched"	"Detected in some"	6	"basal ganglia: 6.0;olfactory region: 14.4"	"Region enriched"	"Detected in many"	4	"olfactory region: 44.8"	HPA062616	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062616: AB_2684808"	"unprognostic (2.04e-2)"	"unprognostic (6.94e-3)"		"unprognostic (1.44e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.55e-3)"		"unprognostic (8.54e-2)"	"unprognostic (3.12e-1)"						"unprognostic (1.01e-1)"			0.7	0.3	4.6	0.3	12.4	0.3	1.1	0.0	6.1	0.6	0.3	0.4	0.0	0.3	0.4	0.3	0.3	5.1	0.3	0.3	2.3	2.2	0.3	0.3	0.3	0.4	1.1	4.3	0.3	0.3	0.3	0.0	1.1	1.0	0.3	0.3	0.0	0.4	0.3	0.6	4.5	0.3	0.3	0.5	0.3	0.3	2.0	1.4	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	9.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	6.8	0.0	0.1	0.2	0.0	0.0	0.0	2.8	0.6	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	12.4	0.0	6.1	2.3	2.2	1.1	4.3	1.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0
SPA17	"CT22, SP17"	ENSG00000064199	"Sperm autoantigenic protein 17"	Q15506	11	124673798-124697518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.2;testis: 82.1"	"Cell type enhanced"	"Detected in many"	22	"Ciliated cells: 459.0;Early spermatids: 1302.0;Late spermatids: 1861.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037568	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA037568: AB_10672905"	"unprognostic (1.41e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.39e-3)"	"prognostic favorable (1.03e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.78e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.71e-1)"	1.3	2.2	5.6	1.3	6.0	2.3	3.5	1.0	5.8	3.5	3.5	4.3	2.8	1.9	2.7	13.7	2.1	28.2	2.8	2.0	5.6	6.8	5.9	1.1	4.5	1.3	3.9	4.3	3.2	1.8	4.4	8.1	1.4	20.1	2.2	3.9	0.8	1.6	2.7	0.7	1.3	1.6	1.9	3.6	1.0	2.2	82.1	2.7	2.6	7.6	1.6	1.7	1.8	1.3	0.5	3.7	4.2	6.0	0.4	1.3	1.8	11.6	8.7	20.0	8.3	6.4	9.6	10.4	8.6	13.1	8.8	7.5	2.8	24.6	5.3	5.8	12.3	10.1	8.3	8.3	14.6	13.9	5.7	6.0	8.3	1.6	5.3	4.6	1.8	3.6	3.9	7.8	15.7	8.1	7.9	8.8	10.9	11.6	4.8	19.6	10.1	1.2	0.4	9.2	14.7	8.3	6.8	3.1	0.0	21.0	5.4	13.3	8.9	19.1	6.4	5.3	10.0	40.0	8.7	8.5	10.2	9.3	4.9	10.9	2.1	1.7	3.3	8.9	1.7	10.8	4.2	4.5	0.8	0.7	3.5	0.6	0.4	1.3	0.8	3.7	0.5	1.1	0.8	0.2	0.4	6.0	1.7	1.2	1.8	5.6	6.0	1.0	5.8	5.6	6.8	3.9	4.3	20.1	2.7	3.0	9.3	0.0	4.4	2.4	2.6	1.9	15.3	459.0	71.7	19.2	3.9	5.3	16.6	24.9	1302.0	4.5	10.5	0.0	13.6	8.5	3.0	3.1	0.0	1.1	10.2	0.0	6.9	2.5	4.0	1861.1	25.9	7.1	1.7	1.8	7.9	8.2	12.0	10.5	17.0	38.2	0.9	12.9	3.4	239.9	61.1	1.9	2.3	1.8	9.4	5.1
SPACA9	"C9orf9, Mast"	ENSG00000165698	"Sperm acrosome associated 9"	Q96E40	9	132878027-132890201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"epididymis: 55.8;fallopian tube: 29.1;testis: 53.8"	"Cell type enriched"	"Detected in some"	4	"Ciliated cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"JURKAT: 32.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022243, HPA051600"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA022243: AB_1845844, HPA051600: AB_2681546"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (8.31e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	2.7	6.0	7.8	1.6	8.4	1.7	3.9	4.3	9.3	5.1	4.8	8.5	7.9	1.7	5.3	55.8	5.3	29.1	4.5	7.0	7.0	8.9	7.0	1.8	4.6	2.1	7.2	7.3	9.2	2.8	2.7	5.8	3.0	6.9	4.1	2.1	5.7	7.7	6.2	1.5	8.0	1.7	4.3	7.7	2.3	3.1	53.8	5.1	6.2	10.2	3.6	3.0	2.9	3.8	6.0	3.0	5.6	3.3	7.8	3.5	1.6	1.9	2.1	3.2	2.7	4.6	5.9	3.9	1.2	2.3	1.7	1.9	0.5	6.1	0.5	2.9	5.7	3.7	2.8	1.3	3.6	1.6	2.3	2.6	0.5	1.5	0.7	6.7	1.4	0.2	6.7	7.7	4.3	4.8	7.3	2.0	32.5	0.5	1.7	4.7	4.2	4.9	5.6	0.7	3.7	2.0	2.3	0.7	1.4	7.1	0.7	0.9	3.2	5.3	0.9	4.2	2.5	7.0	0.5	1.9	3.8	2.6	3.6	0.5	0.7	1.1	1.7	7.0	0.5	1.8	5.6	2.2	3.6	2.2	2.0	2.5	6.0	2.4	1.3	3.0	4.7	2.9	2.6	3.1	7.8	3.3	1.0	3.5	1.6	7.8	8.4	4.3	9.3	7.0	8.9	7.2	7.3	6.9	5.1	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	116.4	9.1	22.7	0.0	14.2	28.2	6.2	0.0	0.0	0.0	0.0	6.2	10.9	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.4	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0
SPAG11A	"EDDM2A, HE2"	ENSG00000178287	"Sperm associated antigen 11A"	Q6PDA7	8	7847876-7868867	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	225	"epididymis: 332.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"NB-4: 10.4"									"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"	NA	NA			"Golgi apparatus"		"HPA023842: AB_2732429, HPA057479: "																		0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	332.8	1.4	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPAG11B	"EDDM2B, EP2, EP2C, EP2D, HE2"	ENSG00000164871	"Sperm associated antigen 11B"	Q08648	8	7442684-7463674	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	232	"epididymis: 362.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"BEWO: 5.7;NB-4: 12.6;RPMI-8226: 5.8;SH-SY5Y: 5.1"									"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"	NA	NA			"Golgi apparatus"		"HPA023842: AB_2732429, HPA057479: "																		0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0			0.0	0.4	362.2	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.1	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.6	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPAG16	"DKFZp666P1710, FLJ22724, PF20, WDR29"	ENSG00000144451	"Sperm associated antigen 16"	Q8N0X2	2	213284379-214410501	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Ciliated cells: 261.0;Early spermatids: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 33.9"	"Low region specificity"	"Detected in many"							HPA037542	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA037542: AB_10672353"	"unprognostic (4.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.17e-1)"	11.1	13.0	28.2	5.4	29.8	1.7	15.8	12.0	22.0	16.7	11.5	21.9	23.1	13.7	14.0	24.8	16.0	34.8	17.0	15.7	27.7	24.6	22.6	13.8	8.1	7.7	31.5	22.0	20.2	11.2	24.0	32.8	7.3	25.7	17.1	13.1	11.1	11.8	19.8	6.1	18.2	7.9	14.3	36.9	5.7	19.2	34.3	18.1	10.5	19.9	11.4	9.8	14.8	11.9	7.5	4.1	1.1	1.1	12.1	10.6	3.0	12.4	5.0	14.3	0.0	9.8	17.6	0.1	6.8	8.2	8.9	9.5	9.8	13.8	5.2	8.2	7.5	14.3	8.8	6.4	8.3	19.0	0.0	5.1	2.7	12.7	12.7	10.9	2.9	0.0	15.0	11.5	7.9	4.6	12.3	3.6	5.5	8.7	6.0	8.9	0.0	9.8	0.0	7.9	0.0	4.2	10.5	15.0	0.2	14.3	12.2	10.4	12.3	7.9	7.3	9.6	12.9	33.9	1.2	3.8	8.6	5.2	4.5	7.1	9.8	4.4	0.2	14.0	0.0	3.8	1.1	0.2	0.7	7.1	1.1	10.1	7.5	8.0	8.9	2.5	7.3	10.6	9.2	0.4	12.1	0.8	4.1	7.4	3.0	28.2	29.8	12.0	22.0	27.7	24.6	31.5	22.0	25.7	18.1	14.9	17.9	11.0	36.9	37.5	34.4	59.6	58.6	261.0	58.0	38.4	90.3	41.9	64.6	34.0	200.5	21.0	10.6	23.3	21.5	17.0	30.9	34.4	9.3	16.0	10.0	38.1	36.7	9.2	4.5	48.7	38.3	6.9	21.9	49.5	35.2	69.4	27.0	10.5	42.1	72.5	64.3	12.9	31.9	158.7	19.0	49.3	19.7	12.1	36.5	43.0
SPANXA1	"CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX"	ENSG00000198021	"Sperm protein associated with the nucleus, X-linked, family member A1"	Q9NS26	X	141583674-141585011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	28	"testis: 14.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1			0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXA2	SPANX	ENSG00000203926	"SPANX family member A2"	Q9NS26	X	141589435-141590772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXB1	"CT11.2, SPANXB2, SPANXF1, SPANXF2"	ENSG00000227234	"SPANX family member B1"	Q9NS25	X	141002591-141003706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 38.5"	"Group enriched"	"Detected in some"	136	"Early spermatids: 450.0;Late spermatids: 1630.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 41.1;GAMG: 8.8;U-2 OS: 14.4"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (8.55e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	41.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	14.4	1.0	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	450.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1630.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	6.5	0.0	7.6	4.0	0.0	0.0	0.0	0.0	0.0
SPANXC	"CT11.3, CTp11"	ENSG00000198573	"SPANX family member C"	Q9NY87	X	141241463-141242496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	24	"testis: 27.3"	"Group enriched"	"Detected in some"	194	"Early spermatids: 365.4;Late spermatids: 1260.1"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 13.3;U-2 OS: 6.5"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (3.56e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	13.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	6.5	0.0	0.5	0.0	0.0	0.2	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	365.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1260.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	4.2	2.0	0.0	0.0	0.0	0.0	0.0
SPANXD	"CT11.4, SPANXE"	ENSG00000196406	"SPANX family member D"	Q9BXN6	X	141697411-141698739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	216	"testis: 21.5"	"Group enriched"	"Detected in some"	148	"Early spermatids: 386.5;Late spermatids: 1076.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 5.1;U-2 OS: 9.8"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	9.8	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	386.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1076.8	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.1	1.5	0.0	0.0	0.0	0.0	0.0
SPANXN2	"CT11.7, SPANX-N2"	ENSG00000268988	"SPANX family member N2"	Q5MJ10	X	143711955-143721423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 5.6"	"Group enriched"	"Detected in some"	121	"Early spermatids: 41.8;Late spermatids: 95.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045652			Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA045652: AB_2679408"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.6			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0
SPANXN3	"CT11.8, SPANX-N3"	ENSG00000189252	"SPANX family member N3"	Q5MJ09	X	143508735-143517475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 28.4"	"Group enriched"	"Detected in some"	116	"Early spermatids: 353.2;Late spermatids: 183.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2 OS: 6.6"									HPA045652			Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA045652: AB_2679408"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	353.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	183.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.0
SPANXN4	"CT11.9, SPANX-N4"	ENSG00000189326	"SPANX family member N4"	Q5MJ08	X	143025918-143034702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 23.7"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 233.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.4;HeLa: 4.2;hTERT-HME1: 1.0"									"HPA045730, HPA059094"	Uncertain		Approved	"Nuclear membrane,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	"Nuclear membrane"	"HPA045730: AB_10961036, HPA059094: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	4.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0
SPARC	ON	ENSG00000113140	"Secreted protein acidic and cysteine rich"	P09486	5	151661096-151687165	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 896.1;Ito cells: 958.1;Peritubular cells: 1044.4;Sertoli cells: 2315.4;Smooth muscle cells: 1190.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 9.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.3;monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 234.0;BJ: 191.0;fHDF/TERT166: 302.0;WM-115: 222.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002306, HPA002989, HPA003020"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		190000000	Vesicles		"CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531"	"unprognostic (3.34e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.97e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.93e-3)"	178.3	58.3	50.2	47.4	93.3	3.4	68.6	33.8	131.3	115.6	42.8	92.3	22.9	13.2	89.0	65.9	36.9	38.5	177.8	65.5	68.3	100.3	46.3	25.0	66.8	25.4	124.7	18.0	55.1	14.1	36.7	16.8	249.1	153.5	46.3	22.4	47.5	15.8	45.3	31.2	40.2	20.6	144.0	202.0	43.8	20.4	75.2	68.8	7.4	38.6	39.4	14.8	104.6	35.9	0.0	0.8	9.3	3.0	0.0	0.3	40.6	0.2	0.2	56.5	2.6	234.0	79.4	5.3	191.0	63.0	79.1	81.6	0.2	0.1	0.0	45.3	302.0	12.9	2.6	7.1	14.5	27.3	0.2	2.6	2.5	0.0	5.2	70.1	0.1	0.2	123.9	20.9	58.2	8.1	93.3	108.6	0.6	2.3	2.0	44.9	0.0	0.2	1.6	26.1	0.0	0.2	0.1	56.1	0.1	0.0	0.0	2.1	4.2	0.1	0.0	25.4	95.1	0.2	6.2	128.2	37.0	57.1	16.7	59.9	0.1	0.2	0.2	32.3	0.1	222.0	2.2	3.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	9.3	0.0	0.0	0.7	0.0	40.6	50.2	93.3	33.8	24.6	68.3	100.3	124.7	18.0	153.5	68.8	77.4	37.5	11.1	26.9	146.3	50.1	28.0	7.6	9.4	30.7	15.7	2.0	100.4	0.0	4.6	11.1	490.8	0.0	23.3	0.3	315.9	896.1	5.2	11.5	5.5	99.3	1.6	0.0	958.1	70.8	28.8	295.7	31.0	222.7	5.4	0.0	10.6	8.6	0.0	1044.4	35.4	63.7	2315.4	1190.8	7.0	6.8	94.6	123.1	5.1	0.0	4.4
SPART	"KIAA0610, SPG20, TAHCCP1"	ENSG00000133104	Spartin	Q8N0X7	13	36301638-36370180	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 120.5;Club cells: 73.9;Proximal tubular cells: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 45.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 45.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039053, HPA039054"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA039053: AB_10672769, HPA039054: AB_2676323"	"unprognostic (3.73e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.18e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.79e-2)"	28.7	34.7	23.2	12.1	28.0	14.5	44.9	21.3	26.7	37.1	22.5	23.1	26.2	9.1	29.9	48.4	17.7	26.1	26.2	17.5	24.7	22.3	33.7	13.7	18.4	12.9	31.8	19.4	46.1	10.3	13.2	29.8	32.2	28.9	26.6	10.0	17.2	11.9	27.0	20.6	12.4	9.7	37.0	35.7	20.2	14.4	18.3	32.5	7.0	25.1	8.7	7.8	31.4	58.7	3.2	6.0	45.8	6.8	4.1	8.3	5.3	0.0	5.9	16.1	0.0	35.4	29.8	11.5	14.4	21.7	14.5	14.4	0.0	0.0	0.0	9.0	17.3	26.7	8.3	21.7	10.0	15.7	1.1	12.5	17.9	7.7	3.8	35.6	18.6	36.3	29.4	16.1	12.0	16.9	36.0	21.2	5.0	7.8	3.1	26.1	1.3	5.5	31.2	8.1	0.0	2.1	0.0	27.0	0.6	16.9	7.4	1.6	3.9	12.2	4.9	15.2	24.2	2.8	22.1	17.5	10.9	5.5	15.0	8.4	3.8	0.0	0.0	12.1	16.2	18.9	45.8	6.7	8.7	4.4	6.7	4.3	3.2	6.2	1.8	4.8	3.2	8.3	4.4	10.6	4.1	6.8	6.0	1.5	5.3	23.2	28.0	21.3	26.7	24.7	22.3	31.8	19.4	28.9	32.5	32.8	45.1	0.0	0.0	0.0	0.0	0.0	0.0	120.5	73.9	26.2	0.0	37.7	56.3	22.0	0.0	0.0	0.0	0.0	13.1	50.7	0.0	0.0	53.5	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	42.3	0.0	0.0	15.2	0.0	0.0	72.6	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063547-32157637	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	12.7	9.6	18.4	14.8	16.4	13.4	9.8	21.1	21.9	14.7	12.7	15.1	12.5	11.5	12.3	8.7	11.1	10.4	10.2	6.2	20.2	18.5	9.4	14.6	9.7	18.9	20.6	10.0	15.1	10.9	11.8	12.3	11.5	17.5	10.3	12.0	6.8	9.3	13.7	15.4	11.5	17.6	11.6	27.0	15.5	9.7	14.4	14.6	21.5	13.4	6.2	13.8	11.3	10.1	5.0	7.1	9.5	9.0	6.6	7.6	4.3	10.8	7.8	12.9	12.6	8.1	9.6	11.6	6.0	8.9	6.3	5.7	10.6	9.5	19.0	5.6	8.3	9.3	7.7	12.7	6.1	7.8	12.7	7.6	20.8	4.2	12.9	7.4	14.5	14.7	5.3	8.1	8.1	7.7	7.7	13.9	6.2	17.0	6.4	6.9	4.6	23.3	12.2	13.4	12.1	4.6	12.4	18.1	12.3	8.6	6.8	18.3	19.7	10.2	8.7	10.0	11.0	5.6	10.0	12.1	7.0	10.8	6.2	7.0	9.7	18.0	15.4	7.6	12.6	8.4	3.4	6.3	6.7	3.6	9.0	5.2	5.0	5.8	5.6	7.1	3.9	5.9	6.0	9.5	6.6	6.3	3.2	7.6	4.3	18.4	16.4	21.1	15.8	20.2	18.5	20.6	10.0	17.5	14.6	8.9	4.1	4.2	5.3	8.5	14.5	7.5	7.6	13.4	6.8	5.2	21.6	7.6	0.0	5.6	2.5	8.7	9.7	0.0	7.0	6.2	5.0	7.3	9.3	10.9	8.8	9.5	10.4	6.2	14.6	6.4	8.1	16.6	1.7	8.2	10.1	8.0	8.4	8.4	9.6	6.5	14.3	0.0	8.1	15.4	22.2	11.4	6.8	7.5	8.4	5.5
SPATA12		ENSG00000186451	"Spermatogenesis associated 12"	Q7Z6I5	3	57060441-57075432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"testis: 26.6"	"Group enriched"	"Detected in some"	125	"Early spermatids: 496.6;Late spermatids: 837.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 5.4;HUVEC TERT2: 2.4;RH-30: 3.1"									"HPA043323, HPA075578"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA043323: AB_10796792, HPA075578: "	"unprognostic (2.31e-1)"	"unprognostic (2.18e-4)"	"unprognostic (3.47e-4)"	"unprognostic (2.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.71e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-3)"	0.2	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.8	0.1	0.3	2.4	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.4	26.6	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.5	0.5	0.0	5.4	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.6	0.0	0.0	1.1	0.2	0.5	0.0	0.0	1.1	2.4	0.0	0.0	0.6	0.2	0.1	0.0	0.0	1.5	1.2	1.5	0.0	3.1	0.1	2.0	1.2	0.0	0.0	0.2	0.0	1.3	0.6	0.0	0.0	0.8	0.0	2.0	0.4	0.3	0.0	0.2	1.0	0.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	496.6	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.3	837.5	4.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	5.3	0.0	0.0	0.0	0.0	4.6	2.3	0.0	0.0	0.0	0.0	0.3
SPATA17	IQCH	ENSG00000162814	"Spermatogenesis associated 17"	Q96L03	1	217631324-217871696	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 48.0"	"Cell type enhanced"	"Detected in many"	21	"Ciliated cells: 161.9;Early spermatids: 584.1;Late spermatids: 424.1;Spermatocytes: 138.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030099	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA030099: AB_2270988"	"unprognostic (4.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.24e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.82e-1)"	0.5	0.6	1.4	0.3	5.2	2.4	0.9	0.5	1.2	1.0	0.5	2.7	2.9	0.6	0.7	9.7	0.5	6.8	0.8	1.1	2.3	2.2	2.8	0.4	3.0	0.3	0.8	1.6	3.3	0.6	3.0	10.8	0.4	11.1	0.7	0.3	1.2	0.6	1.2	2.9	1.0	0.7	0.2	0.7	0.4	0.6	48.0	1.4	0.0	3.1	0.3	0.2	0.5	0.5	1.3	0.6	2.3	0.6	0.6	1.0	0.1	0.6	1.2	1.2	1.2	0.3	2.0	0.9	0.5	0.7	0.6	0.3	0.8	3.2	0.6	1.0	0.4	0.4	2.2	0.8	1.1	0.7	0.6	1.2	0.5	1.5	0.8	0.6	0.3	0.5	0.7	2.3	1.2	1.2	1.4	0.1	0.7	0.7	1.3	0.6	2.5	0.4	1.0	2.3	1.6	1.2	0.4	0.4	0.4	2.3	0.9	4.8	1.9	0.7	0.8	0.6	2.0	1.5	0.6	0.6	0.8	0.6	0.9	0.5	1.3	0.8	0.3	1.9	0.5	1.1	2.3	0.5	0.5	0.9	0.5	0.8	0.7	0.7	0.7	0.3	1.3	0.9	1.0	1.5	0.6	0.6	0.6	0.3	0.1	1.4	5.2	0.5	1.2	2.3	2.2	0.8	1.6	11.1	1.4	3.0	0.0	0.0	0.8	0.6	0.4	1.4	0.0	161.9	25.0	3.5	19.6	0.7	5.0	1.7	584.1	0.5	0.0	0.0	0.6	0.5	0.7	1.6	0.0	0.0	0.2	0.0	1.7	0.0	0.0	424.1	8.1	0.7	1.7	0.0	1.0	5.1	0.2	0.0	6.3	8.4	18.5	0.0	0.1	138.2	8.1	0.9	0.2	0.0	0.6	0.4
SPATA2	"KIAA0757, PD1, PPP1R145, tamo"	ENSG00000158480	"Spermatogenesis associated 2"	Q9UM82	20	49903391-49915508	"Predicted intracellular proteins"	Necrosis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048581, HPA052224"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Nucleoli fibrillar center"	Nucleoplasm	"HPA048581: AB_2680449, HPA052224: AB_2681769"	"unprognostic (4.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-3)"	"unprognostic (8.77e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (8.33e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.57e-2)"	"unprognostic (4.38e-1)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (2.52e-1)"	4.6	6.2	15.3	5.4	19.3	15.4	5.7	16.6	25.7	5.8	10.5	12.8	4.1	11.7	5.4	6.0	5.7	7.1	5.5	5.5	15.2	11.4	5.8	5.4	5.4	5.1	14.4	15.4	6.0	11.9	7.6	6.9	5.5	10.6	8.1	9.8	5.9	8.8	6.6	12.9	5.1	11.2	5.0	19.9	15.6	8.7	18.5	10.2	4.6	11.0	4.0	5.5	5.2	3.6	4.9	3.3	6.1	3.5	3.4	4.8	2.3	5.5	6.9	4.7	4.2	5.4	3.9	7.7	3.6	5.4	12.6	5.3	21.6	4.5	4.3	7.6	3.6	6.5	10.4	3.5	6.0	6.7	5.9	3.4	2.2	4.0	14.0	5.1	6.1	9.2	3.9	7.2	6.5	4.1	4.2	2.6	6.1	7.6	4.9	3.0	11.8	6.1	15.4	7.1	7.6	8.4	4.7	5.1	4.5	4.1	4.4	4.5	4.8	7.2	22.1	5.6	3.8	5.3	5.3	3.7	9.0	7.4	7.4	5.0	12.2	9.3	4.6	7.1	3.2	4.0	0.3	3.5	3.3	3.7	2.5	3.5	3.6	3.4	4.5	3.3	4.9	4.5	4.8	6.1	3.4	1.3	1.6	3.8	2.3	15.3	19.3	16.6	25.7	15.2	11.4	14.4	15.4	10.6	10.2	8.9	2.1	3.9	5.7	6.5	7.4	3.9	12.7	5.3	0.0	0.0	7.9	9.5	3.3	5.2	31.9	6.3	19.1	0.0	7.1	10.6	5.8	5.5	4.6	5.7	4.2	6.4	25.3	9.8	5.7	41.2	4.6	3.4	5.0	5.4	20.8	4.8	7.0	16.5	5.3	3.6	7.5	6.5	5.1	32.5	16.1	6.4	25.2	4.4	16.1	7.0
SPATA20	"FLJ21347, SSP411, Tisp78"	ENSG00000006282	"Spermatogenesis associated 20"	Q8TB22	17	50543058-50555852	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	24	"Early spermatids: 516.6;Late spermatids: 1225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.1;MCF7: 26.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022023, HPA027144, HPA031442"	Enhanced		Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557"	"unprognostic (9.27e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.63e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.12e-3)"	"unprognostic (4.93e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (9.69e-5)"	9.7	29.0	14.9	15.2	13.1	4.6	8.2	17.7	22.8	11.7	13.4	11.4	16.8	9.8	16.0	21.1	10.7	13.5	25.4	36.3	9.8	14.3	15.7	13.1	11.2	8.7	15.0	18.3	20.4	22.4	11.9	10.4	6.9	13.3	15.4	5.8	29.0	18.9	15.0	17.9	8.7	9.9	12.7	13.0	14.1	22.8	62.7	6.8	2.5	22.3	8.5	9.9	13.1	7.9	3.2	8.9	1.1	4.7	9.3	2.6	2.9	3.4	16.0	0.9	10.5	2.4	7.5	2.9	5.9	6.8	2.8	2.2	11.9	5.1	3.7	14.3	4.2	3.1	2.7	0.6	2.9	1.4	5.0	2.3	2.5	3.5	27.1	11.1	0.9	7.4	11.9	3.9	1.5	4.4	3.7	3.6	0.6	0.3	6.9	2.5	26.8	0.0	0.9	1.1	7.3	7.0	1.5	2.5	1.0	13.7	17.0	1.8	4.3	5.2	3.9	6.3	1.1	7.5	0.4	8.1	2.8	8.9	1.6	1.2	13.2	4.0	0.0	5.9	0.5	2.9	0.0	4.5	1.1	2.0	4.7	2.6	3.2	1.5	1.5	8.9	2.2	2.0	2.2	0.3	9.3	4.0	2.0	0.8	2.9	14.9	13.1	17.7	22.8	9.8	14.3	15.0	18.3	13.3	6.8	6.0	5.3	3.4	11.9	9.5	3.4	26.6	17.8	4.0	12.5	22.7	3.9	14.5	23.2	29.1	516.6	10.5	20.1	0.0	34.6	8.5	19.4	14.3	17.3	19.8	30.3	11.1	36.5	9.8	22.6	1225.1	35.4	15.4	20.3	19.0	31.6	24.6	24.1	25.9	35.7	30.1	1.9	6.5	20.6	8.1	10.4	7.8	8.2	10.2	20.5	12.0
SPATA21	"spergen-2, spergen2"	ENSG00000187144	"Spermatogenesis associated 21"	Q7Z572	1	16387117-16437424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"blood: 4.6;testis: 11.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 35.1;Late spermatids: 31.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 11.0"									HPA032080			Approved	Vesicles,Cytosol		No	NA			"Vesicles, Cytosol"		"HPA032080: "	"unprognostic (3.09e-1)"	"unprognostic (8.26e-2)"	"unprognostic (5.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.74e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.71e-2)"	0.0	0.2	0.0	0.0	0.1	1.3	0.0	1.1	0.0	0.1	0.0			0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1		0.1	0.7	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.9	0.1	0.0	0.1	0.2	0.3	11.3			0.0		0.0	0.3	0.0	1.3	0.6	4.6	0.8	0.9	0.8	0.4	0.2	0.8	0.4	0.7	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	1.5	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.0	1.5	11.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.2	0.7	0.2	0.1	0.5	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.1	0.3	0.2	0.0	0.0	1.2	0.6	0.3	0.6	0.2	0.3	0.2	0.1	0.4	0.0	0.4	0.4	0.2	0.3	0.3	0.0	4.6	0.5	0.9	0.7	0.8	0.5	1.1	0.7	0.6	0.4	1.3	0.8	0.3	2.3	0.9	0.5	0.6	0.7	0.4											0.0	0.6	0.0	0.2	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	35.1	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.0	0.0	0.1	4.8	0.0	0.0	1.2	31.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	1.1	0.0	0.3	1.1	0.1	0.4	0.2	0.0	0.0	0.1
SPATA25	"C20orf165, dJ337O18.8, TSG23"	ENSG00000149634	"Spermatogenesis associated 25"	Q9BR10	20	45886489-45887635	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 18.4"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 226.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.2"	"Not detected"	"Not detected"							HPA041386			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA041386: AB_2677446"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.92e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.93e-5)"	"unprognostic (1.12e-1)"	2.4	1.4	1.6	1.6	1.6	0.0	1.6	2.8	1.6	1.8	1.7	1.6	1.6	3.7	2.5	1.6	1.6	2.2	1.6	2.3	1.6	0.8	2.5	3.8	1.6	1.6	1.6	1.6	5.8	1.6	2.3	1.6	1.6	1.6	1.6	1.4	1.6	1.7	2.5	7.9	1.8	2.3	2.9	1.6	1.6	1.1	18.4	1.6	1.6	2.2	1.6	1.6	2.7	1.6	1.2	0.5	0.0	0.1	0.0	0.7	0.0	0.9	3.2	2.4	2.7	3.7	2.2	2.8	0.7	2.8	1.5	0.5	10.2	5.7	1.9	0.9	1.2	3.0	4.4	1.2	0.8	0.5	0.6	2.2	0.9	7.9	6.6	2.8	0.2	1.7	5.2	1.5	0.6	0.8	3.8	1.0	3.1	1.3	2.4	1.1	2.1	1.2	0.1	1.4	0.9	1.8	2.4	1.6	1.2	0.2	1.4	4.6	2.6	2.9	2.1	2.9	1.0	3.5	2.4	0.8	1.8	2.0	1.3	0.9	2.2	1.3	0.5	2.4	1.8	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	2.8	1.6	1.6	0.8	1.6	1.6	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	226.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	35.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0
SPATA2L	"C16orf76, MGC26885, tamo"	ENSG00000158792	"Spermatogenesis associated 2 like"	Q8IUW3	16	89696343-89701705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041182, HPA042453"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA041182: AB_2677352, HPA042453: AB_2678005"	"unprognostic (1.22e-1)"	"unprognostic (9.04e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.86e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.86e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.55e-1)"	6.8	5.3	6.3	5.4	10.3	8.8	3.7	6.8	14.1	4.1	6.9	1.6	4.9	12.3	4.7	7.2	3.9	4.6	7.7	2.8	7.2	4.9	7.5	11.4	6.3	3.6	3.4	7.6	5.4	17.0	5.1	12.9	6.5	2.8	4.2	2.2	4.9	6.1	3.4	1.8	5.0	10.7	3.3	2.0	5.6	7.7	4.6	2.6	6.7	5.6	0.7	5.4	4.0	2.2	5.8	5.9	16.5	7.8	2.4	7.3	4.7	5.3	4.2	1.5	7.0	1.2	1.2	8.2	3.7	1.7	1.7	1.1	8.0	4.5	1.8	5.0	1.2	2.3	9.3	1.3	2.0	0.3	1.7	15.1	1.2	1.5	10.8	3.9	1.0	3.7	1.2	2.6	2.8	0.8	2.0	1.9	2.1	5.5	1.3	1.2	24.2	3.1	5.7	4.3	5.4	5.7	6.8	0.7	5.2	2.5	1.9	8.3	5.4	3.9	4.0	4.5	0.7	10.3	4.1	4.8	1.7	6.4	0.3	1.7	3.2	1.9	1.6	5.3	3.0	3.2	3.3	4.9	6.0	7.3	7.8	5.1	4.8	5.2	5.3	5.3	5.8	4.6	4.9	16.5	2.4	5.8	5.9	3.9	4.7	6.3	10.3	6.8	14.1	7.2	4.9	3.4	7.6	2.8	2.6	3.0	0.3	1.4	16.6	14.0	6.6	0.4	5.1	0.0	0.0	10.4	0.0	7.5	1.7	11.7	4.4	4.9	29.5	0.0	11.8	4.1	5.7	10.1	4.6	5.0	6.8	3.2	22.8	5.5	7.5	1.0	2.6	7.2	8.5	3.6	6.8	5.1	10.5	17.3	2.1	8.4	7.4	0.0	9.2	1.0	2.5	17.3	20.8	5.0	6.2	11.6
SPATA33	"C16orf55, FLJ31606"	ENSG00000167523	"Spermatogenesis associated 33"	Q96N06	16	89657802-89671272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.4"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1519.3;Late spermatids: 2991.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045648, HPA073096"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045648: AB_2679405, HPA073096: AB_2686570"	"unprognostic (1.05e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.03e-3)"	"unprognostic (8.82e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-1)"	2.0	2.7	6.9	2.8	7.3	3.3	3.2	7.8	7.7	2.9	2.9	4.3	1.8	4.8	3.2	9.2	2.7	14.8	3.7	2.1	6.0	5.7	5.3	2.9	4.3	2.3	4.7	6.5	2.1	3.0	4.0	7.3	1.9	5.3	3.2	3.4	2.5	2.4	2.8	1.5	4.1	5.7	2.6	3.6	3.0	3.8	70.4	4.3	2.4	5.1	2.2	3.1	2.1	2.5	5.7	5.5	5.8	3.3	7.3	6.3	3.6	10.3	9.9	12.3	4.4	3.3	2.9	4.3	7.0	2.9	10.2	4.4	9.3	8.7	1.1	3.8	4.7	6.9	14.0	5.4	3.8	7.7	2.0	7.6	1.7	12.0	13.7	1.5	2.2	4.2	3.0	4.5	7.0	3.0	3.9	2.3	9.6	11.1	1.5	6.6	12.1	6.5	5.6	6.8	6.2	7.6	13.3	6.8	3.4	6.0	3.5	11.5	6.3	15.6	2.9	3.8	5.8	12.7	3.0	2.1	7.9	9.8	6.6	5.6	3.6	5.3	4.1	7.7	12.4	2.8	5.8	3.3	5.4	5.2	3.2	6.3	5.7	4.7	6.2	2.6	3.2	5.2	4.1	4.1	7.3	2.9	5.5	3.5	3.6	6.9	7.3	7.8	7.7	6.0	5.7	4.7	6.5	5.3	4.3	6.0	8.9	5.1	7.9	6.4	17.7	5.2	10.2	109.7	13.6	27.9	60.9	3.2	19.9	12.3	1519.3	10.2	15.9	0.0	15.4	4.9	10.5	5.5	1.1	9.8	7.9	22.3	16.8	8.6	2.7	2991.1	28.1	7.3	16.9	4.6	8.9	16.6	11.2	8.6	22.3	26.7	69.1	12.9	12.3	232.7	101.0	6.1	1.1	12.5	12.0	5.5
SPATA45	"C1orf227, LOC149643"	ENSG00000185523	"Spermatogenesis associated 45"	Q537H7	1	212830141-212847649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 4.4;pancreas: 4.4;testis: 14.2"	"Group enriched"	"Detected in some"	23	"Early spermatids: 131.3;Late spermatids: 94.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049921	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA049921: AB_2680953"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-3)"	0.1	0.1	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.1	0.2			0.0	0.3	0.9	0.0	0.9	0.4	0.1	0.3	0.3	0.2	0.4	0.4	0.8	0.4		0.1	4.4	0.0	0.4	0.2		0.2	0.0		0.1	0.0	0.0	0.0	0.2	0.6	0.5	0.5	0.1	14.2			0.3		0.4	0.0	0.1	2.8	0.7	4.4	0.9	0.5	1.2	0.5	0.4	4.0	0.9	2.6	0.8	2.1	2.6	0.4	0.0	0.8	1.2	0.8	0.6	0.9	0.1	0.0	1.7	0.3	1.7	0.0	1.0	3.7	0.0	0.0	0.0	2.1	1.2	0.0	1.7	1.5	0.0	0.4	0.0	0.0	0.0	1.7	0.0	1.8	2.3	2.5	0.2	0.9	0.6	0.8	1.4	2.1	0.2	0.0	2.1	0.4	0.9	2.7	1.6	0.0	0.0	0.9	0.6	1.3	0.0	0.9	0.1	1.9	1.1	1.1	1.7	4.4	0.3	1.6	1.1	0.0	0.4	4.4	0.7	0.9	0.9	0.3	0.1	0.0	0.7	2.8	0.6	1.2	2.4	0.5	0.7	0.1	0.3	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	0.0	0.0	0.0	5.0	0.0	131.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	94.9	1.4	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.9	1.5	0.0	0.0	0.0	0.0	0.0
SPATA5	"AFG2, SPAF"	ENSG00000145375	"Spermatogenesis associated 5"	Q8NB90	4	122923074-123319450	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Hydrolase"	"Deafness, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"Early spermatids: 147.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036450, HPA036451"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA036450: AB_2675131, HPA036451: AB_10670107"	"unprognostic (4.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (1.95e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.79e-1)"	8.2	4.7	5.8	8.5	9.3	6.0	7.8	20.7	8.0	8.3	6.1	6.4	5.6	3.8	12.8	5.5	5.7	6.0	4.4	5.3	5.5	4.6	5.9	5.2	5.3	8.0	7.1	5.2	6.4	5.1	11.2	13.5	5.9	6.9	6.0	6.1	7.4	6.1	5.3	6.4	7.4	4.8	9.1	7.4	7.3	11.6	11.3	9.0	13.6	6.7	5.0	9.3	6.2	7.0	2.9	2.8	2.3	1.9	2.5	2.8	0.7	2.9	3.2	4.0	8.0	3.1	2.1	2.6	4.2	1.8	3.2	3.1	2.1	4.3	4.4	2.8	2.6	2.3	2.7	5.2	2.8	6.3	6.2	1.3	3.8	5.9	3.4	1.4	6.5	4.8	1.5	1.5	4.5	4.2	2.0	3.1	3.0	7.4	7.8	5.5	3.2	10.9	4.5	2.3	4.8	1.6	3.8	8.4	2.4	2.6	2.1	5.9	4.2	3.9	3.4	2.4	5.5	2.4	2.5	3.8	8.5	5.6	5.4	5.0	5.1	5.2	3.1	4.4	5.9	7.3	2.3	1.2	1.1	2.7	1.9	1.6	2.0	2.2	2.3	0.9	2.9	2.4	2.8	1.8	2.5	1.1	2.8	1.1	0.7	5.8	9.3	20.7	8.0	5.5	4.6	7.1	5.2	6.9	9.0	14.9	5.3	4.4	5.1	4.5	5.1	3.4	17.8	9.4	11.4	1.8	13.7	3.9	0.0	2.3	147.3	8.0	2.0	0.0	3.1	3.5	3.7	3.0	4.7	2.1	3.0	3.2	2.4	5.5	3.7	13.2	6.6	4.8	0.0	1.0	1.6	4.9	3.4	2.6	4.2	2.7	11.6	0.0	3.6	13.3	10.0	4.6	1.8	5.3	3.7	2.6
SPATA5L1	"FLJ12286, MGC5347"	ENSG00000171763	"Spermatogenesis associated 5 like 1"	Q9BVQ7	15	45402331-45421419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA043679	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043679: AB_10964179"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.80e-2)"	9.0	8.7	10.7	12.3	10.7	11.1	9.5	21.3	8.2	10.3	9.9	10.0	10.2	12.1	9.8	8.4	17.5	8.8	8.3	9.6	9.6	5.9	10.8	14.8	11.2	14.1	13.5	5.8	12.9	12.0	7.6	7.6	10.6	8.9	9.9	10.2	7.2	9.4	12.8	15.9	16.1	13.2	9.4	7.1	8.6	8.2	12.1	12.0	9.9	11.2	12.3	10.9	10.2	11.9	3.6	3.3	4.8	6.4	3.3	4.7	0.7	7.1	5.5	7.4	5.4	6.1	6.0	9.0	6.4	5.8	7.0	6.9	12.6	4.7	5.2	7.1	4.2	12.8	16.5	11.0	8.0	7.9	7.1	6.1	6.8	8.8	9.8	7.0	9.1	2.9	4.9	9.2	5.7	7.7	8.0	5.5	6.9	11.0	8.5	7.8	4.8	6.3	17.5	5.3	18.0	7.1	7.0	10.4	4.9	8.7	7.1	10.2	5.2	5.3	11.6	5.7	9.2	10.2	16.7	3.4	3.4	5.2	20.8	13.6	7.2	14.4	8.1	8.8	15.1	6.1	0.1	2.8	4.8	4.1	2.6	1.5	1.9	2.8	4.7	3.3	3.6	2.9	3.0	4.2	3.3	6.4	2.5	2.6	0.7	10.7	10.7	21.3	8.2	9.6	5.9	13.5	5.8	8.9	12.0	0.0	1.4	5.4	5.2	4.4	5.7	5.6	10.2	0.0	4.5	3.5	15.7	10.2	3.3	5.6	17.3	6.0	5.5	0.0	6.4	8.8	4.6	3.8	4.6	5.0	6.8	6.4	3.5	0.6	4.3	5.3	7.2	4.1	3.3	6.4	7.2	4.4	4.8	0.0	3.5	4.9	6.5	0.0	4.7	5.4	5.7	5.9	5.6	4.9	7.5	7.0
SPATA6	"FLJ10007, SRF-1, SRF1"	ENSG00000132122	"Spermatogenesis associated 6"	Q9NWH7	1	48295372-48472208	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 61.8"	"Group enriched"	"Detected in many"	31	"Early spermatids: 1331.5;Late spermatids: 2941.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.5;ASC TERT1: 17.7;HSkMC: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028234			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA028234: AB_2672532"	"unprognostic (1.36e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.89e-2)"	"unprognostic (5.71e-3)"	5.8	8.9	6.2	3.0	12.9	1.5	8.4	2.4	8.9	7.5	5.0	12.9	10.1	3.3	6.9	7.9	4.1	16.2	5.9	4.7	7.8	5.6	6.9	2.4	7.5	7.0	14.9	3.9	9.0	5.2	12.8	21.5	5.3	8.5	6.4	4.6	6.6	6.9	12.2	3.8	5.0	3.7	8.3	10.0	4.1	7.3	61.8	13.4	1.1	10.3	2.4	2.2	6.5	12.2	0.2	1.7	5.2	8.2	0.3	0.6	0.7	0.1	0.9	9.5	10.5	8.8	17.7	1.3	1.0	4.0	0.8	0.7	0.1	0.7	0.0	0.6	1.7	5.1	0.2	0.8	2.3	0.7	0.7	1.3	0.1	0.4	0.4	1.8	0.0	0.7	12.6	1.8	1.5	0.5	5.2	3.8	1.5	0.1	0.0	4.0	0.3	0.1	0.1	4.0	0.7	1.0	2.9	0.0	0.9	5.8	1.6	2.3	5.2	3.8	0.4	9.1	8.2	2.3	0.5	1.1	1.4	1.4	2.2	1.5	0.0	0.0	0.0	5.8	0.1	6.3	0.0	1.8	5.2	0.1	4.3	0.0	0.2	0.4	0.0	1.7	0.1	0.6	0.5	0.3	0.3	8.2	0.8	0.0	0.7	6.2	12.9	2.4	8.9	7.8	5.6	14.9	3.9	8.5	13.4	3.0	7.7	0.0	15.5	4.9	17.1	2.8	15.3	68.3	17.0	15.7	43.2	0.3	14.9	7.4	1331.5	8.1	2.1	0.0	9.1	0.6	10.3	7.2	16.1	2.1	4.2	30.2	9.2	9.2	17.5	2941.6	33.9	13.4	18.6	1.8	5.2	21.5	4.5	3.4	23.7	7.7	44.9	19.4	9.2	58.1	20.0	4.5	0.2	0.9	5.2	8.8
SPATA7	"HSD3, LCA3"	ENSG00000042317	"Spermatogenesis associated 7"	Q9P0W8	14	88384924-88470350	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.6"	"Group enriched"	"Detected in many"	24	"Early spermatids: 817.6;Late spermatids: 902.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038082, HPA038083"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA038082: AB_10671738, HPA038083: AB_10671519"	"unprognostic (2.09e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.50e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-3)"	"prognostic favorable (4.16e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.81e-2)"	6.3	7.2	7.8	2.8	10.3	2.2	7.1	18.0	12.5	6.1	4.5	6.5	4.5	2.9	7.7	8.5	3.7	9.6	6.5	5.3	8.1	7.4	10.5	5.9	5.0	3.0	6.4	9.7	13.6	6.9	9.2	15.0	3.6	13.3	5.8	4.1	5.5	4.6	5.9	4.7	6.6	2.8	6.4	5.8	3.7	4.3	55.6	5.9	3.3	13.5	3.9	2.0	5.7	4.4	3.7	4.4	1.7	3.0	0.9	5.6	2.2	2.1	3.3	4.9	6.8	8.1	15.4	5.0	3.7	8.4	4.7	3.1	0.9	4.1	1.5	2.3	5.0	3.5	2.1	2.3	3.5	4.4	2.5	1.6	0.1	1.6	1.1	12.1	3.4	0.3	7.3	5.9	1.9	3.6	15.4	8.6	4.2	1.1	2.4	4.3	2.5	1.5	3.1	0.6	2.6	4.2	3.5	5.1	0.8	7.5	1.3	2.9	4.5	4.7	6.4	3.8	5.1	5.5	3.7	4.4	2.9	3.8	4.8	2.0	2.4	1.2	0.5	5.8	1.0	2.4	0.0	2.2	0.6	4.8	3.0	5.6	3.7	4.0	2.2	4.4	0.9	2.2	4.2	1.7	0.9	1.8	4.3	1.4	2.2	7.8	10.3	18.0	12.5	8.1	7.4	6.4	9.7	13.3	5.9	11.9	5.3	0.8	8.2	2.2	10.8	10.9	5.1	36.1	10.3	3.5	19.6	2.1	8.3	7.6	817.6	5.2	1.1	0.0	6.3	3.2	6.4	3.4	1.1	3.4	5.0	14.3	15.6	6.2	8.6	902.3	19.0	3.3	8.5	4.6	4.4	10.6	5.8	4.8	15.9	19.9	19.4	6.5	5.0	18.2	13.5	1.8	0.9	3.8	4.6	2.7
SPATA9	"FLJ35906, NYD-SP16"	ENSG00000145757	"Spermatogenesis associated 9"	Q9BWV2	5	95652181-95698711	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 29.5"	"Group enriched"	"Detected in some"	15	"Early spermatids: 467.1;Late spermatids: 349.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	20	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 4.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA010848, HPA076967"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA010848: AB_1857422, HPA076967: "	"unprognostic (4.46e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.49e-13)"	"unprognostic (3.39e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-2)"	0.9	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	29.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	2.7	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.3	0.8	2.8	0.0	0.0	0.0	0.2	0.5	1.8	0.2	0.0	0.6	0.6	0.5	1.6	0.0	0.6	0.0	0.9	0.6	1.1	1.7	0.0	2.1	0.0	0.7	2.3	0.8	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.4	0.5	0.0	4.0	0.0	0.7	0.2	0.5	0.4	0.0	0.2	0.0	0.0	0.4	1.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	467.1	0.0	0.0	0.0	0.0	27.7	0.4	0.2	0.0	0.0	1.1	1.6	0.0	0.0	0.3	349.3	3.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.2	0.0	0.2	0.0	0.5	3.6	2.9	0.1	3.5	0.0	0.0	0.1
SPATC1L	C21orf56	ENSG00000160284	"Spermatogenesis and centriole associated 1 like"	Q9H0A9	21	46161148-46184476	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 174.7;Late spermatids: 364.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018979, HPA019165, HPA029394"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148"	"unprognostic (1.46e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.58e-1)"	4.7	11.5	21.5	4.2	31.7	5.1	4.3	13.1	19.0	8.2	5.1	5.6	8.9	5.3	5.3	6.5	4.6	4.0	5.7	5.5	14.4	9.4	4.3	1.5	4.4	5.7	7.8	16.5	10.9	11.7	5.8	7.8	4.7	7.5	16.7	3.6	2.6	9.5	10.1	8.8	7.0	6.3	5.6	5.2	8.1	8.3	23.5	13.6	2.2	3.7	5.0	4.3	4.4	6.4	4.8	5.9	23.6	4.2	4.0	6.9	2.7	1.8	0.0	2.5	4.6	1.4	3.3	1.3	2.7	1.5	1.5	1.1	0.0	1.2	5.9	5.5	3.4	1.8	0.3	0.0	2.1	0.4	5.3	4.4	14.0	0.8	3.3	0.1	0.0	5.9	3.5	1.0	0.0	0.0	2.9	4.9	6.8	24.3	8.9	2.1	3.7	4.5	1.6	10.1	2.6	12.0	10.1	3.3	6.5	2.4	0.5	0.7	4.7	2.1	1.2	5.4	1.8	3.8	5.4	0.3	4.5	5.4	6.4	4.0	14.9	7.9	4.3	5.9	7.8	4.2	1.0	3.9	23.6	3.0	4.2	3.9	4.7	4.4	4.3	5.9	4.8	6.9	6.8	0.2	4.0	2.9	4.8	4.2	2.7	21.5	31.7	13.1	19.0	14.4	9.4	7.8	16.5	7.5	13.6	0.0	0.0	6.0	12.9	20.9	5.7	1.2	17.8	1.4	2.3	3.5	0.0	2.8	13.3	16.5	174.7	13.2	5.4	0.0	17.4	11.5	17.2	25.0	0.0	0.5	11.6	3.2	58.0	8.0	7.3	364.6	30.0	15.4	27.0	5.4	16.3	5.2	14.9	2.9	29.7	9.2	3.4	19.4	12.3	11.2	8.9	35.0	2.6	16.0	17.5	3.7
SPATS1	"FLJ25442, SPATA8, SRSP1"	ENSG00000249481	"Spermatogenesis associated serine rich 1"	Q496A3	6	44342660-44377167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 9.0;testis: 33.5"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 17.4;Early spermatids: 25.7;Late spermatids: 6.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SK-MEL-30: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030897, HPA049722"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030897: AB_2673647, HPA049722: AB_2680861"				"unprognostic (2.30e-3)"														0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.4	0.3	0.0	1.5	0.0	0.0	0.1	4.8	0.1	9.0	0.0	0.0	0.7	0.7	0.0	0.0	1.5	0.0	0.4	0.0	1.6	0.0	0.2	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	1.0	0.0	0.4	0.7	0.7	0.4	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
SPCS1	"HSPC033, SPC1, SPC12, YJR010C-A"	ENSG00000114902	"Signal peptidase complex subunit 1"	Q9Y6A9	3	52704955-52711146	"Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046091, HPA055273"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA046091: AB_10959614, HPA055273: AB_2682768"	"unprognostic (5.47e-2)"	"unprognostic (4.04e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.09e-2)"	31.0	53.4	39.7	28.5	41.5	27.5	42.2	24.2	55.3	39.1	46.3	40.8	46.3	47.8	34.9	53.2	39.1	33.9	35.6	39.4	38.0	47.0	62.3	98.7	37.1	68.9	47.2	38.1	34.7	112.1	30.5	48.8	50.9	41.7	41.0	41.6	38.4	87.7	57.8	43.2	34.3	53.4	34.2	48.3	37.4	45.7	57.1	25.5	42.6	55.2	38.3	52.0	36.6	30.2	40.2	123.4	48.5	27.8	22.2	34.1	43.1	21.5	20.5	19.5	25.2	31.5	25.7	32.5	30.0	27.5	27.2	24.5	21.4	31.6	23.1	13.2	27.1	26.0	20.8	19.7	28.0	26.5	30.8	23.7	27.3	34.0	29.8	35.6	37.8	45.2	21.0	36.8	30.0	32.7	22.3	22.0	29.0	23.2	73.4	27.7	20.9	29.9	38.4	37.1	53.1	42.6	12.2	18.2	116.3	40.0	26.6	14.1	31.8	29.5	31.7	39.8	18.0	35.4	43.4	20.8	24.6	23.1	44.0	35.3	81.0	120.8	32.6	38.1	41.8	32.0	45.3	26.0	48.5	27.8	26.0	32.8	40.2	34.1	30.5	28.4	29.0	32.2	32.8	19.8	22.2	27.8	123.4	33.9	43.1	39.7	41.5	24.2	55.3	38.0	47.0	47.2	38.1	41.7	25.5	59.6	94.5	189.7	185.2	139.0	485.2	136.5	219.1	186.0	126.3	294.8	111.9	309.5	306.7	288.1	445.8	151.7	198.8	93.5	296.3	331.3	163.9	238.4	205.7	300.1	274.6	96.9	161.0	125.8	194.0	878.2	200.2	191.2	361.0	334.6	203.8	220.7	242.0	238.9	180.4	563.8	195.8	161.7	195.7	623.3	495.0	161.2	293.7	203.7	226.0	258.6
SPCS2	KIAA0102	ENSG00000118363	"Signal peptidase complex subunit 2"	Q15005	11	74949247-74979031	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013386	Approved		Approved	Nucleoplasm		NA	NA		220000	Nucleoplasm		"HPA013386: AB_1857426"	"unprognostic (2.43e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (7.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.04e-3)"	"unprognostic (9.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.62e-2)"	21.8	32.8	29.1	25.8	29.2	13.4	28.7	20.0	26.8	36.5	30.4	26.8	49.5	23.2	32.3	61.6	23.3	25.8	21.4	25.2	29.8	27.5	30.0	46.5	24.0	25.3	33.4	33.5	24.0	75.5	41.6	26.7	28.5	32.9	29.2	31.1	18.6	55.9	34.9	26.4	17.2	24.0	24.8	33.4	30.1	26.5	24.2	27.6	20.3	43.9	14.9	38.7	23.8	21.4	78.2	89.7	86.4	45.9	47.9	65.4	71.8	22.3	26.3	35.2	31.5	31.0	20.9	19.2	32.1	31.4	29.6	26.0	51.7	50.8	36.4	40.7	27.1	35.4	41.3	30.4	23.5	37.0	30.0	22.3	36.9	32.0	42.6	35.3	39.1	26.0	18.5	30.7	24.9	41.0	26.1	28.3	26.9	42.4	95.0	26.8	34.0	27.8	25.0	21.5	88.9	25.1	34.7	54.2	82.5	34.1	37.4	28.6	28.7	32.0	43.1	105.2	25.5	41.7	30.0	22.8	33.8	21.0	35.0	28.3	40.6	41.0	67.6	13.9	27.8	34.1	86.4	45.9	41.3	58.3	44.4	65.4	78.2	54.0	55.9	43.4	62.1	41.4	49.6	29.6	47.9	38.2	89.7	50.9	71.8	29.1	29.2	20.0	26.8	29.8	27.5	33.4	33.5	32.9	27.6	80.4	121.2	168.1	276.8	270.4	92.5	52.0	203.8	105.7	150.2	226.8	49.1	294.6	160.8	248.0	23.5	169.0	110.2	186.9	251.0	262.7	270.0	340.7	151.3	327.2	251.3	90.6	120.3	149.8	135.4	21.2	222.9	194.9	494.3	215.6	135.9	198.0	231.8	129.8	183.9	236.3	72.2	168.1	200.5	94.2	127.2	200.6	388.7	197.1	133.3	256.7
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 55.8;salivary gland: 98.0"	"Group enriched"	"Detected in many"	6	"Glandular cells: 80.8;Mucus-secreting cells: 228.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 68.7;OE19: 28.3;SK-BR-3: 47.5;T-47d: 38.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055707			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.4	2.4	0.2	0.0	28.5	0.3	0.7	12.0	6.5	0.2	0.3	4.4	4.0	0.3	0.9	2.4	16.1	0.1	0.4	0.3	0.1	0.1	5.5	0.1	0.3	0.1	0.6	1.3	0.0	0.1	0.2	0.1	55.8	4.0	0.2	98.0	4.5	0.1	3.0	7.8	0.1	0.1	0.1	10.8	0.1	0.1	0.2	0.1	7.8	22.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.7	0.0	0.1	0.0	28.3	9.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	47.5	0.0	0.0	38.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.4	0.3	0.3	0.1	0.1	0.1	0.0	2.1	0.0	12.1	0.1	0.0	0.1	2.5	0.0	3.4	0.0	0.0	0.0	0.0	3.2	1.1	0.0	8.1	0.0	1.1	0.0	0.0	80.8	0.0	0.0	0.0	0.0	5.2	0.6	0.0	2.9	0.0	0.0	3.3	0.0	228.3	0.0	12.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	26.3	9.7
SPDL1	"CCDC99, FLJ20364, hSpindly"	ENSG00000040275	"Spindle apparatus coiled-coil protein 1"	Q96EA4	5	169583634-169604778	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.7"	"Cell type enhanced"	"Detected in many"	11	"Spermatocytes: 97.4;Spermatogonia: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA044700, HPA048146"	Enhanced		Approved	Cytosol		NA	Yes			Cytosol		"HPA044700: AB_2679052, HPA048146: AB_2680284"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.59e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.48e-6)"	"unprognostic (2.63e-3)"	"unprognostic (5.70e-3)"	"unprognostic (8.27e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.93e-1)"	5.5	4.7	6.5	9.0	11.5	9.9	8.0	14.5	11.0	5.5	5.6	6.6	3.4	5.9	6.4	4.4	9.7	4.9	4.9	4.0	7.8	5.8	5.1	3.6	4.7	13.9	8.3	7.1	7.2	4.1	5.6	8.0	8.4	11.6	4.1	6.0	2.0	5.1	3.6	5.0	5.3	5.9	7.7	16.7	8.2	5.3	33.7	10.4	23.9	4.5	8.5	13.6	5.4	5.8	10.7	16.5	3.2	4.6	6.4	9.3	3.0	14.6	17.6	18.0	12.6	4.8	4.5	15.9	46.6	6.2	34.9	31.7	23.1	9.9	13.8	30.9	38.1	24.0	10.3	14.6	20.0	38.3	14.2	16.3	16.1	31.7	9.0	2.2	16.9	13.9	2.1	1.7	14.6	9.2	7.4	15.8	14.3	10.1	10.2	37.1	14.2	13.8	7.2	13.1	7.3	17.1	16.2	17.7	10.2	22.8	5.2	11.6	8.5	21.7	6.2	9.1	13.3	7.0	11.3	11.2	39.8	12.6	11.3	36.1	8.1	17.0	18.6	9.6	15.6	13.3	3.2	2.2	2.9	7.3	3.0	7.7	8.8	6.6	7.7	2.2	10.7	9.3	7.4	0.4	6.4	4.6	16.5	6.4	3.0	6.5	11.5	14.5	11.0	7.8	5.8	8.3	7.1	11.6	10.4	3.0	7.5	6.7	1.7	3.5	7.1	7.2	0.0	4.0	7.9	1.8	0.0	7.9	5.0	4.9	7.6	3.9	0.5	23.3	4.2	21.7	7.5	1.1	8.1	2.9	10.0	3.2	1.7	11.6	4.0	8.7	4.0	6.1	3.3	6.4	1.9	6.1	5.4	1.7	6.0	5.1	3.9	6.5	9.2	97.4	70.9	3.9	4.1	4.4	5.1	2.1
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20009344-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 111.1;monocytes: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 35.6;SuSa: 58.4"	"Low region specificity"	"Detected in all"							"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	10.7	8.3	21.3	7.2	38.0	29.9	8.1	16.0	30.8	7.0	14.9	49.9	0.7	9.5	15.4	6.1	11.4	7.3	20.0	4.1	23.1	15.4	4.3	2.0	5.6	5.7	35.8	21.2	17.0	8.3	3.0	6.8	4.8	29.3	7.3	15.5	3.0	5.9	4.9	4.3	4.8	11.4	11.5	28.2	17.3	9.8	25.8	41.5	0.2	6.7	1.4	6.0	7.0	4.2	2.9	14.7	18.9	9.4	8.5	3.4	3.0	14.2	14.8	8.0	2.6	6.1	3.1	17.4	5.8	4.8	5.8	7.2	24.2	12.7	0.8	18.9	5.0	8.7	10.6	6.1	13.8	2.9	4.3	6.5	5.8	16.2	2.6	2.2	0.6	3.4	3.3	14.0	8.2	9.3	35.6	0.0	2.4	0.7	7.2	4.5	12.1	0.1	3.2	6.4	6.3	3.6	3.5	16.2	8.2	14.3	7.1	2.6	2.7	30.4	14.6	6.4	58.4	12.9	3.8	0.4	0.7	8.9	0.8	15.7	2.8	3.5	1.1	8.6	4.9	3.3	18.9	9.4	17.8	3.1	5.3	2.9	2.4	1.9	3.4	14.7	2.9	1.8	2.4	8.1	8.5	4.6	4.4	0.9	3.0	21.3	38.0	16.0	30.8	23.1	15.4	35.8	21.2	29.3	41.5	20.8	14.3	3.2	11.9	4.8	5.9	6.1	7.6	12.0	6.8	17.4	64.8	3.9	8.3	26.9	75.7	5.2	32.8	23.3	31.4	10.8	9.5	14.6	111.1	0.2	18.6	0.0	7.5	3.1	9.7	40.7	4.6	14.0	20.3	103.6	44.0	19.3	54.5	28.3	42.1	2.4	32.8	58.2	31.9	72.4	64.5	2.3	1.8	10.2	18.6	22.1
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta"	ENSG00000072195	"SPEG complex locus"	Q15772	2	219434846-219498287	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 88.7"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 55.0;Late spermatids: 30.8;Sertoli cells: 45.3;Smooth muscle cells: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 27.9;U-87 MG: 14.6"	"Low region specificity"	"Detected in all"							HPA018904	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	7.7	7.1	10.1	9.1	7.7	1.2	4.2	10.4	9.8	19.2	45.1	4.1	10.5	5.7	31.6	14.1	13.5	19.0	17.4	17.8	8.7	5.3	2.0	1.4	3.0	1.7	4.0	8.0	7.0	2.9	4.7	10.5	4.8	5.5	16.7	4.5	6.7	7.8	23.0	88.7	2.2	9.2	45.2	9.1	1.9	16.1	3.0	3.9	0.0	2.0	16.8	1.6	22.5	12.6	0.0	0.3	0.0	0.0	0.0	0.5	0.7	3.6	0.3	1.8	3.1	0.9	2.9	1.2	7.7	5.2	5.2	3.9	2.8	1.3	0.0	2.8	5.6	2.9	4.5	1.5	1.8	2.0	0.4	1.2	0.4	3.3	0.1	1.3	0.0	0.6	8.2	2.7	4.7	1.1	27.9	0.0	2.0	2.7	0.0	3.7	1.0	0.0	11.0	3.9	0.1	1.4	1.8	4.2	0.6	5.0	0.0	2.1	9.6	0.5	0.0	0.1	9.2	0.3	0.1	0.1	13.0	13.2	1.5	12.1	0.4	0.0	0.1	14.6	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.7	10.1	7.7	10.4	9.8	8.7	5.3	4.0	8.0	5.5	3.9	0.0	2.1	0.0	5.6	2.9	1.1	55.0	5.1	0.0	0.0	1.8	2.0	0.8	0.0	1.2	17.7	1.4	5.9	0.0	1.0	0.7	8.5	2.7	0.0	2.4	1.0	4.8	6.4	3.7	6.6	30.8	9.8	1.7	3.3	1.8	3.3	6.5	0.3	2.9	17.7	2.3	0.8	45.3	36.2	1.1	2.6	1.3	1.1	0.0	2.4	3.5
SPEM2	C17orf74	ENSG00000184560	"SPEM family member 2"	Q0P670	17	7425615-7427568	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.3;hTEC/SVTERT24-B: 1.0;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023649	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA023649: AB_1845606"					"unprognostic (3.00e-1)"					"unprognostic (3.88e-1)"			"unprognostic (1.12e-4)"		"unprognostic (1.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPERT	"CBY2, NURIT"	ENSG00000174015	"Spermatid associated"	Q8NA61	13	45702311-45714559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 66.5"	"Group enriched"	"Detected in some"	81	"Early spermatids: 730.0;Late spermatids: 1376.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.8;HDLM-2: 3.5;hTCEpi: 1.2;JURKAT: 1.1;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039359, HPA040046"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA039359: AB_10794088, HPA040046: AB_10796117"	"unprognostic (2.86e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.19e-4)"		"unprognostic (8.52e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-1)"		"unprognostic (2.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.15e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.8	0.8	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	2.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	730.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1376.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	12.9	0.0	7.4	5.3	0.0	0.0	0.0	0.0	0.0
SPIN2A	"DXF34, SPIN2, TDRD25"	ENSG00000147059	"Spindlin family member 2A"	Q99865	X	57134530-57137625	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 5.2;Cardiomyocytes: 5.0;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 4.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 5.8;HSkMC: 7.2"									"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000162: AB_1080079, HPA069835: AB_2686211"	"unprognostic (3.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-5)"	"unprognostic (3.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.07e-3)"	1.8	1.4	1.8	2.3	1.6	0.2	1.7	5.0	2.9	2.4	1.5			1.9	2.1	0.7	1.0	1.4	1.7	0.9	1.9	1.9	1.7	1.1	1.5	3.2	1.2		3.2	1.4	1.6	2.7	1.2		2.1	2.0		2.1	1.7	0.5	3.5	1.5	2.2	1.2	2.7	1.9	0.8			2.5		2.1	1.5	2.7	1.4	0.5	0.0	0.8	0.0	0.8	0.2	0.9	1.8	5.0	0.9	0.9	1.0	1.3	1.8	0.7	0.4	0.8	0.9	1.5	0.4	0.8	3.1	0.5	1.2	1.1	1.0	0.4	0.6	0.7	0.8	5.8	0.9	1.7	0.8	1.0	7.2	0.8	0.3	0.3	2.3	0.5	0.8	0.7	2.4	1.0	1.2	0.5	2.3	1.8	0.1	0.8	0.9	1.2	0.7	0.8	0.9	3.2	0.9	0.9	0.5	0.2	1.7	0.9	0.9	0.7	2.6	1.1	1.1	0.6	2.4	0.3	0.3	0.7	2.1	0.9	0.0	0.8	0.0	0.5	0.3	0.8	1.4	0.3	0.5	0.0	0.4	0.7	0.1	0.0	0.0	0.3	0.5	0.7	0.2											0.0	0.3	0.0	0.3	0.2	5.2	5.0	0.0	0.0	0.0	0.0	3.9	0.1	1.7	0.4	0.0	0.7	0.0	0.0	0.0	0.1	1.5	0.5	1.1	0.0	0.2	1.6	0.0	1.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	4.8	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4
SPIN2B	"SPIN-2, TDRD26"	ENSG00000186787	"Spindlin family member 2B"	Q9BPZ2	X	57118551-57121546	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000162: AB_1080079, HPA069835: AB_2686211"	"unprognostic (3.21e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.73e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (3.39e-4)"	"unprognostic (9.04e-3)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-3)"	8.9	11.8	14.6	11.1	19.4	5.6	16.1	17.0	24.3	13.0	13.9	8.5	9.9	6.4	12.3	16.2	8.5	9.8	12.0	11.5	14.4	17.3	11.1	8.4	9.3	13.1	15.7	15.8	12.2	9.6	11.6	14.3	9.1	14.4	15.9	16.6	8.2	10.6	15.3	12.0	12.1	9.0	18.2	15.1	12.4	11.1	6.3	13.4	8.8	12.5	6.6	11.9	10.9	14.2	10.8	9.4	1.2	6.1	11.3	13.1	8.3	11.6	8.8	10.5	8.0	10.9	12.3	7.1	7.9	5.1	10.3	6.8	11.4	9.8	2.5	13.3	7.2	9.0	1.8	12.2	4.0	10.7	4.6	14.6	7.1	25.9	14.9	8.9	6.0	5.5	10.2	7.7	6.6	6.9	10.1	8.0	6.5	8.6	8.3	10.7	16.7	8.7	10.9	10.3	3.3	9.9	8.5	13.8	10.7	10.9	5.5	7.2	7.4	13.8	3.4	6.8	16.8	7.6	4.2	8.1	8.7	8.4	14.9	4.7	8.3	5.7	7.3	6.8	11.7	4.8	1.2	5.3	0.6	9.0	6.1	13.0	10.8	11.4	12.3	6.5	8.5	13.1	10.5	0.3	11.3	5.5	9.4	13.1	8.3	14.6	19.4	17.0	24.3	14.4	17.3	15.7	15.8	14.4	13.4	17.9	5.3	4.7	6.7	4.7	10.0	8.4	0.0	1.4	1.2	10.4	0.0	6.7	13.3	5.2	0.0	10.5	5.5	0.0	4.6	4.8	9.3	5.0	10.5	2.9	4.4	11.1	11.1	5.5	2.5	0.0	11.2	2.6	8.5	1.8	7.8	5.2	2.9	10.5	17.7	8.5	5.4	25.8	8.6	0.0	0.4	7.9	2.5	10.1	10.5	4.8
SPIN3	TDRD27	ENSG00000204271	"Spindlin family member 3"	Q5JUX0	X	56818298-56995827	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 7.0;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 17.0"					"Low region specificity"	"Detected in all"			HPA000727	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000727: AB_2196121"	"unprognostic (3.12e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.85e-4)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.98e-2)"	"prognostic favorable (6.30e-4)"	5.7	7.6	10.5	4.8	10.7	0.4	9.4	28.6	14.2	7.8	4.6	7.3	9.2	4.8	10.4	8.3	4.5	7.4	5.5	3.8	9.2	6.6	5.3	5.0	5.4	6.7	6.6	10.3	11.3	10.2	4.4	12.4	4.1	9.6	10.4	7.0	6.5	7.5	7.5	4.2	4.7	6.6	7.6	5.0	6.1	7.5	4.3	8.3	0.3	6.0	1.4	6.9	8.2	6.2	2.7	1.6	3.3	1.5	4.7	4.5	2.2	4.3	6.4	3.6	0.0	7.0	6.2	2.8	3.8	2.0	2.6	3.0	3.7	5.5	0.0	2.6	3.2	7.3	5.1	5.6	2.3	3.2	0.0	1.3	0.5	17.0	2.6	3.8	0.0	4.8	5.4	4.7	2.7	4.3	4.0	1.6	0.0	2.6	8.5	4.4	2.8	0.0	3.5	7.4	2.5	6.1	0.0	3.1	1.7	3.4	5.1	7.3	5.0	4.0	3.9	4.1	5.9	9.7	1.0	1.1	4.4	6.7	7.2	2.0	3.5	2.5	0.0	4.3	0.0	3.3	3.3	1.0	1.9	0.2	1.5	1.7	2.7	3.9	1.6	1.6	0.9	4.5	1.1	0.0	4.7	0.1	0.2	1.0	2.2	10.5	10.7	28.6	13.4	9.2	6.6	6.6	10.3	9.6	8.3	0.0	3.0	0.0	3.6	0.2	2.0	1.0	2.5	1.4	3.4	7.0	0.0	1.9	1.7	3.2	0.0	1.1	0.8	0.0	2.4	1.7	1.8	1.6	1.1	1.1	0.8	1.6	0.0	1.8	1.8	0.0	3.7	1.0	1.7	1.8	0.7	1.0	3.1	0.0	2.5	2.7	2.4	6.5	1.4	0.0	0.0	0.4	0.3	0.0	1.1	2.0
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 27.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol		NA	Yes			Cytosol	Nucleoli	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	3.9	3.2	4.2	5.1	4.4	13.8	13.7	2.3	5.4	5.1	5.9	6.7	2.0	3.5	6.7	4.7	16.8	3.9	3.5	3.2	4.7	6.1	3.3	2.4	16.8	7.6	4.5	2.3	6.6	4.2	4.8	4.7	12.3	5.2	7.2	6.9	4.8	27.4	2.9	1.2	3.5	4.9	5.8	5.2	5.9	3.9	3.4	3.5	11.2	5.6	6.4	11.8	4.3	8.2	1.2	1.4	3.7	2.1	6.0	1.5	0.8	16.0	4.1	9.6	7.8	2.1	3.0	6.9	8.0	3.4	4.7	5.7	2.7	16.0	0.0	3.5	3.7	5.4	5.4	12.3	5.8	8.6	6.9	3.9	20.6	5.5	2.5	0.9	17.8	16.1	1.4	2.0	7.8	4.2	2.3	5.1	3.6	6.2	20.1	10.7	5.4	5.9	9.6	9.9	2.6	6.0	8.3	20.7	4.4	3.4	4.3	0.0	5.3	14.4	4.2	1.5	20.8	9.1	8.5	2.2	9.5	10.7	15.7	5.0	4.4	5.1	10.6	5.0	14.7	5.6	1.7	1.8	3.7	1.5	2.1	0.7	1.2	0.8	0.9	1.4	1.1	0.5	1.0	0.0	6.0	1.7	0.0	0.5	0.8	4.2	4.4	2.3	5.4	4.7	6.1	4.5	2.3	5.2	3.5	0.0	1.3	0.5	1.3	3.0	5.2	1.2	0.0	4.0	2.3	3.5	2.0	5.5	1.7	0.6	0.0	2.7	1.7	0.0	1.2	5.8	3.1	2.6	9.2	0.8	2.2	1.6	6.4	8.6	1.3	0.0	2.8	1.7	5.0	0.0	7.2	1.2	1.3	7.0	3.2	1.0	2.4	0.0	1.6	0.0	0.2	5.5	2.7	3.2	6.0	4.7
SPINDOC	"C11orf84, SPIN-DOC"	ENSG00000168005	"Spindlin interactor and repressor of chromatin binding"	Q9BUA3	11	63813388-63827718	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 3.0;Cytotrophoblasts: 11.7;Hofbauer cells: 4.8;monocytes: 3.6;Syncytiotrophoblasts: 3.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040128, HPA050313"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA040128: AB_10673027, HPA050313: AB_2681083"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	9.2	9.0	9.6	12.3	9.8	5.8	23.3	12.8	15.8	8.8	11.4	6.9	5.8	6.0	13.2	6.0	7.9	8.4	10.1	9.3	9.3	12.2	8.2	3.1	9.9	14.8	9.4	9.1	11.3	8.2	3.3	12.0	28.0	10.8	11.8	4.2	7.8	6.6	12.3	7.7	4.5	6.9	12.9	8.6	10.3	7.4	24.1	6.0	11.8	10.5	3.1	10.5	9.0	39.5	2.0	1.5	2.2	0.1	0.7	1.5	0.2	12.0	16.2	23.7	20.7	4.6	4.5	8.9	9.4	8.1	17.2	12.0	17.0	8.3	20.2	22.0	5.4	22.3	16.0	21.5	4.9	6.3	19.1	9.4	22.3	15.2	14.4	7.4	12.4	19.4	5.2	5.1	13.6	4.9	9.1	10.1	19.5	12.2	10.0	7.3	16.5	25.7	33.8	40.5	3.5	15.1	34.7	16.4	6.9	5.9	7.1	18.1	22.9	14.3	9.2	19.0	15.1	12.7	15.0	11.3	19.4	22.3	23.2	16.4	14.6	20.7	20.1	10.0	11.1	13.6	2.2	0.1	0.4	1.5	0.1	0.2	1.2	0.3	0.9	0.4	2.0	0.7	0.4	0.0	0.7	0.1	1.5	0.6	0.2	9.6	9.8	12.8	15.8	9.3	12.2	9.4	9.1	10.8	6.0	3.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	11.7	0.0	1.8	0.0	0.0	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor, Kazal type 13 (putative)"	Q1W4C9	5	148268180-148286254	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7"	"Group enriched"	"Detected in some"	7	"Leydig cells: 36.8;Peritubular cells: 25.1"	"Group enriched"	"Detected in some"	6	"cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"HeLa: 102.0"									HPA036456	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.2	0.0	85.5	0.0	0.4	86.8	0.1	1.0	0.1	0.8	0.0	0.1	2.1	0.0	0.1	0.1	0.0	0.0	1.4	0.4	0.0	1.0	0.1	0.0	4.0	0.0	0.0	0.1	26.7	0.1	0.2	0.0	0.1	0.0	0.0	2.9	2.7	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	102.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	25.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor, Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3"	"Cell type enriched"	"Detected in some"	24	"Mucus-secreting cells: 2251.6"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 38.2;OE19: 100.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Not detected"	"Not detected"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	0.2	0.4	0.2	24.3	0.3	0.0	0.2	0.2	0.2	0.2	69.3	0.2	0.2	28.8	0.2	0.2	0.3	0.2	35.8	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.4	0.2	0.2	0.3	110.5	2.5	0.2	0.2	0.3	0.2	120.9	4.6	0.2	0.3	0.5	0.3	0.2	0.2	0.2	0.2	0.2	3.4	0.2	0.0	0.0	5.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	6.2	0.2	0.0	0.0	38.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.4	0.0	100.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	3.2	0.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	20.7	0.0	0.0	0.0	0.0	5.2	11.8	0.0	0.0	0.1	0.7	0.0	94.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	84.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2251.6	15.3	0.1	40.3	0.0	0.0	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.1
SPINK9		ENSG00000204909	"Serine peptidase inhibitor, Kazal type 9"	Q5DT21	5	148321203-148339849	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"tongue: 65.0"	"Group enriched"	"Detected in some"	54	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 26.8;Club cells: 27.3;granulocytes: 9.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 18.5;U-266/84: 19.6"					"Low region specificity"	"Detected in single"			HPA038288	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Vesicles"		"HPA038288: AB_10795400"	"unprognostic (1.84e-1)"	"unprognostic (4.87e-3)"			"unprognostic (2.88e-1)"	"unprognostic (9.02e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.90e-1)"	1.0	2.3	2.3	2.2	4.0	6.2	1.0	1.3	3.2	1.0	1.2	1.0	1.0	1.1	2.0	1.5	1.5	0.5	1.0	2.3	2.2	3.3	1.3	1.0	1.0	1.9	1.5	1.0	1.4	1.4	0.5	1.4	2.5	1.0	1.8	1.2	1.0	1.0	1.0	2.4	2.7	1.7	1.0	1.1	1.1	2.0	3.8	1.0	2.7	1.0	65.0	1.1	1.2	1.0	3.4	2.7	10.7	2.9	5.8	2.8	0.2	11.1	2.1	2.9	3.0	0.4	1.1	2.4	3.0	0.1	0.2	0.5	4.6	8.6	3.3	18.5	0.2	1.6	2.3	0.9	0.6	0.8	4.7	2.2	6.5	6.9	2.0	0.2	2.3	2.7	0.1	0.6	0.3	0.1	1.7	0.0	2.3	3.9	14.4	0.4	9.5	2.2	3.4	11.4	4.2	4.4	2.9	2.9	3.6	1.4	9.1	5.2	6.0	3.0	6.5	2.0	8.3	10.6	2.1	7.0	3.4	10.7	3.3	3.5	9.1	19.6	3.3	2.8	2.0	4.6	10.7	2.9	1.3	1.8	1.6	2.1	1.3	2.0	2.1	0.7	3.4	2.6	2.8	10.5	5.8	2.8	2.7	1.3	0.2	2.3	4.0	1.3	3.2	2.2	3.3	1.5	1.0	1.0	1.0	14.9	27.5	0.0	0.1	0.0	0.0	0.3	0.0	26.8	27.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 121.0"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 913.5;Syncytiotrophoblasts: 1399.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 52.1;HaCaT: 59.5;hTCEpi: 42.4;RT4: 48.2;SK-BR-3: 89.3;T-47d: 42.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		3400000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.2	0.5	0.9	11.6	1.2	0.0	12.6	2.9	0.8	12.9	64.4	1.2	38.6	31.9	3.6	25.5	71.1	6.4	30.7	0.8	0.8	0.7	27.9	1.5	18.5	3.7	0.9	0.6	3.4	25.0	28.8	9.7	85.5	1.3	17.5	17.9	3.2	50.8	24.0	0.6	39.1	121.0	2.3	1.0	3.1	17.6	1.9	0.7	4.8	15.4	26.9	44.3	12.8	21.5	5.1	19.0	15.3	10.9	3.6	1.8	3.8	19.0	0.1	0.0	0.1	0.0	0.0	52.1	0.3	0.4	0.6	0.3	30.4	32.0	0.0	22.8	0.0	0.5	59.5	4.9	28.6	0.4	0.1	1.6	0.8	0.5	1.6	0.3	3.3	15.1	0.0	42.4	0.6	2.7	0.5	2.3	1.9	0.4	0.1	0.0	14.8	0.1	2.5	5.9	32.2	2.8	1.9	0.0	3.7	28.8	48.2	12.8	0.6	1.4	89.3	2.3	9.6	42.7	2.5	0.0	0.0	0.3	0.1	0.0	0.1	3.6	0.1	0.1	2.5	0.1	0.0	10.9	7.9	0.3	9.3	0.5	5.1	1.8	0.8	19.0	3.9	0.7	0.2	15.3	3.6	9.6	2.3	0.2	3.8	0.9	1.2	2.9	0.8	0.8	0.7	0.9	0.6	1.3	0.7	53.6	17.1	2.7	86.0	67.5	0.0	0.4	109.5	4.0	18.2	127.4	0.0	913.5	21.6	354.0	0.5	0.7	428.8	0.0	224.2	67.1	7.5	132.0	10.3	0.4	125.6	0.0	141.5	0.0	13.6	0.8	3.4	17.8	13.5	101.8	147.7	0.0	241.9	199.9	0.0	40.0	0.1	0.0	5.2	0.6	5.2	76.9	1399.8	2.2	145.0	168.6
SPIRE2	"KIAA1832, spir-2"	ENSG00000204991	"Spire type actin nucleation factor 2"	Q8WWL2	16	89818179-89871319	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 40.6"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 40.0;Mucus-secreting cells: 37.2;Paneth cells: 34.2;Syncytiotrophoblasts: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 21.5;T-47d: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041413, HPA049415"	Uncertain		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA			Nucleoplasm	"Vesicles, Intermediate filaments"	"HPA041413: AB_2677464, HPA049415: AB_2680755"	"unprognostic (2.92e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.07e-3)"	"unprognostic (6.96e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (2.10e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.95e-3)"	"unprognostic (7.21e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.59e-2)"	1.5	2.1	7.2	3.9	9.3	2.2	1.7	19.5	11.2	2.1	14.8	2.1	5.9	10.9	2.5	3.2	2.5	9.1	7.6	0.8	6.2	7.8	1.9	4.0	3.2	1.0	5.5	6.1	1.6	3.0	8.4	18.4	40.6	7.4	3.5	11.7	2.7	2.2	5.0	1.2	2.0	12.6	1.9	2.5	1.5	20.2	3.8	1.4	0.0	5.0	0.9	1.3	6.4	4.9	2.1	1.6	5.5	1.4	1.7	1.2	0.6	0.2	6.2	3.9	3.3	1.1	0.7	13.2	2.1	1.2	2.9	1.2	2.4	6.6	4.1	0.9	0.6	3.1	6.6	1.7	0.2	0.9	1.6	7.6	0.8	5.1	6.3	1.0	0.2	1.4	1.4	1.5	0.9	0.8	0.3	0.1	0.3	6.3	1.2	0.8	9.2	0.1	1.4	4.3	21.5	3.8	3.1	1.4	0.9	1.5	6.3	10.3	5.3	8.6	3.8	3.7	3.4	14.2	2.2	0.3	1.7	3.7	2.4	1.8	0.5	2.6	0.4	2.6	1.5	3.5	4.6	1.4	0.9	1.1	0.7	0.8	1.2	0.9	0.7	0.3	2.1	1.2	1.2	5.5	1.7	1.3	1.6	0.5	0.6	7.2	9.3	19.5	11.2	6.2	7.8	5.5	6.1	7.4	1.4	6.0	3.7	0.8	3.6	0.8	11.1	2.0	7.6	5.3	1.2	12.2	3.9	11.0	3.3	1.2	2.4	0.5	40.0	0.0	0.3	2.8	1.3	4.5	0.0	1.8	2.2	22.3	15.1	0.0	1.8	1.7	0.9	1.1	0.0	0.0	37.2	2.4	1.0	34.2	1.8	0.8	10.1	0.0	1.0	4.6	8.4	0.5	58.9	0.8	30.5	25.1
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 22.9;Erythroid cells: 23.3;granulocytes: 42.7;Hofbauer cells: 27.4;Kupffer cells: 21.5;Macrophages: 52.4;T-cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 52.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 56.1;HL-60: 49.8;HMC-1: 28.1;K-562: 17.4;MOLT-4: 19.3;REH: 17.4;THP-1: 27.0;U-937: 35.5"									"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002666: , HPA055244: AB_2682756"	"prognostic favorable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	5.7	1.0	1.2	12.9	2.7	33.1	1.6	0.7	1.5	1.3	2.8	2.6	0.0	2.3	1.5	0.6	1.9	1.7	2.8	3.9	1.2	1.4	1.8	1.9	25.0	18.3	3.7	0.2	1.0	1.6	0.2	1.0	0.8	2.3	1.6	2.6	1.6	5.0	0.6	0.8	1.6	6.8	1.0	4.6	15.9	2.0	0.6	1.9	79.7	1.6	1.7	17.4	2.6	1.4	1.0	8.8	3.5	52.1	17.5	26.5	10.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.1	0.0	0.4	0.0	49.8	28.1	0.0	0.0	0.0	0.0	0.0	0.0	10.9	17.4	13.7	0.1	0.0	19.3	12.5	0.0	0.0	0.0	17.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	7.3	0.0	35.5	0.0	2.4	5.5	3.5	26.5	24.3	14.5	1.0	10.7	18.1	8.8	0.3	7.6	13.2	0.9	17.5	52.1	7.0	9.1	10.7	1.2	2.7	0.7	1.5	1.2	1.4	3.7	0.2	2.3	1.9	8.9	22.9	9.3	0.5	1.9	0.6	5.1	0.0	2.7	4.5	1.8	0.0	0.2	0.0	0.0	0.0	0.7	0.0	23.3	0.0	0.3	2.6	0.4	42.7	0.9	27.4	1.6	0.0	4.3	21.5	0.0	0.0	52.4	1.7	1.8	0.0	0.4	0.0	0.0	0.0	0.3	1.9	0.0	1.7	0.2	0.6	1.8	0.2	85.3	0.0	0.7
SPNS1	"HSpin1, LAT, nrs, PP2030, SPIN1, SPINL"	ENSG00000169682	"Sphingolipid transporter 1 (putative)"	Q9H2V7	16	28974221-28984548	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041995, HPA042988"	Enhanced		Approved	"Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol"		NA	NA			Vesicles	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA041995: AB_10959609, HPA042988: AB_10964587"	"unprognostic (3.54e-2)"	"unprognostic (4.57e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.66e-1)"	"unprognostic (7.86e-5)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.85e-7)"	"unprognostic (1.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.12e-2)"	23.4	23.9	14.5	22.0	15.9	38.3	24.2	21.0	22.8	18.2	22.1	24.1	20.1	26.9	25.1	21.3	20.9	17.1	26.8	16.1	14.9	12.1	24.1	28.3	33.4	22.6	15.4	17.0	18.3	20.8	29.5	17.2	40.7	15.4	20.1	12.6	19.8	20.8	22.8	21.3	30.9	22.3	26.3	14.5	27.3	20.7	22.3	17.2	31.0	22.0	24.5	17.2	21.2	19.5	3.1	15.6	7.2	23.5	4.2	7.9	10.1	10.3	24.5	9.3	21.6	17.9	9.9	26.5	11.6	12.0	19.4	17.4	22.3	24.9	6.6	28.6	10.4	16.1	22.0	15.0	12.8	7.0	7.6	25.5	9.6	23.9	27.7	30.4	10.6	20.7	16.5	17.2	20.9	8.9	11.4	17.8	12.4	21.5	12.0	9.7	27.7	11.6	30.4	21.9	8.4	16.2	14.7	11.2	29.6	10.5	10.1	16.7	21.6	8.2	24.7	18.0	8.1	24.6	12.9	15.0	15.8	12.0	22.0	8.9	18.2	14.3	6.2	20.2	16.3	12.7	6.4	18.2	7.2	6.0	23.5	5.0	3.1	6.0	7.9	15.6	2.8	6.2	4.1	3.3	4.2	15.7	6.5	6.8	10.1	14.5	15.9	21.0	22.8	14.9	12.1	15.4	17.0	15.4	17.2	6.0	7.4	9.0	18.6	18.9	27.1	0.4	10.2	12.0	3.4	19.2	27.5	55.8	11.6	51.1	1.5	21.6	16.8	0.0	39.5	59.8	27.5	13.4	20.9	12.1	87.9	25.4	11.7	19.6	37.6	1.9	21.0	27.5	32.1	26.2	18.9	29.6	34.8	14.0	15.6	13.5	33.9	6.5	15.3	17.2	28.3	19.8	73.0	22.5	23.8	17.0
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.9;urinary bladder: 13.7"	"Cell type enhanced"	"Detected in some"	19	"Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7"					"Low region specificity"	"Detected in some"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008"	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.05e-5)"	28.9	0.5	1.8	5.1	1.6	0.3	1.6	0.4	3.9	2.0	0.7	1.5	0.1	1.6	2.4	2.8	0.3	2.1	1.6	0.4	1.2	1.6	0.5	0.2	12.9	0.9	2.6	0.3	1.8	0.1	0.1	1.6	3.5	8.2	1.8	0.9	1.8	0.1	0.3	0.4	0.1	0.9	2.4	3.1	1.9	1.1	11.9	0.6	0.1	0.4	0.8	0.2	13.7	2.1	0.0	0.0	1.9	0.1	0.0	0.0	7.3	10.7	0.3	0.0	0.0	0.2	1.5	0.5	14.1	18.9	13.7	9.2	0.2	0.6	0.1	1.9	15.9	5.6	1.4	0.0	0.2	4.3	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.2	6.9	0.2	19.7	0.6	11.1	9.3	0.7	0.2	0.2	8.1	0.0	0.1	0.0	0.2	0.1	0.3	0.0	1.4	0.0	0.0	33.2	0.0	0.0	0.3	0.0	0.9	0.4	8.2	0.0	17.3	14.5	1.4	9.3	5.3	0.0	0.1	0.0	32.7	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	1.8	1.6	0.4	0.6	1.2	1.6	2.6	0.3	8.2	0.6	0.0	5.9	0.0	4.0	0.1	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	9.9	0.2	0.1	0.0	0.0	8.9	0.5	0.4	1.7	1.1	0.0	13.9	0.0	1.7	0.6	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.2	0.0	0.0	44.4
SPOCK1	"SPOCK, testican-1, TIC1"	ENSG00000152377	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1"	Q08629	5	136975298-137598379	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 92.2"	"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 54.3;Muller glia cells: 252.1;Peritubular cells: 141.1"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 83.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.5;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 75.8;hTERT-RPE1: 144.5;HUVEC TERT2: 75.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007450, HPA026770"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA007450: AB_10603116, HPA026770: "	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.77e-5)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.90e-2)"	11.3	31.0	20.6	4.0	30.4	1.5	9.3	68.2	92.2	20.5	7.4	36.0	5.1	2.1	20.5	26.1	5.6	6.8	14.3	38.6	29.9	16.6	18.0	1.4	1.9	1.7	35.5	29.0	3.2	3.7	1.4	3.7	7.6	19.6	48.9	3.6	5.2	2.9	20.7	5.6	3.2	2.6	23.2	21.7	6.8	3.7	15.9	36.0	0.1	3.3	0.0	1.6	8.1	11.5	0.0	1.6	0.4	2.5	0.0	0.0	0.6	0.5	0.1	38.2	0.0	75.8	15.5	0.0	12.4	11.5	27.0	15.2	0.0	0.0	0.0	0.0	25.9	6.8	0.5	0.1	8.9	8.4	2.1	0.0	0.0	2.3	0.0	0.5	0.0	0.0	27.0	3.6	16.6	2.9	144.5	75.8	0.0	0.0	0.0	7.7	0.0	0.0	0.0	2.4	0.0	3.5	0.0	0.0	0.0	18.0	1.2	0.4	1.8	6.1	0.1	0.0	4.8	0.0	0.1	12.1	38.5	1.3	13.1	3.5	0.0	0.0	0.0	20.9	0.5	17.4	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	20.6	30.4	68.2	28.5	29.9	16.6	35.5	29.0	19.6	36.0	0.0	0.0	0.0	1.7	1.5	5.0	54.3	0.0	0.0	0.0	21.0	2.0	0.4	1.7	0.7	8.2	2.1	0.0	0.0	1.2	0.4	9.5	48.4	0.0	0.0	0.8	7.9	33.7	1.3	2.4	8.9	16.1	1.1	6.8	1.0	0.0	252.1	1.5	0.0	141.1	1.7	3.2	12.9	12.8	7.5	5.9	1.3	0.1	0.0	0.1	2.1
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962689-14267884	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.2"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 163.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 199.1"					"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	74	"T-cells: 7.3"	"Group enriched"	"Detected in some"	35	"EFO-21: 42.0;RPTEC TERT1: 118.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	27000000	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	16.8	5.1	8.3	5.2	12.5	0.0	3.3	4.8	10.7	15.7	9.7	7.6	0.0	9.6	12.0	4.6	5.3	20.3	40.2	4.9	7.2		5.4	0.1	8.1	0.7	5.1	8.8	12.0	0.8	0.0	2.0	12.3	7.5	7.2	15.0	8.5	0.9	2.5	0.0	1.6	12.4	15.7	3.2	1.8	3.9	0.8	5.7	0.0	0.8	0.6	0.0	15.6	9.9	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	118.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	0.0	1.3	0.7	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3											0.0	2.9	10.4	12.6	0.0	8.9	1.2	2.5	1.4	0.0	0.0	2.0	2.6	3.3	3.3	1.3	1.0	19.8	0.0	1.8	3.1	18.3	5.0	2.3	0.0	1.6	1.6	16.0	3.7	0.3	1.2	4.0	0.0	0.0	0.0	18.6	163.5	4.5	10.5	28.3	0.8	29.7	6.5	5.4	0.2	0.6	0.0	4.1	5.0	35.1	8.0
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 238.3;Fibroblasts: 91.2;T-cells: 101.5"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 54.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 54.2"	"Group enriched"	"Detected in some"	6	"HHSteC: 55.2;HSkMC: 97.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1600000	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	18.5	10.2	0.9	11.7	4.2	7.2	27.9	10.7	3.4	63.7	18.0	1.0	6.4	8.5	46.7	25.7	13.9	11.6	26.6	14.4	1.8	0.0	19.3	35.7	13.9	1.6	0.5	1.5	24.2	4.8	0.1	3.2	44.9	1.9	39.4	3.2	3.4	6.3	7.6	8.9	9.1	14.2	23.1	0.6	6.7	9.6	10.6	0.9	1.1	3.5	21.0	3.0	20.1	22.8	0.2	8.7	2.1	0.4	10.0	54.2	22.7	0.0	0.1	0.0	0.0	1.8	13.2	0.5	1.1	0.7	0.1	0.2	0.0	0.0	0.3	1.9	4.5	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	55.2	0.0	0.3	97.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.9	2.5	0.6	1.7	0.1	0.1	0.6	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.1	4.0	0.0	0.2	0.4	0.1	0.0	1.3	0.0	0.8	0.1	0.1	54.2	0.2	1.1	0.1	7.6	22.3	0.1	0.2	3.4	22.0	2.1	10.0	0.4	8.7	0.0	22.7	0.9	4.2	10.7	3.4	1.8	0.0	0.5	1.5	1.9	0.9	0.0	6.4	5.2	1.9	32.6	1.7	4.2	12.7	13.4	2.3	1.8	0.0	3.1	1.7	3.0	0.2	4.5	10.7	0.0	1.2	238.3	91.2	11.8	5.8	32.1	11.2	0.0	13.3	20.3	2.4	0.0	27.6	6.6	25.3	8.2	8.5	0.9	1.4	3.5	8.9	15.1	0.2	6.5	7.1	0.2	0.4	18.7	32.5	101.5	5.8	11.2
SPOPL	BTBD33	ENSG00000144228	"Speckle type BTB/POZ protein like"	Q6IQ16	2	138501801-138573547	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034687	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034687: AB_10670573"	"unprognostic (1.39e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.90e-2)"	"prognostic favorable (3.63e-4)"	"unprognostic (2.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.91e-3)"	13.6	8.8	17.3	14.9	20.0	17.5	18.8	14.5	17.5	11.1	13.1	10.7	10.1	11.1	15.7	6.3	9.9	9.9	10.7	9.8	13.4	11.3	12.9	13.2	13.7	14.7	16.1	13.1	16.2	9.9	13.2	16.7	9.5	16.0	14.1	13.0	9.3	15.1	19.3	9.0	13.5	13.9	17.8	19.4	15.0	13.0	5.7	17.2	5.7	12.4	6.6	13.4	12.7	13.3	1.8	3.5	9.0	2.6	0.6	0.7	0.9	10.0	3.1	5.7	5.5	4.7	7.9	11.0	7.5	5.7	4.7	5.7	11.3	8.3	10.8	7.2	6.4	4.2	4.0	7.4	6.6	10.0	8.4	6.0	6.9	7.3	17.7	4.9	7.5	9.7	5.2	9.8	9.3	8.7	9.6	7.5	2.6	2.2	15.2	7.9	9.8	0.7	7.1	5.1	7.1	5.4	3.8	10.0	6.2	7.4	14.4	6.7	8.3	11.4	10.9	5.5	7.1	6.0	8.3	7.4	7.6	6.5	9.5	11.3	22.0	16.0	8.0	12.8	7.1	6.9	0.6	2.6	4.2	0.6	2.4	0.5	1.7	0.5	0.5	3.5	1.8	0.3	0.3	9.0	0.6	1.9	1.5	0.7	0.9	17.3	20.0	14.5	17.5	13.4	11.3	16.1	13.1	16.0	17.2	11.9	9.9	13.7	9.8	49.3	8.2	10.6	10.2	12.0	28.4	3.5	3.9	5.0	6.6	8.4	1.6	9.8	12.5	0.0	11.6	6.0	8.2	18.4	8.1	10.4	8.4	17.5	18.4	6.2	36.5	2.1	15.8	22.6	11.8	7.2	18.6	6.6	15.9	11.5	14.9	13.9	16.3	6.5	17.8	9.3	22.2	39.1	5.1	7.4	10.2	15.7
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887360-72892158	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 61.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 9.9;monocytes: 9.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		52000	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	13.3	22.6	6.3	6.1	8.2	0.0	36.2	2.0	6.4	6.0	17.1	3.1	8.9	11.4	5.7	19.1	13.4	13.2	11.4	16.1	6.4	6.0	20.3	43.5	7.2	5.3	7.9	5.0	8.7	61.7	16.7	5.5	3.9	7.9	17.3	16.2	4.5	20.9	8.8	16.0	3.3	15.1	9.5	4.9	4.7	15.4	4.9	7.2	1.0	31.7	6.2	3.6	9.5	41.4	0.0	9.9	0.7	9.3	0.0	0.4	2.5	13.5	38.0	0.2	5.9	15.6	5.7	9.5	6.4	9.3	4.8	4.5	24.2	14.1	9.9	7.7	7.5	24.1	12.9	17.0	10.2	4.0	2.8	13.2	14.9	9.4	24.8	5.8	2.3	4.1	5.0	11.4	5.2	5.9	9.8	12.5	7.4	15.3	2.0	6.2	28.5	0.9	8.8	3.2	40.2	36.4	0.0	24.7	5.8	25.2	21.2	2.4	4.4	11.7	26.5	8.7	5.2	11.9	2.8	15.3	5.2	12.8	9.1	11.2	2.2	4.8	0.6	7.5	5.0	9.1	0.0	9.3	0.7	0.4	2.6	0.4	0.0	0.2	0.1	9.9	0.0	0.2	0.4	0.0	0.0	1.0	0.9	0.0	2.5	6.3	8.2	2.0	6.4	6.4	6.0	7.9	5.0	7.9	7.2	11.9	5.3	1.9	19.7	7.4	0.6	40.5	40.8	6.7	7.9	40.1	0.0	14.2	18.3	46.9	0.2	17.6	68.6	0.0	71.1	9.3	12.5	27.5	4.6	52.9	35.3	1.6	10.9	11.6	4.7	0.9	8.6	9.4	13.5	34.3	31.7	8.6	48.5	51.8	5.3	75.1	0.5	6.5	12.5	0.3	6.6	5.6	3.7	1.7	50.4	13.2
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970666-152972574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 51.9;tongue: 18.9"	"Group enriched"	"Detected in some"	27	"Early spermatids: 9.1;Late spermatids: 36.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 3.6;hTCEpi: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055963	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA055963: AB_2682988"		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.1	0.0	0.1	0.7	0.1	0.0	4.9	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.4	0.1	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	51.9	0.1	0.1	0.1	0.1	0.0	2.9	0.1	1.8	0.1	18.9	0.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0
SPRY1	hSPRY1	ENSG00000164056	"Sprouty RTK signaling antagonist 1"	O43609	4	123396795-123403760	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.1"	"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 160.4;Leydig cells: 414.8;Muller glia cells: 173.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 29.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 30.2;AN3-CA: 61.1;ASC diff: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013538, HPA051369, HPA070554"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	Nucleoplasm	"CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.21e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	139.1	12.6	3.3	14.7	4.3	5.8	69.0	4.9	3.5	28.5	24.8	1.9	18.0	4.5	18.6	28.0	38.1	19.1	27.1	34.1	2.6	1.7	10.2	6.4	23.1	9.1	3.3	2.8	32.2	9.8	17.0	9.5	15.6	2.9	25.0	8.8	11.8	14.6	16.5	48.1	25.5	8.1	20.7	2.8	7.1	11.6	28.4	1.5	13.0	29.6	16.3	8.6	60.8	39.9	29.9	0.7	2.8	0.1	6.1	15.5	0.9	1.9	0.5	30.2	61.1	24.8	16.9	2.0	0.1	1.5	0.1	0.6	1.8	3.2	0.0	13.6	0.9	0.1	0.3	0.8	1.4	0.2	0.0	3.1	0.6	0.0	9.4	7.0	4.2	0.0	6.8	0.8	0.2	0.6	3.3	2.5	0.7	0.5	0.5	1.4	0.2	4.9	10.5	7.2	6.9	10.0	2.1	3.2	0.0	4.1	4.4	4.6	3.9	0.0	6.1	5.8	3.3	0.6	0.0	6.2	0.4	0.0	0.1	0.9	0.3	0.0	0.0	0.4	0.8	1.0	0.0	0.1	2.8	0.5	0.0	15.5	9.6	1.8	4.2	0.0	29.9	2.7	2.9	0.1	6.1	0.0	0.7	0.0	0.9	3.3	4.3	4.9	3.5	2.6	1.7	3.3	2.8	2.9	1.5	26.8	27.0	15.2	13.8	44.1	75.2	10.9	35.7	13.4	27.3	26.2	31.4	10.0	68.0	3.5	1.7	160.4	6.3	0.0	9.4	1.5	42.7	12.9	9.2	4.4	8.2	6.4	25.4	120.9	11.6	4.0	414.8	9.7	43.9	1.0	13.1	173.3	8.4	3.5	54.5	12.6	80.4	148.8	86.8	1.9	1.5	37.9	2.6	25.5	14.1	12.5
SPRY3	HSPRY3	ENSG00000168939	"Sprouty RTK signaling antagonist 3"	O43610	X	155767812-155782459	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.5"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 3.5;Cone photoreceptor cells: 3.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.6;EFO-21: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013505	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB013505: "	"unprognostic (3.70e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.52e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.49e-2)"	1.6	2.1	1.3	0.4	1.8	2.8	1.2	7.5	1.5	1.3	0.8			1.2	1.5	5.8	0.8	1.1	0.8	0.9	1.3	1.5	0.9	0.7	0.9	0.3	1.1		2.8	0.4	1.3	1.1	1.9		0.9	1.4		1.1	1.2	1.2	0.4	1.1	1.2	1.2	1.4	0.7	0.1			1.0		0.5	0.8	0.7	0.0	0.5	0.4	0.5	0.2	0.2	0.0	0.5	0.2	2.4	8.6	1.7	0.8	0.0	2.0	1.3	0.6	1.0	0.2	1.4	0.0	4.2	1.1	1.6	0.3	0.9	0.6	0.6	0.2	0.4	1.0	2.2	0.1	0.7	0.4	0.4	2.1	1.1	0.8	0.5	0.8	1.3	0.5	0.1	0.6	1.6	0.3	0.2	0.3	0.8	0.2	0.0	0.5	0.2	2.1	0.9	0.8	0.6	0.6	1.0	0.0	0.5	1.2	0.5	0.6	2.2	0.6	0.9	0.3	0.6	0.7	0.1	1.9	2.1	1.0	1.2	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.0											0.0	0.0	0.0	0.1	0.1	3.5	0.8	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.9	1.1	0.0	0.6	0.1	0.4	0.1	0.0	0.8	0.3	0.0	0.0	1.3	0.6	0.0	0.9	0.1	1.7	0.0	1.0	0.8	0.5	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.1
SPRY4		ENSG00000187678	"Sprouty RTK signaling antagonist 4"	Q9C004	5	142310427-142326455	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 47.2;Ito cells: 48.5;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.0;WM-115: 50.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008086, HPA055471, HPA072661"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"CAB008086: AB_2195454, HPA055471: AB_2682825, HPA072661: AB_2732207"	"unprognostic (9.54e-3)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (6.29e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.59e-2)"	"unprognostic (8.21e-2)"	27.3	20.8	9.0	6.8	9.0	0.7	32.9	6.2	8.3	7.1	8.0	4.9	3.6	8.7	8.3	6.2	4.9	6.5	11.3	17.1	7.4	8.0	12.5	11.5	24.3	3.7	6.5	7.6	5.7	7.4	10.6	28.7	21.8	8.5	13.0	7.5	10.7	4.6	7.3	10.6	3.6	11.7	8.8	6.7	10.7	7.8	2.4	3.9	0.2	17.8	4.0	2.4	12.7	29.1	0.0	0.9	0.0	0.0	0.2	0.1	0.0	1.1	1.9	17.5	36.0	10.5	7.5	4.8	13.1	4.5	2.1	2.3	1.9	1.8	0.0	9.7	3.2	2.3	0.9	0.0	3.7	2.5	0.0	0.0	0.0	0.0	7.7	3.5	0.0	0.0	6.2	0.0	5.7	3.2	3.3	2.0	0.0	4.4	0.0	7.6	1.5	0.0	4.7	8.1	5.8	12.5	0.4	2.5	0.4	6.2	11.3	0.2	5.5	0.2	1.7	14.9	5.2	0.1	0.7	2.9	4.6	0.1	0.9	11.7	0.0	0.6	0.0	7.2	0.0	50.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	9.0	9.0	6.2	8.3	7.4	8.0	6.5	7.6	8.5	3.9	6.0	47.2	0.0	4.2	1.4	5.9	2.8	0.0	0.0	1.2	3.5	0.0	0.9	0.0	1.8	0.7	15.4	5.6	0.0	0.3	1.7	7.2	2.5	3.5	1.7	0.2	0.0	13.3	48.5	3.7	1.3	0.3	0.9	6.8	0.0	6.5	2.2	3.1	3.4	0.4	0.8	0.3	19.4	10.3	0.0	0.1	0.3	2.9	0.5	5.2	1.4
SPRYD3	FLJ14800	ENSG00000167778	"SPRY domain containing 3"	Q8NCJ5	12	53064316-53079420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039426, HPA039685"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Vesicles, Plasma membrane, Actin filaments"	"HPA039426: AB_10673358, HPA039685: AB_2676623"	"unprognostic (7.73e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.27e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.78e-15)"	"unprognostic (9.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.41e-1)"	16.8	15.7	30.4	10.1	51.9	3.3	11.6	27.1	59.3	15.3	11.4	14.9	10.6	10.8	14.1	21.7	15.9	26.8	11.7	23.1	28.3	27.0	11.3	8.0	13.1	8.8	21.5	34.9	26.4	20.4	26.5	20.3	8.0	34.2	18.3	10.0	15.6	23.3	25.1	7.4	13.0	9.8	18.3	14.0	9.8	13.4	4.9	12.2	3.7	20.2	6.6	11.4	12.4	11.4	9.4	9.4	26.7	18.4	9.7	21.0	15.6	12.5	19.6	2.5	5.2	20.9	10.4	3.3	19.4	10.0	7.3	4.7	3.2	10.6	8.1	16.1	23.6	8.9	11.7	3.4	14.7	4.8	8.8	5.2	5.2	11.9	7.3	15.7	9.7	9.2	9.4	23.2	10.4	16.1	14.5	15.0	4.3	4.4	20.6	12.7	27.2	6.9	5.0	1.4	10.2	13.8	3.1	4.3	16.7	9.2	10.1	4.4	4.2	16.6	15.4	7.8	1.4	14.4	7.6	20.8	8.3	8.5	18.8	13.1	11.6	10.3	2.4	24.5	8.6	10.1	15.5	9.8	26.7	21.0	17.5	20.1	9.4	14.5	16.9	9.4	7.5	12.5	14.6	15.5	9.7	18.4	4.5	8.0	15.6	30.4	51.9	27.1	59.3	28.3	27.0	21.5	34.9	34.2	12.2	3.0	8.5	12.3	16.4	5.0	40.6	16.7	22.9	21.4	9.1	17.4	7.9	5.4	10.0	26.1	0.2	16.6	10.3	0.0	31.6	11.7	12.3	17.1	9.3	8.1	10.7	41.3	11.1	15.4	10.0	1.1	15.0	8.1	10.1	16.2	11.7	29.5	23.5	8.2	31.1	12.6	20.2	19.4	23.4	3.0	4.5	8.3	3.5	10.2	7.3	13.7
SPRYD4	DKFZp686N0877	ENSG00000176422	"SPRY domain containing 4"	Q8WW59	12	56468567-56479707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 58.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 141.7;Proximal tubular cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053469	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053469: AB_2682162"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-3)"	"prognostic favorable (4.52e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-1)"	3.8	9.6	3.3	6.0	4.6	4.4	6.2	4.2	6.1	3.8	5.1	6.0	6.7	4.2	4.5	6.3	7.1	3.8	7.4	7.2	3.6	3.6	12.0	58.4	3.1	3.5	4.4	4.3	4.9	12.3	5.0	7.0	4.3	3.7	5.2	6.5	5.8	8.2	6.3	10.5	4.6	6.4	4.3	3.3	4.8	5.0	2.6	3.3	3.8	7.6	7.3	6.1	5.2	4.1	4.6	5.0	3.8	3.8	4.8	3.2	2.5	2.8	3.7	3.2	2.5	2.9	1.8	4.4	2.3	2.4	4.9	3.0	3.4	5.0	3.5	3.1	3.0	3.4	4.9	2.7	4.0	3.1	1.7	5.7	5.1	3.8	5.1	2.8	3.5	5.1	4.1	2.6	3.6	2.9	2.6	5.0	2.4	2.7	15.2	4.1	4.6	1.7	2.5	2.1	3.2	4.3	2.1	2.4	7.3	5.2	3.6	3.3	1.5	4.5	5.4	3.4	2.1	9.2	1.0	2.4	2.2	4.0	3.1	1.8	2.6	1.4	1.2	1.8	3.0	2.6	3.8	3.8	2.0	3.0	3.0	3.2	3.8	2.8	3.0	3.3	4.6	3.2	3.2	3.8	4.8	3.2	5.0	1.2	2.5	3.3	4.6	4.2	6.1	3.6	3.6	4.4	4.3	3.7	3.3	0.0	6.1	11.9	15.2	4.2	13.4	14.0	12.7	2.7	3.4	21.0	15.7	33.1	46.4	21.4	1.0	5.8	18.7	23.3	18.6	19.0	6.1	9.3	10.3	141.7	18.2	15.9	16.8	8.0	10.7	0.5	8.3	5.4	5.0	13.6	14.3	10.1	19.6	7.0	9.9	76.7	17.4	0.0	5.1	4.7	9.7	4.5	30.1	5.2	16.1	17.8
SPRYD7	"C13orf1, CLLD6"	ENSG00000123178	"SPRY domain containing 7"	Q5W111	13	49912706-49936490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043934	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA043934: AB_10960545"	"unprognostic (1.83e-2)"	"prognostic unfavorable (8.48e-6)"	"unprognostic (2.57e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.06e-2)"	7.5	13.2	17.1	5.6	15.5	4.5	8.7	14.9	21.0	6.1	11.0	8.9	4.9	9.2	6.8	8.5	10.4	7.4	6.2	16.2	17.2	20.6	12.5	15.3	14.8	4.6	15.8	14.2	8.5	9.4	11.4	10.7	12.3	13.2	10.0	10.0	6.3	7.6	8.1	30.3	8.7	10.3	10.5	12.9	5.8	10.0	17.0	9.6	1.1	10.2	11.9	5.4	8.2	8.0	7.6	3.6	2.4	5.9	9.2	6.4	2.6	6.9	6.0	3.9	4.3	4.7	6.8	8.8	13.7	6.5	9.7	5.6	10.8	5.7	6.8	4.4	10.1	8.0	6.0	8.6	12.7	13.6	11.2	7.7	7.2	4.7	7.5	16.3	17.3	5.2	5.8	14.4	8.5	16.7	6.1	5.9	3.9	8.1	6.2	22.4	4.2	0.7	8.2	1.5	10.6	6.8	3.3	6.5	4.1	10.1	5.3	3.2	4.0	4.1	9.1	6.7	5.2	8.5	10.8	7.5	8.9	4.9	8.1	13.6	3.8	5.9	5.2	6.9	7.0	9.9	0.8	3.0	2.4	3.1	3.4	6.4	7.6	3.0	4.1	3.6	6.6	2.5	3.7	0.7	9.2	5.9	2.5	4.3	2.6	17.1	15.5	14.9	21.0	17.2	20.6	15.8	14.2	13.2	9.6	122.1	29.1	12.0	20.1	18.0	28.8	56.8	17.8	26.8	29.6	12.2	7.9	32.9	44.7	32.5	87.7	18.4	30.0	0.0	22.5	37.7	18.2	18.3	16.3	38.9	24.2	22.3	22.4	17.8	7.5	10.6	19.5	15.9	21.9	17.2	18.0	18.0	29.5	23.0	19.1	63.2	26.2	6.5	19.6	112.6	46.6	27.0	33.3	12.9	20.8	8.2
SPSB3	"C16orf31, SSB-3"	ENSG00000162032	"SplA/ryanodine receptor domain and SOCS box containing 3"	Q6PJ21	16	1776712-1793700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 138.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046602	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046602: AB_2679717"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.91e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.25e-7)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.72e-4)"	8.5	19.4	7.8	8.2	8.3	12.8	9.5	25.3	11.3	10.5	10.4	10.1	11.0	10.0	7.6	9.5	14.1	9.0	17.7	9.1	6.7	5.7	8.2	138.5	8.3	7.8	11.1	8.8	15.9	19.5	7.5	5.6	7.6	8.4	9.3	4.2	10.6	14.0	12.9	29.4	18.1	8.3	9.4	6.9	8.3	8.6	5.8	8.3	16.3	10.5	6.5	8.9	8.5	9.3	18.0	15.9	32.6	16.8	15.6	34.5	17.0	3.4	5.3	6.5	7.6	9.1	8.9	10.6	4.3	7.0	7.6	8.3	3.8	11.7	1.7	8.6	3.9	2.7	7.0	3.2	6.6	1.2	6.1	7.8	3.4	7.6	5.0	12.6	1.3	6.0	7.8	17.3	4.9	5.7	11.6	11.5	12.0	3.9	9.2	3.7	12.6	8.8	8.6	4.4	6.8	2.6	14.8	2.5	14.1	6.7	0.7	8.5	8.4	5.5	17.2	15.8	4.9	8.5	8.1	8.1	3.5	5.3	6.2	2.9	13.6	15.7	4.4	2.8	4.9	4.0	32.3	16.8	29.7	26.1	15.2	32.6	18.0	24.4	24.1	15.4	16.8	17.6	18.4	32.6	15.6	13.3	15.9	34.5	17.0	7.8	8.3	25.3	11.3	6.7	5.7	11.1	8.8	8.4	8.3	35.7	28.0	37.1	47.6	87.3	69.1	0.2	22.9	26.8	21.6	52.4	37.3	52.7	44.7	43.7	41.0	35.3	65.2	23.3	41.4	63.9	36.6	44.8	33.6	50.8	28.6	85.8	46.8	45.4	33.5	65.6	71.4	44.0	72.6	62.3	50.2	76.4	42.2	71.9	70.4	41.0	84.0	38.8	49.2	18.6	35.8	112.0	53.9	76.1	48.8	50.3
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051402-141148611	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 22.0"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 18.4;Kupffer cells: 4.1;Late spermatids: 6.3;Spermatocytes: 7.6"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.2;NTERA-2: 4.6;RH-30: 5.5;SH-SY5Y: 4.6;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.8	0.9	1.0	0.2	1.5	0.2	0.2	0.2	2.0	0.1	0.3	0.7	0.0	0.2	0.1	0.3	0.2	0.1	0.2	2.2	1.1	1.1	0.4	0.3	1.3	3.2	1.5	0.6	0.1	22.0	0.1	4.6	0.2	1.2	0.2	0.1	0.0	0.1	0.1	1.7	0.2	0.2	0.2	1.9	2.5	0.1	3.6	0.2	0.1	0.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.2	0.3	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	1.1	0.0	4.6	0.0	0.0	0.0	5.5	0.8	0.0	0.0	1.4	4.6	0.0	0.0	0.0	2.7	0.3	0.4	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.5	0.2	1.2	1.1	1.1	1.5	0.6	1.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	7.6	0.7	0.0	0.1	0.0	0.0	0.0
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6"	"Cell type enhanced"	"Detected in some"	22	"Erythroid cells: 46.7;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 23.5;K-562: 28.1;U-937: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		NA	NA		43000000	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	1.9	1.6	3.2	0.7	11.6	32.2	0.7	25.2	10.4	0.8	0.7	0.8	0.3	0.6	0.7	5.2	1.8	0.8	0.8	14.7	3.1	3.2	1.2	0.6	0.9	0.6	2.8	3.5	0.7	2.2	6.5	4.7	4.7	16.4	1.5	0.7	1.1	1.9	1.3	67.6	0.7	0.7	1.0	1.7	1.1	0.7	1.0	1.4	0.0	0.7	17.4	0.6	0.8	0.5	0.0	0.6	0.9	0.0	0.0	0.2	1.5	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	1.4	3.9	0.1	0.0	0.2	2.3	23.5	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.9	28.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	1.3	0.0	0.0	0.1	0.0	0.1	3.8	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	4.3	0.0	0.4	0.9	4.4	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	1.5	3.2	11.6	25.2	10.4	3.1	3.2	2.8	3.5	16.4	1.4	0.0	0.0	0.0	0.4	0.7	8.1	5.5	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	46.7	0.2	0.2	0.3	0.5	2.3	0.0	0.2	15.9	2.9	0.0	0.0	0.0	0.3	0.2	1.7	0.0	0.0	6.5	0.4	0.0	1.1	0.0	1.9	6.5	3.8	0.1	0.2	0.4	0.1	0.0	0.0	0.5
SPTBN1		ENSG00000115306	"Spectrin beta, non-erythrocytic 1"	Q01082	2	54456285-54671445	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 623.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012685, HPA013149"	Supported		Approved	"Golgi apparatus"		NA	NA		1900000	"Golgi apparatus"		"HPA012685: AB_1857433, HPA013149: AB_1857434"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (2.59e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.18e-3)"	81.1	37.1	75.7	16.1	76.4	16.1	63.3	33.8	62.9	27.4	29.0	41.8	44.2	16.6	31.8	27.5	21.3	28.3	33.8	58.9	67.4	48.6	32.8	43.8	60.7	13.4	61.4	44.1	35.9	22.4	103.7	15.7	44.5	42.1	23.2	26.0	31.5	26.8	43.9	23.9	18.9	23.0	27.3	47.8	27.5	26.9	16.0	33.2	6.3	34.2	21.9	14.6	23.7	59.8	6.1	2.1	3.8	0.6	8.2	8.5	4.0	23.8	37.4	13.7	14.2	63.5	37.6	19.9	9.1	18.1	14.3	14.0	25.6	17.3	0.1	28.2	32.2	13.5	28.6	19.3	32.9	14.9	0.1	9.1	9.7	28.2	43.7	26.2	13.6	6.4	16.4	17.3	45.1	31.1	19.5	36.4	24.5	11.5	15.9	21.5	5.5	25.1	3.9	17.5	33.9	18.1	27.8	22.0	9.3	26.2	29.8	8.7	28.7	28.0	10.5	22.6	15.9	5.0	2.6	56.5	21.7	20.3	26.1	13.5	16.6	9.5	8.2	24.5	4.5	38.6	3.2	0.6	3.8	6.3	0.0	6.5	6.1	5.8	5.8	2.1	5.7	8.5	5.9	1.0	8.2	0.0	1.8	4.8	4.0	75.7	76.4	33.8	59.2	67.4	48.6	61.4	44.1	42.1	33.2	378.2	97.0	37.7	33.1	73.7	100.5	238.9	163.1	188.7	110.3	137.9	68.7	20.0	6.6	205.8	9.5	331.3	242.7	0.0	104.6	32.5	149.4	67.0	33.6	154.4	12.2	133.5	79.7	194.0	16.5	16.4	466.0	19.4	140.0	8.2	118.4	127.9	194.7	97.1	623.7	33.1	91.1	161.7	70.4	26.6	45.6	59.6	9.3	34.1	105.1	91.8
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66685248-66729226	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7;skin 1: 36.9"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 82.0;Cone photoreceptor cells: 98.2;Late spermatids: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.3;NTERA-2: 23.5;SCLC-21H: 23.9;SK-BR-3: 16.7;T-47d: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA		4800000	"Plasma membrane"	"Cell Junctions"	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	0.8	4.9	26.2	1.0	38.3	1.7	4.5	29.6	46.7	9.6	0.9	2.0	0.0	1.0	1.1	1.2	12.7	2.6	1.2	0.7	19.7	8.2	12.7	7.1	0.9	0.5	6.5	24.7	0.8	8.3	12.2	3.9	0.7	14.4	6.8	0.7	1.7	13.4	3.1	0.7	36.9	0.9	1.2	1.9	0.9	1.2	18.9	6.2	0.0	0.5	0.1	3.3	1.1	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.5	3.4	1.6	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	8.1	0.0	1.8	0.0	0.3	7.8	11.9	1.1	0.0	0.0	4.7	0.0	20.3	1.1	0.3	3.3	0.3	0.1	5.5	0.0	3.5	1.9	2.9	2.4	3.3	0.0	0.0	12.8	2.6	1.5	23.5	9.2	10.5	10.9	1.3	6.7	4.5	1.1	23.9	14.1	6.6	16.7	1.5	1.3	19.1	0.9	0.6	0.0	4.2	0.6	5.2	0.3	1.2	7.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.2	38.3	29.6	46.7	19.7	8.2	6.5	24.7	14.4	6.2	3.0	0.6	0.0	1.7	3.3	7.4	1.6	2.5	1.4	2.3	82.0	98.2	0.8	0.0	2.4	24.4	0.6	0.0	0.0	8.7	0.3	0.5	3.1	0.0	20.2	0.1	0.0	2.9	1.3	0.0	50.4	1.7	0.0	0.0	1.0	1.6	1.4	6.9	0.0	1.4	1.2	21.0	0.0	0.0	2.7	8.6	10.9	0.2	0.0	0.6	1.4
SPTBN4	"KIAA1642, SPTBN3"	ENSG00000160460	"Spectrin beta, non-erythrocytic 4"	Q9H254	19	40466241-40576464	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 36.3"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 55.4;Cone photoreceptor cells: 53.0;Horizontal cells: 69.9;Rod photoreceptor cells: 67.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 3.5;Karpas-707: 5.1;SCLC-21H: 8.0;SH-SY5Y: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054481	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA054481: AB_2682502"	"unprognostic (1.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.65e-4)"	"unprognostic (3.72e-4)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.02e-1)"	3.1	5.9	13.4	1.2	15.3	1.2	1.2	36.3	27.1	1.4	1.3	1.8	0.0	1.7	2.3	1.3	1.6	2.0	1.8	3.3	9.8	10.8	1.9	1.3	1.2	1.0	7.5	13.0	4.1	3.0	3.3	8.0	1.0	10.4	2.8	1.1	2.6	2.2	2.0	5.1	1.3	1.5	1.8	2.8	1.3	2.5	3.5	3.7	0.0	1.6	0.0	1.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	2.3	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	2.4	0.5	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.3	3.5	5.1	0.0	1.3	0.0	0.0	0.2	0.3	0.9	0.5	0.0	1.1	0.0	0.0	8.0	4.9	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	1.5	0.8	0.0	0.2	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.3	36.3	22.7	9.8	10.8	7.5	13.0	10.4	3.7	0.0	0.0	0.0	0.1	0.1	55.4	4.4	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.2	69.9	15.6	0.6	0.3	0.9	7.5	0.0	1.7	1.0	0.3	4.7	0.2	0.0	6.7	1.4	67.0	0.0	0.9	3.2	4.6	0.4	0.0	0.0	0.2	0.1
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027552			Approved	Mitochondria		Yes	No			Mitochondria		"HPA027552: AB_10601717"	"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	30.0	12.8	15.4	11.4	27.0	27.3	25.6	6.9	18.5	15.3	17.0	32.4	8.5	13.4	10.2	7.6	22.8	13.7	11.1	7.8	20.8	14.1	17.1	7.2	12.2	17.5	33.1	13.3	10.2	7.6	12.8	9.8	18.8	21.2	8.2	18.8	6.0	16.6	9.6	5.5	11.3	15.8	11.0	47.6	23.5	18.8	4.7	34.9	10.0	10.3	8.8	12.0	13.2	17.1	4.8	18.2	15.1	18.2	10.0	4.2	6.9	12.1	8.0	6.1	6.7	6.3	8.0	10.5	18.1	13.4	12.5	13.1	10.1	27.1	12.1	4.6	18.3	6.4	15.0	16.3	10.1	19.0	5.3	4.8	34.4	6.2	6.0	5.4	3.5	11.4	5.2	5.0	8.1	9.1	7.1	17.5	8.4	6.7	5.9	7.1	10.5	9.1	11.9	4.0	19.2	7.2	9.9	6.3	4.1	14.4	27.3	5.9	7.5	6.5	21.8	6.8	11.3	26.8	6.4	11.0	11.5	8.2	4.2	4.1	3.3	5.5	8.2	7.6	12.4	6.5	8.8	18.2	15.1	3.8	13.8	3.5	4.1	3.2	4.2	18.2	4.8	2.2	3.6	11.2	10.0	16.7	6.5	3.3	6.9	15.4	27.0	6.9	18.5	20.8	14.1	33.1	13.3	21.2	34.9	26.8	23.5	25.0	21.1	28.7	13.3	7.3	10.2	24.1	27.3	45.4	33.4	10.3	1.7	21.2	1.4	32.3	28.5	46.7	14.2	10.9	16.6	24.2	49.7	6.6	21.7	4.8	12.7	57.1	63.4	1.5	13.6	29.2	18.6	15.4	36.9	10.3	24.7	28.1	14.9	9.1	18.8	32.3	8.6	6.7	16.0	25.5	5.5	22.7	27.5	47.7
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008979-13169103	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 154.0"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 22.9;Syncytiotrophoblasts: 38.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 10.5"	"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.0;NK-cell: 4.1"	"Group enriched"	"Detected in many"	13	"NK-cells: 4.1;T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.4;RPTEC TERT1: 21.8;U-2197: 15.2;U-87 MG: 28.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA044247: AB_2678872, HPA048079: AB_2680252"	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	3.2	4.5	1.3	1.6	2.2	0.0	4.3	1.7	1.7	4.3	5.0	2.2	4.4	8.3	4.8	9.6	5.6	3.4	5.8	4.8	2.0	1.5	15.6	11.9	5.7	0.7	2.5	2.2	4.3	3.8	10.2	4.2	154.0	10.5	4.5	3.8	3.8	7.8	5.8	1.0	25.1	9.0	3.0	6.9	1.9	2.2	4.2	1.4	5.7	24.3	3.6	1.9	4.8	6.0	0.0	0.2	0.1	0.0	4.1	3.0	0.2	0.7	1.1	0.9	0.0	7.1	10.3	5.5	0.0	1.5	1.0	4.1	8.9	4.5	0.0	0.5	0.2	9.0	12.2	0.0	3.4	1.4	0.0	0.0	0.0	2.8	12.6	0.6	0.0	0.1	5.8	10.7	4.0	1.4	3.8	0.7	2.1	0.0	16.4	11.5	0.2	0.0	0.0	0.0	1.0	1.4	1.1	2.0	7.2	21.8	8.7	0.0	0.1	0.1	1.1	0.0	1.6	9.1	0.2	1.6	4.6	1.5	15.2	1.0	0.1	0.0	0.0	28.8	0.0	0.0	0.1	0.0	0.0	0.5	0.0	3.0	0.0	0.4	0.1	0.0	0.0	0.7	0.1	0.1	4.1	0.0	0.2	0.0	0.2	1.3	2.2	1.7	1.7	2.0	1.5	2.5	2.2	10.5	1.4	6.0	18.2	0.0	4.8	2.2	0.0	15.1	5.1	4.0	6.8	8.7	0.0	22.9	6.6	2.2	15.0	2.2	4.9	0.0	3.8	10.5	7.2	3.4	1.1	18.7	2.5	0.0	0.0	0.6	2.5	8.5	3.4	0.9	0.0	0.0	4.7	13.6	2.5	8.0	2.5	11.9	0.0	0.0	0.3	0.9	0.1	1.9	38.6	1.3	6.1	1.8
SPTSSB	"ADMP, C3orf57, ssSPTb"	ENSG00000196542	"Serine palmitoyltransferase small subunit B"	Q8NFR3	3	161344792-161372880	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 68.6;skin 1: 27.5;stomach 1: 42.0"	"Cell type enhanced"	"Detected in some"	13	"Exocrine glandular cells: 42.0;Glandular cells: 74.2;Melanocytes: 43.9;Suprabasal keratinocytes: 31.9;Urothelial cells: 53.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 24.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	12	"NK-cell: 68.6"	"Lineage enriched"	"Detected in many"	12	"NK-cells: 68.6"	"Group enriched"	"Detected in some"	10	"MCF7: 159.0;RT4: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047712			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA047712: AB_2680127"	"unprognostic (2.09e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.37e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.08e-2)"	"unprognostic (5.37e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.51e-3)"	1.4	0.4	2.0	0.7	3.4	0.5	6.4	8.9	18.5	4.0	0.9	1.6	0.0	0.5	1.0	0.4	5.1	0.6	1.5	0.4	2.2	2.2	0.7	0.6	0.3	1.0	2.0	6.2	0.4	1.5	0.3	0.3	0.3	12.0	12.4	0.8	0.2	8.0	0.4	0.4	27.5	0.5	1.4	1.1	1.1	42.0	0.3	0.4	0.1	0.4	2.1	1.7	23.5	5.4	0.0	0.0	0.2	0.0	68.6	5.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.0	0.0	0.0	0.6	9.7	1.8	0.0	0.0	0.0	0.0	42.2	0.2	1.7	0.0	5.7	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.6	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.2	68.6	0.0	0.0	0.0	0.5	2.0	3.4	8.9	18.5	2.2	2.2	2.0	6.2	12.0	0.4	0.0	0.0	0.0	17.2	3.4	1.5	0.3	2.5	0.0	0.0	3.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	42.0	0.0	0.4	74.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	1.6	0.0	16.3	0.0	0.0	0.0	1.3	0.0	2.7	0.0	0.0	31.9	0.1	0.9	0.0	53.8
SRA1	"SRA, STRAA1"	ENSG00000213523	"Steroid receptor RNA activator 1"	Q9HD15	5	140537340-140558252	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Receptor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 26.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044598, HPA050153"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol		NA	NA			Nucleoplasm	"Microtubules, Cytosol"	"HPA044598: AB_2679013, HPA050153: AB_2681033"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (8.01e-6)"	"unprognostic (9.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-1)"	4.8	9.9	2.5	4.8	3.0	5.6	2.7	13.3	3.5	2.5	3.3			3.1	3.0	4.1	2.5	2.6	3.5	4.3	2.7	3.0	3.5	14.4	4.4	3.5	2.2		4.9	2.7	4.5	7.7	3.7		3.7	3.0		5.5	4.4	4.4	3.9	3.4	3.4	2.1	5.7	4.6	6.8			4.1		3.1	2.3	2.3	9.0	15.6	26.9	16.4	7.5	11.3	14.2	6.2	15.0	8.0	8.3	3.9	5.3	11.2	10.7	6.1	7.0	7.4	27.4	3.9	5.3	7.9	4.1	3.7	4.2	1.4	7.9	2.8	8.2	9.3	4.7	16.3	10.4	8.3	8.4	6.4	10.2	4.1	3.7	1.9	6.2	3.2	9.2	4.7	8.2	4.6	19.1	6.8	13.2	2.4	3.4	12.1	7.6	6.8	5.1	3.6	7.5	5.7	6.6	6.2	5.7	7.2	2.9	7.0	9.6	5.0	6.7	3.5	5.7	8.6	10.3	6.8	5.6	8.2	11.0	4.3	8.1	16.4	12.0	7.0	14.3	6.5	9.0	6.8	6.7	15.6	7.4	5.6	6.4	26.9	7.5	13.3	9.3	11.3	14.2											6.0	53.3	35.8	43.2	46.5	23.0	70.0	68.8	34.8	30.7	31.4	7.9	84.2	96.2	79.1	75.5	39.4	72.4	0.0	128.7	102.6	52.4	64.7	66.9	57.8	81.7	14.3	36.9	43.6	67.7	108.8	23.3	67.0	64.1	111.0	51.7	47.0	131.8	77.2	28.0	111.7	19.5	25.8	48.6	45.0	29.2	40.1	149.7	55.1	40.7	117.5
SRARP	"C1orf64, ERRF, MGC24047"	ENSG00000183888	"Steroid receptor associated and regulated protein"	Q8NEQ6	1	16004236-16008807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 22.0;breast: 14.7"	"Cell type enriched"	"Detected in single"	763	"Distal tubular cells: 76.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 7.7;prostate cancer: 6.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.3"	"Group enriched"	"Detected in some"	12	"Hep G2: 9.2;SK-BR-3: 16.5;T-47d: 5.3"					"Low region specificity"	"Detected in all"			HPA026676	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026676: AB_1853866"	"unprognostic (8.55e-2)"	"unprognostic (1.01e-1)"		"prognostic favorable (1.68e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.41e-2)"		"unprognostic (3.49e-1)"		"unprognostic (8.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.32e-2)"	0.9	1.1	12.8	1.2	19.9	2.2	14.7	7.5	19.3	6.6	0.8	3.5	0.0	1.3	3.8	1.2	1.1	0.8	1.1	1.5	14.1	6.4	2.7	0.9	0.9	1.3	12.8	7.2	1.1	1.1	0.6	0.3	1.0	22.0	2.5	0.8	0.0	8.6	0.8	2.2	2.2	0.9	0.6	7.8	1.1	1.4	1.1	16.6	0.0	3.8	0.0	0.7	1.2	0.3	0.8	0.5	5.3	0.4	1.0	0.6	0.1	0.4	0.1	0.4	0.5	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.1	0.5	0.7	9.2	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.7	0.7	0.0	0.5	0.3	0.4	0.1	0.2	0.2	0.2	0.3	0.2	0.0	0.1	0.5	0.8	0.3	16.5	0.3	0.6	5.3	0.5	0.2	0.6	0.4	0.5	0.1	0.3	0.6	0.3	0.2	0.3	0.7	2.0	0.4	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.1	0.8	0.6	0.6	5.3	1.0	0.3	0.5	0.2	0.1	12.8	19.9	7.5	19.3	14.1	6.4	12.8	7.2	22.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRBD1	FLJ10379	ENSG00000068784	"S1 RNA binding domain 1"	Q8N5C6	2	45388680-45612165	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030567, HPA030568"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA030567: AB_10611244, HPA030568: AB_10601856"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.20e-3)"	"unprognostic (4.14e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.29e-1)"	11.7	9.8	5.5	12.2	7.5	6.8	10.9	6.3	6.8	13.8	10.4	6.3	15.7	6.7	19.3	14.9	8.0	8.6	7.4	9.4	5.5	5.8	11.6	13.2	8.7	11.0	6.4	4.7	11.2	14.9	25.1	20.9	11.5	8.7	12.7	9.9	8.4	16.6	14.5	9.5	8.4	10.7	8.3	7.3	13.9	9.9	12.2	8.0	16.5	12.5	6.1	11.3	9.7	9.4	6.1	7.0	14.3	13.0	9.2	7.7	4.9	13.7	7.1	14.7	9.8	5.4	12.0	11.6	10.6	9.3	10.2	9.4	5.9	5.9	11.9	7.9	7.5	7.6	6.5	14.4	13.4	18.9	16.2	8.0	15.8	5.7	12.7	6.4	13.1	9.3	7.2	5.6	12.0	14.1	4.5	12.2	4.4	11.2	9.0	15.0	12.4	17.5	10.0	16.7	8.9	7.8	12.1	21.1	10.8	11.6	9.0	12.9	10.5	9.3	10.1	10.3	8.0	6.2	4.8	11.3	14.3	11.4	6.8	9.1	9.6	3.5	7.2	8.0	13.0	10.2	3.4	7.2	14.3	6.6	7.9	5.8	6.1	4.9	7.7	7.0	5.3	6.9	6.2	2.6	9.2	13.0	6.7	5.0	4.9	5.5	7.5	6.3	6.8	5.5	5.8	6.4	4.7	8.7	8.0	17.9	4.8	7.3	3.2	3.2	7.6	8.5	12.7	9.4	13.6	3.5	3.9	7.0	8.3	6.5	2.8	8.7	5.4	0.0	8.0	5.9	6.6	2.8	8.1	11.0	8.7	12.7	6.9	6.7	9.9	1.5	6.9	9.2	6.8	10.0	8.2	14.7	4.6	6.8	6.0	8.5	13.5	12.9	3.4	24.1	26.4	3.3	4.7	9.6	4.7	1.3
SRCIN1	"KIAA1684, p140Cap, SNIP"	ENSG00000277363	"SRC kinase signaling inhibitor 1"	Q9C0H9	17	38530016-38605930	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;salivary gland: 11.7;skin 1: 6.1"	"Cell type enhanced"	"Detected in many"	25	"Bipolar cells: 30.8;Cholangiocytes: 20.4;Horizontal cells: 96.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.3;SCLC-21H: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009701, HPA063795"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA009701: AB_1857324, HPA063795: AB_2685124"	"unprognostic (4.53e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.24e-4)"	"unprognostic (4.10e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.07e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-2)"	"prognostic favorable (1.76e-4)"	1.3	2.6	7.9	0.5	9.5	0.6	1.7	16.3	21.2	1.3	0.8	18.4	0.0	1.2	1.0	1.3	0.5	2.1	0.4	0.6	7.0		0.5	1.8	0.8	0.6	9.0	10.5	0.4	1.6	2.2	0.0	0.6	10.2	0.8	0.7	0.5	11.7	1.7	0.9	6.1	0.9	0.5	5.5	0.6	0.9	0.8	10.7	0.0	0.8	0.0	0.4	0.9	0.0	0.3	0.3	1.3	0.2	0.2	0.2	0.0	0.5	0.6	1.2	3.5	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.6	1.0	1.1	0.0	0.9	1.3	1.6	0.2	0.1	1.2	1.4	0.0	0.5	1.4	0.2	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.6	0.1	5.3	0.0	3.2	0.0	0.0	1.7	0.7	0.1	0.1	0.0	0.1	0.5	2.6	16.5	2.4	0.0	1.4	1.0	0.9	2.6	0.5	0.0	0.0	1.6	0.0	0.0	1.1	0.2	0.1	0.1	0.7	0.7	1.3	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.2	0.6	0.2	0.0	0.3	0.0	0.0											0.0	0.6	0.0	0.9	0.7	30.8	2.4	20.4	4.0	0.0	3.5	0.0	0.0	0.0	1.9	0.1	0.1	0.3	0.0	0.2	0.1	0.8	1.4	0.0	9.6	0.3	96.9	9.4	0.6	0.0	0.2	0.6	0.0	0.0	0.0	2.1	1.7	0.5	0.0	0.4	0.0	2.8	0.0	0.3	0.7	2.0	0.6	0.1	0.0	1.1	1.7
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346109-55373096	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 92.9;Extravillous trophoblasts: 88.2;Pancreatic endocrine cells: 133.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 42.6"	"Low region specificity"	"Detected in all"							HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	13.8	12.2	11.5	5.9	13.4	6.6	17.8	7.3	18.3	22.9	11.3	20.3	3.5	6.9	13.8	9.6	24.4	5.9	22.6	10.5	13.2	10.7	12.3	15.0	12.4	10.1	15.5	12.0	3.5	26.8	14.0	7.0	8.8	13.6	8.9	10.9	6.8	16.3	6.6	5.8	15.6	8.3	6.2	22.1	6.9	13.8	4.0	15.3	10.0	7.6	9.9	12.1	12.1	12.1	5.9	28.4	10.3	25.2	3.6	9.2	10.3	4.8	3.2	5.8	5.5	19.5	12.5	2.9	5.3	6.2	2.2	3.6	3.2	10.1	11.5	6.0	8.3	6.2	3.8	4.1	4.9	2.8	3.3	7.3	6.3	3.6	8.6	5.2	11.6	3.5	11.4	9.1	3.8	3.5	4.8	9.0	21.5	10.7	25.8	12.6	6.3	17.0	5.1	7.3	27.6	4.3	5.5	1.8	6.5	7.4	5.2	9.0	5.0	5.6	42.6	3.8	6.0	5.2	10.2	4.4	14.2	2.6	1.0	4.0	13.8	7.6	4.2	18.0	16.0	13.8	10.3	16.5	4.9	7.9	25.1	9.2	5.9	6.0	7.4	14.1	5.2	5.3	7.1	0.8	3.6	25.2	28.4	5.8	10.3	11.5	13.4	7.3	18.3	13.2	10.7	15.5	12.0	13.6	15.3	8.9	15.7	3.0	9.5	12.0	4.6	4.6	45.9	12.0	12.5	5.2	3.9	22.7	3.3	67.0	2.0	14.3	8.4	0.0	92.9	88.2	17.0	22.1	13.9	17.1	62.0	9.5	11.5	17.8	20.9	0.0	1.7	27.9	23.6	24.4	19.3	18.6	133.4	5.8	5.3	12.2	3.8	12.9	9.5	2.1	18.8	26.0	6.3	4.9	20.9	49.7
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837002	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 50.5;SK-BR-3: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710"	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	34.0	78.2	16.4	9.3	17.9	14.8	15.5	5.8	22.3	15.7	13.8	31.9	30.4	28.9	8.6	23.4	20.5	15.7	17.6	10.2	13.5	10.3	9.0	49.9	11.9	14.4	20.3	16.7	20.5	7.7	9.6	12.5	16.0	11.8	18.0	6.4	15.1	72.7	33.0	16.8	14.5	27.4	7.1	13.1	7.3	13.6	16.8	16.2	15.2	9.5	13.6	13.8	11.9	15.0	0.6	0.4	4.7	0.8	0.4	2.2	0.5	14.0	33.0	4.1	25.4	8.4	15.4	7.1	5.2	16.5	4.5	11.0	6.7	27.3	8.8	4.9	4.1	4.2	40.0	4.7	13.8	1.1	5.4	2.0	4.8	27.4	7.0	10.5	0.6	9.2	12.0	5.9	6.3	3.9	3.5	5.1	20.1	9.3	31.6	1.0	34.5	11.6	8.1	5.5	10.8	6.6	8.3	3.0	50.5	3.6	7.3	4.9	20.2	6.1	49.0	14.5	3.0	16.6	9.3	5.8	2.4	12.2	5.8	3.2	9.3	0.8	4.0	14.2	6.9	12.6	0.0	0.8	0.4	1.8	0.5	0.4	0.6	0.8	0.3	0.4	0.4	1.6	2.2	4.7	0.4	0.6	0.3	0.2	0.5	16.4	17.9	5.8	22.3	13.5	10.3	20.3	16.7	11.8	16.2	6.0	17.5	8.2	12.6	8.2	22.4	7.3	17.8	5.3	11.4	19.2	27.5	4.6	1.7	13.5	1.8	8.9	29.9	0.0	20.4	13.9	14.1	19.0	14.9	58.7	10.6	55.6	28.7	12.9	10.4	3.0	27.6	8.3	8.5	13.6	18.3	29.8	13.8	13.5	10.3	5.4	29.3	12.9	10.4	11.3	5.8	15.9	16.6	7.5	21.1	21.3
SREK1IP1	"FLJ36754, P18SRP, SFRS12IP1"	ENSG00000153006	"SREK1 interacting protein 1"	Q8N9Q2	5	64718144-64768685	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 266.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045677, HPA062853"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045677: AB_10964635, HPA062853: AB_2684881"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.60e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.99e-1)"	16.3	12.1	12.2	10.9	16.5	8.3	13.8	13.9	12.8	17.0	16.1	4.1	10.8	8.6	12.5	12.4	25.3	10.8	11.6	13.1	12.3	10.7	18.0	13.1	13.2	12.1	10.6	9.5	14.6	11.7	10.8	20.5	20.2	11.9	15.5	10.4	4.7	10.3	15.0	15.7	18.7	15.2	12.6	15.5	19.0	10.9	11.7	11.5	19.2	13.9	17.9	12.3	24.1	14.6	4.0	8.2	3.8	4.1	4.1	4.7	2.1	7.0	3.6	9.2	7.0	8.3	13.7	5.5	10.7	8.6	7.3	9.8	6.7	7.7	7.3	11.0	8.5	7.0	4.6	8.3	16.1	12.9	8.7	10.1	8.0	6.7	5.9	8.5	8.5	8.1	9.0	15.3	10.2	13.3	7.8	10.8	9.2	7.0	4.5	8.6	2.5	15.1	8.6	4.7	1.9	4.9	7.3	7.5	11.6	12.5	5.6	4.0	5.9	6.7	4.8	10.2	6.7	6.1	16.5	10.9	5.4	3.2	6.4	11.0	6.7	11.3	6.5	10.2	13.4	7.2	3.8	4.1	1.7	4.5	3.0	4.7	3.9	4.6	4.2	3.4	4.0	4.5	4.7	1.6	4.1	1.9	8.2	4.0	2.1	12.2	16.5	13.9	12.8	12.3	10.7	10.6	9.5	11.9	11.5	44.7	36.1	35.8	47.3	72.7	50.8	26.2	76.5	41.5	43.3	82.0	29.5	62.3	76.3	67.8	266.8	54.7	61.7	46.7	64.6	64.7	50.4	43.7	52.0	85.5	55.9	92.2	58.6	78.5	70.9	129.9	88.6	70.4	37.1	46.9	60.5	43.1	140.5	64.5	68.2	63.3	36.0	64.7	57.4	32.7	40.7	90.8	40.7	54.9	45.7	82.3
SRFBP1	"BUD22, FLJ25286, p49, Rlb1, STRAP"	ENSG00000151304	"Serum response factor binding protein 1"	Q8NEF9	5	121961961-122075570	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042737	Approved		Approved	"Nucleoli rim"		NA	NA			"Nucleoli rim"		"HPA042737: AB_10796583"	"unprognostic (8.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.03e-1)"	"unprognostic (8.96e-3)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.45e-2)"	21.8	9.4	11.6	11.1	15.2	10.1	17.2	15.0	14.8	12.7	10.2	6.1	8.5	9.1	13.0	12.1	14.2	11.1	9.6	10.7	11.8	8.0	14.3	12.6	11.2	12.5	13.1	11.9	17.1	10.6	15.5	20.2	11.5	14.2	12.8	10.9	5.1	13.0	9.5	19.7	10.7	9.5	11.3	16.0	15.4	10.1	9.3	14.9	12.5	15.6	13.8	11.6	14.4	17.5	10.3	9.6	2.6	12.8	7.4	11.5	4.3	10.6	7.9	7.3	11.5	8.3	7.8	12.2	10.3	7.5	11.3	13.3	6.4	10.7	13.5	12.0	6.4	19.5	7.9	11.8	14.0	21.2	19.1	6.7	13.0	5.7	6.6	9.0	14.9	10.8	9.3	10.9	14.3	14.1	5.4	12.2	7.0	11.8	11.0	11.8	4.9	10.3	4.8	10.7	8.5	5.2	10.7	17.2	14.2	12.5	11.1	7.5	7.0	9.5	9.4	17.7	9.5	9.6	8.9	8.9	17.6	10.7	12.5	14.9	5.9	11.1	15.6	10.0	12.1	15.4	0.6	7.3	2.6	6.6	12.8	8.4	10.3	7.3	7.2	9.6	8.9	8.6	11.5	1.2	7.4	10.1	9.1	6.7	4.3	11.6	15.2	15.0	14.8	11.8	8.0	13.1	11.9	14.2	14.9	14.9	14.6	31.2	23.5	17.1	37.0	10.9	7.6	20.1	30.7	14.0	23.6	17.2	34.9	27.1	26.2	19.4	4.3	23.3	17.5	18.2	15.9	18.3	43.8	8.2	17.3	44.5	15.5	9.2	6.4	3.4	22.5	17.5	18.6	6.4	11.8	28.6	18.2	7.0	25.1	25.9	28.0	12.9	21.7	20.2	25.6	16.7	10.8	13.1	16.1	22.5
SRGAP1	"ARHGAP13, KIAA1304"	ENSG00000196935	"SLIT-ROBO Rho GTPase activating protein 1"	Q7Z6B7	12	63844293-64162221	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 153.7;Muller glia cells: 159.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 17.4;hTERT-HME1: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052416, HPA078079"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA052416: AB_2681824, HPA078079: "	"unprognostic (3.05e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.54e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.56e-2)"	11.4	5.4	6.6	6.2	9.6	1.2	8.2	6.6	7.7	7.4	6.1	7.1	2.0	3.2	6.2	4.7	7.0	5.3	5.8	4.2	8.6	3.8	5.5	2.5	11.2	2.2	7.0	3.1	7.5	11.3	17.7	6.1	4.2	10.4	3.8	5.9	4.1	13.4	2.4	3.4	3.1	3.9	5.5	12.1	4.9	4.2	9.4	10.9	0.0	9.4	0.3	2.3	5.2	8.9	1.2	0.8	2.9	1.4	1.2	0.8	0.2	3.0	6.4	10.4	1.0	8.0	14.1	2.2	9.5	8.5	3.5	3.1	3.3	2.5	0.0	3.9	17.4	8.8	1.9	0.9	5.4	3.6	2.4	1.0	0.1	4.5	3.4	9.9	0.0	0.1	13.0	5.2	9.9	27.9	4.9	3.2	0.2	0.0	0.1	4.6	1.8	0.0	0.1	0.8	1.6	3.7	0.0	1.9	0.0	4.4	1.6	1.7	3.1	3.7	3.9	2.6	1.7	1.1	0.1	6.7	7.3	1.3	7.7	4.3	0.1	0.0	0.0	6.2	0.7	2.9	2.1	0.9	0.5	0.6	1.4	0.7	0.7	0.7	0.4	0.4	1.2	0.8	0.8	2.9	1.2	0.8	0.8	0.4	0.2	6.6	9.6	6.6	7.7	8.6	3.8	7.0	3.1	10.4	10.9	0.0	3.5	5.9	33.4	6.9	7.1	4.8	40.8	25.4	10.3	8.7	5.9	23.0	10.0	28.5	153.7	14.7	22.3	0.0	22.6	7.9	18.5	30.6	1.1	0.9	10.4	3.2	16.0	25.2	30.1	41.5	20.4	18.1	16.9	41.5	25.0	159.6	29.4	37.4	14.9	10.2	5.0	0.0	17.0	4.7	16.6	3.3	6.1	3.2	20.1	44.2
SRGAP2	"ARHGAP34, FNBP2, KIAA0456, SRGAP2A"	ENSG00000266028	"SLIT-ROBO Rho GTPase activating protein 2"	O75044	1	206203345-206464443	"Disease related genes, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.1"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 53.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA028191, HPA028196, HPA078079"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: "	"unprognostic (2.57e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (2.70e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.18e-3)"	3.5	2.4		2.2		3.3	0.7		4.3	1.3	0.0			0.0	1.4	2.0	1.2	1.7	1.5	0.5			0.7	0.5	2.4	1.9			3.1	0.5	7.4		3.4		0.1	0.1		0.0	0.9	0.0	8.5	0.0	2.3		4.2	0.6	1.0			0.0		1.8	1.1		4.8	12.7	14.1	9.9	1.4	3.0	2.2	19.1	12.9	43.9	11.1	20.9	18.9	17.2	16.6	12.4	14.5	15.9	8.8	14.7	7.5	9.6	18.3	19.4	15.6	13.0	10.9	14.6	9.3	10.6	15.4	23.1	13.2	8.7	10.6	17.3	17.1	9.5	18.6	13.0	15.8	25.1	9.8	12.6	24.4	9.2	13.3	8.4	9.4	14.1	3.4	14.9	19.1	18.0	17.7	6.2	3.5	14.6	6.7	14.1	10.6	20.6	17.2	13.1	18.9	24.9	14.3	17.3	17.5	15.2	16.2	14.5	7.1	17.2	14.8	34.7	0.6	9.3	0.5	2.6	9.4	1.0	2.2	2.1	2.6	6.3	4.8	0.8	1.8	14.1	1.4	9.9	12.7	3.0	2.2											8.9	15.5	13.7	5.2	21.2	41.0	3.3	12.7	4.0	7.9	10.4	3.9	2.9	0.0	5.7	53.8	24.8	0.3	0.0	1.8	17.0	12.3	3.6	8.1	1.5	15.6	1.6	1.2	35.6	37.7	28.5	7.2	27.3	15.1	17.2	1.5	8.2	3.3	0.2	2.5	0.5	5.3	0.0	11.5	7.9	9.4	31.9	3.5	7.5	1.2	4.9
SRGAP2B	SRGAP2P2	ENSG00000196369	"SLIT-ROBO Rho GTPase activating protein 2B"	P0DMP2	1	144887265-145095528	"Predicted intracellular proteins"	Neurogenesis			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 9.6"	"Cell type enhanced"	"Detected in many"	7	"Ito cells: 54.6;Kupffer cells: 49.1"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA078079			Approved	Cytosol		NA	NA			Cytosol		"HPA078079: "	"unprognostic (1.13e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.48e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-5)"	"unprognostic (3.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-1)"	2.5	3.4		1.5		1.6	0.6		2.7	1.3	0.0			0.0	1.4	0.6	1.2	1.7	1.2	0.6			2.2	0.5	2.4	0.9			2.7	0.3	4.4		3.3		0.4	0.0		0.0	0.8	1.9	6.6	0.0	1.8		3.7	0.0	0.2			0.5		0.3	1.2		1.4	4.6	5.0	9.6	0.5	1.6	1.1	6.8	14.7	32.0	6.6	15.4	13.4	10.1	7.6	6.7	6.5	7.5	4.4	12.6	3.4	10.2	4.5	11.6	11.9	8.2	4.4	8.0	3.2	8.3	5.0	10.7	6.2	10.8	4.4	6.6	9.5	6.7	16.0	14.2	9.8	13.0	3.0	2.7	12.2	3.5	7.6	1.9	5.2	5.9	3.4	5.4	5.2	6.9	5.9	5.6	3.0	4.0	5.1	10.1	3.6	16.8	8.3	7.6	11.3	23.5	14.0	14.5	12.4	8.8	5.1	6.3	2.1	5.1	6.0	19.9	1.4	5.1	0.7	0.9	6.9	0.7	1.2	1.4	1.6	3.5	1.4	1.0	1.1	5.0	0.5	9.6	4.6	1.4	1.1											23.8	7.7	8.3	3.5	0.0	11.9	3.2	0.0	14.7	4.5	8.7	2.0	4.7	0.0	5.8	1.0	24.3	0.3	23.3	2.6	14.4	12.3	3.6	1.1	4.7	10.9	0.0	2.4	54.6	49.1	1.7	14.1	15.9	0.0	23.4	0.8	6.3	4.3	0.0	9.2	0.8	2.4	6.5	9.4	2.6	6.4	0.0	2.4	10.1	1.2	3.5
SRGAP2C	SRGAP2P1	ENSG00000171943	"SLIT-ROBO Rho GTPase activating protein 2C"	P0DJJ0	1	121184810-121392822	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 16.5"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 50.6;Erythroid cells: 70.0;Ito cells: 64.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 39.8"									HPA078079			Approved	Cytosol		NA	NA			Cytosol		"HPA078079: "	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.48e-6)"	"unprognostic (2.40e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.18e-4)"	"unprognostic (6.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.71e-7)"	"unprognostic (4.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.66e-2)"	4.7	4.5	3.5	2.8	4.4	4.2	2.7	7.8	6.0	3.5	2.0	8.5	3.3	1.0	3.5	1.2	5.4	3.2	3.0	2.9	3.3		4.6	2.9	5.5	2.5	6.3	4.0	4.8	1.1	16.5	4.6	6.5	6.2	2.1	1.7	2.1	1.3	3.2	1.3	10.9	1.7	3.9	6.4	7.0	1.8	1.3	4.7	4.5	2.0	1.9	2.2	3.1	2.7	1.7	4.2	5.2	7.7	1.0	2.3	1.4	5.2	6.9	15.3	3.4	11.9	10.4	8.5	6.0	4.8	5.1	6.7	0.1	5.4	3.3	5.4	8.2	3.7	2.9	5.4	4.4	6.8	4.4	5.5	4.8	12.0	5.3	6.8	3.2	5.7	7.7	4.4	6.5	8.4	5.8	12.1	2.1	4.4	6.3	3.7	3.1	2.0	4.1	4.8	1.7	3.3	3.0	18.0	3.0	4.8	3.1	2.9	1.9	10.4	3.7	18.7	8.3	4.7	9.5	10.7	9.7	9.6	14.4	8.8	3.7	2.6	2.0	8.4	6.6	39.8	0.5	5.9	1.0	1.9	4.6	1.3	1.7	2.3	2.1	4.2	1.7	1.1	1.6	5.2	1.0	7.7	3.8	2.0	1.4											50.6	11.5	9.3	6.2	0.0	12.1	4.9	5.1	16.0	9.1	10.4	2.0	4.6	1.7	9.3	0.4	29.2	0.4	70.0	4.4	18.8	12.7	4.2	5.8	7.2	16.5	0.0	2.4	64.4	41.9	0.9	18.1	16.7	0.0	27.9	2.6	8.4	5.4	0.6	24.1	0.7	4.5	32.3	12.4	4.7	6.8	0.0	2.1	13.4	1.4	3.8
SRGAP3	"ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP"	ENSG00000196220	"SLIT-ROBO Rho GTPase activating protein 3"	O43295	3	8980591-9363053	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.9"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 228.5;Cone photoreceptor cells: 257.2;Horizontal cells: 216.1;Muller glia cells: 117.0;Rod photoreceptor cells: 104.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HBEC3-KT: 8.4;hTCEpi: 8.3;RT4: 11.2;T-47d: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036959, HPA044074, HPA078079"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: "	"unprognostic (3.63e-3)"	"unprognostic (1.12e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.39e-3)"	1.8	6.1	10.6	1.7	20.4	1.2	3.2	32.4	34.9	9.7	2.1	10.5	0.0	1.9	4.4	3.4	2.6	18.5	2.3	2.7	10.0	11.2	4.9	1.4	2.2	2.3	7.5	9.8	7.2	2.4	2.7	5.7	1.9	15.5	4.7	2.5	4.8	5.7	3.2	2.5	4.0	1.7	2.0	6.1	1.7	2.9	4.4	4.8	0.4	3.3	0.6	2.1	6.7	1.4	0.0	1.9	1.9	0.4	1.0	1.3	0.1	0.5	0.5	9.7	0.4	0.7	1.3	1.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.5	0.0	0.2	4.9	0.2	8.4	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	5.2	0.8	8.3	0.7	0.8	0.3	0.0	2.2	0.0	0.0	0.0	0.1	0.2	2.1	0.9	1.7	0.7	1.1	0.0	0.0	4.2	11.2	1.1	1.3	0.2	3.0	0.1	2.5	10.8	0.0	0.0	0.0	0.4	0.1	0.1	2.9	0.1	0.0	0.8	1.7	0.3	1.2	0.4	1.9	0.0	0.1	0.0	0.0	0.2	0.0	1.9	0.0	0.2	0.0	0.0	1.0	0.1	0.5	1.3	0.1	10.6	20.4	32.4	34.9	10.0	11.2	7.5	9.8	15.5	4.8	3.0	6.4	0.0	23.8	3.7	228.5	8.1	0.0	52.2	27.3	73.3	257.2	1.8	5.0	1.8	18.5	1.8	0.4	0.0	0.4	0.7	4.0	9.9	1.1	1.6	10.6	216.1	2.9	0.6	9.9	15.3	2.3	3.8	1.7	1.0	3.7	117.0	0.5	0.0	1.1	1.0	104.8	0.0	1.4	5.4	4.9	5.1	1.1	2.9	2.2	27.1
SRM	"SPS1, SRML1"	ENSG00000116649	"Spermidine synthase"	P19623	1	11054584-11060024	"Enzymes, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 107.4"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015746	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA015746: AB_1857472"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.25e-5)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.74e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.98e-2)"	26.7	17.7	20.3	29.0	35.4	15.2	16.9	10.2	30.8	14.3	13.3	14.0	11.5	10.8	18.8	9.8	17.7	15.8	14.2	24.9	19.6	16.9	13.9	45.3	14.0	31.0	15.3	15.0	22.8	107.4	8.0	14.5	14.8	15.6	13.1	11.7	15.0	36.0	17.6	43.6	18.2	9.8	22.9	11.7	21.1	14.5	14.4	14.1	17.9	11.9	21.2	20.8	20.2	19.8	10.7	10.2	0.3	6.0	5.0	10.3	2.0	24.9	36.4	12.1	40.4	24.2	26.2	19.0	38.8	19.9	55.5	29.8	44.8	15.1	48.3	22.9	33.6	17.4	19.6	38.6	31.2	18.5	23.7	58.4	30.4	40.3	50.4	35.6	51.0	27.9	26.2	22.6	53.7	47.2	13.0	23.4	31.6	49.4	40.9	27.0	54.8	43.5	44.5	26.4	23.0	70.5	32.7	12.5	78.8	19.7	9.9	23.3	22.3	20.1	43.3	30.3	9.8	15.1	25.9	19.4	36.3	28.6	62.8	43.5	33.0	33.3	72.3	25.2	68.6	41.7	0.0	5.4	0.3	7.0	6.0	10.3	10.7	7.1	9.1	6.4	9.3	8.4	9.7	0.2	5.0	3.1	10.2	7.5	2.0	20.3	35.4	10.2	30.8	19.6	16.9	15.3	15.0	15.6	14.1	0.0	2.9	57.4	63.7	84.3	27.7	26.4	30.6	2.7	1.2	27.9	19.6	62.5	64.6	20.3	3.4	46.6	5.1	23.3	36.6	175.3	66.1	60.8	27.5	47.6	85.0	28.6	26.4	35.6	21.8	10.5	66.4	35.3	64.1	8.2	27.0	28.1	26.0	7.0	49.8	69.0	12.3	0.0	49.9	12.8	74.2	98.9	30.1	23.5	26.6	92.1
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.5;MCF7: 4.7;OE19: 7.0;RT4: 9.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.3	0.0	0.3	0.5	0.3	0.0	1.1	1.1	0.3	0.3	1.8	0.3	0.3	0.4	0.3	10.2	0.4	0.0	0.3	0.3	0.3	0.0	0.9	0.3	0.3	0.3	0.3	0.3	0.3	2.7	0.0	0.3	0.3	0.3	2.2	0.0	0.3	2.5	0.3	0.3	1.7	0.8	0.3	0.3	2.5	4.2	0.9	0.3	0.3	0.3	0.3	0.8	1.5	0.3	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	5.5	0.2	2.2	0.0	0.0	2.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	0.0	7.0	0.8	0.0	0.2	0.0	0.0	9.7	0.8	0.9	0.3	2.0	0.4	0.0	2.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.1	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035739-40039188	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli		NA	NA		400000	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	63.0	81.2	100.0	46.0	102.8	85.9	75.4	65.4	91.3	87.8	62.6	67.9	54.7	50.7	83.0	115.7	75.6	87.8	64.2	114.2	80.7	95.4	107.2	79.6	52.2	60.8	103.5	86.3	99.1	59.1	69.6	82.3	68.8	84.3	84.1	65.0	61.0	71.3	66.4	107.5	44.4	65.7	67.2	86.5	67.5	56.0	43.4	68.9	58.7	98.9	56.6	65.0	80.9	72.7	78.7	151.5	111.2	69.3	63.6	96.4	135.1	24.2	30.4	73.8	55.1	55.3	50.1	36.0	44.7	47.4	38.8	39.9	54.7	20.8	20.4	46.6	54.2	62.1	39.3	58.6	46.5	36.8	48.6	41.9	48.6	97.1	64.0	42.4	43.2	39.7	52.1	53.3	32.1	39.4	73.9	65.2	55.9	50.8	37.4	62.0	36.8	63.8	51.0	40.2	94.1	55.2	43.9	33.7	34.3	83.7	72.4	53.8	48.0	45.1	44.8	29.3	47.6	61.6	80.2	56.1	45.2	30.7	42.6	32.6	30.5	85.1	50.5	43.9	47.2	41.8	76.2	69.3	111.2	68.5	62.5	66.4	78.7	77.7	76.3	74.5	66.1	75.4	72.8	60.7	63.6	56.5	151.5	96.4	135.1	100.0	102.8	65.4	91.3	80.7	95.4	103.5	86.3	84.3	68.9	428.8	342.1	635.3	745.6	592.5	436.3	765.2	639.5	717.4	483.4	943.9	117.8	766.6	2161.9	1141.2	204.6	898.5	667.3	467.2	948.8	912.5	754.8	783.4	543.5	639.1	894.6	328.9	532.2	609.5	565.3	236.1	962.8	751.5	749.0	1439.1	546.1	918.4	1056.2	782.0	927.8	1642.5	369.6	614.4	716.0	645.9	602.6	620.9	634.6	518.4	577.5	829.8
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029567	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Hydrolase, Ribonucleoprotein, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 276.0;Late spermatids: 646.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA048977: AB_2680583, HPA062044: AB_2684668"	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	18.4	27.5	18.6	21.3	21.0	13.6	22.5	18.2	26.0	24.6	19.2	23.2	31.2	19.3	24.1	25.5	22.6	18.0	17.1	21.8	18.7	22.5	34.4	67.8	19.4	24.0	23.7	17.1	21.1	43.2	30.1	47.1	26.4	29.4	23.2	21.7	19.2	48.1	31.2	28.4	19.6	24.4	20.0	22.3	23.5	22.3	30.8	19.4	32.3	23.6	22.5	27.9	23.9	17.6	20.5	23.4	26.3	30.1	29.5	33.4	19.7	20.7	22.5	21.6	20.2	22.3	23.0	25.9	29.8	27.1	30.8	39.5	27.0	23.3	30.3	30.4	28.4	28.5	21.9	29.5	23.4	44.8	30.1	14.8	24.5	21.4	63.3	34.6	26.2	24.8	19.2	23.1	22.7	40.4	24.0	31.0	24.4	21.7	33.2	32.0	34.5	27.9	14.7	16.5	34.4	21.8	22.3	26.4	24.2	36.7	31.8	20.5	22.0	21.4	27.7	27.1	27.5	36.8	18.2	23.5	18.8	20.2	22.3	20.5	28.8	38.6	37.9	13.4	16.9	22.4	15.9	19.8	26.3	23.6	24.0	29.3	20.5	23.6	26.0	23.4	18.6	22.3	21.7	19.3	29.5	30.1	16.0	33.4	19.7	18.6	21.0	18.2	26.0	18.7	22.5	23.7	17.1	29.4	19.4	11.9	36.4	40.4	46.3	35.5	36.9	37.2	33.1	69.6	51.2	38.4	55.0	59.6	54.7	58.2	276.0	33.1	35.1	0.0	69.6	58.9	47.2	64.3	46.2	104.3	43.9	25.4	43.1	39.9	42.5	646.5	35.6	43.2	27.0	55.1	39.6	44.1	49.6	29.4	35.3	59.6	42.9	25.8	33.7	79.0	57.0	44.0	78.6	47.1	27.0	51.8
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 311.7;Late spermatids: 401.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	13.5	7.1	8.1	15.4	11.7	32.1	11.7	22.5	17.8	12.8	23.8	7.8	10.8	20.3	15.2	7.9	24.9	8.9	10.8	8.7	8.9	7.8	17.8	18.9	14.9	14.6	8.0	8.3	9.5	26.0	11.7	17.7	27.9	9.6	10.5	28.7	12.4	17.6	9.4	19.9	26.2	25.7	11.3	7.9	19.0	13.9	32.7	7.6	21.0	8.5	17.0	19.8	15.2	15.7	4.3	2.8	24.6	3.4	5.0	6.7	2.9	29.9	11.4	16.8	25.0	9.4	12.3	21.2	18.4	17.8	17.2	18.3	32.0	10.1	40.0	15.6	11.3	20.0	15.4	32.8	21.9	31.0	27.3	23.6	21.0	13.4	27.7	8.3	31.1	10.4	7.9	12.0	19.8	26.0	13.7	21.6	22.9	44.5	17.0	14.4	10.6	32.0	24.2	13.7	18.3	12.5	22.5	20.1	24.7	17.3	50.4	35.8	13.1	18.9	18.0	12.7	17.8	10.1	20.7	15.6	16.2	12.7	11.0	23.1	10.0	22.1	37.6	6.4	36.1	14.4	24.5	2.1	13.7	4.3	2.5	6.1	4.3	5.7	5.7	2.8	3.3	4.8	5.2	24.6	5.0	3.4	1.6	6.7	2.9	8.1	11.7	22.5	17.8	8.9	7.8	8.0	8.3	9.6	7.6	8.9	26.3	24.4	65.1	37.5	33.6	21.8	12.7	32.1	38.7	21.0	35.3	43.2	24.9	50.7	311.7	24.1	38.6	23.3	58.8	43.3	21.3	68.6	7.0	40.0	19.1	9.5	44.4	11.1	17.1	401.7	20.4	16.9	15.1	36.1	44.8	13.4	78.7	42.1	23.3	44.4	84.4	6.5	23.1	154.9	90.6	36.5	33.2	34.8	87.4	132.9
SRPRB	"APMCF1, SR-beta"	ENSG00000144867	"SRP receptor beta subunit"	Q9Y5M8	3	133784033-133825772	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 104.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011173	Approved		Approved	"Plasma membrane"		NA	NA		54000	"Plasma membrane"		"HPA011173: AB_1857484"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (1.99e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.07e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.79e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.26e-2)"	10.4	15.7	8.7	10.2	9.3	5.8	12.5	5.2	10.2	14.4	11.3	5.1	33.2	8.9	8.0	25.6	16.8	9.1	11.0	10.9	9.0	10.7	17.2	56.3	9.2	17.3	10.4	7.7	8.9	104.0	11.7	15.6	7.7	8.8	9.5	13.4	7.6	53.3	29.9	10.6	8.6	7.4	10.3	7.4	9.5	12.5	14.7	5.4	6.3	16.5	10.2	13.7	8.7	10.4	15.4	20.0	3.8	15.2	14.3	29.0	18.0	12.1	9.9	6.3	20.0	26.3	18.3	11.8	25.8	13.5	14.4	12.5	18.0	9.5	23.1	38.2	19.7	14.5	17.8	19.6	13.9	13.7	15.6	15.7	20.7	9.8	17.0	32.0	32.3	16.8	16.5	23.5	13.1	38.8	8.0	12.2	11.8	17.5	26.9	15.4	17.7	11.1	15.4	11.9	32.4	17.1	13.5	11.7	49.3	17.3	8.4	20.8	8.6	19.8	18.4	7.2	5.0	20.9	15.0	12.1	14.2	8.4	22.3	13.8	34.7	34.5	34.9	12.7	21.5	15.8	3.8	11.6	1.4	21.4	15.2	29.0	15.4	18.3	19.0	13.2	13.4	18.0	21.2	0.8	14.3	9.9	20.0	10.6	18.0	8.7	9.3	5.2	10.2	9.0	10.7	10.4	7.7	8.8	5.4	14.9	22.3	15.6	21.0	33.5	6.2	22.2	43.3	20.1	19.4	34.9	11.8	58.0	10.0	42.5	49.3	24.9	15.5	0.0	58.0	60.5	38.5	38.7	32.3	77.2	46.0	6.4	30.9	17.8	19.9	31.5	29.7	19.3	33.7	10.0	36.2	15.6	40.9	21.0	26.2	24.9	8.8	12.9	23.7	52.8	41.9	27.6	43.3	20.8	32.9	21.4
SRR	"ILV1, ISO1"	ENSG00000167720	"Serine racemase"	Q9GZT4	17	2303383-2325260	"Enzymes, Predicted intracellular proteins"		"Allosteric enzyme, Isomerase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007529, CAB015343"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB015343: AB_2195009, HPA007529: AB_2667853"	"unprognostic (2.96e-1)"	"unprognostic (7.86e-2)"	"unprognostic (6.01e-2)"	"prognostic favorable (6.20e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.16e-4)"	"unprognostic (5.17e-2)"	"prognostic favorable (2.45e-6)"	"unprognostic (6.14e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.84e-2)"	11.6	12.6	17.1	7.7	14.7	13.9	16.7	12.2	24.9	8.4	10.4	13.9	11.4	7.9	10.9	11.3	12.9	10.0	9.6	12.6	15.2	13.0	10.3	9.0	10.9	7.0	12.6	15.6	9.8	14.8	11.0	9.7	6.5	12.4	9.6	8.8	10.6	11.9	9.3	16.9	13.4	7.5	15.0	13.2	7.3	9.2	13.8	9.0	13.4	13.8	6.1	6.0	12.1	7.3	9.7	15.5	5.2	12.6	13.9	13.5	8.7	7.3	13.5	24.4	9.1	13.3	14.1	11.9	15.7	9.8	10.4	10.8	12.4	9.3	13.9	2.1	16.2	7.7	15.6	6.7	5.8	13.3	16.1	13.1	7.2	9.9	4.7	13.4	2.0	4.0	11.9	5.9	23.2	11.2	12.1	15.2	14.8	7.4	10.2	23.1	4.3	14.2	2.7	5.1	7.0	10.1	23.5	27.7	6.4	12.0	3.4	4.8	12.3	13.6	1.7	7.1	8.3	10.7	5.0	11.9	11.2	7.9	12.7	9.3	9.0	12.2	2.5	20.0	6.7	15.2	2.4	8.2	5.2	9.5	8.7	9.9	9.7	12.3	10.1	15.5	8.9	10.4	13.5	1.0	13.9	12.6	10.4	8.9	8.7	17.1	14.7	12.2	24.9	15.2	13.0	12.6	15.6	12.4	9.0	3.0	3.0	1.4	3.9	2.6	7.6	3.6	0.0	5.3	3.4	1.8	0.0	4.2	11.6	8.3	1.1	3.2	2.2	0.0	6.0	3.1	4.6	2.4	0.0	2.6	8.0	15.9	1.7	8.0	3.2	1.0	3.7	3.6	5.0	13.6	2.8	10.8	5.8	0.0	4.9	4.9	5.3	0.0	3.8	14.0	4.7	2.0	2.9	2.5	3.1	2.0
SRRD	"HC/HCC, SRR1L"	ENSG00000100104	"SRR1 domain containing"	Q9UH36	22	26483877-26494658	"Predicted intracellular proteins"	"Biological rhythms, Heme biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA002945	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA002945: AB_1079265"	"unprognostic (3.25e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (9.00e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.96e-1)"	8.7	7.2	12.5	7.1	14.3	9.6	11.3	20.0	17.2	10.6	10.9	10.4	10.5	6.6	12.7	11.5	9.9	10.3	6.9	16.2	10.5	10.1	11.5	15.7	9.5	11.4	10.5	11.8	13.3	14.9	11.8	10.6	9.4	9.4	12.7	9.6	9.6	13.1	13.7	30.0	10.8	7.8	12.5	9.6	9.7	9.0	13.8	7.5	10.4	18.8	11.4	12.4	10.0	9.1	3.2	1.6	1.4	1.4	2.6	3.8	1.0	7.4	4.5	7.7	7.9	8.0	4.8	4.4	5.3	7.4	10.7	9.9	4.4	3.3	16.5	3.7	6.9	5.4	6.8	11.9	11.0	10.5	8.5	11.8	7.3	3.8	7.0	5.7	16.0	5.7	4.6	9.7	7.6	12.0	7.1	9.2	9.9	11.9	10.5	7.0	6.4	7.1	5.0	4.7	8.2	5.7	16.3	9.6	11.9	7.0	5.4	8.2	5.6	6.1	5.5	13.6	6.7	6.6	6.3	7.1	8.3	27.7	4.7	9.2	6.9	5.6	13.9	5.7	6.6	10.8	0.6	1.4	0.8	2.3	1.4	3.4	3.2	2.8	3.3	1.6	2.4	3.8	3.8	1.4	2.6	1.2	1.2	0.7	1.0	12.5	14.3	20.0	17.2	10.5	10.1	10.5	11.8	9.4	7.5	0.0	5.4	8.2	13.0	26.4	12.7	2.4	15.3	1.4	4.5	1.8	2.0	12.1	8.3	23.7	17.5	7.9	2.9	0.0	42.8	18.5	7.5	9.4	11.5	12.7	12.1	12.7	4.6	9.8	2.4	35.9	6.6	7.3	8.5	5.4	4.3	7.1	37.1	0.0	8.5	15.5	7.8	6.5	6.6	14.4	11.0	27.9	14.0	6.7	5.6	14.8
SRRM3	FLJ37078	ENSG00000177679	"Serine/arginine repetitive matrix 3"		7	76201900-76287288	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"brain: 43.2"	"Group enriched"	"Detected in many"	13	"Bipolar cells: 127.8;Cone photoreceptor cells: 451.6;Horizontal cells: 162.1;Rod photoreceptor cells: 475.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 14.4;SH-SY5Y: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019337			Approved	"Plasma membrane,Intermediate filaments,Microtubules"		NA	NA			"Plasma membrane"	"Intermediate filaments, Microtubules"	"HPA019337: AB_1848909"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.15e-2)"	0.6	6.2	8.1	0.7	18.1	0.4	0.4	43.2	14.6	0.4	0.6	0.0	0.0	0.9	0.7	1.1	0.5	0.5	0.5	0.5	5.1		0.5	0.4	0.5	0.4	0.0	10.9	0.6	0.5	0.5	4.4	0.4	10.0	0.5	0.7	1.8	0.6	0.5	0.6	0.5	0.6	0.5	0.6	0.4	1.6	2.9	2.9	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.2	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	10.6	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	5.1	1.8	127.8	6.9	0.0	0.0	0.0	0.0	451.6	0.3	0.0	1.4	18.9	0.0	0.0	0.0	2.1	7.0	2.7	1.2	0.0	0.0	0.4	162.1	11.6	0.6	0.0	23.9	2.0	0.0	3.3	0.0	0.0	14.5	1.2	0.0	2.1	0.3	475.2	0.0	1.4	5.4	2.6	1.0	1.8	0.0	0.0	4.7
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737374	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		140000	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	35.4	40.2	20.6	56.6	30.3	73.1	35.3	33.3	36.2	42.1	37.7	34.0	19.5	41.8	37.0	33.6	51.1	35.1	34.8	32.4	19.9	22.6	36.9	66.7	37.3	64.3	21.6	24.0	47.1	34.2	29.1	33.8	51.2	29.5	31.3	36.5	35.5	35.6	40.5	44.9	41.1	46.6	25.5	23.9	52.5	35.6	29.2	18.9	105.3	41.1	41.3	64.5	30.6	35.7	11.1	30.2	4.2	23.5	15.6	12.7	12.2	48.2	38.9	46.2	32.2	11.3	9.6	48.0	31.2	23.1	36.2	33.6	40.8	33.8	74.4	22.8	29.3	26.1	43.7	45.8	36.0	36.5	31.1	79.8	55.8	37.7	47.4	12.9	61.6	33.4	10.6	8.2	30.0	8.7	14.7	28.2	33.3	56.7	32.9	28.3	38.6	67.6	67.3	54.1	28.1	55.5	68.5	49.7	54.9	24.2	34.8	39.4	56.3	35.6	30.6	16.8	25.4	37.5	45.0	29.5	33.5	43.1	22.2	50.4	43.3	32.5	86.0	30.1	49.0	27.6	1.0	17.5	4.2	12.3	23.5	12.6	11.1	8.5	12.7	30.2	9.8	9.8	9.0	2.1	15.6	14.7	22.4	10.6	12.2	20.6	30.3	33.3	36.2	19.9	22.6	21.6	24.0	29.5	18.9	110.2	104.2	263.7	359.4	409.3	143.7	75.1	117.2	84.3	119.4	83.7	86.4	268.2	132.6	175.8	190.8	186.2	246.5	140.2	136.4	478.7	232.5	241.3	217.7	110.3	220.7	93.8	255.6	111.1	135.5	118.5	147.3	197.1	268.2	218.2	170.4	153.0	146.8	241.8	119.9	87.2	188.9	116.4	279.5	292.6	343.6	387.6	264.3	196.1	264.9	438.8
SRSF5	"HRS, SFRS5, SRP40"	ENSG00000100650	"Serine and arginine rich splicing factor 5"	Q13243	14	69726900-69772005	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043484, HPA056523"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA043484: AB_10797143, HPA056523: AB_2683164"	"unprognostic (2.08e-3)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.07e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	66.6	60.1	67.1	60.9	74.4	131.5	70.3	111.7	88.8	54.3	63.3	67.8	77.1	42.6	71.3	74.6	66.3	79.3	50.1	48.5	66.2	43.0	40.5	60.8	69.4	63.3	86.4	62.1	76.6	41.0	56.4	124.8	59.2	74.0	59.0	54.7	69.2	68.5	75.6	76.0	78.1	74.1	59.7	68.6	66.5	62.0	35.3	75.6	47.8	70.8	52.3	69.1	69.6	55.8	41.2	37.4	60.8	45.1	30.8	38.2	24.4	70.0	20.5	50.2	22.6	31.0	26.9	27.9	33.8	36.4	27.6	29.3	25.7	45.0	72.6	17.9	45.8	28.4	33.5	38.0	48.3	32.6	62.0	20.9	54.7	54.9	28.1	36.1	51.0	41.5	55.7	30.8	31.8	34.1	41.5	38.2	63.2	38.0	43.3	17.1	56.9	58.6	34.6	29.4	55.3	18.9	50.3	23.9	27.9	35.1	86.3	26.2	37.4	57.3	34.8	43.6	31.4	37.9	43.0	47.2	16.2	43.4	17.6	31.6	42.1	27.5	117.5	38.1	43.5	22.2	39.0	24.1	37.2	37.3	43.4	38.2	41.2	33.2	33.4	26.2	40.6	33.2	31.5	60.8	30.8	45.1	37.4	27.4	24.4	67.1	74.4	111.7	88.8	66.2	43.0	86.4	62.1	74.0	75.6	235.2	245.0	272.6	618.6	122.6	370.2	163.3	193.6	401.5	253.6	174.5	225.8	335.9	271.9	173.3	146.9	251.5	417.9	163.5	148.9	193.0	195.8	288.7	459.5	204.3	193.9	357.6	290.6	219.1	193.0	84.2	319.9	251.8	126.5	254.3	249.3	292.6	182.8	399.8	251.0	172.0	307.5	271.7	240.9	175.1	136.3	127.2	626.6	371.3	207.8	495.2
SRSF8	"SFRS2B, SRP46"	ENSG00000263465	"Serine and arginine rich splicing factor 8"	Q9BRL6	11	95067197-95071224	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049905	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.99e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.75e-3)"	5.5	6.4	6.1	4.9	9.6	5.3	9.6	6.0	14.3	8.7	6.9	8.0	9.2	7.1	8.0	8.0	6.8	7.4	6.8	6.4	6.5		9.5	6.8	6.1	8.7	6.1	9.5	10.7	10.4	9.7	8.2	6.5	7.2	9.4	7.5	10.1	11.4	8.6	5.4	6.6	7.8	7.1	4.8	9.0	7.1	3.0	5.0	3.7	11.6	5.3	6.5	6.1	5.5	7.9	3.8	7.0	2.0	5.6	12.4	3.7	4.4	4.7	11.8	0.0	15.8	10.0	13.3	6.7	7.5	3.2	3.4	11.0	14.7	23.8	20.0	10.2	5.8	9.8	9.9	14.7	3.7	14.4	10.7	20.2	5.5	9.8	11.6	20.1	11.0	12.9	15.7	3.4	15.9	9.4	9.9	11.1	15.1	13.3	6.2	6.1	10.4	18.1	6.2	11.8	13.1	13.1	3.6	19.0	12.5	15.0	15.0	15.4	8.3	14.9	9.7	7.8	5.9	11.2	9.1	6.2	8.3	8.3	6.8	7.1	10.9	12.8	3.2	13.6	13.5	7.0	2.0	0.6	5.7	1.1	8.2	7.9	9.6	8.2	3.8	6.9	12.4	9.5	0.6	5.6	1.0	3.5	9.9	3.7											41.7	24.8	82.8	42.9	0.0	45.6	20.1	61.1	17.4	21.6	31.4	31.4	33.1	127.6	32.0	1.3	32.2	43.1	23.3	40.0	43.0	21.6	37.7	10.3	52.9	23.7	17.5	54.6	35.6	22.7	4.2	38.0	25.1	0.0	34.3	75.6	40.4	26.3	42.1	57.3	77.7	48.0	32.3	29.9	3.7	5.9	0.0	42.8	65.1	58.5	30.7
SRSF9	"SFRS9, SRp30c"	ENSG00000111786	"Serine and arginine rich splicing factor 9"	Q13242	12	120461668-120469793	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049849	Supported		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA049849: AB_2680911"	"unprognostic (3.80e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (9.85e-7)"	"unprognostic (9.65e-3)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	25.8	50.7	29.5	37.9	28.5	33.8	31.2	24.9	30.6	31.5	36.4	21.7	35.5	29.8	26.7	37.4	53.6	32.6	42.3	20.7	26.7	27.9	37.2	42.5	27.2	41.4	31.6	25.3	37.1	68.5	34.9	36.5	49.3	27.9	33.1	35.8	29.3	33.9	30.4	17.0	32.4	31.0	25.1	23.8	39.6	33.0	52.5	25.0	53.1	43.7	36.8	51.0	26.5	35.7	22.1	18.7	28.8	15.4	15.7	14.8	5.1	55.7	39.0	59.9	38.5	27.4	27.6	64.1	38.3	34.5	49.3	42.4	46.8	26.3	54.4	44.9	32.1	26.8	33.4	53.9	54.5	54.4	40.7	55.4	46.4	26.2	45.6	35.4	57.1	42.4	29.1	35.2	42.8	37.3	52.9	44.8	35.6	58.2	16.5	42.3	78.0	56.3	111.5	75.0	37.9	34.1	62.9	25.1	52.5	42.6	71.2	53.2	38.0	44.9	23.9	44.3	40.8	72.1	50.4	39.0	36.7	43.5	27.5	41.4	50.7	38.0	68.0	38.6	43.1	38.2	12.3	10.7	28.8	14.8	11.7	11.2	22.1	11.7	13.0	13.9	17.7	11.5	12.8	12.2	15.7	15.4	18.7	11.9	5.1	29.5	28.5	24.9	30.6	26.7	27.9	31.6	25.3	27.9	25.0	23.8	30.4	155.5	203.9	235.3	77.2	1.3	147.7	20.1	26.1	153.5	27.5	301.6	414.4	172.1	51.9	119.1	86.4	23.3	135.5	354.8	182.5	290.8	33.4	118.4	178.0	68.3	138.9	108.1	103.3	17.4	115.3	184.7	190.6	190.2	126.0	96.8	139.8	80.7	145.6	272.7	44.3	51.8	162.7	260.2	249.1	273.9	397.6	97.9	129.8	332.4
SS18	"SSXT, SYT"	ENSG00000141380	"SS18, nBAF chromatin remodeling complex subunit"	Q15532	18	26016253-26091217	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055741, HPA059539"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055741: AB_2682901, HPA059539: AB_2684055"	"unprognostic (2.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.30e-1)"	26.1	40.5	18.7	30.4	26.4	15.5	26.6	17.6	20.2	24.8	21.4	31.8	32.1	14.0	31.7	32.7	29.8	27.2	23.4	22.4	21.6	16.1	30.0	30.9	21.9	25.8	32.6	16.3	39.4	20.6	39.4	41.8	43.2	25.3	28.6	18.7	26.1	26.0	33.5	10.3	31.3	22.6	31.0	23.7	24.7	22.5	28.3	32.6	27.8	35.6	24.7	35.2	25.5	25.9	15.9	13.1	19.9	17.1	20.7	17.6	13.1	19.2	14.0	34.4	16.8	27.4	24.8	17.4	23.7	21.6	21.0	20.1	9.2	16.0	33.7	19.0	27.7	19.0	25.3	18.6	23.0	26.0	21.5	8.9	16.7	20.5	14.8	21.7	25.5	25.9	31.8	27.2	26.3	28.9	21.0	15.7	9.8	12.2	17.3	28.9	19.4	10.4	14.8	6.5	18.1	13.5	12.1	26.7	16.2	22.2	22.8	14.7	22.2	36.2	16.8	10.2	25.8	17.1	15.1	18.0	44.2	8.8	10.2	23.2	31.3	20.8	24.3	20.7	17.8	23.4	19.9	11.7	16.5	15.1	17.1	17.6	15.9	14.6	15.7	13.1	13.0	15.5	17.4	5.6	20.7	16.7	7.4	15.7	13.1	18.7	26.4	17.6	20.2	21.6	16.1	32.6	16.3	25.3	32.6	26.8	21.3	28.3	27.1	7.9	28.5	14.1	17.8	36.1	23.9	22.7	15.7	57.3	18.3	26.4	40.7	25.3	17.2	0.0	22.5	41.2	19.5	22.9	36.8	30.1	23.9	82.6	23.7	24.5	20.0	31.2	30.8	17.1	5.0	12.6	21.1	51.6	26.7	14.0	38.5	23.8	29.7	38.8	27.1	23.4	19.0	11.5	71.2	25.4	14.5	21.7
SS18L2	KIAA-iso	ENSG00000008324	"SS18 like 2"	Q9UHA2	3	42581840-42595114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047377	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA047377: AB_2680020"	"unprognostic (4.09e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (6.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.24e-3)"	12.7	11.6	24.5	17.8	26.4	29.9	20.8	25.2	23.8	14.0	14.8	14.4	9.1	19.4	9.1	20.6	16.6	10.6	11.8	10.8	23.5	20.6	15.8	26.2	11.9	34.8	20.5	15.9	13.5	29.0	10.9	16.1	10.7	17.4	22.2	15.5	11.3	18.6	10.8	10.1	14.9	19.3	8.4	24.0	19.7	15.6	6.4	14.9	20.4	18.7	14.7	32.0	16.0	11.1	48.0	30.0	32.8	25.9	31.0	53.5	32.9	16.1	7.4	14.9	13.5	19.2	15.6	9.3	10.5	12.0	15.7	17.8	14.2	14.8	22.1	9.6	7.2	16.5	9.1	17.8	14.7	17.3	11.0	20.8	24.0	14.5	23.8	13.8	31.3	18.9	12.2	9.5	12.6	11.9	10.9	17.1	19.7	21.7	33.4	12.6	15.3	22.0	38.9	23.6	21.8	18.2	11.7	10.9	30.7	17.4	20.4	8.4	12.0	8.9	14.0	14.1	16.8	18.3	29.3	10.0	9.2	15.1	22.1	19.1	24.3	38.4	37.5	13.6	34.4	8.8	19.0	23.5	32.8	38.4	25.9	51.6	48.0	50.5	45.3	24.9	40.8	43.9	44.1	31.1	31.0	19.2	30.0	53.5	32.9	24.5	26.4	25.2	23.8	23.5	20.6	20.5	15.9	17.4	14.9	11.9	11.8	77.1	64.6	95.1	14.4	16.1	38.2	14.7	15.9	26.2	7.9	47.4	48.0	38.3	2.3	39.4	43.1	23.3	43.1	65.4	37.6	63.9	45.0	58.7	58.5	22.3	52.9	28.3	37.6	2.5	31.9	41.0	49.0	61.3	42.2	24.6	41.3	53.7	14.9	68.9	23.5	12.9	39.1	13.2	24.0	120.8	31.2	95.9	48.0	96.2
SSB	"La, La/SSB, LARP3"	ENSG00000138385	"Sjogren syndrome antigen B"	P05455	2	169791933-169812064	"Predicted intracellular proteins"		RNA-binding	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004643, HPA017287"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004643: AB_425691, HPA017287: AB_1852672"	"unprognostic (5.58e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.05e-3)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.99e-4)"	"prognostic unfavorable (8.30e-8)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (9.81e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (6.17e-6)"	"unprognostic (9.92e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.38e-2)"	52.4	38.5	39.7	35.1	41.8	43.8	38.2	45.8	48.4	37.8	32.7	18.9	24.2	23.7	34.7	42.4	35.8	31.7	28.9	32.7	37.2	42.9	54.0	44.9	27.0	41.3	36.0	34.3	46.5	21.8	40.3	76.9	39.8	51.1	44.5	28.9	19.8	23.5	35.0	44.6	22.4	30.7	38.2	42.4	45.6	26.6	19.4	35.7	35.9	48.1	30.0	38.1	49.3	29.1	32.4	21.0	22.4	33.2	32.3	38.5	22.5	30.8	18.2	39.4	29.3	42.8	39.8	49.3	38.0	25.4	35.7	33.3	55.0	33.9	69.3	43.5	24.8	32.5	33.2	53.2	33.2	49.1	37.6	43.6	83.0	23.0	52.8	38.3	66.6	31.1	30.5	32.0	45.3	27.1	29.4	39.6	26.2	96.4	16.2	74.7	24.3	44.1	69.9	63.5	29.8	18.7	43.8	42.0	50.0	45.1	34.2	37.7	28.8	30.1	22.5	41.9	40.1	25.8	48.1	35.6	26.1	31.1	26.2	36.5	18.9	36.4	59.1	25.8	62.9	28.3	22.4	16.9	19.8	26.9	27.8	38.5	32.4	38.2	33.9	19.6	27.1	34.9	36.8	2.7	32.3	33.2	21.0	33.9	22.5	39.7	41.8	45.8	48.4	37.2	42.9	36.0	34.3	51.1	35.7	80.4	66.3	99.4	177.0	81.5	115.4	84.5	53.5	274.4	111.5	106.4	25.5	182.8	159.2	164.1	16.1	133.2	32.6	46.7	128.2	168.7	141.2	127.2	195.7	71.0	164.6	128.7	70.2	94.5	76.4	34.1	170.6	138.1	75.9	92.0	78.5	142.4	108.6	38.6	175.7	143.3	76.2	213.4	162.9	173.1	145.9	77.2	138.3	109.7	93.4	140.8
SSBP3	"CSDP, FLJ10355, SSDP, SSDP1"	ENSG00000157216	"Single stranded DNA binding protein 3"	Q9BWW4	1	54225432-54413479	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 6.6"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071780			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071780: "	"unprognostic (1.44e-2)"	"prognostic favorable (2.48e-9)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.96e-1)"	12.3	19.9	17.4	11.1	18.8	21.3	12.2	27.8	35.8	24.7	15.7	11.2	12.0	14.5	26.1	7.3	17.2	21.9	17.2	13.1	15.3	13.5	10.6	14.7	10.7	9.6	13.7	21.1	51.9	13.5	6.1	7.8	13.9	11.0	16.4	10.7	12.5	13.6	21.1	13.9	16.7	14.9	16.5	15.1	12.1	26.2	12.8	9.6	40.7	9.9	8.5	9.3	15.4	18.9	0.5	0.7	1.1	0.4	0.3	6.6	1.3	3.9	2.5	22.8	14.4	9.0	5.8	52.8	7.7	6.6	3.2	2.5	4.5	3.5	2.7	14.7	6.8	3.3	12.5	11.3	5.3	3.2	20.3	5.3	26.4	8.3	5.1	8.2	6.9	13.1	10.1	3.9	5.6	1.6	5.6	15.9	16.2	25.8	4.9	3.8	3.7	41.4	8.3	43.6	15.3	11.4	29.6	6.3	10.7	4.4	3.0	34.5	19.5	9.2	18.7	5.0	20.2	9.8	8.0	13.3	6.6	11.6	8.2	5.4	11.1	8.9	6.2	11.0	24.0	2.7	0.0	0.4	1.1	2.3	0.2	2.1	0.5	3.7	3.0	0.7	0.3	6.6	5.2	0.1	0.3	0.4	0.6	0.2	1.3	17.4	18.8	27.8	35.8	15.3	13.5	13.7	21.1	11.0	9.6	11.9	8.9	3.0	36.3	26.4	85.6	15.1	45.9	21.4	13.6	22.7	7.9	45.2	8.3	27.5	29.8	31.7	34.9	46.7	22.5	38.4	36.8	27.8	7.0	84.4	22.8	39.7	107.4	44.2	31.0	27.5	84.8	16.2	21.9	6.4	73.5	53.9	41.6	34.5	128.7	8.9	45.8	25.8	41.2	2.5	14.3	22.6	19.8	9.5	46.0	25.7
SSBP4		ENSG00000130511	"Single stranded DNA binding protein 4"	Q9BWG4	19	18418864-18434562	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071780			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071780: "	"unprognostic (2.81e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-1)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (3.32e-2)"	"prognostic unfavorable (2.04e-10)"	"unprognostic (4.50e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.05e-2)"	20.7	15.9	25.4	17.6	39.9	12.2	8.7	16.3	30.1	15.1	12.5	8.0	15.3	16.7	19.9	8.5	8.7	23.2	7.4	8.6	21.1	15.2	9.7	8.2	14.8	16.2	7.7	16.2	15.0	16.1	6.9	28.6	12.7	10.0	13.3	5.0	11.9	12.4	24.1	25.6	11.6	20.1	8.0	5.7	35.5	23.3	12.1	11.4	11.7	11.1	6.9	9.9	7.2	10.3	10.8	5.4	0.5	17.8	3.4	9.4	3.2	11.6	9.0	8.6	15.2	1.6	6.1	12.1	16.4	3.3	3.7	3.9	3.7	13.0	10.3	14.4	3.5	4.0	13.5	2.2	3.0	1.5	11.0	25.2	18.0	11.0	8.3	6.7	8.3	33.2	5.2	2.4	2.3	0.9	5.1	10.9	20.2	36.0	5.1	1.1	17.5	22.1	27.7	7.0	5.5	26.5	15.2	6.9	10.5	5.6	3.7	15.3	26.3	2.5	7.8	21.6	1.7	8.5	19.6	13.8	6.3	16.7	38.2	10.4	7.6	2.2	6.8	16.5	26.2	12.7	0.0	4.3	0.2	9.4	10.8	6.4	10.8	7.9	8.1	5.4	8.7	4.7	8.1	0.5	3.4	17.8	3.4	4.1	3.2	25.4	39.9	16.3	30.1	21.1	15.2	7.7	16.2	10.0	11.4	6.0	18.1	39.5	27.2	15.2	13.5	5.2	7.6	76.3	19.4	50.6	23.6	17.6	21.6	11.4	7.1	33.8	5.6	0.0	18.2	37.9	45.1	23.7	36.9	10.6	31.0	39.7	57.5	23.9	27.9	21.3	54.1	31.1	18.6	8.2	16.9	21.3	11.8	10.5	48.4	17.3	14.1	38.8	35.9	18.2	59.4	12.8	15.8	51.1	17.8	24.0
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519098	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 16.7;Peritubular cells: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.9;BJ: 17.8;fHDF/TERT166: 18.0;hTERT-RPE1: 17.6;U-87 MG: 19.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		44000000	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	10.7	2.1	3.3	4.9	1.8	0.1	8.1	3.5	1.9	33.0	18.4	1.6	6.3	2.1	33.1	15.2	9.8	11.0	30.9	10.6	1.4	0.6	2.5	1.8	5.8	1.2	1.2	1.6	17.0	1.8	0.3	13.4	2.5	3.0	6.8	3.2	4.7	1.9	15.7	4.7	3.8	5.8	23.8	3.2	7.3	6.9	5.7	1.4	0.5	2.4	4.2	1.6	19.3	10.9	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.3	0.0	2.2	18.9	0.0	17.8	4.0	2.5	3.0	0.2	0.0	0.7	0.2	18.0	0.8	0.0	0.0	0.0	1.3	0.0	0.1	3.1	0.8	0.0	3.7	0.1	5.6	8.9	0.0	3.3	0.0	17.6	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.4	0.6	0.0	0.1	0.4	0.9	0.1	2.0	0.0	1.9	0.2	0.2	0.0	0.3	0.3	0.2	0.7	7.2	0.8	1.0	0.7	2.8	0.2	0.0	0.1	19.3	0.2	3.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	1.8	3.5	1.9	1.4	0.6	1.2	1.6	3.0	1.4	3.0	1.1	0.0	0.2	1.6	5.4	1.8	0.0	0.0	0.0	0.0	2.0	0.1	1.7	0.1	0.4	1.5	1.6	0.0	0.0	0.1	6.0	0.3	0.0	0.0	1.2	3.2	0.0	3.7	0.0	0.4	16.7	1.1	1.7	1.0	0.6	3.2	0.1	0.0	14.9	0.0	1.9	0.0	5.7	0.7	1.1	1.6	0.0	0.0	1.7	0.1
SSFA2	"CS-1, KIAA1927, KRAP, SPAG13"	ENSG00000138434	"Sperm specific antigen 2"	P28290	2	181891833-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 85.5"	"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 167.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: AB_2674271, HPA039989: AB_2676788"	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (5.79e-5)"	14.2	10.1	23.3	11.8	27.0	16.1	21.6	25.8	22.5	17.7	24.4	26.2	9.4	17.5	13.0	8.9	12.0	10.7	18.7	13.6	23.7	19.1	22.8	36.0	23.0	11.2	31.3	17.7	7.2	85.5	10.5	10.2	40.9	24.8	18.1	24.1	22.3	29.2	10.0	16.6	50.6	19.5	14.2	27.8	14.7	26.0	16.7	23.8	9.3	19.6	12.2	7.9	14.3	23.5	1.2	3.8	8.1	6.4	1.0	1.4	1.8	16.4	8.2	24.0	4.0	21.0	17.4	6.8	29.2	28.4	10.3	13.7	8.5	19.1	0.4	9.5	20.5	12.7	14.3	5.8	14.0	19.9	7.5	6.6	16.6	35.3	6.8	15.5	8.5	15.6	10.3	20.7	17.7	24.1	24.4	53.7	8.0	7.4	9.2	28.6	8.3	7.5	11.9	1.6	15.3	19.4	5.6	9.7	5.7	29.0	5.0	4.2	3.7	17.1	6.1	26.1	9.5	4.4	18.6	21.3	24.4	11.8	8.7	15.1	6.3	2.7	6.6	11.4	5.1	18.2	8.1	3.9	5.7	1.4	3.9	0.9	0.6	1.0	0.9	3.8	1.2	1.3	1.1	6.6	1.0	6.4	3.1	0.6	1.8	23.3	27.0	25.8	22.5	23.7	19.1	31.3	17.7	24.8	23.8	134.0	40.6	11.2	36.2	97.1	18.5	23.0	35.7	33.5	35.2	31.4	35.3	19.9	14.9	15.8	9.0	52.6	132.6	0.0	62.2	21.0	25.9	46.7	22.0	89.3	18.4	25.4	105.7	36.8	47.5	13.4	17.5	29.8	55.6	15.4	57.0	17.2	54.1	41.9	16.3	36.3	33.6	38.8	24.5	22.3	25.4	167.2	27.9	12.9	39.3	84.6
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303448-67312607	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.8;eosinophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.8;RT4: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	8.6	5.5	5.6	6.8	9.7	8.1	13.5	17.8	9.4	14.6	15.9	15.4	19.5	12.4	10.1	10.6	27.0	15.2	20.5	7.7	6.0	6.1	10.3	7.5	9.0	3.5	13.6	5.4	17.1	12.0	11.3	7.4	20.0	8.5	19.8	9.2	11.9	19.1	30.5	5.2	18.2	13.6	13.1	9.3	6.9	13.9	4.2	9.7	0.8	12.8	14.0	13.2	33.3	18.6	0.3	1.6	10.8	2.3	1.5	2.2	1.0	6.2	6.7	0.1	0.2	4.8	4.9	7.4	4.1	5.4	2.1	2.0	7.3	16.5	0.3	12.6	3.7	4.5	23.8	2.2	17.2	1.2	1.3	2.5	1.6	10.9	2.9	3.3	0.3	6.1	4.3	15.9	3.1	3.3	5.0	2.4	0.1	0.0	0.6	2.5	21.0	0.2	3.0	1.5	17.0	5.4	7.7	0.2	1.1	7.0	36.0	1.4	2.2	9.5	14.1	4.4	2.6	19.8	5.2	3.9	1.7	3.7	4.8	1.1	0.7	0.3	0.2	4.9	2.7	1.6	10.8	1.4	10.5	2.2	2.3	1.7	0.3	2.1	1.8	1.6	0.2	0.8	0.9	4.5	1.5	1.1	1.1	1.8	1.0	5.6	9.7	17.8	9.4	6.0	6.1	13.6	5.4	8.5	9.7	3.0	5.4	0.0	20.7	6.3	1.1	3.4	15.3	8.1	10.3	15.7	0.0	12.6	3.3	16.4	0.0	3.9	17.2	0.0	19.0	20.2	6.2	13.1	3.5	4.3	6.8	1.6	3.5	4.3	8.6	0.0	12.0	2.9	8.5	12.6	14.7	4.6	16.4	17.5	11.3	6.3	0.4	0.0	8.3	0.3	0.0	9.2	13.2	4.3	18.5	22.9
SSPN	"KRAG, SPN1, SPN2"	ENSG00000123096	Sarcospan	Q14714	12	26121991-26299290	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 172.0;Peritubular cells: 251.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"memory B-cell: 29.7"	"Lineage enriched"	"Detected in many"	21	"B-cells: 29.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.0;hTERT-RPE1: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066432			Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nuclear membrane"	Nucleoplasm	"HPA066432: AB_2685669"	"unprognostic (4.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	12.5	6.8	13.9	6.6	12.6	0.1	11.5	16.5	11.4	24.9	12.7	11.1	4.1	2.7	14.6	10.3	11.4	15.0	14.3	26.2	21.0	6.1	3.8	1.4	5.4	4.5	17.2	8.7	21.5	4.7	2.9	4.8	2.5	20.9	14.5	7.3	7.8	6.8	21.1	38.7	3.6	6.3	20.1	20.4	4.9	6.7	5.8	19.0	3.2	10.0	15.4	6.5	18.2	10.8	29.7	0.0	1.4	0.0	0.0	0.2	0.3	0.3	0.7	2.0	0.0	13.0	7.4	0.1	3.8	5.3	0.5	1.5	0.0	4.7	0.0	0.8	5.2	3.0	1.5	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.6	0.4	1.7	0.4	46.8	0.2	0.0	0.0	0.0	4.0	0.8	0.2	1.1	4.4	0.2	1.2	0.1	5.3	1.4	1.2	4.0	0.2	3.8	1.4	0.3	3.7	2.1	0.4	0.1	1.4	1.8	1.0	1.8	0.9	0.1	0.5	0.0	2.8	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.2	29.7	0.0	0.0	0.0	6.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	13.9	12.6	16.5	11.4	21.0	6.1	17.2	8.7	20.9	19.0	3.0	2.7	20.9	16.5	12.0	1.7	79.0	7.6	6.7	19.4	17.4	0.0	63.3	5.0	8.5	3.3	8.3	8.4	0.0	6.5	5.6	56.4	10.8	0.0	0.0	12.1	6.4	4.7	8.6	0.0	3.1	172.0	7.9	18.6	32.5	9.1	35.9	2.4	7.0	251.4	2.2	2.6	38.8	42.9	0.3	0.9	6.1	23.2	1.0	5.8	17.1
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325985-57335877	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8300	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	25.3	23.2	23.5	37.7	25.1	32.0	38.4	28.5	27.6	27.2	30.5	19.4	28.8	23.0	34.9	28.2	34.6	34.4	33.1	28.4	22.7	20.3	22.6	27.8	26.5	33.7	21.6	20.7	41.8	39.3	39.7	31.2	34.8	22.0	26.6	33.0	17.2	32.8	27.5	47.7	32.9	26.2	28.9	17.1	28.3	29.3	28.3	25.2	44.0	45.9	37.0	42.5	28.7	51.7	10.2	10.3	4.5	5.2	6.9	12.0	4.7	57.5	55.7	52.8	38.6	16.7	18.6	25.9	31.7	30.7	55.5	39.8	38.2	43.1	70.0	33.9	27.8	35.3	44.6	83.7	49.4	70.1	48.8	47.0	44.7	41.0	41.0	26.3	74.0	33.6	18.7	30.2	57.0	79.4	25.8	36.2	54.2	60.7	35.5	37.7	39.0	74.9	65.5	69.4	30.7	34.3	63.3	89.3	68.0	25.9	41.6	55.3	46.9	44.9	38.6	46.8	28.3	46.8	29.2	27.2	37.9	50.1	51.0	54.2	41.4	41.0	72.4	32.1	41.8	49.9	0.8	4.3	4.5	9.4	5.2	9.1	8.7	8.1	10.2	6.1	10.2	8.9	12.0	1.2	6.9	5.0	10.3	9.6	4.7	23.5	25.1	28.5	27.6	22.7	20.3	21.6	20.7	22.0	25.2	71.5	73.4	41.0	69.0	66.5	23.9	23.5	33.1	148.5	102.4	27.9	23.6	89.5	11.6	62.9	64.9	43.6	26.8	0.0	86.1	90.2	43.5	42.4	38.3	31.8	50.8	23.8	27.6	32.5	32.2	93.2	39.4	40.0	27.0	44.1	40.8	23.8	58.2	35.1	41.8	20.2	16.4	19.4	46.2	55.9	93.5	66.7	56.5	36.3	68.4	62.2
SSSCA1	p27	ENSG00000173465	"Sjogren syndrome/scleroderma autoantigen 1"	O60232	11	65570430-65573942	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039789, HPA064670"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA039789: AB_2676680, HPA064670: AB_2732718"	"unprognostic (9.32e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.03e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.34e-2)"	17.6	21.6	20.0	24.6	23.3	34.0	17.9	19.9	39.1	16.6	22.2	15.2	14.6	18.7	23.1	15.4	23.2	19.9	20.9	28.4	19.5	13.8	20.5	40.4	18.1	24.2	15.1	21.7	22.9	50.3	15.7	15.7	21.4	18.7	20.1	7.6	16.8	36.6	20.8	70.5	19.5	17.0	16.9	10.6	20.9	18.7	44.1	12.0	27.6	17.7	25.0	19.6	21.6	16.6	39.6	35.7	10.6	26.9	32.8	29.3	21.2	26.3	20.9	12.6	22.7	7.3	6.3	21.3	18.2	10.5	17.1	12.0	20.6	26.6	25.6	32.8	9.0	12.4	22.1	8.9	20.0	5.2	17.8	15.4	22.2	19.4	15.6	11.6	27.0	18.1	10.5	13.2	12.8	12.1	12.6	13.6	23.8	24.9	31.6	9.0	38.0	31.2	23.7	21.3	9.2	39.6	24.8	9.5	45.8	9.8	13.4	25.3	26.5	11.0	27.3	26.6	5.1	36.8	13.5	15.3	30.1	17.6	35.8	22.7	23.6	31.4	21.6	24.3	18.8	27.5	5.7	26.9	10.6	24.6	21.9	25.9	39.6	25.5	25.0	21.6	33.9	29.3	26.1	8.5	32.8	14.2	35.7	27.1	21.2	20.0	23.3	19.9	39.1	19.5	13.8	15.1	21.7	18.7	12.0	14.9	21.5	51.3	60.8	35.6	8.8	40.3	38.2	40.2	17.0	33.2	2.0	73.2	77.9	84.2	103.1	33.5	42.4	23.3	129.2	67.2	44.0	42.9	54.4	53.9	51.7	20.6	48.1	26.4	27.0	57.4	32.5	27.7	50.6	76.7	29.8	21.7	84.0	31.6	24.8	101.2	13.2	12.9	39.9	77.2	51.3	35.1	66.8	38.8	29.9	66.5
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574869	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 520.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	44.1	32.5	48.0	33.6	51.5	29.3	73.9	42.3	51.5	37.2	40.1	25.4	39.3	41.3	32.6	51.8	45.7	46.2	35.3	44.4	40.7	42.5	38.0	50.9	37.5	49.0	39.4	39.0	38.0	61.8	33.9	39.9	35.8	36.9	33.9	35.9	34.1	54.2	35.8	107.1	36.9	40.8	35.4	35.0	41.7	38.5	28.0	28.4	37.0	50.9	45.3	36.3	30.8	42.2	35.5	30.1	62.0	28.8	20.7	46.5	28.1	41.4	26.6	19.2	29.6	33.1	32.0	19.7	36.1	28.2	31.5	32.9	24.9	48.2	42.2	19.8	28.4	30.8	32.4	31.0	29.7	30.8	35.1	36.6	26.5	23.3	39.3	37.5	33.5	23.2	28.5	25.1	33.7	32.2	26.5	29.4	25.7	45.8	32.7	24.9	36.9	38.3	53.8	33.6	40.9	40.4	30.5	31.0	59.0	34.5	12.8	35.6	24.4	24.4	62.7	106.5	34.0	32.7	29.2	22.4	30.4	19.3	34.2	30.9	39.9	47.9	52.7	31.8	53.4	14.7	37.1	28.3	53.6	25.9	28.8	31.9	35.5	34.4	30.7	30.1	33.1	42.2	34.1	62.0	20.7	25.4	19.0	46.5	28.1	48.0	51.5	42.3	51.5	40.7	42.5	39.4	39.0	36.9	28.4	26.8	71.4	136.9	121.9	165.4	98.0	80.5	117.2	36.1	37.5	96.0	19.6	178.0	247.1	62.6	202.0	95.1	177.2	0.0	92.6	189.0	93.0	151.4	60.0	123.8	125.1	106.5	136.4	90.9	152.3	520.2	97.0	118.3	158.6	91.0	137.9	96.8	78.9	168.6	80.6	258.7	57.5	58.2	97.3	81.2	147.4	192.6	205.2	116.7	134.0	129.8
SSX1	CT5.1	ENSG00000126752	"SSX family member 1"	Q16384	X	48255317-48267444	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 12.6"	"Group enriched"	"Detected in some"	12	"Sertoli cells: 6.5;Spermatocytes: 9.8;Spermatogonia: 22.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;Karpas-707: 41.8;U-2197: 9.7"									HPA045683	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"					"unprognostic (2.25e-1)"		"unprognostic (3.51e-3)"		"unprognostic (2.36e-1)"	"unprognostic (4.32e-3)"				"unprognostic (3.38e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.94e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.7	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	9.8	22.6	0.0	0.0	0.0	0.0	0.0
SSX2	"CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX"	ENSG00000241476	"SSX family member 2"	Q16385	X	52696896-52707189	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	57	"testis: 24.1"	"Cell type enriched"	"Detected in single"	28	"Spermatogonia: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 3.2;U-2197: 1.9"									"HPA045683, CAB046020"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB046020: AB_2194010, HPA045683: AB_2679418"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.6	0.1	0.6	1.9	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 13.5"	"Cell type enriched"	"Detected in single"	10	"Spermatogonia: 4.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;HMC-1: 5.4;PC-3: 5.2;T-47d: 2.3;U-2197: 3.3"									HPA045683	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.9	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.6	0.5	0.1	0.0	0.0	0.2	0.0	5.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	2.3	0.0	1.0	0.0	0.5	3.3	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.4	0.0	0.0	0.0	0.0	0.0
SSX2IP	hMsd1	ENSG00000117155	"SSX family member 2 interacting protein"	Q9Y2D8	1	84643707-84690803	"Predicted intracellular proteins"	"Cell adhesion, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.4"	"Cell type enhanced"	"Detected in many"	16	"Cone photoreceptor cells: 245.4;Early spermatids: 718.3;Late spermatids: 850.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075946	Supported		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA075946: "	"unprognostic (5.18e-3)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.45e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.37e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.46e-2)"	1.8	2.0	10.6	2.8	25.2	6.5	2.7	17.7	25.7	3.9	7.9	1.6	3.0	22.2	5.1	12.4	3.8	3.8	4.6	4.9	9.8	5.0	9.0	7.5	2.2	3.1	3.8	12.4	1.6	3.7	5.6	10.2	3.2	6.9	7.0	4.2	5.2	3.8	6.6	3.1	3.3	13.3	5.6	3.1	2.7	3.7	51.4	5.1	4.8	4.4	1.7	3.2	3.1	3.0	1.5	5.8	4.8	3.2	5.4	11.0	5.0	16.2	8.1	6.5	11.9	2.2	7.0	8.0	27.9	14.3	12.3	10.0	5.7	3.6	16.1	4.9	23.5	15.9	9.1	11.5	9.0	17.4	3.2	9.7	15.2	9.8	4.9	4.6	13.2	1.2	3.0	14.8	13.9	8.8	8.3	4.1	6.2	31.3	6.1	7.8	6.2	9.2	5.2	9.6	3.1	12.7	6.2	28.6	7.1	12.9	9.4	12.8	16.0	7.8	12.8	14.0	4.3	7.4	6.9	1.2	11.8	17.3	16.0	27.5	6.4	7.5	17.6	9.8	11.9	7.2	1.1	1.1	4.8	11.0	2.4	6.2	1.4	3.7	4.5	4.4	1.5	4.6	6.9	1.5	5.4	3.2	5.8	2.0	5.0	10.6	25.2	17.7	25.7	9.8	5.0	3.8	12.4	6.9	5.1	3.0	4.0	3.7	6.9	9.3	28.4	19.4	17.8	17.4	10.3	10.4	245.4	3.2	6.6	5.7	718.3	3.6	10.2	46.7	10.4	1.7	6.6	5.7	4.6	12.5	2.3	19.1	8.1	3.7	1.3	850.2	14.7	4.7	5.0	2.8	7.3	174.8	7.0	3.5	10.6	33.8	147.0	0.0	4.1	42.7	52.8	8.5	0.5	5.3	7.4	2.5
SSX3	CT5.3	ENSG00000165584	"SSX family member 3"	Q99909	X	48346428-48356707	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 18.0"	"Cell type enriched"	"Detected in some"	9	"Spermatogonia: 144.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"Karpas-707: 6.9"									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"															"unprognostic (1.86e-1)"	"unprognostic (2.13e-2)"		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.2	0.4	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	1.6	0.5	0.2	0.2	0.0	0.0	1.6	0.2	0.8	0.3	0.1	0.2	0.8	0.3	0.4	0.0	0.9	0.4	0.4	0.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.7	144.8	0.0	0.0	0.0	0.0	0.0
SSX4	CT5.4	ENSG00000268009	"SSX family member 4"	O60224	X	48383516-48393347	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5"									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.8	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.2	9.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4B	OTTHUMT00000056510	ENSG00000269791	"SSX family member 4B"	O60224	X	48402078-48411910	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5"									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.4	0.0	0.3			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	6.7			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.8	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.2	9.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196763	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 4.3;thyroid gland: 2.9"	"Cell type enriched"	"Detected in single"	14	"Spermatogonia: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BEWO: 10.8"									HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.4	0.0	0.1	0.1	0.4	1.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	0.0	0.5	0.2	0.1	0.8	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.3	0.1	1.6	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.6	0.2	0.1	0.1	0.8	0.0	4.3	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.5	0.2	0.9	0.2	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.7	1.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.4	0.3	0.4	0.1	0.5	0.1	0.4	0.9	0.6	0.0	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644090-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HMC-1: 8.1;RT4: 4.3"									HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418"																"unprognostic (1.29e-1)"		0.1	0.2	0.2	0.4	0.1	0.7	0.1	0.1	1.0	0.1	0.2			0.6	0.2	0.0	1.5	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.5	0.3	0.1		0.8	0.1	0.0	0.1	0.0		0.1	0.0		1.8	0.0	0.1	1.5	0.1	0.0	0.1	0.6	0.4	1.0			0.4		0.0	0.2	0.1	0.0	0.2	1.0	0.7	0.3	0.4	0.0	0.4	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.1	0.6	0.3	1.7	0.7	0.3	0.0	0.0	8.1	0.0	0.2	0.2	0.0	0.3	0.1	0.4	0.2	1.4	0.1	1.0	0.7	0.2	0.0	0.2	0.0	0.4	0.5	0.0	0.0	4.3	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.3	0.1	0.0	0.0	0.3	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.5	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.3	0.7	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"Suppression of tumorigenicity 14"	Q9Y5Y6	11	130159562-130210376	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 94.1"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 295.9;Mucus-secreting cells: 176.7;Paneth cells: 178.5;Urothelial cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 36.0;CAPAN-2: 72.5;HaCaT: 50.8;OE19: 38.5;RPMI-8226: 47.5;SK-BR-3: 33.6;T-47d: 50.8;U-698: 34.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA047014			Approved	Nucleoplasm,Vesicles		NA	NA		220000	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902"	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	10.1	1.8	0.7	21.9	1.8	0.5	5.5	0.8	1.4	8.9	48.6	0.5	23.8	33.8	2.8	16.9	38.9	9.7	32.4	1.1	0.5	0.5	30.5	3.2	9.5	7.5	1.8	0.6	3.6	34.3	8.4	9.5	12.7	1.5	12.1	15.4	0.7	25.1	15.8	0.7	17.8	94.1	1.2	1.8	4.0	16.7	2.1	1.5	5.2	24.0	20.1	28.4	8.3	14.9	3.8	18.2	2.3	2.7	0.0	0.1	0.8	26.4	0.0	0.0	0.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	36.0	72.5	26.1	2.7	0.0	0.0	50.8	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.1	0.2	38.5	0.1	0.0	0.0	47.5	4.7	21.7	2.9	0.0	0.2	33.6	0.0	0.2	50.8	5.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	34.6	0.0	8.0	0.0	0.0	2.7	2.3	0.0	1.5	0.1	3.8	0.0	0.0	4.5	2.3	0.0	0.0	0.3	0.0	0.2	18.2	0.0	0.8	0.7	1.8	0.8	1.4	0.5	0.5	1.8	0.6	1.5	1.5	29.8	25.8	9.3	31.0	36.4	0.0	0.8	38.2	17.4	20.5	59.3	0.0	40.3	3.3	108.8	27.9	0.4	295.9	0.0	80.1	11.6	2.6	89.5	11.5	1.9	60.1	0.0	118.5	0.0	25.4	11.5	1.7	19.0	6.8	8.2	176.7	0.0	114.4	178.5	0.7	10.5	0.0	6.5	1.4	0.2	0.1	38.3	33.2	1.3	155.8	230.3
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375978-70439237	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	12.6	9.1	9.3	17.2	11.9	14.3	8.9	24.1	10.6	11.3	8.8	5.1	9.3	9.2	13.9	5.6	5.8	9.0	6.8	9.2	10.4	6.0	8.8	12.9	9.3	14.9	5.1	4.7	13.6	4.2	8.8	7.2	8.8	6.8	7.5	4.7	9.9	4.9	9.0	33.3	6.0	10.5	12.0	4.0	17.7	5.4	9.6	5.9	16.0	6.6	4.9	12.6	9.1	12.0	3.2	14.3	11.2	2.2	2.8	4.2	1.1	1.4	8.5	7.4	9.8	4.0	5.4	1.7	6.0	6.4	6.7	3.3	5.1	3.3	4.1	10.8	6.5	6.0	1.0	2.9	2.5	3.2	9.7	4.7	17.5	3.5	7.6	4.9	6.4	28.9	4.1	1.4	6.8	1.2	8.2	9.2	7.1	23.9	4.0	3.7	0.7	6.7	17.5	10.0	2.8	4.6	12.9	2.8	5.5	4.5	1.1	3.3	9.7	15.1	0.3	6.6	8.0	1.6	7.1	9.8	8.5	10.2	3.6	4.4	8.4	3.3	8.4	9.3	5.4	11.9	2.7	2.0	5.7	2.0	2.2	1.9	1.7	2.4	2.2	1.0	3.2	4.2	3.3	11.2	2.8	1.3	14.3	2.7	1.1	9.3	11.9	24.1	10.6	10.4	6.0	5.1	4.7	6.8	5.9	8.9	6.9	13.0	3.6	3.0	15.1	5.6	10.2	1.4	2.3	8.7	13.7	3.7	0.0	5.4	14.0	13.1	5.1	46.7	3.8	1.6	10.6	2.2	17.3	11.5	11.6	17.5	12.7	14.7	10.0	25.8	10.9	14.4	1.7	23.4	4.0	5.1	2.4	0.0	7.8	5.0	10.2	6.5	7.1	5.4	8.1	2.0	1.5	8.6	5.2	1.8
ST3GAL5	"SIAT9, SIATGM3S, ST3GalV"	ENSG00000115525	"ST3 beta-galactoside alpha-2,3-sialyltransferase 5"	Q9UNP4	2	85837120-85905199	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.1"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 80.4;Alveolar cells type 2: 105.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 41.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.2;RT4: 22.2;SK-MEL-30: 18.4;U-266/84: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034708, HPA040425, HPA068928"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060"	"unprognostic (7.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.25e-7)"	"unprognostic (2.22e-1)"	"unprognostic (5.74e-2)"	"prognostic favorable (4.99e-4)"	"prognostic favorable (4.48e-4)"	8.0	40.1	15.3	7.2	18.5	4.1	4.2	9.9	34.9	3.3	3.8	18.8	0.0	2.7	8.0	2.9	2.9	4.9	11.8	2.1	14.8	12.0	2.4	7.0	18.0	11.5	14.0	13.4	7.2	2.9	1.5	7.4	24.1	18.1	4.8	5.0	18.7	4.8	2.2	9.5	5.0	3.4	6.2	18.0	11.1	4.1	9.0	13.4	5.5	36.7	0.4	6.9	30.9	7.8	2.5	1.1	1.3	6.1	1.4	1.8	0.5	0.1	12.8	1.2	26.2	10.9	5.9	3.9	2.8	8.6	2.7	2.4	0.2	9.3	0.3	0.1	4.8	1.2	0.5	1.7	3.0	3.4	0.1	1.5	0.2	0.5	0.4	8.7	0.1	3.8	3.3	0.4	1.0	0.4	4.9	6.5	3.5	0.3	14.5	8.8	0.8	0.8	1.4	0.1	4.4	0.0	1.6	8.3	5.1	1.4	22.2	1.8	1.8	0.1	0.0	18.4	2.7	0.1	0.5	2.1	0.0	1.3	0.0	0.2	14.6	19.3	0.2	2.1	2.6	13.2	0.9	1.8	0.1	1.4	6.1	1.8	2.5	0.8	0.9	1.1	1.5	0.7	0.8	1.3	1.4	5.1	0.4	0.3	0.5	15.3	18.5	9.9	21.9	14.8	12.0	14.0	13.4	18.1	13.4	80.4	105.8	40.9	24.7	4.9	49.5	1.6	30.6	14.7	50.0	3.5	55.0	0.3	3.3	8.1	9.5	5.2	0.0	0.0	14.5	0.5	10.3	8.0	33.5	15.5	30.3	68.3	6.4	33.2	46.9	8.7	7.5	25.6	30.4	12.6	0.0	52.2	6.7	0.0	1.8	2.9	41.0	0.0	5.0	6.9	20.0	3.3	0.2	19.7	0.0	5.1
ST5	"DENND2B, HTS1, p126"	ENSG00000166444	"Suppression of tumorigenicity 5"	P78524	11	8693351-8910951	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 371.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046796	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046796: AB_2679812"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	9.6	25.4	9.5	14.9	11.9	1.3	11.0	16.3	13.2	45.1	29.3	14.1	20.4	11.9	71.3	22.2	27.0	41.1	22.4	13.9	8.5	7.5	10.8	10.4	11.0	5.9	7.9	9.7	49.5	14.4	6.5	14.8	19.2	11.6	24.5	11.7	28.9	21.0	28.3	8.4	8.4	17.8	51.4	8.5	22.8	22.4	34.5	8.6	4.5	15.8	9.2	8.6	26.5	19.7	1.3	1.6	1.0	5.9	0.0	0.2	0.6	12.4	1.8	20.6	3.4	6.9	7.2	0.9	11.3	36.7	10.9	10.1	2.5	13.5	0.4	6.8	20.4	4.8	12.6	3.8	16.4	4.3	1.7	5.0	0.0	6.4	8.6	10.4	0.0	0.1	24.5	4.6	6.2	8.3	22.6	2.1	2.0	2.6	1.1	17.6	1.3	0.7	0.5	3.0	12.5	3.0	0.4	12.4	0.7	15.2	9.1	3.9	12.2	9.7	12.7	7.8	7.1	2.1	0.4	5.7	5.9	10.0	19.2	8.8	3.0	5.7	0.1	9.8	0.0	11.9	0.0	0.1	0.0	0.1	0.8	0.0	1.3	0.0	0.0	1.6	1.2	0.1	0.1	1.0	0.0	5.9	0.0	0.2	0.6	9.5	11.9	16.3	13.2	8.5	7.5	7.9	9.7	11.6	8.6	11.9	38.5	0.0	42.4	15.8	27.4	4.4	38.2	28.1	40.9	17.4	538.0	3.3	3.3	35.5	32.9	10.1	19.7	23.3	28.3	1.8	23.7	23.4	1.1	9.6	5.2	1.6	16.7	8.6	3.1	23.3	74.5	3.6	23.6	6.4	22.8	94.1	32.0	7.0	93.7	1.5	371.0	64.7	36.4	18.0	16.6	6.8	2.4	0.0	19.8	25.8
ST6GAL2	"KIAA1877, SIAT2, St6gal2, St6GalII"	ENSG00000144057	"ST6 beta-galactoside alpha-2,6-sialyltransferase 2"	Q96JF0	2	106801600-106887108	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;thyroid gland: 34.0"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 7.7;Ito cells: 2.5;Mucus-secreting cells: 2.3"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;hTERT-RPE1: 7.2;NTERA-2: 4.9;PC-3: 6.4;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014459	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA014459: AB_1857528"	"unprognostic (2.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.56e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.70e-4)"	"unprognostic (4.06e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.07e-2)"	1.2	0.7	14.1	0.7	5.6	1.5	1.3	2.3	16.7	2.1	1.5	4.1	1.7	0.7	3.7	1.9	2.7	1.2	12.7	1.9	5.4	4.0	1.1	3.4	1.2	0.9	3.8	7.1	0.9	0.5	0.5	0.3	2.3	4.2	1.6	3.3	0.0	1.6	1.6	0.7	1.3	0.7	2.8	1.9	0.6	0.9	7.9	1.5	0.0	34.0	1.6	0.8	1.5	1.4	0.7	0.6	1.8	0.5	1.0	0.7	0.5	0.0	5.7	3.1	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.9	0.0	6.4	0.0	0.0	10.2	0.2	0.0	6.8	4.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	8.3	0.1	0.2	0.0	10.9	0.2	0.1	0.0	0.0	0.0	1.4	0.5	0.4	0.6	0.3	0.5	0.4	0.4	0.5	0.2	0.7	0.5	0.7	1.8	1.0	0.3	0.6	0.5	0.5	14.1	5.6	2.3	14.8	5.4	4.0	3.8	7.1	4.2	1.5	0.0	0.0	0.0	0.1	0.8	7.7	1.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.2	0.0	1.2	2.5	0.0	0.0	0.3	0.0	0.0	0.0	2.3	0.8	0.0	0.0	0.7	0.6	0.5	0.0	1.4	0.0	1.3	0.0	0.2	0.0	1.2	0.0
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643838	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 69.4"	"Cell type enriched"	"Detected in many"	6	"Mucus-secreting cells: 708.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	25	"T-cells: 11.2"	"Group enriched"	"Detected in some"	4	"K-562: 23.7;OE19: 44.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		1200000	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.4	0.3	1.2	13.9	2.6	0.7	1.3	0.8	3.2	20.4	50.9	3.1	0.3	19.8	6.3	1.8	19.6	1.5	26.6	4.1	1.6	1.3	0.4	1.1	5.7	1.1	1.8	1.2	2.0	1.1	0.1	0.4	1.7	3.7	2.6	69.4	0.1	20.8	1.4	0.9	0.6	49.0	1.9	1.5	6.0	23.9	4.0	0.6	0.0	0.5	4.5	21.6	1.9	2.6	0.0	0.0	0.4	0.0	0.0	11.2	1.1	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.4	0.0	0.0	4.9	0.0	1.3	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.7	0.0	0.0	0.0	0.1	0.0	0.0	44.4	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.2	0.2	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	1.4	1.1	1.2	2.6	0.8	3.2	1.6	1.3	1.8	1.2	3.7	0.6	14.9	6.9	0.0	5.2	0.1	0.0	1.5	30.6	112.4	76.2	0.0	0.0	0.1	0.0	1.6	0.2	14.2	50.8	0.0	16.6	0.1	0.6	3.2	0.0	0.0	0.2	0.0	31.7	4.3	0.0	0.5	1.4	0.3	0.0	0.0	708.1	0.0	27.0	66.2	0.0	0.0	1.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	108.2	20.7
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;pancreas: 61.0"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 58.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 58.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.5;RPMI-8226: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	8.0	7.8	5.6	7.9	5.6	26.2	12.1	9.8	8.5	9.2	9.3	4.8	28.9	11.7	8.7	9.6	6.9	8.7	12.2	18.4	5.2	3.4	9.4	5.0	13.5	9.7	4.2	4.7	14.9	61.0	2.4	9.4	4.3	4.8	6.1	5.4	4.8	9.3	30.0	12.6	4.0	9.7	6.1	3.9	18.2	7.2	4.3	4.7	4.7	6.3	5.9	12.5	8.9	8.3	6.7	58.8	0.8	3.2	4.3	3.4	2.4	3.2	5.5	1.4	7.0	9.9	7.6	1.0	5.6	6.2	5.7	3.3	3.1	5.9	20.5	8.5	7.0	8.1	7.9	2.9	5.9	0.9	35.5	2.4	6.5	17.6	11.6	12.1	0.5	6.8	9.2	6.3	5.1	4.6	4.6	15.2	3.9	4.6	13.7	2.7	1.5	1.2	0.7	1.6	10.5	13.6	6.2	3.7	50.3	5.8	0.1	12.0	2.7	8.1	17.6	1.0	0.5	3.6	4.2	10.8	4.7	5.4	14.6	8.7	22.4	11.5	6.4	9.4	2.9	0.6	0.8	2.1	0.0	2.9	1.9	3.3	6.7	1.8	3.4	2.8	4.9	2.3	3.1	0.2	4.3	3.2	58.8	3.3	2.4	5.6	5.6	9.8	8.5	5.2	3.4	4.2	4.7	4.8	4.7	8.9	24.5	43.4	11.9	1.9	2.4	10.3	10.2	5.3	4.5	1.8	0.0	0.9	1.7	14.0	0.1	10.8	19.6	23.3	12.5	14.4	11.9	2.0	8.1	1.5	22.1	0.0	65.1	4.9	11.4	0.0	16.1	8.5	6.8	12.6	13.1	14.1	11.9	6.5	40.3	17.3	1.7	12.9	8.9	0.2	1.3	2.8	3.8	10.2	16.4	10.0
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867441-77065711	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell type enriched"	"Detected in some"	7	"Alveolar cells type 1: 50.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Group enriched"	"Detected in many"	4	"amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA065593: AB_2685515, HPA070354: AB_2686260"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.7	10.1	22.1	5.2	22.3	0.4	4.2	0.6	12.7	2.9	3.4	0.3	0.0	1.4	0.9	0.7	3.7	6.9	12.6	1.4	29.4	2.7	0.7	0.6	12.1	1.6	3.0	14.2	6.5	0.8	0.4	8.5	0.9	4.7	4.2	2.7	5.8	1.5	1.6	0.6	1.0	2.1	10.2	0.8	1.0	3.7	1.2	0.2	0.0	0.6	0.0	1.4	4.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	9.1	0.0	0.0	0.0	0.0	0.8	3.2	2.6	0.8	0.0	0.2	0.0	0.0	10.9	0.0	5.2	0.0	0.1	2.8	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.7	0.6	0.0	0.1	2.5	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	9.0	0.0	5.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.1	22.3	0.6	12.7	29.4	2.7	3.0	14.2	4.7	0.2	50.6	0.3	0.0	0.0	0.0	7.3	0.4	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230103	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 107.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	11.1	20.0	12.9	5.0	18.0	12.0	12.3	63.0	25.7	16.7	10.7	9.2	21.6	9.8	12.3	31.2	8.5	15.8	10.0	19.8	10.9	12.3	23.1	31.5	20.0	5.4	11.1	18.7	15.9	30.8	17.6	30.1	21.8	14.9	11.7	10.1	11.0	24.9	19.3	10.1	9.7	9.7	11.3	8.1	9.1	13.5	15.9	8.2	2.9	23.8	7.6	7.0	10.0	9.8	2.6	6.2	1.6	3.3	7.6	10.6	3.2	13.1	7.6	12.4	10.8	14.4	9.9	5.7	10.4	13.2	10.7	16.0	10.2	15.6	3.4	11.4	9.1	16.3	10.8	10.6	11.1	14.6	4.6	15.3	10.3	12.7	9.0	10.0	11.6	17.7	7.6	11.3	13.9	9.7	10.5	11.2	2.3	15.2	24.8	10.1	7.6	0.1	8.9	12.0	17.0	9.1	2.9	8.4	14.5	11.5	7.0	18.6	15.2	11.8	52.1	13.8	10.0	4.5	9.6	8.5	12.6	5.0	13.6	10.2	15.7	11.9	13.0	10.2	10.4	12.6	1.6	3.3	0.4	8.3	1.2	5.9	2.6	5.1	7.3	6.2	0.9	3.5	3.6	0.1	7.6	1.2	6.2	10.6	3.2	12.9	18.0	63.0	25.7	10.9	12.3	11.1	18.7	14.9	8.2	20.8	30.2	7.2	7.2	6.6	10.2	10.1	12.7	4.0	12.5	5.2	0.0	17.1	5.0	5.8	107.8	6.7	2.6	0.0	11.6	18.9	8.8	8.0	18.5	22.6	7.9	3.2	3.5	6.2	13.0	35.2	10.3	5.8	6.8	9.0	5.9	11.8	8.4	3.4	5.6	14.6	0.6	0.0	6.1	14.0	5.6	4.8	17.7	3.1	3.9	7.8
ST7L	"FAM4B, FLJ20284, ST7R, STLR"	ENSG00000007341	"Suppression of tumorigenicity 7 like"	Q8TDW4	1	112523518-112620825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 151.6;Late spermatids: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042324, HPA075418"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA042324: AB_10794273, HPA075418: AB_2686749"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (8.34e-5)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-6)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.16e-4)"	"prognostic favorable (3.04e-5)"	"unprognostic (2.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.27e-2)"	7.7	9.3	5.7	5.5	9.0	8.6	8.2	12.1	7.9	8.1	6.9	10.0	7.2	5.5	10.0	7.8	6.1	7.9	6.0	8.6	5.6	5.9	6.3	7.6	5.7	5.3	6.1	5.1	9.4	11.6	5.2	12.8	6.4	6.3	7.3	8.0	9.4	7.0	9.0	10.2	8.9	6.2	7.9	6.4	5.2	5.8	49.0	7.0	4.6	11.8	4.6	5.6	6.8	7.7	4.2	3.5	0.3	2.1	6.9	5.2	1.9	4.8	1.5	8.7	6.1	11.9	11.8	2.1	6.3	4.8	2.7	4.0	2.8	4.8	2.1	2.6	2.5	8.1	3.4	10.2	8.1	4.1	3.1	6.0	5.9	7.6	1.8	6.8	5.0	6.4	2.2	2.0	3.1	6.4	6.4	8.7	7.4	3.4	6.9	11.0	1.9	2.6	2.0	3.9	2.3	5.3	4.2	4.6	0.8	5.5	6.0	6.4	3.9	3.4	4.7	4.4	1.6	3.6	3.0	8.3	6.2	6.1	8.0	6.0	1.8	1.3	2.1	5.6	8.0	13.5	0.1	1.8	0.2	2.4	2.1	3.9	4.2	3.6	1.8	1.7	1.8	5.2	2.8	0.3	6.9	1.6	3.5	2.4	1.9	5.7	9.0	12.1	7.9	5.6	5.9	6.1	5.1	6.3	7.0	20.8	8.1	4.5	14.2	15.0	16.4	6.1	20.4	12.0	13.6	8.7	5.9	11.0	8.3	7.6	151.6	11.9	5.1	0.0	7.4	5.7	9.2	11.9	8.1	6.8	7.5	23.8	5.2	4.9	7.8	193.4	16.7	7.5	20.3	4.6	9.5	19.1	6.4	3.5	15.2	5.7	22.0	19.4	7.6	33.6	11.3	15.9	5.1	8.7	9.7	9.3
ST8SIA2	"HsT19690, SIAT8B, ST8SIA-II, STX"	ENSG00000140557	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2"	Q92186	15	92393828-92468728	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 17.7;heart muscle: 10.0"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 4.5;Muller glia cells: 2.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 22.2;LHCN-M2: 6.5;RH-30: 10.1;RPMI-8226: 7.3;SH-SY5Y: 4.3;WM-115: 6.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054518, HPA057819"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA054518: AB_2682514, HPA057819: "	"unprognostic (4.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.87e-2)"		"unprognostic (2.32e-1)"	"unprognostic (1.28e-5)"	"unprognostic (3.91e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.00e-1)"	0.3	1.1	1.3	0.2	2.2	0.1	1.2	1.5	3.7	2.6	0.3	0.0	0.0	0.1	1.3	2.5	0.4	0.1	0.7	10.0	3.0	3.6	0.3	0.1	0.1	0.2	2.2	1.4	0.1	0.1	0.1	0.9	0.1	17.7	0.3	0.2	1.0	0.8	0.5	2.1	0.1	0.4	0.2	0.2	0.1	0.2	0.8	0.1	2.5	0.2	1.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.2	0.0	3.5	0.0	0.0	0.0	10.1	7.3	0.0	0.0	0.5	4.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.7	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.2	1.5	2.6	3.0	3.6	2.2	1.4	17.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ST8SIA4	"PST, PST1, SIAT8D"	ENSG00000113532	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4"	Q92187	5	100806935-100903266	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.1;lymphoid tissue: 34.7"	"Cell type enhanced"	"Detected in many"	11	"Kupffer cells: 79.2;Macrophages: 44.4;monocytes: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.1"	"Cell line enhanced"	"Detected in many"		"AF22: 19.1;HDLM-2: 30.8;Karpas-707: 26.5;NB-4: 12.4;RPMI-8226: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051126, HPA053995"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		580000	"Golgi apparatus"		"HPA051126: AB_2681352, HPA053995: AB_2682336"	"unprognostic (2.25e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.80e-7)"	"unprognostic (6.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	11.7	2.7	4.3	16.7	4.3	8.2	6.5	1.3	4.2	3.4	5.3	2.6	0.3	4.0	2.3	4.2	4.3	3.5	6.5	4.7	4.0	8.0	2.6	3.3	17.5	27.9	5.1	1.7	2.5	2.1	1.5	2.4	13.7	11.6	3.4	5.6	2.7	4.0	1.3	2.0	2.1	7.7	3.6	8.0	31.6	3.7	1.6	4.3	34.7	4.9	0.8	13.8	7.4	3.5	4.7	4.9	37.1	8.9	4.0	6.9	4.4	0.0	2.8	19.1	0.0	1.2	1.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	30.8	0.0	1.1	0.2	0.0	0.0	5.7	2.3	1.5	0.0	0.0	0.0	2.5	3.5	4.6	0.0	26.5	1.1	0.2	8.1	12.4	0.1	0.0	0.1	4.6	0.3	19.7	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	5.2	1.2	0.2	0.1	0.0	0.3	8.7	8.8	1.7	0.4	7.1	2.3	18.8	7.5	8.9	5.7	8.8	4.3	4.7	3.8	4.7	4.9	3.6	2.4	4.5	37.1	4.0	8.9	1.5	6.9	4.4	4.3	4.3	1.3	4.2	4.0	8.0	5.1	1.7	11.6	4.3	6.0	13.1	25.4	0.2	7.3	0.4	2.0	0.0	26.8	15.9	0.0	0.0	7.7	1.7	0.0	0.2	16.4	0.0	0.0	0.0	31.1	6.1	0.1	23.1	0.0	20.9	0.0	0.0	7.4	79.2	0.0	0.0	44.4	13.5	119.0	0.0	3.9	0.0	0.0	0.4	0.3	0.6	12.9	5.7	0.4	0.7	4.8	16.0	28.0	0.0	0.4
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.8;brain: 36.4"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 6.9;Collecting duct cells: 1.8;Early spermatids: 2.7;Late spermatids: 5.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Region enhanced"	"Detected in many"		"cerebellum: 36.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"WM-115: 52.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"		NA	NA			"Plasma membrane, Midbody"		"HPA043813: AB_2678683, HPA046771: AB_2679798"	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.6	12.8	3.6	0.6	7.8	0.9	0.5	36.4	16.1	0.5	0.5	1.0	0.0	0.7	0.5	0.9	0.4	0.7	0.6	7.2	4.0	1.8	1.5	0.4	0.5	0.5	2.0	6.9	0.7	0.4	4.9	0.7	0.4	4.1	0.6	0.5	0.0	0.4	0.5	8.2	0.7	0.5	0.5	2.5	0.5	0.7	0.9	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.8	0.4	1.5	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.1	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	52.9	1.0	0.4	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.0	0.8	0.3	0.3	1.5	0.5	0.2	0.4	0.1	0.0	3.6	7.8	36.4	16.1	4.0	1.8	2.0	6.9	4.1	0.7	0.0	0.0	0.0	0.0	0.0	1.0	6.9	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17318383-17454330	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.5"	"Group enriched"	"Detected in some"	7	"Endothelial cells: 8.7;granulocytes: 10.3;Ito cells: 15.4;Melanocytes: 8.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 108.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA011635: AB_2194921, HPA072708: "	"unprognostic (4.86e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-3)"	1.8	0.9	3.1	1.0	5.0	4.0	14.4	2.5	3.4	1.1	1.7	3.3	0.4	1.0	1.6	10.4	2.4	1.3	1.9	9.1	3.7	4.4	2.5	2.4	17.5	0.8	8.8	1.7	1.1	0.5	0.3	1.3	3.5	5.5	4.3	1.8	13.7	1.9	0.6	2.0	2.8	1.3	1.3	4.3	1.5	1.0	1.2	2.5	0.0	1.8	0.5	2.0	1.1	3.9	0.9	0.7	3.8	1.4	2.1	5.6	0.9	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	13.3	0.0	0.1	0.0	0.0	108.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.1	0.9	1.3	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.4	1.3	2.5	0.4	0.5	0.3	1.2	1.4	0.7	0.9	1.0	1.7	2.9	2.1	0.7	0.6	5.6	0.9	3.1	5.0	2.5	3.4	3.7	4.4	8.8	1.7	5.5	2.5	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.7	0.0	0.0	0.0	0.0	0.2	1.6	10.3	0.0	0.1	0.0	0.0	15.4	0.8	0.4	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.0	0.0	0.0
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 90.8"	"Cell type enriched"	"Detected in many"	5	"Ito cells: 1114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	68	"classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8"	"Group enriched"	"Detected in many"	69	"dendritic cells: 2.8;monocytes: 10.8"	"Group enriched"	"Detected in some"	47	"HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		60000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	39.5	37.6	8.0	26.7	12.8	6.5	41.3	3.2	6.8	13.1	23.4	6.9	4.2	16.1	13.6	26.4	9.7	15.5	16.8	19.7	5.4	4.2	19.2	35.8	21.7	80.7	9.1	2.7	9.9	7.1	4.9	11.9	32.1	10.2	13.5	18.0	23.7	10.4	9.7	8.0	5.1	18.7	18.3	7.2	90.8	11.6	9.7	8.7	2.6	11.9	11.4	11.1	15.9	15.4	0.0	2.8	0.0	10.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	33.9	0.0	0.1	0.0	0.0	0.0	0.0	46.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	6.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	8.0	12.8	3.2	6.8	5.4	4.2	9.1	2.7	10.2	8.7	0.0	6.7	12.3	0.5	5.4	1.0	2.0	12.7	0.0	0.0	3.5	0.0	1.3	0.0	0.0	0.4	14.5	0.0	46.7	0.0	1.5	3.8	0.0	17.4	8.3	103.3	0.0	1.2	1114.7	238.9	1.9	4.0	46.3	11.8	0.0	0.0	0.5	0.0	0.0	19.1	0.3	0.0	19.4	1.5	0.7	1.1	4.3	1.8	4.3	0.0	0.2
STAC2	24b2	ENSG00000141750	"SH3 and cysteine rich domain 2"	Q6ZMT1	17	39210536-39225872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 94.0;seminal vesicle: 101.5"	"Cell type enriched"	"Detected in many"	11	"Muller glia cells: 446.6"	"Group enriched"	"Detected in many"	7	"breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.3;HeLa: 25.8;hTEC/SVTERT24-B: 3.8;U-87 MG: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076925			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA076925: "	"unprognostic (1.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (4.05e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.12e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.17e-1)"	2.4	0.9	4.2	1.0	7.4	0.7	29.7	9.5	21.9	4.0	0.9	0.0	94.0	0.9	2.5	13.9	0.8	1.4	0.8	1.0	6.8	3.2	4.8	0.7	0.9	0.8	3.5	6.6	1.2	1.1	0.7	0.5	1.0	13.1	1.8	0.9	8.2	7.8	101.5	0.8	20.1	0.8	1.7	1.4	0.8	0.8	0.9	0.2	0.0	0.7	0.0	0.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	8.3	0.0	3.3	0.0	0.0	0.0	0.4	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.2	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	7.4	9.5	21.7	6.8	3.2	3.5	6.6	13.1	0.2	3.0	8.0	0.0	1.2	0.3	4.8	2.9	0.0	2.7	4.5	3.5	9.8	0.1	5.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.1	17.5	0.0	0.0	0.0	0.0	2.6	0.0	40.5	0.0	0.0	446.6	0.0	0.0	0.0	0.0	11.1	0.0	3.4	0.2	0.9	1.5	0.2	0.0	0.0	0.1
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 85.4"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 79.6;Spermatocytes: 87.4;Spermatogonia: 38.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"memory B-cell: 4.8;naive B-cell: 7.6"	"Lineage enriched"	"Detected in single"	10	"B-cells: 7.6"	"Group enriched"	"Detected in some"	6	"BEWO: 27.0;HMC-1: 34.2;U-698: 9.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA049106, HPA058330"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"	0.4	0.7	0.4	0.9	1.0	0.3	0.2	0.6	3.8	0.3	0.3	1.1	0.5	0.1	0.5	0.4	0.3	7.8	0.4	0.5	0.6	0.2	0.2	3.9	0.3	1.2	0.5	0.6	0.4	1.4	0.0	0.2	0.4	0.5	0.3	0.2	0.5	0.2	0.5	4.1	0.5	2.2	0.4	0.7	5.1	0.1	85.4	0.8	0.7	0.3	0.2	1.6	0.3	0.2	7.6	0.5	0.2	0.7	0.2	0.5	0.3	0.0	2.0	0.8	0.1	0.1	0.0	27.0	1.4	0.0	0.1	0.1	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.0	0.1	0.0	3.8	0.4	0.0	0.0	0.6	0.0	0.0	34.2	0.0	0.0	0.6	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.5	1.6	0.1	0.8	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.5	1.5	0.6	0.4	0.0	0.4	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	9.8	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.1	4.8	0.2	0.5	0.5	7.6	0.4	0.3	0.2	0.2	0.3	0.1	0.0	0.3	0.4	1.0	0.6	0.7	0.6	0.2	0.5	0.6	0.5	0.8	0.0	2.4	79.6	8.0	6.1	7.0	1.8	2.5	14.7	1.2	7.0	2.0	1.7	11.6	0.1	19.3	2.9	1.1	0.0	0.2	2.7	3.3	7.0	1.1	22.9	2.1	19.1	1.2	3.7	2.1	18.4	4.4	4.8	5.0	4.6	4.1	3.2	0.2	0.0	1.8	3.4	7.3	0.0	7.5	87.4	38.7	7.4	2.4	10.4	1.6	9.6
STAM2	Hbp	ENSG00000115145	"Signal transducing adaptor molecule 2"	O75886	2	152116801-152175992	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 107.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035528, HPA035529"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA035528: AB_10601606, HPA035529: AB_10672868"	"unprognostic (1.53e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	17.8	19.1	17.2	12.4	19.9	4.9	21.3	16.1	19.5	19.6	16.7	17.6	17.2	15.1	18.5	16.0	17.8	21.6	15.6	16.1	15.3	15.4	24.6	17.8	17.6	13.0	19.9	14.4	20.6	20.5	23.1	34.0	16.7	20.4	22.1	18.4	14.5	19.5	19.3	14.3	17.6	19.6	19.8	20.0	14.0	18.8	24.3	21.2	16.0	23.8	13.2	14.7	19.5	16.6	2.3	3.3	14.0	6.5	2.5	2.2	1.7	5.4	5.3	5.0	6.0	13.1	15.7	5.3	11.4	13.2	7.4	9.5	5.2	5.2	7.2	9.2	16.2	6.5	5.6	5.5	10.5	12.0	8.8	4.4	5.1	3.7	7.9	15.0	7.5	10.1	11.9	10.2	13.8	18.7	10.8	7.9	4.9	3.3	5.1	15.1	5.4	4.0	5.9	3.1	4.1	7.7	3.2	6.1	3.9	11.6	9.5	2.6	4.1	6.3	5.7	9.4	5.8	7.6	7.0	10.4	16.6	5.3	13.0	6.9	4.3	4.3	4.6	12.5	6.1	9.0	14.0	3.5	4.4	1.9	4.7	1.8	1.7	2.0	2.0	2.7	2.3	1.7	2.1	8.8	2.5	6.5	3.3	2.2	1.7	17.2	19.9	16.1	19.5	15.3	15.4	19.9	14.4	20.4	21.2	23.8	24.4	5.2	9.3	12.2	10.1	27.1	7.6	68.3	35.2	15.7	15.7	6.6	19.9	12.8	107.8	9.8	14.8	0.0	12.2	11.8	13.1	14.9	25.5	13.5	14.5	1.6	7.9	20.3	24.5	38.6	14.7	14.8	13.5	17.2	16.2	13.6	17.2	17.3	14.5	11.4	12.0	25.8	11.3	26.5	19.2	11.5	16.9	6.9	11.9	13.1
STAMBPL1	"ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373"	ENSG00000138134	"STAM binding protein like 1"	Q96FJ0	10	88879734-88975153	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 18.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 37.8;Spermatocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040202	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA040202: AB_10805708"	"unprognostic (2.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (4.41e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.40e-3)"	3.9	15.9	3.7	6.8	5.1	2.8	2.1	12.4	8.9	2.0	5.8	3.4	1.5	4.5	2.7	1.5	2.7	1.2	2.9	4.8	3.3	3.4	1.5	1.7	2.9	11.3	2.6	14.8	8.5	1.8	2.2	6.6	1.5	4.1	1.9	8.0	1.5	1.5	1.5	1.5	3.4	6.1	1.8	3.1	6.0	3.1	18.6	3.2	1.5	1.5	1.5	9.5	3.9	2.7	10.5	15.2	4.3	0.6	13.1	14.7	4.5	6.8	8.1	0.5	0.3	8.1	15.6	0.0	14.4	14.2	9.3	8.3	0.3	13.1	8.4	1.0	7.8	6.2	3.4	2.0	2.9	9.4	7.4	5.1	2.1	5.8	0.4	5.5	9.2	3.0	5.5	0.7	15.5	4.9	10.6	0.2	10.1	0.0	3.8	24.9	1.4	15.3	10.9	3.0	6.5	6.3	1.5	6.1	1.8	3.5	2.6	4.7	5.6	1.8	0.6	16.4	2.0	1.0	1.9	2.1	8.3	6.0	9.9	9.0	8.9	8.4	7.8	9.1	9.4	7.8	4.3	0.6	4.2	6.3	0.6	8.2	10.5	9.2	7.9	0.9	7.0	9.9	5.9	0.9	13.1	0.3	15.2	14.7	4.5	3.7	5.1	12.4	8.9	3.3	3.4	2.6	14.8	4.1	3.2	0.0	5.0	9.3	4.1	8.5	3.7	5.0	0.0	8.1	0.0	5.2	0.0	0.1	0.0	0.8	37.8	2.2	7.4	0.0	1.6	0.1	5.1	1.5	4.7	1.9	3.0	6.4	8.7	1.8	1.0	13.9	6.6	3.5	0.0	1.0	8.1	10.6	1.2	0.0	1.4	0.5	0.2	0.0	6.7	27.6	2.4	9.9	0.1	14.9	13.3	1.6
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637065-39663484	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"SK-BR-3: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	22.2	34.8	23.3	27.5	28.0	33.5	22.8	27.7	30.1	17.1	23.7	38.1	21.7	26.6	20.6	20.7	22.4	25.6	27.7	17.8	21.0	16.8	18.2	24.0	27.0	31.5	28.5	25.7	21.5	32.7	21.9	23.7	26.9	25.7	19.0	9.7	17.9	21.4	26.7	20.8	24.5	34.2	15.8	27.8	32.3	25.3	26.7	26.1	33.0	21.1	15.1	24.8	28.8	18.7	15.3	23.2	35.3	21.2	21.4	25.3	17.4	7.9	12.6	5.7	10.1	6.9	8.4	8.5	6.5	8.5	8.5	7.8	7.4	13.1	7.1	14.2	5.9	10.5	15.2	3.4	7.7	1.9	9.6	12.9	4.8	5.5	8.6	9.7	9.7	10.8	9.1	6.3	9.6	4.6	6.5	8.2	9.9	11.1	9.2	7.8	7.0	9.1	9.2	6.3	5.4	6.9	7.2	9.8	10.5	5.8	9.0	7.2	7.7	4.9	89.9	16.1	4.0	10.6	11.6	7.7	12.0	8.3	13.1	12.2	8.8	10.8	5.7	10.7	10.5	12.3	12.5	21.2	29.3	25.3	19.6	18.5	11.9	18.3	19.0	23.2	15.3	18.4	16.9	35.3	21.4	15.6	10.8	20.4	17.4	23.3	28.0	27.7	30.1	21.0	16.8	28.5	25.7	25.7	26.1	3.0	9.8	21.7	11.2	14.7	13.5	3.0	20.4	5.3	3.4	10.4	35.3	24.1	8.3	20.7	2.3	23.3	21.4	0.0	30.9	31.1	16.0	17.5	18.5	10.6	45.2	17.5	26.4	42.4	36.6	4.1	15.8	20.8	5.0	17.2	11.7	17.0	30.5	15.8	12.4	8.7	13.2	12.9	9.5	8.4	13.9	14.8	33.4	34.8	12.4	16.9
STARD4		ENSG00000164211	"StAR related lipid transfer domain containing 4"	Q96DR4	5	111496033-111512590	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046177, HPA048081"	Approved		Approved	"Plasma membrane"		NA	Yes			"Plasma membrane"		"HPA046177: AB_2679570, HPA048081: AB_2680253"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (2.84e-4)"	5.2	12.4	9.7	11.2	27.3	12.6	3.2	20.7	17.5	8.5	11.0	6.8	5.5	30.0	6.4	12.9	8.4	4.6	7.6	11.0	12.5	12.5	8.2	25.3	22.0	8.8	10.5	7.3	6.6	4.7	17.2	10.8	27.8	25.5	16.5	13.1	7.1	5.9	8.0	1.6	2.6	29.9	5.4	17.0	8.8	13.2	5.1	16.3	5.1	7.7	5.7	7.4	5.2	8.8	2.8	2.8	11.0	3.1	2.9	4.2	2.1	6.8	3.4	16.7	10.0	15.0	30.1	5.7	7.0	16.0	10.6	31.6	12.6	20.5	8.2	2.9	4.5	31.0	3.0	8.4	24.4	10.1	7.8	3.6	6.3	10.9	7.6	16.7	3.1	4.0	16.0	16.8	22.4	16.7	12.4	19.4	8.0	3.5	15.9	7.1	1.3	7.7	5.7	5.7	0.2	1.8	1.8	18.6	7.5	15.4	2.2	9.5	37.1	0.0	4.2	6.3	11.6	5.5	10.1	28.7	8.9	8.1	5.9	2.9	5.5	5.0	7.3	8.5	11.8	4.5	11.0	2.1	1.5	4.2	3.1	2.2	2.8	2.0	3.0	2.8	2.7	2.1	3.1	0.0	2.9	2.2	1.9	1.2	2.1	9.7	27.3	20.7	17.5	12.5	12.5	10.5	7.3	25.5	16.3	23.8	33.3	11.0	1.2	0.9	9.5	17.7	12.7	1.4	4.5	8.7	7.9	13.3	1.7	6.8	6.1	14.6	33.7	0.0	8.1	5.1	5.1	3.1	31.2	16.4	16.3	6.4	20.5	4.9	18.3	7.0	6.6	18.3	3.3	6.4	21.7	6.0	7.4	17.5	7.4	5.3	7.3	19.4	8.7	7.7	9.7	2.3	11.8	8.6	15.5	2.8
STARD5	MGC10327	ENSG00000172345	"StAR related lipid transfer domain containing 5"	Q9NSY2	15	81309053-81324183	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.6"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 22.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 20.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 7.8;RPMI-8226: 7.8;U-266/70: 9.5;U-937: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040662	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA040662: AB_10959593"	"unprognostic (5.35e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.84e-3)"	"unprognostic (7.55e-3)"	2.8	1.0	1.2	8.6	1.5	5.9	2.7	20.8	3.4	14.3	7.7	1.5	6.6	3.5	7.3	22.3	9.2	4.3	4.4	1.9	1.0	1.1	1.4	59.6	4.3	11.1	1.1	1.0	3.2	1.1	0.6	1.0	9.3	1.2	6.1	5.9	1.5	3.2	6.6	0.9	12.4	7.7	3.6	1.9	10.8	3.3	4.4	1.4	1.7	2.5	10.6	9.8	6.1	7.9	2.1	4.8	6.9	4.6	4.8	7.6	5.6	0.4	0.1	0.1	1.2	3.0	3.1	0.2	0.4	0.4	1.0	1.6	0.1	0.1	6.2	0.0	1.8	0.3	5.2	1.5	1.2	0.8	0.1	0.5	2.3	0.3	0.5	0.6	3.5	7.8	2.5	2.6	0.4	0.8	2.0	0.1	2.5	0.7	1.7	0.7	0.2	0.6	5.0	0.4	0.3	0.0	0.1	0.9	7.8	0.4	1.8	0.4	0.1	0.2	0.7	0.7	0.5	0.8	0.8	0.2	1.7	0.9	1.7	0.1	9.5	1.9	2.4	1.2	8.8	0.5	6.9	3.0	4.2	5.8	4.6	5.0	2.1	5.4	6.1	4.8	1.6	7.6	7.5	2.4	4.8	4.0	2.5	6.3	5.6	1.2	1.5	20.8	3.4	1.0	1.1	1.1	1.0	1.2	1.4	0.0	0.6	6.7	12.4	11.7	1.8	0.2	0.0	4.0	2.3	0.0	5.9	2.0	3.3	1.2	11.0	1.0	19.1	0.0	1.2	3.1	7.5	2.2	10.3	22.1	4.8	1.6	10.9	3.7	5.3	0.5	4.6	6.1	1.7	0.0	18.1	1.7	1.6	11.4	9.2	0.5	0.7	0.0	2.1	0.5	0.4	14.3	4.1	4.5	14.0	6.8
STARD7	GTT1	ENSG00000084090	"StAR related lipid transfer domain containing 7"	Q9NQZ5	2	96184859-96208825	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033965, HPA064958, HPA064978"	Supported		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.56e-5)"	"prognostic favorable (3.89e-6)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.72e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.38e-6)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.42e-2)"	17.3	26.6	30.3	20.6	27.1	11.5	32.1	26.5	28.7	14.4	22.6	24.4	15.2	21.6	13.9	12.8	17.0	18.0	13.5	66.7	26.1	24.5	32.5	29.1	24.0	30.1	34.1	17.1	12.4	24.6	28.2	11.7	11.4	23.6	16.1	22.8	17.3	24.2	19.7	74.4	14.4	22.2	15.0	24.1	21.7	17.4	8.1	29.9	26.3	22.7	24.1	32.9	16.4	15.2	26.4	25.0	14.5	18.6	18.1	24.1	13.7	32.3	20.1	26.3	27.2	35.5	17.8	39.8	31.9	27.3	31.4	33.9	47.2	29.9	57.7	35.3	24.7	24.9	26.3	46.6	26.9	41.1	39.1	35.8	50.9	19.8	54.4	16.3	39.0	28.6	17.2	19.9	26.0	25.8	20.0	31.3	23.9	52.6	22.9	27.8	28.1	44.1	39.6	44.8	27.4	30.1	43.7	40.5	57.3	18.9	41.0	50.7	24.2	16.1	51.8	28.5	34.2	15.4	42.9	26.1	26.1	27.1	29.1	31.8	30.6	28.4	51.8	24.1	44.0	28.8	14.5	14.9	13.9	16.4	18.6	16.9	26.4	14.1	17.1	22.7	21.5	16.2	15.0	1.7	18.1	11.8	25.0	24.1	13.7	30.3	27.1	26.5	28.7	26.1	24.5	34.1	17.1	23.6	29.9	125.0	43.6	35.0	37.3	56.6	26.0	163.8	63.7	30.8	52.4	43.6	102.1	30.8	63.0	27.4	2.1	47.5	46.7	0.0	32.7	31.1	29.1	59.0	15.1	103.7	60.0	38.1	42.7	37.4	105.5	5.2	21.6	53.5	40.5	98.2	56.1	31.6	31.3	10.5	23.7	53.6	55.8	25.8	48.4	12.4	39.7	50.2	29.6	41.5	67.9	31.4
STAT5B		ENSG00000173757	"Signal transducer and activator of transcription 5B"	P51692	17	42199168-42276707	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 85.5;Late spermatids: 113.5;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004298, CAB005418, HPA042128, HPA049883, HPA051156"	Approved		Approved	Cytosol		NA	NA		170000	Cytosol		"CAB004298: AB_2197067, CAB005418: AB_632445, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (4.06e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.68e-1)"	"unprognostic (4.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.98e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (9.19e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.13e-1)"	25.7	24.0	13.5	19.5	16.3	21.8	26.2	32.1	15.9	21.6	21.0	13.7	16.3	8.6	31.9	12.0	11.6	24.5	18.1	12.8	11.9	20.1	12.4	13.5	15.8	24.6	16.0	13.9	34.4	12.1	12.0	22.6	55.4	17.2	20.8	10.3	16.4	12.9	21.7	38.3	12.2	14.8	33.1	10.6	22.1	14.4	13.2	15.7	21.7	15.4	9.6	19.8	21.5	33.1	2.5	2.4	18.8	2.8	3.5	8.3	3.8	5.3	8.4	12.5	3.3	15.6	7.9	6.0	5.5	9.8	7.9	6.9	3.6	4.5	17.4	8.3	6.3	15.7	6.9	7.4	4.8	6.3	43.9	8.6	17.0	15.8	5.6	8.6	7.5	27.5	9.7	7.4	5.9	7.6	6.8	12.5	11.8	30.6	3.8	3.2	5.2	35.1	19.7	3.1	12.4	0.0	15.1	7.8	6.0	5.0	8.6	9.2	5.4	10.1	12.9	7.7	2.9	9.1	8.8	9.5	11.1	3.9	5.7	7.6	7.5	3.4	8.7	4.4	7.9	5.7	8.8	2.8	4.6	5.9	2.5	6.4	2.5	8.3	6.7	2.4	2.5	5.9	5.0	18.8	3.5	2.8	1.8	6.9	3.8	13.5	16.3	32.1	15.9	11.9	20.1	16.0	13.9	17.2	15.7	6.0	17.9	3.7	4.7	7.9	18.0	17.3	10.2	5.3	9.1	3.5	19.6	5.9	5.0	7.2	85.5	23.3	6.2	23.3	10.1	5.7	10.8	8.0	15.1	10.2	8.1	9.5	9.8	16.0	14.2	113.5	43.7	11.1	10.1	10.0	7.2	8.4	10.7	7.8	70.0	8.1	13.8	38.8	22.8	4.2	4.1	8.5	10.6	24.5	7.5	5.4
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 12.0;Ductal cells: 5.3;Enterocytes: 4.9;Exocrine glandular cells: 3.5;Pancreatic endocrine cells: 3.5;Paneth cells: 3.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.0;Karpas-707: 31.5;U-266/70: 20.4"	"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.8	1.8	0.2	2.4	5.3	1.4	3.3	4.2	2.5	1.6	1.9	1.8	4.5	0.0	3.4	2.7	3.7	2.4	0.7	0.9	0.6	15.0	1.0	0.2	2.3	2.2	0.7	2.1	2.8	0.8	2.7	1.3	0.7	4.1	0.0	0.0	0.1	31.5	2.8	2.5	0.2	1.8	0.4	2.7	2.0	0.0	0.9	2.6	0.9	1.9	0.8	4.4	3.3	4.2	0.0	0.4	1.1	0.7	0.7	3.2	2.0	7.5	2.3	20.4	3.7	0.0	4.4	1.4	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4											0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	4.9	0.0	3.5	1.1	0.3	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.0	3.5	3.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.5	0.6
STC2	STC-2	ENSG00000113739	"Stanniocalcin 2"	O76061	5	173314713-173329503	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.5;pancreas: 51.8"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 33.9;Ductal cells: 28.6;Extravillous trophoblasts: 43.0;Leydig cells: 21.3"	"Cancer enriched"	"Detected in all"	6	"breast cancer: 91.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 115.7;T-47d: 109.8;U-138 MG: 45.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA045372	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		15000000	"Endoplasmic reticulum"		"HPA045372: AB_10961040"	"prognostic favorable (7.40e-5)"	"unprognostic (2.40e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (5.28e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.17e-8)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.56e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.93e-3)"	3.6	0.7	0.3	1.4	0.8	0.2	68.5	0.4	2.4	6.5	2.4	0.1	1.4	0.5	1.6	2.4	3.1	1.3	5.8	17.4	0.9	0.4	1.7	0.6	17.3	0.7	2.4	0.0	2.0	51.8	1.5	1.2	12.1	2.8	3.0	0.6	0.1	0.6	5.7	10.8	7.4	1.7	8.8	7.1	14.8	2.2	0.8	1.0	0.0	4.5	0.7	0.4	9.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.8	0.3	1.5	5.6	2.4	15.4	26.4	26.3	6.7	13.0	8.4	4.3	0.0	4.0	15.6	34.7	2.4	3.9	8.2	11.8	0.0	2.2	0.0	2.8	5.6	35.2	1.8	0.5	5.1	13.2	15.6	1.1	31.3	1.8	5.5	0.2	0.0	115.7	4.7	0.0	0.0	0.9	2.5	8.9	0.0	3.9	3.0	0.0	0.4	4.2	1.1	1.1	0.1	4.6	1.2	109.8	1.8	16.8	45.4	0.1	26.4	5.5	5.1	2.7	1.2	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.4	2.4	0.9	0.4	2.4	0.0	2.8	1.0	0.0	0.0	0.0	0.2	4.4	10.0	12.1	0.0	0.0	0.0	0.0	0.0	33.9	0.0	28.6	0.5	10.5	0.0	0.0	11.2	43.0	20.0	0.3	0.0	0.0	4.5	0.0	6.9	3.1	0.0	1.1	21.3	0.2	10.1	0.0	0.0	1.1	12.1	0.0	0.4	4.1	2.2	0.0	2.7	0.9	1.0	5.5	18.3	0.0	0.0	0.0
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Predicted membrane proteins"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 82.3;parathyroid gland: 47.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 30.8;Exocrine glandular cells: 31.3;Hepatocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.1;U-87 MG: 46.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		NA	NA		28000	Cytosol	Nucleoli	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	8.1	2.8	2.5	1.2	4.2	5.1	9.2	3.0	2.2	6.4	6.1	3.0	3.7	7.9	1.3	3.1	5.1	4.0	2.8	6.6	2.9	1.4	3.4	82.3	3.9	4.9	3.9	0.4	5.2	9.0	47.4	5.1	4.3	6.1	4.8	2.4	2.1	12.6	9.1	10.9	3.0	9.8	0.9	6.4	1.0	6.7	1.5	3.2	0.2	3.3	6.9	4.0	4.2	3.7	0.8	7.0	0.7	4.3	2.1	0.2	1.5	6.4	7.7	0.0	2.6	3.8	36.1	6.8	2.0	2.2	4.1	3.7	5.8	8.8	0.0	15.6	11.6	29.3	10.9	3.4	6.8	4.6	0.0	11.0	12.5	7.0	11.5	9.5	3.1	2.4	21.4	12.0	24.2	8.7	28.1	3.5	0.0	6.1	1.3	11.5	6.1	0.0	1.8	10.6	9.9	16.1	0.0	4.5	5.5	5.0	16.3	13.0	2.4	5.7	19.8	1.5	1.6	3.9	4.1	15.0	25.5	14.9	5.4	11.1	0.0	0.0	0.0	46.7	7.9	5.2	0.0	4.0	0.7	0.2	4.3	0.0	0.8	0.0	0.0	7.0	0.2	0.0	0.0	0.1	2.1	0.6	0.3	0.0	1.5	2.5	4.2	3.0	2.2	2.9	1.4	3.9	0.4	6.1	3.2	0.0	6.4	0.5	6.8	1.8	0.1	5.5	5.1	30.8	10.3	0.0	0.0	25.8	0.0	7.9	0.2	2.9	10.9	0.0	31.3	3.0	4.3	4.8	3.5	86.3	11.1	0.0	1.7	0.6	3.8	0.0	1.7	6.4	0.0	0.0	4.6	0.0	17.9	7.8	7.1	0.5	0.0	6.5	2.1	0.2	0.0	1.3	19.8	0.0	9.1	8.1
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL, centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.0;testis: 23.8"	"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 18.6;Spermatogonia: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046543			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA046543: AB_2679692"	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.2	1.4	1.3	10.8	2.4	11.0	2.9	1.4	2.2	1.2	4.1	0.9	2.5	3.6	1.5	2.2	5.8	0.9	1.7	2.0	1.4	1.2	1.5	1.6	1.7	5.0	1.3	1.5	1.2	1.5	0.9	0.9	5.5	1.1	1.7	6.4	0.8	3.6	0.5	0.8	4.2	4.0	1.3	1.2	3.4	2.2	23.8	1.0	36.0	1.1	3.5	7.1	1.3	2.1	1.9	1.6	5.4	0.7	3.3	1.2	0.5	16.9	9.1	13.1	11.7	0.9	2.3	8.4	15.0	7.2	16.8	17.7	9.8	8.4	20.0	7.1	7.5	17.3	11.3	15.3	7.9	18.1	14.9	6.9	22.5	11.3	8.6	0.5	18.2	11.5	0.8	1.3	14.4	9.4	2.1	11.1	15.3	15.9	19.1	12.6	7.7	17.6	5.7	15.9	9.4	7.5	11.5	21.4	9.6	4.7	10.2	11.7	7.0	16.1	11.9	7.8	16.3	7.7	10.4	6.5	15.9	16.1	11.4	20.3	6.3	13.1	19.7	7.4	13.9	14.7	4.3	0.7	1.1	1.1	0.4	0.5	1.7	1.2	1.0	0.5	1.9	0.8	0.8	5.4	3.3	0.3	1.6	1.1	0.5	1.3	2.4	1.4	2.2	1.4	1.2	1.3	1.5	1.1	1.0	3.0	0.3	2.2	0.5	0.8	1.2	0.5	0.0	6.7	2.3	0.0	3.9	1.2	0.0	1.2	0.7	0.9	1.8	0.0	0.4	3.8	0.8	1.2	2.3	0.5	2.3	0.0	1.7	1.8	1.9	1.3	0.3	1.2	0.0	4.6	4.3	0.8	1.8	1.5	0.7	0.3	0.7	0.0	0.0	18.6	17.8	2.0	0.7	0.8	3.4	1.4
STIMATE	"MGC52022, TMEM110"	ENSG00000213533	"STIM activating enhancer"	Q86TL2	3	52836219-52897596	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 17.4;Collecting duct cells: 7.0;Hofbauer cells: 8.1;Proximal tubular cells: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA051855	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051855: AB_2681639"	"unprognostic (1.45e-1)"	"unprognostic (7.93e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.55e-4)"	"unprognostic (3.34e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	12.0	13.0	8.9	12.0	13.9	26.4	12.8	11.6	16.1	12.5	10.7	17.8	8.8	7.8	14.4	7.9	9.2	17.7	9.6	8.3	9.5	6.7	9.9	34.7	15.2	18.1	9.9	8.1	12.2	19.2	7.7	8.9	7.8	13.0	10.2	6.7	13.0	12.8	11.5	17.9	10.5	10.1	16.5	10.2	14.9	11.2	8.4	9.5	18.0	11.8	6.8	13.2	12.5	12.5	1.7	4.0	1.7	5.8	0.7	4.6	1.4	6.8	6.0	9.2	15.9	20.9	13.3	18.5	10.1	11.3	13.7	12.6	7.3	7.2	6.7	2.0	11.5	13.1	6.5	10.8	9.8	9.6	14.9	8.3	10.9	7.6	11.4	14.0	16.4	8.4	10.5	13.6	15.3	6.9	8.6	11.1	10.9	3.8	6.7	11.4	5.6	8.9	9.2	8.3	5.6	12.3	4.9	7.1	4.5	6.4	8.9	2.0	6.8	10.2	7.0	9.5	5.4	5.9	14.3	11.2	10.9	6.4	14.3	12.0	13.1	8.4	6.3	9.5	16.5	8.3	0.0	3.3	1.7	2.2	5.8	1.8	1.7	3.5	2.4	4.0	1.5	1.9	1.4	0.3	0.7	5.5	2.3	4.6	1.4	8.9	13.9	11.6	16.1	9.5	6.7	9.9	8.1	13.0	9.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	17.4	1.2	7.0	0.0	1.5	1.7	2.1	0.0	0.0	0.0	0.0	2.5	5.3	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	2.7	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 168.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3700000	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.23e-4)"	"prognostic unfavorable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	27.3	49.7	32.2	32.0	40.5	25.8	41.5	45.3	41.9	28.3	25.5	29.2	20.6	19.2	30.1	25.2	31.5	36.2	21.6	34.4	32.2	42.8	24.7	27.8	25.4	31.9	47.7	22.5	34.1	24.1	39.1	38.3	37.0	40.7	30.1	28.5	20.3	22.6	29.5	51.9	27.6	20.7	33.2	39.7	26.5	24.4	56.4	49.0	29.8	46.1	23.4	41.2	26.0	168.2	32.2	26.8	20.9	39.6	39.5	35.9	39.5	49.3	77.1	48.7	40.5	27.1	18.1	43.8	44.9	24.2	65.2	38.0	56.4	42.4	59.1	52.9	35.5	77.2	52.5	122.1	44.9	71.8	46.4	49.8	83.2	51.8	51.9	23.6	43.9	52.6	18.4	28.3	54.0	40.7	26.6	45.9	44.1	82.2	34.0	37.4	72.3	66.0	59.9	58.6	47.6	65.2	65.0	46.4	59.8	45.5	43.8	39.7	35.3	51.2	54.2	41.7	53.4	57.6	30.4	41.1	41.5	51.3	54.1	60.4	31.0	66.9	62.4	53.7	44.2	59.6	19.0	25.3	20.9	35.9	36.2	35.7	32.2	27.2	32.0	26.8	26.0	30.5	33.8	7.7	39.5	39.6	22.2	24.0	39.5	32.2	40.5	45.3	41.9	32.2	42.8	47.7	22.5	40.7	49.0	41.7	29.9	44.0	125.4	71.4	35.5	38.9	30.6	104.4	56.9	19.2	39.3	105.5	41.4	70.8	21.1	33.5	27.4	23.3	47.8	125.3	57.5	60.1	78.4	24.1	80.9	60.4	64.5	15.4	15.0	52.9	25.3	54.0	59.1	71.3	20.5	32.1	57.8	21.6	37.4	29.8	29.8	25.8	88.2	82.3	133.5	63.0	176.4	42.1	24.4	89.5
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 78.5;T-cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 27.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		24000	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	15.0	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3.0	3.6	5.0	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11.0	9.0	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4.0	5.6	7.8	2.5	3.1	9.0	12.2	5.7	4.6	33.0	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5.0	10.3	22.3	30.8	7.4	18.0	15.6	7.8	7.3	4.5	6.8	5.3	6.6	11.6	10.2	8.5	7.4	6.9	3.8	10.4	9.5	5.4	12.6	15.7	9.2	2.0	12.5	4.8	12.3	3.4	11.4	3.0	2.1	7.6	11.5	13.5	6.5	2.7	10.1	8.4	2.7	6.4	3.7	1.0	13.3	5.2	12.6	8.2	25.8	1.8	3.9	5.8	13.6	3.6	6.2	3.0	9.9	3.1	3.8	5.9	8.3	28.0	5.9	2.9	24.4	8.9	8.3	4.2	5.8	5.5	11.2	16.5	6.0	10.9	17.7	52.3	7.1	10.8	10.0	18.0	21.4	13.3	5.0	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3.0	2.4	2.5	5.4	1.9	4.5	3.5	3.0	12.8	25.0	7.9	6.0	3.8	3.6	2.5	5.3	5.7	1.8	5.9	2.8	1.7	4.4	1.7	17.8	8.4	0.0	5.3	25.1	7.4	6.7	26.7	2.1	30.8	44.5	11.5	20.3	78.5	2.7	2.6	39.2	8.5	9.0	15.0	3.1	7.9	7.0	1.4	1.5	2.2	12.9	8.2	5.7	6.8	3.6	4.2	70.5	4.7	9.5
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43626786	"Enzymes, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 549.3;Urothelial cells: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	7.1	10.1	6.1	43.3	8.2	20.2	8.4	7.9	7.2	4.8	9.3	3.7	2.0	6.1	5.3	4.2	10.1	4.7	8.6	17.7	5.7	5.6	6.7	8.1	15.2	36.6	6.6	2.6	7.3	14.3	1.5	6.3	37.2	5.7	6.2	5.3	3.6	8.6	3.4	10.7	4.8	12.3	5.8	5.3	27.8	11.0	9.0	2.8	30.1	7.3	6.8	37.7	10.3	8.1	10.8	1.4	11.5	0.9	12.7	11.4	2.9	4.4	5.5	5.0	3.4	6.3	8.3	2.1	15.9	17.3	8.7	8.9	4.8	3.2	7.1	25.1	13.3	17.8	9.1	3.8	21.2	12.2	17.5	4.3	6.3	4.1	5.9	4.7	10.8	4.2	6.8	25.0	11.5	10.6	34.5	16.3	7.7	7.4	24.4	10.0	2.0	17.6	5.0	7.7	2.6	18.1	6.1	3.2	14.0	15.2	3.3	2.7	6.1	7.2	3.3	4.6	10.7	3.8	5.5	16.3	19.0	7.2	11.2	17.8	14.8	7.3	10.2	19.3	9.6	30.2	0.7	0.4	11.5	5.8	0.2	5.8	10.8	6.1	9.7	0.3	10.1	11.4	10.2	6.4	12.7	0.9	1.4	3.2	2.9	6.1	8.2	7.9	5.9	5.7	5.6	6.6	2.6	5.7	2.8	113.2	27.8	121.1	549.3	161.6	3.0	25.4	5.1	52.2	81.9	19.2	9.8	44.4	28.2	110.3	36.3	19.4	29.1	0.0	82.8	19.7	31.9	134.1	39.1	7.7	15.8	0.0	6.9	16.5	16.2	8.8	5.5	19.9	33.7	55.1	27.8	8.1	75.9	56.1	2.5	9.7	25.2	6.5	55.6	45.1	29.6	118.9	55.8	186.8	10.0	279.4
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98401403-98942827	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.3;granulocytes: 9.0;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"A-431: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"		NA	NA			"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	16.5	16.6	6.5	8.1	12.4	2.5	20.5	2.6	10.6	17.2	13.1	10.5	14.2	4.6	22.2	13.1	9.0	16.0	12.6	10.0	7.4	4.1	14.7	12.0	16.2	10.8	12.8	3.6	22.8	10.7	15.1	18.9	53.1	9.9	15.0	6.0	8.2	10.8	16.4	11.6	10.0	10.8	23.5	12.9	8.2	9.5	10.1	11.4	3.4	10.6	7.9	5.9	16.4	24.3	1.9	8.3	9.0	8.7	1.8	1.8	2.9	37.3	7.0	7.5	9.8	24.2	12.1	7.5	13.0	11.7	12.2	10.6	5.2	15.9	0.0	11.4	12.9	6.4	15.1	5.2	11.2	19.7	9.0	6.6	10.0	3.5	3.5	8.3	3.3	8.7	8.0	19.4	6.2	17.0	8.0	5.2	5.9	4.2	5.4	8.8	4.7	8.3	4.0	2.2	25.8	2.7	7.4	6.4	3.2	13.8	4.7	1.9	4.3	8.3	9.6	8.0	10.0	7.9	5.4	3.9	8.2	5.2	12.4	7.2	4.3	6.5	2.7	7.4	4.2	13.0	2.1	8.6	4.5	1.3	8.7	1.4	1.9	0.8	1.8	8.3	1.3	1.1	0.7	9.0	1.8	5.4	3.4	0.1	2.9	6.5	12.4	2.6	10.6	7.4	4.1	12.8	3.6	9.9	11.4	35.7	32.0	4.7	38.6	38.8	6.0	15.1	22.9	33.5	42.1	27.9	13.7	36.5	19.9	17.3	118.9	30.2	17.6	0.0	16.5	49.2	41.3	37.6	16.2	18.4	16.1	9.5	8.7	22.1	14.6	63.7	84.3	20.2	23.6	7.2	7.6	15.1	19.7	9.5	69.6	20.3	14.2	38.8	39.6	17.0	11.9	35.4	54.1	8.2	9.3	31.1
STK32A	"MGC22688, YANK1"	ENSG00000169302	"Serine/threonine kinase 32A"	Q8WU08	5	147234963-147387852	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 19.7;brain: 21.1;retina: 31.9"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 5.0;Melanocytes: 15.1;Muller glia cells: 4.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.2"	"Group enriched"	"Detected in some"	5	"RT4: 9.8;SK-MEL-30: 34.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040236			Approved	Centrosome		NA	NA			Centrosome		"HPA040236: AB_10795416"	"unprognostic (1.90e-1)"	"unprognostic (4.71e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.87e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.50e-3)"	"unprognostic (5.53e-5)"	"unprognostic (2.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.67e-3)"	2.1	19.7	4.8	1.3	7.1	0.4	2.3	21.1	7.7	1.2	1.8	6.2	0.6	1.2	1.6	5.6	1.0	1.3	4.3	1.6	4.9	12.6	6.3	0.6	2.1	0.5	12.1	2.2	5.1	4.2	0.4	8.5	0.7	20.7	2.1	1.1	31.9	1.2	1.8	0.6	2.9	1.1	1.4	12.4	0.8	1.4	2.1	6.9	0.0	15.7	0.5	0.5	4.1	2.1	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	3.8	9.8	0.9	0.4	0.0	0.1	34.7	0.1	0.0	0.0	0.1	0.0	0.6	0.4	0.4	1.1	0.2	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.8	7.1	21.1	2.3	4.9	12.6	12.1	2.2	20.7	6.9	0.0	1.6	0.0	0.2	1.3	1.2	0.4	0.0	0.0	1.2	1.8	0.0	0.0	1.7	1.2	5.0	0.0	0.0	0.0	2.4	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.9	0.0	15.1	0.0	0.0	4.6	4.1	0.0	3.9	3.0	0.9	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.6
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051442-5500998	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.6;lymphoid tissue: 33.6"	"Cell type enhanced"	"Detected in some"	25	"Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.3;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.3;dendritic cells: 3.5"	"Cell line enhanced"	"Detected in some"		"GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	5.2	0.8	6.0	2.1	4.8	2.3	7.3	1.0	5.8	6.0	2.1	5.2	1.6	1.2	5.7	1.6	2.3	2.5	4.7	0.9	4.5	7.6	23.6	0.5	1.3	2.8	5.3	2.2	1.2	4.9	0.8	0.8	5.1	4.2	2.3	2.2	3.0	2.9	1.9	2.1	3.6	1.6	7.0	3.9	0.6	9.5	7.1	2.9	33.6	2.8	2.1	1.9	4.2	6.1	1.3	3.5	0.0	0.5	0.0	0.0	0.0	0.0	5.8	0.3	0.0	0.2	0.4	0.0	4.0	0.5	2.7	0.1	0.0	0.0	0.0	0.9	8.2	11.9	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.1	11.7	0.6	0.0	0.0	1.4	0.0	0.0	0.8	1.7	0.0	0.0	10.3	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	3.5	0.3	0.0	0.0	3.0	0.0	1.2	18.7	0.0	0.4	0.0	0.0	0.0	0.0	47.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.0	4.8	1.0	5.8	4.5	7.6	5.3	2.2	4.2	2.9	0.0	0.6	0.0	0.1	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.8	83.1	1.6	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	31.4	1.4	0.9	5.0	0.0	0.0	0.0	0.3	0.0	1.1	13.3	0.0	0.0	0.3	0.9	3.0	0.9	0.0	0.0	0.0	0.0
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 34.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 7.1;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: AB_2683257"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	0.9	6.1	4.7	1.6	7.5	1.1	0.6	6.1	4.4	5.4	5.3	6.8	7.7	2.6	9.6	15.3	2.3	30.7	4.5	11.4	6.6	6.1	7.7	0.4	5.3	2.3	4.9	2.7	10.3	4.6	20.4	29.9	0.3	17.7	5.3	1.3	14.8	1.6	8.9	2.6	0.3	2.5	7.0	6.7	1.2	4.4	34.4	4.6	4.5	14.6	1.5	1.8	3.7	1.4	7.1	0.7	0.0	0.0	0.2	1.4	0.3	0.0	2.0	9.7	0.0	0.0	0.0	0.0	1.7	1.9	4.2	3.9	1.1	0.0	14.0	7.3	0.3	5.5	0.0	4.3	1.3	3.7	0.0	11.9	0.0	2.6	3.3	1.6	7.8	0.0	0.4	0.0	0.1	0.0	14.2	0.3	6.9	0.0	13.1	0.1	0.0	0.2	0.0	6.9	0.0	0.0	5.2	1.3	8.8	3.8	0.0	14.7	3.9	0.0	0.0	0.1	2.7	0.0	0.8	0.0	0.0	6.6	0.1	14.8	3.1	12.4	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.1	0.0	1.4	0.0	4.4	0.0	1.1	0.0	0.2	0.0	0.7	0.2	0.3	4.7	7.5	6.1	4.4	6.6	6.1	4.9	2.7	17.7	4.6	17.9	12.6	5.4	1.1	0.0	19.2	34.4	10.2	245.0	47.8	19.2	66.8	0.1	3.3	7.5	72.9	1.3	0.0	0.0	4.4	2.7	0.3	0.2	1.1	0.0	0.2	1.6	8.7	0.0	0.0	113.1	4.0	0.4	0.0	0.0	1.3	30.6	4.5	0.0	15.9	11.9	83.4	0.0	0.2	126.9	25.1	0.0	0.0	0.0	2.9	0.0
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	"Serine/threonine kinase 35"	Q8TDR2	20	2101611-2177038	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 27.8;testis: 37.6"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 169.1;Horizontal cells: 278.1;Late spermatids: 665.5;Muller glia cells: 155.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026452, HPA051673"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA026452: AB_2671861, HPA051673: AB_2681569"	"unprognostic (2.25e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.99e-2)"	5.3	6.0	10.3	3.6	14.3	4.3	5.1	6.1	13.7	3.7	4.3	3.1	2.5	4.2	4.5	3.5	8.0	5.1	4.3	5.2	5.9	4.8	4.4	5.7	4.2	3.3	4.4	7.6	3.9	5.9	5.3	6.5	3.5	4.0	3.8	5.2	27.8	6.1	4.0	3.5	6.3	4.6	4.9	4.5	4.1	4.1	37.6	4.4	1.7	5.4	6.1	4.5	4.1	3.7	1.8	2.0	3.2	1.4	0.8	2.7	1.2	15.1	12.9	10.0	17.2	4.6	6.4	12.2	6.2	7.7	8.3	8.6	16.9	11.8	10.4	5.1	7.7	13.0	22.9	11.8	14.3	9.5	4.1	5.6	9.9	4.5	18.3	5.9	8.9	4.6	5.5	12.6	13.3	11.5	7.7	7.9	10.1	9.5	8.6	5.4	6.7	11.1	12.6	18.6	12.1	8.7	9.7	9.0	6.6	7.5	15.2	16.7	8.1	11.1	19.9	9.9	12.2	9.8	8.9	6.6	14.3	9.8	7.1	9.8	7.6	9.8	7.3	7.6	9.7	6.2	0.0	1.2	0.7	1.9	1.0	2.5	1.7	2.7	1.3	2.0	1.8	2.6	2.2	3.2	0.8	1.4	1.7	1.3	1.2	10.3	14.3	6.1	13.7	5.9	4.8	4.4	7.6	4.0	4.4	11.9	9.8	1.9	4.0	10.3	110.1	11.0	0.0	0.0	6.8	3.5	141.4	6.0	1.7	5.5	169.1	7.7	8.1	0.0	5.9	9.9	6.4	5.1	9.2	7.8	5.0	278.1	5.8	4.3	6.0	665.5	6.4	3.9	6.8	1.8	7.6	155.8	8.1	11.5	5.6	3.1	88.5	0.0	4.6	14.9	11.5	10.3	4.8	6.4	9.9	5.1
STK38	NDR	ENSG00000112079	"Serine/threonine kinase 38"	Q15208	6	36493892-36547470	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (3.58e-3)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.13e-3)"	19.1	8.4	12.4	39.8	10.0	19.4	32.8	18.8	12.7	16.0	26.3	7.8	14.9	17.0	18.8	16.4	28.1	14.6	18.3	15.3	12.1	7.0	15.0	17.3	21.7	45.9	11.9	6.4	12.3	9.5	7.8	11.0	15.4	9.0	17.0	27.1	11.3	24.8	18.7	14.9	21.8	29.1	28.1	13.1	25.1	16.4	24.4	11.0	34.3	10.6	13.4	28.5	22.4	19.8	10.6	13.1	33.2	30.5	25.8	27.6	22.4	17.8	13.2	14.0	15.1	28.3	21.6	12.2	20.0	16.2	20.8	21.0	10.1	12.3	24.1	15.5	29.7	17.3	19.2	11.6	8.3	24.6	9.8	9.9	17.2	17.2	9.1	14.0	6.5	9.5	14.2	21.9	16.1	10.4	24.0	13.0	12.3	14.0	14.1	29.6	10.7	10.5	17.0	5.8	21.3	11.8	40.8	17.0	6.4	19.7	22.5	16.4	7.8	24.3	11.2	14.0	16.4	12.0	17.2	12.5	16.9	15.0	13.5	12.9	11.8	21.0	17.0	3.8	25.4	16.3	33.2	19.8	15.0	27.6	22.6	21.5	10.6	22.9	24.1	13.1	8.1	20.5	22.3	27.1	25.8	30.5	6.6	21.4	22.4	12.4	10.0	18.8	12.7	12.1	7.0	11.9	6.4	9.0	11.0	17.9	16.5	10.8	8.5	11.9	2.5	15.1	22.9	37.5	50.0	7.0	0.0	11.8	1.7	16.1	5.8	12.4	32.4	0.0	11.2	15.4	19.9	11.5	12.7	13.6	11.7	4.8	13.8	11.1	28.5	4.1	25.0	31.7	16.9	9.0	22.9	6.1	19.6	25.9	28.3	13.6	8.5	12.9	13.7	23.6	9.6	18.4	12.8	23.6	22.1	22.5
STK38L	"KIAA0965, NDR2"	ENSG00000211455	"Serine/threonine kinase 38 like"	Q9Y2H1	12	27243968-27325959	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 19.3;granulocytes: 32.2;monocytes: 13.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038623, HPA051324"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.05e-2)"	21.2	8.4	11.0	14.6	10.9	10.9	27.2	9.6	14.6	13.0	26.3	5.7	9.7	8.4	23.9	18.2	16.8	14.8	18.2	30.2	10.9	7.8	8.9	8.5	10.8	7.8	11.1	11.8	9.6	8.9	30.2	15.2	10.6	11.9	15.3	15.0	6.8	14.0	10.9	9.1	10.8	14.6	52.3	17.0	7.6	15.6	7.5	10.1	10.0	8.8	10.5	9.8	21.9	22.7	4.5	19.3	32.2	13.0	4.0	4.0	5.3	4.2	5.8	15.1	6.7	6.9	4.7	11.2	2.7	4.0	1.7	2.5	7.3	3.2	9.9	6.5	2.4	5.2	7.9	6.8	4.7	2.7	57.8	5.6	6.1	7.0	3.6	5.8	15.0	7.1	5.7	4.9	6.4	8.2	11.2	13.9	12.8	7.4	7.8	3.5	3.0	9.8	16.3	17.9	11.2	8.8	3.7	17.6	7.6	2.5	8.1	2.4	8.1	12.2	7.5	4.7	15.4	3.7	5.1	5.4	6.0	5.3	8.6	7.4	2.8	2.8	10.4	3.0	7.0	2.4	6.0	13.0	22.9	4.0	11.1	2.8	4.5	3.1	3.9	19.3	3.4	3.8	3.1	32.2	4.0	8.1	8.2	4.0	5.3	11.0	10.9	9.6	14.6	10.9	7.8	11.1	11.8	11.9	10.1	17.9	14.4	9.8	27.4	31.5	11.3	44.5	10.2	9.4	20.5	8.7	2.0	10.0	8.3	41.2	13.6	21.5	19.7	0.0	35.8	7.9	16.0	21.3	16.3	13.0	27.6	9.5	18.5	18.4	33.1	2.3	6.1	48.1	20.3	45.1	27.7	7.5	51.1	31.7	11.3	10.5	6.4	19.4	50.7	6.5	12.1	28.0	23.2	12.5	20.5	39.1
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168248141	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 65.7;Urothelial cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870"	"prognostic favorable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	6.2	2.1	8.4	4.6	11.0	1.3	3.5	9.3	14.1	4.3	9.1	8.3	1.7	10.5	2.3	4.7	14.1	1.9	5.9	7.6	9.8	7.4	2.9	0.8	2.4	7.3	12.3	9.7	3.2	9.9	5.0	8.2	1.2	14.2	9.9	11.7	7.1	22.8	3.8	2.2	3.4	6.1	4.3	19.0	2.5	11.2	35.5	5.5	7.2	2.2	1.8	8.0	5.6	5.3	0.7	1.0	0.0	0.7	1.9	3.4	0.5	6.7	4.1	15.5	4.9	9.5	14.1	1.5	17.0	12.5	11.4	10.6	0.0	22.0	18.7	4.7	11.0	9.9	17.7	9.9	12.4	14.3	5.9	6.1	7.7	4.5	13.8	17.8	10.4	0.8	9.7	17.7	13.5	14.1	13.8	7.7	14.7	0.1	0.0	23.9	3.9	18.1	3.7	10.7	14.0	8.6	25.8	6.1	1.5	8.6	16.8	22.9	9.7	5.9	0.9	6.9	7.7	3.1	7.6	7.3	13.8	4.3	9.7	11.1	0.0	0.0	15.0	10.5	9.3	9.3	0.0	0.7	0.0	2.5	0.4	1.3	0.7	1.9	3.4	1.0	0.7	0.4	2.0	0.0	1.9	0.3	0.3	3.3	0.5	8.4	11.0	9.3	14.1	9.8	7.4	12.3	9.7	14.2	5.5	3.0	12.3	0.8	21.2	3.4	13.8	25.8	22.9	6.7	7.9	5.2	15.7	0.1	18.3	9.7	21.3	3.5	23.2	0.0	19.9	0.0	7.3	65.7	0.0	0.0	3.5	19.1	21.9	3.1	5.1	13.5	9.5	5.2	16.9	1.0	13.9	26.9	26.4	17.3	10.6	3.8	25.3	6.5	7.2	19.9	7.7	3.9	0.2	15.2	20.4	55.5
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 143.4;lymphoid tissue: 117.1"	"Cell type enhanced"	"Detected in all"	9	"Early spermatids: 782.4;Late spermatids: 1640.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 79.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 79.3;T-cells: 26.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010107, HPA068438"	Enhanced		Approved	Cytosol		NA	NA		210000	Cytosol		"CAB010107: AB_628297, HPA068438: "	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	7.3	13.2	91.7	17.5	47.4	40.7	10.9	54.1	124.8	6.2	16.7	47.0	2.5	12.7	24.7	7.8	13.0	7.3	9.4	9.5	67.9	88.4	13.2	6.4	11.0	42.8	86.5	58.0	33.6	3.5	4.6	12.1	21.7	43.4	5.2	20.7	7.7	5.3	6.3	3.8	9.5	15.9	18.8	143.4	10.9	9.7	58.2	27.1	117.1	6.1	7.2	43.1	13.0	8.1	8.6	79.3	4.0	1.5	10.1	26.2	9.3	68.4	15.4	153.8	61.4	9.2	8.9	15.6	53.4	42.4	76.4	73.9	10.6	70.4	84.3	30.0	38.9	29.9	20.9	42.6	30.9	114.9	25.5	21.1	52.2	27.3	36.8	3.7	65.7	37.4	5.4	4.5	30.8	35.1	28.6	57.4	109.3	70.5	84.1	98.9	17.8	216.1	96.6	94.3	41.6	20.7	127.9	119.9	50.0	36.9	6.1	104.3	90.5	48.5	24.3	42.6	51.3	34.9	83.8	27.6	51.3	60.9	44.4	44.5	49.6	78.7	104.6	25.3	128.5	55.2	2.0	0.7	4.0	10.4	1.5	6.3	6.4	9.3	13.1	4.2	8.6	15.3	13.7	0.3	10.1	0.7	79.3	26.2	9.3	91.7	47.4	54.1	124.8	67.9	88.4	86.5	58.0	43.4	27.1	38.7	43.0	57.6	148.3	179.2	299.1	70.0	30.6	60.2	76.2	165.7	60.9	218.8	192.3	136.4	782.4	74.2	13.5	140.2	17.6	493.5	139.8	37.1	251.1	7.8	436.3	184.3	240.7	76.1	70.3	1640.5	41.4	141.8	254.8	48.7	70.1	201.0	61.7	45.6	44.2	144.1	147.2	38.8	101.9	532.9	205.4	79.0	109.0	151.0	130.1	26.3
STMN2	"SCG10, SCGN10"	ENSG00000104435	"Stathmin 2"	Q93045	8	79610814-79666175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 153.3"	"Cell type enhanced"	"Detected in some"	26	"Horizontal cells: 139.8;Intestinal endocrine cells: 23.8;Rod photoreceptor cells: 40.3"	"Group enriched"	"Detected in many"	5	"glioma: 26.1;pancreatic cancer: 10.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 5.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.6"	"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 123.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026922			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA026922: AB_1857605"	"unprognostic (4.41e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.20e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-13)"	"unprognostic (1.14e-1)"	"unprognostic (3.86e-1)"	"unprognostic (5.77e-3)"	"unprognostic (9.59e-2)"	1.7	35.4	35.2	5.6	35.0	1.4	2.5	99.8	153.3	5.3	10.7	4.2	0.0	7.7	1.9	1.3	1.8	1.4	3.0	1.3	40.3	71.9	1.4	1.8	1.5	1.6	44.7	60.4	1.4	3.2	1.4	1.5	1.4	102.4	2.5	14.2	2.6	1.7	2.1	1.3	6.4	9.8	4.3	19.0	3.1	2.4	2.2	6.6	0.0	1.3	0.0	1.9	1.5	0.9	0.0	5.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	123.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.6	0.0	0.0	35.2	35.0	99.8	68.3	40.3	71.9	44.7	60.4	102.4	6.6	0.0	0.0	0.0	0.0	0.9	18.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	139.8	23.8	0.0	0.0	8.1	0.3	0.0	1.7	0.0	0.0	17.0	1.1	0.0	0.0	0.0	40.3	0.0	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0
STMN3	SCLIP	ENSG00000197457	"Stathmin 3"	Q9NZ72	20	63639705-63657682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 90.9"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 100.2;Horizontal cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.3;MAIT T-cell: 3.5;memory CD4 T-cell: 6.8;memory CD8 T-cell: 5.8;naive CD4 T-cell: 8.3;naive CD8 T-cell: 6.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 32.3;MOLT-4: 34.9;REH: 35.9;SCLC-21H: 50.4;SH-SY5Y: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012947	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA012947: AB_1857606"	"unprognostic (7.59e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-3)"	9.0	21.0	53.5	13.1	52.7	6.9	7.7	48.8	90.9	10.9	5.3	6.7	1.2	4.2	10.9	4.2	5.9	10.3	7.6	5.0	48.9	47.7	4.6	1.6	6.2	15.2	34.2	63.6	19.8	7.6	6.2	18.6	7.0	45.8	8.2	4.2	6.2	7.5	9.5	3.3	11.6	6.5	10.1	29.5	20.3	6.5	4.1	12.3	11.0	20.9	1.9	8.4	6.6	3.5	1.0	1.3	1.2	0.1	0.0	8.3	2.5	2.5	2.9	19.3	32.3	0.5	1.9	1.3	3.0	0.1	9.4	4.4	18.5	3.5	0.1	9.5	1.1	0.5	17.5	13.4	0.3	2.9	1.2	3.6	1.2	4.0	6.8	2.6	0.9	11.0	4.0	0.1	3.0	0.7	0.4	0.3	8.8	24.2	0.5	2.4	2.9	34.9	4.4	19.8	0.6	21.1	35.9	3.1	14.4	15.8	0.5	50.4	38.4	1.4	0.8	3.6	1.6	0.5	6.5	0.5	0.2	5.4	0.2	0.6	1.2	2.5	0.8	0.5	3.6	12.5	1.0	0.1	1.2	3.3	0.1	3.5	0.3	6.8	5.8	0.1	1.0	8.3	6.8	0.2	0.0	0.1	1.3	1.1	2.5	53.5	52.7	48.8	74.0	48.9	47.7	34.2	63.6	45.8	12.3	6.0	4.5	3.7	5.3	7.2	100.2	2.0	2.5	0.0	3.4	3.5	49.1	9.6	11.6	3.7	9.8	6.7	0.2	0.0	2.1	2.5	15.9	4.6	4.6	0.0	1.9	103.3	35.7	4.9	0.6	12.6	27.9	2.2	6.8	0.0	0.5	25.6	2.3	0.0	33.6	3.9	31.2	12.9	22.6	2.3	5.2	3.8	7.3	18.1	0.6	2.0
STMND1	FLJ23152	ENSG00000230873	"Stathmin domain containing 1"	H3BQB6	6	17102258-17131372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.8;pancreas: 9.1"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 48.2;Club cells: 10.3;Spermatogonia: 21.3"	"Group enriched"	"Detected in some"	6	"breast cancer: 4.1;endometrial cancer: 1.5"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEK 293: 4.1;SCLC-21H: 9.8;T-47d: 11.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA067970	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA067970: AB_2685934"	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (6.88e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.22e-2)"		"unprognostic (3.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.72e-2)"	"unprognostic (5.29e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"		0.1	0.0	0.4	0.1	0.8	0.0	3.7	0.6	0.6	1.6	1.0	2.8	1.4	0.1	0.6	4.7	0.1	21.8	6.0	0.1	0.7	0.9	0.1	0.1	7.7	0.1	0.1	0.1	3.5	9.1	0.0	0.7	0.1	2.5	0.1	1.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	7.4	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.9	1.6	2.8	1.1	0.8	0.8	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.7	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.2	0.8	0.0	4.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.1	0.0	1.1	11.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.7	0.3	0.8	0.6	0.4	0.7	0.3	0.2	0.9	0.8	0.7	2.8	0.8	0.8	1.6	0.2	0.4	0.4	0.8	0.6	0.6	0.7	0.9	0.1	0.1	2.5	0.1	0.0	2.2	0.0	1.2	0.0	0.0	0.4	2.5	48.2	10.3	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.6	1.0	0.8	0.0	0.4	0.0	0.0	6.5	0.3	7.1	21.3	0.6	0.0	0.0	1.0	0.5
STMP1	"C7orf73, PL-5283"	ENSG00000243317	"Short transmembrane mitochondrial protein 1"	E0CX11	7	135662496-135693418	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 209.3;Extravillous trophoblasts: 217.6;monocytes: 256.1;Proximal tubular cells: 171.0;Syncytiotrophoblasts: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 71.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 71.6"	"Low cell line specificity"	"Detected in all"											HPA065565			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA065565: AB_2685512"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.62e-3)"	"unprognostic (6.81e-2)"	15.6	32.2	22.5	19.7	24.3	33.5	27.3	13.8	20.4	20.1	19.0	25.0	20.3	17.4	16.5	26.7	51.4	16.2	19.3	29.5	19.3	20.6	28.4	34.7	19.7	28.1	22.3	13.5	16.5	25.4	14.6	25.4	28.1	20.4	20.7	22.5	31.2	23.0	18.5	40.7	21.1	23.2	21.3	22.0	18.7	19.5	38.7	17.0	38.4	31.9	42.6	34.9	18.2	28.0	5.3	12.5	71.6	13.1	7.6	6.6	9.2	15.2	7.1	17.3	16.1	20.6	29.3	10.5	16.9	16.5	14.1	14.7	4.4	16.9	13.9	15.1	25.5	13.7	6.3	16.6	21.3	19.2	17.4	13.7	21.9	8.2	10.7	20.3	22.2	14.2	18.0	24.4	16.8	15.7	21.3	11.6	18.2	23.5	12.6	30.9	18.9	31.6	25.6	34.0	21.2	18.2	16.0	18.5	23.0	39.2	8.0	21.9	21.1	22.5	15.7	15.7	17.5	6.3	24.6	18.9	13.8	11.2	24.4	23.5	14.6	21.0	27.0	42.5	23.2	24.9	71.6	12.0	25.0	5.3	12.3	5.0	5.3	5.1	5.3	12.5	4.5	4.9	5.4	9.3	7.6	13.1	7.1	6.6	9.2	22.5	24.3	13.8	20.4	19.3	20.6	22.3	13.5	20.4	17.0	38.7	43.1	0.0	0.0	0.0	0.0	0.0	0.0	62.9	51.2	92.5	0.0	209.3	167.5	157.0	0.0	0.0	0.0	0.0	84.6	217.6	0.0	0.0	52.3	0.0	164.1	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	256.1	0.0	0.0	115.5	0.0	0.0	171.0	0.0	0.0	0.0	0.0	0.0	0.0	230.3	0.0	0.0	0.0
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338988-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.9;HHSteC: 57.5;hTCEpi: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		140000000	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	96.0	27.5	29.3	29.7	41.6	89.2	78.6	15.0	19.4	28.7	46.4	23.2	14.6	14.4	35.7	26.7	34.9	28.2	45.2	46.4	27.2	18.5	35.4	114.4	66.0	40.2	24.2	15.1	31.5	11.8	21.0	11.3	77.0	28.1	36.8	16.7	27.7	23.0	28.3	50.6	25.4	25.0	50.4	37.8	48.3	34.5	17.4	23.3	4.4	29.6	25.1	16.1	56.6	51.8	1.4	8.6	5.2	13.2	33.2	43.4	25.8	1.5	9.8	0.8	4.5	105.9	30.4	0.0	26.3	26.2	7.4	11.7	1.3	1.9	12.0	6.5	32.8	4.4	2.6	5.5	24.4	13.2	7.3	2.3	27.9	21.7	3.8	57.5	10.3	5.9	50.4	86.5	11.6	15.4	2.1	26.5	3.7	6.0	16.1	16.1	7.9	0.3	7.9	12.0	0.6	3.1	1.4	0.0	26.1	5.8	0.3	1.0	0.1	22.0	19.5	11.3	8.2	6.7	8.5	33.6	17.2	5.4	17.1	2.4	6.8	7.5	0.7	6.6	10.4	9.2	3.4	8.5	0.9	43.4	13.2	42.8	1.4	22.0	38.9	8.6	1.1	4.1	22.0	5.2	33.2	9.0	1.5	2.0	25.8	29.3	41.6	15.0	19.4	27.2	18.5	24.2	15.1	28.1	23.3	148.9	81.9	21.1	213.5	93.8	3.6	29.1	119.8	124.5	113.7	33.2	5.9	85.6	3.3	48.0	2.7	299.7	8.4	373.8	19.1	46.5	164.1	41.4	34.7	315.8	77.6	3.2	0.0	270.1	169.6	5.7	61.5	72.7	84.4	33.3	0.2	8.0	31.1	14.4	96.9	74.2	4.6	135.8	215.9	21.4	6.8	104.1	144.5	93.2	0.1	170.5
STOML1	"FLJ36370, hUNC-24, SLP-1, STORP"	ENSG00000067221	"Stomatin like 1"	Q9UBI4	15	73978923-73994622	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042353	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA042353: AB_10797387"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.67e-2)"	11.1	10.2	19.2	6.2	18.8	4.2	8.1	7.8	35.3	7.7	6.9	8.3	3.1	5.9	4.6	6.0	7.0	6.2	9.1	14.4	19.0	18.0	4.5	6.1	6.9	8.7	13.4	14.3	9.0	9.9	6.8	8.5	7.9	10.2	7.0	3.7	4.0	7.7	9.7	13.2	7.3	6.5	7.7	12.3	6.3	7.9	6.7	5.9	6.2	10.4	3.6	5.6	6.2	4.4	6.1	11.0	2.2	15.5	6.8	9.4	5.3	3.6	7.0	4.2	5.8	8.6	5.5	3.6	12.0	4.7	6.5	5.5	2.0	20.6	3.7	19.0	9.7	4.9	12.4	4.0	8.4	2.0	12.4	4.4	3.8	5.9	2.3	8.5	2.5	3.1	9.7	6.6	10.3	9.8	5.4	6.1	8.6	9.2	7.2	9.4	5.6	4.7	1.8	2.0	5.7	5.6	2.8	4.3	5.6	13.9	4.1	8.1	5.2	5.4	7.2	7.6	2.8	6.0	2.8	9.3	15.1	4.9	17.2	16.0	7.3	3.5	1.9	13.9	7.8	7.6	0.7	4.0	2.2	5.3	7.0	4.4	4.3	4.4	7.0	6.2	6.1	8.9	9.4	2.0	6.8	15.5	11.0	7.4	5.3	19.2	18.8	7.8	35.3	19.0	18.0	13.4	14.3	10.2	5.9	0.0	2.6	9.5	3.4	2.9	12.3	9.3	2.5	1.4	4.5	7.0	5.9	11.2	1.7	20.5	0.6	7.1	8.0	0.0	16.7	8.1	11.2	5.0	4.6	3.9	9.0	15.9	9.8	4.9	1.8	1.8	8.3	2.3	3.3	2.8	5.7	12.2	17.8	3.6	11.0	5.3	13.7	6.5	5.8	21.9	4.1	1.8	4.7	2.9	5.0	2.0
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 30.6;Horizontal cells: 31.8;Ito cells: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.6;HeLa: 9.9;NTERA-2: 14.7;SH-SY5Y: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: AB_2680875, HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	3.0	2.8	12.0	1.2	12.6	8.4	3.1	20.3	17.5	3.9	2.1	18.2	1.6	1.6	3.2	5.9	8.2	4.7	4.5	4.9	9.6	8.3	3.4	4.0	3.5	1.1	16.2	18.0	5.8	10.6	12.0	8.1	2.4	11.8	4.1	1.7	2.5	11.0	4.2	3.2	6.2	1.8	3.2	9.2	6.2	3.7	1.6	16.4	0.8	9.6	0.8	1.9	4.3	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.7	3.7	11.6	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	1.5	0.0	2.3	0.0	2.4	0.2	6.4	1.0	0.0	0.0	5.1	0.0	9.9	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.4	0.0	1.5	0.0	0.5	0.0	0.1	14.7	0.0	0.5	0.1	4.3	0.0	2.8	3.5	6.0	14.0	2.7	0.0	0.0	4.4	0.2	0.3	0.0	0.0	2.5	0.0	0.1	0.1	3.2	1.8	0.6	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	12.0	12.6	20.3	16.6	9.6	8.3	16.2	18.0	11.8	16.4	11.9	16.6	0.0	5.8	3.8	30.6	19.3	5.1	20.1	12.5	7.0	0.0	2.3	3.3	3.9	0.8	18.3	0.0	0.0	2.7	1.7	1.5	4.2	0.0	4.9	0.9	31.8	1.7	22.1	2.6	2.2	0.6	0.2	1.7	0.0	0.0	15.1	2.4	0.0	4.2	1.9	3.4	0.0	1.0	0.5	2.4	2.9	0.6	0.0	0.0	2.6
STPG1	"C1orf201, FLJ33340, MAPO2"	ENSG00000001460	"Sperm tail PG-rich repeat containing 1"	Q5TH74	1	24356999-24416934	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 225.3;Late spermatids: 476.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA024301			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024301: AB_1845634"	"unprognostic (2.63e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (6.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (2.31e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.42e-1)"	5.5	4.3	6.0	2.6	12.8	1.5	4.2	13.6	23.3	4.7	7.9	12.0	2.4	4.4	4.8	7.1	4.9	20.8	4.2	4.0	6.7	8.7	5.9	1.9	6.2	2.5	6.5	8.0	5.6	4.8	13.0	9.2	1.6	14.2	5.8	6.9	9.9	3.5	4.6	1.5	4.3	5.5	6.4	6.1	2.1	5.1	29.2	7.9	2.5	5.9	1.2	3.4	4.5	3.9	5.2	2.7	1.1	1.4	0.0	4.3	1.9	5.9	3.5	0.5	6.5	4.8	6.9	3.5	8.7	8.4	8.4	8.8	1.5	8.9	0.7	6.0	9.1	7.0	2.4	5.6	6.1	9.7	7.0	5.6	1.0	1.9	1.6	9.8	2.9	1.5	4.1	12.5	12.1	16.0	8.9	6.6	0.0	2.1	0.0	6.3	2.1	0.0	2.4	5.3	6.3	6.0	1.6	0.0	0.2	11.2	2.0	5.4	3.7	4.7	1.8	13.5	5.7	4.8	5.2	4.5	3.0	3.5	1.2	2.5	3.8	3.6	2.1	3.4	0.3	4.8	0.0	0.1	1.1	1.5	1.4	0.2	5.2	1.2	4.3	0.6	3.4	1.4	1.7	0.1	0.0	0.2	2.7	2.5	1.9	6.0	12.8	13.6	23.3	6.7	8.7	6.5	8.0	14.2	7.9	8.9	8.1	2.2	11.4	4.0	12.4	4.8	0.0	65.6	17.0	10.4	13.7	3.8	13.3	6.5	225.3	4.2	16.3	23.3	6.2	7.0	3.8	6.7	11.5	1.3	3.3	9.5	4.6	5.5	1.0	476.4	6.1	4.6	15.1	4.6	5.2	7.4	7.7	10.5	4.2	7.1	16.7	6.5	5.1	14.2	9.4	4.8	3.8	3.9	5.0	51.2
STPG4	"C2orf61, FLJ40172"	ENSG00000239605	"Sperm-tail PG-rich repeat containing 4"	Q8N801	2	47045538-47155378	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 29.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.6;RT4: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047366, HPA052691"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047366: , HPA052691: AB_2681918"	"unprognostic (6.74e-3)"	"unprognostic (5.81e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.36e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.64e-6)"	"unprognostic (5.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	29.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.1	0.0	0.3	0.4	0.1	0.2	0.8	0.5	0.5	0.4	0.4	0.5	0.0	0.2	0.0	0.7	0.5	0.5	0.6	0.0	0.1	0.0	0.0	0.6	0.0	1.1	1.0	0.1	0.8	0.3	0.2	0.1	6.6	0.9	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.1	0.4	1.8	0.4	0.1	0.0	0.4	0.1	0.3	0.0	0.2	0.6	0.3	0.9	0.1	0.2	0.8	0.2	0.0	0.0	0.6	0.2	0.0	0.1	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	2.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STRIP2	"FAM40B, FAR11B, KIAA1170"	ENSG00000128578	"Striatin interacting protein 2"	Q9ULQ0	7	129434433-129488399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6;retina: 55.6;skeletal muscle: 27.4"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 37.1;Muller glia cells: 70.1;Spermatocytes: 32.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.8;U-2197: 23.7;U-87 MG: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019657	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA019657: AB_1848399"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.87e-6)"	"prognostic favorable (5.41e-4)"	"unprognostic (4.06e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.50e-2)"	0.7	2.4	1.9	2.0	36.6	3.7	0.8	7.0	10.0	0.4	0.8	3.0	0.0	0.8	0.8	1.6	1.1	0.4	1.2	10.3	1.5	2.1	5.6	0.6	1.0	2.7	2.2	2.9	0.7	1.3	0.4	4.7	1.3	7.6	1.6	1.4	55.6	1.7	0.5	27.4	1.5	1.0	0.8	1.2	1.5	1.0	13.5	9.4	0.2	0.8	2.1	2.1	0.9	0.3	0.6	0.7	2.5	0.6	0.4	0.9	0.4	7.7	3.4	3.1	4.9	1.2	1.1	13.6	3.2	4.1	5.4	5.3	1.8	4.4	3.3	0.4	1.3	17.7	8.8	3.3	2.9	8.3	19.0	2.8	2.5	5.6	1.9	0.8	1.6	13.3	1.3	1.0	9.2	5.8	9.0	9.3	3.0	10.8	2.1	20.8	0.4	4.1	4.0	3.0	1.7	7.0	2.7	5.8	0.7	2.0	2.9	0.7	0.7	7.4	0.6	1.6	2.5	0.9	3.9	3.3	3.1	3.1	23.7	9.2	1.9	1.2	3.9	21.1	4.1	4.4	2.5	0.6	0.6	0.9	0.4	0.3	0.3	0.6	0.3	0.2	0.6	0.5	0.4	2.0	0.4	0.5	0.7	0.9	0.4	1.9	36.6	7.0	4.8	1.5	2.1	2.2	2.9	7.6	9.4	3.0	0.6	0.0	0.2	0.2	11.0	37.1	0.0	1.4	0.0	0.0	2.0	0.4	0.0	0.8	4.7	0.5	0.0	0.0	3.3	3.4	1.0	0.1	7.0	0.0	0.7	1.6	0.0	0.6	0.0	7.9	0.6	1.3	1.7	13.6	0.0	70.1	3.8	0.0	0.7	9.6	3.5	0.0	0.5	32.7	9.6	0.1	0.2	0.0	0.4	0.6
STRN	"PPP2R6A, STRN1"	ENSG00000115808	Striatin	O43815	2	36843640-36966472	"Cancer-related genes, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017286	Approved		Approved	Nucleoplasm,Cytosol		No	No		11000	Cytosol	Nucleoplasm	"HPA017286: AB_1857618"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.43e-2)"	11.8	8.1	11.4	11.0	22.1	17.4	13.3	16.4	14.2	11.2	14.0	10.9	8.9	10.1	8.6	7.1	25.9	6.8	8.4	25.7	16.2	10.2	11.6	10.2	10.3	9.6	16.9	9.4	9.9	7.1	11.3	6.3	12.6	10.5	8.1	13.7	5.6	16.2	6.9	16.0	16.1	13.2	11.1	34.3	10.9	11.4	9.8	14.8	18.6	8.1	15.5	16.7	11.3	14.4	1.5	0.8	3.7	1.5	0.5	2.1	0.4	23.3	11.8	15.8	6.6	8.7	12.2	15.8	9.5	8.9	9.2	8.5	12.0	7.6	15.5	7.6	11.9	13.2	11.1	13.3	10.4	11.4	17.5	10.2	25.1	10.4	6.2	8.3	15.0	14.1	7.3	9.1	14.7	11.6	6.8	11.7	6.2	18.7	12.3	11.3	6.7	14.9	6.6	12.6	9.5	6.0	9.7	25.0	6.7	7.6	19.3	2.9	9.6	14.1	10.9	8.9	9.2	7.8	5.8	15.5	16.5	16.7	10.2	12.4	12.5	18.8	13.7	8.4	15.1	11.4	3.4	0.8	1.4	2.1	1.5	0.7	1.5	1.5	1.3	0.4	0.9	0.8	0.9	3.7	0.5	1.4	0.8	0.3	0.4	11.4	22.1	16.4	13.0	16.2	10.2	16.9	9.4	10.5	14.8	8.9	7.7	5.2	9.0	18.3	11.7	51.7	10.2	1.4	17.0	22.7	19.6	6.9	8.3	8.8	1.7	17.5	17.3	0.0	7.2	7.9	7.9	14.5	4.7	7.3	7.6	17.5	10.9	15.4	22.2	0.9	8.9	11.0	8.5	10.8	16.4	9.3	12.8	10.5	11.7	7.7	15.4	0.0	10.3	10.3	18.1	29.1	13.6	10.2	13.8	29.3
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		15000	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.5	14.3	15.9	12.1	16.2	10.9	13.5	23.4	17.7	15.8	17.4	11.5	16.5	8.8	14.7	14.8	16.5	10.8	14.0	21.5	14.4	12.1	15.2	22.7	11.6	7.2	12.9	10.1	12.6	13.1	18.0	20.2	14.1	13.9	16.2	14.0	11.4	12.6	17.2	52.0	12.6	11.3	22.0	11.8	11.9	12.9	22.4	14.6	9.3	14.9	13.5	9.7	25.1	20.5	7.0	10.5	8.5	7.9	7.4	10.0	2.4	18.0	15.5	17.4	12.4	14.9	11.2	14.4	17.2	12.7	14.4	14.6	20.7	12.2	10.5	12.6	12.5	7.3	9.9	19.3	11.0	21.4	9.1	6.5	10.4	10.6	40.0	16.1	8.9	11.6	11.9	11.5	11.5	14.1	12.9	11.5	9.8	12.5	10.0	13.9	12.3	11.5	8.6	8.5	12.9	14.5	8.5	20.4	2.8	21.6	25.9	10.9	9.0	19.1	14.0	9.3	17.5	16.0	7.6	13.9	14.2	12.7	8.9	6.8	9.5	10.8	10.3	7.0	6.5	11.3	6.3	7.1	8.3	6.8	7.9	8.9	7.0	8.5	7.7	5.8	6.9	8.6	10.0	8.5	7.4	6.2	10.5	6.4	2.4	15.9	16.2	23.4	17.7	14.4	12.1	12.9	10.1	13.9	14.6	20.8	21.9	13.7	39.9	87.1	24.8	45.2	22.9	24.1	22.7	29.6	25.5	19.0	10.0	31.6	16.6	27.5	18.7	0.0	23.0	16.4	24.9	45.1	8.1	36.5	11.3	35.0	30.7	33.7	22.1	10.5	24.7	21.2	42.2	16.2	16.6	25.1	30.6	14.2	26.2	21.4	28.8	25.8	45.3	61.6	46.8	84.3	27.8	16.0	14.0	41.0
STRN4	"PPP2R6C, ZIN"	ENSG00000090372	"Striatin 4"	Q9NRL3	19	46719507-46746994	"Predicted intracellular proteins, Predicted membrane proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043051, HPA043527, HPA056706"	Supported		Approved	Cytosol		NA	NA		34000	Cytosol		"HPA043051: AB_2678290, HPA043527: AB_10959664, HPA056706: AB_2683214"	"unprognostic (3.57e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (8.31e-3)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (1.56e-1)"	"unprognostic (9.41e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.74e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.84e-1)"	21.8	13.7	22.6	17.8	26.6	27.0	18.7	10.5	34.9	15.3	18.0	17.9	17.8	19.0	19.9	12.6	23.8	16.9	17.0	20.7	23.1	13.4	15.8	11.4	17.4	16.2	15.1	21.4	16.9	26.6	12.7	12.3	22.2	11.8	17.3	11.3	15.7	25.2	18.4	16.6	22.0	20.6	18.5	12.8	22.9	20.2	48.8	15.7	15.0	14.6	11.6	15.5	18.4	16.6	3.1	3.3	10.1	9.8	1.5	1.2	5.7	21.3	28.6	25.0	18.5	7.1	8.0	17.6	18.6	10.0	19.3	16.9	21.2	19.1	10.7	11.2	15.2	15.8	15.2	11.8	18.0	7.7	15.4	24.2	23.6	18.8	18.1	23.1	19.1	25.8	12.9	18.1	12.4	17.1	9.8	17.1	12.6	20.5	14.1	8.0	14.5	21.2	50.0	18.9	22.5	13.5	19.5	15.2	8.3	12.9	38.7	31.0	33.2	26.1	24.4	12.2	11.3	18.3	21.5	23.1	14.5	21.8	9.9	27.3	17.9	25.4	15.9	12.6	12.0	30.0	3.1	6.5	2.9	1.2	9.8	0.3	1.7	1.0	0.8	3.3	3.1	0.5	1.1	10.1	1.5	6.0	3.0	0.3	5.7	22.6	26.6	10.5	34.9	23.1	13.4	15.1	21.4	11.8	15.7	3.0	6.9	3.7	8.9	15.2	12.4	9.0	15.3	2.7	5.7	7.0	11.8	12.5	1.7	11.2	8.2	15.1	19.2	0.0	13.2	14.8	11.9	13.2	0.0	11.1	12.7	28.6	16.8	25.2	20.8	16.9	16.4	11.9	10.1	5.4	20.9	7.5	14.7	14.4	18.7	5.9	7.2	6.5	14.1	19.7	37.7	15.2	16.7	6.9	15.7	13.9
STUM	"C1orf95, DKFZp761P211"	ENSG00000203685	"Stum, mechanosensory transduction mediator homolog"	Q69YW2	1	226548800-226609214	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.2"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HEL: 25.6"	"Group enriched"	"Detected in many"	5	"amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4"	"Low region specificity"	"Detected in many"			HPA074381			Approved	Cytosol		NA	NA			Cytosol		"HPA074381: AB_2732253"	"unprognostic (3.23e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.14e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-3)"	2.8	2.2	30.4	2.1	16.2	0.6	3.5	2.4	32.2	3.7	8.1	6.3	0.0	2.8	3.7	3.0	8.9	3.1	1.6	2.5	21.8	7.0	5.8	0.7	1.2	0.9	6.8	15.9	2.7	1.0	1.9	4.2	1.2	18.2	6.2	3.7	1.4	2.0	2.4	5.0	3.7	3.5	8.7	3.0	1.8	1.8	2.0	7.4	0.0	0.8	0.4	1.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	4.2	0.3	25.6	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.3	0.2	0.0	3.9	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	16.2	2.4	30.0	21.8	7.0	6.8	15.9	18.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
STX10	"hsyn10, SYN10"	ENSG00000104915	"Syntaxin 10"	O60499	19	13144058-13150383	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035303, HPA056439"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035303: AB_10671932, HPA056439: AB_2683135"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.54e-3)"	"prognostic favorable (8.26e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (2.39e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-2)"	18.7	23.1	19.3	24.2	21.1	43.7	23.0	30.0	24.7	22.9	28.3	15.8	23.7	32.2	20.1	19.1	33.2	17.9	23.3	26.1	22.0	14.8	22.5	28.8	25.4	26.7	25.1	21.4	22.0	18.8	19.1	19.9	16.7	22.4	20.9	14.5	17.4	31.1	16.6	19.4	32.3	26.7	23.4	18.8	34.4	26.1	7.4	23.0	26.8	25.0	20.8	23.4	22.2	30.3	9.7	28.3	63.4	39.0	6.7	12.0	16.7	28.4	21.6	15.5	40.5	16.4	17.3	5.3	15.9	16.0	14.5	15.7	9.9	25.5	19.5	24.1	19.7	10.7	21.9	13.4	20.4	8.3	32.7	24.2	17.5	44.2	20.1	12.7	20.2	18.8	17.2	17.4	17.5	11.5	19.2	18.4	26.8	9.2	10.0	10.0	27.3	29.5	37.5	16.2	15.3	36.2	33.3	16.0	27.9	13.7	13.4	17.9	37.0	16.8	19.4	36.4	4.8	13.1	19.5	17.1	22.5	11.7	43.2	22.1	23.3	20.6	15.9	29.2	50.6	17.6	8.6	39.0	26.6	11.9	29.1	10.1	8.9	10.6	12.0	28.3	9.7	9.8	9.5	63.4	6.7	32.5	7.7	11.7	16.7	19.3	21.1	30.0	24.7	22.0	14.8	25.1	21.4	22.4	23.0	14.9	16.3	30.0	30.2	31.5	21.2	11.7	17.8	26.8	22.7	19.2	5.9	15.7	23.2	38.4	0.7	25.1	61.0	0.0	48.9	21.5	30.7	20.2	52.0	16.3	76.2	12.7	15.6	25.2	89.7	1.6	23.3	55.9	45.5	56.9	37.6	19.0	44.0	45.6	29.4	22.4	16.1	25.8	33.0	4.8	15.8	37.8	16.2	35.2	44.9	31.1
STX12	"STX13, STX14"	ENSG00000117758	"Syntaxin 12"	Q86Y82	1	27773183-27824452	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041038, HPA055300"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		No	No			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA041038: AB_10794261, HPA055300: AB_2682778"	"unprognostic (3.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.24e-1)"	38.5	20.2	32.2	16.3	29.6	6.3	22.9	25.8	35.9	20.3	19.4	27.3	23.5	22.9	20.4	42.1	25.7	15.0	25.9	15.3	31.2	31.9	23.2	18.5	31.2	16.3	35.5	29.0	15.2	19.5	16.7	19.6	21.1	32.3	20.8	21.4	11.6	17.7	22.2	14.2	17.1	20.9	23.1	36.9	20.0	38.7	9.0	19.9	6.3	67.0	11.0	13.9	19.4	14.8	7.6	14.2	10.1	21.7	5.2	6.4	8.3	8.8	4.2	11.5	7.5	21.9	26.7	5.9	18.7	27.6	17.2	19.6	5.2	11.5	9.6	20.1	25.0	7.4	7.4	7.5	9.3	17.3	8.5	9.0	5.5	4.7	5.2	17.2	6.0	11.6	25.0	11.4	24.2	13.9	14.2	27.6	5.6	7.2	9.7	18.7	3.2	5.2	4.6	4.8	13.1	6.0	3.3	9.2	5.8	15.2	14.6	12.9	7.0	8.8	7.6	13.5	9.7	5.2	5.4	29.6	8.8	5.0	19.9	6.4	5.8	4.2	5.6	14.2	9.3	12.3	10.1	19.6	7.5	3.7	21.7	6.4	7.6	4.4	5.7	14.2	6.5	4.9	4.1	9.3	5.2	21.0	7.0	4.4	8.3	32.2	29.6	25.8	31.8	31.2	31.9	35.5	29.0	32.3	19.9	50.6	27.6	22.7	84.1	97.1	42.7	15.9	28.1	17.4	38.7	54.1	29.5	25.5	31.5	43.8	1.6	48.9	48.7	0.0	51.3	28.6	42.2	58.3	22.0	15.5	45.8	25.4	39.6	55.3	69.4	1.5	33.4	58.6	50.6	19.8	27.1	61.7	52.7	46.0	44.6	44.7	48.6	38.8	58.4	14.9	17.5	86.7	65.2	22.3	26.7	83.3
STX18	Ufe1	ENSG00000168818	"Syntaxin 18"	Q9P2W9	4	4415742-4542346	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 98.6"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"endometrial cancer: 43.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003019	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA003019: AB_1857622"	"unprognostic (2.33e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.84e-4)"	"prognostic favorable (6.33e-8)"	"unprognostic (4.21e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.69e-4)"	14.0	17.6	12.4	16.0	18.4	9.2	11.0	11.2	15.9	98.6	19.7	19.5	12.2	15.0	46.5	11.9	11.5	38.9	16.1	11.0	11.3	14.2	24.2	14.0	9.8	10.4	14.5	12.3	12.4	18.5	12.2	24.1	17.5	17.3	12.3	11.9	12.7	12.2	14.7	19.0	11.0	19.6	13.5	14.8	14.2	15.0	28.5	10.3	18.1	10.1	9.8	15.0	11.8	12.3	11.2	25.5	7.1	13.0	10.8	13.4	9.3	14.3	9.3	11.1	11.3	9.6	14.0	14.9	16.5	15.2	15.8	13.2	19.6	20.9	19.1	39.8	15.3	14.4	7.8	19.6	9.7	15.6	8.0	9.8	12.0	12.3	23.7	14.3	20.8	10.1	13.1	8.5	13.4	9.8	8.9	13.3	15.4	11.5	17.0	11.2	7.6	18.8	14.8	14.7	11.9	19.4	17.0	8.3	15.2	16.3	8.7	14.1	12.5	12.4	8.3	14.4	10.0	12.2	10.1	15.1	9.6	10.5	8.7	17.7	12.2	18.5	22.0	11.7	16.0	11.9	4.8	10.6	7.1	10.9	10.4	13.4	11.2	10.1	9.9	16.0	9.3	8.5	9.8	2.1	10.8	13.0	25.5	9.1	9.3	12.4	18.4	11.2	15.9	11.3	14.2	14.5	12.3	17.3	10.3	29.8	7.0	10.4	7.5	7.0	20.2	18.3	10.2	34.8	25.0	19.2	19.6	25.1	59.7	27.4	58.7	11.9	28.7	0.0	24.4	16.2	18.5	12.5	8.1	8.3	24.9	9.5	4.7	6.7	14.5	62.0	13.0	16.9	13.5	30.7	19.0	22.5	28.8	24.6	13.8	18.3	16.1	6.5	11.3	58.5	33.4	8.4	26.5	10.7	17.5	10.5
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014369-94028610	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 24.1;Enterocytes: 18.8;Mucus-secreting cells: 26.4;Paneth cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;HaCaT: 2.2;hTCEpi: 7.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.4	0.2	0.3	7.0	0.4	0.0	4.0	1.8	3.5	3.9	11.7	0.1	1.5	5.7	0.5	13.6	12.8	0.8	2.3	0.3	0.5	0.3	1.0	0.4	7.1	0.1	0.3	0.7	0.5	7.7	7.1	0.5	0.7	0.1	4.3	10.6	0.1	9.8	3.2	0.2	6.9	20.9	0.1	0.4	1.0	6.0	0.4	0.1	0.4	0.4	5.0	1.5	0.7	4.1	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	10.6	0.1	0.1	0.0	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.1	7.3	0.0	0.8	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.5	1.2	0.7	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	1.8	3.5	0.5	0.3	0.3	0.7	0.1	0.1	14.9	12.8	0.0	2.2	1.4	3.5	0.0	0.0	24.1	7.9	0.0	11.8	0.1	1.7	3.2	1.1	0.0	18.8	0.0	7.3	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.4	6.7	34.8	0.7	0.0	16.1	0.0	0.3	0.2	0.0	1.6	0.2	0.0	13.9	1.0
STX1A	"HPC-1, p35-1, STX1"	ENSG00000106089	"Syntaxin 1A"	Q16623	7	73699206-73719672	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Neurotransmitter transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 73.7;pituitary gland: 26.9"	"Cell type enhanced"	"Detected in many"	13	"Intestinal endocrine cells: 50.6;Pancreatic endocrine cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.5;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 50.8;U-87 MG: 33.8"	"Group enriched"	"Detected in many"	5	"amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5"	"Group enriched"	"Detected in all"	8	"amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3"	"CAB008372, HPA069176"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA			Vesicles	"Nuclear membrane"	"CAB008372: AB_592786, HPA069176: AB_2686098"	"unprognostic (5.12e-3)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.02e-8)"	"unprognostic (1.11e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.18e-6)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-3)"	"unprognostic (6.20e-2)"	1.4	5.6	27.4	2.4	20.9	7.6	1.4	33.7	73.7	1.7	2.6	1.3	0.8	3.7	2.8	1.8	1.7	2.3	5.5	1.2	22.0	8.3	1.1	1.2	1.8	1.4	4.0	28.0	2.2	5.7	1.5	26.9	2.2	2.6	1.9	2.1	0.1	1.9	1.8	1.1	1.9	3.5	2.6	1.3	1.3	6.2	2.0	0.7	0.0	1.6	0.0	1.1	2.8	1.1	0.4	0.0	0.1	0.2	0.0	2.5	2.7	1.6	7.5	1.2	3.6	1.6	4.2	0.8	5.1	3.4	2.1	1.4	2.6	4.3	1.9	0.7	3.6	11.8	1.3	1.8	3.2	1.6	3.5	1.4	0.6	2.6	1.5	1.8	0.8	1.8	2.5	1.4	14.8	5.2	9.6	3.7	0.3	1.6	2.3	4.0	3.7	0.6	7.3	0.9	2.8	17.0	0.0	0.8	1.9	1.7	1.3	50.8	8.0	1.5	4.2	1.0	1.5	1.4	0.6	13.8	10.5	3.5	8.1	13.5	1.3	0.8	0.9	33.8	0.7	12.3	0.0	0.2	0.0	2.5	0.0	0.9	0.4	0.4	0.6	0.0	0.1	0.8	0.3	0.1	0.0	0.0	0.0	2.4	2.7	27.4	20.9	33.7	49.9	22.0	8.3	4.0	28.0	2.6	0.7	0.0	3.2	0.0	11.2	3.8	4.5	2.2	5.1	2.7	3.4	1.8	3.9	0.4	0.0	3.1	0.0	0.5	1.8	0.0	3.2	1.6	2.4	9.7	15.0	0.2	0.6	7.9	50.6	1.3	0.8	0.0	1.7	1.7	3.3	0.0	2.4	0.8	18.8	0.3	1.4	0.4	1.8	0.0	2.3	1.7	3.3	2.4	0.6	2.2	1.5	12.9
STX1B	"STX1B1, STX1B2"	ENSG00000099365	"Syntaxin 1B"	P61266	16	30989256-31010661	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 64.9"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 36.5;Late spermatids: 9.9"	"Cancer enriched"	"Detected in some"	7	"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 8.4;hTEC/SVTERT24-B: 10.3;hTERT-RPE1: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069176, CAB079008"	Supported	Approved	Approved	"Nuclear membrane,Vesicles"		NA	NA			Vesicles	"Nuclear membrane"	"CAB079008: , HPA069176: AB_2686098"	"unprognostic (1.43e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.40e-4)"	"unprognostic (3.90e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.57e-2)"	1.6	1.9	12.7	1.9	31.8	1.3	1.8	45.8	64.9	1.2	1.4	2.9	0.0	1.4	2.7	4.2	1.9	1.4	1.3	2.1	10.5	10.0	1.4	2.5	1.2	2.4	6.8	26.2	1.3	1.3	1.3	2.2	1.2	39.3	1.8	1.4	1.0	1.9	2.8	1.3	4.0	1.8	2.5	3.8	2.2	1.3	3.2	4.5	0.0	1.3	0.0	2.3	1.3	0.7	0.6	0.3	1.3	0.4	0.5	1.7	0.1	0.1	2.7	4.3	0.6	0.4	0.2	0.1	3.8	5.8	4.8	8.4	0.0	3.1	0.7	0.2	5.0	0.1	0.7	1.9	0.5	5.8	2.3	0.4	0.3	2.2	2.1	0.3	0.1	2.7	1.5	0.1	10.3	0.9	19.0	0.0	0.9	0.4	0.2	5.0	1.2	1.7	0.2	2.1	0.0	0.3	6.3	0.2	0.1	0.4	0.0	5.9	3.7	0.4	0.2	0.0	0.7	0.7	0.1	0.7	2.8	2.2	0.3	0.2	0.3	0.2	0.3	3.1	0.2	0.0	0.9	0.4	0.7	0.3	0.2	0.1	0.5	1.7	0.3	0.1	0.6	0.3	0.4	1.3	0.5	0.1	0.3	0.2	0.1	12.7	31.8	45.8	60.5	10.5	10.0	6.8	26.2	39.3	4.5	0.0	0.0	0.0	0.0	0.7	3.6	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	5.7	0.5	0.0	0.0	0.3	0.0	0.3	0.1	0.0	4.9	0.6	36.5	0.0	0.6	0.0	9.9	0.3	0.0	0.0	1.0	0.0	1.7	0.2	0.0	1.8	2.1	2.9	0.0	0.5	5.2	1.0	0.5	0.7	0.0	0.0	0.0
STX2	"EPIM, EPM, STX2A, STX2B, STX2C"	ENSG00000111450	"Syntaxin 2"	P32856	12	130789600-130839266	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 123.8;Late spermatids: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069176, CAB079007"	Uncertain	Supported	Approved	"Nuclear membrane,Vesicles"		NA	NA			Vesicles	"Nuclear membrane"	"CAB079007: , HPA069176: AB_2686098"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-3)"	15.9	14.5	16.0	15.4	13.4	8.8	27.0	12.5	18.7	13.1	18.8	15.3	8.8	6.1	18.1	15.4	9.6	19.4	14.5	16.4	15.5	11.4	12.2	12.0	18.3	11.9	12.7	12.4	16.0	10.7	11.9	16.3	18.0	17.9	10.2	10.2	9.8	5.2	15.7	6.3	6.1	10.7	23.5	24.8	12.3	11.7	23.2	12.3	9.7	12.6	6.9	9.4	13.5	22.2	2.6	1.6	4.6	2.4	1.4	3.1	0.9	4.7	9.5	13.8	10.8	12.8	29.1	1.4	20.2	16.2	24.9	16.5	2.6	3.3	6.1	3.2	22.1	7.8	1.3	12.6	3.3	26.0	9.3	4.3	3.2	8.3	7.4	13.9	4.7	8.0	10.8	4.1	12.1	9.7	22.0	12.2	6.5	12.8	5.7	21.2	2.8	6.6	4.8	9.2	1.3	13.1	7.0	9.0	3.2	13.7	1.0	13.2	13.0	10.2	0.9	8.5	12.5	3.2	3.1	16.4	14.3	10.1	15.8	8.8	4.2	3.4	4.0	16.5	5.2	11.2	4.6	2.2	2.8	2.4	2.4	2.4	2.6	2.7	2.7	1.5	1.7	2.9	3.1	3.0	1.4	1.2	1.6	1.9	0.9	16.0	13.4	12.5	18.7	15.5	11.4	12.7	12.4	17.9	12.3	20.8	11.3	2.2	1.0	3.1	5.0	13.4	12.7	44.2	11.4	27.9	0.0	1.5	8.3	17.7	123.8	18.3	0.0	23.3	6.4	6.3	25.2	1.9	1.1	13.9	9.6	0.0	6.4	16.5	8.6	61.1	25.9	9.0	13.5	10.0	0.2	8.6	10.4	0.0	23.0	10.0	32.5	12.9	24.7	34.6	27.0	1.3	0.7	7.5	0.2	0.4
STX3	STX3A	ENSG00000166900	"Syntaxin 3"	Q13277	11	59713456-59805882	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 377.4;Cone photoreceptor cells: 371.1;Rod photoreceptor cells: 377.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 14.3;eosinophil: 28.1;neutrophil: 25.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 49.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002191, HPA069176"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			Vesicles	"Nuclear membrane"	"HPA002191: AB_1080165, HPA069176: AB_2686098"	"unprognostic (2.24e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (1.64e-1)"	"unprognostic (3.00e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.07e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.17e-2)"	10.8	16.3	5.3	14.1	8.3	23.4	22.6	11.5	10.7	10.7	19.9	4.9	27.8	23.8	14.2	16.4	12.8	6.8	21.1	9.4	6.2	6.0	25.0	6.4	26.5	15.1	8.7	10.2	12.0	14.8	16.7	21.2	33.6	6.8	12.6	22.9	54.7	16.0	19.8	7.3	11.4	19.7	11.4	7.2	14.5	19.5	11.4	6.2	2.1	12.8	9.3	6.4	11.4	12.2	0.9	2.7	28.1	2.5	0.2	1.4	0.9	12.0	7.1	0.2	3.4	6.2	3.6	9.9	6.5	11.2	15.0	18.7	32.4	11.4	3.4	12.6	4.7	25.7	13.7	18.9	6.7	18.4	3.0	4.0	3.7	5.0	10.0	16.7	12.5	36.6	6.6	14.5	11.6	14.2	9.5	12.0	4.9	32.5	7.1	6.5	7.0	0.1	9.2	18.5	17.6	5.9	4.4	12.6	5.6	28.3	28.8	8.2	12.8	2.8	14.3	49.3	25.5	15.8	8.6	16.7	6.5	14.3	8.9	5.6	8.4	14.6	6.9	9.0	8.3	8.7	14.3	2.5	28.1	1.0	0.7	1.1	0.3	1.4	0.6	2.7	0.9	1.3	0.4	25.7	0.2	0.4	0.4	0.0	0.9	5.3	8.3	11.5	10.7	6.2	6.0	8.7	10.2	6.8	6.2	62.5	29.9	7.8	63.8	45.1	377.4	8.7	28.1	9.4	13.6	10.4	371.1	7.2	14.9	34.0	4.0	29.2	50.3	0.0	22.1	13.8	11.8	83.7	55.6	4.9	14.2	68.3	25.2	21.5	19.0	4.7	3.4	26.8	35.4	12.6	26.9	39.3	38.9	29.4	7.1	51.2	377.2	6.5	14.1	3.9	10.4	52.6	33.9	10.7	21.7	72.9
STX5	"SED5, STX5A"	ENSG00000162236	"Syntaxin 5"	Q13190	11	62806897-62832088	"Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001358	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA001358: AB_1080119"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.22e-3)"	21.3	20.0	17.5	16.2	17.0	28.3	22.6	33.0	24.2	26.9	19.6	17.6	40.9	17.2	21.6	36.4	22.3	23.7	20.1	17.7	17.6	15.7	22.3	42.6	21.0	17.7	18.6	16.7	29.3	33.7	22.8	20.2	37.4	17.4	27.9	18.2	20.6	47.3	32.2	17.1	26.4	23.0	19.2	16.0	24.0	22.1	16.1	19.7	29.1	33.7	16.4	29.0	22.5	22.3	9.4	10.0	24.9	10.4	9.5	9.7	4.7	17.6	11.3	15.1	13.4	20.9	23.1	14.1	17.4	24.6	29.4	23.8	8.4	17.5	11.3	16.3	24.8	17.4	18.6	13.1	16.6	21.8	26.3	12.6	9.8	15.2	17.2	25.3	11.6	15.0	19.0	18.8	26.1	31.8	22.7	14.2	16.6	8.8	31.5	15.6	21.3	15.7	18.9	5.1	15.9	16.7	16.2	14.7	30.1	13.2	9.3	11.5	9.7	14.1	22.3	26.6	12.1	24.7	15.7	15.3	21.5	11.3	24.7	11.1	28.8	16.2	11.9	17.3	8.2	13.0	8.2	8.8	24.9	8.5	10.4	7.4	8.7	6.7	8.2	8.1	9.4	6.4	6.2	14.0	9.5	9.1	10.0	9.7	4.7	17.5	17.0	33.0	24.2	17.6	15.7	18.6	16.7	17.4	19.7	20.8	27.7	62.4	62.4	59.6	17.5	5.3	17.8	18.7	14.8	10.4	25.5	47.3	24.9	37.5	99.8	34.9	32.1	23.3	52.1	66.0	46.9	54.7	52.9	23.6	41.5	17.5	31.6	25.2	33.5	98.9	36.2	32.1	43.9	64.1	31.6	29.4	37.9	31.7	23.7	26.4	17.6	32.3	51.8	27.9	31.3	56.1	148.5	46.7	21.7	66.2
STX8	CARB	ENSG00000170310	"Syntaxin 8"	Q9UNK0	17	9250471-9576591	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 209.0;Late spermatids: 802.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001540	Approved		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA001540: AB_1080168"	"unprognostic (8.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.14e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.51e-1)"	28.6	24.7	26.0	16.5	25.9	23.7	28.1	20.2	33.6	28.3	28.9	23.7	21.9	15.8	36.9	42.5	26.3	19.9	18.1	28.4	20.8	21.1	29.6	29.9	18.7	19.4	23.9	22.4	24.4	30.0	14.9	21.0	20.0	29.0	24.5	23.7	25.8	40.6	26.0	38.4	20.9	20.3	28.4	25.3	19.7	23.2	43.9	20.2	30.0	29.2	17.8	21.4	23.3	23.0	35.4	45.2	48.5	46.2	49.0	59.3	55.7	11.3	19.6	22.5	9.7	27.7	32.2	7.9	16.9	18.0	15.3	19.2	6.8	8.9	13.5	12.9	28.4	17.7	14.9	11.4	23.8	23.3	23.0	16.6	8.4	4.9	14.5	36.9	6.7	18.1	29.2	35.4	15.3	22.9	25.6	19.0	16.4	3.8	6.9	16.7	6.1	13.4	11.6	5.0	14.3	11.0	21.3	16.5	8.4	21.3	10.3	2.0	11.6	9.5	6.0	15.6	27.4	6.7	8.9	23.9	14.9	9.1	8.0	18.3	6.6	6.3	5.8	21.7	14.8	13.8	31.7	46.2	48.5	42.2	38.4	38.4	35.4	45.6	46.5	45.2	32.2	29.2	34.3	14.0	49.0	39.2	38.0	59.3	55.7	26.0	25.9	20.2	33.6	20.8	21.1	23.9	22.4	29.0	20.2	29.8	24.8	41.2	46.2	40.6	15.0	52.6	30.6	28.1	40.9	27.9	11.8	46.4	87.9	54.7	209.0	35.0	37.7	0.0	72.3	39.0	48.3	29.4	53.1	35.8	75.3	6.4	24.0	27.6	43.7	802.8	42.8	53.2	74.2	64.1	37.8	35.2	58.4	54.7	44.6	77.9	19.1	12.9	64.9	40.7	21.3	39.0	36.3	58.6	30.7	36.5
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 127.4"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 111.5;Cone photoreceptor cells: 147.3;Horizontal cells: 79.4;Rod photoreceptor cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6400	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	14.1	16.0	32.4	4.7	42.2	1.5	5.1	86.8	127.4	8.1	4.6	6.5	1.9	3.7	13.2	4.7	6.3	17.9	6.7	12.7	35.0	31.5	7.1	2.7	16.8	3.7	24.6	55.5	14.3	13.2	8.1	22.3	7.9	61.9	6.5	5.3	12.6	8.1	6.6	5.0	5.6	4.6	11.7	13.3	5.9	5.2	5.4	5.3	0.0	10.7	0.9	4.3	5.7	7.6	0.0	0.5	0.0	0.4	0.0	3.4	0.6	4.1	8.6	8.3	9.3	18.8	16.2	7.5	14.5	7.4	8.7	7.7	0.4	4.9	4.0	8.1	9.4	24.3	1.5	7.2	8.9	10.7	9.3	4.9	5.5	23.4	1.5	9.5	0.5	4.8	12.2	5.0	22.8	11.1	14.0	10.3	13.9	5.5	6.3	14.6	7.6	3.9	1.7	7.1	6.7	11.9	2.3	3.9	9.8	7.2	0.2	47.7	23.2	24.4	12.1	41.2	7.7	1.8	1.7	15.4	9.9	5.0	19.5	5.4	13.6	22.3	5.5	19.5	5.9	9.1	0.0	0.4	0.0	0.8	0.1	0.3	0.0	2.2	3.4	0.5	0.0	1.4	1.7	0.0	0.0	0.1	0.3	0.3	0.6	32.4	42.2	86.8	87.7	35.0	31.5	24.6	55.5	61.9	5.3	23.8	57.7	0.8	7.5	10.3	111.5	13.2	0.0	17.4	12.5	3.5	147.3	2.1	6.6	12.0	1.6	21.6	0.0	0.0	7.4	4.6	12.7	9.7	4.7	0.4	3.7	79.4	43.8	20.9	2.7	1.5	19.0	3.2	10.1	1.0	8.8	24.1	5.7	0.0	41.8	8.6	147.7	12.9	12.3	17.7	6.8	6.6	20.5	0.9	0.6	5.5
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809526	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	18.3	18.4	29.8	18.7	42.1	15.2	20.9	21.9	27.1	19.4	20.5	26.3	15.6	18.7	20.3	19.9	18.8	16.0	20.8	14.3	30.4	22.1	30.2	17.8	16.8	18.2	48.0	28.0	16.2	20.5	31.9	18.0	20.3	31.4	18.1	21.9	9.8	17.5	21.3	15.4	19.7	23.8	18.4	56.6	19.8	18.0	11.3	42.5	20.0	27.8	14.6	17.8	20.2	18.3	5.9	8.3	26.2	11.6	8.7	10.2	5.9	22.3	8.9	15.3	8.0	18.7	18.1	21.6	20.8	19.3	14.1	14.4	8.2	9.0	19.9	14.2	16.8	12.8	13.5	10.3	12.3	19.8	22.1	14.3	16.4	12.1	10.6	14.8	25.5	28.2	14.0	17.4	15.7	17.3	17.4	17.3	12.8	12.1	19.6	19.4	15.2	16.1	20.6	16.3	14.8	14.1	13.5	22.3	10.9	22.8	18.7	9.2	8.5	25.5	24.7	30.2	14.6	9.9	24.3	19.4	18.4	10.8	25.5	17.8	13.2	11.4	16.5	33.1	19.7	27.9	26.2	8.8	20.8	7.8	10.6	9.9	5.9	9.2	7.8	8.3	5.4	7.9	7.5	24.3	8.7	11.6	3.9	10.2	5.9	29.8	42.1	21.9	27.1	30.4	22.1	48.0	28.0	31.4	42.5	11.9	25.1	16.6	33.8	39.0	22.8	30.7	25.5	28.1	34.2	19.2	19.6	36.5	38.1	31.9	4.1	26.9	28.6	0.0	24.1	27.4	24.9	28.7	68.1	15.3	28.0	25.4	20.2	14.7	42.9	2.5	31.1	37.2	37.1	42.3	29.5	38.2	25.3	23.0	29.7	42.3	18.4	19.4	27.8	20.9	24.3	35.3	79.9	26.1	24.1	35.8
STXBP4	"MGC50337, Synip"	ENSG00000166263	"Syntaxin binding protein 4"	Q6ZWJ1	17	54968727-55173632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 36.3"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 39.3;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007760, HPA022138, HPA022888, HPA024227"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane"	Cytosol	"CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630"	"unprognostic (5.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.00e-5)"	"unprognostic (4.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	7.7	6.4	5.5	4.3	6.0	3.4	5.2	10.6	4.7	9.9	6.4	4.2	7.5	6.3	12.0	7.2	5.1	7.3	6.6	5.9	6.7	4.7	14.5	3.8	8.0	3.2	4.2	4.5	9.9	5.4	19.3	36.3	4.7	6.8	9.5	4.6	7.6	4.5	9.4	4.0	3.7	5.1	13.2	8.6	5.0	5.5	5.6	5.1	7.2	7.9	2.7	3.5	9.6	8.2	3.2	2.9	4.0	1.2	5.1	2.9	0.7	5.5	8.3	7.7	6.8	6.5	6.4	3.1	4.3	4.2	5.7	5.6	4.9	3.0	3.8	9.3	4.3	5.0	3.3	9.8	4.3	10.5	5.7	5.6	4.9	5.7	10.0	2.7	3.1	1.5	7.3	1.3	8.1	2.0	2.6	5.6	3.3	7.9	3.0	6.7	2.5	10.2	2.0	5.5	4.7	6.0	4.3	8.9	2.3	10.0	3.4	7.4	5.6	6.7	1.1	3.6	4.3	9.7	2.1	4.3	8.0	6.3	4.9	4.5	2.7	2.5	6.5	5.2	4.1	4.7	4.0	1.1	0.1	2.6	0.8	2.9	2.1	2.3	1.7	1.4	3.2	2.1	2.7	0.3	5.1	1.2	2.9	2.1	0.7	5.5	6.0	10.6	4.7	6.7	4.7	4.2	4.5	6.8	5.1	0.0	7.8	0.8	2.2	0.8	5.5	8.1	5.1	22.7	6.8	8.7	39.3	1.3	8.3	5.7	5.2	2.1	2.6	0.0	2.3	1.7	2.8	2.6	7.0	4.0	1.9	7.9	5.8	6.2	2.5	4.6	16.4	2.6	6.8	1.8	1.6	6.6	3.3	2.3	11.0	6.3	19.0	32.3	3.9	8.6	5.8	2.6	0.2	2.9	3.0	1.0
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618939-10674318	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.8;stomach 1: 16.0"	"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 8.1;Enterocytes: 12.5;Mucus-secreting cells: 8.3;Paneth cells: 9.5;Undifferentiated cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.5;HDLM-2: 10.9;HMC-1: 12.1;HUVEC TERT2: 16.6;TIME: 15.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.6	0.3	2.6	2.3	10.6	1.0	3.8	0.1	13.4	2.2	14.4	0.7	0.5	2.1	0.5	1.1	8.9	1.9	6.2	0.1	1.8	1.6	0.5	0.3	1.2	2.4	1.8	4.2	0.4	0.3	0.0	8.4	3.4	2.1	10.6	15.8	0.0	7.8	2.6	0.2	2.6	10.3	0.6	0.6	1.0	16.0	0.3	0.7	0.0	0.4	0.6	2.8	4.3	3.6	0.0	0.0	0.4	0.0	12.5	1.9	0.2	3.0	0.1	0.0	0.4	0.0	0.0	0.9	4.9	0.5	2.3	2.2	1.6	18.5	0.2	3.1	1.2	2.9	0.8	1.0	5.1	4.9	10.9	0.3	0.7	1.3	0.1	0.0	1.4	12.1	0.2	0.3	3.4	0.2	0.4	16.6	0.1	0.2	0.2	5.3	1.7	0.1	0.8	2.7	7.5	1.3	0.0	1.4	0.2	1.6	9.5	0.6	0.0	2.8	2.9	0.0	4.5	2.3	0.3	15.4	0.6	2.6	0.3	0.6	0.0	0.6	0.1	2.1	0.1	3.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.4	12.5	0.0	0.0	0.0	0.2	2.6	10.6	0.1	13.4	1.8	1.6	1.8	4.2	2.1	0.7	0.0	2.1	0.0	0.6	0.2	0.4	0.4	2.5	8.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	12.5	0.0	0.2	0.5	0.0	5.9	1.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	3.6	9.5	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.9	0.2	0.7	6.8	4.8
STYX		ENSG00000198252	"Serine/threonine/tyrosine interacting protein"	Q8WUJ0	14	52730180-52774998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 77.4;Late spermatids: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA040290	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040290: AB_10963686"	"unprognostic (5.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.84e-3)"	12.2	6.4	7.6	14.8	8.3	6.4	19.6	9.9	7.4	9.7	10.1	8.5	8.2	7.1	10.8	6.4	13.2	8.1	9.6	11.5	7.2	5.4	7.5	32.2	12.6	23.5	10.2	5.8	9.7	11.8	7.0	9.4	11.6	7.2	9.9	8.4	7.1	10.2	11.5	26.6	10.9	9.0	15.5	10.0	11.7	11.2	13.9	8.6	16.7	7.7	12.2	14.9	13.4	10.7	7.1	5.4	6.6	6.8	5.4	13.4	6.3	10.5	5.8	8.1	9.6	13.8	19.8	15.4	12.8	9.5	9.4	9.5	8.4	7.8	13.1	10.9	12.0	7.9	8.4	10.0	10.4	16.6	11.6	3.8	6.7	6.5	11.1	11.4	10.6	8.9	14.1	12.7	12.3	12.8	8.4	16.9	11.9	7.9	12.7	12.8	14.5	11.8	7.0	9.7	12.0	12.1	10.1	10.9	7.7	12.2	12.1	1.8	5.4	13.0	8.8	8.3	11.8	21.4	10.8	15.5	16.4	10.5	17.7	7.9	4.7	6.3	8.2	5.3	7.2	13.8	6.6	5.0	4.0	6.8	6.8	9.0	7.1	11.2	9.1	5.4	4.8	13.4	9.9	2.6	5.4	6.1	4.1	12.2	6.3	7.6	8.3	9.9	7.4	7.2	5.4	10.2	5.8	7.2	8.6	6.0	8.6	13.7	9.8	14.7	4.6	19.4	7.6	17.4	9.1	5.2	5.9	11.8	11.6	11.3	77.4	14.3	5.3	0.0	15.9	25.9	11.3	14.4	19.7	51.3	14.2	4.8	4.6	15.4	13.1	67.5	8.9	17.9	3.3	15.4	5.3	6.7	12.5	8.6	10.6	9.2	6.5	25.8	14.0	53.9	23.3	17.1	17.6	20.0	7.5	10.0
SUCLG1		ENSG00000163541	"Succinate-CoA ligase alpha subunit"	P53597	2	84423523-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.6"	"Cell type enhanced"	"Detected in all"	10	"Distal tubular cells: 792.5;Proximal tubular cells: 1327.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		330000	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	26.1	23.3	18.0	15.0	18.9	10.6	23.8	18.9	19.5	14.1	50.1	17.7	23.2	53.9	13.9	19.6	25.0	13.5	14.0	57.7	17.4	17.3	125.6	44.1	12.8	13.3	19.2	17.0	12.7	33.9	36.2	16.3	13.8	17.3	17.1	39.4	16.9	39.3	24.9	57.6	15.6	71.6	26.5	17.1	12.1	21.9	13.3	16.0	16.9	28.8	42.8	15.2	24.3	16.3	26.6	43.5	31.6	40.3	35.2	39.1	46.8	20.8	23.0	18.2	22.1	34.2	23.1	31.5	23.8	20.4	30.7	22.5	52.6	17.3	28.8	16.5	28.5	24.7	30.5	37.4	28.1	36.5	27.7	34.0	25.0	19.8	29.9	29.0	25.4	20.4	27.4	23.0	25.9	35.3	18.8	27.3	23.6	25.3	23.7	27.9	31.9	36.0	23.2	9.5	78.5	41.2	22.9	42.2	31.5	41.2	25.4	22.1	12.3	19.0	39.5	37.9	17.8	24.1	20.0	22.1	24.1	23.4	29.5	29.2	20.8	29.5	24.8	28.2	35.3	21.2	31.6	34.4	28.7	31.4	40.3	34.6	26.6	29.2	35.1	43.5	20.2	32.4	34.2	18.5	35.2	40.0	23.7	39.1	46.8	18.0	18.9	18.9	19.5	17.4	17.3	19.2	17.0	17.3	16.0	59.6	67.8	89.4	89.8	31.5	32.1	379.6	132.5	91.0	108.1	134.3	21.6	202.1	792.5	102.4	24.5	56.3	282.3	23.3	99.5	100.2	83.9	68.7	90.0	177.6	116.1	42.9	102.0	59.5	64.6	28.6	50.6	82.9	113.1	78.5	140.8	56.0	65.8	217.5	69.6	1327.5	31.0	51.8	72.6	79.7	46.4	36.1	157.6	70.5	304.8	88.9
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming beta subunit"	Q96I99	3	67360460-67654614	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 90.9"	"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 290.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		290000	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	17.0	19.3	8.8	26.5	10.0	3.4	12.4	2.4	7.2	15.3	38.9	9.5	16.4	31.4	11.5	18.3	18.6	9.9	27.9	23.6	6.6	6.2	38.3	90.9	14.6	21.1	9.8	6.5	16.5	20.9	5.9	8.5	8.5	7.6	14.0	34.5	9.6	21.0	17.3	57.0	9.3	42.4	23.5	8.6	24.7	25.4	6.5	8.1	9.6	16.4	27.0	16.7	19.9	13.2	19.2	10.2	5.8	18.2	27.1	31.1	18.9	12.8	11.2	11.1	13.5	18.7	32.4	13.5	15.4	22.5	18.1	20.3	12.3	28.7	16.4	5.0	21.6	11.9	6.6	8.6	21.2	23.5	6.9	5.9	14.8	10.1	19.2	24.1	19.5	10.4	24.2	18.5	14.2	32.6	22.5	19.2	12.6	11.3	15.0	39.4	9.0	7.3	6.2	10.4	58.8	6.9	5.1	17.2	24.5	30.7	19.9	2.2	7.5	24.4	28.2	20.3	7.8	21.7	12.5	16.7	18.0	11.9	19.7	18.2	10.3	15.0	11.5	26.5	15.3	21.1	5.8	15.3	5.2	13.8	18.2	16.7	19.2	20.0	17.4	10.2	16.7	31.1	23.7	0.7	27.1	14.8	4.0	18.5	18.9	8.8	10.0	2.4	7.2	6.6	6.2	9.8	6.5	7.6	8.1	32.8	40.3	57.4	34.0	33.0	2.6	146.2	84.1	61.6	42.1	76.8	7.9	46.8	207.2	71.1	2.4	35.8	224.3	46.7	70.7	37.8	47.4	43.6	29.0	290.2	50.0	4.8	55.9	44.8	60.1	4.1	38.3	46.7	40.5	32.5	187.4	22.3	55.1	140.3	44.6	211.1	3.8	32.3	67.3	1.4	6.8	43.2	31.8	55.8	241.0	45.3
SUCO	"C1orf9, CH1, OPT, SLP1"	ENSG00000094975	"SUN domain containing ossification factor"	Q9UBS9	1	172532349-172611833	"Predicted membrane proteins"	Osteogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047251	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		14000	"Nucleoli fibrillar center, Cytosol"		"HPA047251: AB_2679999"	"unprognostic (1.28e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	"unprognostic (7.05e-2)"	8.8	9.2	8.0	6.2	9.8	43.4	9.0	7.9	8.4	8.9	7.6	6.5	48.6	6.1	8.1	39.5	8.3	9.9	7.3	8.0	7.6	8.3	11.2	8.0	6.4	5.5	7.5	5.1	13.4	24.7	16.9	24.7	18.2	8.7	9.0	5.9	9.4	13.0	52.5	2.8	8.7	22.9	6.1	8.8	7.1	8.0	14.3	8.0	11.1	11.0	6.0	7.1	10.7	9.1	9.5	7.7	11.3	6.7	10.4	8.9	4.6	13.9	6.3	18.3	16.3	9.4	9.1	20.7	17.0	10.0	10.8	13.3	11.2	15.0	7.0	10.3	9.7	11.1	22.1	7.8	6.7	18.7	4.0	5.6	5.5	3.9	6.8	11.0	8.7	7.9	8.1	6.8	13.3	11.0	33.7	9.3	8.1	3.5	10.0	16.2	3.3	5.8	6.0	16.6	16.1	14.7	5.9	10.6	4.5	16.8	19.6	9.9	12.7	7.8	13.6	14.9	32.9	13.4	9.6	12.2	9.8	10.4	9.4	17.3	15.2	12.2	12.7	9.5	4.6	15.4	9.4	6.6	11.3	8.6	6.0	8.3	8.3	7.8	7.2	5.4	9.5	8.7	8.9	6.1	10.4	6.7	7.7	5.6	4.6	8.0	9.8	7.9	8.4	7.6	8.3	7.5	5.1	8.7	8.0	44.7	22.8	15.2	31.2	23.4	41.5	21.5	7.6	32.1	46.6	26.2	47.1	30.1	3.3	13.2	28.0	22.2	15.8	23.3	27.4	21.5	20.9	37.1	12.8	13.9	11.7	44.5	25.3	11.6	10.8	39.6	42.3	14.1	25.3	16.2	24.1	65.0	22.9	7.0	26.5	11.8	49.4	25.8	15.3	44.7	24.5	23.6	41.3	20.3	9.9	30.9
SUDS3	"FLJ00052, SAP45, SDS3"	ENSG00000111707	"SDS3 homolog, SIN3A corepressor complex component"	Q9H7L9	12	118376380-118418031	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 220.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040402, HPA041972"	Approved		Supported	"Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear bodies, Cytosol"		"HPA040402: , HPA041972: AB_2677776"	"unprognostic (1.49e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-1)"	12.4	15.6	20.6	10.2	19.1	13.3	17.6	13.3	22.0	17.1	17.2	10.7	10.5	12.9	20.4	15.6	24.7	17.3	12.1	12.9	15.8	11.0	15.3	12.7	13.9	12.2	8.9	18.7	18.6	34.2	22.9	12.2	15.1	14.5	15.7	17.3	13.1	20.4	15.6	15.1	18.7	14.6	20.9	13.4	12.1	14.7	21.6	13.2	13.6	20.5	8.3	17.3	19.9	18.2	9.7	7.7	14.4	4.9	4.6	7.9	4.1	16.2	12.3	16.9	16.8	9.5	12.5	18.2	12.7	13.2	15.0	11.9	13.4	10.5	22.1	13.6	12.2	9.3	19.5	20.1	13.5	17.7	19.4	11.9	15.3	10.0	12.0	10.9	16.9	11.9	8.6	14.4	7.4	13.2	19.5	12.6	21.0	16.7	8.0	13.6	11.1	19.9	22.2	17.5	21.6	9.7	18.1	15.2	15.6	13.7	23.9	13.3	13.1	18.0	10.7	11.0	22.2	35.0	13.9	10.5	10.2	9.7	11.3	8.6	15.2	16.9	16.3	11.3	10.8	12.2	2.0	4.9	6.2	5.9	3.1	7.3	9.7	6.4	6.8	5.2	9.3	7.9	5.3	14.4	4.6	3.0	7.7	5.9	4.1	20.6	19.1	13.3	22.0	15.8	11.0	8.9	18.7	14.5	13.2	26.8	15.7	32.6	40.5	57.6	74.0	31.3	50.9	37.5	22.7	45.4	72.6	28.6	68.0	34.8	220.0	22.8	49.2	0.0	16.8	44.9	31.5	49.6	8.1	26.6	21.7	101.7	35.8	22.1	15.5	29.3	35.6	19.3	27.0	31.5	46.6	34.0	25.3	40.2	38.5	31.4	57.3	25.8	36.0	48.6	59.6	68.8	41.1	20.1	51.7	53.3
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: AB_2678745"	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	22.7	29.9	40.0	23.1	44.8	26.2	27.9	39.7	42.7	17.9	24.0	23.0	14.9	25.8	19.4	20.6	27.1	19.2	18.9	33.8	34.0	28.8	30.8	34.3	19.8	23.5	35.9	28.9	20.8	28.6	14.0	39.8	24.4	36.0	18.1	26.5	14.2	22.5	16.8	26.1	23.1	24.8	21.4	31.1	21.3	23.1	31.2	43.5	15.2	21.6	19.5	27.4	21.8	48.3	17.5	23.4	29.0	19.1	17.5	25.3	13.6	14.4	15.8	23.4	17.7	23.2	19.0	22.5	31.8	21.1	19.9	16.0	34.4	36.4	31.8	9.0	19.7	29.0	25.0	28.9	18.3	29.4	26.2	12.0	29.5	20.7	26.0	16.9	22.9	22.2	13.2	16.7	20.6	15.7	25.7	33.4	20.5	27.5	10.5	30.4	10.2	21.3	42.1	27.4	57.1	15.2	24.5	13.6	13.7	34.6	16.3	7.8	9.9	16.4	13.5	14.9	28.0	13.9	21.9	23.9	16.7	19.5	19.1	27.1	8.3	11.7	28.3	10.0	18.4	24.0	29.0	16.8	26.8	14.9	19.1	14.6	17.5	19.4	20.0	18.6	16.3	14.9	16.5	2.3	17.5	18.2	23.4	25.3	13.6	40.0	44.8	39.7	42.7	34.0	28.8	35.9	28.9	36.0	43.5	35.7	29.0	35.8	53.8	35.3	49.1	109.5	25.5	52.2	44.3	48.8	23.6	57.7	66.3	74.9	142.6	65.3	46.8	70.0	78.0	119.0	50.9	41.8	35.8	37.6	84.7	47.7	32.7	35.6	39.5	64.1	54.4	48.2	45.5	144.3	43.5	84.8	75.8	48.9	56.3	76.3	51.1	25.8	66.5	100.6	92.8	37.8	62.2	49.8	45.0	44.3
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721162-69787961	"Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 137.6"	"Group enriched"	"Detected in many"	4	"Enterocytes: 232.6;Paneth cells: 154.2"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 48.3;OE19: 11.1;TIME: 15.6;U-2197: 13.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	1.2	0.6	0.9	9.3	1.8	1.3	1.1	0.5	1.5	1.1	38.6	0.5	0.7	31.8	0.8	0.6	1.0	1.5	1.2	1.2	0.9	0.9	1.1	24.8	2.4	12.9	1.2	0.7	0.7	0.5	0.0	0.4	0.6	2.0	0.6	20.3	1.3	0.6	0.2	0.4	0.4	137.6	1.4	3.6	13.3	13.9	0.5	0.7	2.0	0.6	0.3	2.0	0.7	1.2	0.2	1.8	21.9	3.2	1.8	3.6	1.6	0.3	0.2	0.3	0.4	0.8	0.9	0.6	0.4	0.2	0.1	0.1	0.3	0.3	0.6	0.3	0.4	0.4	0.5	0.0	0.1	0.3	0.7	0.4	0.5	0.5	0.2	1.2	0.6	0.7	5.5	0.0	0.1	0.2	0.5	48.3	0.7	0.3	1.1	0.4	0.3	0.3	0.5	0.4	11.1	0.2	0.2	1.7	0.3	0.1	0.8	0.7	0.4	0.2	0.2	0.2	0.3	0.7	0.3	15.6	0.5	0.8	13.9	0.3	0.9	0.4	0.2	0.2	1.4	0.6	5.8	3.2	0.8	0.7	1.9	0.2	0.1	1.1	0.3	1.8	0.2	3.6	1.7	21.9	1.8	2.2	0.2	0.5	1.6	0.9	1.8	0.5	1.5	0.9	0.9	1.2	0.7	2.0	0.7	17.9	17.3	2.2	0.0	0.2	0.0	0.4	0.0	22.7	12.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	232.6	0.0	4.0	0.1	0.2	0.1	15.1	42.3	0.3	0.0	32.4	4.3	35.4	0.0	0.0	5.4	0.0	0.0	38.4	0.0	11.4	154.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.8	43.0	0.1
SULT1C4	"SULT1C, SULT1C2"	ENSG00000198075	"Sulfotransferase family 1C member 4"	O75897	2	108377911-108388057	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Cholangiocytes: 22.9;Collecting duct cells: 8.7;Muller glia cells: 12.4"	"Group enriched"	"Detected in many"	6	"glioma: 7.1;renal cancer: 20.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 6.4;HUVEC TERT2: 6.8;SH-SY5Y: 29.5;SuSa: 8.2"					"Low region specificity"	"Detected in all"			HPA034530			Approved	Cytosol		NA	NA			Cytosol		"HPA034530: AB_10670170"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-3)"	"prognostic favorable (9.99e-7)"	"unprognostic (1.79e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.38e-1)"	5.2	2.2	9.5	1.1	14.5	0.7	4.5	7.8	16.3	20.6	3.2	13.0	1.8	1.6	9.9	5.4	2.5	8.4	24.8	9.5	9.2	11.4	15.8	3.2	13.9	1.7	12.7	6.8	25.0	3.1	1.0	6.8	11.3	13.6	6.1	2.2	10.6	1.7	7.7	2.7	0.9	3.1	5.1	8.3	1.4	2.2	2.3	10.0	1.1	4.4	1.1	1.4	4.0	5.6	0.3	0.3	1.4	0.2	0.7	0.4	0.2	0.0	0.1	6.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.7	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.2	0.1	0.1	0.2	0.3	0.2	0.0	0.3	0.2	0.4	1.4	0.7	0.1	0.3	0.1	0.2	9.5	14.5	7.8	7.1	9.2	11.4	12.7	6.8	13.6	10.0	0.0	0.3	0.0	0.2	0.2	1.5	0.6	22.9	0.0	0.0	8.7	0.0	0.2	0.0	0.3	4.9	5.9	0.0	0.0	0.2	0.1	1.6	0.6	0.0	0.0	0.7	1.6	0.0	4.3	0.6	0.4	1.4	0.4	0.0	0.0	0.0	12.4	0.1	0.0	4.2	2.7	0.7	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1
SUMO2	"SMT3B, SMT3H2"	ENSG00000188612	"Small ubiquitin-like modifier 2"	P61956	17	75165586-75182983	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037314, HPA042123, HPA048064"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB037314: AB_796170, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (6.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (9.80e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (5.23e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.89e-3)"	69.0	70.0	77.8	62.6	70.9	63.5	62.6	105.3	73.1	75.4	55.4	50.4	44.5	52.3	69.5	55.7	77.2	58.8	64.3	51.7	68.2	59.4	67.8	60.9	58.0	63.4	57.5	48.3	81.0	62.3	27.9	51.0	60.4	41.5	65.6	48.8	49.7	54.7	53.8	66.9	51.0	53.9	69.9	59.0	69.2	65.8	59.7	44.8	92.6	65.5	50.7	72.1	80.3	61.6	90.7	107.4	130.6	89.3	73.9	119.0	122.6	81.1	33.5	119.0	61.0	34.9	33.7	56.0	64.3	31.5	44.5	41.3	38.4	44.8	71.1	46.1	36.7	58.1	39.7	53.4	39.6	52.6	41.0	81.1	71.1	33.8	65.7	22.9	93.2	64.1	34.1	22.6	39.5	21.7	71.5	45.8	71.0	58.5	58.2	32.8	35.1	142.1	80.6	72.5	61.2	50.7	99.4	113.5	59.3	44.5	68.5	73.1	85.6	77.9	64.8	51.6	96.4	70.1	73.6	51.4	64.9	67.4	49.3	103.1	41.0	37.0	108.9	40.8	55.9	51.8	113.4	76.1	130.6	73.2	84.7	75.9	90.7	92.3	84.5	78.8	77.6	85.6	83.0	68.0	73.9	89.3	107.4	119.0	122.6	77.8	70.9	105.3	73.1	68.2	59.4	57.5	48.3	41.5	44.8	151.8	131.7	396.7	508.4	626.5	212.3	52.6	267.5	252.9	166.1	336.8	47.1	464.8	820.7	515.3	191.2	443.3	254.6	163.5	464.8	790.2	521.7	552.5	345.8	247.7	547.3	220.9	424.4	377.5	577.0	387.5	560.1	510.2	438.6	716.9	336.1	326.4	540.6	399.5	568.9	627.1	118.6	562.7	497.4	793.1	668.9	649.2	472.7	438.0	415.6	703.2
SUMO4	"dJ281H8.4, IDDM5, SMT3H4"	ENSG00000177688	"Small ubiquitin-like modifier 4"	Q6EEV6	6	149400227-149401292	"Predicted intracellular proteins"	"Ubl conjugation pathway"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.9;HeLa: 4.2"									"HPA042123, HPA048064"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.44e-11)"	"unprognostic (4.94e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	1.5	0.8	0.7	1.9	1.7	3.6	2.7	5.1	6.5	2.1	1.1	1.2	1.4	1.6	3.0	3.2	1.7	0.7	1.5	3.6	1.0	0.8	2.3	6.6	2.8	3.9	0.7	1.7	2.9	2.2	1.2	2.6	1.8	2.8	3.1	1.7	1.7	2.5	1.1	2.3	1.3	1.4	1.9	1.9	2.2	1.5	2.0	0.2	1.4	2.1	0.7	1.8	1.4	3.5	1.9	0.7	5.6	1.1	3.2	2.6	0.5	0.2	0.0	0.2	0.2	0.4	0.0	0.5	0.8	0.2	0.4	0.3	0.3	0.3	1.6	0.3	0.0	0.3	0.3	0.0	0.6	0.4	2.9	0.3	0.3	4.2	0.3	0.3	0.2	0.3	0.3	0.2	0.5	1.0	0.2	0.0	0.0	0.6	1.2	0.2	0.0	0.5	0.6	0.5	0.0	0.3	0.4	0.6	0.5	0.0	1.5	0.9	0.2	0.6	0.0	0.0	0.7	0.0	1.7	1.4	0.8	0.7	0.7	0.5	0.6	0.1	0.1	0.5	0.6	0.0	0.3	0.5	0.9	1.3	0.6	0.7	1.1	2.6	1.9	0.7	1.9	1.7	2.4	5.6	3.2	1.1	0.5	2.5	0.5	0.7	1.7	5.1	6.5	1.0	0.8	0.7	1.7	2.8	0.2	3.0	1.0	0.0	1.3	2.6	4.3	9.2	0.0	1.4	1.2	1.8	3.9	0.7	0.0	0.6	0.0	2.1	1.0	0.0	0.8	0.3	1.7	3.5	1.1	1.5	0.9	0.0	1.7	1.3	1.0	0.7	2.0	4.4	0.0	4.6	0.2	2.3	0.9	0.0	1.1	0.0	4.2	6.5	1.4	1.4	0.9	0.6	0.2	1.7	0.4	2.2
SUN3	"MGC33329, SUNC1"	ENSG00000164744	"Sad1 and UNC84 domain containing 3"	Q8TAQ9	7	47987148-48029119	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 30.9"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 435.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"GAMG: 7.2;U-2 OS: 21.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA008344, HPA076890"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA008344: AB_1857656, HPA076890: "	"unprognostic (5.11e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-4)"	"unprognostic (2.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-5)"	"unprognostic (4.88e-1)"	"unprognostic (1.47e-1)"		"unprognostic (2.65e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.58e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	1.5	0.1	0.7	1.2	0.3	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	3.2	0.1	0.0	0.0	7.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	1.3	21.5	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.4	1.2	0.1	0.1	0.7	0.4	0.4	0.0	0.8	0.5	0.2	1.5	0.7	0.1	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	435.2	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	54.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.2	0.0	6.5	0.1	6.7	7.4	0.0	0.7	0.0	0.0	0.0
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351472-21384266	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: AB_2680881"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	21.6	18.3	16.3	21.6	26.2	21.5	21.3	39.1	27.9	22.8	21.3	14.4	20.7	13.5	31.5	18.5	20.9	23.7	14.5	15.9	17.9	16.2	17.7	14.1	17.1	28.0	18.8	22.8	29.0	15.7	40.3	24.0	18.9	28.6	18.8	21.5	11.3	19.3	20.5	21.4	22.1	19.9	27.4	18.9	22.6	19.1	24.9	19.0	32.7	20.3	17.0	29.5	24.6	20.7	23.3	17.1	21.1	20.4	23.2	26.8	16.7	30.4	28.8	39.9	29.2	18.1	18.1	28.4	27.6	22.0	33.7	31.8	27.8	27.5	64.7	10.6	20.0	21.7	32.6	50.5	24.9	51.1	20.6	21.5	39.2	26.3	39.0	18.5	55.4	29.2	15.9	15.3	28.1	31.8	16.3	22.8	36.9	32.2	27.9	27.8	19.7	51.7	16.9	44.6	28.0	28.6	56.0	45.6	35.0	13.5	33.7	40.0	34.1	44.6	26.8	16.7	26.9	14.8	26.3	19.2	29.6	24.7	18.3	29.8	27.8	46.5	65.2	10.9	32.7	22.4	21.1	13.1	19.6	22.8	17.3	26.8	23.3	21.8	25.3	17.1	21.3	25.0	25.1	11.0	23.2	20.4	16.1	20.3	16.7	16.3	26.2	39.1	27.9	17.9	16.2	18.8	22.8	28.6	19.0	59.6	49.3	32.0	29.5	31.6	44.4	58.8	33.1	42.8	59.1	50.6	45.2	48.1	21.6	50.6	100.7	39.8	13.9	23.3	52.8	51.4	33.7	25.7	81.0	29.7	36.5	52.4	22.4	28.3	36.2	67.9	55.3	36.3	16.9	116.4	31.1	49.8	52.6	10.5	56.3	25.0	40.5	19.4	44.2	130.3	136.3	36.3	38.1	45.9	38.2	26.4
SUPT20H	"bA421P11.4, C13orf19, FAM48A, P38IP, SPT20"	ENSG00000102710	"SPT20 homolog, SAGA complex component"	Q8NEM7	13	37009312-37059713	"Predicted intracellular proteins"	"Autophagy, Gastrulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 181.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038906, HPA038907"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA038906: AB_10673482, HPA038907: AB_10697401"	"unprognostic (4.04e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.21e-3)"	10.6	10.9	10.7	11.6	12.8	17.3	15.0	19.0	15.7	14.7	15.2	11.1	10.7	7.8	16.2	9.7	12.0	16.3	11.2	12.2	11.1	8.0	10.7	7.0	17.1	14.3	15.7	8.0	15.4	8.9	8.2	28.3	13.7	13.2	12.7	12.0	9.1	10.2	14.1	15.2	9.7	11.7	16.7	16.4	14.8	11.5	51.5	14.0	21.5	10.8	7.0	15.5	15.9	14.0	12.5	13.7	25.6	19.3	16.1	20.2	13.2	5.9	7.7	23.1	13.2	9.2	12.4	10.1	16.3	10.2	18.4	13.6	12.2	11.8	11.5	6.7	13.3	21.1	10.5	15.1	17.1	25.3	16.5	13.8	36.2	5.2	13.5	17.7	14.1	16.4	9.5	10.8	17.2	29.7	11.7	22.2	15.7	11.7	3.2	21.6	8.9	20.0	10.3	15.1	14.2	8.8	16.4	16.8	2.6	14.1	9.6	4.5	11.9	10.8	9.2	11.6	20.0	6.9	13.1	13.5	7.7	6.5	8.6	13.2	5.1	5.2	11.8	8.4	8.9	14.0	15.5	14.3	19.7	18.0	19.3	15.9	12.5	17.2	16.4	13.7	12.4	20.2	19.4	25.6	16.1	17.4	10.7	19.1	13.2	10.7	12.8	19.0	15.7	11.1	8.0	15.7	8.0	13.2	14.0	20.8	26.4	21.7	13.8	11.9	34.2	14.2	15.3	42.8	30.7	29.6	33.4	27.9	18.3	20.8	66.1	14.3	12.9	0.0	12.8	25.5	20.1	17.3	42.9	7.8	17.1	20.6	30.0	19.6	19.4	13.1	31.7	17.3	6.8	26.2	18.9	15.7	17.7	17.3	31.5	14.7	35.2	32.3	17.0	181.8	65.1	8.7	22.1	27.4	18.6	12.8
SUPT4H1	"Spt4, SPT4H, Supt4a, SUPT4H"	ENSG00000213246	"SPT4 homolog, DSIF elongation factor subunit"	P63272	17	58345175-58353093	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059748			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059748: "	"unprognostic (1.32e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (6.71e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.57e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.54e-1)"	33.3	41.5	34.2	29.8	32.0	67.5	37.4	36.0	53.3	35.1	34.9	29.4	23.9	24.3	36.4	32.0	36.2	31.3	27.5	31.7	29.3	26.7	43.1	52.5	29.7	44.5	30.0	27.3	34.8	34.4	25.5	23.1	41.7	33.5	33.0	32.0	33.0	33.5	31.6	37.4	33.7	36.7	30.3	27.9	41.5	30.5	35.1	20.5	44.1	46.2	37.4	35.9	33.4	29.6	17.8	33.2	73.0	41.4	11.9	21.1	41.7	20.8	39.1	20.3	14.4	21.7	18.8	26.7	22.8	23.1	32.1	31.1	11.7	20.2	21.9	40.0	33.4	24.8	12.6	27.0	27.3	39.1	35.3	29.5	32.9	22.7	47.1	20.7	41.5	24.0	26.4	24.4	23.4	22.0	29.5	25.8	25.9	34.8	25.7	25.7	31.1	43.7	29.3	17.5	26.1	32.9	33.5	28.3	21.7	26.6	22.6	17.9	32.2	12.1	10.6	22.8	27.7	28.8	33.1	20.1	27.7	23.6	14.3	28.0	37.4	81.8	30.2	22.8	14.3	18.7	38.3	39.0	46.3	17.4	41.4	17.0	17.8	16.7	18.1	33.2	14.7	13.5	16.3	73.0	11.9	40.4	18.3	21.1	41.7	34.2	32.0	36.0	53.3	29.3	26.7	30.0	27.3	33.5	20.5	11.9	7.8	101.3	56.0	63.4	27.2	35.4	61.1	12.0	4.5	57.6	0.0	120.6	165.8	108.7	26.1	83.9	83.9	46.7	85.3	139.0	71.9	57.7	88.5	94.4	161.8	12.7	65.8	83.4	132.9	30.6	87.8	149.1	104.6	187.6	59.5	85.7	101.4	71.9	88.8	185.1	22.3	38.8	55.1	55.3	44.8	73.1	125.6	97.2	58.1	65.7
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone"	Q7KZ85	17	28662091-28702684	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: AB_2675094"	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	27.6	30.0	30.0	24.1	32.8	56.3	25.6	31.9	35.7	28.0	30.1	28.5	23.2	19.9	38.6	28.4	24.4	24.1	25.0	23.8	25.7	22.0	24.1	32.6	26.3	26.0	25.7	32.8	33.1	28.8	40.7	34.5	31.9	24.3	26.9	21.8	33.2	28.2	29.2	50.1	38.6	28.7	40.0	29.8	33.1	28.5	23.4	29.0	27.2	27.6	18.4	29.4	30.7	27.1	5.7	8.2	14.4	6.1	5.4	5.6	3.4	18.0	37.8	19.0	21.7	23.2	15.6	14.7	24.8	26.6	29.3	26.3	35.1	8.1	19.2	13.0	24.8	22.6	21.6	27.8	18.0	30.5	35.7	24.7	26.8	30.6	21.7	19.4	28.1	30.0	21.4	10.9	31.1	20.8	19.4	19.2	18.9	26.3	22.8	20.8	21.5	27.7	12.0	14.7	15.9	12.3	14.2	35.0	15.6	14.5	35.8	14.5	19.2	29.1	46.0	15.7	27.3	28.2	20.0	30.2	23.2	19.2	22.0	31.6	29.0	22.2	28.2	26.2	12.7	19.1	14.4	5.9	5.4	5.2	3.9	5.5	5.6	4.3	5.6	4.8	5.7	4.4	3.8	9.0	5.4	6.1	8.2	3.8	3.4	30.0	32.8	31.9	35.7	25.7	22.0	25.7	32.8	24.3	29.0	35.7	51.4	21.7	18.1	19.9	27.9	43.2	22.9	33.5	36.4	19.2	53.0	21.0	5.0	19.2	3.9	24.0	22.2	23.3	18.3	17.3	18.8	16.3	47.6	30.2	20.6	28.6	29.7	19.0	21.5	14.4	23.9	20.4	8.5	27.9	19.2	20.5	25.9	16.7	25.1	9.4	40.8	32.3	22.2	18.4	16.2	21.2	41.6	20.8	17.7	21.8
SUPT7L	"KIAA0764, SPT7L, STAF65, STAF65gamma"	ENSG00000119760	"SPT7 like, STAGA complex gamma subunit"	O94864	2	27650812-27663840	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039565, HPA063643"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039565: AB_10795109, HPA063643: AB_2685070"	"unprognostic (1.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (7.54e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (5.15e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.75e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.23e-3)"	24.5	27.5	23.5	23.3	39.7	33.9	25.3	38.6	47.6	22.4	21.8	35.6	21.4	25.0	31.4	29.3	20.5	27.3	22.9	31.0	26.6	28.0	25.1	28.5	23.9	27.6	25.8	27.2	33.4	23.9	33.2	39.3	29.6	36.7	26.7	29.0	28.8	19.3	26.0	26.1	18.7	24.8	31.7	23.2	32.5	22.9	19.5	25.9	34.7	29.7	18.4	26.0	21.8	23.1	12.5	17.3	20.2	13.0	18.2	18.1	10.9	18.1	15.8	23.2	17.9	21.3	17.5	27.8	17.7	17.2	16.1	17.4	20.3	20.5	15.9	18.8	18.7	22.7	19.9	20.8	19.7	15.8	18.2	20.1	21.6	22.4	23.0	27.9	17.4	21.3	24.4	24.8	23.8	25.1	29.9	20.8	19.6	24.4	19.2	20.8	12.4	15.0	28.7	15.4	18.2	14.0	14.5	24.8	20.2	20.6	17.1	18.5	24.0	15.9	16.7	29.1	30.9	11.5	15.2	15.9	22.5	16.6	11.2	16.8	34.6	25.1	33.1	17.4	21.7	15.2	20.2	12.4	10.7	16.4	13.0	18.1	9.2	12.8	16.6	17.3	12.5	15.6	14.7	3.3	18.2	11.1	11.6	14.1	10.9	23.5	39.7	38.6	47.6	26.6	28.0	25.8	27.2	36.7	25.9	20.8	17.9	6.7	12.2	7.4	16.9	18.1	12.7	24.1	21.6	21.0	39.3	29.5	18.3	16.2	5.9	16.4	10.5	0.0	12.7	24.6	13.6	9.2	18.5	14.0	21.4	14.3	10.4	14.1	11.5	1.9	12.7	12.4	3.3	14.4	11.5	17.2	14.1	7.0	14.5	15.7	23.9	19.4	14.4	22.4	18.3	7.5	35.4	17.0	12.7	9.5
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328774-133336398	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	14.8	16.8	19.9	15.0	22.7	16.2	15.7	16.4	25.8	13.9	16.2	14.0	11.9	21.7	18.6	10.9	17.4	18.5	15.9	13.9	19.1	17.9	14.5	16.2	12.6	17.6	19.6	22.9	27.4	23.1	16.5	11.8	12.5	24.6	15.8	13.1	11.6	18.3	19.5	47.3	17.8	22.3	18.0	23.6	18.8	13.6	16.5	19.8	8.6	14.4	11.1	13.5	15.3	19.1	7.7	8.9	3.9	4.7	4.6	8.5	3.6	4.1	6.4	5.0	7.4	3.1	2.9	8.3	6.5	3.9	5.8	3.7	10.1	7.1	11.9	5.1	3.6	4.3	12.5	6.4	6.9	2.2	7.9	7.2	8.2	7.4	6.0	5.6	13.8	7.1	4.1	6.1	6.1	5.7	5.3	3.0	11.7	17.8	6.5	5.2	10.7	11.2	11.4	14.5	16.8	11.7	11.8	6.9	12.1	5.1	4.0	10.5	8.9	6.4	10.5	5.7	3.2	9.2	7.8	6.2	13.4	7.1	6.7	8.9	4.8	6.8	15.5	5.0	9.5	7.8	3.9	4.7	1.9	6.8	4.4	7.0	7.1	6.2	6.1	4.9	7.7	8.5	7.0	1.3	4.6	3.7	8.9	5.0	3.6	19.9	22.7	16.4	25.8	19.1	17.9	19.6	22.9	24.6	19.8	41.7	23.5	25.1	10.6	21.1	24.6	26.3	30.6	17.4	35.2	21.0	5.9	26.9	18.3	29.0	1.1	20.3	37.7	0.0	16.8	19.1	14.3	11.8	24.3	29.2	18.5	20.6	32.3	12.9	11.1	2.4	25.6	14.2	6.8	21.6	37.2	16.4	23.6	28.1	26.2	11.9	20.1	0.0	17.0	18.9	21.0	24.1	15.9	16.6	47.0	10.5
SUSD1	DKFZP761E1824	ENSG00000106868	"Sushi domain containing 1"	Q6UWL2	9	112040785-112175408	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 24.1;monocytes: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 24.9"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 24.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.7;HEL: 25.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048554	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		530000	Nucleoplasm		"HPA048554: AB_2680439"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (3.63e-6)"	"unprognostic (2.14e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	9.6	13.9	9.1	9.7	13.9	14.1	8.4	3.1	15.3	7.6	10.2	2.7	11.6	8.6	5.7	9.8	4.8	6.7	7.6	11.2	6.1	16.4	15.5	4.4	11.5	15.7	8.3	8.2	3.3	8.1	9.4	8.2	23.3	7.4	5.8	11.4	8.1	10.7	12.8	2.9	3.6	9.9	9.3	5.1	14.5	12.2	5.8	3.5	9.6	5.6	1.4	6.6	13.1	4.6	0.2	24.9	5.8	2.7	1.7	1.6	1.1	1.3	8.5	6.1	0.0	4.5	3.0	19.5	5.4	7.3	7.7	9.9	16.9	11.4	0.1	6.1	9.5	0.5	3.9	2.1	1.0	5.8	22.7	1.8	25.7	6.2	11.4	5.4	6.7	8.3	3.7	0.8	4.3	0.1	5.3	17.9	3.8	13.9	1.1	4.8	1.6	0.9	4.1	2.0	21.0	1.3	5.7	1.4	0.0	1.8	4.5	2.1	5.2	3.0	0.6	0.0	3.5	1.0	7.3	13.6	0.1	2.9	0.8	0.0	0.3	0.3	0.5	5.3	2.6	1.6	3.5	1.4	5.8	1.6	1.6	0.5	0.1	0.4	1.1	1.0	0.2	0.2	1.2	0.5	1.7	2.7	24.9	0.1	1.1	9.1	13.9	3.1	15.3	6.1	16.4	8.3	8.2	7.4	3.5	0.0	4.5	1.5	1.2	0.5	0.0	1.9	2.5	6.7	5.7	12.2	0.0	7.4	0.0	5.6	1.7	2.3	4.7	0.0	6.2	8.8	4.0	1.8	5.7	0.0	14.2	0.0	4.1	10.4	24.1	1.2	0.0	10.8	0.0	18.0	4.5	0.0	8.8	3.5	1.8	1.7	1.6	0.0	3.8	0.3	0.3	0.6	7.2	4.9	5.6	7.3
SUSD2	"BK65A6.2, FLJ22778"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181259-24189110	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 100.1"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 232.3;Alveolar cells type 2: 121.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"SK-BR-3: 138.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA004117	Enhanced		Approved	"Plasma membrane"		NA	NA		3600000	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	6.0	4.2	0.3	1.4	0.9	0.5	11.3	3.8	1.4	10.5	10.5	2.5	1.3	7.8	7.1	8.3	2.8	6.9	5.3	10.8	0.6	2.9	19.5	1.2	100.1	1.4	0.6	2.6	2.6	2.4	1.3	3.6	3.5	9.6	2.8	1.0	2.2	7.9	4.0	3.0	11.8	32.4	2.4	3.0	1.6	2.5	1.9	0.7	0.1	12.7	5.9	1.5	2.3	4.7	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.7	1.5	0.0	0.0	3.0	3.9	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.2	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.2	0.0	0.0	3.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.1	0.1	138.9	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	3.8	1.4	0.6	2.9	0.6	2.6	9.6	0.7	232.3	121.0	0.0	0.2	0.2	0.0	2.8	0.0	5.3	33.0	1.8	0.0	14.1	5.0	0.0	0.0	0.3	1.6	0.0	0.0	0.4	3.5	0.8	3.5	0.0	0.9	0.0	1.7	4.3	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	24.9	0.0	0.0	15.1	0.9	0.9	2.4	22.1	0.0	0.0	0.5
SUSD4	FLJ10052	ENSG00000143502	"Sushi domain containing 4"	Q5VX71	1	223220819-223364202	"Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 33.0;esophagus: 33.8"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 26.6;Horizontal cells: 20.6;Leydig cells: 19.0;Urothelial cells: 26.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7"	"Lineage enriched"	"Detected in single"	66	"T-cells: 11.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.1;RPTEC TERT1: 8.4;SCLC-21H: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058296	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA058296: AB_2683672"	"unprognostic (2.90e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.82e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.51e-6)"	"unprognostic (3.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.11e-2)"	0.8	5.2	15.9	1.5	33.0	0.9	8.1	9.9	21.3	3.4	0.9	4.0	4.7	1.5	0.9	24.3	33.8	3.6	1.3	9.6	30.6	14.6	13.7	4.0	3.2	1.9	6.8	12.8	27.8	7.6	8.3	16.5	1.0	6.6	4.4	0.8	1.2	13.2	5.7	1.2	3.5	0.9	0.9	2.4	0.8	7.6	5.1	3.8	0.3	1.5	8.1	13.8	2.7	9.1	0.0	0.0	0.0	0.1	0.1	11.7	1.8	4.3	0.4	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.7	0.5	4.5	1.3	0.0	1.4	0.1	0.0	7.1	0.2	1.1	0.7	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	5.0	0.4	0.0	0.3	3.2	3.1	0.0	0.1	2.1	0.9	0.0	0.1	0.0	8.4	2.0	29.0	0.3	0.0	2.4	0.0	0.6	1.8	0.2	0.0	1.3	5.2	0.0	2.6	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.1	6.0	0.0	7.4	1.9	0.0	0.0	11.7	2.1	0.0	0.1	0.0	0.0	1.0	1.8	15.9	33.0	9.9	17.9	30.6	14.6	6.8	12.8	6.6	3.8	0.0	4.5	0.0	5.3	0.6	15.9	9.1	0.0	8.1	12.5	15.7	9.8	0.0	26.6	0.6	2.5	0.4	0.0	0.0	6.3	0.0	0.7	6.8	0.0	1.5	2.1	20.6	1.2	0.0	0.0	2.8	19.0	0.1	5.0	0.0	0.0	1.1	2.7	0.0	11.7	0.2	6.1	0.0	1.0	0.5	5.9	1.5	0.0	1.3	0.0	26.8
SUSD6	KIAA0247	ENSG00000100647	"Sushi domain containing 6"	Q92537	14	69611596-69715142	"Predicted membrane proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030464	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA030464: AB_10601128"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.70e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-1)"	25.4	17.4	9.2	26.0	11.9	40.2	19.5	36.4	12.3	12.1	25.0	15.5	14.8	17.2	13.0	31.0	27.0	16.1	19.6	13.2	11.4	8.4	16.7	11.6	30.9	25.3	15.1	8.2	13.4	20.9	13.7	14.6	14.1	13.9	16.0	13.4	14.6	26.6	17.5	10.6	22.5	36.7	14.0	14.1	30.9	17.3	9.1	12.9	12.7	23.4	14.8	27.4	16.4	15.3	4.1	5.3	23.1	9.1	2.9	4.2	5.0	10.8	2.8	4.1	3.7	8.4	6.2	7.5	6.2	13.1	3.5	3.4	3.3	9.7	12.8	7.0	7.7	2.8	15.3	2.3	12.7	3.3	21.8	1.7	10.4	2.2	5.5	13.6	1.7	27.0	9.9	12.7	5.9	11.1	3.8	7.2	4.0	3.1	11.4	4.9	5.3	2.5	4.5	0.8	6.4	2.9	4.3	3.6	5.1	6.8	5.6	1.7	2.8	5.1	14.8	2.2	3.1	6.0	4.7	11.1	8.2	4.9	5.1	2.5	8.0	1.7	9.1	5.3	5.8	4.3	8.9	7.5	8.3	4.1	7.3	4.2	3.9	3.6	2.5	5.3	4.1	3.5	2.5	23.1	2.9	9.1	3.0	3.2	5.0	9.2	11.9	36.4	12.3	11.4	8.4	15.1	8.2	13.9	12.9	11.9	28.8	5.7	25.4	0.0	16.6	11.8	35.7	20.1	20.5	17.4	19.6	3.8	6.6	22.7	0.6	24.8	36.2	23.3	21.3	1.5	7.9	43.6	8.1	12.8	21.0	14.3	7.0	19.6	57.1	1.5	4.9	22.6	0.0	2.8	14.9	3.8	31.1	21.2	6.3	13.3	21.3	25.8	14.4	4.4	14.6	0.0	7.7	13.8	7.8	41.2
SUV39H2	"FLJ23414, KMT1B"	ENSG00000152455	"Suppressor of variegation 3-9 homolog 2"	Q9H5I1	10	14878820-14904315	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 302.5;Late spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045901, HPA057554"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045901: AB_10960702, HPA057554: AB_2683466"	"prognostic unfavorable (5.55e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.39e-1)"	3.0	2.9	4.7	3.4	7.4	4.9	5.2	20.0	8.6	3.1	3.8	1.6	2.1	3.2	3.8	2.3	4.0	3.0	3.2	2.4	5.4	2.8	3.5	3.8	2.7	3.6	3.3	4.4	4.2	2.4	2.4	6.3	5.1	3.3	3.9	4.7	1.6	2.4	3.6	2.4	3.3	2.9	3.7	3.0	3.4	2.7	41.8	4.4	10.3	2.8	4.9	4.0	3.3	2.8	0.8	3.1	0.5	1.8	5.6	4.0	0.8	13.7	13.1	22.0	12.5	4.1	5.0	8.6	7.5	4.6	14.0	19.9	19.6	7.9	11.1	6.8	4.5	12.3	9.7	16.3	9.1	17.3	11.3	10.8	16.7	9.3	12.1	2.4	7.5	8.0	2.4	3.2	14.2	4.4	3.1	9.6	18.9	21.5	7.5	10.3	13.5	14.8	2.1	13.6	12.6	3.5	18.4	14.5	8.9	5.9	6.6	7.3	8.1	11.7	7.3	6.3	13.5	12.9	6.5	5.6	10.1	16.3	12.3	11.9	4.3	16.1	25.5	6.2	8.2	6.5	0.5	0.4	0.3	2.8	1.8	4.0	0.8	2.4	3.5	2.2	0.6	3.8	3.6	0.3	5.6	0.5	3.1	3.7	0.8	4.7	7.4	20.0	8.6	5.4	2.8	3.3	4.4	3.3	4.4	0.0	1.0	0.0	7.0	7.3	7.4	2.4	0.0	4.0	7.9	1.8	9.8	11.4	5.0	3.5	302.5	5.2	0.9	0.0	1.8	20.4	5.5	6.6	2.3	2.9	4.3	11.1	3.4	1.8	1.8	78.4	4.4	2.4	1.7	1.0	2.8	2.4	2.2	1.1	2.5	5.0	9.8	6.5	6.6	37.0	52.7	7.8	7.4	1.8	3.9	10.9
SV2A	"KIAA0736, SV2"	ENSG00000159164	"Synaptic vesicle glycoprotein 2A"	Q7L0J3	1	149903318-149917882	"FDA approved drug targets, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3;parathyroid gland: 34.0"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 95.8;Horizontal cells: 90.6;Muller glia cells: 25.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 27.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002226, HPA007863"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB002226: AB_564144, HPA007863: AB_1080135"	"unprognostic (8.05e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.24e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.81e-3)"	2.0	7.3	20.4	2.8	24.7	4.5	1.5	36.8	75.3	3.2	2.3	4.8	0.9	1.9	5.6	18.0	2.0	3.2	3.2	1.5	22.3	30.5	1.7	1.2	1.8	2.3	21.6	25.1	2.6	1.9	34.0	7.2	1.9	32.9	3.1	2.2	3.1	1.7	3.7	1.1	1.5	2.2	6.6	16.8	2.0	2.0	1.6	6.0	0.3	4.0	0.0	2.0	2.5	1.2	1.2	0.8	2.1	0.7	1.7	2.5	0.6	0.1	0.0	10.3	0.0	1.0	3.0	1.1	4.3	15.2	13.0	18.8	0.3	0.4	0.1	3.9	6.5	13.7	0.2	0.1	0.9	11.2	0.0	2.4	13.5	0.7	0.7	9.9	0.1	0.2	6.8	0.1	20.7	1.5	14.5	1.1	12.4	0.1	14.1	8.5	0.1	13.0	0.6	26.1	0.0	0.0	4.5	6.5	0.2	0.1	0.3	21.6	17.4	0.0	0.1	9.9	10.3	0.1	8.2	0.0	12.1	12.2	0.5	15.8	0.1	0.1	0.0	21.2	0.1	4.8	1.5	0.7	0.4	1.8	0.3	1.9	0.7	1.9	1.1	0.2	1.2	1.0	2.2	2.1	1.7	0.3	0.8	2.5	0.6	20.4	24.7	36.8	40.0	22.3	30.5	21.6	25.1	32.9	6.0	0.0	1.4	0.0	2.0	0.1	95.8	0.6	0.0	1.4	0.0	0.0	3.9	0.3	0.0	0.0	0.3	1.4	0.0	0.0	0.3	0.7	1.5	1.0	0.0	0.0	0.2	90.6	4.1	5.5	0.0	0.0	0.0	0.3	0.0	0.0	0.2	25.1	0.2	0.0	5.3	0.0	11.4	0.0	4.1	1.2	0.8	0.4	0.3	2.5	0.3	0.6
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083172-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 52.2"	"Cell type enriched"	"Detected in some"	4	"Intestinal endocrine cells: 19.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 52.2;pons and medulla: 26.6"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.2"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 4.2"	"Group enriched"	"Detected in some"	5	"Karpas-707: 12.2;SCLC-21H: 5.0;SH-SY5Y: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.5	5.5	0.8	1.3	52.2	0.7	1.2	1.2	9.5	0.7	0.8	0.5	0.0	1.0	0.7	0.9	0.6	1.8	0.6	0.8	0.6	8.3	0.4	0.4	0.4	0.5	5.6	1.9	2.6	0.8	0.9	0.8	0.4	26.6	1.0	1.1	1.1	1.7	1.2	0.3	0.7	1.3	1.0	5.8	0.6	1.6	1.0	6.7	0.0	0.5	0.0	0.4	0.6	0.4	0.1	0.1	4.2	0.2	0.1	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	11.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.8	52.2	1.2	9.5	0.6	8.3	5.6	1.9	26.6	6.7	0.0	0.0	0.0	0.5	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.1	0.0	19.0	0.6	0.0	0.7	0.0	0.0	3.3	0.0	0.5	0.8	0.0	0.0	0.0	0.0	4.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	1.1
SVBP	"CCDC23, MGC45441"	ENSG00000177868	"Small vasohibin binding protein"	Q8N300	1	42807052-42817252	"Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 164.4;Spermatogonia: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008507	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Secreted to blood"	Yes	No			"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA008507: AB_2072066"	"prognostic favorable (6.33e-4)"	"unprognostic (2.68e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	20.1	14.1	25.6	11.1	18.9	32.3	20.1	24.0	20.4	16.2	15.7	17.6	10.4	9.7	20.5	23.9	13.0	20.1	15.5	19.6	21.8	19.7	16.0	15.9	13.8	17.8	23.5	22.3	34.4	9.1	10.7	20.0	23.5	20.4	16.8	14.5	13.6	11.6	14.5	21.1	10.1	11.8	17.1	26.9	14.3	11.5	38.2	18.7	29.2	15.5	16.1	19.4	16.2	15.1	24.5	16.0	30.2	16.8	14.3	44.8	9.7	10.2	4.9	32.3	11.6	13.1	20.9	15.7	8.8	7.3	12.0	12.4	9.0	8.2	11.1	9.7	11.8	9.4	7.1	5.7	9.4	16.2	19.7	9.8	22.3	4.9	17.9	10.6	16.7	14.6	13.1	15.1	6.7	6.9	13.0	12.1	22.4	17.3	6.0	15.3	4.8	16.7	20.0	17.7	9.8	6.0	12.2	24.6	7.8	12.7	11.2	19.3	17.3	10.5	6.1	12.6	35.9	4.8	47.3	9.2	10.6	12.0	8.5	14.2	5.8	7.1	8.0	6.8	11.4	10.0	20.8	16.6	30.2	11.4	15.9	10.3	22.1	20.4	14.0	16.0	24.5	19.2	16.4	29.3	14.3	16.8	13.4	44.8	9.7	25.6	18.9	24.0	20.4	21.8	19.7	23.5	22.3	20.4	18.7	8.9	4.6	32.1	27.2	0.0	5.5	0.0	28.1	13.4	17.0	19.2	2.0	47.5	46.4	41.3	113.1	20.3	12.5	93.5	21.4	53.4	17.5	19.3	10.5	31.8	64.1	6.4	17.5	31.3	40.5	49.2	39.7	28.7	0.0	64.1	23.7	13.2	34.6	28.5	50.5	34.8	13.5	58.2	0.0	164.4	149.9	0.0	51.5	20.0	30.2	25.4
SWI5	"bA395P17.9, C9orf119, SAE3"	ENSG00000175854	"SWI5 homologous recombination repair protein"	Q1ZZU3	9	128275379-128288990	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 892.4;Late spermatids: 836.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA052032	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA052032: AB_2681702"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.38e-2)"	10.2	11.7	14.7	11.8	15.9	6.0	17.9	18.0	13.2	18.2	9.0	12.3	48.0	9.9	13.0	44.8	13.5	20.4	12.7	14.8	12.5	13.2	14.2	18.0	12.5	8.7	16.7	11.0	19.6	13.2	26.5	23.8	10.7	13.6	14.6	8.1	14.1	15.2	50.7	14.1	10.3	9.5	12.8	13.7	7.7	9.2	57.1	16.2	8.9	27.8	12.5	10.5	12.4	17.1	12.6	14.2	28.1	9.6	13.4	15.3	10.0	9.5	17.1	10.2	11.8	27.6	25.3	11.5	16.9	22.5	22.0	14.9	21.9	11.3	9.1	22.6	27.5	13.6	16.1	16.2	22.5	15.0	13.7	12.1	6.9	32.8	17.1	35.6	4.4	6.5	21.2	10.8	36.6	19.8	19.5	21.0	33.6	16.3	14.8	22.4	39.0	9.6	6.4	6.9	22.2	35.7	9.0	14.0	14.5	14.7	5.0	11.7	6.5	21.0	13.5	20.0	11.8	22.4	4.8	13.0	16.0	13.3	30.9	14.2	15.7	23.5	12.1	21.8	6.9	17.2	28.1	9.6	16.4	10.2	5.7	12.0	12.6	10.1	10.2	9.8	12.5	12.2	15.3	6.4	13.4	5.6	14.2	10.0	10.0	14.7	15.9	18.0	13.2	12.5	13.2	16.7	11.0	13.6	16.2	6.0	19.5	14.5	34.6	21.8	13.1	30.0	30.6	14.7	18.2	34.9	11.8	55.7	56.3	21.8	892.4	21.5	27.0	0.0	33.5	35.4	41.0	29.6	9.2	68.6	29.0	1.6	24.5	27.6	19.7	836.9	40.0	17.2	35.4	27.1	23.4	24.7	25.7	20.1	29.7	53.2	17.7	32.3	26.4	56.3	38.7	19.2	97.8	18.3	20.5	27.5
SWSAP1	"C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1"	ENSG00000173928	"SWIM-type zinc finger 7 associated protein 1"	Q6NVH7	19	11374685-11376951	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052712	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA052712: AB_2681925"	"unprognostic (6.45e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-3)"	2.9	7.8	1.9	3.6	2.7	5.8	8.3	5.0	2.5	5.3	4.3	2.7	5.9	4.5	4.8	6.0	6.2	5.4	3.9	3.8	2.1	2.0	6.9	12.8	5.8	6.1	2.8	1.8	6.0	10.2	2.9	5.3	11.9	3.5	4.7	3.2	4.5	6.8	5.1	10.7	5.4	5.1	2.0	2.5	10.5	5.0	15.3	2.7	12.2	7.6	4.8	7.8	5.0	3.4	10.6	11.9	13.5	16.4	8.8	9.6	5.9	4.8	3.9	2.6	2.0	2.7	2.2	3.7	1.3	1.4	2.8	2.6	4.3	3.9	9.1	6.2	1.2	2.1	3.7	2.2	5.0	0.3	3.1	5.3	4.6	2.4	5.8	2.1	7.4	8.1	3.6	4.6	1.6	1.4	2.1	3.4	4.4	5.0	4.7	1.5	9.9	4.1	9.1	6.0	3.8	5.8	3.4	1.2	9.5	5.2	3.4	5.0	4.0	2.0	6.1	3.5	1.6	8.0	7.9	3.4	2.9	1.9	3.5	2.6	6.4	8.0	6.0	1.5	7.9	2.0	2.0	16.4	4.0	7.1	14.6	6.8	10.6	7.4	7.5	11.9	10.2	9.6	8.0	13.5	8.8	13.5	8.3	6.7	5.9	1.9	2.7	5.0	2.5	2.1	2.0	2.8	1.8	3.5	2.7	3.0	1.3	12.6	8.4	2.4	7.1	2.8	2.5	5.3	1.2	15.7	7.9	15.4	34.9	5.9	7.7	5.0	8.4	0.0	9.3	9.5	3.7	5.2	1.1	11.3	10.5	9.5	2.4	4.9	7.1	1.3	10.9	7.6	6.8	6.4	12.0	12.1	5.1	11.5	7.4	13.4	11.0	6.5	4.9	10.3	11.9	2.8	26.5	6.2	7.4	4.7
SWT1	"C1orf26, FLJ20121, HsSwt1"	ENSG00000116668	"SWT1, RNA endoribonuclease homolog"	Q5T5J6	1	185157080-185291765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.1"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 99.9;Late spermatids: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024214, HPA027334"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA024214: AB_1845642, HPA027334: AB_1845643"	"unprognostic (2.67e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.41e-3)"	"unprognostic (5.71e-3)"	"unprognostic (9.26e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.35e-2)"	5.0	4.8	4.1	3.4	6.0	8.7	8.4	6.5	5.9	5.0	5.8	5.7	7.1	5.6	6.6	5.4	3.8	4.1	4.5	4.4	4.2	4.7	5.7	4.7	5.4	7.6	5.2	4.6	7.7	12.4	5.8	9.9	18.1	6.8	5.7	4.1	3.2	6.7	7.9	5.0	3.9	5.4	4.0	9.1	4.8	6.1	39.1	6.5	7.6	6.1	3.2	3.6	5.2	9.1	4.5	1.5	12.0	4.8	1.0	7.2	1.5	1.9	1.7	4.7	2.6	7.9	6.1	4.0	1.9	3.3	2.4	3.8	1.4	1.6	1.9	3.9	1.5	2.5	1.6	2.8	2.6	3.1	5.1	1.9	2.0	1.2	1.8	3.9	0.6	1.7	4.4	2.7	2.7	2.4	4.2	5.9	3.9	4.3	9.6	2.5	0.6	2.2	1.8	5.1	5.1	1.0	1.7	4.2	4.6	2.3	1.1	1.0	7.4	1.6	2.4	6.7	11.6	2.8	1.3	2.8	3.2	2.1	3.1	1.2	17.5	13.3	0.7	3.6	1.2	1.2	12.0	2.5	3.4	2.0	2.2	3.7	3.1	4.0	3.0	1.5	4.5	3.9	2.9	7.2	1.0	4.8	1.4	7.2	1.5	4.1	6.0	6.5	5.9	4.2	4.7	5.2	4.6	6.8	6.5	3.0	0.6	2.2	1.7	0.9	3.9	7.0	2.5	1.4	4.5	5.2	3.9	2.8	0.0	2.2	99.9	3.4	3.5	0.0	2.3	5.4	4.1	2.4	2.3	3.2	3.0	7.9	0.0	8.6	5.7	37.0	4.4	2.8	1.7	3.6	2.9	2.4	1.6	8.6	5.3	5.0	4.4	0.0	1.9	22.7	11.5	0.5	5.6	2.1	2.4	1.6
SYCE3	C22orf41	ENSG00000217442	"Synaptonemal complex central element protein 3"	A1L190	22	50551112-50562905	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 61.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 349.3;Spermatocytes: 429.3;Spermatogonia: 109.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 8.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.8;Karpas-707: 7.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047813			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA047813: AB_2797234"	"unprognostic (2.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.68e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.20e-2)"	0.4	0.4	0.7	0.5	0.9	0.1	0.7	0.2	0.6	0.2	0.4	0.5	0.4	0.1	0.2	1.1	0.2	0.8	0.6	0.1	0.5	0.7	1.0	0.8	0.4	0.9	0.9	0.3	0.1	0.2	0.2	0.4	0.4	0.7	0.1	0.0	0.2	0.7	0.1	0.0	0.2	0.0	0.5	0.7	0.1	0.2	61.5	0.4	0.0	1.1	0.2	0.3	0.7	0.0	0.5	1.9	8.0	1.3	0.0	0.3	0.3	0.4	0.7	0.1	0.3	0.6	0.5	0.4	0.5	0.0	0.0	0.0	0.0	8.8	0.4	3.2	0.0	1.8	0.0	0.9	1.0	0.0	0.0	0.5	0.0	0.6	0.0	4.0	0.0	1.6	2.3	2.0	0.3	1.4	0.5	0.0	1.8	0.0	7.4	0.4	3.3	0.0	0.0	0.3	3.7	0.0	0.0	0.0	3.9	1.2	2.6	0.8	2.3	0.0	2.2	1.4	0.3	2.1	1.8	0.0	0.7	0.8	0.0	0.1	1.9	0.4	1.1	0.9	0.3	0.2	0.0	1.3	1.5	0.0	1.1	0.3	0.0	0.0	0.0	1.9	0.5	0.0	0.2	8.0	0.0	0.9	0.0	0.0	0.3	0.7	0.9	0.2	0.6	0.5	0.7	0.9	0.3	0.7	0.4	0.0	0.0	0.0	0.4	0.1	0.5	0.4	5.1	0.0	0.0	1.8	0.0	4.2	3.3	1.3	349.3	0.1	0.3	0.0	0.6	2.6	0.1	0.3	0.0	1.6	1.4	0.0	0.0	0.6	1.2	52.2	10.0	0.0	0.0	4.6	0.0	0.9	1.2	0.0	6.7	2.1	0.4	45.3	0.0	429.3	109.7	0.1	3.1	0.0	0.3	0.9
SYCP1	"CT8, HOM-TES-14, SCP1"	ENSG00000198765	"Synaptonemal complex protein 1"	Q15431	1	114854803-114995370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 30.6"	"Cell type enriched"	"Detected in some"	14	"Spermatocytes: 1077.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	93	"THP-1: 19.5"	"Region enriched"	"Detected in single"	51	"cerebellum: 16.5"	"Not detected"	"Not detected"			HPA021083	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA021083: AB_1857685"	"unprognostic (2.91e-1)"									"unprognostic (6.89e-3)"				"unprognostic (4.87e-1)"	"unprognostic (8.74e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.5	0.0	1077.5	21.3	0.0	0.0	0.0	0.0	0.0
SYDE1	"7h3, FLJ13511, SYD1"	ENSG00000105137	"Synapse defective Rho GTPase homolog 1"	Q6ZW31	19	15107403-15114988	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.0"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 126.4;Sertoli cells: 84.1;Syncytiotrophoblasts: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013328	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA013328: AB_1848705"	"unprognostic (9.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.65e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (1.82e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.27e-4)"	15.6	7.7	3.5	5.9	4.3	0.1	19.9	2.0	3.5	19.5	13.9	4.4	3.8	4.3	18.6	6.8	10.7	12.2	10.5	9.3	4.0	1.8	9.6	3.3	9.4	4.9	3.1	2.4	17.9	4.6	2.3	3.8	60.0	5.0	11.8	2.9	22.0	3.3	13.6	5.9	4.4	5.7	14.2	2.5	7.6	7.9	7.4	4.3	0.9	8.2	5.8	2.8	12.9	12.8	0.2	0.3	0.0	0.0	0.0	0.5	0.0	4.1	6.4	3.5	9.0	7.9	7.3	2.7	17.5	12.9	17.2	14.7	1.4	2.5	0.0	11.6	17.6	5.9	2.6	2.7	3.1	9.7	0.1	3.0	0.6	11.9	2.8	15.0	0.0	0.0	12.7	2.3	10.3	4.7	10.5	3.1	0.0	0.0	0.0	12.8	2.0	0.0	0.0	5.7	0.1	6.6	0.0	8.6	0.0	4.2	0.5	0.1	6.9	9.8	6.0	11.7	3.5	0.7	0.4	6.6	41.5	12.6	19.0	18.8	0.0	0.1	0.0	11.2	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	2.0	3.5	4.0	1.8	3.1	2.4	5.0	4.3	3.0	1.4	0.5	0.6	2.2	0.3	3.9	2.5	0.0	1.2	1.8	0.0	4.9	0.0	3.9	8.8	12.6	0.0	0.0	0.3	126.4	14.7	0.5	0.0	0.0	3.0	1.6	0.0	19.0	1.3	12.0	27.3	0.8	13.5	0.0	0.0	13.2	1.5	0.0	39.6	5.5	0.4	84.1	29.9	1.2	0.5	2.3	112.5	0.0	0.0	0.1
SYDE2	FLJ13815	ENSG00000097096	"Synapse defective Rho GTPase homolog 2"	Q5VT97	1	85156873-85201046	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 1: 47.6;Cone photoreceptor cells: 51.1;Rod photoreceptor cells: 133.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.4;SK-BR-3: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027138, HPA058378"	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus"		No	No			"Nucleoli, Nucleoli rim, Golgi apparatus"		"HPA027138: AB_1857686, HPA058378: AB_2683696"	"unprognostic (1.68e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.84e-3)"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.69e-2)"	2.5	1.8	1.1	2.6	1.7	0.6	3.8	0.6	2.2	3.5	11.4	0.5	2.0	2.5	3.8	2.6	5.6	2.3	7.7	5.4	2.8	0.9	4.7	6.4	9.1	3.4	0.9	2.4	3.3	9.9	8.4	5.1	5.0	0.9	5.0	2.6	7.2	3.9	2.5	2.4	1.9	9.2	13.3	0.9	1.0	6.0	3.3	1.0	0.6	5.2	1.0	0.8	6.0	9.6	0.3	0.1	1.4	0.1	0.3	0.7	0.2	2.2	0.7	0.7	0.8	2.5	0.8	16.4	2.5	1.6	1.5	2.4	4.3	0.8	0.0	0.8	1.6	3.0	4.3	8.1	1.1	2.4	0.9	2.3	2.0	1.7	1.5	3.0	1.3	0.5	1.1	1.3	1.2	1.1	1.0	0.3	1.5	2.5	0.0	1.2	3.1	1.3	0.2	4.2	1.7	0.9	0.0	4.4	0.5	1.2	5.7	0.1	0.0	1.8	8.9	2.6	3.9	2.0	1.8	0.3	1.9	4.3	0.0	2.5	0.0	0.3	0.9	0.2	0.9	1.7	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.3	0.7	0.3	1.4	0.3	0.0	0.1	0.0	0.2	1.1	1.7	0.6	2.2	2.8	0.9	0.9	2.4	0.9	1.0	47.6	7.7	0.0	8.1	7.3	4.6	21.2	2.5	2.7	10.3	1.8	51.1	7.9	6.6	1.6	2.4	1.8	3.3	0.0	4.0	3.8	5.4	4.5	1.1	6.0	1.3	0.0	18.5	3.1	0.3	0.9	2.0	1.4	18.6	2.8	3.3	6.4	3.2	0.0	2.5	4.6	133.9	0.0	2.0	11.5	7.2	4.0	2.2	2.2	3.7	3.8
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 53.8;Hofbauer cells: 63.0;Kupffer cells: 79.3;Macrophages: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.4;HEL: 22.7;HL-60: 31.3;HMC-1: 20.9;REH: 26.2;THP-1: 24.1;U-698: 18.6;U-937: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		1000000	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.2	3.3	6.0	38.1	9.6	18.2	6.7	1.1	4.5	3.7	10.3	6.7	1.5	12.3	2.3	6.7	16.2	6.9	6.6	5.5	7.2	3.2	8.6	2.5	13.7	36.4	9.1	2.5	2.1	8.9	25.9	3.1	5.0	6.1	4.1	8.3	2.8	8.9	1.8	1.4	8.3	22.2	3.5	11.3	38.5	7.4	5.5	7.9	30.5	18.1	7.8	32.2	8.6	7.5	23.1	24.9	32.8	21.4	8.7	0.1	10.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	39.4	1.1	0.0	1.3	6.1	0.8	3.2	0.0	0.0	5.4	22.7	0.0	0.0	0.0	31.3	20.9	0.0	4.5	0.0	0.4	0.0	0.0	4.9	0.6	3.2	0.0	4.8	0.0	13.7	0.2	14.8	0.0	26.2	0.0	10.8	0.8	5.9	2.1	1.8	0.0	2.8	0.0	0.1	2.5	24.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.6	0.0	22.1	0.0	1.4	21.4	23.3	0.1	19.0	0.1	23.1	0.0	0.0	24.9	17.5	0.0	0.0	32.8	8.7	16.4	18.5	0.0	10.2	6.0	9.6	1.1	4.5	7.2	3.2	9.1	2.5	6.1	7.9	11.9	22.7	53.8	3.7	3.1	0.9	1.6	12.7	12.0	17.0	14.0	0.0	1.2	13.3	12.6	5.5	1.1	18.4	0.0	10.9	1.3	1.1	1.8	40.6	0.9	63.0	0.0	9.9	4.9	79.3	4.7	0.6	66.0	11.8	24.4	23.8	0.0	15.3	28.1	0.0	0.3	0.1	6.5	1.0	0.7	0.7	5.0	1.1	5.3	24.7	6.5
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863290	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 114.2;Late spermatids: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: AB_2678003"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	14.7	15.9	15.3	23.7	24.2	20.7	15.2	25.1	32.2	17.1	18.2	25.3	20.3	18.6	22.6	18.9	17.4	19.3	17.6	14.6	17.3	18.0	15.0	21.6	15.6	27.2	19.3	16.8	21.6	16.3	20.5	24.0	34.8	19.9	17.4	12.2	16.1	21.5	17.5	33.4	21.1	18.0	13.9	18.7	23.0	19.4	38.0	22.0	28.5	20.5	11.6	23.4	16.8	16.7	7.9	9.2	6.5	7.1	4.2	5.2	2.7	19.5	34.6	14.2	10.7	13.9	17.8	23.9	15.6	11.0	16.0	18.3	15.3	18.0	34.5	10.7	17.6	9.1	16.1	19.0	17.0	14.4	26.7	21.3	19.9	23.7	16.1	16.0	21.8	23.4	12.9	10.4	17.2	19.6	11.0	16.5	18.3	26.2	22.6	13.9	18.3	20.2	23.1	12.1	17.1	8.0	21.7	16.5	21.4	11.4	35.4	16.2	20.5	19.1	12.5	12.6	14.9	17.1	30.2	18.2	13.3	21.3	10.2	22.7	29.9	56.5	28.0	15.2	14.7	21.8	2.1	5.1	2.2	3.4	3.8	3.2	4.7	3.0	5.2	4.2	7.9	2.6	2.4	6.5	4.2	7.1	9.2	2.3	2.7	15.3	24.2	25.1	32.2	17.3	18.0	19.3	16.8	19.9	22.0	0.0	7.7	30.4	14.0	18.5	20.9	5.9	22.9	5.3	5.7	24.4	33.4	28.3	46.4	19.9	114.2	15.7	30.0	0.0	14.8	27.8	19.9	17.1	12.7	31.6	15.8	20.6	34.9	31.3	25.6	108.4	17.8	20.1	13.5	41.5	31.6	9.8	17.3	23.0	19.8	10.3	28.0	19.4	14.2	22.9	39.6	18.6	47.9	13.8	27.0	18.6
SYN2	"SYNII, SYNIIa, SYNIIb"	ENSG00000157152	"Synapsin II"		3	12004402-12191400	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	20	"brain: 72.5"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 14.6;Cone photoreceptor cells: 5.9;Horizontal cells: 12.7;Spermatocytes: 4.9;Spermatogonia: 6.6"	"Cancer enhanced"	"Detected in many"		"glioma: 4.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.3;HMC-1: 6.1;NTERA-2: 5.2;SCLC-21H: 4.2;SH-SY5Y: 16.5;SuSa: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037012, CAB079005"		Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB079005: , HPA037012: AB_2675431"	"unprognostic (1.62e-3)"	"unprognostic (1.60e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-4)"	"unprognostic (9.94e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.78e-2)"	3.7	2.7	28.2	0.7	23.3	0.5	1.4	9.2	72.5	1.0	0.8	0.2	0.0	0.8	1.2	1.2	0.5	0.8	0.7	0.7	15.4		1.4	0.4	0.8	0.5	0.0	33.4	1.5	0.5	1.8	0.0	2.3	15.3	0.7	0.9	0.0	0.9	0.6	0.9	0.9	1.2	1.9	2.2	0.8	1.2	2.4	1.6	0.0	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.7	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.1	0.4	0.0	0.5	1.5	0.0	0.4	0.0	0.0	0.0	0.0	5.2	0.1	0.4	0.0	0.0	0.0	0.0	0.2	4.2	16.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	14.6	1.0	0.0	0.0	0.0	0.0	5.9	1.4	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.5	12.7	0.0	0.0	1.6	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	2.3	2.6	0.0	0.0	4.9	6.6	0.0	0.7	0.0	0.0	0.1
SYNC	"SYNC1, SYNCOILIN"	ENSG00000162520	"Syncoilin, intermediate filament protein"	Q9H7C4	1	32680360-32703596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 51.0"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 69.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.8;fHDF/TERT166: 38.9;hTERT-RPE1: 23.8;U-138 MG: 34.1;WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028311, HPA063549"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA028311: AB_2672554, HPA063549: "	"unprognostic (3.99e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.99e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.32e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-4)"	4.2	3.2	3.7	5.8	3.9	0.1	6.8	1.1	4.2	5.9	7.2	3.7	1.2	1.5	7.7	7.7	15.6	5.3	4.8	7.9	3.5	3.9	1.4	1.1	4.6	0.6	3.6	2.6	7.9	0.9	2.7	2.8	1.1	3.5	6.1	4.8	4.6	4.1	8.4	51.0	1.6	4.0	28.5	4.5	1.9	6.5	5.4	1.9	0.0	1.9	23.6	2.3	7.8	2.5	0.0	0.3	0.0	1.8	0.0	0.3	0.0	0.0	1.3	0.1	0.0	6.5	10.2	0.0	10.5	26.8	9.1	6.6	0.1	0.1	0.0	0.5	38.9	11.0	0.4	0.3	0.2	5.5	0.0	0.0	0.2	4.4	0.9	5.2	0.0	0.0	15.7	0.9	10.1	0.3	23.8	2.9	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.1	0.9	0.0	2.0	0.0	10.6	0.0	0.1	0.1	10.6	2.2	0.0	2.1	0.6	0.0	1.7	34.1	1.5	18.1	2.7	0.0	0.0	0.0	9.5	0.1	22.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.7	3.9	1.1	4.2	3.5	3.9	3.6	2.6	3.5	1.9	8.9	6.0	18.0	11.4	19.6	44.6	0.8	17.8	5.3	13.6	8.7	37.3	7.3	5.0	10.7	8.6	8.7	7.8	23.3	4.7	7.6	12.4	10.4	21.9	16.1	4.8	69.9	7.0	20.3	20.5	12.4	38.6	9.9	32.1	4.6	7.0	16.9	6.8	8.0	60.5	7.8	52.5	19.4	12.0	30.1	26.0	19.4	4.2	21.3	8.9	8.5
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607785-85643792	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		77000	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	29.1	28.3	27.9	31.3	36.2	30.4	28.4	35.6	37.9	32.9	29.4	19.2	31.8	20.4	32.7	18.9	48.8	24.5	21.9	31.3	29.3	19.0	25.2	31.3	25.7	35.0	31.9	23.1	26.2	34.9	37.5	27.9	31.3	28.2	23.1	29.6	17.3	31.4	32.8	41.4	27.2	23.7	53.5	28.1	24.7	25.4	19.8	30.1	38.1	42.0	29.8	41.7	31.2	39.4	13.2	20.9	4.6	20.0	18.1	18.6	12.6	32.2	24.2	40.4	23.5	26.6	31.7	25.6	47.9	39.5	43.5	43.2	39.6	21.3	76.3	34.9	46.1	34.6	31.3	59.1	47.5	76.3	26.2	27.1	68.0	29.2	27.2	22.5	83.0	29.3	25.9	27.4	49.7	51.2	23.5	45.8	22.9	68.1	36.0	50.2	35.5	38.8	35.4	38.7	31.2	25.8	58.3	64.6	32.4	35.6	51.8	38.1	30.9	33.3	28.2	19.6	25.2	24.4	51.7	42.0	29.5	24.1	30.9	57.2	22.5	44.4	50.3	27.0	50.2	41.0	1.0	13.0	4.6	17.7	18.6	18.6	13.2	16.8	15.9	20.9	11.9	15.3	16.6	1.6	18.1	20.0	15.5	16.7	12.6	27.9	36.2	35.6	37.9	29.3	19.0	31.9	23.1	28.2	30.1	107.2	97.5	44.7	111.8	131.7	43.4	77.5	48.4	87.0	134.2	43.6	15.7	88.7	46.4	116.0	77.9	92.0	42.3	0.0	85.9	107.5	80.8	88.9	59.0	74.1	86.4	58.8	54.4	52.8	60.2	17.6	68.1	69.2	50.6	61.3	65.0	37.9	106.5	45.6	60.5	62.1	40.3	19.4	102.9	77.7	58.0	123.8	98.7	52.5	77.4	123.7
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63852983-64226433	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 111.4"	"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 579.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 15.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in many"		"eosinophil: 30.3"	"Group enriched"	"Detected in many"	10	"granulocytes: 30.3;T-cells: 16.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Approved	"Nuclear membrane,Intermediate filaments"		No	Yes			"Nuclear membrane, Intermediate filaments"		"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.8	4.5	2.3	18.0	2.8	5.5	29.7	15.8	3.3	16.1	13.4	1.9	7.7	3.6	18.8	13.6	17.2	7.1	8.6	27.3	2.3	2.4	35.6	13.0	15.2	11.0	2.7	2.1	22.8	22.4	60.1	17.6	14.1	16.3	13.7	4.8	13.0	9.8	9.2	111.4	24.1	10.6	10.2	2.3	16.0	6.9	14.3	1.9	16.9	30.9	29.7	15.8	11.1	26.4	2.3	1.1	30.3	0.1	1.5	16.3	1.3	17.7	6.0	8.9	2.8	8.9	2.6	11.8	1.2	1.2	2.0	3.6	2.0	3.7	44.5	1.9	1.2	2.2	8.6	5.8	2.3	2.5	6.7	2.3	0.2	4.4	0.5	1.7	0.7	0.2	3.7	8.4	2.6	2.4	2.0	4.6	5.7	0.2	3.6	1.5	9.9	4.7	0.2	4.0	5.7	1.8	5.6	8.4	1.4	13.5	8.5	8.2	6.1	14.1	3.3	3.8	3.8	3.9	0.1	4.0	3.3	5.3	1.1	3.7	4.9	2.1	16.9	0.9	0.0	4.7	0.2	0.0	30.3	16.3	0.1	11.0	2.1	10.0	10.8	0.0	2.3	4.9	7.4	13.3	1.5	0.1	1.1	11.1	1.3	2.3	2.8	15.8	2.6	2.3	2.4	2.7	2.1	16.3	1.9	285.9	119.8	37.9	110.7	98.9	26.4	222.5	107.0	271.7	293.5	191.9	172.8	136.2	16.6	78.5	6.5	155.5	34.5	0.0	48.5	56.0	55.6	45.4	24.4	28.8	14.9	6.4	44.4	68.7	4.7	8.1	93.5	7.9	45.5	4.6	57.4	99.5	65.8	10.5	50.2	64.2	579.2	109.9	65.5	13.6	7.8	76.5	187.3	96.2	67.0	63.0
SYNGAP1	"KIAA1938, RASA5, SYNGAP"	ENSG00000197283	"Synaptic Ras GTPase activating protein 1"	Q96PV0	6	33419661-33457541	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Autism, Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 21.8;Horizontal cells: 36.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.9"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AF22: 20.9;HMC-1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038373	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038373: AB_10670779"	"unprognostic (3.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (9.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.47e-2)"	4.5	5.0	29.7	11.9	28.6	6.2	4.3	27.2	33.7	7.8	5.9	5.5	2.4	6.0	13.0	5.3	4.2	11.9	6.1	4.4	37.9	7.6	4.0	2.2	5.9	10.3	4.1	38.9	12.8	3.5	10.0	26.1	6.2	7.9	6.3	4.7	3.2	3.7	7.1	2.3	6.2	5.7	11.1	8.7	9.7	4.9	8.7	9.3	8.9	5.6	0.2	7.0	6.9	6.4	1.5	0.1	0.1	0.2	0.0	1.9	0.0	2.0	0.9	20.9	7.7	4.4	4.5	2.7	5.1	3.2	2.8	2.2	8.7	0.9	5.9	1.3	2.4	2.6	3.0	2.6	2.9	2.0	3.4	1.7	14.7	2.3	0.5	2.9	2.2	17.2	3.1	0.9	5.3	2.5	10.8	2.1	4.9	4.6	2.7	2.1	4.4	3.5	3.4	10.5	0.9	2.2	13.8	0.5	2.4	2.1	1.5	5.1	4.1	1.9	3.6	1.6	4.9	7.9	2.1	0.6	6.0	5.9	2.4	0.9	3.2	1.1	4.3	3.4	2.6	1.4	0.0	0.2	0.1	0.3	0.0	0.8	0.1	1.9	0.9	0.0	1.5	0.9	0.2	0.1	0.0	0.1	0.1	0.1	0.0	29.7	28.6	27.2	33.7	37.9	7.6	4.1	38.9	7.9	9.3	0.0	1.3	2.2	1.7	3.2	21.8	1.4	7.6	9.4	4.5	3.5	9.8	0.8	1.7	1.6	4.4	6.2	1.3	0.0	1.2	1.0	8.9	1.5	4.7	0.8	1.6	36.5	9.2	8.6	3.7	1.1	10.6	2.5	3.3	2.8	1.7	5.6	1.7	0.0	12.7	1.9	7.4	19.4	7.8	7.1	6.7	3.8	0.7	12.2	2.8	1.4
SYNGR2		ENSG00000108639	"Synaptogyrin 2"	O43760	17	78168558-78173527	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"monocytes: 1357.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 94.6;OE19: 77.8;SK-BR-3: 88.1;T-47d: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014742	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA014742: AB_2669079"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.84e-1)"	"unprognostic (6.77e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (4.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.78e-2)"	28.6	14.5	10.3	29.0	19.2	28.5	29.9	6.8	15.7	17.9	30.0	32.8	19.3	26.8	16.2	19.9	31.2	21.3	32.2	31.8	15.3	10.6	30.7	55.1	36.7	54.9	30.2	11.1	17.6	76.0	7.9	22.7	29.8	17.8	30.8	20.2	15.6	74.1	23.3	80.5	35.6	28.1	15.3	36.7	39.0	35.1	13.9	21.7	24.3	27.9	35.5	49.4	24.2	19.4	101.5	91.2	57.2	106.3	20.1	29.7	68.5	23.7	47.8	1.1	9.8	0.4	0.1	7.2	8.2	6.7	6.1	3.6	28.3	23.5	20.3	18.3	3.6	6.5	34.4	4.7	10.3	2.0	13.5	24.9	6.7	7.6	19.4	9.0	11.2	50.3	0.4	11.3	2.0	6.2	11.5	12.8	6.6	27.7	94.6	0.5	45.7	10.3	9.4	3.3	77.8	19.0	6.0	2.4	52.2	18.4	23.1	7.2	8.1	7.0	88.1	7.9	4.6	69.5	15.9	4.5	0.1	7.7	3.8	10.7	41.3	15.1	10.7	5.3	6.7	1.1	57.2	65.3	22.2	18.4	91.5	21.0	101.5	24.7	21.0	91.2	96.1	22.2	18.0	28.0	20.1	106.3	51.5	29.7	68.5	10.3	19.2	6.8	15.7	15.3	10.6	30.2	11.1	17.8	21.7	119.1	112.7	134.0	115.8	110.2	3.5	52.9	73.9	46.8	83.0	162.3	5.9	150.6	8.3	284.7	3.1	71.4	82.1	46.7	381.9	51.2	37.8	196.6	97.4	40.4	245.4	4.8	69.7	45.4	129.4	1.6	20.4	180.7	70.9	1357.1	240.8	4.4	243.5	129.6	15.9	33.8	3.9	38.8	49.9	11.1	10.5	142.8	150.1	44.6	152.7	185.5
SYNGR3		ENSG00000127561	"Synaptogyrin 3"	O43761	16	1989660-1994275	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.3"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 3.9;Horizontal cells: 6.4;monocytes: 4.6;Spermatogonia: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.7;HMC-1: 16.6;Karpas-707: 14.0;SK-BR-3: 17.5;U-266/70: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034278, HPA042842"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB034278: AB_2200905, HPA042842: AB_2678198"	"unprognostic (8.89e-3)"	"prognostic favorable (6.92e-4)"	"unprognostic (6.07e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.92e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.12e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.78e-2)"	1.1	11.1	20.3	3.7	21.8	1.6	1.1	24.2	55.3	1.5	2.3	2.6	0.0	2.2	1.0	1.0	1.3	1.1	1.3	1.4	14.6	40.8	1.7	1.0	1.3	4.0	27.1	20.1	1.5	1.0	9.4	3.1	5.4	28.2	1.3	2.2	0.9	2.1	1.1	0.9	1.1	2.5	1.7	4.4	2.2	2.1	4.2	2.0	0.0	1.0	0.0	4.7	1.4	0.2	3.7	0.7	0.0	0.8	4.6	2.7	0.9	0.4	2.1	2.0	0.2	0.2	0.2	2.4	1.0	1.7	0.8	0.7	3.3	1.6	3.2	0.7	0.7	2.2	1.8	2.2	0.3	0.2	25.7	1.5	0.0	2.8	1.6	1.2	0.0	16.6	0.5	0.1	0.0	0.5	3.9	0.2	1.0	9.2	14.0	0.4	2.4	0.1	0.1	10.3	0.3	0.9	0.0	0.3	2.5	1.3	0.0	4.6	5.8	2.3	17.5	0.2	1.1	2.4	0.2	0.4	0.5	8.1	0.0	0.3	22.1	2.5	3.7	0.3	2.9	0.3	0.0	0.8	0.0	0.9	0.3	2.1	3.2	1.7	2.7	0.7	3.7	2.0	0.8	0.0	4.6	0.7	0.0	1.6	0.9	20.3	21.8	24.2	39.3	14.6	40.8	27.1	20.1	28.2	2.0	0.0	1.1	0.0	0.7	0.2	2.6	3.9	0.0	0.0	0.0	0.0	2.0	0.4	1.7	1.7	0.4	0.3	0.0	0.0	0.4	0.6	0.6	0.8	1.1	0.0	0.2	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.6	0.4	0.8	1.2	0.0	0.0	0.0	0.5	0.0	0.2	2.3	8.1	0.3	2.6	2.2	0.0	0.6
SYNGR4		ENSG00000105467	"Synaptogyrin 4"	O95473	19	48364395-48376376	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 41.5"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 147.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 4.1"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"A549: 9.1;SCLC-21H: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030075, HPA059286"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA030075: AB_10610559, HPA059286: AB_2683965"	"unprognostic (1.58e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.49e-4)"	"unprognostic (2.51e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.87e-2)"	"unprognostic (6.19e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.02e-7)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	0.0	0.0	0.2	0.0	0.7	0.0	0.0	4.1	2.0	0.0	0.2	0.0	0.9	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.7	3.0	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.0	41.5	0.0	0.3	0.1	0.0	0.2	0.2	0.0	1.3	0.7	0.1	0.5	0.0	0.9	0.6	0.1	9.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.2	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.5	2.9	0.5	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	3.4	0.1	0.2	0.5	0.2	0.0	0.6	1.7	0.6	0.0	2.6	0.0	0.0	22.9	0.6	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.0	0.8	0.0	0.0	3.1	1.0	0.7	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.7	4.1	0.9	0.2	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	8.7	0.0	0.0	18.9	0.9	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	6.5	0.0	147.5	4.5	0.0	0.0	0.0	0.1	0.1
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728048	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	5.5	6.8	13.6	5.0	25.9	20.6	4.2	19.5	39.0	4.8	4.8	6.5	0.8	3.9	4.6	5.3	3.9	4.0	5.2	5.2	18.3	18.2	7.4	5.5	6.5	5.7	16.6	18.4	4.6	4.5	10.6	10.9	9.3	33.5	3.6	5.5	7.0	3.8	4.0	4.4	5.0	4.6	5.0	7.3	6.0	4.2	9.0	5.7	3.2	6.8	1.5	4.8	4.7	3.3	0.4	3.1	11.5	6.0	0.5	3.0	1.1	5.6	2.8	5.2	5.7	9.1	7.3	10.6	11.7	6.7	7.2	6.0	6.4	2.6	2.1	3.9	7.0	9.6	5.3	9.3	6.8	8.6	6.7	8.9	14.1	9.2	3.5	4.9	5.8	12.5	4.1	5.1	12.4	6.3	5.9	11.2	7.5	10.5	12.1	9.2	5.7	5.4	4.8	3.7	6.2	6.5	5.9	11.3	7.4	7.6	4.1	5.9	4.6	14.4	9.2	5.6	7.4	7.9	7.5	12.3	11.1	5.5	8.9	6.4	6.3	7.3	4.4	8.4	11.0	8.8	3.7	3.4	7.9	1.6	6.0	2.7	0.2	2.4	2.6	3.1	0.4	2.9	2.8	11.5	0.5	5.3	1.6	3.0	1.1	13.6	25.9	19.5	28.7	18.3	18.2	16.6	18.4	33.5	5.7	6.0	4.8	2.9	2.0	4.2	21.5	7.3	5.1	4.0	2.3	1.8	43.2	13.3	5.0	1.6	14.8	7.9	4.9	0.0	1.2	7.9	3.7	2.2	3.5	3.6	8.6	9.5	2.9	8.6	19.0	8.6	2.6	7.5	1.7	1.0	2.7	19.5	2.1	3.5	4.2	5.0	40.7	6.5	3.4	16.4	10.9	2.9	31.8	6.9	4.0	4.1
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981887-158099176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 62.0"	"Cell type enhanced"	"Detected in many"	8	"Pancreatic endocrine cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 46.3;TIME: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol		NA	NA			Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavorable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	2.8	3.9	12.2	4.9	25.1	15.3	6.7	3.0	18.7	3.9	8.7	50.5	3.7	5.8	5.2	9.4	6.0	4.6	8.0	8.5	17.8	10.9	3.2	4.0	2.8	4.4	46.8	8.8	2.9	6.6	1.1	2.9	2.6	33.0	5.3	8.9	1.4	13.5	5.1	4.3	3.1	5.6	6.6	62.0	3.3	7.0	6.5	24.4	3.0	4.4	1.4	5.3	5.9	3.0	3.2	1.1	9.3	1.3	2.4	3.8	0.8	5.4	19.2	1.6	2.5	1.2	4.0	8.5	10.1	20.5	12.1	14.3	9.8	4.6	0.1	6.9	19.4	46.3	5.2	3.4	6.3	14.1	7.6	3.2	10.6	10.0	10.3	2.3	3.7	11.6	2.0	3.4	18.4	4.3	16.4	21.0	5.6	8.1	2.4	5.5	2.5	4.6	4.1	1.8	17.1	10.7	2.0	6.6	4.9	4.0	6.3	12.2	0.7	7.8	4.9	1.9	6.3	3.8	2.3	37.1	9.2	9.4	21.2	12.2	1.0	2.6	0.2	17.2	5.9	6.3	4.5	1.3	1.1	1.9	0.6	3.8	1.9	2.6	1.7	1.1	3.2	2.2	1.7	9.3	2.4	0.8	1.1	2.1	0.8	12.2	25.1	3.0	18.7	17.8	10.9	46.8	8.8	33.0	24.4	3.0	3.5	2.7	16.6	19.3	0.0	10.4	10.2	10.7	6.8	17.4	0.0	5.3	3.3	36.4	22.7	10.5	15.3	0.0	30.7	4.2	14.6	30.3	4.7	4.5	1.9	0.0	16.7	7.4	3.4	37.2	1.1	4.6	10.1	10.8	14.5	1.5	88.4	3.5	6.0	1.4	0.4	0.0	6.6	0.7	1.1	15.1	13.3	5.3	14.5	32.4
SYNJ2BP	Arip2	ENSG00000213463	"Synaptojanin 2 binding protein"	P57105	14	70366496-70417061	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000866	Approved	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA000866: AB_2276678"	"unprognostic (2.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-2)"	12.0	13.8	10.8	8.2	13.0	1.7	11.2	15.8	13.7	11.8	20.1	14.1	14.1	21.0	12.5	10.4	16.3	9.5	11.7	15.7	10.5	8.9	32.0	25.9	10.4	6.8	11.0	6.4	10.3	11.0	28.9	22.2	12.0	13.4	15.3	16.7	11.6	13.2	15.0	27.4	6.7	32.2	15.2	12.4	11.3	16.8	16.9	9.9	7.0	16.9	14.4	7.9	15.4	9.1	4.6	5.1	0.6	5.3	3.8	7.4	1.9	9.7	6.3	11.1	7.4	8.6	10.0	7.8	7.5	7.9	5.4	6.1	6.1	9.2	0.0	7.3	8.7	5.4	8.4	11.1	8.2	12.8	1.3	5.6	3.6	9.7	7.9	7.6	0.0	1.2	7.7	6.8	6.7	3.8	9.6	11.7	4.2	2.1	2.0	9.6	7.0	5.0	1.5	8.1	9.8	7.7	6.3	16.1	2.7	11.7	14.8	8.1	14.2	10.4	8.7	6.1	7.5	16.3	2.5	12.8	12.9	9.0	4.9	6.1	2.7	10.3	0.0	11.4	1.2	10.6	0.6	5.3	0.1	4.3	5.1	4.9	4.6	5.2	5.0	5.1	3.9	7.4	5.9	0.6	3.8	3.3	3.2	3.9	1.9	10.8	13.0	15.8	13.7	10.5	8.9	11.0	6.4	13.4	9.9	35.7	36.9	17.6	23.9	5.4	40.6	75.0	53.5	22.7	35.2	71.5	76.6	33.0	119.3	39.0	15.9	38.3	52.7	0.0	34.4	27.1	19.9	26.7	9.2	42.3	21.8	28.6	19.0	31.3	22.7	5.4	28.1	19.1	13.5	30.7	45.5	35.5	32.5	35.1	38.9	59.1	83.2	25.8	20.2	26.1	10.2	4.3	9.2	29.8	56.5	28.8
SYNJ2BP-COX16		ENSG00000258644	"SYNJ2BP-COX16 readthrough"		14	70326064-70417074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Club cells: 1.2;Distal tubular cells: 1.7;Early spermatids: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA000866, HPA062659"	Approved	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA000866: AB_2276678, HPA062659: AB_2684823"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.41e-2)"	"unprognostic (6.73e-4)"	"unprognostic (6.68e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	5.5	7.1	3.8	4.7	5.7	7.7	5.7	7.1	7.4	5.1	9.3	6.2	6.2	8.2	4.3	4.3	7.4	2.1	5.4	7.0	3.9		15.4	12.3	4.1	4.9	3.4	2.3	4.7	14.0	0.9	10.4	5.2	5.9	6.9	3.6	5.0	3.4	6.7	30.7	2.5	15.5	6.8	3.6	5.4	7.3	16.3	4.1	2.6	7.7	6.4	3.1	6.9	1.6	16.2	18.2	11.1	13.4	18.3	15.8	13.5	18.5	3.4	15.1	10.0	2.4	1.9	10.4	13.4	4.8	6.0	4.1	1.4	19.3	2.2	8.7	3.3	9.0	9.8	1.8	1.8	7.1	0.4	2.0	6.1	6.1	2.5	3.2	3.6	9.8	3.2	1.6	4.5	2.5	9.5	3.5	15.4	2.3	10.4	2.4	3.2	19.9	7.1	15.2	12.4	2.7	14.0	10.0	2.7	3.7	9.8	9.7	7.8	8.0	20.4	14.0	9.8	21.1	13.9	7.7	13.3	33.7	12.4	5.7	13.4	7.2	12.0	15.3	4.0	14.8	11.1	12.1	0.9	11.8	13.4	12.9	16.2	15.6	12.4	14.8	15.7	13.8	14.4	0.4	18.3	8.9	18.2	15.8	13.5											0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.3	1.7	0.2	1.2	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.4	0.7	0.2	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.3	0.0
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659220	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 219.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 2.9;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	27	"B-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 26.4;EFO-21: 21.8;HUVEC TERT2: 21.3;TIME: 51.7;U-87 MG: 45.9"	"Group enriched"	"Detected in many"	6	"amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1"	"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179"	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	17.3	14.6	17.7	4.4	18.9	0.6	5.7	1.4	24.9	4.3	5.5	2.4	0.8	6.6	5.1	4.8	6.7	4.4	6.8	66.1	16.6	4.0	15.8	7.8	11.7	2.4	4.5	5.6	23.3	6.8	2.5	2.8	63.4	3.7	7.6	4.1	16.4	2.6	6.7	222.7	1.8	7.6	8.2	4.8	14.5	4.7	17.4	3.9	0.5	4.0	5.7	2.6	6.2	17.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.1	1.0	0.9	26.4	4.0	5.5	1.4	1.1	6.2	2.8	0.0	21.8	5.7	8.7	2.6	0.0	3.9	0.5	0.0	0.0	0.0	10.6	1.3	6.0	0.0	0.2	1.1	6.3	1.5	1.1	8.2	21.3	0.0	0.0	0.0	1.3	0.4	0.0	0.2	0.8	2.6	3.4	0.1	0.2	0.0	1.0	0.5	2.5	11.7	5.8	6.4	0.2	9.7	0.4	1.9	51.7	5.2	16.3	0.1	1.0	0.2	0.0	0.3	45.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.7	18.9	1.4	24.9	16.6	4.0	4.5	5.6	3.7	3.9	32.8	13.5	0.9	2.8	4.0	1.3	219.1	35.7	5.3	14.8	7.0	2.0	9.9	0.0	44.4	1.6	40.9	50.6	0.0	30.5	5.8	12.3	1.6	0.0	38.0	1.9	0.0	13.3	42.4	6.7	1.9	2.6	1.1	5.0	41.5	9.9	6.1	29.3	25.9	26.2	3.3	0.6	45.3	32.0	0.7	0.4	1.9	21.6	1.3	9.1	3.0
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell type enriched"	"Detected in some"	220	"Cardiomyocytes: 650.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.3	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.7	0.7	0.4	0.5	0.9	0.1	0.1	0.1	0.0	0.4	0.2	0.2	0.3	0.6	0.4	0.6	0.2	0.3	6.2	0.1	1.2	0.1	0.3	0.0	0.5	0.3	0.3	0.3	0.3	0.2	1.9	0.2	0.0	0.7	0.2	5.9	0.3	0.0	0.6	0.3	0.4	0.1	6.3	0.1	0.3	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	1.4	1.3	1.4	650.0	0.0	1.4	1.2	0.0	2.0	0.1	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.9	0.7	1.1	0.2	0.2	0.0	0.0	0.0	0.3	1.0	0.9	0.8	1.7	0.0	0.0	0.8	0.0	0.0	0.4	0.0	1.3	0.0	0.5	0.7	0.6	0.4	0.0	0.7	0.0	0.9
SYNRG	"AP1GBP1, MGC104959, SYNG"	ENSG00000275066	"Synergin gamma"	Q9UMZ2	17	37514797-37609496	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023554, HPA023555"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA023554: AB_1844892, HPA023555: AB_2058337"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.91e-2)"	"prognostic favorable (3.96e-4)"	6.3	5.9	5.4	10.3	9.4	4.8	5.2	9.4	8.6	5.5	6.0	10.4	4.3	5.4	7.4	8.7	5.4	5.0	5.8	6.2	4.8		7.0	5.6	5.7	14.2	6.9	6.3	5.8	6.4	9.6	14.5	5.9	10.8	5.8	6.8	6.2	6.2	6.2	7.3	4.6	5.7	4.8	8.5	10.4	7.5	10.9	8.2	22.7	7.0	3.8	14.2	6.5	4.0	10.4	11.4	8.0	3.4	13.8	13.8	3.2	5.2	8.4	11.4	7.3	7.1	7.8	5.5	7.8	7.9	8.9	10.7	7.5	8.5	9.4	7.4	7.1	8.8	5.2	9.9	4.3	12.5	8.7	7.0	5.1	5.3	4.4	9.2	8.2	11.8	9.1	8.9	10.8	5.6	7.6	12.7	16.7	11.0	8.5	9.4	3.9	18.8	5.0	4.7	4.8	3.5	11.8	9.6	6.2	7.4	9.2	9.7	8.2	7.7	2.4	6.1	14.1	7.0	6.3	11.3	6.2	7.9	5.2	7.1	9.9	12.3	17.2	7.7	4.5	6.3	8.0	3.4	7.2	10.4	2.6	13.8	8.9	9.1	10.5	2.9	10.4	9.4	9.2	7.0	13.8	2.5	11.4	9.2	3.2											50.6	34.2	39.9	14.5	7.6	45.9	24.3	25.5	22.7	25.0	31.4	51.1	13.7	14.9	20.9	33.0	26.1	19.7	0.0	18.8	9.3	12.5	15.8	24.4	19.2	18.3	35.0	40.9	22.1	30.1	39.2	21.0	25.7	15.1	22.6	21.5	37.1	20.1	22.9	22.6	21.6	52.7	12.9	14.4	56.2	22.3	8.2	22.2	76.7	16.5	19.3
SYPL2	Mg29	ENSG00000143028	"Synaptophysin like 2"	Q5VXT5	1	109466628-109482137	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 102.5;tongue: 25.6"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 8.5;Collecting duct cells: 3.5;Hepatocytes: 4.5;Late spermatids: 8.5;Proximal tubular cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 20.2;ASC TERT1: 8.5;BJ: 8.6;BJ hTERT+: 27.3;fHDF/TERT166: 14.1;HAP1: 7.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA076657			Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA076657: "	"unprognostic (1.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.90e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.05e-4)"	"unprognostic (2.54e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.39e-4)"	0.9	3.9	0.8	0.3	0.7	0.1	1.4	0.5	1.2	1.6	1.9	0.3	0.8	0.3	2.5	4.3	1.6	0.4	1.1	7.4	0.8	0.2	6.0	4.7	0.6	0.3	0.3	0.0	1.1	3.2	3.7	0.4	1.2	0.8	1.2	0.5	1.7	1.6	2.2	102.5	0.2	0.6	3.5	0.1	0.4	1.1	6.0	0.2	0.0	5.1	25.6	1.2	2.5	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	20.2	8.5	0.0	8.6	27.3	2.7	1.0	0.0	0.0	0.0	0.0	14.1	0.3	0.0	7.3	0.0	0.5	0.0	3.1	0.0	0.2	0.1	0.4	0.0	0.7	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.9	2.1	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	1.2	0.8	0.2	0.3	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	1.5	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	4.9	0.0	0.0	2.3	0.4	1.5	0.0	0.1	0.0	0.0	0.0
SYT10		ENSG00000110975	"Synaptotagmin 10"	Q6XYQ8	12	33374238-33439819	"Predicted membrane proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;fallopian tube: 8.1"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 2.0;Club cells: 4.5;Distal tubular cells: 6.6;Ito cells: 2.5;Spermatogonia: 4.5"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.8;K-562: 2.2;MCF7: 7.7;NTERA-2: 1.9;RPTEC TERT1: 2.0;RT4: 3.0;SCLC-21H: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA055426			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA055426: AB_2682812"	"unprognostic (3.60e-1)"	"unprognostic (4.93e-2)"		"unprognostic (9.34e-4)"				"unprognostic (5.53e-2)"		"unprognostic (3.67e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.97e-6)"	"unprognostic (4.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.91e-1)"	0.3	1.5	0.6	0.7	10.1	0.1	0.3	0.2	4.1	2.9	3.6	0.9	3.0	1.0	0.3	0.8	0.3	8.1	0.4	0.5	0.8	3.1	3.3	1.4	0.2	0.1	0.6	3.4	0.4	0.2	0.1	5.8	0.2	14.6	1.6	1.6	0.1	1.8	3.2	0.2	0.2	1.3	0.6	2.7	0.2	1.6	0.6	0.3	0.0	0.2	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	7.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.0	4.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.1	0.2	4.1	0.8	3.1	0.6	3.4	14.6	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.5	0.0	1.4	4.5	0.0	0.0	0.0	6.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	4.5	0.0	0.1	0.0	0.0	0.0
SYT15	CHR10SYT	ENSG00000204176	"Synaptotagmin 15"	Q9BQS2	10	46578217-46594173	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 50.6;Alveolar cells type 2: 43.8;Endothelial cells: 14.6;Ito cells: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 26.7"									"HPA036971, HPA036972, HPA064559"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286"	"unprognostic (1.64e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.91e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.19e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-3)"	4.7	2.4	5.7	6.5	4.8	0.2	3.9	3.1	7.0	11.5	1.6	3.3	1.1	1.3	7.1	3.9	5.3	5.3	3.3	4.3	6.1	4.7	2.9	1.1	13.2	5.3	5.1	2.8	2.4	10.4	4.7	2.3	5.6	11.3	2.7	2.0	7.4	9.2	5.6	2.3	11.4	2.4	3.8	2.7	3.1	1.4	2.4	1.1	1.1	2.7	8.3	4.1	3.1	4.3	1.2	1.8	1.2	3.8	1.8	2.2	1.1	2.3	2.8	1.6	0.7	1.6	1.6	1.9	2.9	4.8	1.9	2.3	5.6	4.8	0.6	1.9	2.5	1.7	8.5	0.0	0.7	2.8	1.2	3.0	1.3	2.4	3.8	5.0	2.6	2.4	3.0	0.9	1.4	3.9	2.4	1.1	1.9	0.6	1.7	0.9	4.0	1.3	4.2	1.1	0.4	0.9	1.7	0.0	1.6	3.0	1.2	0.9	1.2	2.0	26.7	1.3	1.5	3.8	1.3	3.0	0.8	3.0	2.0	1.8	2.3	2.3	2.0	1.8	1.6	0.7	0.0	1.7	1.2	2.2	3.8	2.1	1.0	1.7	1.1	1.8	1.2	1.5	1.9	0.7	1.8	2.3	1.1	0.5	1.1	5.7	4.8	3.1	6.4	6.1	4.7	5.1	2.8	11.3	1.1	50.6	43.8	0.0	2.1	5.5	1.8	3.6	0.0	1.4	3.4	1.8	2.0	0.9	1.7	0.8	0.4	14.6	0.9	0.0	5.0	1.0	3.2	1.8	2.3	1.0	0.1	0.0	1.2	25.2	3.1	0.0	3.4	1.1	3.3	0.0	1.2	0.2	3.5	0.0	3.5	1.9	1.6	6.5	3.3	1.1	0.7	4.8	1.0	0.0	1.3	2.2
SYT16	"CHR14SYT, Strep14, SYT14L, yt14r"	ENSG00000139973	"Synaptotagmin 16"	Q17RD7	14	61811974-62112550	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 20.8;testis: 6.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 26.4;Late spermatids: 10.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.6;hTERT-HME1: 4.3;PC-3: 5.5;RPTEC TERT1: 6.5;RT4: 17.1;U-2 OS: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004199, HPA076871"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA004199: AB_1080156, HPA076871: AB_2732324"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (8.88e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.08e-2)"		"unprognostic (9.57e-2)"	"unprognostic (9.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.15e-1)"	0.4	1.3	7.2	0.4	17.2	0.6	0.6	0.7	20.8	0.4	0.4	0.4	0.0	0.4	1.0	2.1	0.4	0.7	0.5	0.5	3.3	3.4	0.7	0.4	0.5	0.5	1.6	12.3	0.4	4.0	0.4	1.9	1.1	1.8	4.6	0.4	0.0	0.4	0.6	0.4	0.5	0.5	0.4	0.9	0.5	2.6	6.8	0.7	0.0	0.5	0.0	0.4	0.9	0.6	0.2	0.1	0.6	0.1	0.1	0.2	0.0	10.6	0.2	0.3	0.0	0.0	0.0	0.1	0.7	1.0	1.0	0.6	0.0	0.0	0.1	0.2	0.0	0.6	0.6	0.0	1.0	1.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	5.5	0.0	0.0	0.0	6.5	17.1	0.3	3.0	0.5	0.7	0.0	1.1	0.0	0.0	0.0	2.9	6.9	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.6	0.1	0.1	0.1	0.0	0.0	7.2	17.2	0.7	18.9	3.3	3.4	1.6	12.3	1.8	0.7	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	3.5	2.0	0.3	0.0	0.1	26.4	0.0	0.0	0.0	0.0	0.5	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	2.1	0.0	0.1	0.0	0.0	0.1
SYT17		ENSG00000103528	"Synaptotagmin 17"	Q9BSW7	16	19167971-19268334	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.2"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 21.0;Distal tubular cells: 23.2;Intestinal endocrine cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 4.1;memory B-cell: 5.1;naive B-cell: 14.7;non-classical monocyte: 13.4"	"Group enriched"	"Detected in many"	8	"B-cells: 14.7;monocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 10.4;CAPAN-2: 20.2;Daudi: 8.9;MCF7: 15.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042059			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042059: AB_2677827"	"unprognostic (3.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.32e-2)"	"unprognostic (4.95e-3)"	3.8	5.2	16.5	1.4	9.2	0.4	4.7	1.0	25.2	3.5	2.4	6.1	1.2	4.3	1.2	3.1	4.0	2.5	1.3	1.3	15.5	16.5	3.8	12.1	7.8	3.2	13.9	10.2	0.8	2.5	21.3	13.4	3.9	7.5	9.7	3.0	7.6	1.5	3.8	0.4	9.9	2.1	1.0	5.5	1.4	4.3	0.6	7.4	0.0	7.1	0.8	4.7	4.2	3.8	14.7	1.6	0.4	13.4	0.0	0.0	0.6	0.0	7.4	0.1	0.0	0.2	0.5	10.4	0.0	0.0	0.1	0.0	0.3	20.2	8.9	2.5	0.0	2.8	3.6	0.5	0.3	0.0	0.0	1.5	0.0	7.4	0.1	0.0	0.0	0.0	0.7	1.8	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.9	5.8	4.1	0.0	0.8	0.7	2.5	4.4	1.6	0.9	2.9	8.0	0.4	5.1	7.9	1.9	0.0	0.0	5.3	0.1	0.0	1.5	0.0	8.2	0.0	0.0	0.0	0.4	0.5	0.0	0.0	4.1	0.0	5.1	0.0	0.0	1.6	14.7	0.0	0.0	0.1	0.0	13.4	0.2	0.0	0.6	16.5	9.2	1.0	22.9	15.5	16.5	13.9	10.2	7.5	7.4	6.0	9.4	2.7	10.1	3.4	0.6	1.4	0.0	5.3	3.4	21.0	0.0	4.2	23.2	3.4	0.1	1.6	1.3	0.0	0.6	11.3	2.4	8.2	0.0	12.4	4.0	1.6	20.7	3.1	1.9	0.0	1.4	2.0	11.8	9.0	9.1	13.2	2.7	7.0	0.7	0.0	0.3	0.0	0.7	0.5	1.7	8.4	3.3	0.0	3.1	6.3
SYT4	"HsT1192, KIAA1342"	ENSG00000132872	"Synaptotagmin 4"	Q9H2B2	18	43267878-43277650	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.8;pituitary gland: 31.5"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 60.4;Cone photoreceptor cells: 21.6;Intestinal endocrine cells: 27.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 74.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010574	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA010574: AB_2668309"			"unprognostic (2.91e-3)"		"unprognostic (2.03e-1)"			"unprognostic (2.37e-2)"		"unprognostic (2.87e-1)"	"unprognostic (7.67e-3)"	"unprognostic (5.30e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.80e-2)"		1.4	17.5	5.7	2.2	24.1	1.0	0.9	60.8	54.6	0.9	1.7	0.9	0.0	1.7	0.9	0.9	1.0	0.9	1.0	1.4	12.9	19.9	1.0	0.9	1.8	1.0	5.9	16.0	1.3	4.7	0.9	31.5	1.0	22.3	1.5	1.7	0.4	1.0	9.8	0.9	1.0	1.7	1.5	5.0	0.9	4.6	2.4	1.4	0.0	1.3	0.0	0.9	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	74.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	24.1	60.8	35.7	12.9	19.9	5.9	16.0	22.3	1.4	0.0	1.4	0.0	0.0	0.1	60.4	2.8	0.0	1.4	4.5	0.0	21.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.8	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYT6		ENSG00000134207	"Synaptotagmin 6"	Q5T7P8	1	114089291-114153919	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 14.9;kidney: 3.7;pancreas: 11.1"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 5.6;Late spermatids: 9.2;Melanocytes: 3.3;Proximal tubular cells: 2.4"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 21.1;WM-115: 14.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 27.9;olfactory region: 87.2"	"Low region specificity"	"Detected in many"			HPA058362			Approved	Vesicles		NA	NA			Vesicles		"HPA058362: "	"unprognostic (7.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	0.3	2.2	2.6	0.8	6.5	0.3	2.1	0.2	10.4	0.4	0.3	5.1	0.0	0.9	0.4	0.2	0.2	0.3	0.5	0.3	2.3	14.9	3.7	0.3	0.4	0.3	2.8	1.3	2.3	11.1	0.7	0.3	1.4	3.9	1.5	0.6	0.9	1.1	0.2	0.4	0.4	0.5	0.3	4.2	0.3	0.3	0.9	3.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.6	6.5	0.2	9.3	2.3	14.9	2.8	1.3	3.9	3.3	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.2	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.7	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 65.2"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 139.2;granulocytes: 122.9;Mucus-secreting cells: 160.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.5;MAIT T-cell: 17.9"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 25.3;OE19: 41.5;RH-30: 51.1;RPTEC TERT1: 36.5"	"Low region specificity"	"Detected in many"							HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (9.07e-4)"	12.8	5.5	27.6	11.8	13.9	1.8	9.7	6.8	32.0	6.5	26.3	6.8	2.1	11.4	7.6	11.8	9.6	6.3	15.0	5.7	13.8	9.0	14.5	3.9	8.1	5.7	8.4	21.5	3.7	2.5	7.2	5.5	9.8	12.4	9.9	39.8	5.7	8.4	5.8	3.7	4.6	17.7	7.8	12.8	5.4	65.2	3.2	5.1	5.8	4.2	5.0	3.8	17.2	11.3	0.1	0.7	0.0	0.0	3.0	17.9	1.7	0.9	2.2	3.5	0.3	0.8	4.6	0.0	8.6	11.3	7.6	17.4	9.7	1.3	0.2	3.2	6.0	11.1	6.3	0.2	0.7	10.1	0.6	0.0	0.0	0.0	0.1	0.5	0.7	0.1	5.8	1.1	16.5	0.2	1.8	0.0	0.2	0.1	0.1	9.6	25.3	0.0	0.2	5.9	41.5	3.9	0.3	51.1	0.0	36.5	13.2	0.1	0.1	1.9	1.5	0.8	3.1	0.1	0.1	0.0	12.0	4.6	7.5	0.4	0.0	0.0	4.5	12.3	0.1	7.3	0.0	0.0	0.0	10.5	0.0	17.9	0.0	2.1	6.3	0.0	0.1	1.7	3.1	0.0	3.0	0.0	0.7	0.8	1.7	27.6	13.9	6.8	32.0	13.8	9.0	8.4	21.5	12.4	5.1	20.8	30.4	1.4	10.2	3.2	8.3	1.6	10.2	139.2	38.7	64.6	7.9	0.7	0.0	8.4	1.1	3.6	40.7	0.0	14.7	0.2	9.3	37.7	122.9	0.4	0.5	1.6	18.5	7.4	4.7	0.4	1.7	3.9	10.1	1.0	160.5	13.4	13.2	34.8	28.3	7.7	8.1	32.3	29.7	3.3	2.1	5.0	0.3	30.0	35.7	46.4
SYTL3	"exophilin-6, SLP3"	ENSG00000164674	"Synaptotagmin like 3"	Q4VX76	6	158650014-158764876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.6"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 58.9;granulocytes: 129.6;T-cells: 171.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"basophil: 55.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 55.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.8;SCLC-21H: 11.2;U-138 MG: 12.8;U-2 OS: 13.9;U-266/70: 19.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030584, HPA030585, HPA030586"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	Yes			"Nucleoli fibrillar center, Vesicles"		"HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226"	"unprognostic (3.56e-3)"	"prognostic favorable (8.84e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	8.3	1.5	2.3	9.0	3.7	9.4	3.8	0.8	2.4	5.1	7.4	7.1	0.6	2.9	4.6	5.5	3.6	11.6	7.3	5.3	3.4	2.0	4.7	2.2	20.2	26.7	3.5	1.3	2.5	2.3	0.9	2.1	1.3	5.5	5.3	1.8	4.8	12.4	4.8	11.4	3.0	12.0	3.5	10.4	21.9	5.8	3.2	3.9	2.3	21.7	1.2	24.5	18.8	3.6	0.2	1.3	55.6	4.5	10.9	10.2	4.4	4.9	0.7	0.0	0.3	0.7	0.7	0.2	2.0	1.3	0.5	1.4	0.4	3.9	0.0	0.4	3.4	1.8	0.5	0.1	0.6	2.0	9.7	0.3	3.8	0.1	0.0	1.2	1.0	16.8	2.2	1.5	4.2	0.7	1.8	1.0	0.7	0.2	3.8	5.0	0.2	0.1	1.3	0.1	0.9	0.7	0.0	4.1	0.5	1.9	0.2	11.2	0.8	0.7	7.1	0.5	0.2	1.3	0.2	5.8	12.8	13.9	0.3	0.4	19.6	4.4	0.4	8.2	5.4	0.4	55.6	4.5	0.2	10.2	0.8	6.0	0.2	4.1	6.8	1.3	0.0	4.5	5.5	9.2	10.9	0.3	0.3	4.1	4.4	2.3	3.7	0.8	2.4	3.4	2.0	3.5	1.3	5.5	3.9	14.9	12.5	12.8	3.1	4.0	0.0	4.0	2.5	58.9	20.5	14.0	2.0	1.1	5.0	0.6	6.2	2.4	1.4	0.0	0.5	0.4	2.4	2.4	129.6	0.9	4.2	0.0	0.0	4.3	8.9	9.9	0.0	9.1	10.1	14.4	1.3	0.1	0.4	0.0	0.7	1.4	0.4	0.0	2.5	2.2	6.6	3.9	1.6	171.2	0.4	2.6
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Leydig cells: 67.3;Peritubular cells: 39.3;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.1;HMC-1: 31.3;RT4: 20.6;TIME: 17.7"	"Region enriched"	"Detected in single"	5	"hypothalamus: 35.1"	"Low region specificity"	"Detected in some"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles		NA	Yes		6100000	Vesicles		"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	3.8	3.1	9.1	2.8	9.5	1.6	4.4	4.3	8.4	18.1	5.3	6.6	4.8	1.7	36.2	5.4	2.6	10.0	2.9	2.1	11.9	6.0	4.2	7.1	3.0	0.7	9.8	2.7	47.3	8.8	1.3	41.9	2.6	9.4	9.2	6.8	1.3	3.8	6.0	4.5	1.4	3.0	22.5	7.8	2.3	5.3	7.8	9.5	0.0	6.2	1.1	1.4	4.3	9.4	0.5	0.3	5.1	0.3	0.5	0.4	2.3	0.1	3.0	0.8	0.0	4.5	2.5	0.0	3.9	2.5	4.2	7.5	0.3	3.9	0.0	1.0	2.7	3.6	3.5	15.1	1.3	4.4	0.0	1.3	0.0	5.1	0.2	1.1	0.0	31.3	0.9	0.3	3.8	0.2	1.6	10.5	0.0	1.4	0.0	1.9	1.0	0.0	0.0	0.6	10.6	0.0	0.0	1.2	0.0	3.7	20.6	7.6	0.3	1.5	5.9	0.8	1.6	3.7	0.3	17.7	2.2	4.7	10.8	0.9	0.0	0.0	0.0	2.7	0.0	2.4	1.1	0.3	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.5	0.4	0.2	5.1	0.5	0.2	0.3	0.1	2.3	9.1	9.5	4.3	8.4	11.9	6.0	9.8	2.7	9.4	9.5	26.8	1.7	0.0	6.9	0.1	0.1	3.6	22.9	6.7	6.8	3.5	0.0	0.2	3.3	5.5	1.6	9.5	15.8	0.0	2.0	0.2	6.3	15.5	3.5	32.1	1.0	0.0	0.0	12.3	1.6	2.0	67.3	0.9	3.3	0.0	18.0	4.6	5.4	25.4	39.3	1.6	0.4	51.8	6.2	1.4	4.6	0.6	0.0	0.7	8.1	7.6
SYTL5		ENSG00000147041	"Synaptotagmin like 5"	Q8TDW5	X	38006582-38128819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.0"	"Cell type enhanced"	"Detected in some"	11	"Club cells: 5.7;Mucus-secreting cells: 10.5;Syncytiotrophoblasts: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6;MCF7: 5.2;OE19: 7.5;SK-MEL-30: 13.4;SuSa: 19.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026074	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			Nucleoplasm	"Microtubules, Cytosol"	"HPA026074: AB_1857697"	"unprognostic (3.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	0.5	6.0	10.5	3.4	11.0	0.0	2.9	0.5	2.5	7.0	7.3	0.5	0.5	2.3	2.6	1.0	12.2	0.2	2.9	0.9	9.2	8.9	1.0	6.1	2.4	0.5	2.4	0.5	0.5	6.4	0.0	1.1	17.0	0.5	2.0	3.5	1.5	7.1	1.7	0.5	0.0	14.3	3.9	1.3	0.8	13.8	0.7	0.5	0.7	0.9	1.2	5.9	1.3	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	5.6	1.3	0.0	0.0	0.5	2.1	0.6	0.0	0.0	0.0	0.0	0.6	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.7	0.1	0.0	0.1	0.1	0.2	5.2	0.0	0.0	2.3	7.5	0.0	0.0	1.9	0.0	0.0	0.4	2.9	0.0	0.3	1.1	13.4	19.0	0.0	0.0	0.0	0.1	4.5	0.0	3.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.5	11.0	0.5	2.5	9.2	8.9	2.4	0.5	0.5	0.5	0.0	1.3	0.0	0.2	0.0	0.0	0.3	0.0	1.4	5.7	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.1	0.0	0.8	3.1	0.1	0.9	0.0	0.9	0.2	0.0	2.9	0.6	0.0	0.0	0.6	0.0	0.0	0.0	10.5	0.0	3.5	2.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.6	0.6
SZRD1	"C1orf144, DKFZp566C0424"	ENSG00000055070	"SUZ RNA binding domain containing 1"	Q7Z422	1	16352575-16398145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024221	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA024221: AB_10603450"	"unprognostic (3.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.98e-6)"	"unprognostic (2.53e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.60e-2)"	34.9	30.7	23.1	25.0	26.3	37.5	33.1	17.1	20.6	30.7	29.0	20.8	15.4	23.0	38.5	23.2	33.7	26.5	30.5	37.0	23.5	14.3	39.8	41.4	26.2	27.2	27.4	11.8	36.3	25.1	32.2	16.8	46.4	22.4	24.8	20.9	27.9	20.8	23.7	55.2	24.9	39.3	31.3	20.9	40.6	27.1	18.3	25.0	32.1	35.0	27.6	33.6	34.3	35.1	30.4	19.2	34.3	36.7	20.0	25.5	29.6	37.4	28.8	39.9	27.6	34.1	39.4	13.2	38.4	50.0	45.7	35.6	28.8	33.4	32.9	43.1	51.2	25.1	20.7	35.7	42.3	33.9	56.6	30.9	37.7	31.0	22.6	30.8	36.6	37.2	39.7	35.5	49.8	33.4	32.3	39.5	28.6	33.8	31.0	41.7	36.4	35.7	28.0	27.8	27.8	33.0	36.7	42.1	38.7	31.0	17.6	31.7	33.0	33.7	21.8	48.6	17.2	22.5	24.2	44.0	31.2	36.5	48.6	38.1	17.2	18.9	39.6	34.8	50.1	41.2	15.0	24.3	34.3	24.5	33.2	24.2	28.3	21.2	22.8	19.2	30.4	19.6	21.1	27.1	20.0	36.7	14.9	25.5	29.6	23.1	26.3	17.1	20.6	23.5	14.3	27.4	11.8	22.4	25.0	17.9	24.2	44.6	45.3	40.5	19.7	39.9	48.4	8.1	12.5	38.4	2.0	50.0	59.7	57.9	17.5	35.9	61.6	23.3	46.5	67.2	40.6	49.4	36.8	45.6	64.1	41.3	45.9	29.4	42.2	39.0	33.4	33.2	42.2	108.2	41.3	23.4	53.3	42.1	33.6	40.9	17.7	38.8	49.1	20.2	19.8	51.1	70.3	40.6	41.6	56.6
SZT2	"C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B"	ENSG00000198198	"SZT2, KICSTOR complex subunit"	Q5T011	1	43389882-43454247	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029012	Approved		Approved	"Nucleoplasm,Vesicles,Actin filaments"		NA	NA			"Nucleoplasm, Vesicles, Actin filaments"		"HPA029012: AB_10600817"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.14e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.47e-7)"	"prognostic unfavorable (2.53e-4)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.84e-3)"	"unprognostic (8.28e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.61e-2)"	10.0	8.4	9.0	15.9	12.8	13.5	10.3	16.1	12.9	10.2	10.2	21.7	12.8	8.8	13.7	8.3	9.4	11.3	8.2	8.6	8.7	6.8	7.9	6.1	10.3	11.1	12.4	9.1	14.9	10.8	23.6	16.1	8.1	10.9	10.9	8.9	13.5	11.4	11.6	10.9	17.4	11.6	12.1	9.9	11.0	10.0	12.2	11.1	13.9	16.3	5.9	12.6	12.3	9.6	1.8	3.0	4.9	1.8	1.3	3.0	1.2	6.3	5.9	6.0	5.3	15.4	9.2	8.4	4.9	7.0	6.8	6.7	2.0	7.8	5.9	6.5	8.6	4.4	7.7	5.0	9.0	5.2	7.5	5.0	10.7	11.4	3.7	6.1	8.5	8.8	8.2	7.2	11.2	10.3	8.0	7.4	7.0	4.7	9.3	5.1	3.2	5.8	3.0	4.9	4.3	6.4	7.4	6.5	7.9	4.3	8.0	5.8	5.4	9.8	9.0	6.7	7.7	5.4	13.1	9.6	7.4	9.3	10.3	8.5	9.7	3.8	4.7	7.7	5.9	5.4	3.8	1.8	4.9	1.5	1.5	3.0	1.4	0.8	0.8	1.5	1.8	1.7	1.3	3.7	1.3	1.7	3.0	1.7	1.2	9.0	12.8	16.1	12.9	8.7	6.8	12.4	9.1	10.9	11.1	23.8	20.0	9.3	3.1	1.6	15.1	4.4	5.1	6.7	7.9	5.2	58.9	5.4	0.0	5.2	11.0	6.0	8.5	0.0	5.7	4.3	5.1	3.8	13.9	9.5	4.8	12.7	3.5	9.8	7.8	11.5	8.6	6.9	5.0	9.0	5.7	7.8	5.7	3.5	5.6	7.1	22.6	19.4	4.3	7.0	6.6	1.6	4.6	12.8	6.4	3.2
TAB3	MAP3K7IP3	ENSG00000157625	"TGF-beta activated kinase 1 and MAP3K7 binding protein 3"	Q8N5C8	X	30827442-30975084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034980, HPA034981"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA034980: AB_10602708, HPA034981: AB_2674394"	"unprognostic (4.39e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.51e-1)"	"prognostic favorable (8.45e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.75e-1)"	6.1	8.0	5.9	6.6	6.9	10.1	6.5	9.1	9.2	7.6	6.5	4.2	17.9	5.2	40.3	7.4	13.2	9.2	10.6	6.9	6.1	5.3	16.9	23.3	8.0	8.1	6.7	6.6	11.3	17.3	25.0	9.4	39.3	9.1	12.9	6.7	9.3	11.5	15.0	8.8	8.1	7.4	9.6	5.2	7.1	8.4	26.7	3.6	8.3	7.7	14.5	15.6	6.6	7.9	1.0	0.6	0.8	1.1	3.9	1.0	0.4	23.2	5.6	5.8	5.9	4.5	6.9	6.1	7.2	9.1	4.9	5.5	6.3	20.0	10.5	4.4	8.3	9.4	12.1	8.9	18.4	7.1	18.1	8.5	9.8	6.6	15.4	3.9	10.3	7.7	4.9	11.1	8.3	21.4	8.5	8.0	8.1	11.2	8.6	6.3	11.2	8.2	5.2	6.9	4.2	9.5	5.3	10.2	7.8	8.2	6.8	4.8	6.9	8.1	12.3	15.6	11.3	10.5	4.1	7.7	5.4	8.0	27.1	6.6	11.3	8.6	10.4	8.5	4.9	7.6	0.2	0.5	0.8	0.7	1.1	0.9	0.8	1.0	0.4	0.6	1.0	1.0	1.0	0.8	3.9	0.8	0.3	0.6	0.4	5.9	6.9	9.1	9.2	6.1	5.3	6.7	6.6	9.1	3.6	11.9	10.4	5.4	6.5	8.0	6.5	10.6	17.8	16.0	7.9	10.4	11.8	12.7	3.3	8.3	0.8	7.7	7.4	23.3	5.9	4.2	5.1	13.1	13.9	24.2	6.8	11.1	6.9	8.6	13.8	0.9	10.0	10.2	5.0	7.2	12.3	6.0	7.7	8.7	15.2	10.2	19.1	0.0	3.1	3.7	1.7	8.8	18.8	6.9	9.3	9.9
TAC3	"NKB, NKNB, ZNEUROK1"	ENSG00000166863	"Tachykinin 3"	Q9UHF0	12	57010000-57028883	"Disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 133.5"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 6.9;Extravillous trophoblasts: 8.1;Syncytiotrophoblasts: 15.3"	"Cancer enriched"	"Detected in many"	7	"urothelial cancer: 40.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"K-562: 15.0;SuSa: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045919	Supported	Supported	Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA045919: AB_10960533"	"unprognostic (4.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.71e-14)"	"unprognostic (1.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	0.5	0.6	3.9	1.5	20.0	0.8	0.5	0.0	11.0	0.5	1.2	0.1	0.0	1.5	0.6	0.5	0.5	0.5	0.6	0.5	4.4	9.5	0.5	0.5	0.5	0.5	0.8	2.1	0.5	0.7	0.5	0.0	133.5	1.5	0.5	1.0	0.3	0.5	0.5	0.5	0.7	3.2	2.0	9.4	0.5	8.1	0.8	0.2	0.0	0.5	0.0	0.6	2.2	0.5	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.0	1.4	0.0	1.1	0.3	0.0	2.9	0.0	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	15.0	0.4	0.0	0.0	0.0	0.2	2.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	2.5	0.7	0.0	0.9	0.0	15.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	20.0	0.0	11.0	4.4	9.5	0.8	2.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	8.1	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	15.3	0.0	1.7	0.0
TACC1		ENSG00000147526	"Transforming acidic coiled-coil containing protein 1"	O75410	8	38728186-38853028	"Predicted intracellular proteins"	"Cell cycle, Cell division"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017041, HPA024702, HPA056841"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB017041: , HPA024702: AB_1857723, HPA056841: "	"unprognostic (1.83e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.31e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.94e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.18e-1)"	55.9	12.8	15.0	15.3	16.7	23.3	39.4	8.2	20.4	32.1	31.9	16.8	25.7	8.3	44.9	16.1	28.7	29.9	18.9	19.9	14.6	12.4	21.3	9.1	26.6	15.0	17.5	13.1	19.5	17.4	13.6	8.1	28.8	15.2	22.8	18.0	23.9	11.8	32.0	20.5	10.4	17.5	36.6	17.4	28.0	20.2	14.2	16.5	8.1	18.5	15.5	13.3	40.0	39.6	1.6	21.2	19.0	8.0	2.3	4.1	3.1	10.7	20.8	15.3	4.7	16.5	11.5	9.9	14.0	18.3	13.5	13.8	9.6	1.7	11.0	8.6	13.8	11.7	10.3	9.1	6.3	28.1	7.8	3.4	42.9	6.4	6.2	19.4	8.5	19.9	20.9	5.9	21.8	7.0	14.1	48.3	13.4	4.4	27.8	40.6	8.0	20.1	4.9	2.1	17.7	9.8	4.5	34.4	1.9	4.5	10.6	1.0	1.2	11.4	11.8	9.5	9.5	5.4	6.6	38.6	16.4	9.9	20.9	11.3	14.5	9.4	9.9	14.9	9.9	19.8	6.4	6.9	9.0	3.8	6.2	4.1	1.3	2.6	3.1	4.5	1.6	2.2	2.4	19.0	2.3	8.0	21.2	2.0	3.1	15.0	16.7	8.2	20.4	14.6	12.4	17.5	13.1	15.2	16.5	202.5	130.7	53.4	44.9	31.3	23.8	42.5	170.7	8.1	51.2	43.6	58.9	51.0	101.2	129.7	3.5	172.1	11.9	0.0	51.9	48.9	114.7	69.5	111.1	31.0	67.2	103.3	36.2	302.0	73.2	7.9	155.9	86.0	38.8	73.1	117.5	67.6	55.5	35.1	193.7	20.3	43.1	187.5	177.2	39.4	58.6	16.6	78.6	66.3	52.4	32.8
TACR2	"NK2R, NKNAR, SKR, TAC2R"	ENSG00000075073	"Tachykinin receptor 2"	P21452	10	69403903-69416867	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 56.3;smooth muscle: 35.5"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 2.7;Horizontal cells: 6.4;Kupffer cells: 2.2;Leydig cells: 2.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.7"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 8.7;U-87 MG: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076573			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA076573: AB_2732313"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.88e-4)"	"unprognostic (5.59e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.32e-1)"	1.6	0.1	0.5	3.1	0.5	0.1	1.2	0.5	1.1	11.1	56.3	0.2	0.4	4.1	12.3	0.9	19.6	7.2	1.2	1.9	0.5	0.3	0.2	0.5	0.8	0.5	0.2	0.4	2.0	0.8	0.0	0.1	0.1	0.4	14.9	8.2	0.2	0.4	0.9	1.1	0.4	14.2	35.5	0.8	0.5	16.5	0.9	0.5	0.1	0.4	0.8	0.4	19.4	3.1	1.2	2.0	0.5	4.2	0.1	0.8	0.3	2.0	1.2	0.4	0.7	3.1	0.2	0.2	0.5	0.3	0.5	0.7	0.7	0.4	0.2	0.5	0.5	0.7	0.8	0.1	0.1	0.0	0.4	0.5	1.6	0.6	1.9	0.3	0.0	3.1	0.5	0.7	0.0	0.1	0.8	0.2	0.1	0.4	2.5	0.0	0.8	0.1	0.5	0.4	1.7	1.9	0.1	0.0	0.0	0.0	1.0	0.8	0.6	1.3	2.7	8.7	0.4	1.2	0.2	0.8	3.1	0.4	1.3	1.1	1.2	1.3	0.2	5.0	0.3	1.8	0.5	1.5	0.1	0.3	4.2	0.4	1.2	0.8	0.3	2.0	0.6	0.4	0.2	0.2	0.1	1.7	0.3	0.1	0.3	0.5	0.5	0.5	1.1	0.5	0.3	0.2	0.4	0.4	0.5	0.0	0.3	0.0	0.2	0.6	0.2	0.5	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	1.1	6.4	0.0	1.3	2.2	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.3	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.4	0.4
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575423-58577773	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Tumor antigen"	"Amyloidosis, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;salivary gland: 56.4"	"Cell type enhanced"	"Detected in many"	15	"Basal glandular cells: 5162.0;Glandular cells: 2977.4;Urothelial cells: 7434.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 12.4"	"Group enriched"	"Detected in many"	65	"dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A-431: 75.7;CAPAN-2: 102.7;HaCaT: 102.9;RT4: 35.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoli, Vesicles"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.7	17.1	0.0	0.0	23.1	0.0			0.0	1.7	2.6	103.9	2.7	0.9	0.0	0.0	0.0	10.4	0.0	8.0	0.0	0.0		0.0	9.0	0.0	0.0	1.5		15.7	0.0		56.4	12.6	0.0	42.1	0.0	0.0	0.0	0.0	7.3	0.0			0.1		20.6	17.7	36.1	0.0	3.7	12.4	3.2	0.0	0.0	1.8	75.7	0.0	0.0	0.1	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	102.7	0.0	9.9	6.4	0.0	102.9	0.0	18.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	1.1	0.0	4.3	0.0	0.0	0.1	0.0	16.3	0.0	0.1	0.0	16.7	0.1	0.0	0.0	0.0	13.8	35.5	0.0	0.0	3.3	27.4	0.1	0.3	17.9	0.1	4.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	12.4	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.8											321.6	110.2	1.3	5162.0	1324.0	0.0	0.3	287.9	277.1	312.8	1212.6	0.0	74.9	36.5	1546.3	0.0	14.3	0.4	0.0	1122.5	4.7	23.0	2977.4	8.1	0.6	7.6	0.0	0.0	0.6	0.3	0.0	0.0	32.3	108.0	54.1	2.9	0.0	1294.2	4.0	0.0	3.3	0.0	0.0	47.2	0.5	0.9	1339.0	65.6	0.0	0.9	7434.9
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876327	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	6.5	10.6	13.8	7.1	18.5	17.8	10.2	18.2	20.0	11.3	9.1	17.0	3.4	8.3	10.5	8.6	10.1	9.8	6.6	9.2	13.2	14.6	12.9	28.9	6.7	10.1	11.1	14.3	12.7	7.5	11.3	13.7	12.5	15.0	9.2	10.2	13.4	8.7	8.4	10.7	8.5	9.0	8.5	10.8	7.3	8.0	12.0	10.3	16.7	11.5	7.1	10.9	8.6	7.8	13.4	13.0	8.1	8.2	16.2	19.5	15.1	8.2	7.9	14.9	8.8	4.5	5.8	8.9	4.3	5.3	7.3	6.3	7.2	6.7	15.7	8.5	5.1	5.9	6.3	12.0	7.7	5.9	9.9	11.5	5.2	6.8	11.8	6.7	14.6	9.6	4.4	8.9	4.3	11.0	5.2	5.9	11.9	18.5	9.6	5.6	5.7	18.0	11.6	22.7	13.3	8.9	15.2	6.6	19.9	9.7	11.1	9.6	16.8	7.8	10.1	9.1	14.3	13.8	15.4	4.4	6.0	6.9	6.5	9.1	13.6	18.5	29.4	4.1	6.7	5.6	1.8	8.1	8.1	14.0	8.2	15.5	13.1	15.2	15.8	13.0	13.4	19.5	15.3	1.3	16.2	6.2	8.5	14.3	15.1	13.8	18.5	18.2	20.0	13.2	14.6	11.1	14.3	15.0	10.3	8.9	2.4	2.9	4.3	5.5	7.4	9.4	0.0	4.0	4.5	3.5	7.9	5.3	5.0	3.2	3.4	3.7	3.8	0.0	3.5	6.3	4.0	4.4	4.7	17.1	3.7	1.6	6.9	3.7	5.1	1.3	4.0	2.5	1.7	5.4	5.3	6.6	3.0	0.0	2.8	5.0	5.7	0.0	3.8	4.7	12.9	4.4	6.1	5.3	5.1	3.2
TADA2A	"ADA2, ADA2A, hADA2, TADA2L"	ENSG00000276234	"Transcriptional adaptor 2A"		17	37406874-37479730	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 76.3;Late spermatids: 56.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076497			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA076497: AB_2686801"	"unprognostic (3.49e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.13e-3)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-3)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (2.25e-5)"	"unprognostic (4.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.41e-2)"	3.9	1.7	2.5	5.1	7.0	3.8	3.2	6.6	11.1	4.8	4.2	5.7	3.0	3.3	5.9	5.5	3.7	4.2	3.5	3.4	4.0		2.7	2.4	4.2	4.2	2.8	5.0	3.8	5.7	4.5	5.7	3.6	6.5	3.9	5.9	6.1	4.4	3.4	7.3	6.7	4.4	6.5	3.0	4.5	3.0	12.4	3.6	5.8	4.6	2.0	5.5	3.4	1.7	10.2	11.4	5.6	7.4	3.9	8.4	3.5	0.8	5.8	6.4	4.4	3.5	3.8	6.2	3.6	3.7	6.5	4.4	7.0	0.0	11.6	5.5	1.9	8.0	8.8	7.8	4.7	8.6	7.6	6.6	6.0	7.1	3.5	4.8	9.0	3.6	3.1	4.4	6.9	3.6	3.5	6.1	14.4	9.3	3.3	7.9	2.8	16.1	7.5	4.3	2.8	3.9	11.2	17.7	8.7	4.0	5.5	7.2	6.4	4.6	2.4	4.2	6.0	7.7	3.3	4.9	7.1	6.0	4.9	5.4	5.2	5.3	13.7	6.9	4.1	5.8	3.2	5.6	5.6	8.4	5.9	5.9	5.9	5.3	6.3	6.3	10.2	8.0	7.3	0.5	3.9	7.4	11.4	4.2	3.5											6.0	5.7	3.7	6.6	2.3	14.5	6.4	7.6	16.0	13.6	8.7	15.7	12.1	1.7	6.0	76.3	8.7	3.8	0.0	5.2	8.5	5.7	4.2	9.3	3.0	7.0	22.3	4.1	4.9	5.3	56.1	7.5	7.2	1.7	11.8	6.3	10.6	5.7	3.5	7.4	4.4	20.9	12.9	3.1	13.5	35.0	2.9	4.2	6.5	6.9	3.3
TADA2B	MGC21874	ENSG00000173011	"Transcriptional adaptor 2B"	Q86TJ2	4	7041899-7057952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 38.1;Rod photoreceptor cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035770	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035770: AB_10603993"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.17e-11)"	"unprognostic (5.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (1.59e-4)"	8.7	15.0	10.9	12.9	15.3	24.0	13.9	12.5	16.0	10.5	10.6	7.5	12.4	10.2	11.5	8.8	11.4	11.0	11.0	15.6	10.9	7.0	12.9	13.6	8.9	12.4	8.3	9.8	15.8	26.2	10.8	9.0	12.6	9.9	10.2	8.0	17.0	20.5	10.8	42.8	10.6	11.3	10.4	6.6	12.4	11.9	13.0	8.9	9.8	12.8	12.7	10.4	10.6	12.8	3.7	2.1	10.3	3.0	2.1	4.4	1.8	8.6	13.2	9.2	10.9	10.3	11.8	8.9	12.8	13.1	16.5	10.2	12.9	13.0	11.5	7.6	14.1	21.9	7.1	12.7	6.7	10.7	6.8	9.7	11.7	8.2	9.7	12.6	13.4	19.2	8.5	14.4	11.0	12.8	11.4	7.6	10.8	13.0	18.7	12.3	8.2	16.1	11.5	11.0	11.6	20.5	10.6	19.0	6.0	15.2	12.2	15.2	10.9	11.0	9.9	13.0	7.8	14.9	20.2	11.8	10.5	8.1	12.7	17.3	17.0	14.2	15.1	8.6	7.3	10.6	1.1	2.2	10.3	4.4	2.6	3.2	3.7	2.9	4.4	1.9	2.7	3.9	2.9	7.1	2.1	3.0	2.1	3.0	1.8	10.9	15.3	12.5	16.0	10.9	7.0	8.3	9.8	9.9	8.9	8.9	15.9	2.2	2.7	4.0	27.8	10.5	5.1	6.7	12.5	7.0	29.5	3.2	5.0	3.9	2.1	3.8	6.6	0.0	8.0	2.5	6.1	4.8	9.2	14.7	4.9	38.1	6.9	2.5	7.9	3.4	15.5	6.0	6.8	3.6	8.7	8.3	6.6	7.0	12.0	6.9	35.0	0.0	2.8	5.9	4.2	5.1	3.7	6.9	5.8	4.7
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843354-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	13.4	11.7	10.2	10.7	11.1	7.8	12.1	14.0	12.7	12.3	7.4	8.4	15.9	7.1	19.2	14.5	16.5	13.6	9.7	8.5	9.3	11.7	17.9	9.9	11.5	13.9	9.2	9.5	12.7	8.9	22.6	19.5	20.2	10.7	12.6	8.1	11.6	10.1	20.1	7.2	11.3	7.5	11.1	8.5	13.9	8.4	17.1	9.2	23.3	14.9	10.9	15.8	9.9	14.4	9.8	11.3	4.9	13.1	8.5	12.9	4.6	12.2	12.2	16.9	5.2	8.5	13.1	27.3	13.4	13.4	14.7	12.7	11.3	9.9	14.4	7.1	10.9	14.3	7.0	14.7	16.6	16.3	14.0	16.0	15.5	5.2	15.1	11.0	12.2	17.4	10.3	9.7	10.8	15.9	11.6	22.0	7.9	10.3	15.4	14.7	8.1	9.1	10.4	20.4	7.9	9.0	5.5	14.3	4.5	14.9	11.0	7.2	18.4	11.5	15.6	11.8	11.7	5.4	9.7	10.2	17.7	20.9	17.3	18.5	7.5	9.0	20.5	10.7	14.1	15.1	2.6	8.4	4.9	11.5	13.1	10.9	9.5	9.5	12.9	11.3	9.8	6.3	9.4	0.4	8.5	10.0	9.4	9.4	4.6	10.2	11.1	14.0	12.7	9.3	11.7	9.2	9.5	10.7	9.2	17.9	19.5	12.3	24.6	14.3	21.2	3.7	2.5	40.2	38.7	12.2	25.5	22.4	11.6	17.0	4.7	12.8	1.6	0.0	16.3	29.6	12.8	9.4	8.1	4.9	11.3	14.3	1.7	8.6	12.9	1.5	17.5	12.3	0.0	14.4	2.9	23.3	13.4	3.5	12.4	19.9	20.2	19.4	13.4	35.8	32.4	11.5	19.8	13.1	4.0	20.2
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"		Yes	No			Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271"	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	13.9	10.6	12.5	19.9	18.4	14.2	12.9	17.3	20.1	15.1	14.7	4.3	17.3	16.8	15.2	9.7	16.0	11.5	18.1	11.1	12.0	7.6	13.6	18.7	15.8	19.0	14.4	13.6	20.9	30.5	9.3	24.3	18.5	13.6	16.4	13.4	3.9	12.3	11.4	31.5	14.5	17.8	18.1	22.1	18.4	13.0	8.0	13.6	13.1	13.2	12.9	12.2	28.1	17.1	24.1	14.3	22.3	9.2	9.0	16.3	2.7	3.9	3.1	4.2	4.2	4.1	16.2	7.6	4.4	3.3	5.7	4.1	10.6	10.7	9.5	8.5	4.3	1.9	11.7	4.9	6.9	6.3	2.6	2.0	9.7	17.5	6.3	4.1	8.8	5.2	4.5	7.5	4.5	7.4	9.0	7.1	5.0	6.6	18.8	7.8	1.2	7.4	17.0	3.2	2.9	2.4	3.5	4.7	8.1	6.5	6.3	3.0	6.3	2.6	9.6	3.0	6.1	11.9	2.2	6.9	8.6	5.7	12.9	6.5	8.4	9.5	8.0	3.1	9.4	2.9	17.4	9.2	14.8	10.0	6.5	10.0	19.5	13.8	10.9	6.2	24.1	16.3	13.6	22.3	9.0	5.2	14.3	9.4	2.7	12.5	18.4	17.3	20.1	12.0	7.6	14.4	13.6	13.6	13.6	83.4	80.4	125.3	241.5	216.9	84.2	23.0	129.9	91.0	139.9	27.9	37.3	149.3	38.1	80.3	12.9	79.2	61.0	0.0	125.2	151.7	105.8	205.9	100.6	46.5	62.1	65.2	105.6	52.2	91.2	12.3	119.0	105.3	75.9	66.7	101.9	39.6	109.2	66.6	63.6	64.8	75.6	71.1	94.7	37.0	70.9	177.4	134.6	106.5	115.9	265.8
TAF3	"TAF140, TAFII140"	ENSG00000165632	"TATA-box binding protein associated factor 3"	Q5VWG9	10	7818504-8016627	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066184			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA066184: AB_2685631"	"unprognostic (3.82e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (2.14e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.30e-3)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.59e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	11.2	11.2	10.6	13.5	13.9	13.1	9.5	24.5	13.0	10.7	10.0	11.1	12.7	6.4	11.7	6.0	7.9	8.3	8.2	11.5	11.5	12.1	9.3	8.2	8.6	12.0	12.8	8.4	16.1	9.5	16.1	15.9	9.9	11.6	9.6	8.1	9.6	7.6	13.3	20.8	10.6	9.6	9.5	12.4	11.4	8.1	15.8	14.2	17.4	9.7	7.3	9.9	10.0	14.4	8.8	4.7	7.7	8.6	8.3	10.8	5.0	7.0	6.6	7.5	3.9	8.5	6.0	10.4	8.4	3.3	6.3	7.3	14.1	5.3	12.1	6.5	4.9	2.6	7.7	8.2	7.3	8.0	9.7	9.0	10.3	4.6	8.9	7.4	6.9	9.5	4.0	7.3	8.9	4.4	4.0	6.0	13.3	11.5	12.6	7.2	13.3	15.6	4.9	5.7	10.3	3.9	12.7	7.1	8.1	3.7	4.4	4.0	5.7	9.1	6.6	8.2	7.7	12.1	7.3	7.4	5.8	10.1	15.2	8.2	7.5	8.9	13.3	5.6	7.9	5.2	7.3	5.6	7.7	9.3	5.0	10.8	7.6	8.4	9.0	4.7	8.8	10.5	9.0	2.2	8.3	8.6	4.6	6.9	5.0	10.6	13.9	24.5	13.0	11.5	12.1	12.8	8.4	11.6	14.2	26.8	28.5	29.8	19.4	28.4	28.0	36.6	10.2	24.1	9.1	26.2	33.4	22.7	0.0	15.2	30.9	22.2	17.1	0.0	12.7	30.6	16.8	12.5	20.9	11.9	17.4	25.4	18.0	13.5	17.5	17.0	25.3	21.9	23.6	16.2	12.1	29.9	12.3	2.9	26.9	3.4	40.5	25.8	28.4	48.9	42.1	37.6	16.7	30.9	11.5	17.3
TAF5L	PAF65B	ENSG00000135801	"TATA-box binding protein associated factor 5 like"	O75529	1	229593111-229626047	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067941			Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA067941: AB_2685929"	"unprognostic (3.41e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.17e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	19.5	8.3	13.0	14.4	12.8	23.0	25.6	13.5	14.7	12.1	15.3	14.7	9.9	12.7	15.8	10.6	15.0	14.1	16.3	12.9	10.5	9.0	9.5	18.6	13.6	15.7	12.1	8.0	12.2	10.4	12.7	11.6	25.0	12.9	15.7	15.8	9.2	13.3	12.3	24.9	10.1	17.0	16.5	12.8	15.6	13.8	8.5	10.5	15.9	13.5	11.9	15.3	17.1	13.2	1.1	1.6	0.2	1.3	2.1	2.6	0.8	16.5	9.6	13.8	11.5	9.5	10.0	35.8	11.2	13.5	14.1	13.2	12.9	13.6	18.7	12.0	12.1	9.2	14.2	15.2	13.8	13.6	13.9	21.8	14.6	9.8	8.1	10.7	19.3	17.0	11.1	13.5	13.9	12.0	5.5	13.7	19.8	19.4	17.3	13.2	8.0	21.8	10.4	19.5	18.7	7.6	19.4	15.5	19.2	9.8	15.4	13.9	16.9	9.6	13.3	15.4	5.3	15.8	20.2	11.8	11.8	14.4	15.5	23.6	9.2	7.0	21.4	8.9	11.7	18.5	0.0	1.1	0.2	2.1	1.2	2.6	1.1	2.2	1.7	1.6	1.0	2.2	1.9	0.2	2.1	1.3	0.7	1.9	0.8	13.0	12.8	13.5	14.7	10.5	9.0	12.1	8.0	12.9	10.5	3.0	6.5	2.2	3.8	5.0	5.7	6.3	7.6	4.0	9.1	3.5	11.8	9.7	1.7	3.6	2.1	6.3	9.1	0.0	7.2	29.3	4.8	5.8	0.0	12.1	8.4	6.4	11.5	6.7	6.9	2.9	4.4	6.8	5.0	10.0	10.6	3.2	5.6	7.0	3.9	2.8	8.3	12.9	6.2	6.5	2.2	4.5	8.7	5.1	8.3	7.0
TAF6	"MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85"	ENSG00000106290	"TATA-box binding protein associated factor 6"	P49848	7	100107070-100119841	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006566			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006566: AB_1080194"	"unprognostic (5.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.37e-1)"	14.1	19.8	21.5	15.4	23.6	13.9	12.0	23.5	35.8	19.4	17.5	12.7	12.6	12.1	24.1	17.6	16.8	23.6	16.8	17.2	20.5	16.3	16.1	10.2	12.9	14.3	13.1	15.9	26.2	16.6	22.6	21.7	19.5	19.3	15.8	13.7	15.6	17.9	23.3	23.1	17.9	13.2	23.7	13.1	14.6	14.0	27.3	14.7	21.7	21.3	11.5	17.0	19.6	14.9	15.3	14.3	13.2	25.7	14.0	18.7	13.1	17.1	32.2	20.9	34.2	27.5	14.6	29.3	18.9	21.2	24.4	22.6	23.9	21.0	15.7	21.6	28.9	41.9	14.6	28.6	22.5	26.3	25.6	18.6	15.1	31.3	15.8	27.4	14.6	14.3	14.9	14.1	35.7	39.5	19.7	19.7	27.9	26.1	29.1	22.0	61.0	31.0	23.7	30.8	15.5	26.0	22.9	25.7	23.3	17.4	14.0	19.0	27.6	23.9	37.1	15.8	31.5	13.5	14.5	19.5	37.0	38.1	47.8	24.4	18.0	31.1	26.4	25.1	20.5	31.8	12.7	11.0	13.2	15.6	11.4	18.7	10.2	15.0	15.7	14.3	15.3	15.3	14.3	6.4	14.0	25.7	8.5	13.9	13.1	21.5	23.6	23.5	35.8	20.5	16.3	13.1	15.9	19.3	14.7	8.9	10.2	11.1	17.3	10.1	12.5	0.9	15.3	16.0	6.8	24.4	0.0	61.4	14.9	20.7	21.7	10.8	11.9	0.0	14.6	30.0	16.7	12.7	0.0	6.4	18.1	12.7	15.0	10.4	7.8	34.8	20.1	9.7	11.8	24.4	11.8	16.7	14.1	14.2	29.4	17.8	11.6	25.8	18.9	24.5	61.1	10.3	28.8	17.5	14.3	12.2
TAF7	"TAF2F, TAFII55"	ENSG00000178913	"TATA-box binding protein associated factor 7"	Q15545	5	141260225-141320821	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006429	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA006429: AB_1080196"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.78e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-2)"	33.2	29.9	29.2	28.8	32.2	31.6	38.7	39.6	33.6	28.6	24.1	26.0	21.0	20.2	34.6	39.8	24.9	35.0	22.2	46.4	30.3	30.8	28.6	29.7	25.3	32.9	32.0	26.1	50.7	24.8	20.1	47.1	38.8	28.9	34.8	26.5	21.3	26.8	28.0	69.5	26.9	30.0	31.8	32.9	37.0	23.9	33.5	28.9	65.5	45.7	33.9	39.1	32.3	53.6	18.8	17.8	49.6	16.5	27.1	29.8	19.8	20.1	16.9	38.6	28.2	34.5	32.1	24.1	26.4	23.6	37.6	36.8	23.7	22.8	54.5	53.0	26.8	40.8	17.4	24.3	24.5	38.0	23.8	27.1	9.8	20.9	19.7	31.5	13.4	20.7	29.2	36.6	14.6	26.0	29.7	27.0	25.0	20.8	42.8	36.0	25.4	30.1	32.7	13.9	25.7	6.2	38.6	51.7	39.8	27.6	27.3	31.0	35.5	21.6	31.2	29.4	30.9	44.4	44.3	24.7	5.3	18.3	17.3	32.0	11.6	47.0	49.4	23.2	31.4	21.2	44.7	11.4	49.6	18.3	13.9	23.7	18.8	21.5	20.3	16.1	18.7	29.8	24.6	34.6	27.1	16.5	17.8	17.9	19.8	29.2	32.2	39.6	33.6	30.3	30.8	32.0	26.1	28.9	28.9	80.4	57.2	110.4	280.4	107.0	136.8	146.1	48.4	112.4	73.9	78.5	90.3	83.2	69.6	99.8	22.8	91.5	110.7	23.3	66.3	65.8	100.9	202.5	150.3	64.8	46.3	114.4	80.8	81.6	47.6	26.8	136.1	79.3	106.3	113.6	89.5	127.1	95.5	150.8	121.3	60.6	90.0	161.7	131.0	119.8	145.9	149.1	118.2	132.3	79.0	199.6
TAF7L	"CT40, TAF2Q"	ENSG00000102387	"TATA-box binding protein associated factor 7 like"	Q5H9L4	X	101268253-101293057	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 36.1"	"Group enriched"	"Detected in some"	6	"Early spermatids: 20.1;Late spermatids: 11.5;Spermatocytes: 29.8;Spermatogonia: 20.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	17	"SiHa: 36.0"					"Low region specificity"	"Detected in all"			"HPA001879, HPA072008"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001879: AB_1857751, HPA072008: "	"unprognostic (1.70e-2)"	"prognostic favorable (8.71e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.12e-2)"	0.1	0.0	1.4	0.1	1.7	0.2	0.1	0.1	0.6	1.6	0.5	0.2	0.1	0.0	0.7	3.5	0.1	0.0	0.1	0.1	0.8	0.2	0.3	0.5	0.1	0.1	0.1	0.8	0.1	0.1	2.5	0.2	0.4	0.3	1.8	0.0	0.4	0.1	1.8	0.1	0.6	0.3	0.1	0.4	0.1	0.1	36.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	1.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.7	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.6	0.0	0.1	0.2	0.1	1.7	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	36.0	0.2	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.7	0.1	0.6	0.8	0.2	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	20.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	2.4	0.1	0.0	0.0	0.6	0.0	11.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.2	29.8	20.2	0.1	1.4	0.0	0.0	0.0
TAF9B	"DN-7, DN7, TAF9L, TAFII31L, TFIID-31"	ENSG00000187325	"TATA-box binding protein associated factor 9b"	Q9HBM6	X	78129748-78139706	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045275, HPA058961"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045275: AB_10962831, HPA058961: AB_2683863"	"unprognostic (3.62e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.68e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.34e-3)"	"unprognostic (9.47e-2)"	"unprognostic (2.62e-1)"	15.5	12.4	25.6	10.3	23.5	10.7	16.6	20.1	27.5	21.5	15.5	20.2	9.9	6.9	24.8	15.6	20.2	17.4	14.2	23.6	21.6	23.0	19.2	14.4	11.5	11.0	21.2	22.1	17.7	11.6	24.4	19.6	13.6	21.3	21.5	10.9	12.9	10.5	19.2	20.7	12.8	9.3	31.9	23.9	10.6	14.0	10.7	19.2	15.9	20.0	11.3	10.9	22.4	12.4	4.5	4.9	1.4	3.3	10.3	13.3	7.2	10.9	9.5	23.5	10.3	9.2	9.4	3.5	9.8	9.1	16.0	8.9	13.2	19.0	12.6	14.1	10.6	13.0	8.7	35.0	8.1	16.7	19.5	12.2	6.8	13.5	12.1	9.2	10.8	7.6	12.0	4.3	17.5	12.1	10.1	9.6	12.6	14.0	27.2	14.1	16.6	16.9	8.4	27.6	14.4	17.9	14.7	30.6	11.5	10.8	22.2	15.0	14.9	27.3	11.9	10.6	12.8	19.2	7.8	10.2	12.4	18.9	13.5	11.8	11.7	23.7	9.3	21.5	21.8	17.3	0.6	3.1	0.9	5.5	3.3	10.2	4.5	12.5	9.5	4.0	4.4	12.8	9.4	1.4	10.3	2.4	4.9	13.3	7.2	25.6	23.5	20.1	27.5	21.6	23.0	21.2	22.1	21.3	19.2	8.9	5.6	4.7	19.7	13.9	13.5	23.0	5.1	2.7	6.8	19.2	7.9	14.7	6.6	5.9	0.8	15.3	0.9	0.0	7.4	13.7	11.2	13.8	2.3	5.5	5.9	7.9	12.1	13.5	3.8	1.1	9.8	5.0	21.9	9.0	4.4	22.1	3.7	3.4	13.1	13.6	9.0	19.4	22.8	2.9	30.4	7.8	7.1	6.5	3.5	8.6
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.9;bone marrow: 55.6;lymphoid tissue: 32.7"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 68.1;Macrophages: 53.7;T-cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.4;HMC-1: 21.0;Karpas-707: 21.9;U-266/84: 9.8;U-698: 20.2;U-937: 16.1"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	4.4	2.3	1.5	16.9	2.1	55.6	2.5	0.9	2.0	1.9	2.5	7.9	1.3	1.7	9.7	1.8	2.7	2.1	4.1	2.0	1.9	3.7	2.2	2.4	8.4	32.7	5.0	1.1	1.9	1.0	0.4	1.4	2.8	3.9	1.9	3.6	3.2	3.2	1.8	0.8	1.4	11.8	12.2	9.2	22.1	2.7	1.7	3.0	32.6	2.2	4.0	32.1	6.8	1.9	14.9	7.8	47.9	7.7	12.0	22.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.0	0.0	0.0	7.4	21.0	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	21.9	0.0	0.0	1.9	3.9	5.9	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	3.4	0.1	0.0	0.0	0.0	0.0	2.4	9.8	20.2	0.0	16.1	0.0	38.7	7.7	23.6	16.4	5.5	18.5	13.9	22.0	19.0	7.8	14.9	17.4	12.1	47.9	12.0	7.0	2.6	15.5	14.4	1.5	2.1	0.9	2.0	1.9	3.7	5.0	1.1	3.9	3.0	3.0	10.0	68.1	0.2	2.5	0.1	0.4	0.0	1.4	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.4	3.7	0.4	18.5	0.8	23.7	0.0	0.0	1.8	19.5	0.9	1.1	53.7	27.0	0.0	0.0	0.3	0.0	0.0	21.2	0.2	0.1	0.0	0.3	0.0	0.1	2.4	0.7	89.6	0.0	0.3
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199321-117204782	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 2168.1;Sertoli cells: 2819.8;Smooth muscle cells: 4737.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 19.0;non-classical monocyte: 26.6"	"Lineage enriched"	"Detected in many"	10	"monocytes: 26.6"	"Cell line enhanced"	"Detected in many"		"BJ: 136.7;BJ hTERT+ SV40 Large T+: 130.0;CACO-2: 122.7;EFO-21: 163.1;fHDF/TERT166: 139.3;hTERT-RPE1: 106.3;LHCN-M2: 96.2;U-138 MG: 126.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 176.0"	"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		8000000	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	73.3	22.6	2.3	67.6	5.9	0.2	60.8	2.1	7.7	278.3	328.7	6.1	156.2	22.3	399.7	156.8	337.9	133.3	227.5	48.7	3.1	3.0	49.5	12.9	44.1	38.6	7.1	11.8	159.2	9.3	1.5	8.0	36.2	14.9	237.5	51.6	39.1	24.1	347.5	36.6	17.9	81.0	481.9	9.1	26.0	114.7	65.1	2.1	1.1	47.3	30.0	11.2	473.0	78.1	2.6	1.4	0.8	26.6	0.0	0.3	0.9	1.2	0.3	21.4	0.5	10.0	9.0	18.0	136.7	59.3	130.0	48.7	122.7	1.9	0.2	163.1	139.3	0.1	3.2	0.3	1.1	37.0	0.4	0.2	0.3	4.6	8.3	55.9	0.1	0.3	23.7	4.6	19.0	2.4	106.3	0.2	0.2	0.2	0.4	96.2	0.2	0.1	1.0	6.5	1.1	0.1	0.1	1.6	0.6	0.2	1.7	0.1	0.5	2.1	0.7	0.1	53.6	0.6	0.3	14.6	126.7	21.3	0.9	5.8	0.6	0.4	1.0	0.7	0.4	0.3	0.8	1.1	0.0	0.1	19.0	0.2	1.6	0.0	0.0	1.4	2.6	0.1	0.0	0.1	0.0	26.6	0.7	0.3	0.9	2.3	5.9	2.1	7.7	3.1	3.0	7.1	11.8	14.9	2.1	35.7	6.7	4.5	353.2	56.7	9.9	1.2	5.1	13.4	5.7	38.4	17.7	30.6	0.0	230.9	2.4	73.9	6.2	0.0	68.1	27.0	232.5	54.7	1.1	9.3	37.9	1.6	2.9	944.1	20.6	8.9	44.8	43.3	91.1	9.0	9.0	3.3	40.6	3.5	2168.1	1.3	10.5	2819.8	4737.3	6.1	4.4	53.2	26.9	10.0	2.6	40.6
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925732	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 2167.7;monocytes: 1311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA		540000000	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavorable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	80.6	26.4	19.7	57.5	25.6	47.9	62.8	7.9	18.3	49.1	45.9	16.6	54.5	43.3	39.2	49.4	96.3	36.3	63.6	57.3	15.9	18.5	68.0	178.2	107.7	65.0	24.3	9.8	45.7	51.2	8.8	18.1	122.2	24.8	43.8	43.0	24.7	67.2	62.9	35.3	62.6	74.6	36.2	20.0	95.8	96.8	46.4	20.2	60.5	37.7	150.7	76.5	57.2	62.0	53.0	114.4	220.7	42.4	44.0	41.7	106.7	110.3	59.7	1.8	0.7	21.3	53.1	68.9	62.2	71.5	135.4	65.9	61.9	86.7	68.6	53.0	73.9	38.0	86.7	30.5	77.5	83.6	78.2	24.7	91.4	57.9	3.6	25.2	64.2	102.9	52.7	60.2	79.7	41.3	90.7	81.5	18.3	39.1	48.3	46.1	42.0	29.0	40.5	51.5	69.2	101.9	0.2	31.8	102.5	28.1	43.3	28.6	27.1	73.0	119.5	32.1	100.7	63.0	63.3	93.5	81.1	94.3	73.5	167.4	19.4	8.6	40.2	104.9	41.2	49.8	66.9	42.4	177.0	34.7	25.2	30.6	53.0	38.6	33.4	68.5	39.7	20.4	22.4	220.7	44.0	18.9	114.4	41.7	106.7	19.7	25.6	7.9	18.3	15.9	18.5	24.3	9.8	24.8	20.2	166.7	130.7	257.0	252.6	487.7	6.1	8.0	109.5	111.1	142.1	174.5	17.7	477.1	63.0	1095.0	40.8	397.3	292.6	0.0	1053.3	2167.7	440.6	225.0	408.8	47.4	432.7	3.2	305.0	192.1	247.2	61.8	109.9	313.3	317.2	1311.1	280.8	63.0	865.9	140.6	60.1	122.4	18.8	181.1	346.3	4.8	17.6	500.5	192.7	223.4	182.9	345.3
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663112	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"blood: 8.8;kidney: 4.6;skeletal muscle: 17.3"	"Cell type enhanced"	"Detected in some"	16	"Cone photoreceptor cells: 3.9;Distal tubular cells: 6.6;Intestinal endocrine cells: 3.4;Muller glia cells: 1.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"					"Group enriched"	"Detected in some"	21	"memory B-cell: 8.8;naive B-cell: 7.9;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	18	"B-cells: 8.8;dendritic cells: 2.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.4;HAP1: 4.9;K-562: 12.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"	0.1	0.3	0.5	0.1	0.7	0.0	0.0	0.3	0.6	0.2	0.0			0.0	0.2	0.9	0.1	0.2	0.0	0.3	0.4	0.5	4.6	0.3	0.0	0.2	0.7		0.3	0.1	0.0	0.8	0.1		0.1	0.1		0.0	0.2	17.3	0.1	0.1	0.0	0.8	0.3	0.0	0.6			0.1		0.4	0.1	0.0	8.8	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.7	2.5	0.7	0.3	0.0	0.3	0.1	0.3	0.1	0.4	3.4	0.2	0.1	0.3	0.0	0.7	0.1	4.9	0.0	0.2	0.6	0.5	1.1	0.0	0.0	0.2	0.6	1.9	0.3	0.6	0.1	0.2	0.2	0.0	0.8	12.9	0.3	0.4	0.3	0.8	0.7	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	2.9	1.2	0.2	0.3	0.2	0.1	0.2	2.1	0.5	0.3	0.8	0.7	1.1	1.0	2.0	0.1	0.2	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.9	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.4	1.1	0.9	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747329-765024	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.6"	"Cell type enhanced"	"Detected in all"	6	"monocytes: 1009.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 148.6;neutrophil: 204.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		39000000	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	39.0	24.2	26.6	34.8	31.3	117.4	44.2	20.6	38.3	27.7	28.5	51.2	18.8	34.2	20.4	20.7	90.0	23.2	33.2	37.5	29.2	23.6	45.8	48.4	37.9	60.0	46.5	26.6	23.4	31.9	14.6	15.8	34.3	30.7	28.3	23.7	15.5	38.3	19.5	31.2	38.4	29.4	40.4	47.5	45.6	35.8	14.8	33.0	34.1	42.2	82.4	43.1	51.4	37.5	8.5	36.1	204.6	60.8	5.9	10.4	45.3	42.2	53.5	15.5	29.3	32.1	18.7	45.7	32.1	41.4	31.8	26.3	22.7	92.2	23.6	43.7	42.1	24.6	45.7	24.5	34.7	16.6	30.8	49.7	40.8	20.7	79.4	34.3	65.2	60.9	15.3	28.0	21.4	17.4	23.0	43.7	29.8	52.9	39.5	29.5	40.4	37.9	77.3	24.3	62.0	43.4	31.6	18.2	84.5	57.8	24.6	38.3	13.4	30.0	62.0	31.1	14.4	29.4	49.6	58.0	14.6	13.7	11.5	30.1	16.7	16.2	28.0	32.4	57.0	58.9	64.7	60.8	148.6	5.6	23.2	6.1	8.5	7.5	6.8	36.1	6.8	6.1	5.7	204.6	5.9	23.2	14.8	10.4	45.3	26.6	31.3	20.6	38.3	29.2	23.6	46.5	26.6	30.7	33.0	131.0	100.4	88.6	136.2	65.4	45.6	40.9	122.3	141.8	86.4	143.1	13.7	355.3	212.2	199.7	61.7	74.4	141.1	280.4	236.4	383.3	78.6	213.8	155.0	128.2	368.8	47.7	97.4	79.8	301.9	17.2	109.0	235.0	133.3	1009.1	137.9	126.1	238.1	181.4	97.9	218.5	43.3	71.1	73.5	122.7	154.7	72.6	440.3	79.1	199.9	251.7
TAMM41	"C3orf31, DKFZp434E0519, MGC16471"	ENSG00000144559	"TAM41 mitochondrial translocator assembly and maintenance homolog"	Q96BW9	3	11790442-11846919	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036834, HPA044861"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036834: AB_10672270, HPA044861: AB_2679116"	"unprognostic (2.40e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.59e-3)"	13.9	12.9	21.8	15.9	27.5	9.1	15.7	25.6	19.8	12.5	12.2	14.2	12.5	11.5	17.7	23.7	15.2	12.4	10.0	13.8	13.9	11.5	12.4	12.0	18.7	25.0	11.3	15.3	21.7	12.9	12.5	15.4	9.9	11.4	10.7	12.0	11.2	11.7	14.2	15.2	17.3	10.4	15.0	13.7	12.3	10.1	14.1	14.8	12.7	10.8	8.4	17.4	13.8	13.8	8.7	8.9	7.7	7.1	7.1	11.3	5.0	4.2	7.9	9.7	6.7	10.5	13.3	17.9	6.5	4.7	10.0	10.0	9.5	7.0	16.2	9.6	6.8	4.4	5.2	16.2	9.8	13.0	6.0	15.3	9.6	7.6	11.0	12.3	17.6	5.1	7.6	14.6	9.4	10.6	6.6	15.4	12.9	14.1	5.0	12.8	12.2	9.9	13.2	7.7	6.6	16.9	9.9	5.5	14.2	15.3	10.4	4.5	3.9	5.7	7.4	10.8	11.4	9.6	8.0	4.0	5.2	6.0	15.6	9.2	3.9	9.5	8.3	6.3	15.0	4.8	2.2	5.3	7.7	7.2	3.6	9.2	8.7	11.3	7.0	8.9	8.0	10.4	10.6	0.2	7.1	7.1	6.6	8.7	5.0	21.8	27.5	25.6	19.8	13.9	11.5	11.3	15.3	11.4	14.8	6.0	6.5	7.3	7.8	3.8	10.6	8.1	0.0	10.7	5.7	3.5	11.8	10.3	8.3	9.7	1.6	5.8	2.8	0.0	8.0	9.1	4.6	5.4	2.3	5.7	8.1	9.5	2.9	4.9	6.5	1.1	7.2	7.2	3.3	4.6	7.3	10.8	6.6	3.5	6.0	7.9	14.0	0.0	6.2	8.4	11.9	3.6	5.8	9.5	7.6	4.6
TANC2	"DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA"	ENSG00000170921	"Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2"	Q9HCD6	17	63009556-63427699	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 31.6"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 43.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023274	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA023274: AB_2199727"	"unprognostic (8.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.09e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.01e-1)"	3.4	3.9	4.4	3.1	8.5	6.2	2.7	2.1	19.5	4.5	1.5	2.8	1.5	1.0	2.7	7.0	3.4	2.5	3.1	2.0	5.2	5.4	3.1	1.5	7.9	1.5	5.2	3.5	3.0	2.3	31.6	5.1	2.8	2.7	2.6	1.1	1.9	3.5	3.4	1.5	4.8	2.0	4.1	7.5	2.7	1.8	10.9	3.4	4.6	2.1	4.4	1.9	6.4	2.9	0.8	1.6	1.1	0.1	2.9	2.2	0.1	12.2	11.6	7.2	1.2	3.7	8.9	13.9	7.8	7.8	7.8	9.7	0.6	3.6	0.0	2.4	13.4	9.9	1.7	11.6	23.1	17.7	4.7	5.3	18.0	17.1	0.6	3.2	4.8	0.0	13.6	13.5	9.1	26.3	8.6	2.4	4.7	2.2	0.0	11.1	9.4	3.1	0.8	0.8	2.2	7.6	2.5	14.4	0.9	6.9	17.0	12.2	13.4	4.4	8.3	3.4	13.1	3.8	1.3	12.5	19.1	10.0	1.2	9.6	0.0	0.0	0.0	7.0	1.3	6.8	0.0	0.1	0.0	2.2	0.1	1.7	0.1	1.2	1.7	0.1	0.8	0.5	1.1	1.1	2.9	0.0	1.6	0.0	0.1	4.4	8.5	2.1	19.5	5.2	5.4	5.2	3.5	2.7	3.4	14.9	41.2	2.0	9.1	22.2	43.0	3.6	10.2	4.0	13.6	26.2	15.7	6.7	1.7	8.8	14.2	9.5	0.5	0.0	12.1	32.1	4.6	8.9	0.0	0.8	7.2	7.9	4.1	16.0	7.8	8.0	5.2	16.1	10.1	13.6	3.9	3.7	20.4	2.9	3.2	1.4	6.8	19.4	4.1	18.0	14.6	13.9	13.7	7.5	1.5	9.6
TANGO6	"FLJ12688, KIAA1746, TMCO7"	ENSG00000103047	"Transport and golgi organization 6 homolog"	Q9C0B7	16	68843604-69085180	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 111.9;Late spermatids: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041312	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA041312: AB_10796342"	"unprognostic (8.55e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (6.02e-2)"	12.5	7.7	8.0	9.6	13.1	7.0	10.7	10.9	15.0	10.2	8.2	14.7	7.2	6.0	12.8	5.6	8.5	8.3	8.0	7.8	7.3	7.7	13.1	27.6	8.4	10.8	9.8	10.6	10.0	11.2	21.6	13.2	7.9	9.3	9.7	7.1	12.1	7.7	10.3	18.5	9.2	7.0	11.1	9.4	9.7	9.1	9.3	12.1	14.5	7.9	5.8	12.6	12.8	12.7	4.0	6.6	2.6	9.0	2.5	6.5	3.8	5.7	11.9	4.0	8.5	6.7	7.6	2.9	7.9	6.6	9.8	8.0	7.7	4.8	13.2	4.4	11.1	5.2	4.8	9.0	10.6	12.3	3.1	5.4	2.4	4.8	7.0	5.5	6.5	6.1	5.7	5.8	13.9	12.7	4.1	9.4	6.3	8.6	2.2	9.2	5.8	6.7	5.2	8.5	5.7	6.4	7.2	5.8	14.6	7.3	3.3	4.1	4.7	19.4	1.1	5.2	5.0	3.8	7.3	5.4	9.3	3.4	9.4	5.6	4.1	3.5	9.0	5.8	2.5	6.1	0.0	4.8	2.6	4.9	9.0	5.2	4.0	4.9	5.0	6.6	3.7	3.1	5.0	0.3	2.5	7.9	1.7	6.5	3.8	8.0	13.1	10.9	15.0	7.3	7.7	9.8	10.6	9.3	12.1	0.0	3.4	6.9	8.2	4.6	8.1	2.8	5.1	0.0	2.3	7.0	9.8	4.5	0.0	1.7	111.9	3.8	1.1	0.0	2.9	2.2	2.7	1.7	1.1	11.6	4.2	4.8	0.0	3.7	7.0	36.7	5.2	4.1	5.0	0.0	1.6	2.9	2.3	2.9	3.2	4.8	8.2	0.0	3.1	3.2	4.4	2.6	2.1	5.7	1.9	7.7
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973641-29992261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	27.8	24.1	26.2	15.1	26.7	12.3	17.7	29.2	30.6	13.5	13.6	21.5	11.8	18.5	16.8	13.0	12.4	14.1	15.1	17.6	25.0	18.2	13.9	10.4	23.0	14.4	22.1	22.7	15.8	16.3	26.2	18.7	22.5	20.7	13.6	9.6	15.0	17.1	15.9	22.8	20.0	19.3	14.8	14.9	26.3	16.0	21.2	20.2	14.0	15.9	9.8	11.5	12.8	18.0	2.6	3.3	4.8	2.8	2.0	3.2	2.0	11.2	21.5	11.8	18.6	13.9	9.3	18.1	20.7	11.1	14.0	13.1	17.2	15.1	12.2	17.6	14.9	9.4	17.6	10.7	10.4	7.6	18.9	22.7	13.1	21.7	17.2	10.1	12.9	25.3	10.9	9.1	14.9	6.0	9.8	23.4	11.7	11.8	12.4	13.3	20.8	15.0	18.3	11.4	8.4	14.5	27.7	17.1	11.3	8.8	10.6	13.9	11.2	11.8	15.8	6.2	7.9	19.8	14.6	32.6	24.2	11.2	17.1	11.9	18.1	11.6	11.5	14.8	14.8	17.6	1.3	2.8	1.5	2.9	2.7	3.1	2.0	2.9	2.6	1.8	2.6	1.6	1.4	4.8	2.0	1.4	3.3	3.2	2.0	26.2	26.7	29.2	30.6	25.0	18.2	22.1	22.7	20.7	20.2	8.9	11.5	2.2	4.2	9.5	13.3	8.1	5.1	4.0	7.9	8.7	37.3	6.7	1.7	7.6	3.1	27.6	23.3	0.0	10.2	4.8	9.3	5.8	3.5	9.7	8.4	9.5	12.6	44.2	12.4	2.1	11.5	5.5	6.8	4.6	14.9	8.7	12.7	14.2	12.0	6.4	19.2	6.5	7.6	21.1	17.2	8.4	10.1	9.2	13.3	5.7
TARBP1	"TRM3, TRMT3, TRP-185"	ENSG00000059588	"TAR (HIV-1) RNA binding protein 1"	Q13395	1	234391313-234479103	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020810, HPA024632"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB020810: , HPA024632: AB_1857770"	"unprognostic (3.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.45e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.14e-10)"	"unprognostic (5.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.27e-2)"	7.2	6.7	10.3	10.5	19.4	12.0	11.4	22.5	22.9	6.5	7.3	10.5	3.0	7.8	7.2	9.8	10.7	10.0	11.3	6.6	7.1	6.8	7.0	4.7	7.6	11.9	6.6	18.2	5.7	12.7	12.9	12.1	10.1	13.0	9.5	11.4	8.7	12.8	5.8	11.0	10.1	8.9	5.7	8.0	8.7	10.2	5.6	6.4	8.7	10.1	6.2	13.6	5.5	7.7	1.2	4.0	0.0	0.3	0.9	1.9	0.2	11.5	8.1	5.4	6.2	8.9	12.3	11.1	4.9	3.8	6.5	4.8	3.8	7.6	10.0	5.3	3.7	5.6	7.6	6.1	6.2	6.3	9.8	9.4	5.5	8.5	5.6	2.8	24.2	4.9	5.1	5.7	4.7	2.6	5.1	6.6	13.6	6.9	6.5	4.5	2.4	10.0	11.9	11.3	12.5	3.3	17.6	3.1	9.9	4.4	6.8	5.7	6.8	6.8	8.9	7.5	3.7	5.7	24.8	4.4	6.0	0.7	6.6	9.9	17.4	11.4	4.4	3.9	11.4	8.9	0.0	0.3	0.0	0.6	0.3	0.9	1.2	0.4	0.4	0.4	0.3	1.9	1.1	0.0	0.9	0.1	4.0	0.0	0.2	10.3	19.4	22.5	22.9	7.1	6.8	6.6	18.2	13.0	6.4	38.7	17.7	11.9	3.5	5.6	29.8	5.2	10.2	30.8	14.8	7.0	35.3	16.9	1.7	4.3	12.6	9.2	4.2	0.0	5.0	12.3	8.0	4.6	3.5	7.6	7.8	54.0	11.1	11.1	5.3	1.5	5.2	9.1	10.1	2.8	11.2	8.2	7.1	3.5	5.6	3.3	17.9	0.0	7.6	3.5	5.1	7.2	10.0	11.8	17.6	4.6
TARBP2	Trbp	ENSG00000139546	"TARBP2, RISC loading complex RNA binding subunit"	Q15633	12	53500921-53506431	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051181, HPA061454, CAB069406"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.04e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (4.75e-6)"	"unprognostic (8.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.31e-1)"	7.3	12.0	7.5	11.5	8.0	6.1	18.6	24.0	9.5	10.7	11.6	11.0	11.0	10.9	8.3	15.7	11.8	14.7	15.8	8.0	7.0	6.1	14.8	27.3	10.3	15.7	9.5	6.3	9.8	17.0	8.6	8.2	23.5	6.6	10.2	7.1	10.3	13.4	11.1	10.9	12.2	10.3	7.6	6.9	13.9	10.3	18.3	6.9	14.8	15.5	8.6	12.9	10.2	12.8	11.1	12.7	5.5	9.8	9.5	12.7	10.7	10.1	29.5	10.6	11.7	6.9	9.4	15.4	8.7	8.5	15.0	8.9	23.9	14.0	9.2	19.0	10.1	9.1	8.1	14.4	13.6	9.0	12.0	22.7	10.8	11.6	17.6	14.4	18.4	12.8	10.2	9.3	14.8	7.5	10.1	17.7	14.9	14.4	16.2	10.9	41.9	12.8	25.9	21.6	7.7	15.3	9.7	6.3	13.1	9.6	11.1	14.3	10.0	4.6	12.0	24.3	8.7	16.5	27.2	8.7	12.9	11.7	4.8	11.0	7.4	14.8	9.8	15.2	9.8	14.8	1.7	9.8	5.5	12.6	9.7	12.1	10.5	12.0	10.9	12.7	11.1	12.7	11.4	0.4	9.5	5.9	11.3	9.9	10.7	7.5	8.0	24.0	9.5	7.0	6.1	9.5	6.3	6.6	6.9	0.0	8.0	13.8	10.6	5.7	7.9	5.5	7.6	4.0	5.7	8.7	9.8	40.0	18.3	18.6	7.5	7.7	8.0	0.0	22.9	39.5	8.5	7.8	10.4	16.8	22.3	1.6	5.2	6.7	7.5	19.2	5.2	7.3	13.5	13.6	9.0	9.5	16.3	10.5	3.9	20.3	11.4	0.0	6.2	10.9	12.9	4.1	26.9	10.2	12.4	7.5
TARS		ENSG00000113407	"Threonyl-tRNA synthetase"	P26639	5	33440696-33469539	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		170000	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavorable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavorable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	17.4	25.6	10.2	16.0	13.1	19.2	17.7	14.4	17.2	12.7	22.1	12.3	18.7	11.6	18.3	19.7	31.0	12.2	11.9	19.1	10.3	10.9	19.2	57.0	17.2	12.7	17.5	7.8	21.3	27.6	21.3	27.0	18.5	16.8	13.9	24.7	10.8	42.1	15.8	25.1	11.7	21.7	21.2	19.5	18.3	21.2	9.6	15.4	17.6	22.8	27.3	21.2	21.8	21.9	13.1	16.0	14.2	12.6	24.0	15.0	9.7	29.7	24.9	20.9	29.5	13.8	26.2	30.4	33.5	28.4	25.3	28.7	30.4	18.6	11.8	12.2	27.6	41.7	21.3	44.5	33.1	52.3	17.5	16.2	17.2	64.0	17.3	43.0	27.6	18.4	25.0	53.2	34.9	45.2	15.8	27.1	29.6	33.7	31.9	32.4	16.5	21.5	9.5	22.2	27.1	18.5	18.3	37.1	17.4	28.8	23.8	12.3	13.9	31.0	22.7	22.1	19.3	11.9	24.7	14.3	19.9	29.7	15.7	23.5	18.8	37.0	18.5	22.2	36.4	21.6	14.2	11.6	10.5	15.0	12.6	14.1	13.1	12.7	15.0	16.0	11.5	11.6	14.7	1.5	24.0	10.1	8.8	12.1	9.7	10.2	13.1	14.4	17.2	10.3	10.9	17.5	7.8	16.8	15.4	23.8	23.7	38.9	37.6	25.4	23.3	57.6	35.7	26.8	39.8	17.4	17.7	32.0	41.4	75.9	12.6	24.1	36.2	93.5	83.0	34.9	31.7	29.7	61.2	66.0	28.4	42.9	39.5	25.8	26.4	6.0	17.8	26.3	10.1	83.8	30.4	67.9	95.7	33.7	22.6	30.4	36.0	12.9	31.5	24.1	22.1	17.2	43.6	22.4	28.9	37.7
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	10.7	21.1	16.5	10.5	17.8	9.2	11.3	17.5	21.4	10.2	10.9	14.8	12.9	9.4	10.5	14.7	15.7	13.0	11.8	20.9	18.1	12.3	15.6	26.8	9.1	14.0	15.0	19.7	13.3	11.5	20.4	12.2	9.4	16.5	9.8	12.5	13.3	11.3	10.9	36.0	13.3	10.5	10.9	13.8	15.1	12.4	10.7	16.6	10.6	12.3	12.2	15.7	12.5	10.8	21.5	17.4	20.4	18.6	21.5	20.9	12.2	17.2	14.4	9.7	14.7	11.0	10.1	18.5	8.4	9.2	16.7	16.8	11.7	16.1	25.0	18.6	6.3	11.5	18.0	23.6	19.5	12.8	15.0	20.5	11.8	13.7	11.8	10.9	16.3	18.1	8.9	16.4	12.6	17.2	10.9	10.7	14.0	20.5	17.6	11.6	20.8	13.7	13.3	12.0	23.9	21.5	14.2	12.4	30.9	11.3	8.1	13.8	16.2	12.7	28.2	19.8	14.4	22.7	25.5	6.3	9.7	10.4	8.0	14.1	17.0	20.0	18.8	14.5	19.0	9.4	15.1	11.0	20.4	15.7	18.3	15.6	21.5	15.4	15.5	17.4	18.6	15.1	15.8	1.7	21.5	18.6	11.7	20.9	12.2	16.5	17.8	17.5	21.4	18.1	12.3	15.0	19.7	16.5	16.6	3.0	13.8	7.2	4.6	3.0	15.8	19.0	12.7	10.7	12.5	7.0	19.6	21.6	10.0	9.9	0.9	6.3	6.6	0.0	8.6	11.4	6.0	3.8	21.9	15.3	11.8	14.3	4.1	7.4	6.5	2.1	7.8	8.0	3.3	16.2	8.9	8.4	9.9	0.0	6.7	6.3	15.4	6.5	7.2	15.4	11.1	3.4	11.8	7.0	10.8	4.1
TARSL2	FLJ25005	ENSG00000185418	"Threonyl-tRNA synthetase like 2"	A2RTX5	15	101653598-101724604	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.7"	"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 78.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 9.7;NK-cells: 9.0;T-cells: 6.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066697	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA066697: AB_2685705"	"unprognostic (9.33e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.76e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.79e-2)"	7.4	6.9	15.1	6.4	20.2	4.8	7.5	15.8	16.2	7.2	7.1	20.2	5.5	6.2	6.5	6.0	6.3	6.5	5.9	21.0	16.9	13.8	8.3	5.9	6.2	6.5	20.0	11.2	11.0	9.8	12.9	10.5	3.7	15.7	9.2	6.2	4.0	7.1	9.7	47.7	4.9	6.5	6.9	19.9	6.2	8.5	5.4	18.9	3.9	9.6	8.0	7.1	7.0	7.8	9.7	2.0	1.6	1.7	9.0	6.1	1.0	2.1	4.0	6.9	3.7	7.4	5.8	3.5	7.4	4.9	5.8	3.6	5.9	1.9	2.8	2.9	8.9	4.7	6.3	12.1	4.3	5.4	3.2	19.5	6.9	2.6	4.6	3.4	3.1	1.4	4.1	4.0	2.7	3.4	6.9	4.1	6.1	6.7	6.1	5.7	3.5	1.7	6.1	8.4	10.6	2.8	3.5	10.5	7.2	4.8	2.1	11.0	6.8	10.0	3.9	4.0	13.3	2.5	6.3	5.5	2.8	6.6	5.6	2.4	8.5	9.5	3.5	7.3	5.6	5.1	0.9	1.1	1.6	3.4	1.7	3.4	4.8	6.1	5.2	0.8	9.7	5.9	3.2	0.3	9.0	0.7	2.0	1.0	1.0	15.1	20.2	15.8	16.2	16.9	13.8	20.0	11.2	15.7	18.9	0.0	5.6	26.9	18.3	16.1	51.2	37.0	5.1	12.0	11.4	5.2	41.2	2.7	16.6	7.6	13.2	12.5	18.0	0.0	10.8	4.0	18.6	13.9	24.3	14.7	4.6	30.2	23.6	8.0	8.9	5.7	21.9	8.6	10.1	9.0	13.5	34.6	17.6	9.3	17.7	17.7	78.2	19.4	16.7	27.4	21.3	10.3	3.5	31.7	12.6	7.1
TAS2R42	"hT2R55, T2R24, T2R55, TAS2R55"	ENSG00000186136	"Taste 2 receptor member 42"	Q7RTR8	12	11185993-11186937	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA036149	Uncertain		Approved	"Nucleoplasm,Actin filaments,Focal adhesion sites"		NA	NA			"Nucleoplasm, Actin filaments"	"Focal adhesion sites"	"HPA036149: AB_10672080"														"unprognostic (2.45e-2)"	"unprognostic (4.17e-2)"			0.0	0.7	0.2	0.2	0.4	0.0	0.0	1.0	0.2	0.0	0.1			0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.6	0.0		0.7	0.0	0.0	0.4	0.0		0.1	0.0		0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.4	0.2	0.4			0.1		0.0	0.0	0.0	0.7	0.4	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.7	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R5	T2R5	ENSG00000127366	"Taste 2 receptor member 5"	Q9NYW4	7	141790217-141791367	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 10.6"									HPA053742			Approved	"Nucleoplasm,Nucleoli,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Nucleoli"	"Cytoplasmic bodies"	"HPA053742: "	"unprognostic (5.48e-3)"	"unprognostic (3.90e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.13e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.39e-2)"	1.0	1.0	0.4	1.4	1.1	0.2	3.2	4.9	0.7	2.5	0.9			0.8	2.8	6.1	1.1	3.0	0.8	0.8	0.6	0.7	1.0	0.5	1.1	1.2	0.4		4.6	1.5	0.1	2.9	1.0		1.7	1.2		1.6	1.0	2.6	8.8	1.7	1.2	1.2	1.9	0.7	1.4			1.7		1.2	1.3	2.4	1.0	0.6	0.5	0.2	0.4	1.4	0.1	0.5	0.2	1.4	0.6	0.9	2.7	1.7	0.6	0.6	0.5	0.9	2.1	0.4	1.1	0.9	0.3	0.0	0.3	1.5	0.8	0.3	0.6	1.7	0.3	1.2	2.7	0.9	1.7	1.3	2.3	10.6	1.2	2.9	3.0	1.0	1.5	2.6	0.4	0.1	1.7	0.6	3.9	1.3	0.2	0.3	0.2	0.1	2.8	0.4	0.7	2.0	1.3	0.3	0.4	0.2	1.7	0.1	0.4	0.3	1.0	0.7	0.6	1.2	1.9	0.4	1.4	0.8	0.8	0.5	0.5	0.2	0.0	1.0	0.0	0.0	0.9	0.3	0.4	0.0	1.0	0.9	1.4	0.0	0.4	0.0	0.6	1.3	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TASP1	"C20orf13, dJ585I14.2, FLJ20212"	ENSG00000089123	"Taspase 1"	Q9H6P5	20	13389392-13638940	"Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030824, HPA030825"	Uncertain		Approved	"Plasma membrane"		No	No			"Plasma membrane"		"HPA030824: AB_10600327, HPA030825: AB_10601575"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.44e-3)"	"unprognostic (9.85e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.67e-2)"	12.1	8.0	6.0	9.1	11.9	6.8	11.4	8.9	15.3	10.7	8.3	6.3	13.4	5.7	21.7	14.2	8.7	13.4	7.2	9.1	6.8	6.4	9.9	7.2	10.5	8.7	4.8	8.1	10.1	11.1	14.6	28.5	10.3	8.2	8.9	9.6	10.8	16.3	11.1	5.0	9.6	9.6	8.4	5.2	9.1	8.9	11.3	4.4	31.3	12.9	9.0	12.2	8.5	11.1	9.7	15.1	3.5	4.8	10.7	15.8	5.6	9.4	5.7	2.4	2.9	2.8	4.3	4.5	3.9	5.6	4.6	5.5	11.6	9.9	4.2	2.7	5.1	5.0	12.7	3.7	13.6	5.5	2.5	4.5	8.6	3.6	14.9	5.7	11.5	3.1	4.9	9.2	4.8	11.4	2.8	4.5	7.7	7.5	0.2	4.0	11.3	21.8	6.4	3.1	8.5	2.6	3.4	9.6	6.5	6.4	7.5	6.2	4.3	6.1	11.8	6.9	3.5	6.2	4.4	4.3	4.4	3.1	4.4	5.5	8.6	11.9	3.0	2.4	2.6	4.1	1.7	3.5	3.5	10.3	4.8	7.3	9.7	10.7	8.1	3.9	8.6	15.8	12.2	1.9	10.7	4.7	15.1	9.8	5.6	6.0	11.9	8.9	15.3	6.8	6.4	4.8	8.1	8.2	4.4	6.0	10.6	9.3	9.6	12.6	12.9	5.2	10.2	24.1	6.8	5.2	9.8	9.8	6.6	9.6	11.6	4.9	3.8	0.0	5.4	10.7	11.8	7.8	15.0	4.9	4.1	11.1	3.5	3.1	1.0	2.7	3.1	4.1	10.1	1.0	9.0	6.3	7.2	10.5	3.2	9.8	15.4	6.5	15.1	23.7	8.1	10.7	5.8	7.9	7.8	5.5
TATDN2	KIAA0218	ENSG00000157014	"TatD DNase domain containing 2"	Q93075	3	10248023-10281218	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036822	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036822: AB_10671972"	"unprognostic (4.51e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.48e-2)"	12.0	13.1	20.4	16.2	22.8	32.8	14.3	17.5	31.6	15.5	13.8	15.8	17.5	14.2	17.2	17.9	16.4	12.6	14.5	13.8	18.3	14.0	14.3	12.2	14.3	21.6	13.7	19.2	22.4	20.8	25.8	16.9	11.1	13.8	17.6	17.2	16.2	20.4	15.3	12.0	19.5	15.2	15.8	13.0	20.6	13.7	10.1	13.5	37.5	18.8	8.6	25.2	12.5	15.2	3.3	3.5	2.5	2.5	2.2	6.0	2.3	9.5	16.1	9.0	7.6	11.6	12.8	38.2	11.5	12.1	15.4	10.1	11.7	8.6	23.3	8.8	17.1	16.2	7.0	15.6	11.0	12.4	14.7	17.8	12.3	15.7	12.4	7.7	17.1	12.9	9.7	12.4	21.7	7.2	10.1	12.5	14.4	13.6	21.2	14.1	18.4	22.6	14.3	12.3	12.8	16.1	12.3	9.6	13.3	9.7	13.9	9.9	11.7	9.8	11.7	5.3	8.9	11.4	16.1	10.1	18.0	11.5	14.6	20.7	13.0	21.2	41.5	15.7	17.5	12.1	2.5	1.6	1.2	4.6	2.5	4.5	2.5	3.9	3.7	1.5	3.3	4.0	6.0	1.3	2.2	1.3	3.5	4.4	2.3	20.4	22.8	17.5	31.6	18.3	14.0	13.7	19.2	13.8	13.5	6.0	14.1	6.5	3.7	11.2	4.4	5.0	12.7	1.4	4.5	10.4	5.9	3.0	1.7	4.8	1.3	7.1	6.2	0.0	7.8	3.4	7.2	8.4	4.7	10.2	8.7	4.8	16.1	9.2	12.3	1.5	6.6	7.7	13.5	1.8	8.9	4.1	6.7	0.0	7.1	4.4	2.7	6.5	4.1	1.7	5.1	10.8	2.1	14.9	9.3	6.4
TATDN3		ENSG00000203705	"TatD DNase domain containing 3"	Q17R31	1	212791828-212816626	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032092	Approved		Approved	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			Nucleoplasm	"Golgi apparatus, Focal adhesion sites"	"HPA032092: AB_10671086"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.34e-3)"	"unprognostic (5.02e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.96e-3)"	13.0	14.8	14.4	10.9	24.7	11.9	11.0	12.5	22.9	7.6	8.8	16.6	6.8	7.0	8.5	15.2	8.3	8.7	8.3	20.7	13.7	15.2	18.3	11.1	8.5	16.2	14.5	18.9	10.1	11.3	12.8	11.9	8.0	22.1	8.0	8.6	11.4	9.4	8.2	29.4	7.4	8.1	11.6	15.5	11.5	11.9	10.5	12.0	11.3	13.1	8.3	10.8	10.6	6.5	15.6	30.1	23.8	24.1	5.3	6.9	8.7	6.6	6.6	5.8	8.6	9.4	14.1	13.4	7.4	8.0	5.9	7.4	1.7	9.4	14.7	7.0	6.3	3.4	4.3	7.1	10.0	6.4	9.0	9.2	7.4	5.5	3.2	10.9	17.7	9.3	11.3	7.2	8.0	19.9	6.4	8.5	21.0	14.4	12.3	6.5	3.1	15.1	5.9	7.8	8.2	4.3	8.7	11.0	26.3	6.1	3.3	12.4	10.6	8.1	13.8	16.2	11.0	14.7	11.0	5.8	4.5	6.0	9.3	7.2	11.0	16.9	24.4	11.6	14.1	6.7	8.5	15.6	23.8	5.5	23.7	4.9	15.6	6.9	6.6	18.4	12.7	5.5	6.6	17.5	5.3	24.1	30.1	6.4	8.7	14.4	24.7	12.5	22.9	13.7	15.2	14.5	18.9	22.1	12.0	6.0	15.2	14.3	8.7	3.9	14.8	33.0	10.2	10.7	3.4	3.5	17.7	10.9	34.9	14.4	7.5	6.3	3.9	0.0	14.5	14.4	6.0	4.5	6.9	5.5	16.4	14.3	9.8	4.3	25.0	2.9	4.9	17.6	13.5	30.7	4.0	14.9	11.0	7.0	4.6	20.7	27.3	6.5	6.9	21.3	16.9	3.9	7.8	10.2	5.8	5.5
TAX1BP1	"CALCOCO3, TXBP151"	ENSG00000106052	"Tax1 binding protein 1"	Q86VP1	7	27739331-27844564	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024432	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA024432: AB_1857783"	"unprognostic (1.38e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.69e-1)"	"prognostic favorable (2.80e-6)"	"unprognostic (1.76e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.03e-1)"	28.5	63.0	31.1	19.5	49.8	34.9	30.7	33.5	48.4	33.8	33.4	16.1	26.7	23.7	27.4	35.5	46.6	30.7	28.2	47.4	30.8	31.9	51.0	35.3	28.7	23.0	41.0	34.8	32.0	29.7	46.3	69.4	65.8	54.1	36.4	31.1	18.7	32.3	32.6	50.3	23.5	41.0	48.8	41.7	34.5	30.3	30.3	35.2	34.2	44.5	27.0	24.6	51.3	29.0	21.1	17.5	59.7	31.3	17.3	33.0	22.5	39.8	22.1	22.6	21.4	35.9	26.2	15.4	29.8	36.7	22.4	28.1	17.9	32.5	8.5	28.2	43.5	38.7	28.4	21.2	19.5	35.1	15.9	11.0	23.0	23.7	35.5	34.0	33.5	27.4	22.1	40.6	26.0	29.9	27.0	24.1	14.8	25.5	26.2	45.2	14.7	14.7	33.1	25.5	52.3	20.8	12.3	24.3	17.4	31.7	45.2	15.0	24.5	41.8	54.7	62.2	45.5	25.5	50.6	25.9	21.2	33.2	26.3	19.6	48.2	33.4	15.9	24.8	63.7	48.4	37.4	24.2	59.7	21.8	29.3	26.3	21.1	25.9	25.3	17.5	17.9	24.0	24.0	48.9	17.3	31.3	16.2	33.0	22.5	31.1	49.8	33.5	48.4	30.8	31.9	41.0	34.8	54.1	35.2	199.5	169.7	106.1	180.8	162.8	267.0	498.7	129.9	654.5	232.0	122.1	90.3	129.6	349.8	187.1	99.7	143.3	138.9	70.0	229.8	91.8	123.1	243.4	143.4	96.2	109.6	151.0	134.4	76.7	127.2	72.2	108.1	171.8	108.0	226.4	131.6	177.5	242.3	125.6	139.7	231.8	140.4	103.5	117.9	217.7	133.4	167.7	519.6	133.7	103.0	398.4
TAX1BP3	TIP-1	ENSG00000213977	"Tax1 binding protein 3"	O14907	17	3662896-3668682	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 339.7;Pancreatic endocrine cells: 400.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046410, HPA063078"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Actin filaments"		NA	NA			"Nucleoli fibrillar center, Actin filaments"	Vesicles	"HPA046410: AB_2679656, HPA063078: AB_2684937"	"unprognostic (6.15e-2)"	"unprognostic (6.46e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.80e-2)"	"unprognostic (5.45e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (5.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-1)"	26.0	34.1	14.1	15.8	17.7	4.6	24.3	5.4	16.7	55.5	41.2	30.6	37.6	33.9	34.9	26.5	62.4	22.7	42.5	55.8	16.0	8.5	35.8	27.0	23.9	11.4	28.3	15.8	27.0	21.0	4.7	8.3	34.3	16.0	24.7	24.6	13.7	29.5	52.0	12.3	35.8	71.9	22.7	18.3	14.5	42.6	23.8	23.0	22.6	19.2	43.0	23.3	29.1	40.8	7.9	41.6	44.7	19.4	4.9	9.1	12.6	29.2	52.4	11.5	6.5	37.7	30.4	13.6	36.8	30.7	39.4	23.2	22.1	23.8	3.1	26.9	47.4	13.0	46.7	6.4	33.8	15.4	8.2	10.9	4.1	13.2	17.2	32.9	0.6	6.4	46.0	54.1	24.3	11.7	28.1	44.2	8.3	1.5	2.4	46.3	27.2	8.2	2.4	11.0	18.8	18.8	8.1	7.0	2.6	41.2	23.3	2.5	7.3	45.4	19.5	6.2	11.9	20.9	3.8	44.2	33.2	12.8	26.1	37.2	0.9	0.4	0.8	20.0	4.8	31.7	44.7	16.9	29.1	7.3	19.4	6.0	7.9	6.8	7.1	14.9	6.5	4.9	6.3	18.8	4.9	17.3	41.6	9.1	12.6	14.1	17.7	5.4	16.7	16.0	8.5	28.3	15.8	16.0	23.0	56.6	26.3	34.2	66.5	84.6	1.4	35.8	79.0	14.7	48.9	94.2	0.0	107.1	74.6	281.8	11.9	58.9	252.2	23.3	339.7	126.9	101.5	60.3	26.5	8.6	65.1	4.8	23.6	71.2	33.3	4.3	161.7	62.3	108.0	114.6	92.8	14.0	400.2	252.6	197.3	113.5	2.6	38.8	42.0	8.4	11.7	66.5	130.1	23.2	71.7	82.9
TAZ	"BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2"	ENSG00000102125	Tafazzin	Q16635	X	154411518-154421726	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039557	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA039557: AB_10672899"	"unprognostic (1.14e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.29e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (4.00e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	11.9	8.7	12.1	15.0	13.6	36.8	11.7	12.4	13.5	10.9	15.4	15.6	12.1	13.9	10.8	13.0	15.1	9.9	14.1	25.9	11.0	8.4	13.3	14.0	14.3	17.3	16.7	9.6	12.6	16.3	10.7	8.9	9.1	13.1	11.1	10.8	12.2	12.7	14.5	27.9	18.6	15.0	11.7	12.8	25.4	12.8	3.4	15.1	17.2	11.8	13.4	14.4	10.8	19.5	16.7	14.7	13.8	10.3	12.3	17.2	7.8	11.0	12.5	4.6	5.1	9.0	5.4	8.8	3.9	7.7	6.0	8.3	4.1	13.8	13.1	21.3	5.7	20.0	16.8	6.5	7.2	4.2	11.2	9.6	2.6	8.0	6.4	10.1	5.0	6.2	5.5	13.2	5.2	11.8	5.6	9.0	16.8	5.2	13.9	5.2	6.7	12.6	15.8	1.3	9.7	13.1	10.5	7.0	17.6	8.2	3.2	5.8	8.2	2.5	7.4	10.7	5.0	4.5	8.9	6.5	4.9	6.3	12.0	5.9	32.4	12.8	27.3	6.0	17.6	5.6	5.7	10.3	13.8	12.1	9.3	11.0	11.3	17.2	15.5	14.7	16.7	14.4	12.5	9.4	12.3	7.4	7.3	12.2	7.8	12.1	13.6	12.4	13.5	11.0	8.4	16.7	9.6	13.1	15.1	6.0	10.2	10.7	6.9	9.6	21.3	18.9	12.7	5.3	13.6	8.7	17.7	4.9	5.0	12.0	0.5	15.0	12.3	0.0	14.5	8.0	9.9	5.6	18.4	7.8	21.2	9.5	5.8	16.0	22.1	1.3	10.6	15.9	13.5	23.4	12.9	15.1	10.8	10.2	8.5	4.4	23.8	12.9	9.2	5.1	0.6	9.8	2.4	23.6	13.6	4.8
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891087-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	13.6	3.7	9.3	19.8	8.3	19.0	9.8	9.5	8.4	36.0	48.9	7.1	24.5	10.2	63.4	16.5	14.9	22.9	30.6	24.0	7.5	6.0	29.0	8.8	13.3	16.6	7.0	7.6	16.1	9.4	55.9	8.0	32.4	7.4	18.0	9.8	18.2	8.3	28.1	41.9	5.6	15.1	31.6	7.4	21.2	18.1	15.6	5.4	30.4	26.1	23.1	13.3	27.2	26.8	6.0	4.8	14.0	16.7	6.2	4.3	2.2	5.7	6.6	12.1	13.0	4.3	12.2	10.4	15.8	26.5	14.9	15.3	3.8	18.9	29.7	3.9	10.5	18.9	0.3	9.1	11.4	23.1	2.3	5.2	11.4	4.6	7.9	7.0	21.1	13.1	14.7	2.3	9.2	6.4	12.5	22.9	20.9	13.9	5.1	15.5	4.4	29.3	19.9	6.8	0.9	6.0	26.1	19.7	8.6	12.3	10.7	10.6	9.5	5.8	5.4	6.6	28.6	5.3	16.4	15.6	19.8	22.5	4.9	22.8	12.6	15.5	78.1	8.6	19.4	17.4	1.9	5.0	14.0	2.6	15.6	4.3	4.8	2.6	2.2	4.8	6.0	2.4	3.0	13.9	6.2	16.7	4.2	2.1	2.2	9.3	8.3	9.5	8.4	7.5	6.0	7.0	7.6	7.4	5.4	11.9	7.0	34.9	12.1	7.0	10.8	58.5	20.4	2.7	6.8	26.2	0.0	18.0	64.6	13.4	22.1	27.3	14.6	23.3	34.7	22.8	13.9	30.2	2.3	16.1	28.6	9.5	42.5	20.9	50.5	34.2	21.6	33.1	10.1	36.1	9.0	9.3	33.5	11.9	18.7	55.2	0.9	38.8	93.2	10.3	20.6	7.5	24.4	26.2	9.9	26.3
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 55.4;bone marrow: 16.0;intestine: 14.5;lymphoid tissue: 35.0"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 2: 31.1;B-cells: 94.5;T-cells: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.9;JURKAT: 12.6;MOLT-4: 23.2;NB-4: 27.9;U-937: 11.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069743	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA069743: AB_2686186"	"prognostic favorable (3.83e-4)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favorable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	1.3	0.4	0.7	20.8	0.8	16.0	0.7	0.4	0.4	0.9	3.0	0.4	0.7	2.4	0.5	0.6	1.6	1.3	1.5	0.8	1.1	0.3	1.9	1.5	5.2	22.4	0.5	0.8	0.6	0.5	0.0	0.4	0.7	0.4	1.1	0.4	1.4	3.6	0.2	0.4	0.4	14.5	0.2	0.8	35.0	3.1	0.7	0.9	27.1	4.6	1.0	27.8	1.8	1.8	39.1	13.1	52.5	30.6	25.9	55.4	49.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.4	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.1	0.0	0.0	0.1	23.2	27.9	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	5.0	0.0	11.5	0.0	33.2	10.0	52.5	51.1	23.7	36.2	37.6	44.5	44.7	13.1	39.1	46.8	42.3	49.1	25.9	30.6	11.0	55.4	49.2	0.7	0.8	0.4	0.4	1.1	0.3	0.5	0.8	0.4	0.9	6.0	31.1	94.5	0.0	1.0	1.3	1.2	0.0	1.4	4.5	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.7	0.1	22.0	0.6	24.4	0.0	1.2	4.3	13.8	0.0	0.0	13.9	3.3	3.6	0.0	0.3	0.0	0.0	0.0	1.0	0.3	0.0	0.6	0.1	0.1	0.9	0.3	117.9	0.0	0.1
TBC1D12	KIAA0608	ENSG00000108239	"TBC1 domain family member 12"	O60347	10	94402504-94535930	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.6"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.2"	"Group enriched"	"Detected in many"	13	"B-cells: 1.4;dendritic cells: 2.2;monocytes: 1.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038277, HPA038645"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA038277: AB_10672584, HPA038645: AB_10672650"	"unprognostic (7.23e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (1.79e-5)"	"unprognostic (7.83e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-1)"	6.9	4.9	8.9	4.0	18.1	1.2	8.1	7.5	14.8	5.3	8.4	39.2	7.1	6.2	5.6	4.0	4.7	4.3	5.1	4.4	12.4	8.5	5.8	4.1	5.2	3.0	25.5	8.7	5.8	7.1	16.8	3.2	7.8	23.1	6.0	9.7	5.9	3.6	6.5	4.3	5.7	6.9	6.0	41.6	5.6	4.2	10.9	21.3	0.2	4.3	1.5	3.5	5.7	4.9	1.4	2.2	0.0	1.1	0.0	0.1	0.2	7.6	3.4	4.5	6.7	6.3	7.7	5.9	5.0	10.3	5.6	5.3	13.6	3.4	0.0	3.0	7.3	5.5	4.3	5.4	3.7	7.2	0.0	6.1	2.4	3.1	4.3	4.8	0.0	1.9	5.2	4.7	5.9	7.6	9.5	6.0	0.0	3.5	8.0	9.0	4.2	0.0	0.0	1.4	5.5	3.6	0.0	5.8	4.0	5.0	3.4	1.9	4.5	5.0	4.3	4.0	4.3	9.4	4.6	5.9	3.9	5.4	6.3	3.9	5.7	5.4	0.0	3.9	0.0	2.1	0.0	1.1	0.0	0.0	0.7	0.0	0.5	0.0	0.0	2.2	1.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	8.9	18.1	7.5	13.4	12.4	8.5	25.5	8.7	23.1	21.3	8.9	4.0	4.5	4.9	17.3	17.2	4.8	2.5	2.7	4.5	8.7	9.8	14.8	0.0	5.2	13.8	10.5	13.6	0.0	4.4	10.7	13.8	9.3	5.7	3.4	16.5	7.9	8.1	9.2	18.7	7.4	7.8	18.3	15.1	10.8	7.6	8.1	6.2	10.5	9.9	5.2	26.8	12.9	11.8	44.7	10.8	16.8	20.4	0.0	11.2	7.6
TBC1D13	FLJ10743	ENSG00000107021	"TBC1 domain family member 13"	Q9NVG8	9	128787204-128810432	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"monocytes: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045865	Approved		Approved	Nucleoli		No	No			Nucleoli		"HPA045865: AB_10965700"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.14e-6)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.58e-7)"	"unprognostic (1.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	12.5	17.4	23.0	8.3	20.8	12.1	10.1	12.0	24.7	9.8	10.7	17.3	8.4	11.7	13.3	14.2	8.4	14.7	10.9	13.4	17.8	18.5	26.0	8.9	10.5	11.0	13.9	12.7	19.3	11.3	30.2	9.7	9.5	14.9	11.6	8.2	12.5	16.9	14.3	16.6	11.6	13.0	12.6	8.7	12.0	11.2	8.1	13.3	8.6	14.1	7.6	11.2	11.2	8.5	5.0	9.0	15.7	2.8	3.4	5.6	3.4	6.3	15.2	16.0	16.0	20.8	10.1	15.6	15.2	13.1	15.8	10.3	16.5	8.5	10.6	10.6	18.0	15.8	17.2	9.7	12.1	9.4	8.4	11.1	11.4	17.8	15.1	12.9	17.1	23.3	14.1	14.4	13.7	8.3	14.1	20.3	11.4	17.5	7.2	18.8	13.6	10.3	10.2	15.2	17.6	23.0	11.7	14.8	24.1	11.6	8.3	16.2	11.3	21.2	13.6	8.9	16.3	14.5	16.1	16.0	19.9	12.5	16.1	12.3	9.3	11.9	10.5	14.5	10.3	14.2	15.7	2.7	4.6	4.9	2.8	4.9	5.0	3.8	4.7	3.1	4.0	3.3	5.6	2.2	3.4	2.1	9.0	2.8	3.4	23.0	20.8	12.0	24.7	17.8	18.5	13.9	12.7	14.9	13.3	3.0	7.0	4.2	2.6	2.1	8.3	8.9	0.0	4.0	3.4	15.7	9.8	4.3	8.3	5.6	1.3	9.5	7.8	0.0	8.6	4.1	5.7	2.8	8.1	11.6	14.2	6.4	5.2	16.0	8.6	2.3	8.6	4.1	0.0	87.4	6.1	6.7	6.8	7.0	7.1	24.8	5.8	6.5	3.5	5.1	9.3	2.8	2.1	5.0	6.0	2.0
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 64.3"	"Low region specificity"	"Detected in all"							"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	20.0	31.2	31.9	24.4	33.8	10.6	22.0	18.1	32.8	16.0	20.2	22.5	17.0	17.3	16.2	21.9	24.3	18.8	15.0	22.9	28.6	27.5	32.1	21.6	20.7	48.4	28.8	20.5	23.3	19.3	23.6	20.7	18.0	29.0	19.6	20.7	26.1	23.2	16.7	35.1	37.3	20.0	17.8	37.3	26.2	35.8	22.4	29.3	24.0	14.9	17.9	19.9	16.7	15.4	5.3	7.5	26.4	8.2	5.5	8.9	6.0	10.5	11.5	13.0	14.5	10.8	9.1	7.9	8.5	9.3	8.0	6.8	11.9	22.1	17.0	5.0	10.1	20.3	7.7	21.8	19.5	9.8	4.7	7.1	28.5	7.6	12.4	7.5	12.8	64.3	7.0	27.7	7.5	12.4	10.2	7.5	16.2	26.9	6.1	9.6	6.9	19.7	13.0	17.6	12.7	13.0	24.8	17.1	18.4	11.9	7.5	19.9	14.2	7.0	7.7	26.1	10.6	10.6	12.3	7.4	8.8	6.7	7.7	12.5	11.8	27.4	17.5	8.3	16.6	8.4	1.7	8.2	3.5	5.9	5.3	8.9	5.2	6.4	6.3	6.9	5.3	4.9	4.5	26.4	5.5	2.4	7.5	7.5	6.0	31.9	33.8	18.1	28.0	28.6	27.5	28.8	20.5	29.0	29.3	6.0	15.3	5.2	6.6	8.0	8.4	3.4	10.2	5.3	11.4	14.0	13.7	10.5	16.6	9.8	45.7	4.7	10.4	0.0	8.7	6.1	5.1	11.2	7.0	21.7	20.9	23.8	6.3	7.4	37.2	22.1	6.6	13.2	18.6	6.4	15.6	10.6	9.0	14.0	8.1	19.2	6.3	0.0	5.2	15.8	18.9	10.5	13.7	15.0	16.6	9.1
TBC1D16	"FLJ20748, MGC25062"	ENSG00000167291	"TBC1 domain family member 16"	Q8TBP0	17	79932343-80035848	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 290.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 4.6;naive B-cell: 1.5;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.5;SK-MEL-30: 55.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024482, HPA065839"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA024482: AB_1857790, HPA065839: AB_2685566"	"unprognostic (4.53e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.99e-3)"	32.2	8.1	10.1	7.8	18.2	1.0	32.6	25.5	11.2	10.7	8.6	6.0	28.4	7.5	11.9	20.9	9.8	12.8	9.3	10.0	8.1	7.8	18.1	13.2	8.5	13.7	8.7	5.6	11.8	18.7	9.3	6.6	7.1	8.2	17.3	5.8	15.4	25.5	24.2	4.5	15.8	7.9	10.8	8.1	8.7	7.6	5.2	9.5	2.7	9.7	7.0	3.9	9.2	14.6	1.5	0.3	0.1	4.7	0.1	0.5	0.3	8.2	7.9	12.3	14.4	52.5	27.7	2.3	4.8	4.8	3.0	3.5	14.8	2.9	0.0	3.4	8.1	5.8	2.6	12.9	4.5	2.3	0.4	6.1	0.0	3.6	6.8	8.9	0.1	1.1	31.1	8.0	6.6	4.8	4.9	13.0	5.6	1.9	5.6	5.7	5.1	2.1	0.7	14.7	10.8	4.3	6.9	7.8	4.7	3.6	10.2	12.6	16.3	4.3	12.1	55.7	8.0	7.9	3.7	8.7	10.7	7.7	8.4	4.2	17.2	3.0	0.9	4.6	3.1	13.5	0.0	0.3	0.0	0.1	4.6	0.5	0.0	0.1	0.2	0.3	1.5	0.2	0.3	0.1	0.1	4.7	0.0	0.0	0.3	10.1	18.2	25.5	11.2	8.1	7.8	8.7	5.6	8.2	9.5	0.0	9.3	0.8	3.6	4.8	6.6	7.2	17.8	2.7	2.3	7.0	9.8	5.2	8.3	13.8	1.0	9.0	3.2	0.0	19.3	1.1	12.8	9.6	7.0	16.2	3.0	290.8	30.5	15.4	43.0	1.6	5.5	3.8	72.6	1.0	6.4	21.5	16.9	2.8	7.4	10.0	7.4	6.5	10.5	0.2	3.4	4.0	1.6	3.8	5.0	5.7
TBC1D19	FLJ11082	ENSG00000109680	"TBC1 domain family member 19"	Q8N5T2	4	26576437-26755351	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039592	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA039592: AB_10671043"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.94e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (1.21e-7)"	"unprognostic (1.04e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.51e-1)"	6.1	13.9	8.6	5.4	10.2	2.8	6.8	11.5	11.2	11.8	8.8	8.7	7.7	3.1	22.4	11.0	4.8	11.9	11.8	10.7	6.6	9.0	24.9	4.6	6.6	3.5	9.3	7.7	13.9	7.7	21.9	23.4	6.1	14.8	8.7	5.1	8.4	5.8	10.4	5.7	4.2	3.8	13.5	8.6	4.4	6.9	10.0	7.1	33.3	12.1	2.9	4.2	8.3	7.0	4.1	2.4	2.3	0.9	6.6	8.7	1.8	1.4	1.3	4.6	2.8	6.8	10.5	1.4	5.9	4.6	2.7	3.0	2.1	3.4	3.2	5.3	8.3	8.8	0.6	2.5	3.3	2.6	1.0	1.3	0.7	3.7	0.7	3.6	1.6	0.7	5.1	2.5	5.4	3.1	11.2	3.7	4.2	2.5	0.0	40.9	0.0	3.4	1.9	2.1	1.7	4.9	2.5	4.7	0.3	10.5	1.3	4.6	1.9	2.8	0.6	2.8	3.7	1.2	0.7	3.3	3.5	1.0	2.6	1.4	0.8	1.7	1.4	12.2	0.9	3.6	1.6	0.9	2.3	8.1	0.9	8.7	3.2	6.2	8.3	1.4	4.1	4.9	5.1	0.1	6.6	0.8	2.4	3.0	1.8	8.6	10.2	11.5	11.2	6.6	9.0	9.3	7.7	14.8	7.1	3.0	2.6	4.7	4.8	3.2	7.5	5.3	2.5	18.7	0.0	19.2	13.7	3.6	5.0	4.8	4.8	5.7	0.4	0.0	2.8	1.7	6.2	2.5	9.2	1.8	1.6	4.8	9.1	6.7	1.6	1.9	8.3	2.3	10.1	1.0	1.9	8.2	2.1	0.0	8.5	11.3	19.4	0.0	4.7	22.0	5.7	4.0	1.6	17.5	1.3	1.6
TBC1D2	"Armus, PARIS1, TBC1D2A"	ENSG00000095383	"TBC1 domain family member 2"	Q9BYX2	9	98198999-98255721	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 53.6;Hofbauer cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 27.5;HaCaT: 36.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030871, HPA076521"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA030871: AB_10670046, HPA076521: "	"unprognostic (2.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.30e-1)"	13.1	4.1	6.6	7.0	15.6	14.5	7.6	7.7	7.6	7.8	12.0	17.8	6.0	15.5	4.4	4.3	25.3	4.4	5.3	2.2	9.5	7.4	4.6	12.6	27.4	4.5	15.2	5.3	4.3	3.0	4.5	3.1	11.9	9.0	8.1	5.9	6.2	10.1	8.8	3.3	18.8	15.2	5.7	14.3	6.7	5.1	3.1	12.2	4.7	7.1	14.7	16.8	14.7	11.6	0.9	7.0	8.1	18.4	0.7	3.9	6.4	27.5	4.0	0.2	0.9	3.1	6.1	9.1	12.2	6.8	8.9	7.4	2.6	12.1	0.4	9.3	7.1	1.9	36.4	0.2	13.6	3.1	0.9	0.5	0.2	14.1	2.0	14.6	0.6	1.1	8.4	22.5	8.9	22.3	15.8	3.1	0.7	0.8	0.3	7.0	3.5	0.1	1.6	0.6	2.7	2.3	0.4	1.8	0.0	13.6	17.2	0.3	0.5	4.1	9.1	1.2	0.6	3.0	0.9	19.0	10.9	3.3	1.8	4.9	0.6	0.5	0.2	11.1	1.0	1.2	1.1	18.4	5.5	1.9	10.8	1.3	0.9	2.8	1.6	7.0	0.6	1.2	1.4	8.1	0.7	8.0	0.9	3.9	6.4	6.6	15.6	7.7	7.6	9.5	7.4	15.2	5.3	9.0	12.2	53.6	12.2	1.9	11.4	7.3	2.4	0.6	7.6	5.3	20.5	3.5	0.0	18.5	3.3	3.7	1.5	3.1	15.0	0.0	2.8	9.4	2.1	3.8	0.0	4.7	31.3	1.6	7.5	0.6	19.8	1.0	1.7	9.3	3.3	3.6	11.1	2.9	8.7	7.0	0.7	2.5	2.2	0.0	2.0	1.6	2.8	9.5	14.5	1.9	4.2	11.1
TBC1D22A	C22orf4	ENSG00000054611	"TBC1 domain family member 22A"	Q8WUA7	22	46762617-47175699	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001173	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA001173: AB_1080212"	"unprognostic (1.62e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (5.95e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.39e-1)"	18.1	17.6	18.3	36.5	16.0	14.0	16.4	10.8	18.5	14.6	23.1	22.4	16.5	22.8	20.6	17.8	24.8	19.6	22.1	15.1	16.1	15.4	18.1	14.8	18.5	26.6	17.3	17.0	16.1	20.5	18.8	15.9	23.2	16.9	12.5	15.3	17.0	23.5	15.5	23.7	22.6	26.3	13.0	18.4	27.2	22.8	14.2	18.2	21.1	17.8	16.5	36.3	16.5	17.3	11.7	10.8	13.2	15.0	4.4	8.6	5.6	13.4	9.4	6.0	7.2	8.7	12.3	7.3	9.2	12.6	10.5	11.4	10.5	10.5	11.8	10.4	14.0	6.6	15.0	5.1	14.4	7.4	5.1	14.3	6.7	8.2	20.2	13.4	14.5	5.4	14.3	17.0	7.2	10.2	12.7	17.3	7.5	4.3	12.7	9.5	6.9	6.4	7.5	5.8	12.7	10.6	8.3	7.0	12.7	12.2	7.0	4.9	9.1	8.5	3.2	14.3	7.8	7.7	9.7	13.9	8.1	11.6	8.5	5.8	8.5	2.7	7.6	20.1	7.5	5.0	2.1	9.0	5.3	5.9	13.0	5.7	10.8	5.5	5.5	10.8	11.7	3.6	4.0	13.2	4.4	15.0	5.3	8.6	5.6	18.3	16.0	10.8	18.5	16.1	15.4	17.3	17.0	16.9	18.2	23.8	16.5	38.9	10.0	5.7	16.7	6.9	10.2	16.0	21.6	7.0	17.7	19.9	10.0	21.8	10.3	16.1	28.0	0.0	20.6	15.8	9.4	9.0	16.2	7.8	29.2	20.6	3.5	20.9	20.7	2.2	9.2	25.5	10.1	51.3	15.2	12.9	26.2	21.2	11.0	16.5	28.1	12.9	7.1	4.9	9.7	6.9	24.3	10.2	16.6	10.2
TBC1D30	KIAA0984	ENSG00000111490	"TBC1 domain family member 30"	Q9Y2I9	12	64781193-64881032	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.8"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 23.0;OE19: 15.2;RPMI-8226: 13.6;RT4: 17.6;SCLC-21H: 16.5;SK-BR-3: 17.0;T-47d: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039772, HPA040043"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA039772: AB_10795409, HPA040043: AB_10795411"	"unprognostic (1.85e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (3.61e-5)"	"unprognostic (9.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.65e-5)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.67e-3)"	"unprognostic (7.80e-3)"	1.8	1.6	4.7	2.3	11.4	0.5	5.3	13.4	15.8	7.6	3.3	1.5	12.4	5.0	3.1	2.5	1.2	2.1	4.8	1.1	7.1	5.5	3.9	1.7	3.9	0.9	4.7	7.0	1.5	19.8	8.9	6.5	1.4	16.5	3.7	3.5	2.0	14.4	11.6	0.9	1.3	3.5	2.4	3.0	2.5	6.9	3.2	2.8	0.0	3.3	0.2	0.7	4.9	1.9	0.0	0.0	2.4	1.1	0.0	1.3	0.3	6.9	1.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.1	6.5	2.2	0.3	1.1	0.0	0.3	0.1	6.8	0.1	0.0	0.0	6.7	0.3	1.2	0.3	0.1	2.3	1.4	0.4	0.0	0.0	0.2	0.6	5.6	1.0	0.0	2.4	0.2	23.0	0.0	0.4	0.9	15.2	6.8	0.1	0.1	13.6	0.8	17.6	16.5	1.3	1.4	17.0	0.2	0.7	12.4	1.1	5.3	0.0	1.0	0.5	3.4	0.0	0.0	0.2	0.1	0.7	0.3	0.0	1.1	0.0	0.4	1.1	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.3	4.7	11.4	13.4	15.8	7.1	5.5	4.7	7.0	16.5	2.8	0.0	4.6	0.5	2.1	0.8	9.4	0.4	5.1	2.7	5.7	3.5	7.9	0.4	8.3	3.1	13.6	4.2	2.6	0.0	4.3	0.3	0.5	7.1	9.2	0.0	1.5	0.0	0.0	2.5	2.5	1.0	0.3	2.8	5.0	1.0	6.3	2.5	3.6	3.5	0.0	1.7	0.5	0.0	0.3	3.3	1.5	1.3	0.1	0.9	3.3	8.4
TBC1D31	"Gm85, MGC21654, WDR67"	ENSG00000156787	"TBC1 domain family member 31"	Q96DN5	8	123041968-123152153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 29.0"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 10.5;T-cells: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023710	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA023710: AB_1858819"	"unprognostic (1.39e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.21e-2)"	"unprognostic (3.18e-5)"	"unprognostic (2.42e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (1.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.78e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.33e-1)"	3.8	4.4	6.7	9.7	10.9	7.3	3.6	13.5	7.7	3.2	5.2	4.5	5.2	6.9	3.8	2.4	4.6	7.5	3.6	5.3	7.2	5.7	4.4	3.8	3.9	11.0	5.5	5.6	2.9	5.4	5.5	8.4	2.7	7.5	3.4	6.3	5.6	3.6	4.1	3.7	4.7	5.9	4.8	4.7	7.4	3.9	9.2	4.7	29.0	5.1	5.2	10.3	5.2	4.1	2.4	2.6	3.0	3.3	9.5	16.8	4.0	10.8	4.6	8.2	6.4	2.8	3.1	4.0	5.9	3.5	7.8	7.1	4.3	4.8	5.0	4.6	2.5	4.9	7.0	7.8	3.9	10.9	10.3	7.7	11.9	4.9	3.7	4.4	5.4	8.4	2.5	2.3	6.4	6.6	2.1	5.5	14.6	9.9	12.1	5.5	8.7	16.9	3.6	6.3	13.7	7.9	8.3	7.3	5.3	5.2	2.9	7.6	5.9	13.1	39.2	4.0	5.6	6.2	4.5	2.9	6.1	12.6	5.0	8.6	9.5	13.7	6.0	5.0	9.8	9.1	2.7	3.1	3.0	8.3	3.3	16.8	2.4	3.8	6.3	2.6	2.3	4.7	5.3	1.6	9.5	1.4	1.6	3.0	4.0	6.7	10.9	13.5	7.7	7.2	5.7	5.5	5.6	7.5	4.7	0.0	4.3	2.2	0.9	0.5	3.1	10.5	0.0	2.7	1.2	1.8	5.9	1.1	0.0	1.4	3.5	1.0	0.9	0.0	1.0	2.1	1.8	0.5	7.0	1.7	3.3	0.0	2.9	0.6	7.5	1.7	1.4	2.1	1.7	3.6	1.9	1.0	0.9	0.0	1.4	1.8	5.7	0.0	2.3	8.4	2.4	1.1	0.1	12.8	2.7	0.3
TBC1D32	"bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235"	ENSG00000146350	"TBC1 domain family member 32"	Q96NH3	6	121079494-121334745	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.4"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 111.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013413	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA013413: AB_10602702"	"unprognostic (3.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.12e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.60e-4)"	"unprognostic (7.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	3.2	7.3	7.3	5.5	8.8	2.4	5.0	3.9	11.1	5.7	3.5	4.8	3.8	4.5	5.1	4.1	4.1	4.8	5.6	3.5	7.0	4.1	4.5	1.8	3.2	3.0	8.1	7.8	6.5	4.0	9.7	25.4	8.2	8.0	5.0	2.4	4.2	4.6	3.2	1.7	5.5	4.6	2.4	7.0	3.1	3.8	9.2	7.9	8.1	7.0	2.1	3.2	3.7	5.1	6.4	10.7	5.8	1.3	3.4	3.7	0.4	1.6	2.0	3.2	4.2	2.9	4.4	1.6	1.8	2.7	3.1	4.6	0.1	1.1	2.9	3.1	2.0	4.7	1.5	1.5	1.6	3.8	22.0	2.1	3.7	0.6	0.7	1.3	1.8	1.5	1.7	1.1	2.9	2.0	3.7	0.6	3.7	2.1	0.0	2.4	1.0	2.1	1.1	1.9	1.0	0.7	1.8	1.6	0.3	1.7	0.8	6.6	3.3	2.3	1.3	1.0	1.8	2.0	1.5	0.4	2.1	2.1	0.5	2.1	1.5	0.0	1.3	2.8	1.0	3.2	5.8	1.3	1.7	2.6	0.7	1.9	3.4	1.9	1.8	0.8	6.4	3.7	2.8	1.1	3.4	1.1	10.7	2.1	0.4	7.3	8.8	3.9	11.1	7.0	4.1	8.1	7.8	8.0	7.9	3.0	5.9	1.5	3.2	5.5	27.8	2.9	5.1	24.1	13.6	7.0	41.2	3.8	0.0	2.2	3.4	3.2	4.2	0.0	1.9	1.3	6.1	2.8	3.5	1.0	1.2	12.7	5.2	3.7	1.3	2.1	2.3	3.3	1.7	1.0	5.2	5.8	0.9	3.5	1.8	1.0	111.1	0.0	3.1	12.6	7.9	4.4	1.9	3.2	2.8	1.8
TBC1D3G		ENSG00000260287	"TBC1 domain family member 3G"	Q6DHY5	17	36323884-36334759	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	10	"testis: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"SiHa: 5.5;U-2197: 1.6"									"HPA046969, HPA047745, HPA052553"	Supported		Approved	Vesicles		NA	NA			Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"					"unprognostic (4.41e-1)"					"unprognostic (1.17e-2)"				"unprognostic (5.01e-2)"				0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	8.7			0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3H		ENSG00000274226	"TBC1 domain family member 3H"	P0C7X1	17	36377531-36388423	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"cervix, uterine: 1.6;testis: 5.0;urinary bladder: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"CAPAN-2: 11.5"									"HPA046969, HPA047745, HPA052553"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		0.0	0.0		0.0		0.2	0.0		0.0	1.6	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.0			0.0		0.0	3.3		0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	22.2	20.9	24.8	21.3	24.7	21.1	17.7	25.5	25.1	21.0	13.3	25.7	14.5	10.3	17.4	15.9	16.4	22.4	18.5	16.2	24.4	20.0	19.9	13.9	16.9	20.4	25.9	14.9	28.3	17.2	35.3	27.8	16.5	21.4	14.2	13.7	16.6	13.9	17.0	10.3	15.2	13.8	17.7	31.3	24.3	12.9	17.3	24.7	10.0	29.1	9.7	21.2	17.8	20.7	13.5	9.7	12.3	8.6	4.2	8.7	4.6	11.7	13.2	10.9	10.2	21.5	31.7	11.9	12.7	18.6	8.3	7.2	6.4	10.7	21.9	13.8	25.7	12.8	3.7	9.5	15.4	17.4	19.2	3.7	21.0	5.3	7.4	13.8	20.3	18.3	20.4	18.5	18.0	11.0	18.8	18.9	13.0	13.1	20.3	20.2	7.9	9.9	4.6	8.9	7.6	13.9	21.9	14.0	15.6	12.5	9.2	4.1	19.3	24.3	5.7	8.6	10.7	16.1	17.0	20.4	23.1	10.4	11.9	13.8	11.8	15.9	21.3	17.8	19.4	21.6	10.2	8.6	12.3	6.7	7.1	8.7	11.7	5.1	4.8	9.7	13.5	3.9	4.4	11.5	4.2	6.4	6.3	5.5	4.6	24.8	24.7	25.5	24.6	24.4	20.0	25.9	14.9	21.4	24.7	14.9	31.2	20.1	17.0	16.4	19.3	16.2	25.5	17.4	39.8	14.0	9.8	12.9	5.0	14.3	52.3	25.4	9.5	23.3	8.7	14.6	17.4	9.9	17.4	16.4	18.6	33.4	12.6	39.3	34.9	30.1	28.4	26.6	13.5	10.0	12.3	23.0	10.9	11.2	28.7	13.5	21.3	6.5	10.5	17.0	26.2	14.9	6.9	14.9	11.7	18.7
TBC1D8	"AD3, GRAMD8, HBLP1, VRP"	ENSG00000204634	"TBC1 domain family member 8"	O95759	2	101007617-101252866	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 76.0;skeletal muscle: 66.3"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 32.5;Ciliated cells: 41.5;Glandular cells: 38.4;monocytes: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 16.6;non-classical monocyte: 20.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.7;ASC TERT1: 26.1;BJ hTERT+: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015211, HPA037496"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"CAB015211: , HPA037496: AB_2675507"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (4.25e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.73e-2)"	"unprognostic (7.98e-3)"	14.4	4.0	3.0	5.5	4.2	7.3	14.1	10.1	5.1	7.6	19.6	2.2	52.8	4.3	7.8	12.2	8.4	13.2	12.0	24.1	4.8	2.7	8.9	12.8	11.8	6.8	3.0	3.8	5.1	27.5	3.9	8.5	4.4	6.1	25.7	3.8	6.7	15.1	76.0	66.3	15.2	22.7	7.7	5.0	11.3	13.3	11.3	2.8	3.3	5.3	8.3	8.0	8.7	8.6	0.6	4.0	0.2	20.6	0.0	0.3	1.8	2.0	12.8	1.0	3.7	36.7	26.1	10.5	1.2	22.5	0.9	1.1	4.5	3.3	0.9	11.5	0.9	18.0	6.5	2.1	9.9	0.6	0.6	1.9	0.6	4.3	15.6	2.5	0.1	11.0	12.1	9.4	1.2	9.4	0.7	13.1	1.8	0.2	1.1	1.1	5.6	1.1	6.4	2.8	1.4	13.8	2.5	3.2	0.2	7.5	13.7	8.1	3.9	1.7	3.1	4.4	1.8	0.9	9.4	10.8	0.5	1.9	1.9	0.8	2.1	0.1	0.0	4.7	3.2	3.3	0.0	5.1	0.2	0.1	16.6	0.2	0.2	0.1	0.1	2.8	0.6	0.3	0.2	0.2	0.0	20.6	4.0	0.1	1.8	3.0	4.2	10.1	5.1	4.8	2.7	3.0	3.8	6.1	2.8	3.0	2.9	0.0	32.5	3.7	5.8	10.6	20.4	41.5	20.5	5.2	3.9	3.9	0.0	5.9	4.8	4.9	1.3	0.0	2.6	2.5	2.3	38.4	6.9	5.0	3.6	1.6	2.9	7.4	11.2	8.6	2.8	12.2	5.0	33.3	1.7	0.9	2.8	0.6	1.8	0.7	3.6	6.5	4.2	1.4	1.9	5.5	2.9	0.0	0.9	24.3
TBC1D8B	"FLJ20298, GRAMD8B, RP11-321G1.1"	ENSG00000133138	"TBC1 domain family member 8B"	Q0IIM8	X	106802680-106876145	"Predicted intracellular proteins"		"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Alveolar cells type 1: 214.4;Alveolar cells type 2: 173.1;Ciliated cells: 192.7;Club cells: 159.3;granulocytes: 104.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023883, HPA027527"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA023883: AB_1857794, HPA027527: AB_2199395"	"unprognostic (6.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.69e-3)"	"unprognostic (8.15e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.16e-2)"	3.8	24.5	4.6	3.5	7.9	3.3	3.9	1.2	7.9	6.0	6.6	2.6	21.5	6.0	5.1	10.4	3.7	4.4	9.6	4.7	4.2	2.5	12.4	14.5	4.1	2.0	6.8	3.3	7.2	10.7	10.0	28.6	4.5	9.0	6.1	5.6	2.2	10.1	16.8	1.8	2.9	13.3	4.1	4.7	2.7	8.5	7.6	7.6	0.5	7.9	3.1	1.8	4.9	4.8	4.7	2.8	5.2	2.2	1.5	2.0	0.4	10.0	3.2	1.5	4.9	15.8	22.4	5.7	11.3	11.7	2.0	6.1	5.4	8.9	3.6	9.3	11.3	8.3	5.2	4.1	5.6	5.1	1.9	4.5	4.8	4.0	5.2	4.1	1.4	2.0	9.8	4.6	4.2	2.0	12.2	5.5	3.0	1.6	6.2	7.0	5.1	3.2	1.9	6.9	14.7	5.1	1.6	2.8	1.5	5.6	7.4	2.5	2.1	8.9	6.9	4.0	7.1	7.9	1.7	6.9	7.4	8.3	9.7	4.1	5.7	6.1	1.1	14.3	1.1	9.2	3.7	2.2	1.1	2.0	1.2	1.6	2.2	1.7	1.5	0.7	4.7	1.4	1.7	5.2	1.5	1.1	2.8	0.7	0.4	4.6	7.9	1.2	7.9	4.2	2.5	6.8	3.3	9.0	7.6	214.4	173.1	1.5	5.8	2.2	3.4	2.2	5.1	192.7	159.3	7.0	3.9	2.4	6.6	7.5	0.8	6.0	8.4	0.0	8.3	2.5	7.6	12.9	104.6	13.9	1.4	0.0	4.6	2.5	2.7	0.4	8.3	1.9	3.3	1.0	15.4	1.5	6.2	10.5	8.1	9.7	3.4	0.0	4.1	1.4	1.7	1.3	2.2	0.0	8.4	7.2
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620765-140756120	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 52.4"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.0"	"Group enriched"	"Detected in many"	38	"B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	15.9	6.2	8.1	9.2	10.0	1.0	33.6	37.6	13.7	9.2	6.7	3.8	32.1	5.2	5.5	6.4	5.9	6.7	9.4	5.7	7.5	13.9	10.7	8.0	10.4	9.6	9.6	8.2	10.9	6.0	9.9	5.7	13.1	11.0	9.8	4.3	10.6	7.3	27.4	1.7	2.8	9.9	5.0	5.3	20.4	10.0	2.9	3.8	1.6	4.3	3.0	12.2	11.1	8.9	9.0	4.6	0.1	2.4	0.1	0.0	0.9	0.4	6.4	6.0	5.1	14.6	13.8	12.2	8.1	8.8	5.9	7.6	1.3	5.6	0.0	5.2	10.6	7.4	1.2	7.4	5.8	5.6	0.0	4.1	3.6	4.6	5.5	5.3	0.5	0.5	11.3	9.7	5.1	20.6	17.3	16.4	2.0	0.0	0.0	5.5	6.3	0.8	0.0	0.9	6.7	5.6	3.9	9.8	9.3	6.8	11.8	8.8	6.2	8.5	15.0	5.5	10.6	3.5	0.2	25.4	15.7	4.7	10.2	7.0	0.0	0.0	0.0	9.5	0.7	8.5	0.0	2.4	0.0	0.0	1.9	0.0	9.0	0.0	0.0	4.0	4.0	0.0	0.0	0.1	0.1	0.7	4.6	0.0	0.9	8.1	10.0	37.6	13.7	7.5	13.9	9.6	8.2	11.0	3.8	50.6	9.4	15.7	8.9	4.0	33.1	6.5	17.8	5.3	6.8	52.4	3.9	10.8	6.6	13.3	0.4	24.1	4.1	0.0	15.0	3.9	11.5	19.8	0.0	14.5	15.9	9.5	7.5	17.8	30.7	0.0	12.0	30.7	8.5	25.2	4.5	40.9	13.2	5.9	25.1	3.8	7.0	0.0	9.5	0.7	1.5	3.3	36.2	0.5	1.7	8.4
TBC1D9B	"GRAMD9B, KIAA0676"	ENSG00000197226	"TBC1 domain family member 9B"	Q66K14	5	179862066-179907859	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038350	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038350: AB_10673170"	"unprognostic (5.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.53e-2)"	"unprognostic (9.45e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (8.22e-2)"	30.4	28.7	31.2	14.3	29.8	17.0	21.2	27.0	37.9	21.7	17.8	36.7	20.6	16.4	18.9	24.5	21.7	20.7	19.0	15.2	31.4	26.6	20.7	22.4	18.3	16.8	34.9	23.3	24.8	24.6	22.7	13.3	14.8	29.0	18.2	14.5	17.5	25.6	21.9	20.3	24.0	18.9	19.1	42.3	18.0	16.1	12.2	24.1	12.0	23.3	12.5	17.2	17.4	19.7	5.4	9.4	5.0	8.1	3.7	5.5	4.9	10.7	16.6	7.6	17.6	23.3	14.9	17.7	13.1	13.6	13.2	13.2	11.1	10.8	7.4	16.2	15.9	17.3	10.3	9.1	30.6	6.1	24.6	10.2	6.6	12.2	7.4	12.5	8.7	23.0	17.2	13.3	10.4	7.5	12.3	14.5	14.8	4.4	8.7	11.8	27.0	5.6	7.2	5.3	8.2	9.5	9.7	5.8	7.3	12.4	17.6	10.9	8.0	12.4	14.8	15.0	8.5	11.7	14.1	14.7	19.3	8.6	9.2	11.5	4.4	5.7	5.8	18.3	11.2	13.6	4.5	5.9	5.0	5.5	8.1	4.5	5.4	4.0	4.7	7.8	5.1	3.9	3.1	0.8	3.7	7.9	9.4	3.4	4.9	31.2	29.8	27.0	37.9	31.4	26.6	34.9	23.3	29.0	24.1	20.8	19.2	17.1	8.5	14.7	25.0	8.4	17.8	10.7	9.1	26.2	7.9	15.5	11.6	18.4	1.7	23.8	22.6	0.0	15.6	18.8	15.9	12.8	10.5	30.0	27.4	58.8	17.3	23.4	26.1	5.4	30.0	21.0	15.1	19.0	21.9	15.8	21.8	23.0	26.9	18.1	17.7	25.8	11.0	6.9	17.5	13.7	11.8	13.1	18.2	11.9
TBCK	"HSPC302, MGC16169"	ENSG00000145348	"TBC1 domain containing kinase"	Q8TEA7	4	106041599-106321495	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 25.3;BJ hTERT+ SV40 Large T+ RasG12V: 44.5;HBF TERT88: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: AB_2681550"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.81e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (8.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-1)"	12.8	19.0	14.2	7.6	15.2	3.4	10.0	16.3	15.2	13.5	8.3	10.0	11.0	4.4	10.9	14.9	10.6	13.0	13.2	9.3	12.1	11.1	17.8	10.5	9.6	6.9	15.0	8.5	17.5	8.2	12.6	24.2	13.7	12.1	11.9	9.1	9.0	9.1	14.6	4.2	8.5	7.2	13.3	10.3	8.5	8.1	12.0	13.8	18.5	13.9	4.6	8.9	14.5	10.7	10.7	6.3	11.9	6.8	5.9	8.4	4.2	0.9	2.5	5.2	1.9	19.6	12.3	0.9	3.9	6.3	25.3	44.5	4.5	3.9	1.7	5.9	13.2	3.7	2.3	3.5	4.8	30.4	2.4	1.0	5.4	2.1	4.7	5.1	2.2	3.2	11.4	4.0	2.3	4.0	11.1	6.6	3.2	4.2	2.1	7.7	3.4	2.8	2.1	1.2	6.6	1.8	2.1	3.2	3.6	6.6	4.5	2.8	2.2	3.4	2.4	3.4	7.3	3.4	4.9	3.7	4.5	2.2	1.0	1.9	1.0	2.8	3.7	6.2	3.3	2.3	11.9	6.4	6.3	6.2	6.8	7.2	6.2	6.8	8.4	6.3	10.7	7.4	6.7	0.5	5.9	4.6	6.1	6.7	4.2	14.2	15.2	16.3	15.2	12.1	11.1	15.0	8.5	12.1	13.8	17.9	28.0	8.9	5.8	2.1	19.0	6.7	5.1	14.7	20.5	14.0	19.6	9.6	3.3	3.8	35.4	8.2	3.8	0.0	0.8	5.5	7.0	4.2	10.5	4.4	5.8	11.1	5.2	9.8	4.7	28.9	10.3	4.3	5.0	2.8	6.4	10.1	2.1	5.8	12.0	6.9	15.8	0.0	3.8	10.4	8.2	2.0	6.2	6.9	5.5	4.2
TBKBP1	"KIAA0775, ProSAPiP2"	ENSG00000198933	"TBK1 binding protein 1"	A7MCY6	17	47694081-47712050	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 13.0;Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.7;NK-cells: 2.2;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062347, HPA064856"	Approved		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA062347: AB_2684744, HPA064856: AB_2685371"	"unprognostic (2.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (8.14e-6)"	"unprognostic (5.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.59e-5)"	12.6	7.8	16.1	8.7	8.4	5.6	6.0	13.5	20.1	11.2	7.3	3.9	5.4	3.1	9.7	5.9	10.9	6.7	7.8	12.2	16.3	14.6	6.3	3.2	7.8	5.3	11.2	15.2	17.9	15.0	9.2	6.4	9.2	8.0	7.4	2.4	12.2	18.2	9.8	30.1	4.6	3.6	12.1	4.2	11.0	5.4	8.5	2.8	2.8	9.1	6.5	6.7	8.0	9.6	0.6	0.5	5.7	0.5	2.2	2.8	0.3	0.2	5.2	9.7	10.3	5.0	5.1	6.3	5.3	5.5	2.6	3.1	32.5	0.8	0.1	5.3	6.5	4.7	0.6	7.6	1.3	1.5	6.3	17.1	13.7	4.6	5.4	11.6	2.6	3.0	10.2	3.5	0.6	0.9	8.2	9.1	3.8	11.8	0.0	1.4	1.4	1.6	12.8	13.5	0.2	3.7	6.1	3.0	5.4	3.3	0.4	8.5	15.8	2.5	0.6	2.7	9.6	5.8	5.9	10.5	8.1	9.6	9.7	0.6	3.6	0.3	6.4	4.7	4.9	2.0	0.0	0.5	0.9	2.8	0.2	1.5	0.0	0.7	2.0	0.5	0.6	0.3	1.0	5.7	2.2	0.0	0.5	0.5	0.3	16.1	8.4	13.5	17.9	16.3	14.6	11.2	15.2	8.0	2.8	0.0	1.4	0.5	3.3	3.5	13.0	2.8	0.0	0.0	1.2	3.5	2.0	0.1	1.7	0.9	5.9	5.2	0.0	0.0	1.5	0.1	3.7	4.7	0.0	1.1	2.7	27.0	5.1	9.8	3.3	4.1	8.1	1.7	1.7	1.0	0.1	4.1	1.1	0.0	8.1	3.7	3.5	0.0	4.2	4.4	5.1	2.6	0.2	1.5	0.0	1.7
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 65.3;Hepatocytes: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.3"	"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	6.5	7.1	10.1	6.0	12.3	4.5	8.1	3.3	8.1	21.4	7.9	13.2	18.0	2.1	33.0	26.4	8.3	12.4	6.7	5.2	8.6	9.0	12.5	11.0	5.2	9.5	7.6	6.0	13.8	11.3	21.0	24.3	14.5	7.5	24.7	4.1	9.8	5.5	33.0	4.9	5.8	4.2	22.4	9.0	5.7	7.0	9.9	8.5	14.7	9.4	3.4	7.1	15.3	24.5	3.2	3.1	17.3	4.2	0.3	3.1	1.7	0.0	13.5	8.6	22.9	8.0	8.4	8.5	5.2	11.6	10.0	10.5	10.1	9.3	14.3	0.3	10.3	4.3	3.1	18.8	4.0	14.6	5.9	9.2	9.0	16.5	11.8	11.3	3.2	32.3	7.4	4.7	10.4	5.5	5.4	9.2	7.9	15.7	25.0	5.7	11.4	7.8	12.1	17.1	6.4	14.5	17.6	6.8	17.6	13.5	7.6	11.0	5.0	12.5	3.1	7.4	23.6	6.1	7.0	13.3	3.5	8.7	0.3	2.0	15.3	11.8	11.4	12.9	7.8	3.3	4.4	4.2	4.9	2.1	2.6	1.7	2.0	1.6	1.9	3.1	3.2	3.1	2.8	17.3	0.3	1.7	0.3	2.5	1.7	10.1	12.3	3.3	8.1	8.6	9.0	7.6	6.0	7.5	8.5	0.0	5.0	15.2	9.4	5.8	11.5	9.5	22.9	12.0	6.8	29.6	21.6	65.3	11.6	9.9	0.8	9.4	2.6	0.0	6.7	2.4	10.0	18.9	10.5	59.7	10.0	6.4	21.9	11.6	32.3	1.7	13.3	19.9	5.0	10.8	4.8	38.8	8.5	3.5	26.9	17.0	22.7	0.0	25.9	1.4	17.9	10.8	37.6	10.7	4.7	22.3
TBL1XR1	"C21, DC42, FLJ12894, IRA1, TBLR1"	ENSG00000177565	"Transducin beta like 1 X-linked receptor 1"	Q9BZK7	3	177019340-177228000	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 71.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019182	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019182: AB_1857800"	"unprognostic (4.11e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-3)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (3.75e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	20.7	26.0	27.4	24.3	26.8	27.3	20.3	27.5	28.1	28.9	29.9	22.6	15.4	24.0	23.9	20.5	23.8	21.9	22.7	30.3	26.2	20.7	19.9	21.8	30.8	27.8	21.4	25.9	26.5	19.9	30.6	11.3	24.0	19.7	24.4	23.2	24.7	21.3	17.7	21.1	17.8	24.3	21.9	19.6	24.7	21.3	17.4	22.3	28.4	45.6	14.9	32.1	29.1	25.5	7.4	13.3	12.9	4.6	6.8	8.3	4.1	23.9	12.3	16.0	9.0	13.6	14.8	9.6	7.6	11.8	6.6	9.1	14.1	19.9	24.6	35.9	10.9	17.5	14.8	11.9	15.8	13.3	25.8	3.7	13.8	21.0	8.4	11.7	21.9	8.2	21.8	8.2	9.7	24.1	13.0	10.3	17.3	10.3	43.6	8.5	8.6	20.4	3.0	10.1	15.4	8.3	11.7	20.4	26.2	5.9	34.0	5.8	9.2	10.2	8.0	9.5	10.5	29.3	16.8	15.7	10.8	9.1	6.0	16.4	23.8	30.5	71.1	7.3	16.4	12.3	11.4	3.0	3.8	5.8	4.6	5.1	7.3	5.7	6.6	4.0	7.4	5.0	6.4	12.9	6.8	3.9	13.3	8.3	4.1	27.4	26.8	27.5	28.1	26.2	20.7	21.4	25.9	19.7	22.3	68.5	47.1	43.4	46.9	81.4	116.0	84.2	48.4	61.6	62.6	99.5	117.8	22.3	24.9	43.8	5.7	62.9	42.8	23.3	37.3	28.5	65.8	123.0	24.3	58.7	32.8	109.7	81.9	55.9	85.4	5.2	59.2	54.6	62.4	31.5	74.5	41.8	53.4	23.0	68.6	46.2	81.2	45.3	41.5	8.4	53.9	97.7	23.0	49.8	75.7	61.8
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	7.1	7.7	10.8	8.9	11.7	19.3	12.2	16.4	16.6	7.3	7.3	5.2	7.8	8.1	7.9	5.6	7.1	8.5	7.4	7.9	15.9	14.2	5.7	8.5	6.6	12.0	10.0	11.8	8.3	6.0	4.7	8.2	9.2	11.1	8.0	9.3	4.6	5.7	9.2	4.4	5.9	7.7	7.2	8.5	7.6	7.2	71.2	8.0	11.7	10.7	5.0	10.2	9.2	12.0	27.8	14.7	43.1	14.9	21.1	30.8	25.3	6.3	7.8	17.9	11.6	13.7	14.2	10.1	12.1	12.8	16.2	21.3	9.1	5.1	19.8	8.3	9.6	18.0	8.4	11.4	13.0	19.6	15.1	14.2	34.8	4.7	10.0	13.9	18.2	13.6	8.7	13.3	18.1	19.6	12.3	15.3	17.5	50.2	13.6	11.5	14.5	15.2	10.9	20.0	9.3	10.2	10.6	10.8	7.6	9.5	5.7	23.3	23.2	7.1	9.4	14.9	15.6	4.3	7.3	13.8	9.3	13.5	20.5	13.2	11.0	11.9	12.9	15.6	11.9	11.1	43.1	13.7	32.7	28.5	13.8	30.8	27.8	24.1	29.9	12.4	25.0	23.4	27.3	31.4	21.1	14.9	14.7	24.6	25.3	10.8	11.7	16.4	16.6	15.9	14.2	10.0	11.8	11.1	8.0	6.0	12.6	23.3	25.8	62.8	20.7	9.2	20.4	12.0	7.9	7.0	17.7	36.2	24.9	25.0	221.6	33.3	12.0	0.0	22.1	57.3	32.7	32.8	40.3	8.9	21.4	14.3	68.1	17.2	16.7	29.8	19.5	20.0	30.4	19.0	22.4	12.3	24.3	21.0	17.3	18.9	9.4	19.4	34.0	178.1	63.9	57.5	204.8	47.3	23.6	36.7
TBX1	"CATCH22, VCF"	ENSG00000184058	"T-box 1"	O43435	22	19756703-19783593	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 36.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 42.8;Late spermatids: 139.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 3.0"	"Group enriched"	"Detected in some"	13	"basophil: 1.0;eosinophil: 2.7"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 10.1;K-562: 48.7;NB-4: 11.5;TIME: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029330			Approved	"Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Nuclear bodies, Cytoplasmic bodies"		"HPA029330: AB_2673002"	"unprognostic (2.54e-1)"	"unprognostic (4.28e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.30e-3)"	"unprognostic (9.14e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (8.90e-4)"	1.4	0.2	0.6	0.6	3.0	0.0	3.7	0.6	0.6	2.5	2.3	0.6	0.6	0.4	0.9	0.6	2.5	2.8	0.6	0.6	0.6	0.0	0.6	0.6	2.2	1.7	0.6	0.6	0.7	0.6	3.7	0.6	0.6	0.6	2.3	0.2	0.6	3.4	0.6	36.5	4.6	0.8	0.6	0.6	0.6	0.1	7.0	0.6	0.6	5.3	0.6	1.9	1.1	3.3	0.0	0.1	2.7	0.0	0.0	0.1	0.0	6.0	0.6	0.1	4.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.6	0.3	5.2	4.5	0.0	0.2	10.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	48.7	0.0	3.3	1.1	0.1	11.5	0.7	0.0	7.1	0.1	4.6	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	1.4	2.1	3.1	15.6	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	1.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	3.0	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	3.2	0.0	1.1	2.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.8	3.0	0.0	0.0	0.2	0.7	0.7	0.9	2.3	0.0	1.5	0.0	0.0	1.3	1.0	139.3	2.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.4	1.9	13.2	2.0	0.1	0.0	0.0	1.6
TBX15	TBX14	ENSG00000092607	"T-box 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.3;skeletal muscle: 84.9;tongue: 37.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 6.3;Hepatocytes: 11.3;Melanocytes: 6.8;Smooth muscle cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 28.2;ASC TERT1: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.8;fHDF/TERT166: 14.4;HSkMC: 20.3;RH-30: 15.3;U-2197: 14.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA052245: AB_2681771, HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	18.1	0.1	0.2	0.1	0.5	0.1	12.5	0.4	0.8	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.2	0.1	0.3	1.2	0.5	0.0	0.1	23.3	0.2	1.3	0.2	0.2	0.1	0.1	0.2	0.5	0.1	2.1	0.7	0.0	0.2	2.8	0.1	84.9	3.6	0.1	0.2	0.6	0.0	0.1	0.4	0.4	0.0	1.9	37.5	2.4	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	28.2	12.0	0.0	2.4	3.3	6.4	10.8	0.0	0.0	0.0	1.4	14.4	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	20.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	0.1	1.2	0.0	0.1	0.0	15.3	0.2	1.6	0.7	0.3	0.0	0.8	0.0	0.3	0.3	0.0	0.3	0.0	3.5	2.1	14.3	0.1	0.2	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.8	0.5	0.0	0.2	0.2	2.1	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.1	1.8	0.0	0.0	0.0	0.0
TBX19	"dj747L4.1, TPIT"	ENSG00000143178	"T-box 19"	O60806	1	168281040-168314426	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"pituitary gland: 50.4"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 9.4;HDLM-2: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005800, HPA072686"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005800: AB_1080219, HPA072686: AB_2732209"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.14e-7)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (8.57e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	1.0	0.4	1.0	1.0	1.0	0.5	2.5	1.0	1.0	1.5	1.3	1.0	1.0	0.8	5.3	1.0	1.1	2.0	1.4	1.0	1.0	0.8	1.0	1.0	2.2	2.1	1.0	1.0	2.9	1.0	0.2	50.4	1.0	1.0	1.2	1.1	1.0	2.2	1.4	1.0	1.9	1.0	3.6	1.0	2.1	0.6	1.0	1.0	1.0	1.0	1.0	1.3	1.3	1.2	1.6	6.3	2.7	2.4	2.6	3.1	1.3	1.6	0.1	1.4	5.3	2.5	1.2	1.7	2.9	1.5	1.0	1.6	2.4	1.7	1.5	2.9	1.1	1.5	9.4	0.8	0.7	1.4	8.1	1.4	0.3	1.7	0.7	2.9	2.6	3.6	2.2	2.6	0.3	1.5	2.6	1.2	0.6	1.8	2.4	1.3	0.3	1.4	2.4	0.4	5.6	1.0	2.2	0.7	0.5	2.3	0.7	1.9	2.8	1.6	1.2	1.6	2.4	0.4	2.2	2.1	1.0	2.4	2.0	2.9	1.6	1.3	1.2	0.2	0.8	2.8	0.5	1.8	0.8	3.1	1.3	1.4	1.2	2.2	2.0	1.8	1.6	1.5	1.3	2.7	2.6	2.4	6.3	2.0	1.3	1.0	1.0	1.0	1.0	1.0	0.8	1.0	1.0	1.0	1.0	0.0	0.3	0.0	1.1	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	2.7	0.9	0.0	0.3	0.2	2.3	3.4	4.6	0.5	1.1	0.0	1.2	0.0	2.1	0.4	3.1	2.8	0.0	2.8	0.7	0.8	1.4	0.0	2.5	0.3	0.0	0.0	0.8	0.5	0.7	2.9	0.1	1.8	0.8	2.0
TBX2		ENSG00000121068	"T-box 2"	Q13207	17	61399896-61409466	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 76.5;Collecting duct cells: 90.7;Muller glia cells: 126.1;Sertoli cells: 168.1;Smooth muscle cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 48.6;MCF7: 28.5;SH-SY5Y: 22.7;SK-MEL-30: 15.5;WM-115: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008586, CAB013636"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013636: , HPA008586: AB_1080222"	"unprognostic (6.18e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.34e-3)"	11.5	3.4	2.0	2.9	3.1	0.4	9.9	1.3	2.3	14.8	4.4	1.9	30.4	4.9	12.2	37.0	5.9	11.3	16.8	6.8	1.8	1.8	28.9	4.6	35.7	1.3	3.6	1.5	8.3	1.8	1.8	3.7	30.4	3.6	15.1	2.2	33.7	2.2	38.1	5.8	2.9	5.5	16.4	1.7	8.8	8.1	9.6	1.5	0.0	8.6	5.0	1.8	19.5	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	48.6	1.6	1.7	5.9	7.5	7.9	0.4	0.1	1.3	0.1	0.0	0.6	1.2	0.9	0.0	0.9	0.0	0.1	0.0	2.9	0.8	0.0	2.3	5.4	0.1	0.7	3.1	0.1	8.9	0.5	0.1	0.0	0.0	0.1	0.0	0.5	28.5	0.0	0.1	0.0	0.0	3.4	0.0	1.9	0.2	0.0	11.5	0.1	22.7	0.0	0.0	15.5	0.1	0.6	0.9	0.0	1.1	0.0	2.8	1.7	0.0	0.1	0.0	6.7	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.1	1.3	2.3	1.8	1.8	3.6	1.5	3.6	1.5	0.0	1.1	0.0	0.2	0.6	76.5	6.7	0.0	0.0	0.0	90.7	21.6	0.3	1.7	0.0	0.7	4.2	0.0	0.0	0.0	0.2	3.7	0.6	0.0	0.0	0.8	1.6	0.0	14.1	1.8	0.0	36.5	1.7	1.7	0.0	0.0	126.1	0.0	0.0	44.6	23.8	11.5	168.1	66.5	0.4	0.6	0.3	0.2	0.0	0.0	0.1
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box 3"	O15119	12	114670254-114684164	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 117.7"	"Cell type enriched"	"Detected in many"	6	"Syncytiotrophoblasts: 513.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 34.0;BJ hTERT+: 32.4;RT4: 42.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.28e-4)"	4.3	60.5	0.9	3.3	1.9	0.0	19.9	0.7	2.3	18.2	12.2	1.7	69.6	14.2	13.1	18.7	1.9	7.5	5.0	6.2	1.2	1.5	4.1	15.1	12.6	0.8	1.2	0.5	15.6	1.1	0.3	5.3	67.8	1.6	32.3	1.5	2.6	7.3	117.7	4.2	4.8	19.4	9.7	1.4	2.6	2.2	3.5	1.2	0.5	36.3	7.3	3.5	24.6	25.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	6.0	0.0	0.0	9.0	12.4	13.5	34.0	32.4	13.2	13.1	5.3	1.4	0.0	0.5	5.9	0.8	1.5	2.8	1.2	16.3	0.0	4.1	0.0	1.5	15.5	2.9	0.0	0.0	5.5	0.8	4.4	9.1	0.0	0.1	0.0	1.2	0.0	1.1	0.5	0.0	0.1	0.0	17.2	1.8	0.0	0.0	0.8	0.0	42.4	2.2	6.6	4.8	2.2	1.1	15.8	1.7	0.0	0.0	4.0	2.6	2.3	11.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.7	2.3	1.2	1.5	1.2	0.5	1.6	1.2	0.0	3.4	0.9	88.0	8.8	6.3	9.8	0.0	0.0	0.0	33.2	3.9	39.8	0.0	0.4	1.3	26.5	25.4	0.0	0.0	5.9	9.5	74.0	0.0	31.0	5.4	1.6	4.7	0.6	1.6	1.8	4.9	0.8	3.3	0.0	13.8	1.5	0.5	23.0	5.6	0.0	2.0	38.8	34.1	0.1	4.7	8.5	513.4	0.7	4.5	62.6
TBX4		ENSG00000121075	"T-box 4"	P57082	17	61452404-61485110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 5.7;Late spermatids: 11.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.4;Hep G2: 2.2;OE19: 2.2;THP-1: 10.7"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"CAB032413, HPA044457"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"CAB032413: AB_2200705, HPA044457: AB_2678948"	"unprognostic (1.03e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-8)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-2)"	0.5	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.0	0.6	15.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	26.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	18.6	4.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.9	0.1	0.0	0.1	5.4	0.5	0.4	0.5	1.9	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	2.2	0.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.2	0.1	0.0	0.2	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.5	0.2	0.0	10.7	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
TBX5	HOS	ENSG00000089225	"T-box 5"	Q99593	12	114353931-114408442	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Atrial fibrillation, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.5;lung: 14.0;placenta: 19.7"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 62.0"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hippocampal formation: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.1;BJ hTERT+: 29.2;BJ hTERT+ SV40 Large T+: 6.8;BJ hTERT+ SV40 Large T+ RasG12V: 8.3;HAP1: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008786, HPA064683"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008786: AB_10601720, HPA064683: AB_2685320"	"unprognostic (3.09e-2)"	"unprognostic (1.53e-1)"			"unprognostic (3.79e-2)"	"unprognostic (2.75e-1)"		"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-7)"	"unprognostic (2.29e-2)"	"unprognostic (1.68e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.38e-3)"	2.2	0.1	0.1	0.0	0.1	0.0	3.8	0.8	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	6.4	0.1	0.0	44.5	2.2	0.1	0.1	0.1	14.0	1.6	0.1	0.1	0.1	0.1	0.0	0.1	19.7	0.5	5.4	0.0	1.4	0.1	0.0	0.1	0.5	0.1	6.6	0.2	0.1	0.1	0.1	0.0	0.0	1.0	0.0	0.0	6.5	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.1	29.2	6.8	8.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	11.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.2	2.2	0.1	0.1	0.1	0.5	0.0	0.0	1.1	0.0	0.0	0.1	3.6	62.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0
TBX6		ENSG00000149922	"T-box 6"	O95947	16	30085793-30091887	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 7.9;Sertoli cells: 6.5;Urothelial cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 9.9;U-266/70: 10.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062498			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062498: AB_2732686"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.62e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.05e-3)"	"unprognostic (4.26e-2)"	1.2	1.4	1.4	1.0	1.5	0.6	0.9	0.9	1.5	2.7	1.2	0.9	0.9	1.8	0.9	1.0	22.8	1.6	1.3	0.9	1.5	1.0	1.8	1.2	1.2	1.2	1.7	0.9	1.9	19.8	3.2	2.3	0.9	2.1	3.2	0.3	2.3	3.9	2.2	2.8	5.0	1.7	0.9	1.5	1.8	7.8	2.4	1.2	1.6	2.3	5.1	16.3	5.5	8.6	4.4	1.3	3.3	2.6	1.3	1.9	1.1	0.9	1.1	0.6	1.1	1.5	0.8	0.8	0.3	0.2	0.0	0.2	1.3	4.3	1.9	2.3	0.2	0.2	1.3	0.5	0.9	0.0	1.4	0.8	1.2	1.7	0.9	1.1	0.2	2.6	0.3	1.2	0.3	0.5	0.9	0.6	4.2	0.1	4.3	0.1	3.6	0.7	0.5	0.9	5.9	0.9	2.8	0.1	3.1	0.0	9.9	1.4	2.0	0.2	0.9	1.2	0.5	1.8	1.7	0.5	1.2	0.7	0.6	0.0	10.4	2.4	0.3	1.2	1.8	0.4	3.1	2.6	0.8	1.8	2.3	1.2	1.3	0.9	1.3	1.3	4.4	1.9	1.7	3.3	1.3	0.8	1.1	1.8	1.1	1.4	1.5	0.9	1.4	1.5	1.0	1.7	0.9	2.1	1.2	0.0	1.1	0.8	2.9	1.0	1.4	0.4	0.0	1.4	0.0	1.8	7.9	1.4	0.0	0.7	0.0	1.4	0.7	0.0	1.0	0.6	0.6	2.9	0.0	0.2	0.5	0.0	0.0	0.6	1.0	0.0	0.9	1.0	0.0	0.0	0.9	1.9	2.1	1.4	1.1	0.4	3.1	6.5	0.1	1.7	2.3	0.9	1.9	0.0	0.7	6.4
TBXA2R		ENSG00000006638	"Thromboxane A2 receptor"	P21731	19	3594506-3606840	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"Ito cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 12.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 11.9;U-2197: 8.6;U-937: 7.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA077366			Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA077366: AB_2686836"	"unprognostic (1.59e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.17e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (7.17e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (4.32e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.02e-1)"	8.7	11.8	1.4	3.9	1.6	2.1	3.9	0.5	1.6	13.5	3.8	1.7	3.9	2.6	7.4	4.8	8.0	4.7	6.0	6.8	2.4	1.5	10.1	18.4	6.7	7.3	1.4	1.9	8.3	2.2	2.5	1.7	10.6	2.7	3.6	1.4	5.0	1.7	4.2	3.1	1.8	4.4	6.5	2.1	14.9	3.7	3.4	1.9	2.2	3.9	3.2	1.8	6.8	9.6	12.6	0.3	3.2	0.4	3.1	9.6	3.9	0.1	0.2	0.2	4.1	0.9	2.2	0.7	3.0	0.8	2.3	1.8	0.1	0.3	0.1	4.4	1.2	2.3	0.1	0.9	0.0	0.9	0.2	1.0	2.9	11.9	0.3	1.2	0.0	5.3	1.1	0.0	3.0	0.0	1.7	0.9	0.0	4.5	0.4	0.4	0.2	0.2	1.5	0.1	0.1	2.6	0.1	0.0	0.2	0.0	0.1	0.2	1.7	0.2	0.4	0.1	0.3	1.8	5.1	2.6	4.8	1.1	8.6	2.8	0.2	0.3	0.2	4.0	7.4	1.1	2.9	0.4	0.2	2.6	0.2	0.3	1.8	0.8	2.3	0.0	12.6	4.6	9.6	3.2	3.1	0.2	0.3	0.2	3.9	1.4	1.6	0.5	1.6	2.4	1.5	1.4	1.9	2.7	1.9	0.0	0.0	1.3	0.1	0.5	0.4	0.8	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.7	0.0	0.0	35.0	1.2	0.0	0.3	0.0	1.7	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.1	0.0	3.1	0.1	1.3	0.5	0.1	0.0	0.0	0.0
TC2N	"C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N"	ENSG00000165929	"Tandem C2 domains, nuclear"	Q8N9U0	14	91779751-91867536	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 100.1"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 183.3;Pancreatic endocrine cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 32.2"	"Group enriched"	"Detected in many"	46	"NK-cells: 12.9;T-cells: 32.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.8;OE19: 31.5;RT4: 18.5;SK-BR-3: 22.5;T-47d: 11.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA027549	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA027549: AB_10603346"	"unprognostic (5.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (6.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.09e-2)"	6.6	1.5	0.9	15.8	0.9	1.9	12.3	0.4	1.9	8.9	10.2	0.6	16.7	5.4	7.6	7.0	11.6	5.4	24.9	4.7	0.9	1.0	3.7	6.8	13.5	11.3	0.8	0.5	5.5	100.1	12.4	8.4	13.1	1.6	9.3	7.0	6.6	29.8	20.1	2.1	6.9	11.7	3.2	1.1	12.3	10.8	4.9	0.1	8.7	10.3	5.8	27.9	8.3	9.5	0.2	0.0	0.4	0.0	12.9	32.2	7.7	4.5	0.7	0.0	0.0	0.8	0.0	6.3	0.0	0.1	0.0	0.0	3.2	9.8	3.0	0.2	0.0	0.1	0.5	4.5	4.6	0.0	0.0	2.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.2	0.0	0.0	0.2	0.0	2.4	0.0	8.1	0.0	0.0	0.6	31.5	0.0	0.0	0.0	0.0	2.2	18.5	3.4	0.0	0.4	22.5	0.0	1.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.7	0.0	32.2	0.2	16.2	18.6	0.0	0.1	13.3	11.0	0.4	12.9	0.0	0.0	5.2	7.7	0.9	0.9	0.4	1.9	0.9	1.0	0.8	0.5	1.6	0.1	38.7	70.6	6.7	26.4	47.5	0.0	0.7	30.6	68.3	59.1	24.4	0.0	0.9	1.7	55.7	12.8	4.0	23.4	0.0	183.3	3.0	10.8	49.3	6.9	0.8	0.2	0.0	30.5	5.5	1.0	21.7	52.6	2.2	57.3	1.0	54.7	3.7	110.5	40.8	12.0	7.7	0.0	0.0	4.3	35.2	8.1	72.1	4.6	54.6	33.0	58.8
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	26.7	25.3	30.7	40.5	31.5	29.6	31.1	26.1	27.4	26.0	28.3	21.9	26.6	20.3	27.3	20.9	27.5	23.6	24.7	21.4	27.8	24.2	26.5	56.8	22.3	39.2	29.7	17.6	28.5	38.4	32.2	28.7	21.1	27.1	31.3	22.5	20.6	25.4	25.4	21.8	22.8	22.4	38.9	36.8	30.0	26.1	17.3	31.3	39.9	54.6	18.6	46.9	39.6	37.3	60.0	31.9	20.5	17.8	25.2	40.1	17.8	27.3	27.7	24.8	25.5	17.6	21.9	17.8	21.7	25.5	25.7	28.7	15.8	22.9	67.2	24.7	24.9	27.4	21.1	31.3	19.9	37.5	38.4	15.7	50.8	13.5	23.3	55.3	19.9	21.9	15.7	53.8	24.2	106.8	21.3	21.9	23.2	32.2	58.4	23.3	13.0	41.1	13.9	40.3	44.5	8.3	31.9	8.7	12.0	35.4	18.7	23.3	16.9	17.9	15.8	58.3	24.2	22.8	22.3	19.4	18.9	17.4	21.2	19.5	36.1	22.6	45.5	33.3	22.8	26.6	18.1	17.8	20.5	30.1	16.8	28.6	60.0	31.4	27.7	22.1	44.4	28.0	29.1	6.4	25.2	15.6	31.9	40.1	17.8	30.7	31.5	26.1	27.4	27.8	24.2	29.7	17.6	27.1	31.3	83.4	82.6	150.6	116.2	120.3	70.8	20.7	79.0	139.2	124.0	94.2	84.4	99.1	142.6	96.9	85.2	85.7	52.6	93.5	95.8	104.8	89.7	121.1	94.9	140.5	76.9	54.0	83.7	48.5	68.2	129.1	124.8	89.2	111.3	118.2	83.8	139.0	101.0	71.9	124.8	130.8	97.6	77.6	122.7	77.9	84.3	131.6	93.7	107.1	78.7	109.8
TCEA3	TFIIS.H	ENSG00000204219	"Transcription elongation factor A3"	O75764	1	23381061-23424740	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 114.0"	"Cell type enhanced"	"Detected in many"	6	"Mucus-secreting cells: 307.1;Undifferentiated cells: 204.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 8.5;naive CD4 T-cell: 14.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.0;Hep G2: 33.2;OE19: 17.1;SiHa: 11.0;T-47d: 17.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044960, HPA055811"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044960: AB_10964053, HPA055811: AB_2682932"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-3)"	"unprognostic (9.18e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.77e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-3)"	"unprognostic (7.37e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.58e-2)"	5.4	17.8	2.5	10.7	1.9	0.1	3.6	1.5	1.5	9.1	12.2	2.2	12.0	4.6	3.8	14.5	12.0	6.2	13.0	20.3	2.4	0.8	12.1	38.0	6.0	1.3	1.2	2.3	19.8	60.4	4.5	3.3	2.5	2.2	16.7	12.5	8.7	32.7	15.9	114.0	8.9	11.9	13.7	2.0	1.6	11.5	2.6	1.3	0.5	8.6	58.3	16.0	8.4	6.9	0.0	2.8	0.0	0.7	0.2	14.3	2.5	0.0	0.1	0.3	0.3	1.7	10.0	5.5	3.9	2.5	2.1	1.2	2.5	0.3	0.1	0.4	4.8	0.6	5.4	0.4	0.0	1.8	0.0	0.0	0.0	4.1	33.2	1.2	0.4	0.0	6.5	1.8	1.8	0.0	4.5	0.2	0.0	0.0	0.0	0.6	0.9	0.2	3.6	0.0	17.1	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.1	11.0	0.5	0.4	1.0	17.5	1.6	0.2	0.0	0.1	0.4	0.0	0.3	2.9	0.0	0.3	0.3	0.3	0.0	0.1	0.0	0.5	0.7	0.5	0.0	8.5	1.2	2.8	0.0	14.3	6.3	0.0	0.2	0.2	0.9	0.7	2.5	2.5	1.9	1.5	1.5	2.4	0.8	1.2	2.3	2.2	1.3	116.1	83.2	2.2	44.3	24.4	1.5	92.9	68.8	45.5	71.7	40.1	2.0	3.0	169.1	22.0	4.7	12.7	145.7	0.0	86.0	28.5	32.8	62.5	9.2	177.9	1.2	23.8	53.7	9.8	7.3	7.2	15.8	16.2	23.6	2.8	307.1	2.9	40.2	98.2	14.5	173.6	1.5	19.4	20.6	0.5	3.5	47.9	1.8	6.1	204.2	55.5
TCEAL2	"my048, MY0876G05, WEX1"	ENSG00000184905	"Transcription elongation factor A like 2"	Q9H3H9	X	102125688-102127711	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;ovary: 46.5"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 143.3;Distal tubular cells: 59.7;Horizontal cells: 92.2;Muller glia cells: 150.4"	"Cancer enhanced"	"Detected in many"		"glioma: 22.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.1"	"Group enriched"	"Detected in some"	4	"HAP1: 7.4;SCLC-21H: 8.1;U-2 OS: 14.6"									HPA076317			Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA076317: AB_2686794"	"unprognostic (2.34e-3)"	"unprognostic (1.35e-2)"	"unprognostic (7.59e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.47e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.11e-3)"	2.4	19.6	34.1	2.6	44.6	1.1	2.4	40.9	84.0	5.8	7.0	8.5	1.8	3.1	19.5	8.6	5.3	7.3	6.4	5.1	30.0	37.9	8.2	1.3	4.4	1.6	25.4	26.5	46.5	3.7	2.8	38.3	1.1	30.1	19.4	3.8	6.6	16.4	21.6	1.2	1.7	3.2	14.0	16.1	2.9	4.2	19.7	9.6	0.0	25.6	0.0	2.1	4.3	2.6	0.1	0.1	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	1.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	14.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.8	0.1	1.7	0.0	0.1	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.1	0.4	34.1	44.6	40.9	41.8	30.0	37.9	25.4	26.5	30.1	9.6	6.0	12.3	0.0	55.7	1.6	143.3	4.6	0.0	0.0	22.7	29.6	5.9	0.0	59.7	0.1	2.9	8.7	0.0	0.0	0.3	0.1	5.3	42.5	2.3	0.0	0.0	92.2	0.0	3.7	0.0	7.5	6.1	1.0	6.8	1.0	0.0	150.4	1.6	0.0	5.3	0.5	40.9	6.5	17.0	1.7	1.1	1.1	0.0	0.0	0.0	6.3
TCEAL5	WEX4	ENSG00000204065	"Transcription elongation factor A like 5"	Q5H9L2	X	103273691-103276872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;testis: 45.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 41.1;Muller glia cells: 64.8;Peritubular cells: 33.6"	"Cancer enhanced"	"Detected in many"		"glioma: 13.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 7.5;SH-SY5Y: 23.4"									"HPA045564, HPA058982"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (1.30e-3)"	"unprognostic (2.41e-1)"		"prognostic unfavorable (9.09e-4)"	"unprognostic (9.68e-2)"	"unprognostic (8.75e-4)"		"unprognostic (1.21e-1)"		"unprognostic (8.11e-2)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.03e-4)"	2.0	11.2	21.9	2.1	31.8	1.3	3.3	32.7	56.4	4.7	2.2	6.6	0.0	1.9	6.0	7.8	1.5	1.6	2.0	2.0	22.3	23.1	1.5	1.3	1.5	1.3	13.0	24.0	5.0	2.1	1.3	23.1	1.3	19.8	3.7	2.0	1.4	2.3	5.4	1.4	1.3	2.4	4.3	11.0	1.3	1.5	45.9	8.4	0.0	3.4	0.0	1.3	2.1	1.1	0.7	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.2	0.0	0.1	0.0	0.0	21.9	31.8	32.7	31.9	22.3	23.1	13.0	24.0	19.8	8.4	0.0	0.0	0.0	0.3	0.1	41.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.4	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.2	1.6	0.0	0.0	0.0	11.5	7.8	0.6	0.0	0.0	0.0	64.8	0.0	0.0	33.6	0.0	5.6	0.0	0.9	2.8	1.7	0.3	0.3	0.0	0.0	0.1
TCEAL8	"MGC45400, WEX3"	ENSG00000180964	"Transcription elongation factor A like 8"	Q8IYN2	X	103252995-103255203	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059115	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059115: AB_2683909"	"unprognostic (1.51e-2)"	"unprognostic (4.56e-2)"	"unprognostic (9.24e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.71e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.80e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.32e-2)"	24.6	30.9	37.3	16.8	32.5	12.4	30.0	34.5	38.5	34.8	25.1	25.6	25.8	14.9	29.6	67.9	26.7	22.7	27.9	43.9	33.4	32.4	33.9	20.2	20.8	20.6	34.5	25.8	36.7	25.0	32.2	64.5	32.9	39.4	31.6	24.7	26.0	29.7	28.6	8.8	19.8	19.9	31.1	34.6	24.3	21.5	21.0	22.5	30.7	35.2	18.8	20.9	31.7	22.4	17.5	28.7	16.3	9.4	33.3	30.3	15.2	9.7	5.1	23.6	11.3	34.9	59.0	11.4	20.3	31.6	18.3	29.8	4.0	20.3	4.8	13.6	24.1	30.3	6.7	4.0	24.5	24.3	0.1	12.7	22.1	7.0	6.1	21.9	22.1	22.8	40.1	14.7	16.3	0.0	39.5	26.1	14.1	27.2	5.3	46.0	0.0	18.5	9.3	26.3	0.7	10.8	7.6	31.5	1.5	26.2	7.6	12.5	16.6	11.2	3.9	26.3	22.9	7.2	7.8	16.4	11.8	15.2	35.1	6.8	5.3	8.8	0.2	19.1	12.2	18.9	16.3	9.4	5.5	19.7	8.2	23.5	17.5	23.9	21.2	16.9	14.8	26.5	22.8	0.9	33.3	6.2	28.7	30.3	15.2	37.3	32.5	34.5	38.5	33.4	32.4	34.5	25.8	39.4	22.5	47.6	65.5	63.1	70.6	54.0	53.1	66.3	114.7	38.8	45.5	92.5	9.8	163.9	232.1	105.5	3.9	69.9	39.3	23.3	96.4	155.7	110.9	59.3	67.1	92.3	87.5	47.7	75.3	154.1	81.0	6.2	116.5	69.4	114.7	83.8	113.8	74.4	76.7	52.6	114.5	208.3	30.0	84.1	75.7	3.7	4.0	51.9	112.8	60.9	77.5	59.9
TCEAL9	"DKFZp313K1940, WBP5, WEX6"	ENSG00000185222	"Transcription elongation factor A like 9"	Q9UHQ7	X	103356489-103358462	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 939.8;Distal tubular cells: 305.1;Extravillous trophoblasts: 389.4;Syncytiotrophoblasts: 652.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011790	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA011790: AB_2214932"	"unprognostic (1.26e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.31e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.58e-2)"	28.2	61.0	17.9	14.7	20.9	3.7	42.1	20.7	24.0	30.8	20.6	10.9	35.0	7.6	32.3	59.6	21.4	20.1	25.6	29.4	19.5	20.5	38.8	12.6	25.9	9.5	23.7	15.0	93.4	15.7	19.6	54.5	67.1	40.3	27.6	17.7	15.2	15.7	45.4	7.8	12.1	11.7	30.2	44.1	26.4	23.1	27.5	23.6	5.4	58.6	18.5	7.6	35.5	75.7	1.8	18.6	0.9	1.3	1.1	3.5	1.3	17.8	8.8	28.0	14.3	60.7	59.2	21.0	37.7	50.5	26.8	43.9	17.0	19.1	0.0	56.0	30.8	49.5	10.8	4.8	24.0	36.1	0.0	10.4	18.3	21.6	10.9	41.8	0.0	0.0	40.5	23.4	35.7	35.8	46.9	44.4	7.8	16.2	1.3	63.4	0.0	8.9	0.1	17.4	0.0	17.0	0.0	55.9	0.0	32.3	33.3	12.7	15.3	23.7	0.7	24.6	31.5	3.8	1.0	36.1	23.9	10.4	71.9	10.4	0.0	1.0	0.1	58.1	0.0	19.0	0.9	1.3	0.0	0.2	0.7	0.0	1.8	1.5	0.5	1.0	1.0	3.5	2.9	0.0	1.1	0.1	18.6	0.9	1.3	17.9	20.9	20.7	24.0	19.5	20.5	23.7	15.0	40.3	23.6	160.8	68.5	0.0	0.0	0.0	0.0	0.0	0.0	18.7	86.4	221.6	0.0	939.8	305.1	198.1	0.0	0.0	0.0	0.0	124.7	389.4	0.0	0.0	10.5	0.0	127.3	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	6.4	0.0	0.0	126.5	0.0	0.0	165.0	0.0	0.0	0.0	0.0	0.0	0.0	652.4	0.0	0.0	0.0
TCEANC	MGC17403	ENSG00000176896	"Transcription elongation factor A N-terminal and central domain containing"	Q8N8B7	X	13653189-13681964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000337, HPA001013"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA000337: , HPA001013: AB_1079371"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.29e-3)"	"unprognostic (4.03e-2)"	"unprognostic (4.29e-6)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.11e-4)"	2.2	2.4	2.1	1.1	2.1	6.3	3.9	3.3	1.8	2.1	1.6			1.3	2.3	5.0	1.1	2.8	1.2	2.0	1.9	2.3	2.1	2.8	2.5	3.6	2.1		4.1	2.7	1.6	2.3	1.5		2.1	2.1		2.3	1.7	2.6	2.0	2.5	2.1	2.4	4.4	1.9	1.0			3.1		2.8	1.9	1.6	5.6	3.7	9.9	2.7	2.4	6.1	3.1	0.7	2.2	2.4	4.2	5.2	6.1	0.9	0.7	1.9	2.0	0.9	0.8	1.7	2.5	2.3	1.6	1.2	1.2	2.1	1.2	0.5	2.6	3.1	1.4	1.3	1.1	2.8	2.0	2.5	5.2	2.0	1.1	8.5	2.9	0.6	2.6	2.5	4.3	2.8	1.8	3.3	2.0	3.2	1.2	0.6	2.6	2.2	5.2	1.1	1.3	2.5	2.3	2.2	2.3	3.0	3.1	2.4	1.9	1.1	1.7	0.9	1.7	0.3	3.5	2.0	1.7	2.5	1.2	0.9	9.9	2.7	6.8	4.7	2.2	5.1	5.6	5.1	6.1	2.2	5.2	6.1	5.6	3.4	2.4	2.4	3.7	5.8	3.1											0.0	1.4	1.4	0.9	0.2	3.3	2.4	2.5	1.4	2.3	3.5	2.0	1.6	3.3	1.2	0.0	1.6	1.3	0.0	0.8	0.9	1.4	1.7	4.7	3.4	1.7	1.6	2.4	1.3	2.1	0.0	3.1	2.5	0.0	2.8	1.5	4.8	0.4	1.5	2.1	2.5	2.4	0.0	1.2	1.1	0.4	0.3	2.7	3.5	1.3	0.7
TCEANC2	"C1orf83, FLJ32112"	ENSG00000116205	"Transcription elongation factor A N-terminal and central domain containing 2"	Q96MN5	1	54053587-54112519	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 24.1;Early spermatids: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046918	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046918: AB_2679864"	"unprognostic (2.80e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.73e-5)"	"unprognostic (8.64e-2)"	"unprognostic (7.93e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.57e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.08e-1)"	5.9	5.9	7.9	7.6	11.1	6.5	5.9	3.0	7.9	6.1	5.4	13.4	6.6	6.8	5.3	6.2	7.9	5.2	4.4	4.4	8.3	6.4	7.2	4.7	4.8	9.4	10.2	4.5	4.3	6.4	6.6	6.2	6.0	8.8	5.1	8.1	6.5	5.5	4.1	9.4	6.8	6.4	6.3	14.1	8.2	5.2	15.4	8.8	15.7	5.7	3.0	10.8	7.3	5.1	7.8	7.6	10.1	8.9	10.2	6.3	3.8	5.2	2.3	5.9	4.9	4.0	6.3	5.7	5.6	4.3	6.3	5.6	1.4	3.3	4.6	4.9	2.4	6.3	5.3	7.8	4.3	8.0	10.2	4.2	6.8	5.5	2.7	2.5	5.0	6.9	4.7	3.7	5.5	3.2	2.8	8.1	10.6	6.7	4.3	5.2	1.9	10.0	3.7	13.7	5.8	3.9	10.0	10.8	6.8	2.3	3.1	5.1	5.4	3.6	5.6	6.7	8.7	5.5	9.5	4.2	5.7	3.6	5.5	6.8	10.0	14.3	6.4	4.8	6.9	7.1	5.9	7.3	10.1	4.7	8.9	4.6	7.3	5.4	5.8	7.6	7.8	6.3	6.2	9.4	10.2	6.5	6.9	4.1	3.8	7.9	11.1	3.0	7.9	8.3	6.4	10.2	4.5	8.8	8.8	8.9	9.1	0.8	1.5	0.6	3.0	7.5	10.2	24.1	7.9	10.4	11.8	4.9	1.7	2.9	22.3	4.4	3.3	0.0	1.6	5.2	3.1	1.7	2.3	4.0	4.2	7.9	3.5	2.5	6.3	18.0	2.8	3.7	1.7	6.4	4.4	3.1	3.2	3.5	2.8	3.4	3.1	0.0	2.5	12.7	2.6	0.9	3.3	5.1	4.4	1.4
TCERG1L	FLJ38950	ENSG00000176769	"Transcription elongation regulator 1 like"	Q5VWI1	10	131092391-131311721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.7;thyroid gland: 24.1"	"Cell type enriched"	"Detected in some"	10	"Horizontal cells: 96.9"	"Cancer enriched"	"Detected in some"	14	"thyroid cancer: 20.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.4;NTERA-2: 1.4;RPMI-8226: 2.2;SuSa: 4.3;U-2 OS: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030816			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030816: AB_10601721"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.69e-2)"		"unprognostic (1.62e-1)"	"unprognostic (4.96e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.03e-1)"	0.4	1.9	2.7	0.4	4.1	0.4	0.6	3.0	9.7	0.5	0.4	0.0	0.0	0.4	0.6	1.1	0.6	0.4	0.4	0.4	3.8	3.5	0.4	0.4	0.5	0.4	0.9	3.9	5.5	0.8	0.4	4.8	0.4	1.5	1.4	0.4	3.8	0.3	1.3	0.3	1.2	0.4	0.4	2.2	0.6	0.5	1.8	0.0	0.6	24.1	0.0	0.6	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	4.1	3.0	9.7	3.8	3.5	0.9	3.9	1.5	0.0	0.0	0.0	0.0	0.1	0.6	4.5	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.6	0.0	0.0	0.0	96.9	0.0	0.0	0.0	0.0	4.4	0.0	10.1	0.0	0.0	0.8	0.1	0.0	4.2	0.0	3.6	0.0	0.0	0.1	4.7	0.5	0.1	0.0	0.0	0.0
TCF19	SC1	ENSG00000137310	"Transcription factor 19"	Q9Y242	6	31158542-31167159	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.3"	"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 33.2;GAMG: 19.8;HEK 293: 18.7;JURKAT: 17.0;Karpas-707: 16.2;SCLC-21H: 20.6;U-138 MG: 20.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA065994			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA065994: "	"unprognostic (1.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (3.54e-10)"	"unprognostic (3.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.21e-1)"	4.3	1.5	1.3	12.4	4.1	2.3	5.2	8.2	3.9	7.0	5.6	2.3	3.7	9.2	4.2	6.2	11.2	3.2	3.8	3.4	1.7	1.1	4.3	1.6	4.8	18.0	3.0	1.0	4.6	3.6	0.4	0.9	1.5	2.0	5.5	4.0	2.3	4.1	6.7	2.5	11.5	6.0	3.9	1.8	8.6	5.9	3.1	1.8	31.3	2.8	14.4	13.8	4.8	6.7	2.0	0.9	0.2	0.3	1.2	3.8	1.2	33.2	0.3	0.3	0.0	2.3	3.0	0.3	0.2	0.0	0.0	0.0	2.1	0.0	0.0	7.5	8.2	19.8	0.0	0.0	12.4	0.0	0.2	18.7	2.9	1.9	0.8	0.0	0.1	8.8	1.2	0.0	0.9	0.0	1.8	7.4	17.0	0.0	16.2	3.2	0.1	0.4	5.3	0.0	0.0	0.0	0.4	2.0	0.2	2.9	0.1	20.6	0.2	0.2	0.0	0.2	2.7	0.0	2.4	0.0	20.6	0.1	0.1	0.1	5.3	6.0	10.2	0.0	0.1	0.1	0.0	0.3	0.0	0.7	0.0	3.8	1.6	1.9	3.4	0.9	2.0	2.4	0.9	0.2	1.2	0.1	0.0	2.6	1.2	1.3	4.1	8.2	3.9	1.7	1.1	3.0	1.0	2.0	1.8	3.0	1.1	6.0	2.1	4.5	2.6	1.2	0.0	0.0	3.4	3.5	0.0	0.6	6.6	1.6	0.3	3.3	1.1	0.0	1.6	7.2	2.7	1.0	1.1	0.2	7.5	1.6	1.2	1.3	1.9	0.4	4.6	4.3	11.8	10.0	3.3	3.3	0.8	0.0	6.0	0.3	0.5	0.0	6.8	0.5	12.8	3.3	0.3	5.1	7.7	0.9
TCF23	"bHLHa24, OUT"	ENSG00000163792	"Transcription factor 23"	Q7RTU1	2	27149004-27156974	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 28.0;endometrium 1: 56.4;ovary: 49.9"	"Group enriched"	"Detected in some"	4	"Peritubular cells: 27.3;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in single"	10	"THP-1: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044596			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA044596: AB_10797258"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.41e-5)"	"unprognostic (7.58e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.58e-4)"	"unprognostic (2.64e-2)"	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	28.0	0.5	0.0	0.5	0.0	56.4	7.2	0.1	14.0	0.4	0.6	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	49.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	16.7	0.1	6.2	0.1	7.5	0.0	0.0	0.1	0.0	0.0	0.7	1.5	1.8	1.4	4.4	1.0	1.3	1.2	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.4	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.0	0.5	0.1	0.6	0.3	0.0	0.1	0.9	0.1	0.7	0.0	0.3	0.2	0.1	0.2	0.3	0.1	0.3	0.3	8.8	0.0	0.2	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.0	4.4	1.0	0.9	1.0	0.5	0.8	1.1	1.1	0.8	0.2	1.8	1.2	1.0	3.9	1.3	0.5	1.4	0.6	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	2.1	0.0	0.5	0.0	0.1	0.6	0.0	0.0	1.2	0.0	2.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	1.8	0.3	0.7	9.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	27.3	0.0	0.5	51.8	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.5
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222331-55664787	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease mutation, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.8"	"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 425.9;Muller glia cells: 397.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"memory B-cell: 29.7;naive B-cell: 22.0;plasmacytoid DC: 85.8"	"Group enriched"	"Detected in many"	36	"B-cells: 29.7;dendritic cells: 85.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.4;SH-SY5Y: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavorable (9.95e-4)"	34.6	16.0	20.3	14.4	17.0	10.7	23.5	48.7	32.4	35.4	13.5	14.9	12.0	6.6	27.4	9.6	12.5	16.9	20.4	19.9	23.5	11.9	6.0	6.2	21.9	16.8	16.7	20.3	31.8	7.2	16.2	15.7	32.8	16.1	9.5	10.1	9.2	9.4	13.2	12.1	12.2	10.7	28.4	15.0	14.6	7.4	17.0	17.5	6.4	16.4	12.7	17.0	18.3	14.5	29.7	85.8	0.3	1.2	1.5	0.1	1.7	0.0	1.1	12.0	3.6	2.8	5.0	0.0	6.0	13.4	4.3	5.7	7.4	1.1	9.2	0.0	13.3	0.9	1.5	5.5	5.3	3.0	42.4	4.1	3.6	0.0	0.0	1.3	1.6	0.9	6.5	1.7	6.0	0.2	2.9	15.6	0.5	5.9	6.9	3.7	0.0	2.2	0.0	3.5	0.0	0.7	13.5	5.0	20.5	0.0	0.2	4.2	53.7	0.0	0.5	0.0	3.8	0.5	0.4	15.7	16.3	5.7	0.6	4.7	5.2	9.7	8.2	3.6	1.6	4.7	0.1	1.1	0.1	0.1	1.2	0.1	29.7	0.0	0.0	3.3	22.0	0.0	0.0	0.3	1.5	1.1	85.8	0.1	1.7	20.3	17.0	48.7	26.9	23.5	11.9	16.7	20.3	16.1	17.5	6.0	19.1	128.9	31.3	103.9	238.0	27.8	2.5	30.8	38.7	21.0	78.5	1.9	0.0	1.2	78.3	425.9	0.0	0.0	6.2	1.2	151.6	15.4	12.8	4.4	33.4	23.8	5.2	251.0	98.7	90.2	190.1	63.0	60.8	33.3	0.0	397.9	3.2	0.0	171.1	1.7	54.4	232.8	142.8	6.7	4.4	73.8	2.2	1.9	0.0	10.9
TCF7L1	TCF3	ENSG00000152284	"Transcription factor 7 like 1"	Q9HCS4	2	85133410-85310388	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 37.8;Ito cells: 37.4;Leydig cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.2;NTERA-2: 42.5;RH-30: 19.3;T-47d: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071298			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA071298: AB_2686383"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (6.16e-5)"	"unprognostic (1.79e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.06e-4)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (5.38e-4)"	21.0	3.9	3.3	6.5	6.4	4.2	28.7	5.1	5.3	28.2	14.7	7.5	14.5	4.1	21.2	11.8	13.8	10.4	9.1	11.6	6.0	3.0	9.3	7.6	11.1	5.5	4.5	3.8	20.3	3.2	11.6	5.7	4.8	6.3	14.0	4.3	16.8	8.8	19.6	13.4	8.3	6.9	17.8	5.9	7.9	6.8	7.3	5.5	2.2	18.6	8.7	6.1	18.0	20.4	3.7	2.0	8.4	1.2	1.8	2.2	0.4	0.9	0.7	14.5	11.0	5.5	1.1	8.8	1.0	3.6	2.5	2.3	2.1	0.9	0.4	1.7	2.3	2.8	2.3	11.0	18.2	1.7	0.8	1.8	0.3	0.8	0.9	0.5	0.8	2.2	0.9	3.4	0.2	0.6	1.2	4.8	0.7	0.3	0.8	2.9	0.6	0.0	0.8	42.5	0.5	0.4	0.3	19.3	0.2	1.2	1.6	0.5	4.5	1.7	7.4	0.5	11.7	18.9	0.3	5.2	2.8	4.2	0.2	1.3	0.5	0.2	0.3	0.1	0.5	2.2	8.4	1.2	2.2	1.2	1.0	1.5	2.1	1.4	1.6	0.4	3.7	1.7	2.2	3.4	1.8	1.0	2.0	1.1	0.4	3.3	6.4	5.1	4.0	6.0	3.0	4.5	3.8	6.3	5.5	6.0	37.8	0.0	11.9	5.4	0.0	6.2	5.1	9.4	11.4	15.7	0.0	5.3	0.0	3.0	22.5	21.0	0.7	0.0	5.0	4.0	12.1	7.6	4.7	5.9	1.5	0.0	0.0	37.4	6.6	3.6	60.4	2.8	3.3	1.8	1.7	5.2	1.3	0.0	26.9	1.4	0.2	6.5	18.1	1.9	10.9	3.0	1.1	0.5	1.2	2.2
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950250-113167678	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 184.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 12.1;non-classical monocyte: 33.1"	"Lineage enriched"	"Detected in many"	13	"monocytes: 33.1"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"midbrain: 84.5;thalamus: 98.3"	"Group enriched"	"Detected in all"	5	"midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	27.4	10.3	8.7	18.7	10.0	7.3	46.4	5.4	10.3	27.4	34.2	15.4	28.1	21.0	26.6	14.9	12.6	18.2	15.3	13.5	8.1	17.9	10.2	22.9	26.9	13.9	8.5	9.0	25.6	13.9	16.5	17.9	24.0	10.2	14.4	23.7	13.9	14.9	52.8	13.7	17.6	40.4	18.0	13.9	27.3	24.0	10.6	10.1	6.6	14.3	9.3	7.0	21.5	16.3	0.0	1.7	2.5	33.1	0.0	0.6	1.1	7.1	18.6	20.4	19.7	10.7	7.1	24.4	5.1	9.9	3.5	4.3	12.3	21.6	0.0	5.7	9.5	4.8	5.1	6.9	8.8	4.5	0.8	6.4	5.0	12.4	11.3	11.4	1.9	1.8	12.6	3.2	5.5	9.4	15.1	5.9	4.2	5.2	0.3	4.1	13.9	3.2	1.2	14.6	8.0	10.7	9.0	15.0	3.2	7.7	9.9	0.4	6.3	7.7	7.6	8.1	16.5	4.9	1.1	13.7	3.3	9.6	8.5	10.4	1.3	0.1	0.1	3.3	4.2	7.4	0.1	1.8	0.1	0.6	12.1	0.4	0.0	0.1	0.5	1.7	0.0	0.1	0.3	2.5	0.0	33.1	0.0	0.0	1.1	8.7	10.0	5.4	10.3	8.1	17.9	8.5	9.0	10.2	10.1	20.8	21.6	4.7	23.8	37.8	2.4	10.6	35.7	20.1	34.2	38.4	5.9	36.9	10.0	28.5	5.5	37.0	121.0	0.0	38.6	184.2	40.4	33.1	0.0	57.7	15.1	4.8	19.0	55.3	68.7	2.7	54.7	21.0	30.4	1.0	68.2	36.6	41.7	91.2	45.6	13.4	5.7	90.5	44.3	3.0	23.4	34.8	23.8	4.3	42.7	42.0
TCHHL1	"S100A17, THHL1"	ENSG00000182898	"Trichohyalin like 1"	Q5QJ38	1	152084144-152089064	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 1.7;skin 1: 3.8;tongue: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"SK-BR-3: 10.7"					"Not detected"	"Not detected"			"HPA042579, HPA063483"	Enhanced		Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane, Nucleoli"		"HPA042579: AB_10794283, HPA063483: AB_2685021"						"unprognostic (8.21e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCHP	"MGC10854, TpMs"	ENSG00000139437	"Trichoplein keratin filament binding"	Q9BT92	12	109900264-109983841	"Predicted intracellular proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038638, HPA061543"	Supported		Supported	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Centrosome, Cytosol"		"HPA038638: AB_10670785, HPA061543: AB_2684556"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	8.6	10.4	16.0	11.3	29.3	8.3	9.3	22.9	25.0	10.2	11.2	19.0	7.5	9.9	13.0	10.9	18.3	8.7	8.3	10.3	15.9	11.0	8.5	7.0	10.0	14.5	23.8	13.9	11.3	12.7	12.1	12.1	10.4	18.6	10.7	9.6	11.0	13.4	11.6	10.8	36.1	10.2	15.0	15.9	15.0	10.2	12.5	24.2	10.9	12.0	7.7	15.1	11.4	15.4	3.2	3.3	4.5	5.2	9.2	7.4	4.4	16.2	14.6	7.9	9.4	7.0	7.6	10.6	15.5	8.2	13.6	7.6	9.1	5.7	22.9	4.5	9.0	7.4	13.7	8.6	9.7	12.3	12.2	8.4	16.6	9.0	8.9	8.5	22.4	12.7	6.2	12.0	14.2	10.8	8.6	12.1	14.5	17.8	4.6	11.2	11.2	20.4	22.8	9.5	4.0	14.8	18.8	15.5	19.3	6.1	14.7	11.7	12.4	11.3	12.2	10.9	5.9	11.0	16.3	13.3	13.9	9.7	8.9	19.7	13.4	16.9	16.4	14.8	18.6	14.5	0.0	4.2	3.4	6.2	2.7	4.3	3.2	5.4	7.4	3.3	2.3	5.4	4.2	4.5	9.2	5.2	2.4	7.2	4.4	16.0	29.3	22.9	25.0	15.9	11.0	23.8	13.9	18.6	24.2	17.9	18.4	6.7	7.8	8.8	25.8	12.2	15.3	36.1	11.4	7.0	17.7	9.1	8.3	17.1	25.7	12.1	10.7	23.3	13.3	7.9	7.2	6.6	12.7	6.6	10.1	23.8	14.3	6.2	12.9	33.9	10.3	9.7	6.8	12.6	9.2	14.6	13.8	10.5	26.2	4.3	23.5	12.9	10.0	18.4	34.3	21.7	5.8	14.9	9.8	34.8
TCIM	"C8orf4, hTC-1, TC-1, TC1"	ENSG00000176907	"Transcriptional and immune response regulator"	Q9NR00	8	40153455-40155308	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	21	"Alveolar cells type 2: 796.6;Collecting duct cells: 190.1;Distal tubular cells: 164.2;Ductal cells: 262.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 14.6;AF22: 41.5;BJ: 15.6;BJ hTERT+: 40.9;EFO-21: 27.2;HeLa: 26.1;RPTEC TERT1: 20.7;SuSa: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027188	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027188: AB_10601150"	"unprognostic (8.88e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.48e-2)"	23.5	5.9	1.8	23.2	4.5	0.0	16.0	0.6	5.9	32.1	24.1	1.0	15.6	6.0	14.3	20.3	22.2	4.3	22.1	38.3	2.0	1.7	44.5	54.7	96.5	5.0	2.7	4.3	11.9	24.4	28.9	6.2	50.2	2.3	29.6	15.2	7.9	89.9	16.3	20.2	4.0	21.2	72.4	4.3	26.7	10.7	4.9	1.4	1.3	15.8	14.4	4.8	35.8	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	41.5	0.0	0.0	0.0	0.1	15.6	40.9	0.0	0.2	0.2	0.0	0.0	27.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	26.1	6.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	1.4	0.0	16.3	0.0	0.0	13.1	0.0	0.4	0.1	0.2	0.3	0.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.5	0.6	5.9	2.0	1.7	2.7	4.3	2.3	1.4	92.3	796.6	0.0	0.0	0.0	0.0	0.0	0.0	16.0	142.1	190.1	0.0	1.4	164.2	262.6	0.0	0.0	0.0	0.0	95.4	11.4	0.0	0.0	24.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	8.2	0.0	0.0	112.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
TCIRG1	"a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7"	ENSG00000110719	"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3"	Q13488	11	68039016-68050895	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 102.9;Kupffer cells: 127.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.6;RPMI-8226: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038742	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038742: AB_10795138"	"unprognostic (5.35e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.50e-11)"	"unprognostic (2.48e-3)"	"unprognostic (7.88e-3)"	"unprognostic (2.50e-1)"	"prognostic favorable (9.45e-6)"	25.8	24.1	5.0	20.1	7.2	39.5	10.2	1.3	5.4	20.1	21.8	3.9	19.9	20.1	14.1	27.1	11.9	12.5	16.4	5.9	2.4	1.6	8.9	25.2	24.1	20.7	7.1	2.2	11.4	69.6	2.6	4.7	14.4	6.9	15.7	4.1	6.8	18.3	11.0	3.5	5.2	25.8	10.8	7.7	44.7	17.4	4.2	5.5	7.5	11.7	8.3	24.3	13.0	13.4	3.3	13.4	40.4	36.8	8.2	4.9	10.7	9.2	17.1	0.2	0.0	7.9	6.2	12.0	18.4	9.0	5.3	5.0	0.3	27.8	0.8	10.1	6.5	8.1	11.7	1.1	7.1	1.1	24.1	0.5	6.4	20.8	5.5	7.3	4.7	40.6	7.2	4.1	6.5	0.4	0.0	3.6	0.3	3.3	2.5	1.7	3.1	0.2	28.2	1.0	13.2	4.3	7.9	0.3	40.4	5.0	5.2	0.9	0.2	7.8	10.2	5.0	1.9	11.1	12.1	12.6	10.3	8.1	28.6	3.3	0.4	0.3	1.3	23.0	7.9	4.9	5.5	16.6	18.8	4.5	28.8	3.7	3.3	3.4	4.9	13.4	2.2	2.0	2.1	40.4	8.2	36.8	9.0	3.3	10.7	5.0	7.2	1.3	5.4	2.4	1.6	7.1	2.2	6.9	5.5	26.8	66.3	28.6	11.5	5.6	0.7	1.2	17.8	29.4	27.3	7.0	0.0	18.1	0.0	29.8	0.3	15.8	46.0	0.0	58.5	45.5	19.9	9.3	48.5	16.3	102.9	0.0	23.0	17.8	127.9	0.2	5.5	82.1	5.0	46.9	25.2	0.9	44.8	87.7	12.4	2.1	0.7	38.8	16.5	0.1	3.0	4.5	22.2	49.4	25.3	17.1
TCL1B	TML1	ENSG00000213231	"T cell leukemia/lymphoma 1B"	O95988	14	95686417-95692643	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3"	"Cell type enriched"	"Detected in some"	13	"Syncytiotrophoblasts: 60.8"	"Cancer enriched"	"Detected in single"	72	"testis cancer: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"naive B-cell: 13.0;plasmacytoid DC: 5.9"	"Group enriched"	"Detected in many"	23	"B-cells: 13.0;dendritic cells: 5.9"	"Cell line enriched"	"Detected in some"	7	"U-698: 104.8"					"Not detected"	"Not detected"			HPA053163	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA053163: AB_2682064"															"unprognostic (1.55e-1)"			0.1	0.2	0.1	0.9	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	1.4	0.4	0.1	0.0	0.1	0.1	0.1	1.1	0.1	0.1	5.3	0.1	0.0	0.2	0.1	0.0	0.1	12.7	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.1	1.8	0.1	7.3	0.0	0.0	0.1	0.0	5.4	0.1	0.1	13.0	5.9	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	104.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.3	0.4	0.0	5.9	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.7	0.0	60.8	0.0	0.0	0.0
TCN2	"D22S676, D22S750, TC2"	ENSG00000185339	"Transcobalamin 2"	P20062	22	30606838-30627278	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 104.9;Ito cells: 111.1;Kupffer cells: 140.0;Proximal tubular cells: 115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 19.2;intermediate monocyte: 29.0;non-classical monocyte: 9.8"	"Lineage enriched"	"Detected in many"	8	"monocytes: 29.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 35.3;HUVEC TERT2: 41.4;Karpas-707: 53.8;RPTEC TERT1: 20.9;TIME: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000837			Approved	Cytosol	"Secreted to blood"	NA	NA		13000000	Cytosol		"HPA000837: AB_1080235"	"unprognostic (6.43e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.53e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.95e-3)"	"unprognostic (4.94e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	39.8	15.2	6.5	7.2	8.1	2.2	30.0	3.4	10.9	13.1	14.8	9.2	9.6	10.9	15.0	23.9	7.0	11.2	31.7	15.8	6.6	7.3	73.2	8.7	21.7	43.3	8.6	8.5	7.8	6.3	5.7	7.9	8.7	10.7	9.6	13.5	13.5	6.8	23.0	5.4	4.5	30.4	17.6	9.0	24.8	8.4	9.7	5.1	1.9	12.8	4.8	4.6	11.6	10.9	0.0	3.4	0.6	29.0	0.0	0.3	6.5	0.0	2.6	12.1	0.0	7.2	35.3	0.4	0.8	8.8	2.2	3.7	1.2	6.1	0.1	13.4	1.7	0.2	0.4	1.0	0.6	0.7	0.0	0.6	0.0	0.3	0.5	17.3	0.1	9.9	5.8	0.7	1.7	1.5	2.5	41.4	0.0	0.2	53.8	3.6	0.0	0.0	0.9	4.7	3.3	0.3	1.3	1.7	18.1	20.9	0.3	4.2	0.5	0.0	0.1	3.5	0.8	0.1	0.5	24.2	7.8	1.0	0.9	0.3	1.4	0.3	0.0	2.7	0.4	0.1	0.0	19.2	0.0	0.0	29.0	0.3	0.0	0.3	0.2	3.4	0.0	0.1	0.2	0.6	0.0	9.8	0.6	0.1	6.5	6.5	8.1	3.4	10.9	6.6	7.3	8.6	8.5	10.7	5.1	3.0	3.8	6.0	0.8	4.6	7.3	5.0	35.7	2.7	4.5	12.2	19.6	0.4	6.6	5.9	0.8	59.1	104.9	0.0	5.2	0.7	11.2	2.0	4.6	5.0	40.3	1.6	6.4	111.1	140.0	1.0	9.8	32.3	21.9	7.2	23.3	6.0	5.6	49.1	9.2	115.0	28.1	12.9	4.7	0.7	7.8	4.5	0.3	2.1	10.0	2.4
TCP11L1	FLJ11336	ENSG00000176148	"T-complex 11 like 1"	Q9NUJ3	11	33039417-33105943	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005769	Approved		Approved	Cytosol		NA	Yes			Cytosol		"HPA005769: AB_2202398"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.99e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.50e-3)"	12.0	10.1	13.0	10.2	19.2	12.8	14.1	15.0	25.3	10.4	15.1	14.7	9.3	11.7	11.1	6.9	9.8	8.2	15.5	10.6	13.9	14.9	11.6	8.1	9.4	8.8	16.8	16.1	11.1	12.6	9.9	12.5	13.3	21.2	10.3	14.4	7.4	8.7	14.4	6.6	10.4	22.9	16.8	16.2	9.8	10.0	10.3	11.1	8.1	7.4	5.0	10.7	10.6	10.9	2.6	11.1	13.1	6.1	4.5	5.7	3.1	6.8	12.5	6.3	6.0	11.0	12.4	4.3	10.0	8.4	7.7	10.4	6.4	3.3	6.9	2.8	19.2	11.5	11.0	8.4	7.7	10.9	8.9	6.7	4.5	13.8	4.6	7.2	4.3	6.4	10.0	9.7	7.9	15.1	8.8	7.5	10.1	2.9	8.4	19.2	9.9	4.6	1.8	4.7	5.1	4.6	5.4	13.1	1.2	7.0	2.6	5.2	10.7	25.2	16.4	4.6	8.5	4.0	1.9	11.4	13.6	19.8	15.2	10.4	10.5	10.3	8.0	9.8	2.3	10.6	13.1	6.1	8.3	3.6	3.7	3.5	2.2	2.0	4.0	5.9	2.6	2.0	2.6	3.6	4.5	0.9	11.1	5.7	3.1	13.0	19.2	15.0	22.9	13.9	14.9	16.8	16.1	21.2	11.1	8.9	0.6	3.0	8.6	2.1	7.2	2.8	5.1	0.0	1.2	0.0	3.9	2.7	1.7	3.6	8.4	3.5	4.2	0.0	3.5	17.4	3.2	3.9	4.6	1.3	5.8	7.9	1.7	4.9	5.3	4.5	1.7	3.7	0.0	31.5	1.0	1.5	5.1	1.5	2.5	4.4	4.9	0.0	7.3	7.6	5.5	2.3	3.9	5.0	1.2	3.3
TCTA		ENSG00000145022	"T cell leukemia translocation altered"	P57738	3	49412206-49416475	"Disease related genes, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007342	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA007342: AB_2202399"	"unprognostic (5.58e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.17e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (3.74e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.00e-15)"	"unprognostic (1.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.41e-3)"	15.4	29.3	21.8	9.2	21.9	7.9	16.3	12.5	26.1	18.3	16.9	23.1	19.5	14.0	13.6	46.9	12.8	20.1	19.3	13.1	20.6	20.8	35.6	27.2	17.2	14.3	23.2	18.5	19.4	18.5	17.9	28.4	19.1	22.2	25.2	21.8	23.3	16.0	20.0	10.5	7.8	19.4	16.5	25.6	15.1	16.3	9.3	12.8	12.6	34.1	10.2	11.4	13.0	8.9	9.5	10.1	14.6	28.0	13.4	13.0	13.4	5.9	7.3	4.8	7.1	21.2	9.3	6.3	12.3	9.2	12.6	10.6	4.3	6.5	7.1	9.1	29.1	14.5	6.9	9.3	12.4	10.3	10.6	6.4	11.8	9.6	5.5	12.8	5.1	15.6	20.0	13.0	13.9	11.2	12.1	12.9	5.7	4.3	16.3	30.6	5.5	6.1	4.5	3.9	11.3	17.1	3.7	5.2	16.7	21.5	7.9	12.8	4.2	14.7	16.3	13.4	10.1	13.9	4.8	11.7	9.5	5.9	19.6	4.6	9.0	11.8	4.8	22.3	9.0	13.0	12.7	11.5	14.6	13.0	21.9	7.6	8.0	8.4	10.0	6.6	9.5	10.4	11.0	13.2	13.4	28.0	10.1	10.7	13.4	21.8	21.9	12.5	26.1	20.6	20.8	23.2	18.5	22.2	12.8	23.8	17.0	11.9	9.0	2.4	10.1	11.0	25.5	29.4	12.5	26.2	11.8	21.6	39.7	13.5	5.9	10.8	32.5	0.0	10.0	10.1	10.8	18.7	5.7	27.2	21.4	9.5	16.8	12.3	20.2	11.1	14.4	13.1	13.5	16.2	16.3	20.7	12.8	21.0	15.2	42.1	10.7	6.5	15.1	7.2	6.1	4.0	16.7	20.1	15.1	7.0
TCTEX1D2	MGC33212	ENSG00000213123	"Tctex1 domain containing 2"	Q8WW35	3	196291219-196318299	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 37.4"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 301.2;Distal tubular cells: 102.8;Early spermatids: 174.6;Spermatocytes: 192.1;Spermatogonia: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 16.6;dendritic cells: 10.9;T-cells: 18.3"	"Cell line enhanced"	"Detected in many"		"T-47d: 38.9"									HPA049555			Approved	Cytosol		NA	NA			Cytosol		"HPA049555: AB_2680816"	"unprognostic (1.16e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (5.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.61e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	4.3	7.4	20.5	5.1	21.6	5.3	7.0	15.0	18.3	5.2	5.3	7.0	7.2	4.7	8.4	10.4	10.7	37.4	6.3	6.3	15.4	18.6	11.8	2.3	9.1	9.1	12.1	15.8	8.7	6.6	6.8	18.8	4.1	10.6	6.4	4.9	6.8	7.6	6.2	3.1	9.2	3.0	5.3	8.7	4.1	5.2	24.2	8.1	6.8	11.2	5.1	6.5	4.9	5.9	16.6	10.9	1.4	2.3	2.9	18.3	5.6	13.6	10.2	15.7	10.2	4.1	8.1	2.2	5.6	3.2	6.0	6.7	3.5	16.7	8.8	10.3	4.0	2.3	14.4	6.4	5.1	5.6	7.7	5.7	3.4	10.1	1.4	4.5	2.2	0.3	4.0	13.5	4.9	6.2	10.9	3.5	17.2	4.9	4.4	11.5	33.5	11.5	11.3	11.1	12.7	19.4	14.5	3.1	3.6	12.8	5.6	19.8	16.7	12.7	6.4	11.2	6.5	38.9	6.5	7.9	5.8	2.5	2.3	6.5	7.5	14.3	18.9	17.4	4.3	9.9	0.0	2.3	1.2	9.2	0.8	5.6	16.6	11.6	7.3	6.0	9.5	7.4	7.3	1.4	2.9	0.6	10.9	18.3	5.6	20.5	21.6	15.0	18.3	15.4	18.6	12.1	15.8	10.6	8.1	8.9	6.9	10.0	18.9	14.7	17.4	5.0	30.6	301.2	39.8	34.9	9.8	24.1	102.8	23.6	174.6	10.5	4.0	0.0	9.4	7.0	11.6	10.3	8.1	3.4	13.5	28.6	24.6	14.7	3.2	30.9	16.1	6.3	18.6	19.8	9.5	29.8	9.2	3.5	29.4	35.2	18.4	12.9	7.3	192.1	110.5	15.9	5.1	11.5	11.9	14.4
TCTN1	"FLJ21127, JBTS13, TECT1"	ENSG00000204852	"Tectonic family member 1"	Q2MV58	12	110614027-110649430	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 186.0;Spermatocytes: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039687, HPA040036"	Approved		Approved	"Nucleoplasm,Actin filaments"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Actin filaments"		"HPA039687: AB_10795293, HPA040036: AB_10794759"	"unprognostic (2.54e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (2.89e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (9.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.27e-2)"	8.0	12.4	11.2	5.1	13.8	3.0	8.9	5.6	10.1	17.7	5.4	12.3	20.6	4.1	10.3	28.7	5.4	35.4	12.3	14.4	11.0	13.0	16.1	7.2	11.6	5.5	11.0	5.3	15.5	9.1	24.1	32.9	8.4	22.1	14.5	4.0	16.3	10.2	20.6	8.0	5.3	4.1	10.3	8.9	6.0	7.2	24.7	8.0	4.4	25.5	3.9	5.2	8.8	12.2	13.7	5.0	8.4	3.5	1.1	2.9	1.9	6.9	8.8	6.2	16.9	17.7	15.4	3.1	4.9	10.2	4.6	4.0	2.0	2.1	1.4	4.4	12.2	4.5	4.9	3.6	3.7	3.3	3.0	5.7	0.4	3.6	4.2	8.4	0.7	0.7	9.6	5.7	6.0	7.3	29.2	3.3	2.2	4.8	2.9	5.6	10.1	0.5	2.4	3.0	3.7	11.8	1.7	3.3	9.9	14.1	1.6	5.3	7.0	8.5	2.0	4.1	4.8	14.2	8.0	3.6	7.9	2.0	2.8	4.2	2.8	1.3	1.9	7.9	0.7	6.3	0.3	2.4	0.4	1.3	3.5	2.9	6.3	1.9	2.7	3.7	13.7	2.9	2.4	8.4	1.1	2.0	5.0	0.6	1.9	11.2	13.8	5.6	10.1	11.0	13.0	11.0	5.3	22.1	8.0	3.0	13.1	7.7	24.6	12.2	10.1	10.2	22.9	186.0	23.9	15.7	29.5	22.5	8.3	18.4	56.3	9.8	0.4	0.0	4.2	7.8	27.9	22.4	3.5	6.8	10.3	3.2	17.3	8.6	3.2	9.5	15.8	7.6	21.9	1.0	5.6	27.8	5.2	0.0	26.9	32.2	30.2	6.5	15.6	102.1	36.2	9.8	15.3	2.2	3.9	12.4
TCTN2	"C12orf38, FLJ12975, JBTS24, MKS8, TECT2"	ENSG00000168778	"Tectonic family member 2"	Q96GX1	12	123671113-123708403	"Disease related genes, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA039900	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA039900: AB_10673366"	"unprognostic (3.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-3)"	"unprognostic (3.14e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.68e-1)"	5.5	5.5	6.4	5.1	18.1	2.3	8.4	10.5	10.0	11.2	5.6	9.1	12.0	2.9	15.7	14.1	4.1	32.0	7.2	5.4	6.2	10.2	11.8	2.3	9.4	4.0	4.4	8.3	18.0	7.9	16.1	18.8	5.3	18.5	11.0	4.9	17.6	11.9	10.2	1.9	10.2	3.9	7.1	4.2	4.5	6.1	17.2	3.2	3.1	15.6	5.1	4.2	5.9	7.5	4.5	4.7	2.4	1.1	1.4	5.4	0.4	10.1	10.0	7.6	10.5	10.4	11.7	8.8	3.9	7.4	8.0	6.7	6.3	10.2	0.3	6.3	6.0	7.3	13.2	4.1	3.4	8.1	2.1	6.1	1.0	7.0	4.7	3.6	2.6	3.9	5.8	7.0	11.3	3.3	24.0	10.7	3.6	5.4	0.2	5.6	5.3	2.9	5.4	4.7	3.9	6.1	2.9	7.6	1.4	10.0	7.4	4.5	5.9	11.9	4.1	5.5	8.1	17.2	3.6	6.6	11.3	5.8	10.1	4.7	2.9	5.8	0.9	14.4	0.3	6.7	2.4	0.5	2.2	3.9	1.1	5.4	3.8	4.4	4.0	0.8	4.5	5.0	5.0	0.8	1.4	0.9	4.7	2.5	0.4	6.4	18.1	10.5	10.0	6.2	10.2	4.4	8.3	18.5	3.2	3.0	4.0	1.7	2.1	3.7	4.8	3.1	7.6	45.5	5.7	7.0	11.8	2.5	0.0	2.5	5.7	1.4	0.5	0.0	1.8	2.7	2.7	2.0	3.5	0.0	1.2	0.0	1.2	4.3	0.0	2.3	2.3	0.4	5.0	1.8	2.0	5.2	1.6	0.0	4.6	1.1	14.4	0.0	1.4	11.9	10.9	1.9	0.9	2.5	2.4	0.8
TCTN3	"C10orf61, DKFZP564D116, JBTS18, TECT3"	ENSG00000119977	"Tectonic family member 3"	Q6NUS6	10	95663396-95694143	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026987	Approved		Approved	Microtubules	"Intracellular and membrane"	NA	NA		2600000	Microtubules		"HPA026987: AB_10600911"	"unprognostic (1.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.78e-2)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.59e-1)"	14.6	21.4	9.3	16.3	12.7	3.9	17.4	9.4	12.2	18.4	13.4	12.2	21.8	11.6	21.7	41.1	15.6	21.7	20.8	15.1	8.5	9.8	23.1	22.9	19.6	26.0	9.3	7.6	25.9	35.3	52.6	19.3	21.7	13.6	17.8	16.2	21.9	19.8	30.1	7.2	15.7	16.6	16.7	7.9	16.3	14.9	20.7	7.3	11.0	43.7	13.6	15.6	16.7	14.9	18.2	24.6	4.5	13.0	15.1	19.6	11.4	11.9	18.0	16.8	35.0	36.6	29.4	10.8	16.4	33.6	18.7	21.3	13.2	21.6	12.0	14.7	23.3	19.5	18.0	16.7	20.3	21.8	13.0	13.1	4.2	10.3	17.7	19.6	15.2	9.6	24.8	19.0	17.9	29.2	34.6	29.8	10.4	8.1	16.6	24.0	12.5	8.0	12.9	5.5	18.7	13.5	10.2	12.9	13.6	27.2	9.0	5.1	11.0	13.4	7.0	18.5	17.1	27.5	13.4	13.4	15.3	9.9	10.7	18.4	7.4	13.1	7.8	22.4	18.0	7.5	4.5	9.0	3.3	15.7	12.8	19.6	18.2	15.3	16.3	24.6	13.4	16.6	13.8	0.7	15.1	13.0	15.0	11.5	11.4	9.3	12.7	9.4	12.2	8.5	9.8	9.3	7.6	13.6	7.3	17.9	11.5	27.4	20.2	12.8	21.2	6.7	22.9	25.4	12.5	29.6	35.3	43.7	6.6	23.6	10.3	17.3	16.3	0.0	18.0	35.2	23.5	15.4	8.1	16.3	24.6	23.8	13.2	17.8	13.8	9.8	19.2	18.0	15.1	13.6	11.3	43.1	13.7	10.5	23.7	16.7	42.0	12.9	17.6	33.7	39.1	10.0	26.3	14.9	20.0	13.1
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044768	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			Nucleoplasm	"Plasma membrane"	"HPA071317: AB_2686388"	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	6.3	6.9	10.8	10.4	11.4	8.3	11.0	10.8	6.6	7.1	7.3	8.4	5.9	9.1	5.6	11.1	8.8	6.2	3.5	5.5	6.3	6.8	5.9	5.5	16.1	6.2	8.1	6.8	7.0	5.5	11.0	7.5	6.3	5.7	9.6	6.1	8.1	4.2	3.1	7.7	7.9	5.8	5.7	11.7	7.0	23.3	3.7	29.8	4.5	4.4	21.0	7.6	7.0	16.4	11.2	15.5	10.6	16.3	23.2	10.7	13.8	7.9	17.6	15.9	4.4	6.1	14.0	13.3	11.0	16.5	15.0	5.7	15.0	17.7	10.0	9.1	5.5	14.3	7.7	12.4	24.1	17.9	8.3	17.9	7.2	6.9	3.8	29.9	10.4	4.4	5.6	11.6	10.8	9.5	20.9	24.3	12.3	18.6	19.5	14.6	22.8	16.1	4.2	16.5	18.6	17.4	33.3	14.0	10.6	11.4	13.2	9.0	11.3	33.2	4.2	12.2	13.2	12.8	16.6	7.2	6.8	9.8	11.9	13.7	23.8	21.6	15.4	13.5	10.4	15.5	6.6	10.7	14.5	10.6	14.3	16.4	15.7	16.3	10.4	13.5	17.7	18.2	4.5	16.3	9.7	11.2	23.2	10.7	6.9	10.4	11.0	10.8	5.5	6.3	6.2	8.1	6.3	3.7	0.0	1.4	6.7	4.6	4.1	3.0	1.1	2.5	12.0	3.4	14.0	7.9	9.1	5.0	7.3	97.8	2.7	2.3	0.0	4.8	12.5	3.9	3.6	2.3	2.9	7.8	3.2	3.5	4.3	5.6	25.8	2.6	6.1	1.7	9.0	5.0	0.6	5.0	3.2	2.8	5.7	2.2	0.0	4.7	26.1	23.8	4.0	8.5	8.7	7.6	2.6
TDRD10	DKFZp434M202	ENSG00000163239	"Tudor domain containing 10"	Q5VZ19	1	154502219-154548147	"Cancer-related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 48.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 47.9;Late spermatids: 66.1;Spermatocytes: 133.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 2.2;HUVEC TERT2: 7.7;RPMI-8226: 2.1;TIME: 4.1"					"Low region specificity"	"Detected in all"			HPA054327			Approved	Vesicles		NA	NA			Vesicles		"HPA054327: AB_2682452"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.33e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.80e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (8.04e-5)"	"unprognostic (1.62e-1)"	4.1	1.4	0.7	1.1	0.9	0.0	2.6	0.7	1.4	1.3	0.8	0.9	1.4	0.5	2.1	2.0	1.0	2.1	1.2	2.3	0.7	0.0	1.0	1.5	3.3	1.6	0.9	1.2	4.6	0.7	0.8	0.8	1.4	1.2	1.1	1.1	0.7	0.7	1.0	1.1	0.7	1.0	1.4	1.2	3.5	0.5	48.4	0.8	0.7	4.9	1.5	1.0	1.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.1	4.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.9	0.7	1.4	0.7	0.0	0.9	1.2	1.2	0.8	3.0	7.9	0.0	0.0	0.6	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	47.9	4.7	0.0	0.0	0.0	0.0	0.7	0.0	1.1	0.0	0.3	0.0	0.0	6.2	3.5	66.1	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	133.2	17.2	0.3	0.0	0.0	0.0	0.0
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"granulocytes: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: AB_2732759"	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	13.7	12.0	13.0	10.3	14.7	6.9	16.9	13.8	14.2	16.7	17.2	11.7	14.2	12.9	15.2	14.2	16.5	14.4	12.7	16.7	12.9	10.6	16.2	13.5	16.9	11.3	13.5	14.8	20.6	21.3	15.3	15.4	12.4	17.7	15.5	15.5	11.1	12.5	14.8	42.4	15.2	16.7	19.0	16.8	12.9	14.8	15.9	15.0	18.7	16.9	18.6	12.1	19.0	15.4	3.8	7.2	2.3	3.5	3.0	6.9	2.1	4.4	4.9	10.9	25.4	4.4	9.5	6.5	5.1	5.8	6.0	3.9	3.2	7.4	10.9	2.1	7.5	5.1	6.3	8.9	7.5	6.5	8.2	6.8	20.3	9.4	6.2	8.5	14.2	10.6	6.4	10.7	3.5	10.6	12.5	8.1	9.0	4.5	6.7	6.5	4.8	12.7	7.4	8.3	16.1	3.8	6.8	5.3	7.2	8.2	5.9	9.7	11.6	7.4	9.0	18.5	7.8	4.6	6.2	6.8	3.8	3.9	4.3	5.6	13.3	11.5	9.4	3.6	7.4	11.7	0.5	2.3	2.3	5.5	3.5	3.8	3.8	6.2	6.2	3.3	2.7	5.2	6.4	0.1	3.0	2.5	7.2	6.9	2.1	13.0	14.7	13.8	14.2	12.9	10.6	13.5	14.8	17.7	15.0	20.8	28.8	13.4	9.0	7.0	29.0	40.4	5.1	33.5	25.0	10.4	51.1	7.3	18.3	11.5	16.8	12.8	9.3	0.0	15.4	8.8	8.3	6.1	143.8	7.2	6.3	19.1	16.7	8.0	9.4	17.0	17.5	11.6	18.6	8.2	13.8	13.4	9.6	15.3	17.3	9.9	28.8	6.5	7.5	33.9	15.5	5.8	5.6	13.8	13.8	6.3
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 37.9"	"Cell type enhanced"	"Detected in many"	23	"Early spermatids: 172.1;Spermatocytes: 66.0;Spermatogonia: 30.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Region enriched"	"Detected in many"	6	"cerebellum: 8.2"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 1.4"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.6;HeLa: 4.0;hTCEpi: 2.3;PC-3: 3.4;SCLC-21H: 1.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA075923, HPA077353"	Enhanced		Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"	Vesicles	"HPA075923: , HPA077353: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.4	0.7	2.6	1.3	0.0	0.7	8.2	1.3	0.7	0.7	0.7	0.7	0.3	0.7	2.9	0.7	0.3	1.7	0.7	1.0	0.8	0.7	1.3	0.7	3.0	1.1	0.7	0.7	0.7	0.4	1.8	1.1	0.7	1.6	0.0	0.9	0.9	0.7	1.5	2.9	0.7	0.7	0.9	1.9	0.3	37.9	0.7	0.7	5.2	0.7	0.7	1.6	0.7	0.0	0.7	0.1	2.4	0.0	0.0	0.4	0.0	0.0	0.2	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.6	0.0	4.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	3.4	0.0	0.0	0.0	0.9	0.7	1.7	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.3	0.6	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.7	0.0	2.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.7	1.3	8.2	0.9	1.0	0.8	1.1	0.7	0.7	0.7	8.9	0.3	0.0	0.4	0.5	8.3	2.9	0.0	0.0	6.8	7.0	5.9	0.0	1.7	0.1	172.1	0.6	0.0	0.0	0.2	0.0	0.5	0.5	0.0	1.6	0.1	4.8	4.1	0.0	0.3	17.5	3.7	0.0	3.3	0.0	0.0	1.4	0.1	0.0	4.2	0.0	6.2	12.9	0.5	66.0	30.6	1.4	0.0	0.0	0.5	0.1
TDRD7	PCTAIRE2BP	ENSG00000196116	"Tudor domain containing 7"	Q8NHU6	9	97411950-97496125	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 33.9;Rod photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.9;HDLM-2: 25.1;THP-1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020800, HPA022250, HPA024529"	Enhanced		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Nucleoplasm	"CAB020800: , HPA022250: , HPA024529: AB_1857869"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (2.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (4.76e-5)"	"unprognostic (4.03e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.67e-1)"	9.5	7.1	10.6	9.1	11.5	8.9	7.7	7.1	10.2	8.8	12.8	8.9	3.7	14.0	9.8	6.0	10.5	8.2	9.2	5.7	8.6	6.6	6.4	7.3	9.8	7.0	10.2	8.8	8.3	9.7	12.5	9.3	7.9	11.6	7.1	12.7	19.0	8.8	7.0	5.1	6.1	16.5	9.6	12.6	8.8	7.6	31.1	9.8	9.3	7.3	4.7	7.3	12.1	8.6	4.3	4.6	9.8	6.1	1.6	2.9	1.8	7.7	5.4	0.0	1.8	4.2	5.5	4.6	4.9	12.4	17.0	19.1	6.9	6.6	0.5	2.4	6.9	26.9	5.9	4.5	2.5	4.6	25.1	3.9	3.5	2.7	5.0	3.8	7.9	8.5	1.8	5.0	5.6	0.5	5.1	7.3	3.8	1.9	0.4	4.4	4.6	3.9	3.9	0.8	9.1	2.9	1.7	2.8	0.1	4.1	5.2	0.8	2.3	6.8	3.1	18.6	3.0	1.8	24.8	7.4	2.1	2.1	5.4	3.7	2.6	3.0	0.4	5.0	4.3	5.5	2.4	3.1	9.8	1.7	6.1	2.4	4.3	2.4	1.8	4.6	3.4	1.8	2.9	5.7	1.6	5.8	0.9	1.6	1.8	10.6	11.5	7.1	10.2	8.6	6.6	10.2	8.8	11.6	9.8	0.0	4.0	4.5	2.4	1.4	6.5	5.2	2.5	16.0	4.5	3.5	17.7	1.3	5.0	4.0	33.9	4.3	8.3	0.0	4.3	1.9	1.5	2.0	0.0	2.4	4.3	4.8	5.8	3.1	3.7	19.8	4.0	4.6	1.7	11.8	7.0	7.8	5.2	7.6	3.5	2.9	41.7	6.5	1.4	19.1	13.6	1.9	0.6	2.6	6.3	3.2
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 46.5"	"Cell type enhanced"	"Detected in many"	10	"Late spermatids: 48.0;Spermatocytes: 46.8;Spermatogonia: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.7	3.5	8.8	4.2	10.9	1.6	4.6	18.0	9.9	2.6	3.3	6.3	7.5	2.5	2.0	6.2	2.1	2.4	2.3	3.6	8.8	8.9	3.1	3.7	4.4	5.4	8.1	7.8	1.4	3.5	46.5	5.5	3.7	15.9	6.2	4.3	2.9	6.4	6.7	4.5	2.5	2.5	3.1	7.6	5.9	3.1	19.3	4.9	8.0	7.3	1.0	5.2	3.7	2.0	3.8	5.3	5.3	7.0	7.3	13.1	4.2	6.3	5.5	4.9	11.4	0.3	0.5	4.8	1.1	0.6	3.4	2.3	3.6	9.2	7.4	10.1	0.4	8.1	3.9	7.2	7.5	5.3	19.2	5.1	7.4	1.6	2.5	2.2	1.4	1.2	0.6	3.0	7.3	3.1	1.0	3.6	14.7	5.7	6.7	1.0	17.2	11.7	2.2	3.8	9.5	9.6	1.4	3.1	15.4	6.0	3.1	7.2	11.8	7.9	6.4	7.4	9.4	13.9	5.6	1.4	1.6	2.9	5.0	6.1	13.8	16.9	8.3	7.4	6.0	2.2	5.3	0.9	1.9	8.8	4.3	13.1	3.8	8.2	8.8	2.0	3.6	6.0	7.5	0.7	7.3	7.0	5.3	9.4	4.2	8.8	10.9	18.0	9.9	8.8	8.9	8.1	7.8	15.9	4.9	3.0	8.8	0.9	1.9	0.2	3.4	2.6	0.0	1.4	2.3	7.0	3.9	2.2	1.7	2.5	17.5	1.0	0.1	0.0	2.2	2.5	0.4	1.7	4.6	0.6	4.4	6.4	0.0	1.3	1.3	48.0	0.3	1.3	1.7	3.6	0.9	1.5	1.8	0.0	2.1	1.3	3.0	12.9	1.2	46.8	21.1	0.1	2.1	1.3	1.0	0.9
TDRP	"C8orf42, INM01, TDRP1, TDRP2"	ENSG00000180190	"Testis development related protein"	Q86YL5	8	489792-545781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 41.9"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 125.8;Syncytiotrophoblasts: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.9;HBEC3-KT: 13.9;hTERT-RPE1: 12.3;SuSa: 14.8"	"Low region specificity"	"Detected in all"							HPA008462	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA008462: AB_1845777"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.46e-4)"	"unprognostic (2.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-1)"	5.7	9.0	7.7	6.1	13.1	0.5	11.0	10.4	9.2	8.5	4.9	3.6	8.4	2.3	9.4	9.8	5.7	12.9	9.9	3.7	7.4	10.3	14.3	9.4	9.6	3.9	6.3	3.6	13.0	13.7	15.2	11.1	41.9	8.4	12.5	2.8	17.7	6.2	12.3	2.3	3.3	2.8	5.0	4.6	2.6	3.6	8.1	3.2	3.0	22.7	3.2	6.3	9.9	12.8	0.4	0.0	0.0	0.1	0.0	0.2	1.1	4.8	4.9	8.6	0.0	0.0	0.0	28.9	2.8	1.7	2.7	2.4	0.0	0.0	0.0	1.2	0.9	2.7	1.0	0.0	13.9	3.4	0.0	0.4	0.0	0.0	7.2	3.3	0.0	2.1	3.4	11.1	0.0	5.2	12.3	0.4	0.0	0.6	0.0	2.9	0.0	0.0	0.0	10.2	0.0	1.0	0.0	0.0	0.0	9.0	7.3	2.6	4.1	0.0	8.7	2.1	14.8	2.9	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	7.7	13.1	10.4	7.5	7.4	10.3	6.3	3.6	8.4	3.2	20.8	9.6	0.9	22.5	20.8	15.6	4.1	10.2	32.1	14.8	17.4	2.0	125.8	36.5	9.2	51.1	18.0	0.0	0.0	4.2	49.4	8.3	25.0	0.0	17.5	11.0	9.5	7.5	7.4	3.8	11.1	6.6	1.9	8.5	0.0	1.5	8.3	4.4	0.0	6.0	15.4	11.0	19.4	16.0	21.2	5.9	6.0	227.6	0.0	0.0	9.2
TECPR2	KIAA0329	ENSG00000196663	"Tectonin beta-propeller repeat containing 2"	O15040	14	102362963-102502481	"Disease related genes, Predicted intracellular proteins"	Autophagy		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 10.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000658	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000658: AB_1079191"	"unprognostic (6.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.76e-3)"	"unprognostic (3.78e-2)"	"prognostic favorable (6.53e-9)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-3)"	8.5	7.0	15.4	8.4	19.3	8.3	7.4	13.5	23.3	10.0	8.5	28.3	6.3	6.2	9.6	11.3	8.2	10.7	7.4	11.0	15.9	12.1	7.0	4.6	7.1	6.8	23.6	14.3	10.2	6.9	17.5	8.4	9.1	14.4	9.8	5.5	12.0	15.2	12.5	12.4	6.2	5.6	13.9	16.3	6.6	6.5	16.9	17.3	7.6	8.7	2.6	4.7	9.1	5.6	0.3	0.3	10.5	0.7	0.2	0.5	0.6	3.8	7.9	7.7	6.3	16.0	12.1	4.3	8.8	10.3	8.9	7.5	1.6	2.9	2.9	5.5	9.2	6.6	7.1	5.3	6.6	7.5	10.7	3.5	3.5	4.2	3.4	7.5	1.9	3.4	7.9	5.9	8.0	5.4	8.5	8.7	3.3	1.7	6.7	8.2	7.4	1.7	2.1	2.9	4.0	8.3	4.1	5.4	0.9	4.5	6.6	6.1	5.7	7.6	2.0	4.9	5.2	9.0	2.6	8.9	6.9	1.7	18.4	3.7	7.0	4.1	0.6	6.7	5.1	7.1	0.5	0.7	1.1	0.4	0.5	0.3	0.1	0.3	0.2	0.3	0.3	0.5	0.2	10.5	0.2	0.1	0.2	0.5	0.6	15.4	19.3	13.5	23.3	15.9	12.1	23.6	14.3	14.4	17.3	8.9	5.8	2.4	2.5	1.8	16.7	11.8	5.1	5.3	5.7	3.5	47.1	5.1	5.0	6.3	22.1	5.8	4.7	0.0	6.2	4.9	4.9	3.1	0.0	5.1	4.3	12.7	4.1	8.0	6.5	19.1	13.3	3.6	3.3	5.4	3.0	20.6	6.4	3.4	17.7	5.7	39.8	19.4	5.0	19.9	15.0	1.4	5.0	2.5	4.3	2.8
TEDC1	C14orf80	ENSG00000185347	"Tubulin epsilon and delta complex 1"	Q86SX3	14	105489855-105499575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Exocrine glandular cells: 11.1;Extravillous trophoblasts: 21.4;Hofbauer cells: 12.7;monocytes: 20.8;Pancreatic endocrine cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039049, HPA039050"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039049: AB_2676320, HPA039050: AB_10670918"	"unprognostic (8.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.73e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-3)"	5.1	2.0	10.5	8.5	13.6	10.8	5.2	5.1	10.3	3.3	7.6	10.7	2.0	9.4	5.5	5.0	5.2	4.0	5.5	3.4	10.3	7.4	2.9	4.0	6.2	8.8	7.9	4.6	2.7	6.4	2.5	4.5	7.9	7.1	3.7	3.2	3.9	5.8	4.6	3.9	10.1	8.3	2.1	7.4	5.9	10.6	9.1	9.5	16.0	5.1	7.1	11.8	6.1	3.5	0.8	5.7	1.4	2.2	0.1	3.7	0.7	7.9	18.5	4.4	6.6	0.4	0.7	12.0	6.4	2.5	7.7	7.4	6.6	15.1	12.1	13.4	1.0	3.0	21.3	1.5	6.8	1.5	14.3	7.6	3.2	10.2	6.5	0.3	6.1	8.9	0.1	2.3	5.2	1.6	1.0	3.0	11.3	5.0	15.2	1.2	30.8	12.7	13.9	5.7	6.8	19.6	10.4	6.8	8.4	2.1	6.8	12.6	7.4	6.6	7.8	4.6	1.0	12.4	6.1	3.8	5.4	9.2	16.4	10.5	8.9	3.7	7.3	6.9	7.0	8.7	0.0	1.2	1.4	1.5	2.2	1.0	0.3	2.2	3.7	1.7	0.8	1.4	0.4	0.4	0.1	2.0	5.7	1.6	0.7	10.5	13.6	5.1	10.3	10.3	7.4	7.9	4.6	7.1	9.5	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.2	1.8	0.0	3.9	3.3	8.1	0.0	0.0	0.0	0.0	11.1	21.4	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	20.8	0.0	0.0	10.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0
TEDC2	"C16orf59, FLJ13909"	ENSG00000162062	"Tubulin epsilon and delta complex 2"	Q7L2K0	16	2460080-2464963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.3;testis: 12.5"	"Cell type enhanced"	"Detected in some"	16	"Cytotrophoblasts: 7.9;Extravillous trophoblasts: 12.0;Hofbauer cells: 3.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051394, HPA055389"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA051394: AB_2681465, HPA055389: AB_2732595"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.38e-3)"	"prognostic unfavorable (2.43e-5)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (4.04e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.03e-1)"	0.8	1.8	2.3	6.2	4.1	9.3	1.1	2.8	4.6	1.2	2.6	0.8	0.0	4.3	1.2	1.4	4.5	1.2	1.4	1.3	2.3	2.7	2.2	1.7	1.0	5.6	2.1	1.9	1.0	1.9	0.3	2.4	3.8	2.0	1.3	2.2	1.0	1.3	0.8	1.0	2.6	3.8	1.1	1.4	2.5	2.2	12.5	0.8	15.3	0.9	4.2	3.9	0.6	2.2	1.2	1.4	0.0	1.0	0.0	2.1	0.7	5.2	16.7	9.6	11.2	0.1	0.6	9.7	4.2	2.5	6.8	6.6	11.5	4.4	7.3	7.0	1.8	3.7	8.1	6.9	4.2	1.6	8.1	9.2	6.6	11.8	11.8	0.2	6.4	8.9	0.6	0.5	6.0	1.6	0.5	3.1	12.3	11.3	2.8	2.3	10.1	11.2	11.9	21.3	5.1	6.1	27.4	8.3	16.6	1.4	2.3	9.1	14.9	4.9	5.2	3.6	2.6	7.6	7.4	1.1	7.3	10.6	6.9	9.5	6.2	10.2	14.7	3.7	6.4	9.9	0.0	0.0	0.0	0.1	0.1	0.0	0.6	2.1	0.0	0.3	1.2	0.7	1.3	0.0	0.0	1.0	1.4	1.9	0.7	2.3	4.1	2.8	4.6	2.3	2.7	2.1	1.9	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	7.9	1.7	2.8	0.0	0.0	0.0	0.0	1.1	12.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"Endothelial cells: 58.3;Ito cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 36.5;NTERA-2: 18.2;TIME: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	8300000	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13.0	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4.0	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3.0	5.3	10.6	5.3	23.4	4.0	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.7	0.0	0.0	0.7	0.0	0.9	0.3	0.0	36.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	39.6	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5	3.0	2.2	0.0	0.0	1.3	0.0	7.8	0.0	0.0	1.2	1.8	0.0	0.4	0.0	0.0	0.6	58.3	0.0	0.0	0.0	1.5	2.4	0.2	0.0	0.8	0.2	0.0	0.0	110.5	10.4	0.4	0.6	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.2	1.1	1.1	0.0	0.0	0.0
TEKT5	"CT149, FLJ32871"	ENSG00000153060	"Tektin 5"	Q96M29	16	10627501-10694945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"testis: 30.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 505.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.0"	"Cell line enriched"	"Detected in some"	13	"BEWO: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043578			Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA043578: AB_10795772"	"unprognostic (5.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.24e-7)"	"unprognostic (3.80e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.12e-5)"	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.9	30.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.9	0.2	0.4	0.2	0.0	0.2	1.3	0.3	0.0	0.3	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	505.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	114.5	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	3.2	1.1	0.3	0.0	0.0	0.0	0.3
TENM2	"KIAA1127, ODZ2, Ten-M2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins"	"Cell adhesion, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.1;heart muscle: 24.7"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 142.6;Horizontal cells: 114.4;Peritubular cells: 58.0"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.7;HBEC3-KT: 17.5;HDLM-2: 17.1;U-138 MG: 31.3;U-2 OS: 27.2;U-251 MG: 20.0"	"Low region specificity"	"Detected in many"							"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli		No	No			Nucleoli		"HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019"	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavorable (7.52e-4)"	0.2	0.4	2.5	0.0	3.5	0.0	1.8	0.5	15.1	0.6	0.3	0.0	0.0	0.3	0.2	0.4	1.4	0.2	0.3	24.7	6.5	0.9	2.7	1.2	0.3	0.0	0.5	1.7	0.7	0.2	0.0	0.4	0.0	2.3	2.2	0.0	0.2	0.3	1.0	0.2	2.3	0.2	0.0	0.6	0.2	0.3	1.2	0.4	0.0	0.4	0.0	0.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	0.0	26.7	0.7	0.0	0.0	17.5	0.3	17.1	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.3	3.1	0.1	2.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.0	1.5	0.0	0.0	31.3	27.2	0.0	20.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.5	15.1	6.5	0.9	0.5	1.7	2.3	0.4	0.0	0.0	0.0	0.7	13.2	9.5	142.6	0.0	0.0	1.2	0.0	17.7	0.0	0.0	2.5	20.1	1.3	0.1	0.0	0.2	0.0	0.7	1.1	1.1	4.2	0.1	114.4	0.0	0.0	0.0	13.2	4.0	0.0	1.7	0.0	0.3	2.1	0.0	0.0	58.0	0.0	1.6	0.0	1.7	0.9	1.1	1.5	0.0	0.0	0.0	0.1
TENM3	"KIAA1455, ODZ3, Ten-M3"	ENSG00000218336	"Teneurin transmembrane protein 3"	Q9P273	4	182143987-182803024	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"		"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Bipolar cells: 28.4;Cytotrophoblasts: 88.5;Extravillous trophoblasts: 46.4;Syncytiotrophoblasts: 111.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 24.4;BEWO: 23.3;HDLM-2: 31.7;T-47d: 31.4"	"Low region specificity"	"Detected in many"							HPA047043	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047043: AB_2679914"	"unprognostic (5.79e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.25e-4)"	9.5	10.8	11.3	3.7	12.5	1.0	9.3	8.5	17.8	3.9	8.5	1.5	5.7	2.4	6.4	2.6	2.4	2.9	5.3	3.5	11.8	9.4	2.7	1.4	2.4	2.3	3.5	15.4	8.4	3.2	17.0	15.0	24.5	5.4	8.3	2.5	6.4	2.0	8.0	4.3	1.4	2.5	5.2	6.1	4.8	2.2	4.7	2.3	0.8	12.3	1.8	3.0	3.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	24.4	0.1	5.0	8.9	23.3	2.8	1.0	2.5	2.2	12.1	6.3	0.0	0.3	18.8	10.6	1.2	5.8	1.2	2.5	31.7	9.7	0.0	0.0	0.0	0.5	0.0	0.0	11.7	0.4	7.9	5.5	5.7	3.5	0.0	0.0	0.1	3.8	0.8	0.0	0.0	7.8	0.0	1.0	0.0	6.3	0.0	0.0	0.0	10.0	9.3	1.4	0.1	0.0	13.8	31.4	1.2	7.6	20.0	14.4	0.0	14.1	0.0	0.0	0.0	10.5	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.5	8.5	17.8	11.8	9.4	3.5	15.4	5.4	2.3	0.0	0.0	0.0	0.2	0.3	28.4	3.3	0.0	0.0	0.0	3.5	3.9	88.5	1.7	0.0	8.3	0.3	0.0	0.0	1.5	46.4	3.1	0.2	0.0	0.6	9.0	4.8	5.1	0.6	0.0	1.8	7.8	0.0	1.7	0.0	0.0	11.8	0.6	0.0	2.5	0.1	2.8	0.0	1.0	3.7	7.1	0.0	111.6	0.0	0.0	0.0
TEPSIN	"C17orf56, ENTHD2, FLJ31528"	ENSG00000167302	"TEPSIN, adaptor related protein complex 4 accessory protein"	Q96N21	17	81228277-81239091	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 8.9;Cytotrophoblasts: 8.3;Hofbauer cells: 7.9;monocytes: 15.4;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063410			Supported	"Nuclear membrane,Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear membrane, Nuclear speckles, Golgi apparatus"		"HPA063410: AB_2685008"	"unprognostic (6.90e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (1.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (7.31e-8)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.16e-3)"	8.5	6.7	8.0	11.9	8.5	17.3	21.3	11.9	9.8	6.0	9.9	9.0	7.3	14.9	7.9	8.6	8.8	8.0	6.6	4.9	8.8	4.7	9.8	13.3	12.5	13.5	12.5	6.3	6.8	11.1	5.3	9.2	7.7	9.8	10.1	6.5	4.8	9.1	9.3	12.4	15.8	12.4	9.8	8.5	17.0	9.7	9.1	9.8	12.2	12.6	7.5	9.0	7.2	7.0	3.0	2.7	7.6	2.9	0.7	1.8	1.2	8.9	13.1	5.1	8.3	3.5	5.9	10.2	8.0	4.5	8.0	7.3	8.5	6.3	6.4	4.5	5.3	7.9	11.6	5.3	6.7	3.8	3.9	17.4	5.3	7.3	12.1	5.3	5.7	11.1	3.0	8.7	3.6	4.2	5.9	12.7	8.7	6.5	6.3	5.1	7.8	10.7	13.3	5.6	7.1	11.3	6.8	6.7	7.0	3.1	5.7	6.8	8.0	9.4	10.4	10.9	10.4	7.1	10.3	8.0	10.8	6.2	8.2	7.6	8.5	5.9	4.8	7.9	4.9	5.3	4.2	2.4	7.6	1.8	2.9	1.1	2.5	1.2	1.4	2.7	3.0	0.8	0.8	4.3	0.7	1.9	2.7	1.6	1.2	8.0	8.5	11.9	9.8	8.8	4.7	12.5	6.3	9.8	9.8	8.9	5.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.3	1.8	0.0	8.3	0.0	4.1	0.0	0.0	0.0	0.0	4.5	7.0	0.0	0.0	5.8	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	5.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0
TERF1	"PIN2, TRBF1, TRF, TRF1"	ENSG00000147601	"Telomeric repeat binding factor 1"	P54274	8	73008864-73048122	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048379			Approved	"Nucleoli fibrillar center,Nuclear bodies"		NA	NA			"Nucleoli fibrillar center"	"Nuclear bodies"	"HPA048379: AB_2680378"	"unprognostic (1.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.53e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	16.3	21.9	28.1	11.6	23.9	24.3	16.6	48.4	31.0	17.0	15.1	14.0	22.2	13.3	21.5	15.0	14.3	17.9	15.6	17.2	26.4	20.6	24.8	20.0	13.0	16.2	20.7	26.0	30.9	13.1	24.9	32.2	15.5	20.3	23.4	14.7	10.6	15.2	21.0	13.0	12.0	13.0	23.7	24.2	12.6	18.6	15.3	23.6	20.6	20.9	10.4	14.3	22.7	20.5	15.5	14.5	14.8	8.5	12.7	16.2	7.3	12.3	11.7	16.4	10.4	11.6	7.7	10.7	12.5	7.8	11.9	10.4	8.6	9.7	6.8	16.2	7.4	16.9	10.8	17.8	8.9	12.1	9.6	17.7	14.4	6.2	8.1	7.2	7.0	11.8	8.3	6.8	9.4	14.4	11.2	10.9	16.7	11.9	11.0	8.2	7.9	21.8	9.2	48.5	27.4	11.3	16.0	7.4	6.1	15.6	7.0	11.2	12.5	12.1	38.4	11.6	41.5	15.7	6.6	8.5	6.9	11.0	13.1	10.2	9.7	9.4	12.6	8.9	9.4	13.5	11.3	7.7	14.8	15.4	7.3	12.9	15.5	13.7	15.4	9.1	15.1	16.2	16.0	6.9	12.7	8.5	14.5	13.3	7.3	28.1	23.9	48.4	31.0	26.4	20.6	20.7	26.0	20.3	23.6	26.8	23.2	38.6	33.9	24.7	75.3	21.6	25.5	24.1	14.8	29.6	80.5	46.4	21.6	29.6	9.2	34.9	13.9	46.7	32.9	51.9	43.3	29.0	35.8	27.3	29.8	66.7	88.4	43.6	25.0	5.7	68.7	30.1	28.7	23.4	23.5	80.3	23.9	21.0	80.2	44.9	53.5	58.2	50.5	82.4	124.6	21.2	26.7	47.4	23.3	23.4
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 226.3;Early spermatids: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 51.4;hTCEpi: 58.1;SK-BR-3: 58.3"					"Low region specificity"	"Detected in single"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.4	5.2	5.9	0.0	2.6	6.7	13.8	12.8	6.2	2.4	2.3	12.9	27.3	0.0	51.4	8.9	0.3	25.2	3.1	18.8	5.9	12.1	10.1	2.4	12.1	6.3	15.7	11.1	0.0	14.9	58.1	8.3	21.1	16.6	6.7	0.0	2.5	8.6	0.6	5.0	0.0	0.1	3.9	28.4	14.9	0.0	0.0	9.6	24.2	9.4	2.7	25.5	18.7	58.3	14.1	17.9	0.0	4.5	11.3	0.1	0.3	18.9	0.1	20.5	9.9	0.2	1.6	5.7	19.4	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7	226.3	36.4	52.3	147.2	177.9	2.3	14.5	38.2	84.3	97.8	34.9	11.8	16.7	18.3	104.8	327.4	24.0	101.5	0.0	97.9	69.1	27.0	83.0	17.4	9.9	14.9	1.6	48.4	15.4	52.9	82.2	1.7	62.3	27.0	36.1	57.8	23.0	142.2	58.6	0.4	10.3	12.6	6.5	20.6	18.2	9.7	107.3	24.4	57.4	44.4	125.3
TESMIN	"CXCDC2, MTL5"	ENSG00000132749	"Testis expressed metallothionein like protein"	Q9Y4I5	11	68707440-68751564	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"testis: 81.0"	"Cell type enhanced"	"Detected in some"	9	"Distal tubular cells: 5.0;Ductal cells: 5.8;Exocrine glandular cells: 3.4;Extravillous trophoblasts: 3.7;Pancreatic endocrine cells: 5.1;Proximal tubular cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 10.7;T-47d: 21.2"	"Not detected"	"Not detected"							HPA018539			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA018539: "	"unprognostic (1.99e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (3.22e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-1)"	0.3	0.5	0.3	1.6	1.4	4.8	3.3	0.1	0.6	0.6	1.9	0.0	3.8	1.0	0.5	1.2	1.3	1.3	1.0	0.4	0.2	0.9	3.2	0.3	0.4	0.9	0.6	0.4	0.8	2.6	2.6	1.9	0.4	1.8	1.7	2.2	0.6	2.5	5.2	0.1	0.5	1.2	0.3	0.7	1.2	0.6	81.0	0.1	5.5	1.5	0.9	2.0	0.5	0.7	0.4	0.1	2.8	1.1	0.0	1.1	0.4	6.2	2.7	1.2	0.0	0.0	0.0	3.2	1.4	0.7	2.0	0.9	0.8	6.3	2.5	1.4	0.2	0.0	3.0	0.9	1.2	1.6	2.6	2.2	1.8	0.9	0.0	0.0	1.3	10.7	0.0	3.4	0.1	2.0	2.7	0.6	3.0	3.8	4.8	0.3	4.1	0.7	3.6	6.5	2.9	2.8	1.6	0.3	0.7	2.3	0.1	4.0	4.3	0.0	1.3	0.0	3.5	21.2	8.7	2.3	0.2	0.4	0.1	0.1	1.9	1.7	2.4	0.1	3.7	1.7	0.0	1.0	1.0	0.3	0.4	0.6	0.0	1.1	0.2	0.1	0.4	0.4	0.3	2.8	0.0	1.1	0.1	0.8	0.4	0.3	1.4	0.1	0.6	0.2	0.9	0.6	0.4	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.7	5.0	5.8	0.0	0.0	0.0	0.0	3.4	3.7	0.0	0.0	2.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.1	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	9.9	6.1	8.7	11.9	11.4	26.3	8.0	4.1	10.0	9.6	7.4	10.1	5.8	8.2	10.1	7.4	16.2	9.2	6.6	6.8	9.0	4.2	6.7	5.5	9.9	9.8	13.7	5.7	8.5	7.0	7.4	29.0	12.4	9.1	6.5	8.0	4.7	13.5	8.2	9.8	16.0	10.2	7.8	15.5	12.9	6.8	3.2	14.6	9.3	7.2	6.9	8.7	9.8	12.3	2.8	5.1	29.0	7.0	2.6	2.1	1.4	4.8	3.1	10.6	10.8	1.9	4.3	4.3	3.5	4.7	5.0	4.9	3.1	6.5	0.5	4.0	4.3	2.4	4.6	10.2	6.1	5.7	6.2	2.7	6.8	6.0	1.1	5.4	15.4	11.3	3.7	8.3	4.8	6.2	8.1	6.6	3.7	7.2	12.7	4.3	3.6	2.5	4.2	2.3	6.4	1.9	7.9	5.3	1.0	4.6	10.2	7.6	6.2	3.8	9.9	0.6	6.0	4.5	11.1	8.5	7.6	6.9	2.2	5.9	8.5	6.1	6.4	4.6	3.8	7.4	10.8	7.0	7.2	2.1	5.5	0.8	2.6	1.2	1.2	5.1	2.8	1.0	1.6	29.0	2.6	6.4	4.5	1.5	1.4	8.7	11.4	4.1	10.0	9.0	4.2	13.7	5.7	9.1	14.6	23.8	26.1	5.6	9.4	12.8	21.1	21.6	7.6	21.4	20.5	8.7	15.7	16.9	6.6	5.6	0.2	12.9	15.8	0.0	6.6	4.8	7.5	10.8	26.6	6.6	13.0	33.4	22.3	9.2	49.2	0.4	7.5	43.4	5.0	11.8	15.9	5.6	6.6	17.3	6.7	2.4	23.8	12.9	8.2	0.2	0.6	31.5	28.6	17.5	12.7	22.5
TET3	"hCG_40738, MGC22014"	ENSG00000187605	"Tet methylcytosine dioxygenase 3"	O43151	2	73986404-74108176	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 44.0;Suprabasal keratinocytes: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050845	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA050845: AB_2681256"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.05e-1)"	"unprognostic (5.30e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.10e-1)"	2.9	2.3	7.2	6.1	10.8	20.9	3.9	26.0	17.1	3.2	5.1	20.6	0.5	6.7	2.9	1.9	10.2	3.0	3.3	1.6	7.1	3.3	2.6	5.1	5.6	4.3	12.0	9.5	2.9	3.6	3.5	4.2	5.7	12.4	3.6	5.5	5.9	5.9	1.8	1.8	18.9	7.2	2.7	5.3	5.5	5.3	2.1	11.7	0.6	3.4	1.7	5.1	4.0	5.0	1.1	1.4	2.5	2.2	0.4	0.9	0.9	6.2	5.5	10.5	6.4	0.9	1.0	19.4	1.3	1.7	2.5	2.0	11.8	5.8	10.5	2.6	1.7	1.1	6.7	9.3	3.7	2.6	4.5	3.7	13.4	4.6	4.0	3.9	14.0	8.3	1.5	9.8	3.1	7.3	3.1	3.8	7.4	9.1	3.5	1.4	10.3	6.9	9.2	5.9	5.4	1.9	10.5	6.6	3.6	2.8	11.7	13.2	11.3	2.8	7.5	3.6	4.4	4.8	11.4	4.8	2.7	11.4	1.3	4.7	3.1	1.3	9.1	1.8	9.8	3.5	0.5	2.0	1.0	0.4	2.2	0.9	1.1	0.5	0.5	1.4	0.9	0.7	0.6	2.5	0.4	0.7	1.4	0.0	0.9	7.2	10.8	26.0	17.1	7.1	3.3	12.0	9.5	12.4	11.7	6.0	7.0	0.0	3.0	44.0	14.5	2.8	5.1	10.7	9.1	1.8	19.6	5.5	0.0	3.0	2.9	5.6	9.5	23.3	3.8	27.5	6.6	4.8	2.3	4.4	8.9	9.5	5.8	3.7	27.8	0.6	0.6	13.8	10.1	9.0	8.4	1.5	5.1	10.5	2.8	1.2	5.8	0.0	5.3	0.5	3.1	59.6	2.1	4.3	6.4	4.8
TEX10	"bA208F1.2, FLJ20287, Ipi1"	ENSG00000136891	"Testis expressed 10"	Q9NXF1	9	100302077-100352939	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045434			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA045434: AB_10965650"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.28e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-3)"	"unprognostic (9.63e-3)"	11.1	8.5	7.6	14.0	10.1	12.2	11.3	12.6	11.1	12.2	9.5	7.7	7.5	6.1	14.2	9.9	12.5	12.1	10.3	10.4	7.7	7.1	7.5	7.9	9.7	15.1	7.3	5.9	14.9	10.3	9.8	13.5	25.4	9.4	10.2	8.1	6.3	10.2	9.1	25.4	16.2	8.7	11.8	9.9	14.4	9.2	24.5	7.2	32.9	10.0	10.2	15.0	11.2	11.9	13.0	9.3	12.4	9.0	9.9	12.6	7.2	11.7	12.9	17.0	19.0	6.2	11.1	26.3	14.8	15.4	19.4	18.1	13.2	13.9	33.4	8.0	9.6	17.9	16.0	24.2	19.1	22.8	13.4	10.7	18.1	8.4	11.5	13.4	26.2	13.6	9.6	10.8	19.7	20.9	9.6	10.5	11.9	20.2	11.0	25.0	18.4	19.1	16.8	34.7	22.9	15.6	18.7	29.0	10.1	14.3	7.7	15.1	12.8	8.1	13.5	13.1	10.9	5.6	7.7	10.7	13.0	11.5	17.3	13.8	7.8	13.2	13.4	13.2	11.8	13.4	12.4	7.6	2.5	9.8	9.0	10.7	12.7	10.0	9.8	9.3	13.0	10.7	12.6	1.9	9.9	6.7	5.4	11.4	7.2	7.6	10.1	12.6	11.1	7.7	7.1	7.3	5.9	9.4	7.2	3.0	9.4	10.0	8.3	19.7	6.7	10.6	0.0	6.7	17.0	8.7	11.8	44.5	3.3	5.8	9.9	8.3	2.1	0.0	7.5	12.7	13.0	6.1	16.2	6.8	8.4	7.9	5.1	6.7	3.8	10.0	8.1	7.5	16.9	7.2	5.2	3.4	6.3	5.3	7.4	3.0	5.9	0.0	12.8	28.4	34.5	19.7	38.6	6.5	6.0	7.1
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 52.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 13.5;Spermatocytes: 29.0;Spermatogonia: 15.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.1;Karpas-707: 11.9;MCF7: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.2	0.1	0.3	1.5	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0.0	52.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.2	0.1	0.0	0.2	2.6	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.2	0.0	0.2	0.0	0.4	0.0	0.2	9.1	1.4	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.5	0.1	11.9	0.0	4.8	0.4	0.1	0.6	0.1	0.1	0.5	0.4	1.8	0.0	0.1	1.4	0.2	0.0	0.1	0.6	0.4	0.4	0.1	0.0	0.1	0.3	0.0	0.0	2.1	0.5	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.1	0.4	0.1	0.0	0.0	0.0	1.2	0.8	0.4	1.4	5.1	0.0	2.3	1.8	0.0	0.9	0.0	0.0	13.5	0.2	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.4	3.1	0.0	0.0	1.8	1.2	3.6	0.3	2.4	3.3	0.0	0.0	0.5	0.1	0.0	0.4	0.0	1.1	0.0	0.9	29.0	15.8	0.1	0.9	0.0	0.0	0.3
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913003	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 73.5;Late spermatids: 38.7;Spermatogonia: 62.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.9;HEL: 20.1;K-562: 5.6;NTERA-2: 3.8;OE19: 4.1;SCLC-21H: 4.3"					"Not detected"	"Not detected"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.1	0.1	0.7	0.2	5.4	0.1	0.1	0.1	1.1	1.2	0.1	0.0	0.0	0.1	10.0	0.6	0.2	0.1	0.8	0.1	1.7	0.5	0.1	0.1	0.1	0.1	0.3	0.3	0.4	0.1	0.1	6.9	0.1	0.9	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.2	8.5	0.4	0.4	0.9	21.3	1.4	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.0	0.0	8.9	1.1	0.0	1.2	3.2	20.1	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.6	0.0	0.0	0.1	0.1	0.1	3.8	4.1	0.3	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	3.7	0.3	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.1	1.1	1.7	0.5	0.3	0.3	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	38.7	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	4.2	0.0	0.0	12.9	0.0	14.2	62.1	0.0	0.1	0.0	0.0	0.0
TEX2	"HT008, KIAA1738, TMEM96"	ENSG00000136478	"Testis expressed 2"	Q8IWB9	17	64147227-64263301	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 41.1;Late spermatids: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"plasmacytoid DC: 18.1"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 18.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020648, HPA057116"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020648: AB_1857908, HPA057116: AB_2683341"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (3.90e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.53e-3)"	"unprognostic (5.59e-3)"	11.7	18.1	22.3	5.0	25.1	11.8	14.3	18.9	22.5	14.0	8.8	22.9	4.2	7.3	10.8	8.7	12.6	10.2	15.8	19.2	23.0	20.1	14.6	23.4	10.7	4.1	29.0	13.8	12.0	21.1	27.2	10.7	8.7	20.5	12.3	10.0	46.2	17.7	13.2	28.1	11.1	7.2	10.8	26.3	8.7	9.1	35.7	17.2	4.9	29.3	10.9	4.9	8.1	8.2	0.6	18.1	0.7	2.6	2.6	1.6	1.4	13.2	6.4	4.0	8.2	19.6	11.6	4.9	18.4	20.9	16.8	11.6	6.0	3.3	4.7	4.8	23.3	10.4	6.6	7.2	22.4	19.1	6.8	5.0	31.6	4.4	11.2	7.3	9.1	5.3	8.5	12.4	11.4	23.4	11.9	8.0	8.0	8.6	5.8	12.5	14.9	8.3	4.2	2.3	10.4	11.6	5.1	36.7	6.6	9.7	6.3	6.2	10.2	9.2	23.6	10.1	23.3	11.1	7.9	9.4	15.7	9.2	12.1	10.6	6.0	8.2	3.1	6.2	8.7	14.1	0.0	2.6	0.7	1.4	0.8	1.6	0.3	1.5	1.6	2.5	0.6	1.6	1.5	0.3	2.6	1.5	18.1	1.0	1.4	22.3	25.1	18.9	22.3	23.0	20.1	29.0	13.8	20.5	17.2	3.0	7.2	2.2	5.5	7.8	4.1	28.9	7.6	8.1	5.7	12.2	5.9	2.1	1.7	4.3	41.1	8.7	5.5	0.0	7.1	1.6	6.4	5.5	3.5	28.6	11.1	9.5	11.6	8.6	7.5	38.4	6.1	3.8	6.8	1.8	10.2	6.0	6.1	2.9	12.0	7.9	18.4	0.0	6.1	14.6	9.5	7.9	1.1	2.2	10.6	4.2
TEX26	"C13orf26, MGC40178"	ENSG00000175664	"Testis expressed 26"	Q8N6G2	13	30932703-30975502	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 19.7;testis: 29.3"	"Group enriched"	"Detected in some"	48	"Early spermatids: 816.5;Late spermatids: 1222.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 19.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SuSa: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079709			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA079709: "					"unprognostic (2.80e-2)"			"unprognostic (1.10e-1)"			"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"		"unprognostic (1.53e-2)"	"unprognostic (9.27e-2)"			0.5	1.2	1.6	0.4	6.3	0.4	0.5	0.2	3.0	1.7	0.4	4.8	0.3	0.4	0.5	1.3	0.5	1.3	0.8	0.5	3.7	5.5	0.4	0.6	0.6	0.4	1.1	2.7	0.4	0.4	0.4	4.2	0.4	19.7	0.7	0.5	0.0	0.5	0.8	0.5	0.4	0.5	0.4	3.7	0.4	0.5	29.3	2.0	0.0	0.4	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	6.3	0.2	3.0	3.7	5.5	1.1	2.7	19.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	21.4	2.3	0.0	0.0	0.0	0.0	0.0	816.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1222.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	9.2	3.3	0.0	0.0	0.0	0.0	0.0
TEX261	"MGC32043, TEG-261"	ENSG00000144043	"Testis expressed 261"	Q6UWH6	2	70985938-70994945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016631	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA016631: AB_2240434"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-1)"	22.9	27.1	14.5	11.1	15.4	9.3	22.2	13.4	21.4	19.9	15.9	21.6	20.9	13.8	17.3	27.2	17.3	20.9	21.2	21.6	14.4	12.0	25.1	36.9	19.8	16.1	17.0	10.9	23.7	50.8	36.1	20.1	19.3	15.0	18.9	18.9	28.7	22.3	21.0	33.5	12.9	23.6	19.6	17.4	16.0	18.4	23.8	15.3	15.5	31.7	14.3	16.3	14.9	13.9	3.8	4.4	12.0	5.3	3.4	6.7	2.8	20.0	19.0	13.3	16.9	40.7	20.8	15.1	23.2	22.2	27.1	17.1	22.2	16.7	16.4	8.8	40.7	25.6	15.2	25.3	27.7	39.5	12.3	21.1	19.6	9.8	23.5	24.0	22.8	16.5	18.7	18.5	26.0	17.8	14.9	27.5	17.1	24.3	10.9	31.6	15.7	19.6	12.6	8.8	32.6	22.4	14.0	41.2	14.1	19.7	17.6	21.9	11.5	24.1	24.1	15.1	9.4	15.6	13.5	22.0	33.4	28.9	17.7	30.8	8.5	7.5	19.5	29.1	30.1	27.9	12.0	5.3	10.0	5.1	5.3	4.3	2.6	5.4	6.7	4.0	3.8	6.2	4.9	4.0	3.4	5.2	4.4	4.3	2.8	14.5	15.4	13.4	21.4	14.4	12.0	17.0	10.9	15.0	15.3	3.0	17.1	18.2	9.4	7.3	13.4	19.8	17.8	1.4	7.9	22.7	35.3	14.3	6.6	21.9	12.0	14.6	19.3	0.0	20.5	14.3	14.1	13.7	2.3	30.4	17.3	7.9	8.1	18.4	15.1	21.6	14.7	8.4	18.6	9.0	17.0	20.6	18.7	13.6	17.3	14.1	68.9	0.0	16.0	46.6	10.9	6.6	15.0	9.2	16.5	7.1
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.8	21.8	3.9	20.1	40.7	19.8	8.0	10.2	24.2	17.0	17.2	11.6	28.2	17.1	7.5	14.6	28.8	11.6	11.0	20.6	8.3	13.7	17.6	16.3	13.6	15.4	36.3	10.2	18.3	26.1	32.9	19.2	19.7	15.5	12.4	13.0	8.5	29.9	17.5	13.7	16.3	23.8	4.3	19.6	24.5	7.9	5.2	32.2	26.8	16.5	5.6	9.2	12.5	34.5	15.7	5.6	16.8	21.7	9.1	17.2	7.2	18.0	13.5	20.9	22.5	8.4	21.0	21.6	17.1	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5	32.8	15.0	27.5	46.0	30.9	30.1	22.8	53.5	25.4	28.4	94.2	55.0	125.5	53.0	63.6	30.2	49.7	69.9	0.0	67.2	73.8	45.6	36.2	16.1	51.7	92.2	39.7	31.6	28.3	36.7	48.4	47.2	49.0	62.4	55.9	51.0	59.8	56.9	65.4	46.0	101.0	46.9	25.8	20.0	310.0	58.8	30.9	63.8	52.4	81.7	32.5
TEX9		ENSG00000151575	"Testis expressed 9"	Q8N6V9	15	56244009-56445997	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 49.7"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 165.9;Early spermatids: 67.3;Spermatocytes: 52.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 4.1;memory B-cell: 14.4;naive B-cell: 6.8"	"Group enriched"	"Detected in many"	11	"B-cells: 14.4;granulocytes: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039415	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA039415: AB_10672775"	"unprognostic (3.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	1.7	5.4	5.3	9.0	14.8	2.0	7.6	4.0	2.3	7.0	4.6	7.8	6.0	8.5	5.7	11.6	7.3	21.6	6.2	1.6	6.1	7.5	11.9	1.2	5.8	4.1	4.0	3.2	7.5	4.1	13.5	49.7	1.0	25.2	5.4	3.5	9.2	9.0	4.5	0.9	4.1	9.6	2.3	4.9	5.5	9.0	19.3	4.0	2.0	14.8	2.0	8.2	2.7	2.2	14.4	0.3	4.1	0.6	0.4	0.8	0.8	5.8	5.3	11.7	10.4	2.9	8.5	1.5	1.3	4.9	3.7	4.4	1.4	5.2	11.7	5.6	0.9	6.4	5.2	5.0	5.5	4.3	1.4	6.1	6.7	5.4	3.8	0.9	3.0	1.3	4.6	10.2	4.1	3.1	5.3	0.1	8.4	3.8	1.3	1.9	3.3	4.8	2.6	5.6	9.7	2.3	1.9	5.5	4.2	12.3	3.3	18.7	7.5	6.5	4.0	4.0	9.0	11.1	3.4	0.6	15.7	4.8	5.0	4.7	1.6	11.8	8.9	6.2	1.3	3.0	4.1	0.1	0.1	0.3	0.6	0.1	14.4	0.4	0.3	0.2	6.8	0.2	0.8	0.3	0.4	0.3	0.3	0.5	0.8	5.3	14.8	4.0	2.3	6.1	7.5	4.0	3.2	25.2	4.0	6.0	6.9	13.7	6.8	3.8	5.1	0.4	2.5	165.9	35.2	10.4	11.8	1.4	18.3	11.8	67.3	2.6	2.6	0.0	6.1	0.4	2.3	2.9	1.1	0.0	1.1	1.6	7.5	1.8	0.0	28.6	4.4	1.1	3.3	1.8	2.5	4.8	3.9	4.3	3.5	15.3	35.9	0.0	3.1	52.4	32.6	1.9	0.2	0.0	3.0	5.2
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847613	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 65.5"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 413.2"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in some"	41	"cerebellum: 4.7;pons and medulla: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 32.4;SH-SY5Y: 60.4"	"Region enhanced"	"Detected in some"		"cerebellum: 11.2"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.2	3.0	0.0	0.0	0.0	0.0	9.4	4.7	0.0	0.2	0.2	0.0	8.8	0.0	0.0	65.5	5.8	0.0	0.0	0.1	0.0	0.1	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	6.3	0.1	0.0	12.2	7.0	0.6	0.0	6.3	0.0	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	60.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.1	0.0	6.3	0.0	0.0	0.0	0.0	0.0	10.4	6.9	0.6	0.0	0.0	0.0	48.8	7.9	10.5	46.4	0.0	11.5	0.3	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.0	1.0	413.2	0.0	0.0	0.0	0.5	0.0	0.0	101.3	0.0	0.0	2.3	0.0	0.0	0.4	0.7	9.7	0.0	0.0	0.5	0.0	3.8	4.1	0.0	0.0	0.0
TFAP4	"AP-4, bHLHc41"	ENSG00000090447	"Transcription factor AP-4"	Q01664	16	4257186-4273075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001912	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA001912: AB_1080251"	"unprognostic (1.61e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.97e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.30e-1)"	8.2	7.0	9.6	11.8	9.6	3.4	7.3	31.6	15.6	10.0	6.8	6.6	5.7	11.1	10.1	3.7	9.9	12.5	7.0	4.8	8.0	6.3	4.4	6.3	5.5	11.1	11.1	7.1	18.7	22.2	6.3	6.7	6.9	8.8	9.0	3.9	6.1	13.2	7.0	8.6	12.2	10.1	5.5	12.8	10.2	8.3	3.1	14.9	13.0	8.4	4.5	7.3	7.4	11.0	1.7	0.5	0.9	0.1	0.1	1.2	1.0	7.0	7.4	6.4	9.4	2.7	7.3	10.7	2.7	7.3	4.8	5.2	3.8	11.1	24.2	7.2	2.7	2.2	10.5	11.7	9.4	1.5	14.2	8.3	7.4	6.9	9.9	3.8	13.0	4.3	6.7	6.1	5.2	14.7	2.2	3.1	8.2	13.7	6.5	1.8	11.1	18.3	21.5	14.7	7.1	9.8	16.1	14.3	25.1	1.8	5.3	13.3	10.0	9.2	9.8	9.0	1.0	4.8	10.2	2.0	6.6	5.1	22.9	7.1	10.6	8.8	20.4	4.4	13.0	4.5	0.0	0.0	0.9	0.4	0.0	1.2	1.7	0.2	0.0	0.3	0.4	0.3	0.7	0.0	0.1	0.1	0.5	0.2	1.0	9.6	9.6	31.6	15.6	8.0	6.3	11.1	7.1	8.8	14.9	3.0	0.0	9.1	8.8	19.2	4.4	2.0	10.2	1.4	1.2	26.2	0.0	7.1	6.6	3.4	0.0	2.9	5.4	0.0	4.9	10.4	8.4	3.9	0.0	2.4	3.7	0.0	7.5	4.9	4.1	0.0	10.9	2.9	3.3	0.0	13.4	1.9	2.7	3.5	4.9	3.8	2.1	6.5	6.6	0.9	0.7	19.4	1.8	8.7	15.8	3.3
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285207	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 45.7;Collecting duct cells: 75.0;Enterocytes: 75.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 7.0"	"Cell type enriched"	"Detected in single"	7	"gdT-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.4;HEL: 9.4;hTCEpi: 10.8;RPTEC TERT1: 26.7;RT4: 19.3;SCLC-21H: 8.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA			"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.0	0.2	0.6	4.0	1.1	0.0	12.9	0.6	0.9	8.7	8.5	1.2	6.3	0.2	0.8	8.2	6.0	1.5	8.7	0.1	0.6	0.1	52.2	0.1	12.3	1.5	0.4	0.0	0.6	2.8	0.4	1.5	4.7	7.0	6.1	10.5	0.8	93.5	2.9	2.4	13.1	1.3	0.4	0.4	0.9	6.2	0.8	0.3	0.4	37.3	7.2	6.3	1.4	4.1	0.0	0.1	0.1	0.1	0.4	2.9	0.0	0.0	1.0	0.0	0.1	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.4	0.0	0.4	0.2	2.7	2.7	0.0	0.0	1.9	9.4	0.0	0.0	0.0	0.0	0.3	0.0	10.8	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.3	1.2	26.7	19.3	8.3	0.0	1.0	0.0	0.0	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.1	0.6	0.9	0.6	0.1	0.4	0.0	7.0	0.3	6.0	20.8	0.0	45.7	1.4	0.0	2.2	25.5	0.0	12.5	75.0	0.0	23.2	26.6	2.2	0.1	0.1	75.7	0.0	1.3	1.2	0.6	33.2	0.0	0.2	4.3	0.0	9.8	0.0	5.4	0.0	0.3	2.1	6.8	0.0	37.4	0.4	4.7	34.0	0.0	23.2	0.0	0.0	0.1	0.0	0.2	2.9	16.9	0.0	34.7	33.5
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 140.3"	"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 731.6;Late spermatids: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 42.8;MOLT-4: 80.4;REH: 42.9;U-698: 70.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	No			Nucleoplasm	"Vesicles, Mitotic spindle"	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	8.4	8.4	6.1	6.3	8.7	20.7	9.3	9.9	8.6	8.9	11.1	6.5	6.5	10.4	9.9	8.6	8.3	7.2	11.6	12.0	7.5	4.9	14.3	9.5	6.8	5.3	6.0	5.0	11.6	8.8	10.4	19.4	13.5	8.0	9.9	6.6	8.8	7.9	6.9	14.5	8.0	14.6	11.8	8.5	5.3	8.6	51.9	5.4	140.3	10.6	4.8	6.4	9.7	8.0	9.3	16.5	24.6	4.5	18.0	14.7	5.7	6.3	2.9	12.3	9.8	4.1	4.5	27.1	3.2	3.7	5.1	8.3	3.7	6.3	22.5	15.0	3.6	9.0	3.8	3.1	6.1	7.2	9.0	5.6	27.1	4.4	4.9	4.0	8.2	9.6	4.2	4.3	5.6	5.4	4.8	3.5	42.8	10.1	1.2	8.8	4.8	80.4	3.1	9.9	3.3	4.0	42.9	8.5	5.2	5.9	3.3	5.4	5.0	10.8	4.0	5.5	9.6	9.3	4.2	2.3	4.9	4.5	3.9	4.0	4.2	3.8	70.6	3.9	2.2	2.3	24.6	2.1	22.3	14.7	3.4	5.7	6.6	6.7	7.6	4.8	9.3	10.1	11.8	2.4	18.0	4.5	16.5	6.1	5.7	6.1	8.7	9.9	8.6	7.5	4.9	6.0	5.0	8.0	5.4	29.8	20.4	15.7	43.3	22.2	30.3	70.0	38.2	54.9	33.0	45.4	31.4	191.4	79.6	29.5	731.6	22.4	31.6	116.8	23.1	95.8	33.4	41.8	31.3	35.9	24.4	35.0	37.2	20.9	9.2	294.5	71.4	15.0	5.0	17.2	32.3	24.6	24.5	32.3	70.7	74.6	34.6	25.8	21.4	52.6	55.1	17.6	83.0	35.5	42.3	22.7
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"		21	42311667-42315651	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"gallbladder: 230.9;thyroid gland: 258.3"	"Cell type enriched"	"Detected in many"	21	"Mucus-secreting cells: 36697.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	30	"eosinophil: 9.5"	"Lineage enriched"	"Detected in single"	63	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9"	"Region enriched"	"Detected in single"	20	"cerebellum: 1.7"	"Not detected"	"Not detected"			"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000		Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	2.2	1.2	0.2	16.8	0.2	0.0	4.3	0.2	0.2	45.1	66.3	0.2	0.5	40.8	2.8	1.2	5.1	8.0	230.9	0.7	0.2	0.3	1.0	0.6	12.6	0.6	0.4	0.2	2.0	4.8	0.0	0.5	0.5	0.2	3.6	63.3	0.3	54.8	0.7	0.6	1.6	70.6	1.5	0.5	5.0	1.1	0.4	0.2	0.3	258.3	14.4	72.6	1.1	1.6	0.0	0.0	9.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	28.4	0.0	0.5	0.1	44.4	4.3	0.0	3.2	0.3	0.0	0.0	8.7	0.1	0.0	0.8	0.0	0.0	13.3	0.0	36.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	14.9	22.3	0.9	17.0	37.0	0.0	13.4	1110.8	464.4	316.2	21.0	0.0	0.3	0.0	9.0	0.0	51.4	1768.3	0.0	62.1	0.6	20.3	103.0	60.8	0.9	1.9	4.8	740.8	82.9	2.6	0.8	2.3	2.5	91.1	0.0	36697.4	0.0	28.0	1779.2	7.4	0.0	0.0	0.0	6.1	0.3	0.3	33.8	0.7	1.0	1243.2	29.6
TFIP11	"DKFZP434B194, Spp382, TIP39"	ENSG00000100109	"Tuftelin interacting protein 11"	Q9UBB9	22	26491225-26512505	"Plasma proteins, Predicted intracellular proteins"	"Biomineralization, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027085			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027085: AB_1857964"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	11.8	13.5	12.7	12.7	13.8	43.9	10.9	13.8	15.4	9.4	9.5	13.1	8.9	9.9	11.8	8.9	14.5	10.7	10.3	11.8	13.2	9.6	12.3	24.7	11.0	17.7	15.5	12.0	10.3	16.3	11.1	12.0	11.5	12.2	10.5	9.8	11.9	10.9	8.7	34.2	16.3	12.7	10.2	10.6	17.8	11.1	40.6	12.3	23.8	15.4	11.0	19.0	11.1	11.5	23.8	15.5	35.4	23.8	19.6	25.5	17.8	11.1	13.2	11.4	12.9	18.3	11.1	11.5	13.7	17.5	21.5	20.4	9.9	8.1	21.8	8.6	17.0	14.2	16.6	16.3	13.2	15.9	15.9	15.5	13.4	8.5	10.1	16.8	31.0	17.2	14.2	18.0	20.4	16.1	11.6	16.4	11.3	18.0	20.8	14.3	13.7	14.1	17.0	11.0	16.3	11.0	21.4	17.6	19.3	12.4	11.3	8.7	12.5	16.4	11.8	16.1	11.8	9.6	14.7	16.1	18.2	29.7	11.4	12.6	15.4	19.6	43.1	14.4	12.5	13.5	35.4	16.9	28.6	23.8	18.2	22.1	22.9	21.1	22.2	15.5	23.8	20.2	18.4	26.8	19.6	23.8	9.7	25.5	17.8	12.7	13.8	13.8	15.4	13.2	9.6	15.5	12.0	12.2	12.3	8.9	8.9	8.2	9.4	14.9	8.0	2.8	15.3	9.4	10.3	12.2	7.9	14.9	11.6	12.8	41.4	9.5	11.9	0.0	17.8	11.7	7.3	6.8	8.1	9.7	11.7	14.3	15.5	11.1	5.6	5.4	10.3	7.4	6.8	10.0	9.6	7.3	21.6	7.6	9.2	8.0	6.4	0.0	5.9	15.6	21.3	14.6	16.2	11.7	7.1	10.0
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 112.6"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 379.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	46	"basophil: 5.5;eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	11	"HEL: 28.5;HMC-1: 39.6;K-562: 26.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.1	0.0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	2.9	0.0	0.6	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	7.8	0.9	0.2	5.3	0.9	12.7	0.0	1.2	0.0	7.9	0.1	0.0	0.4	4.0	0.0	0.0	93.5	0.2	1.1	0.4	0.5	0.0	379.7	0.3	20.6	0.0	7.4	6.9	5.7	0.0	0.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	1.8	0.0	0.7	0.7	2.0	0.5	0.1	2.5	0.5	0.6
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574051-94596257	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		Yes	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	11.1	12.2	7.9	11.4	11.8	5.8	13.4	8.0	7.8	11.9	9.0	9.0	13.4	11.1	13.7	13.2	10.3	10.5	8.7	7.7	7.0	7.0	11.8	31.9	7.8	12.5	11.8	6.8	13.9	14.1	6.2	24.3	10.8	10.1	10.5	10.6	15.4	12.5	12.7	7.6	7.9	11.1	10.3	12.6	11.9	9.8	7.2	12.6	27.1	15.8	8.9	12.5	10.9	9.2	9.9	8.0	10.5	7.0	10.4	17.4	6.7	7.4	3.1	5.2	4.7	7.7	6.2	6.5	6.8	6.5	6.4	6.2	8.5	7.3	11.4	6.9	4.7	4.2	4.7	9.2	5.3	6.6	9.0	3.6	9.2	3.6	7.9	9.8	31.4	6.3	7.2	4.2	3.6	10.3	5.1	5.9	8.4	9.0	4.0	5.8	4.5	8.6	16.2	6.9	12.0	4.0	7.3	5.3	6.7	8.1	3.3	7.4	4.1	5.1	10.8	19.0	9.1	4.8	17.1	5.5	2.6	6.8	3.9	5.6	9.1	4.9	42.1	7.0	11.7	7.0	10.5	5.3	9.6	9.6	6.2	14.5	9.9	11.3	10.5	8.0	7.3	17.4	12.4	1.5	10.4	7.0	7.1	12.5	6.7	7.9	11.8	8.0	7.8	7.0	7.0	11.8	6.8	10.1	12.6	11.9	5.0	15.6	9.5	2.2	4.5	4.7	0.0	10.7	10.3	7.0	2.0	12.9	8.3	9.8	1.1	6.3	5.5	0.0	8.0	15.4	12.0	9.9	10.5	19.8	10.0	1.6	5.2	9.2	7.6	0.4	13.3	9.6	8.5	12.6	8.1	6.3	8.2	7.0	7.8	13.3	4.0	25.8	6.4	12.0	10.4	3.1	8.7	8.7	8.0	8.7
TGFA		ENSG00000163235	"Transforming growth factor alpha"	P01135	2	70447280-70554193	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 36.6;Pancreatic endocrine cells: 47.6;Urothelial cells: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.3;eosinophil: 14.0;neutrophil: 14.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.7"	"Cell line enhanced"	"Detected in many"		"A-431: 24.0;CAPAN-2: 29.7;HBEC3-KT: 25.9;OE19: 19.0;RPTEC TERT1: 26.1;U-87 MG: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042297	Approved		Approved	Vesicles	"Secreted to blood"	No	No	57900		Vesicles		"HPA042297: AB_10793878"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.69e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.21e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (9.19e-2)"	2.0	0.5	8.4	4.3	10.7	1.2	6.2	3.5	7.9	5.7	9.4	21.4	0.3	7.4	1.2	2.8	23.8	5.7	14.6	0.8	10.7	6.9	12.4	4.0	3.5	4.2	10.9	5.2	0.5	12.0	1.0	0.8	1.7	9.4	2.2	7.3	9.7	6.3	1.2	0.4	10.8	13.7	1.3	22.5	5.1	7.6	2.3	12.8	0.2	7.4	17.4	12.1	5.4	10.8	0.0	0.6	14.7	0.4	0.2	2.7	0.4	24.0	3.8	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	29.7	0.0	15.3	0.1	4.1	12.9	0.2	25.9	0.0	0.0	0.6	0.0	0.6	2.0	0.0	0.3	0.0	0.0	10.4	0.0	10.2	1.2	0.0	1.9	0.0	0.1	0.0	0.9	0.0	0.5	0.4	19.0	7.3	0.0	0.1	6.3	26.1	9.3	0.2	0.0	2.0	0.0	0.0	0.0	3.3	0.2	0.2	0.1	1.8	0.0	5.3	0.1	0.1	0.0	24.6	0.8	8.9	6.3	0.4	14.0	1.0	0.1	2.7	0.0	0.6	0.6	0.6	0.0	0.3	0.2	14.7	0.2	0.0	0.0	0.0	0.4	8.4	10.7	3.5	7.9	10.7	6.9	10.9	5.2	9.4	12.8	6.0	2.4	0.0	6.5	14.3	1.4	1.4	28.1	12.0	6.8	24.4	0.0	0.0	1.7	36.6	14.8	1.2	14.9	0.0	8.8	0.0	0.5	11.0	5.7	1.5	3.0	0.0	1.2	0.0	2.2	1.4	0.3	3.1	0.0	30.7	5.8	8.6	47.6	8.5	0.0	6.1	0.7	0.0	0.9	0.0	0.2	21.8	0.0	2.2	4.7	56.3
TGFB1	"CED, DPD1, TGFB, TGFbeta"	ENSG00000105329	"Transforming growth factor beta 1"	P01137	19	41301587-41353911	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 377.2;Hofbauer cells: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000361, HPA073356"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	1290000	38000000	"Golgi apparatus"	Cytosol	"CAB000361: AB_2201910, HPA073356: "	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (8.51e-3)"	"unprognostic (5.63e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.65e-3)"	"unprognostic (2.79e-2)"	"unprognostic (6.39e-2)"	"unprognostic (4.86e-3)"	24.3	14.4	7.7	29.8	11.9	53.1	19.0	2.2	8.2	27.8	15.3	14.3	11.5	11.4	24.1	12.8	24.5	13.0	15.6	17.6	8.8	6.5	19.2	10.4	32.4	33.3	12.0	4.1	15.3	8.2	6.9	9.7	54.7	11.7	17.2	5.8	10.3	10.9	15.9	8.7	14.0	17.6	14.6	12.8	55.8	12.8	9.5	12.3	30.6	10.3	9.1	30.6	28.7	24.6	0.7	1.4	7.5	2.2	0.5	1.7	1.3	14.5	22.9	1.2	0.2	10.6	9.4	2.9	21.1	19.0	6.8	4.6	9.7	9.1	14.4	22.8	28.6	6.7	7.9	4.2	13.5	2.4	19.2	4.5	48.6	5.5	12.3	13.8	13.4	33.2	12.2	4.3	13.2	8.4	33.9	34.2	6.0	26.0	36.4	6.3	10.7	11.4	19.5	2.5	2.9	13.7	12.3	3.2	21.7	12.1	6.3	0.2	1.6	5.8	0.3	4.1	7.4	0.5	12.0	43.2	26.8	20.9	5.6	23.0	20.1	7.8	9.5	26.2	26.8	4.7	1.5	1.9	7.5	1.7	2.2	1.3	0.4	0.9	0.9	1.4	0.7	0.7	0.9	4.7	0.5	2.0	1.4	0.5	1.3	7.7	11.9	2.2	7.6	8.8	6.5	12.0	4.1	11.7	12.3	0.0	0.0	38.4	25.0	39.4	0.1	1.6	5.1	2.7	0.0	15.7	0.0	2.6	0.0	11.9	0.4	42.2	0.0	0.0	14.4	377.2	50.3	9.8	66.6	2.1	124.5	0.0	0.0	65.1	113.9	1.1	11.2	100.1	21.9	10.8	0.3	0.3	34.0	11.6	17.0	7.9	0.5	38.8	45.3	1.7	7.8	16.6	46.6	119.6	0.1	27.1
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Leydig cells: 85.4;Peritubular cells: 168.3;Sertoli cells: 219.9;Smooth muscle cells: 134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		13000000	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	16.8	4.1	1.0	14.4	1.4	0.3	18.5	1.2	1.6	42.9	51.1	1.8	22.1	5.8	80.7	22.7	34.1	28.9	36.2	11.8	0.9	0.7	8.6	2.8	11.2	10.6	1.1	1.3	40.3	2.2	5.1	1.8	11.5	2.3	37.7	10.4	11.1	7.1	34.7	5.7	5.9	12.8	71.9	1.8	11.5	19.6	10.9	0.9	0.7	5.8	7.8	3.6	69.9	23.5	1.3	0.5	8.8	0.0	0.0	2.5	2.3	4.2	5.3	8.7	0.0	8.6	15.8	0.1	22.8	21.4	14.3	9.7	2.2	1.4	0.0	21.5	19.5	9.6	6.3	1.8	4.2	18.8	0.0	0.0	5.0	9.8	1.1	22.0	0.0	6.5	10.2	6.2	8.9	5.3	33.8	9.4	0.0	0.5	0.0	17.4	0.0	0.0	0.5	0.4	0.4	5.4	0.0	10.4	0.0	4.0	2.1	0.0	6.2	8.8	0.0	4.4	7.4	0.0	0.5	25.4	25.8	6.3	7.1	9.9	0.0	0.0	0.0	11.4	0.2	15.8	8.8	0.0	0.1	0.3	0.0	0.5	1.3	1.4	0.2	0.1	0.5	0.2	1.0	0.2	0.0	0.0	0.5	2.5	2.3	1.0	1.4	1.2	1.6	0.9	0.7	1.1	1.3	2.3	0.9	6.0	3.7	0.0	18.4	11.2	0.4	8.1	2.5	0.0	2.3	7.0	0.0	1.2	6.6	27.3	0.9	35.1	1.6	0.0	20.6	1.5	58.4	4.7	5.8	0.0	11.3	0.0	0.0	30.7	0.8	2.1	85.4	3.2	38.8	7.2	4.2	7.1	19.0	0.0	168.3	12.6	1.3	219.9	134.8	1.1	2.7	9.8	1.5	0.5	5.3	4.4
TGFB3	"ARVD, ARVD1"	ENSG00000119699	"Transforming growth factor beta 3"	P10600	14	75958099-75982991	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 31.7;Glandular cells: 27.5;Late spermatids: 36.7;Leydig cells: 25.0;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.8"	"Group enriched"	"Detected in many"	5	"SK-BR-3: 50.4;T-47d: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA063582			Approved	Vesicles	"Secreted to blood"	NA	NA	44800		Vesicles		"HPA063582: AB_2685049"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (4.01e-7)"	"unprognostic (6.38e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.27e-3)"	6.9	4.7	10.6	8.4	14.0	0.4	7.8	3.2	8.6	29.2	4.1	6.7	13.1	2.3	10.4	21.4	4.4	4.9	21.5	17.9	11.9	6.6	4.8	12.2	8.6	4.2	16.8	7.0	3.1	11.1	6.8	4.6	31.0	8.4	25.8	3.2	10.0	5.0	12.0	13.3	1.5	2.9	20.7	13.0	2.2	4.5	3.8	8.8	4.2	4.4	5.7	8.2	11.6	6.4	0.4	0.1	0.0	0.0	0.0	1.8	0.2	0.4	0.1	0.5	5.5	1.0	1.3	0.1	0.2	0.4	0.2	0.2	0.3	1.3	0.0	0.4	1.0	0.1	0.3	1.1	0.1	0.1	0.3	0.5	0.0	1.1	0.6	1.3	0.2	0.3	4.6	0.1	0.4	0.1	1.0	1.3	1.1	0.5	2.5	0.3	2.5	0.2	0.2	0.1	0.3	1.9	1.2	1.6	0.2	0.5	0.2	9.1	2.1	1.6	50.4	0.3	0.7	35.3	0.0	0.3	0.8	1.8	0.8	2.2	0.2	0.2	0.1	1.4	0.3	1.3	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.1	0.6	0.0	0.4	1.8	0.5	0.0	0.0	0.0	0.1	0.3	0.2	10.6	14.0	3.2	8.6	11.9	6.6	16.8	7.0	8.4	8.8	0.0	3.2	0.0	1.2	3.9	0.7	3.4	0.0	6.7	2.3	1.8	3.9	0.5	0.0	0.4	17.1	7.5	1.1	0.0	1.2	0.3	31.7	27.5	0.0	0.2	0.8	0.0	0.0	8.0	0.6	36.7	25.0	1.2	10.1	1.0	0.6	1.7	0.4	0.0	12.0	0.3	2.9	32.3	20.6	0.2	1.0	2.8	1.1	1.3	0.4	0.7
TGFBR3	"betaglycan, BGCAN"	ENSG00000069702	"Transforming growth factor beta receptor 3"	Q03167	1	91680343-91906335	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 105.0;Ito cells: 311.2;Leydig cells: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	22	"NK-cells: 9.0;T-cells: 21.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 67.2;ASC TERT1: 32.8;U-2197: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008257, CAB018971"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA		29000000	Cytosol		"CAB018971: , HPA008257: AB_1080258"	"unprognostic (7.57e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (9.39e-3)"	"prognostic favorable (4.84e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.08e-2)"	40.1	15.9	3.2	6.8	3.1	1.6	63.5	1.8	4.4	30.1	15.2	3.5	30.0	3.4	17.6	21.0	22.2	17.6	23.3	16.3	3.9	1.9	12.5	11.9	18.4	18.1	2.6	2.0	62.4	8.9	4.4	4.4	25.1	4.5	21.7	5.6	8.8	14.7	46.5	19.2	13.4	9.8	34.4	4.1	27.1	11.1	14.0	3.0	1.1	7.5	6.5	3.1	39.2	42.1	0.0	0.6	0.6	0.6	9.0	21.3	3.9	2.7	2.7	4.1	0.7	67.2	32.8	13.0	2.0	10.2	2.4	2.9	1.2	0.4	0.0	0.5	3.7	1.9	0.4	1.0	0.3	1.8	9.5	2.2	0.0	3.4	11.3	1.4	0.1	0.0	7.9	1.3	5.2	1.2	0.3	1.2	0.0	6.5	0.2	0.7	0.0	0.0	0.0	1.7	1.2	0.9	0.1	1.4	0.5	0.9	16.4	0.1	0.0	1.0	0.0	5.7	1.7	0.3	1.0	3.6	4.0	1.0	22.8	0.4	10.1	0.9	0.0	0.8	0.5	0.5	0.6	0.0	0.0	21.3	0.1	11.6	0.0	5.4	11.4	0.0	0.0	1.7	8.0	0.3	9.0	0.6	0.6	2.4	3.9	3.2	3.1	1.8	4.4	3.9	1.9	2.6	2.0	4.5	3.0	8.9	11.9	3.0	10.4	33.4	0.2	17.3	28.1	6.7	6.8	29.6	2.0	23.5	3.3	1.7	48.3	64.2	0.7	23.3	4.2	9.3	105.0	7.3	2.3	17.8	9.7	0.0	23.1	311.2	19.6	18.5	135.4	3.8	33.7	0.0	0.5	2.2	3.5	0.0	70.0	15.9	0.2	12.9	35.4	0.7	1.7	29.7	48.5	30.5	2.3	5.4
TGFBR3L		ENSG00000260001	"Transforming growth factor beta receptor 3 like"	H3BV60	19	7916145-7919097	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pituitary gland: 56.6"	"Cell type enhanced"	"Detected in many"	10	"Sertoli cells: 12.9;T-cells: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"PC-3: 5.7;REH: 13.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074356	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA074356: AB_2686681"	"unprognostic (1.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.65e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.62e-3)"	0.3	2.0	1.6	0.2	2.8	0.6	0.3	1.9	6.4	5.0	0.6	0.0	0.3	6.0	2.8	0.5	0.3	0.7	0.2	2.1	0.7	0.8	3.7	4.0	0.3	0.1	0.5	1.7	0.3	0.3	0.9	56.6	0.4	1.9	2.5	0.1	0.6	0.8	0.7	0.3	0.5	5.7	2.0	0.6	0.3	0.4	0.5	0.0	0.0	0.3	0.0	0.1	1.1	0.8	0.1	0.3	0.0	0.1	0.0	2.9	0.1	0.1	0.2	0.1	0.5	0.1	0.0	3.3	2.7	0.0	0.2	0.0	0.5	0.0	0.1	3.0	0.1	0.0	2.0	0.0	0.0	0.0	3.4	1.1	0.5	0.2	0.6	0.2	1.7	0.4	0.2	0.1	0.0	0.0	0.3	0.0	3.0	0.7	0.5	0.0	1.5	1.2	0.2	0.6	0.2	5.7	13.8	0.0	3.1	0.2	0.0	1.0	2.5	0.3	0.0	0.7	0.0	0.9	0.6	0.2	1.8	2.9	2.0	0.9	0.8	0.9	0.8	0.4	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.6	0.1	0.9	1.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.3	0.0	0.1	1.6	2.8	1.9	6.4	0.7	0.8	0.5	1.7	1.9	0.0	0.0	0.0	0.8	3.2	1.3	1.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.5	0.0	0.0	0.0	0.2	0.5	1.7	0.6	0.0	2.8	0.2	0.0	0.0	2.5	0.0	3.3	1.1	0.5	5.0	0.0	0.0	2.7	0.4	0.0	1.1	4.4	2.4	12.9	4.2	0.2	0.9	1.3	0.3	6.9	0.0	0.4
TGFBRAP1	"TRAP-1, TRAP1, VPS3"	ENSG00000135966	"Transforming growth factor beta receptor associated protein 1"	Q8WUH2	2	105264391-105330034	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037672, HPA038397"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA037672: AB_2675597, HPA038397: AB_10669782"	"unprognostic (1.66e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-2)"	12.7	11.8	9.4	8.9	12.5	23.4	13.6	14.1	18.3	8.3	10.1	15.2	11.1	8.4	11.8	8.4	10.1	9.4	7.1	7.7	9.2	7.2	9.3	6.9	8.8	12.9	11.2	9.9	10.0	11.7	16.4	7.5	12.4	10.9	10.5	10.0	15.5	10.9	13.7	15.3	14.5	10.0	11.2	10.4	11.9	17.1	3.0	11.8	10.3	13.3	9.2	10.5	11.5	12.9	3.3	3.0	3.1	2.5	2.6	5.5	2.0	14.3	11.4	8.3	10.3	9.1	7.2	17.0	10.5	14.4	17.9	17.1	16.7	8.9	14.6	11.4	11.8	18.2	8.8	14.8	24.9	14.8	15.5	15.7	19.6	9.1	13.2	8.3	18.1	15.0	8.7	15.0	14.8	13.2	9.5	18.9	12.9	17.6	7.2	21.5	9.6	12.8	11.7	10.6	9.9	9.6	14.6	13.2	21.1	11.1	17.7	16.5	11.0	8.6	17.4	16.9	6.3	8.6	11.2	13.5	11.3	17.3	9.4	10.6	7.6	9.2	16.1	8.0	12.7	23.3	1.2	2.5	3.1	5.5	2.0	4.8	2.0	3.7	3.1	1.9	3.3	2.3	3.6	1.0	2.6	1.7	3.0	2.6	2.0	9.4	12.5	14.1	18.3	9.2	7.2	11.2	9.9	10.9	11.8	6.0	7.4	5.1	3.0	7.1	12.0	5.5	0.0	1.4	9.1	5.2	15.7	9.0	1.7	5.2	0.1	7.5	4.2	0.0	9.3	4.4	5.6	6.1	2.3	5.4	10.7	14.3	10.9	15.4	12.7	0.0	6.9	5.5	3.3	3.6	9.4	8.9	7.1	0.0	7.8	5.1	6.2	25.8	5.7	0.3	1.1	11.4	6.2	8.6	9.3	2.6
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA053786: AB_2682261, HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	14.0	6.1	2.8	20.0	3.1	4.1	7.8	1.3	3.5	13.7	8.8	4.0	3.5	3.2	23.7	7.9	6.8	18.0	10.2	7.6	2.7	2.5	9.2	13.2	13.7	16.6	4.4	1.6	17.9	33.3	10.5	3.4	9.1	3.9	9.3	3.7	12.1	14.9	5.7	4.1	5.6	8.1	13.7	3.2	20.3	7.0	16.9	2.8	26.7	12.9	6.9	22.1	10.0	7.2	8.2	7.7	14.7	5.4	4.2	7.6	3.8	7.0	1.7	20.3	23.0	3.0	2.7	7.4	4.0	4.7	9.7	7.3	10.4	9.0	19.0	10.7	3.9	4.4	7.3	16.5	10.5	9.5	8.9	5.9	23.8	4.1	13.7	4.6	10.0	5.8	4.3	7.0	2.0	7.6	8.8	9.6	9.2	11.4	11.7	4.7	10.0	17.0	19.2	17.0	10.3	5.1	14.7	24.3	10.3	6.4	4.7	6.1	18.1	1.3	10.8	10.1	17.0	12.9	22.5	6.9	1.5	6.4	0.1	7.6	13.4	5.0	17.9	0.1	12.1	7.6	14.7	5.4	1.7	4.8	4.9	5.2	8.2	4.4	4.9	7.4	6.5	7.6	6.3	2.2	4.2	3.4	7.7	4.2	3.8	2.8	3.1	1.3	3.5	2.7	2.5	4.4	1.6	3.9	2.8	8.9	9.1	6.5	26.2	39.6	0.1	11.2	12.7	5.3	9.1	7.0	2.0	5.2	6.6	16.4	2.0	14.3	0.0	0.0	6.7	1.0	16.9	15.0	16.1	5.9	8.7	0.0	6.3	11.6	7.0	1.9	5.8	8.8	13.5	7.2	2.6	7.2	13.3	6.2	7.1	6.1	1.9	6.5	15.6	2.3	25.6	22.2	7.6	12.8	3.3	13.9
TGIF2LX		ENSG00000153779	"TGFB induced factor homeobox 2 like, X-linked"	Q8IUE1	X	89921882-89922883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 13.3"	"Group enriched"	"Detected in some"	57	"Early spermatids: 59.2;Late spermatids: 39.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SH-SY5Y: 10.2;U-2 OS: 12.0;U-266/84: 18.5"									HPA034543	Supported		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA034543: AB_10603037"															"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	12.0	0.3	0.0	1.0	18.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 11.9;Club cells: 6.8;Distal tubular cells: 24.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 78.3"	"Region enriched"	"Detected in single"	11	"cerebellum: 3.0"	"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;HaCaT: 18.0;HeLa: 11.8;MCF7: 12.9;SK-BR-3: 16.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015159, HPA040171"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		430000	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869"	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	2.9	0.2	0.2	0.4	0.2	0.2	0.7	3.0	0.3	10.1	1.0	0.2	0.2	0.3	0.5	2.0	106.0	1.3	0.2	0.6	0.2	0.0	0.6	0.3	0.9	0.4	0.2	0.2	0.7	1.3	0.2	0.2	0.9	0.2	0.5	0.3	0.4	12.8	1.4	0.7	9.3	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.5	0.4	86.8	70.0	0.4	17.2	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	1.5	0.8	0.7	0.0	0.6	13.1	0.3	0.2	0.7	1.3	0.9	1.3	0.8	1.7	1.0	0.2	18.0	2.1	1.5	0.5	1.4	2.5	1.0	11.8	4.1	0.6	0.6	1.1	1.1	7.1	0.4	1.5	0.4	0.5	2.5	0.7	0.8	0.5	12.9	0.5	1.4	0.2	0.8	1.6	0.8	0.1	0.8	0.5	1.5	0.9	1.2	0.2	16.0	0.0	1.1	1.1	0.8	0.6	0.8	3.8	1.5	0.6	1.1	1.2	0.2	0.3	1.5	0.9	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.2	0.2	3.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	11.9	1.4	0.0	4.2	0.2	0.8	0.8	0.0	0.0	6.8	0.0	0.0	1.1	24.9	1.9	0.1	0.0	0.0	0.0	0.8	0.6	0.6	3.1	4.6	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.4	0.1	0.6	0.0	0.3	0.0	0.8	1.6	1.0	0.0	0.0	4.6
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127387-38166578	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 187.6;placenta: 212.7"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"		Yes	No		1700000	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	33.3	9.5	6.0	18.3	8.1	1.0	7.7	4.3	7.5	94.3	12.6	4.0	4.7	8.4	54.6	21.7	15.8	58.7	62.8	77.1	7.5	3.4	25.3	187.6	61.2	16.4	6.9	3.0	18.7	5.0	5.2	25.6	212.7	8.5	33.6	6.3	57.4	1.9	17.1	19.3	0.7	12.8	43.9	5.7	20.4	13.6	7.4	6.4	0.8	17.0	3.4	3.1	38.2	21.6	1.9	2.4	0.0	2.5	0.0	0.0	0.2	6.3	4.7	0.0	0.1	4.9	0.5	2.4	9.6	4.6	0.0	0.1	7.8	155.5	0.0	52.3	0.1	11.1	0.1	0.0	22.5	0.3	0.0	0.0	1.0	0.2	3.4	20.3	0.0	0.0	0.5	0.0	4.1	0.0	102.6	70.7	0.0	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.9	0.0	0.0	0.1	22.6	0.0	0.8	3.3	0.2	0.0	92.1	0.1	5.9	0.7	4.5	0.0	0.0	0.0	6.3	0.0	1.8	0.0	0.2	0.0	0.0	2.5	0.0	1.9	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	8.1	4.3	7.5	7.5	3.4	6.9	3.0	8.5	6.4	8.9	28.9	15.2	9.8	0.5	0.0	156.9	48.4	16.0	27.3	14.0	2.0	276.1	3.3	184.1	2.3	166.8	4.2	93.5	124.7	21.8	45.8	45.4	2.3	137.1	49.2	0.0	0.0	326.6	22.9	3.5	1.1	11.4	0.0	10.8	0.0	0.4	240.4	0.0	5.6	19.0	0.5	0.0	65.7	0.5	4.9	0.0	312.9	1.3	0.4	12.3
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171877	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"adrenal gland: 83.5;brain: 41.4"	"Cell type enhanced"	"Detected in some"	21	"Collecting duct cells: 1.8;Extravillous trophoblasts: 7.9;Leydig cells: 3.1;Syncytiotrophoblasts: 1.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 4.0"	"Group enriched"	"Detected in many"	6	"hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"PC-3: 35.9;SK-BR-3: 12.8"	"Region enhanced"	"Detected in many"		"olfactory region: 220.1"	"Region enriched"	"Detected in many"	19	"midbrain: 692.0"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374"	"unprognostic (1.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.75e-4)"	"unprognostic (8.82e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.18e-2)"	1.3	83.5	0.0	0.3	5.4	0.2	0.2	0.0	0.7	1.8	0.2	6.2	0.0	0.2	0.3	0.3	0.2	0.3	0.4	0.2	0.3	15.5	0.2	0.2	0.2	0.2	41.4	0.0	0.3	0.3	0.2	0.2	0.9	41.2	0.6	0.2	0.3	0.2	2.0	0.2	0.5	0.4	0.2	0.0	0.3	0.2	0.3	1.5	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	35.9	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.3	15.5	41.4	0.0	41.2	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.1
THADA	"ARMC13, FLJ21877, GITA, KIAA1767"	ENSG00000115970	"THADA, armadillo repeat containing"	Q6YHU6	2	43230836-43596046	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035191, HPA035192"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035191: AB_10670290, HPA035192: AB_2674512"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (8.27e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.14e-1)"	15.7	12.5	8.6	14.2	11.9	12.0	15.8	8.8	10.6	15.0	10.6	13.8	20.2	6.6	25.3	16.8	12.8	15.8	9.7	11.8	7.5	7.1	12.6	18.5	13.5	20.0	10.9	6.1	15.8	17.1	27.2	29.9	9.6	10.9	16.4	10.1	12.7	17.7	12.6	12.7	16.2	11.7	12.4	11.4	17.2	11.1	12.3	10.0	23.1	17.9	12.3	23.3	12.6	19.4	4.9	5.2	14.7	4.7	6.5	5.4	2.6	13.1	15.8	7.2	0.2	19.5	16.9	10.4	8.8	7.3	8.4	7.2	9.2	7.9	12.1	15.2	10.5	11.4	12.3	11.1	15.1	14.5	10.0	11.0	8.6	6.3	12.2	6.8	13.3	7.0	11.0	13.8	17.6	23.1	8.8	11.3	4.5	15.3	6.5	10.1	16.5	13.1	14.9	14.4	19.0	9.0	6.1	13.0	9.1	13.2	11.8	9.5	14.8	8.4	8.2	7.9	8.7	8.4	7.0	9.6	13.9	10.2	10.5	15.9	16.5	10.2	13.7	11.2	13.3	11.1	14.7	3.3	1.4	4.5	4.7	4.8	4.8	5.0	5.4	5.2	4.9	4.7	5.3	2.6	6.5	3.4	4.1	5.3	2.6	8.6	11.9	8.8	10.6	7.5	7.1	10.9	6.1	10.9	10.0	17.9	11.8	7.9	15.9	7.6	11.6	7.5	17.8	18.7	14.8	14.0	15.7	6.6	1.7	7.8	16.4	7.1	3.3	0.0	8.4	4.7	8.7	10.7	5.8	14.0	8.8	3.2	7.0	11.6	5.7	7.4	9.2	8.6	3.3	5.4	4.5	6.7	5.9	6.2	8.1	5.4	24.9	0.0	7.5	20.2	12.8	3.9	4.0	7.5	5.6	6.9
THAP10		ENSG00000129028	"THAP domain containing 10"	Q9P2Z0	15	70881342-70892785	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 17.0;Collecting duct cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 27.6"									"HPA041416, HPA073220"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041416: AB_10795592, HPA073220: "	"unprognostic (1.00e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.15e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.25e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.44e-3)"	3.3	4.6	7.5	2.5	10.9	0.3	3.9	13.4	16.0	4.8	4.1	9.9	0.8	4.3	4.2	4.0	3.9	6.3	3.0	9.4	7.8	10.3	5.8	3.7	3.6	1.8	9.5	6.5	7.8	3.7	8.7	4.6	3.6	11.7	5.7	3.8	7.0	3.7	6.5	3.8	2.4	2.4	4.1	11.6	1.8	5.1	6.2	7.6	0.2	7.0	1.8	1.6	5.5	3.8	0.6	1.1	0.0	7.3	0.8	0.4	0.2	4.7	8.2	5.3	6.8	2.7	3.2	0.1	9.2	4.0	7.9	9.4	1.2	6.5	0.0	5.8	2.4	9.9	7.3	11.2	2.1	7.0	0.0	5.8	1.7	4.7	0.5	1.4	0.4	3.5	1.1	3.5	4.4	4.2	5.6	3.8	0.0	0.5	0.0	5.2	3.6	0.0	1.6	7.8	3.5	3.2	0.0	6.7	0.2	3.1	3.9	5.7	6.1	6.3	2.7	3.9	5.5	3.2	3.8	3.0	5.6	3.8	27.6	6.4	2.3	2.7	0.0	3.3	0.6	7.8	0.0	0.6	0.0	0.1	0.9	0.1	0.6	0.4	0.0	1.1	0.3	0.0	0.3	0.0	0.8	7.3	0.0	0.3	0.2	7.5	10.9	13.4	16.0	7.8	10.3	9.5	6.5	11.7	7.6	0.0	0.3	0.0	3.6	1.5	17.0	5.5	0.0	4.0	1.2	10.4	0.0	0.1	8.3	2.5	6.1	2.2	0.8	0.0	1.0	0.2	2.2	1.8	0.0	1.0	1.2	1.6	2.9	0.6	0.3	4.7	2.3	0.9	0.0	0.0	1.3	4.7	0.7	2.9	4.6	4.8	4.1	0.0	2.0	9.9	1.9	1.3	0.1	0.0	2.9	3.7
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842082-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	15.2	12.1	13.4	13.5	14.5	8.5	31.4	15.0	17.2	23.8	19.1	16.7	13.0	12.0	19.9	13.3	18.9	18.0	16.7	29.5	12.4	12.4	13.9	13.5	14.9	22.2	11.8	9.7	22.6	23.1	17.2	13.3	14.2	12.7	20.4	11.0	17.2	14.8	20.6	40.7	17.7	16.0	19.8	10.4	21.0	15.8	11.8	9.8	30.2	29.0	17.3	18.0	21.7	27.1	10.3	8.7	8.5	10.8	11.5	19.9	10.6	12.5	16.4	11.5	10.8	16.1	11.0	12.1	6.5	11.2	15.6	13.5	21.0	9.8	27.5	13.4	6.5	9.4	14.8	20.1	11.9	8.9	10.2	23.0	10.9	9.5	25.5	14.7	13.9	12.5	10.1	11.8	10.7	9.4	11.4	11.4	19.0	15.7	6.4	9.4	19.6	15.0	25.0	23.1	15.0	14.4	29.7	13.7	24.7	7.8	8.2	16.1	18.2	18.8	6.8	13.5	8.6	16.7	14.3	9.1	10.0	12.2	9.0	7.9	25.8	25.6	27.1	7.7	15.4	10.7	3.5	8.4	8.5	16.8	10.8	13.4	8.9	15.4	15.4	8.7	10.3	19.9	15.8	2.5	11.5	9.7	7.0	18.4	10.6	13.4	14.5	15.0	17.2	12.4	12.4	11.8	9.7	12.7	9.8	20.8	12.5	18.4	21.0	26.0	25.3	13.7	10.2	5.3	4.5	10.4	3.9	17.7	44.7	7.4	0.8	21.5	10.9	0.0	8.1	20.8	20.6	18.6	7.0	10.9	19.5	7.9	12.7	17.2	15.0	1.7	21.9	13.4	10.1	15.4	14.6	27.8	6.0	0.0	29.4	16.5	13.5	19.4	23.6	17.9	25.4	34.3	11.3	30.5	16.0	14.7
THAP12	"DAP4, P52rIPK, PRKRIR, THAP0"	ENSG00000137492	"THAP domain containing 12"	O43422	11	76349956-76380971	"Plasma proteins, Predicted membrane proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 25.9;Exocrine glandular cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 71.5"	"Low region specificity"	"Detected in all"							HPA008758	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008758: AB_1855714"	"unprognostic (2.79e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-2)"	17.0	15.4	19.4	15.5	16.9	17.1	26.4	28.8	15.5	14.6	14.5	7.1	7.2	11.9	17.9	13.7	12.5	14.9	10.2	20.6	13.6	11.2	17.0	25.3	13.2	18.5	11.7	8.7	15.2	32.3	10.4	16.2	20.1	14.2	12.8	16.3	8.2	12.4	12.6	20.6	9.3	14.5	13.8	12.7	21.9	13.8	14.4	13.4	43.2	16.3	11.6	17.2	11.9	23.3	5.1	2.9	2.0	2.1	7.5	7.7	2.4	10.7	8.7	16.6	9.3	11.3	16.2	10.0	11.2	11.7	14.2	12.6	17.3	11.6	29.5	17.2	10.7	12.4	10.7	20.2	13.3	22.8	22.1	6.4	21.0	6.2	8.0	12.5	26.6	10.5	11.5	17.6	12.6	23.7	8.6	12.2	21.1	24.3	16.7	12.6	11.7	22.9	15.0	6.8	28.9	9.5	17.2	37.9	30.5	8.2	11.5	16.2	10.8	10.9	12.1	5.9	11.6	12.2	10.5	10.9	17.0	27.9	34.5	9.8	14.9	15.7	71.5	4.1	14.9	9.1	1.1	2.1	2.0	6.6	2.1	7.7	4.9	6.9	7.2	2.9	5.1	5.1	6.6	0.6	7.5	2.0	1.3	6.3	2.4	19.4	16.9	28.8	15.5	13.6	11.2	11.7	8.7	14.2	13.4	23.8	25.9	0.0	0.0	0.0	0.0	0.0	0.0	10.7	11.4	10.4	0.0	12.3	11.6	9.5	0.0	0.0	0.0	0.0	22.9	18.1	0.0	0.0	7.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	14.4	0.0	0.0	13.9	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
THAP2	DKFZP564I0422	ENSG00000173451	"THAP domain containing 2"	Q9H0W7	12	71663009-71680639	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 335.0;Late spermatids: 120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039790	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA039790: AB_10795157"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.51e-4)"	"unprognostic (1.24e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.80e-2)"	19.8	31.3	10.9	9.9	13.3	14.2	6.1	24.1	14.1	7.7	6.4	7.3	6.2	6.6	7.1	20.0	10.0	6.9	10.2	7.9	11.6	8.1	6.7	5.9	6.8	7.9	16.3	10.4	9.9	6.1	5.5	20.6	7.9	12.6	8.4	6.8	2.5	5.4	5.5	5.7	6.5	6.3	5.3	18.2	7.4	8.2	21.0	16.0	7.0	8.0	4.2	7.7	7.8	11.6	6.5	3.8	2.8	4.1	8.4	11.4	3.1	3.7	4.8	11.3	8.5	8.4	7.0	5.6	6.0	5.5	5.8	4.9	4.6	4.9	2.6	4.1	3.9	7.0	6.8	10.8	3.4	7.5	11.1	5.9	7.3	8.1	7.6	7.5	4.4	3.4	5.2	14.5	5.6	12.2	12.0	8.9	12.9	5.4	5.6	7.7	1.2	3.6	4.4	5.6	7.7	8.0	5.2	3.7	12.7	6.7	5.9	7.9	12.5	6.3	3.9	5.2	8.2	7.1	4.7	3.9	6.0	2.8	5.1	3.9	7.0	8.6	6.0	3.4	5.2	3.6	2.0	2.8	2.8	5.0	3.9	8.2	5.7	7.0	4.8	3.8	6.5	11.4	7.6	2.5	8.4	4.1	1.9	6.8	3.1	10.9	13.3	24.1	14.1	11.6	8.1	16.3	10.4	12.6	16.0	0.0	11.2	16.7	23.3	17.4	11.7	8.7	5.1	10.7	4.5	3.5	3.9	3.4	8.3	6.8	335.0	7.1	11.8	0.0	4.8	6.0	13.1	14.5	57.7	3.9	11.9	12.7	5.2	8.0	7.5	120.5	10.6	15.9	74.2	10.0	7.2	9.8	6.1	10.2	5.3	12.4	7.0	0.0	22.7	17.6	6.8	25.7	2.5	15.0	7.3	21.8
THAP3		ENSG00000041988	"THAP domain containing 3"	Q8WTV1	1	6624866-6635586	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067114	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		No	No			Nucleoplasm	"Nucleoli, Mitochondria"	"HPA067114: AB_2685782"	"unprognostic (1.82e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.26e-3)"	14.2	17.2	16.4	11.4	16.8	12.9	31.4	21.5	20.3	16.5	16.6	13.8	11.8	12.0	15.2	13.6	11.8	16.3	11.9	19.0	16.0	14.5	17.2	17.3	10.8	15.5	18.1	14.1	23.7	28.8	12.1	14.2	11.4	17.6	17.0	7.2	11.5	24.8	16.7	20.9	14.2	11.4	12.7	13.0	15.3	12.0	11.9	16.3	11.6	22.6	9.0	12.9	17.2	21.6	22.2	18.0	10.6	14.7	17.0	22.0	15.0	9.9	9.4	8.6	12.4	14.3	12.9	8.3	9.0	11.8	24.0	15.0	12.6	6.3	8.8	12.2	9.9	8.9	7.9	13.6	8.0	8.4	15.1	22.3	10.1	12.6	11.2	17.9	7.1	10.5	12.0	10.3	15.1	13.3	14.7	10.3	15.5	10.2	11.4	8.8	6.9	12.4	16.2	7.4	11.7	16.0	11.9	10.5	12.7	10.7	2.4	11.4	12.9	11.0	15.2	20.8	7.5	9.7	12.9	9.3	12.8	7.7	8.7	14.0	12.9	13.7	11.6	10.8	15.4	7.2	10.2	14.7	10.6	20.1	11.7	20.2	17.1	19.7	20.8	18.0	22.2	22.0	18.5	9.0	17.0	9.1	16.4	19.3	15.0	16.4	16.8	21.5	20.3	16.0	14.5	18.1	14.1	17.6	16.3	0.0	6.9	9.8	10.6	12.5	10.9	5.6	7.6	14.7	3.4	8.7	5.9	12.9	16.6	9.6	5.3	14.0	11.6	23.3	9.0	15.6	14.6	13.0	5.7	10.0	13.4	4.8	7.5	10.4	13.2	2.3	17.3	8.3	10.1	22.6	7.7	9.8	9.8	8.4	21.9	15.1	6.9	12.9	20.6	8.1	16.0	12.9	13.7	9.2	11.5	13.7
THAP4	CGI-36	ENSG00000176946	"THAP domain containing 4"	Q8WY91	2	241584405-241637449	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"		"DNA-binding, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 189.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044982, HPA053448"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA044982: AB_10959786, HPA053448: AB_2682154"	"unprognostic (3.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.07e-1)"	11.9	11.5	19.3	13.0	22.5	13.3	26.3	13.8	27.5	12.8	21.3	13.5	10.8	23.7	12.7	19.1	23.6	15.3	16.9	52.4	15.4	18.1	38.2	25.1	13.6	11.9	18.3	11.7	16.7	25.0	30.9	15.0	11.2	15.6	17.1	15.4	12.5	19.7	17.4	55.8	18.5	20.4	13.7	11.3	10.3	18.5	22.7	11.4	16.0	19.0	26.1	15.7	19.4	18.3	14.3	13.9	22.9	12.7	12.5	30.2	9.8	15.3	19.3	11.7	21.6	15.7	16.5	18.3	10.1	15.6	17.5	15.5	17.5	14.4	13.7	5.9	18.1	20.0	17.8	23.4	25.8	6.6	10.3	27.4	14.1	13.3	49.8	21.0	16.7	9.9	16.9	20.5	18.6	25.9	12.1	16.1	22.0	24.1	4.8	13.3	30.1	17.0	40.7	20.0	15.7	16.4	19.5	16.3	18.4	36.2	20.5	27.8	18.3	8.5	27.9	23.1	7.5	13.8	19.7	14.0	18.6	13.0	17.6	20.5	11.3	6.6	14.1	14.3	14.3	14.2	15.4	9.3	22.9	17.5	10.8	18.5	13.8	19.4	16.2	9.7	14.3	18.7	14.9	6.5	12.5	12.7	13.9	30.2	9.8	19.3	22.5	13.8	27.5	15.4	18.1	18.3	11.7	15.6	11.4	17.9	14.2	19.1	33.6	17.7	10.1	47.6	35.7	21.4	26.1	38.4	3.9	20.4	189.0	35.2	14.5	15.5	59.6	0.0	24.5	22.1	17.9	31.3	6.9	31.1	15.9	7.9	27.6	13.5	11.0	4.8	16.7	12.4	11.8	18.0	46.5	9.0	25.0	37.4	18.4	59.2	5.1	32.3	17.5	19.3	21.1	22.6	23.0	10.2	47.2	39.1
THAP5	DKFZp313O1132	ENSG00000177683	"THAP domain containing 5"	Q7Z6K1	7	108554543-108569750	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 374.3;Late spermatids: 414.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043170, HPA051488"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043170: AB_10964500, HPA051488: AB_2681504"	"unprognostic (2.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.79e-2)"	12.8	16.9	17.8	13.2	18.9	5.3	16.2	22.9	22.3	16.4	11.3	11.1	16.1	12.1	16.3	16.5	10.0	12.9	9.9	16.5	18.0	17.6	20.4	25.8	12.7	16.1	24.5	18.7	22.5	16.0	22.7	29.4	14.8	20.2	16.8	10.6	8.1	11.5	24.3	19.6	10.3	11.9	12.3	22.3	14.7	12.4	28.9	22.0	19.4	27.9	9.4	16.0	16.7	15.1	16.8	10.5	21.2	11.4	8.9	15.5	6.2	9.2	7.2	9.3	21.0	6.1	8.6	4.9	8.6	9.8	9.6	10.2	3.6	7.8	11.3	15.4	5.9	12.4	4.0	9.5	6.7	12.5	14.5	7.4	8.5	7.5	3.4	13.0	15.1	11.2	5.3	13.2	5.8	13.9	10.2	5.8	12.9	13.2	24.6	9.6	9.3	22.8	6.6	10.9	5.5	7.1	7.2	13.2	26.3	5.8	5.4	10.9	19.3	12.3	14.6	16.8	7.6	6.1	5.7	5.7	18.2	10.0	14.2	10.5	28.5	24.5	20.9	10.0	9.2	16.3	12.4	6.8	10.7	10.0	8.2	13.3	14.6	11.7	9.5	6.1	16.8	15.5	12.9	21.2	8.9	11.4	10.5	8.8	6.2	17.8	18.9	22.9	22.3	18.0	17.6	24.5	18.7	20.2	22.0	14.9	18.1	27.0	11.6	10.9	38.1	25.4	17.8	33.5	15.9	24.4	7.9	11.7	39.7	12.9	374.3	21.4	12.3	23.3	14.6	7.7	14.3	12.6	30.2	22.1	8.3	44.5	15.1	18.4	10.8	414.2	26.2	19.5	33.7	7.2	15.1	47.9	13.0	12.2	26.5	21.5	33.5	25.8	19.6	31.6	24.4	15.7	12.0	21.8	10.6	5.7
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 108.2;Spermatocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	15.7	14.9	11.5	18.7	17.6	14.4	18.6	21.2	17.0	18.4	17.0	24.4	16.5	14.9	20.2	23.8	15.5	15.6	13.5	17.2	12.0	11.9	17.8	21.9	13.1	17.9	21.9	14.0	19.3	14.9	19.9	30.9	24.3	17.8	18.3	14.5	17.3	17.0	13.3	20.3	20.8	21.1	18.8	19.2	17.8	13.1	26.5	21.3	18.0	20.4	16.9	15.2	16.5	14.3	10.7	7.1	18.5	8.7	6.8	13.6	6.5	6.9	5.0	11.1	7.7	12.7	12.5	6.3	16.6	8.6	8.7	9.1	6.3	17.4	10.1	8.6	5.4	9.8	7.4	9.9	7.9	10.7	11.5	6.9	7.3	8.2	8.0	17.5	9.8	8.3	10.5	13.8	9.9	15.4	14.0	4.7	12.1	12.6	20.9	9.2	8.1	8.9	6.7	6.3	9.7	5.1	8.7	12.2	7.0	8.1	5.9	8.5	8.8	7.8	10.7	9.2	9.7	11.6	8.2	5.7	14.9	9.9	17.2	8.5	18.7	9.2	9.6	10.4	7.9	12.5	14.6	8.7	12.2	9.8	7.5	13.0	8.9	11.9	9.2	7.1	10.7	13.6	10.4	18.5	6.8	8.0	5.9	13.0	6.5	11.5	17.6	21.2	16.5	12.0	11.9	21.9	14.0	17.8	21.3	11.9	8.3	14.8	14.8	7.3	20.4	15.1	10.2	22.7	9.1	21.0	29.5	8.4	13.3	7.2	108.2	7.9	9.3	0.0	5.6	7.9	10.4	10.1	10.4	8.5	6.5	15.9	12.1	8.6	13.9	18.2	13.0	10.9	6.8	6.4	10.3	14.3	6.5	7.8	10.6	10.2	17.2	0.0	9.9	56.5	15.1	5.9	6.4	10.1	7.4	6.4
THAP9	FLJ34093	ENSG00000168152	"THAP domain containing 9"	Q9H5L6	4	82900684-82919969	"Predicted intracellular proteins, Transcription factors"	"DNA integration, DNA recombination"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 33.8;Late spermatids: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA037420, HPA037421"	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA037420: AB_2675467, HPA037421: AB_10673631"	"unprognostic (7.54e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.64e-3)"	"unprognostic (8.74e-4)"	3.5	4.0	6.1	4.8	11.4	4.2	7.6	5.6	7.8	4.9	3.7	5.0	6.8	3.6	5.9	8.8	3.4	4.4	3.4	5.9	7.0	5.5	7.3	7.4	4.6	3.9	11.8	4.3	7.9	6.1	8.5	10.3	5.9	7.5	6.0	4.1	3.0	6.6	10.5	20.5	4.2	3.9	3.7	8.8	3.7	3.5	14.0	13.4	6.0	9.8	5.9	3.9	4.6	5.2	3.7	2.6	0.3	4.0	1.5	3.5	1.7	1.5	2.1	8.2	4.5	2.5	3.0	5.7	1.5	2.6	1.6	1.5	3.1	2.8	8.6	2.9	2.1	3.0	2.0	6.4	2.6	2.0	3.3	2.4	3.7	3.2	4.0	2.9	3.4	3.0	3.1	4.2	0.8	4.0	2.5	2.5	7.1	3.2	5.9	2.0	2.1	8.1	4.1	6.5	3.0	1.2	7.5	3.4	5.0	2.9	1.8	6.8	4.7	3.1	4.2	5.6	7.1	2.6	3.0	1.6	2.1	2.3	1.6	1.1	3.9	1.7	8.4	2.5	2.0	3.1	0.0	2.3	0.3	1.6	4.0	2.0	3.7	1.1	1.4	2.6	3.1	3.5	2.9	0.1	1.5	2.7	1.7	0.6	1.7	6.1	11.4	5.6	7.8	7.0	5.5	11.8	4.3	7.5	13.4	3.0	2.2	0.5	2.6	0.7	2.1	5.0	0.0	1.4	2.3	1.8	5.9	2.7	0.0	1.3	33.8	1.5	1.1	0.0	2.2	1.8	1.1	2.3	1.1	0.9	1.1	0.0	2.9	1.3	0.8	43.1	1.7	1.8	0.0	1.0	1.5	4.1	0.9	0.0	0.0	2.1	4.6	6.5	1.2	4.8	5.3	1.5	2.7	0.0	1.4	1.4
THBD	CD141	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049741	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease mutation, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Endothelial cells: 100.4;Leydig cells: 121.1;Peritubular cells: 243.6;Suprabasal keratinocytes: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.8;CAPAN-2: 19.9;EFO-21: 17.3;HaCaT: 16.7;hTCEpi: 22.0;hTERT-RPE1: 11.9;OE19: 14.8;THP-1: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA	5550000	690000	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.96e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.81e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.58e-3)"	"unprognostic (9.71e-2)"	27.0	6.3	1.4	10.5	6.7	6.9	11.8	1.2	2.7	13.2	14.4	1.4	4.3	2.9	9.7	11.5	21.7	15.8	18.2	24.3	5.0	1.5	7.0	10.0	61.9	26.8	2.5	0.1	10.2	7.2	10.0	10.9	16.4	6.2	6.1	3.3	8.8	6.0	4.2	55.5	32.4	14.1	8.5	7.7	44.4	14.4	15.8	2.4	2.1	18.3	32.2	10.4	14.2	10.4	0.0	7.8	17.7	6.2	1.5	0.0	1.1	5.6	5.0	0.1	0.0	12.8	0.7	0.1	0.1	0.0	0.0	0.0	0.0	19.9	0.0	17.3	1.7	0.8	16.7	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	2.4	0.0	0.1	0.5	22.0	0.3	1.4	11.9	5.6	0.0	2.1	0.0	0.5	0.4	0.0	2.0	0.0	14.8	0.8	0.0	0.0	2.4	0.1	8.1	0.3	0.0	4.7	0.6	8.6	1.6	0.0	12.3	10.9	0.0	0.3	1.6	0.0	0.0	0.0	0.0	1.0	2.9	0.4	0.0	2.8	0.0	0.0	6.2	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	17.7	1.5	5.8	7.8	0.0	1.1	1.4	6.7	1.2	2.7	5.0	1.5	2.5	0.1	6.2	2.4	20.8	30.8	2.2	6.9	30.5	0.0	9.0	0.0	2.7	18.2	0.0	0.0	2.5	0.0	1.4	0.7	100.4	0.0	0.0	0.2	35.7	22.8	3.0	7.0	0.8	14.1	0.0	0.0	52.2	38.0	4.5	121.1	62.8	15.1	1.0	0.0	0.0	5.3	0.0	243.6	0.2	0.0	6.5	63.8	0.2	0.9	86.2	35.5	0.0	0.0	32.5
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 194.3;granulocytes: 164.5;Smooth muscle cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.4;pons and medulla: 8.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 14.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.7;HUVEC TERT2: 160.1;LHCN-M2: 119.5;TIME: 233.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA	16000000000	1600000000	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: AB_2684121"	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (8.47e-5)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	79.6	15.2	0.9	81.4	3.4	19.3	41.0	0.7	1.3	25.7	42.7	2.5	6.6	5.0	72.8	30.5	22.7	40.8	57.7	49.0	1.0	1.0	23.4	27.2	118.4	38.8	1.1	0.8	60.9	14.0	1.3	7.7	38.1	8.1	31.9	18.3	8.4	38.0	13.2	22.6	9.2	23.0	63.5	4.5	58.0	46.5	27.5	0.2	0.6	14.0	21.4	18.4	111.8	78.9	0.0	0.5	14.1	7.4	7.5	2.6	8.6	11.7	4.0	3.1	1.1	13.3	15.7	0.0	68.0	55.6	18.7	12.3	11.6	8.9	0.0	25.7	164.7	3.6	41.9	0.1	33.2	9.5	3.0	0.0	3.0	2.3	2.9	2.9	0.0	0.9	35.0	2.4	15.5	35.1	73.9	160.1	0.1	0.1	0.1	119.5	0.9	0.0	0.2	0.5	1.1	1.4	0.0	8.3	0.0	28.1	29.9	0.0	0.0	19.3	1.1	1.1	4.1	11.9	0.2	233.4	65.5	15.5	77.1	78.1	0.1	0.1	0.1	2.1	0.0	70.0	0.2	7.4	14.1	0.8	0.8	2.6	0.0	0.4	0.5	0.5	0.0	0.1	0.1	1.4	7.5	0.1	0.3	0.0	8.6	0.9	3.4	0.7	1.0	1.0	1.0	1.1	0.8	8.1	0.2	23.8	25.3	10.7	130.6	85.1	0.0	35.0	25.5	14.7	26.1	66.3	5.9	2.2	0.0	18.5	0.2	39.3	91.3	0.0	111.9	1.8	194.3	54.9	164.5	7.2	5.9	0.0	3.5	67.5	123.1	0.0	1.7	83.3	37.1	3.6	27.1	0.0	117.5	21.5	0.4	50.2	0.8	6.5	246.9	0.2	0.3	44.5	1.7	5.7	29.3	27.8
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 77.0;Fibroblasts: 41.1;Ito cells: 25.2;Melanocytes: 54.0;Smooth muscle cells: 28.6;Suprabasal keratinocytes: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 83.6;ASC TERT1: 57.4;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HHSteC: 23.4;HSkMC: 31.0;hTEC/SVTERT24-B: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		22000000	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.6	0.3	83.6	57.4	0.0	15.9	21.9	22.1	27.8	0.1	0.0	0.0	0.0	19.0	0.1	0.0	0.7	0.8	12.6	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	31.0	0.0	29.8	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	10.1	0.1	22.5	1.9	0.0	0.3	0.0	6.2	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2	6.0	0.0	0.0	1.2	77.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	41.1	1.1	0.0	0.0	0.2	0.0	0.0	25.2	0.0	0.0	7.5	0.9	54.0	0.0	0.0	0.3	0.8	0.0	15.2	0.3	0.3	0.0	28.6	0.0	0.0	36.9	0.1	0.0	0.0	0.7
THBS3		ENSG00000169231	"Thrombospondin 3"	P49746	1	155195588-155209051	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"Early spermatids: 241.6;Late spermatids: 766.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006293, HPA073242"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		4100000	Vesicles		"HPA006293: AB_10602898, HPA073242: AB_2732223"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.38e-12)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.26e-1)"	10.5	5.5	6.2	12.2	19.5	5.4	15.4	4.7	10.0	20.7	12.6	8.5	8.2	3.4	34.4	24.7	15.1	13.8	19.2	14.4	5.8	3.3	10.1	8.1	8.5	3.2	9.5	6.1	17.5	11.4	12.8	9.5	8.6	7.0	11.4	7.5	8.1	7.5	11.4	5.7	12.9	8.0	24.5	6.1	6.4	8.1	8.3	4.2	1.1	14.3	23.5	7.4	14.4	11.4	1.7	3.5	2.2	4.1	0.9	4.3	2.0	1.4	3.6	13.3	13.5	7.3	8.5	0.8	6.1	9.1	2.8	5.2	0.4	11.0	1.0	6.9	13.4	0.8	3.6	0.3	2.3	2.1	2.4	0.8	0.8	3.9	0.5	7.8	0.7	1.8	14.6	8.1	4.2	5.8	36.1	5.1	2.2	0.7	2.1	2.5	5.3	0.5	1.3	3.0	3.1	1.8	11.8	0.5	2.3	5.9	3.7	19.7	11.2	1.5	3.0	3.1	20.1	8.9	1.8	3.9	9.5	2.2	1.7	2.1	5.2	0.6	0.2	8.6	0.7	0.8	0.0	4.1	1.6	1.8	2.2	1.1	1.7	2.7	2.2	3.5	0.9	3.0	1.0	2.2	0.9	0.7	0.5	4.3	2.0	6.2	19.5	4.7	10.0	5.8	3.3	9.5	6.1	7.0	4.2	0.0	14.7	0.0	2.1	7.0	2.7	1.2	2.5	2.7	1.2	0.0	0.0	1.1	1.7	3.7	241.6	6.3	2.6	0.0	2.3	1.5	11.7	2.2	0.0	3.9	10.0	7.9	4.6	1.8	4.8	766.9	21.6	4.9	10.1	1.0	4.8	1.7	4.0	2.9	9.6	2.8	2.7	0.0	8.1	21.2	2.5	4.5	1.1	0.7	3.1	1.3
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Tissue remodeling, Unfolded protein response"	"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0"	"Cell type enriched"	"Detected in many"	9	"Sertoli cells: 485.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	51	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;SCLC-21H: 4.0;THP-1: 10.9;U-2 OS: 4.7;U-266/70: 4.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		420000000	Vesicles		"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.33e-4)"	69.8	1.0	7.6	2.1	8.3	3.7	9.7	0.8	4.6	1.1	21.4	2.6	1.2	1.3	12.2	13.6	6.5	1.4	4.1	59.0	6.4	6.4	0.8	0.6	1.0	0.9	8.5	1.9	2.1	23.0	5.5	7.8	0.6	10.7	3.7	3.7	4.9	19.8	2.6	61.7	1.5	1.4	94.0	11.5	0.6	4.0	5.5	2.6	2.0	9.9	39.3	4.1	3.4	2.7	0.1	0.0	8.0	0.0	0.0	0.1	0.0	0.2	0.0	5.1	0.3	0.4	2.2	0.5	0.1	0.2	1.5	0.5	0.1	0.6	0.2	0.2	0.4	1.3	0.2	0.2	0.6	1.3	0.2	0.7	0.5	0.0	0.3	2.8	0.0	0.1	1.6	0.3	0.1	0.3	0.5	0.0	0.1	0.0	0.3	0.3	0.7	0.1	0.1	3.9	0.0	0.1	0.0	1.6	0.0	0.4	0.1	4.0	1.2	0.1	0.0	0.4	2.3	0.0	10.9	0.0	0.1	4.7	0.3	0.3	4.2	0.1	0.7	1.8	3.5	0.9	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	8.3	0.8	4.6	6.4	6.4	8.5	1.9	10.7	2.6	0.0	0.6	0.0	0.0	0.2	1.2	5.0	0.0	0.0	1.2	3.5	53.0	0.0	0.0	0.1	28.0	2.2	0.0	0.0	0.0	0.0	2.7	0.8	0.0	0.0	0.1	1.6	8.6	0.6	0.0	3.2	0.9	0.0	1.7	0.0	0.0	1.9	0.0	0.0	41.1	0.6	1.9	485.0	2.2	16.9	1.4	0.9	0.0	0.0	0.0	0.0
THEGL		ENSG00000249693	"Theg spermatid protein like"	P0DJG4	4	56530609-56603507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.9;vagina: 10.7"	"Group enriched"	"Detected in some"	58	"Early spermatids: 18.2;Late spermatids: 14.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 1.8;HSkMC: 3.7;hTEC/SVTERT24-B: 2.3;K-562: 3.0;SH-SY5Y: 2.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA066627, HPA068093"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA066627: , HPA068093: AB_2685951"	"unprognostic (4.33e-2)"	"unprognostic (2.88e-3)"		"unprognostic (7.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.69e-2)"		"unprognostic (3.26e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.41e-2)"	0.1	0.2	0.6	0.1	0.5	0.8	1.9	0.1	1.1	1.7	0.7	0.6	1.0	0.1	0.4	1.3	0.2	0.4	0.8	0.1	0.2	0.4	0.1	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.0	0.3	0.0	0.8	0.7	0.1	0.2	0.2	0.5	0.1	1.2	0.2	1.8	0.2	0.1	0.3	8.9	0.4	0.0	0.1	0.0	0.1	3.0	10.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.3	3.7	0.0	2.3	0.0	0.5	0.4	0.0	3.0	0.0	0.9	0.0	0.8	0.0	0.2	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.1	2.0	0.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.1	0.3	0.8	0.1	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.1	1.1	0.2	0.4	0.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
THEM6	"C8orf55, DSCD75"	ENSG00000130193	"Thioesterase superfamily member 6"	Q8WUY1	8	142727203-142736927	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 28.9;RT4: 40.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023255	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	NA	NA			"Nuclear speckles, Cytosol"		"HPA023255: AB_1845782"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.76e-2)"	"prognostic favorable (6.66e-7)"	"unprognostic (7.02e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (4.49e-4)"	11.9	13.9	9.4	5.6	13.4	6.0	21.6	9.0	20.7	10.8	11.8	12.8	16.6	14.4	5.6	7.1	14.9	12.5	15.0	12.6	10.7	11.5	16.7	35.2	11.0	7.4	8.8	11.7	4.5	30.7	13.4	10.0	10.7	11.6	9.8	6.7	10.0	18.5	15.3	11.3	11.7	14.3	4.8	9.3	8.7	15.1	3.0	7.5	10.3	14.4	15.6	10.6	19.7	7.9	6.5	3.8	4.5	7.4	8.4	14.6	7.5	9.9	8.3	1.2	8.7	4.1	1.4	6.1	5.1	4.3	7.9	5.5	5.0	15.0	4.2	11.8	1.9	2.9	23.2	3.7	11.1	1.3	3.4	10.2	3.2	4.7	10.1	4.5	1.8	3.4	2.0	4.0	1.5	2.2	1.6	6.7	6.0	1.5	2.1	1.3	28.9	7.5	0.4	2.0	18.7	27.1	8.8	0.9	9.6	9.4	40.7	19.6	7.7	7.9	23.7	6.5	1.2	11.6	1.5	3.8	3.4	2.5	9.8	0.9	1.4	1.9	1.8	3.5	9.1	4.2	4.5	4.0	2.0	9.7	7.4	14.6	4.6	10.3	12.5	3.8	6.5	12.5	11.5	0.5	8.4	7.1	2.9	9.1	7.5	9.4	13.4	9.0	20.7	10.7	11.5	8.8	11.7	11.6	7.5	8.9	4.3	2.7	7.4	3.2	9.8	5.3	12.7	0.0	3.4	17.4	5.9	12.1	5.0	10.2	1.7	8.1	19.3	0.0	10.2	9.4	4.1	8.0	0.0	18.1	10.2	15.9	30.6	11.6	1.2	12.4	2.6	2.6	5.0	1.8	12.9	14.6	8.4	3.5	3.9	12.3	11.5	0.0	4.2	2.3	7.2	6.8	2.9	8.5	20.4	21.1
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 109.6"	"Cell type enriched"	"Detected in some"	6	"T-cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.1"	"Group enriched"	"Detected in many"	23	"gdT-cell: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2"	"Lineage enriched"	"Detected in single"	88	"T-cells: 25.2"	"Group enriched"	"Detected in some"	4	"HDLM-2: 16.8;JURKAT: 28.7;MOLT-4: 26.2;RPMI-8226: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	1.4	0.6	1.9	9.6	0.8	2.4	0.8	0.2	7.1	1.0	2.8	0.1	0.5	2.2	0.9	0.9	1.2	0.8	2.4	0.5	1.8	0.6	0.9	0.9	3.6	13.2	1.1	0.1	0.9	0.6	0.0	0.4	0.2	0.5	0.9	1.3	0.8	5.2	0.9	0.3	0.5	5.0	0.8	1.5	5.8	2.0	0.4	0.4	109.6	1.3	1.6	10.4	2.3	1.2	0.0	0.0	0.2	0.0	0.0	25.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	14.5	0.0	14.5	20.5	0.0	0.0	13.1	25.2	0.2	0.0	0.0	0.0	0.7	7.4	1.9	0.8	0.2	7.1	1.8	0.6	1.1	0.1	0.5	0.4	0.0	4.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	40.2	0.0	0.1
THEMIS2	"C1orf38, ICB-1"	ENSG00000130775	"Thymocyte selection associated family member 2"	Q5TEJ8	1	27872543-27886685	"Predicted intracellular proteins"	"Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.0;bone marrow: 72.3;lymphoid tissue: 73.0"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 60.6;Kupffer cells: 120.5;Macrophages: 117.1;monocytes: 154.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 43.6;granulocytes: 72.0;monocytes: 62.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 48.2;U-266/70: 37.4;U-937: 21.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027513, HPA031096"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027513: , HPA031096: AB_10599254"	"unprognostic (7.38e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.56e-3)"	"unprognostic (4.13e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.52e-3)"	13.4	5.2	4.3	27.2	7.2	72.3	5.8	0.9	4.6	3.6	7.2	10.7	0.3	4.1	3.0	6.6	4.6	5.4	9.5	6.5	7.1	4.6	5.9	7.5	22.1	39.0	11.5	2.7	3.8	2.7	1.0	2.7	7.1	7.8	2.8	4.2	6.0	6.0	1.8	2.3	2.3	12.7	6.0	16.4	73.0	4.8	9.9	6.7	12.5	5.3	1.1	25.2	7.8	3.3	6.5	43.6	72.0	62.6	8.5	11.3	40.5	3.2	0.1	1.2	0.2	4.1	5.7	0.5	0.6	7.0	10.3	14.6	0.4	0.8	4.5	0.4	2.2	5.7	0.4	1.8	0.4	1.6	0.6	0.4	6.3	0.1	0.9	8.2	7.8	10.3	2.9	0.1	5.3	0.0	0.5	3.9	0.3	8.8	48.2	0.7	2.1	0.3	6.8	4.1	0.1	0.7	1.4	4.6	7.9	3.0	0.1	0.0	1.8	0.0	0.2	9.0	0.7	0.1	6.9	2.4	0.6	0.0	2.0	0.1	37.4	2.1	0.3	11.6	21.9	0.1	4.4	54.1	47.1	11.3	62.6	10.3	6.5	8.2	9.1	43.6	2.9	7.1	7.3	72.0	8.5	60.9	17.7	7.9	40.5	4.3	7.2	0.9	4.6	7.1	4.6	11.5	2.7	7.8	6.7	3.0	30.7	30.5	1.4	2.9	0.3	0.5	5.1	1.4	5.7	0.0	0.0	0.6	0.0	0.5	0.9	2.2	0.0	0.0	7.5	1.0	1.8	2.2	12.7	0.8	60.6	0.0	10.3	5.5	120.5	3.6	0.6	117.1	16.9	154.1	0.1	0.0	7.4	0.0	0.4	0.3	0.2	0.0	0.5	0.7	1.9	1.0	2.1	49.0	0.0	3.8
THNSL1	"FLJ22002, TSH1"	ENSG00000185875	"Threonine synthase like 1"	Q8IYQ7	10	25016658-25026664	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.0"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037585	Uncertain		Approved	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"	Mitochondria	"HPA037585: AB_10696940"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.11e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.06e-2)"	2.2	8.0	8.6	2.4	10.1	0.8	4.7	4.6	10.4	5.5	3.5	5.4	3.6	3.3	4.7	6.5	2.6	7.2	2.7	4.6	8.9	6.6	12.3	26.0	2.1	5.5	9.5	5.5	9.6	8.7	7.9	13.0	2.3	8.5	3.8	4.0	2.8	4.4	3.7	5.2	2.9	3.0	3.0	9.1	3.2	3.5	7.0	7.7	5.1	10.5	2.1	3.3	2.9	3.9	5.2	3.8	0.6	0.7	11.5	10.4	3.3	5.3	6.2	3.9	7.8	4.0	5.0	1.0	2.6	1.0	2.9	1.9	4.0	6.8	24.8	8.4	1.2	3.2	3.0	5.6	4.9	3.0	3.4	3.1	9.1	1.7	2.6	4.5	0.0	1.5	3.1	9.1	2.1	4.5	5.1	2.0	10.3	7.7	2.9	6.2	8.3	4.9	1.7	7.2	9.4	3.0	2.6	1.0	10.6	8.3	1.2	6.5	3.7	5.2	4.7	9.3	2.2	4.7	0.5	1.9	3.5	3.1	4.6	2.4	2.2	2.8	0.0	5.8	5.0	2.7	0.1	0.4	0.0	3.0	0.5	5.4	5.2	4.4	4.0	2.2	4.0	10.4	6.8	0.6	11.5	0.7	3.8	2.0	3.3	8.6	10.1	4.6	10.4	8.9	6.6	9.5	5.5	8.5	7.7	3.0	2.7	2.0	2.6	0.6	4.1	6.3	2.5	9.4	6.8	3.5	0.0	5.2	13.3	2.8	20.6	1.6	1.4	0.0	1.1	3.3	2.1	1.2	0.0	6.8	1.8	3.2	1.2	1.8	1.6	4.1	2.0	1.0	0.0	1.8	1.1	6.3	1.6	0.0	1.4	8.9	4.7	0.0	1.0	6.4	13.2	0.9	0.8	0.9	3.5	0.9
THOC2	"CXorf3, dJ506G2.1, MRX12, MRX35, THO2"	ENSG00000125676	"THO complex 2"	Q8NI27	X	123600561-123733056	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047921	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047921: AB_10960388"	"unprognostic (2.12e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.43e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	25.9	22.7	25.2	23.3	28.2	21.6	26.6	36.0	29.8	30.1	22.5	17.8	24.8	22.5	27.4	39.8	24.7	21.6	19.9	17.7	25.2	19.2	28.0	20.3	24.0	29.4	28.9	21.9	30.1	23.6	28.3	45.4	22.8	24.9	26.3	23.4	17.2	18.9	24.6	20.6	29.0	31.1	27.0	31.7	27.4	20.0	15.2	29.7	45.3	26.2	20.7	26.3	27.0	21.2	13.5	15.2	9.7	12.7	11.7	16.0	8.2	21.2	17.8	22.8	24.6	16.8	16.2	12.3	14.5	14.4	16.1	21.6	12.4	21.9	21.8	16.7	15.9	15.5	16.3	27.6	10.8	27.4	20.7	25.0	30.5	24.9	16.9	15.7	35.2	21.8	32.0	13.6	18.4	21.3	14.1	14.8	33.4	45.6	19.9	16.2	22.4	30.3	34.6	12.7	28.9	17.6	30.9	14.3	18.0	25.2	24.1	17.6	15.7	40.7	11.3	13.5	19.1	11.2	21.6	15.3	14.5	7.5	20.6	24.4	13.8	20.2	18.8	13.0	31.6	15.8	9.6	9.2	9.7	13.4	12.4	15.6	12.3	14.6	14.4	8.9	13.5	16.0	15.4	5.6	11.7	12.7	15.2	11.1	8.2	25.2	28.2	36.0	29.8	25.2	19.2	28.9	21.9	24.9	29.7	128.1	126.8	63.2	59.8	74.0	64.6	45.3	17.8	91.0	105.8	61.1	149.2	37.4	10.0	44.3	3.8	61.2	57.2	46.7	44.2	29.9	59.6	56.4	77.5	31.4	34.3	50.9	64.8	51.5	45.7	5.4	86.3	57.9	28.7	73.1	47.7	39.1	39.9	35.1	85.9	22.2	106.7	122.9	70.0	45.4	36.7	67.2	36.5	61.8	46.1	67.0
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 65.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Cell type enhanced"	"Detected in some"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	13	"ASC diff: 42.5"	"Low region specificity"	"Detected in all"							HPA040642	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.69e-3)"	62.0	1.6	0.0	18.3	0.0	0.0	22.7	1.0	0.0	0.0	12.2	0.0	2.8	0.0	0.1	1.2	0.1	0.3	16.5	11.7	0.0	0.0	2.1	92.5	0.0	2.9	0.1	0.0	0.0	1.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	45.6	2.0	9.3	7.2	1.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.6	4.3	0.3	5.7	0.3	0.5	0.1	0.0	0.2	1.5	1.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.5	0.1	0.5	0.2	1.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	65.3	0.0	0.0	0.0	0.6	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;epididymis: 11.6;retina: 14.9"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 23.6;Horizontal cells: 85.8;Rod photoreceptor cells: 31.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Daudi: 10.3;SCLC-21H: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051416: AB_2681477, HPA056745: AB_2683224"	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	4.7	0.3	1.7	0.3	1.6	0.1	2.6	0.7	3.2	0.9	0.5	1.1	0.8	0.3	0.9	11.6	1.6	2.8	0.8	1.4	1.8	3.3	2.7	0.6	0.5	0.2	1.8	1.5	0.4	0.3	1.3	3.0	0.7	24.2	2.1	0.3	14.9	1.2	0.7	0.3	0.2	1.5	2.2	3.2	0.2	0.3	1.1	0.3	0.1	2.1	0.0	0.3	0.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.3	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	0.7	3.2	1.8	3.3	1.8	1.5	24.2	0.3	0.0	0.0	0.0	0.4	0.1	1.2	0.6	0.0	0.0	0.0	0.0	23.6	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	85.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	31.7	6.5	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.1
THUMPD1	"FLJ20274, Tan1"	ENSG00000066654	"THUMP domain containing 1"	Q9NXG2	16	20702816-20742084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027851	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA027851: AB_10670036"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.48e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.45e-1)"	"prognostic favorable (8.52e-8)"	"unprognostic (1.98e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-2)"	22.0	20.1	17.5	17.6	24.2	17.8	36.7	23.6	24.7	27.2	23.6	12.4	25.9	12.8	29.1	27.2	16.7	23.3	17.7	16.5	17.6	15.8	22.8	16.6	16.0	18.3	14.2	20.7	29.2	21.9	37.1	27.6	20.3	19.2	33.1	19.2	12.9	18.5	28.7	17.3	16.6	19.7	31.9	13.3	18.6	27.0	15.9	17.2	27.6	23.3	15.0	19.9	25.5	22.0	10.0	5.9	17.8	7.3	13.4	19.6	8.5	9.9	10.9	19.1	10.9	16.2	14.1	11.5	10.0	9.9	9.2	9.0	8.4	10.5	24.7	19.0	11.1	8.5	9.3	12.1	13.1	14.3	14.1	7.2	22.8	9.8	18.3	10.6	36.1	45.7	11.9	17.4	10.0	11.5	10.8	10.5	11.0	43.7	19.0	10.2	11.1	16.9	13.1	16.1	8.6	6.6	23.2	18.3	19.1	10.2	8.6	14.9	10.2	8.4	14.6	9.5	11.8	10.5	11.9	10.7	13.6	7.8	9.0	9.5	20.1	18.6	18.4	10.4	10.0	10.8	7.1	6.0	17.8	15.4	7.0	18.8	10.0	14.7	14.4	5.9	9.5	19.6	16.8	2.8	13.4	7.3	5.0	11.3	8.5	17.5	24.2	23.6	24.7	17.6	15.8	14.2	20.7	19.2	17.2	38.7	40.3	41.6	30.4	42.9	33.8	26.9	45.9	44.2	45.5	29.6	19.6	50.2	33.2	24.4	3.6	42.8	25.2	23.3	29.7	30.3	36.0	37.9	68.3	39.9	26.5	33.4	35.1	35.0	34.5	4.5	38.0	26.5	32.1	32.5	36.4	47.9	21.7	24.6	63.6	39.6	36.3	45.3	41.9	45.3	67.7	48.4	61.1	52.5	39.6	29.8
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119417378-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;smooth muscle: 91.5"	"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 117.3;Leydig cells: 89.2;Muller glia cells: 84.4;Peritubular cells: 72.9;Proximal tubular cells: 127.2;Smooth muscle cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 53.5;BJ: 83.7;BJ hTERT+: 93.7;fHDF/TERT166: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		9800000	Nucleoplasm	"Plasma membrane"	"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	28.7	5.9	42.0	23.2	72.4	0.4	7.0	17.6	97.7	26.9	9.0	7.2	2.1	3.5	20.3	13.9	9.8	7.5	31.6	4.3	63.4	41.1	46.6	2.6	6.5	10.9	29.8	34.8	3.2	5.0	7.3	5.5	19.1	53.8	4.6	13.6	8.5	2.9	15.7	1.4	4.2	4.6	91.5	9.3	6.7	5.7	4.0	6.9	3.1	12.0	1.0	10.8	36.9	7.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.3	12.5	0.0	53.5	38.7	0.0	83.7	93.7	30.0	33.3	0.0	0.0	0.0	0.0	146.5	14.5	0.1	0.4	0.1	22.9	7.1	0.0	4.4	1.5	0.0	16.5	0.0	0.0	28.7	0.0	38.1	1.3	41.7	0.0	2.6	0.0	0.0	23.1	0.0	0.0	0.0	20.0	0.0	0.1	0.0	5.9	0.0	0.0	0.0	2.1	5.7	0.0	0.0	0.0	4.0	0.1	0.2	0.0	43.2	14.4	12.4	12.3	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	42.0	72.4	17.6	97.7	63.4	41.1	29.8	34.8	53.8	6.9	0.0	2.6	0.0	0.4	15.8	13.9	0.8	0.0	0.0	0.0	8.7	0.0	1.5	18.3	1.1	0.8	14.3	0.0	0.0	0.0	2.3	117.3	0.2	1.1	0.0	3.6	30.2	0.0	27.0	0.0	0.9	89.2	1.4	16.9	0.0	0.0	84.4	0.5	0.0	72.9	127.2	19.0	32.3	114.6	0.4	0.4	15.4	3.3	0.0	0.0	0.1
THYN1	THY28	ENSG00000151500	"Thymocyte nuclear protein 1"	Q9P016	11	134248279-134253370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038732, HPA038733"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA038732: AB_10697397, HPA038733: AB_2676183"	"unprognostic (5.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.48e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.01e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.61e-2)"	20.1	22.4	36.7	13.3	39.3	21.4	26.1	29.6	43.6	22.8	22.7	16.0	20.8	16.8	22.8	45.2	16.0	27.9	17.3	27.8	30.2	30.4	22.4	31.6	15.8	20.4	24.9	38.1	37.6	15.6	13.6	25.2	12.3	24.5	29.7	26.0	17.5	14.3	32.7	14.3	15.5	16.7	24.5	23.2	17.7	18.7	24.3	23.1	35.0	29.9	15.6	23.9	22.6	15.7	27.8	30.6	74.0	24.4	29.7	50.7	34.4	7.9	4.8	18.1	14.4	17.6	20.1	10.7	6.9	15.2	16.2	15.3	26.9	19.6	14.9	23.2	9.5	17.4	12.4	27.3	20.9	15.9	15.2	7.7	41.4	6.9	24.2	25.2	32.8	13.7	15.2	11.2	19.2	12.7	21.2	25.4	51.0	19.0	7.2	14.5	4.4	38.1	60.5	21.0	31.8	18.1	18.1	13.4	12.6	22.2	14.0	17.3	14.0	14.2	3.5	8.1	13.8	20.2	16.7	13.4	7.0	10.8	6.3	10.4	8.1	8.4	31.6	10.4	42.9	8.0	37.6	21.7	74.0	36.0	24.4	43.1	27.8	38.3	36.2	23.1	21.8	44.3	50.7	11.3	29.7	22.5	30.6	44.7	34.4	36.7	39.3	29.6	43.6	30.2	30.4	24.9	38.1	24.5	23.1	29.8	30.3	34.7	31.3	21.2	28.4	47.5	45.9	57.6	36.4	34.9	13.7	48.6	72.9	41.7	18.7	37.2	24.6	0.0	48.8	45.0	39.0	15.9	39.3	41.5	45.5	27.0	55.3	25.2	23.0	14.4	46.6	30.2	38.8	40.5	38.5	42.7	42.8	31.6	45.6	69.9	17.8	45.3	31.6	74.4	76.8	18.1	11.6	37.3	53.4	22.6
TIAL1	TIAR	ENSG00000151923	"TIA1 cytotoxic granule associated RNA binding protein like 1"	Q01085	10	119571802-119597029	"Predicted intracellular proteins"	Apoptosis	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060962			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA060962: "	"unprognostic (1.61e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (7.81e-6)"	"unprognostic (5.54e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.32e-3)"	"unprognostic (6.48e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.26e-2)"	30.0	29.6	31.4	29.4	44.4	39.2	46.6	72.8	47.3	27.7	27.3	26.7	26.9	23.8	35.0	37.9	43.9	27.1	27.9	30.1	32.5	20.4	25.7	35.3	30.2	39.5	48.2	25.0	34.6	35.5	40.2	30.7	33.2	33.6	27.7	34.3	20.3	33.6	32.0	51.5	31.7	32.5	30.3	39.3	33.3	32.5	28.1	47.8	38.0	33.3	23.6	40.9	29.5	45.8	5.7	6.6	4.9	5.9	7.8	8.6	2.6	35.2	23.4	40.0	43.7	24.2	33.3	26.7	31.5	39.8	38.6	37.2	27.9	42.7	35.2	19.5	28.6	25.0	33.5	39.2	25.6	50.5	34.4	17.5	26.4	25.9	29.1	29.0	39.9	32.4	28.5	31.5	30.6	51.5	54.2	37.7	26.4	26.4	37.7	35.8	30.6	35.1	36.9	20.0	31.3	19.5	30.2	31.5	23.3	32.0	20.0	14.4	16.9	21.2	20.4	28.1	33.3	21.2	23.8	26.1	24.5	20.8	20.0	33.2	24.8	31.1	28.3	23.1	38.0	17.9	3.7	4.5	3.9	7.2	3.6	7.3	5.4	7.4	6.7	4.6	5.7	7.9	8.3	4.9	7.8	5.9	6.6	8.6	2.6	31.4	44.4	72.8	47.3	32.5	20.4	48.2	25.0	33.6	47.8	41.7	52.6	50.7	60.2	56.4	52.2	33.9	40.8	45.5	53.4	22.7	29.5	57.7	39.7	44.1	8.8	46.0	41.6	70.0	47.3	83.1	46.4	58.7	33.6	41.9	50.6	42.9	50.6	47.3	55.6	5.2	56.7	50.2	35.4	66.7	45.7	43.3	56.5	40.3	42.5	39.4	46.3	51.8	43.6	45.1	43.1	56.1	64.8	68.2	49.4	75.8
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	12.1	0.7	0.2	2.8	19.4	0.0	0.0	1.5	0.5	0.1	2.2	4.1	0.8	0.3	2.2	2.8	1.4	2.4	2.4	0.3	6.7	18.7	0.3	0.1	0.3	0.0	16.4	1.2	0.8	8.2	3.3	1.4	0.0	6.2	0.0	6.1	6.1	7.9	2.8	0.1	3.9	2.9	5.2	3.7	3.8	0.0	1.8	19.4	18.3	4.5	0.8	6.3	0.7	4.4	2.6	0.0	0.1	1.7	7.1	0.0	0.8	6.9	5.1	3.7	4.0	1.4	13.4	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1	3.0	2.9	0.8	40.5	74.4	1.2	1.1	2.5	0.0	18.2	0.0	2.0	7.6	0.0	1.5	10.0	15.8	0.0	0.0	0.6	25.1	7.6	16.1	23.1	3.6	8.2	69.9	5.2	50.3	22.7	9.0	31.9	28.4	10.1	18.0	0.3	39.3	1.1	10.7	54.8	0.0	4.4	6.5	2.1	1.4	6.1	125.3	8.9	6.9	0.9	72.7
TIFA	"MGC20791, T2BP, T6BP, TIFAA"	ENSG00000145365	"TRAF interacting protein with forkhead associated domain"	Q96CG3	4	112274542-112285903	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 46.1;U-266/70: 28.9;U-698: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045889	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Nucleoplasm, Nucleoli"	Cytosol	"HPA045889: AB_10963785"	"unprognostic (2.41e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.49e-3)"	5.7	6.4	3.3	16.7	3.8	19.2	7.4	6.1	4.5	7.0	3.9	2.0	8.4	3.4	3.6	2.3	14.3	4.0	4.2	7.9	4.7	2.1	4.1	14.6	6.7	22.9	5.4	1.6	9.2	32.2	4.1	3.3	7.4	3.9	6.6	3.7	5.4	21.3	4.5	4.0	9.0	8.7	4.7	4.0	20.3	7.1	3.0	4.8	12.5	14.8	7.8	23.2	7.2	7.3	23.2	7.0	11.3	3.8	9.1	17.7	6.1	7.0	1.8	2.6	4.4	3.2	2.6	5.3	5.6	10.6	3.6	6.1	0.9	6.3	21.5	4.6	2.2	5.3	2.1	3.6	4.3	7.5	17.4	2.1	2.1	4.3	2.0	2.2	6.7	2.9	3.5	2.4	3.8	4.2	6.1	5.6	6.0	2.1	46.1	4.7	3.5	11.8	3.7	0.5	4.3	2.3	20.6	6.7	14.3	7.9	4.8	6.1	6.3	4.5	9.5	2.2	1.2	4.0	9.7	4.2	5.7	6.7	4.7	4.4	28.9	26.5	39.8	5.3	4.5	4.1	2.9	3.8	2.0	6.3	2.7	10.3	21.2	11.7	11.0	7.0	23.2	5.4	6.6	11.3	9.1	3.2	6.5	17.7	6.1	3.3	3.8	6.1	4.5	4.7	2.1	5.4	1.6	3.9	4.8	17.9	20.6	34.4	9.9	18.9	1.0	14.1	10.2	6.7	11.4	12.2	0.0	42.8	16.6	12.7	0.0	14.5	5.8	0.0	21.2	17.8	22.6	27.2	3.5	8.5	16.0	0.0	8.6	4.9	10.7	0.0	8.3	11.2	32.1	6.4	7.0	11.3	12.9	3.6	10.3	6.3	0.6	6.5	13.4	0.9	3.0	22.7	66.4	27.3	6.5	10.7
TIGD1	EEYORE	ENSG00000221944	"Tigger transposable element derived 1"	Q96MW7	2	232547968-232550592	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA041717	Approved		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies"	"HPA041717: AB_2677636"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.40e-2)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (3.77e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-3)"	3.9	5.9	13.3	9.2	15.3	19.4	8.9	10.1	11.7	5.4	5.1	10.7	2.0	5.9	8.5	10.1	5.6	7.4	6.9	4.9	13.8	8.2	10.1	5.0	6.9	12.5	9.1	8.0	13.2	5.8	6.3	21.2	6.5	8.6	8.3	6.7	8.3	7.3	7.9	7.5	13.6	6.8	4.3	8.8	11.1	8.1	9.7	10.8	14.2	9.6	4.8	10.6	5.5	5.9	7.1	3.8	7.0	4.8	4.5	9.8	1.9	6.9	5.2	11.3	16.7	4.2	5.5	8.5	5.0	2.8	6.1	7.0	6.6	7.9	11.5	3.8	3.7	6.5	6.6	9.3	2.9	9.5	7.0	8.1	10.3	15.3	7.5	2.6	8.6	6.9	6.1	2.7	6.4	4.0	6.4	3.8	14.3	8.1	12.2	5.3	10.5	10.5	17.3	6.7	4.1	6.3	9.7	10.2	5.2	3.6	8.3	13.5	13.5	5.5	4.8	5.2	8.7	7.2	8.4	6.5	10.2	10.5	6.5	5.1	10.9	7.6	10.8	5.9	8.6	6.4	4.0	4.8	5.3	6.7	4.3	6.1	4.9	6.5	4.3	3.4	7.1	9.8	7.7	7.0	4.5	4.8	3.8	4.5	1.9	13.3	15.3	10.1	11.7	13.8	8.2	9.1	8.0	8.6	10.8	8.9	3.8	2.7	3.6	1.1	4.9	1.2	2.5	0.0	2.3	3.5	7.9	1.8	0.0	1.9	1.3	1.6	2.1	0.0	1.3	1.0	1.9	2.0	0.0	0.6	1.3	6.4	1.2	1.3	1.5	0.0	4.4	2.7	1.7	2.8	1.9	8.2	1.4	3.2	1.8	0.6	6.2	6.5	0.8	2.8	6.1	1.8	1.1	3.5	3.3	2.4
TIGD2		ENSG00000180346	"Tigger transposable element derived 2"	Q4W5G0	4	89111500-89114899	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.1"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 20.3;Syncytiotrophoblasts: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054844, HPA071168"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA054844: AB_2682623, HPA071168: AB_2686353"	"unprognostic (7.11e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.47e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.94e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.02e-4)"	4.0	3.7	3.3	3.5	4.0	2.5	11.2	7.2	5.3	4.8	5.7	3.5	2.3	7.4	3.4	4.8	4.7	2.9	5.4	3.2	3.2	3.6	6.3	34.1	4.2	8.5	3.9	2.7	2.6	5.8	12.9	14.1	27.2	4.0	5.0	4.7	8.1	14.4	4.3	3.3	4.1	7.9	2.8	3.4	4.9	4.8	4.6	4.0	11.3	6.3	2.1	4.9	6.0	4.3	1.8	2.2	11.1	2.6	3.2	2.8	1.2	9.8	4.6	5.0	6.1	5.6	4.3	2.3	6.0	7.3	5.7	4.9	9.3	9.6	4.8	3.2	2.4	4.1	3.1	5.6	9.2	7.9	8.1	1.8	5.6	5.0	4.4	16.7	2.6	4.0	10.7	9.2	2.3	8.4	5.4	2.1	6.4	7.0	8.4	7.1	3.7	4.8	3.0	6.1	10.6	1.5	7.4	8.9	6.4	5.1	19.0	24.4	4.9	5.7	18.9	7.4	7.0	6.6	5.3	1.7	7.5	7.0	2.4	4.5	13.3	4.1	3.7	6.5	4.5	6.3	11.1	1.8	0.2	2.8	2.6	1.4	1.8	1.5	2.2	2.2	1.6	1.4	2.2	0.0	3.2	1.4	0.3	1.5	1.2	3.3	4.0	7.2	5.3	3.2	3.6	3.9	2.7	4.0	4.0	0.0	0.3	1.7	5.1	0.2	3.3	2.5	5.1	1.4	6.8	3.5	9.8	13.6	1.7	2.2	1.2	1.6	1.3	0.0	4.9	7.0	0.5	2.3	0.0	20.3	4.1	0.0	2.4	2.5	2.1	0.5	1.4	2.6	0.0	5.4	2.9	2.3	3.8	2.0	1.1	9.8	6.3	0.0	2.0	1.8	7.9	0.4	32.6	1.9	3.1	1.4
TIGD3		ENSG00000173825	"Tigger transposable element derived 3"	Q6B0B8	11	65354767-65357613	"Predicted intracellular proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 14.9;brain: 8.6"	"Cell type enhanced"	"Detected in some"	16	"Spermatocytes: 16.6;Spermatogonia: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 14.9"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA040016			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA040016: AB_10805600"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.48e-4)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-3)"	0.1	0.7	1.8	0.8	2.7	1.3	3.0	8.6	4.6	0.3	4.1	0.9	0.0	2.6	0.4	0.8	0.4	0.5	0.6	0.4	2.0	1.9	0.8	0.7	1.1	1.1	1.2	0.0	1.0	1.5	1.5	1.9	0.4	3.1	0.5	0.4	1.1	0.5	0.5	0.3	0.2	6.4	0.3	2.0	2.6	1.0	6.9	0.4	3.0	0.4	1.0	0.8	0.6	0.0	0.3	1.2	14.9	1.2	0.1	0.1	0.1	1.4	2.6	2.3	6.0	0.0	0.0	0.8	0.1	0.3	0.6	0.8	2.1	0.3	1.0	1.0	0.2	1.0	1.4	2.3	0.1	0.2	1.8	2.3	0.4	1.4	4.7	0.1	0.9	4.4	0.0	0.2	0.3	0.0	0.1	0.3	2.3	1.4	3.1	0.0	3.4	2.9	1.9	1.3	1.3	1.1	4.2	1.0	4.0	0.1	1.3	6.7	4.2	1.7	2.6	1.1	0.2	4.3	1.4	0.0	0.2	1.1	1.6	1.0	6.4	4.1	1.3	0.1	1.8	0.7	6.5	0.5	8.4	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.2	0.1	0.0	14.9	0.1	1.2	1.2	0.0	0.1	1.8	2.7	8.6	4.6	2.0	1.9	1.2	0.0	3.1	0.4	0.0	0.6	0.0	0.2	1.3	3.7	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	2.2	0.0	1.0	0.0	0.5	0.3	0.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.8	1.8	0.0	0.9	1.7	1.0	0.3	1.0	0.6	0.0	0.4	0.5	3.8	0.0	0.8	16.6	5.3	1.4	0.7	0.0	0.4	0.1
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779764	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.1;testis: 11.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 76.3;Rod photoreceptor cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.6;U-266/70: 6.8;U-266/84: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035649, HPA073768"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035649: AB_10670956, HPA073768: "	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.7	1.0	2.2	0.7	8.6	0.2	2.1	3.5	3.6	2.5	0.8	2.1	3.9	1.1	2.0	4.2	0.6	5.5	0.8	1.0	4.8	2.1	2.0	0.6	3.5	0.5	1.6	3.2	1.7	0.9	5.4	14.1	0.5	5.8	1.3	0.9	5.4	2.0	1.1	1.2	1.3	0.8	0.9	2.7	0.8	1.0	11.8	1.3	0.3	2.1	0.6	0.5	1.0	0.8	0.4	0.0	1.6	1.1	2.1	1.3	0.0	0.6	0.5	3.0	1.2	0.2	0.4	0.3	0.1	0.7	0.3	0.6	0.6	1.3	1.0	0.1	0.1	1.4	0.5	1.1	0.5	0.5	1.0	0.2	1.5	0.7	0.3	0.2	0.6	0.3	0.1	0.5	0.5	0.3	0.6	0.1	2.2	0.4	4.6	0.3	0.3	2.9	0.4	1.4	0.4	0.4	0.5	0.6	0.0	2.0	0.1	1.4	1.6	0.2	0.3	2.9	1.4	0.7	0.2	0.0	0.4	0.6	0.5	0.6	6.8	13.2	0.6	1.0	1.6	2.2	0.0	0.3	0.8	0.0	1.1	0.2	0.0	0.3	1.3	0.0	0.4	0.1	0.4	1.6	2.1	0.2	0.0	0.0	0.0	2.2	8.6	3.5	3.6	4.8	2.1	1.6	3.2	5.8	1.3	0.0	1.0	0.0	0.4	0.0	6.7	0.0	0.0	12.0	0.0	1.8	11.8	0.1	0.0	0.5	76.3	0.1	0.0	0.0	1.0	0.1	0.1	0.3	0.0	0.0	0.5	1.6	1.2	0.0	0.0	8.5	0.3	0.0	0.0	0.0	0.1	12.1	0.4	0.0	0.4	1.5	29.0	0.0	0.0	5.1	1.7	0.0	0.2	0.0	0.4	0.3
TIGD6	DKFZp761E2110	ENSG00000164296	"Tigger transposable element derived 6"	Q17RP2	5	149993118-150001167	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044599	Uncertain		Approved	"Nucleoplasm,Vesicles,Actin filaments"		NA	NA			Nucleoplasm	"Vesicles, Actin filaments"	"HPA044599: AB_10961286"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.30e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.85e-2)"	"prognostic favorable (5.88e-4)"	"unprognostic (1.94e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.18e-1)"	6.9	10.5	5.9	3.9	10.7	2.8	9.9	9.3	9.4	5.8	6.1	10.0	8.9	4.7	6.5	11.1	5.0	6.9	5.1	4.5	6.4	4.7	7.7	7.0	5.3	3.9	7.3	7.1	8.6	6.8	28.0	10.5	5.5	7.1	8.8	5.7	6.4	8.1	12.6	3.8	7.2	5.2	5.9	7.6	5.8	6.1	9.8	8.0	6.1	6.5	3.6	4.3	6.2	6.1	3.5	3.3	2.1	4.0	6.3	8.0	2.6	2.3	6.4	4.3	9.2	12.4	10.2	6.7	6.7	7.1	5.3	5.3	4.1	4.2	1.1	6.0	7.9	6.4	4.2	3.8	4.9	6.3	5.0	3.2	2.0	3.3	2.2	11.0	2.8	5.0	10.5	9.4	6.8	8.9	6.2	4.1	4.6	2.7	5.4	6.5	5.5	3.7	1.3	1.8	3.0	5.4	4.2	4.9	3.0	5.0	3.4	3.3	4.3	4.7	7.6	9.5	5.5	8.5	4.9	5.4	4.3	3.3	4.7	4.9	4.0	1.5	3.0	6.8	3.1	6.6	0.2	4.0	2.1	2.8	3.9	2.5	2.7	3.8	2.8	3.3	3.5	8.0	5.1	0.0	6.3	2.2	2.2	3.7	2.6	5.9	10.7	9.3	9.4	6.4	4.7	7.3	7.1	7.1	8.0	11.9	2.4	0.0	5.8	1.9	4.8	4.6	2.5	2.7	4.5	3.5	0.0	4.6	6.6	4.3	1.1	2.3	2.5	0.0	4.2	2.2	2.5	6.1	3.5	1.3	3.7	3.2	2.9	3.1	1.2	1.9	4.0	2.2	3.3	7.2	2.5	6.1	3.4	2.3	3.2	6.7	5.6	0.0	3.9	16.4	5.5	1.0	3.0	0.9	2.3	3.8
TIMD4		ENSG00000145850	"T cell immunoglobulin and mucin domain containing 4"	Q96H15	5	156919282-156963255	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 32.0;lymphoid tissue: 83.9;testis: 58.9"	"Group enriched"	"Detected in some"	24	"Early spermatids: 1044.9;Late spermatids: 1409.2"	"Cancer enriched"	"Detected in some"	10	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 6.4"	"Group enriched"	"Detected in some"	18	"U-266/70: 46.8;U-266/84: 12.7"									"HPA015625, CAB026027"	Approved		Approved	"Plasma membrane"		NA	NA		18000000	"Plasma membrane"		"CAB026027: , HPA015625: AB_1858018"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.08e-2)"	6.7	0.4	0.4	3.5	0.4	5.3	0.5	0.4	0.4	0.4	1.3	0.0	0.0	0.0	0.4	1.0	1.5	0.4	0.3	0.8	0.4	0.4	1.7	32.0	0.6	83.9	0.5	0.0	0.4	0.4	0.0	0.4	2.8	0.0	1.1	0.1	0.0	6.5	0.0	0.7	0.4	1.1	0.2	0.5	12.5	0.4	58.9	0.0	21.7	0.8	0.2	8.5	5.3	0.4	0.4	0.0	0.0	0.0	0.0	6.4	1.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	2.3	4.5	0.0	0.0	3.0	3.0	0.0	0.0	0.0	0.0	6.4	1.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	1044.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	34.7	0.0	0.0	0.0	52.0	1409.2	13.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.6	0.0	12.9	0.0	10.9	4.3	0.0	0.2	0.0	0.0	0.0
TIMM17B	"DXS9822, JM3"	ENSG00000126768	"Translocase of inner mitochondrial membrane 17B"	O60830	X	48893447-48898143	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029093	Approved		Approved	Microtubules,Mitochondria		NA	NA			Microtubules	Mitochondria	"HPA029093: AB_10600913"	"unprognostic (7.87e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (8.44e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.67e-2)"	"prognostic favorable (7.88e-4)"	14.0	21.1	23.6	15.0	24.2	18.6	16.4	15.1	30.8	16.9	22.3	18.9	13.3	19.2	15.1	19.2	27.4	21.0	19.4	40.6	19.8	17.7	26.2	40.1	19.6	18.3	19.0	15.8	17.8	28.7	19.3	22.9	28.2	15.4	22.4	15.0	19.8	21.5	22.8	54.3	16.1	24.8	15.7	20.5	22.1	18.8	16.7	12.5	36.4	31.1	27.2	19.5	21.6	13.7	36.7	41.5	56.2	41.2	22.9	26.7	35.5	18.5	34.4	21.7	21.2	6.8	5.5	17.9	8.4	13.0	22.4	14.7	30.1	25.3	13.9	13.1	7.4	36.3	14.2	34.0	18.3	8.5	29.2	38.3	10.0	19.7	26.5	19.2	14.7	9.8	7.2	18.4	16.8	22.4	11.2	10.3	24.4	14.7	32.5	10.2	48.3	23.1	36.1	28.0	24.7	32.2	16.4	14.1	49.4	21.9	11.0	21.6	19.3	13.1	21.0	12.5	28.6	45.8	25.9	7.0	10.3	20.2	24.7	14.4	30.1	34.9	16.6	14.3	26.4	12.1	44.4	41.2	56.2	23.4	39.0	26.7	36.7	23.7	26.4	39.5	36.1	23.1	21.2	46.5	22.9	31.5	41.5	23.4	35.5	23.6	24.2	15.1	30.8	19.8	17.7	19.0	15.8	15.4	12.5	23.8	27.5	51.4	44.2	26.9	39.2	36.7	45.9	28.1	17.0	69.8	15.7	89.4	157.5	83.6	4.1	21.6	57.2	46.7	63.8	82.3	26.4	51.5	51.8	47.3	83.3	33.4	78.4	21.5	43.0	6.3	22.2	43.6	42.2	101.8	59.2	31.6	75.0	89.2	21.5	129.9	28.0	32.3	40.1	19.4	36.8	30.1	66.6	44.6	55.4	49.4
TIMM29	C19orf52	ENSG00000142444	"Translocase of inner mitochondrial membrane 29"	Q9BSF4	19	10928733-10933535	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 31.3;Extravillous trophoblasts: 25.5;Hofbauer cells: 19.8;monocytes: 26.2;Syncytiotrophoblasts: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041858	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA041858: AB_10963429"	"unprognostic (8.45e-2)"	"prognostic favorable (9.93e-5)"	"unprognostic (8.99e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-3)"	"prognostic favorable (7.03e-7)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.26e-3)"	13.4	11.4	13.8	11.0	18.0	18.4	8.0	19.9	16.4	8.5	9.9	10.3	7.6	17.5	11.3	7.1	13.8	8.6	9.4	12.5	15.1	8.9	10.5	13.5	8.1	11.6	13.5	9.3	8.3	17.1	7.0	10.8	12.2	11.9	9.9	5.1	11.3	16.8	9.5	30.9	12.1	12.4	10.3	8.3	11.7	15.0	11.3	13.2	12.0	9.2	8.9	9.7	10.1	10.6	13.6	10.3	8.7	8.7	10.9	12.0	3.2	10.7	3.9	3.1	5.2	2.7	2.6	8.9	7.5	3.8	5.4	5.0	7.0	3.5	9.1	13.3	3.4	2.9	10.0	1.6	4.4	0.9	10.9	13.1	10.5	4.0	4.7	4.3	7.5	8.0	2.2	4.3	3.7	1.5	2.1	3.2	7.8	11.4	7.7	2.0	8.8	8.5	14.6	11.3	3.2	17.4	11.6	4.5	11.0	2.2	4.1	8.1	8.4	8.6	4.5	8.8	1.2	6.5	8.2	5.4	8.7	5.3	11.1	11.4	26.7	26.0	9.7	5.4	9.6	7.2	3.5	7.9	8.7	5.6	8.7	8.8	13.6	10.8	12.0	5.6	10.6	10.1	8.5	1.7	10.9	6.7	10.3	11.0	3.2	13.8	18.0	19.9	16.4	15.1	8.9	13.5	9.3	11.9	13.2	3.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	15.7	0.0	31.3	16.6	17.6	0.0	0.0	0.0	0.0	9.2	25.5	0.0	0.0	1.1	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	26.2	0.0	0.0	13.2	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0
TIMP1	"CLGI, EPO, TIMP"	ENSG00000102265	"TIMP metallopeptidase inhibitor 1"	P01033	X	47582313-47586789	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 293.3"	"Cell type enhanced"	"Detected in many"	7	"Ito cells: 2535.0;Leydig cells: 1644.5;Macrophages: 2104.1;Peritubular cells: 1468.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 164.6;ASC TERT1: 220.3;HSkMC: 150.9;U-87 MG: 142.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB022360, HPA053417"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	127000000	750000000	"Golgi apparatus"		"CAB022360: , HPA053417: AB_2682142"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.24e-3)"	"unprognostic (9.12e-3)"	"unprognostic (9.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (1.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	80.2	82.3	6.3	154.0	12.8	9.2	31.8	3.3	8.4	63.5	29.1	6.5	27.2	6.1	48.9	109.6	34.9	53.5	110.9	105.7	9.2	5.5	71.2	115.9	144.8	293.3	8.4	4.8	149.3	22.2	41.8	48.7	125.5	29.5	62.9	19.0	33.4	45.9	42.0	26.1	11.6	13.2	64.5	14.6	69.3	19.3	71.9	4.6	8.8	98.6	14.6	34.8	121.0	46.8	2.3	56.8	57.1	91.5	9.4	26.4	39.7	9.6	16.1	7.9	93.2	164.6	220.3	1.9	104.6	86.5	32.6	26.4	6.3	18.1	0.1	13.8	134.5	18.9	9.5	4.3	44.4	21.1	19.5	10.2	9.9	11.8	9.8	109.5	6.6	126.8	150.9	11.4	99.4	21.2	38.0	14.6	0.0	15.3	7.3	54.0	18.8	0.1	25.5	8.8	11.5	33.8	0.1	16.2	8.6	52.6	6.7	0.1	0.4	62.0	0.4	13.2	15.3	0.8	12.9	14.1	48.9	51.5	57.6	10.2	3.1	6.5	0.3	142.1	16.0	31.7	29.5	54.6	0.8	16.2	91.5	16.0	2.3	26.4	14.3	56.8	1.2	8.6	7.7	57.1	9.4	83.6	1.6	10.7	39.7	6.3	12.8	3.3	5.3	9.2	5.5	8.4	4.8	29.5	4.6	101.3	235.0	76.3	526.8	205.4	19.6	8.1	374.5	117.8	310.5	125.6	0.0	21.5	0.0	407.2	18.1	600.1	19.3	0.0	372.2	201.1	871.1	751.9	475.1	110.9	305.2	0.0	266.3	2535.0	691.3	38.8	1644.5	2104.1	485.9	250.7	58.9	120.3	535.0	52.1	1468.0	7.0	6.7	679.1	606.7	17.9	10.8	152.7	37.6	115.1	45.8	406.7
TIPARP	"DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1"	ENSG00000163659	"TCDD inducible poly(ADP-ribose) polymerase"	Q7Z3E1	3	156673235-156706770	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 174.1;Early spermatids: 204.3;Urothelial cells: 186.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 24.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036796			Approved	Microtubules		NA	NA			Microtubules		"HPA036796: AB_10672268"	"prognostic favorable (2.00e-5)"	"unprognostic (3.50e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (4.90e-3)"	31.6	29.8	10.9	11.1	24.7	31.8	19.9	7.1	16.3	16.2	12.7	14.2	18.8	6.8	18.3	20.7	27.2	27.8	18.8	26.5	16.0	9.4	14.2	21.3	20.2	15.2	16.2	6.2	37.0	14.5	73.8	11.4	6.1	30.9	13.6	7.5	10.0	8.2	36.0	17.4	26.2	22.1	21.6	37.4	8.4	11.3	23.1	12.5	8.4	10.8	19.1	13.8	18.7	16.7	3.7	3.3	24.1	5.4	7.0	6.0	2.2	12.5	8.8	3.0	2.5	11.1	8.2	2.4	21.0	17.0	10.7	14.9	5.0	26.2	3.7	6.8	23.8	14.3	13.1	7.6	50.4	15.9	7.9	5.6	6.3	9.2	3.4	4.7	2.1	11.7	6.6	31.6	10.9	26.3	29.0	9.7	2.8	4.9	15.1	37.1	2.4	1.8	2.8	3.4	15.8	7.4	3.1	6.8	12.9	11.3	6.0	9.2	2.3	16.5	5.1	3.5	7.2	7.9	3.7	21.0	4.6	1.5	8.7	7.5	16.9	3.0	3.3	7.9	3.3	15.5	24.1	3.5	4.7	4.2	2.2	6.0	1.9	4.2	5.6	2.3	3.7	2.6	3.5	10.7	7.0	5.4	3.3	4.7	2.2	10.9	24.7	7.1	16.3	16.0	9.4	16.2	6.2	30.9	12.5	80.4	77.0	6.1	84.9	174.1	4.4	21.3	30.6	46.8	81.9	7.0	37.3	3.3	18.3	29.3	204.3	26.0	33.2	0.0	20.7	6.8	35.1	72.6	116.2	17.0	17.1	20.6	52.3	13.5	16.1	11.0	18.1	36.2	35.4	20.8	21.8	7.8	28.1	28.1	18.0	8.2	9.4	12.9	57.7	61.8	20.2	106.1	6.3	34.5	12.3	186.7
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	8.8	10.4	5.2	11.9	5.4	3.9	16.8	7.2	8.0	11.9	18.9	4.6	13.2	11.6	11.1	11.1	9.7	8.7	14.2	11.6	4.4	6.5	9.2	14.8	16.8	17.6	6.5	5.8	13.4	18.7	14.0	8.8	9.2	5.1	11.1	8.9	10.5	15.3	21.1	10.5	8.4	17.3	13.6	4.7	13.4	8.7	3.5	2.4	3.3	8.0	6.4	9.8	11.8	7.3	6.5	8.7	8.8	10.5	4.4	8.3	6.2	1.9	6.2	3.3	5.6	5.7	8.0	4.0	5.1	8.3	3.6	3.4	9.7	7.4	5.0	8.8	5.2	6.3	5.6	3.5	3.9	1.4	13.2	3.3	13.5	3.5	6.2	4.6	8.2	7.3	6.0	5.5	6.7	4.7	4.3	5.9	4.1	3.6	11.6	4.1	3.5	0.2	1.3	1.5	13.9	5.7	1.7	0.9	4.7	2.8	6.9	4.1	5.3	6.0	6.0	4.2	4.6	16.4	4.3	5.8	2.0	1.9	4.1	3.8	3.2	4.6	3.7	3.1	6.6	6.2	7.7	10.5	4.9	7.7	8.7	7.4	4.3	6.1	8.3	8.7	6.5	5.0	4.9	8.8	4.4	5.7	5.9	6.1	6.2	5.2	5.4	7.2	8.0	4.4	6.5	6.5	5.8	5.1	2.4	6.0	1.6	1.3	1.4	0.3	3.0	0.8	0.0	1.4	3.4	3.5	0.0	2.8	0.0	2.5	0.0	1.5	4.2	0.0	3.5	4.1	1.6	1.9	1.1	4.9	4.4	3.2	1.2	2.5	4.0	0.0	4.4	2.7	1.7	0.0	2.6	2.4	3.0	4.2	4.2	1.7	2.3	0.0	1.2	0.1	0.6	0.1	2.2	1.9	2.4	1.3
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69255208	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 241.2;Rod photoreceptor cells: 273.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"A-431: 53.3"									"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		790000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161"	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favorable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	25.2	9.5	23.7	8.0	29.7	5.7	20.7	35.6	24.9	9.0	20.0	50.3	20.6	27.2	11.9	7.3	28.9	12.6	13.2	19.8	35.1	12.7	23.3	34.5	23.9	5.8	39.7	20.5	20.9	13.2	43.2	3.6	18.0	32.0	13.5	16.7	19.1	18.0	23.1	8.3	18.6	25.7	15.3	39.7	3.5	30.4	17.8	41.1	11.1	22.5	9.0	10.8	26.5	26.6	0.0	0.2	0.4	4.0	0.0	0.5	0.5	53.3	1.7	4.3	4.8	20.1	19.7	23.3	8.1	6.0	13.0	7.1	6.5	19.5	7.7	8.1	4.5	7.0	32.9	6.9	17.1	14.8	27.3	5.0	7.4	4.6	32.9	5.7	3.0	14.1	15.3	12.3	10.1	6.1	3.7	27.2	2.1	4.5	5.2	6.8	7.5	1.1	0.4	10.4	33.4	11.7	3.9	6.1	0.8	33.4	35.6	1.9	3.3	2.9	20.8	0.6	9.9	6.7	1.6	39.0	9.7	10.5	7.5	8.3	5.4	1.1	0.1	11.2	4.3	3.6	0.0	0.7	0.0	0.0	1.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.4	0.0	4.0	0.1	0.5	0.5	23.7	29.7	35.6	17.5	35.1	12.7	39.7	20.5	32.0	41.1	41.7	21.4	1.4	65.1	57.9	241.2	34.6	50.9	9.4	5.7	3.5	33.4	24.0	0.0	27.8	2.7	42.7	67.5	0.0	20.8	23.1	14.7	83.3	5.7	92.7	4.9	17.5	11.1	25.2	17.0	3.6	27.0	2.8	27.0	4.6	41.5	123.0	32.6	42.5	13.1	1.4	273.3	0.0	10.3	21.3	11.1	56.0	36.2	3.1	36.2	146.9
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333210-61353295	"Enzymes, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.2;liver: 42.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 92.7;Proximal tubular cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 40.5;RPMI-8226: 42.7;T-47d: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		4800000	Cytosol	Nucleoplasm	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	3.1	34.7	3.6	6.1	5.3	5.3	4.6	3.7	7.3	3.4	43.4	7.6	8.0	69.5	4.6	7.8	6.2	5.9	8.8	2.8	3.1	2.6	17.4	42.8	3.5	5.2	3.3	5.3	4.5	9.8	3.0	5.5	3.9	4.4	5.0	2.3	7.3	7.2	7.1	4.6	6.1	90.2	2.6	3.1	5.4	5.7	17.1	3.4	5.5	6.4	6.3	6.7	5.4	3.9	9.7	18.4	5.4	11.4	5.3	10.9	7.8	6.1	15.6	2.7	9.5	3.4	3.7	7.7	3.6	3.9	3.4	2.2	7.1	14.8	7.6	12.6	2.6	3.5	8.6	5.1	6.7	1.1	13.1	6.8	4.7	8.2	40.5	5.9	3.9	7.9	5.9	4.6	3.2	11.2	2.9	3.3	5.3	8.2	14.8	2.4	27.9	3.5	3.6	7.5	5.8	10.7	6.2	4.3	42.7	5.4	10.9	10.6	9.5	6.6	11.6	6.0	1.9	42.8	2.8	4.0	6.7	7.0	5.3	2.1	27.4	22.6	6.9	6.9	3.7	6.1	2.3	11.4	5.4	6.7	6.8	8.6	9.7	7.8	6.5	18.4	9.7	5.6	5.9	0.9	5.3	5.3	9.0	10.9	7.8	3.6	5.3	3.7	7.3	3.1	2.6	3.3	5.3	4.4	3.4	0.0	12.6	6.7	10.8	0.0	12.9	3.4	12.7	20.1	12.5	14.0	13.7	25.7	24.9	15.5	7.9	4.5	5.4	0.0	12.8	4.4	3.0	11.6	7.0	92.7	14.9	7.9	12.9	6.2	18.3	9.3	14.1	5.9	0.0	27.9	13.9	8.7	12.3	18.1	21.2	63.4	16.0	6.5	2.4	39.2	14.5	0.0	12.7	5.7	18.4	10.6
TLCD2		ENSG00000185561	"TLC domain containing 2"	A6NGC4	17	1702790-1710438	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 59.3;Cone photoreceptor cells: 121.7;Enterocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 4.1;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 6.6;ASC TERT1: 7.7;HaCaT: 6.3;SiHa: 8.3;T-47d: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046063	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA046063: AB_2679520"	"unprognostic (1.78e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.94e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (3.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.44e-2)"	11.3	9.2	0.5	4.7	1.4	1.7	18.4	0.1	1.5	2.7	9.6	0.3	1.7	7.9	1.8	3.1	6.8	2.7	5.6	4.0	0.6	0.4	2.3	14.8	4.6	0.5	1.2	0.4	4.6	1.2	1.5	0.9	1.6	1.9	4.1	5.4	3.0	2.9	3.6	2.2	2.2	18.4	4.3	1.3	1.1	4.5	0.8	0.5	0.3	2.6	1.2	2.7	4.8	6.3	0.7	0.4	4.1	0.4	0.6	0.5	0.1	0.7	1.5	0.8	2.5	6.6	7.7	0.5	1.3	1.3	0.7	0.5	4.7	2.2	0.1	1.4	2.1	0.7	6.3	1.0	0.6	0.5	0.2	1.1	0.6	2.1	0.4	3.8	0.0	1.7	6.2	2.3	0.8	1.5	2.1	0.5	0.1	0.5	0.3	0.6	1.3	0.0	0.3	0.1	2.3	0.4	0.1	3.7	0.1	0.4	2.2	0.1	0.3	8.3	0.7	1.2	1.1	6.7	0.6	1.8	0.4	2.0	1.4	0.3	0.1	0.0	0.1	0.4	0.2	1.0	4.1	0.4	0.6	0.4	0.2	0.2	0.4	0.5	0.2	0.1	0.7	0.4	0.4	2.7	0.6	0.2	0.4	0.2	0.1	0.5	1.4	0.1	1.5	0.6	0.4	1.2	0.4	1.9	0.5	47.6	59.3	1.4	7.6	0.0	8.1	2.8	15.3	36.1	33.0	10.4	121.7	4.1	0.0	5.8	0.6	8.5	77.5	0.0	8.5	2.5	7.7	6.0	15.1	14.9	4.7	0.0	8.6	17.8	3.9	0.9	12.4	4.3	0.0	1.8	22.4	8.8	11.1	38.7	5.3	0.8	50.0	6.5	2.7	0.2	0.9	0.3	3.3	0.7	26.4	11.7
TLE2	"ESG, ESG2, FLJ41188, GRG2"	ENSG00000065717	"Transducin like enhancer of split 2"	Q04725	19	2997638-3047635	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 37.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 85.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 3.1;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.1;RT4: 20.0;T-47d: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049103	Enhanced		Supported	"Nuclear bodies,Focal adhesion sites"		NA	NA			"Nuclear bodies"	"Focal adhesion sites"	"HPA049103: AB_2680631"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.87e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.39e-6)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.49e-6)"	"unprognostic (2.66e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.88e-4)"	13.4	9.6	9.2	4.6	5.7	1.3	38.3	85.3	16.5	10.9	11.4	4.9	28.6	8.1	15.7	6.6	5.5	13.3	8.5	19.9	5.5	7.6	11.9	3.5	12.5	5.4	8.3	5.3	12.4	16.5	13.8	6.4	7.3	9.7	12.9	4.6	20.6	55.5	27.1	38.5	6.4	5.3	26.2	13.3	10.9	7.4	6.3	4.8	1.1	17.5	5.7	3.2	19.2	27.6	3.1	0.0	0.3	0.0	0.0	3.4	0.7	0.3	1.6	0.1	25.1	4.0	0.7	5.5	0.2	0.0	1.3	0.6	7.8	2.8	0.1	3.5	1.7	0.7	4.4	4.1	1.5	0.3	0.7	1.2	0.0	1.8	0.3	5.1	0.0	0.2	5.6	0.7	2.9	0.0	1.4	10.1	7.1	9.0	0.1	0.1	8.4	0.2	0.1	0.1	0.8	1.6	2.0	1.2	2.3	3.3	20.0	1.3	6.5	1.6	12.5	0.7	0.5	14.6	0.0	6.7	8.2	8.6	0.4	0.2	0.3	0.2	1.6	0.2	1.9	1.5	0.0	0.0	0.3	3.2	0.0	2.3	3.1	2.0	1.0	0.0	0.5	3.4	2.1	0.0	0.0	0.0	0.0	0.7	0.7	9.2	5.7	85.3	16.5	5.5	7.6	8.3	5.3	9.7	4.8	17.9	14.5	0.5	30.2	3.2	37.8	24.4	12.7	5.3	1.2	34.9	2.0	1.3	1.7	9.4	3.3	5.9	3.8	0.0	2.4	3.5	6.9	26.7	0.0	3.0	0.6	1.6	13.3	14.7	0.8	7.6	10.9	1.4	5.0	0.0	12.7	18.3	3.3	8.6	14.2	1.1	2.9	0.0	13.3	1.0	3.4	1.9	5.6	1.5	24.3	27.4
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873258-166103895	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.1;Endothelial cells: 11.3;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 8.7;Karpas-707: 13.6;PC-3: 4.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"cerebellum: 132.6"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	10.1	1.3	1.2	2.6	2.8	0.0	7.9	40.6	2.9	5.0	5.4	0.2	4.2	1.4	3.0	2.7	2.5	2.4	5.4	2.4	2.2	1.7	3.3	0.5	3.1	3.0	1.1	0.6	1.6	4.6	1.1	2.2	13.8	8.5	3.1	2.2	3.3	1.9	1.9	1.6	2.7	4.4	3.3	0.9	0.4	1.7	1.5	0.1	0.0	3.2	1.4	1.6	3.6	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.6	1.5	0.0	1.8	0.0	1.4	0.0	0.0	13.6	0.0	0.0	0.0	0.2	1.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.8	40.6	2.9	2.2	1.7	1.1	0.6	8.5	0.1	0.0	1.1	0.0	0.2	1.5	15.1	4.1	0.0	1.4	1.2	0.0	0.0	3.9	0.0	1.5	0.0	11.3	0.0	0.0	1.9	0.9	1.6	0.8	0.0	0.0	0.2	7.9	0.0	1.8	0.0	0.0	2.8	0.0	1.7	0.0	0.0	0.0	0.1	0.0	4.2	0.8	0.5	0.0	0.3	0.1	0.0	1.5	1.6	0.0	0.0	0.1
TLNRD1	"MESDC1, MGC99595"	ENSG00000140406	"Talin rod domain containing 1"	Q9H1K6	15	81000944-81005788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 27.2;Extravillous trophoblasts: 28.3;Hofbauer cells: 29.4;Pancreatic endocrine cells: 35.9;Proximal tubular cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 25.9;SK-MEL-30: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071716			Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Cytoplasmic bodies"		"HPA071716: AB_2732183"	"unprognostic (1.32e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.37e-3)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (1.47e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.82e-3)"	24.4	13.1	5.8	11.8	19.2	13.7	11.1	18.5	12.6	8.2	12.0	7.0	10.3	8.8	9.7	8.2	9.6	8.7	14.4	10.0	5.9	6.0	9.2	10.1	17.9	12.5	5.8	4.6	6.5	11.9	4.4	7.3	10.7	5.9	7.2	7.4	10.8	7.5	6.6	5.6	4.5	10.1	6.2	8.2	21.4	15.7	2.8	4.6	15.0	6.5	11.0	10.4	7.8	8.7	3.0	2.2	2.0	1.9	4.7	2.9	1.2	6.1	2.0	5.4	3.9	2.4	1.4	9.0	5.7	1.6	3.6	2.6	3.5	5.6	6.8	8.0	1.4	2.1	8.0	3.3	1.8	2.0	25.9	9.7	13.2	1.2	3.8	1.8	4.6	9.6	1.5	2.4	2.2	2.1	1.3	5.3	5.8	7.4	16.8	2.4	3.1	7.2	5.4	8.6	4.0	2.9	9.4	5.5	15.2	2.2	6.3	8.5	7.2	3.2	3.5	25.1	4.9	3.1	4.1	6.3	4.1	13.0	5.7	8.4	11.7	11.5	7.2	2.8	6.7	4.2	2.0	1.3	1.4	2.7	1.9	2.0	3.0	2.9	2.8	0.9	2.3	1.5	2.1	2.0	4.7	1.6	2.2	1.2	1.2	5.8	19.2	18.5	12.6	5.9	6.0	5.8	4.6	5.9	4.6	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	7.9	12.2	0.0	7.5	1.7	12.2	0.0	0.0	0.0	0.0	27.2	28.3	0.0	0.0	2.3	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	5.4	0.0	0.0	35.9	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Cell type enriched"	"Detected in some"	18	"B-cells: 39.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"	"Group enriched"	"Detected in some"	55	"Daudi: 38.2;REH: 12.8;U-698: 13.7"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4	0.0	1.4	39.2	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.0	1.2	0.6	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724730	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 31.7;Ito cells: 59.5;Kupffer cells: 88.0;Macrophages: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 30.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.6;TIME: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	29.2	12.1	15.5	23.5	12.5	17.8	21.9	9.4	10.3	6.9	6.8	10.6	3.0	4.4	5.8	7.7	5.0	6.8	10.6	10.9	19.9	7.5	9.0	16.5	16.0	30.9	12.4	11.4	6.7	3.0	2.9	3.8	22.8	10.5	5.7	7.4	7.2	9.0	3.6	7.4	5.2	6.6	10.4	11.1	41.4	4.5	2.4	13.0	1.1	8.3	5.6	7.5	12.1	16.1	0.6	7.5	30.1	21.4	0.0	0.0	6.9	0.0	0.0	12.7	0.0	5.9	12.0	0.1	5.0	8.8	1.3	0.7	0.0	1.2	1.7	0.2	13.0	3.9	0.0	0.0	1.1	1.9	0.0	0.0	2.7	2.7	0.1	4.4	9.1	0.0	7.4	0.0	2.8	0.3	11.4	15.5	0.0	0.0	29.6	15.4	0.0	0.0	1.8	1.5	1.2	0.6	0.0	14.3	9.3	0.5	14.8	0.0	0.0	3.2	0.0	0.5	1.2	0.0	5.0	21.4	0.7	9.6	0.0	2.4	0.0	0.0	0.0	0.4	9.6	7.6	17.6	21.4	7.2	0.0	19.6	0.0	0.6	0.0	0.0	7.5	0.2	0.0	0.0	30.1	0.0	20.2	0.3	0.0	6.9	15.5	12.5	9.4	10.3	19.9	7.5	12.4	11.4	10.5	13.0	0.0	5.3	1.5	0.1	0.7	0.2	2.5	5.1	2.7	4.5	0.0	0.0	0.2	0.0	0.0	0.0	19.7	0.3	0.0	0.2	0.2	1.9	0.2	15.1	1.8	31.7	0.0	0.0	59.5	88.0	0.0	0.0	33.1	1.7	0.0	0.6	13.8	0.3	1.7	0.0	0.4	0.8	6.5	0.9	0.0	0.2	0.0	0.7	0.0	0.1	2.2
TLR5	"FLJ10052, MGC126430, MGC126431, SLEB1, TIL3"	ENSG00000187554	"Toll like receptor 5"	O60602	1	223109406-223143282	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 17.8;Collecting duct cells: 21.0;Kupffer cells: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0"	"Cell line enhanced"	"Detected in some"		"A-431: 4.4;HaCaT: 6.7;OE19: 3.9;SK-BR-3: 4.3;T-47d: 4.8"	"Low region specificity"	"Detected in many"							CAB009013			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB009013: AB_2240732"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	3.8	2.4	5.3	4.8	7.3	0.4	9.7	0.8	5.3	7.1	2.7	3.4	1.7	1.7	2.4	6.2	9.0	5.6	4.8	5.8	5.0	2.6	4.6	2.2	6.5	12.5	7.0	0.8	22.5	5.3	6.6	6.3	3.5	6.8	6.2	2.3	3.2	12.6	2.9	1.4	3.7	2.3	3.7	12.8	6.7	4.5	2.3	8.1	1.2	4.3	3.5	5.7	5.9	7.8	0.1	12.8	13.4	17.0	0.2	1.4	5.7	4.4	0.4	0.7	0.4	0.3	0.0	0.6	0.2	0.0	0.1	0.1	0.0	1.3	0.0	0.9	0.4	0.1	6.7	0.1	0.5	0.4	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.1	1.9	0.5	0.2	1.7	0.9	0.0	0.0	0.6	1.0	0.3	2.5	3.9	0.0	0.1	0.0	0.2	2.1	0.8	1.8	0.4	1.3	4.3	0.1	1.0	4.8	0.0	0.0	0.1	0.1	0.0	1.2	0.2	0.0	0.2	0.0	0.7	0.5	0.0	17.0	0.2	0.1	15.7	0.2	0.1	0.9	0.2	12.8	0.0	1.4	0.4	13.4	0.2	6.3	0.2	0.6	5.7	5.3	7.3	0.8	5.3	5.0	2.6	7.0	0.8	6.8	8.1	3.0	10.5	0.0	5.9	0.5	0.0	1.7	17.8	8.1	15.9	21.0	2.0	1.2	3.3	3.0	3.3	1.0	0.0	0.0	3.4	0.3	5.0	3.3	2.3	0.6	15.6	0.0	1.2	0.6	23.7	4.0	8.6	11.1	3.3	0.0	0.3	1.1	2.0	0.0	8.1	0.0	0.1	0.0	1.4	4.3	4.5	1.4	0.7	0.0	1.2	6.5
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.2;brain: 16.0;lymphoid tissue: 16.2"	"Cell type enhanced"	"Detected in some"	12	"B-cells: 5.0;Hofbauer cells: 5.9;Kupffer cells: 11.8;Macrophages: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 14.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.5;GAMG: 12.9;RPMI-8226: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062733			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	2.9	2.7	6.1	10.7	7.9	6.4	2.1	2.0	3.9	1.8	1.6	2.6	0.2	1.7	1.4	2.0	1.8	1.9	3.9	1.5	4.5	1.7	1.7	2.1	5.0	11.2	10.6	1.9	1.6	1.2	0.7	1.9	2.8	7.2	1.6	2.4	0.9	4.3	0.5	0.9	1.7	7.8	2.1	16.0	16.2	2.1	0.8	6.8	1.8	1.5	1.1	14.8	5.8	1.9	1.8	1.8	14.2	2.6	0.3	0.4	0.6	1.4	5.7	0.2	0.1	0.3	6.7	0.0	1.6	6.9	0.7	2.3	0.0	12.5	6.9	2.7	0.3	12.9	0.6	0.1	1.2	1.1	0.0	0.5	3.2	6.9	0.2	0.4	3.5	5.2	2.8	1.3	2.8	1.5	0.2	1.4	1.1	3.5	2.2	3.1	0.0	0.0	6.1	0.2	0.0	0.9	3.4	3.1	9.8	0.4	0.1	0.0	0.1	0.2	0.0	0.9	0.3	0.3	1.8	1.9	2.2	7.5	0.9	2.4	0.1	0.0	5.8	5.1	4.1	1.6	0.0	2.6	0.7	0.2	2.4	0.0	1.8	0.1	0.1	1.8	1.2	0.3	0.2	14.2	0.3	1.2	1.3	0.4	0.6	6.1	7.9	2.0	3.9	4.5	1.7	10.6	1.9	7.2	6.8	0.0	0.0	5.0	1.1	0.6	0.7	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.8	0.8	2.3	0.0	5.9	0.0	0.0	0.6	11.8	0.0	0.6	9.5	0.0	1.8	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.4	0.2	0.0	0.6	0.2	0.0	0.0	0.9
TLX2	"Enx, HOX11L1, NCX, Tlx2"	ENSG00000115297	"T cell leukemia homeobox 2"	O43763	2	74513463-74517147	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.0;brain: 4.3;retina: 3.8"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 19.6;Rod photoreceptor cells: 16.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"SH-SY5Y: 38.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062254			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062254: AB_2684727"	"unprognostic (7.30e-2)"	"unprognostic (3.03e-4)"	"unprognostic (9.54e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.40e-1)"	"unprognostic (3.92e-7)"	"unprognostic (2.51e-1)"	"unprognostic (6.86e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.18e-1)"	0.1	8.0	1.7	1.7	4.0	0.2	0.1	0.8	4.3	0.1	2.7	0.0	0.0	1.9	0.1	0.1	0.5	0.1	0.6	0.1	0.4	0.7	0.1	0.1	0.1	0.5	0.8	0.0	0.1	0.6	0.5	0.0	0.2	3.5	0.1	0.7	3.8	0.1	0.1	0.1	0.4	2.5	0.2	0.3	0.2	0.9	3.3	0.6	2.5	0.1	0.0	0.3	2.1	0.4	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	2.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.3	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.0	0.8	4.3	0.4	0.7	0.8	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.5	0.0	0.0	1.7	3.2	0.0	0.0	0.0	0.0	0.0
TM2D1	BBP	ENSG00000162604	"TM2 domain containing 1"	Q9BX74	1	61681046-61725423	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046058, HPA055621"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046058: AB_2679519, HPA055621: AB_2682865"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.79e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	24.2	30.7	32.5	20.0	42.8	16.2	30.1	24.7	50.1	26.2	22.1	25.3	21.2	16.6	26.3	38.9	19.3	25.1	23.7	36.5	27.9	28.3	32.3	23.5	35.9	27.0	32.7	22.2	31.4	27.6	25.9	24.0	28.8	33.6	28.3	23.9	24.4	23.1	25.6	29.6	16.0	20.1	24.2	45.6	20.3	23.4	27.0	22.3	20.2	33.7	16.6	16.0	21.9	20.5	15.3	22.6	27.2	15.7	14.7	15.2	12.5	11.7	5.8	9.0	7.1	27.5	27.0	11.5	21.1	21.6	10.4	14.0	3.7	15.1	9.6	28.2	17.6	20.9	13.5	11.4	15.3	16.2	15.6	13.4	10.6	9.5	8.2	27.0	15.3	19.0	30.0	26.5	12.0	15.2	25.6	19.7	13.0	12.2	18.7	25.2	3.8	7.7	12.1	9.8	10.5	8.3	6.7	17.0	11.8	30.8	9.3	10.1	12.3	12.6	25.1	37.9	12.6	13.7	16.6	17.4	14.1	7.1	7.8	15.9	15.8	14.5	11.8	24.5	15.0	12.4	26.6	12.6	27.2	11.2	14.6	11.1	15.3	13.0	13.5	11.8	13.0	12.3	14.1	7.6	14.7	15.7	22.6	15.2	12.5	32.5	42.8	24.7	50.1	27.9	28.3	32.7	22.2	33.6	22.3	38.7	38.1	38.9	83.1	69.5	54.4	36.2	38.2	58.9	37.5	75.0	56.9	45.4	33.2	46.4	4.1	53.0	41.7	23.3	39.6	53.3	78.6	77.5	60.0	45.7	45.3	65.2	42.2	74.3	58.7	6.8	73.9	51.2	86.0	39.7	38.7	80.4	42.9	56.0	49.8	58.8	62.9	38.8	59.7	165.1	61.8	66.9	44.7	47.9	41.6	90.1
TM2D2	BLP1	ENSG00000169490	"TM2 domain containing 2"	Q9BX73	8	38988808-38996824	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 172.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047152, HPA050547"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Vesicles, Plasma membrane"		"HPA047152: AB_2679957, HPA050547: AB_2681168"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (2.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-2)"	"unprognostic (8.61e-2)"	21.6	26.2	19.9	14.9	24.3	11.3	24.5	18.8	29.6	21.0	15.3	18.4	25.4	17.5	20.1	27.6	17.2	17.9	22.9	19.4	18.7	20.4	32.6	29.0	21.1	18.1	20.5	17.3	23.3	26.8	25.9	17.5	32.6	25.7	22.8	16.6	22.9	18.8	23.4	14.6	18.5	20.7	17.7	16.4	24.3	19.2	26.1	13.9	11.1	39.7	14.9	14.9	16.7	19.5	14.4	33.5	27.2	18.8	17.4	22.8	19.2	14.0	22.7	10.6	14.6	24.8	16.7	14.6	29.9	18.4	22.7	20.6	17.3	12.2	4.9	23.6	22.1	25.5	15.3	11.2	18.1	24.8	5.9	8.6	11.3	13.3	18.6	22.0	3.3	14.7	20.3	17.8	17.8	8.7	16.6	29.1	8.4	12.4	14.7	30.2	8.7	8.2	11.4	13.4	21.2	9.0	7.0	13.7	8.3	25.9	11.2	3.5	6.9	11.4	8.0	14.7	19.6	19.6	7.1	26.1	18.4	13.8	26.8	15.0	10.3	22.7	8.7	14.0	7.7	12.8	27.2	16.2	14.5	18.0	18.8	19.6	14.3	21.2	19.6	17.0	14.4	20.2	19.6	4.5	17.4	15.6	33.5	22.8	19.2	19.9	24.3	18.8	29.6	18.7	20.4	20.5	17.3	25.7	13.9	11.9	14.3	17.6	48.8	31.1	21.6	15.1	30.6	20.1	20.5	48.8	19.6	78.2	24.9	57.6	44.6	26.6	11.9	0.0	33.5	82.1	36.1	49.2	21.9	33.7	172.6	22.3	9.9	66.3	32.3	35.5	33.4	33.8	25.3	106.4	10.7	40.2	58.6	15.2	23.3	48.2	29.3	0.0	18.1	33.0	59.4	13.6	66.8	22.0	14.9	50.4
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA054064: AB_2682366"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	17.8	25.1	32.8	14.1	33.1	15.4	26.0	30.7	46.7	24.9	16.9	21.3	15.3	15.2	26.3	29.1	15.3	22.5	18.7	28.3	35.3	49.8	20.6	32.8	17.5	23.0	28.2	35.8	37.6	28.2	23.5	25.7	19.6	26.8	21.5	15.6	19.1	20.9	24.0	22.6	16.8	15.0	20.7	22.7	17.0	15.8	20.6	19.1	16.0	29.1	14.2	19.2	19.2	16.1	21.4	14.3	38.4	20.2	24.1	24.1	18.0	8.5	21.3	11.4	20.6	32.9	24.5	14.0	11.3	18.8	13.5	15.1	11.4	24.4	14.0	15.7	15.4	22.7	20.2	17.7	14.6	10.7	13.3	39.0	20.9	18.5	19.3	21.7	16.2	25.0	20.3	29.6	8.1	16.9	18.9	18.5	18.2	17.1	21.2	21.2	17.3	11.8	17.2	17.6	38.9	7.2	14.5	14.5	21.7	27.2	22.6	15.4	14.1	15.6	16.6	22.5	20.5	15.7	21.5	14.7	14.3	14.7	9.5	12.4	20.1	29.7	15.1	12.1	20.4	11.7	14.8	20.2	38.4	21.7	19.9	24.1	15.5	17.9	16.5	14.3	21.4	23.9	22.1	34.4	24.1	15.0	12.1	18.0	18.0	32.8	33.1	30.7	46.7	35.3	49.8	28.2	35.8	26.8	19.1	23.8	33.2	37.0	49.5	58.8	44.9	33.5	22.9	16.0	28.4	40.1	31.4	64.8	16.6	54.9	5.7	52.5	22.0	0.0	37.4	54.4	51.9	46.9	24.3	51.6	29.9	65.2	25.9	53.4	45.9	8.8	68.1	37.2	25.3	39.7	23.1	57.0	28.6	23.2	59.1	32.7	43.7	71.1	42.7	85.4	85.7	48.4	76.1	47.2	25.4	34.6
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endothelial cells: 155.8;Ito cells: 174.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 29.6;EFO-21: 62.5;GAMG: 12.4;HUVEC TERT2: 20.7;NTERA-2: 14.9"					"Low region specificity"	"Detected in all"			"HPA053639, HPA069378"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA053639: , HPA069378: AB_2686133"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	17.9	4.8	7.1	4.0	8.8	0.1	14.4	3.7	7.3	7.9	3.5	1.7	4.7	3.1	7.6	7.2	5.4	5.6	9.0	10.8	8.4	6.2	26.6	9.7	7.4	8.0	9.3	1.5	5.4	8.0	4.2	7.4	14.1	12.3	9.1	2.9	11.9	3.5	5.6	9.3	2.7	3.9	12.3	7.4	34.6	3.5	2.6	8.2	0.6	12.0	5.7	4.0	6.0	5.8	0.9	0.6	1.2	0.4	2.8	0.5	0.0	0.0	29.6	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	62.5	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.9	20.7	0.0	0.0	0.0	1.9	0.2	0.0	0.0	14.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	2.6	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.7	1.2	0.4	0.4	0.3	0.2	0.1	0.5	0.4	0.2	0.0	0.9	0.4	0.5	0.5	2.8	0.3	0.6	0.1	0.0	7.1	8.8	3.7	7.3	8.4	6.2	9.3	1.5	12.3	8.2	0.0	4.1	2.2	0.0	2.9	0.1	1.1	7.6	1.4	0.0	1.8	0.0	0.0	8.3	21.2	0.3	155.8	0.0	0.0	0.2	0.0	0.9	1.0	1.1	0.6	0.1	0.0	0.0	174.3	13.0	1.0	2.0	0.2	1.7	1.0	0.0	0.6	1.2	0.0	6.3	25.4	0.0	0.0	2.1	0.0	0.2	2.5	0.0	1.3	0.0	0.4
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362156-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	86	"intestine: 147.8"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 33.2;Enterocytes: 27.7;Late spermatids: 61.3;Paneth cells: 11.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 7.2;RPMI-8226: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	46.5	0.0	0.0	73.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.1	0.1	147.8	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	1.2	1.1	0.5	1.7	0.7	0.0	0.1	7.2	0.2	0.1	0.0	0.0	1.3	0.9	0.1	0.0	0.0	1.4	0.5	0.2	0.1	0.4	0.2	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.2	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.4	0.8	0.3	0.0	0.1	1.6	0.3	0.1	0.1	0.5	0.1	4.5	0.1	0.3	0.6	1.7	1.1	0.1	0.0	0.1	0.3	0.1	0.3	0.6	0.3	2.0	0.2	0.5	0.3	0.4	0.2	0.2	0.2	0.8	0.5	0.1	0.7	0.3	0.3	0.7	0.4	0.4	0.0	1.1	0.7	0.5	1.1	1.7	0.1	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	11.5	0.7	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.2	0.0
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149473974-149503281	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 196.0;intestine: 126.4;liver: 81.8"	"Cell type enriched"	"Detected in many"	5	"Cholangiocytes: 2236.9"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.3"	"Group enriched"	"Detected in some"	6	"A549: 15.4;OE19: 14.2;RPTEC TERT1: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	68.2	0.0	0.0	70.3	0.2	0.1	0.3	0.3	196.0	0.2	0.2	0.2	0.4	81.8	0.3	0.0	0.2	0.0	0.2	24.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.2	126.4	0.0	0.2	0.3	2.3	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.3	0.2	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.6	0.1	14.2	0.0	0.0	0.3	0.9	24.0	0.0	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.1	0.0	3.4	2236.9	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.8	0.0	2.6	23.3	1.7	0.1	0.0	0.0	0.0	475.7	0.1	0.0	2.9	8.0	11.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	7.6	0.0	0.0	2.1	0.0	0.0	1.1	3.6	0.1	0.0	0.1	0.0	0.1	0.1
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.1"	"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 176.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 22.1;RPTEC TERT1: 25.4;T-47d: 49.4"					"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: AB_2686551"	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	27.7	78.1	6.9	2.2	12.5	2.0	10.0	5.6	21.7	4.7	3.1	22.4	5.1	4.8	1.5	11.0	11.5	6.4	8.5	28.2	7.4	6.6	8.3	38.6	5.1	1.7	10.3	9.6	13.5	22.6	11.8	6.2	2.2	13.2	19.8	2.3	5.4	28.5	3.3	3.3	17.9	2.8	1.3	7.3	1.9	8.8	5.3	8.8	1.9	7.4	13.6	10.4	2.6	6.1	7.4	22.6	1.8	1.0	7.3	7.6	3.0	2.6	3.6	8.5	12.2	3.4	0.2	5.4	0.6	1.3	1.0	1.1	8.8	12.4	5.4	9.6	0.4	0.3	4.3	3.7	6.0	0.7	5.2	1.9	3.3	1.0	17.7	6.9	1.3	3.7	1.5	1.8	4.9	0.6	4.0	0.9	10.3	1.9	4.2	0.3	22.1	2.3	5.8	4.6	5.6	4.1	7.2	0.4	12.7	25.4	3.9	9.6	10.8	0.4	9.3	2.1	5.6	49.4	3.6	0.6	0.1	1.3	1.2	0.8	9.6	6.0	3.1	0.8	2.1	0.3	0.5	1.0	1.8	5.5	0.8	4.3	7.1	3.5	4.5	0.9	7.4	7.6	5.5	0.7	7.3	0.5	22.6	3.1	3.0	6.9	12.5	5.6	21.7	7.4	6.6	10.3	9.6	13.2	8.8	8.9	36.6	11.1	5.3	1.6	15.6	89.9	50.9	6.7	5.7	41.8	9.8	64.7	14.9	20.7	26.9	4.5	21.7	0.0	24.2	1.7	3.3	37.3	6.9	79.7	12.7	23.8	57.1	4.3	6.3	49.4	9.2	3.5	11.8	13.6	16.5	176.3	28.8	11.5	2.1	62.4	21.2	12.9	2.3	10.9	9.4	6.0	68.7	8.5	12.4	8.4
TM9SF1	"HMP70, MP70"	ENSG00000100926	"Transmembrane 9 superfamily member 1"	O15321	14	24189143-24195687	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059249	Supported		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA059249: AB_2683959"	"unprognostic (3.27e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.18e-3)"	13.3	20.4	6.3	10.9	6.6	3.4	14.0	5.4	8.1	18.5	15.6	10.4	33.1	10.7	17.7	21.8	14.1	23.4	18.4	14.6	6.2	6.0	24.5	46.4	17.0	14.6	6.2	7.1	17.6	39.9	27.4	12.3	25.1	6.5	16.9	9.4	15.6	31.8	36.0	10.1	12.0	16.8	13.6	5.9	12.7	14.7	10.3	5.6	9.6	32.3	12.9	12.1	12.8	12.4	10.6	25.8	18.0	13.6	14.5	10.8	8.6	9.5	16.0	7.1	5.5	14.1	11.0	11.1	18.7	21.3	22.5	25.3	8.0	18.6	5.7	12.5	15.9	10.7	21.5	4.4	11.3	12.3	9.5	7.5	4.4	8.3	16.5	9.9	8.1	10.3	12.8	15.9	14.2	8.2	10.9	12.8	3.2	5.2	11.0	13.4	15.0	4.8	5.6	3.3	13.5	18.9	7.2	10.5	9.5	7.8	13.0	7.2	8.3	22.6	10.2	9.1	5.4	9.6	3.6	12.8	19.7	9.0	10.3	11.7	15.5	11.8	4.1	6.6	4.5	13.4	17.2	13.6	15.2	10.0	10.9	10.8	10.2	9.9	8.7	15.0	10.6	9.2	8.7	18.0	14.5	10.4	25.8	9.9	8.6	6.3	6.6	5.4	8.1	6.2	6.0	6.2	7.1	6.5	5.6	14.9	4.0	3.9	5.0	3.0	4.2	1.0	5.1	45.5	7.9	1.8	13.7	8.2	0.0	6.6	9.3	6.0	4.2	0.0	4.3	8.1	5.9	6.7	2.3	4.3	3.7	0.0	1.7	4.9	1.0	3.8	4.9	3.2	1.7	5.4	2.3	6.1	4.6	4.2	4.2	2.3	6.6	6.5	6.2	5.6	5.1	4.1	10.0	4.5	3.7	3.5
TM9SF3	SMBP	ENSG00000077147	"Transmembrane 9 superfamily member 3"	Q9HD45	10	96518109-96587452	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039609	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		320000	Vesicles	"Golgi apparatus"	"HPA039609: AB_10673535"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.95e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (4.14e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.18e-2)"	28.4	23.9	19.6	31.0	19.3	12.8	24.5	16.0	18.9	29.3	54.2	16.5	49.9	42.9	31.5	27.3	28.4	23.7	57.7	37.3	19.5	19.2	28.7	50.8	25.2	17.0	20.8	13.5	31.3	33.6	27.4	20.3	50.7	18.7	35.6	35.7	18.5	43.0	57.9	18.4	22.4	60.0	21.4	26.3	25.6	69.6	15.4	18.3	27.1	33.1	16.1	26.6	34.7	34.4	3.3	11.2	7.7	3.6	5.5	6.5	2.4	35.3	24.2	26.9	37.6	39.4	29.5	32.3	48.9	36.3	21.2	17.6	28.9	70.0	26.1	27.2	43.2	26.8	33.5	24.3	27.0	40.0	29.2	20.9	23.2	21.4	22.7	29.7	47.4	27.1	27.1	27.3	30.0	52.1	64.6	23.3	24.1	23.0	30.2	32.3	16.1	18.3	18.3	17.1	58.0	14.9	22.8	34.0	20.4	30.2	26.3	12.5	28.1	25.9	24.9	24.9	33.6	42.9	18.0	40.7	26.5	22.5	26.5	44.7	31.3	35.5	24.2	36.0	33.2	18.4	7.7	3.6	5.5	5.8	3.5	6.5	3.3	6.2	6.3	4.3	2.2	4.8	6.0	4.2	5.5	3.5	11.2	6.0	2.4	19.6	19.3	16.0	18.9	19.5	19.2	20.8	13.5	18.7	18.3	47.6	38.4	61.0	98.4	103.7	51.1	59.3	117.2	33.5	64.8	134.3	53.0	66.4	18.3	67.7	13.2	79.4	171.7	23.3	126.1	84.8	99.2	200.9	40.3	110.7	53.4	55.6	118.9	75.5	84.6	9.5	86.3	61.4	97.8	28.9	300.1	50.1	110.9	118.1	77.4	50.6	47.5	64.7	95.1	44.1	44.5	105.5	117.9	54.9	188.1	132.3
TMA7	"CCDC72, HSPC016"	ENSG00000232112	"Translation machinery associated 7 homolog"	Q9Y2S6	3	48440257-48444208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.14e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.31e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.64e-3)"	38.7	54.0	76.1	41.7	82.7	72.5	49.8	41.7	55.8	35.3	49.0	22.6	44.7	37.8	28.4	72.6	43.0	30.5	40.3	49.8	61.4	61.6	50.3	50.3	36.6	50.3	63.6	46.0	41.7	59.5	21.6	45.4	28.7	53.3	36.9	47.0	39.2	39.6	37.4	107.4	28.4	41.1	36.5	57.4	41.5	39.0	35.0	41.0	37.9	38.3	67.6	56.6	29.9	37.7	125.7	139.0	192.1	98.7	79.4	146.7	204.3	65.2	47.4	76.9	55.0	63.8	62.3	53.0	54.0	42.6	51.8	51.5	38.5	47.3	42.7	38.6	46.9	67.6	25.6	67.0	60.9	57.9	52.5	57.1	80.5	102.1	98.1	49.7	91.3	54.0	57.0	65.5	48.9	47.7	50.8	65.3	76.4	43.0	45.7	73.8	67.6	106.2	124.3	102.5	71.0	76.5	30.4	48.2	72.3	89.0	88.5	25.3	64.3	60.8	44.5	81.2	74.5	42.9	135.7	48.8	44.0	79.1	67.9	105.3	76.3	112.4	102.9	56.4	88.3	45.5	141.0	98.7	192.1	110.7	89.8	119.5	125.7	146.7	132.9	104.9	100.5	146.3	140.0	188.5	79.4	87.7	139.0	143.8	204.3	76.1	82.7	41.7	55.8	61.4	61.6	63.6	46.0	53.3	41.0	223.4	369.4	511.1	446.0	636.3	196.3	594.9	570.7	348.0	349.2	854.9	100.1	706.5	1455.6	502.0	547.1	428.3	899.7	443.9	893.2	693.8	535.7	516.2	437.2	865.9	741.4	112.8	610.5	535.9	636.7	794.0	598.9	617.4	737.2	776.3	895.2	244.7	727.5	821.9	436.7	886.4	223.1	349.3	415.1	507.5	743.5	785.4	368.1	657.2	795.4	485.3
TMC4		ENSG00000167608	"Transmembrane channel like 4"		19	54160108-54173250	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 45.8;seminal vesicle: 49.1"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 180.2;Paneth cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.4;neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"OE19: 13.2;T-47d: 24.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048635	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA048635: AB_2680470"	"unprognostic (7.55e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.68e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"prognostic favorable (1.54e-8)"	"unprognostic (6.70e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.79e-2)"	1.2	0.4	0.8	4.7	1.2	0.0	6.5	0.5	0.7	3.7	31.0	0.0	32.0	19.7	2.0	16.2	2.9	8.7	21.8	1.7	0.9	0.8	11.8	0.8	9.6	0.0	0.8	0.0	3.8	25.0	0.3	11.1	6.9	0.0	8.6	7.5	0.0	34.5	49.1	0.8	1.3	45.8	0.8	0.6	0.3	8.2	0.6	0.0	1.0	17.1	2.8	5.6	6.7	2.7	0.0	0.0	1.5	1.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.5	0.7	0.9	0.8	0.8	0.0	0.0	0.0	26.8	25.9	0.5	19.7	2.2	0.3	1.6	58.6	71.0	25.0	43.6	0.0	19.8	11.6	62.6	0.0	1.3	180.2	0.0	57.0	5.4	1.9	25.5	5.7	1.0	3.3	0.0	40.0	1.8	2.2	0.0	1.1	2.8	1.7	1.8	82.2	0.1	44.7	96.5	0.7	21.6	0.2	25.8	9.9	0.1	2.3	1.5	19.6	2.1	71.7	32.6
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 108.7"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 547.4;Club cells: 299.1;Pancreatic endocrine cells: 236.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 37.3;OE19: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.7	0.3	0.3	4.8	0.3	0.1	5.6	0.3	0.7	3.8	66.1	0.6	0.6	19.1	2.1	16.9	1.4	1.9	15.9	0.4	0.4	0.3	0.3	1.8	17.6	0.2	0.3	0.4	1.8	5.4	4.5	1.0	3.7	1.0	8.4	9.8	1.7	18.9	0.2	0.3	0.8	108.7	0.3	0.2	0.3	19.5	2.6	0.2	0.2	0.8	1.7	4.1	1.5	1.1	0.5	0.7	2.2	0.6	0.9	0.8	0.3	3.5	5.8	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.2	0.0	0.1	2.3	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	1.3	21.6	1.6	0.0	0.0	1.3	0.1	0.1	0.3	0.1	0.0	1.1	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.2	0.3	0.3	0.2	0.4	0.8	0.3	0.2	0.5	0.2	0.3	2.2	0.9	0.4	0.7	0.1	0.3	0.3	0.3	0.3	0.7	0.4	0.3	0.3	0.4	1.0	0.2	145.9	125.6	0.0	19.6	0.7	0.1	0.8	122.3	547.4	299.1	21.0	2.0	31.1	0.0	107.5	21.7	0.4	170.3	0.0	144.9	1.6	0.8	88.4	5.7	0.0	2.3	3.2	37.4	0.6	0.0	28.2	0.3	0.9	1.7	1.8	97.1	0.1	236.7	190.0	0.7	0.4	1.5	0.0	0.9	1.8	1.1	1.5	13.6	0.0	77.1	46.1
TMC7	FLJ21240	ENSG00000170537	"Transmembrane channel like 7"	Q7Z402	16	18983934-19063942	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8;testis: 14.9"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 117.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029465	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA029465: AB_10600914"	"unprognostic (1.80e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-3)"	"unprognostic (7.60e-5)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (7.60e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.66e-2)"	"prognostic favorable (9.20e-4)"	3.6	0.7	6.2	1.9	11.4	0.7	2.0	8.5	11.1	1.1	6.7	24.8	0.0	4.4	1.5	1.3	0.9	1.0	2.6	1.6	9.7	5.3	1.0	0.7	5.2	0.7	15.7	6.6	0.7	0.9	1.4	0.7	7.7	12.8	2.8	8.2	0.6	0.7	1.9	1.6	2.0	4.9	2.2	15.7	1.1	5.4	14.9	12.8	0.0	1.6	0.0	0.6	9.6	1.3	1.6	1.2	2.9	0.8	1.6	1.0	0.2	1.9	4.0	1.2	2.0	0.2	1.7	5.3	0.7	1.1	0.7	1.8	1.3	9.3	0.2	8.9	0.7	2.0	7.3	3.2	3.1	0.9	0.1	2.3	0.2	3.2	5.7	0.2	0.2	0.1	0.4	4.5	7.2	8.1	2.4	3.0	4.1	2.2	0.7	3.2	4.5	0.3	0.3	3.4	12.1	5.9	0.2	3.5	0.3	1.3	9.7	0.7	2.0	2.2	6.1	0.6	5.6	1.8	0.7	2.6	1.2	2.0	1.4	3.5	0.5	1.0	0.3	6.2	0.3	1.0	2.5	0.8	0.8	0.9	0.6	0.5	0.9	0.9	0.7	0.3	1.6	0.9	1.0	2.9	1.6	0.4	1.2	0.5	0.2	6.2	11.4	8.5	8.3	9.7	5.3	15.7	6.6	12.8	12.8	3.0	3.8	0.0	2.5	0.3	0.6	0.8	2.5	0.0	1.2	0.0	0.0	0.1	0.0	2.8	117.6	3.0	3.9	0.0	10.0	1.5	0.4	2.0	0.0	0.2	0.2	0.0	1.2	4.3	0.0	29.3	1.1	1.2	0.0	0.0	5.4	0.2	9.6	6.8	0.4	0.0	2.5	0.0	1.0	5.4	10.0	0.9	0.2	0.0	3.3	15.2
TMCC3	KIAA1145	ENSG00000057704	"Transmembrane and coiled-coil domain family 3"	Q9ULS5	12	94567124-94650562	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 44.2;Urothelial cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.2;neutrophil: 30.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 30.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 18.2;Karpas-707: 24.6;U-266/84: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014272	Approved		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA014272: AB_1858059"	"unprognostic (1.03e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.11e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	10.6	4.0	10.2	7.7	20.9	8.1	9.9	2.7	9.9	11.0	19.7	32.6	6.8	13.1	6.9	3.0	6.1	5.5	4.7	4.4	14.7	10.8	7.4	3.5	5.9	3.9	25.8	7.4	5.2	2.8	5.0	4.7	15.7	17.8	7.7	15.0	7.3	5.8	5.1	20.2	7.0	23.0	7.2	25.5	11.6	6.4	2.2	20.4	0.1	12.0	3.3	5.3	7.2	5.9	2.5	1.1	30.0	3.0	1.3	1.5	1.1	4.4	0.2	1.1	0.0	0.4	1.6	8.0	0.0	0.0	0.3	1.1	0.0	1.0	0.1	0.0	0.0	4.0	11.0	6.2	7.5	1.5	2.0	1.5	2.9	0.5	0.0	0.3	0.0	6.0	1.0	1.0	4.2	6.0	6.7	18.2	0.0	0.1	24.6	0.6	0.2	0.0	0.2	0.5	1.5	3.8	0.0	0.3	2.9	1.2	9.4	0.1	0.5	0.1	4.7	0.2	5.4	0.0	0.2	11.0	0.0	0.1	0.0	1.9	11.5	16.4	0.1	2.3	0.9	1.0	6.5	1.8	19.2	1.5	2.6	0.1	2.5	0.6	0.8	1.0	1.4	0.0	1.0	30.0	1.3	3.0	1.1	0.0	1.1	10.2	20.9	2.7	9.9	14.7	10.8	25.8	7.4	17.8	20.4	0.0	2.4	6.0	26.2	18.3	1.7	1.7	5.1	0.0	0.0	7.0	0.0	12.5	0.0	1.4	4.6	12.1	44.2	0.0	3.4	2.7	3.4	12.5	0.0	0.5	3.5	0.0	11.5	21.5	13.7	4.7	1.7	11.0	3.3	22.6	11.3	0.0	7.7	18.7	1.1	8.4	0.2	6.5	3.1	0.0	1.1	14.2	5.9	4.9	5.5	78.1
TMCO3	"C13orf11, FLJ20623"	ENSG00000150403	"Transmembrane and coiled-coil domains 3"	Q6UWJ1	13	113490995-113554590	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 17.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039561, HPA048126"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA039561: AB_2676573, HPA048126: AB_2680276"	"unprognostic (7.89e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (6.78e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (2.93e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.47e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (4.10e-4)"	16.1	20.5	15.1	11.1	14.2	40.3	14.5	38.7	14.6	21.3	15.7	18.6	16.7	13.0	23.1	15.5	13.1	17.2	23.2	17.0	14.4	13.0	18.0	15.5	13.8	9.4	17.4	9.6	16.9	46.1	18.6	18.6	23.2	21.2	16.1	14.1	17.1	25.8	14.5	10.2	7.7	17.6	18.9	20.7	14.8	27.8	11.0	11.3	7.2	7.5	13.4	11.3	13.2	23.9	2.6	5.0	17.4	8.5	4.1	1.8	2.0	27.1	9.2	13.4	9.2	27.7	41.0	7.3	29.8	28.5	13.1	13.3	10.1	12.1	6.5	7.6	32.6	17.9	11.0	7.0	10.8	20.5	13.3	7.2	5.8	14.9	10.0	26.1	9.5	12.3	33.2	25.6	9.8	20.4	34.1	21.4	4.2	8.3	9.3	22.9	4.9	4.9	5.7	6.7	13.0	14.6	6.3	8.2	4.6	21.9	3.7	11.8	9.8	9.2	20.4	9.5	19.9	12.0	18.1	33.3	14.9	15.9	10.8	12.5	11.5	6.5	4.2	49.2	5.0	7.1	2.4	6.9	6.8	1.1	4.4	1.4	2.6	1.4	1.8	5.0	1.4	1.5	1.5	17.4	4.1	8.5	1.1	1.2	2.0	15.1	14.2	38.7	14.6	14.4	13.0	17.4	9.6	21.2	11.3	11.9	13.7	13.7	30.6	8.8	15.6	16.5	25.5	33.5	21.6	24.4	13.7	17.6	5.0	37.3	11.6	32.2	18.2	0.0	32.8	48.1	26.7	79.7	26.5	8.9	17.4	20.6	32.8	31.9	30.8	28.3	33.9	20.1	16.9	30.7	58.9	26.1	43.8	28.3	44.9	12.8	17.6	6.5	32.0	17.7	13.2	6.1	10.9	12.7	15.2	27.6
TMCO4	DKFZp686C23231	ENSG00000162542	"Transmembrane and coiled-coil domains 4"	Q5TGY1	1	19682213-19799945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014601, HPA014620"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA014601: AB_2204302, HPA014620: AB_2669051"	"unprognostic (3.31e-3)"	"unprognostic (8.94e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (6.99e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-2)"	"prognostic favorable (4.12e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.81e-2)"	"prognostic favorable (3.64e-4)"	10.6	8.8	2.4	9.0	3.3	2.5	11.3	0.9	2.3	9.1	6.1	2.8	15.2	11.8	16.9	15.1	8.0	7.3	7.4	4.9	1.6	1.3	9.5	7.9	5.2	12.6	2.6	1.2	8.6	15.3	17.3	10.5	7.3	3.3	12.1	3.9	8.8	25.8	19.0	2.0	5.2	6.4	11.2	2.0	9.1	8.7	3.3	2.4	3.5	10.8	7.6	9.5	11.6	10.0	7.2	9.3	2.7	8.1	4.6	6.7	4.4	5.8	3.6	0.0	0.2	5.0	3.6	4.1	4.4	13.4	8.6	4.8	2.9	27.5	10.2	6.5	12.5	3.8	4.5	1.1	4.4	1.7	8.6	1.1	3.9	4.3	1.4	4.1	0.0	5.4	3.7	4.9	2.9	1.6	3.1	4.1	0.2	0.7	6.9	3.7	4.9	0.0	2.2	0.4	7.8	5.1	1.9	11.5	6.2	7.4	4.6	0.0	0.5	5.8	8.0	9.1	0.6	7.0	6.6	2.5	6.7	3.1	4.6	3.0	0.8	0.3	2.9	7.6	8.8	4.1	0.1	4.8	2.7	6.3	8.1	6.2	5.6	6.7	6.6	9.3	7.2	5.2	4.3	0.3	4.6	4.9	0.2	4.9	4.4	2.4	3.3	0.9	2.3	1.6	1.3	2.6	1.2	3.3	2.4	11.9	8.3	8.2	10.2	2.5	0.1	5.6	2.5	24.1	7.9	10.4	0.0	8.0	8.3	9.0	0.3	4.3	6.7	0.0	14.6	16.0	4.5	12.2	3.5	4.4	8.2	0.0	5.8	5.5	6.3	0.0	5.8	5.7	10.1	12.6	10.8	2.8	10.4	5.8	5.3	6.0	0.6	0.0	7.5	0.2	2.0	2.3	6.1	8.2	12.1	6.5
TMCO6	"FLJ39769, PRO1580"	ENSG00000113119	"Transmembrane and coiled-coil domains 6"	Q96DC7	5	140639427-140645408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037473, HPA037474"	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA037473: AB_10671049, HPA037474: AB_10671050"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.20e-2)"	9.0	15.9	4.0	10.2	6.0	4.9	9.1	9.9	7.9	10.0	10.3	9.6	5.8	5.6	9.6	8.0	9.6	11.8	9.0	5.2	4.4	5.2	6.1	21.4	5.8	9.9	6.1	5.8	13.2	9.9	6.1	7.2	10.5	6.0	7.5	4.3	6.0	16.9	5.9	5.4	7.4	8.5	5.6	6.6	12.0	6.7	19.0	5.2	14.7	8.4	5.5	11.4	7.7	7.7	9.1	7.6	13.4	10.2	4.3	11.3	4.8	3.0	5.9	4.0	5.8	4.0	4.2	14.8	2.5	2.7	3.0	3.2	9.1	5.5	12.1	6.4	1.8	3.5	6.0	3.1	6.7	1.4	4.4	11.2	9.3	2.7	6.3	5.4	5.3	3.5	6.9	1.6	3.8	6.0	2.1	7.1	10.2	3.8	4.0	3.6	5.9	12.1	11.9	4.5	6.9	9.2	10.3	8.3	12.2	3.6	2.7	7.0	2.9	6.9	13.1	6.1	2.5	10.6	6.1	3.3	0.1	2.9	1.1	0.9	7.0	4.1	5.5	1.9	8.2	3.6	10.6	7.3	5.8	6.1	9.9	6.8	9.1	8.1	6.2	7.6	6.4	11.3	4.8	13.4	4.3	10.2	2.1	8.7	4.8	4.0	6.0	9.9	7.9	4.4	5.2	6.1	5.8	6.0	5.2	6.0	1.3	5.1	6.5	1.6	5.0	0.6	2.5	5.3	0.0	10.4	5.9	6.3	0.0	3.2	1.7	4.2	3.5	0.0	2.1	6.8	2.8	3.2	0.0	8.5	4.1	0.0	7.0	6.2	4.1	0.9	3.7	2.7	1.7	4.6	3.7	3.9	3.4	4.3	4.6	1.6	4.2	6.5	2.2	16.6	15.1	1.9	5.3	9.6	6.8	5.7
TMED8	FAM15B	ENSG00000100580	"Transmembrane p24 trafficking protein family member 8"	Q6PL24	14	77335021-77377109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001205	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA001205: AB_2204460"	"unprognostic (1.07e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.77e-1)"	8.2	12.8	13.4	16.3	18.3	10.3	12.1	15.0	16.1	9.7	7.0	6.5	8.0	5.3	10.4	8.3	5.9	8.6	6.6	7.6	11.3	21.2	15.7	5.9	7.1	23.6	12.4	16.6	11.6	8.6	19.3	26.0	6.8	16.9	9.4	7.6	11.6	7.3	9.7	4.3	7.6	8.8	8.7	13.9	12.0	9.4	12.4	11.8	12.6	16.4	2.4	27.2	7.9	8.5	5.3	2.3	4.8	2.2	1.2	1.6	1.0	7.7	6.4	7.6	6.8	4.8	4.3	6.5	4.9	3.2	5.2	5.6	4.0	4.4	31.0	4.2	4.0	4.3	5.4	5.6	5.6	8.1	9.7	3.4	10.3	5.0	4.2	3.3	5.0	28.6	4.5	4.0	6.7	6.1	5.2	7.3	25.8	5.2	8.4	5.1	7.6	7.9	7.4	3.8	5.7	6.5	6.4	7.0	2.5	5.4	4.8	9.5	5.7	8.5	5.1	6.2	6.1	8.3	8.4	5.2	5.4	3.5	9.6	5.7	6.8	12.9	15.7	6.1	9.4	7.8	3.7	1.6	4.8	0.8	2.2	1.0	4.9	1.2	1.0	1.4	5.3	0.7	1.2	2.6	1.2	1.9	2.3	1.6	1.0	13.4	18.3	15.0	16.1	11.3	21.2	12.4	16.6	16.9	11.8	3.0	5.6	18.2	4.3	6.0	30.4	14.6	10.2	25.4	3.4	21.0	102.1	8.9	5.0	5.1	3.8	6.0	4.1	23.3	4.1	8.8	7.5	6.5	0.0	8.5	6.8	27.0	42.6	8.0	20.3	6.3	13.6	8.4	5.0	7.2	6.9	14.1	5.4	3.5	13.4	17.4	36.4	12.9	7.1	6.5	14.1	7.9	3.4	5.3	5.9	3.7
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039739, HPA075651"			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039739: AB_2676657, HPA075651: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	11.0	10.9	8.4	7.3	14.2	5.1	58.9	6.3	16.5	22.7	11.4	13.7	7.7	8.4	33.3	14.5	15.1	19.2	15.4	12.4	8.7	8.6	37.2	12.0	11.4	16.1	9.5	9.4	13.0	27.8	10.7	8.5	17.8	11.6	13.9	8.6	11.5	20.9	59.7	15.5	13.8	9.5	11.6	10.1	11.0	13.6	16.9	8.9	10.0	25.4	12.9	13.2	12.5	11.6	23.8	25.9	11.7	25.0	23.8	27.2	17.8	9.8	24.2	8.6	7.2	20.6	19.9	8.7	10.3	15.7	20.5	19.6	17.9	25.7	11.1	2.9	10.6	16.0	15.2	10.0	17.9	15.7	12.0	20.2	8.3	19.4	36.2	17.8	13.4	14.5	17.8	20.5	14.5	20.6	18.5	17.9	19.5	17.1	21.9	12.7	13.2	14.4	15.4	4.0	10.8	27.3	12.5	18.8	20.1	17.1	8.0	11.3	9.0	6.6	0.2	24.5	11.4	11.9	25.8	10.7	18.8	12.7	8.2	20.2	22.8	15.7	5.1	19.7	12.7	16.7	11.7	24.9	8.6	19.4	25.0	21.8	22.7	24.5	22.3	25.9	23.8	27.2	22.1	9.1	23.8	17.8	25.2	25.1	17.8	8.4	14.2	6.3	16.5	8.7	8.6	9.5	9.4	11.6	8.9	17.9	12.5	26.3	26.3	18.3	10.4	28.5	20.4	22.7	13.6	38.4	5.9	59.3	31.5	30.3	10.8	20.2	20.8	0.0	43.1	35.2	18.8	20.8	23.0	18.6	33.4	11.1	22.5	31.3	25.9	8.7	12.0	20.9	32.1	47.7	31.6	16.0	40.2	17.5	11.7	25.6	11.4	6.5	16.0	48.6	17.9	19.7	37.3	17.9	43.5	22.6
TMEM102	"CBAP, FLJ36878"	ENSG00000181284	"Transmembrane protein 102"	Q8N9M5	17	7435443-7437679	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 49.0;Pancreatic endocrine cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 11.3;HMC-1: 13.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024433	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA024433: AB_1858071"	"unprognostic (2.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (1.10e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.42e-3)"	6.6	8.6	1.6	5.8	6.0	3.7	8.2	0.9	3.5	3.5	8.0	2.9	7.4	7.1	2.3	3.1	11.7	2.9	6.5	4.1	2.2	0.9	9.1	7.1	6.0	11.9	7.3	0.1	1.9	7.6	3.8	1.5	6.1	3.2	4.8	2.8	2.0	8.3	3.0	4.1	9.6	10.9	1.0	3.7	7.9	6.3	6.9	3.5	17.8	9.1	4.1	13.2	4.8	4.6	1.5	1.2	7.4	2.1	1.9	2.1	0.8	5.5	3.9	0.4	0.0	1.5	0.7	3.2	1.2	1.6	0.8	1.7	2.1	5.9	5.6	5.3	0.6	0.8	11.3	1.0	6.2	0.2	5.0	7.0	5.2	2.4	2.0	0.7	3.0	13.0	0.4	5.9	0.4	1.1	2.0	2.6	4.9	1.9	0.3	0.0	3.3	3.4	5.4	0.2	5.4	3.3	5.6	0.4	1.9	5.5	3.7	0.2	3.8	0.6	5.1	1.5	1.1	2.7	1.2	3.4	0.3	0.3	0.6	0.1	1.1	1.5	0.8	1.7	2.7	2.6	0.0	0.9	7.4	1.7	1.9	1.0	1.5	1.8	2.1	1.1	1.4	1.4	1.5	0.1	1.9	2.1	1.2	1.6	0.8	1.6	6.0	0.9	3.5	2.2	0.9	7.3	0.1	3.2	3.5	0.0	0.0	9.3	3.6	3.3	0.0	0.8	7.6	0.0	0.0	1.8	0.0	8.3	6.6	17.2	14.6	1.4	15.3	0.0	19.1	5.1	0.9	2.0	0.0	3.2	6.8	1.6	1.2	2.5	9.1	49.0	0.9	6.9	1.7	12.6	7.0	1.6	27.1	14.0	0.7	7.4	0.6	0.0	1.4	0.9	1.9	6.1	4.2	6.5	6.3	13.7
TMEM104	"FLJ00021, FLJ20255"	ENSG00000109066	"Transmembrane protein 104"	Q8NE00	17	74776483-74839779	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044330	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA044330: AB_10960543"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (7.46e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.75e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (8.14e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.46e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.00e-2)"	11.5	15.5	10.6	11.6	12.1	15.4	7.7	10.5	13.9	8.1	7.9	19.1	9.5	7.6	7.4	8.9	9.3	6.8	9.6	9.0	11.4	8.2	10.9	19.9	14.7	19.0	17.3	9.1	9.4	18.7	21.0	14.7	12.5	13.1	8.0	6.7	10.0	15.1	9.1	7.5	9.7	7.7	9.4	18.5	10.4	8.3	17.4	14.2	7.5	11.7	6.5	10.2	10.6	6.1	4.9	8.8	5.7	7.7	3.9	7.9	5.0	6.3	15.6	8.4	9.4	11.9	7.4	5.0	11.0	11.1	14.1	15.7	12.8	6.9	3.4	3.5	12.5	14.4	7.2	8.4	6.1	7.5	2.5	11.9	8.4	6.3	8.8	8.7	13.7	7.8	5.9	6.8	14.3	3.1	4.2	10.0	8.3	4.8	5.3	9.6	6.0	8.2	5.6	4.6	8.4	12.5	5.2	13.2	5.6	6.3	5.6	7.1	9.3	6.1	7.9	8.1	6.6	10.1	21.4	7.9	29.8	7.6	11.3	14.2	3.6	3.1	3.8	11.5	14.4	11.3	2.2	7.7	5.7	7.9	6.5	4.0	4.9	7.6	7.2	8.3	1.6	6.3	4.4	3.6	3.9	6.6	8.8	7.5	5.0	10.6	12.1	10.5	13.9	11.4	8.2	17.3	9.1	13.1	14.2	6.0	7.2	0.8	1.0	2.3	2.3	36.1	10.2	0.0	3.4	5.2	2.0	3.3	0.0	3.9	1.6	2.3	3.9	0.0	4.8	3.3	2.7	2.1	1.1	11.5	10.6	0.0	7.9	3.1	6.3	1.7	2.6	5.5	0.0	4.6	4.0	4.0	5.3	3.1	2.1	1.6	3.0	0.0	1.4	4.3	4.1	1.9	3.2	2.9	2.6	1.3
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: AB_2684993"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.8	4.0	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.6	0.3	0.0	0.1	1.8	0.0	0.0	0.0	2.3	0.0	0.5	0.0	10.3	45.3	0.0	0.0	0.1	2.8	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.9	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3	3.0	2.9	0.0	0.5	2.2	11.4	1.2	0.0	0.0	9.1	0.0	96.2	1.8	0.0	0.0	57.1	1.4	0.0	0.0	0.3	7.2	1.1	0.2	1.1	0.0	0.2	1.6	0.0	0.0	0.0	29.1	0.9	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.7	0.0	56.3	0.0	1.4	19.1	8.0	1.4	0.9	0.0	0.0	0.3
TMEM109	MGC5508	ENSG00000110108	"Transmembrane protein 109"	Q9BVC6	11	60913874-60923443	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011785	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA011785: AB_1858075"	"unprognostic (5.23e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (2.68e-4)"	40.2	21.2	7.7	22.4	11.5	10.4	45.4	13.4	17.4	39.7	28.8	17.0	17.7	12.0	43.1	25.9	38.0	30.0	32.0	32.7	9.9	8.3	27.0	31.7	30.0	26.0	16.5	9.5	42.6	28.5	23.2	18.9	36.2	12.4	38.5	11.8	44.1	43.4	27.5	41.9	28.4	19.2	38.0	10.5	28.8	25.1	16.6	12.1	21.5	36.9	35.2	33.0	35.6	44.7	25.5	83.1	9.5	13.7	19.9	36.2	21.9	24.5	21.7	14.0	23.3	35.5	16.4	11.7	23.1	20.8	24.5	21.3	19.3	26.1	28.3	43.0	25.5	14.7	32.2	14.5	9.9	14.9	22.0	19.3	20.0	10.2	4.2	10.5	40.5	17.9	11.1	12.6	19.0	9.5	8.7	29.6	22.9	10.3	74.5	17.4	44.5	29.8	17.4	24.0	12.5	22.2	29.7	27.3	40.6	12.0	12.6	5.7	10.1	18.3	44.4	21.9	9.8	24.9	7.4	30.3	31.6	15.2	39.8	20.9	25.6	18.8	15.2	28.1	17.5	36.5	6.2	13.7	9.5	35.8	12.1	36.2	22.3	20.8	30.3	40.8	25.5	19.0	24.3	1.5	19.9	8.8	83.1	15.5	21.9	7.7	11.5	13.4	17.4	9.9	8.3	16.5	9.5	12.4	12.1	65.5	21.0	47.9	39.3	45.1	12.5	30.7	20.4	22.7	22.7	24.4	0.0	104.3	21.6	63.3	20.4	85.0	6.5	0.0	69.7	95.5	55.6	29.5	49.7	16.6	62.1	28.6	6.9	50.3	19.6	7.5	82.8	53.7	49.0	53.3	10.1	27.1	44.7	19.5	91.6	13.3	33.9	38.8	64.8	6.0	6.8	44.3	44.5	56.6	16.5	34.5
TMEM110-MUSTN1		ENSG00000248592	"TMEM110-MUSTN1 readthrough"		3	52833121-52897562	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.0"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 2: 1.4;Cholangiocytes: 2.5;Club cells: 1.2;Exocrine glandular cells: 1.6;Ito cells: 1.3;Kupffer cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.3;Karpas-707: 9.1"									HPA051855	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051855: AB_2681639"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.95e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.11e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.01e-6)"	"unprognostic (5.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.09e-5)"	13.3	6.7	3.8	5.4	7.6	5.2	5.8	5.2	9.6	4.9	5.5	8.6	3.7	4.1	8.6	3.4	6.4	4.2	3.8	5.8	4.1	3.7	8.0	23.6	5.0	8.6	6.6	3.4	5.2	9.2	2.0	3.8	3.9	6.0	4.1	2.6	6.0	5.5	3.1	58.0	4.2	7.9	7.8	4.8	5.7	5.0	3.9	4.1	8.6	4.4	2.7	6.1	5.8	5.7	0.9	1.6	1.6	1.7	0.0	2.3	0.4	1.5	0.8	1.6	6.2	0.5	0.0	0.0	3.2	1.0	0.2	0.4	0.0	1.0	1.1	0.5	0.0	2.2	1.4	1.6	1.6	0.0	8.3	3.3	2.1	0.0	0.0	0.2	1.4	3.2	0.0	0.6	0.6	1.3	0.0	0.3	4.2	0.9	9.1	0.1	1.0	1.9	1.1	1.1	0.6	4.2	0.3	0.0	2.0	0.3	0.0	0.6	0.4	0.8	0.9	1.9	0.4	0.7	3.1	0.9	1.1	2.9	1.2	1.8	4.2	3.8	1.2	1.4	4.0	1.7	0.0	0.2	1.6	0.4	1.7	2.3	0.9	0.7	0.9	0.8	0.3	0.0	0.0	0.4	0.0	0.0	1.6	0.6	0.4	3.8	7.6	5.2	7.6	4.1	3.7	6.6	3.4	6.0	4.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.2	0.0	0.0	0.3	0.0	1.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
TMEM116	FLJ90167	ENSG00000198270	"Transmembrane protein 116"	Q8NCL8	12	111931282-112013185	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 48.7;Spermatocytes: 128.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"T-cells: 14.9"	"Cell line enhanced"	"Detected in many"		"RT4: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040720	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA040720: AB_10795623"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.12e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.19e-3)"	3.7	10.7	4.4	3.0	8.4	1.0	10.2	6.7	6.6	5.3	4.1	11.2	9.1	9.5	3.9	6.4	4.9	4.2	5.8	20.2	5.3	3.7	26.8	10.0	7.2	3.7	8.7	5.5	4.7	4.1	31.2	9.6	2.7	14.0	4.5	3.4	5.9	12.5	7.0	5.0	11.8	9.0	5.1	8.2	3.9	8.7	20.8	7.3	6.0	6.6	3.6	5.6	8.6	4.5	2.5	3.0	3.0	3.3	1.5	14.9	3.4	4.2	4.4	6.3	7.0	6.3	5.0	4.3	3.4	5.6	4.5	4.9	3.3	3.5	4.9	2.2	2.6	5.5	4.3	3.5	3.7	3.9	11.7	2.8	3.1	4.2	4.1	10.1	1.2	0.5	6.1	6.4	5.8	10.1	4.8	1.5	9.4	5.9	4.0	4.6	6.3	1.8	10.0	7.8	10.2	2.9	5.0	2.5	8.4	14.1	23.9	6.0	4.0	3.7	3.3	5.8	8.9	11.9	16.5	1.1	4.3	1.3	3.8	1.5	4.7	8.2	4.6	6.0	3.9	6.0	0.8	1.8	3.0	6.5	3.3	5.2	2.1	14.9	12.1	2.1	2.5	7.9	8.6	0.3	1.5	2.4	3.0	13.5	3.4	4.4	8.4	6.7	6.6	5.3	3.7	8.7	5.5	14.0	7.3	3.0	14.4	1.5	6.8	4.8	10.6	21.6	5.1	12.0	2.3	27.9	15.7	16.1	19.9	3.0	48.7	3.4	7.8	0.0	3.6	4.8	5.6	3.6	5.7	5.0	4.5	9.5	0.0	1.8	5.2	26.7	8.6	3.7	6.8	2.8	2.4	13.0	3.0	1.9	4.6	8.8	17.6	6.5	4.2	128.4	21.3	4.6	33.5	12.9	2.6	5.9
TMEM120B		ENSG00000188735	"Transmembrane protein 120B"	A0PK00	12	121712752-121783001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 23.1;cerebellum: 35.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014066	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	Cytosol	"HPA014066: AB_1845296"	"unprognostic (8.80e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.29e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.86e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.72e-2)"	7.9	7.0	5.6	4.7	23.1	9.3	5.6	35.6	6.9	11.1	4.4	3.3	8.6	4.2	10.0	5.4	2.8	12.2	4.5	3.9	5.9	3.8	4.5	4.7	5.3	4.0	4.5	4.3	5.0	14.3	5.9	11.6	2.4	6.0	5.2	3.1	5.5	14.9	6.2	17.2	5.7	3.8	8.0	2.9	4.3	4.9	3.4	5.8	1.9	10.6	4.0	3.8	3.6	7.1	4.1	4.0	3.6	1.6	2.4	3.4	1.3	4.8	16.6	3.9	11.4	4.9	6.5	8.0	6.4	7.4	6.2	5.0	10.5	5.6	5.2	4.0	6.5	6.1	8.3	9.1	7.7	3.3	3.1	8.4	7.2	5.2	6.5	6.7	5.1	5.7	6.0	6.9	7.0	5.1	11.0	3.8	11.6	6.4	3.8	3.7	7.8	8.4	7.0	7.0	3.3	10.3	10.0	16.1	6.9	3.2	5.3	15.0	10.7	6.3	5.0	5.6	7.5	11.3	4.1	5.3	8.3	9.4	5.3	5.6	8.9	3.1	3.8	10.6	6.6	8.3	3.1	1.4	1.7	3.4	1.6	2.8	2.9	3.3	2.7	1.6	4.1	2.4	2.8	3.6	2.4	1.5	4.0	2.8	1.3	5.6	23.1	35.6	6.9	5.9	3.8	4.5	4.3	6.0	5.8	23.8	12.6	12.3	4.4	5.8	35.4	6.1	12.7	4.0	7.9	10.4	21.6	5.6	6.6	7.6	14.5	4.9	21.9	0.0	10.8	5.8	6.5	5.4	4.6	2.9	5.1	12.7	6.3	1.8	4.0	26.1	6.1	8.5	1.7	36.9	3.0	2.5	19.5	4.5	6.0	4.9	21.7	6.5	7.1	6.2	4.9	6.0	9.5	28.8	3.6	3.9
TMEM121	"hole, MGC4659, TMEM121A"	ENSG00000184986	"Transmembrane protein 121"	Q9BTD3	14	105526603-105530202	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 12.6"	"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 9.5;Muller glia cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.5;MCF7: 8.9;PC-3: 11.7;REH: 7.5;SCLC-21H: 6.1;WM-115: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049857	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA049857: AB_2680917"	"unprognostic (4.25e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.48e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.90e-2)"	3.2	2.6	7.2	2.5	8.8	1.5	1.7	3.3	12.6	2.5	1.6	7.9	1.9	1.5	3.0	2.9	1.6	3.1	1.3	2.3	7.4	6.0	2.5	3.0	1.9	2.5	5.0	3.9	2.7	2.9	2.5	3.5	1.6	3.0	3.8	0.8	2.7	2.8	2.7	1.1	2.1	1.9	1.6	4.3	7.1	3.4	1.6	1.6	0.0	2.9	0.4	1.0	1.1	4.7	4.7	0.5	0.0	0.0	1.8	3.1	0.6	0.0	4.5	0.4	4.1	0.0	0.2	0.8	2.8	0.6	0.5	0.0	0.0	1.5	1.3	9.5	0.0	0.8	0.4	0.4	0.1	0.0	0.6	2.2	0.1	0.4	1.5	0.7	0.0	1.6	0.3	0.0	0.1	0.0	0.2	0.4	0.5	0.1	0.0	0.2	8.9	0.2	0.0	1.4	0.1	11.7	7.5	0.0	0.1	0.1	0.0	6.1	2.3	0.5	0.0	2.2	0.1	2.7	0.3	1.6	1.3	2.4	0.2	0.5	0.7	0.0	0.0	0.1	0.5	6.2	0.0	0.0	0.0	1.8	0.0	2.6	4.7	3.1	1.6	0.5	1.7	1.9	1.2	0.0	1.8	0.0	0.0	0.2	0.6	7.2	8.8	3.3	8.2	7.4	6.0	5.0	3.9	3.0	1.6	0.0	0.3	0.5	2.4	4.0	4.3	1.2	0.0	1.4	1.2	5.2	0.0	0.2	0.0	1.0	1.3	7.1	0.0	0.0	0.2	1.2	3.8	1.7	0.0	1.7	0.3	9.5	0.0	7.4	0.3	1.5	4.0	0.0	6.8	0.0	0.0	17.0	0.0	0.0	6.0	0.0	1.1	0.0	1.7	0.5	3.1	2.3	0.2	0.0	0.0	0.6
TMEM121B	CECR6	ENSG00000183307	"Transmembrane protein 121B"	Q9BXQ6	22	17116299-17121367	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;prostate: 14.1"	"Group enriched"	"Detected in some"	8	"granulocytes: 1.1;Hofbauer cells: 2.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.3;monocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"AF22: 6.3;SCLC-21H: 15.0;THP-1: 12.1;U-937: 10.0"	"Group enriched"	"Detected in many"	8	"amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0"	"Low region specificity"	"Detected in many"			HPA068790	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Nucleoplasm, Plasma membrane"	"HPA068790: AB_2686036"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.49e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.88e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.10e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.71e-1)"	1.3	1.8	7.4	2.2	12.0	2.2	2.0	8.1	19.1	1.0	0.8	2.4	0.0	1.1	1.1	2.3	0.8	1.2	1.0	2.3	7.1	4.0	0.8	0.8	0.9	0.8	2.9	6.9	0.9	2.7	0.8	2.0	1.9	2.3	14.1	1.0	0.2	1.2	1.0	2.8	1.5	0.9	1.3	2.5	1.1	1.0	2.4	4.2	0.0	0.6	0.0	0.8	1.0	0.3	0.0	0.5	4.3	3.2	0.0	0.0	0.6	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.1	0.3	0.0	0.8	3.2	2.2	0.0	0.1	0.2	3.1	0.0	0.3	0.1	15.0	2.3	0.0	0.0	0.3	0.9	0.0	12.1	0.6	0.7	0.3	0.2	0.0	0.2	0.3	0.9	0.0	10.0	0.3	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.6	7.4	12.0	8.1	18.0	7.1	4.0	2.9	6.9	2.3	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM123	"KCT3, PORIMIN"	ENSG00000152558	"Transmembrane protein 123"	Q8N131	11	102396332-102470384	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 142.0"					"Low region specificity"	"Detected in all"			"CAB026001, HPA062862"			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026001: , HPA062862: AB_2732691"	"unprognostic (2.64e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.65e-2)"	21.3	23.1	18.8	30.1	23.3	39.8	38.6	7.4	18.8	35.2	38.2	19.1	15.1	12.4	65.3	20.8	31.9	21.6	20.8	36.8	20.7	14.0	27.0	95.4	39.5	55.5	22.6	13.7	27.8	24.7	14.5	8.5	23.9	21.1	34.9	19.9	13.9	53.3	22.2	13.2	29.7	17.6	29.7	22.4	39.9	23.7	22.9	24.6	71.9	66.0	20.1	27.1	43.7	39.8	23.3	30.3	48.3	29.2	52.4	55.5	51.3	29.2	26.2	27.2	25.2	34.8	28.5	18.5	22.8	49.4	46.7	52.0	33.2	142.0	49.3	58.8	52.8	33.5	31.8	29.5	37.6	51.7	29.7	10.8	25.7	10.3	49.4	30.7	54.4	19.2	31.8	42.9	33.3	50.0	65.2	52.2	26.6	17.2	0.1	38.5	9.4	47.2	17.1	16.2	48.6	24.1	29.0	75.1	47.3	44.4	29.0	12.9	15.2	27.7	37.9	15.0	30.5	23.4	21.3	61.1	31.4	35.2	27.2	17.1	19.1	10.6	50.1	9.1	60.7	20.7	30.1	26.8	48.3	26.3	29.2	40.0	16.7	41.3	31.8	30.3	23.3	55.5	46.9	17.6	52.4	24.2	8.1	42.9	51.3	18.8	23.3	7.4	18.8	20.7	14.0	22.6	13.7	21.1	24.6	116.1	70.4	106.9	216.5	142.4	0.7	46.0	145.2	156.6	139.9	155.3	0.0	39.5	68.0	142.3	41.1	161.1	25.3	46.7	102.9	31.6	66.8	247.8	57.7	245.2	98.2	1.6	86.9	279.3	203.3	16.8	87.2	149.4	153.5	211.0	157.1	3.3	143.2	24.6	87.7	40.5	1.0	64.7	91.8	25.6	58.6	154.8	25.4	130.8	142.2	235.1
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269994-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 73.6;salivary gland: 47.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 113.2;Alveolar cells type 2: 120.0;Enterocytes: 84.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 13.4;BEWO: 11.5;CACO-2: 10.5;CAPAN-2: 25.1;OE19: 16.0;SK-BR-3: 21.6;T-47d: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015796			Approved	Midbody,Cytosol		NA	NA			"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favorable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.8	0.0	5.3	4.6	7.1	0.0	4.9	0.9	5.0	7.4	14.4	1.0	20.7	15.1	1.8	12.5	3.3	6.6	18.9	1.0	8.9	4.3	9.4	1.4	42.5	0.8	10.7	0.8	2.0	73.6	9.6	15.7	5.6	1.1	8.8	9.1	1.5	47.8	19.0	0.8	3.7	29.4	0.8	21.1	0.8	11.6	1.2	0.8	1.1	33.6	3.8	5.0	1.4	3.5	0.0	0.8	0.0	0.0	1.8	0.9	0.2	13.4	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	10.5	25.1	0.0	0.6	0.0	0.0	6.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.5	16.0	0.0	0.0	0.0	0.3	0.2	4.3	6.5	0.0	0.0	21.6	0.0	2.0	17.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.9	0.2	0.0	1.8	0.0	0.8	0.0	0.2	5.3	7.1	0.9	1.9	8.9	4.3	10.7	0.8	1.1	0.8	113.2	120.0	0.5	1.7	0.0	0.0	0.4	43.3	29.4	47.8	15.7	0.0	26.1	14.9	32.4	3.1	0.0	84.2	0.0	34.1	1.2	0.2	16.8	1.1	0.0	2.0	0.0	20.8	0.0	0.0	6.0	0.3	0.8	0.0	1.0	59.6	1.7	27.0	37.4	1.1	23.1	0.0	0.0	0.2	1.0	0.2	0.4	6.1	0.0	32.2	5.4
TMEM126A	"DKFZp586C1924, OPA7"	ENSG00000171202	"Transmembrane protein 126A"	Q9H061	11	85647967-85656547	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046648	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA046648: AB_2679737"	"unprognostic (3.79e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.60e-5)"	"unprognostic (8.25e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.17e-1)"	18.3	17.4	24.9	15.9	23.3	23.7	20.0	13.2	30.0	13.9	16.2	9.5	15.6	19.8	13.2	20.6	17.2	12.5	16.0	44.4	20.9	20.7	22.0	28.5	12.6	15.0	21.8	22.9	13.7	27.7	13.1	19.9	14.1	19.9	14.0	18.3	8.9	25.2	15.7	49.5	12.2	15.1	16.5	18.0	14.1	19.1	21.4	18.8	10.5	16.5	36.4	15.6	14.0	18.7	14.5	19.1	6.3	15.3	8.4	16.5	11.1	14.7	18.6	16.7	11.5	22.5	22.7	13.6	17.6	19.2	26.4	26.1	22.9	23.8	8.5	21.0	21.1	10.1	16.2	17.2	18.6	24.5	21.6	9.6	23.3	22.1	24.9	28.3	29.4	19.7	19.6	22.9	23.3	25.0	14.2	24.1	23.2	16.4	14.0	29.3	19.6	15.9	37.5	17.1	56.2	21.2	16.3	16.8	27.5	18.5	19.5	12.0	12.2	15.9	25.1	14.6	16.2	31.2	20.2	14.2	25.7	18.3	48.0	20.1	9.4	16.5	22.3	13.5	21.2	30.4	2.9	13.4	6.3	12.5	15.3	16.5	14.5	16.4	14.6	19.1	13.2	15.6	15.4	1.2	8.4	13.1	14.4	14.1	11.1	24.9	23.3	13.2	30.0	20.9	20.7	21.8	22.9	19.9	18.8	26.8	18.7	34.9	49.1	28.2	13.7	101.5	20.4	36.1	39.8	36.6	5.9	57.3	124.3	42.5	119.6	29.2	27.0	0.0	80.4	63.4	39.0	59.0	36.9	66.1	83.8	7.9	20.8	21.5	49.7	48.6	27.3	53.8	32.1	67.7	42.7	22.6	54.2	31.6	25.1	79.5	15.1	19.4	51.4	99.1	51.5	36.8	44.3	39.2	55.6	50.7
TMEM131L	"DKFZp586H1322, KIAA0922"	ENSG00000121210	"Transmembrane 131 like"	A2VDJ0	4	153466346-153636711	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.4"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 11.1;Ciliated cells: 10.7;Exocrine glandular cells: 8.0;monocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.3;MOLT-4: 34.7;U-698: 44.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043472, HPA048443"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			Vesicles	"Nucleoli fibrillar center"	"HPA043472: AB_2678496, HPA048443: AB_2680395"	"unprognostic (1.12e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.71e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.51e-2)"	7.5	1.9	2.1	37.9	6.0	27.3	6.6	0.5	3.0	6.5	5.6	2.3	3.5	1.5	11.9	7.9	6.6	5.0	4.3	5.6	2.5	1.6	3.4	13.0	6.1	27.6	2.2	1.6	4.9	23.0	0.8	6.4	2.5	2.1	5.3	3.1	5.3	10.3	3.2	17.5	5.2	10.0	8.1	3.0	26.5	6.0	3.2	3.9	69.4	4.1	5.5	36.8	7.1	5.8	18.5	13.3	13.6	23.7	14.9	17.9	10.3	2.0	1.3	5.7	6.0	3.4	3.0	0.1	2.9	1.4	2.1	2.6	9.2	1.3	37.3	0.7	3.9	2.3	2.0	4.4	5.1	3.1	3.4	3.2	7.3	2.5	2.3	2.2	8.0	0.4	2.7	3.2	2.7	2.5	2.3	5.2	6.9	6.8	0.1	2.0	3.7	34.7	5.8	5.1	0.0	1.9	12.1	5.6	2.4	1.4	0.8	4.3	3.3	2.3	5.2	3.0	3.1	2.0	5.9	4.1	2.8	5.0	3.3	2.4	4.1	4.1	44.2	0.8	4.8	2.2	6.1	12.4	13.1	8.5	23.7	11.2	18.5	10.7	7.9	13.3	17.3	17.9	12.0	13.6	14.9	18.6	1.3	12.9	10.3	2.1	6.0	0.5	3.0	2.5	1.6	2.2	1.6	2.1	3.9	6.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.4	0.0	0.0	0.5	1.7	1.9	0.0	0.0	0.0	0.0	8.0	0.2	0.0	0.0	4.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	5.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM132A	"FLJ20539, GBP, HSPA5BP1"	ENSG00000006118	"Transmembrane protein 132A"	Q24JP5	11	60924463-60937159	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.1"	"Cell type enhanced"	"Detected in many"	13	"Horizontal cells: 240.0;Muller glia cells: 177.4;Rod photoreceptor cells: 141.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 46.0;MCF7: 45.5;SK-BR-3: 46.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051979, HPA060492"	Enhanced		Approved	Mitochondria		No	No		1900000	Mitochondria		"HPA051979: AB_2681681, HPA060492: "	"unprognostic (2.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.98e-5)"	"unprognostic (7.94e-3)"	"unprognostic (3.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (1.55e-9)"	"unprognostic (3.31e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.41e-3)"	3.6	6.1	28.6	9.2	25.2	1.2	4.4	23.9	58.1	14.0	3.2	11.3	0.8	3.4	14.4	2.2	4.8	3.2	6.2	4.0	17.0	22.9	3.1	1.3	4.5	2.4	20.4	21.4	6.9	3.9	1.5	6.6	19.8	13.8	4.1	2.0	19.3	21.5	2.9	4.3	1.8	2.6	4.6	9.3	2.5	8.5	3.4	9.7	0.0	2.0	1.0	6.0	4.9	2.0	0.4	0.1	1.6	0.1	0.0	0.1	0.1	9.0	12.7	11.4	24.3	0.9	0.5	20.2	6.8	22.2	6.3	5.2	4.4	8.6	0.0	46.0	2.0	22.1	17.2	2.6	11.9	2.4	0.1	3.7	0.2	8.1	8.3	8.5	0.1	0.3	2.1	2.3	11.7	1.8	10.3	10.8	1.8	0.5	0.6	2.0	45.5	0.2	0.0	15.1	0.3	7.3	0.1	4.8	1.0	9.5	4.7	11.4	27.0	4.9	46.7	4.1	6.0	32.4	0.1	12.6	2.4	11.6	0.7	12.9	0.1	0.0	0.4	20.5	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.1	28.6	25.2	23.9	36.8	17.0	22.9	20.4	21.4	13.8	9.7	0.0	0.0	0.0	2.1	1.1	42.9	0.7	2.5	0.0	3.4	5.2	17.7	20.0	1.7	65.2	0.4	8.2	0.0	0.0	11.6	24.7	6.1	6.7	0.0	0.0	2.9	240.0	15.0	8.0	0.3	0.6	1.7	0.0	0.0	5.4	1.8	177.4	47.3	0.0	3.2	0.3	141.6	6.5	1.0	1.0	3.6	0.6	22.7	0.0	2.1	6.3
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.5"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 14.3;Cone photoreceptor cells: 5.9;Leydig cells: 8.3;Peritubular cells: 14.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"gdT-cell: 5.4"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.4"	"Group enriched"	"Detected in some"	6	"AF22: 6.1;ASC diff: 8.7;Daudi: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Approved	Centrosome,Cytosol		NA	NA		110000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	37.5	4.2	9.6	1.1	7.0	0.8	23.3	5.0	6.6	22.0	2.5	4.2	8.9	1.2	5.9	5.7	4.7	13.4	5.1	3.5	5.0	3.8	1.3	0.8	1.6	2.0	4.9	3.1	7.9	4.1	0.9	0.6	5.1	4.6	3.7	1.3	5.3	2.9	9.1	1.9	2.2	1.4	2.1	3.9	1.1	1.5	2.1	5.4	0.0	1.1	0.9	1.3	3.8	10.5	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	6.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.6	7.0	5.0	6.6	5.0	3.8	4.9	3.1	4.6	5.4	0.0	0.0	0.0	0.0	0.3	14.3	0.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.3	0.0	1.7	0.0	0.0	0.4	0.1	0.0	14.2	0.0	2.1	0.0	1.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Predicted membrane proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;kidney: 8.8"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 9.0"	"Group enriched"	"Detected in some"	8	"glioma: 7.6;renal cancer: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 1.4;T-cells: 2.6"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		140000	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.4	0.5	4.9	0.4	4.1	0.2	0.3	17.3	8.7	1.2	0.4	1.7	0.3	4.9	0.6	0.5	0.4	0.4	0.8	0.5	2.9	5.1	8.8	1.3	0.4	0.7	4.5	2.8	0.5	0.2	0.3	0.0	0.9	5.3	0.4	0.5	0.0	0.8	0.8	0.3	0.8	2.8	0.6	20.0	0.7	0.6	2.4	2.2	0.0	0.4	0.0	0.6	0.7	0.1	0.0	0.0	0.0	0.0	1.4	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.8	3.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.4	0.5	0.0	0.0	2.6	1.8	0.0	1.4	0.0	0.0	0.0	0.4	4.9	4.1	17.3	6.9	2.9	5.1	4.5	2.8	5.3	2.2	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.4	0.7	1.3	0.0	0.0	0.0	0.0	0.0
TMEM136	MGC17839	ENSG00000181264	"Transmembrane protein 136"	Q6ZRR5	11	120325129-120333682	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 51.1;Rod photoreceptor cells: 91.0;Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 5.7"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074432			Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA074432: AB_2686689"	"unprognostic (1.02e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.65e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.28e-2)"	4.4	18.9	9.1	2.7	13.8	1.0	5.7	5.8	15.1	4.6	2.9	13.8	3.2	2.1	7.6	14.0	2.6	7.4	5.6	19.1	8.2	5.7	4.8	1.9	4.9	4.0	13.0	7.7	9.0	9.7	9.4	7.9	10.4	12.0	8.4	2.3	9.0	2.4	5.9	1.8	2.0	3.1	6.9	13.7	4.2	2.8	5.4	8.8	0.0	7.8	0.7	2.9	3.2	4.1	0.0	5.7	0.0	0.0	0.0	0.9	0.0	1.6	4.3	8.2	7.8	8.2	12.9	2.1	3.6	8.9	5.8	9.5	2.2	7.3	0.0	11.3	2.3	12.0	1.2	7.2	2.7	6.5	0.0	4.5	5.4	3.9	3.8	9.2	0.0	0.0	11.1	2.0	8.2	12.7	13.1	6.7	6.7	1.4	10.8	7.8	2.0	0.0	0.0	3.5	0.4	2.7	4.1	3.3	0.5	7.7	1.6	5.3	5.1	5.1	0.6	1.0	9.6	6.8	0.2	4.8	6.4	6.6	1.4	2.1	0.1	0.0	0.0	1.9	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.9	0.0	9.1	13.8	5.8	11.5	8.2	5.7	13.0	7.7	12.0	8.8	8.9	5.1	0.0	16.7	3.3	12.1	21.0	7.6	6.7	9.1	22.7	51.1	9.2	5.0	19.5	1.5	6.3	0.5	0.0	11.4	3.2	11.6	28.9	0.0	0.5	1.1	12.7	18.8	4.9	0.6	1.5	3.1	1.0	5.0	23.4	1.6	17.1	17.9	0.0	2.1	3.7	91.0	45.3	14.6	6.9	6.5	3.1	7.9	0.0	0.7	10.7
TMEM138	"HSPC196, JBTS16"	ENSG00000149483	"Transmembrane protein 138"	Q9NPI0	11	61362001-61369509	"Disease related genes, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042373	Approved		Approved	Microtubules		NA	Yes			Microtubules		"HPA042373: AB_10793880"	"unprognostic (1.30e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (2.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.46e-1)"	12.4	38.3	7.5	13.5	11.3	15.4	13.0	8.2	11.4	13.5	11.6	15.0	7.9	9.2	17.3	22.5	10.2	15.2	11.4	8.6	7.7	7.1	18.7	46.3	14.1	13.8	12.2	10.4	29.4	12.8	16.5	13.0	19.7	9.5	16.1	15.4	28.4	14.8	10.8	6.3	16.2	16.7	15.0	11.2	17.6	11.9	10.7	11.4	13.7	14.5	11.4	17.8	12.9	12.4	15.5	17.0	22.6	15.9	14.9	16.4	13.1	6.8	14.0	6.7	8.3	20.4	9.4	7.3	8.8	13.7	14.2	12.9	7.1	9.8	6.2	7.9	11.5	20.1	12.8	10.9	14.1	17.1	7.5	7.1	4.6	12.4	8.9	15.3	8.7	13.9	13.5	20.0	24.2	16.6	5.4	13.1	7.4	11.6	10.9	23.7	19.7	7.2	10.2	9.2	9.7	15.2	5.9	3.5	12.4	14.0	16.9	6.9	5.4	10.2	11.5	12.1	5.1	17.7	6.7	6.9	19.2	7.4	12.2	9.6	10.0	8.9	6.0	9.5	10.6	9.1	22.6	15.9	15.0	14.8	15.4	15.9	15.5	14.1	13.9	10.1	14.1	15.3	13.7	3.9	14.9	10.0	17.0	16.4	13.1	7.5	11.3	8.2	11.4	7.7	7.1	12.2	10.4	9.5	11.4	14.9	27.5	19.9	14.7	17.6	26.4	3.5	2.5	40.2	19.4	19.2	76.6	48.7	13.3	14.9	22.4	17.5	14.7	0.0	13.8	34.8	19.7	13.2	35.9	13.9	42.9	14.3	9.2	11.6	17.3	5.3	29.4	21.1	35.4	22.6	9.2	25.4	14.7	14.0	26.9	16.5	164.4	0.0	12.2	18.4	17.1	17.9	23.0	27.4	12.1	10.3
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1;kidney: 22.6;placenta: 28.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.5	2.2	0.9	2.8	1.9	0.0	2.1	0.6	1.6	6.3	14.7	6.0	1.5	22.7	1.6	3.5	0.4	4.6	4.8	2.3	1.6	1.1	22.6	7.8	5.5	0.1	4.2	0.7	0.9	9.6	6.4	2.0	28.0	4.8	1.6	2.9	1.4	6.1	2.2	0.1	1.1	25.1	0.4	13.4	0.8	2.0	3.0	2.1	0.1	8.8	0.4	0.7	2.1	2.4	0.5	0.3	0.9	3.2	0.0	2.0	0.4	9.7	0.7	0.1	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	2.3	18.3	0.1	12.9	0.0	0.8	8.3	0.0	4.2	0.0	0.1	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.2	0.0	0.6	0.7	0.4	0.0	0.2	0.7	0.1	0.1	0.0	32.2	2.5	0.1	0.0	0.5	11.3	0.0	0.2	31.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	3.2	0.0	0.5	1.3	0.8	0.0	0.0	1.1	0.6	0.0	0.0	2.4	0.3	2.0	0.4	0.9	1.9	0.6	1.6	1.6	1.1	4.2	0.7	4.8	2.1	14.9	5.1	0.0	2.4	0.1	0.0	2.0	35.7	2.7	5.7	48.8	0.0	26.6	29.9	42.9	12.0	0.3	54.0	0.0	4.0	4.7	0.3	0.3	0.0	13.4	1.7	0.0	3.5	1.3	0.6	8.8	0.0	0.1	5.0	1.8	4.3	8.3	23.3	23.0	0.0	67.4	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	7.4	1.2
TMEM141	MGC14141	ENSG00000244187	"Transmembrane protein 141"	Q96I45	9	136791355-136793257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 530.6;Enterocytes: 541.1;Paneth cells: 627.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.4;T-47d: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014615, HPA050244"	Approved		Supported	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA014615: AB_2204756, HPA050244: AB_2681061"	"unprognostic (2.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	10.0	15.5	15.7	23.4	15.3	15.5	22.9	11.6	28.3	17.2	54.4	21.0	22.4	21.9	9.4	31.1	35.5	22.6	27.9	22.8	15.2	12.2	38.5	43.4	14.4	23.0	19.9	19.3	13.8	46.3	20.6	23.1	31.7	22.0	49.0	51.4	12.5	32.5	27.5	13.5	22.0	25.6	10.5	19.1	14.1	23.3	16.5	13.8	16.3	28.6	26.0	15.2	16.4	16.3	11.1	42.7	9.0	19.4	12.4	11.3	12.2	15.0	11.0	9.8	6.1	12.4	10.0	21.2	8.5	13.4	10.6	8.5	14.5	13.7	14.5	13.3	9.2	9.6	22.6	4.2	25.0	3.4	10.5	7.6	8.1	6.1	16.1	18.1	8.4	10.1	9.6	42.9	8.1	23.0	12.1	15.7	19.3	8.0	7.8	13.8	30.8	11.5	6.5	4.7	64.4	12.4	9.6	10.3	42.7	24.0	8.5	16.5	7.4	9.2	35.1	9.6	8.8	62.6	8.2	10.7	7.6	6.0	13.8	5.5	5.1	7.9	7.7	11.4	12.2	10.8	6.5	13.8	9.0	11.3	19.4	10.2	8.7	7.9	8.1	11.2	11.1	10.9	10.0	3.3	12.4	16.0	42.7	7.5	12.2	15.7	15.3	11.6	28.3	15.2	12.2	19.9	19.3	22.0	13.8	53.6	66.5	48.0	79.9	36.1	13.8	38.7	140.1	40.2	47.8	111.7	7.9	153.9	530.6	139.6	35.4	42.8	541.1	0.0	69.3	125.8	30.6	159.7	40.5	149.9	127.7	4.8	198.8	60.2	56.6	92.7	34.8	37.5	81.0	99.2	409.6	43.5	87.4	627.8	28.0	354.2	22.0	45.3	28.3	48.3	42.6	54.8	229.4	48.4	378.9	92.2
TMEM143	FLJ10922	ENSG00000161558	"Transmembrane protein 143"	Q96AN5	19	48332356-48364237	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.1"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 22.1;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014476, HPA058645"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA014476: AB_1858092, HPA058645: "	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (5.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-1)"	6.2	5.6	3.3	3.5	5.7	2.7	3.2	5.1	6.6	2.6	4.4	4.4	4.1	4.3	4.1	3.8	4.0	3.0	3.2	27.0	3.4	2.7	6.1	9.7	2.9	3.5	4.7	4.5	3.2	4.2	3.1	3.2	3.0	3.9	3.4	3.1	4.7	4.5	4.1	70.1	4.8	4.8	5.3	3.2	4.6	3.7	2.5	4.3	5.4	3.9	16.5	5.1	3.7	2.5	5.0	3.4	3.6	2.3	7.6	5.7	2.7	3.6	5.7	1.9	3.5	3.9	6.3	3.8	3.4	2.0	2.4	3.1	5.0	4.7	6.6	6.5	2.3	1.1	4.1	1.9	2.5	1.4	9.1	4.3	4.0	4.6	8.3	3.3	3.2	3.9	5.4	3.1	1.2	3.4	2.8	1.9	10.4	2.9	9.9	3.0	2.1	4.4	12.3	2.4	6.7	2.1	7.1	1.4	11.0	3.2	2.7	7.2	7.0	1.9	2.5	1.5	2.3	3.5	2.8	2.3	2.8	3.2	2.0	1.7	20.9	6.2	5.4	2.3	4.3	2.4	3.6	2.3	2.7	4.7	1.5	5.7	5.0	3.7	4.0	3.4	3.4	5.5	3.3	1.7	7.6	2.3	1.3	2.3	2.7	3.3	5.7	5.1	6.6	3.4	2.7	4.7	4.5	3.9	4.3	3.0	0.6	0.8	3.1	0.2	3.2	22.1	0.0	6.7	0.0	1.8	7.9	8.4	11.6	2.4	0.5	1.5	4.3	23.3	2.1	5.0	4.1	0.9	1.1	6.7	4.7	0.0	2.9	0.6	1.0	0.4	2.3	2.2	8.5	2.8	3.0	4.0	1.2	5.8	1.1	12.7	6.5	0.0	3.1	4.7	5.5	0.9	3.1	4.4	3.9	0.8
TMEM144	FLJ11155	ENSG00000164124	"Transmembrane protein 144"	Q7Z5S9	4	158201604-158255411	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	6	"brain: 88.7"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 195.0;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.3;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.7;hTCEpi: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063554			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063554: AB_2685039"	"unprognostic (1.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.27e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-2)"	4.7	6.7	20.7	2.0	60.9	1.5	9.2	4.7	37.7	4.7	7.4	88.7	0.2	14.3	3.7	8.3	3.1	3.9	6.8	8.2	31.5	18.3	1.9	1.7	3.5	0.9	80.4	26.6	8.6	3.8	3.0	1.4	3.5	48.9	5.4	8.6	0.0	3.1	7.2	1.4	1.9	9.6	4.2	79.2	2.2	5.4	15.8	67.4	0.0	9.2	0.0	0.8	5.1	1.9	0.0	4.3	0.1	3.3	0.4	0.1	0.7	2.6	7.1	0.1	1.4	5.2	7.8	23.7	1.2	1.9	1.1	1.7	8.9	9.8	0.0	1.4	0.3	5.1	1.2	3.3	11.0	1.5	0.0	3.2	4.4	2.2	7.9	1.8	5.5	1.4	5.6	13.6	4.6	1.6	0.3	5.9	1.1	2.9	0.1	8.2	3.0	0.0	0.0	1.8	7.3	1.7	0.0	0.0	0.3	2.0	7.5	1.1	0.0	0.2	9.6	2.7	4.3	6.8	1.5	1.2	2.2	1.8	0.4	1.3	0.0	0.6	0.6	3.0	0.8	1.5	0.0	3.3	0.0	0.0	1.4	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.4	0.7	4.3	0.0	0.7	20.7	60.9	4.7	35.1	31.5	18.3	80.4	26.6	48.9	67.4	8.9	7.8	0.0	6.7	2.7	0.0	10.6	17.8	5.3	4.5	0.0	0.0	11.5	0.0	9.5	195.0	3.6	34.8	0.0	11.4	5.8	2.0	5.7	4.6	1.0	24.1	0.0	4.7	3.1	19.9	77.6	9.8	10.7	3.3	3.6	17.2	1.3	10.6	14.7	8.5	5.6	0.0	0.0	2.2	1.2	1.7	4.4	7.3	0.0	14.5	4.2
TMEM145	FLJ90805	ENSG00000167619	"Transmembrane protein 145"	Q8NBT3	19	42313325-42325062	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 74.5"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 57.8;Cone photoreceptor cells: 27.5;Horizontal cells: 65.2;Rod photoreceptor cells: 30.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Region enriched"	"Detected in all"	4	"cerebellum: 74.5"	"Group enriched"	"Detected in some"	8	"basophil: 4.5;neutrophil: 15.5"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 15.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 11.9;PC-3: 8.8;SCLC-21H: 22.7;SH-SY5Y: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060462	Enhanced	Approved	Approved	Vesicles		NA	NA			Vesicles		"HPA060462: AB_2684285"	"unprognostic (9.56e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.20e-4)"	"unprognostic (7.35e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.31e-2)"	1.6	6.2	8.0	1.2	7.7	2.5	1.3	74.5	30.5	0.6	1.2	3.8	0.0	1.7	1.1	1.6	1.0	1.1	1.4	1.3	5.8	8.5	0.9	1.4	0.8	1.5	5.1	7.6	1.2	3.7	3.0	6.4	0.6	9.3	1.2	1.2	2.8	1.1	0.9	2.3	3.3	1.1	1.2	3.9	1.5	2.0	3.3	3.2	0.0	1.3	0.0	1.1	1.0	0.3	1.3	0.8	15.5	0.9	0.6	0.9	0.8	0.5	2.8	2.1	6.5	0.2	0.2	0.9	0.2	0.1	1.0	2.6	0.5	0.7	1.5	0.3	0.7	0.6	0.2	1.5	0.4	1.2	6.8	1.7	2.8	2.6	2.4	0.2	1.7	11.9	0.6	0.5	0.4	0.6	0.2	1.1	0.8	1.5	5.6	0.1	0.6	0.4	1.9	1.3	2.0	8.8	0.2	0.6	5.3	0.1	1.0	22.7	10.8	1.0	0.7	1.4	0.1	2.0	1.9	0.3	1.9	1.9	1.3	0.7	1.2	3.1	1.4	0.7	1.1	5.2	4.5	0.9	0.9	0.6	0.8	0.3	1.0	0.6	0.4	0.2	1.3	0.6	0.9	15.5	0.6	0.7	0.8	0.4	0.8	8.0	7.7	74.5	18.1	5.8	8.5	5.1	7.6	9.3	3.2	0.0	0.0	0.0	0.4	0.2	57.8	0.4	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.3	1.1	0.0	0.3	65.2	0.0	1.8	1.2	0.0	0.0	0.0	5.0	0.0	0.0	11.9	0.1	0.0	0.4	0.0	30.8	0.0	0.0	5.1	17.9	0.1	0.0	0.0	0.0	0.0
TMEM147	"MGC1936, NIFIE14"	ENSG00000105677	"Transmembrane protein 147"	Q9BVK8	19	35545595-35547526	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067837			Approved	"Golgi apparatus,Actin filaments"		NA	NA			"Golgi apparatus, Actin filaments"		"HPA067837: "	"unprognostic (6.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (4.98e-6)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	22.7	46.2	22.3	19.3	26.8	15.6	53.2	18.9	42.0	23.1	23.4	16.3	30.0	18.9	23.7	47.2	29.5	24.8	30.2	57.5	20.1	22.0	33.3	29.8	29.9	53.2	26.3	19.0	22.6	88.4	31.7	23.3	20.1	22.8	18.1	24.5	23.1	30.5	33.1	39.1	33.1	17.5	26.8	26.6	18.0	22.9	41.8	19.2	9.8	39.4	31.4	18.9	21.0	25.4	40.9	54.9	22.6	51.8	21.8	35.1	47.2	29.8	65.4	13.1	30.5	58.0	26.6	21.5	19.0	31.3	23.7	22.1	30.9	18.2	17.4	30.6	28.9	25.9	11.8	22.5	27.4	19.6	27.5	30.9	18.8	19.7	36.2	46.3	26.5	20.8	28.9	42.9	22.3	56.0	20.6	21.7	23.9	24.3	61.7	25.1	36.6	15.2	14.7	18.5	90.6	28.5	14.7	12.1	41.2	37.3	30.4	11.6	19.4	17.7	40.7	36.4	13.8	14.7	22.3	14.0	27.0	21.6	15.3	38.4	32.4	32.7	9.6	23.5	36.0	21.7	7.3	51.8	22.6	25.1	47.3	35.1	40.9	34.0	28.9	47.0	34.7	25.7	26.0	3.0	21.8	33.3	54.9	32.9	47.2	22.3	26.8	18.9	42.0	20.1	22.0	26.3	19.0	22.8	19.2	41.7	36.1	61.0	106.8	89.9	51.4	92.9	122.3	33.5	42.1	148.3	17.7	150.6	94.5	199.6	77.8	100.8	76.7	0.0	219.9	199.2	111.4	171.1	50.6	97.2	232.5	42.9	85.5	72.4	122.6	242.1	129.2	109.7	227.7	61.3	96.0	111.2	180.6	63.1	113.8	224.3	45.9	116.4	81.2	327.5	106.5	146.7	115.7	69.2	124.9	160.1
TMEM14A	"C6orf73, PTD011"	ENSG00000096092	"Transmembrane protein 14A"	Q9Y6G1	6	52671109-52686588	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072536	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA072536: AB_2686531"	"unprognostic (6.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.56e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.64e-1)"	8.7	24.4	26.7	6.2	32.0	4.3	12.9	25.7	40.0	13.9	12.5	13.5	5.8	18.9	14.3	19.3	18.0	16.3	12.6	8.1	25.5	40.7	25.8	52.7	9.0	8.8	28.3	22.6	21.0	23.8	9.2	12.9	7.9	31.7	19.0	13.3	25.7	9.6	11.7	2.0	6.8	17.4	13.4	29.1	6.5	20.3	8.4	10.7	5.8	14.6	11.1	11.6	14.1	11.6	22.3	14.3	6.4	0.2	4.0	25.7	11.9	67.3	10.2	7.6	21.5	20.8	16.1	6.4	13.6	18.7	12.6	19.6	15.6	17.5	8.3	15.2	17.1	26.6	25.8	16.8	22.8	21.3	33.3	13.8	12.2	16.7	25.5	6.8	6.2	15.3	14.4	16.1	13.8	3.1	16.7	17.0	10.6	2.5	23.7	14.9	13.7	12.1	7.1	4.5	44.7	17.9	9.6	10.8	6.5	24.4	13.0	39.6	19.2	15.2	12.2	25.4	9.9	18.8	12.0	12.5	17.5	23.6	6.8	21.9	11.4	9.6	12.5	24.6	3.9	13.9	6.4	0.2	6.4	16.4	0.0	10.6	22.3	21.2	17.2	7.8	13.2	16.4	17.5	0.9	4.0	0.0	14.3	25.7	11.9	26.7	32.0	25.7	40.0	25.5	40.7	28.3	22.6	31.7	10.7	23.8	14.5	18.0	51.6	42.9	20.8	12.5	50.9	61.6	33.0	48.8	7.9	51.8	54.7	95.2	1.1	42.1	22.0	0.0	122.4	120.9	88.8	80.6	25.3	119.7	38.4	4.8	32.1	33.7	7.3	2.0	40.3	16.9	84.4	6.4	47.0	24.6	77.7	28.8	47.0	136.7	10.1	6.5	75.2	4.4	24.5	33.4	12.9	22.7	47.2	49.8
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291870-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 48.5"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 8.1;Cholangiocytes: 5.1;Horizontal cells: 14.3;Intestinal endocrine cells: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	1.4	3.8	12.4	1.5	16.8	1.4	1.4	5.9	48.5	1.4	1.5	41.8	0.0	1.5	1.4	1.4	1.4	1.4	2.8	1.6	22.7	14.3	1.4	1.4	1.4	1.4	21.2	13.1	1.5	2.4	1.8	3.3	1.4	22.2	1.4	1.4	1.0	1.5	1.4	1.4	1.4	1.5	1.4	43.2	1.4	3.9	1.6	13.6	0.0	1.4	0.0	1.4	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	1.3	0.0	3.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	18.4	4.2	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.4	16.8	5.9	31.1	22.7	14.3	21.2	13.1	22.2	13.6	0.0	0.0	0.0	0.1	0.0	8.1	0.6	5.1	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	14.3	7.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618632-152680165	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 65.9;Ciliated cells: 60.2;granulocytes: 97.2;Suprabasal keratinocytes: 169.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 75.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.7;HMC-1: 28.5;Karpas-707: 22.2;U-266/70: 27.8;U-937: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	1.4	0.7	0.8	12.5	0.8	8.3	2.0	0.7	0.7	5.0	1.4	1.3	0.9	1.0	1.1	1.2	36.1	1.1	2.4	1.7	0.8	0.8	1.0	4.8	7.9	20.4	1.3	0.1	0.7	0.8	0.1	3.5	3.5	0.8	3.9	1.1	0.5	16.1	2.5	1.3	28.7	3.0	2.2	1.2	16.2	2.7	0.6	0.1	8.2	1.5	26.0	38.0	7.1	6.3	8.3	2.9	75.4	6.0	0.1	3.4	2.2	12.2	0.0	0.1	0.0	0.2	3.5	5.6	3.1	11.5	3.4	6.5	0.1	1.6	12.6	1.3	2.8	3.7	9.0	0.0	24.7	6.3	0.0	0.0	0.7	0.1	0.0	3.7	9.7	28.5	3.4	11.9	10.9	9.5	0.0	8.4	7.8	0.0	22.2	0.2	0.8	3.8	3.0	0.6	0.0	2.9	0.4	0.0	0.0	19.5	7.5	0.0	0.5	0.7	2.4	0.4	3.5	0.3	6.9	3.4	0.5	2.0	0.3	4.3	27.8	9.4	6.9	4.7	22.1	2.6	49.8	5.8	44.8	0.8	5.9	1.5	8.3	1.8	1.3	2.9	7.2	1.8	1.2	75.4	0.1	6.0	0.3	3.4	2.2	0.8	0.8	0.7	0.7	0.8	0.8	1.3	0.1	0.8	0.1	11.9	22.9	42.2	7.7	65.9	0.0	1.4	0.0	60.2	19.4	21.0	2.0	21.8	0.0	6.1	0.0	5.7	0.0	0.0	3.3	12.7	5.5	5.3	97.2	3.9	4.2	3.2	1.2	0.6	8.7	0.0	0.6	15.0	5.0	0.0	0.6	0.0	12.8	9.1	0.0	0.3	0.4	0.0	1.9	0.0	0.2	169.9	21.6	15.8	3.1	23.5
TMEM159	promethin	ENSG00000011638	"Transmembrane protein 159"	Q96B96	16	21158377-21180616	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 107.6;Suprabasal keratinocytes: 131.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 14.6;cerebellum: 13.7"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018033, HPA063509"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA018033: AB_2204762, HPA063509: AB_2685026"	"unprognostic (7.62e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.68e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-3)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (8.11e-5)"	"unprognostic (8.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.57e-2)"	35.6	12.7	2.2	6.0	14.6	1.8	27.4	13.7	2.8	25.3	13.5	1.0	10.1	2.7	28.3	9.8	37.1	8.4	23.9	32.4	1.4	1.6	11.3	1.2	10.7	7.6	1.2	1.6	22.0	6.1	5.6	1.2	5.3	1.7	29.7	6.4	10.9	35.2	7.9	57.5	32.5	7.3	45.5	1.5	3.6	7.9	10.9	1.4	6.1	17.4	35.5	21.9	43.7	21.1	11.4	11.3	12.2	8.6	7.5	13.1	7.3	5.9	2.8	3.1	11.3	29.4	18.9	1.6	2.7	12.0	1.2	2.3	2.1	8.2	7.8	3.2	9.0	5.5	9.0	5.1	4.6	1.3	3.5	1.8	3.6	1.0	4.0	6.8	2.8	9.6	7.0	24.0	6.6	21.3	4.8	6.7	4.4	2.5	2.4	2.1	10.5	2.1	2.1	2.7	5.0	1.7	11.2	1.6	2.9	14.8	17.9	0.4	0.4	7.6	10.4	3.5	6.1	17.2	2.1	4.7	1.7	2.2	9.5	0.7	0.2	0.6	2.5	8.5	2.5	1.9	12.2	8.6	8.0	10.1	5.9	8.7	11.4	13.1	8.6	5.0	9.2	9.6	8.8	3.9	7.5	7.1	11.3	13.0	7.3	2.2	14.6	13.7	2.8	1.4	1.6	1.2	1.6	1.7	1.4	8.9	18.1	0.5	34.8	107.6	0.5	54.1	12.7	4.0	22.7	21.0	0.0	3.4	6.6	16.7	0.5	15.3	21.3	0.0	18.5	1.9	18.8	41.3	15.1	0.0	9.7	1.6	13.9	9.2	11.9	0.0	62.5	15.3	28.7	26.2	28.8	23.3	18.9	40.7	35.0	16.3	1.8	32.3	32.3	2.2	6.1	131.2	1.6	10.1	27.2	56.7
TMEM161A	"FLJ20422, FLJ39645"	ENSG00000064545	"Transmembrane protein 161A"	Q9NX61	19	19119169-19138513	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043365	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA043365: AB_10796793"	"unprognostic (4.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.15e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.18e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.89e-3)"	10.4	18.3	10.6	9.2	13.5	8.1	10.3	12.8	11.7	12.2	10.5	9.8	15.8	10.0	17.2	8.6	11.7	12.4	15.5	12.7	8.6	6.9	12.7	21.1	9.1	12.1	13.4	8.4	14.2	18.6	17.3	6.6	6.4	9.9	12.8	5.3	12.7	17.1	13.6	34.5	13.5	9.1	9.9	7.8	8.8	10.6	5.3	11.6	15.0	20.8	13.8	9.1	10.8	12.6	6.8	23.5	1.5	7.2	6.7	13.5	5.4	16.1	11.3	6.4	13.8	13.9	9.3	10.2	6.8	8.4	8.5	11.2	9.5	20.2	14.1	33.6	5.1	5.8	13.1	10.3	15.8	5.6	6.4	37.5	5.4	6.2	12.8	18.5	7.1	9.0	14.5	13.3	8.4	12.5	8.1	9.4	17.2	18.0	17.1	5.9	19.5	10.3	15.0	6.1	18.7	18.6	16.5	5.4	28.0	6.5	6.6	8.7	8.8	10.3	13.1	8.3	4.7	10.5	12.7	5.5	7.9	3.9	17.7	12.7	15.9	9.9	8.4	8.7	14.7	11.4	1.5	7.2	1.4	10.0	6.3	8.8	5.7	9.1	8.1	10.1	6.8	10.8	9.1	0.8	6.7	6.3	23.5	13.5	5.4	10.6	13.5	12.8	11.7	8.6	6.9	13.4	8.4	9.9	11.6	6.0	16.5	7.3	11.6	5.5	15.3	6.9	25.5	6.7	7.9	10.4	9.8	16.1	6.6	17.7	0.7	9.4	6.3	0.0	11.1	12.3	9.1	11.9	16.1	20.4	14.0	15.9	5.2	9.8	9.1	0.5	10.9	6.7	11.8	5.4	8.4	18.1	11.0	3.5	16.6	25.9	13.1	12.9	13.3	7.9	9.8	7.5	10.3	10.0	16.6	6.7
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 69.7"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 25.9"	"Cell line enhanced"	"Detected in all"		"HMC-1: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	15.0	8.6	9.2	6.1	10.9	11.1	9.2	2.6	6.8	3.9	17.0	6.0	36.3	14.5	4.5	4.1	10.5	5.5	8.8	14.7	6.6	5.9	8.4	1.7	35.8	7.6	4.6	3.5	11.9	17.2	11.1	8.7	6.6	7.0	6.2	14.8	18.7	7.6	69.7	32.0	15.2	33.1	4.6	2.9	6.9	9.9	2.2	5.1	4.5	11.4	6.0	5.8	5.0	5.1	0.4	1.4	25.9	1.7	1.1	0.9	0.8	4.8	11.1	9.1	5.9	11.3	8.3	5.5	2.4	5.7	5.2	3.3	8.6	7.6	3.8	16.5	3.7	12.7	7.1	7.9	12.8	5.1	10.6	5.4	26.3	6.0	3.6	6.7	11.5	37.6	11.5	22.6	9.3	12.9	14.2	10.0	7.0	8.1	4.7	9.1	9.7	12.0	14.7	8.1	16.6	8.0	5.5	7.0	3.2	8.2	5.1	8.5	9.5	15.5	15.3	7.1	8.8	4.4	11.5	22.3	4.4	3.2	5.1	3.4	2.8	3.4	3.1	11.5	14.5	11.6	25.9	1.7	7.2	0.3	1.5	0.9	0.1	0.4	0.3	1.4	0.4	0.2	0.3	8.8	1.1	0.9	0.2	0.5	0.8	9.2	10.9	2.6	6.8	6.6	5.9	4.6	3.5	7.0	5.1	3.0	26.0	3.2	3.3	4.2	0.2	19.7	10.2	1.4	6.8	15.7	2.0	1.9	3.3	4.0	0.3	5.2	32.2	0.0	9.9	4.7	3.4	7.9	3.5	1.5	12.0	0.0	26.6	6.2	25.0	0.5	1.7	5.8	1.7	21.6	12.9	0.8	9.8	14.4	1.4	3.0	0.9	0.0	3.1	0.2	0.0	6.9	2.3	4.3	17.8	6.4
TMEM167A	"FLJ30508, MGC23909, TMEM167"	ENSG00000174695	"Transmembrane protein 167A"	Q8TBQ9	5	83052846-83077863	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA077278			Approved	Vesicles		NA	NA			Vesicles		"HPA077278: "	"unprognostic (5.38e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.78e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.06e-3)"	"unprognostic (7.74e-2)"	"unprognostic (9.94e-3)"	"unprognostic (3.99e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.29e-2)"	22.9	38.0	29.3	20.9	31.3	19.8	23.2	24.2	32.8	24.9	18.8	21.8	12.2	20.5	16.9	20.6	16.7	13.1	21.2	21.8	27.8	28.4	26.2	25.3	21.4	16.3	32.9	20.9	12.9	23.6	22.2	32.9	26.1	35.5	18.0	22.8	15.2	21.3	15.9	15.6	16.1	19.7	17.3	26.7	18.2	17.5	9.7	25.3	22.8	22.2	16.1	17.5	18.4	14.3	2.9	8.4	13.2	15.6	3.9	4.3	6.8	13.1	8.0	30.2	26.8	44.6	31.2	27.7	20.8	16.3	13.5	17.8	12.1	17.1	8.4	13.1	24.6	18.2	11.1	20.1	27.0	22.5	11.6	12.4	22.7	15.0	18.6	17.5	11.6	14.9	24.3	19.1	17.4	16.4	22.1	16.6	12.7	12.5	17.1	19.8	11.5	14.2	12.8	31.2	6.9	13.7	12.7	19.4	23.2	19.0	10.5	14.3	18.7	13.9	14.7	20.6	28.9	26.5	27.5	22.5	8.5	8.4	24.5	18.6	10.0	27.8	8.5	15.7	21.1	20.1	13.2	15.0	6.8	2.6	14.2	3.0	2.9	3.6	3.2	8.4	2.4	3.9	3.0	8.8	3.9	15.6	4.0	4.3	6.8	29.3	31.3	24.2	32.8	27.8	28.4	32.9	20.9	35.5	25.3	32.8	22.1	57.6	46.9	42.6	42.8	42.8	76.5	28.1	26.1	47.1	39.3	88.2	144.2	76.0	12.3	56.7	80.5	0.0	105.9	256.8	99.2	99.3	32.3	96.2	144.4	31.8	48.8	49.7	208.1	14.6	43.7	117.7	89.4	108.2	77.1	46.8	108.0	74.8	46.7	173.3	28.5	32.3	52.7	47.3	64.5	58.7	150.0	55.8	58.1	92.4
TMEM168	"DKFZp564C012, FLJ13576"	ENSG00000146802	"Transmembrane protein 168"	Q9H0V1	7	112762382-112790592	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020389, HPA077143"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA020389: AB_1858101, HPA077143: "	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.30e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (1.60e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.30e-2)"	14.4	14.9	9.0	11.4	14.6	5.6	15.4	6.9	15.7	15.7	21.2	17.9	17.6	13.2	17.4	18.3	19.1	15.0	12.1	18.9	11.8	8.2	18.8	11.8	13.5	21.3	12.6	7.8	17.5	9.9	28.2	12.7	26.3	15.5	16.6	24.3	18.4	19.6	14.5	11.0	25.5	18.4	19.7	15.7	16.4	14.3	13.9	12.4	17.8	17.5	12.6	17.4	14.7	16.9	15.4	17.9	16.5	16.9	13.7	22.4	10.0	9.2	7.9	7.4	6.7	12.8	26.2	10.5	10.4	9.8	3.9	3.4	10.0	9.9	9.9	7.0	10.2	8.9	10.1	7.5	9.0	10.2	15.5	7.7	8.4	9.8	5.7	8.6	9.5	11.0	12.7	23.5	4.5	6.7	3.7	11.4	8.0	11.5	9.1	14.1	14.9	8.2	6.0	6.0	9.8	6.1	5.5	3.7	14.4	9.8	17.8	5.6	11.0	13.6	18.6	7.9	9.5	10.4	8.5	16.2	18.9	9.6	8.7	13.3	15.6	13.2	11.2	12.2	8.4	23.7	16.5	16.9	12.5	14.2	13.7	16.9	12.4	15.3	13.8	17.9	15.4	22.4	15.5	9.4	13.7	13.5	12.2	13.7	10.0	9.0	14.6	6.9	15.7	11.8	8.2	12.6	7.8	15.5	12.4	11.9	18.2	6.4	16.7	27.6	30.5	13.7	10.2	2.7	22.7	31.4	25.5	25.1	0.0	5.4	1.5	13.4	13.1	0.0	7.8	7.0	13.4	17.7	11.5	11.1	7.7	15.9	19.8	18.4	8.9	1.5	17.0	9.4	23.6	1.8	33.2	19.0	4.6	7.0	13.8	7.1	28.6	6.5	8.5	16.2	12.1	22.7	11.9	11.4	26.4	11.9
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 14.3;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.4;LHCN-M2: 6.9;RPTEC TERT1: 12.5;SCLC-21H: 10.7;SH-SY5Y: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	1.7	2.9	5.9	2.5	6.2	1.3	0.9	9.7	16.8	2.1	1.3	3.9	1.6	1.9	1.1	1.9	0.9	2.9	2.5	1.1	5.5	6.3	4.9	4.2	2.1	2.4	5.5	4.8	1.1	1.0	0.8	2.4	0.7	9.1	1.4	1.2	4.9	0.9	1.1	1.5	1.6	1.7	1.2	6.6	2.6	1.0	1.3	2.5	0.7	6.7	0.0	2.0	1.1	0.7	3.0	0.2	4.3	5.7	0.7	6.3	1.3	0.1	0.4	8.4	0.2	1.0	0.1	0.0	0.3	0.2	0.2	0.8	0.4	2.5	0.1	6.3	0.4	0.5	0.2	1.1	0.0	0.2	1.2	0.4	2.7	0.1	1.5	1.8	0.2	0.6	0.6	0.6	0.6	0.8	2.0	0.0	0.9	0.0	0.4	6.9	0.7	0.2	0.3	4.4	0.0	0.1	1.5	2.5	0.2	12.5	0.0	10.7	15.4	0.3	0.2	6.1	4.2	0.4	1.1	0.1	0.2	0.5	0.2	0.4	1.9	2.0	0.4	1.9	0.2	1.6	1.3	1.8	0.3	2.3	1.5	1.7	2.4	4.0	2.7	0.0	3.0	4.2	1.9	4.3	0.7	5.7	0.2	6.3	1.3	5.9	6.2	9.7	11.5	5.5	6.3	5.5	4.8	9.1	2.5	0.0	0.0	0.5	0.0	0.0	14.3	0.6	5.1	0.0	0.0	5.2	21.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	4.7	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.4	2.4	11.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1
TMEM17	FLJ34583	ENSG00000186889	"Transmembrane protein 17"	Q86X19	2	62500221-62511894	"Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 29.4;Spermatocytes: 36.9;Spermatogonia: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018100	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA018100: AB_2240686"	"unprognostic (8.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.87e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.49e-6)"	3.3	8.2	6.1	1.0	10.8	0.9	3.7	2.2	10.1	3.0	1.7	4.3	1.5	1.5	3.5	2.9	4.1	6.7	4.4	3.2	13.5	14.6	6.7	3.4	2.6	1.2	6.0	8.2	5.1	6.8	7.6	10.2	2.5	9.3	3.9	1.2	4.1	3.3	3.3	2.5	3.5	1.1	2.4	4.5	1.0	1.9	7.0	4.4	0.9	7.1	1.3	1.6	2.2	1.7	0.3	5.5	1.5	0.7	0.9	0.9	1.0	3.9	5.2	5.5	2.1	2.9	3.6	3.5	2.9	2.7	2.4	2.4	0.4	7.0	0.0	3.9	3.9	7.9	3.8	2.4	1.6	1.8	3.7	1.7	1.8	2.2	0.4	4.2	2.5	2.5	3.3	4.6	2.0	4.6	3.9	3.1	0.4	1.6	0.2	6.0	1.0	0.4	0.6	2.8	3.3	3.3	0.3	0.7	0.3	4.9	1.1	1.4	4.8	3.0	1.2	10.1	2.0	1.7	3.4	1.9	4.8	2.7	5.7	2.9	0.6	0.1	0.0	6.9	0.4	9.6	0.9	0.7	0.1	0.2	0.2	0.0	0.1	0.1	0.1	1.6	0.3	0.1	0.9	1.5	0.9	0.2	5.5	0.1	1.0	6.1	10.8	2.2	10.1	13.5	14.6	6.0	8.2	9.3	4.4	3.0	2.6	0.0	2.3	4.4	6.6	2.2	7.6	29.4	9.1	5.2	7.9	1.9	0.0	4.3	2.4	1.9	0.0	0.0	7.5	1.7	3.5	0.8	1.1	1.8	2.1	9.5	1.2	5.5	1.2	2.1	4.4	0.3	3.3	1.0	0.6	9.0	6.6	0.0	3.5	2.1	3.7	6.5	0.8	36.9	19.6	2.5	0.3	0.0	0.9	0.9
TMEM170B		ENSG00000205269	"Transmembrane protein 170B"	Q5T4T1	6	11538278-11583524	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"bone marrow: 31.1"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 23.8;Kupffer cells: 40.6;Macrophages: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 3.2;granulocytes: 2.4;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 18.2;U-937: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055134	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA055134: AB_2682709"	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.45e-5)"	"unprognostic (3.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-4)"	"unprognostic (3.97e-2)"	10.1	4.8	11.7	6.4	9.6	31.1	6.1	13.5	18.6	3.1	3.3	4.9	2.0	1.6	4.1	5.2	2.5	2.8	3.0	4.5	10.1	8.8	5.9	12.8	8.8	3.5	8.3	8.7	3.9	3.3	5.8	4.2	4.0	8.4	3.4	2.2	4.2	2.5	3.7	8.3	1.8	2.0	4.7	8.2	5.7	2.4	5.2	6.0	4.2	4.4	1.2	2.2	2.7	3.1	0.2	3.2	2.4	2.9	0.1	0.3	0.5	0.7	1.2	7.5	6.7	1.4	0.1	1.5	0.6	1.7	1.0	1.2	0.4	0.4	5.9	3.4	0.4	1.9	0.0	8.4	0.5	2.7	1.6	4.3	3.3	0.8	1.0	0.5	5.3	3.5	0.5	0.1	1.1	0.0	1.7	0.7	5.6	0.2	0.1	1.5	1.1	6.3	9.2	2.1	0.7	1.0	3.2	7.2	0.9	0.8	1.5	5.1	4.4	0.4	2.4	2.7	11.2	2.4	18.2	0.1	1.4	1.6	2.8	1.7	5.2	10.4	5.3	1.2	13.6	1.8	2.4	2.9	1.5	0.2	1.6	0.1	0.0	0.1	0.1	1.8	0.2	0.3	0.2	1.1	0.1	0.6	3.2	0.0	0.5	11.7	9.6	13.5	13.5	10.1	8.8	8.3	8.7	8.4	6.0	3.0	1.3	0.5	0.7	1.5	12.0	5.2	2.5	0.0	2.3	0.0	3.9	1.8	5.0	0.6	0.4	1.4	0.0	0.0	1.2	0.3	2.3	1.0	1.1	5.8	6.6	23.8	1.7	1.8	40.6	0.2	0.9	21.8	0.0	1.0	0.5	11.8	0.9	0.0	1.4	4.5	8.4	6.5	1.2	5.4	4.6	0.6	1.6	1.7	0.6	0.4
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.2	22.9	20.5	13.5	24.0	17.8	12.2	29.0	27.6	17.4	10.8	23.5	16.8	13.6	13.4	14.9	13.4	12.9	16.0	13.3	18.4	19.8	11.7	24.2	14.1	21.9	16.9	25.4	9.3	26.3	18.7	26.4	11.8	20.4	15.0	6.2	17.1	26.8	16.8	14.5	25.8	12.4	10.4	17.2	18.7	14.8	11.8	17.9	13.0	19.7	9.2	12.0	16.2	9.6	13.8	29.3	16.9	23.4	9.5	13.6	11.8	3.3	6.1	3.5	4.8	17.0	8.9	8.2	8.2	6.0	5.0	7.5	2.8	13.4	2.5	5.1	8.6	8.8	5.5	3.2	6.5	2.2	6.2	7.5	5.2	9.0	2.8	9.8	2.7	9.7	12.6	7.9	4.5	3.0	3.6	3.1	5.4	5.2	20.9	4.4	10.9	6.9	11.2	2.2	3.9	17.2	4.8	2.1	7.2	4.8	3.2	9.6	8.5	5.7	3.6	5.4	1.8	16.0	7.5	4.1	9.3	2.1	10.7	6.3	14.2	3.7	4.9	9.0	6.0	7.5	16.9	19.8	15.5	13.6	23.4	9.1	12.5	11.7	10.1	17.2	13.8	8.4	11.9	16.4	9.5	21.6	29.3	11.0	11.8	20.5	24.0	29.0	27.6	18.4	19.8	16.9	25.4	20.4	17.9	11.9	9.9	12.9	8.5	5.6	24.5	8.7	5.1	4.0	5.7	14.0	3.9	21.7	1.7	7.4	4.4	8.2	12.4	0.0	10.0	9.3	12.7	8.2	6.9	23.8	13.5	44.5	15.5	8.6	15.3	3.2	11.5	11.0	18.6	4.6	8.1	43.7	8.0	14.4	15.2	6.7	25.4	12.9	9.5	22.3	10.2	6.8	15.8	13.1	7.0	5.4
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805120	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 76.8;liver: 234.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 542.2;Hepatocytes: 864.2;monocytes: 525.8;Paneth cells: 691.0;Proximal tubular cells: 954.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 38.4;intermediate monocyte: 27.1"	"Lineage enriched"	"Detected in many"	4	"monocytes: 38.4"	"Cell line enriched"	"Detected in some"	30	"HSkMC: 127.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	10.5	4.9	5.8	17.1	6.0	0.7	7.8	1.2	4.3	6.2	32.2	4.8	2.0	16.1	3.6	12.8	7.5	6.3	34.2	15.0	5.2	4.5	76.8	234.5	8.8	23.5	6.9	3.4	19.0	5.0	0.4	2.2	8.9	6.6	6.3	22.3	22.8	3.9	2.0	3.1	3.3	51.2	6.5	6.9	17.3	7.1	3.7	5.4	2.1	4.8	4.8	9.2	13.5	9.1	0.4	9.3	3.3	38.4	0.0	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	127.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	3.3	0.1	27.1	0.1	0.4	0.0	0.1	9.3	0.0	0.0	0.0	0.5	0.0	12.9	0.6	0.1	10.7	5.8	6.0	1.2	4.3	5.2	4.5	6.9	3.4	6.6	5.4	0.0	6.9	29.6	0.4	6.5	48.5	19.4	150.3	14.7	15.9	190.1	3.9	0.5	129.3	42.7	0.1	9.6	542.2	0.0	23.6	0.8	57.1	2.4	26.7	864.2	53.0	0.0	71.1	29.4	40.2	0.5	55.8	35.8	5.0	525.8	156.3	73.3	68.7	691.0	7.1	954.7	4.4	0.0	20.0	0.7	1.5	7.3	1.1	7.2	159.5	0.9
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.3;liver: 247.9"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 572.0;Hepatocytes: 1056.4;monocytes: 841.4;Paneth cells: 725.5;Proximal tubular cells: 817.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 92.3;intermediate monocyte: 68.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 92.3"	"Group enriched"	"Detected in some"	17	"HSkMC: 120.5;THP-1: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA047509: AB_2680072"	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	13.9	5.5	7.8	19.8	10.7	1.1	11.7	2.1	6.3	8.6	27.6	5.7	2.0	18.3	3.8	15.2	9.6	9.0	50.2	26.8	7.6	5.2	62.9	247.9	11.2	22.9	10.5	3.3	20.3	6.8	0.3	3.2	12.5	8.4	6.1	27.9	22.0	5.1	3.2	2.5	4.2	53.1	10.7	13.2	23.5	10.6	5.2	8.7	4.3	4.9	7.0	10.5	14.7	11.6	0.2	20.0	5.7	92.3	0.0	0.4	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	120.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	38.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	92.3	5.7	0.2	68.0	0.4	0.2	0.0	0.0	20.0	0.0	0.0	0.0	1.1	0.0	36.2	0.9	0.0	42.0	7.8	10.7	2.1	6.3	7.6	5.2	10.5	3.3	8.4	8.7	3.0	12.4	33.9	0.5	11.2	135.3	52.1	175.8	12.0	19.4	355.9	2.0	0.8	140.9	63.8	13.3	17.2	572.0	0.0	29.9	1.1	82.5	3.5	52.1	1056.4	94.1	6.4	123.0	27.0	68.8	9.8	40.3	84.1	15.1	841.4	193.4	69.9	82.8	725.5	3.2	817.7	17.3	0.0	22.6	3.2	3.4	13.7	2.3	14.6	213.0	1.0
TMEM177	MGC10993	ENSG00000144120	"Transmembrane protein 177"	Q53S58	2	119679167-119686507	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036689, HPA053816"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA036689: AB_2675253, HPA053816: AB_2682272"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.05e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.90e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	3.5	9.5	10.0	6.0	11.4	1.3	8.8	10.4	16.9	6.7	13.5	9.0	6.1	20.1	8.1	11.9	6.7	13.5	9.4	9.2	9.5	8.7	15.2	27.9	4.6	7.6	7.6	9.8	10.5	10.4	7.7	19.2	4.1	6.6	7.2	11.7	7.3	9.1	9.0	13.5	8.3	16.5	8.1	6.6	5.1	7.7	9.0	8.8	6.7	7.3	4.9	6.4	6.3	5.7	7.4	4.9	2.1	2.3	5.7	15.9	5.3	11.2	10.0	8.8	8.4	2.4	2.4	4.5	4.2	5.3	12.5	9.6	25.1	6.3	18.7	10.5	3.7	10.3	6.9	14.2	14.5	7.3	8.8	26.4	9.6	5.9	27.8	5.3	6.0	7.1	6.5	10.4	9.9	6.5	4.8	8.0	11.4	14.8	2.5	6.7	9.3	10.5	12.0	22.5	8.3	15.3	9.6	8.6	11.0	12.5	5.9	17.4	10.2	5.7	11.8	13.1	8.7	9.0	10.4	6.4	6.2	15.2	4.7	8.3	2.5	1.8	11.4	2.3	7.6	11.1	0.0	2.3	2.1	7.7	1.9	7.8	6.0	6.6	7.6	4.3	7.4	15.9	9.8	0.7	5.7	1.1	4.9	6.2	5.3	10.0	11.4	10.4	16.9	9.5	8.7	7.6	9.8	6.6	8.8	3.0	0.0	3.7	5.8	2.6	11.5	13.4	15.3	5.3	10.3	5.2	13.7	11.2	56.3	13.6	1.9	4.1	9.8	0.0	12.5	8.5	4.7	5.0	0.0	23.7	5.4	11.1	2.4	2.5	0.8	1.3	6.9	2.2	13.5	7.2	5.3	8.4	10.6	7.0	11.7	28.6	19.9	0.0	3.1	7.2	4.8	1.8	1.7	2.5	12.4	3.8
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 87.4"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 12.2;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 15.4;Rod photoreceptor cells: 5.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 87.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	2.9	4.2	13.3	0.9	10.6	0.6	6.8	87.4	35.6	1.6	1.9	6.4	0.0	2.3	3.8	2.0	1.8	3.3	3.1	3.6	16.4	7.4	18.9	2.7	5.8	0.8	10.7	10.9	1.8	2.2	1.3	2.5	3.6	17.0	12.2	2.2	3.7	3.8	2.1	2.3	3.5	2.4	2.9	22.6	1.6	3.5	1.2	5.3	0.0	5.7	0.8	2.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	0.0	0.1	1.8	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	7.1	0.1	0.0	0.6	0.0	0.0	0.4	0.1	10.4	0.2	0.0	0.2	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	10.6	87.4	18.8	16.4	7.4	10.7	10.9	17.0	5.3	0.0	1.3	0.0	0.6	0.3	2.1	3.7	0.0	4.0	1.2	12.2	5.9	0.3	0.0	0.3	0.3	3.1	0.4	0.0	0.2	0.0	0.2	4.1	0.0	0.2	0.2	1.6	15.4	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.3	0.0	0.0	0.7	5.8	0.0	0.4	0.2	0.2	0.5	0.5	0.0	0.4	0.1
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074232-141480380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 23.0;Cardiomyocytes: 39.1;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 7.1;HDLM-2: 6.4;NTERA-2: 6.0;RPTEC TERT1: 9.8;SCLC-21H: 7.7;WM-115: 10.4"									HPA048771	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA048771: AB_2680517"	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.9	1.7	5.2	0.7	7.4	0.1	0.7	3.2	13.4	0.5	0.8	1.0	2.3	0.1	1.1	0.6	1.8	0.3	0.7	11.6	4.8	5.8	2.9	0.6	0.4	1.5	4.9	1.0	0.2	2.6	20.6	18.5	0.1	1.8	2.8	0.4	0.5	4.4	0.8	4.5	0.2	1.2	1.3	2.4	0.8	0.5	0.8	0.4	1.0	9.5	0.1	3.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.6	0.3	1.8	0.1	2.8	0.8	1.0	0.0	0.0	2.2	2.4	0.2	0.5	0.0	7.1	0.0	2.3	6.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.0	6.0	0.0	0.0	0.4	1.1	3.0	9.8	2.8	7.7	4.7	0.1	0.3	1.0	1.5	1.0	0.0	0.0	0.1	1.2	3.2	0.0	0.1	0.0	0.0	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.4	3.2	9.6	4.8	5.8	4.9	1.0	1.8	0.4	0.0	0.0	0.0	0.4	0.5	23.0	39.1	0.0	0.0	0.0	1.8	2.0	0.0	1.7	0.0	0.8	0.1	0.0	0.0	0.3	0.0	0.2	3.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	3.8	1.2	0.0	0.7	2.8	1.6	0.0	0.8	0.5	0.7	0.1	0.2	0.0	0.0	1.6
TMEM18	"DKFZp434C1714, lncND"	ENSG00000151353	"Transmembrane protein 18"	Q96B42	2	667335-677439	"Predicted membrane proteins, Transporters"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040233	Approved		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA040233: AB_10794737"	"unprognostic (9.01e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.98e-3)"	"unprognostic (8.08e-2)"	18.9	22.1	13.7	11.3	14.4	12.9	23.4	10.0	18.7	17.6	17.4	16.0	12.0	13.9	19.3	19.5	16.1	15.6	18.1	12.3	13.4	14.5	17.3	18.1	12.2	12.5	14.8	15.6	43.7	31.7	13.2	13.5	19.6	12.3	19.2	9.5	18.3	19.5	16.5	28.3	14.2	15.5	18.4	21.9	12.5	13.4	19.1	11.4	23.9	23.1	19.7	13.8	15.0	14.1	17.3	19.7	5.8	14.4	16.2	14.8	11.2	9.8	9.4	11.6	13.1	12.9	19.8	12.3	13.6	10.8	12.2	11.6	1.8	16.1	14.0	25.6	16.7	6.3	14.0	4.7	15.7	10.1	21.8	11.3	8.2	5.6	20.2	16.6	8.2	7.4	14.1	16.0	20.7	14.1	10.5	3.7	23.8	8.3	8.7	16.3	33.2	19.1	19.8	8.5	8.6	13.9	11.1	6.2	10.6	11.2	10.7	9.6	15.6	7.9	14.6	14.7	5.3	9.8	15.3	11.6	11.2	15.3	7.4	20.5	11.6	19.0	12.1	13.7	9.1	7.8	3.7	14.4	5.8	11.3	13.8	11.8	17.3	12.5	9.2	14.9	13.6	14.8	13.9	1.2	16.2	14.1	19.7	14.4	11.2	13.7	14.4	10.0	18.7	13.4	14.5	14.8	15.6	12.3	11.4	20.8	26.2	26.8	25.3	31.9	18.7	21.3	28.1	34.8	27.3	26.2	7.9	62.0	26.6	32.1	11.2	32.9	25.7	46.7	39.9	50.7	45.7	34.7	28.9	31.8	43.3	19.1	19.0	31.9	30.8	9.1	58.7	29.1	38.8	26.2	36.8	41.0	36.0	43.2	48.1	36.3	27.2	19.4	40.1	80.7	64.7	37.8	67.9	17.3	41.4	31.5
TMEM181	"GPR178, KIAA1423"	ENSG00000146433	"Transmembrane protein 181"	Q9P2C4	6	158536436-158635428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 49.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040189, HPA040228"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA040189: AB_10793959, HPA040228: "	"unprognostic (1.93e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (9.87e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.26e-1)"	7.1	5.6	32.4	4.8	49.2	3.1	8.6	5.3	36.6	13.4	10.1	4.2	6.5	10.9	8.4	3.9	6.3	5.8	7.3	5.3	18.5	8.7	3.3	6.4	6.7	3.4	5.5	23.3	5.6	18.5	8.1	21.5	6.5	11.2	9.4	11.5	4.3	22.4	10.0	4.9	7.0	12.6	7.8	7.3	7.6	16.3	16.0	8.5	2.3	9.7	2.1	3.2	9.9	7.0	1.0	2.1	7.7	3.4	3.9	4.7	1.4	10.2	5.9	8.4	12.9	22.3	20.5	16.1	23.2	13.6	12.1	13.9	10.0	12.6	4.3	12.0	19.2	26.0	15.2	12.4	15.3	19.3	6.3	8.9	8.0	8.8	21.1	18.2	10.0	7.7	16.9	15.1	13.5	18.3	18.3	19.4	6.2	15.2	5.4	19.8	6.2	4.4	12.5	6.5	20.4	7.6	4.3	9.7	4.9	11.6	8.0	24.9	17.1	17.0	16.0	11.1	12.1	6.1	14.1	18.4	12.6	8.5	20.8	20.0	3.2	2.2	4.8	15.2	12.6	11.9	7.7	2.2	5.7	4.7	2.3	3.6	0.9	2.7	3.7	1.6	1.0	2.4	3.2	1.6	3.9	3.4	2.1	2.6	1.4	32.4	49.2	5.3	36.6	18.5	8.7	5.5	23.3	11.2	8.5	11.9	31.5	2.4	11.3	18.1	13.4	14.8	20.4	5.3	7.9	15.7	17.7	7.7	3.3	22.0	3.2	24.0	29.3	0.0	28.2	10.9	15.0	29.8	10.5	18.6	8.9	19.1	42.6	20.3	14.2	4.0	12.0	13.6	13.5	4.6	34.5	6.0	36.3	28.1	16.6	4.8	14.4	6.5	17.1	14.2	22.6	18.3	4.3	20.1	24.4	29.1
TMEM182	FLJ30294	ENSG00000170417	"Transmembrane protein 182"	Q6ZP80	2	102736905-103019900	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA045861			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA045861: AB_2679475"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.12e-4)"	"unprognostic (5.35e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.36e-2)"	2.4	1.1	1.2	1.0	1.3	0.3	1.1	1.7	1.8	1.4	1.0	0.5	1.5	1.0	0.6	2.3	1.8	1.1	0.8	40.3	1.2	1.9	1.4	1.7	0.6	0.8	1.2	0.5	1.0	1.1	1.5	6.8	0.8	2.8	1.9	1.0	0.9	3.8	1.2	53.9	0.5	0.9	1.1	1.2	0.8	1.0	0.8	0.4	1.8	2.0	37.8	4.0	1.2	0.7	4.4	3.1	0.3	0.3	2.4	4.1	1.1	4.9	2.8	2.1	6.6	2.7	2.7	7.7	2.7	2.4	2.7	3.9	9.2	6.9	4.1	9.2	0.9	4.4	2.9	2.3	3.7	5.7	9.1	1.8	6.1	1.3	5.8	3.2	5.5	4.9	3.4	6.8	4.3	3.8	1.9	0.4	5.9	4.3	1.6	2.7	3.6	2.9	5.3	3.6	4.7	3.0	3.1	5.6	3.9	3.8	4.3	5.5	1.9	3.6	3.9	8.6	2.9	3.3	2.9	0.3	4.3	3.1	3.3	3.3	4.0	10.0	3.4	4.4	9.1	6.5	0.0	0.0	0.3	3.9	0.3	3.2	4.4	2.8	2.2	1.3	1.9	3.8	4.1	0.1	2.4	0.3	3.1	0.8	1.1	1.2	1.3	1.7	1.8	1.2	1.9	1.2	0.5	2.8	0.4	20.8	10.5	5.9	0.8	0.3	0.1	134.4	0.0	17.4	23.9	3.5	0.0	1.9	0.0	1.3	0.6	0.0	0.4	23.3	2.9	2.1	1.0	1.0	3.5	1.9	1.0	0.0	6.3	0.0	0.6	0.4	0.6	0.7	6.8	0.0	2.2	2.3	1.7	0.0	0.7	2.4	0.3	0.0	0.9	0.9	2.2	0.5	0.9	1.0	1.7	2.7
TMEM183A	C1orf37	ENSG00000163444	"Transmembrane protein 183A"	Q8IXX5	1	203007386-203024848	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA072607			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA072607: AB_2686539"	"unprognostic (2.94e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (6.46e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.28e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.01e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	12.2	12.6	22.4	13.5	20.8	50.1	17.2	31.9	30.4	14.4	21.1	12.4	6.7	20.0	13.6	15.2	19.3	12.0	15.0	11.5	19.8	21.0	16.0	21.1	13.4	20.2	19.3	14.8	15.0	29.9	12.0	8.2	10.9	20.8	15.0	23.6	11.1	22.2	13.6	8.8	16.1	18.8	17.6	12.4	14.5	15.8	27.7	12.3	23.3	20.5	14.8	17.7	15.3	20.7	17.4	27.2	35.6	24.4	26.4	23.7	24.3	12.7	12.4	15.9	26.1	21.1	15.9	26.3	12.8	12.7	14.9	13.1	15.0	13.5	31.9	9.3	16.5	6.0	16.2	21.3	18.0	12.4	10.3	25.9	15.7	14.5	16.5	15.3	28.1	13.9	15.6	20.1	12.2	24.8	15.1	18.7	25.8	32.2	11.6	13.8	28.4	22.9	28.9	43.8	17.3	19.8	17.7	27.2	25.6	23.0	12.5	20.5	25.7	19.2	32.1	18.4	26.5	22.9	22.2	13.8	10.1	14.1	17.2	14.0	11.8	18.9	24.7	11.1	21.9	10.6	21.1	24.4	35.6	18.1	20.4	17.9	16.6	20.5	20.5	27.2	17.4	23.7	19.3	21.3	26.4	18.5	19.5	21.2	24.3	22.4	20.8	31.9	30.4	19.8	21.0	19.3	14.8	20.8	12.3	14.9	15.6	44.9	49.0	65.3	20.7	10.9	48.4	28.1	28.4	33.2	9.8	46.3	59.7	71.4	117.2	35.8	68.3	23.3	66.2	74.0	37.9	74.7	17.3	45.7	54.3	17.5	50.6	32.5	53.2	96.3	25.0	47.0	37.1	59.5	68.9	18.9	55.2	56.1	27.6	74.5	26.2	19.4	47.6	72.3	76.8	71.8	43.1	44.7	83.1	77.4
TMEM184B	"C22orf5, DKFZP586A1024, FM08, HS5O6A"	ENSG00000198792	"Transmembrane protein 184B"	Q9Y519	22	38219291-38273034	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024076	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA024076: AB_1858106"	"unprognostic (1.52e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.94e-6)"	"unprognostic (1.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.96e-1)"	21.8	16.5	23.9	14.7	24.1	6.0	27.5	26.4	40.0	22.4	14.4	31.2	12.2	18.5	12.1	9.5	11.0	14.2	16.1	17.8	25.8	21.5	13.0	7.4	20.5	8.6	26.1	22.2	10.8	18.0	27.3	21.9	41.2	23.8	12.3	12.5	20.1	16.8	17.3	19.0	10.9	16.5	15.7	41.2	14.1	19.3	5.8	20.9	3.9	16.7	10.6	9.2	20.0	15.4	1.6	7.3	12.4	3.1	6.2	5.8	2.6	17.3	15.2	9.0	7.1	17.9	14.4	20.8	18.8	26.8	15.5	13.8	11.1	8.1	3.3	14.8	28.0	14.0	21.6	8.1	18.5	10.5	11.8	14.5	6.6	11.1	9.2	18.9	5.1	9.2	12.0	16.5	18.2	20.4	16.0	19.3	5.1	4.1	11.7	13.4	9.9	3.2	4.3	7.3	13.0	14.0	5.6	8.1	3.3	11.5	19.3	19.5	3.4	14.1	20.7	10.0	10.9	11.4	3.8	28.4	15.8	16.2	13.8	11.4	24.3	60.1	2.7	22.9	3.8	13.5	12.4	3.1	4.6	5.8	2.4	5.3	1.6	3.3	4.3	4.7	1.2	2.3	2.7	11.2	6.2	1.6	7.3	1.0	2.6	23.9	24.1	26.4	35.4	25.8	21.5	26.1	22.2	23.8	20.9	6.0	15.0	1.5	15.0	11.0	17.0	14.6	10.2	4.0	9.1	14.0	2.0	27.6	3.3	15.0	4.9	26.7	7.5	0.0	19.1	38.8	21.0	27.4	2.3	3.4	13.3	14.3	24.9	16.0	7.5	1.7	10.9	10.2	13.5	16.2	16.0	40.7	22.7	7.0	12.7	4.2	8.1	19.4	23.4	2.3	6.6	8.4	65.6	10.1	9.4	30.1
TMEM184C	"FLJ10846, TMEM34"	ENSG00000164168	"Transmembrane protein 184C"	Q9NVA4	4	147617383-147672044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054013	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA054013: AB_2682343"	"unprognostic (5.45e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.31e-7)"	"unprognostic (4.68e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.31e-3)"	10.4	18.4	11.3	9.6	13.1	5.5	10.0	12.3	15.9	11.8	13.0	12.3	14.3	11.8	12.4	9.8	10.7	10.0	9.6	14.3	11.8	11.3	18.0	18.7	9.2	7.7	16.1	11.8	15.7	11.6	107.2	10.5	14.0	12.7	12.0	11.6	9.3	12.1	12.8	16.2	9.5	14.8	10.1	14.0	10.0	10.6	8.3	14.1	11.7	32.9	10.3	9.4	11.8	11.2	12.8	17.3	17.7	18.1	14.7	22.8	11.6	9.2	14.5	18.4	14.0	25.2	24.6	12.1	17.3	20.3	12.9	15.0	11.9	17.7	8.6	8.7	13.5	12.8	11.1	14.9	13.3	14.3	19.1	8.7	11.1	11.2	8.6	19.4	14.8	16.6	18.3	18.0	14.2	14.9	18.8	16.6	9.8	14.2	24.3	18.0	13.8	12.8	5.4	11.8	21.1	8.5	12.8	6.3	14.8	14.3	17.3	14.3	18.5	9.4	14.7	15.1	14.9	14.7	9.3	16.2	16.4	8.9	13.3	11.0	26.6	34.8	11.5	19.2	8.9	17.7	17.7	14.1	15.5	18.0	18.0	22.8	12.3	16.7	16.4	17.3	12.8	15.9	14.8	11.0	14.7	18.1	11.9	15.3	11.6	11.3	13.1	12.3	15.9	11.8	11.3	16.1	11.8	12.7	14.1	8.9	5.7	6.4	6.6	4.0	7.7	16.5	10.2	5.3	14.8	5.2	11.8	12.5	1.7	10.6	19.6	9.8	8.5	0.0	11.1	10.6	8.4	7.2	20.8	8.5	9.0	11.1	5.2	6.7	10.4	10.3	10.0	8.8	5.0	4.6	8.3	7.8	7.5	3.5	13.8	5.3	6.2	6.5	7.3	5.4	4.9	3.0	7.2	6.4	9.9	6.4
TMEM185A	"CXorf13, FAM11A, FRAXF"	ENSG00000269556	"Transmembrane protein 185A"	Q8NFB2	X	149596556-149631912	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (9.76e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"	4.3	5.0	6.8	4.8	6.2	1.7	4.1	7.2	8.2	5.1	3.8	3.1	7.3	2.3	6.2	7.4	5.8	5.8	5.3	12.0	4.4		4.4	3.1	3.4	3.3	3.0	3.3	13.8	5.4	7.3	4.8	10.8	6.0	5.5	3.5	6.3	4.8	7.2	4.5	6.2	3.3	6.6	3.7	7.8	2.7	12.3	4.0	3.8	3.8	4.5	4.3	4.6	5.8	5.3	7.7	12.2	5.0	13.5	10.4	6.3	11.1	11.3	13.1	7.7	17.8	12.1	5.2	11.0	13.5	11.2	16.9	6.9	19.3	13.7	24.7	12.2	15.0	14.2	15.1	10.4	12.2	8.8	11.3	7.9	13.2	7.4	12.9	11.5	8.1	11.5	17.7	11.5	7.2	13.0	9.6	10.4	3.3	8.9	8.0	18.3	7.9	7.9	9.8	5.7	12.7	7.8	19.9	7.8	12.9	14.7	4.5	6.5	8.4	14.5	14.4	12.5	7.7	6.6	11.5	8.5	7.8	15.6	13.5	8.4	7.4	20.1	15.1	13.5	11.7	2.2	5.0	12.2	10.1	3.0	9.0	5.3	7.3	10.4	7.7	5.0	10.3	9.2	7.1	13.5	2.5	5.7	9.0	6.3											6.0	1.6	3.9	10.3	9.8	13.3	9.3	2.5	9.4	2.3	14.0	5.9	23.0	3.3	4.1	0.2	10.2	5.5	0.0	8.1	9.7	19.0	9.2	5.7	6.6	9.5	17.5	12.6	23.4	12.5	1.9	21.0	6.9	13.5	19.0	6.9	12.9	8.9	8.7	22.3	4.8	8.1	45.3	14.0	6.9	15.8	17.6	14.4	8.6	5.0	14.1
TMEM185B	"FAM11B, FLJ20979"	ENSG00000226479	"Transmembrane protein 185B"	Q9H7F4	2	120221278-120223408	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.44e-4)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (5.71e-7)"	"unprognostic (3.09e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	16.9	14.2	10.4	12.7	14.2	14.4	15.7	8.3	15.2	14.4	12.7	24.7	9.9	9.8	17.7	10.6	16.3	17.1	12.4	18.3	13.2	9.7	12.3	19.1	14.5	18.4	15.3	9.2	14.6	20.2	46.3	12.2	13.8	13.1	16.1	10.4	15.1	16.2	12.6	16.5	11.9	12.6	16.8	14.5	12.6	13.4	19.4	13.4	16.3	19.1	15.5	13.2	15.9	12.9	1.4	2.6	5.8	3.4	4.6	2.4	0.6	24.7	10.4	7.1	11.5	12.3	17.3	18.4	17.9	17.1	17.5	15.4	31.3	24.4	0.0	17.7	15.6	17.8	16.0	7.2	15.0	19.7	10.7	14.2	11.0	7.2	7.1	17.6	0.0	19.8	14.7	18.5	18.7	22.8	11.7	12.3	10.4	12.7	12.8	15.2	17.0	9.4	11.0	10.7	10.0	22.1	7.4	0.0	8.2	13.9	16.7	10.8	9.0	16.2	19.8	14.5	9.0	11.4	12.4	14.7	7.8	21.2	13.9	6.7	8.9	11.0	10.2	9.3	10.9	18.2	0.0	1.9	2.3	1.6	3.4	1.9	0.8	2.0	1.0	2.6	1.4	1.6	2.4	5.8	4.6	2.2	0.8	1.9	0.6	10.4	14.2	8.3	15.2	13.2	9.7	15.3	9.2	13.1	13.4	14.9	1.6	6.4	26.6	7.4	2.1	7.9	5.1	6.7	2.3	7.0	5.9	9.2	1.7	14.8	8.4	7.7	4.9	0.0	10.8	25.8	8.4	11.0	6.9	3.4	13.2	1.6	1.2	5.5	5.1	5.1	4.4	5.6	6.8	5.4	3.7	8.8	9.8	3.5	2.1	3.3	3.6	0.0	8.0	17.3	11.5	3.9	12.1	5.1	4.7	15.8
TMEM186	"C16orf51, DKFZP564K2062"	ENSG00000184857	"Transmembrane protein 186"	Q96B77	16	8780384-8797648	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018226, HPA063559"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA018226: AB_1845579, HPA063559: AB_2685041"	"unprognostic (3.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.93e-8)"	"unprognostic (1.06e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.89e-2)"	6.6	12.0	8.2	6.2	10.4	1.9	11.0	5.4	13.2	7.4	10.6	8.2	9.4	10.1	11.0	14.2	9.6	10.4	9.7	11.5	7.4	7.6	9.6	15.9	6.2	8.2	9.1	12.6	9.7	11.8	16.3	11.8	8.4	7.8	8.4	12.5	10.4	14.0	8.4	16.9	8.8	9.2	15.1	10.3	10.1	9.1	11.7	6.2	7.0	11.9	7.7	11.0	10.4	6.2	14.3	10.4	11.8	13.8	9.5	17.2	8.4	6.8	10.7	8.0	10.1	13.7	7.3	7.6	7.8	8.1	10.4	8.6	10.3	11.4	20.7	6.7	5.7	7.1	13.1	14.1	11.1	11.9	12.0	13.6	8.7	13.8	21.9	15.4	9.6	7.1	8.7	18.9	11.3	16.7	8.5	9.3	17.3	14.8	11.4	6.0	18.3	7.4	9.4	10.1	14.6	9.4	15.7	10.4	22.7	11.0	5.8	12.3	11.7	10.7	15.2	9.2	8.5	18.2	7.8	5.9	7.4	10.4	18.1	6.4	10.5	11.1	10.0	11.5	17.8	5.9	11.8	10.0	7.5	9.4	9.6	12.5	14.3	10.0	10.6	10.4	12.7	17.2	13.2	4.8	9.5	13.8	8.1	13.0	8.4	8.2	10.4	5.4	13.2	7.4	7.6	9.1	12.6	7.8	6.2	6.0	7.0	11.3	6.9	7.2	5.8	2.5	5.1	8.1	11.4	10.4	0.0	19.8	18.3	12.1	34.1	4.4	8.5	0.0	9.7	10.0	4.3	6.0	6.9	11.6	11.6	12.7	13.2	4.3	3.3	62.1	8.6	3.7	6.8	10.0	8.6	8.9	8.9	7.0	6.0	16.1	5.3	12.9	4.7	13.2	10.0	8.3	12.6	6.4	15.3	5.5
TMEM187	"CXorf12, DXS9878E, ITBA1"	ENSG00000177854	"Transmembrane protein 187"	Q14656	X	153972327-153983195	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA038134	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA038134: AB_10669517"	"unprognostic (1.51e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.14e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.04e-2)"	8.8	13.0	9.2	6.8	10.2	3.4	10.5	13.2	9.0	7.6	9.0	10.5	13.9	6.8	8.8	9.3	9.5	12.0	6.8	8.1	9.6	6.0	7.6	10.2	7.7	10.2	10.4	9.0	10.9	24.4	7.5	13.0	7.3	11.0	10.3	4.5	6.7	14.1	10.1	8.5	10.7	10.9	6.8	8.0	10.0	8.0	5.9	8.7	8.4	10.8	2.9	9.9	7.9	7.4	13.4	19.6	17.8	9.8	10.1	22.5	10.9	8.4	9.7	2.1	7.7	8.4	7.5	1.2	3.5	1.7	1.0	3.4	1.9	14.6	1.3	20.0	2.8	5.3	7.7	2.9	5.1	0.8	10.9	4.0	2.3	5.1	3.1	7.1	1.1	2.6	8.4	7.7	3.0	4.3	4.8	2.6	5.1	2.1	11.0	4.4	9.1	4.5	1.5	1.6	9.5	10.7	4.2	1.2	14.1	5.3	2.7	2.9	2.8	5.1	4.3	3.6	2.1	8.1	2.8	4.8	1.7	1.8	7.0	1.9	7.8	5.2	1.7	5.2	5.1	0.9	17.8	9.8	11.9	14.7	7.3	14.7	9.7	18.1	15.9	7.4	13.4	22.5	13.9	9.5	10.1	6.9	19.6	17.6	10.9	9.2	10.2	13.2	9.0	9.6	6.0	10.4	9.0	11.0	8.7	0.0	4.6	4.1	5.2	2.5	3.5	3.6	17.8	2.7	1.2	7.0	5.9	11.8	1.7	9.2	0.3	3.8	6.5	23.3	7.7	9.1	9.6	5.3	3.5	13.5	10.8	1.6	2.4	4.9	6.0	0.0	13.6	4.8	10.1	9.0	6.7	12.4	8.0	3.5	13.4	6.8	4.3	6.5	5.5	0.2	8.8	4.1	8.2	5.1	7.6	3.3
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.6	14.4	11.3	7.4	13.6	5.3	12.1	12.0	11.9	11.6	9.7	10.5	6.2	8.3	9.7	10.0	7.8	10.1	8.9	10.4	9.9	9.4	40.7	37.7	9.1	8.5	13.0	10.6	21.8	21.3	20.3	14.2	9.3	13.1	19.4	11.7	24.7	11.3	7.8	19.0	7.4	8.2	8.6	13.3	10.8	10.5	8.6	11.3	3.1	22.9	5.2	6.6	12.1	7.3	18.2	12.0	3.4	12.5	13.4	12.8	7.7	6.3	9.6	3.5	8.8	9.1	3.2	8.1	9.7	14.3	10.1	11.3	5.6	10.5	14.0	5.8	6.2	16.5	5.7	13.0	9.9	11.7	9.0	6.7	7.8	7.2	6.3	23.3	19.1	10.5	11.7	21.2	9.1	18.6	8.8	8.2	7.6	13.2	23.6	12.4	13.8	3.3	5.6	7.3	13.3	8.3	7.5	3.0	12.7	8.2	9.4	7.5	7.8	15.1	24.1	15.3	5.4	11.7	8.8	6.1	4.5	5.5	14.0	10.9	23.2	30.6	19.5	10.7	10.6	17.8	2.0	12.5	3.4	9.7	10.9	12.8	18.2	7.5	9.9	11.6	15.2	8.3	10.0	1.4	13.4	5.8	12.0	6.0	7.7	11.3	13.6	12.0	11.9	9.9	9.4	13.0	10.6	13.1	11.3	29.8	33.4	17.1	16.9	8.7	34.9	28.7	48.4	12.0	22.7	52.4	15.7	23.8	10.0	18.4	13.5	19.6	13.2	0.0	22.3	16.3	19.5	28.7	38.3	68.1	32.6	35.0	20.8	27.0	24.1	7.5	36.8	24.0	27.0	9.0	15.9	31.7	12.7	14.0	31.5	49.7	25.3	6.5	13.2	13.1	11.9	11.3	28.1	19.8	22.9	12.3
TMEM198	"MGC99813, TMEM198A"	ENSG00000188760	"Transmembrane protein 198"	Q66K66	2	219543663-219550595	"Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0"	"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 20.6;Intestinal endocrine cells: 18.4;Muller glia cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 17.3;SH-SY5Y: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042385, HPA062897"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA042385: AB_2677972, HPA062897: "	"unprognostic (2.59e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.89e-4)"	"unprognostic (6.39e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	3.0	9.4	14.4	3.1	10.3	0.9	2.3	14.2	22.0	3.3	2.6	4.1	1.4	16.1	4.0	2.5	2.7	2.5	3.9	3.4	16.5	5.2	3.0	2.6	2.4	1.8	4.1	11.9	10.9	20.0	5.2	13.0	2.6	6.2	4.0	1.8	3.0	7.0	4.3	3.5	2.2	6.4	3.5	7.5	1.8	4.7	5.0	4.9	0.0	4.0	0.5	1.9	3.8	1.2	0.2	2.6	0.1	0.0	0.8	0.4	0.4	0.5	0.1	4.8	8.2	1.0	0.9	4.3	2.5	1.3	2.0	1.7	10.5	1.4	2.1	2.4	1.5	5.0	2.9	1.7	1.2	0.4	7.1	2.0	1.7	2.1	8.6	1.5	0.6	4.0	2.1	0.7	0.9	2.3	2.2	0.0	1.5	6.2	7.0	1.2	1.0	0.1	0.5	6.2	0.8	0.7	0.2	2.9	2.4	1.2	1.1	17.3	15.0	0.6	1.7	4.1	0.9	0.2	3.3	0.1	2.2	0.9	2.0	1.0	6.7	1.9	2.2	2.0	0.1	3.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	0.0	2.6	0.0	0.4	14.4	10.3	14.2	22.0	16.5	5.2	4.1	11.9	6.2	4.9	0.0	1.4	0.0	1.1	0.1	8.1	1.6	0.0	0.0	0.0	0.0	2.0	0.8	1.7	2.7	0.7	0.0	1.0	0.0	7.0	0.6	2.2	0.8	0.0	1.5	0.2	20.6	18.4	0.0	0.3	1.3	2.6	0.0	1.7	1.0	0.9	9.8	1.8	0.8	4.6	1.6	6.5	0.0	2.8	9.2	3.1	0.1	2.4	0.5	0.1	0.3
TMEM2		ENSG00000135048	"Transmembrane protein 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 67.6"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 36.6;BEWO: 34.0;OE19: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044889	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		130000	"Plasma membrane"	Vesicles	"HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	23.3	3.9	6.0	10.5	4.4	12.4	13.6	8.9	6.0	3.0	18.6	1.9	10.1	12.2	4.5	5.2	4.4	4.9	19.2	9.5	8.6	3.6	9.3	24.9	35.7	14.0	4.0	4.1	3.1	9.2	24.0	9.5	67.6	4.3	5.5	13.1	7.9	9.5	10.2	5.5	6.4	20.0	5.5	5.1	15.6	14.5	3.7	2.4	6.4	8.0	4.6	8.8	11.4	6.8	6.3	0.9	5.5	2.1	0.5	4.1	1.4	5.8	28.0	36.6	1.7	3.8	6.9	34.0	19.7	12.6	13.7	10.1	7.8	8.0	0.1	5.9	5.0	3.0	8.7	11.8	2.7	18.6	0.7	3.6	10.0	5.9	20.8	5.9	0.0	2.7	7.1	3.0	10.6	2.4	3.6	18.0	0.8	1.4	3.0	7.4	4.9	1.1	0.1	7.6	36.1	2.7	0.9	10.9	0.7	8.6	18.9	1.8	0.2	5.1	3.6	5.3	11.8	2.5	0.3	7.8	9.3	10.5	5.1	9.8	0.6	8.4	0.3	1.8	0.9	11.7	0.2	2.1	5.5	2.7	1.9	0.8	0.7	2.9	2.6	0.9	6.3	4.1	2.0	4.5	0.5	1.8	0.2	3.9	1.4	6.0	4.4	8.9	6.0	8.6	3.6	4.0	4.1	4.3	2.4	32.8	30.4	9.4	38.3	26.8	5.5	0.0	33.1	4.0	17.0	0.0	9.8	36.3	0.0	0.0	10.6	37.9	75.4	0.0	0.0	12.0	19.0	42.5	4.6	27.6	35.9	0.0	9.7	115.4	56.5	2.9	2.8	14.9	16.9	0.0	32.3	73.6	0.0	26.4	1.1	0.0	35.2	6.5	20.8	1.0	0.6	19.2	75.1	62.3	28.3	40.3
TMEM200C	TTMA	ENSG00000206432	"Transmembrane protein 200C"	A6NKL6	18	5882072-5895955	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.1"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 6.6;Cone photoreceptor cells: 5.9;Peritubular cells: 2.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.8;NTERA-2: 4.5;PC-3: 20.8;SH-SY5Y: 3.3;U-2 OS: 10.6;U-251 MG: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047253, HPA050490"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA047253: AB_2680001, HPA050490: AB_2681144"	"unprognostic (6.57e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.82e-4)"	"unprognostic (2.48e-10)"	"unprognostic (2.94e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.38e-2)"	0.4	6.3	2.6	1.0	3.7	0.1	3.5	0.7	5.7	0.8	0.5	1.7	0.1	0.5	1.6	3.2	0.6	1.1	1.3	2.9	2.7	3.5	2.0	5.3	0.5	1.1	3.7	1.6	1.9	0.2	0.1	3.3	0.1	1.7	0.9	0.3	2.7	10.1	0.7	0.1	0.7	0.6	0.5	1.2	1.6	1.3	3.5	1.5	0.1	0.2	0.1	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	20.8	1.2	0.0	0.0	0.0	0.0	1.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	10.6	0.0	3.6	0.0	0.0	0.0	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	0.7	4.7	2.7	3.5	3.7	1.6	1.7	1.5	0.0	1.4	0.0	0.0	0.1	6.6	1.2	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	2.1	0.0	1.2	0.0	0.9	0.1	0.4	0.3	0.0	0.0	0.0	0.1
TMEM205	"MBC3205, UNQ501"	ENSG00000105518	"Transmembrane protein 205"	Q6UW68	19	11342776-11346518	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 396.4;Hepatocytes: 417.5;Late spermatids: 488.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Nuclear membrane"	"HPA041504: AB_10795595"	"unprognostic (2.54e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.56e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	15.8	40.5	25.7	10.6	29.4	14.5	19.3	16.2	36.3	30.3	19.2	19.8	34.6	18.7	15.5	29.7	14.6	25.9	27.8	31.7	24.5	23.6	36.1	90.8	19.4	22.9	25.2	21.9	21.7	50.5	52.4	21.7	17.5	20.6	24.3	11.3	31.8	28.6	28.4	30.0	15.0	18.2	16.9	21.4	14.2	17.2	23.1	13.2	11.1	46.6	15.4	13.3	21.3	13.1	21.9	43.1	11.0	71.0	10.4	14.8	32.1	19.3	48.1	5.9	20.1	11.8	14.2	11.2	7.4	17.1	16.2	12.7	14.6	6.2	17.4	44.9	14.9	16.1	19.9	8.5	22.2	10.9	20.4	8.1	4.6	16.7	23.9	29.8	7.8	14.9	13.4	22.7	10.4	17.4	16.3	19.5	16.7	14.0	74.6	10.0	49.0	11.7	21.9	10.6	25.3	36.9	11.1	9.2	46.0	39.4	35.1	10.7	16.3	7.8	32.1	18.0	7.4	27.9	22.8	11.4	20.4	7.8	22.2	16.4	44.5	44.3	10.3	19.7	35.1	15.6	5.2	71.0	7.1	14.6	29.8	14.8	21.9	12.2	12.8	43.1	18.4	9.8	11.8	11.0	10.4	17.5	31.0	14.6	32.1	25.7	29.4	16.2	36.3	24.5	23.6	25.2	21.9	20.6	13.2	62.5	59.8	25.2	116.9	45.7	27.8	62.3	178.3	58.9	89.9	144.8	11.8	101.4	51.4	137.3	396.4	66.1	62.3	0.0	143.8	66.1	80.7	116.5	28.8	417.5	85.9	25.4	113.0	63.3	78.3	488.1	74.8	50.9	91.1	31.5	72.5	72.5	99.5	66.6	64.0	180.1	27.1	45.3	59.3	30.7	14.9	47.2	80.9	37.9	73.4	104.8
TMEM209	"FLJ14803, NET31"	ENSG00000146842	"Transmembrane protein 209"	Q96SK2	7	130164715-130207770	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031678	Uncertain		Approved	"Nuclear membrane,Nuclear speckles,Vesicles"		NA	NA			"Nuclear membrane, Nuclear speckles, Vesicles"		"HPA031678: AB_10603135"	"unprognostic (3.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.24e-1)"	12.0	33.5	9.9	9.1	12.1	9.4	12.2	12.7	13.3	9.4	12.2	23.8	9.5	10.4	16.4	11.8	8.8	11.2	8.1	7.9	9.9	10.9	11.6	16.9	10.3	12.2	11.6	12.0	13.7	19.8	19.0	18.7	18.6	16.4	10.3	12.9	19.0	16.5	10.3	10.1	11.1	19.0	10.5	19.1	13.3	8.8	17.8	11.3	24.9	18.6	8.0	13.1	11.1	8.9	14.1	10.8	10.0	13.4	13.8	20.5	10.4	9.5	9.2	12.6	15.5	7.3	7.5	9.3	8.8	8.9	8.0	10.8	10.2	17.4	14.2	6.6	5.6	14.9	14.4	14.7	10.2	14.3	17.5	8.4	7.4	15.6	6.7	13.0	15.5	7.5	8.3	10.5	15.9	16.0	4.9	6.1	14.8	23.9	16.8	9.7	12.4	29.5	9.4	18.7	8.6	8.2	15.9	14.1	23.5	8.0	12.3	11.3	17.4	20.0	32.1	12.6	10.3	10.4	10.4	4.8	14.6	5.7	15.2	21.0	22.3	32.6	29.6	23.7	18.0	22.4	10.0	8.9	9.5	17.0	13.4	17.7	14.1	17.4	15.4	8.6	14.0	20.5	17.3	1.3	13.8	11.3	10.8	17.3	10.4	9.9	12.1	12.7	13.3	9.9	10.9	11.6	12.0	16.4	11.3	3.0	10.5	8.2	3.0	4.1	13.0	6.9	7.6	8.1	11.4	8.7	3.9	6.6	1.7	5.0	22.4	9.0	7.0	0.0	7.9	7.4	8.1	5.0	9.3	8.2	7.0	4.8	13.3	7.4	11.3	4.9	6.1	7.5	6.8	4.6	10.2	19.3	6.0	11.2	4.9	3.9	13.9	0.0	5.8	12.6	15.1	4.6	5.5	11.5	8.1	3.8
TMEM212	FLJ23172	ENSG00000186329	"Transmembrane protein 212"	A6NML5	3	171843349-171938715	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.2;lung: 10.0;ovary: 12.8"	"Cell type enhanced"	"Detected in some"	30	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 22.8;Ciliated cells: 167.3;Club cells: 46.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045736			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA045736: AB_2679436"	"unprognostic (3.39e-2)"			"unprognostic (1.78e-2)"	"unprognostic (3.05e-1)"			"unprognostic (5.54e-2)"		"unprognostic (3.06e-1)"				"unprognostic (2.87e-1)"				0.4	0.4	0.5	0.6	0.8	2.2	0.4	0.4	0.5	1.6	0.8	0.9	0.4	0.2	1.3	2.5	0.8	19.2	0.4	0.4	0.6	0.7	0.4	3.3	10.0	0.6	0.4	0.4	12.8	0.4	0.0	0.4	0.4	0.7	0.4	0.8	0.4	0.4	2.1	1.1	1.5	0.5	0.4	0.4	0.4	0.4	1.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	4.1	3.2	6.3	2.1	3.8	2.7	0.5	4.1	2.5	2.8	3.1	0.8	0.4	5.5	3.0	0.9	1.2	1.2	2.0	3.3	5.4	3.6	1.4	3.1	2.9	1.7	1.3	2.6	7.1	2.8	6.4	6.5	2.7	0.5	3.7	5.4	1.1	1.5	1.4	1.2	1.8	1.3	3.4	4.4	8.6	0.9	2.7	3.2	4.1	4.9	2.1	2.7	2.7	4.4	4.5	1.1	3.2	3.4	3.3	4.1	3.1	2.3	3.3	3.6	3.3	6.6	4.6	5.0	7.2	3.2	5.1	4.0	3.6	2.3	3.4	2.4	6.3	2.1	1.8	2.7	1.8	2.1	1.9	2.0	1.8	1.1	4.1	2.3	2.5	5.0	3.8	2.0	3.2	1.3	0.5	0.5	0.8	0.4	0.4	0.6	0.7	0.4	0.4	0.7	0.4	32.8	22.8	0.0	0.0	0.0	0.0	0.0	0.0	167.3	46.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0
TMEM214	FLJ20254	ENSG00000119777	"Transmembrane protein 214"	Q6NUQ4	2	27032910-27041695	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034551			Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Golgi apparatus, Cytosol"		"HPA034551: AB_10602481"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.39e-10)"	"unprognostic (1.54e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.92e-2)"	21.8	20.8	9.9	16.3	13.2	9.4	21.0	10.4	13.6	23.2	19.8	11.6	34.5	13.7	23.0	33.4	15.8	18.2	22.6	22.3	8.7	9.7	22.1	47.5	18.9	10.5	10.8	9.4	24.0	57.7	29.1	31.8	30.8	12.7	19.1	20.4	16.9	56.0	36.8	16.9	18.0	20.2	21.7	8.5	19.4	19.4	13.5	11.7	11.4	23.3	10.8	21.1	22.5	16.9	4.1	7.6	8.7	5.7	8.7	8.1	3.1	24.6	16.4	9.9	21.1	32.5	33.5	21.7	32.5	44.1	23.8	26.9	15.7	20.6	11.4	16.5	47.6	18.8	17.7	12.0	23.0	19.3	10.8	13.7	14.9	13.0	32.3	41.0	13.6	25.4	29.0	16.4	20.6	35.4	18.2	25.6	7.5	13.5	23.3	26.6	17.6	6.9	10.1	7.1	33.2	13.3	9.3	18.4	27.2	17.9	17.3	8.6	10.1	15.1	25.9	11.7	10.2	14.2	8.2	22.0	17.3	16.9	17.5	18.1	31.4	21.2	17.8	22.4	17.0	24.0	8.7	5.1	3.9	6.3	5.7	8.1	4.1	4.9	4.4	4.3	3.8	2.4	3.6	0.9	8.7	3.2	7.6	3.6	3.1	9.9	13.2	10.4	13.6	8.7	9.7	10.8	9.4	12.7	11.7	3.0	16.1	5.2	8.2	6.8	9.2	5.9	28.1	12.0	13.6	14.0	9.8	37.7	1.7	21.0	4.9	15.5	25.3	46.7	30.1	52.9	20.9	18.0	13.9	27.6	24.1	6.4	17.1	32.5	18.0	6.8	30.2	11.5	5.0	12.6	24.8	7.0	20.2	17.0	19.1	9.0	8.4	25.8	12.3	13.9	10.7	8.2	60.0	12.1	21.0	8.9
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783499-32787399	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.0;retina: 6.5;testis: 17.9"	"Cell type enhanced"	"Detected in some"	32	"Bipolar cells: 564.3;Early spermatids: 108.6;Late spermatids: 188.4"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 6.6;SH-SY5Y: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"			Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA052804: AB_2681957, HPA063207: AB_2732697"	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.1	0.0	1.8	0.4	1.5	0.0	0.1	0.1	0.9	1.9	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.1	0.0	0.9	0.9	1.5	0.0	0.0	0.1	0.0	1.7	0.2	0.7	0.0	0.0	0.1	0.0	0.6	0.1	0.0	6.5	0.1	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	17.9	0.0	0.0	3.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.1	0.8	0.9	1.5	1.7	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	564.3	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	108.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	188.4	2.6	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.7	0.0	21.9	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212180-37258155	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 20.1"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 13.1;Exocrine glandular cells: 13.9;Pancreatic endocrine cells: 14.4;Spermatocytes: 19.2;Urothelial cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HEL: 4.8;hTEC/SVTERT24-B: 3.4;HUVEC TERT2: 5.0;TIME: 13.1"					"Not detected"	"Not detected"			"HPA045432, HPA071187"			Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA045432: AB_2732519, HPA071187: AB_2732174"	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.3	2.7	0.4	0.4	1.4	1.3	0.3	0.4	1.1	0.3	0.3	1.6	0.0	0.4	0.2	1.1	1.4	0.4	0.7	0.4	0.3	0.4	0.9	0.5	0.5	0.1	0.9	1.0	1.1	3.1	0.6	2.3	0.2	1.0	0.4	0.3	1.1	1.5	0.1	1.0	0.5	0.4	0.5	1.6	0.2	0.2	20.1	0.9	0.0	0.5	0.0	0.3	0.4	0.3	0.1	0.4	0.2	0.0	0.0	0.6	0.1	0.1	0.0	0.3	0.0	0.2	1.3	0.0	0.4	2.8	1.0	3.7	0.7	0.5	0.1	0.2	0.0	1.5	0.5	0.3	0.3	1.1	0.1	0.2	4.8	0.0	0.1	0.3	0.0	2.8	0.5	0.7	3.4	0.2	1.2	5.0	0.4	1.3	0.0	0.5	0.0	0.1	0.4	0.2	0.0	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.2	0.6	0.0	0.1	13.1	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.0	1.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.1	0.4	1.4	0.4	1.1	0.3	0.4	0.9	1.0	1.0	0.9	0.0	1.1	0.0	8.5	2.3	0.4	0.2	0.0	2.7	2.3	1.8	0.0	0.7	3.3	13.1	12.1	2.1	1.2	0.0	13.9	0.4	2.4	6.4	5.7	0.0	0.8	3.2	1.7	0.0	0.0	11.8	0.6	1.4	1.7	0.0	0.2	6.0	14.4	0.0	0.0	1.0	0.5	0.0	0.8	19.2	0.8	2.6	0.9	0.0	0.4	14.2
TMEM218		ENSG00000150433	"Transmembrane protein 218"	A2RU14	11	125096545-125111763	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038489	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038489: AB_10672748"	"unprognostic (3.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.63e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.95e-2)"	"prognostic favorable (5.50e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.72e-2)"	24.2	19.0	14.0	13.2	15.7	7.0	13.5	11.9	12.4	14.7	12.3	16.8	12.3	12.5	17.5	16.3	12.8	20.8	16.5	10.4	14.1	9.3	13.1	13.6	11.9	13.7	13.6	10.0	17.8	19.7	12.8	17.4	8.8	10.5	17.4	9.4	18.0	15.0	11.1	9.7	8.8	12.4	14.7	11.7	17.5	13.3	7.8	11.3	10.0	13.0	12.0	12.4	14.2	13.6	18.0	28.7	18.5	25.2	19.1	14.0	15.4	7.6	15.1	9.6	11.6	8.9	12.4	5.8	7.7	5.9	6.0	7.8	1.5	22.8	9.7	19.4	4.7	9.2	9.0	6.0	7.3	8.0	13.5	8.6	21.7	4.1	6.1	8.8	6.8	8.1	9.7	9.8	10.6	12.7	9.7	8.7	12.1	8.7	12.4	10.3	3.9	1.7	14.3	7.8	21.1	14.4	10.0	11.6	7.4	5.3	7.7	8.3	12.5	10.5	4.2	5.4	5.9	20.0	9.8	11.1	7.3	6.7	8.6	8.3	7.2	6.0	8.0	5.9	14.2	12.9	18.5	25.2	10.1	14.0	18.8	12.2	18.0	13.3	13.2	28.7	13.7	11.5	13.5	9.6	19.1	17.4	24.9	11.7	15.4	14.0	15.7	11.9	12.4	14.1	9.3	13.6	10.0	10.5	11.3	17.9	12.0	16.9	15.8	10.8	6.9	7.7	10.2	20.1	6.8	14.0	0.0	24.0	23.2	17.4	1.1	15.8	5.2	0.0	14.1	15.6	17.7	11.9	3.5	13.9	37.3	22.3	10.4	17.2	20.5	1.1	9.5	19.0	16.9	21.6	10.0	21.8	12.4	0.0	15.6	16.2	12.2	25.8	16.5	14.6	10.2	12.4	8.1	13.6	13.3	15.2
TMEM221		ENSG00000188051	"Transmembrane protein 221"	A6NGB7	19	17435509-17448567	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 11.4"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 13.7;Muller glia cells: 51.3;Rod photoreceptor cells: 22.4"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.4;PC-3: 11.3;REH: 6.3"									"HPA041580, HPA062945"	Supported		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA041580: AB_10795700, HPA062945: "	"unprognostic (3.60e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.51e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-2)"	"unprognostic (9.14e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.47e-4)"	"unprognostic (2.37e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-1)"	1.0	6.1	5.4	0.7	2.9	0.5	1.6	1.3	7.0	0.9	0.8	1.1	0.0	0.4	1.2	3.1	0.9	6.2	1.5	1.2	6.0	2.1	0.7	0.4	0.7	0.6	1.2	2.5	11.4	5.4	10.2	2.5	0.5	3.3	3.8	0.4	6.5	3.3	4.6	0.6	1.2	0.6	0.6	3.1	0.5	0.6	2.4	1.8	0.0	1.4	1.1	0.4	0.9	3.3	0.0	1.6	0.0	0.1	0.0	0.7	0.1	0.8	2.5	1.0	7.4	0.0	0.0	0.2	0.3	0.0	0.1	0.4	0.1	0.2	0.2	1.5	0.0	0.6	0.3	2.2	0.1	0.0	0.1	1.9	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.7	0.0	0.5	0.1	0.1	0.0	0.1	0.2	0.3	1.6	0.6	11.3	6.3	0.2	0.0	0.5	0.5	0.1	0.3	0.0	0.0	0.1	0.7	0.3	0.3	0.1	0.1	0.2	0.3	0.1	0.5	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.1	5.4	2.9	1.3	7.0	6.0	2.1	1.2	2.5	3.3	1.8	0.0	0.3	0.0	0.1	0.0	0.9	0.3	2.5	0.0	0.0	0.0	13.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	1.6	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	51.3	0.1	0.0	1.1	0.0	22.4	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA016579: AB_2669392, HPA059374: AB_2683995"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	18.4	22.0	28.0	12.0	31.4	19.5	17.8	23.2	45.4	18.1	17.1	32.1	13.2	14.4	16.5	25.0	22.8	29.8	21.3	27.5	28.9	30.8	20.6	35.0	18.8	15.0	26.0	20.8	22.3	24.6	19.9	22.4	20.0	26.7	22.9	14.3	26.4	21.7	25.2	19.9	15.6	21.3	18.6	21.5	15.2	16.7	20.7	16.4	19.4	24.0	14.9	19.1	17.8	13.3	22.8	19.9	36.5	21.0	19.2	23.2	15.7	12.2	14.9	12.5	20.5	19.6	14.2	10.1	19.0	21.9	26.0	22.2	6.1	25.8	7.8	14.9	20.2	12.1	17.0	13.7	18.5	10.9	10.3	26.3	13.0	12.4	14.0	29.1	12.9	13.0	24.8	10.5	24.9	14.2	12.0	17.3	15.6	9.8	18.1	16.2	10.9	18.5	13.6	23.5	12.7	18.7	15.4	8.7	15.7	25.2	7.2	27.0	23.8	14.7	20.8	18.3	4.7	20.5	20.9	15.8	15.4	13.0	24.7	17.9	19.5	17.3	8.1	23.3	25.1	22.1	19.3	13.7	17.0	22.3	20.3	17.0	22.8	20.7	17.0	12.0	18.9	20.9	21.4	36.5	19.2	21.0	19.9	23.2	15.7	28.0	31.4	23.2	45.4	28.9	30.8	26.0	20.8	26.7	16.4	8.9	15.7	15.7	11.9	10.4	39.6	7.7	10.2	5.3	5.7	12.2	13.7	26.0	33.2	33.2	19.8	15.4	22.2	23.3	35.0	28.5	23.5	15.6	16.2	11.3	24.4	41.3	28.7	9.2	9.1	60.6	18.7	11.4	25.3	29.7	17.4	52.7	36.4	17.5	18.7	17.0	17.1	12.9	14.6	18.9	17.7	11.8	25.7	22.3	19.1	10.1
TMEM223	MGC3196	ENSG00000168569	"Transmembrane protein 223"	A0PJW6	11	62771629-62792021	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA			"Nucleoplasm, Nuclear membrane, Mitochondria"		"HPA014504: AB_1853881"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.75e-2)"	10.9	20.6	12.8	13.4	19.5	8.7	11.6	11.1	25.5	11.7	15.2	13.4	12.0	16.6	12.7	15.5	12.3	11.9	11.8	21.7	12.6	12.8	19.5	20.4	10.5	16.2	12.4	15.6	12.5	38.7	10.4	13.0	10.9	13.2	14.8	11.6	13.9	22.4	15.0	21.3	16.2	18.2	8.4	11.1	16.1	16.2	8.2	11.6	19.0	13.4	10.6	14.2	11.1	10.2	32.4	28.0	8.9	16.6	23.1	30.7	15.3	15.3	13.2	7.9	10.8	6.3	7.3	10.8	8.3	7.3	9.4	7.9	11.5	18.9	11.6	20.5	5.9	12.4	23.5	9.5	10.2	5.4	18.3	17.8	8.6	14.8	13.7	11.7	10.5	10.2	7.8	10.4	6.2	7.8	11.1	7.2	15.4	13.0	8.7	6.9	22.4	10.5	23.4	15.6	16.1	16.0	13.1	9.6	25.8	14.5	9.8	13.5	17.9	8.7	17.7	21.9	8.4	26.4	9.9	7.5	11.3	13.6	10.3	9.8	17.9	14.2	13.2	13.4	9.5	11.7	7.3	16.1	8.9	28.4	16.6	27.2	28.2	28.1	27.6	17.5	32.4	30.7	29.8	7.5	23.1	10.5	28.0	23.9	15.3	12.8	19.5	11.1	25.5	12.6	12.8	12.4	15.6	13.2	11.6	11.9	3.5	22.6	13.7	11.9	18.5	16.8	40.8	36.1	13.6	19.2	11.8	41.9	53.0	32.8	1.9	17.5	26.1	0.0	38.3	35.7	20.6	16.0	19.6	34.8	32.6	6.4	19.8	31.3	19.6	2.6	30.2	16.6	18.6	16.2	29.2	14.8	31.4	14.0	24.8	47.6	17.3	19.4	9.6	6.3	21.2	12.2	11.9	29.9	38.6	14.5
TMEM229A		ENSG00000234224	"Transmembrane protein 229A"	B2RXF0	7	124030916-124033023	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;intestine: 16.4;testis: 10.6"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 3.3;Cytotrophoblasts: 1.9;Muller glia cells: 1.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"SH-SY5Y: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056391	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA056391: AB_2683114"					"unprognostic (2.52e-2)"			"unprognostic (3.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.21e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.31e-1)"		"unprognostic (4.31e-3)"	0.4	1.5	6.9	0.5	7.6	0.4	0.4	1.3	9.0	0.8	0.5	7.6	0.0	16.4	0.7	1.2	0.4	1.7	0.6	0.9	8.0	4.6	0.5	0.4	0.5	0.4	10.6	4.9	1.0	0.4	2.5	1.0	0.6	5.6	0.8	0.6	0.6	0.7	0.5	0.4	0.4	7.7	0.7	7.3	0.6	3.7	10.6	8.7	0.0	0.5	0.0	0.4	1.1	0.1	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	6.9	7.6	1.3	6.1	8.0	4.6	10.6	4.9	5.6	8.7	0.0	0.0	0.0	0.0	0.0	3.3	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1
TMEM231	"ALYE870, FLJ22167, JBTS20, MKS11, PRO1886"	ENSG00000205084	"Transmembrane protein 231"	Q9H6L2	16	75536744-75556286	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 58.4"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 119.1;Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 33.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA042081	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA042081: AB_10795391"	"unprognostic (4.29e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-1)"	3.7	5.3	7.9	2.8	14.7	2.5	4.1	5.0	12.4	7.1	4.1	16.6	3.6	4.0	6.4	10.1	3.1	58.4	4.8	7.9	9.1	9.9	4.7	2.5	7.3	2.7	6.5	9.9	14.3	4.7	6.6	7.7	3.6	14.3	5.4	3.5	6.6	3.1	5.6	1.9	3.3	4.2	7.7	6.2	2.7	3.2	8.5	6.6	0.2	8.0	1.0	2.2	3.5	3.0	5.0	3.2	6.2	0.9	1.0	3.5	1.3	3.9	2.4	6.3	10.5	6.1	15.1	3.5	4.3	5.6	5.4	6.6	1.5	6.3	4.3	6.1	6.2	4.6	9.5	0.7	5.0	3.3	0.8	2.6	0.2	3.2	1.4	5.4	2.4	1.9	3.3	6.2	5.5	13.4	9.8	3.8	4.1	4.2	0.2	1.6	10.1	1.5	4.7	3.8	0.6	2.2	0.8	0.9	9.6	7.0	1.4	5.3	3.5	8.7	2.2	4.0	2.2	2.0	2.7	5.6	4.2	3.6	2.7	2.3	8.2	7.2	1.3	10.6	1.2	4.2	3.0	0.9	0.6	1.7	0.9	3.5	5.0	1.8	2.9	2.5	2.4	1.6	2.4	6.2	1.0	0.5	3.2	0.5	1.3	7.9	14.7	5.0	12.4	9.1	9.9	6.5	9.9	14.3	6.6	3.0	4.6	0.0	4.2	0.9	15.3	4.0	0.0	119.1	19.4	7.0	49.1	1.0	0.0	2.5	14.1	4.9	4.6	0.0	2.0	0.9	3.1	3.9	1.1	1.1	0.8	12.7	2.9	3.7	0.8	3.3	1.7	1.8	0.0	4.6	5.9	6.0	1.5	4.5	3.5	1.4	33.5	0.0	3.7	10.8	9.0	0.9	0.2	1.0	5.0	2.2
TMEM233	IFITMD2	ENSG00000224982	"Transmembrane protein 233"	B4DJY2	12	119593459-119643066	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 88.0"	"Cell type enriched"	"Detected in some"	4	"granulocytes: 76.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 12.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.5;hTERT-RPE1: 4.7;RH-30: 6.1;U-2197: 9.2;U-87 MG: 37.0"	"Not detected"	"Not detected"							"HPA047506, HPA075435"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047506: AB_10963068, HPA075435: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.66e-1)"	0.6	0.3	0.8	0.0	0.4	0.0	0.6	0.1	8.8	0.2	0.2	0.0	0.0	0.1	0.9	0.6	0.2	0.2	1.0	0.7	0.2	0.5	0.5	0.3	0.6	0.2	0.1	1.4	0.6	0.1	1.7	0.4	0.0	0.4	0.4	0.1	0.7	0.5	0.3	88.0	0.1	0.2	0.5	0.3	0.2	0.2	0.2	0.0	0.1	11.1	5.2	0.3	0.4	1.8	0.3	0.3	0.7	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	11.5	0.0	4.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.3	0.2	0.5	0.7	0.6	0.1	0.3	0.1	0.1	0.8	0.4	0.1	1.5	0.2	0.5	0.1	1.4	0.4	0.0	3.0	1.4	0.0	0.3	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	7.2	6.8	0.0	0.0	7.8	0.0	0.4	0.3	76.3	0.0	0.1	7.9	0.0	18.4	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.1	0.0	0.2	2.3	0.2	0.1	0.1	0.0	0.0	0.2
TMEM234	"C1orf91, dJ622L5.7, FLJ90779, RP4-622L5"	ENSG00000160055	"Transmembrane protein 234"	Q8WY98	1	32214472-32222359	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015049	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA015049: AB_1856409"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.37e-2)"	7.9	9.2	7.0	9.5	9.2	5.7	8.6	9.5	12.2	9.4	9.4	9.9	21.9	5.0	9.6	22.2	10.4	11.8	12.3	11.0	7.4	8.4	11.5	7.3	9.8	9.9	6.0	7.6	12.6	10.8	14.5	14.9	12.5	6.6	10.2	9.3	14.8	8.8	25.0	6.3	5.3	7.4	9.6	5.8	9.0	9.4	15.9	4.7	8.6	15.3	4.0	9.4	6.8	9.0	5.2	7.5	23.2	8.3	7.0	6.4	4.1	8.2	6.8	3.6	3.9	10.5	8.3	4.0	12.2	9.0	6.3	4.8	4.5	8.8	2.5	14.2	11.6	4.9	6.9	4.6	9.0	5.6	5.3	5.4	5.2	10.0	5.1	8.0	6.1	3.5	10.7	9.6	6.8	5.0	11.7	9.3	2.7	4.7	1.8	11.0	2.4	2.4	4.9	6.9	2.1	5.0	3.3	2.9	2.9	14.3	4.0	4.7	4.8	9.2	5.2	4.0	12.3	2.4	2.0	11.0	2.4	3.8	9.1	8.7	3.1	1.5	1.2	7.2	2.3	8.4	11.7	8.0	11.9	4.1	8.3	6.4	4.5	3.3	4.4	7.5	5.2	2.4	3.0	23.2	7.0	5.9	5.6	1.9	4.1	7.0	9.2	9.5	12.2	7.4	8.4	6.0	7.6	6.6	4.7	8.9	1.0	5.8	6.2	2.4	5.6	2.8	2.5	22.7	6.8	22.7	2.0	22.7	1.7	18.9	18.4	7.7	12.9	0.0	13.5	19.1	7.5	6.4	3.5	5.8	16.7	1.6	5.8	9.2	7.5	41.2	8.6	6.3	13.5	15.4	10.8	8.0	15.1	11.5	7.4	9.8	11.5	6.5	6.9	26.5	15.3	2.8	17.8	5.7	8.4	5.8
TMEM241	"C18orf45, FLJ44259, MGC11386"	ENSG00000134490	"Transmembrane protein 241"	Q24JQ0	18	23197144-23437961	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029489, HPA059922"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA029489: AB_2673067, HPA059922: AB_2684164"	"unprognostic (1.44e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.15e-4)"	"unprognostic (7.07e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-3)"	"unprognostic (9.53e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.93e-1)"	"prognostic unfavorable (5.80e-4)"	5.8	3.6	6.4	4.3	11.3	2.6	6.3	2.0	11.9	6.0	4.3	4.2	2.2	4.1	5.7	5.0	5.2	4.6	4.5	4.0	3.9	4.0	3.1	5.4	4.3	3.6	3.1	5.2	4.9	6.5	7.0	6.5	6.1	5.2	2.7	6.3	3.5	4.8	2.6	3.4	3.9	2.9	7.6	3.5	4.1	3.7	2.1	2.6	1.9	6.8	4.9	5.1	5.4	4.7	3.0	2.3	1.3	3.1	8.4	2.2	1.4	3.1	6.2	1.2	4.1	6.5	5.8	3.7	1.5	1.9	1.5	3.5	1.2	7.4	11.9	3.4	2.9	6.8	6.0	3.2	5.5	5.2	1.4	0.4	2.5	4.5	2.6	3.6	2.6	2.0	6.6	6.1	6.2	7.4	4.0	6.7	5.4	5.2	4.2	5.4	3.4	2.7	0.5	1.4	10.6	1.2	2.0	5.6	11.4	2.6	2.3	4.4	4.2	7.3	3.9	4.7	5.5	4.1	1.2	2.5	10.6	2.5	3.7	4.2	8.4	6.4	5.0	3.4	8.0	6.7	1.3	0.7	0.0	1.3	3.1	2.2	1.8	0.2	1.2	2.3	3.0	1.1	1.9	0.0	8.4	1.2	0.7	1.5	1.4	6.4	11.3	2.0	11.9	3.9	4.0	3.1	5.2	5.2	2.6	0.0	5.8	0.0	2.4	2.5	1.0	1.4	0.0	9.4	5.7	3.5	3.9	6.8	0.0	2.0	0.0	1.6	2.0	0.0	1.9	8.0	2.7	3.0	2.3	3.4	2.8	9.5	1.2	3.7	0.3	0.0	1.7	2.1	1.7	0.0	2.9	1.0	2.5	2.5	1.1	3.0	1.1	0.0	2.2	0.5	5.3	3.9	3.9	1.5	2.3	2.6
TMEM245	"C9orf5, CG-2"	ENSG00000106771	"Transmembrane protein 245"	Q9H330	9	109015152-109119945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023892	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023892: AB_1845828"	"unprognostic (1.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.46e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-2)"	16.5	35.5	14.4	7.2	18.1	4.0	24.2	15.7	20.6	14.0	19.2	14.7	22.0	7.7	18.4	17.3	14.6	18.7	15.3	25.2	12.6	14.9	29.0	16.2	20.5	12.3	14.5	14.8	29.0	20.3	43.2	14.9	17.5	13.7	16.4	10.7	22.1	14.5	22.3	29.8	9.2	16.8	23.1	13.6	10.4	17.2	12.2	14.3	12.3	52.1	8.9	7.5	20.8	11.2	3.5	3.5	6.3	3.3	5.4	9.0	2.7	13.7	18.4	13.6	4.6	32.0	18.4	30.0	19.9	15.4	21.5	17.0	24.6	27.7	12.5	20.4	15.1	20.9	21.8	17.2	12.8	25.5	16.1	7.4	15.4	15.4	14.5	14.0	11.7	12.2	19.6	13.1	20.9	19.4	23.2	17.9	13.8	10.3	13.8	24.4	9.1	15.5	5.4	15.1	18.6	16.6	8.9	27.0	7.7	22.9	13.5	7.5	7.4	13.1	13.2	13.1	21.1	17.5	6.6	19.6	16.8	12.6	15.6	22.6	9.2	23.8	4.0	23.3	6.3	24.3	6.3	2.6	2.2	4.0	1.8	4.9	2.7	6.8	5.6	2.5	3.5	9.0	6.2	1.0	5.4	3.3	3.5	6.5	2.7	14.4	18.1	15.7	20.6	12.6	14.9	14.5	14.8	13.7	14.3	107.2	79.6	16.9	16.5	22.3	43.1	117.8	63.7	32.1	31.8	82.0	100.1	40.7	3.3	19.7	5.9	48.2	31.1	93.5	27.0	14.5	19.9	23.7	30.1	82.0	15.7	60.4	30.0	48.5	21.0	5.4	38.0	15.7	21.9	10.0	34.9	49.9	24.5	34.3	48.1	28.4	30.3	45.3	36.0	28.7	40.4	24.8	12.6	17.3	34.3	19.9
TMEM246	"C9orf125, MGC12992"	ENSG00000165152	"Transmembrane protein 246"	Q9BRR3	9	101473171-101533537	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 14.4;hTERT-RPE1: 16.4;OE19: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011318, HPA054041"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA011318: AB_2668482, HPA054041: AB_2682353"	"unprognostic (2.58e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.52e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.16e-2)"	3.4	10.2	10.8	3.1	19.4	0.8	2.9	23.2	31.1	17.1	12.6	7.6	1.6	8.0	5.9	4.0	11.0	13.5	7.0	27.3	17.6	20.6	4.6	2.6	5.4	0.8	10.8	14.3	19.4	10.9	19.6	9.2	1.0	23.2	7.0	10.8	8.1	4.6	9.7	4.3	11.2	7.1	6.7	8.5	1.8	15.1	2.9	4.0	0.0	4.3	4.4	2.9	4.7	8.3	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	8.1	6.3	0.0	0.2	0.1	0.0	5.4	7.9	3.9	7.9	0.4	4.3	0.0	1.8	9.8	0.4	12.8	0.0	8.9	2.4	0.0	3.2	4.4	6.1	0.0	0.3	0.0	0.0	3.5	14.4	0.0	2.1	16.4	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	7.8	26.2	0.0	0.0	3.2	0.0	5.9	1.5	10.7	10.1	3.0	0.0	0.0	1.6	0.0	7.5	0.0	6.1	3.8	0.0	0.0	0.5	0.0	0.0	8.7	0.0	2.7	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	10.8	19.4	23.2	31.1	17.6	20.6	10.8	14.3	23.2	4.0	20.8	0.3	0.0	13.2	4.7	38.3	42.4	33.1	9.4	10.3	15.7	3.9	0.0	0.0	12.9	2.2	5.9	16.1	0.0	15.0	0.1	1.5	11.6	0.0	6.2	0.0	15.9	23.6	1.3	0.3	0.8	4.9	0.0	0.0	1.0	35.3	1.4	12.8	38.6	10.6	4.2	4.4	12.9	5.2	2.3	1.0	8.7	0.0	0.0	26.7	23.0
TMEM248	"C7orf42, FLJ10099, FLJ13090"	ENSG00000106609	"Transmembrane protein 248"	Q9NWD8	7	66921225-66958551	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016495	Uncertain		Approved	Vesicles		NA	NA		1200000	Vesicles		"HPA016495: AB_1848643"	"unprognostic (6.74e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (6.67e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.57e-2)"	32.2	33.0	23.8	30.2	30.6	11.9	44.6	28.0	28.4	38.7	32.8	23.8	39.0	32.1	40.6	32.9	26.0	36.1	40.7	28.2	24.6	30.4	30.9	46.3	31.6	38.3	20.9	21.3	40.8	58.4	47.2	28.9	35.6	21.0	34.7	32.4	39.4	36.9	36.8	19.1	23.7	44.8	34.7	23.8	32.6	33.7	33.3	20.6	40.1	37.7	24.0	35.9	33.2	40.7	10.7	10.1	8.6	5.2	9.0	9.3	2.3	18.2	21.5	18.2	25.9	41.5	32.0	16.0	22.5	38.8	21.5	23.3	15.5	24.0	18.6	27.5	30.3	29.4	16.6	15.6	18.6	26.8	17.0	11.5	13.6	15.4	17.9	26.9	22.5	18.9	28.7	21.6	18.0	15.0	31.4	27.9	14.6	25.9	12.5	34.0	11.1	21.1	27.8	27.0	18.9	14.7	15.5	21.2	31.4	29.1	14.1	12.7	27.2	19.8	36.5	19.9	28.4	18.3	20.8	25.7	30.3	14.9	19.7	24.6	15.4	17.3	20.9	25.3	25.2	28.7	2.3	5.0	8.6	7.9	5.2	9.3	9.6	8.5	8.1	3.9	10.7	8.4	8.8	7.4	9.0	3.1	10.1	5.6	2.3	23.8	30.6	28.0	28.4	24.6	30.4	20.9	21.3	21.0	20.6	47.6	36.0	52.8	43.6	57.4	17.6	20.0	56.0	26.8	22.7	50.6	5.9	43.1	10.0	31.7	90.3	43.5	63.0	23.3	40.8	69.9	58.2	82.8	27.7	96.6	46.4	17.5	26.6	55.9	54.2	141.2	59.0	47.5	47.2	24.4	75.1	91.8	47.7	67.4	61.9	30.6	12.3	32.3	48.4	79.2	60.9	64.5	73.7	59.8	53.0	69.4
TMEM25	FLJ14399	ENSG00000149582	"Transmembrane protein 25"	Q86YD3	11	118531041-118547280	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 20.3;SK-BR-3: 19.0;T-47d: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012163, HPA051562"	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		4900000	"Golgi apparatus, Vesicles"		"HPA012163: AB_1858112, HPA051562: AB_2681535"	"unprognostic (1.53e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.15e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.01e-2)"	4.8	15.0	15.0	3.7	23.3	1.7	12.0	28.0	36.5	9.4	19.4	9.5	6.7	35.5	10.1	21.2	9.0	9.2	7.1	6.4	11.9	17.0	14.7	10.6	8.0	3.5	10.7	19.5	19.4	14.1	17.3	15.9	4.9	14.0	12.5	3.2	14.4	16.1	15.5	12.7	6.2	26.2	8.7	9.7	4.0	6.7	3.9	5.1	1.5	12.7	4.3	4.6	8.3	6.1	3.8	3.4	0.5	0.2	6.6	11.1	3.8	1.8	0.4	3.3	5.3	3.4	0.5	3.2	2.9	5.5	2.7	5.6	14.7	10.4	0.1	11.4	2.8	6.2	8.2	0.0	10.0	2.4	6.3	6.1	0.2	2.9	3.4	9.0	0.1	0.2	4.2	6.1	3.0	0.5	20.3	3.9	7.5	1.3	6.5	2.7	2.2	3.1	0.2	2.7	0.0	7.1	4.3	2.3	6.5	14.1	0.2	9.8	6.5	2.8	19.0	0.0	5.1	24.7	0.3	1.3	1.2	6.1	0.2	0.8	6.6	4.3	1.6	0.2	0.1	0.1	0.5	0.2	0.2	5.6	0.2	7.5	3.8	7.9	3.1	0.5	3.0	11.1	5.8	0.4	6.6	0.2	3.4	6.1	3.8	15.0	23.3	28.0	36.5	11.9	17.0	10.7	19.5	14.0	5.1	6.0	3.8	3.4	10.2	5.0	24.2	5.0	2.5	10.7	7.9	15.7	27.5	30.1	10.0	14.8	1.7	4.9	1.4	0.0	5.8	13.6	6.0	5.5	9.2	7.7	2.5	11.1	10.9	2.5	0.0	3.8	21.6	0.2	6.8	5.4	3.2	24.3	5.9	1.4	21.9	20.2	34.1	0.0	6.1	4.1	5.1	3.1	13.6	4.1	2.9	2.7
TMEM251	"C14orf109, DKFZP564F1123"	ENSG00000153485	"Transmembrane protein 251"	Q8N6I4	14	93184951-93187089	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 96.2;Hofbauer cells: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048559	Uncertain		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Cell Junctions"	"Golgi apparatus"	"HPA048559: AB_2680441"	"unprognostic (1.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.99e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.17e-2)"	15.8	19.5	12.2	10.7	14.3	3.9	23.1	11.5	14.2	21.9	19.6	11.4	19.6	15.5	13.0	26.2	10.8	15.8	11.5	23.2	12.2	12.8	25.0	14.4	24.1	19.1	19.0	11.1	12.4	23.6	16.4	17.2	12.5	15.8	26.1	19.5	18.3	18.7	18.5	22.6	10.4	17.9	11.5	17.3	13.3	16.5	8.7	15.1	14.2	19.4	11.0	11.7	13.3	11.8	6.0	8.7	13.7	12.7	5.4	6.6	4.4	7.1	7.5	10.1	10.7	11.8	4.6	6.8	4.9	5.8	8.6	11.2	5.3	7.4	8.1	10.1	4.7	11.4	9.5	11.0	8.1	11.8	7.3	8.6	6.9	5.6	10.6	11.2	9.5	11.0	6.1	9.3	6.9	11.1	4.5	8.7	9.0	5.6	7.9	6.9	33.9	6.9	7.8	5.9	18.1	8.1	4.1	10.2	7.1	10.7	14.3	9.8	9.2	7.5	4.1	29.1	9.0	11.3	7.0	3.8	4.3	7.0	9.1	6.3	10.5	12.6	8.2	8.1	4.0	6.5	4.8	10.8	13.7	4.7	9.7	3.1	5.3	5.5	5.3	8.7	6.0	6.1	6.6	10.7	5.4	12.7	7.6	4.4	4.4	12.2	14.3	11.5	14.2	12.2	12.8	19.0	11.1	15.8	15.1	3.0	11.8	14.9	29.1	20.6	14.3	17.3	22.9	10.7	9.1	29.6	25.5	33.6	96.2	24.2	1.6	10.0	23.3	0.0	23.1	15.7	13.9	37.4	17.3	14.7	100.3	12.7	14.5	8.0	21.1	1.5	10.9	26.7	30.4	10.0	33.3	20.5	15.7	17.5	10.3	58.4	25.2	38.8	15.6	3.3	14.3	27.1	22.9	10.7	30.8	29.7
TMEM254	"bA369J21.6, C10orf57, FLJ13263"	ENSG00000133678	"Transmembrane protein 254"	Q8TBM7	10	80078646-80092557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA029105, HPA072613"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA029105: AB_2672909, HPA072613: AB_2732205"	"unprognostic (9.40e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.39e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.96e-2)"	8.4	13.4	10.8	6.0	14.1	4.7	15.9	6.9	13.5	14.1	13.1	11.7	14.7	10.1	12.4	40.1	35.8	17.3	10.5	4.8	9.4	6.3	10.0	30.8	6.8	9.0	7.7	9.0	8.7	12.1	8.3	10.1	14.8	9.5	25.8	13.7	10.7	16.3	9.1	3.0	43.9	13.4	6.6	8.2	6.9	9.0	21.5	8.8	8.6	11.8	12.4	15.4	13.0	20.5	12.6	14.7	27.7	18.1	9.8	22.9	11.9	7.3	7.0	11.9	9.1	14.6	18.3	18.1	7.1	5.2	5.2	5.3	5.3	22.7	5.6	12.1	9.0	4.9	7.8	4.8	5.9	5.5	9.2	8.5	1.5	2.3	7.4	6.6	6.9	7.5	11.8	26.9	4.6	4.0	11.3	4.6	4.8	4.1	12.2	5.2	14.9	5.6	5.1	6.4	6.4	23.0	6.9	1.4	4.8	7.2	6.1	4.2	6.9	6.6	16.5	7.1	8.3	23.4	4.6	6.7	4.1	7.1	6.9	4.0	8.4	11.9	0.4	10.3	7.1	3.4	27.7	16.2	7.4	11.9	18.1	14.9	12.6	13.8	12.3	13.2	9.6	22.9	15.6	1.7	9.8	17.6	14.7	16.0	11.9	10.8	14.1	6.9	13.5	9.4	6.3	7.7	9.0	9.5	8.8	8.9	8.1	6.0	5.0	7.2	7.4	2.6	15.3	37.5	14.8	8.7	15.7	33.9	18.3	12.1	3.1	5.2	10.5	0.0	7.5	30.9	5.3	21.9	5.7	28.8	17.1	15.9	8.1	5.5	11.1	5.9	8.6	9.2	3.3	16.2	22.8	14.5	9.5	18.2	11.0	17.0	11.1	12.9	3.8	24.2	8.7	21.0	19.0	6.9	18.7	6.5
TMEM255B	"FAM70B, MGC20579"	ENSG00000184497	"Transmembrane protein 255B"	Q8WV15	13	113759240-113816995	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Endothelial cells: 51.3;granulocytes: 39.2;Ito cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in many"	7	"granulocytes: 17.0;monocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.7;HUVEC TERT2: 20.4;PC-3: 20.7;RPMI-8226: 13.2;TIME: 19.1;U-87 MG: 21.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043334	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043334: AB_10795982"	"unprognostic (2.20e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (4.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.83e-1)"	18.5	6.6	3.9	7.1	4.5	1.5	11.8	2.0	4.7	11.1	3.9	2.3	4.3	3.5	10.1	5.3	3.9	6.6	7.5	7.3	6.5	3.7	9.0	6.6	11.7	7.9	5.4	2.1	4.6	4.7	3.1	8.0	2.4	6.1	8.8	3.2	3.3	3.8	5.1	4.6	6.0	4.5	10.4	4.9	9.5	4.4	4.6	4.0	0.1	12.4	2.4	3.7	8.1	29.9	1.5	1.3	17.0	4.8	0.0	0.0	1.0	5.3	0.0	0.3	0.0	1.5	0.0	0.0	2.5	5.7	2.9	1.8	0.2	0.1	0.1	0.0	3.9	6.8	0.8	0.5	0.3	1.2	0.0	0.6	0.1	0.2	0.0	0.9	1.4	15.7	1.1	1.3	6.3	2.4	8.4	20.4	0.3	0.0	0.1	6.3	0.1	0.7	0.4	0.6	0.8	20.7	0.9	0.4	13.2	2.9	0.2	1.2	2.8	0.1	0.7	0.0	0.6	0.3	4.2	19.1	0.8	5.8	0.3	0.9	0.0	0.0	1.0	21.8	1.4	0.1	17.0	4.8	0.6	0.0	4.5	0.0	0.8	0.0	0.0	1.3	1.5	0.0	0.0	2.2	0.0	3.2	0.0	0.0	1.0	3.9	4.5	2.0	4.7	6.5	3.7	5.4	2.1	6.1	4.0	6.0	7.4	0.5	1.1	5.3	0.7	6.7	0.0	0.0	0.0	1.8	0.0	0.0	1.7	8.3	0.6	51.3	0.0	23.3	1.5	0.1	3.7	1.3	39.2	0.4	11.0	0.0	1.2	111.1	17.8	0.4	7.2	14.4	8.5	4.6	0.0	0.5	1.5	0.0	2.8	0.0	0.7	6.5	4.1	1.4	17.0	4.1	0.0	0.0	0.4	0.6
TMEM256	"C17orf61, MGC40107"	ENSG00000205544	"Transmembrane protein 256"	Q8N2U0	17	7402975-7404137	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 456.8;Proximal tubular cells: 475.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA062732			Approved	Vesicles		NA	NA			Vesicles		"HPA062732: AB_2684852"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.69e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-2)"	28.7	23.5	23.4	20.7	31.8	19.8	48.2	15.0	32.9	18.7	40.7	12.1	32.8	48.6	18.7	30.7	19.9	22.1	26.1	54.0	20.2	15.8	32.6	54.8	25.3	54.0	25.0	20.1	21.8	73.8	13.0	12.9	9.4	28.4	22.4	16.2	16.8	38.5	39.7	26.3	16.1	42.4	23.6	37.5	18.9	23.0	7.4	16.3	11.1	16.7	24.4	17.1	20.5	18.0	28.2	30.2	5.0	23.5	13.8	19.5	27.3	22.1	28.9	15.5	21.6	26.5	33.2	14.7	10.2	14.2	16.2	15.3	11.5	12.6	19.2	18.8	10.0	13.4	18.9	9.7	30.3	11.6	10.1	32.6	12.2	11.0	29.7	18.3	4.2	16.8	29.3	14.3	21.3	17.7	22.4	23.4	21.2	9.1	13.2	20.5	11.4	14.2	13.8	7.2	9.5	19.2	22.8	14.1	22.1	38.9	9.2	1.8	13.1	15.9	12.4	16.7	16.2	22.5	7.8	14.5	7.8	14.9	15.8	13.0	11.2	13.7	9.7	20.6	5.7	14.9	3.8	23.5	5.0	14.0	16.9	17.1	28.2	16.8	16.1	21.7	26.3	19.5	17.9	1.4	13.8	12.2	30.2	16.5	27.3	23.4	31.8	15.0	32.9	20.2	15.8	25.0	20.1	28.4	16.3	41.7	45.6	142.1	74.5	77.6	24.2	55.1	117.2	103.1	53.4	125.6	7.9	74.7	252.0	108.1	4.3	65.3	317.0	46.7	166.5	182.0	82.7	95.4	66.9	456.8	174.6	19.1	120.3	103.7	156.8	4.0	127.1	107.5	136.7	150.5	165.7	71.2	171.2	198.6	66.8	475.2	32.2	58.2	87.2	6.6	42.6	117.1	39.0	86.3	181.5	71.4
TMEM258	C11orf10	ENSG00000134825	"Transmembrane protein 258"	P61165	11	61768501-61792802	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044602	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA044602: AB_10961423"	"unprognostic (6.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (1.34e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.58e-1)"	15.3	23.1	18.9	16.5	22.5	23.9	31.0	16.2	25.2	28.2	21.6	19.7	34.6	17.7	21.2	81.8	18.1	26.7	22.4	36.6	19.5	15.8	19.0	32.0	33.2	35.9	24.7	19.0	32.2	117.2	6.8	29.1	19.8	18.8	20.0	24.5	13.3	54.0	31.0	22.2	14.0	16.1	18.4	20.1	19.7	21.2	19.9	19.4	17.3	25.3	24.8	22.9	15.7	19.1	53.3	107.7	87.4	51.7	31.0	51.4	50.2	24.4	42.4	36.9	29.3	57.5	56.0	20.5	19.7	32.3	19.5	22.7	36.5	44.2	17.4	37.4	46.2	38.2	26.5	32.0	37.8	25.8	25.5	28.5	14.6	46.5	56.1	54.3	30.5	17.0	47.4	58.3	24.1	63.6	49.7	36.0	39.7	36.0	66.9	31.7	81.3	21.4	53.3	45.9	57.0	29.1	24.0	24.8	111.2	40.5	40.2	29.1	30.6	17.6	37.5	34.6	35.1	41.6	61.1	17.8	22.4	20.2	28.7	14.0	43.6	34.3	28.7	31.6	18.7	23.2	87.4	51.7	59.1	40.6	43.7	49.7	53.3	48.3	45.1	42.6	42.3	41.6	41.1	39.8	31.0	42.2	107.7	51.4	50.2	18.9	22.5	16.2	25.2	19.5	15.8	24.7	19.0	18.8	19.4	95.3	210.6	191.2	192.8	203.3	34.4	466.4	425.4	301.2	234.3	301.8	17.7	370.2	250.4	433.9	186.9	238.5	290.8	23.3	568.5	499.5	345.7	260.4	219.6	452.5	405.4	35.0	298.8	324.7	368.7	111.6	310.7	338.3	539.9	431.0	448.2	326.7	464.8	390.9	201.5	405.8	52.5	168.1	247.3	313.1	426.1	243.9	424.8	226.6	405.7	222.4
TMEM259	"ASBABP1, C19orf6, MBRL, MGC4022"	ENSG00000182087	"Transmembrane protein 259"	Q4ZIN3	19	1009648-1021179	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042669, HPA054801"	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear speckles"	"HPA042669: AB_10794916, HPA054801: AB_2682604"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.12e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (8.92e-6)"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.10e-3)"	39.5	39.2	35.7	42.3	39.2	46.4	36.9	54.8	44.3	35.4	41.0	46.1	33.9	43.7	39.6	27.4	37.0	34.8	38.6	43.9	34.8	26.1	37.1	59.2	40.5	44.6	44.1	30.0	38.4	59.0	43.5	55.7	47.9	40.1	41.1	23.3	47.8	49.0	36.2	39.3	62.3	42.9	30.1	27.5	61.8	48.5	36.0	40.2	38.0	47.6	24.9	45.4	37.9	37.0	3.8	6.7	2.5	5.2	2.5	5.5	3.0	36.1	23.3	16.2	18.4	20.0	19.4	28.6	30.8	26.8	25.5	27.5	21.4	20.4	25.1	30.3	23.2	12.0	41.4	16.3	30.2	11.3	32.0	27.5	14.7	28.8	23.5	35.5	28.2	37.4	25.9	30.9	20.4	25.6	24.3	22.1	25.6	24.8	50.8	16.9	15.8	30.9	25.9	24.0	18.4	19.2	35.2	12.3	31.7	20.1	34.1	22.5	23.6	19.5	24.8	21.1	13.7	24.3	36.7	25.6	25.5	14.6	35.6	32.0	72.1	27.0	27.8	30.0	23.2	25.2	0.9	3.9	2.2	5.5	3.5	4.1	3.8	3.2	5.5	6.0	3.4	3.5	3.9	2.5	2.5	5.2	6.7	3.2	3.0	35.7	39.2	54.8	44.3	34.8	26.1	44.1	30.0	40.1	40.2	29.8	50.0	37.4	47.9	55.4	118.9	11.8	33.1	5.3	18.2	62.8	92.3	47.3	10.0	22.9	16.0	38.2	90.7	0.0	29.5	40.4	37.6	50.4	15.0	43.3	44.1	98.5	38.6	31.3	21.9	8.9	39.4	40.7	42.2	27.9	67.4	75.8	34.5	56.2	32.2	18.2	165.0	32.3	46.0	45.3	38.1	56.8	68.9	41.5	49.9	59.1
TMEM260	"C14orf101, FLJ20392"	ENSG00000070269	"Transmembrane protein 260"	Q9NX78	14	56488354-56650606	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 61.0"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003502	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA003502: AB_1078314"	"unprognostic (4.63e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (7.11e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.81e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-2)"	7.8	7.4	7.3	11.0	10.6	3.8	9.1	13.3	9.9	61.0	8.8	13.7	11.6	8.1	11.8	12.1	6.7	11.4	10.3	6.0	8.9	8.6	10.7	8.7	8.4	8.8	10.8	7.5	14.8	13.6	12.4	17.2	8.7	9.7	8.7	9.1	8.7	7.4	13.0	5.2	8.6	10.7	8.9	12.2	9.2	8.4	10.1	8.3	17.6	12.6	4.6	8.8	10.1	9.7	2.0	4.6	2.9	2.8	6.3	3.5	2.0	7.4	5.2	4.0	8.6	14.4	11.9	7.9	7.9	8.8	5.2	6.3	2.4	5.5	6.0	7.8	5.9	5.9	8.6	9.3	5.8	8.3	7.5	4.7	3.9	2.4	3.3	10.1	5.4	9.4	14.5	10.4	2.9	10.1	9.6	6.8	4.7	4.8	6.5	6.8	4.9	2.8	2.0	3.7	12.2	8.3	4.0	6.4	2.0	8.8	11.0	8.5	4.2	8.9	6.5	5.2	7.9	8.2	8.4	9.5	10.6	4.1	7.9	3.9	3.9	3.1	3.5	6.7	4.0	5.2	0.0	2.8	2.9	3.5	1.9	2.4	1.8	2.4	1.8	2.2	2.0	3.2	2.3	1.4	6.3	1.7	4.6	2.9	2.0	7.3	10.6	13.3	9.9	8.9	8.6	10.8	7.5	9.7	8.3	17.9	12.1	4.2	7.4	4.7	14.2	2.9	0.0	17.4	5.7	21.0	3.9	7.9	1.7	6.8	69.7	4.7	6.3	0.0	3.3	6.5	6.7	8.2	11.5	7.5	5.5	6.4	17.2	8.6	13.9	25.8	14.1	7.8	1.7	5.4	10.8	5.6	5.0	7.0	10.3	3.7	17.1	0.0	4.2	7.9	8.5	4.8	9.3	5.7	10.8	6.8
TMEM263	"C12orf23, MGC17943"	ENSG00000151135	"Transmembrane protein 263"	Q8WUH6	12	106955719-106978778	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014453, HPA042339"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA014453: , HPA042339: AB_10795503"	"unprognostic (2.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (7.84e-4)"	"unprognostic (4.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.53e-1)"	14.5	17.6	13.7	15.1	14.7	4.0	25.9	10.6	12.4	29.0	13.9	5.2	26.7	10.8	22.6	27.9	13.2	12.8	19.6	25.3	10.9	16.0	24.4	44.8	12.9	18.2	11.3	10.4	24.0	28.1	12.8	65.3	40.9	11.6	21.1	12.3	10.0	25.2	26.8	10.1	5.6	15.0	18.9	10.4	15.0	18.9	12.4	6.9	32.1	32.8	7.0	12.1	21.2	23.2	11.9	9.1	5.9	0.9	11.5	17.9	8.3	8.9	8.0	15.4	10.3	36.1	40.9	6.4	33.9	31.8	16.8	21.3	8.5	3.9	0.8	10.5	48.3	9.4	4.1	9.6	13.5	23.3	16.0	9.8	12.4	12.6	17.7	18.5	0.6	7.9	28.4	6.4	18.3	15.2	39.0	20.4	9.6	5.8	3.4	22.9	7.3	9.3	5.6	4.9	5.6	15.4	20.7	11.4	2.0	16.7	7.6	7.9	10.7	18.1	8.6	13.4	12.4	10.1	3.6	23.7	14.2	8.7	18.6	8.6	14.2	8.1	8.3	11.2	2.1	22.3	5.9	0.8	0.9	10.2	0.9	12.0	9.2	9.9	8.7	2.6	11.9	17.9	16.0	0.7	11.5	0.3	9.1	10.2	8.3	13.7	14.7	10.6	11.0	10.9	16.0	11.3	10.4	11.6	6.9	8.9	17.6	20.1	43.8	0.0	24.3	46.6	12.7	22.7	20.5	22.7	29.5	34.9	77.9	16.2	24.1	20.3	13.5	0.0	28.5	63.2	46.3	43.7	29.9	42.7	11.8	11.1	27.6	28.8	5.0	29.3	43.7	6.9	0.0	12.6	48.2	31.2	18.5	8.6	41.1	34.0	18.5	25.8	39.5	31.2	23.2	0.0	30.1	14.6	17.4	23.5
TMEM267	"C5orf28, FLJ21657"	ENSG00000151881	"Transmembrane protein 267"	Q0VDI3	5	43444252-43483893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 15.7;Cytotrophoblasts: 23.5;Distal tubular cells: 23.2;Ductal cells: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059946, HPA072991"			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA059946: AB_2684175, HPA072991: "	"unprognostic (8.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.77e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.40e-3)"	9.9	8.1	9.0	7.8	9.4	3.9	14.2	13.8	12.5	11.7	7.7	5.7	6.8	7.1	11.1	11.7	9.4	8.9	7.5	8.3	6.3	8.5	12.1	7.1	8.1	9.0	9.9	11.2	10.9	17.3	9.9	23.0	6.3	11.6	9.6	9.7	8.9	12.3	9.9	7.1	9.8	8.6	9.2	9.4	9.5	9.1	7.9	7.9	6.1	36.8	7.6	8.8	10.4	9.0	11.6	9.7	9.0	11.6	13.7	18.0	11.0	10.1	9.3	5.0	11.2	9.5	19.1	5.7	14.6	9.0	7.9	5.8	4.0	21.8	11.3	20.1	14.8	8.3	8.6	4.8	6.6	11.5	13.5	7.8	6.5	20.1	4.5	17.4	13.3	9.5	15.6	18.9	11.8	16.8	8.0	8.8	13.6	8.5	21.0	17.3	8.7	7.3	7.9	2.2	10.2	9.2	5.0	12.4	13.7	9.8	10.3	7.0	5.0	29.1	16.7	14.2	4.8	24.2	9.7	11.4	12.9	10.5	7.9	7.2	9.0	12.8	11.1	9.7	19.3	11.3	9.0	8.6	3.1	12.3	10.0	18.0	11.6	16.4	13.0	9.7	9.6	16.9	14.0	1.6	13.7	11.6	7.5	13.0	11.0	9.0	9.4	13.8	12.5	6.3	8.5	9.9	11.2	11.6	7.9	6.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	12.0	3.4	15.7	0.0	23.5	23.2	13.2	0.0	0.0	0.0	0.0	12.1	8.1	0.0	0.0	2.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	5.4	0.0	0.0	10.7	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0
TMEM268	"C9orf91, DKFZp547P234, FLJ38045"	ENSG00000157693	"Transmembrane protein 268"	Q5VZI3	9	114611206-114646422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 9.3;Ciliated cells: 8.1;Hofbauer cells: 7.8;monocytes: 33.3;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017199	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA017199: AB_1845845"	"unprognostic (8.57e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (3.61e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	9.1	9.0	9.6	8.5	15.8	3.8	9.7	4.4	31.0	7.3	6.6	5.1	3.4	4.3	7.7	7.6	4.8	5.7	4.8	3.7	12.5	9.1	3.8	6.3	6.6	10.6	8.5	15.3	10.2	5.6	15.1	4.6	5.9	8.7	15.9	6.8	11.1	8.9	9.1	5.0	4.3	6.4	8.8	7.7	15.5	7.5	4.8	5.0	10.3	7.9	2.0	11.4	7.8	5.4	4.3	8.4	2.3	2.5	1.5	1.9	0.9	2.6	4.6	2.2	4.7	6.3	4.6	1.7	2.6	4.5	3.6	3.6	3.5	1.0	11.6	2.2	2.9	10.2	4.5	4.3	2.1	3.0	5.9	2.9	3.6	3.4	2.1	10.8	7.5	1.8	4.1	3.8	4.9	5.2	4.5	2.3	14.9	7.1	30.3	2.5	7.8	8.7	2.2	5.7	3.3	4.6	9.9	2.5	9.8	2.0	2.1	7.5	4.8	8.5	11.2	22.9	1.4	14.9	7.0	1.3	3.5	4.1	1.4	4.6	16.8	15.7	12.5	1.9	6.4	6.4	0.5	2.5	0.5	1.3	2.1	0.5	2.3	1.3	0.7	1.4	4.3	1.9	1.5	2.3	1.5	1.8	8.4	0.2	0.9	9.6	15.8	4.4	31.0	12.5	9.1	8.5	15.3	8.7	5.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	8.1	2.3	0.0	0.0	3.8	0.0	1.5	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	33.3	0.0	0.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0
TMEM270	"MGC26719, WBSCR28"	ENSG00000175877	"Transmembrane protein 270"	Q6UE05	7	73861159-73865893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 35.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;GAMG: 1.5;MCF7: 5.3;PC-3: 1.8;RPMI-8226: 1.4;U-2197: 1.4;U-87 MG: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077196			Approved	Vesicles		NA	NA			Vesicles		"HPA077196: AB_2732334"	"unprognostic (3.84e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.87e-5)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.31e-3)"		"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.23e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.4	1.5	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.4	0.0	0.3	1.8	0.0	0.0	1.4	0.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM31	MGC39655	ENSG00000179363	"Transmembrane protein 31"	Q5JXX7	X	103710909-103714028	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	22	"testis: 46.6"	"Group enriched"	"Detected in some"	63	"Early spermatids: 531.0;Late spermatids: 2031.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 3.0;BEWO: 7.3;MCF7: 10.4;NTERA-2: 3.2;U-937: 3.9"									HPA052760			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA052760: "	"unprognostic (9.42e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.91e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.68e-2)"	0.2	0.0	0.3	0.2	0.6	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.4	1.4	0.2	0.4	0.2	0.2	0.5	0.8	0.2	0.2	0.2	0.2	0.6	0.2	0.8	0.2	0.4	0.2	0.6	0.2	0.3	0.0	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.7	0.2	0.0	46.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.0	1.8	0.0	0.9	0.0	0.8	0.1	0.0	0.0	3.0	0.1	0.3	0.0	7.3	0.1	0.1	0.4	0.5	0.0	0.3	0.1	0.2	0.0	0.5	0.0	1.2	0.0	0.4	0.0	2.7	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.3	10.4	0.3	2.0	3.2	0.5	0.0	1.2	0.0	0.1	0.0	0.0	0.9	0.6	0.7	0.1	0.3	1.5	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.8	0.0	3.9	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.9	0.2	0.0	1.4	2.0	0.8	0.4	0.0	0.0	0.9	1.8	0.0	0.1	0.3	0.6	0.2	0.2	0.5	0.8	0.6	0.2	0.2	0.2	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.2	531.0	0.0	0.0	0.0	0.6	7.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	1.3	0.0	2031.4	12.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.1	0.1	0.0	12.9	0.3	20.4	11.3	0.3	2.4	0.0	0.0	0.0
TMEM35B	ZMYM6NB	ENSG00000243749	"Transmembrane protein 35B"	Q8NCS4	1	34981535-34985353	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.3;Ciliated cells: 28.1;Club cells: 11.4;granulocytes: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.0;CAPAN-2: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051024	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051024: AB_2681316"	"unprognostic (3.34e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.07e-1)"	23.1	20.6	6.4	10.7	8.0	5.3	24.4	5.7	7.9	23.7	13.8	9.3	12.6	7.4	22.3	19.0	15.2	19.7	26.1	17.6	6.4	5.8	27.5	24.4	25.3	28.0	9.9	7.6	20.0	20.5	9.2	14.6	29.5	9.6	29.6	12.6	26.6	14.2	17.4	10.5	7.2	16.0	18.3	10.2	19.0	12.9	21.4	7.8	17.9	48.7	9.8	18.4	22.0	19.1	24.9	37.3	29.4	26.8	36.4	53.1	38.4	9.1	7.0	1.7	2.8	43.0	25.5	3.5	10.0	16.8	7.2	9.8	6.9	40.6	4.7	15.6	10.3	11.1	9.9	3.1	8.5	5.8	17.3	4.7	9.8	3.7	8.2	23.6	6.5	10.3	25.3	8.0	6.4	13.6	14.5	14.0	9.7	6.3	13.4	12.5	5.6	4.7	6.5	7.6	0.0	4.9	6.4	13.8	1.5	19.2	9.1	4.2	1.4	15.2	0.2	13.4	8.3	3.8	9.9	14.2	9.6	9.0	8.4	5.7	7.8	4.4	3.2	9.7	10.6	8.0	29.4	24.5	25.4	47.3	26.8	50.7	24.9	52.3	51.9	16.8	21.0	46.1	46.3	7.6	36.4	21.9	37.3	53.1	38.4	6.4	8.0	5.7	7.9	6.4	5.8	9.9	7.6	9.6	7.8	20.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	28.1	11.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	8.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438520	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 110.5;kidney: 82.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 276.4;Hepatocytes: 166.8;Muller glia cells: 140.1;Proximal tubular cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.8;naive CD4 T-cell: 3.3"	"Group enriched"	"Detected in many"	31	"monocytes: 2.8;T-cells: 3.3"	"Group enriched"	"Detected in some"	5	"EFO-21: 13.4;Hep G2: 35.1;RPTEC TERT1: 29.4"	"Low region specificity"	"Detected in many"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA053794: AB_2682265"	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	18.5	5.2	0.6	5.9	1.0	0.0	10.0	0.5	1.2	6.7	60.3	1.8	3.8	16.2	3.1	3.8	2.8	1.4	18.5	5.7	1.0	0.4	82.5	40.8	9.5	8.7	0.9	0.7	5.9	5.8	20.1	0.7	13.4	1.3	4.5	5.6	6.3	2.8	6.5	1.6	4.4	110.5	1.9	1.4	11.5	6.6	6.4	0.7	1.2	21.0	1.6	2.2	3.4	2.4	0.0	0.0	0.0	2.8	0.0	3.3	0.6	0.0	3.5	0.3	0.1	2.2	0.2	0.5	0.1	0.0	0.0	0.0	5.4	3.1	0.0	13.4	1.6	0.3	0.8	1.4	0.0	0.0	0.0	1.4	0.4	2.0	35.1	3.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	2.8	0.0	0.1	5.3	0.0	0.3	0.0	0.3	2.6	0.0	0.1	0.0	0.0	4.6	29.4	2.3	0.4	0.2	0.1	1.4	0.0	2.6	0.6	0.8	1.8	0.0	5.3	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.6	1.0	0.5	1.2	1.0	0.4	0.9	0.7	1.3	0.7	23.8	8.1	15.4	0.2	1.8	2.6	1.2	86.6	1.4	3.4	17.4	0.0	40.2	43.1	18.4	0.1	2.9	276.4	0.0	47.2	3.4	14.1	0.1	1.1	166.8	54.9	6.4	8.7	82.3	51.8	0.9	46.1	4.3	1.7	1.0	14.5	140.1	16.0	45.6	3.5	167.4	17.7	0.0	1.9	0.0	1.0	2.5	87.1	1.8	12.4	1.6
TMEM38A	"MGC3169, TRIC-A"	ENSG00000072954	"Transmembrane protein 38A"	Q9H6F2	19	16661127-16690029	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 158.8"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 21.6;Cardiomyocytes: 22.4;Cone photoreceptor cells: 80.5;Peritubular cells: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 12.1;U-266/70: 12.2;U-698: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048100, HPA050463"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048100: , HPA050463: AB_2681137"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.78e-5)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.99e-10)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.96e-2)"	1.3	1.6	3.6	1.1	7.9	2.3	1.2	5.1	12.2	1.3	1.4	2.1	3.1	1.3	1.1	6.6	3.5	1.8	1.0	5.4	3.0	3.8	2.0	2.7	2.1	1.3	5.2	3.7	1.2	1.3	1.7	2.2	0.9	4.8	2.9	1.5	8.3	2.7	2.4	158.8	1.0	1.1	1.1	1.9	1.0	5.3	1.6	1.4	0.0	1.8	30.1	1.9	1.1	0.4	3.9	0.5	20.3	2.9	2.1	0.5	0.6	3.0	0.6	0.8	4.7	2.6	0.3	0.4	1.1	0.6	0.7	1.5	0.9	4.4	12.1	1.9	0.2	4.2	2.5	6.2	1.3	0.7	0.8	1.8	0.0	1.8	1.0	0.7	0.1	0.2	1.1	4.8	0.9	0.5	3.6	0.3	2.2	0.1	1.1	0.5	4.6	0.1	1.2	1.2	11.3	7.2	6.3	1.1	3.2	4.6	2.3	7.8	5.4	3.3	0.4	1.5	0.4	2.3	1.0	0.0	0.9	2.3	2.9	0.5	12.2	8.8	20.3	1.1	7.2	0.9	20.3	2.9	8.2	0.0	1.1	0.0	2.8	0.4	0.0	0.2	3.9	0.1	0.1	1.6	2.1	0.7	0.5	0.5	0.6	3.6	7.9	5.1	12.2	3.0	3.8	5.2	3.7	4.8	1.4	3.0	1.0	0.8	2.8	1.0	21.6	22.4	0.0	1.4	1.2	0.0	80.5	0.0	1.7	3.1	0.0	3.3	0.7	0.0	2.2	0.1	2.1	3.6	0.0	6.7	0.4	12.7	4.1	8.0	5.6	0.5	9.8	0.0	3.3	0.0	5.8	12.1	7.1	0.0	21.2	1.0	10.2	0.0	2.8	0.5	0.4	0.3	0.1	0.0	2.4	0.9
TMEM39A	FLJ10902	ENSG00000176142	"Transmembrane protein 39A"	Q9NV64	3	119429500-119468830	"Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039140	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA039140: AB_10673303"	"unprognostic (2.16e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (9.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (4.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.41e-2)"	13.7	12.7	5.6	13.0	8.8	9.3	13.2	10.5	6.4	18.3	8.7	10.4	27.0	9.6	20.8	18.3	10.9	13.5	13.4	14.4	5.1	3.8	9.7	16.7	15.2	11.0	8.9	2.4	17.6	37.5	8.3	47.9	19.5	7.6	13.9	9.5	12.1	30.2	30.0	8.7	10.7	10.6	9.6	8.4	11.8	11.5	15.4	8.0	11.3	17.4	9.5	19.2	11.9	13.0	8.6	18.1	11.5	11.2	11.9	13.8	9.2	15.9	8.0	14.3	10.1	28.5	26.7	15.1	15.8	27.1	17.1	23.8	14.0	12.2	6.7	15.0	14.5	21.2	16.6	14.7	6.2	18.9	6.6	5.7	8.2	6.1	14.2	19.2	15.2	12.3	16.1	10.4	12.4	30.3	19.5	11.3	10.4	8.0	19.3	9.5	7.3	8.0	5.5	13.7	15.9	16.0	8.7	7.4	14.3	5.0	6.2	6.2	8.7	14.9	8.6	21.3	10.5	8.1	14.3	9.7	10.6	10.1	7.4	9.9	22.2	6.2	15.9	15.9	11.0	15.1	11.5	11.2	8.0	13.5	6.2	13.8	8.5	8.4	11.3	13.2	8.6	7.0	7.1	4.7	11.9	4.8	18.1	9.8	9.2	5.6	8.8	10.5	6.4	5.1	3.8	8.9	2.4	7.6	8.0	8.9	12.0	7.5	13.8	20.3	4.5	9.8	2.5	12.0	7.9	7.0	5.9	22.9	5.0	10.2	19.6	8.0	5.6	0.0	12.5	45.9	30.1	16.5	1.1	9.8	12.1	1.6	10.4	7.4	21.0	4.2	15.8	13.2	10.1	45.9	14.6	4.8	9.1	3.5	12.4	3.4	6.3	6.5	13.9	23.2	14.7	19.1	50.0	15.8	10.8	17.5
TMEM39B	FLJ10315	ENSG00000121775	"Transmembrane protein 39B"	Q9GZU3	1	32072031-32102866	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040191, HPA040224"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA040191: AB_10805706, HPA040224: AB_10795274"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (2.82e-6)"	"unprognostic (1.10e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (5.11e-9)"	"unprognostic (2.20e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.10e-1)"	13.4	10.2	6.2	7.4	10.1	6.1	10.8	6.2	14.3	18.2	10.7	11.5	8.2	7.1	18.8	11.9	8.2	11.8	9.4	10.0	5.8	7.9	6.7	13.7	9.3	13.5	7.2	11.7	16.1	6.6	7.8	9.9	16.9	8.3	9.7	8.1	10.8	8.5	13.7	9.9	13.0	8.4	12.6	7.0	9.5	9.0	18.3	7.1	22.9	10.8	10.3	13.1	12.7	11.3	11.5	21.6	5.1	14.1	4.4	10.6	8.3	8.1	2.4	2.9	7.8	10.0	6.0	4.1	7.7	11.8	9.3	9.0	4.2	12.0	8.7	11.6	5.3	5.7	9.3	2.3	11.4	2.6	4.8	7.5	5.7	5.2	2.2	12.1	10.1	5.8	8.8	4.2	14.2	10.3	5.1	5.6	5.0	7.4	7.8	8.0	3.8	6.5	3.0	10.4	9.2	5.8	12.0	11.2	12.3	4.1	4.4	7.2	4.3	10.5	5.4	8.2	1.1	4.2	4.8	8.4	14.6	9.7	5.3	7.5	3.9	5.9	9.5	8.9	8.7	11.1	2.5	14.1	5.1	5.3	12.0	7.2	11.5	7.9	6.6	14.4	11.5	10.6	8.6	3.7	4.4	8.7	21.6	8.2	8.3	6.2	10.1	6.2	14.3	5.8	7.9	7.2	11.7	8.3	7.1	8.9	0.6	14.5	14.4	9.8	7.7	2.2	7.6	2.7	7.9	3.5	17.7	28.7	1.7	7.4	2.4	17.5	4.7	0.0	13.8	18.0	17.0	4.9	15.0	5.5	13.5	6.4	5.2	12.3	15.7	0.9	11.2	12.6	10.1	19.8	7.6	4.3	5.3	2.9	13.1	3.4	5.6	6.5	12.2	10.3	15.1	8.9	34.1	10.1	9.3	3.5
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733525-12769457	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5"	"Cell type enhanced"	"Detected in many"	24	"Cytotrophoblasts: 120.6;Suprabasal keratinocytes: 176.4;Syncytiotrophoblasts: 549.0;Urothelial cells: 120.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 73.7;hTCEpi: 16.6;hTERT-HME1: 21.0;RT4: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044165, HPA073122"	Enhanced		Approved	Cytosol		NA	NA		7000000	Cytosol		"HPA044165: AB_10961279, HPA073122: "	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.0	0.0	0.0	0.0	0.2	1.4	1.8	0.0	0.0	11.7	0.0	0.0	0.4	0.0	0.9	0.6	62.9	1.6	0.1	1.6	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	53.6	0.1	2.3	0.0	0.0	6.6	1.4	0.4	24.0	0.0	0.7	0.0	1.1	0.0	0.4	0.0	0.4	0.0	40.5	41.8	10.6	18.6	0.0	0.5	4.5	0.6	0.0	0.3	21.1	7.4	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.3	0.3	0.4	0.2	1.1	0.0	0.0	0.0	0.2	2.1	0.0	73.7	1.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	16.6	0.0	21.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.4	10.3	0.0	0.0	0.0	9.2	0.0	1.4	0.8	0.2	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.0	0.0	0.5	0.0	21.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	71.9	57.1	0.0	3.3	0.0	22.7	6.8	1.8	0.0	120.6	0.0	0.5	0.6	0.4	0.0	0.0	0.0	12.6	4.3	9.6	0.0	0.6	9.6	0.0	0.0	0.0	0.3	1.6	0.3	0.2	10.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.3	0.2	1.9	176.4	549.0	0.0	0.0	120.1
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 54.4"	"Cell type enhanced"	"Detected in many"	4	"monocytes: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059101: AB_2683905, HPA059790: AB_2684125"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	8.1	23.9	7.8	4.8	10.2	9.3	10.1	4.9	11.5	10.6	26.8	11.7	6.3	24.5	9.1	11.1	20.6	9.0	8.6	8.3	7.5	8.4	15.8	26.1	11.3	9.0	8.1	5.4	14.2	10.7	6.7	5.7	9.0	8.6	10.1	8.6	11.9	11.2	9.4	8.3	16.6	54.4	8.0	8.7	12.4	8.7	11.2	7.4	11.3	9.0	18.1	16.7	8.8	12.5	12.8	16.4	7.8	8.4	8.5	16.7	6.5	20.9	7.6	5.1	6.2	8.1	8.7	15.0	8.1	7.1	10.2	7.5	19.8	8.3	6.5	15.5	7.5	14.5	14.6	14.0	8.6	10.4	10.9	12.9	11.3	4.6	19.9	9.0	12.1	6.4	8.1	12.9	9.2	10.6	6.5	7.8	8.3	20.0	16.3	6.5	8.1	7.4	7.0	8.4	16.6	12.1	7.5	7.8	11.9	8.8	15.4	5.1	6.6	7.0	18.0	12.3	7.6	21.5	9.5	5.6	6.1	7.6	12.6	16.8	24.0	36.6	13.1	9.3	7.3	7.3	7.8	6.3	5.1	13.2	6.6	16.7	12.8	13.6	14.3	7.0	12.4	15.0	16.1	2.4	8.5	8.4	16.4	11.1	6.5	7.8	10.2	4.9	11.5	7.5	8.4	8.1	5.4	8.6	7.4	8.9	26.2	17.6	29.0	47.2	17.7	11.3	22.9	4.0	14.8	19.2	17.7	23.4	6.6	28.6	0.4	17.9	38.7	0.0	48.5	20.2	16.7	43.7	8.1	34.2	16.5	15.9	17.9	14.1	11.1	1.8	13.3	14.3	8.5	100.0	26.4	14.6	45.8	15.9	12.7	22.4	29.5	19.4	17.2	23.7	14.2	74.0	38.4	15.2	30.8	81.8
TMEM41B	KIAA0033	ENSG00000166471	"Transmembrane protein 41B"	Q5BJD5	11	9280654-9314780	"Predicted membrane proteins"	"Autophagy, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014946	Uncertain		Approved	Peroxisomes		NA	NA			Peroxisomes		"HPA014946: AB_2205037"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (6.18e-2)"	"unprognostic (9.37e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.18e-2)"	9.2	11.6	11.9	8.7	13.0	15.5	10.5	13.7	17.6	8.0	14.3	20.1	15.6	21.8	7.3	10.6	13.5	7.8	10.5	10.7	11.9	14.6	14.6	23.0	19.3	9.5	16.2	12.9	9.1	14.6	18.8	13.4	13.8	20.1	14.0	11.3	10.1	11.8	11.1	8.8	15.9	21.2	5.9	13.5	10.2	15.5	14.9	14.6	14.9	21.3	8.5	11.0	9.6	8.8	7.2	6.0	8.0	2.4	7.1	9.2	3.7	13.1	13.8	7.8	6.7	7.6	11.1	18.7	11.8	11.3	7.0	12.9	6.6	42.8	5.7	11.0	7.5	10.5	17.3	9.0	7.1	8.7	9.8	6.9	4.6	9.3	6.8	9.9	4.2	6.5	9.4	10.2	6.7	8.4	6.0	5.9	6.4	9.9	14.4	13.5	4.7	6.8	1.8	24.0	7.8	7.2	4.6	10.8	7.9	10.8	13.2	2.4	8.5	11.8	9.9	8.2	9.1	8.8	6.6	8.2	7.7	9.0	11.9	6.1	4.6	7.1	10.3	8.6	2.7	6.4	6.3	1.9	7.4	4.7	1.6	4.3	7.2	4.4	5.1	3.1	5.9	9.2	7.6	8.0	7.1	2.4	6.0	4.0	3.7	11.9	13.0	13.7	17.6	11.9	14.6	16.2	12.9	20.1	14.6	44.7	63.2	19.3	50.5	67.5	35.1	20.2	38.2	20.1	33.0	29.6	62.8	39.2	6.6	23.1	1.2	17.5	47.2	23.3	34.4	43.5	26.9	51.9	16.2	46.5	19.9	19.1	38.1	19.6	16.5	1.4	16.7	20.5	18.6	27.1	37.0	25.3	41.4	28.5	13.1	18.2	37.4	19.4	24.2	39.0	41.7	55.7	46.9	20.6	29.6	53.6
TMEM44	DKFZp686O18124	ENSG00000145014	"Transmembrane protein 44"	Q2T9K0	3	194587673-194633689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 50.3;Mucus-secreting cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 3.2;NK-cell: 11.5"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.2;NK-cells: 11.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043718	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA043718: AB_10794662"	"unprognostic (8.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.31e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.78e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (6.55e-13)"	"unprognostic (1.23e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.66e-2)"	13.2	2.8	4.8	6.2	11.8	10.6	21.2	1.9	7.3	6.6	11.8	2.4	9.2	4.6	6.8	22.9	5.1	4.9	7.9	5.9	6.1	6.3	5.6	3.6	15.1	6.3	5.2	7.8	5.1	3.3	1.3	2.3	12.0	6.7	4.8	11.9	3.3	7.0	5.8	6.7	3.4	6.0	5.6	3.7	9.0	6.7	4.1	3.3	4.1	5.3	5.5	3.7	5.0	6.7	0.3	0.6	3.2	0.4	11.5	0.8	0.0	6.3	5.1	7.8	8.3	2.9	9.8	6.9	4.9	9.2	4.1	6.5	2.8	12.6	1.1	23.3	5.7	11.8	7.4	2.6	3.7	2.7	10.4	3.7	7.1	5.3	2.1	5.3	2.2	11.3	6.3	4.1	9.2	4.1	19.4	16.6	7.0	2.0	0.3	13.2	5.9	3.3	5.6	4.1	6.2	8.4	6.3	4.9	0.2	4.2	3.6	2.2	4.7	3.5	1.1	7.2	3.4	5.3	4.7	19.6	12.3	4.6	3.8	6.3	0.9	0.7	2.2	18.4	8.6	6.1	3.2	0.3	0.3	0.5	0.2	0.1	0.2	0.2	0.8	0.0	0.3	0.1	0.3	0.8	11.5	0.4	0.6	0.0	0.0	4.8	11.8	1.9	7.3	6.1	6.3	5.2	7.8	6.7	3.3	0.0	2.9	3.7	3.0	0.5	0.8	1.1	0.0	2.7	3.4	5.2	2.0	6.6	0.0	5.1	0.6	15.2	13.4	0.0	4.3	2.8	4.8	5.1	17.3	0.8	3.0	0.0	5.8	50.3	2.2	0.0	2.8	0.8	1.7	0.0	20.6	0.6	9.6	17.5	1.8	0.1	0.3	6.5	1.2	0.5	5.9	0.5	7.3	1.5	16.2	5.1
TMEM45A	"DERP7, FLJ10134"	ENSG00000181458	"Transmembrane protein 45A"	Q9NWC5	3	100492619-100577444	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 118.9"	"Cell type enhanced"	"Detected in many"	9	"Club cells: 118.3;Early spermatids: 138.9;Hepatocytes: 109.4;Suprabasal keratinocytes: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.3;myeloid DC: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 94.3;ASC TERT1: 27.6;HSkMC: 29.0"					"Low region specificity"	"Detected in all"			HPA062101	Uncertain		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA062101: AB_2684682"	"unprognostic (5.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.43e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.18e-11)"	"unprognostic (1.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-5)"	"unprognostic (2.68e-2)"	5.3	5.2	1.6	3.0	7.3	0.6	12.5	0.3	1.9	8.6	2.7	1.9	2.5	1.0	8.5	5.7	4.4	5.2	5.7	5.7	1.3	0.9	1.4	45.2	5.8	5.2	4.4	0.7	6.4	20.2	0.3	25.1	20.2	2.1	5.9	1.8	3.1	23.9	2.2	2.4	118.9	1.7	6.6	2.2	2.2	2.0	5.4	4.4	0.0	6.5	3.7	12.2	7.7	18.5	0.5	2.9	0.9	3.3	0.0	0.5	2.0	6.1	0.4	0.6	2.1	94.3	27.6	0.0	14.8	13.8	2.1	19.4	0.5	0.1	0.0	7.4	9.7	5.6	7.0	0.5	2.8	5.3	1.5	1.8	5.2	2.3	1.7	5.9	0.0	0.3	29.0	1.6	3.8	5.8	8.9	0.8	0.0	0.1	0.7	5.0	0.0	0.0	0.1	0.7	0.0	3.7	0.0	5.3	0.0	0.1	0.2	0.6	4.4	3.6	1.9	1.5	4.3	0.2	2.9	2.0	14.4	10.1	0.1	3.3	12.2	6.9	0.0	11.3	0.4	9.5	0.0	3.3	0.9	0.3	0.0	0.0	0.5	0.2	0.3	2.9	0.0	0.1	0.5	0.4	0.0	0.5	1.6	0.0	2.0	1.6	7.3	0.3	1.9	1.3	0.9	4.4	0.7	2.1	4.4	56.6	52.0	7.0	4.3	84.0	3.3	1.9	0.0	97.7	118.3	0.0	0.0	2.2	0.0	7.1	138.9	3.8	0.0	0.0	13.5	42.5	64.8	3.2	60.4	109.4	5.6	7.9	1.2	12.3	6.1	11.8	15.0	5.0	21.9	1.8	1.7	1.4	8.9	0.3	26.2	0.0	0.8	6.5	16.4	1.2	1.9	222.8	6.3	3.2	0.0	4.1
TMEM45B	"BC016153, FLJ40787"	ENSG00000151715	"Transmembrane protein 45B"	Q96B21	11	129815819-129860003	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 106.6"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 253.0;Paneth cells: 150.7;Undifferentiated cells: 102.5;Urothelial cells: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 3.6;naive CD4 T-cell: 4.3;neutrophil: 13.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 13.1;T-cells: 4.3"	"Group enriched"	"Detected in some"	5	"OE19: 82.8;RT4: 33.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015474, HPA015878"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015474: , HPA015878: AB_2205046"	"unprognostic (4.92e-3)"	"unprognostic (7.94e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	0.2	0.2	0.6	9.0	0.9	0.0	4.0	0.3	0.7	6.6	50.3	0.5	1.7	40.4	1.2	4.1	29.5	6.5	9.3	0.4	1.2	0.6	9.6	13.2	4.5	1.9	0.4	0.7	1.4	3.1	0.0	2.9	1.2	2.3	4.0	29.0	0.3	7.3	2.4	0.2	10.9	106.6	1.5	0.5	0.6	7.4	0.7	0.2	0.5	9.1	21.9	19.9	9.4	10.9	0.6	0.4	13.1	0.6	0.7	4.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	9.7	4.2	0.0	1.8	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.0	82.8	12.6	0.0	0.0	0.6	5.4	33.4	1.0	0.1	0.0	2.7	0.0	0.0	9.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.6	0.1	0.3	0.2	0.3	0.2	3.6	0.9	0.0	0.6	4.3	0.7	13.1	0.7	0.2	0.4	0.6	1.3	0.6	0.9	0.3	0.7	1.2	0.6	0.4	0.7	2.3	0.2	17.9	8.4	0.5	10.0	3.0	0.0	0.6	22.9	68.3	21.6	43.6	0.0	4.0	11.6	20.5	0.2	0.3	253.0	0.0	7.3	0.6	0.9	18.6	2.3	2.6	0.5	0.0	53.3	0.0	1.6	0.0	0.3	1.9	3.3	0.0	64.7	0.0	32.6	150.7	0.0	1.2	0.3	0.0	1.0	0.0	0.0	18.2	0.3	0.7	102.5	96.6
TMEM47	"BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9"	ENSG00000147027	"Transmembrane protein 47"	Q9BQJ4	X	34627064-34657288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 68.7;Muller glia cells: 146.8;Peritubular cells: 87.4;Sertoli cells: 90.5;Smooth muscle cells: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 27.5;fHDF/TERT166: 84.5;RPTEC TERT1: 20.8;U-2197: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046658	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA046658: AB_2679742"	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.67e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.05e-6)"	"unprognostic (2.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.94e-2)"	19.7	11.3	22.3	4.3	28.3	0.0	19.0	8.1	18.5	26.7	13.7	15.0	7.6	4.5	24.8	18.7	19.2	19.5	15.4	18.4	24.1	17.2	15.0	12.8	11.7	2.9	10.5	9.5	15.3	5.9	2.0	4.5	0.6	14.0	18.4	8.1	19.0	17.1	26.0	11.8	3.6	6.3	29.9	6.9	3.7	8.5	7.0	15.7	0.3	10.9	4.8	2.1	21.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.6	5.3	11.2	8.5	0.0	27.5	0.0	5.4	4.7	0.0	0.0	0.0	2.3	84.5	0.0	0.0	3.5	0.9	8.1	0.0	2.4	0.0	3.5	0.0	6.4	0.0	0.0	7.6	0.0	2.2	2.4	9.8	6.1	0.0	0.0	0.0	10.2	0.2	0.0	0.0	1.5	0.1	0.0	0.0	6.3	0.0	20.8	8.0	0.1	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.2	11.1	1.1	18.5	1.1	0.0	0.0	0.0	4.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	28.3	8.1	12.4	24.1	17.2	10.5	9.5	14.0	15.7	17.9	1.1	0.0	11.6	7.2	6.6	24.4	10.2	1.4	2.3	15.7	5.9	0.0	6.6	0.8	0.4	30.5	0.0	0.0	4.4	0.1	42.9	11.2	2.3	12.9	0.1	28.6	0.0	39.3	0.6	1.1	68.7	2.1	62.4	0.0	0.0	146.8	3.3	0.0	87.4	11.5	6.1	90.5	67.4	0.3	1.9	4.5	0.1	0.0	0.0	10.9
TMEM50A	SMP1	ENSG00000183726	"Transmembrane protein 50A"	O95807	1	25337917-25362361	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065192			Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA065192: AB_2685429"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-3)"	"prognostic favorable (8.64e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (7.39e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.39e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-3)"	"unprognostic (3.44e-2)"	36.2	45.6	29.2	23.2	39.1	19.4	43.4	30.5	29.4	29.7	32.7	21.5	25.6	26.5	29.4	31.5	36.7	23.5	30.9	32.6	30.9	23.6	39.1	31.8	34.2	36.3	29.3	18.5	22.6	29.7	21.7	13.6	40.4	19.9	32.8	38.6	19.1	56.5	33.0	21.5	25.7	39.6	27.8	38.1	39.4	26.5	17.5	20.4	32.7	39.2	29.6	28.1	37.1	31.0	13.0	14.0	56.5	26.8	19.2	25.0	23.1	8.5	9.8	16.5	8.5	31.0	27.9	5.8	17.4	27.9	33.1	37.1	7.9	21.5	9.9	9.8	61.9	12.4	12.5	12.9	14.2	36.2	26.1	18.5	21.2	10.8	12.0	22.9	16.1	17.2	30.4	20.9	24.5	14.2	15.7	23.8	11.2	14.1	15.6	31.2	6.0	10.5	19.7	19.3	14.1	8.1	9.3	18.1	17.5	33.3	6.3	13.8	8.8	18.0	12.7	13.9	15.6	6.5	10.6	35.2	18.5	7.7	30.2	7.2	10.9	11.8	9.1	24.1	24.2	10.2	56.5	19.1	26.3	24.0	23.0	25.0	13.0	21.1	24.4	14.0	10.1	15.5	21.1	39.7	19.2	26.8	13.0	23.4	23.1	29.2	39.1	30.5	29.4	30.9	23.6	29.3	18.5	19.9	20.4	134.0	76.3	88.7	152.8	225.1	40.2	88.4	119.8	104.4	70.5	160.5	25.5	94.3	43.1	257.7	13.8	175.4	107.8	46.7	188.7	283.9	172.6	238.9	122.5	56.8	203.7	23.8	79.6	140.6	162.8	8.4	140.7	195.1	189.0	268.7	149.5	99.5	250.4	140.3	93.0	82.3	29.5	207.0	211.1	93.4	46.0	277.7	151.8	110.7	95.4	208.9
TMEM50B	C21orf4	ENSG00000142188	"Transmembrane protein 50B"	P56557	21	33432485-33480011	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034199, HPA068995"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"CAB034199: AB_2205160, HPA068995: AB_2686066"	"unprognostic (3.22e-1)"	"unprognostic (5.93e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (9.58e-3)"	"unprognostic (3.41e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.32e-3)"	12.8	16.1	12.1	12.4	14.6	5.6	20.3	31.1	14.1	16.1	12.0	13.7	25.3	12.9	16.5	32.0	11.8	16.5	16.9	14.0	13.1	13.5	21.0	14.3	14.3	8.9	14.8	11.2	27.8	19.4	14.7	20.3	10.0	16.4	18.1	11.6	19.5	10.5	32.4	16.1	10.9	16.1	22.0	14.1	16.0	15.1	14.9	12.2	6.9	51.0	8.6	8.8	16.5	15.3	9.3	12.4	20.3	10.5	10.9	16.3	11.9	9.3	1.9	3.6	5.1	20.7	15.0	3.0	8.8	9.9	6.1	4.5	2.5	8.0	5.9	8.1	7.2	8.1	3.7	4.9	5.1	4.4	6.3	5.7	10.9	1.6	5.0	9.5	7.1	6.1	7.4	4.9	4.8	3.7	10.2	7.3	5.7	7.5	10.4	8.2	6.0	5.6	7.6	1.5	15.9	4.1	3.0	7.1	9.0	11.0	7.1	3.4	5.3	10.6	11.1	8.8	2.0	12.3	9.5	6.3	4.5	3.3	5.6	2.8	10.7	18.0	7.5	4.2	12.1	7.2	7.9	8.4	20.3	11.3	9.2	9.1	9.3	12.6	11.4	11.3	8.5	13.8	13.5	1.7	10.9	10.5	12.4	16.3	11.9	12.1	14.6	31.1	14.1	13.1	13.5	14.8	11.2	16.4	12.2	26.8	50.7	27.6	88.0	65.8	53.8	42.3	50.9	57.6	30.7	78.5	102.1	30.2	23.2	30.3	32.6	54.4	51.5	0.0	27.5	33.5	55.1	133.9	28.9	51.2	32.7	41.3	20.7	94.5	34.9	29.6	66.2	26.8	79.2	31.5	40.9	66.5	26.7	35.1	112.4	48.1	79.3	97.0	62.6	182.7	78.6	81.9	34.6	41.5	39.2	92.9
TMEM51	"C1orf72, FLJ10199"	ENSG00000171729	"Transmembrane protein 51"	Q9NW97	1	15152532-15220480	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Urothelial cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	23	"dendritic cells: 1.7;monocytes: 2.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014547, HPA019441"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA014547: AB_1858121, HPA019441: AB_2670142"	"unprognostic (1.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (7.81e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.91e-2)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.67e-3)"	4.6	14.1	4.7	7.7	4.4	0.4	7.0	14.2	5.1	9.7	22.4	4.5	14.3	15.9	5.3	7.6	12.0	7.2	25.3	3.7	5.0	2.2	23.5	3.9	10.4	7.4	4.1	3.4	15.4	36.7	14.5	5.2	7.5	4.2	12.3	7.8	16.1	7.5	15.5	1.2	5.3	22.9	8.9	5.7	7.1	18.9	3.4	3.9	2.0	3.8	12.3	8.4	18.5	22.2	0.0	1.7	0.0	2.8	0.0	0.0	0.3	19.1	10.3	5.9	1.4	1.0	2.2	0.0	2.2	9.3	6.8	9.3	13.5	21.6	0.0	7.3	1.4	9.8	18.6	2.0	7.2	3.9	0.0	5.1	0.4	0.5	13.3	8.6	0.0	18.8	0.7	6.4	8.9	9.8	4.4	6.3	0.8	2.9	0.0	3.5	6.6	0.0	0.0	1.0	15.3	3.9	2.7	3.7	3.3	17.3	19.9	0.9	17.5	1.8	7.6	18.4	3.7	1.0	2.0	4.4	7.1	6.3	3.1	6.9	0.2	0.3	0.0	7.0	0.3	8.3	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	4.7	4.4	14.2	5.1	5.0	2.2	4.1	3.4	4.2	3.9	0.0	1.6	2.7	51.9	16.3	0.0	1.8	20.4	6.7	4.5	47.1	0.0	4.2	5.0	64.9	0.4	8.7	12.9	0.0	64.3	0.7	5.6	48.2	0.0	0.4	43.7	0.0	18.4	8.6	24.2	0.0	2.6	18.8	13.5	19.8	16.3	0.0	65.3	25.9	13.1	11.8	0.0	32.3	39.4	0.5	1.9	18.4	1.1	0.0	13.2	98.9
TMEM52B	"C12orf59, FLJ31166"	ENSG00000165685	"Transmembrane protein 52B"	Q4KMG9	12	10170542-10191801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"kidney: 85.1"	"Cell type enriched"	"Detected in some"	16	"Distal tubular cells: 603.5"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 6.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"CACO-2: 46.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058096	Enhanced		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA058096: AB_2683603"	"unprognostic (1.10e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.14e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.18e-1)"	0.1	0.0	0.1	0.1	0.6	0.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	85.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	2.0	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	3.7	1.4	1.3	0.6	0.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	46.3	0.0	0.0	0.0	0.3	2.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	6.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.4	4.4	0.0	1.6	2.5	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	1.4	1.3	1.0	0.4	0.2	0.4	0.4	0.4	0.5	3.7	0.9	0.5	0.5	1.0	0.6	0.2	0.6	0.4	0.4	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	12.2	0.0	38.1	603.5	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.6	0.0	0.3	4.2	1.7	2.8	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.2	0.0	16.2	0.0	0.0	0.0
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674555	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.7;liver: 44.7"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 845.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 38.7"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 38.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Golgi apparatus"	"Focal adhesion sites"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	8.3	9.0	6.0	4.4	8.7	6.0	7.0	2.4	11.8	4.9	11.0	8.8	4.6	16.6	5.7	7.2	4.5	5.3	7.6	9.3	6.2	6.1	14.8	44.7	7.3	6.4	6.8	6.2	7.7	5.4	3.3	6.4	4.3	8.0	5.2	7.2	13.9	6.0	3.8	4.2	3.9	16.4	4.5	6.1	4.8	7.7	18.8	4.4	3.6	8.2	3.1	4.0	7.3	3.7	5.3	38.7	3.6	8.6	2.8	3.1	2.8	7.6	8.8	8.0	5.8	10.4	7.9	9.6	2.2	6.7	4.4	6.6	2.8	24.2	2.4	7.3	2.1	17.0	6.9	2.2	4.7	2.3	3.8	5.6	2.8	3.6	13.4	10.4	2.2	10.3	9.3	7.3	8.8	1.9	4.8	2.4	5.5	1.2	3.1	2.6	4.5	2.5	6.5	4.6	5.9	5.2	4.0	1.1	23.6	13.1	8.0	5.6	5.4	2.4	9.6	12.4	5.9	3.0	5.8	1.0	3.2	5.5	4.6	2.8	2.2	2.6	1.3	8.4	5.7	3.7	3.6	5.2	2.3	3.0	8.6	2.6	5.3	3.1	2.5	2.6	5.0	1.5	2.0	0.5	2.8	6.0	38.7	3.0	2.8	6.0	8.7	2.4	11.8	6.2	6.1	6.8	6.2	8.0	4.4	6.0	11.8	2.4	6.7	1.4	5.6	24.6	10.2	18.7	9.1	19.2	3.9	11.6	38.1	14.3	155.5	8.7	50.1	23.3	22.5	13.2	5.6	7.8	5.8	81.3	29.8	17.5	13.8	8.0	8.3	845.8	8.3	7.2	8.5	1.8	18.4	12.9	16.0	56.1	11.7	39.8	12.4	25.8	7.3	5.1	8.3	1.9	7.8	4.1	15.4	10.3
TMEM54	CAC-1	ENSG00000121900	"Transmembrane protein 54"	Q969K7	1	32894594-32901438	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.7"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 673.9;Mucus-secreting cells: 310.3;Paneth cells: 422.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 48.3;OE19: 57.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061992			Approved	Vesicles		NA	NA			Vesicles		"HPA061992: AB_2684652"	"unprognostic (2.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.40e-2)"	3.2	3.3	16.1	21.5	10.7	0.0	8.5	2.7	10.6	10.0	70.0	8.2	7.0	37.9	8.5	9.4	28.8	5.0	24.2	4.5	9.7	9.4	11.4	4.4	7.2	2.4	10.9	5.7	6.2	12.4	9.0	4.7	47.3	6.8	14.7	37.4	7.4	11.8	8.4	1.9	26.9	76.7	7.3	7.3	3.1	35.0	3.7	6.0	1.1	23.6	16.9	14.2	12.5	15.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	29.9	8.1	0.0	7.8	14.9	9.0	29.3	4.4	7.2	10.7	13.8	20.2	48.3	0.0	13.1	5.9	13.6	18.4	7.0	25.9	3.2	34.8	1.4	0.0	2.9	1.0	10.8	0.1	0.4	7.7	23.7	16.3	4.5	7.2	4.7	3.1	4.1	0.0	5.5	32.1	0.0	0.6	2.5	57.6	14.1	4.0	12.2	0.1	3.9	38.5	0.4	4.0	3.1	20.1	10.1	5.0	21.8	5.8	8.9	10.5	11.2	23.5	9.4	1.1	2.5	3.5	7.5	0.7	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	10.7	2.7	10.6	9.7	9.4	10.9	5.7	6.8	6.0	17.9	25.1	9.7	74.9	18.1	5.9	2.8	76.5	6.7	6.8	45.4	3.9	34.8	23.2	128.9	43.4	11.3	673.9	0.0	180.9	127.1	10.8	130.2	5.7	1.5	7.4	0.0	58.3	12.9	1.8	20.3	18.4	3.7	13.5	5.4	310.3	13.7	137.0	422.1	23.0	38.7	8.7	6.5	11.3	11.1	8.9	55.7	53.8	0.0	231.5	148.6
TMEM56	FLJ31842	ENSG00000152078	"Transmembrane protein 56"	Q96MV1	1	95117338-95197607	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.2"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 68.8;Erythroid cells: 186.9;Hepatocytes: 246.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 3.3;naive B-cell: 1.6;neutrophil: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"A-431: 13.9;GAMG: 13.1;RH-30: 23.2"									HPA046762			Approved	"Nuclear speckles"		No	No			"Nuclear speckles"		"HPA046762: AB_2679792"	"unprognostic (1.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	3.3	6.6	6.1	1.6	6.5	10.4	2.0	10.9	10.6	2.0	8.2	3.8	2.8	3.6	2.5	2.1	1.9	2.2	4.5	15.1	4.2	3.2	3.9	74.2	2.6	0.7	3.5	5.7	1.5	6.5	5.4	6.8	3.1	4.7	3.8	6.6	28.1	4.8	2.7	7.2	1.7	6.6	8.1	4.1	1.0	3.9	3.2	3.2	0.0	4.8	1.7	0.8	4.8	3.1	3.3	0.1	1.0	0.1	0.0	0.3	0.1	13.9	8.0	1.1	1.7	0.5	0.0	1.9	0.5	0.3	1.8	4.3	5.8	6.7	0.0	7.0	0.2	13.1	0.1	4.7	0.7	3.2	9.7	2.6	0.3	6.8	1.2	0.5	0.2	0.4	0.8	0.2	1.4	0.0	2.9	0.0	0.8	12.2	0.7	0.4	1.1	0.8	0.0	1.1	0.4	4.4	0.0	23.2	0.3	7.8	9.1	2.9	2.3	9.9	7.0	4.1	1.2	7.6	0.2	0.1	0.2	6.0	0.7	4.9	2.5	4.8	0.0	1.0	0.0	1.4	0.3	0.1	0.1	0.1	0.0	0.0	3.3	0.2	0.2	0.0	1.6	0.3	0.1	1.0	0.0	0.0	0.1	0.1	0.1	6.1	6.5	10.9	10.6	4.2	3.2	3.5	5.7	4.7	3.2	6.0	22.6	10.7	4.2	1.0	3.2	68.8	25.5	4.0	3.4	14.0	0.0	6.6	1.7	13.6	13.9	1.0	39.2	186.9	21.0	1.3	5.1	21.2	0.0	246.3	0.5	0.0	15.6	17.2	5.0	36.7	2.6	0.0	1.7	0.0	18.7	37.5	10.3	13.6	2.1	12.4	1.0	6.5	4.2	3.3	6.0	0.4	3.8	1.0	13.3	4.2
TMEM62	FLJ23375	ENSG00000137842	"Transmembrane protein 62"	Q0P6H9	15	43123279-43185146	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 29.2;U-266/84: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044461, HPA062359"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies"		"HPA044461: AB_2678950, HPA062359: AB_2684747"	"unprognostic (7.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.56e-2)"	"prognostic favorable (9.72e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	11.6	8.6	7.6	9.5	12.0	9.6	28.6	21.1	13.9	10.4	15.5	15.1	9.8	15.5	9.9	15.4	10.7	9.4	14.0	7.3	7.8	9.8	9.5	12.3	13.0	10.5	10.2	8.2	6.1	12.0	16.5	10.8	12.3	12.7	8.6	17.6	11.9	16.9	9.2	14.5	8.5	17.3	11.0	11.9	9.6	12.0	3.1	7.8	4.6	10.5	8.9	13.7	13.2	9.0	2.5	4.6	2.6	1.8	3.8	5.0	0.9	7.0	3.8	1.7	3.3	2.1	2.8	18.2	6.8	8.6	12.1	16.9	6.0	14.0	7.1	3.9	6.4	10.9	13.6	7.3	5.3	4.4	8.4	3.2	5.8	8.4	4.5	4.7	6.0	5.3	2.0	6.4	5.2	3.7	3.4	6.6	1.8	5.1	6.2	1.3	1.6	0.0	1.4	0.6	29.2	1.6	3.5	1.8	3.8	6.4	9.0	11.1	4.7	5.3	13.4	3.2	2.0	7.2	6.1	3.8	6.0	2.5	4.2	10.9	5.2	31.3	5.0	5.5	6.7	5.2	1.5	1.8	2.6	2.4	0.8	2.9	1.9	3.2	2.7	2.0	2.5	1.9	2.6	0.5	3.8	1.0	4.6	5.0	0.9	7.6	12.0	21.1	13.9	7.8	9.8	10.2	8.2	12.7	7.8	14.9	2.9	8.3	3.5	2.1	5.3	2.4	10.2	5.3	4.5	12.2	9.8	18.1	5.0	11.3	1.1	4.7	10.7	0.0	12.9	21.2	3.1	2.2	4.7	5.8	6.7	1.6	4.1	3.7	6.5	2.4	2.3	5.7	5.0	7.2	9.7	7.5	11.1	9.0	1.1	2.9	9.5	6.5	4.7	1.8	0.8	2.5	28.5	3.1	9.1	3.7
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.8;pituitary gland: 21.1"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 7.2;Intestinal endocrine cells: 18.4;Late spermatids: 4.8;Paneth cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 11.8;Karpas-707: 15.9;RPMI-8226: 8.1;SCLC-21H: 21.7;SK-BR-3: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.4	14.1	3.4	1.0	8.4	1.1	5.2	63.8	16.3	1.5	5.8	1.9	0.0	1.8	0.3	6.8	4.8	0.6	0.5	0.3	3.2	9.7	0.7	0.4	0.9	0.6	4.6	6.0	0.4	6.7	1.2	21.1	1.1	6.6	0.4	4.3	0.9	1.3	0.2	0.8	4.4	2.2	1.1	1.8	3.2	3.1	9.9	1.2	0.0	3.2	0.6	0.6	0.3	2.9	0.1	0.7	2.0	1.7	1.7	1.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	11.8	2.3	0.0	2.0	1.6	2.5	0.9	0.0	0.8	0.9	0.2	1.2	0.0	0.0	2.0	0.1	0.0	5.0	0.0	0.1	0.0	0.0	5.6	0.0	15.9	0.0	5.9	1.6	0.1	0.5	0.0	0.0	0.0	0.8	8.1	0.2	0.0	21.7	3.2	0.2	19.2	0.0	0.4	1.9	1.0	0.0	0.0	4.1	0.0	0.0	1.3	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.5	1.0	0.7	0.1	0.5	0.4	2.0	1.7	1.7	0.0	0.0	0.4	3.4	8.4	63.8	13.0	3.2	9.7	4.6	6.0	6.6	1.2	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	2.0	0.1	1.7	0.0	7.2	0.0	2.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	2.0	3.2	18.4	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.1	0.1	0.3	6.6	0.4	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0
TMEM68	FLJ32370	ENSG00000167904	"Transmembrane protein 68"	Q96MH6	8	55696424-55773407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018216, HPA019173"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA018216: AB_2205185, HPA019173: AB_1858129"	"unprognostic (4.43e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.63e-1)"	10.4	18.3	14.0	8.4	18.0	10.6	14.6	18.9	20.5	13.0	15.1	16.3	16.0	14.6	15.4	17.9	16.1	25.4	12.5	7.4	13.8	13.2	20.6	14.6	11.3	10.5	12.7	10.2	15.7	13.5	15.9	18.5	15.6	13.2	15.8	16.6	13.1	14.0	12.2	7.8	17.6	18.3	14.4	13.3	12.9	12.0	9.8	11.7	22.7	18.8	13.4	12.3	17.1	13.0	9.2	7.2	21.7	7.7	8.2	10.5	3.9	12.4	7.5	12.8	7.7	10.8	12.5	22.4	11.0	8.5	10.7	10.4	10.6	23.5	13.7	13.1	7.3	13.7	15.8	9.9	14.7	11.9	18.7	11.2	16.5	6.8	11.1	11.9	7.0	9.2	8.4	22.7	10.8	25.5	15.8	9.7	14.9	15.8	13.8	15.6	6.5	17.4	9.6	13.8	27.2	3.9	12.8	5.3	8.8	17.7	9.7	10.6	9.4	7.4	12.1	21.7	17.4	17.8	9.1	7.6	8.2	10.3	14.0	9.0	11.9	14.9	17.2	11.1	11.7	12.6	21.7	7.1	5.0	7.2	4.4	10.5	9.2	8.6	7.6	7.2	9.2	7.2	10.1	7.9	8.2	7.7	6.4	6.3	3.9	14.0	18.0	18.9	20.5	13.8	13.2	12.7	10.2	13.2	11.7	11.9	10.1	7.5	25.1	30.3	17.3	4.1	20.4	56.2	21.6	24.4	13.7	26.7	11.6	14.9	1.3	9.5	14.5	0.0	7.0	17.4	11.9	20.6	5.7	11.0	11.5	20.6	14.5	10.4	14.9	1.1	12.0	10.1	6.8	13.6	23.7	17.2	12.5	19.2	13.1	17.7	15.2	25.8	9.5	15.8	12.3	31.0	18.5	11.5	14.1	24.8
TMEM69	"C1orf154, FLJ21029"	ENSG00000159596	"Transmembrane protein 69"	Q5SWH9	1	45687214-45694443	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026993	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026993: AB_10601824"	"prognostic favorable (2.24e-4)"	"unprognostic (2.47e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.66e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.41e-3)"	"unprognostic (3.65e-2)"	6.0	9.0	7.0	5.8	11.0	2.6	12.2	6.8	13.8	5.3	7.5	7.3	2.9	8.3	5.6	9.9	12.1	6.0	5.6	11.6	6.3	6.2	8.4	7.6	8.3	8.8	6.9	5.0	8.9	7.8	10.7	5.5	6.8	10.8	7.0	8.4	4.7	7.9	5.7	8.2	7.7	8.2	6.2	9.1	7.8	5.7	12.1	9.4	10.1	7.5	8.8	9.3	8.4	11.1	8.7	10.9	5.4	15.6	4.6	8.2	6.1	13.1	3.2	9.1	7.4	7.0	9.0	22.4	8.6	10.2	14.6	14.2	9.0	6.9	16.0	6.0	8.2	10.8	17.8	7.3	19.6	15.0	11.1	8.5	32.6	8.0	9.7	12.4	15.6	16.1	10.5	20.4	13.4	8.5	9.4	11.9	15.4	19.5	11.1	9.1	4.8	8.6	11.2	21.7	8.0	8.8	13.5	8.3	16.2	15.4	14.0	10.6	9.5	9.1	24.6	14.7	16.6	12.8	16.0	8.9	6.7	11.5	14.8	10.3	8.9	11.0	12.2	9.4	11.7	9.8	5.0	12.2	5.0	5.1	12.7	6.4	8.7	7.2	5.7	10.9	8.3	8.2	6.3	5.4	4.6	15.6	6.8	6.8	6.1	7.0	11.0	6.8	13.8	6.3	6.2	6.9	5.0	10.8	9.4	0.0	12.2	15.7	21.6	17.9	11.2	7.9	7.6	13.4	17.0	17.4	0.0	53.1	36.5	19.2	1.5	11.6	17.1	0.0	15.4	28.9	13.5	20.5	5.8	12.5	33.1	6.4	23.1	14.1	39.0	3.0	17.3	26.0	16.9	12.6	21.0	12.4	13.5	10.5	12.0	27.2	10.5	12.9	8.6	18.4	14.9	22.7	49.9	14.9	23.6	18.4
TMEM74	"FLJ30668, NET36"	ENSG00000164841	"Transmembrane protein 74"	Q96NL1	8	108606850-108787615	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 2.7;Cone photoreceptor cells: 5.9;Rod photoreceptor cells: 7.9;Spermatogonia: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory B-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.2;NTERA-2: 6.5;SCLC-21H: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015672, HPA076461"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA015672: AB_1858132, HPA076461: "	"unprognostic (8.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.75e-4)"	"unprognostic (8.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.46e-3)"	1.3	1.4	4.8	1.1	4.2	0.4	0.9	13.1	12.0	0.7	2.7	10.4	0.0	0.9	0.7	0.7	2.9	1.0	0.9	7.5	5.9	2.8	0.7	2.2	0.8	0.8	3.2	6.1	0.9	2.7	0.4	1.1	0.5	9.3	1.0	1.3	1.0	0.9	1.1	5.5	2.0	1.4	2.9	14.1	0.6	0.9	2.7	6.8	0.7	0.8	0.8	0.9	0.9	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.1	0.0	0.1	3.0	0.7	0.0	0.4	5.2	1.9	0.8	0.3	0.1	0.5	0.7	0.0	0.0	0.1	0.1	0.1	0.5	3.6	0.0	0.2	0.0	0.0	0.2	0.0	6.5	0.0	3.7	0.0	3.7	0.0	0.0	0.0	14.2	0.1	0.0	0.5	0.0	1.6	0.2	0.2	0.0	1.7	3.0	0.0	0.3	0.6	0.1	0.0	2.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.2	13.1	7.3	5.9	2.8	3.2	6.1	9.3	6.8	0.0	0.0	0.0	0.6	0.8	2.7	0.6	0.0	0.0	0.0	0.0	5.9	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.5	0.2	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	7.9	0.0	0.7	0.2	5.1	0.5	0.1	0.0	0.0	0.0
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.9;intestine: 16.0"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 10.3;Horizontal cells: 17.5;Intestinal endocrine cells: 15.0;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.9;Hep G2: 9.9;K-562: 16.8;Karpas-707: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA045213: AB_10961999"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-4)"	"unprognostic (9.58e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (1.20e-1)"	"unprognostic (9.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.07e-3)"	2.3	0.3	4.3	0.3	13.9	0.0	1.1	2.3	7.3	0.1	0.7			12.5	0.6	0.3	0.7	3.9	2.5	3.9	2.3	6.9	0.6	1.0	9.4	0.9	2.3		0.0	0.6	0.2	3.5	12.2		0.5	0.9		3.3	11.3	2.9	4.6	16.0	1.1	1.1	0.6	2.7	0.9			1.6		0.4	0.7	0.0	1.6	0.1	0.0	0.1	0.0	0.5	0.3	0.0	5.0	2.8	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.7	0.1	1.0	0.0	2.9	0.3	3.7	0.5	0.1	0.0	4.7	1.1	0.0	9.9	0.0	0.0	1.4	0.0	1.1	0.0	0.2	0.2	0.1	0.7	16.8	7.6	0.0	0.1	0.1	0.1	3.4	1.2	0.4	0.0	0.2	0.0	0.8	0.7	0.7	2.1	0.1	0.0	0.1	1.2	0.0	0.1	2.0	0.0	3.3	0.1	0.2	3.3	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3											0.0	0.0	0.0	0.4	0.2	10.3	1.6	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.5	0.8	3.6	2.0	0.0	0.2	1.0	0.2	0.7	0.0	0.6	0.0	17.5	15.0	3.1	0.8	0.4	0.0	0.0	1.7	1.8	2.7	0.2	1.4	1.7	0.0	0.3	2.7	19.4	5.7	0.2	0.2	0.6	1.1	0.0	0.8	0.4
TMEM79	"FLJ16057, FLJ32254, MATT, MGC13102"	ENSG00000163472	"Transmembrane protein 79"	Q9BSE2	1	156282935-156293185	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 47.5;skin 1: 35.7;tongue: 37.2"	"Cell type enhanced"	"Detected in many"	9	"Suprabasal keratinocytes: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 22.0;SK-BR-3: 18.1;T-47d: 19.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA055214	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA055214: AB_2682741"	"unprognostic (3.12e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (6.37e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.37e-1)"	1.2	1.3	2.4	1.2	5.1	2.0	3.4	3.4	3.7	12.5	1.2	3.6	1.9	1.8	1.3	1.9	47.5	1.5	1.9	1.0	2.0	1.1	1.1	1.4	1.0	1.8	5.6	1.4	1.5	1.0	3.8	2.5	4.5	3.1	19.0	1.1	1.2	9.4	2.1	1.9	35.7	1.3	1.1	3.2	1.6	1.6	0.9	5.2	3.7	1.5	37.2	24.2	3.3	20.5	5.2	4.1	7.8	4.1	3.0	5.2	3.1	8.2	4.9	1.7	3.2	1.2	1.3	4.1	2.4	1.0	4.4	1.7	5.7	2.3	1.6	5.3	0.6	1.6	7.4	1.9	3.7	1.9	5.5	2.8	1.5	2.0	1.6	2.3	1.7	2.3	1.3	22.0	3.3	3.3	3.2	0.9	5.6	6.9	10.3	2.0	9.8	4.8	2.7	2.5	6.2	3.9	5.7	1.6	3.3	0.9	2.6	3.0	3.3	2.9	18.1	4.7	2.1	19.4	5.0	2.3	8.1	2.7	2.9	6.4	8.0	8.3	3.5	5.6	4.1	6.1	0.0	4.1	5.6	3.9	1.4	3.9	3.7	3.4	4.0	3.2	5.2	4.4	5.2	7.8	3.0	2.6	4.1	4.0	3.1	2.4	5.1	3.4	3.7	2.0	1.1	5.6	1.4	3.1	5.2	3.0	1.0	2.0	1.1	11.7	3.2	0.8	5.1	2.7	2.3	1.8	2.0	5.9	1.7	1.9	0.1	1.5	2.6	0.0	2.9	1.6	1.9	11.3	0.0	2.0	3.0	7.9	2.9	1.3	2.4	0.0	1.4	1.4	5.0	6.4	2.1	1.5	3.0	2.5	0.7	1.1	2.2	0.0	0.8	1.2	1.9	29.0	6.2	3.5	2.6	4.9
TMEM80	FLJ38216	ENSG00000177042	"Transmembrane protein 80"	Q96HE8	11	695428-705028	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA059592, HPA067046"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA059592: AB_2684076, HPA067046: AB_2685769"	"unprognostic (1.48e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.39e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.23e-3)"	12.9	12.7	10.5	17.7	18.9	4.4	20.0	15.9	20.5	14.8	14.1	18.3	12.8	19.1	17.9	21.8	22.9	17.0	10.9	7.7	15.3	9.4	16.5	10.2	12.2	15.5	12.6	15.2	18.2	16.1	16.8	19.7	7.6	13.5	17.9	15.0	18.1	25.2	19.1	12.6	20.4	16.5	15.4	9.4	20.0	19.3	13.8	14.3	33.8	27.2	7.4	18.3	16.3	15.8	21.5	16.1	24.6	21.5	13.9	17.7	14.0	19.7	10.0	6.4	8.3	14.2	6.7	10.1	4.9	2.7	5.2	5.7	11.2	24.1	8.9	4.2	7.6	9.3	15.2	9.4	5.6	3.8	6.1	23.8	5.3	9.9	8.0	8.4	7.0	9.8	15.5	11.5	2.3	3.7	10.3	6.1	10.7	6.6	10.3	6.6	6.5	9.2	4.8	5.9	16.7	4.6	6.4	4.3	17.3	7.4	3.1	17.6	5.7	7.2	13.8	6.8	4.5	10.1	6.7	8.6	8.8	4.3	1.9	3.6	4.9	1.5	8.0	9.3	8.9	3.7	6.1	19.8	24.6	16.3	18.8	14.2	19.8	12.3	12.2	15.7	21.5	17.7	15.5	9.4	13.9	21.5	16.1	14.8	14.0	10.5	18.9	15.9	20.5	15.3	9.4	12.6	15.2	13.5	14.3	6.0	16.5	15.2	16.9	13.6	19.0	14.6	12.7	12.0	9.1	19.2	7.9	28.0	10.0	10.3	5.0	15.7	16.4	23.3	14.9	7.3	14.1	13.9	6.9	5.8	15.3	52.4	11.6	14.7	12.1	9.2	39.4	14.4	11.8	10.0	19.9	20.9	9.4	5.8	26.9	7.9	8.6	32.3	20.8	50.2	65.2	15.1	12.7	15.7	20.0	9.0
TMEM81	"HC3107, KVLA2788, MGC75217, UNQ2788"	ENSG00000174529	"Transmembrane protein 81"	Q6P7N7	1	205083129-205084460	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.2"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 3.5;Early spermatids: 7.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052515			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA052515: AB_2681858"	"unprognostic (9.19e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (8.91e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.67e-4)"	1.5	2.7	2.8	1.6	3.8	2.0	2.1	11.2	5.3	2.1	1.3			1.2	1.5	3.5	1.4	1.2	1.1	2.2	3.3	2.7	4.2	3.3	1.5	2.3	2.8		2.3	1.0	3.4	2.2	2.0		1.8	1.7		1.4	2.1	4.6	4.1	1.2	1.7	2.4	3.0	1.0	6.1			1.4		2.7	0.9	1.6	1.5	1.5	4.3	1.4	0.2	4.6	0.9	2.4	3.7	6.2	8.1	9.1	3.6	3.1	4.5	2.7	2.3	1.4	6.5	1.7	4.5	3.2	2.5	3.4	2.1	9.9	3.8	4.0	3.9	3.9	3.7	5.2	3.2	6.3	1.9	2.1	3.6	6.8	3.6	1.8	6.1	4.5	5.4	8.3	1.9	2.9	4.7	4.3	8.1	4.7	3.0	5.4	3.0	7.1	4.6	5.3	2.3	3.9	6.1	2.8	3.4	7.1	10.0	2.5	8.0	2.1	4.3	2.3	5.5	4.8	4.3	5.3	3.6	6.2	2.9	7.3	4.3	1.2	0.2	4.6	1.4	0.2	1.5	2.3	1.1	1.5	1.4	2.5	4.0	2.5	0.2	1.4	1.5	2.7	0.9											0.0	0.0	0.5	0.5	2.1	0.6	1.2	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.5	7.9	1.0	0.3	0.0	0.5	0.3	0.8	0.6	0.0	1.0	0.5	1.6	0.0	0.6	0.0	1.3	0.0	0.0	1.7	0.0	0.2	1.1	0.7	0.0	0.4	1.4	1.0	0.0	0.6	0.2	1.1	2.3	0.1	0.0	0.8	0.4
TMEM86A	FLJ90119	ENSG00000151117	"Transmembrane protein 86A"	Q8N2M4	11	18693122-18704785	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 6.5"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.5;monocytes: 3.7;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057119	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA057119: AB_2683342"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.24e-1)"	6.9	4.9	4.7	3.6	5.7	0.7	5.6	3.4	9.7	3.8	3.3	7.0	1.2	2.5	4.0	3.8	3.9	4.4	6.6	8.1	6.9	3.7	15.3	6.7	5.7	11.1	6.7	3.2	12.3	8.2	7.0	3.9	7.1	5.0	2.9	3.2	16.7	4.6	2.7	4.7	24.4	3.2	3.4	7.2	9.2	3.3	4.1	3.7	5.3	3.7	3.9	4.2	5.2	5.4	0.2	6.5	0.3	3.7	0.2	1.7	1.4	0.0	0.2	0.7	3.4	3.1	0.0	0.1	0.7	0.6	0.6	0.5	0.0	0.4	0.0	1.3	0.6	3.4	0.3	0.2	0.1	0.4	0.2	2.0	0.2	0.1	0.0	2.4	0.0	3.0	4.3	1.3	0.1	0.3	0.8	1.8	1.9	0.6	0.0	1.4	1.8	0.0	0.0	0.2	0.5	1.8	0.0	5.6	0.0	19.2	4.1	1.1	1.4	1.0	3.5	1.5	1.3	4.2	0.4	2.1	0.6	0.3	0.2	0.1	3.5	2.7	0.0	1.2	0.0	1.2	0.0	3.7	0.3	0.4	2.8	1.0	0.0	0.4	0.9	6.5	0.2	1.0	1.7	0.0	0.2	0.9	3.8	1.0	1.4	4.7	5.7	3.4	9.7	6.9	3.7	6.7	3.2	5.0	3.7	0.0	0.0	0.0	0.6	0.1	3.9	2.0	0.0	0.0	0.0	10.4	7.9	0.4	6.6	5.3	6.8	0.6	0.0	0.0	6.9	0.3	0.8	0.9	0.0	1.0	34.1	0.0	3.4	4.3	6.4	6.3	2.0	5.7	0.0	1.8	0.6	2.9	7.5	0.0	1.8	5.6	4.5	6.5	0.1	6.5	0.7	0.3	1.9	0.0	0.0	0.3
TMEM87B	FLJ14681	ENSG00000153214	"Transmembrane protein 87B"	Q96K49	2	112055223-112119318	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035183	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA035183: AB_10600829"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.28e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.32e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.25e-3)"	10.8	14.5	5.6	19.5	7.1	5.1	17.2	6.5	8.5	11.6	20.8	6.6	36.8	22.1	14.5	14.3	14.5	10.1	17.0	7.3	5.8	6.5	10.0	13.1	14.6	25.8	6.6	5.4	9.6	15.8	11.3	22.8	20.1	7.4	23.5	21.3	7.0	18.3	43.8	3.8	12.0	37.9	10.3	8.2	22.4	17.3	5.5	5.7	11.6	12.3	11.0	17.9	13.9	12.0	8.4	3.7	4.9	8.3	4.6	10.1	4.9	10.4	3.3	2.9	13.2	12.5	17.1	11.3	18.0	24.1	11.6	14.3	8.2	14.7	10.1	9.5	23.4	16.0	17.9	1.9	10.6	14.8	6.5	2.0	14.1	2.2	7.0	12.2	9.7	15.2	11.3	12.9	14.2	11.4	11.0	12.0	4.8	8.3	6.8	16.1	6.5	4.5	4.7	2.4	17.3	8.7	3.8	4.6	8.3	9.8	15.1	2.4	3.2	8.0	19.5	16.2	8.0	10.7	6.8	13.6	11.7	3.6	9.2	4.0	5.5	8.9	6.4	13.3	4.8	8.3	4.9	4.0	3.3	4.7	7.0	8.1	8.4	10.1	6.4	3.6	6.6	9.3	5.1	2.4	4.6	8.3	3.7	9.7	4.9	5.6	7.1	6.5	8.5	5.8	6.5	6.6	5.4	7.4	5.7	26.8	15.2	12.8	12.9	10.9	5.0	4.0	20.4	6.7	15.9	17.4	2.0	14.2	0.0	38.0	16.9	12.0	39.9	0.0	77.9	21.9	14.0	32.4	12.7	8.5	19.4	6.4	16.7	33.2	39.3	19.3	9.2	15.0	3.3	10.8	46.5	3.3	61.0	38.2	2.8	5.7	7.6	0.0	10.3	2.3	5.1	11.2	24.4	9.6	28.8	18.6
TMEM8A	"M83, PGAP6, TMEM6, TMEM8"	ENSG00000129925	"Transmembrane protein 8A"	Q9HCN3	16	370773-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 67.7;Syncytiotrophoblasts: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	8.4	9.3	6.9	9.5	7.8	15.2	13.5	7.7	7.9	6.8	16.6	7.3	24.1	17.7	7.3	29.6	11.8	6.5	15.2	10.0	5.6	4.3	28.7	33.5	13.0	10.7	7.1	3.2	8.3	44.2	11.5	10.7	45.5	6.7	11.4	6.0	8.8	22.5	8.8	12.8	3.7	25.0	5.0	4.7	13.2	17.5	26.3	6.0	12.6	12.3	5.2	14.6	9.3	8.8	2.0	2.9	24.3	5.5	0.9	7.6	3.3	4.4	11.8	6.8	12.5	9.3	8.4	13.6	12.9	13.5	6.6	9.5	46.4	21.1	4.8	17.5	12.4	10.1	6.4	3.0	14.2	1.8	13.6	11.3	7.9	8.0	26.4	21.6	5.9	15.0	9.7	4.3	10.1	2.9	6.7	15.2	5.4	12.6	7.4	8.2	27.8	8.3	11.7	10.8	7.2	4.7	18.1	7.8	10.9	10.7	11.5	8.1	9.3	7.2	7.3	37.9	3.7	13.1	11.9	22.1	18.8	20.3	13.0	6.8	14.9	7.4	9.5	9.5	6.3	11.9	4.6	5.0	6.3	7.4	5.5	5.9	1.8	5.8	5.8	2.5	2.0	7.6	5.5	24.3	0.9	3.8	2.9	4.3	3.3	6.9	7.8	7.7	7.9	5.6	4.3	7.1	3.2	6.7	6.0	14.9	12.5	10.7	3.2	2.6	5.7	12.5	10.2	1.4	1.2	22.7	9.8	46.7	5.0	27.5	15.5	8.7	67.7	23.3	36.8	5.9	6.6	11.5	1.1	25.5	24.7	17.5	26.6	14.7	14.5	58.4	2.6	10.1	6.8	8.2	26.1	8.2	42.6	38.6	1.8	9.9	7.8	12.9	6.1	1.1	2.5	2.8	83.8	7.5	18.9	6.8
TMEM8B	"C9orf127, NAG-5, NGX6"	ENSG00000137103	"Transmembrane protein 8B"	A6NDV4	9	35814451-35865518	"Predicted membrane proteins, Transporters"	"Cell adhesion, Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 27.2"	"Lineage enriched"	"Detected in many"	18	"dendritic cells: 27.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052130, HPA062701"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA052130: AB_2681740, HPA062701: AB_2684839"	"unprognostic (5.54e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (5.93e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (8.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	9.7	19.5	28.2	5.7	30.4	3.4	9.4	22.9	34.4	15.5	13.0	16.9	14.9	8.7	18.4	11.5	9.3	18.3	12.1	17.8	25.3	14.1	11.3	4.7	10.4	5.9	12.9	21.2	33.3	14.6	28.4	23.6	7.7	18.3	19.3	9.4	17.5	19.9	24.0	19.1	9.2	8.4	18.1	13.0	8.7	13.1	13.6	15.4	5.6	17.3	5.1	4.9	14.2	11.9	0.9	27.2	0.6	1.5	0.5	0.6	1.1	2.9	3.1	11.0	8.6	12.4	10.4	1.3	2.6	5.1	2.9	3.6	1.3	0.8	2.3	6.3	7.1	8.5	1.1	2.9	4.3	2.4	1.8	4.9	0.7	2.2	3.1	8.8	0.2	0.3	9.7	5.6	3.0	3.2	9.4	1.6	10.7	1.0	6.5	5.1	1.1	6.0	1.3	1.6	2.4	4.3	6.7	2.2	5.7	3.0	1.3	2.6	7.7	4.0	1.9	3.9	3.8	3.0	1.1	2.6	6.9	2.2	6.7	1.0	8.7	2.6	2.6	6.3	1.1	4.2	0.4	1.5	0.1	0.6	0.3	0.5	0.9	0.6	0.6	4.7	0.9	0.6	0.5	0.6	0.5	0.3	27.2	0.4	1.1	28.2	30.4	22.9	34.4	25.3	14.1	12.9	21.2	18.3	15.4	11.9	13.5	0.9	7.2	3.9	3.9	10.1	10.2	4.0	7.9	14.0	2.0	29.0	1.7	4.4	20.2	2.9	3.9	0.0	3.4	5.3	7.2	9.2	1.1	2.9	2.9	1.6	6.4	1.3	1.9	9.9	13.6	3.3	10.1	0.0	5.6	8.2	3.2	8.6	18.4	4.1	5.0	6.5	6.1	8.0	4.4	1.4	10.9	3.8	6.3	8.2
TMEM9	TMEM9A	ENSG00000116857	"Transmembrane protein 9"	Q9P0T7	1	201134772-201171574	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008483			Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Vesicles	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA008483: "	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.90e-2)"	12.4	33.4	32.3	8.4	33.3	10.1	20.4	19.9	43.5	31.3	13.1	23.0	20.1	10.9	24.4	30.4	12.0	34.5	17.2	18.4	31.2	35.9	25.7	21.8	18.2	13.4	24.2	29.4	32.8	36.0	20.2	19.0	12.3	23.0	25.9	11.3	28.3	26.3	22.0	15.9	11.0	9.5	16.6	17.0	9.4	15.2	22.2	12.2	7.8	30.7	7.0	10.8	17.6	14.9	28.0	29.3	21.2	32.7	15.1	36.8	37.2	15.0	28.5	18.1	41.8	9.8	14.0	32.1	11.9	12.7	19.0	17.2	27.9	24.5	8.0	17.4	17.8	17.6	30.2	18.9	19.5	9.4	5.1	32.5	13.9	46.0	18.2	18.9	6.6	13.0	16.6	21.7	17.7	10.8	23.0	11.7	11.3	24.8	8.8	16.3	19.3	8.0	10.9	27.6	13.8	70.5	14.5	27.0	10.4	21.8	11.7	16.9	34.5	21.2	36.4	21.9	28.2	44.7	11.7	8.7	21.4	17.8	17.0	14.3	36.2	31.1	6.1	16.2	7.2	10.3	19.1	32.7	16.9	25.5	20.9	28.7	28.0	24.8	20.9	26.9	27.0	36.8	24.2	21.2	15.1	18.9	29.3	21.5	37.2	32.3	33.3	19.9	43.5	31.2	35.9	24.2	29.4	23.0	12.2	47.6	38.0	4.5	30.3	11.4	64.1	33.1	48.4	54.9	40.9	34.9	29.5	35.6	14.9	74.6	47.8	25.3	7.4	0.0	65.8	41.2	50.3	37.0	12.7	32.1	24.1	7.9	30.6	29.4	15.0	47.1	65.6	14.5	21.9	11.8	25.4	102.0	41.4	18.2	49.8	48.1	26.0	12.9	32.0	44.2	81.2	12.2	10.9	12.8	28.5	22.0
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500090	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: AB_2681207"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	14.6	25.6	26.6	11.2	32.0	13.9	9.8	24.4	32.7	11.7	16.7	30.3	8.2	15.4	13.0	8.5	14.5	27.4	13.7	21.1	21.7	13.3	14.0	9.6	17.0	10.6	24.0	23.0	17.1	13.9	17.2	18.6	18.6	21.9	12.5	11.5	25.4	11.8	12.5	40.4	16.2	15.2	9.4	15.9	14.3	14.8	16.5	23.4	10.7	18.4	9.6	9.2	13.7	7.1	4.6	6.2	5.5	4.6	4.3	7.1	4.5	7.6	20.1	16.6	26.1	8.3	9.5	23.9	4.6	10.2	7.9	8.1	6.7	12.1	10.9	15.4	8.0	12.2	10.1	8.0	12.7	4.4	9.6	11.3	11.0	9.0	10.1	11.3	12.2	24.0	16.4	7.1	7.8	6.9	6.9	14.3	9.3	11.4	12.7	10.3	8.9	25.3	7.6	6.9	9.4	7.8	18.0	19.7	10.0	7.7	20.2	14.8	15.7	5.5	23.9	13.8	12.8	14.8	14.6	8.2	7.9	10.0	8.2	6.5	27.5	7.8	5.9	9.3	11.3	10.7	0.2	4.6	5.5	7.1	2.9	5.4	2.0	3.3	4.7	4.6	4.6	2.8	4.4	1.2	4.3	2.7	6.2	4.1	4.5	26.6	32.0	24.4	32.7	21.7	13.3	24.0	23.0	21.9	23.4	11.9	12.0	0.0	3.8	0.0	39.1	0.0	7.6	5.3	11.4	8.7	29.5	12.8	0.0	6.3	3.5	3.6	13.2	0.0	8.1	8.9	1.3	3.8	5.8	7.2	13.1	19.1	7.0	14.1	8.9	1.6	6.4	3.6	0.0	2.8	11.6	14.5	5.6	10.5	8.5	3.3	33.4	6.5	0.0	13.3	7.8	0.0	16.8	2.5	11.0	2.4
TMIGD1	"TMIGD, UNQ9372"	ENSG00000182271	"Transmembrane and immunoglobulin domain containing 1"	Q6UXZ0	17	30316333-30334059	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	33	"intestine: 47.3"	"Cell type enriched"	"Detected in some"	14	"Enterocytes: 341.7"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021946			Approved	Mitochondria		NA	NA			Mitochondria		"HPA021946: AB_1858140"			"unprognostic (1.28e-1)"										"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"				0.2	0.0	0.2	1.1	0.2	0.0	0.2	0.2	0.2	0.2	26.8	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	1.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	33.9	0.2	0.2	0.2	0.2	0.0	47.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	341.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	24.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0
TMOD2	NTMOD	ENSG00000128872	"Tropomodulin 2"	Q9NZR1	15	51751561-51816368	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 68.6"	"Cell type enhanced"	"Detected in many"	11	"Horizontal cells: 82.6"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 12.8;monocytes: 8.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041365	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA041365: AB_10794665"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (5.33e-4)"	"prognostic favorable (4.53e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.89e-1)"	5.9	6.3	25.4	6.1	29.6	1.6	5.1	22.0	68.6	7.0	6.1	9.1	4.6	3.1	6.0	4.4	4.9	6.0	5.2	4.9	21.6	18.1	3.5	2.2	4.5	4.9	16.9	22.6	6.5	3.1	6.7	4.4	3.0	29.5	3.7	5.1	2.9	3.8	9.6	2.7	4.6	4.7	6.7	11.4	4.5	3.7	3.1	9.6	1.2	4.3	0.2	4.7	4.7	4.6	2.5	1.6	12.8	8.8	1.3	2.2	1.1	0.8	0.5	1.7	4.0	8.2	8.9	0.3	4.5	1.5	3.5	3.7	0.0	0.4	3.6	0.1	3.5	3.6	2.4	7.2	4.0	1.1	0.0	3.5	0.0	0.7	0.0	1.4	1.4	0.2	5.1	5.5	0.5	1.0	4.6	0.7	9.6	0.0	0.1	4.3	0.6	2.9	0.5	1.1	0.0	0.8	2.3	1.0	0.1	0.5	1.2	26.5	6.5	4.2	0.0	1.2	2.3	1.0	0.2	1.6	9.4	0.7	5.9	3.2	0.0	0.0	0.0	2.9	9.8	4.3	0.1	5.9	7.8	2.2	2.3	1.0	2.5	1.3	1.0	1.6	1.8	1.7	0.7	12.8	1.3	8.8	1.2	0.4	1.1	25.4	29.6	22.0	38.3	21.6	18.1	16.9	22.6	29.5	9.6	0.0	5.5	3.0	2.9	4.2	24.2	5.4	0.0	4.0	2.3	10.4	21.6	0.1	6.6	3.4	20.6	11.4	0.3	0.0	1.5	0.0	2.8	1.7	0.0	0.2	4.2	82.6	22.4	13.5	7.8	15.1	10.3	5.7	1.7	27.9	0.3	11.6	2.1	0.0	5.3	1.0	19.7	6.5	4.2	6.3	4.7	6.6	0.2	4.4	0.4	1.8
TMOD3	UTMOD	ENSG00000138594	"Tropomodulin 3"	Q9NYL9	15	51829628-51947295	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Alveolar cells type 1: 369.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001849	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		21000000	Cytosol	"Actin filaments"	"HPA001849: AB_1080313"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (7.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.58e-3)"	23.0	9.6	7.3	14.2	9.7	7.7	14.1	7.5	7.7	16.4	16.0	4.6	32.4	13.3	13.4	11.8	53.1	12.0	12.0	10.5	7.7	6.3	16.6	14.6	25.4	10.3	8.1	4.2	12.7	9.3	8.0	9.2	20.2	8.5	11.0	13.9	6.9	20.8	21.4	5.9	15.4	21.7	11.1	8.7	20.5	14.4	6.6	8.0	19.6	11.4	21.9	22.7	16.5	27.2	14.4	17.6	28.3	21.9	10.7	15.1	9.4	23.6	23.7	9.6	2.5	9.5	16.0	10.9	11.0	15.1	11.5	10.4	9.1	18.0	5.8	9.0	11.7	8.2	34.8	8.8	24.8	14.8	9.6	3.9	8.5	26.2	7.4	10.7	10.9	9.4	10.7	24.2	9.3	28.9	14.3	20.3	8.4	9.0	8.8	13.9	17.5	7.2	7.3	5.3	15.1	3.9	8.7	11.4	14.9	18.8	16.3	2.3	6.3	18.4	12.4	6.6	13.5	8.4	8.8	22.1	14.8	9.8	11.9	12.7	5.3	15.5	6.4	9.5	20.0	8.7	22.7	17.7	24.0	14.8	20.9	13.1	12.0	12.8	12.9	12.4	14.4	11.1	10.3	28.3	10.7	21.9	17.6	15.1	9.4	7.3	9.7	7.5	7.7	7.7	6.3	8.1	4.2	8.5	8.0	369.2	56.9	24.7	56.4	94.9	9.3	43.7	30.6	88.3	134.2	40.1	13.7	46.5	34.9	68.2	29.3	115.0	73.8	23.3	62.5	56.4	63.7	135.6	137.6	46.1	47.0	14.3	17.9	73.1	47.6	83.9	41.7	68.9	30.4	56.9	46.7	16.4	111.6	56.1	41.8	38.7	12.9	12.9	48.2	11.7	11.4	115.6	42.9	50.7	44.2	216.2
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33096801	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	6.3	5.4	3.7	6.8	5.2	20.3	6.8	5.3	7.4	4.5	6.9	4.1	7.4	6.4	6.5	12.0	7.0	5.4	9.9	4.4	3.6	3.7	13.9	13.1	9.3	9.6	3.5	3.0	5.7	9.7	12.1	5.2	8.4	4.9	4.6	6.5	9.0	7.7	6.5	3.8	10.3	11.0	4.6	3.8	7.2	6.8	3.2	2.3	2.4	9.5	2.2	7.2	5.3	5.0	0.8	2.2	4.2	5.5	0.1	1.4	0.9	1.3	1.7	1.0	1.6	1.2	1.0	25.5	0.6	0.9	1.5	0.9	2.5	3.5	0.7	1.1	1.6	0.8	1.4	1.6	1.4	2.5	3.8	0.6	3.1	1.7	1.9	0.8	2.6	4.5	1.1	1.2	1.9	1.3	0.7	1.8	1.6	2.3	2.7	1.1	1.2	1.1	1.2	1.0	0.3	1.0	1.3	0.5	1.7	1.4	1.7	0.2	0.6	0.8	2.4	0.6	1.3	1.3	3.8	2.5	2.3	2.9	1.2	2.4	2.2	1.4	0.4	2.9	2.0	1.5	0.0	2.3	0.7	0.4	5.5	1.4	0.8	0.5	0.1	2.2	0.3	0.0	0.0	4.2	0.1	2.3	0.4	0.5	0.9	3.7	5.2	5.3	7.4	3.6	3.7	3.5	3.0	4.9	2.3	0.0	2.2	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	1.3	0.0	0.7	1.2	0.3	0.2	0.0	0.2	0.8	1.6	0.0	0.6	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.4	0.9	0.4	0.3	2.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.6	0.1
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	67	"intestine: 154.6"	"Cell type enriched"	"Detected in single"	11	"Early spermatids: 4.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	20	"U-138 MG: 20.3;U-87 MG: 56.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 9.3"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	80.5	0.0	0.0	154.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	42.4	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.5	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.1	0.0	0.3	0.0	0.1	56.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9"	"Cell type enhanced"	"Detected in many"	18	"Enterocytes: 108.9;Paneth cells: 61.7;Undifferentiated cells: 54.6;Urothelial cells: 226.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 37.9;HaCaT: 16.2;OE19: 64.5;RPTEC TERT1: 26.6;RT4: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.3	0.3	0.2	14.2	0.3	0.0	0.3	0.3	0.2	11.4	23.5	0.1	0.0	16.1	3.1	2.8	60.9	0.6	45.4	0.3	0.3	0.3	17.7	0.3	3.2	0.0	0.2	0.0	0.3	0.4	0.0	0.3	0.8	0.1	9.9	26.2	0.2	4.0	0.0	0.3	2.4	27.4	4.2	0.2	0.3	13.7	0.7	0.0	0.6	0.3	13.7	41.0	43.9	22.3	0.5	0.1	4.5	0.7	0.2	0.1	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	37.9	0.0	1.4	0.0	0.0	16.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	1.1	0.0	64.5	0.0	0.0	0.0	0.0	26.6	33.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.9	0.2	0.7	0.1	0.1	0.0	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.0	1.7	0.0	21.5	1.0	0.0	0.6	0.0	17.4	36.4	10.4	0.0	0.1	0.0	0.1	2.6	0.0	108.9	0.0	6.6	1.6	0.2	6.8	5.7	0.0	0.2	0.0	4.1	0.0	0.0	1.3	0.0	1.0	0.0	0.0	49.1	0.0	30.7	61.7	0.0	1.4	0.0	0.0	0.7	0.0	0.1	5.5	0.2	0.0	54.6	226.3
TMPRSS5	"MGC141886, MGC148044"	ENSG00000166682	"Transmembrane serine protease 5"	Q9H3S3	11	113687546-113706373	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0"	"Cell type enhanced"	"Detected in some"	14	"Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 4.8;Muller glia cells: 3.4"	"Cancer enhanced"	"Detected in some"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.3;CAPAN-2: 7.1;WM-115: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010992			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA010992: AB_1858152"	"unprognostic (1.53e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.19e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.04e-3)"	2.1	1.7	10.8	1.0	24.0	3.2	2.2	2.1	14.8	1.2	1.0	21.6	0.0	1.0	1.2	0.9	1.8	1.1	2.2	1.2	11.5	5.7	0.9	0.9	0.9	1.1	11.6	12.7	1.4	1.2	0.6	1.5	1.2	16.5	1.2	1.3	0.9	15.0	1.4	6.0	2.7	0.7	1.2	16.9	1.1	2.4	2.3	8.8	0.0	1.1	0.4	1.3	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.8	4.3	2.5	0.5	0.4	0.6	1.2	0.5	0.6	0.9	2.5	7.1	0.3	3.2	0.5	0.8	0.8	0.3	0.4	0.3	0.4	1.3	1.0	0.6	0.0	0.3	1.0	0.8	0.6	0.6	0.5	1.2	0.5	0.8	1.7	0.8	0.5	0.9	0.0	0.8	1.2	0.5	4.3	0.2	0.9	0.5	0.0	0.7	0.4	0.6	1.0	0.5	0.1	3.5	0.6	0.5	0.5	0.5	0.9	1.7	0.6	0.7	0.5	0.2	0.1	0.4	0.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.0	2.1	12.3	11.5	5.7	11.6	12.7	16.5	8.8	0.0	0.0	0.0	0.2	0.2	0.5	0.4	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.4	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1
TMSB4X	"TB4X, TMSB4"	ENSG00000205542	"Thymosin beta 4, X-linked"	P62328	X	12975108-12977227	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 1074.5"	"Cell type enhanced"	"Detected in all"	9	"Hofbauer cells: 27421.6;monocytes: 60748.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			CAB033806	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		400000000	"Nucleoplasm, Vesicles, Cytosol"		"CAB033806: AB_2256019"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	122.3	97.5	79.8	105.4	76.4	169.0	87.1	33.2	74.8	92.3	93.3	62.0	59.7	38.5	83.7	67.2	62.7	53.0	92.5	54.9	90.8	67.8	69.6	50.8	134.4	205.2	111.4	84.0	61.9	51.0	4.4	23.4	53.4	74.3	46.6	86.6	31.2	42.3	100.4	28.9	39.6	71.5	75.1	195.6	205.7	98.9	26.4	63.8	96.8	34.4	48.6	154.5	112.2	62.1	296.5	495.3	775.0	554.0	272.7	521.9	1074.5	144.7	121.2	238.2	375.3	292.0	320.2	0.5	76.7	200.8	59.6	102.7	24.9	121.8	34.7	74.2	232.8	107.2	63.8	35.2	51.4	80.2	202.6	2.0	43.2	71.9	0.3	68.1	168.5	358.6	149.0	73.7	70.5	61.7	146.2	358.0	92.6	5.4	0.5	210.8	51.5	200.3	365.8	85.6	69.8	83.6	154.4	84.3	141.5	354.7	42.4	25.3	10.8	111.2	5.2	14.1	184.0	139.7	171.2	287.9	87.0	43.2	493.2	76.2	113.1	82.0	67.2	133.1	69.9	62.7	544.9	512.5	775.0	364.8	524.7	309.6	296.5	407.3	391.0	495.3	275.6	345.8	349.0	576.0	272.7	554.0	204.1	521.9	1074.5	79.8	76.4	33.2	74.8	90.8	67.8	111.4	84.0	74.3	63.8	4880.5	5161.6	6027.5	2141.8	7849.2	355.4	69.7	3189.8	1104.2	2643.4	6528.7	21.6	260.6	1848.6	14106.6	104.1	8207.2	4374.5	256.9	19960.8	448.9	5187.8	2457.6	4102.8	814.3	27421.6	58.8	1698.6	5862.6	15729.2	176.0	3640.8	24463.6	6022.8	60748.0	4889.5	45.5	20394.3	5909.2	5673.8	362.6	82.8	5639.7	7491.8	44.2	114.3	8329.0	380.3	13550.6	2818.5	7177.4
TMTC1	"ARG99, FLJ31400, FLJ41625, OLF"	ENSG00000133687	"Transmembrane and tetratricopeptide repeat containing 1"	Q8IUR5	12	29500840-29784759	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 23.2;Endothelial cells: 46.9;Ito cells: 33.2;Sertoli cells: 45.3;Smooth muscle cells: 28.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 2.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 29.2;HSkMC: 19.9;hTERT-HME1: 35.8;LHCN-M2: 19.9;RH-30: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016720	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA016720: AB_1858155"	"unprognostic (1.67e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.63e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.49e-4)"	"unprognostic (5.89e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.51e-3)"	29.3	12.8	12.9	4.6	30.8	0.5	25.8	2.2	9.0	11.4	8.4	2.9	4.3	3.0	7.4	2.9	6.1	12.6	6.2	15.7	15.2	8.1	13.1	2.4	6.7	2.4	5.4	7.8	8.7	2.9	10.0	18.7	2.7	9.1	6.4	5.4	7.1	3.7	8.3	13.7	2.9	4.6	12.7	4.9	34.1	7.4	2.8	6.2	0.8	3.7	4.4	2.0	8.9	10.5	0.1	0.1	0.4	2.3	0.1	0.1	0.3	0.0	0.0	5.2	0.0	16.6	11.2	0.0	5.4	11.1	1.4	1.2	0.0	0.0	0.0	2.7	3.4	6.1	0.0	0.1	0.1	0.0	0.1	1.6	0.0	15.7	0.2	29.2	0.7	0.0	19.9	1.9	13.8	35.8	4.2	0.8	0.0	0.0	0.7	19.9	0.0	0.0	0.0	4.0	0.0	7.2	0.0	41.8	0.7	0.0	0.1	0.4	0.4	0.6	0.0	1.3	2.0	0.0	0.2	2.2	1.3	0.8	0.7	4.3	7.3	0.0	0.0	9.5	0.0	0.1	0.2	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	2.3	0.1	0.0	0.3	12.9	30.8	2.2	7.6	15.2	8.1	5.4	7.8	9.1	6.2	3.0	1.1	0.0	1.0	3.0	7.1	23.2	0.0	1.4	0.0	3.5	0.0	0.0	0.0	0.0	6.5	46.9	0.0	0.0	0.0	0.0	7.5	2.4	0.0	4.9	0.5	0.0	0.0	33.2	14.6	4.8	7.5	2.4	10.1	0.0	0.0	0.4	0.0	0.0	17.3	0.6	1.2	45.3	28.9	0.5	0.4	1.8	1.6	0.0	0.0	0.1
TMTC2	DKFZp762A217	ENSG00000179104	"Transmembrane and tetratricopeptide repeat containing 2"	Q8N394	12	82686880-83134870	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 30.2;Melanocytes: 30.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.1;myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 16.6;WM-115: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026954, HPA026955"	Uncertain		Approved	"Plasma membrane,Actin filaments"		No	No			"Plasma membrane"	"Actin filaments"	"HPA026954: AB_2256025, HPA026955: AB_10602282"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.61e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.84e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.06e-2)"	4.7	1.7	9.1	8.9	19.7	2.9	5.9	8.1	15.7	8.1	12.5	27.3	15.2	4.6	8.5	7.4	11.4	15.4	11.9	3.1	13.4	8.7	10.6	1.7	9.6	2.8	17.6	15.3	3.1	6.6	6.5	4.7	5.1	14.3	9.9	9.1	2.5	8.3	30.3	2.0	7.4	6.2	10.4	22.5	2.2	13.1	4.6	18.0	0.4	7.9	1.1	4.3	10.5	11.5	0.8	2.6	0.0	3.1	0.0	0.3	0.9	0.8	3.3	16.6	0.1	2.2	2.1	1.5	1.0	0.3	0.9	0.1	0.2	1.7	0.0	0.3	5.9	0.6	1.4	4.8	2.5	0.2	3.7	2.8	0.0	2.5	0.1	0.2	1.1	0.5	0.6	2.2	0.1	0.8	1.7	1.4	1.8	0.0	2.2	0.2	1.7	0.8	4.3	0.6	3.0	2.8	0.0	0.7	0.3	1.5	7.2	4.4	8.0	1.5	2.4	10.8	3.0	2.5	0.2	0.8	2.9	0.9	3.7	1.3	4.1	2.8	0.6	0.6	1.9	40.4	0.0	3.1	0.0	0.1	1.0	0.3	0.8	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	9.1	19.7	8.1	11.6	13.4	8.7	17.6	15.3	14.3	18.0	8.9	6.2	2.4	14.8	12.8	30.2	1.1	15.3	10.7	15.9	14.0	7.9	9.2	0.0	3.9	5.6	8.0	2.6	0.0	7.1	1.6	7.9	11.3	0.0	1.0	1.8	7.9	2.4	1.3	9.8	4.0	5.5	5.5	30.4	1.8	8.2	12.1	8.1	2.9	1.1	1.4	1.6	6.5	2.1	0.4	0.9	10.0	3.4	1.3	4.8	12.8
TMTC4	"FLJ14624, FLJ22153"	ENSG00000125247	"Transmembrane and tetratricopeptide repeat containing 4"	Q5T4D3	13	100603927-100675093	"Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.7"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016489, HPA057056"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA016489: AB_1858157, HPA057056: "	"unprognostic (1.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	4.1	4.4	11.4	4.4	13.7	1.9	5.7	10.6	21.8	6.6	7.0	45.7	8.3	8.5	8.7	7.5	4.8	13.2	4.9	3.2	16.9	8.7	11.5	9.8	3.5	3.6	16.9	10.0	5.3	12.8	7.5	3.3	4.0	29.6	7.9	7.6	4.6	6.9	5.6	9.4	6.5	7.3	6.0	25.2	3.9	7.9	9.7	11.3	4.2	7.2	3.9	4.6	7.7	4.3	2.4	6.4	0.2	3.3	1.3	4.4	1.4	5.0	4.3	22.2	11.7	2.9	6.0	24.9	2.9	2.5	2.7	2.2	4.3	9.3	15.0	9.6	2.4	5.2	3.6	6.9	3.0	3.3	8.5	4.9	6.3	8.0	6.7	3.1	8.2	0.1	8.4	5.9	1.0	5.0	7.6	12.1	8.2	4.7	1.9	3.2	4.4	5.9	4.7	6.0	14.8	4.2	6.5	3.9	3.3	11.2	3.9	11.4	11.9	5.5	10.8	2.8	14.0	7.9	23.2	18.9	2.4	4.2	2.2	4.9	5.0	4.1	2.9	11.9	5.4	7.1	0.0	2.0	0.2	2.7	2.1	2.4	2.0	2.6	4.4	6.4	2.4	3.0	1.1	0.0	1.3	3.3	4.2	3.8	1.4	11.4	13.7	10.6	21.8	16.9	8.7	16.9	10.0	29.6	11.3	6.0	3.8	4.6	6.6	2.7	17.6	9.0	17.8	6.7	6.8	5.2	7.9	9.1	1.7	9.8	4.1	4.6	7.9	0.0	16.4	15.9	5.7	9.1	0.0	12.4	3.8	25.4	10.3	52.2	8.7	4.7	3.7	4.1	3.3	0.0	11.2	9.6	12.0	7.0	6.3	12.4	7.5	6.5	4.2	8.8	31.8	5.1	2.6	2.6	12.6	4.7
TMUB1	"C7orf21, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081080-151083546	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	10.6	15.2	10.3	16.1	11.0	13.7	17.8	9.1	16.0	9.7	27.5	9.0	17.0	31.8	10.4	15.4	21.6	9.6	18.0	17.3	10.6	9.6	25.5	35.5	12.9	15.6	10.2	10.0	13.1	51.5	9.5	21.1	18.9	8.3	16.1	6.0	12.7	29.6	12.9	33.8	15.1	39.2	12.8	8.7	16.1	24.0	11.5	8.5	23.9	23.6	12.9	19.1	18.7	11.8	8.0	4.2	18.2	3.6	3.1	9.5	1.8	24.4	22.1	5.2	26.8	3.4	4.2	19.5	10.0	8.5	9.0	10.0	19.0	29.9	16.4	21.6	4.9	11.6	16.7	5.8	8.9	2.0	30.0	20.5	7.0	20.5	28.8	8.8	8.6	24.8	6.5	7.4	7.5	2.0	6.8	6.6	17.0	43.7	22.4	4.0	39.5	28.7	37.2	22.3	14.4	13.4	18.0	6.6	30.3	9.3	19.0	19.1	21.3	8.1	12.5	13.1	3.2	9.8	12.0	8.0	11.4	8.4	14.3	16.5	35.3	19.4	11.2	26.4	16.2	14.4	3.5	2.7	18.2	5.4	3.6	4.7	4.4	8.0	5.8	2.8	8.0	7.8	4.5	4.7	3.1	2.2	4.2	9.5	1.8	10.3	11.0	9.1	16.0	10.6	9.6	10.2	10.0	8.3	8.5	6.0	5.6	49.1	25.7	23.5	14.7	8.1	22.9	0.0	0.0	21.0	13.7	83.6	29.9	61.9	8.5	23.9	135.7	0.0	95.6	50.7	20.3	31.1	16.1	44.1	39.1	19.1	39.6	21.5	20.8	2.5	11.5	25.8	30.4	58.7	75.9	22.0	80.5	108.7	15.6	34.6	14.8	38.8	29.9	25.1	10.6	32.2	79.1	52.4	64.5	33.0
TMUB2	MGC3123	ENSG00000168591	"Transmembrane and ubiquitin like domain containing 2"	Q71RG4	17	44186970-44191731	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043137	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043137: AB_10794388"	"unprognostic (4.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.78e-3)"	22.5	27.0	21.2	22.6	26.7	39.9	37.6	32.4	39.0	27.3	24.0	25.9	30.5	25.2	27.4	26.4	31.0	24.2	26.6	21.2	21.2	20.4	28.9	29.4	22.9	24.7	19.9	23.1	27.9	33.5	30.7	25.2	38.9	21.0	30.3	23.6	23.3	30.7	34.1	22.9	29.0	29.6	23.4	18.8	40.0	25.8	46.0	19.6	21.1	34.6	20.9	23.1	26.0	25.0	10.0	10.2	29.9	13.3	5.5	8.1	8.2	11.4	22.6	14.4	13.4	22.8	18.1	11.3	15.2	16.5	28.4	29.0	11.7	21.5	8.0	16.5	18.8	21.6	21.9	10.1	14.4	17.9	19.5	21.0	8.3	20.5	17.8	23.6	9.3	18.7	21.9	21.1	19.3	12.1	24.1	19.8	13.4	9.5	23.9	18.5	8.1	12.9	12.5	4.8	9.8	19.1	11.7	17.5	12.8	17.9	13.0	11.6	11.8	7.9	7.5	15.0	15.6	22.0	12.0	16.3	23.7	14.6	16.6	13.5	17.6	12.8	7.7	18.2	7.9	15.9	29.9	13.3	24.1	8.1	11.7	6.8	7.7	6.7	7.7	8.5	10.0	6.5	7.3	29.3	5.5	11.7	10.2	7.6	8.2	21.2	26.7	32.4	39.0	21.2	20.4	19.9	23.1	21.0	19.6	32.8	32.9	37.3	18.6	11.6	29.4	15.3	20.4	16.0	23.9	21.0	29.5	39.5	3.3	17.1	42.2	20.1	33.5	0.0	16.3	24.5	18.8	21.2	20.9	10.4	35.9	20.6	32.1	20.3	30.1	22.0	20.1	27.2	13.5	27.1	22.9	27.2	20.1	34.5	22.6	6.8	25.9	25.8	17.9	60.2	26.6	13.0	80.9	25.4	23.4	20.9
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712600-57740973	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	29.5	40.5	33.6	21.0	39.0	13.7	30.8	26.5	60.5	28.0	40.6	50.7	29.0	33.3	22.5	36.7	32.7	25.5	20.0	33.0	32.6	32.1	47.4	71.7	24.4	22.1	40.4	30.4	25.9	40.6	49.8	25.8	26.2	45.3	31.1	49.3	38.4	27.9	34.4	21.9	21.9	34.0	26.1	42.3	25.4	29.9	19.1	31.3	24.0	34.4	25.8	27.0	22.2	22.6	17.7	23.1	17.9	37.5	16.5	21.8	18.8	28.5	33.5	19.3	34.7	36.0	19.3	21.1	34.5	26.8	34.0	28.9	31.8	49.2	26.8	38.6	27.7	50.6	52.8	48.8	27.6	36.1	19.2	21.2	25.9	27.1	31.8	29.7	36.1	35.7	23.6	40.4	37.6	60.0	18.7	19.3	22.6	44.4	31.7	37.9	14.6	21.3	41.2	37.3	53.3	46.0	29.0	24.2	56.7	42.3	32.3	22.1	31.6	26.6	61.9	38.3	19.6	55.3	23.9	16.1	32.1	21.0	42.7	35.6	31.2	60.8	27.1	36.1	25.7	47.5	15.9	19.6	17.9	17.1	33.1	21.6	17.7	17.3	20.0	19.0	15.3	21.8	21.8	5.2	16.5	37.5	23.1	14.3	18.8	33.6	39.0	26.5	60.5	32.6	32.1	40.4	30.4	45.3	31.3	35.7	30.6	38.1	36.3	28.5	43.9	38.7	40.8	34.8	34.2	47.1	29.5	94.9	36.5	67.4	1.6	34.9	38.2	0.0	37.5	68.8	35.4	39.2	42.7	45.2	57.0	28.6	27.6	33.7	27.3	1.9	45.1	35.0	45.5	31.5	45.0	90.9	45.2	35.1	41.1	38.0	52.4	38.8	26.2	56.1	68.8	28.5	83.3	22.4	61.2	41.0
TMX4	"DJ971N18.2, KIAA1162, PDIA14, TXNDC13"	ENSG00000125827	"Thioredoxin related transmembrane protein 4"	Q9H1E5	20	7977348-8019829	"Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 607.5;Late spermatids: 1164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000399, HPA015752"	Enhanced		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA000399: AB_1858471, HPA015752: AB_1858470"	"unprognostic (3.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.14e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.96e-1)"	"unprognostic (5.80e-3)"	"unprognostic (3.16e-1)"	"prognostic favorable (2.60e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.06e-2)"	11.2	24.6	15.4	10.6	20.8	15.7	12.2	19.9	30.5	27.5	17.6	11.7	34.2	8.0	18.0	21.6	10.0	18.6	13.3	35.0	15.5	30.9	18.5	17.3	11.6	14.7	15.6	16.2	23.0	11.0	23.9	40.9	7.6	21.8	16.7	8.2	14.7	24.2	31.4	21.7	6.5	10.2	19.2	10.7	9.9	13.7	48.2	7.2	8.5	16.3	8.8	8.7	14.8	11.2	10.1	9.9	51.2	8.0	11.5	17.8	13.5	4.2	6.4	6.4	7.2	14.3	15.9	1.9	11.1	15.4	7.1	5.1	4.3	10.7	11.5	8.8	11.1	10.4	3.9	4.6	6.8	7.4	5.8	5.1	5.7	2.8	7.0	13.5	21.0	8.5	9.6	8.7	6.1	14.4	17.1	8.1	8.7	7.0	29.6	7.8	2.9	0.6	13.2	5.1	6.5	7.1	6.6	22.9	12.0	10.1	2.5	12.8	15.7	18.4	0.8	10.9	4.2	7.8	10.3	10.7	19.1	5.3	7.1	10.8	29.9	8.3	23.1	9.2	10.5	13.3	22.6	8.0	23.3	12.2	4.7	12.0	10.1	12.5	17.8	9.9	8.1	7.6	10.2	51.2	11.5	5.0	3.3	15.9	13.5	15.4	20.8	19.9	30.5	15.5	30.9	15.6	16.2	21.8	7.2	32.8	26.9	44.7	51.6	14.5	52.6	198.1	50.9	28.1	23.9	55.8	55.0	16.8	18.3	23.8	607.5	41.3	21.6	0.0	28.7	5.3	46.6	47.3	59.9	47.0	23.0	87.4	53.6	33.7	36.0	1164.8	71.4	37.5	43.9	7.2	21.4	79.0	22.5	19.8	52.6	20.7	90.7	32.3	28.1	158.4	45.1	13.7	6.9	66.0	23.9	26.3
TNFAIP1	"B12, B61, BTBD34, EDP1, MGC2317"	ENSG00000109079	"TNF alpha induced protein 1"	Q13829	17	28335602-28347009	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013333, HPA014641"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA013333: AB_1858160, HPA014641: AB_1858159"	"unprognostic (4.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.32e-2)"	"prognostic unfavorable (7.48e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.43e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.02e-2)"	23.1	20.4	17.5	13.3	20.9	5.4	20.7	17.5	32.2	17.2	13.5	17.7	12.6	12.9	17.3	12.1	29.2	12.9	21.1	28.6	14.6	11.4	22.9	69.9	27.8	11.7	15.0	16.5	15.2	30.3	19.5	12.7	43.2	14.2	14.3	12.4	19.2	17.5	15.8	14.8	19.5	16.2	22.1	13.9	40.4	16.8	13.3	14.3	12.5	17.7	18.5	14.7	19.8	15.6	7.2	10.9	11.0	9.6	11.2	10.0	5.8	13.3	19.9	13.1	9.3	11.2	9.9	12.8	16.0	19.7	19.5	15.4	52.4	8.2	3.0	11.1	20.9	9.9	15.7	7.1	27.4	15.1	7.4	9.6	2.4	19.9	7.9	15.1	4.2	4.1	12.8	32.1	15.5	12.1	18.9	22.7	5.8	6.0	4.1	9.1	8.4	7.6	2.7	3.2	12.1	7.0	3.4	16.9	4.7	28.7	14.4	9.7	10.5	20.1	33.7	8.7	19.3	14.1	3.7	24.2	14.6	14.4	11.3	12.2	6.9	5.8	3.0	11.6	3.1	9.3	2.2	8.6	11.0	8.6	8.6	10.0	7.2	6.3	7.6	10.9	5.4	6.2	7.2	2.9	11.2	9.6	5.7	5.4	5.8	17.5	20.9	17.5	32.2	14.6	11.4	15.0	16.5	14.2	14.3	35.7	11.7	6.0	35.7	21.9	22.0	17.3	20.4	13.4	13.6	21.0	15.7	29.0	19.9	56.1	28.8	44.4	10.0	0.0	71.6	29.4	14.3	38.6	6.9	26.4	9.5	11.1	16.7	54.6	12.9	4.2	7.2	6.0	0.0	45.1	9.9	9.5	88.7	12.2	7.4	13.5	9.3	12.9	11.3	3.9	5.5	24.8	57.9	6.5	8.4	39.9
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103123442-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 414.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 25.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 128.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: AB_2673552"	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (7.17e-5)"	27.3	17.0	3.8	58.2	5.7	20.1	19.3	2.5	3.6	23.5	12.9	2.8	4.7	8.1	16.7	18.7	35.5	14.3	30.9	12.7	2.9	3.6	18.8	13.6	32.0	17.9	4.6	3.0	9.7	9.0	17.4	3.5	33.0	6.1	21.7	6.1	16.3	25.1	7.1	12.5	13.2	11.3	28.0	3.8	35.9	8.3	13.0	2.9	11.0	8.5	31.4	48.6	39.8	16.3	0.1	5.0	25.9	9.8	0.1	0.1	1.9	5.5	27.4	0.2	0.1	1.8	7.9	9.2	1.6	7.0	4.4	1.5	0.3	24.9	0.0	20.5	8.0	23.4	17.7	1.9	0.0	2.1	0.9	0.1	2.5	19.1	0.1	3.4	1.2	3.4	3.0	0.2	1.4	0.0	1.7	2.3	1.3	2.5	6.0	0.6	0.5	0.0	1.9	1.6	3.2	2.2	1.1	3.1	4.0	14.0	128.9	0.2	0.3	25.2	8.8	0.3	1.0	14.2	8.1	4.7	0.9	2.4	5.1	5.0	5.4	0.4	0.1	6.7	5.6	2.6	2.5	8.8	4.6	0.0	9.8	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	25.9	0.1	6.9	0.2	0.0	1.9	3.8	5.7	2.5	3.6	2.9	3.6	4.6	3.0	6.1	2.9	0.0	33.8	0.5	27.9	25.1	0.6	12.5	40.8	25.4	30.7	26.2	0.0	0.8	0.0	129.0	29.4	40.9	0.4	0.0	39.8	58.7	62.7	91.7	33.4	6.4	46.3	0.0	16.6	22.1	116.0	36.8	7.8	125.1	28.7	414.8	0.0	8.0	86.0	6.5	2.1	5.5	0.4	19.4	41.0	1.1	2.8	29.2	4.0	2.5	0.2	83.4
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867188-137883312	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.4"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 688.4;Suprabasal keratinocytes: 651.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 31.8;Karpas-707: 48.1;REH: 41.8;U-266/84: 35.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	27.4	6.0	1.5	58.6	1.8	112.4	17.2	0.4	1.5	7.7	15.7	3.2	2.6	5.1	9.7	7.3	12.7	12.1	17.0	11.7	2.1	1.3	6.8	8.1	45.1	38.8	2.1	2.6	37.5	7.2	2.1	3.7	14.5	4.6	13.8	6.3	7.2	8.2	3.5	10.7	20.5	17.2	8.2	3.8	25.9	8.0	9.3	2.1	38.6	5.7	9.2	31.4	23.3	9.5	7.1	18.6	10.0	9.7	7.5	20.5	9.0	8.9	1.4	0.5	0.8	3.0	5.1	2.1	5.1	19.9	1.4	1.8	9.9	2.9	2.0	13.1	5.8	31.8	6.8	0.3	14.7	2.6	14.5	0.5	2.0	5.1	5.8	3.3	2.7	3.6	4.6	2.1	16.8	16.0	1.7	0.8	5.3	4.0	48.1	2.4	0.5	14.7	11.5	0.3	0.6	0.4	41.8	10.4	1.4	4.3	4.3	0.2	0.0	1.0	1.5	4.3	2.1	1.0	3.3	4.0	14.4	1.7	12.9	2.9	15.5	35.9	4.1	5.2	3.4	1.7	5.6	9.7	5.5	14.8	7.1	20.5	6.2	15.1	13.3	10.3	7.1	10.0	7.4	10.0	7.5	3.7	18.6	14.7	9.0	1.5	1.8	0.4	1.5	2.1	1.3	2.1	2.6	4.6	2.1	35.7	83.1	25.1	141.6	688.4	1.0	4.2	30.6	41.5	26.1	0.0	27.5	5.5	1.7	50.3	2.3	27.0	39.0	0.0	23.4	88.6	55.5	117.9	248.4	10.2	45.4	0.0	11.3	45.4	74.2	2.4	6.4	241.1	123.2	82.0	12.5	1.7	27.9	8.2	5.6	2.2	13.3	6.5	87.3	0.9	2.3	651.8	19.3	101.2	8.5	60.3
TNFAIP8L2	FLJ23467	ENSG00000163154	"TNF alpha induced protein 8 like 2"	Q6P589	1	151156629-151159749	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 63.1;lymphoid tissue: 38.7"	"Cell type enhanced"	"Detected in some"	14	"Hofbauer cells: 59.6;Kupffer cells: 56.1;Macrophages: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 12.8;HL-60: 7.5;HMC-1: 19.9;NB-4: 10.8;THP-1: 41.5;U-937: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062742			Approved	Vesicles		NA	NA			Vesicles		"HPA062742: "	"unprognostic (3.19e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.15e-3)"	"prognostic favorable (3.64e-4)"	"unprognostic (9.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.23e-1)"	8.5	4.2	5.7	13.8	8.8	4.1	2.7	1.3	4.5	2.0	3.2	4.0	0.0	3.9	2.0	2.6	2.1	3.0	4.1	2.8	4.1	3.3	2.9	6.0	8.2	20.9	8.2	2.2	1.8	2.0	0.3	1.9	7.0	7.2	2.6	4.6	1.8	6.4	1.4	1.0	2.7	6.9	3.9	8.0	38.7	2.5	1.0	6.9	21.0	1.8	1.2	12.8	7.2	1.9	17.7	56.4	63.1	50.6	47.1	43.9	44.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.1	0.0	0.0	7.5	19.9	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.0	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	41.5	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.8	0.0	16.3	0.0	53.4	50.6	50.0	23.3	45.4	22.9	15.6	28.8	23.5	56.4	17.7	43.9	31.5	63.1	47.1	41.2	13.3	31.6	44.8	5.7	8.8	1.3	4.5	4.1	3.3	8.2	2.2	7.2	6.9	0.0	1.7	16.4	0.0	0.2	0.2	0.0	5.1	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.7	0.2	59.6	0.0	0.0	1.3	56.1	0.0	0.3	47.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.3	0.3	13.8	0.0	0.0
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.0;smooth muscle: 47.0"	"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 9.9;Leydig cells: 8.3;Smooth muscle cells: 9.2;Spermatocytes: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.9;ASC TERT1: 32.9;HSkMC: 12.1;HUVEC TERT2: 28.1;LHCN-M2: 26.4;TIME: 37.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (3.51e-4)"	4.6	2.4	11.8	4.1	3.8	0.8	10.5	0.6	5.8	9.8	4.1	1.8	2.8	1.2	47.0	9.9	11.5	20.9	3.7	5.5	11.4	3.1	1.9	1.5	6.6	5.4	1.9	5.6	17.5	1.6	0.6	1.8	1.4	3.3	6.6	5.0	0.6	1.9	3.5	2.1	10.7	3.2	47.0	1.5	14.7	2.9	3.4	1.1	0.0	2.5	4.7	2.4	12.3	18.8	1.4	1.0	3.7	1.5	1.7	0.8	0.3	0.0	0.1	0.0	0.0	12.9	32.9	0.1	0.1	0.0	0.3	0.5	0.0	0.3	0.0	0.6	1.8	4.1	0.0	0.4	0.3	0.1	0.0	0.3	0.0	0.9	2.1	3.4	0.1	0.7	12.1	2.6	2.4	9.5	2.2	28.1	0.0	0.0	0.0	26.4	0.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.2	37.7	2.9	0.2	9.7	0.7	0.1	0.0	0.0	6.1	0.0	0.0	2.8	1.5	0.7	0.5	0.7	0.6	0.8	0.6	0.5	0.3	1.4	0.6	0.8	3.7	1.7	1.0	1.0	0.4	0.3	11.8	3.8	0.6	5.8	11.4	3.1	1.9	5.6	3.3	1.1	0.0	0.3	0.0	0.6	3.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.3	0.0	3.7	0.4	0.0	0.0	2.7	0.0	9.9	2.5	2.5	0.4	8.3	2.8	1.7	1.0	2.8	0.0	0.1	1.1	4.9	0.0	0.2	6.5	9.2	16.8	0.4	7.3	0.0	0.0	2.6	0.4
TNFRSF10D	"CD264, DcR2, TRAILR4, TRUNDD"	ENSG00000173530	"TNF receptor superfamily member 10d"	Q9UBN6	8	23135588-23164030	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 9.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 24.5;LHCN-M2: 61.9;WM-115: 58.8"									HPA070971			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA070971: AB_2686330"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.72e-1)"	16.0	3.1	4.9	7.3	10.0	10.5	10.2	3.4	10.3	5.9	8.5	2.6	5.5	6.2	8.9	5.7	4.1	8.0	11.5	6.5	7.0	3.4	12.1	31.5	12.5	5.1	9.0	0.9	9.8	5.2	2.5	4.3	4.1	9.0	9.0	10.9	3.9	3.9	4.4	3.9	3.1	11.2	10.9	6.3	6.9	7.2	4.3	9.2	2.9	6.0	6.8	6.6	7.3	26.0	2.1	4.5	2.4	3.3	0.3	9.0	2.4	3.5	3.1	4.0	2.3	3.1	12.3	0.0	19.2	7.3	1.4	2.0	5.9	3.0	0.0	4.0	11.4	0.0	1.2	3.3	16.8	12.7	0.0	3.0	1.0	1.8	5.0	13.5	0.6	1.3	15.4	18.8	5.1	3.5	18.0	24.5	0.1	0.0	0.0	61.9	0.0	0.0	1.9	3.2	10.6	0.0	0.7	0.0	0.9	4.7	1.6	0.0	0.0	2.0	0.0	0.0	9.5	0.0	2.4	14.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.0	0.9	58.8	2.4	3.3	1.5	0.0	1.4	0.1	2.1	3.2	1.1	4.5	0.8	9.0	3.5	2.2	0.3	1.9	0.0	1.0	2.4	4.9	10.0	3.4	10.3	7.0	3.4	9.0	0.9	9.0	9.2	0.0	12.7	0.5	3.2	4.4	0.0	1.4	2.5	5.3	5.7	1.8	0.0	0.1	0.0	5.7	0.4	31.4	5.9	0.0	1.8	0.2	2.5	4.7	7.0	6.6	2.6	0.0	1.7	11.6	9.8	0.0	0.3	3.6	8.5	1.0	4.8	0.3	8.4	2.9	0.4	2.1	0.0	0.0	11.7	0.7	2.7	2.0	0.1	1.3	6.3	3.3
TNFRSF12A	"CD266, FN14, TweakR"	ENSG00000006327	"TNF receptor superfamily member 12A"	Q9NP84	16	3018445-3022383	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.3"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 1094.9;Ductal cells: 954.3;Exocrine glandular cells: 607.7;Pancreatic endocrine cells: 874.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 25.0"	"Group enriched"	"Detected in many"	8	"eosinophil: 38.1;neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 38.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA007853	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		170000	"Plasma membrane, Cytosol"		"HPA007853: AB_1858463"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.06e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.04e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.98e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.17e-2)"	10.8	14.2	2.4	11.3	5.1	2.7	21.2	0.9	3.0	8.0	18.9	3.2	4.1	14.5	11.6	10.2	10.7	6.4	28.1	27.0	5.0	2.6	50.4	36.2	23.0	2.6	4.8	0.5	6.4	47.0	51.1	20.0	81.3	25.0	11.1	1.9	2.8	17.3	6.9	23.3	5.0	31.0	16.8	4.3	3.9	13.2	5.3	3.3	1.2	11.5	11.5	4.7	14.8	5.2	0.0	4.1	38.1	3.5	2.0	2.4	1.1	24.5	19.9	2.2	4.1	4.1	9.3	13.2	51.8	37.5	44.4	28.6	8.6	43.9	0.1	68.6	34.4	51.6	27.2	0.5	37.9	17.0	0.9	1.3	0.1	6.7	7.2	28.0	0.4	1.8	8.6	26.3	46.6	55.9	38.3	12.8	0.0	2.7	0.3	46.7	46.5	0.0	3.3	10.7	11.0	43.8	0.2	24.9	1.0	44.9	4.9	2.5	0.9	36.9	17.2	30.5	7.7	9.0	0.7	22.5	80.0	36.9	52.9	84.9	0.8	0.3	0.3	25.0	2.3	62.8	3.5	3.5	38.1	1.8	2.0	2.4	0.0	0.8	1.5	4.1	0.0	0.4	0.8	29.9	2.0	1.3	0.1	1.0	1.1	2.4	5.1	0.9	3.0	5.0	2.6	4.8	0.5	25.0	3.3	95.3	43.1	5.0	1094.9	544.0	0.9	57.7	163.1	50.9	130.8	172.7	2.0	112.5	54.7	954.3	0.6	22.7	41.3	0.0	607.7	131.7	179.4	600.3	58.8	15.3	38.1	0.0	26.1	28.8	4.6	0.4	5.8	29.4	106.3	16.2	4.6	20.6	874.5	25.8	6.3	93.5	5.1	6.5	212.1	7.7	4.1	314.4	158.1	8.6	12.4	560.0
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 60.5;skin 1: 47.9"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 55.3;Ciliated cells: 84.3;Suprabasal keratinocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.9;T-reg: 4.0"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.5;BJ hTERT+: 26.9;fHDF/TERT166: 20.4;Hep G2: 27.9;SK-MEL-30: 46.5;WM-115: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA010135: AB_1079797"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.3	1.3	1.0	0.4	1.4	0.6	4.6	0.8	2.0	3.4	1.5	3.0	17.1	0.7	5.3	7.3	5.1	14.3	2.3	14.7	1.5	1.5	7.1	0.5	7.9	0.6	3.0	1.3	3.4	2.2	0.1	8.0	3.8	2.8	12.7	0.8	11.4	60.5	13.0	1.2	47.9	0.9	4.1	1.9	2.5	2.4	2.7	1.1	0.8	5.7	8.0	3.7	2.7	4.0	1.9	0.7	0.7	0.0	0.6	4.0	0.2	0.0	1.0	1.2	0.0	1.6	16.5	1.2	1.2	26.9	0.6	0.9	7.8	0.0	0.0	0.0	20.4	0.1	0.0	1.1	0.9	1.2	0.0	0.9	0.2	0.8	27.9	0.7	0.0	0.3	7.8	0.2	7.8	0.1	0.5	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.0	0.7	9.6	1.7	0.0	4.5	0.0	2.8	0.1	10.7	1.8	0.0	0.0	46.5	1.3	0.0	0.1	0.0	3.9	0.2	0.0	1.1	0.0	0.0	0.0	1.5	0.0	28.9	0.0	0.0	0.7	0.0	0.0	0.4	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.7	4.0	0.2	1.0	1.4	0.8	2.0	1.5	1.5	3.0	1.3	2.8	1.1	0.0	17.3	0.0	3.6	55.3	0.6	19.1	2.5	84.3	14.8	8.7	7.9	0.2	0.0	9.9	1.1	2.9	0.0	0.0	0.9	0.0	9.8	18.5	1.1	0.6	0.1	0.0	0.0	0.0	0.0	0.8	10.6	0.2	13.5	0.0	0.0	3.0	7.4	0.0	13.1	18.8	2.5	0.0	5.7	0.9	2.1	70.1	0.0	0.5	0.0	0.5
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.4"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 142.4;Glandular cells: 135.6;Syncytiotrophoblasts: 149.4;Urothelial cells: 360.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	35	"plasmacytoid DC: 31.6"	"Lineage enriched"	"Detected in single"	309	"dendritic cells: 31.6"	"Cell line enhanced"	"Detected in many"		"OE19: 39.2;RT4: 99.8;SuSa: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1300000	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	25.9	3.7	9.7	8.7	13.6	5.9	7.8	7.4	20.8	9.6	19.3	26.9	1.0	6.4	9.1	3.0	21.8	9.9	18.7	4.1	13.8	16.0	26.2	4.6	9.5	11.5	26.8	7.9	5.0	17.9	35.6	4.4	17.0	29.5	10.2	18.5	3.0	15.2	2.4	3.5	2.7	10.2	8.2	63.4	11.6	30.4	5.8	10.1	11.5	2.9	19.2	16.5	41.2	11.6	0.0	31.6	0.1	0.0	0.0	0.0	0.2	29.2	9.5	9.3	2.9	25.5	7.5	10.5	3.4	6.7	1.0	0.4	16.4	20.7	2.1	13.8	2.4	20.0	17.7	1.3	12.6	0.6	0.0	2.9	0.0	1.2	16.5	14.9	0.4	0.1	13.4	15.1	0.6	11.5	0.8	4.9	1.9	0.7	0.0	0.3	5.7	2.5	0.2	7.3	39.2	9.8	5.4	2.8	3.1	17.7	99.8	6.7	1.4	2.9	2.8	2.4	43.8	2.1	2.0	1.0	2.8	2.5	0.1	3.1	0.0	0.0	3.0	4.5	2.1	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.2	9.7	13.6	7.4	20.8	13.8	16.0	26.8	7.9	29.5	10.1	0.0	12.7	0.0	142.4	21.1	0.6	7.6	35.7	10.7	25.0	1.8	0.0	24.6	13.3	69.3	45.6	5.6	30.3	0.0	25.8	16.8	14.1	135.6	19.6	0.0	20.6	0.0	11.5	1.8	36.8	29.9	2.6	5.8	11.8	0.0	40.2	4.4	63.5	46.7	1.1	48.5	1.3	77.6	16.2	0.6	1.4	8.7	149.4	1.3	14.0	360.8
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"	NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.6	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.3	2.2	0.0	3.0	0.0	1.0	3.2	0.4	3.7	0.0	20.2	1.5	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.2	1.9	3.2	0.9	0.0	0.0	0.0	1.6	0.0	8.0	1.0	1.1	5.5	0.6	0.2	19.7	0.8	0.5	3.9	5.4	0.0	1.9	0.1	0.3	1.7	2.2	1.7	1.0	1.5	0.0	1.5	0.0	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8	3.0	5.3	0.5	1.8	21.9	0.8	0.8	2.5	2.7	2.3	1.8	2.0	0.4	0.0	0.1	0.3	5.5	16.9	0.0	0.4	1.6	3.2	1.1	6.9	1.1	3.2	4.8	6.4	9.8	1.6	0.0	2.6	2.1	6.8	1.0	17.6	11.2	0.9	11.5	8.9	0.3	9.3	0.0	0.8	0.5	1.1	25.0	0.1	36.2	28.4	6.7
TNFRSF9	"4-1BB, CD137, ILA"	ENSG00000049249	"TNF receptor superfamily member 9"	Q07011	1	7915894-7943165	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 13.5;lymphoid tissue: 18.3"	"Group enriched"	"Detected in some"	4	"granulocytes: 62.3;monocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 47.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA071425			Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA071425: AB_2686394"	"unprognostic (7.23e-2)"	"unprognostic (1.72e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-4)"	"unprognostic (9.47e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (2.69e-8)"	"unprognostic (1.64e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.55e-2)"	0.8	1.0	0.3	11.0	0.3	1.9	0.5	0.2	0.3	0.4	0.5	0.1	0.1	0.6	0.3	0.1	0.6	0.8	1.6	1.8	0.3	1.0	0.7	0.7	2.1	10.8	0.3	0.1	0.3	0.6	0.0	0.5	0.2	0.5	0.4	0.7	0.3	2.1	0.1	0.3	0.5	2.3	0.1	0.3	7.9	0.7	0.5	0.1	18.3	0.7	0.9	17.5	1.4	0.4	0.5	1.1	6.6	1.5	4.1	13.5	1.1	1.2	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	1.0	0.4	0.1	0.4	0.0	0.8	0.2	0.0	0.2	0.5	47.0	0.1	0.2	0.2	0.0	0.9	0.0	0.5	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.7	0.0	0.2	0.2	0.2	1.6	0.1	0.2	0.1	0.1	0.1	5.8	0.2	0.0	1.1	1.5	0.2	1.5	0.4	0.2	0.2	1.0	8.0	1.1	0.5	0.3	1.6	6.6	4.1	0.1	0.3	13.5	1.1	0.3	0.3	0.2	0.3	0.3	1.0	0.3	0.1	0.5	0.1	0.0	1.7	0.0	0.4	0.2	0.0	0.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	1.0	0.0	0.4	0.3	62.3	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	1.8	5.0	53.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.4	0.0	12.9	0.0	0.3
TNFSF12	"APO3L, DR3LG, TWEAK"	ENSG00000239697	"TNF superfamily member 12"	O43508	17	7548891-7557890	"Predicted secreted proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Cytokine, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.8;BJ hTERT+: 11.2;fHDF/TERT166: 9.7;HDLM-2: 9.9;HSkMC: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	853000	150000	Vesicles		"HPA035984: , HPA052967: AB_2682000"	"unprognostic (2.96e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.71e-2)"	"prognostic favorable (5.70e-5)"	"unprognostic (5.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.09e-2)"	"unprognostic (6.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.38e-1)"	32.9	16.7	23.0	14.0	16.9	2.9	20.4	15.7	21.8	22.1	27.4	9.5	18.0	9.5	17.6	18.6	24.5	19.8	30.1	23.3	16.3	13.3	15.0	8.8	23.8	16.8	14.8	13.9	31.3	20.6	9.0	8.4	13.4	7.8	27.8	6.2	19.7	26.7	32.7	12.8	8.2	11.3	24.2	9.1	21.6	18.0	7.4	8.5	2.6	11.3	9.6	11.0	26.0	37.7	2.6	2.4	10.5	5.7	2.4	6.9	0.8	0.0	0.0	0.5	0.0	9.1	11.8	2.5	4.0	11.2	4.5	2.7	0.0	1.4	0.0	3.5	9.7	0.4	0.9	0.4	0.4	0.4	9.9	1.7	0.6	0.3	0.8	8.9	0.0	0.0	10.3	1.1	1.5	0.1	2.1	7.3	0.0	0.1	0.0	3.9	0.0	0.0	0.3	0.4	0.0	5.0	0.1	0.0	0.1	7.2	0.0	0.0	4.7	1.3	0.0	3.8	0.1	0.7	0.4	7.0	6.1	0.5	0.0	2.1	0.0	0.0	0.0	1.1	0.0	5.4	4.0	3.1	10.5	5.2	5.7	6.9	2.6	3.8	2.8	1.8	2.5	4.4	4.1	2.2	2.4	1.4	2.4	4.1	0.8	23.0	16.9	15.7	21.8	16.3	13.3	14.8	13.9	7.8	8.5	8.9	9.8	8.7	9.8	5.5	7.7	3.8	12.7	0.0	4.5	15.7	0.0	1.2	6.6	12.4	0.4	20.4	1.1	0.0	10.6	0.8	13.3	9.0	34.5	2.9	40.2	19.1	1.2	28.8	42.6	0.0	46.9	42.4	18.6	28.9	1.7	29.4	7.9	0.0	47.4	29.4	2.2	58.2	36.0	0.2	1.2	6.6	0.7	21.4	3.7	4.6
TNFSF12-TNFSF13	TWE-PRIL	ENSG00000248871	"TNFSF12-TNFSF13 readthrough"		17	7549099-7561601	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	40	"Alveolar cells type 2: 3.0;Ciliated cells: 2.7;Club cells: 6.8;granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.9;eosinophil: 10.5;intermediate monocyte: 6.5;myeloid DC: 2.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 10.5;monocytes: 6.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.5;fHDF/TERT166: 3.2;HUVEC TERT2: 2.9;U-138 MG: 4.6;U-251 MG: 4.7"	"Low region specificity"	"Detected in many"							"HPA004863, HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA004863: AB_1078187, HPA035984: , HPA052967: AB_2682000"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.23e-2)"	10.0	8.6	3.2	6.1	3.1	5.6	5.6	3.2	6.1	5.9	3.5	1.9	4.8	2.7	3.8	5.0	7.0	3.1	8.9	4.3	3.1	3.1	3.1	3.1	6.6	7.1	3.1	3.4	5.9	3.3	2.0	3.1	2.4	1.3	8.2	1.7	5.4	4.4	4.4	3.1	3.1	3.6	6.9	3.1	5.6	5.7	3.1	1.6	0.0	3.1	1.9	4.8	7.5	11.5	1.2	2.7	10.5	6.5	0.4	1.1	1.6	0.0	0.4	0.0	0.0	0.0	0.6	0.4	1.3	4.5	1.6	2.5	0.0	0.2	0.0	0.8	3.2	0.0	0.0	1.4	0.0	0.9	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	0.5	1.0	0.9	0.0	0.0	2.9	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.4	0.9	0.0	0.0	0.0	1.7	0.0	0.0	2.2	0.4	0.0	1.1	0.0	0.0	0.0	1.3	4.6	0.3	0.0	4.7	0.0	0.0	0.0	1.0	0.0	0.6	0.8	3.9	10.5	0.4	6.5	0.5	0.8	0.7	0.4	2.7	1.2	0.4	0.3	0.5	0.4	0.5	1.4	1.1	1.6	3.2	3.1	3.2	6.1	3.1	3.1	3.1	3.4	1.3	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 76.5;lymphoid tissue: 39.6"	"Cell type enhanced"	"Detected in many"	23	"Hofbauer cells: 88.9;Kupffer cells: 144.9;Macrophages: 141.3;monocytes: 457.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7"	"Cell line enriched"	"Detected in some"	7	"U-937: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA	393000	530000	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	7.2	8.2	3.0	18.5	8.2	13.2	3.4	1.4	5.2	1.6	4.2	2.1	1.0	7.8	1.2	6.5	3.5	2.9	9.4	9.4	5.7	2.9	3.1	5.0	13.2	39.6	7.2	2.6	2.9	2.7	0.5	2.1	6.4	5.7	3.7	6.4	2.6	5.4	1.8	1.6	1.6	6.8	3.5	11.6	23.5	3.4	1.0	4.9	7.2	5.1	1.7	12.7	8.5	3.8	1.0	31.0	76.5	53.7	0.6	5.3	20.8	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.2	0.8	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.3	0.1	0.0	0.1	3.6	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.1	3.8	0.1	0.0	3.9	61.0	0.6	1.2	53.7	14.4	0.8	39.8	5.3	0.6	3.5	0.7	31.0	1.0	1.7	0.5	76.5	0.6	31.7	11.5	2.8	20.8	3.0	8.2	1.4	5.2	5.7	2.9	7.2	2.6	5.7	4.9	14.9	17.5	3.7	0.7	6.4	0.3	0.5	12.7	2.7	5.7	5.2	0.0	0.5	1.7	2.0	1.0	1.3	0.5	0.0	29.2	0.9	13.3	1.6	4.7	1.5	88.9	0.0	1.2	4.9	144.9	0.2	4.9	141.3	8.5	457.1	0.2	0.4	1.9	0.0	1.8	1.0	0.0	6.5	5.0	0.1	0.1	4.1	0.9	6.2	1.2	1.3
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784635-114806126	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;kidney: 16.2;salivary gland: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	NA	NA	1110000		"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	1.2	1.3	0.3	3.1	0.5	0.0	0.7	0.2	0.9	1.9	7.3	0.1	1.3	10.8	0.9	1.3	2.8	0.8	2.0	0.3	1.7	0.3	16.2	0.5	5.2	0.5	0.4	0.1	0.7	1.4	0.2	0.5	6.0	0.7	9.8	2.2	0.6	28.7	4.4	0.3	0.6	15.0	2.0	0.4	1.5	3.0	0.6	0.1	0.9	1.3	1.8	2.4	6.4	1.6	0.3	2.8	1.2	1.8	0.3	0.1	0.4	0.4	3.6	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.2	2.5	1.3	0.0	0.0	0.4	11.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	7.3	0.0	0.0	14.0	0.0	0.0	0.8	0.4	0.5	0.0	0.0	0.2	13.1	0.0	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.0	0.6	0.0	5.0	1.0	0.0	6.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.8	0.1	0.1	1.8	0.0	0.3	0.1	0.0	2.8	0.3	0.1	0.1	1.2	0.3	0.2	1.5	0.0	0.4	0.3	0.5	0.2	0.9	1.7	0.3	0.4	0.1	0.7	0.1	11.9	8.9	0.0	4.4	0.5	0.1	0.5	0.0	0.0	1.2	7.0	0.0	0.5	0.0	4.0	0.2	0.0	6.9	0.0	1.8	0.1	0.8	4.6	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	9.0	1.8	0.2	1.1	0.0	0.4	9.6	0.1	0.0	1.0	0.0	0.0	0.5	0.2	0.0	3.9	5.1
TNFSF4	"CD252, gp34, OX-40L, TXGP1"	ENSG00000117586	"TNF superfamily member 4"	P23510	1	173183734-173207313	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"		Cytokine	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.5;testis: 14.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;monocytes: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 18.7;HHSteC: 8.1;HUVEC TERT2: 36.8;LHCN-M2: 30.6"									HPA059579	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059579: AB_2684071"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-7)"	"unprognostic (3.73e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.98e-2)"	2.1	4.0	1.7	8.2	2.3	0.9	3.7	4.5	3.4	1.7	1.8	1.0	0.8	0.3	1.5	1.5	1.6	1.4	2.1	2.1	3.0	2.0	1.5	1.6	2.5	11.5	1.9	0.8	2.7	2.1	1.0	3.3	1.2	1.2	2.8	2.5	1.0	0.8	1.0	0.8	0.3	2.5	1.6	1.9	9.7	1.4	14.4	1.2	9.3	0.8	0.8	3.7	1.6	1.6	1.3	2.6	1.7	0.2	3.4	1.2	6.5	0.0	0.0	0.2	0.5	1.3	6.7	0.0	1.8	0.4	0.1	0.1	0.0	0.0	0.0	0.3	18.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	8.1	0.1	0.0	2.9	0.1	0.9	0.1	0.6	36.8	0.7	0.0	0.2	30.6	0.0	0.3	0.1	0.1	0.0	0.3	0.9	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.1	0.3	0.6	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.4	0.6	0.1	0.1	3.4	2.0	0.0	0.2	0.3	1.1	0.1	0.8	1.1	0.7	0.9	0.8	1.3	1.2	1.1	1.7	3.4	0.1	2.6	0.9	6.5	1.7	2.3	4.5	3.4	3.0	2.0	1.9	0.8	1.2	1.2	0.0	0.3	0.0	0.4	0.7	0.0	1.2	0.0	1.4	0.0	1.8	0.0	0.1	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.1	1.2	0.5	0.0	0.9	0.4	0.0	0.0	0.0	0.8	0.9	0.3	0.2	1.7	12.6	0.0	1.0	0.2	0.0	1.8	0.0	0.3	0.0	1.9	0.2	0.2	0.5	0.0	1.5	0.0	0.1
TNFSF9	4-1BB-L	ENSG00000125657	"TNF superfamily member 9"	P41273	19	6530999-6535928	"Plasma proteins, Predicted intracellular proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"B-cells: 7.5;granulocytes: 9.2;Intestinal endocrine cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.8"					"Low region specificity"	"Detected in all"			HPA059857			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA059857: AB_2684144"	"unprognostic (2.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.88e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-3)"	3.2	2.3	3.9	5.6	7.7	10.7	1.3	4.8	7.4	11.7	3.8	7.2	0.3	1.5	1.0	1.4	11.2	2.5	3.7	1.6	4.8	4.9	1.3	1.5	14.3	3.4	6.2	1.7	1.0	1.4	0.5	0.5	3.2	5.5	1.5	6.4	0.1	2.3	0.8	1.7	1.9	1.6	1.9	4.9	2.4	1.4	5.9	5.5	0.8	0.7	7.7	7.1	3.0	10.2	2.0	0.9	0.1	0.0	0.1	3.4	0.0	4.8	6.2	0.1	2.2	1.2	2.9	0.2	0.7	2.2	1.7	8.2	0.1	8.4	5.2	3.2	1.4	0.0	8.9	2.5	1.0	0.4	0.0	1.2	0.8	8.7	2.0	0.1	0.1	40.8	0.5	4.8	9.5	2.6	1.2	0.3	0.7	4.9	0.0	0.6	0.7	0.4	0.8	0.8	0.3	4.4	0.5	0.0	1.2	10.8	0.1	0.0	0.0	13.8	0.8	2.1	0.3	0.5	7.5	2.8	0.0	4.6	12.3	0.0	12.8	4.5	9.5	4.9	2.7	2.8	0.1	0.0	0.0	0.5	0.0	0.3	2.0	0.1	3.4	0.3	0.4	0.2	0.3	0.0	0.1	0.0	0.9	0.0	0.0	3.9	7.7	4.8	7.4	4.8	4.9	6.2	1.7	5.5	5.5	0.0	5.0	7.5	0.4	2.4	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.5	0.0	0.2	0.0	1.0	0.5	9.2	0.0	3.4	0.0	13.6	0.0	1.9	0.0	0.0	4.1	3.3	2.8	1.0	0.5	0.6	1.5	0.0	0.0	0.1	0.0	1.9	0.0	0.0	1.1	0.1	0.0	1.5	0.1
TNK1		ENSG00000174292	"Tyrosine kinase non receptor 1"	Q13470	17	7380534-7389774	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 6.4;cerebellum: 11.4;cerebral cortex: 4.0;pons and medulla: 4.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 1.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;HBEC3-KT: 7.0;hTCEpi: 7.9;T-47d: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA012065, HPA056452"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA012065: AB_1858165, HPA056452: "	"unprognostic (4.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.77e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.52e-4)"	3.4	0.6	1.1	2.2	6.4	0.4	7.9	11.4	4.0	5.4	11.7	0.4	7.7	7.1	5.1	5.3	7.2	3.5	6.3	2.0	1.0	0.4	4.6	6.9	3.2	2.7	1.5	0.8	4.4	6.8	5.4	2.7	2.5	4.3	8.9	4.5	7.7	10.5	4.8	1.8	8.3	11.3	5.1	0.7	2.4	9.6	2.2	0.6	0.6	11.6	5.7	5.2	4.5	4.4	1.6	0.1	0.4	0.0	0.0	3.8	0.6	6.4	1.0	0.2	0.4	0.0	0.0	4.4	0.2	0.0	0.4	0.4	3.3	3.0	0.0	2.6	0.3	0.1	10.5	0.0	7.0	0.1	0.7	1.5	0.0	3.7	1.9	0.4	0.0	0.3	0.1	7.9	0.0	1.2	0.2	0.0	2.8	0.8	0.0	0.0	4.9	0.6	0.0	0.9	5.6	0.9	0.2	0.2	0.7	4.9	3.0	0.2	0.5	3.6	5.3	1.0	0.3	8.7	0.1	1.7	0.2	0.8	0.2	0.0	0.5	1.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.0	0.0	1.9	1.6	1.8	1.2	0.1	1.5	3.3	3.8	0.4	0.0	0.0	0.0	0.8	0.6	1.1	6.4	11.4	4.0	1.0	0.4	1.5	0.8	4.3	0.6	6.0	4.3	0.5	2.1	2.3	1.2	0.8	2.5	0.0	2.3	1.8	0.0	0.2	0.0	4.4	1.1	0.7	10.4	0.0	5.9	0.4	1.0	4.0	0.0	2.5	0.1	0.0	2.9	1.3	0.0	0.6	1.1	0.1	0.0	0.0	6.3	0.2	6.4	6.5	0.4	1.4	2.4	0.0	0.9	0.6	0.9	2.0	0.6	1.0	6.4	1.8
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	"Tyrosine kinase non receptor 2"	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 47.1;Horizontal cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041954	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041954: AB_10794164"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-3)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (6.82e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.00e-4)"	9.2	7.6	36.3	16.2	27.6	38.9	8.5	20.7	43.7	6.0	6.3	17.6	3.8	6.6	8.0	6.6	13.0	10.7	6.5	10.6	28.4	21.8	4.1	7.2	9.3	18.1	21.6	31.8	8.6	7.8	5.1	19.3	8.4	20.0	10.8	3.9	5.3	16.8	8.2	30.5	37.1	6.9	7.6	10.3	17.0	12.1	7.7	21.8	3.4	4.6	9.8	12.8	7.7	12.3	6.1	3.1	6.3	3.2	0.9	1.9	1.2	31.9	3.1	5.2	5.5	7.2	4.6	31.1	6.2	5.9	3.7	3.4	4.9	24.7	9.3	21.6	8.4	6.3	11.4	4.5	7.6	1.1	21.9	5.7	8.4	10.4	3.5	3.2	4.3	4.2	3.4	12.2	5.1	6.1	10.6	4.7	3.5	3.4	12.9	3.4	23.5	1.8	15.7	4.9	8.5	11.5	5.4	6.2	9.4	3.3	15.5	6.3	6.4	4.0	16.2	7.9	5.2	26.5	5.4	7.6	8.6	5.0	4.4	17.1	28.2	3.0	5.8	7.7	14.0	6.3	2.0	2.4	0.9	1.9	3.2	1.1	2.7	1.8	1.0	1.1	6.1	1.4	1.3	6.3	0.9	2.8	3.1	0.2	1.2	36.3	27.6	20.7	33.3	28.4	21.8	21.6	31.8	20.0	21.8	6.0	4.8	11.8	6.8	6.2	26.5	12.8	5.1	5.3	11.4	0.0	47.1	10.6	1.7	3.5	0.8	7.5	6.9	0.0	4.5	2.6	5.3	7.2	1.1	13.5	7.2	93.8	5.8	9.8	20.5	0.8	6.1	11.4	5.0	9.0	1.4	6.6	19.1	3.5	6.0	1.4	20.9	0.0	5.5	3.9	10.0	9.3	3.5	8.9	3.3	16.3
TNKS	"PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1"	ENSG00000173273	Tankyrase	O95271	8	9555914-9782346	"Enzymes, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025690	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA025690: AB_10602249"	"unprognostic (2.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.45e-3)"	"unprognostic (8.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.01e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.36e-2)"	9.1	13.4	17.8	8.7	19.6	14.6	14.0	26.5	22.3	18.1	8.9	17.0	12.5	8.5	14.9	25.3	7.7	11.9	8.9	9.5	18.6	17.9	9.0	9.1	10.3	12.9	28.7	17.2	19.2	10.2	23.9	20.0	11.0	20.1	11.5	10.0	10.9	9.4	11.7	22.1	15.6	9.8	11.0	21.0	8.7	10.1	26.3	21.8	15.6	13.7	4.4	11.7	10.8	13.6	6.8	3.6	7.4	2.8	2.9	4.8	1.2	6.1	8.1	20.8	12.5	13.2	17.7	7.7	9.5	10.8	7.7	8.8	4.8	4.9	13.2	3.9	9.3	10.4	6.5	11.8	8.9	11.2	3.4	6.1	9.2	7.4	10.8	11.9	4.7	5.7	12.5	10.8	8.0	15.8	12.6	10.4	10.3	8.6	14.1	14.2	4.0	11.9	7.2	13.6	6.7	4.7	9.6	12.9	3.8	9.3	12.5	21.2	15.6	7.4	7.1	13.4	13.2	4.7	7.1	13.9	12.7	7.8	8.6	7.0	4.9	7.9	9.4	13.7	6.7	12.2	4.8	2.3	1.8	4.4	2.2	2.4	4.2	3.5	4.2	2.8	6.8	4.2	4.8	7.4	2.9	2.8	3.6	1.7	1.2	17.8	19.6	26.5	22.3	18.6	17.9	28.7	17.2	20.1	21.8	14.9	9.4	11.0	11.2	10.2	32.0	14.3	17.8	26.8	9.1	8.7	13.7	9.0	1.7	9.8	118.1	10.9	9.0	0.0	7.4	7.7	14.9	11.9	9.3	15.8	6.2	39.7	13.3	20.9	9.4	58.4	15.5	7.3	11.8	1.8	13.5	18.4	11.2	13.1	17.0	6.0	36.2	0.0	9.9	30.7	13.5	13.6	10.3	11.5	11.7	10.2
TNKS2	"PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL"	ENSG00000107854	"Tankyrase 2"	Q9H2K2	10	91798312-91865276	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036606			Approved	Microtubules		NA	NA			Microtubules		"HPA036606: AB_10673470"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"	17.6	16.3	16.7	23.0	18.6	26.9	18.4	27.9	20.0	18.8	13.9	18.3	18.3	11.9	18.9	18.8	24.7	16.7	17.2	12.2	16.6	14.9	14.6	16.8	17.0	22.9	20.3	14.9	26.0	19.3	20.8	26.7	47.5	16.1	16.7	14.3	16.1	21.4	16.0	39.7	23.9	16.5	18.9	18.0	22.8	15.8	9.5	17.9	42.9	24.5	21.0	23.8	18.6	18.9	3.6	5.2	3.8	2.5	3.3	3.5	1.4	14.2	12.1	25.0	21.2	17.7	16.2	27.9	15.3	28.0	18.7	23.0	10.7	11.6	13.4	7.4	19.9	12.6	15.4	15.6	11.8	26.6	13.5	15.1	11.1	11.6	11.9	17.2	21.3	16.6	16.4	15.7	18.9	33.8	28.3	17.5	12.1	8.1	14.9	19.4	7.6	18.3	14.6	12.5	6.5	8.1	17.2	15.6	10.1	12.8	15.4	6.5	11.8	15.4	6.8	19.0	21.0	16.5	14.9	18.9	10.1	8.6	13.3	14.5	18.8	15.4	17.5	13.4	16.1	9.0	1.0	2.5	3.8	3.5	2.3	3.0	3.5	3.3	3.2	3.4	3.6	2.8	2.4	2.5	3.3	2.2	5.2	1.7	1.4	16.7	18.6	27.9	20.0	16.6	14.9	20.3	14.9	16.1	17.9	38.7	18.2	20.6	28.6	66.2	37.6	18.2	10.2	37.5	27.3	41.8	45.2	36.2	6.6	14.8	4.0	33.7	12.9	0.0	21.2	46.2	23.5	36.2	2.3	30.5	23.0	39.7	31.8	35.6	54.0	5.9	28.7	29.3	32.1	17.2	20.1	33.3	24.0	11.5	33.2	14.5	30.9	45.3	29.7	16.3	19.4	95.4	84.4	29.7	13.4	52.2
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451102-52454070	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"heart muscle: 431.6;skeletal muscle: 765.7"	"Cell type enriched"	"Detected in many"	8	"Cardiomyocytes: 2506.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 88.3"	"Not detected"	"Not detected"			"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		260000	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	2.0	0.3	0.1	0.0	0.1	0.0	0.7	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	17.8	12.8	0.1	0.0	431.6	0.1	0.1	0.6	0.1	2.6	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.2	0.5	5.5	0.1	0.7	10.4	0.0	765.7	0.4	0.1	0.1	0.7	0.1	0.1	0.7	0.0	0.0	3.0	86.9	8.7	0.4	0.2	0.2	0.6	0.0	0.0	0.0	4.0	0.5	0.2	1.8	1.3	0.2	0.0	0.2	2.9	0.1	0.1	0.1	0.1	24.3	12.2	0.2	24.4	3.5	0.0	0.1	0.0	0.1	0.0	0.4	0.6	0.1	16.0	16.2	0.1	0.1	0.0	25.3	0.4	0.0	0.2	0.2	0.0	0.7	0.0	1.9	0.7	0.0	0.0	0.2	0.2	5.4	0.2	0.0	1.0	0.8	1.2	4.6	0.0	0.0	0.1	2.5	0.0	1.5	9.8	0.2	0.0	0.0	37.5	0.3	0.0	1.0	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	4.0	0.2	0.9	0.5	0.0	0.1	1.4	0.5	0.0	0.0	0.0	0.6	2.5	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.5	0.0	116.1	13.0	0.0	0.6	1.3	0.2	2506.5	0.0	0.0	7.9	3.5	2.0	44.2	23.2	6.6	0.6	0.0	0.7	0.0	11.8	4.0	14.0	0.6	0.0	0.6	4.1	0.0	318.5	0.6	0.0	3.6	20.8	1.0	5.0	0.0	0.3	1.5	4.4	0.0	166.9	0.5	0.0	0.0	15.5	1.2	0.4	0.6	26.0	0.8	1.5	4.1
TNNC2		ENSG00000101470	"Troponin C2, fast skeletal type"	P02585	20	45823214-45833745	"FDA approved drug targets, Predicted intracellular proteins"		"Muscle protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 851.6"	"Group enriched"	"Detected in many"	6	"Enterocytes: 242.7;Mucus-secreting cells: 94.6;Paneth cells: 103.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Hep G2: 9.9;HSkMC: 15.7;SCLC-21H: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043174, HPA058481"	Enhanced		Approved	Nucleoplasm,Vesicles		No	NA		63000	Nucleoplasm	Vesicles	"HPA043174: AB_10806380, HPA058481: AB_2683729"	"unprognostic (1.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.12e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.03e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.13e-1)"	12.0	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	2.7	4.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.4	0.1	0.0	7.8	0.1	851.6	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	169.1	6.6	0.1	0.1	6.0	0.8	2.4	1.1	0.3	4.1	11.9	0.1	0.0	0.3	0.5	1.7	1.2	1.8	0.2	0.4	0.0	0.1	0.2	1.2	0.4	1.2	1.0	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.0	1.0	9.9	0.4	0.3	0.2	15.7	0.2	0.1	0.8	0.4	0.0	1.2	0.1	0.5	0.2	1.2	0.7	0.1	0.0	0.4	0.6	0.3	0.6	0.2	0.3	0.1	11.8	0.6	1.7	0.1	0.4	0.5	1.4	0.4	0.5	0.3	0.4	0.9	0.2	1.6	0.4	0.3	1.6	0.1	0.2	0.0	0.7	1.4	0.2	1.1	0.7	6.0	1.5	0.2	0.3	3.8	0.0	0.3	2.4	0.3	0.8	0.8	4.1	11.9	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	3.0	1.1	4.2	0.5	0.7	1.3	0.4	2.5	0.0	4.5	3.5	0.0	2.1	3.3	1.3	2.9	0.1	242.7	0.0	4.7	0.2	2.6	0.7	0.0	0.8	0.2	0.0	22.0	0.0	0.0	26.3	1.1	0.5	0.0	0.0	94.6	1.4	2.5	103.7	2.8	0.7	1.7	0.0	3.6	2.3	5.8	7.3	0.1	0.0	25.8	0.5
TNNI2	"AMCD2B, DA2B, FSSV"	ENSG00000130598	"Troponin I2, fast skeletal type"	P48788	11	1838989-1841680	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skeletal muscle: 635.0;tongue: 527.7"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 241.7;Syncytiotrophoblasts: 72.9"	"Group enriched"	"Detected in many"	10	"cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.4;granulocytes: 26.7"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 23.2;hTCEpi: 66.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB018697, HPA055938"	Enhanced		Approved	"Plasma membrane,Intermediate filaments"		NA	NA		29000	"Plasma membrane"	"Intermediate filaments"	"CAB018697: AB_628400, HPA055938: AB_2682976"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-2)"	13.9	0.1	0.1	0.1	0.1	0.5	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	16.5	11.6	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.3	0.0	1.2	0.1	0.0	15.7	0.4	635.0	4.8	0.2	0.1	0.2	0.4	0.1	0.1	0.0	0.0	3.0	527.7	11.5	2.1	0.1	2.3	46.4	26.7	8.6	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	23.2	0.6	0.1	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.1	5.6	66.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	2.0	0.0	0.0	0.8	1.5	0.0	0.6	0.0	0.6	0.0	0.4	0.0	0.0	8.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	6.1	3.1	26.7	0.0	6.5	0.0	1.9	0.0	0.0	4.3	2.3	0.0	0.0	21.1	0.2	8.6	46.4	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	4.1	7.2	0.5	22.2	0.0	4.9	20.4	10.7	3.4	0.0	0.0	31.7	0.0	1.2	0.0	0.7	0.0	0.0	0.5	241.7	2.3	0.0	10.4	0.0	38.5	0.0	0.0	0.0	18.2	0.0	0.3	18.6	0.0	3.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	5.6	72.9	0.9	0.0	0.5
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	367	"heart muscle: 419.3"	"Cell type enriched"	"Detected in many"	56	"Cardiomyocytes: 9185.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 7.1;HMC-1: 11.9;K-562: 21.6;OE19: 30.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		1700000	Cytosol	Vesicles	"CAB009349: AB_793465, HPA046428: AB_2679661"	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	419.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.7	0.7	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.1	0.9	3.7	0.0	0.6	0.5	0.7	0.1	0.0	0.0	7.1	1.7	0.0	1.0	0.3	0.0	11.9	0.0	0.3	0.0	0.1	0.0	0.0	0.4	21.6	0.4	0.0	0.3	0.1	0.0	0.4	30.9	0.2	0.9	0.2	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.6	5.4	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	6.2	0.0	9185.5	10.2	6.7	2.3	5.2	0.0	0.9	0.0	0.6	46.9	0.1	0.0	0.0	0.2	0.4	3.1	0.0	0.0	0.0	1.9	1.6	1.7	0.0	0.0	164.8	0.3	0.2	1.7	0.0	0.2	1.8	1.1	0.0	1.8	0.0	0.2	0.0	0.0	4.2	10.3	2.5	2.1	0.0	0.4	0.0
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132794-55149354	"Disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 1047.7"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 54.4;Cardiomyocytes: 49.6;Spermatogonia: 26.7;Suprabasal keratinocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 53.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 53.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 121.8;RH-30: 91.7"	"Region enriched"	"Detected in many"	5	"thalamus: 136.6"	"Low region specificity"	"Detected in some"			"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavorable (4.66e-4)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	3.2	0.0	1.6	0.0	1.0	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.0	0.1	0.0	24.4	22.3	0.4	0.1	6.1	0.9	0.4	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	7.2	0.0	0.0	11.5	0.0	1047.7	1.8	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	9.2	124.4	17.8	0.3	0.1	0.1	9.9	53.3	11.6	0.1	0.1	2.6	24.8	14.6	0.1	3.2	0.0	0.2	4.8	1.1	4.3	1.6	4.8	5.3	16.6	0.3	9.7	0.4	13.0	12.7	3.4	10.8	1.3	1.6	27.6	4.7	1.5	0.9	0.5	0.3	121.8	5.4	17.6	0.5	18.7	18.5	0.0	5.0	23.6	23.1	1.5	23.7	0.4	0.0	3.1	6.3	29.0	15.9	91.7	2.9	3.8	0.8	0.9	7.2	1.5	0.2	8.0	1.3	15.1	14.5	0.5	24.1	35.9	0.9	1.8	0.1	0.9	1.2	25.4	3.7	7.3	0.5	11.6	53.3	0.0	5.9	0.1	0.0	0.1	0.0	9.9	0.1	0.1	0.1	0.5	0.1	2.6	0.2	0.0	2.6	1.6	1.0	0.1	1.0	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.4	1.5	49.6	0.0	6.7	0.0	0.0	0.0	1.3	0.0	1.8	1.3	0.0	0.0	0.0	0.0	14.0	8.0	0.0	0.0	0.0	13.2	0.0	2.4	1.8	12.0	6.0	0.3	4.2	3.3	0.0	0.2	0.8	0.4	0.0	0.0	0.0	0.6	0.0	0.9	2.8	26.7	26.6	3.0	0.0	0.3	0.1
TNPO2	"FLJ12155, IPO3, KPNB2B, TRN2"	ENSG00000105576	"Transportin 2"	O14787	19	12699194-12724011	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046446, HPA071498"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"CAB046446: AB_10603392, HPA071498: AB_2686405"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (2.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.76e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-3)"	"unprognostic (7.63e-2)"	21.7	19.8	37.1	16.0	35.7	17.8	13.5	33.1	44.7	17.9	13.9	23.2	12.7	13.4	20.7	20.9	22.9	22.4	15.9	20.0	31.1	24.9	14.3	10.1	13.7	16.6	24.8	36.6	32.9	16.0	26.6	19.1	16.1	22.2	16.8	15.9	18.2	15.1	20.0	15.2	36.6	12.5	23.3	25.2	15.3	12.9	24.1	20.9	14.9	17.8	9.9	17.8	18.9	14.7	1.6	4.3	2.6	1.2	0.4	3.3	0.7	17.6	13.5	20.8	26.5	12.7	16.8	13.5	20.4	13.5	29.6	20.9	18.4	9.6	12.0	16.0	17.2	8.3	23.6	36.8	20.2	16.5	14.8	29.5	18.5	21.2	22.3	14.3	32.6	17.8	14.9	16.0	19.6	20.9	19.2	13.8	24.4	28.7	11.5	16.3	30.6	27.3	22.5	24.1	13.1	40.8	26.3	16.2	22.0	17.5	12.9	51.0	25.3	16.6	21.1	10.1	14.7	14.7	11.6	13.8	45.5	12.0	24.3	29.9	22.9	22.0	20.5	13.5	29.7	16.1	0.6	0.9	0.3	2.1	0.8	3.0	1.5	1.5	1.7	1.2	1.6	2.7	3.3	2.6	0.4	1.2	4.3	0.5	0.7	37.1	35.7	33.1	42.1	31.1	24.9	24.8	36.6	22.2	20.9	6.0	19.9	11.8	8.5	27.5	38.9	15.9	17.8	6.7	9.1	21.0	94.2	9.1	5.0	8.3	9.5	17.5	10.5	0.0	7.3	5.6	14.7	12.6	3.5	15.3	8.9	54.0	22.0	18.4	11.3	15.4	28.7	9.5	8.5	10.8	17.0	24.7	13.1	5.8	30.4	14.6	32.2	6.5	17.8	24.7	10.0	36.3	12.1	11.5	15.0	8.0
TNRC6A	"CAGH26, GW182, KIAA1460, TNRC6"	ENSG00000090905	"Trinucleotide repeat containing 6A"	Q8NDV7	16	24610209-24827632	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Horizontal cells: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015305, HPA017869"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA015305: AB_1850454, HPA017869: AB_1850456"	"unprognostic (2.64e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.35e-2)"	17.3	23.6	14.7	23.2	15.1	10.2	17.0	25.0	19.3	20.8	17.0	15.6	17.2	10.5	26.6	23.1	12.5	20.2	12.6	13.4	11.3	9.4	13.0	17.0	14.0	16.7	14.5	10.9	26.7	20.1	42.6	25.4	12.6	16.2	16.4	12.8	17.8	16.6	18.6	26.5	16.5	16.0	27.5	19.4	14.2	15.8	11.4	14.7	15.9	19.6	14.9	13.8	16.4	16.4	5.4	5.2	2.3	2.7	3.3	3.9	1.3	11.5	16.2	19.2	10.4	16.6	22.1	10.9	19.8	16.1	14.5	15.9	11.8	9.7	11.7	8.6	19.8	14.9	13.1	23.8	16.7	21.9	11.9	12.3	11.7	17.8	16.2	14.3	11.9	8.3	22.1	8.7	18.9	12.5	17.9	19.8	7.8	17.7	7.5	18.7	13.6	10.0	7.9	27.4	5.6	8.1	19.6	14.9	10.6	11.0	10.8	9.4	13.1	13.9	8.6	7.6	15.2	9.9	7.9	18.1	18.6	12.8	9.1	13.9	16.5	13.0	19.6	17.3	7.5	13.3	2.3	2.7	1.9	3.0	1.6	2.5	5.2	2.9	2.7	1.0	5.4	3.9	2.7	1.5	3.3	1.6	5.2	2.9	1.3	14.7	15.1	25.0	19.3	11.3	9.4	14.5	10.9	16.2	14.7	35.7	51.8	48.1	14.8	31.0	84.5	67.4	58.6	22.7	38.7	43.6	111.9	18.0	14.9	20.3	16.0	35.8	32.0	23.3	21.0	12.6	36.1	20.9	38.1	104.9	18.0	166.8	53.7	65.1	54.2	8.1	63.9	27.5	28.7	23.4	36.7	48.9	23.3	33.4	76.4	12.2	83.3	19.4	26.9	44.2	27.2	25.1	6.9	31.7	32.1	14.0
TNRC6C	"FLJ20015, KIAA1582"	ENSG00000078687	"Trinucleotide repeat containing 6C"	Q9HCJ0	17	77959240-78108835	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 119.8;Cone photoreceptor cells: 223.8;Rod photoreceptor cells: 142.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 12.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022007, HPA062051"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022007: AB_2670877, HPA062051: AB_2684670"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.83e-2)"	"prognostic favorable (6.56e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.70e-2)"	5.5	3.6	8.9	7.4	15.1	3.6	5.1	13.3	13.8	6.0	3.8	14.5	4.4	2.3	6.9	7.6	3.1	6.9	4.7	6.9	8.5	7.6	3.3	3.4	4.2	7.5	13.3	6.3	9.1	4.4	6.1	7.6	1.9	12.2	6.1	3.0	10.9	6.0	4.9	11.1	3.3	3.8	5.6	7.5	6.0	3.6	13.2	14.3	3.4	4.1	6.1	5.5	3.6	4.1	1.1	0.7	12.9	0.3	3.1	2.7	0.5	3.1	3.0	5.4	5.8	2.3	1.8	0.0	4.8	4.0	3.4	2.8	3.1	0.9	0.0	2.0	3.6	2.4	0.3	4.0	0.1	2.1	2.5	4.1	11.1	1.0	3.5	2.1	2.6	5.7	1.5	1.5	1.3	3.2	1.5	7.1	11.0	2.1	5.6	3.5	4.2	24.9	1.4	2.8	1.4	2.2	3.3	10.9	2.1	0.8	4.5	6.7	12.3	5.7	7.4	2.6	2.8	5.6	3.9	5.2	7.6	2.6	3.9	5.8	4.3	0.7	3.2	2.1	4.1	5.4	12.9	0.3	1.3	1.9	0.2	2.2	1.0	2.1	2.0	0.2	1.1	2.3	2.7	1.2	3.1	0.3	0.7	0.9	0.5	8.9	15.1	13.3	12.5	8.5	7.6	13.3	6.3	12.2	14.3	26.8	26.7	6.1	8.5	19.6	119.8	26.0	30.6	6.7	9.1	8.7	223.8	0.1	1.7	6.2	7.2	25.7	5.3	23.3	5.1	0.3	19.5	13.9	22.0	15.5	2.0	69.9	38.3	29.4	12.9	5.3	47.5	6.1	15.1	2.8	9.0	33.0	6.8	3.5	40.3	4.3	142.8	0.0	31.6	23.5	19.9	12.4	0.2	36.3	5.9	3.8
TOB1	"APRO5, TOB, TROB, TROB1"	ENSG00000141232	"Transducer of ERBB2, 1"	P50616	17	50862223-50867978	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047839	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA047839: AB_2680175"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.04e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.92e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-2)"	"unprognostic (6.97e-2)"	14.3	68.4	10.5	10.4	15.7	19.6	29.5	11.3	13.4	20.9	24.2	23.6	24.2	16.9	7.9	12.9	30.2	17.4	42.7	21.7	12.0	11.8	22.5	57.5	17.7	7.5	12.0	10.2	21.5	74.4	30.2	20.0	5.6	13.9	24.5	18.3	36.5	32.4	56.0	60.4	44.7	26.3	23.7	11.9	6.1	28.8	9.0	13.1	8.9	30.3	31.0	13.8	38.8	22.9	7.8	21.3	63.0	25.1	4.8	51.2	25.2	11.0	22.8	7.4	3.0	14.0	7.0	5.6	8.3	20.6	5.4	6.7	9.1	14.3	10.1	16.0	11.3	5.4	15.8	5.0	14.1	5.7	5.0	7.3	1.2	26.7	15.0	19.5	5.1	5.0	14.9	17.5	6.2	32.3	7.3	2.6	3.1	4.1	8.9	11.4	30.1	4.0	4.9	2.6	27.8	8.7	3.5	9.4	12.0	21.4	23.0	4.3	10.6	14.1	42.1	4.9	11.9	66.4	6.9	3.4	6.3	4.4	6.9	3.9	13.6	14.2	4.7	5.1	2.6	2.4	63.0	10.5	49.9	46.6	18.6	51.2	7.8	43.4	36.4	21.3	6.2	38.4	46.2	23.6	4.8	25.1	6.9	35.9	25.2	10.5	15.7	11.3	13.4	12.0	11.8	12.0	10.2	13.9	13.1	107.2	101.9	31.7	161.4	251.6	130.0	101.0	127.4	71.0	51.2	64.6	53.0	14.5	87.9	38.8	73.3	29.2	99.6	23.3	47.3	1.2	76.4	113.9	61.3	179.4	31.5	17.5	195.2	33.2	33.0	32.8	24.5	54.0	67.4	26.2	199.4	88.3	38.3	178.0	56.3	51.2	56.2	161.7	81.2	43.1	8.3	201.7	9.2	75.9	142.2	265.3
TOB2	"APRO5, bK223H9, TOB4, TOBL, TROB2"	ENSG00000183864	"Transducer of ERBB2, 2"	Q14106	22	41433492-41447023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016603, HPA054112"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA016603: AB_2669400, HPA054112: AB_2682385"	"unprognostic (1.21e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (3.08e-5)"	"unprognostic (3.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.18e-6)"	"unprognostic (1.50e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.13e-2)"	27.3	20.7	25.4	12.5	27.6	5.4	14.1	53.5	22.0	18.0	16.1	23.2	12.2	14.0	14.5	9.8	17.1	25.2	24.4	16.4	25.5	9.9	16.0	13.4	13.5	10.6	35.8	13.6	21.8	18.1	26.2	13.2	13.8	23.1	17.6	10.1	17.6	9.6	15.1	47.3	13.9	16.1	13.3	18.3	12.2	17.7	9.1	36.5	13.6	23.2	17.0	12.1	12.8	21.1	13.4	10.3	4.9	10.0	4.6	9.9	5.7	16.9	7.8	13.7	9.3	32.3	22.7	13.4	11.3	17.5	14.4	12.8	10.2	8.1	10.4	11.5	16.3	5.6	14.9	12.7	6.3	13.2	10.7	16.4	5.7	10.9	15.4	22.2	15.3	7.7	20.8	10.9	17.2	7.5	14.6	14.4	3.6	8.6	11.7	11.7	18.9	6.3	8.9	11.7	22.4	8.5	13.9	9.2	8.9	10.2	11.9	6.4	4.2	28.5	15.4	20.7	8.9	8.5	7.7	17.9	14.3	13.4	11.1	10.5	11.2	4.8	5.7	8.7	6.6	9.4	4.2	6.9	4.8	9.9	10.0	9.2	13.4	8.2	8.1	6.5	10.3	4.3	6.1	4.9	4.6	9.3	10.3	6.9	5.7	25.4	27.6	53.5	22.0	25.5	9.9	35.8	13.6	23.1	36.5	44.7	45.7	18.2	58.0	112.6	49.6	49.5	50.9	56.2	36.4	45.4	60.9	28.9	19.9	26.5	38.6	35.9	84.5	0.0	16.8	27.5	49.4	69.7	32.4	25.5	17.2	23.8	52.1	48.5	21.1	45.5	61.9	25.5	50.6	35.1	55.4	65.6	27.4	54.1	77.1	26.1	95.8	51.8	63.1	24.2	25.7	119.6	53.0	27.3	50.5	89.9
TOGARAM1	"crescerin, Crescerin-1, FAM179B, KIAA0423"	ENSG00000198718	"TOG array regulator of axonemal microtubules 1"	Q9Y4F4	14	44962208-45074431	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 71.0;Club cells: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050849, HPA053559"	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA050849: AB_2681257, HPA053559: AB_2682190"	"unprognostic (2.91e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.63e-2)"	"unprognostic (6.49e-2)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.60e-1)"	6.9	11.6	13.6	7.0	17.5	6.0	9.0	16.3	34.4	12.3	6.7	10.0	9.8	4.8	10.3	9.9	8.1	17.5	8.3	13.7	14.5	10.5	14.0	8.0	12.9	8.4	13.1	17.0	13.9	11.1	15.5	20.1	9.9	11.0	9.9	6.6	6.8	7.8	11.5	19.1	6.5	5.9	9.2	13.0	7.1	6.4	9.3	12.5	9.1	15.4	5.2	6.7	8.6	6.7	1.7	1.8	6.9	1.0	1.9	1.4	0.8	3.1	5.1	5.0	1.3	11.4	13.6	3.5	4.4	9.7	8.5	10.2	2.1	3.4	2.9	5.1	7.1	4.4	5.9	9.0	2.8	9.6	2.6	3.3	2.4	2.7	2.5	8.4	4.2	2.6	7.8	5.3	4.6	8.3	10.2	6.7	1.6	1.7	3.5	8.8	4.7	5.4	2.3	1.7	4.6	4.0	2.7	12.2	2.0	8.1	11.0	5.2	2.0	5.2	7.9	7.9	5.5	5.8	3.4	5.0	5.8	4.5	7.5	3.2	3.5	2.4	3.4	3.3	0.8	4.9	6.9	1.0	2.2	1.1	0.9	1.3	1.0	1.4	1.1	1.3	1.7	1.4	0.9	0.1	1.9	0.9	1.8	1.4	0.8	13.6	17.5	16.3	34.4	14.5	10.5	13.1	17.0	11.0	12.5	14.9	12.2	0.0	0.0	0.0	0.0	0.0	0.0	71.0	37.5	15.7	0.0	8.3	1.7	8.9	0.0	0.0	0.0	0.0	5.0	6.5	0.0	0.0	9.3	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	11.8	0.0	0.0	7.4	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29061373	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 56.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.8;NB-4: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA037561, HPA037562, HPA075216"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: "	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.3	2.3	3.0	1.7	8.4	2.6	0.4	3.4	1.7	0.6	0.6	7.1	0.0	0.8	1.1	14.4	0.7	15.7	0.5	2.6	3.3	3.9	0.3	0.5	14.2	1.1	2.1	2.0	4.5	0.8	0.1	6.1	0.6	15.3	0.5	0.4	0.1	0.5	0.1	1.7	0.6	0.7	0.8	2.5	2.2	1.5	3.2	6.1	0.0	0.3	0.3	1.3	0.4	0.3	0.3	0.3	0.6	0.3	0.6	3.7	1.0	0.2	0.2	0.3	0.2	0.3	0.0	0.7	0.1	2.3	0.7	2.2	0.4	0.3	0.3	0.3	0.0	0.3	0.9	0.4	0.0	0.7	0.4	1.4	0.2	2.0	0.5	0.9	2.0	3.8	0.2	0.3	0.0	0.0	0.8	0.3	2.7	0.3	1.0	0.8	0.2	0.8	3.6	2.7	1.2	0.7	0.1	0.7	1.5	1.1	0.3	2.6	1.8	0.1	0.1	0.1	0.4	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.5	0.5	0.2	1.7	1.3	0.1	0.5	0.3	0.3	3.7	0.1	2.0	0.2	0.6	2.9	0.1	0.3	0.4	1.0	0.6	0.6	0.2	0.3	1.5	1.0	3.0	8.4	3.4	1.2	3.3	3.9	2.1	2.0	15.3	6.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	56.2	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TOLLIP	IL-1RAcPIP	ENSG00000078902	"Toll interacting protein"	Q9H0E2	11	1274371-1309654	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 368.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038621, HPA038622"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		34000	"Plasma membrane, Cytosol"		"HPA038621: AB_10673177, HPA038622: AB_10675946"	"unprognostic (8.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (8.89e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-2)"	15.3	16.7	31.2	8.8	32.5	9.0	11.9	28.3	63.0	10.7	12.7	12.9	8.6	18.6	8.3	10.3	29.4	10.7	13.7	15.8	28.0	20.3	20.9	37.1	12.3	9.6	18.1	32.1	12.8	41.8	13.7	18.7	9.9	17.4	15.6	6.6	12.9	15.9	16.8	23.4	24.0	15.7	9.0	13.5	13.2	15.1	24.5	11.8	5.9	12.6	11.8	10.9	14.6	14.8	13.9	26.9	49.0	34.8	11.1	12.6	18.3	15.5	16.5	8.4	9.5	18.0	11.3	7.3	13.8	12.6	16.3	14.5	17.8	9.9	7.3	13.4	12.7	24.9	14.1	7.5	16.9	4.4	14.9	15.3	5.9	3.5	26.7	25.7	11.2	15.1	17.0	19.9	9.6	9.3	8.9	10.1	11.1	9.7	19.8	13.3	13.0	14.2	13.8	10.2	16.9	21.9	10.8	8.6	7.2	10.7	20.8	22.6	13.3	12.4	15.1	15.2	4.5	11.9	12.8	18.4	17.7	7.6	7.4	7.9	20.2	17.9	8.9	27.8	7.4	13.8	9.5	34.8	35.9	9.6	30.0	8.0	10.9	10.3	8.9	26.9	13.9	8.1	7.6	49.0	11.1	27.5	14.1	12.6	18.3	31.2	32.5	28.3	63.0	28.0	20.3	18.1	32.1	17.4	11.8	8.9	20.0	26.9	36.3	59.4	38.5	20.3	48.4	8.1	11.4	22.7	7.9	44.1	59.7	60.5	147.2	26.6	50.7	0.0	59.7	34.1	29.7	40.2	38.0	95.4	77.7	69.9	49.7	36.8	41.9	368.3	20.1	32.1	67.4	51.3	30.4	38.6	64.1	38.6	29.0	95.9	16.9	6.5	26.9	57.0	27.2	86.4	87.3	22.3	24.9	55.4
TOM1		ENSG00000100284	"Target of myb1 membrane trafficking protein"	O60784	22	35299275-35347994	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.8"	"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000818, HPA001749"	Approved		Approved	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		14000	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA000818: AB_2666101, HPA001749: AB_1080323"	"unprognostic (3.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.20e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.16e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.31e-2)"	17.0	21.2	9.5	10.2	13.8	31.1	13.7	10.2	24.6	16.0	14.6	12.0	7.5	17.4	14.1	15.5	31.6	11.7	15.4	19.1	8.8	15.2	16.1	27.4	17.5	8.2	11.6	11.3	12.1	11.8	21.8	16.8	39.0	23.2	10.2	6.4	17.5	37.0	10.1	83.8	29.1	18.6	7.1	8.4	10.6	8.4	13.6	8.7	10.0	14.8	25.9	19.9	12.1	17.6	4.6	15.2	40.9	31.2	4.6	14.7	17.0	6.7	6.8	3.9	6.4	28.4	16.9	18.8	6.7	20.1	12.9	14.5	9.4	6.3	2.7	12.4	20.7	8.4	3.1	4.1	7.0	4.6	7.6	9.3	2.2	7.7	19.7	26.8	4.3	10.2	22.8	8.7	18.2	6.3	8.8	9.0	5.1	4.4	6.7	6.3	6.5	3.4	10.1	3.0	8.4	4.0	6.3	5.7	5.7	5.1	5.1	6.8	5.2	15.1	15.6	14.8	3.5	8.0	7.1	9.3	15.4	13.3	11.7	3.2	7.8	4.9	7.0	20.6	4.5	5.0	5.9	31.2	13.1	6.4	18.9	5.3	4.6	9.8	6.1	15.2	4.0	7.9	5.3	40.9	4.6	19.4	8.1	14.7	17.0	9.5	13.8	10.2	24.6	8.8	15.2	11.6	11.3	23.2	8.7	20.8	37.5	13.7	9.2	11.3	9.7	19.8	10.2	14.7	20.5	12.2	11.8	57.0	23.2	33.4	21.6	14.1	43.9	0.0	34.2	48.4	23.6	12.1	22.0	27.7	54.8	11.1	15.5	14.7	31.9	17.5	10.6	37.8	18.6	22.6	16.2	19.9	27.7	15.3	12.0	28.5	8.1	6.5	16.7	9.9	5.3	19.2	142.3	10.9	12.7	9.1
TOM1L2		ENSG00000175662	"Target of myb1 like 2 membrane trafficking protein"	Q6ZVM7	17	17843511-17972422	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 81.5"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022541, HPA023304"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA		66000	"Intermediate filaments"	"Golgi apparatus"	"HPA022541: AB_1858182, HPA023304: AB_1858183"	"unprognostic (2.32e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (2.58e-4)"	"prognostic favorable (1.92e-4)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.21e-9)"	"unprognostic (7.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.51e-2)"	11.8	14.8	24.7	7.3	27.4	3.5	10.4	23.2	38.2	10.5	12.8	32.3	8.7	8.8	12.8	8.2	35.9	12.7	8.8	81.5	25.9	21.8	13.1	4.4	14.4	4.8	24.4	23.8	15.7	12.2	28.7	14.4	6.3	42.3	21.1	9.7	19.5	9.7	19.3	32.0	29.0	10.5	16.0	16.4	7.7	10.9	14.7	20.9	4.3	24.8	13.7	10.5	12.0	11.0	2.7	2.2	14.6	3.9	1.4	5.3	1.8	11.1	13.3	3.6	2.8	8.9	9.0	5.6	19.2	9.1	10.9	9.0	12.2	8.1	2.0	25.1	18.8	5.7	46.6	2.9	11.2	6.5	3.1	5.2	3.3	12.0	2.3	5.5	0.7	2.3	10.5	7.8	9.9	7.4	9.6	10.8	3.2	1.2	2.9	13.7	11.7	1.4	1.8	0.6	15.8	8.2	1.8	8.7	5.0	14.1	21.7	4.1	3.8	8.5	11.2	6.8	28.1	5.7	1.5	13.8	10.1	2.7	20.2	7.0	2.6	2.1	0.8	11.6	1.0	24.0	7.1	3.9	5.1	3.5	1.2	2.5	2.0	3.2	2.8	1.8	2.7	5.3	3.9	14.6	1.4	3.4	2.2	1.5	1.8	24.7	27.4	23.2	38.2	25.9	21.8	24.4	23.8	42.3	20.9	29.8	13.4	12.3	11.9	9.6	69.6	59.0	20.4	14.7	11.4	10.4	149.2	6.4	5.0	10.3	25.9	9.5	25.8	0.0	7.7	16.0	10.4	37.1	2.3	11.3	8.1	90.6	19.7	12.9	7.3	46.0	24.5	6.5	11.8	10.0	17.1	32.4	12.4	31.7	24.1	7.9	76.8	19.4	13.2	14.6	10.7	15.1	26.9	8.7	13.3	45.0
TOMM34	"HTOM34P, TOM34"	ENSG00000025772	"Translocase of outer mitochondrial membrane 34"	Q15785	20	44942130-44960486	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.2;testis: 53.2"	"Cell type enhanced"	"Detected in many"	12	"monocytes: 303.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018845, HPA056875"	Enhanced		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Vesicles, Mitochondria"	"HPA018845: AB_1858184, HPA056875: AB_2683264"	"unprognostic (4.96e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (4.47e-5)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (2.55e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (5.79e-3)"	4.4	17.9	14.9	6.4	56.2	8.7	7.3	4.2	18.1	7.2	7.1	5.3	5.6	5.8	7.1	25.6	7.2	24.9	6.8	6.3	35.3	11.0	11.9	7.9	5.9	8.8	8.6	14.4	13.9	8.2	11.2	10.5	15.1	13.9	7.6	9.3	8.0	6.3	9.0	6.3	5.5	5.6	7.7	5.7	5.8	7.0	53.2	5.6	7.0	8.3	7.2	10.4	8.8	6.3	18.8	26.1	9.5	11.5	8.7	12.3	10.7	33.1	11.7	10.4	22.1	9.6	9.5	23.5	19.3	28.2	24.2	17.7	47.2	12.5	22.8	16.7	15.1	24.7	21.0	25.4	41.8	28.3	4.0	11.8	17.9	15.5	33.2	12.3	11.7	11.1	10.3	11.7	33.8	60.8	21.3	24.6	9.4	20.3	9.4	22.9	21.9	12.3	16.2	12.2	17.7	44.5	10.7	11.0	24.6	19.7	18.7	17.9	10.6	26.4	18.4	22.8	8.4	13.8	10.2	14.5	32.0	21.1	15.3	28.8	8.2	9.6	18.9	29.2	14.0	12.4	8.3	11.1	9.5	10.4	11.5	11.0	17.3	10.9	11.0	26.1	18.8	12.3	9.7	3.1	8.7	11.2	13.7	12.3	10.7	14.9	56.2	4.2	18.1	35.3	11.0	8.6	14.4	13.9	5.6	6.0	8.6	13.0	69.8	12.2	3.6	9.0	7.6	64.3	18.2	12.2	3.9	98.4	26.6	29.7	14.0	10.8	6.7	0.0	26.6	29.1	11.6	59.4	9.2	9.6	19.7	3.2	11.5	5.5	3.9	24.2	6.4	10.5	6.8	303.0	8.2	13.2	32.2	9.3	6.0	16.5	4.1	0.0	12.2	45.4	36.6	9.7	47.3	6.9	12.8	47.8
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	16.0	25.3	13.6	16.9	15.6	19.7	20.6	17.7	27.0	10.2	20.5	10.9	10.1	20.0	11.8	10.5	22.9	13.5	11.4	21.5	15.3	14.9	16.5	36.9	15.1	22.3	15.6	13.3	18.2	19.2	16.2	11.9	15.3	20.2	11.2	16.7	11.5	11.5	13.5	32.3	14.7	15.1	11.6	11.9	12.7	12.6	12.3	8.8	14.2	11.6	18.6	15.6	10.9	12.5	7.3	7.0	5.1	6.8	4.7	8.7	2.0	30.8	52.3	19.1	26.3	7.1	6.4	24.3	22.2	12.3	42.1	30.2	56.8	21.4	45.6	23.9	14.6	23.9	33.4	49.5	31.9	19.2	17.6	44.9	30.6	20.5	44.7	15.2	39.0	27.5	10.1	18.1	32.6	20.7	7.9	14.5	22.0	48.2	15.9	16.4	38.5	42.3	28.7	33.4	44.1	32.6	43.3	21.7	26.5	19.3	42.9	29.8	19.1	23.6	49.8	15.8	11.1	16.7	39.6	11.9	29.2	29.6	20.3	57.8	17.2	35.6	44.7	21.6	41.5	30.7	0.7	5.5	5.1	4.7	6.8	5.2	7.3	4.5	6.5	7.0	4.2	7.9	8.7	1.1	4.7	5.9	6.9	4.8	2.0	13.6	15.6	17.7	27.0	15.3	14.9	15.6	13.3	20.2	8.8	14.9	5.3	28.9	52.0	77.6	63.2	14.2	30.6	0.0	10.3	29.6	27.5	84.7	33.2	54.9	9.5	29.3	31.6	23.3	33.2	145.9	33.4	37.4	19.5	20.8	91.8	66.7	28.2	11.1	20.4	5.6	24.7	36.1	37.1	39.7	43.5	43.9	41.3	28.8	23.0	28.3	55.9	19.4	40.6	53.5	60.1	78.2	61.0	26.6	93.2	64.9
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	34.3	45.6	58.1	26.6	2.9	5.9	12.9	47.1	25.4	43.4	38.5	21.4	26.3	55.4	24.0	15.9	26.0	54.7	44.6	18.8	58.3	29.5	29.8	36.6	29.2	35.6	0.2	51.2	39.0	1.3	1.5	30.5	31.1	9.4	22.8	36.1	39.5	38.0	46.8	11.9	59.3	34.4	24.1	24.9	18.2	50.4	90.2	23.0	10.4	22.0	34.3	24.7	38.0	47.5	15.0	35.3	39.8	23.6	14.9	28.6	40.4	33.0	45.2	21.8	24.6	48.3	16.1	35.3	47.7	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3	0.0	1.3	28.7	1.4	10.4	0.0	1.1	2.5	0.0	6.8	0.0	0.0	8.4	0.0	0.9	12.5	0.7	2.1	280.4	0.0	81.4	9.7	1.2	0.0	3.9	64.5	0.0	0.0	27.6	30.0	15.2	4.4	13.1	1.7	2.8	5.9	0.0	0.2	3.6	1.8	0.0	0.0	71.1	1.4	527.8	241.9	5.4	7.4	7.7	24.2	2.6
TOP3B		ENSG00000100038	"DNA topoisomerase III beta"	O95985	22	21957025-21982816	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072114			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA072114: "	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.11e-4)"	10.4	11.7	12.1	16.1	17.4	20.8	10.9	17.2	17.1	12.5	11.0	16.9	14.9	15.4	16.1	11.0	14.2	11.0	11.2	10.1	12.7	5.5	13.4	15.3	12.7	17.0	18.7	6.5	20.2	12.1	13.5	21.0	12.1	16.2	15.6	14.9	14.1	13.3	13.3	13.4	17.5	16.1	14.5	17.4	23.6	11.8	11.1	16.9	13.1	14.2	5.7	18.9	10.5	14.3	9.0	8.8	2.7	6.8	6.1	9.3	5.2	9.7	9.3	19.1	7.6	7.1	5.9	11.9	6.5	8.1	15.0	13.3	10.1	4.2	13.4	4.9	6.7	6.3	17.9	8.6	11.5	12.1	6.8	20.6	10.5	12.0	10.4	9.6	14.3	6.9	2.9	17.6	12.4	6.0	8.7	12.5	7.8	49.2	7.3	7.0	9.9	8.9	11.1	7.8	7.1	8.9	14.1	12.7	2.1	7.4	13.0	12.5	9.1	7.9	7.1	6.0	8.0	5.5	9.2	9.0	6.2	13.0	5.8	7.9	10.8	8.8	12.7	4.8	8.7	6.4	2.5	6.7	2.7	9.3	6.8	6.5	7.5	5.8	6.5	7.4	9.0	5.9	5.7	2.3	6.1	3.8	8.8	6.7	5.2	12.1	17.4	17.2	17.1	12.7	5.5	18.7	6.5	16.2	16.9	0.0	1.6	4.7	2.3	1.5	4.5	0.0	12.7	5.3	1.2	3.5	9.8	4.1	1.7	4.1	0.9	2.5	4.1	0.0	3.7	3.0	2.8	3.6	1.1	4.4	3.5	1.6	4.6	7.4	3.7	1.1	9.8	2.7	5.0	2.8	3.9	2.4	5.2	3.5	7.1	2.2	5.3	6.5	1.4	5.4	4.7	1.4	3.3	5.7	5.6	2.5
TOR4A	"C9orf167, FLJ20245"	ENSG00000198113	"Torsin family 4 member A"	Q9NXH8	9	137277749-137282641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Undifferentiated cells: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 22.9;TIME: 20.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044913	Enhanced		Approved	Nucleoplasm		NA	NA		1500000	Nucleoplasm		"HPA044913: AB_10965030"	"unprognostic (1.95e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.99e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (5.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.93e-3)"	"unprognostic (2.56e-1)"	8.7	3.0	1.6	9.1	3.1	3.2	3.8	0.6	1.7	6.0	12.9	2.8	7.6	12.5	5.0	4.7	8.4	4.6	23.2	12.4	1.5	1.3	8.0	6.6	14.8	7.5	2.8	1.1	9.4	4.0	0.4	2.1	4.9	2.3	3.4	5.8	5.5	1.8	9.7	1.8	2.0	14.5	1.9	2.4	19.4	15.6	1.9	2.0	2.9	5.0	1.4	13.3	4.5	3.9	0.9	1.6	3.7	3.5	0.7	0.7	0.9	8.0	10.6	0.0	0.3	0.1	0.8	0.8	13.4	9.2	6.2	3.3	1.3	15.3	0.8	18.9	4.7	0.4	16.7	0.0	4.4	2.1	0.6	0.7	8.8	7.3	7.1	13.4	3.8	22.9	0.5	4.7	1.2	2.4	7.1	8.4	0.0	13.2	1.0	1.0	0.8	0.0	10.6	1.3	8.7	11.9	2.1	2.9	5.4	7.4	0.0	0.4	0.1	9.7	0.1	0.2	0.3	0.8	11.9	20.5	0.3	7.4	1.4	2.2	0.1	0.5	5.1	2.3	3.5	3.0	1.6	2.3	3.7	0.5	2.1	0.6	0.7	0.4	0.1	1.6	0.9	0.0	0.1	1.4	0.7	3.5	0.2	0.7	0.9	1.6	3.1	0.6	1.7	1.5	1.3	2.8	1.1	2.3	2.0	0.0	5.1	3.9	2.1	2.4	0.0	5.6	25.5	1.4	2.3	12.2	0.0	0.1	0.0	9.4	0.1	3.8	20.6	0.0	1.9	0.1	0.9	1.4	10.3	0.8	12.7	0.0	6.9	26.4	25.2	0.0	2.3	8.2	0.0	11.8	23.9	0.8	14.0	24.9	3.9	0.4	0.5	19.4	3.1	0.0	0.9	2.0	0.0	2.2	28.7	10.8
TOX	"KIAA0808, TOX1"	ENSG00000198846	"Thymocyte selection associated high mobility group box"	O94900	8	58805418-59119208	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 88.8"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 30.6;Intestinal endocrine cells: 44.1;Mucus-secreting cells: 25.4;T-cells: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 27.9;MOLT-4: 52.6;SH-SY5Y: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018322, HPA073241"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA018322: AB_1858199, HPA073241: AB_2686584"	"unprognostic (7.60e-4)"	"unprognostic (6.16e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.73e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	1.3	1.2	10.5	15.7	6.3	2.8	1.5	1.9	15.6	2.1	13.4	1.5	1.2	10.0	1.5	1.1	3.7	1.1	5.0	0.9	6.3	9.8	3.2	1.7	4.9	17.7	4.8	12.0	6.6	2.4	2.9	3.7	1.5	2.2	2.4	9.3	2.6	1.8	1.3	0.5	1.0	10.7	2.8	2.3	5.7	10.0	6.5	2.5	88.8	1.5	0.8	19.4	2.6	2.3	3.4	0.8	10.2	0.1	10.4	21.0	3.1	0.3	0.0	5.8	0.0	0.6	1.3	0.0	1.2	2.8	0.7	0.1	0.0	0.0	0.0	0.0	5.2	0.3	0.4	1.4	0.0	0.1	0.2	0.5	0.0	1.1	0.0	4.9	1.0	0.2	0.7	0.1	0.8	1.1	0.3	9.5	27.9	0.0	0.0	0.4	0.0	52.6	0.0	1.0	0.0	0.1	1.1	4.0	0.0	0.1	0.1	5.4	16.5	0.0	0.0	0.0	1.4	0.0	0.0	0.1	1.5	0.7	4.8	1.6	0.0	0.0	3.6	0.1	0.0	1.0	10.2	0.1	1.8	7.5	0.0	3.4	3.4	5.5	11.3	0.8	0.6	2.1	6.3	0.2	10.4	0.0	0.0	21.0	3.1	10.5	6.3	1.9	15.6	6.3	9.8	4.8	12.0	2.2	2.5	8.9	30.6	6.0	0.1	1.1	15.4	1.2	2.5	18.7	4.5	1.8	0.0	2.6	0.0	0.7	1.3	1.6	4.0	0.0	0.6	0.2	1.9	0.1	16.1	0.0	2.9	0.0	44.1	0.0	0.0	1.7	0.9	1.5	0.0	0.0	25.4	12.4	2.1	2.9	0.4	0.7	1.9	0.0	1.0	1.2	0.4	1.1	0.7	35.8	5.1	0.1
TOX4	"C14orf92, KIAA0737, LCP1"	ENSG00000092203	"TOX high mobility group box family member 4"	O94842	14	21476597-21499175	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017880, HPA027551"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA017880: AB_1845573, HPA027551: AB_10601701"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.46e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (8.05e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.94e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.48e-3)"	16.5	15.1	18.0	13.4	24.7	18.8	16.9	19.9	29.8	19.8	17.3	21.0	10.9	12.7	18.9	16.2	21.8	15.6	14.7	19.2	17.0	18.4	14.3	15.8	15.8	13.7	19.3	15.9	17.0	17.0	23.2	15.5	21.3	25.3	15.6	15.9	16.0	19.7	19.2	46.0	20.2	20.0	20.5	17.3	14.7	16.9	18.0	13.3	19.5	17.7	16.6	21.6	18.2	14.4	18.4	23.7	34.1	19.9	19.1	21.4	17.6	13.1	14.0	11.7	11.0	17.0	16.3	15.6	12.8	25.3	27.3	26.4	13.5	16.0	8.0	9.0	21.0	21.8	16.0	19.1	19.7	35.0	14.1	7.7	8.9	9.5	18.7	22.0	16.5	14.7	21.2	20.4	21.4	20.6	18.7	19.3	15.3	11.0	13.8	19.4	11.2	16.2	9.1	6.5	19.7	22.1	14.6	12.1	9.3	12.7	16.8	10.8	11.1	12.6	13.5	11.0	16.2	12.8	6.3	12.6	13.8	13.0	12.4	11.2	18.2	19.6	18.0	6.7	8.0	14.6	25.2	19.6	27.0	17.3	19.9	18.6	17.0	15.3	16.2	17.7	18.4	16.4	17.9	34.1	19.1	17.7	23.7	21.4	17.6	18.0	24.7	19.9	29.8	17.0	18.4	19.3	15.9	25.3	13.3	62.5	50.7	37.3	55.5	77.5	75.7	44.9	30.6	56.2	53.4	43.6	27.5	65.5	53.0	41.6	55.4	48.4	49.5	0.0	45.0	53.5	45.5	50.9	59.0	40.3	38.8	39.7	66.1	33.2	39.0	26.6	45.1	51.1	37.1	54.1	38.1	47.5	41.6	40.7	41.4	44.0	47.2	32.3	52.0	104.2	54.7	77.7	222.3	66.1	37.7	58.6
TP53TG3	"P53TG3, TP53TG3A"	ENSG00000183632	"TP53 target 3"	Q9ULZ0	16	32673528-32676732	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.9;placenta: 1.4;testis: 4.3"	"Cell type enhanced"	"Detected in single"	34	"Early spermatids: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 3.4;HMC-1: 1.5;SK-MEL-30: 1.2;SuSa: 1.1;U-2 OS: 1.6"									"HPA047832, HPA060916"			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA047832: , HPA060916: "																		0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.0			0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	1.4		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.3			0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TP53TG3B		ENSG00000261509	"TP53 target 3B"	Q9ULZ0	16	33360274-33363478	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"epididymis: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HMC-1: 3.6;K-562: 2.1;SH-SY5Y: 2.0"									"HPA047832, HPA060916"			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA047832: , HPA060916: "																		0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0			0.0	0.0	21.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TP53TG3D		ENSG00000205456	"TP53 target 3D"	Q9ULZ0	16	32252719-32255922	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 8.7;testis: 5.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 53.8;Late spermatids: 17.1;Spermatocytes: 29.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.5;HEL: 3.2;HMC-1: 4.0;RH-30: 3.1;SCLC-21H: 3.4;U-2 OS: 3.6"									"HPA047832, HPA060916"			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA047832: , HPA060916: "	"unprognostic (1.65e-2)"				"unprognostic (1.92e-1)"	"unprognostic (5.60e-2)"		"unprognostic (1.57e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.47e-2)"		"unprognostic (2.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-1)"		0.1	2.0	0.9	0.2	1.5	0.0	0.1	3.3	1.8	0.0	0.1			0.1	0.4	8.7	0.8	0.3	0.1	0.6	0.6	1.8	0.0	0.0	0.1	0.2	1.0		0.2	0.0	0.0	0.6	1.0		0.7	0.0		0.2	0.0	0.0	0.8	0.0	0.0	1.7	0.5	0.1	5.1			0.2		0.0	0.0	0.4	0.8	0.0	0.7	0.4	0.0	0.6	1.5	0.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.5	0.2	0.0	0.0	0.1	3.1	0.3	0.0	0.0	3.4	1.0	0.0	0.0	0.9	0.6	0.8	0.0	0.0	0.3	3.6	0.6	0.0	1.7	0.8	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.5	0.1	0.7	0.0	0.2	0.0	0.3	1.5											0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	1.1	0.0	5.0	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.0	6.5	0.0	29.4	5.0	0.1	0.0	0.0	0.0	0.0
TP53TG3E		ENSG00000275034	"TP53 target 3 family member E"	Q9ULZ0	16	33303739-33306935	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.3;placenta: 1.6;salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.5;AN3-CA: 3.2;SH-SY5Y: 1.3;U-266/70: 1.1"									"HPA047832, HPA060916"			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA047832: , HPA060916: "																		0.0	0.0		0.6		0.2	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.1	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		1.6		0.0	0.0		1.0	0.0	0.0	0.3	0.0	0.0		0.0	0.1	0.0			0.0		0.0	0.0		0.0	0.1	1.3	0.0	0.0	0.0	1.2	0.0	1.5	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TP53TG3F		ENSG00000278848	"TP53 target 3 family member F"	Q9ULZ0	16	33459045-33462249	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	21	"epididymis: 11.6;testis: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.4;EFO-21: 1.8;HEL: 3.5;HMC-1: 2.1;K-562: 1.9;RPMI-8226: 1.6;U-2 OS: 2.6;U-266/84: 3.7"									"HPA047832, HPA060916"			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA047832: , HPA060916: "																		0.0	0.1		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	11.6	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.8			0.0		0.0	0.0		0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.7	0.5	0.0	0.0	0.5	2.6	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
TPBG	"5T4, 5T4-AG"	ENSG00000146242	"Trophoblast glycoprotein"	Q13641	6	82363206-82370828	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 67.5;Urothelial cells: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 3.2"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.9;hTCEpi: 30.5;hTEC/SVTERT24-B: 27.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010554	Enhanced		Approved	Nucleoplasm		NA	NA		330000	Nucleoplasm		"HPA010554: AB_1858206"	"unprognostic (3.03e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.55e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.57e-2)"	10.2	2.9	0.4	4.8	15.7	1.2	10.2	0.0	8.8	22.0	4.6	1.9	12.1	4.2	12.6	4.6	35.2	8.4	9.3	5.3	0.7	2.0	6.6	1.7	4.1	3.0	4.3	1.4	5.8	4.8	4.1	11.2	16.9	17.6	14.1	4.6	5.1	11.5	9.4	2.6	12.6	4.9	16.2	4.5	5.7	6.2	3.3	7.9	4.2	13.0	6.8	4.5	22.9	25.5	0.0	0.0	0.0	0.1	0.0	3.2	0.0	4.5	6.8	2.5	5.0	9.1	13.1	4.3	21.4	24.9	4.3	5.9	0.8	6.4	0.0	2.3	11.7	12.1	8.9	2.8	11.7	4.6	0.0	3.6	2.6	3.3	0.2	7.4	0.2	2.2	8.3	30.5	27.9	10.4	3.9	1.0	0.2	0.4	0.0	1.1	9.3	0.0	0.0	2.9	2.0	5.4	0.0	4.8	0.0	6.3	6.4	1.2	3.9	4.7	6.8	0.0	4.9	11.3	0.9	3.1	3.7	3.7	7.9	4.6	0.0	0.0	0.0	18.2	0.3	3.9	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.7	0.0	8.8	0.7	2.0	4.3	1.4	17.6	7.9	11.9	6.2	0.0	63.5	60.3	0.1	2.0	12.7	5.3	18.2	52.4	0.0	36.6	0.0	30.7	6.2	17.9	2.6	0.0	40.7	67.5	22.6	45.6	0.0	0.0	3.2	1.6	1.2	6.7	1.2	4.1	11.8	4.0	16.9	0.0	16.1	1.7	26.7	16.4	5.6	0.4	0.2	32.3	19.1	1.9	5.3	27.4	55.2	2.9	9.7	71.2
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048897-69162440	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Melanocytes: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 21.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli		NA	NA			Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (7.60e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.88e-2)"	11.0	6.2	6.3	8.7	11.1	9.2	9.4	14.5	14.0	18.0	18.0	9.2	11.3	15.0	22.4	12.4	11.2	13.8	12.1	7.5	6.2	4.9	11.6	15.7	8.7	10.4	6.0	7.7	12.1	6.8	6.4	7.2	7.1	8.8	13.1	7.4	20.7	8.1	17.8	8.1	16.1	13.7	15.6	6.0	10.9	11.4	8.5	4.9	6.4	7.3	7.4	10.1	11.0	11.2	2.0	7.5	7.1	9.9	6.9	3.2	3.6	3.4	8.9	2.7	4.2	2.6	2.1	11.7	3.9	4.7	4.7	2.8	7.6	10.9	4.5	5.6	4.8	3.7	8.0	2.2	4.4	1.4	2.8	2.3	6.1	9.5	2.5	2.5	4.3	8.3	3.3	2.3	2.4	2.5	1.9	3.2	7.4	2.9	21.1	2.9	8.1	3.6	10.3	3.2	10.1	3.2	3.4	2.2	5.5	4.7	5.6	2.4	3.2	4.5	10.2	15.7	4.1	6.6	5.7	2.9	3.2	4.7	5.9	3.6	5.5	2.3	2.3	5.2	4.6	6.7	4.3	9.8	2.9	1.0	9.8	0.9	2.0	2.1	2.1	7.5	1.5	1.7	2.0	7.1	6.9	9.9	3.2	3.2	3.6	6.3	11.1	14.5	14.0	6.2	4.9	6.0	7.7	8.8	4.9	8.9	1.0	7.5	2.1	3.5	1.5	3.2	7.6	0.0	1.2	12.2	2.0	2.3	14.9	6.0	16.2	2.9	6.2	23.3	7.6	3.7	3.5	1.2	2.3	12.9	10.5	0.0	0.0	6.2	15.4	1.7	5.8	7.4	33.7	4.6	2.9	2.5	3.7	3.5	6.3	9.6	4.2	6.5	5.9	1.9	3.8	3.0	1.6	2.6	3.4	1.4
TPD52	"D52, hD52, N8L"	ENSG00000076554	"Tumor protein D52"	P55327	8	80034745-80231232	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.3"	"Group enriched"	"Detected in many"	6	"B-cells: 24.3;NK-cells: 6.8;T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 47.0;SK-BR-3: 106.8"									"HPA028427, HPA062167"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		42000	Cytosol	"Golgi apparatus"	"HPA028427: AB_10610561, HPA062167: AB_2684704"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.77e-3)"	"unprognostic (8.24e-2)"	"unprognostic (3.75e-1)"	"unprognostic (7.99e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-2)"	3.2	3.9	33.9	20.2	23.2	3.2	30.9	37.5	43.3	8.3	45.2	19.7	7.3	38.1	4.1	23.2	18.1	6.3	13.2	4.5	35.4	26.9	18.4	15.1	7.8	15.8	27.4	24.0	1.5	26.0	19.1	19.1	13.6	20.3	42.5	51.3	17.4	33.5	8.0	3.1	18.2	40.3	4.4	31.4	9.8	32.7	2.1	19.8	3.5	25.8	7.3	22.2	9.5	10.0	24.3	2.4	2.5	0.0	6.8	11.1	4.1	23.5	6.3	0.3	4.2	0.0	0.0	9.7	1.5	2.3	6.5	3.2	3.2	6.9	34.3	8.5	0.1	4.8	9.7	9.7	6.6	4.6	4.2	8.2	4.8	9.0	5.2	0.0	1.5	0.1	0.0	4.7	0.0	2.3	4.1	0.3	23.7	0.0	47.0	0.0	7.8	7.5	7.0	2.1	26.9	15.9	0.0	0.1	21.7	11.3	5.7	12.2	8.3	7.3	106.8	19.7	10.0	10.4	6.1	0.4	0.0	6.7	0.1	5.5	17.7	15.3	28.1	4.2	0.0	0.4	0.2	0.0	2.5	6.4	0.0	11.1	24.3	6.4	5.5	1.1	22.4	4.2	4.8	0.2	6.8	0.0	2.4	4.1	4.1	33.9	23.2	37.5	43.3	35.4	26.9	27.4	24.0	20.3	19.8	41.7	50.8	108.7	73.1	71.7	178.1	18.6	71.4	9.4	42.1	62.8	111.9	80.5	144.2	102.2	14.7	19.9	163.1	23.3	69.8	107.3	5.1	215.6	1.1	34.2	11.9	30.2	163.1	7.4	9.7	11.2	1.1	9.6	99.5	155.1	243.8	34.7	73.4	282.9	1.4	102.9	204.5	0.0	9.1	1.6	17.7	108.9	193.4	42.4	174.5	107.5
TPD52L1	"D53, hD53"	ENSG00000111907	"Tumor protein D52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 95.2;salivary gland: 104.6"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 118.7;Distal tubular cells: 149.2;Exocrine glandular cells: 97.5;Extravillous trophoblasts: 106.8;Melanocytes: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 52.5;hTCEpi: 46.2;MCF7: 68.6;RPTEC TERT1: 53.2;SK-BR-3: 37.1;T-47d: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	10.3	95.2	31.5	4.3	47.5	1.0	25.7	2.6	32.9	10.5	8.5	9.2	31.0	4.3	6.2	27.6	43.3	13.9	10.8	26.0	21.4	9.5	11.7	22.0	4.7	2.9	15.4	12.8	9.0	18.0	10.3	8.7	4.0	16.1	16.6	5.8	13.0	104.6	32.7	34.4	11.8	4.6	27.1	5.5	1.4	10.3	2.6	18.2	0.0	23.5	20.1	11.0	18.1	14.6	1.1	0.9	5.9	1.2	5.3	1.7	1.0	7.0	8.0	0.0	52.5	0.4	0.1	12.5	1.2	1.1	0.0	0.1	12.8	9.0	0.0	27.0	5.9	1.7	16.2	1.6	11.2	0.0	0.1	11.2	0.1	11.3	0.1	1.1	0.0	0.0	1.4	46.2	0.0	6.1	16.4	0.0	0.0	5.6	0.1	0.9	68.6	0.0	0.1	0.8	6.9	4.4	0.0	0.0	0.0	53.2	1.8	1.7	0.0	13.5	37.1	0.8	2.0	31.6	0.1	0.0	0.3	1.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	2.7	1.2	0.8	0.8	0.6	0.8	0.8	1.3	0.6	0.5	1.1	1.7	1.2	5.9	5.3	0.3	0.9	0.4	1.0	31.5	47.5	2.6	32.9	21.4	9.5	15.4	12.8	16.1	18.2	0.0	21.2	0.5	40.2	17.4	1.7	40.6	17.8	13.4	13.6	118.7	3.9	27.1	149.2	28.9	5.4	30.1	4.6	0.0	97.5	106.8	3.1	35.2	2.3	56.3	9.5	0.0	15.5	4.3	1.9	3.4	16.1	4.1	124.9	1.0	9.1	3.2	37.3	0.0	34.3	26.2	1.3	0.0	15.6	2.8	5.3	32.5	12.0	2.9	9.7	17.9
TPD52L2	"D54, hD54"	ENSG00000101150	"Tumor protein D52 like 2"	O43399	20	63865228-63891545	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 153.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047489	Approved		Approved	Vesicles,Cytosol		NA	NA		1500000	Vesicles	Cytosol	"HPA047489: AB_2680067"	"unprognostic (1.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (3.63e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.74e-8)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.15e-3)"	48.6	40.9	28.1	33.5	33.6	55.4	43.3	33.4	40.2	40.1	35.8	35.0	34.6	25.3	38.4	29.7	52.2	33.9	32.2	45.3	27.6	30.0	31.0	24.7	30.3	38.3	26.6	34.1	33.4	30.1	20.5	30.6	42.9	33.8	33.8	24.2	29.0	27.4	43.7	32.3	33.9	25.0	48.0	27.4	36.5	28.1	35.0	24.7	19.4	40.9	32.8	31.8	40.9	55.6	13.0	17.6	50.5	25.4	16.7	14.4	23.1	33.2	17.3	10.7	13.1	24.9	39.7	16.1	38.5	34.0	68.6	29.2	63.7	38.2	13.5	42.6	38.7	40.9	32.9	21.8	52.3	40.0	7.5	9.2	12.8	22.7	38.4	26.5	16.3	13.3	28.5	59.0	27.5	44.5	24.3	31.4	14.4	26.6	19.9	26.9	18.5	15.6	20.7	15.5	33.0	61.2	21.7	11.9	21.6	27.0	14.9	16.5	18.5	45.4	35.1	31.2	16.7	23.9	33.0	33.1	55.2	15.9	32.0	28.0	12.8	20.1	16.3	51.7	15.2	17.0	18.8	25.4	16.7	11.6	19.9	14.4	13.0	12.7	13.1	17.6	11.9	13.0	11.7	50.5	16.7	16.5	8.8	13.8	23.1	28.1	33.6	33.4	40.2	27.6	30.0	26.6	34.1	33.8	24.7	14.9	22.6	28.2	24.7	39.2	18.0	36.1	12.7	13.4	13.6	21.0	5.9	67.3	33.2	47.5	6.1	36.0	31.5	0.0	28.0	87.4	44.4	36.3	38.1	12.1	153.9	7.9	17.9	20.3	47.0	9.5	38.9	46.7	27.0	53.3	22.5	31.7	55.9	19.8	61.2	27.2	17.3	45.3	60.4	11.6	22.0	36.9	91.0	26.1	25.2	37.4
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.8;skeletal muscle: 211.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		270000000	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	20.2	41.2	41.2	24.3	46.9	27.4	83.4	93.2	196.1	27.1	39.1	12.8	18.6	40.1	17.2	22.6	51.0	22.1	33.3	94.9	36.7	33.1	43.1	40.8	48.8	140.2	34.0	34.6	19.9	87.0	32.1	16.8	27.1	70.7	19.0	43.5	21.1	26.0	28.7	211.0	25.8	37.8	29.4	20.8	20.1	21.6	15.7	19.4	14.2	20.2	38.4	38.0	23.0	28.0	55.4	170.3	145.5	148.2	81.2	67.1	234.8	115.0	103.1	54.7	84.5	53.6	56.6	96.6	83.3	92.0	157.5	191.0	106.5	63.3	67.6	16.8	82.2	81.5	57.3	130.0	139.2	174.7	89.1	96.8	87.5	75.6	70.2	39.9	99.6	71.9	61.4	58.1	121.4	104.7	221.1	95.7	34.4	45.2	26.0	120.8	84.7	52.3	84.2	134.8	98.1	65.8	30.7	90.0	69.3	98.6	82.2	38.9	64.8	72.7	75.6	40.3	119.8	17.3	74.9	59.1	84.5	72.3	54.6	122.1	50.8	20.8	100.9	169.5	62.0	60.6	87.7	146.1	145.5	56.1	148.2	57.0	55.4	56.5	54.5	170.3	44.3	39.9	49.3	61.1	81.2	127.8	30.7	67.1	234.8	41.2	46.9	93.2	196.1	36.7	33.1	34.0	34.6	70.7	19.4	125.0	186.6	268.1	429.8	608.3	247.2	505.0	410.2	145.9	159.3	369.9	104.1	935.0	1278.3	1116.4	147.7	369.6	973.7	70.0	686.0	1611.5	538.5	310.9	357.6	425.4	827.4	281.3	408.6	284.8	382.5	523.4	258.3	552.8	639.4	1545.5	419.4	603.3	953.1	852.2	247.5	1236.2	208.3	194.1	473.8	15.1	66.8	538.4	1279.9	363.9	717.3	571.4
TPK1	"HTPK1, PP20"	ENSG00000196511	"Thiamin pyrophosphokinase 1"	Q9H3S4	7	144451941-144836395	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 70.4;Late spermatids: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.3;CACO-2: 6.5;EFO-21: 8.3;TIME: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021545, HPA021849"	Approved		Approved	Vesicles		NA	NA		78000	Vesicles		"HPA021545: AB_1858209, HPA021849: AB_1858210"	"unprognostic (4.05e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.22e-3)"	12.2	7.4	5.1	9.6	4.7	3.6	7.6	4.0	7.2	4.3	8.4	4.2	2.4	18.2	5.1	5.0	3.3	3.9	5.4	6.4	5.6	6.6	6.0	6.2	8.8	23.3	4.9	3.1	4.4	3.3	3.6	4.6	7.0	4.4	3.7	8.5	8.9	7.1	4.1	3.0	2.9	13.9	5.1	6.0	15.1	4.0	5.9	2.0	5.1	4.9	4.1	14.2	5.5	3.3	5.4	9.6	3.4	7.4	4.0	5.5	3.8	0.2	0.2	0.3	27.3	0.2	0.2	2.2	0.1	0.1	0.0	0.0	6.5	1.1	0.4	8.3	0.4	0.5	0.0	0.5	0.3	0.2	1.6	0.4	0.1	0.1	0.1	0.7	2.0	0.6	0.5	0.5	0.3	0.4	0.7	5.2	1.0	0.5	1.2	0.1	0.8	0.6	3.0	0.7	0.8	2.3	0.2	0.6	0.9	4.2	2.4	0.2	0.0	0.4	0.0	0.5	0.5	0.3	3.9	6.2	0.3	0.7	0.5	0.3	0.6	1.5	0.6	0.9	5.2	0.2	0.3	7.3	0.2	3.9	5.3	4.0	5.0	4.4	3.5	9.6	5.4	5.2	4.2	3.4	4.0	7.4	2.3	5.5	3.8	5.1	4.7	4.0	7.2	5.6	6.6	4.9	3.1	4.4	2.0	8.9	3.2	15.9	2.3	2.1	3.2	4.5	10.2	2.7	0.0	3.5	7.9	35.1	16.6	4.2	70.4	7.7	15.5	0.0	5.7	11.9	5.3	2.4	7.0	3.9	14.8	1.6	1.2	6.7	13.9	75.1	4.6	16.2	8.5	7.2	4.3	2.4	6.9	7.4	1.1	6.9	4.5	0.0	3.4	7.9	11.8	1.5	26.8	6.4	6.3	3.6
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 544.2;skeletal muscle: 589.5"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 12627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 23.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 206.7;SuSa: 259.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		280000000	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	17.9	5.7	5.5	32.4	5.2	1.2	15.2	5.6	5.1	48.1	119.7	2.4	84.2	14.6	72.4	38.3	121.6	36.2	75.3	544.2	4.1	2.6	14.5	4.4	10.5	3.3	3.3	7.0	27.0	29.3	1.9	3.2	17.7	4.1	72.5	28.0	19.1	12.9	81.3	589.5	6.5	39.5	245.2	2.7	6.5	51.7	9.6	2.3	0.4	7.7	121.7	5.9	193.8	38.7	2.7	8.4	23.8	11.6	1.2	3.4	9.9	33.8	22.3	27.0	1.3	9.4	5.9	88.9	95.4	35.1	58.7	43.6	15.7	6.7	0.1	43.8	95.3	39.4	18.8	22.9	15.3	39.1	0.8	3.2	5.0	24.1	7.6	26.5	0.2	1.1	8.3	8.8	48.2	12.8	206.7	15.3	0.8	0.5	1.2	44.8	17.5	1.5	0.4	32.1	8.0	3.8	0.5	9.5	0.9	83.8	18.7	6.4	4.4	11.4	18.1	4.0	259.0	13.2	0.9	70.7	77.6	38.1	11.5	67.6	0.3	0.2	0.4	21.9	1.3	53.7	23.8	6.1	2.9	2.5	11.6	2.0	2.7	2.4	2.7	8.4	2.6	2.6	2.3	6.7	1.2	7.9	1.7	3.4	9.9	5.5	5.2	5.6	5.1	4.1	2.6	3.3	7.0	4.1	2.3	53.6	87.9	11.7	166.6	63.8	52.3	12627.3	392.4	116.4	116.0	301.8	361.3	128.4	159.2	2265.1	4.5	128.8	537.1	0.0	1464.0	2646.2	335.9	214.6	50.8	122.9	165.5	49.3	257.1	251.7	29.3	13.2	189.8	54.2	77.6	57.7	811.2	43.7	1740.7	585.7	1062.5	207.5	461.5	1021.9	1520.7	21.6	75.4	44.2	86.2	21.9	280.4	186.5
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease mutation, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 738.4;tongue: 203.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		410000000	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (6.73e-6)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.39e-5)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	10.1	7.3	10.8	10.8	10.5	26.5	6.2	6.4	11.2	4.6	9.6	3.9	3.2	7.9	4.1	27.9	18.3	4.4	6.7	29.7	7.7	8.1	7.2	6.8	9.6	12.9	8.9	5.8	4.8	23.2	3.6	3.2	6.7	5.0	5.7	10.7	4.4	20.5	2.5	738.4	5.9	8.2	5.2	7.7	11.7	6.9	5.4	4.4	6.7	9.3	203.6	28.6	6.8	4.9	38.9	72.6	154.8	95.9	35.4	54.4	146.1	66.5	33.2	42.5	27.9	36.0	47.1	42.9	57.2	52.9	75.9	57.3	61.8	62.4	50.1	46.6	64.5	30.5	61.7	42.1	60.2	81.0	34.7	22.9	61.7	32.4	41.6	28.6	90.2	82.0	35.5	33.0	66.9	51.5	34.2	116.7	36.9	46.3	53.9	93.7	39.9	70.2	93.1	95.7	113.6	72.2	60.2	29.5	71.0	54.8	50.8	29.9	56.1	43.5	57.9	56.7	59.2	80.8	107.9	87.2	66.5	48.1	63.7	89.6	45.9	75.4	67.0	60.1	68.0	105.0	70.8	64.7	154.8	54.4	87.8	48.6	38.9	48.5	51.1	72.6	30.1	36.6	47.3	74.9	35.4	95.9	36.0	52.1	146.1	10.8	10.5	6.4	11.2	7.7	8.1	8.9	5.8	5.0	4.4	577.7	334.3	245.8	179.3	132.8	84.5	62.7	104.4	335.9	395.8	92.5	29.5	101.3	89.5	278.9	51.0	357.1	327.9	0.0	302.5	278.2	125.9	137.0	499.8	99.0	485.9	287.6	135.3	175.6	320.5	131.0	43.1	444.6	145.1	764.7	164.6	45.8	384.6	230.6	28.0	130.8	59.1	19.4	73.4	34.9	54.6	125.3	85.2	233.3	208.9	254.0
TPM4		ENSG00000167460	"Tropomyosin 4"	P67936	19	16067021-16103005	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 230.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004685, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		950000000	"Actin filaments"	Cytosol	"CAB004685: AB_425723, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.27e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-3)"	"unprognostic (7.38e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	66.2	17.9	13.3	60.0	13.7	10.8	47.4	46.2	11.5	90.2	40.5	14.6	56.4	17.4	87.1	63.3	149.3	49.4	108.4	39.2	14.5	12.4	32.4	12.2	69.7	27.1	16.0	10.5	102.4	15.4	8.4	16.2	65.0	19.7	84.1	31.8	18.6	47.6	64.6	29.9	39.0	25.2	127.2	22.5	99.7	37.5	30.6	11.7	11.5	20.0	92.2	60.1	177.3	70.5	22.2	35.0	40.7	32.7	24.7	52.5	48.6	59.8	23.7	46.0	28.0	106.9	159.3	57.6	83.9	101.8	71.1	73.4	24.6	62.6	2.7	65.6	104.6	52.4	32.3	19.2	48.1	93.0	39.4	11.0	30.2	34.1	19.7	58.8	5.4	72.2	98.6	15.6	58.1	66.8	82.3	81.3	14.1	3.4	38.0	98.1	20.3	16.2	19.0	24.0	54.9	28.9	22.2	39.5	13.0	16.4	51.3	8.3	26.3	56.4	25.3	29.7	46.3	0.5	8.3	95.2	123.9	15.7	230.2	77.5	6.6	15.6	13.3	85.9	15.9	41.9	40.7	30.1	2.2	34.8	32.7	26.3	22.2	26.9	31.2	35.0	18.8	7.8	18.3	35.2	24.7	16.2	27.4	52.5	48.6	13.3	13.7	46.2	11.5	14.5	12.4	16.0	10.5	19.7	11.7	372.2	149.0	112.7	891.9	382.9	46.3	46.3	96.8	158.0	326.4	230.3	9.8	212.0	11.6	660.1	53.8	384.6	203.3	0.0	501.5	677.9	318.1	567.0	235.4	1.9	313.9	4.8	90.0	275.0	103.4	37.2	160.2	324.4	135.0	331.0	106.2	5.7	698.7	90.9	514.4	15.6	10.7	329.8	423.9	12.0	11.3	300.5	475.8	117.4	88.9	901.5
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693395	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 77.5"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 35.7;Bipolar cells: 18.7;Horizontal cells: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.5;NK-cell: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 8.6;AN3-CA: 6.4;SCLC-21H: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favorable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.5	5.8	27.0	1.3	29.6	1.0	2.7	17.0	77.5	2.1	3.2	69.0	0.1	4.6	2.3	1.3	9.0	8.6	2.1	6.0	33.9	23.9	3.2	2.3	8.3	1.0	25.8	25.0	1.8	5.2	2.4	4.4	2.4	30.1	2.4	2.2	0.2	4.8	3.7	6.2	5.6	7.5	3.5	24.7	2.7	3.8	1.6	4.3	0.0	6.0	1.9	1.8	3.4	0.6	0.0	0.2	1.5	0.0	1.0	0.5	0.1	0.3	8.6	0.4	6.4	0.9	0.0	1.2	0.2	0.0	0.0	0.0	0.3	1.0	0.2	0.6	0.0	2.2	3.4	3.4	0.0	0.0	1.7	2.9	0.2	3.6	0.2	1.0	0.3	0.4	0.0	0.8	0.0	0.2	0.2	0.1	0.2	0.1	3.2	0.0	0.3	0.2	0.5	0.2	0.9	0.9	0.3	0.1	1.2	0.3	1.2	15.8	1.9	0.9	0.4	4.2	0.4	0.8	0.2	0.1	0.2	3.4	0.1	0.2	1.2	0.3	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.2	0.1	0.1	27.0	29.6	17.0	40.8	33.9	23.9	25.8	25.0	30.1	4.3	35.7	7.7	0.0	1.0	3.7	18.7	16.1	5.1	16.0	9.1	1.8	0.0	0.0	1.7	1.7	6.9	0.0	8.5	0.0	0.6	0.1	0.7	0.6	4.6	2.0	2.5	39.7	9.8	1.3	0.0	3.6	0.3	0.0	1.7	0.0	5.7	0.8	1.0	5.8	0.4	1.1	2.1	0.0	1.9	1.4	0.2	2.8	0.0	0.0	4.1	2.4
TPPP3	"CGI-38, p20, p25gamma"	ENSG00000159713	"Tubulin polymerization promoting protein family member 3"	Q9BW30	16	67389809-67393535	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 211.3"	"Cell type enhanced"	"Detected in many"	19	"Ciliated cells: 1619.4;Melanocytes: 475.8;Suprabasal keratinocytes: 432.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 26.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 29.0;OE19: 19.5;RH-30: 15.5;SCLC-21H: 23.9;SH-SY5Y: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047629, HPA061691"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		29000	"Nucleoli fibrillar center"		"HPA047629: AB_2680108, HPA061691: "	"unprognostic (1.63e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.86e-3)"	9.6	7.6	30.5	2.9	20.7	1.0	21.9	3.7	25.0	12.8	11.9	70.3	2.0	6.4	7.2	15.1	24.8	211.3	6.0	11.3	36.4	41.9	6.1	1.9	36.3	1.7	26.4	22.1	14.1	6.5	2.2	5.8	70.6	24.5	3.4	4.3	2.2	5.2	4.2	14.4	28.1	9.8	10.0	40.6	3.8	11.3	2.6	24.4	0.1	3.5	37.6	6.1	7.4	5.5	0.0	14.1	5.2	26.2	0.0	0.1	3.6	0.2	29.0	0.3	0.2	0.2	4.8	0.1	0.8	0.2	0.2	0.4	1.8	5.8	0.0	0.4	0.4	0.1	5.5	4.5	0.0	0.0	0.0	1.7	0.0	0.8	0.8	0.0	0.0	0.0	1.2	0.1	1.8	0.0	0.9	0.3	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.9	19.5	0.0	0.0	15.5	0.1	0.0	0.0	23.9	10.3	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	10.9	5.2	0.0	15.4	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	2.6	0.0	26.2	0.1	0.0	3.6	30.5	20.7	3.7	23.8	36.4	41.9	26.4	22.1	24.5	24.4	14.9	90.7	0.0	8.9	269.9	1.4	4.0	15.3	1619.4	170.6	17.4	3.9	1.8	5.0	47.8	55.6	19.9	16.9	0.0	1.6	3.9	95.0	5.4	25.3	0.0	2.7	0.0	170.8	3.1	2.6	16.8	27.0	16.0	475.8	1.8	30.4	78.6	13.2	14.4	3.2	0.2	7.3	232.8	118.8	3.7	3.4	432.9	66.9	0.9	22.1	7.7
TPRA1	"FLJ32197, GPR175, TMEM227, TPRA40"	ENSG00000163870	"Transmembrane protein adipocyte associated 1"	Q86W33	3	127573069-127598251	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019784	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA019784: AB_2670266"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.91e-3)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.28e-2)"	17.6	21.0	14.6	11.4	13.5	22.4	22.1	20.3	16.7	22.6	25.8	15.9	26.9	17.1	21.5	16.7	19.5	21.9	18.2	15.4	14.9	12.4	18.1	23.5	20.4	13.1	16.3	11.6	21.9	30.4	24.0	15.9	35.7	14.0	19.5	11.1	21.0	24.3	19.5	31.3	28.7	18.2	16.9	10.7	17.7	16.8	18.3	12.5	13.9	30.2	15.8	14.5	19.5	19.8	9.5	19.2	13.7	16.3	6.5	14.1	7.3	21.5	15.5	6.2	12.3	24.0	13.3	23.3	13.5	15.2	11.2	10.2	10.0	14.1	18.9	24.6	16.6	36.9	22.8	10.2	15.5	5.9	11.9	9.1	12.4	21.1	9.6	26.3	7.8	24.3	13.2	13.1	7.7	19.1	23.4	8.4	13.0	7.5	17.6	13.7	17.9	8.7	21.2	10.5	11.3	12.0	16.3	9.4	16.8	13.1	8.8	12.5	4.8	21.0	25.8	17.1	5.1	13.0	18.3	15.4	13.7	8.3	29.4	7.4	15.1	11.2	18.2	15.2	18.8	10.4	3.6	16.3	13.7	10.2	11.0	12.9	9.5	12.4	14.1	19.2	8.2	9.9	10.0	10.3	6.5	9.6	13.4	8.7	7.3	14.6	13.5	20.3	16.7	14.9	12.4	16.3	11.6	14.0	12.5	20.8	6.5	13.8	19.1	44.4	7.0	11.1	10.2	4.0	9.1	24.4	3.9	48.5	5.0	23.8	2.4	25.4	18.2	0.0	17.0	37.2	30.5	18.2	18.4	17.9	30.0	4.8	16.7	19.6	16.2	1.1	31.1	22.0	28.7	81.2	16.1	11.2	24.3	15.9	18.4	12.3	8.6	12.9	24.4	7.7	18.1	47.6	57.0	12.1	19.6	17.8
TPRG1L	"FAM79A, FLJ21811, RP11-46F15.3"	ENSG00000158109	"Tumor protein p63 regulated 1 like"	Q5T0D9	1	3625002-3630127	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063163, CAB079051"		Supported	Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB079051: , HPA063163: AB_2684953"	"unprognostic (1.92e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.46e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-3)"	"prognostic favorable (1.76e-9)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	18.3	19.1	34.3	9.7	46.6	14.5	17.4	23.1	57.7	19.3	24.0	12.9	17.2	24.5	16.5	21.2	28.7	24.8	19.3	25.0	32.9	32.8	32.1	34.9	16.8	14.6	25.7	41.7	25.9	17.4	11.7	20.5	12.7	41.4	17.1	23.4	19.1	18.7	25.0	29.5	25.4	28.3	18.1	13.2	13.4	17.4	8.7	13.6	8.0	21.9	17.3	18.2	17.1	16.3	5.1	7.9	17.0	3.2	2.6	7.1	3.2	11.3	8.2	5.0	9.0	38.3	26.7	4.7	17.0	23.5	15.8	10.5	15.3	10.5	4.2	15.2	23.1	8.5	18.0	6.0	15.7	13.4	13.3	9.7	5.9	9.5	17.7	23.3	8.5	7.0	20.1	23.2	13.0	13.4	19.3	22.2	7.4	4.2	15.1	22.0	5.2	6.1	8.8	6.8	26.3	19.2	5.1	7.5	10.0	16.3	12.0	14.2	14.0	9.1	18.9	18.0	12.1	11.8	7.4	25.2	13.3	3.9	30.1	4.8	13.7	17.7	4.7	7.8	18.8	1.7	12.8	3.2	4.9	5.6	2.6	7.1	4.2	6.4	5.5	2.8	5.1	5.9	6.8	17.0	2.6	2.5	7.9	3.4	3.2	34.3	46.6	23.1	57.7	32.9	32.8	25.7	41.7	41.4	13.6	14.9	16.2	8.0	8.5	10.6	44.4	33.5	20.4	17.4	5.7	10.4	7.9	8.9	10.0	15.8	2.4	13.0	47.9	0.0	30.6	10.6	9.7	9.0	8.1	49.9	13.0	119.2	18.5	27.0	14.8	3.1	17.3	9.7	6.8	13.6	29.1	57.4	26.8	23.0	20.1	31.6	27.8	6.5	13.8	4.7	13.2	16.6	7.7	10.0	24.1	7.2
TPRN	"C9orf75, DFNB79, FLJ90254"	ENSG00000176058	Taperin	Q4KMQ1	9	137191617-137204193	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.8;pancreas: 45.3"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 109.1;Mucus-secreting cells: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 27.8;T-47d: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.9"	"HPA020899, HPA076667"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA020899: AB_1845835, HPA076667: "	"unprognostic (5.41e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (2.94e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.77e-2)"	"prognostic favorable (5.16e-9)"	"unprognostic (1.96e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.44e-2)"	3.2	3.8	8.5	5.0	16.8	3.2	3.3	26.1	17.9	3.4	18.5	32.8	2.3	23.6	2.8	1.8	8.2	4.2	4.8	3.6	11.2	7.0	12.1	10.0	5.8	3.0	25.3	7.1	4.7	45.3	2.8	2.7	4.3	11.0	4.4	8.1	13.1	8.7	4.8	5.0	8.0	29.0	2.4	11.9	3.7	10.8	4.7	21.7	0.2	2.5	2.3	3.5	3.8	2.7	1.2	2.3	0.2	2.9	2.9	2.2	0.6	4.5	5.2	1.7	7.9	2.5	2.6	14.1	3.2	2.0	3.3	1.8	17.4	5.6	8.4	4.8	1.6	4.3	14.0	3.6	1.8	0.4	5.3	5.1	3.9	7.8	11.4	3.7	6.0	5.1	2.2	3.5	2.9	2.0	2.1	2.0	3.8	7.1	3.0	0.9	27.8	3.9	13.0	6.3	25.0	6.8	11.8	4.2	12.7	7.3	9.6	11.5	4.2	4.9	23.2	5.7	1.4	26.9	9.5	2.3	6.0	2.8	9.4	6.8	2.5	4.8	4.3	4.3	5.4	3.3	0.0	2.9	0.2	1.3	2.6	0.4	1.1	1.3	1.8	2.1	1.2	0.6	1.2	0.0	2.9	1.5	2.3	2.2	0.6	8.5	16.8	26.1	17.9	11.2	7.0	25.3	7.1	11.0	21.7	17.9	5.6	2.7	1.1	1.5	15.5	7.3	12.7	1.4	1.2	15.7	5.9	4.7	6.6	7.1	2.3	1.9	109.1	23.3	38.5	1.1	1.6	2.8	1.1	14.4	3.1	11.1	8.6	4.3	3.2	3.8	3.1	2.1	5.0	1.8	43.9	10.9	16.4	23.2	4.2	16.6	5.9	6.5	1.7	1.0	5.5	2.5	1.6	0.0	21.2	1.7
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	69	"testis: 78.6"	"Group enriched"	"Detected in some"	14	"Spermatocytes: 282.4;Spermatogonia: 73.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.4;K-562: 8.6;Karpas-707: 7.0;MCF7: 5.1;PC-3: 5.2;RPMI-8226: 9.5;SuSa: 8.9;U-2 OS: 4.6;U-266/70: 8.5"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.1	0.0	0.0	0.7	0.2	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0		0.1	0.8	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.4	0.0	0.9	0.0	78.6	0.0	0.4	0.1	0.4	0.8	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	7.0	0.0	5.1	0.0	0.0	1.2	0.0	5.2	0.0	0.0	9.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	8.9	0.0	0.0	0.0	2.0	4.6	2.4	0.0	8.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	12.9	0.0	282.4	73.0	0.0	0.9	0.0	0.0	0.0
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 12.3"	"Cell type enhanced"	"Detected in some"	23	"Collecting duct cells: 1.8;Early spermatids: 3.5;Spermatocytes: 9.3;Spermatogonia: 2.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.1;Karpas-707: 2.9"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.0	0.1	0.4	0.2	1.0	0.0	0.1	0.7	0.8	0.0	0.1			0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.4		0.0	0.0	0.0	0.1	0.1		0.0	0.1		0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	12.3			0.0		0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	10.1	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	2.9	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	9.3	2.5	0.1	0.1	0.0	0.0	0.0
TRA2A	"AWMS1, htra-2-alpha, tra2a"	ENSG00000164548	"Transformer 2 alpha homolog"	Q13595	7	23504780-23532041	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054018	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoli	"Nucleoplasm, Vesicles"	"HPA054018: AB_2682344"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.77e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.28e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.36e-3)"	23.4	29.4	27.8	29.5	34.1	70.6	27.4	38.1	27.5	30.3	22.9	29.0	31.6	19.8	32.7	34.5	29.4	25.9	17.6	18.7	28.6	29.3	21.3	21.8	28.6	32.2	35.8	18.5	36.8	27.4	14.9	46.6	24.4	28.2	26.4	30.1	23.7	21.9	26.7	15.7	31.6	22.6	35.2	30.4	33.8	21.1	25.9	37.3	35.6	24.7	20.5	38.0	25.0	31.8	15.5	23.9	20.4	23.0	14.7	21.7	8.2	19.3	21.4	33.3	52.1	17.9	11.3	21.5	24.7	11.7	24.8	20.5	17.6	26.6	36.6	14.3	18.3	29.6	32.2	39.9	23.0	31.3	22.0	23.3	22.4	23.7	27.8	18.7	26.1	21.1	13.3	15.9	18.7	23.5	22.5	28.2	16.3	43.5	18.0	28.1	18.9	31.5	43.8	29.9	24.0	22.2	36.1	26.3	21.9	28.7	28.0	28.9	23.5	23.1	26.7	16.5	25.7	21.0	29.4	25.4	19.8	28.3	18.1	28.6	20.1	25.1	30.0	17.0	35.6	26.3	11.5	14.9	18.5	21.7	23.0	18.7	15.5	20.3	19.8	16.8	14.4	17.7	20.9	20.4	14.7	20.4	23.9	20.0	8.2	27.8	34.1	38.1	27.5	28.6	29.3	35.8	18.5	28.2	37.3	56.6	68.2	70.3	85.9	92.7	49.7	37.0	48.4	77.6	60.3	83.7	49.1	76.6	21.6	48.0	48.5	63.2	67.9	70.0	38.1	71.1	87.2	68.2	83.3	62.7	48.6	35.0	113.5	70.0	86.5	17.7	60.1	73.9	54.0	60.5	57.4	42.4	49.0	80.7	63.6	32.1	101.0	71.1	79.3	92.3	54.5	98.9	98.6	97.5	61.7	73.5
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185915906-185938136	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		40000	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	36.2	38.0	34.9	52.5	32.4	34.5	34.1	29.8	29.1	30.5	39.5	20.3	31.7	22.4	37.8	32.3	36.5	27.1	31.0	26.4	29.9	30.1	33.0	37.1	27.1	36.9	29.8	21.9	28.9	31.0	28.6	31.3	38.0	20.9	31.6	27.5	26.1	26.6	32.3	50.8	22.7	24.9	35.7	27.1	31.9	28.7	38.4	25.1	57.2	29.6	47.3	42.8	34.0	50.3	34.5	37.0	30.7	21.0	20.6	25.0	10.7	31.8	13.1	33.0	16.8	9.6	7.6	18.2	25.8	16.7	28.5	22.6	21.1	16.8	30.8	31.1	13.2	19.7	20.8	36.1	25.1	33.6	25.9	22.9	28.8	11.9	28.0	12.8	30.5	23.3	7.3	12.5	16.8	16.3	9.2	21.8	15.4	27.5	19.7	21.8	16.7	75.5	44.3	49.2	31.1	20.5	45.9	26.6	35.9	27.7	13.9	24.5	24.4	17.0	24.0	30.4	17.7	24.2	33.9	12.4	19.3	25.3	16.1	38.8	36.3	88.4	57.5	19.9	35.5	30.4	30.7	21.0	16.1	20.2	17.1	18.1	31.7	19.8	18.7	18.3	34.5	25.0	22.7	22.1	20.6	18.6	37.0	18.5	10.7	34.9	32.4	29.8	29.1	29.9	30.1	29.8	21.9	20.9	25.1	59.6	114.4	168.3	155.0	229.4	101.5	57.6	104.4	62.9	102.4	66.3	184.6	157.7	61.3	105.4	125.7	154.8	106.8	233.6	94.8	196.4	163.4	151.8	191.8	78.1	151.9	68.3	218.4	179.9	244.9	31.1	118.2	213.7	128.2	216.4	142.0	89.2	85.0	121.0	110.3	42.8	196.4	103.5	173.1	132.6	147.0	227.8	179.8	202.0	165.8	133.4
TRABD	PP2447	ENSG00000170638	"TraB domain containing"	Q9H4I3	22	50185915-50199598	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000822	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA000822: AB_10959384"	"unprognostic (9.37e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (2.80e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.98e-3)"	8.9	10.3	8.3	28.8	13.4	45.5	12.0	15.3	11.4	10.6	14.7	7.4	19.9	15.9	9.3	15.6	19.9	9.2	18.1	10.0	9.0	4.9	13.4	20.0	13.1	25.6	12.4	6.1	10.2	42.9	5.9	12.0	9.6	9.5	14.8	6.0	8.4	24.6	19.5	14.0	13.0	18.3	9.3	9.6	19.5	16.5	9.7	11.8	21.0	13.2	13.2	33.1	11.5	13.1	6.9	33.0	23.0	14.2	14.7	13.6	9.2	22.6	15.0	5.4	8.9	2.9	3.5	13.7	7.9	5.2	6.6	5.6	9.5	10.9	14.1	7.8	3.6	5.2	14.2	6.9	14.0	1.3	9.8	32.5	8.0	23.3	16.0	11.7	16.4	16.1	5.6	8.6	4.8	6.6	3.8	6.4	13.6	9.9	23.0	2.8	25.1	11.3	18.6	7.9	7.6	14.3	31.7	7.4	29.6	5.1	22.0	6.3	10.7	6.8	24.6	11.2	2.4	10.5	16.6	7.1	5.6	13.8	7.2	8.8	28.1	4.9	16.8	6.8	11.4	8.6	7.0	14.2	23.0	10.9	12.5	10.2	6.9	9.8	9.8	15.4	3.6	6.7	7.7	19.5	14.7	7.6	33.0	13.6	9.2	8.3	13.4	15.3	11.4	9.0	4.9	12.4	6.1	9.5	11.8	8.9	22.9	69.8	39.9	37.4	31.1	8.3	12.7	13.4	18.2	31.4	17.7	22.9	23.2	46.8	13.0	20.2	51.8	0.0	54.3	43.7	24.4	43.9	27.6	21.2	42.8	41.3	17.3	12.3	48.9	6.3	30.0	57.1	40.5	126.2	38.4	28.4	67.6	66.2	30.4	24.5	29.9	19.4	25.5	52.8	29.8	39.9	25.6	58.6	43.9	81.4
TRADD	Hs.89862	ENSG00000102871	"TNFRSF1A associated via death domain"	Q15628	16	67154180-67160298	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"monocytes: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004602, HPA071341"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB004602: AB_2209061, HPA071341: AB_2732178"	"unprognostic (2.66e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (1.40e-4)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.83e-1)"	12.2	13.3	8.7	15.9	10.5	5.6	10.1	2.1	6.9	11.9	12.3	10.8	13.0	10.2	10.4	11.1	17.4	11.6	14.5	7.3	6.5	3.1	15.0	11.8	11.6	14.4	10.5	4.4	12.8	17.9	9.7	8.4	14.9	9.5	13.7	7.4	9.0	15.4	10.5	6.6	14.8	12.1	8.7	7.2	20.3	21.8	4.4	9.8	9.7	19.5	11.0	22.4	11.7	12.0	20.8	21.4	25.6	20.0	10.5	50.5	14.3	8.8	7.5	0.1	2.9	7.0	5.9	9.7	7.0	5.1	3.3	5.2	4.7	7.2	4.7	12.0	6.0	7.0	16.2	1.2	6.1	2.7	13.5	7.0	3.1	3.4	4.6	8.6	3.9	8.0	6.1	8.9	4.5	1.7	8.7	6.3	5.0	4.5	7.5	4.9	8.1	4.6	7.8	0.1	8.6	22.7	9.2	3.7	18.5	5.6	5.8	1.5	4.5	15.4	3.5	4.4	2.9	6.1	5.5	7.2	4.5	4.8	7.3	4.9	15.0	4.8	5.6	10.9	3.5	5.2	12.0	12.3	25.6	16.7	15.3	25.1	20.8	50.5	28.9	15.2	18.5	14.8	11.9	21.6	10.5	20.0	21.4	22.2	14.3	8.7	10.5	2.1	6.9	6.5	3.1	10.5	4.4	9.5	9.8	3.0	7.5	39.0	21.6	15.3	1.0	3.3	22.9	6.7	4.5	5.2	0.0	29.2	26.6	55.2	1.2	18.8	23.1	0.0	33.5	37.2	28.6	34.8	9.2	18.7	41.8	0.0	18.5	12.3	34.6	1.5	27.9	29.1	54.0	256.1	25.5	4.7	54.2	28.3	28.7	65.5	2.1	25.8	22.1	1.8	7.9	22.5	25.5	30.6	21.7	32.5
TRAF1	EBI6	ENSG00000056558	"TNF receptor associated factor 1"	Q13077	9	120902393-120929173	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	15	"monocytes: 550.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;T-cells: 11.1"	"Group enriched"	"Detected in many"	6	"HDLM-2: 35.9;WM-115: 45.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001852, CAB009593"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009593: , HPA001852: AB_1080344"	"unprognostic (1.45e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (2.19e-5)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.42e-5)"	"unprognostic (1.85e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.64e-1)"	"unprognostic (9.87e-3)"	5.4	8.6	9.5	21.6	20.5	8.7	5.7	4.7	13.7	5.3	6.5	17.5	9.2	4.3	6.6	7.4	5.2	6.7	8.6	7.5	11.4	5.5	7.8	4.9	7.4	33.1	14.8	11.2	10.9	3.9	5.3	11.0	3.6	12.5	10.0	5.0	9.4	10.3	7.2	2.4	8.2	8.9	7.8	7.6	15.5	6.6	3.1	19.1	3.5	7.9	2.2	24.0	9.0	10.0	0.2	2.8	0.0	0.4	1.4	11.1	2.0	1.2	0.8	0.1	0.0	1.5	3.7	0.0	0.3	2.0	0.6	1.1	0.1	0.7	2.4	0.4	0.4	6.0	0.5	0.2	0.1	0.7	35.9	0.0	0.2	0.8	0.1	1.1	0.1	2.8	1.8	1.9	2.3	1.7	0.7	0.3	0.7	0.0	4.9	0.3	0.1	0.0	1.0	0.4	0.5	0.1	0.6	0.6	4.9	0.2	0.1	0.4	0.0	0.3	0.1	0.1	1.1	0.3	0.4	0.3	0.5	0.3	2.0	6.4	3.8	1.3	1.2	1.2	0.2	45.4	0.0	0.3	0.0	3.6	0.4	6.4	0.2	8.8	7.4	0.4	0.2	2.7	4.0	0.0	1.4	0.3	2.8	11.1	2.0	9.5	20.5	4.7	13.7	11.4	5.5	14.8	11.2	12.5	19.1	6.0	0.0	6.7	4.1	8.7	0.3	2.3	2.5	0.0	6.8	3.5	17.7	0.0	1.7	24.7	0.5	2.7	0.5	0.0	1.6	0.0	2.8	2.0	36.8	1.8	2.8	0.0	1.7	0.6	3.4	0.6	1.7	14.8	6.8	550.0	0.5	1.0	9.9	0.0	1.8	0.7	6.6	0.0	5.1	1.4	0.5	9.2	0.0	25.9	0.6	1.7
TRAF3IP2	"ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522"	ENSG00000056972	"TRAF3 interacting protein 2"	O43734	6	111556454-111606278	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.8;hTERT-HME1: 36.2;U-2197: 37.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036352	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA036352: AB_10672085"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-1)"	"prognostic favorable (4.73e-5)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (1.11e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.31e-1)"	16.0	13.3	11.9	12.4	12.0	13.4	18.2	3.5	12.5	15.7	16.4	6.0	27.1	16.4	22.4	16.1	24.3	22.5	13.4	7.9	10.2	5.0	9.2	5.6	11.7	8.3	6.1	4.8	8.9	15.5	9.1	11.7	17.9	18.8	11.9	15.8	11.2	19.1	32.6	10.6	30.4	13.6	13.7	13.8	6.3	16.6	3.9	7.7	12.9	16.2	21.0	18.5	11.9	15.9	5.4	2.0	8.0	1.4	2.9	11.8	2.0	7.2	2.5	0.6	3.3	9.6	10.3	4.2	7.3	19.3	3.5	4.5	1.5	4.2	1.1	2.9	9.4	10.4	16.0	2.8	28.8	4.0	9.1	1.9	1.3	3.3	3.2	3.2	1.8	5.6	15.0	20.8	8.4	36.2	7.3	6.5	1.9	3.5	0.4	3.4	6.3	5.5	4.6	2.2	8.4	2.7	9.5	3.4	0.7	9.1	11.8	5.6	0.4	3.5	19.2	12.4	3.0	8.9	5.0	1.7	5.0	1.9	37.9	8.0	0.2	2.0	3.7	10.5	3.0	11.2	8.0	1.4	3.5	2.9	0.3	10.0	4.6	5.6	3.8	2.0	5.4	5.9	5.5	1.5	2.9	0.1	0.2	11.8	2.0	11.9	12.0	3.5	12.5	10.2	5.0	6.1	4.8	18.8	7.7	3.0	14.4	4.7	52.7	26.8	6.7	4.5	7.6	22.7	15.9	3.5	11.8	14.5	5.0	30.6	0.1	17.9	20.6	0.0	27.9	23.8	11.2	36.1	18.6	4.5	5.6	6.4	12.7	1.3	1.8	0.4	6.6	8.5	11.8	9.0	14.6	12.4	18.7	19.2	7.1	4.9	4.5	0.0	13.3	0.6	2.4	21.5	17.5	5.0	20.8	42.3
TRAF3IP3	T3JAM	ENSG00000009790	"TRAF3 interacting protein 3"	Q9Y228	1	209756032-209782320	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 86.5;lymphoid tissue: 69.5"	"Cell type enhanced"	"Detected in many"	20	"B-cells: 61.1;granulocytes: 55.6;T-cells: 188.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 39.7;JURKAT: 22.7;Karpas-707: 16.5;MOLT-4: 20.5;NB-4: 23.6;THP-1: 22.3;U-266/70: 24.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040796	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA040796: AB_10794861"	"prognostic favorable (4.11e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.36e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-5)"	"unprognostic (3.83e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-4)"	"unprognostic (3.08e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.21e-2)"	2.2	0.8	1.7	30.6	2.1	9.8	1.3	0.6	1.5	1.5	3.8	2.2	0.3	2.3	1.5	1.4	2.5	1.7	4.6	1.2	1.7	1.4	3.4	2.4	5.8	32.6	3.8	0.6	1.2	1.3	0.0	1.0	1.0	2.7	2.2	3.6	1.7	8.4	1.3	0.7	1.1	19.8	1.0	3.8	38.3	4.1	1.4	2.6	69.5	2.4	1.5	33.6	5.7	1.9	43.9	25.3	54.9	29.5	50.1	86.5	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	39.7	0.0	3.7	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	16.5	0.0	0.0	20.5	23.6	0.0	0.0	0.0	2.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	24.5	8.5	1.5	0.0	11.1	0.0	54.9	24.1	24.8	48.9	25.7	51.8	43.9	67.8	55.9	25.3	41.4	76.9	60.8	6.5	50.1	29.5	18.6	86.5	56.3	1.7	2.1	0.6	1.5	1.7	1.4	3.8	0.6	2.7	2.6	3.0	14.8	61.1	3.6	2.1	1.5	0.6	2.5	1.4	0.0	0.0	0.0	0.3	10.0	0.1	8.9	0.7	0.2	0.0	0.2	0.3	1.1	0.4	55.6	3.2	22.1	0.0	0.0	4.3	27.4	5.7	0.3	22.8	10.1	5.4	0.2	0.0	0.0	0.0	0.0	5.6	0.3	0.0	0.3	0.5	0.2	1.9	0.3	188.4	0.4	2.0
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	16.0	18.2	18.3	22.3	20.6	28.5	39.1	28.7	25.6	22.1	29.4	9.1	21.1	37.3	20.4	18.3	32.9	21.9	36.9	21.0	18.3	14.8	21.3	47.3	18.3	40.9	13.4	14.7	19.3	41.6	17.7	20.3	19.5	12.8	16.2	16.9	13.0	24.4	23.1	25.5	32.2	37.8	28.8	14.1	21.4	25.1	13.2	10.6	26.1	20.3	30.9	21.9	21.9	28.9	6.7	12.3	7.7	13.9	3.0	7.1	5.2	20.7	26.6	15.2	27.2	15.8	29.8	17.9	16.0	20.2	18.9	17.1	32.3	26.8	13.3	19.0	20.4	12.1	24.4	14.2	28.4	7.2	21.0	18.2	19.0	35.4	24.7	20.9	20.2	27.6	29.5	23.8	18.2	23.9	15.6	36.5	26.4	20.3	18.0	18.0	47.5	20.7	23.5	29.9	28.7	13.0	38.7	25.3	26.7	15.2	11.2	30.7	25.5	13.4	25.8	17.5	8.3	29.3	24.9	27.5	23.0	32.4	21.4	17.4	26.1	19.3	17.6	13.1	13.1	17.8	3.7	10.0	7.7	5.4	13.9	5.0	6.7	5.3	5.7	12.3	4.9	3.8	4.5	6.9	3.0	9.4	6.0	7.1	5.2	18.3	20.6	28.7	25.6	18.3	14.8	13.4	14.7	12.8	10.6	0.0	8.6	11.9	15.5	25.5	14.6	3.4	17.8	4.0	4.5	14.0	5.9	20.5	14.9	35.4	3.8	23.9	60.0	0.0	51.6	30.1	20.0	27.8	9.2	26.1	37.6	35.0	32.6	23.4	38.3	9.1	23.0	18.8	10.1	35.1	35.9	10.5	45.1	40.3	20.8	18.9	8.9	6.5	16.0	4.8	21.5	28.4	22.3	12.9	33.8	29.6
TRAFD1	FLN29	ENSG00000135148	"TRAF-type zinc finger domain containing 1"	O14545	12	112125501-112153609	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"monocytes: 186.7;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039254, HPA039266"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039254: AB_10805358, HPA039266: AB_10795142"	"unprognostic (7.80e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (1.07e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (3.92e-5)"	15.1	13.1	11.0	21.9	19.2	20.5	16.6	11.9	19.8	15.6	31.6	42.1	15.2	12.7	15.1	12.8	26.0	12.8	14.0	16.9	12.2	10.8	12.7	12.5	21.2	25.5	26.2	10.7	15.3	10.2	15.3	14.9	15.5	22.2	18.5	16.8	22.7	16.4	16.7	10.3	28.1	16.0	20.5	25.0	25.0	15.2	30.9	23.4	28.2	13.0	13.0	29.7	25.6	17.4	13.2	11.4	59.1	21.4	14.8	13.8	19.3	10.7	12.2	19.8	18.4	13.5	12.9	10.2	12.3	17.9	17.5	13.9	13.1	9.8	12.2	10.6	13.0	7.5	21.9	19.2	12.1	11.8	21.3	18.3	19.9	17.3	7.1	23.5	12.3	31.0	16.6	20.5	12.4	17.0	17.5	15.2	7.7	22.2	7.6	11.0	18.1	13.5	16.9	16.2	13.1	14.4	19.2	12.1	20.6	11.3	40.6	16.8	13.0	25.6	25.3	6.8	15.5	16.4	17.1	9.7	8.0	5.7	7.8	6.5	18.5	16.3	13.1	8.5	9.7	8.6	59.1	21.4	48.3	10.7	19.4	7.3	13.2	10.5	9.6	11.4	12.2	9.7	8.9	42.8	14.8	20.0	7.5	13.8	19.3	11.0	19.2	11.9	19.8	12.2	10.8	26.2	10.7	22.2	23.4	17.9	9.6	8.8	6.8	10.9	7.0	8.9	7.6	4.0	13.6	12.2	23.6	17.2	5.0	18.4	1.0	9.5	9.3	0.0	18.2	12.6	12.4	16.5	11.5	4.0	13.2	14.3	15.0	8.6	12.5	1.7	10.9	14.1	6.8	186.7	9.2	8.8	21.6	14.0	12.0	4.2	10.9	0.0	6.4	51.7	15.3	13.2	22.1	9.6	9.7	9.0
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828599-49856574	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.0"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 11.8;Spermatogonia: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavorable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	4.8	1.6	3.4	6.0	10.7	9.5	3.0	7.4	3.0	3.5	3.7	2.0	3.2	2.3	3.8	2.4	4.5	3.0	2.9	1.5	2.7	2.7	1.6	1.2	1.3	8.1	2.0	2.8	3.4	1.6	1.6	2.0	2.5	3.0	2.9	4.8	2.7	3.1	1.7	2.8	6.7	3.4	3.4	5.1	3.7	1.9	25.0	3.4	11.5	2.2	3.1	6.8	1.9	3.0	5.1	1.6	0.6	3.0	2.7	4.9	1.6	6.4	7.9	11.3	11.4	1.0	1.6	9.4	7.8	3.8	16.6	15.9	9.6	7.5	16.0	5.6	4.5	11.6	8.6	11.9	9.0	12.4	9.2	7.9	12.0	9.6	8.5	0.4	9.8	10.1	1.1	1.3	13.3	7.1	2.0	4.3	14.3	8.6	11.6	7.3	9.4	16.2	12.5	9.1	7.7	13.1	9.0	7.7	9.3	3.0	9.1	5.5	9.4	8.7	7.3	5.5	8.5	6.6	13.9	3.3	10.6	12.7	14.6	15.3	8.5	20.3	17.1	5.3	13.3	9.5	0.0	1.5	0.6	2.3	0.8	2.0	5.1	1.3	4.9	1.3	3.8	1.7	2.6	0.3	2.7	3.0	1.6	0.8	1.6	3.4	10.7	7.4	3.0	2.7	2.7	2.0	2.8	3.0	3.4	3.0	1.1	2.2	0.6	1.0	3.1	2.0	0.0	0.0	0.0	3.5	0.0	2.1	0.0	1.3	3.3	0.7	0.5	0.0	0.8	6.7	1.4	0.5	0.0	0.8	3.0	0.0	0.0	0.6	0.3	4.0	2.3	0.5	1.7	2.8	1.3	1.9	0.9	0.0	1.1	0.3	3.6	0.0	1.0	11.8	9.5	0.3	0.8	2.9	2.3	0.1
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225889	"Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.9;skeletal muscle: 101.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 240.0;Rod photoreceptor cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favorable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	11.3	5.9	14.7	8.3	15.7	7.6	8.6	20.5	20.1	7.1	23.5	15.4	4.2	15.5	6.1	8.0	14.9	9.6	21.9	71.9	15.1	12.4	9.5	7.7	11.0	9.8	14.3	15.6	4.1	6.5	16.8	11.0	9.7	16.2	7.8	11.9	23.8	22.9	7.7	101.1	21.6	23.7	7.9	11.7	12.2	26.9	7.0	10.6	4.9	14.4	31.9	14.2	19.1	10.5	7.1	4.8	1.6	4.3	1.7	1.8	1.1	7.5	6.6	13.1	5.6	9.2	9.0	17.2	10.2	11.5	6.7	7.3	4.3	10.7	14.8	5.4	25.3	7.3	3.6	9.1	23.5	7.3	13.4	6.5	10.2	6.7	12.1	4.6	11.6	8.1	7.7	10.1	14.8	13.6	9.7	13.4	4.0	5.2	11.9	8.5	3.1	1.2	6.1	5.7	20.6	5.1	5.4	4.9	12.4	9.2	57.0	8.5	9.9	3.9	5.7	5.4	11.4	5.1	9.8	13.7	5.8	6.9	34.8	5.9	8.9	7.5	13.4	6.4	10.2	5.6	1.6	2.5	1.0	1.2	4.3	1.1	5.0	1.8	1.5	2.8	7.1	0.8	1.8	1.1	1.7	2.4	4.8	0.8	1.1	14.7	15.7	20.5	20.1	15.1	12.4	14.3	15.6	16.2	10.6	29.8	26.7	25.6	13.5	33.8	21.5	240.0	28.1	84.3	35.2	14.0	94.2	20.3	1.7	9.5	1.0	20.2	61.3	0.0	10.9	15.7	10.1	17.2	10.4	8.5	13.4	31.8	21.9	4.3	13.9	2.7	1.7	23.7	23.6	4.6	35.6	32.5	17.2	36.5	2.5	7.9	131.7	32.3	18.4	0.7	3.6	37.8	13.2	5.3	28.1	23.2
TRAK2	"ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98"	ENSG00000115993	"Trafficking kinesin protein 2"	O60296	2	201377207-201451579	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 96.9"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 130.8;Cone photoreceptor cells: 68.7;Horizontal cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015827, HPA062163"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA015827: AB_1858238, HPA062163: AB_2684702"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (7.42e-5)"	"unprognostic (1.48e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.82e-3)"	16.9	13.4	20.4	9.9	23.9	28.0	14.5	11.8	19.4	11.3	14.1	31.5	5.4	7.8	9.1	9.4	10.6	8.9	11.5	42.7	25.6	21.8	15.8	9.2	12.9	9.8	43.1	12.2	6.7	9.0	17.2	11.8	15.0	31.0	8.4	15.5	9.6	14.0	10.2	8.4	5.9	9.4	13.1	96.9	10.8	8.0	4.7	23.2	5.6	22.1	7.1	8.6	10.1	18.8	14.6	3.9	4.6	6.4	10.3	11.3	5.3	3.9	5.7	3.8	13.9	25.9	37.4	4.1	14.4	12.7	10.6	12.4	8.3	3.7	2.5	5.9	20.0	10.6	3.9	8.0	4.5	18.3	7.3	4.3	5.7	10.4	6.2	14.3	4.4	6.9	20.0	4.4	11.1	9.0	11.7	15.4	3.9	4.5	11.0	22.5	5.7	3.5	2.7	4.2	4.4	11.5	4.4	9.3	4.0	9.1	5.6	7.0	9.2	7.8	6.3	24.4	6.0	4.5	4.6	18.0	17.1	6.4	11.7	8.9	6.1	10.5	3.1	14.5	7.0	8.8	1.8	4.7	4.6	7.6	6.4	6.9	8.0	9.6	6.5	3.9	14.6	6.5	7.0	2.6	10.3	5.4	2.2	11.3	5.3	20.4	23.9	11.8	19.4	25.6	21.8	43.1	12.2	31.0	23.2	14.9	24.3	7.1	3.4	7.3	34.1	130.8	30.6	17.4	15.9	8.7	68.7	8.1	6.6	12.5	1.5	13.7	23.4	0.0	12.6	3.8	11.8	6.3	18.5	11.4	9.4	73.1	28.4	17.8	11.4	2.4	7.5	9.4	25.3	10.0	20.9	3.7	9.9	10.5	12.0	8.2	21.7	12.9	16.9	7.1	14.4	3.6	4.7	10.2	20.4	5.4
TRAM2	KIAA0057	ENSG00000065308	"Translocation associated membrane protein 2"	Q15035	6	52497402-52576915	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 54.4;ASC TERT1: 58.3;fHDF/TERT166: 52.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA035092, HPA057925"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA035092: AB_10610562, HPA057925: AB_2683557"	"unprognostic (2.32e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.12e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-1)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.19e-2)"	17.3	4.9	2.0	11.8	3.7	2.7	29.4	2.0	3.3	13.3	12.5	4.3	4.4	9.2	12.7	9.0	8.3	11.5	11.8	10.5	3.3	2.2	7.7	23.7	12.6	13.1	4.0	2.2	15.6	6.8	1.9	4.0	46.7	6.0	9.9	10.2	12.0	6.2	4.0	6.3	7.6	15.9	17.6	5.3	20.0	8.4	11.6	2.7	4.9	11.7	6.0	12.1	14.0	19.6	3.6	3.1	2.8	5.4	2.0	2.8	1.8	9.1	4.1	4.8	4.7	54.4	58.3	8.4	27.0	27.4	22.7	21.1	8.8	1.9	2.2	4.5	52.3	16.2	2.0	3.1	16.9	28.7	5.0	1.6	4.9	4.1	11.1	15.5	1.2	2.7	21.1	1.7	19.8	8.8	33.2	26.0	1.9	3.0	16.5	32.4	3.3	1.7	3.6	2.2	3.6	1.8	2.2	12.6	18.5	5.4	1.5	1.1	1.8	6.2	2.8	6.5	10.6	4.3	2.6	41.1	38.2	8.3	13.7	14.7	11.3	19.2	6.4	13.9	3.3	23.2	0.2	2.8	2.8	2.8	3.4	1.5	3.6	2.2	1.7	3.1	2.0	1.2	2.0	0.8	2.0	5.4	1.5	0.8	1.8	2.0	3.7	2.0	3.3	3.3	2.2	4.0	2.2	6.0	2.7	6.0	2.7	11.5	2.5	7.2	3.0	7.1	5.1	5.3	4.5	7.0	23.6	31.3	3.3	3.4	31.2	13.7	4.1	23.3	2.7	25.0	27.7	2.3	2.3	25.6	13.0	4.8	8.6	23.4	12.1	84.2	19.2	4.2	25.3	0.0	15.0	1.7	5.6	0.0	21.9	2.9	13.7	12.9	12.0	22.4	4.9	3.6	17.3	6.4	4.7	1.4
TRANK1	"KIAA0342, LBA1"	ENSG00000168016	"Tetratricopeptide repeat and ankyrin repeat containing 1"	O15050	3	36826820-36945098	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.3"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 14.9;Enterocytes: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 42.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 42.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.8;HMC-1: 15.6"	"Low region specificity"	"Detected in all"							HPA035508	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035508: AB_10671105"	"unprognostic (7.11e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.04e-3)"	"unprognostic (9.13e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.07e-3)"	4.1	3.6	4.5	10.4	11.2	6.9	4.7	21.5	12.0	8.5	14.2	1.7	3.1	8.6	12.3	4.5	3.1	19.3	7.3	4.1	3.3	3.9	3.2	7.9	6.2	13.9	2.9	6.6	9.0	2.8	5.0	3.8	3.7	6.0	7.9	10.9	4.4	4.9	5.0	2.6	2.9	23.1	10.5	3.2	9.9	6.0	2.9	1.7	15.1	5.8	1.1	16.2	9.8	6.0	5.2	0.5	42.3	1.3	2.8	5.7	0.9	0.7	0.9	0.2	0.0	2.4	9.7	0.0	0.7	5.1	2.3	4.5	0.0	3.9	38.8	1.6	2.9	7.7	0.2	0.1	0.5	0.4	1.9	0.0	6.3	2.6	0.0	3.1	1.7	15.6	3.2	2.0	1.7	0.1	0.5	2.8	4.2	5.0	5.6	1.7	0.0	4.9	0.7	0.2	0.0	1.0	1.4	0.1	0.7	0.8	1.7	0.3	0.0	3.9	1.0	0.3	0.4	0.6	2.2	1.9	1.8	0.7	0.1	0.6	5.5	1.1	8.6	0.3	1.4	0.2	2.5	0.6	3.9	5.6	0.9	4.2	4.0	4.8	5.7	0.5	5.2	4.4	4.2	42.3	2.8	1.3	0.0	4.0	0.9	4.5	11.2	21.5	12.0	3.3	3.9	2.9	6.6	6.0	1.7	14.9	5.6	3.9	1.2	0.7	1.1	2.4	2.5	5.3	4.5	3.5	2.0	1.0	0.0	2.2	0.2	3.3	15.2	0.0	1.6	1.1	3.0	1.9	5.8	13.9	4.2	0.0	5.2	6.2	6.3	0.0	4.0	3.6	5.0	1.0	8.8	1.4	3.0	12.2	5.6	0.6	0.7	0.0	1.7	0.2	0.2	0.6	0.6	13.8	3.8	1.4
TRAPPC11	"C4orf41, FLJ12716, foigr, gry"	ENSG00000168538	"Trafficking protein particle complex 11"	Q7Z392	4	183659267-183713594	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038173			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA038173: "	"unprognostic (2.24e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.14e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.66e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.92e-2)"	18.3	28.1	14.0	14.2	24.5	11.5	17.8	21.8	24.7	17.0	16.1	19.3	10.9	12.2	19.8	16.1	18.3	17.4	12.9	15.6	15.5	12.6	17.5	18.9	15.2	16.7	14.4	15.1	24.9	16.7	27.9	31.3	21.2	17.1	16.9	17.5	17.0	19.7	14.8	26.0	18.0	16.5	18.2	12.8	15.2	17.4	17.3	14.8	26.2	17.2	10.7	19.3	22.1	16.8	4.2	10.5	6.4	18.8	8.0	6.6	5.7	9.3	9.1	15.0	14.8	18.9	20.9	11.4	13.7	13.9	11.6	10.7	5.6	12.1	12.9	3.9	13.8	9.0	6.8	13.6	13.0	13.4	14.2	5.9	16.2	7.8	7.9	17.4	17.4	16.1	16.0	14.0	11.5	13.5	15.2	16.9	15.2	12.9	27.0	14.4	6.7	20.8	8.4	5.6	6.4	6.8	14.5	8.9	9.7	14.8	9.6	10.2	13.5	13.4	13.9	13.4	14.0	10.7	19.3	16.9	6.6	7.8	6.3	7.7	14.1	7.6	7.8	13.5	11.7	11.5	3.1	10.3	6.4	5.0	12.2	6.6	4.2	5.4	5.2	10.5	3.1	5.1	5.2	2.9	8.0	18.8	2.7	4.3	5.7	14.0	24.5	21.8	24.7	15.5	12.6	14.4	15.1	17.1	14.8	3.0	12.6	5.2	2.5	3.9	10.7	12.6	10.2	14.7	10.3	7.0	7.9	6.4	3.3	6.8	38.8	6.7	8.4	0.0	8.0	7.3	5.8	5.3	7.0	7.8	10.3	7.9	12.6	10.4	14.6	2.0	12.4	10.0	3.3	10.0	7.9	8.0	7.6	5.8	10.6	4.3	12.5	0.0	4.8	6.0	14.7	5.4	5.8	7.9	8.5	4.8
TRAPPC13	"C5orf44, FLJ13611, FLJ26957, MGC48585"	ENSG00000113597	"Trafficking protein particle complex 13"	A5PLN9	5	65624716-65666233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037777	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA037777: AB_10672464"	"unprognostic (3.66e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.25e-2)"	10.4	12.9	16.1	10.3	22.5	7.5	14.0	14.5	22.7	12.1	11.3	12.8	10.2	9.8	11.9	10.4	13.4	9.7	9.8	17.7	17.1	17.7	21.6	16.9	11.0	10.2	17.3	14.2	10.1	8.2	20.6	22.4	11.8	19.5	20.6	14.3	10.5	9.9	12.4	15.2	8.0	13.3	13.9	18.9	10.7	11.0	10.6	15.1	18.0	18.7	11.7	10.8	11.5	9.9	6.6	10.1	14.7	13.7	9.1	13.1	9.8	12.8	8.7	13.8	24.8	10.7	13.7	13.3	15.3	13.9	18.9	20.8	7.4	18.2	13.1	16.9	12.3	20.4	11.9	15.6	15.9	22.4	9.1	11.5	8.4	10.9	6.8	14.6	10.2	12.7	9.7	12.6	14.7	19.0	11.5	16.7	19.2	10.0	12.5	16.7	13.5	17.0	3.9	6.3	7.6	4.7	14.9	17.3	15.2	13.8	14.7	17.4	12.5	18.7	11.3	14.0	8.0	16.4	13.4	11.4	6.7	9.3	14.8	15.4	8.3	16.0	20.9	14.1	18.5	12.7	14.7	9.4	3.8	10.1	10.1	13.1	6.6	9.9	8.4	10.1	5.4	9.9	9.9	3.6	9.1	13.7	7.6	10.4	9.8	16.1	22.5	14.5	22.7	17.1	17.7	17.3	14.2	19.5	15.1	17.9	10.9	3.7	6.2	5.0	12.2	5.9	15.3	9.4	6.8	7.0	9.8	10.4	13.3	10.8	15.5	11.2	7.9	0.0	9.3	8.2	8.5	9.8	3.5	9.7	10.9	12.7	14.9	8.6	12.6	7.9	6.9	9.9	6.8	10.0	8.4	11.8	8.6	3.5	12.4	18.9	14.3	6.5	10.1	15.1	8.0	5.9	12.7	8.3	8.3	10.8
TRAPPC2	"hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L"	ENSG00000196459	"Trafficking protein particle complex 2"	"P0DI81, P0DI82"	X	13712244-13734635	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004665, HPA063308"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"CAB004665: AB_425678, HPA063308: AB_2684982"	"unprognostic (1.97e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (2.13e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.35e-4)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.89e-5)"	6.5	6.4	15.6	9.5	13.7	9.5	9.4	24.1	16.1	10.5	9.4	10.1	8.8	8.2	16.4	8.7	8.5	9.4	7.6	6.4	14.4	14.2	10.1	10.1	7.8	16.1	10.4	13.0	11.7	11.2	8.9	19.5	7.2	11.5	8.9	9.1	10.2	8.1	8.3	4.9	10.3	8.8	16.0	11.5	11.1	10.7	4.3	11.1	4.3	8.8	4.2	16.4	8.1	9.4	11.2	10.7	13.7	6.6	18.5	16.1	9.0	6.8	5.3	8.2	20.9	6.3	4.8	3.3	6.4	5.5	5.1	5.5	4.5	8.5	11.6	10.3	5.3	6.7	9.0	10.8	9.2	7.0	11.7	16.2	8.6	12.5	3.6	4.8	11.8	16.6	6.3	5.2	10.9	14.9	10.3	4.5	8.5	10.8	20.0	5.2	11.3	11.6	15.6	7.9	5.7	9.5	11.4	10.8	11.3	8.0	5.1	8.7	11.6	11.8	9.5	8.2	13.0	11.8	7.9	5.9	5.2	4.6	9.2	4.0	10.3	10.1	14.5	4.8	8.4	5.2	13.7	4.9	8.6	16.1	6.6	16.0	11.2	12.8	15.8	4.3	11.1	10.8	15.5	10.0	18.5	5.4	10.7	15.3	9.0	15.6	13.7	24.1	16.1	14.4	14.2	10.4	13.0	11.5	11.1	8.9	6.2	22.8	8.2	13.5	14.5	9.8	20.4	4.0	11.4	8.7	11.8	12.7	18.3	9.2	12.6	7.7	9.1	0.0	11.8	15.8	11.6	9.3	9.2	11.3	10.0	19.1	11.6	11.1	9.5	3.8	11.8	9.5	8.5	9.0	14.7	8.3	15.9	17.6	10.6	20.2	13.6	6.5	11.4	4.5	3.3	15.4	15.0	27.7	13.4	10.5
TRAPPC2B	"MIP-2A, SEDLP, SEDLP1, TRAPPC2P1"	ENSG00000256060	"Trafficking protein particle complex 2B"	P0DI82	19	57363511-57365353	"Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 32.7;Syncytiotrophoblasts: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA063308			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA063308: AB_2684982"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.39e-2)"	14.6	23.3	13.4	9.9	17.1	11.6	17.2	23.8	16.7	11.5	12.5	6.7	12.1	7.0	12.2	15.1	15.4	11.4	13.7	26.5	18.0	14.0	12.9	14.5	12.4	15.0	11.6	14.5	15.8	9.7	12.2	16.4	16.9	18.1	14.3	7.9	9.0	11.4	10.4	28.8	11.5	8.6	12.7	15.1	14.3	10.2	31.2	9.6	12.7	17.6	16.8	13.7	15.4	9.5	26.7	21.5	32.2	13.2	22.8	15.5	13.4	9.2	7.6	10.4	6.6	9.7	10.9	9.5	6.2	14.6	9.6	29.1	3.6	7.1	7.1	9.0	8.5	16.6	3.3	5.2	10.5	10.3	3.4	36.4	7.4	12.4	8.0	10.2	7.8	11.4	11.8	13.2	7.6	5.3	11.2	7.0	8.1	2.2	0.1	11.3	2.6	11.4	6.8	3.5	0.6	15.0	5.7	9.9	10.6	10.7	14.5	11.1	8.6	6.6	6.7	5.7	9.4	10.6	10.1	7.5	8.9	7.8	4.4	10.3	11.4	14.5	14.2	12.8	4.8	9.1	32.2	13.2	16.3	7.5	11.6	14.7	25.0	15.5	12.3	14.8	26.7	15.0	12.0	15.3	22.8	10.3	21.5	13.4	13.4	13.4	17.1	23.8	16.7	18.0	14.0	11.6	14.5	18.1	9.6	8.9	12.5	0.0	0.0	0.0	0.0	20.1	0.0	24.1	18.2	17.4	0.0	32.7	21.6	26.8	0.0	0.0	0.0	0.0	19.3	17.8	10.3	0.0	19.8	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	20.8	0.0	0.0	21.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	0.0
TRAPPC2L	HSPC176	ENSG00000167515	"Trafficking protein particle complex 2 like"	Q9UL33	16	88856220-88862686	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041714	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA041714: AB_10793930"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (3.75e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.94e-2)"	22.7	46.1	29.5	18.6	29.2	19.8	22.4	15.9	37.4	18.5	21.8	25.5	16.0	16.2	15.8	40.4	17.4	19.0	25.0	26.0	22.9	24.4	20.2	21.9	13.9	24.3	24.9	22.5	21.5	25.6	8.7	16.0	13.7	22.1	15.8	15.7	20.0	17.3	17.3	53.8	19.0	14.7	14.1	27.3	18.3	21.5	33.9	18.1	11.5	19.2	25.1	16.6	16.1	16.4	41.2	45.6	10.8	39.0	24.6	47.7	40.9	16.1	11.3	19.2	14.5	14.4	18.4	19.8	14.6	16.6	22.5	8.6	31.4	21.3	12.4	25.8	18.5	23.7	17.3	26.1	20.9	16.4	10.8	15.6	8.2	11.3	39.6	21.4	23.2	6.6	17.8	13.2	30.3	15.4	12.8	18.0	28.2	24.6	9.9	15.4	50.3	31.0	72.0	19.3	31.0	21.1	29.8	16.0	12.8	17.2	18.7	20.8	10.2	49.3	15.2	13.3	11.1	39.0	24.8	14.2	15.0	16.4	19.6	16.5	14.0	23.7	57.5	17.9	34.8	17.8	10.0	39.0	10.8	34.0	31.2	34.2	41.2	39.2	36.6	37.7	35.2	36.9	31.4	6.8	24.6	29.7	45.6	47.7	40.9	29.5	29.2	15.9	37.4	22.9	24.4	24.9	22.5	22.1	18.1	53.6	71.3	55.9	50.7	46.0	33.8	99.4	96.8	84.3	56.9	50.6	9.8	81.9	203.9	107.9	165.4	58.3	90.1	23.3	135.1	126.2	77.9	44.2	34.7	115.6	192.6	14.3	59.6	60.8	93.2	316.5	68.4	63.6	77.6	140.7	65.3	52.4	118.4	69.1	54.8	205.0	32.3	58.2	87.6	150.3	142.7	56.8	64.8	59.5	70.9	46.7
TRAPPC3	BET3	ENSG00000054116	"Trafficking protein particle complex 3"	O43617	1	36136570-36156053	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028408	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA028408: AB_10601826"	"unprognostic (3.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (7.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.10e-3)"	"unprognostic (6.53e-2)"	28.7	53.5	31.9	29.4	31.9	17.8	41.0	27.3	33.6	28.4	33.6	21.9	33.6	24.3	28.9	46.3	39.7	27.8	33.4	39.4	26.3	29.4	39.7	36.6	26.0	24.4	28.7	26.1	19.9	37.0	29.0	32.4	42.8	30.2	29.9	31.7	28.8	30.8	35.6	34.2	32.4	27.2	36.6	26.8	28.3	31.1	33.7	23.3	28.0	48.4	35.6	37.4	32.4	38.6	37.6	52.6	56.9	55.4	35.9	51.6	55.6	32.7	23.8	16.1	24.9	42.0	33.9	31.6	30.2	38.7	36.2	35.2	19.6	31.7	14.0	28.7	33.1	28.7	24.4	24.6	40.4	41.3	27.3	37.8	26.1	27.7	28.4	49.2	27.3	27.8	28.9	35.5	33.7	33.2	37.6	45.1	36.9	31.5	23.7	43.4	25.3	32.1	25.6	21.4	27.5	35.2	22.6	22.8	31.3	45.7	27.1	24.5	17.9	24.6	27.8	47.8	43.4	17.9	20.6	33.5	21.3	24.2	41.5	40.0	29.0	29.2	22.9	36.5	30.9	21.4	54.0	53.1	56.9	36.3	55.4	37.5	37.6	43.2	38.1	52.6	33.9	41.9	37.8	53.9	35.9	43.6	43.3	51.6	55.6	31.9	31.9	27.3	33.6	26.3	29.4	28.7	26.1	30.2	23.3	23.8	28.8	54.4	94.1	89.8	39.6	51.3	50.9	22.7	23.9	36.6	15.7	128.6	144.2	122.4	210.9	67.3	56.3	23.3	162.6	126.4	66.1	106.5	45.0	39.5	127.5	50.9	46.3	27.6	50.2	99.5	39.7	66.2	91.1	134.3	44.1	49.9	150.1	66.2	48.8	80.1	23.0	32.3	57.1	95.6	83.7	108.0	160.1	47.9	48.6	103.8
TRAPPC3L	"bA259P20.2, BET3L, FLJ11180"	ENSG00000173626	"Trafficking protein particle complex 3 like"	Q5T215	6	116494989-116545610	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.9;placenta: 9.7"	"Group enriched"	"Detected in some"	6	"Ito cells: 6.2;Kupffer cells: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA060912			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA060912: "	"unprognostic (1.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.09e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.47e-3)"	1.1	0.9	0.8	0.5	0.9	4.3	1.0	0.6	1.3	0.7	0.8	0.7	0.4	0.7	1.1	2.2	0.9	0.8	1.3	2.6	1.5	1.6	1.3	5.2	3.4	5.0	1.4	0.4	1.1	0.5	1.5	0.8	9.7	0.8	1.8	0.1	3.4	1.1	0.5	1.8	2.6	1.9	1.6	2.3	10.9	0.9	1.9	0.4	0.4	2.1	0.4	0.4	0.9	0.7	0.4	0.7	2.1	0.5	0.4	0.6	7.0	1.6	0.9	2.2	3.2	0.7	2.3	2.2	1.2	1.0	0.8	1.1	1.0	1.4	2.7	1.4	0.5	1.6	1.9	0.7	1.4	1.2	1.5	1.1	2.6	3.3	1.2	1.2	1.8	1.5	1.4	0.9	0.7	1.0	3.1	1.5	2.1	1.6	12.6	0.8	2.8	1.6	2.1	2.1	0.7	1.1	1.7	1.5	4.0	1.5	2.6	2.1	1.6	1.6	1.0	1.2	2.7	1.6	1.6	2.3	2.4	2.0	2.6	1.2	2.5	1.5	1.7	1.8	1.8	1.5	1.1	0.4	0.6	0.5	0.4	0.3	0.3	0.4	0.4	0.3	0.4	0.6	0.4	2.1	0.4	0.5	0.7	0.3	7.0	0.8	0.9	0.6	1.3	1.5	1.6	1.4	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	6.2	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TRAPPC4	"PTD009, SBDN, TRS23"	ENSG00000196655	"Trafficking protein particle complex 4"	Q9Y296	11	119018432-119025454	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039752, HPA041371"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039752: AB_2676664, HPA041371: AB_2677439"	"unprognostic (5.26e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.18e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	20.4	26.8	17.1	11.8	21.2	16.3	14.8	15.6	20.1	16.1	20.4	16.1	33.7	20.4	13.6	20.4	16.3	14.3	19.4	15.4	16.1	20.1	30.1	20.3	16.3	15.3	17.5	16.2	16.4	19.4	11.9	21.1	16.2	16.5	20.2	13.8	16.2	14.4	24.8	26.4	12.7	23.8	14.5	17.1	15.5	18.1	19.6	12.1	16.4	18.2	10.0	18.1	18.1	10.6	29.9	28.6	39.7	28.0	26.3	47.2	29.4	7.8	8.1	9.2	9.5	11.3	7.9	4.3	31.5	17.3	19.3	15.5	18.7	3.2	9.1	22.3	11.7	14.2	7.4	14.1	11.5	14.8	16.4	8.5	15.3	7.8	20.5	16.3	12.2	7.7	11.4	10.4	18.5	14.0	13.0	16.7	10.9	17.0	3.6	11.1	17.9	13.9	11.7	7.3	16.2	22.2	12.6	7.2	10.9	13.4	10.3	3.5	8.6	6.1	6.9	7.6	11.5	28.3	11.0	12.3	5.3	10.3	6.6	10.2	5.0	9.5	22.7	5.9	9.8	8.7	29.8	20.8	39.7	28.9	22.9	29.3	29.9	33.7	32.9	20.0	26.7	31.4	34.0	17.9	26.3	28.0	28.6	47.2	29.4	17.1	21.2	15.6	20.1	16.1	20.1	17.5	16.2	16.5	12.1	35.7	33.8	45.4	44.7	45.6	57.7	26.6	40.8	57.6	26.1	68.0	13.7	80.8	119.3	82.0	34.8	45.8	33.3	23.3	66.2	46.8	39.3	43.2	60.1	17.8	69.7	36.5	64.9	38.6	20.9	10.4	41.1	30.8	28.7	109.2	29.3	83.4	80.0	31.7	57.3	132.7	51.2	45.3	43.2	88.9	76.0	51.6	73.0	53.2	32.6	39.9
TRAPPC5	"MGC52424, TRS31"	ENSG00000181029	"Trafficking protein particle complex 5"	Q8IUR0	19	7680843-7687703	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 33.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042221, HPA049064"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA042221: AB_2677907, HPA049064: AB_2680618"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.86e-8)"	"unprognostic (3.09e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-1)"	23.1	35.3	30.1	23.4	31.6	50.9	24.1	18.8	44.9	18.7	24.2	17.7	19.6	27.3	18.4	23.7	31.8	16.0	22.3	27.5	27.8	25.2	32.0	47.9	17.5	32.3	24.1	25.7	21.7	39.1	12.2	19.4	26.7	20.7	21.6	9.4	22.3	42.5	22.4	83.5	26.7	28.1	16.0	17.8	31.2	28.6	46.1	14.8	23.1	27.6	28.3	26.8	20.1	17.0	46.7	70.9	85.7	61.8	14.4	34.1	44.6	13.9	30.5	4.9	13.5	4.0	6.0	14.9	11.1	8.1	10.9	11.2	18.0	9.7	14.6	22.4	7.6	6.2	13.0	3.1	11.1	2.1	11.1	47.3	5.4	20.5	37.6	14.0	9.6	11.0	9.8	14.9	8.3	3.8	3.7	13.7	15.3	7.7	21.4	5.3	43.9	16.4	34.2	15.8	6.2	74.7	10.7	6.9	21.0	11.8	33.5	13.0	11.3	9.4	17.9	15.4	1.8	14.3	10.4	13.8	13.2	10.9	24.8	11.0	19.5	9.7	9.6	18.3	11.9	17.6	28.9	61.8	23.1	20.0	60.9	19.2	46.7	25.1	22.0	70.9	45.7	25.0	21.7	85.7	14.4	54.3	30.3	34.1	44.6	30.1	31.6	18.8	44.9	27.8	25.2	24.1	25.7	20.7	14.8	3.0	2.2	8.4	1.0	1.6	4.9	0.8	2.5	2.7	6.8	5.2	2.0	2.8	0.0	20.8	9.9	0.9	26.4	0.0	16.7	4.1	1.7	1.7	1.1	13.4	8.5	7.9	10.9	11.1	22.2	33.1	1.4	8.5	1.7	16.2	14.0	1.1	21.0	24.6	3.2	9.3	4.6	0.0	1.4	2.3	0.5	1.5	2.9	5.0	14.0	1.1
TRAPPC6B		ENSG00000182400	"Trafficking protein particle complex 6B"	Q86SZ2	14	39147811-39170532	"Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047928	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA047928: AB_2680214"	"unprognostic (3.89e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.18e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	13.7	19.0	23.9	12.3	26.0	5.0	17.4	38.9	33.5	14.3	11.5	11.0	12.5	12.7	14.3	14.9	15.2	8.7	11.3	15.6	23.7	20.5	16.5	27.9	12.0	12.7	17.5	23.7	11.9	10.4	17.5	19.7	14.7	21.6	15.7	12.5	13.1	10.8	16.4	15.7	13.1	10.0	13.9	14.8	14.0	10.5	14.3	14.9	14.0	18.7	9.7	13.7	14.2	11.2	5.0	7.2	8.9	9.8	11.2	6.3	3.5	10.8	4.7	8.4	8.1	12.1	13.7	6.7	14.2	12.3	12.8	12.7	8.0	20.9	6.8	10.0	12.9	6.4	8.5	12.4	8.9	15.8	12.7	6.1	9.2	6.9	23.3	17.3	12.9	12.7	13.0	15.3	10.9	14.8	20.5	11.1	12.6	10.3	14.5	13.3	13.4	9.7	9.4	7.1	8.4	19.2	7.5	15.7	6.5	14.1	21.7	8.3	6.7	16.9	10.3	14.9	9.3	19.5	8.3	15.9	11.8	6.1	10.0	7.6	13.9	19.2	10.4	5.8	7.6	11.3	8.9	4.9	7.6	4.5	9.8	4.0	5.0	6.3	5.1	7.0	3.0	5.3	5.3	4.9	11.2	9.6	7.2	5.3	3.5	23.9	26.0	38.9	30.8	23.7	20.5	17.5	23.7	21.6	14.9	20.8	14.2	7.7	15.1	20.0	23.9	22.2	15.3	6.7	11.4	17.4	33.4	11.7	46.4	12.2	22.3	17.6	8.4	23.3	15.1	11.1	16.0	15.6	28.8	19.7	13.8	22.3	16.0	25.2	10.8	10.6	15.0	19.0	16.9	10.0	11.4	14.7	17.3	11.8	16.6	16.2	39.0	25.8	20.8	67.4	27.7	22.0	18.9	17.5	8.8	25.8
TRAPPC8	"GSG1, HsT2706, KIAA1012, TRS85"	ENSG00000153339	"Trafficking protein particle complex 8"	Q9Y2L5	18	31829173-31953136	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041107	Approved		Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA041107: AB_10793869"	"unprognostic (4.04e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (1.85e-9)"	"unprognostic (3.55e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.92e-1)"	16.2	17.0	12.9	18.1	16.5	13.6	15.4	20.8	19.5	16.0	18.1	16.3	15.3	15.0	16.9	13.0	18.8	14.8	13.8	15.5	12.9	12.1	20.1	26.4	14.1	17.5	15.6	12.7	14.5	15.7	24.1	19.8	19.3	19.2	14.8	16.6	17.5	17.0	17.5	25.0	20.5	25.5	15.1	14.6	19.8	15.7	40.7	13.6	28.2	18.7	13.3	19.0	16.1	18.7	2.7	2.8	9.9	2.8	3.0	4.3	1.1	8.2	7.1	8.2	6.3	12.5	12.0	9.1	11.0	11.8	10.4	10.3	4.8	6.3	11.7	8.9	10.7	9.4	12.8	11.9	6.2	14.5	13.3	5.6	9.7	7.1	6.0	9.6	28.2	11.5	10.6	8.7	9.6	14.0	11.6	11.8	9.9	14.1	10.9	10.4	5.7	12.0	9.8	8.3	24.3	6.1	12.8	9.8	12.4	10.4	13.1	6.4	7.5	14.1	8.5	9.9	13.8	9.4	12.5	14.2	11.1	5.5	4.0	6.7	13.9	15.4	17.6	10.7	12.4	11.3	9.9	2.7	2.8	2.0	2.8	4.3	2.5	2.7	2.4	2.8	2.7	2.4	2.6	4.5	3.0	2.7	2.1	2.9	1.1	12.9	16.5	20.8	19.5	12.9	12.1	15.6	12.7	19.2	13.6	26.8	10.8	12.4	8.3	16.0	12.7	18.9	30.6	18.7	15.9	10.4	27.5	8.9	1.7	9.0	30.5	11.3	20.6	0.0	8.1	8.4	11.0	13.5	3.5	30.6	14.4	11.1	12.1	20.9	24.8	32.3	14.4	11.3	10.1	10.8	13.2	11.0	12.1	8.6	8.9	12.1	22.8	12.9	7.5	81.7	43.9	23.7	17.2	11.7	11.0	12.8
TRAPPC9	"IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120"	ENSG00000167632	"Trafficking protein particle complex 9"	Q96Q05	8	139730343-140458579	"Disease related genes, Predicted intracellular proteins"	Differentiation		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 44.7;Late spermatids: 78.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026579			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA026579: AB_1854459"	"unprognostic (1.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.11e-6)"	"unprognostic (2.09e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.62e-1)"	9.7	12.0	13.0	14.7	17.9	13.8	8.3	18.3	22.0	11.3	10.3	17.2	12.5	11.3	11.4	9.8	12.1	17.4	12.8	14.7	13.0	13.7	12.2	10.0	9.5	10.6	14.5	11.7	11.5	15.4	42.0	28.2	14.1	15.1	10.4	9.0	17.2	12.7	12.7	38.3	8.8	12.7	10.5	13.2	10.5	11.1	7.9	9.1	24.8	14.2	10.0	15.3	10.1	8.3	6.3	6.3	14.2	5.0	7.5	7.1	4.6	6.7	12.0	5.5	14.8	11.7	7.0	3.7	4.2	7.2	2.4	3.9	4.3	7.9	8.2	10.3	8.6	3.5	8.6	7.3	6.9	2.5	11.8	4.4	13.0	7.1	4.3	8.2	3.3	10.4	6.7	6.6	1.9	6.1	8.2	9.4	9.5	4.6	7.2	3.8	18.6	19.8	4.1	1.6	21.8	10.6	8.5	2.0	13.4	8.2	8.2	13.7	7.8	7.1	3.4	7.4	5.9	10.9	4.7	5.5	3.3	5.9	7.7	3.4	10.1	7.5	5.6	7.0	7.0	5.3	14.2	4.9	4.0	6.5	5.0	7.1	4.5	4.5	5.1	5.1	6.3	4.7	5.5	7.8	7.5	4.7	6.3	3.3	4.6	13.0	17.9	18.3	22.0	13.0	13.7	14.5	11.7	15.1	9.1	3.0	8.8	3.7	3.6	2.1	12.5	11.7	2.5	16.0	5.7	10.4	19.6	9.3	8.3	6.3	44.7	7.1	12.3	0.0	5.3	3.7	2.7	4.9	8.1	8.2	6.4	27.0	29.2	4.3	9.9	78.2	5.5	4.1	10.1	1.0	10.4	12.8	5.3	5.9	7.4	17.6	12.9	6.5	4.3	2.6	5.9	2.6	12.2	9.6	8.5	4.7
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822698-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"blood: 57.9;lymphoid tissue: 128.9"	"Cell type enriched"	"Detected in some"	10	"T-cells: 74.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 57.9"	"Group enriched"	"Detected in many"	160	"granulocytes: 53.1;T-cells: 57.9"	"Group enriched"	"Detected in some"	23	"JURKAT: 16.4;MOLT-4: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		NA	NA			"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	2.6	0.3	0.2	8.2	0.2	1.8	1.3	0.2	0.3	0.8	1.0	0.1	0.1	0.9	0.7	0.3	0.9	0.8	1.9	0.7	0.2	0.2	1.1	1.0	4.0	17.8	0.2	0.2	0.5	0.5	0.0	0.4	0.3	0.3	1.1	1.0	0.1	1.9	0.3	0.4	1.0	5.5	0.2	0.3	9.0	1.6	0.5	0.1	128.9	1.1	1.0	9.8	2.8	1.1	0.1	0.1	53.1	0.1	0.3	57.9	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	1.1	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.1	0.1	0.0	10.5	0.0	21.2	0.1	42.1	21.6	0.0	0.0	57.9	14.2	0.6	0.3	0.1	0.1	17.9	22.9	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.1	0.0	5.6	0.9	0.1	7.4	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	2.3	0.6	0.2	0.0	0.0	1.8	0.0	1.4	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	6.9	0.1	74.0	0.0	0.0
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 855.7;Muller glia cells: 805.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.6;K-562: 1.8;MCF7: 6.1;SCLC-21H: 1.2;SK-BR-3: 2.0"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.1	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	5.8	855.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.9	12.0	0.0	1.7	0.0	0.0	805.6	0.0	0.0	10.6	0.0	13.4	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286719	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 96.9;bone marrow: 38.5;lung: 34.2"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 31.6;Hofbauer cells: 25.6;Kupffer cells: 32.3;Macrophages: 79.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 96.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 96.9"	"Group enriched"	"Detected in some"	5	"SuSa: 6.5;U-87 MG: 23.8"									"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	10.2	0.6	0.7	21.1	1.5	38.5	1.0	0.6	2.1	0.7	0.9	0.7	0.5	0.1	1.0	1.5	0.6	4.2	5.1	3.7	1.2	0.9	1.1	3.7	34.2	8.0	2.7	0.1	2.1	1.8	0.2	2.7	31.2	2.3	0.9	0.0	2.5	1.3	0.1	2.4	0.4	1.1	3.8	3.9	12.1	1.0	2.6	0.6	0.3	2.2	1.9	1.0	3.9	0.7	0.2	5.0	96.9	12.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	1.5	0.0	0.0	12.8	0.3	0.0	3.1	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	96.9	0.0	1.4	0.1	0.0	4.1	0.7	1.5	0.6	2.1	1.2	0.9	2.7	0.1	2.3	0.6	6.0	31.6	2.7	0.1	0.3	0.0	0.3	2.5	13.4	19.4	0.0	0.0	0.3	0.0	0.3	10.6	0.5	0.0	0.0	0.2	0.9	0.7	0.1	5.8	0.2	25.6	0.0	0.0	1.3	32.3	13.1	0.0	79.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	12.2	0.0	0.0	0.0
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell type enriched"	"Detected in some"	11	"monocytes: 44.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Cell line enriched"	"Detected in single"	167	"HEL: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		94000000	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 20.8;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.1"					"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	4.9	8.7	9.3	7.7	8.7	16.7	4.0	18.1	10.8	12.0	5.1	2.9	9.7	4.2	10.0	4.0	12.6	7.2	6.9	2.8	4.5	3.9	5.2	1.4	4.0	9.2	2.5	4.7	10.2	2.5	7.5	9.3	3.4	3.5	8.8	4.7	7.3	3.7	5.2	1.3	8.4	6.6	8.6	4.9	9.0	5.6	11.2	4.8	23.4	3.3	3.6	12.7	13.3	11.0	0.4	1.4	8.1	1.1	2.7	3.0	1.1	5.2	3.6	4.1	5.2	1.9	4.3	5.8	4.0	6.4	4.6	3.8	0.0	2.8	4.9	0.8	6.0	6.3	6.3	5.2	4.9	3.7	55.1	0.4	5.2	3.0	0.0	1.3	9.6	16.9	1.7	6.9	4.1	1.6	4.1	0.0	3.3	0.0	1.6	2.0	1.1	2.4	16.4	4.5	3.8	3.8	4.5	0.3	1.8	2.7	6.5	3.3	1.7	2.4	0.0	0.4	2.3	2.3	13.1	1.7	2.6	3.0	4.2	1.1	0.6	3.5	5.3	1.7	8.8	0.0	2.1	1.1	8.1	3.0	0.4	2.9	0.4	2.2	2.7	1.4	0.0	1.9	2.0	3.8	2.7	0.2	1.2	2.1	1.1	9.3	8.7	18.1	10.8	4.5	3.9	2.5	4.7	3.5	4.8	3.0	2.2	0.8	2.6	7.3	10.8	1.6	2.5	4.0	5.7	5.2	0.0	2.7	0.0	1.3	2.3	3.8	2.3	0.0	0.9	0.7	7.0	1.7	11.5	0.0	2.7	7.9	2.9	8.0	4.4	2.0	13.0	5.8	3.3	1.8	1.9	4.9	0.9	2.9	20.8	0.2	0.5	25.8	4.4	2.4	6.1	6.5	1.0	7.0	2.8	3.4
TRIAP1	"HSPC132, MDM35, P53CSV, WF-1"	ENSG00000170855	"TP53 regulated inhibitor of apoptosis 1"	O43715	12	120443961-120446412	"Predicted intracellular proteins, Transporters"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053640	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA053640: AB_2682213"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.87e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.97e-2)"	11.7	16.8	10.6	12.5	13.1	14.6	20.6	9.1	12.4	9.4	12.5	8.0	12.0	10.0	9.9	11.6	15.4	9.3	12.7	17.3	13.6	8.3	12.5	34.5	14.2	13.6	15.5	11.9	7.7	36.5	5.7	8.6	17.8	13.5	12.4	17.0	6.8	19.3	8.6	29.1	16.8	12.1	11.1	10.4	12.3	12.3	11.2	11.6	11.7	11.2	21.5	13.9	12.0	10.0	17.4	28.2	9.0	24.8	22.2	25.5	19.6	15.9	21.9	20.1	13.7	17.5	27.1	48.2	21.0	15.0	18.7	15.5	18.2	8.9	31.7	17.9	17.1	7.5	11.0	23.3	34.7	19.8	14.0	26.0	19.2	15.3	47.8	26.1	32.2	14.9	27.9	43.8	18.3	26.3	18.8	38.6	17.6	30.7	8.2	27.2	20.1	24.1	43.5	28.7	19.6	17.8	20.1	19.0	32.8	24.0	17.9	19.8	13.0	24.2	8.3	17.9	33.2	27.8	18.9	21.8	12.1	18.2	12.1	12.7	21.2	33.4	34.0	18.5	25.0	21.0	9.0	22.0	8.0	20.7	24.8	24.9	17.4	20.3	19.7	28.2	15.8	25.5	22.0	1.9	22.2	16.5	25.4	17.6	19.6	10.6	13.1	9.1	12.4	13.6	8.3	15.5	11.9	13.5	11.6	3.0	14.6	36.3	21.1	45.4	8.2	10.2	45.9	17.4	6.8	7.0	5.9	113.6	56.3	43.3	5.9	25.3	16.1	0.0	43.5	66.9	27.2	25.9	17.3	49.7	46.9	3.2	21.2	22.7	22.8	3.9	15.3	20.8	37.1	53.3	21.2	9.4	40.3	14.0	17.3	36.6	9.3	19.4	26.9	34.9	34.6	62.4	63.0	29.9	38.3	23.3
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430321-125438405	"Enzymes, Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 84.2;thyroid gland: 90.7"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 192.3;Basal glandular cells: 267.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1"	"Group enriched"	"Detected in many"	11	"granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"HEL: 55.1;U-266/70: 33.8;U-266/84: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA063982: AB_2685165"	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	26.7	6.5	5.9	17.6	6.5	84.2	13.3	4.3	6.1	10.4	12.4	4.4	6.6	4.9	6.2	6.7	10.9	10.9	21.0	11.1	4.3	4.0	16.6	63.5	28.9	14.6	4.2	3.9	6.4	23.6	20.9	7.2	15.5	4.5	12.1	13.3	15.0	14.5	9.1	22.3	10.4	16.9	11.3	3.1	15.9	18.5	5.6	3.1	9.2	90.7	17.6	12.1	12.4	9.0	0.2	0.5	10.8	3.7	0.0	3.1	0.1	4.1	4.7	0.6	1.3	1.3	2.7	7.5	2.7	3.8	2.0	0.6	6.3	5.5	7.5	2.5	1.9	12.1	3.1	2.0	2.6	1.7	3.3	9.9	55.1	2.1	12.3	3.5	27.5	5.0	2.6	4.0	8.2	18.8	9.8	5.8	0.1	4.8	24.0	0.2	4.4	2.5	4.3	4.6	9.9	9.2	5.2	0.9	8.2	16.2	15.8	4.0	1.5	6.6	7.2	26.2	4.3	1.9	1.3	3.0	2.2	2.8	2.1	3.3	33.8	33.7	10.5	3.9	0.2	5.1	0.0	0.9	10.8	0.0	1.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	5.8	0.0	3.7	0.3	3.1	0.1	5.9	6.5	4.3	6.1	4.3	4.0	4.2	3.9	4.5	3.1	125.0	192.3	11.2	267.7	89.0	20.4	14.4	17.8	33.5	64.8	15.7	0.0	9.2	10.0	31.3	0.4	32.9	172.0	0.0	21.2	17.2	32.4	153.9	29.9	128.8	29.9	20.6	107.4	8.6	53.9	1.4	0.3	47.3	54.0	40.5	87.2	21.4	42.4	51.5	0.4	21.6	3.4	0.0	14.4	0.0	1.3	56.1	25.6	4.5	56.6	79.9
TRIB2	"GS3955, TRB2"	ENSG00000071575	"Tribbles pseudokinase 2"	Q92519	2	12716889-12742734	"Enzymes, Predicted membrane proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 89.7;Muller glia cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 24.8"	"Group enriched"	"Detected in many"	9	"B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.0;HEL: 40.3;K-562: 54.8;SK-MEL-30: 40.0;WM-115: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001305	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001305: AB_1080371"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.31e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.13e-2)"	19.6	30.9	13.2	17.7	13.3	7.0	23.2	23.2	23.0	10.8	12.3	10.5	6.7	8.7	23.0	22.6	8.1	11.6	14.5	18.2	15.0	10.8	24.8	10.6	18.9	33.0	13.4	16.2	52.3	14.4	6.6	11.3	23.0	15.5	16.3	6.9	35.7	9.9	13.6	6.9	8.2	11.9	17.6	10.4	38.9	19.5	13.9	10.1	37.3	12.1	6.2	33.4	21.9	23.2	7.1	0.6	1.5	0.1	9.5	24.8	4.5	0.0	0.0	31.3	41.0	11.3	10.4	0.0	1.7	1.6	1.1	1.8	0.2	3.4	3.5	1.2	3.7	0.2	0.5	2.3	3.5	0.9	3.9	6.4	40.3	0.1	0.6	14.0	2.2	15.4	9.6	3.6	4.5	1.2	11.1	4.9	5.3	54.8	0.0	1.7	0.3	5.1	9.6	14.8	1.5	4.0	0.0	10.4	1.4	7.1	5.1	26.9	12.8	0.2	1.6	40.0	9.8	0.0	0.2	3.0	14.9	7.5	0.1	3.8	0.0	0.0	5.0	8.0	7.9	54.9	0.8	0.1	1.5	7.3	0.0	8.8	5.3	14.4	7.7	0.6	7.1	8.5	5.2	0.3	9.5	0.1	0.0	24.8	4.5	13.2	13.3	23.2	23.0	15.0	10.8	13.4	16.2	15.5	10.1	3.0	8.8	8.0	10.2	5.5	46.7	13.3	20.4	6.7	11.4	15.7	29.5	1.9	6.6	13.3	3.9	36.4	0.0	0.0	89.7	0.1	7.1	10.3	33.5	5.4	4.4	19.1	0.0	63.3	5.3	10.7	71.7	2.5	28.7	1.8	0.0	115.1	49.1	0.0	70.0	0.7	66.1	51.8	22.5	0.9	2.7	4.6	0.7	20.8	0.0	11.1
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"gallbladder: 12.1;intestine: 29.3;liver: 14.1"	"Cell type enhanced"	"Detected in some"	18	"Enterocytes: 70.3;Mucus-secreting cells: 18.4;Paneth cells: 56.1;Proximal tubular cells: 18.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"HEL: 19.5"					"Low region specificity"	"Detected in all"			HPA047527	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	8.6	0.0	0.2	0.2	0.0	12.1	0.0	0.0	0.0	4.3	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	29.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	70.3	0.0	1.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	5.7	56.1	0.0	18.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	10.6	0.0
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 52.9"	"Cell type enhanced"	"Detected in many"	8	"Pancreatic endocrine cells: 96.1;Suprabasal keratinocytes: 67.9;Urothelial cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"T-reg: 25.1"	"Lineage enriched"	"Detected in many"	11	"T-cells: 25.1"	"Cell line enhanced"	"Detected in many"		"A549: 58.6;HaCaT: 47.3;HeLa: 42.7;OE19: 74.3"									"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (6.71e-4)"	6.1	13.5	7.4	4.8	12.8	7.0	6.7	7.4	11.7	16.0	5.0	7.8	6.6	10.2	7.0	2.8	52.9	4.0	7.5	6.5	8.0	4.4	5.7	2.2	6.2	10.9	11.3	5.6	3.7	6.2	1.9	5.7	15.8	9.8	4.1	5.2	5.0	14.7	5.7	11.4	15.6	5.5	5.4	5.9	4.6	14.4	5.5	7.8	4.7	7.4	5.3	16.3	11.7	23.3	0.4	1.5	0.6	2.3	0.5	25.1	1.3	18.3	58.6	1.8	4.0	8.7	10.0	2.0	3.0	10.8	3.8	5.3	3.5	24.0	2.0	11.6	13.3	22.7	47.3	5.3	13.6	2.5	24.3	3.4	0.9	42.7	1.9	14.5	1.0	2.0	5.5	8.6	8.3	4.8	10.6	8.1	2.3	1.1	9.6	10.2	6.5	4.0	2.3	2.7	74.3	3.5	1.7	15.1	1.4	19.4	23.9	1.3	3.8	13.4	15.2	4.5	11.1	2.3	2.5	12.5	4.8	5.7	2.3	10.4	2.3	2.5	0.1	7.4	2.5	12.1	0.1	2.3	0.6	0.8	0.6	0.5	0.3	3.0	0.9	1.5	0.4	0.8	1.6	0.5	0.5	0.3	0.3	25.1	1.3	7.4	12.8	7.4	11.7	8.0	4.4	11.3	5.6	9.8	7.8	35.7	1.6	3.7	46.8	27.4	6.4	8.8	10.2	5.3	12.5	10.4	17.7	12.0	0.0	46.8	0.8	16.1	4.3	0.0	15.3	6.7	10.5	16.4	4.6	2.4	3.5	3.2	4.1	3.7	2.6	2.0	6.6	4.4	6.8	18.0	16.5	6.7	96.1	24.6	4.2	3.7	8.7	6.5	8.3	7.6	11.5	67.9	3.9	5.7	13.3	116.8
TRIM16L	TRIM70	ENSG00000108448	"Tripartite motif containing 16 like"	Q309B1	17	18697998-18736118	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.5"	"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 44.3;HaCaT: 22.6;HeLa: 35.4;OE19: 51.5"									HPA066431	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA066431: AB_2685668"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.89e-3)"	"unprognostic (5.66e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (7.08e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	2.8	4.4	2.0	1.0	3.1	0.5	7.1	1.0	3.0	2.2	3.6	1.3	1.0	2.0	1.4	3.2	10.5	3.3	8.1	16.8	2.0	2.5	3.5	2.8	2.4	1.0	4.7	1.0	1.3	1.3	0.1	1.0	1.8	3.1	3.6	1.0	2.1	2.6	3.7	22.5	0.8	1.1	6.5	4.7	1.0	3.0	2.9	1.4	1.0	4.5	12.7	3.4	6.7	11.8	1.5	0.8	0.4	1.4	2.7	2.1	1.8	4.7	44.3	0.2	1.9	5.4	2.2	3.5	0.4	3.7	1.6	3.3	0.8	19.1	0.5	3.5	12.7	8.8	22.6	0.5	1.0	0.8	0.1	0.6	0.3	35.4	0.4	13.3	0.0	0.4	2.3	1.3	2.4	0.9	7.0	0.5	0.4	0.0	0.0	4.3	4.7	0.1	0.5	0.4	51.5	0.9	0.5	2.3	0.0	3.2	2.8	0.1	1.0	5.0	1.0	2.7	0.3	2.3	0.3	9.9	1.1	5.7	1.8	6.3	0.5	0.5	0.0	3.7	0.4	8.4	0.1	0.7	0.4	0.7	1.4	1.0	1.5	1.0	0.6	0.8	1.1	1.6	1.5	0.3	2.7	0.5	0.2	2.1	1.8	2.0	3.1	1.0	1.9	2.0	2.5	4.7	1.0	3.1	1.4	6.0	3.2	0.8	8.5	3.4	2.7	5.5	10.2	8.1	1.2	1.8	7.9	2.0	3.3	9.0	0.5	2.6	0.9	0.0	5.3	3.7	2.5	3.8	3.5	2.5	1.4	3.2	2.4	2.5	3.4	0.7	3.4	2.1	0.0	15.4	3.2	3.5	21.6	0.0	1.8	6.8	2.4	0.0	2.8	3.2	5.6	5.6	0.9	1.3	3.4	6.3
TRIM17	"RBCC, RNF16, terf"	ENSG00000162931	"Tripartite motif containing 17"	Q9Y577	1	228407940-228416861	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;testis: 18.3"	"Group enriched"	"Detected in some"	56	"Early spermatids: 233.3;Late spermatids: 64.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;HEL: 3.5;NTERA-2: 3.3;SH-SY5Y: 4.1;T-47d: 9.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054908	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA054908: AB_2682638"	"prognostic favorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (7.42e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.96e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-1)"	1.3	0.8	14.4	1.5	19.1	1.1	1.9	25.8	11.8	1.5	0.9	0.6	1.7	1.4	3.6	1.7	1.3	3.9	1.7	1.5	8.9	3.4	1.2	0.6	1.7	2.0	0.7	9.2	2.2	1.1	0.8	1.0	1.3	2.7	2.0	0.8	1.9	5.9	3.8	0.8	3.5	1.6	1.1	0.9	5.3	1.4	18.3	4.7	0.0	2.9	0.1	1.2	2.5	1.3	1.7	0.6	0.7	0.3	0.0	1.0	0.1	0.3	0.7	0.5	0.4	0.0	0.0	7.8	0.5	0.0	0.0	0.1	1.7	0.9	0.1	1.9	0.0	0.2	1.7	0.0	0.0	0.1	0.3	0.8	3.5	1.0	0.2	1.6	0.1	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.5	0.2	0.5	0.1	0.1	0.3	0.0	3.3	0.1	0.2	0.1	0.1	0.0	0.0	0.8	0.5	4.1	0.0	0.4	0.0	0.8	9.6	0.2	0.0	0.4	1.7	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.7	0.9	0.1	1.0	0.6	0.2	1.0	0.0	1.7	1.0	0.8	0.2	0.0	0.2	0.6	0.0	0.1	14.4	19.1	25.8	11.8	8.9	3.4	0.7	9.2	2.7	4.7	0.0	0.3	0.0	1.1	0.2	1.1	0.6	0.0	2.7	2.3	1.8	0.0	0.0	0.0	0.7	233.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.0	1.1	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.0	0.0	1.2	1.6	0.3	0.7	0.5	0.0	0.6
TRIM2	"CMT2R, KIAA0517, RNF86"	ENSG00000109654	"Tripartite motif containing 2"	Q9C040	4	153152342-153339320	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.0"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 5.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 28.6;NTERA-2: 23.5;RPTEC TERT1: 26.7;SK-MEL-30: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035853, HPA035854"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659"	"unprognostic (8.94e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.58e-14)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.13e-2)"	4.2	9.9	28.4	4.4	35.7	0.6	12.2	28.9	56.9	19.6	17.8	67.0	5.9	13.5	9.7	15.1	8.5	12.9	10.3	6.2	38.9	25.3	22.1	6.4	5.9	2.3	39.4	34.6	10.9	8.2	1.0	10.9	2.5	45.3	11.5	19.2	4.6	30.1	11.8	1.8	3.8	14.4	6.6	44.2	8.8	23.5	1.9	44.7	0.0	38.9	0.6	4.3	7.6	5.5	1.9	0.8	0.3	0.6	0.3	5.4	0.7	4.8	0.2	28.6	12.5	10.8	12.4	0.5	6.4	8.7	1.8	2.7	2.8	0.3	0.2	4.1	11.1	5.5	4.3	13.3	2.4	1.9	0.1	5.0	0.2	2.9	0.6	12.6	0.2	0.1	8.0	1.4	3.6	2.3	7.0	1.7	0.3	0.2	0.1	2.2	0.4	1.4	0.0	23.5	14.3	5.7	0.8	5.2	0.0	26.7	6.3	9.2	18.1	3.0	11.6	25.6	4.3	1.2	0.2	2.4	8.0	2.3	6.2	3.0	0.1	0.0	0.1	11.9	0.1	9.8	0.3	0.6	0.1	0.1	0.0	0.0	1.6	5.4	0.1	0.8	1.9	1.6	1.0	0.2	0.3	0.0	0.1	2.6	0.7	28.4	35.7	28.9	41.1	38.9	25.3	39.4	34.6	45.3	44.7	6.0	22.3	3.2	14.9	6.3	65.3	26.2	12.7	81.7	61.4	55.8	27.5	1.4	86.2	8.4	2.7	14.0	51.1	0.0	23.1	0.4	18.1	22.3	1.1	10.9	1.1	104.9	59.8	18.4	1.5	2.1	27.3	2.6	60.8	4.6	59.2	78.7	19.0	31.6	30.8	12.2	20.8	25.8	9.9	0.4	0.9	3.4	0.6	1.0	74.3	26.7
TRIM21	"RNF81, Ro/SSA, RO52, SSA1"	ENSG00000132109	"Tripartite motif containing 21"	P19474	11	4384897-4393696	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004566, HPA005673"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004566: AB_628286, HPA005673: AB_1080090"	"prognostic favorable (4.83e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.26e-6)"	"unprognostic (9.12e-3)"	18.2	12.1	4.9	13.7	6.5	15.0	9.8	2.5	6.4	15.0	11.7	6.4	6.0	12.5	11.6	10.3	14.6	10.4	10.8	8.5	5.0	5.3	12.9	14.9	14.6	21.4	6.8	4.0	17.4	10.7	4.3	9.9	19.9	8.6	18.0	12.0	8.5	11.9	8.6	4.5	6.9	21.8	12.0	4.7	28.3	13.5	6.0	4.7	21.5	19.1	6.8	17.0	11.6	13.5	10.9	22.0	72.4	27.5	14.5	19.5	28.6	5.7	6.8	3.4	3.2	7.1	10.7	4.8	7.4	14.0	29.4	32.6	3.1	16.8	8.8	3.4	10.9	30.4	8.3	6.0	11.3	9.1	14.8	6.7	13.6	3.9	2.8	15.8	16.0	13.6	10.4	6.8	5.9	4.1	10.7	17.9	7.7	4.2	9.7	9.7	5.1	8.4	11.8	2.9	6.6	3.5	5.9	4.5	4.9	11.6	5.4	0.0	1.5	6.1	6.8	8.2	5.8	2.3	11.0	16.1	7.2	5.6	3.7	2.7	5.1	4.0	5.6	6.5	12.7	5.1	18.8	26.9	60.1	19.3	27.5	16.8	10.5	16.6	17.1	22.0	10.9	14.9	15.7	72.4	14.5	24.4	7.4	19.5	28.6	4.9	6.5	2.5	6.4	5.0	5.3	6.8	4.0	8.6	4.7	8.9	4.6	4.7	4.4	1.8	0.5	2.5	5.1	10.7	11.4	5.2	0.0	5.5	6.6	10.3	0.0	6.2	6.7	0.0	7.4	7.2	2.8	3.4	11.6	7.6	8.6	1.6	2.4	9.8	11.0	0.4	4.0	7.2	1.7	10.0	6.9	1.4	9.9	5.8	6.7	3.1	0.0	12.9	4.2	0.3	0.4	1.5	7.6	8.3	4.8	2.8
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56887909-56914038	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 20.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 20.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		35000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	20.0	19.7	7.5	23.6	8.9	32.6	19.3	11.6	7.8	15.3	22.5	5.0	8.0	15.3	13.4	12.6	17.7	15.3	18.4	8.3	5.8	6.3	10.1	27.0	20.8	15.9	6.7	5.5	13.3	15.3	13.6	11.5	55.0	7.4	12.2	14.3	12.5	14.5	11.5	11.7	23.1	20.7	10.1	5.2	35.8	14.1	12.8	6.5	26.2	11.8	15.1	18.5	10.6	35.9	1.7	2.4	20.0	2.3	0.8	1.5	0.7	28.5	14.2	3.5	11.8	26.5	22.4	0.0	11.3	22.9	27.1	23.3	13.8	15.7	27.9	23.5	10.8	29.6	17.0	17.0	15.2	15.2	23.8	13.5	18.0	11.0	15.3	22.7	21.5	13.0	10.0	25.6	14.1	30.0	12.9	17.9	19.2	4.4	17.1	13.7	19.1	24.0	15.5	2.2	23.7	27.6	17.2	11.7	17.6	15.8	22.6	6.8	6.4	8.9	14.3	26.2	2.3	19.4	17.5	11.9	12.7	9.1	19.5	11.7	9.7	18.5	4.6	12.3	14.8	4.9	3.0	2.3	0.9	0.9	1.9	1.1	1.7	0.8	0.8	2.4	1.4	0.6	0.8	20.0	0.8	1.4	1.7	1.5	0.7	7.5	8.9	11.6	7.8	5.8	6.3	6.7	5.5	7.4	6.5	32.8	17.5	11.5	7.3	16.5	8.7	7.0	12.7	20.1	20.5	8.7	27.5	4.1	0.0	16.7	2.1	22.4	32.6	0.0	18.7	8.3	7.8	14.6	3.5	28.7	12.5	3.2	17.9	28.3	31.6	1.2	8.9	23.3	13.5	5.4	26.1	5.2	26.1	26.4	8.9	6.3	19.2	6.5	6.4	0.3	0.0	26.7	13.3	8.6	21.8	16.6
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923989	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	11.5	10.6	8.8	25.5	9.7	7.9	9.3	10.1	12.2	11.2	10.2	8.7	20.2	23.8	12.1	13.2	7.8	12.1	11.4	8.1	8.2	9.6	10.1	22.5	10.4	17.4	12.6	8.3	14.7	31.0	7.4	13.9	13.7	10.6	13.7	4.6	7.7	17.0	25.2	12.2	9.7	19.4	9.2	8.4	18.6	18.5	9.2	9.2	16.7	12.5	7.9	12.1	9.9	11.8	12.5	12.5	13.8	13.9	11.2	15.9	13.8	3.3	2.3	1.0	6.1	0.8	1.7	0.7	4.6	1.1	1.4	1.7	1.7	1.4	7.7	8.0	1.3	3.0	7.4	1.1	2.7	0.1	3.0	13.1	11.0	0.5	2.3	1.3	4.6	1.7	1.3	1.7	1.2	0.5	0.1	1.2	8.0	10.6	3.3	0.4	1.3	6.4	2.4	0.0	2.1	7.4	9.1	7.0	14.3	1.1	1.1	3.3	13.1	5.6	3.4	7.4	0.3	3.3	3.6	4.0	3.5	7.1	6.3	2.7	12.2	14.6	12.2	1.8	11.7	5.2	12.6	13.8	8.8	12.7	13.9	15.9	12.5	12.6	14.4	12.5	10.5	11.8	12.1	13.8	11.2	12.1	9.8	10.4	13.8	8.8	9.7	10.1	12.2	8.2	9.6	12.6	8.3	10.6	9.2	14.9	21.9	30.9	26.1	25.2	11.0	14.9	30.6	24.1	19.4	27.9	15.7	41.3	18.3	35.7	9.4	29.1	15.7	23.3	37.7	49.1	24.4	31.4	20.8	36.5	36.4	7.9	26.5	25.2	23.8	4.4	22.2	24.5	8.5	25.2	24.4	9.8	42.8	19.5	17.3	24.1	13.1	19.4	21.1	5.1	11.2	17.1	38.1	26.2	24.4	24.0
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111275-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Region enriched"	"Detected in single"	8	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020053, HPA074841"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA020053: AB_1858280, HPA074841: "	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	0.3	0.2	0.1	0.0	0.1	0.1	7.3	0.0	0.1	30.4	0.6	0.2	1.6	0.3	3.1	2.9	176.3	3.7	0.8	0.1	0.1	0.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.2	0.0	2.2	24.4	1.1	11.1	0.5	0.0	25.5	4.8	0.9	90.1	0.2	1.6	0.3	0.0	0.2	0.7	0.0	7.5	0.1	113.6	93.6	9.6	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.4	0.0	0.8	0.0	0.1	54.2	0.0	12.4	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	72.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	28.5	0.2	0.9	40.5	5.7	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	97.6	241.7	0.0	1.1	2.5	33.5	13.6	0.0	0.0	37.9	0.0	1.3	21.4	0.4	2.1	0.0	3.9	5.0	5.4	34.5	1.1	0.0	4.4	0.0	2.4	0.0	0.0	78.0	0.6	1.7	21.9	0.0	2.3	0.0	33.2	0.8	0.0	0.2	0.0	0.0	7.2	0.6	1.4	402.6	20.7	0.0	1.4	144.0
TRIM3	"BERP, HAC1, RNF22, RNF97"	ENSG00000110171	"Tripartite motif containing 3"	O75382	11	6448613-6474459	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043396, HPA048233"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043396: AB_2678460, HPA048233: AB_2680321"	"unprognostic (1.24e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (4.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.93e-1)"	6.9	5.4	9.0	5.8	8.8	1.6	6.2	34.0	17.1	6.3	8.1	9.4	3.4	22.6	8.7	2.6	3.7	5.9	5.3	6.1	6.8	7.0	3.9	3.8	6.2	3.0	8.1	9.6	5.8	5.3	2.8	3.8	5.3	14.3	7.7	6.5	6.1	9.2	7.7	9.3	7.1	19.5	8.9	7.3	4.9	8.6	3.0	7.0	0.7	4.2	2.5	2.1	6.6	5.8	0.5	3.9	1.8	3.0	2.0	1.9	1.5	4.3	7.5	3.0	5.1	5.1	4.9	4.1	6.2	3.7	4.8	5.4	4.5	3.0	2.4	2.2	4.7	5.6	3.0	3.1	4.6	1.8	2.8	4.6	0.7	7.5	3.0	3.1	0.2	2.5	4.2	2.2	3.7	2.0	2.0	4.8	1.7	1.0	2.9	4.6	9.0	0.2	0.6	2.2	8.9	6.5	1.4	2.6	2.9	1.1	2.2	3.1	4.9	3.4	33.9	4.0	1.6	12.8	0.8	8.1	12.7	6.0	9.2	4.1	3.4	2.0	0.5	6.9	1.0	4.7	0.0	3.0	1.8	1.7	2.9	1.3	0.4	1.4	1.4	3.9	0.5	0.5	1.9	0.0	2.0	0.8	0.8	1.5	1.5	9.0	8.8	34.0	17.1	6.8	7.0	8.1	9.6	14.3	7.0	6.0	0.0	2.0	2.6	4.2	8.5	1.7	2.5	2.7	0.0	0.0	9.8	1.6	0.0	2.8	3.1	4.7	17.1	0.0	2.9	2.0	6.1	4.0	1.1	1.9	4.1	7.9	4.6	4.3	1.0	3.9	5.5	2.8	6.8	3.6	10.7	1.7	2.6	5.7	4.9	2.4	8.7	12.9	10.2	1.9	4.9	4.6	0.7	0.7	5.2	1.6
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687302-116701300	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA050060: AB_2681000"	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (4.53e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	9.5	9.1	6.6	5.8	11.5	0.8	8.0	23.2	17.1	12.8	7.9	7.2	6.2	6.7	17.0	8.0	8.8	15.9	8.2	8.9	5.7	7.3	6.2	5.0	6.3	8.4	5.7	9.8	12.6	12.5	12.2	7.7	7.0	9.1	10.3	7.4	10.4	10.9	9.2	23.9	6.6	8.9	12.9	5.3	6.9	6.8	6.5	2.2	9.4	8.4	6.2	8.3	11.1	8.8	6.1	3.5	0.2	2.6	5.6	16.0	4.7	6.5	15.0	8.9	9.8	18.1	13.0	6.7	12.2	13.4	13.9	11.7	10.0	7.2	6.8	5.4	18.7	10.4	14.0	10.8	13.7	12.7	5.9	5.2	3.6	9.7	6.1	9.4	2.4	12.0	11.2	12.4	13.1	7.8	15.4	9.0	7.6	5.0	5.8	16.3	8.4	6.4	0.0	8.1	15.8	9.1	7.6	24.0	4.4	5.7	15.3	8.9	4.5	9.6	6.7	6.9	9.4	18.5	2.4	11.1	13.0	10.4	9.5	9.1	9.5	2.5	10.6	10.8	1.6	12.7	0.0	1.3	0.0	9.3	2.6	7.2	6.1	8.2	7.4	1.8	4.4	8.3	8.4	0.2	5.6	2.1	3.5	16.0	4.7	6.6	11.5	23.2	17.1	5.7	7.3	5.7	9.8	9.1	2.2	6.0	1.1	3.0	5.1	3.8	11.5	6.1	7.6	6.7	5.7	8.7	0.0	6.0	1.7	7.8	2.8	2.4	2.4	0.0	7.0	3.6	6.5	2.8	2.3	3.9	5.8	1.6	4.1	2.5	2.7	1.3	4.9	1.4	1.7	1.0	5.2	4.1	4.9	3.5	11.3	2.2	4.5	0.0	3.6	9.8	11.1	3.1	6.2	4.6	4.9	3.4
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392777-114511160	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 155.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favorable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	15.2	12.8	16.9	18.4	19.9	27.1	17.1	38.3	21.8	16.9	14.3	11.0	21.9	10.9	19.8	38.3	16.4	15.0	15.6	10.8	18.1	12.5	17.3	15.0	14.3	15.2	12.1	18.0	19.8	15.7	21.8	22.4	27.2	15.2	16.5	13.0	10.7	16.4	19.1	14.3	19.5	14.8	20.2	12.9	14.9	14.1	29.0	16.3	20.5	17.9	9.8	16.6	17.9	28.7	3.4	4.0	12.2	2.8	4.7	4.4	1.0	13.1	7.1	13.4	10.0	5.7	6.0	22.9	6.7	7.2	9.4	10.0	8.0	5.6	14.1	7.0	7.8	6.1	7.6	12.2	7.8	13.0	10.6	7.2	13.6	9.4	9.3	6.3	17.1	11.3	5.7	5.8	11.1	11.4	7.2	7.8	12.0	16.9	10.0	8.9	49.4	17.2	7.3	18.1	5.0	7.2	14.9	20.5	4.6	6.7	20.7	9.3	9.8	12.7	15.4	12.1	9.0	7.0	9.4	8.8	6.5	10.6	15.1	9.4	7.0	6.5	14.7	9.2	10.0	18.5	12.2	1.6	7.4	3.5	1.8	3.1	3.4	3.7	3.7	2.0	2.2	2.9	4.4	4.8	4.7	2.8	4.0	2.0	1.0	16.9	19.9	38.3	21.8	18.1	12.5	12.1	18.0	15.2	16.3	17.9	29.5	19.1	25.9	46.9	71.6	22.0	25.5	10.7	25.0	52.4	92.3	49.7	1.7	18.3	155.1	31.1	23.6	23.3	20.5	27.8	32.1	38.2	36.9	40.5	26.3	25.4	50.1	37.4	44.7	78.9	45.5	39.2	18.6	17.2	31.4	33.5	25.3	32.6	34.6	12.6	58.2	32.3	23.7	54.0	29.6	48.4	73.3	35.5	28.9	48.8
TRIM34	RNF21	ENSG00000258659	"Tripartite motif containing 34"	Q9BYJ4	11	5619764-5644398	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"	24	"Ciliated cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.5;SK-BR-3: 17.6"									HPA077996			Approved	Nucleoli,Centrosome		NA	NA			Centrosome	Nucleoli	"HPA077996: AB_2686873"	"unprognostic (8.66e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.16e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.76e-2)"	15.9	14.6	2.7	12.2	2.9	1.4	7.3	0.9	3.4	9.3	7.9	6.0	8.5	6.6	15.7	10.6	8.7	7.8	5.6	4.1	3.6	2.2	7.1	4.4	7.9	11.7	2.6	3.9	11.4	5.5	4.5	5.5	8.7	4.7	9.5	6.8	7.8	10.2	6.3	2.0	6.2	14.2	5.8	6.2	16.6	6.1	4.6	4.3	12.5	7.0	5.0	14.3	10.0	7.8	12.8	15.9	15.2	15.9	5.9	9.5	7.8	2.3	1.3	0.5	0.2	5.3	8.3	16.5	3.5	10.2	9.1	8.9	1.0	8.1	8.1	1.6	4.7	6.8	3.7	0.3	7.5	4.6	10.6	0.3	4.3	0.4	0.4	2.4	4.7	3.0	8.7	6.5	4.6	1.5	7.1	11.6	7.2	0.2	0.6	4.3	1.0	4.2	2.7	0.0	3.2	0.7	6.3	0.3	0.5	5.4	6.2	0.0	0.0	0.1	17.6	2.6	1.6	3.1	2.3	9.3	2.4	0.5	0.9	1.3	0.9	1.1	3.1	6.8	0.6	1.2	8.7	14.3	3.6	5.6	15.9	6.1	12.6	5.4	6.9	15.9	12.8	6.8	5.7	15.2	5.9	13.5	8.1	9.5	7.8	2.7	2.9	0.9	3.4	3.6	2.2	2.6	3.9	4.7	4.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRIM35	"HLS5, KIAA1098, MAIR"	ENSG00000104228	"Tripartite motif containing 35"	Q9UPQ4	8	27284887-27311319	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3;Ito cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019647	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019647: AB_1858291"	"unprognostic (7.67e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.61e-2)"	"unprognostic (9.64e-3)"	"unprognostic (9.35e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (8.79e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.86e-2)"	"prognostic favorable (5.59e-7)"	"unprognostic (1.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.92e-1)"	10.6	7.2	5.7	8.1	8.9	8.6	17.7	5.7	12.9	8.2	7.9	8.7	17.3	7.2	10.2	6.6	11.7	8.2	6.3	6.9	10.9	5.9	11.3	14.6	8.4	12.7	7.3	7.3	8.7	11.6	6.8	5.1	7.1	7.0	8.3	5.4	5.4	23.4	27.7	5.8	32.7	7.3	9.7	12.6	7.8	6.8	10.4	6.6	10.2	6.1	7.4	9.0	8.6	10.8	5.2	5.9	8.7	3.0	7.8	12.8	4.8	9.0	6.5	3.8	4.9	38.1	9.5	8.8	5.5	4.3	5.1	5.5	9.2	1.8	8.0	5.7	6.0	4.5	9.0	5.4	10.6	3.9	4.5	4.1	7.9	5.1	7.8	9.9	4.2	6.8	13.7	24.1	7.2	14.4	2.7	5.0	7.7	5.5	9.0	4.1	4.6	14.2	5.9	6.6	5.8	5.3	7.2	4.9	6.9	3.5	7.1	6.5	6.2	4.6	4.4	7.6	3.8	2.8	6.9	5.9	4.7	9.7	14.7	5.3	4.1	4.3	5.9	6.7	6.3	4.5	8.7	2.8	3.4	8.6	2.7	9.7	5.2	11.2	9.5	3.5	3.7	7.7	11.3	1.1	7.8	3.0	5.9	12.8	4.8	5.7	8.9	5.7	12.9	10.9	5.9	7.3	7.3	7.0	6.6	3.0	5.0	2.2	5.6	18.5	3.3	3.6	7.6	0.0	4.5	12.2	5.9	3.0	0.0	3.5	0.6	4.7	3.4	23.3	4.5	2.1	3.8	3.7	5.7	17.4	2.5	4.8	2.4	25.8	8.4	0.4	11.8	4.1	6.8	5.4	2.8	2.2	4.1	0.0	10.3	5.0	3.6	0.0	5.2	1.4	4.3	19.4	1.3	5.0	3.0	2.7
TRIM36	"HAPRIN, RBCC728, RNF98"	ENSG00000152503	"Tripartite motif containing 36"	Q9NQ86	5	115124762-115180546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 88.8"	"Group enriched"	"Detected in many"	39	"Early spermatids: 1875.0;Late spermatids: 3810.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.5;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	43	"dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061321			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA061321: AB_2684479"	"unprognostic (6.36e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.33e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.82e-13)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.80e-3)"	1.0	1.4	6.8	1.4	7.6	0.8	3.2	0.6	11.7	1.4	4.8	7.7	0.0	8.2	1.1	1.0	0.8	1.9	1.0	0.7	10.1	7.2	0.9	0.9	1.6	0.8	7.1	8.6	3.5	1.5	0.7	8.2	1.3	18.3	5.7	4.8	5.1	1.0	1.0	0.7	1.0	7.9	1.1	8.7	0.9	2.0	88.8	4.7	0.0	0.8	0.0	0.9	0.8	1.0	0.1	7.5	4.2	7.7	0.0	0.0	0.8	2.4	0.7	1.2	6.2	0.1	0.1	1.5	0.5	2.1	1.1	1.3	0.9	1.2	0.0	1.0	0.1	8.8	0.6	5.8	1.1	0.8	0.4	1.9	4.3	2.5	1.2	0.2	4.2	3.6	0.1	1.1	0.5	1.5	1.4	0.0	8.2	0.1	5.9	1.7	3.3	1.1	3.8	4.9	0.4	2.8	0.9	17.8	1.4	0.6	0.0	19.9	14.5	3.8	0.4	2.3	0.6	4.3	5.4	0.5	1.7	1.3	1.3	1.9	0.9	0.5	0.0	1.9	2.4	0.8	0.0	1.7	4.2	0.0	1.6	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.3	0.0	7.7	1.6	0.0	0.8	6.8	7.6	0.6	11.7	10.1	7.2	7.1	8.6	18.3	4.7	0.0	4.3	0.0	0.8	2.1	4.8	2.0	0.0	6.7	0.0	1.8	53.0	0.0	0.0	0.4	1875.0	0.7	21.6	0.0	1.6	0.4	0.6	8.8	1.1	0.0	2.5	4.8	3.4	0.6	1.6	3810.8	13.8	6.3	8.5	5.4	11.8	5.7	1.4	9.1	12.0	0.0	73.6	6.5	2.8	33.1	23.0	1.1	0.2	0.0	7.0	0.1
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991226	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"B-cells: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"		NA	NA			Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (8.20e-5)"	"prognostic favorable (4.94e-9)"	13.3	8.4	2.5	15.7	2.3	12.0	7.9	1.1	3.4	17.2	12.1	3.1	20.5	6.7	26.2	22.3	15.7	8.9	9.2	5.8	2.8	2.3	26.1	8.8	14.0	14.4	3.7	1.8	11.5	4.3	1.0	4.3	10.3	3.5	15.5	7.8	9.2	9.8	16.5	9.0	5.3	14.6	13.1	4.5	17.6	6.6	5.3	2.9	16.6	13.7	9.5	20.1	18.0	15.4	16.5	10.1	12.1	12.9	6.7	7.9	6.3	3.5	2.0	0.3	4.3	10.4	13.9	3.6	4.5	9.0	8.8	14.6	1.6	3.8	7.9	7.4	5.5	8.5	5.6	2.7	4.4	5.2	8.0	1.8	3.6	3.3	1.4	13.8	4.2	7.4	13.9	3.3	5.4	1.9	7.3	7.6	3.9	2.3	4.4	10.4	1.7	4.0	4.8	1.4	0.0	2.7	6.2	4.3	8.2	10.4	7.1	0.1	0.1	3.4	7.1	12.0	0.5	1.0	5.5	7.7	1.6	2.7	2.7	3.0	5.1	3.7	8.9	4.3	5.2	9.7	10.1	10.6	4.7	7.6	12.9	7.4	14.3	6.5	6.8	10.1	16.5	6.2	6.7	12.1	6.7	11.4	9.5	7.9	6.3	2.5	2.3	1.1	3.4	2.8	2.3	3.7	1.8	3.5	2.9	23.8	43.9	100.5	47.4	13.3	0.6	3.5	22.9	17.4	29.6	43.6	0.0	19.8	14.9	19.1	0.9	42.0	39.9	0.0	13.0	17.5	17.0	35.9	34.6	14.8	28.8	0.0	17.4	27.0	84.3	2.2	18.4	61.3	10.1	49.5	29.9	0.3	17.8	40.3	17.7	62.8	0.7	6.5	18.9	0.2	0.2	8.2	17.7	36.2	23.3	78.5
TRIM39-RPP21		ENSG00000248167	"TRIM39-RPP21 readthrough"		6	30328907-30346854	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"esophagus: 1.8;testis: 1.2"	"Group enriched"	"Detected in some"	10	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.3;Club cells: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.4;LHCN-M2: 2.2;MCF7: 1.8"									HPA051120	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051120: AB_2681348"	"unprognostic (1.20e-1)"	"unprognostic (7.35e-2)"			"unprognostic (2.56e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.60e-1)"	"unprognostic (1.33e-1)"			"unprognostic (1.56e-1)"	"unprognostic (5.84e-4)"		"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-2)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	1.8	0.6	0.0	0.0			0.4	0.0	0.2	0.0			0.3	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919600	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	19.1	22.6	13.5	22.1	15.9	6.7	22.1	20.1	15.5	19.5	17.3	12.4	22.5	13.9	21.9	18.8	16.4	19.0	19.8	11.1	13.3	9.3	16.6	17.9	21.1	22.4	15.3	8.8	35.0	23.2	18.9	27.4	16.1	12.2	21.9	15.7	18.4	19.4	33.8	9.4	20.7	18.3	18.1	11.9	18.2	17.4	16.2	14.5	18.4	20.5	11.9	18.8	20.0	28.9	18.6	17.0	20.0	19.2	13.9	30.3	17.4	9.7	11.7	7.0	5.8	18.4	17.3	3.1	16.4	20.0	13.7	16.0	6.2	9.6	14.2	0.1	13.9	12.1	11.6	9.2	10.1	14.0	14.4	0.7	11.6	6.2	9.7	26.0	16.7	16.6	18.4	21.5	10.6	27.0	18.7	11.9	7.2	16.9	22.0	11.4	12.1	12.3	15.0	5.3	14.7	10.1	7.0	10.0	16.2	15.2	12.6	8.2	5.8	12.5	19.2	19.5	10.7	8.8	9.6	14.5	15.2	13.6	29.1	15.7	18.5	20.2	11.5	10.0	18.8	20.1	20.0	19.2	15.3	20.6	19.2	23.8	18.6	21.6	23.5	17.0	18.6	30.3	22.2	8.2	13.9	16.6	12.7	21.5	17.4	13.5	15.9	20.1	15.5	13.3	9.3	15.3	8.8	12.2	14.5	23.8	15.3	18.2	24.1	22.2	20.2	4.8	12.7	16.0	10.3	21.0	17.7	13.3	8.3	12.8	5.2	16.1	9.7	23.3	11.3	5.9	15.1	19.8	27.6	17.5	12.8	6.4	8.6	17.8	20.0	8.4	28.7	15.4	21.9	18.0	10.3	34.3	12.7	11.8	25.8	13.4	20.0	0.0	23.1	19.3	8.2	20.1	13.6	18.7	12.1	22.0
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136108-30148735	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 13.5;placenta: 39.4"	"Group enriched"	"Detected in some"	7	"Enterocytes: 3.6;Intestinal endocrine cells: 1.7;Paneth cells: 3.5;Spermatocytes: 1.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	52	"HEL: 5.1"	"Region enriched"	"Detected in single"	19	"thalamus: 3.4"	"Low region specificity"	"Detected in all"			HPA043818	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	4.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.2	0.0
TRIM44	"DIPB, MC7"	ENSG00000166326	"Tripartite motif containing 44"	Q96DX7	11	35662805-35818007	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049053, HPA057633"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA049053: AB_2680613, HPA057633: AB_2683484"	"unprognostic (2.73e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-1)"	18.8	18.1	25.2	17.7	31.5	8.2	17.3	34.8	35.1	18.4	18.0	25.1	12.6	16.2	19.4	16.7	14.5	17.9	18.1	17.5	25.8	23.0	28.1	21.9	18.1	18.1	26.7	31.9	17.0	23.5	23.0	21.7	20.2	32.0	16.9	17.7	13.3	16.1	18.8	20.3	11.8	17.9	19.2	29.7	20.3	17.0	12.3	25.1	12.8	23.4	7.2	19.5	19.7	19.4	4.1	4.9	0.9	3.7	3.2	3.4	1.5	10.4	9.0	14.4	6.6	10.9	16.6	0.0	9.9	11.8	12.4	11.4	10.4	7.1	14.0	9.4	12.9	14.1	8.2	4.9	11.3	14.0	9.1	9.4	15.0	11.9	5.9	14.5	11.7	13.0	12.5	12.7	7.3	19.9	13.8	13.0	4.9	23.3	5.0	13.0	6.3	12.4	5.7	8.1	2.2	7.8	8.6	37.3	7.5	11.5	14.3	9.9	8.5	14.8	10.6	11.2	8.2	16.0	10.0	14.6	16.0	13.1	9.0	11.2	8.6	7.6	0.0	13.2	12.6	11.9	0.4	2.6	0.9	2.6	3.3	2.4	3.0	2.5	2.5	2.1	4.1	3.3	3.4	0.2	3.2	3.7	4.9	0.9	1.5	25.2	31.5	34.8	35.1	25.8	23.0	26.7	31.9	32.0	25.1	56.6	58.2	57.3	44.5	23.8	206.3	47.8	56.0	65.6	66.0	24.4	192.4	44.7	28.2	55.3	13.1	55.2	43.4	0.0	61.0	21.9	34.7	61.7	57.7	50.0	38.1	79.4	49.3	44.8	51.7	8.1	33.4	50.8	18.6	47.7	40.8	82.5	47.5	39.9	35.0	62.1	177.2	97.0	38.1	57.6	80.7	23.3	43.6	34.5	43.5	50.6
TRIM49D1	"TRIM49D, TRIM49D1P, TRIM49DP"	ENSG00000223417	"Tripartite motif containing 49D1"	C9J1S8	11	89911111-89921767	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"blood: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	199	"basophil: 19.8"	"Lineage enriched"	"Detected in single"	199	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 2.1"									HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.1	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM49D2	"TRIM49D2P, TRIM49L, TRIM49L1"	ENSG00000233802	"Tripartite motif containing 49D2"	C9J1S8	11	89924064-89933063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"blood: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	160	"basophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"	"Cell line enriched"	"Detected in single"	6	"U-2 OS: 3.5"									HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0		0.1		0.6	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.3	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.6			0.0		0.0	0.1		0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312539-73328082	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"pancreas: 17.2;stomach 1: 22.8"	"Cell type enhanced"	"Detected in some"	14	"Distal tubular cells: 1.7;Early spermatids: 1.9;Spermatocytes: 4.4;Spermatogonia: 4.5"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	33	"Hep G2: 12.3"									"HPA019862, HPA047843"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA019862: AB_1858305, HPA047843: AB_2680176"	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0		0.0	17.2	0.2	0.0	0.3		0.0	0.0		0.0	0.0	1.8	0.0	1.0	0.0	0.0	0.1	22.8	4.4			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	1.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.4	4.5	0.0	0.1	0.0	0.0	0.0
TRIM51	"SPRYD5, TRIM51A"	ENSG00000124900	"Tripartite motif-containing 51"	Q9BSJ1	11	55883297-55891810	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 11.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	50	"melanoma: 4.3"					"Cell type enriched"	"Detected in single"	111	"basophil: 11.0"	"Lineage enriched"	"Detected in single"	111	"granulocytes: 11.0"	"Group enriched"	"Detected in some"	124	"SK-MEL-30: 36.0;WM-115: 9.2"									"HPA044988, HPA077883"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA044988: AB_2679171, HPA077883: AB_2732362"									"unprognostic (9.60e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.1	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM52	RNF102	ENSG00000183718	"Tripartite motif containing 52"	Q96A61	5	181254417-181261139	"Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA054565, HPA056819"	Approved		Approved	"Nucleoli,Intermediate filaments"		NA	NA			Nucleoli	"Intermediate filaments"	"HPA054565: AB_2682525, HPA056819: AB_2683245"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.23e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (2.96e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (4.07e-4)"	9.2	13.0	17.8	15.3	19.7	10.9	11.5	42.3	24.2	10.9	10.9	9.8	15.4	11.8	12.1	14.3	6.6	10.3	8.2	9.1	15.0	10.5	11.2	9.7	11.0	18.8	18.0	12.0	17.7	14.6	15.3	19.4	8.6	16.2	13.8	10.2	8.1	14.0	15.6	9.8	14.5	12.6	8.3	14.0	16.9	11.3	11.7	20.8	15.3	16.8	5.0	13.9	10.3	15.1	5.4	2.7	5.6	2.5	5.5	11.2	3.7	3.6	4.2	6.8	8.8	12.4	7.9	6.1	4.0	3.5	3.9	3.4	6.0	6.7	7.9	4.4	4.3	10.6	6.7	3.7	5.3	4.6	13.4	7.8	3.0	15.9	5.1	3.0	9.2	7.0	7.9	4.5	4.2	2.4	6.4	4.6	11.7	3.2	18.6	4.0	6.9	5.0	8.4	2.4	4.1	5.5	6.0	3.7	5.4	3.2	4.8	7.8	6.3	5.7	4.1	3.6	6.3	7.7	6.3	5.6	7.9	4.1	3.7	3.7	13.7	6.7	5.4	8.9	8.1	3.0	5.0	2.5	5.6	8.4	2.2	9.3	5.4	9.0	9.2	2.0	4.2	11.2	8.9	2.6	5.5	2.0	2.7	5.9	3.7	17.8	19.7	42.3	24.2	15.0	10.5	18.0	12.0	16.2	20.8	17.9	20.5	8.3	5.9	7.8	26.6	6.6	7.6	16.0	23.9	7.0	37.3	3.1	3.3	3.0	24.4	10.1	6.7	0.0	2.2	1.0	9.3	5.3	17.3	2.6	3.6	27.0	8.6	8.6	6.2	3.6	11.8	8.7	5.0	3.6	6.8	19.8	2.1	5.9	8.9	2.8	42.6	0.0	14.8	14.9	6.4	5.4	3.5	10.2	7.5	3.4
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282392-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 187.1"	"Cell type enhanced"	"Detected in some"	20	"Cardiomyocytes: 75.1;Exocrine glandular cells: 36.7;Pancreatic endocrine cells: 31.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Cell type enriched"	"Detected in single"	16	"NK-cell: 7.0"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 7.0"	"Group enriched"	"Detected in some"	9	"HAP1: 8.4;NTERA-2: 18.0"	"Region enhanced"	"Detected in some"		"amygdala: 3.2"	"Not detected"	"Not detected"			HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	2.1	1.8	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.9	0.1	6.3	1.6	0.0	0.0	35.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.0	187.1	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0	1.3	40.3	2.2	0.1	0.0	0.3	0.0	0.0	0.0	7.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	8.4	0.0	0.0	0.0	0.3	0.0	1.5	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	18.0	0.0	0.0	0.6	0.7	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.1	12.7	0.0	0.0	3.5	0.0	0.0	0.0	3.6	1.0	0.0	2.0	0.0	36.7	0.0	0.0	0.2	4.6	0.0	0.1	0.0	0.0	0.6	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	31.1	1.9	0.7	2.1	0.0	0.0	0.2	3.7	1.9	0.0	0.0	0.0	2.9	0.3
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175487	"Predicted intracellular proteins, Predicted membrane proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4"	"Cell type enhanced"	"Detected in some"	26	"Cardiomyocytes: 96.0;Ciliated cells: 17.4;Hepatocytes: 28.0"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.3"	"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"LHCN-M2: 97.8"	"Region enriched"	"Detected in single"	8	"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	2.1	0.0	0.3	0.2	0.2	0.0	0.1	3.3	0.1	0.4	0.1	0.1	0.3	0.0	0.0	6.6	0.8	3.0	0.1	34.3	0.4	0.1	2.7	22.0	0.1	0.4	0.1	0.1	0.5	0.1	0.0	2.0	1.4	0.8	0.3	0.0	0.1	1.0	0.0	37.0	0.3	0.1	0.0	0.1	0.1	0.1	3.8	0.0	0.0	0.9	24.4	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	14.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	97.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.3	6.4	0.0	0.5	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	3.3	0.1	0.4	0.1	0.1	0.1	0.8	0.0	0.0	1.3	0.0	0.1	0.0	0.0	96.0	0.0	17.4	2.3	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.1	0.0	0.0	1.3	1.3	3.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.9	0.0	6.5	0.0	9.3	1.0	0.0	3.2	0.0	0.0	0.1
TRIM56	RNF109	ENSG00000169871	"Tripartite motif containing 56"	Q9BRZ2	7	101085439-101097967	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024358	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA024358: AB_1858308"	"unprognostic (6.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.44e-3)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.63e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.13e-4)"	14.3	12.0	6.2	15.7	9.3	4.7	24.5	3.2	11.1	14.9	15.0	6.8	22.3	9.7	14.3	13.1	12.9	12.8	13.7	8.7	7.5	5.2	10.8	10.4	23.7	11.7	15.8	5.2	17.3	10.8	10.7	15.2	14.0	8.8	12.5	8.3	7.5	12.2	22.1	8.7	13.2	12.8	15.2	8.5	17.2	10.3	5.6	12.0	9.7	14.0	9.1	12.0	13.6	22.0	3.3	2.1	7.4	2.4	7.7	3.6	1.0	9.9	12.5	5.4	6.9	12.5	13.0	6.5	8.3	7.4	13.5	12.6	5.9	14.5	11.8	9.0	6.9	18.8	11.5	2.2	7.6	9.1	11.8	3.5	7.4	15.7	4.4	11.2	13.1	16.9	8.2	11.1	8.8	14.4	13.2	7.1	7.6	12.9	15.0	9.3	13.6	11.0	14.6	5.4	5.3	10.4	10.2	8.8	7.7	7.1	10.4	0.3	0.2	9.2	25.8	7.0	7.2	5.9	8.6	13.4	19.0	16.9	14.2	8.9	7.4	7.4	9.3	9.4	10.7	14.8	2.5	2.4	2.1	3.6	1.5	2.6	2.0	2.7	2.3	0.8	3.3	2.6	3.4	7.4	7.7	2.1	2.1	1.1	1.0	6.2	9.3	3.2	11.1	7.5	5.2	15.8	5.2	8.8	12.0	68.5	72.4	41.5	67.9	4.6	3.2	19.1	89.2	77.6	52.4	48.8	2.0	33.7	3.3	51.6	1.8	75.8	45.5	23.3	41.2	22.2	26.5	58.9	14.0	41.9	17.0	9.5	28.1	86.5	38.1	0.8	122.6	36.3	1.7	21.6	43.9	23.6	46.8	49.1	88.8	6.7	2.8	64.7	27.4	4.7	6.6	2.9	24.9	62.3	41.9	50.8
TRIM59	"Mrf1, RNF104, TRIM57, TSBF1"	ENSG00000213186	"Tripartite motif containing 59"	Q8IWR1	3	160432445-160485773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.6;lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017750	Uncertain		Approved	"Rods & Rings"		NA	Yes			"Rods & Rings"		"HPA017750: AB_1858312"	"unprognostic (3.74e-1)"	"prognostic favorable (4.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.00e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.02e-3)"	"unprognostic (2.44e-11)"	"unprognostic (7.92e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.91e-3)"	1.3	1.4	8.0	6.0	19.3	18.6	2.7	2.1	14.5	1.8	3.5	30.6	0.3	3.6	4.1	1.3	6.6	2.8	3.6	1.2	13.4	6.4	2.0	1.6	2.6	13.8	28.3	6.3	2.1	2.4	2.7	2.5	2.6	14.3	2.9	3.5	0.1	2.6	1.6	1.6	6.8	4.0	3.8	14.5	6.3	3.3	10.4	28.4	24.6	2.8	0.3	14.5	6.1	3.1	7.8	4.7	16.1	2.2	8.8	15.2	2.6	8.9	7.1	9.1	0.6	3.6	5.0	12.0	14.2	12.3	17.8	17.1	0.7	15.6	23.9	10.6	10.6	5.6	15.3	0.0	5.8	23.5	21.7	8.6	0.8	2.1	1.0	5.1	10.5	1.4	4.2	1.7	8.6	6.1	10.8	12.4	3.6	11.2	10.2	16.6	9.4	6.4	0.7	23.9	5.8	11.9	9.0	7.9	10.7	6.2	2.9	5.9	1.3	4.0	11.9	0.3	12.8	14.1	9.8	9.4	1.3	4.2	2.1	1.3	17.0	6.1	6.0	1.5	13.8	1.4	16.1	2.2	3.7	8.3	2.2	9.4	7.8	13.6	11.2	3.2	6.9	9.4	11.1	2.7	8.8	1.0	4.7	15.2	2.6	8.0	19.3	2.1	11.8	13.4	6.4	28.3	6.3	14.3	28.4	0.0	6.2	12.3	4.2	4.2	0.4	0.7	2.5	1.4	1.2	1.8	5.9	4.1	0.0	1.7	23.4	1.8	1.1	0.0	1.7	9.8	1.8	1.8	1.1	0.0	2.5	0.0	10.4	2.5	3.0	10.7	0.3	2.1	3.3	1.0	2.2	0.5	1.4	3.5	0.7	1.4	1.3	0.0	0.5	12.5	13.9	3.9	2.1	12.8	4.4	2.7
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 16.1;thyroid gland: 15.5"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 14.4;Late spermatids: 9.0;Spermatocytes: 18.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HHSteC: 9.7;HSkMC: 6.5;hTERT-RPE1: 5.2;SuSa: 6.9;U-266/70: 12.9;U-266/84: 6.5"									HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA049109: AB_2680636"	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.4	5.4	1.8	3.0	2.5	3.3	1.6	1.3	2.1	2.6	1.4	1.1	7.2	2.2	2.8	1.9	0.8	3.5	3.1	5.9	2.4	3.0	1.0	1.1	2.1	2.9	2.7	1.3	5.8	0.9	1.5	6.8	1.8	3.8	2.1	1.1	2.9	0.9	1.9	1.2	1.1	1.7	2.1	4.2	4.7	1.5	16.1	1.6	2.7	15.5	0.7	2.8	3.0	5.2	5.5	5.1	3.6	1.3	7.8	4.1	1.5	0.2	0.4	0.9	0.8	0.6	0.6	0.6	2.4	0.8	0.0	0.0	0.3	0.3	0.7	0.2	3.5	0.2	0.3	0.6	0.6	0.4	0.4	0.5	0.2	0.5	0.7	9.7	0.5	0.6	6.5	0.5	2.1	0.2	5.2	0.2	0.3	0.5	1.4	0.3	0.4	0.3	0.7	3.8	0.0	0.0	0.5	0.2	1.0	0.3	0.9	0.8	0.5	0.1	0.3	0.4	6.9	0.3	0.3	0.7	1.2	0.4	0.1	0.2	12.9	6.5	0.4	0.3	0.2	0.3	3.6	1.3	0.1	3.3	1.1	3.4	3.6	1.6	3.3	1.5	5.5	4.1	4.0	0.5	7.8	0.8	5.1	0.4	1.5	1.8	2.5	1.3	2.1	2.4	3.0	2.7	1.3	3.8	1.6	0.0	3.5	2.2	0.6	0.2	0.7	1.7	0.0	0.0	0.0	3.5	3.9	0.1	0.0	0.3	14.4	0.3	0.0	0.0	0.6	0.0	0.7	0.3	0.0	0.4	1.0	1.6	0.0	0.0	0.6	9.0	1.1	0.3	0.0	2.8	0.0	2.8	0.1	0.0	1.4	2.5	0.3	0.0	0.3	18.1	3.4	0.0	0.2	2.9	0.0	0.5
TRIM62	"DEAR1, FLJ10759"	ENSG00000116525	"Tripartite motif containing 62"	Q9BVG3	1	33145402-33182059	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 9.5;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050061			Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Vesicles, Focal adhesion sites"		"HPA050061: AB_2681001"	"unprognostic (1.57e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-3)"	4.8	11.8	10.1	6.4	19.2	9.3	6.2	19.0	13.9	5.6	4.9	31.8	1.6	5.6	4.9	6.9	6.9	5.1	4.9	5.3	12.3	10.5	5.3	2.7	5.6	9.6	28.1	9.1	6.7	4.8	7.5	9.2	19.6	15.4	8.7	5.4	5.0	10.8	7.5	6.7	20.5	5.8	6.9	12.8	8.3	6.5	4.0	23.7	8.7	6.3	5.1	10.4	9.8	7.3	3.0	1.8	6.0	3.5	1.7	8.5	2.1	2.9	2.3	20.7	3.4	5.2	2.3	6.3	2.9	8.7	5.4	4.8	2.4	3.0	4.7	3.2	2.6	2.6	6.0	4.1	3.8	5.2	4.5	3.2	5.4	2.5	1.9	5.0	1.7	13.5	4.5	3.5	7.2	1.8	8.9	5.4	4.3	0.8	3.1	5.5	7.8	5.3	1.7	4.9	3.7	2.9	6.7	10.8	2.2	3.5	7.7	5.0	3.1	3.2	12.2	13.8	12.1	3.4	1.2	5.2	2.3	3.2	6.6	2.2	5.8	2.5	2.3	4.2	3.2	2.8	2.2	2.0	6.0	2.7	3.5	4.6	2.2	4.1	3.7	1.8	3.0	2.8	2.7	4.4	1.7	2.2	0.8	8.5	2.1	10.1	19.2	19.0	13.9	12.3	10.5	28.1	9.1	15.4	23.7	3.0	2.1	0.9	0.7	2.4	2.4	0.6	0.0	0.0	0.0	1.8	0.0	0.8	0.0	1.4	0.5	1.0	1.1	0.0	1.7	1.6	1.3	2.2	1.1	0.6	1.0	9.5	1.7	1.3	1.2	0.0	2.3	1.2	0.0	1.0	2.0	1.4	2.1	0.0	4.6	0.6	0.8	6.5	2.0	1.1	0.4	4.1	1.1	1.9	0.9	1.7
TRIM65		ENSG00000141569	"Tripartite motif containing 65"	Q6PJ69	17	75880335-75897003	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021575, HPA021578, HPA064820"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359"	"unprognostic (1.82e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.74e-6)"	"unprognostic (5.36e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.86e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-3)"	"unprognostic (7.50e-3)"	15.5	8.2	12.8	12.1	20.0	10.8	13.6	26.7	16.6	15.7	12.7	17.6	11.9	13.9	15.7	9.3	14.0	14.4	12.9	11.0	16.5	12.3	11.3	8.2	13.3	14.6	22.4	8.1	17.7	15.7	14.9	12.7	8.1	16.1	12.4	12.0	15.8	14.7	15.2	16.5	21.6	12.8	13.0	11.4	17.2	12.7	5.4	21.3	11.7	13.1	11.0	14.8	12.7	15.4	5.3	3.4	4.4	3.0	5.2	5.9	1.6	13.6	14.8	5.3	14.9	9.8	13.6	2.6	5.5	7.3	9.3	6.9	5.3	11.7	14.7	4.0	5.8	10.5	9.5	11.1	12.3	4.0	6.6	19.8	11.9	13.5	7.9	10.4	12.5	12.7	9.8	9.8	6.2	10.0	6.6	20.5	18.5	18.2	14.8	5.6	14.7	22.6	20.1	12.2	13.3	12.3	21.1	7.1	23.2	6.8	5.1	11.9	11.4	8.7	13.3	14.6	6.8	15.8	15.1	11.0	19.5	9.0	8.7	10.2	12.5	4.6	3.8	12.4	20.2	8.3	2.8	3.0	4.4	5.2	2.7	5.9	4.1	3.9	5.3	2.7	5.3	4.3	4.2	3.1	5.2	1.5	3.4	3.5	1.6	12.8	20.0	26.7	16.6	16.5	12.3	22.4	8.1	16.1	21.3	6.0	4.5	7.6	5.3	2.6	15.0	3.4	5.1	1.4	3.4	8.7	11.8	0.7	1.7	3.3	0.3	5.2	2.3	23.3	3.0	3.0	4.1	4.2	6.9	3.2	8.0	4.8	0.0	6.2	5.6	0.0	12.7	7.9	8.5	1.0	6.9	7.1	4.7	2.9	8.9	4.0	12.2	0.0	3.8	0.5	2.5	3.1	0.5	5.0	4.8	2.5
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 81.8;tongue: 34.0"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 15.9;Cardiomyocytes: 22.9;Sertoli cells: 12.9;Suprabasal keratinocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	16	"cerebellum: 21.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 4.9;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.4;HDLM-2: 24.1;PC-3: 13.3;TIME: 11.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	1.3	0.9	0.1	0.9	0.5	0.5	3.4	21.7	1.3	2.5	0.8	0.3	1.1	0.5	1.0	6.4	13.0	0.6	1.7	2.2	0.1	0.8	2.2	0.5	0.9	0.6	0.2	0.2	0.6	4.2	1.6	1.9	0.5	0.5	2.0	0.6	0.6	5.9	1.1	81.8	9.5	0.6	0.9	0.3	0.8	1.4	0.9	0.2	0.1	3.3	34.0	13.5	1.6	2.9	0.7	0.8	0.1	4.9	0.5	2.2	1.1	6.1	3.0	0.0	0.3	0.5	0.5	0.2	1.4	0.0	0.5	1.2	0.3	8.1	0.4	4.3	1.7	2.6	11.4	3.3	9.3	0.1	24.1	1.3	0.5	7.9	0.1	1.6	0.0	1.4	0.1	7.2	0.2	4.6	1.8	2.6	1.1	0.3	1.3	0.2	0.8	0.3	0.2	0.0	9.7	13.3	0.3	4.2	0.9	3.3	0.0	0.3	0.7	2.9	0.2	4.1	0.1	0.7	0.2	11.0	0.1	2.4	0.4	4.3	1.9	0.2	0.7	0.3	0.4	1.0	0.0	4.9	0.1	1.4	1.9	2.2	0.4	1.2	1.4	0.8	0.7	2.2	1.8	0.1	0.5	1.4	0.6	2.2	1.1	0.1	0.5	21.7	1.3	0.1	0.8	0.2	0.2	0.5	0.2	0.0	1.4	0.0	3.9	15.9	5.7	22.9	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.4	0.6	1.4	2.4	0.0	2.0	0.4	0.8	1.8	0.0	0.2	1.1	0.0	0.0	1.8	9.4	0.0	0.9	1.6	1.7	0.0	3.1	0.5	3.2	8.5	1.4	1.1	2.7	12.9	9.0	0.9	0.4	24.8	0.0	0.0	2.2	2.4
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32818018-32897826	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 6.5;testis: 11.1"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 8.9;Extravillous trophoblasts: 13.2;Spermatogonia: 12.6"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.9;BEWO: 36.1;Hep G2: 23.3;NTERA-2: 31.9;SuSa: 30.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.1	0.0	0.7	0.1	1.9	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.7	2.2	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.5	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.6	0.0	23.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.2	2.5	31.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.0	0.5	2.7	0.7	0.2	0.0	1.9	0.0	8.9	2.6	0.0	0.0	0.0	0.4	2.8	0.0	1.4	3.4	0.0	0.0	3.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.9	0.4	0.0	0.0	0.3	12.6	0.0	3.3	0.0	0.0	0.0
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214021-31231537	"Predicted intracellular proteins, Transporters"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 71.6;tongue: 37.7"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Club cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	12	"cerebellum: 3.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 4.8;LHCN-M2: 8.9;RH-30: 23.1;U-266/70: 14.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	2.3	0.1	0.1	0.1	0.2	0.3	0.1	3.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	5.5	1.8	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	71.6	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.2	37.7	1.9	0.0	0.0	2.0	1.9	4.9	1.3	2.1	1.3	0.4	0.1	0.2	0.2	0.3	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.7	0.3	0.2	4.8	0.2	1.0	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.5	8.9	0.2	0.1	0.4	0.2	0.1	0.3	0.3	23.1	3.0	0.0	0.3	1.9	0.2	0.2	0.3	0.1	0.3	0.2	2.0	0.1	0.2	0.3	0.2	0.1	14.4	1.2	0.2	0.2	0.4	0.2	4.5	1.3	1.5	1.1	1.2	1.0	1.3	1.0	0.9	0.8	2.0	1.3	1.3	4.9	2.1	1.2	1.9	0.8	0.4	0.1	0.2	3.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	6.7	0.0	2.0	0.1	0.8	2.6	0.0	0.0	4.5	0.0	2.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.2	1.4	1.1	0.0	0.2	0.0	0.0	0.6	1.9	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	1.6
TRIM74	"MGC45440, TRIM50C"	ENSG00000155428	"Tripartite motif containing 74"	Q86UV6	7	72959485-72969466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 10.9"	"Cell type enhanced"	"Detected in single"	22	"Ciliated cells: 1.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 7.7;Hep G2: 5.4"									HPA047843			Approved	Cytosol		NA	NA			Cytosol		"HPA047843: AB_2680176"	"unprognostic (8.78e-3)"	"unprognostic (3.78e-4)"	"unprognostic (5.84e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.78e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-3)"	1.1	1.6	0.6	1.0	1.4	1.7	1.0	4.8	0.7	1.1	0.5			2.4	1.3	2.5	0.4	2.3	0.8	0.5	0.6	0.8	1.3	2.3	0.6	1.9	0.4		1.7	5.0	0.2	1.6	0.1		1.6	0.5		1.2	1.0	0.8	1.5	1.2	0.8	0.7	1.6	10.9	6.0			1.5		0.5	0.4	1.0	2.2	0.2	0.7	0.1	0.0	1.1	0.0	0.0	0.3	1.4	1.5	0.5	0.0	0.0	0.8	0.0	0.2	0.5	2.0	1.5	1.0	0.2	0.0	0.5	0.7	0.1	0.1	0.1	0.8	7.7	1.2	0.0	5.4	0.2	2.4	3.3	0.8	0.3	0.0	0.4	1.1	0.0	1.9	1.0	4.6	0.1	2.2	0.9	3.8	0.1	0.0	1.7	1.7	0.6	0.8	2.2	0.8	0.6	0.7	0.8	0.0	1.7	0.2	0.1	1.1	2.7	0.3	1.0	0.5	0.0	3.5	2.7	0.6	1.2	1.4	0.7	0.7	0.0	0.7	1.0	0.0	1.1	2.2	0.7	0.2	0.0	0.1	0.8	0.2	0.0	0.0	0.1	0.2	0.5	0.0											0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 9.8;testis: 6.2"	"Cell type enhanced"	"Detected in some"	17	"Cytotrophoblasts: 13.9;Early spermatids: 18.8;Extravillous trophoblasts: 5.5;Syncytiotrophoblasts: 7.4"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 58.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.1	0.1	0.2	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	9.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	12.6	0.0	0.0	0.0	0.0	7.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	0.3	2.4	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	58.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	18.8	0.0	0.0	0.0	0.0	5.5	0.3	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.5	0.0	7.4	0.0	0.0	0.3
TRIO	ARHGEF23	ENSG00000038382	"Trio Rho guanine nucleotide exchange factor"	O75962	5	14143702-14532128	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008157, HPA064664"	Supported		Approved	Vesicles,Cytosol		No	No			Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: AB_2685315"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.23e-1)"	29.7	13.7	27.6	15.8	18.9	5.8	30.3	32.6	29.7	13.7	18.5	11.3	9.2	8.3	23.1	19.3	10.4	12.2	25.2	15.1	18.9	15.0	11.7	12.6	15.8	10.9	11.0	17.7	28.9	11.5	17.2	19.6	13.7	12.3	16.3	16.5	23.3	10.5	14.0	19.8	16.0	15.6	22.7	11.6	24.2	13.7	11.3	11.5	7.4	10.0	11.9	12.3	15.6	16.9	3.8	2.7	0.3	1.9	4.3	0.6	0.4	12.3	4.4	10.7	5.1	23.0	30.2	12.3	11.5	13.7	9.2	10.6	2.8	4.9	2.8	8.6	15.5	22.5	3.8	1.8	5.4	19.1	7.9	2.5	1.5	12.0	3.5	11.9	3.8	4.3	14.1	5.7	32.5	10.4	8.7	8.1	1.9	0.3	1.9	22.3	2.3	0.0	2.6	2.7	1.3	4.0	2.8	6.5	9.5	9.0	5.6	4.9	19.7	9.7	2.5	5.1	14.1	1.5	0.6	18.8	17.8	11.3	12.9	13.5	0.0	0.6	3.6	63.2	2.5	4.2	0.3	1.5	0.0	0.1	1.9	0.3	2.0	0.0	0.0	1.4	3.8	0.0	0.0	0.0	4.3	1.4	2.7	0.6	0.4	27.6	18.9	32.6	29.7	18.9	15.0	11.0	17.7	12.3	11.5	17.9	23.4	9.0	13.2	14.5	29.9	15.7	10.2	16.0	22.7	10.4	13.7	7.6	0.0	18.3	1.9	24.8	13.6	0.0	12.1	17.8	12.4	32.5	17.3	15.3	13.2	27.0	17.3	11.1	12.3	2.4	72.8	16.8	5.0	6.4	21.7	7.1	29.1	16.1	40.3	2.9	3.0	6.5	11.5	2.8	6.4	12.0	6.9	4.6	17.1	20.1
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751526	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.7"	"Cell type enhanced"	"Detected in many"	10	"monocytes: 342.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 19.4"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 19.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		15000	Vesicles	Nucleoplasm	"HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244"	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	19.7	10.7	6.0	9.2	7.2	2.3	16.8	3.7	5.4	25.6	19.1	4.5	20.6	9.7	17.8	16.7	44.8	12.0	17.6	18.1	6.5	1.9	14.0	4.5	19.5	5.4	6.7	3.5	22.4	12.9	7.0	4.8	25.4	7.0	19.2	6.6	20.2	16.1	18.3	103.7	10.4	10.1	20.9	6.7	7.1	11.3	8.7	5.4	2.8	31.7	21.6	21.7	24.3	26.5	1.5	19.4	0.1	0.7	1.6	0.9	0.4	26.8	16.3	5.7	8.6	22.5	23.7	20.6	17.4	20.1	19.9	17.4	22.1	15.5	0.5	23.5	14.6	16.1	20.0	12.9	25.3	11.8	16.9	5.2	8.7	15.4	16.8	18.5	0.4	2.8	27.3	17.2	17.7	13.6	26.3	20.4	1.2	12.7	7.4	14.5	9.1	2.3	6.0	12.1	16.8	13.9	3.9	11.8	7.8	16.7	13.4	0.0	6.6	22.8	10.3	6.5	13.9	10.7	4.7	39.7	13.4	24.0	34.9	18.2	7.8	4.2	2.6	21.7	2.5	8.7	0.0	0.7	0.0	0.5	0.1	0.7	1.2	0.2	0.9	3.8	1.5	0.3	0.2	0.1	1.6	0.1	19.4	0.0	0.4	6.0	7.2	3.7	5.4	6.5	1.9	6.7	3.5	7.0	5.4	26.8	20.3	3.7	99.7	75.9	13.2	7.5	17.8	9.4	30.7	15.7	35.3	6.1	5.0	41.3	9.7	37.9	25.1	0.0	33.6	32.8	73.7	86.2	27.8	3.4	8.7	0.0	7.5	38.1	4.0	10.0	51.8	30.9	35.4	342.7	15.5	11.4	60.8	24.3	33.9	18.2	16.8	32.3	85.5	1.9	5.9	72.8	11.9	4.3	21.7	106.3
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: AB_2686295"	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	13.0	15.0	10.5	10.8	12.5	7.7	12.1	18.5	14.1	17.4	13.0	8.8	15.2	11.1	13.3	12.7	14.7	11.4	11.2	12.9	9.2	6.7	15.5	16.1	10.6	9.4	12.2	11.1	16.0	27.1	27.1	34.9	24.4	15.2	14.5	11.0	9.4	15.1	15.3	24.0	12.4	15.9	11.2	10.7	15.2	16.2	14.0	13.5	16.4	18.4	11.1	11.9	15.8	12.5	20.0	12.7	17.0	13.0	12.1	14.1	3.9	12.5	12.8	8.3	8.8	14.7	22.8	12.6	20.0	15.4	10.0	11.4	7.7	20.5	8.8	14.8	17.6	7.8	16.6	10.9	9.7	21.8	13.4	3.3	9.9	11.5	7.3	11.2	11.6	9.9	8.7	11.9	17.6	15.1	11.1	15.8	4.9	6.5	10.2	15.5	17.6	6.6	2.9	3.8	12.3	9.2	8.2	16.0	4.4	8.9	20.6	6.1	5.5	16.2	9.5	6.2	8.8	20.8	5.9	20.9	11.6	8.2	12.0	9.0	9.1	13.9	8.0	13.6	6.6	14.5	8.2	8.8	17.0	13.3	8.0	12.8	11.8	14.1	12.1	6.9	20.0	13.5	14.1	8.7	12.1	13.0	12.7	12.2	3.9	10.5	12.5	18.5	14.1	9.2	6.7	12.2	11.1	15.2	13.5	50.6	65.6	24.1	27.5	14.7	56.7	99.6	35.7	71.0	62.6	36.6	68.7	34.2	14.9	55.0	10.9	42.7	24.5	0.0	40.6	23.8	31.0	32.3	35.9	30.6	22.0	41.3	30.9	30.7	25.7	8.5	57.5	21.2	6.8	33.3	38.0	54.1	40.4	28.1	50.9	21.4	64.7	58.2	23.7	107.2	64.1	14.9	60.6	21.0	28.1	33.1
TRIP12	KIAA0045	ENSG00000153827	"Thyroid hormone receptor interactor 12"	Q14669	2	229763838-229923239	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036835, HPA045893"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036835: AB_2675340, HPA045893: AB_2679486"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.49e-3)"	"unprognostic (4.87e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.01e-2)"	29.6	28.1	23.6	25.4	26.9	26.9	23.1	20.5	26.2	24.0	23.1	26.2	24.3	14.3	25.3	26.3	30.6	19.9	20.7	35.9	19.0	19.3	26.2	24.9	26.2	26.5	23.1	20.5	24.3	18.8	32.4	33.1	27.2	24.8	25.8	21.3	22.3	25.5	22.0	62.7	23.6	22.0	26.2	23.3	32.5	23.4	77.1	24.0	42.2	28.0	21.5	31.5	26.5	27.4	7.0	9.1	25.8	12.0	9.1	12.7	6.1	24.1	27.3	25.1	21.0	23.9	29.1	23.3	37.4	25.3	27.1	30.2	21.9	19.4	9.4	27.4	33.3	34.8	18.9	36.5	26.6	39.7	38.7	13.3	65.8	22.9	19.3	20.7	49.4	43.0	25.2	20.5	45.0	28.9	21.1	35.3	23.8	48.6	10.2	30.9	18.4	27.6	17.1	19.6	12.3	12.5	25.1	49.5	8.3	20.1	41.6	25.5	18.2	0.5	12.5	25.7	22.8	12.7	30.3	49.0	35.2	25.0	22.8	28.8	17.7	20.2	30.9	26.8	19.5	29.4	18.8	9.9	15.7	9.5	11.3	9.7	7.0	8.8	9.2	9.1	6.8	7.3	7.0	25.8	9.1	12.0	9.0	12.7	6.1	23.6	26.9	20.5	26.2	19.0	19.3	23.1	20.5	24.8	24.0	83.4	49.3	17.2	24.2	27.5	29.6	80.3	38.2	65.6	51.2	29.6	49.1	23.6	13.3	31.9	89.6	47.2	37.6	0.0	38.7	20.9	28.2	43.4	37.1	48.3	30.9	39.7	17.9	58.3	81.5	79.5	32.2	36.5	25.3	26.2	30.2	28.2	45.3	32.3	42.8	26.2	32.5	19.4	30.1	113.9	53.0	31.7	35.5	27.7	25.5	54.5
TRIP13	16E1BP	ENSG00000071539	"Thyroid hormone receptor interactor 13"	Q15645	5	892643-919357	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.4;testis: 52.9"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 109.7;Early spermatids: 114.7;Late spermatids: 165.0;Spermatocytes: 66.2;Spermatogonia: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005727, HPA053093"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005727: AB_10603220, HPA053093: AB_2682042"	"unprognostic (1.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (2.34e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.44e-3)"	"unprognostic (1.73e-3)"	"prognostic favorable (1.39e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.34e-1)"	1.5	0.9	1.7	8.6	1.2	3.4	1.7	0.6	1.6	1.6	2.7	0.4	1.4	2.4	1.6	1.9	5.3	4.9	2.4	1.2	1.4	1.7	1.3	0.8	1.5	4.7	0.6	0.6	2.1	1.0	0.0	1.9	2.8	1.0	1.0	4.5	0.4	1.3	1.0	0.6	1.4	2.5	2.5	0.7	3.8	1.4	52.9	0.3	16.4	0.5	8.8	6.3	1.1	1.8	2.7	2.3	0.0	0.3	3.3	4.8	0.9	19.5	22.6	14.7	20.8	1.3	3.3	15.4	20.6	10.3	32.8	30.8	21.2	13.5	17.6	14.8	12.1	28.5	14.3	31.1	14.7	41.0	26.3	24.2	12.3	42.5	15.4	0.3	19.9	7.3	1.4	1.0	27.3	11.9	3.4	16.0	14.2	18.0	15.6	22.3	13.3	19.3	16.5	16.1	11.5	19.7	11.6	27.3	32.8	8.7	10.5	14.6	15.0	31.3	11.3	6.0	13.3	21.8	9.3	8.1	17.5	21.7	14.2	22.9	9.2	20.0	19.1	10.3	22.8	19.0	0.0	0.1	0.0	1.0	0.1	0.5	2.7	1.4	1.9	0.3	2.1	0.6	0.2	0.0	3.3	0.3	2.3	4.8	0.9	1.7	1.2	0.6	1.6	1.4	1.7	0.6	0.6	1.0	0.3	0.0	1.4	3.7	3.5	3.1	0.6	0.2	0.0	109.7	4.5	0.0	0.0	3.6	0.0	3.1	114.7	1.4	0.8	0.0	1.6	20.1	1.9	2.1	5.7	0.2	6.2	3.2	4.1	3.1	1.5	165.0	2.0	3.2	0.0	1.8	2.4	0.8	1.8	1.5	2.1	1.0	0.7	6.5	0.3	66.2	77.5	1.3	2.9	4.3	2.8	2.0
TRIP6	"MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1"	ENSG00000087077	"Thyroid hormone receptor interactor 6"	Q15654	7	100867138-100873454	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046454, CAB046460, HPA052813"	Approved		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		12000	"Plasma membrane, Focal adhesion sites, Cytosol"		"CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961"	"unprognostic (7.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	15.5	14.7	10.9	16.2	11.2	6.0	18.1	4.2	7.3	36.7	14.6	9.4	22.5	4.4	28.2	30.8	27.2	18.5	43.5	14.5	8.7	7.7	21.6	24.1	18.4	5.8	11.7	9.4	22.0	19.2	28.0	6.5	13.6	9.7	22.1	3.9	22.7	23.0	38.2	8.3	23.9	6.5	25.5	9.7	7.9	9.9	17.5	7.8	7.3	26.6	30.6	12.6	25.0	23.6	3.1	7.7	0.2	4.7	0.0	1.7	0.5	27.0	11.2	5.8	27.7	8.8	10.2	29.1	16.9	18.1	23.2	21.8	10.5	31.2	1.1	17.8	19.0	28.9	20.2	8.5	32.5	5.9	3.9	11.5	0.1	18.6	0.1	23.2	13.0	1.6	18.5	21.4	15.4	24.2	13.7	11.9	4.1	17.0	0.2	20.0	47.5	0.2	20.5	20.0	11.1	10.0	10.2	5.8	2.7	14.3	6.7	2.1	0.3	14.1	42.7	16.8	9.0	4.5	16.6	18.2	34.1	32.1	36.9	39.4	0.2	0.4	0.1	21.2	1.6	51.3	0.0	1.9	0.2	0.2	3.0	0.6	3.1	1.5	1.3	3.1	2.5	1.7	0.7	0.2	0.0	4.7	7.7	1.3	0.5	10.9	11.2	4.2	7.3	8.7	7.7	11.7	9.4	9.7	7.8	44.7	35.0	7.5	130.2	117.2	0.0	14.4	38.2	10.7	37.5	57.6	0.0	99.2	68.0	79.4	0.8	30.6	3.6	0.0	73.3	72.2	63.2	50.1	8.1	26.8	40.2	1.6	4.7	19.6	7.0	2.2	60.9	26.5	35.4	31.5	10.3	87.6	78.1	10.5	68.2	104.6	3.3	71.1	72.2	0.9	2.5	85.9	111.1	6.1	17.5	140.8
TRIR	"C19orf43, fSAP18, MGC2803, TERCIR"	ENSG00000123144	"Telomerase RNA component interacting RNase"	Q9BQ61	19	12730640-12734775	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 325.2;Exocrine glandular cells: 329.0;Extravillous trophoblasts: 428.3;monocytes: 432.0;Pancreatic endocrine cells: 322.0;Proximal tubular cells: 402.3;Syncytiotrophoblasts: 484.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059965	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059965: AB_2684182"	"unprognostic (5.57e-2)"	"unprognostic (2.73e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.02e-2)"	58.6	48.6	51.6	64.7	48.9	62.7	53.7	46.3	51.2	61.9	66.0	33.6	45.5	46.8	49.7	68.4	60.0	37.8	59.2	51.5	45.8	41.4	49.1	97.1	45.4	51.8	47.1	39.3	62.3	53.8	31.4	40.2	62.1	31.3	60.4	40.4	36.7	55.6	48.0	77.3	42.5	55.6	47.6	45.1	65.1	48.4	45.8	32.6	87.1	59.5	39.0	59.1	62.2	80.7	24.7	13.6	33.8	10.9	10.6	16.1	5.6	44.5	24.1	30.2	22.3	24.4	26.0	29.2	38.0	23.4	29.2	28.6	31.8	15.7	35.4	49.8	22.5	23.9	30.9	30.2	24.1	23.7	40.2	58.2	23.7	27.4	51.6	23.8	34.1	45.0	26.3	29.7	22.2	17.8	24.6	27.6	25.7	32.7	14.8	26.9	96.4	56.5	80.4	34.4	26.0	68.6	49.2	23.7	35.4	34.1	30.5	34.3	45.8	26.0	26.7	42.7	20.8	23.2	52.6	28.5	35.2	28.2	54.7	48.5	49.6	53.2	39.5	29.8	41.7	24.6	8.0	10.9	33.8	11.4	9.3	13.3	24.7	14.8	14.6	9.7	17.5	14.0	12.5	21.0	10.6	8.7	13.6	16.1	5.6	51.6	48.9	46.3	51.2	45.8	41.4	47.1	39.3	31.3	32.6	65.5	65.4	0.0	0.0	0.0	0.0	0.0	0.0	56.2	62.6	174.5	0.0	325.2	230.5	276.3	0.0	0.0	0.0	0.0	329.0	428.3	0.0	0.0	23.3	0.0	314.8	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	432.0	0.0	0.0	322.0	0.0	0.0	402.3	0.0	0.0	0.0	0.0	0.0	0.0	484.5	0.0	0.0	0.0
TRMO	"C9orf156, HSPC219"	ENSG00000136932	"TRNA methyltransferase O"	Q9BU70	9	97904489-97922570	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021281, HPA052197"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021281: AB_2670649, HPA052197: AB_2681758"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-2)"	"prognostic favorable (4.81e-10)"	"unprognostic (1.97e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.39e-2)"	12.2	15.9	13.6	22.5	14.2	20.4	19.3	15.9	14.9	13.5	10.0	19.2	14.9	9.4	15.1	17.3	12.9	15.0	10.6	9.1	13.0	12.3	13.9	17.6	17.9	23.0	14.2	16.3	13.9	13.7	15.7	26.7	10.4	13.3	14.0	11.6	13.4	19.7	11.7	14.1	15.0	14.8	10.1	15.0	20.8	12.8	18.2	14.2	22.8	26.1	10.3	19.1	11.9	10.7	15.8	13.4	28.8	13.7	11.9	25.8	12.0	14.9	9.6	5.2	6.3	6.5	5.4	9.0	7.7	8.8	12.2	9.2	13.3	10.9	9.5	5.3	7.4	13.8	14.2	8.4	6.1	9.6	11.2	6.9	7.6	11.6	11.8	13.6	14.7	12.8	9.5	13.6	6.6	5.7	7.4	5.4	7.6	12.2	12.1	8.4	21.7	6.2	10.2	7.2	16.3	10.8	7.6	11.5	6.9	11.4	12.2	9.4	8.2	5.8	12.2	12.4	4.6	5.3	8.2	8.1	6.8	6.8	14.1	11.5	13.4	9.5	4.8	7.1	7.7	5.9	20.1	12.8	28.8	12.9	13.7	15.9	11.9	19.8	15.5	13.4	15.8	25.8	17.9	20.9	11.9	9.1	7.8	20.2	12.0	13.6	14.2	15.9	14.9	13.0	12.3	14.2	16.3	13.3	14.2	11.9	4.0	7.8	13.4	0.0	8.7	0.0	7.6	10.7	12.5	5.2	0.0	7.7	6.6	7.8	27.5	3.7	2.6	0.0	8.5	6.1	4.1	4.9	0.0	6.4	9.5	6.4	2.4	3.1	8.9	10.5	4.6	2.8	0.0	8.2	7.0	11.6	8.4	7.0	6.7	7.0	4.2	6.5	0.0	14.8	14.5	0.0	15.3	10.2	4.9	6.4
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	15.5	15.0	19.1	19.8	23.5	23.1	16.6	19.5	22.6	15.0	16.3	17.3	15.5	14.9	19.2	19.0	17.6	19.6	19.4	13.2	15.7	13.4	14.4	17.3	13.5	26.8	22.1	14.7	29.1	23.8	16.3	14.4	14.4	21.9	18.1	14.5	10.9	14.9	15.6	21.4	22.1	16.1	16.5	12.4	25.0	16.3	16.8	20.1	12.2	15.6	12.1	19.6	17.3	18.8	11.2	14.9	3.1	15.7	4.3	10.2	8.5	15.4	10.4	11.3	19.2	11.5	14.8	16.2	17.4	8.7	19.2	16.7	11.1	12.7	19.4	22.8	9.3	10.0	14.3	18.9	15.3	8.9	12.6	26.4	15.4	26.8	18.7	20.9	30.8	18.2	20.9	20.6	19.9	18.8	12.3	14.1	14.5	33.3	6.2	11.9	17.1	12.5	33.3	26.8	9.8	24.5	21.1	14.6	26.7	11.9	15.7	26.9	12.2	10.8	22.6	18.1	8.6	8.8	17.3	15.6	27.7	10.8	16.7	30.4	10.8	20.8	17.9	12.9	32.7	14.4	1.2	15.7	0.5	8.1	11.9	7.7	10.4	8.6	7.7	14.9	11.2	10.2	7.7	3.1	4.3	7.5	8.8	5.6	8.5	19.1	23.5	19.5	22.6	15.7	13.4	22.1	14.7	21.9	20.1	11.9	16.2	35.0	22.3	21.3	8.0	6.4	12.7	10.7	4.5	12.2	2.0	19.4	5.0	14.1	16.4	17.5	6.3	0.0	12.8	18.8	13.9	10.4	28.9	8.6	41.5	7.9	6.9	7.4	88.1	36.5	13.0	39.6	16.9	23.4	9.6	5.8	12.2	5.8	12.0	11.2	11.1	12.9	16.5	21.7	18.3	18.1	12.9	18.7	17.4	18.4
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	7.4	10.3	9.9	10.9	10.3	10.1	9.8	13.7	12.3	10.6	11.8	12.7	12.8	8.3	17.3	9.5	10.4	9.6	10.6	7.0	9.9	9.2	8.2	8.0	8.6	13.1	16.4	9.8	15.4	10.5	9.0	13.8	7.4	10.0	14.8	7.1	12.1	10.3	12.1	7.8	20.4	9.7	11.8	12.7	12.1	10.8	5.0	10.4	10.0	12.4	5.6	13.6	14.8	10.1	9.2	4.6	6.6	5.3	4.6	7.6	2.7	5.3	6.3	8.2	7.3	5.0	4.1	3.8	5.3	3.8	5.4	4.7	3.8	4.7	10.0	3.9	4.0	3.2	6.2	3.9	6.4	4.9	4.3	6.9	8.7	15.6	3.9	9.2	8.9	6.3	4.7	6.6	4.7	9.1	6.5	5.5	12.1	7.0	4.4	4.1	3.8	9.1	7.0	7.3	5.6	7.8	9.3	2.9	5.2	5.2	4.9	11.2	10.8	4.3	5.4	4.7	5.4	5.9	6.5	5.4	4.2	6.1	6.7	4.6	5.0	6.8	7.9	2.5	7.1	8.5	6.6	5.3	2.8	6.7	4.6	7.6	6.6	6.0	6.3	2.5	9.2	7.3	6.7	5.4	4.6	3.2	4.6	3.9	2.7	9.9	10.3	13.7	12.3	9.9	9.2	16.4	9.8	10.0	10.4	3.0	6.2	23.8	10.8	6.5	15.5	7.4	10.2	8.1	9.1	3.5	5.9	13.3	10.0	9.6	1.6	12.0	7.8	23.3	11.0	7.0	7.4	11.1	13.9	6.6	7.2	15.9	13.3	9.2	11.4	0.2	13.6	12.3	10.1	7.2	12.9	12.8	8.8	7.0	22.3	6.7	12.8	25.8	8.6	4.4	3.2	6.6	10.2	19.2	9.0	7.8
TRMT11	"C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1"	ENSG00000066651	"TRNA methyltransferase 11 homolog"	Q7Z4G4	6	125986430-126039276	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030473			Approved	"Nuclear bodies"		Yes	No			"Nuclear bodies"		"HPA030473: AB_2673493"	"unprognostic (2.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-1)"	10.0	12.6	14.3	12.5	17.7	3.6	15.5	33.9	19.4	17.9	12.6	9.4	11.2	16.1	25.9	15.1	13.2	12.8	12.9	16.1	15.0	12.6	18.8	28.0	10.1	12.4	12.7	16.4	19.2	10.4	15.9	38.1	13.3	15.4	12.8	15.0	14.8	11.7	13.8	10.6	7.4	20.6	15.7	15.2	9.6	12.9	9.8	11.1	8.0	18.0	9.8	13.7	11.5	12.5	8.0	4.7	1.3	2.0	7.5	11.7	4.0	8.6	6.5	13.2	2.8	6.9	7.5	7.8	7.4	11.3	8.1	12.0	19.9	9.1	12.2	13.6	4.8	17.0	12.0	14.3	7.5	12.4	9.8	20.5	9.5	12.9	24.8	11.9	15.6	2.6	7.5	7.2	9.5	15.6	12.8	3.6	5.2	21.6	2.4	8.4	13.2	7.2	8.2	9.3	8.6	8.3	4.9	10.0	7.3	9.5	5.4	16.6	7.8	9.1	8.3	16.1	9.8	6.5	12.6	3.6	5.4	4.1	12.4	12.9	6.7	0.7	3.3	11.0	12.1	9.4	1.3	2.0	0.0	6.8	1.5	11.7	8.0	9.1	7.5	4.1	6.7	11.4	10.4	0.3	7.5	0.7	4.7	6.8	4.0	14.3	17.7	33.9	19.4	15.0	12.6	12.7	16.4	15.4	11.1	6.0	22.4	12.3	23.6	11.8	57.1	11.4	20.4	25.4	25.0	7.0	68.7	16.7	16.6	15.9	7.7	10.5	8.0	0.0	14.1	12.2	17.6	11.7	18.4	21.5	6.4	19.1	8.7	4.9	6.5	3.0	23.9	6.9	3.3	14.4	9.6	20.7	12.4	14.0	23.0	23.3	75.1	6.5	12.1	9.5	7.0	8.8	12.5	5.7	12.8	16.0
TRMT112	"HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2"	ENSG00000173113	"TRNA methyltransferase subunit 11-2"	Q9UI30	11	64316460-64318084	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039901, HPA040006"	Uncertain		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA039901: AB_10796334, HPA040006: AB_10793859"	"unprognostic (1.48e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (6.08e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.28e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-2)"	44.2	77.0	41.9	40.9	37.6	48.3	57.9	30.9	48.5	52.8	39.2	33.5	38.4	25.9	50.9	58.6	54.2	68.1	49.4	47.4	37.4	51.8	47.4	68.6	41.7	58.2	42.8	34.3	81.9	53.4	36.3	54.0	54.5	35.1	55.7	26.9	50.0	44.5	50.5	53.6	38.6	28.6	50.3	38.7	52.7	35.6	54.6	31.0	64.7	85.5	55.2	57.3	56.2	62.8	132.1	97.2	92.4	58.5	53.2	98.2	112.6	55.2	81.2	27.2	41.5	26.2	21.5	28.3	25.0	24.9	25.3	20.3	41.6	54.4	39.1	80.5	20.8	49.3	46.9	40.9	45.4	19.4	48.8	45.9	43.6	73.3	97.6	29.2	34.9	30.6	25.7	46.4	22.8	43.3	33.7	25.6	29.3	36.6	53.7	23.7	147.4	52.5	71.2	75.8	38.5	71.1	31.6	30.4	58.3	29.3	58.0	18.2	85.4	34.6	43.0	75.3	26.5	69.3	33.4	24.2	32.4	41.1	56.1	49.0	44.7	73.3	65.1	44.2	36.2	34.4	92.4	58.5	81.7	67.6	47.2	69.2	132.1	88.5	74.6	59.3	112.8	98.2	85.3	69.7	53.2	42.3	97.2	77.4	112.6	41.9	37.6	30.9	48.5	37.4	51.8	42.8	34.3	35.1	31.0	148.9	141.4	296.9	372.8	310.8	83.7	116.1	109.5	184.7	136.5	260.0	21.6	493.9	416.1	187.8	41.9	242.2	75.4	93.5	194.0	407.3	280.9	262.1	212.4	203.5	342.2	49.3	148.3	151.6	168.6	45.5	277.3	210.4	318.9	410.2	121.7	120.6	209.3	112.3	205.4	428.2	59.7	213.4	272.5	160.9	491.0	346.4	344.5	233.3	139.2	362.3
TRMT12	"FLJ20772, Trm12, TYW2"	ENSG00000183665	"TRNA methyltransferase 12 homolog"	Q53H54	8	124450820-124462150	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.2"	"Low region specificity"	"Detected in all"							HPA023939	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA023939: AB_1848793"	"unprognostic (2.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.99e-5)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.25e-4)"	"unprognostic (1.04e-2)"	10.8	11.6	16.7	8.4	20.9	4.1	15.0	13.8	18.3	11.8	9.5	8.0	6.8	7.5	11.9	10.7	9.6	13.2	8.6	9.9	19.4	9.9	12.9	9.8	9.8	11.8	13.6	14.3	8.8	10.1	14.7	17.7	8.9	14.7	12.0	11.2	7.8	12.0	11.0	18.0	9.9	9.6	14.3	12.9	11.0	10.6	11.7	13.4	9.1	14.9	12.0	10.7	10.2	8.5	5.8	5.0	6.3	6.1	5.1	7.6	4.4	7.4	6.5	5.4	4.2	10.3	5.3	1.3	4.7	5.6	7.0	6.0	4.0	5.2	7.6	6.6	4.8	4.5	5.2	7.7	7.8	8.3	7.5	5.9	7.3	6.2	1.3	8.1	0.0	6.0	6.6	10.4	6.8	8.7	2.0	5.8	8.0	10.2	5.3	4.3	37.2	8.6	3.1	0.0	17.4	6.1	2.7	3.6	5.0	6.4	8.1	9.2	7.4	7.0	26.2	9.8	4.8	7.4	3.1	4.6	4.9	12.8	3.6	5.3	5.5	7.7	2.9	4.4	2.6	3.9	0.5	6.1	6.3	4.5	4.9	5.6	4.0	6.1	4.6	5.0	5.8	7.6	7.4	2.4	5.1	5.5	1.5	3.7	4.4	16.7	20.9	13.8	18.3	19.4	9.9	13.6	14.3	14.7	13.4	8.9	6.9	5.9	5.4	4.6	5.6	2.7	7.6	8.1	1.2	3.5	15.7	5.8	5.0	4.9	11.1	5.2	3.6	0.0	5.4	4.5	3.3	3.4	9.2	5.1	4.5	7.9	2.9	3.7	3.2	14.2	3.7	3.3	5.0	2.8	4.2	3.9	3.6	3.5	5.6	6.6	8.3	0.0	5.5	10.7	3.8	3.8	4.1	4.3	3.7	4.3
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150497	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	13.0	12.2	13.9	21.7	24.1	5.9	18.3	26.5	22.5	17.4	13.1	18.2	24.2	13.6	17.4	15.4	13.7	13.9	9.6	12.0	14.4	9.0	12.1	13.0	9.6	20.9	23.1	12.8	21.4	18.1	23.8	26.8	13.2	15.6	14.9	14.4	10.8	14.3	17.4	16.9	17.9	14.2	14.3	19.4	16.5	12.6	11.1	25.8	17.8	16.5	12.0	17.6	13.9	15.8	15.1	9.6	2.2	4.5	5.4	13.6	3.9	10.7	6.3	10.6	7.4	5.7	11.3	11.7	11.4	4.5	8.7	7.3	7.5	4.5	17.8	14.2	9.0	5.8	9.8	19.5	8.8	15.1	17.9	15.5	10.6	13.9	7.2	10.4	18.3	10.0	7.8	10.1	16.4	21.7	5.5	7.9	13.3	22.2	11.5	8.7	4.1	14.9	9.7	14.8	10.4	12.7	16.0	16.1	9.7	7.1	8.6	6.9	11.6	10.5	10.1	13.4	10.9	5.9	16.3	8.2	11.6	7.8	9.7	15.1	14.8	11.9	21.1	13.1	14.7	4.4	0.1	4.5	2.2	8.5	4.4	10.4	14.8	9.0	8.3	5.2	15.1	13.6	11.1	1.9	5.4	3.5	9.6	6.2	3.9	13.9	24.1	26.5	22.5	14.4	9.0	23.1	12.8	15.6	25.8	23.8	13.4	31.3	12.1	8.7	36.7	10.0	17.8	25.4	28.4	14.0	27.5	11.7	11.6	9.2	7.7	11.7	9.1	0.0	5.2	8.8	10.8	10.7	20.8	9.9	6.7	27.0	19.5	17.2	6.1	4.3	23.0	9.9	10.1	8.2	8.1	19.7	7.8	12.5	17.3	8.4	45.1	19.4	12.2	36.3	22.8	10.5	6.1	19.7	13.2	8.4
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118098-185157072	"Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	7.6	12.9	9.4	10.1	12.8	5.9	8.9	14.2	11.3	10.5	10.0	9.6	9.6	9.6	9.3	11.3	10.5	12.6	8.2	13.2	10.3	10.6	15.3	16.0	10.3	11.1	11.2	9.1	13.7	8.3	18.0	26.9	9.7	11.9	11.7	8.5	5.2	7.6	10.0	27.4	5.5	8.7	8.5	12.4	12.8	8.4	29.4	12.8	16.5	12.4	7.6	13.0	11.8	12.2	16.2	12.1	19.0	15.8	11.0	12.7	8.1	7.8	14.5	10.0	7.5	14.8	13.6	14.2	7.6	6.9	10.4	11.0	13.1	15.2	8.6	19.1	5.2	16.0	10.2	16.8	10.0	10.3	10.2	7.3	8.2	11.0	13.3	10.3	12.1	13.7	6.5	13.6	10.6	10.8	11.1	11.4	11.7	21.6	11.9	12.4	6.6	9.2	7.1	16.5	16.2	3.0	10.9	14.4	13.7	10.0	8.8	8.9	7.9	14.8	14.5	10.3	23.9	14.8	6.8	11.0	9.6	7.7	6.6	10.2	19.1	25.6	13.7	6.3	10.8	9.2	16.8	9.8	19.0	7.4	13.4	7.9	11.7	9.7	8.9	12.1	16.2	12.2	9.5	11.1	11.0	15.8	5.1	12.7	8.1	9.4	12.8	14.2	11.3	10.3	10.6	11.2	9.1	11.9	12.8	11.9	10.4	9.8	7.8	2.4	8.7	25.8	10.2	45.5	15.9	15.7	7.9	13.5	23.2	9.3	32.0	7.0	7.9	0.0	5.3	9.1	7.4	5.4	8.1	20.2	11.2	3.2	5.8	8.6	13.7	15.5	11.5	12.8	1.7	18.0	7.9	9.5	6.6	10.5	11.3	18.8	8.2	0.0	5.2	83.9	26.0	2.0	9.5	7.5	7.1	4.7
TRMT2A	HTF9C	ENSG00000099899	"TRNA methyltransferase 2 homolog A"	Q8IZ69	22	20111866-20117392	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 119.6;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001077	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001077: AB_1079092"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.19e-3)"	"unprognostic (5.93e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.99e-8)"	"unprognostic (4.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.14e-3)"	14.3	22.5	12.6	18.8	13.6	14.3	13.4	16.3	19.7	13.9	16.6	17.4	15.4	18.2	13.1	15.6	16.1	15.3	17.1	12.8	13.1	11.4	13.2	22.8	11.1	22.8	12.4	14.4	15.2	23.6	10.8	18.5	15.8	11.2	16.8	6.1	14.2	36.5	16.1	14.8	18.4	16.2	12.4	12.7	23.2	16.7	16.9	13.4	26.8	15.6	12.7	18.3	13.1	11.0	9.7	14.0	7.0	14.9	9.5	15.2	11.5	6.4	7.5	2.9	4.7	2.9	2.2	10.0	5.8	3.0	4.6	4.1	8.9	5.6	8.9	5.0	2.7	3.6	10.1	2.1	3.3	0.6	9.2	24.4	10.3	10.0	8.0	8.0	16.1	10.3	3.9	4.3	4.9	1.8	3.2	4.8	7.7	38.5	6.2	3.2	10.2	9.1	10.2	5.5	7.3	9.5	10.5	5.0	3.7	2.6	7.3	7.7	5.9	3.6	9.3	9.3	1.3	6.4	13.7	4.5	5.7	7.6	4.4	5.0	22.2	9.9	6.8	7.6	6.9	5.7	6.6	11.5	7.0	10.5	14.9	15.2	9.7	10.9	12.1	14.0	6.8	12.2	11.5	1.5	9.5	12.0	12.4	8.5	11.5	12.6	13.6	16.3	19.7	13.1	11.4	12.4	14.4	11.2	13.4	11.9	17.3	11.5	8.8	8.8	13.6	5.2	12.7	6.7	10.3	10.4	7.9	21.8	11.6	9.3	119.6	8.7	12.3	0.0	11.3	15.3	11.3	9.1	25.3	15.5	22.1	14.3	17.9	7.4	20.8	166.9	16.4	12.7	6.8	14.4	10.6	21.7	11.7	10.1	13.4	8.4	12.4	6.5	8.8	17.3	12.1	9.8	23.8	17.8	15.1	8.5
TRMT2B	"CXorf34, FLJ12687"	ENSG00000188917	"TRNA methyltransferase 2 homolog B"	Q96GJ1	X	101009346-101052116	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003745, HPA035120, HPA040814"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: "	"prognostic unfavorable (1.58e-5)"	"unprognostic (6.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.30e-7)"	"unprognostic (4.58e-2)"	"unprognostic (4.82e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.60e-2)"	7.6	10.4	6.9	8.9	10.3	9.1	8.5	7.0	14.2	9.6	11.4	6.9	10.7	8.1	8.1	8.6	12.9	7.4	7.3	13.0	10.7	6.6	12.3	9.5	9.4	12.6	9.5	6.6	11.3	10.4	18.5	17.6	5.9	10.7	10.1	12.6	13.4	15.3	10.4	17.6	9.5	13.5	7.9	8.4	16.6	11.4	4.0	7.9	18.2	12.8	5.3	17.7	9.9	9.5	16.5	8.1	14.8	8.2	14.4	19.2	11.5	15.3	13.3	2.7	6.3	6.3	3.3	8.4	8.0	10.7	8.9	13.4	14.3	12.3	13.6	15.9	7.3	18.2	9.6	12.2	11.1	11.3	11.7	7.7	8.6	11.0	6.7	5.6	15.3	14.1	4.2	6.6	12.9	6.0	6.3	17.2	14.8	8.8	13.0	8.2	15.5	19.0	8.1	3.7	18.9	9.9	15.6	13.1	13.0	6.6	9.1	4.0	5.2	13.6	9.9	7.9	7.8	6.5	7.4	10.1	11.4	6.9	10.5	7.1	8.3	12.5	12.7	8.8	17.6	8.7	9.6	8.2	14.8	13.8	6.5	14.6	14.9	16.1	13.3	7.4	16.5	19.2	16.1	4.8	14.4	7.0	8.1	13.0	11.5	6.9	10.3	7.0	14.2	10.7	6.6	9.5	6.6	10.7	7.9	6.0	7.5	4.4	5.2	2.1	0.4	9.0	2.5	5.3	3.4	14.0	2.0	5.0	6.6	3.6	0.0	3.7	4.2	0.0	3.1	2.6	1.6	4.2	12.7	3.0	3.0	1.6	6.4	2.5	3.5	0.0	3.1	2.8	1.7	2.8	5.2	4.5	3.9	6.0	3.5	5.6	1.8	0.0	1.4	0.2	3.6	1.4	4.2	8.7	5.6	4.7
TRMT44	"C4orf23, FLJ35725, METTL19, TRM44"	ENSG00000155275	"TRNA methyltransferase 44 homolog"	Q8IYL2	4	8436140-8493531	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045461	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045461: AB_10961276"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.34e-3)"	11.5	7.6	13.3	7.3	17.5	13.1	15.4	20.3	16.2	10.1	9.2	14.1	10.1	7.1	16.3	10.7	13.6	12.3	8.6	9.8	12.1	6.3	7.1	8.9	8.8	9.8	12.2	14.7	17.1	9.7	11.3	10.9	10.2	8.7	10.8	7.2	9.4	12.4	8.7	11.5	17.2	7.6	9.7	6.7	8.1	11.3	15.8	13.8	7.8	9.9	9.0	10.7	10.8	11.4	2.1	2.1	0.4	2.1	0.8	3.0	0.5	5.6	6.0	7.4	8.8	8.0	7.8	16.2	6.8	4.8	8.9	8.0	7.3	8.1	7.7	3.3	2.7	7.2	4.3	10.8	6.6	7.9	3.9	5.3	7.2	9.3	5.7	6.9	12.4	6.0	4.7	9.1	6.8	7.5	7.6	9.5	5.3	11.0	8.4	5.6	3.7	10.3	9.1	8.5	7.2	9.0	7.7	8.0	4.9	7.7	6.9	8.1	5.6	4.4	4.0	5.9	8.8	3.6	4.8	5.6	5.5	3.0	5.1	10.4	9.8	6.1	7.1	6.1	11.7	5.3	0.4	1.2	0.1	2.3	1.2	1.6	0.8	2.1	2.5	2.1	2.1	3.0	0.9	0.2	0.8	2.1	1.7	0.2	0.5	13.3	17.5	20.3	16.2	12.1	6.3	12.2	14.7	8.7	13.8	8.9	5.3	2.2	3.7	6.1	7.8	2.6	12.7	5.3	2.3	7.0	23.6	8.6	5.0	4.2	3.0	3.9	2.3	0.0	3.9	5.3	5.1	3.9	4.7	2.9	4.0	3.2	1.7	3.1	4.6	1.4	5.5	2.9	1.7	4.6	2.3	3.2	3.6	2.5	3.5	2.2	10.9	0.0	1.8	6.2	6.1	5.1	13.6	3.2	2.8	7.0
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971451-60981358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	15.8	10.1	7.9	13.8	12.1	5.4	12.9	9.3	11.8	10.9	8.6	5.7	11.9	7.5	12.0	10.9	11.1	10.0	6.7	6.8	7.7	7.1	12.5	13.9	6.6	7.3	6.7	8.3	17.1	11.1	15.9	13.1	10.8	9.0	10.6	8.1	4.8	11.5	9.9	14.8	9.7	7.4	9.2	6.3	8.6	8.1	24.9	5.9	12.4	10.4	12.1	7.2	13.3	9.0	7.2	7.4	0.9	7.5	2.0	6.0	3.7	28.9	7.4	10.9	15.2	9.7	14.5	11.9	10.9	8.4	11.7	9.4	5.4	17.4	14.9	12.2	7.9	8.8	13.4	13.7	15.8	15.4	14.7	6.9	10.9	5.0	6.0	15.8	19.3	6.1	11.4	15.3	10.6	15.8	10.4	10.2	13.0	14.2	5.4	17.1	10.9	9.9	9.7	10.0	11.3	12.3	3.2	25.3	12.6	9.9	9.9	13.4	13.3	12.1	12.2	9.7	9.9	20.4	11.6	9.6	13.6	16.5	9.6	10.4	3.3	6.1	7.0	9.5	4.2	12.6	0.1	4.6	0.9	3.5	7.5	5.0	7.2	5.2	5.2	4.2	4.9	5.6	5.1	0.4	2.0	7.5	7.4	6.0	3.7	7.9	12.1	9.3	11.8	7.7	7.1	6.7	8.3	9.0	5.9	6.0	7.5	8.3	16.7	5.7	5.0	7.1	0.0	18.7	25.0	10.4	3.9	11.0	1.7	7.1	162.4	8.6	2.9	0.0	6.5	11.6	7.7	5.7	5.8	5.9	9.5	3.2	5.2	11.6	6.1	35.3	10.3	8.2	6.8	4.6	7.3	10.4	7.2	3.5	7.1	8.8	4.5	12.9	6.2	10.9	10.9	3.8	16.0	4.6	7.1	10.7
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937235-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA047032: AB_2679911, HPA050408: AB_2681117"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	10.5	12.9	10.5	11.3	12.1	20.6	8.5	15.0	10.5	7.3	7.4	5.7	47.8	5.1	9.1	7.9	11.9	7.9	5.6	13.2	8.4	9.5	10.2	10.1	7.2	13.2	8.3	11.8	9.6	9.6	9.8	13.9	9.4	13.6	7.2	8.2	5.1	8.2	33.9	24.4	9.9	8.6	8.0	8.2	12.2	7.5	15.5	7.9	10.3	8.7	10.6	12.7	8.8	7.9	9.2	17.8	5.9	8.7	13.9	11.6	7.1	25.5	12.6	8.5	13.0	4.8	6.2	11.9	12.3	6.3	12.1	10.1	16.6	11.3	30.5	6.4	6.8	15.8	19.6	17.0	19.6	20.2	6.3	11.9	25.1	5.8	14.8	9.5	23.0	6.6	6.2	10.3	21.5	16.2	4.1	5.1	11.9	15.1	9.5	13.8	7.1	23.9	12.5	19.2	16.5	15.9	15.9	16.9	16.7	8.2	16.3	16.6	25.7	15.0	19.4	19.7	8.5	10.3	11.2	5.0	14.3	13.4	13.2	24.7	15.5	29.9	35.7	6.3	19.0	14.0	2.0	7.9	5.9	9.6	8.7	11.0	9.2	10.8	11.6	17.8	8.2	11.2	11.6	0.8	13.9	7.6	8.1	11.3	7.1	10.5	12.1	15.0	10.5	8.4	9.5	8.3	11.8	13.6	7.9	6.0	16.9	15.9	15.9	19.1	17.7	21.3	12.7	34.8	34.2	27.9	9.8	23.4	29.9	18.1	3.0	15.3	3.9	0.0	26.5	20.1	12.3	14.0	34.6	16.3	15.9	25.4	13.2	3.7	13.2	6.3	10.6	27.0	16.9	9.0	8.2	12.2	17.8	7.0	6.7	17.9	9.8	12.9	20.5	59.7	110.3	21.0	24.5	17.5	9.9	14.2
TRMT61A	"C14orf172, FLJ40452, GCD14, Gcd14p, hTRM61"	ENSG00000166166	"TRNA methyltransferase 61A"	Q96FX7	14	103529184-103537073	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024269			Approved	Mitochondria		NA	NA			Mitochondria		"HPA024269: "	"unprognostic (5.12e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.70e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.28e-1)"	12.4	10.6	9.0	10.4	16.4	9.1	8.2	10.3	16.7	9.7	16.7	16.0	9.2	10.5	14.9	8.9	10.6	14.3	10.9	6.2	10.7	8.1	9.1	9.6	7.5	8.0	11.7	8.7	10.5	20.7	6.7	5.9	6.7	10.5	13.1	4.6	9.0	14.4	18.3	9.7	15.5	8.6	19.9	9.1	7.9	9.7	10.9	11.3	6.0	11.9	7.5	7.5	11.9	8.5	3.8	4.1	0.3	12.2	3.0	3.7	2.6	5.5	13.9	2.1	4.4	2.2	2.4	8.9	6.2	2.8	7.8	4.3	18.9	9.6	9.0	7.8	3.2	4.5	14.4	4.6	4.7	2.2	6.1	8.6	6.9	5.2	10.0	4.0	8.9	5.4	2.6	6.1	6.8	2.8	1.8	1.3	6.6	10.2	4.4	2.6	16.1	10.8	6.8	7.5	11.7	28.3	13.5	6.8	7.8	3.1	8.3	11.4	7.1	7.1	6.7	8.3	0.9	12.5	5.2	2.6	7.1	7.6	18.6	12.6	6.0	3.8	11.4	7.6	7.1	13.4	0.0	2.6	0.3	3.4	6.5	2.5	3.4	2.7	3.7	4.1	3.8	3.2	3.1	0.1	3.0	12.2	2.8	2.0	2.6	9.0	16.4	10.3	16.7	10.7	8.1	11.7	8.7	10.5	11.3	0.0	8.9	7.7	12.9	23.2	11.5	45.6	5.1	2.7	2.3	7.0	3.9	11.1	14.9	15.6	3.6	11.3	7.4	0.0	10.4	11.8	12.7	10.0	2.3	7.8	10.9	28.6	10.3	4.3	7.3	11.9	10.3	6.1	10.1	16.2	7.8	7.5	15.5	8.6	17.3	12.7	10.7	0.0	19.1	6.6	10.8	26.2	10.1	7.5	13.3	9.6
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 64.7;thyroid gland: 26.5"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 26.8;Club cells: 18.2;Collecting duct cells: 14.0;Distal tubular cells: 10.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Group enriched"	"Detected in all"	7	"cerebellum: 64.7;pons and medulla: 31.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 7.1;BJ: 10.2;fHDF/TERT166: 13.7;RPTEC TERT1: 4.8;SCLC-21H: 5.2;U-266/84: 4.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 77.4"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	2.1	0.9	2.0	1.1	4.1	1.2	3.5	64.7	6.0	2.0	1.8	6.6	0.8	1.4	1.9	2.5	1.3	2.4	2.7	6.0	6.7	2.9	2.7	1.7	1.7	1.0	2.0	2.8	0.6	1.7	2.3	1.2	7.1	31.5	1.2	2.1	5.8	2.3	1.9	4.4	5.1	1.5	0.9	1.9	1.6	1.5	1.8	1.0	0.0	26.5	1.3	0.7	1.3	0.9	1.0	0.6	2.8	0.6	1.9	0.6	0.0	0.1	0.2	7.1	0.0	0.0	0.0	1.7	10.2	2.3	1.4	0.7	0.1	0.3	0.2	0.5	13.7	1.3	0.3	0.1	0.3	1.5	0.1	0.4	0.4	0.4	0.1	0.0	0.2	0.7	0.2	3.6	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.3	0.1	0.2	0.8	0.1	0.0	1.1	0.1	0.1	4.8	0.2	5.2	0.1	0.1	0.1	0.2	2.4	0.2	0.0	0.0	0.2	0.9	1.0	0.2	0.4	4.9	0.1	0.1	0.2	1.8	2.6	0.6	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.2	1.0	0.5	0.6	2.8	1.9	0.3	0.6	0.2	0.0	2.0	4.1	64.7	5.0	6.7	2.9	2.0	2.8	31.5	1.0	6.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	26.8	18.2	14.0	0.0	0.9	10.0	0.9	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TRNAU1AP	"FLJ20503, SECP43, TRSPAP1"	ENSG00000180098	"TRNA selenocysteine 1 associated protein 1"	Q9NX07	1	28553085-28578545	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032068, HPA032069"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA032068: AB_2674135, HPA032069: AB_10603998"	"unprognostic (4.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.93e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (5.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.76e-1)"	11.4	10.5	12.6	11.3	14.7	9.3	13.4	19.6	14.1	12.4	10.9	15.4	12.0	7.0	11.7	14.8	10.8	13.2	8.7	12.3	11.7	12.1	11.4	8.7	13.2	15.7	19.3	13.3	12.8	11.6	14.0	9.2	10.8	13.6	10.3	11.6	10.7	10.5	14.0	7.9	17.3	9.4	14.0	12.8	11.1	10.2	7.2	17.1	15.4	8.4	9.0	16.9	12.9	9.5	4.8	4.3	9.1	5.9	12.9	7.5	2.7	4.5	2.7	8.0	5.4	7.4	14.1	3.8	6.2	12.5	11.5	10.3	4.2	7.2	7.0	2.4	6.8	5.4	3.5	8.7	9.8	11.5	6.1	9.9	5.2	9.6	2.8	6.8	4.0	4.5	15.1	8.5	8.9	7.0	8.1	16.2	7.2	6.1	5.7	11.1	3.1	6.8	4.7	5.7	4.9	6.0	4.9	5.6	4.9	12.4	4.6	4.7	6.2	7.3	6.5	6.7	9.0	7.1	4.9	4.6	3.0	2.9	4.6	5.5	7.5	9.4	4.3	7.2	8.8	8.4	6.9	3.5	9.1	5.7	5.9	6.0	4.8	6.2	7.2	4.3	4.7	7.5	4.8	2.2	12.9	3.5	2.8	4.0	2.7	12.6	14.7	19.6	14.1	11.7	12.1	19.3	13.3	13.6	17.1	32.8	33.0	23.2	18.6	15.7	33.7	18.5	22.9	54.9	35.2	17.4	33.4	27.7	14.9	32.7	9.3	19.6	14.6	23.3	28.3	39.5	19.7	18.5	33.6	7.8	29.5	22.3	9.9	25.2	25.4	3.2	26.7	27.0	13.5	36.1	13.0	23.6	32.8	13.6	21.2	15.0	33.0	32.3	25.7	15.4	24.9	17.9	57.2	30.0	15.1	26.0
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.1"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 4.0;Fibroblasts: 4.4;Horizontal cells: 7.9;Leydig cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 17.9;SH-SY5Y: 16.1;SuSa: 37.2"					"Low region specificity"	"Detected in all"			HPA071449			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA071449: "	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	4.5	4.2	21.7	2.1	15.5	1.6	3.7	11.3	23.8	8.0	2.5	7.9	1.4	1.7	16.3	8.6	2.4	7.1	5.6	2.9	17.9	15.6	5.3	13.2	2.5	2.3	10.5	13.2	21.7	5.7	7.6	20.2	5.5	22.3	7.4	3.2	5.0	1.5	6.9	32.1	1.5	1.8	10.9	8.9	1.4	2.0	3.6	14.2	4.2	9.2	0.1	2.4	3.6	5.0	0.7	2.6	0.0	0.2	5.2	1.2	0.4	0.0	0.1	17.9	0.0	3.5	4.8	0.0	0.9	6.1	0.9	0.3	0.0	0.0	0.0	2.5	6.4	1.4	0.1	0.1	0.3	0.5	0.0	11.0	8.2	0.0	0.6	1.3	0.0	0.0	11.2	0.0	5.7	0.0	5.7	0.4	4.3	0.0	0.1	6.6	0.0	0.1	0.0	9.1	0.0	0.0	5.2	7.8	0.0	1.7	0.1	12.0	16.1	0.0	0.2	1.5	37.2	0.0	1.0	0.0	7.5	7.8	0.1	1.0	2.8	0.4	0.0	1.1	0.0	6.5	0.0	0.0	0.0	1.2	0.0	0.7	0.7	0.1	0.4	0.0	0.5	0.3	0.7	0.0	5.2	0.2	2.6	0.0	0.4	21.7	15.5	11.3	23.8	17.9	15.6	10.5	13.2	22.3	14.2	0.0	0.0	0.0	1.1	0.3	4.0	1.6	0.0	0.0	3.4	3.5	0.0	0.6	0.0	1.4	0.3	0.7	0.0	0.0	0.2	0.5	4.4	0.4	1.1	0.0	0.4	7.9	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	2.9	0.3	0.0	3.5	0.3	1.0	0.0	0.4	1.0	1.0	0.1	0.6	0.5	0.0	0.3
TROVE2	"Ro60, SSA2"	ENSG00000116747	"TROVE domain family member 2"	P10155	1	193059422-193091777	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 316.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002835, HPA005142"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		28000	Cytosol	Nucleoplasm	"HPA002835: AB_1857490, HPA005142: AB_2667307"	"unprognostic (1.91e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (5.62e-2)"	21.2	13.7	13.3	11.4	16.2	29.7	18.5	13.7	16.5	16.9	12.3	13.2	11.7	8.4	15.3	10.9	16.8	11.3	10.9	18.0	13.9	7.7	14.3	13.6	15.0	13.0	19.6	11.8	19.8	12.1	16.8	13.0	13.6	15.1	17.3	9.4	11.4	14.8	14.7	23.4	16.5	11.6	22.7	20.4	14.7	10.9	24.3	17.0	15.1	14.9	8.7	12.9	19.9	19.8	19.1	13.9	38.3	14.6	19.6	24.3	14.5	8.8	15.8	18.3	17.1	15.9	14.7	11.1	13.5	12.6	9.4	12.7	8.1	12.1	18.3	12.5	15.1	8.9	13.6	14.4	10.2	16.6	22.6	11.0	22.1	15.1	10.8	14.6	25.7	16.2	13.7	12.2	17.2	19.2	9.5	15.2	8.0	24.0	24.6	16.1	14.4	15.4	6.8	13.8	7.5	5.2	12.8	15.8	20.8	9.1	18.4	6.5	12.9	16.5	20.2	17.3	13.2	16.6	8.8	20.4	18.0	6.6	16.9	17.2	14.4	14.7	17.4	9.6	12.9	27.6	38.3	13.9	17.4	24.3	13.1	23.4	19.1	17.9	20.3	13.9	17.2	19.0	21.2	22.7	19.6	14.6	12.2	17.9	14.5	13.3	16.2	13.7	16.0	13.9	7.7	19.6	11.8	15.1	17.0	71.5	25.9	47.7	45.1	63.0	52.6	45.3	35.7	34.8	28.4	45.4	117.8	40.8	34.9	43.8	316.3	70.0	20.6	46.7	33.6	38.5	64.8	51.1	57.8	29.4	29.3	44.5	32.6	40.5	33.7	126.5	78.9	44.3	45.5	49.5	21.2	163.1	32.0	20.1	97.9	43.8	149.2	129.4	76.9	43.9	41.4	67.5	40.2	59.1	19.9	30.7
TRPC1	HTRP-1	ENSG00000144935	"Transient receptor potential cation channel subfamily C member 1"	P48995	3	142724074-142807888	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 18.1;Cone photoreceptor cells: 15.7;Horizontal cells: 12.7;Rod photoreceptor cells: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009387, HPA021130"	Supported		Approved	Vesicles		NA	NA			Vesicles		"CAB009387: AB_2240941, HPA021130: AB_1858361"	"unprognostic (1.66e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (1.44e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.49e-2)"	6.8	8.3	8.5	3.5	13.4	1.2	6.8	23.0	15.9	17.7	8.3	11.4	4.3	2.6	20.4	9.2	6.5	10.1	9.1	15.9	10.0	11.4	6.0	2.0	5.4	3.3	9.4	12.2	24.5	3.0	12.2	14.4	6.1	14.7	12.3	4.9	13.0	3.7	13.6	2.4	6.2	4.7	17.6	11.4	5.0	4.4	8.0	7.9	0.4	8.9	3.9	2.3	9.3	8.9	0.6	0.0	0.0	0.0	0.3	1.3	0.3	3.2	4.6	8.4	1.0	7.6	18.7	3.8	5.1	8.1	6.5	9.6	1.4	0.9	0.0	1.7	5.3	11.4	0.3	2.3	2.4	9.4	0.8	3.4	5.1	1.9	2.2	3.1	0.2	0.0	9.0	2.4	6.0	7.3	11.0	3.7	0.0	0.2	0.0	9.1	2.0	0.3	0.4	4.7	0.0	2.4	0.0	4.0	0.0	4.5	0.1	5.4	4.0	6.3	0.0	1.1	8.0	2.6	0.0	3.4	8.2	1.3	11.0	6.9	3.4	1.4	1.6	6.2	0.1	2.4	0.0	0.0	0.0	0.2	0.0	1.2	0.6	1.3	0.6	0.0	0.3	1.2	1.3	0.0	0.3	0.0	0.0	0.0	0.3	8.5	13.4	23.0	15.9	10.0	11.4	9.4	12.2	14.7	7.9	3.0	0.3	0.0	2.2	2.6	18.1	10.1	0.0	2.7	0.0	5.2	15.7	0.1	0.0	0.2	2.1	2.9	0.0	0.0	0.2	0.2	7.2	0.8	0.0	0.0	0.1	12.7	1.7	4.3	0.0	1.7	7.8	0.0	1.7	0.0	0.0	6.8	0.1	0.0	10.3	0.3	15.0	0.0	9.0	10.3	2.1	1.0	0.2	0.0	0.0	0.2
TRPC4AP	"C20orf188, dJ756N5.2, DKFZp586C1223, DKFZP727M231, PPP1R158, TRRP4AP"	ENSG00000100991	"Transient receptor potential cation channel subfamily C member 4 associated protein"	Q8TEL6	20	35002404-35092871	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051197, HPA065061"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051197: AB_2681384, HPA065061: AB_2685416"	"unprognostic (3.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.25e-8)"	"unprognostic (1.33e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	36.5	43.3	26.3	30.1	38.2	51.4	35.1	36.7	48.3	27.7	31.9	64.0	36.9	30.7	33.9	31.8	31.5	28.4	30.1	30.1	29.0	31.0	30.4	41.9	38.7	32.3	43.5	34.0	30.4	45.3	41.3	47.9	48.1	43.6	32.9	31.6	29.2	39.9	33.1	50.5	35.0	31.8	32.5	31.9	43.7	37.3	24.5	38.8	46.9	34.8	23.0	34.9	29.0	28.5	10.9	23.2	28.6	20.9	14.2	15.9	13.3	16.3	20.0	17.9	18.4	27.8	26.8	27.5	26.6	31.3	30.6	35.3	43.7	24.5	15.3	25.5	30.7	31.3	21.9	16.2	37.9	23.7	8.1	12.6	39.1	17.2	39.9	27.7	22.6	26.8	29.7	24.0	22.9	19.7	32.2	33.8	31.9	18.3	18.5	24.3	12.3	27.3	25.6	14.1	15.1	27.4	17.2	25.8	15.6	26.3	21.4	15.9	16.0	28.6	48.7	18.6	22.3	17.6	18.5	33.1	38.2	17.3	20.5	15.8	17.0	9.1	12.8	41.2	11.3	19.4	16.4	16.7	28.1	14.8	18.3	15.8	10.9	12.4	15.9	23.2	10.1	11.0	11.5	28.6	14.2	20.9	10.1	14.0	13.3	26.3	38.2	36.7	48.3	29.0	31.0	43.5	34.0	43.6	38.8	17.9	13.1	18.6	13.7	13.5	24.8	11.2	10.2	9.4	11.4	19.2	74.6	43.4	3.3	26.2	11.1	23.8	26.9	0.0	24.0	36.5	21.0	20.5	19.6	18.1	32.7	63.5	19.7	17.2	20.0	5.5	23.6	23.9	11.8	25.2	22.2	25.3	31.2	21.0	21.5	8.7	28.4	38.8	17.9	22.6	25.3	13.8	57.2	20.3	20.9	18.7
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 99.0"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 705.2"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	113	"SK-MEL-30: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"		NA	NA			"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: AB_2669090, HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	99.0	0.4	0.0	0.2	10.4	0.0	0.1	1.9	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.1	0.3	0.7	0.2	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.0	3.8	705.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	30.8	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	12.7	0.0	0.0	0.0	2.4	0.0	0.0	150.1	0.0	0.0	10.0	0.0	0.0	0.0	0.6	18.1	0.0	0.0	7.9	3.8	0.9	0.8	0.0	0.0	0.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529063-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 36.6;kidney: 28.0;retina: 105.2"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 278.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.1"	"Cell line enriched"	"Detected in some"	4	"HAP1: 19.4"	"Low region specificity"	"Detected in all"							"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.9	1.7	6.0	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3.0	0.7	1.3	1.3	1.4	9.4	6.0	28.0	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5.0	1.1	0.8	0.7	1.0	8.1	1.1	1.6	5.3	5.9	0.0	2.1	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.1	0.1	1.3	3.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	19.4	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.2	0.0	0.0	1.2	4.5	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.2	0.0	1.0	0.0	1.3	0.0	0.2	0.0	0.4	0.2	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.0	4.5	36.6	3.8	9.4	6.0	8.3	3.5	34.8	5.9	3.0	4.0	0.0	0.9	0.3	9.5	4.8	2.5	1.4	4.5	15.7	62.8	0.0	5.0	0.0	3.9	1.3	0.0	0.0	0.2	0.0	1.5	0.4	0.0	0.0	0.2	1.6	14.8	0.6	0.0	1.7	5.2	1.1	0.0	0.0	0.0	278.6	0.1	0.0	8.5	25.8	4.7	0.0	1.0	1.5	0.4	0.6	0.2	0.8	0.0	0.3
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 120.1;Mucus-secreting cells: 88.2;Paneth cells: 80.4;Undifferentiated cells: 78.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"OE19: 15.6;RT4: 32.4;SK-BR-3: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		6500	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	6.7	3.8	3.5	13.7	3.7	4.3	8.5	3.0	6.8	8.2	25.2	4.5	8.6	20.6	7.9	9.1	7.7	5.4	24.8	9.3	2.7	2.2	14.2	23.6	9.4	3.5	2.6	5.7	2.7	17.4	3.4	3.3	5.0	6.9	20.2	11.4	10.6	16.2	13.2	16.4	16.1	26.8	9.4	2.5	3.4	18.3	4.2	2.2	0.4	10.1	11.5	6.8	9.9	8.6	1.1	5.4	4.9	6.8	1.0	0.7	2.1	6.0	4.5	1.1	5.0	3.8	3.6	3.6	5.1	3.0	1.4	1.9	3.3	9.5	0.2	1.3	3.4	1.9	7.9	0.7	1.5	0.6	0.1	1.6	1.0	1.9	2.0	3.4	0.1	6.6	4.3	7.0	2.6	1.2	1.7	2.4	0.5	2.4	1.2	3.5	9.0	0.4	0.5	0.6	15.6	6.9	2.2	1.0	0.3	2.4	32.4	0.4	1.1	2.1	21.3	1.1	0.4	11.6	2.0	6.1	7.6	4.2	4.2	0.1	2.2	2.2	0.2	4.3	3.9	2.8	2.7	6.8	1.1	0.6	4.0	0.5	0.8	0.5	0.4	5.4	1.1	0.6	0.7	4.9	1.0	1.5	4.9	0.3	2.1	3.5	3.7	3.0	6.8	2.7	2.2	2.6	5.7	6.9	2.2	29.8	1.6	11.7	13.4	11.1	2.1	14.9	22.9	2.7	3.4	14.0	0.0	5.3	16.6	7.6	2.1	9.2	120.1	0.0	16.1	5.7	6.6	47.1	5.7	64.7	16.1	0.0	20.8	15.4	9.7	3.1	6.4	7.9	37.1	14.4	88.2	6.3	25.2	80.4	6.7	3.8	2.4	32.3	9.1	6.6	11.9	10.0	2.9	0.0	78.1	25.3
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.5	8.5	7.1	7.9	20.6	15.5	8.7	10.8	15.0	6.9	9.1	11.7	4.7	18.6	5.3	12.4	17.8	14.4	9.5	7.9	9.9	10.3	5.7	14.8	13.1	6.1	18.8	15.3	11.5	14.4	9.4	7.8	14.7	10.1	5.5	11.8	16.7	14.3	12.5	13.4	9.8	7.5	5.4	11.8	5.3	10.8	9.9	9.1	9.6	20.2	5.9	7.5	7.4	11.9	14.5	13.1	7.4	16.7	8.4	11.0	5.2	50.9	12.4	9.7	21.5	17.9	11.9	31.3	10.2	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0	17.9	25.3	18.2	14.9	28.0	22.9	21.4	28.1	24.1	7.9	12.2	11.8	18.5	3.3	9.7	25.2	18.5	16.9	23.3	11.1	8.0	17.0	21.2	16.3	35.0	12.7	20.6	17.7	15.4	18.6	17.9	24.5	17.0	18.6	14.4	17.3	9.1	12.8	12.9	19.1	9.6	21.5	12.9	13.7	13.6	19.4	21.1	13.6	17.5	16.3	9.0
TRPT1	MGC11134	ENSG00000149743	"TRNA phosphotransferase 1"	Q86TN4	11	64223799-64226254	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038705, HPA038706"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038705: AB_2676161, HPA038706: AB_10671863"	"unprognostic (2.50e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.58e-3)"	8.1	12.2	10.8	11.1	12.6	4.4	9.1	6.4	12.1	8.8	15.1	10.9	37.4	12.5	7.8	15.3	13.3	10.4	13.5	34.4	10.9	10.3	16.9	13.7	7.0	8.3	13.6	8.5	8.7	23.3	9.1	11.6	8.5	10.8	11.3	10.8	9.9	22.3	33.5	58.8	10.8	13.1	7.0	10.1	10.3	12.2	18.9	10.3	17.2	13.3	23.9	13.2	11.9	7.7	22.9	31.7	14.5	16.2	12.4	13.2	6.5	10.7	10.7	11.9	19.1	14.8	10.9	14.8	7.3	14.1	12.9	10.9	7.0	16.4	10.9	29.3	11.9	10.0	15.1	5.2	15.7	4.5	10.5	6.4	5.5	10.8	12.1	21.4	6.9	9.8	8.1	9.3	14.3	12.7	24.3	9.0	21.8	9.6	12.2	10.7	25.5	12.8	14.8	7.6	14.6	11.9	17.0	8.9	30.8	33.2	12.9	10.6	15.3	5.8	14.4	21.1	8.5	16.6	11.2	10.5	8.9	6.8	17.3	7.1	24.4	6.0	6.9	21.3	3.6	14.2	6.0	9.4	14.5	10.9	16.2	8.4	20.8	10.5	11.2	13.0	22.9	11.9	13.2	8.3	12.4	13.9	31.7	13.2	6.5	10.8	12.6	6.4	12.1	10.9	10.3	13.6	8.5	10.8	10.3	8.9	17.2	12.7	16.5	11.7	9.7	39.2	35.7	49.5	14.8	26.2	0.0	38.4	81.2	35.4	121.1	14.3	67.0	23.3	51.2	36.0	16.3	24.7	23.2	22.7	21.9	9.5	25.8	19.6	13.4	59.9	18.4	14.8	35.4	36.1	72.6	18.7	41.3	45.6	15.9	57.2	10.3	6.5	28.3	51.6	13.5	16.2	30.1	17.8	33.0	17.7
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557995	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 15.4;skeletal muscle: 29.1"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 16.7;Enterocytes: 10.8;Suprabasal keratinocytes: 21.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.4"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 3.6;BEWO: 5.4;CACO-2: 4.3;RH-30: 13.3;T-47d: 5.6;U-266/70: 3.5"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.0"	HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: AB_2686149"	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.4	0.2	0.4	3.2	2.4	0.9	4.1	0.3	1.2	0.6	10.6	0.1	0.3	3.2	0.2	0.2	2.3	0.3	0.8	0.3	0.4	0.3	0.2	1.1	0.3	0.5	0.4	0.2	0.3	0.9	0.0	0.7	0.4	0.0	0.2	2.9	0.3	0.5	0.4	29.1	8.4	15.4	0.5	0.5	0.4	1.6	0.8	0.0	0.0	0.2	9.7	3.0	0.7	2.1	0.7	0.6	2.9	0.6	0.6	0.7	0.1	3.6	0.0	0.5	0.1	0.3	0.6	5.4	0.2	0.0	0.0	0.0	4.3	1.0	0.2	1.1	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.6	0.1	0.2	0.8	0.3	0.0	0.7	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.2	0.1	0.3	0.5	0.1	13.3	0.2	0.0	0.2	0.1	0.0	0.2	0.6	0.0	0.0	5.6	0.2	0.1	0.1	0.2	0.1	0.1	3.5	2.8	0.0	0.1	0.1	0.0	2.9	0.4	0.4	0.7	0.2	0.5	0.7	0.4	0.7	0.1	0.5	0.4	0.6	1.0	0.6	0.6	0.6	0.2	0.1	0.4	2.4	0.3	1.2	0.4	0.3	0.4	0.2	0.0	0.0	0.0	4.5	1.4	4.0	16.7	0.8	2.4	2.5	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.2	1.6	10.8	0.0	0.0	0.7	4.3	2.9	0.0	0.4	0.2	4.8	0.0	0.0	0.0	0.0	2.8	2.2	6.8	0.0	0.7	2.0	0.8	0.8	3.2	0.8	0.9	0.0	0.9	0.0	1.1	21.5	0.5	2.1	0.6	2.2
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA054376: AB_2682467"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	9.6	14.2	10.7	18.4	13.4	18.8	14.9	22.8	14.4	14.1	11.3	15.4	10.0	10.6	15.1	10.1	11.3	17.1	11.4	11.4	10.7	9.5	10.8	11.0	13.1	17.1	12.4	9.4	22.4	16.2	26.7	29.9	12.2	9.6	11.8	10.2	13.7	11.8	16.7	11.7	16.9	13.3	16.9	14.2	14.5	11.5	19.3	12.1	37.1	16.6	7.7	19.3	12.8	11.5	2.7	3.1	5.7	0.9	1.3	2.7	0.3	12.3	14.4	15.0	12.7	7.4	7.6	7.5	5.4	7.3	8.6	8.3	11.2	5.5	17.2	8.7	10.1	16.6	6.4	15.5	7.5	9.5	9.9	15.2	10.5	10.5	6.5	5.5	18.8	7.8	7.1	4.4	14.0	12.0	6.0	11.0	15.6	17.9	32.7	8.0	23.8	23.0	7.5	11.4	7.5	8.9	17.0	8.6	13.1	4.5	13.8	11.9	14.8	13.8	9.1	4.6	12.8	4.6	8.5	11.5	11.6	16.9	15.3	12.7	13.5	15.3	25.5	8.2	9.7	11.4	5.7	0.9	0.6	1.5	0.6	2.7	2.0	2.7	1.3	0.9	2.7	1.9	1.8	2.9	1.3	0.9	3.1	2.0	0.3	10.7	13.4	22.8	14.4	10.7	9.5	12.4	9.4	9.6	12.1	14.9	13.9	4.5	3.7	14.1	13.1	9.2	5.1	4.0	10.3	14.0	25.5	7.7	0.0	6.7	3.0	9.0	6.1	0.0	5.7	4.3	8.0	6.5	5.7	10.9	7.0	20.6	12.1	9.2	8.7	4.0	8.1	8.4	8.5	5.4	10.6	5.8	7.9	3.5	8.1	4.3	8.5	0.0	6.1	14.4	8.0	18.6	9.2	9.2	9.5	6.0
TRUB1	PUS4	ENSG00000165832	"TruB pseudouridine synthase family member 1"	Q8WWH5	10	114938193-114977676	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037914, HPA057552"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA037914: AB_10672399, HPA057552: AB_2683465"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.20e-3)"	"unprognostic (9.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-1)"	7.2	29.0	14.7	7.7	19.5	3.3	10.9	11.5	22.0	10.0	8.9	9.2	7.8	8.4	12.6	9.4	9.9	9.6	8.1	20.2	14.7	15.8	15.4	13.0	6.2	8.7	11.0	10.9	16.8	8.3	13.1	9.6	7.0	18.1	11.7	10.2	7.7	9.5	11.3	8.2	6.6	7.6	10.8	10.2	9.6	7.9	17.9	8.0	12.7	11.9	9.2	9.2	8.7	8.3	9.2	6.0	4.0	8.2	10.2	8.5	6.0	13.8	10.8	10.7	26.5	7.7	10.4	14.4	11.9	13.5	16.2	18.5	8.8	14.3	17.2	13.9	9.3	7.1	11.9	14.3	14.8	24.1	13.0	15.4	7.9	5.4	15.7	13.3	14.7	11.8	10.6	20.4	11.5	22.8	17.3	9.1	13.9	8.1	7.0	19.2	6.6	13.7	11.7	10.0	9.3	10.7	13.8	27.0	10.4	21.4	7.0	10.0	11.0	10.0	14.9	26.1	12.0	11.9	9.1	8.1	7.5	7.5	11.8	14.5	13.4	10.8	14.4	10.5	18.8	6.7	4.0	3.3	1.1	6.0	5.1	8.5	9.2	6.4	6.3	6.0	7.1	8.5	7.8	0.3	10.2	8.2	5.4	7.6	6.0	14.7	19.5	11.5	22.0	14.7	15.8	11.0	10.9	18.1	8.0	11.9	5.9	10.9	3.2	4.9	14.1	12.6	7.6	8.1	11.4	8.7	2.0	7.4	18.3	7.2	43.0	6.0	5.4	0.0	4.3	5.4	8.7	3.1	10.3	18.5	6.5	23.8	7.5	15.4	7.6	5.4	7.8	4.0	3.3	2.8	7.7	10.9	5.9	0.0	9.6	21.4	5.5	6.5	7.6	13.4	19.0	6.0	5.1	4.4	11.0	5.0
TSACC	"C1orf182, SIP, SSTK-IP"	ENSG00000163467	"TSSK6 activating cochaperone"	Q96A04	1	156337314-156346995	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 262.0"	"Group enriched"	"Detected in many"	10	"Early spermatids: 5429.3;Late spermatids: 13574.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"basophil: 12.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029897			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA029897: AB_2756315"	"unprognostic (3.95e-1)"	"unprognostic (5.82e-3)"	"unprognostic (8.24e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.63e-6)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.28e-2)"	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.1	0.0	1.6	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	262.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	2.0	2.1	12.0	0.6	2.3	2.1	0.4	3.3	4.5	2.0	2.2	1.5	2.7	3.7	1.6	0.9	2.2	2.4	4.1	2.4	4.8	2.6	0.9	2.4	3.8	3.8	0.5	2.1	2.8	8.3	3.3	6.6	4.4	1.0	3.0	2.9	1.0	6.4	2.2	2.9	1.2	0.7	4.8	9.0	3.1	0.4	5.7	2.9	1.8	6.2	8.1	5.5	3.4	0.8	4.7	5.7	2.0	3.1	1.7	2.3	6.3	2.5	9.1	3.4	3.2	1.6	1.4	2.3	1.2	2.2	5.7	9.1	7.3	0.9	1.7	1.2	12.0	0.5	0.1	1.5	0.3	0.7	1.7	1.1	1.3	0.3	2.0	2.1	1.8	0.2	2.3	0.6	2.1	1.2	0.4	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.8	0.2	0.2	0.2	0.6	0.0	4.0	2.3	3.5	0.0	4.6	1.7	1.0	5429.3	0.0	0.0	0.0	0.6	1.1	0.3	0.4	0.0	3.0	0.9	0.0	0.0	0.0	0.3	13574.2	103.3	0.0	0.0	0.0	0.4	0.3	1.3	0.0	80.6	3.7	0.9	51.8	0.1	941.5	81.3	0.4	2.3	0.0	0.4	0.6
TSC22D1	"MGC17597, TGFB1I4, TSC22"	ENSG00000102804	"TSC22 domain family member 1"	Q15714	13	44432143-44577147	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 989.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 8.9;granulocytes: 17.7;NK-cells: 7.9"	"Cell line enhanced"	"Detected in many"		"HEL: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077414			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA077414: AB_2686839"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.78e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.08e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.14e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.48e-2)"	43.1	38.6	71.6	23.7	82.3	6.6	56.6	32.6	94.8	73.7	49.9	27.9	14.1	27.3	68.3	62.5	46.4	67.6	49.7	54.1	64.2	63.9	46.3	36.7	37.7	14.1	71.2	49.2	63.7	15.5	44.7	36.4	40.8	54.6	72.6	47.7	56.6	31.0	39.5	49.6	20.4	48.6	64.4	46.0	11.1	36.7	27.9	38.6	31.7	38.2	24.3	17.4	39.7	31.6	1.1	8.9	17.7	2.3	7.9	2.5	24.6	5.1	16.4	16.1	6.5	10.2	12.8	18.7	5.7	23.5	6.3	6.7	18.4	18.4	8.5	12.0	13.6	13.6	13.1	6.9	46.5	8.8	1.6	5.4	58.6	30.0	5.6	9.5	3.3	7.5	19.2	20.3	16.7	40.8	48.9	14.0	4.7	1.6	0.0	11.7	5.2	10.5	2.7	11.4	35.8	15.4	7.6	3.2	2.5	12.4	8.6	8.4	11.3	15.7	15.6	4.5	17.4	7.6	4.7	12.2	7.0	6.4	14.5	8.3	0.1	1.5	2.7	17.7	2.8	16.2	17.7	1.0	2.7	2.5	0.9	2.4	0.7	0.8	1.1	0.9	1.1	0.9	1.3	4.8	7.9	2.3	8.9	1.5	24.6	71.6	82.3	32.6	94.8	64.2	63.9	71.2	49.2	54.6	38.6	110.2	291.2	23.4	328.2	392.6	138.9	236.4	86.6	290.4	395.8	413.5	108.0	484.2	313.4	140.3	674.0	250.8	383.6	0.0	140.7	189.0	164.9	477.0	312.3	64.8	94.3	120.8	215.8	101.3	19.7	989.9	84.8	43.1	381.3	11.8	181.4	229.5	176.7	143.7	128.3	121.8	134.1	439.8	322.5	50.2	24.5	533.2	978.5	27.4	139.7	385.5
TSC22D2	"KIAA0669, TILZ4a, TILZ4b, TILZ4c"	ENSG00000196428	"TSC22 domain family member 2"	O75157	3	150408335-150466431	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004926	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA004926: AB_1080401"	"unprognostic (4.65e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.28e-3)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (1.10e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.49e-1)"	22.4	13.5	15.3	18.6	15.2	33.3	13.7	20.5	28.2	15.5	14.3	12.3	10.0	6.7	25.3	16.5	23.0	13.4	25.0	23.7	14.2	13.2	17.3	31.7	15.5	10.6	15.9	14.6	16.4	12.2	11.7	12.8	17.8	14.5	14.0	13.9	12.6	11.3	18.5	17.3	10.9	13.8	28.2	13.7	14.0	15.7	23.9	15.7	19.4	15.3	11.6	10.9	16.7	23.8	4.1	2.9	5.6	6.9	5.0	4.8	2.7	20.4	2.8	9.1	8.7	12.0	5.9	26.4	20.4	7.8	15.1	18.7	11.3	10.3	6.7	11.8	15.3	31.0	8.7	9.1	7.5	30.2	5.3	5.1	7.1	5.2	5.7	13.7	4.3	5.0	10.8	5.8	9.8	14.8	9.1	9.4	3.3	12.2	11.1	10.4	7.2	4.6	5.4	11.7	6.1	5.7	4.9	16.7	7.9	9.6	12.1	5.3	4.7	9.4	5.0	19.9	11.5	4.8	5.8	15.0	10.0	10.4	11.8	18.8	15.0	2.9	9.3	6.8	13.3	5.8	1.2	3.5	4.4	3.0	4.2	4.8	3.0	3.8	3.2	2.8	4.1	2.9	2.9	5.6	5.0	6.9	2.9	1.5	2.7	15.3	15.2	20.5	28.2	14.2	13.2	15.9	14.6	14.5	15.7	59.6	31.5	11.2	64.3	132.2	16.9	39.2	20.4	6.7	18.2	12.2	27.5	21.8	14.9	13.1	15.0	26.3	47.3	0.0	12.1	24.7	49.4	47.1	65.6	35.1	16.5	15.9	30.3	25.8	19.9	21.3	17.3	22.5	40.5	19.8	28.2	31.8	19.0	38.6	14.2	8.1	19.8	12.9	46.4	36.3	24.4	94.6	45.9	15.2	23.5	72.6
TSC22D3	"DIP, DSIPI, GILZ, hDIP, TSC-22R"	ENSG00000157514	"TSC22 domain family member 3"	Q99576	X	107713221-107777342	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"T-cells: 554.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 59.0;ASC TERT1: 40.6;HHSteC: 97.8;HSkMC: 37.0;hTCEpi: 87.0;Karpas-707: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001916, CAB034364"	Approved		Approved	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Nuclear speckles, Golgi apparatus"	"CAB034364: AB_2272198, HPA001916: AB_2666504"	"unprognostic (3.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.49e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.73e-3)"	"unprognostic (4.40e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-1)"	"unprognostic (9.64e-2)"	69.1	48.4	18.2	72.7	21.0	72.4	142.4	31.8	32.7	53.3	49.0	10.6	36.7	16.7	37.2	26.6	58.7	45.4	47.8	42.6	18.8	12.2	33.8	20.9	83.3	98.8	22.0	16.2	54.6	20.0	7.1	18.8	31.3	20.8	51.8	37.2	39.8	172.4	40.7	163.5	65.2	54.6	45.4	22.9	55.7	49.3	20.3	19.2	29.7	59.8	36.1	62.7	75.3	89.6	47.9	31.7	191.5	62.4	69.0	82.4	105.1	1.5	2.7	1.4	3.8	59.0	40.6	0.5	2.5	2.1	1.1	1.3	0.0	5.3	3.4	6.1	2.0	0.8	7.9	2.8	8.0	0.5	1.0	1.3	1.6	11.2	0.1	97.8	0.3	5.7	37.0	87.0	0.9	24.3	12.0	4.4	0.3	0.5	54.9	10.0	5.4	0.1	5.8	2.4	1.6	1.7	0.1	3.5	7.2	3.9	1.0	0.3	3.1	2.4	13.4	18.4	2.7	2.5	7.7	6.5	3.6	1.1	0.7	0.5	12.1	5.2	1.6	1.8	6.8	1.0	42.7	34.0	126.9	55.2	40.4	40.6	47.9	63.4	53.6	31.7	45.5	59.6	55.4	191.5	69.0	62.4	6.4	82.4	105.1	18.2	21.0	31.8	32.7	18.8	12.2	22.0	16.2	20.8	19.2	59.6	147.5	391.8	38.4	97.7	53.4	30.5	48.4	41.5	87.6	45.4	0.0	2.0	197.3	24.0	16.1	115.1	41.9	210.2	19.9	91.5	234.0	81.2	340.0	64.2	107.3	58.8	61.5	157.1	231.9	22.5	213.4	235.9	415.0	13.6	19.2	6.1	17.0	17.3	300.5	23.9	16.4	426.9	193.6	5.2	6.7	69.3	8.2	554.2	28.4	23.7
TSC22D4	"THG-1, TILZ2"	ENSG00000166925	"TSC22 domain family member 4"	Q9Y3Q8	7	100463359-100479279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.2"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 493.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006757	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006757: AB_1080403"	"unprognostic (2.34e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.81e-3)"	11.2	11.9	77.8	16.4	83.5	32.4	7.7	17.8	92.4	9.7	9.9	96.1	3.4	12.4	9.1	6.2	10.3	9.9	8.0	10.2	69.5	53.8	8.9	5.1	10.2	18.7	97.2	40.6	11.7	9.7	8.8	7.1	12.2	60.5	11.5	6.2	11.8	49.2	13.0	7.8	17.2	12.5	8.0	89.8	24.0	11.7	8.0	62.3	6.7	5.8	1.7	12.2	8.6	5.7	6.9	7.5	32.2	11.4	10.2	13.8	8.8	12.3	9.3	3.2	10.6	11.3	13.5	6.0	9.4	15.9	9.1	8.4	4.9	7.6	11.2	11.2	7.6	20.8	9.6	3.8	8.5	3.2	19.2	7.7	10.0	9.8	4.2	18.1	13.2	26.8	15.2	7.7	10.5	10.5	10.8	18.7	9.0	22.1	20.7	7.3	22.5	16.5	60.8	4.3	10.9	13.3	27.3	2.5	15.5	7.5	6.8	2.7	7.5	13.0	25.0	19.6	5.5	7.0	19.6	15.5	12.4	12.6	30.2	6.9	13.0	12.3	7.9	11.4	20.4	14.9	5.0	10.9	15.6	11.7	11.4	9.1	6.9	10.0	10.8	7.2	6.6	9.6	10.0	32.2	10.2	10.8	7.5	13.8	8.8	77.8	83.5	17.8	65.4	69.5	53.8	97.2	40.6	60.5	62.3	11.9	6.2	54.1	32.3	29.1	13.9	11.6	45.9	4.0	4.5	38.4	5.9	27.8	116.0	50.9	1.4	25.1	57.3	0.0	29.7	30.6	33.2	48.6	16.1	9.5	68.0	17.5	32.2	43.6	53.1	3.1	42.3	43.7	52.3	86.6	28.4	493.0	47.4	43.5	37.4	15.9	11.6	45.3	36.0	0.9	3.6	29.5	66.1	90.8	30.2	50.5
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029237	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	14.2	17.5	20.6	13.2	22.1	16.2	17.3	14.0	34.0	16.4	16.8	25.4	7.8	11.2	16.7	24.5	12.7	13.9	12.3	17.2	22.1	19.0	12.8	14.2	15.9	16.3	27.6	16.6	15.0	19.2	13.0	13.4	16.0	20.7	16.3	11.8	13.2	13.9	14.5	31.8	13.7	10.3	15.0	34.5	13.4	13.9	12.4	24.2	20.8	19.4	15.4	15.2	13.7	12.5	14.0	20.2	15.9	14.2	28.2	21.9	17.6	22.7	7.6	9.9	12.2	8.3	7.9	28.2	10.9	19.6	16.5	16.3	7.1	9.9	14.8	12.0	12.2	10.1	10.5	10.7	9.2	16.9	21.7	6.8	6.7	5.7	9.4	15.3	26.4	9.4	5.4	17.9	7.2	15.1	6.7	9.2	25.6	14.9	41.5	14.6	11.0	26.3	13.4	21.2	27.1	8.6	16.7	16.5	31.3	10.5	7.6	10.3	15.2	14.3	11.4	27.6	10.9	14.4	16.6	4.7	11.0	24.8	7.5	17.4	56.5	38.6	22.6	10.5	14.8	23.9	15.9	9.8	13.5	20.4	14.2	17.6	14.0	19.3	20.9	20.2	10.4	15.0	20.4	1.8	28.2	13.0	18.1	21.9	17.6	20.6	22.1	14.0	34.0	22.1	19.0	27.6	16.6	20.7	24.2	44.7	7.2	17.1	10.6	9.8	8.6	28.6	10.2	6.7	14.8	12.2	3.9	38.5	46.4	27.7	1.2	12.0	3.3	0.0	36.4	40.6	19.8	10.9	31.2	33.9	27.3	3.2	6.4	17.8	13.1	1.7	20.1	20.1	32.1	24.4	7.9	13.0	30.5	3.5	18.4	51.8	12.1	12.9	20.6	40.8	50.7	11.5	18.9	35.9	10.2	9.5
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484432-12539623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.8	10.6	9.7	8.8	19.1	6.7	10.9	16.5	14.0	10.4	9.8	12.7	8.4	5.8	14.0	9.9	7.9	12.8	10.3	14.3	10.5	12.3	9.8	7.3	7.3	10.9	11.5	7.6	18.0	11.9	14.3	15.3	4.9	10.2	10.5	10.9	13.5	7.2	13.1	16.7	15.3	6.1	12.3	12.3	6.1	8.5	11.3	9.1	9.9	12.5	9.6	8.1	8.6	8.3	8.5	7.1	2.6	4.2	5.0	13.7	5.6	7.8	13.7	7.4	9.6	12.5	13.3	17.0	7.4	6.6	8.0	5.8	7.7	8.4	9.4	5.2	6.0	9.5	7.3	12.3	12.7	9.1	7.4	15.2	10.3	18.3	7.9	9.6	16.2	4.0	11.5	14.8	14.5	17.8	5.9	6.4	13.8	15.3	5.2	9.2	14.8	12.4	7.4	10.4	22.2	16.5	9.4	5.1	18.9	11.9	8.1	4.8	8.4	6.9	6.2	5.8	5.3	11.2	11.3	5.7	5.1	5.0	6.9	11.5	4.9	12.5	11.8	6.8	16.4	6.3	2.4	4.2	0.3	6.4	4.2	10.9	8.5	9.8	7.4	5.9	8.3	13.7	11.7	2.6	5.0	3.6	7.1	3.5	5.6	9.7	19.1	16.5	14.0	10.5	12.3	11.5	7.6	10.2	9.1	3.0	3.5	10.9	9.7	2.6	27.2	6.2	15.3	9.4	2.3	10.4	41.2	7.4	1.7	4.9	1.3	5.6	2.6	0.0	3.7	3.2	3.8	5.0	4.7	5.5	4.1	9.5	4.1	3.1	4.0	2.1	8.3	3.2	3.3	1.0	4.7	8.7	3.5	3.5	9.6	5.0	33.9	6.5	5.1	10.3	19.3	4.3	1.6	5.7	8.2	8.0
TSEN54	"SEN54, SEN54L"	ENSG00000182173	"TRNA splicing endonuclease subunit 54"	Q7Z6J9	17	75516060-75524739	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease mutation, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 79.7;T-cells: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024543, HPA053097"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024543: , HPA053097: AB_2682043"	"unprognostic (3.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.60e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (2.33e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (2.62e-5)"	"unprognostic (7.26e-3)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.78e-5)"	"unprognostic (8.69e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.54e-4)"	6.2	7.9	8.1	9.7	11.0	12.9	7.1	24.6	9.0	8.0	12.4	10.9	8.6	18.9	7.2	6.1	12.8	9.1	27.0	4.9	12.2	5.0	12.3	9.8	9.5	10.4	15.8	9.4	7.3	21.6	7.6	10.7	5.9	11.7	11.0	7.3	4.7	13.6	11.5	7.9	19.5	17.3	7.4	9.5	15.2	17.4	7.4	10.5	10.9	10.4	8.6	13.1	8.5	8.9	4.6	10.5	7.5	3.4	17.0	34.0	9.6	14.9	17.1	4.8	9.7	1.6	1.9	12.7	3.9	2.5	8.0	6.4	20.2	12.3	19.3	5.2	1.5	5.6	13.9	6.2	5.8	3.6	5.1	22.5	14.8	10.5	12.5	4.0	6.0	30.5	2.3	7.5	3.6	3.3	1.8	5.4	12.3	17.4	6.9	2.3	26.0	19.8	17.3	6.5	14.4	17.1	14.6	15.2	14.3	4.3	8.3	16.3	12.6	8.6	23.2	6.2	6.7	16.5	8.6	2.6	8.5	13.4	10.6	8.2	17.0	7.8	10.3	4.7	19.7	3.9	7.5	1.6	5.0	34.0	3.4	22.5	4.6	13.8	25.2	3.9	2.9	11.1	21.2	0.2	17.0	3.2	10.5	7.7	9.6	8.1	11.0	24.6	9.0	12.2	5.0	15.8	9.4	11.7	10.5	8.9	8.1	6.7	11.3	23.5	13.9	2.0	10.2	2.7	7.9	8.7	3.9	10.6	10.0	14.6	4.6	8.7	16.8	0.0	15.1	14.6	8.9	7.7	79.7	7.7	11.2	30.2	18.0	6.2	4.6	4.2	4.4	4.5	15.1	17.2	15.7	15.2	12.5	16.7	7.1	9.8	6.8	12.9	8.7	15.8	26.0	21.2	6.3	62.1	19.6	7.3
TSFM	"EF-TS, EF-Tsmt"	ENSG00000123297	"Ts translation elongation factor, mitochondrial"	P43897	12	57782589-57808071	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 157.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006204			Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA006204: AB_1080405"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.93e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (8.82e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	14.5	46.2	16.6	14.7	21.5	15.3	18.5	18.2	24.3	12.7	18.8	13.3	17.6	17.8	11.6	13.7	16.1	12.4	10.3	27.7	14.6	15.6	27.0	30.2	10.1	14.6	15.4	20.8	10.3	19.6	17.0	13.1	11.6	17.8	11.7	18.3	11.1	13.5	14.1	33.5	14.7	13.4	17.7	11.6	12.5	14.0	23.2	13.6	11.3	15.4	26.9	13.4	14.4	13.0	18.5	18.7	9.0	16.8	20.0	23.5	16.0	8.4	9.8	5.9	8.8	5.5	5.5	8.6	7.1	6.3	11.6	8.1	11.4	11.2	21.2	13.6	6.2	6.5	10.0	9.9	10.2	8.8	8.6	12.0	12.9	8.3	10.0	8.4	16.4	7.8	6.4	10.5	8.8	5.0	8.9	7.1	12.0	16.6	11.5	8.7	9.8	9.7	17.9	9.1	12.3	13.1	11.8	157.2	19.0	11.0	9.6	12.8	7.9	7.6	13.4	12.9	5.5	23.2	12.0	5.2	6.3	8.9	9.2	7.6	8.5	17.4	16.5	8.9	9.9	7.5	3.7	14.8	9.0	18.6	13.8	23.5	18.5	20.9	18.4	18.7	16.4	21.2	21.7	4.2	20.0	16.8	14.7	18.1	16.0	16.6	21.5	18.2	24.3	14.6	15.6	15.4	20.8	17.8	13.6	17.9	9.6	15.6	12.7	23.0	19.8	29.9	35.7	20.1	13.6	43.6	13.7	59.0	81.2	56.0	69.4	9.6	12.7	23.3	75.2	41.0	20.6	14.1	21.9	32.5	31.6	14.3	13.3	17.8	7.3	33.2	21.0	18.6	25.3	102.8	18.4	20.6	51.6	17.5	22.6	110.7	16.3	58.2	17.6	36.4	60.1	31.7	39.8	15.0	32.8	9.2
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18527232	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		14000	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	24.7	30.5	18.4	14.2	25.5	23.5	27.6	22.7	25.9	22.5	23.1	23.7	21.6	20.5	25.8	27.7	34.3	23.9	18.4	31.8	17.7	20.6	33.4	29.0	20.1	23.4	21.6	21.4	23.2	39.5	33.2	23.5	38.5	24.6	21.9	28.4	19.4	25.4	22.4	44.5	27.3	25.7	23.1	21.7	20.5	23.0	33.7	20.2	27.5	32.3	37.1	25.5	24.2	25.5	20.5	18.2	42.3	29.2	14.3	22.0	22.2	14.4	23.8	21.1	14.6	25.0	26.2	19.7	22.4	30.3	27.5	27.2	16.3	7.6	19.5	13.8	25.0	29.6	22.2	21.0	20.3	30.5	27.4	25.7	12.1	12.6	24.0	32.2	18.1	20.9	22.6	41.4	14.3	39.0	29.0	22.5	18.9	19.6	16.6	33.2	26.0	11.4	19.7	13.0	31.3	24.2	10.3	21.4	16.2	18.4	20.6	15.1	27.0	21.5	18.1	28.6	22.1	18.0	18.2	12.1	18.5	11.3	38.4	16.6	10.7	20.5	15.5	19.0	10.1	23.5	42.3	19.5	40.7	14.9	21.7	15.0	20.5	14.4	15.9	18.2	18.0	15.4	16.4	34.5	14.3	29.2	15.4	22.0	22.2	18.4	25.5	22.7	25.9	17.7	20.6	21.6	21.4	24.6	20.2	59.6	51.0	42.1	71.0	37.8	39.6	60.3	56.0	107.1	37.5	41.8	23.6	165.8	106.1	92.2	31.6	49.6	64.6	46.7	89.0	89.6	50.5	62.3	42.8	34.8	70.2	35.0	59.1	46.6	42.2	12.6	52.0	49.4	54.0	107.4	58.3	78.3	101.0	58.3	40.7	95.2	33.9	45.3	45.3	142.6	153.8	42.3	247.6	44.5	43.7	75.7
TSGA10	"CEP4L, CT79"	ENSG00000135951	"Testis specific 10"	Q9BZW7	2	98997261-99154964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 55.7"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 127.2;Early spermatids: 359.6;Late spermatids: 192.4;Spermatocytes: 112.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036879			Approved	Cytosol		NA	NA			Cytosol		"HPA036879: AB_10671715"	"unprognostic (1.71e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-6)"	"unprognostic (1.06e-2)"	"unprognostic (9.91e-3)"	"unprognostic (9.79e-2)"	"unprognostic (8.37e-4)"	2.2	2.2	4.9	1.7	7.1	1.7	2.6	9.5	6.4	2.5	2.0	6.1	2.7	2.1	2.3	3.6	1.7	15.1	2.2	1.3	4.7	3.4	3.3	1.6	2.9	2.1	5.9	4.5	1.7	3.2	2.9	12.2	1.5	4.7	2.2	2.5	1.0	2.3	1.8	1.1	3.1	1.7	1.3	4.2	1.9	2.5	55.7	6.6	1.8	4.5	0.7	1.9	2.3	2.3	2.5	1.2	0.6	0.7	2.3	3.5	0.9	1.4	0.5	2.5	0.9	1.5	1.5	1.9	0.0	0.1	0.4	0.5	0.3	1.8	1.4	0.6	0.0	1.0	0.4	0.5	0.2	0.7	1.7	1.5	0.1	0.0	0.5	0.2	1.0	3.6	1.8	2.1	0.2	0.3	1.5	0.0	1.6	0.0	0.1	1.6	0.3	0.5	0.5	0.4	0.6	0.4	0.6	0.3	0.4	9.0	1.4	3.5	0.4	1.7	1.5	0.2	3.0	0.4	0.5	0.8	0.4	0.9	0.1	0.3	1.2	0.3	0.3	0.8	2.2	0.9	0.3	0.7	0.6	1.9	0.1	2.1	2.1	2.2	2.6	0.1	2.5	3.5	2.1	0.0	2.3	0.0	1.2	2.2	0.9	4.9	7.1	9.5	6.4	4.7	3.4	5.9	4.5	4.7	6.6	3.0	8.6	9.1	8.8	3.2	17.9	6.2	15.3	127.2	18.2	22.7	27.5	5.7	21.6	6.4	359.6	3.4	5.1	0.0	9.3	3.7	3.6	8.1	4.7	6.6	3.9	19.1	14.9	2.5	2.4	192.4	10.3	2.9	1.7	4.6	7.3	15.4	5.1	11.4	9.2	11.0	34.3	6.5	2.7	112.7	30.1	3.9	7.8	5.9	8.3	8.4
TSGA13		ENSG00000213265	"Testis specific 13"	Q96PP4	7	130668648-130687432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 16.5"	"Group enriched"	"Detected in some"	9	"Early spermatids: 62.7;Late spermatids: 126.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.0;THP-1: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022968	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA022968: AB_2671013"					"unprognostic (1.49e-1)"					"unprognostic (1.13e-2)"		"unprognostic (1.86e-1)"		"unprognostic (1.34e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.2	0.6	0.8	0.5	0.3	0.1	0.5	0.0	0.0	0.9	0.7	0.2	0.4	0.0	0.2	1.0	0.0	0.6	0.2	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.0	0.4	0.9	0.1	0.3	0.4	0.1	0.2	1.1	0.6	0.2	0.5	0.2	0.3	0.2	0.2	0.1	0.2	0.6	0.5	0.4	1.2	0.8	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	4.6	0.5	0.1	1.4	1.4	0.0	0.0	10.7	3.4	0.0	7.9	0.1	0.0	0.0	62.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.8	126.7	0.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.1	0.0	0.1	1.2	0.6	0.4	0.6	0.0	0.0	0.0
TSHZ1	"NY-CO-33, SDCCAG33, TSH1"	ENSG00000179981	"Teashirt zinc finger homeobox 1"	Q6ZSZ6	18	75210755-75289950	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Peritubular cells: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.9"	"Region enriched"	"Detected in many"	5	"olfactory region: 81.2"	"Low region specificity"	"Detected in all"			HPA006982	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006982: AB_1079886"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.12e-2)"	"unprognostic (9.05e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (3.42e-3)"	16.2	9.4	13.8	10.3	16.8	3.6	25.6	25.9	23.2	20.9	22.4	8.5	9.3	15.3	13.1	11.3	11.7	19.0	11.9	13.6	11.9	9.2	13.9	9.3	9.3	10.0	9.9	7.7	41.6	8.9	12.6	18.5	32.1	12.7	10.8	10.8	13.7	13.3	13.6	9.4	12.0	17.5	13.5	19.0	10.2	11.5	8.7	7.9	14.3	9.7	5.2	6.2	14.7	19.9	1.2	1.7	1.2	1.2	3.2	5.1	1.4	3.3	4.0	1.4	8.2	12.4	6.0	1.4	15.3	14.5	2.5	4.9	2.0	8.2	6.7	2.0	13.9	2.9	3.0	1.8	4.4	0.9	27.9	15.1	5.2	9.3	2.6	3.2	12.2	6.1	6.0	4.7	2.1	4.2	4.0	6.5	7.9	2.9	12.1	4.2	3.2	8.7	6.9	0.5	3.9	5.0	8.0	4.2	8.0	4.9	2.4	10.4	7.9	4.3	5.6	4.2	0.6	1.3	6.4	4.9	5.7	3.9	3.9	2.4	4.0	9.5	5.5	5.5	10.4	5.1	0.0	1.2	1.2	4.8	0.5	3.4	1.0	2.4	4.2	1.7	1.2	3.7	5.1	0.8	3.2	0.5	1.7	1.0	1.4	13.8	16.8	25.9	23.2	11.9	9.2	9.9	7.7	12.7	7.9	11.9	12.3	6.2	4.8	15.0	42.4	21.6	22.9	12.0	10.3	3.5	2.0	3.7	3.3	4.4	1.0	26.9	17.4	0.0	8.8	1.7	35.1	6.4	6.9	18.1	5.4	11.1	16.3	18.4	12.9	2.4	59.8	10.0	8.5	1.8	17.0	16.6	3.3	10.5	176.0	16.7	10.9	25.8	11.8	0.7	4.9	11.5	3.0	15.8	16.4	5.2
TSHZ2	"C20orf17, OVC10-2, TSH2, ZABC2, ZNF218"	ENSG00000182463	"Teashirt zinc finger homeobox 2"	Q9NRE2	20	52972407-53495330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Leydig cells: 433.5;Peritubular cells: 755.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.1"	"Lineage enriched"	"Detected in many"	4	"T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 19.9;ASC diff: 8.7;HeLa: 17.4;SiHa: 11.3;U-2197: 10.2"	"Low region specificity"	"Detected in many"							HPA038123	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038123: AB_10670657"	"unprognostic (9.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (3.30e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.88e-8)"	"unprognostic (6.26e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.37e-7)"	"unprognostic (2.97e-3)"	16.2	12.3	2.8	5.7	3.5	0.2	10.3	1.0	9.8	12.9	7.4	1.8	27.7	2.0	11.8	15.9	7.6	7.3	11.4	3.9	4.8	3.5	2.7	11.1	3.0	3.6	3.5	5.8	17.2	3.4	2.1	2.6	1.2	4.6	7.6	1.9	0.1	11.2	35.8	3.9	4.9	3.1	8.3	14.3	4.4	4.4	9.6	2.5	0.0	5.0	5.8	3.0	9.0	16.5	0.9	0.3	1.3	0.1	0.2	6.1	1.0	0.0	0.0	1.3	19.9	8.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	3.7	1.1	0.0	17.4	0.0	0.2	0.0	0.4	3.1	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.3	11.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	2.0	10.2	0.0	0.0	0.2	0.0	2.1	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.8	4.1	0.2	0.0	0.9	6.1	0.4	1.3	0.2	0.1	0.3	4.3	1.0	2.8	3.5	1.0	9.8	4.8	3.5	3.5	5.8	4.6	2.5	0.0	1.1	5.4	18.1	40.3	4.5	2.8	43.3	5.3	10.3	34.9	2.0	1.0	0.0	36.1	8.8	67.1	0.0	0.0	8.9	0.6	19.5	29.7	1.1	80.0	1.1	0.0	6.3	12.3	1.0	6.7	433.5	1.5	11.8	1.0	0.6	53.3	10.9	0.6	755.6	0.1	1.3	38.8	7.8	1.8	1.7	35.4	0.7	8.7	1.5	6.7
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31274945-31349547	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 18.6;Ito cells: 19.6;Leydig cells: 16.4;Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.9"	"Group enriched"	"Detected in many"	35	"granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.0;RH-30: 26.7;U-138 MG: 18.9;U-87 MG: 12.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 20.4;hippocampal formation: 16.8"	"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		No	No			Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	5.7	3.3	4.4	4.0	6.6	1.0	5.2	1.1	17.3	13.0	11.6	0.7	2.4	2.5	19.4	8.5	5.6	9.5	11.5	4.6	3.3	2.0	2.8	1.3	4.9	1.2	1.6	8.0	28.0	1.5	1.1	7.2	4.8	2.8	9.5	3.7	4.9	2.8	8.9	1.6	2.5	4.3	16.4	3.3	4.5	6.1	3.3	1.2	0.0	8.5	1.7	0.7	11.1	11.4	0.0	0.0	4.9	2.2	0.0	3.2	0.7	0.0	1.1	0.4	0.0	5.9	13.0	0.0	3.4	4.9	2.1	3.8	0.0	0.7	0.0	0.0	8.4	4.4	0.5	1.5	3.1	4.7	0.0	1.3	0.0	0.0	0.0	11.4	2.8	5.3	7.6	2.8	7.8	3.9	0.0	0.0	2.5	0.0	0.0	9.8	0.5	0.0	0.0	0.5	0.0	0.0	3.3	26.7	0.0	0.0	0.0	0.0	8.1	0.0	0.0	2.6	2.7	0.0	2.0	0.0	18.9	6.0	2.1	4.8	0.0	0.0	0.0	12.2	4.9	0.5	0.0	2.2	0.0	3.2	0.8	0.1	0.0	0.9	1.0	0.0	0.0	0.3	0.8	4.9	0.0	0.4	0.0	0.7	0.7	4.4	6.6	1.1	17.3	3.3	2.0	1.6	8.0	2.8	1.2	3.0	0.6	0.0	6.8	4.2	13.9	1.6	0.0	1.4	6.8	3.5	0.0	0.3	0.0	0.3	0.1	6.7	0.0	0.0	0.6	0.2	18.6	3.3	1.1	0.0	9.1	15.9	0.0	19.6	11.6	0.0	16.4	6.1	5.0	0.0	0.0	0.2	0.5	0.0	27.6	0.0	0.1	0.0	10.3	0.0	5.0	1.5	0.7	0.5	0.0	2.4
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798154	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.8"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 41.4;ASC diff: 70.9;OE19: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted - unknown location"	NA	NA		2100000	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (2.87e-4)"	"prognostic favorable (1.66e-4)"	"prognostic unfavorable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	33.1	2.8	1.0	3.6	1.4	0.6	26.9	1.5	2.0	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43.0	3.4	15.7	4.5	48.5	9.3	10.8	7.0	15.0	21.4	13.0	0.8	3.0	8.7	9.0	0.8	1.5	12.2	16.0	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	41.4	4.6	4.5	70.9	9.1	8.5	1.4	7.8	3.1	3.0	5.3	11.4	0.1	8.1	5.1	13.2	16.6	2.6	10.2	0.9	8.5	1.4	2.0	10.7	14.8	13.4	0.7	3.1	9.3	11.2	5.5	4.5	5.9	3.8	1.5	4.5	0.3	2.8	19.1	0.1	1.5	6.1	44.7	1.8	1.3	4.4	6.5	7.3	7.2	4.2	6.9	7.9	6.2	3.8	4.1	8.3	0.6	1.1	8.7	6.9	21.1	3.3	0.3	0.1	0.3	4.1	2.1	1.5	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1.0	1.4	1.5	2.0	1.2	0.3	1.7	1.3	3.4	0.8	0.0	0.3	0.0	13.0	15.3	3.2	3.9	15.3	2.7	5.7	1.8	0.0	42.8	0.0	5.8	0.2	3.6	20.6	23.3	19.6	58.8	39.7	6.5	1.1	427.8	8.4	0.0	7.5	8.6	9.5	1.2	34.5	1.6	5.0	2.8	14.2	10.4	17.7	20.1	42.5	21.9	0.5	0.0	13.4	0.4	2.3	19.7	36.6	4.4	11.3	17.0
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		320000	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: AB_2684063"	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	14.9	18.7	23.1	13.0	24.6	43.0	25.6	17.8	27.7	18.6	23.1	23.7	11.8	17.2	17.9	19.1	18.2	15.2	16.3	18.7	20.6	23.0	24.7	22.0	15.0	22.6	22.8	20.1	17.5	20.7	19.3	17.9	13.8	23.3	15.0	18.9	16.5	16.3	18.2	29.4	18.9	16.4	14.3	22.0	17.5	15.4	33.9	17.6	28.3	17.2	18.7	17.4	13.9	14.2	22.1	22.7	22.0	24.4	19.6	23.1	20.7	21.4	9.8	14.4	12.1	13.4	10.6	8.0	18.4	16.7	19.4	19.2	27.2	11.9	30.0	21.7	16.6	11.5	10.1	21.0	16.9	26.9	16.6	17.2	17.7	14.0	24.3	15.0	24.7	12.6	9.0	18.8	21.9	14.5	8.5	15.8	14.6	26.7	14.4	17.5	11.1	15.0	27.7	17.5	11.4	18.6	25.3	16.2	22.1	23.4	14.2	18.9	11.8	12.0	17.4	20.7	11.6	11.6	18.4	11.8	14.0	23.8	9.2	17.4	13.3	37.9	33.6	16.2	16.7	16.9	17.2	24.4	22.0	19.6	22.2	22.7	22.1	20.4	17.0	22.7	18.0	23.1	20.1	7.9	19.6	19.0	16.5	20.2	20.7	23.1	24.6	17.8	27.7	20.6	23.0	22.8	20.1	23.3	17.6	29.8	26.1	37.9	30.5	34.8	31.1	31.9	35.7	21.4	25.0	40.1	21.6	29.5	36.5	47.5	50.8	37.3	18.6	23.3	52.8	29.2	29.4	23.8	39.3	39.9	31.5	15.9	19.1	60.8	29.8	10.8	33.6	31.9	64.1	36.9	25.3	80.9	38.3	21.0	29.4	48.2	26.8	25.8	37.1	109.7	104.5	38.3	23.8	36.3	34.9	22.0
TSNARE1	FLJ31164	ENSG00000171045	"T-SNARE domain containing 1"	Q96NA8	8	142212080-142403240	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 18.8"									HPA074249	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA074249: "	"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.33e-4)"	9.0	8.4	14.3	10.1	14.3	5.3	9.0	14.4	18.4	11.2	8.9	15.6	7.4	15.2	12.6	10.5	7.4	13.2	8.2	7.2	8.6	8.0	8.6	6.6	9.2	8.2	12.7	12.9	17.9	24.3	9.0	9.8	4.8	11.6	10.5	4.3	10.5	17.1	11.5	11.7	31.9	16.5	7.4	8.4	13.2	11.3	8.9	14.3	6.3	12.3	6.5	9.7	9.3	8.8	1.2	1.5	3.9	5.0	1.2	2.3	1.4	5.0	5.0	3.3	4.1	2.6	2.4	10.4	1.5	2.4	1.5	1.6	1.5	5.5	2.7	8.2	1.2	2.6	4.5	1.5	5.2	0.6	3.0	4.7	2.9	1.2	5.4	6.9	7.1	7.4	4.6	4.9	0.0	3.5	3.1	1.6	14.2	6.0	0.3	1.0	6.6	5.9	6.4	3.3	5.0	11.9	0.0	1.7	4.5	2.9	6.2	13.7	8.3	6.7	5.6	9.9	1.7	3.7	6.4	4.1	2.4	6.6	4.5	3.1	0.4	2.0	4.2	4.5	18.8	2.5	3.9	1.3	0.3	2.3	5.0	1.6	0.8	1.3	0.6	1.5	1.2	0.5	0.9	0.1	1.2	3.5	0.0	1.5	1.4	14.3	14.3	14.4	18.4	8.6	8.0	12.7	12.9	11.6	14.3	0.0	1.4	0.0	1.9	3.9	2.0	3.1	2.5	2.7	0.0	1.8	2.0	0.2	3.3	1.4	1.8	1.4	1.3	0.0	1.6	1.5	0.6	1.2	0.0	1.1	1.7	0.0	1.7	1.3	3.0	3.9	0.9	1.2	3.3	1.8	0.7	2.9	1.4	0.0	1.4	1.4	0.7	0.0	1.3	3.9	3.2	6.6	0.2	2.2	0.8	0.9
TSNAX	TRAX	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528653-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		100000	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	27.4	29.9	23.9	17.1	26.7	12.0	23.4	28.0	33.1	19.7	16.2	21.9	17.2	15.8	20.0	24.6	18.0	16.4	16.7	22.7	25.1	23.9	29.1	23.0	18.4	22.6	22.1	22.1	18.6	14.6	32.3	36.0	18.3	28.5	21.3	18.0	19.6	17.5	19.9	52.5	20.6	14.8	18.9	28.2	24.0	15.5	17.5	24.4	24.5	26.7	25.4	22.0	19.1	17.3	10.0	11.7	54.6	17.5	18.7	13.5	11.0	11.0	9.1	13.9	11.4	10.3	12.7	15.8	12.6	19.1	16.2	14.0	7.8	15.6	15.6	21.3	13.7	6.0	12.1	11.0	11.4	21.1	13.9	19.2	15.0	9.4	10.3	14.2	24.7	31.9	15.5	12.6	15.6	12.1	10.2	11.7	11.4	24.2	11.1	21.9	4.5	15.9	12.1	20.5	9.3	11.1	15.8	15.3	21.1	18.1	12.8	13.3	25.6	13.1	16.7	42.4	5.9	24.3	42.0	10.9	11.2	10.2	22.4	22.6	18.9	24.9	17.4	18.3	19.6	30.6	54.6	11.2	29.2	11.4	13.5	10.8	10.0	12.3	11.2	11.7	9.9	13.2	12.7	11.4	18.7	17.5	6.8	13.5	11.0	23.9	26.7	28.0	33.1	25.1	23.9	22.1	22.1	28.5	24.4	26.8	32.9	25.4	17.9	38.9	58.2	20.9	38.2	26.8	17.0	40.1	27.5	39.1	46.4	25.0	7.5	33.3	20.5	46.7	27.1	39.0	28.8	14.4	75.1	26.0	42.6	62.0	27.7	27.6	51.1	7.5	31.1	45.0	25.3	37.9	29.8	64.5	23.0	23.4	33.9	36.6	45.9	38.8	35.6	28.1	70.9	44.9	30.3	35.8	22.4	12.2
TSNAXIP1	TXI1	ENSG00000102904	"Translin associated factor X interacting protein 1"	Q2TAA8	16	67806765-67832148	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.2;testis: 40.6"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 46.8;Early spermatids: 85.4;Late spermatids: 137.1;Spermatocytes: 56.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.1;SiHa: 4.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA053516			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053516: AB_2682175"	"unprognostic (9.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.59e-3)"	0.9	1.9	4.8	1.1	9.2	0.6	0.9	2.0	3.9	1.3	0.9	3.3	1.9	0.5	1.8	3.6	0.7	14.2	1.2	0.7	3.8	3.3	1.6	0.8	2.1	0.7	1.2	3.7	2.5	2.2	2.9	6.9	0.7	6.3	1.0	0.7	1.0	1.0	2.0	0.5	0.8	0.6	1.2	0.9	0.8	1.2	40.6	2.5	0.0	1.1	0.0	0.7	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.4	1.1	0.4	2.5	7.1	3.5	0.9	0.9	0.0	1.6	0.5	2.4	0.7	0.8	1.1	1.1	0.2	0.8	1.4	1.0	1.1	1.5	0.4	0.9	0.0	0.8	0.1	1.1	1.7	0.2	0.9	0.9	3.6	0.5	0.5	0.0	1.4	0.5	0.3	0.0	0.0	0.3	0.6	0.7	0.2	0.4	1.7	0.7	0.1	3.6	0.7	2.0	2.1	4.5	0.1	0.4	0.9	1.8	0.1	0.9	0.4	0.1	0.3	0.2	1.3	2.1	0.2	0.3	0.2	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.8	9.2	2.0	3.9	3.8	3.3	1.2	3.7	6.3	2.5	0.0	2.4	0.0	0.4	0.1	3.1	8.1	0.0	46.8	5.7	5.2	3.9	0.4	0.0	0.6	85.4	0.6	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.8	0.2	3.2	0.0	0.6	0.0	137.1	2.6	0.5	0.0	0.0	0.0	3.5	0.1	0.0	1.8	2.1	10.0	6.5	0.3	56.4	11.2	0.3	0.5	0.0	0.0	0.1
TSPAN1	"NET-1, TSPAN-1"	ENSG00000117472	"Tetraspanin 1"	O60635	1	46175073-46185958	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.0;testis: 119.0"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 1113.5;Collecting duct cells: 549.6;Enterocytes: 573.6;Late spermatids: 654.5;Paneth cells: 587.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 455.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	90	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in some"		"A-431: 21.3;CAPAN-2: 36.8;HaCaT: 25.7;hTCEpi: 29.8;OE19: 42.8;RPTEC TERT1: 107.8;RT4: 51.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011909	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA011909: AB_2668565"	"unprognostic (1.21e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.28e-6)"	"unprognostic (5.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.90e-2)"	"unprognostic (4.30e-2)"	1.7	0.6	1.7	4.8	2.4	0.0	1.5	11.4	3.5	9.0	59.9	1.8	1.5	2.2	1.8	4.6	1.9	13.9	2.6	2.6	2.2	0.0	46.0	1.9	5.7	2.1	2.4	1.7	1.5	1.5	15.4	3.3	1.5	2.1	22.7	70.0	3.3	16.1	7.8	1.5	0.1	18.3	1.9	1.8	1.6	24.6	119.0	1.9	1.6	13.9	1.8	1.9	21.0	1.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	21.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	36.8	0.0	6.9	0.0	0.0	25.7	0.0	18.8	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	29.8	0.1	10.6	0.6	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.0	0.0	42.8	1.3	0.0	0.0	0.2	107.8	51.7	0.3	0.0	0.0	2.2	0.1	0.1	1.5	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	1.7	2.4	11.4	3.5	2.2	0.0	2.4	1.7	2.1	1.9	23.8	19.0	15.7	180.5	0.9	0.0	0.6	15.3	1113.5	208.1	549.6	0.0	0.1	39.7	40.8	130.9	1.2	573.6	0.0	480.2	0.1	1.0	212.2	11.5	2.6	0.2	0.0	193.7	2.5	0.3	654.5	4.6	4.0	5.0	2.8	525.2	0.0	292.8	587.5	1.8	400.8	0.0	0.0	0.3	4.2	1.9	1.1	0.0	0.8	136.2	439.3
TSPAN11		ENSG00000110900	"Tetraspanin 11"	A1L157	12	30926428-30996599	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 25.6"	"Cell type enhanced"	"Detected in some"	10	"Ito cells: 7.4;Late spermatids: 8.4;Leydig cells: 4.4;Muller glia cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.6;HSkMC: 18.4;NTERA-2: 14.8;SCLC-21H: 7.1;SH-SY5Y: 14.2;SuSa: 9.1"	"Low region specificity"	"Detected in many"							HPA066789			Approved	Vesicles		NA	NA			Vesicles		"HPA066789: AB_2685723"	"unprognostic (4.10e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.51e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.28e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.79e-1)"	3.1	2.5	6.4	16.0	3.8	0.0	2.5	15.2	12.7	9.0	25.6	9.0	3.0	4.4	6.4	7.8	8.8	2.4	12.2	8.8	5.0	4.7	1.6	1.0	8.5	2.6	4.1	3.8	1.9	1.4	0.3	1.5	0.8	3.8	5.4	11.0	12.2	3.8	6.8	0.8	6.5	10.9	8.3	2.6	2.6	4.5	1.6	3.7	0.0	4.0	12.3	8.9	6.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.5	0.0	1.1	1.6	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	14.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	7.1	14.2	0.1	0.0	0.0	9.1	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	3.8	15.2	4.3	5.0	4.7	4.1	3.8	3.8	3.7	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.1	0.0	0.0	7.4	0.0	8.4	4.4	1.1	1.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.2	0.2	1.0	0.0	0.0	0.0	0.0
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 110.2;Collecting duct cells: 97.7;Distal tubular cells: 160.8;Proximal tubular cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.2;HUVEC TERT2: 23.7;RH-30: 21.7;RPTEC TERT1: 34.7;RT4: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules		NA	NA			Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	6.8	40.9	3.1	4.3	3.9	0.0	4.5	2.2	3.3	8.1	19.3	2.1	36.8	13.5	6.1	8.7	3.6	3.7	13.6	22.2	3.2	2.7	40.7	12.6	16.9	1.6	2.7	2.3	2.5	12.8	1.1	10.3	9.9	3.3	7.9	7.1	2.9	33.7	15.1	2.3	1.2	31.0	4.1	1.8	18.4	7.6	3.0	2.2	0.5	18.7	3.5	3.2	10.4	3.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	6.2	0.1	1.3	0.4	6.0	0.1	0.2	0.5	2.0	1.0	1.5	0.0	4.3	0.1	0.7	0.1	3.1	0.6	0.8	0.0	21.2	1.1	6.2	0.9	3.4	0.0	1.0	0.1	0.0	0.1	0.1	0.8	23.7	0.0	0.2	0.7	2.7	0.8	0.0	0.1	9.9	4.1	3.8	0.0	21.7	0.7	34.7	26.4	5.1	3.0	0.2	0.5	0.0	8.7	3.2	0.7	1.0	5.1	1.6	0.0	2.6	6.5	0.0	0.0	0.7	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.9	2.2	3.3	3.2	2.7	2.7	2.3	3.3	2.2	110.2	36.0	1.7	16.9	2.3	0.0	56.0	43.3	9.4	29.6	97.7	0.0	34.8	160.8	6.2	0.4	28.0	15.4	0.0	6.4	39.5	5.6	12.3	2.3	28.6	3.7	0.0	9.2	8.6	0.3	1.2	3.7	1.5	5.0	0.0	22.1	0.5	4.2	26.2	0.7	93.5	0.0	0.0	13.4	0.1	6.9	1.8	20.3	0.5	26.6	20.7
TSPAN13	"NET-6, TM4SF13"	ENSG00000106537	"Tetraspanin 13"	O95857	7	16753535-16784536	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 461.6;Mucus-secreting cells: 362.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 24.7;plasmacytoid DC: 51.3"	"Group enriched"	"Detected in many"	41	"B-cells: 24.7;dendritic cells: 51.3"	"Cell line enhanced"	"Detected in many"		"OE19: 74.3;SCLC-21H: 34.3;SK-BR-3: 49.6;T-47d: 92.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007426	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007426: AB_10603137"	"unprognostic (3.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (5.69e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (2.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	20.8	24.2	17.7	7.6	24.9	6.2	25.6	10.7	33.0	18.6	23.6	3.0	21.0	25.2	5.9	12.3	8.8	5.7	16.0	6.8	14.5	21.7	3.3	22.2	53.4	14.8	12.0	15.9	2.1	55.2	4.6	48.0	19.0	14.0	15.1	29.1	8.5	49.1	19.2	4.1	4.7	27.8	5.9	3.6	12.9	31.3	3.1	3.4	3.6	13.0	7.1	18.5	12.1	10.6	24.7	51.3	0.9	0.0	0.8	0.0	1.2	7.1	5.9	7.6	8.0	0.9	0.0	2.1	15.4	2.5	0.4	0.7	20.8	11.1	0.2	3.9	5.5	1.9	11.1	8.7	12.9	3.4	0.2	9.4	3.0	2.4	2.2	2.1	0.2	0.6	0.9	5.6	0.8	0.9	4.4	4.7	3.2	10.0	0.0	0.4	20.4	0.4	0.4	5.3	74.3	7.2	8.2	0.0	7.4	24.0	13.6	34.3	5.2	2.8	49.6	0.7	11.3	92.8	0.8	0.4	0.2	2.7	0.2	5.0	4.5	0.1	0.1	7.1	0.1	10.8	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	24.7	0.0	0.0	0.9	0.8	0.0	51.3	0.0	1.2	17.7	24.9	10.7	33.0	14.5	21.7	12.0	15.9	14.0	3.4	461.6	65.1	58.0	67.1	37.8	65.4	15.8	38.2	25.4	58.0	27.9	7.9	258.0	6.6	62.2	1.0	52.8	83.8	46.7	178.4	88.6	42.3	128.5	9.2	25.9	34.7	14.3	103.4	9.8	15.8	1.8	0.6	4.3	30.4	105.6	362.8	2.3	99.4	94.7	0.7	0.7	7.4	32.3	10.8	0.7	16.8	34.6	168.2	8.7	117.0	107.7
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451473-69507669	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 106.8;Exocrine glandular cells: 167.5;Mucus-secreting cells: 103.1;Pancreatic endocrine cells: 141.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 17.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.9;EFO-21: 48.7;MCF7: 36.8;OE19: 33.8;PC-3: 60.5;SK-BR-3: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044657, HPA071160"	Approved		Approved	"Nuclear bodies,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nuclear bodies, Plasma membrane"	"Vesicles, Cytosol"	"HPA044657: AB_10967927, HPA071160: "	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	34.2	3.1	11.5	9.7	22.7	0.9	24.9	40.4	17.0	8.9	30.4	49.2	12.5	24.0	15.1	8.4	7.1	16.2	17.1	8.3	18.0	9.2	10.2	3.0	20.4	4.9	33.1	11.2	3.0	10.8	1.4	3.3	17.7	16.8	17.6	24.9	5.4	16.8	17.0	9.9	4.6	21.5	23.0	43.0	13.5	46.4	4.0	28.3	0.8	6.7	2.7	4.8	22.6	6.8	0.0	2.7	0.0	0.0	0.1	17.4	0.5	11.1	23.2	0.4	0.0	0.5	0.0	2.7	0.0	0.4	0.6	1.5	10.0	34.9	0.0	48.7	0.5	2.1	22.8	1.6	2.5	0.7	9.2	4.6	0.6	0.7	2.2	0.2	0.0	0.4	0.5	0.7	0.3	0.3	1.7	8.9	4.6	0.2	0.0	0.2	36.8	0.1	0.2	0.6	33.8	60.5	0.8	0.4	0.4	6.8	20.7	7.9	3.0	0.1	30.7	3.8	4.1	13.4	0.5	7.7	0.0	0.1	0.0	3.8	0.2	1.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	17.4	0.0	2.7	2.5	2.7	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.9	0.5	11.5	22.7	40.4	17.0	18.0	9.2	33.1	11.2	16.8	28.3	29.8	5.8	2.7	9.7	3.2	3.0	0.8	25.5	14.7	6.8	27.9	5.9	1.5	3.3	106.8	26.3	18.7	73.5	0.0	167.5	9.1	4.7	50.7	1.1	0.0	20.5	1.6	38.6	11.1	5.6	4.9	0.6	10.5	27.0	27.1	103.1	36.7	141.3	88.3	0.0	1.3	1.4	12.9	7.6	0.9	17.7	2.8	2.5	2.5	61.6	27.1
TSPAN17	"FBX23, FBXO23, TM4SF17"	ENSG00000048140	"Tetraspanin 17"	Q96FV3	5	176647387-176659054	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030447			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030447: AB_2673484"	"unprognostic (1.70e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.46e-1)"	11.1	29.3	18.7	12.8	12.6	39.1	14.7	18.3	20.9	8.7	14.7	7.1	12.4	13.1	9.0	10.5	16.6	11.2	16.8	16.5	13.3	10.4	16.4	15.0	13.5	19.8	9.2	9.2	8.6	30.5	12.3	19.5	10.3	10.4	12.4	11.8	9.1	11.7	15.8	30.2	11.2	14.6	11.7	6.6	15.7	15.3	18.4	11.2	3.4	11.9	13.7	15.8	14.5	9.4	2.6	3.1	0.8	4.9	3.7	9.3	3.4	16.0	16.3	10.9	19.9	15.2	13.1	17.0	12.1	17.7	17.9	17.9	4.9	18.5	7.2	22.1	20.8	37.0	12.3	5.4	28.1	11.0	53.0	11.4	2.7	7.1	5.8	13.9	5.8	10.1	15.5	15.9	14.2	8.7	12.2	24.5	5.6	13.5	7.8	18.1	26.5	1.2	2.5	8.8	15.7	17.9	6.1	9.3	4.0	16.8	11.9	16.6	11.7	13.1	15.3	16.3	9.5	12.5	7.4	18.9	19.5	20.3	14.6	15.1	4.4	5.7	3.1	21.3	12.4	11.3	0.0	3.1	0.8	5.4	3.1	4.3	1.6	4.1	8.8	3.1	2.6	2.9	3.9	0.5	3.7	4.9	0.8	9.3	3.4	18.7	12.6	18.3	20.9	13.3	10.4	9.2	9.2	10.4	11.2	11.9	9.8	8.2	9.5	2.6	9.7	12.3	12.7	1.4	5.7	10.4	11.8	0.8	5.0	32.2	0.8	7.9	26.0	23.3	49.2	16.3	9.1	11.8	0.0	11.6	13.6	1.6	13.8	12.3	8.9	0.4	6.4	8.6	6.8	14.4	19.4	6.5	35.7	19.5	6.7	11.0	24.8	0.0	8.6	1.1	2.4	4.6	1.0	13.1	20.4	11.9
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Muller glia cells: 483.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7"	"Group enriched"	"Detected in all"	5	"B-cells: 69.7;dendritic cells: 46.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	64.0	31.4	71.6	16.9	66.5	6.0	43.3	36.8	67.5	31.4	75.3	49.4	74.2	70.6	28.4	95.9	16.8	53.8	39.4	24.6	58.1	63.7	44.9	17.8	41.9	22.9	64.4	45.8	33.0	31.6	53.6	44.0	23.1	54.1	21.3	82.7	44.3	30.8	60.9	79.3	16.3	71.2	27.6	49.2	19.1	46.1	21.3	40.4	14.2	43.0	24.7	25.4	23.2	15.2	69.7	46.7	1.5	10.8	8.3	6.9	12.1	20.8	56.9	47.3	29.8	83.1	51.2	15.6	33.4	36.4	41.2	45.1	34.6	43.6	20.5	49.7	34.5	39.4	47.4	44.8	22.9	31.0	22.9	67.9	14.6	43.6	32.7	40.3	18.8	10.8	48.1	27.7	22.7	20.3	63.0	50.4	13.7	15.4	18.1	40.3	7.9	16.6	17.9	33.4	67.0	25.3	21.0	58.8	21.6	67.8	11.9	42.9	47.5	22.9	19.4	62.1	47.4	20.8	35.7	47.7	38.3	15.0	23.0	46.7	39.9	54.2	10.9	33.9	28.2	21.8	0.8	7.5	1.5	5.1	9.9	5.4	69.4	2.6	3.7	14.8	69.7	6.9	6.3	0.7	8.3	10.8	46.7	0.6	12.1	71.6	66.5	36.8	64.2	58.1	63.7	64.4	45.8	54.1	40.4	104.2	182.8	49.0	53.9	30.8	241.7	81.1	112.1	176.7	158.1	64.6	172.8	77.0	21.6	218.3	24.0	52.8	344.7	0.0	309.7	26.2	81.8	155.9	22.0	27.0	57.7	120.8	87.8	60.2	53.5	44.3	59.5	31.1	69.2	23.4	234.6	483.1	209.9	302.5	48.4	50.7	133.3	25.8	63.7	84.0	50.0	29.9	63.5	26.1	164.4	170.4
TSPAN31	SAS	ENSG00000135452	"Tetraspanin 31"	Q12999	12	57738013-57750211	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"glioma: 54.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 60.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030758, HPA057489"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol"		Yes	No			"Golgi apparatus"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA030758: , HPA057489: AB_2683447"	"unprognostic (2.66e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (4.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (9.91e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.58e-1)"	27.0	26.4	19.4	18.2	22.5	5.4	21.8	14.3	20.5	21.9	20.1	30.5	23.0	16.3	23.1	37.6	21.3	27.7	23.3	23.3	19.1	17.8	32.1	29.2	20.7	14.5	20.3	16.0	32.0	32.1	31.4	22.7	31.5	19.4	23.3	19.0	32.1	24.6	22.0	19.8	15.2	24.0	17.5	24.3	23.1	18.2	11.4	17.1	14.6	42.4	16.5	20.7	20.2	16.8	17.6	35.4	18.6	24.8	23.7	22.0	18.8	3.6	8.8	9.1	2.3	21.0	13.9	5.9	5.8	7.6	3.1	3.1	6.1	19.6	3.3	12.8	13.2	3.8	7.6	2.4	12.2	4.4	8.7	6.5	4.4	7.3	2.5	20.8	4.4	7.8	12.3	14.5	6.0	12.7	9.4	8.1	1.7	3.2	9.6	9.9	7.3	3.4	2.6	1.9	6.6	2.8	4.2	60.0	8.5	12.7	7.4	3.1	7.8	6.2	9.1	4.5	2.2	17.1	6.9	11.1	5.0	4.1	2.7	3.0	11.9	2.6	1.6	13.5	3.0	7.6	18.6	15.7	11.1	22.0	15.7	21.3	17.6	17.8	18.9	15.6	16.8	17.8	16.7	5.3	23.7	24.8	35.4	12.1	18.8	19.4	22.5	14.3	18.5	19.1	17.8	20.3	16.0	19.4	17.1	44.7	25.9	22.0	37.5	10.0	39.9	4.2	22.9	25.4	21.6	29.6	39.3	16.4	8.3	31.1	0.9	23.2	21.6	0.0	34.1	12.3	23.7	26.6	43.9	17.4	19.7	20.6	25.4	20.3	15.6	2.1	23.9	24.1	30.4	24.4	20.3	54.9	31.7	21.0	16.3	15.9	55.1	19.4	23.6	8.7	4.8	11.0	20.5	14.9	21.2	28.5
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318200	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 10.7;Cardiomyocytes: 13.4;granulocytes: 29.0;Macrophages: 13.0;T-cells: 23.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"HEL: 15.8;HL-60: 6.9;NB-4: 5.7;THP-1: 6.1;U-937: 9.6"	"Low region specificity"	"Detected in many"							HPA024135	Uncertain		Approved	Nucleoplasm		NA	NA		37000	Nucleoplasm		"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	1.2	0.4	0.3	6.3	0.5	17.5	0.5	0.4	1.0	1.3	1.3	2.1	0.0	0.2	1.6	1.6	0.9	0.6	1.4	11.9	0.3	0.4	0.9	0.8	3.1	5.1	0.5	0.3	0.8	0.4	0.0	0.4	0.9	0.5	1.2	0.1	1.7	5.6	0.9	0.3	0.5	1.1	1.8	0.8	5.8	1.4	0.4	1.1	7.4	0.5	2.1	11.5	1.0	0.8	1.1	14.9	17.9	19.3	25.3	13.2	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	15.8	0.0	0.1	0.7	6.9	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	9.6	0.0	17.9	15.2	2.0	13.0	17.9	8.1	1.1	4.7	11.1	14.9	0.6	3.7	13.2	8.4	25.3	19.3	0.7	5.8	9.5	0.3	0.5	0.4	1.0	0.3	0.4	0.5	0.3	0.5	1.1	0.0	10.7	2.7	0.0	0.8	0.0	13.4	0.0	2.7	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.9	0.0	29.0	0.0	4.4	0.0	0.0	0.0	6.6	3.5	0.9	13.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.0	23.5	0.0	0.0
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144892-129169697	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 56.8"	"Cell type enhanced"	"Detected in many"	11	"Macrophages: 25.0;monocytes: 64.9;Peritubular cells: 30.8;Proximal tubular cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.3;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.9;HEL: 32.6;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	2.8	3.5	7.4	13.4	7.7	3.8	3.5	7.5	10.0	1.9	4.3	9.9	8.7	3.8	1.5	15.9	3.4	2.6	3.8	5.4	7.2	12.4	56.8	17.2	3.2	15.9	12.1	6.5	1.8	13.0	9.4	13.0	4.6	7.9	8.0	4.8	5.5	20.5	9.5	7.1	4.5	7.1	2.8	8.0	13.7	4.3	6.8	6.0	10.4	8.5	2.9	19.6	6.2	2.4	6.4	2.8	0.2	3.2	0.4	0.9	2.1	1.2	2.7	0.8	20.9	0.0	0.0	1.0	0.0	0.2	0.5	0.2	0.4	1.9	15.8	1.6	0.5	12.2	1.4	10.8	3.3	0.8	13.4	8.3	32.6	0.8	5.9	0.8	4.5	0.6	0.6	3.3	0.1	1.1	0.0	0.5	9.4	0.3	2.0	0.0	3.6	9.5	0.1	6.0	0.9	2.9	2.9	0.4	0.4	1.7	3.9	4.9	5.9	2.0	0.6	11.0	6.2	4.5	1.9	0.0	0.0	1.5	1.7	0.5	38.6	4.5	6.8	0.3	14.5	2.0	0.0	1.1	0.0	0.1	3.2	0.0	5.3	0.1	0.0	2.8	6.4	0.9	0.1	0.2	0.4	0.2	1.1	0.0	2.1	7.4	7.7	7.5	10.0	7.2	12.4	12.1	6.5	7.9	6.0	0.0	1.1	24.2	0.8	2.3	3.8	5.6	0.0	2.7	0.0	5.2	3.9	0.1	11.6	2.0	2.0	0.4	0.8	0.0	7.4	0.2	1.1	2.5	0.0	12.5	7.1	0.0	3.4	0.6	17.8	3.3	2.6	25.0	1.7	64.9	0.3	4.8	3.0	0.0	30.8	50.8	1.4	0.0	0.0	0.5	0.7	2.6	0.1	1.5	0.2	1.0
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627109-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 88.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 313.3;Late spermatids: 1149.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 34.2"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 43.2;RT4: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	27.0	9.8	7.0	4.4	6.6	0.1	33.0	2.9	4.9	15.9	17.8	12.6	6.4	9.7	11.1	10.4	27.1	24.2	10.0	5.7	7.4	7.3	26.7	68.2	8.3	3.6	6.9	4.1	27.6	25.1	19.6	17.7	23.6	34.2	15.5	20.3	16.7	88.4	6.7	3.5	4.7	11.6	4.7	10.4	8.6	8.0	17.5	6.6	2.9	24.6	11.0	19.8	17.2	11.5	0.3	0.2	0.8	0.2	0.3	6.6	1.4	7.9	10.6	28.7	14.5	12.6	6.8	11.6	4.5	7.1	9.0	21.1	23.8	13.9	0.0	19.1	4.6	6.2	6.5	0.1	8.6	10.6	0.0	15.4	1.4	6.9	26.5	7.0	0.0	1.1	13.3	4.2	7.9	3.1	13.1	19.1	0.0	0.0	0.0	9.2	8.2	0.0	0.1	43.2	12.0	8.0	0.0	13.6	0.0	14.1	65.2	1.8	7.8	4.5	3.9	6.0	24.1	5.7	1.0	5.3	5.6	8.6	9.2	2.9	0.0	0.0	0.0	5.0	0.0	4.0	0.5	0.1	0.2	1.0	0.1	3.5	0.3	2.4	0.8	0.0	0.2	6.6	3.8	0.8	0.3	0.2	0.2	0.1	1.4	7.0	6.6	2.9	4.9	7.4	7.3	6.9	4.1	34.2	6.6	3.0	8.5	7.8	36.0	6.4	0.7	7.3	61.1	115.1	21.6	89.0	0.0	26.5	19.9	64.9	313.3	22.2	51.9	0.0	11.1	33.5	17.7	46.5	0.0	94.2	3.8	0.0	32.3	58.9	11.8	1149.4	30.5	2.9	10.1	1.8	42.7	38.6	20.9	46.0	33.6	37.7	1.5	19.4	7.5	19.0	32.2	4.6	11.3	3.5	78.3	78.2
TSPAN8	"CO-029, TM4SF3"	ENSG00000127324	"Tetraspanin 8"	P19075	12	71125085-71441898	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 235.3"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 1761.5;Mucus-secreting cells: 790.5;Paneth cells: 2064.2;Undifferentiated cells: 1231.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 283.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 211.9"	"Low region specificity"	"Detected in many"							"HPA022273, CAB026009, HPA044337"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB026009: , HPA022273: , HPA044337: AB_2678899"	"unprognostic (1.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.66e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (7.36e-5)"	1.9	0.8	0.7	24.1	2.3	0.0	1.1	0.6	1.3	2.0	139.5	2.8	1.5	83.2	1.2	1.5	1.1	1.3	30.8	1.0	0.7	0.7	7.6	3.7	5.1	1.0	4.7	1.0	6.9	9.9	0.0	0.8	0.7	3.5	14.2	79.5	2.6	11.7	1.0	12.5	2.4	235.3	3.4	9.7	0.6	55.5	1.6	2.7	0.6	1.8	3.1	5.0	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	211.9	17.7	0.0	0.0	0.4	3.4	4.1	0.4	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.3	0.6	1.3	0.7	0.7	4.7	1.0	3.5	2.7	0.0	2.1	2.7	36.6	18.4	0.2	0.4	346.5	45.5	54.6	41.8	0.0	0.8	107.8	562.4	25.2	2.2	1761.5	0.0	594.9	0.6	38.2	601.4	4.6	21.3	0.2	0.0	167.5	1.8	2.1	10.6	40.9	3.5	60.8	13.6	790.5	7.2	214.1	2064.2	30.1	2.1	0.4	0.0	20.6	0.5	0.9	11.8	0.9	1.5	1231.3	12.4
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.2;heart muscle: 58.5"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 66.4;Extravillous trophoblasts: 79.2;Syncytiotrophoblasts: 67.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.2"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RH-30: 63.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 125.3"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		1900000	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	12.7	5.3	2.6	4.0	5.9	0.3	16.2	58.2	11.5	17.6	6.6	3.0	16.1	3.6	20.9	11.2	6.8	8.8	13.8	58.5	2.9	2.7	21.3	25.3	13.6	3.9	2.8	3.3	15.3	6.5	17.4	3.8	27.7	4.5	10.7	2.7	21.8	8.4	17.7	7.1	13.3	5.4	9.5	2.6	8.4	5.6	5.7	2.3	6.0	9.4	9.4	4.3	8.1	13.6	0.0	0.0	0.6	0.1	0.0	1.1	3.6	0.4	3.5	6.0	5.1	4.9	4.7	14.1	6.8	20.6	4.4	5.8	8.2	3.2	0.2	6.8	3.9	4.2	0.9	2.4	2.5	2.6	1.1	2.7	9.3	2.7	5.8	13.5	0.0	0.7	6.0	2.2	9.1	4.2	14.8	15.0	0.3	0.2	0.2	3.8	5.3	0.0	0.2	8.4	2.1	1.9	2.7	63.6	0.8	18.4	1.6	10.7	7.2	4.5	11.5	4.4	12.9	4.0	0.0	8.8	2.4	7.3	3.9	6.4	0.0	0.0	0.0	6.1	0.1	2.6	0.0	0.1	0.0	1.1	0.1	0.3	0.0	0.2	0.6	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	3.6	2.6	5.9	58.2	11.5	2.9	2.7	2.8	3.3	4.5	2.3	0.0	2.6	0.9	10.8	17.1	66.4	45.8	10.2	1.4	3.4	12.2	2.0	49.9	5.0	16.1	1.4	32.2	2.4	0.0	7.8	79.2	21.2	16.1	0.0	33.3	5.4	31.8	5.8	38.1	3.3	2.4	16.1	0.9	11.8	1.0	2.6	3.3	9.1	0.0	16.3	18.2	4.2	19.4	19.5	1.4	3.4	10.5	67.5	0.0	1.9	9.7
TSPO2	"BZRPL1, dJ34B21.2"	ENSG00000112212	"Translocator protein 2"	Q5TGU0	6	41042554-41044337	"Predicted intracellular proteins, Predicted membrane proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"bone marrow: 32.4"	"Cell type enriched"	"Detected in some"	84	"Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060691, HPA066996"			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA060691: , HPA066996: AB_2685761"	"unprognostic (1.89e-3)"	"unprognostic (8.35e-3)"	"unprognostic (2.57e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.76e-2)"	0.1	0.0	0.1	0.1	0.1	32.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	1.3	2.5	0.4	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	1.3	0.1	3.3	4.5	1.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.3	0.2	0.5	0.0	15.8	0.0	0.4	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.2	0.8	0.2	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.3	210.2	0.8	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TSPY1	"CT78, TSPY"	ENSG00000258992	"Testis specific protein, Y-linked 1"	Q01534	Y	9466955-9469748	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	105	"testis: 10.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	9	"testis cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	361	"U-266/70: 64.9;U-266/84: 60.7"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (2.91e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.9	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
TSPY10		ENSG00000236424	"Testis specific protein, Y-linked 10"		Y	9527880-9530682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	11	"testis: 6.3"	"Cell type enriched"	"Detected in single"	14	"Spermatogonia: 8.6"	"Cancer enriched"	"Detected in single"	13	"testis cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 36.6"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (5.36e-1)"			0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.6	0.0	0.0	0.0	0.0	0.0
TSPY2	TSPYQ1	ENSG00000168757	"Testis specific protein, Y-linked 2"	A6NKD2	Y	6246223-6249019	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	104	"testis: 13.5"	"Cell type enriched"	"Detected in some"	8	"Spermatogonia: 26.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	426	"U-266/70: 41.9;U-266/84: 43.2"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (3.69e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	26.0	0.0	0.0	0.0	0.0	0.0
TSPY3	CT78	ENSG00000228927	"Testis specific protein, Y-linked 3"	P0CV98	Y	9398421-9401223	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	4	"testis: 7.6"	"Cell type enriched"	"Detected in single"	25	"Spermatogonia: 6.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	75	"U-266/70: 50.9;U-266/84: 46.1"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (4.19e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.2	0.0	1.8	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	50.9	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.1	0.0	0.0	0.0	0.0	0.0
TSPY4		ENSG00000233803	"Testis specific protein, Y-linked 4"	"P0CV99, P0CW01"	Y	9337464-9340284	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	222	"testis: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	604	"U-266/70: 178.3;U-266/84: 187.8"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	178.3	187.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0
TSPY8		ENSG00000229549	"Testis specific protein, Y-linked 8"	P0CW00	Y	9357797-9360599	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	10	"testis: 4.1"	"Cell type enriched"	"Detected in single"	12	"Spermatogonia: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	230	"U-266/84: 77.1"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	77.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.9	0.0	0.0	0.0	0.0	0.0
TSPYL5	KIAA1750	ENSG00000180543	"TSPY like 5"	Q86VY4	8	97273474-97277964	"Predicted intracellular proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 165.5;Late spermatids: 304.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 16.4;K-562: 13.7;SCLC-21H: 29.2;SH-SY5Y: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031347	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	No			Cytosol	"Golgi apparatus"	"HPA031347: AB_10601454"	"prognostic favorable (1.21e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.31e-2)"	"unprognostic (3.13e-1)"	5.5	8.3	9.0	4.0	19.7	1.3	11.3	8.4	24.0	11.5	8.0	9.3	20.1	1.9	14.2	14.9	4.5	11.9	6.3	11.1	9.1	15.0	8.5	1.9	6.6	5.5	8.6	9.1	23.9	8.0	5.5	12.8	4.1	17.4	14.6	3.4	7.1	8.7	17.7	10.5	3.8	3.7	13.3	7.1	6.4	7.4	46.4	5.2	6.3	7.9	4.4	6.6	9.8	4.6	1.5	2.3	0.7	0.5	1.0	1.3	0.4	0.0	7.4	0.0	0.0	0.2	0.2	0.0	5.8	0.0	5.8	3.8	0.0	0.2	0.0	8.1	6.9	0.0	2.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	9.4	0.0	8.2	0.0	0.0	0.0	16.4	13.7	0.0	0.2	10.7	0.0	0.0	0.0	0.0	0.1	10.6	0.0	0.0	4.9	0.0	29.2	22.6	0.0	1.9	0.0	4.1	0.0	0.9	0.0	0.0	12.8	0.0	0.0	6.9	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.5	0.0	0.7	0.5	0.1	2.3	1.5	1.3	0.5	0.0	1.0	0.2	2.2	1.1	0.4	9.0	19.7	8.4	24.0	9.1	15.0	8.6	9.1	17.4	5.2	6.0	2.6	0.0	4.2	2.1	10.9	10.6	2.5	5.3	3.4	8.7	19.6	0.1	5.0	5.6	165.5	9.0	0.0	0.0	2.9	0.1	7.3	6.3	0.0	0.8	5.1	7.9	2.4	4.9	3.9	304.7	22.7	2.6	6.8	2.8	0.0	11.4	4.2	0.0	19.8	0.9	11.5	6.5	5.6	28.1	26.0	1.4	0.1	0.0	0.2	3.1
TSPYL6		ENSG00000178021	"TSPY like 6"	Q8N831	2	54253184-54256272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 41.1"	"Group enriched"	"Detected in some"	9	"Spermatocytes: 27.4;Spermatogonia: 22.4"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	66	"K-562: 13.4"									"HPA034699, HPA034700"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA034699: AB_2674288, HPA034700: AB_10670159"	"unprognostic (8.21e-2)"				"unprognostic (4.25e-1)"			"unprognostic (1.06e-2)"		"unprognostic (1.00e-1)"			"unprognostic (5.54e-6)"	"unprognostic (4.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	27.4	22.4	0.0	0.0	0.0	0.0	0.0
TSR1	FLJ10534	ENSG00000167721	"TSR1, ribosome maturation factor"	Q2NL82	17	2322503-2337507	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024434, HPA053087"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024434: AB_1858413, HPA053087: AB_2682040"	"unprognostic (1.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.95e-3)"	"unprognostic (9.80e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.46e-3)"	15.6	11.8	11.2	14.0	14.1	11.8	14.7	12.5	15.9	10.3	12.8	12.1	11.7	7.9	15.9	10.8	20.0	12.5	10.5	14.8	11.5	9.3	10.6	18.5	9.8	13.3	13.3	12.7	14.5	23.8	14.2	9.6	13.7	11.1	12.6	12.9	10.5	12.8	15.7	42.2	16.2	9.8	20.1	10.6	11.6	12.7	18.3	11.4	14.4	10.7	25.0	15.4	14.2	12.3	8.3	11.4	1.4	10.7	5.6	11.8	5.7	26.8	27.7	12.9	26.0	10.5	12.3	27.2	21.2	11.7	12.9	9.9	44.1	11.2	27.3	19.6	16.6	12.3	23.1	27.8	24.6	16.6	12.9	32.9	20.1	22.3	20.3	14.6	18.6	14.7	12.4	15.4	24.8	28.5	14.1	12.5	14.9	26.5	15.3	15.9	15.5	18.4	9.0	31.8	19.1	16.7	19.9	17.7	19.1	15.9	16.9	9.4	20.9	18.5	14.4	14.5	12.8	13.5	8.1	13.9	18.2	15.3	22.1	40.4	11.5	15.0	16.8	17.8	21.2	22.6	1.4	6.7	1.4	8.9	10.7	11.8	7.5	7.2	7.6	11.4	8.3	7.6	9.0	1.1	5.6	10.3	4.3	8.7	5.7	11.2	14.1	12.5	15.9	11.5	9.3	13.3	12.7	11.1	11.4	29.8	30.6	20.8	29.5	30.6	17.1	16.9	15.3	30.8	42.1	14.0	17.7	25.6	3.3	19.5	61.9	13.5	3.3	0.0	14.2	34.6	17.5	16.0	41.6	12.1	14.1	17.5	9.9	11.1	8.6	57.0	12.0	12.2	15.1	19.0	10.1	11.2	18.8	7.0	11.3	9.8	18.9	19.4	24.7	23.8	50.8	36.0	20.3	12.2	14.4	26.7
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2, ribosome maturation factor"	Q969E8	X	54440401-54445487	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	20.8	25.0	52.9	13.8	53.1	15.3	19.2	27.6	44.3	18.2	17.2	30.8	16.9	13.9	18.4	33.9	16.2	21.1	14.8	22.2	45.3	46.2	26.5	23.7	17.5	14.9	53.8	34.4	22.9	17.2	30.7	19.0	19.8	31.0	20.8	20.6	19.0	16.6	25.4	35.5	17.2	14.7	19.7	54.3	18.1	16.5	8.4	27.5	10.2	23.9	10.8	22.0	17.7	16.8	39.6	15.4	28.7	21.2	24.7	41.4	21.1	20.3	26.1	19.1	17.4	17.3	12.5	17.1	20.2	16.5	18.9	16.2	24.6	22.3	22.3	14.0	17.7	33.7	21.1	46.7	28.0	25.2	29.0	23.1	18.2	19.5	19.2	10.7	31.4	19.0	11.6	15.4	26.3	27.2	14.9	13.1	18.8	18.5	16.7	19.2	37.4	23.9	24.8	30.4	18.4	29.7	21.5	35.6	18.9	20.1	18.1	24.2	16.8	38.5	19.3	21.4	34.7	39.2	11.0	17.9	13.9	24.5	29.1	17.2	17.9	27.0	26.7	20.4	25.0	20.8	24.5	15.3	28.7	35.1	20.5	28.8	38.7	33.3	31.8	13.9	39.6	41.4	31.7	9.4	24.7	21.2	15.4	35.5	21.1	52.9	53.1	27.6	44.3	45.3	46.2	53.8	34.4	31.0	27.5	23.8	23.8	40.1	37.8	29.1	55.8	44.8	22.9	45.5	39.8	33.2	25.5	86.7	106.1	35.8	0.8	36.5	26.0	0.0	28.8	60.7	42.6	34.1	43.9	22.9	39.7	54.0	17.4	23.4	12.3	2.1	32.2	27.9	38.8	70.3	30.8	56.3	30.9	28.6	42.5	51.9	48.8	45.3	43.4	12.2	43.7	27.7	63.5	41.1	28.8	29.1
TSR3	"C16orf42, MGC24381"	ENSG00000007520	"TSR3, acp transferase ribosome maturation factor"	Q9UJK0	16	1349240-1351911	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040760, HPA046265"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA040760: AB_2677122, HPA046265: AB_10963942"	"unprognostic (4.04e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.14e-1)"	25.1	17.9	23.3	16.6	23.2	13.0	26.1	14.3	28.0	13.1	19.1	18.4	19.7	21.8	14.1	18.2	19.9	15.1	15.4	25.2	21.6	16.9	17.5	19.3	15.7	28.6	22.7	14.2	15.2	39.6	13.0	12.7	13.9	16.4	16.8	8.4	14.2	35.0	18.9	64.6	16.3	17.7	19.3	18.0	17.1	21.3	12.2	13.5	14.5	15.0	20.8	17.6	15.7	17.8	8.9	5.5	11.9	4.5	2.4	7.1	1.8	21.2	23.7	9.8	13.0	11.7	14.3	16.6	19.9	8.8	14.2	13.2	26.2	21.7	13.6	26.7	13.3	15.1	22.4	8.9	16.4	4.9	26.3	40.9	6.0	19.5	20.5	21.3	12.8	11.8	15.0	23.8	12.7	12.5	11.1	15.4	22.0	19.0	11.9	11.6	38.0	18.7	21.7	16.5	12.3	28.8	33.4	12.0	36.5	12.4	8.5	15.6	20.1	15.3	19.2	24.9	8.2	18.4	16.0	16.8	23.5	25.3	20.0	24.1	25.5	17.0	17.8	11.9	15.5	15.9	11.1	4.5	11.9	5.3	3.7	6.7	7.2	6.7	4.9	3.6	8.9	7.1	6.5	11.8	2.4	3.9	5.5	4.8	1.8	23.3	23.2	14.3	28.0	21.6	16.9	22.7	14.2	16.4	13.5	17.9	18.1	34.4	33.5	25.0	24.4	8.0	35.7	12.0	13.6	24.4	11.8	42.7	87.9	33.9	3.1	25.1	36.0	0.0	40.4	42.3	32.0	47.2	8.1	46.4	42.5	17.5	23.1	26.4	29.8	3.3	25.9	26.9	45.5	31.5	31.0	35.9	32.5	28.8	30.1	95.2	24.1	6.5	33.5	14.2	41.5	36.3	24.9	26.6	29.9	35.3
TSSC4		ENSG00000184281	"Tumor suppressing subtransferable candidate 4"	Q9Y5U2	11	2400488-2403878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041801, HPA058763"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041801: AB_10793934, HPA058763: AB_2683811"	"unprognostic (1.98e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.38e-2)"	25.6	11.7	12.1	13.9	12.5	33.0	13.2	10.7	20.9	17.5	21.5	12.7	10.9	15.9	20.6	13.3	16.7	16.4	15.1	23.2	11.9	11.0	14.1	19.4	13.8	16.8	15.2	12.7	17.7	20.9	10.3	14.7	19.8	11.2	18.2	5.6	13.1	20.2	19.0	32.5	16.2	16.1	19.0	10.5	18.5	14.0	29.1	10.7	21.7	22.7	25.2	14.7	20.2	36.2	54.0	44.9	55.3	44.7	43.0	49.0	37.3	19.6	24.6	8.1	12.8	6.9	5.0	15.5	13.4	9.3	16.4	11.3	18.1	25.5	14.3	11.9	10.6	18.6	19.5	9.4	15.6	3.1	16.4	25.7	8.3	13.1	18.4	18.8	14.3	17.6	12.0	22.5	10.5	10.0	7.1	11.3	14.6	18.9	16.1	7.7	25.4	17.0	26.0	23.5	15.0	29.0	19.3	7.2	12.8	8.2	16.5	21.0	21.4	11.5	26.0	15.7	4.5	13.6	16.9	14.9	21.7	11.3	20.1	15.5	32.5	27.9	12.0	18.6	14.7	22.5	55.3	44.7	43.8	46.1	38.2	49.0	43.5	45.9	47.2	44.9	54.0	41.4	39.0	43.2	43.0	40.1	43.3	47.8	37.3	12.1	12.5	10.7	20.9	11.9	11.0	15.2	12.7	11.2	10.7	17.9	16.2	42.7	41.3	59.8	34.6	18.3	10.2	4.0	9.1	12.2	11.8	43.5	43.1	51.7	56.0	37.9	61.3	0.0	43.9	40.6	30.5	45.3	17.3	25.6	34.2	27.0	54.9	31.9	25.2	132.0	41.1	33.6	30.4	52.3	30.7	42.1	51.2	49.1	31.8	36.6	29.3	38.8	55.1	87.9	67.3	72.0	68.7	43.7	31.2	45.8
TSSK3	"SPOGA3, STK22C"	ENSG00000162526	"Testis specific serine kinase 3"	Q96PN8	1	32351521-32364312	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 68.1"	"Group enriched"	"Detected in some"	52	"Early spermatids: 242.3;Late spermatids: 839.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037516			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA037516: AB_2675517"	"unprognostic (5.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-3)"	1.1	2.0	0.8	1.7	0.8	8.2	1.1	3.9	0.8	1.3	0.9	0.8	1.4	2.5	1.8	2.9	0.8	1.3	1.0	0.9	0.8	0.0	0.9	1.3	1.4	2.4	0.8	0.8	2.0	1.2	0.0	0.8	0.8	1.0	1.0	0.0	0.8	1.4	0.8	1.7	3.4	2.9	0.8	0.8	3.4	1.2	68.1	0.8	0.8	1.3	0.8	0.8	0.9	1.1	0.6	0.1	0.1	0.7	0.3	2.3	0.1	2.3	2.3	6.0	3.5	0.0	1.2	5.4	0.7	1.1	0.0	0.0	0.5	1.2	1.2	0.9	0.0	1.0	3.7	0.0	0.0	0.0	3.5	7.2	2.7	9.8	3.7	4.4	1.1	3.4	0.1	0.9	0.0	1.3	6.3	0.0	4.6	3.1	5.8	0.0	0.6	1.4	1.5	1.5	0.4	1.2	1.9	1.7	4.4	0.0	1.9	1.8	3.8	0.8	2.8	4.1	4.4	1.9	2.7	2.9	2.1	3.4	3.0	2.4	8.5	2.8	1.8	3.7	3.9	0.5	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.2	0.0	0.1	0.6	2.3	0.9	0.1	0.3	0.5	0.0	0.0	0.1	0.8	0.8	3.9	0.8	0.8	0.0	0.8	0.8	1.0	0.8	0.0	0.3	0.0	0.4	0.1	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.2	242.3	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	839.4	8.6	0.0	0.0	0.0	0.3	0.9	0.2	0.0	8.9	0.6	1.4	6.5	0.0	10.3	3.8	0.0	0.2	0.0	0.2	0.2
TSSK4	"C14orf20, STK22E"	ENSG00000139908	"Testis specific serine kinase 4"	Q6SA08	14	24205697-24208362	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 46.1"	"Cell type enriched"	"Detected in some"	15	"Early spermatids: 178.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060660, HPA077103"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA060660: AB_2684339, HPA077103: AB_2732332"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-3)"	"unprognostic (3.42e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (8.98e-2)"	"unprognostic (7.26e-2)"	0.6	0.9	0.6	1.7	0.6	3.1	0.6	1.5	1.8	0.6	0.6	0.6	0.6	1.5	0.8	0.9	1.4	0.8	1.7	0.6	0.6	0.4	0.6	0.6	0.8	2.8	0.6	0.6	0.8	0.9	0.0	0.6	0.6	0.6	0.6	0.0	0.6	1.4	0.6	1.0	4.7	1.6	0.6	0.6	1.5	0.6	46.1	0.6	0.6	1.4	0.6	0.6	1.0	0.6	2.1	1.7	2.0	1.0	1.8	2.0	0.7	1.0	4.1	4.0	1.5	0.1	0.0	4.3	1.6	0.1	0.0	0.0	2.1	3.7	3.1	0.9	0.1	0.8	3.8	0.0	0.1	0.0	1.6	3.1	3.5	4.8	3.0	0.0	1.5	3.8	0.0	0.0	0.0	0.6	3.6	0.1	3.7	1.3	2.0	0.0	3.8	3.6	1.7	0.7	0.9	3.2	3.0	1.6	2.7	0.0	5.3	2.2	2.1	2.7	2.5	0.8	1.8	1.6	1.8	1.4	2.9	1.8	3.8	1.3	4.3	4.8	4.8	1.0	2.8	0.9	0.0	1.0	2.0	2.0	1.0	0.7	2.0	1.6	1.6	0.6	2.1	1.6	1.7	2.0	1.8	0.9	1.7	0.7	0.7	0.6	0.6	1.5	0.6	0.6	0.4	0.6	0.6	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	178.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.1	0.0	0.0	0.0
TSTA3	"FX, P35B, SDR4E1"	ENSG00000104522	"Tissue specific transplantation antigen P35B"	Q13630	8	143612618-143618048	"Enzymes, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		600000	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	9.4	12.0	7.0	9.5	10.1	16.3	10.2	6.1	13.8	8.6	18.7	8.4	16.6	24.8	8.4	9.9	28.0	7.7	23.7	15.7	8.1	7.8	11.7	40.0	8.9	16.5	6.8	8.1	9.7	60.1	6.4	14.2	21.9	12.2	13.9	14.9	9.5	35.4	14.2	16.8	28.4	20.2	6.9	4.7	11.3	35.5	24.6	5.6	14.7	13.0	17.8	24.8	9.8	10.4	18.7	25.6	17.7	21.0	28.1	26.9	20.5	16.4	12.0	6.0	18.0	5.1	4.9	11.2	13.6	13.4	9.7	7.3	14.6	17.5	7.2	13.4	9.6	4.0	11.8	9.1	18.5	4.4	18.6	13.2	10.6	21.2	16.9	10.4	7.1	12.2	6.1	9.6	6.5	23.3	7.9	15.7	12.9	11.8	10.5	7.3	49.8	9.2	10.8	8.2	47.2	16.4	10.6	4.6	22.1	19.6	16.5	12.4	9.7	9.3	18.4	13.7	4.5	23.4	10.4	13.1	6.4	25.6	7.6	13.1	7.9	5.6	5.3	9.9	16.3	9.6	10.5	15.9	17.7	21.0	21.0	21.2	16.1	22.7	22.6	18.0	18.7	16.9	18.7	16.3	28.1	16.3	25.6	26.9	20.5	7.0	10.1	6.1	13.8	8.1	7.8	6.8	8.1	12.2	5.6	14.9	27.3	38.0	42.2	74.1	12.6	12.5	61.1	18.7	12.5	8.7	5.9	73.8	46.4	110.8	79.5	30.8	86.0	46.7	170.3	125.9	25.3	69.4	25.3	62.7	61.4	12.7	59.5	26.4	25.1	197.6	38.0	25.2	28.7	33.3	168.9	16.3	123.1	69.1	32.2	68.8	9.3	12.9	27.2	56.2	48.1	108.3	73.3	42.9	88.1	73.3
TSTD1	KAT	ENSG00000215845	"Thiosulfate sulfurtransferase like domain containing 1"	Q8NFU3	1	161037631-161038990	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.5;OE19: 39.8;SK-BR-3: 52.8;T-47d: 51.1;U-266/70: 59.7;U-266/84: 41.9"	"Region enriched"	"Detected in some"	4	"olfactory region: 8.2"	"Low region specificity"	"Detected in many"			"HPA006518, HPA006655"	Approved		Approved	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytosol, Cytoplasmic bodies"		"HPA006518: AB_2667608, HPA006655: AB_10600919"	"unprognostic (6.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.88e-3)"	9.1	19.9	14.8	15.4	29.8	13.1	24.2	3.6	13.9	10.1	18.1	4.4	45.4	12.2	4.2	34.7	23.3	21.8	16.0	14.4	12.2	8.1	28.4	26.0	19.2	14.6	4.1	13.2	15.0	62.2	27.7	32.9	10.1	6.3	26.0	12.8	11.9	79.8	46.0	9.2	18.7	16.5	5.6	1.9	10.4	14.1	15.0	5.5	20.4	61.3	19.5	27.1	12.3	11.0	77.0	30.9	55.0	14.8	42.1	58.7	31.9	21.4	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	21.2	4.6	13.0	0.0	0.0	19.9	0.0	8.5	0.0	17.8	16.0	2.4	8.1	0.0	2.3	8.0	0.1	0.1	5.3	0.0	0.9	0.0	2.9	19.1	0.0	25.2	2.5	37.5	21.7	0.1	0.1	39.8	0.1	7.1	0.0	33.0	18.5	6.0	13.1	7.0	0.0	52.8	0.1	11.1	51.1	0.1	0.1	0.0	8.0	0.1	0.9	59.7	41.9	4.6	0.0	0.0	0.0	55.0	3.6	51.2	36.3	10.5	34.8	75.8	47.8	40.2	10.9	77.0	54.7	45.9	51.6	42.1	14.8	30.9	58.7	31.9	14.8	29.8	3.6	13.9	12.2	8.1	4.1	13.2	6.3	5.5	235.2	172.5	87.8	263.5	76.6	11.5	49.7	221.7	445.7	177.5	349.0	25.5	237.9	580.3	133.0	14.1	14.6	335.6	0.0	132.4	100.5	27.4	450.5	120.3	124.5	63.7	3.2	210.0	12.3	18.3	14.6	7.8	47.2	143.4	288.6	340.6	29.3	129.9	191.5	9.2	413.9	23.8	19.4	22.1	31.3	40.7	118.7	126.3	120.4	248.2	338.2
TSTD2	"C9orf97, PP4189"	ENSG00000136925	"Thiosulfate sulfurtransferase like domain containing 2"	Q5T7W7	9	97600080-97633575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022537, HPA024241, HPA064304"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022537: AB_1845850, HPA024241: AB_1845851, HPA064304: AB_2685238"	"unprognostic (7.24e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.75e-4)"	"unprognostic (2.21e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	11.9	11.8	11.9	7.4	11.6	3.3	12.1	18.9	15.1	14.2	12.4	14.9	10.6	6.9	14.8	10.6	10.0	12.7	11.0	14.9	9.8	8.4	12.8	14.4	11.0	8.9	12.4	9.5	17.2	15.7	19.8	17.0	13.9	12.5	12.2	11.3	11.1	10.2	13.1	21.1	9.2	9.7	14.4	13.8	8.7	11.2	11.6	12.4	10.6	16.2	12.1	12.0	14.4	9.7	6.2	6.5	5.2	7.0	11.2	10.4	5.3	10.9	8.6	13.8	8.9	9.3	7.8	12.1	7.2	8.8	9.9	10.4	8.5	3.6	11.4	3.5	9.1	11.9	15.1	12.3	7.0	11.2	7.6	5.5	7.8	9.9	6.4	10.9	11.5	10.3	10.3	12.0	9.6	17.0	9.0	7.5	11.9	13.9	8.6	8.5	5.3	13.6	5.7	11.3	14.0	8.4	11.3	20.4	5.9	6.8	5.0	10.0	7.8	9.2	6.4	8.4	11.1	4.9	6.5	7.9	8.6	8.3	10.1	8.1	12.3	16.1	5.9	7.2	5.8	6.2	4.3	3.9	5.2	6.4	7.0	10.4	5.8	6.4	7.7	6.5	6.2	7.2	6.9	1.6	11.2	5.2	2.9	3.6	5.3	11.9	11.6	18.9	15.1	9.8	8.4	12.4	9.5	12.5	12.4	17.9	11.7	7.8	3.6	1.4	25.8	15.2	7.6	21.4	23.9	1.8	23.6	5.9	14.9	7.4	15.6	6.7	4.9	23.3	6.3	3.6	5.4	4.5	19.7	11.6	4.6	20.6	18.4	6.2	5.7	5.9	7.5	3.5	5.0	4.6	5.1	12.0	9.0	4.3	9.9	6.4	20.3	19.4	5.4	19.0	25.6	3.6	9.2	5.3	4.9	3.3
TTC12	"FLJ13859, FLJ20535, TPARM"	ENSG00000149292	"Tetratricopeptide repeat domain 12"	Q9H892	11	113314529-113383544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.8"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 78.9;Early spermatids: 130.7;Late spermatids: 140.2;Spermatocytes: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038542, HPA038543, HPA061364"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038542: AB_2676072, HPA038543: AB_10674686, HPA061364: AB_2684492"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (3.14e-4)"	"prognostic favorable (2.48e-5)"	"unprognostic (2.11e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.33e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.03e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (5.95e-5)"	"unprognostic (3.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.35e-2)"	3.1	6.1	3.8	8.8	5.2	1.3	8.1	3.1	4.4	9.0	4.7	7.3	16.3	2.8	10.8	14.9	4.3	13.1	6.8	5.4	3.5	4.5	7.2	4.4	4.9	9.8	3.9	2.1	6.9	5.1	17.5	25.7	3.4	5.7	9.8	5.1	10.0	9.5	13.1	3.5	4.7	4.2	11.5	4.0	4.2	4.6	44.8	4.7	2.5	12.1	5.9	8.4	7.2	4.6	6.4	4.0	3.1	1.8	2.9	5.7	2.2	3.8	2.4	5.9	6.2	4.3	5.4	3.5	3.5	6.7	4.8	4.6	2.9	10.6	2.0	5.2	0.1	3.9	8.3	0.0	17.0	7.1	2.2	2.7	0.8	7.7	4.3	8.7	0.0	1.4	5.9	6.7	0.0	10.4	9.1	3.4	0.0	3.5	1.4	8.5	4.8	0.0	0.7	3.8	13.3	4.5	0.0	1.0	3.6	8.7	2.8	5.2	7.0	18.2	6.6	3.5	8.4	11.6	2.4	1.2	0.8	4.2	3.6	6.1	1.2	2.0	0.1	4.0	0.4	0.0	0.0	1.8	3.0	3.5	1.8	5.4	4.5	4.7	3.8	4.0	6.4	5.7	5.0	3.1	2.9	1.8	3.3	1.8	2.2	3.8	5.2	3.1	4.4	3.5	4.5	3.9	2.1	5.7	4.7	0.0	4.8	0.5	3.5	1.1	6.7	5.4	7.6	78.9	18.2	5.2	2.0	6.2	5.0	4.9	130.7	1.6	2.6	0.0	4.2	1.5	2.9	2.5	2.3	2.0	2.3	1.6	4.6	0.6	0.6	140.2	3.1	1.2	1.7	1.0	3.2	5.6	4.3	2.6	3.5	7.2	8.7	6.5	1.7	51.6	5.1	1.5	2.3	0.5	3.6	1.8
TTC13	FLJ22584	ENSG00000143643	"Tetratricopeptide repeat domain 13"	Q8NBP0	1	230906243-230978875	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018022, HPA051558"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018022: AB_2211524, HPA051558: AB_2681534"	"unprognostic (2.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.10e-2)"	"prognostic favorable (7.66e-4)"	"unprognostic (2.60e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.60e-11)"	"unprognostic (4.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.54e-3)"	10.5	7.1	8.9	16.6	26.7	13.1	9.6	11.2	12.4	7.3	13.6	12.5	8.6	10.5	9.3	9.2	8.5	9.2	8.9	7.0	9.9	7.9	6.9	9.0	12.2	23.4	13.3	9.3	8.2	13.7	13.5	15.5	9.9	12.6	8.1	21.6	7.9	9.6	9.5	15.6	12.8	15.6	8.4	14.7	21.3	15.6	3.9	13.7	18.4	9.8	6.2	18.9	8.0	9.1	4.2	10.8	7.6	7.7	11.9	10.0	5.1	7.6	7.8	7.7	14.9	7.2	4.7	15.8	11.2	8.8	6.3	7.1	11.4	8.3	14.1	10.3	6.7	6.3	12.3	5.0	4.1	4.2	15.7	15.4	4.2	8.3	7.7	7.6	8.6	3.9	4.1	7.3	5.9	5.5	6.3	11.1	6.1	4.4	8.2	5.8	3.9	4.5	8.2	8.7	25.5	9.7	7.4	11.0	19.6	6.6	5.3	10.6	9.2	8.5	8.8	14.9	3.5	9.4	11.2	5.6	7.5	1.0	10.0	19.7	10.2	16.7	4.3	7.3	5.5	12.2	7.6	7.6	6.8	10.0	5.8	6.8	4.2	7.0	8.2	10.8	3.9	5.7	6.8	2.9	11.9	7.7	7.4	5.4	5.1	8.9	26.7	11.2	12.4	9.9	7.9	13.3	9.3	12.6	13.7	6.0	9.0	9.9	1.2	3.0	4.0	2.5	0.0	0.0	4.5	1.8	5.9	3.7	1.7	4.4	1.4	4.5	2.6	0.0	7.5	4.4	2.8	1.5	9.2	5.9	4.6	11.1	5.8	2.5	7.0	1.7	2.6	7.1	1.7	1.0	10.7	4.0	3.5	8.6	6.3	1.1	10.0	6.5	3.9	2.3	2.4	2.4	1.4	12.8	7.0	1.0
TTC14	"FLJ00166, KIAA1980"	ENSG00000163728	"Tetratricopeptide repeat domain 14"	Q96N46	3	180602130-180617828	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009295	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009295: AB_1858425"	"unprognostic (2.72e-1)"	"unprognostic (4.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.33e-3)"	17.2	20.3	30.0	30.4	32.0	23.1	20.5	18.2	32.4	22.8	20.8	15.8	25.6	19.3	29.0	37.9	12.7	25.2	16.9	16.8	25.6	15.4	22.3	14.1	18.6	30.7	22.8	28.7	41.9	24.3	33.7	49.0	18.0	22.1	26.4	19.0	15.9	15.5	28.7	11.9	17.8	20.7	17.5	23.8	25.7	19.8	16.6	24.3	41.1	35.2	11.1	23.0	20.3	23.4	14.2	18.2	17.1	13.7	14.3	15.0	5.9	8.7	7.0	11.0	6.4	15.0	12.9	10.5	12.7	10.3	9.3	15.3	9.6	11.8	13.3	13.7	9.1	21.0	12.7	10.3	6.7	12.5	24.4	10.4	12.4	16.2	22.3	11.1	13.2	11.5	16.6	13.1	9.2	4.6	15.3	7.3	17.0	5.2	2.6	10.4	2.5	10.0	1.0	7.8	11.2	14.2	11.8	6.9	14.1	5.3	6.7	9.4	9.3	12.2	6.2	12.0	11.9	22.7	12.9	11.5	18.9	9.7	8.5	23.4	19.9	30.2	29.7	9.0	16.8	8.2	17.1	9.8	10.4	11.6	10.7	14.1	14.2	12.2	11.4	7.4	12.5	15.0	11.9	7.8	14.3	13.7	18.2	10.4	5.9	30.0	32.0	18.2	32.4	25.6	15.4	22.8	28.7	22.1	24.3	8.9	32.3	41.3	27.4	15.8	104.5	11.7	48.4	33.5	31.8	62.8	110.0	27.3	3.3	22.4	5.0	35.9	27.6	0.0	28.2	16.2	30.9	22.4	58.8	23.5	20.7	76.3	37.5	39.9	24.9	4.0	85.7	28.0	28.7	28.9	19.8	67.7	26.1	30.8	76.4	5.6	125.3	84.1	27.8	33.0	28.7	13.4	20.6	50.7	18.3	18.0
TTC21A	"IFT139A, STI2"	ENSG00000168026	"Tetratricopeptide repeat domain 21A"	Q8NDW8	3	39107704-39138903	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 51.9"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 41.5;Early spermatids: 60.9;Late spermatids: 68.3;Spermatocytes: 73.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;naive B-cell: 2.7"	"Group enriched"	"Detected in many"	6	"B-cells: 2.7;monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035510, HPA035511"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035510: AB_2674659, HPA035511: AB_10671514"	"unprognostic (1.85e-3)"	"unprognostic (6.95e-3)"	"unprognostic (7.74e-3)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.58e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.91e-4)"	0.9	0.8	2.5	2.2	4.1	0.7	0.8	1.0	2.9	0.9	0.9	2.2	1.9	0.9	1.8	3.0	0.9	2.0	0.7	0.9	2.4	0.8	0.9	0.9	1.0	1.0	0.9	3.6	1.0	2.1	0.9	7.0	0.7	2.9	0.9	0.7	1.4	1.0	0.8	1.0	0.9	0.8	0.6	0.9	0.8	0.9	51.9	1.9	0.0	0.9	0.0	1.6	0.8	0.9	2.7	0.3	0.3	1.7	0.0	0.0	0.1	0.6	1.1	0.3	0.7	0.0	0.7	0.9	1.2	0.9	0.9	0.5	0.0	0.6	2.6	0.0	0.4	0.2	0.5	0.4	1.7	0.2	1.1	0.5	0.1	1.1	0.0	1.3	1.0	0.8	0.9	0.9	0.0	1.3	1.1	0.0	0.7	0.0	3.8	0.0	1.2	0.1	0.4	0.1	0.0	0.0	0.2	0.2	0.4	0.0	1.1	1.3	0.5	1.2	3.0	1.3	0.3	2.9	0.1	0.6	0.3	0.5	2.5	0.5	2.7	0.3	0.2	1.0	0.0	0.6	0.0	0.5	0.0	0.0	1.7	0.0	2.0	0.0	0.0	0.3	2.7	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	2.5	4.1	1.0	2.9	2.4	0.8	0.9	3.6	2.9	1.9	0.0	4.0	3.2	3.9	0.6	3.8	5.6	2.5	41.5	5.7	1.8	7.9	1.2	0.0	1.3	60.9	1.8	2.0	0.0	1.6	1.5	1.7	1.9	1.1	1.0	1.3	4.8	4.1	3.7	1.8	68.3	6.6	2.1	3.3	1.0	2.2	3.1	1.4	2.5	5.6	0.8	13.9	6.5	2.3	73.9	3.4	0.5	3.1	1.3	1.9	2.1
TTC23	"FLJ12572, HCC-8"	ENSG00000103852	"Tetratricopeptide repeat domain 23"	Q5W5X9	15	99136323-99251223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039806, HPA040369"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039806: AB_10793921, HPA040369: AB_10795381"	"prognostic favorable (3.17e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.40e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.56e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.23e-1)"	9.5	10.7	6.0	6.1	8.6	1.0	9.7	5.4	7.5	13.2	15.5	12.2	11.9	3.7	20.3	9.9	10.7	10.6	10.4	11.9	7.7	4.7	10.6	8.2	8.1	3.0	9.8	7.5	17.5	11.7	10.7	10.2	10.0	10.5	13.7	8.7	14.0	8.4	12.0	7.8	8.6	6.4	12.3	15.7	5.2	8.7	16.2	9.0	5.1	14.1	7.7	5.0	13.0	11.4	0.5	2.4	3.8	1.3	2.0	0.5	0.1	6.8	7.1	11.0	12.6	13.1	14.8	4.6	8.5	10.4	9.1	10.3	6.1	11.9	1.7	17.1	9.6	8.2	13.3	3.5	8.4	9.9	2.2	11.7	7.3	12.5	4.8	7.6	1.6	0.5	10.4	7.6	7.1	6.8	9.9	15.2	3.3	5.6	1.0	8.5	4.1	5.8	1.8	5.9	1.8	4.9	1.8	14.3	2.6	7.3	9.2	4.8	2.1	11.1	4.5	10.3	11.5	7.6	7.6	9.9	11.5	6.9	7.7	10.8	6.0	8.1	2.3	10.3	0.5	6.8	3.8	0.5	0.6	0.3	1.3	0.3	0.4	0.4	0.5	2.4	0.5	0.3	0.3	1.8	2.0	0.5	1.9	0.4	0.1	6.0	8.6	5.4	7.5	7.7	4.7	9.8	7.5	10.5	9.0	3.0	6.5	0.0	4.3	2.2	1.7	6.9	7.6	4.0	5.7	5.2	0.0	4.1	5.0	4.5	6.9	5.3	2.9	0.0	5.5	3.7	4.8	2.4	1.1	5.1	3.4	7.9	0.0	9.2	4.3	5.6	8.3	0.8	1.7	1.0	4.8	10.0	4.0	2.9	9.6	4.4	4.7	6.5	4.0	16.8	8.1	3.4	1.6	0.0	6.0	2.4
TTC24		ENSG00000187862	"Tetratricopeptide repeat domain 24"	A2A3L6	1	156579727-156586770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 13.3;lymphoid tissue: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 13.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"JURKAT: 12.4;MOLT-4: 3.7;REH: 13.9;U-698: 2.7"									HPA029799			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029799: AB_10601684"	"unprognostic (2.43e-3)"	"unprognostic (5.61e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.48e-6)"	"unprognostic (6.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-1)"	"unprognostic (7.96e-2)"	"unprognostic (4.87e-9)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.76e-4)"	0.2	0.0	0.2	2.7	0.3	2.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	8.4	0.2	0.2	0.2	0.2	0.0	3.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.6	0.0	2.6	0.2	0.2	5.1	0.4	0.2	0.2	1.4	0.2	0.2	7.5	0.2	0.2	2.2	13.3	0.3	0.0	3.8	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	1.1	0.1	2.2	0.2	1.9	0.3	3.8	0.0	13.3	0.0	0.6	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0
TTC26	"dyf-13, DYF13, FLJ12571, IFT56"	ENSG00000105948	"Tetratricopeptide repeat domain 26"	A0AVF1	7	139133744-139191986	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 89.7;Spermatocytes: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036338, HPA036339"	Enhanced		Approved	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments, Cytosol"		"HPA036338: AB_10673351, HPA036339: AB_10673386"	"unprognostic (3.40e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.56e-1)"	3.5	6.5	6.9	2.5	8.1	3.3	5.6	6.9	8.3	6.1	3.1	4.4	7.4	1.3	6.6	7.6	3.1	20.9	4.5	3.5	5.7	5.1	8.3	1.9	5.1	2.8	2.7	4.8	8.8	3.2	13.0	20.1	3.8	8.4	5.6	2.8	5.4	3.6	5.5	2.3	3.2	2.2	4.6	2.7	2.6	3.1	17.4	3.9	3.8	7.3	2.8	3.1	3.7	3.9	3.6	2.5	5.3	1.5	1.6	2.3	0.9	11.2	8.5	7.5	8.9	9.4	10.9	3.7	5.5	5.7	9.0	9.2	5.4	8.1	2.4	9.2	4.2	14.7	5.6	8.3	6.4	13.1	7.0	7.2	3.0	6.8	4.6	4.7	8.6	2.1	6.2	5.8	13.4	6.1	5.6	6.6	5.9	6.7	1.6	7.1	10.5	14.7	10.1	7.5	3.3	7.5	5.1	8.9	4.0	7.7	3.3	11.0	7.9	13.4	5.7	7.7	2.3	6.9	4.7	4.6	8.4	7.3	7.6	10.0	3.6	4.6	1.8	14.6	4.3	9.8	1.2	0.5	1.2	2.1	0.5	1.1	3.6	1.5	1.4	1.1	2.4	2.3	1.7	5.3	1.6	1.5	2.5	1.0	0.9	6.9	8.1	6.9	8.3	5.7	5.1	2.7	4.8	8.4	3.9	0.0	2.6	2.7	1.7	1.0	6.9	1.7	7.6	89.7	19.4	5.2	11.8	1.0	0.0	4.8	15.8	2.1	0.0	0.0	2.3	2.8	3.1	1.1	5.7	1.7	1.8	0.0	1.2	4.3	0.6	12.2	3.7	2.2	3.3	2.8	0.9	4.5	1.6	2.9	4.9	4.6	16.0	0.0	2.1	40.9	5.7	1.5	0.3	1.7	0.6	0.5
TTC27	FLJ20272	ENSG00000018699	"Tetratricopeptide repeat domain 27"	Q6P3X3	2	32628032-32821051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031246	Approved		Approved	Nucleoli,Mitochondria		No	No		11000	Mitochondria	Nucleoli	"HPA031246: AB_10603139"	"unprognostic (3.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (6.28e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	18.4	18.2	7.0	18.8	11.5	9.9	17.8	8.6	10.7	16.4	11.9	16.1	12.0	8.2	25.1	13.6	17.5	14.7	8.5	14.3	8.2	6.9	11.0	15.7	10.8	13.6	12.5	8.1	18.6	17.7	15.7	19.4	11.9	8.9	14.7	13.1	13.2	17.2	14.7	18.7	16.8	11.0	15.3	11.0	19.3	13.4	17.4	10.3	16.4	14.9	15.5	20.4	14.6	14.6	9.6	9.6	0.3	9.0	8.4	12.5	5.7	22.0	10.7	7.4	5.8	6.2	12.7	3.8	9.2	7.6	14.2	12.5	16.5	13.4	19.3	8.3	13.8	14.8	11.1	11.9	14.3	20.9	9.2	14.6	21.9	5.9	22.4	12.1	20.9	11.6	8.4	13.2	17.2	18.7	7.1	12.9	4.9	30.1	5.7	12.7	8.8	16.5	7.3	13.6	10.0	11.2	11.1	16.2	16.9	11.0	12.9	6.2	8.9	7.6	7.2	8.5	9.0	8.8	5.0	10.7	9.1	10.0	10.7	15.7	8.3	2.1	21.9	9.8	16.3	9.7	0.0	4.5	0.0	9.1	9.0	10.0	9.3	10.0	8.9	9.6	9.6	12.5	9.8	0.3	8.4	6.1	4.7	8.7	5.7	7.0	11.5	8.6	10.7	8.2	6.9	12.5	8.1	8.9	10.3	8.9	7.2	4.5	8.0	4.9	5.4	6.7	0.0	16.0	9.1	0.0	3.9	10.8	6.6	7.7	14.7	6.3	1.7	0.0	8.3	10.2	6.2	5.0	11.5	3.9	7.0	3.2	7.0	4.3	7.2	0.9	7.8	4.6	5.0	7.2	4.6	4.6	5.3	5.9	6.7	3.8	5.6	6.5	7.1	18.4	10.4	5.0	5.4	6.1	7.6	5.4
TTC28	KIAA1043	ENSG00000100154	"Tetratricopeptide repeat domain 28"	Q96AY4	22	27978014-28679865	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 42.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003099			Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA003099: AB_1079195"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (4.30e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (4.36e-1)"	4.6	3.0	1.4	1.1	2.0	0.0	4.2	0.6	1.3	6.0	4.1			1.4	7.6	6.5	3.0	5.7	3.7	2.8	1.2	1.0	2.8	2.1	4.7	0.5	0.9		11.8	2.7	3.2	2.4	5.4		3.3	1.3		3.7	4.4	2.6	1.6	2.1	5.3	1.0	1.6	3.1	5.0			4.3		0.2	4.3	3.4	1.0	2.5	0.4	0.2	0.9	0.6	0.5	0.0	5.3	13.8	5.9	8.3	12.4	0.3	4.0	7.5	5.7	5.0	0.4	0.0	0.0	5.6	11.7	1.9	0.8	8.9	0.2	3.1	0.5	5.9	0.8	6.7	5.0	3.8	0.1	5.5	12.3	0.3	3.7	2.6	3.9	10.4	3.6	3.4	0.5	1.3	1.9	0.1	0.4	2.5	0.0	3.4	5.4	3.5	0.1	2.7	0.2	3.9	8.6	5.6	0.2	3.7	4.0	2.8	0.5	9.6	6.8	3.4	4.4	3.0	1.8	0.2	0.1	2.4	0.1	2.9	0.4	0.2	0.1	0.5	0.1	0.3	0.3	0.4	0.3	0.3	1.0	0.6	0.5	0.4	0.9	0.2	2.5	0.1	0.5											3.0	12.2	2.0	4.6	5.4	32.1	8.9	7.6	2.7	2.3	12.2	17.7	4.5	0.0	4.3	7.2	28.6	2.6	0.0	5.2	1.2	19.2	5.3	1.1	12.4	3.2	27.0	8.6	29.4	5.9	5.6	29.1	4.8	10.1	1.0	4.9	12.1	5.1	5.1	42.8	14.1	22.1	12.9	18.6	22.9	11.4	3.3	2.1	4.9	6.7	3.0
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	22.9	22.1	34.0	18.7	36.5	12.0	23.4	39.2	40.0	34.9	20.6	15.9	26.7	13.0	21.6	33.3	15.3	19.5	19.0	21.5	29.1	16.5	21.4	17.0	15.4	14.3	17.7	27.5	34.5	25.8	27.4	50.4	15.2	34.7	28.9	19.9	16.1	24.5	25.4	21.6	16.1	16.8	21.6	21.7	13.6	21.3	19.5	19.9	19.7	35.4	11.1	15.1	23.3	18.9	10.6	12.8	4.8	5.7	9.1	18.6	3.8	21.7	7.8	36.3	6.8	35.0	51.1	12.6	24.0	29.9	10.8	14.7	10.2	11.0	18.8	8.4	40.2	10.1	7.2	10.9	14.8	15.3	19.9	7.8	38.0	11.6	13.4	12.8	21.2	12.3	26.4	9.1	11.0	9.8	21.8	16.0	16.7	22.8	22.1	20.3	16.8	20.6	5.5	10.3	14.5	13.2	27.6	17.4	9.9	12.6	16.9	27.7	21.1	29.8	17.1	15.4	8.7	19.4	8.3	20.9	15.5	6.2	19.0	9.0	22.2	15.9	18.8	25.6	21.2	11.7	2.9	4.4	4.8	9.1	4.8	13.6	9.5	10.6	12.3	7.9	10.6	18.6	11.3	0.7	9.1	5.7	12.8	7.2	3.8	34.0	36.5	39.2	40.0	29.1	16.5	17.7	27.5	34.7	19.9	116.1	118.5	109.7	81.2	58.5	344.6	127.3	56.0	75.0	101.2	71.5	214.0	39.6	140.9	74.9	160.4	67.6	60.1	0.0	65.5	79.7	132.8	164.9	62.4	80.5	56.3	311.4	182.6	102.5	80.0	149.3	194.5	74.4	200.8	61.3	133.8	187.6	72.0	84.2	245.4	81.7	228.9	51.8	103.8	264.1	280.4	54.8	44.1	76.7	118.3	90.4
TTC30A	"FLJ13946, IFT70A"	ENSG00000197557	"Tetratricopeptide repeat domain 30A"	Q86WT1	2	177612992-177618966	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 29.4;Early spermatids: 31.2;Spermatocytes: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (7.75e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.67e-3)"	"unprognostic (6.07e-2)"	2.7	4.1	3.8	1.5	7.1	0.4	5.6	2.2	7.1	4.2	3.4	5.9	7.8	2.2	5.0	10.9	2.4	8.4	4.8	4.4	3.7	4.2	6.9	4.6	3.7	1.4	3.6	6.6	5.5	4.4	11.6	8.1	1.9	4.8	3.9	3.3	5.0	8.1	4.0	3.5	1.9	2.5	3.6	3.0	1.7	3.6	24.5	2.1	2.6	9.6	4.6	1.7	3.1	1.7	0.5	1.6	1.9	1.6	0.2	2.7	1.0	5.7	3.3	3.3	0.0	6.7	5.6	2.4	2.8	8.1	5.0	5.3	1.0	4.2	1.3	5.4	4.8	6.8	4.8	2.2	6.1	5.5	0.4	1.8	1.1	1.6	1.4	2.7	1.4	1.3	3.4	4.0	2.8	1.1	4.8	2.3	2.9	0.8	0.5	3.5	2.9	4.4	2.6	1.8	2.0	1.2	2.9	8.8	0.6	6.3	1.5	10.8	7.2	2.5	4.9	3.0	8.1	2.8	1.4	2.1	3.1	1.9	3.4	2.3	2.2	2.1	0.4	7.7	0.1	3.0	0.0	1.3	1.9	0.4	1.6	0.1	0.4	0.1	0.4	1.6	0.5	2.7	1.2	0.7	0.2	1.3	0.6	1.0	1.0	3.8	7.1	2.2	7.1	3.7	4.2	3.6	6.6	4.8	2.1	8.9	1.9	0.0	1.1	0.7	2.2	3.1	2.5	29.4	4.5	7.0	2.0	0.8	1.7	4.1	31.2	1.4	1.7	0.0	3.5	0.7	1.5	1.0	0.0	2.9	0.7	15.9	6.9	4.3	0.3	6.8	2.0	0.2	1.7	0.0	2.5	10.6	2.4	0.0	2.1	3.8	11.3	0.0	0.9	33.6	4.6	0.4	0.2	0.0	2.3	0.3
TTC30B	"fleer, FLJ30990, IFT70B"	ENSG00000196659	"Tetratricopeptide repeat domain 30B"	Q8N4P2	2	177548998-177553014	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 42.8;Spermatocytes: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.65e-1)"	2.4	4.6	4.4	1.9	4.9	0.7	10.5	3.2	5.1	4.8	4.0	7.7	3.8	3.1	4.9	8.9	3.7	13.2	4.5	2.3	3.9	3.8	10.8	4.3	5.5	2.5	3.1	1.5	6.0	5.2	8.0	7.0	3.3	3.4	3.5	3.7	4.5	4.4	4.2	1.2	3.0	3.7	3.1	5.2	3.1	4.7	11.5	2.9	7.7	10.4	1.6	2.8	3.3	2.2	3.2	3.9	6.5	3.4	1.9	2.2	1.6	2.8	4.3	5.7	1.1	5.1	6.0	3.9	1.8	5.3	4.7	5.0	2.4	7.1	1.1	4.7	3.3	5.4	7.0	6.8	7.2	4.5	1.6	3.4	2.0	2.7	2.1	4.3	2.5	3.5	4.9	6.8	4.6	3.5	5.7	3.7	5.4	2.6	1.0	2.8	4.8	5.0	3.9	2.6	3.9	1.1	3.9	4.9	1.2	7.0	3.1	13.9	7.8	2.1	4.9	3.3	8.1	5.0	4.8	3.2	2.6	1.4	3.3	1.5	2.6	2.9	0.3	5.9	1.0	4.3	6.5	3.4	2.8	1.7	3.3	1.1	1.4	1.2	1.8	3.9	3.2	2.2	2.2	2.0	1.9	2.2	2.8	1.0	1.6	4.4	4.9	3.2	5.1	3.9	3.8	3.1	1.5	3.4	2.9	3.0	2.9	0.5	0.4	0.6	2.1	0.8	5.1	42.8	9.1	0.0	2.0	2.1	5.0	3.6	6.2	1.6	2.3	0.0	2.5	1.1	2.1	0.5	1.1	2.4	1.1	4.8	1.2	2.5	1.8	4.0	1.4	1.0	1.7	0.0	2.5	6.6	2.4	0.0	2.1	3.7	11.0	0.0	1.3	23.3	3.4	0.6	0.5	0.5	2.3	0.1
TTC31	FLJ12788	ENSG00000115282	"Tetratricopeptide repeat domain 31"	Q49AM3	2	74483073-74494886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041783	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA041783: AB_10794306"	"unprognostic (2.38e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (2.64e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.56e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (2.49e-4)"	9.2	8.9	7.4	12.3	11.7	11.5	8.6	13.8	9.3	9.0	15.7	8.6	5.3	10.5	11.6	9.4	8.7	7.9	14.5	7.4	8.9	3.7	9.9	23.6	8.2	10.4	10.4	7.7	9.7	13.4	13.2	10.0	13.7	8.3	8.0	9.5	10.5	8.1	7.5	6.5	11.1	16.2	9.3	7.0	13.6	11.6	8.6	12.2	11.5	7.7	9.7	11.5	10.6	8.5	9.3	9.7	8.1	10.2	7.5	9.0	7.8	11.1	10.1	6.6	3.4	3.8	11.3	7.7	6.2	8.6	11.3	7.9	8.6	8.3	15.7	4.9	4.9	10.4	8.1	6.1	6.7	5.6	17.2	6.3	16.7	9.0	14.7	7.5	6.8	11.1	8.2	9.0	9.6	6.0	7.6	7.6	7.2	11.1	6.7	7.0	10.3	10.1	4.0	4.1	8.2	5.0	10.0	17.3	7.4	6.2	8.3	3.3	12.2	5.8	9.1	6.3	3.8	6.8	3.8	14.0	7.8	12.9	4.8	9.1	9.9	7.9	10.2	9.6	7.9	7.2	6.4	10.2	8.1	8.4	10.2	9.0	9.3	6.5	8.0	9.7	7.3	6.3	6.8	1.4	7.5	10.2	5.7	8.3	7.8	7.4	11.7	13.8	9.3	8.9	3.7	10.4	7.7	8.3	12.2	14.9	8.6	11.5	3.5	2.5	10.2	2.9	12.7	4.0	9.1	8.7	37.3	7.1	1.7	4.7	3.3	4.5	8.1	0.0	4.8	4.3	3.5	2.7	18.5	18.6	7.3	4.8	5.8	4.3	7.3	3.8	5.8	7.8	3.3	10.8	5.3	8.1	4.8	5.5	5.3	5.0	22.2	6.5	4.1	8.9	8.7	2.9	6.8	7.5	6.3	3.3
TTC32		ENSG00000183891	"Tetratricopeptide repeat domain 32"	Q5I0X7	2	19896643-19901986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036024	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036024: AB_10673493"	"unprognostic (2.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.92e-3)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (5.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.27e-2)"	11.8	8.9	12.8	10.8	24.7	30.1	17.4	24.1	18.9	10.8	11.0	17.5	11.9	11.5	13.6	28.5	7.8	11.8	11.8	7.3	14.9	11.8	9.4	12.6	10.1	13.7	29.6	9.2	16.9	8.7	13.4	17.0	8.2	16.9	16.6	10.4	14.5	11.4	13.1	19.6	14.2	12.1	9.4	18.4	13.9	10.6	12.9	23.6	15.5	13.7	12.9	9.5	11.9	11.7	9.3	5.4	21.6	5.9	4.5	12.8	3.8	14.4	9.2	8.3	6.1	3.8	8.3	1.7	3.1	5.3	5.3	3.5	4.6	16.7	9.1	1.8	3.3	6.4	9.2	3.9	10.3	3.4	13.3	15.8	9.3	12.3	8.3	8.2	9.1	16.8	7.8	6.3	5.8	14.1	4.2	4.9	15.0	17.3	18.8	4.4	4.4	6.5	13.5	6.5	5.6	16.3	7.8	5.6	15.3	14.5	5.7	13.7	12.8	10.8	5.8	11.5	10.2	7.9	3.5	3.4	7.4	8.2	7.7	4.2	19.0	17.3	15.4	12.0	8.9	4.3	6.1	5.9	16.5	5.9	4.3	6.7	8.8	9.2	6.1	5.4	9.3	12.8	9.7	21.6	4.5	4.8	3.8	10.9	3.8	12.8	24.7	24.1	18.9	14.9	11.8	29.6	9.2	16.9	23.6	8.9	11.8	18.3	25.0	16.8	36.8	13.2	12.7	44.2	14.8	12.2	13.7	11.6	38.1	9.2	12.5	15.7	9.3	0.0	21.9	9.3	13.9	17.2	8.1	23.3	8.0	39.7	27.2	5.5	7.1	4.6	18.4	17.0	6.8	11.8	16.5	44.9	10.9	15.0	9.2	18.7	34.7	12.9	16.5	86.3	21.3	22.8	8.0	17.3	13.6	17.4
TTC33	OSRF	ENSG00000113638	"Tetratricopeptide repeat domain 33"	Q6PID6	5	40512333-40755975	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038252, HPA038253"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA038252: AB_10674551, HPA038253: AB_10671739"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.28e-3)"	11.0	11.8	13.5	6.9	27.7	1.5	11.0	20.4	20.1	11.7	9.9	6.4	8.1	8.2	12.3	7.8	9.1	10.1	9.0	13.4	11.5	12.1	14.7	15.0	9.0	8.9	8.8	19.4	15.2	8.6	15.6	15.1	9.0	13.1	11.5	9.2	7.3	9.3	10.6	24.2	6.4	9.1	10.5	9.5	8.4	8.7	9.0	9.8	14.3	12.8	5.5	9.2	10.8	9.0	7.2	5.3	15.9	10.8	7.8	10.0	8.2	5.2	4.6	9.0	11.5	6.3	9.1	4.1	7.2	7.6	7.9	8.1	2.3	5.5	16.6	4.4	5.4	9.3	2.8	8.6	3.9	13.1	18.7	6.5	3.6	15.6	6.5	6.4	9.3	5.3	5.4	7.4	7.4	7.6	9.9	10.9	10.5	8.4	12.8	9.5	1.3	16.4	9.1	2.7	3.6	4.5	15.9	17.9	9.3	8.4	3.2	6.5	7.4	18.1	8.9	9.7	7.3	7.1	10.6	7.5	9.5	8.6	6.0	5.9	10.5	11.3	9.0	6.4	12.5	7.5	15.9	6.1	11.1	8.1	9.0	8.7	7.2	8.5	7.5	5.3	6.9	10.0	8.0	9.0	7.8	10.8	3.9	9.0	8.2	13.5	27.7	20.4	20.1	11.5	12.1	8.8	19.4	13.1	9.8	14.9	6.1	11.5	4.6	12.8	12.1	15.9	5.1	14.7	4.5	7.0	5.9	4.5	16.6	6.9	9.6	11.3	5.8	0.0	5.4	3.4	12.8	5.9	12.7	7.9	4.6	4.8	2.9	11.1	8.2	5.9	13.0	6.3	10.1	18.0	6.8	17.3	6.6	7.0	13.1	8.5	20.6	12.9	11.3	27.0	15.7	15.9	2.2	7.5	5.8	4.0
TTC38	FLJ20699	ENSG00000075234	"Tetratricopeptide repeat domain 38"	Q5R3I4	22	46267961-46294008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 59.8;liver: 92.8"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 78.3;Hepatocytes: 110.0;Proximal tubular cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 36.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.1;NK-cells: 13.5;T-cells: 36.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029302, HPA075893"	Approved		Approved	Cytosol		NA	NA		19000	Cytosol		"HPA029302: AB_10601704, HPA075893: "	"unprognostic (7.78e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.92e-3)"	"prognostic favorable (3.21e-6)"	"unprognostic (8.34e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.72e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.02e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.97e-1)"	"unprognostic (8.33e-2)"	10.5	8.1	3.8	8.8	5.0	16.1	14.0	3.9	4.4	5.5	31.6	5.5	6.2	31.2	6.6	5.0	6.7	5.9	15.0	10.9	3.8	3.3	47.2	92.8	5.3	5.0	6.0	2.2	10.0	19.8	3.0	5.9	3.1	5.3	8.7	12.9	7.5	10.4	6.9	8.6	3.9	59.8	5.2	3.9	8.4	9.1	2.5	5.5	1.0	8.2	4.7	4.2	5.3	5.8	0.9	4.0	10.1	4.3	13.5	36.0	13.4	5.6	6.3	8.0	16.7	7.5	6.5	8.1	8.4	5.5	9.1	7.2	10.3	4.2	0.0	5.4	8.5	3.6	5.2	8.0	6.7	3.3	12.7	18.0	7.5	14.1	35.4	10.5	4.1	29.5	11.2	3.5	4.1	4.8	6.3	7.6	0.1	5.5	9.4	5.8	5.6	0.1	13.1	6.1	10.6	6.3	0.0	3.9	3.8	6.2	6.6	1.4	11.3	11.5	7.9	6.2	3.8	12.7	8.4	8.9	6.5	7.2	5.0	5.2	7.3	4.3	0.8	4.3	6.5	6.6	10.1	4.3	8.0	36.0	4.1	3.9	0.9	3.5	16.0	4.0	0.7	1.5	15.4	2.9	13.5	3.0	1.6	1.6	13.4	3.8	5.0	3.9	4.4	3.8	3.3	6.0	2.2	5.3	5.5	0.0	6.9	6.0	4.9	3.0	2.5	8.7	30.6	4.0	3.4	8.7	5.9	8.8	19.9	8.8	0.1	7.2	78.3	0.0	8.9	7.4	5.2	8.0	17.3	110.0	11.4	4.8	20.1	8.0	11.1	0.7	6.9	8.7	5.0	16.2	36.7	9.0	10.3	45.8	13.1	122.9	4.9	6.5	5.2	1.7	4.3	7.2	5.4	35.9	47.2	4.2
TTC39B	"C9orf52, FLJ33868"	ENSG00000155158	"Tetratricopeptide repeat domain 39B"	Q5VTQ0	9	15163622-15307360	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 2.0;gdT-cell: 4.1;MAIT T-cell: 5.4;memory CD4 T-cell: 5.6;memory CD8 T-cell: 6.3;naive CD4 T-cell: 6.7;naive CD8 T-cell: 4.1;NK-cell: 7.6;T-reg: 4.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.0;NK-cells: 7.6;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"HEL: 27.2;RT4: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063162			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA063162: AB_2684952"	"unprognostic (1.64e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (9.64e-6)"	"unprognostic (5.99e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.89e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (3.31e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.48e-1)"	7.3	4.9	3.6	7.2	7.9	2.3	7.7	35.9	12.9	8.2	10.5	1.7	1.8	9.0	10.0	4.4	14.2	6.1	11.2	3.0	3.6	5.6	14.6	8.5	8.6	8.9	5.3	6.4	6.6	6.3	3.7	13.5	2.2	20.8	4.6	9.3	3.8	6.3	3.4	3.7	15.1	15.2	6.9	5.9	6.8	8.8	8.5	2.9	1.3	4.7	4.7	9.3	6.2	8.1	1.0	0.6	2.0	0.9	7.6	6.7	3.4	2.6	0.5	0.8	3.9	3.8	7.0	0.8	3.4	6.2	2.7	6.5	0.5	1.1	0.0	0.4	4.2	3.2	2.3	0.6	4.2	2.3	2.9	0.5	27.2	1.2	4.9	6.2	0.0	0.6	6.8	3.3	5.6	6.3	1.9	3.8	2.3	0.1	6.2	6.8	0.8	1.4	0.1	1.0	8.2	0.8	0.3	2.1	1.2	5.8	15.5	2.0	0.4	0.8	2.0	0.6	1.3	8.7	1.7	2.8	1.5	1.3	2.1	0.9	0.1	0.0	0.0	1.4	0.3	0.7	2.0	0.9	1.2	4.1	0.7	5.4	0.3	5.6	6.3	0.6	1.0	6.7	4.1	0.7	7.6	0.9	0.1	4.9	3.4	3.6	7.9	35.9	12.9	3.6	5.6	5.3	6.4	20.8	2.9	11.9	17.5	2.7	6.0	15.3	23.4	2.7	7.6	16.0	9.1	7.0	0.0	2.7	14.9	5.3	30.6	6.3	28.8	0.0	19.0	0.9	8.9	7.4	27.8	10.4	4.2	12.7	12.2	6.2	3.7	25.3	6.6	5.6	6.8	2.8	14.3	16.0	10.1	44.2	12.0	32.1	3.9	0.0	10.3	2.3	1.9	18.7	3.4	20.1	12.6	13.2
TTC39C	"C18orf17, FLJ33761, HsT2697"	ENSG00000168234	"Tetratricopeptide repeat domain 39C"	Q8N584	18	23992773-24135610	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 92.2"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 120.1;Hepatocytes: 148.6;Late spermatids: 236.0;Rod photoreceptor cells: 233.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 35.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065705, HPA065713"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065705: AB_2685538, HPA065713: AB_2685542"	"prognostic favorable (1.48e-4)"	"unprognostic (6.37e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (2.32e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.48e-3)"	9.0	14.2	6.2	12.0	4.9	17.7	10.9	5.1	12.2	8.7	6.3	2.4	1.5	5.1	9.8	6.5	9.4	9.0	17.2	3.9	5.3	2.7	3.3	92.2	7.1	14.1	2.2	6.7	5.9	9.8	1.3	13.4	1.5	6.2	9.7	4.6	20.8	11.8	3.9	4.7	24.2	6.2	5.3	2.2	6.7	6.1	14.3	1.0	12.0	3.7	5.7	20.9	8.3	9.3	5.2	8.8	0.5	1.9	5.7	35.5	4.2	6.6	4.9	3.3	2.2	21.1	22.3	12.1	9.5	21.8	7.6	7.8	0.6	3.7	10.9	9.4	16.6	5.7	8.3	6.5	8.3	6.1	16.3	6.7	3.2	23.9	12.3	4.1	17.1	8.5	18.0	11.3	4.3	6.1	14.1	0.5	7.9	0.1	0.1	4.8	5.1	2.8	5.2	8.2	2.9	12.7	15.7	5.0	4.2	7.9	10.1	8.8	7.0	18.4	6.1	5.8	3.6	4.8	6.3	4.2	6.7	5.0	5.1	4.8	0.2	0.0	15.9	9.0	17.9	4.5	0.5	1.9	0.0	11.2	1.9	28.8	5.2	24.9	14.0	2.5	3.3	10.7	9.0	0.5	5.7	1.5	8.8	35.5	4.2	6.2	4.9	5.1	12.2	5.3	2.7	2.2	6.7	6.2	1.0	0.0	4.3	22.3	15.8	40.9	14.4	3.1	53.5	12.0	2.3	7.0	43.2	0.5	0.0	9.7	120.1	3.0	2.2	0.0	10.1	12.5	12.4	19.8	2.3	148.6	11.3	12.7	4.1	4.9	24.7	236.0	10.3	20.8	13.5	1.8	9.0	20.5	8.2	0.0	7.4	1.1	233.7	0.0	8.3	23.8	1.7	75.3	0.5	59.9	4.6	16.7
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715822-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	10.9	10.6	14.5	13.4	17.6	3.5	17.1	13.7	14.0	18.2	10.9	12.8	12.7	9.1	14.9	14.1	11.9	15.7	8.0	13.4	14.6	14.0	13.2	16.4	8.9	13.0	13.5	9.3	18.5	16.6	15.6	14.6	12.5	12.9	13.5	10.8	9.2	13.1	14.7	33.3	14.7	8.5	12.8	20.4	10.3	11.2	13.3	12.0	11.7	11.5	15.1	14.0	11.4	13.6	11.5	11.3	8.6	11.7	15.0	14.9	10.5	9.9	7.5	8.9	4.5	14.4	7.3	7.8	13.7	6.8	17.8	10.7	9.4	2.8	18.4	7.4	9.2	19.5	5.8	19.9	13.5	18.0	15.6	15.7	17.7	3.4	5.3	12.6	13.4	4.3	6.5	13.8	25.9	15.9	7.7	7.3	14.5	18.9	2.3	9.6	4.7	11.9	8.1	18.7	13.1	14.4	11.0	18.9	8.3	8.7	2.8	5.8	4.1	11.6	6.2	11.5	15.3	5.6	7.3	7.0	8.7	9.6	8.8	18.4	6.6	11.7	14.6	11.2	15.3	8.8	5.9	10.3	8.6	12.5	11.7	13.3	11.5	10.3	11.8	11.3	11.0	14.9	13.2	0.2	15.0	11.3	9.6	9.3	10.5	14.5	17.6	13.7	14.0	14.6	14.0	13.5	9.3	12.9	12.0	8.9	1.6	4.5	2.5	1.0	4.1	2.8	2.5	4.0	7.9	0.0	0.0	3.1	0.0	2.9	0.4	2.1	1.3	0.0	3.6	2.0	1.7	1.5	6.9	2.4	1.2	4.8	1.2	3.7	1.2	0.0	3.7	1.6	1.7	8.2	1.3	3.3	3.2	1.1	2.5	2.5	3.1	0.0	0.8	7.2	8.7	1.4	1.1	2.2	2.3	1.7
TTC6	"C14orf25, NCRNA00291"	ENSG00000139865	"Tetratricopeptide repeat domain 6"	Q86TZ1	14	37595847-38041442	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 9.7;prostate: 20.5"	"Cell type enhanced"	"Detected in some"	14	"Club cells: 18.2;Early spermatids: 30.4;Late spermatids: 14.0"	"Group enriched"	"Detected in some"	7	"breast cancer: 2.2;prostate cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 7.3;MCF7: 10.7;RT4: 7.5;T-47d: 20.7"									HPA069293			Approved	Centrosome		NA	NA			Centrosome		"HPA069293: AB_2686110"	"unprognostic (7.92e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.60e-4)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-4)"	"unprognostic (5.60e-2)"	"unprognostic (8.91e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.07e-3)"	0.0	0.0	0.3	1.3	0.6	0.0	9.7	0.3	0.6	0.2	2.2	0.2	0.0	0.6	0.0	1.3	0.6	0.4	1.0	0.0	0.8	0.9	0.0	7.9	5.6	0.0	0.7	0.4	0.4	0.0	0.0	1.1	0.3	0.1	20.5	0.5	0.0	3.0	1.1	0.0	0.8	1.2	2.5	0.6	0.0	3.8	6.0	0.0	0.0	0.0	0.6	2.3	2.2	4.6	0.6	0.2	0.4	0.0	0.0	0.1	0.0	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.4	0.0	0.0	2.2	1.2	0.2	0.0	0.0	3.1	0.0	0.9	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	10.7	0.0	0.0	0.0	1.5	4.0	0.0	0.0	0.0	1.0	7.5	2.2	0.0	0.0	4.1	0.0	0.0	20.7	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.3	0.6	0.8	0.9	0.7	0.4	0.1	0.0	0.0	6.7	0.0	2.6	0.0	0.0	0.6	2.5	8.1	18.2	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	2.5	0.0	0.0	7.5	0.0	0.0	14.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.4	0.4	0.0	0.0	0.0	0.8	2.7
TTC7B	TTC7L1	ENSG00000165914	"Tetratricopeptide repeat domain 7B"	Q86TV6	14	90524564-90816479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 28.6;Sertoli cells: 25.8;Syncytiotrophoblasts: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.0;eosinophil: 9.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058363, HPA059577"	Enhanced		Supported	"Plasma membrane"		NA	NA		11000	"Plasma membrane"		"HPA058363: AB_2683692, HPA059577: AB_2684069"	"unprognostic (9.37e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.20e-6)"	"unprognostic (2.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.07e-2)"	16.2	9.0	29.1	6.6	20.1	6.7	7.1	40.6	33.7	10.0	7.9	10.9	5.6	3.8	11.0	5.0	11.8	5.7	7.0	23.8	26.0	15.9	7.7	6.7	8.9	2.8	14.7	18.3	9.9	17.2	6.7	7.0	19.2	20.3	10.1	3.6	8.8	8.6	11.1	37.4	3.2	4.2	13.1	8.8	10.6	6.1	2.7	8.1	0.3	5.9	2.5	2.1	8.1	4.8	0.4	0.7	9.7	0.6	0.5	1.2	0.7	8.5	7.8	9.2	6.7	8.6	10.2	30.3	6.9	6.0	9.3	10.1	2.0	2.3	0.1	11.0	7.8	11.0	0.1	5.9	4.8	9.1	15.5	6.4	19.3	4.0	1.8	8.6	0.4	33.7	7.6	3.3	5.0	6.2	8.6	13.3	7.6	10.7	15.9	8.9	9.1	0.2	7.5	5.2	0.5	6.7	16.7	15.2	2.8	3.0	6.4	14.1	9.7	6.9	2.9	14.7	6.1	4.1	5.9	15.2	9.6	7.6	7.0	11.2	5.4	2.7	0.1	13.8	1.8	9.3	7.0	0.3	9.7	0.2	0.6	0.3	0.3	0.3	0.2	0.4	0.4	0.3	0.2	1.4	0.5	0.2	0.7	1.2	0.7	29.1	20.1	40.6	27.8	26.0	15.9	14.7	18.3	20.3	8.1	3.0	0.6	0.0	1.8	2.5	10.9	18.1	0.0	5.3	0.0	5.2	15.7	11.0	1.7	2.2	3.9	5.8	0.0	0.0	2.0	6.5	4.1	2.6	7.0	8.1	6.9	28.6	1.2	9.2	3.9	1.1	6.4	2.8	11.8	3.6	0.0	5.4	1.2	0.0	6.7	2.8	17.7	25.8	5.2	1.5	1.6	1.8	25.2	0.5	0.0	1.0
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 47.9"	"Cell type enhanced"	"Detected in some"	26	"Bipolar cells: 37.7;Horizontal cells: 17.5;Rod photoreceptor cells: 7.3"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria	"Secreted in brain"	NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	1.0	1.8	45.5	1.4	10.3	1.0	1.0	24.6	47.9	1.0	1.2	1.2	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	22.3	14.0	1.0	1.0	1.0	1.0	7.5	9.9	1.0	1.0	1.0	0.0	1.0	7.1	1.0	1.0	0.3	1.0	1.0	1.0	1.0	1.2	1.1	2.5	1.0	1.1	1.1	1.0	0.0	1.0	0.0	1.0	1.0	0.0	0.1	0.5	0.0	1.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	25.1	1.3	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	45.5	10.3	24.6	31.3	22.3	14.0	7.5	9.9	7.1	1.0	0.0	0.0	0.0	0.0	0.0	37.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	17.5	1.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.7	0.0	7.3	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.2	0.1
TTC9C	MGC29649	ENSG00000162222	"Tetratricopeptide repeat domain 9C"	Q8N5M4	11	62728069-62740293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055169	Approved		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA055169: AB_2682724"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.67e-7)"	"prognostic favorable (4.15e-5)"	"unprognostic (7.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-2)"	17.1	19.0	23.4	20.9	24.2	6.5	18.4	26.2	29.3	19.1	19.3	15.8	21.2	25.0	22.9	21.6	18.0	22.6	18.7	13.2	21.5	22.6	20.9	17.2	16.4	28.2	20.4	20.0	32.9	22.3	12.3	18.3	23.1	22.3	18.5	18.8	16.7	21.6	20.0	21.1	24.4	18.2	19.0	17.0	23.2	18.4	17.0	17.5	31.1	24.3	13.3	27.9	21.3	18.0	25.2	20.2	31.0	23.9	16.8	22.7	14.0	20.2	17.5	14.6	14.3	20.1	24.4	10.8	20.8	21.4	25.7	21.2	15.5	20.2	15.4	39.8	14.6	22.3	18.4	21.6	6.5	20.0	40.1	10.8	17.0	25.6	18.6	23.1	11.4	19.0	16.1	13.9	20.8	21.1	18.6	18.8	18.6	12.3	15.6	24.4	14.8	18.1	24.3	12.4	16.5	13.9	14.4	18.6	23.3	16.2	8.0	12.8	10.5	18.0	16.0	25.2	13.5	21.0	11.0	16.2	26.3	15.3	29.0	14.9	16.4	24.6	17.1	14.3	8.8	13.6	31.0	23.9	23.1	14.4	21.3	11.0	25.2	15.4	14.2	20.2	22.6	15.4	13.9	15.3	16.8	13.8	20.2	22.7	14.0	23.4	24.2	26.2	29.3	21.5	22.6	20.4	20.0	22.3	17.5	14.9	10.4	25.9	12.6	26.3	17.1	7.0	7.6	13.4	15.9	17.4	7.9	29.1	23.2	20.0	18.9	21.4	16.9	0.0	13.1	36.2	23.8	13.9	8.1	7.8	33.4	27.0	5.8	13.5	24.8	15.9	26.2	19.0	15.1	42.3	12.6	13.2	18.1	18.2	25.8	20.6	16.8	32.3	18.4	27.7	26.6	29.1	19.9	20.8	15.3	17.6
TTI1	"KIAA0406, smg-10"	ENSG00000101407	"TELO2 interacting protein 1"	O43156	20	37983007-38033468	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034230, HPA068338"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB034230: AB_1564322, HPA068338: AB_2685975"	"unprognostic (7.14e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (3.30e-5)"	"unprognostic (1.11e-1)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	9.2	14.2	16.6	10.5	16.2	9.5	11.1	15.5	16.3	10.8	9.8	16.0	9.2	7.4	12.7	12.7	10.2	12.8	7.3	11.3	10.2	9.0	10.7	15.2	9.6	13.4	14.9	12.9	15.4	24.5	16.6	22.8	13.2	15.6	12.8	13.5	13.9	11.7	14.9	22.0	10.4	9.8	13.8	15.8	12.5	11.3	13.0	14.1	17.6	15.4	4.9	15.3	13.7	10.0	10.2	12.9	17.0	11.6	10.3	13.9	9.1	9.8	14.6	16.2	6.1	6.6	9.3	17.4	11.2	6.6	16.7	14.3	34.1	12.9	16.2	11.7	6.3	18.6	15.7	18.1	23.4	16.6	6.4	7.1	22.2	14.5	17.5	7.5	17.7	10.5	7.1	15.5	16.6	10.1	6.4	12.4	17.3	23.3	11.1	12.6	10.1	23.9	12.4	15.9	15.4	15.4	15.7	26.1	19.0	6.4	10.6	14.8	13.2	17.1	30.4	3.9	17.5	17.2	8.6	8.1	22.6	15.0	12.0	11.4	9.7	8.4	18.3	13.2	11.7	11.6	12.9	9.8	17.0	11.9	11.6	13.4	10.2	9.3	11.7	12.9	9.7	13.9	11.1	6.2	10.3	6.9	6.3	11.7	9.1	16.6	16.2	15.5	16.3	10.2	9.0	14.9	12.9	15.6	14.1	8.9	12.3	4.9	2.9	2.7	7.3	11.5	10.2	20.1	9.1	3.5	9.8	12.3	1.7	3.9	5.3	4.6	2.9	0.0	2.8	8.9	3.5	5.2	2.3	6.8	4.6	7.9	2.9	5.5	0.6	2.7	6.1	3.8	3.3	7.2	5.0	6.4	3.7	4.8	6.3	3.7	8.2	0.0	3.6	13.1	11.5	2.6	12.0	5.0	4.5	3.5
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.6	1.1	3.5	13.6	15.5	9.5	22.7	27.8	10.9	10.2	19.8	12.1	6.6	23.8	17.3	21.1	9.5	31.6	18.0	17.0	18.3	10.6	8.9	0.0	21.5	11.9	0.4	1.0	15.8	10.1	3.3	12.8	27.9	19.9	20.4	19.2	9.9	12.2	15.5	14.1	12.0	9.7	11.0	43.8	8.2	5.7	8.6	16.5	9.7	9.1	9.9	5.6	13.5	9.3	16.3	5.3	10.2	10.2	6.6	24.7	4.6	15.5	11.0	3.6	20.0	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2	3.0	0.6	0.0	0.5	1.1	0.0	0.7	0.0	4.0	3.4	0.0	2.0	4.1	3.3	0.4	19.9	0.1	0.2	23.3	0.2	13.1	0.8	0.2	1.1	0.0	5.2	0.0	1.7	0.0	2.4	12.8	0.9	1.2	0.0	9.0	1.0	0.3	0.4	0.0	0.7	0.0	1.2	6.5	0.2	63.4	28.5	0.3	3.1	0.0	1.2	0.7
TTL	MGC46235	ENSG00000114999	"Tubulin tyrosine ligase"	Q8NG68	2	112482154-112541739	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066819			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA066819: AB_2685728"	"unprognostic (1.05e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.95e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	4.4	4.0	9.9	4.2	11.9	7.1	11.3	5.0	12.5	3.3	4.1	9.2	2.5	3.1	4.6	4.2	5.2	3.2	4.9	10.3	9.4	6.5	3.9	3.3	5.9	4.4	8.1	5.3	3.2	3.8	4.1	2.4	5.3	5.9	3.2	3.9	2.6	3.0	3.7	13.1	6.0	3.2	5.8	5.4	4.0	3.2	3.0	6.5	5.1	4.2	5.2	3.8	4.8	2.9	1.8	1.2	2.7	1.3	1.0	1.3	0.5	3.7	2.9	3.7	8.2	4.4	6.3	1.4	6.4	5.3	6.9	5.9	3.5	1.4	3.5	3.6	5.5	4.5	2.6	6.4	3.3	8.3	2.4	3.6	2.9	4.1	4.4	2.0	4.1	1.5	2.8	2.3	10.0	5.3	3.1	5.8	2.4	4.8	2.8	5.4	1.9	3.6	2.3	3.2	1.1	5.8	3.9	4.1	1.9	2.1	2.9	7.8	5.4	5.0	1.7	8.9	2.5	1.7	2.4	5.8	8.2	6.0	6.4	4.8	1.6	3.1	2.9	9.0	3.1	3.5	2.7	1.3	1.0	1.3	0.8	1.1	0.8	1.0	1.0	0.4	1.8	0.9	1.1	2.4	1.0	1.1	1.2	0.8	0.5	9.9	11.9	5.0	12.5	9.4	6.5	8.1	5.3	5.9	6.5	11.9	8.3	3.7	4.2	18.0	16.4	32.0	5.1	2.7	7.9	12.2	11.8	2.6	0.0	6.0	6.1	13.0	5.0	46.7	8.3	2.1	9.4	5.0	0.0	9.4	10.2	7.9	10.9	20.9	24.8	3.6	2.8	15.5	6.8	10.8	5.5	9.1	8.6	5.8	5.3	4.9	21.2	6.5	9.0	1.9	4.3	15.7	1.0	6.1	5.2	3.7
TTLL1	C22orf7	ENSG00000100271	"Tubulin tyrosine ligase like 1"	O95922	22	43039644-43089428	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 24.1;Early spermatids: 30.7;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048392	Approved		Approved	Nucleoli,Mitochondria		No	No			Nucleoli	Mitochondria	"HPA048392: AB_2680384"	"unprognostic (1.02e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.18e-3)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (8.22e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	4.0	7.3	16.5	3.6	12.0	2.9	6.8	12.8	16.6	7.6	4.6	8.8	0.9	2.5	7.1	12.5	5.7	14.6	5.7	12.5	13.9	12.6	6.1	2.1	5.3	4.9	9.2	14.1	8.3	4.2	8.5	9.8	3.9	13.2	7.7	4.6	6.8	4.7	6.0	4.4	5.8	2.9	5.9	10.0	4.5	5.4	14.0	8.4	4.7	10.3	1.8	4.8	5.4	4.6	4.7	10.4	7.0	6.5	9.9	14.1	6.2	0.8	1.5	12.8	9.7	14.5	12.9	0.6	4.3	4.8	2.5	4.2	0.1	1.9	0.9	3.1	7.9	1.5	0.6	1.1	1.1	2.5	1.1	2.1	1.3	0.7	1.2	10.4	3.2	1.7	10.6	16.6	1.6	4.1	10.7	8.2	10.9	0.3	8.3	9.2	4.2	3.0	5.2	1.7	3.4	0.9	7.4	7.2	0.7	4.6	1.1	3.2	6.1	3.4	1.7	11.8	6.9	5.1	5.4	7.8	2.7	1.8	6.2	0.6	2.9	0.8	0.3	6.8	5.9	4.8	5.2	5.9	7.0	13.0	6.5	12.2	3.1	11.4	14.1	10.4	4.7	9.7	12.2	1.7	9.9	4.9	6.7	6.9	6.2	16.5	12.0	12.8	16.6	13.9	12.6	9.2	14.1	13.2	8.4	0.0	2.4	0.5	2.5	2.1	5.3	4.0	2.5	24.1	4.5	1.8	5.9	2.5	13.3	5.5	30.7	3.3	0.5	0.0	4.2	1.2	5.1	3.2	1.1	0.4	4.3	4.8	0.0	6.7	2.1	14.5	3.7	2.3	8.5	4.6	2.6	5.5	4.4	7.0	5.6	5.7	10.1	6.5	1.4	8.6	37.7	2.4	0.6	2.9	1.5	1.3
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187133	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		2100000	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: AB_2666770"	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	7.3	13.8	7.2	14.7	8.3	14.0	11.2	13.6	12.3	10.9	21.5	5.5	8.9	15.0	7.1	8.7	46.3	9.0	36.0	6.9	7.3	7.1	8.4	19.4	5.3	9.2	6.5	5.9	16.5	29.8	4.4	7.0	6.8	7.1	9.4	12.1	7.0	13.5	7.9	5.5	16.4	13.9	5.9	4.0	9.7	20.7	18.3	5.3	10.7	7.6	23.7	23.5	8.3	15.2	3.5	3.8	1.3	4.7	4.3	5.6	3.3	31.6	13.4	5.4	13.4	8.3	5.7	17.6	10.5	3.7	10.1	5.3	21.7	18.2	30.6	12.7	8.6	4.9	22.7	22.6	19.2	2.6	3.8	35.8	7.5	21.5	18.6	13.1	33.6	7.8	9.1	23.3	12.0	12.9	5.4	10.6	15.1	46.0	7.2	4.6	29.5	23.3	18.2	19.7	22.3	13.4	23.8	18.7	44.0	8.5	10.5	16.6	6.8	22.2	32.6	11.7	2.6	12.8	15.0	10.1	6.7	9.5	12.9	14.5	12.3	15.1	22.6	7.6	17.3	9.1	0.0	4.7	0.7	5.6	2.4	5.5	3.5	5.5	4.1	3.8	2.7	5.5	3.7	1.3	4.3	3.1	3.3	3.5	3.3	7.2	8.3	13.6	12.3	7.3	7.1	6.5	5.9	7.1	5.3	6.0	7.0	9.9	8.6	10.0	8.4	3.6	20.4	2.7	3.4	7.0	3.9	5.7	5.0	13.9	0.7	3.6	35.1	23.3	7.3	14.1	4.1	13.4	0.0	30.4	8.7	0.0	8.7	9.2	13.8	1.6	8.1	5.0	10.1	4.6	29.3	3.8	18.9	54.1	15.9	7.7	4.6	0.0	7.2	2.2	12.8	15.8	3.4	3.8	33.9	13.1
TTLL2	"C6orf104, dJ366N23.3, NYD-TSPG"	ENSG00000120440	"Tubulin tyrosine ligase like 2"	Q9BWV7	6	167325086-167359503	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 54.1"	"Group enriched"	"Detected in some"	167	"Early spermatids: 407.9;Late spermatids: 161.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 6.3"	"Not detected"	"Not detected"							HPA027985			Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane, Nucleoli"		"HPA027985: AB_2211832"	"unprognostic (5.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.47e-4)"		"unprognostic (7.57e-2)"	"unprognostic (2.63e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	54.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0
TTLL4	KIAA0173	ENSG00000135912	"Tubulin tyrosine ligase like 4"	Q14679	2	218710845-218755416	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.1"	"Cell type enhanced"	"Detected in many"	13	"Muller glia cells: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027091, HPA050252"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA027091: AB_10601828, HPA050252: AB_2681064"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (3.83e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (6.63e-12)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.29e-3)"	6.1	9.0	10.6	11.1	15.1	7.1	9.0	11.2	12.7	5.9	7.7	17.7	5.9	7.9	8.5	5.5	9.2	10.5	7.0	5.9	10.9	6.8	6.3	7.7	8.7	8.0	16.6	6.3	6.9	9.1	8.8	14.5	11.0	13.1	8.4	9.3	11.2	8.9	5.8	7.0	10.8	8.0	7.6	16.7	7.6	12.6	39.1	14.1	8.6	5.3	5.3	11.9	6.1	7.7	4.0	6.8	13.5	11.3	1.8	3.2	3.9	9.0	6.1	16.3	8.2	4.2	3.3	23.0	6.3	4.9	10.0	8.6	25.7	10.7	7.1	5.4	4.6	9.7	10.1	17.1	8.3	11.8	8.5	15.6	9.2	9.2	24.4	6.0	11.3	6.8	5.4	5.1	9.0	10.2	4.3	9.5	8.0	26.0	11.2	5.5	5.2	6.2	7.7	18.7	6.5	4.3	14.9	7.4	9.3	10.0	7.1	6.7	6.5	4.6	6.9	11.9	26.1	5.5	5.8	4.0	9.0	9.4	6.2	5.9	5.9	4.9	16.1	4.7	7.1	11.6	0.1	11.3	0.7	3.2	5.7	2.9	4.0	2.3	2.2	6.8	3.2	1.5	1.4	13.5	1.8	7.4	4.0	1.4	3.9	10.6	15.1	11.2	12.7	10.9	6.8	16.6	6.3	13.1	14.1	3.0	4.3	2.9	9.9	4.0	5.9	1.4	2.5	1.4	4.5	7.0	25.5	5.5	0.0	4.7	28.9	2.3	2.6	0.0	3.3	6.9	3.7	11.6	1.1	1.7	7.0	3.2	5.2	2.5	3.2	13.2	2.8	5.4	3.3	7.2	4.4	91.9	5.0	2.9	1.4	1.4	12.6	0.0	3.1	14.4	12.1	3.6	4.8	2.5	4.4	10.3
TTLL6	FLJ35808	ENSG00000170703	"Tubulin tyrosine ligase like 6"	Q8N841	17	48762235-48817214	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.8;intestine: 5.0;testis: 17.6"	"Group enriched"	"Detected in many"	11	"Ciliated cells: 40.2;Early spermatids: 40.1;Late spermatids: 142.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HDLM-2: 9.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA052397	Enhanced		Approved	Vesicles,Microtubules		NA	NA			Microtubules	Vesicles	"HPA052397: AB_2681812"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.21e-5)"	"unprognostic (1.10e-2)"	"unprognostic (6.01e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.09e-3)"	0.1	0.0	0.5	3.3	0.5	0.0	0.1	0.1	1.1	0.2	3.6	0.1	1.3	1.6	0.8	0.1	0.1	4.8	1.4	0.1	0.8	0.4	1.8	0.1	1.1	0.1	0.2	1.1	0.8	0.6	0.0	0.3	0.1	0.9	0.1	5.0	0.3	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.1	17.6	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	9.9	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	1.1	0.8	0.4	0.2	1.1	0.9	0.1	3.0	1.6	0.0	0.0	0.0	0.1	0.4	0.0	40.2	6.8	1.8	0.0	0.0	1.7	0.1	40.1	0.0	3.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	4.1	1.8	0.0	142.0	1.1	0.0	0.0	0.0	3.1	0.3	0.0	2.6	0.0	2.1	0.4	0.0	0.0	5.6	0.3	0.0	0.0	0.0	3.3	0.1
TTPAL	"C20orf121, dJ179M20.3"	ENSG00000124120	"Alpha tocopherol transfer protein like"	Q9BTX7	20	44475886-44494603	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.1;HSkMC: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046957, HPA066532"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA046957: AB_10959741, HPA066532: AB_2685686"	"unprognostic (8.71e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.09e-5)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.93e-2)"	9.5	6.2	6.3	7.2	8.3	9.1	7.6	6.5	13.1	8.2	4.6	4.8	5.1	4.3	6.3	9.2	7.0	6.9	5.3	4.2	5.8	7.9	5.7	32.0	4.0	9.7	5.9	11.5	6.6	7.6	11.1	12.8	5.0	9.8	6.4	5.0	6.4	6.2	7.3	3.8	14.7	5.3	6.6	3.6	5.7	5.5	6.4	3.0	5.8	9.3	5.5	9.2	5.9	7.9	5.9	3.1	4.2	3.5	7.9	7.6	3.4	8.6	4.5	3.5	6.2	40.1	15.6	3.5	9.4	13.2	9.2	7.9	16.7	5.3	5.4	8.1	8.7	16.8	8.6	4.4	14.8	10.0	5.6	2.0	2.5	4.7	4.8	11.1	3.8	6.1	34.6	9.7	9.0	15.2	4.3	3.1	4.6	3.2	5.7	7.3	10.0	3.7	2.4	4.2	4.7	7.6	1.1	3.8	2.9	3.6	6.3	7.8	3.7	13.1	5.7	5.8	4.5	6.3	2.4	3.1	20.5	8.2	6.1	8.1	8.5	5.7	5.9	9.9	2.7	6.0	0.7	1.6	2.6	6.7	3.2	7.1	5.9	5.7	6.7	1.7	5.8	5.1	7.6	4.2	7.9	3.5	3.1	5.7	3.4	6.3	8.3	6.5	13.1	5.8	7.9	5.9	11.5	9.8	3.0	8.9	10.7	18.4	13.5	5.7	21.7	4.4	12.7	6.7	10.3	21.0	23.6	6.0	1.7	10.0	4.1	5.6	7.8	70.0	8.2	6.9	9.4	11.5	9.2	37.6	4.3	17.5	9.1	6.7	11.0	7.9	17.3	5.3	3.3	3.6	4.9	11.2	10.0	8.6	10.6	3.8	18.9	6.5	11.3	7.7	10.7	17.6	9.2	13.8	8.0	9.5
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31591726-31599021	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 1008.0;liver: 680.8;retina: 332.4"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 22945.1"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Region enriched"	"Detected in many"	9	"pons and medulla: 1008.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 31.4;EFO-21: 11.1;Hep G2: 48.2;U-2 OS: 14.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 1006.9"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	345000000000	180000000000	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	0.5	0.4	3.6	0.4	3.0	0.6	0.4	5.8	60.8	0.4	0.6	361.3	0.0	0.9	0.4	0.4	0.4	0.4	3.3	0.4	115.6	4.4	1.0	680.8	0.4	0.4	7.1	0.0	0.4	62.3	1.6	0.5	0.4	1008.0	0.4	0.5	332.4	0.4	0.4	0.4	1.0	0.6	0.4	4.9	0.5	2.0	0.4	0.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.6	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	48.2	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	14.5	0.0	1.1	0.0	0.6	4.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.0	5.8	60.8	115.6	4.4	7.1	0.0	1008.0	0.6	0.0	0.0	32.7	0.0	0.5	25.4	1.4	973.2	0.0	0.0	5.2	153.2	0.2	5.0	2.7	5.4	0.1	1.1	163.5	1.6	0.6	0.6	0.2	0.0	22945.1	2.3	25.4	342.4	228.9	289.5	6.6	0.3	0.0	0.0	0.0	1.5	13.2	212.8	2.9	0.0	1.1	45.2	0.0	0.4	3.4	0.6	0.1	3.3	0.5	1.6	0.0
TUB	rd5	ENSG00000166402	"Tubby bipartite transcription factor"	P50607	11	8019244-8106112	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Sensory transduction"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 39.3;Horizontal cells: 28.6;Rod photoreceptor cells: 51.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 13.3;HEK 293: 18.2;HeLa: 24.3;SCLC-21H: 27.6;SH-SY5Y: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017997, HPA049019"	Enhanced		Approved	"Nucleoli,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Centriolar satellite"	Nucleoli	"HPA017997: AB_1858449, HPA049019: AB_2680601"	"unprognostic (2.53e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.35e-5)"	"unprognostic (8.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-2)"	5.0	18.3	18.9	2.8	16.1	0.7	4.5	12.4	36.4	18.2	4.2	6.3	2.8	2.5	24.3	10.7	3.6	20.8	5.5	10.2	20.5	17.9	11.7	1.0	3.4	2.2	25.1	22.6	17.9	5.1	11.0	18.4	4.6	17.7	8.7	2.9	11.3	5.6	9.0	3.1	6.5	2.4	12.0	9.2	2.1	2.4	5.1	9.1	0.5	10.5	2.9	1.3	5.2	8.7	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.9	7.1	8.8	6.7	2.3	0.0	4.8	1.2	5.2	6.8	0.0	0.0	0.0	0.4	6.4	2.4	0.0	13.3	1.0	4.5	0.0	18.2	0.0	24.3	2.9	1.1	0.0	0.2	3.5	1.2	2.3	0.0	0.4	0.4	8.2	0.0	0.0	2.4	0.6	0.0	0.0	4.9	0.0	0.0	6.6	0.1	0.0	0.0	0.2	27.6	20.6	3.4	0.0	1.3	3.2	0.8	0.1	0.0	2.9	6.9	0.4	2.0	0.0	0.0	0.0	2.5	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.2	1.2	0.0	0.7	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.9	16.1	12.4	36.4	20.5	17.9	25.1	22.6	17.7	9.1	0.0	0.0	0.0	1.7	0.7	14.6	2.2	0.0	6.7	1.2	0.0	39.3	0.1	5.0	0.1	3.3	0.5	0.0	0.0	0.0	0.3	6.2	0.7	1.1	0.0	0.2	28.6	1.7	1.8	0.0	3.7	13.6	0.0	1.7	0.0	0.0	11.7	0.0	0.0	13.8	6.3	51.9	0.0	1.3	1.5	1.1	0.6	0.0	0.0	0.0	0.1
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278630-133312337	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Ciliated cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.3	26.7	16.7	17.3	25.6	29.4	21.4	28.6	33.4	20.3	19.3	22.5	25.2	19.2	23.2	18.9	19.8	35.1	21.7	18.6	21.9	17.2	24.4	22.2	22.8	27.7	16.3	26.5	28.3	30.9	31.9	23.0	17.0	22.3	20.8	16.0	19.0	26.8	22.3	30.4	24.1	19.7	17.6	16.7	25.6	20.1	33.5	15.4	25.6	23.0	18.3	19.5	19.3	18.2	6.1	14.3	17.3	11.9	12.1	10.4	8.7	18.3	25.5	9.4	9.6	10.1	11.0	12.1	14.4	23.4	17.8	18.0	26.6	12.9	13.9	8.1	16.4	6.5	12.4	12.6	11.8	7.9	13.0	24.1	8.9	12.6	14.6	12.7	19.0	16.4	11.4	10.3	16.5	20.6	18.1	11.7	9.2	10.8	11.3	14.4	25.1	10.4	21.0	8.2	12.0	20.3	8.3	11.0	6.0	11.6	9.6	6.5	12.8	10.3	11.6	11.5	6.0	8.4	9.7	14.1	8.7	7.8	11.4	12.8	11.3	7.7	16.2	34.9	8.6	5.5	5.0	11.9	11.9	7.6	11.2	8.5	6.0	7.6	8.0	14.3	6.1	8.7	9.0	17.3	12.1	11.8	6.5	10.4	8.7	16.7	25.6	28.6	33.4	21.9	17.2	16.3	26.5	22.3	15.4	44.7	36.3	20.8	22.9	12.4	41.4	30.5	22.9	143.2	43.3	38.4	29.5	33.5	19.9	30.5	19.9	21.8	31.4	23.3	32.0	27.4	24.7	25.0	38.2	26.3	41.0	36.5	28.2	28.3	39.5	22.0	31.4	45.0	13.5	75.7	32.6	38.3	28.6	31.7	33.2	44.0	69.1	32.3	15.9	63.2	56.2	12.0	35.6	26.1	32.4	26.7
TUFT1		ENSG00000143367	"Tuftelin 1"	Q9NNX1	1	151540305-151583583	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 54.9"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 61.5;Suprabasal keratinocytes: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 72.2"	"HPA028112, HPA054301"	Approved	Approved	Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA028112: AB_10603224, HPA054301: AB_2682442"	"unprognostic (6.16e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.29e-3)"	"unprognostic (9.06e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (4.53e-2)"	3.4	4.0	2.7	3.3	2.5	3.8	11.6	8.5	4.5	13.3	8.1	1.1	6.7	4.6	5.9	6.9	23.4	3.1	9.7	3.0	2.0	4.0	9.4	3.9	5.3	2.2	1.9	3.9	5.4	9.3	7.8	5.7	33.1	3.3	7.5	8.3	3.3	18.8	9.4	1.7	54.9	9.8	9.6	1.8	1.1	7.4	5.0	1.5	0.5	3.6	12.0	14.4	11.9	12.2	1.2	1.6	6.5	1.1	0.2	6.0	0.9	14.6	5.0	3.7	4.3	0.8	0.7	23.9	3.9	3.5	15.7	15.1	15.9	11.7	1.3	24.6	4.6	7.4	17.2	6.5	6.0	11.5	9.7	3.2	0.8	8.5	2.4	12.5	0.3	1.8	2.5	7.1	12.3	27.4	9.3	1.2	1.8	1.3	10.1	4.8	6.0	0.7	0.2	4.4	10.8	4.3	0.0	10.6	5.0	13.0	22.7	7.4	3.0	25.2	17.2	3.0	11.7	13.7	0.7	3.2	2.8	19.8	17.4	26.1	2.5	4.8	0.1	2.4	0.3	1.7	6.5	1.1	1.1	0.7	0.3	1.4	1.2	1.9	1.0	1.6	0.6	1.7	0.6	4.5	0.2	0.6	0.2	6.0	0.9	2.7	2.5	8.5	4.5	2.0	4.0	1.9	3.9	3.3	1.5	23.8	1.3	0.0	41.3	61.5	1.8	8.9	7.6	1.4	9.1	14.0	0.0	22.2	11.6	15.0	2.1	0.7	37.6	0.0	13.3	12.0	7.4	24.8	4.6	9.3	3.5	0.0	30.9	1.8	0.0	1.9	2.3	2.6	8.5	2.8	21.4	2.0	31.3	21.6	4.9	9.1	0.5	6.5	5.6	0.7	3.4	58.2	47.5	3.2	17.0	26.9
TULP2	"CT65, TUBL2"	ENSG00000104804	"Tubby like protein 2"	O00295	19	48880965-48898733	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.6;testis: 25.5"	"Group enriched"	"Detected in some"	43	"Early spermatids: 174.6;Late spermatids: 168.8"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 6.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;U-266/70: 6.4;U-266/84: 6.9"					"Not detected"	"Not detected"			HPA075828			Approved	Cytosol	"Secreted in male reproductive system"	NA	NA			Cytosol		"HPA075828: "	"unprognostic (9.97e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.69e-4)"	"unprognostic (6.79e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.94e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.59e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.97e-1)"	0.2	0.3	0.2	0.2	0.2	4.3	0.2	0.3	0.4	0.2	0.2	0.2	0.2	0.0	0.8	0.8	0.5	0.6	0.5	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	1.3	0.2	0.0	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.0	0.2	25.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	6.6	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	1.1	1.9	0.9	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.9	0.9	1.8	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.7	0.0	0.9	0.0	1.1	0.0	0.0	0.0	0.1	0.0	6.4	6.9	0.3	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	6.6	0.0	0.0	0.2	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	174.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.8	168.8	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.1	1.4	0.4	0.0	0.0	0.0	0.0
TUSC1	"CCDC89B, TSG-9"	ENSG00000198680	"Tumor suppressor candidate 1"	Q2TAM9	9	25676389-25678440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051426	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			Vesicles	Nucleoplasm	"HPA051426: AB_2681481"	"unprognostic (9.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	19.8	13.1	10.9	6.2	12.2	3.6	13.8	9.9	17.4	15.3	13.2	10.7	9.7	11.3	17.6	14.0	9.3	15.0	11.0	11.0	10.4	10.5	13.8	12.2	9.3	4.3	12.3	11.3	16.5	10.3	9.6	9.1	17.9	10.4	15.8	8.4	10.2	14.9	14.2	15.6	14.8	11.9	12.1	8.6	7.5	11.8	32.0	11.9	2.9	20.0	11.4	6.7	11.0	14.9	0.6	1.8	0.0	0.8	0.0	0.1	0.0	6.6	1.4	1.5	0.0	4.9	4.1	0.0	5.1	0.0	2.0	2.4	0.1	2.4	0.0	1.6	6.0	5.3	0.0	3.6	6.4	1.2	0.0	7.1	25.9	7.7	0.0	2.4	0.0	0.0	5.0	9.0	2.2	5.1	0.0	2.1	0.0	0.0	0.0	2.3	3.3	0.0	0.1	1.3	5.3	6.6	0.0	1.0	0.1	2.7	3.1	0.5	11.7	6.3	5.3	5.2	3.0	4.6	7.3	4.5	0.0	9.5	0.1	0.0	0.0	0.0	0.0	6.2	1.7	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.8	1.8	0.0	0.0	10.9	12.2	9.9	17.4	10.4	10.5	12.3	11.3	10.4	11.9	11.9	5.4	0.0	35.5	54.0	25.2	9.7	17.8	2.7	5.7	15.7	3.9	24.7	56.3	6.4	50.7	21.8	8.0	0.0	10.7	12.0	22.0	30.2	0.0	16.4	8.1	20.6	12.6	15.4	2.2	5.0	28.4	5.3	27.0	1.0	12.7	29.9	6.4	10.5	20.5	18.1	13.4	32.3	39.6	89.6	11.5	33.1	24.3	0.0	12.8	15.6
TUSC2	"C3orf11, FUS1, PAP, PDAP2"	ENSG00000114383	"Tumor suppressor candidate 2"	O75896	3	50320027-50328251	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 269.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030116			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA030116: AB_10602253"	"unprognostic (1.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (8.70e-7)"	"unprognostic (9.22e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-3)"	13.4	16.3	28.5	12.2	27.2	9.2	15.1	18.9	38.1	11.9	15.9	11.1	13.9	11.1	10.3	26.2	10.8	18.6	15.5	22.0	26.4	25.8	18.9	18.0	13.5	13.2	26.2	17.0	12.0	15.3	21.3	12.3	15.3	27.3	13.2	15.0	12.2	13.5	17.0	29.9	8.8	12.1	12.3	13.2	14.2	13.9	15.2	8.1	12.0	21.1	15.0	17.2	9.9	8.5	19.5	20.4	26.3	17.3	17.1	22.0	22.9	12.2	10.2	14.4	15.6	15.9	8.3	15.8	10.1	13.6	19.1	16.2	18.0	11.3	21.0	11.1	9.3	19.6	7.9	17.5	13.1	16.8	12.3	16.1	10.3	9.6	19.2	14.0	18.2	18.2	9.0	21.2	19.0	9.5	13.4	19.6	16.9	12.5	10.1	10.9	9.3	19.0	23.4	19.5	15.3	14.8	6.6	7.0	17.2	19.1	13.4	7.7	15.9	7.3	13.1	14.5	14.9	12.5	22.3	15.4	5.7	14.0	12.9	20.2	25.0	38.7	14.7	12.7	12.1	8.9	10.2	17.3	26.3	20.4	15.3	20.4	19.4	18.1	21.2	11.3	19.5	20.9	22.0	24.5	17.1	13.9	20.4	19.5	22.9	28.5	27.2	18.9	38.1	26.4	25.8	26.2	17.0	27.3	8.1	11.9	17.1	52.9	27.8	51.1	49.3	31.3	56.0	42.8	12.5	54.1	21.6	54.3	97.8	67.6	91.0	42.5	47.7	0.0	64.8	46.8	29.0	59.9	29.9	66.0	66.6	69.9	48.4	33.2	42.6	269.2	25.0	30.8	52.3	60.5	39.6	40.9	64.1	59.6	23.3	141.5	35.8	12.9	44.8	55.4	54.5	79.7	58.2	40.5	40.0	51.0
TUT1	"FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase"	ENSG00000149016	"Terminal uridylyl transferase 1, U6 snRNA-specific"	Q9H6E5	11	62575045-62592177	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA069055, HPA071838"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA069055: AB_2686075, HPA071838: AB_2686456"	"unprognostic (3.81e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-3)"	10.9	12.1	10.7	9.9	13.6	7.8	12.9	13.5	13.3	10.5	8.7	15.9	13.0	12.9	11.5	10.8	10.0	16.9	13.7	10.7	13.6	8.3	12.2	22.7	9.6	18.1	15.5	9.5	14.5	26.2	15.5	16.2	12.3	13.0	13.9	6.2	11.9	16.4	11.9	20.5	13.9	11.7	10.2	11.4	14.6	12.5	18.6	13.2	17.1	14.0	8.8	13.6	11.5	9.8	13.1	9.4	6.6	7.3	9.8	16.0	7.2	7.3	9.2	6.4	8.9	7.8	4.5	8.3	7.9	4.8	6.7	5.8	8.2	14.4	11.7	18.2	3.8	8.4	13.8	11.7	9.2	3.4	9.0	6.2	12.0	9.4	7.8	8.7	8.5	5.5	6.3	9.9	8.3	12.8	6.3	6.4	15.2	18.0	12.1	5.6	16.0	12.0	18.1	7.3	4.8	11.3	13.5	10.2	28.4	6.2	4.2	10.6	14.9	6.0	11.4	9.8	5.6	15.9	8.3	5.7	7.6	6.8	8.8	6.0	21.1	18.5	14.4	8.9	6.7	6.2	5.9	5.9	6.6	10.5	7.3	14.6	9.8	9.9	8.4	7.8	13.1	16.0	12.5	3.6	9.8	5.3	9.4	8.9	7.2	10.7	13.6	13.5	13.3	13.6	8.3	15.5	9.5	13.0	13.2	0.0	7.9	8.1	4.8	2.4	7.4	3.2	10.2	9.4	2.3	10.4	5.9	10.6	5.0	7.3	25.9	13.4	5.6	0.0	6.4	6.5	3.8	6.1	2.3	16.2	5.0	1.6	6.9	12.3	4.0	12.8	6.6	3.1	10.1	2.8	6.0	9.3	5.4	3.5	3.2	4.9	8.7	0.0	1.4	9.2	14.8	1.9	11.7	6.9	6.0	2.8
TVP23A	"FAM18A, YDR084C"	ENSG00000166676	"Trans-golgi network vesicle protein 23 homolog A"	A6NH52	16	10760919-10818794	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 13.3"	"Cell type enriched"	"Detected in many"	8	"monocytes: 50.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.6;SH-SY5Y: 6.1;U-266/70: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060582	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA060582: AB_2684326"	"unprognostic (6.70e-4)"	"unprognostic (1.64e-3)"	"unprognostic (2.38e-2)"	"unprognostic (8.24e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.39e-5)"	"unprognostic (4.96e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.42e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.78e-7)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.87e-4)"	1.9	4.3	10.1	3.3	11.0	5.5	1.1	5.6	13.3	1.7	1.4	2.3	1.6	2.4	2.4	2.3	1.2	2.3	3.2	2.5	9.4	8.0	1.3	1.5	2.3	6.1	6.6	11.8	8.7	2.0	0.5	3.6	0.8	5.7	4.6	1.4	3.1	2.1	3.7	1.9	2.5	2.6	2.8	2.9	3.2	2.1	2.8	3.1	1.3	1.5	0.0	2.6	2.4	1.4	1.6	3.8	0.8	0.8	0.5	0.8	0.4	0.4	0.8	0.9	1.0	0.0	0.3	0.8	0.2	0.0	0.0	0.1	0.2	0.8	1.3	0.5	0.2	0.7	1.2	0.0	0.0	0.0	2.8	0.6	0.4	1.7	1.2	0.0	0.3	1.6	0.4	0.0	0.4	0.0	0.6	0.0	0.7	0.4	1.2	0.0	0.8	0.8	1.1	3.6	0.3	0.1	2.0	0.3	0.3	0.1	1.3	0.6	6.1	0.2	0.6	0.1	0.7	0.6	0.5	0.9	1.0	0.8	1.2	0.5	3.2	0.5	0.9	0.9	1.1	0.5	0.6	0.8	0.2	0.6	0.6	0.4	0.9	0.8	0.2	3.8	1.6	0.4	0.4	0.8	0.5	0.6	0.8	0.2	0.4	10.1	11.0	5.6	13.3	9.4	8.0	6.6	11.8	5.7	3.1	0.0	2.6	0.0	0.0	1.0	6.4	0.5	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.6	0.6	0.0	0.0	0.5	0.2	1.5	0.0	0.0	0.0	0.8	1.6	0.0	0.0	1.3	0.0	2.6	5.0	1.7	50.5	0.0	4.8	0.2	0.0	1.4	1.0	0.9	0.0	0.8	1.4	2.7	0.9	1.1	0.0	0.0	0.1
TVP23C-CDRT4	FAM18B2-CDRT4	ENSG00000259024	"TVP23C-CDRT4 readthrough"		17	15436021-15563561	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 2: 1.3;Ciliated cells: 4.0;Club cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 26.8"									HPA065603			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA065603: AB_2685517"	"unprognostic (3.95e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.67e-3)"	"unprognostic (9.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.08e-1)"	4.1	8.3	3.4	3.6	4.8	1.4	2.8	12.3	7.3	7.5	2.8	3.6	9.8	4.5	5.4	7.2	5.0	8.1	4.1	3.4	3.0	5.0	4.5	1.8	3.1	1.8	4.2	5.3	7.9	7.6	10.5	15.6	3.5	8.3	4.7	3.2	6.6	6.1	5.9	1.8	3.1	5.1	2.5	4.5	4.1	3.4	7.1	2.3	1.0	7.4	0.8	3.6	4.0	3.6	1.9	1.9	7.9	0.6	5.3	4.8	1.5	4.1	3.2	2.6	5.0	2.6	3.2	6.7	2.8	11.3	5.1	6.0	3.3	0.8	0.0	6.0	6.0	1.9	3.8	2.6	2.0	4.9	5.1	2.6	1.6	2.5	5.7	6.1	2.0	4.2	2.0	1.2	3.0	12.4	13.5	4.5	2.7	2.2	2.2	1.1	1.7	3.0	4.2	1.7	3.2	2.3	0.5	0.0	0.0	2.8	2.8	1.7	4.1	2.7	0.5	1.4	26.8	2.1	1.2	2.0	0.2	2.0	1.3	1.8	4.7	2.4	0.0	0.5	0.0	0.7	7.9	0.6	6.9	4.5	0.4	4.8	1.9	3.8	4.0	1.6	1.3	2.3	2.9	0.2	5.3	0.3	1.9	3.4	1.5	3.4	4.8	12.3	7.3	3.0	5.0	4.2	5.3	8.3	2.3	0.0	1.3	0.0	0.0	0.0	0.4	0.0	0.0	4.0	2.3	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.6	0.0	0.2	0.0	0.0	0.3
TXK	"BTKL, PSCTK5, PTK4, RLK, TKL"	ENSG00000074966	"TXK tyrosine kinase"	P42681	4	48066393-48134256	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4"	"Cell type enriched"	"Detected in some"	9	"T-cells: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 43.5"	"Group enriched"	"Detected in many"	26	"NK-cells: 43.5;T-cells: 17.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;HMC-1: 11.3;U-266/70: 5.5;U-266/84: 6.8;WM-115: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062482			Approved	Vesicles		NA	NA			Vesicles		"HPA062482: AB_2684778"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.04e-2)"	1.8	1.5	0.3	15.3	0.4	3.9	1.5	0.2	0.6	0.8	2.1	0.3	0.2	1.3	1.3	11.6	2.4	2.6	1.7	0.7	0.2	0.4	2.1	2.8	4.0	49.1	0.5	0.5	0.5	1.0	0.4	1.3	28.4	0.6	0.9	1.0	1.0	6.1	0.2	0.5	1.7	7.9	0.4	0.4	17.8	1.0	1.7	0.2	14.0	1.9	0.2	19.3	2.4	1.4	0.0	0.1	1.1	0.0	43.5	17.5	10.6	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	4.8	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.4	0.2	0.1	2.4	0.0	0.0	0.0	0.3	11.3	0.0	0.0	0.1	0.0	0.8	0.1	0.4	0.2	0.0	0.7	0.0	0.0	2.1	0.0	0.6	0.8	0.3	0.0	0.0	1.4	1.3	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.2	0.4	0.0	0.0	0.3	0.1	5.5	6.8	0.4	0.0	0.4	25.4	1.1	0.0	0.3	13.2	0.0	17.4	0.0	6.8	6.4	0.0	0.0	17.5	11.9	0.8	43.5	0.0	0.1	5.1	10.6	0.3	0.4	0.2	0.6	0.2	0.4	0.5	0.5	0.6	0.2	0.0	2.6	0.8	0.5	0.3	0.0	0.2	2.5	0.0	0.0	0.0	3.9	0.2	1.7	1.3	4.3	0.1	0.0	0.0	0.0	0.1	0.5	0.4	1.1	1.0	1.2	0.0	0.0	4.3	5.1	1.3	0.3	0.5	1.7	0.0	0.0	2.3	0.2	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.2	1.0	0.5	43.1	0.2	0.6
TXLNA	DKFZp451J0118	ENSG00000084652	"Taxilin alpha"	P40222	1	32179686-32198285	"Cancer-related genes, Predicted intracellular proteins"	Exocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045383, HPA072477"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Centrosome"	"HPA045383: AB_10967649, HPA072477: AB_2686525"	"prognostic favorable (6.24e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (5.53e-4)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (3.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.69e-5)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (7.21e-7)"	"unprognostic (3.94e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	22.5	29.4	20.2	19.4	27.5	14.0	17.9	23.2	26.4	20.3	23.7	17.0	23.4	16.6	30.4	24.7	24.2	25.0	24.6	16.4	18.5	13.9	20.9	44.8	19.0	19.9	25.6	13.4	26.5	23.6	31.5	35.9	19.3	21.8	24.6	18.5	20.8	23.9	23.3	16.5	31.0	18.9	28.3	19.9	23.5	21.2	38.4	22.9	17.0	22.8	18.8	26.0	19.3	23.5	8.0	14.3	8.4	12.2	14.2	13.9	9.0	19.5	16.8	17.5	19.7	22.8	30.0	14.2	28.1	22.4	27.2	26.1	18.7	21.3	22.4	11.5	27.2	8.9	22.2	23.9	18.4	24.8	25.6	18.5	35.5	24.4	24.4	24.2	25.7	28.2	30.0	24.8	28.7	13.6	20.1	21.4	27.3	14.4	23.2	22.2	10.9	18.8	16.6	25.5	14.0	15.5	22.2	26.6	19.7	18.6	25.1	18.4	18.9	29.1	18.5	29.8	22.5	17.1	15.7	22.2	28.8	24.9	37.9	35.8	34.7	26.8	20.4	29.8	35.1	26.5	8.4	9.0	4.5	13.9	9.7	11.9	7.3	9.6	10.3	6.9	8.0	8.4	9.1	1.3	14.2	12.2	14.3	7.0	9.0	20.2	27.5	23.2	26.4	18.5	13.9	25.6	13.4	21.8	22.9	20.8	21.3	7.7	9.2	7.8	13.9	7.7	10.2	28.1	19.4	14.0	37.3	8.8	1.7	15.8	11.5	15.8	11.9	0.0	14.2	12.0	17.1	10.3	12.7	28.6	15.9	25.4	25.2	16.0	12.4	13.3	22.2	11.7	5.0	20.8	15.4	13.8	18.6	2.9	19.4	11.8	24.5	12.9	21.1	21.8	24.5	10.7	5.7	10.2	12.1	6.7
TXLNG	"CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX"	ENSG00000086712	"Taxilin gamma"	Q9NUQ3	X	16786427-16844519	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000297, HPA000841"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA000297: AB_1078590, HPA000841: AB_1078589"	"unprognostic (2.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.00e-3)"	16.2	20.1	14.4	13.5	17.5	14.9	14.0	24.9	19.9	13.2	11.1	5.6	13.0	9.9	12.0	8.4	8.4	12.0	9.1	6.9	12.4	10.1	9.4	9.6	9.2	13.8	11.8	10.1	21.1	10.3	13.9	20.1	6.9	12.8	8.6	7.5	5.4	8.4	17.2	17.3	7.4	8.6	10.3	11.2	8.8	8.9	7.1	17.4	6.0	12.8	5.5	13.5	13.6	23.8	6.5	3.4	1.6	3.0	4.3	7.4	3.4	12.1	7.6	7.4	12.9	13.5	7.4	3.9	4.9	4.7	5.6	5.5	10.6	7.3	25.6	12.4	2.7	16.2	7.9	25.1	16.0	10.1	7.8	30.5	9.2	10.5	6.8	5.6	13.6	6.6	4.3	7.8	13.0	23.6	7.6	7.0	10.6	17.5	7.6	4.3	7.3	12.4	7.6	21.9	8.1	8.9	8.6	10.0	21.2	4.5	6.1	11.9	8.7	11.3	10.8	9.0	13.2	13.1	5.6	3.4	3.5	4.7	12.4	8.4	8.0	12.2	26.0	4.5	9.0	3.5	1.0	3.0	1.6	5.3	2.2	6.7	6.1	5.7	6.0	3.3	6.5	6.9	7.4	1.1	4.3	2.5	3.4	5.8	3.4	14.4	17.5	24.9	19.9	12.4	10.1	11.8	10.1	12.8	17.4	14.9	16.1	17.2	49.4	36.5	34.3	11.5	12.7	14.7	31.8	8.7	5.9	12.4	18.3	14.9	2.7	11.1	8.0	23.3	14.5	11.5	21.3	27.3	12.7	15.6	8.2	27.0	13.8	12.9	6.5	1.5	25.0	8.7	16.9	4.6	12.6	12.9	13.0	5.8	19.8	14.6	21.3	6.5	16.8	12.9	38.1	30.5	18.3	20.0	15.2	24.5
TXNDC15	"2310047H23Rik, C5orf14, FLJ22625"	ENSG00000113621	"Thioredoxin domain containing 15"	Q96J42	5	134873803-134901525	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015483	Approved		Approved	"Golgi apparatus"		NA	NA		48000000	"Golgi apparatus"		"HPA015483: AB_1845722"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (2.36e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.50e-1)"	23.5	40.5	16.3	22.8	28.1	5.6	22.6	24.9	30.5	30.3	26.1	23.8	36.1	17.0	32.4	40.8	19.0	24.6	24.8	30.7	14.8	16.3	26.3	26.9	25.7	26.2	18.2	20.4	26.5	38.8	23.6	40.9	28.1	19.9	26.5	18.6	27.7	37.8	33.9	24.3	16.3	18.3	28.6	18.8	31.7	23.0	16.6	18.4	13.1	40.4	16.7	21.1	25.6	22.6	23.2	22.5	20.2	24.5	19.3	24.9	20.7	8.9	24.3	12.2	21.0	18.5	26.7	1.7	35.8	39.3	12.4	28.1	17.7	11.6	11.1	20.3	29.6	24.5	6.2	8.4	14.6	11.2	25.2	11.2	5.9	14.9	12.9	17.1	3.7	15.6	17.1	12.2	17.1	10.5	18.6	18.7	5.3	2.8	32.9	17.3	10.8	5.8	7.5	5.5	8.6	10.2	8.6	16.2	35.0	9.5	8.8	8.3	9.9	21.8	5.2	17.2	6.2	7.9	5.4	25.5	18.7	11.2	17.1	12.0	22.5	35.2	9.6	28.9	7.9	12.1	20.2	24.5	13.8	24.2	23.7	24.9	23.2	19.6	24.9	22.5	15.9	16.7	19.2	5.8	19.3	22.6	22.2	21.2	20.7	16.3	28.1	24.9	30.5	14.8	16.3	18.2	20.4	19.9	18.4	56.6	29.3	23.1	24.0	22.6	34.5	31.1	28.1	30.8	31.8	22.7	19.6	28.0	11.6	31.8	3.4	35.1	10.5	0.0	28.9	37.1	52.6	24.2	29.0	23.2	31.5	60.4	12.1	38.6	30.6	4.5	58.7	28.1	65.8	34.3	14.3	38.9	19.7	15.2	42.8	23.7	27.8	45.3	38.7	20.9	73.7	20.6	25.1	27.7	13.3	16.1
TXNDC16	KIAA1344	ENSG00000087301	"Thioredoxin domain containing 16"	Q9P2K2	14	52430590-52552522	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 49.1;Rod photoreceptor cells: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002543	Approved		Approved	Mitochondria	"Secreted - unknown location"	NA	NA			Mitochondria		"HPA002543: AB_1079199"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.36e-1)"	"unprognostic (5.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.04e-1)"	7.0	5.2	10.2	5.9	12.5	5.4	8.6	20.5	15.0	12.1	7.0	7.4	16.1	5.1	8.5	18.4	4.8	5.4	6.5	5.6	9.2	9.4	6.4	8.9	6.1	5.0	9.5	11.3	13.4	7.8	8.6	9.4	7.0	8.9	32.8	7.4	8.1	5.6	24.2	4.2	6.5	5.9	5.6	14.0	11.5	7.4	8.2	10.5	9.7	5.1	3.4	4.8	7.8	7.3	1.2	5.3	3.6	6.3	1.1	4.7	2.2	6.1	0.6	6.9	3.8	5.1	3.8	5.4	2.0	2.7	3.5	6.8	2.2	5.0	10.0	6.9	1.6	2.1	5.8	7.9	2.8	5.4	4.1	10.3	4.6	5.1	2.0	3.7	5.4	2.2	7.0	2.6	4.4	3.3	3.1	3.8	4.4	5.8	15.6	3.0	2.9	6.7	3.8	7.6	4.1	3.7	13.6	13.0	9.0	4.4	6.3	22.5	7.8	9.9	10.4	2.8	6.0	6.6	4.0	2.1	4.7	2.4	5.3	3.4	4.3	5.8	10.1	1.3	5.7	2.7	2.4	6.3	2.5	2.7	4.8	2.9	1.2	2.8	2.0	5.3	0.8	1.4	1.4	3.6	1.1	5.2	2.2	4.7	2.2	10.2	12.5	20.5	15.0	9.2	9.4	9.5	11.3	8.9	10.5	8.9	5.4	5.2	5.3	6.0	35.7	7.9	7.6	5.3	6.8	7.0	7.9	1.7	1.7	3.1	3.3	6.3	5.2	23.3	3.5	1.5	3.3	19.5	2.3	10.5	3.0	9.5	17.7	12.9	15.9	2.7	25.6	5.0	1.7	1.0	17.2	8.4	1.5	9.5	49.1	2.6	45.5	0.0	4.4	9.8	8.4	7.3	0.9	5.7	8.7	3.5
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910814	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 23.3;Mucus-secreting cells: 19.0;Pancreatic endocrine cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.6;plasmacytoid DC: 17.5"	"Group enriched"	"Detected in many"	21	"B-cells: 9.6;dendritic cells: 17.5"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 162.2;U-266/84: 344.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		14000000	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	20.2	15.7	3.7	42.1	6.3	6.0	61.9	4.6	6.8	28.8	69.8	7.5	18.3	35.0	28.3	20.9	25.3	21.5	30.2	28.6	4.4	5.2	23.2	96.2	24.5	117.9	5.9	4.3	26.1	63.3	7.9	10.6	22.4	7.2	17.6	29.0	10.9	71.5	29.1	10.1	9.9	33.6	16.3	7.5	84.2	36.8	12.3	5.2	6.4	18.0	19.8	48.2	35.8	21.7	9.6	17.5	0.0	0.5	0.0	0.6	0.3	9.5	9.4	6.5	22.0	56.8	24.3	10.7	21.5	21.0	15.0	16.3	14.0	7.1	10.1	38.0	33.0	16.6	7.6	11.6	10.6	17.1	8.6	9.9	15.5	8.2	25.2	16.6	17.5	15.5	16.6	15.6	14.3	15.8	33.2	80.3	6.4	9.6	73.9	10.2	8.5	4.1	10.6	8.6	15.1	20.5	7.3	9.5	162.2	12.1	8.7	10.2	5.5	27.7	16.9	12.1	32.5	8.6	7.7	22.0	17.2	12.0	14.7	22.7	86.2	344.1	17.9	8.8	11.1	23.5	0.0	0.2	0.0	0.6	0.5	0.5	9.6	0.1	0.4	0.7	3.3	0.1	0.3	0.0	0.0	0.0	17.5	0.5	0.3	3.7	6.3	4.6	6.8	4.4	5.2	5.9	4.3	7.2	5.2	0.0	4.5	0.0	0.0	0.8	0.0	0.2	0.0	2.7	3.4	0.0	0.0	0.8	0.0	8.2	0.1	0.7	1.0	23.3	9.2	1.2	1.7	0.4	1.1	2.4	1.3	0.0	4.7	5.5	1.5	0.0	0.0	0.3	3.3	1.0	19.0	0.0	10.3	0.0	0.4	0.2	0.2	6.5	0.4	0.0	0.1	0.1	1.0	0.0	7.0	0.1
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996600	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Sertoli cells: 1177.1;T-cells: 976.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 109.0;HSkMC: 145.0;hTCEpi: 73.9;hTERT-RPE1: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	127.7	10.6	4.1	17.0	4.6	10.5	73.6	2.5	6.0	45.9	49.8	16.1	25.0	6.3	39.3	22.8	41.0	20.3	20.4	55.3	4.8		34.8	11.7	52.3	82.6	6.5	4.2	34.1	25.8	9.3	20.2	19.1	8.3	47.4	16.1	18.8	18.5	19.5	97.0	15.3	27.7	34.6	9.2	39.0	13.6	23.1	6.0	29.0	85.3	16.0	41.5	52.5	32.3	64.9	35.5	134.9	58.3	65.3	90.0	132.5	5.9	0.0	1.4	0.1	33.1	109.0	3.3	7.1	14.4	6.5	8.9	3.8	8.1	1.6	42.4	1.9	1.0	1.6	1.4	13.5	17.4	7.8	0.7	4.8	2.1	3.4	1.5	19.9	10.2	145.0	73.9	13.2	23.2	87.5	2.5	6.7	19.3	13.4	3.3	8.1	3.3	19.0	4.0	12.0	5.3	3.0	11.9	51.8	16.9	13.3	6.8	11.1	30.7	8.9	24.4	3.0	3.2	28.5	6.1	18.0	1.1	33.6	11.6	18.8	17.9	1.5	4.4	9.2	9.4	94.7	53.3	123.0	90.0	58.3	83.1	58.8	76.5	79.9	35.5	64.9	76.0	80.3	134.9	65.3	49.9	16.7	70.6	132.5											211.4	256.3	523.2	152.7	62.8	5.2	378.6	219.1	167.3	228.6	258.2	27.5	4.8	381.3	68.3	6.0	390.7	127.9	140.2	46.4	5.0	157.0	217.7	358.0	65.3	218.0	6.4	157.7	332.7	859.8	16.4	606.1	469.7	102.9	128.0	291.4	3.4	148.2	357.3	420.4	90.8	3.3	1177.1	168.0	6.4	34.1	63.1	9.2	976.9	145.3	211.3
TXNL4A	"DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD"	ENSG00000141759	"Thioredoxin like 4A"	P83876	18	79970811-80033949	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"		Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041324			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA041324: AB_2677410"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	28.2	35.8	57.2	27.7	43.9	36.7	30.2	21.7	43.4	22.0	29.4	30.7	22.9	23.9	15.8	38.9	26.5	21.0	21.8	33.5	47.9	42.7	29.0	42.5	18.4	35.1	52.6	25.4	14.1	64.9	22.1	38.4	23.2	32.7	21.1	25.2	24.0	46.8	20.5	35.5	26.6	25.1	19.0	37.7	26.9	23.2	41.6	20.8	40.2	28.8	26.8	32.2	23.5	16.9	12.7	25.0	8.4	9.6	11.3	12.7	4.4	21.8	29.5	26.3	25.0	21.5	22.7	23.3	23.8	19.3	32.4	29.5	27.4	15.6	26.7	8.9	22.7	22.0	18.6	31.6	27.7	21.5	31.1	40.1	19.1	44.8	64.4	27.5	54.8	31.4	21.1	24.6	23.0	29.6	20.7	30.4	33.2	16.7	39.0	22.5	39.6	38.8	37.2	20.5	16.7	63.9	23.7	17.6	55.0	31.8	34.7	40.3	29.3	11.8	35.2	43.4	23.7	17.2	32.7	14.3	28.6	35.1	13.0	29.0	17.3	65.0	43.9	26.8	41.8	26.2	8.4	8.4	6.8	12.2	9.6	8.4	12.3	10.0	9.6	11.4	12.7	10.2	11.9	6.8	11.3	9.5	25.0	12.7	4.4	57.2	43.9	21.7	43.4	47.9	42.7	52.6	25.4	32.7	20.8	17.9	41.8	50.0	60.5	77.4	32.4	73.1	63.7	25.4	52.4	62.8	33.4	96.1	305.1	118.9	207.4	51.7	39.3	23.3	108.6	136.0	58.6	137.6	10.5	80.8	109.4	42.9	54.1	37.4	48.3	186.2	38.9	65.4	89.4	102.8	78.3	48.2	121.8	56.1	42.5	211.1	37.3	45.3	91.2	74.9	65.0	96.0	80.9	50.7	65.4	100.5
TXNL4B	"Dim2, DLP, FLJ20511"	ENSG00000140830	"Thioredoxin like 4B"	Q9NX01	16	72044289-72094431	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065865			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA065865: AB_2685571"	"unprognostic (1.45e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	11.1	10.0	14.1	11.5	16.3	15.6	12.3	18.6	17.0	11.0	11.7	18.5	10.4	12.8	10.2	10.3	12.2	13.3	11.2	9.3	13.2	12.2	9.8	20.8	8.8	13.0	20.9	13.6	27.8	12.6	11.0	19.9	9.4	13.7	9.8	10.8	9.8	10.7	10.3	11.3	10.1	10.4	8.7	17.2	10.0	10.0	18.9	15.3	14.0	10.9	6.0	11.9	8.6	13.7	10.8	9.4	18.3	14.2	5.0	13.7	9.9	6.9	10.5	5.8	7.9	4.3	5.1	12.9	9.2	7.5	16.1	12.2	10.7	6.4	10.2	6.7	4.7	7.5	9.5	10.2	5.4	12.6	5.1	9.6	9.4	8.0	16.0	9.2	11.1	8.2	5.3	3.8	14.2	13.4	6.2	6.8	11.4	22.6	6.2	7.6	13.3	13.3	9.7	10.5	4.4	9.7	13.8	7.3	13.7	5.9	5.3	13.2	11.4	8.6	4.0	11.9	4.6	9.4	7.1	6.5	7.7	11.2	6.4	8.6	12.3	19.8	42.5	8.7	7.6	7.6	18.3	9.8	12.9	9.2	10.9	13.7	10.8	9.5	7.8	8.5	9.0	13.1	12.7	13.9	5.0	14.2	9.4	10.5	9.9	14.1	16.3	18.6	17.0	13.2	12.2	20.9	13.6	13.7	15.3	3.0	8.8	13.1	6.9	7.6	3.4	1.4	7.6	8.1	5.7	5.2	2.0	11.7	5.0	9.4	1.6	7.9	8.4	0.0	8.8	14.7	6.5	6.9	9.2	11.9	10.8	9.5	8.6	8.0	8.7	3.2	10.9	7.4	6.8	9.0	8.4	5.8	6.2	3.5	8.5	9.9	4.5	0.0	8.2	7.4	7.5	7.2	16.2	7.5	7.3	5.7
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380676	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favorable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favorable (4.16e-4)"	16.8	19.0	22.9	36.0	22.6	49.4	17.5	24.4	23.9	17.8	19.4	26.7	13.9	20.0	19.3	20.2	15.0	16.8	21.8	17.0	18.3	14.0	24.0	34.4	27.5	31.5	24.7	17.4	20.0	21.3	19.0	24.8	13.9	19.1	21.1	18.6	21.6	24.4	15.4	15.6	24.4	23.8	16.7	17.9	47.9	18.5	6.4	22.8	33.9	20.9	13.5	34.7	16.7	15.1	5.8	15.8	22.9	13.4	5.3	9.1	7.3	8.6	12.7	7.6	11.9	10.1	14.3	7.3	11.9	12.2	15.1	16.7	9.7	5.8	13.2	14.1	13.3	10.4	8.8	9.2	14.0	8.0	23.3	14.2	24.4	25.3	23.9	15.9	10.2	28.2	13.8	9.9	17.2	10.2	9.5	14.6	17.5	10.2	37.0	13.3	27.3	15.0	63.2	2.4	8.6	22.2	15.0	6.5	13.5	12.3	28.0	7.2	8.8	11.6	12.3	8.5	6.2	6.8	17.4	12.4	20.4	7.3	23.5	14.0	30.5	23.7	12.1	10.2	21.4	11.4	6.6	13.4	17.0	9.1	10.2	5.9	5.6	5.5	8.1	15.8	5.8	3.8	5.1	22.9	5.3	9.7	9.0	6.8	7.3	22.9	22.6	24.4	23.9	18.3	14.0	24.7	17.4	19.1	22.8	11.9	19.9	6.7	4.8	6.0	8.4	23.6	12.7	5.3	10.3	8.7	3.9	6.0	44.7	6.5	1.4	7.5	10.2	0.0	9.5	6.9	9.4	5.5	18.5	20.2	13.0	0.0	4.6	14.1	30.7	6.4	6.9	18.0	15.1	15.4	8.3	7.4	9.1	11.5	9.2	19.5	9.7	0.0	8.6	1.4	4.3	6.4	5.6	19.2	9.0	4.9
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530056	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.8"	"Cell type enriched"	"Detected in many"	5	"monocytes: 2738.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 23.0;eosinophil: 18.2;intermediate monocyte: 22.4;myeloid DC: 12.2;neutrophil: 6.7;non-classical monocyte: 15.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 12.2;granulocytes: 18.2;monocytes: 23.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.2;HHSteC: 40.2;Karpas-707: 38.8;U-266/70: 18.6"	"Low region specificity"	"Detected in some"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		16000000	"Nuclear bodies, Golgi apparatus"	Cytosol	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	25.2	7.9	2.8	41.6	8.4	12.1	19.0	1.5	4.4	10.7	10.7	3.8	2.3	10.4	4.4	15.7	22.0	13.7	9.6	15.0	7.0	2.6	18.6	38.1	28.8	57.8	6.5	0.4	7.5	5.8	1.7	3.9	11.5	9.1	7.9	4.9	5.4	16.5	3.8	10.0	8.8	13.9	7.3	15.2	43.9	12.4	3.0	5.0	13.3	12.5	25.5	28.8	12.4	9.4	0.9	12.2	18.2	23.0	0.8	0.9	2.6	6.7	0.8	0.0	0.1	1.0	1.3	0.6	1.2	0.1	2.4	5.4	0.0	16.2	0.5	0.8	2.7	0.8	5.9	0.2	0.3	0.0	2.8	1.4	0.3	1.1	0.4	40.2	0.1	7.7	2.5	2.4	3.2	0.0	0.1	0.0	0.0	0.2	38.8	0.2	0.1	0.0	1.0	0.0	0.9	2.1	0.2	0.0	7.8	0.0	0.0	0.0	1.4	6.2	8.5	0.6	0.0	0.7	4.9	1.5	0.0	0.6	0.1	0.2	18.6	3.8	0.4	0.2	0.1	0.2	2.5	23.0	18.2	0.3	22.4	0.2	0.8	0.3	0.2	12.2	0.9	0.2	0.1	6.7	0.8	15.9	1.1	0.9	2.6	2.8	8.4	1.5	4.4	7.0	2.6	6.5	0.4	9.1	5.0	11.9	35.6	80.8	45.0	52.0	2.9	2.0	40.8	21.4	19.4	31.4	3.9	11.5	24.9	326.6	1.8	45.0	161.9	0.0	563.3	281.5	67.3	63.5	54.1	80.8	472.8	0.0	16.1	38.1	417.7	8.6	4.6	429.6	108.0	2738.6	29.6	2.0	289.0	94.7	1.8	76.1	5.4	25.8	44.2	1.4	8.3	49.4	28.0	34.5	27.7	63.3
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710290	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 277.3"	"Cell type enriched"	"Detected in some"	19	"Melanocytes: 2358.5"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Region enriched"	"Detected in some"	5	"pons and medulla: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	52	"SK-MEL-30: 177.7"	"Group enriched"	"Detected in some"	5	"olfactory region: 5.6;thalamus: 2.0"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Approved	Vesicles		NA	NA		16000	Vesicles		"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.2	0.0	0.2	0.2	0.3	0.0	1.7	0.2	1.0	0.2	0.5	1.3	0.2	1.6	0.2	0.3	3.6	0.2	1.4	21.5	0.9	0.1	5.7	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	5.0	0.2	1.8	277.3	1.1	0.2	1.3	51.1	1.4	0.4	1.1	0.2	0.6	0.5	0.2	0.2	0.2	0.9	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	177.7	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	1.0	0.9	0.1	0.2	0.3	5.0	0.2	0.0	0.0	0.0	0.0	82.0	0.6	39.7	0.0	0.0	0.0	3.5	2.0	0.0	122.7	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.3	0.3	0.0	2358.5	0.0	0.0	15.4	0.0	0.0	0.0	0.8	1.3	0.0	3.1	0.5	0.7	14.6	0.0	0.0	0.0	0.1
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	15.4	19.1	10.2	12.3	15.4	11.9	15.1	14.9	15.3	18.8	12.9	21.2	18.2	14.1	22.7	15.3	12.0	15.5	10.8	12.9	10.8	9.8	15.2	17.7	11.1	15.5	14.1	10.8	19.4	23.9	22.9	28.0	13.2	14.5	14.9	16.5	17.8	15.3	14.7	26.2	14.4	12.8	14.0	13.9	15.1	12.6	13.7	13.4	19.7	19.0	13.6	23.3	15.3	15.2	9.6	8.3	3.6	9.1	11.2	11.8	5.3	10.6	13.6	8.3	17.2	12.5	8.7	9.7	11.4	8.7	9.0	8.5	15.5	13.9	18.5	17.5	10.5	12.7	12.6	17.2	14.0	13.1	14.5	13.2	8.0	11.3	10.5	12.4	18.4	10.6	8.9	14.2	12.2	18.8	7.1	8.2	13.5	21.0	11.2	10.3	10.5	11.6	15.5	14.6	18.0	12.2	13.2	11.6	23.3	12.2	10.8	12.8	12.7	13.7	26.6	11.4	16.6	18.1	13.1	9.6	10.4	7.4	8.2	15.5	11.3	15.9	22.3	8.5	17.4	14.3	2.0	7.0	3.6	8.6	7.8	11.7	8.5	9.4	9.8	8.3	9.6	11.5	11.8	2.0	11.2	9.1	6.6	6.8	5.3	10.2	15.4	14.9	15.3	10.8	9.8	14.1	10.8	14.5	13.4	6.0	15.4	4.5	4.9	9.3	9.0	8.1	10.2	9.4	4.5	10.4	3.9	16.5	0.0	6.6	5.5	6.7	4.7	0.0	6.0	10.7	7.7	4.9	33.5	12.5	6.9	3.2	4.6	6.7	4.3	3.1	7.8	8.9	8.5	10.0	12.1	7.7	6.1	3.5	7.8	2.1	11.7	19.4	7.1	17.0	22.7	14.8	12.7	8.5	9.7	2.8
TYW1B	"LINC00069, MGC87315, NCRNA00069, RSAFD2"	ENSG00000277149	"TRNA-yW synthesizing protein 1 homolog B"		7	72558744-72828198	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 8.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (2.61e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.96e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.33e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	2.7	1.6	1.8	4.5	3.8	4.4	4.2	6.0	3.3	5.6	2.9	5.8	7.4	1.5	6.0	5.2	3.4	4.1	1.5	2.3	1.9		3.1	7.9	2.9	2.4	3.9	1.7	10.1	5.7	2.0	11.6	3.0	3.4	4.1	4.4	4.7	4.1	5.9	4.4	2.5	2.9	3.6	4.7	3.0	3.1	7.2	3.8	6.0	5.9	1.8	6.0	3.1	1.1	7.5	5.4	5.7	3.5	2.4	3.0	0.9	2.3	2.5	1.0	2.0	1.6	0.5	1.1	1.2	0.5	1.1	1.1	8.0	4.2	7.3	0.7	0.8	1.0	1.1	1.9	0.8	1.3	7.9	2.3	0.7	1.2	4.7	0.8	7.4	2.1	3.8	0.6	1.3	0.9	0.7	0.7	1.6	10.0	7.7	1.1	1.0	2.4	3.8	1.8	3.1	4.6	1.4	5.5	2.6	1.1	0.8	1.8	0.9	1.5	8.4	4.3	3.3	2.1	2.6	3.2	1.8	4.3	9.7	1.4	6.7	8.1	8.3	0.5	2.1	9.7	4.0	3.5	5.7	3.0	1.8	2.8	7.5	2.0	1.8	1.4	5.2	2.3	2.7	4.3	2.4	1.7	5.4	2.0	0.9											0.0	1.3	4.7	1.8	0.0	3.4	4.8	2.5	2.7	1.2	0.0	9.8	3.5	0.0	2.0	3.3	1.4	1.2	0.0	0.6	1.5	2.1	1.6	1.1	1.5	2.9	1.6	0.0	1.3	1.5	0.4	0.9	0.7	0.0	2.8	2.3	1.6	1.0	0.3	0.7	0.5	8.1	0.0	1.7	5.5	5.1	0.0	1.6	2.2	1.1	0.9
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"		No	No			Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	16.5	19.7	13.7	13.5	17.7	11.9	18.3	15.0	19.9	20.4	17.7	7.5	13.7	9.5	21.0	15.2	20.6	16.4	10.0	21.1	11.1	12.9	20.4	17.0	11.3	14.3	16.2	17.2	30.0	14.4	22.2	34.3	13.5	17.0	20.7	12.3	8.6	13.8	15.7	12.3	10.5	10.9	24.7	15.6	16.0	14.8	12.3	18.1	12.3	23.5	14.3	16.9	23.5	33.3	9.7	9.0	6.0	8.0	13.6	13.9	5.2	8.6	7.3	12.6	8.9	14.3	15.7	19.1	14.9	13.7	14.3	12.6	15.4	7.4	22.7	13.7	12.8	21.0	7.1	14.4	17.2	17.9	14.1	12.4	17.8	22.3	29.8	9.4	35.6	11.6	11.9	17.4	18.2	17.6	11.5	12.7	15.8	30.8	17.5	18.3	7.3	17.3	11.9	33.5	13.0	17.0	16.4	26.3	10.2	12.2	11.3	9.8	8.3	7.1	19.4	22.9	14.3	10.6	13.1	8.2	6.3	17.3	17.1	17.8	10.1	18.3	15.9	14.2	12.9	18.2	6.0	6.0	1.6	10.3	8.0	9.9	9.7	9.1	9.3	9.0	8.8	13.2	13.9	0.5	13.6	5.9	8.7	8.4	5.2	13.7	17.7	15.0	19.9	11.1	12.9	16.2	17.2	17.0	18.1	14.9	22.9	32.0	34.6	22.8	31.3	26.5	17.8	24.1	36.4	15.7	3.9	37.5	66.3	29.4	14.9	24.8	8.0	0.0	51.1	41.5	28.2	34.8	20.7	29.2	29.0	47.7	13.3	17.8	27.2	18.5	40.3	22.8	20.3	29.7	17.0	18.0	31.2	7.0	57.7	43.8	19.9	12.9	38.0	31.8	45.3	19.8	18.7	27.7	24.9	23.3
TYW5	"C2orf60, FLJ37953"	ENSG00000162971	"TRNA-yW synthesizing protein 5"	A2RUC4	2	199929975-199955736	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028294, HPA045803"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA028294: AB_2672549, HPA045803: AB_10964878"	"unprognostic (3.44e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.72e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.30e-3)"	"unprognostic (9.54e-2)"	"unprognostic (6.98e-3)"	"unprognostic (2.87e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.42e-3)"	4.5	7.5	5.7	7.4	9.3	6.7	4.4	7.8	8.4	4.2	5.1	4.0	5.2	5.8	4.4	6.4	6.1	5.8	3.8	5.5	7.3	5.0	5.5	8.8	3.5	5.4	7.0	3.5	5.5	6.3	6.2	7.5	5.2	5.7	4.6	4.5	4.5	4.4	4.6	4.2	6.7	6.1	4.5	7.4	5.5	4.8	4.2	6.8	4.2	5.4	2.9	5.3	5.9	4.2	2.4	1.4	2.2	2.4	0.1	3.4	0.7	2.4	4.0	2.9	1.8	2.2	1.4	5.9	5.2	2.3	3.9	3.2	4.0	3.0	1.4	3.8	2.4	4.3	2.7	7.4	2.4	4.9	4.7	3.0	3.2	5.7	4.8	5.7	4.7	3.0	3.0	4.9	2.7	4.0	4.0	3.5	2.0	4.4	3.2	2.3	3.0	3.5	4.2	4.7	2.4	7.5	2.2	3.6	2.0	4.7	3.4	3.1	1.5	3.0	5.2	6.1	7.2	3.0	4.2	3.6	2.9	2.7	2.9	3.7	2.6	4.6	2.5	2.6	3.9	3.6	2.1	1.7	2.2	1.4	1.3	1.6	2.4	1.9	2.6	1.4	1.4	2.0	3.4	1.3	0.1	2.4	0.4	2.1	0.7	5.7	9.3	7.8	8.4	7.3	5.0	7.0	3.5	5.7	6.8	6.0	19.9	3.9	12.5	7.3	19.7	4.6	5.1	6.7	7.9	12.2	115.8	8.8	3.3	7.0	1.9	7.1	5.8	0.0	5.5	7.9	8.9	14.1	5.8	7.3	5.4	7.9	2.4	9.2	6.9	0.8	5.8	8.2	6.8	10.8	6.7	34.0	8.4	5.8	5.3	8.6	31.5	6.5	9.2	7.9	12.8	5.3	7.0	6.7	10.0	16.1
U2AF1L4	"MGC33901, U2AF1L3, U2af26"	ENSG00000161265	"U2 small nuclear RNA auxiliary factor 1 like 4"	Q8WU68	19	35742464-35745445	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA052083, HPA061644"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052083: AB_2681720, HPA061644: AB_2684574"	"prognostic favorable (2.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.58e-5)"	"unprognostic (3.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.67e-2)"	"prognostic favorable (8.58e-5)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (1.06e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.05e-4)"	5.3	9.7	12.1	4.5	15.0	4.6	4.5	9.3	12.5	4.8	5.7	8.7	8.0	2.7	5.7	6.0	4.9	6.1	5.1	24.3	11.1	10.2	7.0	4.4	4.7	2.8	9.5	10.3	10.7	4.7	11.7	6.6	5.8	8.7	6.7	2.8	10.9	2.5	9.1	19.8	3.4	5.8	6.8	8.5	5.0	4.1	10.7	6.0	2.7	7.4	4.3	5.3	4.2	3.1	9.2	8.4	2.2	3.2	0.8	9.9	5.2	3.7	13.6	1.8	3.2	0.0	1.7	3.1	3.4	3.5	8.7	8.6	5.4	3.1	1.6	6.7	7.8	7.8	1.9	6.9	5.3	5.4	10.4	1.0	1.7	3.4	5.8	10.9	2.5	5.6	2.0	2.3	3.6	2.1	3.2	1.6	4.9	4.1	4.7	5.5	8.0	7.6	2.6	3.0	9.0	2.4	1.9	3.2	0.0	2.0	0.6	4.6	4.5	5.0	3.3	0.9	4.9	3.8	5.0	2.9	5.5	2.4	1.2	5.6	5.5	6.4	3.5	3.6	5.7	6.6	0.0	2.1	1.5	3.1	3.2	3.0	9.2	6.0	5.9	2.0	6.9	9.0	8.6	2.2	0.8	2.4	8.4	9.9	5.2	12.1	15.0	9.3	12.3	11.1	10.2	9.5	10.3	8.7	6.0	17.9	23.1	37.4	12.7	9.2	24.6	4.4	5.1	8.1	5.7	8.7	13.7	13.1	23.2	9.0	9.3	13.6	20.3	23.3	11.0	8.2	16.2	10.7	33.7	13.2	17.4	19.1	12.1	9.8	13.9	11.0	14.4	21.2	28.7	36.9	12.1	10.3	8.1	23.0	11.7	22.6	28.0	12.9	12.8	37.9	13.4	7.8	24.7	42.6	10.1	10.7
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 107.8;U-251 MG: 70.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		19000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	38.4	18.5	7.0	17.4	9.8	17.2	24.8	9.0	13.4	16.1	26.9	5.7	45.7	17.2	10.9	19.4	23.6	15.7	18.3	22.5	7.7	7.8	11.0	67.1	16.0	7.4	6.6	8.9	20.4	31.4	5.1	16.0	21.5	9.1	13.9	26.9	7.8	43.9	62.5	19.4	12.4	33.4	28.8	7.1	8.1	23.0	37.7	3.7	5.6	12.4	13.5	15.3	24.4	16.7	8.3	5.6	8.1	1.6	6.2	16.1	4.8	30.5	2.2	6.1	4.9	29.8	23.9	4.2	44.9	16.6	34.7	28.3	5.8	14.4	1.2	10.1	34.4	12.5	5.3	6.9	13.1	57.2	4.8	10.3	5.4	7.0	11.4	14.0	9.2	3.7	11.0	6.2	38.0	107.8	15.9	21.2	9.6	30.5	12.6	46.4	5.6	5.3	5.9	4.5	31.4	10.0	4.8	11.9	14.9	5.4	3.6	6.6	6.8	19.6	12.2	10.4	7.5	6.0	10.5	36.0	17.5	16.1	44.0	70.2	21.2	7.4	10.1	10.0	4.3	11.0	1.0	1.6	8.1	13.0	1.6	16.1	8.3	7.9	13.3	3.4	6.5	7.6	9.5	1.6	6.2	0.8	5.6	3.9	4.8	7.0	9.8	9.0	13.4	7.7	7.8	6.6	8.9	9.1	3.7	6.0	30.4	17.9	120.0	119.7	10.0	26.6	17.8	53.5	38.7	15.7	7.9	22.4	61.3	24.8	36.3	23.3	84.7	0.0	56.9	52.1	141.3	91.8	33.4	88.9	14.0	6.4	52.6	21.5	7.0	11.8	46.9	15.2	81.0	27.9	124.5	14.0	55.8	69.1	38.9	20.2	12.3	19.4	160.3	182.9	121.8	71.5	81.7	20.1	59.9	111.6
UAP1L1		ENSG00000197355	"UDP-N-acetylglucosamine pyrophosphorylase 1 like 1"	Q3KQV9	9	137077501-137084539	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 18.6;Horizontal cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044356	Approved		Approved	"Intermediate filaments,Cytosol"		No	No			"Intermediate filaments"	Cytosol	"HPA044356: AB_10959902"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.64e-3)"	10.5	14.7	13.6	9.8	20.6	5.0	16.3	3.4	17.5	13.0	8.8	22.1	8.6	10.0	7.3	9.7	5.9	5.8	9.4	11.3	14.7	8.1	12.5	3.1	11.6	12.2	24.9	9.3	3.9	10.5	8.5	14.7	10.9	14.2	12.8	6.7	14.1	15.2	10.9	2.5	9.0	9.4	6.6	13.5	20.3	10.8	3.5	29.1	1.4	13.3	4.9	10.3	11.4	13.9	2.1	1.8	0.6	3.7	0.3	3.0	1.2	0.4	2.8	0.0	7.5	13.0	6.1	2.2	3.8	10.1	10.8	7.6	5.4	1.2	1.7	2.3	3.9	19.7	5.8	14.1	0.9	2.2	4.6	1.2	3.7	4.2	5.2	29.0	0.0	15.3	4.4	1.0	6.1	5.1	5.1	8.4	3.5	1.1	8.6	7.2	6.2	0.3	3.7	1.2	13.2	4.0	5.9	0.1	5.2	4.3	0.5	4.5	2.8	0.9	21.2	8.6	1.9	11.4	10.2	6.6	19.6	4.2	13.6	1.8	9.5	13.5	3.6	17.0	4.0	5.5	0.4	3.7	0.1	0.8	2.0	3.0	2.1	0.4	1.3	1.8	1.0	1.0	1.3	0.6	0.3	0.0	1.1	1.7	1.2	13.6	20.6	3.4	17.5	14.7	8.1	24.9	9.3	14.2	29.1	0.0	5.9	2.9	0.5	5.5	4.8	3.5	7.6	0.0	1.2	0.0	2.0	0.3	10.0	1.3	0.1	2.1	0.2	0.0	0.8	4.6	4.4	1.9	4.6	0.2	18.6	19.1	1.7	7.4	12.7	0.0	2.3	8.1	8.5	5.4	1.7	6.5	0.9	1.9	3.5	3.1	4.7	0.0	3.4	0.5	1.5	3.9	1.1	2.6	2.3	0.1
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA		9600	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473"	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	19.1	25.3	29.7	22.2	31.0	53.7	26.8	30.9	31.4	20.3	19.7	31.3	15.9	16.1	22.8	25.4	25.4	19.5	18.4	38.2	23.8	22.7	24.7	17.6	19.3	28.7	37.5	21.2	20.4	15.1	17.9	28.0	27.8	40.8	22.6	22.6	21.8	28.0	20.4	25.0	27.6	21.9	24.0	30.2	27.8	17.3	13.5	31.9	28.4	18.2	17.2	31.0	22.9	20.4	18.9	22.3	35.6	27.8	20.2	22.2	26.0	26.8	11.4	28.1	17.1	26.3	34.9	21.7	24.1	27.3	26.3	26.5	14.1	19.0	20.5	7.0	25.9	26.5	15.5	21.6	27.6	30.0	37.3	13.7	27.7	21.5	14.2	20.3	27.1	23.3	27.4	18.5	24.8	20.8	32.4	33.8	16.9	11.4	17.6	34.6	9.6	17.8	18.3	24.9	34.1	9.8	13.9	20.8	18.8	41.9	34.4	12.1	16.9	25.4	18.5	20.6	31.6	12.6	26.7	25.6	20.0	17.6	25.9	33.4	20.2	32.3	24.4	20.5	30.2	25.4	34.7	25.4	35.6	14.3	27.8	16.1	18.9	18.9	17.6	22.3	16.0	17.9	18.0	24.4	20.2	27.7	11.4	22.2	26.0	29.7	31.0	30.9	31.4	23.8	22.7	37.5	21.2	40.8	31.9	32.8	28.9	17.1	23.8	30.0	21.0	57.2	20.4	37.5	23.9	33.2	37.3	64.4	16.6	30.4	10.9	27.1	14.3	0.0	20.5	47.2	31.1	21.5	40.5	16.2	30.1	31.8	17.9	20.3	43.2	7.9	37.4	39.1	28.7	53.3	15.3	27.7	25.3	8.6	35.7	26.4	44.9	25.8	29.3	32.3	33.0	37.4	47.5	33.8	16.6	28.2
UBA52	"CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40"	ENSG00000221983	"Ubiquitin A-52 residue ribosomal protein fusion product 1"	P62987	19	18571730-18577550	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 9484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041344, HPA049132, HPA056624"	Supported		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196"	"unprognostic (1.98e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	84.7	73.8	71.1	76.4	76.5	167.0	101.5	32.8	71.1	83.2	73.0	48.7	67.8	47.7	79.0	93.2	102.7	78.8	82.0	85.9	58.2	50.2	74.1	135.5	67.7	182.7	64.0	59.0	150.3	225.2	56.5	62.8	71.6	55.5	75.8	74.0	51.6	96.0	75.2	191.4	104.6	68.0	91.9	72.0	101.1	75.5	89.5	52.1	121.2	97.6	131.7	145.1	99.9	161.7	200.5	157.0	75.1	132.4	109.7	205.0	246.6	104.4	83.5	62.7	104.6	163.0	155.1	155.6	80.7	112.1	134.1	107.1	151.2	97.9	151.5	83.5	133.0	52.8	70.9	121.3	143.5	126.9	40.6	189.4	82.9	129.9	170.4	118.7	179.8	106.3	179.4	196.4	91.9	133.7	117.4	134.3	97.0	131.1	210.1	114.3	174.9	143.6	161.4	140.3	199.6	180.9	118.8	62.6	173.5	129.2	158.9	81.8	99.0	58.6	142.1	139.9	97.9	63.0	232.8	99.7	67.3	56.3	141.7	142.6	129.4	171.7	149.9	91.6	204.3	91.1	50.7	132.4	69.8	119.4	107.2	162.2	200.5	178.5	142.6	147.6	199.1	205.0	165.6	75.1	109.7	96.1	157.0	138.5	246.6	71.1	76.5	32.8	71.1	58.2	50.2	64.0	59.0	55.5	52.1	431.7	622.2	2582.1	1573.2	1686.3	110.3	294.0	1008.9	451.1	705.2	621.1	64.8	1723.9	1331.3	1227.6	2621.0	1327.6	1318.3	1448.3	1974.2	2396.3	1301.0	1468.3	776.0	1485.4	2254.1	98.5	1063.9	1146.6	2650.9	9484.0	1736.3	2494.7	1186.1	2394.1	1524.2	239.6	1703.1	1730.2	972.7	1715.5	163.6	685.6	1317.8	523.4	597.0	1957.5	1909.1	1690.5	1603.6	1847.3
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805207-49813946	"Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 22.7;HEL: 21.2;HMC-1: 41.2;HSkMC: 19.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1400000	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: AB_2683631"	"prognostic favorable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.48e-4)"	11.3	12.1	6.8	22.0	7.5	16.0	11.5	2.0	6.7	10.8	12.7	14.4	25.4	19.6	17.2	31.6	17.7	12.9	33.1	9.1	6.7	3.9	15.9	11.9	18.8	28.2	6.0	6.2	19.1	9.5	1.4	8.4	8.9	9.4	18.5	12.1	14.2	24.5	34.2	3.3	9.0	25.5	11.3	7.7	35.9	13.2	3.4	5.9	20.4	17.8	18.4	23.5	12.6	13.1	12.4	14.3	24.8	21.7	11.1	11.8	13.0	4.3	0.0	0.3	0.1	12.2	12.9	1.4	2.3	10.6	16.9	22.7	0.0	9.3	0.1	1.9	8.6	7.3	2.4	0.0	4.2	1.5	11.3	0.0	21.2	0.2	1.3	9.0	2.0	41.2	19.8	0.2	6.6	0.4	11.8	8.5	0.7	0.0	1.3	3.9	0.1	4.3	5.1	0.0	0.0	0.4	5.5	0.4	0.7	3.5	8.6	0.0	0.3	2.8	4.2	1.4	0.2	0.4	14.1	3.7	3.3	0.4	1.4	0.9	0.0	0.0	0.1	9.2	7.5	0.7	13.9	14.7	24.8	11.8	21.7	10.3	12.3	10.8	10.5	14.3	12.4	9.9	8.9	4.6	11.1	17.2	5.2	10.6	13.0	6.8	7.5	2.0	6.7	6.7	3.9	6.0	6.2	9.4	5.9	29.8	23.6	22.9	5.9	3.4	0.1	6.9	15.3	2.7	13.6	12.2	0.0	4.5	0.0	7.6	4.5	14.3	35.5	0.0	6.9	2.2	8.9	5.1	80.8	6.7	18.2	0.0	9.1	17.8	21.9	24.1	10.3	10.6	0.0	10.8	19.5	2.9	5.1	12.9	10.6	4.1	1.1	6.5	7.1	0.9	0.4	4.1	2.4	27.4	15.3	5.0
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961380	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 113.2"	"Cell type enhanced"	"Detected in all"	6	"Erythroid cells: 233.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 60.5;K-562: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		54000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favorable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	7.6	5.7	12.4	5.8	13.4	27.1	6.2	10.9	12.7	6.1	11.0	8.0	6.8	9.9	6.2	10.3	10.0	9.4	5.1	22.2	11.0	8.6	8.8	7.6	6.4	5.8	11.6	7.4	7.8	6.7	6.9	6.6	9.3	8.7	7.4	7.8	7.7	9.2	9.2	113.2	15.7	9.6	9.3	10.1	5.7	6.1	10.9	7.8	3.9	6.1	21.9	9.0	7.6	8.3	3.2	9.7	5.1	18.8	2.2	3.6	4.0	9.1	10.7	7.6	11.0	5.8	6.7	14.3	8.0	6.9	10.0	8.1	14.8	11.7	11.1	7.8	6.6	11.9	31.3	10.6	9.3	4.5	60.5	10.0	9.2	19.2	8.3	6.0	12.0	8.8	6.3	12.2	6.3	6.2	6.7	8.3	10.5	76.7	9.0	7.9	18.9	9.7	12.3	18.0	21.6	18.2	11.1	14.3	14.6	7.1	5.9	11.8	13.0	11.6	10.5	8.1	7.1	8.9	13.0	6.7	5.7	8.6	6.8	9.9	5.3	9.8	13.2	10.5	10.9	7.7	3.4	11.3	5.1	3.1	17.2	3.3	3.2	3.6	2.1	9.7	2.0	1.9	2.2	2.5	2.2	18.8	1.0	2.7	4.0	12.4	13.4	10.9	12.7	11.0	8.6	11.6	7.4	8.7	7.8	14.9	7.7	13.7	32.8	36.1	36.5	74.9	12.7	91.0	14.8	26.2	29.5	121.1	79.6	15.6	80.0	25.3	39.3	233.6	20.0	20.6	17.0	18.9	6.9	26.7	64.5	12.7	16.1	16.0	27.7	144.8	18.1	30.0	33.7	43.3	32.5	43.1	17.5	46.5	21.2	21.9	35.3	19.4	19.8	43.5	52.7	56.7	50.6	10.1	47.7	37.6
UBAC2	"FLJ30548, PHGDHL1, RP11-178C10.1"	ENSG00000134882	"UBA domain containing 2"	Q8NBM4	13	99200774-99386434	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013448	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA013448: AB_1855301"	"unprognostic (7.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.26e-2)"	16.7	15.6	9.1	15.6	10.4	11.0	24.2	8.2	13.9	14.6	14.6	10.0	18.3	16.7	17.2	17.1	29.6	18.1	15.4	15.5	11.0	7.6	15.1	20.0	20.6	36.5	8.2	10.1	15.1	25.5	11.8	9.5	22.1	9.8	11.1	14.6	11.9	19.5	13.7	26.9	26.3	17.6	13.8	11.7	13.4	14.9	24.8	8.1	21.6	20.6	17.3	24.5	17.2	15.8	25.3	23.9	24.7	23.1	31.3	37.5	31.8	13.1	8.3	6.3	9.1	16.0	17.4	15.2	6.9	24.7	12.6	9.8	8.0	28.6	5.5	12.3	10.5	7.8	12.1	9.1	11.8	7.3	9.3	9.0	9.1	4.4	4.9	13.6	11.4	7.0	13.5	14.9	7.2	22.8	16.7	11.0	10.5	8.0	2.8	10.2	3.5	8.7	2.9	7.9	27.4	6.5	7.0	5.5	4.0	8.6	6.7	6.8	10.1	5.7	17.2	10.0	10.5	11.5	36.8	7.8	4.9	4.9	5.1	7.5	3.9	3.3	1.9	10.7	17.7	9.6	20.8	23.1	17.3	27.3	22.1	37.5	19.6	23.4	27.3	18.6	25.3	32.7	32.2	24.7	31.3	21.2	23.9	15.1	31.8	9.1	10.4	8.2	13.9	11.0	7.6	8.2	10.1	9.8	8.1	6.0	18.4	15.9	23.5	24.2	26.2	19.7	17.8	25.4	14.8	22.7	25.5	99.9	19.9	38.6	19.2	23.6	34.4	0.0	30.4	70.7	31.5	23.0	21.9	25.0	43.6	30.2	8.1	12.9	33.8	16.7	32.5	40.2	28.7	16.2	26.9	44.7	25.3	35.1	47.7	18.3	21.9	32.3	24.0	59.0	37.8	29.0	110.8	50.4	33.9	23.3
UBALD1	FAM100A	ENSG00000153443	"UBA like domain containing 1"	Q8TB05	16	4608883-4615027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA066771	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA066771: AB_2685717"	"unprognostic (7.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.63e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-2)"	23.0	16.7	20.5	17.9	25.0	37.5	11.9	32.4	39.2	12.1	19.3	15.1	11.7	23.7	20.4	11.0	15.0	13.9	12.4	14.8	20.9	14.2	19.6	32.9	15.7	13.8	12.0	22.2	14.8	27.2	9.0	12.1	27.9	16.9	18.9	5.3	13.6	19.4	18.1	38.3	16.7	19.5	14.2	11.5	23.9	25.9	13.2	13.0	9.9	17.3	11.3	11.6	17.8	12.8	1.9	2.8	11.3	4.5	1.5	2.6	1.5	5.4	15.9	3.8	5.9	2.5	3.3	17.0	8.3	3.4	3.2	4.6	7.8	6.5	8.2	9.3	2.6	2.4	15.2	2.4	8.4	0.9	17.1	24.2	7.6	16.6	12.0	5.2	4.7	13.1	4.7	6.3	4.9	2.4	3.7	3.4	6.3	11.5	8.6	1.2	27.1	7.9	26.0	14.2	4.9	14.1	11.4	4.7	26.4	2.8	8.0	11.0	10.1	9.8	15.2	13.0	2.3	9.7	7.8	10.1	6.5	7.4	26.1	5.3	16.8	13.5	9.2	2.6	6.5	3.4	1.3	2.3	11.3	2.5	3.5	1.6	1.9	2.0	2.6	2.8	1.8	2.1	2.2	3.9	1.5	4.5	1.8	2.4	1.5	20.5	25.0	32.4	39.2	20.9	14.2	12.0	22.2	16.9	13.0	8.9	8.0	9.8	49.6	97.9	8.9	3.6	7.6	2.7	7.9	17.4	3.9	58.7	26.6	19.0	30.4	15.8	17.3	0.0	20.4	54.1	23.1	30.9	10.4	31.6	20.8	9.5	81.1	15.4	16.8	89.2	15.0	18.1	20.3	17.2	21.3	12.0	21.6	17.5	18.7	33.8	8.7	45.3	30.6	11.5	17.7	89.8	90.2	15.3	12.8	32.8
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	26.4	34.6	25.7	17.5	25.0	81.9	28.6	29.1	29.5	24.2	26.0	26.5	14.5	16.6	25.3	20.0	40.5	20.4	22.9	34.4	24.0	23.6	25.6	38.6	27.7	17.3	27.0	20.0	26.8	20.7	26.7	19.2	26.8	25.5	20.4	19.0	21.5	19.4	24.3	62.3	22.6	24.6	26.4	26.3	21.4	20.9	33.5	26.0	17.2	23.6	22.1	25.4	29.2	29.5	10.5	17.8	45.9	19.6	17.4	26.5	19.2	20.9	11.8	13.6	14.8	25.3	15.7	11.5	16.8	23.7	18.9	25.8	12.8	8.8	14.7	7.6	25.1	16.1	10.8	18.9	26.5	18.3	21.1	8.5	13.1	26.5	13.3	23.1	14.5	17.5	19.4	44.0	22.4	29.5	28.8	20.9	14.5	10.0	14.7	17.6	8.8	13.4	20.4	14.8	14.5	17.7	12.1	9.7	8.5	40.5	14.0	7.8	10.9	18.7	19.5	8.6	12.7	9.5	14.5	14.8	9.7	15.0	14.5	15.6	7.3	9.1	15.5	19.5	11.8	28.5	9.0	19.6	24.1	15.4	17.1	26.5	10.5	15.5	16.1	17.8	8.8	15.1	12.3	45.9	17.4	14.5	9.9	19.1	19.2	25.7	25.0	29.1	29.5	24.0	23.6	27.0	20.0	25.5	26.0	62.5	24.2	13.9	57.1	41.7	12.9	11.4	12.7	25.4	38.7	7.0	23.6	29.1	16.6	29.7	56.8	17.9	20.6	23.3	35.1	29.2	28.2	45.4	24.4	20.8	19.3	6.4	15.4	12.9	17.1	45.7	27.0	22.9	23.6	20.8	15.4	23.6	35.8	23.0	40.0	15.8	11.4	19.4	28.6	21.7	20.6	51.6	74.9	25.4	16.8	59.0
UBAP2	"bA176F3.5, FLJ22435, KIAA1491"	ENSG00000137073	"Ubiquitin associated protein 2"	Q5T6F2	9	33921693-34048949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021684	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA021684: AB_2211887"	"unprognostic (2.71e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-3)"	"prognostic favorable (1.95e-4)"	"unprognostic (8.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.77e-2)"	13.0	23.8	11.8	13.9	12.8	17.0	11.6	15.1	14.5	11.6	11.9	12.8	9.4	10.0	18.6	10.8	16.8	10.7	10.5	11.5	10.4	8.6	12.7	9.5	11.6	11.0	8.4	10.7	15.2	13.5	13.4	18.2	18.3	11.5	12.7	14.4	12.3	17.6	11.7	38.1	18.4	9.7	12.2	10.6	10.4	12.0	27.5	11.5	24.7	15.4	21.0	19.2	11.6	13.6	4.7	6.8	4.7	10.5	7.5	8.2	3.3	18.2	16.9	12.2	15.4	12.1	10.7	14.7	14.7	9.2	15.2	14.8	22.8	9.7	21.3	4.7	12.2	11.7	10.7	20.5	16.1	17.0	15.6	10.0	11.8	21.5	24.9	9.9	26.7	19.1	9.9	13.7	19.3	13.5	8.0	12.2	13.1	16.2	17.6	13.7	12.2	19.8	45.4	13.0	10.3	13.3	15.4	7.6	13.5	14.7	13.8	12.6	8.7	17.4	14.2	4.3	12.8	12.6	12.0	14.3	9.1	12.3	10.7	16.3	6.8	14.2	22.9	10.0	10.3	22.5	2.6	4.3	4.7	3.9	5.2	8.2	4.7	4.8	5.4	5.0	2.5	4.3	5.8	2.6	7.5	10.5	6.8	5.3	3.3	11.8	12.8	15.1	14.5	10.4	8.6	8.4	10.7	11.5	11.5	50.6	20.2	9.0	24.4	25.0	26.2	52.5	10.2	21.4	35.2	12.2	56.9	37.2	3.3	18.9	83.6	26.8	12.7	23.3	17.1	31.0	14.7	20.0	13.9	11.6	14.4	15.9	24.1	12.9	14.3	60.5	28.1	14.3	25.3	17.2	25.5	15.1	23.5	28.1	23.0	14.0	28.1	25.8	15.5	69.4	62.7	27.1	61.0	10.2	24.8	20.2
UBAP2L	"KIAA0144, NICE-4"	ENSG00000143569	"Ubiquitin associated protein 2 like"	Q14157	1	154220179-154271510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 107.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035068	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA035068: AB_10696366"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (5.10e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.96e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (7.40e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-1)"	33.8	33.0	39.1	34.8	47.5	32.7	32.3	34.3	46.6	31.2	31.3	32.9	25.5	20.6	40.6	30.3	36.1	34.8	28.3	36.9	38.3	25.2	26.7	23.9	35.1	34.1	26.5	39.5	42.7	25.0	42.1	40.6	43.9	30.5	29.2	25.8	31.2	31.8	32.8	53.2	36.8	25.3	36.6	30.2	30.5	27.4	37.5	30.2	34.6	33.8	26.6	38.5	37.9	32.4	18.3	24.3	17.6	26.5	24.6	20.6	18.3	42.5	41.1	40.3	31.7	28.7	32.9	34.6	49.1	35.5	44.7	31.1	44.1	33.2	53.3	51.1	41.1	21.2	37.1	52.8	36.2	39.4	46.9	45.2	57.6	42.6	36.8	27.1	60.0	34.2	31.3	15.8	40.3	25.8	28.0	35.2	20.9	52.4	25.9	35.0	46.4	46.8	22.5	75.0	31.3	39.1	33.7	31.8	47.1	27.9	49.9	41.2	49.8	56.5	53.1	21.4	46.3	53.4	41.6	56.5	27.7	29.4	34.0	46.6	56.8	61.1	72.6	29.7	33.0	41.4	8.8	19.2	13.2	17.5	25.1	19.1	15.6	16.4	15.7	24.3	18.3	19.1	20.6	17.6	24.6	26.5	11.4	14.7	18.3	39.1	47.5	34.3	46.6	38.3	25.2	26.5	39.5	30.5	30.2	23.8	33.4	27.4	15.2	16.4	18.0	33.7	10.2	26.8	37.5	17.4	7.9	42.0	14.9	26.8	78.5	19.4	11.8	0.0	23.4	31.4	24.6	14.5	24.3	17.8	30.9	14.3	22.4	28.3	22.4	107.3	19.8	23.2	18.6	20.8	19.9	17.4	24.0	11.5	21.2	11.9	20.2	12.9	20.8	25.7	41.7	17.9	65.1	14.6	19.9	18.0
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 17.6;lymphoid tissue: 62.3"	"Cell type enriched"	"Detected in some"	14	"T-cells: 16.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"gdT-cell: 6.9;MAIT T-cell: 12.1;memory CD4 T-cell: 15.1;memory CD8 T-cell: 13.1;naive CD4 T-cell: 17.6;naive CD8 T-cell: 12.8;T-reg: 13.6"	"Lineage enriched"	"Detected in many"	15	"T-cells: 17.6"	"Group enriched"	"Detected in some"	6	"HEL: 13.4;JURKAT: 23.5;MOLT-4: 27.5"	"Region enriched"	"Detected in single"	13	"hippocampal formation: 0.5"	"Low region specificity"	"Detected in all"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	1.1	0.7	0.3	19.7	0.3	2.6	0.8	0.3	0.3	0.9	2.8	0.1	0.0	1.9	0.8	0.8	1.2	1.3	3.2	1.1	0.3	0.4	1.4	1.1	6.0	23.1	0.4	0.0	0.7	0.6	0.0	0.6	0.4	0.3	1.2	1.0	1.1	5.0	0.2	0.3	0.5	5.9	0.6	0.7	10.8	2.2	0.4	0.0	62.3	1.4	1.1	14.1	2.6	1.1	0.0	0.0	0.3	0.0	1.1	17.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	13.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	23.5	2.5	0.0	0.0	0.0	27.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	12.1	0.0	15.1	13.1	0.0	0.0	17.6	12.8	0.3	1.1	0.0	0.0	13.6	5.1	0.3	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	16.2	0.0	0.0
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655675-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.5;lymphoid tissue: 27.7"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 29.2;Extravillous trophoblasts: 45.7;Hofbauer cells: 34.3;Kupffer cells: 31.7;Syncytiotrophoblasts: 39.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 32.5;pons and medulla: 21.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 42.6;HMC-1: 32.5;hTEC/SVTERT24-B: 26.5;REH: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038607"	Approved		Approved	"Plasma membrane"		NA	NA		2200000	"Plasma membrane"		"HPA038605: AB_10669648, HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	4.3	1.3	2.8	5.5	4.0	7.2	1.5	32.5	4.9	4.0	1.5	0.7	0.0	1.7	1.3	0.3	1.8	1.1	2.4	1.3	3.4	3.5	1.5	1.7	5.5	10.9	5.1	1.9	0.8	1.2	0.6	0.9	16.8	21.2	1.3	1.8	0.9	1.3	0.9	1.8	4.1	2.4	2.3	2.1	27.7	1.7	2.1	0.2	23.9	2.9	1.7	3.8	3.4	1.3	1.0	1.7	9.8	11.0	6.5	4.9	1.8	4.5	11.1	2.0	2.7	0.9	1.6	10.6	16.2	9.0	6.6	5.1	4.4	2.4	1.8	1.3	8.6	6.3	2.2	0.0	5.8	10.5	0.0	0.3	42.6	0.3	3.7	2.5	5.1	32.5	1.4	0.3	26.5	9.8	7.2	4.4	1.9	0.0	0.0	6.4	0.1	6.3	3.3	0.9	4.6	2.6	25.4	1.2	0.2	10.4	3.8	4.6	0.1	4.3	0.3	3.6	4.4	0.0	1.4	11.4	8.6	4.6	5.0	6.7	0.4	0.0	5.4	4.5	7.3	15.5	0.0	1.3	9.8	2.0	6.5	2.2	0.3	2.6	1.8	1.7	1.0	3.0	1.6	2.8	6.5	11.0	0.2	4.9	1.8	2.8	4.0	32.5	4.9	3.4	3.5	5.1	1.9	21.2	0.2	0.0	6.6	0.0	3.5	6.4	0.6	1.2	0.0	0.0	1.2	3.5	0.0	29.2	0.0	9.2	1.9	4.2	0.4	0.0	8.3	45.7	4.2	2.9	12.7	0.0	34.3	11.1	0.0	4.9	31.7	2.8	0.0	19.6	1.7	0.0	0.0	0.5	16.9	0.0	0.4	0.0	1.1	0.0	4.2	0.0	0.5	5.3	39.8	7.2	0.3	2.7
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559925	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.2"	"Group enriched"	"Detected in some"	16	"Ductal cells: 316.2;Exocrine glandular cells: 231.1;monocytes: 265.1;Pancreatic endocrine cells: 685.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RT4: 13.8"	"Not detected"	"Not detected"							HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	3.4	0.4	0.0	53.2	0.0	0.4	1.8	0.0	0.4	0.7	1.8	0.0	0.0	1.5	0.6	1.6	4.2	1.2	2.9	1.8	0.0	0.0	13.4	16.3	5.1	26.3	0.0	0.0	0.5	14.6	0.4	0.7	0.4	1.0	5.6	3.0	1.0	11.3	0.7	3.1	0.6	15.5	0.7	0.2	18.6	3.5	0.4	0.0	26.3	2.7	4.5	50.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	3.0	1.9	0.0	0.0	0.1	0.0	0.0	22.9	16.0	15.9	0.0	0.0	0.0	1.7	316.2	0.0	0.0	3.3	0.0	231.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	265.1	3.1	0.0	685.5	6.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628433	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favorable (5.09e-5)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	35.6	25.0	41.2	31.5	39.9	44.2	35.9	31.9	49.6	43.9	50.4	35.5	31.5	22.2	35.5	52.2	44.8	47.6	27.1	34.8	39.5	40.5	37.2	39.5	34.8	55.6	40.5	36.1	35.3	41.7	23.8	35.3	33.6	35.9	30.8	46.4	30.7	30.5	37.9	80.6	33.2	37.4	39.3	41.9	41.3	29.1	68.0	29.3	71.0	34.4	31.2	64.5	42.2	36.1	34.3	39.3	40.8	23.0	22.5	41.7	19.5	34.1	22.8	40.0	27.9	27.0	34.7	25.6	36.1	33.8	42.6	49.9	58.6	32.5	48.8	47.6	37.2	52.7	21.7	39.2	60.9	57.1	31.5	22.9	27.7	25.2	33.7	52.9	27.0	24.7	27.2	31.5	42.3	63.3	36.9	45.4	32.3	24.0	41.8	39.5	34.3	41.6	38.5	22.0	12.0	24.8	31.8	41.6	35.3	44.8	40.4	36.5	24.1	31.5	40.6	57.4	89.9	25.4	24.0	29.7	32.6	18.1	27.0	44.1	30.1	48.9	68.5	23.3	44.6	25.9	14.8	20.9	40.8	22.6	18.8	24.7	34.1	32.7	31.7	23.4	34.3	41.7	35.2	34.5	22.5	23.0	39.3	40.0	19.5	41.2	39.9	31.9	49.6	39.5	40.5	40.5	36.1	35.9	29.3	29.8	71.1	173.0	150.9	152.6	68.0	80.9	79.0	36.1	43.3	64.6	76.6	160.4	182.4	173.6	500.3	117.4	113.7	70.0	156.3	191.8	125.8	164.5	136.2	71.0	157.1	89.0	118.5	93.9	121.3	409.1	96.7	157.7	145.1	191.2	112.3	128.4	182.8	103.7	88.1	147.6	99.0	116.4	156.8	337.7	125.2	178.2	208.7	191.8	148.1	221.1
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926438-43956136	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 25.3"					"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.86e-4)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	10.1	13.1	14.7	5.0	13.3	4.5	9.1	13.8	17.4	8.8	7.6	11.4	7.9	5.3	7.5	11.2	8.0	9.0	7.2	23.8	14.2	10.0	12.7	15.3	8.4	5.3	12.1	9.4	7.9	17.4	8.7	6.9	5.9	11.9	8.7	6.2	8.1	10.6	9.1	48.6	9.4	5.3	10.3	12.8	7.3	6.5	5.1	6.1	2.7	9.6	16.1	5.7	7.7	6.5	10.7	11.8	12.9	20.5	7.7	14.0	6.7	3.8	3.2	2.0	9.1	9.4	3.8	1.5	1.9	4.7	2.4	3.2	1.7	4.6	3.7	5.3	5.0	6.8	4.4	2.5	2.1	3.7	8.3	4.2	4.0	5.0	4.4	3.5	8.7	8.2	2.9	4.4	2.7	4.2	3.5	3.0	4.6	4.4	7.8	3.3	2.5	5.1	5.0	4.4	4.7	4.2	3.2	2.8	5.8	5.1	4.7	7.4	25.3	4.0	8.1	3.0	3.8	4.0	2.6	2.6	1.6	5.1	3.4	5.5	11.2	8.4	1.8	4.8	11.4	8.9	6.3	11.7	12.9	9.3	18.4	9.5	10.3	11.6	10.5	11.8	10.7	14.0	11.5	1.1	7.7	20.5	10.2	9.4	6.7	14.7	13.3	13.8	17.4	14.2	10.0	12.1	9.4	11.9	6.1	0.0	6.2	8.8	8.1	5.6	8.3	21.8	5.1	2.7	6.8	15.7	2.0	9.7	46.4	15.9	5.0	11.9	8.4	0.0	24.7	17.3	10.8	9.8	4.6	22.2	24.7	11.1	18.0	9.2	7.3	8.0	11.2	12.9	15.1	24.4	7.1	9.1	14.6	5.8	20.5	38.0	10.4	6.5	12.0	15.1	8.3	9.8	6.4	6.9	7.9	9.3
UBE2E1	UbcH6	ENSG00000170142	"Ubiquitin conjugating enzyme E2 E1"	P51965	3	23805903-23891316	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030445, CAB073413"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB073413: , HPA030445: AB_10669599"	"unprognostic (7.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.91e-3)"	"unprognostic (7.13e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (9.97e-7)"	"unprognostic (3.69e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	32.0	28.1	50.8	34.7	44.4	56.1	52.6	38.7	43.4	41.9	40.6	32.4	27.5	23.9	35.3	35.6	57.9	29.5	29.9	58.5	47.3	43.2	33.6	34.0	34.9	44.9	52.0	36.9	36.5	32.0	41.6	22.5	44.5	38.1	38.5	37.8	23.2	30.3	36.4	52.2	33.3	25.8	44.1	55.6	36.3	29.9	24.3	43.3	33.8	41.4	38.0	47.3	52.2	46.3	6.7	7.6	6.8	9.1	7.0	7.2	4.1	33.9	21.4	33.7	16.8	20.6	30.1	29.5	25.7	40.0	28.9	38.8	16.1	37.6	30.1	21.8	24.8	24.6	11.0	39.8	31.8	37.9	36.3	44.5	41.5	16.1	19.6	29.7	40.9	22.1	28.4	30.0	36.8	49.5	34.0	45.9	21.1	29.0	33.5	23.1	17.5	28.7	44.5	49.5	18.7	54.9	32.0	14.8	86.5	45.0	24.3	9.8	35.1	23.0	21.4	37.0	35.2	24.0	54.1	29.8	21.2	26.3	15.7	19.1	28.0	16.5	59.5	22.9	39.3	16.4	2.4	8.4	6.8	4.5	9.1	6.5	6.5	5.4	3.8	7.3	6.7	7.2	4.3	3.3	7.0	5.8	7.6	3.9	4.1	50.8	44.4	38.7	43.4	47.3	43.2	52.0	36.9	38.1	43.3	41.7	28.2	30.6	52.3	64.2	26.4	54.9	28.1	46.8	28.4	17.4	3.9	83.0	48.0	80.0	20.6	53.7	35.4	0.0	68.5	82.1	57.3	58.6	40.3	19.1	88.2	19.1	44.5	42.4	63.6	39.3	37.7	75.5	92.8	111.0	36.1	49.9	62.2	59.6	45.6	32.6	20.9	51.8	80.2	36.3	62.2	78.9	60.3	35.4	44.6	59.6
UBE2E2	"FLJ25157, UbcH8"	ENSG00000182247	"Ubiquitin conjugating enzyme E2 E2"	Q96LR5	3	23203020-23591793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.2;intermediate monocyte: 17.8;memory B-cell: 12.3;myeloid DC: 20.9;naive B-cell: 14.8;non-classical monocyte: 18.3;plasmacytoid DC: 27.1"	"Group enriched"	"Detected in many"	6	"B-cells: 14.8;dendritic cells: 27.1;monocytes: 18.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003303, HPA028872, HPA030445, CAB073417"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.68e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.19e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.11e-3)"	22.7	11.4	19.2	12.0	23.3	7.6	15.9	18.8	32.7	22.4	14.5	20.8	7.5	5.9	17.7	31.9	19.7	12.0	18.5	23.4	21.3	21.8	19.1	15.8	16.7	17.7	14.1	19.7	19.0	9.8	15.5	14.4	9.0	20.9	18.2	6.4	8.4	11.2	17.0	32.0	14.8	7.2	22.4	17.6	15.9	11.1	17.8	13.3	14.8	16.8	11.1	14.5	17.0	16.2	14.8	27.1	0.4	18.3	0.8	3.6	5.2	17.1	6.2	16.3	0.3	14.5	16.2	14.8	10.8	18.5	10.2	14.4	1.7	14.1	14.9	7.5	9.5	14.1	1.7	11.8	16.9	13.2	0.1	11.9	0.0	7.3	2.0	10.4	0.0	12.0	12.8	17.8	14.7	24.8	10.5	9.8	11.8	0.8	15.9	9.2	2.7	7.8	3.3	11.6	9.8	9.0	16.4	6.3	17.1	10.0	0.4	4.2	8.7	11.9	7.0	0.2	12.3	15.0	9.9	8.5	10.1	14.3	6.7	12.2	15.3	5.0	22.0	9.5	6.7	2.8	0.0	15.2	0.0	0.2	17.8	0.3	12.3	0.5	0.2	20.9	14.8	3.6	1.3	0.4	0.8	18.3	27.1	0.2	5.2	19.2	23.3	18.8	32.7	21.3	21.8	14.1	19.7	20.9	13.3	20.8	9.8	36.3	10.5	22.8	22.7	32.7	20.4	5.3	4.5	29.6	15.7	28.0	58.0	12.3	17.6	20.4	0.0	0.0	25.6	33.5	29.3	47.2	0.0	38.4	44.7	30.2	1.7	14.7	43.5	12.0	36.5	55.4	74.2	35.1	0.7	10.9	13.5	0.3	49.8	98.2	2.9	32.3	50.9	33.5	99.2	36.9	32.3	2.5	0.5	5.1
UBE2F	NCE2	ENSG00000184182	"Ubiquitin conjugating enzyme E2 F (putative)"	Q969M7	2	237966827-238042782	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Extravillous trophoblasts: 231.1;monocytes: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037444	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA037444: AB_10672491"	"unprognostic (1.73e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.04e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.51e-1)"	14.5	18.4	21.3	13.6	17.6	19.9	17.2	12.2	19.8	16.7	15.8	17.7	12.3	13.6	14.7	32.2	25.0	11.0	16.3	34.6	20.2	21.6	14.6	24.1	12.9	26.4	23.4	10.1	10.4	62.8	16.3	13.2	22.2	24.2	14.9	19.6	11.4	15.3	18.2	32.1	10.3	17.9	20.2	20.2	14.6	15.1	13.9	16.8	15.8	32.9	17.4	17.7	18.7	16.4	10.9	23.1	35.6	30.0	39.9	29.1	24.6	13.5	7.7	17.8	18.2	23.2	28.3	25.2	12.7	18.3	14.4	14.8	8.4	8.7	7.0	4.6	28.5	31.4	11.5	20.1	27.7	22.6	10.6	7.8	9.6	9.8	27.4	29.2	4.0	22.7	16.2	45.8	19.0	29.0	13.4	25.5	33.0	29.3	4.5	26.0	20.3	10.9	17.7	19.6	19.5	11.8	13.3	11.8	12.4	21.7	5.7	11.9	17.8	14.9	11.3	23.6	31.2	10.2	16.8	15.8	15.9	14.0	18.0	13.6	5.6	4.3	13.7	18.8	12.2	11.7	35.6	21.0	25.2	29.1	27.6	11.5	10.9	19.9	17.6	18.6	10.1	18.6	18.8	15.6	39.9	30.0	23.1	20.5	24.6	21.3	17.6	12.2	19.8	20.2	21.6	23.4	10.1	24.2	16.8	6.0	20.2	41.4	18.8	28.8	21.7	44.5	28.1	24.1	5.7	26.2	7.9	72.4	48.0	42.5	17.3	25.5	37.0	70.0	68.9	231.1	37.6	41.8	20.8	40.0	129.2	25.4	40.1	23.9	54.8	47.2	23.9	61.5	33.7	312.0	46.7	15.8	69.1	29.2	29.0	52.2	19.3	38.8	35.6	90.0	52.7	35.3	54.9	47.3	30.7	31.1
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.6"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 254.1;Suprabasal keratinocytes: 209.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045681: AB_2679417, HPA050551: AB_2681171"	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	10.8	11.1	12.6	17.8	13.5	14.3	11.2	11.6	15.3	13.0	19.4	17.8	8.9	11.9	13.3	8.5	27.4	9.2	9.7	26.9	13.5	11.2	14.6	17.7	8.9	18.7	15.2	9.7	9.1	17.1	12.0	6.0	11.4	14.5	14.0	13.3	8.8	11.9	12.0	95.6	14.1	16.6	14.6	19.4	15.0	11.9	11.8	13.6	21.3	12.5	20.7	23.3	17.7	16.5	23.7	13.1	24.4	11.5	20.5	20.6	13.1	21.2	23.1	21.6	15.8	17.7	18.7	30.8	20.8	16.7	19.8	17.5	15.9	10.9	33.4	21.8	20.4	16.2	23.1	26.8	19.3	32.0	17.5	21.8	12.5	12.3	18.1	17.4	18.1	23.7	15.9	28.9	18.8	27.4	14.0	26.5	22.5	21.8	36.2	16.3	9.5	23.0	16.6	23.8	15.8	12.0	29.9	11.4	30.5	23.1	14.0	9.3	17.4	19.6	17.1	16.1	33.3	16.7	11.9	19.8	19.9	15.2	23.3	23.2	14.1	16.5	47.2	15.3	17.0	15.3	8.1	10.3	24.4	15.4	10.8	20.6	23.7	20.1	20.1	13.1	15.5	20.2	20.5	18.6	20.5	11.5	9.6	18.3	13.1	12.6	13.5	11.6	15.3	13.5	11.2	15.2	9.7	14.5	13.6	20.8	11.8	63.6	34.1	254.1	16.5	62.6	30.6	13.4	13.6	24.4	5.9	36.7	69.6	27.6	105.5	28.7	35.4	0.0	23.2	45.9	34.4	47.3	20.7	52.9	41.3	14.3	36.9	32.5	36.1	173.0	18.1	34.1	64.1	33.3	32.7	23.0	32.9	27.5	19.8	61.3	13.9	6.5	47.9	63.9	47.7	209.5	55.8	43.3	26.8	53.3
UBE2H	"GID3, UBC8, UBCH"	ENSG00000186591	"Ubiquitin conjugating enzyme E2 H"	P62256	7	129830732-129952949	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003302	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003302: AB_1858526"	"unprognostic (1.15e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (1.13e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.23e-1)"	29.0	49.9	31.1	16.6	31.0	22.5	24.5	36.1	30.2	31.1	27.3	33.2	26.6	15.2	35.5	25.3	32.1	29.4	26.6	61.0	26.4	25.4	27.6	28.1	26.3	17.5	28.1	23.4	27.6	52.3	41.8	29.5	37.9	33.3	24.1	16.8	22.9	28.5	28.8	46.3	21.3	16.5	31.5	26.2	19.1	22.7	24.7	29.5	24.7	37.7	23.6	29.5	25.5	34.3	6.1	3.7	7.8	2.2	1.3	6.5	1.9	22.1	12.0	14.3	14.5	35.4	30.5	24.7	20.5	26.5	12.6	14.1	6.4	23.8	9.2	25.7	20.2	32.6	16.9	12.2	21.8	16.5	11.3	6.5	3.2	17.7	7.7	27.9	6.3	10.1	41.0	29.0	17.0	27.3	28.0	24.5	9.8	7.5	26.7	19.4	7.9	8.4	6.9	22.4	15.1	14.3	6.6	7.3	19.6	26.3	29.1	5.4	16.5	18.8	42.1	11.0	44.9	4.4	6.2	24.8	13.7	6.9	19.3	20.4	24.4	17.5	15.2	27.3	7.6	13.3	3.5	2.2	5.1	4.7	1.7	6.4	3.8	4.7	4.2	2.0	6.1	6.0	6.4	7.8	1.3	2.1	3.7	6.5	1.9	31.1	31.0	36.1	30.2	26.4	25.4	28.1	23.4	33.3	29.5	38.7	38.0	39.2	140.7	129.5	52.7	101.3	53.5	54.9	53.4	68.0	56.9	93.6	34.9	51.9	67.1	55.4	27.8	116.8	62.1	57.4	57.8	206.4	14.9	63.8	35.3	41.3	56.6	44.8	35.5	35.6	40.9	28.3	45.5	12.6	27.9	82.0	95.7	31.7	73.9	39.7	32.0	12.9	55.1	22.7	17.7	134.4	167.6	24.9	23.0	232.4
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698044-39782792	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		150000	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	27.2	21.8	27.0	21.2	27.6	17.3	21.6	38.6	40.7	17.0	33.2	11.8	14.1	29.1	19.9	18.5	29.9	14.9	18.5	28.1	27.7	26.8	26.6	44.5	17.1	17.9	24.1	26.4	16.9	15.8	18.9	26.9	29.8	25.2	19.7	24.0	13.4	18.4	17.3	31.8	22.0	24.6	18.8	19.2	16.9	29.3	16.0	15.9	21.3	23.6	19.7	18.8	22.8	20.4	17.6	23.7	20.6	19.9	10.9	14.1	8.9	24.2	24.9	13.4	12.7	8.4	7.9	22.8	33.4	7.1	9.0	9.4	37.6	25.0	30.3	29.4	9.4	22.1	10.2	25.8	14.6	14.4	20.3	18.5	39.2	25.2	32.5	10.6	42.1	22.2	7.4	16.5	12.6	13.6	9.4	11.7	13.3	39.8	10.9	9.2	23.5	29.3	23.4	17.8	14.0	19.0	17.3	40.3	11.3	12.5	33.8	27.9	12.3	25.0	9.5	14.9	15.5	12.2	14.1	32.0	14.0	29.7	16.6	30.7	15.4	45.0	33.3	7.3	27.0	16.4	13.9	16.6	20.6	13.5	14.3	12.7	17.6	14.1	12.6	16.6	12.5	10.7	12.0	13.3	10.9	19.9	23.7	13.7	8.9	27.0	27.6	38.6	37.7	27.7	26.8	24.1	26.4	25.2	15.9	53.6	50.8	35.6	49.5	109.2	60.1	57.3	45.9	71.0	67.1	47.1	27.5	74.8	56.3	76.3	97.5	58.3	92.6	70.0	77.7	144.5	61.6	76.6	33.5	101.0	71.4	98.5	57.3	61.4	71.5	150.7	60.4	73.4	54.0	103.6	63.5	70.2	109.4	73.0	53.0	81.7	38.2	38.8	67.9	71.4	46.9	120.6	123.3	48.4	65.5	98.3
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 110.3"									"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8800000	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	27.8	34.9	34.8	23.5	29.6	31.3	24.9	25.5	36.9	25.9	27.7	38.4	22.8	26.4	25.6	29.2	38.0	26.9	23.0	33.0	30.7	30.8	27.4	36.0	23.5	32.5	34.3	33.1	24.3	23.9	24.3	21.7	30.1	36.9	27.5	31.7	29.3	30.6	26.7	43.5	23.9	34.4	33.1	36.2	28.5	25.1	35.7	22.6	25.3	25.0	32.4	33.9	28.4	22.2	34.7	49.9	46.1	45.8	34.6	46.9	54.9	24.9	14.4	21.1	16.5	23.1	20.7	12.2	21.1	24.1	27.1	25.8	16.4	12.1	23.6	10.6	27.9	20.5	21.4	28.1	22.9	27.1	23.5	30.4	27.3	14.1	19.5	15.4	39.0	19.7	18.2	20.0	19.7	14.3	19.6	30.4	14.7	110.3	12.7	29.3	18.4	20.2	28.2	15.5	28.0	15.2	16.6	31.8	6.4	25.4	20.1	19.0	14.1	16.8	21.2	19.4	20.3	13.2	21.6	21.8	19.3	24.8	16.2	21.4	12.4	20.0	21.6	26.1	18.1	18.2	30.8	40.4	46.1	41.4	45.8	38.8	34.7	39.6	44.2	49.9	31.2	34.5	41.6	34.2	34.6	37.6	48.4	46.9	54.9	34.8	29.6	25.5	36.9	30.7	30.8	34.3	33.1	36.9	22.6	101.3	71.0	116.9	138.6	111.5	51.2	50.6	107.0	125.8	95.5	68.0	15.7	283.0	167.5	270.4	53.8	105.0	174.1	140.2	335.7	335.1	102.8	131.4	126.9	137.0	262.0	65.2	120.8	104.3	125.9	41.0	80.8	163.0	119.8	326.4	95.3	76.6	339.4	136.8	97.6	204.5	41.2	103.5	83.5	134.5	117.6	113.3	311.1	142.4	115.8	190.0
UBE2L6	UBCH8	ENSG00000156587	"Ubiquitin conjugating enzyme E2 L6"	O14933	11	57551656-57568284	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003328, CAB073407"	Enhanced		Approved	Cytosol		NA	NA		34000	Cytosol		"CAB073407: , HPA003328: AB_1858539"	"prognostic favorable (6.75e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.42e-2)"	31.1	31.0	32.0	34.1	28.6	30.4	40.4	18.2	25.6	23.3	19.1	17.0	17.1	19.0	21.9	30.0	19.9	28.6	27.4	18.4	23.5	27.4	28.3	55.1	50.5	45.0	28.9	20.4	27.1	21.8	17.9	18.5	21.7	25.8	26.0	18.8	18.7	42.8	22.2	10.1	15.9	23.5	28.3	23.6	47.9	21.4	7.7	23.6	44.0	33.6	15.1	34.4	33.0	49.0	49.2	53.6	113.6	83.4	61.2	66.4	112.6	8.7	4.4	15.0	4.7	31.7	39.5	1.6	5.1	30.5	45.2	58.9	1.6	22.8	28.1	18.1	15.5	39.1	7.0	6.4	16.8	9.6	25.5	0.2	27.6	0.0	6.3	58.7	6.3	9.2	42.2	3.9	21.2	5.8	16.8	14.2	29.7	1.2	19.5	8.1	11.1	42.6	15.3	3.9	0.0	5.6	37.7	9.1	19.2	12.1	9.8	0.3	7.8	10.2	0.8	22.4	2.7	11.2	3.2	5.2	9.4	3.3	7.1	1.6	26.6	26.8	0.5	26.4	16.0	2.0	56.7	71.6	62.5	51.2	83.4	56.4	49.2	53.4	53.4	53.6	39.7	46.5	48.8	113.6	61.2	68.3	34.0	66.4	112.6	32.0	28.6	18.2	25.6	23.5	27.4	28.9	20.4	25.8	23.6	26.8	17.4	54.4	23.2	20.7	10.2	5.2	28.1	24.1	27.3	12.2	3.9	3.0	54.7	68.9	3.6	46.7	22.7	23.3	57.3	31.0	37.7	34.1	53.1	27.3	148.0	12.7	23.0	41.1	54.9	9.6	44.5	69.1	8.5	44.1	29.8	31.5	45.0	31.7	31.5	19.8	3.9	25.8	41.2	1.9	6.0	24.2	2.9	74.7	21.7	24.6
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558960	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 134.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	18.1	26.0	51.8	16.3	38.9	32.1	13.6	28.4	52.4	15.2	20.4	17.0	20.5	17.8	17.3	19.6	24.9	19.3	17.4	43.2	35.1	33.9	19.6	19.1	16.5	18.1	32.1	30.5	19.4	20.2	25.9	22.8	32.0	26.4	18.4	16.7	15.0	20.9	22.6	61.9	19.2	15.9	19.2	19.8	18.5	17.9	31.8	16.1	32.7	22.2	21.2	19.9	18.2	23.5	3.8	7.6	10.9	4.3	1.8	3.8	2.1	21.5	39.3	19.9	18.9	10.6	12.7	14.5	22.5	19.8	16.3	14.1	23.7	16.8	22.7	17.0	15.9	32.7	14.1	22.1	22.2	12.3	25.8	134.3	33.0	25.3	15.4	26.0	29.8	26.2	13.6	17.4	24.8	29.5	17.9	19.6	21.5	16.0	28.7	21.6	22.1	23.8	27.1	12.6	25.2	34.4	22.2	16.6	29.2	18.8	27.2	35.1	28.7	19.5	23.9	21.0	7.6	14.3	27.4	14.6	51.1	10.4	16.0	39.8	34.8	52.5	24.3	32.5	26.5	33.3	6.8	4.3	4.1	3.5	2.8	2.7	3.4	3.8	3.7	3.1	3.8	3.7	2.5	10.9	1.8	2.7	7.6	3.1	2.1	51.8	38.9	28.4	52.4	35.1	33.9	32.1	30.5	26.4	16.1	6.0	15.4	10.4	28.7	35.8	101.5	34.7	17.8	12.0	6.8	17.4	19.6	18.8	6.6	15.3	18.8	19.0	45.1	23.3	26.0	17.2	20.9	42.6	19.6	28.7	30.5	103.3	39.5	20.3	27.6	27.8	16.1	18.1	33.7	11.8	28.6	85.9	31.9	25.4	13.1	25.9	58.3	25.8	25.5	26.4	7.9	49.7	43.8	15.2	31.9	47.5
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome		No	No			Nucleoplasm	Centrosome	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	17.3	18.7	26.5	16.2	29.4	24.2	19.4	26.4	29.0	20.0	21.2	18.7	8.2	16.2	18.3	25.4	20.9	21.8	18.2	17.6	24.5	25.8	25.7	27.4	23.0	26.3	22.8	21.0	21.7	27.2	21.4	29.3	24.5	27.2	21.4	25.7	18.5	19.0	19.8	19.1	21.6	21.4	21.9	19.1	26.0	20.5	30.0	22.0	25.1	21.0	14.0	29.9	19.3	18.5	3.2	5.1	8.1	3.1	4.7	6.2	1.6	17.2	14.9	21.1	16.1	21.7	22.4	18.3	17.1	26.0	22.0	17.8	16.7	18.4	21.2	24.6	23.8	18.4	15.0	24.8	19.8	19.0	21.3	15.7	16.8	13.3	16.1	27.4	27.3	27.1	21.5	26.3	17.8	20.7	24.0	28.2	19.7	14.1	26.3	28.1	26.7	16.6	20.1	28.8	41.3	25.4	19.2	14.7	22.3	24.2	18.3	21.5	30.1	17.3	32.6	27.9	37.7	19.9	41.7	19.6	14.3	15.9	16.9	18.2	32.2	23.8	28.1	16.0	19.4	21.5	8.1	2.8	5.6	4.8	3.1	4.3	3.0	4.5	5.9	2.5	3.2	5.0	5.7	4.4	4.7	2.6	5.1	6.2	1.6	26.5	29.4	26.4	29.0	24.5	25.8	22.8	21.0	27.2	22.0	29.8	21.6	22.7	16.5	14.3	38.7	26.9	25.5	34.8	20.5	15.7	3.9	15.3	10.0	13.0	2.7	27.8	23.7	0.0	18.0	14.1	15.8	22.6	10.4	34.2	23.2	57.2	32.3	32.5	41.4	4.3	16.4	19.3	13.5	15.4	30.4	45.6	21.9	11.5	18.0	15.1	19.3	12.9	13.2	30.7	24.4	16.7	16.4	20.8	20.4	22.9
UBE2R2	"CDC34B, FLJ20419, MGC10481, UBC3B"	ENSG00000107341	"Ubiquitin conjugating enzyme E2 R2"	Q712K3	9	33817567-33920404	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 295.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061000, HPA074334"			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA061000: AB_2684408, HPA074334: "	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.82e-3)"	"unprognostic (4.61e-3)"	"unprognostic (3.05e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.43e-1)"	26.1	19.7	29.4	19.7	26.8	13.9	39.3	23.7	32.3	25.6	24.1	27.9	16.3	28.0	26.1	18.4	25.3	22.3	21.8	29.2	25.5	20.3	22.1	34.5	23.0	27.1	30.5	23.2	29.8	44.5	15.7	13.9	24.6	21.6	21.0	21.4	19.3	18.7	20.8	56.1	28.1	25.7	28.5	24.2	21.6	20.8	34.5	29.6	36.7	19.5	22.5	25.7	35.8	30.5	3.3	4.2	21.9	11.6	5.0	2.1	2.4	16.5	18.1	35.0	15.2	19.3	31.5	10.8	14.7	20.5	17.3	17.3	14.5	12.4	14.1	6.0	20.5	12.6	7.4	18.3	16.8	19.0	23.2	9.7	12.2	20.0	18.4	27.5	14.4	13.3	26.7	25.0	14.1	26.8	27.7	29.0	17.0	11.4	15.2	17.1	9.6	27.1	38.0	19.9	14.2	15.1	25.3	10.6	7.3	18.3	12.5	16.4	19.7	17.2	15.4	11.0	23.2	13.5	17.6	21.7	16.7	15.2	11.5	13.6	9.7	9.1	19.8	15.9	8.4	35.9	12.4	7.5	4.1	2.0	7.5	1.3	3.1	1.9	1.6	4.2	3.3	1.9	1.7	21.9	5.0	11.6	2.6	2.1	2.4	29.4	26.8	23.7	32.3	25.5	20.3	30.5	23.2	21.6	29.6	20.8	30.7	29.5	39.6	93.8	61.0	106.8	56.0	22.7	25.0	21.0	13.7	52.6	13.3	43.8	295.7	77.1	60.6	23.3	59.7	65.2	54.0	68.4	12.7	72.1	68.5	57.2	69.2	77.3	105.2	195.4	62.2	81.9	33.7	49.5	57.3	87.1	69.4	38.6	71.5	49.6	30.1	58.2	41.9	90.2	66.2	105.3	69.2	30.5	49.0	79.7
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407777	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 226.9;Spermatocytes: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	Yes			"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	10.2	9.2	18.0	19.5	15.9	68.0	4.7	11.4	21.6	6.1	12.0	9.1	4.5	8.4	7.1	7.2	17.1	6.0	9.7	18.0	18.7	18.1	5.9	5.6	6.3	22.9	13.7	14.4	6.4	6.0	3.7	12.9	9.8	12.9	7.0	7.1	6.2	4.9	5.3	7.3	6.2	7.3	10.7	15.3	11.0	10.6	69.4	8.2	60.2	5.9	14.3	21.1	10.0	7.1	4.5	3.1	6.0	1.9	0.6	2.6	0.3	60.3	32.7	28.8	22.9	1.8	2.6	5.1	49.2	14.9	30.4	27.7	22.1	21.6	58.8	20.4	12.3	36.6	17.8	28.8	12.8	13.5	46.0	95.7	35.1	18.8	7.1	5.5	42.0	34.2	2.9	3.6	22.3	21.6	6.6	11.9	32.1	34.9	41.2	19.0	16.0	56.8	21.8	72.2	16.9	55.5	50.1	22.2	21.1	8.1	12.9	73.1	39.6	62.7	15.6	27.9	9.1	11.1	22.8	18.2	18.3	52.1	15.6	116.9	33.2	79.7	69.0	19.2	29.7	66.3	1.1	1.9	2.9	1.8	1.5	1.2	4.5	2.6	2.6	1.5	1.6	2.5	1.5	6.0	0.6	0.9	3.1	1.0	0.3	18.0	15.9	11.4	21.6	18.7	18.1	13.7	14.4	12.9	8.2	0.0	4.3	37.3	136.4	144.5	56.5	2.4	7.6	0.0	0.0	19.2	51.1	34.3	13.3	44.4	86.7	31.2	25.8	70.0	26.4	226.9	94.9	63.2	18.4	9.6	55.5	30.2	88.9	22.7	24.7	27.7	16.1	39.9	70.9	55.1	28.4	76.7	57.6	28.1	11.7	14.8	59.0	12.9	96.6	216.2	140.8	101.4	50.0	44.7	30.4	121.0
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.4	29.1	43.3	20.4	4.0	7.4	24.8	33.3	18.6	38.1	26.9	20.7	37.4	35.5	13.2	12.1	28.4	24.9	40.0	19.5	34.4	32.2	22.9	21.7	15.8	23.6	1.8	25.9	26.4	2.6	4.7	29.9	12.5	9.1	22.1	40.1	27.3	29.3	29.8	28.3	46.4	33.1	16.8	31.7	14.8	36.0	46.1	30.8	14.6	14.6	34.1	34.8	23.3	28.7	11.1	13.5	30.2	16.4	10.8	17.2	27.5	30.0	39.5	14.9	29.1	45.2	17.0	27.0	35.6	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8	0.0	2.1	10.4	11.0	12.7	5.2	12.2	0.0	6.7	7.9	5.2	0.0	33.9	5.0	11.2	13.0	1.9	2.7	186.9	6.6	82.9	4.8	2.2	8.1	1.7	23.5	9.5	1.2	4.3	1.8	6.6	2.8	5.2	3.3	3.6	9.0	1.3	7.8	0.0	3.9	7.9	0.9	6.5	1.9	115.5	96.9	9.5	18.8	9.5	19.6	4.1
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA045161: AB_10960706, HPA073181: AB_2686578"	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	15.2	14.2	13.5	13.3	21.8	17.5	13.4	18.9	24.4	12.0	9.8	11.3	11.0	7.9	13.4	10.5	16.6	9.4	15.2	14.8	19.0	12.3	21.9	23.4	13.6	11.6	11.6	13.0	11.8	12.7	18.4	20.9	13.6	18.4	12.0	11.5	9.5	12.2	10.6	16.4	10.6	8.5	12.8	12.6	13.6	10.0	16.4	12.3	14.7	17.1	4.8	12.9	16.8	12.8	5.0	8.1	23.0	9.4	4.7	4.3	4.8	8.6	5.7	7.0	7.5	12.2	12.5	6.1	9.5	10.5	9.2	9.6	4.7	9.7	4.0	7.9	9.9	14.0	8.8	10.2	9.7	15.3	6.5	6.2	8.1	5.9	7.2	8.2	4.5	11.6	9.8	10.9	10.7	19.2	8.3	11.1	4.5	4.0	8.6	13.9	6.9	9.7	4.8	5.3	12.3	11.2	2.9	7.1	3.4	17.0	9.5	5.2	5.7	7.6	24.7	11.4	7.9	11.5	8.0	9.9	11.1	8.4	8.4	6.9	7.3	7.5	3.0	9.7	7.1	9.5	12.9	9.4	11.5	3.5	8.8	4.3	5.0	3.6	2.6	6.3	4.3	3.2	3.8	23.0	4.7	9.4	8.1	4.0	4.8	13.5	21.8	18.9	24.4	19.0	12.3	11.6	13.0	18.4	12.3	14.9	12.3	22.7	24.3	49.1	33.4	20.4	20.4	9.4	11.4	50.6	15.7	15.8	43.1	21.3	107.9	29.2	13.4	116.8	15.1	16.5	23.4	29.3	20.7	25.1	35.4	39.7	22.3	20.3	43.6	45.7	19.0	46.1	40.5	76.7	12.2	23.6	17.3	14.0	17.7	41.3	27.1	19.4	60.9	31.4	29.8	56.3	46.1	34.9	12.5	36.9
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	19.3	19.4	20.3	23.1	25.0	17.8	20.2	30.0	25.1	21.7	19.9	14.3	19.8	14.1	21.0	22.1	19.8	18.5	17.2	24.0	22.2	20.8	20.2	24.6	19.7	23.1	19.1	19.5	23.0	17.2	26.1	24.6	20.1	20.9	20.6	17.9	13.3	19.3	21.5	70.2	18.4	18.8	21.2	19.9	18.8	16.9	26.4	16.4	36.4	25.0	26.6	19.5	19.9	26.6	15.6	11.9	11.6	14.8	21.1	16.0	5.7	19.6	11.1	28.1	16.7	16.4	19.5	13.8	30.3	19.0	21.5	19.6	25.7	9.8	35.4	23.0	22.6	21.2	18.2	35.5	21.4	26.3	18.2	11.9	29.3	18.8	15.2	24.7	35.3	21.7	23.1	20.1	20.3	26.0	22.4	16.9	31.1	29.5	25.3	33.7	10.7	29.3	10.3	18.2	21.5	16.2	30.0	42.0	15.6	19.5	31.0	28.9	21.8	24.6	26.7	34.9	19.0	21.8	20.0	21.6	37.7	31.2	18.1	22.1	28.9	34.1	47.7	21.6	19.3	19.6	8.6	8.7	11.6	13.3	7.6	15.2	12.0	14.0	15.9	11.9	15.6	16.0	14.2	2.0	21.1	14.8	11.1	10.1	5.7	20.3	25.0	30.0	25.1	22.2	20.8	19.1	19.5	20.9	16.4	89.3	73.3	52.7	60.3	63.2	78.1	154.5	43.3	71.0	67.1	36.6	53.0	43.4	16.6	42.2	101.1	45.8	39.4	0.0	43.1	41.8	44.5	85.9	62.2	52.0	41.5	76.3	65.9	47.3	56.6	43.8	52.6	44.6	50.6	37.9	48.7	54.8	47.5	42.1	60.8	44.0	56.4	77.6	54.5	143.0	88.7	79.3	61.9	44.9	47.9	87.8
UBE3B		ENSG00000151148	"Ubiquitin protein ligase E3B"	Q7Z3V4	12	109477402-109536705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041012	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles"	Mitochondria	"HPA041012: AB_10964435"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	14.5	19.3	17.2	12.9	21.2	9.2	15.3	19.7	27.8	14.4	17.3	23.3	14.0	14.6	17.4	16.2	20.1	19.3	13.9	28.6	14.6	11.6	19.8	16.4	15.5	13.1	18.6	13.9	18.4	20.3	25.5	15.1	16.8	15.8	17.5	21.2	20.7	15.7	17.4	34.0	21.6	16.3	18.6	15.2	17.0	17.3	24.5	18.3	18.2	21.1	17.6	15.9	19.5	19.6	15.9	14.5	22.4	16.7	14.3	18.2	11.4	10.4	16.5	13.0	9.4	22.2	17.9	11.4	13.8	15.8	16.8	11.3	17.3	10.7	6.5	10.3	22.6	14.3	13.5	13.1	17.7	16.2	14.3	9.3	12.4	10.8	15.6	14.2	10.1	10.4	20.3	16.5	16.2	19.5	25.4	18.1	15.5	13.6	6.2	19.1	16.3	6.9	14.8	13.3	11.7	19.9	11.5	12.2	12.7	14.4	18.8	12.1	22.4	16.1	21.9	10.7	15.9	22.4	10.8	16.5	20.8	6.0	10.6	9.8	13.9	11.5	11.5	20.7	8.5	17.2	22.4	15.3	14.3	15.9	16.7	15.7	15.9	15.3	11.2	14.5	12.9	12.9	17.1	19.5	14.3	13.6	13.5	18.2	11.4	17.2	21.2	19.7	27.8	14.6	11.6	18.6	13.9	15.8	18.3	11.9	10.8	6.7	10.0	4.5	20.4	32.1	10.2	14.7	14.8	15.7	31.4	15.7	10.0	16.0	11.8	13.5	15.1	23.3	13.2	9.3	8.4	15.1	9.2	16.0	11.1	20.6	8.6	12.9	17.1	24.6	11.5	11.0	10.1	14.4	15.8	16.7	18.8	10.5	9.2	17.7	25.0	6.5	8.5	9.6	12.7	6.4	19.8	10.9	13.8	12.2
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138913-157269372	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favorable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	24.7	21.0	14.0	17.9	23.1	12.4	19.8	25.5	29.9	21.3	23.4	17.2	15.3	17.4	28.8	16.8	26.8	18.8	24.8	31.8	14.4	13.8	21.2	30.5	16.7	16.7	14.5	15.1	20.7	22.1	29.6	20.3	21.3	22.3	19.0	21.0	20.2	31.7	21.5	51.2	21.2	23.9	25.7	16.1	20.5	21.8	35.9	11.1	20.3	15.6	24.5	24.4	23.1	19.1	2.5	4.0	2.1	4.6	3.7	6.6	2.9	22.8	18.2	11.7	23.3	21.0	22.1	12.9	25.3	21.9	21.4	21.7	16.3	19.1	12.4	22.5	27.9	27.9	14.5	18.1	23.3	25.4	22.5	16.6	12.6	12.7	11.7	20.9	18.8	18.5	19.5	21.6	23.7	19.7	16.3	24.9	10.4	18.3	13.8	30.2	20.0	18.4	11.9	18.5	20.5	21.9	10.6	13.1	25.4	22.1	25.2	18.7	19.3	24.9	21.5	18.5	13.6	11.1	13.2	22.3	27.0	5.8	66.1	31.3	13.9	13.9	12.5	31.0	28.1	30.8	0.5	3.5	2.1	4.8	4.6	6.6	2.5	5.2	5.2	4.0	2.5	4.9	5.9	1.3	3.7	4.5	3.6	5.2	2.9	14.0	23.1	25.5	29.9	14.4	13.8	14.5	15.1	22.3	11.1	20.8	19.5	9.7	13.9	24.5	31.4	31.5	28.1	16.0	9.1	24.4	62.8	12.2	8.3	17.0	8.4	19.9	22.1	0.0	15.2	14.4	14.7	19.9	9.2	39.2	13.9	30.2	23.5	24.5	21.2	8.5	14.4	15.0	5.0	12.6	20.6	10.9	22.5	10.5	24.1	16.5	42.8	0.0	17.6	20.4	27.4	29.1	12.6	13.8	22.4	27.3
UBE3D	"C6orf157, DKFZp434A1520, H10BH, UBE2CBP, YJR141W"	ENSG00000118420	"Ubiquitin protein ligase E3D"	Q7Z6J8	6	82892398-83065841	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 40.2;Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027231	Uncertain		Approved	"Rods & Rings"		NA	NA			"Rods & Rings"		"HPA027231: AB_2256689"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.91e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.39e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.18e-1)"	4.6	9.0	6.3	6.2	9.5	3.0	8.7	13.1	10.6	6.7	5.5	6.0	4.9	7.5	6.9	5.0	6.7	14.0	5.1	5.4	6.1	9.1	7.9	4.9	4.1	7.6	7.4	7.2	8.0	10.1	8.9	11.0	4.2	5.9	4.1	6.8	6.4	6.5	5.6	8.8	4.1	4.2	8.7	5.8	8.2	6.3	3.7	7.7	4.5	10.0	5.2	7.8	8.6	6.0	6.6	3.1	0.3	2.7	1.3	8.2	3.2	2.7	3.8	3.8	3.5	3.1	5.0	3.0	3.0	3.7	3.8	6.5	5.5	1.5	12.6	4.6	1.8	6.6	2.9	7.3	3.6	6.0	5.3	16.6	7.3	2.1	6.0	4.2	6.2	3.6	3.9	5.1	4.1	5.0	2.8	4.9	6.9	10.4	5.8	3.2	3.1	3.8	7.9	4.7	10.0	6.2	5.8	8.6	5.0	7.2	3.7	6.8	4.2	1.7	4.3	2.6	5.3	2.7	4.5	1.5	1.7	4.5	3.6	7.2	6.4	12.8	4.3	2.8	11.5	3.4	0.0	1.0	0.3	4.7	2.7	6.1	6.6	5.2	3.7	3.1	4.4	5.6	8.2	0.0	1.3	1.2	2.3	5.2	3.2	6.3	9.5	13.1	10.6	6.1	9.1	7.4	7.2	5.9	7.7	6.0	5.4	9.3	4.8	5.6	11.1	2.4	2.5	40.2	4.5	7.0	33.4	5.9	1.7	4.6	1.5	5.2	2.0	0.0	4.0	4.1	6.2	2.7	1.1	2.4	4.4	6.4	7.5	4.3	3.2	0.8	6.4	3.6	6.8	0.0	5.2	5.1	3.7	6.2	3.9	4.2	15.7	6.5	3.6	5.9	15.9	5.9	2.5	4.4	6.6	3.4
UBFD1	"FLJ38870, FLJ42145, UBPH"	ENSG00000103353	"Ubiquitin family domain containing 1"	O14562	16	23557362-23574389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051746			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA051746: AB_2681587"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.45e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.06e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.46e-1)"	10.2	16.2	11.9	8.9	13.0	7.1	10.0	23.1	19.5	11.7	9.2	9.4	15.2	6.1	16.4	14.9	9.6	13.9	11.8	21.2	11.3	17.6	12.3	15.4	7.6	8.7	13.0	11.8	14.5	17.5	28.5	17.2	16.5	13.6	12.5	9.4	12.3	12.3	12.6	52.8	7.6	7.0	14.6	7.4	9.1	8.1	27.6	7.0	16.2	16.4	11.1	11.7	10.9	12.9	2.8	4.1	1.0	1.9	3.0	4.0	1.1	6.5	14.8	21.1	15.2	24.2	30.2	19.8	20.2	16.6	16.1	15.2	11.2	11.2	14.5	31.6	24.7	10.9	9.0	33.2	13.4	20.8	24.0	19.6	7.5	13.4	24.4	12.9	7.9	14.6	21.5	10.1	15.7	14.8	24.9	15.5	11.8	19.1	8.0	17.7	13.6	11.2	14.3	50.3	10.7	6.6	20.5	13.0	11.9	15.1	5.5	21.0	19.2	6.7	13.1	11.8	21.1	17.9	11.7	16.4	9.1	10.5	9.8	10.5	12.0	12.0	8.8	16.6	9.5	13.7	0.0	1.3	1.0	4.0	1.9	2.3	1.6	2.8	3.9	3.0	2.8	1.7	2.3	0.0	3.0	1.0	4.1	2.3	1.1	11.9	13.0	23.1	19.5	11.3	17.6	13.0	11.8	13.6	7.0	6.0	1.6	3.0	8.4	7.8	11.4	31.3	10.2	5.3	3.4	19.2	21.6	16.4	13.3	11.9	38.7	10.5	5.5	0.0	9.9	21.4	13.5	12.6	0.0	16.6	11.5	6.4	6.9	4.3	7.5	54.1	17.3	4.3	10.1	10.8	9.3	10.8	9.0	7.6	9.2	13.6	14.1	25.8	8.2	20.4	22.5	12.4	30.1	5.3	8.6	10.7
UBIAD1	"SCCD, TERE1"	ENSG00000120942	"UbiA prenyltransferase domain containing 1"	Q9Y5Z9	1	11273206-11296049	"Disease related genes, Predicted membrane proteins"	"Menaquinone biosynthesis, Ubiquinone biosynthesis"	"Prenyltransferase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044862			Approved	Vesicles		NA	NA			Vesicles		"HPA044862: AB_2679117"	"unprognostic (1.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-3)"	"unprognostic (7.55e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.80e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.25e-1)"	12.1	11.8	9.2	10.2	11.8	9.2	12.0	10.2	13.1	9.6	9.8	17.6	5.0	7.8	13.0	9.7	8.8	14.4	11.9	11.6	9.0	8.3	9.9	38.1	8.7	18.6	14.1	6.1	17.5	23.4	14.6	10.0	9.1	11.0	10.6	10.0	11.9	11.2	10.2	24.8	11.3	9.5	11.5	15.5	12.9	10.7	17.7	13.6	17.9	12.2	9.6	17.5	11.7	8.7	22.0	10.7	9.5	8.7	9.6	27.0	11.4	8.5	8.5	6.8	13.0	5.0	4.7	9.1	9.4	7.7	10.2	9.3	9.8	7.9	16.9	9.7	6.7	9.6	11.8	17.1	11.3	12.5	11.8	14.7	11.3	9.1	13.0	9.2	17.2	9.9	7.1	15.4	13.7	16.4	5.4	7.4	15.7	13.4	14.1	6.8	8.7	11.1	8.7	8.1	16.1	12.6	10.6	15.1	20.5	7.8	5.7	8.4	9.0	10.0	10.0	12.7	2.9	7.4	9.1	6.1	9.0	9.7	9.3	12.2	11.5	15.9	31.5	5.7	22.9	11.1	4.8	6.5	9.5	13.1	8.7	14.6	22.0	17.8	13.3	8.6	20.7	27.0	18.3	2.0	9.6	7.3	10.7	16.6	11.4	9.2	11.8	10.2	13.1	9.0	8.3	14.1	6.1	11.0	13.6	8.9	13.4	15.8	11.6	13.7	11.1	8.4	7.6	10.7	23.9	5.2	7.9	8.9	10.0	8.9	26.6	8.4	5.1	23.3	11.2	12.1	10.3	9.4	6.9	18.6	7.9	12.7	4.7	4.3	6.9	17.6	11.5	11.3	5.0	5.4	9.7	9.8	9.3	3.5	10.3	7.9	13.9	0.0	10.3	16.1	13.8	11.0	15.8	12.1	13.1	8.9
UBL3	"DKFZP434K151, FLJ32018, HCG-1, PNSC1"	ENSG00000122042	"Ubiquitin like 3"	O95164	13	29764371-29850684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 305.5;Late spermatids: 259.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053772, HPA058781"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA053772: AB_2682258, HPA058781: AB_2683818"	"unprognostic (2.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (8.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.84e-1)"	11.9	11.7	27.9	9.1	35.2	10.3	16.7	22.6	32.3	22.9	16.5	28.8	12.2	15.0	24.0	14.8	24.0	15.4	17.5	10.8	32.6	30.5	19.9	22.4	20.2	9.3	36.7	23.6	17.8	30.5	20.6	17.4	13.6	31.2	12.8	15.5	17.1	14.9	13.5	14.7	13.0	17.3	17.5	45.9	12.9	38.4	11.6	30.0	10.8	22.7	8.3	9.9	12.4	15.4	2.7	7.7	8.0	8.4	5.0	23.7	6.3	4.0	2.5	8.0	4.8	11.4	11.0	8.5	33.5	19.7	14.4	11.6	6.0	9.2	3.5	7.6	33.2	6.6	4.0	3.6	5.0	41.4	5.5	4.5	3.7	3.5	4.8	3.6	5.4	5.0	6.4	16.3	7.5	4.9	12.5	5.1	4.2	1.8	2.5	6.0	27.2	4.0	4.6	4.8	9.5	3.7	4.6	10.4	4.0	9.4	4.8	9.4	4.7	4.7	16.4	33.7	17.9	8.8	9.3	4.4	18.7	4.6	10.2	4.4	6.0	2.3	2.7	6.6	4.7	12.3	5.4	8.2	6.8	8.2	8.0	3.8	2.2	10.4	7.9	7.7	2.7	6.0	7.4	8.0	5.0	8.4	3.6	23.7	6.3	27.9	35.2	22.6	29.7	32.6	30.5	36.7	23.6	31.2	30.0	178.6	37.4	26.8	90.8	68.5	165.7	26.8	53.5	69.6	71.7	34.9	72.6	12.5	77.9	33.9	305.5	46.6	52.9	0.0	32.7	68.1	38.8	65.5	13.9	50.8	33.9	90.6	58.3	30.7	50.9	259.4	32.2	45.6	92.8	38.7	52.9	150.0	46.0	25.9	31.1	38.3	62.8	19.4	45.3	48.6	18.5	69.9	24.7	39.5	31.8	92.4
UBL7	"BMSC-UbP, MGC14421"	ENSG00000138629	"Ubiquitin like 7"	Q96S82	15	74445977-74461182	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 133.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040423, HPA041897"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040423: AB_10673442, HPA041897: AB_2677732"	"unprognostic (4.21e-2)"	"prognostic favorable (6.37e-5)"	"unprognostic (2.93e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.43e-2)"	14.4	18.0	30.0	16.6	31.8	16.4	17.0	20.8	58.4	20.7	19.4	22.7	15.2	18.2	17.9	19.6	18.4	22.0	15.9	27.6	29.0	21.1	18.6	17.2	16.4	23.1	26.8	26.1	18.4	21.4	30.2	14.3	18.9	33.0	17.5	20.7	15.0	19.8	21.4	45.5	23.0	16.1	23.0	28.3	22.5	18.5	34.8	16.1	36.9	28.2	18.6	34.9	17.7	14.4	26.6	75.5	32.8	28.7	25.8	31.6	23.1	11.5	12.6	20.6	27.6	21.6	28.4	13.9	18.8	23.1	24.8	30.6	15.4	16.9	17.0	20.3	23.1	32.1	18.9	57.3	25.5	23.6	22.4	35.0	22.2	21.1	27.6	20.8	13.7	19.2	21.7	23.2	20.5	28.3	21.3	20.5	38.6	19.0	25.5	25.1	15.9	17.0	21.4	49.2	19.8	15.5	18.4	16.2	37.9	21.2	13.5	20.3	40.2	18.4	17.4	25.1	29.7	18.4	23.0	11.9	22.9	13.5	11.4	23.3	25.7	48.9	18.9	14.9	25.1	19.7	13.6	26.2	28.5	18.8	28.7	17.9	26.6	18.9	19.5	35.1	26.4	18.5	21.8	32.8	25.8	25.7	75.5	31.6	23.1	30.0	31.8	20.8	58.4	29.0	21.1	26.8	26.1	33.0	16.1	29.8	12.8	34.0	19.7	14.1	5.1	24.3	17.8	14.7	9.1	14.0	7.9	57.5	49.7	32.9	58.1	18.2	27.7	23.3	30.3	57.0	17.9	16.9	18.5	15.8	37.4	4.8	22.5	19.6	32.9	133.3	22.7	32.8	20.3	111.8	22.7	16.2	27.8	26.6	19.8	36.8	7.7	19.4	20.0	48.1	27.4	22.0	57.2	32.0	28.2	21.8
UBOX5	"KIAA0860, RNF37, Ubce7ip5, UIP5"	ENSG00000185019	"U-box domain containing 5"	O94941	20	3107573-3160196	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028871	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028871: AB_10603140"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.80e-5)"	"unprognostic (4.02e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.33e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-2)"	10.1	9.9	9.6	10.0	13.0	17.7	15.4	14.9	16.3	11.6	12.7	12.3	9.0	8.6	14.1	8.8	11.2	13.9	8.8	10.8	10.0	9.1	13.7	12.2	10.1	19.6	10.0	10.2	15.2	17.8	12.8	11.6	11.1	11.9	11.8	8.8	9.5	13.2	13.6	34.1	16.3	10.7	12.2	7.9	10.4	10.8	15.1	9.3	14.9	10.4	11.1	11.5	12.8	9.7	8.7	7.0	11.4	7.0	7.5	8.4	5.5	6.3	6.5	5.2	3.3	6.8	3.8	2.7	5.4	4.9	6.5	6.5	6.1	5.5	4.8	2.1	4.5	7.5	8.8	3.4	8.1	4.0	1.4	2.9	8.3	2.0	5.7	5.5	3.5	3.3	4.9	6.1	5.2	6.7	5.3	4.2	4.0	6.8	4.7	3.8	4.2	7.1	5.2	4.0	6.7	3.9	4.8	6.5	3.4	4.1	6.6	6.4	6.2	3.4	20.0	4.2	4.2	8.5	2.6	4.7	4.4	2.8	4.8	4.3	6.4	9.3	4.3	2.4	3.6	3.1	11.1	7.0	11.4	7.1	7.0	7.3	8.7	8.0	5.8	7.0	6.8	8.4	8.1	11.4	7.5	5.9	5.6	7.6	5.5	9.6	13.0	14.9	16.3	10.0	9.1	10.0	10.2	11.9	9.3	11.9	5.9	4.4	3.4	1.6	6.8	1.0	2.5	1.4	2.3	0.0	5.9	6.2	0.0	3.2	1.1	2.2	4.0	0.0	3.7	3.3	3.3	4.1	2.3	3.8	4.3	6.4	9.8	6.2	4.8	1.2	6.4	2.9	3.3	5.4	5.1	3.9	3.6	3.5	3.5	4.4	4.7	6.5	2.0	8.6	4.2	2.0	8.5	2.9	5.0	5.6
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563639-56567868	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes		200000	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.4	20.8	27.0	13.9	40.7	9.4	16.2	34.9	35.3	17.3	13.6	17.8	15.0	11.1	17.0	16.7	18.1	18.2	14.5	20.8	26.2	28.6	13.9	18.9	14.0	16.4	21.2	26.6	27.0	10.6	25.5	18.3	15.6	20.8	21.1	12.5	13.3	13.7	21.5	24.6	13.5	11.6	18.7	18.8	13.9	12.9	5.4	16.7	18.0	20.9	10.9	17.7	16.4	14.1	5.5	10.9	25.0	19.4	12.1	20.4	10.9	18.6	13.9	14.0	16.3	32.2	20.6	8.8	15.1	18.0	11.4	12.6	7.8	8.8	14.3	16.6	17.8	17.8	11.0	26.6	16.9	13.8	22.1	16.0	5.8	19.2	8.2	16.9	11.3	12.8	19.1	21.4	15.3	13.4	16.5	9.9	9.3	6.7	15.8	17.9	8.7	14.5	9.9	11.6	6.0	16.6	13.0	18.1	13.5	23.0	14.6	17.3	16.2	21.8	9.7	8.8	25.6	16.2	8.4	11.1	12.1	12.4	17.4	9.1	6.0	7.4	9.9	13.6	12.0	10.2	25.0	14.1	14.1	9.9	19.3	11.1	5.1	15.1	11.5	10.9	5.5	20.4	12.2	12.4	12.1	19.4	3.9	14.1	10.9	27.0	40.7	34.9	35.3	26.2	28.6	21.2	26.6	20.8	16.7	20.8	12.1	13.7	34.3	27.7	41.9	31.1	12.7	13.4	9.1	17.4	17.7	23.0	14.9	17.9	0.0	17.1	14.4	0.0	14.5	22.2	23.5	24.0	12.7	19.2	21.1	39.7	32.8	18.4	34.3	0.4	23.0	18.9	16.9	27.9	18.1	22.1	15.8	14.0	34.3	10.9	31.2	12.9	32.5	0.3	0.2	26.6	33.4	17.5	18.8	32.1
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	16.7	13.2	13.7	18.3	16.7	28.4	18.8	21.8	18.1	18.2	16.2	14.8	10.5	11.3	21.0	12.9	10.8	15.9	14.2	19.7	10.0	15.4	14.4	10.6	16.6	14.9	11.8	10.5	16.3	16.4	26.3	25.6	16.2	18.9	15.3	12.9	12.5	11.8	16.8	23.6	11.0	14.4	18.2	12.1	14.7	13.8	13.7	14.7	23.2	18.8	9.7	14.3	17.3	19.7	4.6	5.0	5.5	4.2	6.2	7.2	1.8	5.0	7.3	8.4	6.9	13.4	10.4	8.0	12.4	13.6	10.9	14.1	9.3	3.9	5.9	7.3	12.6	13.7	8.8	12.2	10.8	13.0	12.1	5.9	23.3	14.7	4.5	9.3	16.4	11.2	11.2	6.1	13.4	10.9	10.7	12.3	12.0	13.3	9.0	13.5	2.8	8.8	4.9	4.8	13.4	7.6	11.7	11.6	5.1	11.0	11.9	8.6	7.6	16.2	8.6	5.7	10.2	8.3	8.6	16.8	13.5	8.3	12.0	12.5	10.6	18.0	17.1	9.2	10.4	12.1	4.4	3.0	5.2	5.7	4.2	6.5	4.1	5.9	6.9	2.9	4.6	5.9	7.2	5.5	6.2	3.4	5.0	4.1	1.8	13.7	16.7	21.8	18.1	10.0	15.4	11.8	10.5	18.9	14.7	44.7	27.8	14.6	10.3	9.4	26.8	24.5	17.8	17.4	25.0	8.7	25.5	10.4	0.0	8.8	11.6	17.9	10.8	0.0	12.5	6.2	15.0	9.4	27.7	8.5	7.3	30.2	13.8	14.7	16.2	13.2	15.0	10.5	8.5	10.0	10.0	15.6	8.9	9.1	19.4	6.7	39.2	12.9	19.1	25.3	14.9	6.4	30.9	20.8	10.0	7.4
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564062-42693504	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 25.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	19.8	18.8	14.4	21.8	16.7	22.1	18.6	26.6	20.4	17.2	19.3	17.8	17.8	20.1	29.5	16.8	16.2	15.6	16.2	16.8	13.8	13.2	17.8	24.0	19.3	18.0	16.7	12.9	20.8	24.6	28.0	26.3	16.3	17.2	16.5	20.1	15.8	18.3	15.6	33.5	18.0	24.6	19.9	15.9	21.3	18.2	9.2	17.2	26.1	20.1	14.9	17.7	18.9	29.8	3.6	3.5	25.2	5.7	3.9	4.4	1.9	14.4	7.3	8.5	13.3	17.5	16.9	11.5	11.1	12.0	9.9	10.3	10.5	6.0	9.9	8.9	12.0	11.5	14.6	12.2	9.5	12.6	13.3	8.6	15.7	10.8	13.6	14.2	15.1	10.8	11.9	10.4	9.8	10.8	12.2	11.1	14.4	18.3	12.6	9.4	11.6	11.8	13.4	7.7	28.5	7.1	10.6	12.7	14.8	11.3	12.6	10.1	8.0	11.2	10.8	10.9	13.5	10.6	14.7	16.0	9.0	7.1	11.0	8.0	11.7	10.3	15.3	4.7	11.4	5.4	10.4	4.6	9.2	4.4	4.8	3.7	3.4	2.9	3.4	3.5	3.6	3.0	3.3	25.2	3.9	5.7	2.6	3.3	1.9	14.4	16.7	26.6	20.4	13.8	13.2	16.7	12.9	17.2	17.2	14.9	21.1	12.8	17.4	14.7	41.6	32.9	22.9	25.4	22.7	19.2	56.9	14.8	14.9	14.7	4.6	21.1	31.4	93.5	13.2	11.0	18.8	19.9	19.7	28.1	12.0	60.4	12.1	18.4	28.9	3.9	23.6	24.6	18.6	17.2	19.6	23.5	14.1	22.9	22.6	9.6	50.0	38.8	23.4	9.2	8.1	14.2	14.4	32.0	18.0	18.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 97.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.9	7.6	8.1	10.7	16.2	12.9	6.8	16.2	9.4	9.4	7.6	11.7	5.7	10.2	14.1	12.6	7.6	11.9	9.7	8.2	11.7	10.5	8.3	37.1	8.1	12.3	8.1	12.2	12.0	7.7	7.7	12.3	8.2	7.5	9.2	5.1	19.3	11.1	16.0	8.4	7.9	6.0	6.3	9.1	6.4	7.6	13.3	10.8	6.8	12.7	16.0	8.7	11.4	10.5	6.5	6.8	6.9	6.9	11.7	14.2	5.7	11.1	10.2	9.0	7.0	9.4	11.7	7.2	7.8	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4	41.7	21.1	7.5	11.4	23.0	40.4	97.6	15.3	9.4	19.4	12.2	76.6	14.8	3.3	8.0	6.6	23.7	13.4	23.3	9.5	6.8	18.3	22.3	16.1	32.7	8.9	60.4	16.0	31.9	21.5	7.4	23.9	16.8	15.1	4.6	12.5	63.3	9.4	14.0	18.0	10.2	53.7	25.8	26.4	13.0	7.6	25.3	19.2	13.1	9.9	12.3
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074506-19210276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 240.8;Suprabasal keratinocytes: 220.9;Urothelial cells: 215.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	24.4	25.4	22.4	29.0	25.4	58.3	23.7	28.5	32.5	22.4	28.5	26.3	31.5	18.2	34.0	32.5	22.7	20.3	27.3	20.5	23.3	15.9	25.5	29.7	31.2	20.3	21.0	20.9	35.5	21.0	40.9	31.4	28.4	25.0	30.7	20.5	30.6	24.7	27.1	55.9	69.0	25.5	39.3	20.2	26.5	30.2	41.1	21.6	37.7	26.1	17.3	25.9	43.4	29.0	4.6	9.1	18.3	18.5	2.7	3.4	4.6	22.2	22.5	20.4	15.0	38.1	19.7	17.6	17.3	18.4	18.9	17.3	35.9	19.2	13.4	16.3	22.9	16.6	15.3	15.9	17.3	17.7	11.1	14.1	30.7	21.7	23.3	26.9	18.8	20.4	17.6	22.2	38.5	37.2	18.5	20.7	23.9	21.0	12.5	17.9	15.9	8.9	22.9	16.5	45.7	12.7	12.4	15.9	11.2	17.1	13.1	14.4	14.3	20.5	11.8	14.8	19.5	8.2	14.8	32.0	22.2	13.9	26.2	19.4	14.9	9.0	15.6	15.2	29.1	18.8	18.3	18.5	2.9	3.4	3.8	2.9	4.6	3.0	1.9	9.1	2.9	2.7	2.5	9.8	2.7	1.3	4.3	2.1	4.6	22.4	25.4	28.5	32.5	23.3	15.9	21.0	20.9	25.0	21.6	32.8	42.3	16.3	79.1	240.8	54.0	15.6	40.8	30.8	26.1	29.6	143.3	19.2	11.6	31.4	14.7	21.1	36.4	23.3	35.5	14.1	29.1	39.1	18.5	77.9	54.8	74.7	16.8	28.8	47.4	19.9	28.4	42.8	47.2	36.1	30.4	30.7	51.2	14.0	33.6	88.2	48.0	19.4	26.8	37.4	17.9	220.9	28.4	21.0	19.5	215.5
UBR7	C14orf130	ENSG00000012963	"Ubiquitin protein ligase E3 component n-recognin 7 (putative)"	Q8N806	14	93207056-93229215	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 246.4;Late spermatids: 271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000861	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000861: AB_1078321"	"unprognostic (9.60e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.12e-5)"	"unprognostic (1.14e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.94e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	14.1	12.3	16.4	12.5	22.9	17.0	17.5	20.0	25.8	17.1	15.7	17.7	11.3	11.1	14.9	13.4	14.8	13.7	11.9	19.0	14.2	12.8	15.3	13.2	11.9	18.0	14.0	17.1	17.0	20.4	28.2	11.5	11.4	13.3	13.9	17.1	13.6	13.7	14.9	19.9	15.2	12.7	14.1	16.9	13.8	14.1	21.1	14.3	31.9	15.4	12.9	23.3	13.4	13.3	18.1	10.7	15.8	9.5	11.5	16.5	8.2	6.5	8.7	13.5	11.2	6.3	6.8	4.8	13.8	9.8	15.4	11.7	6.3	7.4	15.5	11.6	7.0	6.7	7.9	14.4	7.7	15.8	12.0	7.8	11.2	9.4	6.0	2.9	16.4	12.6	4.1	5.4	8.5	5.4	5.7	8.6	14.9	10.4	15.6	14.7	19.1	26.6	9.0	6.2	17.2	15.9	20.5	24.1	8.5	5.2	10.7	16.9	12.1	9.9	8.3	4.1	8.3	15.0	11.3	6.5	11.3	6.1	9.7	14.2	18.1	27.7	16.0	9.9	12.7	9.6	15.8	7.3	11.8	12.7	9.1	13.3	18.1	11.4	11.7	7.8	14.8	10.0	10.6	11.5	11.5	9.5	10.7	16.5	8.2	16.4	22.9	20.0	25.8	14.2	12.8	14.0	17.1	13.3	14.3	14.9	5.4	14.3	6.6	17.6	5.8	15.3	10.2	2.7	10.3	10.4	9.8	7.8	10.0	8.8	246.4	8.2	9.2	23.3	11.2	13.2	10.2	4.3	4.7	10.4	11.8	3.2	5.2	14.1	10.1	271.2	8.6	8.5	13.5	7.2	7.6	12.6	8.2	5.8	11.7	7.0	13.4	6.5	10.7	34.9	27.7	11.8	5.5	10.7	10.7	3.3
UBTD1	FLJ11807	ENSG00000165886	"Ubiquitin domain containing 1"	Q9HAC8	10	97498868-97571209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.5;neutrophil: 8.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034825	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			Vesicles	"Plasma membrane, Cytosol"	"HPA034825: AB_10602254"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.66e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.78e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.50e-3)"	16.0	5.6	7.7	7.3	7.1	10.2	20.5	5.1	9.0	11.5	4.6	5.8	9.7	2.9	6.6	13.9	8.1	8.3	9.0	23.8	6.8	6.5	15.6	11.2	26.0	8.3	9.1	4.8	8.9	12.9	3.1	7.8	5.3	6.4	6.5	1.5	8.9	10.7	10.8	24.2	22.7	2.5	7.0	6.7	5.3	4.1	30.3	5.7	1.0	12.9	10.9	4.4	10.3	8.6	0.3	1.7	8.5	3.4	0.0	0.4	0.5	9.0	9.0	2.4	11.9	10.1	9.5	2.8	10.4	15.3	11.2	8.6	6.0	7.9	1.1	12.7	7.0	7.0	10.9	2.4	13.9	1.5	2.7	4.7	1.1	2.8	7.5	14.6	1.0	3.1	13.1	4.7	12.1	3.0	17.2	17.8	2.4	0.6	1.7	7.1	4.3	0.4	9.2	3.9	1.7	16.6	0.9	4.2	1.0	8.6	3.4	0.8	2.5	4.7	2.9	13.4	2.2	10.8	6.8	19.1	14.2	8.7	14.8	13.5	2.2	2.5	0.4	11.9	6.1	7.3	1.3	3.4	7.5	0.2	0.8	0.2	0.3	0.1	0.0	1.7	0.0	0.1	0.0	8.5	0.0	0.9	1.2	0.4	0.5	7.7	7.1	5.1	8.1	6.8	6.5	9.1	4.8	6.4	5.7	38.7	19.9	0.0	7.7	23.1	2.2	14.1	7.6	9.4	13.6	7.0	3.9	2.8	10.0	16.1	52.6	20.4	0.3	0.0	11.2	9.4	17.5	12.5	0.0	5.8	24.5	6.4	0.0	4.9	7.3	20.2	11.8	8.5	10.1	9.0	0.1	10.1	16.8	0.0	8.9	8.1	15.9	12.9	9.0	5.9	5.7	26.0	2.4	0.9	0.2	6.2
UBXN11	"SOC, SOCI, UBXD5"	ENSG00000158062	"UBX domain protein 11"	Q5T124	1	26281328-26318363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 103.4;Late spermatids: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 32.4;intermediate monocyte: 28.1;myeloid DC: 16.6;non-classical monocyte: 22.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 16.6;monocytes: 32.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028600, HPA031357"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA028600: AB_10604001, HPA031357: AB_2673840"	"unprognostic (1.78e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (8.18e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.53e-1)"	"prognostic favorable (4.90e-4)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (8.41e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.59e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-2)"	5.4	7.6	16.6	10.2	25.7	18.9	5.6	7.0	21.5	8.6	4.6	7.9	9.0	4.2	6.7	23.8	4.3	35.4	8.4	5.9	17.0	15.0	9.3	3.7	12.0	8.2	9.8	12.3	9.7	8.2	8.4	18.3	5.2	12.7	5.4	3.5	13.6	8.3	8.3	6.2	6.0	4.4	5.0	5.6	11.7	4.8	27.4	8.5	6.2	15.7	2.7	5.7	6.1	3.9	5.3	16.6	2.4	32.4	1.9	5.7	13.2	17.4	7.9	3.9	7.9	2.9	2.2	13.7	3.9	6.1	10.8	7.9	3.1	15.5	10.2	5.9	2.4	7.2	9.5	2.4	6.3	2.8	5.1	9.3	1.7	11.2	7.5	5.1	7.4	3.5	3.3	6.8	18.2	4.6	3.4	3.0	7.5	6.6	7.1	3.6	7.8	4.2	3.6	7.9	4.9	6.1	8.7	2.9	9.2	6.0	2.6	18.7	4.4	9.6	9.1	6.7	2.1	7.0	7.2	2.8	6.3	9.5	9.3	5.7	6.7	19.0	11.6	7.7	10.3	5.1	0.7	32.4	1.5	3.4	28.1	4.1	4.4	5.0	3.9	16.6	5.3	5.7	3.6	2.4	1.9	22.5	2.5	4.1	13.2	16.6	25.7	7.0	21.5	17.0	15.0	9.8	12.3	12.7	8.5	0.0	1.4	9.1	13.3	19.1	9.8	1.1	7.6	17.4	7.9	22.7	21.6	7.5	11.6	11.5	103.4	4.4	1.7	0.0	7.5	17.4	10.8	8.6	10.3	2.4	19.7	22.3	8.6	7.4	69.6	252.6	11.8	30.3	10.1	3.6	4.3	12.1	6.8	2.9	9.6	21.2	50.8	19.4	7.8	13.9	22.6	11.7	6.1	13.1	5.6	11.0
UBXN2A	UBXD4	ENSG00000173960	"UBX domain protein 2A"	P68543	2	23927285-24004909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065482, HPA069096"	Supported		Approved	Centrosome		NA	NA			Centrosome		"HPA065482: AB_2685495, HPA069096: AB_2686084"	"unprognostic (5.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.86e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (9.26e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.75e-2)"	12.7	10.6	10.8	8.3	10.7	9.6	13.8	16.7	10.6	9.4	14.0	12.2	9.5	12.1	13.4	9.1	11.7	9.2	8.2	17.7	10.0	11.6	9.1	12.0	10.0	7.8	12.7	8.9	9.3	7.8	17.3	13.6	14.0	13.3	9.9	9.1	11.1	9.9	11.4	24.3	10.3	13.3	14.9	11.3	6.8	8.2	7.3	11.9	9.8	9.4	7.5	9.1	12.0	15.0	6.5	7.3	6.9	4.0	8.6	7.1	2.8	10.8	7.2	10.1	6.8	11.7	10.3	5.1	11.2	7.6	11.0	7.6	5.4	4.9	9.4	3.5	7.1	7.7	4.7	9.7	8.0	9.8	18.9	9.2	11.1	5.1	8.0	8.7	7.0	5.0	12.5	6.4	9.6	7.3	7.8	6.4	7.3	12.4	9.5	9.4	8.2	9.1	4.5	8.0	7.0	5.3	12.5	25.1	4.1	4.6	8.6	5.0	12.1	10.7	5.4	13.9	7.6	3.1	4.0	10.6	7.9	8.3	7.2	7.1	13.7	14.6	13.5	6.1	6.5	7.9	6.9	4.0	4.4	6.2	2.2	6.8	6.5	6.5	5.9	3.1	5.8	7.1	6.5	4.0	8.6	2.7	7.3	4.7	2.8	10.8	10.7	16.7	10.6	10.0	11.6	12.7	8.9	13.3	11.9	23.8	19.2	18.0	25.0	22.7	15.9	39.2	5.1	13.4	12.5	15.7	41.2	29.3	14.9	23.7	1.1	20.2	23.1	0.0	23.5	27.6	23.0	29.0	16.3	13.4	13.3	39.7	4.1	22.1	13.3	1.6	24.5	15.0	33.7	28.9	13.1	23.5	28.6	28.1	25.1	14.7	28.8	32.3	20.6	16.2	12.0	27.4	31.2	22.4	17.2	32.8
UBXN2B	p37	ENSG00000215114	"UBX domain protein 2B"	Q14CS0	8	58411264-58451501	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 27.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 27.6;monocytes: 7.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045278	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA045278: AB_10963578"	"unprognostic (1.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.42e-2)"	9.6	11.7	20.2	14.1	18.8	17.8	13.9	27.2	25.4	8.9	11.1	9.8	7.4	9.3	10.4	14.0	8.4	10.9	10.7	12.0	25.5	13.3	19.6	22.7	12.1	11.6	16.0	20.0	12.0	11.4	22.0	11.7	9.1	14.7	12.3	11.6	6.7	15.0	11.2	12.1	7.8	9.3	14.4	19.7	14.9	10.8	11.1	16.9	11.7	17.7	6.5	11.2	11.4	13.1	2.3	3.6	27.6	7.3	3.0	3.2	3.0	7.1	14.7	10.9	13.3	2.0	1.3	8.1	4.3	7.8	5.6	7.0	5.5	15.8	8.6	9.3	5.2	14.3	7.2	15.9	7.6	7.5	7.9	8.1	10.0	13.2	7.5	8.3	8.8	9.7	3.6	12.2	3.0	12.3	12.7	6.4	12.4	7.3	15.2	4.7	7.0	15.7	9.9	15.4	24.0	3.0	9.4	5.2	7.7	17.1	10.6	4.7	16.5	7.3	7.9	12.3	11.2	15.7	11.0	1.4	5.1	11.0	8.8	9.0	8.0	9.3	12.0	13.5	8.4	5.9	7.0	7.1	12.3	2.8	6.9	3.1	2.3	2.7	2.4	3.6	2.1	3.1	2.9	27.6	3.0	7.3	2.0	3.2	3.0	20.2	18.8	27.2	25.4	25.5	13.3	16.0	20.0	14.7	16.9	8.9	8.3	17.9	8.9	5.0	14.8	17.1	5.1	5.3	5.7	10.4	21.6	13.5	8.3	10.6	27.9	5.3	12.7	0.0	9.6	13.2	6.8	12.6	23.1	16.3	20.8	11.1	11.5	5.5	30.4	45.3	9.8	28.9	8.5	5.4	8.7	10.9	9.0	7.0	13.8	24.3	26.1	0.0	7.6	17.2	14.7	5.8	7.2	10.1	10.4	7.3
UBXN6	"UBXD1, UBXDC2"	ENSG00000167671	"UBX domain protein 6"	Q9BZV1	19	4444999-4457822	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1030.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040906, HPA041313, HPA061872"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (5.68e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.78e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.79e-1)"	29.1	47.7	29.0	20.0	38.0	38.4	22.9	30.5	45.9	21.0	21.8	12.4	42.3	26.2	23.3	45.9	26.3	24.9	35.6	35.1	29.7	21.8	29.2	37.6	23.4	26.6	25.4	30.5	35.1	45.3	18.9	35.6	22.9	23.3	23.7	8.1	20.8	42.1	46.7	72.0	25.4	28.9	30.3	21.7	22.2	22.8	41.5	18.4	11.9	38.8	42.2	12.0	26.9	22.5	7.4	13.6	12.9	10.3	3.6	8.7	6.1	21.1	14.9	7.2	15.5	18.2	22.7	10.8	21.7	25.9	15.9	16.9	9.2	17.9	9.5	19.8	21.3	8.1	12.3	5.5	16.6	5.8	16.6	12.0	7.9	15.8	12.2	30.0	9.9	15.9	20.6	22.0	12.4	12.1	19.4	19.3	13.1	16.2	25.8	11.7	13.4	19.6	16.8	11.5	8.2	13.1	9.0	10.3	22.3	15.0	13.3	20.9	30.3	12.1	12.6	35.2	3.5	14.9	16.2	23.2	21.1	16.3	44.9	14.2	58.1	22.8	9.4	40.4	18.6	18.7	8.5	9.2	12.9	5.5	10.3	8.7	6.8	6.5	7.3	8.9	7.4	7.7	6.1	9.1	3.6	6.0	13.6	6.9	6.1	29.0	38.0	30.5	45.9	29.7	21.8	25.4	30.5	23.3	18.4	38.7	26.7	33.5	31.1	33.1	37.4	40.3	53.5	13.4	14.8	41.8	25.5	47.8	68.0	49.1	229.6	25.1	103.4	163.5	56.3	38.0	42.3	43.5	34.5	55.5	48.0	12.7	45.0	38.1	35.1	1030.1	92.6	36.5	50.6	50.5	58.2	45.3	60.0	59.6	68.6	86.4	28.5	71.1	28.3	142.6	29.6	35.9	66.6	27.7	54.3	44.3
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol		No	No		490000	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	13.7	39.1	23.6	11.9	37.6	17.4	21.4	17.5	18.7	10.6	21.2	11.4	12.8	12.8	9.0	40.5	37.7	8.1	12.4	15.5	20.6	12.6	20.7	36.8	10.3	12.2	18.2	13.5	7.7	20.8	9.5	28.9	26.3	14.7	12.4	25.0	6.1	24.0	14.9	31.7	28.8	15.0	16.9	13.3	15.3	14.5	24.6	18.6	18.9	28.1	29.8	20.2	16.0	16.2	17.4	46.0	15.8	43.5	20.5	23.4	17.3	51.7	8.7	7.6	5.2	14.2	17.0	21.9	19.6	19.5	25.6	28.7	48.0	25.2	26.8	14.2	20.6	19.5	28.6	17.7	47.7	38.9	14.3	15.5	16.9	14.4	30.6	20.5	40.3	12.7	15.0	33.1	20.0	32.2	10.8	24.9	21.8	18.5	7.7	38.4	18.6	16.4	26.4	11.3	60.9	26.2	13.1	12.2	17.6	30.1	21.1	22.9	6.7	11.2	21.8	9.0	17.1	12.5	11.5	19.2	11.2	13.3	11.9	26.2	10.8	12.0	31.2	22.6	43.7	8.0	15.6	24.1	15.8	10.9	43.5	14.2	17.4	19.9	15.5	33.6	16.0	19.8	18.3	5.4	20.5	36.2	46.0	23.4	17.3	23.6	37.6	17.5	18.7	20.6	12.6	18.2	13.5	14.7	18.6	8.9	22.6	16.0	62.8	67.9	8.8	22.6	35.7	28.1	42.1	43.6	2.0	84.6	77.9	139.8	157.4	22.0	32.0	0.0	124.1	137.9	25.4	82.5	23.1	42.0	76.8	15.9	23.1	17.2	26.4	26.7	15.5	32.1	25.3	20.8	45.7	8.6	125.1	31.7	11.0	96.2	8.8	19.4	18.6	110.6	30.9	69.3	141.3	20.3	55.3	79.8
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531268	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	13.2	15.9	21.7	13.7	22.5	13.7	15.6	29.9	23.2	15.0	15.6	17.3	20.8	11.4	12.2	19.3	14.5	17.6	16.5	21.0	19.6	18.4	18.3	26.7	12.7	12.9	20.4	19.1	21.3	24.0	17.6	14.4	16.4	14.8	14.9	9.2	17.6	24.1	18.3	30.0	12.0	12.2	14.8	19.9	12.1	13.4	15.7	15.6	12.5	18.5	10.8	11.5	13.6	9.4	7.9	6.6	9.4	7.8	6.8	13.5	6.1	7.0	15.7	18.2	23.3	12.9	9.2	15.5	11.5	17.0	20.0	15.2	15.6	6.5	7.7	7.0	13.8	15.6	13.8	16.9	14.7	8.6	14.1	15.7	7.2	23.6	9.8	18.5	11.8	10.7	10.3	13.9	16.1	11.7	12.1	12.2	19.2	9.0	5.9	14.6	28.2	16.0	6.0	21.5	13.9	15.7	15.4	28.1	12.9	12.8	6.7	24.6	15.5	16.6	12.7	17.9	8.7	24.8	7.0	8.9	22.2	11.3	13.7	11.2	12.2	15.6	9.8	11.0	8.3	15.4	2.3	6.2	9.4	8.5	7.8	11.3	7.9	10.1	7.6	5.7	7.9	13.5	6.8	4.1	6.8	2.7	6.6	12.3	6.1	21.7	22.5	29.9	23.2	19.6	18.4	20.4	19.1	14.8	15.6	14.9	5.3	14.9	10.3	12.7	17.5	12.9	7.6	0.0	3.4	14.0	7.9	26.0	24.9	19.6	15.1	13.4	17.0	0.0	22.9	12.0	15.5	11.2	2.3	19.4	22.3	25.4	11.6	11.1	11.1	20.2	16.4	8.2	15.1	27.1	11.8	17.7	15.6	11.6	18.7	23.7	10.2	19.4	18.9	29.3	29.4	10.9	21.5	9.6	11.8	7.1
UCK2	UMPK	ENSG00000143179	"Uridine-cytidine kinase 2"	Q9BZX2	1	165827531-165911618	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.8"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057128			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057128: AB_2683346"	"unprognostic (5.37e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-3)"	"prognostic unfavorable (9.22e-8)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.12e-13)"	"unprognostic (2.49e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.83e-1)"	12.5	7.1	6.5	11.1	8.6	11.6	17.5	16.9	9.6	9.3	18.4	8.9	11.0	15.3	10.1	15.3	20.5	8.8	9.0	9.6	6.4	6.6	6.6	14.6	11.1	10.3	10.5	6.6	7.5	17.6	7.9	9.4	65.8	11.2	8.1	19.9	5.0	16.1	9.9	20.9	15.0	24.8	10.0	8.2	7.7	13.2	7.2	7.9	13.1	6.4	12.4	12.3	9.0	11.1	3.4	14.7	0.8	5.6	3.4	3.9	2.0	25.2	26.3	14.2	12.7	7.3	12.2	23.1	27.9	20.6	29.8	34.0	24.9	27.8	12.5	19.9	17.3	12.1	20.8	26.6	32.8	26.7	22.9	22.4	14.5	22.6	25.6	18.2	28.3	11.1	11.5	16.9	56.2	35.0	7.2	19.6	24.1	38.3	18.0	26.7	18.3	25.1	18.2	38.9	35.2	25.5	11.5	15.6	42.5	13.8	16.5	21.4	25.3	19.9	39.4	19.3	28.3	24.3	27.0	20.4	16.7	23.3	18.9	29.5	24.2	36.0	46.3	14.4	18.8	12.7	0.8	5.6	0.1	1.8	3.7	3.9	3.4	1.7	2.4	14.7	3.4	0.0	1.4	0.2	3.4	3.2	14.0	2.2	2.0	6.5	8.6	16.9	9.6	6.4	6.6	10.5	6.6	11.2	7.9	0.0	1.4	3.0	24.7	20.4	4.3	4.1	12.7	1.4	4.5	8.7	0.0	1.2	6.6	15.0	94.9	15.3	22.2	0.0	19.1	46.9	11.0	10.1	0.0	4.9	11.9	0.0	6.4	4.9	3.5	31.3	6.1	7.1	10.1	17.2	13.7	4.0	38.8	14.4	3.2	5.8	4.2	0.0	9.0	5.2	11.5	26.0	22.1	4.8	18.3	20.9
UCKL1	"FLJ20517, URKL1"	ENSG00000198276	"Uridine-cytidine kinase 1 like 1"	Q9NWZ5	20	63939829-63956415	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004722, HPA004769"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA004722: AB_1080455, HPA004769: AB_1080453"	"unprognostic (1.03e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.87e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.26e-3)"	17.4	18.1	16.5	16.0	18.3	21.1	19.8	50.4	20.7	18.5	21.9	21.6	17.3	32.0	18.0	17.7	19.7	17.9	12.0	21.0	17.1	9.4	21.3	20.6	15.6	18.3	20.3	11.5	31.7	22.6	14.1	22.1	17.5	15.7	19.4	9.1	31.0	28.9	24.4	52.3	27.9	29.8	18.1	11.8	26.7	20.1	11.5	19.7	16.7	24.1	33.1	20.1	16.2	21.2	22.2	8.9	6.3	14.0	5.3	14.8	7.9	11.5	12.3	10.6	14.1	7.8	6.7	17.1	9.3	6.4	19.3	9.7	29.3	9.0	11.7	15.7	6.0	13.2	19.0	8.2	12.8	3.8	4.9	13.8	8.9	24.6	42.8	8.6	15.1	17.0	9.3	11.5	7.7	6.4	7.7	8.9	11.6	12.5	12.5	6.0	14.9	17.7	26.4	7.8	9.2	28.8	18.1	8.0	20.1	7.9	16.8	25.2	14.7	13.4	13.2	14.2	5.5	13.8	13.7	9.8	20.5	7.7	13.3	12.0	13.1	7.0	5.4	10.5	10.8	7.7	4.2	7.7	6.3	13.2	12.9	14.8	22.2	12.8	11.2	8.9	12.7	7.5	9.0	1.2	5.3	14.0	5.1	13.5	7.9	16.5	18.3	50.4	20.7	17.1	9.4	20.3	11.5	15.7	19.7	23.8	8.8	20.2	17.9	16.8	27.5	18.2	22.9	8.1	11.4	8.7	78.5	27.3	19.9	17.0	1.9	16.5	26.3	0.0	9.6	20.5	15.0	11.6	12.7	10.5	16.0	19.1	20.6	10.4	9.1	2.2	16.4	13.4	10.1	22.6	20.8	17.1	16.9	23.0	19.4	12.3	130.6	25.8	18.7	10.7	14.0	16.7	27.9	9.6	21.7	17.1
UCN	"UI, UROC"	ENSG00000163794	Urocortin	P55089	2	27307400-27308445	"Predicted secreted proteins"	Hearing	Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 8.5"	"Cell type enhanced"	"Detected in some"	5	"Exocrine glandular cells: 3.2;Rod photoreceptor cells: 3.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 20.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB010911	Approved		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	133000		"Endoplasmic reticulum"		"CAB010911: AB_261834"	"unprognostic (7.35e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.42e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.84e-7)"	"unprognostic (4.84e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	1.1	2.8	4.6	1.3	5.5	2.4	1.0	3.1	4.5	0.9	0.7			0.8	1.9	1.4	0.6	1.9	2.0	4.2	4.7	3.8	0.7	3.2	1.6	1.6	3.1		2.3	1.8	0.0	2.2	2.4		1.2	0.0		1.3	0.9	8.5	0.8	1.2	1.0	2.8	3.0	0.5	1.5			1.5		0.4	0.5	0.4	0.0	0.0	0.0	0.7	2.9	0.9	0.2	1.2	2.7	0.4	0.8	1.2	1.1	5.3	0.4	1.1	0.4	0.4	0.2	2.1	1.0	0.6	0.4	1.2	0.4	0.5	0.3	0.0	3.3	4.5	2.4	1.7	2.1	3.1	0.2	2.7	1.6	2.1	0.2	2.5	2.7	0.0	2.0	2.3	1.9	0.1	2.0	1.3	7.1	4.5	0.1	2.9	3.4	2.4	1.5	0.1	0.5	0.8	2.3	1.1	0.1	5.8	0.3	1.1	3.2	0.2	0.9	5.0	1.5	1.9	20.1	2.1	0.7	3.9	5.7	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	2.9	0.4	0.0	0.6	0.2											0.0	0.3	0.0	0.2	0.5	2.7	0.4	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.5	0.0	3.2	0.6	0.5	0.7	0.0	0.8	0.7	1.6	0.0	1.3	1.9	0.0	1.4	1.3	0.0	0.0	0.2	2.0	0.9	0.0	0.7	0.3	3.3	0.0	0.1	0.9	0.6	0.0	0.7	1.0	0.6	0.1
UCN2	"SRP, UCN-II, UCNI, URP"	ENSG00000145040	"Urocortin 2"	Q96RP3	3	48561727-48563773	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 18.6;vagina: 6.3"	"Cell type enriched"	"Detected in single"	5	"Basal keratinocytes: 2.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 18.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.7;hTEC/SVTERT24-B: 12.4;SiHa: 10.8;U-251 MG: 11.4;WM-115: 31.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066841	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	98600		Vesicles		"HPA066841: AB_2685735"	"unprognostic (7.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-14)"	"unprognostic (4.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-2)"	1.7	0.0	0.3	0.5	0.9	0.1	0.6	0.3	0.3	2.0	0.3	0.3	0.3	0.1	1.8	1.1	3.7	0.1	0.6	0.3	0.3	0.5	0.9	0.3	0.3	0.3	1.6	0.3	0.3	0.3	0.0	0.3	0.3	0.9	3.3	0.1	0.3	1.6	0.7	0.3	18.6	0.3	0.4	0.3	0.5	0.1	1.1	0.3	0.3	0.3	0.3	0.3	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	1.0	0.6	1.5	5.4	6.8	3.4	2.5	0.0	0.0	0.0	0.2	1.3	4.1	1.0	0.0	6.5	1.8	5.0	0.1	0.1	8.9	0.8	1.1	0.0	0.3	0.7	15.7	12.4	2.5	2.4	0.0	0.1	0.0	0.1	0.5	0.0	0.0	1.0	0.4	0.0	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.0	10.8	0.0	8.1	1.0	0.1	0.2	0.0	1.5	1.0	0.1	11.4	0.0	0.1	0.0	5.1	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.5	1.6	0.3	0.9	0.3	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000281-74009435	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 99.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 14.7;Late spermatids: 10.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	0.9	0.2	0.2	0.3	0.2	0.6	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	1.0	0.2	99.6	0.3	0.2	0.2	0.2	0.5	0.1	0.6	0.2	0.2	0.6	6.4	0.8	0.2	0.2	0.8	0.1	0.7	0.3	0.2	2.1	0.4	0.2	2.1	2.1	1.8	0.8	0.4	0.4	0.5	0.5	0.5	0.3	0.5	0.4	1.1	0.3	0.4	0.3	2.2	0.8	0.4	0.8	18.3	0.7	0.4	2.4	0.2	0.6	1.2	1.7	0.5	1.4	1.3	0.1	0.4	0.7	1.0	0.5	1.4	0.7	1.2	0.8	1.6	1.0	1.6	1.4	1.6	4.3	0.6	1.1	0.6	1.2	1.3	0.5	0.9	0.7	0.4	0.2	1.1	0.4	0.3	1.4	0.7	1.3	1.6	1.7	0.8	0.3	1.1	0.7	0.0	0.3	0.7	2.1	0.1	0.9	0.0	1.5	1.8	0.0	0.8	0.6	1.2	0.1	0.2	0.0	0.1	0.4	0.4	0.2	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.5	0.1	0.1	2.2	0.5	0.0	2.7	1.2	0.0	0.0	0.3	0.0	0.3	14.7	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.8	10.7	0.0	0.0	0.0	0.0	0.6	0.7	0.3	0.0	0.7	0.0	1.6	0.0	0.1	1.2	0.7	0.3	0.2	2.2	0.6	0.0
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	17.3	15.0	13.3	11.6	12.9	5.5	20.8	9.7	13.3	17.1	18.2	16.4	12.9	15.1	15.0	16.3	17.8	12.6	13.0	13.2	13.1	12.1	21.8	17.2	13.3	12.3	15.6	10.9	13.8	11.8	19.1	14.2	16.2	15.5	17.9	20.0	11.4	14.8	13.9	20.4	20.2	15.9	18.3	23.0	12.5	13.4	10.0	15.0	14.3	15.2	11.8	11.5	16.5	13.5	5.2	7.1	11.1	8.5	8.7	7.6	3.8	9.2	11.1	5.3	5.1	17.2	15.4	5.1	10.0	14.1	13.3	12.9	4.6	2.6	2.8	5.6	11.8	11.6	14.3	4.7	10.3	15.3	8.3	6.3	4.1	5.2	5.1	7.7	6.3	6.2	10.6	11.0	6.5	9.3	9.5	12.4	0.2	3.1	2.8	16.9	6.9	0.2	2.1	1.4	14.2	11.5	1.0	12.2	3.5	16.0	14.6	2.2	4.7	11.0	14.1	8.8	6.8	11.2	3.8	9.3	12.3	6.5	20.4	9.8	0.6	6.3	0.6	10.6	5.0	12.5	6.9	8.3	5.0	7.6	8.5	7.1	4.5	5.5	6.1	5.5	5.2	3.6	4.7	11.1	8.7	6.6	7.1	3.8	3.8	13.3	12.9	9.7	13.3	13.1	12.1	15.6	10.9	15.5	15.0	14.9	17.1	0.8	5.1	5.6	8.9	8.5	2.5	21.4	13.6	22.7	9.8	7.4	3.3	9.2	2.3	7.1	18.7	0.0	11.4	6.2	6.9	7.6	5.8	13.0	10.8	14.3	8.7	12.9	15.3	1.4	7.5	10.4	6.8	6.4	14.4	12.3	11.0	7.0	17.3	11.4	11.0	12.9	7.5	6.5	5.9	8.2	6.4	6.9	13.0	6.5
UFC1	HSPC155	ENSG00000143222	"Ubiquitin-fold modifier conjugating enzyme 1"	Q9Y3C8	1	161152776-161158856	"Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027481, HPA028722"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA		180000	"Nuclear speckles"	Cytosol	"HPA027481: AB_10599850, HPA028722: AB_10601674"	"unprognostic (2.16e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.62e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.22e-2)"	34.2	38.6	52.6	25.4	54.7	35.1	45.6	21.1	41.8	35.4	37.3	27.8	47.7	36.9	31.5	57.2	40.6	69.9	40.8	36.0	42.5	45.9	56.1	55.2	32.0	29.8	46.3	35.6	48.7	85.5	39.3	40.6	54.2	34.4	44.0	46.8	29.2	63.6	40.3	34.3	36.1	48.6	35.8	34.4	39.1	39.1	22.2	33.9	38.9	50.2	38.9	38.9	37.9	33.4	41.1	43.6	22.4	33.0	40.9	54.1	48.0	22.4	20.8	18.4	23.1	24.7	39.7	38.8	22.9	27.0	21.9	19.4	27.2	46.1	31.2	38.5	31.8	15.1	11.7	15.4	22.0	16.3	26.5	42.2	19.0	31.0	32.6	24.5	41.9	48.6	33.8	35.7	27.3	18.9	37.3	38.1	31.8	31.5	22.9	27.9	27.1	19.4	38.3	33.8	67.0	22.9	23.8	13.4	43.4	42.4	27.4	21.2	33.7	20.0	66.3	26.3	31.0	25.3	78.0	28.5	16.3	15.9	15.6	33.4	39.9	51.0	28.2	25.8	26.7	20.6	22.4	32.8	20.4	39.0	33.0	47.2	41.1	41.8	41.5	40.4	31.0	36.7	39.5	6.0	40.9	24.0	43.6	54.1	48.0	52.6	54.7	21.1	41.8	42.5	45.9	46.3	35.6	34.4	33.9	65.5	68.2	142.4	148.8	88.7	59.5	99.6	142.7	566.1	94.4	99.5	39.3	208.4	373.0	191.0	103.8	125.8	138.7	140.2	332.6	317.7	97.7	152.4	116.6	83.9	213.1	44.5	196.3	79.8	133.0	302.8	97.2	153.3	124.9	257.9	166.3	88.5	242.7	175.4	85.6	257.5	52.6	64.7	102.4	96.2	34.8	105.8	361.2	152.3	163.7	181.2
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449910-19479215	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 105.1;Ductal cells: 98.8;Exocrine glandular cells: 123.6;monocytes: 132.6;Pancreatic endocrine cells: 115.9;Syncytiotrophoblasts: 142.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	27.8	28.0	22.7	24.3	38.0	38.7	23.9	25.3	30.4	21.1	28.9	23.3	24.7	21.7	32.8	40.3	31.6	21.3	21.7	35.6	21.9	22.9	28.0	46.6	24.6	34.8	44.3	15.9	22.4	34.7	22.5	22.6	31.6	33.0	21.7	27.7	21.9	26.7	24.4	57.9	27.3	24.7	28.3	39.7	26.7	26.2	31.8	29.9	37.8	27.8	26.9	31.7	23.9	23.7	27.7	35.3	53.5	42.8	31.1	67.6	37.5	31.8	23.2	19.8	30.0	16.3	11.5	15.2	26.4	26.4	36.5	33.8	25.7	13.9	22.3	20.5	22.1	16.8	27.7	23.2	23.1	31.8	41.0	24.5	23.5	16.4	20.3	15.5	37.2	32.1	10.5	23.8	31.1	15.3	10.7	29.2	11.8	131.8	43.0	22.2	46.3	23.9	22.8	14.2	40.2	19.7	29.1	46.9	8.6	22.4	30.1	16.3	18.3	20.7	22.5	20.7	21.6	13.5	17.9	31.7	30.8	41.9	25.6	28.3	18.4	36.6	29.0	25.9	19.0	28.1	39.8	29.0	47.8	36.1	42.8	34.7	27.7	41.6	37.3	25.5	23.9	35.9	35.1	53.5	31.1	41.1	35.3	67.6	37.5	22.7	38.0	25.3	30.4	21.9	22.9	44.3	15.9	33.0	29.9	23.8	34.6	0.0	0.0	0.0	0.0	0.0	0.0	50.9	30.7	26.2	0.0	105.1	71.3	98.8	0.0	0.0	0.0	0.0	123.6	90.9	0.0	0.0	25.6	0.0	79.3	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	132.6	0.0	0.0	115.9	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	142.5	0.0	0.0	0.0
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399540-185425985	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	15.8	20.3	12.5	10.3	14.9	4.1	18.7	11.3	20.3	17.3	17.4	16.3	17.0	11.0	19.4	17.4	20.1	17.3	13.5	24.2	11.4	11.7	28.1	19.2	13.2	11.6	14.6	11.3	30.5	20.1	18.3	22.8	12.3	17.0	18.4	12.6	13.7	14.4	20.3	40.8	16.6	13.6	16.9	20.2	14.2	17.3	23.7	14.6	15.8	23.5	19.2	12.2	20.8	13.3	15.6	13.0	5.5	7.9	13.9	17.9	8.2	12.2	7.5	21.1	15.2	19.1	19.8	11.7	12.7	12.9	15.2	14.4	12.5	15.7	12.3	5.9	15.3	11.4	9.7	16.4	20.6	15.8	13.2	9.5	6.5	7.3	11.3	21.1	9.9	8.1	11.6	16.1	13.3	13.7	19.6	24.3	16.0	16.5	24.9	19.6	7.4	13.2	7.4	5.4	8.9	10.8	13.0	8.3	14.8	14.6	7.1	12.6	11.8	7.9	12.9	15.4	13.1	9.9	7.0	14.1	6.3	11.2	4.4	9.8	22.7	8.7	5.9	20.5	6.2	16.1	5.5	7.9	5.4	16.3	6.8	17.1	15.6	16.5	17.6	9.8	11.0	17.8	17.9	0.4	13.9	6.6	13.0	14.0	8.2	12.5	14.9	11.3	20.3	11.4	11.7	14.6	11.3	17.0	14.6	6.0	19.2	16.7	28.0	19.6	46.6	23.8	10.2	28.1	29.6	19.2	62.8	22.2	94.5	25.2	125.0	22.7	9.1	23.3	28.8	24.6	26.8	16.4	27.8	14.9	23.8	17.5	18.6	14.1	16.7	32.5	32.8	19.1	33.7	14.4	16.8	50.3	19.5	19.3	39.6	62.7	79.4	64.7	30.1	53.7	53.4	16.6	35.0	21.5	15.3	15.4
UGP2	"UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840940-63891562	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 93.6;T-reg: 29.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 93.6;T-cells: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA		12000000	"Centrosome, Mitochondria"	Nucleoplasm	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	58.2	14.7	23.3	13.6	22.5	7.8	25.2	12.4	30.4	13.3	38.2	6.7	7.4	12.3	15.5	12.5	19.8	12.7	12.2	46.3	18.8	13.2	33.0	185.5	12.7	15.2	17.3	18.3	12.0	13.4	17.1	22.9	31.0	19.3	11.0	33.1	5.7	18.5	12.9	104.1	11.0	17.2	16.8	8.6	9.9	13.0	8.1	10.5	31.0	17.4	75.5	12.7	19.7	19.5	6.4	5.9	93.6	7.8	12.7	29.9	11.0	27.5	14.5	13.9	9.3	47.4	61.5	58.3	35.6	29.1	19.2	22.9	37.1	23.4	28.9	10.7	38.2	17.5	12.1	16.8	22.3	31.2	19.3	7.1	18.3	10.3	25.3	22.7	16.1	16.1	40.3	40.9	18.0	18.6	25.9	26.6	9.8	9.1	11.7	80.1	10.8	21.8	15.2	33.3	45.0	10.2	17.9	27.6	16.6	34.0	16.0	7.3	6.0	28.4	36.6	13.5	44.1	10.4	11.5	36.3	20.1	31.7	29.9	18.7	21.0	9.4	36.6	24.1	25.3	61.3	93.6	7.0	9.7	9.9	7.8	10.3	6.4	11.4	10.3	5.9	6.2	12.6	11.2	9.0	12.7	7.6	5.5	29.9	11.0	23.3	22.5	12.4	30.4	18.8	13.2	17.3	18.3	19.3	10.5	26.8	52.5	51.7	74.0	67.3	48.5	238.8	89.2	73.6	69.4	45.4	60.9	359.1	205.6	116.3	61.0	61.3	412.6	0.0	90.6	369.3	148.4	77.6	65.8	448.9	107.3	82.6	42.9	66.3	100.6	64.7	73.4	90.8	91.1	173.1	112.3	37.4	81.0	167.8	72.9	209.2	49.4	71.1	124.3	71.2	57.5	50.6	395.3	112.8	144.5	90.3
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951010-36001028	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 44.0;liver: 47.7"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	42	"RH-30: 25.3"									"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	5.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	44.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.2	0.1	6.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.2	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	47.1	0.0	0.0	3.3	0.0	91.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.1	0.1	0.0	0.0	2.5	2.2	12.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	58.6	0.3	6.5	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035017-36071358	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8"									HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.1	1.1	0.1	0.0	0.2	6.4	1.6	0.1	0.6	0.1	0.1	0.5	0.4	0.0	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.6	5.6	0.8	0.1	0.0	0.5	0.0	0.2	0.0	0.0	1.7	0.2	2.0	0.6	0.0	2.9	0.1	0.0	0.1	14.4	0.1	0.0	0.3	1.4	0.1	13.2	0.0	37.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.0	0.4	5.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	9.3	0.0	3.9	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	5.7	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.6	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598455-114678224	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 96.6"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 24.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 25.7;Spermatogonia: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 7.3;naive B-cell: 10.6"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.5;OE19: 41.1;RPTEC TERT1: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.9	0.8	13.2	2.8	30.0	1.0	3.1	2.7	44.8	4.9	15.5	66.6	0.0	18.4	2.7	0.6	1.2	3.0	7.1	0.9	24.2	12.4	20.1	0.8	1.0	3.2	53.9	15.9	0.8	4.8	0.3	0.9	0.5	38.3	0.9	17.3	0.0	4.5	0.8	0.8	1.8	16.1	1.5	96.6	1.3	10.0	3.3	42.6	0.0	8.5	0.0	3.4	0.8	1.0	10.6	0.0	0.9	0.0	0.0	0.6	0.3	0.2	0.1	1.7	0.3	0.1	0.0	0.3	0.1	0.0	0.0	1.2	5.8	21.5	6.4	0.5	0.1	5.1	9.1	0.0	0.0	0.0	0.1	4.5	0.1	9.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.1	5.4	1.3	0.0	0.1	0.1	0.7	2.5	41.1	3.2	0.6	10.3	0.1	21.3	0.2	12.1	1.8	0.0	1.9	0.3	0.4	0.3	2.1	0.4	0.5	7.3	0.3	6.8	2.1	0.3	0.2	10.6	0.3	6.6	0.2	0.0	0.9	0.0	0.0	0.6	7.3	0.1	0.0	0.0	10.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	13.2	30.0	2.7	24.4	24.2	12.4	53.9	15.9	38.3	42.6	6.0	1.0	8.1	1.2	0.0	0.0	0.4	7.6	2.7	6.8	24.4	0.0	0.0	8.3	1.8	5.5	0.1	20.6	0.0	11.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	46.4	0.0	0.0	1.7	1.1	0.7	1.7	0.0	25.7	0.0	9.1	17.5	0.0	1.3	0.0	0.0	0.2	10.6	36.2	0.1	0.0	0.0	21.1	0.9
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529629	"Enzymes, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071190			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		Yes	No			"Nucleoplasm, Golgi apparatus"	Midbody	"HPA071190: AB_2686358"	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	21.6	22.0	23.5	18.9	26.2	30.1	23.5	10.8	30.5	14.3	16.3	17.2	30.8	16.3	11.5	12.9	16.0	12.9	12.1	11.4	27.0	31.8	27.9	32.4	16.9	24.3	30.6	20.3	12.1	11.8	25.0	12.5	16.5	33.4	14.7	17.4	14.1	15.9	22.9	30.6	11.5	21.8	9.6	20.5	21.3	16.8	10.4	14.1	23.0	17.1	11.7	24.1	16.1	12.8	5.7	4.3	4.5	9.2	5.9	8.5	4.0	21.1	9.9	5.2	12.7	14.9	11.8	11.7	28.0	15.3	23.0	16.6	6.4	13.3	17.3	24.5	20.9	11.2	12.3	9.9	15.5	37.1	23.7	7.2	17.1	12.3	5.8	11.5	24.9	20.0	12.1	16.4	22.6	21.7	16.1	13.2	12.0	14.9	24.1	39.4	8.9	13.2	6.6	6.9	15.9	13.4	8.5	23.3	14.4	15.3	21.9	9.5	8.8	24.7	23.0	18.0	7.5	19.9	28.0	20.5	26.3	14.9	18.1	39.0	25.0	34.7	20.5	21.9	12.2	23.8	4.5	3.3	3.7	8.2	8.6	8.5	5.4	6.2	6.8	3.6	5.7	6.3	7.1	2.0	5.9	9.2	4.3	4.9	4.0	23.5	26.2	10.8	30.5	27.0	31.8	30.6	20.3	33.4	14.1	17.9	32.1	50.1	25.7	26.2	21.7	29.4	56.0	41.5	50.0	50.6	11.8	22.6	48.0	23.2	35.7	30.8	40.7	0.0	20.2	32.6	19.3	44.8	45.0	71.0	27.6	22.3	32.1	35.0	64.6	34.6	19.8	51.7	27.0	44.1	35.0	13.6	28.8	34.8	18.4	49.4	21.6	0.0	27.3	23.4	22.0	21.5	18.8	52.2	31.1	52.1
UHRF1BP1	"C6orf107, dJ349A12.1, FLJ20302, ICBP90"	ENSG00000065060	"UHRF1 binding protein 1"	Q6BDS2	6	34792015-34883138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032099, HPA032100"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA032099: AB_10696057, HPA032100: AB_10671087"	"unprognostic (2.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.58e-2)"	"unprognostic (4.39e-3)"	"unprognostic (9.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.24e-2)"	7.6	9.3	7.6	7.6	8.2	18.7	6.7	18.5	10.9	4.8	5.9	7.1	4.7	5.1	5.5	4.4	6.0	5.3	4.5	13.7	6.1	5.8	6.1	10.9	8.0	6.9	5.5	6.8	6.6	13.1	15.1	9.5	8.1	7.7	6.0	6.3	6.8	8.6	5.1	22.2	4.9	5.5	6.4	7.6	6.8	7.2	22.5	5.5	8.5	9.4	3.2	6.8	5.9	10.8	1.5	1.2	1.1	4.5	1.4	1.3	0.8	8.5	6.1	5.5	17.7	2.9	2.1	9.9	5.0	3.4	4.9	7.0	12.1	2.3	12.9	5.5	5.2	8.6	6.5	19.9	2.8	6.7	6.6	6.4	11.4	5.9	10.1	11.8	10.3	7.2	4.8	8.3	3.9	8.4	4.6	6.1	11.3	19.0	5.1	2.1	8.1	7.9	6.7	2.5	6.2	4.3	4.8	8.8	7.7	6.6	7.9	6.6	6.7	12.6	6.6	16.9	5.9	12.7	13.5	3.7	2.4	9.0	3.8	5.5	7.7	11.9	8.2	1.3	14.4	6.0	0.5	1.2	1.1	1.3	1.7	1.3	1.3	1.2	1.3	1.2	1.5	0.6	1.0	0.7	1.4	4.5	0.5	0.4	0.8	7.6	8.2	18.5	10.9	6.1	5.8	5.5	6.8	7.7	5.5	14.9	4.6	1.5	2.5	0.9	9.5	14.6	5.1	4.0	10.3	0.0	19.6	5.6	1.7	5.1	8.0	4.5	3.5	0.0	5.0	3.0	3.5	8.1	1.1	5.1	12.9	4.8	9.1	17.8	11.7	11.0	5.2	8.2	0.0	10.8	3.4	5.6	7.9	2.9	2.5	3.8	11.3	12.9	3.4	13.7	11.9	2.5	4.1	2.6	3.7	5.4
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149964007-149973710	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.9;lung: 9.7;testis: 10.5"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 23.1;JURKAT: 17.8"									"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: AB_2686332"	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.7	0.6	2.0	0.4	0.6	0.5	0.5	13.9	1.5	0.4	0.7	0.2	0.0	0.4	0.5	0.5	0.8	0.9	0.5	1.2	1.5	0.3	1.2	0.9	9.7	0.2	0.3	0.0	1.2	0.4	0.6	0.6	1.3	1.0	0.8	0.4	0.5	1.0	0.2	1.6	0.6	0.3	0.3	1.2	0.3	0.9	10.5	0.2	0.2	3.8	0.6	0.5	0.7	4.9	0.7	0.1	0.9	1.8	0.3	3.5	0.3	2.7	1.3	2.6	1.4	2.6	7.7	2.7	3.6	1.1	1.6	2.8	1.8	3.1	2.7	2.9	12.4	6.6	2.6	23.1	4.5	4.3	12.0	3.8	0.2	0.9	0.0	13.6	0.1	1.0	8.4	5.6	11.4	3.0	1.3	2.3	17.8	2.2	0.0	4.0	3.2	2.8	0.0	0.9	1.7	4.2	1.2	2.4	0.3	4.9	2.0	0.9	0.3	5.3	3.3	0.8	1.6	2.6	5.3	1.9	1.3	2.3	5.1	3.2	0.4	0.4	2.5	7.9	4.0	3.3	0.1	0.2	0.1	2.4	1.3	3.5	0.7	1.2	2.8	0.1	0.2	0.7	1.2	0.9	0.3	1.8	0.0	1.9	0.3	2.0	0.6	13.9	1.5	1.5	0.3	0.3	0.0	1.0	0.2	6.0	2.1	0.0	0.4	0.1	0.0	0.4	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	0.0	0.0	0.0	0.1
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942000-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.8"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 6.9;Exocrine glandular cells: 7.4;Ito cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.0;U-2197: 23.1"									CAB018974	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Vesicles, Plasma membrane"		"CAB018974: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	3.3	1.7	4.5	1.9	2.3	4.3	5.9	5.3	6.5	1.6	0.6	0.0	0.0	0.9	0.6	0.5	10.8	0.5	1.6	4.1	4.4	1.0	1.9	1.7	6.2	1.1	1.0	2.1	0.2	1.6	0.3	1.1	4.4	3.9	0.6	0.7	0.3	1.5	0.4	0.6	1.0	0.4	2.0	0.6	0.5	0.7	3.6	0.1	0.5	3.5	4.6	2.4	4.1	5.2	0.0	0.0	0.0	0.0	0.8	5.5	0.9	9.2	0.8	0.2	2.9	0.5	2.8	1.6	9.6	5.6	10.1	8.3	3.5	5.3	0.0	14.7	10.9	14.5	6.6	3.6	8.8	5.8	4.2	1.9	0.5	1.4	0.0	3.6	0.0	0.7	1.3	6.8	8.9	3.9	8.2	5.7	8.0	1.1	0.0	7.4	6.4	0.8	0.0	0.0	1.7	4.9	1.4	2.2	0.0	14.3	2.7	0.3	0.0	32.0	0.7	0.9	1.6	0.9	4.0	8.9	6.6	8.3	23.1	11.0	0.0	0.0	0.4	9.5	5.1	4.7	0.0	0.0	0.0	5.5	0.0	0.6	0.0	1.8	3.2	0.0	0.0	0.6	3.9	0.0	0.8	0.0	0.0	3.0	0.9	4.5	2.3	5.3	6.5	4.4	1.0	1.0	2.1	3.9	0.1	0.0	2.2	0.0	5.4	3.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	6.9	6.3	3.8	0.0	0.0	7.4	0.2	0.9	0.9	0.0	0.0	1.8	0.0	0.0	9.2	1.2	6.4	0.0	1.7	1.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	1.0	2.3	3.2	2.5	0.0	2.9	0.0	3.2
ULK1	"ATG1, ATG1A"	ENSG00000177169	"Unc-51 like autophagy activating kinase 1"	O75385	12	131894651-131923167	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 50.9;Rod photoreceptor cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9;plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063990			Approved	Cytosol		NA	NA			Cytosol		"HPA063990: AB_2685167"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.21e-3)"	"unprognostic (8.01e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.04e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.03e-2)"	"unprognostic (9.09e-3)"	"unprognostic (8.19e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.16e-1)"	10.9	18.6	14.6	9.2	49.6	33.2	8.9	24.0	24.4	14.4	11.8	6.9	13.3	11.7	16.5	10.7	9.8	10.6	16.2	17.4	11.5	8.3	9.0	15.8	9.0	8.3	7.9	12.0	18.2	59.6	13.8	23.8	17.2	11.6	13.4	4.0	13.9	18.1	13.4	33.4	24.3	11.5	10.2	5.4	16.5	11.4	11.4	11.4	13.8	10.7	9.6	6.5	12.1	10.9	0.6	6.4	6.9	1.7	0.2	0.8	0.6	5.2	16.9	7.8	9.7	3.5	2.9	10.7	8.3	6.0	3.6	2.9	3.6	5.4	1.4	8.8	5.8	7.2	5.2	1.7	3.3	1.0	5.6	10.2	3.5	13.8	4.9	6.6	2.5	7.8	5.3	9.1	3.9	1.6	9.9	4.4	10.8	4.6	4.2	2.3	11.9	15.6	14.7	8.6	2.4	16.2	11.8	2.8	6.9	2.1	6.5	19.9	11.0	8.9	9.2	4.6	8.3	13.9	17.1	8.3	8.5	5.1	14.8	3.8	18.6	6.7	1.9	14.4	4.4	9.8	0.2	1.7	2.3	0.8	0.7	0.2	0.1	0.7	0.7	0.3	0.6	0.5	0.5	6.9	0.2	0.7	6.4	0.5	0.6	14.6	49.6	24.0	24.4	11.5	8.3	7.9	12.0	11.6	11.4	14.9	16.7	11.8	5.7	12.8	23.0	18.0	17.8	4.0	11.4	7.0	37.3	4.0	1.7	8.0	0.7	12.0	5.2	0.0	10.9	2.6	9.3	12.0	3.5	23.1	4.8	50.9	18.4	6.2	11.9	1.9	11.5	5.4	5.0	3.6	15.4	12.6	18.3	7.0	14.9	2.4	87.3	12.9	10.3	3.9	5.9	16.9	14.4	8.3	8.3	6.9
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 279.5;Late spermatids: 329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	4.3	4.8	5.1	4.7	8.3	10.3	4.2	4.3	5.4	11.9	2.8	5.9	6.0	2.1	10.7	10.9	2.8	12.3	3.1	13.1	5.2	3.0	5.4	3.4	5.5	4.2	3.1	4.2	4.5	3.6	13.5	19.7	9.0	5.8	4.4	2.8	6.7	4.2	4.5	1.4	3.5	3.3	5.1	5.7	4.4	3.4	27.5	3.4	6.3	7.1	1.7	8.4	4.0	6.0	6.4	5.1	10.7	6.3	2.6	10.3	5.2	7.3	1.7	2.7	3.0	1.1	1.7	4.6	2.5	2.6	3.1	2.6	0.9	2.2	8.6	1.4	5.8	3.0	3.7	3.2	1.9	2.8	1.1	0.9	1.6	5.4	2.9	3.9	5.6	1.7	1.6	2.2	15.0	3.1	3.9	2.1	5.9	1.9	7.2	2.2	5.9	7.0	4.5	3.3	1.8	3.1	1.6	8.5	3.7	6.5	7.1	1.4	9.9	2.6	1.2	2.1	1.8	3.0	1.8	6.2	2.0	2.2	13.2	2.1	4.3	8.0	3.6	11.0	5.9	2.4	5.7	5.8	5.8	8.0	6.3	6.5	5.6	8.6	7.2	5.1	6.4	6.5	9.2	10.7	2.6	3.2	4.6	10.3	5.2	5.1	8.3	4.3	5.4	5.2	3.0	3.1	4.2	5.8	3.4	8.9	5.8	1.9	2.8	1.8	5.4	12.8	5.1	53.5	4.5	3.5	51.1	2.8	0.0	2.3	279.5	4.4	1.1	0.0	2.1	3.9	3.3	1.2	1.1	5.9	6.5	11.1	1.7	1.8	4.1	329.6	6.1	5.6	0.0	6.4	1.1	11.2	2.8	0.0	3.9	5.0	25.1	6.5	3.3	29.9	8.7	3.1	3.5	4.4	1.7	0.8
UMAD1	"RPA3-AS1, RPA3OS"	ENSG00000219545	"UBAP1-MVB12-associated (UMA) domain containing 1"		7	7640711-7968020	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044806	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044806: AB_10961141"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.08e-3)"	"unprognostic (9.24e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.87e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.73e-8)"	"unprognostic (6.66e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.58e-1)"	4.1	8.7	7.0	6.5	8.5	3.8	6.7	6.8	8.8	4.2	6.1	5.3	9.6	7.6	6.2	7.8	4.2	5.0	5.1	6.6	5.5		8.7	7.0	6.6	6.9	7.5	8.3	7.2	18.7	12.5	17.0	4.2	8.1	10.0	5.8	6.1	11.4	11.9	3.5	2.6	8.1	6.3	7.3	5.1	11.6	2.4	6.3	8.6	12.9	3.5	6.3	7.1	8.4	17.0	9.7	27.4	13.0	10.1	22.0	10.9	14.1	10.5	5.4	6.2	7.8	9.2	6.2	8.8	10.1	6.9	10.6	4.4	10.6	7.7	9.3	5.4	28.0	9.2	6.1	8.8	8.7	5.8	4.7	4.2	8.0	5.1	8.7	7.7	9.9	8.7	11.1	10.0	7.7	8.1	4.2	10.2	8.6	23.9	9.1	11.5	7.0	4.2	9.7	9.5	8.8	7.8	12.7	12.3	12.6	6.5	2.2	8.9	12.3	15.9	12.4	16.7	12.4	9.5	4.6	7.1	16.7	13.9	8.8	17.2	18.8	8.9	16.0	11.1	21.8	22.8	9.7	24.6	12.1	12.4	15.0	17.0	17.3	15.1	8.1	16.2	20.5	15.3	27.4	10.1	13.0	9.7	22.0	10.9											23.8	11.0	5.3	24.5	0.0	6.5	10.1	12.7	17.4	18.2	14.0	13.7	14.4	33.2	7.4	6.3	6.0	11.2	0.0	12.8	17.6	9.6	27.0	14.0	8.9	14.4	14.3	5.8	4.9	9.8	2.8	12.4	9.3	0.0	7.2	14.3	11.3	9.3	11.0	7.4	26.2	9.4	25.8	7.4	3.0	4.6	0.0	17.7	10.2	9.9	19.2
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730366-124749273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 91.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	8.4	12.2	4.9	6.8	6.8	4.8	8.0	9.3	7.6	5.9	9.1	8.5	5.2	8.4	6.8	6.7	13.2	8.2	6.6	3.6	4.0	3.9	9.6	20.7	5.2	10.1	7.3	3.6	8.9	19.0	9.5	9.3	11.6	4.7	6.4	7.1	6.4	8.9	4.0	10.9	9.5	8.5	5.5	5.9	9.8	8.3	6.8	6.2	10.6	7.4	12.0	9.3	7.8	6.4	16.6	13.1	4.6	9.8	10.2	13.0	7.9	1.4	4.4	5.0	2.1	3.0	3.5	5.3	7.5	2.3	3.2	2.7	3.8	2.0	3.8	8.3	2.9	6.6	8.4	7.1	2.5	5.0	4.4	4.1	7.8	2.8	2.6	2.6	8.2	5.9	3.9	2.3	2.0	3.9	1.9	1.4	7.7	3.5	1.8	2.3	3.4	10.0	1.6	11.1	3.9	2.8	6.6	6.0	3.2	2.5	2.5	4.0	2.6	11.3	4.0	4.2	3.8	4.0	3.0	14.4	2.5	5.0	6.9	3.0	7.5	10.2	10.5	2.8	3.4	2.5	4.5	9.0	4.6	12.5	9.8	12.1	13.7	8.9	11.3	13.1	16.6	13.0	10.4	0.6	10.2	8.0	9.7	10.3	7.9	4.9	6.8	9.3	5.7	4.0	3.9	7.3	3.6	4.7	6.2	6.0	7.8	5.2	15.9	14.1	8.0	5.7	12.7	22.7	10.3	8.7	3.9	56.7	24.9	23.5	3.1	13.4	10.4	0.0	26.6	27.5	9.3	9.3	11.5	28.8	19.3	4.8	9.2	8.0	5.4	3.9	12.7	9.6	3.3	21.6	9.4	10.1	19.5	7.0	13.1	19.5	7.7	12.9	9.9	19.7	30.7	16.7	91.3	12.8	15.8	15.5
UNC119B	"MGC5139, POC7B"	ENSG00000175970	"Unc-119 lipid binding chaperone B"	A6NIH7	12	120710435-120723640	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077812	Enhanced		Approved	"Cytokinetic bridge,Mitotic spindle,Mitochondria,Cytosol"		Yes	No			"Cytokinetic bridge, Mitotic spindle"	"Mitochondria, Cytosol"	"HPA077812: "	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (9.35e-2)"	"prognostic favorable (6.69e-10)"	"unprognostic (2.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.42e-2)"	12.7	33.5	18.1	9.2	18.6	9.5	16.3	17.0	17.2	16.0	12.1	15.0	18.7	8.6	20.7	15.0	11.6	42.8	14.9	13.2	18.9	19.7	27.1	14.7	14.0	9.3	14.2	16.0	33.7	17.1	40.8	25.8	13.4	20.4	18.4	12.3	14.6	14.1	23.8	6.7	13.6	11.4	17.5	15.5	13.4	14.5	21.9	15.2	16.1	38.6	7.3	13.7	12.1	16.3	2.1	2.5	2.1	5.8	2.5	4.0	1.4	11.5	11.2	23.4	20.0	23.5	17.5	19.9	14.4	16.8	16.4	7.4	13.4	4.8	11.7	5.7	16.0	7.9	12.3	24.7	16.1	17.0	9.1	12.5	5.4	8.3	8.3	15.9	14.8	8.6	13.7	16.6	12.2	18.9	26.5	18.4	17.8	13.1	1.3	13.8	10.2	13.5	12.2	28.9	13.2	13.9	16.3	15.6	6.0	19.6	24.3	14.1	17.8	34.4	6.8	11.8	17.3	26.8	10.2	11.5	15.3	10.5	6.5	9.6	9.5	8.2	7.2	18.1	7.5	16.5	0.2	1.1	1.3	3.3	0.6	2.1	1.8	3.0	3.8	1.2	2.1	4.0	3.2	2.1	2.5	5.8	2.5	2.8	1.4	18.1	18.6	17.0	17.2	18.9	19.7	14.2	16.0	20.4	15.2	3.0	6.9	2.9	6.5	2.6	8.1	3.5	5.1	18.7	5.7	17.4	9.8	9.1	13.3	6.6	11.8	6.3	3.5	0.0	6.7	4.0	6.2	10.2	2.3	5.5	2.7	7.9	13.7	8.6	3.7	2.2	12.0	1.8	5.0	0.0	6.1	11.2	6.9	5.8	15.2	11.8	9.8	12.9	5.0	11.4	14.5	2.9	4.3	9.2	8.0	6.4
UNC13B	"hmunc13, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 53.6;Alveolar cells type 2: 55.9;Cone photoreceptor cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"		Yes	No			Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: AB_2684742"	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favorable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	11.9	12.1	9.3	9.0	18.3	1.4	10.4	16.6	18.8	12.2	21.4	10.1	35.0	11.5	10.6	8.4	14.9	11.1	14.6	11.1	9.2	7.1	22.1	21.5	37.6	2.2	9.5	9.5	7.9	28.7	21.7	13.7	6.3	10.1	20.5	25.1	27.2	20.7	33.6	21.1	14.6	13.0	12.2	9.4	5.0	15.8	16.2	9.1	0.8	12.5	11.6	5.8	8.6	10.4	0.9	1.9	0.0	0.4	0.0	0.3	0.4	5.4	7.2	8.1	13.0	15.6	8.7	6.8	8.9	4.0	6.6	9.0	6.0	2.5	0.0	4.1	11.6	11.7	2.6	20.3	10.3	8.5	0.0	6.5	3.3	20.6	7.7	7.5	1.2	3.7	6.9	8.1	10.4	10.8	10.6	21.3	9.0	7.4	4.6	7.7	4.1	1.1	0.1	7.3	16.9	7.6	0.0	5.0	1.9	9.1	7.1	8.7	9.1	6.2	3.9	6.5	14.0	6.6	4.2	19.5	4.6	4.3	7.1	6.8	7.4	8.8	0.0	5.0	10.3	4.6	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.3	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	9.3	18.3	16.6	18.8	9.2	7.1	9.5	9.5	10.1	9.1	53.6	55.9	0.8	1.2	2.7	37.4	11.0	17.8	10.7	25.0	8.7	90.3	3.2	3.3	6.0	5.6	6.7	14.8	0.0	10.6	1.9	3.1	10.8	2.3	11.1	4.1	6.4	23.6	4.9	2.2	8.5	2.0	3.1	6.8	0.0	28.6	6.7	8.2	14.1	2.8	6.8	42.9	6.5	4.7	7.5	8.3	6.5	2.4	0.0	16.7	2.6
UNC45B	"CMYA4, UNC45"	ENSG00000141161	"Unc-45 myosin chaperone B"	Q8IWX7	17	35147817-35189345	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 181.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.9;testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.5"	"Group enriched"	"Detected in some"	11	"BEWO: 4.7;HSkMC: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017861			Approved	Cytosol		NA	NA			Cytosol		"HPA017861: AB_1847012"	"unprognostic (7.17e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.49e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.13e-6)"	"unprognostic (6.77e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	0.3	48.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.2	62.5	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.2	23.2	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	0.2	2.9	0.0	0.7	1.8	0.0	0.0	0.4	2.0	0.2	0.3	0.3	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	181.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	25.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	42.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0
UNC5A	"KIAA1976, UNC5H1"	ENSG00000113763	"Unc-5 netrin receptor A"	Q6ZN44	5	176810477-176880898	"Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 11.9;brain: 35.3"	"Cell type enhanced"	"Detected in some"	24	"Horizontal cells: 4.8;Late spermatids: 1.9;Muller glia cells: 10.3;Rod photoreceptor cells: 2.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.8;eosinophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.8"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 44.3"	"Group enriched"	"Detected in all"	4	"amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1"	"Low region specificity"	"Detected in all"			HPA071450			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA071450: AB_2686397"	"unprognostic (5.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.66e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.07e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.77e-5)"	"unprognostic (6.39e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.17e-2)"	0.9	11.9	10.5	1.1	11.1	1.2	1.4	35.3	30.9	1.1	0.7	0.4	0.0	1.3	0.8	0.9	0.7	1.5	1.0	0.7	7.6	4.6	0.7	0.7	0.9	1.7	1.6	12.6	0.9	3.2	0.6	5.1	0.6	2.1	0.8	0.7	0.3	0.9	0.7	0.6	0.7	0.9	0.8	0.8	0.6	1.2	1.3	0.5	0.0	0.8	0.0	0.7	0.9	0.2	0.0	0.0	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	1.7	0.0	0.0	0.0	1.2	5.1	0.0	44.3	1.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.3	1.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	10.5	11.1	35.3	22.2	7.6	4.6	1.6	12.6	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	10.3	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026911-41039217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 52.2;kidney: 60.9;liver: 29.9"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 40.8;Collecting duct cells: 21.0;Exocrine glandular cells: 59.0;Hepatocytes: 25.2;Pancreatic endocrine cells: 25.3;Proximal tubular cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"OE19: 31.1;RPTEC TERT1: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA015725	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	0.4	0.2	0.4	0.6	0.4	0.3	0.5	0.4	0.4	0.4	9.9	0.5	0.4	23.7	0.8	0.8	0.5	0.7	10.2	0.4	0.4	0.1	60.9	29.9	0.9	0.4	0.4	0.4	0.5	17.7	0.1	0.6	0.8	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.6	52.2	0.4	0.4	1.2	15.9	0.6	0.4	0.4	0.7	0.4	0.4	0.4	0.4	0.3	1.0	0.7	0.3	0.0	2.4	0.2	0.3	0.1	0.4	0.6	0.1	0.1	0.4	0.0	0.0	0.0	0.0	4.9	0.1	0.0	1.8	0.0	0.0	0.1	0.1	0.2	0.0	0.7	0.9	0.4	0.0	2.6	0.1	0.2	0.1	0.1	0.4	0.0	0.3	0.0	0.0	2.0	0.3	0.3	0.0	0.1	0.6	1.5	0.2	31.1	0.1	0.6	0.0	0.3	9.5	0.0	0.4	0.4	0.0	0.0	0.9	0.5	0.1	0.1	0.1	0.0	0.3	0.2	0.0	3.1	1.5	0.4	0.0	1.0	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.2	0.7	0.2	0.1	0.3	0.4	0.0	0.0	0.0	0.3	1.0	2.4	0.2	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	3.0	1.4	0.9	0.6	0.7	0.2	0.6	40.8	0.0	0.0	21.0	3.9	0.4	3.3	14.5	1.7	0.2	5.9	0.0	59.0	0.7	0.4	0.5	0.0	25.2	0.3	1.6	1.2	1.3	0.6	0.0	0.3	1.0	1.7	1.0	2.7	0.3	25.3	1.5	0.7	29.6	0.3	0.0	0.3	0.4	0.7	0.1	0.7	0.5	4.1	0.3
UNC79	KIAA1409	ENSG00000133958	"Unc-79 homolog, NALCN channel complex subunit"	Q9P2D8	14	93333219-93707876	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.6;pituitary gland: 18.9"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 42.7;Early spermatids: 28.8;Horizontal cells: 38.1;Late spermatids: 12.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 8.5;SCLC-21H: 6.3;SH-SY5Y: 4.0;U-937: 3.0"	"Low region specificity"	"Detected in all"							HPA071881			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA071881: AB_2732189"	"unprognostic (8.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.70e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.73e-3)"	"unprognostic (8.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.47e-2)"	1.1	3.9	7.1	1.0	12.1	0.9	1.0	17.6	14.6	1.0	1.1	4.5	0.0	1.1	1.1	1.1	1.2	2.0	1.1	1.2	6.7	5.8	1.4	1.1	1.0	1.0	3.2	9.1	1.1	5.0	1.4	18.9	1.0	6.8	1.0	1.1	1.3	1.0	1.0	1.6	1.0	1.1	1.2	3.0	0.9	1.9	7.0	3.5	0.0	1.3	0.0	1.0	1.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.1	0.0	0.0	8.5	0.0	0.0	0.2	0.2	6.3	4.0	0.1	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	7.1	12.1	17.6	14.6	6.7	5.8	3.2	9.1	6.8	3.5	0.0	0.0	0.0	0.2	0.2	42.7	2.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.3	28.8	0.3	0.4	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.2	38.1	0.0	0.0	0.6	12.6	0.6	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.4	1.4	4.7	0.0	1.0	3.3	1.6	0.3	0.6	0.0	0.1	0.3
UNC80	"C2orf21, FLJ33496, KIAA1843, UNC-80"	ENSG00000144406	"Unc-80 homolog, NALCN channel complex subunit"	Q8N2C7	2	209771993-209999300	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 10.0;brain: 27.2;pituitary gland: 20.1;testis: 6.9"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 111.2;Cone photoreceptor cells: 62.8;Horizontal cells: 49.3;Muller glia cells: 36.9;Rod photoreceptor cells: 74.9"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 5.2;SCLC-21H: 8.5;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042472, HPA050959"	Enhanced		Approved	"Nuclear bodies,Vesicles"		NA	NA			"Nuclear bodies"	Vesicles	"HPA042472: AB_10965318, HPA050959: "	"unprognostic (7.91e-3)"	"unprognostic (2.25e-4)"	"unprognostic (1.44e-2)"	"unprognostic (3.20e-4)"	"unprognostic (1.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.16e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.40e-3)"	0.9	10.0	10.2	0.9	19.3	0.9	0.9	27.2	23.4	1.0	1.0	2.1	0.0	1.0	1.3	1.8	0.9	1.7	3.6	1.0	8.0	7.4	1.0	0.9	1.1	0.8	5.4	13.5	2.1	3.2	1.4	20.1	0.9	14.5	3.2	1.1	3.0	0.9	1.5	0.8	1.2	1.1	1.3	2.2	1.1	1.9	6.9	4.9	0.0	1.5	0.0	0.8	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	8.5	4.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	19.3	27.2	20.2	8.0	7.4	5.4	13.5	14.5	4.9	0.0	0.6	0.0	0.2	0.7	111.2	1.7	0.0	1.4	1.2	0.0	62.8	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.1	0.0	0.1	49.3	0.0	0.0	0.0	7.6	0.9	0.0	0.0	0.0	0.0	36.9	0.2	0.0	1.8	0.0	74.9	0.0	0.0	2.1	2.9	0.1	0.0	0.0	0.0	0.3
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991104-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 31.3;RPMI-8226: 87.0;SK-BR-3: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176"	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	8.0	2.7	5.7	9.7	7.4	9.2	5.0	6.2	7.0	4.7	11.9	5.3	6.9	11.8	2.3	5.7	5.5	4.1	13.9	4.6	8.7	6.0	5.9	7.1	13.4	20.8	3.6	0.4	3.0	5.2	0.8	3.3	6.7	2.7	5.3	1.2	5.0	12.3	9.0	6.1	3.7	16.9	2.7	3.5	28.6	10.7	4.1	2.2	2.6	5.3	2.4	13.3	5.9	2.8	2.5	13.6	5.7	6.6	1.8	0.2	0.9	4.5	8.2	0.6	3.3	1.8	0.6	7.1	2.0	1.8	3.2	2.9	0.6	31.3	10.0	7.8	0.9	2.7	10.9	0.2	1.7	0.1	3.5	2.3	1.0	2.6	1.5	2.8	7.1	5.7	1.5	1.8	0.9	0.3	1.2	0.6	1.5	0.7	4.7	0.5	4.3	0.0	5.6	1.5	11.0	4.4	5.9	0.0	87.0	2.8	2.5	0.9	1.4	3.4	23.4	4.5	0.2	8.7	9.3	2.2	2.1	3.1	3.1	0.2	3.3	4.4	1.6	4.0	7.3	2.5	0.1	3.6	5.7	0.1	6.6	0.2	2.4	0.2	0.2	4.7	2.5	0.0	0.0	3.1	1.8	6.6	13.6	0.0	0.9	5.7	7.4	6.2	7.0	8.7	6.0	3.6	0.4	2.7	2.2	8.9	7.8	29.4	21.8	3.5	0.0	1.6	35.7	36.1	6.8	15.7	0.0	9.0	1.7	33.6	0.6	5.8	24.2	0.0	20.5	41.1	8.3	14.1	6.9	4.0	87.3	4.8	4.1	5.5	53.9	0.0	4.0	51.3	21.9	53.3	14.2	4.8	34.0	21.0	3.9	5.7	0.3	0.0	4.2	0.0	0.9	5.6	6.1	9.6	18.7	30.4
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232907-1237318	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 44.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	20	"cerebellum: 44.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"NB-4: 47.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Region enriched"	"Detected in many"	8	"cerebellum: 19.3"	HPA063294			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063294: AB_2684977"					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.1	0.1	0.0	0.2	0.0	0.1	0.1	44.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	3.5	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	1.1	0.9	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097574-109110992	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol		NA	Yes			Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	16.3	44.1	17.0	19.4	17.0	10.0	22.8	10.5	14.4	13.5	20.3	10.2	21.4	12.6	11.8	10.8	22.5	11.8	11.0	15.4	13.5	13.1	20.4	23.3	7.1	12.1	19.6	12.2	12.3	12.7	17.3	8.9	18.6	12.0	12.9	22.1	10.7	16.6	19.7	29.1	22.5	13.5	11.0	19.7	13.2	12.3	35.6	9.8	35.1	25.1	19.8	19.0	11.5	14.4	9.8	3.9	5.8	3.0	8.7	19.5	7.9	20.1	20.7	20.0	18.1	33.3	9.6	19.1	11.9	8.2	18.9	14.5	16.4	13.9	26.5	18.0	10.7	9.9	12.8	22.0	12.4	18.4	22.4	40.9	25.9	12.0	27.7	5.0	38.4	16.0	8.6	11.4	9.0	5.0	15.1	13.6	31.9	20.9	8.9	12.7	25.2	35.3	45.4	35.5	32.9	32.0	32.6	30.1	22.6	11.8	25.5	28.5	15.8	21.5	18.5	10.4	27.2	34.5	18.0	7.0	16.4	14.7	10.8	16.5	17.3	37.2	50.3	12.5	25.9	20.0	5.8	1.5	2.7	13.4	3.0	19.5	9.8	15.9	15.5	3.9	9.2	10.3	11.5	0.0	8.7	3.0	2.8	14.0	7.9	17.0	17.0	10.5	14.4	13.5	13.1	19.6	12.2	12.0	9.8	0.0	4.5	6.7	10.0	16.0	2.6	10.6	7.6	2.7	2.3	40.1	3.9	41.8	16.6	11.9	3.2	11.6	7.3	0.0	5.5	24.6	10.3	5.9	7.0	20.3	15.7	4.8	8.1	14.7	2.9	3.4	13.0	4.5	13.5	5.4	18.2	11.8	5.9	7.0	13.8	14.6	3.0	6.5	9.0	18.6	64.3	18.2	17.0	17.8	34.2	7.6
UPF3A	"HUPF3A, RENT3A, UPF3"	ENSG00000169062	"UPF3A, regulator of nonsense mediated mRNA decay"	Q9H1J1	13	114281584-114305817	"Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018325, HPA061316"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA018325: AB_1858638, HPA061316: AB_2684477"	"unprognostic (9.08e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.44e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.71e-4)"	11.3	16.3	16.9	10.9	20.2	11.9	10.9	32.8	21.9	10.4	9.9	18.6	13.0	13.8	13.1	12.3	10.1	13.2	9.2	7.1	16.1	14.9	11.0	7.5	9.2	12.0	20.2	16.0	12.7	15.4	8.1	12.8	8.5	17.2	12.1	8.7	10.0	11.9	16.1	16.1	11.9	11.9	10.2	23.6	11.8	11.2	34.5	16.7	10.7	24.0	7.4	7.9	11.2	9.3	11.7	15.6	4.1	5.5	11.1	9.5	4.3	23.3	6.9	15.3	13.7	7.3	12.8	9.8	18.1	13.1	11.6	13.0	10.4	8.3	23.0	5.3	8.3	7.8	12.6	7.5	6.0	14.7	16.8	14.8	19.8	19.6	11.4	12.8	34.3	8.9	8.6	12.5	7.8	9.2	12.3	9.2	6.0	12.0	10.7	11.6	7.1	13.9	9.2	20.4	15.6	6.9	18.3	8.6	13.4	10.4	7.5	17.4	19.2	14.4	22.3	12.9	10.8	16.5	30.9	11.8	12.4	20.7	6.7	11.3	23.4	16.2	31.9	22.8	19.8	10.1	1.9	5.5	4.1	6.8	4.4	5.3	11.7	7.1	7.0	6.0	9.1	7.4	6.7	0.8	11.1	5.1	15.6	9.5	4.3	16.9	20.2	32.8	21.9	16.1	14.9	20.2	16.0	17.2	16.7	62.5	46.2	54.7	55.8	61.0	74.4	18.2	43.3	133.8	69.4	55.8	78.5	57.6	87.9	47.2	134.0	84.2	27.6	0.0	61.9	38.0	72.4	48.5	52.2	59.5	40.0	74.7	55.2	57.7	33.2	66.4	93.2	41.0	52.3	48.7	45.2	66.8	45.9	35.1	82.4	45.3	72.8	84.1	54.5	503.7	176.2	62.9	33.9	57.5	58.3	32.4
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"kidney: 40.1;liver: 22.1"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 11.6;Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Nucleoplasm	"Vesicles, Mitochondria"	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	1.2	0.4	1.8	0.3	4.1	0.3	1.6	6.9	2.0	0.4	0.3	1.5	0.7	0.3	1.2	2.4	1.0	0.4	2.5	0.8	2.9	1.2	40.1	22.1	0.3	0.4	1.2	0.9	0.6	0.4	0.3	3.9	0.4	1.3	2.3	0.3	1.1	1.7	0.7	0.3	0.6	0.4	0.3	2.3	0.3	0.3	0.4	1.0	0.0	0.5	0.0	0.7	0.4	0.2	0.8	0.0	1.0	0.1	0.0	0.2	0.0	0.3	0.2	0.6	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.9	0.0	0.7	0.8	0.9	0.0	0.0	0.0	0.1	1.1	0.6	1.2	1.4	0.3	0.0	0.3	0.6	0.6	0.4	0.4	0.5	0.0	0.4	0.8	0.1	0.0	0.2	0.2	0.0	0.0	1.2	0.1	0.4	0.3	1.2	0.4	1.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.8	4.1	6.9	2.0	2.9	1.2	1.2	0.9	1.3	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
UPRT	"DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3"	ENSG00000094841	"Uracil phosphoribosyltransferase homolog"	Q96BW1	X	75274085-75304600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000805	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000805: AB_1080482"	"unprognostic (3.12e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.53e-3)"	8.8	15.3	14.6	7.9	15.8	14.9	10.7	20.3	18.7	11.5	9.9	10.8	10.8	14.2	10.0	12.5	13.0	10.2	8.4	12.0	13.1	17.7	15.5	11.3	10.0	10.7	14.9	9.6	8.7	14.1	18.7	19.5	7.6	13.2	12.8	11.0	9.1	13.1	8.6	13.3	7.4	10.5	14.0	10.9	11.0	13.9	3.0	12.4	10.6	13.9	6.5	11.9	9.1	7.9	8.3	11.1	8.9	16.4	14.7	13.3	7.4	7.8	5.6	6.2	5.8	6.7	7.3	5.9	5.5	6.6	6.0	6.7	4.9	5.3	11.0	4.8	5.7	10.6	3.4	14.3	5.0	9.7	10.0	5.7	6.9	5.9	6.2	6.5	13.5	14.4	5.5	3.5	8.3	4.3	9.5	10.4	9.1	8.0	11.1	15.6	3.3	15.3	8.3	12.6	5.8	9.2	7.2	16.4	5.3	15.3	4.6	0.4	6.5	7.8	8.1	7.6	11.5	3.6	8.6	8.7	7.6	4.6	13.9	4.7	7.6	24.6	10.7	8.1	14.9	4.8	5.1	7.4	8.9	8.3	10.7	9.5	8.3	8.3	8.5	11.1	7.2	10.5	9.3	1.3	14.7	16.4	5.0	13.3	7.4	14.6	15.8	20.3	18.7	13.1	17.7	14.9	9.6	13.2	12.4	6.0	5.3	8.2	7.9	5.6	6.2	5.2	0.0	1.4	6.8	8.7	0.0	6.4	23.2	7.6	1.4	7.1	5.2	0.0	5.3	11.5	5.6	6.9	24.2	5.8	10.5	9.5	5.8	14.1	10.8	0.5	4.0	11.0	13.5	4.6	5.9	8.8	4.7	2.9	3.2	13.4	6.3	6.5	7.2	0.4	1.7	5.3	10.2	8.9	6.0	5.6
UQCC1	"BFZB, C20orf44, CBP3, FLJ10850, UQCC"	ENSG00000101019	"Ubiquinol-cytochrome c reductase complex assembly factor 1"	Q9NVA1	20	35302566-35412141	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.2"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034875	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA034875: AB_10603226"	"unprognostic (9.66e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.45e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.34e-2)"	12.6	19.2	13.7	10.6	24.5	2.5	10.1	19.6	23.9	10.9	13.3	15.7	12.1	13.0	14.2	14.2	10.5	11.7	8.4	34.3	13.5	15.9	20.0	17.2	8.7	10.9	16.6	18.2	11.9	10.8	19.8	17.0	10.1	20.1	11.9	17.5	15.8	12.1	12.9	70.2	9.2	11.3	15.5	15.5	11.2	12.2	13.2	13.4	8.9	14.2	17.1	13.8	11.0	9.9	13.5	13.5	16.3	11.9	19.7	15.2	9.6	6.9	10.1	11.4	10.5	11.6	12.7	1.6	13.2	14.4	23.7	16.5	32.7	13.8	22.3	25.1	8.3	20.1	18.5	20.1	22.9	18.1	6.6	7.9	29.9	13.5	26.2	7.4	17.9	8.9	12.5	23.5	12.7	15.9	17.6	8.0	18.1	12.8	7.4	16.5	9.1	20.4	6.4	9.6	13.8	20.8	11.2	17.9	12.2	21.9	7.9	16.1	10.8	11.3	54.1	11.7	10.1	8.0	11.4	7.5	16.2	10.3	8.5	12.0	11.4	12.3	9.2	29.0	10.4	13.0	16.3	7.7	11.0	12.7	11.9	15.2	10.3	12.1	12.5	13.5	13.5	14.6	13.2	0.3	19.7	7.7	11.5	11.2	9.6	13.7	24.5	19.6	23.9	13.5	15.9	16.6	18.2	20.1	13.4	0.0	5.6	3.7	8.0	5.7	19.3	39.9	7.6	13.4	5.7	15.7	7.9	18.9	51.4	16.0	8.7	7.0	10.5	0.0	11.2	11.9	8.0	6.7	8.1	12.5	10.1	17.5	11.5	4.3	5.9	7.9	9.8	7.0	13.5	17.2	8.9	14.0	16.8	3.5	11.3	14.0	21.4	6.5	8.2	18.4	16.4	4.5	14.5	7.0	12.8	8.8
UQCC2	"bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1"	ENSG00000137288	"Ubiquinol-cytochrome c reductase complex assembly factor 2"	Q9BRT2	6	33694293-33711727	"Disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 791.0;Late spermatids: 864.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039111	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA039111: AB_2676352"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.43e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.07e-1)"	13.4	22.9	26.1	13.3	31.4	14.6	17.7	15.0	22.9	12.4	15.8	12.0	12.3	12.8	17.4	23.4	15.2	10.9	9.2	71.0	19.2	23.0	18.3	23.4	8.9	12.3	22.8	22.6	11.5	25.3	7.9	24.5	14.4	20.6	15.7	17.2	18.9	19.6	14.3	76.4	12.2	10.4	20.0	20.0	12.9	15.9	30.9	18.3	12.3	19.0	22.0	14.9	10.9	11.0	39.7	38.9	7.2	39.6	21.9	31.5	34.8	42.7	30.8	34.5	29.9	28.7	28.9	27.2	24.4	24.5	34.0	33.7	49.4	18.1	17.2	39.5	29.4	52.4	23.1	23.4	34.1	30.3	21.9	38.5	33.7	20.4	68.3	47.1	31.4	27.6	29.5	55.0	27.3	44.2	19.7	25.3	33.2	35.9	35.7	39.9	46.0	30.4	65.3	20.9	32.8	35.1	22.0	28.3	58.3	24.1	40.7	59.4	21.1	26.9	41.3	33.7	19.1	36.2	80.0	23.4	39.1	33.2	25.2	50.2	27.5	38.2	29.1	11.8	47.6	45.1	7.2	27.0	5.2	24.0	39.6	29.1	39.7	30.3	27.4	31.9	32.8	31.5	28.4	2.6	21.9	32.7	38.9	31.1	34.8	26.1	31.4	15.0	22.9	19.2	23.0	22.8	22.6	20.6	18.3	26.8	27.7	65.4	71.0	52.0	115.5	791.0	94.3	38.8	39.8	73.3	47.1	122.2	331.5	87.4	273.9	53.4	58.0	93.5	155.9	94.8	61.5	91.6	57.8	134.7	186.1	66.7	95.6	51.5	60.7	864.2	72.8	62.9	79.2	67.7	57.9	48.7	112.6	54.0	78.8	214.9	98.9	0.0	58.5	99.8	96.6	66.7	79.8	40.6	79.2	104.5
UQCRFS1	"RIP1, RIS1, RISP, UQCR5"	ENSG00000169021	"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	P47985	19	29205321-29213541	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.3"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 1206.2;Distal tubular cells: 877.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041863, HPA050339"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041863: AB_10794638, HPA050339: AB_2681095"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (7.91e-3)"	"unprognostic (3.93e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.92e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-2)"	15.2	27.1	20.1	10.8	18.3	25.4	28.2	18.3	33.4	11.9	27.3	9.1	9.8	24.3	10.5	14.3	16.9	11.9	14.2	95.3	19.4	14.8	34.9	33.8	12.0	21.2	18.3	13.1	9.1	26.4	15.9	10.6	10.8	17.6	11.8	30.3	11.5	17.0	13.9	112.3	12.9	27.0	19.6	11.5	11.3	18.8	16.6	6.5	17.7	12.9	55.0	14.5	13.7	10.0	18.5	35.6	14.9	29.9	15.0	22.1	45.1	21.8	37.0	13.8	12.4	22.6	17.3	15.3	17.1	17.9	23.7	26.3	22.4	13.6	19.9	18.1	19.3	19.4	23.3	30.1	20.4	28.7	13.5	30.1	28.2	14.6	20.3	19.2	26.8	24.8	20.8	22.1	16.2	24.7	14.0	18.9	24.9	20.0	12.5	25.4	20.2	18.7	20.1	14.4	46.7	14.4	17.1	18.4	15.1	29.5	26.4	16.8	8.2	15.6	30.9	19.6	16.1	14.4	22.4	11.9	16.1	24.5	11.0	17.7	6.0	11.3	18.4	14.2	23.3	11.4	14.9	29.9	14.0	17.9	29.3	17.8	18.5	19.2	18.3	35.6	15.7	20.4	19.4	9.1	15.0	24.3	19.7	22.1	45.1	20.1	18.3	18.3	33.4	19.4	14.8	18.3	13.1	17.6	6.5	50.6	43.5	83.4	229.0	131.1	67.3	1206.2	170.7	48.2	45.5	108.2	15.7	255.3	877.0	208.2	176.6	94.4	303.4	70.0	204.7	204.0	122.3	162.8	88.9	250.4	234.4	49.3	153.7	93.9	135.6	102.8	85.4	113.1	156.9	178.5	238.4	96.8	186.1	196.4	76.7	532.4	58.7	97.0	163.6	296.9	77.1	140.0	319.3	108.3	325.0	307.9
URM1	"C9orf74, MGC2668"	ENSG00000167118	"Ubiquitin related modifier 1"	Q9BTM9	9	128371319-128392016	"Predicted intracellular proteins"	"tRNA processing, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053645, HPA065160"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA053645: AB_2682215, HPA065160: AB_2685423"	"unprognostic (7.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.04e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.43e-6)"	"unprognostic (1.77e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.17e-2)"	27.2	28.9	25.4	22.4	25.5	31.3	23.2	19.4	40.9	23.4	26.3	36.0	19.7	30.9	25.0	24.4	26.5	26.9	22.9	32.3	25.0	21.4	25.5	39.1	20.8	28.5	29.2	22.9	23.4	53.2	21.2	19.6	28.6	32.0	23.7	25.2	22.2	29.2	23.9	34.9	24.4	36.6	26.4	31.8	30.6	25.6	19.2	21.4	34.9	28.0	29.7	28.8	23.0	20.5	12.4	16.7	10.2	17.7	11.3	15.5	11.5	9.0	17.7	16.0	10.8	16.3	16.1	14.5	8.3	14.7	21.4	14.7	14.0	14.5	18.1	7.0	18.9	14.1	30.3	20.3	18.8	10.8	12.8	14.0	15.3	21.3	16.4	15.9	18.5	15.4	20.8	16.8	16.7	14.4	15.5	25.9	21.0	20.6	12.9	15.2	20.3	26.3	27.3	20.0	36.6	21.2	21.6	20.7	22.8	17.3	8.1	14.4	19.0	15.8	26.8	20.3	10.0	25.7	15.4	14.6	15.8	15.0	15.7	14.4	12.4	22.9	18.6	16.5	16.1	19.5	5.6	14.3	10.2	15.5	17.7	13.1	12.3	13.5	14.2	16.7	12.4	13.5	14.4	3.7	11.3	16.1	12.4	14.9	11.5	25.4	25.5	19.4	40.9	25.0	21.4	29.2	22.9	32.0	21.4	14.9	23.2	41.0	28.6	20.1	18.6	19.3	15.3	14.7	10.3	26.2	13.7	74.6	59.7	60.6	1.9	40.5	64.5	0.0	97.1	67.0	38.6	29.5	36.9	19.5	72.0	9.5	21.4	36.2	33.2	2.7	28.7	35.3	50.6	87.4	43.2	22.6	72.9	43.2	29.4	39.9	14.1	19.4	24.2	21.3	25.3	20.8	60.0	45.0	55.7	26.7
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823248	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		15000	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	13.8	16.1	48.6	9.0	46.6	33.2	13.9	12.8	35.3	8.9	11.4	15.7	12.8	13.2	9.3	41.2	10.5	11.3	11.5	31.4	36.9	20.4	22.6	25.5	10.0	16.8	22.7	23.4	14.5	14.1	14.4	12.0	7.9	20.0	12.9	12.4	14.0	18.1	14.0	45.6	9.8	12.0	13.0	12.5	11.7	12.5	13.8	13.8	10.8	16.4	14.4	12.7	9.4	6.3	17.3	27.1	2.4	15.6	24.7	21.3	17.8	17.7	19.3	14.1	31.2	18.8	19.1	19.0	23.0	39.8	16.2	16.2	8.3	21.6	24.8	10.7	28.5	11.3	10.2	8.1	16.3	15.2	30.6	15.5	52.7	10.9	13.7	26.6	22.2	12.4	23.9	9.4	11.3	30.3	22.5	14.8	18.4	9.1	23.6	27.0	21.2	19.4	25.0	15.3	13.3	20.1	13.8	15.5	14.7	21.2	11.0	11.0	19.0	23.0	17.8	31.2	15.0	15.8	21.2	14.7	21.5	8.0	16.5	19.5	21.8	15.8	16.9	29.9	9.0	10.1	2.4	15.6	2.2	16.1	15.4	18.5	15.7	16.0	20.4	27.1	17.3	21.3	16.3	1.2	24.7	14.6	12.9	14.2	17.8	48.6	46.6	12.8	35.3	36.9	20.4	22.7	23.4	20.0	13.8	17.9	20.2	41.0	10.4	8.2	45.4	60.5	33.1	20.1	17.0	34.9	43.2	49.6	86.2	49.2	45.5	19.3	27.7	186.9	52.4	38.4	25.6	22.0	11.5	53.9	68.9	44.5	13.9	27.6	41.0	95.8	33.1	23.1	59.1	66.7	19.6	51.6	42.5	10.5	38.2	117.1	33.3	6.5	28.2	41.5	71.3	11.2	16.7	38.9	37.7	19.7
USF2	"bHLHb12, FIP"	ENSG00000105698	"Upstream transcription factor 2, c-fos interacting"	Q15853	19	35268978-35279821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029764, HPA046567"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029764: AB_2673190, HPA046567: AB_2679702"	"unprognostic (6.10e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.07e-2)"	"prognostic favorable (5.12e-5)"	"unprognostic (7.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.28e-4)"	40.6	48.6	50.9	42.7	56.8	52.8	53.0	52.5	60.5	23.4	26.2	41.2	25.9	36.5	26.3	23.4	25.8	23.6	23.1	52.6	50.8	35.5	22.1	47.9	29.1	48.8	48.6	43.6	54.1	41.8	34.9	36.4	22.1	40.2	22.5	19.7	31.7	34.0	21.6	108.9	35.1	35.8	24.4	48.5	42.9	30.6	13.0	51.2	22.7	29.9	24.9	32.5	26.8	35.6	7.1	27.3	17.8	5.8	5.8	7.2	3.7	38.7	39.0	20.4	19.2	35.2	18.0	19.1	21.0	25.0	19.1	14.5	18.1	20.1	37.2	33.7	17.9	20.9	11.8	18.8	16.4	10.0	62.5	29.0	22.1	23.4	29.0	21.4	36.9	38.1	15.6	23.2	12.5	19.5	33.3	13.0	25.0	26.5	55.8	15.0	44.4	40.4	14.7	16.9	35.8	13.2	39.7	25.9	35.1	15.9	24.8	34.4	26.1	39.1	42.6	70.6	18.6	17.2	29.7	21.9	32.5	21.9	21.3	28.2	56.2	56.2	40.4	30.1	23.6	42.3	17.8	4.7	5.7	3.9	5.8	4.8	5.6	4.0	5.1	7.1	7.1	3.6	3.5	4.2	5.8	3.5	27.3	7.2	3.7	50.9	56.8	52.5	60.5	50.8	35.5	48.6	43.6	40.2	51.2	6.0	19.0	63.3	21.7	21.1	61.7	62.0	20.4	5.3	9.1	29.6	31.4	20.0	48.0	27.2	0.6	27.9	41.8	0.0	49.5	31.8	22.8	23.4	19.7	42.9	101.1	89.0	50.1	31.3	52.2	2.4	29.7	43.7	25.3	34.3	33.1	60.1	34.5	36.6	29.4	35.6	44.7	12.9	29.9	9.5	10.4	21.7	14.6	39.9	28.2	27.4
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724593-75814286	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 94.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"		NA	NA		43000	"Golgi apparatus"	"Nucleoli fibrillar center"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	18.1	22.1	9.9	14.9	11.5	4.1	14.6	13.8	13.2	18.1	16.5	9.1	24.9	13.0	18.6	25.3	20.1	15.8	12.1	35.4	10.9	10.4	18.7	38.8	13.6	10.8	11.5	11.7	23.2	23.6	16.8	32.1	23.1	16.1	19.4	14.0	11.4	20.8	22.2	94.4	13.2	17.3	19.1	14.7	13.5	14.8	15.3	10.6	15.0	20.7	27.0	14.1	23.8	18.8	10.1	14.6	16.8	21.2	19.1	20.7	11.2	14.2	11.3	16.0	21.3	39.2	52.0	14.6	33.6	41.3	18.5	22.6	11.2	22.2	18.8	20.8	30.8	16.0	16.6	23.8	20.9	28.0	20.7	9.3	13.0	10.1	23.6	30.8	17.1	15.0	29.4	25.8	19.3	37.9	36.0	27.7	13.2	22.4	21.7	27.4	9.4	16.8	9.0	21.8	30.3	6.8	11.2	15.2	15.1	27.7	16.6	12.8	12.4	12.3	26.2	21.2	24.9	19.2	14.0	21.2	17.0	10.6	30.8	12.6	20.5	11.0	9.2	25.3	10.3	20.1	16.8	11.4	10.1	15.2	16.5	20.7	9.3	12.9	14.5	14.6	10.1	13.6	13.1	7.0	19.1	21.2	11.8	12.9	11.2	9.9	11.5	13.8	13.2	10.9	10.4	11.5	11.7	16.1	10.6	56.6	72.1	28.3	45.2	33.8	31.7	119.3	33.1	77.6	72.8	24.4	41.2	41.6	29.9	33.3	7.0	31.7	32.6	0.0	42.1	41.2	49.4	55.7	47.4	50.5	38.8	25.4	38.5	33.2	29.4	7.8	72.8	35.6	27.0	52.3	62.2	30.7	47.4	31.6	64.3	39.6	50.3	38.8	44.0	44.7	71.1	35.3	75.7	29.2	38.5	52.8
USP12	USP12L1	ENSG00000152484	"Ubiquitin specific peptidase 12"	O75317	13	27066142-27171896	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, HPA059492"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007288: AB_1080531, HPA059492: "	"unprognostic (6.72e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.73e-1)"	15.7	10.4	18.3	23.3	17.8	46.0	15.6	16.6	18.3	12.1	30.6	16.1	8.8	13.0	15.3	11.6	23.5	9.5	14.5	11.3	19.3	15.9	18.3	27.9	19.9	19.6	20.5	7.5	12.0	13.4	10.7	16.2	14.8	12.4	17.5	19.1	10.1	8.9	9.5	9.8	17.3	33.0	43.8	18.5	16.5	14.7	11.0	13.1	8.4	12.0	6.6	18.5	42.8	24.2	4.6	3.0	5.3	2.1	2.3	3.6	1.2	12.1	7.6	14.6	7.6	9.8	12.6	5.2	17.1	12.1	9.5	7.1	13.8	19.1	17.3	8.6	13.5	23.1	7.5	9.5	9.9	20.4	27.9	8.2	26.7	9.9	9.7	12.4	15.4	18.8	7.8	14.6	10.7	12.4	12.1	21.9	12.0	8.9	8.4	19.7	7.1	9.4	20.6	10.5	15.6	13.5	10.8	18.7	4.1	18.8	8.6	16.2	9.8	14.7	12.4	13.8	19.1	5.8	15.0	25.8	10.0	9.6	21.3	15.5	6.5	7.2	12.3	16.8	9.2	11.1	0.0	1.2	5.3	1.5	1.3	2.5	3.2	2.4	2.0	1.6	4.6	1.6	1.7	1.2	2.3	2.1	3.0	3.6	1.2	18.3	17.8	16.6	15.5	19.3	15.9	20.5	7.5	12.4	13.1	26.8	25.1	15.1	22.9	81.5	21.6	22.6	10.2	16.0	10.3	22.7	37.3	12.2	24.9	11.8	16.7	31.9	32.8	46.7	14.0	5.6	31.0	29.2	12.7	22.2	12.6	27.0	20.1	17.2	15.8	8.2	7.2	23.3	37.1	44.1	23.6	10.9	19.7	25.8	6.0	15.7	29.9	32.3	45.3	2.5	8.9	69.1	9.2	13.8	20.4	30.3
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179652755-179789401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.8;skeletal muscle: 90.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 182.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"MAIT T-cell: 15.4"	"Lineage enriched"	"Detected in many"	8	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.4	7.5	2.0	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2.0	2.3	2.3	3.4	6.0	2.5	2.1	2.1	7.2	3.0	3.3	9.8	1.9	3.0	3.0	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2.0	1.9	0.0	0.4	0.0	15.4	0.7	12.5	5.4	10.2	7.8	4.6	6.4	4.9	7.4	8.5	10.9	9.2	7.9	4.4	15.5	8.3	8.9	12.3	0.9	11.4	4.5	13.0	36.6	4.9	4.1	8.1	7.4	3.3	11.4	0.0	6.9	1.6	8.5	10.8	5.3	8.7	6.1	2.0	20.0	9.0	8.2	6.9	2.1	7.9	1.1	4.9	11.9	10.1	12.7	7.4	3.5	5.8	7.5	7.1	9.5	4.3	3.0	16.4	8.2	9.4	13.2	10.5	11.3	28.4	9.7	8.1	31.7	6.1	7.7	12.2	0.0	0.2	0.0	1.3	0.4	15.4	2.0	1.3	2.9	1.5	0.6	1.0	1.0	0.0	0.0	0.4	1.9	0.6	0.7	2.0	2.8	2.9	4.1	2.0	2.3	2.1	2.1	3.0	1.3	8.9	31.0	4.3	1.7	2.3	12.7	182.3	5.1	2.7	9.1	1.8	5.9	8.7	13.3	1.0	2.1	9.7	0.3	0.0	3.7	1.6	7.1	3.4	2.3	6.8	3.7	15.9	9.2	27.6	3.1	2.0	8.6	4.7	13.5	0.0	1.6	6.3	1.6	5.8	8.9	2.7	9.7	12.9	5.3	5.1	2.1	1.4	4.2	3.2	3.8	1.6
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 399.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	25.4	21.7	24.4	27.4	24.2	20.4	22.8	32.4	23.1	24.2	24.3	13.5	23.6	20.4	22.6	28.2	27.1	19.4	17.0	23.8	23.8	22.6	28.4	34.0	16.8	20.7	25.8	19.5	27.3	23.6	31.6	41.6	45.9	25.3	26.0	22.3	13.3	20.6	28.8	35.8	16.1	33.2	26.2	28.6	29.1	20.8	20.1	25.3	37.6	28.4	25.6	25.5	30.8	17.1	30.9	23.5	21.2	20.5	19.9	26.2	10.1	22.0	8.8	14.1	12.6	10.0	16.5	13.3	21.6	14.4	15.0	14.3	11.0	14.4	22.5	6.5	20.7	22.9	10.1	17.4	15.7	19.6	21.6	18.5	30.1	10.7	12.2	14.9	29.5	16.7	14.1	16.6	19.5	18.1	11.1	14.3	12.9	24.7	39.9	17.3	10.1	18.1	10.8	15.0	18.0	11.5	12.2	34.8	25.8	12.3	16.0	15.3	16.3	14.0	22.4	18.9	10.0	15.4	20.2	14.4	17.6	21.8	16.1	22.1	34.1	46.8	23.7	18.3	21.4	17.4	21.2	16.2	20.9	25.4	16.1	19.8	26.4	23.9	22.8	14.9	30.9	26.2	24.8	15.5	19.9	20.5	23.5	24.5	10.1	24.4	24.2	32.4	23.1	23.8	22.6	25.8	19.5	25.3	25.3	80.4	84.0	98.9	106.9	50.8	161.8	74.6	53.5	112.4	87.6	50.6	84.4	70.3	112.7	61.8	399.0	40.7	72.4	23.3	103.3	66.4	62.2	82.7	136.5	77.6	53.4	68.3	79.3	46.1	54.6	89.6	81.1	59.7	59.1	95.6	64.7	103.3	77.6	75.8	81.7	60.8	186.0	58.2	71.0	80.0	64.3	56.2	135.5	69.2	70.2	111.6
USP18		ENSG00000184979	"Ubiquitin specific peptidase 18"	Q9UMW8	22	18149899-18177397	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 39.7;Extravillous trophoblasts: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 48.9;BJ hTERT+ SV40 Large T+ RasG12V: 53.2"									HPA044768	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA044768: AB_10963697"	"unprognostic (2.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.38e-2)"	20.4	6.4	4.8	13.0	4.8	6.3	15.4	1.9	5.5	5.3	6.3	5.6	3.2	5.2	6.1	9.5	6.0	6.5	7.1	5.4	4.4	4.6	8.8	20.9	14.0	15.9	4.3	4.8	4.9	4.2	3.8	7.8	7.6	4.7	4.8	3.9	5.7	11.7	2.3	9.7	4.2	15.5	4.5	4.1	10.6	6.4	10.6	4.0	22.4	10.6	2.9	7.7	4.3	6.9	4.1	2.9	6.6	8.8	11.0	11.0	4.8	3.7	3.8	1.1	4.9	5.0	3.7	5.0	1.9	4.6	48.9	53.2	0.6	5.3	0.0	3.0	1.0	15.6	1.3	5.7	1.7	1.6	16.7	7.9	7.3	0.5	6.9	0.6	1.7	7.0	1.6	0.6	3.4	0.0	0.2	10.8	5.5	0.3	0.4	0.4	6.4	8.5	4.3	3.4	4.0	2.9	3.4	7.6	0.0	0.9	3.2	4.1	3.2	2.3	4.0	18.2	4.6	2.7	1.7	17.7	0.3	1.0	1.1	1.9	0.9	11.4	0.0	4.4	4.4	2.8	2.7	3.2	6.6	7.8	8.8	10.0	4.1	6.7	10.1	1.6	2.7	7.9	8.8	0.5	11.0	6.6	2.9	11.0	4.8	4.8	4.8	1.9	4.0	4.4	4.6	4.3	4.8	4.7	4.0	8.9	3.7	0.5	3.7	1.4	0.2	0.4	5.1	8.1	6.8	0.0	0.0	4.5	39.7	5.1	1.2	6.0	4.3	0.0	9.9	27.4	3.1	3.8	0.0	4.3	7.7	0.0	2.9	9.2	4.5	1.4	3.4	1.8	3.3	0.0	2.2	3.9	9.2	2.9	6.7	5.7	0.2	6.5	1.2	6.2	0.4	0.9	1.3	1.5	2.8	2.5
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381726	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 79.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 399.1;Late spermatids: 802.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	3.1	4.8	6.9	1.4	12.2	1.5	1.6	12.6	16.1	2.5	5.9	10.0	0.0	7.9	2.6	6.4	5.9	7.0	2.2	26.8	5.7	3.1	29.7	10.6	2.2	0.7	5.7	6.2	2.9	10.1	18.4	7.6	1.3	6.7	2.3	3.9	19.1	3.2	2.4	79.9	4.6	11.7	4.2	3.8	0.8	2.7	36.1	8.8	0.0	2.2	25.2	1.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	3.5	0.3	0.5	2.0	0.1	0.1	0.8	0.4	0.2	0.0	0.4	3.6	0.5	6.1	1.1	0.6	0.9	0.6	4.8	1.8	0.1	4.2	0.6	1.7	2.6	7.5	1.7	0.0	1.7	0.6	0.3	0.4	1.2	0.8	0.3	4.6	8.4	0.5	1.0	2.4	0.0	0.4	0.9	1.2	0.8	0.0	1.3	0.9	2.8	0.2	7.4	2.2	2.1	1.6	0.4	1.1	5.4	3.7	0.0	0.0	0.9	0.5	0.6	35.2	7.7	0.1	0.0	1.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.3	0.3	6.9	12.2	12.6	16.1	5.7	3.1	5.7	6.2	6.7	8.8	3.0	2.4	0.0	4.5	2.2	73.3	74.6	5.1	42.8	9.1	5.2	90.3	0.3	96.2	2.6	399.1	2.2	31.5	0.0	1.4	0.5	4.6	1.0	0.0	19.8	13.2	9.5	0.0	1.3	1.5	802.9	6.1	1.3	0.0	0.0	1.6	37.9	1.5	10.5	6.7	24.9	128.7	19.4	18.6	19.9	14.9	3.4	1.1	1.5	2.2	2.0
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881838	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 42.3;K-562: 25.9;MOLT-4: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	7.8	13.2	10.5	15.2	14.6	24.4	8.5	23.0	19.6	13.2	12.1	12.7	10.2	9.7	13.3	6.2	9.3	11.6	12.5	8.8	10.5	13.7	8.0	7.3	9.1	19.6	9.6	16.1	16.8	12.9	11.5	19.0	8.0	11.9	14.9	6.1	10.8	13.7	17.2	10.2	14.0	11.8	20.0	8.8	14.6	10.2	14.0	8.8	51.5	19.3	4.2	15.3	15.6	10.0	3.8	2.4	4.8	1.7	9.0	10.7	5.4	2.5	2.5	4.4	6.0	5.8	5.0	6.3	4.1	3.5	3.2	2.2	2.1	2.8	3.5	3.6	4.0	3.6	6.5	2.6	3.0	1.3	19.0	3.5	6.5	6.8	1.4	4.1	6.1	4.8	4.4	4.4	4.2	3.1	5.6	3.4	42.3	25.9	4.4	1.9	6.8	23.8	14.5	3.5	5.4	6.0	4.0	5.0	5.9	2.5	2.8	1.0	4.9	4.8	6.2	3.9	2.7	6.4	8.5	5.0	3.5	1.6	4.7	2.7	4.3	6.3	2.4	7.0	8.0	3.3	1.0	1.7	4.8	8.6	1.4	9.3	3.7	8.8	8.3	2.4	3.8	10.4	8.9	2.8	9.0	1.3	2.1	10.7	5.4	10.5	14.6	23.0	19.6	10.5	13.7	9.6	16.1	11.9	8.8	8.9	8.6	3.2	2.3	2.5	7.9	5.9	2.5	4.0	2.3	1.8	3.9	5.1	3.3	2.2	1.1	2.4	4.0	0.0	3.4	2.1	3.8	3.0	1.1	5.6	3.0	9.5	8.1	7.4	2.1	2.8	5.8	3.1	3.3	3.6	4.6	5.8	2.3	3.7	4.6	2.2	5.9	0.0	6.2	12.2	4.4	1.8	5.1	11.3	5.1	1.4
USP22	"KIAA1063, USP3L"	ENSG00000124422	"Ubiquitin specific peptidase 22"	Q9UPT9	17	20999593-21043760	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044980	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA044980: AB_10794503"	"unprognostic (7.24e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.17e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.07e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (8.95e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.79e-2)"	22.5	33.0	40.7	21.5	49.5	25.9	24.6	66.1	66.4	26.8	23.6	31.9	25.1	18.9	36.7	29.3	21.9	33.9	23.0	44.1	38.7	47.6	27.7	22.9	26.1	25.1	31.0	40.7	45.6	24.5	47.4	32.2	22.4	35.1	27.5	20.5	28.7	20.0	29.5	47.6	22.1	21.1	31.2	24.8	23.7	22.7	20.2	23.7	41.2	32.8	24.8	27.3	25.1	23.2	13.7	12.1	13.4	13.3	8.9	15.5	6.9	19.6	35.6	34.6	29.7	20.2	21.0	16.5	22.6	17.4	20.4	17.4	41.0	8.9	26.9	21.8	34.7	13.8	21.1	33.5	27.0	30.6	12.8	23.2	22.3	23.7	19.9	24.0	24.5	19.5	23.1	16.2	23.1	24.3	23.3	25.4	17.7	25.3	9.8	28.8	20.2	34.3	11.7	17.8	23.3	11.7	38.0	54.8	18.3	18.8	28.9	16.7	34.4	29.2	12.1	23.7	99.0	20.3	14.5	32.2	20.9	27.8	21.4	30.5	10.5	14.1	89.5	21.2	13.1	32.2	6.8	13.3	12.6	11.0	9.8	11.1	10.9	11.7	10.9	12.1	13.7	15.5	14.6	13.4	8.9	12.2	10.2	7.8	6.9	40.7	49.5	66.1	66.4	38.7	47.6	31.0	40.7	35.1	23.7	38.7	45.6	40.4	39.5	29.3	90.6	20.9	58.6	29.4	35.2	57.6	88.4	42.1	19.9	47.1	31.0	40.9	35.1	0.0	50.6	33.9	44.7	49.2	29.0	55.2	34.1	111.2	84.7	78.0	53.0	39.2	47.2	23.7	33.7	24.4	42.7	58.7	59.0	38.6	67.5	45.1	54.5	12.9	38.8	14.2	16.6	25.5	55.0	23.0	46.6	38.9
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27, X-linked"	A6NNY8	X	49879948-49882565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 17.9;Ciliated cells: 24.1;Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 21.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA077264: AB_2686831"	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.8	3.3	1.8	5.9	2.9	0.3	7.7	1.7	7.4	3.9	5.9	4.8	2.2	1.1	12.7	4.1	3.1	4.7	3.8	3.9	2.2		3.5	3.5	6.1	1.9	1.3	3.2	8.8	3.2	4.1	0.8	15.5	2.8	4.1	1.7	4.1	5.2	3.9	7.5	2.6	4.7	3.9	1.3	2.0	1.9	3.8	1.9	2.8	3.2	3.6	2.2	3.7	3.1	1.7	1.0	0.7	0.7	0.3	1.3	0.4	1.8	4.7	5.5	6.3	5.2	4.3	4.6	2.1	3.4	2.4	2.0	8.5	2.1	1.2	2.0	5.4	7.9	3.0	7.8	5.2	3.5	2.4	3.7	2.0	1.4	7.7	3.5	0.6	4.3	6.0	3.6	3.4	3.4	5.9	3.3	5.5	3.9	2.0	3.8	4.5	2.9	1.7	6.0	3.5	3.3	3.1	4.8	0.4	3.9	1.8	1.4	4.1	4.0	3.8	4.9	17.9	4.4	1.4	2.5	2.8	5.4	4.8	0.8	1.9	0.5	0.8	3.2	1.7	3.0	0.7	0.4	0.1	0.6	0.4	0.8	0.6	0.5	0.3	1.0	1.7	0.8	0.6	0.7	0.3	0.7	0.4	1.3	0.4											17.9	13.3	0.0	4.1	2.6	9.7	2.3	0.0	24.1	13.6	0.0	0.0	34.3	5.0	1.1	0.0	3.1	0.7	0.0	0.6	2.0	1.8	2.5	2.3	1.7	3.4	4.8	4.1	3.1	0.3	0.0	2.0	1.1	0.0	1.0	1.2	10.2	1.2	0.0	3.2	2.6	2.0	6.5	1.7	0.0	1.4	1.9	21.9	1.3	1.7	1.7
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 33.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	No	No			Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	16.0	9.0	5.9	20.4	6.5	38.6	21.3	33.4	6.6	12.7	19.1	6.0	16.8	16.2	18.1	13.3	13.6	10.4	14.2	7.6	6.6	4.4	12.9	10.8	17.5	28.2	8.1	3.9	19.5	27.1	7.1	8.2	10.2	7.9	12.4	11.5	8.2	18.5	14.8	12.4	15.9	19.0	16.1	8.0	23.6	14.7	10.3	7.8	22.7	12.5	11.4	22.5	21.3	17.9	11.4	20.6	52.6	28.1	7.2	12.9	13.4	9.2	30.2	15.6	9.8	7.7	12.6	13.8	7.9	9.9	7.7	9.5	11.8	17.3	9.4	12.6	7.9	5.1	11.7	14.6	12.3	7.5	15.3	7.9	10.6	10.8	12.7	6.6	6.3	12.8	9.0	16.3	9.3	16.2	7.8	16.7	16.9	14.1	12.0	4.9	14.3	13.1	10.2	19.7	18.9	13.1	19.2	9.4	16.6	9.2	31.7	13.7	10.6	4.9	16.2	9.7	8.9	9.7	12.3	15.8	8.9	18.6	5.2	10.5	10.8	19.9	20.8	8.6	17.5	7.4	28.8	28.1	3.5	8.4	22.6	9.3	10.3	11.9	8.6	20.6	11.4	12.9	9.3	52.6	7.2	18.7	4.1	9.1	13.4	5.9	6.5	33.4	6.6	6.6	4.4	8.1	3.9	7.9	7.8	35.7	60.4	35.8	31.2	46.8	31.1	9.1	20.4	36.1	43.3	15.7	11.8	17.3	34.9	36.4	19.7	20.3	33.9	0.0	32.3	46.8	16.4	35.8	25.5	20.8	22.8	12.7	42.1	11.1	75.5	53.6	14.7	64.4	40.5	27.1	32.5	24.6	35.0	31.7	17.3	19.9	17.8	12.9	25.2	10.2	41.8	51.6	28.5	37.4	34.7	33.1
USP31	KIAA1203	ENSG00000103404	"Ubiquitin specific peptidase 31"	Q70CQ4	16	23061406-23149270	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 55.8;Basal keratinocytes: 59.3;Spermatogonia: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006937	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006937: AB_1080523"	"unprognostic (6.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (5.59e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-3)"	6.3	5.3	11.2	4.0	16.6	7.1	8.7	12.7	16.5	10.9	4.9	19.7	2.6	3.7	15.3	7.7	9.3	6.5	4.1	11.0	9.0	6.3	6.2	7.7	7.3	3.6	24.6	8.1	3.7	6.3	20.6	10.4	7.4	17.4	9.6	4.9	2.8	6.0	8.5	10.9	15.9	3.4	14.2	14.8	2.8	3.5	20.7	19.3	1.7	4.2	2.4	4.9	13.4	9.5	0.5	0.8	0.6	1.3	0.1	2.1	0.2	9.5	10.1	2.9	4.0	5.3	4.2	2.7	3.3	3.0	4.3	5.2	6.4	5.8	3.2	3.6	4.2	7.0	12.6	7.2	13.1	7.1	2.3	2.9	1.3	5.8	13.4	6.7	3.3	3.6	3.5	11.3	8.0	18.5	1.6	7.6	3.2	3.9	10.0	5.8	6.5	1.6	2.8	5.8	3.2	3.1	7.9	8.2	6.4	6.4	14.3	7.8	5.1	5.2	10.3	2.9	3.4	4.1	7.4	4.5	8.8	6.5	4.4	9.0	3.3	5.4	3.4	6.3	4.5	3.5	0.1	0.7	0.6	0.8	0.3	2.1	0.1	0.7	1.5	0.8	0.5	0.8	0.8	0.1	0.1	1.3	0.2	1.3	0.2	11.2	16.6	12.7	16.5	9.0	6.3	24.6	8.1	17.4	19.3	6.0	3.0	6.1	55.8	59.3	12.6	9.2	10.2	8.1	7.9	5.2	2.0	11.1	0.0	6.1	3.6	14.6	1.4	0.0	7.2	6.2	5.4	14.2	1.1	25.0	4.2	0.0	4.6	7.4	3.1	8.9	7.2	2.9	6.8	1.0	3.5	4.8	7.6	0.0	4.2	9.1	7.4	19.4	7.1	23.8	60.3	23.2	6.3	1.3	5.2	19.5
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60179094-60422470	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.4"	"Cell type enhanced"	"Detected in all"	11	"Cone photoreceptor cells: 227.8;Rod photoreceptor cells: 128.6;Spermatocytes: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 28.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 28.4;granulocytes: 13.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 61.6"									HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA044365: AB_2678914"	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	9.5	13.9	17.3	10.8	19.5	20.6	10.9	14.6	20.3	8.0	8.5	18.9	7.9	7.2	8.2	5.4	13.1	7.4	9.1	11.1	14.7	12.2	15.5	19.7	12.5	8.6	18.8	14.3	7.4	8.5	17.3	11.4	9.8	19.2	8.7	8.9	11.6	8.2	9.0	23.0	12.2	7.2	9.8	16.5	12.1	8.1	58.4	18.1	7.3	15.6	7.9	8.5	8.8	8.5	1.4	28.4	13.5	2.1	0.6	1.1	0.9	11.1	12.7	6.8	10.8	17.2	16.2	6.4	9.1	13.8	12.0	15.4	6.6	7.3	6.9	7.7	16.8	19.3	5.9	11.5	12.6	21.2	5.2	5.1	13.8	10.1	7.2	17.1	10.9	12.6	15.1	9.3	16.1	14.9	12.4	13.1	8.3	13.9	5.7	14.8	61.6	11.0	7.7	7.9	10.7	6.1	5.3	17.9	4.1	12.6	8.1	4.8	7.2	7.6	2.2	11.7	12.3	9.4	15.2	11.0	18.2	19.0	11.4	8.5	5.9	11.2	6.5	9.1	8.6	11.8	4.3	2.1	7.2	1.0	1.8	0.7	1.4	0.7	0.8	4.1	1.1	0.5	1.0	13.5	0.6	2.0	28.4	1.1	0.9	17.3	19.5	14.6	20.3	14.7	12.2	18.8	14.3	19.2	18.1	6.0	13.1	7.7	11.6	23.9	16.9	7.6	5.1	6.7	13.6	5.2	227.8	4.3	3.3	9.0	69.1	8.4	6.8	23.3	6.3	5.3	10.4	9.3	11.5	10.6	16.5	12.7	7.9	9.2	33.2	25.6	12.0	27.7	5.0	14.4	4.2	10.3	8.4	9.1	5.3	3.7	128.6	25.8	9.5	100.3	9.1	19.2	4.1	12.9	4.4	7.1
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	30.8	27.1	28.1	18.8	32.1	24.6	28.6	55.3	37.5	21.6	20.4	20.6	18.5	20.2	23.3	23.0	17.8	19.2	21.7	17.0	30.7	30.6	26.0	20.3	21.0	20.7	26.0	25.4	25.3	17.0	28.8	23.4	34.6	38.7	24.6	21.0	21.4	19.5	19.8	16.3	19.4	23.8	19.8	21.4	22.3	19.5	19.9	21.6	27.8	25.1	12.9	20.3	21.0	20.0	15.7	12.2	33.2	18.4	12.3	17.8	10.6	16.1	7.4	25.6	17.7	36.9	32.3	22.0	17.7	16.9	21.6	24.3	9.8	14.0	12.1	16.8	17.2	35.5	12.8	18.6	12.1	26.6	11.1	14.5	42.7	18.1	8.5	23.0	14.5	10.8	23.7	9.5	20.9	15.4	20.9	19.2	11.1	16.6	10.6	16.2	6.2	13.1	14.5	24.7	12.6	14.7	12.6	27.0	8.5	20.4	16.6	21.5	16.6	12.4	16.5	24.7	22.8	9.2	15.8	16.1	20.0	14.2	20.1	16.7	8.7	11.0	11.8	15.1	17.2	10.1	33.2	15.4	20.0	15.1	15.0	15.3	13.4	14.7	15.2	11.5	15.7	17.8	15.6	20.9	12.3	18.4	12.2	13.2	10.6	28.1	32.1	55.3	37.5	30.7	30.6	26.0	25.4	38.7	21.6	41.7	36.3	21.6	16.5	15.2	50.9	31.5	20.4	36.1	25.0	33.2	55.0	21.0	8.3	16.9	2.8	26.4	26.8	0.0	13.4	15.9	21.2	23.9	22.0	18.1	16.5	58.8	34.1	28.8	33.6	3.6	33.1	22.3	21.9	19.8	26.0	34.5	15.7	28.6	30.1	19.2	40.3	19.4	17.5	36.1	26.3	14.3	10.0	27.5	22.9	20.0
USP34	"KIAA0570, KIAA0729"	ENSG00000115464	"Ubiquitin specific peptidase 34"	Q70CQ2	2	61187463-61470769	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025815, HPA070764"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025815: AB_1858681, HPA070764: AB_2686308"	"unprognostic (4.04e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.01e-2)"	17.2	19.6	31.8	37.2	25.6	24.8	28.3	77.1	35.5	22.5	22.7	14.4	31.1	11.4	22.2	44.5	18.6	17.5	20.0	16.9	30.5	24.0	20.5	21.5	29.7	34.2	22.0	21.2	24.7	17.2	33.5	40.3	13.4	22.0	22.7	21.5	21.2	16.9	45.2	27.0	31.6	21.0	22.7	20.8	24.8	19.3	26.4	25.3	21.7	23.2	13.9	33.5	19.1	16.7	6.0	5.8	3.4	4.6	5.2	7.5	2.3	16.8	12.1	15.7	16.3	29.9	20.1	13.2	10.4	14.7	9.3	8.9	16.9	6.5	40.0	11.1	22.4	9.9	9.3	12.4	13.7	17.4	14.3	9.8	24.2	11.7	27.2	25.2	17.9	15.4	21.9	17.8	17.0	25.4	22.8	19.6	11.4	16.5	13.0	20.7	15.8	11.8	26.1	10.6	17.2	9.6	12.7	19.2	10.7	27.5	20.7	13.0	13.9	16.4	12.2	17.9	21.0	6.4	13.0	17.5	14.8	19.7	8.7	13.6	15.1	7.4	42.0	13.9	16.7	12.6	3.4	2.0	2.8	7.5	2.2	6.7	5.1	5.1	5.5	1.8	6.0	5.8	7.5	3.4	5.2	4.6	5.8	4.5	2.3	31.8	25.6	77.1	35.5	30.5	24.0	22.0	21.2	22.0	25.3	59.6	60.6	35.3	50.1	54.3	132.9	41.8	56.0	33.5	59.1	31.4	235.6	26.6	8.3	35.4	108.3	51.2	38.6	0.0	29.1	19.8	45.2	63.1	31.2	36.3	19.7	101.7	46.7	23.4	40.3	105.2	52.6	41.4	38.8	30.7	32.2	62.5	38.7	38.4	62.9	18.3	185.3	25.8	46.7	97.9	106.7	53.6	44.6	40.8	31.2	57.6
USP35	KIAA1372	ENSG00000118369	"Ubiquitin specific peptidase 35"	Q9P2H5	11	78188812-78214711	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 32.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 20.7;Late spermatids: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"eosinophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055213, HPA058592"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA055213: AB_2682740, HPA058592: AB_2683766"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	4.9	17.1	5.1	5.4	9.3	3.8	5.2	10.4	15.0	6.4	5.8	8.0	6.3	5.5	6.8	5.4	5.6	5.4	5.6	8.7	6.1	6.7	5.0	13.8	5.6	4.8	6.7	8.8	6.6	6.4	32.4	12.0	7.1	15.0	5.0	3.4	7.7	4.0	5.6	5.6	3.2	5.3	7.8	4.5	4.6	3.9	5.3	4.0	1.9	7.7	2.9	4.1	5.2	6.6	0.0	0.1	3.4	0.6	0.1	0.3	0.2	2.1	3.3	5.7	6.0	9.7	9.0	3.9	4.9	5.8	5.8	4.1	8.3	4.6	1.7	5.1	9.2	6.2	5.7	3.8	7.6	3.4	12.2	2.0	2.8	8.6	4.8	7.6	1.8	8.3	7.6	5.1	12.1	3.5	11.5	7.1	6.2	3.9	4.2	4.5	1.9	4.6	7.2	1.7	6.0	5.3	2.8	5.3	2.0	4.6	3.9	2.8	5.4	3.8	5.0	1.8	8.5	4.2	1.5	8.6	10.7	6.1	12.6	2.6	5.7	1.8	2.6	3.2	1.9	6.2	0.0	0.2	3.4	0.1	0.6	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.2	5.1	9.3	10.4	15.0	6.1	6.7	6.7	8.8	15.0	4.0	0.0	2.6	0.0	0.1	0.7	0.7	1.8	0.0	0.0	0.0	0.0	5.9	0.6	0.0	0.8	20.7	1.5	0.8	0.0	1.7	1.3	2.0	0.2	0.0	3.0	1.3	0.0	0.0	2.5	0.8	31.6	1.4	0.9	1.7	3.6	0.6	0.5	1.8	0.0	2.8	0.8	0.5	6.5	0.9	0.9	1.6	0.9	0.2	3.9	0.7	0.1
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 117.3;Late spermatids: 116.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	10.4	8.4	9.2	9.7	10.5	19.2	9.0	16.2	10.0	8.3	6.6	10.4	8.0	5.8	9.6	15.8	8.2	7.8	7.0	6.9	7.4	5.5	6.1	7.4	8.1	10.5	8.7	7.8	15.3	6.9	10.7	17.1	8.5	8.7	7.3	7.0	7.4	9.7	9.6	11.1	9.9	7.2	8.1	10.2	7.0	6.6	22.2	10.5	13.4	9.8	5.4	9.4	10.5	9.1	7.4	6.1	7.4	4.8	5.9	9.0	2.5	7.4	5.4	11.5	8.8	3.0	3.7	9.8	5.7	4.1	9.9	11.2	10.2	5.9	6.8	6.2	4.4	7.6	7.1	12.5	6.3	10.9	9.2	6.6	18.3	11.0	6.7	3.4	11.9	9.2	2.0	3.8	10.4	7.5	3.6	4.2	11.9	13.2	13.1	6.2	5.5	15.3	8.2	9.8	4.8	4.7	12.4	17.2	6.2	3.4	8.8	12.6	6.8	9.1	4.5	5.7	11.5	5.2	8.4	5.4	11.2	9.8	6.2	7.4	8.9	7.9	13.9	6.0	8.8	7.6	6.5	4.2	7.4	7.0	4.8	7.3	5.4	5.8	5.9	4.4	7.4	9.0	5.7	3.5	5.9	4.4	6.1	7.3	2.5	9.2	10.5	16.2	10.0	7.4	5.5	8.7	7.8	8.7	10.5	0.0	8.3	11.5	5.5	17.3	16.4	3.3	2.5	10.7	10.3	7.0	25.5	6.1	0.0	4.6	117.3	9.0	5.1	0.0	2.0	5.4	9.3	10.2	4.7	10.2	6.5	14.3	9.9	11.6	8.1	116.2	9.2	13.7	20.3	5.4	8.1	9.9	4.6	6.8	9.2	3.6	21.1	6.5	10.3	40.0	12.8	18.1	6.1	17.9	7.0	5.8
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223830	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	7.7	7.8	6.6	6.6	6.5	19.1	8.3	7.4	7.8	7.9	12.1	8.6	8.8	8.8	8.3	7.1	8.6	7.1	7.6	12.5	6.6	5.3	9.3	15.2	12.7	11.1	10.3	5.1	6.3	8.8	10.0	6.2	11.4	5.9	6.6	6.6	7.1	7.2	7.0	45.3	8.9	13.2	6.5	10.8	10.6	7.4	7.5	8.2	22.6	8.6	10.2	8.4	7.8	8.8	6.3	8.1	12.5	5.7	12.3	9.9	5.0	4.8	4.5	4.0	6.9	5.3	5.3	3.0	7.7	7.5	7.2	6.1	13.1	7.2	6.0	5.5	6.5	4.6	3.8	9.5	7.7	5.9	14.6	6.1	5.5	5.4	2.8	7.3	11.1	5.5	6.4	7.1	7.3	5.9	5.1	7.1	6.9	11.9	18.9	4.7	7.7	14.5	2.1	3.6	9.8	8.9	9.5	6.0	5.7	4.6	5.6	8.2	7.4	6.0	10.5	6.7	3.1	6.4	4.2	8.4	6.6	5.4	5.7	8.0	21.1	35.7	10.9	6.7	8.5	5.5	12.5	5.4	11.7	7.5	5.7	9.6	6.3	6.6	6.5	8.1	5.7	6.7	5.7	5.4	12.3	5.7	3.5	9.9	5.0	6.6	6.5	7.4	7.7	6.6	5.3	10.3	5.1	5.9	8.2	20.8	13.7	10.5	16.5	47.6	7.5	15.1	7.6	13.4	14.8	0.0	11.8	10.9	1.7	7.5	27.8	12.0	18.4	0.0	6.6	5.8	9.7	16.1	3.5	32.7	9.2	7.9	29.4	17.8	14.5	15.4	6.4	12.2	11.8	1.8	19.9	13.6	8.5	11.5	8.9	14.2	8.2	12.9	15.1	9.5	5.1	51.7	22.3	13.4	14.5	38.1
USP40	FLJ10785	ENSG00000085982	"Ubiquitin specific peptidase 40"	Q9NVE5	2	233475520-233566782	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005821	Uncertain		Approved	"Vesicles,Focal adhesion sites"		NA	NA			Vesicles	"Focal adhesion sites"	"HPA005821: AB_1080526"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.53e-2)"	12.5	20.5	11.0	8.2	17.7	3.5	16.1	8.2	13.5	12.4	12.1	26.1	22.5	11.6	16.2	28.1	13.9	13.4	13.2	10.8	11.3	8.5	16.9	15.7	13.9	7.6	22.1	10.1	19.6	17.2	22.8	24.3	16.3	16.5	16.1	11.2	16.4	13.9	19.7	13.6	21.7	15.2	17.1	20.1	11.4	16.3	23.3	18.9	9.8	21.2	9.4	12.0	18.0	11.8	1.9	5.0	0.4	2.8	1.4	2.2	1.4	9.5	11.1	10.2	6.9	15.0	14.1	9.0	9.4	7.3	8.8	9.6	7.9	11.4	0.2	2.8	15.1	22.6	17.0	7.8	16.7	12.6	0.0	5.1	7.5	9.2	13.3	13.1	3.1	5.1	13.4	12.1	12.9	18.2	15.4	10.1	4.6	12.1	1.8	12.3	7.7	3.4	4.7	4.5	9.9	9.0	0.0	21.2	4.4	10.4	15.4	5.6	6.1	7.5	7.8	9.7	8.0	8.8	7.1	9.9	12.2	7.6	5.1	11.4	3.4	2.6	0.4	15.9	5.7	10.6	0.0	2.7	0.0	1.3	2.8	0.6	1.3	1.5	1.3	4.0	1.9	1.9	2.2	0.4	1.4	2.3	5.0	2.0	1.4	11.0	17.7	8.2	13.5	11.3	8.5	22.1	10.1	16.5	18.9	29.8	31.5	3.7	9.6	6.5	18.6	8.9	10.2	24.1	23.9	15.7	23.6	17.1	6.6	7.9	6.7	7.1	10.9	0.0	10.6	8.8	7.4	11.3	9.2	20.9	7.0	22.3	14.5	12.3	10.4	7.8	6.4	6.7	3.3	5.4	9.1	13.0	9.7	8.6	7.8	11.6	20.8	12.9	8.2	31.2	14.9	9.3	13.2	4.4	11.2	7.1
USP42	FLJ12697	ENSG00000106346	"Ubiquitin specific peptidase 42"	Q9H9J4	7	6104884-6161564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 70.7;Spermatocytes: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064800			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064800: AB_2685355"	"unprognostic (1.48e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.66e-1)"	6.7	5.6	5.7	5.7	9.5	19.8	7.2	14.1	10.6	8.5	7.4	10.4	5.5	8.1	14.1	7.0	6.9	8.1	6.5	5.4	5.8	6.0	7.4	7.1	7.3	6.5	6.7	4.9	10.6	11.7	10.5	10.9	8.2	6.2	7.4	6.5	8.9	6.6	6.3	7.4	9.2	9.2	8.7	9.9	7.8	6.7	25.2	8.1	14.3	7.7	6.2	8.3	7.6	6.9	1.9	2.2	3.3	2.4	1.9	4.3	0.8	8.4	6.3	11.4	11.1	6.6	5.0	7.8	4.6	5.9	5.4	5.4	4.4	4.5	10.1	3.0	5.7	8.0	7.9	9.5	5.0	5.9	2.4	7.4	4.6	5.4	4.5	5.6	10.8	5.3	5.9	6.0	5.8	7.5	5.0	6.6	8.5	17.8	6.8	3.6	7.5	6.5	12.1	12.9	4.4	4.8	12.4	8.9	6.9	5.1	4.5	8.8	15.5	5.8	12.2	3.6	10.9	5.6	5.6	5.5	4.9	18.1	6.1	5.4	6.1	5.1	8.8	4.1	6.6	9.5	2.3	1.1	3.3	2.1	2.4	3.0	1.9	2.6	1.3	1.1	1.1	1.7	4.3	1.4	1.9	1.2	2.2	1.8	0.8	5.7	9.5	14.1	10.6	5.8	6.0	6.7	4.9	6.2	8.1	11.9	6.5	11.5	16.3	35.9	18.1	6.9	0.0	10.7	6.8	1.8	21.6	7.3	0.0	9.4	70.7	12.2	12.5	0.0	8.9	6.5	8.5	16.7	9.2	7.8	7.2	20.6	10.3	14.7	7.0	32.5	13.3	11.5	10.1	6.4	14.6	11.3	10.2	7.0	12.0	4.2	17.9	12.9	11.3	67.4	32.6	36.3	22.4	12.1	11.3	13.5
USP44	FLJ14528	ENSG00000136014	"Ubiquitin specific peptidase 44"	Q9H0E7	12	95516560-95551490	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.8"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 343.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 10.9"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.6"	"Group enriched"	"Detected in many"	39	"B-cells: 5.6;T-cells: 8.6"	"Cell line enhanced"	"Detected in some"		"HEL: 10.0;JURKAT: 22.6;NTERA-2: 54.2"					"Low region specificity"	"Detected in some"			HPA026543			Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Nucleoli fibrillar center, Microtubules"		"HPA026543: AB_1858692"	"unprognostic (2.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.83e-4)"	"unprognostic (7.18e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.07e-2)"	1.3	1.0	0.7	1.2	1.3	0.5	1.4	10.9	2.1	1.7	1.7	1.7	1.4	0.5	3.0	1.0	0.9	1.6	1.1	1.0	0.7	0.6	1.9	0.2	4.7	1.9	1.3	1.2	1.6	3.6	4.8	4.0	0.3	1.8	1.7	0.6	2.3	1.8	2.6	0.4	0.6	1.3	1.2	0.6	1.9	1.0	26.8	1.2	0.8	1.7	0.0	1.6	1.1	2.3	5.6	0.1	0.1	0.0	0.1	8.6	1.3	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.4	1.3	0.5	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	10.0	0.0	0.0	2.3	4.0	0.2	0.0	0.0	0.3	0.0	0.2	0.2	22.6	1.5	0.0	0.0	0.0	5.1	0.0	54.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	3.5	2.3	0.0	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	1.5	0.0	3.4	5.6	2.3	2.0	0.0	4.4	8.6	5.5	0.1	0.1	0.0	0.1	0.3	1.3	0.7	1.3	10.9	2.1	0.7	0.6	1.3	1.2	1.8	1.2	11.9	19.9	0.0	2.9	0.9	6.2	1.2	0.0	0.0	6.8	7.0	5.9	2.1	0.0	3.9	343.6	2.3	0.0	0.0	2.7	0.3	1.0	2.7	0.0	0.0	0.1	0.0	0.0	1.3	0.3	78.5	5.2	0.4	3.3	1.0	0.0	3.4	1.3	0.0	3.2	1.1	8.6	6.5	3.1	10.0	5.2	0.6	0.9	1.7	0.0	1.6
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432379-99521728	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	9.8	9.1	8.5	10.2	12.2	7.2	9.0	28.4	11.6	9.0	9.7	8.6	8.9	13.7	15.7	9.6	10.0	8.1	11.9	11.5	7.7	8.5	12.2	9.0	7.1	12.7	9.8	8.0	10.7	9.6	10.2	21.7	9.6	15.0	9.9	13.1	7.9	9.8	8.4	14.6	11.8	12.4	10.8	10.6	9.9	8.9	5.7	9.4	7.1	10.7	10.4	9.5	8.8	15.0	8.6	5.1	3.7	2.5	2.6	6.2	1.4	4.2	3.0	6.0	8.5	11.2	10.6	6.4	7.4	8.3	7.7	11.1	6.3	4.8	11.3	5.5	7.4	9.1	5.8	9.2	7.3	10.7	8.9	8.8	11.0	6.0	4.9	8.6	10.2	6.3	11.3	5.9	6.9	11.9	8.2	11.4	10.3	26.5	11.3	7.3	3.9	3.2	9.8	9.7	6.6	6.5	4.8	4.5	6.3	10.8	5.0	8.5	7.0	5.3	6.9	5.4	7.9	3.7	5.0	11.5	4.2	5.4	6.2	11.2	4.8	4.4	20.7	7.3	9.7	7.5	3.7	2.0	0.6	4.9	1.3	6.2	7.4	4.2	5.6	3.5	8.6	3.0	2.9	0.5	2.6	2.5	5.1	3.5	1.4	8.5	12.2	28.4	11.6	7.7	8.5	9.8	8.0	15.0	9.4	3.0	4.3	4.4	6.8	2.1	7.9	7.1	7.6	12.0	3.4	3.5	17.7	5.3	5.0	3.9	10.8	5.3	5.8	0.0	2.3	5.9	3.8	5.6	2.3	3.8	3.5	9.5	2.4	8.0	4.1	5.9	12.0	3.9	3.3	13.6	2.3	5.6	4.3	2.9	8.1	13.4	7.6	0.0	6.2	1.8	5.5	2.5	6.2	5.1	6.0	6.5
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590972-52659335	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 123.5;Early spermatids: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.7	9.5	26.0	3.5	20.9	2.8	7.0	23.7	29.4	8.9	4.2	12.8	5.2	4.8	7.2	6.2	12.4	7.8	5.8	28.9	21.9	19.0	10.8	3.1	4.4	3.7	19.1	13.9	12.3	5.6	12.2	5.3	10.6	12.7	7.7	4.6	5.3	8.0	7.8	13.7	8.0	4.5	5.5	18.9	3.5	6.3	12.2	15.0	1.0	10.0	4.3	5.8	7.3	5.7	1.4	4.4	2.0	1.4	1.2	3.9	1.0	5.4	3.8	12.5	9.2	13.6	17.1	13.8	8.9	7.2	6.6	5.6	7.7	4.2	3.6	10.5	8.8	9.3	3.2	21.7	10.3	12.1	3.1	7.6	5.6	3.7	8.6	13.6	7.3	6.5	14.5	9.7	6.8	6.4	12.9	9.8	5.1	5.5	5.1	13.9	4.9	3.1	3.9	9.2	6.0	4.7	8.0	9.1	0.7	14.2	10.0	7.5	9.0	4.3	14.9	8.5	12.5	5.4	5.5	9.0	6.5	14.2	7.6	13.3	5.2	2.4	2.9	10.0	4.5	8.0	2.0	1.4	0.3	2.3	1.2	1.7	1.4	3.9	2.0	2.8	1.2	0.9	0.8	0.3	1.2	0.9	4.4	1.2	1.0	26.0	20.9	23.7	24.3	21.9	19.0	19.1	13.9	12.7	15.0	6.0	4.5	1.9	9.8	4.7	123.5	42.3	12.7	24.1	11.4	14.0	3.9	10.5	18.3	10.3	151.7	8.4	3.8	0.0	10.5	10.9	10.3	17.3	0.0	5.7	5.0	33.4	4.1	7.4	7.6	24.3	26.7	4.4	8.5	14.4	5.6	21.3	9.7	7.6	33.9	12.6	7.9	6.5	8.3	3.0	11.5	7.2	6.4	4.4	6.0	15.9
USP47		ENSG00000170242	"Ubiquitin specific peptidase 47"	Q96K76	11	11841423-11959323	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029286, HPA029289"	Supported		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Intermediate filaments"	Vesicles	"HPA029286: AB_10599852, HPA029289: AB_10601675"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	16.6	17.0	17.9	18.5	20.9	20.3	16.9	25.7	19.0	16.4	18.1	16.2	21.3	11.6	18.0	15.0	18.7	13.7	13.5	25.5	18.1	13.4	14.6	25.1	16.6	13.4	21.9	12.9	16.9	19.6	38.8	31.8	23.7	19.3	18.0	14.2	10.2	15.1	19.2	58.1	18.4	15.1	21.3	19.5	13.3	18.1	16.8	23.9	27.9	16.8	12.4	15.2	21.3	19.4	9.7	10.1	14.0	13.2	22.8	19.3	9.7	21.4	13.1	23.5	11.1	17.0	18.8	10.8	24.7	18.7	16.3	18.5	12.9	19.1	24.3	11.8	22.9	19.4	14.7	18.1	12.4	25.2	23.6	15.3	14.6	24.2	9.0	15.1	18.9	20.5	17.4	17.1	10.7	23.8	18.6	18.1	17.2	29.1	21.0	19.9	8.5	17.0	8.4	6.3	21.3	10.6	17.6	24.8	7.5	17.6	24.9	8.2	16.7	22.1	15.4	13.7	15.1	12.3	13.9	20.0	23.1	14.1	19.6	15.0	6.6	15.2	23.0	15.9	11.7	16.6	13.3	7.7	14.0	15.2	9.5	19.3	9.7	13.8	14.7	10.1	8.6	17.9	15.3	3.6	22.8	13.2	6.1	9.9	9.7	17.9	20.9	25.7	19.0	18.1	13.4	21.9	12.9	19.3	23.9	65.5	50.8	26.5	58.2	63.1	66.5	188.1	30.6	62.9	67.1	22.7	45.2	55.8	21.6	33.6	26.3	35.8	25.1	23.3	33.7	29.2	48.3	58.2	51.0	50.0	24.2	60.4	56.9	30.1	18.5	22.9	40.9	32.0	23.6	27.9	30.5	80.7	36.7	31.6	47.0	17.9	50.6	51.8	47.2	72.0	59.0	76.9	105.2	47.3	32.2	47.7
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852128-6866632	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		820000	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	18.6	28.7	23.1	17.8	32.6	13.6	12.9	24.6	50.9	15.9	21.5	26.8	13.8	17.6	22.3	12.8	27.7	19.1	14.7	22.4	23.9	28.6	14.9	24.8	14.4	18.6	23.6	33.2	14.4	13.2	29.7	19.6	21.7	36.8	19.5	16.1	11.6	14.1	22.7	41.2	33.5	18.1	25.3	23.6	14.1	15.9	30.9	18.7	22.8	19.2	20.4	19.9	21.3	16.0	10.8	18.6	5.3	16.6	10.8	17.1	16.6	25.6	40.1	27.0	30.5	18.4	17.0	34.5	27.9	21.4	33.4	24.4	37.9	25.5	31.0	14.7	29.0	26.5	22.7	29.6	27.7	21.4	58.2	25.1	28.4	32.3	20.6	14.3	25.6	30.0	17.1	16.1	28.9	20.0	22.4	28.5	12.5	24.4	12.5	27.5	28.1	38.5	12.8	52.6	26.2	17.0	30.3	35.2	21.5	19.1	25.0	14.9	30.1	19.0	29.0	12.1	35.1	11.6	21.1	27.6	28.3	34.3	21.5	34.7	15.0	34.6	47.3	31.5	16.4	27.5	2.3	12.3	5.3	17.1	16.6	16.1	10.8	15.2	14.4	18.6	10.0	14.6	14.8	0.9	10.8	14.7	13.6	12.9	16.6	23.1	32.6	24.6	50.9	23.9	28.6	23.6	33.2	36.8	18.7	8.9	12.5	13.0	9.5	10.3	18.1	8.1	17.8	4.0	5.7	21.0	56.9	38.0	10.0	25.9	8.7	7.9	17.7	0.0	17.8	24.3	16.4	7.4	14.9	19.7	24.7	38.1	16.0	9.2	12.1	15.5	21.3	9.6	15.1	47.7	14.7	13.8	16.9	17.8	31.8	14.7	14.5	32.3	9.7	24.5	23.8	13.6	44.2	14.1	22.7	5.6
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 34.1"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 24.4;Ciliated cells: 17.4;Muller glia cells: 29.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4;naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	0.6	2.7	2.0	0.3	2.9	0.1	0.9	2.3	1.8	1.4	0.6			0.0	1.8	34.1	0.2	3.4	0.3	1.0	1.8	3.7	2.2	0.5	0.7	0.4	1.6		4.1	0.8	3.6	1.8	1.3		1.3	0.3		0.3	1.5	0.0	0.5	0.5	1.1	1.4	0.9	0.3	1.3			3.2		0.5	0.7	0.5	0.9	0.0	2.4	0.0	0.6	2.4	0.1	0.0	0.8	5.4	1.6	2.7	1.4	0.0	0.9	0.4	1.0	1.3	1.7	0.7	0.0	6.4	1.2	1.1	0.3	1.4	0.6	1.6	1.7	0.1	1.4	0.3	0.0	1.1	3.3	0.3	5.5	0.1	0.6	0.0	0.4	0.3	4.1	4.1	4.1	0.9	3.5	3.2	1.7	6.7	0.0	0.3	4.6	1.0	2.1	1.3	0.2	0.0	1.1	1.5	0.2	5.0	10.2	1.3	1.7	0.2	2.1	2.9	0.5	0.1	6.5	2.6	1.3	1.4	1.8	1.4	0.0	0.0	2.4	0.3	0.0	0.0	0.6	0.6	0.0	0.0	0.9	2.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1											3.0	5.6	0.0	1.7	0.8	24.4	5.0	0.0	17.4	3.4	3.5	5.9	3.4	8.3	1.0	0.3	5.8	0.0	0.0	0.0	2.1	4.3	1.1	1.1	0.8	6.1	6.4	3.5	4.9	3.9	0.8	3.7	2.5	5.0	0.0	0.3	29.9	0.3	0.0	7.8	12.2	15.2	0.0	3.9	3.6	6.7	0.4	2.3	1.7	0.2	0.4
USP53	KIAA1350	ENSG00000145390	"Ubiquitin specific peptidase 53"	Q70EK8	4	119212587-119295517	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 84.0;SK-MEL-30: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035844, HPA035845"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035844: AB_10669532, HPA035845: AB_2674817"	"unprognostic (9.33e-2)"	"unprognostic (1.49e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (4.37e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.54e-6)"	"prognostic favorable (3.58e-8)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	26.7	11.9	4.6	11.2	7.9	0.7	20.7	10.9	6.2	16.5	15.0	2.9	27.4	4.5	11.6	16.1	17.9	24.7	8.2	18.6	6.4	5.3	20.2	6.6	26.1	8.7	8.8	4.0	11.4	19.3	6.2	33.9	10.4	13.4	10.7	13.1	17.2	17.7	25.8	33.7	11.3	11.2	9.0	15.5	14.1	13.6	10.2	4.9	4.8	10.7	15.6	8.0	20.5	27.0	1.9	0.8	3.1	0.0	2.2	5.1	0.9	2.8	1.7	0.6	0.0	16.1	16.2	3.5	18.0	84.0	1.6	2.1	1.8	2.6	11.5	0.6	5.3	3.1	1.4	1.4	1.3	4.2	1.5	1.1	0.7	1.3	0.6	12.6	0.9	0.1	5.4	3.9	5.7	8.2	3.1	7.6	0.7	1.7	0.4	2.1	0.6	0.7	1.3	1.7	1.7	0.9	0.2	2.9	2.2	4.2	1.8	0.9	0.7	1.0	7.1	26.0	3.6	1.8	0.6	8.2	0.5	1.8	6.8	1.6	0.8	1.2	1.9	8.2	0.4	2.0	3.1	0.0	0.2	1.3	0.0	1.4	1.7	2.6	2.0	0.4	1.9	5.1	2.7	0.6	2.2	0.0	0.8	2.2	0.9	4.6	7.9	10.9	6.2	6.4	5.3	8.8	4.0	13.4	4.9	32.8	45.2	11.8	55.8	55.0	22.5	82.3	28.1	24.1	35.2	113.4	27.5	41.0	38.1	22.7	3.3	36.0	117.1	0.0	53.9	14.3	44.2	81.1	67.2	21.7	7.6	23.8	33.3	24.5	17.1	2.6	17.5	32.4	13.5	78.5	63.2	26.1	75.8	58.3	10.3	14.2	29.1	6.5	33.5	14.1	3.0	36.9	41.6	17.0	43.2	107.0
USP54	"bA137L10.3, bA137L10.4, C10orf29, FLJ37318"	ENSG00000166348	"Ubiquitin specific peptidase 54"	Q70EL1	10	73497538-73625953	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7;Glandular cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047663, HPA063665"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047663: AB_2680116, HPA063665: "	"unprognostic (2.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.89e-3)"	"unprognostic (6.63e-4)"	"prognostic favorable (7.00e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.91e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.95e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	2.9	1.7	12.3	2.5	33.8	0.5	7.7	7.9	21.3	7.9	7.8	43.8	1.8	2.5	4.2	4.5	10.2	7.7	3.1	4.0	14.1	6.8	2.7	1.6	9.0	0.6	49.5	14.2	4.0	6.3	7.1	3.4	1.2	28.6	5.8	11.1	3.4	8.8	3.6	12.0	6.1	2.9	4.0	25.4	1.5	11.3	4.7	42.8	0.4	24.3	1.2	3.6	5.6	4.0	2.4	2.2	1.3	2.4	1.5	3.2	2.3	6.3	6.6	10.2	9.6	2.7	3.2	3.2	3.4	6.7	5.7	6.6	5.5	10.5	4.8	4.0	3.5	4.4	8.8	6.5	2.4	7.6	2.3	6.1	3.0	4.8	3.7	2.2	3.3	1.2	2.5	2.3	6.6	6.6	11.6	2.6	3.5	4.7	0.7	3.9	3.2	3.2	2.1	4.7	17.8	24.0	4.8	9.1	1.8	4.1	6.2	3.3	3.2	6.5	8.0	7.7	6.3	10.4	3.0	3.5	2.2	6.7	4.3	4.3	1.7	3.1	3.4	5.4	3.1	2.0	0.8	2.3	1.3	1.6	1.9	3.1	2.4	2.7	2.5	1.9	1.0	3.2	1.9	0.1	1.5	2.4	2.2	3.0	2.3	12.3	33.8	7.9	21.3	14.1	6.8	49.5	14.2	28.6	42.8	44.7	23.5	0.0	4.6	2.4	7.1	5.6	5.1	17.4	15.9	12.2	15.7	0.6	0.0	4.1	1.6	4.5	11.4	0.0	7.1	0.8	2.9	59.6	3.5	1.7	1.2	4.8	9.9	3.1	0.6	1.7	3.1	1.4	8.5	1.0	20.7	13.0	8.8	7.0	10.3	1.1	11.1	6.5	3.8	8.0	6.6	3.4	1.1	1.3	10.5	10.5
UTP11	"CGI-94, UTP11L"	ENSG00000183520	"UTP11, small subunit processome component"	Q9Y3A2	1	38009258-38024824	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 74.7"	"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 54.9;Exocrine glandular cells: 58.5;Pancreatic endocrine cells: 60.3;Syncytiotrophoblasts: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045830	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045830: AB_10969917"	"unprognostic (1.95e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.44e-8)"	"unprognostic (3.51e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (1.42e-8)"	"unprognostic (1.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	11.3	12.4	9.1	9.6	8.4	9.3	9.7	7.5	11.3	10.6	12.1	6.0	6.9	7.3	11.4	9.1	13.8	9.8	8.6	11.5	12.9	9.5	9.1	13.1	7.4	8.6	9.3	8.7	10.7	11.5	6.6	10.2	11.4	11.2	12.9	8.7	6.7	10.0	8.8	74.7	9.4	7.6	19.7	10.9	10.2	10.4	9.3	5.7	10.5	8.1	26.1	10.6	22.6	10.9	12.9	18.7	9.6	22.5	21.9	17.7	12.3	15.0	9.1	16.0	15.6	12.0	16.4	14.6	17.1	16.3	23.2	21.4	13.4	18.9	25.2	16.1	13.8	11.4	13.2	18.1	15.0	29.1	18.9	16.6	29.3	12.3	11.7	16.2	29.2	19.3	15.1	9.7	25.6	22.4	14.5	18.5	19.3	33.5	13.7	26.2	10.7	22.6	30.2	38.9	16.9	12.2	20.1	34.2	23.4	15.2	14.7	21.2	17.6	15.0	13.0	27.5	17.6	11.8	18.0	13.6	15.9	19.2	17.3	32.5	13.1	25.6	21.3	21.3	32.1	19.5	8.4	18.9	9.6	16.9	20.5	17.7	10.5	13.5	14.0	18.7	12.9	12.4	15.0	5.7	21.9	22.5	18.0	15.6	12.3	9.1	8.4	7.5	11.3	12.9	9.5	9.3	8.7	11.2	5.7	32.8	35.8	0.0	0.0	0.0	0.0	0.0	0.0	46.8	38.7	24.4	0.0	47.4	33.2	54.9	0.0	0.0	0.0	0.0	58.5	41.6	0.0	0.0	23.3	0.0	47.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	33.3	0.0	0.0	60.3	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	65.1	0.0	0.0	0.0
UTP14C	"2700066J21Rik, KIAA0266"	ENSG00000253797	"UTP14C, small subunit processome component"	Q5TAP6	13	52024691-52033600	"Predicted intracellular proteins"	"Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (7.89e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.47e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (7.35e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.46e-5)"	"unprognostic (2.44e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.04e-2)"	4.8	4.8	5.3	3.4	5.9	0.5	6.2	6.6	5.9	6.8	5.3			4.6	6.7	4.6	3.6	5.2	3.9	5.5	5.1	5.2	8.0	7.9	4.5	3.5	5.5		6.1	5.8	8.9	4.8	6.6		7.1	5.9		5.7	5.5	5.3	2.9	4.5	5.3	6.2	4.4	5.7	2.3			9.1		3.8	4.6	4.2	4.1	5.8	6.7	4.8	3.5	6.8	3.1	4.2	6.8	14.1	11.1	14.5	10.5	10.9	12.3	9.6	8.3	7.7	6.7	9.0	10.5	3.3	11.6	10.5	10.0	12.4	6.8	11.0	10.7	8.8	20.2	4.8	6.5	9.9	17.9	14.0	9.2	13.0	6.4	12.4	10.9	6.8	12.5	11.6	5.3	12.4	3.1	10.9	10.0	12.8	19.5	4.9	10.7	9.9	4.5	14.1	6.9	4.6	9.5	7.3	11.0	8.4	13.5	9.8	14.2	10.3	7.7	8.0	8.6	8.4	5.4	7.8	12.7	4.1	6.7	14.4	6.7	3.7	5.4	4.6	4.8	3.9	3.0	4.9	3.7	4.4	4.1	6.8	6.7	2.4	3.5	3.9	5.8	5.2	3.1											6.0	17.4	11.2	5.0	5.3	13.0	18.5	20.4	12.0	13.6	15.7	3.9	8.5	0.0	6.0	0.3	10.6	10.8	0.0	6.6	8.1	10.8	11.1	11.5	28.1	7.9	23.8	17.9	12.3	14.8	0.0	9.8	6.7	8.5	2.8	15.1	13.6	6.8	14.0	13.4	5.0	10.6	6.5	7.6	6.6	12.2	7.3	5.8	6.9	12.7	5.4
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20, small subunit processome component"	O75691	12	101280109-101386616	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"		No	No			Nucleoli	"Plasma membrane"	"HPA049341: AB_2680720"	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	14.7	11.9	8.4	10.7	9.7	8.3	15.3	8.4	9.6	14.1	8.0	11.8	7.0	5.0	12.5	8.4	10.9	10.3	5.8	8.3	6.7	5.8	8.0	12.0	12.0	17.8	9.0	6.3	16.3	14.2	17.9	9.5	9.7	8.2	8.8	10.1	9.9	13.8	8.5	13.1	10.8	8.0	9.4	7.1	11.3	8.6	12.6	9.7	11.9	9.8	11.0	12.9	9.4	13.8	3.1	2.8	0.1	1.1	2.0	2.8	0.6	4.5	11.3	8.6	4.0	7.7	9.1	10.6	7.9	6.2	12.6	7.0	13.0	3.3	12.1	4.2	8.7	9.5	9.5	19.0	8.1	16.4	5.4	7.7	12.8	6.1	9.7	4.3	21.2	5.9	5.9	4.2	17.4	6.0	4.8	8.6	6.2	20.1	2.5	9.1	5.9	9.2	6.0	22.6	6.3	11.9	10.5	14.1	9.4	5.3	13.8	9.9	6.7	14.7	9.3	8.9	7.4	9.8	4.7	9.7	14.9	7.3	10.3	15.2	4.6	6.8	20.3	8.1	9.7	22.8	0.1	0.8	0.1	1.9	1.1	1.9	3.1	2.1	2.4	1.4	2.4	2.3	2.8	0.1	2.0	0.7	2.8	1.8	0.6	8.4	9.7	8.4	9.6	6.7	5.8	9.0	6.3	8.2	9.7	8.9	6.9	6.5	7.6	9.0	9.5	9.8	7.6	8.1	14.8	3.5	9.8	6.7	5.0	5.6	1.3	9.0	1.3	0.0	9.7	7.0	7.8	8.4	12.7	6.7	5.1	20.6	6.3	7.4	6.3	0.9	8.9	3.8	3.3	1.0	4.4	3.4	6.1	0.0	7.8	2.3	8.0	6.5	6.2	15.6	22.4	9.7	2.4	5.7	8.0	7.5
UTP23	"C8orf53, MGC14595"	ENSG00000147679	"UTP23, small subunit processome component"	Q9BRU9	8	116766503-116849463	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044418	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA044418: AB_10961139"	"prognostic unfavorable (5.18e-5)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.45e-3)"	"unprognostic (7.73e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.27e-2)"	14.5	11.9	16.9	13.1	21.4	39.5	13.6	25.2	20.0	12.3	12.3	9.3	9.3	8.5	15.6	10.1	11.4	12.9	10.5	11.6	14.4	10.0	9.7	11.6	12.4	18.8	15.4	15.5	20.0	12.7	9.7	15.8	12.8	13.3	13.8	8.3	6.8	11.7	13.4	11.7	11.3	11.5	12.7	13.0	13.2	11.0	8.9	16.2	13.1	16.4	8.7	12.0	13.7	13.7	27.4	23.3	24.2	21.7	16.3	33.3	15.9	10.9	11.9	6.5	5.9	9.3	11.5	4.9	10.8	6.3	7.2	7.9	12.4	7.3	16.2	10.6	5.2	6.8	7.9	8.9	5.8	9.5	16.0	17.3	20.1	9.1	8.2	9.2	10.1	9.6	9.0	7.1	7.1	9.6	5.0	7.7	13.0	13.0	12.4	7.5	20.0	24.5	6.0	5.8	18.0	22.4	13.8	7.0	14.0	4.4	10.1	12.0	9.5	7.0	28.4	9.9	3.7	12.7	7.6	8.6	7.8	10.7	17.9	14.5	15.0	22.8	19.9	9.8	13.1	8.7	24.2	16.3	20.6	26.8	16.8	23.2	27.4	24.4	21.1	14.1	27.3	33.3	23.2	16.2	16.3	21.7	23.3	26.4	15.9	16.9	21.4	25.2	20.0	14.4	10.0	15.4	15.5	13.3	16.2	38.7	31.5	28.3	17.9	19.5	21.6	21.0	10.2	24.1	29.6	7.0	5.9	25.2	23.2	14.5	5.4	22.0	6.9	23.3	18.0	16.2	23.5	11.4	40.5	11.5	14.8	15.9	11.5	25.8	9.1	3.1	26.7	15.6	10.1	15.4	13.7	24.6	10.8	10.5	26.9	13.4	22.2	12.9	18.0	38.8	22.6	14.2	16.6	17.8	14.5	15.5
UTP3	"CRLZ1, DKFZp761F222, FLJ23256, SAS10"	ENSG00000132467	"UTP3, small subunit processome component"	Q9NQZ2	4	70688479-70690551	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035655, HPA041453"	Approved		Supported	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA035655: AB_10601832, HPA041453: AB_2677488"	"unprognostic (2.44e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.44e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.24e-2)"	19.9	23.4	17.6	21.3	17.9	14.5	17.1	20.1	20.3	15.7	16.1	12.1	12.1	14.3	19.4	14.2	23.5	19.4	13.3	18.9	17.0	12.1	24.5	27.5	16.4	26.7	15.5	16.2	17.2	17.0	16.4	21.2	22.9	18.4	14.5	15.2	9.9	16.0	16.7	18.1	20.1	22.8	18.2	14.7	38.7	19.5	11.5	20.3	33.3	16.5	21.6	27.2	15.5	17.6	7.3	13.6	6.3	12.7	6.5	8.6	5.2	12.3	12.1	16.2	13.5	23.1	17.5	13.9	25.7	16.6	14.7	14.4	15.7	16.5	54.4	16.2	21.9	16.9	10.4	23.7	35.2	21.5	16.8	13.6	20.7	16.2	16.8	25.1	31.2	18.4	23.7	21.2	18.0	17.8	16.4	19.7	16.0	23.6	18.4	23.8	25.5	28.9	17.5	11.3	25.5	17.7	12.4	22.4	22.2	26.6	20.0	13.7	18.7	10.9	25.0	15.9	18.6	13.7	12.6	21.9	15.1	25.6	14.3	16.4	26.9	19.8	39.6	18.4	15.4	13.1	6.3	11.1	5.5	7.0	12.7	7.3	7.3	5.8	7.8	13.5	6.8	8.6	7.2	0.9	6.5	10.8	13.6	7.0	5.2	17.6	17.9	20.1	20.3	17.0	12.1	15.5	16.2	18.4	20.3	53.6	50.4	14.5	40.4	20.4	18.4	17.9	10.2	60.2	61.4	12.2	5.9	22.5	16.6	25.7	0.7	22.8	13.4	23.3	25.9	12.8	18.2	14.0	28.8	23.7	19.4	15.9	14.5	19.6	29.5	1.5	16.1	25.1	11.8	14.4	12.3	26.4	20.3	8.6	23.7	25.4	21.9	12.9	25.5	11.6	9.3	22.3	18.1	21.8	12.7	31.6
UTY	"KDM6AL, KDM6C"	ENSG00000183878	"Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked"	O14607	Y	13248379-13480673	"Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 14.9;U-266/84: 11.4;U-698: 14.9"									"HPA000568, HPA001165"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nucleoli, Nucleoli rim"	"HPA000568: AB_1858705, HPA001165: AB_1080541"			"unprognostic (7.52e-2)"		"unprognostic (6.60e-2)"	"unprognostic (4.04e-6)"	"unprognostic (6.47e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-2)"		"unprognostic (9.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-2)"	5.3	5.1	3.0	15.4	10.3	9.0	5.1	6.1	11.0	0.4	8.4	18.0	18.4	4.3	0.4	16.5	7.2	0.4	6.5	4.7	3.5	3.4	5.0	6.9	11.9	19.0	3.3	0.0	0.5	15.1	0.4	6.3	5.9	13.0	14.0	10.6	16.8	10.9	16.1	9.3	7.4	10.1	18.6	4.8	17.4	5.7	6.7	0.0	37.7	6.3	10.3	22.0	7.2	0.0	6.1	4.8	6.6	3.8	9.9	6.7	1.3	0.0	1.8	0.0	0.0	0.0	0.0	6.6	3.3	5.7	3.7	5.7	0.0	0.0	9.0	0.0	3.8	0.0	0.0	0.0	0.0	5.3	4.9	0.0	14.9	0.1	0.0	4.9	0.0	0.0	6.0	5.9	0.0	0.0	0.0	0.0	3.1	0.0	0.0	4.1	0.0	5.1	0.1	0.0	0.0	0.0	0.0	2.4	4.0	4.1	6.1	3.7	0.0	0.0	0.0	10.7	6.8	0.0	3.2	4.3	6.6	0.0	0.0	2.3	10.2	11.4	14.9	0.6	0.0	0.0	1.8	2.8	5.8	4.7	3.4	6.7	5.0	4.6	3.6	3.0	6.1	6.5	4.7	6.6	9.9	3.8	4.8	5.3	1.3	3.0	10.3	6.1	11.0	3.5	3.4	3.3	0.0	13.0	0.0	14.9	22.3	25.2	17.2	10.1	30.4	5.2	2.5	10.7	13.6	17.4	60.9	8.5	0.0	2.9	0.3	7.7	1.0	0.0	0.0	2.7	7.6	12.2	15.1	0.0	2.4	35.0	1.7	8.6	13.3	0.9	10.0	15.3	8.5	10.8	0.0	18.3	2.5	0.0	11.0	1.3	38.6	0.0	6.2	1.8	5.9	13.4	11.1	21.3	0.0	16.0
VAC14	"ArPIKfyve, FLJ10305, TAX1BP2"	ENSG00000103043	"Vac14, PIKFYVE complex component"	Q08AM6	16	70687439-70801161	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027766, HPA075382"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA027766: AB_1848651, HPA075382: "	"unprognostic (9.25e-2)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-1)"	26.3	26.6	22.9	22.8	21.8	16.3	17.4	15.6	34.9	17.9	18.4	27.0	18.5	19.8	18.8	15.8	21.0	20.9	17.0	22.2	22.9	23.5	25.7	27.1	20.1	34.9	22.3	20.8	19.2	27.8	33.7	21.4	20.1	25.8	17.9	14.1	22.9	24.3	19.4	23.3	24.6	21.6	19.2	22.2	29.0	20.0	21.7	20.6	31.2	26.0	16.3	22.9	21.0	16.3	5.5	9.7	6.6	5.9	3.7	5.5	1.9	11.4	11.3	9.6	10.7	14.0	10.2	14.7	8.3	13.2	15.9	7.4	14.0	18.5	14.7	10.9	10.0	19.1	14.5	12.6	13.5	7.5	4.4	13.1	7.4	8.6	17.3	36.1	12.7	15.7	16.9	14.2	23.5	21.5	9.6	15.1	13.6	13.0	6.7	13.9	16.5	11.7	21.2	16.9	9.2	10.7	14.2	7.0	21.7	7.6	7.9	11.5	12.5	27.5	8.4	19.0	7.6	12.5	11.9	11.9	21.2	12.2	13.4	9.0	9.6	11.8	28.1	35.4	11.3	9.6	1.3	4.8	6.6	2.9	5.9	2.5	4.0	3.7	5.5	9.7	5.5	3.5	3.1	1.6	3.7	5.4	5.1	2.3	1.9	22.9	21.8	15.6	34.9	22.9	23.5	22.3	20.8	25.8	20.6	3.0	3.4	9.3	7.4	3.8	8.1	10.7	15.3	9.4	4.5	3.5	2.0	13.6	5.0	17.1	14.0	6.7	11.3	23.3	19.5	22.7	6.6	7.1	5.7	13.2	37.6	9.5	8.7	19.6	15.9	40.6	5.8	10.7	10.1	26.2	9.0	6.0	16.7	10.4	3.2	12.2	7.1	6.5	5.6	4.8	12.6	8.0	16.4	3.9	9.3	5.4
VAMP4		ENSG00000117533	"Vesicle associated membrane protein 4"	O75379	1	171700160-171742247	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050418	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA050418: AB_2681121"	"unprognostic (9.38e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.66e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (5.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (5.43e-6)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.15e-1)"	16.0	20.1	14.3	13.0	25.3	7.3	14.1	24.3	22.9	13.2	12.3	12.7	15.6	12.3	13.9	14.4	13.8	10.9	13.2	12.1	16.1	16.1	13.1	13.0	16.3	16.0	16.0	21.6	11.7	15.7	19.8	30.3	16.0	26.8	12.2	11.6	17.2	15.5	20.6	9.0	15.4	12.1	12.9	20.6	14.9	13.3	18.3	15.3	13.2	18.5	7.5	13.0	14.2	13.7	9.5	7.3	12.8	10.4	10.4	14.6	10.8	6.7	2.2	6.1	4.9	9.2	10.9	3.9	12.4	9.9	3.1	3.9	1.9	9.1	4.3	11.2	10.0	4.7	4.6	2.4	4.1	4.5	7.6	3.6	3.6	3.0	1.6	5.6	3.1	2.8	4.9	7.3	3.8	7.3	8.9	5.7	5.9	8.8	5.3	6.6	2.3	7.4	4.3	2.9	13.2	8.7	6.3	4.7	11.1	6.5	2.2	3.7	7.1	6.2	6.6	5.2	7.0	9.0	5.9	6.6	9.8	3.3	13.8	11.8	19.4	16.1	5.8	15.0	2.8	7.7	10.0	10.4	12.8	10.5	8.4	14.6	9.5	14.2	12.0	4.9	7.6	10.2	10.9	3.8	10.4	8.3	7.3	12.4	10.8	14.3	25.3	24.3	22.6	16.1	16.1	16.0	21.6	26.8	15.3	20.8	9.4	6.5	12.4	13.7	11.3	10.7	7.6	9.4	9.1	3.5	21.6	9.7	13.3	7.2	21.1	18.0	10.3	0.0	6.7	12.0	18.5	15.5	24.3	12.9	13.6	9.5	9.8	14.7	13.3	31.4	8.6	10.6	11.8	9.0	12.2	13.4	8.5	14.4	12.4	11.1	8.5	19.4	12.9	28.6	17.6	15.2	11.2	20.3	6.9	12.8
VAMP5		ENSG00000168899	"Vesicle associated membrane protein 5"	O95183	2	85584408-85593412	"Predicted membrane proteins"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 294.0;Ito cells: 443.2;Kupffer cells: 298.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 34.3;HUVEC TERT2: 64.1;LHCN-M2: 75.3;TIME: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035082	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA035082: AB_10610564"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (9.61e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.60e-1)"	26.2	25.8	12.6	18.9	14.1	11.7	27.5	4.3	9.2	17.9	22.1	8.5	9.2	7.6	18.9	27.2	24.3	18.3	18.8	37.0	11.0	10.9	18.5	31.2	28.8	32.1	16.8	9.6	19.6	6.3	3.2	7.2	24.4	17.7	29.0	6.9	16.0	7.7	13.0	70.9	9.5	17.0	25.5	14.1	33.3	12.3	13.7	8.1	18.0	17.5	19.8	13.0	21.8	25.8	10.2	13.8	27.5	80.4	14.3	39.4	39.3	0.1	0.0	0.4	0.0	16.3	28.6	0.4	17.3	27.5	17.0	18.8	6.8	2.6	0.0	0.4	29.9	9.2	0.2	0.0	0.4	7.6	24.5	0.5	0.3	0.4	9.5	34.3	0.7	0.1	19.8	1.7	7.1	0.2	25.1	64.1	10.9	0.0	0.0	75.3	2.4	10.6	2.3	0.0	4.7	0.1	15.9	0.0	0.4	0.4	0.6	0.0	0.6	0.1	4.9	0.1	0.4	0.5	0.8	43.8	0.4	1.2	1.3	0.0	0.0	0.5	0.4	20.0	0.9	11.6	8.2	38.1	27.5	31.7	80.4	29.8	9.7	24.1	23.5	12.8	10.2	18.5	22.3	11.8	14.3	64.4	13.8	39.4	39.3	12.6	14.1	4.3	9.2	11.0	10.9	16.8	9.6	17.7	8.1	17.9	30.0	50.0	38.6	54.0	0.8	75.5	81.5	29.4	37.5	41.8	0.0	16.6	24.9	28.6	1.2	294.0	58.6	0.0	43.2	6.9	187.6	42.9	43.8	141.5	73.6	3.2	12.1	443.2	298.8	4.7	178.4	77.9	261.5	100.0	11.0	11.5	39.6	48.9	155.2	64.7	0.5	58.2	94.7	4.8	3.2	39.5	18.1	106.6	7.6	32.9
VAMP8	EDB	ENSG00000118640	"Vesicle associated membrane protein 8"	Q9BV40	2	85561562-85582031	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 172.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 82.0;NB-4: 128.2;THP-1: 63.7;U-937: 85.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006882, HPA007215, CAB037132, CAB037147"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		210000	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: "	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (8.07e-9)"	"prognostic favorable (1.59e-6)"	16.5	8.2	7.1	20.7	11.2	27.6	24.2	1.9	6.2	16.3	49.4	5.7	43.5	24.1	6.0	25.5	65.4	17.1	28.8	13.0	4.7	3.8	67.7	46.5	53.1	48.0	10.5	3.2	7.1	58.0	15.4	8.3	108.1	11.9	22.1	31.9	7.7	90.7	40.4	9.0	43.3	87.1	6.8	10.4	53.5	28.7	5.5	8.4	24.5	47.5	35.4	34.9	20.6	30.4	39.2	172.5	37.7	69.7	41.4	51.3	100.9	23.9	3.1	0.2	0.2	0.2	0.1	23.9	0.0	0.0	0.0	0.0	17.8	22.0	5.3	17.4	0.1	1.8	17.0	0.2	42.9	0.0	21.8	16.6	27.6	10.6	20.2	0.3	82.0	28.6	0.2	30.5	0.0	7.1	0.1	5.5	0.1	19.7	1.1	9.8	33.6	0.0	128.2	0.3	30.0	2.5	0.5	0.9	36.0	49.7	36.0	0.8	0.3	11.7	62.1	1.9	13.0	22.8	63.7	11.0	0.0	1.5	0.3	0.2	0.3	13.5	31.4	0.3	85.1	0.1	37.7	69.7	25.2	40.4	57.7	38.8	39.2	46.8	39.5	63.5	37.8	37.3	39.1	4.5	41.4	34.3	172.5	51.3	100.9	7.1	11.2	1.9	6.2	4.7	3.8	10.5	3.2	11.9	8.4	345.4	256.8	171.2	244.0	230.2	1.1	5.5	331.2	341.3	271.8	347.2	0.0	869.6	648.2	536.4	20.3	29.2	900.3	0.0	637.4	386.9	34.1	294.8	263.2	244.8	1050.6	0.0	124.1	155.3	836.3	34.0	8.6	660.7	334.0	762.0	322.8	2.4	674.2	501.5	7.1	797.0	1.6	45.3	25.8	28.4	6.4	288.3	734.1	248.2	230.6	528.7
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641953-115698224	"Disease related genes, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 37.3;Ito cells: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.5;NK-cells: 8.9;T-cells: 4.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB076375: AB_2665604, HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	7.0	8.6	2.2	5.8	3.1	2.0	16.4	1.2	2.5	14.0	9.3	5.3	8.3	4.0	13.2	8.8	14.4	13.7	5.3	12.7	3.2	2.3	11.8	7.1	12.1	7.4	2.1	1.9	8.9	11.5	5.5	2.2	5.3	2.4	9.4	7.1	6.6	9.5	11.0	2.1	9.8	6.6	15.9	2.0	4.7	6.6	7.9	2.6	18.0	11.8	10.0	10.0	10.2	9.4	0.3	3.5	0.0	0.8	8.9	4.3	1.4	21.5	9.2	3.0	4.0	11.2	10.1	6.0	8.4	6.1	11.0	8.8	5.3	10.8	0.0	14.5	9.7	10.4	27.3	5.0	14.9	7.3	25.2	6.1	12.0	8.5	4.3	4.1	3.5	5.2	5.3	10.5	7.8	8.4	5.8	10.9	20.6	7.2	6.7	11.0	28.8	17.6	1.4	7.5	12.6	8.8	0.0	8.7	6.2	5.1	14.5	2.7	3.6	15.1	10.0	7.2	5.9	5.1	3.9	11.6	7.6	12.0	16.5	15.2	0.9	1.0	0.0	10.2	6.3	18.5	0.0	0.8	0.0	3.0	0.5	0.8	0.3	1.9	2.9	3.5	0.0	0.7	3.3	0.0	8.9	0.8	3.0	4.3	1.4	2.2	3.1	1.2	2.5	3.2	2.3	2.1	1.9	2.4	2.6	3.0	2.7	1.9	6.3	6.5	4.0	6.3	2.5	6.7	1.2	8.7	37.3	3.7	0.0	14.9	4.6	7.7	7.7	0.0	12.1	5.8	6.4	7.0	0.0	2.4	3.8	0.0	6.4	31.9	1.5	1.9	5.5	1.8	0.0	19.0	7.9	4.2	16.1	5.8	7.8	5.7	0.7	6.5	5.7	1.0	9.4	5.6	0.3	1.8	8.3	6.5
VARS2	"DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL"	ENSG00000137411	"Valyl-tRNA synthetase 2, mitochondrial"	Q5ST30	6	30908242-30926459	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062449, HPA070267"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062449: AB_2684766, HPA070267: AB_2686245"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.43e-2)"	7.2	7.8	6.3	12.5	8.6	6.9	6.8	21.4	11.4	4.2	6.5	8.9	6.2	6.2	8.8	6.2	20.6	6.3	7.4	4.9	7.4	6.4	12.0	13.5	7.3	12.9	5.6	9.3	8.8	12.5	8.5	9.7	5.1	7.9	6.0	8.1	4.6	8.2	10.5	9.4	11.0	7.4	4.4	6.3	7.8	8.6	8.3	3.4	13.4	8.2	4.6	10.0	4.8	6.1	1.8	1.3	0.1	0.9	0.2	1.8	0.5	8.6	6.9	3.7	14.8	3.1	2.3	0.1	1.2	0.8	1.2	1.1	6.0	4.9	6.5	5.1	0.9	3.4	0.0	10.4	0.0	1.9	3.4	8.9	7.8	5.8	0.6	2.7	1.6	0.0	1.8	2.6	3.7	0.8	0.4	0.9	11.0	0.0	7.4	3.0	0.0	2.5	0.0	0.9	0.0	0.9	6.1	0.0	6.3	4.9	0.0	4.5	0.1	0.0	3.3	3.7	3.2	10.1	4.1	1.6	9.2	0.6	0.5	0.1	6.8	10.5	13.5	0.0	0.3	6.1	0.0	0.2	0.0	1.1	0.9	1.8	1.8	1.0	1.6	1.0	0.7	0.6	0.3	0.1	0.2	0.6	1.3	1.2	0.5	6.3	8.6	21.4	11.4	7.4	6.4	5.6	9.3	7.9	3.4	6.0	15.1	9.3	4.8	3.5	6.2	11.0	10.2	6.7	4.5	8.7	0.0	7.5	1.7	5.3	1.2	3.8	10.5	0.0	6.1	9.2	3.5	2.0	12.7	19.2	8.2	7.9	12.6	8.6	7.5	0.5	3.7	4.9	1.7	8.2	7.2	2.9	6.7	5.9	3.9	10.7	5.7	0.0	3.4	9.1	8.1	3.6	2.9	7.5	8.6	3.3
VASH2	FLJ12505	ENSG00000143494	"Vasohibin 2"	Q86V25	1	212950520-212992037	"Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.2"	"Group enriched"	"Detected in some"	12	"Early spermatids: 75.2;Late spermatids: 59.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"AF22: 9.6;AN3-CA: 11.7;NTERA-2: 18.4;RH-30: 54.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045820			Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA045820: "	"unprognostic (2.22e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-5)"	"unprognostic (1.95e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.81e-4)"	3.1	0.7	2.6	5.8	6.0	1.4	3.7	1.1	4.8	3.3	1.4	0.1	1.0	1.3	4.2	3.8	7.8	1.5	4.9	2.8	1.5	1.8	1.1	0.8	2.2	3.8	1.2	1.7	1.8	0.8	1.8	7.7	1.4	3.6	7.7	1.2	5.7	1.6	1.6	1.6	1.2	2.0	3.5	1.1	2.1	1.3	23.2	1.1	9.7	1.2	3.1	3.7	2.9	6.3	0.2	3.2	0.0	0.0	0.0	0.4	0.0	0.1	0.6	9.6	11.7	0.1	0.0	1.5	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.1	0.0	0.2	0.0	3.9	0.0	0.4	7.7	1.4	0.7	0.5	0.5	0.0	0.0	0.1	1.5	0.0	0.5	0.0	0.2	0.1	4.4	0.0	2.3	0.8	0.1	4.9	0.6	18.4	0.0	1.4	2.9	54.2	0.5	0.0	0.7	2.2	3.4	1.2	0.1	0.1	5.2	1.8	0.3	0.0	0.4	1.1	0.2	0.5	1.3	2.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	3.2	0.4	0.0	2.6	6.0	1.1	4.8	1.5	1.8	1.2	1.7	3.6	1.1	0.0	0.6	0.0	0.7	1.3	1.9	0.8	0.0	1.4	0.0	0.0	2.0	0.1	0.0	0.5	75.2	0.3	0.0	0.0	0.2	0.2	5.8	1.4	0.0	0.0	0.2	1.6	1.2	0.0	0.3	59.3	0.3	1.3	0.0	1.0	0.0	0.8	0.1	0.0	0.7	0.3	2.1	0.0	1.7	1.0	1.0	1.4	0.0	0.0	0.0	0.4
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383528	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"U-2197: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"	NA	Yes		2400000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	22.4	10.2	4.9	7.7	6.7	3.8	28.6	1.6	6.5	19.9	5.1	5.6	6.4	5.1	14.3	13.6	16.2	9.9	10.2	12.9	4.4	1.8	21.6	14.1	17.2	5.2	2.7	2.9	21.0	9.8	1.7	5.9	30.2	4.8	12.9	2.0	33.6	7.9	13.1	7.0	16.0	4.0	9.4	3.6	7.9	6.5	14.7	3.5	0.0	15.2	5.5	8.2	16.6	19.0	0.3	0.2	0.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	2.8	3.2	1.2	5.3	5.2	1.6	2.7	0.3	0.6	0.0	1.9	3.5	0.2	0.0	0.0	0.1	0.2	1.2	0.1	0.1	1.5	1.6	10.2	0.0	0.0	3.3	0.0	4.0	0.1	2.7	0.0	0.0	0.2	0.0	0.2	1.8	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.9	2.5	4.2	0.0	0.2	0.9	0.2	0.0	4.9	1.3	126.7	0.6	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	6.7	1.6	6.5	4.4	1.8	2.7	2.9	4.8	3.5	6.0	12.5	0.9	6.0	8.5	0.0	12.9	35.7	1.4	3.4	22.7	0.0	3.0	6.6	10.3	1.0	3.3	0.2	0.0	2.6	6.4	108.9	7.4	3.5	12.9	2.8	0.0	0.0	4.9	0.3	1.8	46.3	1.2	13.5	0.0	0.4	16.3	17.4	0.0	57.3	12.5	0.7	97.0	96.8	0.5	5.1	6.6	8.4	1.8	0.2	3.3
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788530-77980107	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.3;brain: 47.1;retina: 32.1"	"Group enriched"	"Detected in some"	15	"Horizontal cells: 281.3;Muller glia cells: 83.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BJ hTERT+: 27.7;fHDF/TERT166: 15.1;NTERA-2: 32.6;U-87 MG: 34.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.1	57.3	7.9	3.0	41.3	1.2	1.0	28.4	20.1	1.3	3.4	5.7	0.0	2.4	1.8	6.3	2.0	1.4	3.8	12.7	3.8	47.1	5.3	1.4	0.9	1.0	8.4	12.7	0.9	2.1	0.6	1.5	2.0	27.2	0.8	5.2	32.1	0.9	1.0	0.6	0.6	3.1	2.6	15.4	0.7	1.7	2.1	5.8	0.0	2.0	0.0	2.4	1.4	0.4	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	3.2	0.0	0.0	1.1	27.7	0.3	0.3	0.0	0.0	0.0	0.0	15.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	32.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.4	0.0	6.0	0.0	7.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	41.3	28.4	9.1	3.8	47.1	8.4	12.7	27.2	5.8	0.0	0.0	0.0	0.0	0.0	7.2	8.7	5.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	281.3	2.9	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	83.1	0.1	0.0	0.0	0.0	11.8	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0
VAV1	VAV	ENSG00000141968	"Vav guanine nucleotide exchange factor 1"	P15498	19	6772714-6857366	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.7;bone marrow: 25.7;lymphoid tissue: 43.1"	"Group enriched"	"Detected in many"	5	"B-cells: 26.9;granulocytes: 34.6;Hofbauer cells: 42.9;Kupffer cells: 22.9;Macrophages: 27.7;T-cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 31.3;Karpas-707: 35.7;MOLT-4: 33.9;REH: 22.5;THP-1: 26.3;U-266/70: 21.4;U-266/84: 25.9;U-937: 28.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001864, HPA005925"	Enhanced		Approved	Cytosol		NA	NA		30000	Cytosol		"HPA001864: AB_1858722, HPA005925: "	"unprognostic (2.93e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.28e-1)"	5.1	3.0	3.1	19.0	5.6	25.7	2.3	0.7	2.2	1.7	3.5	4.0	0.3	2.8	1.9	2.6	2.6	2.6	3.1	3.3	2.5	3.0	2.7	2.6	8.5	25.1	5.3	1.2	2.0	1.5	5.2	1.8	4.4	3.5	3.2	3.7	2.3	5.8	1.1	0.8	1.4	10.7	2.6	8.7	37.1	2.5	1.5	4.8	43.1	2.0	1.2	20.0	6.1	2.4	9.3	10.5	25.7	22.8	11.5	14.7	10.5	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.9	15.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.5	18.6	0.0	0.0	0.0	18.0	31.3	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.7	35.7	0.0	2.6	33.9	10.3	0.0	0.0	0.0	22.5	0.0	12.1	0.6	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.2	26.3	0.0	0.0	0.4	0.0	0.0	21.4	25.9	17.5	0.0	28.4	0.0	0.9	11.5	11.9	14.7	18.8	10.5	9.3	10.7	12.7	10.5	9.2	11.8	10.6	25.7	11.5	22.8	9.0	8.5	10.5	3.1	5.6	0.7	2.2	2.5	3.0	5.3	1.2	3.5	4.8	3.0	4.8	26.9	0.5	1.1	0.2	0.7	0.0	5.3	1.2	0.0	0.0	0.4	0.0	5.1	3.2	1.1	0.0	0.0	0.3	0.6	1.2	0.2	34.6	0.0	42.9	0.0	1.2	1.3	22.9	1.3	0.0	27.7	1.7	1.8	0.9	0.0	5.9	5.8	0.0	0.0	0.0	0.0	0.3	1.2	0.9	0.6	1.1	25.5	2.1	0.6
VAV2		ENSG00000160293	"Vav guanine nucleotide exchange factor 2"	P52735	9	133761894-133992604	"Plasma proteins, Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 34.9;Hepatocytes: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.4"	"Group enriched"	"Detected in many"	36	"B-cells: 6.4;dendritic cells: 2.0;monocytes: 3.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003224	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA003224: AB_1080554"	"unprognostic (1.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.16e-2)"	"prognostic favorable (7.39e-7)"	"unprognostic (8.64e-3)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (3.97e-2)"	6.3	19.2	6.8	13.3	5.6	1.9	8.1	2.8	7.3	7.7	16.6	5.8	9.3	15.5	9.8	9.2	5.4	9.5	21.3	5.7	5.4	6.9	16.0	30.3	17.2	12.5	7.7	5.5	6.1	44.1	8.8	6.5	9.6	9.6	7.8	7.3	9.4	12.1	11.0	1.7	4.6	28.1	7.6	4.7	13.8	7.0	3.5	4.0	3.1	11.6	3.9	13.3	8.6	17.3	6.4	2.0	0.0	3.6	0.0	0.1	0.7	4.8	8.6	13.5	5.4	3.7	6.3	34.9	9.8	5.4	8.3	5.0	13.0	7.6	1.4	8.0	9.7	10.7	29.0	12.7	21.1	4.3	8.2	2.9	1.6	10.8	14.5	13.9	3.9	0.6	6.2	13.6	7.3	10.4	5.5	9.2	2.9	2.8	2.4	5.7	24.7	0.3	2.0	6.6	21.2	8.2	13.2	11.4	4.7	18.8	8.8	15.0	10.2	25.7	17.2	3.5	9.1	10.4	5.7	7.4	11.8	6.6	11.6	13.4	0.1	0.1	2.7	7.8	3.5	7.2	0.0	1.4	0.0	0.1	3.6	0.0	6.4	0.0	0.1	2.0	4.5	0.0	0.0	0.0	0.0	2.4	1.2	0.0	0.7	6.8	5.6	2.8	7.3	5.4	6.9	7.7	5.5	9.6	4.0	0.0	4.8	11.3	2.4	4.5	1.0	3.2	30.6	1.4	7.9	34.9	0.0	0.6	3.3	8.1	2.6	4.2	29.3	0.0	10.8	14.7	5.4	4.7	0.0	35.0	5.2	0.0	27.1	9.8	4.5	5.8	6.6	5.5	1.7	10.8	6.3	5.3	18.4	11.4	5.6	11.7	1.4	12.9	8.5	0.1	1.9	2.4	0.8	0.0	11.6	2.0
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 21.8"	"Cell type enhanced"	"Detected in single"	27	"Cardiomyocytes: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 7.7;WM-115: 5.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8"	"Low region specificity"	"Detected in many"			HPA028946	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	NA			"Nucleoli rim"	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.4	0.4	1.4	0.4	21.8	0.4	0.4	0.0	7.0	0.5	0.5	9.5	0.0	0.4	0.4	0.4	0.5	0.4	0.5	0.4	1.5	5.2	0.4	0.4	0.4	0.4	0.7	4.3	0.4	0.4	0.7	0.5	0.4	1.2	0.4	0.5	0.0	0.4	0.5	0.7	0.4	0.5	0.4	1.3	0.4	0.4	2.1	2.9	0.0	0.4	0.0	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.7	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	21.8	0.0	7.0	1.5	5.2	0.7	4.3	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0
VAX2	DRES93	ENSG00000116035	"Ventral anterior homeobox 2"	Q9UIW0	2	70900590-70965373	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4;retina: 21.2"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 8.7;Cone photoreceptor cells: 15.7;Horizontal cells: 11.1;monocytes: 7.2;Muller glia cells: 7.2;Rod photoreceptor cells: 17.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;MCF7: 7.5;RH-30: 6.5;SCLC-21H: 6.6;SH-SY5Y: 7.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"basal ganglia: 2.1;hypothalamus: 4.7"	HPA009708			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA009708: AB_2668261"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.74e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.65e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.18e-2)"	2.7	2.6	4.4	1.4	1.9	0.4	2.1	16.4	7.9	1.9	0.8	1.1	0.0	0.5	3.6	0.8	1.8	1.1	0.6	1.5	2.5	4.1	0.6	0.3	0.9	0.6	1.4	1.1	2.3	6.9	0.9	2.2	1.2	0.8	2.3	0.6	21.2	4.5	0.6	2.0	1.5	0.5	1.9	1.6	0.4	0.4	0.8	1.0	0.0	0.7	1.2	0.4	1.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.0	1.2	6.6	1.8	1.0	3.7	1.2	0.5	0.1	0.0	0.1	0.0	0.0	0.0	2.9	2.2	0.3	2.5	0.0	0.2	0.0	4.1	0.0	0.1	2.8	0.8	0.0	0.0	1.8	0.0	0.3	0.0	1.9	0.6	0.3	0.0	0.0	2.4	7.5	0.0	0.1	2.9	0.0	0.1	0.0	6.5	0.0	2.0	1.6	6.6	7.9	5.1	0.0	2.7	0.2	2.9	0.2	1.2	3.1	0.7	1.5	1.3	0.0	0.0	0.0	1.5	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.9	16.4	2.7	2.5	4.1	1.4	1.1	0.8	1.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	15.7	0.1	1.7	1.4	0.0	0.4	0.0	0.0	0.6	0.2	0.8	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.2	0.0	7.2	0.6	0.0	0.0	0.0	17.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0
VCAN	"CSPG2, PG-M"	ENSG00000038427	Versican	P13611	5	83471465-83582303	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 557.1;Kupffer cells: 784.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 55.5;myeloid DC: 21.3"	"Group enriched"	"Detected in many"	31	"dendritic cells: 21.3;monocytes: 55.5"	"Cell line enhanced"	"Detected in some"		"AF22: 43.6;HSkMC: 29.6;hTERT-RPE1: 140.3;RPTEC TERT1: 55.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004726, CAB008979"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		5200000	Vesicles		"CAB008979: , HPA004726: AB_1080561"	"unprognostic (7.90e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.09e-2)"	"unprognostic (6.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (4.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.17e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.30e-3)"	33.3	18.3	14.8	53.2	10.3	20.1	12.3	4.8	16.2	25.2	8.4	17.9	1.7	3.6	14.5	23.5	9.0	7.6	23.2	35.7	19.8	8.9	8.5	3.1	25.8	21.2	13.9	9.8	5.3	3.2	3.7	2.0	52.0	14.4	8.9	8.9	3.3	6.5	4.1	9.0	9.3	4.7	33.9	18.2	18.4	6.2	8.7	19.4	1.1	5.7	6.5	2.3	24.4	9.8	0.0	21.3	1.2	55.5	0.1	0.1	17.7	0.0	0.8	43.6	0.0	17.7	12.2	0.0	0.3	0.8	0.3	0.2	0.4	0.0	0.0	6.7	15.7	0.5	0.0	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.3	0.8	0.0	0.0	29.6	0.0	18.5	0.1	140.3	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	7.4	0.0	1.4	0.0	9.1	0.0	55.4	0.0	0.5	2.2	0.0	0.0	0.0	5.0	0.0	0.0	16.8	13.3	0.0	24.4	25.0	0.0	0.0	0.0	6.1	0.0	2.3	1.2	55.5	0.1	0.1	7.7	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.9	0.1	0.8	0.4	0.0	17.7	14.8	10.3	4.8	9.8	19.8	8.9	13.9	9.8	14.4	19.4	17.9	29.9	3.0	4.4	34.3	0.0	6.8	30.6	25.4	30.7	24.4	0.0	7.1	0.0	1.6	0.8	12.1	0.0	0.0	0.6	5.1	557.1	1.5	11.6	2.1	24.5	0.0	0.0	23.4	784.4	0.7	17.3	132.2	42.2	5.4	0.0	0.0	19.5	0.0	110.7	1.2	0.0	0.0	33.9	0.3	0.4	25.1	9.6	4.4	0.0	0.8
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667217	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane"	Centrosome	"HPA023932: AB_2671373"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	9.5	8.7	15.7	12.6	14.5	30.9	8.9	14.4	15.1	7.5	8.4	7.0	3.8	7.0	7.8	8.7	8.1	6.9	7.0	6.7	10.2	9.2	8.3	12.3	10.5	13.6	10.3	13.7	7.8	9.0	14.0	5.9	8.0	12.3	7.0	7.8	6.0	9.0	7.1	14.8	7.3	10.0	6.3	9.6	14.7	8.0	10.8	11.7	11.6	8.0	2.8	13.3	7.9	7.0	2.6	3.4	11.3	8.8	2.8	4.3	1.7	9.0	8.2	4.2	5.6	13.0	9.2	4.1	7.3	7.4	5.6	6.5	4.8	8.5	12.2	2.1	9.7	6.9	8.0	6.8	6.1	8.0	9.0	4.9	13.5	8.1	6.0	7.8	4.5	14.6	9.9	9.0	6.1	11.1	6.9	6.0	6.7	9.1	11.8	8.2	4.4	9.7	7.8	8.0	7.6	5.7	6.3	6.6	6.1	8.1	7.1	2.5	4.8	5.6	8.6	6.3	5.6	8.8	7.5	12.0	7.4	5.5	6.5	4.8	10.5	5.1	13.1	7.3	6.5	5.5	9.2	3.2	6.7	4.3	5.2	3.6	2.0	2.7	3.1	3.4	2.6	2.2	2.9	11.3	2.8	8.8	1.3	3.3	1.7	15.7	14.5	14.4	15.1	10.2	9.2	10.3	13.7	12.3	11.7	17.9	14.6	9.0	8.1	15.0	11.1	16.5	12.7	12.0	11.4	7.0	21.6	8.8	3.3	9.7	4.3	9.9	14.0	23.3	11.7	4.8	12.3	11.3	18.5	20.2	12.4	11.1	5.8	15.4	47.5	4.5	7.5	18.0	10.1	10.8	15.0	11.8	10.8	15.3	14.9	9.9	10.8	6.5	10.8	26.8	14.7	18.1	8.2	26.6	13.3	14.2
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.1;parathyroid gland: 45.8"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 101.9;Paneth cells: 43.0;Undifferentiated cells: 54.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 23.0;HDLM-2: 32.4;U-937: 31.8"	"Region enhanced"	"Detected in single"		"olfactory region: 2.5"	"Not detected"	"Not detected"			"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.0	9.2	0.2	10.0	0.3	2.5	7.8	0.3	0.6	3.5	40.9	0.4	4.1	21.2	1.2	7.7	10.2	1.1	10.7	1.5	0.5	0.3	13.0	0.6	8.3	3.8	0.5	0.1	1.3	6.5	45.8	11.7	4.4	0.6	2.1	12.6	0.4	4.9	2.8	5.3	15.2	57.1	1.2	1.5	3.1	2.6	1.5	0.2	2.0	1.9	9.4	8.2	4.0	5.2	0.7	5.7	7.5	7.0	0.2	0.8	1.2	5.5	0.9	0.0	0.0	4.8	7.0	0.1	6.8	3.5	5.8	5.0	4.0	4.7	1.4	7.4	4.6	4.1	10.4	0.2	23.0	2.7	32.4	1.7	2.4	1.3	0.3	3.5	4.9	7.8	9.4	10.8	6.4	10.5	9.2	0.4	0.5	0.7	1.5	2.6	3.7	0.1	2.4	0.0	13.8	7.5	0.1	0.0	3.5	5.2	5.5	2.6	0.1	5.8	16.7	2.1	0.0	18.8	2.7	0.4	11.1	2.9	3.2	3.8	0.9	0.0	1.2	3.4	31.8	2.8	0.2	3.7	2.1	0.0	7.0	0.1	0.7	0.3	0.0	5.7	0.1	0.1	0.0	7.5	0.2	6.9	0.6	0.8	1.2	0.2	0.3	0.3	0.6	0.5	0.3	0.5	0.1	0.6	0.2	11.9	15.3	1.9	8.2	32.1	0.4	1.2	0.0	9.4	11.4	7.0	0.0	0.1	6.6	3.7	0.1	0.8	101.9	0.0	9.4	0.1	7.8	3.9	6.9	0.4	3.6	0.0	20.8	0.0	6.6	0.0	0.0	18.7	8.5	6.4	30.0	0.2	14.7	43.0	0.4	17.5	0.2	0.0	2.8	0.7	0.3	35.5	0.2	3.2	54.4	8.4
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 38.1;pituitary gland: 70.3"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 2.2;pons and medulla: 5.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.5	16.0	0.3	0.2	0.3	1.1	1.4	2.2	3.5	1.9	0.4	0.7	2.0	0.2	0.4	12.1	0.2	3.4	1.1	0.4	0.8	0.5	20.7	0.6	38.1	0.1	0.7	0.1	1.1	8.6	0.7	70.3	1.6	5.5	1.2	0.3	17.7	6.9	4.9	0.2	0.7	0.2	0.1	0.3	2.3	0.6	1.7	0.2	0.1	1.1	0.5	0.6	0.5	0.8	0.0	0.0	1.5	0.7	0.0	0.0	5.1	1.8	0.2	4.3	0.0	2.5	9.4	0.0	11.0	24.5	3.3	4.8	0.3	1.7	0.0	4.3	11.8	0.5	0.0	0.1	0.2	18.3	0.0	0.0	1.8	0.2	0.0	0.8	0.0	0.0	2.7	0.1	14.0	2.8	26.3	65.1	0.0	0.6	0.0	8.9	0.2	0.0	0.0	1.7	0.5	1.6	0.0	0.3	0.0	1.6	0.9	0.1	0.0	0.3	0.5	4.3	0.0	18.9	0.0	38.7	13.1	0.4	4.5	15.1	0.0	0.0	0.0	10.5	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.1	0.3	0.3	2.2	0.4	0.8	0.5	0.7	0.1	5.5	0.2	247.1	124.4	0.0	0.2	1.5	0.0	0.3	12.7	14.7	26.1	29.6	2.0	1.6	39.7	5.5	67.1	0.0	0.0	0.0	8.7	0.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	63.8	1.4	0.4	27.0	1.0	0.2	0.8	2.0	2.8	0.4	24.1	0.3	0.0	0.0	0.3	0.6	0.4	0.0	0.0	0.6	0.1
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302790	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.93e-5)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	12.3	21.4	15.4	14.3	17.2	5.1	14.6	28.3	27.2	12.9	14.4	9.1	19.0	9.5	17.1	15.9	15.6	11.5	12.1	14.7	11.8	9.5	12.1	10.4	13.8	9.6	11.0	14.0	13.3	12.6	15.7	20.4	19.6	11.4	15.8	10.6	10.3	10.9	13.9	42.7	16.1	11.0	16.2	12.5	7.2	10.7	7.2	12.2	13.6	29.8	14.5	10.0	15.7	12.2	5.2	4.4	1.1	3.5	2.4	5.0	1.2	10.3	9.6	13.3	7.2	10.2	7.3	5.1	7.6	9.6	6.1	9.7	3.5	4.9	13.4	5.0	6.6	3.3	5.4	9.5	6.7	11.4	9.0	5.3	5.1	2.5	3.6	5.5	10.1	3.0	9.2	11.7	5.7	16.5	14.2	12.8	6.6	3.0	5.3	5.5	2.8	8.7	4.8	6.7	3.3	9.8	7.9	6.3	4.3	17.7	7.5	9.0	7.8	7.3	11.1	3.5	12.4	13.7	1.7	10.2	5.5	2.1	2.4	4.2	5.2	7.8	11.4	2.1	3.7	2.8	0.5	3.1	1.1	3.6	3.5	4.7	5.2	5.0	2.1	4.4	3.6	2.4	2.0	0.3	2.4	0.9	1.8	3.5	1.2	15.4	17.2	28.3	18.8	11.8	9.5	11.0	14.0	11.4	12.2	65.5	43.0	27.5	49.9	69.0	66.8	41.6	33.1	29.4	47.8	31.4	80.5	32.2	8.3	45.1	8.5	39.8	29.7	0.0	39.7	17.6	29.0	46.9	28.8	32.6	18.8	58.8	36.9	40.5	28.3	8.3	30.2	23.7	35.4	20.8	26.8	23.0	54.7	29.1	31.1	18.9	146.1	6.5	34.3	27.3	17.9	63.2	92.6	20.3	20.7	66.0
VGLL3	VGL-3	ENSG00000206538	"Vestigial like family member 3"	A8MV65	3	86876388-86991119	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 195.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 105.6;Extravillous trophoblasts: 167.0;Late spermatids: 52.5;Leydig cells: 122.6;Peritubular cells: 140.4;Syncytiotrophoblasts: 67.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"U-2197: 106.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054983	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA054983: AB_2682663"	"unprognostic (9.08e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.73e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.05e-1)"	22.5	1.0	0.5	3.4	0.5	0.2	8.6	0.2	0.3	6.3	6.2	0.4	3.3	0.6	8.2	7.8	6.1	5.2	6.8	4.3	1.0	0.7	1.8	0.6	16.1	3.6	0.6	0.3	10.6	2.7	0.7	0.4	195.7	0.8	8.0	1.6	2.8	1.9	3.1	7.5	4.0	2.1	11.9	0.8	2.4	2.9	8.0	0.3	0.1	3.4	1.9	1.0	12.2	9.2	1.1	0.6	2.3	0.5	0.8	0.7	0.1	1.5	2.6	14.2	0.0	19.0	23.8	0.2	9.8	6.9	8.4	10.5	3.0	0.6	0.0	0.0	15.3	0.9	1.3	0.9	0.9	11.6	5.5	0.0	0.7	0.9	0.0	8.7	0.1	0.0	18.1	1.5	12.3	5.5	4.5	1.2	0.0	0.0	0.0	10.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	18.9	0.1	0.0	1.6	0.0	0.0	4.2	0.1	0.0	0.5	0.0	0.0	0.5	18.7	2.7	106.2	0.3	0.0	0.0	0.0	3.4	0.0	0.7	2.3	0.5	0.7	0.4	0.3	0.4	0.5	0.5	0.3	0.2	1.1	0.6	0.7	2.0	0.8	0.4	0.6	0.5	0.1	0.5	0.5	0.2	0.3	1.0	0.7	0.6	0.3	0.8	0.3	3.0	2.1	0.0	7.4	7.1	0.0	0.7	0.0	5.3	4.5	10.4	0.0	20.7	0.0	10.3	105.6	1.5	0.0	0.0	2.1	167.0	26.2	18.3	0.0	0.0	6.7	0.0	0.0	4.3	0.0	52.5	122.6	2.4	3.3	0.0	0.0	15.8	8.4	0.0	140.4	0.0	0.3	12.9	17.8	1.4	1.0	4.5	67.5	0.0	0.0	3.7
VGLL4	KIAA0121	ENSG00000144560	"Vestigial like family member 4"	Q14135	3	11556070-11771350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038225, HPA038614"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Nucleoli fibrillar center"	Nucleoplasm	"HPA038225: AB_10674549, HPA038614: AB_2676115"	"unprognostic (1.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.26e-1)"	22.3	29.3	26.6	20.7	25.1	10.5	28.2	18.0	23.8	32.3	18.6	22.8	17.8	18.9	35.6	23.3	23.6	36.0	28.9	20.7	23.3	13.2	22.5	10.6	20.4	15.2	22.4	14.9	65.4	18.4	27.2	19.6	19.9	19.7	21.8	14.7	28.8	28.7	23.5	13.8	24.2	18.6	24.7	28.2	15.8	18.6	25.4	23.3	30.0	37.5	21.3	19.9	23.4	30.3	5.6	5.3	16.2	5.8	6.3	11.3	5.8	10.3	7.0	20.1	6.1	25.5	13.8	37.7	6.9	14.3	6.1	6.0	5.9	10.3	14.1	16.0	10.9	10.7	7.0	9.2	11.5	4.3	8.5	14.0	15.1	7.0	9.8	19.9	11.8	10.0	17.2	24.0	8.3	10.7	36.0	22.8	15.0	5.4	2.4	9.4	8.9	14.0	13.6	12.4	15.3	12.4	18.1	13.6	18.4	14.0	15.0	8.8	25.4	7.9	8.5	17.7	13.8	8.3	11.7	12.0	16.6	8.1	10.8	17.4	3.8	10.9	30.9	18.3	20.2	32.1	16.2	4.4	1.0	11.3	2.5	7.3	5.6	6.2	9.2	5.3	4.0	8.5	8.9	2.6	6.3	5.8	4.5	3.1	5.8	26.6	25.1	18.0	23.8	23.3	13.2	22.4	14.9	19.7	23.3	29.8	14.4	15.2	51.3	57.4	41.2	2.8	43.3	53.5	31.8	41.8	139.4	60.4	53.0	61.8	12.4	50.4	28.1	23.3	31.6	68.9	55.2	68.7	13.9	13.0	28.2	69.9	33.3	55.9	17.0	12.4	67.9	13.8	42.2	25.2	29.4	89.9	45.9	42.1	85.2	21.3	50.6	32.3	46.2	10.2	27.7	66.6	37.4	18.8	36.0	58.0
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.3;stomach 1: 52.5"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 130.9;Paneth cells: 94.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.2;OE19: 40.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA035675, HPA035676"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA035675: AB_10671223, HPA035676: "	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (1.35e-4)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	2.7	2.1	7.1	12.3	7.2	6.3	3.4	4.7	5.3	5.3	28.0	1.7	3.9	33.2	6.2	3.2	3.8	4.1	21.8	3.3	5.3	4.1	2.8	0.6	7.0	7.3	2.9	4.6	3.9	2.2	0.6	3.4	3.6	2.9	8.5	14.8	4.5	3.8	4.8	1.0	5.1	46.3	3.8	3.4	6.3	52.5	3.5	3.5	12.1	4.5	3.1	9.6	15.0	3.8	5.4	4.6	0.1	3.9	4.0	9.2	4.8	4.2	0.0	0.1	0.2	1.5	1.2	0.4	1.2	1.0	1.2	1.2	3.2	13.2	2.0	1.9	0.8	0.0	1.0	0.9	0.1	0.2	0.4	0.0	3.7	0.0	0.3	1.9	3.9	5.1	1.8	1.2	1.2	0.0	0.0	2.4	8.5	3.7	1.2	1.4	0.0	6.2	4.4	0.1	40.5	0.0	2.4	0.0	1.0	0.4	5.1	0.0	0.1	0.0	0.3	0.9	0.0	0.3	6.4	1.4	0.5	0.2	1.6	0.0	0.7	1.5	0.6	0.3	5.6	2.6	0.0	3.9	0.0	8.7	2.4	9.2	4.4	5.8	4.9	2.6	5.4	7.4	5.4	0.1	4.0	1.6	4.6	6.8	4.8	7.1	7.2	4.7	5.3	5.3	4.1	2.9	4.6	2.9	3.5	8.9	9.0	0.5	5.1	2.1	0.8	1.5	10.2	12.0	14.8	0.0	0.0	2.4	0.0	2.1	4.9	3.7	130.9	0.0	15.4	2.8	3.7	5.4	8.1	0.0	2.0	1.6	9.2	3.1	1.0	14.5	3.4	2.7	1.7	1.8	40.6	26.2	22.9	94.7	2.5	1.4	0.4	0.0	3.8	4.5	2.4	1.3	0.8	10.0	38.0	23.8
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750798-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.5;lymphoid tissue: 64.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.7;Melanocytes: 27.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 2.2;SH-SY5Y: 7.0;TIME: 4.9;U-2 OS: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	122000		"Endoplasmic reticulum"		"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	1.2	5.7	9.7	64.7	8.3	0.3	0.9	1.5	20.1	0.6	31.5	0.5	0.3	7.5	0.7	0.4	13.1	0.5	4.2	1.1	12.4	7.7	0.9	0.6	1.7	0.4	2.7	8.3	0.4	3.8	0.5	0.4	0.5	1.6	6.3	28.3	3.2	0.4	6.9	0.8	0.4	32.5	18.0	0.4	5.2	13.2	0.5	0.1	0.0	1.3	0.5	0.4	9.1	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.4	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	2.0	0.2	0.2	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.7	8.3	1.5	20.1	12.4	7.7	2.7	8.3	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.3	4.2	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
VIPR2	"VPAC2, VPAC2R"	ENSG00000106018	"Vasoactive intestinal peptide receptor 2"	P41587	7	159028175-159144957	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Muller glia cells: 32.3;Rod photoreceptor cells: 44.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 13.1"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 13.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 4.2;HMC-1: 6.5;MOLT-4: 8.8;U-266/70: 29.8"	"Region enhanced"	"Detected in some"		"olfactory region: 33.2"	"Low region specificity"	"Detected in all"			HPA062707	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA062707: AB_2684842"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.89e-2)"	9.6	1.2	2.1	2.9	1.3	0.6	2.1	0.9	10.2	18.0	10.6	1.5	14.1	2.1	11.5	14.3	3.1	3.3	4.7	13.3	2.6	1.8	1.0	0.6	0.6	3.0	1.9	2.3	10.8	15.7	0.3	2.6	6.4	2.1	8.4	1.5	4.9	1.1	24.0	7.3	0.6	3.9	7.1	2.4	1.1	8.3	2.4	1.1	16.9	0.4	0.7	0.8	5.7	9.9	0.0	13.1	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.2	8.8	0.0	0.7	0.0	0.0	2.2	0.1	0.5	0.0	0.0	2.1	1.7	0.1	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	29.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.1	0.0	0.0	13.1	0.0	0.1	2.1	1.3	0.9	10.2	2.6	1.8	1.9	2.3	2.1	1.1	0.0	0.0	0.0	2.2	0.6	1.4	6.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	5.8	0.0	1.5	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	9.5	0.0	1.7	0.0	0.0	32.3	0.8	0.0	2.5	0.3	44.5	0.0	8.0	3.7	2.1	0.0	0.0	2.9	0.0	0.1
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 193.2"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 872.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 193.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 193.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: AB_2685348"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	22.0	37.8	20.4	21.9	24.9	13.0	18.6	20.0	28.7	18.2	32.0	27.8	16.7	40.5	18.3	15.4	22.9	14.4	25.2	19.6	21.7	22.3	22.9	43.0	22.4	20.1	23.1	15.6	16.5	22.9	19.0	20.1	27.9	29.8	17.3	29.3	20.0	17.8	13.9	19.8	19.2	39.7	14.3	26.4	36.6	19.0	17.6	16.2	14.4	18.1	12.5	16.8	19.5	17.6	3.3	10.9	193.2	39.9	3.8	4.1	24.7	20.3	41.0	13.3	20.5	28.5	17.5	21.4	32.4	23.1	20.2	27.2	26.8	29.3	11.7	48.4	21.9	22.1	25.3	15.4	18.6	25.2	30.0	19.3	15.0	23.5	28.2	27.8	17.0	18.4	26.8	15.9	26.0	22.1	16.2	21.4	10.0	19.6	20.7	20.9	56.0	15.8	8.9	15.0	42.3	21.1	8.7	23.4	24.1	25.0	23.8	9.6	21.7	18.5	15.7	21.5	19.1	32.5	14.6	30.2	27.2	26.0	21.6	26.7	32.2	36.9	16.3	30.0	10.4	27.4	7.0	35.1	4.4	3.8	24.4	4.0	3.3	3.7	4.0	10.9	2.8	3.5	3.8	193.2	3.8	39.9	3.6	4.1	24.7	20.4	24.9	20.0	28.7	21.7	22.3	23.1	15.6	29.8	16.2	83.4	125.2	71.3	872.7	143.1	32.8	26.9	112.1	278.4	247.9	261.7	55.0	83.1	19.9	167.6	5.2	128.4	394.9	0.0	118.5	105.1	178.7	606.4	129.6	93.2	107.6	27.0	298.1	52.2	269.6	8.8	33.1	306.0	123.2	55.9	173.1	46.7	132.9	326.1	33.2	57.2	44.2	90.5	178.6	63.8	38.3	113.3	147.0	90.6	149.1	526.3
VPS11	"PEP5, RNF108"	ENSG00000160695	"VPS11, CORVET/HOPS core subunit"	Q9H270	11	119067692-119081978	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039020	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039020: AB_10674847"	"unprognostic (6.97e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.44e-4)"	"unprognostic (4.07e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-1)"	6.2	7.3	5.3	5.3	10.2	10.2	6.5	5.6	16.3	6.7	4.6	11.3	4.5	4.8	6.6	6.9	5.1	8.2	5.6	5.5	4.7		6.3	3.4	6.2	7.4	5.7	7.9	8.6	6.5	12.5	8.3	8.4	9.4	6.6	5.2	8.6	5.8	7.5	5.5	7.5	4.6	7.5	3.2	6.3	4.4	5.2	5.4	9.3	8.6	3.4	6.7	6.0	0.9	9.8	17.8	15.7	15.2	12.8	14.3	12.0	5.7	5.7	6.7	4.9	13.4	12.6	6.7	7.0	9.6	9.1	9.1	9.3	10.8	7.9	10.2	13.5	14.7	9.6	8.1	9.6	7.2	8.3	5.6	17.7	7.2	9.7	17.6	10.2	11.1	13.6	10.6	13.9	7.3	12.8	11.5	9.0	12.6	12.9	10.7	14.1	7.9	9.4	2.9	9.7	10.7	9.3	9.1	5.2	8.7	11.9	4.8	8.1	8.5	11.0	7.7	6.7	17.2	8.8	10.2	8.9	3.7	3.7	5.2	6.1	5.5	7.1	6.0	12.8	7.6	15.7	15.2	12.8	13.2	11.6	14.3	9.8	11.5	12.5	17.8	9.8	10.8	13.1	3.0	12.8	14.5	7.6	12.9	12.0											6.0	10.9	8.0	4.2	2.6	11.2	5.5	5.1	6.7	13.6	8.7	11.8	8.9	8.3	6.7	6.7	9.8	7.9	0.0	8.8	5.8	6.6	2.8	15.0	4.7	14.9	4.8	9.2	11.6	14.3	1.4	15.8	10.8	6.8	10.8	10.9	9.5	6.7	7.0	14.5	9.1	14.2	12.9	8.9	8.6	6.5	4.3	11.8	9.6	7.9	3.1
VPS13B	"CHS1, COH1"	ENSG00000132549	"Vacuolar protein sorting 13 homolog B"	Q7Z7G8	8	99013266-99877580	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043865			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA043865: AB_2678704"	"unprognostic (4.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.65e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.90e-1)"	11.3	10.5	9.6	13.8	10.4	22.1	10.3	13.4	11.8	12.4	9.3	6.6	10.8	4.8	22.4	8.0	10.4	11.6	8.8	7.9	8.7	4.7	7.9	6.2	12.3	12.5	9.9	7.4	16.5	8.1	18.3	21.2	7.9	8.5	10.0	7.5	6.5	9.9	9.6	8.4	11.0	9.6	18.4	11.0	9.8	8.8	10.7	8.4	15.6	9.5	4.9	10.7	12.5	11.8	5.0	1.0	9.8	3.3	1.0	2.9	0.8	8.1	5.9	7.2	5.3	13.5	16.3	3.5	5.3	9.7	5.3	7.1	3.5	4.2	4.5	6.9	8.9	3.9	3.8	4.9	4.9	9.6	7.3	4.5	9.9	6.2	2.7	4.3	4.7	7.3	10.5	4.6	8.5	12.2	7.4	7.5	7.7	7.4	12.2	6.0	5.0	9.8	2.7	2.3	8.5	2.2	7.9	5.1	8.6	3.5	7.7	2.1	5.9	8.2	3.9	4.0	6.7	7.1	5.4	10.4	8.0	7.5	7.0	4.5	5.0	5.7	12.4	6.0	7.7	5.5	3.5	1.9	4.3	2.1	1.7	1.9	5.0	1.8	1.6	0.8	2.9	2.9	1.9	9.8	1.0	3.3	1.0	2.1	0.8	9.6	10.4	13.4	11.8	8.7	4.7	9.9	7.4	8.5	8.4	17.9	9.8	10.0	7.2	7.8	14.3	10.9	7.6	4.0	13.6	3.5	35.3	4.1	0.0	4.4	6.3	7.4	7.4	0.0	4.0	3.2	11.0	9.0	3.5	4.5	5.9	11.1	8.6	6.2	17.3	6.5	25.6	9.3	6.8	6.4	10.6	9.7	3.6	10.5	19.4	3.1	14.0	0.0	9.2	20.0	6.1	8.4	3.5	12.9	8.0	5.8
VPS13C	"FLJ10381, FLJ20136, KIAA1421"	ENSG00000129003	"Vacuolar protein sorting 13 homolog C"	Q709C8	15	61852389-62060473	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043507	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA043507: AB_10960840"	"unprognostic (1.09e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.58e-3)"	19.6	16.6	15.6	16.2	19.7	12.0	13.7	22.3	18.5	17.0	14.2	8.7	13.1	8.9	18.8	11.6	8.0	14.3	12.1	13.8	14.8	8.4	12.9	10.0	15.6	20.8	20.7	12.4	23.7	14.5	24.9	37.1	10.2	19.3	11.7	12.5	5.9	15.2	13.1	21.5	10.6	16.0	15.7	25.5	21.5	16.4	8.7	21.6	19.7	15.8	7.4	18.3	19.4	12.3	9.2	9.2	4.2	7.6	3.2	5.4	1.7	4.8	8.7	3.2	3.2	15.4	12.7	3.9	3.8	15.6	3.9	4.7	3.4	3.2	16.6	4.6	7.5	7.9	5.4	11.6	4.1	3.3	11.8	2.1	16.5	4.9	3.3	7.2	7.7	11.1	9.4	3.0	4.2	8.4	8.4	11.6	16.7	5.1	11.5	5.9	2.3	4.6	2.7	2.1	5.9	2.2	11.4	10.0	4.4	6.7	19.4	4.5	5.5	7.0	4.1	4.4	6.1	4.5	10.9	17.1	8.7	5.0	4.9	4.9	5.6	5.3	10.0	7.0	17.2	4.2	4.2	6.8	3.6	5.4	4.9	4.7	7.3	4.5	4.4	4.5	9.2	5.1	4.2	1.7	3.2	7.6	9.2	3.4	1.7	15.6	19.7	22.3	18.5	14.8	8.4	20.7	12.4	19.3	21.6	62.5	53.6	32.1	23.0	16.6	77.8	68.4	28.1	117.8	105.8	54.1	137.4	11.5	8.3	26.4	4.1	40.1	16.9	23.3	25.7	6.5	30.0	23.2	84.6	19.6	27.4	117.6	50.9	40.5	60.5	4.7	46.6	69.7	33.7	62.3	26.5	34.0	26.9	17.5	48.4	11.6	89.6	32.3	30.9	19.1	22.1	20.5	6.9	55.4	21.7	23.8
VPS13D	"FLJ10619, KIAA0453"	ENSG00000048707	"Vacuolar protein sorting 13 homolog D"	Q5THJ4	1	12230032-12512047	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 141.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027332, HPA051621"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA027332: AB_2672223, HPA051621: AB_2681555"	"unprognostic (2.97e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"prognostic favorable (7.42e-12)"	"unprognostic (5.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.31e-2)"	11.7	9.8	16.6	8.5	16.4	8.0	16.6	18.5	19.7	19.9	12.5	17.0	11.7	6.9	12.8	15.3	16.1	10.8	10.2	15.8	15.7	13.2	15.4	11.0	12.3	9.9	16.5	13.8	15.9	11.9	28.1	14.1	9.2	13.3	18.6	11.3	14.0	15.1	16.8	30.3	39.2	9.7	17.3	14.8	10.2	12.8	11.6	13.6	8.6	21.7	11.3	14.4	10.8	17.9	4.1	3.9	6.0	1.9	1.7	3.6	0.9	8.2	4.7	5.3	4.1	14.3	11.4	2.5	4.0	7.0	6.9	6.6	3.1	5.8	7.7	5.1	11.4	5.8	7.5	9.2	7.9	9.7	4.2	3.1	6.6	7.3	2.5	6.0	9.5	3.5	9.6	11.2	8.8	8.7	8.6	10.9	7.5	13.5	4.0	6.3	3.8	5.6	3.7	2.1	4.5	6.0	4.9	6.4	2.3	4.9	4.9	2.6	3.6	11.7	8.7	8.3	5.3	7.4	3.2	11.9	4.3	4.5	11.1	3.3	3.5	2.9	12.3	4.9	6.8	6.5	6.0	1.9	1.4	3.3	1.9	3.5	2.5	3.6	2.3	1.5	4.1	3.2	2.5	2.6	1.7	1.4	3.9	1.7	0.9	16.6	16.4	18.5	19.7	15.7	13.2	16.5	13.8	13.3	13.6	17.9	18.9	9.8	42.5	19.3	35.3	67.8	12.7	20.1	25.0	17.4	68.7	6.1	3.3	7.4	81.4	17.1	17.2	23.3	12.3	6.0	9.9	29.1	11.6	18.1	10.0	44.5	13.8	19.0	16.5	141.6	21.3	14.3	11.8	6.4	14.6	23.4	13.5	10.5	20.5	8.4	33.6	45.3	33.0	16.7	11.3	27.5	12.4	12.5	10.4	35.6
VPS25	"DERP9, EAP20, MGC10540"	ENSG00000131475	"Vacuolar protein sorting 25 homolog"	Q9BRG1	17	42773436-42779599	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004978, HPA052217, HPA057284"	Uncertain		Approved	Centrosome		NA	Yes			Centrosome		"CAB004978: AB_426095, HPA052217: AB_2681765, HPA057284: AB_2683397"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (7.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.76e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	18.5	22.8	14.0	16.9	17.4	17.9	26.2	11.0	28.2	21.0	28.8	20.9	23.9	25.3	21.5	32.8	45.9	28.7	22.6	18.0	15.5	12.2	48.7	48.0	17.4	22.0	12.7	15.3	21.7	41.3	28.5	15.7	36.7	17.3	21.3	33.3	27.4	32.6	18.7	24.7	26.0	37.9	20.5	11.3	21.2	25.1	26.6	11.5	32.1	29.2	31.9	37.4	18.7	22.8	19.8	33.2	42.4	35.4	31.0	20.2	22.3	17.4	36.3	27.7	16.7	35.3	24.2	25.7	22.2	31.4	45.7	32.0	31.1	20.6	17.5	37.2	32.3	24.2	18.3	38.1	48.4	29.7	15.9	47.9	13.2	24.0	46.0	36.5	24.7	17.7	32.8	31.3	40.5	43.5	27.2	28.6	21.1	45.0	17.7	27.4	25.1	35.5	27.3	21.3	39.9	25.6	13.3	33.5	28.3	54.8	20.0	23.6	18.2	12.5	16.2	33.6	44.6	37.3	26.3	15.4	29.1	18.7	16.3	23.6	17.5	9.9	25.4	25.5	16.9	21.3	28.8	32.2	42.4	17.1	35.4	17.4	19.8	18.7	20.2	33.2	17.0	19.1	18.1	18.7	31.0	31.2	22.4	17.1	22.3	14.0	17.4	11.0	28.2	15.5	12.2	12.7	15.3	17.3	11.5	23.8	27.6	21.6	37.4	12.4	22.7	23.4	50.9	58.9	38.7	59.3	13.7	121.4	112.7	124.9	2.0	24.1	66.4	46.7	133.4	153.4	26.3	34.8	28.8	40.4	88.0	22.3	39.4	25.2	36.7	4.2	25.6	28.4	40.5	55.1	64.5	42.1	108.5	61.4	28.7	82.0	23.0	32.3	21.5	37.9	47.3	19.9	101.7	28.4	58.3	47.7
VPS26C	"DCRA, DSCR3"	ENSG00000157538	"VPS26 endosomal protein sorting factor C"	O14972	21	37223420-37267919	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 23.9;Exocrine glandular cells: 24.1;Hofbauer cells: 29.0;monocytes: 28.9;Pancreatic endocrine cells: 26.6;Proximal tubular cells: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023288	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023288: AB_1847872"	"unprognostic (1.01e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.16e-1)"	23.5	29.1	14.2	15.9	17.4	16.5	17.0	17.1	19.4	16.2	23.4	20.8	12.1	25.5	17.8	13.8	20.6	15.4	17.6	21.3	17.1	11.9	29.2	28.6	19.9	18.1	18.3	16.9	16.8	23.9	14.5	14.7	20.9	15.6	15.9	23.7	22.1	17.3	15.3	30.8	16.8	31.2	19.7	17.4	24.6	21.5	7.4	17.8	21.3	16.7	13.3	20.6	23.0	16.1	19.6	24.2	40.3	30.2	24.9	26.9	24.5	12.2	5.8	12.8	10.8	23.6	21.3	14.2	12.3	27.4	11.4	16.7	8.0	13.4	8.8	4.6	28.3	26.8	6.1	13.6	13.2	10.9	21.1	9.8	14.9	5.9	7.7	20.6	11.0	10.2	18.4	13.1	13.0	21.1	20.1	21.0	16.6	9.4	19.7	21.5	5.8	18.9	9.4	14.2	19.4	5.7	17.5	6.1	12.9	13.9	9.5	10.3	14.0	8.5	16.6	26.1	17.1	15.7	8.9	16.6	12.9	4.5	13.6	7.1	30.3	30.5	12.2	20.4	18.9	14.1	23.5	24.5	40.3	26.9	30.2	25.0	19.6	23.2	24.4	24.2	14.7	21.5	22.6	25.4	24.9	26.3	9.6	26.7	24.5	14.2	17.4	17.1	19.4	17.1	11.9	18.3	16.9	15.6	17.8	8.9	21.6	0.0	0.0	0.0	0.0	0.0	0.0	8.1	12.5	8.7	0.0	13.0	18.3	23.9	0.0	0.0	0.0	0.0	24.1	21.0	0.0	0.0	8.1	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	28.9	0.0	0.0	26.6	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0
VPS29	"DC15, DC7, PEP11"	ENSG00000111237	"VPS29, retromer complex component"	Q9UBQ0	12	110491097-110502117	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039748	Uncertain		Supported	Vesicles,Cytosol		NA	NA		140000	"Vesicles, Cytosol"		"HPA039748: AB_10674426"	"unprognostic (9.46e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (4.29e-3)"	39.2	34.9	35.6	28.5	38.5	44.4	32.6	23.0	46.6	30.3	38.0	24.4	29.5	33.6	31.5	50.4	51.2	29.0	27.5	35.9	31.5	30.9	62.2	51.2	31.3	33.1	32.8	27.8	27.6	31.4	18.3	31.4	34.5	46.6	41.6	43.5	27.3	34.1	40.6	64.0	25.2	36.2	47.3	28.9	43.1	34.9	17.0	23.8	29.8	38.3	32.9	38.0	51.5	27.4	40.5	67.4	52.7	79.9	41.7	46.0	72.1	31.7	31.3	29.8	21.2	33.5	33.3	23.6	30.3	31.7	30.6	27.7	31.3	27.9	29.6	31.9	29.9	28.8	30.4	39.3	28.0	32.1	35.0	31.5	36.1	39.5	25.7	29.2	43.0	31.7	21.9	24.0	25.9	28.7	37.6	53.4	37.2	34.4	27.7	54.8	16.0	33.6	61.2	17.0	28.4	40.3	22.5	30.5	41.4	50.9	47.5	32.1	17.0	34.3	30.5	37.9	26.9	41.5	33.3	30.0	26.6	17.5	36.7	35.3	18.9	26.4	34.7	31.0	41.2	28.3	43.9	57.6	52.7	31.9	73.2	35.1	40.5	40.7	37.3	67.4	31.4	37.4	36.8	38.5	41.7	79.9	45.3	46.0	72.1	35.6	38.5	23.0	46.6	31.5	30.9	32.8	27.8	46.6	23.8	71.5	94.8	96.1	135.1	127.5	39.4	250.4	84.1	64.3	80.8	96.0	25.5	160.1	245.4	200.0	41.5	113.7	129.2	93.5	157.1	168.3	132.5	122.3	149.1	158.7	359.0	39.7	79.9	84.7	157.7	66.8	85.4	222.9	168.7	333.6	105.3	60.6	179.9	147.3	99.3	306.8	85.6	155.2	150.4	117.3	94.5	151.2	149.5	101.5	149.3	145.2
VPS33A		ENSG00000139719	"VPS33A, CORVET/HOPS core subunit"	Q96AX1	12	122229564-122266521	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038701			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038701: AB_10673473"	"unprognostic (3.98e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (9.11e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (4.63e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.09e-2)"	10.4	15.2	13.4	13.6	17.3	12.6	12.7	17.3	19.9	9.6	13.7	14.2	10.5	11.7	11.7	16.8	10.5	12.8	10.4	9.5	13.6	14.4	12.6	12.5	10.8	14.9	13.7	16.8	12.9	11.4	14.7	19.3	17.3	16.8	10.8	11.7	13.0	11.5	14.5	17.1	14.3	11.8	13.6	13.4	16.6	11.2	16.3	9.9	16.1	10.4	9.1	15.8	11.3	11.6	11.6	11.7	21.3	13.7	13.1	17.4	9.6	7.9	10.6	10.9	4.3	8.4	6.5	12.6	7.3	8.0	12.8	8.1	17.3	4.0	8.9	6.2	4.9	9.0	6.8	19.5	7.7	11.1	11.9	10.5	9.1	7.3	15.0	10.8	12.3	9.9	7.2	6.5	9.0	7.3	10.6	8.3	9.8	20.4	4.6	8.3	9.0	5.9	12.7	15.7	6.5	11.4	10.4	10.0	10.5	5.4	8.4	7.9	12.1	15.3	4.6	14.1	11.7	19.7	8.3	5.4	5.8	9.2	10.9	6.7	14.4	31.1	13.9	9.2	8.0	7.9	21.3	11.2	17.9	11.8	12.2	10.6	11.6	13.4	12.5	11.7	9.2	9.6	11.1	9.5	13.1	13.7	7.4	17.4	9.6	13.4	17.3	17.3	19.9	13.6	14.4	13.7	16.8	16.8	9.9	8.9	3.8	8.5	4.0	2.9	15.7	5.9	5.1	13.4	3.4	7.0	9.8	18.5	3.3	12.0	15.9	4.5	7.0	0.0	10.9	17.9	3.5	2.2	13.9	7.7	18.2	3.2	17.2	8.6	8.1	9.7	7.5	11.0	3.3	22.6	6.9	12.1	12.1	7.4	10.6	9.5	15.1	19.4	5.2	34.2	29.0	2.6	18.1	12.9	7.3	1.7
VPS35L	"C16orf62, MGC16824"	ENSG00000103544	"VPS35 endosomal protein sorting factor like"	Q7Z3J2	16	19555240-19706793	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 24.9;Distal tubular cells: 24.9;Hofbauer cells: 37.3;Syncytiotrophoblasts: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042969, HPA053547"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042969: AB_10794920, HPA053547: AB_2682183"	"unprognostic (7.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.31e-8)"	"unprognostic (1.82e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-2)"	19.1	22.5	21.3	13.5	28.6	10.6	15.3	20.1	35.0	21.4	16.5	44.4	9.9	12.5	27.9	21.4	16.1	18.6	16.4	16.1	21.8	21.1	20.7	15.9	14.7	13.9	23.5	14.0	22.7	14.3	37.9	24.6	18.7	28.8	15.4	18.4	22.6	15.4	18.6	18.2	12.5	13.5	23.8	23.9	25.5	12.6	26.1	21.6	16.0	21.5	9.3	15.3	17.2	14.5	11.7	25.5	12.6	23.8	21.9	14.7	15.6	9.0	16.1	15.0	12.0	19.3	27.1	2.3	13.4	22.4	14.7	17.0	2.3	15.8	11.0	29.2	22.1	0.1	2.5	11.8	7.1	16.2	0.6	6.5	6.4	14.5	0.2	25.7	10.4	13.5	19.4	10.3	13.5	8.6	20.8	23.4	5.4	8.8	2.6	23.9	6.4	9.1	2.7	9.7	1.5	2.0	7.8	4.8	2.7	16.2	2.0	9.3	9.4	16.4	0.5	7.4	12.2	5.5	9.1	24.3	7.5	7.1	10.5	1.4	10.1	17.9	4.1	14.7	8.5	11.9	12.6	21.1	9.4	11.9	23.8	14.7	9.2	11.5	11.7	25.5	11.7	13.4	11.9	2.5	21.9	20.8	6.7	12.0	15.6	21.3	28.6	20.1	35.0	21.8	21.1	23.5	14.0	28.8	21.6	6.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	14.8	15.7	0.0	24.9	24.9	16.2	0.0	0.0	0.0	0.0	14.9	15.4	0.0	0.0	3.5	0.0	37.3	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	12.6	0.0	0.0	10.9	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0
VPS36	"C13orf9, CGI-145, Eap45"	ENSG00000136100	"Vacuolar protein sorting 36 homolog"	Q86VN1	13	52412602-52450628	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 249.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039734, HPA043947"	Approved		Supported	"Vesicles,Lysosomes,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Lysosomes"	"Plasma membrane, Cell Junctions"	"HPA039734: AB_2676652, HPA043947: AB_2678744"	"unprognostic (2.43e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.57e-2)"	"prognostic favorable (9.91e-6)"	"unprognostic (6.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.83e-2)"	16.4	14.5	16.5	15.9	22.3	7.0	23.5	36.8	27.7	17.1	21.1	13.6	12.8	23.8	22.4	12.9	24.6	16.6	18.0	20.3	15.4	13.0	22.6	20.2	17.5	15.6	16.2	18.5	20.0	19.0	14.4	20.1	21.7	25.9	20.1	24.7	18.2	21.6	18.3	23.4	44.6	27.9	23.7	13.8	22.3	15.7	4.2	13.8	18.1	20.0	16.8	18.1	20.3	21.7	14.4	14.9	13.9	19.2	19.4	19.3	11.8	3.8	6.4	11.3	7.4	11.8	16.5	9.7	8.8	6.8	8.9	5.4	7.5	12.7	13.5	4.7	12.6	5.7	10.8	8.9	10.6	10.0	10.0	8.6	15.8	10.1	6.7	14.0	21.2	17.2	11.5	20.9	6.1	10.0	10.0	9.0	17.6	11.6	11.9	17.2	4.9	15.4	21.3	10.7	15.1	3.3	16.2	6.4	8.2	15.7	10.0	5.8	12.2	6.2	14.9	13.4	13.8	8.7	35.4	14.0	5.8	6.9	5.7	9.9	8.9	11.1	14.3	5.9	15.0	13.3	13.9	13.5	10.9	12.1	14.8	19.3	14.4	13.3	15.1	14.3	12.3	12.4	13.2	3.7	19.4	19.2	14.9	14.3	11.8	16.5	22.3	36.8	27.7	15.4	13.0	16.2	18.5	25.9	13.8	77.4	38.5	35.3	43.5	38.0	114.4	71.9	38.2	33.5	47.8	31.4	113.9	51.3	58.0	31.0	1.2	57.1	58.8	0.0	25.7	34.0	26.8	47.9	42.8	49.9	37.6	49.3	47.8	33.7	36.4	1.9	46.1	34.1	27.0	27.9	56.5	33.0	27.4	59.4	49.1	58.0	249.2	45.3	28.3	8.4	18.5	50.8	31.9	37.6	49.4	40.0
VPS37A	"FLJ32642, HCRP1, PQBP2, SPG53"	ENSG00000155975	"VPS37A, ESCRT-I subunit"	Q8NEZ2	8	17246571-17302427	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024705, HPA024781"	Supported		Approved	Vesicles,Centrosome,Cytosol		NA	NA			Vesicles	"Centrosome, Cytosol"	"HPA024705: AB_10601776, HPA024781: AB_10602100"	"unprognostic (8.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.18e-1)"	23.5	21.3	15.1	13.5	15.6	12.8	22.1	23.1	18.1	21.3	23.5	15.8	16.4	18.6	19.1	15.1	22.7	13.3	15.5	34.4	15.8	14.9	23.3	25.9	18.4	14.4	16.6	10.4	21.7	15.8	34.2	20.8	31.6	16.1	20.0	16.2	20.7	15.2	22.7	41.8	16.5	27.3	24.4	20.2	16.4	14.9	27.7	14.6	17.3	18.0	16.4	14.8	27.6	22.7	10.1	11.7	25.0	15.2	20.6	15.5	11.4	7.1	11.7	10.2	9.0	22.8	18.2	11.2	25.5	21.6	23.5	20.4	7.9	7.0	6.1	13.9	20.4	21.8	7.0	11.5	11.2	27.9	6.3	3.4	11.2	6.0	8.3	26.6	4.3	10.7	17.6	21.8	21.7	22.3	16.4	16.7	9.8	8.3	16.0	24.7	4.9	13.2	11.2	10.2	16.0	6.2	6.5	11.5	7.3	19.7	9.9	12.3	6.5	10.1	10.1	15.7	21.4	6.7	9.2	14.2	14.2	7.2	20.3	13.2	5.1	10.2	7.1	16.2	8.4	14.5	25.0	15.2	13.5	12.9	11.3	15.5	9.9	12.4	12.3	11.7	10.1	11.6	13.8	15.9	20.6	10.0	10.8	11.4	11.4	15.1	15.6	23.1	18.1	15.8	14.9	16.6	10.4	16.1	14.6	14.9	10.4	17.9	24.6	35.0	25.3	34.3	17.8	13.4	17.0	7.0	55.0	31.3	31.5	25.5	50.2	19.4	18.4	23.3	13.6	47.1	22.9	36.7	9.2	19.8	37.7	20.6	17.2	22.7	16.2	26.4	23.9	24.0	20.3	20.8	14.4	22.6	24.3	15.6	24.4	36.8	59.4	25.8	38.9	96.4	34.1	33.1	94.5	22.3	14.0	42.5
VPS37C	FLJ20847	ENSG00000167987	"VPS37C, ESCRT-I subunit"	A5D8V6	11	61130256-61161617	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043348	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA043348: AB_10794658"	"unprognostic (1.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-1)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.37e-7)"	"unprognostic (1.99e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.05e-2)"	12.8	12.7	15.6	13.8	14.5	9.8	13.9	10.0	17.4	15.4	18.4	16.0	17.3	19.1	16.1	15.0	20.9	14.5	14.3	15.0	15.5	9.2	15.4	12.1	13.9	8.0	12.5	10.2	16.3	22.6	14.7	19.8	19.5	13.4	19.5	12.5	18.2	29.1	18.2	20.6	24.1	26.4	16.7	13.6	13.0	23.7	18.6	15.3	5.9	14.0	14.9	14.4	17.3	14.6	1.1	1.9	6.8	4.5	0.4	0.8	1.0	17.4	7.1	9.0	8.3	4.4	9.4	19.9	8.9	23.8	13.4	9.0	8.3	8.0	4.5	12.5	12.0	10.7	9.7	8.1	9.5	6.9	10.0	6.2	6.0	4.9	9.0	14.1	4.6	7.1	8.1	14.6	11.1	14.1	7.8	8.6	3.2	15.3	7.4	8.8	21.2	0.9	6.7	10.8	7.6	10.1	1.6	4.0	10.9	10.1	9.4	5.5	13.6	9.0	27.3	14.1	7.9	26.1	11.1	6.6	13.0	9.4	12.8	10.8	3.7	5.0	3.8	11.5	5.6	8.4	0.8	2.5	2.8	0.6	4.5	0.8	1.1	0.4	0.7	1.9	1.1	0.5	0.3	6.8	0.4	4.1	0.3	0.3	1.0	15.6	14.5	10.0	17.4	15.5	9.2	12.5	10.2	13.4	15.3	14.9	5.9	3.7	11.5	11.1	4.1	5.6	12.7	9.4	5.7	12.2	9.8	24.3	10.0	13.7	7.3	7.0	14.8	0.0	17.2	18.7	12.1	15.6	0.0	5.5	15.3	23.8	15.6	4.9	10.5	5.8	7.2	10.5	6.8	11.8	16.5	8.8	18.1	10.5	12.7	5.4	36.8	0.0	14.3	13.2	13.4	17.3	29.4	3.3	9.9	12.2
VPS37D	"MGC35352, WBSCR24"	ENSG00000176428	"VPS37D, ESCRT-I subunit"	Q86XT2	7	73667825-73672112	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 10.7;Collecting duct cells: 10.4;Distal tubular cells: 8.3;Muller glia cells: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040978	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA040978: AB_10805833"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (4.19e-2)"	"prognostic favorable (5.80e-9)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.43e-1)"	2.6	1.7	7.2	0.8	8.3	0.6	2.9	7.5	9.2	4.7	1.9	3.8	1.7	4.1	3.9	6.9	0.9	6.4	3.2	3.9	6.0	7.6	8.8	6.2	1.8	0.7	5.1	2.6	6.0	5.3	3.8	2.4	1.0	5.3	4.5	0.7	2.2	7.2	5.0	2.8	2.3	2.4	1.9	3.8	1.2	1.9	5.5	3.3	0.8	7.4	0.2	0.5	3.6	5.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.7	2.9	2.3	4.8	1.6	3.2	1.4	1.2	2.0	1.0	1.2	0.3	0.8	1.0	1.1	1.6	2.7	0.3	2.5	1.1	0.3	0.4	2.5	0.0	0.2	3.2	4.2	0.0	1.4	2.5	0.7	1.4	0.5	4.6	1.1	4.1	1.3	0.2	1.4	3.5	0.7	0.1	1.6	0.8	4.2	0.1	0.1	0.2	3.9	0.3	4.7	15.0	0.0	2.0	2.7	0.4	4.8	0.2	1.7	2.9	4.0	1.7	1.0	1.9	0.2	1.3	6.5	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	7.2	8.3	7.5	7.2	6.0	7.6	5.1	2.6	5.3	3.3	0.0	0.0	0.0	0.5	0.9	10.7	1.6	0.0	0.0	0.0	10.4	0.0	0.1	8.3	3.3	0.7	0.5	0.0	0.0	0.7	0.3	0.9	1.4	0.0	5.1	0.1	0.0	4.7	1.8	0.0	0.7	1.7	0.0	5.0	1.0	0.0	7.7	1.8	0.6	2.5	6.3	4.9	0.0	1.4	0.5	5.7	1.0	0.2	0.0	0.2	0.3
VPS45	"h-vps45, H1, VPS45A, VPS45B"	ENSG00000136631	"Vacuolar protein sorting 45 homolog"	Q9NRW7	1	150067279-150145329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 156.0;Late spermatids: 101.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027425, HPA027441"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA027425: AB_10599415, HPA027441: AB_10602284"	"unprognostic (1.57e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.36e-3)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (4.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-2)"	15.5	22.1	26.4	9.8	29.6	4.9	15.9	40.7	25.9	19.1	15.4	12.2	13.8	10.5	16.0	21.0	14.9	13.5	12.1	32.4	19.6	16.7	18.9	10.6	13.3	10.4	17.4	21.8	13.0	8.7	20.0	26.5	14.9	17.6	17.3	15.5	13.5	11.7	18.7	14.3	12.4	13.8	22.3	19.8	12.6	13.8	9.0	20.1	12.3	17.7	9.3	12.8	15.5	12.4	11.1	18.6	12.7	20.1	9.3	12.3	12.4	15.9	12.5	21.9	14.2	20.4	16.3	10.1	23.2	12.5	24.4	20.3	9.2	14.0	9.8	14.1	19.4	10.7	13.7	22.4	14.2	26.8	19.2	16.4	12.5	17.7	8.5	13.5	8.9	16.3	14.2	13.3	23.3	12.4	16.1	19.7	20.1	17.4	14.9	21.3	27.0	17.4	8.9	15.1	14.8	20.3	12.2	22.3	13.9	16.9	15.4	15.2	32.2	18.1	16.1	23.9	26.1	26.1	23.9	17.1	11.2	13.3	10.0	16.2	11.2	24.1	9.5	16.7	12.7	15.9	12.7	19.0	3.2	12.3	20.1	11.5	11.1	10.7	11.6	18.6	8.6	10.2	10.8	1.9	9.3	13.3	10.2	11.8	12.4	26.4	29.6	40.7	25.9	19.6	16.7	17.4	21.8	17.6	20.1	11.9	12.3	6.6	7.5	6.5	19.3	42.4	10.2	8.1	4.5	15.7	17.7	18.9	6.6	10.2	156.0	7.5	7.3	0.0	6.4	7.5	10.8	6.9	5.8	6.2	16.6	28.6	7.5	12.3	14.0	101.3	19.8	10.7	10.1	12.6	6.8	19.3	8.4	12.2	13.8	7.3	21.7	32.3	12.3	16.4	15.6	6.8	12.4	7.1	9.2	6.8
VPS4B	"SKD1, SKD1B, VPS4-2"	ENSG00000119541	"Vacuolar protein sorting 4 homolog B"	O75351	18	63389190-63422483	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040393, CAB046445, HPA057649"	Approved		Approved	"Vesicles,Intermediate filaments"		No	No		34000	Vesicles	"Intermediate filaments"	"CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489"	"unprognostic (8.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	16.8	13.0	14.3	14.3	17.2	28.0	17.2	15.4	19.1	19.8	24.0	21.8	15.5	20.0	16.7	12.1	55.0	13.1	15.1	9.9	13.7	16.0	15.6	20.5	14.3	21.6	17.0	14.7	11.9	14.0	17.5	17.4	27.4	23.4	14.3	22.2	9.3	21.8	15.0	9.9	22.1	28.7	15.2	20.2	17.3	18.7	9.0	14.6	27.8	17.0	17.6	31.8	18.6	24.7	20.7	13.6	56.4	20.6	19.1	18.9	15.4	18.7	6.9	7.7	8.4	12.0	17.0	13.5	16.5	15.6	12.6	13.8	5.1	13.4	18.1	10.8	12.0	10.7	40.8	9.2	18.0	16.8	13.1	7.5	9.0	9.7	7.9	17.2	31.1	19.8	15.4	28.1	11.1	19.8	12.8	11.7	10.5	4.5	17.0	17.9	6.5	19.4	9.8	8.0	7.6	10.9	16.3	16.4	17.4	15.9	22.0	13.2	11.7	12.4	12.2	18.4	10.3	11.7	17.0	18.0	19.5	9.5	7.3	10.8	57.1	27.4	23.3	11.2	14.7	14.5	39.4	16.8	36.0	16.5	16.6	15.4	18.9	17.4	17.0	13.6	20.7	15.8	16.6	56.4	19.1	20.6	13.6	18.9	15.4	14.3	17.2	15.4	19.1	13.7	16.0	17.0	14.7	23.4	14.6	107.2	43.6	46.5	38.8	61.1	39.4	35.8	45.9	89.7	64.8	31.4	21.6	56.4	38.1	41.7	73.2	41.4	81.3	23.3	36.8	46.3	33.4	30.3	55.7	52.3	40.7	41.3	43.7	33.7	56.7	9.1	45.5	48.9	30.4	30.7	72.2	37.9	63.8	86.0	34.3	37.8	28.4	58.2	32.9	26.0	26.6	72.9	117.4	69.2	60.0	67.1
VPS51	"ANG2, ANG3, C11orf2, C11orf3, FFR"	ENSG00000149823	"VPS51, GARP complex subunit"	Q9UID3	11	65089324-65111860	"Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039650, HPA061447"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoli	"HPA039650: AB_10673147, HPA061447: AB_2684521"	"unprognostic (2.36e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.41e-9)"	"unprognostic (7.77e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.18e-1)"	22.1	19.5	17.5	19.4	24.3	30.3	21.7	29.8	33.8	23.4	30.9	16.9	22.4	31.2	27.7	15.5	22.9	20.9	25.0	27.7	15.9	13.0	18.5	24.7	16.6	35.0	14.5	19.2	53.2	77.6	22.9	14.5	21.7	15.9	22.0	15.7	17.2	54.2	18.4	39.4	32.0	27.7	24.4	13.2	20.5	30.3	17.5	12.6	36.5	34.7	24.4	21.9	24.6	22.4	15.6	14.8	9.9	10.5	21.8	19.8	10.5	21.8	24.2	11.9	14.5	5.3	13.2	22.2	8.6	17.7	17.6	13.1	17.5	29.0	38.2	24.8	16.7	9.1	18.8	12.5	19.4	6.4	22.2	18.9	22.8	24.6	16.8	17.4	24.6	20.9	22.7	13.3	13.0	10.8	14.0	19.3	17.9	23.1	27.5	7.1	29.8	32.9	24.6	19.2	9.9	18.5	20.6	5.7	46.1	12.0	24.6	19.8	27.2	6.4	36.8	21.5	7.4	30.0	12.3	15.6	11.9	10.5	14.8	12.3	35.1	27.2	21.4	13.3	8.9	8.5	7.0	10.0	9.9	13.3	10.5	15.5	15.3	18.5	19.8	14.8	15.6	16.9	14.7	6.3	21.8	10.3	13.4	11.9	10.5	17.5	24.3	29.8	33.8	15.9	13.0	14.5	19.2	15.9	12.6	17.9	45.0	65.3	52.1	43.6	62.1	5.6	35.7	5.3	12.5	29.6	27.5	63.6	53.0	43.3	65.8	40.2	144.6	0.0	103.8	66.7	40.9	44.2	38.0	45.2	39.6	63.5	91.9	45.4	49.7	145.2	49.5	26.5	47.2	65.9	97.4	47.8	56.6	144.0	51.2	58.6	41.1	25.8	45.3	35.7	31.3	47.9	96.5	55.8	135.4	40.9
VPS53	"FLJ10979, HCCS1"	ENSG00000141252	"VPS53, GARP complex subunit"	Q5VIR6	17	508668-721717	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 237.4;Late spermatids: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 15.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022988, HPA024446"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	Cytosol	"HPA022988: AB_1848679, HPA024446: AB_1848680"	"unprognostic (8.62e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.39e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.31e-1)"	10.0	9.7	15.7	9.0	19.3	13.0	8.8	34.5	21.6	10.5	11.4	11.5	11.7	8.5	10.2	9.1	16.3	10.0	9.2	9.1	13.4	14.0	10.0	8.8	11.1	8.0	11.8	17.5	10.6	8.8	14.4	13.0	10.4	15.9	10.8	12.0	9.3	9.6	11.3	13.9	19.6	9.1	10.5	10.3	9.2	13.5	13.5	11.7	12.2	14.7	6.0	12.5	8.9	9.9	2.8	2.8	15.5	7.2	1.2	2.3	0.8	9.4	13.2	5.9	6.3	9.1	7.1	3.2	10.0	5.7	9.9	8.1	7.9	3.1	6.4	5.9	9.7	6.0	9.4	8.2	8.1	10.9	6.0	9.2	5.3	9.9	5.8	5.7	4.8	6.9	6.8	5.4	8.7	6.3	6.2	8.2	6.5	4.7	6.2	7.9	4.7	6.0	1.8	4.7	3.6	5.1	8.8	2.7	3.5	6.5	10.0	4.2	6.8	11.8	4.4	5.1	5.7	4.5	2.1	13.9	6.2	4.5	9.1	6.4	3.8	2.5	3.9	9.0	3.0	4.9	15.5	2.0	2.3	2.3	3.5	1.6	1.9	1.8	1.8	1.7	2.8	1.8	1.9	2.4	1.2	7.2	2.8	1.0	0.8	15.7	19.3	34.5	21.6	13.4	14.0	11.8	17.5	15.9	11.7	11.9	23.4	12.8	12.1	22.7	47.2	15.5	15.3	18.7	27.3	38.4	66.8	8.1	1.7	14.5	237.4	14.3	19.3	0.0	15.8	6.2	12.3	15.8	23.1	14.7	18.3	60.4	23.6	16.5	18.4	133.5	17.3	19.0	10.1	18.0	21.4	20.4	20.3	14.0	21.5	7.9	53.1	6.5	13.3	29.9	19.0	33.9	7.4	24.5	16.6	14.8
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54, GARP complex subunit"	Q9P1Q0	2	63892146-64019072	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	15.5	14.2	10.1	11.1	13.2	12.6	14.3	22.1	12.9	18.6	17.1	11.4	17.3	12.9	16.3	14.4	13.3	14.4	13.7	12.5	11.3	8.5	15.8	15.5	15.2	9.6	14.3	10.6	18.0	21.0	34.2	32.1	13.0	12.1	17.3	13.5	14.3	31.9	19.4	12.2	13.1	16.9	17.5	10.4	13.3	13.7	12.2	12.5	18.3	17.5	11.3	11.3	13.5	26.2	3.1	2.8	4.1	3.2	3.0	4.3	1.0	16.7	9.3	17.0	13.3	12.5	13.2	12.5	10.9	16.4	11.6	11.5	16.9	10.9	11.7	8.2	14.3	17.2	7.8	16.7	9.8	20.6	16.6	11.1	11.1	7.1	28.5	11.7	7.5	4.7	12.2	14.8	8.2	17.8	13.9	17.4	8.4	12.1	9.9	14.6	7.4	7.7	7.4	10.3	17.0	6.7	7.8	16.7	6.6	12.7	9.8	9.8	14.7	9.4	12.1	12.4	14.0	8.7	14.8	12.4	14.9	11.9	9.0	17.7	22.8	6.2	15.0	10.9	15.1	12.6	4.1	3.2	1.3	2.1	3.2	2.6	2.4	2.1	2.5	1.8	3.1	2.8	2.2	3.0	3.0	2.5	2.8	4.3	1.0	10.1	13.2	22.1	12.9	11.3	8.5	14.3	10.6	12.1	12.5	14.9	18.2	4.6	7.4	9.8	17.8	11.7	7.6	8.1	18.2	1.8	11.8	5.3	1.7	6.5	41.8	11.3	9.5	0.0	11.3	5.4	11.3	16.0	2.3	14.3	7.0	22.3	12.7	8.6	8.6	28.3	17.3	8.8	5.0	0.0	17.7	8.9	10.1	11.5	11.7	8.4	16.4	19.4	8.9	13.2	6.0	9.2	4.6	6.4	11.0	12.2
VPS72	"Swc2, TCFL1, YL-1, YL1"	ENSG00000163159	"Vacuolar protein sorting 72 homolog"	Q15906	1	151169987-151195321	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065709			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA065709: AB_2685540"	"unprognostic (2.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.16e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (4.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-1)"	23.7	19.7	28.2	20.9	26.3	11.8	19.2	30.2	30.2	21.0	19.2	20.6	20.5	17.8	26.1	21.6	24.6	26.5	19.2	22.0	25.7	26.2	20.1	14.9	18.2	19.6	26.5	25.1	27.3	18.5	19.8	16.4	23.7	21.8	23.8	17.7	19.2	23.8	24.6	66.6	22.5	16.3	32.8	27.0	19.3	19.6	17.3	21.9	21.4	22.2	20.2	26.4	29.0	21.3	35.4	28.8	41.4	25.8	38.2	33.8	27.9	20.1	13.8	32.4	23.3	14.3	12.6	27.8	22.0	11.7	17.7	12.9	14.8	17.0	20.4	27.1	16.5	12.3	19.0	23.9	14.2	13.4	24.1	25.2	17.4	10.9	10.1	20.0	25.6	15.7	10.1	19.7	20.1	16.8	18.5	23.1	25.3	33.1	15.2	13.9	33.8	22.0	17.4	37.7	36.2	23.0	24.3	18.6	31.9	16.4	10.3	22.9	40.9	15.1	23.5	26.4	31.9	26.4	38.1	21.7	9.3	15.6	14.7	27.8	28.6	40.2	32.8	15.3	17.8	17.0	25.9	25.8	41.4	32.1	24.5	31.0	35.4	28.9	27.2	28.8	27.4	28.9	26.2	18.9	38.2	19.6	18.3	33.8	27.9	28.2	26.3	30.2	27.3	25.7	26.2	26.5	25.1	21.8	21.9	6.0	7.8	16.6	24.1	25.2	13.8	11.3	25.5	10.7	12.5	22.7	3.9	48.9	54.7	44.6	9.5	27.5	20.1	23.3	40.3	44.6	28.0	21.9	31.1	16.2	28.2	14.3	19.4	22.7	20.8	9.5	23.3	19.8	40.5	40.5	28.1	22.4	46.9	27.9	23.3	25.9	11.5	51.8	32.2	34.2	33.8	27.7	52.7	20.8	25.4	31.0
VPS8	"FLJ32099, KIAA0804"	ENSG00000156931	"VPS8, CORVET complex subunit"	Q8N3P4	3	184812143-185052614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036871	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA036871: AB_10672103"	"unprognostic (4.36e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.97e-2)"	12.6	11.1	14.9	11.1	20.9	22.6	12.0	21.6	24.8	15.5	12.5	18.2	8.0	9.1	16.4	19.0	11.5	10.1	12.5	20.3	17.1	19.3	12.5	9.2	13.8	14.8	21.5	13.6	16.7	10.1	21.8	23.6	13.3	28.4	12.8	16.7	12.1	9.5	12.0	28.4	14.2	9.9	14.5	21.9	14.9	14.1	17.8	15.9	13.2	17.5	9.0	11.5	12.5	11.6	3.9	6.0	17.7	4.9	3.9	6.4	3.1	10.2	6.3	9.6	9.6	20.0	17.9	6.4	10.1	11.2	7.4	10.4	7.9	5.4	11.1	17.8	15.8	30.6	12.2	10.3	12.4	14.4	20.0	9.2	12.1	7.8	4.7	12.4	8.2	16.3	12.7	11.9	10.5	10.7	13.7	18.7	10.4	6.2	8.0	13.5	7.3	6.5	4.9	6.3	10.6	6.0	8.1	18.4	8.6	7.4	18.0	9.8	6.4	11.8	12.5	9.2	14.9	19.8	4.3	16.4	11.5	6.5	11.6	8.9	9.9	12.0	15.2	13.1	10.3	8.9	11.7	4.9	16.2	4.0	3.7	3.8	3.5	4.3	4.0	6.0	3.9	6.4	4.3	17.7	3.9	4.6	1.7	3.5	3.1	14.9	20.9	21.6	24.8	17.1	19.3	21.5	13.6	28.4	15.9	11.9	8.6	13.7	7.9	9.3	20.3	23.2	12.7	16.0	7.9	8.7	17.7	10.2	6.6	7.7	11.6	12.0	9.3	0.0	4.0	4.9	9.5	7.7	2.3	6.7	17.6	11.1	17.3	12.3	16.2	13.6	9.8	20.2	10.1	31.5	14.3	12.1	6.3	11.9	12.0	7.0	16.6	6.5	8.1	45.6	24.9	14.1	6.4	14.4	10.7	12.9
VPS9D1	"ATP-BL, C16orf7"	ENSG00000075399	"VPS9 domain containing 1"	Q9Y2B5	16	89707134-89720986	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	13	"neutrophil: 16.6"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 16.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007847, HPA023620"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA007847: AB_1845582, HPA023620: AB_1845583"	"unprognostic (7.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.63e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.91e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-3)"	8.6	15.4	16.1	19.2	17.9	14.2	5.3	22.7	30.6	6.7	7.1	13.3	8.8	16.6	7.1	7.2	17.0	7.0	9.3	11.0	17.2	16.3	11.7	15.0	8.2	10.4	12.6	24.1	6.4	12.2	16.5	17.6	6.8	17.6	7.9	4.9	10.2	15.3	8.4	12.8	12.6	13.0	6.2	9.3	15.7	10.3	13.5	10.6	1.7	9.3	7.5	7.7	8.5	7.6	0.2	0.2	16.6	0.6	0.1	0.4	0.1	4.6	6.9	7.7	8.3	7.8	7.7	6.5	8.5	8.8	7.3	3.6	6.0	10.2	4.7	5.5	9.2	4.1	10.6	0.6	4.8	2.1	4.2	11.8	3.3	6.0	7.2	6.0	1.9	8.2	8.4	4.4	8.8	2.0	11.9	5.0	4.4	8.4	2.9	4.8	20.7	3.5	7.4	2.9	3.6	8.0	8.8	6.4	2.9	5.8	7.3	6.5	6.9	10.8	4.1	8.6	2.5	18.3	8.2	7.9	9.7	12.1	7.8	5.1	13.4	4.2	4.1	14.0	5.1	8.0	1.2	0.6	0.3	0.2	0.4	0.0	0.2	0.1	0.1	0.2	0.2	0.4	0.2	16.6	0.1	0.2	0.0	0.2	0.1	16.1	17.9	22.7	30.6	17.2	16.3	12.6	24.1	17.6	10.6	6.0	6.1	4.1	1.8	1.8	12.3	7.2	2.5	1.4	5.7	8.7	9.8	2.6	6.6	4.4	10.5	2.2	9.8	0.0	6.7	1.9	4.1	1.4	4.6	9.6	4.3	7.9	10.4	8.6	9.4	16.4	5.8	6.4	3.3	1.0	4.1	6.6	4.9	3.6	5.6	4.9	11.9	0.0	4.3	8.6	4.3	3.3	2.5	3.1	6.3	1.7
VRK3		ENSG00000105053	"Vaccinia related kinase 3"	Q8IV63	19	49976467-50025946	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 77.2"	"Group enriched"	"Detected in all"	6	"Early spermatids: 469.4;Late spermatids: 1260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	9.7	11.9	9.2	9.4	12.7	10.7	8.3	12.0	14.1	8.9	13.4	11.9	9.3	13.4	15.7	10.8	8.4	18.0	12.2	7.4	9.3	11.1	16.7	16.2	8.5	13.4	10.4	9.9	11.2	11.5	7.1	11.8	10.7	9.8	9.4	11.7	14.2	14.3	8.5	11.8	7.7	17.3	7.5	11.0	12.8	10.9	77.2	9.1	24.7	14.1	6.0	12.9	9.9	8.0	24.5	19.7	47.3	20.9	33.5	30.1	18.1	16.0	16.7	12.3	13.2	16.3	15.1	12.8	11.6	13.9	17.3	19.1	8.9	18.0	19.4	8.3	11.2	12.1	12.0	11.4	9.9	14.0	16.9	23.4	15.1	10.1	15.4	12.3	18.8	26.6	13.5	14.9	10.0	10.6	15.5	14.2	21.3	18.3	29.0	12.4	6.8	25.4	12.7	6.6	28.6	14.4	20.5	12.9	24.8	14.7	17.0	13.8	6.7	11.4	14.0	12.6	11.4	12.9	20.1	10.7	17.7	10.3	7.1	9.0	18.8	23.9	10.2	14.2	11.7	12.1	37.0	17.8	32.4	23.8	18.8	19.1	24.5	21.7	22.7	19.7	21.9	22.1	20.4	47.3	33.5	20.9	18.8	30.1	18.1	9.2	12.7	12.0	14.1	9.3	11.1	10.4	9.9	9.8	9.1	6.0	29.4	27.3	13.1	6.0	34.9	7.1	20.4	56.2	26.1	14.0	135.5	38.6	26.6	25.3	469.4	15.8	62.6	23.3	28.7	31.8	13.8	24.2	17.4	37.6	29.7	30.2	21.4	25.2	25.0	1260.7	20.4	23.9	13.5	47.7	27.2	28.4	29.0	71.9	24.4	60.6	112.4	12.9	10.5	91.2	49.8	9.5	47.9	33.7	27.6	26.7
VRTN	"C14orf115, FLJ10811, vertnin"	ENSG00000133980	"Vertebrae development associated"	Q9H8Y1	14	74303069-74360008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.9;lymphoid tissue: 4.5;testis: 5.8"	"Cell type enhanced"	"Detected in single"	25	"Spermatocytes: 1.9"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"NTERA-2: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001460	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001460: AB_1078318"			"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"				"unprognostic (1.37e-1)"		"unprognostic (5.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.78e-2)"		"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"			0.1	0.1	0.1	2.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.5	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.2	0.2	5.8	0.0	0.0	0.1	0.0	1.9	0.1	0.1	0.8	1.2	1.4	0.5	0.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.5	0.3	0.3	0.2	0.3	0.2	0.5	0.2	0.8	0.3	0.4	1.4	0.8	0.5	1.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.0
VSIG1	MGC44287	ENSG00000101842	"V-set and immunoglobulin domain containing 1"	Q86XK7	X	108044970-108079184	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 29.5;stomach 1: 66.6;testis: 87.4"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 14.1;Late spermatids: 8.0;Pancreatic endocrine cells: 19.7"	"Group enriched"	"Detected in many"	17	"lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.7;T-reg: 11.2"	"Lineage enriched"	"Detected in many"	4	"T-cells: 11.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.8;HUVEC TERT2: 11.9;PC-3: 4.0;TIME: 3.0"	"Not detected"	"Not detected"							"HPA001445, HPA036310, HPA036311"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350"	"unprognostic (4.33e-3)"	"unprognostic (4.60e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-3)"	0.1	0.0	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.3	0.8	0.1	0.3	0.1	0.2	0.2	0.0	29.5	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.0	1.3	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	66.6	87.4	0.1	0.1	0.1	0.1	0.4	1.5	0.1	2.6	0.1	0.6	0.1	0.2	11.7	2.5	0.2	1.0	0.0	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.5	0.0	5.8	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.3	0.4	1.0	0.1	1.9	0.1	11.9	0.1	0.1	0.3	0.0	0.4	0.4	0.3	0.4	1.1	4.0	0.4	0.0	0.0	0.7	1.1	0.2	0.1	0.2	0.2	0.6	0.0	0.1	0.0	3.0	0.3	0.9	0.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	1.0	0.0	3.7	2.6	7.7	3.3	0.0	1.0	11.7	5.4	0.4	0.2	0.1	0.1	11.2	2.5	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	23.8	14.1	0.0	0.6	0.6	0.8	0.4	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.0	4.9	0.3	0.0	0.0	4.1	0.0	0.2	0.6	2.3	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.6	0.2	0.0	0.0	0.0	0.1	19.7	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.5	0.0	0.1	0.5	0.0	0.9
VSIG10		ENSG00000176834	"V-set and immunoglobulin domain containing 10"	Q8N0Z9	12	118063593-118136026	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 60.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 22.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062022	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA062022: AB_2732675"	"unprognostic (1.32e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-2)"	8.1	10.2	2.6	9.8	3.1	0.4	18.0	2.9	2.6	8.2	31.6	2.7	5.2	11.7	4.5	4.5	8.9	4.0	7.6	3.6	2.4	2.2	6.2	11.9	11.6	3.8	3.2	1.4	5.9	10.9	8.9	4.0	12.2	3.4	8.4	13.9	4.0	6.3	6.4	12.9	4.6	60.9	3.8	2.5	3.3	5.5	3.9	2.5	1.7	26.3	6.1	4.9	6.1	8.6	0.7	2.4	3.5	2.0	0.4	0.6	0.4	4.9	7.3	3.1	10.5	13.1	5.9	7.9	8.5	5.5	4.2	3.5	2.1	11.8	0.7	3.4	6.3	7.9	12.1	22.0	2.2	5.0	2.4	3.3	1.1	6.9	3.2	2.6	0.6	1.8	2.7	6.4	3.2	2.0	12.3	9.2	2.4	1.4	0.1	3.9	5.2	0.0	0.7	9.7	14.5	4.6	1.8	8.6	0.0	6.2	16.1	2.7	3.4	8.3	3.5	2.2	7.0	7.7	3.3	10.7	4.9	3.1	6.0	4.3	0.1	0.1	0.0	7.1	3.5	9.7	0.6	2.0	2.3	0.4	0.6	0.6	0.0	0.4	0.2	2.4	0.7	0.4	0.6	3.5	0.4	0.2	0.7	0.6	0.4	2.6	3.1	2.9	2.2	2.4	2.2	3.2	1.4	3.4	2.5	17.9	22.9	0.8	12.2	2.2	9.7	9.2	20.4	4.0	6.8	27.9	11.8	33.6	16.6	22.4	5.1	15.5	75.3	0.0	17.6	31.6	6.0	13.2	2.3	24.2	9.5	4.8	48.5	16.5	4.3	6.5	16.7	7.2	3.3	10.8	45.7	23.2	20.5	45.6	13.8	9.9	8.0	0.0	5.6	3.9	6.5	2.8	11.7	2.9	51.9	14.0
VSIG10L		ENSG00000186806	"V-set and immunoglobulin domain containing 10 like"	Q86VR7	19	51331536-51342124	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 9.5;Melanocytes: 5.0;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 5.9;OE19: 13.7;T-47d: 10.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA060453, HPA066745"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060453: AB_2684280, HPA066745: AB_2685712"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (2.40e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.90e-4)"	"unprognostic (1.42e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.19e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.1	9.8	0.1	0.0	2.0	0.1	0.6	0.0	70.9	0.0	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	72.9	2.6	0.2	4.9	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	37.6	52.2	0.1	10.8	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.1	1.2	0.1	0.5	0.5	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.9	0.7	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.6	0.7	0.1	0.2	5.9	0.0	0.0	1.0	0.0	0.7	0.2	0.0	0.0	0.0	0.3	0.5	1.7	0.0	0.5	0.0	0.1	0.8	13.7	0.6	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.2	10.8	0.0	0.1	0.0	0.2	0.9	0.0	1.4	0.9	0.1	0.7	0.2	0.3	0.0	0.6	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	1.1	0.6	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.1	0.4	0.7	0.0	0.0	0.7	1.4	0.9	1.1	1.0	4.0	9.5	1.2	1.3	3.2	0.0	2.0	1.8	5.0	1.8	0.6	1.2	0.4	0.2	3.9	0.8	0.4	6.5	1.0	0.5	2.2	0.4	0.5	0.0	0.4	0.3
VSIG2	"CTH, CTXL"	ENSG00000019102	"V-set and immunoglobulin domain containing 2"	Q96IQ7	11	124747472-124752238	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 38.2;stomach 1: 105.5"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 296.5;Mucus-secreting cells: 283.0;Paneth cells: 482.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"OE19: 98.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035919, HPA050147"	Enhanced		Approved	Nucleoplasm		NA	NA		81000	Nucleoplasm		"HPA035919: AB_10669981, HPA050147: AB_2681032"	"unprognostic (1.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.36e-2)"	1.3	0.1	0.3	11.2	0.4	0.2	3.3	0.3	0.5	5.2	23.5	0.7	0.3	0.7	1.0	0.8	8.6	2.9	38.2	0.6	0.3	0.2	1.6	0.7	25.3	0.3	0.3	0.3	2.2	0.4	0.0	0.3	0.7	0.5	18.5	24.3	0.4	12.4	0.8	0.3	0.3	2.0	3.5	0.3	0.3	105.5	1.2	0.3	0.3	28.9	3.1	5.3	26.0	14.7	0.3	1.4	0.6	3.8	0.8	2.1	2.7	0.0	0.0	1.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.7	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	98.4	0.8	0.0	0.8	0.0	0.0	16.0	0.0	0.2	0.0	1.0	0.0	0.1	0.1	0.5	0.9	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	3.8	0.0	0.0	0.6	1.6	0.0	1.8	0.3	1.4	0.3	2.0	1.6	0.6	0.8	0.5	0.0	2.1	2.7	0.3	0.4	0.3	0.5	0.3	0.2	0.3	0.3	0.5	0.3	116.1	39.3	0.0	14.5	0.7	0.6	0.4	76.5	17.4	43.3	3.5	0.0	0.0	1.7	4.7	0.0	4.5	296.5	0.0	82.7	0.0	0.5	69.3	1.1	0.0	0.1	0.0	64.2	4.3	0.3	0.0	1.4	2.3	3.3	0.0	283.0	0.0	152.0	482.9	0.0	0.0	0.0	0.0	4.4	0.3	0.4	0.4	0.0	0.0	145.8	135.8
VSIR	"B7-H5, B7H5, C10orf54, GI24, PD-1H, SISP1, VISTA"	ENSG00000107738	"V-set immunoregulatory receptor"	Q9H7M9	10	71747559-71773498	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 111.3"	"Cell type enhanced"	"Detected in many"	19	"Cytotrophoblasts: 279.2;Extravillous trophoblasts: 255.7;monocytes: 118.2;Syncytiotrophoblasts: 566.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 111.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.5;HaCaT: 20.2;HMC-1: 33.8;U-937: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007968			Approved	Nucleoplasm		NA	NA		360000	Nucleoplasm		"HPA007968: AB_1845518"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.37e-3)"	"unprognostic (3.29e-1)"	20.8	5.7	13.3	23.4	14.8	55.3	30.4	3.4	10.2	10.7	12.9	10.5	5.4	16.6	14.7	8.8	13.7	15.0	10.8	13.6	13.0	9.8	5.8	4.1	20.1	60.0	12.4	7.2	17.5	4.4	2.4	3.8	48.2	11.8	11.0	7.1	8.1	8.6	8.7	4.7	9.1	16.3	12.7	11.1	55.1	10.2	6.4	11.8	4.6	7.7	10.1	17.6	14.1	24.8	1.9	24.4	111.3	44.9	5.8	11.7	40.1	3.3	6.5	0.0	0.1	3.5	2.9	3.1	1.2	7.9	1.5	2.6	2.6	26.5	0.2	1.7	11.2	0.0	20.2	0.0	0.7	0.4	0.1	0.0	4.4	1.4	0.2	4.9	0.7	33.8	2.4	0.8	0.2	0.1	2.3	0.5	0.6	0.1	2.5	0.9	0.1	0.7	5.5	0.0	5.0	1.3	0.0	0.3	1.5	0.0	1.5	0.0	0.1	1.7	1.3	1.2	0.4	0.1	9.5	1.7	0.0	0.0	5.4	0.0	1.8	0.9	0.0	0.1	29.5	0.1	22.0	42.3	81.0	8.9	40.5	11.7	1.8	8.9	8.4	24.4	1.9	8.3	8.3	111.3	5.8	44.9	6.4	8.8	40.1	13.3	14.8	3.4	10.2	13.0	9.8	12.4	7.2	11.8	11.8	26.8	11.6	0.0	0.0	0.0	0.0	0.0	0.0	6.7	11.4	10.4	0.0	279.2	0.0	37.3	0.0	0.0	0.0	0.0	9.6	255.7	0.0	0.0	29.1	0.0	66.9	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	118.2	0.0	0.0	36.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	566.7	0.0	0.0	0.0
VSNL1	"HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1"	ENSG00000163032	"Visinin like 1"	P62760	2	17539126-17657018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 165.7"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 23.4;Cardiomyocytes: 27.7;Club cells: 29.6;Hepatocytes: 16.8;Suprabasal keratinocytes: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 44.2;Hep G2: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053808			Approved	Cytosol		NA	NA			Cytosol		"HPA053808: AB_2682270"	"unprognostic (1.04e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (4.90e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.14e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.51e-2)"	1.4	13.6	36.5	1.7	48.8	1.2	3.9	91.6	165.7	1.8	3.0	3.3	0.0	1.3	1.7	1.2	18.0	1.9	1.3	17.5	34.8	27.9	2.0	10.5	2.4	1.2	19.9	66.1	2.8	1.7	1.2	0.2	3.4	64.0	3.0	3.6	0.1	3.2	1.5	1.7	5.2	1.3	1.6	7.1	1.3	1.7	1.5	1.4	0.0	1.5	3.1	4.1	2.3	3.4	0.1	0.7	0.2	0.1	0.1	0.5	0.1	0.2	0.0	0.5	8.0	0.9	1.3	0.0	0.0	0.0	0.0	0.2	0.1	4.8	0.0	0.0	0.0	0.0	44.2	0.3	1.5	0.0	0.0	0.2	0.0	0.0	44.7	0.0	0.0	0.1	0.3	2.3	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	8.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	3.6	3.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.6	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.5	0.1	0.2	0.1	0.1	0.7	0.0	0.1	36.5	48.8	91.6	138.6	34.8	27.9	19.9	66.1	64.0	1.4	0.0	0.3	0.0	23.4	16.3	6.9	27.7	2.5	0.0	29.6	0.0	0.0	0.3	1.7	0.0	3.9	0.7	0.0	0.0	0.2	0.1	5.8	4.9	0.0	16.8	0.5	3.2	1.2	0.0	0.3	4.7	0.6	0.0	3.3	1.0	4.0	3.2	0.3	0.0	0.0	1.4	10.5	0.0	1.4	1.8	0.6	17.7	0.3	0.7	4.1	8.8
VSTM1	UNQ3033	ENSG00000189068	"V-set and transmembrane domain containing 1"	Q6UX27	19	54040825-54063953	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 53.5;bone marrow: 39.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 15.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	15	"eosinophil: 53.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 53.5"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 4.0;U-2 OS: 3.6"									HPA059365			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA059365: "	"unprognostic (5.13e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.30e-1)"		"unprognostic (1.09e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.67e-2)"	0.9	0.2	0.7	0.1	0.2	39.4	0.1	0.0	0.5	0.2	0.1	1.3	0.0	0.1	0.3	0.1	0.1	0.6	0.1	4.2	0.7	0.2	0.5	1.2	4.0	7.2	0.6	0.0	0.2	1.1	0.1	8.7	2.0	0.2	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.8	0.3	0.1	7.9	0.1	0.5	0.3	3.0	0.4	0.0	0.1	0.8	0.0	0.0	0.0	53.5	3.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	53.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.6	0.0	0.0	2.1	0.7	0.2	0.0	0.5	0.7	0.2	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	2.2	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
VSTM4	"C10orf72, FLJ31737"	ENSG00000165633	"V-set and transmembrane domain containing 4"	Q8IW00	10	49014245-49115509	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 81.0;Late spermatids: 104.4;Sertoli cells: 58.2"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 22.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 6.9;RH-30: 8.0;SH-SY5Y: 6.8;U-138 MG: 9.1;U-2197: 20.4;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017279	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Vesicles"		"HPA017279: AB_10959519"	"unprognostic (8.46e-2)"	"unprognostic (5.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.25e-4)"	13.0	31.6	7.2	3.4	6.7	0.4	10.5	3.3	7.1	18.2	6.2	9.3	3.1	2.0	13.2	5.9	6.1	6.5	11.7	10.3	7.2	4.4	9.3	3.0	8.9	7.0	8.9	5.4	27.2	1.3	22.8	4.6	7.7	10.1	11.2	4.4	15.1	2.8	9.2	3.8	4.2	4.1	12.5	7.9	2.8	5.4	7.8	6.0	2.9	20.8	6.9	3.4	9.4	8.6	1.8	0.9	2.7	0.9	1.7	0.7	0.2	0.0	0.1	2.7	0.1	1.1	0.6	0.1	2.1	3.5	0.8	0.2	0.1	0.1	0.1	0.1	5.0	2.9	0.1	0.1	0.0	0.4	2.6	1.2	0.1	0.0	0.1	0.1	0.1	0.0	4.1	0.0	3.6	0.0	0.0	0.0	0.7	6.9	0.1	0.6	0.1	0.0	0.1	0.5	0.0	0.0	0.0	8.0	4.1	0.0	0.1	0.1	6.8	0.1	0.1	0.0	0.3	0.1	0.2	0.0	9.1	1.1	20.4	0.1	0.0	5.5	0.0	10.0	0.1	0.1	1.9	0.9	0.4	0.6	0.3	0.5	0.8	0.4	0.3	0.2	1.8	0.7	0.6	2.7	1.7	0.5	0.9	0.3	0.2	7.2	6.7	3.3	7.1	7.2	4.4	8.9	5.4	10.1	6.0	3.0	17.4	0.0	1.7	5.8	5.0	12.1	0.0	6.7	17.0	0.0	2.0	0.4	1.7	0.1	81.0	6.4	0.0	0.0	0.0	0.3	22.4	0.7	11.6	3.2	0.5	4.8	0.0	3.7	1.9	104.4	8.9	4.0	6.8	1.0	0.0	10.9	0.2	0.0	13.8	6.1	2.7	58.2	30.0	1.4	3.4	3.8	0.3	1.3	0.0	0.6
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224689	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		22000	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	18.8	19.5	20.5	15.5	28.2	17.2	20.6	25.0	39.3	17.2	22.0	18.5	9.6	24.2	16.0	17.1	31.4	17.9	14.9	21.2	19.8	20.3	24.9	29.9	13.5	19.3	20.1	20.7	15.3	15.6	16.3	21.7	30.5	30.7	16.8	26.3	11.2	19.4	13.5	48.6	20.9	32.7	17.0	24.0	20.8	14.6	12.9	18.2	33.6	18.0	24.3	24.0	18.4	19.7	29.0	30.9	58.6	38.1	30.9	30.1	36.1	18.4	15.9	26.0	39.8	23.0	25.3	18.0	42.0	25.1	38.5	36.8	26.9	14.5	30.2	28.4	37.6	29.3	23.7	27.6	28.6	53.4	20.4	24.3	32.7	17.1	32.1	17.0	50.7	19.0	20.9	33.6	38.4	24.9	20.7	24.6	23.6	30.3	15.2	32.1	27.0	32.9	26.4	19.5	23.9	18.3	30.3	20.9	18.4	29.6	20.6	27.3	21.2	23.6	18.2	21.1	22.7	19.7	34.6	17.8	17.4	24.2	29.0	30.1	15.0	25.9	34.4	11.4	28.4	26.4	58.6	31.0	49.5	23.5	38.1	30.1	29.0	26.8	27.4	30.9	26.6	29.8	29.9	19.1	30.9	37.4	19.0	25.7	36.1	20.5	28.2	25.0	39.3	19.8	20.3	20.1	20.7	30.7	18.2	20.8	16.9	15.6	15.3	22.3	9.1	37.0	10.2	40.2	25.0	15.7	0.0	28.5	14.9	26.8	2.2	15.7	29.3	0.0	24.4	30.4	20.0	13.7	11.6	22.7	24.3	11.1	20.7	8.0	20.8	2.1	10.9	15.6	8.5	18.0	24.5	21.3	24.7	17.5	11.7	24.5	10.8	6.5	8.2	20.6	25.7	27.0	26.5	16.2	23.7	15.3
VTCN1	"B7-H4, B7H4, B7S1, B7X, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 52.4;Ductal cells: 73.6;Exocrine glandular cells: 31.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 74.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA			"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	46.4	0.1	0.1	6.7	0.1	0.1	7.0	0.0	2.6	29.9	0.4	14.2	1.9	0.2	0.1	0.1	27.0	0.9	0.3	0.1	0.1	0.1	4.5	35.9	0.0	1.4	3.0	0.1	1.5	0.0	0.1	17.5	3.6	0.2	2.2	0.1	0.8	0.1	0.1	1.5	2.5	0.1	0.2	0.1	0.5	1.5	2.1	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	74.4	0.0	9.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	2.4	0.0	0.0	1.2	0.0	4.0	10.3	52.4	0.0	1.7	0.0	73.6	1.6	0.0	0.0	0.0	31.1	1.1	0.0	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.9
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 24.4;testis: 51.9"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 178.0;Early spermatids: 410.6;Late spermatids: 741.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.0;U-138 MG: 1.7"					"Low region specificity"	"Detected in many"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036700: AB_2675261, HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.0	0.2	1.7	0.0	0.0	0.0	0.2	1.1	0.2	2.0	0.0	0.0	0.5	4.3	0.0	24.4	0.5	0.4	1.7	1.6	0.0	0.0	4.0	0.0	0.1	0.1	2.3	0.0	0.0	1.1	0.1	3.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	51.9	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.1	1.7	1.6	0.1	0.1	3.2	0.3	0.0	0.6	0.0	1.1	0.2	0.6	0.8	0.0	178.0	19.4	1.8	29.5	0.0	0.0	0.0	410.6	0.0	0.2	0.0	0.4	0.1	0.4	0.3	0.0	0.0	0.2	0.0	1.7	1.8	0.0	741.4	4.4	0.9	0.0	1.0	1.3	0.3	0.1	1.5	5.3	0.0	0.5	0.0	0.3	16.1	5.4	0.4	0.0	0.0	0.8	0.5
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115362-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	15	"granulocytes: 538.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 25.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.2;HEL: 20.3;HHSteC: 15.8;HUVEC TERT2: 18.7;RPTEC TERT1: 20.6"					"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	14.8	20.2	13.8	7.5	13.4	1.6	16.0	2.3	9.3	15.5	23.9	7.5	10.0	16.7	16.6	17.0	12.6	9.9	19.9	6.5	14.1	24.6	16.0	4.3	19.4	6.8	12.5	6.6	9.6	15.3	5.5	34.2	25.9	15.2	22.5	28.4	10.3	31.2	13.2	3.0	17.9	24.0	13.6	15.0	6.0	17.8	6.3	7.6	3.9	13.7	7.1	9.8	14.9	11.8	4.5	4.8	25.6	5.3	4.3	7.5	3.6	0.0	0.2	3.6	0.2	3.9	3.6	1.3	0.5	0.2	0.3	0.1	0.2	28.2	0.0	3.5	0.6	4.9	0.1	0.7	6.4	0.0	9.6	0.0	20.3	5.1	0.6	15.8	0.2	9.5	10.7	0.7	0.6	2.1	1.4	18.7	2.7	1.1	3.5	1.1	0.1	0.4	0.3	5.7	0.0	0.7	0.0	12.6	0.1	20.6	0.2	3.2	0.3	0.5	0.2	1.0	8.7	2.5	0.9	0.5	0.1	2.7	0.1	0.0	1.3	1.1	0.0	11.7	0.4	0.2	25.6	4.8	0.5	2.9	3.3	0.7	4.5	3.2	1.7	4.8	2.3	4.1	2.6	0.3	4.3	5.3	2.6	7.5	3.6	13.8	13.4	2.3	9.3	14.1	24.6	12.5	6.6	15.2	7.6	8.9	36.5	0.8	11.6	15.2	2.9	2.4	7.6	25.4	14.8	31.4	2.0	7.8	8.3	19.7	32.8	3.6	25.8	0.0	25.0	2.1	7.8	8.4	538.2	2.4	29.2	30.2	14.5	1.8	5.6	3.6	2.6	6.0	5.0	2.8	22.5	12.0	20.8	17.3	0.4	11.5	1.1	0.0	3.8	0.2	2.3	10.9	1.6	4.9	22.5	14.0
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.6;epididymis: 6.4;testis: 6.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 7.7;Late spermatids: 6.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA			Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	1.2	0.7	0.2	3.3	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	0.0	6.4	0.1	0.7	0.5	0.1	2.8	3.3	2.0	0.0	0.1	0.2	0.2	0.4	0.0	0.1	2.2	5.6	0.2	17.6	0.2	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.5	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.5	2.8	3.3	0.2	0.4	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
VWA5B2	"DKFZp761K032, LOC90113"	ENSG00000145198	"Von Willebrand factor A domain containing 5B2"	Q8N398	3	184230429-184242329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 35.9;brain: 10.1;pancreas: 11.0"	"Cell type enriched"	"Detected in some"	34	"Intestinal endocrine cells: 107.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036823, HPA036824, HPA061412"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507"	"unprognostic (3.92e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-1)"	0.4	35.9	9.2	0.4	4.8	0.2	0.4	9.8	10.1	0.5	2.5	0.4	0.4	1.7	0.4	0.4	0.4	1.2	0.4	0.4	9.5	3.3	0.4	0.4	2.4	0.4	1.9	0.4	3.7	11.0	1.6	3.4	0.4	0.4	0.9	0.4	0.4	0.5	2.4	0.4	0.1	2.4	0.4	0.4	0.4	2.8	1.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	1.5	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.0	0.0	27.1	1.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.7	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	4.8	9.8	10.1	9.5	3.3	1.9	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	3.2	107.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Enterocytes: 1.8;Intestinal endocrine cells: 4.1;Paneth cells: 2.3;Proximal tubular cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.2;HeLa: 3.4;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.5"	"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA			"Plasma membrane, Cytosol"		"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.5	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.2	0.5	0.7	0.3	0.1	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.4	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.2	0.0	0.6	0.2	3.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.3	0.0	2.1	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.5	1.3	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3	0.0	0.6	0.0	0.5	0.1	0.4	0.7	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.4	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5
VWA8	KIAA0564	ENSG00000102763	"Von Willebrand factor A domain containing 8"	A3KMH1	13	41566837-41961120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 37.6;Cone photoreceptor cells: 33.4;Rod photoreceptor cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039075, HPA045478"	Uncertain		Approved	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"HPA039075: AB_2676334, HPA045478: AB_2679341"	"unprognostic (9.93e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (8.56e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.44e-1)"	"prognostic favorable (6.38e-14)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.26e-1)"	10.1	15.1	7.1	14.1	9.7	6.3	11.0	11.4	10.5	12.2	10.0	8.2	10.4	8.7	14.9	10.7	9.1	8.3	12.1	16.0	6.7	7.9	21.8	25.8	6.8	8.3	8.8	6.0	9.5	11.1	17.2	16.3	6.4	9.8	8.6	9.6	15.1	15.2	8.7	31.4	7.3	11.1	11.9	6.9	6.9	8.9	5.5	5.6	17.5	9.0	16.4	11.8	11.7	6.9	2.5	2.5	1.8	1.5	4.1	4.9	2.4	4.1	6.0	6.2	8.5	5.9	8.6	5.8	6.7	9.7	6.0	4.8	7.9	6.6	11.0	4.5	5.7	4.8	14.8	5.7	16.0	7.5	12.4	10.2	10.3	5.8	9.9	6.3	13.5	1.4	10.0	10.0	5.7	13.8	8.2	5.9	8.7	9.9	7.8	5.3	5.5	7.6	7.0	9.3	10.7	5.8	0.0	3.9	11.4	16.1	14.9	3.9	8.3	8.3	13.0	9.1	7.1	5.4	10.4	5.4	4.5	4.8	5.8	6.2	8.1	7.7	17.2	5.0	6.6	5.9	1.8	1.1	0.2	3.4	1.1	4.9	2.3	2.0	2.9	2.5	2.5	2.7	3.5	0.7	4.1	1.5	1.5	1.1	2.4	7.1	9.7	11.4	10.5	6.7	7.9	8.8	6.0	9.8	5.6	14.9	1.6	2.4	9.6	3.5	9.5	37.6	10.2	8.1	11.4	5.2	33.4	6.5	1.7	3.6	23.6	2.8	6.5	23.3	1.4	1.6	3.4	13.4	0.0	15.3	3.5	3.2	2.9	2.5	3.2	10.5	5.5	4.1	5.0	1.8	8.4	4.5	3.6	9.1	4.9	7.9	43.7	0.0	5.2	4.2	3.2	2.5	2.4	4.3	8.3	8.6
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 29.5"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 1.7;Cardiomyocytes: 4.7;Ciliated cells: 1.4;Glandular cells: 2.2;Urothelial cells: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 10.8;NTERA-2: 5.4;SCLC-21H: 8.7"					"Low region specificity"	"Detected in many"			"HPA026619, HPA036044"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Cytosol	Nucleoplasm	"HPA026619: AB_2671920, HPA036044: AB_2674916"	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.4	0.5	1.6	0.3	2.7	2.3	2.3	0.4	2.3	0.8	0.9	0.0	0.9	0.2	0.7	4.9	0.8	1.5	0.7	4.1	0.8	0.5	0.7	0.5	0.7	0.2	0.4	0.5	0.5	0.9	0.0	29.5	0.3	0.5	1.5	0.3	0.1	5.7	5.5	0.4	0.6	0.6	0.2	0.4	0.5	2.0	0.6	0.0	0.1	6.2	0.0	1.3	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.5	0.0	0.3	1.8	0.0	2.1	0.7	0.8	0.4	3.0	0.2	0.0	0.0	0.7	0.4	2.1	2.0	0.6	4.0	2.2	3.5	4.8	0.0	0.0	1.1	2.4	0.1	0.3	0.0	1.2	2.7	0.8	1.2	10.8	0.0	0.0	1.2	0.0	0.0	5.4	0.0	0.6	0.0	0.0	1.6	0.0	1.3	8.7	1.4	0.0	1.7	0.0	1.4	0.0	1.1	0.1	0.0	1.0	0.0	0.9	3.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.9	0.1	1.6	2.7	0.4	2.3	0.8	0.5	0.4	0.5	0.5	0.0	0.0	1.0	0.0	1.7	0.2	0.0	4.7	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.4	1.6
WAPL	"FOE, KIAA0261, WAPAL"	ENSG00000062650	"WAPL cohesin release factor"	Q7Z5K2	10	86435256-86521815	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037874, HPA037875, HPA066141"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Mitotic spindle,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytokinetic bridge, Mitotic spindle, Centrosome, Cytosol"	"HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: "	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.78e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	15.3	15.4	16.0	15.5	16.9	19.8	15.6	23.6	15.0	13.4	14.0	12.1	6.8	12.5	16.0	8.7	20.4	12.6	11.2	13.3	15.3	8.2	14.5	23.1	17.5	19.3	14.8	11.5	14.8	13.6	18.1	18.2	19.0	13.4	13.9	13.1	9.4	14.9	10.6	34.4	20.4	16.0	16.0	16.4	18.2	13.5	28.1	16.4	39.2	15.9	9.4	22.4	15.1	15.9	5.2	6.2	14.3	8.7	3.9	7.7	3.1	20.2	9.5	16.7	22.0	13.3	14.2	14.7	17.8	22.0	15.2	16.6	20.6	17.9	30.8	12.1	15.9	13.4	19.1	18.9	15.3	23.4	20.0	12.4	18.6	15.2	22.6	15.2	37.6	21.5	11.1	17.9	19.4	32.7	17.3	16.9	18.0	19.5	18.6	17.3	17.3	23.4	14.1	14.8	12.7	9.6	16.7	13.5	12.2	13.1	18.0	6.5	12.6	15.7	10.6	19.3	17.3	23.2	20.1	16.2	14.6	17.4	12.8	23.3	18.3	25.4	32.6	13.4	26.9	10.3	14.3	4.7	9.4	4.7	5.3	7.0	5.2	6.3	6.5	6.2	4.8	7.2	5.7	7.3	3.9	8.7	4.7	7.7	3.1	16.0	16.9	23.6	15.0	15.3	8.2	14.8	11.5	13.4	16.4	77.4	51.5	21.9	40.4	0.0	47.2	0.0	12.7	25.4	38.7	15.7	19.6	36.2	18.3	52.5	61.6	29.2	15.6	70.0	46.0	25.0	22.4	50.1	23.3	41.2	35.6	52.4	17.5	28.8	48.6	27.3	29.7	49.5	0.0	56.9	31.7	45.3	46.8	37.1	30.4	26.7	127.3	64.7	0.0	125.1	82.8	0.0	63.6	38.9	32.2	54.7
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"Wiskott-Aldrich syndrome"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 55.9"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 72.2;Hofbauer cells: 95.2;Kupffer cells: 94.9;Macrophages: 70.0;T-cells: 87.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 21.7;HEL: 19.1;HMC-1: 46.5;MOLT-4: 19.7;NB-4: 21.5;RPMI-8226: 26.5;THP-1: 19.5;U-266/70: 24.6;U-937: 24.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		320000	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	7.6	4.0	4.9	28.9	7.8	30.7	3.3	2.0	5.1	2.7	4.4	5.9	0.5	4.8	2.4	5.6	3.7	4.5	4.4	3.0	4.6	4.1	4.1	5.0	12.6	29.9	7.6	1.3	2.6	2.2	0.7	2.6	5.4	6.0	3.2	3.2	3.5	5.4	1.9	1.4	2.2	14.3	3.7	12.8	55.9	4.1	1.7	7.3	53.2	2.8	1.4	33.2	5.8	2.5	2.1	3.5	20.3	5.3	2.1	3.2	2.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	21.7	0.1	0.0	0.1	0.7	0.0	0.0	0.0	12.5	0.1	19.1	0.2	0.0	0.2	9.8	46.5	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.2	13.4	0.0	2.2	19.7	21.5	0.1	0.3	0.1	17.3	0.0	26.5	0.0	0.0	0.1	0.2	0.3	0.2	0.2	0.1	0.1	19.5	0.1	0.0	0.1	0.3	0.0	24.6	12.0	15.2	0.1	24.8	0.0	1.8	4.6	20.3	3.0	5.0	2.2	1.8	2.3	2.5	3.5	2.1	2.1	2.3	18.1	2.1	5.3	1.8	3.2	2.0	4.9	7.8	2.0	5.1	4.6	4.1	7.6	1.3	6.0	7.3	3.0	21.3	72.2	0.1	2.2	0.0	0.8	0.0	2.7	0.0	0.0	0.0	0.8	1.7	0.1	0.5	0.5	0.0	23.3	0.3	0.9	1.5	0.2	46.2	0.9	95.2	0.0	1.2	5.5	94.9	0.8	0.0	70.0	3.3	45.9	0.0	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.6	1.4	1.1	1.3	1.1	87.0	0.0	0.1
WASF2	"SCAR2, WAVE2"	ENSG00000158195	"WAS protein family member 2"	Q9Y6W5	1	27404226-27490158	"Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022632, HPA045288"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		470000	"Plasma membrane"	Cytosol	"CAB022632: , HPA045288: AB_2679287"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (5.29e-8)"	"unprognostic (3.94e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.26e-2)"	36.9	23.3	22.0	23.8	30.0	30.0	28.6	13.6	24.0	31.9	28.8	33.2	13.2	15.7	36.9	16.0	55.3	28.8	22.3	20.5	22.8	13.1	20.2	11.6	29.4	31.1	32.5	12.6	38.8	24.0	21.3	14.8	29.7	23.2	26.4	23.3	22.2	25.6	26.1	11.4	35.1	26.7	42.9	31.5	34.0	26.4	20.7	32.7	32.3	21.6	22.2	35.2	39.1	30.3	18.9	21.8	36.9	38.4	8.5	12.9	16.8	24.4	11.7	27.3	24.8	19.9	26.1	15.8	20.0	18.6	22.1	19.9	10.1	26.5	17.0	19.4	31.2	15.0	19.7	21.9	32.8	26.5	23.8	13.8	37.1	20.8	11.9	26.8	29.6	21.4	23.8	35.8	24.0	45.0	24.0	27.6	19.0	29.5	8.9	29.9	8.8	22.0	13.6	21.9	12.5	18.1	46.1	33.5	17.4	15.8	13.9	13.6	15.0	34.9	15.6	26.1	17.3	13.0	18.0	36.2	18.4	19.1	38.0	15.7	18.3	24.1	22.8	21.7	36.8	20.6	14.8	23.3	18.5	12.9	29.1	10.5	14.1	10.2	8.9	14.8	18.9	10.7	8.1	36.9	8.5	38.4	21.8	10.2	16.8	22.0	30.0	13.6	24.0	22.8	13.1	32.5	12.6	23.2	32.7	62.5	51.0	92.0	173.5	131.5	24.5	30.1	86.6	64.3	69.4	85.5	13.7	174.6	53.0	89.1	42.3	188.8	120.0	46.7	88.6	107.9	114.2	242.5	56.7	41.4	133.0	19.1	104.2	120.3	180.2	47.6	152.8	97.4	72.6	162.3	79.4	56.5	119.6	91.2	171.5	37.6	19.4	135.8	119.5	121.8	114.1	170.0	120.0	87.1	89.2	299.4
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 35.7;Ciliated cells: 76.3;Club cells: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	24.0	21.0	15.8	31.4	19.3	24.7	27.1	22.5	18.3	19.1	21.2	16.2	12.6	19.4	22.8	15.3	15.7	15.5	14.4	42.9	17.6	13.9	26.1	12.1	20.7	20.2	15.3	15.8	22.5	14.0	21.2	27.0	17.7	22.0	16.7	23.0	13.1	17.5	16.5	15.5	19.2	21.3	16.8	14.6	27.4	16.2	9.4	14.8	27.0	21.4	9.8	20.2	18.4	27.4	6.6	9.0	11.7	13.9	9.0	12.5	8.8	11.1	5.4	9.2	10.8	37.6	21.0	7.5	13.1	27.8	19.5	20.8	12.5	16.7	9.8	8.2	19.5	18.3	12.2	13.3	11.0	19.3	9.4	9.7	7.0	10.8	12.5	26.2	11.9	12.2	21.6	13.9	21.3	13.5	20.5	14.7	8.4	11.3	9.9	23.4	7.9	6.5	19.5	7.5	7.1	25.5	10.0	13.4	5.8	13.4	12.8	3.2	9.9	12.2	11.3	17.4	14.2	14.0	8.2	21.5	10.0	8.4	28.1	10.7	10.3	20.3	8.4	21.9	21.9	4.0	1.2	10.7	11.7	12.0	13.9	12.5	6.6	10.2	11.0	9.0	6.5	10.2	7.4	5.1	9.0	8.2	5.3	10.4	8.8	15.8	19.3	22.5	18.3	17.6	13.9	15.3	15.8	22.0	14.8	35.7	22.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	42.1	14.0	0.0	6.6	0.0	14.2	0.0	0.0	0.0	0.0	13.5	5.7	0.0	0.0	14.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	10.0	0.0	0.0	12.2	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792961	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 26.2;Ciliated cells: 45.5;Collecting duct cells: 22.7;granulocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	17.2	15.8	10.0	33.6	15.7	30.1	27.2	24.9	17.1	16.7	15.8	10.7	15.9	12.2	18.3	17.0	12.3	13.2	13.6	23.2	14.2	10.2	20.6	12.8	17.3	14.8	16.0	8.4	20.2	10.1	22.7	16.5	13.4	16.2	13.4	18.5	13.0	15.3	24.0	17.1	14.8	17.0	15.8	14.0	15.5	12.5	10.1	15.3	19.4	14.9	13.2	14.6	19.3	14.8	10.7	11.4	17.2	20.3	12.2	13.4	11.6	11.2	12.2	9.9	11.3	25.9	23.0	6.0	13.3	21.9	15.7	15.2	7.4	11.1	9.3	9.1	19.6	15.0	10.3	11.1	6.1	15.9	8.7	9.2	9.6	15.2	5.7	27.5	9.6	12.0	21.7	14.8	17.0	12.8	15.5	16.2	7.9	15.3	7.4	19.3	5.9	6.4	16.7	7.2	6.8	1.9	8.1	14.6	4.8	11.7	17.8	4.8	10.9	15.4	7.8	18.6	10.6	10.5	9.7	27.2	8.2	8.8	21.7	8.9	10.5	16.2	9.3	11.6	23.2	4.3	12.5	16.9	11.0	13.0	18.2	12.5	10.7	10.8	13.4	11.4	9.6	10.8	9.7	17.2	12.2	20.3	8.4	10.1	11.6	10.0	15.7	24.9	17.1	14.2	10.2	16.0	8.4	16.2	15.3	32.8	26.2	0.0	0.0	0.0	0.0	0.0	0.0	45.5	21.6	22.7	0.0	6.2	3.3	10.9	0.0	0.0	0.0	0.0	12.1	5.4	0.0	0.0	27.9	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	18.0	0.0	0.0	10.6	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0
WASHC3	"CCDC53, CGI-116"	ENSG00000120860	"WASH complex subunit 3"	Q9Y3C0	12	102012927-102062149	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 106.1;Hofbauer cells: 63.8;monocytes: 81.2;Proximal tubular cells: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038339	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA038339: AB_2675966"	"unprognostic (4.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	15.1	22.4	25.3	11.1	24.2	8.4	18.4	11.1	22.0	19.8	17.3	18.6	17.5	10.0	20.5	27.9	17.2	13.5	14.8	23.7	23.3	24.2	29.0	29.1	14.4	13.9	24.6	18.9	13.9	10.3	25.1	22.5	14.7	22.5	19.4	16.6	15.3	13.2	26.9	17.8	12.3	12.3	23.1	27.6	13.6	15.4	61.7	20.0	17.2	18.8	19.3	19.5	17.1	13.9	25.3	22.5	40.2	26.0	21.5	44.5	19.8	6.0	8.3	7.5	4.4	26.8	35.2	7.1	8.5	16.6	12.7	13.7	7.5	5.6	6.5	6.1	18.4	14.0	10.9	7.9	20.4	16.4	15.6	4.7	9.0	6.2	10.2	24.9	7.3	5.2	20.5	27.7	16.4	16.5	34.6	17.1	16.1	5.2	6.7	32.5	8.1	7.6	13.6	2.2	12.7	15.2	4.1	10.8	9.5	20.9	10.0	7.0	3.8	11.4	7.8	17.2	14.8	10.0	4.8	8.0	14.5	3.7	7.9	5.9	16.9	10.9	7.9	20.1	5.6	6.0	40.2	17.0	35.8	16.0	25.4	18.4	25.3	23.5	20.5	22.5	21.7	17.7	20.6	7.1	21.5	26.0	21.6	44.5	19.8	25.3	24.2	11.1	22.0	23.3	24.2	24.6	18.9	22.5	20.0	26.8	37.4	0.0	0.0	0.0	0.0	0.0	0.0	41.5	26.1	31.4	0.0	49.8	106.1	40.5	0.0	0.0	0.0	0.0	34.1	41.5	0.0	0.0	37.2	0.0	63.8	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	81.2	0.0	0.0	34.2	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"Wiskott-Aldrich syndrome like"	O00401	7	123681935-123749067	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 212.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 45.1;U-2197: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favorable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	17.9	19.3	25.6	11.6	29.5	3.8	20.7	21.0	39.3	23.7	31.2	17.0	8.9	27.4	21.0	14.6	22.5	14.8	21.7	15.4	35.2	22.5	33.3	34.5	15.3	5.5	18.8	23.0	27.8	21.9	36.7	16.9	25.4	28.6	19.9	28.8	18.0	16.9	19.5	21.6	14.4	30.2	18.2	16.6	12.1	22.0	17.3	15.0	10.0	26.7	12.0	9.7	23.7	21.1	4.6	4.5	4.9	6.2	6.2	4.3	1.5	10.9	8.1	8.9	7.6	14.1	14.6	11.6	7.6	12.8	5.6	7.3	6.6	13.9	1.1	6.1	11.5	12.1	8.3	16.5	8.4	8.8	1.9	6.6	0.9	6.7	7.1	15.3	1.4	0.9	11.7	15.8	8.3	14.3	12.8	9.7	1.1	4.8	2.1	13.4	6.6	1.8	1.9	16.7	11.7	7.4	1.1	7.2	2.4	11.9	45.1	11.0	16.2	10.5	31.6	20.5	14.5	6.1	1.4	11.0	15.2	4.3	42.8	7.4	2.4	0.8	2.4	13.1	1.2	12.1	4.9	4.1	1.8	4.3	4.1	3.6	4.6	2.8	2.6	3.5	3.2	3.6	3.8	1.8	6.2	6.2	4.5	1.4	1.5	25.6	29.5	21.0	39.3	35.2	22.5	18.8	23.0	28.6	15.0	80.4	46.6	7.8	37.8	53.7	27.6	63.7	61.1	45.5	51.2	50.6	19.6	36.7	44.7	43.5	16.7	34.6	105.1	0.0	46.9	46.1	45.8	67.4	3.5	49.7	11.1	25.4	65.3	56.4	14.8	6.2	44.5	13.4	28.7	14.4	96.1	57.1	59.0	118.1	60.8	80.1	28.9	19.4	43.2	15.5	19.8	59.7	68.0	7.5	56.6	212.0
WBP1	WBP-1	ENSG00000239779	"WW domain binding protein 1"	Q96G27	2	74458329-74460891	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 21.4;monocytes: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057067	Approved		Approved	Cytosol		No	No			Cytosol		"HPA057067: AB_2683326"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (6.05e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (6.83e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (6.36e-4)"	17.6	23.5	37.6	12.6	34.8	15.1	18.1	12.1	27.5	22.4	14.9	34.4	23.6	15.9	19.2	26.1	19.0	31.0	20.6	21.2	30.9	22.7	23.0	26.4	15.4	15.5	28.6	17.2	27.6	35.9	27.7	22.1	15.4	20.8	29.8	10.2	32.1	49.1	25.5	15.3	19.7	15.8	16.4	25.2	14.7	17.9	10.6	17.0	40.5	36.0	17.2	17.6	18.7	19.2	19.2	30.3	15.3	18.5	21.5	24.0	16.5	6.1	29.3	17.8	20.1	22.8	17.5	13.4	6.6	12.3	6.6	5.4	15.2	11.7	6.0	11.8	15.2	10.1	9.1	7.2	17.1	6.4	23.7	17.0	8.4	13.8	21.3	14.6	3.0	8.3	24.6	18.3	8.8	13.1	31.8	13.1	15.9	3.3	21.5	16.7	41.7	10.3	7.7	12.7	16.1	15.6	10.4	20.1	9.0	17.5	26.0	10.5	26.4	8.8	14.6	18.1	16.6	19.5	8.1	8.1	16.0	13.2	6.2	6.4	32.9	11.4	7.0	17.2	7.9	14.1	15.3	18.5	12.2	18.1	14.2	15.9	19.2	16.0	17.6	19.4	18.8	22.4	19.4	13.0	21.5	12.0	30.3	24.0	16.5	37.6	34.8	12.1	27.5	30.9	22.7	28.6	17.2	20.8	17.0	3.0	3.4	0.0	0.4	0.8	1.7	0.4	0.0	21.4	5.7	1.8	2.0	1.1	1.7	4.1	1.3	1.1	3.4	0.0	3.5	1.2	1.2	1.6	1.1	0.8	1.4	0.0	1.7	0.6	3.5	1.3	2.0	1.4	0.0	9.0	4.4	1.5	5.0	3.5	1.1	3.1	1.8	0.0	1.2	0.1	0.2	1.1	1.5	1.5	4.5	0.3
WBP1L	"C10orf26, FLJ20154, OPAL1"	ENSG00000166272	"WW domain binding protein 1 like"	Q9NX94	10	102743970-102816267	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037635, HPA038371"	Uncertain		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA037635: AB_10672462, HPA038371: AB_2675980"	"unprognostic (3.28e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (5.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.53e-1)"	23.8	23.0	11.5	12.9	13.7	2.3	14.2	9.5	14.2	19.0	14.5	12.2	13.3	9.0	18.9	14.9	13.1	18.9	15.3	23.6	11.9	8.9	11.6	21.3	13.3	11.5	14.9	8.0	23.6	9.3	12.5	13.5	14.1	17.5	15.2	9.2	20.2	21.8	14.9	77.3	20.1	12.3	16.3	15.0	12.5	15.0	11.0	10.1	23.2	26.1	35.5	11.1	17.6	11.4	6.1	8.2	14.7	16.7	12.4	8.7	8.9	10.1	13.2	7.3	12.3	24.3	19.8	14.9	10.4	28.3	10.4	13.1	9.0	15.9	8.8	14.1	16.0	8.4	11.3	5.3	9.0	7.9	8.8	5.6	17.8	6.0	6.4	15.8	8.5	21.2	21.3	16.2	13.3	10.3	23.9	20.2	10.7	8.6	11.1	17.7	13.3	10.3	9.5	5.5	7.8	6.5	20.7	19.2	5.6	9.2	10.1	1.7	7.0	5.7	5.8	11.7	13.7	23.7	9.5	15.0	10.0	10.4	11.3	9.2	20.6	10.8	6.5	14.2	16.5	4.4	6.6	11.8	14.7	8.7	13.7	6.9	6.1	7.4	8.4	8.2	6.0	6.8	7.2	14.4	12.4	16.7	5.2	7.5	8.9	11.5	13.7	9.5	14.2	11.9	8.9	14.9	8.0	17.5	10.1	20.8	21.3	12.6	8.9	7.2	5.5	12.1	15.3	20.1	17.0	12.2	0.0	27.0	1.7	13.1	1.9	18.4	17.0	0.0	22.1	12.1	18.9	19.8	38.0	44.0	23.3	12.7	8.7	23.9	39.9	1.0	12.0	16.5	10.1	18.0	15.7	8.3	18.1	11.5	18.4	9.2	3.7	19.4	19.6	5.0	6.1	10.3	33.4	8.7	10.9	8.9
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Approved	Nucleoplasm,Cytosol		No	No		870000	"Nucleoplasm, Cytosol"		"HPA065682: AB_2685530, HPA068819: AB_2686042"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	37.4	50.4	59.5	22.8	79.8	29.9	22.6	62.5	119.3	24.3	20.4	75.2	15.0	27.0	22.9	19.7	25.7	36.6	26.4	51.6	58.7	56.4	32.0	48.7	31.9	22.3	62.1	56.2	41.8	35.7	36.8	24.5	23.0	110.8	32.2	17.2	40.3	55.5	33.6	47.1	28.2	25.9	23.0	55.6	30.5	27.4	28.5	44.3	10.6	26.8	15.7	21.5	24.5	18.3	14.9	11.1	63.5	25.5	11.2	15.1	16.8	25.5	29.8	11.2	13.3	23.1	23.1	14.8	8.3	26.2	19.2	23.9	14.8	26.2	13.3	21.3	11.8	61.1	15.4	11.7	25.1	17.7	9.8	22.6	24.5	18.1	24.0	47.7	10.1	41.9	25.6	24.0	22.7	31.9	33.9	37.2	20.6	16.4	40.3	15.4	26.1	20.8	20.8	9.5	18.1	19.8	14.3	22.5	24.7	27.9	15.9	18.9	29.5	14.5	25.3	40.4	21.4	34.1	25.3	21.3	19.6	17.3	19.0	13.1	37.3	26.7	9.9	55.0	9.4	13.9	42.8	16.7	56.0	11.6	20.5	12.9	14.9	13.0	11.7	11.1	12.0	12.6	10.3	63.5	11.2	25.5	8.6	15.1	16.8	59.5	79.8	62.5	119.3	58.7	56.4	62.1	56.2	110.8	44.3	77.4	66.5	53.1	106.6	54.1	107.3	69.8	50.9	25.4	33.0	50.6	70.7	59.5	137.6	109.6	243.3	60.2	61.9	23.3	166.3	55.9	37.9	110.3	63.7	57.0	115.5	106.5	32.2	41.7	53.9	234.4	55.0	64.6	57.3	124.4	36.0	83.7	108.2	69.1	50.5	60.3	104.3	25.8	37.3	33.5	25.6	69.9	154.5	55.4	22.9	81.3
WBP2NL	"FLJ26145, GRAMD7, MGC26816, PAWP"	ENSG00000183066	"WBP2 N-terminal like"	Q6ICG8	22	41998725-42058456	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 24.8"	"Group enriched"	"Detected in many"	16	"Early spermatids: 223.5;Late spermatids: 587.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.3;HDLM-2: 1.0;HHSteC: 1.1;HSkMC: 1.1;THP-1: 1.6"									HPA048557	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA048557: AB_2680440"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-4)"	"unprognostic (2.77e-3)"	"unprognostic (6.12e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (9.84e-4)"	"unprognostic (3.31e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.36e-5)"	1.1	0.9	3.0	1.2	2.9	0.6	2.4	3.6	4.6	0.9	0.9	3.2	1.8	0.8	1.4	4.1	0.8	2.0	1.1	0.8	2.3	1.2	1.2	0.9	1.3	1.1	2.0	2.4	2.4	2.8	2.6	2.4	0.8	2.8	1.3	1.0	2.0	1.9	1.5	0.8	1.6	1.0	0.9	3.7	1.0	1.1	24.8	3.3	0.0	2.3	0.0	1.1	0.9	1.7	1.1	1.5	0.0	0.6	0.4	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	4.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.5	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.1	1.6	0.0	0.0	0.2	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	0.0	0.0	0.9	0.4	0.0	1.5	1.1	0.3	0.3	0.0	0.4	0.2	0.6	1.4	0.2	3.0	2.9	3.6	4.6	2.3	1.2	2.0	2.4	2.8	3.3	0.0	3.2	2.0	1.2	0.3	16.2	0.7	2.5	0.0	5.7	0.0	19.6	1.8	3.3	0.9	223.5	0.7	2.0	0.0	1.2	0.9	0.3	0.9	0.0	1.5	1.2	9.5	4.6	2.5	4.6	587.8	6.1	2.1	1.7	0.0	1.9	2.8	0.9	3.7	5.3	1.5	20.6	0.0	0.8	25.5	15.6	0.6	1.6	2.5	1.7	0.9
WDCP	"C2orf44, FLJ21945"	ENSG00000163026	"WD repeat and coiled coil containing"	Q9H6R7	2	24029340-24049575	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	12	"Collecting duct cells: 8.7;Distal tubular cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041054	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA041054: AB_10796566"	"unprognostic (1.07e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (5.14e-8)"	"unprognostic (7.69e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.00e-1)"	11.7	9.6	8.3	7.6	9.4	2.4	9.2	14.6	9.8	9.6	9.3	11.5	8.4	5.3	10.7	8.0	7.4	7.2	5.6	6.8	7.1	6.9	7.5	8.9	5.4	12.4	8.3	4.8	11.6	7.7	11.2	9.4	8.5	8.7	8.7	6.2	7.8	7.1	12.9	13.8	5.9	7.5	7.4	8.0	9.4	7.0	12.5	9.2	17.9	8.9	5.5	13.7	9.4	6.4	4.9	4.3	1.5	3.8	5.0	7.8	4.2	7.3	11.4	12.6	8.7	8.6	6.9	4.5	9.0	4.8	9.4	9.0	10.3	3.4	19.4	3.9	4.6	7.9	5.4	17.8	6.1	9.8	11.6	10.2	11.8	5.7	10.7	5.9	10.7	8.2	4.1	4.8	9.6	4.8	4.9	8.8	11.3	16.3	5.4	9.8	3.3	13.9	6.4	15.1	7.4	8.9	15.4	21.2	7.8	4.4	3.6	9.7	13.4	4.4	4.3	5.5	9.2	3.3	4.8	8.4	7.6	8.4	4.5	8.1	8.9	11.2	27.4	4.8	11.5	5.9	0.0	2.4	1.5	7.5	3.8	7.8	4.9	5.0	5.5	4.3	4.7	6.8	7.5	0.7	5.0	2.6	1.6	7.1	4.2	8.3	9.4	14.6	9.8	7.1	6.9	8.3	4.8	8.7	9.2	3.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	8.7	0.0	2.6	6.6	2.1	0.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.7;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in some"	10	"B-cells: 20.5;Early spermatids: 25.8;Hofbauer cells: 11.8;Kupffer cells: 11.7;Late spermatids: 11.6;Macrophages: 21.6;monocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7"	"Group enriched"	"Detected in many"	7	"B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 30.0;HDLM-2: 27.5;HL-60: 10.5;THP-1: 9.3;U-698: 12.8;U-937: 12.4"	"Low region specificity"	"Detected in many"							HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	2.7	1.5	3.6	31.2	5.4	8.6	1.5	0.9	2.7	1.2	1.6	5.2	0.0	1.1	1.2	1.5	1.5	1.5	2.6	1.4	3.1	1.9	1.7	1.2	9.4	20.8	5.3	0.6	1.1	1.1	0.2	1.1	0.8	3.7	1.2	1.5	1.2	5.7	0.4	0.9	2.0	10.2	1.3	7.3	19.1	1.6	1.5	4.4	4.1	1.6	0.9	26.6	3.0	1.2	12.5	19.7	6.2	1.7	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	3.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	12.4	0.0	0.0	1.7	0.0	0.0	1.6	0.0	8.9	0.0	0.1	6.7	12.5	0.0	0.0	6.2	0.0	0.8	19.7	0.0	0.6	3.6	5.4	0.9	2.7	3.1	1.9	5.3	0.6	3.7	4.4	0.0	0.6	20.5	0.0	0.3	0.0	1.1	0.0	0.0	1.2	1.8	0.0	0.1	1.7	0.0	25.8	0.3	0.0	0.0	0.0	0.1	0.9	0.0	5.7	0.0	11.8	0.0	0.0	0.0	11.7	11.6	0.3	21.6	1.7	17.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.6	0.3	0.2	0.0	0.0	0.0
WDPCP	"BBS15, C2orf86, fritz, hFrtz"	ENSG00000143951	"WD repeat containing planar cell polarity effector"	O95876	2	63121383-63827843	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 157.8;Alveolar cells type 2: 91.0;Ciliated cells: 161.9;Club cells: 104.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044144	Uncertain		Approved	"Cell Junctions"		Yes	No			"Cell Junctions"		"HPA044144: AB_10969458"	"unprognostic (3.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.22e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-1)"	7.2	7.6	7.9	5.4	13.8	15.6	6.6	10.7	14.2	6.4	4.6	7.8	5.6	3.7	8.1	9.3	4.9	8.6	5.3	10.8	7.8	7.5	8.1	5.1	5.5	6.7	7.0	10.1	9.5	5.0	6.9	17.1	5.7	9.8	5.8	4.5	10.4	4.8	4.5	9.3	6.7	3.9	8.7	9.4	6.2	6.3	13.1	8.5	7.5	7.8	4.5	6.3	5.1	4.9	5.6	4.6	8.7	4.3	6.3	7.0	1.6	6.0	5.8	4.8	5.5	5.4	5.6	5.0	6.1	2.9	3.6	3.3	4.7	3.5	6.0	5.0	3.6	4.5	4.9	2.7	2.7	4.6	8.0	4.5	7.7	5.5	3.7	2.8	6.2	5.9	3.3	2.7	3.9	2.3	5.2	3.3	9.6	3.4	9.2	4.0	7.0	8.0	6.7	5.9	3.0	2.4	7.5	5.1	6.1	2.4	4.0	6.4	8.0	4.0	5.6	7.3	7.5	5.7	5.4	6.8	7.0	10.7	5.9	5.4	7.1	4.9	11.6	7.6	6.7	6.8	8.7	4.3	2.8	3.6	2.3	7.0	3.7	3.1	4.6	3.2	5.6	4.1	6.1	3.7	6.3	1.9	4.6	2.7	1.6	7.9	13.8	10.7	14.2	7.8	7.5	7.0	10.1	9.8	8.5	157.8	91.0	3.7	3.2	3.7	15.6	7.6	2.5	161.9	104.6	1.8	21.6	2.3	1.7	1.8	31.9	3.6	0.4	0.0	1.9	2.3	4.2	1.8	60.4	0.9	3.4	11.1	0.0	4.3	2.4	11.0	4.0	3.9	5.0	1.0	0.9	8.5	1.9	0.9	3.5	3.5	24.3	0.0	4.2	12.7	7.0	3.0	1.6	5.3	0.6	1.7
WDR11	"BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15"	ENSG00000120008	"WD repeat domain 11"	Q9BZH6	10	120851175-120909524	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038980	Approved		Approved	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA038980: AB_10675955"	"unprognostic (8.98e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.84e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.80e-3)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.38e-2)"	18.6	21.9	10.6	17.4	17.2	6.2	16.4	17.1	18.9	17.3	15.5	21.5	18.0	14.5	22.6	15.9	19.6	21.0	15.7	10.6	11.5	12.7	25.2	19.8	14.9	17.0	13.9	10.6	19.4	16.1	33.9	17.7	18.4	26.0	16.5	17.3	19.0	20.3	21.5	8.5	14.8	19.9	17.5	20.0	19.7	18.9	12.8	12.9	20.6	24.0	11.7	19.8	22.0	17.3	6.4	6.8	15.5	16.3	3.9	3.3	3.4	11.9	11.8	11.6	19.0	16.2	20.7	8.0	11.5	23.1	12.8	16.3	6.6	13.4	8.6	6.0	17.0	10.1	11.7	13.4	15.9	15.9	11.7	11.4	9.4	9.5	6.3	15.3	12.9	10.8	16.9	12.7	11.6	19.0	23.2	24.2	6.6	7.3	10.8	13.7	5.1	8.1	5.1	5.6	10.7	7.4	3.3	19.5	7.4	14.9	9.9	5.7	10.2	10.0	11.1	30.4	20.1	8.2	8.4	17.8	8.8	5.4	1.3	10.7	5.5	3.4	10.8	12.6	10.7	4.6	15.5	5.9	2.5	3.3	8.0	2.6	6.4	2.3	3.1	6.8	3.8	2.4	2.5	0.5	3.9	16.3	1.6	2.9	3.4	10.6	17.2	17.1	18.9	11.5	12.7	13.9	10.6	26.0	12.9	6.0	13.1	32.1	11.9	10.6	38.8	7.3	33.1	22.7	19.4	24.4	92.3	15.7	10.0	17.0	1.9	19.4	28.5	23.3	9.2	10.5	17.5	16.4	9.2	25.2	29.5	23.8	26.0	35.6	35.6	2.8	40.3	21.6	3.3	18.0	23.3	24.7	18.7	24.5	36.4	15.6	88.1	19.4	11.9	25.8	14.0	12.4	12.7	14.4	19.3	15.0
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874782-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	5.8	9.7	7.2	5.5	16.1	6.7	7.6	11.5	15.2	5.9	6.2	6.5	3.7	8.9	7.1	7.0	8.0	6.7	5.0	8.4	6.8	8.6	11.1	8.7	4.2	6.4	7.4	8.9	7.3	5.7	6.7	8.0	6.6	12.6	4.9	8.7	6.7	5.4	5.2	11.0	7.7	6.0	7.4	6.2	5.3	5.6	17.1	8.2	9.6	7.1	5.1	7.5	5.8	5.6	5.4	6.9	3.6	5.0	3.6	5.9	3.0	4.4	4.7	5.4	10.1	10.2	8.8	9.8	6.7	5.4	8.4	8.1	11.8	6.2	8.0	6.2	5.4	7.4	5.6	14.6	10.8	13.4	4.0	9.0	13.6	7.5	13.9	6.6	17.7	8.4	7.9	7.8	9.9	19.7	5.6	8.7	8.8	21.3	5.3	9.1	5.1	12.1	10.4	12.3	5.9	11.9	8.8	8.4	12.6	9.1	5.3	9.5	8.3	5.3	7.0	8.2	9.8	4.1	11.7	6.9	7.5	6.1	6.2	7.4	7.0	10.4	13.5	7.4	12.1	7.4	3.6	4.7	2.0	4.2	5.0	5.9	5.3	4.0	4.3	6.0	5.4	5.2	5.0	2.1	3.6	4.5	6.9	4.3	3.0	7.2	16.1	11.5	15.2	6.8	8.6	7.4	8.9	12.6	8.2	8.9	16.3	6.0	16.7	18.2	9.1	22.5	10.2	17.4	17.0	5.2	2.0	21.5	13.3	14.9	8.1	10.6	10.0	0.0	9.1	29.0	15.4	7.7	15.0	13.6	15.8	14.3	5.2	8.0	9.1	6.6	15.8	9.5	1.7	8.2	9.1	5.8	12.6	3.5	14.5	29.9	7.8	12.9	15.1	35.1	32.6	15.2	18.0	10.2	17.2	16.0
WDR13		ENSG00000101940	"WD repeat domain 13"	Q9H1Z4	X	48590042-48608867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000913	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA000913: AB_1858795"	"unprognostic (5.03e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.65e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.54e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.32e-2)"	24.5	30.4	39.9	13.9	36.9	15.7	19.1	14.4	33.9	18.6	25.5	17.6	41.5	23.0	26.0	41.2	23.1	30.8	21.1	49.8	30.2	18.9	24.2	50.2	19.3	11.1	20.0	35.8	35.0	74.7	21.8	24.4	23.9	17.0	19.6	14.4	16.5	30.4	35.8	48.5	21.7	22.0	20.2	17.5	17.4	22.7	11.0	20.5	8.6	21.9	21.1	10.5	17.9	19.7	16.8	21.1	29.2	28.2	17.3	13.8	15.9	15.0	22.0	11.0	34.1	15.2	22.4	8.5	10.4	19.0	12.1	11.1	13.0	24.1	10.4	10.0	21.3	9.8	12.9	5.5	22.8	4.3	12.4	9.7	7.1	26.0	23.6	34.7	6.1	19.5	21.2	32.6	17.2	31.6	21.3	16.6	6.1	7.0	13.4	16.8	21.6	8.4	10.8	8.0	6.5	17.4	8.1	11.7	18.9	21.4	12.0	12.8	15.9	11.8	24.6	24.1	8.1	15.7	11.9	27.4	12.6	18.8	19.9	10.0	15.6	5.7	3.8	18.7	9.2	17.3	29.2	23.1	12.7	11.9	24.7	9.5	16.8	12.6	11.3	21.1	13.4	10.0	11.4	16.0	17.3	28.2	13.3	13.8	15.9	39.9	36.9	14.4	33.9	30.2	18.9	20.0	35.8	17.0	20.5	41.7	42.0	25.3	61.2	31.1	44.1	67.8	58.6	60.2	33.0	19.2	51.1	39.7	87.9	76.1	5.1	50.7	69.1	0.0	103.3	29.1	47.2	41.1	30.0	41.4	38.7	31.8	48.5	54.6	33.6	15.2	47.8	29.6	55.6	47.7	52.9	50.7	86.4	59.6	40.7	122.9	50.2	45.3	55.3	9.7	15.3	26.1	59.2	20.8	54.6	57.8
WDR17		ENSG00000150627	"WD repeat domain 17"	Q8IZU2	4	176065834-176182818	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 15.7;Cone photoreceptor cells: 60.9;Horizontal cells: 20.6;Rod photoreceptor cells: 35.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.9;SCLC-21H: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042766, HPA054501"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA042766: AB_10806372, HPA054501: AB_2732586"	"unprognostic (3.41e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.43e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (6.04e-4)"	"unprognostic (3.66e-4)"	"unprognostic (9.25e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.24e-3)"	2.1	5.8	12.4	2.2	22.1	1.5	3.3	12.2	23.9	2.0	2.9	3.4	0.0	1.6	4.5	6.2	1.9	3.5	3.0	1.3	9.7	7.1	6.2	1.0	3.6	1.8	4.4	16.3	4.0	3.0	19.0	22.5	0.7	7.9	2.3	3.1	6.0	1.7	2.2	0.7	1.2	1.8	2.8	4.0	2.9	3.1	4.1	6.9	0.1	10.2	0.0	1.6	1.9	1.5	1.1	0.7	2.6	1.6	1.3	0.8	0.2	0.0	3.7	8.9	0.1	0.2	0.6	0.3	0.2	0.0	0.8	3.1	0.2	0.1	6.1	0.0	0.1	4.8	0.1	3.9	2.0	0.8	0.0	3.1	0.0	0.7	0.0	0.3	3.3	4.8	1.4	1.2	0.1	0.5	1.3	0.0	7.1	0.0	0.3	0.6	1.6	3.4	0.1	2.0	0.0	1.9	0.0	3.8	0.0	0.5	0.0	10.2	7.4	0.0	2.4	6.2	1.4	0.4	0.0	0.0	1.2	1.7	0.1	5.7	4.4	2.9	3.5	7.0	0.0	2.4	2.6	0.6	0.3	0.6	1.6	0.3	1.1	0.6	0.4	0.2	0.8	0.7	0.8	1.7	1.3	0.3	0.7	0.3	0.2	12.4	22.1	12.2	21.8	9.7	7.1	4.4	16.3	7.9	6.9	0.0	4.3	0.0	0.4	0.1	15.7	0.8	2.5	12.0	2.3	0.0	60.9	0.0	1.7	0.3	1.2	0.5	0.0	0.0	0.5	0.0	0.5	0.2	3.5	0.0	0.2	20.6	4.6	1.8	0.3	0.8	0.9	0.2	1.7	0.0	0.0	9.5	0.3	0.0	1.4	4.4	35.8	0.0	1.0	2.6	4.5	0.0	0.0	0.0	0.0	0.3
WDR19	"DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182404-39285810	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 41.1"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 41.5;Spermatocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;ASC TERT1: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	8.5	7.6	8.1	4.8	12.9	3.4	9.2	21.0	14.5	13.2	7.8	5.7	7.8	1.9	15.5	11.2	5.4	20.9	8.6	5.1	11.7	4.1	8.6	7.0	8.6	4.4	6.0	11.0	19.0	6.6	10.1	41.1	6.3	14.6	8.1	4.3	6.9	7.6	8.2	3.1	6.0	5.7	9.5	9.7	4.3	8.0	12.7	7.3	6.8	17.1	3.8	5.0	9.9	8.9	3.9	1.1	1.5	2.0	2.3	2.4	0.8	3.2	2.3	5.5	6.6	25.4	28.5	2.5	4.3	9.7	4.5	6.0	1.4	3.7	5.3	2.1	4.1	9.7	1.9	5.4	2.8	5.0	0.3	3.9	1.0	4.4	2.7	7.9	5.2	1.4	17.3	6.1	6.0	3.8	12.5	5.4	5.4	4.7	5.3	5.4	1.1	3.5	3.6	1.8	1.9	2.6	4.3	5.6	2.4	3.7	1.3	6.1	5.6	4.2	1.4	2.8	6.9	2.8	1.9	3.9	4.4	3.0	9.7	4.2	3.9	3.6	3.7	6.6	1.5	2.0	0.7	1.2	0.9	1.7	2.0	1.3	3.4	2.1	2.4	1.1	3.9	2.1	2.1	1.5	2.3	1.7	0.7	1.4	0.8	8.1	12.9	21.0	14.5	11.7	4.1	6.0	11.0	14.6	7.3	11.9	5.7	3.2	4.9	4.2	7.6	3.8	2.5	41.5	12.5	17.4	9.8	1.0	0.0	4.5	3.0	4.5	0.0	0.0	3.1	2.0	5.6	3.1	2.3	10.6	2.7	23.8	2.4	4.3	1.9	2.6	15.3	2.9	1.7	1.0	2.2	7.3	2.9	0.0	17.7	3.4	22.5	0.0	3.8	30.3	10.2	4.1	1.1	1.0	1.0	1.8
WDR24	"C16orf21, DKFZp434F054, JFP7"	ENSG00000127580	"WD repeat domain 24"	Q96S15	16	684622-690444	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039506	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA039506: AB_10795148"	"unprognostic (9.07e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.15e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.05e-1)"	"prognostic favorable (3.75e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	8.8	11.6	10.9	9.8	11.3	9.3	9.2	18.9	17.6	7.6	7.8	8.2	6.5	12.1	10.2	10.2	9.4	9.3	8.5	9.9	9.5	7.8	9.0	15.7	15.3	17.7	8.7	11.1	12.8	14.5	17.0	11.9	9.2	8.8	10.3	3.6	8.8	16.2	8.8	16.9	13.5	10.2	10.0	10.6	13.3	10.5	17.6	9.5	17.9	11.8	7.9	6.5	9.2	7.8	7.1	7.7	6.5	10.3	4.3	10.7	7.1	4.4	10.3	4.8	6.6	4.6	3.3	8.4	5.6	5.0	7.0	6.1	11.2	6.6	6.9	9.8	2.5	1.9	7.0	4.6	5.5	1.5	11.6	14.6	4.7	13.8	4.3	7.3	5.7	7.4	5.8	3.7	5.0	4.2	3.7	3.8	6.8	9.2	7.8	2.6	16.3	10.0	4.2	7.3	2.3	8.1	14.9	3.9	12.7	2.3	3.1	11.9	5.4	6.4	11.0	6.2	2.3	10.0	5.8	5.6	5.2	5.4	5.6	5.4	16.9	15.3	11.3	3.3	5.7	7.1	6.5	7.5	4.0	10.7	4.5	8.7	7.1	6.9	7.8	7.7	6.4	8.2	7.7	1.8	4.3	10.3	6.2	8.9	7.1	10.9	11.3	18.9	17.6	9.5	7.8	8.7	11.1	8.8	9.5	6.0	3.8	4.5	2.2	1.0	4.5	3.3	2.5	20.1	4.5	7.0	2.0	5.6	6.6	4.4	13.1	2.2	6.7	23.3	4.7	3.7	2.0	3.3	4.6	7.8	4.4	20.6	9.7	2.5	8.1	30.6	5.2	2.9	0.0	3.6	5.3	5.6	3.7	2.8	2.8	5.4	2.1	19.4	2.3	19.5	8.5	1.4	6.2	3.2	4.1	1.6
WDR25	"C14orf67, MGC4645"	ENSG00000176473	"WD repeat domain 25"	Q64LD2	14	100376418-100530303	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003113	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			Nucleoplasm		"HPA003113: AB_2215263"	"unprognostic (5.31e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.36e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.62e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.51e-2)"	6.9	10.9	10.8	5.0	13.5	7.9	9.5	14.4	14.8	15.2	8.3	11.2	5.4	6.8	11.1	9.4	7.6	14.0	7.2	7.6	10.8	9.4	7.6	9.0	7.5	6.8	8.6	13.3	11.0	16.2	7.7	13.4	7.2	9.4	9.2	5.7	10.9	11.9	9.7	11.4	6.1	5.8	7.3	7.5	6.8	8.4	15.0	11.3	6.4	17.3	4.4	6.6	7.4	6.6	9.9	11.9	19.5	13.9	4.2	10.8	10.0	3.3	5.9	4.1	15.2	6.7	6.3	3.4	6.2	9.9	7.2	7.3	2.7	6.3	4.8	7.8	5.1	2.0	6.0	3.9	7.6	3.8	4.7	2.8	3.2	6.7	4.6	12.3	3.7	3.7	9.4	9.0	5.2	7.9	6.3	5.2	5.8	3.9	7.1	4.7	12.7	5.5	4.2	3.2	4.0	10.5	4.0	5.8	3.3	5.5	2.7	9.7	10.2	5.0	1.9	8.3	4.1	7.0	1.3	8.8	2.7	3.2	10.6	3.5	4.8	2.4	2.4	9.6	2.8	5.2	19.5	13.9	19.5	7.5	11.8	7.8	9.9	10.0	8.0	11.9	7.2	10.8	7.9	7.3	4.2	12.4	9.2	9.7	10.0	10.8	13.5	14.4	14.8	10.8	9.4	8.6	13.3	9.4	11.3	0.0	5.4	3.4	3.8	2.9	8.0	2.0	0.0	9.4	3.4	3.5	9.8	7.2	8.3	9.6	8.2	6.7	5.9	0.0	29.6	4.1	6.6	2.6	3.5	7.2	5.9	4.8	5.2	5.5	4.4	4.2	6.4	3.5	5.0	5.4	6.1	12.1	13.6	3.5	10.6	13.5	15.2	12.9	8.0	10.9	15.2	2.6	5.8	5.3	6.8	1.8
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385143-224437033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.9"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 178.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	8.2	7.2	6.7	6.7	6.7	18.5	7.2	8.2	7.3	7.8	7.0	6.7	6.7	4.0	6.8	9.3	13.0	5.9	7.0	7.5	6.7	5.0	6.7	9.3	9.0	7.2	6.7	6.7	7.0	6.9	9.2	6.7	8.7	6.7	7.0	6.7	6.7	7.2	6.7	15.2	9.9	6.7	7.1	6.7	10.2	6.3	63.9	6.7	6.7	7.0	6.7	7.4	6.7	8.3	1.5	2.1	8.3	3.9	2.7	2.7	1.3	11.9	6.2	19.3	8.9	25.8	29.4	13.9	17.6	28.8	16.1	15.2	9.8	13.6	14.2	17.7	28.3	6.2	10.9	11.3	15.1	26.5	11.1	12.9	9.8	8.1	9.2	28.1	10.2	17.2	27.3	21.9	17.0	16.1	26.7	26.8	8.7	12.9	14.7	21.1	6.6	10.5	9.9	18.6	12.4	7.2	9.7	20.2	11.2	19.6	12.1	7.0	17.9	20.0	27.1	21.5	21.1	31.1	16.8	28.1	13.8	6.3	12.9	21.1	15.7	7.5	9.7	15.7	7.3	17.0	4.1	1.9	3.3	2.7	2.4	1.5	1.5	1.9	2.1	1.8	1.4	1.4	2.1	8.3	2.7	3.9	2.1	1.6	1.3	6.7	6.7	8.2	6.7	6.7	5.0	6.7	6.7	6.7	6.7	98.3	43.8	19.4	25.3	99.0	23.8	42.4	45.9	41.5	50.0	33.2	29.5	23.4	5.0	19.2	178.7	37.6	21.6	0.0	20.3	11.8	51.5	39.3	46.2	31.0	44.5	36.5	34.0	44.2	119.9	79.7	34.2	49.8	43.9	12.6	40.3	16.9	26.6	25.9	26.5	17.0	22.9	19.4	41.9	36.4	24.6	107.0	57.1	31.6	23.8	59.3
WDR31	FLJ35921	ENSG00000148225	"WD repeat domain 31"	Q8NA23	9	113313222-113340298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 54.9;Ciliated cells: 34.8;Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019340, HPA019347"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA019340: AB_1858800, HPA019347: AB_2215267"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-3)"	"prognostic favorable (1.85e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.90e-9)"	"unprognostic (9.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-3)"	"unprognostic (8.50e-2)"	2.2	6.8	4.1	1.0	8.2	1.5	4.7	1.7	5.5	3.2	2.4	4.0	8.8	1.5	4.5	3.3	2.4	6.3	2.3	8.9	3.3	4.1	5.6	3.1	2.3	0.9	3.5	2.7	3.7	3.0	16.6	11.2	1.0	4.0	3.4	2.2	5.8	10.2	7.5	1.3	2.5	1.1	2.2	3.6	0.8	2.1	7.3	1.7	3.8	7.1	1.4	0.8	3.0	2.0	1.6	0.9	4.4	1.0	2.3	1.4	0.8	5.5	4.2	1.5	3.0	5.1	5.9	1.4	1.4	2.7	1.4	1.7	0.7	3.6	2.1	1.0	2.1	4.1	3.7	1.2	2.7	2.7	3.3	0.3	1.7	2.2	0.7	5.8	0.9	0.3	3.1	3.6	5.8	5.2	4.0	1.1	3.3	4.5	1.9	1.5	3.8	2.4	1.4	0.9	5.3	5.3	2.1	1.3	2.6	3.7	1.2	3.6	2.7	6.7	1.2	3.2	1.2	8.8	0.9	0.6	2.0	2.2	5.0	1.5	4.0	3.8	0.5	3.0	1.4	1.9	4.4	1.0	1.0	0.9	0.6	0.8	0.9	1.0	0.8	0.8	1.6	1.4	1.3	3.4	2.3	0.7	0.9	0.7	0.8	4.1	8.2	1.7	5.5	3.3	4.1	3.5	2.7	4.0	1.7	6.0	8.0	0.0	4.6	4.7	4.5	54.9	5.1	34.8	12.5	1.8	27.5	0.3	5.0	1.4	23.9	1.5	0.3	0.0	0.2	0.2	1.7	3.4	4.7	2.6	0.7	6.4	0.0	0.6	1.2	21.5	1.7	2.0	0.0	0.0	1.5	7.2	1.2	0.0	1.4	4.8	40.9	0.0	2.3	22.7	8.7	3.8	0.2	0.0	2.3	2.4
WDR34	"bA216B9.3, DIC5, FAP133, MGC20486"	ENSG00000119333	"WD repeat domain 34"	Q96EX3	9	128633661-128656787	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 159.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 19.1;naive B-cell: 25.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 25.3"	"Cell line enhanced"	"Detected in all"		"MCF7: 89.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040764, HPA041091"	Approved		Approved	Cytosol		NA	Yes			Cytosol		"HPA040764: AB_10795625, HPA041091: AB_10796237"	"unprognostic (1.45e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.01e-5)"	"unprognostic (2.27e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (8.79e-4)"	"unprognostic (6.04e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.65e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-1)"	6.3	23.0	8.2	16.9	9.0	23.4	21.3	4.2	12.3	12.6	13.6	7.4	24.1	17.3	11.4	19.9	17.3	24.4	24.2	13.6	8.0	9.1	23.6	16.0	14.4	9.1	5.6	8.0	13.1	23.9	14.8	18.2	15.1	14.2	14.5	8.3	11.2	21.6	24.1	7.3	12.3	14.3	9.2	6.2	11.6	16.1	51.0	7.1	42.1	33.1	17.8	13.7	8.6	11.2	25.3	5.6	0.9	2.5	2.0	2.8	1.9	23.2	42.1	11.4	16.6	2.5	3.7	33.5	10.3	6.8	14.1	9.0	20.7	42.3	8.8	7.1	6.2	13.3	38.9	9.9	10.7	3.5	20.0	8.9	5.6	29.9	10.5	3.1	8.8	9.0	1.7	5.4	14.1	4.0	5.2	9.6	24.2	17.3	7.4	7.4	89.2	31.9	22.6	14.0	19.7	26.2	34.5	14.4	28.8	8.8	7.7	27.5	22.3	31.2	28.7	7.5	3.1	49.2	8.6	6.2	17.2	25.6	20.6	19.2	8.6	21.0	8.2	15.4	8.8	15.6	0.9	0.5	0.2	0.8	0.8	1.2	19.1	1.5	2.1	1.4	25.3	0.6	0.9	0.4	2.0	2.5	5.6	2.8	1.9	8.2	9.0	4.2	12.3	8.0	9.1	5.6	8.0	14.2	7.1	44.7	36.9	20.1	22.9	11.9	2.1	18.2	53.5	68.3	44.3	33.2	0.0	49.8	69.6	49.2	78.8	9.8	97.6	23.3	49.4	74.8	25.8	19.9	14.9	50.3	18.9	3.2	54.1	14.1	3.8	159.5	19.0	5.3	21.9	2.8	42.2	17.0	36.8	31.3	18.7	64.3	11.3	12.9	11.7	106.6	71.8	10.2	31.2	7.2	46.6	15.9
WDR37	KIAA0982	ENSG00000047056	"WD repeat domain 37"	Q9Y2I8	10	1049538-1132297	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 168.7;Late spermatids: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037376, HPA037565"	Enhanced		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA037376: AB_10672789, HPA037565: AB_10696937"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.75e-5)"	"unprognostic (2.59e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.62e-2)"	"prognostic favorable (1.46e-6)"	"unprognostic (3.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (5.98e-2)"	10.6	17.4	26.3	11.4	24.2	24.5	10.4	19.4	35.4	7.4	9.2	11.8	10.1	9.8	9.4	12.1	9.9	9.3	8.3	22.1	25.7	14.1	9.7	10.7	10.9	14.6	12.0	29.5	12.4	11.4	12.1	16.3	8.8	16.0	9.5	9.0	10.6	8.9	7.6	21.9	14.9	11.9	8.9	11.7	23.3	11.6	23.3	16.8	7.1	12.8	8.1	12.5	7.7	8.5	7.3	6.7	7.5	8.6	14.0	14.1	6.3	9.4	6.8	8.9	7.3	8.6	12.5	6.8	12.2	6.5	7.3	7.3	8.7	8.2	5.1	7.7	15.4	1.5	9.3	4.7	13.8	6.4	6.9	8.5	11.4	6.7	5.8	6.2	6.9	13.1	15.9	10.6	10.4	3.8	8.9	16.2	9.7	7.7	5.6	11.6	8.3	7.1	5.2	5.1	7.2	4.4	11.5	5.3	8.0	10.2	10.2	4.2	8.8	5.7	10.4	9.3	7.1	9.9	13.5	21.6	6.0	2.3	19.4	9.5	12.6	10.5	6.7	13.7	7.6	4.3	7.5	6.3	4.7	14.1	8.5	12.0	7.3	8.1	10.4	6.7	6.7	9.1	10.3	6.0	14.0	8.6	6.3	6.8	6.3	26.3	24.2	19.4	35.4	25.7	14.1	12.0	29.5	16.0	16.8	3.0	7.2	6.2	10.5	11.8	14.2	22.2	0.0	2.7	7.9	10.4	11.8	5.3	0.0	4.0	168.7	9.6	5.6	0.0	5.2	3.5	5.5	10.7	11.5	6.7	8.0	7.9	10.3	31.9	20.6	73.7	11.5	12.1	15.1	3.6	8.4	6.1	6.4	7.6	17.0	3.3	14.2	6.5	9.5	11.6	15.8	10.8	9.5	10.2	5.7	11.6
WDR38		ENSG00000136918	"WD repeat domain 38"	Q5JTN6	9	124853417-124857890	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"fallopian tube: 51.4"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 83.0;Early spermatids: 23.2;Late spermatids: 80.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 12.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;HDLM-2: 3.0;HeLa: 2.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA056607			Approved	Vesicles		NA	NA			Vesicles		"HPA056607: AB_2683188"	"unprognostic (5.66e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-5)"	"unprognostic (1.01e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.42e-2)"	0.2	0.2	2.0	0.2	3.1	0.2	0.2	0.2	0.5	2.9	0.2	10.6	0.0	0.2	0.7	11.9	0.2	51.4	0.2	0.3	2.8	3.3	0.2	0.2	10.8	0.2	0.3	0.4	6.0	0.2	0.2	1.0	0.2	8.8	0.2	0.2	0.0	0.2	0.3	0.3	0.3	0.2	0.3	0.7	0.2	0.2	7.0	1.3	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.3	0.5	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.1	0.4	2.5	0.1	0.1	0.3	1.1	0.1	0.2	0.0	0.0	3.0	0.3	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.7	0.1	0.3	0.6	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.7	0.0	0.2	1.3	0.0	0.0	0.0	0.5	0.5	0.2	0.4	0.5	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.1	0.2	0.5	2.8	3.3	0.3	0.4	8.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	83.0	9.1	0.0	0.0	0.0	0.0	0.2	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	80.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0
WDR4	"TRM82, TRMT82"	ENSG00000160193	"WD repeat domain 4"	P57081	21	42843094-42879568	"Predicted intracellular proteins"	"DNA damage, tRNA processing"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017381	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA017381: AB_1858807"	"unprognostic (3.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.48e-7)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.46e-2)"	9.1	9.3	8.4	14.2	8.4	12.1	7.5	9.3	11.1	7.6	7.2	6.7	6.5	10.7	12.5	5.1	17.4	8.2	8.1	6.1	8.3	4.9	7.3	12.2	7.8	18.2	8.9	8.4	9.7	22.0	6.9	8.4	8.9	8.5	7.0	7.0	6.8	11.8	8.4	13.1	10.2	7.5	7.4	6.6	11.7	7.3	10.9	9.6	10.1	9.3	11.3	17.0	8.5	11.1	7.5	9.1	0.2	8.8	4.4	5.5	4.4	14.6	20.6	5.5	7.8	3.3	3.6	13.4	8.5	3.1	7.2	4.7	20.6	7.6	24.5	5.0	6.0	10.5	8.1	19.1	10.8	5.1	7.8	18.2	24.6	21.5	17.3	5.9	15.1	6.1	2.0	4.7	9.8	7.2	2.6	9.4	8.8	29.6	9.1	6.3	12.2	15.5	8.6	13.8	11.0	20.2	17.1	3.3	24.2	5.4	9.0	13.1	8.4	8.9	13.3	4.2	1.9	8.7	11.7	6.9	11.2	7.4	5.1	17.0	12.5	8.7	19.8	5.4	24.1	13.1	0.0	5.4	0.2	3.5	8.8	4.7	7.5	4.7	4.3	9.1	7.2	4.8	4.9	0.0	4.4	5.0	4.4	5.5	4.4	8.4	8.4	9.3	11.1	8.3	4.9	8.9	8.4	8.5	9.6	0.0	4.5	6.0	7.4	7.6	3.4	2.0	0.0	1.4	1.2	0.0	2.0	14.1	0.0	6.4	2.9	4.9	3.3	0.0	5.7	17.8	3.8	5.6	10.3	6.4	11.5	3.2	5.2	3.7	1.8	2.5	2.6	4.8	6.8	1.8	3.6	2.4	6.8	0.0	2.8	5.7	4.0	6.5	6.2	9.7	9.1	9.5	9.6	3.8	7.0	8.8
WDR41	FLJ10904	ENSG00000164253	"WD repeat domain 41"	Q9HAD4	5	77425970-77620611	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043124	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA043124: AB_10793990"	"unprognostic (1.81e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.15e-3)"	"unprognostic (6.11e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.90e-3)"	16.2	12.8	18.8	13.1	21.7	17.3	16.2	19.5	23.3	15.1	12.6	17.7	9.4	9.4	13.3	13.3	20.6	17.5	12.2	16.9	18.8	17.5	15.8	14.8	14.0	13.9	21.4	20.0	9.4	21.3	14.4	15.8	11.4	28.9	12.0	13.8	11.5	13.7	12.0	19.7	12.8	11.2	19.2	23.3	12.5	11.5	26.6	19.8	8.1	23.1	12.9	16.6	13.5	13.6	8.9	24.8	24.0	18.1	15.8	5.7	7.3	6.8	11.8	16.6	24.2	17.3	24.8	13.0	21.8	23.6	10.3	19.2	10.7	11.5	20.8	10.1	20.6	17.8	8.9	12.4	29.8	11.1	25.0	14.2	8.3	13.8	9.2	26.5	17.5	20.7	15.7	38.4	11.7	25.5	11.4	16.5	11.8	8.2	22.7	16.8	14.7	9.2	11.3	6.1	6.9	4.7	22.2	22.7	14.6	11.3	5.8	9.7	11.9	18.6	11.7	18.1	20.8	11.7	22.0	14.4	14.0	11.4	7.6	15.9	20.7	16.8	37.2	19.2	7.9	23.3	11.4	14.0	24.0	5.7	16.3	5.5	8.9	3.4	5.1	24.8	5.4	2.3	4.2	6.8	15.8	18.1	11.1	2.6	7.3	18.8	21.7	19.5	23.3	18.8	17.5	21.4	20.0	28.9	19.8	35.7	10.5	11.5	21.9	10.6	34.7	14.7	12.7	20.1	9.1	17.4	19.6	7.4	31.5	19.8	146.0	11.7	3.5	0.0	18.1	22.6	22.6	18.9	15.1	11.1	24.0	22.3	5.8	8.0	22.7	78.8	8.9	25.0	16.9	8.2	7.6	12.9	15.9	5.8	7.8	14.0	16.3	6.5	18.7	46.9	43.9	12.4	5.3	17.3	10.3	21.6
WDR45B	"WDR45L, WIPI3"	ENSG00000141580	"WD repeat domain 45B"	Q5MNZ6	17	82614562-82648553	"Predicted intracellular proteins"	Autophagy		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 316.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017886			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA017886: AB_1858810"	"unprognostic (1.91e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.23e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.93e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.02e-1)"	25.4	31.0	37.1	17.2	39.0	38.7	38.9	30.3	38.1	27.4	23.5	35.3	19.9	21.8	25.6	24.9	39.9	32.7	29.5	29.4	36.6	29.2	26.6	22.9	23.5	26.6	38.2	28.5	32.8	35.6	29.9	24.2	19.6	39.2	26.6	21.2	18.8	32.6	23.8	20.9	28.4	25.0	29.3	53.3	19.3	29.5	47.7	39.1	6.8	26.5	23.3	23.5	23.3	24.8	10.0	15.6	22.1	19.3	8.9	12.6	11.9	29.2	20.1	17.0	15.5	15.7	14.6	20.2	21.9	24.7	35.9	30.8	24.0	15.6	8.4	13.7	19.5	22.9	16.3	16.3	18.6	33.1	5.3	32.4	17.1	11.5	18.6	20.7	13.5	13.1	15.8	19.6	19.1	18.0	15.5	28.9	11.3	12.7	7.9	20.0	18.8	9.6	9.2	21.7	23.5	26.8	10.5	30.7	8.6	19.4	29.3	22.1	32.6	21.6	22.2	25.6	20.8	26.4	10.3	19.7	37.3	29.3	26.2	39.0	20.4	8.7	12.4	24.3	13.6	27.3	16.5	19.3	22.1	12.3	19.2	12.6	10.0	9.7	10.4	15.6	9.9	8.7	7.9	16.2	8.9	14.8	8.0	7.6	11.9	37.1	39.0	30.3	38.1	36.6	29.2	38.2	28.5	39.2	39.1	29.8	45.5	39.3	40.6	53.1	35.0	17.3	63.7	66.9	76.2	40.1	11.8	45.7	74.6	105.9	126.0	49.0	65.0	0.0	119.7	62.3	43.4	67.1	71.6	61.8	40.3	42.9	45.5	45.4	49.5	316.4	52.9	44.0	54.0	54.1	58.5	56.9	135.0	52.0	45.3	50.9	30.8	32.3	51.5	70.5	153.1	63.2	90.4	39.5	52.5	79.5
WDR47	KIAA0893	ENSG00000085433	"WD repeat domain 47"	O94967	1	108970214-109042113	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.6"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 83.1;Suprabasal keratinocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027287, HPA027289"	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Actin filaments"	Nucleoplasm	"HPA027287: AB_10599416, HPA027289: AB_10601862"	"unprognostic (8.55e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.05e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.39e-3)"	"unprognostic (7.90e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.09e-2)"	7.1	7.2	17.7	5.1	24.0	10.1	6.4	19.9	42.6	8.0	5.6	9.5	3.4	3.7	9.4	5.8	13.7	8.4	7.1	7.5	20.1	20.6	7.5	3.6	6.7	5.0	14.8	21.0	7.6	5.6	10.4	4.4	6.3	24.8	7.3	5.4	5.8	4.7	7.2	14.2	20.3	4.1	9.8	12.7	5.3	5.6	19.9	11.3	5.5	6.1	4.8	7.0	6.8	6.3	3.5	5.6	18.8	5.0	2.2	4.6	2.0	10.8	3.3	6.3	8.0	12.6	11.1	3.4	12.4	7.6	8.3	9.3	3.2	1.6	4.9	6.7	11.8	6.1	12.2	9.0	5.4	10.9	9.0	5.0	4.1	7.3	3.6	7.2	6.3	6.1	6.8	9.1	12.9	6.3	10.1	9.8	5.8	2.4	6.9	14.1	6.4	6.1	5.0	2.7	3.5	6.6	8.7	16.2	2.7	13.8	9.4	11.3	10.2	10.8	5.8	8.6	7.1	2.7	6.5	16.7	11.1	5.1	19.3	10.1	4.4	3.6	4.0	12.9	6.3	16.4	11.4	4.7	5.8	3.2	5.0	2.8	2.0	2.9	3.4	5.1	3.5	2.6	2.2	18.8	2.2	4.5	5.6	4.6	2.0	17.7	24.0	19.9	32.4	20.1	20.6	14.8	21.0	24.8	11.3	11.9	9.2	1.9	4.3	83.1	15.1	17.6	12.7	18.7	10.3	7.0	43.2	2.1	5.0	2.7	24.9	11.7	2.4	0.0	0.8	1.6	6.1	2.2	2.3	1.7	3.9	11.1	2.9	4.9	5.6	30.9	7.8	8.6	23.6	5.4	1.0	12.6	3.3	0.0	14.2	4.8	31.5	6.5	17.6	25.7	26.2	91.2	4.1	4.3	1.7	3.3
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 21.6;fallopian tube: 20.7"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 50.9;Club cells: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2"	"Group enriched"	"Detected in many"	24	"dendritic cells: 5.2;monocytes: 5.6"	"Cell line enhanced"	"Detected in some"		"AF22: 3.4;NTERA-2: 3.8;THP-1: 17.1;U-937: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA036225: AB_10696652, HPA036226: AB_2675007"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.5	0.7	6.5	1.1	6.8	3.6	0.6	12.6	5.0	1.2	0.9	8.5	0.0	3.9	1.2	4.4	2.1	20.7	0.7	4.7	12.3	5.4	1.0	0.4	4.0	0.9	7.6	2.8	3.2	0.9	0.4	1.7	0.4	21.6	0.7	0.6	0.0	0.7	0.4	0.4	0.5	8.0	0.7	17.6	1.1	0.8	1.5	14.2	0.0	0.5	0.0	1.0	0.8	0.6	0.2	5.2	0.0	5.6	0.0	0.0	0.7	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	5.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	6.5	6.8	12.6	3.7	12.3	5.4	7.6	2.8	21.6	14.2	0.0	1.1	0.0	0.8	0.0	0.0	1.0	0.0	50.9	18.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.0"	"Group enriched"	"Detected in many"	6	"Early spermatids: 232.6;Late spermatids: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	4.3	4.3	5.9	6.8	6.9	7.2	5.2	6.4	5.9	4.0	4.2	4.5	7.1	2.1	4.9	6.6	5.1	3.9	3.5	4.0	4.8	3.8	4.0	5.4	3.8	5.5	5.9	4.3	4.3	3.3	7.5	11.9	4.4	6.1	4.1	4.1	4.8	4.0	4.5	6.8	6.7	4.5	4.1	5.0	6.2	4.0	48.0	4.6	7.4	4.2	3.2	6.5	3.9	4.2	7.5	5.9	13.9	6.7	6.5	14.9	4.9	19.1	4.1	7.4	6.6	7.6	6.6	11.9	10.1	7.9	11.5	10.9	11.2	10.2	9.1	34.1	6.1	10.6	11.2	9.3	8.7	14.4	14.3	8.1	9.2	10.1	7.3	9.5	12.9	7.6	5.4	12.8	10.2	11.2	5.7	8.9	11.6	8.9	17.6	8.7	17.8	10.9	13.2	10.1	12.2	12.0	13.1	12.7	19.4	6.3	6.7	7.3	8.0	7.0	10.5	14.8	10.4	27.0	12.1	8.3	9.8	9.2	10.9	19.7	15.0	30.0	27.2	6.5	16.6	9.8	9.6	5.1	13.9	8.6	4.4	14.0	7.5	12.3	8.7	4.1	7.1	10.3	6.2	4.4	6.5	6.7	5.9	14.9	4.9	5.9	6.9	6.4	5.9	4.8	3.8	5.9	4.3	6.1	4.6	0.0	3.2	0.8	2.8	3.8	3.1	2.7	2.5	1.4	4.5	3.5	0.0	4.7	5.0	4.2	232.6	5.2	1.0	0.0	3.7	5.5	2.8	2.3	9.2	2.4	3.9	3.2	0.0	3.1	4.5	86.7	4.6	5.0	5.0	8.2	1.5	3.6	2.6	1.9	3.2	3.5	2.3	19.4	6.2	27.9	13.1	4.1	3.9	5.7	2.3	2.3
WDR54	FLJ12953	ENSG00000005448	"WD repeat domain 54"	Q9H977	2	74421678-74425755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 56.8"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 297.1;Spermatocytes: 180.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043257, HPA053558"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043257: AB_10795981, HPA053558: AB_2682189"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.85e-2)"	4.8	6.3	9.4	5.4	17.0	5.0	4.8	8.4	15.4	7.0	3.9	6.0	10.5	3.0	7.0	7.8	3.1	56.8	7.2	3.4	9.9	11.6	7.9	1.4	8.1	8.6	4.8	13.0	8.4	5.4	21.3	16.0	5.4	7.8	5.0	3.7	10.5	3.9	9.0	1.5	3.5	3.9	6.8	3.5	7.7	5.7	27.6	3.7	20.6	5.8	2.5	8.9	6.2	4.0	12.6	23.1	2.3	5.3	13.2	18.7	10.0	15.8	29.5	14.5	12.6	5.2	9.8	4.5	8.1	16.8	21.4	19.9	2.4	12.6	14.2	8.5	9.1	13.1	13.7	10.2	36.4	18.8	10.6	6.2	6.9	16.3	1.6	5.4	10.9	5.7	4.4	10.3	21.7	11.3	25.2	11.1	22.5	2.8	16.8	11.7	24.7	17.1	11.5	11.1	3.8	11.2	14.8	16.3	29.6	18.8	8.0	25.3	19.6	6.4	5.8	9.4	4.4	9.4	5.2	5.5	11.0	19.3	11.8	18.1	18.3	9.2	3.6	32.4	6.6	7.9	2.3	4.2	0.3	16.2	5.3	16.3	12.6	18.7	17.4	14.1	11.1	13.2	12.8	0.3	13.2	4.5	23.1	17.5	10.0	9.4	17.0	8.4	15.4	9.9	11.6	4.8	13.0	7.8	3.7	3.0	13.8	25.3	15.6	6.3	45.6	1.3	20.4	297.1	38.7	22.7	78.5	8.0	16.6	23.9	56.6	23.3	0.5	0.0	5.4	8.0	13.4	11.9	12.7	0.8	7.7	30.2	27.7	27.0	8.6	82.2	15.8	7.8	11.8	44.1	4.5	45.6	11.0	1.7	20.8	19.6	99.9	0.0	18.9	180.1	17.7	4.3	2.4	29.9	4.0	9.5
WDR59	FLJ12270	ENSG00000103091	"WD repeat domain 59"	Q6PJI9	16	74871367-75000173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041084, HPA048218"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041084: AB_10793867, HPA048218: AB_2680318"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.16e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (8.83e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.21e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.61e-2)"	10.1	16.8	24.2	13.5	27.4	14.7	15.2	29.0	27.6	14.4	13.6	23.8	17.4	13.7	19.9	23.4	15.2	14.9	13.7	16.2	22.3	17.6	17.5	31.3	11.5	12.3	24.7	19.1	23.3	15.1	30.3	28.7	17.9	22.9	15.0	15.4	13.6	15.5	14.5	22.9	21.9	15.9	16.2	19.7	15.0	14.5	14.0	30.6	17.7	22.4	7.3	16.2	13.0	15.0	3.5	1.6	1.5	1.6	2.0	7.6	1.0	8.2	12.7	14.8	14.1	11.7	10.6	12.6	5.3	9.2	11.4	13.1	17.1	14.6	11.5	5.8	9.8	10.7	13.3	11.7	12.6	16.3	6.9	12.5	14.8	8.2	27.6	7.1	10.6	18.0	12.2	10.3	13.7	13.2	14.7	11.7	28.4	21.7	5.8	5.4	24.2	16.3	19.1	11.8	18.0	5.2	16.4	6.5	9.5	12.3	7.4	9.1	10.0	15.1	8.8	6.7	16.4	13.3	9.4	10.1	7.1	11.0	8.1	4.5	11.1	15.0	25.2	12.6	7.5	7.7	1.3	1.5	1.4	2.4	0.8	7.6	3.5	4.2	3.4	0.9	2.6	2.8	3.1	1.5	2.0	1.6	1.6	1.9	1.0	24.2	27.4	29.0	27.6	22.3	17.6	24.7	19.1	22.9	30.6	14.9	13.9	15.2	16.6	19.9	38.3	14.9	25.5	20.1	15.9	21.0	58.9	29.8	8.3	11.4	31.1	10.5	13.6	0.0	8.4	15.3	12.7	14.4	12.7	21.2	9.3	19.1	21.2	18.4	13.0	58.8	12.4	11.8	8.5	15.4	11.8	13.3	10.6	14.0	11.0	16.8	51.1	19.4	8.2	15.6	15.2	21.1	39.6	10.7	14.0	21.7
WDR6		ENSG00000178252	"WD repeat domain 6"	Q9NNW5	3	49007062-49015953	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042622	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA042622: AB_10966784"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.94e-2)"	"prognostic favorable (4.52e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	15.8	36.7	21.5	26.1	23.5	14.9	19.7	29.9	29.9	32.7	31.0	30.8	56.4	27.5	39.0	37.0	18.7	33.1	32.6	20.4	20.1	20.4	26.0	22.0	21.1	28.2	22.8	26.9	60.9	46.0	56.7	55.8	24.3	22.1	39.0	22.1	34.3	33.4	54.4	23.9	26.6	28.3	40.8	17.5	29.1	24.7	23.7	22.1	26.9	50.7	20.3	25.1	31.2	24.6	12.3	14.4	10.3	12.9	11.7	18.9	12.0	17.6	24.3	40.2	34.1	27.0	22.1	27.2	26.3	21.7	29.8	24.2	21.5	25.6	28.3	16.8	41.9	22.9	20.1	32.1	36.8	21.3	22.5	21.3	26.8	59.6	28.4	27.4	27.7	12.1	39.6	26.5	27.5	20.8	41.4	21.7	30.2	15.2	30.4	26.9	35.0	32.1	31.6	35.7	16.1	22.6	18.8	17.2	17.8	35.3	52.4	19.6	36.7	19.7	16.2	11.4	30.7	28.2	22.2	28.9	22.2	35.7	21.5	34.9	53.6	22.9	24.6	30.1	35.5	15.9	3.7	9.1	10.3	16.9	12.9	18.9	12.0	12.5	12.9	11.3	12.3	14.7	10.9	3.4	11.7	6.5	14.4	10.5	12.0	21.5	23.5	29.9	29.9	20.1	20.4	22.8	26.9	22.1	22.1	20.8	44.0	22.5	20.1	15.9	23.5	2.0	28.1	22.7	38.7	45.4	45.2	35.1	8.3	25.4	3.7	17.3	21.2	0.0	22.4	17.9	19.9	24.4	27.8	38.0	22.8	35.0	69.4	23.9	14.5	4.2	35.4	16.4	11.8	20.8	31.0	44.4	24.7	21.0	26.5	25.9	45.7	25.8	16.9	22.3	17.6	9.9	47.3	24.1	30.2	15.3
WDR60	"FAP163, FLJ10300"	ENSG00000126870	"WD repeat domain 60"	Q8WVS4	7	158856578-158956747	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 401.8;Rod photoreceptor cells: 217.0;Spermatocytes: 279.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020607, HPA021316"	Approved		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA020607: AB_1858817, HPA021316: AB_2215577"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	14.5	9.5	19.0	7.7	18.0	6.0	11.2	18.0	22.8	12.1	13.7	9.8	8.6	10.9	11.4	15.3	8.2	17.3	8.7	17.4	15.9	8.7	10.3	4.9	10.4	6.1	9.0	16.7	12.2	7.3	19.9	24.5	8.3	13.7	8.4	7.7	8.0	9.5	9.1	33.5	7.9	11.7	9.2	12.4	8.7	9.4	44.3	14.2	7.0	13.1	4.9	4.5	12.4	9.0	12.9	24.1	18.6	5.0	5.5	8.0	1.3	10.3	10.4	7.4	17.6	5.8	5.6	3.3	6.5	5.9	5.4	5.9	5.0	9.5	4.1	10.3	4.0	6.6	4.9	3.4	7.0	6.1	4.4	6.8	5.5	6.4	2.2	5.8	6.2	12.8	4.6	5.3	4.2	1.8	12.9	4.4	3.0	16.3	2.3	6.3	6.1	10.3	5.7	6.4	3.9	6.8	9.3	7.4	5.0	9.2	5.3	14.8	10.5	13.3	8.1	7.6	6.7	5.9	3.9	5.4	6.8	2.4	22.1	4.8	6.2	6.6	8.9	18.6	6.1	10.1	18.6	5.0	2.5	8.0	3.1	7.2	10.2	6.2	6.6	3.0	12.9	6.0	6.2	3.1	5.5	3.2	24.1	2.8	1.3	19.0	18.0	18.0	22.8	15.9	8.7	9.0	16.7	13.7	14.2	23.8	36.3	9.3	15.4	17.3	71.4	70.2	10.2	198.1	54.6	45.4	155.1	14.0	24.9	22.0	401.8	45.0	49.0	0.0	12.1	9.5	23.7	13.6	11.6	11.3	7.0	82.6	30.5	17.2	11.8	138.6	55.3	12.9	21.9	9.0	28.1	49.5	14.2	22.8	55.9	18.1	217.0	51.8	38.1	279.9	49.8	13.7	9.6	14.6	23.0	9.7
WDR7	"KIAA0541, TRAG"	ENSG00000091157	"WD repeat domain 7"	Q9Y4E6	18	56651343-57036606	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 29.5;Rod photoreceptor cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042074, HPA051057"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042074: AB_2677833, HPA051057: AB_2732563"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (4.80e-2)"	"unprognostic (4.52e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	8.0	11.3	14.2	7.9	21.2	9.1	6.8	16.7	34.0	7.5	7.7	11.9	6.1	6.0	7.1	8.1	6.6	6.4	7.7	8.8	17.3	17.9	7.9	10.4	7.2	9.5	14.4	16.4	6.6	6.2	15.6	19.0	6.9	21.1	11.1	7.4	7.9	6.1	8.8	10.5	5.7	6.1	8.3	12.5	8.3	6.9	6.2	12.1	13.2	13.1	4.0	8.2	7.4	6.3	4.5	6.3	9.2	8.7	7.4	9.0	3.2	3.9	6.6	7.6	4.2	12.0	7.0	1.9	7.8	6.7	6.5	7.7	2.6	2.5	10.9	3.1	7.0	5.5	4.2	7.6	6.1	8.1	12.6	4.6	10.3	5.4	2.4	7.2	15.4	13.1	5.9	5.1	8.6	5.8	5.4	8.0	5.2	4.9	15.1	8.0	3.8	10.6	4.6	3.2	2.0	4.4	4.8	5.8	5.3	4.9	7.1	9.9	4.9	5.6	2.7	3.6	6.7	4.2	4.4	7.0	9.3	4.7	2.8	4.2	15.2	11.3	11.9	7.6	7.8	6.2	7.2	5.0	9.2	6.6	7.6	8.2	4.4	7.5	6.7	6.3	4.5	7.9	7.2	4.6	7.4	8.7	3.0	9.0	3.2	14.2	21.2	16.7	23.7	17.3	17.9	14.4	16.4	21.1	12.1	3.0	4.5	3.7	1.4	2.6	22.0	11.0	7.6	5.3	10.3	0.0	29.5	1.6	3.3	2.6	13.5	6.7	3.6	0.0	3.1	1.0	3.0	3.7	10.4	6.2	5.2	25.4	8.1	8.6	19.1	4.3	5.2	6.4	0.0	4.6	2.7	7.4	2.7	2.9	7.8	3.1	26.3	6.5	3.8	1.9	1.5	2.0	0.6	4.3	3.5	1.4
WDR70	FLJ10233	ENSG00000082068	"WD repeat domain 70"	Q9NW82	5	37379212-37753435	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043064, HPA048149"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA043064: , HPA048149: AB_2680287"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.11e-2)"	17.5	13.4	15.4	21.9	22.8	16.3	17.7	30.9	21.1	15.7	16.3	12.0	16.9	10.4	19.6	13.5	15.0	15.6	10.0	13.0	15.8	8.7	11.2	11.8	13.0	18.8	16.2	13.0	18.6	13.9	12.6	14.4	14.0	17.9	13.2	14.3	7.9	15.6	14.4	36.3	17.2	13.3	16.2	18.3	14.0	13.9	12.7	16.5	13.9	13.2	8.4	15.1	17.4	15.7	12.7	15.8	12.6	17.5	11.1	10.3	7.1	9.2	6.1	12.2	15.3	12.4	12.2	16.6	11.8	11.1	13.6	11.6	10.0	9.6	15.1	7.0	11.4	10.6	8.6	10.1	10.8	15.3	14.4	12.6	11.4	18.7	7.0	9.3	19.1	10.2	11.7	8.3	10.4	14.5	10.5	11.2	11.4	14.2	6.3	8.5	6.2	12.3	9.4	8.4	7.4	10.9	14.2	30.5	15.4	6.9	11.1	10.5	9.9	39.1	8.7	8.5	9.7	11.4	12.1	12.8	12.5	12.0	12.1	9.3	8.4	12.5	17.5	8.3	17.1	10.3	6.2	14.5	12.6	8.8	17.5	9.7	11.4	10.3	9.5	15.3	12.7	10.2	9.8	3.5	11.1	15.8	15.8	9.8	7.1	15.4	22.8	30.9	21.1	15.8	8.7	16.2	13.0	17.9	16.5	29.8	26.1	27.6	11.3	8.1	35.4	17.3	12.7	30.8	12.5	8.7	35.3	21.8	16.6	16.0	16.9	15.5	15.1	0.0	18.0	22.3	13.1	6.6	19.6	20.9	16.6	23.8	13.3	18.4	24.4	5.4	27.3	19.8	11.8	21.6	20.9	20.1	14.0	17.5	21.2	10.3	56.8	12.9	11.7	31.2	27.5	6.8	18.5	20.2	23.2	8.6
WDR72	FLJ38736	ENSG00000166415	"WD repeat domain 72"	Q3MJ13	15	53513741-53762878	"Disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 64.1;thyroid gland: 36.3"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 21.0;Hepatocytes: 38.9;Proximal tubular cells: 75.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.1;OE19: 14.9;RPMI-8226: 13.9;RPTEC TERT1: 9.1;SuSa: 13.6;U-266/70: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048212, HPA057410, HPA059819"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133"	"unprognostic (6.39e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (3.33e-16)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (7.67e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.7	0.2	0.1	3.0	0.8	0.6	4.9	0.3	0.8	4.6	0.2	0.1	0.1	64.1	13.1	0.8	0.1	0.1	0.1	0.5	1.3	1.5	0.9	0.8	0.1	0.2	0.1	0.3	11.2	0.4	0.1	1.1	0.6	0.1	0.1	0.1	0.2	1.1	0.1	0.1	36.3	0.4	0.5	0.6	0.1	0.2	0.0	0.1	0.0	0.2	0.8	0.1	0.0	8.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	2.6	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.9	14.9	0.1	0.0	0.1	13.9	9.1	2.9	1.6	0.0	0.0	0.1	0.0	13.6	2.0	0.0	0.1	0.3	0.4	0.0	0.1	6.4	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.2	0.3	0.5	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	6.0	5.1	0.0	0.8	0.1	0.4	0.4	7.6	0.0	0.0	21.0	0.0	0.3	8.3	1.0	0.9	0.0	0.0	0.0	0.5	1.0	0.2	0.2	0.0	38.9	0.1	3.2	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	75.4	0.0	0.0	0.0	1.1	0.9	0.4	0.1	0.0	0.3	4.9
WDR74	FLJ10439	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.4"	"Group enriched"	"Detected in many"	4	"Club cells: 168.4;Early spermatids: 612.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	14.2	13.2	12.6	19.7	13.8	77.4	14.2	14.6	21.5	12.5	12.5	10.9	8.7	10.8	14.1	10.2	16.1	15.1	12.8	12.6	12.2	11.9	15.5	19.7	10.0	18.1	15.4	16.5	17.4	20.6	9.4	8.0	11.9	13.6	12.5	11.2	8.0	16.5	9.8	42.1	19.8	10.6	11.5	9.5	18.0	13.4	23.5	16.6	16.0	20.0	19.1	16.0	12.4	14.0	39.1	44.8	15.9	34.8	26.8	16.7	11.9	16.4	19.8	7.7	12.8	6.4	8.8	24.0	9.2	10.0	20.1	13.4	28.9	20.2	28.9	26.3	7.6	16.2	22.0	23.7	18.4	15.8	18.4	17.5	14.6	21.8	25.0	18.8	28.9	9.6	8.5	20.7	12.8	42.6	6.6	9.8	21.1	31.8	8.6	9.1	31.6	27.6	46.0	31.5	18.9	26.3	28.2	13.3	50.4	14.2	9.4	17.2	19.4	10.7	22.0	29.7	7.8	15.5	22.4	7.0	11.8	14.2	26.3	23.1	21.4	29.7	35.1	13.0	17.7	15.3	8.7	34.8	3.2	11.7	16.9	14.7	18.6	12.1	11.0	29.2	39.1	16.7	14.8	15.9	26.8	11.3	44.8	13.7	11.9	12.6	13.8	14.6	21.5	12.2	11.9	15.4	16.5	13.6	16.6	35.7	64.8	46.3	33.6	92.8	13.9	1.4	33.1	44.2	168.4	15.7	15.7	47.5	36.5	39.1	612.8	32.3	22.2	0.0	34.8	40.2	35.6	20.1	41.7	28.4	34.0	3.2	39.4	17.8	30.3	74.1	30.5	38.9	28.7	18.0	28.7	13.4	36.2	26.6	20.1	37.0	11.0	19.4	37.3	14.7	27.4	95.5	29.1	57.9	38.1	31.5
WDR75	"FLJ12519, NET16, UTP17"	ENSG00000115368	"WD repeat domain 75"	Q8IWA0	2	189441433-189475565	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038199			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038199: AB_10674548"	"unprognostic (1.23e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.50e-8)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.15e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-2)"	24.8	23.8	15.4	20.7	20.4	17.7	25.5	25.5	25.6	26.8	16.4	16.1	18.4	15.1	25.5	27.3	20.1	21.7	15.6	14.9	16.5	17.0	21.6	18.5	13.7	25.2	20.0	17.5	28.9	22.4	19.0	21.7	17.5	20.7	18.5	19.5	13.9	15.4	14.5	16.7	22.6	17.4	20.9	23.6	24.1	17.6	18.2	24.2	28.9	15.5	25.3	24.0	24.8	19.2	8.1	9.9	3.3	7.8	7.8	13.7	5.6	13.2	12.8	16.2	20.3	17.8	18.9	20.2	28.3	12.5	31.0	24.1	27.0	14.5	29.2	16.0	8.5	12.2	18.9	31.0	18.3	30.5	19.2	14.5	39.0	23.4	19.9	16.8	42.1	19.1	15.6	15.4	22.2	31.2	13.0	20.3	16.2	37.9	16.6	20.5	14.3	19.5	28.1	39.2	15.2	35.3	18.5	26.5	22.8	15.1	16.6	15.9	16.2	18.0	16.2	14.1	27.8	15.0	17.7	19.3	18.3	20.3	14.2	20.5	18.4	29.5	35.7	13.1	19.2	15.5	1.3	5.2	3.3	8.0	7.8	13.7	8.1	8.2	10.5	9.9	6.8	10.8	9.5	0.0	7.8	5.0	5.4	10.4	5.6	15.4	20.4	25.5	25.6	16.5	17.0	20.0	17.5	20.7	24.2	26.8	13.1	8.1	18.3	15.0	6.0	15.4	2.5	10.7	7.9	1.8	7.9	16.5	10.0	12.6	1.4	13.1	5.1	0.0	14.5	13.3	11.8	6.5	4.7	7.8	9.4	15.9	8.6	9.8	30.6	2.1	16.7	8.6	13.5	4.6	10.6	4.4	13.8	8.6	14.9	11.0	8.8	19.4	15.5	28.4	27.9	9.8	14.4	13.1	10.4	14.7
WDR76	FLJ12973	ENSG00000092470	"WD repeat domain 76"	Q9H967	15	43826963-43868419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 37.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatogonia: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039804, HPA040626"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear bodies"		NA	Yes			"Nuclear bodies"	"Nucleoli fibrillar center"	"HPA039804: AB_10795297, HPA040626: AB_10795527"	"unprognostic (2.26e-1)"	"unprognostic (7.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (6.98e-4)"	"prognostic unfavorable (8.02e-5)"	"unprognostic (4.24e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (1.35e-8)"	"unprognostic (7.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.28e-2)"	5.4	1.8	2.4	21.9	3.0	17.5	4.8	12.9	6.0	5.3	6.3	1.5	1.6	3.6	4.9	3.6	8.2	3.3	2.1	2.5	2.4	2.0	2.8	2.5	5.1	19.8	2.4	2.1	4.2	4.8	3.9	3.3	4.3	3.3	4.2	6.8	4.5	4.6	2.4	1.4	6.3	5.8	7.0	3.9	6.5	4.8	6.7	2.1	37.2	2.9	7.1	21.9	5.3	5.5	3.2	1.6	0.4	0.8	5.7	8.3	2.6	11.1	5.7	13.6	10.4	1.5	3.7	3.7	18.8	11.2	20.6	26.0	7.2	5.9	16.5	8.3	8.7	10.4	16.2	14.0	6.7	18.0	25.6	8.3	20.3	18.2	2.3	0.8	20.6	9.1	1.1	1.1	11.3	2.6	3.0	6.5	17.9	15.3	28.9	14.1	3.9	19.9	4.8	4.8	3.5	5.9	21.4	23.4	10.4	3.8	11.6	10.5	10.4	11.8	7.5	2.3	4.4	11.6	10.0	2.9	19.0	9.0	21.2	19.0	14.3	35.6	42.1	13.6	18.3	10.4	0.0	0.8	0.4	5.1	0.5	5.4	2.5	6.4	4.4	1.3	3.2	5.2	4.1	0.0	5.7	0.2	1.6	8.3	2.6	2.4	3.0	12.9	6.0	2.4	2.0	2.4	2.1	3.3	2.1	3.0	2.2	6.0	3.1	6.5	2.0	1.2	0.0	0.0	3.4	1.8	9.8	5.5	1.7	2.0	1.5	3.5	0.8	0.0	3.5	11.4	2.5	1.6	5.7	0.4	7.5	1.6	0.0	3.1	3.3	0.6	1.7	3.1	3.3	3.6	2.2	7.3	0.9	1.5	2.1	0.6	15.7	6.5	5.3	8.7	44.7	5.1	3.0	10.9	5.6	1.3
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 68.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	11.2	16.5	10.0	17.3	16.2	5.9	9.7	8.5	18.1	9.8	10.9	14.3	5.7	9.5	13.9	15.7	19.0	68.6	15.7	16.6	9.9	10.8	13.6	19.2	9.9	16.8	12.1	9.6	14.6	14.0	15.1	11.7	12.1	15.8	12.6	16.6	10.3	16.4	13.4	27.2	8.9	11.1	13.0	7.9	16.5	14.5	12.9	9.3	19.3	9.9	23.2	22.7	19.1	11.0	24.9	25.7	6.2	17.7	26.7	16.1	11.9	20.7	18.2	17.4	14.3	10.5	6.1	24.2	15.7	8.4	24.1	15.9	26.7	7.8	35.4	15.4	13.3	15.6	15.1	31.4	30.1	29.2	14.0	24.6	21.1	21.3	38.4	11.8	21.6	36.1	7.5	21.6	23.6	15.2	6.4	16.0	15.8	28.1	9.4	23.2	26.2	27.7	11.3	34.2	19.5	30.5	27.7	27.4	13.5	21.4	36.8	14.4	10.5	13.8	17.4	12.5	23.3	14.0	14.9	11.6	13.4	26.9	25.9	33.3	7.8	9.8	31.8	16.9	24.3	39.1	6.2	11.6	2.9	13.9	17.7	15.5	24.9	15.1	15.5	25.7	21.6	16.1	15.0	1.7	26.7	15.5	16.1	12.5	11.9	10.0	16.2	8.5	18.1	9.9	10.8	12.1	9.6	15.8	9.3	11.9	10.7	30.3	21.0	18.4	11.9	21.5	12.7	37.5	9.1	17.4	23.6	49.7	21.6	29.8	2.7	9.8	7.4	0.0	11.8	45.7	9.9	13.5	15.1	13.4	41.0	7.9	15.1	8.0	19.6	2.7	6.9	17.8	5.0	10.8	16.5	8.4	20.0	7.0	8.5	24.4	9.2	12.9	13.1	12.3	22.6	16.2	38.1	17.5	21.3	22.3
WDR81	"CAMRQ2, FLJ33817, PPP1R166, SORF-2"	ENSG00000167716	"WD repeat domain 81"	Q562E7	17	1716523-1738599	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023044, HPA063703"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA023044: AB_1858822, HPA063703: "	"unprognostic (1.00e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.90e-3)"	"unprognostic (6.10e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.60e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (3.26e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.90e-2)"	12.7	12.2	8.9	12.1	8.4	10.7	22.9	7.0	11.7	12.6	9.1	10.5	26.4	11.3	14.9	11.6	7.4	12.8	9.3	9.0	8.4	4.3	9.6	22.7	17.2	21.4	9.2	4.4	18.5	8.3	3.5	9.9	8.9	8.5	11.9	4.6	10.6	10.1	21.8	13.1	16.7	12.7	11.6	5.0	19.0	8.4	6.3	8.2	17.3	8.1	5.2	10.3	11.6	16.2	2.8	6.9	5.1	5.0	4.2	3.0	1.9	0.5	10.8	1.5	7.3	10.5	5.8	8.0	0.6	0.1	0.4	0.0	1.4	4.0	4.2	5.8	4.3	5.6	10.2	5.3	7.2	0.3	7.9	11.3	0.1	7.4	4.9	18.0	3.4	6.6	14.5	7.4	5.2	3.2	2.1	4.0	3.4	0.3	5.4	6.0	5.2	1.1	5.8	3.4	3.2	7.6	5.5	2.5	5.6	3.0	1.5	2.1	4.6	3.9	3.3	12.6	0.1	4.9	5.0	6.0	4.2	5.0	6.7	5.5	0.4	0.9	2.4	6.5	5.5	2.9	0.0	3.1	5.1	2.6	5.0	3.0	2.8	2.7	2.6	3.8	2.3	1.8	2.4	0.6	4.2	4.3	6.9	2.4	1.9	8.9	8.4	7.0	11.7	8.4	4.3	9.2	4.4	8.5	8.2	11.9	9.3	4.7	2.5	2.3	4.7	2.6	5.1	4.0	3.4	0.0	3.9	2.1	1.7	2.5	0.5	2.9	5.9	0.0	3.8	1.7	3.1	2.4	4.6	20.9	20.3	4.8	1.2	5.5	17.2	0.4	15.3	9.1	0.0	5.4	4.0	2.8	4.7	3.4	14.2	11.1	1.7	19.4	2.0	0.5	1.5	1.5	1.9	2.9	3.5	1.3
WDR83	MORG1	ENSG00000123154	"WD repeat domain 83"	Q9BRX9	19	12666800-12675832	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042629, HPA042838"	Uncertain		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA042629: AB_10794763, HPA042838: AB_10794173"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.56e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (3.12e-4)"	6.4	7.8	10.2	6.2	9.1	8.8	6.5	17.2	14.5	7.1	5.2	9.1	2.3	4.9	5.8	6.1	5.9	11.3	5.2	9.2	8.5	8.9	8.1	5.9	6.0	8.3	12.4	11.6	9.2	11.6	9.4	6.7	4.9	9.1	6.9	2.6	7.7	14.6	6.9	4.6	11.3	6.3	3.8	7.0	7.4	7.1	9.2	10.6	11.7	9.2	2.6	5.8	6.0	5.7	8.8	19.4	5.4	11.1	17.6	11.3	8.6	4.9	8.3	4.7	6.5	9.3	3.5	3.8	4.7	4.4	5.7	6.0	9.6	4.3	7.5	6.9	4.2	3.2	5.6	5.5	7.3	1.0	7.6	12.2	5.9	5.5	6.0	7.4	8.2	7.0	6.4	5.9	4.6	3.8	3.8	5.7	16.3	5.2	0.8	2.6	18.8	11.9	6.7	3.8	5.8	14.4	8.5	6.1	7.0	5.4	5.9	9.9	6.6	5.1	7.0	4.1	2.7	3.9	8.1	3.1	6.4	2.0	5.1	4.9	19.1	12.8	3.3	10.0	6.3	4.1	4.5	11.1	4.6	9.2	9.6	10.7	8.1	8.9	8.6	11.1	8.8	8.7	11.3	5.4	17.6	4.7	19.4	9.8	8.6	10.2	9.1	17.2	14.5	8.5	8.9	12.4	11.6	9.1	10.6	0.0	15.6	12.6	11.4	13.7	20.5	4.2	12.7	10.7	7.9	17.4	11.8	11.1	14.9	13.6	13.8	10.5	9.3	0.0	15.2	11.6	11.0	13.4	13.9	7.2	11.5	19.1	9.2	9.2	11.6	43.7	14.7	14.8	15.1	18.0	6.7	15.0	11.1	5.9	17.0	22.6	20.4	19.4	13.2	25.0	16.9	14.1	7.6	16.2	8.1	12.2
WDR83OS	"C19orf56, PTD008"	ENSG00000105583	"WD repeat domain 83 opposite strand"	Q9Y284	19	12668071-12671356	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065685	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065685: AB_2685531"	"unprognostic (1.73e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (4.17e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	43.7	59.8	39.3	29.4	39.4	48.7	64.6	25.3	42.7	51.2	52.0	37.1	53.0	29.7	43.3	84.9	60.6	68.2	66.6	53.2	35.1	35.9	54.2	70.2	49.5	47.7	38.6	29.1	69.6	104.0	33.0	45.8	64.6	27.4	60.0	45.4	35.4	69.7	55.7	56.3	46.7	53.3	51.3	42.2	40.9	41.2	43.3	30.1	30.7	84.8	60.3	49.0	45.1	61.8	87.0	94.2	99.3	101.3	84.2	77.9	107.6	29.6	28.6	36.1	40.7	47.1	38.9	15.6	22.0	28.2	25.9	22.5	24.7	25.9	11.8	51.5	50.3	23.4	23.7	32.8	33.9	22.2	27.8	48.0	15.4	28.3	39.8	36.6	26.8	24.9	39.5	43.9	28.0	33.3	49.8	33.7	25.5	27.3	30.7	33.0	95.1	20.1	64.9	30.2	39.0	83.6	17.1	18.1	47.0	31.7	33.6	29.4	46.1	24.3	26.1	30.5	24.8	32.0	47.8	23.6	46.8	13.1	51.2	32.1	55.4	62.6	18.5	40.3	46.4	30.2	98.0	101.3	96.1	70.3	92.3	65.9	87.0	67.4	71.9	94.2	79.1	62.0	68.8	99.3	84.2	95.4	64.6	77.9	107.6	39.3	39.4	25.3	42.7	35.1	35.9	38.6	29.1	27.4	30.1	74.5	37.5	152.6	167.3	152.5	39.0	119.0	183.4	42.8	61.4	324.5	25.5	375.2	339.8	234.8	5.0	170.5	280.3	46.7	221.1	281.1	204.6	188.6	147.4	250.1	254.1	47.7	187.6	164.5	230.9	14.5	157.9	197.6	281.7	241.7	209.3	164.9	220.3	245.4	136.2	435.1	44.1	97.0	189.6	99.3	110.7	193.5	338.8	153.0	222.7	198.5
WDR88	PQWD	ENSG00000166359	"WD repeat domain 88"	Q6ZMY6	19	33132090-33175795	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 25.2"	"Group enriched"	"Detected in some"	15	"Early spermatids: 24.8;Late spermatids: 9.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 6.4"					"Not detected"	"Not detected"			"HPA041916, HPA050336"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA041916: AB_10804121, HPA050336: AB_2681093"	"unprognostic (1.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.33e-4)"	"unprognostic (5.14e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.67e-2)"	0.3	0.5	0.4	1.1	0.6	1.0	0.3	0.7	1.4	0.3	0.3	0.3	0.3	0.7	0.3	0.3	0.7	0.2	0.6	1.2	0.4	0.4	0.3	0.3	0.3	1.6	0.3	0.3	1.0	1.0	0.0	0.5	0.3	0.3	0.3	0.0	0.3	1.1	0.3	0.3	0.9	0.9	0.3	0.3	0.6	0.3	25.2	0.3	0.3	1.4	0.3	0.3	0.3	0.3	1.2	0.6	0.6	1.3	2.9	1.4	0.3	1.0	2.2	1.5	2.7	0.8	0.0	2.0	0.8	0.0	0.2	0.0	1.1	2.2	2.7	1.4	0.0	1.6	0.8	0.0	0.3	0.0	5.5	0.8	2.5	1.7	0.5	0.0	1.9	2.2	0.0	0.0	0.0	0.0	0.6	0.0	6.4	1.7	2.8	0.0	3.2	1.1	1.2	1.1	0.9	0.9	2.1	0.8	0.5	0.0	1.3	3.9	3.9	2.7	1.2	0.6	1.9	3.4	2.0	1.5	0.7	2.1	1.2	0.4	2.6	1.8	1.5	0.4	4.2	1.1	0.0	0.4	0.4	1.4	1.3	1.3	0.0	1.2	1.0	0.3	1.2	0.8	0.7	0.6	2.9	0.6	0.6	0.2	0.3	0.4	0.6	0.7	0.8	0.4	0.4	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	0.0
WDR89	"C14orf150, MGC9907"	ENSG00000140006	"WD repeat domain 89"	Q96FK6	14	63597039-63641861	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000813	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA000813: AB_1078324"	"prognostic favorable (3.37e-4)"	"unprognostic (6.46e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.29e-1)"	13.2	12.6	11.5	11.6	13.4	4.6	13.7	19.3	18.8	12.5	10.3	9.5	7.4	8.0	14.6	11.5	10.5	11.9	8.6	8.1	11.0	10.7	14.8	16.1	9.1	17.8	15.7	11.6	15.0	14.0	16.2	16.3	12.9	12.3	12.0	12.1	8.3	8.7	8.4	13.2	10.8	8.9	10.5	11.8	13.8	8.5	8.6	14.4	21.0	16.9	7.6	17.0	11.6	10.2	7.0	4.3	0.6	3.6	8.4	14.0	4.9	25.1	11.0	13.7	7.3	8.3	9.0	19.6	10.2	5.6	10.3	11.5	7.8	11.9	24.5	8.4	3.0	7.1	11.7	16.7	9.9	18.3	15.8	9.6	16.6	6.9	9.7	10.5	21.1	11.5	8.2	12.8	11.8	17.7	6.4	10.0	18.2	13.5	13.6	7.7	12.6	17.6	12.0	12.3	18.0	21.9	13.0	13.9	13.7	11.4	9.7	11.7	9.6	10.9	11.7	7.7	13.8	13.5	11.5	6.8	12.5	11.8	8.1	12.1	7.9	5.8	15.0	5.6	15.5	8.8	0.0	2.5	0.3	8.2	2.5	10.5	7.0	8.7	7.5	4.3	6.9	14.0	12.1	0.6	8.4	3.6	2.8	8.7	4.9	11.5	13.4	19.3	18.8	11.0	10.7	15.7	11.6	12.3	14.4	8.9	4.1	4.5	10.0	8.7	6.6	4.0	5.1	1.4	9.1	5.2	3.9	9.1	11.6	6.2	2.2	5.8	2.6	0.0	4.8	11.5	4.5	6.4	1.1	7.8	5.6	1.6	3.5	6.2	6.0	3.6	4.0	4.0	3.3	3.6	4.2	6.5	3.2	0.0	6.0	6.2	8.2	12.9	4.3	6.2	12.6	9.5	5.8	5.2	5.0	5.5
WDR90	"C16orf15, C16orf16, C16orf17, C16orf18, C16orf19, FLJ36483, KIAA1924"	ENSG00000161996	"WD repeat domain 90"	Q96KV7	16	649311-667833	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 38.8;Rod photoreceptor cells: 35.4;Spermatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA049362, HPA061785"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049362: AB_2680728, HPA061785: AB_2684606"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.89e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.55e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.84e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.48e-2)"	4.5	10.5	5.9	8.7	8.0	14.2	6.5	11.1	6.6	11.2	6.5	7.7	11.5	8.5	15.6	12.5	5.9	13.8	10.3	4.2	5.1	4.1	8.9	5.5	6.1	5.4	4.3	3.8	13.4	10.3	7.0	16.7	6.9	6.8	8.5	3.5	11.4	7.9	8.9	3.2	13.5	7.4	6.8	4.6	4.3	8.4	34.3	6.2	9.8	13.4	9.1	7.9	5.0	6.1	3.3	1.9	0.0	0.8	0.0	1.7	0.8	5.6	7.9	4.5	10.8	1.7	1.1	0.3	4.2	1.6	3.1	3.7	10.3	8.0	4.9	3.3	1.3	0.1	12.5	2.2	3.4	0.7	8.3	7.8	1.6	28.3	9.3	0.5	8.8	7.8	2.3	2.8	6.3	1.4	1.1	2.2	7.8	0.5	12.6	1.3	4.1	6.8	8.3	4.4	4.7	2.6	19.3	1.7	8.1	3.4	5.3	8.5	8.9	3.9	8.0	0.8	0.3	16.5	7.2	2.4	7.7	7.7	8.3	5.4	12.8	5.5	5.2	2.2	4.7	4.9	0.0	0.1	0.0	0.3	0.8	0.0	3.3	0.5	1.7	0.2	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.8	5.9	8.0	11.1	6.6	5.1	4.1	4.3	3.8	6.8	6.2	0.0	7.8	0.0	2.9	3.1	8.1	2.8	22.9	38.8	7.9	8.7	13.7	2.5	0.0	4.5	4.4	4.2	2.9	0.0	3.2	2.2	3.3	2.6	0.0	4.7	2.3	11.1	1.2	1.8	1.2	3.6	5.8	1.7	3.3	0.0	6.7	7.6	3.7	2.9	4.2	1.1	35.4	6.5	3.1	37.0	21.3	1.9	2.1	0.7	7.2	1.6
WDR92	"FLJ31741, Monad"	ENSG00000243667	"WD repeat domain 92"	Q96MX6	2	68122936-68157560	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 48.2;Cone photoreceptor cells: 45.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035335, HPA035336"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035335: AB_10959456, HPA035336: AB_10964348"	"unprognostic (3.55e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.61e-1)"	"unprognostic (3.56e-3)"	"unprognostic (9.86e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.15e-2)"	9.5	12.4	16.6	12.8	26.5	5.2	12.3	19.8	17.3	9.2	10.0	12.3	6.5	9.2	11.1	23.7	10.5	16.2	7.8	12.7	12.2	10.7	8.7	9.8	8.3	12.9	8.7	7.9	11.3	13.5	15.8	17.1	8.2	15.0	12.2	11.9	10.9	10.8	12.4	15.4	14.9	8.6	16.2	9.5	11.1	9.2	12.8	12.3	10.2	12.9	12.2	12.1	10.1	10.2	8.8	7.9	1.9	4.1	9.0	8.5	4.8	14.4	10.3	11.6	11.9	13.3	13.9	10.4	13.2	9.1	11.3	11.8	8.0	12.3	17.9	4.7	9.0	15.9	14.7	12.0	8.1	14.5	11.8	14.5	17.2	12.7	8.0	6.7	19.1	5.2	8.7	10.5	9.4	8.2	12.2	11.0	14.1	13.0	10.8	12.6	9.1	12.5	16.7	12.2	13.4	12.3	14.9	16.0	13.9	11.3	8.2	12.9	10.9	8.6	15.2	11.4	12.1	11.8	12.0	13.7	18.0	8.1	11.5	11.4	7.6	11.1	11.7	18.8	18.8	9.2	0.7	3.9	1.9	5.7	4.1	7.7	8.8	6.1	6.3	4.6	8.5	8.0	8.5	1.6	9.0	2.7	7.9	5.9	4.8	16.6	26.5	19.8	17.3	12.2	10.7	8.7	7.9	15.0	12.3	3.0	7.5	12.4	4.4	3.1	22.3	3.1	0.0	48.2	13.6	5.2	45.2	11.9	1.7	6.6	4.7	5.8	1.0	23.3	5.7	7.3	5.3	2.5	12.7	5.0	6.2	11.1	0.0	3.7	1.6	2.2	7.2	4.0	1.7	5.4	3.0	10.1	5.1	3.5	8.9	6.3	21.5	6.5	4.1	27.1	14.3	3.6	4.2	4.1	7.3	1.7
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235793-159286799	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: AB_2683628"	"unprognostic (1.37e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	10.3	14.2	9.7	6.6	12.7	10.9	14.8	18.9	14.0	10.3	8.5	8.9	10.6	5.8	9.8	22.1	11.1	11.8	9.9	11.5	9.7	10.6	27.7	8.2	10.7	16.1	11.5	7.0	16.4	15.5	19.4	23.8	15.7	9.2	11.3	9.2	16.0	11.8	8.7	7.7	8.2	7.7	9.9	9.5	10.5	9.0	7.7	10.2	8.5	22.2	6.1	9.2	10.0	15.0	9.8	10.3	2.8	9.3	16.2	13.0	6.2	6.1	4.6	4.2	6.6	7.6	8.8	14.2	4.8	9.5	8.8	15.5	9.9	10.0	8.2	5.1	7.2	15.1	3.7	11.7	4.4	12.4	3.2	9.7	8.4	5.3	10.0	9.3	7.1	11.7	5.1	16.4	10.8	8.9	16.9	7.2	10.9	11.1	6.2	8.3	6.3	5.1	13.2	5.7	10.4	9.9	8.0	6.2	4.4	10.1	8.9	7.8	5.1	5.0	6.5	11.2	20.4	5.0	12.6	3.0	6.3	4.6	8.8	4.6	3.2	5.3	7.6	11.1	8.9	3.9	2.7	9.3	2.8	13.0	7.0	9.8	9.8	5.2	8.1	10.3	8.9	6.3	7.4	0.6	16.2	6.3	9.7	2.6	6.2	9.7	12.7	18.9	14.0	9.7	10.6	11.5	7.0	9.2	10.2	11.9	5.0	6.7	7.4	4.7	6.4	10.7	10.2	17.4	9.1	19.2	2.0	20.1	29.9	7.2	3.0	6.6	5.1	0.0	3.1	7.7	8.8	6.6	11.5	1.7	15.4	4.8	5.2	6.2	13.9	2.1	11.8	9.5	5.0	3.6	5.5	6.0	4.7	9.0	10.6	17.4	8.9	0.0	7.1	10.5	20.2	5.5	19.2	10.1	7.0	5.1
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234516-27308633	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	14.7	17.5	20.2	11.1	22.0	13.2	12.1	21.8	28.4	15.0	15.3	20.7	14.1	13.3	14.5	9.1	12.4	21.1	11.0	29.1	18.0	15.0	13.6	13.0	14.3	13.3	15.8	16.1	15.8	22.3	49.3	12.3	10.9	19.7	14.3	10.1	29.6	20.6	16.5	51.1	20.9	14.2	12.8	15.1	13.2	15.2	28.3	16.5	21.0	19.4	12.1	14.0	15.0	12.3	1.3	1.5	5.6	0.8	0.8	3.3	1.2	13.0	5.7	9.3	0.9	13.3	11.1	3.9	8.1	13.6	8.7	10.6	1.9	13.2	11.1	9.8	16.1	6.5	6.8	8.7	12.3	7.5	15.3	15.0	11.5	6.6	5.2	12.0	5.9	15.6	10.5	20.2	10.8	9.9	15.9	11.8	3.7	11.7	11.9	9.1	7.2	9.6	14.5	4.4	8.7	12.5	4.8	7.0	12.3	10.2	2.9	13.7	11.8	10.5	4.5	9.5	7.3	6.7	10.4	10.0	7.1	4.4	10.1	3.9	17.2	9.2	5.4	14.6	11.4	8.5	0.3	0.5	5.6	3.3	0.8	1.3	1.3	0.8	1.4	1.5	0.8	0.6	1.5	4.8	0.8	0.6	1.0	0.9	1.2	20.2	22.0	21.8	28.4	18.0	15.0	15.8	16.1	19.7	16.5	8.9	12.5	5.1	9.7	11.4	24.2	12.2	7.6	6.7	5.7	29.6	51.1	10.4	8.3	13.9	22.7	7.1	16.7	0.0	12.2	4.0	7.2	12.5	1.1	15.5	11.3	20.6	16.0	17.8	18.9	50.8	15.8	9.7	10.1	14.4	19.3	16.1	13.2	5.8	15.6	14.3	68.8	6.5	8.1	34.9	5.7	15.2	13.7	13.8	15.5	12.8
WDYHV1	"C8orf32, FLJ10204"	ENSG00000156795	"WDYHV motif containing 1"	Q96HA8	8	123416725-123467230	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.8"	"Low region specificity"	"Detected in all"							"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: AB_2682228"	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	10.5	15.5	13.2	7.9	13.6	6.3	17.2	14.3	16.8	14.5	9.9	13.9	10.7	5.8	11.2	12.0	10.2	9.8	8.8	24.8	12.8	19.8	13.6	9.1	8.6	11.4	17.0	10.8	20.4	21.3	9.0	12.8	8.2	16.2	13.5	9.5	9.7	8.3	12.5	19.2	9.8	5.4	13.0	17.0	7.9	10.0	17.5	15.6	5.3	14.4	9.1	11.3	10.1	9.1	5.9	7.2	8.7	7.5	13.1	9.2	5.5	9.1	10.8	12.7	6.7	5.5	12.6	5.7	7.6	6.7	7.2	9.2	6.4	6.1	7.3	6.9	5.3	10.2	5.3	8.1	8.8	9.7	17.2	7.1	7.9	5.2	8.7	7.7	3.0	3.4	8.5	5.4	9.6	11.8	9.3	7.2	13.8	5.9	10.1	10.6	28.5	8.8	6.2	5.1	21.2	7.4	5.1	8.0	5.8	9.6	8.1	6.5	14.1	7.8	39.8	12.1	14.3	6.6	3.3	3.9	9.6	15.1	7.1	9.2	7.6	15.4	9.0	7.8	4.6	6.0	8.7	6.3	2.5	7.8	7.5	8.4	5.2	8.4	7.3	7.2	5.9	6.5	7.4	1.8	13.1	4.0	4.6	9.2	5.5	13.2	13.6	14.3	16.8	12.8	19.8	17.0	10.8	16.2	15.6	3.0	6.7	12.0	8.7	6.6	5.4	16.2	7.6	1.4	5.7	14.0	2.0	10.4	33.2	10.5	7.6	8.2	3.3	0.0	13.2	18.4	7.7	13.3	8.1	4.2	12.0	4.8	0.0	10.4	9.5	11.5	8.1	7.2	10.1	9.0	6.2	6.0	10.4	9.1	11.0	11.2	7.2	12.9	11.3	20.6	28.7	7.9	8.4	4.3	8.8	8.7
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573681-9593457	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 165.0;Suprabasal keratinocytes: 167.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004619, HPA068845"	Approved		Approved	Nucleoli		No	No			Nucleoli		"CAB004619: AB_628447, HPA068845: AB_2686048"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	6.9	3.5	2.0	26.1	2.1	6.6	27.4	5.3	1.6	12.8	18.0	2.5	15.4	3.7	21.9	14.3	22.1	12.4	20.2	23.0	2.0	2.2	6.8	19.3	10.2	10.9	1.8	1.2	11.1	4.4	4.9	6.1	42.7	4.7	17.0	4.7	5.9	12.8	17.8	12.0	33.3	10.4	22.9	2.4	8.0	12.5	28.3	2.0	35.9	12.0	26.8	26.4	19.8	14.7	8.5	0.1	6.4	0.0	2.1	7.8	0.6	14.4	5.6	21.5	11.9	18.9	9.5	42.6	17.9	13.8	10.0	10.0	10.2	17.8	33.9	6.7	7.8	9.4	17.5	14.7	6.9	12.8	12.1	12.0	13.3	9.0	6.8	2.0	20.1	13.3	3.1	7.5	4.7	16.6	10.4	6.2	13.2	21.6	23.6	17.4	3.4	20.5	10.9	32.4	10.0	6.4	19.8	16.9	7.3	7.9	30.5	8.1	10.6	12.1	14.3	8.7	26.8	9.0	9.6	7.1	18.1	12.6	7.3	14.2	5.5	16.5	44.8	7.7	11.1	12.6	0.0	0.0	6.4	2.0	0.0	0.2	8.5	2.0	3.3	0.1	3.6	0.1	1.6	0.1	2.1	0.0	0.1	7.8	0.6	2.0	2.1	5.3	1.6	2.0	2.2	1.8	1.2	4.7	2.0	47.6	26.9	13.5	165.0	156.6	1.8	53.3	66.2	49.5	56.9	40.1	0.0	78.4	11.6	22.0	18.2	13.0	34.2	23.3	11.8	154.6	38.6	75.9	6.9	86.3	14.7	1.6	58.5	9.2	1.6	29.5	10.9	8.4	16.9	2.8	32.0	9.3	20.6	25.7	10.3	6.7	4.4	6.5	22.1	42.6	52.9	167.1	114.8	13.1	37.4	55.3
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 132.4;monocytes: 161.5;T-cells: 221.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 45.4;HMC-1: 37.8;Karpas-707: 65.4;U-266/70: 52.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		290000	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300"	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	20.6	7.3	10.5	47.0	14.4	23.2	21.6	2.1	9.2	17.1	16.5	20.2	6.6	8.7	14.3	11.4	10.3	9.8	17.2	12.0	14.6	10.5	9.0	7.8	22.6	55.7	21.1	5.6	8.7	4.7	5.7	4.2	15.6	10.9	10.6	10.7	10.5	10.5	11.7	4.0	7.3	21.3	13.8	44.2	55.5	9.9	4.5	14.9	42.9	11.4	8.9	51.7	22.8	15.3	12.3	8.2	52.7	12.9	17.8	25.0	15.3	0.1	1.4	3.5	0.0	8.8	15.7	3.6	6.5	5.6	2.6	4.1	0.4	0.3	45.4	2.0	9.8	3.3	0.1	0.5	0.0	3.4	30.7	0.8	23.9	5.9	0.0	3.4	19.9	37.8	6.6	1.1	6.1	0.5	3.4	5.7	3.9	0.6	65.4	7.7	0.0	22.0	18.3	4.0	0.0	0.2	19.0	1.4	8.5	2.4	0.1	0.5	7.3	0.0	1.8	3.9	6.8	0.0	9.7	4.4	9.0	2.5	6.4	6.2	52.2	31.9	23.7	13.5	13.6	24.7	12.1	10.8	26.2	25.0	11.9	21.0	12.3	16.8	24.5	8.2	10.3	13.8	18.1	52.7	17.8	12.9	3.6	18.7	15.3	10.5	14.4	2.1	9.2	14.6	10.5	21.1	5.6	10.9	14.9	17.9	30.3	74.6	5.1	11.1	0.9	8.9	0.0	0.0	7.9	3.5	23.6	1.3	5.0	1.8	29.6	27.4	0.0	0.0	10.1	70.1	48.8	3.9	65.8	1.3	77.2	0.0	4.7	37.4	132.4	57.3	23.3	101.7	25.3	161.5	1.0	1.2	12.1	0.0	17.0	27.9	3.3	12.9	27.7	3.9	2.0	9.7	3.4	221.6	1.9	2.7
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 132.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 25.0;eosinophil: 53.0"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 53.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.6;ASC TERT1: 40.2;HHSteC: 50.7;HSkMC: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	18.4	11.0	6.0	6.5	10.0	10.5	19.6	7.6	9.6	16.1	15.9	7.8	39.7	5.7	9.0	12.9	8.1	6.7	10.7	34.8	5.3	3.7	20.2	11.5	14.4	12.2	8.5	5.3	6.9	23.9	10.0	10.2	33.5	9.4	8.4	17.9	11.5	30.2	19.3	49.3	11.8	7.7	10.0	7.5	8.9	14.5	4.6	6.5	1.6	10.0	25.2	9.8	10.3	10.3	1.1	2.2	53.0	5.7	2.5	3.1	3.3	1.0	2.2	1.9	2.8	52.6	40.2	10.7	7.7	36.8	3.1	10.0	1.6	1.6	0.5	3.5	16.5	11.0	0.8	0.7	4.9	5.5	0.9	0.9	7.6	0.7	9.4	50.7	0.5	11.0	42.3	9.1	12.3	16.8	10.3	13.9	1.1	0.4	19.2	9.3	6.5	0.1	1.5	0.4	2.8	3.2	0.1	6.7	7.4	4.7	3.7	0.5	2.6	1.7	24.1	39.1	10.7	12.4	2.1	13.2	15.3	2.2	7.0	1.9	16.8	19.0	2.2	23.1	3.6	6.8	25.0	4.6	53.0	3.1	5.5	1.4	1.1	0.8	3.0	2.2	0.4	0.0	1.5	9.7	2.5	5.7	1.5	0.6	3.3	6.0	10.0	7.6	9.6	5.3	3.7	8.5	5.3	9.4	6.5	8.9	11.5	11.1	11.2	6.9	11.0	6.7	25.5	53.5	33.0	15.7	2.0	35.8	26.6	25.2	5.6	10.8	13.4	70.0	49.5	132.1	43.1	46.3	6.9	10.6	31.2	9.5	11.5	41.1	15.3	3.6	42.8	14.5	40.5	47.7	56.7	12.4	33.5	11.5	39.6	54.2	12.4	25.8	15.5	4.4	4.5	5.9	104.6	17.5	25.7	23.5
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190188-5233826	"Predicted intracellular proteins"	Autophagy		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	24.5	23.6	33.9	17.8	34.7	32.7	21.9	30.6	47.4	20.6	21.7	27.8	17.4	20.3	24.4	23.1	25.4	25.3	20.5	30.5	27.9	27.2	23.5	27.5	21.9	22.3	26.0	31.2	25.0	30.8	28.7	23.2	27.0	26.1	25.0	17.2	25.0	34.7	25.5	28.3	31.8	18.2	22.9	25.6	22.0	23.0	49.3	26.0	26.6	24.1	15.9	23.4	22.9	20.5	6.1	6.9	13.0	6.3	2.6	9.2	2.2	27.2	17.4	17.1	29.1	26.3	27.6	26.3	24.3	28.0	26.0	27.5	16.9	25.4	19.5	18.7	30.4	32.4	20.0	17.2	19.8	20.3	10.0	26.7	13.3	17.6	18.6	26.0	20.8	14.6	29.0	23.9	29.5	16.4	26.0	36.1	26.8	37.6	17.7	23.5	28.3	15.8	36.1	35.5	14.6	25.6	26.1	24.4	32.0	17.1	13.3	21.3	32.1	17.8	30.7	21.1	29.9	18.8	39.8	28.6	16.6	35.0	27.7	18.1	31.8	29.6	22.2	27.1	24.2	24.5	0.3	4.9	13.0	5.1	6.3	3.1	5.6	6.7	9.1	4.5	6.1	8.5	5.4	9.9	2.6	4.2	6.9	9.2	2.2	33.9	34.7	30.6	47.4	27.9	27.2	26.0	31.2	26.1	26.0	35.7	26.9	47.2	36.3	48.8	67.7	25.4	25.5	21.4	17.0	17.4	58.9	79.1	61.3	36.3	146.8	28.9	32.1	46.7	36.2	84.9	33.8	70.9	31.1	55.0	59.9	44.5	37.9	47.9	51.5	127.3	39.4	39.2	42.2	65.9	47.0	87.1	45.2	38.5	52.6	60.3	50.4	51.8	32.0	181.0	130.5	62.0	126.1	42.4	42.2	42.4
WISP1	"CCN4, WISP-1, WISP1-OT1, WISP1-UT1"	ENSG00000104415	"WNT1 inducible signaling pathway protein 1"	O95388	8	133191039-133231690	"Cancer-related genes, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 1.6;Fibroblasts: 2.1;Sertoli cells: 6.5;Smooth muscle cells: 2.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 8.1;HSkMC: 45.6;hTEC/SVTERT24-B: 26.0;U-2197: 24.9"	"Region enriched"	"Detected in single"	6	"olfactory region: 11.9"	"Low region specificity"	"Detected in single"			"HPA007121, CAB012205"	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol		"CAB012205: , HPA007121: AB_1858844"	"unprognostic (7.77e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (7.52e-3)"	"unprognostic (2.55e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.67e-3)"	4.2	11.0	0.6	7.7	1.6	0.0	2.3	0.6	2.9	14.7	3.9	1.0	0.0	1.2	18.5	6.4	2.2	6.5	8.5	4.0	0.7	0.3	18.0	2.9	8.9	13.4	0.8	0.4	13.0	1.0	0.2	2.7	3.5	1.2	3.4	0.9	4.5	1.3	4.2	2.0	1.6	3.9	14.4	6.2	14.6	3.8	3.7	0.4	0.3	1.3	2.7	4.2	14.4	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.1	1.7	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	45.6	0.0	26.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	6.0	0.3	24.9	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	1.6	0.6	2.9	0.7	0.3	0.8	0.4	1.2	0.4	0.0	0.3	0.0	0.7	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	2.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4
WIZ	ZNF803	ENSG00000011451	"Widely interspaced zinc finger motifs"	O95785	19	15419980-15449951	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: AB_2671308"	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	28.0	17.5	27.6	18.3	21.6	13.6	20.9	15.8	24.4	17.5	17.3	12.8	18.0	18.2	25.2	12.0	16.3	16.3	15.3	17.3	23.0	11.4	13.8	18.4	13.5	17.5	14.1	19.0	21.6	26.9	14.3	10.9	13.7	13.7	17.4	7.7	12.4	21.9	23.1	24.4	21.5	16.8	16.5	11.9	18.0	15.6	40.9	15.8	18.6	13.3	14.6	12.1	19.3	21.4	2.0	1.5	0.7	3.6	2.5	1.2	0.5	13.5	9.3	13.4	17.0	19.3	7.9	10.9	14.2	7.0	11.9	8.2	8.2	25.5	11.3	23.5	12.9	7.2	11.6	7.3	10.0	2.9	8.8	12.5	8.2	7.2	6.4	12.3	9.4	12.3	14.0	13.2	8.6	9.4	7.4	10.7	8.9	12.8	9.7	8.0	27.6	17.1	8.7	18.1	13.3	22.2	16.0	6.1	11.4	7.7	10.6	18.3	23.3	12.5	11.4	9.2	4.8	12.5	8.9	17.2	27.3	10.8	21.4	18.1	14.4	8.6	12.2	11.4	11.4	18.4	0.0	1.4	0.0	1.2	1.2	1.0	0.5	0.8	1.2	1.0	2.0	1.0	1.0	0.7	2.5	3.6	1.5	0.8	0.5	27.6	21.6	15.8	24.4	23.0	11.4	14.1	19.0	13.7	15.8	11.9	5.8	8.5	5.5	14.1	8.8	9.1	12.7	0.0	3.4	12.2	0.0	6.1	3.3	12.3	6.3	13.5	5.0	0.0	17.1	8.3	9.9	8.6	1.1	13.2	6.7	6.4	6.4	13.5	10.2	6.4	14.7	7.1	6.8	5.4	9.5	7.1	16.5	0.0	18.0	4.7	7.5	12.9	10.8	27.2	26.0	17.8	6.2	4.4	10.5	11.8
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls"	ENSG00000116729	"Wntless Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 10.0;neutrophil: 29.1"	"Group enriched"	"Detected in many"	46	"granulocytes: 29.1;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AF22: 70.0;ASC TERT1: 54.2;SuSa: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	13.7	17.2	33.5	14.3	39.0	1.5	14.5	6.8	26.6	20.0	28.3	25.8	51.6	9.1	19.5	55.1	26.7	19.9	37.1	24.1	23.1	25.4	36.8	8.9	20.3	6.9	27.0	18.6	31.4	34.7	12.1	9.8	29.2	44.5	29.0	22.8	37.8	14.5	47.4	5.3	19.3	14.1	46.2	30.5	10.8	24.4	12.2	22.3	1.9	8.9	13.5	8.2	29.6	17.0	0.0	0.4	29.1	10.0	0.0	0.0	1.9	1.9	2.9	70.0	0.0	38.8	54.2	40.6	9.7	23.9	13.5	18.8	4.2	4.6	0.0	9.8	2.7	12.6	20.3	15.7	15.9	11.5	0.1	11.7	0.0	8.4	0.0	33.9	0.0	0.1	38.7	10.7	33.1	10.9	13.7	31.7	3.7	0.0	0.1	19.9	0.3	0.0	0.2	3.1	4.2	4.7	0.0	14.7	0.0	2.3	10.5	3.9	8.2	8.9	0.4	11.6	66.2	1.9	0.2	36.7	13.0	10.4	20.8	13.1	4.7	0.1	0.0	29.9	0.3	23.7	0.0	10.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.1	0.0	0.3	0.1	0.0	1.9	33.5	39.0	6.8	23.8	23.1	25.4	27.0	18.6	44.5	22.3	44.7	28.8	2.4	56.2	37.7	7.2	27.1	35.7	115.1	44.3	26.2	131.6	119.4	8.3	69.5	13.0	20.8	38.0	0.0	52.3	3.0	31.4	26.5	5.7	10.2	20.8	12.7	9.2	34.4	10.2	7.0	30.2	10.7	18.6	12.6	24.7	7.3	63.3	28.8	51.9	30.0	160.2	38.8	20.8	0.5	0.7	26.2	46.1	1.8	33.6	39.6
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 101.2"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.5;Hep G2: 18.8;SCLC-21H: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.9	8.2	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.6	0.1	11.5	1.5	0.0	0.8	0.2	6.5	0.0	0.0	0.0	7.5	0.0	3.5	18.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.3	0.0	0.0	6.0	0.1	0.1	7.3	4.4	0.2	0.0	0.0	9.3	0.0	0.7	23.9	9.4	1.5	6.5	0.6	0.8	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0											0.0	0.0	0.8	8.1	1.1	57.3	56.7	30.6	5.3	9.1	0.0	151.2	11.9	0.0	11.7	0.9	0.5	34.4	0.0	8.0	5.6	1.1	12.9	0.0	0.0	2.9	1.6	31.2	0.6	1.0	1.9	0.9	0.0	1.7	1.0	57.9	60.6	3.3	42.1	5.6	0.7	101.2	12.9	4.4	0.4	6.6	4.8	13.0	0.0	51.8	6.4
WNK3	PRKWNK3	ENSG00000196632	"WNK lysine deficient protein kinase 3"	Q9BYP7	X	54192823-54358642	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 31.6;testis: 26.7"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 178.0;Spermatogonia: 48.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Group enriched"	"Detected in many"	10	"B-cells: 1.1;T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"AF22: 5.9;AN3-CA: 4.5;HAP1: 6.8;NTERA-2: 11.9;SiHa: 5.8;SuSa: 5.3;U-2 OS: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077678	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA077678: AB_2686850"	"unprognostic (1.86e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.87e-5)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.99e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.74e-2)"	0.9	5.0	3.9	0.9	4.3	0.8	1.7	3.0	3.6	1.5	0.7	1.7	13.9	1.0	1.3	31.6	1.1	1.8	1.1	1.5	3.9	3.4	2.8	8.7	0.9	1.0	2.3	3.0	5.7	0.9	2.2	14.0	1.2	3.9	2.2	0.7	1.3	1.2	4.8	0.7	0.9	0.7	1.5	3.3	1.0	1.2	26.7	3.5	0.0	1.7	0.0	0.8	1.3	1.9	1.1	0.0	0.1	0.0	0.1	1.9	0.1	0.0	0.0	5.9	4.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	6.8	0.1	0.2	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	2.8	0.8	0.0	1.2	0.2	1.9	1.8	5.8	0.0	0.7	5.3	0.5	0.0	0.3	0.0	5.2	0.0	1.2	0.0	4.0	0.0	1.6	0.0	2.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.1	1.9	0.4	0.1	0.1	0.0	0.0	0.0	0.1	3.9	4.3	3.0	3.6	3.9	3.4	2.3	3.0	3.9	3.5	0.0	2.9	0.8	4.6	3.3	24.5	178.0	2.5	0.0	5.7	7.0	13.7	0.2	5.0	1.4	4.2	3.1	0.0	0.0	0.0	0.3	3.1	4.8	5.8	41.5	0.1	33.4	0.0	17.8	0.6	14.6	14.7	0.5	0.0	0.0	0.0	20.7	0.3	0.0	41.1	3.1	40.9	6.5	3.3	30.2	48.2	1.0	0.1	0.0	0.0	1.1
WNT10B	"SHFM6, WNT-12"	ENSG00000169884	"Wnt family member 10B"	O00744	12	48965340-48971763	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enriched"	"Detected in some"	11	"Extravillous trophoblasts: 12.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"K-562: 8.1;T-47d: 9.7;U-266/84: 8.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA055048, HPA062539"	Enhanced		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"		"HPA055048: AB_2682683, HPA062539: AB_2684793"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.73e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.99e-3)"	"unprognostic (3.05e-2)"	"unprognostic (5.39e-6)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.25e-1)"	2.3	0.6	10.9	2.6	23.4	2.1	1.8	0.0	14.3	0.5	1.7	0.5	3.0	2.8	0.4	3.2	1.5	0.6	1.1	1.2	7.3	4.9	0.2	0.3	1.3	3.0	3.0	7.2	1.2	0.0	0.1	1.1	7.0	4.1	1.0	1.6	0.7	1.7	1.4	1.6	5.0	3.3	2.0	0.8	2.9	2.0	1.7	0.3	0.2	0.5	1.2	2.9	1.8	1.6	0.0	0.0	0.0	0.0	0.0	1.6	0.2	2.1	1.4	0.0	2.0	0.0	0.0	5.4	1.5	2.8	0.6	0.2	4.2	4.7	0.0	0.4	0.3	1.8	2.6	5.6	0.4	0.2	1.2	7.4	2.4	1.8	0.1	0.0	0.8	3.5	0.0	0.4	0.1	2.5	4.9	0.0	1.8	8.1	0.3	0.8	2.8	0.1	2.8	0.0	1.5	3.0	0.0	0.7	2.6	0.0	0.5	0.1	0.0	0.3	0.2	0.7	2.8	9.7	3.1	0.0	3.1	6.0	0.4	0.7	3.1	8.7	0.0	1.2	6.2	0.2	0.0	0.0	0.0	1.6	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.2	10.9	23.4	0.0	13.9	7.3	4.9	3.0	7.2	4.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.8	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	1.1	0.9	0.0	0.0
WNT2	"INT1L1, IRP"	ENSG00000105989	"Wnt family member 2"	P09544	7	117276631-117323289	"Cancer-related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 10.4;lung: 10.9;placenta: 40.9"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 24.8;Fibroblasts: 9.4;Hofbauer cells: 6.8;Ito cells: 11.1;Late spermatids: 7.0;Syncytiotrophoblasts: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 21.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 12.6"	"Low region specificity"	"Detected in all"			HPA020920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA020920: AB_1858850"	"unprognostic (1.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-1)"	1.8	0.0	0.2	0.1	1.1	0.0	1.4	0.3	2.3	3.0	0.2	0.4	0.4	0.0	10.4	2.7	0.4	1.0	0.2	0.7	0.9	0.9	0.3	0.8	10.9	0.0	0.1	0.5	0.8	0.1	0.0	0.2	40.9	0.5	7.6	0.0	0.9	0.1	0.5	0.0	1.1	0.2	1.2	0.2	1.5	0.1	0.7	0.0	0.0	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	2.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.3	2.3	0.9	0.9	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.3	0.0	0.0	3.8	0.0	0.0	24.8	0.4	0.0	0.0	0.0	2.9	9.4	0.2	0.0	0.0	6.8	0.0	0.0	11.1	1.0	7.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.3	1.6	0.1	2.4	7.6	0.0	0.0	0.1
WNT2B	"WNT13, XWNT2"	ENSG00000134245	"Wnt family member 2B"	Q93097	1	112466541-112530165	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 66.7"	"Group enriched"	"Detected in many"	4	"Leydig cells: 74.2;Peritubular cells: 185.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.8;HSkMC: 13.0;SuSa: 5.3;TIME: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047274, HPA066368"			Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	Nucleoplasm	"HPA047274: AB_2732539, HPA066368: AB_2685664"	"unprognostic (2.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.65e-4)"	"unprognostic (5.41e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-2)"	3.4	1.9	1.7	3.4	4.6	0.2	2.1	2.6	2.9	9.2	12.0	0.8	3.7	3.9	7.5	5.4	7.6	4.4	8.0	3.6	1.6	1.7	1.8	0.5	5.2	0.9	2.0	2.4	28.7	2.0	1.2	1.9	6.0	1.5	7.3	6.8	66.7	1.7	18.3	1.3	13.4	9.1	12.9	3.0	1.2	4.4	16.2	0.8	0.5	1.4	5.6	1.9	10.3	8.5	2.3	1.2	1.7	0.7	0.8	1.2	0.1	0.7	0.4	3.4	0.8	3.4	6.8	0.6	1.4	1.5	0.4	0.6	0.3	0.7	1.8	0.3	1.6	0.4	2.1	1.1	0.5	0.3	0.1	0.7	0.2	1.1	0.5	2.9	0.2	0.8	13.0	1.2	0.6	0.2	1.9	1.7	0.5	0.2	0.3	0.4	0.5	0.1	0.2	0.6	0.1	0.5	0.1	0.5	0.0	2.4	0.4	0.5	0.5	1.3	0.2	1.1	5.3	0.1	0.4	5.2	0.5	2.0	1.3	0.4	0.2	0.1	0.0	1.4	0.2	1.3	0.9	0.7	1.0	0.9	0.3	0.8	1.4	1.2	1.0	0.3	2.3	0.4	0.7	1.7	0.8	0.5	1.2	0.4	0.1	1.7	4.6	2.6	2.9	1.6	1.7	2.0	2.4	1.5	0.8	11.9	3.5	0.5	1.6	9.0	13.0	3.9	2.5	4.0	2.3	1.8	25.5	1.6	0.0	0.7	3.5	8.4	2.3	0.0	1.2	0.7	7.8	1.5	2.3	0.0	1.0	4.8	8.1	4.9	1.6	2.8	74.2	5.7	3.3	1.8	1.7	8.2	1.6	4.2	185.6	0.6	30.4	0.0	2.8	4.2	4.2	12.2	1.6	1.9	1.5	2.0
WNT3	"INT4, MGC131950, MGC138321, MGC138323"	ENSG00000108379	"Wnt family member 3"	P56703	17	46762506-46833154	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 7.8;skin 1: 17.2"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 39.5;Early spermatids: 27.0;Late spermatids: 45.9;Suprabasal keratinocytes: 15.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 13.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.3;U-698: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA066281: AB_2685647"	"unprognostic (1.84e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.41e-4)"	"unprognostic (4.73e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.10e-8)"	"unprognostic (1.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	0.5	0.6	1.0	0.6	3.9	0.4	0.4	1.4	4.7	0.2	0.2	3.8	0.1	4.7	0.3	0.4	0.6	0.4	0.4	0.6	1.4	2.9	0.6	7.8	0.3	2.9	2.1	3.5	0.6	0.3	6.0	0.9	0.7	4.1	0.8	0.6	0.1	1.2	0.3	0.5	17.2	1.4	0.5	1.6	0.5	0.4	2.4	2.3	0.1	0.6	1.4	0.5	0.2	0.3	1.0	1.4	0.2	0.3	0.0	1.2	0.1	2.6	0.0	10.3	0.0	0.0	0.0	0.9	0.8	0.6	1.8	0.0	2.6	2.0	1.9	1.1	0.4	2.0	1.2	0.4	0.0	2.3	0.0	0.2	0.0	0.5	2.3	0.0	0.0	0.3	0.0	1.4	0.3	0.6	1.7	0.5	0.2	1.6	0.0	0.3	0.4	0.0	1.6	0.1	1.0	1.2	1.1	1.9	0.1	0.1	0.0	0.2	0.7	1.4	0.0	0.5	0.8	0.0	2.5	0.0	3.2	1.4	0.5	0.7	0.3	0.2	11.3	0.5	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.3	1.4	1.2	0.1	1.0	3.9	1.4	4.7	1.4	2.9	2.1	3.5	4.1	2.3	0.0	1.0	0.0	0.5	39.5	1.1	0.9	0.0	0.0	0.0	0.0	0.0	1.8	1.7	0.7	27.0	0.1	1.0	0.0	2.1	0.1	0.9	1.1	0.0	3.9	0.2	7.9	0.0	0.0	0.0	45.9	0.3	0.0	1.7	1.0	0.5	0.2	1.9	0.6	0.4	0.3	0.6	0.0	0.6	0.4	1.1	15.4	0.2	0.0	0.6	0.3
WNT3A		ENSG00000154342	"Wnt family member 3A"	P56704	1	228007051-228061260	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"lung: 7.4;placenta: 19.9"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 11.9;Basal glandular cells: 2.4;Basal keratinocytes: 3.1;Syncytiotrophoblasts: 2.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HEK 293: 2.8;U-2 OS: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA066281: AB_2685647"	"unprognostic (9.84e-3)"	"prognostic favorable (6.11e-5)"	"unprognostic (2.40e-1)"	"unprognostic (3.37e-1)"		"unprognostic (7.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.54e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	7.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	19.9	0.1	2.4	0.0	0.1	1.7	0.1	0.1	3.0	0.1	0.1	0.6	0.1	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	11.9	0.0	0.0	2.4	3.1	0.0	1.4	0.0	0.0	1.2	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	2.4	0.0	0.0	0.5
WNT4	WNT-4	ENSG00000162552	"Wnt family member 4"	P56705	1	22117305-22143969	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 34.3;skin 1: 28.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 14.8;Intestinal endocrine cells: 28.3;Mucus-secreting cells: 10.2;Suprabasal keratinocytes: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 10.2;SCLC-21H: 12.5;SK-BR-3: 10.6;T-47d: 4.2"	"Low region specificity"	"Detected in many"							HPA011397	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA011397: AB_1858854"	"unprognostic (1.85e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (2.14e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.49e-2)"	0.5	6.5	1.0	0.3	1.0	0.0	1.4	0.6	1.7	4.3	1.7	1.1	1.0	2.0	3.1	6.6	6.9	6.4	6.4	0.6	1.5	3.1	1.1	1.2	1.4	0.3	1.0	1.7	34.3	1.9	0.0	3.7	11.8	1.7	7.7	1.0	1.7	3.0	1.8	2.7	28.6	4.1	1.2	1.5	0.3	2.8	0.9	0.8	1.4	2.2	5.4	2.8	2.0	3.5	0.0	0.0	2.8	0.0	0.0	0.4	0.0	1.5	0.1	3.1	0.1	0.1	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	0.3	10.2	0.0	0.8	0.0	0.3	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.4	0.2	0.4	0.0	0.0	0.0	1.9	12.5	0.0	0.1	10.6	0.7	0.8	4.2	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.6	1.7	1.5	3.1	1.0	1.7	1.7	0.8	3.0	7.5	0.0	3.4	14.8	0.0	0.6	0.0	2.7	6.8	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.9	3.8	0.0	0.4	0.1	0.0	28.3	1.3	0.0	0.0	0.0	0.0	5.0	0.0	10.2	0.0	0.9	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.2	0.0	0.5	2.6
WNT5B		ENSG00000111186	"Wnt family member 5B"	Q9H1J7	12	1529891-1647243	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Muller glia cells: 42.4;Urothelial cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 4.6;eosinophil: 3.5;intermediate monocyte: 2.1;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;granulocytes: 3.5;monocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"BJ: 51.9;BJ hTERT+: 32.6;BJ hTERT+ SV40 Large T+: 38.0;BJ hTERT+ SV40 Large T+ RasG12V: 31.6;fHDF/TERT166: 36.2;HBF TERT88: 33.4;hTEC/SVTERT24-B: 33.2;U-138 MG: 33.0"	"Low region specificity"	"Detected in many"							HPA061991			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA061991: "	"unprognostic (7.44e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.71e-2)"	4.1	1.7	1.6	6.5	3.4	0.1	4.1	1.0	1.7	8.0	14.1	1.3	19.4	3.0	6.3	6.2	11.9	4.8	3.6	2.9	1.4	3.0	2.7	3.3	2.7	4.0	1.8	0.5	5.3	0.7	13.6	7.1	2.7	2.3	23.4	4.4	5.8	14.2	16.5	0.7	3.4	5.2	17.8	1.4	4.3	4.0	1.7	1.0	2.9	1.2	5.1	5.0	23.3	14.3	0.0	2.1	3.5	4.6	0.0	0.2	1.3	0.0	0.0	0.3	0.0	8.1	14.4	0.0	51.9	32.6	38.0	31.6	1.9	0.2	0.6	0.1	36.2	25.6	0.7	0.7	0.0	33.4	12.0	1.7	2.8	0.0	0.0	2.0	0.0	0.0	12.0	0.7	33.2	9.5	15.4	0.0	0.0	2.0	11.8	8.9	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.5	0.8	0.4	0.0	0.2	0.7	1.1	0.1	0.0	4.2	0.0	0.2	0.0	33.0	1.3	12.9	26.4	3.2	0.4	0.1	3.2	0.0	0.3	0.0	4.6	3.5	0.0	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.3	1.6	3.4	1.0	1.7	1.4	3.0	1.8	0.5	2.3	1.0	0.0	1.1	0.0	10.4	0.8	1.1	1.6	0.0	4.0	3.4	0.0	0.0	0.8	0.0	0.8	0.1	0.5	1.0	0.0	0.6	0.7	3.3	9.8	0.0	1.5	4.1	0.0	0.0	0.6	1.9	0.2	2.0	1.3	3.3	5.4	2.2	42.4	1.7	4.8	2.5	0.0	2.8	6.5	2.3	0.5	5.3	1.1	0.6	0.0	1.9	15.0
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257"	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	6.9	6.9	8.1	10.3	8.0	13.3	6.8	11.8	10.7	7.4	7.2	10.6	6.8	6.8	8.4	8.4	7.9	25.6	7.7	6.8	7.5	6.6	9.4	6.6	8.7	12.7	7.9	5.8	7.8	12.0	6.1	7.6	8.1	7.8	5.3	7.3	7.8	6.6	6.6	9.8	8.1	7.7	7.8	5.4	12.5	7.2	11.4	8.3	22.8	7.6	6.6	12.8	7.5	6.2	4.7	6.6	20.0	5.8	4.2	8.5	3.5	11.2	21.1	15.2	15.2	4.6	4.3	8.9	7.3	7.8	24.0	22.4	12.2	7.0	13.5	7.7	6.5	10.6	12.5	17.4	12.9	18.5	8.1	22.6	6.2	14.0	10.2	4.1	4.8	8.1	3.4	5.0	21.1	4.8	3.6	15.5	16.2	5.9	4.4	9.5	10.2	13.8	11.6	8.1	8.9	10.6	18.3	10.0	7.9	8.8	4.0	7.0	10.6	11.5	6.2	6.1	7.9	8.4	5.1	5.4	9.5	10.1	0.0	18.8	3.5	8.9	7.1	8.6	8.2	11.6	20.0	5.2	4.6	5.4	5.8	6.3	3.3	4.2	6.0	4.7	4.7	3.8	4.4	2.7	4.2	2.3	6.6	8.5	3.5	8.1	8.0	11.8	10.7	7.5	6.6	7.9	5.8	7.8	8.3	3.0	4.3	9.3	4.9	3.4	4.6	2.3	2.5	32.1	3.4	10.4	5.9	9.2	3.3	8.2	2.6	4.0	3.4	0.0	8.8	14.2	3.8	1.7	1.1	4.9	6.8	1.6	2.9	3.1	7.0	1.3	2.3	4.4	3.3	9.0	5.2	6.3	5.5	3.5	2.1	5.6	6.2	0.0	4.7	13.3	6.7	4.0	3.4	5.3	6.3	3.1
WRNIP1	"bA420G6.2, FLJ22526, WHIP"	ENSG00000124535	"Werner helicase interacting protein 1"	Q96S55	6	2765414-2786952	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031752, HPA031753"	Enhanced		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA031752: AB_10603004, HPA031753: AB_2674028"	"unprognostic (5.52e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	15.4	23.1	29.9	19.8	32.1	31.2	22.4	42.5	33.5	22.2	21.9	23.3	25.7	17.7	19.8	29.7	32.8	28.0	24.7	28.8	30.9	30.1	23.3	25.8	21.2	23.4	27.4	26.2	23.2	37.4	39.2	31.2	32.3	21.3	22.5	22.6	23.9	34.6	22.0	29.0	27.8	19.6	18.5	20.2	20.7	19.3	24.6	24.2	34.1	31.6	36.0	25.3	18.8	29.2	3.4	4.2	9.1	2.8	3.7	6.5	2.3	31.5	15.9	16.2	26.5	17.2	14.9	21.6	14.5	20.4	26.8	26.7	25.1	14.8	28.4	39.7	18.7	29.1	24.6	26.5	29.2	26.2	28.3	29.1	29.7	18.1	39.2	19.6	18.6	20.6	15.1	23.9	24.6	26.8	18.7	33.9	27.0	22.6	10.3	19.5	30.9	27.5	33.8	13.9	21.8	19.8	22.0	23.7	28.8	28.4	19.5	49.0	14.0	17.2	17.5	33.8	26.7	22.5	21.0	18.4	20.1	15.2	17.4	35.1	13.3	23.1	22.1	7.9	20.3	27.2	9.1	2.6	3.4	6.5	2.8	2.1	3.4	4.7	4.8	2.1	2.4	5.5	5.2	1.1	3.7	1.4	4.2	6.5	2.3	29.9	32.1	42.5	33.5	30.9	30.1	27.4	26.2	21.3	24.2	17.9	10.5	3.7	10.8	28.8	23.9	17.3	35.7	21.4	7.9	10.4	7.9	26.5	3.3	12.6	42.1	18.0	18.7	0.0	11.8	20.2	14.8	14.5	9.2	21.9	11.1	7.9	38.2	30.1	13.8	11.0	20.8	12.7	20.3	7.2	24.1	18.0	15.9	11.5	20.8	11.3	16.5	6.5	11.8	21.4	24.7	28.1	21.3	4.5	23.0	13.2
WSB1	"DKFZp564A122, DKFZp564B0482, SWIP1"	ENSG00000109046	"WD repeat and SOCS box containing 1"	Q9Y6I7	17	27294076-27315926	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003293	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003293: AB_1858863"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.07e-5)"	"unprognostic (2.59e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.74e-2)"	32.9	18.7	19.1	36.3	45.0	36.4	26.1	15.4	28.7	37.9	26.5	59.6	17.6	23.8	47.1	34.6	21.7	34.8	45.8	28.7	23.4	20.7	31.5	15.0	48.4	26.9	56.2	29.6	38.4	21.0	18.0	25.8	61.9	39.5	26.9	27.1	37.6	17.7	29.1	17.0	18.3	23.2	38.1	57.4	55.7	26.0	18.1	48.0	17.9	22.0	12.9	28.8	29.5	30.9	10.6	26.3	27.9	31.1	8.2	12.1	9.0	11.9	8.5	26.7	15.3	16.9	21.0	28.7	10.7	15.2	8.4	16.4	12.7	4.8	12.1	12.2	14.6	10.7	11.4	16.1	7.9	12.8	33.4	13.1	19.2	15.3	12.8	31.9	13.2	28.4	25.3	10.8	12.3	7.5	13.0	33.6	12.7	19.2	11.6	15.0	7.4	16.9	15.1	7.9	6.5	7.0	13.9	14.5	7.2	12.6	9.8	8.6	11.7	11.1	11.2	14.5	33.5	9.0	17.6	18.6	10.5	8.0	14.2	10.1	5.2	13.2	12.3	9.9	10.5	9.3	21.4	16.2	27.9	9.4	28.1	11.2	9.1	7.8	10.2	26.3	10.6	7.5	8.5	15.2	8.2	31.1	8.6	12.1	9.0	19.1	45.0	15.4	28.7	23.4	20.7	56.2	29.6	39.5	48.0	205.4	388.8	133.9	158.7	221.3	81.0	61.8	112.1	108.4	153.6	226.8	327.9	278.3	23.2	90.7	148.8	245.0	158.8	46.7	56.5	165.8	262.8	163.6	159.4	41.9	187.7	77.9	186.5	265.8	360.3	17.5	130.9	273.2	187.3	65.9	159.4	241.1	67.5	164.9	115.2	20.0	357.0	122.9	185.4	104.8	96.4	245.0	597.5	103.6	107.7	135.9
WSCD1	KIAA0523	ENSG00000179314	"WSC domain containing 1"	Q658N2	17	6057807-6124427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;lymphoid tissue: 16.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 70.9;Enterocytes: 18.3;Late spermatids: 67.5"	"Group enriched"	"Detected in many"	7	"glioma: 18.8;renal cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.9;HUVEC TERT2: 13.4;OE19: 13.9;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015919	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015919: AB_2216211"	"unprognostic (1.50e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	3.9	2.6	11.2	1.6	7.3	0.4	1.3	17.1	24.7	1.5	8.7	11.2	0.0	4.7	1.5	1.4	1.2	1.7	1.6	3.8	10.5	9.7	6.2	1.1	1.8	1.9	11.9	5.3	0.8	2.4	2.3	2.7	6.5	8.5	1.2	5.4	1.1	1.8	1.3	13.3	2.0	5.7	2.1	12.2	16.7	1.4	12.9	10.5	0.6	1.3	0.0	1.6	1.0	2.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	3.1	21.9	1.7	0.1	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	5.4	0.1	0.0	0.0	7.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	13.4	0.0	0.0	0.5	0.6	0.4	0.0	0.0	7.3	13.9	13.5	0.0	27.7	0.8	4.6	1.1	8.5	0.0	0.1	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.2	7.3	17.1	7.3	10.5	9.7	11.9	5.3	8.5	10.5	0.0	0.0	0.0	0.0	0.3	5.6	2.8	0.0	0.0	0.0	1.8	0.0	0.7	1.7	0.3	70.9	3.0	18.3	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	1.6	0.0	8.0	0.3	67.5	0.6	0.0	1.7	0.0	2.8	9.1	0.3	5.7	0.0	1.2	2.8	0.0	1.4	0.5	2.8	0.5	0.0	0.0	5.6	0.1
WWC1	"KIAA0869, KIBRA, PPP1R168"	ENSG00000113645	"WW and C2 domain containing 1"	Q8IX03	5	168291651-168472303	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 78.7"	"Cell type enhanced"	"Detected in many"	6	"Club cells: 63.7;Cone photoreceptor cells: 86.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 30.4;RPTEC TERT1: 67.9;SK-BR-3: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038016, HPA038017"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA038016: AB_10697091, HPA038017: AB_10669513"	"unprognostic (3.60e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-1)"	2.9	0.9	17.6	2.2	23.5	0.7	13.1	4.8	14.2	4.3	6.8	11.4	10.2	14.3	2.3	4.7	10.1	10.7	8.9	0.9	15.2	12.9	27.1	16.5	11.8	2.1	16.0	9.2	1.4	15.5	9.8	3.8	15.8	12.2	10.2	4.2	10.0	78.7	13.3	0.6	9.3	15.0	1.3	9.9	1.0	12.5	1.4	10.4	0.0	17.9	3.8	6.2	4.1	3.9	0.4	0.2	1.2	0.3	0.3	0.3	1.5	12.6	14.4	2.4	0.1	0.0	0.0	25.4	0.9	0.2	4.5	4.0	30.4	19.0	0.0	15.5	0.3	12.5	9.0	4.9	11.8	5.3	0.0	4.8	0.0	7.3	7.5	0.2	1.1	0.0	1.6	3.6	8.4	7.5	3.5	0.0	0.7	0.0	1.8	0.3	14.1	0.0	0.0	3.4	15.3	2.1	0.0	0.1	7.3	67.9	17.5	8.0	3.0	17.0	35.5	4.4	3.2	17.6	1.1	0.0	0.8	9.0	0.1	9.3	0.2	0.0	0.0	0.9	0.0	2.2	1.2	0.3	0.2	0.3	0.1	0.2	0.3	0.3	0.1	0.0	0.4	0.2	0.2	0.9	0.3	0.1	0.2	0.3	1.5	17.6	23.5	4.8	14.2	15.2	12.9	16.0	9.2	12.2	10.4	59.6	59.5	1.4	10.5	10.5	1.3	1.7	28.1	38.8	63.7	55.8	86.4	10.0	11.6	41.8	0.4	0.5	15.3	0.0	34.7	1.7	2.6	23.7	1.1	14.7	1.2	0.0	7.5	1.8	0.8	0.0	1.1	0.8	10.1	1.8	7.5	16.4	53.6	7.8	0.7	41.8	7.8	0.0	1.4	0.3	3.0	12.2	15.2	0.5	11.5	15.7
WWC2	"BOMB, FLJ22029"	ENSG00000151718	"WW and C2 domain containing 2"	Q6AWC2	4	183099293-183320777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 244.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"monocytes: 1.9;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"SiHa: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044005	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA044005: AB_10960552"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (7.16e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (3.27e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.52e-2)"	10.8	6.7	8.2	4.8	9.1	0.9	12.3	3.5	7.4	11.6	8.5	8.6	9.8	2.4	17.6	7.1	6.7	8.6	9.7	12.3	9.6	4.8	20.3	19.9	28.8	3.3	10.0	7.2	12.8	13.1	15.5	5.9	14.9	9.1	8.9	3.4	16.5	11.3	9.9	5.5	5.4	4.0	11.2	9.9	6.4	8.9	15.4	8.5	0.0	16.8	4.5	3.1	9.8	17.0	0.0	0.4	0.0	1.9	0.4	2.1	0.3	10.1	4.3	9.4	8.4	7.1	7.9	10.9	13.8	11.0	15.3	11.0	19.1	9.9	0.0	7.0	22.2	5.3	3.7	14.5	5.7	19.5	0.0	4.4	10.3	10.0	9.8	7.3	4.8	11.4	6.0	4.4	10.1	9.5	12.7	10.1	1.5	7.3	0.5	11.6	2.9	0.0	3.2	9.0	0.3	3.7	0.0	8.6	5.5	21.8	2.7	0.6	4.8	33.8	29.7	4.4	15.7	7.2	1.6	15.1	5.7	16.0	3.3	9.9	0.0	0.0	0.1	5.6	2.2	10.0	0.0	1.4	0.0	0.6	1.1	1.0	0.0	0.6	0.2	0.4	0.0	2.1	0.6	0.0	0.4	1.9	0.0	0.0	0.3	8.2	9.1	3.5	7.4	9.6	4.8	10.0	7.2	9.1	8.5	244.2	50.8	0.0	6.7	21.3	3.2	25.8	43.3	14.7	37.5	7.0	60.9	11.9	23.2	13.2	30.2	20.4	0.0	0.0	12.4	7.5	16.9	19.6	18.5	33.7	8.5	0.0	1.2	16.5	13.1	16.8	16.4	7.1	11.8	7.2	0.1	11.8	23.0	0.0	19.8	19.0	60.1	25.8	18.0	29.8	16.8	13.4	5.5	1.0	0.1	7.6
WWC3	"BM042, KIAA1280"	ENSG00000047644	"WWC family member 3"	Q9ULE0	X	10015562-10144478	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 56.9"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 58.6;Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 54.2"					"Low region specificity"	"Detected in all"			HPA039814	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA			Cytosol	"Actin filaments"	"HPA039814: AB_10674987"	"unprognostic (2.53e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (9.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.50e-2)"	10.2	13.2	8.9	9.8	12.6	5.3	10.3	13.7	10.1	10.0	13.1	18.2	56.9	4.5	11.6	22.0	12.4	8.9	10.8	15.4	10.0	7.2	7.2	3.9	21.0	12.5	13.1	6.4	18.7	9.4	9.9	6.7	25.7	10.6	11.3	5.6	12.6	9.0	44.4	7.6	12.3	10.8	13.2	9.4	11.8	11.2	6.9	11.8	6.2	12.2	8.1	10.2	10.2	18.1	6.6	0.7	12.3	1.0	2.7	6.9	2.1	6.8	7.7	9.4	3.1	4.0	5.6	8.9	3.8	6.8	2.3	2.6	1.0	7.1	0.7	0.0	5.1	9.2	3.6	2.2	4.0	1.9	5.0	0.7	1.5	5.1	0.7	8.6	0.0	2.4	3.6	8.5	5.8	6.2	12.6	10.9	1.3	0.1	9.2	5.6	14.0	1.6	0.4	8.8	3.6	2.7	4.9	0.4	2.9	2.3	3.5	1.0	2.7	4.7	6.1	4.1	18.3	54.2	0.5	14.6	6.9	0.1	10.1	4.2	7.5	5.1	2.5	4.2	2.5	10.1	4.1	1.0	0.2	6.9	0.8	6.0	2.4	3.4	5.1	0.5	6.6	3.2	3.8	12.3	2.7	0.8	0.7	1.6	2.1	8.9	12.6	13.7	10.1	10.0	7.2	13.1	6.4	10.6	11.8	20.8	58.6	4.2	12.1	4.9	6.3	17.9	7.6	6.7	13.6	5.2	5.9	11.9	0.0	5.6	0.6	20.4	5.1	46.7	8.2	5.3	11.6	11.0	3.5	5.5	9.2	3.2	15.4	31.3	21.9	0.4	11.8	7.4	15.1	0.0	3.0	3.2	7.9	5.8	23.3	2.1	2.1	19.4	16.5	0.7	1.1	11.4	6.6	7.9	3.3	7.6
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342738-86478420	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	15.4	9.1	9.7	15.6	14.1	5.2	20.9	8.5	9.5	11.5	16.9	7.5	21.1	8.7	11.9	19.3	11.7	7.2	22.0	40.7	8.7	8.5	16.9	37.2	10.2	15.9	10.0	7.8	10.1	11.3	40.7	7.3	15.6	12.7	17.8	11.3	8.9	11.8	9.4	58.0	13.8	13.0	18.4	9.9	19.1	11.4	10.4	9.5	11.1	11.2	18.0	12.5	14.5	12.3	3.7	2.6	6.5	2.8	2.9	10.4	2.3	22.6	10.6	7.4	5.2	9.3	9.2	6.8	8.3	8.8	6.6	7.9	7.5	14.0	9.7	5.6	14.1	9.2	19.5	10.3	13.3	11.4	12.1	8.3	11.2	9.4	17.5	6.8	4.4	5.8	8.3	16.9	7.2	13.4	10.2	29.1	11.5	5.9	11.5	11.1	11.3	10.6	3.4	4.5	31.7	12.0	7.0	8.9	8.6	14.8	17.3	2.2	5.2	8.2	41.6	8.8	16.8	12.4	4.2	33.4	9.9	11.7	10.4	4.2	13.6	8.3	10.0	12.2	0.8	7.5	6.5	2.8	4.8	7.2	2.4	6.0	3.7	8.7	7.1	1.9	3.6	10.4	6.3	1.7	2.9	2.8	2.6	8.0	2.3	9.7	14.1	8.5	9.5	8.7	8.5	10.0	7.8	12.7	9.5	23.8	19.9	7.5	24.5	31.8	24.5	71.8	45.9	10.7	17.0	27.9	55.0	21.8	36.5	16.7	18.9	25.5	14.8	0.0	32.4	2.7	17.3	35.8	3.5	77.6	43.8	38.1	22.8	64.4	64.9	9.4	30.0	17.5	28.7	10.8	25.5	21.3	37.0	14.0	34.3	38.8	48.9	6.5	13.0	10.9	14.7	34.5	19.2	20.3	18.3	32.8
XAB2	"HCNP, HCRN, NTC90, SYF1"	ENSG00000076924	"XPA binding protein 2"	Q9HCS7	19	7619525-7629565	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048751			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048751: AB_2680512"	"unprognostic (1.13e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (1.99e-3)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.80e-3)"	13.5	18.4	12.2	13.3	17.8	35.7	17.8	22.9	22.6	16.3	12.1	19.2	12.1	16.3	15.5	12.1	17.8	18.9	12.7	17.5	11.9	10.3	20.1	24.6	13.0	17.0	16.8	11.4	29.6	34.3	11.9	12.2	14.6	13.3	15.2	5.3	13.6	28.7	18.1	18.0	19.5	13.8	13.7	13.4	18.8	22.8	30.2	15.8	24.8	21.4	13.2	15.9	18.6	15.6	15.2	9.0	9.9	14.1	8.9	16.7	13.8	15.5	14.3	8.7	11.3	9.2	6.9	17.0	9.2	10.8	16.3	16.6	18.4	10.3	10.5	18.2	8.5	11.9	13.8	12.3	13.3	4.2	18.5	15.8	14.0	12.1	16.1	11.9	18.5	12.7	12.1	11.1	11.5	8.3	8.8	9.9	22.8	12.5	28.2	5.0	17.3	17.3	28.9	19.7	9.8	28.3	19.4	11.0	18.4	6.5	12.3	12.4	14.2	10.4	10.2	9.0	6.0	13.0	16.5	9.7	7.5	12.3	16.9	15.4	48.6	28.6	15.3	12.8	15.8	11.1	8.3	12.2	9.9	14.8	11.6	13.6	12.3	13.8	11.0	9.0	15.2	16.7	12.6	7.3	8.9	14.1	7.8	15.8	13.8	12.2	17.8	22.9	22.6	11.9	10.3	16.8	11.4	13.3	15.8	0.0	2.6	13.7	12.3	17.4	13.6	0.8	22.9	0.0	3.4	45.4	11.8	36.8	29.9	16.2	26.4	13.5	25.0	0.0	30.1	23.1	15.3	13.9	19.6	36.5	17.5	3.2	17.9	14.7	16.5	13.5	26.2	9.3	25.3	31.5	17.7	13.8	14.4	14.4	20.5	74.5	11.3	38.8	18.8	34.6	47.5	15.6	55.2	20.3	16.2	12.7
XAF1	"BIRC4BP, HSXIAPAF1, XIAPAF1"	ENSG00000132530	"XIAP associated factor 1"	Q6GPH4	17	6755447-6775647	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 56.6;Club cells: 50.0;granulocytes: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 34.2;HHSteC: 15.2"									HPA057302	Approved		Supported	"Nucleoplasm,Mitochondria,Rods & Rings"		Yes	NA			Mitochondria	"Nucleoplasm, Rods & Rings"	"HPA057302: AB_2683405"	"unprognostic (6.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.09e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.08e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.73e-7)"	"unprognostic (2.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.15e-3)"	32.8	7.5	12.2	27.0	13.2	17.5	14.4	4.3	14.0	12.8	10.5	8.9	11.4	15.3	15.6	22.4	11.8	12.0	20.1	13.1	10.7	7.9	19.1	37.9	25.1	15.8	11.0	9.6	34.6	2.7	2.2	8.6	15.2	16.4	13.2	10.1	9.9	26.4	9.0	9.1	10.7	14.4	14.7	10.8	35.0	14.0	5.4	11.0	17.3	10.5	9.2	11.3	12.0	13.4	4.3	7.7	13.1	11.6	7.7	8.5	5.3	2.0	0.1	0.2	0.5	2.8	6.3	0.2	2.5	10.4	33.1	34.2	0.2	3.0	0.5	0.8	3.8	11.9	1.2	0.0	0.5	3.8	4.5	0.1	0.7	0.3	0.4	15.2	0.4	3.1	2.9	0.0	4.4	0.1	0.1	2.7	9.6	0.2	10.8	1.0	0.1	2.2	8.8	0.2	0.1	0.8	4.3	0.1	0.2	0.0	1.9	0.2	0.2	1.2	0.2	5.5	0.2	0.3	12.1	0.3	0.4	0.3	0.9	0.2	1.6	0.5	0.2	0.9	7.2	0.8	13.1	8.8	4.2	7.5	11.6	5.7	3.3	5.9	5.2	7.7	4.3	4.0	4.1	10.6	7.7	10.7	0.8	8.5	5.3	12.2	13.2	4.3	14.0	10.7	7.9	11.0	9.6	16.4	11.0	56.6	31.7	5.4	5.3	4.6	0.2	1.6	12.7	36.1	50.0	0.0	0.0	0.1	0.0	1.1	3.1	24.8	8.1	23.3	1.7	3.5	8.7	2.7	46.3	13.6	15.0	0.0	1.7	28.8	16.4	0.6	33.6	22.5	5.0	3.6	8.4	1.0	6.2	0.0	25.8	0.2	0.3	19.4	3.9	0.3	0.6	2.4	0.3	13.8	6.6	5.4
XAGE1A	"CT12.1a, GAGED2, XAGE-1, XAGE1"	ENSG00000204379	"X antigen family member 1A"	Q9HD64	X	52495676-52500812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 28.7"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 9.3;Spermatogonia: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 74.6;NB-4: 72.7;THP-1: 74.6;U-2 OS: 54.5;U-266/70: 35.5;U-266/84: 96.5;U-937: 59.9"									HPA046363			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046363: "																		0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	72.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.5	0.0	0.1	0.2	0.0	5.1	74.6	0.0	0.0	54.5	0.0	10.4	35.5	96.5	0.1	0.0	59.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0
XAGE1B	CT12.1b	ENSG00000204382	"X antigen family member 1B"	Q9HD64	X	52512077-52520803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 28.8"	"Cell type enhanced"	"Detected in single"	28	"Spermatogonia: 1.9"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 78.4;NB-4: 76.2;THP-1: 74.1;U-2 OS: 56.8;U-266/70: 35.7;U-266/84: 97.4;U-937: 60.9"									HPA046363			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046363: "																		0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.8			0.0		0.3	0.0	0.0	0.0	4.7	0.0	0.2	0.0	0.0	0.0	0.3	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	78.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.1	76.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.6	0.0	0.2	0.3	0.0	5.3	74.1	0.0	0.0	56.8	0.0	10.5	35.7	97.4	0.1	0.0	60.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.0	0.0	0.0	0.0	0.0
XAGE5	"CT12.5, GAGED5, XAGE-5"	ENSG00000171405	"X antigen family member 5"	Q8WWM1	X	52812204-52818301	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	6	"testis: 5.1"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 9.6"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	34	"U-2 OS: 22.7"									"HPA052507, HPA055941"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Nucleoplasm, Vesicles"		"HPA052507: AB_2681855, HPA055941: AB_2682978"															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	9.6	0.0	1.6	0.0	0.0	0.0
XIAP	"API3, BIRC4, hILP"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913979	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: AB_2677993"	"prognostic unfavorable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	17.4	14.4	20.0	18.1	20.2	12.0	15.9	21.3	18.9	17.2	19.4	14.5	22.9	16.1	17.4	17.0	18.9	12.6	14.7	15.7	18.9	22.1	19.8	19.4	16.5	15.5	18.8	14.6	13.9	19.7	36.6	26.1	18.2	15.9	15.6	16.8	16.9	14.6	22.9	21.5	14.2	23.4	17.0	19.0	15.8	16.2	7.0	12.3	13.9	24.3	11.4	14.0	15.4	20.5	5.7	4.3	11.1	3.9	3.3	5.5	1.9	11.7	10.0	7.9	6.8	9.4	12.1	10.3	12.8	9.5	7.0	6.0	4.5	13.8	11.0	19.0	10.9	13.3	4.4	11.7	8.0	12.9	11.4	6.4	7.4	8.4	6.8	11.9	13.4	15.4	8.3	12.5	11.6	15.0	8.1	9.6	8.3	11.7	12.7	13.5	12.2	7.5	6.5	6.5	11.7	7.9	8.0	9.2	11.6	10.5	17.1	5.4	7.9	17.5	10.1	10.3	7.3	6.2	6.6	11.9	0.4	4.8	21.0	14.2	10.7	10.7	12.2	14.4	9.6	8.8	11.1	2.6	3.5	5.0	2.3	4.7	4.6	3.8	5.5	1.4	5.7	4.4	3.0	8.2	3.3	3.9	4.3	2.5	1.9	20.0	20.2	21.3	18.9	18.9	22.1	18.8	14.6	15.9	12.3	74.5	82.4	26.9	28.9	23.7	71.7	36.7	56.0	46.8	63.7	50.6	90.3	15.7	23.2	32.6	2.2	45.7	74.1	0.0	46.9	25.4	27.8	42.3	57.9	73.4	26.6	71.5	45.5	66.3	41.2	1.5	39.4	43.8	8.5	27.9	52.4	42.8	52.8	48.9	48.4	48.2	129.5	64.7	27.8	10.4	19.9	31.0	31.8	33.1	39.8	58.3
XIRP1	"CMYA1, DKFZp451D042, Xin"	ENSG00000168334	"Xin actin binding repeat containing 1"	Q702N8	3	39183210-39192596	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"heart muscle: 95.0;skeletal muscle: 219.0"	"Cell type enriched"	"Detected in single"	1478	"Cardiomyocytes: 827.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 9.3;LHCN-M2: 2.3;RH-30: 6.2;SuSa: 1.9"									"HPA016750, HPA018458, CAB026391"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885"	"unprognostic (2.19e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-5)"	"unprognostic (2.08e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.12e-2)"	1.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.7	1.9	0.0	0.4	95.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.2	0.3	1.1	0.0	0.0	1.3	0.0	219.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	4.9	18.2	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	827.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888487-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 292.8"	"Cell type enriched"	"Detected in some"	66	"Cardiomyocytes: 1858.5"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;HEL: 1.5;HUVEC TERT2: 8.7;U-2197: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.3	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.0	292.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	2.3	51.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.2	0.7	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1858.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685756-37732130	"Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.6"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 21.1;Erythroid cells: 23.3;Mucus-secreting cells: 12.1;Undifferentiated cells: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	40	"basophil: 9.4;eosinophil: 6.8"	"Lineage enriched"	"Detected in single"	94	"granulocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"HEL: 25.2;HL-60: 13.0;K-562: 16.2;NB-4: 11.9;RPMI-8226: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		No	No			Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.6	2.9	4.9	3.0	5.1	14.0	1.1	10.2	8.3	1.8	16.5	1.2	0.0	12.9	1.2	0.8	2.7	4.8	2.0	8.1	4.7	6.6	1.4	2.1	1.5	0.7	3.0	5.9	1.2	7.9	2.2	3.8	1.4	4.4	2.1	13.8	1.0	8.6	1.5	5.9	1.2	23.6	3.2	1.6	1.2	13.3	3.5	0.2	0.1	1.4	5.9	0.8	2.9	2.5	0.0	0.0	9.4	0.0	0.0	0.0	0.7	9.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.4	0.1	0.0	0.4	1.6	8.9	0.0	0.0	0.0	2.4	25.2	1.4	0.0	0.0	13.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.2	6.4	0.1	0.9	0.1	11.9	3.2	0.4	3.2	0.0	0.0	11.4	0.0	0.6	2.4	0.0	0.4	0.8	0.0	0.5	1.2	3.2	0.0	0.0	0.4	0.0	1.4	5.5	9.1	0.0	0.1	6.9	0.0	9.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	4.9	5.1	10.2	8.3	4.7	6.6	3.0	5.9	4.4	0.2	0.0	0.6	0.0	0.2	0.3	0.5	5.9	0.0	1.4	0.0	0.0	5.9	0.1	0.0	0.0	0.9	0.0	21.1	23.3	2.6	0.1	0.0	1.1	0.0	0.8	0.1	3.2	5.8	0.0	0.0	0.2	0.0	0.0	1.7	0.0	12.1	0.0	1.2	8.6	0.7	0.0	0.9	0.0	1.7	4.6	4.3	1.0	0.0	0.0	10.8	0.4
XKR4	KIAA1889	ENSG00000206579	"XK related 4"	Q5GH76	8	55102389-55542054	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 25.5;Club cells: 17.0;Cone photoreceptor cells: 33.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"REH: 3.7;RPTEC TERT1: 15.0"	"Low region specificity"	"Detected in all"							"HPA025072, HPA028083"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA025072: AB_1858886, HPA028083: AB_10601025"	"unprognostic (7.15e-4)"	"unprognostic (1.28e-3)"	"unprognostic (6.98e-2)"	"unprognostic (5.63e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.96e-2)"	1.2	1.4	18.7	4.3	5.6	0.8	0.7	4.4	12.1	2.1	5.1	0.6	0.3	1.5	1.0	1.4	2.5	1.1	1.4	2.6	8.6	4.5	0.9	0.7	0.7	2.0	2.0	8.8	0.9	1.1	0.5	5.3	0.6	2.0	1.2	2.2	2.5	2.0	2.9	0.8	1.4	2.0	3.5	1.2	0.9	1.5	0.9	3.4	0.6	0.7	0.6	2.3	1.0	1.6	0.8	0.3	2.2	0.2	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.7	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.2	0.3	0.2	0.1	0.1	0.6	0.2	0.1	0.0	0.8	0.2	0.3	1.2	0.7	0.1	0.3	0.1	0.1	18.7	5.6	4.4	11.5	8.6	4.5	2.0	8.8	2.0	3.4	8.9	25.5	0.0	0.5	0.3	6.5	1.4	0.0	9.4	17.0	3.5	33.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.7	0.5	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	1.1	8.5	2.8	0.0	0.6	0.7	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.7
XKR6	"C8orf21, C8orf5, C8orf7"	ENSG00000171044	"XK related 6"	Q5GH73	8	10896045-11201366	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 39.8;Cone photoreceptor cells: 13.7;Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 6.2;U-266/84: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA024828, HPA064769"	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA024828: AB_2215165, HPA064769: AB_2732720"	"unprognostic (8.63e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.92e-6)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.75e-3)"	"unprognostic (8.65e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.29e-3)"	2.0	2.9	3.0	4.8	13.1	4.1	2.5	21.4	6.3	1.9	2.7	1.4	1.9	1.7	2.4	1.3	3.8	2.2	2.0	1.5	3.4	1.6	2.3	1.0	2.7	3.9	1.3	4.4	0.9	5.1	3.3	8.8	1.2	5.3	3.2	2.1	1.1	5.2	5.0	0.8	3.9	3.3	1.6	1.4	3.8	3.3	7.5	2.4	0.1	3.0	0.2	3.6	3.0	2.3	1.3	0.6	0.0	0.0	1.2	0.3	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.0	2.0	0.6	0.6	1.8	0.0	0.5	5.0	0.0	1.0	3.0	0.2	2.2	2.7	0.9	0.1	0.6	1.6	0.2	0.0	0.9	0.0	4.3	0.5	1.8	0.0	2.2	2.2	1.1	0.0	0.1	6.2	0.8	0.5	0.0	0.0	3.3	0.3	1.2	0.0	0.0	1.2	2.4	1.8	3.3	1.9	1.0	0.1	0.0	2.7	0.0	0.8	0.0	2.6	1.3	0.0	0.9	1.8	10.2	4.6	1.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.1	0.0	1.3	0.2	0.0	0.0	1.2	0.0	0.6	0.2	0.1	3.0	13.1	21.4	6.3	3.4	1.6	1.3	4.4	5.3	2.4	6.0	0.3	6.4	3.7	1.5	39.8	1.5	5.1	0.0	1.2	3.5	13.7	0.0	1.7	2.0	6.5	1.0	1.0	0.0	4.5	0.0	0.4	3.2	0.0	0.0	0.4	25.4	4.1	4.3	1.0	1.4	0.0	0.0	1.7	0.0	0.7	6.6	3.1	0.9	0.0	0.8	6.0	0.0	1.0	3.5	4.5	1.1	0.0	1.5	1.2	3.1
XKR8	FLJ10307	ENSG00000158156	"XK related 8"	Q9H6D3	1	27959462-27968096	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 47.1"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 47.7;monocytes: 27.9"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in all"	10	"eosinophil: 47.1;neutrophil: 24.3"	"Lineage enriched"	"Detected in all"	15	"granulocytes: 47.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049984, HPA053529"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA049984: AB_2680982, HPA053529: AB_2682179"	"prognostic favorable (8.63e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.87e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-2)"	2.6	2.3	2.8	4.2	3.8	10.3	1.8	8.3	1.8	2.3	2.5			4.1	3.3	2.9	2.4	3.2	2.9	3.2	2.8	1.9	3.3	8.6	3.1	3.0	3.0		3.6	8.7	3.5	2.4	7.8		3.5	2.4		5.6	3.7	2.9	2.0	3.1	3.5	4.9	5.6	4.7	1.6			3.5		2.4	2.8	2.4	1.3	2.6	47.1	2.5	2.8	3.0	1.9	4.6	2.5	3.0	2.9	3.3	6.2	7.6	6.9	7.5	8.8	9.0	6.6	3.7	0.0	5.7	7.6	1.9	2.6	5.5	3.3	3.1	7.5	10.0	6.1	2.0	4.5	5.4	0.0	0.0	6.5	5.5	9.5	2.7	9.4	8.6	4.6	0.0	1.8	5.0	2.2	3.3	2.2	13.9	4.4	5.7	5.4	0.0	3.3	5.7	2.4	2.1	0.0	2.0	2.8	0.1	6.6	2.0	4.7	3.6	7.0	0.2	13.1	2.2	7.3	7.0	0.8	17.3	0.0	0.3	3.5	2.5	47.1	3.0	2.4	2.9	1.3	3.0	2.6	2.6	1.3	2.6	2.6	24.3	2.8	1.7	1.2	2.9	1.9											3.0	0.6	8.8	3.3	1.6	3.9	2.4	2.5	0.0	4.5	3.5	0.0	47.7	3.3	6.8	0.4	5.2	4.5	0.0	9.9	12.2	4.8	4.7	1.1	4.3	12.1	3.2	1.7	6.2	6.6	0.5	3.1	5.4	1.7	27.9	5.2	15.4	6.3	0.0	3.5	3.6	0.9	6.5	2.5	0.6	5.9	2.6	18.8	8.7	4.5	3.4
XKR9		ENSG00000221947	"XK related 9"	Q5GH70	8	70669365-70790371	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 17.1"	"Cell type enriched"	"Detected in many"	11	"Spermatocytes: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.4;hTCEpi: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044430	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044430: AB_10961283"	"unprognostic (1.79e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.29e-1)"	"unprognostic (6.96e-6)"	"unprognostic (3.65e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.71e-2)"	0.9	3.4	1.9	0.8	4.3	0.9	1.1	0.6	6.4	0.9	1.7	1.9	0.0	4.9	0.7	2.5	1.1	0.7	4.1	1.0	2.3	1.5	1.0	7.5	2.1	1.0	1.3	7.3	1.0	1.3	0.3	2.1	0.8	7.4	1.4	1.0	2.6	2.0	0.2	0.9	1.7	9.6	3.5	1.7	1.0	3.6	17.1	0.7	0.0	1.0	0.0	1.0	2.5	1.2	1.2	0.3	0.9	0.2	0.6	3.1	0.2	3.9	0.3	0.8	0.4	0.0	1.0	0.6	1.6	0.8	0.5	1.7	5.4	0.4	0.5	2.7	0.1	1.9	0.1	0.1	0.9	2.0	0.8	0.5	0.4	0.3	0.6	0.1	1.2	2.2	1.1	11.1	0.3	0.0	0.5	0.0	2.6	0.2	3.9	0.3	0.5	0.7	0.6	2.2	0.1	0.5	0.5	1.1	0.2	0.3	2.9	2.4	0.4	0.9	1.6	0.5	0.3	0.5	0.2	0.4	0.5	1.1	0.8	0.6	3.4	0.9	2.5	0.2	0.5	0.3	0.9	0.1	0.3	0.9	0.1	1.7	0.9	1.7	0.8	0.1	1.2	2.6	1.7	0.6	0.6	0.2	0.3	3.1	0.2	1.9	4.3	0.6	6.4	2.3	1.5	1.3	7.3	7.4	0.7	6.0	2.1	0.0	3.1	2.4	2.3	0.4	2.5	4.0	4.5	0.0	7.9	0.8	0.0	1.0	4.0	0.1	1.2	0.0	3.9	0.3	0.7	1.1	0.0	0.5	0.3	1.6	0.0	0.0	0.0	2.9	0.9	0.2	0.0	0.0	1.0	1.5	5.3	0.2	0.4	0.3	5.4	0.0	0.3	89.2	5.1	0.6	0.8	0.0	0.1	1.8
XPA	"XP1, XPAC"	ENSG00000136936	"XPA, DNA damage recognition and repair factor"	P23025	9	97674909-97697357	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000155, HPA056856"	Supported		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"CAB000155: , HPA056856: AB_2683258"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.55e-3)"	"prognostic favorable (4.28e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.17e-1)"	18.7	17.5	20.1	17.1	21.0	10.6	17.4	26.8	20.8	20.3	25.2	17.2	11.7	20.6	25.5	15.4	18.9	15.0	19.5	12.9	17.2	15.3	24.9	24.2	14.8	16.7	18.6	17.5	17.2	14.5	23.0	23.1	12.8	17.7	20.3	13.6	16.4	16.1	21.7	43.3	16.3	22.2	27.5	17.1	16.2	25.1	6.4	15.8	15.7	31.5	11.9	21.6	22.0	16.4	22.2	23.4	12.7	15.8	19.7	21.6	11.3	23.0	5.4	8.1	10.0	9.9	9.7	5.6	6.3	10.0	11.5	7.8	14.1	19.4	13.0	6.1	6.9	7.7	11.6	6.4	7.6	9.8	8.9	12.9	10.2	11.8	7.8	10.8	12.1	12.4	8.4	8.2	5.3	5.5	7.8	12.8	10.8	14.1	10.2	6.3	7.2	15.7	14.6	5.5	22.0	9.0	16.0	17.3	11.0	18.3	9.0	11.4	11.5	9.0	6.9	8.1	6.4	10.1	7.3	8.0	4.0	10.1	15.9	13.6	18.1	14.5	8.2	10.0	8.7	7.9	6.0	13.3	12.7	16.2	13.1	18.7	19.5	17.7	15.6	13.5	22.2	21.6	18.6	1.5	19.7	15.8	23.4	18.3	11.3	20.1	21.0	26.8	20.8	17.2	15.3	18.6	17.5	17.7	15.8	23.8	31.5	27.5	17.4	15.3	99.5	29.1	50.9	34.8	40.9	21.0	76.6	27.4	102.8	31.2	1.2	29.2	16.9	0.0	33.5	8.3	24.2	16.3	29.0	40.6	30.4	79.4	21.5	17.8	17.5	2.6	40.9	29.8	13.5	49.5	21.3	71.6	24.5	21.0	44.6	38.3	99.8	32.3	31.9	12.8	16.4	16.4	11.7	25.3	26.3	20.2
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738974-129769538	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 145.6;kidney: 49.7"	"Cell type enhanced"	"Detected in some"	23	"Enterocytes: 21.3;Hepatocytes: 11.6;Proximal tubular cells: 49.7"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2"	"Group enriched"	"Detected in many"	7	"monocytes: 4.4;T-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.3;ASC TERT1: 33.4;HSkMC: 16.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		8900000	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	4.7	0.5	0.0	1.1	0.1	0.0	3.2	0.0	0.1	1.7	57.4	0.1	0.8	37.0	1.2	1.7	4.2	3.4	1.3	2.6	0.0	0.0	49.7	8.0	1.0	1.2	0.0	0.0	3.5	0.9	0.0	0.0	0.6	0.1	3.6	2.0	0.7	0.7	0.3	1.6	2.1	145.6	2.5	0.1	0.2	1.7	1.2	0.0	0.1	0.9	1.4	0.3	4.0	10.7	0.4	0.8	0.2	4.4	0.0	7.3	1.3	0.0	0.0	0.5	0.0	6.3	33.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.3	2.1	2.2	0.0	2.4	4.8	0.3	0.4	0.7	3.6	0.2	0.0	4.4	0.8	2.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	5.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	4.4	0.0	0.0	11.6	0.7	0.0	1.2	0.6	0.3	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	5.8	0.0	49.7	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.0	0.2	0.0
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097979-28211920	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"neutrophil: 56.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 56.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (8.80e-4)"	18.4	14.1	24.3	32.0	25.0	47.9	17.7	16.0	30.6	12.4	17.7	30.4	9.9	13.4	13.5	12.0	16.8	14.1	14.9	9.6	27.5	23.9	13.3	19.1	20.6	54.6	25.6	16.9	15.3	13.2	22.0	18.0	25.9	21.7	14.1	17.0	16.3	19.4	13.1	8.3	18.8	18.3	16.3	23.8	50.4	14.8	28.9	19.8	37.1	18.0	7.8	31.8	17.2	13.2	5.2	2.6	56.4	4.4	2.7	6.5	2.0	28.5	20.5	18.1	19.4	12.6	20.0	20.8	35.4	32.0	41.4	42.0	28.7	20.5	20.3	30.5	32.1	21.1	18.7	42.9	27.1	50.4	45.7	26.6	22.2	28.9	32.0	29.7	31.0	25.0	15.7	20.2	36.8	36.5	17.8	23.8	20.7	40.4	10.3	28.0	32.0	37.2	36.9	30.6	13.9	19.6	34.9	21.5	33.6	15.4	14.6	35.3	19.2	17.5	29.2	15.5	21.0	21.0	20.5	25.1	35.0	23.5	29.8	29.4	24.0	30.3	30.1	26.7	32.3	29.5	4.7	2.7	8.4	4.1	3.0	4.4	5.2	4.7	4.4	2.0	3.9	5.2	6.5	56.4	2.7	4.4	2.6	3.8	2.0	24.3	25.0	16.0	30.6	27.5	23.9	25.6	16.9	21.7	19.8	8.9	13.9	21.7	8.2	16.6	23.8	6.6	2.5	9.4	10.3	22.7	29.5	9.8	6.6	13.3	27.6	10.6	14.7	0.0	16.4	13.9	12.4	15.6	2.3	14.0	19.9	20.6	22.7	8.6	23.4	30.6	10.0	14.7	6.8	27.1	21.5	8.3	18.1	14.0	8.1	5.0	26.3	6.5	11.3	29.5	29.2	18.6	7.0	20.8	17.0	12.6
XRCC2	FANCU	ENSG00000196584	"X-ray repair cross complementing 2"	O43543	7	152644779-152676165	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 12.7;testis: 11.7"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 19.4;Spermatocytes: 22.4;Spermatogonia: 24.3;Syncytiotrophoblasts: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065153			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA065153: AB_2685422"	"unprognostic (9.31e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.36e-5)"	"unprognostic (9.98e-3)"	"unprognostic (5.82e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-15)"	"unprognostic (4.52e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.73e-2)"	1.3	1.3	3.4	4.5	2.0	5.4	2.4	4.4	2.6	1.6	1.5	2.5	0.6	1.1	1.9	2.2	2.6	1.3	0.6	2.5	3.3	1.1	1.1	1.3	1.4	3.0	1.9	1.9	2.0	1.2	0.4	1.3	7.2	2.7	1.5	2.9	0.6	1.5	1.3	1.1	1.6	1.9	1.3	1.8	1.8	1.5	11.7	2.2	12.7	1.2	1.1	3.6	1.3	1.6	1.8	1.0	3.1	1.1	1.1	1.6	0.6	7.5	4.5	6.7	7.3	0.8	0.7	7.7	5.4	2.0	4.7	4.7	5.7	6.6	10.7	4.2	2.1	7.4	5.5	5.4	4.4	8.7	5.1	5.6	7.7	6.1	3.1	0.3	11.5	3.8	0.5	0.4	7.7	2.0	1.0	1.6	6.4	15.9	9.2	2.7	5.2	10.6	2.7	8.8	4.5	4.1	8.5	9.0	6.0	1.4	5.0	6.4	6.1	6.1	2.7	1.1	4.5	2.2	2.5	3.2	6.3	2.8	5.9	10.0	3.3	6.5	9.4	3.3	6.2	8.2	2.0	0.9	1.5	1.6	0.6	1.1	1.3	1.3	1.1	0.3	1.8	1.6	0.8	3.1	1.1	1.1	1.0	1.5	0.6	3.4	2.0	4.4	2.6	3.3	1.1	1.9	1.9	2.7	2.2	0.0	1.4	1.5	0.9	1.1	4.8	0.6	0.0	0.0	2.3	1.8	0.0	7.1	0.0	0.6	6.1	0.6	0.0	0.0	0.2	19.4	1.9	0.5	0.0	0.0	2.1	0.0	0.0	1.8	1.2	3.6	0.9	0.4	0.0	1.0	1.4	2.0	0.3	0.0	1.1	0.1	2.0	0.0	0.5	22.4	24.3	1.3	10.5	0.5	1.5	0.8
XYLB	"FLJ10343, FLJ12539"	ENSG00000093217	Xylulokinase	O75191	3	38346760-38421348	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Xylose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.0"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 42.9;Proximal tubular cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 6.4;monocytes: 3.6;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037863, HPA038415"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA037863: AB_10672729, HPA038415: AB_10672592"	"unprognostic (2.48e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.37e-2)"	2.3	3.2	2.7	1.9	3.4	2.5	3.0	10.3	4.7	2.7	5.9	2.3	1.6	5.8	3.7	3.6	3.1	1.9	2.5	1.5	1.8	1.8	11.3	34.0	1.8	1.3	1.9	3.3	2.8	6.1	1.2	3.1	1.4	4.1	2.1	5.1	3.0	7.1	1.8	1.3	1.9	9.8	3.6	2.0	1.6	3.7	2.1	1.6	2.3	1.5	1.8	1.3	2.7	2.9	0.4	6.4	1.1	3.6	0.9	3.9	1.1	3.0	5.8	2.1	4.7	2.9	3.3	5.2	4.3	1.6	3.9	3.8	7.8	3.3	2.7	1.1	5.5	5.0	2.1	6.3	2.6	4.3	3.8	4.9	5.3	4.5	21.3	1.8	7.6	5.8	2.1	4.4	5.3	2.1	1.2	3.5	7.2	14.6	5.3	3.7	1.6	6.5	1.0	3.1	6.4	7.0	3.2	4.2	3.9	0.4	4.8	2.6	2.5	2.5	11.6	9.4	1.9	5.6	4.4	1.4	7.4	5.8	11.2	1.9	2.8	4.6	7.4	4.0	6.3	5.4	0.5	2.2	0.7	1.5	3.6	1.0	0.3	1.2	0.8	6.4	0.4	1.5	1.5	1.1	0.9	2.9	1.3	3.9	1.1	2.7	3.4	10.3	4.7	1.8	1.8	1.9	3.3	4.1	1.6	0.0	2.2	0.0	1.6	0.8	3.1	0.8	0.0	1.4	2.3	0.0	0.0	3.2	1.7	0.9	0.2	1.0	4.9	0.0	2.6	3.0	1.3	0.9	0.0	42.9	3.4	0.0	0.0	1.8	1.2	0.0	1.4	2.3	0.0	1.0	4.7	0.4	1.3	6.6	1.8	19.9	5.0	0.0	0.9	0.3	2.7	0.6	1.1	0.5	4.5	1.8
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470881	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 92.3;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;ASC TERT1: 11.9;U-2197: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA		30000	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	5.7	5.9	6.3	21.6	3.1	5.9	7.0	3.8	6.7	8.0	7.4	1.4	0.9	3.9	7.4	3.0	4.9	3.2	4.4	3.8	6.3	4.2	1.9	0.9	2.9	7.5	4.3	2.2	5.5	2.6	0.2	1.8	5.4	2.6	4.4	4.9	3.4	2.6	4.3	1.3	4.1	4.7	5.1	3.9	6.3	3.2	3.0	2.1	4.6	2.7	6.7	6.6	4.7	4.2	1.2	0.8	1.2	3.6	0.9	0.7	0.5	0.0	0.1	2.7	0.0	19.2	11.9	3.3	8.5	4.3	1.0	0.4	0.2	0.2	2.1	0.0	10.3	0.3	0.2	0.0	1.7	1.5	4.1	0.2	2.6	0.0	0.0	0.2	3.7	3.5	4.4	0.2	5.5	0.8	1.6	0.0	0.2	0.3	8.0	1.0	0.3	0.0	4.0	2.9	1.4	0.0	1.2	0.0	0.4	0.0	3.9	0.7	5.2	0.6	2.6	0.5	2.1	0.7	2.3	0.0	9.0	1.0	19.7	0.0	9.0	0.5	3.9	10.0	4.2	7.6	0.6	0.6	1.2	0.6	2.5	0.7	1.2	0.5	0.3	0.8	1.2	0.5	0.4	0.3	0.9	3.6	0.2	0.7	0.5	6.3	3.1	3.8	5.3	6.3	4.2	4.3	2.2	2.6	2.1	3.0	4.5	7.5	1.5	7.0	13.3	2.7	0.0	0.0	1.2	0.0	92.3	9.8	0.0	1.2	0.4	2.2	5.1	0.0	1.4	16.8	16.2	3.4	2.3	0.0	3.3	0.0	12.1	2.5	8.5	0.4	11.8	8.0	3.3	2.8	3.8	1.3	2.6	7.0	47.0	0.2	4.1	6.5	5.7	0.2	2.5	16.2	11.0	4.4	6.5	4.2
YAE1D1	"C7orf36, GK003"	ENSG00000241127	"Yae1 domain containing 1"	Q9NRH1	7	39566376-39610320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019226, HPA031249"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA019226: AB_1845759, HPA031249: AB_2673807"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-3)"	11.9	17.3	24.1	14.2	26.0	2.7	20.2	28.6	23.6	16.5	20.3	15.9	16.3	15.7	19.5	26.2	15.9	18.4	12.6	17.8	19.1	17.4	17.3	13.0	12.2	10.1	20.1	20.3	25.2	13.2	16.9	27.6	12.5	18.1	15.6	22.8	10.9	15.2	14.5	14.1	12.1	22.2	17.8	21.1	11.2	15.2	20.9	23.4	9.9	16.7	8.6	10.2	15.2	13.6	12.2	8.0	12.0	5.2	7.5	19.2	6.6	11.6	7.8	16.7	18.3	13.2	13.5	9.9	17.2	15.2	15.9	18.1	6.6	7.0	6.6	8.5	14.4	27.5	12.3	15.7	12.0	15.6	6.5	13.0	6.1	9.7	12.9	12.0	6.2	4.6	12.3	10.0	16.6	18.7	9.6	13.8	5.9	19.2	3.0	13.8	8.2	5.1	12.6	36.8	14.8	9.3	7.0	9.8	7.6	15.1	10.9	21.2	24.0	14.1	19.7	18.1	19.3	17.7	12.1	9.2	8.4	15.6	10.2	14.8	9.8	20.7	14.3	10.0	14.3	24.4	12.0	5.0	6.3	8.3	5.2	9.0	12.2	10.7	12.0	5.7	11.4	19.2	13.5	0.5	7.5	3.8	8.0	11.5	6.6	24.1	26.0	28.6	23.6	19.1	17.4	20.1	20.3	18.1	23.4	6.0	5.6	3.4	6.2	4.2	12.8	14.9	5.1	28.1	23.9	15.7	2.0	13.0	28.2	12.3	33.7	10.5	17.3	0.0	10.7	11.2	12.2	4.5	9.2	7.8	8.6	3.2	8.6	4.3	4.0	12.1	20.8	3.4	5.0	4.6	21.5	18.3	12.6	11.4	20.1	21.4	11.2	6.5	11.3	33.4	26.0	5.0	4.2	6.9	13.6	3.1
YBEY	C21orf57	ENSG00000182362	"YbeY metallopeptidase (putative)"	P58557	21	46286337-46297751	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.3"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 253.1;Late spermatids: 197.2;Spermatocytes: 177.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016593, HPA018162"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016593: AB_1845698, HPA018162: AB_1845699"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.81e-1)"	"unprognostic (2.78e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-3)"	7.0	8.3	9.5	8.9	10.3	4.1	10.9	8.9	12.1	7.6	11.1	11.6	10.1	8.9	6.6	12.0	5.9	8.2	6.8	8.1	9.0	9.1	8.8	11.0	10.1	10.9	11.4	10.5	8.2	11.3	10.1	10.0	4.7	9.2	10.4	9.7	7.3	10.5	9.6	11.5	9.4	12.4	6.3	13.6	7.0	6.8	58.3	8.5	6.8	7.5	12.7	10.6	6.3	6.4	21.8	16.0	14.8	7.8	12.7	16.8	6.8	10.1	8.9	7.6	9.2	5.8	22.4	7.4	6.9	10.4	6.9	8.4	4.7	1.7	12.9	6.1	7.1	3.6	3.3	3.2	3.2	6.3	12.2	12.8	3.7	5.8	1.8	16.8	4.1	0.4	15.4	13.9	5.4	11.3	9.0	4.4	6.4	8.8	15.5	8.0	8.6	8.1	5.4	22.3	3.8	9.3	17.2	3.6	24.7	14.0	4.7	5.6	9.9	9.4	4.3	18.6	2.6	2.2	3.7	5.4	6.6	2.4	5.3	4.5	19.4	34.3	22.2	12.0	4.6	4.0	14.8	6.1	4.6	9.6	6.8	9.3	21.8	11.6	11.7	6.9	15.5	11.4	13.0	2.1	12.7	7.8	16.0	16.8	6.8	9.5	10.3	8.9	12.1	9.0	9.1	11.4	10.5	9.2	8.5	3.0	6.1	22.7	30.1	41.1	13.0	19.0	15.3	10.7	13.6	17.4	7.9	14.0	54.7	31.5	253.1	18.0	46.6	0.0	67.1	20.6	27.3	31.8	11.5	43.2	21.8	15.9	30.8	22.1	27.5	197.2	37.7	32.3	37.1	17.2	53.4	14.0	43.0	49.1	23.0	56.4	21.1	6.5	27.0	177.3	30.9	52.9	8.0	22.4	53.3	31.2
YDJC		ENSG00000161179	"YdjC chitooligosaccharide deacetylase homolog"	A8MPS7	22	21628089-21630064	"Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061005			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061005: AB_2684412"	"unprognostic (5.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (9.84e-4)"	"unprognostic (9.35e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.60e-2)"	"prognostic favorable (8.98e-5)"	5.0	6.5	8.1	12.4	6.9	4.0	4.9	5.8	12.3	9.4	9.8	6.0	6.9	10.3	5.4	5.8	9.4	8.3	7.0	3.5	8.6	5.7	12.4	10.2	5.3	13.3	5.9	3.8	7.9	19.2	9.2	4.4	7.3	5.8	7.1	6.2	4.3	8.2	6.1	4.6	8.1	11.8	4.5	5.9	10.2	7.4	4.2	3.8	10.3	14.6	7.5	13.8	7.1	5.5	20.4	18.1	11.6	15.4	21.4	16.0	11.7	3.8	0.9	0.1	0.3	1.2	0.9	4.4	1.7	1.0	1.0	1.7	0.3	1.5	3.8	6.4	0.0	1.0	3.4	1.2	2.9	1.6	3.3	13.0	5.4	0.7	4.7	1.6	9.6	4.1	1.4	5.9	0.8	7.5	1.1	2.9	5.8	39.8	0.7	0.7	4.0	3.5	13.6	1.5	11.0	7.3	2.4	0.0	3.8	7.1	2.0	5.1	3.2	1.6	2.5	3.5	0.0	3.4	4.6	2.4	0.4	4.8	1.0	2.2	7.4	4.2	3.5	0.4	2.9	0.8	7.6	15.4	11.6	11.1	13.6	11.2	18.1	15.8	12.1	18.1	20.4	13.8	12.6	5.6	21.4	9.7	12.3	16.0	11.7	8.1	6.9	5.8	12.3	8.6	5.7	5.9	3.8	5.8	3.8	6.0	8.0	46.3	34.3	22.1	4.4	3.2	17.8	4.0	3.4	41.8	0.0	36.6	33.2	53.1	17.0	14.7	35.8	0.0	37.1	56.3	10.3	33.7	11.5	13.0	26.8	3.2	15.5	3.7	14.1	3.2	9.8	24.8	13.5	70.3	27.8	5.3	44.3	33.4	6.3	52.1	4.7	19.4	8.2	13.0	32.4	19.8	19.3	33.0	35.4	36.1
YEATS2	"FLJ10201, FLJ12841, FLJ13308, KIAA1197"	ENSG00000163872	"YEATS domain containing 2"	Q9ULM3	3	183697818-183812625	"Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045891	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045891: AB_10961271"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.33e-3)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (6.90e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.08e-2)"	11.1	8.5	17.9	18.9	21.0	20.4	13.1	27.2	22.7	13.7	12.8	17.9	4.9	9.0	16.0	8.5	13.1	17.5	10.9	10.7	15.5	14.9	10.5	5.9	16.1	19.1	14.1	17.8	25.8	8.9	18.1	20.2	17.9	14.9	14.2	11.6	12.8	12.5	12.9	8.4	13.6	10.7	19.6	16.2	13.6	9.8	13.0	15.0	21.7	16.2	5.1	18.5	15.0	14.3	2.6	2.8	10.5	8.0	1.5	2.7	2.3	18.9	5.7	16.9	7.5	8.3	12.3	18.8	11.3	8.8	16.9	19.9	14.0	6.9	17.4	21.0	9.9	26.2	12.2	16.4	10.9	17.3	14.2	9.7	17.6	6.2	6.8	12.8	13.0	10.2	8.4	8.5	12.1	14.7	16.9	17.1	18.1	6.9	14.7	12.6	5.1	18.8	10.1	15.2	6.9	11.4	26.8	15.9	20.9	6.8	8.4	16.4	11.7	8.4	28.8	14.9	14.9	14.2	9.0	14.4	15.6	11.4	7.8	12.6	14.1	11.0	29.6	12.1	13.1	11.0	0.1	6.0	1.6	2.7	2.5	1.9	2.6	2.3	1.9	2.0	1.8	1.9	2.1	10.5	1.5	8.0	2.8	0.9	2.3	17.9	21.0	27.2	22.7	15.5	14.9	14.1	17.8	14.9	15.0	32.8	2.9	7.6	2.7	1.8	18.1	8.7	2.5	9.4	5.7	5.2	9.8	3.9	0.0	5.5	1.9	9.5	4.0	0.0	3.5	7.5	4.3	4.8	6.9	2.1	6.0	12.7	8.2	8.0	8.4	2.1	9.2	5.8	1.7	2.8	5.8	6.1	6.9	0.0	8.9	0.8	16.5	0.0	4.1	1.9	14.3	3.0	1.7	3.2	4.3	2.1
YEATS4	"GAS41, NuBI-1, YAF9"	ENSG00000127337	"YEATS domain containing 4"	O95619	12	69359703-69390796	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Spermatocytes: 352.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072532			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA072532: AB_2686530"	"unprognostic (7.23e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.05e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.77e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	10.0	13.4	10.7	12.9	11.7	33.1	15.6	21.2	16.0	9.4	10.3	8.2	5.6	11.4	10.6	13.6	12.7	10.8	7.3	10.2	10.2	11.4	13.0	12.6	8.8	17.6	13.8	8.1	10.7	19.2	6.0	14.7	9.2	11.5	9.6	12.1	12.1	12.1	9.0	12.5	9.5	11.2	9.7	11.7	12.1	10.3	51.6	10.9	22.6	12.2	13.4	16.7	10.1	9.8	13.5	10.7	14.7	15.1	12.8	23.1	13.0	17.3	8.9	17.5	10.8	4.1	6.6	14.1	10.5	11.3	18.7	15.6	10.3	5.2	35.4	10.3	5.7	9.5	13.5	13.9	10.7	18.4	17.3	15.2	20.3	7.1	12.5	5.7	29.4	18.0	4.8	13.7	9.9	14.8	9.5	10.6	29.4	17.1	43.3	9.1	8.7	41.3	32.2	24.5	11.7	12.3	22.0	16.5	17.2	10.4	15.8	19.5	13.3	10.9	10.6	17.1	11.5	20.3	17.4	6.2	7.7	7.8	21.3	12.8	11.5	14.0	38.6	8.3	14.1	13.4	5.2	7.8	14.7	13.5	11.0	15.1	13.2	18.9	14.1	10.7	13.5	23.1	19.5	4.0	12.8	15.1	8.9	18.3	13.0	10.7	11.7	21.2	16.0	10.2	11.4	13.8	8.1	11.5	10.9	6.0	19.6	31.4	31.2	26.4	23.3	22.2	15.3	24.1	25.0	10.4	11.8	38.5	39.7	23.6	5.4	14.6	15.1	46.7	33.9	48.2	16.2	30.4	18.5	16.6	33.0	17.5	16.9	9.8	10.0	12.0	17.3	24.0	11.8	56.9	25.2	21.7	26.2	17.5	22.6	28.7	21.9	19.4	14.6	352.0	74.5	28.0	19.7	33.1	35.3	31.0
YIF1B	FinGER8	ENSG00000167645	"Yip1 interacting factor homolog B, membrane trafficking protein"	Q5BJH7	19	38305104-38317273	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 83.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039328, HPA055257, HPA062675"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA039328: AB_2676445, HPA055257: AB_2682762, HPA062675: AB_2684830"	"unprognostic (2.51e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.53e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.94e-3)"	15.8	16.5	18.6	24.1	21.3	46.0	17.1	19.3	34.4	13.9	15.8	27.4	13.9	15.7	12.4	12.4	17.5	14.8	13.0	18.4	21.8	19.6	16.7	59.7	17.6	25.2	23.5	24.0	13.9	21.0	10.8	15.1	18.2	25.9	12.4	12.9	13.5	21.2	12.0	20.3	14.3	14.2	14.2	27.1	24.3	11.5	13.5	20.9	18.2	11.7	16.6	15.7	15.6	12.5	10.8	67.3	38.5	35.9	9.1	14.6	24.3	11.9	30.6	13.7	16.2	20.0	18.6	10.9	29.2	22.3	21.7	31.9	14.9	9.0	21.0	12.8	33.5	23.3	7.7	24.2	15.2	8.3	22.2	12.8	32.2	13.7	15.4	27.7	22.4	38.2	15.2	13.6	22.2	9.7	21.9	20.1	28.0	41.4	58.3	19.2	12.7	23.5	26.9	10.5	20.5	9.8	24.4	16.7	32.1	13.9	11.3	10.0	16.8	9.5	21.7	15.5	11.1	8.4	45.0	19.1	21.5	21.5	30.9	23.0	21.9	32.2	13.9	27.8	41.3	15.4	15.4	35.9	38.5	14.6	26.2	12.8	10.8	13.8	13.0	67.3	8.4	11.5	11.6	9.8	9.1	14.7	28.4	12.8	24.3	18.6	21.3	19.3	34.4	21.8	19.6	23.5	24.0	25.9	20.9	0.0	5.6	13.7	16.9	15.8	10.7	3.7	12.7	9.4	1.2	21.0	11.8	40.5	0.0	33.6	4.5	16.1	10.9	0.0	24.4	43.9	31.0	17.7	23.0	28.2	83.7	11.1	13.8	42.4	37.3	8.2	8.3	37.6	33.7	28.9	14.7	19.4	18.4	14.0	8.5	12.9	11.0	6.5	4.2	17.9	28.5	17.6	23.1	12.9	20.9	18.0
YIPF1	"DJ167A19.1, FinGER1"	ENSG00000058799	"Yip1 domain family member 1"	Q9Y548	1	53851719-53889834	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014716, HPA073931"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA014716: AB_1847686, HPA073931: "	"unprognostic (4.94e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.96e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.35e-1)"	10.1	15.6	12.8	9.1	13.9	8.0	18.2	6.9	12.8	11.2	12.1	8.8	11.5	11.0	6.6	12.2	14.0	10.2	10.8	13.4	10.6	12.1	16.1	31.8	11.9	14.1	12.4	9.1	11.8	13.7	7.2	15.5	15.4	14.4	17.8	14.4	10.2	17.1	14.3	18.7	13.9	10.6	9.4	10.6	13.3	13.0	10.8	11.1	10.3	33.5	9.8	15.7	12.9	16.2	8.1	11.4	26.7	14.5	6.9	16.0	10.2	6.9	4.2	6.7	4.7	7.9	8.9	6.0	5.0	7.9	9.3	12.2	4.8	2.1	2.3	8.5	6.0	14.3	8.3	8.8	11.1	9.6	17.6	7.0	5.8	4.7	7.2	10.9	6.4	5.5	8.9	10.5	7.4	9.0	7.9	10.0	8.7	6.0	6.7	9.0	5.9	6.5	9.3	4.9	8.2	7.0	4.1	6.3	9.9	7.9	3.6	3.0	3.8	4.7	9.0	23.0	22.1	13.9	7.2	4.5	3.8	3.9	6.7	4.3	13.5	15.4	4.3	5.8	5.3	3.3	12.5	12.5	13.2	8.5	11.3	8.0	8.1	7.3	8.5	11.4	7.7	7.1	6.7	26.7	6.9	14.5	7.8	16.0	10.2	12.8	13.9	6.9	12.8	10.6	12.1	12.4	9.1	14.4	11.1	6.0	13.0	10.7	15.1	7.6	6.5	8.5	28.1	14.7	15.9	8.7	0.0	65.7	10.0	23.6	22.9	8.7	11.7	0.0	28.3	23.0	8.3	37.4	9.2	17.4	34.5	9.5	9.2	13.5	19.9	41.4	5.5	15.8	10.1	16.2	23.0	16.2	25.6	12.9	8.9	13.5	5.4	0.0	6.2	12.7	18.3	9.5	108.4	13.8	9.5	22.0
YIPF2	"FinGER2, MGC3262"	ENSG00000130733	"Yip1 domain family member 2"	Q9BWQ6	19	10922185-10928681	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 137.6;Syncytiotrophoblasts: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019902	Approved		Approved	"Golgi apparatus,Mitochondria"		No	No			"Golgi apparatus, Mitochondria"		"HPA019902: AB_1858925"	"unprognostic (1.27e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.00e-2)"	11.8	16.4	9.2	8.3	9.3	13.5	12.9	12.0	16.8	16.0	13.8	11.9	15.3	17.0	14.4	26.7	17.1	17.6	16.7	11.9	9.7	10.6	16.4	34.3	11.8	9.6	10.7	10.3	18.4	56.4	11.1	40.7	35.5	11.9	14.0	8.4	16.6	53.5	20.7	11.1	11.2	14.6	8.8	8.4	10.2	18.4	52.0	10.6	11.0	22.1	12.9	12.5	13.9	13.8	10.8	22.3	16.2	14.7	7.2	9.8	6.7	23.4	8.7	5.8	9.2	14.7	13.8	11.9	18.8	21.8	12.8	18.2	25.8	19.4	4.6	30.7	19.3	6.3	18.3	4.5	18.0	3.6	15.1	16.3	9.1	9.7	13.9	24.0	15.3	19.0	13.5	12.8	9.0	14.0	18.5	9.9	11.6	11.4	25.1	8.7	40.0	9.6	15.6	11.1	16.3	20.9	8.4	5.4	23.4	12.2	11.1	17.4	8.7	13.1	20.9	17.7	5.9	19.9	21.3	14.5	16.1	6.0	23.4	13.3	37.4	14.5	8.5	25.7	26.9	17.1	16.2	13.2	5.6	9.8	14.7	7.6	10.8	7.9	9.0	14.8	7.2	7.0	9.8	2.1	7.2	12.4	22.3	7.8	6.7	9.2	9.3	12.0	16.8	9.7	10.6	10.7	10.3	11.9	10.6	14.9	20.5	9.3	35.0	6.1	17.3	0.4	20.4	21.4	17.0	33.2	15.7	94.1	23.2	58.8	86.2	17.8	35.4	23.3	70.3	97.9	24.7	46.0	21.8	21.7	35.3	17.5	41.7	19.0	13.7	19.8	32.5	13.1	5.0	26.2	53.9	20.9	45.9	45.6	24.1	19.5	15.3	6.5	13.3	137.6	10.6	6.0	145.8	12.8	47.0	38.9
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511827-43516990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	26.8	51.0	26.1	20.3	36.8	19.3	28.1	24.2	48.9	33.5	30.4	38.1	40.3	31.9	31.2	50.5	31.9	34.4	39.9	30.9	26.2	25.5	44.2	62.0	30.0	21.1	26.1	21.4	34.0	73.7	47.0	38.9	59.3	29.7	36.0	29.9	36.8	75.4	31.8	30.6	26.9	38.4	27.4	28.1	28.0	38.8	27.8	22.6	27.9	51.2	31.3	32.9	32.8	26.5	11.7	18.5	74.3	19.7	14.6	18.3	16.0	19.0	13.4	19.8	38.3	44.6	36.1	11.9	23.0	35.7	19.1	24.2	16.0	13.9	7.8	18.4	42.2	16.5	19.2	14.5	22.4	12.1	14.3	20.8	12.2	19.8	30.4	34.6	12.9	18.4	36.0	29.3	16.2	16.1	32.5	28.7	13.3	13.2	18.1	22.7	29.2	9.8	16.5	10.2	99.8	14.9	8.7	9.1	20.6	34.0	20.3	16.0	22.9	10.4	13.9	24.3	15.7	22.9	27.2	27.3	21.7	11.4	11.9	15.8	21.3	17.1	15.5	15.4	11.2	14.6	26.2	19.7	28.3	15.3	18.5	13.3	11.7	13.8	13.5	18.5	11.7	11.3	12.6	74.3	14.6	18.4	17.0	18.3	16.0	26.1	36.8	24.2	48.9	26.2	25.5	26.1	21.4	29.7	22.6	32.8	25.2	38.7	57.7	36.1	56.4	26.7	56.0	32.1	39.8	52.4	35.3	167.5	41.4	124.0	24.9	56.8	99.6	23.3	88.8	180.7	66.2	64.5	40.3	62.3	87.8	55.6	102.8	65.7	41.3	59.8	64.7	40.3	62.4	92.8	108.3	110.5	105.8	94.7	62.9	58.6	49.3	32.3	47.5	38.7	38.1	31.0	220.8	42.4	69.7	72.1
YIPF4	"FinGER4, MGC11061"	ENSG00000119820	"Yip1 domain family member 4"	Q9BSR8	2	32277910-32316594	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017884	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA017884: AB_1853855"	"unprognostic (5.61e-3)"	"unprognostic (8.50e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.11e-2)"	15.2	15.3	15.7	12.3	19.2	6.0	19.5	24.9	27.2	15.6	16.0	21.7	16.9	13.6	19.6	17.7	15.3	13.3	12.3	19.1	17.7	16.5	18.7	24.0	13.4	12.9	18.5	13.3	17.9	32.9	14.2	22.3	19.2	17.6	16.1	15.0	15.4	24.1	14.2	16.8	16.5	14.6	15.8	17.7	15.4	14.7	15.2	16.3	18.7	23.6	12.2	13.6	14.6	14.2	5.0	5.8	16.5	6.0	7.0	5.4	4.4	8.4	4.3	8.5	7.6	9.9	12.7	4.5	7.3	7.4	7.7	5.1	5.7	6.5	4.5	5.1	7.9	7.5	6.7	9.0	6.4	10.0	7.3	14.0	7.3	10.0	10.3	11.8	9.6	6.3	8.9	12.4	6.9	11.0	10.6	6.5	5.1	10.0	9.5	8.3	5.6	7.5	10.1	6.9	9.1	7.4	5.3	12.6	8.5	8.2	3.7	9.7	9.2	6.2	6.4	10.9	5.8	3.5	8.3	7.2	10.2	4.8	7.1	6.9	14.2	17.4	5.5	16.1	9.4	5.6	12.5	6.0	5.9	5.0	5.4	4.3	5.0	5.1	4.7	4.9	4.8	5.4	4.7	16.5	7.0	5.2	5.8	4.7	4.4	15.7	19.2	24.9	18.9	17.7	16.5	18.5	13.3	17.6	16.3	86.4	64.5	59.0	48.6	45.6	109.0	77.0	50.9	49.5	40.9	40.1	100.1	58.6	28.2	42.9	22.0	54.1	56.2	46.7	34.1	57.3	61.5	64.5	39.3	72.0	43.8	95.3	54.9	63.8	64.4	15.3	80.3	61.7	77.6	48.7	58.6	63.3	40.9	62.2	70.4	50.8	120.9	77.6	52.3	130.7	39.6	57.6	161.2	62.3	46.1	46.3
YIPF5	"FinGER5, SMAP-5"	ENSG00000145817	"Yip1 domain family member 5"	Q969M3	5	144158159-144170714	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042338, HPA073622"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Endoplasmic reticulum, Golgi apparatus, Vesicles"	Nucleoplasm	"HPA042338: AB_2677953, HPA073622: AB_2686618"	"prognostic unfavorable (7.83e-5)"	"unprognostic (1.13e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.12e-5)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.49e-2)"	26.6	26.6	18.4	14.7	21.2	15.8	22.5	19.2	22.6	23.9	22.2	17.2	22.5	26.5	25.7	22.0	27.2	18.9	19.0	18.3	15.1	18.5	23.0	27.8	20.4	21.0	16.2	20.5	19.6	41.7	21.5	45.3	37.1	21.8	16.8	23.4	18.9	32.7	18.3	11.9	24.5	30.5	25.2	19.7	18.8	23.8	20.7	16.2	14.0	20.2	21.2	20.1	24.1	19.9	22.3	27.2	28.8	28.1	23.7	36.7	23.4	11.5	7.7	10.1	8.0	24.2	26.2	9.2	39.5	26.9	17.8	28.8	12.3	12.2	6.3	19.1	42.8	20.5	10.7	9.6	19.4	24.1	8.8	8.3	4.7	13.5	12.5	19.6	10.4	7.8	19.8	18.2	15.9	13.1	30.8	16.9	7.0	4.9	10.7	24.0	6.0	5.1	5.9	6.5	7.4	8.5	5.4	15.0	10.5	11.1	10.3	6.9	8.5	13.7	7.4	17.5	10.7	15.3	6.9	64.9	21.0	10.2	20.3	15.5	9.7	16.1	8.0	20.1	10.0	15.3	25.6	21.0	28.8	30.3	28.1	34.3	22.3	31.0	33.6	25.0	21.5	32.8	30.8	15.6	23.7	25.4	27.2	36.7	23.4	18.4	21.2	19.2	22.6	15.1	18.5	16.2	20.5	21.8	16.2	35.7	24.3	40.2	21.0	26.2	39.5	19.3	22.9	49.5	26.1	19.2	31.4	48.9	26.6	36.5	8.3	38.7	36.0	46.7	60.0	68.2	45.1	27.2	35.8	30.5	33.0	31.8	14.3	33.2	27.9	5.3	32.8	24.3	28.7	34.3	44.6	54.8	46.2	31.9	31.8	30.4	43.2	38.8	28.8	78.4	48.5	22.7	56.4	34.5	25.2	18.5
YIPF6	"FinGER6, MGC21416"	ENSG00000181704	"Yip1 domain family member 6"	Q96EC8	X	68498323-68537285	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003720	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA003720: AB_1080626"	"unprognostic (5.07e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.32e-2)"	13.3	15.6	16.5	7.2	17.7	4.9	15.8	12.9	17.1	16.0	12.3	17.3	11.6	11.5	14.0	16.2	13.6	13.7	11.2	11.9	14.9	14.4	19.6	28.3	12.7	6.2	17.6	13.1	11.5	26.8	18.0	32.9	32.4	16.1	21.1	14.6	11.7	16.0	16.1	18.1	10.9	14.4	16.9	17.1	8.8	14.9	6.9	15.3	4.3	22.4	7.4	10.9	13.4	11.4	4.0	3.8	12.4	4.6	3.1	2.7	3.1	11.5	9.5	12.2	4.0	16.9	10.7	11.6	9.4	12.1	7.5	9.5	9.7	12.4	0.1	16.4	8.2	11.6	9.4	16.0	6.6	13.2	3.4	9.4	4.7	11.2	9.3	15.3	5.6	7.6	10.2	12.7	11.0	14.5	13.7	7.6	6.6	7.8	10.8	10.8	10.2	3.3	5.0	12.9	18.1	12.2	3.2	14.9	6.5	13.3	11.3	12.8	14.1	15.0	11.2	11.2	11.9	7.0	5.7	9.1	7.5	6.6	27.4	17.6	6.3	7.5	2.5	13.0	8.9	13.3	5.4	4.6	5.2	2.7	4.6	1.8	4.0	2.7	2.3	3.3	2.5	2.7	2.4	12.4	3.1	4.2	3.8	2.6	3.1	16.5	17.7	12.9	15.6	14.9	14.4	17.6	13.1	16.1	15.3	65.5	102.0	29.5	53.1	31.0	52.2	31.9	35.7	56.2	60.3	54.1	45.2	87.0	29.9	37.4	20.1	38.0	36.0	23.3	38.3	78.0	44.1	79.2	51.0	53.4	38.8	42.9	52.2	41.1	19.9	45.3	39.4	40.2	33.7	17.2	48.8	63.4	44.2	31.6	44.6	57.6	50.2	25.8	43.8	21.3	29.6	37.9	233.2	30.6	31.6	72.1
YJEFN3	"FLJ44968, hYjeF_N3-19p13.11"	ENSG00000250067	"YjeF N-terminal domain containing 3"	A6XGL0	19	19528861-19537581	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.8"	"Group enriched"	"Detected in many"	16	"Early spermatids: 137.6;Late spermatids: 456.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 11.4;HEK 293: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA060789	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060789: AB_2684366"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.99e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.37e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.25e-4)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.17e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-3)"	1.2	0.9	24.2	1.4	47.8	0.8	1.0	0.8	26.5	1.1	1.3	1.1	0.0	1.0	1.3	6.6	1.0	1.6	0.9	0.8	29.5	8.3	1.0	0.8	1.4	1.4	7.7	10.2	1.1	1.0	1.7	0.8	1.3	3.6	2.0	1.6	4.1	0.9	1.5	1.6	3.0	1.6	1.2	1.0	1.1	1.4	7.1	5.1	0.0	1.7	0.0	1.3	1.5	0.0	0.5	0.5	0.3	1.1	0.0	2.2	0.3	0.3	0.8	1.9	0.8	0.3	0.5	11.4	0.5	0.1	0.5	0.7	0.9	0.6	0.4	1.5	0.1	0.2	1.1	0.3	0.2	0.0	0.1	13.4	0.0	1.6	0.0	0.1	0.3	0.6	0.1	0.6	0.3	0.4	0.1	0.0	0.9	0.9	0.6	0.0	1.0	0.0	0.1	3.6	0.0	2.6	2.1	0.4	0.4	0.0	0.1	0.3	3.2	0.2	0.0	0.2	0.6	1.3	1.6	0.7	0.3	0.7	3.5	0.8	3.2	2.2	0.6	0.2	1.7	0.4	0.0	0.7	0.0	0.7	1.1	0.8	0.3	1.2	0.6	0.5	0.5	0.7	1.1	0.3	0.0	0.7	0.0	2.2	0.3	24.2	47.8	0.8	26.5	29.5	8.3	7.7	10.2	3.6	5.1	8.9	0.3	1.3	2.5	1.8	18.1	1.6	2.5	2.7	6.8	0.0	9.8	1.3	1.7	1.7	137.6	1.6	4.7	0.0	0.5	1.0	2.7	2.1	1.1	1.0	1.0	9.5	5.2	1.8	0.3	456.0	3.4	1.5	1.7	0.0	6.3	7.2	0.5	3.5	1.8	0.3	14.9	6.5	3.9	14.0	9.6	3.6	1.5	2.9	5.0	0.9
YKT6		ENSG00000106636	"YKT6 v-SNARE homolog"	O15498	7	44200968-44214294	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030817, HPA030818"	Approved		Approved	Mitochondria,Cytosol		No	No			Cytosol	Mitochondria	"HPA030817: AB_10599828, HPA030818: AB_10602102"	"unprognostic (1.25e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.30e-3)"	"unprognostic (7.80e-3)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.66e-3)"	26.5	21.9	35.1	21.4	30.6	31.1	23.1	19.0	32.2	21.8	27.6	26.5	27.9	21.1	21.0	32.6	31.1	16.0	16.8	22.3	34.9	33.5	24.4	17.3	19.6	25.7	36.1	24.0	14.3	51.2	29.7	21.6	25.7	26.8	21.3	26.7	18.3	39.1	24.6	29.1	21.8	21.7	27.1	31.4	20.5	24.9	27.3	25.1	22.2	21.0	23.4	26.3	17.5	15.5	7.7	11.1	15.7	12.8	7.2	12.4	6.3	22.6	23.9	20.1	28.1	25.3	22.2	16.6	45.7	35.1	25.6	26.0	25.1	18.8	21.6	20.6	44.8	49.3	28.0	24.6	30.2	32.7	26.0	23.5	12.6	17.7	15.7	31.7	26.7	23.1	20.7	29.6	31.2	33.4	22.7	30.8	19.9	29.2	16.0	33.9	23.4	19.9	29.7	49.2	30.4	40.0	21.9	18.2	18.6	21.1	19.1	23.6	46.4	21.7	34.7	24.7	29.8	27.3	27.6	35.2	27.5	34.1	27.2	50.2	42.7	47.1	32.1	37.4	23.7	53.8	5.9	11.2	15.7	7.8	12.8	11.0	6.9	9.2	12.4	10.3	7.7	8.8	8.6	9.5	7.2	12.1	11.1	9.4	6.3	35.1	30.6	19.0	32.2	34.9	33.5	36.1	24.0	26.8	25.1	11.9	10.3	13.7	14.7	23.1	6.4	17.3	7.6	1.4	6.8	19.2	9.8	21.7	21.6	42.1	21.1	14.0	30.8	0.0	71.4	49.0	21.6	29.1	1.1	14.3	36.6	12.7	13.3	11.1	19.6	5.9	9.2	17.2	25.3	55.1	24.1	9.8	58.9	17.5	12.7	18.2	7.7	0.0	18.4	15.6	18.8	22.6	41.2	8.5	18.3	28.6
YPEL5	CGI-127	ENSG00000119801	"Yippee like 5"	P62699	2	30146941-30160533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.9"	"Cell type enhanced"	"Detected in all"	4	"monocytes: 480.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042809	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA042809: AB_2678179"	"unprognostic (7.22e-3)"	"unprognostic (6.50e-3)"	"unprognostic (9.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.67e-3)"	29.6	32.5	39.0	20.1	38.2	164.9	32.9	34.2	52.9	31.2	34.6	20.7	38.2	19.4	28.7	40.9	35.1	25.6	30.8	26.1	38.1	39.5	40.5	29.8	31.9	30.5	35.3	32.5	30.0	23.4	24.6	26.0	48.1	36.4	33.8	22.2	33.1	28.7	47.6	27.7	26.1	29.1	36.8	30.6	29.6	27.2	31.4	18.3	34.2	39.0	20.6	28.2	40.1	25.2	21.3	35.0	72.4	31.9	12.5	21.6	30.9	9.9	5.5	12.0	5.9	34.1	33.1	10.2	14.1	43.7	8.2	12.7	4.5	10.3	5.9	9.6	28.4	19.0	5.4	2.7	14.4	11.6	26.1	5.4	3.1	2.5	7.2	29.1	1.0	7.2	34.1	29.4	15.5	20.0	35.6	15.5	3.9	4.3	10.5	22.1	5.2	3.2	7.2	6.7	11.5	6.5	1.9	16.3	5.6	27.5	19.4	4.8	14.9	7.2	6.9	17.5	23.0	7.7	5.8	20.3	22.3	8.6	6.1	3.9	25.1	9.8	7.9	15.9	2.8	9.0	41.7	19.6	43.1	13.6	21.8	13.5	21.3	16.6	15.9	18.2	17.4	16.0	14.1	72.4	12.5	31.9	35.0	21.6	30.9	39.0	38.2	34.2	52.9	38.1	39.5	35.3	32.5	36.4	18.3	77.4	75.1	107.8	142.4	118.9	71.0	67.4	35.7	57.6	64.8	96.0	45.2	147.4	117.7	76.8	214.0	63.9	69.5	116.8	69.5	110.5	88.3	121.7	81.7	36.8	91.0	60.4	200.3	49.1	87.4	400.6	53.5	101.5	161.9	480.7	69.6	83.5	86.2	73.7	77.8	97.1	49.3	51.8	103.9	99.6	72.4	124.6	341.2	117.6	43.7	247.9
YRDC	"FLJ23476, IRIP, SUA5"	ENSG00000196449	"YrdC N6-threonylcarbamoyltransferase domain containing"	Q86U90	1	37802944-37808185	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 58.4;Urothelial cells: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 9.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030147	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030147: AB_10603327"	"unprognostic (2.98e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (5.43e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-2)"	10.8	10.0	7.7	9.3	8.0	41.6	13.0	10.6	13.1	8.2	9.6	9.8	7.2	8.2	8.3	8.8	16.3	8.8	13.5	9.0	8.6	9.0	11.7	22.5	9.3	16.2	8.1	7.4	8.1	19.7	7.5	11.3	22.2	8.5	9.2	12.2	8.7	12.5	6.6	13.0	14.6	11.9	9.5	7.5	11.2	10.2	20.6	7.0	13.5	9.3	11.5	12.0	9.1	9.2	1.6	1.6	9.6	1.1	0.9	2.1	0.7	10.5	7.6	8.2	10.4	5.7	6.6	23.7	8.8	7.1	13.9	8.8	10.1	10.2	25.5	14.4	8.7	16.0	8.6	15.4	14.1	13.0	15.3	15.4	17.8	9.3	10.5	12.6	23.1	18.5	6.8	21.2	15.4	22.4	9.1	9.7	19.7	27.6	11.5	11.0	7.5	13.4	13.7	30.8	15.4	16.2	13.6	13.3	16.6	11.4	10.8	21.4	22.1	9.5	12.3	30.0	15.3	6.7	10.3	9.0	12.0	12.5	13.1	28.9	23.7	33.2	21.2	10.5	15.1	19.1	9.6	1.1	0.9	1.2	1.1	1.1	1.0	1.7	0.9	0.9	1.6	1.9	2.1	1.3	0.9	0.7	1.6	1.7	0.7	7.7	8.0	10.6	13.1	8.6	9.0	8.1	7.4	8.5	7.0	0.0	8.6	8.3	58.4	45.0	10.7	3.4	15.3	4.0	4.5	5.2	5.9	21.5	19.9	5.2	2.7	12.0	6.4	0.0	7.9	42.6	12.4	31.3	6.9	9.8	11.4	20.6	15.0	7.4	6.7	1.8	3.7	9.6	5.0	3.6	9.8	9.4	12.2	5.8	3.9	11.7	8.0	6.5	18.9	15.1	35.7	43.2	34.0	10.0	9.6	71.6
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350089	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (7.29e-5)"	22.1	16.6	25.1	28.8	33.2	101.8	24.3	38.4	25.8	30.3	20.8	24.4	24.0	16.7	29.2	25.1	25.4	20.2	17.6	18.5	23.5	19.6	19.8	19.5	21.1	26.8	26.1	23.4	39.7	24.2	27.6	32.4	33.2	22.8	25.2	21.3	13.8	22.7	30.2	32.9	26.1	21.2	27.6	25.4	23.6	20.6	17.7	35.1	30.2	23.8	20.2	26.7	34.8	30.3	18.0	15.1	41.6	9.3	7.5	11.1	3.2	17.6	10.6	21.7	13.0	13.1	11.4	18.0	19.5	12.3	12.2	12.9	13.1	16.3	29.0	16.0	9.9	9.9	13.4	20.3	17.1	19.9	21.4	12.3	22.1	15.2	14.5	13.4	23.3	17.1	10.8	18.6	10.9	26.2	15.7	13.2	14.1	20.8	17.1	17.8	13.5	27.1	21.0	16.3	17.3	10.5	23.8	24.6	12.9	19.1	20.5	18.9	14.8	17.0	18.4	14.1	21.2	14.4	16.3	13.9	14.1	14.9	9.7	12.8	17.8	11.9	30.3	9.5	15.2	12.9	20.2	8.3	14.7	9.9	5.0	7.7	12.7	8.0	7.9	4.6	18.0	11.1	9.2	41.6	7.5	9.3	15.1	7.3	3.2	25.1	33.2	38.4	25.8	23.5	19.6	26.1	23.4	22.8	35.1	104.2	120.5	72.4	101.3	106.6	102.8	78.1	73.9	139.2	159.3	69.8	66.8	58.2	44.7	60.9	61.3	76.3	40.0	23.3	49.7	94.0	62.9	98.5	88.2	72.1	37.8	85.8	82.2	47.9	51.2	14.3	69.0	70.8	60.8	45.1	60.5	91.4	65.5	48.7	63.6	32.1	131.7	51.8	97.3	131.7	89.6	117.6	99.5	74.8	54.4	85.9
YTHDC2	"DKFZp564A186, FLJ10053, FLJ2194"	ENSG00000047188	"YTH domain containing 2"	Q9H6S0	5	113513683-113595285	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 92.8;Spermatocytes: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037364, HPA072678"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytoplasmic bodies"	"HPA037364: AB_10672788, HPA072678: AB_2686548"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.82e-3)"	"unprognostic (3.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	15.2	16.3	12.4	18.5	16.8	12.8	15.3	25.2	26.1	16.5	12.7	11.7	9.0	13.6	17.7	14.6	16.1	14.2	12.2	13.0	10.4	10.5	14.3	18.3	12.4	18.7	12.8	10.2	19.9	14.7	35.5	26.2	10.3	18.6	12.8	15.3	14.9	15.5	13.3	18.5	16.5	16.5	13.2	13.7	19.3	13.4	20.5	13.3	19.7	16.2	15.4	18.4	14.7	14.8	9.5	5.5	4.2	4.9	5.7	5.7	1.7	11.1	10.1	13.1	22.2	7.3	9.7	14.4	8.7	9.6	11.1	17.4	7.0	6.3	20.4	6.2	7.2	14.3	10.9	15.8	19.4	14.6	8.8	14.3	11.1	18.1	9.5	10.8	8.8	9.8	7.9	7.5	7.0	12.8	10.5	15.4	9.3	10.8	9.4	9.8	3.7	12.2	6.3	6.1	3.3	6.7	5.2	11.4	15.8	9.3	14.8	10.5	8.8	11.6	8.5	8.9	8.6	12.0	8.0	13.4	17.1	6.0	8.8	11.7	9.7	12.1	12.8	9.8	10.1	7.2	0.0	4.3	4.2	4.5	2.8	5.3	9.5	5.3	4.8	3.6	8.1	5.7	4.7	1.8	5.7	4.9	5.5	3.7	1.7	12.4	16.8	25.2	26.1	10.4	10.5	12.8	10.2	18.6	13.3	26.8	29.1	18.2	17.4	11.7	58.8	17.3	12.7	28.1	30.7	12.2	78.5	11.1	0.0	15.3	22.0	18.5	11.2	23.3	16.5	8.1	14.7	12.8	11.6	19.7	14.4	49.3	6.9	20.9	27.6	37.6	18.4	18.8	11.8	17.2	13.0	25.3	13.7	7.0	13.8	15.2	92.8	25.8	19.4	97.9	24.0	12.5	15.1	21.2	13.6	15.2
YTHDF3	FLJ31657	ENSG00000185728	"YTH N6-methyladenosine RNA binding protein 3"	Q7Z739	8	63168553-63212786	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048703			Approved	"Nuclear membrane,Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	"Nuclear membrane, Cytosol"	"HPA048703: "	"unprognostic (1.06e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.65e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.11e-1)"	21.7	17.5	12.2	12.8	15.2	53.2	16.0	16.7	17.3	19.4	20.2	14.3	16.8	14.2	24.3	13.6	17.7	17.6	17.6	26.9	11.9	11.4	18.8	26.8	16.8	12.4	14.2	10.6	25.1	15.6	16.6	19.3	29.0	16.8	21.2	15.6	12.9	18.1	18.8	28.0	12.7	24.7	19.4	14.4	18.1	15.9	13.3	14.2	20.1	17.2	15.9	14.1	21.0	15.9	8.2	16.9	21.2	24.9	9.7	11.0	10.1	16.3	22.2	21.3	16.0	28.6	24.6	14.7	29.8	25.0	18.9	22.5	18.8	16.4	17.3	6.5	29.0	21.4	15.6	28.1	19.8	28.1	14.0	13.3	32.2	16.8	12.7	26.0	9.1	15.9	32.5	15.3	20.2	28.4	19.4	15.9	10.8	18.8	15.9	28.4	11.3	17.5	8.5	29.7	21.5	16.4	13.3	16.3	8.5	17.8	29.0	8.8	15.6	21.1	19.1	21.6	19.1	25.6	11.6	28.6	17.6	17.1	15.7	15.9	19.1	17.2	25.9	18.0	12.9	21.2	20.6	16.6	17.4	8.9	19.4	9.8	7.4	9.0	10.5	16.9	8.2	11.0	10.5	21.2	9.7	24.9	5.1	9.4	10.1	12.2	15.2	16.7	17.3	11.9	11.4	14.2	10.6	16.8	14.2	29.8	42.7	14.7	18.8	34.5	15.4	42.4	22.9	28.1	25.0	19.2	5.9	17.0	6.6	14.3	5.1	22.5	31.0	0.0	14.3	22.2	31.9	23.9	22.0	57.7	27.0	19.1	39.1	32.5	51.9	4.7	22.2	36.1	16.9	17.2	28.6	14.5	18.6	28.1	24.8	23.7	12.7	12.9	21.7	10.8	21.7	27.5	22.1	20.0	23.5	30.7
YWHAG	PPP1R170	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326794-76359031	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 117.8;skeletal muscle: 91.8"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 363.1;Suprabasal keratinocytes: 371.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013274, CAB018389, HPA026918, HPA061603"	Approved	Approved	Supported	"Nucleoplasm,Nucleoli rim,Cytosol"		NA	NA		160000000	Cytosol	"Nucleoplasm, Nucleoli rim"	"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: "	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	52.4	31.2	46.3	17.7	54.6	7.3	17.2	36.2	117.8	13.4	14.2	13.3	4.6	14.4	15.0	7.0	18.6	9.0	17.0	33.1	50.2	56.2	15.9	22.0	12.9	12.1	45.9	49.8	13.3	18.0	14.8	7.8	16.6	74.6	14.7	14.0	8.6	10.0	13.3	91.8	11.7	12.5	20.2	22.8	12.7	11.2	8.9	13.5	6.8	8.8	13.8	14.3	14.7	13.2	3.1	5.9	3.2	5.0	1.1	3.3	1.7	37.4	47.2	41.7	53.0	42.8	24.7	18.9	43.6	21.6	27.1	29.4	29.6	40.4	52.9	15.0	38.7	45.1	35.1	52.3	48.1	38.1	35.8	22.8	50.1	32.3	32.8	39.1	61.1	49.0	27.1	46.2	31.6	65.5	28.8	42.9	28.8	68.7	59.9	40.3	35.3	43.6	45.2	46.3	30.3	33.1	51.1	42.3	58.4	42.4	25.6	22.4	62.3	48.3	62.0	30.8	56.2	43.1	37.0	45.3	52.9	30.7	46.9	58.2	19.9	37.2	81.5	47.5	57.8	56.3	3.2	5.0	1.1	2.1	4.6	3.3	3.1	2.4	2.6	5.2	1.8	1.8	2.0	1.1	1.1	3.8	5.9	2.0	1.7	46.3	54.6	36.2	88.9	50.2	56.2	45.9	49.8	74.6	13.5	29.8	23.7	44.7	105.7	363.1	100.2	200.1	43.3	22.7	45.5	36.6	11.8	29.7	31.5	43.8	87.4	64.2	34.1	46.7	32.8	61.5	84.6	106.7	66.8	81.5	75.7	117.6	81.9	48.5	90.6	18.9	42.8	83.5	89.4	41.5	31.5	23.8	60.8	28.8	40.7	41.0	26.9	32.3	122.6	10.3	16.7	371.9	56.2	18.7	33.8	146.6
YWHAH	YWHA1	ENSG00000128245	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta"	Q04917	22	31944461-31957603	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 154.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025918, HPA061603"	Uncertain		Approved	"Nucleoli rim,Cytosol"		NA	NA		130000000	Cytosol	"Nucleoli rim"	"CAB025918: , HPA061603: "	"unprognostic (3.77e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.59e-5)"	"unprognostic (8.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.81e-2)"	21.5	18.6	87.9	20.6	47.4	16.3	19.3	41.9	154.3	13.7	24.4	10.0	4.3	17.2	13.1	14.1	14.0	16.4	18.6	15.2	78.8	59.1	11.7	11.5	25.0	13.5	35.5	101.6	10.0	16.7	5.2	10.4	22.4	49.5	12.3	20.1	6.8	9.9	15.6	13.9	9.9	17.4	25.9	19.4	12.8	26.9	3.7	9.1	6.3	10.5	5.5	15.1	18.5	10.6	8.1	16.6	14.9	14.4	17.7	12.8	9.6	68.7	27.5	30.8	17.9	18.7	17.3	19.5	66.8	33.0	38.6	44.0	29.1	23.9	40.6	16.3	61.3	19.6	33.3	36.8	36.7	36.4	35.9	32.0	23.9	21.6	26.0	18.9	77.1	26.8	15.7	19.6	32.4	23.2	24.5	31.5	14.6	33.0	29.7	29.3	27.7	23.4	35.5	36.6	29.8	30.1	33.6	42.3	21.5	24.3	29.7	66.1	21.7	38.0	26.6	23.8	41.9	15.2	19.1	50.3	38.9	38.9	28.5	42.4	16.5	25.5	50.8	28.2	31.1	34.1	7.8	14.4	14.9	5.7	11.8	8.1	8.1	7.0	8.1	16.6	7.6	2.8	3.6	8.7	17.7	12.2	4.5	12.8	9.6	87.9	47.4	41.9	126.3	78.8	59.1	35.5	101.6	49.5	9.1	47.6	23.7	81.8	190.9	296.7	53.4	42.8	104.4	28.1	20.5	120.4	21.6	126.3	197.3	124.3	2.1	136.1	126.2	116.8	139.6	127.7	124.6	221.7	40.3	62.5	235.5	50.9	72.4	94.5	125.5	9.1	56.7	261.3	285.1	89.2	93.7	65.8	158.8	99.3	76.0	76.7	58.1	155.2	217.9	21.2	37.4	297.2	29.1	84.7	98.9	163.9
YY1	"DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1"	ENSG00000100811	"YY1 transcription factor"	P25490	14	100238298-100282792	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001119, CAB009392"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"CAB009392: AB_2218501, HPA001119: AB_1858930"	"unprognostic (7.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (6.75e-3)"	"unprognostic (8.31e-3)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	32.7	28.8	26.3	27.0	25.8	45.3	33.8	33.6	26.4	28.1	37.6	24.9	34.6	26.4	29.5	33.7	34.1	24.4	27.4	38.3	27.6	21.9	31.4	42.8	31.8	30.6	26.5	21.1	26.9	27.7	32.5	23.6	35.2	24.1	29.3	28.2	21.5	25.6	23.1	39.9	27.2	31.0	25.9	26.5	30.6	25.3	22.6	25.8	60.2	40.9	23.3	35.2	29.7	47.0	8.2	6.3	14.2	7.0	12.0	9.0	3.0	23.8	12.6	25.9	20.6	20.7	25.9	28.2	23.7	21.4	25.8	26.1	15.2	40.1	36.5	33.8	20.7	15.6	25.0	28.2	24.4	35.2	28.4	22.8	33.9	14.7	19.5	19.2	40.5	29.7	15.7	29.3	17.8	24.5	23.6	24.5	26.9	26.3	25.5	24.4	29.6	44.1	22.1	27.1	38.6	21.7	36.0	36.1	19.8	28.9	23.7	27.6	20.6	31.6	22.9	32.1	23.6	35.1	37.2	22.3	16.0	20.1	39.0	20.7	26.8	27.2	50.6	22.3	26.3	20.8	5.1	7.0	14.2	5.5	5.9	7.0	6.3	7.6	7.7	6.1	8.2	7.1	6.8	12.2	12.0	4.5	6.3	9.0	3.0	26.3	25.8	33.6	26.4	27.6	21.9	26.5	21.1	24.1	25.8	50.6	53.8	77.0	90.1	211.3	79.2	72.5	61.1	36.1	38.7	64.6	76.6	101.0	61.3	59.0	8.2	94.0	85.8	23.3	70.8	103.7	89.5	134.5	70.4	100.7	71.3	120.8	105.6	87.2	94.9	11.0	87.8	94.4	72.6	45.1	80.2	80.6	70.0	88.8	94.7	71.8	75.3	90.5	110.2	79.0	66.8	212.4	146.8	81.6	102.0	131.5
YY1AP1	"HCCA2, YAP, YY1AP"	ENSG00000163374	"YY1 associated protein 1"	Q9H869	1	155659443-155689000	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006986, HPA064249"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA006986: AB_1080620, HPA064249: AB_2685226"	"unprognostic (1.96e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (6.81e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.84e-2)"	18.6	15.1	21.1	20.3	22.2	35.9	19.5	29.1	27.3	20.5	24.4	20.5	12.4	12.3	21.9	22.0	21.8	19.2	19.9	29.0	16.8	13.6	14.5	18.7	21.6	18.7	18.9	17.2	23.9	20.1	23.6	20.1	18.0	18.1	18.1	19.7	19.2	18.6	21.6	52.4	22.8	16.3	23.5	14.8	17.3	18.1	50.1	20.7	24.4	18.3	18.8	25.8	22.0	20.0	17.8	22.3	31.9	18.0	26.9	25.5	20.5	24.1	12.6	16.2	18.4	18.4	16.7	34.9	15.7	23.0	28.4	24.3	19.3	26.1	19.3	15.5	23.0	14.6	24.0	24.3	21.9	26.8	17.9	12.2	16.2	14.9	12.1	19.5	25.3	22.0	17.7	22.6	21.5	26.7	19.8	17.5	18.9	21.0	27.6	20.7	21.7	25.9	12.5	25.5	33.2	18.6	20.7	14.0	30.7	17.3	17.9	16.3	19.4	20.7	30.1	20.0	30.7	32.4	41.9	14.2	16.0	14.2	16.7	20.7	35.7	23.4	48.2	15.8	16.7	18.3	22.2	17.8	31.9	24.2	18.0	25.3	17.8	20.9	25.3	22.3	13.9	18.3	18.2	19.6	26.9	16.6	10.4	25.5	20.5	21.1	22.2	29.1	27.3	16.8	13.6	18.9	17.2	18.1	20.7	17.9	26.1	14.1	26.3	30.8	22.8	20.7	20.4	16.0	21.6	12.2	41.2	20.0	11.6	15.0	56.6	23.2	21.3	0.0	16.6	23.6	21.6	23.5	24.3	18.8	18.8	15.9	33.6	16.0	21.9	62.5	25.9	23.2	18.6	20.8	22.5	20.4	14.2	14.4	24.1	9.6	24.3	6.5	24.7	66.3	20.6	31.1	37.6	20.8	21.9	27.8
YY2	ZNF631	ENSG00000230797	"YY2 transcription factor"	O15391	X	21855987-21858727	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.5"	"Cell type enriched"	"Detected in many"	8	"Spermatogonia: 52.4"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA001119, HPA030335"	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA001119: AB_1858930, HPA030335: AB_2673434"	"unprognostic (1.90e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.78e-4)"	"unprognostic (4.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	1.6	1.8	0.7	1.4	0.9	0.3	1.4	1.8	0.8	1.6	1.2			0.3	2.8	1.9	1.3	1.6	1.2	1.2	0.5	0.6	1.0	2.5	1.4	0.7	0.8		3.3	1.4	1.5	2.5	2.2		1.8	0.9		1.3	1.6	1.2	1.8	0.8	2.0	1.1	0.9	0.9	9.5			1.6		0.6	1.1	1.5	1.5	1.2	0.0	0.6	1.4	2.7	0.5	3.6	3.3	2.3	7.3	2.9	1.2	0.3	4.0	2.3	4.7	5.3	2.7	6.1	4.2	2.4	5.2	6.0	2.0	5.0	5.5	8.2	3.0	4.8	1.1	8.9	2.2	5.0	4.5	2.2	2.4	4.1	3.5	5.8	3.6	2.9	1.6	4.2	5.0	8.2	2.5	2.4	4.6	4.3	1.8	4.4	2.3	3.9	6.4	2.5	1.6	1.3	3.3	2.3	2.0	6.6	6.3	3.5	1.5	3.1	8.6	1.7	14.9	4.7	3.4	3.9	2.6	5.6	2.2	6.8	0.0	0.6	0.0	0.8	0.1	0.6	1.5	1.3	0.8	0.6	1.1	2.7	0.6	0.0	1.4	0.4	1.2	1.2	0.5											0.0	1.6	0.0	0.7	0.8	2.3	0.8	0.0	0.0	0.0	1.8	3.9	2.5	0.0	0.8	0.4	1.8	0.4	0.0	0.6	1.1	1.9	1.2	1.1	2.1	1.9	6.4	1.2	1.8	2.2	1.0	5.8	1.8	0.0	3.6	0.3	1.3	1.3	0.0	3.5	0.3	3.4	0.0	0.5	6.9	52.4	1.3	1.7	0.0	0.6	1.1
Z82206.1		ENSG00000225528			22	39960397-39964718	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	14	"blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3"	"Group enriched"	"Detected in some"	5	"Distal tubular cells: 6.6;granulocytes: 3.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 4.0;JURKAT: 3.2;K-562: 16.1;MOLT-4: 2.7"									HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.0	0.0		0.5		4.1	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.3	2.3			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1		1.0	0.1	0.0			0.0		1.1	0.3		3.6	3.0	5.7	2.2	2.2	8.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	16.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.8	4.4	5.2	2.2	4.5	3.6	6.5	5.7	2.7	3.2	6.7	8.1	4.3	2.2	1.9	3.0	4.2	7.6											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Z83844.3		ENSG00000285304			22	37639693-37666932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.3"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA000757	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA000757: AB_1079951"																		2.4	0.1	1.8	12.3	2.7	8.5	1.0	2.4	3.5	3.7	7.5	2.0	0.9	8.4	1.3	2.0	11.6	1.9	2.4	1.0	1.5		0.3	1.0	3.7	8.2	1.7	1.5	2.5	0.9	2.8	0.0	6.0	1.8	3.5	5.7	1.4	4.4	2.8	0.0	2.2	12.5	2.6	2.5	13.4	1.6	0.9	2.4	10.5	0.3	10.4	16.3	4.6	2.0	1.6	3.6	0.1	2.7	1.7	2.6	1.5	9.2	1.6	5.3	3.3	1.5	4.6	5.9	2.7	8.5	10.1	10.6	7.4	2.3	6.7	1.1	3.0	3.3	8.0	5.7	13.9	3.2	6.9	5.1	14.0	0.2	7.4	3.0	21.4	19.3	5.4	6.6	11.8	1.1	4.8	0.6	4.3	4.0	5.0	0.4	11.2	0.9	2.0	5.4	16.0	1.3	8.7	3.6	5.5	1.1	3.3	3.0	5.5	0.7	3.5	6.1	3.9	4.6	10.7	1.2	1.5	5.5	0.7	0.0	9.1	3.4	6.1	3.6	14.8	10.1	0.0	2.7	0.1	2.2	1.3	1.8	1.6	1.4	2.1	3.6	0.9	2.6	1.6	0.0	1.7	2.7	2.2	2.5	1.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZADH2	MGC45594	ENSG00000180011	"Zinc binding alcohol dehydrogenase domain containing 2"	Q8N4Q0	18	75195108-75209348	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021468, HPA053646"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA021468: AB_1858932, HPA053646: AB_2682216"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.79e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.23e-1)"	14.1	12.1	15.6	12.5	22.5	12.7	28.1	19.1	24.1	15.5	18.9	10.8	13.6	13.7	12.8	19.0	18.1	13.5	15.7	24.4	17.4	11.3	18.0	23.4	13.3	12.7	12.9	18.4	19.6	19.5	22.4	20.5	26.2	19.3	13.8	21.4	13.5	16.3	14.1	34.5	15.8	24.0	16.9	12.1	15.0	15.5	7.1	11.2	11.2	20.7	15.5	14.5	17.4	15.5	2.7	3.3	12.1	5.2	2.5	4.8	2.3	9.4	6.3	6.7	13.8	10.5	13.6	7.4	17.2	20.0	6.8	8.5	3.8	13.5	6.6	2.8	17.0	8.0	12.9	8.3	14.5	4.8	41.3	12.2	14.9	13.9	7.5	7.5	25.1	15.2	15.0	14.6	5.4	12.5	12.6	13.9	15.8	8.0	24.5	12.9	11.1	6.3	12.4	1.7	9.2	14.4	13.5	10.8	21.9	13.2	16.1	12.5	10.3	9.5	9.8	10.9	5.0	9.8	12.5	12.3	13.4	10.2	4.2	5.4	4.0	17.4	4.5	8.8	21.8	10.7	1.9	5.0	12.1	4.8	4.2	3.8	2.7	4.1	4.5	3.3	2.5	2.3	3.5	2.7	2.5	5.2	2.5	4.4	2.3	15.6	22.5	19.1	24.1	17.4	11.3	12.9	18.4	19.3	11.2	32.8	14.1	10.4	16.0	8.7	56.1	45.6	17.8	5.3	10.3	26.2	5.9	8.2	16.6	10.1	0.4	23.3	27.4	0.0	18.6	5.9	16.9	16.0	6.9	20.7	14.3	23.8	22.5	19.6	18.6	1.1	33.9	14.8	11.8	14.4	25.7	20.9	12.7	21.0	59.4	14.6	39.1	19.4	9.8	0.3	6.3	9.7	5.6	10.0	27.0	18.3
ZBBX	FLJ23049	ENSG00000169064	"Zinc finger B-box domain containing"	A8MT70	3	167240287-167381346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;epididymis: 14.2;fallopian tube: 23.4;testis: 33.3"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 290.4;Early spermatids: 339.8;Late spermatids: 178.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.4;CAPAN-2: 1.7;SCLC-21H: 1.5;SuSa: 5.2;U-87 MG: 1.8"					"Low region specificity"	"Detected in many"			"HPA036327, HPA036328"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036327: AB_10672240, HPA036328: AB_2675063"	"unprognostic (2.68e-3)"	"unprognostic (4.49e-2)"		"unprognostic (6.94e-2)"	"unprognostic (3.99e-1)"			"unprognostic (4.08e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"		0.3	0.6	2.5	0.3	12.9	0.3	0.3	0.0	3.3	1.3	0.4	4.5	0.0	0.3	1.1	14.2	0.3	23.4	0.3	0.3	4.7	3.9	0.5	0.3	7.2	0.4	0.4	2.6	6.9	0.3	0.8	5.3	0.4	22.0	0.4	0.3	0.0	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.3	0.4	33.3	3.4	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.2	0.4	0.0	0.0	1.1	0.6	0.0	0.1	0.6	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	12.9	0.0	3.3	4.7	3.9	0.4	2.6	22.0	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	290.4	40.9	1.8	0.0	0.0	0.0	0.0	339.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	178.7	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	21.8	10.0	0.0	0.0	0.0	0.0	0.0
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500967	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 43.3"					"Low region specificity"	"Detected in all"			HPA077591	Approved		Approved	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Nucleoplasm, Centrosome"	"Nuclear membrane"	"HPA077591: AB_2686847"	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	8.5	10.5	24.8	6.0	30.7	3.1	63.7	24.8	29.0	36.8	8.1	1.7	1.7	10.6	28.9	2.8	6.1	6.4	7.1	43.4	27.3	7.2	39.6	13.6	5.9	6.0	25.1	19.6	28.7	10.4	6.8	27.8	37.5	32.5	6.8	6.4	1.7	7.7	6.3	29.5	9.5	11.2	5.1	30.4	7.9	6.6	3.4	27.1	1.7	5.4	1.7	4.8	5.8	31.4	12.7	13.7	13.0	12.4	5.4	11.5	10.2	5.2	13.1	9.6	10.5	6.1	6.5	43.3	7.4	8.2	4.4	5.1	16.7	4.6	10.4	8.6	9.9	12.1	2.5	9.1	7.7	3.3	12.2	12.2	7.7	11.2	14.2	8.0	4.7	16.2	9.6	6.1	4.6	3.5	6.6	10.4	7.1	9.8	3.4	8.5	3.7	7.9	3.8	23.5	3.4	7.8	6.4	9.4	4.9	7.4	10.2	11.4	11.2	6.3	17.1	11.8	11.2	4.7	10.2	14.2	9.5	5.0	5.2	8.1	4.2	0.0	17.2	3.8	6.8	5.3	1.8	11.6	9.7	11.5	12.4	10.3	9.4	6.8	6.5	13.7	12.7	6.6	5.4	13.0	5.4	9.3	10.1	6.6	10.2	24.8	30.7	24.8	29.0	27.3	7.2	25.1	19.6	32.5	27.1	11.9	9.4	11.5	14.3	13.5	56.5	22.9	48.4	14.7	7.9	24.4	13.7	13.2	10.0	21.0	0.2	17.9	19.8	0.0	20.2	15.4	16.9	18.3	14.9	33.1	15.5	9.5	14.9	13.5	11.8	0.8	18.4	17.7	8.5	19.0	19.5	19.9	20.8	17.3	21.5	15.8	22.4	6.5	14.4	0.0	3.2	9.8	31.8	12.5	21.9	11.5
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595443	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 21.0;thyroid gland: 74.5"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 41.7"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.4"	"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.0;T-cells: 2.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.1	0.9	1.4	0.0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0.0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0.0	0.4	4.0	0.1	0.1	0.0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21.0	74.5	7.5	7.4	0.2	6.2	4.0	0.0	0.1	0.0	0.5	2.5	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.1	14.0	0.0	0.0	19.4	0.0	43.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	3.6	0.6	0.3	0.0	4.0	1.9	2.5	0.1	0.5	0.0	0.0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	41.7	1.4	0.0	0.2	3.9	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.7	0.0	0.1
ZBED3	MGC15435	ENSG00000132846	"Zinc finger BED-type containing 3"	Q96IU2	5	77072072-77087323	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.9;JURKAT: 19.6;MOLT-4: 17.8"					"Low region specificity"	"Detected in all"			HPA055995	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA055995: AB_2683000"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.82e-2)"	"unprognostic (8.64e-3)"	"unprognostic (3.63e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.08e-1)"	14.4	5.2	8.0	3.0	16.6	3.4	13.0	6.7	10.8	10.5	6.9	20.5	6.4	5.7	15.8	12.7	3.8	10.6	5.3	6.5	9.5	6.2	18.0	16.2	7.3	3.3	22.7	7.2	12.2	10.9	13.9	9.0	3.6	9.5	7.8	6.5	8.3	8.3	10.3	3.7	3.9	5.0	13.0	10.5	5.0	8.7	4.0	13.7	5.2	16.4	1.6	2.8	5.4	5.8	0.2	1.8	0.3	1.1	0.1	0.8	0.2	3.2	2.6	3.4	18.9	14.5	1.0	0.2	1.1	3.2	1.7	4.5	5.6	1.5	0.0	7.1	2.1	0.7	0.4	1.8	1.1	1.5	1.0	3.5	2.5	5.7	6.4	8.6	3.3	1.0	16.2	4.4	0.8	3.3	2.7	5.3	19.6	0.0	7.0	1.0	3.2	17.8	0.5	2.3	0.8	1.6	7.5	6.6	1.0	7.8	1.2	3.8	8.0	3.8	3.2	5.4	1.4	4.8	2.4	2.1	1.5	2.9	3.3	4.4	5.1	4.8	7.3	2.3	6.5	3.4	0.0	1.1	0.3	0.4	0.4	0.4	0.1	0.3	0.5	0.9	0.2	0.8	0.8	0.3	0.1	0.1	1.8	0.0	0.2	8.0	16.6	6.7	10.8	9.5	6.2	22.7	7.2	9.5	13.7	0.0	3.2	3.0	3.4	1.1	8.3	9.6	10.2	0.0	3.4	12.2	11.8	1.3	14.9	4.1	3.4	9.0	2.0	0.0	5.1	0.2	4.8	4.4	1.1	24.6	8.2	3.2	15.5	9.2	10.2	1.5	16.4	4.6	6.8	0.0	5.1	13.8	3.7	3.5	10.6	16.5	14.4	0.0	3.3	1.4	3.3	1.3	0.2	0.0	6.4	1.4
ZBED5	Buster1	ENSG00000236287	"Zinc finger BED-type containing 5"	Q49AG3	11	10812074-10858796	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048472, HPA050994"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA048472: AB_2680408, HPA050994: AB_2681300"	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.05e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (5.69e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.87e-4)"	21.6	18.5	20.4	32.6	21.6	21.5	27.5	43.2	30.2	35.6	24.7	22.0	17.2	18.4	34.7	27.6	22.5	30.8	19.8	32.7	21.3	13.1	24.0	13.0	24.5	38.1	24.0	23.4	40.2	24.4	42.0	44.6	20.9	27.1	30.1	22.7	16.3	24.9	19.1	32.6	36.8	29.4	22.4	30.5	35.6	22.2	17.2	25.3	45.0	34.9	17.7	32.3	30.0	26.4	18.4	12.4	5.8	8.4	13.4	14.5	6.2	20.1	16.3	28.5	18.5	15.5	24.4	14.7	16.5	17.2	11.4	11.2	11.6	44.0	22.4	12.5	12.2	15.6	25.0	17.7	17.2	15.4	21.5	16.0	5.7	34.2	7.1	12.8	18.3	7.7	16.4	25.2	8.5	18.9	20.1	14.0	11.2	15.0	25.4	16.2	10.2	17.8	19.9	15.4	14.8	21.7	27.1	15.8	11.8	13.3	28.4	14.1	25.1	17.1	22.1	13.1	16.9	20.9	10.3	13.8	24.4	17.6	16.2	11.5	12.5	15.4	17.6	21.1	13.0	18.5	0.7	6.7	5.8	9.3	7.3	12.0	16.7	11.1	11.7	9.6	18.4	14.5	14.0	5.6	13.4	8.4	12.4	9.4	6.2	20.4	21.6	43.2	30.2	21.3	13.1	24.0	23.4	27.1	25.3	53.6	24.1	23.3	40.9	30.8	31.1	31.9	17.8	56.2	47.8	21.0	27.5	14.5	19.9	19.1	5.8	16.5	10.2	0.0	14.1	8.6	17.9	19.1	8.1	5.7	10.6	27.0	26.6	23.9	15.9	4.9	25.3	17.7	15.1	11.8	15.8	20.1	15.4	17.5	25.8	12.4	32.3	19.4	24.0	41.8	17.0	31.1	10.4	17.3	16.0	21.0
ZBED6		ENSG00000257315	"Zinc finger BED-type containing 6"	P86452	1	203795714-203854999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA026439, HPA028490, HPA028526, HPA068807"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533, HPA068807: AB_2686040"	"unprognostic (1.79e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.28e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.47e-2)"	9.1	10.1	7.8	4.9	6.3	4.3	21.8	13.3	7.3	12.1	8.4	6.8	6.2	8.4	12.2	4.7	8.7	7.4	8.1	6.8	8.6	2.4	8.3	9.9	8.9	6.7	9.6	4.1	12.0	10.0	10.1	18.9	13.3	7.7	7.6	5.4	4.0	11.0	7.4	11.7	10.6	10.8	6.3	8.5	8.8	7.6	18.6	7.6	9.7	11.9	5.5	6.9	9.0	19.8	0.7	1.5	0.4	0.5	1.8	0.8	0.1	3.8	5.3	8.6	4.0	10.7	19.2	3.9	4.6	13.9	4.4	5.6	1.2	4.1	2.8	1.1	10.4	2.2	5.4	2.8	5.1	7.8	6.0	2.1	5.6	5.2	1.4	4.9	3.4	3.5	9.8	3.4	5.1	5.5	9.9	13.6	3.3	5.9	10.0	9.8	2.4	2.8	3.3	2.2	2.1	2.3	1.8	7.2	2.5	3.9	5.3	1.8	9.9	6.1	9.1	2.4	9.6	10.5	5.1	15.9	7.7	6.2	3.0	3.3	4.0	1.4	1.0	7.2	2.3	6.3	0.0	0.5	0.2	0.8	0.2	0.1	0.7	0.3	0.6	0.4	0.2	0.1	0.6	0.4	1.8	0.2	1.5	0.3	0.1	7.8	6.3	13.3	7.3	8.6	2.4	9.6	4.1	7.7	7.6	8.9	4.6	4.8	31.2	14.2	18.0	1.7	7.6	13.4	17.0	0.0	29.5	12.1	0.0	0.1	0.8	11.5	20.6	0.0	0.0	11.2	15.3	35.0	33.4	3.8	5.4	11.1	17.7	7.4	5.0	0.8	18.4	9.8	13.5	0.0	5.4	18.8	0.1	14.4	14.2	0.0	18.7	25.8	18.6	5.6	5.4	14.9	29.2	15.2	10.6	38.3
ZBED6CL	C7orf29	ENSG00000188707	"ZBED6 C-terminal like"	Q96FA7	7	150329789-150332721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"adrenal gland: 37.4;parathyroid gland: 11.3"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 7.9;Exocrine glandular cells: 11.0;Pancreatic endocrine cells: 19.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.8;K-562: 17.5"									"HPA019724, HPA055805"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane"	Vesicles	"HPA019724: AB_1845756, HPA055805: AB_2682929"	"prognostic favorable (9.48e-5)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.35e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.44e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.86e-2)"	"unprognostic (7.82e-2)"	"unprognostic (8.52e-3)"	"unprognostic (1.50e-3)"	0.4	37.4	0.4	2.6	0.4	1.7	0.8	0.3	0.2	1.1	1.4			1.6	2.0	0.2	1.2	1.9	0.4	0.4	0.3	0.6	1.8	5.6	1.5	3.9	0.3		3.1	3.2	11.3	2.5	0.0		1.5	1.5		1.1	0.9	0.1	2.2	2.1	0.6	0.1	2.3	1.7	0.3			1.8		3.7	1.3	0.8	3.6	1.0	2.8	1.0	2.8	3.5	2.4	4.5	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.4	6.3	4.7	2.6	2.3	0.0	0.0	1.8	0.0	0.0	0.3	40.8	3.3	3.1	6.7	10.7	1.3	0.0	4.8	0.9	2.4	0.0	0.0	0.1	0.2	9.1	17.5	6.8	0.0	2.0	7.7	1.9	3.0	1.8	0.0	0.0	0.3	5.7	2.1	9.0	8.6	5.0	6.9	1.9	0.3	1.4	0.6	2.1	0.1	0.0	0.0	0.0	0.0	5.5	1.5	0.0	0.0	0.0	0.0	0.0	1.0	1.0	2.7	0.7	3.2	2.2	2.4	3.4	0.7	3.6	3.5	2.9	2.8	2.8	0.2	1.0	2.2	2.4											0.0	1.0	0.0	0.3	0.2	1.0	0.6	5.1	0.0	2.3	1.8	7.9	1.3	5.0	2.1	0.0	0.0	0.9	0.0	11.0	0.7	0.6	0.3	1.1	2.6	0.5	0.0	4.6	0.0	1.6	0.0	2.6	0.0	0.0	3.6	2.0	1.4	19.3	0.0	1.1	0.7	0.5	0.0	0.2	0.5	0.9	0.1	1.6	0.0	2.3	0.5
ZBED9	"Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452"	ENSG00000232040	"Zinc finger BED-type containing 9"	Q6R2W3	6	28570535-28616212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 13.2;testis: 17.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 17.9;Spermatocytes: 27.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 7.8;hTCEpi: 7.1;K-562: 12.5;U-266/84: 6.0"									HPA007246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA007246: AB_1080727"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.96e-2)"	"unprognostic (9.46e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.21e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	0.8	1.8	2.6	0.4	7.2	0.4	2.3	9.5	4.7	2.3	1.1	0.3	9.3	0.7	1.6	7.5	1.0	3.1	0.7	1.2	2.4	2.3	2.3	3.2	1.9	0.5	1.3	2.9	4.1	3.4	3.2	6.9	3.0	3.5	3.4	1.5	0.8	2.4	13.2	0.5	0.7	0.8	1.1	0.8	0.6	1.0	17.6	0.7	0.0	4.1	0.0	0.6	1.4	1.2	0.5	0.7	1.1	0.7	0.4	1.4	0.2	1.8	1.8	1.9	0.0	0.0	0.0	2.3	0.4	0.0	0.4	1.2	0.0	1.2	0.0	7.8	0.1	3.8	1.0	0.0	2.1	0.4	0.0	5.2	0.5	1.2	1.8	1.3	0.0	0.0	1.1	7.1	0.1	3.5	1.1	0.0	0.0	12.5	0.0	0.1	1.4	0.0	0.1	1.8	0.0	0.9	0.7	0.8	0.1	2.0	2.2	2.0	4.9	0.0	2.0	0.0	2.8	0.0	0.6	0.0	0.0	2.2	0.0	1.2	0.0	6.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.3	0.4	0.1	0.2	0.4	0.4	0.2	0.5	1.4	1.0	1.1	0.4	0.7	0.7	0.1	0.2	2.6	7.2	9.5	4.7	2.4	2.3	1.3	2.9	3.5	0.7	0.0	2.7	0.0	0.8	0.0	1.6	1.6	5.1	1.4	1.2	0.0	2.0	2.0	1.7	1.7	17.9	0.0	0.4	0.0	1.2	1.1	0.4	1.1	0.0	1.6	0.3	0.0	1.2	0.0	0.0	3.2	2.3	0.0	0.0	0.0	1.4	1.1	0.6	0.0	0.0	0.7	1.1	0.0	0.0	27.7	2.9	0.0	0.8	0.0	0.9	0.6
ZBTB14	"ZFP161, ZNF478"	ENSG00000198081	"Zinc finger and BTB domain containing 14"	O43829	18	5289019-5297053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050758, HPA070819"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA050758: AB_2681226, HPA070819: AB_2686316"	"unprognostic (5.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.72e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.90e-2)"	11.2	9.1	13.1	11.6	13.4	6.8	10.8	24.3	12.8	8.7	8.7	10.7	10.8	7.2	12.5	14.9	10.8	9.3	10.3	7.1	13.1	10.2	9.8	11.3	11.0	19.5	14.5	7.6	14.2	12.1	12.8	8.7	8.5	7.3	9.8	8.7	10.3	9.8	11.1	6.9	11.8	12.7	7.5	16.4	17.4	9.8	10.8	8.2	30.8	15.9	7.0	18.1	11.2	11.8	10.1	8.6	14.3	8.2	7.5	13.4	7.6	7.1	9.5	12.5	9.2	9.4	12.4	8.3	7.1	10.6	10.1	8.9	9.1	9.4	25.1	6.3	8.6	11.6	6.7	9.1	10.7	10.2	4.9	4.9	9.9	8.7	8.3	6.6	12.4	12.0	9.9	9.1	7.0	6.6	10.9	15.6	18.2	6.3	8.3	10.2	7.8	18.6	8.3	11.0	8.9	4.9	11.1	8.0	7.2	8.5	8.8	11.1	10.9	10.9	7.2	11.5	13.0	8.6	14.3	8.7	13.1	10.9	10.1	10.6	5.3	5.3	15.5	13.8	10.7	11.5	10.9	5.7	14.3	9.9	8.2	9.9	8.3	12.7	11.4	8.6	10.1	13.4	12.7	1.3	7.5	7.3	6.5	7.9	7.6	13.1	13.4	24.3	12.8	13.1	10.2	14.5	7.6	7.3	8.2	6.0	4.1	11.1	1.3	2.2	6.5	2.8	2.5	1.4	1.2	5.2	0.0	4.0	5.0	4.2	0.8	6.3	4.0	0.0	2.9	4.9	4.5	2.5	16.1	5.7	6.2	4.8	1.2	9.2	5.9	1.7	5.5	5.2	1.7	4.6	5.1	8.2	3.2	4.2	5.3	4.0	5.8	0.0	4.1	0.7	11.7	2.6	1.8	4.4	4.4	0.6
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364117-151391548	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	11.1	7.7	10.3	10.6	8.6	14.4	13.3	11.7	10.7	9.3	10.3	8.2	9.2	7.9	11.1	8.1	8.5	10.7	11.5	8.4	8.4	6.6	7.7	9.9	13.1	14.4	11.0	6.8	17.4	14.4	8.6	5.3	9.2	10.3	8.7	9.9	6.9	11.1	12.3	14.0	8.6	10.6	14.6	9.6	12.0	9.4	7.7	11.1	27.7	32.2	8.0	13.0	11.2	13.9	5.7	6.6	15.1	10.7	7.8	14.1	6.3	8.8	6.4	9.9	7.4	10.6	11.2	10.6	14.1	20.3	17.8	17.0	12.4	7.3	22.8	7.9	14.1	18.0	10.6	15.8	17.1	22.3	10.3	11.8	10.2	7.7	18.7	15.8	27.6	12.7	11.8	10.3	16.3	20.0	10.2	10.4	10.8	18.6	13.4	12.5	19.8	14.9	12.9	12.0	11.0	9.8	14.3	9.3	9.1	13.5	13.5	11.0	7.7	11.1	14.6	11.0	10.4	9.8	16.6	8.5	15.1	16.4	6.9	18.6	17.9	18.6	25.5	6.2	15.1	10.7	13.6	6.0	15.1	11.3	6.6	14.1	5.7	10.3	13.4	6.6	4.4	8.7	10.5	6.9	7.8	10.7	2.7	8.3	6.3	10.3	8.6	11.7	10.7	8.4	6.6	11.0	6.8	10.3	11.1	8.9	5.8	5.9	7.3	14.0	2.9	7.6	5.1	8.1	11.4	0.0	0.0	5.2	11.6	4.2	7.2	8.7	4.6	0.0	2.5	16.2	8.2	12.0	9.2	2.4	6.6	1.6	8.6	4.3	7.6	8.9	8.1	9.4	10.1	1.0	6.6	2.9	3.9	0.0	3.9	4.1	1.8	6.5	14.2	3.2	6.8	15.9	10.4	14.9	6.4	8.2
ZBTB22	"BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A"	ENSG00000236104	"Zinc finger and BTB domain containing 22"	O15209	6	33314406-33317942	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA043848			Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA043848: AB_10961146"	"unprognostic (1.32e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.54e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.32e-3)"	7.0	15.4	9.5	5.7	11.0	4.9	8.3	9.0	18.1	11.0	8.0	9.4	6.4	12.0	12.5	20.9	11.6	9.9	11.0	10.1	11.6	7.2	8.8	6.8	10.6	12.4	7.4	14.9	14.8	20.3	37.6	8.2	15.9	8.7	9.2	9.7	8.8	8.8	11.3	7.8	13.1	10.1	11.0	7.7	10.7	8.5	7.5	6.4	7.2	14.9	3.0	8.9	9.9	9.7	1.8	1.8	3.3	1.7	0.6	3.2	0.8	0.2	0.3	7.2	3.7	7.2	3.8	4.3	5.4	8.8	7.2	6.3	0.1	3.3	2.0	4.1	11.7	9.5	0.5	0.3	3.9	4.5	7.3	4.4	6.3	5.6	2.4	0.0	2.0	3.0	12.7	12.9	0.2	3.3	8.4	0.6	5.3	1.3	8.2	3.1	4.6	3.7	6.5	0.0	0.3	1.5	0.4	0.0	4.5	5.3	0.3	7.9	0.4	0.6	0.3	3.3	4.5	0.6	0.3	10.4	3.5	4.8	0.1	0.1	3.5	3.8	2.2	5.7	1.9	5.0	2.0	0.8	3.3	1.3	1.7	0.4	1.8	1.6	1.0	1.1	1.6	3.2	0.8	1.5	0.6	0.7	1.8	0.4	0.8	9.5	11.0	9.0	18.1	11.6	7.2	7.4	14.9	8.7	6.4	0.0	5.3	3.7	13.4	5.7	18.8	3.8	2.5	0.0	2.3	7.0	7.9	5.7	19.9	9.1	0.9	6.7	5.4	0.0	6.3	3.7	6.2	8.5	3.5	1.6	4.7	19.1	7.5	5.5	5.4	1.1	8.6	4.6	1.7	16.2	7.8	14.7	5.6	7.0	6.0	6.2	17.6	12.9	5.0	1.4	1.3	6.5	8.5	6.9	5.9	11.6
ZBTB24	"BIF1, KIAA0441, PATZ2, ZNF450"	ENSG00000112365	"Zinc finger and BTB domain containing 24"	O43167	6	109462594-109483237	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017872, HPA049003"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Centrosome"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Centrosome"	"HPA017872: AB_2669673, HPA049003: AB_2680596"	"unprognostic (8.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.77e-2)"	9.6	7.1	6.6	13.8	13.7	16.6	10.1	12.7	11.5	9.5	7.5	11.4	6.8	7.6	9.8	7.5	8.4	8.4	6.4	5.5	7.0	6.8	9.1	6.6	8.5	16.9	11.5	8.8	8.3	8.2	19.1	10.0	12.4	8.8	8.8	8.5	9.6	9.8	9.1	9.7	12.2	11.1	8.5	7.7	13.7	8.6	9.0	12.1	17.4	10.8	5.2	17.1	10.0	10.2	5.7	2.2	1.7	1.5	2.4	5.3	1.0	3.9	4.1	3.8	9.4	6.1	6.2	6.2	4.5	6.3	5.8	6.6	5.7	3.1	16.9	5.9	5.7	6.9	5.2	9.5	7.1	8.7	10.4	9.3	13.7	5.5	4.3	4.5	11.1	7.0	6.2	5.9	5.8	10.1	4.0	4.7	8.0	11.4	9.5	5.9	6.8	15.8	7.5	9.3	4.0	4.6	10.0	5.3	7.0	7.1	6.8	6.4	5.6	5.8	6.2	14.4	5.5	4.3	12.1	4.6	4.7	4.7	3.9	9.8	4.6	3.6	17.3	6.1	8.8	7.8	0.1	1.2	1.7	1.5	1.1	0.9	5.7	3.0	1.8	1.4	5.6	3.9	2.2	0.8	2.4	1.5	2.2	5.3	1.0	6.6	13.7	12.7	11.5	7.0	6.8	11.5	8.8	8.8	12.1	11.9	7.8	15.9	6.2	9.0	17.3	3.3	7.6	8.1	5.7	3.5	29.5	7.0	3.3	6.8	1.3	4.5	5.5	0.0	7.9	9.4	7.3	5.9	9.2	5.0	6.9	9.5	9.2	3.1	12.6	1.1	6.6	8.9	8.5	22.6	11.1	8.1	5.5	3.5	6.0	6.1	63.1	0.0	4.2	4.6	29.8	8.4	6.5	14.9	7.8	5.8
ZBTB3	FLJ23392	ENSG00000185670	"Zinc finger and BTB domain containing 3"	Q9H5J0	11	62748319-62754188	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035321, HPA035322"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA035321: AB_2674569, HPA035322: AB_10610567"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (5.52e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.56e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (1.65e-5)"	"prognostic favorable (9.98e-4)"	"unprognostic (3.37e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.43e-2)"	4.7	6.0	5.8	5.3	10.7	5.5	7.7	6.5	10.9	5.3	6.0	17.8	7.4	5.8	7.9	5.3	6.2	11.1	5.9	7.6	6.1	4.8	5.6	6.8	7.3	5.5	13.1	7.1	6.8	11.5	6.8	4.2	5.6	8.5	5.2	5.6	7.2	8.6	6.2	6.3	14.2	6.7	4.8	6.6	7.9	12.2	9.7	12.1	10.8	7.2	4.2	7.2	5.9	6.0	6.0	7.2	12.3	10.0	6.7	7.9	7.4	3.3	5.0	4.2	5.5	8.0	4.0	3.6	3.5	3.9	4.1	3.7	3.3	4.3	5.2	5.4	3.7	3.0	7.1	3.7	3.9	2.0	6.0	6.2	2.8	10.6	3.9	3.9	4.3	6.0	4.3	4.6	3.2	4.9	5.3	3.4	4.4	4.9	5.7	4.1	6.6	5.2	4.8	12.4	2.5	2.5	4.0	3.3	5.1	3.2	4.3	3.9	3.6	3.7	4.8	2.6	6.3	6.8	3.1	3.1	6.3	2.8	4.4	2.0	5.8	4.1	4.4	6.0	2.5	2.5	2.2	10.0	12.3	6.0	7.8	7.2	6.0	6.1	7.1	7.2	5.5	7.1	5.5	3.6	6.7	6.4	2.1	7.9	7.4	5.8	10.7	6.5	10.9	6.1	4.8	13.1	7.1	8.5	12.1	3.0	2.4	0.8	1.5	0.7	2.3	2.5	2.5	0.0	1.2	0.0	5.9	3.2	6.6	2.4	11.4	1.1	1.3	0.0	1.7	1.8	1.9	0.7	0.0	2.5	2.0	0.0	0.0	0.6	2.1	6.6	1.4	0.8	0.0	0.0	2.9	1.5	1.8	3.7	2.8	1.9	4.1	0.0	1.0	3.4	2.4	1.0	2.1	0.7	1.9	1.1
ZBTB37	"MGC2629, ZNF908"	ENSG00000185278	"Zinc finger and BTB domain containing 37"	Q5TC79	1	173868082-173903549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 49.0;Rod photoreceptor cells: 67.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023438	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA023438: AB_1858954"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.96e-2)"	6.4	4.0	6.9	6.5	9.8	11.1	5.8	6.4	7.9	5.3	4.0	11.2	3.7	4.0	9.1	5.5	3.4	4.6	4.7	5.6	7.2	3.7	5.3	4.8	6.0	7.7	9.9	5.2	7.6	4.5	6.8	9.2	4.7	7.8	5.3	3.9	10.6	4.6	4.9	4.0	7.0	5.2	6.8	9.5	7.9	5.1	18.4	8.8	7.7	6.1	2.8	6.3	4.8	5.5	1.8	2.4	6.0	1.0	2.3	2.8	0.8	2.4	3.7	5.6	2.4	3.5	2.8	6.2	2.2	1.6	4.0	2.9	4.6	3.1	6.6	4.7	3.4	2.1	3.1	4.8	2.4	3.4	3.7	3.0	9.1	3.9	2.2	2.1	5.3	5.8	2.5	1.7	6.0	4.0	2.5	2.0	4.7	8.0	4.4	4.2	1.8	3.6	1.4	5.4	1.8	0.9	2.4	5.0	2.2	2.2	6.1	4.2	5.3	3.1	4.3	4.4	6.2	6.2	5.6	3.6	5.3	5.7	2.6	3.5	8.0	5.9	10.6	3.5	3.0	3.2	0.4	1.0	3.4	2.8	1.0	1.2	0.7	1.3	2.0	0.6	1.8	0.7	1.8	6.0	2.3	1.0	2.4	1.0	0.8	6.9	9.8	6.4	7.9	7.2	3.7	9.9	5.2	7.8	8.8	6.0	4.6	11.9	3.1	2.6	26.9	8.4	12.7	9.4	2.3	10.4	31.4	6.8	6.6	2.8	40.4	5.2	3.9	0.0	3.3	3.4	4.3	4.2	2.3	4.3	4.2	17.5	3.4	13.5	15.1	49.0	8.1	7.6	10.1	2.8	3.6	11.9	2.5	3.5	12.4	4.4	67.3	6.5	6.2	17.6	13.3	5.1	7.7	12.9	3.3	2.7
ZBTB39	"KIAA0352, ZNF922"	ENSG00000166860	"Zinc finger and BTB domain containing 39"	O15060	12	56998834-57006446	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 19.2;Horizontal cells: 20.6;Spermatogonia: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016866, HPA020306"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA016866: AB_2669470, HPA020306: AB_2670406"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (7.00e-2)"	5.5	5.2	6.9	8.5	9.0	10.5	9.6	9.9	10.1	6.0	6.7	11.9	5.5	4.7	9.0	5.9	6.6	7.7	4.5	4.8	6.2	4.8	5.2	9.5	6.3	7.8	7.1	6.7	10.1	8.8	8.4	4.0	8.0	6.9	6.1	5.3	6.5	6.5	7.9	6.0	6.5	8.3	8.2	8.1	12.5	7.5	18.0	7.8	6.4	6.0	5.3	8.9	7.1	6.1	1.8	2.1	2.9	1.3	2.5	2.7	0.9	2.2	3.7	10.5	5.3	2.4	2.6	6.9	2.2	2.7	3.6	2.6	3.8	1.6	7.2	2.9	2.2	2.3	3.0	8.0	3.4	3.5	3.3	5.6	7.9	2.2	3.0	2.2	6.0	6.6	1.9	3.3	2.8	4.6	3.9	4.1	8.2	9.8	6.6	2.6	2.6	8.8	5.1	10.4	2.3	3.1	8.5	32.2	3.4	1.6	4.5	5.2	6.7	3.1	4.1	3.1	10.2	3.4	6.7	3.2	3.0	6.6	1.4	2.7	8.6	5.6	7.7	1.9	3.4	1.8	2.9	1.3	0.0	1.9	0.9	1.9	1.5	1.9	2.6	1.5	1.8	1.4	2.7	0.0	2.5	0.3	2.1	0.6	0.9	6.9	9.0	9.9	10.1	6.2	4.8	7.1	6.7	6.9	7.8	0.0	1.1	0.9	1.6	1.3	9.6	2.8	5.1	4.0	2.3	0.0	15.7	2.3	0.0	1.4	19.2	3.4	0.8	0.0	1.5	1.5	1.8	2.7	1.1	2.4	1.6	20.6	1.2	8.0	2.7	12.4	1.7	1.8	1.7	3.6	2.2	2.0	2.2	1.9	5.3	1.1	7.4	6.5	0.4	11.6	17.4	1.4	1.8	2.6	2.3	1.0
ZBTB40	"KIAA0478, ZNF923"	ENSG00000184677	"Zinc finger and BTB domain containing 40"	Q9NUA8	1	22451851-22531157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042386			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042386: AB_10794649"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.78e-8)"	"unprognostic (8.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.34e-2)"	14.1	21.0	8.3	13.5	12.3	11.2	10.8	18.0	12.6	13.9	11.7	14.1	10.9	10.6	21.5	10.5	8.8	13.1	11.9	8.4	9.6	6.4	11.7	8.2	11.5	17.8	12.9	7.3	15.3	15.5	19.0	31.6	8.5	11.6	13.6	11.6	13.5	14.6	10.6	12.7	11.5	18.1	14.4	12.8	23.2	12.5	9.2	13.0	16.6	14.4	6.8	19.5	12.9	14.8	2.5	1.7	1.6	2.1	7.6	3.0	0.8	7.0	8.0	13.3	14.0	10.0	8.4	12.0	6.1	6.7	9.4	10.3	7.2	8.7	8.2	7.3	7.3	7.7	9.1	13.5	6.5	11.3	10.8	11.3	17.4	15.2	8.5	8.7	10.2	16.9	7.0	9.7	12.5	9.6	7.4	8.1	11.7	18.5	0.1	7.7	5.2	6.9	13.0	8.0	5.9	6.7	11.8	10.4	9.3	4.7	7.6	11.2	9.2	11.5	8.5	4.9	8.6	16.1	8.7	9.9	11.6	9.6	11.9	6.0	5.7	7.5	8.4	7.0	12.8	8.3	1.6	1.0	0.6	2.4	2.1	3.0	1.8	1.9	2.0	1.7	2.5	1.9	2.3	0.4	7.6	1.0	1.1	2.7	0.8	8.3	12.3	18.0	12.6	9.6	6.4	12.9	7.3	11.6	13.0	11.9	14.7	11.3	3.1	5.0	13.1	11.0	10.2	6.7	15.9	1.8	29.5	4.2	1.7	4.9	3.6	6.3	3.4	0.0	6.4	3.7	4.7	4.3	15.1	2.9	4.1	11.1	15.5	4.9	4.5	4.7	5.5	4.5	13.5	0.0	5.2	8.2	5.8	7.0	6.3	1.9	23.1	12.9	5.2	5.9	8.5	3.6	2.4	5.1	5.1	2.4
ZBTB41	"DKFZp686C06120, FLJ36199, FRBZ1, ZNF924"	ENSG00000177888	"Zinc finger and BTB domain containing 41"	Q5SVQ8	1	197153680-197200542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034841, HPA034842"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA034841: AB_2674355, HPA034842: AB_10669995"	"unprognostic (2.36e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.01e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.58e-1)"	2.6	3.8	4.1	1.8	4.0	0.2	5.9	10.8	5.0	4.5	2.2			2.1	3.2	3.8	2.4	2.8	3.2	2.3	4.0	4.7	4.3	3.3	2.3	2.4	4.2		5.9	2.9	5.6	3.8	2.2		3.3	2.5		2.9	2.6	3.3	2.4	1.8	2.2	4.8	3.0	3.2	2.6			6.4		2.2	3.1	2.1	1.5	1.4	1.7	0.7	1.8	2.2	0.7	7.3	4.1	5.5	4.4	8.8	13.3	4.4	4.4	7.3	4.7	4.5	2.6	6.2	2.7	6.5	10.1	2.8	6.1	3.8	3.9	7.5	2.4	2.3	2.2	5.6	2.4	7.8	4.3	2.2	5.4	10.2	4.7	8.2	9.6	3.2	3.1	5.1	3.3	12.0	3.6	3.2	2.4	2.1	5.1	1.5	2.2	7.7	4.8	5.8	4.2	7.9	7.0	8.0	14.1	8.4	4.2	10.7	3.3	5.2	9.3	5.4	7.3	5.8	3.8	1.9	2.9	4.4	1.6	12.9	1.7	0.7	0.4	1.2	0.4	2.2	1.5	1.6	1.6	1.4	1.4	2.2	2.0	0.0	1.8	0.6	0.7	1.0	0.7											17.9	6.2	7.2	4.6	6.6	13.6	12.8	7.6	10.7	10.3	15.7	2.0	3.3	1.7	6.1	2.9	5.5	3.8	0.0	4.9	3.2	6.1	8.3	1.1	8.3	3.7	23.8	12.6	8.0	7.9	2.7	14.4	4.6	11.8	6.4	6.5	30.0	6.0	0.0	11.3	9.1	8.1	6.5	6.1	6.5	4.5	8.8	2.9	4.5	7.6	5.2
ZBTB43	"FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B"	ENSG00000169155	"Zinc finger and BTB domain containing 43"	O43298	9	126805006-126838210	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016825	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA016825: AB_1858959"	"unprognostic (1.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.14e-1)"	"unprognostic (5.41e-3)"	"prognostic favorable (8.73e-4)"	"unprognostic (6.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.13e-2)"	6.6	6.2	7.8	4.9	12.1	51.7	6.6	10.6	13.6	5.8	5.6	9.5	3.0	5.6	6.6	5.2	10.3	5.3	5.9	9.5	7.9	5.7	5.1	9.0	9.3	6.0	8.6	7.1	7.1	5.9	9.6	9.3	8.2	8.1	5.1	6.6	7.5	7.4	4.4	34.7	14.6	6.7	6.0	8.5	5.7	7.4	15.7	9.3	5.3	6.2	7.1	10.1	5.5	7.0	6.1	5.2	10.6	6.3	9.0	10.7	4.3	4.6	3.6	6.5	6.0	5.6	7.9	6.8	6.6	6.1	4.9	4.4	8.7	3.2	6.5	3.1	6.2	9.9	13.5	5.8	6.1	6.1	6.1	3.8	4.5	10.6	3.7	7.5	6.2	8.5	9.6	15.5	7.9	19.9	4.7	3.7	5.4	7.7	15.1	7.2	5.0	5.4	4.0	5.9	5.0	6.2	4.7	21.1	5.2	5.4	5.4	5.8	5.4	6.7	6.4	5.8	6.2	5.9	4.0	3.5	5.9	5.7	6.6	5.3	16.2	11.5	2.5	7.4	5.3	4.8	10.6	6.3	5.3	10.7	6.3	10.2	6.1	5.8	6.2	5.2	5.1	6.4	7.3	3.5	9.0	4.8	2.8	8.2	4.3	7.8	12.1	10.6	13.6	7.9	5.7	8.6	7.1	8.1	9.3	32.8	40.1	29.9	62.2	75.4	37.7	33.5	22.9	20.1	46.6	26.2	102.1	15.5	1.7	27.3	73.1	17.3	40.0	0.0	16.1	10.4	25.7	47.1	30.1	22.9	13.6	25.4	10.9	17.2	14.6	30.4	16.4	26.4	23.6	11.8	16.6	33.0	31.3	14.2	13.4	5.8	56.4	12.9	25.9	42.1	61.8	102.6	43.5	20.1	18.1	123.4
ZBTB44	"BTBD15, HSPC063, ZNF851"	ENSG00000196323	"Zinc finger and BTB domain containing 44"	Q8NCP5	11	130226677-130314686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052589	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052589: AB_2681874"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.03e-2)"	"unprognostic (7.60e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.34e-1)"	"unprognostic (8.45e-3)"	"unprognostic (6.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.78e-2)"	14.6	14.1	27.8	10.6	22.3	10.6	21.2	42.4	29.0	13.5	12.1	11.8	22.0	9.2	13.1	18.4	13.7	15.4	9.6	13.6	25.4	9.4	27.4	14.7	15.2	15.3	17.4	17.4	18.4	13.7	24.2	14.7	12.9	16.9	12.5	10.6	8.5	16.7	19.2	38.8	15.6	12.4	10.2	11.8	14.1	11.8	34.2	21.8	28.2	14.6	8.4	16.3	16.5	28.6	3.5	4.1	5.8	2.2	3.7	5.8	1.1	6.7	4.5	6.8	6.5	9.7	9.3	7.7	4.3	6.7	3.5	4.5	7.4	21.0	22.6	21.4	6.6	9.6	7.2	9.5	8.3	6.1	18.2	5.8	32.3	5.1	4.7	5.5	17.0	24.9	6.0	9.6	6.2	13.6	8.1	5.5	12.2	9.6	33.4	4.2	4.8	15.1	11.0	6.2	9.9	7.5	10.5	6.1	7.6	10.0	5.9	14.3	6.2	12.7	7.9	3.2	6.6	15.1	12.8	6.3	7.9	7.0	3.9	4.6	6.2	9.0	19.3	2.0	21.1	6.6	2.2	1.8	2.3	5.8	2.2	3.7	3.0	3.4	3.4	2.1	3.5	2.8	3.3	5.8	3.7	1.6	4.1	3.9	1.1	27.8	22.3	42.4	29.0	25.4	9.4	17.4	17.4	16.9	21.8	23.8	29.6	39.5	29.4	64.1	42.4	36.1	45.9	17.4	20.5	73.3	55.0	26.8	16.6	19.9	44.5	29.3	14.8	46.7	17.7	14.9	37.6	40.5	10.3	39.9	13.2	19.1	18.6	38.1	33.7	39.7	68.1	24.4	21.9	6.4	27.5	21.6	20.9	11.5	74.3	67.0	37.1	38.8	25.8	78.2	59.9	71.8	22.4	39.5	34.6	33.9
ZBTB45	"FLJ14486, ZNF499"	ENSG00000119574	"Zinc finger and BTB domain containing 45"	Q96K62	19	58513530-58538911	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035754, HPA075485"	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA035754: AB_10603461, HPA075485: "	"unprognostic (1.38e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.40e-1)"	15.3	11.1	11.8	12.0	13.4	11.1	10.2	15.1	24.9	15.2	10.9	13.5	11.4	14.6	14.9	8.7	11.6	12.5	10.3	10.0	12.6	10.0	9.8	7.7	11.0	10.1	10.3	8.5	16.6	13.9	9.1	8.8	10.9	11.2	14.5	4.7	13.2	21.5	11.0	21.0	17.2	14.7	11.8	7.3	13.3	14.6	7.5	9.2	15.8	15.9	9.1	14.4	13.5	10.5	7.9	8.7	13.2	11.3	7.0	9.8	5.5	10.4	15.1	4.0	6.2	4.0	3.3	4.7	5.5	2.3	1.4	1.4	2.9	7.0	16.7	8.4	3.2	4.2	6.6	2.0	4.9	0.6	10.8	27.0	8.8	7.6	3.6	2.4	5.3	5.7	3.1	3.6	2.3	2.0	2.8	2.9	17.6	7.8	0.8	2.3	7.6	8.7	5.7	5.7	5.9	13.1	6.8	2.4	10.1	3.1	10.1	12.7	8.8	4.2	11.8	3.0	2.4	18.4	3.8	5.4	6.7	2.9	2.2	5.5	19.4	13.6	8.7	7.8	2.2	4.2	9.2	6.7	13.2	8.1	10.2	9.8	6.1	5.8	7.7	7.2	7.9	7.1	5.0	5.9	7.0	11.3	8.7	5.1	5.5	11.8	13.4	15.1	24.9	12.6	10.0	10.3	8.5	11.2	9.2	8.9	0.3	5.9	3.1	1.4	4.1	2.8	0.0	2.7	1.2	12.2	0.0	8.2	5.0	9.9	0.6	4.4	3.9	0.0	7.7	6.0	3.2	3.2	0.0	5.7	5.8	6.4	9.9	9.8	4.0	0.6	5.5	2.6	6.8	14.4	4.7	2.9	7.4	0.0	9.2	3.6	2.8	12.9	2.7	3.1	3.2	2.4	4.7	4.5	5.7	1.7
ZBTB46	"BTBD4, BZEL, FLJ13502, RINZF, ZNF340"	ENSG00000130584	"Zinc finger and BTB domain containing 46"	Q86UZ6	20	63743666-63831244	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 17.7;Ito cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"NB-4: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013997	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013997: AB_1858961"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (3.87e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.12e-1)"	9.2	4.6	6.3	3.8	4.3	2.3	6.0	24.2	6.1	8.1	1.9	2.6	3.2	2.2	9.9	8.0	2.3	6.7	4.4	10.1	4.3	3.8	7.3	3.6	6.4	5.7	4.3	3.0	12.4	6.2	3.4	8.8	7.1	5.3	3.8	1.3	9.4	5.1	6.6	7.3	2.9	3.0	3.3	2.5	14.8	2.4	3.5	2.7	1.8	8.5	4.4	2.0	4.0	10.7	0.2	3.4	0.3	0.6	0.7	0.7	0.2	2.5	2.5	8.6	2.8	0.4	0.9	4.7	1.2	2.9	0.5	0.3	5.9	6.7	0.4	9.1	0.1	3.2	2.5	0.5	0.1	0.4	0.9	2.3	0.5	2.5	5.4	2.0	0.8	1.5	0.5	0.1	0.1	0.0	1.3	0.8	0.3	3.2	0.8	1.6	6.2	0.4	11.8	1.5	3.3	5.4	3.2	4.2	3.6	0.5	1.7	8.6	2.6	2.1	5.2	0.8	4.9	6.4	8.1	0.7	7.3	4.1	3.5	1.4	1.8	4.9	0.8	1.3	1.7	1.3	0.0	0.4	0.2	0.6	0.6	0.3	0.2	0.4	0.6	3.4	0.0	0.4	0.4	0.3	0.7	0.2	0.1	0.7	0.2	6.3	4.3	24.2	6.1	4.3	3.8	4.3	3.0	5.3	2.7	0.0	0.6	0.0	1.1	0.3	4.2	9.0	2.5	0.0	2.3	1.8	17.7	3.5	0.0	1.4	0.4	7.5	0.0	0.0	0.5	0.7	2.5	1.9	2.3	0.0	2.6	1.6	1.2	33.2	5.4	0.9	7.5	2.5	1.7	2.8	0.0	3.8	1.8	0.0	8.1	1.1	9.0	0.0	1.8	0.5	1.7	0.4	3.1	0.0	0.1	1.6
ZBTB47	"DKFZp434N0615, KIAA1190, ZNF651"	ENSG00000114853	"Zinc finger and BTB domain containing 47"	Q9UFB7	3	42653684-42665854	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 28.1;skeletal muscle: 33.1"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 7.9;Early spermatids: 9.9;Melanocytes: 8.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 33.9;fHDF/TERT166: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074057	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074057: AB_2686657"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.86e-2)"	"unprognostic (8.99e-2)"	"prognostic favorable (7.96e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.10e-2)"	5.8	3.3	11.4	3.1	18.0	0.5	2.8	3.3	11.3	4.8	4.4	15.7	0.7	1.1	5.4	1.5	4.4	3.1	4.4	28.1	16.1	4.7	1.2	2.0	2.6	2.1	8.6	9.1	5.0	4.5	2.7	3.0	2.1	6.3	4.8	1.0	2.9	7.6	6.2	33.1	2.8	1.4	5.8	12.8	1.7	3.0	3.1	16.7	0.7	5.2	4.2	1.6	3.7	3.3	0.0	0.9	2.8	1.6	0.3	0.3	0.4	3.6	3.3	2.0	1.3	33.9	13.2	0.7	8.8	7.6	3.9	2.8	0.7	1.5	0.0	3.6	18.0	1.4	0.9	0.5	3.4	0.8	0.0	4.4	2.2	9.5	0.8	10.4	0.0	3.0	14.1	6.2	4.9	4.3	10.0	4.2	0.0	2.0	2.6	7.7	0.9	0.1	0.3	1.1	0.1	2.2	2.7	3.9	1.0	2.1	0.8	2.3	3.8	4.1	0.7	3.3	0.9	4.6	4.8	9.5	8.1	4.7	7.8	3.5	0.1	0.0	0.0	7.4	2.6	2.4	0.0	1.6	0.1	0.3	1.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	2.8	0.3	0.9	0.0	0.0	0.4	11.4	18.0	3.3	9.3	16.1	4.7	8.6	9.1	6.3	16.7	0.0	0.6	0.0	1.2	3.5	4.8	7.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.6	9.9	1.5	0.0	0.0	1.1	0.1	3.0	1.1	4.6	0.5	1.2	0.0	0.0	1.8	1.8	1.4	3.1	1.3	8.5	1.0	0.0	6.6	0.7	0.2	2.8	0.6	1.7	0.0	5.6	0.0	0.2	2.8	0.1	0.0	0.0	1.0
ZBTB49	"FLJ38559, ZNF509"	ENSG00000168826	"Zinc finger and BTB domain containing 49"	Q6ZSB9	4	4290251-4321786	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024450	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			Nucleoplasm	"Microtubules, Cytosol"	"HPA024450: AB_1859311"	"unprognostic (4.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.54e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.88e-5)"	7.3	5.4	5.0	6.0	9.0	11.8	6.8	9.2	8.7	7.2	6.2	9.9	3.4	4.5	9.5	7.0	5.6	6.3	5.3	6.2	6.1	5.1	4.7	5.9	6.5	7.5	6.8	5.3	10.6	7.7	6.0	13.3	5.6	8.9	7.9	4.4	7.1	10.0	6.5	10.1	4.8	6.3	6.5	6.1	9.2	6.0	10.3	6.7	6.7	8.1	5.0	8.5	7.8	5.8	2.9	1.9	12.1	2.7	3.2	6.4	1.8	2.0	3.4	4.3	7.2	5.8	6.1	5.1	2.6	5.1	5.7	4.4	3.0	4.0	7.4	2.7	2.8	7.0	3.6	7.5	4.3	5.9	2.4	2.9	8.6	2.3	4.2	4.9	5.2	3.2	3.9	3.6	5.2	3.4	3.2	5.7	8.0	4.4	4.0	5.3	3.4	10.2	10.2	7.3	3.0	4.6	6.1	5.6	4.6	2.2	3.7	5.2	5.0	5.7	2.2	5.7	6.0	3.1	5.1	5.5	5.1	2.3	3.4	5.5	4.9	4.8	6.3	3.7	4.4	5.0	3.7	2.6	12.1	6.4	2.7	5.0	2.2	3.6	6.0	1.9	2.9	4.1	4.7	6.2	3.2	2.2	0.4	3.2	1.8	5.0	9.0	9.2	8.7	6.1	5.1	6.8	5.3	8.9	6.7	0.0	1.4	2.7	1.6	2.3	2.4	1.6	0.0	1.4	2.3	1.8	3.9	1.6	0.0	1.8	1.5	2.2	0.9	0.0	2.2	1.2	2.0	1.5	1.1	1.5	1.6	1.6	1.2	3.7	2.6	0.0	1.4	2.1	3.3	3.6	1.7	1.7	1.0	2.9	2.1	0.8	7.8	0.0	1.1	9.5	5.3	2.3	1.3	2.9	1.3	1.0
ZBTB5	KIAA0354	ENSG00000168795	"Zinc finger and BTB domain containing 5"	O15062	9	37438114-37465399	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021521	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA021521: AB_2670736"	"unprognostic (2.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.81e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.80e-1)"	7.9	9.2	6.7	10.8	9.5	16.0	10.6	12.8	11.2	10.6	10.0	15.9	7.0	8.7	11.8	11.5	24.6	8.8	7.7	8.4	8.7	5.9	11.0	17.2	11.3	11.7	14.0	6.9	12.5	12.4	11.4	7.9	11.8	9.9	11.3	8.4	9.8	11.9	16.5	7.4	16.6	11.1	7.6	10.4	10.8	10.1	20.4	11.7	15.2	14.8	7.8	17.8	9.5	12.7	2.7	2.6	0.4	1.2	1.1	3.2	1.2	6.6	7.7	19.9	12.3	5.1	3.6	8.5	5.5	4.3	6.8	5.6	5.7	4.9	13.6	6.0	4.1	5.0	8.1	12.9	4.6	5.2	10.0	6.7	5.0	19.8	6.6	5.0	6.1	4.4	3.5	11.6	3.4	7.2	7.7	7.5	10.9	11.7	11.6	5.0	4.2	12.8	4.5	5.0	7.2	3.9	11.7	9.6	5.1	6.5	6.0	9.2	16.5	5.4	8.7	4.2	10.5	13.9	6.0	5.1	4.8	13.3	2.8	5.2	6.2	6.8	11.9	4.4	5.3	5.0	0.4	1.2	0.2	2.2	0.9	2.6	2.7	1.9	1.9	2.6	2.7	2.9	3.2	0.1	1.1	0.1	0.8	1.5	1.2	6.7	9.5	12.8	11.2	8.7	5.9	14.0	6.9	9.9	11.7	14.9	6.2	4.2	6.7	12.7	1.8	3.1	5.1	4.0	11.4	1.8	5.9	3.1	0.0	3.4	1.8	3.3	3.3	0.0	2.8	1.9	4.3	8.9	1.1	7.4	2.1	12.7	8.1	5.5	2.8	3.3	3.7	1.8	3.3	2.8	4.5	3.9	3.3	3.5	3.5	2.6	4.8	0.0	5.1	7.5	7.2	15.8	4.8	1.9	4.5	6.5
ZBTB6	"ZID, ZNF482"	ENSG00000186130	"Zinc finger and BTB domain containing 6"	Q15916	9	122908056-122913330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054111, HPA076894"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA054111: AB_2682384, HPA076894: AB_2686818"	"unprognostic (9.74e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.84e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.31e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.92e-2)"	11.9	10.4	10.7	11.8	12.2	5.2	12.9	17.7	13.2	13.7	9.4	9.0	10.7	10.4	12.6	8.2	11.6	9.4	7.3	9.7	10.2	9.4	11.0	9.2	12.4	26.2	15.6	10.3	13.8	10.0	11.6	14.0	14.1	10.5	10.2	9.0	6.3	9.9	11.4	14.0	10.0	15.0	10.0	13.2	14.0	9.7	9.5	14.4	22.7	13.8	10.1	16.0	11.1	9.3	2.1	2.3	11.8	3.9	3.8	4.0	2.4	4.1	4.8	7.9	7.2	8.4	8.1	8.0	7.0	8.6	7.0	6.3	5.0	5.3	6.6	4.4	6.3	6.3	19.0	8.2	8.6	8.8	9.3	6.5	7.0	10.4	4.6	8.3	9.2	12.7	6.6	13.1	6.4	10.7	8.7	6.4	8.4	7.3	8.2	10.1	7.7	9.3	6.2	9.9	12.3	8.3	5.0	21.7	9.2	7.4	6.8	10.0	12.9	10.8	10.6	6.6	8.7	13.3	6.1	6.5	7.7	6.0	7.8	8.0	14.4	17.2	1.8	9.0	6.3	7.8	11.8	2.3	3.3	2.0	2.5	2.7	2.1	2.8	1.9	2.3	1.7	4.0	3.5	3.0	3.8	3.9	1.3	2.9	2.4	10.7	12.2	17.7	12.1	10.2	9.4	15.6	10.3	10.5	14.4	6.0	2.2	0.0	2.7	1.9	7.3	2.8	7.6	4.0	9.1	1.8	9.8	1.7	0.0	2.1	7.6	2.9	2.6	0.0	2.1	1.0	2.5	3.2	7.0	2.4	2.1	6.4	2.9	7.4	9.2	3.2	2.8	5.4	1.7	1.8	4.2	7.4	2.6	3.4	7.4	3.3	9.1	6.5	2.5	5.2	3.0	2.4	1.6	5.1	3.3	2.7
ZBTB7A	"DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A"	ENSG00000178951	"Zinc finger and BTB domain containing 7A"	O95365	19	4044364-4066945	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037214, CAB037285, HPA046387"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037214: AB_609875, CAB037285: AB_609874, HPA046387: AB_2679648"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (6.50e-6)"	"unprognostic (7.54e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.34e-6)"	"prognostic favorable (1.79e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.36e-2)"	19.6	13.6	18.1	14.3	19.5	17.5	13.6	26.3	26.6	15.2	23.3	14.3	16.0	27.1	16.7	10.6	29.8	12.6	21.1	11.1	20.6	10.4	11.6	12.2	13.7	14.2	13.2	11.6	12.0	12.1	16.2	11.4	12.9	16.8	14.2	11.6	12.4	16.3	14.0	32.0	21.9	22.7	14.2	10.2	19.5	29.2	5.6	13.2	12.4	10.6	15.8	20.5	17.7	16.0	2.9	2.2	4.9	3.7	2.8	2.2	0.5	17.5	8.7	1.5	5.5	12.4	12.8	6.1	12.7	8.0	3.7	3.9	3.1	7.8	8.2	8.5	9.7	5.1	15.6	2.0	6.4	3.3	15.1	8.6	4.9	6.2	4.2	8.4	7.1	17.4	7.0	10.7	5.2	5.2	7.8	4.2	3.9	9.3	7.7	4.2	12.3	8.4	4.9	3.8	8.3	11.0	6.3	4.6	8.2	5.9	7.7	6.7	5.1	7.9	18.0	7.7	1.4	10.1	12.2	12.6	14.0	6.5	18.7	16.4	15.5	6.6	4.7	17.6	7.3	8.9	1.6	2.8	0.8	2.2	3.7	1.8	2.9	1.3	1.7	0.8	1.9	1.0	2.0	4.9	2.8	2.9	2.2	0.9	0.5	18.1	19.5	26.3	26.6	20.6	10.4	13.2	11.6	16.8	13.2	38.7	38.6	34.0	57.5	78.6	100.0	23.6	79.0	18.7	21.6	40.1	51.1	18.0	23.2	18.6	4.0	41.1	124.6	23.3	17.5	8.9	23.5	73.0	25.5	59.6	21.6	151.0	46.0	63.8	54.1	4.4	40.9	49.9	35.4	16.2	105.5	27.3	24.2	77.7	46.3	15.9	69.0	32.3	43.4	3.8	1.7	99.5	45.0	54.2	87.3	93.1
ZBTB8A	"BOZF1, FLJ90065, ZBTB8, ZNF916A"	ENSG00000160062	"Zinc finger and BTB domain containing 8A"	Q96BR9	1	32539427-32605939	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 33.2;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031768, HPA031769, HPA031770"	Approved		Approved	"Nuclear speckles,Focal adhesion sites"		NA	NA			"Nuclear speckles, Focal adhesion sites"		"HPA031768: AB_10610568, HPA031769: AB_2674036, HPA031770: AB_2674037"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.45e-5)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.15e-2)"	8.8	4.9	4.4	3.2	5.0	2.3	19.1	11.1	5.9	13.6	6.2	4.8	12.2	3.8	12.7	8.6	7.2	7.8	5.7	6.9	4.4	3.4	5.7	4.4	14.0	1.9	3.3	4.5	8.6	10.9	10.7	8.9	5.5	7.9	7.8	6.2	6.9	9.9	11.4	10.3	4.8	4.2	15.4	5.2	2.7	6.4	6.2	3.5	1.8	11.2	6.6	3.0	9.1	7.6	1.6	2.1	4.1	1.0	2.6	1.0	0.5	6.6	1.9	7.8	8.4	5.6	7.5	5.9	6.7	5.3	6.3	6.4	0.8	5.4	5.4	4.6	7.2	2.8	5.2	7.7	5.3	5.6	1.4	5.2	0.3	6.6	2.9	7.2	1.2	0.4	5.0	7.6	4.6	12.1	6.3	7.0	4.9	1.1	3.9	6.3	6.8	3.6	0.6	7.1	3.3	2.8	6.6	11.4	4.3	3.9	6.9	6.6	6.0	9.3	4.7	8.9	4.3	6.1	3.1	7.2	8.4	6.9	11.5	4.8	7.1	3.4	4.2	5.8	1.4	3.5	4.1	1.0	0.8	0.8	0.6	1.0	0.8	0.7	0.7	0.7	1.6	0.8	0.9	3.8	2.6	0.8	2.1	0.6	0.5	4.4	5.0	11.1	5.9	4.4	3.4	3.3	4.5	7.9	3.5	14.9	14.4	1.5	6.3	3.7	10.5	3.6	5.1	4.0	4.5	7.0	21.6	2.5	1.7	5.7	3.8	12.8	3.5	0.0	4.5	5.1	10.1	7.2	2.3	3.6	1.4	6.4	4.7	20.3	4.0	3.9	18.4	4.8	3.3	1.0	4.5	4.1	5.0	3.5	33.2	2.4	8.7	32.3	11.3	0.9	4.3	3.3	1.3	2.5	8.7	5.4
ZBTB8OS	ARCH	ENSG00000176261	"Zinc finger and BTB domain containing 8 opposite strand"	Q8IWT0	1	32600172-32650903	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046315	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA046315: AB_2679623"	"unprognostic (3.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (5.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.11e-8)"	"unprognostic (1.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.42e-1)"	16.1	18.8	20.9	21.2	22.3	14.5	16.7	21.7	21.1	13.1	25.6	11.9	21.4	24.9	13.9	29.5	20.6	15.5	12.2	20.7	16.9	15.8	23.2	26.6	15.5	25.9	23.5	18.6	10.4	20.3	9.2	36.6	13.6	20.9	15.9	26.8	15.3	19.0	18.5	29.5	13.4	28.6	16.2	18.0	22.3	20.6	11.1	23.0	8.4	18.7	20.3	32.5	14.8	13.5	36.0	26.1	33.8	35.4	22.4	40.1	18.0	18.4	10.7	9.5	16.1	16.8	15.4	13.1	21.0	21.2	16.8	17.1	25.2	20.7	20.6	19.4	15.3	18.6	13.9	16.6	16.4	22.5	27.4	15.3	16.7	22.2	41.9	13.9	23.9	15.5	15.3	18.0	14.7	17.8	10.5	18.2	25.3	16.4	28.0	21.4	14.5	18.2	14.0	29.6	28.8	16.6	14.7	20.6	20.0	19.9	22.0	19.3	14.9	17.0	17.1	26.3	27.1	11.7	19.9	12.9	23.4	14.2	18.8	26.1	42.6	41.7	58.0	16.8	29.9	23.1	15.8	29.2	33.8	24.4	33.9	23.5	36.0	27.0	28.9	20.4	23.1	22.5	24.2	32.5	22.4	35.4	26.1	40.1	18.0	20.9	22.3	21.7	21.1	16.9	15.8	23.5	18.6	20.9	23.0	20.8	53.8	37.9	26.7	15.2	44.5	57.6	33.1	40.2	31.8	36.6	41.2	44.3	76.3	54.3	27.3	35.0	79.9	23.3	46.1	51.1	32.5	30.0	41.7	75.0	66.3	15.9	36.1	34.4	66.8	24.3	33.9	58.6	49.0	83.8	44.2	24.2	63.5	46.3	43.5	103.7	51.5	32.3	36.3	42.1	29.1	13.7	54.5	49.8	48.8	32.5
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457548	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 3.9;Intestinal endocrine cells: 1.7;Melanocytes: 1.7;Suprabasal keratinocytes: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.3;GAMG: 15.7;U-698: 11.6"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	4.5	7.1	5.5	5.4	5.9	4.4	3.3	4.9	7.4	5.4	4.4	6.4	2.4	6.6	4.5	8.7	5.4	4.8	4.2	4.4	5.9	5.1	7.7	5.4	3.7	6.6	4.4	4.5	10.6	11.3	8.5	17.3	4.5	4.2	5.9	7.1	4.6	6.3	3.9	5.7	5.0	3.9	3.8	3.5	5.4	3.7	12.7	3.8	9.7	6.8	4.0	13.7	7.8	4.3	0.8	2.6	8.5	2.2	1.9	4.3	1.0	0.1	0.1	4.6	0.7	2.3	0.1	10.3	0.1	0.2	0.0	0.0	1.6	0.0	1.6	1.5	0.1	15.7	0.0	4.4	1.8	0.6	1.8	0.0	6.1	0.0	0.0	0.0	2.3	6.0	0.2	0.2	2.7	2.7	0.0	0.0	0.3	2.5	0.5	2.0	0.5	0.4	0.0	2.9	0.2	0.4	3.0	2.8	2.0	2.4	2.1	0.5	0.3	3.0	0.1	1.0	0.2	0.5	0.4	1.5	0.3	0.1	0.9	1.1	0.0	1.7	11.6	0.2	1.9	0.0	8.5	1.5	0.5	3.9	1.5	1.9	0.3	1.9	4.3	2.6	0.8	3.6	3.2	1.4	1.9	2.2	0.3	3.2	1.0	5.5	5.9	4.9	7.4	5.9	5.1	4.4	4.5	4.2	3.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.8	0.0	0.0	1.7	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	3.1	0.0	0.0	0.7	0.0
ZC2HC1A	"C8orf70, CGI-62, FAM164A"	ENSG00000104427	"Zinc finger C2HC-type containing 1A"	Q96GY0	8	78666047-78719765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.6;T-reg: 17.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 20.9;SK-BR-3: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024726	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			Cytosol	"Actin filaments"	"HPA024726: AB_1846597"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.19e-7)"	"unprognostic (2.96e-1)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.05e-3)"	7.6	6.2	16.1	6.1	21.2	2.0	14.3	23.6	20.0	12.7	8.0	8.4	6.7	3.3	19.7	9.1	11.5	19.5	10.0	8.1	16.5	15.7	8.3	2.9	12.6	5.1	11.9	22.6	23.6	4.9	26.1	26.1	11.4	25.8	12.8	7.8	5.0	7.5	10.9	4.2	43.1	5.8	13.1	13.8	5.9	5.8	8.6	11.0	1.5	19.8	4.2	8.4	11.0	12.1	5.1	3.3	20.6	8.1	0.6	17.7	1.5	2.4	3.0	5.7	4.6	12.2	12.9	2.5	6.8	4.6	3.4	4.4	0.8	4.4	4.1	2.9	6.9	7.3	2.0	3.4	3.8	5.1	13.6	2.2	0.5	2.8	2.4	7.3	0.7	1.4	9.2	6.5	2.8	8.4	10.5	4.7	1.4	0.7	20.9	7.2	2.4	0.8	1.2	1.4	0.2	4.9	0.0	7.3	0.9	5.1	5.3	2.2	9.0	5.3	39.2	7.4	5.5	1.0	0.1	3.8	10.8	4.5	4.9	3.3	5.2	5.3	2.7	5.1	0.0	4.1	20.6	3.9	0.1	0.1	4.1	0.0	5.1	4.0	0.2	3.3	3.3	1.2	0.4	0.1	0.6	8.1	0.2	17.7	1.5	16.1	21.2	23.6	20.0	16.5	15.7	11.9	22.6	25.8	11.0	62.5	21.3	5.6	36.7	26.0	25.1	14.5	5.1	128.5	31.8	17.4	3.9	23.8	23.2	15.7	8.0	13.3	0.0	0.0	7.3	25.2	18.0	13.1	5.8	0.8	13.6	44.5	8.6	17.2	6.9	3.0	17.8	11.2	15.1	16.2	2.9	34.9	8.1	0.0	34.6	8.7	22.2	6.5	20.6	29.8	28.8	36.9	14.5	4.4	3.0	10.6
ZC2HC1C	"C14orf140, FAM164C"	ENSG00000119703	"Zinc finger C2HC-type containing 1C"	Q53FD0	14	75064170-75079987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 75.7"	"Group enriched"	"Detected in many"	8	"Ciliated cells: 48.2;Early spermatids: 103.8;Late spermatids: 150.0;Spermatocytes: 54.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA050928, HPA065062"	Enhanced		Approved	"Nuclear speckles,Mitochondria"		No	No			"Nuclear speckles"	Mitochondria	"HPA050928: AB_2681277, HPA065062: AB_2732728"	"unprognostic (8.01e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (4.63e-13)"	"unprognostic (4.69e-3)"	"unprognostic (7.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.81e-1)"	0.7	2.1	2.3	0.5	5.3	0.2	1.3	1.8	3.4	1.5	2.0	2.3	4.6	2.5	1.0	18.2	1.3	8.2	1.5	2.9	3.0	3.0	4.3	6.8	2.2	0.1	2.3	2.3	0.8	3.6	5.2	10.9	3.3	4.7	1.0	1.8	1.2	2.3	5.7	3.0	1.1	1.9	1.0	1.9	0.6	1.2	75.7	2.3	0.6	5.9	0.5	0.4	1.2	0.4	1.6	0.6	0.8	0.3	3.8	3.8	0.8	6.0	4.7	1.0	5.3	0.3	0.3	2.8	0.5	2.1	2.7	1.2	7.7	11.1	5.6	4.3	0.5	3.7	2.4	0.0	0.1	1.9	5.9	0.6	1.4	1.6	2.7	3.7	0.1	3.7	1.1	0.6	3.4	0.1	3.1	1.6	0.4	8.0	2.5	1.3	1.3	0.6	0.7	1.7	3.5	3.3	0.1	0.3	2.7	6.0	0.4	9.7	2.3	3.5	3.1	2.8	1.0	4.4	1.8	0.8	1.7	1.9	2.9	1.1	5.6	8.3	2.9	2.4	1.0	0.9	0.8	0.3	0.8	1.9	0.0	0.5	1.6	1.6	0.5	0.3	0.8	0.7	0.8	0.4	3.8	0.2	0.6	3.8	0.8	2.3	5.3	1.8	3.4	3.0	3.0	2.3	2.3	4.7	2.3	6.0	8.9	0.9	1.5	1.5	4.4	5.6	5.1	48.2	10.3	10.4	9.8	1.9	3.3	3.2	103.8	1.7	2.6	0.0	1.2	1.0	1.3	2.0	1.1	3.9	1.4	11.1	5.1	1.8	1.0	150.0	2.8	0.9	3.3	1.0	3.1	3.1	1.5	0.0	2.5	5.7	8.4	6.5	0.5	54.1	5.3	0.6	4.2	0.0	3.3	0.8
ZC3H10	"FLJ14451, ZC3HDC10"	ENSG00000135482	"Zinc finger CCCH-type containing 10"	Q96K80	12	56118159-56127514	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039236, HPA062265"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA039236: AB_10795463, HPA062265: AB_2684730"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.31e-5)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-1)"	11.3	10.1	7.9	9.0	11.8	4.1	8.6	11.2	10.4	10.9	10.4	12.9	6.5	5.4	13.2	7.3	7.1	8.9	8.9	7.7	7.3	4.7	7.9	8.1	7.7	8.3	11.1	5.9	13.3	11.2	8.2	9.4	7.9	9.2	13.5	4.6	9.0	8.7	9.8	13.6	7.7	7.0	7.4	6.8	11.5	7.7	24.6	12.0	13.3	10.0	5.2	7.2	10.5	9.7	6.2	7.1	7.6	12.7	10.9	7.1	4.7	4.5	8.1	6.4	5.1	8.0	5.4	5.0	5.5	3.6	3.3	2.6	2.1	2.7	4.8	9.0	3.9	1.8	6.1	3.3	1.9	2.1	8.6	8.5	7.4	7.6	2.3	4.8	6.6	4.7	3.4	4.4	3.8	4.4	6.1	4.9	5.8	3.8	9.2	4.3	2.8	7.5	2.9	4.4	2.6	6.7	7.5	6.9	4.5	2.8	2.2	6.3	6.1	3.1	4.8	4.9	5.1	7.8	6.1	7.0	3.1	7.3	6.1	4.0	7.7	4.8	2.8	4.1	3.3	7.6	3.6	7.0	7.6	6.9	7.9	7.1	5.2	5.5	5.9	7.1	6.2	5.4	5.3	4.9	10.9	12.7	3.3	2.7	4.7	7.9	11.8	11.2	10.4	7.3	4.7	11.1	5.9	9.2	12.0	0.0	3.4	6.0	2.5	0.7	8.2	2.4	5.1	4.0	0.0	7.0	19.6	5.1	13.3	4.1	36.2	3.2	4.2	0.0	2.6	2.4	3.1	1.9	2.3	2.4	4.6	12.7	1.2	6.2	5.1	9.8	4.9	2.9	3.3	9.0	2.3	9.7	2.8	2.8	4.9	3.5	15.5	0.0	4.7	15.0	11.6	1.5	5.4	2.5	1.9	1.2
ZC3H11A	"KIAA0663, ZC3HDC11A"	ENSG00000058673	"Zinc finger CCCH-type containing 11A"	O75152	1	203795654-203854999	"Predicted intracellular proteins"	"mRNA transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA026439, HPA028490, HPA028526"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533"	"unprognostic (8.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.41e-1)"	21.7	18.1	19.0	17.7	15.9	23.2	49.0	27.7	17.9	16.8	20.4	16.9	15.7	18.4	21.9	12.5	18.8	15.2	13.7	15.5	20.7	12.8	16.2	23.9	20.8	22.4	22.9	11.0	19.0	17.2	23.0	42.7	30.8	18.8	16.9	16.8	11.0	19.5	15.6	23.0	23.4	25.4	15.5	20.5	23.9	18.5	42.1	18.7	23.1	21.0	14.1	22.8	21.5	44.7	6.7	5.1	15.1	6.3	5.9	9.5	4.9	13.8	11.2	22.0	14.4	13.6	10.5	24.1	16.1	11.1	13.2	14.8	15.6	17.6	17.8	9.9	16.3	10.6	19.9	17.3	9.4	18.0	25.9	12.5	17.1	18.4	7.7	7.5	23.7	30.8	9.0	11.6	13.9	13.7	16.4	11.7	19.4	33.8	24.4	10.7	11.4	26.1	9.6	21.2	9.9	9.3	19.2	25.8	11.7	9.5	24.3	16.4	15.4	16.0	13.1	14.6	26.2	14.2	17.8	18.6	19.3	17.2	16.5	15.0	18.1	17.0	28.4	12.3	13.8	14.6	15.1	4.4	6.5	6.9	4.3	9.5	6.7	6.3	6.2	5.1	5.0	8.0	5.8	9.2	5.9	6.3	2.8	5.8	4.9	19.0	15.9	27.7	17.9	20.7	12.8	22.9	11.0	18.8	18.7	11.9	25.6	37.1	51.4	90.1	41.6	53.6	56.0	20.1	22.7	0.0	43.2	26.1	0.0	0.2	31.1	62.7	40.4	46.7	0.2	22.8	64.8	79.2	24.3	53.9	28.2	79.4	44.9	55.3	49.7	7.6	55.8	34.3	45.5	0.0	60.1	40.3	0.4	38.4	63.3	0.0	47.2	77.6	59.5	48.9	36.6	97.5	42.7	34.6	45.7	81.4
ZC3H11B	ZC3HDC11B	ENSG00000215817	"Zinc finger CCCH-type containing 11B"		1	219608347-219613145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	4	"testis: 8.9"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 1.4;Collecting duct cells: 1.8;monocytes: 1.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA026439, HPA028490, HPA028526"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533"	"unprognostic (1.75e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.87e-2)"	0.1	0.1		0.5		0.1	0.0		0.1	0.0	0.0			0.2	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.4	0.8	0.1	0.0		0.1	0.0	8.9			0.0		0.0	0.0		0.5	0.7	2.1	0.9	0.6	0.9	0.6	1.0	0.8	2.2	1.3	0.4	0.3	1.9	1.9	0.3	0.3	0.4	0.9	0.9	0.7	0.5	0.3	1.0	1.5	0.2	0.2	0.3	3.1	0.8	0.5	1.1	0.8	0.1	0.8	1.8	0.2	0.1	0.4	0.5	0.8	0.0	1.9	2.2	2.3	0.2	0.4	1.6	1.1	1.2	0.2	0.6	0.7	1.5	0.7	0.2	0.9	0.9	1.4	1.1	1.7	1.3	1.0	1.4	3.2	1.1	1.0	1.3	1.0	2.0	1.4	1.2	1.1	2.3	1.4	2.0	1.0	0.9	0.7	0.7	0.4	0.8	0.5	0.6	0.7	0.7	0.5	0.7	0.6	2.1	0.6	0.3	0.3	0.9	0.6											0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZC3H12B	"CXorf32, MCPIP2"	ENSG00000102053	"Zinc finger CCCH-type containing 12B"	Q5HYM0	X	65366638-65507887	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 6.1"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 6.0;Bipolar cells: 3.8;Intestinal endocrine cells: 4.1;Peritubular cells: 3.9"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA000836	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Endoplasmic reticulum"	"Golgi apparatus, Vesicles"	"HPA000836: AB_2217374"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.44e-3)"	"unprognostic (7.86e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.71e-2)"	0.3	0.9	2.6	0.5	3.9	0.1	0.5	2.8	6.1	1.9	1.1			0.9	2.6	0.8	0.4	2.0	1.1	0.5	2.8	2.5	1.2	0.5	0.6	0.7	1.7		3.3	0.1	2.7	2.7	0.0		1.8	1.1		0.3	2.4	0.0	0.3	0.9	1.8	1.5	0.4	1.3	0.0			1.5		0.2	1.0	0.7	1.3	0.8	0.7	0.4	0.8	1.8	0.2	0.3	0.4	5.1	0.7	0.0	0.0	0.6	1.2	2.7	0.0	0.8	0.7	0.5	0.8	0.3	1.4	0.0	0.8	1.3	0.0	0.1	0.7	3.7	1.7	2.3	0.7	0.1	1.5	0.4	0.2	0.0	0.1	0.0	1.1	0.0	4.1	0.9	4.1	0.1	0.0	2.1	0.6	2.1	2.8	1.0	2.4	0.2	1.0	0.1	0.2	0.2	2.4	0.0	0.1	0.2	3.0	0.1	1.2	0.0	0.1	1.0	1.7	0.5	0.9	1.0	1.7	3.2	2.2	0.0	0.6	0.4	0.1	0.6	0.2	0.5	0.9	0.8	0.8	0.2	1.3	1.8	0.8	0.7	0.8	0.2	0.8	0.4	0.2											6.0	0.3	1.5	0.2	0.0	3.8	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.2	0.1	0.4	0.3	0.0	0.4	0.1	1.6	4.1	0.6	0.0	0.0	2.3	0.0	0.0	0.0	1.3	0.8	0.2	0.0	3.9	0.3	1.4	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.9	0.1
ZC3H12C	"KIAA1726, MCPIP3"	ENSG00000149289	"Zinc finger CCCH-type containing 12C"	Q9C0D7	11	110093361-110171841	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 32.8;Basal keratinocytes: 42.1;Suprabasal keratinocytes: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038836, HPA038837"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Nuclear membrane, Golgi apparatus"		"HPA038836: AB_2676229, HPA038837: AB_10675953"	"unprognostic (1.22e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.90e-2)"	"prognostic favorable (9.90e-6)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.11e-1)"	6.9	8.1	7.7	3.5	12.6	4.6	4.8	21.4	12.0	7.1	7.3	8.7	6.8	2.6	7.9	4.2	5.2	6.0	7.6	6.8	9.3	4.8	5.6	6.4	6.3	2.0	9.2	5.2	11.5	5.5	8.4	13.2	4.1	9.9	5.8	6.1	5.8	4.9	5.6	18.4	9.3	4.5	10.8	11.1	2.7	5.1	12.0	11.0	0.2	13.3	4.0	2.2	7.9	4.2	0.0	0.0	7.1	0.2	0.0	0.3	0.0	4.3	2.6	10.4	0.0	4.8	11.2	2.0	1.7	11.4	3.1	5.1	3.3	4.1	0.0	6.5	5.1	7.7	4.2	2.0	6.1	6.1	16.3	1.4	6.9	3.3	1.2	5.5	0.0	3.3	18.0	5.9	5.3	8.8	6.1	4.2	0.0	0.6	1.0	6.3	0.6	0.0	0.0	1.6	0.1	9.3	0.0	3.6	0.4	3.4	8.9	4.7	8.5	4.0	0.2	7.5	2.1	2.5	2.5	7.0	6.8	3.3	3.5	3.7	0.4	0.0	0.0	4.1	1.2	7.9	7.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.7	12.6	21.4	12.0	9.3	4.8	9.2	5.2	9.9	11.0	32.8	7.5	0.5	3.4	42.1	8.0	13.0	5.1	0.0	1.2	5.2	3.9	1.2	0.0	5.7	8.5	12.8	7.0	0.0	3.1	0.4	10.8	10.3	0.0	6.4	8.8	14.3	8.5	13.5	5.9	9.3	8.9	4.6	21.9	2.8	8.2	5.2	3.1	14.4	7.8	5.1	2.7	0.0	3.5	1.7	0.8	58.2	0.7	0.0	6.8	6.7
ZC3H13	"DKFZp434D1812, KIAA0853"	ENSG00000123200	"Zinc finger CCCH-type containing 13"	Q5T200	13	45954465-46052759	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039340, HPA040140, HPA047806"	Uncertain		Approved	"Nuclear membrane,Actin filaments"		NA	NA			"Nuclear membrane, Actin filaments"		"HPA039340: AB_2676454, HPA040140: AB_2676858, HPA047806: AB_2680161"	"unprognostic (1.50e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.45e-1)"	"unprognostic (9.21e-3)"	16.4	11.7	17.7	13.9	30.3	15.4	17.3	17.8	26.9	18.9	15.4	19.0	14.2	9.4	20.6	16.9	13.5	13.4	12.4	11.9	20.3	15.9	14.3	67.5	13.5	15.9	23.0	23.2	20.5	10.5	22.2	18.3	17.0	24.5	17.5	13.8	7.6	14.3	16.9	19.8	14.7	13.3	20.8	24.9	16.9	12.7	11.9	25.7	25.2	19.3	10.6	14.2	21.0	12.3	18.4	20.3	28.4	15.2	13.0	19.4	8.0	6.7	8.5	20.2	8.4	14.7	15.3	10.0	12.1	9.7	10.4	7.1	12.4	11.8	18.5	8.1	12.0	6.8	12.1	13.1	10.1	16.2	16.3	15.2	21.6	8.0	10.8	8.8	26.6	11.9	11.6	8.2	10.6	12.3	9.0	10.3	10.4	11.5	5.7	10.1	9.2	13.4	12.9	19.8	12.1	5.6	14.0	13.3	5.6	7.9	9.6	5.6	12.5	11.0	7.5	64.7	13.8	5.7	11.8	18.2	8.8	8.1	7.9	10.6	5.6	6.8	18.7	10.0	14.6	11.4	19.9	13.3	22.9	19.4	15.2	18.7	13.6	15.5	13.1	10.4	18.4	15.7	12.7	28.4	13.0	14.4	20.3	16.0	8.0	17.7	30.3	17.8	26.9	20.3	15.9	23.0	23.2	24.5	25.7	199.5	190.7	89.3	56.4	36.1	81.4	159.8	91.7	120.5	122.8	52.4	41.2	76.6	23.2	57.3	3.5	66.9	33.2	46.7	42.3	65.9	68.7	53.3	119.7	190.6	57.8	81.0	53.4	77.3	82.1	6.0	71.1	51.0	27.0	89.2	29.4	78.7	44.7	37.7	76.7	14.6	66.7	51.8	55.2	139.4	101.3	44.3	67.2	69.8	32.8	47.4
ZC3H3	"KIAA0150, ZC3HDC3"	ENSG00000014164	"Zinc finger CCCH-type containing 3"	Q8IXZ2	8	143437655-143541453	"Predicted intracellular proteins"	"mRNA transport, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023658, HPA050577"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023658: AB_1858973, HPA050577: "	"unprognostic (1.15e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (4.38e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"unprognostic (2.18e-1)"	11.9	7.9	9.9	10.1	11.1	28.0	9.1	17.3	16.6	6.3	7.5	11.9	9.8	20.8	9.4	4.4	9.2	7.6	7.1	6.0	7.9	4.5	12.6	26.9	9.3	8.5	7.3	8.7	8.6	10.1	5.7	6.4	8.8	8.5	7.9	3.6	9.1	12.0	7.7	15.1	10.9	16.5	10.0	5.0	13.4	11.8	23.2	7.4	13.8	9.4	7.0	9.1	8.0	7.7	5.2	5.3	13.4	8.1	2.9	9.2	6.7	7.6	11.4	3.6	8.6	2.2	2.6	10.1	4.4	3.2	5.7	4.7	6.1	7.1	5.5	8.1	3.6	3.1	8.8	2.9	4.6	1.2	11.9	10.2	7.0	6.9	9.6	5.5	3.4	6.2	5.9	4.3	4.7	3.3	2.6	4.1	5.4	11.5	10.2	2.3	19.9	16.2	6.5	6.6	6.3	18.6	9.4	2.9	17.2	4.0	4.7	9.3	6.1	8.7	7.6	4.7	2.0	12.2	6.4	5.6	5.0	15.3	10.9	7.6	9.3	6.2	4.7	6.5	8.2	5.4	9.1	6.3	8.6	6.2	8.1	7.3	5.2	7.1	7.5	5.3	4.7	9.2	7.3	13.4	2.9	5.0	4.5	5.1	6.7	9.9	11.1	17.3	16.6	7.9	4.5	7.3	8.7	8.5	7.4	0.0	2.9	5.6	3.1	6.3	6.7	1.2	0.0	0.0	1.2	5.2	7.9	6.8	1.7	5.6	4.9	3.6	12.7	0.0	6.4	7.5	5.6	3.5	5.7	12.2	7.3	4.8	10.3	2.5	7.3	5.8	4.9	8.1	3.3	8.2	7.9	5.6	5.9	0.0	5.3	8.8	7.0	12.9	2.1	12.7	14.0	7.5	10.3	5.1	7.4	4.8
ZC3H6	"FLJ41410, FLJ45877, KIAA2035, ZC3HDC6"	ENSG00000188177	"Zinc finger CCCH-type containing 6"	P61129	2	112275594-112340063	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036019, HPA036020, HPA076065"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA036019: AB_10673228, HPA036020: AB_2674904, HPA076065: AB_2732300"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.99e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.45e-2)"	10.9	8.8	8.1	6.2	18.9	5.8	11.2	16.6	14.3	10.9	8.1	11.4	7.7	5.3	9.1	11.9	6.7	10.3	6.5	9.4	8.9	7.4	7.6	6.4	7.4	8.9	15.6	10.5	20.5	7.1	13.8	18.3	7.0	11.1	9.8	6.2	8.6	8.2	8.0	16.4	14.3	7.5	10.5	11.5	10.0	6.9	9.4	13.1	12.4	12.5	5.2	8.6	13.4	8.6	5.5	2.9	3.9	3.4	1.8	4.5	1.1	1.7	0.8	4.0	3.7	3.5	7.0	1.2	2.0	3.1	1.2	2.6	0.4	2.4	2.9	1.5	1.1	3.4	1.1	1.2	0.5	1.7	3.2	0.4	0.5	0.9	0.1	3.3	0.9	0.8	2.7	5.4	1.4	9.2	5.7	1.9	3.6	0.7	4.9	2.8	1.6	1.7	1.2	2.5	1.1	0.9	1.1	0.2	2.5	1.7	0.3	2.8	3.9	1.9	1.1	2.0	2.2	1.2	1.1	3.0	2.0	0.3	2.2	0.9	5.2	1.5	2.5	3.7	1.9	4.9	1.5	1.8	2.3	2.9	1.3	3.2	3.7	3.9	3.0	1.6	5.5	4.5	3.7	3.9	1.8	3.4	2.9	3.2	1.1	8.1	18.9	16.6	14.3	8.9	7.4	15.6	10.5	11.1	13.1	35.7	23.5	7.8	27.2	15.3	64.1	63.7	17.8	37.5	26.1	21.0	51.1	17.6	24.9	10.4	9.8	27.8	9.0	0.0	13.1	6.2	18.3	24.3	25.5	15.8	10.9	108.1	15.5	23.4	15.2	11.0	42.8	13.5	5.0	16.2	13.3	47.9	11.9	9.1	33.9	18.3	82.7	32.3	26.8	70.4	48.8	16.2	6.6	22.4	14.0	17.2
ZC3HAV1	"FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043520-139109719	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"T-cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: AB_2683903"	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favorable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	14.3	14.8	6.8	19.8	6.6	52.6	13.8	1.6	5.6	11.2	11.5	6.7	10.8	6.9	10.0	10.9	14.2	9.5	10.4	7.0	5.4	7.2	11.2	13.1	17.2	44.4	7.5	4.0	10.6	11.0	9.8	11.4	8.5	8.6	11.2	10.2	9.3	16.9	11.5	3.8	9.5	14.8	10.8	9.0	22.6	9.6	7.8	6.9	43.9	18.2	8.8	26.1	10.8	29.0	16.3	7.0	28.8	11.9	15.6	27.9	11.8	11.4	14.2	2.0	11.8	18.8	18.1	8.6	13.0	10.0	22.8	23.5	10.2	15.0	10.1	12.3	20.8	19.7	13.1	15.9	15.5	13.0	17.9	5.9	20.1	14.4	12.6	10.8	23.3	18.7	18.4	9.9	25.9	5.8	8.5	16.9	15.3	17.0	11.4	9.7	10.9	19.2	27.2	8.0	8.8	8.7	22.8	7.1	9.8	15.6	14.5	3.7	7.5	20.1	14.2	17.3	4.8	8.3	14.6	21.3	4.9	7.1	13.3	10.7	8.7	9.1	23.8	10.9	21.8	11.5	28.8	8.2	11.9	19.4	10.6	24.6	14.3	27.9	23.5	6.4	16.3	27.3	26.4	22.1	15.6	11.9	7.0	24.2	11.8	6.8	6.6	1.6	5.6	5.4	7.2	7.5	4.0	8.6	6.9	23.8	44.5	82.7	23.7	25.4	2.1	4.4	30.6	28.1	20.5	50.6	3.9	10.5	8.3	17.4	2.2	46.7	36.0	23.3	18.3	17.5	51.6	34.7	31.2	29.9	30.5	0.0	51.0	46.1	44.1	1.2	17.3	62.3	37.1	37.9	31.3	15.0	19.2	26.4	25.1	31.0	0.7	12.9	57.9	0.7	0.7	19.4	1.9	124.6	27.3	23.0
ZC4H2	"HCA127, KIAA1166, WWS"	ENSG00000126970	"Zinc finger C4H2-type containing"	Q9NQZ6	X	64915802-65034713	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 27.7;REH: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049584	Approved		Approved	Vesicles,Microtubules		NA	NA			"Vesicles, Microtubules"		"HPA049584: AB_2680825"	"unprognostic (9.55e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.51e-5)"	"unprognostic (5.34e-2)"	7.0	9.7	11.7	6.6	12.3	4.8	7.4	12.7	15.0	10.4	12.2	15.6	8.1	8.1	12.8	8.4	6.4	12.5	8.0	10.4	10.6	14.7	9.9	10.0	6.4	5.6	11.7	10.8	14.7	5.3	20.0	20.3	2.2	16.9	10.5	9.6	10.0	8.9	12.2	3.2	5.3	7.8	16.2	12.3	6.2	9.5	2.5	12.4	12.7	10.8	2.3	5.4	8.2	6.1	4.7	3.9	0.0	2.0	3.6	7.9	3.0	0.0	0.9	17.0	7.6	0.1	0.0	2.5	3.7	5.6	4.7	8.2	1.2	6.1	2.8	2.0	2.7	0.0	0.0	7.2	2.8	4.6	0.0	5.7	5.1	2.6	2.2	1.1	5.1	1.7	3.1	2.3	2.1	4.4	6.5	8.0	16.4	1.4	6.4	5.2	0.0	14.0	0.0	27.7	2.5	6.4	20.3	9.0	0.1	4.1	0.0	0.0	11.9	0.0	0.0	0.7	10.0	1.5	0.8	5.0	2.2	5.1	0.2	0.0	0.9	0.1	10.4	6.3	4.3	0.0	0.0	1.3	0.0	3.3	2.0	5.9	4.7	4.8	5.0	1.8	4.1	7.9	4.6	0.0	3.6	0.5	3.9	2.4	3.0	11.7	12.3	12.7	15.0	10.6	14.7	11.7	10.8	16.9	12.4	3.0	0.0	2.7	1.9	0.6	2.5	3.3	2.5	0.0	2.3	1.8	3.9	0.1	1.7	5.9	0.3	2.8	2.1	0.0	4.9	0.7	1.9	1.0	2.3	3.2	0.9	0.0	3.5	4.3	0.8	0.2	6.6	0.0	0.0	0.0	1.9	3.8	4.2	2.6	8.1	3.8	1.4	12.9	3.9	0.5	0.4	0.5	0.0	0.9	3.2	0.7
ZCCHC10	FLJ20094	ENSG00000155329	"Zinc finger CCHC-type containing 10"	Q8TBK6	5	132996985-133026604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038944	Approved		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"HPA038944: AB_10673601"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.89e-3)"	18.6	17.3	14.5	18.2	14.1	30.6	16.4	18.1	20.6	17.4	24.1	10.5	15.4	18.3	18.7	15.4	26.9	14.9	14.2	17.3	13.7	12.4	19.6	23.5	21.0	26.0	11.9	15.2	17.3	17.7	9.8	27.4	23.0	15.3	16.1	22.1	10.0	17.9	16.8	31.5	14.0	21.7	14.0	17.5	23.6	17.8	20.3	14.1	25.6	13.9	22.4	26.5	17.8	17.3	48.1	27.2	16.5	28.0	22.9	27.7	18.8	11.9	12.4	16.5	13.6	8.3	7.5	21.6	12.6	9.8	16.1	18.7	31.4	14.8	33.2	19.3	8.4	12.7	15.1	20.1	16.1	17.5	19.5	26.7	19.3	15.3	23.2	12.3	16.5	22.5	6.8	18.5	9.8	16.0	8.8	15.9	16.5	20.8	18.4	12.2	15.6	25.7	19.2	17.9	12.7	13.1	23.1	19.5	14.4	14.8	17.2	13.0	10.9	20.1	8.2	23.2	23.4	18.2	21.5	16.1	13.8	16.4	9.0	18.1	15.6	24.7	46.6	11.3	29.6	16.2	16.5	28.0	16.4	19.7	25.3	20.6	39.7	24.1	23.5	27.2	48.1	21.2	21.8	14.6	22.9	25.3	24.0	27.7	18.8	14.5	14.1	18.1	20.6	13.7	12.4	11.9	15.2	15.3	14.1	26.8	38.6	82.1	33.1	29.7	26.0	45.6	61.1	30.8	35.2	12.2	7.9	43.8	28.2	33.8	5.0	32.1	53.0	0.0	58.5	44.4	38.5	26.8	32.3	53.9	41.1	27.0	36.4	38.1	58.5	5.0	22.7	44.8	33.7	38.7	50.6	17.3	47.2	73.7	28.0	70.8	25.2	12.9	34.4	62.4	63.2	33.1	51.5	45.7	45.4	45.6
ZCCHC11	"KIAA0191, PAPD3, TUT4"	ENSG00000134744	"Zinc finger CCHC-type containing 11"	Q5TAX3	1	52408282-52553487	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 229.7;Horizontal cells: 198.6;Rod photoreceptor cells: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	13.8	19.1	18.4	25.6	19.0	20.5	18.7	50.9	21.3	22.4	13.3	11.8	16.1	7.7	22.1	22.0	11.5	16.8	14.0	13.5	17.8	16.5	14.2	17.7	13.3	27.4	15.4	14.6	28.3	17.6	34.4	56.0	18.8	16.3	16.1	10.5	12.1	12.6	20.6	44.6	28.1	17.1	20.3	26.6	20.9	12.3	24.9	21.1	31.9	23.9	14.6	25.1	18.3	17.0	23.2	26.0	26.7	4.3	10.3	15.0	2.2	10.3	9.8	24.2	16.3	9.5	12.2	16.8	9.2	13.5	13.4	15.6	10.1	5.4	22.1	10.9	12.8	21.8	8.6	18.1	9.8	17.2	18.0	16.5	23.3	12.7	21.0	15.8	25.2	13.3	14.4	21.7	14.4	17.9	17.1	9.3	15.5	18.9	11.1	11.2	0.1	25.1	18.0	17.5	5.3	12.5	22.3	24.6	17.3	14.5	8.6	13.0	12.9	14.2	6.1	13.8	28.7	8.4	13.2	7.8	10.5	14.2	9.6	11.2	24.3	31.9	31.8	6.9	13.8	7.6	26.7	4.3	13.8	11.8	1.7	8.8	19.1	12.4	9.5	2.1	23.2	15.0	9.9	16.2	10.3	1.4	26.0	9.3	2.2	18.4	19.0	50.9	21.3	17.8	16.5	15.4	14.6	16.3	21.1	56.6	47.0	71.8	47.7	40.9	133.4	0.0	45.9	66.9	56.9	0.0	229.7	39.6	0.0	0.0	48.0	31.6	5.9	0.0	0.0	15.9	34.0	45.0	55.6	29.2	14.9	198.6	35.3	38.1	14.9	22.9	59.2	16.4	16.9	0.0	15.8	50.0	0.0	12.2	57.3	0.0	193.4	19.4	28.8	108.0	77.6	44.5	30.9	55.4	16.1	36.0
ZCCHC12	"FLJ16123, PNMA7A, SIZN, SIZN1"	ENSG00000174460	"Zinc finger CCHC-type containing 12"	Q6PEW1	X	118823790-118826968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 51.3;endometrium 1: 53.4;fallopian tube: 60.7;smooth muscle: 72.5"	"Cell type enhanced"	"Detected in some"	13	"Intestinal endocrine cells: 1.2;Muller glia cells: 1.6"	"Cancer enriched"	"Detected in many"	76	"thyroid cancer: 256.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"naive CD8 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.5;HEK 293: 14.1;NTERA-2: 4.5;SH-SY5Y: 3.6;SuSa: 3.0"									"HPA031016, HPA034940"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA031016: AB_2673698, HPA034940: AB_10671098"	"unprognostic (1.29e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.34e-4)"	"unprognostic (9.18e-13)"	"unprognostic (4.14e-3)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (1.18e-1)"	0.9	4.8	30.5	1.2	20.2	0.8	1.0	20.3	17.3	9.7	1.1	1.6	0.9	1.0	53.4	11.6	0.8	60.7	1.0	0.8	28.7	51.3	0.8	0.8	0.9	1.1	4.4	11.6	6.7	0.8	0.8	7.9	0.8	14.7	1.0	1.0	1.1	0.8	1.1	0.8	0.8	1.1	72.5	4.5	0.9	0.8	1.0	0.8	0.0	2.9	0.0	1.1	0.8	1.7	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.0	0.0	0.4	0.0	0.3	0.0	5.5	0.0	0.2	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	3.6	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.2	30.5	20.2	20.3	17.3	28.7	51.3	4.4	11.6	14.7	0.8	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0
ZCCHC18	"PNMA7B, SIZN2"	ENSG00000166707	"Zinc finger CCHC-type containing 18"	P0CG32	X	104112131-104115846	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 9.6;ovary: 9.4"	"Cell type enhanced"	"Detected in some"	8	"Intestinal endocrine cells: 4.1;Muller glia cells: 3.2;Sertoli cells: 6.5;T-cells: 6.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"B-cells: 3.0;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.6;Karpas-707: 8.6;SH-SY5Y: 5.8"					"Low region specificity"	"Detected in all"			"HPA034940, HPA078516"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034940: AB_10671098, HPA078516: "	"unprognostic (7.20e-2)"	"unprognostic (7.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.44e-6)"	"unprognostic (4.05e-2)"	"unprognostic (1.02e-6)"	"unprognostic (3.82e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.14e-3)"	0.9	2.3	3.4	3.3	9.4	1.1	2.6	9.6	9.2	1.7	0.9	1.2	0.5	1.1	3.6	1.1	1.0	1.6	1.4	1.2	3.1	7.7	0.5	0.3	1.0	4.9	3.8	4.9	9.4	2.6	0.3	2.3	0.7	4.7	1.5	1.1	1.2	0.5	1.8	1.0	0.5	2.6	1.9	2.5	3.4	1.4	2.2	2.2	0.0	0.4	0.2	5.1	2.0	1.1	3.0	0.0	0.0	0.0	0.1	2.2	0.3	0.0	0.2	3.5	2.5	0.3	0.0	0.2	0.7	0.1	0.6	0.6	0.1	0.0	4.6	0.1	0.2	0.8	0.0	2.1	0.0	0.3	1.3	1.7	0.8	0.2	0.0	0.4	2.6	0.8	0.2	0.0	0.4	0.0	2.1	0.7	0.3	0.0	8.6	0.2	0.0	0.0	0.1	2.0	0.0	0.6	3.1	0.9	0.0	0.5	0.3	2.5	5.8	0.2	0.0	0.0	0.4	0.0	0.3	1.6	0.2	1.1	0.2	1.0	0.2	0.0	2.2	0.1	2.5	0.7	0.0	0.0	0.0	1.4	0.0	2.2	2.5	1.1	1.7	0.0	3.0	1.2	1.6	0.0	0.1	0.0	0.0	0.8	0.3	3.4	9.4	9.6	7.2	3.1	7.7	3.8	4.9	4.7	2.2	0.0	1.1	0.0	0.1	0.1	0.6	0.6	0.0	2.7	2.3	1.8	0.0	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	1.6	4.1	0.0	0.3	0.0	1.4	0.0	1.7	0.0	0.0	3.2	0.0	0.0	1.1	0.1	0.8	6.5	2.1	0.0	0.2	0.0	0.0	6.1	0.0	0.0
ZCCHC2	"C18orf49, FLJ20222, FLJ20281, KIAA1744"	ENSG00000141664	"Zinc finger CCHC-type containing 2"	Q9C0B9	18	62523007-62587709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 99.1"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 114.5;Late spermatids: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040943	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"	Nucleoplasm	"HPA040943: AB_10795496"	"unprognostic (9.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	12.6	5.0	6.8	7.0	7.5	22.8	16.0	8.0	6.8	7.5	8.5	6.0	5.3	6.8	6.9	7.1	6.5	7.4	9.0	8.5	5.3	5.7	5.8	23.0	10.1	7.6	8.1	5.7	8.8	6.3	7.8	8.5	8.2	5.5	8.1	5.8	4.5	99.1	5.9	16.8	11.3	7.5	7.6	5.6	8.9	6.5	13.4	8.9	10.8	7.8	4.3	6.4	11.0	19.3	1.6	1.0	4.9	1.6	0.6	2.0	0.4	6.0	5.2	4.5	8.9	13.8	5.9	8.6	3.4	5.2	8.3	8.3	2.8	3.7	17.0	4.6	5.7	6.8	10.2	14.5	7.6	3.4	11.7	6.8	4.4	12.1	19.0	4.7	8.5	6.5	5.8	9.9	5.2	9.8	6.0	15.5	7.7	4.7	5.7	2.7	4.9	5.5	3.6	2.9	4.4	5.2	7.4	4.8	0.1	5.7	6.1	5.7	3.5	5.8	13.1	5.1	8.5	4.6	6.8	6.6	8.1	5.6	3.2	4.9	2.2	4.3	7.3	6.1	3.6	3.0	0.0	1.0	2.4	1.7	1.6	1.2	0.5	1.1	1.5	0.3	1.6	2.0	1.3	4.9	0.6	0.3	1.0	1.2	0.4	6.8	7.5	8.0	6.8	5.3	5.7	8.1	5.7	5.5	8.9	23.8	19.7	4.2	13.1	23.7	27.6	18.8	15.3	9.4	14.8	15.7	51.1	6.3	3.3	5.4	114.5	20.9	7.7	0.0	5.3	10.1	7.6	13.8	2.3	28.0	12.5	41.3	12.1	17.8	39.8	110.8	7.5	21.1	6.8	4.6	13.2	9.2	4.8	10.5	7.4	4.3	19.1	6.5	15.3	11.5	6.6	16.2	5.7	7.5	10.3	10.5
ZCCHC24	"C10orf56, FLJ90798, Z3CXXC8"	ENSG00000165424	"Zinc finger CCHC-type containing 24"	Q8N2G6	10	79382325-79445627	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 40.7;Hepatocytes: 44.7;Ito cells: 57.1;Leydig cells: 63.6;Peritubular cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.5;ASC TERT1: 37.4;BJ hTERT+: 28.5;HSkMC: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038348	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA038348: AB_10669538"	"unprognostic (3.47e-3)"	"unprognostic (8.70e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.35e-6)"	"unprognostic (1.84e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.95e-3)"	27.9	9.0	30.9	9.5	54.4	1.8	9.8	11.1	36.0	22.9	19.8	56.8	4.2	4.6	18.0	6.9	10.3	15.5	16.8	19.1	30.6	19.7	3.5	13.5	10.2	4.8	56.7	23.5	20.1	4.0	3.9	3.0	11.4	36.2	14.5	6.8	4.5	6.2	20.7	34.8	5.0	5.4	25.6	36.8	7.0	9.0	6.6	51.9	0.0	6.0	2.5	3.2	14.9	7.3	0.0	3.4	0.6	2.4	0.7	0.9	0.5	0.9	0.9	3.2	2.8	43.5	37.4	0.8	7.5	28.5	4.5	5.2	0.8	0.0	0.0	4.1	15.1	1.5	0.0	0.5	0.1	3.8	1.8	2.0	0.4	2.3	0.9	11.3	1.1	0.6	38.8	0.4	4.0	1.1	13.3	0.9	0.2	1.4	1.6	3.8	0.3	0.0	4.4	0.7	0.2	9.3	0.2	3.8	0.6	0.5	1.2	0.1	4.0	2.3	0.3	9.4	3.2	1.1	2.1	0.6	4.3	4.0	11.7	2.5	2.9	1.9	0.0	8.8	1.4	15.3	0.0	2.4	0.6	0.9	1.1	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.2	0.6	0.7	0.1	3.4	0.4	0.5	30.9	54.4	11.1	36.0	30.6	19.7	56.7	23.5	36.2	51.9	0.0	1.6	0.0	1.5	6.8	0.0	16.5	7.6	1.4	1.2	0.0	0.0	0.6	0.0	0.8	1.7	17.0	0.0	0.0	0.7	0.8	40.7	3.6	1.1	44.7	8.5	0.0	0.0	57.1	15.9	3.7	63.6	6.8	15.1	1.0	0.4	16.4	0.7	0.0	61.5	1.4	0.7	12.9	21.2	0.7	1.0	4.0	1.3	4.3	0.0	1.1
ZCCHC3	"C20orf99, dJ1103G7.7"	ENSG00000247315	"Zinc finger CCHC-type containing 3"	Q9NUD5	20	296968-300321	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042972			Approved	Vesicles		NA	NA			Vesicles		"HPA042972: AB_10959663"	"unprognostic (5.98e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (4.30e-1)"	"unprognostic (3.34e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.74e-2)"	1.5	2.1		1.8		3.1	1.1		1.2	2.1	1.2			1.5	2.0	2.5	0.6	2.6	1.0	1.4			1.4	1.4	1.1	3.3			4.4	1.8	1.5		4.5		1.5	0.9		1.2	2.0	1.2	0.4	1.4	1.0		2.7	1.6	1.4			1.3		3.1	0.9		4.5	4.8	6.1	2.9	2.1	3.7	1.6	8.4	6.6	20.8	10.3	6.8	7.0	12.3	5.3	5.8	5.9	6.1	10.0	5.0	7.6	3.5	3.3	6.2	11.7	10.5	5.9	5.6	4.1	9.7	15.5	3.1	31.3	7.9	17.6	4.3	6.7	7.0	3.6	4.3	6.2	9.4	8.8	19.1	7.8	4.5	3.7	13.4	21.7	18.5	8.2	7.0	19.8	9.9	9.8	5.2	5.4	8.8	12.8	6.3	12.8	16.1	9.3	5.9	33.1	4.1	6.1	6.1	2.4	6.3	14.4	18.3	15.0	2.2	11.5	5.9	6.1	2.9	4.5	3.4	1.4	3.3	3.2	3.0	2.9	2.0	4.5	3.7	3.5	0.8	2.1	1.3	4.8	2.7	1.6											0.0	7.8	13.0	19.4	14.1	26.8	7.0	20.4	8.1	5.7	8.7	7.9	19.5	3.3	5.8	0.4	13.4	10.7	0.0	4.7	10.9	14.8	13.5	0.0	9.2	9.1	35.0	20.2	18.4	10.5	0.0	16.1	6.7	11.8	2.8	14.5	17.7	4.9	10.5	9.9	5.7	20.6	6.5	7.3	3.9	9.7	5.0	17.3	7.5	12.4	14.0
ZCCHC4	"FLJ23024, HSPC052, ZGRF4"	ENSG00000168228	"Zinc finger CCHC-type containing 4"	Q9H5U6	4	25312785-25370383	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035575, HPA035576"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles, Golgi apparatus"		"HPA035575: AB_2674682, HPA035576: AB_10671516"	"unprognostic (5.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.07e-2)"	11.5	10.3	9.7	14.6	12.8	8.1	12.4	13.1	12.4	11.3	9.5	12.8	12.5	8.9	14.6	10.4	9.1	11.7	8.0	10.6	9.0	6.5	9.3	8.8	8.7	11.5	13.7	7.0	15.4	9.4	12.7	11.6	10.7	9.8	10.9	10.0	11.6	10.0	10.3	16.6	10.4	10.4	13.5	10.0	12.4	9.1	11.2	10.9	15.0	11.3	7.6	11.1	11.0	12.7	6.5	4.4	2.4	3.8	6.5	7.5	3.9	3.9	2.4	8.1	3.6	6.4	8.1	7.2	10.0	10.7	11.8	13.7	3.8	10.4	6.5	2.8	6.1	11.7	3.1	7.8	7.3	16.5	1.5	4.2	6.0	5.4	6.4	8.1	9.7	4.4	6.3	8.2	11.2	8.8	7.0	5.6	10.1	10.7	3.3	9.9	2.9	10.0	12.9	11.1	6.4	5.3	6.8	12.4	3.9	6.3	4.1	7.6	5.2	4.3	3.6	6.4	8.3	5.3	5.9	4.4	9.9	4.1	6.4	13.3	6.5	8.1	9.5	10.7	9.5	9.5	2.4	3.2	1.0	5.3	3.8	7.5	6.0	6.8	6.4	4.4	6.5	6.7	7.3	1.8	6.5	3.6	3.5	6.5	3.9	9.7	12.8	13.1	12.4	9.0	6.5	13.7	7.0	9.8	10.9	0.0	4.3	1.4	3.6	3.3	3.9	4.5	0.0	10.7	6.8	0.0	2.0	5.0	3.3	3.2	1.1	4.1	2.6	0.0	2.0	4.0	3.2	1.9	1.1	2.4	4.6	3.2	2.4	3.1	5.2	0.0	3.7	4.4	3.3	2.8	4.1	4.8	2.7	3.7	4.9	3.7	4.5	0.0	5.2	6.0	7.7	3.0	3.1	5.7	3.8	2.0
ZCCHC6	"FLJ13409, KIAA1711, PAPD6, TUT7"	ENSG00000083223	"Zinc finger CCHC-type containing 6"	Q5VYS8	9	86287733-86354454	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.1;monocytes: 15.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	11.2	9.3	7.7	22.6	11.2	17.0	17.3	9.7	13.7	10.8	13.5	5.6	12.8	9.4	8.6	8.1	23.1	8.3	10.3	10.1	9.4	5.2	7.4	33.1	16.3	19.5	9.8	5.1	9.0	12.9	9.2	18.6	33.3	9.0	19.3	10.8	4.5	14.0	13.6	12.5	30.9	15.6	9.7	13.6	22.2	11.7	10.3	10.7	23.3	8.7	15.2	16.9	13.7	14.3	4.4	4.3	42.1	15.7	4.5	5.7	2.9	9.9	10.8	6.4	9.3	16.5	25.1	7.9	13.6	13.3	6.0	7.0	4.9	8.9	14.2	12.4	9.0	6.2	17.6	7.6	7.7	9.0	16.6	4.1	10.2	11.5	9.1	14.0	11.6	14.9	16.6	16.1	9.6	11.4	9.5	10.1	7.9	9.6	15.4	16.8	10.7	9.7	7.0	5.2	17.2	7.3	4.9	11.2	6.5	10.7	19.6	4.7	3.7	8.3	11.0	4.7	8.2	4.1	5.3	15.5	5.8	7.0	10.2	9.3	17.8	13.9	10.6	13.8	7.0	7.6	11.5	7.1	7.1	5.7	9.1	4.9	4.4	3.2	4.1	4.3	4.4	3.7	4.0	42.1	4.5	15.7	2.0	3.0	2.9	7.7	11.2	9.7	13.7	9.4	5.2	9.8	5.1	9.0	10.7	59.6	30.7	5.3	28.7	28.0	13.1	0.0	12.7	26.8	37.5	0.0	17.7	18.4	0.0	0.0	77.5	14.4	23.4	0.0	0.0	14.3	9.9	42.1	45.1	45.3	20.1	17.5	16.0	17.2	62.4	17.6	15.8	40.3	30.4	0.0	18.3	11.4	0.0	20.7	12.4	0.0	14.9	12.9	10.3	19.8	7.8	35.4	77.3	27.7	17.7	54.5
ZCWPW1	"DKFZp434N0510, FLJ10057, ZCW1"	ENSG00000078487	"Zinc finger CW-type and PWWP domain containing 1"	Q9H0M4	7	100400826-100428992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 42.2"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 370.4;Spermatogonia: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 14.8;hTERT-HME1: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020911			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA020911: AB_1858990"	"unprognostic (1.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (1.92e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (5.26e-4)"	3.5	2.7	3.8	2.5	8.2	2.4	4.1	3.5	4.8	2.5	3.0	7.9	2.5	1.1	3.7	4.3	2.3	4.7	2.7	3.5	3.8	3.1	3.3	5.3	2.6	3.3	8.9	3.1	5.9	2.3	4.9	2.3	1.7	5.7	3.0	1.8	2.1	1.9	3.7	3.3	4.0	2.5	3.3	6.6	3.5	2.2	42.2	6.8	1.8	4.8	1.5	3.3	3.7	3.2	11.4	3.2	13.5	7.4	2.7	4.5	1.8	5.5	2.5	1.2	2.1	7.2	5.8	0.8	2.8	3.3	2.4	3.1	0.9	1.8	14.8	11.4	2.1	5.5	1.5	1.3	0.9	3.8	1.1	1.1	4.5	0.6	0.7	2.3	1.8	2.8	3.2	6.0	1.9	13.8	1.1	0.2	3.0	3.2	4.5	2.2	5.1	1.5	4.1	0.5	2.8	0.7	3.4	1.0	0.9	2.0	1.2	4.2	1.8	7.2	2.0	4.4	1.2	3.0	3.0	0.3	6.3	2.5	5.4	1.0	1.6	1.9	6.7	2.4	5.0	5.4	3.2	1.4	13.5	2.1	2.9	3.3	11.4	2.6	2.8	1.6	11.4	4.5	3.1	5.0	2.7	7.4	3.2	1.5	1.8	3.8	8.2	3.5	4.8	3.8	3.1	8.9	3.1	5.7	6.8	0.0	9.0	5.1	8.8	7.1	11.2	4.8	0.0	28.1	11.4	5.2	2.0	1.0	10.0	4.7	24.3	5.3	3.0	0.0	3.1	0.5	6.9	5.5	20.7	9.6	3.1	4.8	2.4	4.3	7.3	43.2	15.3	5.5	1.7	2.8	2.3	11.3	4.0	2.9	7.4	7.2	4.9	45.3	3.4	370.4	163.3	4.0	1.1	7.0	3.5	6.0
ZCWPW2	ZCW2	ENSG00000206559	"Zinc finger CW-type and PWWP domain containing 2"	Q504Y3	3	28349146-28538122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 46.6;Spermatocytes: 62.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035035, HPA039839"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035035: AB_10602256, HPA039839: AB_2676708"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.53e-2)"	"unprognostic (6.09e-4)"	"unprognostic (3.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-4)"	"unprognostic (1.06e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.38e-2)"	2.6	3.1	3.9	2.8	5.3	1.3	3.4	4.8	4.2	3.3	2.9	3.1	5.2	2.1	6.2	4.1	2.8	2.6	4.1	5.1	3.5	2.7	3.2	2.7	4.4	1.9	3.9	2.3	5.0	3.5	3.7	10.5	2.5	3.9	4.2	2.0	2.9	4.8	2.6	9.6	3.6	2.4	5.7	5.4	2.4	2.8	16.1	5.1	2.8	5.2	0.4	2.6	2.7	2.6	0.9	1.4	3.6	2.4	0.6	2.4	0.7	0.7	0.4	1.8	0.8	2.5	5.9	3.0	2.4	2.0	0.9	0.8	0.6	1.9	1.8	1.2	1.4	1.7	1.1	0.5	0.6	1.1	0.9	0.8	0.6	2.2	0.6	1.8	0.7	1.2	3.5	1.6	0.7	1.1	3.2	2.0	3.7	0.8	2.2	3.8	1.0	0.5	1.4	0.8	0.3	2.5	0.6	0.7	1.3	2.8	0.3	0.9	2.8	0.2	1.2	1.6	2.1	1.0	5.6	1.9	2.3	1.1	1.6	1.4	0.9	0.6	0.5	6.6	1.1	2.4	2.7	2.4	3.1	0.8	2.1	0.5	0.4	0.8	0.6	1.0	0.9	1.8	2.4	3.6	0.6	0.5	1.4	0.8	0.7	3.9	5.3	4.8	4.2	3.5	2.7	3.9	2.3	3.9	5.1	0.0	1.3	0.0	2.7	0.6	2.3	10.1	0.0	1.4	4.5	0.0	0.0	1.8	5.0	0.5	46.6	0.1	0.1	0.0	0.7	1.2	1.9	1.5	2.3	0.4	1.2	3.2	1.2	1.3	1.2	9.4	4.4	0.8	0.0	1.0	1.6	3.1	0.8	0.0	4.6	2.1	1.7	0.0	2.0	62.1	5.7	1.4	1.0	0.5	0.5	1.3
ZDBF2	"FLJ45338, KIAA1571, Slx9"	ENSG00000204186	"Zinc finger DBF-type containing 2"	Q9HCK1	2	206274663-206314428	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.9"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SuSa: 13.4"					"Low region specificity"	"Detected in many"			"HPA039121, HPA050311"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039121: AB_2676357, HPA050311: AB_2681081"	"unprognostic (8.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.73e-3)"	"unprognostic (7.59e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.40e-1)"	4.4	12.0	8.6	3.5	26.9	2.2	4.2	14.7	12.7	5.4	3.7	2.1	5.1	2.0	7.2	6.1	3.1	5.1	4.4	4.5	8.9	8.3	4.9	3.6	3.2	3.8	3.7	10.8	14.8	8.3	5.6	20.9	7.5	9.0	4.7	2.6	3.8	3.7	5.3	5.4	3.9	3.0	5.1	4.0	4.2	3.4	5.4	3.1	2.5	6.5	2.9	3.3	3.7	3.5	0.7	0.5	0.3	0.0	0.3	1.4	0.2	1.7	0.3	6.0	1.1	2.0	1.8	8.4	1.7	2.0	0.8	1.2	0.9	1.4	0.0	0.8	2.1	3.5	0.4	3.8	1.3	1.6	2.1	3.6	0.0	3.4	0.2	2.6	1.8	3.8	1.8	2.1	1.5	3.6	6.1	2.2	1.4	0.3	2.3	2.6	0.3	0.4	0.0	8.1	0.1	1.7	0.0	6.2	0.0	1.0	0.9	3.1	7.5	3.0	0.0	2.4	13.4	0.2	0.0	3.3	0.7	2.9	0.7	1.3	5.4	1.3	0.3	4.2	0.0	2.0	0.3	0.0	0.0	0.3	0.0	0.9	0.5	1.0	0.6	0.0	0.7	1.1	0.7	0.0	0.3	0.0	0.5	1.4	0.2	8.6	26.9	14.7	12.7	8.9	8.3	3.7	10.8	9.0	3.1	3.0	3.8	0.5	1.6	3.5	24.3	7.6	2.5	13.4	5.7	10.4	13.7	3.9	0.0	2.3	2.8	3.6	0.7	0.0	1.9	5.9	4.8	3.0	12.7	2.0	0.4	7.9	7.5	3.7	0.3	4.2	4.0	0.0	1.7	0.0	1.1	9.7	1.7	0.0	4.9	1.7	16.8	0.0	13.7	4.7	8.0	2.9	7.6	1.3	0.4	0.9
ZDHHC1	"C16orf1, HSU90653, ZNF377"	ENSG00000159714	"Zinc finger DHHC-type containing 1"	Q8WTX9	16	67394419-67416833	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 24.6;Late spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.6;ASC TERT1: 15.1;U-138 MG: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042531, HPA048659"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA042531: AB_2678041, HPA048659: AB_2680483"	"unprognostic (8.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.05e-3)"	"prognostic favorable (1.25e-6)"	"unprognostic (1.68e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.55e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.63e-3)"	9.6	6.3	4.3	3.9	6.6	0.5	10.2	5.3	10.5	16.9	7.4	5.5	7.9	3.8	13.5	16.4	6.3	22.6	14.0	6.2	4.5	3.7	11.2	3.8	7.8	4.9	5.3	3.5	17.1	16.2	11.5	14.0	15.1	6.5	11.6	3.2	11.2	14.7	12.1	8.0	10.8	3.9	9.3	3.3	10.1	6.2	25.7	2.6	0.6	31.3	9.3	4.9	6.9	9.7	0.0	2.4	0.3	3.6	0.0	0.0	0.8	5.1	6.2	1.5	8.2	13.6	15.1	0.0	2.9	11.1	2.9	3.5	0.0	3.2	0.0	1.3	5.2	3.0	3.3	0.5	0.5	0.6	1.6	4.7	0.4	0.1	0.4	6.9	0.3	4.3	7.2	6.4	3.2	0.9	6.9	3.8	0.0	0.0	0.0	2.0	0.5	0.0	0.0	3.0	2.0	0.1	0.0	0.1	0.0	4.2	3.1	2.2	7.5	0.5	0.2	6.7	0.6	2.1	1.2	5.0	13.1	2.1	6.3	3.5	1.5	0.3	0.0	8.0	0.1	5.4	0.0	2.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.8	4.3	6.6	5.3	10.5	4.5	3.7	5.3	3.5	6.5	2.6	0.0	0.0	0.0	5.5	6.4	2.4	0.8	15.3	1.4	1.2	7.0	3.9	1.4	8.3	2.9	24.6	4.5	2.1	0.0	3.4	0.1	6.6	6.0	0.0	1.6	2.0	3.2	8.6	7.4	15.2	44.2	13.6	1.3	5.0	0.0	12.5	8.3	2.2	3.5	10.3	5.1	0.3	0.0	6.4	8.7	5.1	6.1	4.8	0.0	6.2	4.4
ZDHHC11	"FLJ13153, ZNF399"	ENSG00000188818	"Zinc finger DHHC-type containing 11"	Q9H8X9	5	795606-850986	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.2"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 17.9;Ciliated cells: 42.8;Club cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 11.5"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.67e-1)"	"unprognostic (9.76e-3)"	"unprognostic (4.47e-5)"	"unprognostic (5.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (5.23e-5)"	"unprognostic (4.80e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-2)"	1.8	1.4	3.4	1.0	4.2	0.7	2.7	11.0	3.8	1.6	1.5	6.3	1.0	9.5	1.7	2.9	3.2	10.3	1.2	6.4	4.2	3.8	2.0	2.6	7.5	1.0	15.2	1.9	1.5	1.9	1.8	7.8	1.2	10.9	2.7	1.2	1.0	1.4	3.4	2.1	2.7	1.7	1.0	5.0	2.4	5.9	6.3	6.1	1.0	1.1	2.3	1.8	1.0	1.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	7.4	4.1	0.8	1.3	0.3	5.5	0.3	0.1	0.2	0.1	1.0	0.3	3.0	0.8	0.1	0.9	6.9	2.2	0.0	0.1	9.0	4.8	0.3	2.6	3.7	0.3	4.3	0.3	0.4	0.3	0.9	1.0	0.3	0.0	1.2	0.7	1.7	0.2	3.3	0.4	2.6	7.3	0.0	2.9	4.5	2.8	4.1	0.2	1.5	4.1	0.7	0.2	0.1	3.1	8.4	11.5	0.7	0.4	0.2	6.9	3.9	0.1	5.5	7.7	0.9	0.3	8.9	0.2	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.2	11.0	3.8	4.2	3.8	15.2	1.9	10.9	6.1	17.9	9.6	0.0	0.3	1.6	2.0	6.7	0.0	42.8	23.9	0.0	0.0	0.2	0.0	0.4	6.6	0.8	1.7	0.0	0.0	0.1	1.7	0.4	3.5	1.7	0.3	6.4	1.7	1.3	0.0	6.8	0.6	0.0	0.0	0.0	2.0	0.3	0.2	1.1	0.0	0.8	1.7	6.5	1.0	9.3	3.8	1.4	0.2	0.0	1.1	0.3
ZDHHC11B		ENSG00000206077	"Zinc finger DHHC-type containing 11B"	P0C7U3	5	710360-766952	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.5;Ciliated cells: 36.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;RPMI-8226: 4.5;SCLC-21H: 6.6;THP-1: 7.2"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.81e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.79e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.39e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.31e-1)"	0.3	1.8	2.9	0.0	3.7	0.0	0.6	11.7	5.3	0.0	1.1			3.8	0.5	0.4	2.8	3.4	0.5	3.8	3.9	2.9	0.4	0.6	5.3	0.0	2.8		0.8	2.4	1.5	3.7	0.1		0.6	1.9		1.0	0.4	3.3	4.8	5.9	0.0	2.5	3.3	3.8	0.8			0.7		0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	1.9	0.8	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.2	1.0	0.3	0.0	0.8	2.4	5.1	0.2	0.0	3.1	2.3	0.1	1.9	0.9	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	0.3	0.0	0.0	4.5	0.1	1.5	6.6	1.9	0.1	0.0	0.6	0.6	0.1	7.2	0.1	0.0	2.6	0.0	0.0	2.5	0.8	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1											17.9	16.5	0.0	1.0	2.4	6.1	7.3	2.5	36.1	10.3	3.5	0.0	0.0	0.0	0.6	1.1	1.1	2.4	0.0	0.7	0.0	1.1	0.4	1.1	1.6	1.3	9.5	2.9	0.6	0.0	0.0	0.9	0.0	0.0	0.0	2.3	0.5	0.1	0.6	0.0	0.3	0.2	6.5	2.1	1.0	0.8	2.8	0.0	0.0	1.7	0.8
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type containing 12"	Q96GR4	9	128720869-128724127	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 77.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 54.8"	"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	7.3	10.9	3.9	15.3	4.5	21.8	11.2	2.5	6.5	7.5	21.2	6.8	19.3	16.2	5.9	8.3	27.2	6.9	21.5	9.2	3.5	3.1	20.6	23.6	14.2	28.0	3.8	3.8	5.0	40.5	4.3	5.0	24.7	4.8	11.1	8.4	7.7	26.3	13.3	7.5	16.8	33.0	5.4	5.8	14.9	18.7	9.2	2.7	23.6	10.3	16.4	24.4	10.1	11.7	22.2	50.6	77.4	28.7	17.4	26.1	18.8	14.2	39.0	1.6	8.4	5.1	3.5	16.4	9.2	8.2	10.1	6.8	31.9	16.5	9.9	8.6	6.9	17.6	37.7	3.5	18.2	1.0	18.2	9.4	5.2	29.7	14.0	10.4	8.7	24.2	5.6	12.6	8.2	3.1	4.8	7.4	18.8	5.2	25.3	1.9	54.8	11.9	17.5	7.2	31.7	32.3	5.4	5.9	28.5	7.7	13.4	11.6	8.4	12.5	17.3	4.9	2.7	26.7	9.3	7.4	0.0	10.5	7.1	12.3	16.4	28.9	4.4	16.8	10.1	11.1	39.2	26.5	77.4	23.5	24.7	20.3	20.3	21.8	22.5	21.0	22.2	22.7	20.6	56.8	17.4	28.7	50.6	26.1	18.8	3.9	4.5	2.5	6.5	3.5	3.1	3.8	3.8	4.8	2.7	14.9	8.1	54.1	42.0	14.3	0.9	9.6	79.0	4.0	11.4	43.6	0.0	147.4	11.6	94.7	58.6	14.7	157.1	70.0	176.4	191.0	11.1	49.6	18.4	48.9	121.4	0.0	49.2	28.3	52.9	22.4	8.9	39.8	40.5	159.7	93.7	14.5	109.4	171.9	6.7	32.7	1.7	6.5	9.5	23.1	17.5	24.6	112.1	48.4	94.2	52.6
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type containing 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.7	5.2	6.3	9.3	8.0	6.8	7.3	13.2	9.7	8.8	13.2	5.8	7.1	8.7	6.4	5.6	36.4	10.5	6.9	7.7	6.2	7.1	10.8	2.3	4.7	6.9	5.4	5.2	5.8	14.0	10.9	20.1	9.4	9.4	7.1	14.7	6.4	11.2	5.9	2.1	14.9	12.3	4.9	4.7	6.3	14.4	11.2	4.8	15.0	7.7	18.2	27.5	15.3	14.5	6.3	4.3	23.4	5.8	4.3	7.5	3.5	15.9	7.6	7.3	6.2	2.6	3.0	7.0	7.7	7.1	8.6	10.0	4.6	3.8	8.2	5.3	6.4	19.4	24.4	10.4	5.0	9.5	10.1	9.1	4.3	4.8	3.7	6.0	5.8	7.4	3.4	6.0	3.6	5.1	8.1	54.4	11.5	4.1	4.1	8.8	5.2	7.4	4.7	6.0	15.1	7.0	8.2	10.1	1.9	8.9	10.6	12.7	9.3	9.2	11.2	4.1	7.3	5.3	6.7	15.6	7.7	5.4	11.7	6.1	3.5	10.8	7.5	9.2	6.0	13.4	7.4	3.5	23.4	6.8	5.8	6.1	6.3	5.3	7.5	4.3	4.2	5.1	6.5	4.4	4.3	4.6	4.2	6.8	3.5	6.3	8.0	13.2	9.7	6.2	7.1	5.4	5.2	9.4	4.8	8.9	12.5	4.9	19.3	21.5	10.4	32.9	10.2	33.5	21.6	15.7	9.8	7.5	5.0	17.2	73.0	9.3	13.5	0.0	17.0	15.7	10.6	33.7	11.5	0.8	5.5	15.9	15.0	9.2	5.9	36.4	7.2	7.4	3.3	29.7	21.1	61.2	17.7	14.0	2.1	2.2	8.5	0.0	5.6	38.7	22.6	31.7	5.3	8.7	18.7	44.2
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type containing 14"	Q8IZN3	6	157381133-157678146	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063754	Approved		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	6.4	3.9	9.0	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4.0	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22.0	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5.0	1.5	4.2	0.0	0.1	0.4	0.9	0.4	1.7	1.8	0.6	2.6	1.4	1.1	5.9	2.7	2.5	1.9	1.7	2.2	1.3	4.3	0.9	2.2	3.7	0.9	1.5	1.5	1.8	33.4	2.1	8.4	0.7	1.0	1.9	1.1	1.9	0.7	1.6	2.0	0.8	1.7	2.9	1.9	6.7	3.2	1.1	1.1	0.7	2.8	1.1	3.4	2.2	0.1	0.3	2.5	4.0	0.7	4.3	1.3	3.2	2.1	2.3	1.2	0.3	1.3	4.0	2.9	2.1	5.7	3.5	0.7	0.8	0.6	1.0	3.0	3.2	0.0	0.1	0.0	0.5	0.0	0.9	1.5	0.4	0.4	0.0	0.8	0.0	0.3	0.0	0.4	0.0	4.2	0.0	0.4	9.0	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8	3.0	0.0	2.7	2.3	11.4	14.5	14.4	15.3	0.0	1.2	7.0	5.9	8.9	10.0	5.2	7.8	10.5	6.6	0.0	2.8	1.8	7.9	14.3	0.0	21.2	9.2	116.0	2.4	24.5	12.1	4.0	7.5	3.6	10.1	1.8	12.2	4.8	2.5	9.9	9.6	3.3	5.7	0.0	7.2	2.4	4.1	7.3	17.6	5.0	9.7	2.4
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type containing 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 6.0;Cardiomyocytes: 6.9;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 5.7;K-562: 3.6;LHCN-M2: 4.0;MOLT-4: 4.2;NTERA-2: 3.7;RH-30: 5.8;RPTEC TERT1: 3.2;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003618	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686"	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	3.0	5.4	4.9	1.5	6.8	1.1	5.3	6.2	9.9	5.8	3.4	3.9	2.4	1.3	6.5	3.7	3.2	4.5	3.3	5.4	5.9	8.7	5.3	1.2	4.1	1.6	4.8	5.3	8.5	4.7	5.0	8.7	0.7	7.0	4.0	2.3	5.4	12.7	6.9	1.6	2.8	1.8	5.2	6.4	2.9	2.1	2.6	3.1	2.0	6.6	2.1	1.5	2.6	3.1	0.3	0.4	0.7	0.2	0.5	1.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	3.6	0.1	4.0	0.0	4.2	0.1	3.7	0.0	0.0	0.0	5.8	0.0	3.2	0.0	1.6	4.8	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.5	1.0	0.0	0.7	2.9	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.2	1.6	1.1	0.7	0.5	0.1	0.4	0.0	0.3	4.9	6.8	6.2	9.6	5.9	8.7	4.8	5.3	7.0	3.1	6.0	1.9	0.0	1.4	3.5	3.7	6.9	2.5	0.0	2.3	5.2	3.9	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.6	0.0	0.9	1.0	1.1	0.0	0.1	0.0	1.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.3	0.3	0.0	3.5	1.0	2.1	6.5	1.4	0.1	0.4	3.1	0.0	0.0	0.0	0.3
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type containing 16"	Q969W1	10	97446131-97457370	"Enzymes, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	12.0	13.7	15.9	10.8	17.3	6.4	17.9	17.6	24.6	17.1	17.9	15.6	18.1	15.1	15.5	21.2	17.6	11.5	14.4	18.1	13.2	11.0	23.3	37.4	20.8	11.1	10.9	13.0	15.1	22.5	21.8	15.4	30.7	10.5	16.0	18.9	18.1	28.5	14.1	20.7	14.0	15.7	17.6	8.5	13.2	19.4	16.4	10.8	14.7	19.6	15.4	16.1	15.1	20.0	9.3	14.2	9.4	10.4	13.0	12.0	5.8	21.7	25.5	17.0	21.0	27.3	18.7	17.8	23.9	31.9	27.6	26.5	19.8	19.5	19.2	27.6	34.9	24.2	25.6	21.4	33.8	24.7	19.0	24.8	12.2	17.9	18.8	21.9	14.4	17.9	20.9	22.4	32.3	23.3	30.0	28.3	17.8	9.7	14.6	35.0	20.7	21.8	19.8	13.9	19.8	22.2	15.0	17.3	17.6	23.4	10.1	8.3	11.8	14.6	15.1	12.9	17.7	19.9	14.2	17.3	17.4	16.2	11.2	27.9	14.0	22.6	11.8	20.1	22.5	9.1	0.3	9.8	9.4	7.0	10.4	8.0	8.2	12.0	11.1	14.2	9.3	9.9	9.8	0.5	13.0	10.4	10.9	9.4	5.8	15.9	17.3	17.6	24.6	13.2	11.0	10.9	13.0	10.5	10.8	17.9	17.2	14.5	15.7	4.6	15.1	9.7	15.3	6.7	27.3	12.2	3.9	35.3	21.6	31.3	20.3	9.2	12.9	0.0	28.4	55.1	10.0	16.3	6.9	15.8	21.8	12.7	6.9	8.0	7.3	5.7	8.1	7.5	3.3	24.4	16.7	10.4	30.7	10.5	3.5	17.8	10.6	6.5	4.9	16.1	12.7	3.8	31.7	7.5	17.9	14.1
ZDHHC18	DKFZp667O2416	ENSG00000204160	"Zinc finger DHHC-type containing 18"	Q9NUE0	1	26826710-26857602	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 86.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 27.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040234	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA040234: AB_10805709"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (1.36e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	20.5	8.2	13.3	22.7	18.9	86.2	39.0	21.4	18.4	10.2	13.0	11.9	7.5	11.7	12.4	6.4	19.3	9.9	13.5	9.8	13.5	20.0	7.8	14.5	16.2	23.5	16.3	12.8	9.6	10.8	7.1	10.5	20.3	15.2	10.7	13.9	11.2	14.1	9.8	8.7	16.3	12.2	16.6	10.4	27.1	10.8	7.0	9.5	11.7	14.6	10.1	23.3	16.5	24.7	0.2	0.4	27.0	0.6	0.5	1.3	0.2	18.5	8.3	13.5	9.3	11.3	7.9	13.3	11.2	13.3	19.7	14.7	7.6	11.9	8.6	7.2	14.8	10.3	13.1	14.3	6.7	17.0	54.3	12.2	8.3	6.1	10.5	9.7	7.3	7.3	6.8	9.1	18.1	12.0	7.1	11.0	13.3	8.6	17.9	7.8	9.0	13.9	5.9	12.9	11.6	8.0	11.6	11.6	9.1	8.3	4.7	6.3	7.6	7.5	5.7	8.1	10.8	5.1	7.3	9.3	13.7	10.5	22.3	12.8	21.3	15.3	7.4	7.7	13.4	9.3	0.0	0.2	5.1	0.9	0.6	0.7	0.2	0.6	0.6	0.4	0.1	0.4	0.4	27.0	0.5	0.4	0.2	1.3	0.2	13.3	18.9	21.4	18.4	13.5	20.0	16.3	12.8	15.2	9.5	8.9	9.3	9.8	7.5	22.8	39.0	4.8	12.7	0.0	6.8	1.8	25.5	8.9	0.0	3.2	2.9	8.0	12.3	23.3	2.5	6.3	7.1	12.5	1.1	10.4	6.6	17.5	2.9	6.7	6.9	1.4	5.8	8.9	10.1	36.9	4.3	4.8	6.7	9.5	3.5	2.2	33.0	0.0	5.5	2.2	11.1	31.7	5.1	8.7	5.2	13.2
ZDHHC2	"DHHC2, ZNF372"	ENSG00000104219	"Zinc finger DHHC-type containing 2"	Q9UIJ5	8	17156029-17224799	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023331, HPA023334"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA023331: AB_2671165, HPA023334: "	"unprognostic (8.92e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (5.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.10e-2)"	10.1	22.5	14.8	9.4	14.5	24.4	14.8	22.8	12.2	12.9	13.4	17.5	17.4	9.3	7.0	10.5	5.3	12.8	6.4	10.1	13.0	14.0	24.2	7.5	12.7	10.3	13.6	10.9	13.0	27.0	19.2	20.2	6.1	14.7	12.0	10.3	21.2	15.9	13.7	15.9	3.4	9.1	8.8	25.9	11.2	14.1	14.2	14.5	13.8	32.3	10.4	10.2	17.3	8.7	5.3	4.6	4.9	2.7	4.4	7.0	1.5	0.9	5.2	10.2	2.1	9.0	16.1	6.0	17.6	21.4	10.0	11.9	1.6	14.7	10.6	6.9	15.3	25.2	0.6	13.7	8.7	18.6	6.9	6.9	9.6	7.6	2.1	9.0	10.1	1.1	6.7	1.4	12.5	11.4	23.1	16.4	12.7	1.1	28.6	12.0	0.2	7.4	6.1	6.5	7.8	8.1	7.4	10.2	3.9	18.1	11.3	5.5	3.6	7.5	0.0	1.6	15.9	0.4	4.6	13.5	5.1	15.6	11.2	17.5	5.7	21.3	12.5	14.1	9.3	2.3	2.6	2.6	4.9	4.1	2.7	7.0	5.3	5.1	4.9	2.2	4.6	4.7	5.0	1.8	4.4	1.6	4.6	2.6	1.5	14.8	14.5	22.8	12.2	13.0	14.0	13.6	10.9	14.7	14.5	41.7	20.1	11.5	11.9	2.7	37.3	11.3	10.2	6.7	14.8	48.8	72.6	0.5	18.3	19.5	6.7	9.0	6.3	0.0	29.1	0.9	7.4	32.3	8.1	7.3	11.7	11.1	18.9	5.5	21.8	8.2	4.6	15.5	21.9	4.6	15.0	23.4	34.3	10.5	2.8	19.8	80.1	12.9	7.6	5.5	2.5	2.4	0.3	13.4	13.7	23.7
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type containing 20"	Q5W0Z9	13	21372573-21459370	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 77.2;Kupffer cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	7.5	7.0	8.3	9.4	33.6	14.9	11.3	6.4	15.3	10.3	10.9	21.0	7.6	10.8	9.3	5.6	18.4	7.1	10.0	5.4	12.7	11.8	3.8	7.6	10.6	12.3	47.4	4.9	6.5	6.1	4.0	5.3	10.8	26.1	9.2	9.6	3.1	10.4	9.9	5.5	12.2	15.4	8.9	45.0	8.6	23.1	22.0	35.8	10.4	10.0	5.1	10.9	16.2	9.6	4.6	7.8	8.8	15.2	10.1	10.2	11.1	13.2	7.7	11.2	7.1	10.5	11.1	27.5	14.6	14.7	9.8	8.7	13.9	40.9	14.2	7.9	17.8	10.3	21.7	12.9	11.2	18.5	15.4	8.2	24.9	4.8	7.7	5.9	16.8	10.8	10.0	7.9	9.6	6.8	12.4	15.1	18.4	6.9	6.0	14.4	11.2	23.5	6.4	9.1	35.2	7.6	18.9	20.2	4.9	11.6	24.9	10.7	4.9	19.1	12.0	7.8	12.0	11.0	8.6	26.2	10.3	9.9	17.3	10.8	6.2	7.6	14.7	7.4	9.7	29.1	8.8	15.2	3.4	10.2	14.2	9.4	4.6	8.8	8.7	7.8	3.7	8.3	8.5	2.7	10.1	12.0	3.9	9.3	11.1	8.3	33.6	6.4	15.3	12.7	11.8	47.4	4.9	26.1	35.8	47.6	26.9	15.8	6.9	0.9	8.3	6.4	17.8	20.1	36.4	10.4	7.9	18.2	0.0	8.6	77.2	15.0	29.0	0.0	10.5	16.6	10.3	19.1	13.9	17.4	19.9	17.5	23.1	19.6	86.8	67.8	14.4	35.8	1.7	7.2	29.0	4.4	18.7	23.0	10.3	6.2	9.6	19.4	6.9	9.7	12.3	1.4	37.3	20.8	23.4	16.9
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type containing 21"	Q8IVQ6	9	14611071-14693471	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Muller glia cells: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA065254: AB_2685446"	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.28e-6)"	6.5	10.8	15.9	7.9	16.8	4.2	11.6	29.0	22.6	7.8	8.5	9.3	3.8	12.2	9.8	11.7	14.4	7.5	6.7	9.0	13.8	10.4	9.4	4.8	9.2	11.1	9.4	16.5	10.0	8.4	11.5	22.2	7.8	14.8	10.0	9.9	6.6	8.3	7.4	7.7	15.7	12.6	7.7	9.9	9.5	7.9	7.3	9.7	4.7	11.3	9.9	10.7	7.7	11.3	5.2	1.4	0.5	0.8	2.8	1.7	0.6	5.4	2.8	5.6	3.6	0.9	1.0	4.3	7.0	2.2	2.5	2.9	1.4	2.6	5.4	1.7	4.9	3.1	3.6	3.8	2.3	3.6	10.8	2.9	23.0	6.1	2.7	3.0	4.0	7.7	1.9	5.3	2.9	1.9	4.6	14.6	2.2	1.9	0.6	4.4	3.0	0.9	3.9	3.9	2.3	5.3	0.0	2.6	2.7	7.7	6.1	3.4	9.1	3.2	4.0	2.1	4.4	5.0	6.6	10.3	1.8	2.7	1.8	6.4	2.3	4.2	0.0	3.8	0.2	1.8	0.5	0.4	0.1	1.2	0.8	1.3	5.2	1.2	1.1	0.2	3.5	0.8	1.2	0.0	2.8	0.6	1.4	1.7	0.6	15.9	16.8	29.0	22.6	13.8	10.4	9.4	16.5	14.8	9.7	20.8	17.9	23.9	7.6	8.5	42.8	16.2	20.4	10.7	22.7	41.8	41.2	7.1	5.0	13.7	4.0	14.8	33.7	0.0	15.6	5.4	9.4	16.4	10.4	6.8	9.6	35.0	15.0	30.7	15.1	4.5	17.8	11.7	1.7	12.6	13.4	75.7	25.7	10.5	29.4	7.9	50.3	6.5	11.3	14.6	16.1	17.6	6.4	10.2	10.2	13.2
ZDHHC23	MGC42530	ENSG00000184307	"Zinc finger DHHC-type containing 23"	Q8IYP9	3	113947901-113965401	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.8"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 20.4;Late spermatids: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7;naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016808	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016808: AB_1859002"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.48e-7)"	"unprognostic (2.58e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.90e-4)"	"unprognostic (3.29e-3)"	1.0	0.8	6.3	2.1	5.9	0.4	1.9	2.7	10.4	1.4	7.7	0.9	2.2	6.0	1.5	1.6	1.7	2.1	1.8	1.3	8.9	1.9	4.7	3.2	2.4	2.7	0.9	4.7	1.1	4.4	8.2	3.5	0.4	1.4	1.8	9.9	1.2	4.9	1.4	1.2	2.9	5.4	0.7	0.9	1.9	5.0	25.8	0.6	0.8	5.5	0.9	2.8	1.7	1.5	2.7	1.1	0.5	0.0	0.0	0.5	0.1	13.1	3.3	0.4	7.8	1.2	0.2	11.5	5.2	1.6	1.0	1.6	5.4	8.9	6.1	4.6	3.0	8.6	8.7	10.0	1.4	1.7	3.6	4.6	5.6	4.8	3.3	0.4	6.2	5.2	0.2	1.7	0.2	0.6	1.2	0.8	6.5	0.0	3.6	0.1	7.6	5.1	0.4	2.4	13.6	3.7	0.9	4.5	5.0	5.6	6.5	13.7	3.5	4.0	13.5	2.6	3.2	8.1	2.1	0.2	3.8	7.6	0.8	2.3	4.0	5.2	9.8	3.2	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.1	0.0	1.7	0.1	0.0	0.5	0.0	0.0	1.1	0.1	0.1	6.3	5.9	2.7	10.4	8.9	1.9	0.9	4.7	1.4	0.6	0.0	1.0	5.9	1.6	2.7	1.8	1.2	10.2	5.3	2.3	15.7	7.9	0.6	0.0	2.1	20.4	1.4	15.7	0.0	1.6	1.2	0.6	3.5	0.0	5.4	0.4	0.0	13.3	1.8	0.3	26.8	1.1	1.2	3.3	1.0	12.2	3.8	0.7	9.5	0.0	3.4	0.7	0.0	0.3	11.6	1.9	2.4	0.2	0.0	11.4	1.7
ZDHHC24		ENSG00000174165	"Zinc finger DHHC-type containing 24"	Q6UX98	11	66520637-66546238	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016619	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA016619: AB_2288672"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.55e-3)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (8.76e-2)"	"unprognostic (7.74e-3)"	"unprognostic (7.11e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.35e-1)"	11.7	17.4	10.5	10.3	12.8	14.1	12.3	5.7	15.5	7.7	8.3	13.8	10.8	9.1	9.4	17.0	12.2	9.0	11.3	9.9	10.7	11.8	17.3	13.4	11.1	20.4	12.8	10.3	6.5	19.4	22.6	9.6	13.7	9.3	11.4	7.7	10.0	12.4	13.1	7.9	13.2	9.4	7.1	10.0	16.0	12.4	9.9	10.5	11.7	17.7	7.9	13.4	10.0	7.8	5.8	17.2	2.4	5.5	6.6	7.2	4.6	4.7	7.6	2.5	6.5	6.2	5.1	6.3	4.0	3.4	3.2	2.2	6.6	7.7	1.4	10.9	3.4	8.5	11.6	1.9	3.5	2.3	6.8	4.8	2.9	3.7	4.1	5.8	3.0	7.2	6.1	6.3	2.7	3.8	3.8	5.3	11.0	4.2	4.2	4.0	10.3	5.7	8.3	5.0	12.0	6.5	7.3	5.3	8.9	3.9	3.8	3.5	5.5	6.4	6.7	11.0	2.9	9.3	2.4	8.3	7.4	2.3	8.6	2.9	6.3	2.0	2.0	6.5	1.4	8.0	2.4	5.5	1.0	6.2	4.8	5.7	5.4	5.0	7.2	6.3	5.8	3.0	5.4	2.4	6.6	4.4	17.2	5.1	4.6	10.5	12.8	5.7	15.5	10.7	11.8	12.8	10.3	9.3	10.5	11.9	8.8	14.9	12.3	7.1	8.8	3.8	12.7	5.3	2.3	22.7	9.8	28.2	8.3	42.7	10.7	17.0	37.0	0.0	42.7	30.1	14.0	21.3	9.2	14.3	58.2	22.3	13.8	20.3	38.9	10.2	6.9	18.7	16.9	38.7	17.0	17.5	34.3	31.6	9.2	24.8	10.3	19.4	12.2	31.9	2.7	7.0	20.1	28.7	19.6	19.7
ZDHHC3	"DHHC3, GODZ, ZNF373"	ENSG00000163812	"Zinc finger DHHC-type containing 3"	Q9NYG2	3	44915257-44976185	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 493.4;Late spermatids: 1185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012465, HPA016616"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB012465: , HPA016616: AB_1859004"	"unprognostic (2.80e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.81e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-2)"	23.1	25.8	11.7	17.5	14.0	29.5	39.8	12.5	20.8	17.2	27.9	13.7	17.8	18.4	19.2	17.9	29.1	13.0	22.7	34.6	11.2	9.1	21.7	19.0	20.2	16.1	12.1	7.7	16.5	15.0	16.9	8.8	19.5	19.4	16.1	28.9	14.7	17.4	22.5	20.0	43.0	33.2	15.4	13.6	15.4	20.9	48.0	10.1	14.1	20.4	22.1	20.6	21.4	20.7	5.4	11.4	17.1	10.0	6.0	7.1	5.2	12.0	9.7	8.8	12.1	37.5	19.0	9.8	10.6	13.3	13.6	12.3	11.6	15.9	11.0	5.8	18.8	8.2	15.5	13.5	18.8	14.5	10.8	5.7	9.7	13.4	8.5	8.5	25.1	7.9	16.3	23.3	13.0	12.9	10.7	14.3	11.0	14.2	9.8	12.5	7.8	7.6	18.3	11.7	27.2	19.4	5.7	7.4	8.3	13.5	37.8	2.7	10.6	12.8	13.2	5.8	13.9	10.0	17.4	15.2	11.8	10.9	13.8	13.9	6.7	12.5	10.8	10.8	38.5	8.8	17.1	10.0	13.8	6.5	5.5	6.1	4.7	4.7	7.1	11.4	5.4	4.9	6.3	11.4	6.0	7.2	6.7	6.9	5.2	11.7	14.0	12.5	20.8	11.2	9.1	12.1	7.7	19.4	10.1	38.7	75.1	15.7	29.8	42.7	9.4	24.0	25.5	16.0	18.2	50.6	5.9	40.9	61.3	37.0	493.4	30.7	99.2	23.3	69.9	48.5	26.6	52.0	18.5	25.9	43.7	14.3	34.4	38.1	31.1	1185.8	48.1	27.2	23.6	30.7	65.3	25.6	78.0	59.6	42.1	23.7	8.6	19.4	23.7	52.6	40.9	52.7	85.0	20.8	60.2	82.9
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type containing 5"	Q9C0B5	11	57667747-57701187	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	19.6	18.2	6.9	14.2	16.1	13.0	17.3	12.4	19.2	20.0	18.7	14.1	20.9	14.6	19.8	15.9	45.8	16.0	19.1	18.2	8.2	8.1	27.8	24.8	18.7	18.0	8.5	8.2	16.2	21.3	31.4	13.9	31.4	12.8	15.5	18.2	19.1	29.3	18.4	31.3	33.2	25.9	15.2	8.7	21.5	16.3	35.7	7.8	26.4	25.5	23.9	39.1	23.3	26.0	9.4	13.4	15.5	11.3	6.9	13.1	9.0	28.4	31.6	12.4	12.6	27.5	21.2	23.4	26.8	32.1	22.4	16.8	19.1	35.1	19.2	34.8	31.6	19.3	40.3	19.3	31.7	20.0	23.6	8.7	16.3	14.5	17.0	30.8	30.5	27.7	29.8	28.7	33.1	33.7	18.6	25.2	16.2	21.4	24.3	28.3	17.1	17.1	8.5	15.0	21.1	19.0	17.1	25.1	23.7	25.6	42.2	9.0	11.5	24.9	28.2	26.1	17.5	30.2	17.5	29.5	29.1	15.1	30.5	18.6	17.7	21.9	16.5	21.6	15.8	25.2	15.5	8.1	9.8	11.1	10.1	13.1	9.0	10.9	9.4	8.0	9.4	11.0	11.1	10.2	6.9	11.3	13.4	9.8	9.0	6.9	16.1	12.4	19.2	8.2	8.1	8.5	8.2	12.8	7.8	14.9	10.9	5.3	10.2	14.3	17.5	18.1	12.7	14.7	20.5	12.2	35.3	8.5	3.3	13.1	15.8	11.7	31.9	0.0	15.7	8.4	8.5	14.0	19.6	13.2	11.0	12.7	11.1	13.5	16.1	6.8	10.9	12.0	1.7	9.0	16.2	9.6	19.0	19.3	7.1	10.2	45.0	0.0	9.2	6.5	6.6	17.3	15.6	8.7	15.8	15.9
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type containing 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	20.7	19.2	25.7	16.9	23.0	9.2	23.4	24.4	35.3	14.3	9.9	14.0	17.3	11.6	16.0	10.9	13.9	13.6	14.4	16.0	18.7	10.6	15.2	16.5	14.6	15.4	17.7	17.6	18.0	23.9	17.4	21.0	16.4	19.0	13.4	7.0	17.5	20.4	16.6	20.5	22.2	11.2	13.0	10.4	19.8	15.9	8.4	18.6	8.9	18.5	7.9	11.1	12.9	14.5	2.0	4.1	4.0	1.5	1.3	2.5	0.5	11.5	7.4	11.8	15.5	17.3	10.4	10.6	21.8	14.9	14.8	13.3	3.8	6.0	0.0	9.0	18.1	8.0	15.9	6.2	16.7	7.3	16.6	23.7	5.6	19.4	8.8	14.3	0.0	7.9	18.1	11.3	11.4	9.6	9.1	16.5	8.3	38.6	9.1	13.1	5.6	6.8	15.1	6.0	5.1	11.7	14.6	10.3	4.1	6.4	14.1	19.0	9.6	8.8	4.3	10.4	5.6	0.3	7.9	18.9	33.7	24.7	18.9	9.7	13.2	4.3	4.4	9.9	7.3	9.9	4.0	1.2	0.3	2.5	1.5	1.3	0.8	0.7	1.2	0.4	2.0	1.3	1.8	0.0	1.3	0.8	4.1	2.0	0.5	25.7	23.0	24.4	35.3	18.7	10.6	17.7	17.6	19.0	18.6	3.0	1.9	2.7	3.4	8.0	11.5	6.8	5.1	0.0	3.4	10.4	13.7	3.1	1.7	4.5	0.5	9.0	2.4	0.0	3.8	6.1	8.0	4.0	5.7	7.8	4.2	12.7	4.1	11.6	4.9	1.3	10.0	5.0	5.0	2.8	5.5	8.3	6.2	4.3	13.8	1.9	11.0	6.5	5.5	0.3	2.3	8.5	2.9	2.5	4.8	2.7
ZDHHC9	"CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type containing 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	18.2	7.3	16.7	6.7	24.7	3.2	14.2	7.8	33.9	14.1	14.7	78.3	5.1	21.1	8.4	8.4	9.8	7.9	10.4	7.4	24.1	15.2	25.4	27.0	15.6	3.0	24.9	13.9	8.0	17.4	19.6	7.1	11.5	28.4	13.4	17.3	3.8	13.2	8.3	7.4	19.7	22.2	10.4	32.7	2.4	12.8	2.8	25.3	1.2	9.6	5.7	4.3	10.8	9.4	4.6	7.8	2.6	6.8	3.4	7.6	3.3	15.0	7.9	11.4	23.0	39.4	31.1	9.3	14.9	17.1	7.2	9.0	12.5	19.7	0.5	25.5	15.9	18.6	10.2	12.8	15.0	10.4	0.8	8.0	3.0	8.3	16.4	15.6	2.0	5.4	33.7	24.4	11.7	17.4	12.6	13.5	5.0	3.2	6.1	11.5	13.1	2.8	3.7	6.1	33.8	13.7	2.7	7.3	8.8	10.4	8.4	9.0	7.6	4.2	22.1	6.9	14.0	9.4	3.3	10.9	7.3	2.5	17.1	12.0	5.7	4.0	1.8	13.1	8.3	3.6	0.0	3.3	2.6	4.8	2.9	6.1	4.6	5.8	4.7	3.7	2.7	7.6	4.3	0.0	3.4	6.8	7.8	2.5	3.3	16.7	24.7	7.8	33.9	24.1	15.2	24.9	13.9	28.4	25.3	20.8	28.7	3.0	9.8	16.6	9.1	3.5	28.1	5.3	17.0	43.6	2.0	5.0	3.3	16.9	1.1	10.3	26.8	0.0	17.0	17.3	20.5	23.0	2.3	41.5	4.4	1.6	17.3	6.7	2.1	1.3	11.2	4.6	10.1	0.0	24.9	1.2	26.6	10.5	7.1	24.6	2.4	0.0	13.7	6.1	6.0	16.8	8.6	2.5	25.5	13.6
ZER1	"C9orf60, Hzyg, ZYG, ZYG11BL"	ENSG00000160445	"Zyg-11 related cell cycle regulator"	Q7Z7L7	9	128729786-128772414	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048464			Approved	Cytosol		NA	NA			Cytosol		"HPA048464: AB_2756306"	"unprognostic (1.37e-1)"	"prognostic favorable (1.18e-6)"	"unprognostic (9.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.65e-1)"	"unprognostic (4.90e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (5.15e-11)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.14e-1)"	15.4	17.1	36.0	9.7	32.0	12.0	12.5	28.0	45.3	15.9	18.2	19.7	11.3	27.4	16.7	12.3	23.8	21.9	14.4	29.9	27.0	28.5	15.7	11.1	16.5	10.4	19.9	34.2	22.1	22.0	24.1	18.2	13.1	29.1	20.6	11.0	14.7	21.9	22.2	40.3	17.4	25.3	14.0	13.5	12.5	14.1	25.8	18.8	16.9	19.0	8.5	9.3	17.9	12.6	5.0	5.7	15.8	5.8	5.5	7.7	4.9	8.8	9.8	6.5	8.9	19.5	13.5	18.0	8.5	14.8	11.9	9.7	8.8	10.1	5.5	9.7	14.9	8.9	19.5	7.1	12.7	5.0	10.9	9.4	3.8	17.4	6.4	15.3	5.5	10.6	16.8	19.2	12.0	8.5	16.2	10.1	11.1	6.8	12.1	8.1	33.7	10.4	6.2	6.5	12.4	12.7	9.5	8.7	20.8	8.9	12.0	12.7	9.6	14.4	18.5	9.8	7.9	27.0	6.6	11.3	9.8	4.4	12.5	5.1	15.2	14.1	4.3	14.5	3.3	7.1	10.9	3.7	10.0	5.6	5.6	7.7	3.8	5.8	7.2	3.9	5.0	6.5	5.9	15.8	5.5	5.8	5.7	5.3	4.9	36.0	32.0	28.0	45.3	27.0	28.5	19.9	34.2	29.1	18.8	11.9	15.6	2.4	3.3	2.5	19.4	19.8	5.1	10.7	2.3	5.2	13.7	3.9	1.7	4.4	4.2	5.8	24.2	0.0	8.2	2.1	4.9	6.4	10.3	6.8	5.1	20.6	6.9	8.6	6.6	1.3	10.3	3.2	8.5	10.8	14.0	10.3	6.5	21.0	9.9	9.9	12.2	12.9	4.2	10.2	3.1	5.1	7.1	3.3	8.9	2.3
ZFAND1	FLJ14007	ENSG00000104231	"Zinc finger AN1-type containing 1"	Q8TCF1	8	81701334-81732903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023383	Approved		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA023383: AB_1859008"	"unprognostic (6.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.74e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.04e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.36e-2)"	18.9	17.7	12.5	10.8	23.2	14.8	25.8	24.3	25.9	22.8	19.4	8.6	16.0	16.1	21.6	17.9	19.9	20.8	14.4	14.8	12.7	15.8	19.6	26.6	16.2	13.8	14.8	16.2	35.8	35.1	16.0	31.1	12.6	27.4	23.7	18.7	10.3	23.3	18.1	16.9	13.5	20.2	23.7	16.5	17.5	20.3	10.3	13.2	19.0	42.6	16.1	17.0	26.7	21.3	18.5	20.0	6.4	13.9	17.2	25.1	16.8	19.2	6.1	8.6	7.5	11.8	23.8	8.6	11.5	15.5	10.1	13.2	6.8	15.2	18.9	13.6	8.7	11.3	13.0	9.9	16.5	15.3	15.9	9.9	10.8	10.4	8.0	21.7	13.2	7.2	19.4	39.8	7.0	69.1	17.5	12.6	18.1	16.3	27.1	10.5	12.6	16.3	9.6	2.5	40.4	19.4	11.2	7.3	8.4	12.7	17.8	8.8	5.7	8.3	5.3	18.9	10.3	17.5	9.8	8.0	7.5	11.0	10.7	15.9	10.8	6.6	11.6	8.9	1.2	5.7	6.4	13.9	3.9	11.3	10.2	19.4	18.5	18.5	15.0	20.0	13.4	25.1	18.7	1.4	17.2	11.8	11.6	21.1	16.8	12.5	23.2	24.3	25.9	12.7	15.8	14.8	16.2	27.4	13.2	23.8	31.8	35.2	67.7	85.2	26.9	16.8	43.3	10.7	26.1	24.4	3.9	30.8	87.9	21.1	2.7	39.1	10.5	46.7	43.0	38.4	35.5	55.7	34.6	19.1	26.1	22.3	22.5	24.5	42.4	2.3	36.8	31.1	47.2	22.6	34.4	13.7	30.0	28.1	28.0	54.2	12.7	32.3	63.4	18.2	18.1	68.5	27.3	52.2	30.5	52.1
ZFAND2B	AIRAPL	ENSG00000158552	"Zinc finger AN1-type containing 2B"	Q8WV99	2	219195237-219209651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 133.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035159, HPA035160"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA035159: AB_2674499, HPA035160: AB_10670697"	"unprognostic (3.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.77e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.38e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.02e-2)"	13.4	12.9	16.4	14.6	16.9	23.8	13.5	22.3	24.6	14.8	30.0	20.2	15.9	30.5	15.3	14.2	22.2	13.1	22.2	11.6	16.2	13.3	20.0	28.5	15.2	27.3	18.8	17.9	14.1	29.1	18.6	18.0	22.2	15.6	14.7	18.5	11.3	17.3	14.2	15.9	23.4	34.7	24.5	17.5	22.6	21.8	9.5	13.9	23.0	30.0	12.9	19.3	14.7	16.6	29.1	20.5	36.6	27.8	30.7	32.5	25.4	10.6	7.3	8.3	11.7	8.9	9.4	11.6	10.8	12.7	15.6	15.5	16.3	9.1	8.6	11.5	18.4	12.7	7.4	7.7	13.7	12.5	13.3	12.0	19.8	12.0	14.1	18.2	10.5	22.9	7.7	30.2	15.3	36.6	8.8	10.4	19.1	11.5	24.6	15.2	18.4	17.3	22.1	4.3	14.8	8.4	10.8	5.0	14.8	14.7	9.0	18.2	8.2	5.2	8.8	12.0	9.8	7.5	22.3	11.0	15.7	14.8	18.1	15.3	10.2	3.3	15.5	15.4	20.8	12.2	17.7	21.7	28.6	32.1	27.8	28.0	25.4	29.3	31.3	16.4	29.1	26.7	32.5	36.6	30.7	21.9	20.5	30.2	25.4	16.4	16.9	22.3	24.6	16.2	13.3	18.8	17.9	15.6	13.9	20.8	26.3	36.4	21.1	24.2	13.5	11.1	25.5	8.1	9.1	19.2	13.7	22.5	48.0	34.1	3.4	27.0	133.2	0.0	57.4	20.0	23.7	23.5	32.3	35.5	29.9	7.9	38.6	14.7	29.1	5.5	29.7	26.7	33.7	13.6	57.3	20.9	46.6	94.7	28.0	57.5	14.9	25.8	33.0	5.7	13.0	31.6	42.9	46.7	47.7	24.8
ZFAND3	"FLJ13222, TEX27"	ENSG00000156639	"Zinc finger AN1-type containing 3"	Q9H8U3	6	37819499-38154624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	23	"Early spermatids: 795.9;Late spermatids: 2445.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016755	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA016755: AB_1859011"	"unprognostic (3.32e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.41e-2)"	"unprognostic (4.33e-1)"	26.7	27.5	31.0	26.0	31.1	23.9	37.6	26.2	31.4	28.6	27.0	26.6	26.0	24.5	25.9	31.2	22.2	21.4	33.5	30.5	29.9	24.1	31.6	35.6	24.8	26.1	30.4	22.2	23.9	26.1	33.9	31.6	31.4	24.2	23.7	20.2	24.3	20.3	31.0	77.9	19.4	26.9	35.4	33.4	21.9	25.1	60.5	27.3	26.4	32.1	19.7	19.3	30.7	34.0	3.0	4.4	9.2	2.8	2.9	2.6	1.4	17.2	10.7	37.0	26.2	22.4	23.3	12.8	28.9	33.7	26.1	27.9	21.0	10.2	7.2	22.2	30.7	30.6	11.9	14.1	21.3	35.9	27.4	9.0	21.7	5.6	20.0	52.6	9.0	19.0	29.3	28.1	27.5	46.8	32.1	22.5	17.1	10.3	15.3	19.7	14.9	14.1	7.6	11.0	25.6	11.2	14.9	14.9	8.7	24.7	29.5	23.0	20.2	16.2	14.2	49.7	31.4	21.8	19.1	24.5	27.5	20.9	14.7	18.0	14.9	13.5	21.8	10.3	14.3	28.3	0.7	2.7	8.8	2.6	2.8	1.8	1.9	1.9	2.0	1.3	3.0	1.7	2.6	9.2	2.9	2.1	4.4	2.4	1.4	31.0	31.1	26.2	31.4	29.9	24.1	30.4	22.2	24.2	27.3	20.8	8.6	15.7	25.6	24.3	24.2	20.2	20.4	6.7	3.4	45.4	21.6	27.7	63.0	22.6	795.9	23.8	49.2	23.3	25.1	25.5	23.1	42.8	4.7	43.1	29.1	28.6	15.5	24.5	37.3	2445.8	35.9	24.9	13.5	20.8	27.9	32.1	31.8	24.1	51.9	29.5	21.8	32.3	24.0	65.7	37.2	26.3	72.0	21.8	17.2	47.7
ZFAND4	"ANUBL1, FLJ40185"	ENSG00000172671	"Zinc finger AN1-type containing 4"	Q86XD8	10	45615501-45672780	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 49.1"	"Group enriched"	"Detected in many"	9	"Early spermatids: 369.5;Late spermatids: 511.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"Daudi: 31.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057543, HPA074103"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA057543: AB_2683461, HPA074103: "	"unprognostic (1.57e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.85e-5)"	"unprognostic (3.23e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-3)"	2.7	4.1	3.0	7.3	5.2	2.6	4.5	14.7	3.6	3.5	2.9	6.8	4.2	2.9	5.0	2.5	2.5	4.1	2.9	3.3	3.2	4.4	3.2	4.4	3.3	6.1	5.0	1.7	3.3	3.7	3.1	9.7	2.0	5.5	3.9	3.5	4.8	2.9	3.9	2.7	4.0	2.6	3.0	5.1	3.6	2.4	49.1	5.8	9.7	4.8	2.1	6.2	2.9	2.8	1.9	0.8	2.0	1.6	3.2	2.4	0.4	0.9	0.8	1.4	1.9	3.1	2.5	0.0	1.2	2.4	1.3	1.4	0.0	0.9	31.3	1.4	0.8	1.9	0.2	1.1	0.7	1.7	4.6	1.3	0.9	1.1	0.9	2.2	0.0	6.5	2.3	1.5	0.4	1.3	1.1	1.5	4.4	0.8	5.5	1.3	0.1	3.0	0.6	1.3	1.1	0.7	0.4	1.1	0.0	1.2	0.9	2.6	1.8	0.9	1.2	1.0	1.7	2.7	1.7	1.0	0.5	2.3	2.1	1.6	3.8	6.7	0.0	1.1	3.0	0.5	2.0	0.8	0.0	1.9	0.6	2.4	1.9	1.9	1.6	0.7	1.4	1.5	2.2	0.1	3.2	1.6	0.8	1.2	0.4	3.0	5.2	14.7	3.6	3.2	4.4	5.0	1.7	5.5	5.8	6.0	1.9	4.7	2.9	0.7	6.9	3.1	2.5	10.7	0.0	1.8	25.5	0.2	1.7	1.1	369.5	2.0	2.0	0.0	1.5	0.2	1.1	3.5	2.3	4.5	1.9	3.2	1.7	1.8	1.8	511.2	6.1	1.1	3.3	1.8	2.1	4.0	1.4	0.0	2.8	3.1	7.3	6.5	0.6	51.6	13.9	1.9	0.1	3.2	1.9	1.4
ZFAND5	"ZA20D2, ZFAND5A, ZNF216"	ENSG00000107372	"Zinc finger AN1-type containing 5"	O76080	9	72351425-72365235	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018129, HPA077824"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA018129: AB_1859012, HPA077824: "	"unprognostic (1.97e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.03e-2)"	82.5	57.6	26.9	15.5	35.2	36.6	57.1	31.7	34.3	28.6	23.1	20.3	31.4	10.8	25.7	35.5	29.0	27.4	28.7	33.0	24.3	22.6	32.6	56.5	31.6	23.6	24.3	21.1	59.3	20.9	17.0	45.4	22.4	25.1	24.0	15.1	22.4	17.2	52.7	207.5	17.6	15.8	28.4	25.9	24.1	23.2	26.7	21.7	14.6	23.1	29.5	16.5	39.2	29.3	7.0	13.6	15.4	32.1	8.6	6.8	7.8	22.2	22.8	26.9	11.9	34.8	16.6	20.3	26.3	36.7	14.2	11.1	2.8	21.0	12.4	16.0	41.2	20.1	24.9	62.0	10.3	21.3	83.9	9.6	9.8	13.1	13.9	25.7	14.0	14.6	21.7	19.1	14.8	16.6	33.1	25.1	12.0	9.4	16.4	16.6	5.9	18.3	8.0	34.7	20.9	15.9	14.3	14.0	13.1	46.2	21.6	19.7	17.6	16.6	18.3	21.5	29.2	8.1	12.3	19.1	11.8	14.6	20.8	18.0	23.7	20.6	6.5	15.9	9.6	29.2	15.1	13.6	15.4	5.2	21.6	5.7	7.0	6.8	6.6	13.6	6.2	6.3	5.6	12.2	8.6	32.1	2.9	4.8	7.8	26.9	35.2	31.7	34.3	24.3	22.6	24.3	21.1	25.1	21.7	163.8	158.6	37.3	496.3	301.3	88.2	288.5	91.7	88.3	127.4	125.6	70.7	117.4	126.0	118.6	62.4	115.1	102.1	46.7	122.4	145.8	149.1	300.6	109.4	271.5	176.8	38.1	131.1	95.2	243.2	35.2	109.6	177.8	197.4	297.6	71.5	51.7	193.5	79.3	87.7	95.7	65.3	84.1	204.0	123.7	99.9	254.7	189.3	64.8	81.2	398.4
ZFAND6	"AWP1, ZA20D3, ZFAND5B"	ENSG00000086666	"Zinc finger AN1-type containing 6"	Q6FIF0	15	80059568-80138393	"Predicted intracellular proteins"	"Apoptosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034845, HPA052746, HPA077824"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034845: AB_10671234, HPA052746: , HPA077824: "	"unprognostic (2.04e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.48e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (8.20e-4)"	34.3	33.9	22.8	28.5	20.9	26.3	39.7	23.7	20.1	22.2	26.0	16.1	21.3	20.5	28.7	33.3	30.9	21.6	21.7	33.9	23.0	22.2	33.0	55.0	27.1	34.2	22.3	17.2	22.8	22.3	22.9	27.1	33.6	21.2	24.1	23.7	23.9	23.5	20.7	55.2	19.8	33.7	33.1	29.0	34.4	22.1	56.0	21.9	25.0	47.2	28.7	30.1	27.5	19.5	44.9	20.2	79.2	31.1	15.5	21.0	23.6	20.3	42.3	31.5	18.0	32.5	25.9	30.0	24.3	33.9	21.3	29.2	14.8	35.7	22.6	31.6	24.8	20.8	16.7	33.4	24.3	22.8	13.7	28.9	54.1	20.2	20.9	38.1	19.2	35.8	22.9	31.9	23.5	32.0	29.4	31.9	19.7	21.5	17.9	23.2	21.5	15.1	19.1	19.7	18.3	14.3	12.5	27.9	51.5	52.8	34.2	6.5	18.7	20.9	24.3	61.4	40.9	23.9	27.9	29.4	22.4	18.3	14.4	23.5	24.0	47.0	26.5	23.3	33.4	15.6	79.2	17.6	54.6	19.7	22.8	17.1	44.9	18.0	18.9	20.2	29.6	19.0	21.0	42.7	15.5	31.1	17.5	17.2	23.6	22.8	20.9	23.7	20.1	23.0	22.2	22.3	17.2	21.2	21.9	50.6	65.5	114.2	120.6	132.8	41.4	77.8	94.3	120.5	39.8	71.5	39.3	106.7	169.1	90.4	449.7	71.9	71.9	93.5	86.9	109.2	74.4	154.0	101.7	120.4	124.0	30.2	79.3	74.3	105.4	383.1	49.2	110.5	118.1	216.4	74.2	71.0	95.0	87.7	59.1	180.4	74.0	90.5	76.2	235.8	150.3	148.0	328.5	96.4	55.7	161.1
ZFAT	"KIAA1485, ZFAT1, ZNF406"	ENSG00000066827	"Zinc finger and AT-hook domain containing"	Q9P243	8	134477788-134713049	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 68.8"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 57.3;Early spermatids: 44.4;Late spermatids: 36.0;Syncytiotrophoblasts: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 22.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020989, HPA063592"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA020989: AB_2670552, HPA063592: AB_2685051"	"unprognostic (2.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-3)"	"unprognostic (5.91e-3)"	"unprognostic (2.45e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (6.27e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.33e-1)"	4.5	2.9	4.2	3.5	4.2	1.7	5.0	6.8	4.5	3.0	7.8	2.6	2.8	3.2	5.0	3.1	4.2	3.3	2.4	3.8	3.0	1.7	12.4	2.8	4.1	4.5	2.5	2.8	3.3	3.3	3.7	4.6	68.8	2.9	3.9	2.6	4.3	3.7	4.2	8.5	3.4	3.8	3.9	2.0	4.4	3.6	3.5	3.0	4.8	3.3	2.8	4.0	6.0	5.3	0.6	22.1	0.8	0.5	0.0	0.5	0.5	5.7	9.0	3.3	4.1	6.4	6.4	2.8	6.2	5.5	5.8	5.8	6.2	7.2	6.4	5.5	6.4	3.4	4.4	6.6	7.8	7.4	5.4	8.8	12.0	9.2	4.6	5.0	6.7	5.9	5.4	4.0	6.4	8.2	5.2	7.0	2.4	4.5	12.0	4.8	7.4	6.9	0.8	4.6	5.8	5.9	4.3	4.3	2.7	5.4	8.6	3.7	3.1	6.4	4.9	5.2	3.9	4.1	6.4	7.6	3.4	5.0	4.8	7.0	4.4	5.8	6.4	4.3	5.0	6.4	0.7	0.3	0.8	0.3	0.5	0.3	0.6	0.2	0.5	0.3	0.6	0.4	0.2	0.7	0.0	0.3	22.1	0.1	0.5	4.2	4.2	6.8	4.5	3.0	1.7	2.5	2.8	2.9	3.0	3.0	3.5	6.0	1.2	1.3	3.6	1.6	0.0	0.0	3.4	1.8	3.9	57.3	0.0	2.0	44.4	1.1	1.1	0.0	1.3	13.9	2.4	1.2	2.3	1.0	7.1	1.6	0.0	0.6	2.4	36.0	3.1	2.0	8.5	3.6	1.3	2.6	2.9	0.0	2.5	9.2	5.9	0.0	1.6	2.9	5.5	1.5	106.0	1.3	1.1	1.1
ZFC3H1	"CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2"	ENSG00000133858	"Zinc finger C3H1-type containing"	O60293	12	71609472-71667725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007072, HPA007151"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA007072: AB_1846134, HPA007151: AB_1846133"	"unprognostic (3.90e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	12.1	12.8	17.6	19.1	17.4	22.7	12.9	35.3	23.8	15.4	16.9	6.7	14.6	8.0	13.7	17.3	15.1	12.8	12.7	12.1	14.6	7.7	10.7	8.0	16.4	19.1	14.8	12.3	17.1	11.6	17.6	17.6	14.6	14.9	12.6	13.2	6.7	12.0	14.2	11.6	12.2	15.2	12.4	14.7	15.9	13.5	17.5	17.6	16.8	13.5	8.4	17.1	15.7	20.8	14.8	12.7	29.7	10.3	4.2	7.2	1.1	10.4	10.6	7.7	5.3	10.7	19.1	4.6	8.2	13.2	13.0	12.9	9.8	5.8	13.5	4.7	10.1	5.3	11.3	10.9	4.8	17.3	13.7	8.0	13.2	16.4	4.5	6.0	14.4	6.5	10.6	10.4	9.1	3.9	16.7	13.0	11.1	12.2	6.0	11.9	3.2	10.1	5.0	7.7	4.9	6.1	8.8	9.4	10.4	9.8	7.7	5.3	4.8	8.3	5.3	5.4	8.7	14.2	9.5	9.8	7.3	5.0	4.2	4.1	10.4	6.3	10.5	8.5	10.1	5.1	20.7	10.3	12.1	7.2	4.8	5.5	9.2	6.2	4.6	3.9	14.8	5.8	4.9	29.7	4.2	8.7	12.7	4.9	1.1	17.6	17.4	35.3	23.8	14.6	7.7	14.8	12.3	14.9	17.6	32.8	23.8	26.2	48.6	42.6	31.6	15.1	5.1	21.4	34.2	14.0	21.6	11.9	1.7	17.8	75.9	28.7	28.5	0.0	14.5	12.8	33.8	39.6	47.4	9.8	15.6	55.6	20.1	20.9	18.0	52.4	29.7	35.1	10.1	27.1	23.4	18.9	21.4	35.1	21.5	5.8	31.7	25.8	25.5	29.6	25.8	35.8	9.6	24.9	21.5	64.9
ZFHX2	"KIAA1056, KIAA1762, ZFH-5, ZNF409"	ENSG00000136367	"Zinc finger homeobox 2"	Q9C0A1	14	23520855-23556192	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.5;testis: 17.9"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 30.6;Late spermatids: 13.8;Spermatocytes: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;SuSa: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000720, HPA005146"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Nucleoli fibrillar center"	Nucleoplasm	"HPA000720: AB_10603462, HPA005146: AB_1859250"	"unprognostic (7.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.08e-4)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.75e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.90e-2)"	1.7	2.6	5.1	1.9	5.8	0.9	1.7	15.5	12.4	1.7	1.6	3.9	1.2	1.1	1.9	2.0	1.2	6.6	1.9	1.2	6.8	4.9	3.0	1.1	2.1	1.5	4.5	6.3	2.0	1.9	7.4	8.1	1.2	5.4	2.0	1.2	1.6	1.8	4.0	2.3	2.1	1.2	2.4	3.2	1.1	1.8	17.9	6.1	0.0	2.1	0.0	1.4	1.8	0.7	0.3	0.5	2.3	0.4	0.0	0.9	0.0	0.2	5.1	4.1	8.1	2.8	0.4	0.3	1.1	0.4	0.6	2.1	0.5	0.4	0.3	0.5	0.1	0.5	0.1	2.1	0.3	0.9	3.6	1.3	4.1	0.0	1.0	0.4	0.7	3.0	0.6	0.1	0.8	0.3	2.2	0.5	3.6	0.6	0.7	0.1	1.4	0.5	0.5	5.0	0.6	1.2	2.2	0.1	0.0	2.2	1.9	4.5	2.9	0.7	1.1	0.3	6.6	1.7	1.0	0.1	0.0	2.1	1.3	0.5	0.5	1.6	0.2	0.1	0.3	0.2	0.0	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.2	0.5	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	5.1	5.8	15.5	12.4	6.8	4.9	4.5	6.3	5.4	6.1	0.0	0.6	0.0	0.4	0.1	9.0	2.0	0.0	6.7	3.4	1.8	0.0	0.2	1.7	2.8	30.6	0.6	0.0	0.0	2.1	0.0	0.8	1.2	0.0	0.0	0.8	7.9	6.4	0.6	0.6	13.8	0.6	0.7	0.0	1.8	0.7	3.9	1.3	0.0	0.4	1.0	3.2	0.0	0.2	19.2	1.1	0.0	0.2	0.0	0.6	0.1
ZFHX4	"FLJ20980, ZFH4"	ENSG00000091656	"Zinc finger homeobox 4"	Q86UP3	8	76681219-76867285	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 29.1"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 75.7;Cholangiocytes: 48.4;Early spermatids: 49.4;Hepatocytes: 24.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 13.1;TIME: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023837	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA023837: AB_1859013"	"unprognostic (2.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.63e-3)"	"unprognostic (6.14e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.15e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.20e-7)"	"unprognostic (3.50e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.50e-4)"	"unprognostic (5.89e-4)"	4.9	8.8	6.2	2.1	10.7	0.8	5.8	1.4	8.5	6.3	5.1	7.7	14.1	1.0	2.2	8.9	1.7	2.0	2.9	1.5	7.2	4.3	1.6	7.3	1.1	1.5	8.3	4.3	5.5	1.5	1.2	13.7	1.1	5.9	3.2	2.0	8.0	1.6	29.1	6.5	1.4	1.3	11.8	11.6	1.2	2.0	15.6	9.8	0.0	1.2	2.4	1.0	7.8	5.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	2.5	0.0	4.9	6.4	0.0	2.1	3.0	2.4	2.6	0.0	0.0	0.0	4.0	3.5	1.2	0.2	4.9	0.6	4.5	0.0	7.2	0.1	0.0	0.0	1.3	0.0	0.3	13.1	0.2	6.4	2.6	4.5	0.4	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.4	0.2	4.2	0.0	4.4	0.0	3.9	0.0	0.0	4.6	0.0	0.5	0.0	0.0	0.6	0.0	28.6	2.5	3.8	7.2	4.8	7.4	0.7	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	10.7	1.4	8.5	7.2	4.3	8.3	4.3	5.9	9.8	0.0	1.0	0.0	0.0	0.5	75.7	3.2	48.4	0.0	0.0	5.2	2.0	0.0	0.0	0.0	49.4	0.9	0.0	0.0	0.0	0.0	4.7	0.2	0.0	24.6	0.3	4.8	0.0	1.8	0.3	17.6	12.7	1.1	0.0	0.0	0.0	19.8	0.0	0.0	20.1	0.0	5.3	0.0	1.6	8.6	1.5	1.0	0.0	0.0	0.0	0.6
ZFP1	"FLJ34243, ZNF475"	ENSG00000184517	"ZFP1 zinc finger protein"	Q6P2D0	16	75148492-75172236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044916, HPA062910"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044916: AB_2679144, HPA062910: AB_2684902"	"unprognostic (1.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.24e-5)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (5.55e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-1)"	6.0	5.9	13.7	4.6	14.8	4.1	7.4	14.8	19.0	8.6	6.6	8.9	5.9	4.2	9.1	5.6	5.2	7.1	6.6	7.1	12.8	9.9	7.8	23.2	6.1	6.7	10.2	10.0	11.4	4.9	11.9	7.1	7.1	12.8	6.7	5.0	5.0	3.6	7.8	7.4	4.8	4.0	9.5	10.7	5.1	4.5	7.6	9.4	18.1	11.6	3.7	7.4	6.8	5.0	3.6	1.9	3.0	3.2	4.4	4.7	2.2	2.5	5.3	7.4	6.8	4.2	5.7	3.0	3.1	3.6	7.0	8.4	4.3	1.9	10.7	3.5	2.5	2.7	3.3	6.8	4.5	7.8	5.6	4.3	3.8	2.0	3.1	3.8	3.7	12.5	3.9	4.4	4.9	6.5	7.0	4.5	10.1	4.6	2.3	5.0	9.7	13.0	3.5	2.4	2.0	2.1	12.2	3.3	3.4	2.9	2.1	7.7	6.0	7.8	2.2	2.8	2.0	5.0	3.0	3.1	6.4	6.7	2.9	3.4	9.5	9.0	23.9	3.0	5.2	4.7	3.0	1.7	0.7	4.3	3.2	4.6	3.4	2.9	4.7	1.9	3.6	3.9	4.1	0.1	4.4	1.4	0.8	4.4	2.2	13.7	14.8	14.8	19.0	12.8	9.9	10.2	10.0	12.8	9.4	6.0	3.7	2.4	2.0	4.7	4.6	3.1	2.5	2.7	2.3	1.8	0.0	2.3	1.7	2.9	3.5	3.9	0.4	0.0	1.9	2.1	4.7	1.4	1.1	10.6	1.8	12.7	6.9	2.5	4.6	4.3	3.1	1.6	1.7	2.8	0.9	6.5	1.6	0.0	3.9	3.4	2.9	0.0	6.1	17.0	8.2	5.1	3.4	4.5	1.7	2.0
ZFP14	"KIAA1559, ZNF531"	ENSG00000142065	"ZFP14 zinc finger protein"	Q9HCL3	19	36334453-36379199	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 58.6;Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030637	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA030637: AB_10602353"	"unprognostic (1.89e-1)"	"unprognostic (3.80e-2)"	"unprognostic (9.61e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.75e-5)"	4.8	6.7	9.1	6.0	11.7	2.7	10.0	13.8	11.5	7.5	5.1	10.3	5.6	6.7	11.4	13.1	5.6	8.0	4.8	4.6	9.6	7.8	8.2	5.0	5.0	8.3	14.6	9.8	10.7	5.1	12.9	14.9	5.1	10.6	7.8	5.2	6.5	6.0	8.0	3.5	7.9	6.5	7.6	11.6	8.3	6.1	2.8	12.8	9.2	10.9	3.1	8.3	6.2	7.0	10.4	5.7	5.7	4.4	5.8	9.5	1.7	2.1	3.8	7.7	7.1	6.7	3.4	1.8	1.0	3.3	2.1	3.3	2.5	1.7	6.1	2.8	1.5	1.7	0.8	3.2	0.5	2.3	2.3	2.4	5.4	3.8	2.1	2.2	4.4	5.8	1.5	1.4	0.9	0.2	4.0	2.9	7.2	1.6	0.1	3.3	1.5	6.8	1.8	5.8	3.2	1.7	5.7	4.4	1.8	2.2	4.2	4.3	6.5	3.8	1.2	2.2	4.2	2.4	3.5	2.0	2.2	4.9	2.3	1.1	1.7	2.8	3.2	0.4	0.6	3.8	5.7	4.0	5.3	6.2	4.4	6.3	10.4	6.8	7.8	3.8	9.4	9.5	9.5	2.5	5.8	3.9	5.7	6.3	1.7	9.1	11.7	13.8	11.5	9.6	7.8	14.6	9.8	10.6	12.8	0.0	4.0	26.2	5.8	2.9	58.6	4.9	12.7	12.0	4.5	12.2	49.1	6.7	6.6	6.4	1.5	9.2	8.7	0.0	3.9	2.0	5.8	5.7	12.7	3.4	7.2	44.5	12.7	7.4	6.7	0.4	14.4	8.5	3.3	7.2	9.5	21.4	4.4	12.7	18.4	7.9	95.4	32.3	4.1	4.7	7.7	2.3	2.1	11.5	8.0	4.8
ZFP28	"KIAA1431, mkr5"	ENSG00000196867	"ZFP28 zinc finger protein"	Q8NHY6	19	56538948-56556810	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028879	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA028879: AB_10603841"	"unprognostic (5.02e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.32e-4)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-1)"	3.1	3.6	4.9	1.4	4.1	0.4	3.7	6.1	7.0	3.4	2.5			1.1	5.6	4.2	2.3	3.1	3.2	3.6	5.4	5.7	3.1	0.1	3.5	1.6	5.0		10.1	2.5	6.1	4.0	2.9		4.3	1.6		2.3	4.0	1.9	2.7	1.2	4.4	5.5	2.8	2.1	5.1			4.0		1.8	2.8	2.5	3.1	1.5	3.9	0.5	2.4	3.7	0.9	0.0	1.7	7.9	2.4	2.7	2.6	4.1	5.1	4.9	4.1	6.8	0.0	1.1	0.0	2.6	6.1	8.0	0.2	3.8	1.7	6.3	0.0	6.6	5.2	0.2	0.0	7.6	0.2	6.0	7.1	2.2	6.2	0.1	8.2	0.8	2.8	1.0	0.1	5.3	0.0	2.6	0.9	3.6	0.0	1.7	4.0	10.2	0.0	5.5	3.3	0.0	7.2	0.0	0.3	1.2	7.5	3.0	5.2	1.9	3.8	4.2	0.4	6.2	0.1	0.2	0.4	0.1	0.1	0.4	0.0	0.5	3.9	0.5	0.3	2.6	1.9	2.6	1.8	1.1	3.1	2.1	1.6	0.5	2.4	0.4	1.5	3.7	0.9											8.9	2.2	0.0	2.2	5.0	7.8	3.9	0.0	2.7	2.3	5.2	3.9	0.8	6.6	2.4	2.4	3.7	0.2	0.0	0.7	0.6	2.4	2.3	3.5	0.4	0.7	9.5	2.4	2.5	0.0	1.4	3.7	1.3	5.0	1.8	0.3	5.6	1.0	1.5	4.6	2.3	5.4	0.0	4.1	3.8	5.3	3.3	0.6	1.0	0.9	1.3
ZFP3	"FLJ30726, ZNF752"	ENSG00000180787	"ZFP3 zinc finger protein"	Q96NJ6	17	5078248-5096374	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 13.4;Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 7.5;SH-SY5Y: 7.7;SiHa: 7.0"	"Low region specificity"	"Detected in all"							"HPA053085, HPA057290"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA053085: AB_2682039, HPA057290: AB_2683400"	"unprognostic (3.71e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.69e-7)"	"unprognostic (8.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.29e-3)"	4.9	6.3	11.0	10.0	10.4	1.9	8.9	19.6	14.7	6.8	8.9	11.9	9.6	13.0	6.9	6.9	6.7	11.2	6.3	12.4	9.8	7.6	10.2	3.3	7.3	9.2	7.9	8.3	9.9	11.3	16.6	10.8	5.2	11.4	7.9	10.9	7.4	10.7	15.4	33.3	6.7	11.3	6.3	8.5	10.2	8.3	9.9	11.8	10.6	11.1	3.5	11.2	6.6	5.7	5.4	1.4	1.4	2.2	1.9	4.3	1.6	0.0	1.3	0.3	0.0	1.2	0.6	0.0	2.8	0.0	2.2	2.5	5.6	2.6	0.0	4.0	2.8	1.0	5.7	0.0	0.0	1.2	0.0	0.1	0.2	2.1	0.0	3.9	0.0	7.5	2.0	0.0	1.5	0.0	0.0	0.7	0.2	0.0	0.1	0.4	0.0	0.1	0.2	0.3	4.0	0.6	0.0	0.8	1.8	3.5	3.4	3.6	7.7	7.0	5.8	3.6	1.3	3.5	5.5	0.0	0.0	1.2	2.0	4.0	0.1	0.2	0.0	0.0	0.0	3.2	0.0	2.0	1.4	2.8	2.2	1.7	2.1	1.6	2.5	1.4	5.4	4.3	3.0	0.2	1.9	1.9	0.9	1.6	1.6	11.0	10.4	19.6	14.7	9.8	7.6	7.9	8.3	11.4	11.8	0.0	3.4	0.0	0.4	0.2	3.9	6.3	0.0	13.4	2.3	1.8	7.9	1.0	0.0	1.3	0.4	1.6	2.1	0.0	1.0	0.3	0.9	0.4	1.1	0.0	1.4	3.2	0.0	5.5	1.2	0.0	1.4	1.2	0.0	0.0	1.7	3.2	0.4	0.0	1.1	1.1	6.0	0.0	0.5	6.6	4.3	0.1	0.7	0.0	2.5	0.4
ZFP30	"KIAA0961, ZNF745"	ENSG00000120784	"ZFP30 zinc finger protein"	Q9Y2G7	19	37613749-37692337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030606	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA030606: AB_10602684"	"unprognostic (1.86e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.64e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (5.96e-2)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.01e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-3)"	5.0	6.6	10.2	5.4	15.3	1.7	8.3	20.0	12.3	6.1	5.5	6.5	5.5	3.8	8.5	6.9	6.0	7.4	4.6	5.3	8.0	7.1	6.0	4.1	5.4	6.4	11.2	9.4	9.4	6.3	9.5	10.7	7.5	9.6	8.0	5.0	5.0	5.3	8.0	5.2	9.3	4.9	11.3	10.9	6.6	5.3	16.5	10.6	6.1	10.8	1.9	6.4	5.9	9.2	4.3	2.0	4.9	1.3	5.8	4.0	2.1	6.6	5.7	9.6	13.5	5.2	5.1	2.9	6.9	6.4	5.2	5.6	4.7	1.1	0.0	7.1	6.2	4.2	2.5	9.5	3.6	5.3	10.1	3.7	6.6	7.2	3.6	3.9	0.9	5.1	3.8	5.7	4.5	6.9	4.2	3.0	4.7	5.0	0.1	6.7	3.0	7.1	3.4	2.0	0.8	4.0	2.9	12.5	0.1	3.2	11.1	10.7	11.6	8.1	3.2	2.5	3.9	4.3	1.8	5.8	7.1	24.0	3.3	6.9	3.7	3.8	4.3	0.0	0.0	5.3	4.9	1.2	2.8	2.8	1.3	3.7	1.3	3.1	2.4	0.9	4.3	3.8	4.0	0.9	5.8	0.4	2.0	2.3	2.1	10.2	15.3	20.0	12.3	8.0	7.1	11.2	9.4	9.6	10.6	6.0	2.6	2.7	1.2	0.7	10.9	6.3	2.5	2.7	3.4	3.5	3.9	2.1	1.7	2.4	43.5	2.8	0.9	0.0	2.0	1.2	3.0	1.7	9.2	0.9	2.0	7.9	4.1	3.7	1.6	11.7	6.9	1.1	0.0	1.8	4.2	5.2	1.6	0.0	6.0	2.1	8.0	6.5	3.1	5.9	3.3	0.4	0.7	3.1	1.7	0.7
ZFP36	"G0S24, NUP475, RNF162A, TIS11, TTP"	ENSG00000128016	"ZFP36 ring finger protein"		19	39406813-39409412	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 1665.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 32.0;ASC TERT1: 41.6;hTCEpi: 50.6;Karpas-707: 43.7;U-266/70: 32.2;U-266/84: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006009	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA006009: AB_1859030"	"unprognostic (2.30e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.20e-1)"	"unprognostic (3.61e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.20e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.92e-3)"	109.7	49.3	7.7	112.8	40.3	90.1	63.0	7.5	26.2	60.2	52.9	25.4	12.4	22.8	47.3	23.9	121.7	98.2	78.0	32.5	28.8	7.9	23.2	43.8	124.6	24.9	10.9	2.3	53.9	21.5	29.3	31.4	20.8	47.7	55.8	26.4	45.3	34.3	46.6	82.9	61.6	58.0	56.4	50.0	35.1	42.7	27.8	8.4	15.5	35.5	106.5	58.3	114.5	57.7	12.0	15.4	72.5	19.3	3.8	9.5	7.9	6.9	4.3	1.1	0.9	32.0	41.6	2.1	5.5	6.8	3.3	2.4	3.7	7.5	4.5	1.6	9.6	3.1	3.6	0.6	10.3	1.0	5.0	0.4	1.9	3.3	2.3	18.4	1.7	12.2	17.2	50.6	2.4	18.4	4.0	1.8	5.0	2.5	43.7	5.6	6.4	3.0	4.3	0.4	20.2	0.7	4.7	0.6	8.5	3.7	12.6	0.4	1.1	2.5	6.3	1.3	1.8	4.4	9.8	2.7	4.2	1.5	7.5	1.5	32.2	43.3	4.8	3.8	3.7	1.6	23.9	14.9	15.0	9.5	15.6	7.7	11.2	8.0	9.5	15.4	12.0	9.2	8.7	72.5	3.8	19.3	11.8	9.2	7.9	7.7	40.3	7.5	26.2	28.8	7.9	10.9	2.3	47.7	8.4	390.1	865.0	231.9	792.8	1030.8	0.2	426.2	160.5	275.7	310.5	76.8	3.9	54.1	26.6	160.4	5.3	744.2	811.8	23.3	94.1	80.0	725.1	1061.8	658.8	174.2	657.2	1.6	607.3	243.7	446.3	5.2	516.4	1156.0	598.9	97.4	396.2	22.4	113.8	624.3	131.2	38.7	6.1	756.7	1665.5	1.2	3.3	1386.1	129.0	596.6	239.7	602.1
ZFP37	ZNF906	ENSG00000136866	"ZFP37 zinc finger protein"	Q9Y6Q3	9	113038380-113056759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049112	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			"Nucleoplasm, Vesicles"		"HPA049112: AB_2680637"	"unprognostic (3.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.54e-3)"	"prognostic favorable (1.96e-4)"	"unprognostic (7.84e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.07e-1)"	3.8	4.4	4.9	3.1	19.2	0.9	6.7	10.9	9.9	6.5	3.6	5.3	4.0	2.1	10.5	5.8	3.2	6.3	3.5	3.7	10.5	5.6	5.8	1.7	3.2	2.8	6.7	10.6	17.0	3.2	4.3	8.5	3.2	10.7	6.3	2.9	2.8	3.2	4.8	3.2	3.2	2.5	6.2	9.1	4.7	3.0	5.1	5.9	0.4	6.9	2.4	3.2	4.3	5.6	2.3	0.9	0.2	0.4	1.3	5.6	0.7	0.6	1.8	7.7	6.4	4.3	8.3	3.9	2.4	3.6	2.7	2.3	0.0	1.8	4.3	1.9	2.5	3.5	1.6	0.0	0.9	4.2	5.3	0.9	0.2	3.8	2.0	2.3	0.0	0.9	2.3	0.8	3.2	6.3	6.6	1.5	0.0	0.4	3.8	5.6	0.0	0.0	0.0	7.9	4.6	0.0	0.0	10.7	0.6	2.0	0.0	6.6	6.2	7.5	1.6	1.4	4.0	6.3	0.0	0.6	6.3	2.8	7.3	3.6	1.5	2.9	0.0	4.8	0.1	3.8	0.2	0.1	0.1	2.5	0.4	1.9	2.3	2.2	2.2	0.9	1.1	1.8	2.5	0.2	1.3	0.0	0.1	5.6	0.7	4.9	19.2	10.9	9.9	10.5	5.6	6.7	10.6	10.7	5.9	0.0	0.3	0.0	0.8	0.2	10.6	2.0	0.0	0.0	0.0	0.0	5.9	0.7	3.3	1.2	0.6	2.2	0.0	0.0	0.8	1.3	2.1	0.4	5.7	1.1	0.4	6.4	1.2	1.3	0.0	0.0	2.0	0.4	0.0	0.0	0.1	3.1	0.2	0.2	2.1	2.2	5.2	6.5	1.5	5.6	4.1	0.0	0.1	0.5	0.1	0.4
ZFP41	"FLJ00028, FLJ38705, ZNF753"	ENSG00000181638	"ZFP41 zinc finger protein"		8	143246821-143262705	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (4.92e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.20e-1)"	7.8	6.6	10.3	6.5	9.0	4.1	5.6	12.6	13.7	8.0	8.8	10.7	6.5	9.4	12.5	6.8	5.7	9.2	5.6	6.3	10.8	14.3	6.5	5.8	6.3	6.7	10.7	7.4	13.1	9.1	11.4	10.2	3.5	9.6	7.7	4.5	8.9	12.6	9.1	8.1	12.1	9.1	7.3	7.4	8.5	7.2	10.6	8.6	4.6	8.0	4.6	6.7	6.7	10.0	0.9	3.7	0.1	0.9	0.7	2.2	0.8	7.1	11.4	5.0	6.6	5.8	4.5	5.9	4.3	2.4	8.5	5.8	5.6	6.0	4.0	6.5	5.6	8.7	5.9	5.4	5.7	4.2	6.3	6.6	5.0	5.5	4.4	8.1	2.0	3.1	4.7	8.1	5.5	8.1	5.9	4.0	2.9	10.6	3.9	4.0	12.8	5.3	2.2	7.4	8.8	11.3	2.8	4.1	1.4	3.7	6.5	6.3	8.7	12.2	3.4	6.4	4.5	8.5	3.9	4.2	6.5	11.6	5.0	6.9	6.3	4.8	1.9	5.7	4.8	8.4	0.0	0.6	0.1	1.3	0.9	2.2	0.4	1.1	0.9	0.5	0.9	1.9	1.2	0.0	0.7	0.1	3.7	0.9	0.8	10.3	9.0	12.6	13.7	10.8	14.3	10.7	7.4	9.6	8.6	0.0	1.3	1.3	0.6	1.0	1.4	2.8	2.5	4.0	1.2	3.5	5.9	0.2	1.7	1.6	1.3	0.7	2.7	0.0	0.8	0.9	1.1	0.4	0.0	3.9	1.0	6.4	2.9	1.8	2.2	1.4	1.1	0.9	1.7	0.0	3.2	2.7	1.2	4.3	2.1	1.1	2.2	0.0	1.1	7.7	3.4	0.3	0.2	0.0	2.9	0.3
ZFP62	"FLJ34231, ZET, ZNF755"	ENSG00000196670	"ZFP62 zinc finger protein"	Q8NB50	5	180847611-180861285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048629	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA048629: AB_2680467"	"unprognostic (2.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.49e-2)"	"unprognostic (7.11e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.29e-3)"	10.9	8.6	17.2	16.0	20.2	4.0	14.4	19.9	16.5	14.3	14.5	11.9	15.1	13.7	15.6	16.4	15.1	16.8	13.2	9.7	17.6	9.5	11.9	8.3	10.4	17.7	18.3	12.8	22.5	15.2	18.9	16.3	10.1	16.4	15.1	18.4	10.1	15.6	18.5	14.5	16.0	15.5	18.8	15.7	13.4	16.3	8.8	22.1	26.9	25.4	10.5	20.0	16.0	14.8	7.0	3.8	7.7	4.9	4.8	10.3	4.2	7.9	5.9	12.8	16.5	9.4	8.4	15.8	8.1	6.2	6.8	9.4	14.4	19.9	19.6	13.1	3.7	7.8	11.9	6.1	14.5	10.2	33.4	11.3	11.0	15.9	4.8	6.4	10.0	6.6	6.5	11.6	6.9	11.9	10.4	6.0	11.7	9.1	10.8	9.2	18.7	14.4	5.5	9.0	7.2	14.4	12.8	13.1	10.9	5.6	14.4	16.9	11.8	11.9	9.0	8.8	9.4	13.8	9.0	8.6	10.4	9.1	5.0	8.2	11.4	13.0	9.8	8.6	13.5	8.1	7.7	3.2	3.9	4.0	4.3	7.8	6.9	5.5	5.8	3.4	7.0	10.3	8.6	1.5	4.8	4.9	3.8	5.6	4.2	17.2	20.2	19.9	16.5	17.6	9.5	18.3	12.8	16.4	22.1	8.9	11.2	13.8	7.6	6.4	8.3	8.1	5.1	4.0	5.7	0.0	2.0	5.5	13.3	8.5	17.8	8.4	10.9	23.3	14.2	5.8	3.7	6.8	8.1	4.3	5.6	1.6	9.9	9.8	7.9	25.0	15.8	3.3	5.0	6.4	15.8	10.0	12.1	3.5	11.0	7.7	13.3	12.9	6.1	24.7	13.6	4.1	4.7	8.5	15.7	7.4
ZFP64	"dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338"	ENSG00000020256	"ZFP64 zinc finger protein"	"Q9NPA5, Q9NTW7"	20	52051663-52204308	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035112, HPA058387"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035112: AB_10672859, HPA058387: AB_2683702"	"unprognostic (3.86e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (4.68e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	9.4	12.1	11.5	10.6	14.5	9.7	10.1	11.6	18.7	12.7	13.2	14.5	12.6	13.3	14.4	9.7	16.3	13.9	15.0	9.4	10.5	10.3	10.9	11.8	9.1	12.1	10.2	11.9	16.7	10.9	14.8	11.5	8.8	11.6	16.5	11.5	15.1	13.7	12.3	9.4	22.3	13.0	11.0	11.1	11.6	11.9	12.8	9.2	22.9	14.3	12.5	16.7	13.6	13.6	8.6	6.7	12.4	6.6	7.8	7.8	4.3	19.7	11.1	8.6	20.6	4.4	8.0	12.4	6.7	10.1	15.0	12.7	10.5	8.2	8.7	13.6	12.2	12.6	26.8	7.0	15.2	9.4	3.6	21.7	5.2	19.9	11.3	12.1	5.9	3.9	7.0	23.3	7.6	8.8	7.8	10.3	9.5	6.2	11.5	3.8	8.3	8.0	5.0	8.6	10.9	8.5	8.9	4.5	8.7	7.1	8.0	8.9	10.4	13.2	16.7	12.8	7.5	11.2	7.1	6.7	10.6	15.8	11.6	4.3	12.3	11.1	7.1	10.3	5.9	7.1	7.4	5.4	12.4	7.8	3.1	5.7	8.6	5.9	6.1	6.7	6.0	6.8	6.4	3.2	7.8	6.6	6.5	5.3	4.3	11.5	14.5	11.6	18.7	10.5	10.3	10.2	11.9	11.6	9.2	3.0	3.5	2.2	4.3	7.7	5.0	3.9	0.0	4.0	1.2	0.0	2.0	3.7	6.6	6.9	4.9	3.5	4.4	0.0	5.0	7.1	4.3	3.1	6.9	5.0	3.5	1.6	6.4	11.1	3.8	8.0	6.1	2.2	3.3	1.8	10.2	2.3	4.7	3.5	6.7	3.8	4.8	6.5	5.1	9.1	2.1	11.7	1.0	4.4	8.4	2.5
ZFP69	"FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A"	ENSG00000187815	"ZFP69 zinc finger protein"	Q49AA0	1	40477215-40496343	"Predicted intracellular proteins, Transcription factors"	"Lipid metabolism, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 6.0;Early spermatids: 5.9;Spermatogonia: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"THP-1: 36.3"	"Low region specificity"	"Detected in many"							"HPA027808, HPA054942"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027808: AB_10601031, HPA054942: AB_2682644"	"unprognostic (1.07e-2)"	"unprognostic (6.00e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (7.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.81e-1)"	5.1	3.4	8.3	5.8	8.5	4.1	5.1	6.8	5.8	4.7	5.3	7.5	5.1	4.4	5.6	5.6	4.4	5.2	8.9	7.3	6.7	5.6	3.7	4.7	5.6	6.3	9.0	2.4	6.8	6.7	8.1	3.1	5.3	8.6	5.6	4.9	3.9	4.9	6.0	1.2	6.7	4.9	9.7	8.7	6.9	4.8	8.4	8.4	9.4	5.2	2.9	6.8	6.1	14.3	1.1	0.6	0.1	0.5	4.8	2.0	0.6	3.3	0.0	2.0	2.6	2.5	2.6	3.4	1.8	2.1	2.8	3.3	1.8	2.6	6.0	2.4	2.9	3.7	2.7	3.8	1.6	3.3	5.4	2.6	4.4	3.0	2.9	2.0	0.1	4.8	2.6	4.0	1.9	2.9	0.9	1.6	0.1	2.5	0.0	1.6	1.7	4.5	5.6	3.8	0.3	0.0	2.5	7.1	2.8	1.5	2.5	2.6	4.2	3.1	2.9	5.1	3.2	0.0	36.3	0.7	1.3	2.6	3.6	0.2	0.1	4.6	3.8	2.4	0.9	3.5	0.0	0.5	0.1	1.6	0.2	2.0	1.1	1.2	1.9	0.6	0.6	0.6	2.0	0.1	4.8	0.4	0.0	0.6	0.6	8.3	8.5	6.8	5.8	6.7	5.6	9.0	2.4	8.6	8.4	6.0	0.0	0.9	0.3	0.9	1.3	1.2	0.0	1.4	0.0	0.0	0.0	1.0	1.7	1.3	5.9	1.8	0.3	0.0	1.2	1.2	0.7	0.2	0.0	0.9	1.1	0.0	0.0	0.6	1.5	2.5	1.1	1.4	1.7	1.8	1.4	1.6	0.8	0.0	1.8	0.5	0.8	0.0	0.5	2.7	4.6	0.4	0.2	0.7	1.4	0.1
ZFP69B	"FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B"	ENSG00000187801	"ZFP69 zinc finger protein B"	Q9UJL9	1	40450102-40463718	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 2.9;Spermatogonia: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044289	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044289: AB_10962717"	"unprognostic (2.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.05e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-5)"	"unprognostic (1.64e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.89e-1)"	1.6	1.7	7.8	4.6	11.1	1.1	2.8	8.2	12.8	3.1	2.5	1.8	0.1	2.6	4.3	2.4	2.2	1.6	3.3	1.8	6.3	4.9	1.6	2.4	1.6	3.7	3.6	5.8	2.0	3.5	3.2	3.6	1.1	4.7	2.0	3.1	1.2	1.9	1.8	1.2	1.4	1.8	3.0	3.2	2.3	2.5	4.0	3.8	5.0	2.7	0.9	5.5	3.8	1.7	2.1	1.2	0.9	2.1	1.3	4.1	1.0	3.3	1.3	5.7	14.0	2.1	5.7	1.6	3.2	3.1	1.5	2.8	1.6	2.2	6.3	3.2	2.8	2.9	1.2	2.9	2.8	3.3	5.5	1.2	2.6	3.2	4.8	1.5	0.4	4.2	1.3	4.7	5.2	6.9	1.5	2.0	8.5	6.8	6.4	4.4	2.3	8.5	0.6	7.7	1.2	1.4	4.8	5.6	3.0	2.9	3.3	7.7	8.0	5.1	4.4	2.2	3.4	2.3	7.4	4.3	4.8	10.1	4.4	4.6	9.8	9.3	13.8	6.3	0.9	4.9	0.0	0.3	0.9	2.6	2.1	3.5	2.0	1.8	1.4	1.2	2.1	3.4	3.0	0.2	1.3	0.7	0.5	4.1	1.0	7.8	11.1	8.2	12.8	6.3	4.9	3.6	5.8	4.7	3.8	0.0	0.0	0.0	0.6	0.2	2.9	0.4	0.0	0.0	0.0	1.8	0.0	0.4	0.0	1.0	0.0	0.3	0.0	0.0	0.2	1.3	0.4	0.2	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.8	0.9	0.0	0.4	0.0	1.7	0.0	0.3	1.5	5.9	0.1	0.0	0.8	0.1	0.3
ZFP82	"KIAA1948, MGC45380, ZNF545"	ENSG00000181007	"ZFP82 zinc finger protein"	Q8N141	19	36383120-36418656	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 21.6;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051669, HPA060470"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA051669: AB_2732568, HPA060470: AB_2684290"	"unprognostic (1.52e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.14e-4)"	"unprognostic (9.63e-2)"	"unprognostic (9.17e-4)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.91e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.05e-1)"	4.3	5.0	9.8	8.8	9.3	1.5	8.7	15.0	13.9	9.9	5.2	5.3	2.4	2.4	9.1	12.4	2.7	9.0	5.4	7.3	8.5	9.7	5.5	1.8	4.9	7.8	8.3	6.3	13.8	2.7	8.0	10.1	7.0	8.3	7.4	3.3	3.6	4.1	6.8	2.1	2.2	3.6	7.8	6.8	6.3	3.1	6.4	8.7	9.3	10.8	1.6	8.6	5.8	6.9	9.6	3.1	1.1	1.1	4.7	9.2	2.9	0.0	2.6	8.4	8.8	2.9	3.7	2.8	3.4	4.3	7.0	9.0	1.6	1.2	7.4	5.8	4.1	5.8	0.2	0.0	0.9	8.8	6.9	4.2	6.6	1.9	2.1	6.7	0.0	5.8	5.7	1.3	5.0	1.5	0.0	3.2	9.2	0.0	0.0	6.8	0.0	11.4	0.0	7.8	0.0	1.5	9.6	5.7	2.2	3.4	4.2	0.1	8.7	0.0	0.5	5.4	8.4	1.6	5.1	0.4	2.5	4.4	4.4	5.7	5.0	3.4	11.3	0.0	0.0	5.4	0.0	0.9	1.1	6.0	1.1	6.0	9.6	5.9	6.8	2.7	9.0	9.2	8.1	0.1	4.7	1.1	3.1	3.6	2.9	9.8	9.3	15.0	13.9	8.5	9.7	8.3	6.3	8.3	8.7	0.0	8.3	1.9	2.5	0.9	19.2	3.5	2.5	8.1	3.4	5.2	21.6	6.8	8.3	4.5	4.8	4.2	0.0	0.0	1.2	5.4	4.5	1.7	5.8	0.5	3.7	31.8	2.9	2.5	1.9	1.3	5.5	3.5	5.0	1.0	0.3	9.4	1.4	0.0	7.1	4.5	10.4	19.4	4.2	10.8	6.3	0.5	1.1	4.9	1.0	0.9
ZFP90	"KIAA1954, NK10, ZNF756"	ENSG00000184939	"ZFP90 zinc finger protein"	Q8TF47	16	68530090-68576072	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029017	Uncertain		Supported	"Vesicles,Plasma membrane,Centrosome"		NA	NA			"Vesicles, Plasma membrane, Centrosome"		"HPA029017: AB_10669653"	"unprognostic (3.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.60e-2)"	9.6	9.0	16.9	11.5	19.3	7.8	16.2	24.0	19.5	14.2	8.9	18.9	10.4	4.4	15.8	18.2	7.6	14.3	9.5	10.3	15.5	19.8	11.6	7.9	9.6	12.4	16.7	20.5	18.1	8.7	29.1	16.5	8.3	20.0	13.1	9.3	11.4	8.7	13.6	10.0	13.2	8.3	13.6	16.1	13.2	11.2	11.6	19.6	15.8	11.0	3.6	15.5	11.3	9.6	5.8	2.6	7.8	1.9	5.2	8.8	3.0	7.0	7.7	14.5	13.8	13.0	13.9	6.5	6.7	7.7	9.2	10.7	5.4	4.8	7.6	8.7	8.5	7.8	6.7	8.9	8.6	10.6	6.7	3.7	1.9	1.5	9.1	10.1	0.0	7.2	12.0	14.1	8.5	11.9	16.6	7.4	14.7	3.8	2.9	11.3	12.7	7.6	7.3	5.5	4.2	5.8	13.9	5.1	5.0	6.3	5.1	16.6	12.6	19.2	1.4	7.2	11.3	11.6	10.1	5.2	8.7	5.2	7.3	3.9	5.5	10.3	9.3	2.9	2.7	6.9	7.8	1.7	2.8	6.4	1.9	8.8	5.8	6.0	7.4	2.4	4.1	8.7	7.5	0.5	5.2	1.3	2.6	6.8	3.0	16.9	19.3	24.0	19.5	15.5	19.8	16.7	20.5	20.0	19.6	17.9	6.2	6.4	6.3	3.1	20.5	8.5	12.7	29.4	10.3	19.2	13.7	3.0	6.6	8.7	13.2	7.1	0.9	0.0	5.4	1.7	8.2	5.2	11.5	4.3	5.7	17.5	15.4	9.8	8.2	11.3	15.3	6.1	3.3	0.0	5.2	11.8	5.8	2.9	16.6	5.7	16.9	0.0	7.5	6.3	18.3	4.0	1.1	11.4	4.5	2.7
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein"	Q96JP5	11	58579111-58621042	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 181.7;Late spermatids: 146.8;Spermatocytes: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024037, CAB025417, HPA065325"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	17.1	14.7	20.1	13.6	25.6	32.0	14.9	24.4	21.7	15.3	18.1	23.2	15.8	16.2	16.3	11.8	16.3	13.6	13.8	26.5	20.3	15.4	16.3	19.4	15.0	14.4	20.8	18.1	14.9	14.3	26.7	17.0	14.2	19.7	13.1	21.9	11.2	14.5	15.5	33.8	17.5	19.6	16.9	21.6	15.0	13.9	71.0	19.4	15.7	16.8	14.6	15.9	17.8	21.4	4.6	7.0	5.4	5.0	3.7	5.4	2.8	24.8	14.3	16.8	17.0	16.1	19.5	9.2	20.6	38.7	23.8	20.4	7.8	26.3	29.8	20.4	25.9	23.8	22.2	17.0	21.8	31.4	15.8	9.6	19.6	14.5	8.4	18.3	24.7	32.4	17.0	21.5	33.5	39.3	19.8	23.6	20.2	19.4	28.3	30.6	8.3	21.3	13.7	8.8	14.4	13.9	16.6	28.4	19.7	17.5	24.0	18.0	14.4	26.2	24.1	33.5	9.5	26.9	18.6	26.4	30.2	20.8	45.3	22.8	16.4	12.1	24.7	26.6	13.9	30.7	3.9	5.0	3.5	5.4	4.5	3.0	4.5	3.3	3.3	4.9	4.6	3.6	4.6	5.4	3.7	4.2	7.0	2.6	2.8	20.1	25.6	24.4	21.7	20.3	15.4	20.8	18.1	19.7	19.4	23.8	34.8	33.2	21.5	53.3	28.8	39.5	48.4	25.4	21.6	17.4	15.7	10.3	11.6	19.8	181.7	27.0	27.7	46.7	27.1	10.5	32.9	25.9	48.6	41.4	14.5	33.4	24.2	25.8	36.8	146.8	28.4	27.0	21.9	20.8	30.4	19.8	24.5	11.5	25.5	19.1	19.0	19.4	20.6	142.7	40.2	58.2	11.6	21.8	37.2	34.3
ZFPM1	"FOG, FOG1, ZC2HC11A, ZNF89A"	ENSG00000179588	"Zinc finger protein, FOG family member 1"	Q8IX07	16	88453317-88537016	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 30.4"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 19.6;Cone photoreceptor cells: 27.5;Horizontal cells: 33.4;Muller glia cells: 36.6"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 12.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 14.5;K-562: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046603	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA046603: AB_2679718"	"unprognostic (1.29e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (4.24e-4)"	4.3	3.7	3.7	7.9	2.9	12.0	2.2	6.8	3.3	2.9	11.2	1.6	4.7	18.5	3.8	4.5	2.8	3.7	30.4	4.7	3.9	3.0	2.7	15.2	5.4	5.5	2.7	1.9	7.3	24.5	1.5	5.6	1.8	2.1	7.0	1.7	7.7	6.9	7.3	2.2	3.8	15.4	1.5	2.1	12.7	21.5	12.7	0.8	15.7	3.8	1.4	9.4	4.8	2.2	0.3	0.6	1.5	0.3	0.6	1.3	0.3	1.1	2.9	2.2	4.5	0.4	0.1	9.3	3.1	0.4	1.0	0.3	9.2	1.1	4.5	2.4	0.4	1.1	7.2	0.1	2.5	0.2	3.4	1.9	14.5	5.7	8.0	1.7	0.8	4.9	1.0	1.7	1.1	0.4	1.1	1.0	1.2	21.5	0.3	0.8	5.5	5.1	5.2	1.5	7.0	2.5	1.5	1.0	2.1	1.0	3.6	6.0	10.1	3.8	0.2	3.0	1.2	2.4	2.4	3.6	3.9	2.5	1.7	0.6	1.1	0.7	0.4	1.1	1.7	3.7	0.0	0.1	1.5	0.9	0.2	0.2	0.1	0.4	1.3	0.2	0.3	0.3	0.5	0.9	0.6	0.3	0.6	0.1	0.3	3.7	2.9	6.8	3.3	3.9	3.0	2.7	1.9	2.1	0.8	3.0	2.1	0.5	4.4	0.8	19.6	11.8	7.6	0.0	0.0	1.8	27.5	0.3	1.7	1.2	0.5	1.9	5.1	0.0	4.3	0.1	2.1	2.3	0.0	5.9	0.8	33.4	5.8	4.9	4.8	0.7	0.9	0.9	1.7	0.0	6.7	36.6	2.9	4.5	1.4	1.1	17.4	0.0	1.9	0.3	0.4	1.3	0.2	0.0	4.1	1.8
ZFR	"SPG71, ZFR1"	ENSG00000056097	"Zinc finger RNA binding protein"	Q96KR1	5	32354350-32444761	"Predicted intracellular proteins"		"Developmental protein, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016666	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016666: AB_1859060"	"unprognostic (7.45e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	22.5	24.2	36.0	16.9	42.8	21.7	22.1	37.3	40.7	23.6	19.4	29.9	11.7	15.0	23.9	18.7	21.8	23.9	19.6	27.6	36.2	27.6	25.1	20.2	15.8	19.8	32.1	28.3	33.5	21.2	33.0	26.5	28.7	29.4	22.6	19.0	16.1	21.1	21.9	37.4	15.1	20.3	22.9	36.3	17.4	16.9	23.6	38.6	20.0	28.6	11.3	20.7	24.1	23.5	14.6	14.2	23.4	20.0	18.7	15.9	10.5	16.1	24.1	28.3	17.6	31.3	23.0	24.8	25.0	21.2	26.6	19.1	24.0	14.4	23.8	16.4	24.4	34.8	12.7	36.7	17.7	37.5	22.4	20.6	29.1	26.0	23.5	27.5	29.8	24.0	21.8	22.3	28.1	51.7	24.2	20.0	11.8	29.1	20.1	27.1	12.2	26.0	12.6	20.8	17.1	18.1	21.3	38.1	13.0	19.9	26.7	15.8	16.7	37.2	21.7	22.3	20.9	13.5	36.9	22.5	26.5	24.8	19.4	20.8	10.0	17.6	26.9	19.5	24.1	32.0	23.4	12.7	15.7	13.8	20.0	15.9	14.6	13.3	14.0	14.2	11.6	12.9	12.9	8.2	18.7	19.2	7.7	12.2	10.5	36.0	42.8	37.3	35.7	36.2	27.6	32.1	28.3	29.4	38.6	47.6	46.0	30.2	44.4	23.1	60.3	96.3	38.2	68.3	79.6	29.6	21.6	33.4	41.4	44.6	35.2	42.5	25.7	0.0	31.4	27.3	40.7	54.7	73.0	33.5	28.7	73.1	37.9	35.6	32.1	25.8	49.2	33.2	28.7	49.5	24.0	69.5	39.3	40.1	57.3	32.7	51.9	38.8	44.8	101.1	71.8	21.5	46.5	37.3	30.0	46.1
ZFR2	KIAA1086	ENSG00000105278	"Zinc finger RNA binding protein 2"	Q9UPR6	19	3804024-3869032	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;pituitary gland: 19.8;testis: 20.3"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 29.9;Cone photoreceptor cells: 25.5;Early spermatids: 21.1;Horizontal cells: 30.2;Rod photoreceptor cells: 35.3;Spermatocytes: 26.9"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"HMC-1: 17.8;NTERA-2: 30.6;SiHa: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043275, HPA055678"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043275: , HPA055678: AB_2682883"	"unprognostic (1.74e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.60e-3)"	"unprognostic (5.47e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.18e-2)"	1.0	6.8	13.0	1.2	17.0	1.3	1.3	2.2	16.9	1.5	0.9	1.9	0.0	0.9	0.9	0.8	0.8	2.4	1.2	1.1	7.6	12.2	0.9	0.9	1.4	1.1	4.9	10.9	1.0	1.7	0.8	19.8	0.8	7.4	1.3	1.0	5.7	1.2	1.1	0.9	1.2	1.4	0.8	3.9	1.3	1.3	20.3	2.3	0.0	1.2	0.0	1.4	0.8	0.2	0.9	0.2	1.5	0.2	1.7	4.5	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	30.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.6	9.0	0.0	0.5	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.2	3.4	0.0	4.5	0.2	2.6	1.9	0.0	0.9	3.9	3.4	0.5	1.7	0.0	0.2	0.8	1.4	13.0	17.0	2.2	15.0	7.6	12.2	4.9	10.9	7.4	2.3	0.0	0.6	0.0	0.5	0.9	29.9	1.1	0.0	2.7	0.0	0.0	25.5	0.0	0.0	0.3	21.1	0.5	0.0	0.0	0.2	0.1	0.2	0.4	1.1	0.0	0.1	30.2	0.0	0.0	0.0	7.5	0.9	0.0	1.7	0.0	0.0	4.0	0.3	0.0	0.0	0.2	35.3	0.0	0.3	26.9	14.1	0.1	0.0	2.2	0.0	0.4
ZFX	ZNF926	ENSG00000005889	"Zinc finger protein, X-linked"	P17010	X	24149173-24216255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001748, HPA003877, HPA071863"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.22e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.95e-2)"	20.3	8.8	10.8	8.2	11.7	25.9	23.5	22.1	12.6	18.5	12.2	7.2	8.4	6.6	18.5	11.0	10.6	15.8	7.2	17.8	10.1	6.6	16.6	11.3	9.7	12.7	13.1	9.6	20.2	11.8	20.2	17.9	23.2	10.4	16.4	6.5	7.0	9.4	13.1	24.1	8.9	11.8	15.7	11.3	12.4	10.1	5.4	14.7	16.4	13.9	8.9	10.6	12.5	25.3	11.9	9.6	16.6	10.3	9.9	10.7	7.0	8.0	10.9	11.3	13.1	15.3	10.7	5.9	7.6	7.2	8.8	9.2	6.7	6.0	9.3	10.3	11.7	19.3	10.3	12.9	14.1	11.8	9.0	16.0	8.2	33.8	3.9	6.4	10.8	14.5	9.3	4.5	17.1	22.3	9.5	11.0	5.6	9.7	10.1	6.3	4.4	7.7	8.0	6.5	3.5	8.4	10.6	9.0	8.1	5.2	13.0	6.0	9.0	23.0	9.2	7.4	7.8	5.8	5.7	10.8	7.8	4.6	10.8	5.3	5.7	7.5	9.3	6.1	4.6	9.0	11.2	8.7	13.5	10.6	10.3	10.7	8.4	9.9	10.6	9.6	11.9	9.9	9.4	16.6	9.9	9.4	6.9	5.7	7.0	10.8	11.7	22.1	12.6	10.1	6.6	13.1	9.6	10.4	14.7	17.9	11.8	18.4	16.0	19.6	19.3	13.7	22.9	16.0	22.7	7.0	19.6	46.1	5.0	13.6	1.5	25.5	11.9	23.3	13.8	10.2	28.3	17.9	27.6	20.7	15.1	14.3	19.7	27.6	25.3	3.1	33.1	20.1	28.7	19.8	15.1	15.6	11.6	14.2	33.6	9.4	19.1	32.3	26.9	9.3	25.2	18.2	17.3	22.5	15.1	15.4
ZFY	ZNF911	ENSG00000067646	"Zinc finger protein, Y-linked"	P08048	Y	2935281-2982506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA001748, HPA071863"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA071863: AB_2686463"			"unprognostic (1.07e-1)"		"unprognostic (7.43e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"		"unprognostic (2.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.91e-1)"		"unprognostic (2.54e-2)"	4.1	2.9	2.8	6.8	4.3	9.6	3.4	6.8	5.3	0.0	5.4	2.8	14.1	3.2	0.0	9.1	7.2	0.0	7.0	6.1	3.0	3.0	2.7	13.1	10.1	10.9	2.6	0.0	0.0	10.0	0.1	3.3	5.8	4.5	10.6	8.0	3.5	15.8	10.2	7.0	2.9	6.3	5.8	3.3	9.1	4.7	10.5	0.0	12.6	7.2	5.7	5.8	6.1	0.0	5.8	5.9	4.7	4.7	6.2	7.0	2.7	0.0	3.6	0.0	0.0	0.0	0.0	6.5	9.1	8.8	7.8	7.6	0.0	0.0	7.0	0.0	9.5	0.0	0.0	0.0	0.0	10.5	10.5	0.0	12.9	0.1	4.6	6.9	0.0	0.0	7.6	6.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	8.8	0.0	5.3	0.0	2.9	0.0	0.0	0.0	5.7	2.7	5.3	11.9	6.2	0.0	0.0	0.0	9.1	4.3	0.0	4.2	7.9	7.6	0.0	0.0	4.6	4.9	0.0	11.8	1.0	0.0	0.0	0.0	4.7	4.7	5.0	3.9	7.0	4.3	5.5	2.8	5.9	5.8	6.3	3.0	3.2	6.2	3.3	4.3	3.1	2.7	2.8	4.3	6.8	5.3	3.0	3.0	2.6	0.0	4.5	0.0	8.9	8.0	16.9	9.6	9.8	11.8	5.9	5.1	8.1	13.6	1.8	7.9	4.4	0.0	2.7	28.3	7.3	0.0	0.0	0.0	1.2	7.8	7.9	6.9	0.5	2.6	12.7	1.7	8.0	5.0	59.3	9.2	8.5	3.3	3.6	0.0	11.2	2.1	0.0	10.3	2.9	7.8	12.9	7.6	19.0	3.8	8.3	3.1	11.4	0.0	10.5
ZFYVE27	"FLJ32919, SPG33"	ENSG00000155256	"Zinc finger FYVE-type containing 27"	Q5T4F4	10	97737121-97760907	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037523, HPA069876"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA037523: AB_10672351, HPA069876: AB_2686218"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (7.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (7.80e-4)"	10.1	22.6	16.1	12.7	20.8	20.7	11.8	28.6	33.0	10.3	17.4	15.7	17.4	25.6	11.6	25.4	9.8	17.9	14.1	12.8	17.6	20.7	15.5	18.2	11.3	15.2	15.1	23.4	17.1	15.4	19.6	24.3	14.3	17.6	13.3	17.5	25.6	14.0	11.8	7.9	17.1	24.0	9.4	14.7	18.1	14.9	14.2	13.3	12.2	13.1	5.5	14.7	8.5	10.4	11.2	8.5	13.4	12.6	9.0	15.2	11.7	10.4	12.9	7.8	17.2	8.9	6.2	10.6	10.7	11.3	12.5	12.3	11.4	21.8	16.2	12.3	7.7	16.1	23.5	11.3	10.4	6.7	16.7	11.3	7.6	12.7	10.6	11.4	12.2	15.4	10.1	12.6	12.3	9.5	20.2	7.0	13.7	11.4	11.0	9.3	8.1	9.8	23.3	6.3	9.1	10.0	11.4	7.8	7.6	12.0	6.5	6.3	12.2	7.2	6.1	27.8	7.4	13.3	12.2	7.4	6.3	7.5	9.6	20.3	12.8	10.7	8.5	15.8	15.8	7.2	7.1	8.4	13.4	15.2	9.1	13.1	10.9	10.5	12.0	8.0	11.2	12.1	12.9	12.1	9.0	12.6	8.5	13.4	11.7	16.1	20.8	28.6	33.0	17.6	20.7	15.1	23.4	17.6	13.3	3.0	10.7	11.5	10.1	7.2	28.2	7.7	15.3	6.7	3.4	14.0	55.0	6.5	6.6	13.2	4.6	9.5	29.9	0.0	13.9	5.2	6.2	10.4	13.9	9.6	7.3	35.0	19.4	6.2	8.6	1.3	8.9	8.4	10.1	11.8	12.3	15.2	11.2	22.8	8.5	7.0	41.6	19.4	7.8	6.6	7.7	4.8	11.3	15.0	12.0	14.8
ZFYVE28	KIAA1643	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418663	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 63.6"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 28.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 11.2;NB-4: 12.1;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: AB_2683477"	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	4.5	8.6	7.7	5.1	15.8	3.1	3.7	63.6	15.1	3.7	7.4	4.6	1.8	10.4	4.1	3.1	3.4	4.3	5.9	2.4	7.1	5.5	5.7	4.2	4.4	6.1	7.9	8.0	3.4	7.3	7.9	7.5	1.8	9.9	2.9	5.1	5.8	9.5	5.4	4.3	5.7	11.9	2.8	9.4	7.0	7.5	7.9	6.7	1.2	5.3	3.1	4.0	4.5	3.2	3.1	0.7	0.9	0.4	0.3	4.4	1.3	0.8	1.0	0.2	3.7	2.2	0.7	0.1	1.8	3.1	1.0	0.3	0.1	6.7	0.0	1.9	3.2	2.6	3.8	1.2	0.3	0.6	9.7	1.3	0.2	4.3	0.3	4.4	0.7	11.2	3.0	0.6	1.1	0.1	7.0	3.1	1.0	1.8	8.2	0.9	2.2	0.1	12.1	0.1	2.0	8.2	0.0	0.0	3.9	1.5	0.5	5.8	0.4	1.8	0.1	1.0	0.1	2.5	0.3	0.5	1.8	0.0	5.5	0.1	12.8	9.3	0.2	5.4	2.3	1.8	0.9	0.4	0.1	4.4	0.0	1.9	0.9	2.3	3.2	0.7	3.1	3.2	3.2	0.1	0.3	0.3	0.2	4.0	1.3	7.7	15.8	63.6	15.1	7.1	5.5	7.9	8.0	9.9	6.7	0.0	1.7	0.0	3.2	5.3	10.7	3.3	5.1	1.4	3.4	10.4	17.7	0.3	6.6	2.7	28.4	4.5	16.9	0.0	2.0	0.2	1.9	1.5	9.2	4.9	1.8	7.9	2.4	5.5	1.9	5.8	1.4	7.1	6.8	4.6	5.9	1.4	2.1	9.0	2.1	3.1	16.3	0.0	2.8	2.1	9.0	4.3	0.2	21.0	5.2	4.1
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"salivary gland: 1069.4"	"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 160.9;Glandular cells: 457.9;Mucus-secreting cells: 224.9;Urothelial cells: 223.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 15.2;OE19: 32.4;SK-BR-3: 14.0;T-47d: 12.8"									"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.7	0.2	0.0	0.2	0.1	0.1	0.1	0.5	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.0	0.0	1.6	0.3	0.0	1069.4	0.2	0.1	0.8	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	78.5	3.7	0.2	0.2	0.0	1.1	1.7	11.4	1.1	0.4	1.7	0.0	0.6	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.1	1.2	0.0	2.5	0.0	0.0	0.0	5.0	1.4	1.3	1.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.1	2.1	0.1	15.2	0.0	0.2	0.1	32.4	2.9	0.0	0.0	4.8	0.1	3.6	0.0	0.0	0.0	14.0	0.0	0.1	12.8	0.0	1.8	0.0	0.3	1.1	0.0	0.0	0.2	0.2	0.2	3.7	0.1	1.7	6.7	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	1.1	7.3	0.0	0.4	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.9	8.0	0.0	0.0	89.2	1.4	5.7	1.8	0.0	0.0	0.0	3.6	5.3	0.1	36.1	0.0	25.2	2.7	0.8	457.9	5.7	0.0	13.1	0.0	55.9	0.6	2.9	3.1	0.0	2.6	79.2	1.8	224.9	0.0	30.0	80.9	0.0	0.0	0.0	0.0	0.3	1.0	0.1	21.0	0.2	0.0	68.0	223.9
ZGLP1	"GATAD3, GLP-1, GLP1"	ENSG00000220201	"Zinc finger, GATA-like protein 1"	P0C6A0	19	10304803-10309880	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 12.3;Kupffer cells: 16.8;Macrophages: 7.8;Spermatogonia: 16.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NB-4: 26.6;U-937: 6.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA049855	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA049855: AB_2680916"	"unprognostic (1.73e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-4)"	"unprognostic (2.82e-2)"	"unprognostic (6.57e-7)"	"unprognostic (6.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-4)"	0.5	0.9	2.5	2.0	6.5	0.9	1.0	8.0	5.4	1.4	0.9			2.2	2.1	0.7	0.6	2.6	1.8	0.6	2.9	3.4	2.4	3.0	1.0	3.6	1.0		3.9	3.1	1.9	4.8	2.0		3.4	0.3		5.1	2.5	1.4	4.8	1.6	0.2	0.9	2.6	1.4	3.7			5.3		1.4	1.2	0.9	0.3	0.3	0.1	0.3	0.0	1.0	0.1	0.4	1.0	1.4	0.5	0.9	0.4	3.6	0.8	0.2	0.7	1.5	1.0	0.3	1.5	0.8	0.2	0.6	1.5	1.0	0.3	0.2	1.3	4.6	1.4	1.3	0.5	0.6	0.0	0.4	0.8	2.1	0.7	0.4	0.6	0.2	1.2	1.4	1.0	0.9	1.6	0.1	26.6	2.2	0.3	1.7	1.5	0.7	0.7	0.6	0.6	1.2	1.4	0.3	0.3	1.2	0.4	2.1	0.4	0.5	2.1	2.4	2.0	0.2	5.2	6.1	0.6	0.4	6.7	0.9	0.0	0.3	0.0	1.0	0.1	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1											0.0	2.6	0.9	0.4	0.8	1.4	0.4	0.0	1.4	1.2	1.8	0.0	0.4	0.0	0.4	0.4	0.8	0.4	0.0	0.0	0.3	0.6	0.8	0.0	1.0	12.3	6.4	0.0	0.6	16.8	0.6	0.9	7.8	3.3	1.8	0.2	1.1	0.3	0.8	0.7	0.3	1.3	0.0	0.4	1.8	16.8	0.6	0.1	0.0	1.1	0.0
ZGPAT	"dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP"	ENSG00000197114	"Zinc finger CCCH-type and G-patch domain containing"	Q8N5A5	20	63707465-63736142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.1"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.3;Club cells: 2.3;granulocytes: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056705			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA056705: AB_2683213"	"unprognostic (4.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.58e-2)"	"prognostic favorable (6.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-3)"	9.3	9.8	9.6	13.6	14.5	14.5	8.0	20.2	13.2	7.6	8.9	12.0	10.8	11.1	12.9	6.1	9.1	8.1	11.2	8.8	10.3	7.1	11.7	56.1	7.2	11.0	16.9	10.7	7.3	12.6	8.3	10.8	9.0	14.2	8.3	3.9	8.0	14.0	8.8	9.2	10.5	10.8	9.4	8.5	11.7	10.3	14.9	15.0	11.3	8.0	5.8	13.5	8.3	9.2	15.6	21.7	19.2	16.4	20.2	23.8	13.0	8.6	11.1	4.4	7.0	3.6	2.5	10.1	9.0	6.0	14.3	6.0	23.8	11.9	9.0	17.2	5.0	13.8	15.8	2.9	10.6	1.8	6.0	7.7	8.4	9.7	24.3	7.1	5.2	14.9	6.4	9.0	5.8	2.3	3.8	7.7	10.9	9.2	8.5	4.7	8.6	12.9	12.5	7.1	12.8	14.0	13.6	3.3	9.1	7.9	8.0	8.3	10.4	12.8	14.5	8.0	2.3	9.9	14.8	8.7	22.3	7.9	8.4	11.4	8.4	13.2	12.3	14.0	5.2	9.9	6.6	16.0	19.2	23.8	16.4	23.1	15.6	20.4	21.5	15.1	14.5	20.3	20.5	17.0	20.2	13.2	21.7	19.8	13.0	9.6	14.5	20.2	13.2	10.3	7.1	16.9	10.7	14.2	15.0	3.0	4.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.2	0.2	0.0	2.3	1.6	0.2	0.0	1.7	0.6	1.8	0.0	0.0	0.4	1.7	0.0	0.0	0.3	0.3	0.0	0.0	0.4	1.0	0.0	0.3	0.0	0.1	0.3	0.2	0.0	0.0	0.1
ZGRF1	"C4orf21, FLJ11331"	ENSG00000138658	"Zinc finger GRF-type containing 1"	Q86YA3	4	112539333-112636995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"	8	"Rod photoreceptor cells: 19.0;Spermatocytes: 17.1;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA030704, HPA030706"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA030704: AB_2673577, HPA030706: AB_10601784"	"unprognostic (8.48e-2)"	"unprognostic (6.17e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.83e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.72e-3)"	"unprognostic (7.60e-10)"	"unprognostic (3.45e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.02e-4)"	2.5	1.8	3.3	4.9	4.8	13.8	2.8	13.8	6.5	2.5	2.4	0.5	0.1	2.6	2.6	1.5	3.0	2.1	1.3	1.5	3.1	1.0	1.6	1.6	2.7	5.0	2.5	3.3	3.2	2.2	0.9	4.5	3.5	3.5	2.1	3.1	1.1	2.7	2.3	2.9	3.0	3.2	2.1	4.2	3.8	2.6	7.3	4.1	17.0	2.7	2.2	5.8	2.1	2.5	2.5	2.8	1.3	2.9	1.1	1.6	0.4	3.7	2.7	9.4	6.6	0.7	1.3	3.6	6.7	2.8	6.8	6.1	5.2	5.6	9.8	2.0	2.0	2.8	3.0	9.7	3.5	7.8	5.3	2.5	6.1	4.3	1.6	0.3	13.7	4.1	0.6	0.4	8.5	2.3	0.9	2.7	10.5	8.7	11.1	4.6	6.1	18.3	5.0	4.9	3.9	3.3	10.3	14.0	3.3	1.2	3.3	4.4	7.4	3.0	4.1	1.2	7.2	1.9	4.0	3.2	8.6	8.4	4.5	5.3	4.2	7.3	13.1	3.9	4.7	4.8	0.0	0.6	1.3	1.0	2.9	0.6	1.3	0.5	0.2	0.1	2.5	1.6	1.6	0.9	1.1	0.7	2.8	1.0	0.4	3.3	4.8	13.8	6.5	3.1	1.0	2.5	3.3	3.5	4.1	0.0	2.2	6.4	1.2	0.0	9.0	2.0	0.0	1.4	6.8	1.8	7.9	1.9	0.0	0.8	2.3	0.7	0.7	0.0	0.4	2.7	1.4	1.0	2.3	0.4	1.5	4.8	1.2	0.0	1.0	1.4	0.6	2.6	0.0	0.0	1.1	2.0	0.5	0.9	2.1	0.3	19.0	0.0	0.8	17.1	11.5	0.0	0.7	2.2	1.2	0.4
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406860	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 52.2"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Early spermatids: 2.8;Late spermatids: 6.7;Muller glia cells: 4.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	18	"cerebellum: 52.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.7;ASC diff: 5.3;BEWO: 4.0;MCF7: 5.3;SH-SY5Y: 5.6;U-2197: 4.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 118.4"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030194: AB_2673367"	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.2	0.0	0.2	0.0	0.4	0.0	0.0	52.2	7.9	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.0	0.0	0.0	3.7	3.5	0.5	0.0	1.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.7	0.0	5.3	2.2	4.0	1.9	0.4	0.2	0.5	0.0	0.0	0.0	2.4	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.4	0.0	4.4	2.0	0.0	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	52.2	0.4	0.3	0.8	0.3	0.4	2.9	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ZIK1	ZNF762	ENSG00000171649	"Zinc finger protein interacting with K protein 1"	Q3SY52	19	57578456-57593777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.7;NTERA-2: 20.0;REH: 14.3;U-266/84: 18.7"	"Low region specificity"	"Detected in all"							HPA059975	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA059975: AB_2684184"	"unprognostic (2.14e-2)"	"unprognostic (9.03e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-6)"	"unprognostic (6.21e-2)"	"unprognostic (5.15e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.50e-1)"	4.0	4.9	5.6	4.1	6.7	6.2	5.2	14.4	8.2	5.2	4.5	4.8	4.7	1.2	5.0	7.5	2.3	8.3	4.0	5.4	4.3	5.0	3.8	1.3	4.1	10.8	3.7	5.3	10.4	2.7	12.9	6.2	5.4	5.5	6.2	2.4	7.5	5.7	7.2	5.0	3.8	5.0	4.5	3.7	8.4	2.8	8.2	3.0	12.7	9.3	1.9	10.1	6.5	2.8	10.8	3.3	8.8	2.2	4.3	8.4	3.0	0.0	0.0	13.1	0.0	0.5	0.5	0.0	4.5	4.2	6.6	6.0	0.0	0.1	0.0	3.3	2.3	5.2	0.3	0.0	7.2	9.4	0.0	16.7	2.6	0.0	1.3	1.5	0.0	5.0	2.8	0.0	5.1	0.0	0.6	0.5	1.0	0.1	0.0	2.2	0.0	9.8	1.3	20.0	0.0	1.6	14.3	0.0	3.1	1.9	0.0	9.6	9.7	0.1	0.0	0.4	10.7	0.0	0.2	0.0	6.0	3.1	0.0	5.3	0.1	18.7	4.9	0.0	0.0	5.9	2.1	1.8	8.8	2.2	2.2	4.4	8.0	4.3	2.8	2.9	10.8	8.4	3.9	0.5	4.3	1.8	3.3	4.9	3.0	5.6	6.7	14.4	8.2	4.3	5.0	3.7	5.3	5.5	3.0	0.0	0.0	1.3	1.6	0.9	3.4	2.0	5.1	0.0	1.2	5.2	0.0	2.0	3.3	2.7	1.7	2.1	0.0	0.0	0.2	0.7	1.3	1.0	3.5	0.0	1.6	3.2	0.0	2.5	1.0	2.2	2.0	0.9	0.0	1.0	0.0	4.5	0.3	0.0	2.1	0.4	4.4	6.5	0.9	0.7	4.9	0.6	1.0	2.6	0.0	1.1
ZIM2	ZNF656	ENSG00000269699	"Zinc finger imprinted 2"	Q9NZV7	19	56774552-56840729	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;ovary: 35.4"	"Cell type enhanced"	"Detected in some"	11	"Early spermatids: 24.1;Horizontal cells: 9.5;Late spermatids: 24.5;Spermatogonia: 18.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.4;Hep G2: 9.8;NTERA-2: 2.8;RH-30: 2.9;U-2 OS: 2.1;U-266/84: 2.0"									HPA071856			Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA071856: AB_2686460"	"unprognostic (9.01e-4)"				"unprognostic (8.77e-2)"		"unprognostic (5.09e-2)"			"unprognostic (4.60e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"		1.6	13.1	8.5	1.6	44.0	1.4	2.5	8.2	19.1	2.2	1.7	4.8	0.0	1.6	3.2	1.2	1.7	2.8	1.4	2.6	8.1	6.5	2.0	1.7	1.4	1.5	3.0	13.7	35.4	1.5	1.8	21.1	18.3	18.2	2.0	1.5	0.1	3.7	2.0	1.3	1.4	1.8	2.2	3.9	1.7	1.5	11.4	6.1	0.0	2.2	0.0	2.0	1.9	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.9	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	44.0	8.2	19.1	8.1	6.5	3.0	13.7	18.2	6.1	0.0	0.0	0.0	0.0	0.1	3.8	0.8	0.0	0.0	0.0	0.0	0.0	4.6	1.7	0.0	24.1	0.0	0.0	0.0	0.0	0.9	0.4	0.1	0.0	0.0	0.5	9.5	0.0	0.0	0.0	24.5	1.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.4	0.0	2.4	0.0	0.0	7.5	18.3	0.1	8.2	0.0	0.0	0.0
ZKSCAN1	"KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33"	ENSG00000106261	"Zinc finger with KRAB and SCAN domains 1"	P17029	7	100015572-100041689	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006672	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		Yes	No			"Nuclear bodies"	"Nucleoplasm, Mitochondria"	"HPA006672: AB_1080707"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.09e-3)"	11.7	19.5	16.1	12.1	23.9	8.1	23.6	15.0	23.9	16.8	21.2	38.9	16.3	18.1	16.2	18.3	19.8	23.0	25.1	10.8	18.8	15.2	14.2	47.6	11.7	12.2	26.1	27.3	20.6	26.7	18.3	14.3	11.1	27.6	24.3	24.3	14.7	25.0	19.4	11.9	32.5	16.5	14.3	23.6	13.5	33.0	16.4	23.1	17.3	12.5	11.4	12.1	14.4	17.5	6.1	7.3	13.3	10.0	11.7	7.5	4.5	9.2	6.8	18.1	19.8	18.7	22.8	6.8	10.4	12.7	6.2	6.3	4.1	8.8	10.5	13.3	11.6	11.0	7.7	10.4	9.0	12.0	10.1	6.4	8.5	8.3	10.6	10.6	16.1	10.2	15.3	14.4	8.4	28.3	17.0	13.7	12.5	19.5	9.2	12.3	12.3	15.3	9.6	7.3	17.4	8.6	9.1	9.2	9.4	10.5	14.6	21.1	25.2	16.2	21.3	18.3	10.8	10.8	10.8	20.6	13.7	13.4	15.9	10.5	10.7	18.5	10.9	9.3	11.6	17.9	13.3	4.7	5.0	6.8	4.0	6.7	5.1	5.4	6.7	7.3	6.1	7.5	5.3	5.3	11.7	10.0	5.2	4.3	4.5	16.1	23.9	15.0	23.9	18.8	15.2	26.1	27.3	27.6	23.1	23.8	39.4	30.6	38.6	13.4	91.6	37.3	142.7	161.9	56.9	43.6	141.4	32.1	13.3	46.0	35.7	43.9	59.0	0.0	38.3	12.7	32.9	84.1	33.6	124.6	17.1	84.2	212.3	35.6	28.8	14.6	47.5	27.1	38.8	27.9	82.8	74.9	41.8	84.2	50.2	23.0	68.3	19.4	22.2	28.9	14.6	18.7	55.2	18.7	98.9	47.9
ZKSCAN2	"FLJ23199, ZNF694, ZSCAN34"	ENSG00000155592	"Zinc finger with KRAB and SCAN domains 2"	Q63HK3	16	25236001-25257931	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 14.9;Cone photoreceptor cells: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049141	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus"	"HPA049141: AB_2680652"	"unprognostic (2.71e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.28e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.70e-6)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.03e-2)"	3.4	4.0	5.9	2.6	5.8	4.5	4.8	6.2	7.6	6.1	3.7	7.3	3.5	2.0	6.4	4.4	2.2	4.9	2.9	5.0	5.3	6.5	4.4	4.5	3.4	5.6	5.2	5.1	10.5	3.3	11.8	8.0	4.7	5.4	4.7	3.0	5.5	4.0	5.0	7.5	2.0	3.0	5.2	5.1	3.3	3.1	12.7	4.6	6.7	5.8	4.4	3.2	4.1	3.0	0.7	1.6	0.9	0.6	2.0	1.4	0.5	2.3	2.3	10.6	6.6	4.3	4.1	4.3	2.6	3.9	3.8	3.7	6.0	1.7	7.6	2.8	2.9	4.2	1.7	7.0	3.4	4.6	4.2	4.8	4.5	4.2	9.2	5.7	3.6	2.4	5.4	4.2	3.6	6.1	4.1	3.0	5.6	8.1	3.8	3.6	2.4	8.9	3.9	5.8	0.8	2.2	10.6	7.8	1.6	3.1	3.3	8.4	8.4	3.2	2.8	2.8	5.3	3.4	5.9	2.9	6.2	4.1	2.4	4.0	5.2	4.2	9.2	2.1	2.9	3.7	0.0	0.6	0.9	0.7	0.4	1.0	0.5	1.1	0.8	0.8	0.7	1.1	1.4	0.0	2.0	0.5	1.6	0.2	0.5	5.9	5.8	6.2	7.6	5.3	6.5	5.2	5.1	5.4	4.6	14.9	2.9	1.5	2.2	0.7	6.8	2.8	0.0	1.4	0.0	1.8	13.7	3.0	0.0	1.3	3.2	2.2	0.9	0.0	0.8	1.7	1.9	1.9	1.1	2.6	1.3	6.4	4.7	0.6	1.5	1.3	4.6	0.8	1.7	1.0	1.5	3.7	1.9	0.0	3.5	1.1	8.8	0.0	1.4	9.8	7.9	0.5	3.4	0.8	1.3	1.3
ZKSCAN5	"ZFP95, ZNF914, ZSCAN37"	ENSG00000196652	"Zinc finger with KRAB and SCAN domains 5"	Q9Y2L8	7	99504651-99534700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003201	Uncertain		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA003201: AB_10610701"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.59e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.35e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.42e-1)"	6.3	7.2	8.4	5.9	11.8	5.4	8.1	16.5	12.6	7.2	6.1	12.9	3.8	3.7	7.7	8.4	5.4	7.6	5.9	7.4	9.8	8.2	7.4	6.6	6.8	6.7	9.9	8.2	8.9	7.6	10.5	9.0	7.7	9.8	7.6	6.4	6.8	4.7	8.8	9.5	5.2	5.3	9.9	7.2	6.9	5.5	17.8	10.2	12.5	8.7	4.6	8.6	7.3	5.8	1.7	4.0	4.7	2.8	3.8	4.7	2.4	5.6	9.5	11.4	15.1	8.5	6.3	4.6	9.8	10.0	12.1	11.9	6.5	5.3	9.7	9.3	7.6	14.8	4.1	10.5	6.9	12.3	5.8	5.0	6.1	6.4	6.1	8.6	9.1	10.3	5.6	9.6	10.5	16.2	7.7	8.6	8.9	12.9	13.6	13.0	7.2	13.0	10.0	9.8	5.2	7.7	8.0	10.1	8.2	7.6	5.7	8.0	13.0	9.3	8.1	7.1	9.7	5.0	7.0	7.7	15.3	11.1	12.2	8.3	9.1	12.9	15.2	6.8	6.2	13.6	1.3	1.5	4.7	4.7	2.8	4.1	1.7	1.7	2.3	4.0	0.9	3.5	3.7	0.3	3.8	1.7	1.6	2.9	2.4	8.4	11.8	16.5	12.6	9.8	8.2	9.9	8.2	9.8	10.2	6.0	2.7	7.1	1.6	2.4	5.4	5.0	0.0	1.4	6.8	3.5	13.7	2.9	0.0	2.6	3.9	3.5	3.8	0.0	2.9	2.8	3.4	2.0	5.7	3.0	2.8	9.5	5.8	5.5	3.5	1.6	3.7	3.9	0.0	2.8	2.7	8.1	3.8	0.0	5.3	2.1	6.3	6.5	3.1	10.9	5.9	2.5	2.2	3.5	2.3	0.9
ZKSCAN7	"FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39"	ENSG00000196345	"Zinc finger with KRAB and SCAN domains 7"	Q9P0L1	3	44555193-44594173	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Early spermatids: 13.1;Late spermatids: 11.0;Spermatocytes: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;NTERA-2: 5.1;SH-SY5Y: 8.0;SuSa: 5.0"	"Low region specificity"	"Detected in all"							"HPA048312, HPA049906, HPA071850"	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458"	"unprognostic (3.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.17e-3)"	3.4	6.0	5.7	6.3	3.9	1.9	5.3	9.9	6.1	6.1	3.9	6.0	6.1	2.0	6.9	9.5	2.9	6.4	5.3	4.8	5.6	3.9	4.5	4.6	5.1	5.1	4.4	3.4	13.0	6.7	6.8	18.2	3.4	4.1	6.6	3.5	7.2	3.7	5.8	4.3	2.2	3.8	7.2	3.9	4.8	3.7	18.6	4.4	12.1	6.0	1.9	4.8	5.5	5.9	3.7	2.5	2.0	1.2	2.4	3.4	1.2	0.0	0.0	4.6	6.6	1.3	0.7	0.0	2.2	1.9	2.3	2.7	0.0	0.1	0.1	0.8	1.5	0.8	0.0	0.0	1.4	2.9	0.0	0.0	0.2	1.4	1.7	4.1	0.0	0.0	3.2	1.5	1.3	0.0	0.0	0.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	5.1	0.0	0.0	0.0	2.1	0.0	1.3	0.6	3.1	8.0	0.1	0.2	0.0	5.0	0.0	3.1	0.7	1.4	0.5	1.8	0.0	0.2	0.1	0.0	0.3	0.0	1.1	2.0	1.2	1.6	3.4	0.5	1.0	1.3	2.1	2.6	1.0	3.7	1.6	3.2	1.6	2.4	1.1	2.5	2.1	1.2	5.7	3.9	9.9	6.1	5.6	3.9	4.4	3.4	4.1	4.4	0.0	0.3	0.0	0.6	0.1	5.0	3.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.6	13.1	0.6	0.0	0.0	0.4	0.0	0.9	0.3	0.0	1.0	0.9	3.2	2.9	0.0	0.0	11.0	0.9	0.2	0.0	1.0	0.0	4.1	0.9	0.0	2.5	0.6	4.0	0.0	0.3	9.4	3.4	0.4	0.1	0.7	0.4	0.1
ZKSCAN8	"LD5-1, ZNF192, ZSCAN40"	ENSG00000198315	"Zinc finger with KRAB and SCAN domains 8"	Q15776	6	28141910-28159472	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003483: AB_1080686"	"unprognostic (2.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.80e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.33e-3)"	16.5	12.1	13.4	10.3	15.6	17.7	16.1	27.7	16.5	17.7	16.3	20.8	12.5	9.2	21.8	19.9	10.0	17.2	11.0	10.7	13.5	9.3	11.2	10.9	14.1	13.9	18.4	13.3	25.0	15.4	21.9	22.6	12.8	14.0	15.1	11.9	17.2	13.9	17.2	12.0	11.5	15.9	18.3	18.2	14.4	14.1	12.8	18.2	18.1	17.1	8.8	14.5	16.7	12.4	3.8	1.9	4.1	4.2	3.0	3.1	1.3	5.8	3.7	18.1	17.9	11.6	10.9	5.7	6.7	12.1	8.5	10.9	4.1	3.5	12.9	10.9	6.4	7.4	5.1	11.5	4.4	12.7	6.9	9.8	11.7	7.1	9.5	10.7	14.3	8.8	11.4	7.6	8.9	13.6	15.2	8.8	11.5	17.9	4.9	9.1	3.0	10.0	12.7	6.8	1.5	4.2	10.7	11.4	10.2	6.3	7.2	13.7	17.3	7.8	3.7	8.5	10.8	4.2	8.1	7.3	13.0	7.5	4.3	8.8	12.0	8.5	10.7	3.7	10.1	6.9	4.1	1.3	1.3	2.7	3.3	3.1	1.5	1.7	1.2	1.0	3.8	2.8	2.3	0.5	3.0	4.2	1.9	1.6	1.3	13.4	15.6	27.7	16.5	13.5	9.3	18.4	13.3	14.0	18.2	3.0	9.4	0.9	2.0	4.2	8.8	6.9	10.2	5.3	5.7	7.0	5.9	3.3	0.0	2.5	2.9	7.0	1.7	0.0	2.5	1.7	5.4	3.9	4.7	7.8	3.6	6.4	6.9	7.4	9.1	3.4	8.3	4.7	1.7	2.8	4.9	7.5	2.4	0.0	8.5	1.4	8.1	0.0	7.2	10.8	5.7	2.5	1.9	6.9	3.9	2.0
ZMAT1	KIAA1789	ENSG00000166432	"Zinc finger matrin-type 1"	Q5H9K5	X	101882288-101932031	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"epididymis: 38.7"	"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.6;U-266/70: 6.3"					"Low region specificity"	"Detected in all"			HPA012827	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012827: AB_1859070"	"unprognostic (9.30e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.20e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.09e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.38e-2)"	6.1	13.0	11.4	9.9	12.4	10.0	9.9	7.1	12.8	5.0	4.9	16.5	7.0	4.0	7.4	38.7	3.0	7.3	7.2	7.6	11.1	9.6	9.6	6.5	10.8	10.9	10.2	11.4	11.9	7.3	14.5	31.4	2.3	9.2	9.3	3.4	13.6	7.9	14.2	5.1	4.3	5.4	8.3	12.0	10.7	4.1	5.9	11.3	7.0	18.8	3.2	7.5	3.3	3.7	3.7	3.2	2.6	1.1	0.6	1.6	0.6	0.4	0.0	1.5	1.5	0.0	0.0	0.2	0.6	0.1	0.0	0.7	0.0	1.8	2.7	0.2	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.3	0.3	1.1	2.8	0.0	12.6	1.0	0.0	0.1	0.2	1.9	0.0	0.2	2.1	0.0	0.1	3.4	0.0	0.6	1.7	1.0	0.0	0.1	1.7	2.2	3.1	3.1	0.9	0.0	0.0	0.1	6.3	0.4	0.0	0.6	3.0	0.9	2.6	1.1	1.7	0.9	0.4	1.6	2.0	1.3	1.4	0.2	3.7	1.6	1.4	0.8	0.6	0.7	3.2	0.6	0.6	11.4	12.4	7.1	12.8	11.1	9.6	10.2	11.4	9.2	11.3	14.9	34.0	4.5	5.8	3.7	34.3	22.7	5.1	22.7	26.1	14.0	41.2	0.0	3.3	3.2	8.5	10.8	1.1	23.3	2.5	0.0	5.4	9.2	15.1	9.0	3.1	15.9	9.9	12.3	6.1	7.5	1.7	9.3	6.8	8.2	2.9	38.4	1.6	1.4	1.1	3.7	54.5	0.0	8.6	10.3	9.7	2.5	0.1	8.7	2.1	4.1
ZMAT2	"FLJ31121, hSNU23, Snu23"	ENSG00000146007	"Zinc finger matrin-type 2"	Q96NC0	5	140698680-140706676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036518	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA036518: AB_10671960"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (2.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.38e-3)"	"unprognostic (6.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.84e-2)"	25.3	25.1	36.7	19.9	50.4	32.1	31.9	31.2	52.4	23.6	26.7	16.0	24.9	17.7	27.7	29.1	29.7	27.1	17.6	18.1	60.2	27.6	31.2	29.4	21.3	25.3	28.4	53.8	26.5	17.6	36.5	21.9	24.1	33.6	22.7	30.0	13.9	24.6	26.5	102.9	25.1	19.9	25.2	36.1	26.2	24.7	15.2	19.8	24.4	23.7	29.8	33.9	20.9	30.7	12.3	11.8	42.5	15.1	11.2	17.1	11.5	22.3	37.6	24.5	41.7	40.2	27.0	33.0	23.4	25.6	32.5	35.6	57.6	37.4	25.2	37.9	40.0	36.5	21.5	34.6	46.7	41.4	27.5	30.8	20.4	45.5	40.0	25.5	47.5	27.1	31.0	36.0	33.5	39.2	32.5	27.4	40.6	22.7	28.1	29.9	34.3	38.4	33.4	18.2	15.8	24.2	26.9	28.9	27.4	28.5	32.8	29.1	22.3	32.9	33.1	34.3	36.3	45.3	41.8	22.7	28.6	15.4	14.8	35.7	18.4	37.3	28.5	30.5	33.2	21.7	20.9	15.1	23.6	13.4	12.3	17.1	12.3	14.8	13.7	10.9	12.0	14.0	14.7	42.5	11.2	12.0	11.8	13.9	11.5	36.7	50.4	31.2	52.4	60.2	27.6	28.4	53.8	33.6	19.8	47.6	66.5	76.7	61.0	50.5	28.3	71.2	79.0	100.4	79.6	66.3	5.9	109.7	99.5	67.5	6.5	62.6	68.8	163.5	58.5	105.3	53.9	57.5	77.7	83.2	72.9	15.9	66.0	46.6	91.4	9.8	52.3	72.0	55.6	129.0	47.6	71.0	61.9	73.7	54.5	126.4	18.0	51.8	51.5	36.1	75.4	55.3	173.5	79.8	53.0	81.0
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.5;brain: 21.6;thyroid gland: 29.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 18.2;Late spermatids: 39.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"NK-cell: 11.5"	"Lineage enriched"	"Detected in single"	115	"NK-cells: 11.5"	"Group enriched"	"Detected in some"	5	"AF22: 21.1;U-2197: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Nucleoplasm, Nucleoli"		"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.79e-3)"	0.8	2.0	4.4	0.9	15.3	0.8	0.9	0.6	20.4	3.3	1.0	0.9	0.0	0.7	1.4	1.0	0.7	0.9	1.0	1.5	6.1	4.0	1.2	0.7	0.8	0.9	3.3	7.8	1.6	0.7	0.7	5.3	1.0	21.6	1.6	1.2	1.4	0.8	1.5	0.7	0.7	0.8	0.8	1.0	1.3	1.0	2.9	3.9	0.0	29.1	0.0	0.9	0.8	0.2	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	1.2	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	0.2	0.0	0.0	1.2	0.3	0.0	0.0	0.0	1.8	3.4	0.0	0.0	0.0	0.6	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	4.4	15.3	0.6	20.4	6.1	4.0	3.3	7.8	21.6	3.9	0.0	0.0	0.0	0.2	0.0	6.0	0.4	2.5	0.0	0.0	0.0	5.9	0.0	1.7	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	39.7	2.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0
ZMYM1	"FLJ23151, MYM"	ENSG00000197056	"Zinc finger MYM-type containing 1"	Q5SVZ6	1	35059786-35115859	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064019			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA064019: AB_2685178"	"unprognostic (7.82e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.85e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-1)"	7.6	6.2	6.5	6.1	5.9	1.8	9.9	5.4	6.0	10.7	7.0	6.7	6.6	5.1	8.6	10.5	8.8	8.0	5.5	5.7	5.4	3.6	6.8	5.0	6.4	6.4	8.3	4.0	12.0	11.1	7.4	13.0	7.5	7.3	8.7	6.1	6.6	8.3	8.0	4.7	7.6	6.4	8.1	8.9	6.8	6.1	11.4	7.8	10.6	9.0	4.1	6.1	10.3	9.1	2.0	2.3	7.1	4.3	6.0	4.4	1.6	10.0	5.3	8.2	7.1	9.0	10.4	4.6	9.1	6.9	7.9	8.6	5.6	10.9	6.4	4.0	5.0	4.4	10.1	7.6	6.9	14.2	1.8	3.2	6.8	5.1	4.8	5.2	4.7	3.1	7.6	6.0	12.4	11.8	6.0	12.1	6.4	6.1	2.4	8.8	5.0	6.7	1.8	12.8	3.9	4.7	4.3	9.0	0.0	3.9	5.8	4.1	5.1	8.7	6.8	8.3	12.2	5.6	2.8	5.9	6.7	7.9	5.0	9.2	0.0	0.5	0.9	3.7	3.5	5.3	7.1	1.4	2.3	3.8	1.9	4.4	2.0	3.2	2.8	1.7	1.7	2.8	3.2	0.5	6.0	4.3	2.3	2.8	1.6	6.5	5.9	5.4	6.0	5.4	3.6	8.3	4.0	7.3	7.8	11.9	6.2	4.2	9.3	1.4	6.0	4.3	2.5	8.1	5.7	14.0	0.0	5.0	8.3	5.7	3.7	5.1	2.1	0.0	3.1	5.3	5.0	6.1	5.8	3.2	3.8	11.1	1.7	3.7	5.9	4.4	6.9	2.3	1.7	4.6	3.5	6.9	3.2	0.0	7.4	4.4	4.3	12.9	4.3	19.4	14.7	1.3	3.1	4.3	3.8	5.8
ZMYM2	"FIM, MYM, RAMP, ZNF198"	ENSG00000121741	"Zinc finger MYM-type containing 2"	Q9UBW7	13	19958670-20091829	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031765	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA031765: AB_10601927"	"unprognostic (2.96e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.80e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.07e-4)"	15.0	17.3	15.9	18.1	23.3	22.2	16.1	23.9	26.8	18.3	16.8	14.0	13.7	13.3	20.0	14.0	18.5	16.1	15.7	17.1	14.4	12.0	17.3	13.7	15.4	14.2	12.9	20.2	21.7	16.2	17.1	32.1	14.0	23.2	19.4	13.8	13.8	18.2	17.6	19.7	18.3	14.5	15.3	16.2	16.3	16.0	44.5	16.5	38.0	24.3	10.4	19.7	19.5	17.2	5.5	6.3	7.4	5.9	5.4	7.9	3.5	6.4	5.8	22.3	9.6	9.9	10.6	10.6	6.7	10.8	8.7	10.4	8.9	13.3	15.4	6.2	9.4	8.3	10.3	16.4	7.2	11.8	6.1	4.6	27.2	8.7	4.4	9.9	22.9	8.3	10.5	13.5	6.9	7.1	13.8	14.7	15.9	10.3	11.0	11.9	9.1	22.1	6.5	20.6	19.5	3.6	24.7	24.3	7.2	6.7	9.4	26.1	26.0	13.0	9.3	12.2	15.7	12.3	16.4	8.6	4.3	6.9	5.2	3.5	8.7	6.8	15.9	3.7	5.4	10.3	0.2	5.2	4.0	5.5	5.9	6.7	5.5	7.5	5.6	6.1	4.5	7.9	6.9	7.4	5.4	4.9	6.3	5.4	3.5	15.9	23.3	23.9	26.8	14.4	12.0	12.9	20.2	23.2	16.5	41.7	35.3	47.7	40.3	48.9	111.9	33.0	28.1	36.1	46.6	48.8	106.0	13.1	5.0	20.1	90.8	35.1	23.6	0.0	15.4	10.5	38.8	45.9	45.1	28.4	19.1	68.3	53.6	43.6	57.0	140.1	51.8	45.1	32.1	20.8	31.0	48.9	25.9	31.6	38.5	13.7	112.6	32.3	39.3	94.3	48.9	39.0	9.5	45.9	27.6	70.2
ZMYM4	"KIAA0425, MYM, ZNF198L3, ZNF262"	ENSG00000146463	"Zinc finger MYM-type containing 4"	Q5VZL5	1	35268967-35422058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051301, HPA054802"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA051301: AB_2681431, HPA054802: AB_2682605"	"unprognostic (8.95e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (9.75e-9)"	"unprognostic (9.76e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.21e-1)"	16.6	15.9	17.9	17.3	22.1	13.6	19.7	28.1	24.7	22.0	14.8	17.1	18.3	10.2	19.8	18.2	15.0	17.9	15.7	13.1	17.6	19.0	15.8	14.4	14.1	15.0	15.8	14.6	27.0	15.7	26.1	22.6	19.6	22.2	21.0	13.6	18.2	18.0	26.8	15.9	12.9	12.5	16.6	15.2	16.0	15.4	36.3	13.6	26.7	21.6	13.0	18.8	17.2	14.7	4.2	9.8	3.5	8.2	9.6	4.4	2.5	12.8	10.4	32.1	16.2	9.4	20.4	11.8	15.3	23.1	18.7	24.4	11.2	12.9	23.9	9.4	19.1	9.1	8.3	22.2	11.3	27.0	13.5	15.4	29.2	12.2	9.5	17.0	25.0	13.2	15.4	10.1	18.1	17.2	15.6	20.7	13.3	31.8	6.6	22.6	7.7	21.1	13.9	26.7	6.7	10.0	23.7	20.6	11.6	13.4	17.0	18.5	18.0	18.4	13.5	20.9	21.1	10.9	19.0	24.9	17.4	18.1	7.6	16.4	7.2	13.4	18.4	12.6	19.1	16.6	2.4	5.0	3.5	4.3	7.1	4.4	4.2	4.2	3.8	4.8	3.7	4.1	3.9	1.0	9.6	8.2	9.8	3.1	2.5	17.9	22.1	28.1	24.7	17.6	19.0	15.8	14.6	22.2	13.6	11.9	15.0	11.0	16.2	10.2	27.2	29.5	35.7	22.7	22.7	26.2	29.5	12.4	5.0	19.4	48.6	21.1	5.3	0.0	20.5	10.2	15.8	19.3	13.9	16.1	11.2	22.3	21.5	17.2	18.4	69.6	24.5	13.7	5.0	13.6	13.8	20.1	18.6	9.0	21.5	9.1	33.8	19.4	15.5	22.9	10.4	9.9	11.8	11.7	12.2	24.5
ZMYM5	"MYM, ZNF198L1, ZNF237"	ENSG00000132950	"Zinc finger MYM-type containing 5"	Q9UJ78	13	19823482-19863636	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA015544, HPA020879"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015544: , HPA020879: AB_2670524"	"unprognostic (4.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	10.2	10.6	7.4	10.5	8.6	11.4	10.7	18.2	11.9	9.7	8.5	6.0	6.2	6.9	9.3	10.6	12.4	8.5	10.9	9.0	8.5	5.6	7.6	7.8	8.9	10.6	13.7	5.5	11.0	8.2	6.4	18.6	8.1	9.2	9.7	7.5	7.6	9.5	9.4	9.5	8.7	10.7	9.7	13.2	9.6	8.1	25.2	10.6	22.1	10.8	7.5	12.3	10.9	10.9	12.8	9.9	15.6	8.7	9.3	13.1	5.4	6.6	3.4	8.2	6.3	5.8	9.2	2.9	6.5	10.0	10.3	8.7	8.3	13.2	9.2	6.8	9.3	12.9	6.3	5.9	7.5	12.1	7.3	4.7	17.1	6.2	5.7	17.8	12.6	9.3	11.2	9.2	5.6	10.7	11.0	10.6	6.1	6.9	8.0	9.8	16.4	9.2	12.6	4.3	8.8	5.3	10.3	10.2	3.6	8.8	7.4	7.4	7.1	8.0	6.9	20.9	8.9	10.3	10.8	8.4	5.7	4.2	7.6	4.5	13.1	5.7	13.7	5.6	5.4	9.1	15.6	7.0	9.9	11.7	6.3	12.4	12.8	13.1	11.2	7.0	11.1	10.4	11.1	13.7	9.3	8.7	9.9	10.5	5.4	7.4	8.6	18.2	11.9	8.5	5.6	13.7	5.5	9.2	10.6	26.8	12.9	4.8	15.6	21.6	30.4	12.6	20.4	8.1	15.9	10.4	17.7	15.2	6.6	13.9	11.9	15.5	9.6	23.3	9.2	8.4	17.8	15.9	32.4	7.3	9.9	27.0	26.5	16.0	14.9	16.7	21.0	16.5	20.3	11.8	10.2	15.2	11.9	11.5	17.3	8.4	27.9	32.3	22.6	66.1	52.8	19.1	7.0	28.7	9.3	27.5
ZMYM6	"Buster2, MYM, ZBED7, ZNF198L4, ZNF258"	ENSG00000163867	"Zinc finger MYM-type containing 6"	O95789	1	34986165-35031968	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011004, HPA071865"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011004: AB_1859075, HPA071865: AB_2686464"	"prognostic favorable (1.30e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.11e-6)"	"unprognostic (1.77e-3)"	"unprognostic (4.83e-3)"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.29e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.84e-3)"	12.8	14.7	9.4	13.3	15.9	21.3	11.6	16.3	16.0	10.7	10.9	14.6	9.8	11.0	13.3	13.6	12.8	11.7	10.7	10.8	8.6	8.3	11.7	9.7	12.2	14.9	13.8	10.2	15.9	11.5	13.7	33.7	7.9	17.0	11.0	12.9	12.5	12.9	11.0	8.0	13.6	15.3	11.9	16.7	20.1	11.6	14.9	10.1	16.2	15.4	8.4	14.7	12.5	11.2	10.1	12.3	9.0	9.3	6.5	9.3	4.3	9.3	5.1	9.4	8.9	10.7	13.5	5.8	7.8	11.7	9.5	10.3	4.0	10.3	13.0	8.4	11.5	6.4	9.2	10.4	8.3	11.6	8.9	6.1	11.4	7.4	5.4	9.4	15.8	13.4	11.3	11.9	10.4	8.7	7.2	10.5	10.3	17.5	14.2	9.4	3.1	7.3	10.7	9.4	5.3	8.3	10.3	12.4	7.3	7.8	7.3	9.8	9.1	9.1	8.6	10.7	9.7	5.7	8.8	10.7	11.8	8.7	12.4	11.5	8.8	13.4	9.5	12.0	15.2	9.4	4.6	9.3	9.0	9.3	7.5	8.1	8.1	6.4	5.3	8.3	10.1	9.1	6.1	4.9	6.5	9.1	12.3	6.8	4.3	9.4	15.9	16.3	16.0	8.6	8.3	13.8	10.2	17.0	10.1	11.9	13.9	8.8	4.6	5.4	12.2	13.7	10.2	6.7	6.8	15.7	19.6	3.1	5.0	5.1	1.3	5.2	7.3	0.0	4.7	2.8	5.4	3.5	9.3	6.8	6.8	12.7	3.5	6.7	21.1	1.1	7.8	15.2	1.7	11.8	7.1	7.7	4.7	6.8	10.6	5.8	18.2	12.9	8.2	13.4	17.7	5.6	4.5	6.9	7.9	5.4
ZMYND10	"BLU, CILD22"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50346852	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 55.7;testis: 99.4"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 293.1;Early spermatids: 194.4;Late spermatids: 324.6;Spermatocytes: 352.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 10.6;U-87 MG: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035255			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.1	0.1	1.9	0.2	4.8	0.3	0.6	0.3	0.8	1.6	0.1	5.5	0.2	0.2	0.9	4.6	0.2	55.7	0.3	0.1	2.6	3.1	0.5	0.2	4.7	0.2	0.2	0.3	4.2	0.2	1.4	1.6	0.1	10.2	0.1	0.1	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.5	0.2	0.1	99.4	1.2	0.1	0.8	0.1	0.1	0.1	0.0	0.4	1.1	0.8	0.7	3.8	2.5	0.5	2.7	1.0	0.4	0.8	1.0	1.6	0.8	0.4	1.8	3.0	0.9	0.2	1.4	1.0	1.1	1.7	0.3	0.6	2.4	0.1	0.3	1.1	1.1	2.5	3.6	0.1	0.1	0.7	1.2	0.1	0.3	3.8	0.2	2.7	0.2	2.2	0.6	0.6	0.5	1.4	0.5	3.4	0.0	0.4	1.1	1.1	0.1	0.8	3.7	0.1	2.9	1.2	0.3	0.8	0.2	0.1	10.6	0.9	0.0	0.8	0.8	1.8	0.2	1.4	0.6	0.3	7.4	3.4	0.2	0.3	0.4	0.3	2.5	0.4	1.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.8	3.8	0.7	0.4	0.1	0.5	1.9	4.8	0.3	0.8	2.6	3.1	0.2	0.3	10.2	1.2	3.0	6.1	0.0	0.3	0.5	1.2	0.8	0.0	293.1	29.6	1.8	3.9	0.1	0.0	0.7	194.4	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.0	0.5	0.5	0.0	0.0	1.3	0.0	324.6	8.3	0.2	1.7	0.0	0.4	1.0	0.1	0.0	5.3	0.7	5.7	0.0	0.4	352.7	8.5	0.4	0.1	0.7	0.2	0.1
ZMYND19	MIZIP	ENSG00000165724	"Zinc finger MYND-type containing 19"	Q96E35	9	137582079-137590490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"Cone photoreceptor cells: 229.7;Rod photoreceptor cells: 694.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020642, HPA050761"	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA020642: AB_1859078, HPA050761: AB_2681228"	"unprognostic (2.30e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.72e-1)"	9.5	11.6	11.9	10.3	14.2	9.1	15.5	13.1	20.6	8.5	9.2	7.3	12.3	10.1	8.1	7.5	16.5	8.4	8.4	9.5	12.7	11.0	8.1	12.8	9.3	12.3	9.7	13.0	10.7	26.2	8.0	11.5	9.9	10.2	10.8	6.9	7.9	14.2	9.0	13.7	19.1	8.0	11.7	7.4	9.8	14.4	41.8	9.6	9.2	8.2	9.0	10.6	8.5	10.1	1.9	2.6	0.8	4.7	0.4	3.3	0.4	10.5	16.7	15.9	17.2	8.6	8.4	16.1	14.5	9.8	16.0	12.3	19.7	10.8	19.1	16.8	9.6	15.4	26.8	19.4	14.6	5.1	12.3	18.8	9.9	31.0	15.3	13.5	21.2	13.0	6.6	22.5	14.5	14.3	7.1	8.4	15.2	23.9	8.4	9.6	35.5	24.6	32.4	23.1	31.8	23.4	27.0	14.1	29.3	9.7	9.0	23.1	15.1	14.0	30.2	12.6	7.4	20.3	33.1	7.9	19.8	15.0	29.3	23.4	8.2	19.4	20.5	12.2	16.5	13.5	0.0	0.9	0.8	1.4	4.7	3.3	1.9	1.0	0.7	0.9	1.0	1.6	1.3	0.0	0.4	0.5	2.6	2.7	0.4	11.9	14.2	13.1	20.6	12.7	11.0	9.7	13.0	10.2	9.6	8.9	7.4	3.0	3.9	15.5	19.8	6.0	5.1	1.4	2.3	1.8	229.7	4.1	0.0	3.3	2.8	3.1	2.6	0.0	3.1	5.8	5.1	7.9	1.1	6.7	3.9	11.1	2.4	2.5	2.7	3.2	2.6	2.5	5.0	1.8	7.5	22.1	3.7	3.5	2.8	2.2	694.3	0.0	5.3	28.8	28.5	19.9	3.8	2.2	5.2	6.5
ZMYND8	"PRKCBP1, RACK7"	ENSG00000101040	"Zinc finger MYND-type containing 8"	Q9ULU4	20	47209214-47356889	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020949	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA020949: AB_1857223"	"prognostic unfavorable (2.56e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (7.06e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	11.9	30.2	22.0	18.3	26.9	24.1	16.1	33.2	30.5	12.1	15.0	18.1	24.1	11.8	11.2	37.4	15.2	17.7	13.4	10.0	21.0	18.1	12.3	9.5	11.9	13.3	28.7	17.8	15.5	13.1	17.0	43.2	12.6	23.0	10.7	16.0	14.8	14.6	17.0	15.9	17.8	15.0	9.6	17.4	16.8	20.9	13.7	30.0	25.5	12.1	6.2	17.8	17.5	12.6	15.3	12.6	19.3	5.9	12.4	9.4	3.0	8.1	5.1	27.9	11.2	4.8	6.7	18.3	6.5	5.4	6.9	7.1	32.1	7.9	7.8	10.7	4.9	8.4	5.7	12.0	29.0	10.4	3.3	4.5	32.7	1.8	28.3	17.5	3.4	17.3	6.6	13.4	7.6	29.4	12.6	18.5	2.8	26.3	5.4	12.5	9.5	1.2	13.4	26.4	6.0	7.4	16.5	4.6	6.7	9.3	14.9	11.7	4.4	3.1	9.9	13.3	22.8	5.2	6.7	43.3	7.4	5.2	7.2	6.0	3.8	7.1	7.1	25.2	5.5	24.4	19.3	5.9	7.6	7.0	5.6	6.9	11.1	7.0	7.1	3.5	15.3	9.4	9.3	15.4	12.4	4.8	12.6	6.7	3.0	22.0	26.9	33.2	30.5	21.0	18.1	28.7	17.8	23.0	30.0	41.7	63.3	14.9	25.6	7.8	102.2	20.6	35.7	92.3	75.1	85.5	151.2	21.5	13.3	25.2	13.5	34.3	43.4	70.0	24.8	35.2	26.0	18.1	30.2	13.1	18.8	81.0	54.1	34.4	37.6	17.0	25.6	18.4	10.1	19.0	47.7	29.6	39.0	37.9	25.1	10.5	45.8	32.3	14.7	7.2	23.8	7.3	55.6	15.2	28.6	22.7
ZNF10	KOX1	ENSG00000256223	"Zinc finger protein 10"	P21506	12	133130575-133159465	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 57.6"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003204	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA003204: AB_1080663"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.13e-3)"	4.8	12.7	5.7	4.9	11.5	6.3	10.5	13.0	9.9	9.3	7.9	7.8	14.4	3.0	12.7	20.7	5.1	10.2	9.9	6.7	5.0	5.6	7.3	7.6	6.4	4.4	8.5	6.4	18.2	10.3	22.6	57.6	4.2	8.3	12.2	5.4	8.8	6.2	16.4	5.1	7.2	5.6	12.3	8.8	5.0	8.2	12.1	7.9	6.8	17.3	5.1	5.6	8.1	7.2	4.4	4.4	1.8	0.7	8.6	8.8	2.4	3.1	2.0	10.0	0.0	11.3	4.7	6.1	4.1	3.7	5.1	3.5	3.6	2.2	0.0	5.7	4.1	2.8	1.6	6.4	3.4	3.7	0.0	5.9	7.4	9.4	3.7	3.4	4.5	2.5	4.9	3.2	5.5	6.1	7.6	4.1	5.8	5.3	0.0	6.0	1.1	10.8	9.5	10.3	2.0	4.1	8.9	6.4	5.0	3.9	7.3	10.2	6.4	8.1	1.1	3.4	4.8	6.3	4.4	4.0	3.7	3.4	3.5	3.4	0.2	0.0	11.8	1.2	1.6	3.4	1.1	0.6	1.8	4.0	0.7	4.5	4.2	4.6	5.5	1.7	4.4	8.8	4.4	0.7	8.6	0.5	4.4	1.2	2.4	5.7	11.5	13.0	9.9	5.0	5.6	8.5	6.4	8.3	7.9	0.0	7.0	3.7	4.2	3.4	16.5	6.7	2.5	1.4	9.1	0.0	29.5	3.5	1.7	1.7	11.6	2.3	1.7	0.0	1.2	1.7	3.1	4.1	10.4	3.8	2.1	4.8	12.1	1.3	3.1	4.7	2.6	2.8	3.3	1.8	3.0	6.1	0.9	2.3	6.3	1.7	16.3	0.0	11.3	13.7	13.8	3.3	3.2	4.4	3.0	1.4
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491123	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 64.8;skeletal muscle: 111.1"	"Cell type enriched"	"Detected in all"	9	"Cardiomyocytes: 1626.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 48.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: AB_2682431"	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	14.9	5.4	8.8	6.6	10.4	9.0	10.3	6.3	9.1	7.1	7.8	4.5	4.5	3.9	7.4	6.3	12.7	5.4	6.1	64.8	9.2	6.3	6.4	3.7	7.8	6.0	7.6	6.4	6.6	4.4	8.4	7.1	5.0	11.9	7.8	5.6	11.3	6.0	5.7	111.1	4.3	5.9	10.9	8.0	6.3	6.0	5.7	7.2	3.4	5.7	46.9	6.8	7.0	17.7	8.3	10.8	48.5	19.6	3.9	5.1	4.5	14.4	8.4	14.7	16.2	37.2	32.8	9.0	11.8	11.2	10.3	11.0	19.7	4.2	9.7	10.5	14.4	11.8	16.6	15.2	12.0	15.8	15.7	7.3	18.6	19.6	7.0	10.7	22.2	11.1	24.7	8.1	15.7	17.5	9.2	16.5	12.2	22.0	1.3	16.7	5.7	8.5	5.4	6.2	11.4	8.6	8.1	26.7	5.3	5.4	16.3	9.4	5.0	23.8	11.2	13.2	12.0	10.3	14.5	24.9	11.1	17.1	14.7	17.2	8.1	15.6	36.4	9.9	17.8	19.2	19.9	19.6	7.6	5.1	15.9	4.5	6.7	4.2	4.2	10.5	8.3	3.8	3.4	48.5	3.9	18.5	10.8	3.8	4.5	8.8	10.4	6.3	9.1	9.2	6.3	7.6	6.4	11.9	7.2	125.0	90.2	37.8	49.6	34.2	58.0	1626.8	56.0	188.7	61.4	27.9	90.3	31.5	34.9	37.0	133.3	49.8	30.9	23.3	36.8	30.7	62.9	79.6	42.8	32.7	46.8	33.4	38.7	57.1	104.1	80.0	34.8	64.4	62.4	28.9	28.5	43.3	51.2	23.0	87.0	34.8	75.4	45.3	46.4	55.4	37.4	26.1	25.6	29.4	33.7	64.4
ZNF112	"ZFP112, ZNF228"	ENSG00000062370	"Zinc finger protein 112"	Q9UJU3	19	44326555-44367217	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 7.0;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023856	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA023856: AB_1859018"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (1.54e-5)"	"unprognostic (1.65e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.57e-3)"	5.7	6.5	9.0	1.7	11.4	0.3	8.0	20.5	10.8	6.3	5.7	6.7	3.2	4.8	7.2	7.4	5.0	7.6	4.4	6.1	9.1	5.5	5.5	3.0	4.6	1.5	12.9	5.8	8.6	5.2	9.1	16.4	4.6	8.1	7.8	5.5	5.2	5.2	7.8	3.8	5.2	4.8	5.4	12.7	3.5	5.8	13.1	13.1	1.0	7.8	4.2	2.8	5.2	6.0	1.6	1.8	0.0	1.7	0.4	0.2	0.3	4.1	2.6	7.3	4.3	4.4	3.9	1.7	3.9	6.6	3.7	5.6	1.7	3.0	0.0	2.9	3.3	3.4	3.7	4.3	2.7	6.0	0.0	5.3	4.8	4.2	1.7	3.6	0.0	0.0	4.1	4.8	2.9	6.0	6.4	4.4	0.0	1.7	11.6	4.3	1.0	0.0	0.0	4.0	1.0	1.5	0.0	7.9	2.1	3.5	4.5	3.5	5.7	5.2	1.0	2.7	6.5	2.1	0.0	5.9	5.9	4.4	16.9	3.2	0.0	0.0	0.1	3.5	0.0	4.6	0.0	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.0	1.8	1.6	0.0	0.2	0.0	0.4	1.7	0.5	0.0	0.3	9.0	11.4	20.5	10.8	9.1	5.5	12.9	5.8	8.1	13.1	0.0	0.3	0.0	1.0	0.3	7.0	3.9	0.0	2.7	1.2	0.0	0.0	1.0	1.7	1.2	2.6	0.3	1.1	0.0	1.1	0.6	1.0	0.6	0.0	0.0	0.4	7.9	1.2	2.5	0.0	0.8	0.6	0.0	0.0	0.0	1.7	4.3	0.6	0.0	1.4	1.1	2.2	0.0	0.3	2.6	1.7	0.4	0.2	0.0	1.2	0.3
ZNF114	MGC17986	ENSG00000178150	"Zinc finger protein 114"	Q8NC26	19	48270102-48287608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 11.5"	"Cell type enhanced"	"Detected in many"	12	"Club cells: 4.5;Syncytiotrophoblasts: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;Hep G2: 19.9;NTERA-2: 10.3;REH: 10.5"									"HPA025019, HPA029553"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA025019: AB_1859080, HPA029553: AB_10603005"	"unprognostic (1.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.63e-1)"	1.5	1.0	3.7	2.2	2.7	2.1	1.2	1.2	3.3	2.3	0.6	2.1	1.0	0.9	2.4	2.4	1.3	1.9	1.5	1.7	3.7	4.6	1.6	0.5	1.4	1.9	2.6	0.8	1.2	5.3	4.2	1.6	7.5	2.1	3.1	0.4	2.5	3.7	1.3	3.7	3.7	0.7	1.4	3.5	1.6	0.7	1.6	1.7	1.0	11.5	0.5	1.1	1.3	5.7	2.6	3.5	5.4	0.7	2.0	0.6	0.4	2.7	4.3	5.2	0.5	0.3	0.0	17.0	0.5	0.0	1.6	2.1	1.5	4.3	0.1	5.0	0.3	1.9	5.6	7.1	0.3	1.8	0.1	0.4	0.6	1.3	19.9	1.6	2.7	0.5	0.3	0.5	0.8	0.1	0.5	0.3	0.7	0.7	0.4	0.3	8.1	0.2	8.4	10.3	7.4	0.9	10.5	0.0	0.3	0.2	2.3	2.1	2.4	2.8	0.0	3.0	3.3	1.1	5.0	0.7	0.8	1.8	1.5	0.5	0.4	0.1	0.1	0.2	1.5	0.8	3.3	0.7	0.9	0.5	0.6	0.3	0.9	0.6	0.4	1.7	2.6	0.5	0.4	5.4	2.0	0.7	3.5	0.2	0.4	3.7	2.7	1.2	3.3	3.7	4.6	2.6	0.8	2.1	1.7	3.0	2.6	0.0	0.8	0.3	1.2	0.4	0.0	1.4	4.5	0.0	0.0	1.9	1.7	0.1	2.1	1.1	0.0	0.0	0.5	2.1	0.8	0.7	0.0	0.4	1.4	0.0	0.0	1.8	0.8	0.0	1.1	1.1	0.0	0.0	0.0	1.3	0.4	0.0	0.7	0.0	0.6	0.0	0.8	0.5	2.7	0.1	12.8	0.0	0.0	1.0
ZNF117	"H-plk, HPF9"	ENSG00000152926	"Zinc finger protein 117"	Q03924	7	64971776-65006684	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 34.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.2;SuSa: 16.7;THP-1: 15.4"									HPA031148			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"		"HPA031148: AB_2673759"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (2.17e-11)"	"unprognostic (1.08e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	11.1	13.2	1.3	3.4	1.5	2.1	7.1	2.1	3.7	3.1	2.1			0.5	4.2	6.5	5.2	2.8	5.6	2.7	1.1	1.3	2.3	0.9	3.9	2.6	1.0		5.0	2.1	2.4	4.0	5.3		2.8	2.2		3.6	2.4	0.6	4.2	1.6	2.8	1.3	3.4	1.8	5.3			3.4		2.6	2.5	4.5	1.0	0.7	6.2	1.9	0.9	0.6	0.2	1.2	0.1	14.5	15.2	5.5	2.5	8.2	3.1	0.7	0.8	1.5	0.6	6.2	5.3	2.6	1.6	2.4	0.9	1.7	0.4	1.8	1.6	1.4	2.4	0.4	2.9	0.5	0.0	1.5	3.2	0.6	0.6	0.6	5.9	2.4	6.3	9.8	3.6	3.6	2.7	5.4	5.5	6.1	1.7	0.2	7.2	1.0	1.0	2.0	2.3	2.3	12.4	1.5	0.6	0.7	16.7	2.7	15.4	7.2	4.4	0.5	2.6	1.9	2.5	4.5	2.8	1.6	6.9	2.7	0.4	0.6	1.0	0.6	1.9	0.6	1.0	0.4	0.4	0.7	1.0	0.4	0.4	6.2	0.9	0.5	0.7	0.5	0.2											3.0	34.7	0.0	4.9	3.0	14.3	6.1	15.3	22.7	25.0	5.2	0.0	4.1	10.0	9.4	1.7	7.0	1.7	0.0	24.3	2.3	5.0	6.1	10.4	3.0	5.5	27.0	5.1	19.0	9.8	2.5	8.1	7.0	5.0	1.8	3.6	10.0	17.7	0.0	4.9	2.1	7.4	6.5	4.1	6.5	7.9	4.1	9.3	4.9	2.8	10.4
ZNF12	"GIOT-3, KOX3, ZNF325"	ENSG00000164631	"Zinc finger protein 12"	P17014	7	6688433-6706923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063402			Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA063402: AB_2685005"	"unprognostic (2.68e-1)"	"unprognostic (6.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.89e-3)"	"unprognostic (5.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.46e-3)"	16.7	12.1	12.1	15.6	11.7	8.8	17.0	25.4	13.5	18.9	17.7	9.2	16.0	12.2	17.4	17.9	15.1	15.1	11.9	12.6	10.1	9.7	15.6	13.8	12.2	15.1	10.3	12.8	19.6	13.2	25.2	20.0	20.3	10.3	23.9	13.2	8.6	14.7	16.1	9.5	13.8	18.6	12.5	16.1	18.6	12.9	7.5	13.9	21.1	21.9	7.9	16.0	21.9	29.3	2.1	1.9	9.4	0.9	1.9	3.5	0.4	12.0	5.7	11.4	14.3	11.7	12.0	11.0	7.6	13.8	9.8	10.3	7.8	7.0	9.2	5.3	9.4	22.1	14.5	9.4	7.4	15.0	3.5	7.1	9.2	8.6	7.7	11.0	14.6	10.0	13.1	16.6	7.0	11.4	14.6	7.1	7.4	14.6	8.5	12.9	9.5	5.6	13.5	13.8	3.8	8.8	7.4	16.4	5.6	8.0	12.0	10.5	18.6	8.8	16.1	9.2	15.0	10.2	16.7	7.0	11.1	14.0	8.8	10.0	8.1	5.2	9.4	9.0	9.9	14.6	9.4	0.9	1.1	2.5	0.7	3.5	2.0	2.1	2.8	0.9	2.1	2.7	3.4	0.9	1.9	0.8	1.9	1.7	0.4	12.1	11.7	25.4	13.5	10.1	9.7	10.3	12.8	10.3	13.9	8.9	9.9	13.7	14.1	23.9	26.7	16.2	12.7	9.4	10.3	3.5	15.7	9.8	1.7	7.7	0.4	15.5	6.8	23.3	5.7	7.5	14.2	10.8	11.5	9.0	8.4	35.0	7.5	16.0	11.5	0.8	20.8	7.2	5.0	5.4	11.1	19.5	7.5	7.0	21.2	5.7	19.8	25.8	14.4	12.3	6.0	19.6	7.2	6.4	11.5	14.9
ZNF121	"D19S204, ZHC32, ZNF20"	ENSG00000197961	"Zinc finger protein 121"	P58317	19	9560353-9584533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA054961	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Nucleoplasm, Centrosome"	Nucleoli	"HPA054961: AB_2682651"	"unprognostic (3.06e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.91e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.80e-3)"	"prognostic favorable (6.59e-5)"	"unprognostic (9.36e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.75e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.75e-5)"	13.8	8.9	10.4	11.0	12.3	21.0	14.0	16.1	11.8	10.6	8.9	6.2	12.5	6.7	9.4	10.0	16.5	12.4	7.6	10.3	10.3	5.0	9.2	13.2	14.6	13.0	13.6	6.3	13.8	12.5	22.3	20.2	8.3	11.0	11.8	10.6	5.3	14.1	13.7	9.4	18.6	12.3	12.3	14.8	12.4	11.1	6.2	13.0	12.2	11.3	10.4	12.1	15.8	12.7	6.0	4.6	2.9	4.5	7.1	6.8	1.8	7.7	5.0	6.0	12.5	2.8	3.3	9.3	2.7	2.4	4.0	5.0	8.7	3.4	8.8	7.7	2.1	2.2	7.7	12.2	7.1	5.7	4.2	19.8	27.5	12.3	7.7	3.5	13.6	13.8	4.5	6.3	4.0	10.5	3.6	2.9	9.7	9.8	15.0	2.9	6.5	10.1	31.3	14.8	3.1	8.7	6.5	8.2	6.1	3.9	33.0	10.7	5.4	5.3	5.2	3.1	12.5	4.3	4.4	4.2	12.8	7.2	4.4	6.9	16.0	8.7	10.4	3.5	8.0	4.4	2.9	3.6	2.1	5.5	4.4	6.8	4.0	4.9	5.1	4.1	6.0	6.1	6.8	2.8	7.1	4.5	4.6	4.3	1.8	10.4	12.3	16.1	11.8	10.3	5.0	13.6	6.3	11.0	13.0	6.0	8.0	14.1	29.6	20.0	6.5	9.7	7.6	10.7	17.0	8.7	11.8	10.7	6.6	9.0	1.1	7.1	3.3	23.3	4.7	9.4	7.3	18.2	14.0	9.6	4.6	6.4	13.1	9.2	8.9	0.4	5.8	9.2	8.5	1.8	9.2	2.5	9.4	3.5	7.8	4.2	7.0	6.5	6.6	5.4	11.3	27.7	8.8	13.8	12.3	32.8
ZNF124	"HZF-16, HZF16"	ENSG00000196418	"Zinc finger protein 124"	Q15973	1	247121975-247172016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.7;salivary gland: 23.4"	"Group enriched"	"Detected in many"	31	"Early spermatids: 319.1;Late spermatids: 835.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA031127	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA031127: AB_10602685"	"unprognostic (3.97e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (1.03e-4)"	1.9	1.1	1.2	1.9	1.0	2.8	2.1	1.9	1.4	1.6	3.9			3.5	4.1	2.3	1.7	1.7	1.8	1.5	1.5	1.7	3.4	1.9	2.8	3.0	1.8		3.1	3.9	0.5	0.8	2.2		2.3	4.0		23.4	1.2	1.1	2.2	4.2	1.8	2.1	5.2	2.6	2.8			2.4		3.4	3.1	1.8	10.6	12.6	10.0	14.7	9.9	12.3	6.3	3.6	2.8	7.9	10.4	3.0	1.9	19.9	3.8	2.3	4.0	4.1	4.2	3.3	7.4	4.5	3.0	2.7	4.0	9.4	3.0	5.7	0.4	2.6	6.5	3.3	8.9	2.9	11.6	7.5	2.3	2.4	3.9	3.8	1.9	5.7	8.7	9.1	5.2	5.0	3.2	11.9	7.5	20.5	7.1	6.5	12.6	6.4	5.2	3.8	11.0	12.4	12.6	5.6	4.4	3.8	9.9	3.2	18.6	6.5	3.0	4.5	3.3	6.8	4.5	5.5	10.9	1.2	11.9	6.3	6.2	8.8	10.0	7.0	9.9	10.1	10.6	9.1	8.5	12.6	6.7	12.3	11.8	2.0	9.9	14.7	9.9	6.7	6.3											14.9	9.9	3.7	3.6	3.2	3.3	4.4	5.1	4.0	7.9	3.5	3.9	3.1	1.7	4.3	319.1	8.8	6.6	0.0	4.3	5.7	2.7	4.0	10.5	0.8	7.2	0.0	7.5	2.5	18.7	835.8	11.2	14.2	6.8	5.4	5.6	2.1	3.7	10.7	11.3	4.9	5.2	6.5	3.3	7.4	12.8	1.4	1.1	4.3	8.0	5.7
ZNF132	pHZ-12	ENSG00000131849	"Zinc finger protein 132"	P52740	19	58432814-58440222	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	7	"Cholangiocytes: 2.5;Cone photoreceptor cells: 3.9;Horizontal cells: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA008726	Uncertain		Approved	"Vesicles,Intermediate filaments"		NA	NA			Vesicles	"Intermediate filaments"	"HPA008726: AB_1080664"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.26e-13)"	"unprognostic (2.70e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.72e-1)"	2.9	4.7	4.0	2.5	5.9	0.8	5.1	11.8	8.5	5.9	4.1	6.6	4.5	2.5	4.2	7.2	3.5	7.9	4.7	5.9	6.0	4.5	6.2	2.1	3.6	3.3	4.4	5.5	7.6	4.3	15.3	12.1	3.7	5.9	6.1	2.4	5.4	5.8	6.7	3.7	4.7	2.6	5.9	4.2	4.5	3.6	7.2	6.0	3.1	10.8	2.8	4.3	5.7	6.3	3.9	2.9	2.0	2.6	2.6	5.7	2.1	1.7	2.1	4.8	1.7	5.6	4.6	0.2	3.7	4.5	3.0	2.7	0.1	1.5	4.5	0.3	4.4	3.0	1.8	0.0	5.4	2.1	0.7	8.2	0.8	1.4	1.1	5.0	1.7	3.0	5.2	1.9	5.2	3.2	3.5	2.6	0.7	0.7	0.5	5.6	0.6	1.0	0.1	4.9	0.6	1.7	0.6	1.1	1.3	1.8	2.0	4.3	4.4	1.5	1.3	1.5	5.4	0.3	4.4	3.3	3.1	0.4	0.8	0.7	5.9	1.1	0.0	1.5	0.1	1.9	0.0	1.9	2.0	2.2	2.2	5.7	2.9	2.9	1.2	2.9	3.9	4.6	3.7	0.2	2.6	2.6	2.4	2.5	2.1	4.0	5.9	11.8	8.5	6.0	4.5	4.4	5.5	5.9	6.0	0.0	0.3	0.0	0.5	0.0	0.8	2.2	2.5	0.0	0.0	0.0	3.9	0.4	0.0	0.4	2.2	0.0	0.0	0.0	0.3	0.1	0.4	0.9	1.1	1.0	0.4	3.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.7	1.2	1.5	0.0	0.4	1.4	0.4	0.3	0.3	0.0	0.0	0.2
ZNF133	"pHZ-13, pHZ-66, ZNF150"	ENSG00000125846	"Zinc finger protein 133"	P52736	20	18288283-18316996	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001493	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA001493: AB_1080666"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.46e-6)"	"unprognostic (6.01e-3)"	"unprognostic (8.60e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.52e-1)"	10.0	10.1	12.4	11.4	15.9	5.6	20.8	25.4	18.4	13.9	11.6	14.4	12.6	7.7	18.2	24.9	13.2	14.2	11.2	10.6	12.0	12.0	12.1	9.6	10.6	7.4	10.3	12.1	19.5	12.5	17.9	24.7	12.5	14.1	14.9	10.2	9.2	13.6	13.9	17.2	22.2	8.1	15.7	12.1	12.5	9.9	8.9	13.2	7.1	14.7	9.3	9.5	10.0	12.1	5.4	5.4	3.4	4.5	10.7	8.7	3.5	7.0	7.7	6.1	8.7	14.9	10.4	13.0	6.6	9.8	8.5	12.3	6.1	8.3	1.8	4.0	7.8	9.7	15.4	5.8	17.3	8.0	2.0	4.0	4.8	6.6	13.6	11.3	4.0	0.7	10.1	11.9	7.1	20.8	11.6	8.1	8.0	5.6	2.1	7.3	7.0	5.0	6.7	5.0	8.4	7.7	4.4	8.4	4.5	8.3	4.8	8.6	8.8	5.1	13.9	9.5	8.9	5.3	11.1	5.7	9.0	4.3	6.3	6.5	6.7	6.7	0.6	2.7	2.7	5.1	1.2	4.3	3.4	8.7	3.0	5.8	4.7	7.4	5.9	5.4	5.4	5.8	6.8	1.5	10.7	4.5	2.8	5.5	3.5	12.4	15.9	25.4	18.4	12.0	12.0	10.3	12.1	14.1	13.2	6.0	11.6	3.2	2.4	1.9	7.1	5.9	2.5	4.0	3.4	1.8	3.9	3.5	3.3	3.9	11.4	3.6	1.5	0.0	2.0	2.7	4.2	2.1	6.9	3.4	3.8	3.2	1.2	4.9	1.9	18.8	7.2	2.1	0.0	1.0	3.9	3.1	3.3	0.0	4.2	2.7	5.2	0.0	3.0	5.4	1.7	2.8	1.9	0.5	3.3	2.3
ZNF134	pHZ-15	ENSG00000213762	"Zinc finger protein 134"	P52741	19	57614233-57624723	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009064	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009064: AB_1080668"	"unprognostic (3.60e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.88e-1)"	"unprognostic (4.29e-2)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	10.8	12.6	12.7	9.4	17.7	18.9	13.7	26.2	14.6	11.3	12.4	10.6	10.9	6.4	13.9	11.6	11.5	12.2	9.5	11.5	11.3	9.3	10.6	8.8	10.6	12.2	10.9	13.4	14.5	8.7	24.4	18.9	14.1	13.7	13.8	8.5	12.1	12.1	16.0	13.5	15.3	10.8	14.6	10.0	13.1	10.8	14.2	9.9	17.1	15.3	8.4	14.9	15.9	9.7	10.2	5.1	8.0	4.6	12.9	9.8	5.8	1.6	4.4	10.6	5.7	4.7	6.5	5.4	5.0	7.5	6.7	3.4	1.4	1.9	3.3	3.2	5.6	5.1	1.4	4.8	8.4	11.6	0.0	22.4	10.4	4.4	4.1	7.0	6.8	7.8	8.6	8.4	5.1	11.5	8.9	4.5	5.5	1.3	3.9	10.0	2.4	13.5	2.9	14.8	1.0	9.5	8.0	15.6	5.2	5.0	14.3	8.5	10.0	7.5	3.3	4.9	12.2	4.6	5.5	5.8	10.1	4.4	2.3	6.0	10.5	13.9	4.9	5.3	1.2	6.6	1.9	4.6	8.0	7.3	3.3	9.8	10.2	7.7	7.9	5.1	9.5	9.0	9.0	3.8	12.9	3.5	3.8	4.7	5.8	12.7	17.7	26.2	14.6	11.3	9.3	10.9	13.4	13.7	9.9	8.9	2.6	11.2	10.5	4.7	8.3	9.3	10.2	5.3	5.7	3.5	11.8	7.8	6.6	7.2	0.5	6.4	1.2	0.0	3.2	3.3	5.0	8.1	5.8	4.3	4.6	7.9	1.2	5.5	4.1	0.9	6.6	4.7	3.3	7.2	4.8	9.1	3.0	3.5	13.8	4.0	10.4	6.5	7.2	0.9	14.3	6.8	13.6	9.6	3.8	12.6
ZNF135	"pHZ-17, ZNF61, ZNF78L1"	ENSG00000176293	"Zinc finger protein 135"	P52742	19	58059239-58086310	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 15.7;Distal tubular cells: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 6.7;MOLT-4: 7.0;T-47d: 8.2"					"Low region specificity"	"Detected in all"			HPA006961	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA006961: AB_1080670"	"unprognostic (4.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-2)"	"unprognostic (9.18e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.34e-1)"	"prognostic favorable (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.25e-1)"	4.6	3.5	8.4	3.1	13.7	1.7	8.6	7.3	10.6	7.9	5.4	12.0	4.5	1.9	11.8	11.2	3.9	8.6	5.7	4.5	6.4	5.2	5.9	1.1	3.8	2.9	6.4	9.1	15.9	3.3	21.4	11.0	5.3	8.1	8.6	3.0	9.5	3.0	7.6	2.6	6.2	2.7	9.6	5.3	4.9	3.4	8.9	10.4	7.3	10.6	1.2	3.2	6.4	5.1	3.9	3.9	3.4	0.2	4.5	3.7	0.8	0.0	0.0	1.5	0.0	0.1	0.0	0.0	3.7	0.0	5.1	0.3	0.0	0.2	0.0	3.9	5.5	3.0	0.2	0.0	0.0	5.7	0.0	6.0	0.0	0.0	0.0	2.3	0.0	6.2	6.7	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	3.9	0.0	7.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	2.7	4.4	5.8	0.2	0.0	0.0	0.0	5.9	8.2	0.0	0.0	0.0	3.4	0.0	0.0	0.3	2.4	0.0	0.0	0.0	2.9	0.0	0.1	3.4	0.0	0.2	0.2	0.9	0.3	0.3	1.7	3.9	3.7	2.1	0.1	4.5	0.0	3.9	0.2	0.8	8.4	13.7	7.3	10.6	6.4	5.2	6.4	9.1	8.1	10.4	0.0	0.6	0.0	2.4	2.1	10.7	5.3	2.5	5.3	1.2	8.7	15.7	0.8	18.3	5.3	11.1	2.4	0.0	0.0	0.6	0.1	1.5	2.5	4.7	0.2	0.5	14.3	2.4	6.2	0.3	8.2	7.2	0.0	1.7	0.0	1.0	7.1	0.3	0.0	6.3	2.1	14.4	0.0	3.1	8.9	7.2	2.8	0.6	1.0	0.6	1.3
ZNF136	pHZ-20	ENSG00000196646	"Zinc finger protein 136"	P52737	19	12163064-12189881	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA054120			Approved	Nucleoli		NA	NA			Nucleoli		"HPA054120: AB_2682389"	"unprognostic (1.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.46e-3)"	"prognostic favorable (4.75e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	12.6	10.8	7.2	15.3	11.0	20.5	13.0	19.6	12.4	13.2	9.5	7.1	10.5	4.5	13.3	13.0	5.9	11.6	8.2	8.0	7.3	7.2	9.4	6.0	11.1	12.7	7.5	11.3	19.0	7.5	13.0	16.8	10.6	10.2	13.0	8.6	8.3	10.1	8.9	9.9	10.4	9.4	12.9	12.5	11.7	10.0	10.2	6.8	16.0	14.4	3.6	10.7	12.6	11.3	9.7	5.1	13.5	4.1	8.7	10.0	4.0	2.1	1.2	7.4	7.7	4.1	4.7	4.5	4.0	4.4	3.9	4.1	1.4	0.7	10.1	5.3	2.9	3.7	2.2	3.5	2.4	5.0	5.0	4.6	5.7	3.7	2.5	3.1	12.1	10.3	5.0	4.4	3.7	4.6	5.7	2.8	8.6	4.2	16.3	4.9	3.0	8.3	4.8	8.7	0.7	4.5	6.6	9.4	3.9	4.2	7.7	7.7	7.2	5.1	1.2	4.2	6.4	3.2	6.3	5.7	9.7	3.3	4.0	3.5	11.1	19.2	11.5	3.6	4.6	5.0	13.5	3.9	9.0	7.9	3.7	9.4	9.0	8.9	8.5	4.2	9.7	10.0	8.4	11.6	8.7	4.1	5.1	5.9	4.0	7.2	11.0	19.6	12.4	7.3	7.2	7.5	11.3	10.2	6.8	6.0	6.5	14.5	9.8	4.8	18.5	2.4	12.7	2.7	11.4	8.7	17.7	6.5	5.0	5.4	1.7	6.9	3.9	23.3	3.4	5.8	7.7	7.8	8.1	2.4	4.9	19.1	9.8	8.6	5.3	0.9	12.4	6.9	1.7	10.8	5.3	12.8	4.2	5.1	13.8	3.4	15.2	6.5	11.3	19.4	28.6	2.8	8.2	10.0	4.3	9.8
ZNF14	"GIOT-4, KOX6"	ENSG00000105708	"Zinc finger protein 14"	P17017	19	19710471-19733097	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049863	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA049863: AB_2680921"	"unprognostic (1.04e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (8.09e-6)"	"unprognostic (1.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.05e-3)"	7.4	5.3	7.9	8.7	10.5	11.9	12.8	23.3	10.3	11.3	7.0	8.1	6.6	3.9	9.4	9.6	5.7	9.3	6.0	6.6	8.1	7.6	8.4	1.7	4.9	10.5	12.2	6.0	15.7	7.5	12.7	10.7	8.8	9.4	12.3	5.1	6.5	7.1	9.9	3.4	7.2	7.2	8.9	9.0	9.4	7.0	6.2	10.7	7.1	13.8	3.1	10.9	9.8	7.7	10.3	3.0	11.4	3.6	6.5	18.4	6.3	3.5	3.6	6.1	7.9	4.1	4.5	7.3	3.7	5.1	5.5	6.0	3.4	2.8	9.5	6.2	3.9	3.1	3.6	6.3	3.7	6.9	2.3	7.3	4.5	2.7	4.5	5.0	0.1	6.9	4.5	3.9	3.8	3.3	7.3	3.4	4.7	5.2	4.5	5.4	5.9	8.0	5.1	7.9	6.7	10.4	4.2	9.9	4.6	3.9	7.2	6.1	4.4	0.1	4.3	5.8	5.4	6.0	9.2	2.1	4.8	1.3	5.6	4.8	3.6	4.2	8.4	0.3	5.0	2.8	11.4	1.8	6.1	9.6	3.1	15.1	10.3	13.1	12.0	2.6	8.2	18.4	14.5	4.1	6.5	3.6	3.0	8.4	6.3	7.9	10.5	23.3	10.3	8.1	7.6	12.2	6.0	9.4	10.7	0.0	3.0	1.5	3.8	2.2	4.5	1.9	0.0	4.0	1.2	3.5	0.0	2.6	3.3	1.3	0.5	2.3	0.3	0.0	1.2	1.5	2.8	1.8	1.1	0.0	1.5	6.4	2.9	1.3	0.6	0.5	1.7	2.4	3.3	0.0	1.6	3.5	1.0	0.9	3.5	2.2	5.6	6.5	2.1	3.2	3.0	1.3	1.8	5.3	1.5	2.0
ZNF140	pHZ-39	ENSG00000196387	"Zinc finger protein 140"	P52738	12	133079838-133107544	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003655, HPA048332"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003655: , HPA048332: AB_2680362"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.67e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.13e-3)"	13.0	12.5	8.8	8.3	11.8	5.4	14.7	15.5	12.7	14.4	9.4	11.1	12.7	11.5	16.6	13.9	10.7	13.8	10.6	10.4	11.0	8.2	11.4	10.9	9.0	14.0	12.2	10.0	18.1	14.4	9.6	23.5	9.9	9.2	14.4	7.4	9.4	12.9	12.5	9.6	13.5	9.6	15.5	8.8	10.0	10.3	10.2	10.2	15.0	17.6	9.3	13.4	10.8	11.6	13.7	9.4	14.9	8.7	14.2	18.8	8.0	4.4	3.7	7.8	0.2	4.8	8.2	8.3	4.2	2.3	2.9	3.0	2.5	2.1	1.8	7.1	4.8	3.7	4.0	4.1	3.0	3.6	0.2	5.1	5.1	4.7	4.0	8.6	4.5	9.4	9.0	7.6	5.1	13.4	9.2	5.7	7.2	2.5	2.2	7.1	6.2	9.4	10.0	7.8	2.1	2.6	7.3	1.0	4.8	5.4	8.0	7.1	10.1	8.2	4.9	4.9	4.3	7.7	8.2	8.3	0.7	5.2	4.1	2.6	2.3	0.0	4.0	0.8	4.9	4.5	10.2	5.5	14.9	10.8	8.7	14.8	13.7	12.5	12.5	9.4	10.8	18.8	14.0	9.8	14.2	5.3	4.9	13.8	8.0	8.8	11.8	15.5	12.7	11.0	8.2	12.2	10.0	9.2	10.2	0.0	16.0	5.6	10.1	6.4	7.1	6.1	2.5	10.7	19.4	0.0	9.8	7.2	11.6	8.3	9.2	6.4	4.7	0.0	5.2	6.2	7.4	7.7	7.0	3.9	5.0	6.4	13.2	9.2	5.4	3.6	8.3	5.6	8.5	2.8	6.3	8.3	5.8	8.5	7.8	7.9	6.7	0.0	6.6	18.8	11.3	5.3	12.5	9.6	5.9	8.4
ZNF142	"KIAA0236, pHZ-49"	ENSG00000115568	"Zinc finger protein 142"	P52746	2	218637916-218659655	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049594	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA049594: AB_2680829"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-1)"	"unprognostic (8.20e-3)"	"unprognostic (9.08e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.63e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	10.4	10.4	16.7	13.6	18.2	23.6	10.9	22.8	21.0	11.8	12.5	18.2	8.4	8.2	14.4	7.7	13.6	12.6	12.3	12.5	17.0	11.7	11.2	7.7	11.3	15.0	14.3	15.0	12.9	14.7	19.8	15.5	9.0	12.5	12.7	10.0	10.2	11.7	15.5	18.7	18.7	12.2	14.4	12.6	14.4	12.7	12.3	15.7	16.3	13.2	7.9	14.3	14.9	11.7	4.4	3.5	3.1	3.1	1.7	4.5	2.0	6.0	10.5	8.4	11.5	7.8	6.6	9.1	7.2	4.2	10.0	7.2	20.3	4.8	8.7	6.7	6.2	8.6	11.4	16.7	9.8	6.6	10.7	14.3	11.2	20.7	10.8	5.0	15.8	11.9	4.5	9.0	12.0	10.7	5.0	8.0	9.8	17.9	16.7	5.5	14.1	12.0	8.9	10.8	3.3	9.7	18.3	4.5	8.4	6.0	12.3	14.0	10.6	5.3	11.9	4.0	8.4	6.6	5.5	9.1	10.6	11.0	7.5	10.5	10.4	6.1	14.8	6.1	7.4	9.9	2.3	3.1	3.1	4.5	0.7	2.3	4.4	3.2	2.4	2.7	2.2	4.0	2.4	1.9	1.7	0.5	3.5	4.0	2.0	16.7	18.2	22.8	21.0	17.0	11.7	14.3	15.0	12.5	15.7	3.0	0.3	2.2	1.7	5.3	2.6	4.8	2.5	0.0	2.3	3.5	5.9	1.8	0.0	2.4	1.5	1.9	3.0	0.0	3.2	1.8	2.0	2.1	1.1	2.9	2.5	1.6	0.0	4.3	5.1	3.1	3.4	2.9	3.3	1.8	2.7	2.0	3.8	2.6	3.5	1.7	3.2	6.5	0.8	4.8	4.9	5.4	0.9	4.4	3.2	2.0
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	22.7	9.8	11.6	13.6	11.7	20.9	16.4	25.4	11.8	16.8	14.7	11.0	12.8	11.8	20.8	19.5	14.7	13.4	10.7	13.2	11.9	10.8	11.9	12.1	14.0	18.0	12.6	8.7	18.8	10.7	10.3	24.0	15.7	11.4	17.4	12.9	11.7	14.9	13.0	27.0	12.8	13.5	16.1	15.2	18.7	11.6	20.4	13.8	27.4	18.8	10.4	17.3	25.0	21.8	13.0	12.0	31.2	15.6	10.2	17.0	10.5	15.2	14.9	18.8	12.2	15.3	14.3	16.9	16.9	13.8	13.1	14.4	20.8	19.1	15.1	7.9	13.7	11.2	17.5	18.1	13.5	19.8	15.1	21.9	14.3	21.9	14.4	12.6	19.8	14.4	12.5	16.2	17.8	15.7	17.1	13.0	14.0	15.4	18.6	14.3	13.2	18.1	8.1	20.9	17.7	15.7	16.5	17.0	9.3	11.6	18.8	12.9	12.6	18.8	12.8	11.1	17.3	11.8	11.1	12.5	17.4	12.4	12.1	15.0	9.2	15.7	25.9	11.1	11.3	9.9	20.6	14.2	31.2	17.0	13.9	15.3	13.0	15.2	13.8	12.0	11.2	14.2	12.2	25.7	10.2	15.6	5.8	16.6	10.5	11.6	11.7	25.4	11.8	11.9	10.8	12.6	8.7	11.4	13.8	6.0	15.5	5.7	33.1	23.7	6.6	14.0	5.1	13.4	7.9	5.2	7.9	8.5	3.3	11.2	13.0	11.3	5.1	0.0	10.1	13.6	10.5	16.9	13.9	8.5	8.8	4.8	6.3	4.9	7.1	7.8	10.9	14.1	10.1	9.0	6.0	14.3	11.6	7.4	6.3	5.3	13.5	58.2	16.0	42.3	21.7	20.6	15.3	15.7	6.6	28.8
ZNF154	pHZ-92	ENSG00000179909	"Zinc finger protein 154"	Q13106	19	57697367-57709194	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 7.6;Cone photoreceptor cells: 7.9;granulocytes: 10.4;Horizontal cells: 7.9;Rod photoreceptor cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.1;HSkMC: 4.6;MOLT-4: 6.5;NTERA-2: 4.5;SuSa: 10.0"									HPA076284	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA076284: "	"unprognostic (3.32e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.35e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.11e-1)"	2.8	5.9	7.9	5.7	10.2	2.5	4.3	17.9	9.3	3.1	5.7	2.6	9.9	2.2	2.8	3.6	4.4	3.1	4.1	5.6	7.8	3.1	3.8	1.8	3.6	8.8	2.2	6.4	3.4	3.4	11.9	11.5	6.0	5.1	4.5	2.8	7.3	5.0	12.6	3.1	2.0	5.4	5.6	3.6	8.4	3.2	2.3	3.9	11.4	10.5	0.6	8.3	6.6	2.1	3.1	1.5	5.1	0.3	2.7	3.2	0.8	0.2	0.3	8.1	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.1	0.2	0.4	0.4	0.2	2.0	0.3	0.2	0.0	0.0	0.2	0.2	0.6	0.3	1.1	0.2	2.9	0.4	0.8	4.6	0.0	0.5	0.0	2.8	0.1	0.4	0.3	0.6	1.8	0.1	6.5	0.3	4.5	0.3	0.2	0.3	0.8	0.2	0.1	1.1	0.5	0.3	0.3	0.3	0.1	10.0	0.4	0.5	0.2	0.2	0.5	0.2	0.3	0.8	0.3	0.4	0.1	0.3	0.2	1.8	0.3	5.1	1.1	0.1	3.2	1.3	0.6	1.5	0.3	3.1	1.0	1.4	1.9	2.7	0.2	1.5	0.1	0.8	7.9	10.2	17.9	9.3	7.8	3.1	2.2	6.4	5.1	3.9	0.0	3.4	2.2	1.1	0.3	7.6	3.1	0.0	1.4	0.0	1.8	7.9	0.2	0.0	1.7	0.0	1.6	0.0	0.0	0.2	0.1	1.4	1.7	10.4	0.2	1.3	7.9	0.0	1.8	0.0	0.0	0.3	1.1	0.0	1.0	0.0	3.2	0.1	0.0	1.4	0.0	10.1	0.0	0.4	0.4	0.9	0.4	0.2	3.1	0.0	1.5
ZNF155	pHZ-96	ENSG00000204920	"Zinc finger protein 155"	Q12901	19	43967862-43998325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003220	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA003220: AB_1080675"	"unprognostic (2.71e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.98e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.57e-2)"	9.9	9.7	6.1	5.2	9.4	4.2	9.4	16.0	11.1	10.1	7.6	11.7	9.6	5.4	12.8	12.0	7.0	7.7	6.2	9.7	7.2	7.5	8.9	10.6	7.4	8.0	6.8	5.4	10.6	5.7	15.8	13.0	7.1	9.4	9.9	8.0	7.7	10.0	8.1	6.2	8.8	10.8	10.1	9.4	11.5	8.3	5.2	7.4	10.1	13.3	8.5	8.9	13.1	6.4	6.2	5.1	11.8	3.5	6.4	9.3	4.9	4.5	3.8	9.7	8.8	5.4	6.2	2.8	3.7	3.5	2.7	3.8	2.5	2.3	0.0	4.8	5.8	3.7	3.5	3.2	8.0	4.4	5.0	8.0	9.5	8.1	2.7	5.5	3.0	5.6	8.8	6.4	5.4	8.0	7.8	6.1	0.2	0.1	0.1	7.1	4.0	4.3	3.5	5.9	1.9	3.4	0.0	10.3	3.4	7.1	14.8	6.5	8.7	9.2	0.5	3.6	8.8	6.2	8.4	4.5	5.9	8.7	3.8	5.4	10.8	7.7	0.0	5.0	0.7	5.4	10.3	3.4	11.8	8.5	3.5	8.4	5.3	6.1	9.3	5.1	6.2	7.4	6.8	3.0	6.4	2.7	3.0	5.2	4.9	6.1	9.4	16.0	11.1	7.2	7.5	6.8	5.4	9.4	7.4	0.0	2.2	0.0	1.1	1.3	4.2	0.4	0.0	0.0	1.2	0.0	0.0	1.5	1.7	1.5	0.3	1.7	1.6	0.0	1.3	0.4	1.5	0.9	1.1	1.3	1.5	6.4	0.0	2.5	0.3	0.5	2.6	1.1	1.7	1.0	1.3	3.8	0.9	0.0	5.3	1.8	2.8	0.0	1.9	0.9	1.0	1.1	0.9	1.8	1.3	1.0
ZNF160	"F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18"	ENSG00000170949	"Zinc finger protein 160"	Q9HCG1	19	53066606-53103436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 28.8"									HPA023599	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA023599: AB_2218442"	"unprognostic (1.18e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.90e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.65e-5)"	"unprognostic (5.20e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.67e-5)"	17.7	28.0	15.7	18.5	19.9	8.1	17.2	26.4	20.0	16.3	15.5	21.6	14.1	9.6	22.7	17.2	11.0	15.5	16.8	13.8	14.5	8.9	19.7	13.2	17.3	12.8	22.5	15.2	25.9	12.7	20.9	18.2	16.1	18.8	15.1	13.3	9.9	14.3	19.3	10.2	13.1	12.1	17.4	19.6	31.5	13.2	15.2	22.4	19.0	29.5	7.5	12.5	18.0	15.0	9.1	4.3	10.7	5.9	17.5	11.2	5.4	5.6	5.1	7.1	10.8	11.9	8.4	12.1	6.2	8.4	5.0	8.1	4.4	3.6	6.5	5.4	5.7	6.7	4.2	6.6	6.4	10.1	4.8	8.1	10.0	3.8	2.4	6.5	0.0	6.9	10.4	6.6	5.4	7.7	12.8	5.4	7.7	5.0	0.0	9.5	3.9	8.3	6.2	6.6	1.5	8.3	5.3	7.5	5.0	7.9	28.8	6.0	7.8	0.0	5.0	0.9	23.7	5.3	5.8	10.3	14.1	5.1	4.1	4.5	3.7	15.4	9.3	2.5	2.5	6.7	9.0	3.1	10.7	7.1	4.2	10.3	8.4	7.3	9.5	4.3	9.1	11.2	8.7	6.5	17.5	5.9	4.1	7.3	5.4	15.7	19.9	26.4	20.0	14.5	8.9	22.5	15.2	18.8	22.4	20.8	29.1	11.9	8.4	3.5	21.1	18.3	17.8	10.7	14.8	8.7	27.5	7.4	5.0	5.9	25.5	16.1	8.1	0.0	5.9	6.7	7.1	9.0	17.4	4.3	5.6	44.5	8.1	36.2	10.0	8.1	10.0	9.5	1.7	2.8	6.8	12.0	6.4	7.0	13.4	4.7	17.9	12.9	10.0	7.9	7.6	3.4	8.7	20.0	5.1	9.8
ZNF165	"CT53, ZSCAN7"	ENSG00000197279	"Zinc finger protein 165"	P49910	6	28080975-28089563	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.9"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 113.2;Intestinal endocrine cells: 51.6;Syncytiotrophoblasts: 66.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.7;GAMG: 14.0"					"Low region specificity"	"Detected in all"			HPA007247			Approved	"Nuclear speckles,Microtubules"		NA	NA			"Nuclear speckles, Microtubules"		"HPA007247: AB_2797217"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.19e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (9.82e-5)"	0.4	0.8	1.2	2.1	1.7	0.7	2.2	1.3	2.4	1.5	2.6	0.9	7.9	2.0	1.1	6.3	2.5	1.8	0.6	0.8	1.7	1.1	3.5	2.7	2.6	0.9	0.8	0.3	0.7	5.4	3.1	7.7	6.2	4.0	1.2	3.6	0.6	2.5	1.3	0.4	1.0	3.4	0.4	0.5	1.0	2.2	23.9	0.5	1.2	3.1	1.4	2.5	1.2	1.2	8.6	4.2	1.6	0.6	0.2	1.7	0.5	10.5	0.7	0.7	0.5	0.3	0.5	18.7	0.4	0.5	0.8	0.7	7.3	7.9	1.0	3.1	0.2	14.0	4.1	1.7	5.2	0.6	0.2	2.9	0.3	1.2	7.9	0.3	1.8	1.4	0.3	2.9	0.6	7.8	0.5	0.2	0.6	1.8	0.3	0.5	3.0	0.3	2.0	1.5	9.6	0.9	1.3	0.6	6.1	4.3	5.2	7.8	0.6	0.8	9.3	0.7	2.1	4.3	0.3	0.1	0.5	0.8	0.3	0.7	2.6	7.0	2.7	0.3	2.0	0.3	0.0	0.3	1.6	0.7	0.6	1.5	6.0	0.9	0.5	1.2	8.6	1.7	1.3	1.1	0.2	0.2	4.2	0.4	0.5	1.2	1.7	1.3	2.4	1.7	1.1	0.8	0.3	4.0	0.5	6.0	9.5	11.5	12.9	7.6	0.8	0.5	2.5	17.4	6.8	3.5	0.0	6.9	3.3	13.6	113.2	0.9	23.8	0.0	10.7	7.5	0.6	4.0	0.0	0.0	1.3	0.0	51.6	0.0	0.6	7.2	0.9	1.5	5.0	2.8	4.7	1.2	17.1	10.5	2.1	1.4	2.4	0.0	1.3	12.3	2.7	10.3	66.6	1.3	5.6	36.9
ZNF169	MGC51961	ENSG00000175787	"Zinc finger protein 169"	Q14929	9	94259311-94301454	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041769, HPA061185"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	"Vesicles, Cytosol"	"HPA041769: AB_2677662, HPA061185: "	"unprognostic (1.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.27e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.45e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-4)"	4.5	4.2	6.5	8.5	10.9	5.9	7.8	12.7	13.5	7.4	6.7	8.3	4.4	5.6	7.7	8.7	4.1	7.5	5.7	4.6	8.6	5.7	5.5	3.2	5.0	11.0	9.8	8.5	9.4	5.2	5.9	4.9	4.3	8.2	6.6	11.1	5.8	7.2	5.6	8.6	10.0	8.6	6.6	7.1	10.6	8.1	4.3	9.5	10.5	8.0	5.0	10.0	6.9	6.5	9.5	4.5	6.1	6.9	6.7	9.1	3.4	3.9	3.5	3.9	6.9	1.9	4.9	4.4	1.4	2.7	3.0	3.2	2.3	6.0	9.5	1.9	2.3	3.3	7.9	8.0	3.6	4.1	5.5	8.6	6.7	7.9	4.4	2.8	10.1	6.9	4.2	4.0	2.6	4.2	3.9	3.8	9.3	6.0	3.0	3.9	3.8	4.7	5.6	6.4	8.3	4.3	4.1	2.8	3.1	2.7	3.6	4.1	4.9	2.7	4.8	2.0	4.1	3.1	4.4	4.1	2.9	3.6	3.5	3.0	5.2	1.9	2.0	2.6	6.7	2.7	3.2	6.5	6.1	5.5	6.9	6.9	6.3	6.2	3.9	4.5	9.5	6.7	9.1	5.6	6.7	5.0	4.2	6.5	3.4	6.5	10.9	12.7	13.5	8.6	5.7	9.8	8.5	8.2	9.5	3.0	0.3	2.7	1.7	0.2	5.0	0.8	0.0	2.7	3.4	1.8	3.9	0.4	0.0	0.9	0.9	2.2	2.4	0.0	0.7	0.6	0.9	1.6	0.0	1.0	0.7	4.8	1.2	1.3	4.4	0.6	5.5	2.3	0.0	1.8	2.5	2.8	1.0	2.5	3.2	0.3	4.4	0.0	1.1	4.8	2.2	0.4	0.3	3.9	1.5	1.8
ZNF174	ZSCAN8	ENSG00000103343	"Zinc finger protein 174"	Q15697	16	3401235-3409370	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009656	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Actin filaments, Cytosol"	"HPA009656: AB_1080679"	"unprognostic (4.33e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.94e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.06e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.83e-1)"	10.0	11.6	11.1	9.0	16.0	5.7	12.8	15.8	24.3	13.0	14.8	18.1	9.4	9.6	16.8	18.8	11.0	17.7	13.4	15.3	11.8	12.0	11.1	9.9	8.7	11.6	15.1	10.5	21.0	9.1	28.5	15.2	8.2	15.7	14.7	11.7	16.1	12.2	18.2	14.1	11.4	9.7	16.8	13.3	11.9	10.5	13.5	15.7	18.8	12.2	9.1	12.8	14.8	10.8	9.5	6.9	23.1	6.4	6.8	11.5	6.7	6.3	10.5	12.1	13.6	14.7	10.6	8.3	6.0	14.8	13.0	11.9	8.3	11.1	22.0	9.5	10.5	11.8	9.2	11.2	10.0	12.3	13.9	11.5	11.3	9.9	10.0	10.6	12.9	13.7	12.7	11.8	11.0	11.0	12.6	11.0	15.4	17.9	9.9	13.3	10.6	12.8	10.8	13.2	9.4	13.0	18.4	13.6	17.3	9.5	3.2	11.4	8.8	11.7	13.0	10.0	12.0	12.7	14.4	8.8	9.7	10.6	7.8	7.8	12.3	13.3	17.3	5.2	8.1	9.1	13.1	5.7	23.1	9.1	6.4	8.7	9.5	9.4	10.2	6.9	7.1	11.5	8.5	6.8	6.8	4.2	3.6	8.8	6.7	11.1	16.0	15.8	24.3	11.8	12.0	15.1	10.5	15.7	15.7	3.0	1.3	1.4	1.4	1.6	6.9	4.4	7.6	1.4	1.2	0.0	5.9	5.3	3.3	4.4	4.3	3.8	3.3	0.0	3.7	3.5	2.8	1.7	1.1	3.2	3.8	3.2	3.5	2.5	1.8	3.1	8.1	1.3	3.3	1.8	2.0	7.4	3.6	3.2	9.2	3.7	8.1	0.0	1.5	11.8	9.5	1.6	2.4	3.8	3.4	0.6
ZNF175	OTK18	ENSG00000105497	"Zinc finger protein 175"	Q9Y473	19	51571298-51592508	"Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 25.5;RT4: 23.2;TIME: 23.4"					"Low region specificity"	"Detected in all"			HPA002717	Uncertain		Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA002717: AB_1080681"	"unprognostic (9.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.33e-3)"	"unprognostic (9.94e-2)"	"unprognostic (6.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (3.50e-3)"	6.1	6.7	11.2	6.1	12.6	4.7	8.4	26.2	16.0	7.7	6.5	7.1	9.4	8.4	9.2	8.5	5.5	7.6	4.9	6.6	12.7	7.4	7.3	6.4	8.0	8.7	11.1	10.3	14.5	7.3	19.8	10.9	12.1	11.4	7.6	6.1	6.4	9.1	9.5	6.4	5.5	7.9	8.1	8.8	9.7	6.7	15.0	11.7	9.2	10.8	5.0	9.2	8.7	11.9	2.1	4.6	0.6	1.3	0.9	2.2	0.7	1.8	3.2	3.3	3.4	3.5	4.8	0.0	4.1	5.3	3.9	4.7	3.3	2.8	3.3	2.4	4.1	2.4	3.1	3.5	2.8	7.0	0.0	5.2	25.5	5.0	1.1	3.0	4.2	16.4	1.9	2.7	7.9	3.9	19.8	6.2	3.3	8.5	3.5	4.2	0.0	4.5	3.2	1.8	2.2	3.3	0.0	4.2	1.6	2.1	23.2	4.1	3.0	3.9	1.3	2.5	2.7	1.0	3.5	23.4	6.0	2.7	1.4	4.0	4.6	8.4	3.4	16.6	2.5	3.0	0.1	1.3	0.0	1.7	0.5	1.8	1.9	1.6	1.4	1.4	2.1	2.2	1.7	0.6	0.9	0.3	4.6	0.3	0.7	11.2	12.6	26.2	16.0	12.7	7.4	11.1	10.3	11.4	11.7	6.0	4.8	2.4	1.5	1.0	6.1	3.1	2.5	5.3	7.9	5.2	2.0	6.3	1.7	1.6	9.5	2.9	2.0	0.0	1.4	1.2	2.6	1.6	13.9	2.1	2.7	15.9	1.7	5.5	6.6	7.0	3.1	2.0	3.3	1.8	1.2	2.3	4.5	0.0	2.5	1.4	7.4	0.0	2.1	5.8	4.1	1.3	10.1	1.8	2.1	0.7
ZNF18	"HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38"	ENSG00000154957	"Zinc finger protein 18"	P17022	17	11977439-11997510	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006144	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA006144: AB_1080683"	"unprognostic (2.99e-3)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (5.12e-6)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (1.52e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.53e-3)"	8.3	6.8	8.2	7.0	13.9	15.7	9.6	9.4	15.5	8.5	7.2	13.2	3.5	6.4	14.1	9.5	8.8	7.5	7.2	7.3	9.0	8.7	6.5	13.2	6.2	10.5	9.9	9.8	10.4	7.8	8.4	11.8	5.1	14.5	9.8	9.2	12.5	9.0	7.1	8.2	12.8	8.2	7.8	10.8	12.3	6.2	15.5	9.2	15.6	8.4	14.3	10.2	7.7	7.6	9.1	8.8	19.6	7.6	7.0	11.2	5.6	2.2	4.7	5.0	7.4	9.4	8.4	2.6	3.3	5.8	4.3	4.6	2.1	3.9	7.7	4.9	3.5	3.7	4.7	4.1	5.1	4.7	5.8	3.5	4.5	4.8	3.0	6.7	2.6	6.1	6.9	8.4	3.2	6.0	4.9	6.5	9.1	2.6	3.6	5.8	2.3	8.4	5.1	3.7	8.2	2.1	7.0	5.0	3.4	6.2	2.7	1.9	4.2	5.6	2.7	4.3	30.3	3.9	2.4	5.0	5.1	2.5	2.3	2.4	4.0	2.9	3.8	5.9	5.9	6.0	10.6	5.9	6.6	11.0	5.8	10.2	9.1	10.2	10.3	5.8	8.2	11.0	11.2	19.6	7.0	7.6	8.8	10.6	5.6	8.2	13.9	9.4	15.5	9.0	8.7	9.9	9.8	14.5	9.2	0.0	1.3	0.5	1.1	1.8	1.8	1.2	2.5	1.4	0.0	1.8	2.0	2.0	1.7	2.4	23.1	1.4	2.9	0.0	0.8	1.8	2.4	1.0	2.3	3.2	3.6	1.6	1.2	1.3	2.1	19.5	3.1	1.9	1.7	2.8	3.6	1.8	2.1	3.4	3.2	2.5	1.1	0.0	2.2	11.2	3.2	1.9	1.3	4.4	3.1	1.0
ZNF180	HHZ168	ENSG00000167384	"Zinc finger protein 180"	Q9UJW8	19	44474428-44500524	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028979, HPA028980"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028979: AB_10600328, HPA028980: AB_10611524"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.38e-3)"	8.2	8.6	7.3	10.0	9.1	6.7	10.5	13.4	8.7	10.3	7.7	7.1	10.4	8.8	11.1	6.3	7.5	9.7	8.0	5.9	6.8	5.6	9.4	9.5	7.0	10.7	6.9	5.1	11.9	8.0	16.4	13.7	7.5	8.7	12.3	8.7	6.7	7.4	11.6	6.0	8.8	10.7	7.7	6.6	12.8	7.7	8.1	8.3	17.7	11.2	7.2	8.6	8.2	8.7	6.0	3.8	6.5	3.4	3.6	9.6	3.0	8.3	2.4	10.3	7.1	2.2	4.2	6.9	4.2	4.4	6.8	8.3	4.5	1.6	1.1	5.3	5.9	6.1	2.2	5.9	10.1	8.6	8.5	4.4	10.2	2.7	3.0	2.2	12.6	6.1	4.5	3.9	4.7	5.7	6.8	5.0	4.0	5.0	7.1	5.4	1.6	6.4	4.2	6.2	7.3	4.7	4.5	5.3	5.5	6.9	15.0	8.7	6.8	8.1	7.3	4.5	6.7	4.4	10.5	4.0	12.4	5.5	1.4	6.8	1.9	5.7	3.8	4.1	5.5	6.2	5.8	3.4	6.5	3.5	2.4	4.6	5.4	4.5	5.5	3.8	6.0	5.8	5.4	2.9	3.6	2.7	1.8	9.6	3.0	7.3	9.1	13.4	8.7	6.8	5.6	6.9	5.1	8.7	8.3	6.0	1.0	0.9	1.6	2.3	6.4	4.1	0.0	5.3	4.5	1.8	3.9	4.5	6.6	3.2	4.8	2.1	2.1	23.3	3.7	2.8	2.4	2.0	1.1	2.9	2.8	1.6	4.1	7.4	3.8	0.9	2.6	2.2	5.0	2.8	4.5	5.6	3.2	5.7	4.2	2.9	4.6	6.5	3.1	2.4	5.3	1.1	2.6	5.7	4.3	1.4
ZNF181	"HHZ181, MGC44316"	ENSG00000197841	"Zinc finger protein 181"	Q2M3W8	19	34734155-34745378	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043701, HPA062305"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043701: AB_10960859, HPA062305: AB_2684743"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.34e-2)"	"prognostic favorable (5.45e-4)"	8.5	12.1	13.4	7.2	14.2	3.9	13.0	20.8	15.1	11.1	12.0	9.4	12.7	11.7	11.6	8.1	8.3	11.4	8.9	17.0	12.4	10.1	11.2	17.2	9.7	8.3	17.4	11.2	22.8	15.7	16.3	19.3	6.7	13.7	12.2	8.9	6.9	9.3	13.9	25.5	5.7	13.6	10.6	14.6	11.2	9.8	8.3	15.8	11.0	13.1	10.1	10.7	11.8	9.3	12.0	5.8	5.4	12.1	8.4	16.1	5.6	3.6	6.1	7.4	9.6	12.0	9.3	2.2	4.4	8.0	5.0	5.8	4.2	3.9	5.8	12.8	7.0	6.7	3.5	5.0	5.0	3.8	12.0	5.1	10.9	7.5	5.9	14.2	6.4	3.8	7.4	8.1	3.5	6.9	12.3	4.7	12.6	8.7	0.2	9.8	2.6	12.4	4.3	4.7	8.4	5.0	8.5	9.0	7.3	6.8	4.4	5.0	9.4	9.9	2.7	10.0	6.3	5.7	10.0	6.6	12.8	6.4	3.1	4.8	9.0	13.1	4.8	5.1	1.6	6.4	2.6	3.6	5.4	7.5	5.0	7.7	7.5	10.2	10.2	5.1	12.0	16.1	11.4	0.7	8.4	12.1	5.8	6.2	5.6	13.4	14.2	20.8	15.1	12.4	10.1	17.4	11.2	13.7	15.8	14.9	4.0	0.5	3.6	1.4	15.3	38.2	0.0	24.1	13.6	5.2	3.9	2.6	14.9	4.6	1.7	6.0	4.7	0.0	4.4	0.9	3.9	2.4	2.3	6.7	3.2	12.7	4.1	6.7	4.7	1.8	8.6	5.0	5.0	1.8	6.6	13.2	2.4	5.7	11.3	6.7	13.1	0.0	6.6	12.7	9.6	0.6	0.9	5.7	4.7	0.9
ZNF182	"HHZ150, KOX14, Zfp182, ZNF21"	ENSG00000147118	"Zinc finger protein 182"	P17025	X	47974851-48003978	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059574	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059574: AB_2684068"	"unprognostic (1.86e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.88e-3)"	"unprognostic (6.88e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (1.01e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.59e-2)"	"prognostic favorable (1.55e-7)"	6.8	6.9	10.2	7.3	15.2	8.7	8.8	22.1	12.9	8.3	6.5	7.1	5.4	5.7	8.1	9.7	4.7	7.6	6.5	5.0	9.1	6.4	7.7	7.3	7.0	11.9	10.2	7.1	9.9	9.4	11.0	16.9	6.7	9.9	8.4	7.1	4.7	6.1	7.7	4.2	7.3	7.9	6.1	7.7	12.6	7.3	5.8	12.9	16.1	13.2	3.5	12.1	7.0	8.7	7.9	4.3	7.4	8.5	4.9	9.0	4.4	3.6	4.8	6.2	5.9	3.5	4.0	2.4	4.7	5.6	6.9	8.3	3.7	4.9	9.4	3.5	3.0	6.4	4.5	10.1	2.7	8.4	6.6	5.9	4.7	6.2	4.8	4.4	8.7	7.7	3.4	5.8	5.8	7.0	8.2	4.1	9.3	4.0	7.0	6.3	2.7	6.7	15.6	9.7	2.4	5.7	5.7	11.6	10.3	6.0	2.5	5.7	7.8	7.6	2.5	4.4	14.1	6.2	7.6	4.1	5.5	6.0	7.8	3.9	9.3	7.6	7.3	3.8	7.4	3.6	3.1	3.4	7.0	6.2	3.4	7.0	7.9	5.6	5.7	4.3	5.6	9.0	7.5	7.4	4.9	8.5	3.2	5.2	4.4	10.2	15.2	22.1	12.9	9.1	6.4	10.2	7.1	9.9	12.9	11.9	6.5	3.7	0.7	0.2	6.3	2.7	2.5	4.0	2.3	1.8	2.0	1.8	0.0	2.3	0.3	1.4	0.7	0.0	1.6	1.1	1.4	1.0	0.0	2.1	1.4	1.6	7.5	4.9	4.6	0.0	2.3	3.3	3.3	3.6	4.4	3.8	2.5	1.4	1.8	1.9	2.7	0.0	1.3	3.0	2.0	1.0	0.7	2.5	2.3	0.9
ZNF189		ENSG00000136870	"Zinc finger protein 189"	O75820	9	101398873-101410660	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 61.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034814	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA034814: AB_10601030"	"unprognostic (3.87e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.32e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.57e-2)"	15.6	15.8	15.1	6.3	28.2	2.8	11.6	13.9	15.9	9.5	9.0	16.8	9.0	8.6	10.0	61.6	5.5	7.8	16.3	10.9	18.7	9.3	10.6	12.5	6.8	6.8	15.4	11.4	11.8	23.0	11.2	23.6	6.3	14.1	10.3	7.5	5.0	6.7	9.4	11.6	4.4	9.7	9.7	25.1	9.9	8.7	9.3	16.1	8.5	9.6	3.7	10.2	6.1	8.0	3.6	2.2	4.1	3.0	3.6	4.7	1.9	5.5	4.6	15.0	10.9	13.5	9.5	7.2	8.0	12.3	9.4	8.2	9.7	4.4	7.5	5.4	9.6	9.9	10.9	7.5	7.6	8.4	9.9	5.2	8.2	7.2	20.6	10.1	8.5	7.2	11.5	10.5	8.3	13.0	12.9	11.6	9.2	9.7	10.9	13.8	3.1	10.2	3.7	10.8	12.3	5.2	7.3	21.5	5.7	8.9	6.5	15.6	9.8	8.6	6.0	8.6	10.3	4.9	10.9	9.7	9.2	6.7	7.6	6.1	10.4	16.0	3.6	8.0	3.4	9.3	1.3	2.5	4.1	2.3	3.0	2.4	2.8	4.0	4.7	2.2	3.6	4.7	4.1	1.4	3.6	2.3	1.7	2.0	1.9	15.1	28.2	13.9	15.9	18.7	9.3	15.4	11.4	14.1	16.1	8.9	5.4	2.4	7.4	8.8	7.9	20.2	22.9	8.1	12.5	1.8	3.9	3.6	8.3	5.3	1.9	9.0	4.9	0.0	15.9	1.7	8.0	5.2	9.2	7.8	4.7	7.9	5.2	8.0	14.0	1.5	10.3	6.6	6.8	1.8	5.3	6.7	8.4	4.9	10.3	11.4	3.3	12.9	9.2	6.2	3.4	5.6	1.6	5.4	3.6	3.5
ZNF19	"KOX12, MGC51021"	ENSG00000157429	"Zinc finger protein 19"	P17023	16	71464555-71565089	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 32.0"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 13.4;Rod photoreceptor cells: 24.7;Spermatocytes: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA063685	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA063685: AB_2685090"	"unprognostic (5.59e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-4)"	"unprognostic (6.02e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.04e-6)"	"unprognostic (3.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.87e-2)"	4.7	3.3	4.8	4.1	6.8	2.5	6.3	4.3	5.2	3.8	2.6	7.1	2.9	3.3	5.6	14.4	4.6	9.1	6.9	4.7	4.9	4.1	5.6	3.4	4.5	3.4	3.0	4.4	4.8	6.4	3.9	32.0	1.7	6.8	3.6	2.2	5.2	4.9	3.2	9.0	6.9	3.4	2.6	4.5	3.1	3.0	18.7	5.5	3.0	8.9	2.0	2.6	2.8	1.9	6.1	3.5	4.4	2.5	2.5	4.3	1.7	2.5	1.7	5.7	6.2	2.8	3.8	3.7	3.0	1.4	2.4	3.0	3.8	6.3	4.5	4.1	1.6	3.8	2.4	3.0	2.9	1.1	2.7	3.3	4.6	4.1	4.9	0.9	4.9	4.1	5.0	3.8	2.8	5.3	4.8	2.3	6.2	2.9	4.2	1.8	3.5	3.3	3.6	2.9	1.1	4.5	2.1	4.7	1.8	2.9	5.5	9.1	5.8	6.1	1.8	5.0	4.2	4.5	3.7	2.7	6.2	3.1	4.3	3.5	4.0	3.3	1.7	5.6	3.0	3.4	4.4	2.4	2.1	3.1	2.2	1.3	5.4	3.4	3.0	1.9	6.1	4.3	3.9	4.3	2.5	2.5	3.5	1.4	1.7	4.8	6.8	4.3	4.8	4.9	4.1	3.0	4.4	6.8	5.5	0.0	2.7	0.5	2.0	0.2	3.2	1.1	0.0	13.4	2.3	1.8	9.8	1.1	5.0	3.4	2.4	1.1	1.7	0.0	1.2	0.7	1.0	1.6	0.0	2.9	1.2	9.5	1.2	2.5	0.6	3.6	0.6	0.6	0.0	1.0	1.5	3.8	2.2	1.4	1.8	2.1	24.7	6.5	1.0	14.6	7.0	0.5	0.5	0.9	1.2	0.7
ZNF195		ENSG00000005801	"Zinc finger protein 195"	O14628	11	3339261-3379222	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030605	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030605: AB_10602686"	"unprognostic (2.30e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.24e-4)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.79e-7)"	12.2	11.3	14.0	13.2	18.8	15.0	20.9	28.0	22.7	13.4	15.4	19.6	10.8	13.5	13.4	25.3	10.8	12.6	11.1	9.6	15.2	16.9	16.4	14.6	12.7	16.5	16.9	10.5	10.6	16.0	8.8	20.8	9.9	22.5	16.4	19.4	9.3	13.2	9.7	13.0	13.5	14.0	11.3	15.4	19.5	13.3	6.9	20.0	25.8	15.9	8.6	15.9	13.1	12.9	13.6	12.2	9.9	9.2	13.0	19.1	8.2	8.1	8.8	15.2	18.4	5.3	6.7	22.3	8.3	7.1	8.9	11.1	9.3	15.1	13.2	5.2	5.4	12.3	11.3	16.9	10.1	12.9	6.4	14.1	9.8	8.7	9.3	6.9	16.1	14.7	8.5	9.8	7.4	12.5	6.3	11.1	17.3	17.1	8.6	9.7	6.5	19.1	12.8	35.4	9.1	9.0	16.8	9.4	6.7	14.0	19.1	25.5	25.3	9.1	11.5	7.6	14.4	5.6	14.5	7.8	4.2	8.1	7.6	7.3	7.9	11.0	20.9	4.3	11.9	7.4	1.9	8.4	9.9	12.0	9.2	15.2	13.6	14.8	14.6	12.2	12.7	14.0	15.6	1.4	13.0	7.7	10.7	19.1	8.2	14.0	18.8	28.0	22.7	15.2	16.9	16.9	10.5	22.5	20.0	14.9	21.6	16.5	15.0	10.8	14.9	15.5	10.2	21.4	21.6	7.0	9.8	8.4	8.3	20.8	2.4	11.1	8.5	0.0	16.3	9.2	6.2	6.5	5.8	6.7	9.6	17.5	19.5	9.2	11.4	0.0	5.5	8.5	6.8	7.2	13.1	17.0	22.6	11.5	5.3	9.1	12.8	0.0	7.5	10.0	8.7	5.9	3.3	12.8	14.5	15.4
ZNF197	"D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41"	ENSG00000186448	"Zinc finger protein 197"	O14709	3	44584888-44648471	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA054567	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054567: AB_2682527"	"unprognostic (1.06e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.85e-2)"	9.9	9.9	14.0	12.4	16.1	4.2	12.7	23.7	15.4	13.5	10.9	8.6	18.3	8.9	13.6	13.4	8.3	11.0	9.2	9.8	13.2	12.4	10.2	12.8	9.4	9.7	15.0	14.0	18.4	10.2	17.8	23.5	11.1	16.0	13.7	11.1	9.2	9.0	19.8	18.2	10.8	8.8	17.6	18.3	10.1	9.2	10.1	16.2	11.8	15.9	8.9	9.6	12.0	15.7	2.7	3.2	0.9	8.4	2.5	1.7	0.7	3.0	1.4	14.0	4.5	7.9	8.6	0.4	6.2	7.9	5.4	5.8	3.0	2.6	3.0	3.7	5.2	3.1	2.1	7.1	5.4	6.1	0.7	1.7	12.7	5.3	2.1	7.6	10.2	3.3	9.1	8.1	5.8	9.8	7.9	3.8	4.4	7.9	5.0	8.7	0.7	5.8	6.7	9.2	3.3	4.4	1.9	10.1	3.7	5.7	3.7	6.0	10.1	5.8	2.7	8.4	7.9	7.8	8.8	4.4	6.0	4.3	8.4	5.1	6.5	7.5	2.0	4.7	3.1	5.9	0.6	1.4	0.9	1.5	0.6	1.5	1.1	1.4	1.4	1.9	2.7	1.7	1.0	0.9	2.5	8.4	3.2	1.5	0.7	14.0	16.1	23.7	14.7	13.2	12.4	15.0	14.0	16.0	16.2	14.9	5.4	3.7	4.2	2.3	11.8	10.1	2.5	5.3	14.8	0.0	7.9	1.0	1.7	6.4	11.8	4.5	4.5	0.0	7.7	0.5	4.3	4.0	3.5	6.7	4.0	15.9	5.8	5.5	3.5	2.2	5.2	3.6	5.0	7.2	6.5	12.2	5.8	7.0	4.9	3.7	8.9	6.5	4.2	10.8	5.3	3.0	0.3	5.2	5.0	2.6
ZNF2	"A1-5, Zfp661, ZNF661"	ENSG00000275111	"Zinc finger protein 2"	Q9BSG1	2	95165432-95184317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041358	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041358: AB_10795539"	"unprognostic (1.18e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	5.1	4.1	5.2	3.2	6.3	0.7	4.0	6.4	6.1	5.3	2.6	6.4	2.5	3.3	5.4	5.7	3.5	4.8	2.3	4.6	5.1		4.2	2.7	3.5	4.3	5.3	5.0	6.5	2.8	6.5	7.1	3.1	5.2	4.8	2.5	4.9	3.7	5.5	4.2	4.7	2.2	4.1	6.1	4.3	3.5	4.3	5.9	4.3	5.0	4.5	5.0	4.3	4.0	7.2	5.0	15.1	6.2	4.2	8.6	4.5	5.4	5.2	6.5	10.8	9.7	7.6	4.2	6.1	8.0	8.4	11.0	5.6	3.7	3.5	4.3	5.7	5.9	4.5	6.9	4.6	8.8	7.6	5.9	8.0	4.3	7.0	7.9	4.1	5.2	6.5	6.5	7.6	11.9	9.3	7.2	6.6	5.3	2.9	8.6	4.9	5.9	5.7	2.8	4.8	7.2	5.7	11.2	4.5	4.8	3.2	5.5	7.5	5.7	8.2	6.9	5.7	5.1	6.3	5.8	10.1	5.9	8.0	5.1	5.0	4.3	4.3	6.8	5.4	7.7	5.9	4.4	15.1	8.6	6.2	6.2	7.2	7.0	7.5	5.0	6.9	8.5	8.6	3.6	4.2	4.7	4.1	7.6	4.5											0.0	1.7	0.5	0.6	0.9	2.8	2.4	2.5	4.0	2.3	1.8	0.0	1.3	5.0	1.5	1.6	1.6	0.7	0.0	1.6	1.1	1.2	0.7	1.1	1.6	2.2	1.6	0.0	1.3	3.2	0.4	2.0	1.7	0.0	0.0	0.7	3.6	0.8	0.0	2.8	2.2	2.9	6.5	1.9	4.2	6.8	1.0	1.4	2.1	1.2	0.6
ZNF20	KOX13	ENSG00000132010	"Zinc finger protein 20"	P17024	19	12092843-12140407	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 32.1;Early spermatids: 34.4;Late spermatids: 39.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 18.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA020887	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA020887: AB_2218842"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.08e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.21e-3)"	3.3	4.0	2.7	3.5	4.0	4.9	6.3	3.5	3.7	7.3	4.4	2.3	9.5	1.8	6.3	7.8	4.5	10.3	2.7	2.5	3.0	2.8	5.6	2.6	3.6	4.3	2.8	1.3	6.6	6.1	4.0	9.5	3.8	4.0	9.1	4.4	2.7	4.6	4.0	1.9	6.2	7.5	3.9	2.9	6.0	4.4	14.8	3.8	8.9	9.3	3.9	3.9	5.3	4.5	2.3	2.2	18.5	2.2	6.0	3.3	1.0	3.3	0.1	4.6	9.6	2.1	3.5	3.6	3.0	5.3	2.7	3.8	1.0	1.9	3.2	3.4	3.4	4.0	2.1	2.5	2.1	2.8	2.6	0.7	1.3	3.5	1.6	1.2	0.1	3.0	3.0	4.6	1.1	1.6	3.1	1.6	6.5	2.0	0.5	5.7	1.3	4.1	3.6	7.8	1.6	2.6	3.1	2.6	1.7	3.4	7.3	2.0	4.6	2.7	1.9	3.9	4.7	3.6	5.2	0.0	6.5	2.2	6.3	2.0	5.3	2.9	3.1	0.4	0.0	2.5	9.7	2.2	5.1	1.5	1.1	1.5	1.5	1.3	1.5	1.2	2.3	1.4	1.2	18.5	6.0	2.0	2.2	3.3	1.0	2.7	4.0	3.5	3.7	3.0	2.8	2.8	1.3	4.0	3.8	0.0	0.0	0.0	0.7	0.1	0.5	0.7	2.5	32.1	0.0	1.8	2.0	0.8	1.7	2.0	34.4	0.1	2.3	0.0	2.1	1.0	0.4	1.7	2.3	2.1	1.3	0.0	4.1	0.0	1.0	39.3	0.6	0.2	0.0	1.8	1.3	0.5	1.9	2.5	0.0	1.9	1.3	0.0	0.4	7.6	1.7	0.5	0.9	0.0	1.2	1.4
ZNF200		ENSG00000010539	"Zinc finger protein 200"	P98182	16	3222325-3236221	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 27.3"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 31.6;Spermatocytes: 38.8;Spermatogonia: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018981, HPA059310"	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA018981: AB_1859021, HPA059310: AB_2683974"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.21e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.23e-3)"	5.4	5.5	4.4	7.5	5.4	3.0	5.7	8.6	7.0	5.1	4.9	6.0	4.7	5.5	6.0	6.8	5.1	5.9	4.7	5.2	4.0	4.3	4.8	6.4	5.2	9.5	4.6	3.3	6.2	3.9	7.3	7.1	8.2	5.6	5.3	5.0	4.2	5.1	4.7	4.0	4.1	5.4	5.3	3.8	10.4	4.7	27.3	5.0	9.6	6.8	2.9	8.3	5.8	4.9	5.8	5.0	19.3	5.1	8.7	10.1	5.4	4.9	5.2	11.7	8.3	4.3	4.6	14.1	6.4	8.0	8.9	8.2	7.8	4.2	9.7	5.0	5.2	5.2	3.7	9.1	7.0	10.6	9.0	8.4	8.0	6.9	6.4	5.8	13.6	19.1	4.6	5.8	6.5	5.9	5.1	7.6	6.9	8.8	7.4	7.7	4.5	9.7	7.1	18.4	6.1	5.0	11.8	16.1	11.3	5.5	2.8	6.7	9.9	6.1	4.7	5.3	8.3	6.7	15.3	5.2	9.1	8.5	3.1	5.6	19.0	18.6	8.3	2.2	8.5	7.0	19.3	3.9	13.6	8.5	5.1	8.2	5.8	7.8	10.1	5.0	5.6	8.0	8.9	16.9	8.7	4.7	3.1	9.0	5.4	4.4	5.4	8.6	7.0	4.0	4.3	4.6	3.3	5.6	5.0	3.0	3.0	0.5	4.1	2.9	5.3	3.4	7.6	2.7	5.7	3.5	11.8	5.9	3.3	3.9	31.6	7.0	2.6	23.3	3.4	5.3	5.1	3.4	4.7	3.8	6.0	0.0	6.4	6.7	7.1	17.1	5.2	6.9	6.8	3.6	4.0	5.7	2.9	4.0	2.8	1.9	6.1	6.5	5.7	38.8	31.2	2.8	4.9	6.5	3.3	4.2
ZNF202	"ZKSCAN10, ZSCAN42"	ENSG00000166261	"Zinc finger protein 202"	O95125	11	123724177-123741675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Club cells: 15.9;Spermatocytes: 12.9;Spermatogonia: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059229			Approved	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Nucleoli rim, Mitotic chromosome"	"Nuclear bodies"	"HPA059229: "	"unprognostic (3.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (9.93e-7)"	"unprognostic (2.61e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	7.2	6.5	9.2	16.1	11.6	6.0	10.4	11.9	10.9	9.5	8.2	9.2	8.1	5.6	13.1	13.9	8.8	9.7	6.1	6.2	7.3	5.5	6.6	7.3	7.8	10.6	10.5	6.4	15.1	14.1	11.1	11.5	8.2	7.0	10.6	11.0	7.2	9.2	8.6	8.5	10.9	8.9	12.3	7.0	14.1	8.0	24.0	7.8	8.9	10.3	5.4	11.7	9.1	10.5	4.1	3.6	0.1	3.6	3.0	5.6	3.0	4.0	6.0	10.7	12.9	5.0	7.3	8.5	6.3	5.3	6.2	5.4	6.6	10.9	12.3	6.1	5.0	9.8	10.4	10.9	7.4	8.6	5.1	6.4	20.3	3.9	7.0	6.7	12.4	6.3	5.3	15.3	6.9	20.9	5.3	7.1	10.7	11.4	8.1	7.8	4.4	10.7	16.3	17.1	14.4	9.3	13.4	7.0	4.6	5.7	7.8	7.7	8.9	5.5	6.8	4.5	9.7	11.5	8.7	5.8	11.6	6.9	8.2	6.4	5.5	3.7	8.4	3.1	13.8	7.6	0.0	2.1	0.1	3.8	3.6	3.4	3.4	4.8	4.9	3.6	4.1	5.6	5.0	0.0	3.0	1.5	2.3	4.0	3.0	9.2	11.6	11.9	10.9	7.3	5.5	10.5	6.4	7.0	7.8	6.0	0.3	6.0	2.5	2.6	2.8	2.5	0.0	0.0	15.9	3.5	0.0	1.9	1.7	1.9	3.8	2.2	0.9	0.0	2.9	1.4	1.9	1.6	3.5	1.6	1.5	6.4	2.9	3.1	1.9	3.6	1.7	2.5	0.0	1.0	3.4	2.4	2.9	0.0	1.1	1.3	2.3	6.5	1.0	12.9	14.0	2.6	0.7	2.5	2.9	2.1
ZNF205	"Zfp13, ZNF210"	ENSG00000122386	"Zinc finger protein 205"	O95201	16	3112560-3120517	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001791	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001791: AB_1080688"	"unprognostic (8.46e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.71e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.17e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-3)"	10.7	10.6	11.4	7.0	13.6	3.5	9.8	16.4	16.8	11.8	11.1	14.2	17.2	13.9	13.0	9.3	10.6	14.2	14.9	12.9	11.5	10.1	13.6	12.4	10.3	5.3	13.0	12.1	17.2	18.3	16.5	10.9	11.0	12.0	12.9	6.1	10.2	15.4	14.8	30.6	19.0	11.1	9.7	9.0	9.0	11.5	5.6	14.3	1.4	14.4	9.0	4.6	8.2	12.4	0.6	0.3	1.5	0.5	2.7	2.4	0.6	7.6	9.2	8.8	14.1	3.5	4.7	12.1	6.4	6.7	8.4	10.4	4.9	7.3	0.3	8.4	4.0	5.4	11.9	7.7	6.6	4.0	2.0	15.5	3.2	12.8	6.2	7.9	0.4	1.8	5.1	10.4	8.0	5.5	8.7	9.6	0.2	6.8	5.8	4.2	12.9	0.1	0.3	9.3	5.0	7.6	0.4	11.1	6.9	4.9	4.3	12.5	10.9	6.6	14.3	9.3	4.8	10.1	2.8	5.5	8.5	9.8	8.2	9.0	0.1	5.8	0.3	3.7	0.4	7.1	0.0	0.5	1.5	2.1	0.4	1.8	0.4	0.7	1.9	0.3	0.6	1.8	2.4	0.2	2.7	0.0	0.2	1.1	0.6	11.4	13.6	16.4	16.8	11.5	10.1	13.0	12.1	12.0	14.3	0.0	0.0	2.4	3.8	5.0	7.3	1.1	10.2	0.0	0.0	5.2	3.9	7.8	5.0	10.5	0.7	5.6	15.6	0.0	11.8	12.1	5.6	2.9	4.6	8.3	7.6	6.4	9.9	7.4	4.6	0.9	15.8	2.5	5.0	5.4	13.2	8.5	11.9	7.0	18.4	12.2	8.2	25.8	5.8	1.7	1.1	4.8	4.0	0.0	12.0	1.6
ZNF211	"CH2H2-25, ZNF-25"	ENSG00000121417	"Zinc finger protein 211"	Q13398	19	57630395-57642779	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA011340, HPA049967"	Approved		Approved	"Mitochondria,Rods & Rings"		NA	NA			Mitochondria	"Rods & Rings"	"HPA011340: AB_2668488, HPA049967: AB_2680973"	"unprognostic (6.47e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.72e-3)"	8.8	11.3	11.1	10.1	13.5	24.2	11.7	18.3	14.2	10.1	10.0	17.5	14.8	5.2	12.3	13.2	7.2	10.9	9.3	11.5	11.0	10.4	11.3	6.5	11.1	13.3	12.0	12.4	13.4	7.3	25.7	16.7	13.9	12.2	12.6	10.2	15.4	8.7	14.9	6.8	12.0	12.5	10.3	10.7	17.7	17.6	6.1	9.1	17.7	16.5	5.4	15.1	12.9	10.3	10.5	7.6	12.7	6.2	7.0	13.7	6.5	3.9	2.5	11.6	10.4	6.8	6.8	6.8	5.5	6.8	7.9	5.3	2.0	2.3	3.7	2.4	5.8	4.7	0.9	5.5	8.3	16.8	4.6	13.6	7.2	5.7	4.8	5.9	5.0	7.6	6.3	10.1	5.9	5.6	11.7	6.0	6.8	1.6	4.8	9.7	1.8	10.2	3.4	4.7	5.1	6.1	6.3	8.7	3.3	6.8	15.2	5.4	7.5	6.6	3.3	2.5	13.6	3.5	7.1	3.8	8.1	3.9	3.4	4.6	6.7	8.5	7.8	2.2	4.1	4.7	7.9	6.2	12.7	8.4	5.9	13.7	8.8	11.1	12.1	7.6	10.5	13.2	9.3	8.3	7.0	3.9	1.6	11.8	6.5	11.1	13.5	18.3	14.2	11.0	10.4	12.0	12.4	12.2	9.1	3.0	4.3	11.2	1.1	1.0	3.9	4.5	2.5	10.7	1.2	1.8	7.9	6.2	0.0	2.9	0.4	3.8	3.2	0.0	1.0	4.0	1.9	1.8	5.7	1.5	3.4	0.0	1.2	5.5	6.3	0.4	1.1	2.9	1.7	3.6	3.0	4.2	1.3	0.0	2.1	1.0	6.6	12.9	2.5	2.7	3.0	1.5	14.9	7.0	2.4	2.5
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142805	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 18.5;Late spermatids: 41.1;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: AB_2683225"	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	5.7	8.2	9.0	6.0	10.3	6.0	5.7	10.8	16.7	5.0	6.2	14.6	4.7	9.3	7.5	5.1	8.4	6.8	6.0	9.1	9.5	7.7	4.4	2.4	6.3	8.8	7.1	9.3	10.3	12.1	8.7	7.3	4.1	9.1	6.5	2.5	6.8	17.4	5.9	11.1	16.9	11.2	6.8	7.6	7.5	6.9	20.1	8.0	7.5	9.2	4.7	5.4	7.1	5.8	4.8	3.2	3.5	2.5	4.0	4.7	1.8	3.4	10.7	4.8	11.3	4.6	3.9	5.9	6.2	2.5	3.3	3.9	3.4	7.0	4.1	6.1	4.0	4.8	8.3	2.2	6.9	1.3	8.6	8.3	2.9	11.8	6.6	8.9	7.0	7.7	3.7	8.6	4.6	1.7	2.5	2.5	8.1	7.4	9.2	2.1	14.6	6.6	8.7	8.2	3.6	8.2	8.9	5.6	7.5	2.6	2.3	9.9	8.5	9.4	5.6	4.4	3.2	7.4	12.2	6.1	6.7	6.2	7.6	4.3	5.2	4.8	6.3	2.7	9.3	5.1	0.0	1.6	3.4	3.7	2.5	3.2	2.7	3.6	2.4	1.6	4.8	4.7	3.4	3.5	4.0	1.9	3.2	2.0	1.8	9.0	10.3	10.8	16.7	9.5	7.7	7.1	9.3	9.1	8.0	0.0	0.6	1.7	1.3	1.6	5.9	3.3	2.5	1.4	1.2	0.0	2.0	1.4	1.7	3.5	18.5	2.2	8.5	0.0	4.3	1.6	2.5	1.7	4.6	1.0	2.8	7.9	2.4	2.5	4.1	41.1	6.1	2.3	0.0	3.6	5.3	4.6	4.9	3.5	6.7	2.3	5.2	19.4	4.4	8.9	3.8	1.8	1.1	0.0	5.2	1.3
ZNF215	"ZKSCAN11, ZSCAN43"	ENSG00000149054	"Zinc finger protein 215"	Q9UL58	11	6926404-7001004	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.6"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 7.0;Cone photoreceptor cells: 5.9;Spermatogonia: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 18.1"					"Low region specificity"	"Detected in all"			"HPA047243, HPA051010"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA047243: , HPA051010: AB_2681308"	"unprognostic (2.18e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	1.2	1.4	1.5	9.0	1.8	1.4	2.7	0.7	4.0	1.9	4.2	0.3	0.9	4.6	2.3	5.2	2.8	1.4	1.1	1.4	1.2	2.2	2.9	1.6	1.5	6.7	0.7	1.4	1.9	10.4	0.0	0.8	0.7	1.9	2.7	5.5	1.2	4.2	2.0	0.9	1.6	5.5	0.9	1.1	4.8	1.6	6.1	0.0	6.5	2.7	2.1	11.6	3.3	2.2	2.5	2.9	4.0	1.8	1.5	1.4	0.8	2.6	1.2	1.8	0.6	1.3	1.6	5.8	6.2	5.3	3.2	6.4	0.2	0.1	8.7	2.0	3.3	4.1	3.1	5.1	6.1	6.1	0.0	7.0	0.1	0.8	0.1	1.3	5.3	0.4	2.8	2.9	0.1	6.7	1.6	5.1	0.1	10.2	3.0	1.3	0.1	0.2	0.2	8.5	0.0	1.7	0.2	0.1	1.0	0.2	4.8	0.1	0.2	0.0	2.2	0.2	4.5	0.2	2.2	2.4	2.0	5.8	2.4	0.1	0.4	0.1	18.1	4.6	0.3	1.8	4.0	1.8	0.6	0.8	1.0	0.3	2.5	0.6	1.4	1.7	2.5	1.4	0.8	2.7	1.5	0.5	2.9	0.7	0.8	1.5	1.8	0.7	4.0	1.2	2.2	0.7	1.4	1.9	0.0	0.0	0.0	2.2	1.3	0.3	0.5	0.2	0.0	0.0	1.2	7.0	5.9	0.3	1.7	0.1	0.2	0.0	1.3	0.0	1.5	2.2	0.5	0.4	1.1	1.0	0.4	3.2	1.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.6	0.2	0.4	0.0	0.0	0.8	0.0	0.0	0.9	1.5	7.5	0.3	0.0	0.0	2.5	0.6
ZNF221		ENSG00000159905	"Zinc finger protein 221"		19	43951223-43967709	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 22.4"	"Cell type enhanced"	"Detected in some"	7	"Bipolar cells: 2.6;Cone photoreceptor cells: 2.0;Melanocytes: 1.7;Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA059435	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA059435: AB_2684016"	"unprognostic (2.06e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	3.8	5.4	7.9	2.0	7.5	2.0	4.3	22.4	9.5	4.2	3.2	4.2	1.9	1.7	4.5	3.2	2.9	4.6	2.3	3.8	7.9	3.9	4.0	3.5	3.5	2.2	7.3	6.0	7.1	3.0	10.4	10.1	4.5	7.0	5.4	2.7	2.5	3.4	4.3	2.1	3.7	2.6	4.8	7.8	3.4	3.4	3.5	11.3	1.2	6.0	1.2	2.4	4.9	3.3	1.6	1.9	1.6	1.2	3.5	1.7	0.9	2.1	1.8	5.8	4.4	2.1	3.9	1.4	2.2	3.3	1.8	3.3	2.4	0.9	0.0	1.2	2.3	1.6	0.9	2.3	1.5	3.8	0.0	4.1	5.8	7.4	0.9	1.6	0.6	2.7	4.6	1.2	3.4	1.3	3.6	3.7	0.0	0.2	0.0	2.6	0.1	0.0	1.0	5.1	0.7	1.8	0.1	6.5	0.7	1.4	6.9	4.8	3.9	4.3	0.4	0.5	3.4	1.6	4.9	6.0	2.5	5.7	1.3	1.9	3.0	3.8	0.0	0.8	2.4	2.7	1.5	0.8	1.2	1.1	1.2	1.5	0.6	1.7	1.7	1.9	1.6	1.1	0.7	1.6	3.5	0.9	1.8	0.7	0.9	7.9	7.5	22.4	9.5	7.9	3.9	7.3	6.0	7.0	11.3	0.0	1.3	0.0	0.0	0.0	2.6	0.6	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.5	0.3	0.0	0.0	0.0	0.4	0.1	0.3	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.7	0.0	0.0	1.4	0.3	0.0	0.4	0.1	2.2	0.0	0.2	1.1	0.2	0.1	0.2	0.0	0.0	0.3
ZNF222		ENSG00000159885	"Zinc finger protein 222"	Q9UK12	19	44025342-44033112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004086	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA004086: AB_2273259"	"unprognostic (1.91e-3)"	"unprognostic (3.41e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (5.56e-7)"	"unprognostic (2.19e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-3)"	4.8	7.7	8.1	5.1	9.1	8.0	8.3	18.3	12.6	6.2	4.4	7.5	5.3	2.9	5.1	7.3	3.5	5.5	6.4	7.5	11.5	8.2	5.9	5.1	5.7	7.2	8.8	7.8	8.9	5.4	6.6	12.7	5.4	10.7	6.6	5.0	5.7	6.9	6.4	3.7	4.5	5.0	6.0	9.3	8.8	5.5	15.4	11.1	10.3	7.6	5.0	7.3	8.5	6.6	7.6	4.0	8.9	3.6	6.1	9.7	4.0	3.9	4.6	7.9	7.1	6.1	6.2	0.4	4.2	7.6	5.0	7.8	2.4	2.6	1.4	6.6	4.7	6.0	1.3	5.4	4.0	6.3	5.8	5.9	6.5	5.8	3.8	7.6	0.2	5.9	4.7	5.5	4.1	7.1	8.0	4.6	5.8	1.2	2.8	6.2	0.5	4.4	2.6	4.7	1.8	2.3	0.1	8.4	2.1	4.2	12.4	4.2	9.7	6.9	1.3	5.7	7.2	1.7	6.3	3.4	5.5	5.3	3.2	5.2	11.3	9.2	0.1	2.9	0.1	6.1	8.9	3.6	7.0	9.2	2.3	7.7	7.4	8.7	8.9	3.6	7.6	9.7	7.3	7.5	6.1	2.8	4.0	6.0	4.0	8.1	9.1	18.3	12.6	11.5	8.2	8.8	7.8	10.7	11.1	0.0	1.0	0.0	1.7	2.3	4.9	1.9	0.0	0.0	1.2	5.2	0.0	1.8	6.6	2.3	43.5	1.8	0.7	0.0	1.1	0.9	2.1	1.0	4.6	1.0	2.0	6.4	2.9	1.3	1.2	1.5	1.7	1.2	1.7	1.0	1.7	6.5	0.8	0.0	2.1	1.2	2.6	0.0	2.7	5.1	1.2	1.5	0.9	4.1	1.2	0.6
ZNF223		ENSG00000178386	"Zinc finger protein 223"	Q9UK11	19	44051367-44067991	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 21.6"									"HPA067823, HPA079175"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA067823: AB_2685906, HPA079175: "	"unprognostic (6.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-4)"	6.5	8.0	6.6	5.9	14.7	3.2	10.1	19.8	17.3	7.6	8.0	9.6	6.0	7.1	7.7	11.3	6.5	7.5	9.5	8.8	9.4	8.5	7.5	4.7	7.0	6.0	6.7	7.4	7.7	6.2	10.8	9.8	9.7	15.3	12.3	10.7	7.1	7.7	9.4	3.5	8.8	9.2	7.8	5.7	8.6	8.8	6.2	7.9	6.7	11.7	4.6	7.6	9.0	6.2	4.4	7.7	11.6	7.1	6.6	9.3	2.6	2.5	1.4	5.5	1.3	3.6	4.6	0.1	3.9	4.3	3.5	5.1	2.6	4.3	0.0	3.7	3.0	2.1	2.5	0.0	4.4	3.8	0.0	4.1	5.1	3.9	3.5	2.7	0.2	0.1	4.5	3.5	3.0	2.9	5.0	3.9	0.1	0.2	0.0	3.9	2.0	0.0	1.8	4.1	1.7	1.9	0.0	2.2	1.2	4.2	21.6	3.4	8.1	6.8	0.9	2.7	7.4	3.9	4.7	3.9	3.3	3.2	1.8	1.4	2.6	4.4	0.0	1.4	0.0	3.2	11.6	5.8	8.7	2.8	7.1	4.3	3.6	4.7	2.4	6.4	4.4	9.3	4.0	0.5	6.6	2.9	7.7	4.0	2.6	6.6	14.7	19.8	17.3	9.4	8.5	6.7	7.4	15.3	7.9	0.0	0.6	0.0	0.5	0.0	2.9	0.8	2.5	1.4	0.0	1.8	2.0	1.6	3.3	1.9	2.7	2.1	0.7	0.0	0.4	0.4	0.2	0.5	0.0	0.6	1.4	3.2	0.0	2.5	1.6	0.8	1.4	1.2	0.0	1.0	2.4	1.5	1.1	0.0	1.8	1.0	1.2	0.0	0.0	1.9	1.9	0.0	0.8	0.0	2.1	0.7
ZNF225		ENSG00000256294	"Zinc finger protein 225"	Q9UK10	19	44112181-44134816	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.9"									HPA073778			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073778: AB_2686634"	"unprognostic (1.52e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.03e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.82e-2)"	"unprognostic (7.18e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.60e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.17e-4)"	6.0	8.3	8.7	4.9	8.5	4.1	16.0	15.8	8.8	8.4	5.6	10.8	9.9	4.7	7.9	5.1	5.8	6.4	5.5	5.9	7.6	5.1	6.0	6.3	5.3	7.3	10.2	6.0	10.3	6.2	7.9	11.0	6.2	8.7	6.9	4.8	7.4	6.2	7.1	4.6	6.0	6.1	6.5	7.3	8.2	5.5	21.4	9.9	11.8	7.8	2.0	7.1	6.5	6.0	6.7	6.4	11.4	6.7	6.0	7.6	3.3	2.6	4.3	5.6	6.5	8.5	7.6	1.3	4.3	6.6	5.1	6.7	2.6	1.6	1.1	3.3	4.7	3.0	2.3	5.1	3.2	4.6	2.6	4.9	7.7	5.5	2.4	4.9	4.7	7.4	7.1	3.9	4.6	7.5	8.8	5.0	3.5	2.2	1.4	4.4	0.8	3.4	3.4	5.1	1.9	4.4	2.9	7.8	2.5	5.1	5.3	3.4	5.9	7.8	18.9	2.2	6.0	2.1	8.1	5.0	4.8	5.0	2.3	2.9	6.2	3.7	0.8	2.3	2.8	4.2	11.4	4.7	7.4	5.3	6.7	5.2	5.0	4.1	4.0	6.4	6.7	7.6	5.5	1.2	6.0	2.7	2.8	5.3	3.3	8.7	8.5	15.8	8.8	7.6	5.1	10.2	6.0	8.7	9.9	0.0	1.7	0.8	0.6	0.2	4.2	1.2	0.0	2.7	2.3	1.8	0.0	1.7	3.3	1.1	4.8	1.6	0.7	0.0	1.2	0.9	1.4	0.3	0.0	1.6	1.3	6.4	1.2	3.1	4.4	1.9	2.6	1.1	0.0	0.0	0.6	3.2	1.1	2.0	1.8	0.8	3.7	0.0	0.5	3.9	2.0	0.4	0.2	2.2	1.0	0.3
ZNF226		ENSG00000167380	"Zinc finger protein 226"	Q9NYT6	19	44165073-44178381	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006145, CAB034353"	Uncertain		Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"CAB034353: AB_2219110, HPA006145: AB_10696203"	"unprognostic (1.30e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (8.34e-4)"	"unprognostic (4.09e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.37e-5)"	10.5	26.2	23.2	10.2	24.9	8.9	18.6	37.6	20.8	9.6	12.0	18.0	14.9	12.0	12.4	23.9	9.4	14.7	15.0	13.9	19.9	19.1	13.8	15.6	11.1	16.0	26.8	22.3	18.7	7.8	12.2	38.7	11.5	21.3	19.6	13.1	12.2	9.7	14.8	7.6	10.9	12.0	11.0	21.5	15.5	14.0	14.5	28.6	15.9	21.5	5.5	13.5	14.4	11.3	19.4	13.3	24.6	10.6	16.9	19.7	9.4	9.3	10.4	11.7	8.6	11.1	17.8	5.3	9.7	21.9	11.0	20.1	7.2	11.6	3.3	12.4	12.4	15.2	5.2	5.1	9.6	13.3	5.3	12.2	13.2	12.7	5.4	9.7	8.5	9.0	20.1	12.8	13.3	26.9	21.3	14.2	10.0	2.7	3.3	20.9	3.1	9.2	3.6	5.7	5.4	7.7	5.6	9.3	6.5	10.7	25.9	8.4	13.4	19.6	7.2	4.5	12.0	11.7	12.4	11.1	10.1	12.5	5.5	11.5	16.3	14.8	9.6	9.2	5.9	10.7	24.6	10.5	6.6	16.2	10.6	18.2	13.8	16.4	15.9	12.4	19.4	19.7	17.2	7.9	16.9	9.0	13.3	17.7	9.4	23.2	24.9	37.6	20.8	19.9	19.1	26.8	22.3	21.3	28.6	14.9	14.4	12.9	14.5	3.5	41.4	25.8	20.4	24.1	10.3	10.4	25.5	11.6	29.9	20.2	11.2	13.5	15.4	0.0	24.4	5.9	15.4	23.8	10.5	21.5	15.3	20.6	11.6	16.0	20.5	5.1	17.8	15.0	20.3	19.8	17.5	25.6	19.2	20.1	20.8	33.8	29.7	6.5	11.3	14.3	18.3	5.1	10.8	27.3	11.3	16.5
ZNF227		ENSG00000131115	"Zinc finger protein 227"	Q86WZ6	19	44207547-44237268	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA030573	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA030573: AB_10610702"	"unprognostic (3.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.64e-4)"	10.4	11.5	13.6	8.3	13.3	6.3	12.7	24.7	14.4	12.9	10.3	13.0	8.7	8.0	15.4	12.1	10.1	12.6	9.0	8.9	12.3	11.7	10.0	11.0	9.4	14.0	13.5	12.5	17.6	9.9	18.5	28.0	11.4	15.7	13.3	9.0	9.6	9.3	11.2	10.0	9.6	8.9	12.8	15.3	13.4	12.6	10.7	17.6	20.8	12.7	4.3	16.2	12.3	13.2	12.1	5.8	13.0	4.5	10.6	13.1	4.9	5.3	7.6	9.1	11.3	7.4	6.5	4.3	5.2	7.5	5.1	9.9	3.7	4.2	9.3	8.1	4.8	6.1	3.1	10.3	5.5	6.9	12.1	13.0	16.2	8.1	4.5	5.3	14.1	7.2	5.9	6.2	5.0	9.4	8.4	7.5	10.9	1.6	0.2	5.4	2.8	13.2	3.7	14.6	5.5	4.0	7.9	9.2	7.9	5.2	9.7	15.5	15.9	11.7	5.3	4.1	9.3	4.4	7.6	6.4	5.6	9.3	4.2	6.6	21.8	28.8	20.4	3.7	5.9	7.5	13.0	4.5	8.6	10.7	3.2	11.7	11.4	10.0	10.3	5.4	12.1	13.1	11.1	4.1	10.6	2.9	5.8	11.8	4.9	13.6	13.3	24.7	14.4	12.3	11.7	13.5	12.5	15.7	17.6	0.0	1.0	5.1	3.8	2.7	6.0	6.2	2.5	1.4	6.8	5.2	2.0	4.6	3.3	3.4	18.5	8.1	2.1	0.0	3.6	3.8	3.6	7.0	1.1	3.9	3.7	7.9	2.4	9.2	5.7	16.6	5.2	3.5	1.7	4.6	4.9	5.2	4.7	3.5	5.3	2.4	4.5	6.5	4.7	4.4	6.9	3.3	1.8	6.4	4.2	2.5
ZNF229		ENSG00000278318	"Zinc finger protein 229"	Q9UJW7	19	44417519-44448578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 4.8;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 4.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.1"									HPA001494	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA001494: AB_1080692"	"unprognostic (2.59e-1)"	"unprognostic (7.41e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.04e-3)"	"prognostic favorable (8.43e-5)"	"unprognostic (3.66e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.34e-1)"	1.7	4.1	6.6	0.5	8.2	0.4	2.3	7.7	4.0	2.9	1.2	1.5	1.1	1.7	3.6	2.6	1.9	4.8	1.4	3.1	4.8		2.1	1.7	1.4	0.8	1.8	2.2	6.0	0.9	10.5	8.7	2.5	3.9	2.9	0.4	3.4	2.5	2.2	1.9	0.8	0.6	2.7	4.5	1.2	1.2	2.1	3.8	1.5	6.6	0.0	0.8	2.7	0.9	1.4	0.4	0.5	0.1	4.8	1.1	0.4	0.0	4.8	3.8	0.1	4.1	2.7	0.0	5.9	2.5	3.3	4.2	0.0	0.7	0.0	2.7	3.6	5.3	2.0	0.0	4.4	2.2	0.0	1.7	0.7	1.1	0.3	6.7	0.1	0.0	4.2	0.1	2.8	9.1	3.9	2.9	0.0	0.2	0.0	3.7	0.1	0.0	0.0	3.4	0.0	1.3	0.0	0.0	1.6	3.0	7.5	1.2	1.2	2.7	0.4	0.0	2.8	0.1	0.0	3.0	2.5	0.1	0.8	0.2	5.0	2.8	0.0	0.0	0.0	3.6	0.0	0.1	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.4	1.1	0.4	0.0	4.8	0.0	0.4	0.0	0.4											0.0	0.0	0.0	0.5	0.1	4.8	3.3	0.0	2.7	0.0	0.0	3.9	0.7	3.3	1.6	0.6	0.6	0.0	0.0	1.1	0.3	0.2	1.6	0.0	0.0	0.6	1.6	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	3.8	1.7	0.0	1.8	1.2	4.9	0.0	0.5	1.9	2.2	0.0	0.7	0.0	0.5	0.6
ZNF23	"KOX16, Zfp612, ZNF359, ZNF612"	ENSG00000167377	"Zinc finger protein 23"	P17027	16	71447597-71463095	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 6.0;Ciliated cells: 16.0;Club cells: 5.7;Cone photoreceptor cells: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023534	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA023534: AB_1859140"	"unprognostic (8.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.04e-2)"	7.1	5.5	8.5	6.3	11.5	5.6	7.7	16.4	14.3	6.7	8.1	5.1	4.6	5.5	9.3	14.9	6.1	10.3	5.2	6.0	11.6	9.6	7.6	6.5	8.7	9.5	11.3	13.9	11.4	6.1	11.1	19.5	5.5	11.4	8.4	7.6	8.4	6.4	8.0	7.4	8.5	6.4	11.4	8.8	8.2	6.0	8.7	9.6	5.4	10.2	7.0	9.5	7.4	7.3	4.6	4.2	1.7	3.6	4.0	4.9	1.8	4.7	4.1	10.4	7.5	5.9	5.5	6.4	11.5	8.5	7.7	5.6	5.4	5.2	10.2	3.1	7.5	6.8	3.5	6.1	6.8	6.9	2.4	4.4	5.6	4.0	4.1	5.9	10.3	4.0	6.5	5.2	8.0	13.9	8.4	2.3	5.2	8.3	3.1	7.2	11.1	4.0	4.9	8.8	2.3	3.7	2.7	3.1	3.1	5.4	4.1	8.3	8.8	3.8	2.8	3.0	4.5	3.6	4.8	9.6	16.1	4.5	4.4	7.5	5.4	6.3	14.4	12.2	4.3	8.8	1.7	1.8	1.2	4.5	3.6	3.9	3.0	2.5	4.9	2.5	4.6	4.9	3.8	0.0	4.0	2.0	4.2	4.1	1.8	8.5	11.5	16.4	14.3	11.6	9.6	11.3	13.9	11.4	9.6	6.0	2.9	0.5	0.2	0.2	2.2	0.3	0.0	16.0	5.7	0.0	5.9	0.2	1.7	1.8	0.1	0.1	0.4	0.0	0.9	0.3	0.2	0.2	2.3	0.8	0.3	3.2	0.0	1.8	0.0	0.0	0.6	0.1	0.0	0.0	1.0	1.3	1.2	0.3	0.0	0.0	3.3	0.0	0.4	1.8	1.2	0.0	0.0	0.0	1.3	0.1
ZNF230	FDZF2	ENSG00000159882	"Zinc finger protein 230"	Q9UIE0	19	44002948-44013926	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA006172			Approved	Mitochondria		No	No			Mitochondria		"HPA006172: AB_2667532"	"unprognostic (3.55e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.08e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.14e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.42e-5)"	7.2	6.0	6.0	7.8	6.4	7.2	8.3	13.3	7.8	8.1	5.2	4.4	5.2	3.4	6.2	5.8	4.3	6.6	4.2	4.7	5.1	4.2	5.3	5.6	6.2	8.9	6.9	4.4	11.3	4.3	7.7	10.2	6.1	5.9	7.2	5.3	6.2	5.3	6.8	2.6	7.3	6.4	4.9	7.2	11.1	5.2	6.8	5.5	16.6	8.6	3.9	9.6	9.0	9.3	5.5	4.3	13.9	4.8	3.2	6.0	3.4	2.9	2.4	5.1	5.2	4.1	5.1	2.0	4.3	4.3	3.9	7.1	1.5	1.7	2.4	2.9	3.1	2.5	2.5	4.2	3.9	5.9	3.0	5.3	4.2	5.4	1.8	2.4	5.3	3.6	3.8	3.6	4.4	4.5	5.3	2.7	2.9	0.8	0.1	4.0	1.5	6.0	3.9	2.9	2.0	2.4	4.5	7.1	1.2	2.3	3.6	2.8	6.5	6.0	2.1	3.1	3.7	1.8	12.5	3.4	6.2	4.6	1.8	3.2	3.1	3.0	0.4	3.0	4.0	3.8	7.6	4.1	9.8	4.7	4.8	4.9	4.8	5.3	4.8	4.3	5.5	6.0	5.5	13.9	3.2	2.3	2.6	4.5	3.4	6.0	6.4	13.3	7.8	5.1	4.2	6.9	4.4	5.9	5.5	0.0	2.1	4.5	2.9	2.5	8.5	5.3	12.7	0.0	3.4	3.5	15.7	3.4	3.3	2.6	1.5	3.8	3.2	0.0	2.2	2.7	3.9	1.9	1.1	3.0	2.8	7.9	1.2	3.7	2.1	1.2	6.1	4.6	3.3	8.2	2.4	5.2	0.8	0.0	4.2	1.4	8.9	6.5	4.1	15.0	4.1	2.4	2.6	7.2	2.6	1.7
ZNF233	FLJ38032	ENSG00000159915	"Zinc finger protein 233"	A6NK53	19	44259880-44275317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 25.2"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 23.3;Spermatocytes: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 10.7;U-266/84: 10.0"									HPA020975	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020975: AB_1859145"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-3)"	"unprognostic (6.88e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.71e-4)"	"unprognostic (1.55e-1)"	0.6	2.3	4.4	2.1	6.3	3.9	2.5	10.9	8.5	1.3	4.3	0.8	0.2	1.9	0.9	2.8	1.4	2.2	1.8	4.8	4.1	5.0	2.1	0.8	1.2	2.3	3.3	6.1	1.2	1.6	3.1	11.2	2.2	6.2	4.8	2.2	2.1	1.6	2.3	2.5	3.8	1.8	1.6	3.4	2.2	2.1	25.2	2.4	3.3	3.5	2.7	1.0	1.6	0.8	4.7	3.9	3.3	1.2	3.4	2.2	0.5	0.7	2.7	3.1	3.1	3.2	0.6	1.3	1.2	0.8	1.0	1.8	2.8	3.3	1.2	2.9	0.8	1.5	1.3	0.1	0.7	1.1	0.6	3.8	1.9	3.5	2.9	2.2	1.3	1.3	0.7	0.5	0.7	1.9	4.3	1.3	1.4	1.3	5.9	0.2	1.6	1.0	1.0	3.2	0.6	0.8	2.0	0.4	2.4	0.7	2.4	4.3	6.4	1.2	0.8	2.1	5.7	5.1	1.5	0.8	1.3	0.8	0.9	0.8	10.7	10.0	2.2	4.4	1.3	1.4	3.3	1.0	0.9	1.6	1.1	1.5	2.7	1.4	1.1	0.5	4.7	2.0	2.2	2.4	3.4	1.2	3.9	2.1	0.5	4.4	6.3	10.9	8.5	4.1	5.0	3.3	6.1	6.2	2.4	0.0	0.3	0.0	0.1	0.0	3.7	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	23.3	0.0	0.4	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.5	0.0	1.2	0.0	0.0	4.5	0.6	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	4.2	0.0	0.1	8.7	1.9	0.0	0.0	0.0	0.3	0.0
ZNF234	"HZF4, ZNF269"	ENSG00000263002	"Zinc finger protein 234"	Q14588	19	44141557-44160309	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001664	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA001664: AB_1080694"	"unprognostic (9.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.31e-2)"	"prognostic favorable (4.34e-5)"	8.0	11.7	8.2	8.1	12.7	1.4	10.1	18.3	10.5	8.3	7.6	12.0	9.5	7.6	8.5	6.4	7.5	7.0	7.0	9.4	8.8	5.1	8.1	7.2	7.5	9.0	14.7	8.2	11.7	7.3	12.4	14.3	9.6	10.6	8.9	7.8	7.4	8.7	7.8	7.7	9.2	9.0	9.0	11.1	12.2	8.0	6.4	14.2	11.6	10.1	3.4	10.4	8.5	7.7	6.2	4.2	5.4	4.4	7.2	7.7	3.1	4.8	3.4	8.3	7.9	9.9	10.2	3.8	6.3	4.6	5.0	8.3	4.2	3.0	0.1	4.3	5.7	4.7	3.7	6.2	4.0	6.0	0.0	7.5	9.6	7.0	5.5	4.7	0.0	6.8	5.7	9.1	5.4	6.2	6.9	5.5	0.0	0.6	0.1	7.4	1.5	6.4	2.3	5.5	3.1	3.2	0.0	9.4	1.5	3.1	9.4	4.6	7.7	4.5	3.8	3.3	8.9	4.2	3.9	5.6	9.3	7.6	1.7	5.7	5.2	4.3	0.1	1.0	0.0	7.4	2.4	3.6	5.4	6.8	4.4	5.7	4.1	4.0	4.7	4.2	6.2	7.7	7.3	1.4	7.2	3.1	2.9	2.1	3.1	8.2	12.7	18.3	10.5	8.8	5.1	14.7	8.2	10.6	14.2	0.0	1.3	2.2	2.2	2.7	4.4	8.0	0.0	1.4	5.7	1.8	2.0	4.9	5.0	3.6	5.4	2.9	1.7	0.0	1.8	2.2	4.3	2.0	3.5	0.9	2.3	4.8	3.5	4.9	3.2	4.4	6.4	1.4	1.7	1.8	2.3	2.9	2.0	3.2	5.3	1.7	5.9	6.5	3.1	3.9	4.7	2.5	2.6	5.0	2.1	1.8
ZNF235	"ANF270, HZF6, ZFP93, ZNF270"	ENSG00000159917	"Zinc finger protein 235"	Q14590	19	44228729-44305046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045582	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045582: AB_10963792"	"unprognostic (2.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.38e-2)"	5.6	4.8	8.1	6.6	10.4	1.8	8.1	13.9	10.3	6.1	7.7	10.7	10.1	5.0	13.2	6.5	5.2	7.1	4.9	6.9	7.8	7.5	6.7	5.5	6.6	7.4	8.5	4.1	8.1	6.2	10.1	9.0	7.3	9.4	7.7	6.0	6.9	5.8	8.2	6.5	4.4	6.4	6.9	7.1	8.2	5.3	6.8	8.5	10.7	9.1	2.9	9.3	6.2	5.9	10.9	8.3	14.5	3.7	5.6	7.5	2.4	2.0	3.2	6.4	6.4	4.8	2.9	2.4	1.2	3.8	2.3	2.8	2.0	3.5	3.4	3.2	2.4	3.6	1.7	5.6	2.6	2.8	0.0	6.9	7.3	4.9	2.9	3.9	4.1	4.4	2.9	3.5	2.6	3.1	4.0	3.8	6.3	1.7	0.0	2.5	1.6	6.7	0.8	7.6	3.5	2.0	3.3	6.1	2.9	4.6	5.0	4.6	13.0	3.4	4.1	3.0	6.7	3.2	5.0	4.4	2.1	3.0	0.6	1.4	7.8	7.8	2.4	1.8	1.1	3.4	14.5	3.7	3.6	6.8	3.0	4.7	6.9	5.1	5.8	2.7	10.9	7.5	6.5	2.0	5.6	2.9	8.3	3.7	2.4	8.1	10.4	13.9	10.3	7.8	7.5	8.5	4.1	9.4	8.5	0.0	0.0	2.7	0.6	0.5	1.7	1.9	2.5	0.0	0.0	0.0	5.9	1.2	0.0	0.9	0.9	1.4	1.1	0.0	0.0	0.4	0.7	0.8	2.3	0.9	1.2	1.6	0.0	2.5	1.8	0.0	0.6	1.3	1.7	0.0	0.7	1.2	0.4	2.8	3.2	0.4	1.6	0.0	1.9	2.6	4.8	0.5	1.3	3.9	1.0	0.1
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822607-76970727	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	5.7	5.2	7.0	9.1	11.2	10.8	10.0	15.3	11.0	7.2	5.8	7.3	6.7	5.0	7.6	7.1	5.6	7.6	6.3	5.1	8.3	5.7	4.7	4.3	6.4	6.2	8.3	3.5	11.3	7.1	12.2	8.9	5.6	7.3	6.2	4.1	5.4	6.6	12.6	5.7	9.9	5.5	5.8	6.5	5.5	5.8	16.6	10.6	10.4	6.5	1.9	10.0	6.2	12.7	9.0	4.6	5.9	3.4	3.0	5.4	1.2	4.2	5.7	8.0	5.9	6.2	6.0	3.6	3.3	4.6	5.3	4.2	4.0	4.0	6.0	1.6	4.3	5.6	7.8	5.5	4.6	4.4	6.4	5.6	5.7	6.6	4.7	3.8	9.1	6.6	5.9	5.1	5.0	7.7	5.7	5.3	9.6	5.4	5.1	5.3	4.0	11.2	5.1	4.4	1.3	4.5	7.1	8.3	4.0	3.9	6.7	4.6	4.8	5.9	3.6	4.1	3.9	4.3	6.4	5.4	9.1	3.7	2.4	4.9	3.5	4.7	7.8	6.0	5.0	6.8	1.1	3.4	5.9	5.4	2.9	5.2	9.0	4.0	3.7	2.2	8.1	4.6	4.8	3.7	3.0	2.7	4.6	3.9	1.2	7.0	11.2	15.3	11.0	8.3	5.7	8.3	3.5	7.3	10.6	8.9	6.4	3.7	7.4	6.4	14.6	6.9	10.2	14.7	6.8	7.0	9.8	6.9	1.7	4.3	6.0	7.5	4.3	23.3	3.4	6.0	7.7	6.0	1.1	5.7	5.3	23.8	5.8	7.4	8.7	3.3	9.8	5.3	6.8	5.4	4.7	10.8	3.9	2.9	6.7	2.2	14.3	6.5	8.2	27.0	18.5	7.3	5.0	5.1	5.2	5.8
ZNF239	"HOK-2, MOK2"	ENSG00000196793	"Zinc finger protein 239"	Q16600	10	43556344-43574618	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 26.8;Late spermatids: 9.8;Spermatogonia: 7.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 4.2;T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 18.1;T-47d: 14.1"					"Low region specificity"	"Detected in all"			"HPA030843, HPA046679"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA030843: AB_2673632, HPA046679: AB_10960498"	"unprognostic (1.74e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-7)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.90e-3)"	"unprognostic (4.13e-2)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	5.0	5.0	8.8	5.6	9.3	0.9	10.4	5.7	8.2	6.8	5.3	5.2	2.1	2.9	8.8	4.5	2.5	8.7	3.5	4.1	6.5	5.1	4.6	2.6	2.7	5.3	5.3	8.5	8.1	8.7	9.9	8.6	2.0	7.2	10.6	5.8	1.7	6.2	9.4	4.9	1.3	3.3	9.8	3.7	2.7	4.7	14.5	6.8	1.6	6.5	1.4	5.1	6.1	10.4	4.2	0.1	0.0	0.0	0.5	8.8	1.9	0.0	3.1	3.7	3.6	5.2	3.9	0.0	6.6	0.7	7.9	7.0	8.0	7.2	0.0	2.5	3.5	3.0	0.2	0.0	0.3	10.1	0.1	5.3	0.0	5.3	0.0	4.1	0.0	2.4	4.3	0.1	6.2	0.0	2.4	0.2	0.0	10.3	0.0	6.5	3.4	1.0	1.0	18.1	3.4	3.6	0.0	0.0	0.2	6.6	2.8	7.0	9.5	2.9	0.1	0.4	5.4	14.1	4.4	0.8	0.0	8.1	0.2	8.3	0.9	6.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.1	0.0	5.0	3.6	4.8	3.2	0.1	4.2	8.8	5.2	0.0	0.5	0.0	0.0	2.5	1.9	8.8	9.3	5.7	8.2	6.5	5.1	5.3	8.5	7.2	6.8	0.0	0.3	0.0	1.4	0.0	3.1	0.4	0.0	0.0	2.3	3.5	0.0	0.1	1.7	1.7	26.8	0.1	0.0	0.0	0.3	1.1	0.7	0.8	0.0	0.2	0.3	0.0	0.0	0.6	0.0	9.8	0.3	0.0	0.0	1.0	0.6	1.2	1.2	0.0	1.4	1.4	0.6	0.0	1.0	5.7	7.5	0.0	0.1	0.0	1.2	0.1
ZNF248	bA162G10.3	ENSG00000198105	"Zinc finger protein 248"	Q8NDW4	10	37776526-37858106	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 46.4;Cone photoreceptor cells: 45.2;Horizontal cells: 39.7;Rod photoreceptor cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018237, HPA018287, HPA018455"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018237: AB_2669815, HPA018287: AB_2669829, HPA018455: AB_2669869"	"unprognostic (6.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.50e-4)"	"prognostic favorable (1.04e-4)"	"unprognostic (6.37e-3)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.22e-4)"	"prognostic unfavorable (6.71e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.68e-3)"	5.1	7.7	11.0	6.4	18.3	0.7	8.2	29.8	16.2	11.7	14.0	9.5	11.4	5.7	16.1	15.5	6.1	12.6	7.0	8.0	11.5	10.3	6.3	4.9	6.4	6.3	11.2	12.7	14.1	5.8	17.7	23.8	6.7	11.4	13.5	9.6	8.4	7.4	18.1	7.9	7.4	6.8	12.3	7.7	7.4	6.7	7.0	13.3	3.1	14.2	4.6	6.7	8.0	8.9	6.7	3.8	1.4	1.8	4.0	8.9	3.0	5.4	4.6	1.0	12.9	9.3	7.9	5.7	5.6	2.9	5.8	6.3	5.6	6.9	7.2	4.9	3.9	4.4	6.9	7.4	4.0	5.1	12.5	8.2	8.9	9.5	6.8	4.7	7.3	6.1	3.2	7.6	3.0	2.5	11.7	5.3	7.9	3.8	5.2	8.5	2.6	7.4	4.8	3.9	3.6	24.9	6.9	13.1	5.1	7.2	2.7	5.4	10.4	4.8	2.7	3.2	8.4	7.1	2.1	5.2	5.3	5.7	4.2	3.4	8.2	8.6	6.0	7.1	9.8	2.5	1.1	1.8	1.4	5.7	1.2	6.2	5.8	5.1	4.8	3.8	6.7	8.9	7.6	0.2	4.0	1.6	3.5	2.6	3.0	11.0	18.3	29.8	16.2	11.5	10.3	11.2	12.7	11.4	13.3	11.9	11.8	6.6	7.0	1.8	46.4	19.3	10.2	6.7	9.1	5.2	45.2	5.0	6.6	3.3	0.6	5.6	4.0	0.0	1.4	2.6	8.5	4.5	4.7	3.9	3.7	39.7	5.2	5.5	1.3	1.5	9.2	2.8	1.7	3.6	4.0	22.6	3.4	3.6	11.3	3.3	40.3	0.0	10.3	8.4	10.8	2.4	2.2	3.3	4.9	3.7
ZNF25	"FLJ31890, KOX19, Zfp9"	ENSG00000175395	"Zinc finger protein 25"	P17030	10	37949572-37976633	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030190	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		No	No			"Nucleoplasm, Golgi apparatus"		"HPA030190: AB_10602687"	"unprognostic (9.42e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.61e-1)"	9.7	12.1	17.0	4.0	21.7	2.7	8.7	23.2	27.6	10.9	8.1	7.3	3.4	2.7	11.3	7.5	6.5	7.3	7.1	11.1	13.3	16.7	6.8	3.5	6.9	4.9	12.7	23.7	13.1	4.0	7.1	10.7	5.4	16.0	8.9	5.4	5.1	4.5	11.0	22.9	5.1	3.7	11.6	9.5	7.1	4.4	5.2	11.6	1.2	6.3	5.7	4.9	8.4	5.4	2.3	3.4	6.0	8.5	1.8	3.7	2.2	1.6	3.0	3.3	6.7	12.5	9.6	0.6	3.6	4.9	2.8	4.3	0.5	2.3	3.0	1.0	6.3	1.1	0.4	0.9	1.5	4.6	7.0	1.6	4.8	0.0	1.0	7.9	3.2	3.1	6.8	6.6	3.1	3.6	11.3	4.8	3.9	0.4	2.3	6.8	0.9	1.0	2.4	0.6	0.5	2.2	1.1	3.7	0.6	3.4	0.6	1.2	7.7	1.2	0.2	4.5	1.3	2.9	5.1	6.9	4.4	0.8	7.1	2.2	2.9	1.3	1.2	8.4	6.2	2.9	2.3	2.8	6.0	3.1	4.7	3.4	2.0	2.7	2.6	3.4	2.3	3.7	3.0	0.5	1.8	8.5	0.5	2.2	2.2	17.0	21.7	23.2	27.6	13.3	16.7	12.7	23.7	16.0	11.6	3.0	2.7	3.4	2.0	3.1	17.7	20.4	5.1	12.0	3.4	7.0	5.9	1.0	1.7	1.7	26.3	5.8	0.8	0.0	2.1	0.4	8.5	2.0	8.1	2.9	5.1	15.9	0.0	10.4	10.2	20.4	11.2	10.1	3.3	5.4	1.1	12.8	1.6	0.0	15.2	3.0	7.1	0.0	13.3	3.2	7.2	3.4	0.2	4.5	0.7	0.7
ZNF250	"MGC9718, ZFP647, ZNF647"	ENSG00000196150	"Zinc finger protein 250"	P15622	8	144876497-144902168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA020853	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA020853: AB_1859152"	"unprognostic (1.16e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.43e-7)"	"unprognostic (2.23e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-2)"	"prognostic favorable (8.26e-4)"	6.5	7.0	8.4	9.4	10.0	4.5	21.2	33.0	11.1	13.8	9.0	8.6	7.3	9.2	15.8	11.4	9.1	10.7	7.2	7.1	6.3	7.6	10.5	5.6	9.3	5.9	9.3	9.5	16.4	8.6	12.5	14.7	10.0	10.0	10.6	6.8	10.4	8.8	12.4	10.6	14.8	9.1	12.2	6.5	8.3	6.9	6.1	9.2	9.7	19.9	6.0	8.8	12.7	12.0	12.2	7.5	6.4	5.9	6.1	12.7	5.0	4.8	3.7	13.1	11.1	7.6	5.4	4.7	5.7	6.3	9.0	8.0	2.3	3.5	12.9	9.9	6.6	3.6	6.3	6.5	6.8	6.5	3.7	8.0	10.5	13.4	3.6	3.7	2.0	3.9	4.0	9.2	7.0	8.3	8.6	4.9	8.0	8.5	10.9	8.2	8.9	12.5	4.8	3.7	5.8	10.9	15.2	6.0	5.6	9.2	3.9	13.0	10.3	11.1	4.1	5.0	5.5	5.9	5.7	5.0	10.0	8.9	8.0	5.1	5.7	4.4	7.6	4.9	7.0	4.2	4.6	5.9	6.4	12.7	3.3	9.8	12.2	9.4	7.3	7.5	11.0	11.1	9.2	3.3	6.1	4.2	3.2	12.4	5.0	8.4	10.0	33.0	11.1	6.3	7.6	9.3	9.5	10.0	9.2	11.9	4.0	0.9	2.7	4.8	7.4	3.6	2.5	5.3	2.3	5.2	0.0	1.9	3.3	6.6	5.1	5.0	2.0	0.0	1.6	1.2	5.6	1.6	2.3	2.4	1.5	7.9	4.1	4.9	2.8	2.4	3.7	4.1	5.0	1.8	1.6	3.6	2.8	0.0	4.9	1.9	9.8	12.9	4.1	6.3	4.3	4.8	1.6	5.3	3.4	2.0
ZNF251		ENSG00000198169	"Zinc finger protein 251"	Q9BRH9	8	144720907-144756417	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018290	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018290: AB_1859153"	"unprognostic (1.16e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.42e-9)"	"unprognostic (5.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-3)"	10.1	6.7	14.1	8.6	11.8	4.0	10.5	26.0	12.5	13.1	9.9	12.0	8.5	8.7	14.3	25.9	6.4	11.3	11.2	7.9	10.2	9.2	9.8	6.6	8.4	10.8	10.5	9.6	13.8	9.0	17.6	15.1	10.2	10.0	11.8	12.0	9.8	12.0	14.2	11.5	8.8	9.6	11.1	8.7	11.4	10.8	12.0	12.8	9.9	19.6	6.1	10.0	9.5	10.4	2.6	2.4	2.3	0.9	2.7	3.7	1.5	5.0	1.9	11.3	4.2	5.5	8.7	1.2	6.7	3.9	3.6	7.0	1.1	5.2	5.8	4.8	5.4	3.0	7.7	3.4	3.7	7.0	3.5	3.3	6.2	16.1	1.3	4.7	1.0	3.4	7.7	4.7	2.7	3.6	11.5	3.1	9.6	4.3	1.7	2.5	0.3	5.7	0.6	4.8	1.8	0.0	8.3	1.6	2.5	1.0	2.2	5.6	4.4	5.7	1.8	4.5	6.3	4.2	1.9	1.7	5.0	10.6	6.5	4.6	3.9	1.0	6.5	4.3	2.0	2.6	0.0	0.2	2.3	1.8	0.6	3.3	1.4	2.8	3.0	2.4	2.6	3.7	1.2	0.1	2.7	0.9	1.4	2.5	1.5	14.1	11.8	26.0	12.5	10.2	9.2	10.5	9.6	10.0	12.8	0.0	4.0	0.5	3.3	1.9	4.9	2.9	2.5	8.1	14.8	1.8	5.9	1.6	5.0	1.4	14.3	5.7	1.3	0.0	1.4	1.1	2.7	3.2	1.1	1.0	1.3	4.8	1.2	0.6	3.8	5.8	7.2	2.6	1.7	3.6	2.1	3.1	1.6	1.5	4.2	2.4	5.7	12.9	2.1	8.7	11.1	2.8	1.1	3.5	1.7	1.7
ZNF26	"FLJ20755, KOX20"	ENSG00000198393	"Zinc finger protein 26"	P17031	12	132986365-133032952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA018329, HPA042406"	Uncertain		Approved	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA018329: AB_1859157, HPA042406: AB_2677982"	"unprognostic (7.31e-3)"	"unprognostic (7.60e-3)"	"unprognostic (7.26e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-12)"	"unprognostic (8.24e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.64e-4)"	9.9	7.7	7.3	10.5	10.6	19.4	13.2	11.1	12.8	7.8	7.7	11.3	10.2	7.8	12.7	18.3	7.6	9.5	11.6	6.7	7.6	6.6	9.1	11.6	9.5	12.8	9.9	8.1	11.4	11.9	7.7	11.9	8.8	9.9	12.4	8.5	11.1	11.2	8.6	7.4	13.0	9.5	8.8	7.5	15.7	7.6	11.8	11.3	12.0	11.6	9.2	12.8	8.6	9.6	7.5	3.5	9.3	2.9	6.5	9.6	5.5	4.3	3.7	4.7	5.6	2.0	3.0	9.5	3.4	4.2	4.9	3.7	1.7	3.5	3.0	5.0	3.4	3.5	3.0	3.3	3.3	6.0	2.2	5.5	7.1	3.5	2.0	3.3	11.8	8.1	3.8	4.0	5.5	7.7	3.9	2.7	4.9	5.4	0.8	4.2	3.8	9.0	8.1	11.5	2.3	6.0	8.7	7.0	5.8	2.4	6.8	5.8	12.6	4.3	3.2	4.2	3.2	9.5	7.7	4.5	6.2	5.9	5.4	5.2	3.5	0.2	14.6	3.8	5.4	7.2	9.3	2.6	6.0	8.2	2.9	8.6	5.5	7.4	6.5	3.5	7.5	9.6	8.0	2.4	6.5	2.2	3.0	6.1	5.5	7.3	10.6	11.1	12.8	7.6	6.6	9.9	8.1	9.9	11.3	20.8	16.5	11.0	7.4	0.0	26.6	4.0	10.2	5.3	14.8	5.2	23.6	5.4	3.3	6.7	0.6	8.4	3.8	0.0	4.9	3.7	4.8	5.2	9.2	4.3	4.5	25.4	8.1	9.8	9.5	1.1	7.5	3.9	0.0	2.8	5.4	8.8	6.6	3.5	5.6	2.3	24.5	0.0	3.2	7.2	9.5	0.0	4.0	13.6	5.6	7.1
ZNF263	"FPM315, ZKSCAN12, ZSCAN44"	ENSG00000006194	"Zinc finger protein 263"	O14978	16	3263800-3301401	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035085, HPA035086"	Approved		Supported	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			Cytosol	"Nucleoplasm, Mitotic spindle"	"HPA035085: AB_10671099, HPA035086: AB_10603244"	"unprognostic (2.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.98e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.66e-1)"	28.3	17.8	21.5	16.9	25.7	15.0	23.3	26.4	23.5	21.9	19.2	18.1	14.0	13.8	30.4	23.4	15.4	24.2	17.6	14.6	15.7	14.2	16.9	17.1	18.5	20.4	20.3	18.1	30.7	23.0	36.4	24.8	20.1	16.8	21.8	16.8	20.2	19.5	21.1	15.8	22.7	18.2	18.6	14.0	23.6	20.5	17.3	16.5	18.9	20.1	14.5	28.8	20.2	27.6	6.6	5.5	9.6	5.0	6.7	9.2	3.3	8.6	11.2	13.4	19.4	10.7	14.1	17.4	11.9	18.3	14.3	15.6	12.2	13.6	31.9	12.4	15.3	13.3	11.0	18.2	12.1	14.4	17.5	18.2	14.5	15.0	11.7	12.5	21.4	17.8	16.2	25.4	13.0	19.2	16.1	12.2	20.6	16.3	21.7	11.7	11.9	19.7	16.5	24.9	10.2	9.6	32.1	13.6	25.1	10.0	8.7	19.4	20.3	13.0	14.1	14.5	16.3	15.6	25.6	12.6	15.2	14.6	11.2	11.1	23.3	24.7	38.5	5.9	10.8	10.7	2.1	3.9	9.6	6.0	4.2	6.9	4.5	7.3	8.0	5.5	6.6	9.2	6.8	5.0	6.7	5.0	4.6	4.9	3.3	21.5	25.7	26.4	23.5	15.7	14.2	20.3	18.1	16.8	16.5	0.0	14.4	9.1	14.5	15.5	10.2	3.6	12.7	4.0	4.5	1.8	0.0	9.7	6.6	8.9	41.6	11.1	6.0	0.0	8.6	8.9	10.8	11.4	6.9	5.8	8.0	3.2	12.7	5.5	8.9	26.2	7.5	8.0	15.1	8.2	9.2	10.1	8.2	3.5	7.4	5.0	9.0	12.9	18.6	11.4	10.4	18.1	9.3	10.0	11.7	11.9
ZNF264	KIAA0412	ENSG00000083844	"Zinc finger protein 264"	O43296	19	57191500-57222846	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA046330			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046330: "	"unprognostic (2.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.19e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.65e-2)"	10.4	10.7	8.1	10.2	12.4	12.1	14.5	15.0	11.2	12.2	8.2	10.9	17.6	8.0	13.2	10.1	11.3	12.2	8.9	7.2	8.3	5.2	10.5	11.6	14.2	13.5	12.4	10.2	15.6	21.2	14.7	13.7	11.3	10.0	10.5	8.0	9.6	12.8	13.5	8.3	11.6	12.9	10.6	9.0	17.3	13.4	15.9	11.1	16.3	13.1	10.4	11.6	11.3	10.6	6.6	3.3	7.1	2.8	4.1	6.6	2.0	7.1	5.1	5.9	4.6	4.2	5.9	2.4	4.2	6.6	5.8	10.5	3.5	5.8	2.3	2.9	5.9	4.8	7.7	0.0	5.8	8.4	0.1	21.1	9.6	8.0	2.7	5.0	1.8	9.1	6.1	3.2	7.2	16.8	4.9	5.5	5.7	0.1	0.2	5.2	0.0	7.9	2.4	3.8	2.0	12.9	2.9	7.5	7.7	4.7	10.0	6.6	4.4	8.5	2.6	3.3	5.2	4.7	4.6	8.1	7.7	6.7	2.3	6.0	10.4	12.3	7.3	5.9	0.1	3.2	1.5	1.8	7.1	3.6	2.7	2.5	6.6	5.1	3.5	2.3	3.8	6.6	6.3	1.7	4.1	2.8	3.3	3.6	2.0	8.1	12.4	15.0	11.2	8.3	5.2	12.4	10.2	10.0	11.1	14.9	20.2	17.9	9.2	1.3	20.1	7.4	30.6	8.1	12.5	15.7	29.5	5.8	6.6	10.0	20.8	12.5	8.8	0.0	13.5	7.4	4.7	13.1	8.1	11.9	11.3	30.2	15.5	26.4	17.2	14.4	9.2	7.2	0.0	8.2	12.0	11.1	12.0	2.9	14.9	9.2	19.8	25.8	5.9	18.1	16.2	1.1	4.1	14.0	9.9	13.7
ZNF266	HZF1	ENSG00000174652	"Zinc finger protein 266"	Q14584	19	9412598-9435578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 46.5"									"HPA026836, HPA054110"	Uncertain		Supported	"Nucleoplasm,Vesicles,Rods & Rings"		NA	NA			Vesicles	"Nucleoplasm, Rods & Rings"	"HPA026836: AB_2672018, HPA054110: AB_2682383"	"unprognostic (2.50e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.60e-2)"	"prognostic favorable (3.94e-6)"	"unprognostic (1.72e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.00e-3)"	"prognostic favorable (3.03e-5)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (9.15e-5)"	14.7	12.1	11.0	21.5	12.5	12.8	17.6	19.0	10.0	21.8	15.7	13.1	9.6	8.6	17.2	55.8	12.7	14.6	12.8	11.7	8.2	5.4	10.9	10.4	15.8	21.0	14.5	4.9	18.9	11.2	12.5	19.8	13.0	11.4	23.8	15.7	14.4	14.4	13.5	9.3	19.1	20.8	17.0	10.9	31.3	13.5	13.0	11.4	34.6	20.8	7.3	23.4	14.4	14.2	6.9	3.8	5.6	5.5	12.6	13.0	5.1	10.8	2.8	8.1	15.3	5.8	11.3	6.5	12.0	10.2	9.9	16.6	5.8	4.7	12.1	7.7	5.9	3.7	4.1	10.2	6.4	11.9	3.4	16.8	16.6	14.8	8.5	5.2	9.5	10.2	10.7	8.8	5.4	8.3	9.9	8.0	14.5	8.6	0.1	9.2	1.0	13.8	46.5	8.4	4.9	9.1	6.2	8.4	8.4	7.8	13.5	6.9	10.8	5.5	6.5	6.7	8.4	4.8	7.3	7.2	9.3	3.6	14.0	6.1	19.8	26.3	14.4	2.9	9.1	7.0	4.8	4.1	5.6	13.0	4.8	8.5	6.0	7.2	9.2	3.3	6.9	10.6	10.2	3.6	12.6	5.5	3.8	8.7	5.1	11.0	12.5	19.0	10.0	8.2	5.4	14.5	4.9	11.4	11.4	0.0	11.0	14.5	6.3	3.5	8.1	5.0	2.5	4.0	7.9	3.5	11.8	3.8	3.3	4.8	0.7	5.2	6.2	23.3	3.2	2.7	4.7	6.2	11.5	2.5	4.2	7.9	9.1	12.3	11.7	1.4	5.8	7.9	5.0	8.2	6.4	4.3	3.4	5.1	4.2	1.1	9.3	6.5	5.6	3.5	7.8	4.1	3.9	14.1	6.3	5.4
ZNF267	HZF2	ENSG00000185947	"Zinc finger protein 267"	Q14586	16	31873758-31917357	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003866	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003866: AB_1080698"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.64e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.34e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.21e-2)"	19.3	5.1	5.4	21.3	7.2	23.8	9.9	8.2	7.5	10.7	9.8	3.9	1.3	7.3	7.3	7.8	14.6	6.4	10.6	6.6	5.4	5.3	9.2	6.8	21.7	20.4	7.0	5.1	8.2	6.1	7.5	7.1	10.5	7.7	8.6	7.7	3.4	10.3	4.3	10.8	5.7	11.2	6.3	11.1	31.1	6.8	9.6	8.0	20.0	7.9	11.0	18.4	12.3	8.7	9.6	8.3	34.8	11.5	6.9	8.9	5.0	5.1	5.3	5.5	4.3	3.9	4.7	16.7	4.3	7.1	6.0	9.1	10.5	8.3	9.0	7.8	3.4	5.9	6.7	8.8	6.8	11.5	13.8	7.4	9.4	3.3	9.5	3.6	10.0	22.3	6.5	4.7	8.4	6.2	4.3	8.4	7.2	15.1	22.3	8.1	7.1	6.8	6.7	5.1	4.0	3.3	6.8	15.4	8.1	6.8	23.0	1.8	2.7	6.6	5.8	6.1	10.0	3.5	14.2	10.2	5.9	5.2	5.1	7.1	12.7	6.9	9.5	7.7	8.3	3.5	13.8	10.8	14.4	5.8	10.8	8.5	9.6	7.7	5.8	8.3	6.8	6.0	7.2	34.8	6.9	11.5	4.9	8.9	5.0	5.4	7.2	8.2	7.5	5.4	5.3	7.0	5.1	7.7	8.0	8.9	10.1	20.4	34.3	28.3	4.3	5.2	5.1	20.1	11.4	3.5	0.0	12.4	6.6	15.6	9.8	23.3	4.6	0.0	17.4	8.6	20.6	27.4	59.9	2.0	19.4	11.1	7.5	9.2	23.5	5.2	5.5	52.4	13.5	94.6	4.9	3.1	30.8	5.8	3.2	10.0	3.9	0.0	13.7	15.8	29.5	22.3	7.0	23.0	3.8	46.4
ZNF268	HZF3	ENSG00000090612	"Zinc finger protein 268"	Q14587	12	133181409-133214831	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001794	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA001794: AB_2666437"	"unprognostic (7.65e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.63e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.59e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.53e-3)"	8.8	13.5	9.3	13.0	10.3	4.6	13.4	11.2	13.0	11.7	9.0	8.5	13.3	6.2	11.1	14.7	11.8	12.6	10.4	7.9	9.0	8.2	13.5	17.3	10.1	13.2	7.9	8.8	19.7	9.6	20.6	14.2	17.6	11.1	15.7	7.8	9.6	9.9	10.4	6.0	8.0	8.0	12.0	8.2	11.4	9.6	9.6	8.5	12.9	16.6	11.2	9.3	12.0	9.4	10.0	7.4	5.7	8.0	10.6	15.7	5.1	5.2	9.1	16.8	14.7	7.5	10.6	11.8	7.7	8.9	7.4	6.2	7.9	3.8	6.3	12.1	9.2	8.4	4.9	8.3	10.0	9.3	0.2	6.7	12.8	4.3	10.0	7.6	10.8	10.4	13.5	9.8	8.9	14.5	10.4	8.5	5.8	8.7	6.2	12.5	6.4	4.4	5.2	13.2	6.6	0.4	4.2	6.5	5.6	4.1	12.2	12.9	10.5	15.8	5.5	7.1	14.9	14.5	9.2	9.4	8.4	10.5	2.8	7.1	2.2	3.2	9.9	4.6	5.7	8.8	1.7	4.9	5.7	8.5	4.9	5.7	10.0	9.6	10.7	7.4	8.2	15.7	10.7	1.5	10.6	8.0	5.9	4.9	5.1	9.3	10.3	11.2	13.0	9.0	8.2	7.9	8.8	11.1	8.5	17.9	21.1	7.3	5.3	1.5	23.0	7.8	10.2	6.7	18.2	7.0	19.6	10.4	5.0	7.5	12.6	6.4	3.1	0.0	5.6	7.3	7.1	6.3	2.3	9.2	8.3	20.6	3.5	10.4	6.5	3.4	9.8	4.8	5.0	3.6	9.2	17.5	6.6	10.4	10.6	8.7	17.4	6.5	4.4	11.8	15.9	2.5	7.2	6.9	7.2	3.5
ZNF273	HZF9	ENSG00000198039	"Zinc finger protein 273"	Q14593	7	64870172-64930966	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 95.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA077549			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA077549: AB_2732352"	"unprognostic (7.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.02e-5)"	"unprognostic (2.54e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.85e-2)"	2.8	1.5	1.9	1.7	4.1	5.5	4.8	8.6	3.7	3.5	1.5	2.1	1.0	1.4	2.6	0.7	2.9	3.4	0.9	1.7	2.7	1.6	1.7	1.8	1.8	5.0	4.4	2.6	3.7	1.7	0.9	2.8	2.1	5.2	1.9	1.9	0.0	1.8	1.7	1.9	12.1	1.6	1.4	2.6	3.8	1.7	9.2	5.1	11.5	5.8	4.2	3.5	2.2	1.8	3.2	1.8	5.0	0.7	0.7	2.5	1.0	2.2	1.6	3.6	5.2	0.5	1.2	3.0	1.0	0.7	1.5	2.8	2.5	2.0	5.9	3.2	0.4	2.8	0.7	7.2	1.4	1.2	2.9	2.6	3.1	0.9	0.8	0.2	3.1	2.1	0.8	0.9	2.5	2.4	1.1	1.4	8.8	8.3	2.2	1.8	2.0	6.5	3.1	7.1	1.2	2.5	6.9	5.6	3.5	0.8	1.3	3.3	3.4	2.8	1.4	1.6	7.3	2.6	4.2	0.7	1.8	1.9	1.3	2.1	2.2	2.9	8.7	0.5	3.0	1.3	5.0	0.6	3.1	1.0	0.7	1.9	3.2	2.1	1.4	1.7	2.4	1.7	2.5	1.0	0.7	0.5	1.8	2.2	1.0	1.9	4.1	8.6	3.7	2.7	1.6	4.4	2.6	5.2	5.1	3.0	2.9	8.7	5.1	22.1	5.3	3.7	2.5	95.0	13.6	1.8	0.0	5.2	6.6	2.6	20.2	8.0	0.3	23.3	2.5	10.4	7.5	3.1	3.5	0.8	3.1	4.8	0.0	6.7	4.3	8.2	5.8	3.7	5.0	3.6	1.7	2.9	2.6	5.8	3.2	1.1	2.6	0.0	3.3	16.7	7.9	16.6	2.4	7.2	3.3	2.5
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 39.1"					"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	9.9	7.6	5.9	8.8	7.0	8.8	15.4	16.6	6.7	7.5	9.9	11.7	14.0	6.3	10.0	12.2	11.7	9.8	14.7	12.0	5.9	4.8	7.3	14.0	12.0	12.8	12.5	5.5	16.8	8.9	20.3	10.9	7.6	9.5	10.4	5.8	14.5	8.6	11.0	11.2	11.4	10.6	10.6	8.7	10.7	8.3	19.3	7.9	6.1	15.3	8.6	10.9	11.2	12.8	16.3	6.7	23.0	8.0	14.0	18.1	8.8	9.0	6.4	10.7	4.4	6.8	10.1	10.4	7.5	4.1	8.2	7.4	3.7	6.7	3.1	4.9	4.6	8.8	2.6	5.0	10.5	11.4	6.4	39.1	14.6	6.3	6.0	11.1	10.4	24.2	8.0	13.5	10.1	19.5	8.5	6.5	5.0	10.9	14.1	6.1	5.9	5.6	9.3	10.2	5.3	6.3	12.7	2.7	13.4	6.2	3.8	7.0	3.1	10.0	4.4	8.4	8.5	10.6	19.7	6.2	4.5	6.7	5.1	8.4	6.4	6.8	10.3	2.0	11.5	9.3	13.7	4.7	23.0	9.3	5.1	14.3	13.8	12.2	13.2	6.7	16.3	18.1	13.0	17.3	14.0	8.0	3.1	15.3	8.8	5.9	7.0	16.6	6.7	5.9	4.8	12.5	5.5	9.5	7.9	14.9	18.7	18.2	36.1	9.3	30.1	14.3	12.7	10.7	10.3	17.4	41.2	9.0	1.7	10.9	14.5	11.3	11.9	0.0	4.9	9.9	6.6	25.3	28.8	6.8	6.8	19.1	6.3	4.3	10.2	8.1	11.2	13.4	6.8	10.0	8.8	20.1	9.3	17.5	11.3	9.0	60.4	19.4	11.8	17.9	12.8	10.7	14.0	25.3	7.6	21.2
ZNF275		ENSG00000063587	"Zinc finger protein 275"	Q9NSD4	X	153334155-153360110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 38.6"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 25.5;Peritubular cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 36.2;U-698: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000566	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA000566: AB_1080700"	"unprognostic (6.96e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.14e-2)"	6.5	38.6	5.9	3.4	5.9	2.2	11.5	5.9	6.9	5.8	3.5	7.0	20.4	2.8	5.9	12.6	2.5	5.4	4.9	3.0	6.8	6.9	3.8	8.5	3.3	7.0	8.8	5.3	30.3	8.5	5.8	6.9	2.1	6.2	5.1	3.2	3.8	6.3	27.9	3.1	2.5	4.5	5.6	10.7	6.8	4.1	10.5	6.5	3.9	4.7	1.7	5.3	4.0	2.6	4.5	2.7	0.7	1.7	2.8	5.0	2.0	6.0	2.7	5.3	3.7	6.1	6.0	2.6	4.2	7.0	2.7	4.1	2.8	1.4	10.4	8.7	7.9	4.0	1.0	6.0	3.8	4.0	2.4	4.8	3.3	2.6	3.9	8.2	4.2	3.1	7.1	2.7	2.3	4.3	4.4	3.3	5.7	5.1	0.0	4.8	4.4	4.9	3.5	2.4	5.9	4.3	6.0	5.6	3.6	2.0	4.0	2.7	3.7	2.1	0.2	5.1	3.4	1.0	7.5	3.5	4.1	4.9	6.8	5.4	36.2	9.6	20.7	3.7	8.5	2.8	0.7	1.7	0.2	3.7	1.5	4.4	4.5	3.4	3.3	1.6	4.4	5.0	4.2	0.1	2.8	1.4	2.7	4.6	2.0	5.9	5.9	5.9	6.5	6.8	6.9	8.8	5.3	6.2	6.5	0.0	5.8	5.2	3.4	3.0	6.6	4.7	10.2	1.4	2.3	8.7	11.8	1.3	6.6	2.6	1.2	4.1	1.6	0.0	4.4	3.4	7.2	4.9	2.3	25.5	2.2	0.0	0.0	8.0	5.3	2.0	13.3	3.1	3.3	1.0	6.2	6.3	4.4	2.9	37.1	6.5	2.2	12.9	11.4	3.3	3.4	1.9	0.7	3.8	5.0	1.7
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740903	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.7	9.8	9.0	18.6	13.1	25.5	7.9	20.2	12.3	10.8	11.1	30.6	9.4	16.0	9.0	8.4	14.5	11.4	9.5	6.7	9.8	7.3	8.4	10.1	9.6	21.7	21.3	11.2	13.5	10.9	11.0	11.6	7.4	12.6	10.2	8.8	8.1	11.3	11.4	11.4	18.5	15.3	6.8	9.9	22.2	12.2	6.4	18.4	11.1	10.1	8.1	15.1	9.5	10.3	2.9	2.0	4.5	1.9	5.0	10.1	2.4	5.0	4.3	3.5	9.1	2.8	3.9	6.1	3.5	2.1	3.2	1.2	5.5	5.4	6.7	4.4	3.7	1.6	9.4	4.4	3.9	2.4	4.1	23.5	6.0	8.0	2.1	5.5	5.8	7.9	5.4	5.2	4.3	3.6	3.2	4.9	6.0	11.0	5.7	1.5	7.1	7.3	13.3	2.6	5.0	9.6	11.8	3.8	4.5	4.0	3.0	9.5	8.0	7.6	6.9	4.2	2.2	9.3	8.4	5.5	5.4	7.3	4.2	3.0	20.8	6.7	3.5	4.3	9.7	5.3	4.3	1.7	2.8	10.1	1.9	4.8	2.0	5.5	7.6	1.8	2.9	5.6	7.2	4.5	5.0	1.2	2.0	4.0	2.4	9.0	13.1	20.2	11.3	9.8	7.3	21.3	11.2	12.6	18.4	8.9	14.1	17.5	7.4	10.2	13.9	2.0	5.1	4.0	10.3	10.4	19.6	4.0	1.7	7.1	1.6	10.0	16.3	0.0	5.8	3.4	6.9	7.2	11.6	9.8	8.0	6.4	6.9	20.3	10.5	1.3	10.6	15.3	8.5	5.4	11.8	12.3	6.8	11.5	9.9	2.4	23.5	12.9	5.6	15.1	10.6	14.1	3.3	34.9	14.0	8.9
ZNF277	"NRIF4, ZNF277P"	ENSG00000198839	"Zinc finger protein 277"	Q9NRM2	7	112206588-112343096	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027307	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA027307: AB_1859164"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (9.47e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	15.2	14.8	11.2	12.9	16.2	10.9	20.1	9.3	13.8	13.6	13.9	8.4	8.8	13.7	14.7	8.8	18.4	12.6	14.3	14.4	11.8	9.1	22.7	30.0	19.2	14.3	11.3	11.9	15.4	23.5	13.5	16.4	8.1	11.6	17.1	14.2	5.5	14.9	12.9	12.7	17.7	13.4	15.9	16.1	13.7	14.6	10.2	14.1	23.9	22.4	11.1	15.6	26.6	13.6	13.3	10.4	9.5	14.3	12.4	17.2	9.1	5.9	6.2	8.3	10.3	13.7	38.1	6.4	5.8	12.8	4.9	10.4	5.7	9.3	13.3	11.6	6.2	11.1	5.0	5.2	10.1	11.6	7.0	8.0	5.4	6.1	12.6	13.4	10.3	7.9	21.9	18.1	9.4	12.4	19.8	16.9	14.7	9.5	14.2	9.2	9.6	14.4	20.1	4.9	7.9	6.4	8.0	9.8	13.8	14.4	6.8	6.3	12.7	7.1	13.7	14.1	13.3	5.5	11.0	10.4	6.8	4.1	17.7	5.5	10.4	8.4	13.2	5.8	10.2	7.6	7.1	11.6	9.5	11.2	14.3	15.9	13.3	15.2	17.2	10.4	11.2	16.3	13.5	9.3	12.4	11.6	10.1	17.0	9.1	11.2	16.2	9.3	13.8	11.8	9.1	11.3	11.9	11.6	14.1	35.7	18.2	13.7	16.1	18.3	10.0	11.8	22.9	10.7	18.2	5.2	2.0	10.4	23.2	20.2	37.5	16.5	11.8	0.0	27.0	13.8	12.7	16.7	7.0	17.3	19.2	30.2	17.7	10.4	39.5	4.4	15.8	26.3	11.8	36.9	21.0	5.8	24.3	21.0	23.7	25.9	11.4	19.4	13.3	20.6	7.8	21.2	11.6	28.4	22.1	18.1
ZNF280A	"3'OY11.1, SUHW1, ZNF280, ZNF636"	ENSG00000169548	"Zinc finger protein 280A"	P59817	22	22513736-22520270	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.6;epididymis: 5.6;retina: 2.2"	"Cell type enhanced"	"Detected in some"	30	"Melanocytes: 1.7;Syncytiotrophoblasts: 4.2"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;EFO-21: 1.9;K-562: 13.0;SK-MEL-30: 3.5"					"Not detected"	"Not detected"			HPA044475			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044475: AB_10960420"			"unprognostic (7.53e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-2)"		"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.65e-3)"			"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"			0.0	5.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.1	5.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.2	0.0	1.0	0.0	0.1	1.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	13.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.5	0.3	0.5	0.2	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.2	0.0	0.0	0.0
ZNF280B	"5'OY11.1, SUHW2, ZNF279, ZNF632"	ENSG00000275004	"Zinc finger protein 280B"	Q86YH2	22	22484421-22509154	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.4;testis: 19.2"	"Group enriched"	"Detected in many"	14	"Early spermatids: 147.7;Late spermatids: 74.6;Spermatocytes: 65.0;Spermatogonia: 149.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 13.1;U-2 OS: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059519	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059519: AB_2684050"	"unprognostic (7.32e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.80e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.34e-2)"	0.3	2.1	4.3	0.9	5.5	0.6	0.5	3.9	6.8	0.7	0.5	1.6	0.0	0.4	1.5	1.3	0.5	1.2	0.6	0.8	1.8		0.5	0.3	0.5	1.2	1.7	3.2	2.5	0.7	2.0	5.6	0.5	6.6	1.3	0.7	3.5	0.5	1.4	0.8	0.6	0.6	1.1	2.2	1.1	0.6	19.2	1.2	0.0	2.3	0.0	1.2	0.6	0.0	3.3	3.1	12.4	6.4	6.8	5.4	2.0	0.0	1.9	2.2	0.0	0.0	0.0	2.9	0.4	0.0	0.0	0.0	1.1	0.8	2.0	2.1	0.0	1.8	0.0	1.8	0.3	0.0	0.0	3.5	2.3	0.4	2.7	1.6	1.6	3.0	0.9	0.0	1.8	0.0	0.3	1.9	2.2	13.1	0.8	0.7	0.0	2.0	1.1	1.6	0.9	0.4	1.7	0.0	0.2	0.6	0.0	1.2	1.6	0.0	0.0	0.7	2.0	0.0	1.4	0.8	3.3	6.9	0.7	0.0	1.2	1.2	1.2	2.0	1.5	0.1	12.4	2.3	3.8	2.9	3.3	5.4	3.1	3.6	3.1	2.0	3.3	4.5	4.9	5.9	6.8	6.4	3.1	3.5	2.0											0.0	1.1	2.7	0.5	0.1	6.6	1.2	5.1	0.0	1.2	0.0	3.9	0.1	0.0	1.9	147.7	0.3	0.0	0.0	3.0	0.2	0.5	0.6	0.0	0.0	2.4	4.8	2.9	2.5	0.6	74.6	2.3	0.4	5.0	2.8	0.9	6.0	2.1	0.0	6.7	2.9	7.9	6.5	0.3	65.0	149.7	0.0	0.2	0.5	1.2	0.0
ZNF280C	"FLJ20095, SUHW3, ZNF633"	ENSG00000056277	"Zinc finger protein 280C"	Q8ND82	X	130202711-130268899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 11.4;Spermatogonia: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051494, HPA055788"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA051494: AB_2681506, HPA055788: AB_2682921"	"unprognostic (2.97e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.98e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.16e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.27e-8)"	"unprognostic (1.71e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.85e-2)"	5.4	4.5	3.9	7.1	6.8	6.2	4.9	5.6	6.8	7.6	4.4	5.4	2.9	3.7	10.6	13.3	4.6	5.0	5.1	3.3	3.8	4.2	4.0	4.1	4.1	5.7	4.2	4.2	6.8	4.6	4.9	12.5	4.8	5.8	5.5	4.0	5.1	4.1	3.8	4.5	4.5	4.4	5.0	5.8	6.0	3.8	21.5	2.8	8.2	4.9	3.6	6.8	4.9	5.4	4.0	2.3	2.7	2.9	4.5	4.9	1.1	3.4	4.4	11.8	10.5	3.5	4.9	4.4	3.3	4.4	3.6	5.4	2.7	5.6	8.3	13.3	2.4	7.0	3.4	8.1	2.6	6.3	7.2	2.3	3.6	3.4	2.0	2.8	11.5	3.3	3.6	1.2	5.0	5.3	3.5	4.0	5.4	1.7	5.1	4.1	4.4	6.2	4.7	6.8	5.2	3.7	8.7	4.0	3.2	3.7	5.6	5.7	7.9	3.2	1.9	3.8	5.0	2.1	4.0	4.0	3.9	3.3	6.4	8.6	2.1	1.3	4.7	3.6	10.5	3.6	2.7	1.4	1.5	3.0	2.2	4.9	4.0	3.8	3.5	1.9	3.2	2.7	3.7	0.8	4.5	2.9	2.3	4.8	1.1	3.9	6.8	5.6	6.8	3.8	4.2	4.2	4.2	5.8	2.8	3.0	2.2	3.7	1.9	0.8	2.6	1.0	0.0	4.0	1.2	1.8	2.0	1.6	0.0	1.1	0.2	1.8	1.1	0.0	1.6	1.5	1.7	1.3	0.0	2.1	1.4	4.8	4.6	3.1	1.9	0.0	3.1	1.7	0.0	4.6	0.7	0.8	1.0	1.9	2.8	1.9	2.9	6.5	1.5	11.4	35.1	1.4	0.7	1.5	1.9	2.0
ZNF280D	"FLJ20086, SUHW4, ZNF634"	ENSG00000137871	"Zinc finger protein 280D"	Q6N043	15	56630181-56734086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA030233	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus, Centrosome"	"HPA030233: AB_10602590"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.72e-2)"	16.5	15.7	10.5	9.2	13.3	22.8	16.5	23.0	18.8	21.1	14.3	14.2	12.6	8.1	21.2	9.0	12.0	18.2	9.9	11.4	10.3	7.0	11.0	14.0	11.4	9.8	11.3	14.9	27.2	16.9	14.4	28.0	12.2	16.9	18.1	12.4	8.5	18.8	11.7	22.0	9.8	11.2	24.8	16.3	11.1	14.6	8.4	14.5	46.3	13.6	8.4	10.0	23.6	19.6	6.1	5.9	10.0	4.1	3.0	4.3	1.8	8.6	4.9	9.1	13.9	9.2	12.9	6.7	13.4	9.5	5.6	6.4	3.4	9.0	14.6	5.6	9.4	5.3	6.4	4.5	3.5	6.7	7.4	2.7	1.5	8.1	5.3	9.2	13.1	4.4	8.4	4.9	3.8	5.4	13.7	12.2	15.2	7.6	17.0	8.5	6.1	8.7	1.5	0.0	10.2	4.0	2.8	15.0	10.4	6.5	10.1	7.3	13.4	11.2	6.9	4.3	0.5	7.6	12.2	10.7	8.2	12.4	7.5	10.7	8.9	13.4	0.0	9.2	19.5	8.8	10.0	4.1	5.4	3.6	3.7	3.6	6.1	3.4	3.1	5.9	5.5	3.5	4.3	0.6	3.0	3.2	5.9	3.0	1.8	10.5	13.3	23.0	18.8	10.3	7.0	11.3	14.9	16.9	14.5	8.9	17.6	17.1	16.1	9.8	79.9	32.7	15.3	9.4	13.6	3.5	78.5	18.6	6.6	10.3	12.9	31.2	14.9	0.0	12.2	17.5	22.1	18.3	17.3	26.7	30.7	65.2	31.0	31.9	32.7	32.5	30.8	15.5	15.1	10.0	22.7	21.1	10.9	3.5	19.8	11.5	78.5	6.5	18.4	45.7	26.2	12.2	11.1	18.8	19.7	11.6
ZNF282	HUB1	ENSG00000170265	"Zinc finger protein 282"	Q9UDV7	7	149195485-149226248	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024374	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024374: AB_1851322"	"unprognostic (1.79e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.11e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	13.6	11.7	12.6	12.7	11.5	17.5	13.1	20.7	18.1	19.1	16.1	16.6	16.8	17.7	17.9	14.1	17.9	17.2	18.1	12.5	10.2	8.4	12.4	14.4	12.3	11.2	10.8	11.8	18.5	26.6	12.2	12.3	24.9	10.8	21.4	7.8	13.3	17.8	15.8	20.7	19.5	14.5	15.1	8.9	15.2	14.6	6.4	12.9	14.2	14.1	16.3	12.7	17.0	13.8	3.9	2.4	3.5	1.8	1.8	3.4	1.0	11.6	11.5	6.8	16.3	6.0	7.1	10.0	10.6	7.8	9.4	9.4	10.5	12.8	11.7	16.1	6.6	8.3	12.9	8.0	10.1	3.6	17.6	28.2	9.8	7.5	8.9	8.9	12.3	11.1	8.1	13.8	9.0	9.9	7.1	9.7	7.9	18.8	9.2	5.0	13.7	25.9	18.3	22.0	6.7	14.5	16.9	6.6	16.3	5.1	11.2	15.5	14.8	11.8	14.2	9.7	3.8	9.1	12.0	12.1	13.5	3.0	16.1	15.4	13.3	7.9	8.7	11.2	10.7	11.5	0.0	1.8	3.5	2.1	1.5	2.3	0.9	2.7	2.1	1.0	3.9	1.4	1.8	1.8	1.8	1.7	2.4	3.4	1.0	12.6	11.5	20.7	18.1	10.2	8.4	10.8	11.8	10.8	12.9	3.0	5.0	1.9	2.4	6.4	10.9	4.0	7.6	0.0	2.3	1.8	3.9	9.2	0.0	4.4	25.4	4.5	8.3	0.0	3.7	4.7	4.7	4.3	5.7	7.5	5.3	14.3	12.6	6.2	4.5	21.6	5.8	2.5	1.7	3.6	10.2	5.4	5.3	9.5	5.3	3.2	7.0	12.9	3.8	1.1	1.2	5.6	4.2	1.5	9.3	3.3
ZNF283		ENSG00000167637	"Zinc finger protein 283"	Q8N7M2	19	43827292-43852017	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 19.7;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 22.6"					"Low region specificity"	"Detected in all"			HPA072977			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA072977: AB_2686563"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.49e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.63e-2)"	5.4	6.5	9.1	4.5	12.3	2.6	10.6	18.7	12.7	6.7	6.4	9.1	6.7	6.5	11.5	9.2	7.1	9.0	6.4	10.9	11.8	8.2	6.6	4.6	5.2	6.4	14.7	11.9	11.3	5.8	12.1	17.6	6.6	11.1	9.2	8.5	6.9	7.4	6.4	6.0	8.9	6.9	7.6	15.0	7.2	7.8	3.6	15.7	6.4	10.5	5.1	6.5	6.5	7.6	5.3	4.6	11.9	4.2	7.0	5.1	2.2	6.6	4.8	4.8	9.3	4.5	8.1	4.2	3.8	4.9	4.5	6.4	3.9	3.3	0.1	2.9	6.3	5.6	6.1	6.2	4.8	7.3	1.6	7.8	5.7	8.2	2.8	3.2	3.3	4.2	6.1	6.2	5.6	6.9	5.9	3.8	2.0	6.4	1.8	5.9	3.2	1.8	2.8	4.5	3.3	2.9	0.0	3.5	1.6	3.9	8.8	5.6	7.9	7.6	5.2	3.3	4.7	2.8	6.0	4.1	6.7	22.6	3.5	4.7	5.0	4.8	0.4	2.9	0.4	4.6	6.7	4.2	3.9	4.3	3.1	5.0	4.5	4.2	2.7	3.0	5.3	5.1	3.5	11.9	7.0	2.9	4.6	4.3	2.2	9.1	12.3	18.7	12.7	11.8	8.2	14.7	11.9	11.1	15.7	8.9	19.7	0.8	2.1	2.2	10.3	4.5	2.5	4.0	10.3	0.0	21.6	2.5	6.6	2.4	1.1	2.8	2.4	0.0	1.6	1.7	2.8	1.7	3.5	1.0	2.1	6.4	5.8	6.2	2.2	0.0	2.3	2.8	1.7	3.6	3.3	3.6	2.0	3.4	3.2	1.1	34.1	0.0	3.3	1.5	4.1	1.4	2.4	1.3	4.0	2.2
ZNF286A	"KIAA1874, ZNF286"	ENSG00000187607	"Zinc finger protein 286A"	Q9HBT8	17	15699577-15720787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 49.4"									HPA021594			Approved	Nucleoli		No	No			Nucleoli		"HPA021594: AB_2670768"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.47e-4)"	"unprognostic (4.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.94e-2)"	3.7	5.9	6.6	5.5	9.5	2.0	6.0	8.2	7.8	9.7	5.3	6.5	10.0	2.5	11.3	10.0	7.6	6.6	6.6	11.5	7.6	6.5	6.1	3.2	3.5	7.0	8.7	4.7	14.3	2.9	9.8	15.9	4.0	9.4	7.1	3.5	7.1	4.7	8.3	3.8	4.0	3.5	8.4	10.7	4.5	3.4	14.2	9.0	5.2	8.0	3.8	6.0	6.9	6.0	6.4	2.7	1.0	3.6	6.0	9.8	2.5	13.4	15.2	22.2	10.7	6.5	9.4	7.1	6.3	5.5	10.5	8.4	9.1	4.8	12.0	5.2	5.3	9.0	11.9	15.7	7.4	13.1	8.8	12.2	8.2	15.6	7.8	6.4	4.0	4.0	8.8	4.7	9.9	10.0	12.2	13.8	20.2	7.1	2.4	14.7	3.7	17.6	3.7	20.5	8.0	3.6	13.2	32.3	5.9	7.6	5.2	7.0	15.9	13.7	5.9	4.8	49.4	5.5	2.4	6.1	6.6	7.0	5.7	9.5	5.3	8.3	0.0	8.0	0.1	7.3	0.8	1.6	1.0	6.9	1.9	7.1	4.0	7.9	7.0	2.5	6.4	9.2	9.8	1.0	6.0	3.6	2.7	9.5	2.5	6.6	9.5	8.2	7.8	7.6	6.5	8.7	4.7	9.4	9.0	17.9	0.0	4.9	4.1	6.3	2.1	3.6	2.5	2.7	6.8	1.8	2.0	1.2	1.7	3.4	10.2	3.0	0.2	0.0	1.4	1.5	3.3	2.9	3.5	0.5	1.1	3.2	5.2	1.8	0.6	8.2	4.6	1.1	1.7	1.0	2.0	1.3	3.4	0.8	4.9	2.1	1.6	0.0	3.5	10.5	5.4	4.8	1.0	2.5	1.2	4.1
ZNF286B	"ZNF286C, ZNF286L, ZNF590"	ENSG00000249459	"Zinc finger protein 286B"	P0CG31	17	18658429-18682262	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 5.8;Cholangiocytes: 5.1"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA068125	Uncertain		Approved	"Nuclear speckles,Cytosol"		No	No			"Nuclear speckles"	Cytosol	"HPA068125: AB_2685960"	"unprognostic (3.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.20e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.20e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	0.7	0.9	1.4	1.2	1.4	0.8	1.5	6.5	2.8	2.0	1.2			0.3	3.4	1.8	2.3	1.9	1.1	0.8	1.5	1.8	1.6	0.2	0.7	1.2	1.4		5.4	0.6	1.3	1.4	1.0		1.4	1.4		0.8	1.4	2.9	1.4	0.9	1.9	1.5	1.3	1.2	1.1			1.0		1.6	1.4	1.7	3.0	0.9	1.1	1.7	3.2	4.2	1.0	3.0	2.6	5.1	5.1	2.0	3.3	4.0	2.7	0.8	1.3	1.1	6.1	0.3	4.2	1.6	2.2	1.2	3.4	5.5	2.0	2.7	1.8	5.8	2.7	2.0	1.0	2.5	0.0	2.4	3.6	2.0	5.9	2.9	2.5	3.0	5.0	1.8	0.4	2.8	1.1	6.3	1.9	2.1	1.8	0.8	3.0	7.7	0.1	1.0	0.9	2.9	9.1	4.1	1.3	2.3	11.0	3.7	1.2	2.9	1.6	6.1	4.4	4.2	2.0	2.5	0.2	1.6	1.3	3.7	1.1	0.8	0.5	3.4	0.9	3.0	2.1	3.2	3.8	0.7	3.0	3.9	4.2	0.9	3.2	1.7	0.9	3.5	1.0											3.0	0.0	0.5	0.6	5.8	1.6	1.2	5.1	0.0	0.0	1.8	2.0	0.9	0.0	1.2	0.6	2.5	0.0	0.0	1.1	1.4	3.6	0.6	1.1	0.4	0.4	0.0	0.0	4.3	1.2	0.2	2.0	0.5	1.7	0.0	0.8	0.5	1.3	0.8	1.4	0.6	0.5	0.0	1.0	1.9	2.5	4.0	0.6	0.8	0.6	0.4
ZNF287	"ZKSCAN13, ZSCAN45"	ENSG00000141040	"Zinc finger protein 287"	Q9HBT7	17	16551387-16569206	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029290	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA029290: AB_10603465"	"unprognostic (4.74e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.28e-5)"	"unprognostic (5.69e-3)"	"unprognostic (5.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.87e-1)"	5.9	8.8	7.3	3.6	10.2	1.4	7.1	13.7	12.6	7.2	4.8	11.5	3.0	1.9	6.7	9.1	4.5	6.5	4.5	9.8	7.7	6.0	6.5	0.8	4.9	5.2	9.5	7.3	9.8	4.7	16.3	13.6	3.3	10.8	7.1	4.3	8.1	4.5	8.3	6.2	7.5	4.0	6.8	6.4	5.1	5.1	5.5	9.9	8.2	8.4	4.5	6.0	7.7	4.3	9.6	2.7	0.4	2.5	6.0	9.5	4.1	3.6	6.6	6.1	6.4	4.2	8.1	1.4	3.2	5.7	6.2	7.7	1.3	2.8	1.7	3.5	5.2	4.2	5.8	3.7	5.5	7.5	2.5	3.1	0.0	0.4	0.0	5.3	0.0	5.5	6.1	3.9	2.6	3.9	6.0	3.8	7.7	0.4	0.0	8.6	3.4	5.3	0.2	1.5	3.1	3.2	0.0	7.0	0.1	3.8	1.9	3.5	5.7	9.7	1.3	3.9	17.5	4.8	0.6	2.9	3.8	2.0	4.8	4.1	3.0	2.2	0.0	5.6	0.0	4.8	0.0	0.6	0.4	7.9	0.8	6.7	9.6	8.5	7.9	2.7	7.0	9.5	9.4	0.0	6.0	2.5	1.7	6.3	4.1	7.3	10.2	13.7	12.6	7.7	6.0	9.5	7.3	10.8	9.9	3.0	1.7	0.0	1.4	0.6	4.0	7.7	0.0	9.4	4.5	0.0	3.9	0.1	5.0	4.4	1.6	3.1	0.0	0.0	7.9	0.8	2.5	0.7	6.9	0.0	1.0	15.9	2.4	1.3	1.0	2.3	2.0	1.3	0.0	1.0	0.5	4.0	3.7	0.0	3.2	1.9	3.7	6.5	1.2	7.0	4.7	1.3	0.0	4.5	1.0	0.3
ZNF292	"bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16"	ENSG00000188994	"Zinc finger protein 292"	O60281	6	87152833-87264196	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032154, HPA050618"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA032154: AB_10601930, HPA050618: AB_2681190"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.36e-2)"	11.8	10.2	15.2	16.7	16.8	31.1	14.5	31.1	19.7	15.0	13.9	10.3	11.4	11.2	16.4	15.1	11.1	11.1	9.8	11.6	13.6	9.0	9.8	10.8	9.7	14.8	18.2	9.8	20.6	12.5	14.6	20.7	12.3	15.3	14.0	10.2	12.0	15.0	11.2	9.3	14.0	15.7	12.3	18.6	12.2	11.6	8.7	19.6	25.6	14.1	5.7	16.5	22.6	22.9	16.7	10.4	35.8	7.6	4.3	8.3	3.0	6.3	3.8	12.8	11.2	7.3	6.7	13.3	4.9	6.4	5.9	8.2	6.4	4.5	9.8	7.3	6.5	8.4	6.6	7.9	7.5	12.9	22.2	6.0	13.2	4.9	5.1	5.5	10.6	6.0	6.6	7.4	5.8	7.6	9.5	5.4	10.6	9.6	15.1	6.4	3.5	6.1	9.5	6.4	2.2	3.5	12.9	12.7	3.7	5.2	13.8	9.6	13.5	6.3	4.2	4.8	7.7	4.2	12.8	6.1	7.9	5.5	5.8	7.8	14.0	9.1	6.7	8.7	9.2	5.7	18.0	7.6	7.9	6.9	2.2	6.5	16.6	7.4	7.5	3.2	16.7	8.3	7.1	35.8	4.3	2.3	10.4	7.1	3.0	15.2	16.8	31.1	19.7	13.6	9.0	18.2	9.8	15.3	19.6	56.6	56.6	44.4	25.9	58.7	160.5	61.0	40.8	32.1	48.9	24.4	115.8	19.3	8.3	84.7	16.4	40.7	47.6	0.0	33.2	25.7	35.7	37.4	27.8	15.3	23.3	176.4	45.4	36.2	26.5	6.4	55.5	39.5	30.4	44.1	44.3	74.5	51.7	42.1	62.2	11.6	93.9	32.3	37.3	48.7	29.8	44.9	177.1	57.3	40.7	34.6
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076588	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.8;lymphoid tissue: 26.2"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 36.9;Paneth cells: 28.6;Undifferentiated cells: 23.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 16.6;SK-BR-3: 11.2;U-698: 19.4"	"Low region specificity"	"Detected in many"							"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA046940: AB_2679871, HPA049576: AB_2680821"	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	1.4	0.8	2.4	22.8	3.4	10.5	7.3	6.6	1.4	3.0	7.1	0.4	3.2	6.4	1.0	1.2	11.3	1.4	4.0	1.4	2.0	1.7	1.4	1.0	3.4	15.9	1.1	0.1	0.6	2.7	0.3	3.5	0.7	0.8	2.4	1.0	0.8	13.8	3.4	0.8	6.2	10.1	0.6	1.3	16.9	5.5	2.6	0.6	4.3	1.7	9.5	26.2	2.0	2.7	29.8	26.7	14.7	6.2	14.7	3.5	2.6	3.0	2.1	0.0	0.4	0.0	0.2	1.8	0.5	0.0	0.2	0.2	3.5	1.2	16.6	1.9	0.1	0.0	5.8	0.8	1.3	0.0	3.5	4.4	4.8	0.9	3.4	0.9	2.7	5.1	0.7	0.6	0.7	0.0	0.1	0.5	0.3	3.5	5.9	0.0	4.6	0.2	4.6	1.9	2.0	4.4	9.3	0.0	10.0	0.4	1.1	3.1	0.3	2.1	11.2	0.1	0.3	2.4	5.5	1.1	0.0	1.7	0.1	0.0	6.1	6.1	19.4	0.1	3.5	0.1	14.7	3.6	5.7	3.0	6.2	3.5	29.8	1.6	3.3	8.8	22.4	0.7	1.7	1.8	14.7	5.8	26.7	1.4	2.6	2.4	3.4	6.6	1.4	2.0	1.7	1.1	0.1	0.8	0.6	0.0	1.1	18.6	12.1	10.8	0.9	0.9	0.0	2.7	1.2	3.5	3.9	0.3	0.0	1.9	0.4	0.0	13.3	0.0	0.8	1.9	1.7	2.8	9.2	0.0	3.0	0.0	5.1	1.3	3.0	0.0	0.0	4.1	3.3	36.9	19.9	0.5	1.0	28.6	1.1	0.3	1.6	0.0	2.0	0.9	10.9	8.8	0.7	10.2	23.5	5.7
ZNF3	"A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113"	ENSG00000166526	"Zinc finger protein 3"	P17036	7	100064033-100082548	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003719	Supported	Supported	Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA003719: AB_1080701"	"unprognostic (5.92e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.73e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (2.20e-4)"	16.1	12.8	12.8	9.8	16.8	20.7	19.2	18.3	22.6	18.6	16.4	39.5	16.6	19.3	23.9	20.5	15.2	33.9	11.6	11.5	14.8	11.2	15.0	19.3	11.7	11.1	20.8	11.1	22.5	18.9	17.9	17.8	13.3	21.1	15.6	17.8	19.7	16.4	16.3	18.9	15.4	22.1	14.6	18.0	15.6	16.0	11.8	21.9	21.4	17.6	11.1	16.6	16.7	15.5	16.2	11.2	17.9	12.2	17.3	17.2	9.4	6.2	7.0	19.3	27.6	9.8	7.7	11.3	8.0	9.1	12.2	10.4	8.7	9.4	9.0	14.6	7.6	9.9	8.5	14.2	8.7	10.0	9.9	12.0	7.3	9.1	11.9	11.6	13.0	6.9	9.5	10.9	8.1	19.1	13.5	10.8	13.4	20.3	14.3	11.0	16.8	30.5	13.1	26.6	11.3	12.8	13.1	15.6	22.3	10.9	12.4	21.7	30.2	9.3	27.9	12.4	19.1	8.2	13.2	8.3	15.2	10.9	10.8	10.3	19.2	21.7	17.9	7.7	11.7	14.2	12.3	9.8	17.9	14.2	9.6	17.2	13.3	12.5	14.9	9.9	16.2	14.2	15.5	4.1	17.3	12.2	11.2	11.5	9.4	12.8	16.8	18.3	22.6	14.8	11.2	20.8	11.1	21.1	21.9	11.9	35.9	12.2	8.4	6.8	16.1	9.8	25.5	38.8	14.8	3.5	15.7	10.4	6.6	16.8	1.1	14.6	19.7	0.0	9.6	5.9	8.5	10.1	15.0	12.4	5.7	17.5	25.2	10.4	12.0	1.1	14.1	6.0	3.3	11.8	17.4	20.5	13.3	17.5	14.2	10.6	18.3	6.5	7.3	10.3	17.4	7.9	8.7	11.8	15.8	7.4
ZNF30	"DKFZp686N19164, FLJ20562, KOX28"	ENSG00000168661	"Zinc finger protein 30"	P17039	19	34926903-34945170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 12.7;Rod photoreceptor cells: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA030400	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030400: AB_10603245"	"unprognostic (3.04e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.10e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-2)"	3.4	5.2	11.1	2.6	10.9	0.7	5.9	21.4	11.6	5.3	3.9	5.0	2.9	4.2	4.5	3.4	3.4	7.0	2.6	5.0	7.0	5.4	4.6	6.5	6.0	5.1	10.0	6.5	5.6	6.9	6.4	7.7	3.3	6.6	5.8	4.5	5.8	4.6	5.2	5.3	5.6	3.9	5.1	7.2	5.4	4.8	3.9	8.3	2.4	4.4	2.0	5.1	3.8	4.0	3.4	1.3	2.8	0.4	6.9	7.2	1.8	3.6	8.2	3.5	8.8	6.3	4.0	0.1	3.6	2.6	3.3	3.7	5.8	1.2	0.0	4.8	2.3	1.2	2.3	10.1	5.1	4.2	0.0	4.8	2.7	4.4	4.4	3.2	3.6	2.5	3.5	4.6	3.3	4.4	1.4	5.2	7.2	8.7	0.0	5.3	2.7	2.6	1.6	4.9	8.9	4.3	3.4	2.7	0.9	2.5	3.2	4.6	6.6	0.0	0.1	3.4	3.8	3.3	1.0	3.7	7.0	3.7	2.5	4.8	2.4	11.5	1.0	1.4	0.0	4.0	2.8	0.1	0.1	4.8	0.4	4.7	3.4	3.8	2.2	1.3	2.1	7.2	7.2	0.0	6.9	0.0	1.2	3.4	1.8	11.1	10.9	21.4	11.6	7.0	5.4	10.0	6.5	6.6	8.3	0.0	0.6	0.0	0.2	0.3	5.3	2.8	0.0	4.0	0.0	1.8	5.9	0.1	3.3	0.9	0.2	3.5	0.0	0.0	1.2	0.5	0.6	0.3	5.7	1.0	0.7	12.7	1.2	5.5	1.8	0.4	2.0	0.1	1.7	0.0	1.4	3.5	1.0	0.0	2.1	1.3	10.0	0.0	1.0	2.6	2.4	0.1	0.0	1.7	1.3	0.3
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 7.0;Spermatocytes: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 3.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.2;HeLa: 18.9"									"HPA028975, HPA051777"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		NA	NA			Nucleoplasm	"Nucleoli, Nucleoli rim, Nuclear bodies"	"HPA028975: AB_2672851, HPA051777: AB_2681606"	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	4.5	1.3	4.8	4.0	12.0	3.6	7.2	12.5	6.4	7.4	4.3	5.4	4.1	4.1	11.7	5.3	7.5	5.4	5.4	4.0	7.5	3.2	7.3	1.5	3.0	4.4	8.2	2.4	16.6	7.3	1.0	7.3	2.4	7.4	7.0	4.4	3.6	3.8	3.9	1.5	6.9	5.8	6.4	9.2	5.1	7.1	14.9	9.1	1.5	9.3	2.7	4.4	5.5	6.2	3.8	1.2	1.1	1.5	1.7	1.0	0.8	1.2	2.8	17.2	0.0	1.5	3.6	0.0	4.2	3.3	3.7	5.4	1.4	2.1	0.0	3.7	3.5	11.2	2.5	0.0	9.7	5.8	0.0	5.6	0.0	18.9	2.2	3.1	0.1	0.0	5.5	3.0	7.7	9.1	5.3	6.3	0.1	0.0	9.2	3.7	0.0	0.0	0.8	16.5	0.0	0.0	0.0	2.5	4.9	2.7	3.1	9.7	16.1	9.9	8.6	5.7	10.9	5.7	0.0	2.7	5.0	2.1	3.6	7.6	0.3	0.1	0.0	0.5	0.1	10.3	0.0	0.6	1.1	0.7	1.5	0.1	0.9	1.0	0.0	1.2	3.8	0.7	0.4	0.2	1.7	0.1	0.1	0.0	0.8	4.8	12.0	12.5	6.4	7.5	3.2	8.2	2.4	7.4	9.1	0.0	0.3	0.0	2.5	1.3	3.6	0.4	0.0	0.0	2.3	7.0	0.0	0.7	1.7	2.1	1.3	2.1	0.4	0.0	1.4	1.9	3.0	2.0	0.0	0.2	0.4	0.0	2.9	0.6	0.6	0.5	2.3	0.7	0.0	1.8	0.7	3.9	1.4	0.0	1.1	1.1	4.6	6.5	1.7	6.6	3.8	1.9	0.7	1.3	1.2	2.6
ZNF302	"ZNF135L, ZNF140L, ZNF327"	ENSG00000089335	"Zinc finger protein 302"	Q9NR11	19	34677639-34686397	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA059503			Approved	"Vesicles,Cytokinetic bridge"		Yes	No			"Vesicles, Cytokinetic bridge"		"HPA059503: AB_2684043"	"unprognostic (3.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (9.85e-5)"	12.4	18.0	21.8	12.5	23.7	3.5	23.6	36.5	22.5	16.0	14.3	14.7	16.5	11.7	19.2	21.3	10.0	18.7	10.6	23.6	22.2	18.1	16.4	17.1	13.8	15.5	26.8	18.4	28.6	19.1	26.7	22.8	11.8	21.4	19.1	15.1	13.0	12.4	21.8	29.8	12.4	12.1	18.4	22.8	15.5	12.3	14.0	25.7	12.6	18.8	10.2	15.3	13.7	9.7	17.3	14.1	14.4	7.8	12.0	21.1	6.0	5.8	9.1	19.0	7.4	17.9	14.2	6.5	10.1	12.6	9.4	10.2	6.7	4.9	9.1	12.8	7.3	7.0	4.6	9.2	5.7	10.1	0.6	7.9	17.5	9.8	0.2	9.8	0.1	1.2	13.0	8.7	5.5	0.8	11.8	7.9	6.5	0.0	0.1	14.5	3.0	8.9	9.1	8.5	10.4	6.1	6.9	15.8	4.7	9.7	7.7	8.5	14.0	9.2	3.0	12.0	10.8	6.8	13.9	7.6	4.1	10.2	3.5	4.9	10.9	19.1	2.8	3.9	1.3	19.2	14.4	7.0	11.2	10.9	6.3	14.8	15.0	12.3	10.2	5.8	17.3	21.1	16.3	3.9	12.0	7.8	14.1	9.6	6.0	21.8	23.7	36.5	22.5	22.2	18.1	26.8	18.4	21.4	25.7	26.8	22.2	16.7	26.9	23.8	54.4	49.8	22.9	32.1	27.3	21.0	49.1	14.1	38.1	14.4	24.3	32.4	12.0	0.0	10.0	7.4	27.1	32.5	27.8	10.4	8.5	46.1	19.1	23.4	12.4	3.9	55.0	19.9	23.6	10.0	13.3	67.9	9.0	14.4	48.1	11.2	83.5	51.8	46.4	71.2	41.9	18.7	4.6	26.6	12.2	24.7
ZNF304		ENSG00000131845	"Zinc finger protein 304"	Q9HCX3	19	57351307-57359898	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA050531	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA050531: AB_2681160"	"unprognostic (4.44e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (1.52e-7)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.31e-1)"	"unprognostic (9.00e-3)"	8.5	11.3	8.5	7.8	13.5	6.0	10.8	20.1	12.0	7.7	8.5	7.7	7.2	4.2	9.3	12.6	8.8	8.9	7.1	10.6	7.1	7.0	7.6	5.6	8.7	11.8	8.8	11.0	11.7	5.2	16.4	9.6	9.0	8.6	9.7	5.2	7.4	8.1	10.9	8.5	9.9	7.1	8.8	6.7	11.0	6.8	6.9	8.6	11.1	11.7	9.9	11.4	9.2	6.1	5.5	3.9	5.7	5.6	5.9	6.1	3.8	5.6	2.8	6.9	8.7	5.7	5.4	4.3	5.6	8.7	6.5	14.8	0.0	2.6	4.6	3.6	6.5	3.4	2.0	3.9	7.5	9.6	1.5	18.4	7.4	7.3	3.9	4.1	4.0	4.6	6.6	10.0	6.2	8.8	6.9	4.1	10.5	2.2	0.0	6.8	1.5	8.5	2.3	4.6	0.0	8.9	5.5	11.1	5.9	4.6	12.1	5.5	5.9	5.9	4.6	4.0	6.5	5.6	5.9	4.6	9.3	5.5	2.8	6.0	7.5	6.4	6.9	5.7	0.1	4.7	5.7	2.8	2.3	3.3	2.3	6.1	5.5	5.6	4.6	3.9	4.6	4.7	4.8	0.2	5.9	5.6	2.1	4.4	3.8	8.5	13.5	20.1	12.0	7.1	7.0	8.8	11.0	8.6	8.6	0.0	0.3	2.0	0.6	5.7	6.0	4.0	7.6	6.7	5.7	0.0	0.0	1.5	1.7	1.4	0.3	3.7	0.4	0.0	0.9	0.7	1.3	1.4	0.0	2.1	1.3	3.2	0.0	9.2	1.9	0.6	1.7	1.4	3.3	0.0	1.5	1.0	0.8	0.0	2.1	1.3	2.3	0.0	2.0	1.6	4.2	4.8	0.9	2.5	0.9	1.0
ZNF319	"KIAA1388, Zfp319"	ENSG00000166188	"Zinc finger protein 319"	Q9P2F9	16	57994668-58000453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052584	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052584: AB_2681873"	"unprognostic (1.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.87e-5)"	"unprognostic (8.69e-2)"	"unprognostic (3.72e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.80e-2)"	8.0	8.4	7.6	7.5	7.7	21.3	7.1	11.2	15.0	11.0	8.0	10.6	5.1	6.7	12.0	8.0	6.1	9.7	10.6	6.7	7.3	8.2	7.8	5.7	8.5	10.4	7.1	6.2	13.7	10.6	17.1	7.0	9.4	9.4	8.7	4.3	11.2	8.6	10.8	8.9	6.9	6.6	8.8	6.4	13.9	6.5	6.1	6.0	16.9	19.8	5.6	10.2	11.2	6.2	1.6	2.9	7.4	2.6	1.8	5.3	2.5	4.9	13.5	6.7	9.0	6.2	7.6	5.6	7.1	7.0	6.9	3.4	5.3	2.9	8.4	13.0	6.8	5.6	5.5	5.5	7.6	4.2	3.6	5.3	3.1	5.8	6.3	12.3	4.0	10.7	11.1	9.0	5.5	12.0	6.6	4.3	6.2	6.6	1.4	5.7	4.3	7.7	6.9	3.7	2.4	13.5	13.7	4.5	8.3	4.5	12.8	4.8	5.1	11.8	4.4	4.5	4.8	1.6	6.0	8.4	5.4	3.2	2.7	5.4	7.6	3.2	6.5	4.0	4.2	5.8	0.0	2.6	7.4	5.3	1.9	3.6	1.6	2.8	3.7	2.9	1.6	1.9	3.0	4.8	1.8	1.5	1.1	2.3	2.5	7.6	7.7	11.2	15.0	7.3	8.2	7.1	6.2	9.4	6.0	3.0	4.3	0.0	0.5	0.8	2.0	5.1	5.1	4.0	1.2	0.0	0.0	1.4	3.3	2.1	0.2	1.6	1.0	0.0	2.5	0.9	1.6	0.6	1.1	1.6	1.9	0.0	4.7	4.9	9.1	0.0	2.8	1.2	0.0	1.0	1.4	2.8	2.7	0.0	3.2	1.0	2.9	0.0	1.0	1.9	0.7	1.1	0.2	2.5	1.3	0.0
ZNF32	KOX30	ENSG00000169740	"Zinc finger protein 32"	P17041	10	43643859-43648856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039148			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Nuclear bodies"	Nucleoplasm	"HPA039148: AB_2676365"	"unprognostic (1.05e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.15e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.90e-3)"	"prognostic favorable (3.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (6.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	14.4	16.2	24.4	12.4	23.6	4.4	29.2	21.1	20.1	20.2	20.4	19.0	18.0	7.9	21.9	37.7	12.6	20.7	14.7	26.1	22.2	20.8	22.1	17.7	13.7	12.2	27.7	17.7	28.7	26.0	18.7	20.3	10.3	22.5	22.5	15.1	14.7	18.5	25.4	45.7	14.4	11.0	23.4	19.8	14.2	14.5	8.6	25.8	15.4	25.8	14.5	15.4	17.9	25.4	14.2	11.2	8.5	6.9	23.0	21.7	10.3	9.6	8.6	13.0	19.6	24.0	25.9	4.2	8.6	26.2	16.2	14.7	5.8	4.9	0.0	15.3	18.4	7.6	5.7	8.3	8.4	11.9	10.5	9.1	2.5	5.4	6.6	22.5	0.2	7.9	26.5	19.4	10.0	12.1	15.6	12.2	34.5	7.4	0.0	20.3	8.8	9.5	8.8	10.1	9.8	4.5	14.8	14.6	2.2	16.2	3.8	16.7	14.8	7.1	5.3	13.5	15.0	19.6	9.0	5.2	9.1	11.0	6.6	2.1	5.8	15.1	0.0	3.2	6.2	8.4	4.1	6.9	8.5	19.3	6.1	19.1	13.3	15.5	21.4	11.2	14.2	20.0	21.7	0.6	23.0	5.4	9.5	10.8	10.3	24.4	23.6	21.1	20.1	22.2	20.8	27.7	17.7	22.5	25.8	8.9	14.7	20.1	21.3	9.7	22.4	10.9	15.3	13.4	11.4	17.4	7.9	14.8	89.5	34.7	1.8	18.7	6.1	0.0	41.6	15.5	19.7	29.1	29.0	22.5	26.1	15.9	26.7	17.2	15.9	0.4	39.1	14.8	16.9	12.6	17.5	29.0	29.6	14.0	51.2	43.0	19.9	32.3	22.7	11.2	13.0	13.4	5.6	23.0	18.1	13.6
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: AB_2678346, HPA046692: AB_2679755"	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	8.8	9.7	7.7	5.4	10.9	0.4	10.1	10.6	15.4	13.1	8.6	7.9	9.5	6.9	12.7	10.8	6.8	9.2	11.5	13.3	8.4	6.9	9.5	7.0	7.9	6.7	8.8	7.0	14.8	6.9	15.0	18.0	8.6	11.8	12.3	8.6	8.6	8.2	15.5	7.7	5.0	7.9	9.7	10.7	8.7	7.6	8.2	12.5	4.3	13.6	6.7	7.2	11.8	8.4	11.2	7.9	10.5	11.2	17.6	11.4	4.9	5.8	4.4	17.5	20.1	11.5	15.4	6.3	7.8	10.4	10.9	13.2	8.6	3.6	7.1	18.9	6.8	13.7	7.4	13.0	5.1	13.7	10.9	11.8	12.5	5.8	8.4	13.1	0.0	11.4	9.4	18.0	7.2	8.2	13.7	9.4	8.8	14.3	7.6	12.0	3.3	8.8	10.5	5.1	5.4	5.4	9.8	12.4	10.1	6.7	9.3	14.2	15.0	9.3	8.8	16.4	8.9	8.2	8.1	9.3	18.2	7.3	7.4	7.9	8.0	16.0	6.8	3.9	2.0	18.3	3.3	8.7	10.5	11.4	7.4	8.3	11.2	5.8	7.4	7.0	10.5	6.8	9.9	8.3	17.6	11.2	7.9	4.4	4.9	7.7	10.9	10.6	15.4	8.4	6.9	8.8	7.0	11.8	12.5	6.0	8.0	16.7	14.7	3.5	32.6	4.8	10.2	10.7	15.9	8.7	7.9	10.4	29.9	14.8	2.6	13.5	8.7	0.0	8.9	9.8	12.8	21.0	12.7	6.0	11.3	44.5	18.9	14.1	6.5	2.5	27.9	10.4	8.5	8.2	12.9	25.0	13.2	11.8	24.8	11.1	12.6	32.3	14.6	17.0	10.2	5.6	8.0	8.5	9.4	21.0
ZNF324	"ZF5128, ZNF324A"	ENSG00000083812	"Zinc finger protein 324"	O75467	19	58467045-58475436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 35.6;Horizontal cells: 31.8;Rod photoreceptor cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 35.6"									HPA039774	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA039774: AB_10673149"	"unprognostic (8.60e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.74e-5)"	"unprognostic (6.39e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (3.56e-1)"	7.7	8.0	8.9	11.5	10.8	12.6	7.4	15.8	14.0	9.8	8.8	11.9	10.2	8.5	12.0	9.1	12.7	10.5	9.2	7.6	9.9	9.3	6.5	10.5	7.7	10.5	10.4	11.5	14.6	15.0	10.2	12.7	7.1	7.1	10.6	6.0	7.2	11.2	13.3	5.8	11.9	7.3	8.2	9.3	8.3	8.6	8.0	9.7	16.8	11.9	8.1	10.7	9.3	7.2	6.4	6.4	13.1	5.0	6.0	11.8	3.4	4.1	5.2	3.6	5.4	4.1	3.6	3.9	3.3	4.2	3.4	3.1	4.6	2.1	6.5	3.2	2.8	4.9	5.3	4.6	4.6	1.6	5.6	35.6	4.5	4.0	2.2	3.3	7.5	5.3	2.7	5.8	4.8	2.2	3.9	2.4	5.6	6.3	4.2	3.7	3.3	6.7	4.1	2.8	4.4	7.9	7.2	4.5	4.1	2.4	8.3	7.3	5.7	3.7	6.0	2.6	2.9	3.0	5.5	4.2	10.3	2.3	3.6	5.7	6.2	6.2	3.3	5.2	3.6	3.2	2.3	4.7	7.2	9.5	5.0	10.7	5.3	7.6	10.5	3.2	6.4	11.8	8.9	13.1	6.0	3.9	6.4	7.2	3.4	8.9	10.8	15.8	14.0	9.9	9.3	10.4	11.5	7.1	9.7	0.0	1.7	5.1	4.5	8.0	35.6	5.6	2.5	2.7	3.4	0.0	23.6	4.1	0.0	4.0	0.9	4.2	9.2	0.0	3.6	3.2	4.6	5.2	1.1	2.9	2.5	31.8	7.5	5.5	1.8	0.7	11.8	3.6	3.3	1.8	5.0	16.4	3.2	7.4	13.8	1.4	57.5	6.5	7.8	10.7	13.8	11.7	5.6	8.7	5.6	4.1
ZNF324B	FLJ45850	ENSG00000249471	"Zinc finger protein 324B"	Q6AW86	19	58451604-58457833	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"NK-cell: 8.3"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 29.4"									HPA023400	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA023400: AB_1859195"	"unprognostic (2.75e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (5.58e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.94e-2)"	7.4	6.2	6.9	8.3	12.4	5.0	9.0	11.4	12.6	8.7	5.9	7.6	9.8	5.9	8.5	5.0	8.4	9.0	6.8	4.7	6.6	5.5	6.2	6.6	7.3	6.8	9.1	7.0	10.2	10.1	8.0	8.4	4.8	8.8	7.5	6.1	8.4	8.9	8.5	8.2	11.2	6.0	7.4	5.3	10.3	8.0	11.3	9.3	9.4	8.0	6.0	6.4	9.3	6.9	1.1	0.6	1.3	1.0	8.3	1.3	0.7	4.3	7.2	4.0	6.6	2.8	2.5	2.9	3.9	2.9	3.2	2.3	2.5	1.9	5.9	2.5	2.3	3.3	3.6	5.2	3.6	2.5	6.0	29.4	5.1	5.4	1.0	2.9	8.3	7.6	2.5	3.6	3.6	3.1	2.1	2.3	5.3	7.3	3.6	3.3	2.8	6.1	2.0	2.2	5.1	4.1	5.8	5.2	3.5	2.1	8.7	9.5	5.4	3.7	6.0	0.9	2.9	2.2	2.4	2.6	7.7	2.0	4.1	6.3	7.8	7.0	4.4	3.0	3.6	2.9	0.0	1.0	0.1	1.3	0.6	0.9	0.5	0.6	0.9	0.6	1.1	1.3	0.9	1.3	8.3	0.4	0.6	0.4	0.7	6.9	12.4	11.4	12.6	6.6	5.5	9.1	7.0	8.8	9.3	0.0	0.3	0.5	0.9	0.7	3.0	0.8	0.0	2.7	3.4	1.8	21.6	0.8	0.0	2.0	0.7	0.7	1.1	0.0	1.4	0.7	1.1	0.6	0.0	1.0	0.8	4.8	0.0	1.3	1.9	1.3	2.8	0.4	0.0	1.8	0.8	1.5	1.5	0.0	2.5	0.8	5.8	6.5	1.1	3.1	1.9	0.9	0.6	1.5	1.1	0.9
ZNF326	"FLJ20403, ZAN75, Zfp326, ZIRD"	ENSG00000162664	"Zinc finger protein 326"	Q5BKZ1	1	89995112-90035531	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 134.9;Cone photoreceptor cells: 351.5;Rod photoreceptor cells: 448.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028450, HPA028461, HPA028466"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677"	"prognostic favorable (9.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.84e-4)"	12.7	13.4	18.4	12.7	27.8	45.2	17.7	20.2	18.5	11.8	14.1	23.2	16.3	18.5	18.3	17.1	17.5	11.9	13.9	12.5	19.2	15.2	13.4	15.2	11.5	15.3	26.1	14.1	21.8	20.2	14.4	18.0	14.5	22.8	13.3	20.7	23.9	15.7	9.4	19.2	14.5	18.9	17.8	31.3	11.0	14.6	10.6	27.8	17.3	14.1	10.5	15.1	11.9	17.2	6.8	8.4	3.6	6.1	7.8	4.3	2.2	17.2	15.8	24.6	11.7	11.0	5.2	26.0	17.5	6.8	14.5	9.1	14.6	12.6	21.6	12.5	9.0	16.0	15.6	25.6	11.4	20.0	12.6	12.3	19.5	15.4	13.3	3.7	22.9	9.6	4.6	5.4	14.4	9.2	10.2	8.4	10.1	26.0	9.4	11.7	8.2	23.6	13.0	23.1	14.6	18.0	16.8	24.9	5.8	12.0	19.4	21.6	14.0	20.1	18.7	8.5	18.2	10.3	6.0	11.4	17.1	17.2	14.4	17.3	8.0	7.9	21.6	4.1	18.1	10.9	2.1	5.1	3.6	4.0	6.1	3.2	4.2	3.2	3.4	4.0	6.8	3.2	4.3	2.5	7.8	4.6	8.4	2.8	2.2	18.4	27.8	20.2	18.5	19.2	15.2	26.1	14.1	22.8	27.8	20.8	44.0	32.0	53.5	57.9	134.9	34.4	15.3	45.5	44.3	22.7	351.5	36.5	16.6	45.3	3.4	38.7	63.7	0.0	48.0	73.0	29.8	46.9	48.7	28.0	22.6	65.2	67.4	24.5	16.4	4.2	40.0	32.7	37.1	46.9	33.4	49.5	37.7	66.6	31.8	14.7	448.1	25.8	38.7	58.0	40.9	39.5	41.3	22.4	36.2	68.1
ZNF329	FLJ12586	ENSG00000181894	"Zinc finger protein 329"	Q86UD4	19	58126252-58155110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044373, HPA077958"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044373: AB_10966569, HPA077958: "	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.53e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-3)"	"prognostic favorable (8.58e-9)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.52e-1)"	7.1	7.2	9.2	5.2	11.7	10.3	11.7	15.9	14.7	10.8	6.9	8.1	5.7	3.5	10.6	10.7	5.6	10.5	7.0	6.7	9.2	10.0	11.8	8.0	6.9	6.8	8.5	6.7	11.2	5.4	20.4	10.7	7.9	10.6	10.1	6.1	9.7	7.1	9.1	2.7	7.2	5.9	9.6	6.5	8.2	6.1	23.7	7.6	8.6	11.3	3.5	8.0	8.7	15.1	8.0	5.0	6.4	1.7	5.3	7.6	2.2	3.2	1.7	7.7	13.3	6.2	6.4	0.1	4.2	8.9	4.6	3.5	1.4	2.5	2.0	2.3	7.5	2.8	1.1	1.3	5.8	5.7	1.5	10.3	6.6	2.3	2.4	6.0	3.9	6.4	6.6	6.2	4.5	9.3	7.4	6.0	4.7	1.6	8.8	6.6	1.1	6.8	2.4	5.8	1.7	5.6	3.7	7.6	2.0	4.9	6.6	5.1	4.8	6.7	0.8	3.3	10.4	7.7	2.2	3.6	12.1	3.3	1.1	0.0	5.2	15.4	4.9	2.6	0.1	6.9	4.8	1.6	6.4	2.5	1.7	4.4	5.8	4.8	4.3	2.1	8.0	7.6	4.6	4.9	5.3	1.1	5.0	2.1	2.2	9.2	11.7	15.9	14.7	9.2	10.0	8.5	6.7	10.6	7.6	3.0	0.3	0.0	2.1	1.4	11.9	4.0	7.6	1.4	3.4	3.5	5.9	1.9	1.7	2.0	1.1	3.8	0.5	0.0	1.4	1.1	1.8	1.5	2.3	3.4	1.3	7.9	2.4	3.7	1.3	1.3	2.6	1.7	0.0	0.0	1.6	5.6	0.9	0.2	1.4	1.7	7.5	0.0	1.9	5.8	6.1	1.4	1.3	4.4	1.4	1.4
ZNF331	"RITA, ZNF361, ZNF463"	ENSG00000130844	"Zinc finger protein 331"	Q9NQX6	19	53520981-53580269	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 66.4;ovary: 86.4"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 234.6;Smooth muscle cells: 196.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 36.4;RT4: 27.8"					"Low region specificity"	"Detected in all"			HPA063157			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063157: AB_2684951"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.24e-1)"	"unprognostic (8.16e-2)"	"unprognostic (7.62e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.69e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (6.74e-2)"	19.1	66.4	6.8	9.0	8.2	18.6	10.5	11.4	9.5	9.4	5.3	8.4	8.9	2.1	9.5	11.6	4.9	19.5	23.8	15.5	5.1	7.7	6.6	6.1	15.6	4.0	6.8	5.5	86.4	9.9	11.3	29.0	23.3	7.2	10.2	4.2	9.9	4.7	31.5	6.3	5.2	4.8	8.5	9.1	4.5	6.3	8.1	6.0	3.8	7.8	4.4	4.8	25.7	9.2	8.1	4.1	6.5	7.4	4.6	14.7	5.2	0.1	5.1	10.3	11.8	8.0	5.9	17.2	7.3	6.5	5.6	10.2	5.5	2.6	4.1	1.9	4.3	2.6	3.0	7.4	5.5	10.0	0.0	36.4	5.1	8.7	3.3	5.8	3.2	7.2	5.9	3.6	6.2	3.0	3.1	2.5	6.4	0.2	1.6	5.5	3.6	7.2	6.8	4.6	0.1	7.6	8.9	6.5	4.2	3.3	27.8	7.3	7.4	3.4	9.7	2.4	21.4	1.7	2.9	2.6	7.9	7.0	4.6	4.8	20.3	13.2	7.7	0.1	0.4	6.1	0.5	4.9	6.5	8.7	3.8	13.4	8.1	9.4	8.8	3.6	8.1	14.7	9.7	0.7	4.6	7.4	4.1	9.4	5.2	6.8	8.2	11.4	9.5	5.1	7.7	6.8	5.5	7.2	6.0	17.9	70.7	15.9	15.3	39.8	52.9	16.5	7.6	17.4	20.5	73.3	27.5	32.9	8.3	2.9	128.2	19.9	2.1	0.0	3.6	30.4	36.8	11.9	234.6	3.9	60.1	28.6	22.5	14.7	33.7	61.5	22.5	79.8	43.9	3.6	5.1	25.1	2.3	3.5	18.4	3.7	35.8	0.0	196.7	34.4	19.8	44.3	37.2	74.7	3.2	9.4
ZNF333	KIAA1806	ENSG00000160961	"Zinc finger protein 333"	Q96JL9	19	14689801-14733746	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA043973, HPA054680"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043973: AB_10961277, HPA054680: AB_2682571"	"unprognostic (8.16e-2)"	"unprognostic (2.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.32e-5)"	"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.06e-3)"	10.7	8.1	8.8	7.8	11.3	12.2	9.4	16.2	12.1	11.4	9.9	14.3	7.0	4.5	16.5	11.0	5.3	10.8	6.6	6.3	8.6	6.9	5.8	4.9	8.7	7.3	16.8	9.8	15.3	9.1	8.2	7.5	7.4	10.3	8.8	5.9	10.3	5.7	8.5	14.5	7.7	6.5	11.6	9.6	13.0	6.7	8.8	12.8	6.7	6.9	4.3	6.6	9.5	8.8	2.7	4.9	7.9	5.0	13.5	5.4	2.4	1.5	0.9	5.8	7.8	8.4	7.9	2.2	3.5	4.9	3.1	4.5	0.4	1.4	2.4	4.0	4.6	1.0	1.5	2.0	1.4	4.6	5.6	1.5	9.9	2.1	2.4	6.9	4.0	5.7	7.3	3.9	2.9	8.2	4.3	4.5	3.0	2.0	4.8	3.9	0.8	2.6	9.5	2.3	3.3	1.8	3.7	3.3	2.3	3.0	2.1	3.2	6.2	3.2	0.4	5.7	2.5	1.5	6.7	7.2	5.3	2.4	8.5	3.7	2.3	1.0	2.5	5.5	6.9	6.2	7.9	4.0	6.0	4.0	5.0	5.4	2.6	3.6	3.0	4.9	2.7	4.1	3.6	7.0	13.5	4.3	2.4	3.0	2.4	8.8	11.3	16.2	12.1	8.6	6.9	16.8	9.8	10.3	12.8	6.0	8.3	1.7	5.0	2.7	12.5	2.7	0.0	4.0	2.3	3.5	3.9	2.5	1.7	2.2	4.6	6.5	1.1	0.0	2.6	2.1	5.9	3.7	16.1	1.8	4.4	7.9	2.4	6.7	9.9	2.5	9.2	6.5	1.7	4.6	1.0	5.2	2.1	2.5	8.5	1.3	17.7	12.9	6.2	10.8	6.8	2.4	1.1	4.9	2.2	3.1
ZNF334	bA179N14.1	ENSG00000198185	"Zinc finger protein 334"	Q9HCZ1	20	46499630-46513559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.7;plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.6;NK-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.1;BEWO: 15.2;NTERA-2: 8.1;SCLC-21H: 10.1;SuSa: 18.1"	"Low region specificity"	"Detected in all"							HPA050022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050022: AB_2680994"	"unprognostic (3.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.71e-3)"	3.1	7.3	11.1	2.2	14.3	1.9	9.5	18.2	12.0	6.4	2.6	8.1	11.5	2.9	9.2	13.4	2.4	12.1	5.8	2.1	9.8	7.8	6.8	4.1	4.7	2.1	5.8	6.9	22.5	7.5	2.9	20.4	7.0	11.5	12.8	3.5	7.0	6.8	10.0	1.5	3.0	3.8	4.9	7.6	3.1	7.0	8.3	8.8	2.7	10.8	1.7	1.8	5.2	4.5	0.4	3.6	0.2	0.5	2.7	0.1	0.1	0.0	0.0	12.1	0.0	0.8	0.1	15.2	1.0	0.1	0.9	0.1	0.0	3.1	0.0	0.0	0.3	3.7	0.0	0.0	0.2	0.4	0.0	2.5	3.8	0.1	4.3	3.3	0.0	0.0	3.9	0.0	1.0	0.0	0.5	0.1	0.1	2.5	0.0	0.1	0.0	0.0	6.8	8.1	2.0	1.0	0.0	0.0	0.0	3.3	2.9	10.1	5.7	0.0	0.3	0.2	18.1	0.0	3.4	0.0	0.1	5.5	0.1	0.0	0.9	4.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.2	0.2	0.1	0.0	0.1	2.7	0.0	3.6	0.0	0.1	11.1	14.3	18.2	12.0	9.8	7.8	5.8	6.9	11.5	8.8	8.9	5.0	0.0	3.4	0.1	11.8	1.4	2.5	13.4	9.1	3.5	2.0	3.6	5.0	3.8	0.4	1.1	0.0	0.0	1.1	3.1	2.0	2.2	2.3	1.0	1.4	9.5	0.0	3.7	0.0	1.3	2.6	0.0	0.0	0.0	1.3	11.0	1.9	0.0	1.8	2.8	11.0	0.0	1.6	5.1	7.7	0.0	0.8	0.0	1.6	1.4
ZNF337	dJ694B14.1	ENSG00000130684	"Zinc finger protein 337"	Q9Y3M9	20	25674215-25696841	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044303, HPA064219"	Approved		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA044303: AB_2678890, HPA064219: AB_2685215"	"unprognostic (2.14e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.54e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.36e-4)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.82e-3)"	10.4	9.8	11.7	9.0	14.3	10.8	13.6	49.5	14.8	17.9	14.6	16.1	13.3	7.0	19.8	19.4	9.6	18.0	9.0	8.4	10.9	9.8	9.4	6.9	13.5	12.3	15.1	14.2	23.1	8.4	20.3	19.0	9.3	11.2	16.6	10.9	11.0	8.6	17.2	11.9	12.9	11.1	15.4	9.4	13.4	8.7	7.0	14.9	19.0	12.2	6.0	11.0	14.3	26.1	3.8	3.9	4.8	3.9	5.3	9.6	3.8	7.8	14.4	11.5	8.0	9.4	11.9	9.7	6.8	6.1	5.4	6.7	2.9	7.4	10.0	6.5	6.2	11.1	12.9	7.7	22.2	7.3	3.6	6.1	6.2	9.3	12.5	8.3	5.5	6.7	11.1	19.9	6.2	18.4	13.8	8.3	13.2	5.4	8.9	10.3	8.8	15.0	10.1	3.1	4.4	10.2	9.4	10.8	4.9	5.5	8.7	9.4	10.0	7.0	11.0	9.2	14.8	6.4	7.7	11.0	11.5	6.1	7.6	8.9	12.5	6.7	3.6	5.5	4.7	9.2	0.0	2.4	4.8	7.2	3.9	7.9	3.8	6.0	6.8	3.9	3.2	8.4	9.6	0.1	5.3	2.2	3.9	3.9	3.8	11.7	14.3	49.5	14.8	10.9	9.8	15.1	14.2	11.2	14.9	6.0	12.5	1.5	4.6	1.8	8.8	0.8	5.1	22.7	17.0	3.5	2.0	2.8	3.3	3.3	0.8	4.6	1.1	0.0	2.7	1.9	3.1	3.9	4.7	2.9	2.7	6.4	5.2	3.1	4.8	0.0	6.6	1.6	1.7	2.8	4.3	9.2	2.6	0.0	5.3	1.7	13.0	0.0	3.1	5.6	9.6	2.0	1.9	4.8	2.4	1.5
ZNF33A	"FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK"	ENSG00000189180	"Zinc finger protein 33A"	Q06730	10	38010650-38065088	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 112.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.69e-3)"	"unprognostic (7.96e-3)"	"unprognostic (4.89e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.39e-3)"	11.7	13.9	10.6	18.5	13.2	10.9	19.4	34.6	15.9	17.1	14.4	8.9	31.3	13.7	16.1	17.9	14.1	16.2	12.4	11.5	13.5	10.9	16.8	16.9	12.0	14.2	18.2	13.5	16.3	21.8	24.1	49.7	12.0	18.8	17.7	17.0	9.7	18.9	27.7	16.7	14.4	16.9	17.8	17.3	17.4	17.1	6.4	16.4	12.8	18.9	11.0	16.7	16.1	15.9	7.0	6.8	17.2	6.5	4.8	6.8	3.2	10.9	6.2	11.6	9.7	5.5	7.3	9.0	5.0	5.0	6.5	7.2	6.6	10.0	21.4	5.5	6.7	3.7	7.2	13.7	8.8	6.0	12.8	15.2	17.0	12.2	9.0	5.8	24.0	14.2	6.2	16.1	4.8	7.4	12.0	5.4	12.2	8.9	11.5	6.4	7.1	9.9	5.5	11.7	5.5	7.3	8.6	7.8	9.9	9.2	10.2	8.8	13.9	7.7	8.6	4.4	8.2	10.5	6.4	4.9	5.7	8.4	6.3	3.9	9.1	11.1	12.9	5.3	13.4	2.6	9.6	3.8	6.3	6.2	5.4	5.5	7.0	5.5	4.1	3.6	7.0	6.8	5.3	17.2	4.8	6.5	6.8	3.7	3.2	10.6	13.2	34.6	15.9	13.5	10.9	18.2	13.5	18.8	16.4	56.6	54.0	38.9	30.3	10.5	35.0	62.5	22.9	112.4	63.7	26.2	31.4	24.2	21.6	27.2	3.1	25.0	16.5	0.0	25.3	16.4	10.8	34.2	32.4	34.5	16.9	28.6	32.7	14.1	20.0	5.3	22.2	27.9	10.1	32.5	29.4	19.9	26.6	31.6	22.6	31.4	29.8	25.8	15.9	16.5	17.2	11.2	29.7	25.5	25.2	35.9
ZNF33B	"KOX2, KOX31, ZNF11B"	ENSG00000196693	"Zinc finger protein 33B"	Q06732	10	42574185-42638568	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 74.5;Ciliated cells: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (3.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.61e-2)"	6.6	8.0	6.1	8.0	6.3	1.9	16.1	19.1	8.0	10.2	9.8	2.2	16.5	6.8	9.3	8.6	8.6	15.0	6.6	4.6	5.6	8.1	16.7	8.2	6.9	8.3	5.1	8.5	19.4	31.8	16.6	29.9	8.1	9.3	14.1	8.2	5.2	16.4	13.9	4.8	9.5	11.4	7.8	5.0	10.9	11.0	3.8	2.8	10.8	20.8	4.1	6.6	11.0	10.2	14.8	8.6	11.3	6.1	6.1	16.9	8.5	9.7	2.5	6.6	6.7	2.4	0.3	8.2	6.4	4.7	3.9	5.5	5.4	11.3	14.7	3.8	2.3	6.0	8.3	12.6	4.2	4.4	8.7	9.4	5.9	9.1	8.8	2.8	13.8	4.8	4.0	15.6	2.4	13.3	10.4	3.3	8.2	7.9	11.3	2.4	4.1	5.4	3.3	7.2	4.8	5.9	5.9	6.5	6.2	10.5	13.8	11.9	11.6	3.8	8.1	3.7	6.2	10.3	4.2	4.0	2.1	9.7	3.5	6.5	7.3	11.1	4.6	1.4	10.4	1.8	11.3	6.1	5.3	9.0	5.0	12.8	14.8	13.2	9.1	5.3	12.6	16.9	11.9	1.9	6.1	3.9	8.6	10.3	8.5	6.1	6.3	19.1	8.0	5.6	8.1	5.1	8.5	9.3	2.8	74.5	28.6	15.9	16.2	4.2	16.4	29.4	33.1	73.6	47.8	19.2	9.8	15.2	18.3	21.8	2.1	9.5	6.8	0.0	31.3	14.1	4.7	12.3	8.1	9.8	7.0	9.5	24.3	12.3	11.3	1.9	19.0	6.4	6.8	13.6	16.8	10.3	25.6	25.1	11.0	19.2	9.0	0.0	4.2	7.1	10.0	3.4	9.6	12.5	20.8	9.8
ZNF341	dJ553F4.3	ENSG00000131061	"Zinc finger protein 341"	Q9BYN7	20	33731657-33792269	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Club cells: 6.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023240, HPA024607, HPA067108"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780"	"unprognostic (1.74e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.31e-2)"	"prognostic favorable (3.93e-4)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.17e-5)"	"unprognostic (4.84e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.67e-3)"	"unprognostic (3.68e-2)"	4.5	4.3	7.3	6.9	10.4	7.7	5.1	10.4	9.1	6.5	4.9	7.2	2.1	5.8	6.5	3.5	6.7	5.4	5.2	4.5	6.8	3.1	3.1	3.6	4.7	5.5	8.8	6.3	5.5	5.4	4.0	5.2	5.4	4.9	4.9	4.9	3.7	5.7	6.9	7.2	8.2	5.0	4.9	4.2	5.8	4.5	7.4	6.9	4.9	4.9	2.9	4.7	6.5	5.5	2.6	1.5	5.9	2.4	2.2	2.4	1.4	1.8	8.3	3.0	4.0	3.0	2.1	11.2	2.8	1.7	2.7	1.3	6.2	5.3	3.8	3.8	2.0	3.0	3.6	2.8	4.9	0.9	3.7	2.8	4.3	3.4	2.9	1.1	2.4	4.7	2.1	3.0	2.1	1.2	2.3	2.7	4.5	2.2	1.6	2.4	3.8	2.2	1.0	2.6	3.5	4.2	2.6	1.3	1.8	1.5	6.4	2.1	1.9	8.2	5.5	1.0	2.4	6.3	2.2	2.1	3.5	1.2	0.9	2.2	1.2	1.6	2.9	4.3	1.6	2.7	3.5	1.9	5.9	1.9	2.4	1.6	2.6	1.2	1.3	1.5	2.5	1.1	2.4	3.8	2.2	1.5	1.1	1.0	1.4	7.3	10.4	10.4	9.1	6.8	3.1	8.8	6.3	4.9	6.9	3.0	6.1	4.7	1.0	0.3	2.3	2.0	2.5	5.3	6.8	1.8	2.0	2.2	0.0	1.5	0.5	0.7	4.2	0.0	1.2	2.6	1.3	1.9	2.3	0.8	1.2	1.6	1.2	1.3	2.2	0.0	0.6	2.5	0.0	0.0	2.1	0.2	1.6	0.8	0.4	0.3	2.1	0.0	0.6	1.1	2.2	0.9	1.7	0.0	1.3	1.8
ZNF343	MGC10715	ENSG00000088876	"Zinc finger protein 343"	Q6P1L6	20	2481817-2524702	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA030587, HPA052438"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030587: AB_10603246, HPA052438: AB_2681833"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (9.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.88e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.65e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.53e-2)"	11.6	8.6	10.4	8.0	11.9	3.9	12.4	20.6	15.0	10.6	12.3	10.7	8.5	5.1	13.9	18.0	8.9	10.6	8.1	7.8	10.0	7.1	9.3	8.0	9.4	9.9	9.1	7.6	12.7	12.8	17.2	10.9	9.4	10.4	10.2	10.1	9.0	8.7	10.4	13.8	11.3	7.5	13.0	9.1	8.2	8.9	7.5	9.5	5.4	11.4	6.6	9.8	11.3	12.9	8.9	5.3	4.5	3.9	1.8	7.6	3.0	9.6	10.4	7.0	7.7	8.1	8.4	2.5	6.7	7.6	8.4	8.7	5.4	5.7	12.4	2.6	6.8	9.6	9.2	10.8	12.3	10.9	3.3	5.3	8.0	4.6	10.7	7.3	4.8	3.0	7.6	12.4	10.1	16.3	8.8	8.2	9.7	10.4	6.3	7.9	3.4	10.3	3.2	7.1	8.4	11.1	8.5	9.5	7.4	4.2	2.6	8.2	13.1	8.5	14.0	8.0	6.0	4.9	4.1	5.3	11.6	5.3	8.4	7.7	12.9	20.6	6.4	3.1	6.6	6.7	0.6	3.9	4.5	5.1	3.8	5.4	7.0	6.3	4.4	3.9	8.9	5.8	7.6	3.3	1.8	3.4	5.3	5.7	3.0	10.4	11.9	20.6	15.0	10.0	7.1	9.1	7.6	10.4	9.5	3.0	1.0	2.4	1.3	1.8	4.5	1.6	0.0	1.4	3.4	1.8	0.0	2.0	1.7	1.9	0.6	2.1	1.1	0.0	0.8	1.1	2.1	1.2	1.1	2.4	1.2	7.9	2.9	1.8	1.0	0.0	3.7	1.2	1.7	1.0	2.0	2.7	1.9	0.0	2.8	2.5	2.9	0.0	3.1	3.9	3.3	1.9	0.7	1.5	1.8	1.3
ZNF346	"JAZ, Zfp346"	ENSG00000113761	"Zinc finger protein 346"	Q9UL40	5	177022696-177081189	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018485	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018485: AB_1859213"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-2)"	"unprognostic (5.71e-3)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (9.85e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.88e-7)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (5.11e-2)"	"unprognostic (7.86e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.44e-2)"	9.0	12.1	17.0	14.8	21.3	10.6	12.4	26.8	21.6	13.2	10.7	15.2	11.2	9.1	17.4	16.0	13.8	16.9	10.0	11.4	14.7	14.3	11.5	10.1	8.9	13.2	10.9	19.3	27.0	12.5	16.1	19.0	10.0	13.6	13.0	10.7	14.7	11.1	15.1	16.7	14.7	9.2	18.0	10.5	13.1	9.7	16.8	12.5	15.8	19.6	9.1	17.4	10.8	12.1	7.3	4.0	5.9	3.7	17.0	8.5	4.5	4.2	7.2	12.8	17.5	6.7	6.9	10.3	7.3	7.9	12.3	13.6	9.8	6.6	11.0	8.3	7.5	10.6	5.9	12.4	11.7	11.9	33.8	10.1	7.5	9.0	8.6	8.0	12.4	7.1	6.8	7.1	11.8	8.6	7.4	13.8	13.1	8.9	7.1	5.7	13.7	16.4	6.2	5.7	5.5	12.9	17.6	8.9	5.1	8.5	5.1	16.3	7.0	9.5	6.9	6.0	6.6	9.6	6.7	7.8	9.9	7.7	6.6	8.0	6.3	6.9	12.9	4.0	10.6	8.1	0.3	3.7	5.9	8.5	3.5	5.4	5.1	5.9	5.5	4.0	7.3	7.5	7.5	3.9	17.0	3.5	3.6	5.6	4.5	17.0	21.3	26.8	21.6	14.7	14.3	10.9	19.3	13.6	12.5	0.0	5.9	6.1	2.8	2.6	11.8	3.4	7.6	0.0	3.4	5.2	5.9	7.9	8.3	5.2	2.1	6.3	2.8	0.0	5.0	4.6	3.9	1.0	2.3	3.2	4.9	7.9	4.6	3.7	2.7	4.0	4.6	2.2	3.3	3.6	3.2	8.4	3.4	2.6	6.0	3.6	6.1	0.0	4.2	10.8	10.2	4.3	2.7	5.2	2.8	1.6
ZNF347	ZNF1111	ENSG00000197937	"Zinc finger protein 347"	Q96SE7	19	53124072-53159075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023448	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA023448: AB_1859214"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.01e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.59e-3)"	7.3	7.1	6.1	6.4	6.2	20.5	6.9	14.7	8.4	8.4	6.3	11.2	4.4	3.2	8.5	6.9	6.3	6.7	7.2	6.3	5.8	4.5	5.1	2.7	6.3	6.4	6.6	7.1	9.6	11.7	7.2	11.7	8.4	10.3	7.3	4.4	3.6	8.6	6.0	3.9	8.1	4.6	10.1	10.7	10.7	5.2	5.7	5.4	12.1	8.2	3.7	6.1	7.5	7.4	5.0	2.9	11.0	2.2	6.0	3.0	1.3	0.6	0.6	6.5	10.8	4.2	4.6	6.2	6.9	7.2	8.3	9.9	1.1	1.7	6.1	2.8	5.9	9.4	3.0	0.6	1.3	10.7	1.2	4.7	1.0	3.7	2.1	2.6	1.4	6.4	5.1	0.5	6.1	0.0	3.0	2.1	3.7	5.0	2.2	4.3	0.7	10.0	3.2	7.8	0.3	3.4	2.7	0.4	1.4	3.3	16.1	4.7	5.0	1.1	2.1	2.7	8.8	5.9	2.7	3.3	10.4	6.8	5.7	9.9	0.9	5.4	10.9	1.6	1.1	5.7	4.6	1.7	2.5	2.8	1.5	2.8	2.9	2.5	2.6	1.7	5.0	3.0	2.6	11.0	6.0	2.2	2.9	2.5	1.3	6.1	6.2	14.7	8.4	5.8	4.5	6.6	7.1	10.3	5.4	17.9	14.3	3.2	4.1	1.8	9.5	6.2	2.5	32.1	11.4	3.5	3.9	2.7	1.7	2.4	0.2	10.5	2.6	0.0	3.5	2.8	2.7	3.8	3.5	1.0	2.3	7.9	1.2	12.9	5.7	0.4	4.9	3.6	1.7	3.6	3.1	4.1	2.9	0.0	3.5	0.8	13.8	0.0	3.8	1.5	4.9	1.8	2.9	5.3	3.1	2.6
ZNF35	"HF.10, HF10, Zfp105"	ENSG00000169981	"Zinc finger protein 35"	P13682	3	44648727-44660791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051859, HPA054738"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051859: AB_2681642, HPA054738: AB_2682588"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.91e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.30e-1)"	8.8	5.9	8.3	6.2	10.4	6.2	8.2	8.7	11.5	8.1	8.3	8.4	7.2	5.2	10.8	11.0	8.8	6.4	6.8	7.9	7.3	6.3	10.2	4.5	7.1	5.3	8.2	7.0	6.4	6.3	8.4	15.3	5.9	10.8	8.7	6.6	7.7	7.2	8.8	8.1	7.9	7.6	12.0	8.5	11.9	7.4	17.7	7.5	3.9	7.9	8.4	8.8	8.3	7.0	4.0	3.9	1.5	4.0	4.6	2.4	1.9	3.1	2.4	6.3	8.0	4.1	3.3	1.2	3.8	5.4	6.8	6.5	4.2	1.4	2.7	1.7	5.3	3.0	2.3	0.3	5.5	7.1	0.0	2.2	9.0	4.4	0.2	3.8	8.9	6.9	3.4	4.3	6.1	5.5	3.3	5.4	0.1	6.0	2.6	7.4	2.0	0.2	2.9	13.9	2.3	6.7	0.1	6.7	4.7	3.6	8.9	3.5	9.0	4.9	3.0	0.8	5.4	8.0	5.6	5.5	7.3	5.3	3.9	7.6	7.2	11.0	1.5	6.2	4.4	5.6	0.0	3.8	1.5	2.2	4.0	1.4	3.6	0.6	2.4	3.9	4.0	1.1	1.2	0.2	4.6	3.7	1.6	0.2	1.9	8.3	10.4	8.7	11.5	7.3	6.3	8.2	7.0	10.8	7.5	6.0	8.3	6.1	3.3	2.5	4.5	2.8	5.1	5.3	3.4	1.8	0.0	0.2	1.7	6.5	8.0	4.9	1.6	0.0	7.6	0.1	2.6	2.8	0.0	0.4	3.3	6.4	2.4	4.3	4.0	4.9	1.1	3.8	1.7	3.6	1.5	4.3	7.5	2.0	4.2	2.4	6.2	0.0	3.1	15.4	9.6	2.5	0.3	2.2	2.3	3.0
ZNF354B	"FLJ25008, KID2"	ENSG00000178338	"Zinc finger protein 354B"	Q96LW1	5	178859953-178888122	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029056	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029056: AB_10603006"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.24e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (2.88e-4)"	"unprognostic (6.72e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.15e-3)"	14.2	8.8	13.1	9.4	15.3	5.4	15.0	22.8	13.3	14.5	11.7	8.1	9.3	8.9	14.2	10.0	8.6	10.7	9.2	7.3	13.7	5.6	10.0	7.4	9.8	10.3	15.8	7.7	13.0	13.0	15.8	20.4	28.6	11.2	13.3	8.1	4.7	10.7	11.7	12.9	10.7	9.8	9.7	11.6	12.4	10.1	7.3	16.3	12.8	15.5	8.3	9.5	11.6	11.9	8.1	3.8	2.6	3.3	2.2	5.9	1.6	4.4	3.5	6.6	14.9	6.5	6.4	16.8	5.5	5.1	5.4	6.3	4.4	8.0	0.0	6.1	4.9	7.5	9.2	8.3	9.2	6.7	0.0	6.8	5.1	11.6	3.2	5.6	0.1	3.6	5.8	5.7	4.4	6.9	8.3	4.8	7.8	4.2	0.0	5.8	4.9	8.1	11.6	3.5	2.1	4.7	7.8	3.6	4.9	4.7	5.4	7.4	7.7	6.7	6.0	4.3	6.7	5.3	8.9	5.6	9.6	8.7	3.4	4.1	3.3	4.7	0.2	0.6	0.0	5.0	2.6	3.3	1.3	5.9	1.9	5.4	4.8	4.2	3.3	2.8	8.1	5.1	5.1	0.9	2.2	2.2	3.8	3.5	1.6	13.1	15.3	22.8	13.3	13.7	5.6	15.8	7.7	11.2	16.3	8.9	4.5	0.0	6.0	4.0	6.2	6.9	5.1	8.1	9.1	7.0	7.9	15.2	0.0	3.9	0.4	9.0	1.1	0.0	1.9	5.0	3.8	4.3	0.0	1.9	4.3	11.1	0.0	7.4	3.4	0.0	4.6	5.4	0.0	1.0	2.4	4.3	2.0	0.0	4.9	1.5	6.2	0.0	5.6	6.9	10.9	4.6	28.9	4.4	1.9	2.8
ZNF358	"FLJ10390, ZFEND"	ENSG00000198816	"Zinc finger protein 358"	Q9NW07	19	7515292-7521026	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030887, HPA063624"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030887: AB_10602688, HPA063624: AB_2685064"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.52e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.60e-2)"	23.7	21.1	33.6	7.9	26.1	2.1	31.6	21.4	54.7	30.1	26.1	20.2	17.5	19.2	22.4	19.5	18.0	27.9	20.9	36.4	29.1	22.5	17.4	17.9	14.4	6.8	24.9	20.2	46.1	25.0	21.1	17.7	12.2	15.0	23.1	12.6	19.1	32.3	30.8	95.9	11.7	18.0	24.9	16.8	13.8	18.3	8.5	18.3	4.4	27.3	13.5	7.7	24.7	24.3	2.6	1.4	4.6	1.8	0.7	2.4	0.7	10.3	7.0	13.2	21.0	28.4	31.6	11.3	3.9	25.7	18.0	15.9	3.0	7.4	0.0	15.3	21.0	2.8	4.1	5.4	10.0	5.8	0.0	11.6	2.0	8.6	4.2	31.2	0.3	0.1	27.5	19.0	8.5	7.4	27.0	18.8	0.0	5.2	0.0	15.8	5.1	0.0	7.5	13.5	4.3	12.4	11.5	7.1	1.1	9.4	4.5	14.7	29.3	4.9	4.1	14.1	8.9	3.1	5.5	8.8	11.6	8.5	17.2	5.9	14.1	7.6	0.0	10.7	0.0	16.0	4.6	1.7	1.1	1.8	1.8	1.3	0.4	0.6	1.0	0.9	2.6	1.4	2.4	0.0	0.7	0.4	1.4	0.0	0.7	33.6	26.1	21.4	54.7	29.1	22.5	24.9	20.2	15.0	18.3	8.9	12.0	3.0	9.8	6.9	20.2	103.8	12.7	1.4	3.4	15.7	13.7	2.5	5.0	11.1	4.1	17.6	35.9	0.0	14.4	4.4	16.5	10.0	14.9	38.9	8.8	47.7	35.1	29.4	15.9	4.7	35.1	7.1	5.0	2.8	27.3	32.3	15.6	17.5	35.0	24.2	15.2	12.9	19.8	0.5	0.7	3.1	2.5	3.9	19.2	10.4
ZNF362	"FLJ25476, lin-29, RN"	ENSG00000160094	"Zinc finger protein 362"	Q5T0B9	1	33256545-33300719	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059239	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA059239: AB_2683955"	"unprognostic (8.31e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.66e-1)"	21.6	14.0	18.1	12.0	17.2	8.9	21.7	24.5	30.5	18.6	17.3	13.8	9.6	11.0	23.7	23.8	14.2	20.1	20.7	28.0	15.4	13.8	16.8	8.8	18.7	26.3	12.8	15.6	23.3	19.9	16.4	19.1	17.9	12.3	20.4	8.8	27.4	22.8	21.7	26.1	23.5	11.6	28.1	13.1	22.6	14.0	8.5	10.3	17.9	17.4	14.1	15.3	20.1	15.4	6.0	8.3	6.0	4.6	4.2	4.7	2.5	3.3	5.4	23.7	9.4	6.3	4.4	15.6	4.7	5.5	5.8	6.2	5.6	11.4	1.7	10.3	5.9	1.8	11.3	5.5	2.6	2.4	10.0	5.0	8.5	3.3	6.8	5.6	4.0	6.9	9.4	6.6	2.5	2.2	5.9	7.9	11.3	0.9	2.9	4.4	8.1	13.0	6.7	14.1	2.0	5.1	21.3	5.6	0.7	4.6	5.4	8.4	25.4	13.3	4.2	20.9	10.6	4.1	10.4	11.4	3.5	4.8	8.3	3.1	8.9	8.2	1.8	2.8	3.6	10.4	3.8	4.6	6.0	4.7	4.1	3.4	3.0	3.5	4.1	3.3	6.0	3.1	2.9	3.5	4.2	4.5	8.3	2.6	2.5	18.1	17.2	24.5	30.5	15.4	13.8	12.8	15.6	12.3	10.3	8.9	11.3	1.9	4.0	9.0	12.3	19.4	7.6	1.4	9.1	10.4	0.0	9.4	1.7	5.5	0.9	10.5	3.1	0.0	6.5	5.7	9.7	2.2	9.3	6.6	8.7	7.9	1.7	19.6	14.5	5.4	12.7	6.1	8.5	1.0	4.0	7.7	3.7	8.5	20.1	9.9	4.5	6.5	11.3	0.9	2.5	8.3	3.0	4.9	6.9	1.3
ZNF365	"KIAA0844, UAN"	ENSG00000138311	"Zinc finger protein 365"	"Q70YC4, Q70YC5"	10	62374192-62672011	"Disease related genes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.3"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 12.6;Horizontal cells: 17.5;Rod photoreceptor cells: 4.9;Urothelial cells: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 3.4;memory CD4 T-cell: 3.1;memory CD8 T-cell: 3.5;naive CD8 T-cell: 3.7;NK-cell: 7.4;T-reg: 7.5"	"Group enriched"	"Detected in many"	51	"NK-cells: 7.4;T-cells: 7.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.3;PC-3: 11.2;U-251 MG: 14.4;U-87 MG: 10.3"	"Group enriched"	"Detected in all"	4	"amygdala: 328.0;basal ganglia: 309.9;cerebral cortex: 424.1;hippocampal formation: 348.1;thalamus: 127.9"	"Low region specificity"	"Detected in all"			HPA052446	Enhanced		Supported	"Vesicles,Centriolar satellite"		NA	NA			"Vesicles, Centriolar satellite"		"HPA052446: AB_2681836"	"unprognostic (7.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-6)"	"unprognostic (2.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.89e-2)"	0.9	2.5	11.8	1.0	19.4	1.0	1.3	8.4	41.3	2.0	0.9	13.1	0.0	1.1	1.2	1.5	11.7	1.0	4.0	2.0	9.6	7.4	1.1	1.2	3.1	1.1	7.5	16.0	1.0	1.3	9.0	1.8	1.2	6.9	3.0	1.1	1.0	1.2	3.3	1.0	2.6	0.9	0.9	10.5	1.3	1.0	1.6	9.1	0.0	1.6	0.0	2.2	1.9	1.2	0.1	0.0	0.1	0.1	7.4	7.5	1.0	5.7	0.8	0.5	0.7	0.6	0.3	0.3	4.3	4.5	2.2	1.9	0.6	1.4	0.4	0.7	2.6	7.4	17.3	0.5	0.3	3.0	0.2	0.4	0.3	1.5	0.4	0.2	0.3	1.4	0.3	0.3	5.9	0.8	6.2	0.7	0.3	0.4	0.6	4.3	2.1	0.7	0.5	0.9	0.3	11.2	0.4	0.5	0.4	0.5	2.6	0.2	0.9	1.1	0.9	0.4	0.6	0.1	0.3	3.1	1.2	5.6	0.6	14.4	0.2	0.5	0.3	10.3	0.6	1.9	0.0	0.0	0.0	3.4	0.1	0.0	0.0	3.1	3.5	0.0	0.1	0.6	3.7	0.1	7.4	0.1	0.0	7.5	1.0	11.8	19.4	8.4	32.3	9.6	7.4	7.5	16.0	6.9	9.1	0.0	0.0	0.0	3.3	0.5	12.6	2.4	0.0	0.0	0.0	3.5	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.1	17.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.6	4.9	0.0	1.2	0.0	0.4	0.4	0.0	0.0	0.0	6.7
ZNF37A	"KOX21, ZNF37"	ENSG00000075407	"Zinc finger protein 37A"	P17032	10	38094334-38150293	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003172	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA003172: AB_1080709"	"unprognostic (8.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.09e-2)"	8.2	10.1	11.9	9.9	15.3	4.9	9.9	23.2	13.9	11.8	9.9	11.0	6.6	8.0	12.5	10.5	6.9	10.1	8.7	7.8	11.5	9.9	10.4	9.1	10.2	9.2	16.3	10.7	13.5	16.7	20.0	25.0	8.2	12.8	10.3	8.5	9.0	12.7	15.4	6.7	10.7	9.0	16.3	12.0	9.7	10.1	4.1	16.2	8.2	14.0	3.9	9.8	8.5	8.4	5.6	2.9	2.5	4.7	6.4	5.4	1.7	11.7	6.1	5.4	10.2	8.3	8.2	5.9	9.1	3.4	4.2	5.7	4.8	3.5	17.3	2.8	5.0	5.8	4.8	10.1	7.6	6.6	11.1	9.6	17.4	6.9	6.8	7.2	18.2	11.3	6.2	12.8	7.2	6.1	8.5	5.5	8.3	11.3	12.3	9.0	2.7	10.2	2.8	4.8	4.1	10.0	7.4	14.8	3.5	4.5	4.6	4.4	7.6	6.3	5.1	5.1	6.0	9.3	5.7	9.4	8.0	8.6	7.6	8.7	13.9	14.9	6.8	5.3	13.1	5.0	2.5	2.4	2.2	3.9	1.9	5.1	3.5	4.5	3.9	2.3	5.6	5.4	4.5	2.0	6.4	4.7	2.9	2.4	1.7	11.9	15.3	23.2	13.9	11.5	9.9	16.3	10.7	12.8	16.2	23.8	35.8	21.7	11.7	7.2	60.7	27.9	2.5	13.4	25.0	10.4	51.1	8.7	1.7	15.7	2.6	20.2	5.6	0.0	10.3	5.5	13.1	13.0	39.3	9.3	6.2	39.7	40.2	22.1	10.2	1.1	26.2	10.8	5.0	9.0	9.8	28.9	11.0	7.0	26.5	6.3	50.9	12.9	18.4	18.0	12.4	5.3	3.2	16.6	13.3	8.1
ZNF382	"FLJ14686, KS1"	ENSG00000161298	"Zinc finger protein 382"	Q96SR6	19	36604817-36634113	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 27.6"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 22.7;Early spermatids: 21.4;Horizontal cells: 47.7;Late spermatids: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049259	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049259: AB_2680694"	"unprognostic (5.43e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.76e-5)"	"unprognostic (8.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.22e-2)"	3.3	5.9	6.7	3.5	10.5	1.9	3.3	27.6	13.8	4.2	3.9	4.9	2.3	1.3	4.8	4.2	3.1	5.8	3.0	7.5	6.2	6.2	3.8	1.5	2.7	5.1	5.6	11.2	4.7	2.6	4.8	11.0	4.6	9.4	3.6	1.9	4.4	3.3	3.1	1.7	1.4	2.8	4.3	5.5	5.5	2.2	6.7	5.3	3.6	5.7	2.0	6.3	4.0	2.0	9.0	2.4	3.5	0.7	4.5	9.0	2.7	0.2	0.1	4.5	6.4	1.9	2.6	1.5	2.0	0.6	5.9	6.1	0.1	0.4	3.9	4.3	2.4	2.6	0.1	5.8	0.1	3.8	10.9	2.6	6.3	0.3	1.6	5.2	0.9	7.6	3.5	0.2	3.3	0.2	6.0	0.7	7.7	0.1	0.2	3.8	0.6	8.8	2.1	3.0	0.0	2.2	0.4	1.9	1.7	1.6	0.2	0.6	8.7	0.3	0.3	3.5	6.8	2.7	0.7	0.2	1.4	0.3	0.3	5.7	10.0	0.7	0.4	0.1	0.1	3.5	2.1	0.6	3.5	5.6	0.7	9.0	9.0	8.8	6.2	2.3	6.6	7.6	8.4	1.2	4.5	0.7	2.4	5.0	2.7	6.7	10.5	27.6	13.8	6.2	6.2	5.6	11.2	9.4	5.3	3.0	0.0	0.0	0.6	0.1	22.7	9.8	0.0	2.7	1.2	3.5	9.8	1.8	5.0	2.4	21.4	2.1	0.0	0.0	0.4	0.8	2.0	0.4	0.0	0.4	2.4	47.7	0.0	1.3	0.6	15.0	0.6	1.1	1.7	1.0	0.1	4.0	0.2	0.0	1.1	1.3	12.7	0.0	1.2	4.4	2.8	0.0	0.1	2.1	0.0	0.4
ZNF384	"CAGH1A, CIZ, NMP4, NP, TNRC1"	ENSG00000126746	"Zinc finger protein 384"	Q8TF68	12	6666477-6689572	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004051	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004051: AB_1859228"	"unprognostic (1.90e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.13e-2)"	20.5	22.8	18.9	30.9	19.9	33.4	22.1	36.1	23.0	23.2	23.3	19.5	16.8	22.1	29.8	17.6	21.1	24.2	25.3	16.1	16.0	10.8	20.7	19.9	19.7	21.9	19.7	17.7	31.3	25.8	25.8	20.5	23.9	14.8	22.7	21.4	18.6	22.4	20.6	22.7	24.1	29.4	24.8	14.2	33.6	21.3	20.5	18.7	39.7	27.0	17.5	29.7	25.2	28.9	10.2	11.1	14.2	13.3	15.6	17.3	7.3	10.5	20.3	25.0	16.7	17.7	12.6	33.6	15.3	14.3	14.9	15.9	22.2	22.7	25.0	5.8	17.2	21.6	14.3	18.4	14.1	17.0	45.1	16.7	28.6	26.9	11.5	12.5	27.1	21.2	13.8	13.7	18.3	28.6	28.1	12.8	17.7	14.9	8.7	16.2	16.4	24.4	17.5	48.4	19.3	8.9	24.3	26.8	9.6	13.2	28.5	7.8	25.3	15.9	21.3	13.7	44.0	5.6	22.5	15.9	16.4	22.9	12.8	18.0	12.1	11.4	45.6	16.1	9.8	18.5	3.3	8.0	14.2	17.3	9.7	13.8	10.2	11.0	13.6	11.1	8.8	10.8	12.1	14.2	15.6	13.3	7.4	13.2	7.3	18.9	19.9	36.1	23.0	16.0	10.8	19.7	17.7	14.8	18.7	0.0	8.3	8.0	2.9	7.0	4.7	2.3	12.7	4.0	3.4	1.8	9.8	5.8	0.0	3.8	3.4	5.8	9.7	0.0	4.3	4.4	6.1	4.4	5.7	5.8	6.1	0.0	3.5	9.2	14.1	1.8	7.8	7.2	5.0	6.4	13.6	6.0	5.7	14.1	8.1	3.1	7.6	0.0	3.4	6.7	6.3	8.5	6.1	10.2	11.2	3.8
ZNF385A	"DKFZp586G1122, Hzf, ZFP385, ZNF385"	ENSG00000161642	"Zinc finger protein 385A"	Q96PM9	12	54369133-54391298	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 81.6"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 219.7;Cone photoreceptor cells: 161.0;Horizontal cells: 136.7;Rod photoreceptor cells: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 16.6;monocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 29.4;HBEC3-KT: 28.0;HEL: 35.2;hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039799			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039799: AB_10795117"	"unprognostic (8.56e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.75e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.07e-3)"	23.7	4.3	23.6	16.3	27.3	16.8	7.9	13.2	32.5	7.9	5.7	12.8	2.3	4.8	3.2	10.7	28.1	6.2	8.9	4.3	18.4	22.6	2.3	3.8	11.6	8.9	31.8	15.4	2.0	2.0	13.8	8.5	12.6	19.4	10.3	5.4	35.5	8.9	10.1	5.9	81.6	5.7	8.7	16.4	13.9	4.4	2.1	16.1	5.5	18.1	21.9	21.9	25.8	14.9	0.8	16.6	1.6	16.8	0.0	0.2	6.6	0.8	3.4	5.3	6.6	6.1	4.1	14.6	0.6	2.6	2.8	2.4	7.0	2.6	1.9	2.4	1.4	2.2	29.4	2.0	28.0	0.9	1.8	2.8	35.2	2.3	1.3	2.7	0.5	24.7	3.6	31.6	3.1	7.9	6.8	1.7	4.9	16.9	0.1	1.2	15.6	1.7	5.0	3.0	3.3	2.7	6.2	0.4	6.9	2.1	23.0	2.3	10.6	0.2	19.9	1.4	6.4	23.5	14.7	1.7	1.5	3.5	1.7	1.7	0.5	0.1	1.6	6.3	1.6	3.8	1.6	15.3	0.0	0.0	16.8	0.0	0.6	0.0	0.0	16.6	0.8	0.0	0.2	1.2	0.0	11.9	1.6	0.0	6.6	23.6	27.3	13.2	32.5	18.4	22.6	31.8	15.4	19.4	16.1	0.0	0.0	5.0	20.2	32.2	219.7	3.1	2.5	2.7	2.3	8.7	161.0	56.0	8.3	3.5	0.4	2.9	0.0	0.0	0.5	5.3	14.9	11.9	1.1	1.0	53.9	136.7	4.6	2.5	63.8	0.0	13.8	52.2	8.5	19.0	0.0	74.9	2.2	0.0	8.5	2.1	153.5	0.0	4.7	2.2	2.5	57.7	91.1	1.3	0.0	27.3
ZNF385B	"FLJ25270, ZNF533"	ENSG00000144331	"Zinc finger protein 385B"	Q569K4	2	179441982-179861505	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.0"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 81.3;Bipolar cells: 179.5;Distal tubular cells: 69.6;Rod photoreceptor cells: 128.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.2;HAP1: 16.3;U-698: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046086			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA046086: AB_2679532"	"prognostic favorable (4.86e-8)"	"unprognostic (8.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (1.04e-9)"	"unprognostic (7.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-3)"	1.7	4.2	3.2	1.1	14.4	0.9	8.3	33.0	23.2	2.4	1.8	0.9	1.1	1.0	2.1	5.2	1.6	1.2	1.2	23.1	4.2	2.1	9.5	21.3	20.1	2.1	2.7	9.5	18.4	0.8	0.5	0.8	2.9	15.6	14.4	1.3	10.1	1.4	1.1	11.2	1.9	1.2	1.0	1.3	1.0	8.5	10.6	6.1	0.0	1.0	2.9	1.1	1.4	2.9	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	8.2	0.0	0.0	3.1	0.0	16.3	0.0	0.2	0.0	2.0	0.0	0.4	0.5	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.6	0.0	0.9	0.0	0.6	0.6	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.2	0.1	0.6	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.2	14.4	33.0	23.2	4.2	2.1	2.7	9.5	15.6	6.1	26.8	81.3	0.0	0.6	3.1	179.5	26.0	7.6	2.7	2.3	0.0	51.1	0.0	69.6	0.0	50.4	0.3	0.0	0.0	0.0	0.0	3.3	8.2	1.1	12.1	0.2	1.6	1.7	1.3	0.0	21.9	0.6	0.4	1.7	0.0	0.0	5.8	0.1	0.0	0.4	10.6	128.3	0.0	1.4	2.6	0.7	0.6	0.1	0.0	0.0	0.9
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99486519-99500324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	11.3	8.3	10.0	11.5	11.8	77.5	12.2	16.4	13.2	10.8	10.9	11.7	8.8	10.7	11.0	7.7	12.2	11.2	9.3	10.4	7.9	6.2	9.4	9.5	12.6	12.2	11.2	6.6	14.3	12.0	7.9	16.2	8.4	9.7	13.0	9.1	10.1	10.1	9.0	14.8	13.6	13.5	9.1	9.1	19.1	10.9	9.5	11.0	15.6	11.4	8.8	17.5	11.9	11.6	17.6	22.3	31.6	17.0	24.3	29.3	17.0	7.8	7.8	5.3	11.1	8.2	5.6	10.5	6.7	8.9	7.8	7.6	8.2	8.7	9.4	9.7	6.9	11.0	7.6	7.1	8.5	7.7	6.8	9.4	9.2	9.3	9.0	6.6	13.1	16.1	7.4	7.4	7.6	8.1	5.8	8.9	8.4	13.2	18.7	7.1	14.7	13.5	21.5	11.8	9.8	9.4	7.7	5.8	16.3	8.4	11.2	6.3	13.1	7.8	19.0	12.6	13.5	4.9	16.3	9.3	9.5	9.5	13.6	8.3	15.4	16.1	15.2	6.7	13.3	9.9	31.6	14.3	24.1	23.1	17.0	24.2	17.6	23.6	25.0	15.6	17.2	29.3	23.1	26.3	24.3	16.7	22.3	25.2	17.0	10.0	11.8	16.4	13.2	7.9	6.2	11.2	6.6	9.7	11.0	14.9	22.4	32.0	29.5	31.6	8.1	7.0	2.5	20.1	11.4	10.4	11.8	13.3	14.9	13.3	5.6	16.9	25.5	0.0	12.4	14.8	17.4	23.7	57.7	10.5	16.3	14.3	20.0	12.9	22.1	1.1	14.4	20.8	27.0	15.4	14.7	12.4	14.1	18.6	12.7	9.5	10.6	12.9	17.0	42.5	30.3	31.0	24.8	44.5	15.8	52.9
ZNF397	"MGC13250, ZNF47, ZSCAN15"	ENSG00000186812	"Zinc finger protein 397"	Q8NF99	18	35241030-35267133	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026087	Uncertain		Approved	"Nucleoli,Plasma membrane,Microtubules,Cytosol"		NA	NA			"Nucleoli, Plasma membrane, Cytosol"	Microtubules	"HPA026087: AB_1859243"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.09e-3)"	15.1	17.7	20.3	16.8	31.1	5.7	20.6	23.9	26.4	16.2	15.0	27.9	16.7	13.3	22.7	16.5	13.4	15.2	12.9	14.6	20.2	13.8	14.9	12.7	13.6	18.8	34.8	19.3	23.6	17.1	25.3	24.8	14.7	25.6	18.4	18.0	13.8	17.5	16.3	15.0	17.2	15.9	18.9	30.5	19.0	16.7	11.9	35.1	22.0	20.2	8.3	19.2	17.3	16.8	13.3	8.1	12.4	9.4	4.8	9.4	2.2	2.9	5.8	13.8	12.5	15.3	13.0	6.6	6.1	6.1	3.0	4.0	2.1	4.2	15.1	5.5	4.8	4.2	8.1	8.9	6.6	4.3	9.5	5.5	0.6	7.6	6.1	5.1	7.2	5.5	5.8	9.0	3.6	10.6	10.9	1.9	11.7	8.8	10.6	7.8	6.4	12.1	5.6	11.9	2.3	2.3	12.8	4.0	10.7	6.3	7.9	15.0	12.9	9.9	5.3	5.9	12.6	9.2	5.4	3.0	10.2	5.7	3.4	2.7	17.2	6.4	8.8	9.0	5.1	9.6	9.4	5.1	8.4	6.6	8.0	4.8	10.3	6.3	5.3	3.6	13.3	9.4	6.5	12.4	4.8	9.4	8.1	3.2	2.2	20.3	31.1	23.9	26.4	20.2	13.8	34.8	19.3	25.6	35.1	32.8	16.0	27.0	17.0	3.7	46.9	14.4	12.7	21.4	22.7	14.0	33.4	18.5	11.6	16.1	39.6	17.9	14.2	0.0	9.5	11.4	15.4	13.7	11.5	11.3	9.2	31.8	29.7	25.2	15.6	39.9	17.3	10.9	8.5	14.4	12.0	27.7	9.7	16.5	21.2	8.6	46.3	32.3	7.2	26.0	19.1	4.0	12.2	15.2	13.4	9.7
ZNF398	"KIAA1339, P51, P71, ZER6"	ENSG00000197024	"Zinc finger protein 398"	Q8TD17	7	149126416-149182802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071533			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA071533: AB_2686412"	"unprognostic (4.11e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.97e-2)"	"unprognostic (9.27e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.89e-1)"	8.9	8.1	12.7	10.2	12.5	15.6	10.6	25.9	16.0	11.7	10.7	10.2	10.5	8.8	9.8	10.2	14.3	10.4	8.6	9.3	10.9	9.0	9.3	10.7	9.2	10.0	10.7	11.4	11.1	13.4	14.7	20.9	8.6	9.8	12.7	8.6	8.5	11.2	12.5	10.0	17.2	9.5	9.7	9.8	12.6	11.1	18.1	12.6	13.0	8.7	7.4	12.3	9.9	11.1	2.9	1.6	6.1	2.0	1.9	3.8	1.2	7.6	6.4	5.0	9.7	7.5	5.3	6.4	4.7	6.0	5.4	5.9	5.4	3.6	8.9	5.4	7.8	4.8	6.4	8.6	5.9	3.8	5.9	11.9	5.9	5.1	3.5	5.2	6.6	6.2	6.0	8.7	5.8	6.2	3.9	3.6	3.6	9.1	3.2	5.7	9.6	9.8	6.8	36.0	6.4	6.8	7.7	5.7	6.7	4.0	12.8	7.5	8.3	6.5	8.0	3.9	5.6	5.0	7.4	4.8	5.5	1.6	9.8	5.8	10.3	4.9	6.9	7.5	5.5	5.3	5.1	1.6	6.1	3.1	2.0	3.7	2.9	2.1	3.4	1.5	2.5	3.3	3.8	3.1	1.9	1.7	1.6	3.0	1.2	12.7	12.5	25.9	16.0	10.9	9.0	10.7	11.4	9.8	12.6	6.0	2.9	3.7	3.5	6.9	7.4	5.8	0.0	2.7	4.5	5.2	5.9	3.1	0.0	3.6	19.4	4.5	3.3	0.0	2.5	4.0	4.7	4.5	4.6	2.8	3.2	3.2	1.7	4.9	4.7	19.2	6.6	3.4	8.5	2.8	3.3	5.3	4.4	2.6	8.5	2.4	9.7	0.0	2.5	16.6	7.9	7.4	2.6	1.8	3.3	8.1
ZNF404		ENSG00000176222	"Zinc finger protein 404"	Q494X3	19	43872363-43901385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 2: 5.6;granulocytes: 6.9;Horizontal cells: 4.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.6;U-2 OS: 31.2"					"Low region specificity"	"Detected in all"			"HPA032014, HPA063607"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments"		NA	Yes			"Nucleoli, Nucleoli rim"	"Intermediate filaments"	"HPA032014: AB_10602591, HPA063607: AB_2732705"	"unprognostic (3.76e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-5)"	"unprognostic (1.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.80e-3)"	0.9	2.2	4.6	0.7	4.8	0.1	2.6	5.8	4.8	1.5	2.5			0.2	2.0	10.9	1.2	3.7	2.2	6.0	4.6	4.4	1.5	1.0	1.8	3.1	6.0		7.5	0.8	2.6	8.2	2.6		4.6	1.6		2.6	2.2	1.5	2.9	1.0	1.8	7.0	3.9	1.9	3.4			2.6		1.2	1.5	1.1	1.9	0.9	1.9	0.4	2.1	1.9	0.6	2.3	0.3	2.4	0.3	6.0	8.6	1.4	3.2	1.6	2.0	2.8	0.2	0.8	0.0	3.4	1.5	0.0	0.3	0.4	1.6	2.8	0.3	2.3	0.8	0.0	0.9	2.2	0.2	0.6	5.1	3.9	1.5	1.4	7.0	1.7	0.0	0.1	0.0	1.9	0.2	0.0	0.0	1.9	0.1	0.5	0.0	1.3	0.4	2.0	1.5	1.3	1.0	1.3	0.6	1.6	4.5	0.1	0.9	0.7	2.9	31.2	2.6	1.8	4.1	5.3	0.0	4.1	0.0	1.6	0.0	0.3	1.9	0.7	0.0	0.8	0.9	1.4	0.0	0.4	1.9	1.9	1.5	0.0	2.1	0.4	0.9	1.3	0.6											0.0	5.6	0.0	0.5	0.0	3.7	4.0	0.0	1.4	0.0	0.0	0.0	1.2	0.0	0.5	0.9	0.4	0.2	0.0	0.2	1.0	0.8	0.6	6.9	0.0	0.6	4.8	2.4	1.3	0.3	0.0	0.9	0.1	0.0	0.0	0.6	3.5	0.2	0.0	3.2	0.3	2.5	0.0	1.0	1.6	1.9	0.0	0.8	0.0	0.8	0.6
ZNF407	"FLJ13839, FLJ20307, KIAA1703"	ENSG00000215421	"Zinc finger protein 407"	Q9C0G0	18	74597870-75065671	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028255, HPA041673"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA028255: AB_10603466, HPA041673: AB_2677610"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.04e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.79e-5)"	"unprognostic (8.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	7.7	6.3	8.5	11.7	11.4	12.0	7.6	15.5	10.5	11.8	9.4	5.3	5.8	5.8	11.7	5.2	7.3	9.4	5.5	8.1	7.3	5.2	6.6	6.0	7.4	7.9	7.8	5.7	12.8	6.0	14.9	13.2	10.8	9.0	7.6	6.0	5.9	8.4	7.7	13.3	7.7	10.3	8.7	7.5	11.2	7.5	10.0	7.7	18.1	9.4	8.2	7.6	9.9	9.2	2.4	3.6	6.0	2.6	3.0	3.1	0.9	4.6	4.9	5.6	5.1	4.1	6.1	4.0	6.2	5.5	4.6	5.0	2.0	2.7	6.7	1.9	8.7	3.1	5.5	5.2	6.8	6.9	11.1	3.2	8.6	6.6	3.8	3.7	13.0	7.6	5.5	3.1	7.4	6.5	4.4	6.9	4.8	4.9	10.0	7.0	3.7	6.3	1.8	3.2	1.7	4.4	6.5	7.2	5.3	3.3	8.8	5.3	5.0	5.8	3.7	4.4	4.2	4.2	5.6	9.6	10.5	4.4	2.9	4.9	3.5	7.2	7.1	3.8	5.6	6.2	4.0	1.9	2.3	3.1	2.6	2.9	2.1	2.3	1.7	0.7	2.4	2.6	3.1	6.0	3.0	1.6	3.6	0.6	0.9	8.5	11.4	15.5	10.5	7.3	5.2	7.8	5.7	9.0	7.7	6.0	4.6	6.1	4.7	2.9	10.7	16.5	5.1	8.1	5.7	5.2	5.9	3.4	0.0	3.8	3.2	5.8	5.4	0.0	2.5	2.3	3.8	4.2	1.1	5.1	2.7	4.8	4.1	2.5	5.6	2.2	4.9	4.4	5.0	2.8	4.9	8.1	3.4	3.7	4.2	1.9	13.7	6.5	3.3	9.6	12.2	3.6	4.3	5.1	3.3	3.8
ZNF408	FLJ12827	ENSG00000175213	"Zinc finger protein 408"	Q9H9D4	11	46700818-46705912	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017892	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA017892: AB_1859248"	"unprognostic (7.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (3.01e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.99e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-2)"	7.5	5.8	6.6	7.9	7.8	20.8	10.4	11.9	8.4	9.3	11.4	6.9	5.8	8.6	9.9	4.3	9.7	8.1	8.6	8.8	6.6	5.3	6.2	14.8	5.6	10.7	7.4	3.7	9.6	16.4	4.2	6.6	11.7	4.9	9.6	5.0	6.6	13.8	8.0	11.3	11.3	8.2	6.1	8.4	9.2	8.9	13.1	6.5	14.2	10.8	6.6	9.9	10.4	13.0	11.9	9.9	10.0	11.1	7.6	14.6	9.3	4.0	9.9	4.7	8.3	5.9	5.1	12.1	5.4	7.7	11.2	8.4	8.9	4.6	6.5	5.1	6.6	8.3	10.5	5.8	10.8	4.0	4.9	12.0	6.1	6.4	10.6	11.1	6.7	8.9	10.2	10.6	5.7	8.0	6.0	5.5	9.8	9.5	5.8	4.6	13.2	7.7	12.8	19.2	13.9	12.1	8.6	7.0	9.9	5.8	10.8	6.6	8.6	10.7	13.5	8.5	4.5	11.8	11.1	6.2	11.1	7.3	9.1	10.8	8.3	7.2	9.5	7.2	7.3	8.8	5.2	10.4	10.0	12.7	11.1	9.7	9.3	12.0	14.6	9.9	11.9	13.7	10.4	9.6	7.6	8.1	7.7	10.7	9.3	6.6	7.8	11.9	8.4	6.6	5.3	7.4	3.7	4.9	6.5	6.0	2.1	6.4	4.3	6.0	5.4	4.0	5.1	1.4	1.2	1.8	0.0	8.9	10.0	7.3	4.4	3.1	7.7	0.0	4.2	5.0	4.8	3.3	0.0	6.2	4.6	3.2	8.1	8.0	5.9	2.0	5.8	3.1	10.1	5.4	6.8	6.5	5.1	2.9	6.0	4.3	3.6	12.9	5.1	8.7	7.8	3.6	8.8	5.0	5.8	5.0
ZNF41	"MGC8941, MRX89"	ENSG00000147124	"Zinc finger protein 41"	P51814	X	47445879-47482946	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 5.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA069102	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069102: AB_2686086"	"unprognostic (9.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.87e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (3.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	8.8	8.0	8.5	11.8	12.2	2.4	10.2	15.2	12.1	10.6	9.5	8.4	8.6	6.8	8.6	9.4	8.3	7.2	9.8	15.2	8.9	7.9	8.8	8.8	8.8	9.4	8.9	8.6	8.8	10.1	20.0	13.8	7.9	9.3	9.3	11.5	7.1	11.0	8.4	26.7	7.6	9.1	9.8	7.9	10.7	8.5	4.3	11.1	12.8	11.5	9.2	11.5	9.7	8.5	6.9	6.5	4.8	6.2	5.6	7.9	4.0	6.0	6.6	5.5	14.0	6.8	7.6	3.8	8.3	7.0	7.2	8.3	3.7	6.6	8.7	4.6	10.9	9.3	9.5	12.4	5.7	9.1	13.7	4.7	2.1	9.2	2.3	4.7	8.6	7.8	5.5	7.3	8.2	10.8	6.5	6.6	7.3	6.2	9.5	9.0	9.0	8.9	4.7	9.3	5.5	10.4	8.3	7.2	8.9	5.5	10.3	7.6	7.8	12.2	9.6	4.8	6.8	10.0	4.8	9.8	7.7	6.0	15.5	5.9	6.9	9.3	9.4	6.6	17.3	8.2	1.4	4.7	4.8	6.5	6.2	7.9	4.9	5.9	7.2	6.5	6.9	6.7	6.1	1.1	5.6	3.0	4.3	4.8	4.0	8.5	12.2	15.2	12.1	8.9	7.9	8.9	8.6	9.3	11.1	3.0	3.8	0.0	1.9	0.6	3.4	3.6	0.0	2.7	1.2	0.0	0.0	0.2	1.7	1.2	0.0	2.1	1.7	0.0	1.2	0.6	1.0	1.2	1.1	1.6	0.9	0.0	0.0	5.5	1.2	0.0	0.9	2.0	1.7	0.0	1.6	1.6	1.4	3.4	0.7	0.7	3.3	0.0	1.2	1.1	1.5	0.1	0.7	0.8	1.7	1.7
ZNF410	"APA-1, APA1"	ENSG00000119725	"Zinc finger protein 410"	Q86VK4	14	73886617-73932511	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 10.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002871			Approved	"Nuclear bodies"		Yes	No			"Nuclear bodies"		"HPA002871: AB_1080712"	"unprognostic (5.84e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (5.86e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.19e-1)"	24.2	22.6	14.2	12.9	18.6	37.9	22.3	21.5	20.8	20.2	20.2	21.8	19.2	14.3	28.8	33.8	24.0	19.4	17.7	15.4	13.7	12.8	22.7	20.7	19.5	17.3	15.7	12.5	30.9	19.1	17.2	27.0	32.7	16.6	21.7	18.5	20.2	18.0	21.7	14.5	26.4	20.8	21.7	14.5	20.6	18.6	37.2	15.9	28.3	26.0	17.2	30.5	20.4	20.5	26.5	27.3	43.5	28.2	34.0	33.2	30.5	18.7	15.0	18.2	19.9	19.8	17.3	22.2	21.7	24.4	38.2	35.1	16.1	16.8	15.6	9.4	26.9	12.6	17.5	17.8	21.8	35.8	22.7	11.1	14.9	14.2	12.0	29.4	12.2	20.1	15.9	30.9	18.7	36.2	17.1	20.1	19.0	15.5	14.0	18.2	35.8	18.4	20.7	6.5	23.3	17.9	16.5	20.9	10.0	23.9	18.2	17.2	22.1	23.9	22.2	22.3	15.9	21.0	21.5	14.0	27.3	25.8	15.6	19.2	19.3	34.4	19.8	17.3	14.0	22.6	35.1	27.6	43.5	31.4	25.7	33.2	23.6	32.1	31.0	27.3	26.5	28.3	28.8	21.2	34.0	28.2	18.2	27.1	30.5	14.2	18.6	21.5	20.8	13.7	12.8	15.7	12.5	16.6	15.9	0.0	1.9	2.2	1.2	0.6	1.5	1.2	0.0	0.0	4.5	0.0	3.9	1.5	0.0	1.0	2.6	1.1	1.6	0.0	0.8	1.1	1.2	0.9	10.4	0.0	1.0	1.6	0.0	1.8	1.0	0.0	1.1	2.6	1.7	0.0	0.7	0.9	1.1	0.6	0.4	0.3	4.6	0.0	2.3	2.3	1.9	1.0	2.2	4.9	0.6	1.3
ZNF414	"MGC15716, Zfp414"	ENSG00000133250	"Zinc finger protein 414"	Q96IQ9	19	8509678-8514164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053769	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053769: AB_2682255"	"unprognostic (7.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.26e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.67e-6)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.71e-4)"	16.6	16.2	14.3	13.6	22.7	20.8	10.6	17.6	28.6	13.2	10.9	22.4	5.6	21.4	16.6	10.0	11.6	11.6	9.7	9.9	14.1	11.4	12.0	13.1	10.7	15.8	15.5	14.8	16.7	13.7	9.2	15.3	14.0	17.3	15.8	4.6	13.4	20.5	14.1	23.6	25.5	16.6	7.7	12.5	22.8	19.1	13.6	20.3	19.9	15.7	6.1	13.5	11.8	12.3	3.0	3.4	5.4	2.1	2.5	2.7	1.2	5.4	4.7	2.6	4.2	0.7	1.7	5.8	4.1	1.6	2.7	2.5	4.2	2.7	7.6	12.2	1.3	2.0	7.7	0.8	3.4	0.4	6.8	19.1	4.8	4.4	4.9	3.8	4.1	6.5	3.1	2.5	2.2	0.9	1.5	1.1	4.8	6.3	11.2	1.7	6.8	9.3	24.2	7.7	1.4	13.5	10.9	1.3	7.6	1.9	4.5	9.0	14.0	4.6	3.5	3.7	0.5	6.7	4.8	4.3	8.1	4.1	11.7	5.4	16.4	6.8	5.9	6.5	3.5	4.3	3.0	1.6	0.8	1.8	1.4	1.0	2.5	2.7	2.7	1.6	3.0	2.6	2.6	5.4	2.5	2.1	3.4	1.4	1.2	14.3	22.7	17.6	28.6	14.1	11.4	15.5	14.8	17.3	20.3	0.0	0.6	4.9	12.9	10.5	17.5	1.7	7.6	0.0	0.0	3.5	9.8	23.8	13.3	3.0	21.5	6.7	11.9	0.0	4.7	18.3	12.7	8.8	4.6	9.7	11.4	11.1	21.4	11.1	9.1	59.9	19.0	9.6	8.5	5.4	12.8	17.9	3.8	11.5	15.2	13.5	18.9	12.9	7.8	24.4	30.2	10.7	26.3	10.5	11.7	8.1
ZNF415		ENSG00000170954	"Zinc finger protein 415"	Q09FC8	19	53107879-53133077	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 22.6;Early spermatids: 90.1;Late spermatids: 37.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 16.6"									HPA005553	Approved		Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Nucleoli fibrillar center, Microtubules"		"HPA005553: AB_1859252"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.84e-2)"	7.0	17.6	13.3	3.2	15.2	1.2	9.7	19.5	16.2	9.2	6.6	14.7	4.7	2.4	8.7	15.9	4.1	7.6	6.2	17.6	13.8	10.6	6.5	1.5	5.5	3.5	20.9	14.6	11.2	5.6	11.5	8.3	4.8	17.8	11.4	6.4	4.0	6.8	9.3	4.5	4.4	4.0	8.1	12.9	5.8	5.3	22.6	18.5	3.3	12.3	1.6	3.2	6.8	6.0	6.9	4.5	5.7	1.1	4.6	2.8	1.0	0.2	0.0	3.8	11.0	0.6	0.6	8.7	4.0	6.4	5.9	9.0	6.9	0.2	0.0	2.3	7.0	6.8	0.1	0.0	0.0	5.8	0.0	0.5	0.0	0.3	0.0	2.1	0.0	6.1	6.7	0.1	1.4	0.0	0.6	0.0	0.3	0.2	0.2	3.2	0.5	6.8	0.1	7.9	0.0	0.4	0.0	0.0	0.3	4.9	16.6	2.4	5.9	0.5	0.1	0.0	10.0	5.6	0.3	0.0	2.7	2.8	0.2	4.7	0.1	6.9	4.9	0.3	0.0	9.0	5.0	1.1	5.7	0.6	0.5	0.5	5.4	1.3	0.4	1.8	6.9	2.8	2.6	1.5	4.6	0.7	4.5	0.8	1.0	13.3	15.2	19.5	16.2	13.8	10.6	20.9	14.6	17.8	18.5	0.0	3.8	0.0	2.2	0.5	4.2	22.6	0.0	8.1	6.8	3.5	2.0	3.0	11.6	4.4	90.1	3.0	0.5	0.0	4.1	2.7	1.4	2.7	0.0	0.0	0.6	1.6	0.0	4.3	0.3	37.4	1.7	0.9	0.0	1.0	1.6	4.7	3.1	0.0	4.2	0.0	2.6	0.0	2.6	10.4	3.6	0.3	1.6	0.0	1.1	2.3
ZNF416	FLJ20557	ENSG00000083817	"Zinc finger protein 416"	Q9BWM5	19	57571566-57578927	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 7.9;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA063318			Approved	"Nuclear bodies,Cytosol"		No	No			Cytosol	"Nuclear bodies"	"HPA063318: AB_2684983"	"unprognostic (1.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.57e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.20e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-1)"	6.1	6.8	7.0	5.1	10.7	5.0	8.7	13.0	10.7	6.8	6.1	7.0	5.9	3.2	6.9	9.5	8.9	8.2	4.4	6.1	6.5	5.3	6.1	4.6	6.7	7.1	5.3	8.6	10.9	3.9	8.7	7.0	6.6	5.8	6.7	4.9	7.0	6.3	7.6	6.6	13.5	4.8	8.2	3.8	6.3	4.9	9.3	8.1	12.8	8.8	4.8	9.1	7.7	6.9	9.7	4.4	1.9	2.8	9.5	9.4	4.3	3.3	3.3	7.0	5.5	4.3	6.1	4.7	3.3	6.1	6.6	4.3	2.3	1.8	2.3	2.5	4.3	4.8	1.2	4.0	5.7	8.3	3.6	16.4	5.4	3.6	1.9	7.7	4.7	3.5	6.1	6.0	4.2	8.9	5.3	4.6	5.6	0.8	1.9	8.8	1.4	9.9	2.2	8.2	3.9	6.1	5.0	10.4	4.9	4.6	7.1	5.0	5.7	6.0	3.2	3.0	8.2	2.9	5.8	3.4	7.2	3.5	2.3	5.0	5.8	9.5	6.2	1.6	3.2	4.4	1.1	2.8	1.9	4.8	2.1	8.9	7.4	6.8	7.2	4.4	9.7	9.4	6.8	0.9	9.5	1.8	3.9	3.1	4.3	7.0	10.7	13.0	10.7	6.5	5.3	5.3	8.6	5.8	8.1	0.0	0.3	2.2	1.3	1.4	3.3	0.8	2.5	0.0	1.2	0.0	0.0	1.8	3.3	2.4	2.7	1.0	0.4	0.0	0.7	0.7	1.3	1.0	2.3	1.0	1.4	7.9	0.0	0.0	0.8	1.3	0.9	0.0	0.0	0.0	1.5	2.9	1.1	0.0	0.7	1.3	2.5	6.5	0.7	0.2	4.1	2.0	1.6	0.5	0.6	1.4
ZNF420	FLJ32191	ENSG00000197050	"Zinc finger protein 420"	Q8TAQ5	19	37007857-37130314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA059675	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059675: AB_2684101"	"unprognostic (1.00e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.40e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (7.94e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (2.42e-1)"	"unprognostic (7.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.63e-2)"	6.0	7.4	9.3	6.6	12.6	2.2	9.7	21.2	12.1	9.2	6.6	6.1	5.8	4.2	8.6	6.9	5.8	9.7	4.9	5.7	10.6	7.9	7.4	5.5	4.7	7.6	12.5	7.7	14.8	5.3	12.5	16.0	5.6	10.0	7.6	4.5	4.6	5.6	7.3	8.4	6.2	4.9	9.7	8.7	7.0	5.3	15.5	10.6	9.3	12.3	3.1	7.9	5.8	8.6	10.7	4.8	5.8	3.4	11.1	11.8	5.1	0.0	7.0	6.5	6.8	6.0	3.9	3.6	4.1	4.3	4.9	7.5	1.4	1.4	3.3	8.7	2.8	3.1	1.2	6.4	2.1	5.6	10.8	5.3	7.3	4.2	2.7	6.2	5.9	3.3	4.0	4.7	5.0	3.5	5.5	2.7	5.6	4.1	0.3	5.5	2.3	10.2	2.3	7.4	2.6	4.1	5.8	13.6	7.0	2.7	4.4	9.2	10.5	6.2	2.5	3.3	4.9	4.1	5.2	3.0	5.0	7.9	4.6	4.9	10.1	12.6	8.1	0.0	1.2	4.4	1.8	2.5	5.8	9.0	3.4	9.7	8.7	10.1	9.4	4.8	10.7	10.5	11.3	0.4	11.1	3.3	2.5	11.8	5.1	9.3	12.6	21.2	12.1	10.6	7.9	12.5	7.7	10.0	10.6	11.9	11.3	1.7	2.4	8.9	20.3	4.8	2.5	9.4	7.9	3.5	0.0	7.5	6.6	3.2	25.4	5.6	1.4	0.0	1.1	3.5	4.5	3.4	12.7	3.8	3.6	15.9	5.8	8.6	3.8	24.2	8.9	2.2	6.8	1.8	2.7	6.0	1.7	3.5	8.9	3.7	8.8	25.8	6.1	14.0	7.0	7.5	3.3	7.9	4.0	1.8
ZNF426	MGC2663	ENSG00000130818	"Zinc finger protein 426"	Q9BUY5	19	9523224-9538645	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029342	Approved		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA029342: AB_10603007"	"unprognostic (3.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.41e-3)"	"prognostic favorable (2.57e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.81e-4)"	8.0	7.0	6.5	5.0	8.9	6.7	9.3	13.5	8.8	10.9	7.8	7.5	7.2	3.9	10.3	7.2	28.2	8.5	5.9	7.1	8.0	4.5	6.6	3.1	6.8	7.2	6.4	5.4	12.8	5.8	9.1	7.9	7.3	7.0	8.4	5.4	7.8	8.8	7.7	6.7	6.6	5.6	10.5	8.0	5.9	6.7	7.9	7.3	9.9	9.1	6.7	7.4	11.1	11.9	8.8	4.4	9.8	6.7	8.7	12.7	3.9	4.4	1.5	9.2	9.7	6.2	8.2	5.2	5.8	8.7	7.7	9.5	2.0	2.1	4.5	4.7	5.6	5.4	3.8	9.5	6.7	11.7	2.1	7.3	18.7	7.6	3.4	5.6	0.6	6.1	10.4	5.9	8.6	12.4	8.5	8.3	7.9	7.4	0.5	7.4	0.4	10.7	9.1	11.5	1.0	3.6	5.8	11.4	4.7	4.3	11.7	5.2	7.0	9.7	3.5	7.9	8.3	4.8	4.4	6.7	11.0	6.4	4.8	6.1	5.3	7.4	3.9	1.6	0.3	7.8	9.8	3.9	6.9	11.2	5.6	9.9	8.6	8.7	10.9	4.4	8.8	12.7	11.9	8.3	8.7	6.7	4.1	8.1	3.9	6.5	8.9	13.5	8.8	8.0	4.5	6.4	5.4	7.0	7.3	26.8	34.0	5.4	13.4	3.1	22.8	8.7	2.5	24.1	19.4	7.0	19.6	10.8	18.3	9.4	24.1	12.7	3.2	23.3	3.5	8.2	7.7	12.5	26.7	2.5	6.6	35.0	3.5	12.3	7.6	4.9	15.8	7.4	3.3	10.0	5.9	22.7	5.7	3.5	20.8	5.0	18.2	6.5	8.8	12.5	9.8	2.5	11.9	12.5	6.9	16.1
ZNF428	"C19orf37, MGC51082, Zfp428"	ENSG00000131116	"Zinc finger protein 428"	Q96B54	19	43607219-43619874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042596, HPA048072"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA042596: AB_2678070, HPA048072: AB_2680249"	"unprognostic (2.45e-3)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (3.60e-5)"	"unprognostic (3.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.74e-2)"	18.8	31.2	36.8	15.8	37.6	18.9	9.2	25.9	48.8	13.7	14.2	14.4	8.8	17.0	18.8	14.9	8.8	13.0	18.4	19.9	31.3	28.7	17.4	15.5	13.1	15.5	27.0	31.1	19.2	19.4	9.8	19.2	12.7	18.0	20.1	6.3	14.8	21.7	13.2	37.7	6.6	13.7	17.2	22.2	16.8	16.6	19.7	17.0	17.8	16.6	8.7	8.9	10.0	11.4	7.8	7.1	9.4	3.2	3.1	8.5	1.0	11.2	9.0	14.1	23.3	5.4	4.0	6.6	8.5	3.9	6.0	6.3	5.5	7.5	19.0	19.5	6.5	3.8	2.8	5.6	1.6	2.0	15.9	23.9	20.7	9.4	9.3	10.6	16.2	17.2	7.3	3.6	5.3	2.8	6.2	8.4	13.6	21.6	12.0	6.2	11.9	40.0	29.1	9.4	5.0	6.3	39.9	6.5	13.9	7.2	6.8	27.1	31.6	12.3	7.6	19.0	3.9	4.6	23.3	16.5	7.2	20.5	6.8	13.0	13.4	16.1	33.2	10.4	16.6	15.8	2.5	2.5	9.4	7.8	1.4	4.4	5.2	7.1	7.4	2.7	7.8	8.5	3.7	1.3	3.1	3.2	7.1	4.1	1.0	36.8	37.6	25.9	48.8	31.3	28.7	27.0	31.1	18.0	17.0	0.0	3.8	39.5	61.1	28.5	98.9	17.9	63.7	4.0	3.4	62.8	13.7	115.0	126.0	77.7	112.3	58.4	31.5	0.0	69.0	37.8	99.2	49.9	36.8	47.0	89.6	54.0	155.7	74.9	36.5	48.8	82.3	46.8	108.0	43.3	49.3	108.0	64.6	46.0	85.2	176.5	53.3	71.1	93.7	20.4	56.9	22.6	46.1	73.0	46.0	41.6
ZNF429		ENSG00000197013	"Zinc finger protein 429"	Q86V71	19	21496682-21556270	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004139			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004139: AB_2667147"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.96e-8)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.48e-1)"	6.3	14.3	12.0	4.8	13.1	4.3	11.2	15.3	14.2	10.2	6.7	12.3	10.3	5.4	7.5	12.4	6.2	10.8	5.6	4.9	9.6	7.6	11.3	11.1	6.4	9.0	12.6	8.6	14.3	14.3	17.7	24.1	7.4	12.3	8.7	8.9	8.4	9.3	8.2	5.2	11.0	6.2	5.7	9.1	10.6	8.4	11.3	12.9	7.5	16.6	5.1	7.5	7.8	7.5	7.2	2.7	10.4	2.4	9.2	9.5	2.8	0.3	0.9	5.2	6.1	3.6	3.7	4.7	2.7	2.0	3.8	5.8	0.6	3.3	4.4	7.6	1.8	3.3	1.4	3.0	1.2	7.5	1.3	3.6	0.8	0.7	1.6	1.9	4.6	1.8	3.3	1.8	2.3	0.7	3.5	0.2	7.0	7.2	0.9	5.9	3.2	11.0	2.9	5.3	0.1	1.7	5.0	2.9	1.8	4.2	5.2	8.6	3.5	0.2	0.2	1.8	10.8	6.1	2.9	0.6	0.5	1.1	4.3	2.0	0.7	3.6	5.9	0.3	0.4	1.7	10.0	1.8	8.4	4.9	2.2	5.3	7.2	6.8	6.5	1.6	6.4	9.5	8.6	10.4	9.2	2.4	2.7	4.1	2.8	12.0	13.1	15.3	14.2	9.6	7.6	12.6	8.6	12.3	12.9	26.8	9.9	1.5	5.8	2.5	13.6	4.8	5.1	17.4	14.8	7.0	5.9	7.7	18.3	6.3	27.6	5.0	4.0	0.0	4.4	6.1	5.8	5.1	3.5	5.4	3.0	3.2	6.4	6.7	2.1	3.9	10.6	4.3	5.0	1.8	5.6	10.0	5.0	6.2	5.6	10.6	7.6	19.4	5.1	14.2	16.8	1.8	5.7	10.2	5.8	3.1
ZNF433	FLJ40981	ENSG00000197647	"Zinc finger protein 433"	Q8N7K0	19	12014732-12035741	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 158.8;Late spermatids: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA073724	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA073724: AB_2686631"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.90e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-3)"	"prognostic favorable (8.33e-15)"	"unprognostic (1.06e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.69e-2)"	5.0	4.3	4.2	2.4	8.9	12.8	8.2	7.8	7.2	6.1	3.7	4.8	4.6	2.2	7.1	10.8	7.7	5.1	5.0	5.9	7.7	3.5	10.3	5.4	4.3	3.3	5.1	3.4	11.0	13.8	7.2	7.6	5.1	5.6	7.1	3.7	5.9	13.0	9.6	13.5	9.5	2.9	6.6	4.1	4.6	5.1	26.7	3.4	0.8	10.0	3.9	4.0	6.1	5.8	3.8	6.0	9.4	2.2	8.6	3.6	1.7	5.2	0.7	4.7	11.4	3.9	3.8	6.1	4.9	3.3	5.2	5.6	3.0	1.1	3.5	2.7	4.0	3.6	2.1	0.0	5.1	5.1	1.0	1.7	4.3	0.9	3.2	4.1	4.4	10.0	4.4	4.8	3.6	1.7	3.9	0.0	12.1	1.1	1.0	5.7	2.6	8.4	5.7	1.6	0.1	5.0	3.8	3.1	0.6	7.8	11.0	4.0	2.8	0.0	3.0	2.2	5.0	6.1	6.2	3.9	6.1	2.7	10.3	3.4	8.5	9.8	7.1	1.3	6.6	3.7	9.4	2.0	7.2	2.4	1.5	2.1	2.5	2.1	2.7	6.0	3.8	3.0	3.6	4.5	8.6	2.2	5.8	1.4	1.7	4.2	8.9	7.8	7.2	7.7	3.5	5.1	3.4	5.6	3.4	3.0	3.2	0.0	3.4	1.5	5.6	5.1	5.1	6.7	2.3	5.2	15.7	8.3	6.6	3.4	158.8	2.1	0.0	0.0	3.3	3.9	2.5	2.2	3.5	2.4	5.3	6.4	0.0	1.3	1.3	98.7	2.8	1.0	5.0	0.0	0.3	3.8	2.9	0.0	3.9	4.5	7.6	6.5	3.1	11.8	5.9	2.3	2.9	0.0	0.8	2.0
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369442	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.2;HSkMC: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	14.5	18.6	10.1	4.7	13.0	2.9	12.9	13.6	15.8	10.7	8.7	11.8	8.6	6.3	15.1	17.5	18.4	10.2	11.2	11.7	9.9	6.1	6.7	4.3	7.8	5.6	12.9	9.6	20.3	8.1	11.6	6.5	8.5	11.3	12.1	6.9	6.3	16.9	13.4	7.2	15.6	6.1	12.7	12.6	8.0	6.8	10.4	10.0	5.7	12.3	9.7	8.0	12.5	11.2	1.6	2.8	1.6	2.1	6.6	2.3	1.6	2.8	1.8	6.5	3.4	7.3	15.2	3.1	2.5	3.5	3.3	3.9	1.0	2.4	1.9	2.9	3.6	2.1	3.5	11.6	4.3	3.6	2.3	2.5	2.0	3.7	1.6	2.9	0.8	1.4	27.7	6.3	2.8	3.3	6.0	4.7	2.3	2.4	1.4	3.5	1.3	2.1	1.6	0.2	1.3	2.8	2.8	2.7	1.8	2.7	7.2	3.0	3.7	7.1	3.6	2.8	2.3	2.0	1.0	3.7	2.8	2.1	2.2	1.4	2.1	2.6	1.6	2.2	1.7	2.2	0.0	1.8	1.6	2.0	2.1	2.0	1.3	1.4	2.1	2.8	1.6	2.3	2.0	1.3	6.6	2.0	0.4	2.2	1.6	10.1	13.0	13.6	15.8	9.9	6.1	12.9	9.6	11.3	10.0	0.0	0.3	0.8	1.0	4.6	3.6	4.8	2.5	2.7	0.0	5.2	5.9	2.9	0.0	2.7	0.9	8.7	2.7	0.0	4.3	1.5	4.6	3.4	0.0	3.0	1.8	9.5	3.5	1.8	2.6	1.1	9.2	0.7	5.0	6.4	3.9	11.8	3.9	5.8	11.0	2.1	2.1	0.0	2.0	4.7	6.0	8.4	2.4	1.0	2.9	1.1
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.5;HUVEC TERT2: 14.6;U-937: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	21.8	5.8	9.8	10.0	10.2	7.9	9.7	11.8	9.9	10.6	12.9	13.0	2.6	6.2	22.6	11.3	8.3	10.2	9.2	13.8	9.3	6.2	6.2	8.6	12.0	7.1	10.1	6.6	10.2	4.5	6.6	17.3	6.4	9.6	9.0	6.9	7.7	9.5	9.6	29.1	8.9	7.6	14.3	8.6	13.6	8.3	10.1	11.9	7.7	15.8	8.7	5.2	10.5	12.1	3.1	3.1	14.1	7.8	3.8	3.9	3.5	2.8	2.8	2.4	2.1	14.5	10.1	1.4	2.2	3.2	3.5	4.4	0.1	3.4	3.8	2.6	3.9	3.3	0.7	1.2	1.7	5.0	8.7	0.9	1.6	1.6	0.1	8.1	1.3	1.8	4.8	2.9	5.0	2.9	3.2	14.6	4.5	3.2	2.7	4.8	2.0	4.3	7.3	0.2	2.0	1.2	1.9	3.5	2.2	5.0	0.7	1.8	2.0	1.1	0.4	1.5	1.7	1.1	12.3	6.1	1.6	2.7	4.7	2.7	0.6	1.0	0.0	3.2	19.2	1.1	1.4	7.8	3.3	2.3	7.4	1.7	1.2	1.8	3.0	2.4	3.1	3.6	2.0	14.1	3.8	4.4	3.1	3.9	3.5	9.8	10.2	11.8	9.9	9.3	6.2	10.1	6.6	9.6	11.9	3.0	3.7	0.5	1.9	0.9	5.4	10.1	2.5	5.3	5.7	3.5	5.9	2.7	6.6	3.0	9.5	3.7	2.0	0.0	3.8	4.0	3.1	1.0	11.6	1.0	7.0	3.2	0.0	6.2	11.7	5.7	3.7	9.1	0.0	3.6	2.5	1.8	3.2	0.0	7.8	2.7	5.0	6.5	5.1	6.4	6.4	2.0	1.4	1.8	2.3	2.0
ZNF44	"KOX7, ZNF504, ZNF55, ZNF58"	ENSG00000197857	"Zinc finger protein 44"	P15621	19	12224686-12294887	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 81.2;Early spermatids: 95.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003146	Supported		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			Nucleoplasm	"Microtubules, Cytosol"	"HPA003146: AB_1080723"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.65e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.56e-3)"	"unprognostic (7.30e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (9.21e-6)"	10.5	8.4	9.6	7.3	13.1	20.2	13.6	19.3	9.8	9.8	11.6	7.9	20.8	8.2	9.6	13.2	10.3	9.5	8.1	7.0	8.5	4.6	11.7	15.2	9.6	9.6	12.2	6.9	15.9	11.1	8.7	12.1	7.0	9.4	11.1	13.0	9.1	9.2	18.1	17.3	15.4	11.1	14.1	11.6	13.9	9.6	13.8	12.8	6.5	11.3	6.5	10.5	10.7	10.8	4.7	3.1	15.1	3.0	11.5	9.5	3.5	3.6	1.0	2.8	4.9	2.8	2.8	12.0	5.2	2.3	8.3	7.4	4.9	2.0	3.6	6.5	4.9	2.4	3.8	3.5	3.6	7.2	0.0	3.3	3.4	4.8	12.9	3.8	0.0	9.3	2.9	5.7	5.1	6.6	3.4	3.2	4.4	2.2	0.7	5.2	3.7	5.2	6.0	2.7	3.6	6.2	3.6	6.2	4.4	5.0	8.6	3.1	3.7	6.6	2.6	1.6	7.8	5.5	5.8	3.7	10.0	2.7	9.7	4.5	7.7	9.7	3.5	0.2	3.1	2.9	9.8	1.6	15.1	8.0	3.0	9.4	4.7	8.6	8.6	1.4	3.2	9.5	9.2	5.3	11.5	3.0	3.1	5.7	3.5	9.6	13.1	19.3	9.8	8.5	4.6	12.2	6.9	9.4	12.8	26.8	14.5	9.3	5.4	8.0	16.5	15.1	22.9	32.1	17.0	61.1	35.3	14.0	81.2	8.3	95.8	7.1	14.2	0.0	8.0	6.3	8.0	6.5	23.1	11.1	7.2	15.9	15.0	14.1	7.9	23.8	13.0	10.8	10.1	3.6	11.5	10.6	7.3	11.5	5.6	9.1	35.3	19.4	9.8	17.6	17.9	10.2	7.2	19.2	11.8	8.6
ZNF440	FLJ37933	ENSG00000171295	"Zinc finger protein 440"	Q8IYI8	19	11814284-11835201	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 12.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 20.1"									HPA047845	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (2.48e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.57e-4)"	"prognostic favorable (1.18e-4)"	"unprognostic (9.81e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.88e-4)"	8.5	6.3	5.2	6.4	7.7	7.8	9.5	12.7	9.1	10.1	13.0	4.5	9.2	7.5	11.0	8.6	15.2	19.6	6.0	4.9	10.4	4.4	9.1	5.8	10.7	5.9	5.2	5.7	10.7	8.5	19.2	9.5	21.2	11.1	12.4	15.2	5.4	11.0	10.6	5.4	20.4	11.7	6.0	7.9	7.2	11.4	9.0	6.1	6.6	8.7	9.2	7.0	19.1	10.7	1.8	2.4	12.1	3.6	3.8	2.4	1.0	5.1	0.0	5.9	7.2	4.5	4.0	15.6	3.7	3.0	4.4	3.9	5.5	4.5	2.9	3.6	3.3	2.2	6.5	3.0	7.0	6.2	0.2	2.0	4.1	3.3	4.4	2.2	0.0	9.4	2.3	4.8	2.8	0.8	3.1	2.5	4.0	15.2	0.3	5.1	2.2	3.6	5.3	4.5	1.8	4.7	3.0	7.7	1.2	3.2	20.1	3.4	2.7	5.7	2.4	4.1	6.6	10.3	7.9	2.6	10.2	2.1	7.4	3.2	5.5	3.9	3.9	4.8	2.6	3.7	12.1	1.9	2.4	1.7	1.2	2.0	1.4	2.1	1.9	2.4	1.8	1.5	2.4	3.6	3.8	3.6	1.5	2.4	1.0	5.2	7.7	12.7	9.1	10.4	4.4	5.2	5.7	11.1	6.1	14.9	6.4	0.9	9.2	2.6	5.3	2.5	2.5	83.0	20.5	8.7	33.4	23.6	3.3	3.1	16.5	3.6	15.4	0.0	3.2	15.6	2.3	6.2	10.4	1.1	3.9	6.4	6.4	4.3	4.4	3.6	2.6	3.3	3.3	1.0	9.5	2.2	4.2	12.4	1.8	1.3	12.4	0.0	3.8	9.3	2.5	4.3	24.9	4.9	11.5	8.4
ZNF441	FLJ38637	ENSG00000197044	"Zinc finger protein 441"	Q8N8Z8	19	11767000-11784078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 14.9;Rod photoreceptor cells: 19.1;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA063338			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA063338: AB_2684989"	"unprognostic (1.97e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.42e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.70e-3)"	7.6	5.7	7.5	10.6	15.5	1.6	11.3	18.4	11.1	9.6	6.0	4.4	9.4	4.4	8.9	12.1	5.4	7.7	6.9	7.0	7.0	6.7	12.4	8.1	6.6	9.5	5.4	7.1	16.4	6.6	12.1	13.3	8.1	11.6	11.1	6.3	6.6	6.7	9.9	13.9	6.1	7.9	10.8	4.9	8.2	5.9	5.0	5.5	7.2	13.5	3.8	8.1	11.1	7.0	4.5	1.5	2.1	3.6	2.1	4.2	1.7	2.6	0.0	3.3	2.8	4.1	4.4	3.5	6.5	3.6	4.8	4.6	2.9	0.9	5.5	3.4	4.3	2.4	2.0	2.1	4.0	5.7	0.0	2.3	2.6	2.2	4.7	3.6	0.1	4.7	5.3	4.4	3.4	2.7	3.3	2.7	2.3	4.1	0.1	7.5	0.0	5.8	1.6	0.6	1.1	4.6	2.2	6.6	1.7	4.0	4.4	2.5	4.0	4.3	1.5	2.4	3.4	4.3	5.8	1.3	10.6	2.5	9.2	4.3	5.8	8.4	2.4	0.7	0.1	4.2	0.0	1.0	2.1	2.9	0.9	2.2	3.6	2.9	3.9	1.5	4.5	3.8	4.2	1.3	2.1	3.6	1.0	2.1	1.7	7.5	15.5	18.4	11.1	7.0	6.7	5.4	7.1	11.6	5.5	14.9	5.4	0.8	0.7	0.3	11.3	7.1	0.0	0.0	6.8	10.4	13.7	1.6	3.3	1.3	0.1	4.5	1.4	0.0	1.0	0.6	1.3	0.6	2.3	1.9	0.7	6.4	0.0	4.9	0.3	0.0	2.3	2.3	3.3	0.0	0.7	7.2	0.9	0.8	6.7	2.7	19.1	19.4	3.1	2.9	2.3	0.0	0.7	1.8	0.8	0.4
ZNF442	FLJ14356	ENSG00000198342	"Zinc finger protein 442"	Q9H7R0	19	12345949-12365905	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 8.7"									"HPA045738, HPA053407"	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane"	Vesicles	"HPA045738: AB_10968057, HPA053407: AB_2682138"	"unprognostic (2.61e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.99e-2)"	4.7	3.1	2.8	5.5	6.0	1.5	5.1	8.3	3.8	6.6	3.4	1.0	2.9	1.9	5.5	5.5	3.8	5.5	2.0	3.9	2.6	2.5	8.1	5.2	3.4	3.6	2.7	2.4	17.1	4.8	4.3	5.2	3.1	7.1	6.2	3.9	4.3	3.0	6.8	8.0	3.6	2.6	8.7	5.0	4.7	2.7	3.5	3.4	3.9	5.8	2.5	3.1	8.5	4.6	5.7	1.3	5.0	1.0	1.0	3.4	0.9	0.4	0.1	2.8	3.7	1.8	1.0	0.4	3.8	1.1	3.5	2.8	2.7	0.9	3.3	1.2	2.1	1.3	0.8	2.3	1.9	3.3	0.1	0.5	0.2	4.1	2.5	1.4	0.1	3.2	1.6	2.1	1.5	0.5	0.3	0.4	2.4	4.7	0.4	3.1	2.5	3.8	0.6	2.3	0.5	1.6	0.2	4.2	0.1	1.4	2.2	0.2	0.7	0.0	0.2	0.0	3.5	3.8	2.6	0.1	4.5	2.2	5.6	2.3	3.5	8.7	0.1	0.2	0.1	1.8	1.0	0.7	5.0	2.0	1.0	1.3	5.7	1.3	1.2	1.3	1.3	3.4	2.1	1.7	1.0	0.9	1.2	0.1	0.9	2.8	6.0	8.3	3.8	2.6	2.5	2.7	2.4	7.1	3.4	0.0	1.6	0.5	0.7	0.3	1.4	2.4	2.5	2.7	0.0	1.8	5.9	0.4	1.7	0.8	1.0	2.1	0.0	0.0	0.8	0.2	1.7	0.7	2.3	0.9	1.2	0.0	1.2	3.7	2.2	0.4	0.6	0.8	3.3	2.8	0.6	2.0	0.3	0.0	0.4	3.8	1.5	0.0	1.5	1.0	1.9	0.5	0.3	0.0	0.2	0.4
ZNF443	ZK1	ENSG00000180855	"Zinc finger protein 443"	Q9Y2A4	19	12429707-12441112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.9"									"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (5.64e-3)"	"unprognostic (1.51e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.38e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.74e-7)"	"unprognostic (3.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (3.91e-4)"	5.5	3.4	5.5	9.5	6.9	1.0	8.5	13.6	5.9	7.6	7.2	2.0	21.4	4.0	6.6	6.3	4.9	5.2	4.2	3.3	4.3	4.5	10.6	5.8	4.7	3.2	4.2	3.0	4.9	5.9	9.3	4.1	6.3	5.0	7.0	6.7	1.9	5.7	12.9	1.9	7.3	8.9	3.6	5.9	3.6	4.7	3.4	4.1	16.9	4.8	3.7	4.3	7.9	9.6	4.0	2.2	4.8	1.2	3.1	7.1	2.0	3.3	1.4	6.0	5.3	1.8	1.5	8.2	2.5	1.8	3.3	3.1	3.2	0.9	3.9	4.4	1.9	1.3	2.0	3.8	2.4	2.8	0.0	2.1	1.6	1.9	7.4	0.4	3.7	4.6	1.4	1.5	1.6	0.7	2.2	1.9	5.0	2.7	0.0	3.6	4.0	13.9	5.1	5.1	3.3	5.2	1.6	6.2	4.7	4.0	12.4	2.8	4.7	4.0	2.2	0.6	3.4	0.1	4.7	1.2	6.6	2.7	3.7	2.3	2.5	3.6	2.5	0.9	3.8	1.4	4.8	1.2	1.6	2.1	0.6	7.1	4.0	4.5	4.3	2.2	3.2	4.0	2.7	0.7	3.1	0.3	1.1	3.3	2.0	5.5	6.9	13.6	5.9	4.3	4.5	4.2	3.0	5.0	4.1	0.0	0.3	2.2	1.2	0.9	1.5	1.6	2.5	2.7	1.2	0.0	3.9	6.5	1.7	2.6	4.1	1.6	1.5	0.0	1.0	0.9	1.1	0.5	0.0	1.6	1.1	1.6	2.9	1.3	1.9	1.3	0.6	0.7	0.0	0.0	2.3	2.5	1.0	1.7	2.1	1.7	2.2	0.0	1.4	1.2	4.9	2.3	1.4	3.2	2.6	0.6
ZNF445	"ZKSCAN15, ZNF168, ZSCAN47"	ENSG00000185219	"Zinc finger protein 445"	P59923	3	44431720-44477670	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 34.4;Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006678	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA006678: AB_10603329"	"unprognostic (7.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.05e-1)"	6.8	6.4	8.3	6.4	10.9	4.5	7.5	16.5	10.9	8.6	7.1	11.7	8.0	5.1	13.6	7.7	5.2	8.3	6.1	6.3	7.7	7.0	6.3	7.5	6.7	6.6	11.3	10.5	13.0	7.6	16.1	13.9	7.1	7.9	8.6	6.6	9.9	8.1	8.2	11.2	8.2	5.7	12.3	6.6	7.0	7.3	6.5	8.9	14.2	6.9	4.8	8.1	6.7	8.2	1.1	1.1	4.1	2.5	1.9	1.5	0.5	2.5	2.9	9.1	7.1	5.1	5.2	4.1	3.5	2.9	5.3	5.3	4.4	2.3	4.5	2.2	3.6	3.4	2.1	6.1	2.4	6.4	4.9	2.3	8.3	5.9	4.3	3.2	10.5	7.0	3.6	3.0	5.9	3.8	4.5	3.7	6.4	6.4	3.4	4.2	1.7	10.0	7.1	6.2	1.6	2.7	4.5	5.7	2.2	2.9	5.3	4.5	5.6	5.4	2.8	1.4	7.1	5.2	4.6	4.4	7.5	6.7	4.6	4.4	2.7	2.0	3.8	2.8	5.3	4.5	2.7	1.3	2.3	1.2	0.8	1.1	0.7	0.9	0.9	0.9	1.1	1.5	1.1	4.1	1.9	2.5	1.1	0.4	0.5	8.3	10.9	16.5	10.9	7.7	7.0	11.3	10.5	7.9	8.9	11.9	16.7	7.3	4.1	3.7	34.4	7.8	2.5	12.0	10.3	10.4	35.3	3.3	1.7	4.4	1.9	6.8	2.6	0.0	7.3	1.5	6.1	5.2	10.5	8.5	4.7	27.0	6.9	10.4	14.0	1.6	8.6	7.7	0.0	1.0	6.5	13.4	4.4	3.5	9.2	2.3	30.0	12.9	6.1	5.7	6.1	2.3	1.1	5.7	6.9	3.4
ZNF446	"FLJ20626, ZKSCAN20, ZSCAN52"	ENSG00000083838	"Zinc finger protein 446"	Q9NWS9	19	58474017-58481230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 22.8"					"Low region specificity"	"Detected in all"			"HPA052786, HPA078262"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA052786: , HPA078262: "	"unprognostic (1.52e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.94e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.94e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-3)"	3.6	4.6	5.2	5.1	6.7	4.0	5.0	8.9	8.8	6.7	4.9	5.3	15.1	3.7	7.2	6.2	3.4	11.0	10.0	5.5	5.3	4.8	6.2	6.5	4.3	8.6	5.5	5.9	11.9	13.6	9.7	8.8	2.9	6.7	7.2	3.0	4.4	9.4	7.5	3.5	5.6	4.2	8.5	4.9	4.3	4.8	7.8	3.7	17.1	6.8	3.2	6.4	5.7	10.1	6.8	6.0	5.6	9.8	3.0	7.5	3.6	3.5	7.5	5.2	4.7	5.2	9.7	5.0	2.2	6.8	1.8	2.6	3.6	3.1	3.5	3.1	2.9	8.3	5.6	2.0	2.8	0.9	5.1	22.8	4.4	5.6	3.0	7.7	2.2	6.5	8.0	5.3	3.1	3.3	8.8	4.5	6.4	2.5	2.4	2.8	4.3	5.9	2.6	1.7	3.3	4.6	5.2	3.6	4.6	3.8	6.6	6.1	5.8	4.3	5.8	3.7	3.0	4.1	2.8	3.4	9.0	3.2	2.1	4.9	8.1	10.8	2.2	4.7	1.3	3.2	5.2	4.4	4.6	6.4	5.9	3.9	4.9	7.5	4.1	6.0	6.8	5.1	6.3	5.6	3.0	9.8	3.9	6.0	3.6	5.2	6.7	8.9	8.8	5.3	4.8	5.5	5.9	6.7	3.7	3.0	2.7	1.7	1.8	1.8	8.5	0.8	15.3	5.3	4.5	5.2	7.9	4.6	3.3	6.5	4.6	2.9	6.7	0.0	4.5	3.2	4.0	1.9	8.1	2.9	3.8	7.9	10.3	1.8	4.0	4.4	6.6	2.1	3.3	1.8	5.6	10.1	4.2	3.7	4.9	4.4	8.2	0.0	3.3	20.6	8.5	3.1	2.9	2.5	5.4	1.1
ZNF449	"FLJ23614, ZSCAN19"	ENSG00000173275	"Zinc finger protein 449"	Q6P9G9	X	135344796-135363152	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018079	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA018079: AB_1859277"	"unprognostic (5.51e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.61e-2)"	"unprognostic (4.22e-2)"	13.7	15.8	5.3	6.7	10.4	1.9	11.6	7.5	10.8	10.1	7.2	6.0	4.8	5.0	14.0	10.9	7.5	6.0	8.6	8.3	5.0	6.1	6.1	5.0	7.3	5.8	6.3	9.6	9.7	16.1	12.5	9.8	11.0	12.2	9.6	5.5	6.6	8.6	7.5	7.6	5.8	5.3	12.4	5.0	9.5	7.6	4.8	4.7	5.3	10.6	4.6	6.4	12.1	8.9	1.5	2.6	3.6	6.6	5.6	5.7	2.2	2.9	4.3	8.7	7.1	7.9	15.9	4.3	5.7	4.4	3.7	9.0	1.4	4.0	1.8	7.4	4.5	5.0	3.4	6.1	2.5	5.9	2.5	5.1	2.4	4.1	2.1	6.0	1.9	3.7	6.1	7.7	3.1	9.2	5.2	6.9	4.7	2.3	2.1	10.4	1.7	2.4	2.2	3.0	2.9	4.7	2.0	5.9	2.7	5.5	1.7	2.1	5.2	1.4	4.2	4.3	5.8	3.1	2.1	6.8	8.5	3.1	5.7	5.0	1.6	2.0	1.4	3.3	3.3	5.5	1.7	2.7	3.6	3.0	3.4	5.7	1.5	2.7	4.1	2.6	1.1	2.6	2.6	0.6	5.6	6.6	1.5	2.4	2.2	5.3	10.4	7.5	10.8	5.0	6.1	6.3	9.6	12.2	4.7	0.0	2.1	0.5	0.8	0.8	6.6	8.1	0.0	2.7	1.2	1.8	0.0	1.9	0.0	1.4	0.2	3.6	0.4	0.0	0.6	1.7	2.5	1.0	1.1	0.5	3.3	9.5	2.9	8.0	2.2	0.0	4.9	2.2	3.3	5.4	1.1	4.4	1.2	0.8	3.9	0.3	2.9	0.0	1.3	1.0	2.2	1.9	1.0	1.8	0.6	0.3
ZNF451	"COASTER, dJ417I1.1, KIAA0576, KIAA1702"	ENSG00000112200	"Zinc finger protein 451"	Q9Y4E5	6	57086844-57170307	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 214.0;Late spermatids: 315.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028838			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028838: AB_10603330"	"unprognostic (5.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.17e-2)"	13.2	17.8	14.2	10.8	30.9	61.8	14.4	23.3	21.2	13.8	12.8	15.5	11.6	8.8	14.9	16.1	11.7	12.0	11.2	11.2	15.4	13.0	11.9	13.3	13.5	15.2	20.5	13.9	14.3	11.9	14.5	27.6	18.0	20.3	14.9	10.8	8.8	11.3	11.8	11.2	12.3	12.0	18.9	21.1	15.5	12.9	27.5	21.0	16.5	16.6	7.8	14.1	14.9	12.9	14.2	14.2	19.3	10.0	7.7	12.3	6.8	9.3	5.1	12.9	7.9	12.3	15.9	12.4	10.4	13.1	12.7	13.8	11.7	4.7	10.3	6.9	11.5	15.1	8.9	12.6	11.6	20.6	8.3	8.9	26.7	9.3	10.8	9.4	14.8	11.6	11.2	11.8	14.0	17.7	9.4	12.4	14.8	35.6	10.0	10.8	6.8	18.5	12.8	7.0	7.2	5.7	12.7	16.5	9.6	8.4	16.1	15.3	10.3	11.3	7.5	12.3	15.9	9.0	14.3	8.1	12.8	13.2	16.4	12.1	9.7	16.2	21.0	11.2	18.4	6.3	19.3	10.0	9.7	10.8	8.3	10.6	9.6	9.3	6.4	10.6	14.2	12.3	9.4	5.0	7.7	8.5	14.2	7.2	6.8	14.2	30.9	23.3	21.2	15.4	13.0	20.5	13.9	20.3	21.0	23.8	28.0	21.7	12.6	50.0	55.6	22.7	28.1	36.1	25.0	29.6	70.7	34.1	8.3	12.4	214.0	28.6	18.6	116.8	11.9	26.4	47.4	21.6	40.6	25.6	15.7	46.1	35.3	49.7	29.7	315.8	34.8	30.7	32.1	10.0	21.2	32.3	15.3	11.5	38.9	11.0	66.7	6.5	38.5	46.0	30.2	37.4	11.0	24.9	21.0	14.7
ZNF460	"HZF8, ZNF272"	ENSG00000197714	"Zinc finger protein 460"	Q14592	19	57280051-57293569	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.3"									"HPA053004, HPA066506"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053004: AB_2682012, HPA066506: AB_2685681"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.10e-2)"	9.5	23.2	7.7	6.2	12.0	24.7	9.2	9.4	10.1	6.8	5.6	12.7	7.5	3.6	6.5	5.4	7.7	5.7	6.5	8.7	7.4	5.0	7.0	8.5	7.9	5.5	14.6	7.0	13.2	6.5	10.3	13.0	8.0	8.6	7.0	4.8	6.4	8.3	7.3	8.7	9.6	5.1	7.4	10.8	7.8	5.9	9.6	10.7	5.9	8.3	6.7	8.6	5.9	7.5	5.4	0.4	3.4	2.8	2.0	3.6	1.6	1.6	2.4	1.9	2.7	2.0	1.7	5.0	1.1	1.5	1.2	3.7	3.0	0.9	2.3	1.1	1.3	1.1	1.1	2.6	1.3	2.1	1.8	5.0	2.3	1.8	1.5	2.2	3.9	2.6	0.9	2.3	3.2	3.7	1.0	0.8	2.6	2.2	17.3	1.4	1.2	2.4	0.6	2.7	1.2	2.4	1.7	2.7	1.1	0.8	3.1	2.5	1.3	2.7	1.4	1.6	1.3	1.2	2.7	1.1	3.7	4.3	0.5	2.1	7.5	3.2	4.0	1.3	1.5	1.1	0.0	1.2	2.6	2.2	2.8	2.3	2.3	1.7	1.2	0.4	5.4	3.6	1.5	3.4	2.0	1.9	0.2	2.7	1.6	7.7	12.0	9.4	10.1	7.4	5.0	14.6	7.0	8.6	10.7	3.0	1.0	1.7	2.8	2.7	3.9	4.2	0.0	2.7	2.3	0.0	0.0	1.2	0.0	1.2	2.2	2.7	0.4	0.0	0.3	1.7	1.7	2.8	0.0	1.5	0.9	7.9	0.0	7.4	3.0	0.0	1.7	1.8	1.7	3.6	0.6	2.9	1.6	0.0	1.4	0.8	3.2	0.0	5.7	2.8	1.2	2.0	2.2	1.3	0.8	3.4
ZNF461	"GIOT-1, MGC33911"	ENSG00000197808	"Zinc finger protein 461"	Q8TAF7	19	36637192-36666853	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 31.6;Club cells: 21.6;granulocytes: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA021139	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA021139: AB_10961418"	"unprognostic (8.37e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.01e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.11e-3)"	6.0	8.7	8.1	5.6	12.3	6.3	7.2	13.5	12.0	7.1	5.9	8.5	4.7	1.5	10.2	7.1	5.2	7.6	5.8	5.0	6.9	7.5	6.8	5.1	5.4	6.9	7.0	8.6	10.8	4.0	7.9	12.1	8.7	8.7	6.7	4.7	5.7	4.8	6.3	4.1	5.9	5.4	8.5	7.4	7.9	5.4	8.1	9.2	5.9	10.6	3.1	7.6	6.2	7.3	3.3	2.3	1.0	2.3	2.2	6.2	1.6	2.9	5.3	4.0	5.1	2.8	6.3	2.5	3.1	3.5	4.9	6.8	0.9	1.3	0.4	6.7	4.4	4.8	0.5	2.8	3.4	5.3	5.4	4.0	4.6	0.7	2.0	4.5	3.9	5.6	3.9	6.2	1.6	4.4	5.8	3.0	2.5	0.2	0.4	4.9	3.1	6.1	1.0	2.3	0.4	2.0	0.4	3.9	0.9	1.5	6.7	4.7	6.7	0.3	2.3	4.2	4.3	2.5	1.5	3.0	3.0	3.8	1.9	3.8	8.8	13.0	1.6	0.0	0.8	3.8	0.0	0.8	1.0	2.5	2.3	3.1	2.8	4.1	6.2	2.3	3.3	3.1	2.2	0.1	2.2	0.4	0.7	3.5	1.6	8.1	12.3	13.5	12.0	6.9	7.5	7.0	8.6	8.7	9.2	26.8	31.6	1.3	1.7	3.0	5.5	1.6	5.1	14.7	21.6	3.5	0.0	2.4	1.7	1.2	17.7	3.4	0.2	0.0	0.8	2.4	3.0	1.7	31.3	1.0	1.5	3.2	2.9	4.3	2.2	4.1	0.9	1.9	0.0	0.0	1.0	1.9	0.7	0.0	1.8	1.5	3.2	0.0	3.1	7.7	4.2	3.0	2.4	4.3	1.2	1.5
ZNF462	"DKFZP762N2316, KIAA1803, Zfp462"	ENSG00000148143	"Zinc finger protein 462"	Q96JM2	9	106863097-107013634	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022283	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022283: AB_2220602"	"unprognostic (4.22e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-2)"	4.8	11.9	10.4	5.0	11.0	0.8	6.4	25.4	9.5	10.4	6.5	13.2	7.7	2.3	13.3	5.1	10.7	9.1	6.0	8.6	10.6	6.6	5.6	2.9	5.3	1.8	8.1	7.8	11.5	2.1	18.1	10.0	5.6	10.0	11.4	6.4	8.1	12.6	11.9	22.1	11.2	3.3	10.8	9.7	4.8	3.3	9.1	9.8	1.5	11.7	5.4	2.5	5.6	9.3	0.4	0.5	1.1	0.6	1.8	1.7	0.3	3.2	7.6	15.2	10.4	5.1	3.8	2.2	2.0	2.9	2.0	2.2	9.3	3.3	0.0	5.7	2.1	9.3	5.1	9.8	9.0	2.5	0.1	1.3	0.0	2.5	0.0	2.0	1.6	0.3	3.5	4.1	4.5	12.5	5.4	1.0	4.0	0.0	4.2	5.5	5.7	1.8	0.1	11.6	0.0	7.4	0.0	10.2	0.2	5.8	2.8	7.0	8.0	3.8	0.1	3.3	10.1	7.8	0.0	1.0	2.6	9.0	5.9	6.3	0.0	0.1	0.1	4.3	0.2	9.3	1.1	0.2	0.3	0.7	0.4	1.2	0.3	0.7	0.3	0.3	0.4	1.7	0.5	0.7	1.8	0.6	0.5	0.3	0.3	10.4	11.0	25.4	7.7	10.6	6.6	8.1	7.8	10.0	9.8	20.8	23.2	1.3	10.3	29.9	56.8	21.4	20.4	13.4	12.5	7.0	29.5	9.6	5.0	6.7	52.2	23.3	6.3	0.0	2.3	4.1	10.4	13.6	16.2	0.0	1.6	17.5	16.1	39.3	1.0	10.4	13.6	1.3	11.8	3.6	19.9	20.3	4.8	0.0	25.5	14.7	38.6	25.8	19.8	1.2	12.8	10.0	2.6	0.0	16.8	6.4
ZNF467	"EZI, Zfp467"	ENSG00000181444	"Zinc finger protein 467"	Q7Z7K2	7	149764182-149773479	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 47.5;Distal tubular cells: 33.2;Kupffer cells: 44.2;Muller glia cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 27.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 27.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.1;EFO-21: 11.0;HMC-1: 12.8;MCF7: 10.6;SK-BR-3: 10.0;T-47d: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042907	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042907: AB_10966965"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.40e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.25e-2)"	10.6	8.2	10.5	8.8	16.5	20.1	15.2	3.5	7.4	7.9	6.7	3.2	22.1	2.9	8.5	6.4	4.2	10.0	7.5	11.6	10.1	4.6	14.9	9.2	15.8	24.2	6.3	2.9	8.9	10.8	3.5	11.0	6.2	5.8	5.1	3.7	20.4	12.3	18.4	4.3	11.8	5.2	7.0	9.9	21.4	10.4	2.3	11.0	9.6	11.8	4.0	5.6	4.6	13.3	0.0	3.5	27.7	5.4	0.1	0.4	1.4	0.0	2.7	3.2	22.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	6.8	0.1	11.0	0.1	0.1	0.3	1.6	0.0	0.1	0.1	0.3	1.2	0.0	0.0	6.8	0.0	12.8	4.6	1.1	0.0	0.1	8.0	2.4	0.5	2.0	0.5	0.0	10.6	0.4	1.1	0.3	0.9	6.9	1.7	0.0	8.2	1.5	0.0	1.2	1.0	0.0	10.0	0.0	1.1	12.4	1.3	5.4	0.1	3.6	0.0	0.0	0.5	0.0	0.1	0.1	3.8	0.1	0.0	5.4	2.2	0.2	2.2	0.1	0.0	0.2	0.2	3.5	0.0	0.4	0.1	27.7	0.1	0.7	1.6	0.0	1.4	10.5	16.5	3.5	7.4	10.1	4.6	6.3	2.9	5.8	11.0	0.0	0.3	0.0	0.5	3.2	47.5	1.7	0.0	1.4	1.2	0.0	2.0	0.2	33.2	4.8	0.3	15.5	0.0	0.0	2.5	0.1	4.7	1.2	0.0	5.7	19.3	6.4	2.9	24.5	44.2	0.0	1.4	17.6	1.7	8.2	0.0	69.9	2.2	0.0	1.8	7.5	5.5	0.0	3.1	0.1	2.0	6.5	0.3	1.5	0.0	0.3
ZNF469	KIAA1858	ENSG00000225614	"Zinc finger protein 469"	Q96JG9	16	88427471-88440757	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 5.0;Ito cells: 3.7;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"A549: 5.7;BJ hTERT+: 6.3;HeLa: 5.6;SiHa: 6.7;THP-1: 8.6"					"Low region specificity"	"Detected in many"			HPA069784			Approved	Vesicles		NA	NA			Vesicles		"HPA069784: AB_2686196"	"unprognostic (1.80e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.71e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.17e-3)"	"unprognostic (7.08e-3)"	"unprognostic (5.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.71e-7)"	"unprognostic (2.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.34e-2)"	1.8	0.8	2.5	2.3	2.2	0.1	0.7	0.0	2.2	4.3	0.2			0.4	2.9	0.0	0.2	1.3	2.6	0.4	2.5	1.6	0.0	0.1	0.5	1.3	1.6		4.3	0.8	0.0	0.0	0.5		1.3	0.0		0.6	0.8	1.5	0.2	0.8	2.1	1.6	1.9	0.9	0.3			0.0		0.5	1.7	0.4	0.1	1.5	0.0	0.3	0.0	0.2	0.0	0.0	5.7	0.2	0.0	0.9	1.3	0.0	3.6	6.3	0.8	0.1	0.0	0.2	0.0	0.1	4.8	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	5.6	0.0	4.1	0.2	0.1	1.4	0.0	1.4	0.0	1.0	3.7	0.0	0.0	0.0	1.0	0.5	0.0	0.9	0.7	0.1	4.7	0.4	0.0	0.0	0.0	0.0	0.0	2.9	6.7	0.0	0.0	0.1	1.2	8.6	4.5	5.1	1.3	2.8	0.9	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0											0.0	2.6	0.0	0.5	0.2	0.0	5.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	1.9	0.2	0.4	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	2.5	3.2	0.0	3.7	0.3	0.0	0.0	1.3	0.0	1.0	0.0	0.3	0.5	0.0	1.4	0.0	0.0	6.5	3.1	0.0	0.2	0.1	0.1	0.0	0.0	0.3
ZNF48	"DKFZp762K013, FLJ31751, MGC43952, ZNF553"	ENSG00000180035	"Zinc finger protein 48"	Q96MX3	16	30378106-30400108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023806	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA023806: AB_1859335"	"unprognostic (5.35e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (5.36e-2)"	"prognostic favorable (7.50e-5)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	5.6	7.7	8.9	9.1	9.8	4.4	6.7	15.7	16.1	9.1	11.5	10.1	12.1	9.0	12.8	5.7	5.5	10.7	9.5	6.7	8.9	8.7	6.6	6.4	8.0	10.0	9.0	8.5	6.7	15.1	18.8	8.8	4.7	7.1	7.6	6.1	8.0	9.7	12.6	12.1	6.3	6.4	11.2	5.7	7.3	7.9	3.9	9.8	16.1	7.5	7.2	7.3	9.0	8.3	1.4	1.6	1.3	0.2	2.6	3.1	0.5	4.7	8.1	19.8	15.8	2.5	2.0	6.7	3.3	6.0	7.9	7.1	3.8	6.2	8.9	6.6	3.0	2.1	3.8	9.6	5.2	4.2	6.5	11.8	3.9	3.9	5.5	3.6	5.2	5.6	1.5	6.7	6.2	4.2	6.9	6.5	8.6	6.8	4.2	3.1	15.3	12.1	6.4	16.8	3.8	3.0	28.1	4.3	11.8	4.2	3.7	15.4	19.2	1.4	10.6	1.4	5.6	7.0	5.2	2.8	4.5	5.1	4.2	4.0	5.1	5.8	8.7	2.4	3.3	1.0	0.0	0.2	1.3	3.1	0.2	2.4	1.1	1.7	1.8	0.5	1.4	2.1	2.3	0.0	2.6	0.1	1.6	1.7	0.5	8.9	9.8	15.7	16.1	8.9	8.7	9.0	8.5	7.1	9.8	3.0	2.1	6.4	2.6	2.7	10.3	4.8	7.6	0.0	4.5	3.5	7.9	3.1	1.7	8.9	0.1	3.8	2.6	0.0	6.4	1.6	2.2	2.2	17.3	2.8	2.4	15.9	9.2	3.1	2.6	0.0	2.6	1.9	1.7	10.8	3.6	6.0	7.2	5.3	6.3	3.1	7.0	0.0	3.7	3.2	3.0	4.5	0.2	3.2	5.5	1.5
ZNF483	"KIAA1962, ZKSCAN16, ZSCAN48"	ENSG00000173258	"Zinc finger protein 483"	Q8TF39	9	111525159-111577844	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.3;pituitary gland: 40.4"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 44.0;Horizontal cells: 33.4;Muller glia cells: 21.7;Rod photoreceptor cells: 22.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055041			Approved	Nucleoli		NA	NA			Nucleoli		"HPA055041: AB_2682681"	"unprognostic (4.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.95e-3)"	"unprognostic (9.18e-5)"	"unprognostic (2.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-4)"	"unprognostic (7.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.17e-2)"	3.2	10.1	13.9	2.1	30.5	7.7	5.6	35.9	36.3	6.1	4.0	8.6	2.9	2.0	10.0	11.9	2.4	7.0	4.9	4.7	18.1	7.3	5.1	2.5	3.9	3.4	9.5	23.0	12.6	4.3	13.6	40.4	1.8	24.4	7.2	2.4	5.9	3.2	7.7	2.3	3.5	2.9	5.5	9.8	4.8	3.9	11.8	10.3	0.0	12.5	0.0	3.1	4.7	4.8	2.5	1.0	4.6	1.0	2.1	6.5	1.5	0.3	3.2	3.2	4.8	0.4	0.6	1.0	0.4	1.6	3.2	3.0	0.4	1.5	0.5	0.5	1.3	2.4	0.9	1.5	1.7	1.9	0.2	1.9	1.7	4.5	2.6	0.9	0.6	0.4	1.2	0.6	1.7	0.9	2.4	2.9	2.1	1.3	0.9	0.7	3.0	0.2	0.8	11.8	1.5	1.1	0.3	4.9	0.4	1.2	1.3	6.9	3.3	1.2	0.6	0.8	3.0	1.9	0.4	0.5	1.0	1.6	1.5	2.2	0.7	1.9	0.4	1.1	0.5	0.7	4.6	1.0	0.6	4.8	0.5	2.7	1.5	3.3	2.3	0.3	2.5	5.9	6.5	3.4	2.1	0.7	1.0	1.6	1.5	13.9	30.5	35.9	36.3	18.1	7.3	9.5	23.0	24.4	10.3	0.0	7.5	0.0	4.4	0.7	44.0	2.9	0.0	1.4	6.8	7.0	19.6	0.9	5.0	0.8	17.5	1.8	0.2	0.0	1.8	0.5	3.1	3.3	0.0	2.1	0.3	33.4	2.9	0.6	0.0	6.7	4.4	1.0	1.7	0.0	0.0	21.7	0.9	0.0	9.6	0.0	22.6	6.5	2.3	7.5	2.7	1.3	0.6	0.0	0.1	3.0
ZNF484	"BA526D8.4, FLJ33884"	ENSG00000127081	"Zinc finger protein 484"	Q5JVG2	9	92845031-92878038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.0"	"Cell type enhanced"	"Detected in some"	7	"Ciliated cells: 6.7;Club cells: 7.9;Horizontal cells: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA028973	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028973: AB_10610703"	"unprognostic (5.52e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.84e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.77e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.51e-1)"	6.5	6.6	9.9	5.4	14.6	10.1	6.5	33.0	13.9	7.7	4.8	7.8	4.7	3.7	7.0	5.3	4.2	6.2	4.7	4.9	11.7	7.0	7.3	5.2	5.8	6.6	12.5	7.1	9.1	4.5	12.1	14.0	7.9	12.6	7.0	5.2	4.6	5.0	6.3	3.7	4.2	5.0	6.2	17.1	7.7	6.0	4.8	13.5	2.8	9.0	1.9	7.9	7.3	5.8	5.6	2.5	5.3	3.5	4.5	7.4	3.0	4.1	5.1	6.7	4.3	3.5	4.3	0.0	3.4	5.5	6.1	6.7	1.6	3.2	3.6	3.0	2.7	4.3	6.8	4.9	5.1	6.5	5.8	2.1	3.1	4.1	3.3	5.4	2.5	5.6	4.8	3.9	6.7	7.1	4.5	5.3	4.0	3.3	14.6	6.5	4.2	3.7	1.2	5.6	4.7	2.5	3.1	8.2	2.6	3.2	4.8	4.7	4.2	6.0	1.7	3.4	5.3	0.4	2.0	5.7	5.5	5.3	2.8	2.4	5.5	2.7	2.1	3.6	2.1	4.3	1.4	2.5	5.3	5.3	3.5	6.5	3.7	5.4	4.4	2.2	5.6	7.4	6.7	1.4	4.5	3.1	2.5	4.4	3.0	9.9	14.6	33.0	13.9	11.7	7.0	12.5	7.1	12.6	13.5	0.0	1.0	0.0	0.5	0.1	4.2	1.7	0.0	6.7	7.9	1.8	0.0	0.9	1.7	1.1	0.5	0.9	0.8	0.0	0.4	0.9	0.7	0.4	2.3	0.2	0.7	4.8	0.0	0.0	0.8	0.0	0.6	0.2	0.0	0.0	0.9	3.1	0.7	0.9	1.4	1.3	3.5	0.0	1.0	0.5	0.8	0.1	0.6	1.3	0.5	0.5
ZNF487	"KRBO1, ZNF487P"	ENSG00000243660	"Zinc finger protein 487"	B1APH4	10	43436841-43483179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 32.1"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 78.9;Early spermatids: 155.2;Late spermatids: 196.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037820			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA037820: AB_10697083"	"unprognostic (1.97e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.97e-4)"	"unprognostic (5.85e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.92e-2)"	4.1	2.7	4.8	2.7	5.3	5.1	3.9	11.1	9.1	4.6	3.5	3.3	2.2	3.3	5.1	3.1	2.8	7.9	4.9	3.2	6.6	5.0	3.3	3.1	4.0	2.9	5.6	7.4	6.1	2.3	3.7	6.9	2.6	11.2	3.3	2.7	4.0	2.5	4.0	1.7	3.3	3.5	4.2	8.1	3.1	3.0	32.1	6.4	4.3	4.4	2.0	2.9	4.3	3.4	3.2	5.1	13.9	3.9	3.5	4.7	2.6	2.4	2.3	2.8	3.0	3.6	7.2	0.7	4.0	6.9	3.7	4.0	3.6	6.6	6.1	0.7	4.7	3.7	3.9	0.9	1.5	4.6	0.6	1.5	1.9	0.5	2.0	4.4	1.9	2.8	7.1	3.3	6.0	4.5	7.5	1.3	1.3	1.0	1.2	2.7	4.1	3.9	1.6	0.8	1.3	2.5	2.0	1.0	2.4	8.2	2.6	2.8	1.9	3.4	2.0	2.2	1.8	3.1	2.3	2.0	3.4	2.4	1.9	1.1	0.5	1.6	6.7	8.2	2.7	1.3	2.5	3.9	5.8	4.7	2.8	4.0	2.8	3.5	4.3	5.1	3.2	3.0	3.6	13.9	3.5	1.5	3.9	1.8	2.6	4.8	5.3	11.1	9.1	6.6	5.0	5.6	7.4	11.2	6.4	20.8	3.7	7.2	5.4	1.5	4.9	3.1	5.1	78.9	9.1	5.2	7.9	1.4	10.0	3.7	155.2	4.9	5.2	0.0	1.8	3.3	4.0	5.1	0.0	2.4	3.0	6.4	7.5	3.7	5.7	196.9	4.4	5.6	1.7	2.8	4.6	8.0	1.7	3.7	6.3	9.1	17.1	0.0	3.6	6.7	7.6	2.5	1.4	5.0	3.0	5.5
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384273	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 29.7;intestine: 25.8"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 30.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 23.7;HDLM-2: 34.3;RT4: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA035957: AB_10672234, HPA035958: AB_2674887"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.4	0.4	5.7	0.4	18.5	0.3	1.2	2.9	14.2	0.5	3.2	17.0	0.0	25.8	0.5	2.3	0.9	0.5	0.6	0.4	15.1		1.1	0.3	0.5	0.3	19.8	6.0	0.7	0.3	0.3	0.0	4.1	21.4	0.6	1.1	0.0	0.6	0.4	0.3	2.2	12.5	0.4	29.7	0.3	0.6	1.2	12.8	0.0	0.3	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	6.8	1.2	0.3	0.0	0.0	0.1	0.2	0.3	0.4	0.4	2.7	6.4	0.1	0.4	0.0	2.7	23.7	0.6	2.6	0.3	34.3	0.7	0.1	0.7	0.2	0.0	0.0	0.3	0.0	6.2	0.2	0.6	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.2	0.1	1.8	5.1	0.6	0.0	3.0	0.0	0.1	19.1	5.7	1.0	1.6	0.2	0.0	2.7	0.5	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	5.6	5.0	0.3	0.0	0.0	1.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.1	30.2	0.0	0.8	0.3
ZNF497	FLJ44773	ENSG00000174586	"Zinc finger protein 497"	Q6ZNH5	19	58354357-58362848	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 6.0;Ciliated cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 17.5"									HPA047872	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA047872: AB_2680196"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.24e-1)"	0.8	2.3	3.3	2.8	5.5	2.3	5.0	7.5	6.2	3.3	1.7	3.1	3.0	2.0	4.1	3.7	3.6	9.1	3.1	2.0	7.2	3.3	3.7	5.0	3.2	3.8	2.0	4.5	4.5	6.0	3.8	5.9	1.8	5.8	3.2	1.2	1.4	7.7	1.9	0.8	4.6	3.1	0.6	3.5	3.6	2.8	2.3	0.6	2.5	4.9	2.0	1.5	1.4	2.1	4.7	4.8	2.3	2.8	2.1	4.8	1.9	1.7	5.9	5.3	5.1	0.2	0.1	7.1	3.2	0.0	0.0	0.0	0.4	1.9	3.4	1.7	0.0	3.0	0.8	0.6	0.4	0.0	3.6	17.5	3.1	1.6	1.0	0.3	1.2	8.2	0.4	0.8	0.1	0.6	5.9	0.0	8.6	2.5	0.5	0.1	6.0	4.3	4.4	3.3	1.4	1.8	10.7	3.9	1.8	0.5	1.4	4.1	5.9	1.7	5.2	2.9	2.8	7.1	3.5	0.5	5.9	3.1	0.5	1.0	7.7	9.1	3.0	1.6	3.5	3.2	2.3	2.8	0.9	2.4	1.1	2.6	3.8	2.8	2.9	2.7	4.7	2.9	4.8	1.0	2.1	0.9	4.8	3.1	1.9	3.3	5.5	7.5	4.2	7.2	3.3	2.0	4.5	5.8	0.6	6.0	0.3	0.0	0.4	0.2	1.4	0.6	0.0	5.3	1.2	0.0	0.0	1.7	1.7	1.1	1.0	0.3	0.4	0.0	0.2	0.4	0.2	0.2	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	1.1	0.4	0.3	0.0	0.7	1.5	0.0	0.0	0.0	1.1	0.3	0.2	0.0	1.2	0.0
ZNF501	"MGC21738, ZNF52"	ENSG00000186446	"Zinc finger protein 501"	Q96CX3	3	44729596-44737083	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 9.5;Spermatogonia: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.7"					"Low region specificity"	"Detected in all"			HPA044161	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044161: AB_2678841"	"unprognostic (8.89e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.02e-2)"	5.6	2.8	6.8	3.6	8.3	1.3	8.5	11.7	8.0	7.0	6.2	7.5	4.7	2.6	7.5	4.0	4.7	7.3	4.5	5.6	7.3	4.8	5.0	2.3	4.7	6.8	5.9	6.7	10.0	5.3	2.7	5.7	5.9	4.9	8.1	4.1	3.6	4.9	7.3	5.3	4.4	3.6	8.0	6.3	4.9	4.4	6.7	9.8	4.2	6.6	3.4	4.3	7.2	7.2	3.4	1.1	2.9	1.1	2.7	3.5	1.2	0.0	0.0	2.1	0.0	3.9	6.7	0.8	2.4	2.2	2.6	3.0	0.9	0.9	1.8	0.0	1.1	1.9	0.7	0.0	0.9	2.5	0.0	1.2	0.0	0.2	1.7	5.4	0.0	0.0	3.9	2.5	2.9	0.2	0.8	1.6	0.0	0.0	0.0	0.8	0.0	0.8	0.1	4.9	1.1	0.0	1.3	0.0	1.0	2.2	1.4	2.6	1.7	1.4	1.5	1.0	4.1	0.1	0.1	1.0	0.1	2.3	2.4	1.9	4.2	2.6	0.0	0.1	0.0	3.1	2.0	0.7	2.9	2.4	0.9	3.3	2.9	2.3	2.6	1.1	3.4	3.5	2.4	1.1	2.7	1.1	1.0	2.3	1.2	6.8	8.3	11.7	8.0	7.3	4.8	5.9	6.7	4.9	9.8	0.0	0.3	0.0	1.7	0.8	2.9	2.0	0.0	1.4	2.3	3.5	2.0	1.5	0.0	2.1	0.6	2.1	0.5	0.0	1.7	1.5	2.5	0.9	0.0	0.8	1.4	9.5	1.2	1.8	1.8	1.3	1.4	0.8	0.0	1.0	0.7	7.0	1.7	0.0	1.4	1.0	3.2	6.5	1.9	4.8	10.2	1.4	0.2	1.7	0.9	0.7
ZNF503	"FLJ45745, MGC2555, Nlz2"	ENSG00000165655	"Zinc finger protein 503"	Q96F45	10	75397830-75401906	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Smooth muscle cells: 105.0"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.6;myeloid DC: 1.4"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.4;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 39.0;PC-3: 50.6;U-87 MG: 15.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026848	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA026848: AB_10610704"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.63e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.63e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.97e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	9.4	23.1	2.3	6.2	7.2	2.2	14.1	0.8	4.7	47.8	10.2	3.0	20.8	9.0	28.1	15.1	27.8	14.1	15.3	5.8	3.4	3.0	22.1	5.7	16.5	2.6	4.8	1.5	38.1	19.4	4.0	3.0	4.8	7.5	21.3	2.5	18.5	6.4	50.7	2.9	3.2	6.6	10.1	8.0	7.6	9.4	7.3	2.9	0.5	7.7	8.5	3.7	14.4	25.0	0.0	1.4	0.0	1.6	0.0	0.0	0.1	1.7	1.6	0.3	2.1	3.7	2.5	0.5	1.6	0.9	0.6	0.6	2.5	6.9	0.0	4.6	1.5	0.3	3.1	0.2	1.6	0.4	0.0	39.0	0.0	4.2	8.1	2.9	2.0	4.4	6.7	1.6	1.2	0.7	5.7	0.1	0.2	0.0	0.0	0.9	0.8	0.0	6.1	0.0	1.2	50.6	0.0	1.9	0.0	0.9	1.3	1.4	1.8	2.8	0.2	8.4	0.3	0.3	1.4	1.3	5.1	5.8	10.5	4.2	0.0	0.0	0.0	15.7	9.0	4.0	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.3	7.2	0.8	3.6	3.4	3.0	4.8	1.5	7.5	2.9	35.7	12.3	2.2	37.9	24.2	18.3	13.2	7.6	0.0	9.1	38.4	19.6	0.5	49.7	39.4	0.0	21.8	0.8	23.3	30.0	0.4	30.7	20.3	5.8	8.9	12.0	6.4	3.5	39.9	27.3	1.1	55.3	16.3	23.6	5.4	6.1	5.6	32.4	0.0	46.3	28.3	21.2	38.8	105.0	0.2	2.4	12.2	0.2	0.0	7.2	12.7
ZNF510	KIAA0972	ENSG00000081386	"Zinc finger protein 510"	Q9Y2H8	9	96755865-96778129	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049139	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA049139: AB_2680651"	"unprognostic (2.70e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.18e-2)"	9.1	9.2	10.9	6.5	15.7	5.7	12.7	23.0	13.9	14.4	8.8	6.3	11.6	4.6	11.5	8.1	7.9	10.7	6.5	7.4	11.5	10.3	8.9	8.5	8.4	11.4	8.6	12.3	14.9	10.7	13.5	19.8	6.9	10.1	12.6	9.3	5.2	7.5	11.2	9.2	6.2	6.8	11.3	9.2	10.1	6.8	8.2	9.1	14.9	11.2	4.3	13.3	13.9	10.7	5.9	1.3	3.8	2.9	6.4	7.7	2.1	5.1	5.2	11.5	8.5	9.8	9.2	5.9	5.8	11.4	9.7	8.6	4.9	3.8	6.7	3.1	6.1	9.5	11.2	3.3	5.4	8.7	10.7	5.5	9.4	9.7	2.5	5.8	3.6	6.2	7.9	7.2	8.3	10.4	9.1	9.3	12.9	9.6	6.5	9.4	4.6	10.4	4.8	8.1	7.5	5.3	6.8	18.8	3.3	5.1	4.9	11.9	9.5	11.2	5.2	5.7	8.4	3.8	6.8	8.2	6.2	5.9	7.0	6.7	11.4	12.0	4.9	3.5	2.5	6.2	2.3	1.2	3.8	3.8	1.9	7.7	3.6	5.0	3.0	1.0	5.9	5.7	5.2	0.4	6.4	2.9	1.3	7.1	2.1	10.9	15.7	23.0	13.9	11.5	10.3	8.6	12.3	10.1	9.1	3.0	2.7	2.0	1.4	1.4	10.5	4.4	0.0	4.0	3.4	3.5	2.0	2.0	1.7	1.9	5.0	2.7	1.0	0.0	2.3	1.2	1.7	1.4	1.1	1.0	1.7	15.9	1.2	5.5	3.4	5.6	5.5	2.2	5.0	1.0	1.8	3.8	1.3	1.7	3.9	1.5	7.0	6.5	1.4	3.2	4.9	1.3	0.7	3.2	1.4	1.0
ZNF511	MGC30006	ENSG00000198546	"Zinc finger protein 511"	Q8NB15	10	133308475-133313162	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA035360	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"	"Intracellular and membrane"	NA	NA			"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA035360: AB_10601931"	"unprognostic (3.35e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.52e-2)"	11.4	11.2	10.1	13.2	10.3	14.8	20.5	16.9	11.0	12.0	18.3	8.7	17.1	8.2	16.8	13.2	13.1	15.4	11.7	20.6	9.4	7.7	13.8	21.2	11.4	16.4	9.6	8.7	21.2	30.1	9.9	13.6	9.7	8.2	17.4	10.9	11.4	17.3	13.6	25.9	9.3	19.1	15.5	8.8	12.7	12.1	21.3	10.8	12.3	16.0	23.2	11.9	12.2	16.8	21.5	19.3	21.6	18.9	12.8	15.6	15.3	11.2	13.0	7.3	9.0	7.6	6.4	6.9	6.4	10.6	15.4	13.0	21.3	11.6	14.1	5.3	7.2	9.4	10.3	11.5	9.9	6.0	9.6	32.7	7.3	5.8	10.8	6.1	13.2	10.6	6.3	5.4	11.7	5.5	8.6	6.9	5.6	11.4	3.9	5.3	18.4	3.8	16.9	7.9	9.2	24.2	6.3	9.5	2.9	7.8	4.1	4.3	6.9	5.3	5.9	7.6	4.3	5.0	7.5	6.7	6.4	6.3	5.5	15.3	5.0	7.6	16.3	7.6	6.3	2.5	10.6	18.9	21.6	14.3	14.9	11.8	21.5	12.5	15.6	18.9	14.7	14.4	13.5	2.9	12.8	14.7	19.3	10.4	15.3	10.1	10.3	16.9	11.0	9.4	7.7	9.6	8.7	8.2	10.8	14.9	12.6	26.7	38.9	26.3	19.5	20.6	22.9	17.4	13.6	21.0	7.9	51.6	59.7	31.3	18.3	19.9	31.6	0.0	35.6	53.1	31.6	36.6	77.2	44.5	43.0	20.6	51.3	13.5	23.5	4.5	38.6	44.9	15.1	70.3	85.0	25.5	31.4	45.6	28.7	56.4	18.9	25.8	29.9	56.3	46.2	31.5	23.6	29.9	64.1	35.3
ZNF512	KIAA1805	ENSG00000243943	"Zinc finger protein 512"	Q96ME7	2	27582969-27623215	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031430	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031430: AB_10603844"	"prognostic favorable (9.79e-4)"	"unprognostic (4.19e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (7.75e-3)"	"prognostic favorable (5.08e-9)"	"unprognostic (6.08e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (1.10e-2)"	"unprognostic (8.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-2)"	"unprognostic (5.60e-3)"	11.0	12.8	12.0	13.3	19.9	5.2	15.6	18.5	22.4	18.1	14.8	20.4	12.1	7.4	23.7	14.7	9.9	20.8	12.3	12.0	11.0	14.3	12.1	6.7	12.9	14.5	12.1	15.4	33.7	8.1	28.0	27.6	12.1	18.8	17.8	11.7	18.7	11.3	19.1	7.2	6.8	12.5	17.4	14.2	15.0	11.0	12.0	11.6	21.3	19.6	6.6	15.8	17.2	14.0	9.6	6.3	14.6	5.2	17.0	14.6	8.5	11.6	10.3	21.4	9.5	10.6	12.1	0.0	5.8	8.2	11.0	13.0	7.9	7.4	10.2	6.5	6.6	9.1	4.0	18.9	5.4	11.7	9.4	15.2	21.3	8.4	12.0	8.2	13.8	9.7	11.0	6.0	8.5	2.5	8.8	17.4	17.9	18.4	7.5	16.1	1.4	1.4	10.6	14.8	7.7	0.0	23.2	30.2	8.8	7.8	3.2	21.0	20.9	5.5	3.5	16.2	10.7	4.3	8.0	14.3	3.9	9.4	3.9	7.5	7.6	5.3	17.6	5.8	17.3	7.9	14.6	4.2	7.3	8.7	5.2	11.7	9.6	10.9	12.4	6.3	8.0	14.6	12.2	1.2	17.0	4.1	4.5	7.5	8.5	12.0	19.9	18.5	22.4	11.0	14.3	12.1	15.4	18.8	11.6	8.9	13.9	9.3	8.3	3.4	20.9	14.5	7.6	9.4	9.1	17.4	15.7	1.4	8.3	5.9	8.4	10.5	1.8	0.0	1.6	0.9	8.0	7.3	5.8	3.9	4.5	17.5	8.6	11.6	6.0	5.4	13.8	5.5	1.7	4.6	5.5	16.6	3.2	0.0	16.3	2.9	13.9	19.4	11.7	8.9	7.9	2.6	1.0	8.2	4.9	6.7
ZNF514	FLJ14457	ENSG00000144026	"Zinc finger protein 514"	Q96K75	2	95147330-95165413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028974	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA028974: AB_10603845"	"unprognostic (8.79e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-2)"	7.1	7.6	7.8	5.1	16.4	1.7	12.7	14.9	12.9	10.4	10.5	15.7	12.0	9.4	15.0	27.1	8.1	11.5	6.7	8.4	14.2	8.4	9.8	5.0	8.4	7.0	17.0	9.9	20.6	9.6	12.5	23.5	7.9	11.5	12.1	9.6	10.1	11.5	11.6	12.0	11.6	9.4	10.6	12.5	8.9	10.0	19.8	18.0	14.0	15.2	10.3	7.8	8.9	10.9	7.7	5.2	10.4	5.3	6.4	11.3	5.5	13.4	4.7	12.5	8.4	9.4	12.6	9.7	5.3	5.7	8.6	9.2	7.0	5.0	2.1	2.7	5.7	14.3	8.2	6.6	4.9	9.8	4.4	8.8	2.5	6.3	5.7	4.0	1.4	6.8	7.7	15.1	5.4	3.8	13.5	4.2	7.6	6.9	2.4	6.7	6.4	3.6	6.8	4.2	4.4	4.7	6.5	4.4	4.7	5.8	5.7	11.7	8.5	5.6	2.7	5.7	19.1	5.2	5.0	4.4	6.2	8.5	2.0	4.3	7.1	5.2	3.5	6.8	2.8	4.1	10.4	5.3	9.9	5.1	2.6	6.1	7.3	6.8	4.8	5.2	7.7	11.3	9.2	1.5	6.4	3.0	4.1	7.1	5.5	7.8	16.4	14.9	12.9	14.2	8.4	17.0	9.9	11.5	18.0	8.9	6.4	7.8	7.3	4.9	14.3	11.4	17.8	8.1	4.5	0.0	17.7	5.3	23.2	5.3	34.4	8.3	5.3	0.0	4.5	3.0	5.6	9.3	1.1	6.4	6.8	14.3	9.2	7.4	3.5	34.3	9.8	3.8	6.8	3.6	10.1	11.8	4.6	3.5	7.1	15.0	34.1	6.5	4.1	12.2	10.6	5.5	3.1	6.9	6.8	9.5
ZNF516	"HsT287, KIAA0222"	ENSG00000101493	"Zinc finger protein 516"	Q92618	18	76358190-76495190	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"THP-1: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015792	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA015792: AB_1859314"	"prognostic favorable (7.09e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.63e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	4.2	5.4	8.3	5.7	9.9	15.1	4.7	2.0	4.8	20.8	5.9	4.5	18.6	4.1	25.2	8.0	6.3	15.8	3.9	3.5	5.1	2.9	3.4	5.1	5.0	4.2	4.7	3.9	17.0	4.6	8.7	10.8	2.6	6.4	7.3	1.8	13.1	6.4	13.3	8.6	6.3	4.1	9.1	3.3	6.3	4.5	18.6	4.6	3.0	4.8	4.0	4.9	8.0	10.9	0.4	1.6	12.2	2.2	1.0	0.6	0.4	1.5	1.7	12.4	16.3	3.7	5.5	1.5	9.4	7.9	2.0	3.8	3.5	5.7	8.1	2.0	10.0	5.1	3.3	6.8	9.0	1.4	0.0	5.3	0.7	0.0	7.6	9.1	5.3	5.4	10.4	4.1	4.3	4.5	2.8	2.3	3.4	0.0	0.0	2.0	3.2	0.1	9.5	6.2	1.0	0.4	3.5	1.3	4.1	3.2	7.0	12.5	7.7	0.1	0.0	10.1	5.2	2.0	21.7	1.5	4.7	8.2	0.1	0.9	0.0	0.2	6.2	2.8	3.7	12.0	2.7	2.2	3.0	0.1	1.5	0.6	0.1	0.2	0.1	1.6	0.4	0.6	0.3	12.2	1.0	1.6	1.0	0.0	0.4	8.3	9.9	2.0	4.8	5.1	2.9	4.7	3.9	6.4	4.6	8.9	8.5	3.9	14.0	17.3	14.8	7.6	7.6	9.4	2.3	1.8	29.5	0.2	3.3	4.9	69.3	9.0	5.2	0.0	2.5	0.3	10.2	10.7	1.1	11.3	7.1	3.2	12.1	8.0	20.3	27.6	28.1	14.9	11.8	8.2	5.4	6.5	4.5	5.3	32.9	4.4	29.5	12.9	17.3	3.4	33.4	17.7	0.5	2.9	3.5	17.5
ZNF517		ENSG00000197363	"Zinc finger protein 517"	Q6ZMY9	8	144798876-144811169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 14.0"									HPA055337			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055337: AB_2682788"	"unprognostic (9.54e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.57e-2)"	2.9	6.5	5.3	3.1	4.5	1.5	8.5	7.3	8.6	3.3	3.0	2.7	5.3	3.6	5.6	3.1	3.2	4.1	3.2	5.8	6.8	3.2	3.9	3.2	4.6	6.5	5.6	6.1	7.5	3.8	4.5	3.9	4.4	4.2	3.7	0.5	5.4	6.9	1.9	9.6	10.5	4.5	1.4	4.1	4.3	3.6	3.6	4.4	3.0	4.1	1.4	1.4	4.1	2.8	4.1	1.1	0.5	2.4	1.4	2.2	1.2	2.1	3.9	6.6	6.4	1.0	2.0	3.4	1.9	0.5	0.4	0.3	1.3	2.3	1.2	4.6	0.6	2.8	2.1	0.3	0.7	0.9	4.6	1.7	2.7	2.1	14.0	2.5	0.6	2.8	1.4	1.7	0.3	1.3	3.7	1.5	3.4	3.1	1.8	1.1	3.4	2.7	1.6	4.6	4.2	4.4	3.9	2.0	0.9	0.6	2.6	2.9	8.4	5.3	2.1	2.0	3.4	5.4	2.4	1.8	4.4	6.9	2.3	1.9	3.0	0.5	0.8	4.8	1.1	3.6	0.4	1.2	0.0	1.8	2.4	1.5	4.1	1.7	1.2	1.1	0.7	1.4	1.2	0.5	1.4	1.4	0.5	2.2	1.2	5.3	4.5	7.3	8.6	6.8	3.2	5.6	6.1	4.2	4.4	0.0	0.3	0.0	5.0	0.5	3.6	2.8	5.1	0.0	1.2	0.0	7.9	0.6	1.7	0.8	1.2	1.1	1.0	0.0	0.4	0.5	0.8	1.2	0.0	1.7	1.3	3.2	1.2	3.1	1.6	0.0	0.9	1.3	0.0	0.0	1.0	2.3	0.7	0.0	1.1	2.2	3.7	0.0	1.4	3.0	2.6	1.0	0.3	1.0	0.8	4.4
ZNF518A	"KIAA0335, ZNF518"	ENSG00000177853	"Zinc finger protein 518A"	Q6AHZ1	10	96129715-96205288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029049			Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA029049: AB_2672885"	"unprognostic (1.48e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.16e-3)"	3.5	2.8	4.8	4.6	5.9	6.1	6.9	7.1	5.6	5.7	6.4	6.5	5.9	4.4	6.0	7.7	3.8	4.0	4.4	2.8	4.1		6.1	4.0	4.2	4.9	8.1	4.5	7.3	4.8	5.0	15.1	5.8	7.7	5.6	6.6	4.6	3.4	4.2	2.2	5.3	8.7	5.6	7.1	5.0	6.1	15.0	5.5	12.2	7.3	3.9	5.4	4.0	4.2	4.4	4.8	11.0	7.9	3.9	5.6	2.3	2.8	6.4	7.2	0.0	3.7	4.2	8.7	3.0	1.7	3.3	3.4	6.0	6.9	10.4	2.9	1.9	4.7	4.1	8.2	2.9	3.0	4.8	4.4	15.6	2.2	9.8	3.2	16.9	9.5	2.7	7.1	3.4	5.6	2.4	3.9	12.3	13.3	7.0	3.2	2.8	9.9	10.3	11.1	3.1	0.4	11.2	8.2	4.2	3.9	5.8	2.1	5.1	4.2	4.0	3.1	12.5	4.8	10.8	2.5	1.6	6.1	2.1	3.2	6.5	16.4	6.1	1.1	13.0	1.6	11.0	4.5	5.4	3.2	4.8	5.1	4.4	3.9	3.2	2.8	4.1	5.6	3.8	4.5	3.9	7.9	4.8	4.0	2.3											53.6	26.2	21.5	15.3	0.0	58.9	23.0	20.4	18.7	27.3	38.4	41.2	35.7	16.6	19.5	13.8	17.3	38.1	0.0	22.4	24.4	8.2	20.6	9.2	25.2	24.3	71.5	58.8	36.2	28.9	11.8	32.5	31.3	0.0	13.6	31.2	37.1	25.4	45.6	23.7	14.8	61.0	19.4	12.2	64.6	88.8	0.0	36.6	27.7	30.2	15.4
ZNF518B	KIAA1729	ENSG00000178163	"Zinc finger protein 518B"	Q9C0D4	4	10439874-10457410	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031215, HPA031216"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031215: AB_10600200, HPA031216: AB_10601449"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.89e-3)"	11.2	9.6	9.4	10.5	12.2	6.1	12.9	16.0	13.2	11.4	10.3	6.0	9.6	6.4	10.4	11.4	7.7	8.3	7.8	11.0	9.3	9.9	6.2	4.2	7.5	12.6	7.5	7.6	15.8	5.7	10.5	12.7	13.1	8.3	12.7	5.4	9.3	12.1	13.5	12.1	6.5	11.4	10.0	6.4	11.1	7.9	15.1	4.7	19.5	14.1	7.3	14.8	10.7	11.5	9.5	4.5	11.8	5.3	6.8	4.8	2.3	4.9	3.4	13.2	3.8	1.7	2.6	0.0	5.8	1.4	3.6	4.3	0.0	0.0	0.0	5.9	8.4	10.2	0.1	3.0	6.4	8.0	0.0	5.5	16.0	0.0	0.0	7.7	0.0	7.1	7.5	3.8	5.7	0.0	7.4	12.2	12.0	17.2	0.0	2.9	0.0	10.8	0.4	12.8	2.5	7.7	9.3	5.6	1.8	0.1	7.0	9.9	2.9	2.7	0.0	1.8	11.0	2.1	4.3	9.2	0.0	12.1	0.0	5.4	6.8	5.0	9.4	0.7	0.9	0.7	2.8	2.5	11.8	2.9	2.6	3.8	9.5	4.6	3.3	4.5	5.2	4.8	4.4	6.5	6.8	5.3	1.5	3.4	2.3	9.4	12.2	16.0	13.2	9.3	9.9	7.5	7.6	8.3	4.7	3.0	4.6	4.2	17.0	14.2	9.2	23.8	5.1	5.3	10.3	0.0	9.8	7.9	3.3	2.4	10.3	12.6	4.2	0.0	3.3	7.4	6.7	17.5	16.1	1.6	7.7	11.1	1.2	9.2	8.2	15.2	15.0	5.0	1.7	4.6	2.7	8.3	1.9	2.9	20.1	1.0	10.6	0.0	6.2	12.3	8.3	12.4	7.7	5.7	3.0	15.8
ZNF519	"FLJ36809, HsT2362"	ENSG00000175322	"Zinc finger protein 519"	Q8TB69	18	14057457-14132490	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 14.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA028982	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA028982: AB_10610705"	"unprognostic (1.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.65e-4)"	1.8	1.4	2.8	1.9	7.6	1.4	2.8	13.7	14.4	5.7	4.6	0.7	0.8	1.2	7.0	2.6	3.4	4.5	1.8	1.9	3.4	1.6	0.8	1.0	2.7	6.6	1.7	4.0	8.7	1.2	1.1	1.5	1.2	3.0	2.6	2.6	2.0	1.6	2.7	1.0	2.0	2.1	6.0	2.1	2.2	1.4	3.0	2.5	1.1	2.0	0.9	1.9	4.3	3.8	1.7	0.1	0.0	0.6	0.5	3.5	0.7	1.3	0.3	6.0	6.3	0.8	1.2	1.6	1.6	0.9	3.5	3.2	2.7	1.2	3.1	1.7	1.2	1.6	1.0	4.9	1.2	4.1	1.9	3.3	5.5	1.8	1.1	0.2	11.3	2.4	0.6	1.6	2.9	1.2	1.0	0.6	4.7	2.7	4.7	2.0	1.8	6.9	4.4	2.7	3.5	1.4	7.4	5.8	3.9	0.9	1.9	9.3	2.5	2.3	0.8	1.8	4.0	0.7	3.1	0.4	5.7	7.6	2.5	1.8	1.8	1.2	4.5	1.8	4.4	4.7	0.0	0.3	0.0	1.1	0.6	1.8	1.7	1.4	1.5	0.1	0.8	3.5	2.2	0.0	0.5	0.5	0.1	2.0	0.7	2.8	7.6	13.7	14.4	3.4	1.6	1.7	4.0	3.0	2.5	6.0	7.4	4.2	2.4	1.8	14.4	4.4	2.5	2.7	1.2	0.0	2.0	2.3	1.7	2.0	0.7	2.1	0.1	0.0	1.7	3.5	3.9	1.2	3.5	0.8	1.5	3.2	1.2	3.7	2.4	1.1	6.1	1.8	1.7	1.0	1.3	5.0	0.8	0.0	8.5	0.6	6.8	0.0	2.2	6.9	11.5	1.1	0.7	4.4	2.5	1.4
ZNF521	"EHZF, Evi3"	ENSG00000198795	"Zinc finger protein 521"	Q96K83	18	25061926-25352190	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.1"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 27.9;Endothelial cells: 22.4;Horizontal cells: 14.3;Ito cells: 14.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 69.1"	"Group enriched"	"Detected in some"	5	"basophil: 8.8;plasmacytoid DC: 9.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 9.8;granulocytes: 8.8"	"Cell line enhanced"	"Detected in many"		"AF22: 32.0;fHDF/TERT166: 15.0;HUVEC TERT2: 21.9;THP-1: 17.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 105.4"	"HPA023056, HPA023849"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023056: AB_1859315, HPA023849: AB_1859316"	"unprognostic (8.80e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.52e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.82e-4)"	9.2	11.3	5.2	2.8	7.0	1.9	9.1	69.1	11.5	11.0	3.4	9.1	4.7	1.7	19.8	5.9	3.8	9.0	10.0	7.0	5.8	5.1	3.1	1.2	6.4	4.0	8.4	2.8	20.5	1.4	1.4	16.8	8.0	12.2	4.4	3.5	6.7	8.7	3.0	3.8	4.6	3.2	13.3	12.2	18.5	2.4	3.4	8.9	0.5	5.3	6.9	2.6	7.4	5.4	0.0	9.8	8.8	0.1	1.7	0.0	0.1	0.0	0.0	32.0	0.0	5.1	9.0	0.1	4.6	6.7	1.6	1.0	0.0	0.0	0.0	0.0	15.0	0.0	0.1	0.0	0.0	1.3	0.0	1.9	6.3	0.3	0.2	0.9	0.0	9.6	11.1	0.0	0.1	0.0	0.0	21.9	7.6	0.1	0.0	2.8	0.0	4.1	0.0	2.2	0.0	0.0	0.0	7.2	0.5	0.0	0.0	4.1	2.6	0.4	0.0	0.0	3.0	0.0	17.8	12.4	12.7	1.0	3.7	0.7	0.0	0.0	0.1	4.8	0.0	10.4	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	9.8	0.0	0.1	5.2	7.0	69.1	4.3	5.8	5.1	8.4	2.8	12.2	8.9	0.0	4.8	0.0	0.1	3.3	27.9	9.1	0.0	2.7	1.2	0.0	2.0	0.0	0.0	0.0	1.6	22.4	0.0	0.0	0.0	0.0	7.2	0.2	12.7	0.0	0.1	14.3	1.2	14.1	1.6	3.6	9.2	0.9	13.5	0.0	0.0	0.7	0.0	0.0	7.4	3.1	2.7	0.0	3.3	0.1	1.5	3.9	0.1	0.0	0.0	0.1
ZNF524	MGC23143	ENSG00000171443	"Zinc finger protein 524"	Q96C55	19	55600022-55603138	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA050981	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050981: AB_2681298"	"unprognostic (6.69e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.59e-2)"	"prognostic favorable (4.98e-8)"	10.4	7.9	7.9	9.9	8.2	9.4	36.6	6.9	10.3	7.1	10.9	5.5	15.8	15.8	7.9	13.6	12.8	8.7	16.2	9.6	7.5	4.4	8.4	10.8	10.5	14.1	12.2	4.8	7.1	31.4	5.4	7.8	5.4	7.5	10.6	4.5	4.5	22.9	13.8	32.1	13.8	12.3	6.4	8.1	11.8	13.3	4.0	9.5	7.9	12.9	12.1	5.9	8.4	16.5	13.2	16.5	16.4	21.2	10.1	19.1	12.4	8.7	8.8	1.3	6.1	4.0	8.5	10.0	5.7	3.4	3.7	3.7	2.6	10.2	4.5	3.3	3.2	2.1	7.1	0.8	4.3	0.5	13.2	22.3	5.4	4.9	4.6	10.0	3.4	7.0	7.0	10.3	3.0	3.1	3.8	6.8	5.8	5.0	9.2	1.9	5.1	3.4	7.5	1.5	8.5	10.0	4.5	3.1	13.3	4.7	5.0	6.2	3.9	5.6	8.1	6.3	1.1	3.8	11.6	5.8	3.1	5.4	6.0	7.4	4.0	4.7	2.1	8.6	9.0	4.2	11.5	21.2	16.4	12.7	18.3	11.7	11.6	13.2	12.2	16.5	13.2	15.8	8.6	13.4	10.1	12.1	5.1	19.1	12.4	7.9	8.2	6.9	10.3	7.5	4.4	12.2	4.8	7.5	9.5	6.0	13.1	16.6	18.3	22.3	9.0	9.6	15.3	5.3	5.7	7.0	5.9	18.6	14.9	22.8	2.1	23.4	69.5	0.0	45.9	15.9	12.5	14.5	10.3	20.3	34.9	6.4	22.4	33.7	61.7	3.6	16.7	26.7	28.7	19.0	48.1	7.2	32.4	49.5	20.5	25.8	6.4	19.4	15.1	0.9	4.1	31.1	21.4	30.8	43.9	16.6
ZNF526	"KIAA1951, MGC4267"	ENSG00000167625	"Zinc finger protein 526"	Q8TF50	19	42220271-42228201	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 41.9;Club cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023070, HPA056609"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA023070: AB_2671057, HPA056609: AB_2683189"	"unprognostic (2.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.84e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.30e-1)"	10.1	7.0	5.9	12.3	9.1	8.5	8.5	14.5	10.0	10.6	8.5	8.6	9.2	8.3	12.2	6.4	8.4	9.3	5.0	6.8	7.5	4.3	7.0	7.6	7.3	9.1	8.7	6.6	12.0	9.0	10.1	11.7	8.6	6.2	9.9	5.6	7.5	11.1	9.1	11.7	13.0	10.1	6.3	4.6	9.1	7.9	11.6	8.1	13.8	7.6	6.1	11.5	9.0	10.3	6.9	6.1	2.5	7.1	4.5	10.7	4.3	7.1	23.3	6.9	6.1	7.9	7.6	6.0	8.4	7.8	8.9	9.8	12.2	5.2	11.7	6.1	8.9	4.0	5.3	7.3	9.1	5.6	6.9	8.7	11.7	10.9	11.7	7.3	7.4	7.6	7.5	7.4	8.9	9.3	5.5	5.5	6.3	11.1	7.4	5.6	10.0	7.4	4.8	4.5	6.3	8.4	8.7	8.4	5.2	4.0	13.1	7.0	6.2	9.6	9.7	7.0	5.5	3.9	13.3	7.4	11.0	7.6	4.6	10.5	9.0	5.3	8.1	7.3	7.3	9.1	2.5	5.1	1.9	7.0	5.4	10.7	6.9	5.5	6.3	4.2	6.7	6.7	8.3	1.2	4.5	7.1	6.1	5.4	4.3	5.9	9.1	14.5	10.0	7.5	4.3	8.7	6.6	6.2	8.1	20.8	41.9	6.4	4.0	4.8	7.6	2.0	0.0	14.7	28.4	3.5	13.7	6.4	3.3	3.3	4.6	4.7	4.7	0.0	2.4	7.0	4.1	2.5	23.3	3.2	3.9	6.4	13.2	4.3	4.7	5.5	6.6	4.6	0.0	4.6	5.0	3.3	2.6	3.5	2.8	2.4	8.7	0.0	4.2	5.8	9.8	4.4	8.6	5.0	4.9	2.1
ZNF527	KIAA1829	ENSG00000189164	"Zinc finger protein 527"	Q8NB42	19	37371061-37393066	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 11.8;Rod photoreceptor cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA037740, HPA037741"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA037740: AB_10672284, HPA037741: AB_2675642"	"unprognostic (4.36e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.26e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.05e-4)"	"unprognostic (8.34e-3)"	"unprognostic (8.92e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.17e-4)"	6.0	6.3	6.7	4.7	10.2	6.6	8.5	10.2	13.0	7.8	6.8	9.3	2.7	3.4	9.6	6.0	5.5	6.1	4.3	7.1	8.0	5.7	7.3	5.9	5.2	7.2	6.8	9.1	10.8	6.4	10.2	13.5	5.4	9.8	6.9	7.4	8.2	5.8	7.6	10.1	5.0	5.0	9.5	5.8	6.7	5.1	7.2	7.5	6.7	7.6	4.8	7.3	6.9	7.2	6.3	2.6	6.8	2.5	4.7	6.8	3.9	3.9	4.4	4.0	4.8	4.1	6.9	2.4	4.0	3.6	4.1	5.2	3.6	1.0	3.6	5.0	3.8	3.4	1.1	6.9	3.6	5.0	6.8	2.7	4.4	4.7	0.9	4.8	7.2	4.8	4.9	4.0	4.7	8.2	4.3	3.6	6.1	1.8	2.5	4.4	1.4	5.6	1.6	2.3	4.8	1.5	4.6	6.1	4.9	2.6	3.8	5.1	2.7	6.4	2.0	2.0	4.0	4.7	4.9	5.1	5.1	4.4	3.8	4.6	7.3	9.3	10.5	0.0	5.0	3.3	2.7	1.6	6.8	6.5	2.5	5.5	6.3	4.0	5.9	2.6	5.4	6.4	6.8	0.8	4.7	1.4	2.4	4.2	3.9	6.7	10.2	10.2	13.0	8.0	5.7	6.8	9.1	9.8	7.5	8.9	7.4	0.5	1.7	2.4	6.4	7.2	2.5	4.0	3.4	0.0	11.8	1.9	3.3	1.4	1.0	2.5	1.1	0.0	1.4	1.1	2.2	1.6	1.1	1.8	1.4	6.4	1.2	3.1	0.6	0.8	2.3	1.6	0.0	1.0	2.0	3.6	0.4	0.0	1.4	2.1	10.6	0.0	2.5	5.0	3.4	1.4	1.7	1.8	1.7	1.1
ZNF528	KIAA1827	ENSG00000167555	"Zinc finger protein 528"	Q3MIS6	19	52397849-52418412	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 24.5;U-266/84: 30.9"									HPA065435			Approved	"Nuclear speckles,Cytosol"		No	No			"Nuclear speckles"	Cytosol	"HPA065435: "	"unprognostic (1.90e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.26e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-3)"	9.8	11.7	16.6	8.9	20.2	5.8	12.2	21.1	21.4	12.4	9.1	15.7	7.9	5.5	15.3	21.7	10.0	15.6	11.4	11.4	15.3	11.2	11.1	5.2	9.3	9.3	17.5	11.4	21.3	6.4	12.7	21.0	10.9	15.3	13.4	10.0	13.3	12.8	12.1	7.6	12.6	7.5	9.8	15.6	11.8	10.0	13.8	22.0	8.2	19.9	5.1	11.5	12.6	10.8	10.5	8.4	10.6	5.0	16.5	12.7	3.4	0.1	0.0	2.9	17.7	6.9	8.5	7.5	6.6	10.9	4.0	9.0	0.2	3.3	0.1	1.6	8.1	10.3	2.0	0.0	4.3	5.2	0.0	4.9	2.7	1.0	1.6	10.1	0.1	7.4	8.6	7.6	4.4	0.0	1.2	9.6	0.1	1.7	0.3	5.8	0.1	9.9	1.4	7.7	0.1	4.7	0.1	12.0	3.1	5.0	24.5	12.3	10.2	0.0	0.5	4.1	11.1	11.8	1.5	11.0	7.0	8.1	2.7	8.9	0.3	30.9	6.0	3.5	0.1	10.9	7.1	5.0	10.6	6.7	4.7	12.7	7.3	8.1	10.0	5.0	10.5	8.0	7.1	1.4	16.5	5.0	8.4	8.9	3.4	16.6	20.2	21.1	21.4	15.3	11.2	17.5	11.4	15.3	22.0	6.0	2.7	2.7	3.5	3.3	18.7	10.9	5.1	10.7	6.8	1.8	13.7	3.5	3.3	4.1	1.1	7.5	2.6	0.0	1.7	4.0	3.0	6.9	8.1	1.0	3.1	20.6	1.2	4.9	3.2	2.9	4.6	4.7	1.7	0.0	4.9	14.1	5.0	7.0	3.9	3.1	21.5	0.0	3.9	13.0	10.4	2.8	2.6	9.6	3.4	3.8
ZNF529	KIAA1615	ENSG00000186020	"Zinc finger protein 529"	Q6P280	19	36534774-36605276	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA031311	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031311: AB_10604158"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.84e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.61e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.39e-5)"	9.0	11.8	13.8	11.6	22.4	15.9	12.4	22.6	18.3	9.5	7.6	16.0	8.1	6.5	14.4	12.7	6.2	13.3	8.5	11.7	13.4	12.2	7.1	8.1	9.2	13.4	20.4	16.5	15.5	6.1	17.0	17.2	10.3	16.0	10.5	7.1	9.0	6.9	8.1	8.5	13.7	8.0	10.2	16.9	11.4	7.1	16.7	18.4	15.3	12.2	3.7	12.4	7.4	8.6	5.3	2.7	6.3	2.1	3.9	6.3	2.4	3.7	7.6	10.6	12.3	6.3	7.7	4.8	5.7	3.5	3.7	7.9	3.8	2.9	9.1	7.7	5.2	4.0	1.7	8.6	3.4	6.5	13.0	9.4	11.8	5.1	2.6	7.3	8.9	7.1	8.6	5.6	4.6	7.6	6.2	3.0	7.4	5.2	0.7	7.6	1.2	9.5	3.4	7.6	0.1	2.9	2.8	7.6	4.9	3.4	8.4	5.3	10.6	7.5	3.1	2.8	5.0	3.6	6.5	5.6	8.0	5.2	5.1	6.9	12.6	6.3	8.9	0.2	3.0	5.2	6.3	2.1	2.6	4.4	1.4	6.3	5.3	5.0	4.9	2.2	4.9	5.7	4.5	1.0	3.9	1.4	2.7	5.6	2.4	13.8	22.4	22.6	18.3	13.4	12.2	20.4	16.5	16.0	18.4	3.0	3.5	6.5	4.7	8.8	19.0	14.3	2.5	5.3	6.8	7.0	23.6	2.9	5.0	3.0	3.4	6.8	1.4	23.3	1.4	2.5	6.2	5.9	2.3	6.8	3.3	71.5	2.9	5.5	2.6	1.4	6.1	5.3	5.0	0.0	3.2	8.2	1.9	2.9	6.3	3.4	22.6	0.0	7.5	14.9	10.5	8.0	2.7	10.0	2.5	5.5
ZNF530	KIAA1508	ENSG00000183647	"Zinc finger protein 530"	Q6P9A1	19	57599885-57612722	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 7.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEK 293: 37.8;U-266/84: 27.5"									HPA045868	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA045868: AB_2679478"	"unprognostic (1.57e-1)"	"unprognostic (3.02e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.19e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-1)"	3.2	3.5	6.3	4.7	6.9	7.0	4.4	12.4	7.1	2.5	2.6	2.6	1.4	2.7	2.9	5.3	2.3	2.0	3.1	11.0	5.1	4.4	3.2	2.3	4.6	7.6	5.8	4.0	2.4	4.1	3.2	2.0	3.4	3.3	4.0	2.3	4.5	3.7	3.9	14.6	4.7	2.6	2.1	4.1	5.4	4.6	3.6	3.5	7.2	2.5	2.7	5.6	3.6	2.5	6.5	3.6	3.5	3.1	5.6	6.5	3.4	3.2	3.0	2.2	1.8	0.1	1.0	3.4	2.0	0.8	3.4	2.0	2.1	0.5	0.4	1.7	0.7	2.1	1.1	1.8	1.5	3.7	0.1	37.8	6.5	5.5	1.2	0.3	2.3	3.1	0.7	0.8	3.2	0.9	1.0	0.7	2.4	0.8	1.6	1.1	1.2	3.3	1.8	3.3	0.2	7.2	0.4	6.9	3.2	0.6	5.6	2.5	2.3	2.4	0.6	0.6	2.0	1.5	3.7	1.0	4.4	2.7	0.9	4.1	7.5	27.5	4.5	2.7	2.6	3.0	1.9	3.1	1.8	6.3	1.9	5.0	6.5	4.3	6.5	3.6	5.8	5.9	4.8	3.5	5.6	2.1	3.5	5.6	3.4	6.3	6.9	12.4	7.1	5.1	4.4	5.8	4.0	3.3	3.5	6.0	1.0	0.0	0.5	1.5	2.9	7.3	2.5	0.0	0.0	0.0	0.0	1.4	1.7	1.7	0.2	2.2	0.4	0.0	2.5	1.1	1.2	1.2	2.3	0.6	1.6	0.0	0.0	1.3	0.3	0.0	0.9	1.1	5.0	1.0	0.0	5.8	1.0	1.1	1.4	0.5	4.3	6.5	1.4	2.3	2.9	1.5	1.1	1.5	0.8	0.8
ZNF532	FLJ10697	ENSG00000074657	"Zinc finger protein 532"	Q9HCE3	18	58862600-58986480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Glandular cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 40.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015322	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015322: AB_2304947"	"unprognostic (3.43e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (4.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (5.76e-4)"	12.3	7.0	14.3	8.0	17.1	0.6	11.4	44.6	22.5	17.5	12.3	23.7	11.6	3.7	35.5	11.2	12.3	15.0	13.1	18.6	14.7	11.9	7.2	2.3	10.4	7.8	14.2	13.4	29.6	4.2	14.5	18.2	13.7	15.0	27.1	7.2	14.5	7.8	19.6	29.5	8.8	6.1	22.5	18.9	8.5	7.1	12.5	17.2	2.5	13.6	7.0	8.9	13.0	19.8	6.7	1.4	0.0	2.2	0.4	1.0	0.7	6.9	9.8	40.7	21.4	6.7	15.0	2.0	12.9	12.0	8.8	8.0	3.4	7.6	8.5	9.9	15.7	4.6	11.5	0.3	9.4	8.8	6.3	8.5	0.0	14.7	0.2	8.9	0.0	0.0	11.6	18.4	9.2	16.9	12.2	9.9	0.0	0.1	10.7	10.4	0.0	0.0	0.1	21.5	0.3	6.3	0.2	10.5	1.4	6.1	0.9	9.2	24.5	8.4	0.9	14.2	29.0	10.3	5.7	7.3	24.0	17.9	0.1	10.1	0.1	7.1	2.3	8.6	0.0	18.4	0.0	0.4	0.0	1.0	2.2	0.3	6.7	0.5	0.5	1.4	3.6	0.1	0.3	0.0	0.4	0.3	0.2	0.0	0.7	14.3	17.1	44.6	21.4	14.7	11.9	14.2	13.4	15.0	17.2	11.9	9.8	8.2	10.0	9.4	31.7	13.7	10.2	9.4	10.3	1.8	25.5	1.7	0.0	4.5	3.4	21.0	0.0	0.0	0.4	1.7	15.8	38.3	0.0	0.0	3.8	33.4	4.1	17.8	8.8	2.8	10.6	10.9	8.5	3.6	0.0	23.3	3.8	0.3	17.0	1.4	8.5	12.9	15.6	2.3	21.3	8.2	2.9	2.5	0.3	10.3
ZNF536	KIAA0390	ENSG00000198597	"Zinc finger protein 536"	O15090	19	30228290-30713538	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 44.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 29.2;Horizontal cells: 66.7;Muller glia cells: 58.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.0;HAP1: 8.9;SH-SY5Y: 24.4;U-937: 5.9;WM-115: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077341			Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA077341: AB_2732340"	"unprognostic (1.98e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.68e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.46e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.45e-1)"	1.1	6.0	9.9	2.0	21.0	0.6	0.8	14.3	24.1	4.2	4.0	44.5	0.0	2.7	1.7	1.3	6.9	1.0	1.3	2.9	13.3	7.7	0.8	0.7	1.0	0.7	20.9	9.6	0.9	0.9	0.7	3.4	0.7	18.3	3.7	4.1	4.8	1.6	2.4	1.4	1.2	4.2	1.2	23.1	1.5	2.1	5.0	18.4	0.0	6.9	0.0	0.7	2.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	8.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	24.4	0.0	0.0	1.6	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	5.9	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	21.0	14.3	15.1	13.3	7.7	20.9	9.6	18.3	18.4	0.0	0.0	0.0	0.1	0.3	29.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.5	66.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	9.5	0.0	1.9	0.3	0.4	0.3	0.0	0.0	0.0	0.1
ZNF540	DKFZp547B0714	ENSG00000171817	"Zinc finger protein 540"	Q8NDQ6	19	37551406-37614097	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"pituitary gland: 30.7"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 23.5;Early spermatids: 14.0;Horizontal cells: 17.5;Rod photoreceptor cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 6.8"									HPA003444	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA003444: AB_1080732"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-4)"	"unprognostic (4.24e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.88e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (8.08e-2)"	"unprognostic (8.33e-5)"	2.8	9.3	8.6	3.9	29.9	1.2	6.0	23.7	16.7	5.8	4.4	5.0	5.3	3.9	6.0	9.4	3.0	4.2	3.6	9.1	8.6	12.1	6.3	2.6	5.0	6.3	9.0	9.1	13.8	3.8	13.3	30.7	2.3	11.0	7.1	3.6	9.0	6.1	8.9	2.9	6.0	4.5	3.8	7.9	6.3	4.6	11.5	9.5	2.7	14.4	3.1	6.0	3.4	4.0	3.1	0.3	1.2	0.1	3.0	7.1	1.8	0.4	0.0	2.6	2.6	6.8	4.1	0.2	0.9	0.9	1.1	2.1	0.2	0.0	1.2	0.3	2.4	0.6	1.0	1.8	0.9	0.9	3.7	2.6	0.9	1.2	0.0	1.8	1.2	2.0	1.8	2.4	0.7	0.0	0.5	0.1	5.1	0.4	0.0	1.6	0.1	1.7	0.7	0.9	0.3	0.5	1.4	1.6	0.8	0.6	0.4	2.7	3.0	1.0	0.3	0.3	1.9	1.3	0.7	0.0	1.0	3.1	1.2	0.9	3.6	2.0	2.5	0.0	0.4	0.6	0.0	0.0	1.2	3.9	0.1	3.9	2.9	4.1	4.4	0.1	3.1	6.8	7.1	0.2	3.0	0.0	0.3	4.2	1.8	8.6	29.9	23.7	16.7	8.6	12.1	9.0	9.1	11.0	9.5	3.0	1.6	0.8	1.1	1.4	23.5	8.7	0.0	0.0	2.3	1.8	5.9	0.2	6.6	0.1	14.0	0.9	0.4	0.0	0.4	0.3	0.9	0.4	3.5	0.8	0.7	17.5	0.0	2.5	0.3	4.3	2.3	0.9	3.3	0.0	0.0	5.2	0.3	0.0	5.3	2.1	19.7	6.5	3.3	4.4	2.7	1.1	0.1	3.5	0.2	0.0
ZNF541	DKFZp434I1930	ENSG00000118156	"Zinc finger protein 541"	Q9H0D2	19	47520685-47555856	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 17.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 18.8;Late spermatids: 8.5;Proximal tubular cells: 10.3;Spermatocytes: 28.8;Spermatogonia: 9.8"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.7"					"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"HEL: 3.1;SiHa: 10.2;U-87 MG: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058541, HPA076453"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA058541: AB_2683748, HPA076453: AB_2732310"	"unprognostic (4.49e-2)"	"prognostic favorable (2.94e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.92e-5)"	"unprognostic (7.98e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-2)"	1.2	2.6	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.4			0.1	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.9	0.0	0.1	0.1	0.0		2.2	0.0	0.0	0.4	0.3		0.0	0.0		0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.5	0.0	17.7			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.1	0.0	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	1.0	0.3	0.0	0.2	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	1.1	1.5	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	18.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	8.5	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.3	0.8	0.0	0.0	28.8	9.8	0.1	0.0	0.0	0.0	0.0
ZNF543	DKFZp434H055	ENSG00000178229	"Zinc finger protein 543"	Q08ER8	19	57320509-57330776	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA046330			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046330: "	"unprognostic (9.20e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.71e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.84e-2)"	6.2	6.0	6.6	4.0	10.1	5.0	8.0	18.1	10.3	5.7	5.3	7.4	7.1	2.3	6.5	5.4	7.7	6.9	4.7	5.2	7.0	4.0	5.1	3.9	5.1	6.5	8.4	5.8	14.8	5.7	10.0	10.8	8.1	7.2	6.4	3.5	7.5	6.8	7.3	6.7	8.9	4.8	6.2	7.7	7.2	4.9	11.0	8.0	15.8	7.9	2.4	8.0	6.5	5.1	6.4	3.6	7.3	3.5	5.2	5.6	3.5	3.3	4.5	4.2	6.6	3.7	3.3	5.1	2.0	3.6	3.8	6.8	1.4	2.0	5.4	2.8	2.7	2.5	1.9	3.6	3.7	5.0	2.4	9.7	5.2	4.7	4.1	4.1	5.0	3.5	3.6	3.9	3.0	6.3	3.2	2.9	6.3	2.8	1.0	2.8	0.4	5.8	1.6	3.8	0.3	3.5	5.5	6.4	5.7	2.5	8.2	7.8	5.5	5.7	2.3	3.9	3.9	2.8	4.7	2.8	5.6	4.0	1.1	3.7	8.1	5.3	6.2	2.7	2.3	2.9	2.2	3.4	7.3	3.8	3.2	4.9	6.0	4.1	5.6	3.6	6.4	5.0	4.9	3.6	5.2	3.5	2.4	2.1	3.5	6.6	10.1	18.1	10.3	7.0	4.0	8.4	5.8	7.2	8.0	3.0	0.3	0.5	1.1	2.4	4.2	1.4	2.5	0.0	2.3	0.0	5.9	2.4	5.0	1.4	12.4	2.9	0.2	0.0	0.4	1.2	0.9	1.6	2.3	1.0	1.3	6.4	0.0	1.3	0.6	8.6	1.4	2.0	1.7	0.0	1.3	3.9	0.2	0.0	2.1	0.6	4.9	6.5	1.4	2.3	1.9	2.3	1.8	1.8	1.1	1.3
ZNF544	AF020591	ENSG00000198131	"Zinc finger protein 544"	Q6NX49	19	58228594-58277495	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 52.3"					"Low region specificity"	"Detected in all"			HPA002732	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA002732: AB_1080735"	"unprognostic (5.28e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (3.61e-3)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (4.94e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.49e-1)"	7.0	10.2	14.0	12.7	12.9	6.8	12.8	20.6	14.4	11.7	8.0	10.7	5.4	4.3	18.3	31.2	10.8	20.1	9.4	13.9	12.0	12.2	10.2	7.3	7.2	9.7	12.6	13.7	12.6	12.1	22.8	19.1	9.9	11.1	10.1	8.5	16.2	8.7	9.6	3.7	11.7	7.4	10.4	13.0	10.2	8.8	19.6	12.0	13.9	16.5	8.9	12.0	10.4	7.9	11.7	8.4	12.5	3.8	14.4	11.1	5.4	15.5	6.1	4.2	4.7	4.5	7.7	10.3	7.4	3.4	14.1	9.9	5.3	6.8	20.7	3.6	8.8	0.0	5.3	5.1	16.3	19.8	9.6	52.3	15.8	12.2	2.5	12.5	9.5	12.7	5.3	24.2	9.6	26.8	13.5	12.4	0.1	8.9	0.0	8.2	4.9	19.9	6.6	9.7	3.3	2.9	6.9	4.7	16.0	9.6	24.5	23.0	0.0	8.9	4.5	3.2	7.7	6.5	6.9	10.4	2.6	9.2	2.7	8.4	18.1	35.3	0.0	0.0	0.0	6.4	2.3	2.3	12.5	7.6	3.8	7.0	9.3	6.8	9.6	5.3	11.7	8.3	11.1	2.8	14.4	0.9	8.4	5.5	5.4	14.0	12.9	20.6	14.4	12.0	12.2	12.6	13.7	11.1	12.0	6.0	9.9	20.6	9.3	5.3	24.8	10.6	17.8	16.0	20.5	7.0	43.2	13.7	16.6	6.3	33.3	7.2	4.7	0.0	3.8	8.6	5.8	10.4	10.4	6.6	11.2	20.6	11.1	7.4	4.6	46.6	5.2	5.1	8.5	1.8	5.7	18.3	6.7	0.0	3.5	6.8	35.7	19.4	5.1	46.0	26.2	6.8	9.8	12.2	7.6	10.1
ZNF546	"MGC43537, ZNF49"	ENSG00000187187	"Zinc finger protein 546"	Q86UE3	19	39984134-40021041	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 25.9;Spermatocytes: 50.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA030838			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030838: AB_10603332"	"unprognostic (4.38e-6)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.58e-5)"	4.1	5.1	5.0	3.7	7.1	2.5	4.7	7.9	6.6	4.2	3.6	7.6	7.3	2.0	6.3	3.8	2.8	5.7	2.9	4.9	4.7	3.8	4.8	5.5	3.2	3.8	7.9	4.4	7.3	3.7	6.5	8.5	3.1	6.8	4.6	2.7	5.2	2.9	6.1	5.6	3.8	3.4	5.3	8.3	5.4	3.1	20.8	7.9	6.6	6.0	2.8	4.4	3.6	3.3	2.7	2.8	2.6	2.4	2.5	4.7	1.2	0.2	4.6	2.0	2.6	4.7	3.4	0.3	1.8	2.8	2.2	3.0	0.2	0.6	2.5	2.1	1.6	1.2	0.2	1.0	0.3	3.3	2.6	3.3	3.2	3.2	1.7	2.5	3.2	2.2	2.7	2.0	1.3	3.5	2.8	2.8	4.5	4.0	6.1	2.3	0.6	1.5	0.7	0.7	0.3	0.6	1.8	1.7	1.2	1.1	0.4	1.4	1.5	1.0	0.2	1.8	2.7	0.9	1.4	1.1	0.7	1.5	0.3	1.4	4.6	4.4	0.5	1.7	1.3	1.4	1.6	1.5	2.6	3.7	2.4	2.5	2.7	2.4	2.2	2.8	2.4	4.7	4.1	1.1	2.5	1.2	0.7	3.0	1.2	5.0	7.1	7.9	6.6	4.7	3.8	7.9	4.4	6.8	7.9	0.0	5.8	1.9	0.7	0.5	8.2	5.1	2.5	5.3	1.2	3.5	11.8	1.0	1.7	1.0	25.9	2.9	0.3	0.0	0.4	0.1	1.3	0.7	0.0	2.9	1.6	1.6	0.0	5.5	2.1	4.8	4.0	1.8	0.0	0.0	0.0	5.6	0.5	0.0	3.9	3.1	9.1	0.0	1.2	50.8	2.6	0.0	0.2	1.3	0.8	0.6
ZNF548	FLJ32932	ENSG00000188785	"Zinc finger protein 548"	Q8NEK5	19	57389850-57402992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 33.1"									HPA066042	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA066042: AB_2685602"	"prognostic favorable (7.85e-4)"	"unprognostic (4.61e-2)"	"unprognostic (5.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (5.85e-2)"	18.6	9.2	11.0	17.0	18.1	26.8	17.5	27.5	16.3	9.7	13.1	13.2	7.4	7.5	14.3	12.7	11.0	14.3	13.4	16.0	9.2	7.0	9.6	9.5	16.1	24.0	12.9	10.7	18.6	8.1	14.5	14.0	10.6	11.5	13.1	10.3	14.1	10.5	10.1	13.5	12.8	19.6	16.1	9.1	23.6	10.6	9.8	10.4	13.5	14.6	9.8	20.4	12.2	11.5	10.2	4.9	3.4	3.3	7.3	9.7	3.8	5.6	5.1	10.1	7.1	5.3	5.8	1.9	4.5	7.0	6.9	13.2	1.1	14.4	5.6	2.9	4.5	4.5	2.3	4.1	5.2	7.6	2.8	13.3	5.9	33.1	6.5	4.2	6.5	12.0	6.7	7.3	6.7	10.4	6.6	3.5	11.6	0.3	0.0	6.0	1.5	10.2	2.2	2.7	0.2	5.7	11.7	10.9	8.0	3.9	10.1	6.0	7.2	6.2	2.6	3.2	8.8	5.9	5.6	5.4	8.1	7.6	2.7	7.3	13.9	9.2	8.4	5.7	3.4	8.1	2.2	2.4	3.4	6.8	2.6	9.7	6.6	6.3	8.4	4.9	10.2	9.1	9.5	2.1	7.3	3.3	4.1	9.3	3.8	11.0	18.1	27.5	16.3	9.2	7.0	12.9	10.7	11.5	10.4	3.0	7.0	7.2	4.9	6.0	4.6	4.5	10.2	5.3	3.4	7.0	5.9	3.6	3.3	3.6	7.4	9.0	2.1	0.0	2.1	2.3	4.4	3.1	9.2	6.4	3.6	1.6	5.8	10.4	4.1	3.4	5.2	2.8	0.0	2.8	3.4	5.7	2.5	0.0	3.9	2.4	9.1	0.0	8.1	11.6	5.7	5.0	3.7	7.5	2.1	1.7
ZNF549	FLJ34917	ENSG00000121406	"Zinc finger protein 549"	Q6P9A3	19	57527325-57557542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 13.4"	"Group enriched"	"Detected in all"	4	"B-cells: 4.7;NK-cells: 13.4;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 16.5"									HPA039511	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039511: AB_10671998"	"unprognostic (6.27e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.01e-4)"	"unprognostic (4.03e-3)"	"unprognostic (2.51e-8)"	"unprognostic (2.88e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.89e-3)"	"unprognostic (9.11e-3)"	4.7	6.2	7.3	11.8	11.0	5.9	9.3	18.8	10.3	5.2	5.8	8.0	4.0	3.6	7.2	7.7	3.9	8.0	6.9	5.4	9.0	6.2	5.6	2.6	7.6	8.8	9.5	7.0	11.2	4.5	12.5	13.8	6.9	7.0	8.3	4.4	6.5	5.6	6.7	5.4	7.3	6.1	7.3	10.6	9.9	5.2	7.2	8.5	11.2	9.1	3.0	9.7	6.5	11.6	4.7	1.8	1.8	1.2	13.4	5.8	2.1	1.4	1.8	7.4	6.1	2.2	1.8	1.8	3.4	4.2	3.4	16.5	1.9	1.3	2.0	2.5	3.1	4.2	0.8	2.3	5.0	5.6	0.2	13.6	9.2	1.4	2.8	3.2	7.6	6.5	3.3	3.9	3.4	4.8	4.9	2.1	5.3	0.1	0.3	6.1	0.8	8.5	3.2	6.3	0.2	4.9	6.1	6.1	4.1	1.3	3.5	3.0	5.3	0.1	0.5	4.0	6.6	4.1	6.0	1.8	6.5	4.5	0.3	5.0	3.5	10.1	6.4	1.1	2.6	5.9	0.7	1.0	1.8	3.0	0.8	4.1	2.7	4.1	4.6	1.8	4.7	5.8	3.7	0.8	13.4	1.2	1.6	2.4	2.1	7.3	11.0	18.8	10.3	9.0	6.2	9.5	7.0	7.0	8.5	0.0	3.2	2.7	1.0	1.4	8.6	2.7	5.1	8.1	0.0	1.8	13.7	1.4	3.3	1.2	0.4	2.9	0.4	0.0	0.6	0.7	2.1	1.4	5.8	0.6	1.3	7.9	3.5	4.9	1.6	0.0	2.8	1.1	5.0	0.0	0.3	4.1	0.6	1.5	2.1	0.6	14.6	6.5	1.4	0.7	3.8	1.4	0.9	2.9	0.8	0.9
ZNF550	MGC41917	ENSG00000251369	"Zinc finger protein 550"	Q7Z398	19	57535257-57559863	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003251	Uncertain		Approved	Vesicles,Microtubules		NA	NA			Vesicles	Microtubules	"HPA003251: AB_1080736"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.52e-1)"	8.7	6.8	8.7	10.5	11.1	7.1	10.2	15.0	10.6	10.1	6.0	8.9	10.0	4.4	10.1	8.1	6.4	8.7	5.6	9.2	8.6	5.5	6.2	6.2	6.6	11.7	10.2	4.6	16.8	7.7	12.5	16.6	10.9	9.1	11.0	5.0	6.5	9.2	8.1	14.2	10.7	8.6	8.4	7.2	12.2	5.9	6.4	9.6	12.8	8.6	4.0	11.6	9.4	7.3	4.7	2.9	2.7	2.4	6.9	9.4	3.3	3.3	2.6	6.7	6.5	2.7	5.6	0.0	4.5	4.1	4.1	2.0	2.7	3.2	1.1	3.2	3.2	3.4	3.0	3.6	4.0	5.2	0.1	18.7	8.6	7.5	3.6	3.8	7.9	3.6	4.9	3.3	3.3	10.1	6.0	3.3	8.7	1.4	0.1	5.0	0.7	11.5	3.4	7.5	1.0	4.9	9.6	7.6	9.1	2.4	5.7	6.5	8.6	5.7	3.8	3.2	5.4	4.4	5.5	3.6	5.9	3.7	2.1	4.7	18.9	16.8	8.0	2.2	4.8	5.1	1.7	2.2	2.7	5.7	2.4	6.7	3.5	6.9	3.8	2.9	4.7	9.4	5.8	0.6	6.9	1.0	1.3	5.9	3.3	8.7	11.1	15.0	10.6	8.6	5.5	10.2	4.6	9.1	9.6	0.0	1.4	3.2	3.6	4.5	4.7	4.7	2.5	6.7	4.5	0.0	5.9	3.6	1.7	2.4	0.8	4.4	0.4	0.0	1.0	2.3	2.8	4.9	4.7	3.0	1.9	11.1	3.5	4.3	3.4	0.2	4.4	1.5	3.3	1.0	2.5	2.7	1.8	0.0	0.7	0.6	4.9	0.0	2.3	3.9	4.3	5.9	4.3	6.5	2.3	3.1
ZNF551	DKFZp686H1038	ENSG00000204519	"Zinc finger protein 551"	Q7Z340	19	57681969-57717301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.4"	"Low region specificity"	"Detected in all"							HPA038187			Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA038187: AB_2675884"	"unprognostic (1.96e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.68e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.83e-3)"	"prognostic favorable (1.32e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.54e-1)"	6.6	5.6	4.4	8.3	6.9	12.8	7.9	17.3	5.2	5.2	5.1	6.8	8.6	4.2	6.3	5.9	5.3	5.9	6.1	4.9	4.9	4.6	5.1	3.2	3.8	10.8	3.8	3.3	6.8	10.7	6.1	11.3	5.3	4.9	6.0	5.1	6.4	6.0	5.8	8.8	7.3	5.6	6.8	4.0	8.2	5.1	18.1	5.7	13.0	11.1	5.2	10.3	6.4	6.0	6.6	4.7	2.1	3.1	4.7	8.1	3.8	2.6	5.9	7.3	5.3	1.4	1.7	7.8	3.2	2.3	4.5	2.1	5.0	2.6	4.8	2.1	2.4	3.3	3.0	4.9	7.3	7.1	0.0	21.4	8.5	0.2	2.2	1.3	6.0	7.8	3.0	2.8	4.6	4.2	2.6	1.8	5.1	5.8	0.0	4.0	2.5	12.3	2.4	15.4	5.1	9.6	7.8	12.7	6.4	1.8	15.4	7.1	5.9	4.8	3.1	2.5	7.3	3.9	7.9	2.2	5.2	5.4	1.7	6.0	5.3	11.3	11.0	1.0	3.0	4.9	1.9	2.1	2.1	3.3	3.1	6.2	6.6	4.9	5.2	4.7	5.5	8.1	7.3	1.1	4.7	1.6	3.8	3.9	3.8	4.4	6.9	17.3	5.2	4.9	4.6	3.8	3.3	4.9	5.7	6.0	3.8	2.2	5.2	4.6	7.5	1.2	2.5	6.7	9.1	1.8	7.9	3.4	1.7	2.7	9.6	2.0	1.6	0.0	0.9	2.4	1.9	2.9	1.1	1.7	2.3	3.2	2.4	2.5	2.4	2.7	3.1	2.1	1.7	0.0	3.3	4.0	1.4	0.0	4.6	0.6	14.6	0.0	1.3	7.0	14.0	6.1	2.4	3.3	4.1	7.9
ZNF556	FLJ11637	ENSG00000172000	"Zinc finger protein 556"	Q9HAH1	19	2867335-2883445	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.6;brain: 22.3;ovary: 11.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 12.2;Ciliated cells: 8.1;Club cells: 9.1;granulocytes: 7.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	16	"cerebellum: 22.3"	"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 14.6"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 14.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.2;HBEC3-KT: 7.7;Hep G2: 12.1;RH-30: 18.0;THP-1: 6.5"									HPA060593			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060593: AB_2684328"	"unprognostic (1.36e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.23e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.54e-3)"	0.3	0.2	0.5	0.3	0.5	1.0	0.5	22.3	0.5	0.7	0.3	0.0	1.7	0.1	1.6	0.7	3.1	4.2	0.8	0.2	0.4	0.3	2.6	0.1	0.4	0.3	0.4	0.1	11.3	2.6	0.4	1.6	0.8	1.3	0.4	0.1	0.1	1.0	0.1	4.5	0.7	0.2	0.3	0.5	0.3	0.3	3.5	0.0	0.6	0.2	8.7	0.9	0.2	0.2	0.4	14.6	1.2	0.2	0.6	0.2	0.1	1.9	0.3	0.0	3.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.2	0.1	2.4	1.2	0.1	0.0	0.1	0.0	7.7	0.0	0.1	0.0	0.1	3.2	12.1	0.1	0.2	3.8	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	2.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	18.0	1.5	0.0	0.3	0.1	2.9	0.0	0.3	0.0	0.1	3.7	6.5	0.0	0.1	0.1	4.7	0.1	2.1	3.9	0.1	0.2	0.1	0.1	1.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.2	0.6	0.1	14.6	0.1	0.1	0.5	0.5	22.3	0.5	0.4	0.3	0.4	0.1	1.3	0.0	3.0	12.2	0.0	2.3	0.3	2.2	0.4	0.0	8.1	9.1	3.5	2.0	0.4	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.2	0.5	1.5	7.0	0.0	0.2	3.2	0.0	1.3	1.2	0.0	0.6	1.4	0.0	0.0	0.0	0.8	0.1	0.0	0.4	0.6	4.6	0.0	0.5	5.6	4.7	0.1	0.2	0.8	0.0	1.6
ZNF557	MGC4054	ENSG00000130544	"Zinc finger protein 557"	Q8N988	19	7069444-7087968	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003151, HPA029291"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No			"Nucleoplasm, Intermediate filaments"	Cytosol	"HPA003151: AB_1859344, HPA029291: AB_10602357"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (2.56e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.51e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.81e-3)"	6.8	9.2	7.2	8.1	9.4	13.1	8.5	12.4	9.9	7.0	6.5	11.1	7.2	5.1	9.5	7.7	8.7	8.5	6.0	5.5	5.9	5.6	6.9	10.3	6.8	9.7	7.6	8.1	9.8	9.0	7.0	12.9	6.7	9.2	7.5	6.4	7.2	9.2	10.5	5.3	7.2	7.6	7.6	6.7	11.7	8.0	8.4	9.8	21.7	9.0	4.0	11.3	7.0	7.1	10.7	11.1	9.3	6.7	13.7	11.5	4.0	3.6	4.4	4.1	8.4	6.3	4.7	3.4	3.9	5.0	5.1	6.9	5.1	2.5	7.1	6.9	4.8	3.6	5.0	8.0	5.1	4.8	9.1	4.9	10.2	7.9	2.7	4.5	10.3	10.9	6.2	6.0	5.6	7.6	4.5	4.7	6.6	4.2	12.8	7.5	5.3	7.9	3.1	3.9	3.9	6.2	5.6	6.1	4.2	3.2	9.5	4.8	5.9	5.8	4.3	4.4	3.9	3.5	6.3	7.0	4.4	3.3	8.6	4.1	12.2	9.3	6.8	4.9	5.5	3.5	9.3	6.7	8.6	9.5	5.5	10.6	7.6	10.3	8.6	7.2	10.7	11.5	9.6	7.4	13.7	5.2	11.1	9.3	4.0	7.2	9.4	12.4	9.9	5.9	5.6	7.6	8.1	9.2	9.8	3.0	4.1	8.8	5.9	1.3	8.3	4.5	2.5	5.3	7.9	7.0	0.0	5.2	13.3	6.0	0.8	5.3	4.5	23.3	5.4	3.8	4.0	5.1	8.1	4.0	5.3	15.9	5.2	7.4	7.3	0.0	4.0	6.4	0.0	4.6	6.6	5.2	5.0	3.7	5.3	6.7	6.4	0.0	4.8	15.9	16.4	1.1	4.8	6.4	5.1	6.4
ZNF559	MGC13105	ENSG00000188321	"Zinc finger protein 559"	Q9BR84	19	9323772-9351162	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA059632, HPA065485"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA059632: AB_2684089, HPA065485: AB_2685497"	"unprognostic (1.35e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (6.99e-4)"	"unprognostic (7.28e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	9.3	11.1	17.7	8.4	16.2	2.7	14.1	39.5	16.1	13.6	10.4	17.2	11.4	5.1	18.8	18.8	5.9	17.3	8.2	11.9	14.2	8.2	11.2	7.5	10.4	11.8	17.6	15.5	24.0	7.6	22.1	29.2	9.8	16.2	13.6	9.3	11.2	8.3	11.4	3.3	8.7	9.8	16.3	16.2	14.9	8.8	13.7	19.8	10.7	14.0	3.4	10.3	10.2	11.3	12.5	5.3	18.9	4.3	14.2	15.8	6.2	8.7	4.7	9.3	11.3	5.5	5.0	2.4	5.3	11.0	8.0	6.8	2.3	1.0	7.1	6.3	7.7	10.9	3.1	5.6	5.0	10.2	11.4	7.5	9.6	7.8	3.1	9.8	8.4	10.6	10.5	9.1	9.0	11.2	6.8	6.7	10.7	7.0	25.2	5.0	0.0	11.4	26.6	15.1	1.5	7.8	5.6	11.3	9.6	4.9	12.3	10.5	8.8	10.4	1.7	12.5	14.2	7.5	6.4	5.6	14.7	3.3	12.0	8.0	2.0	0.0	6.9	2.6	5.3	9.2	18.9	3.4	7.5	9.1	3.2	12.0	11.9	9.6	9.6	5.3	12.5	15.8	12.7	1.9	14.2	4.3	4.4	8.4	6.2	17.7	16.2	39.5	16.1	14.2	8.2	17.6	15.5	16.2	19.8	3.0	3.5	6.2	5.8	3.4	26.6	7.1	10.2	6.7	3.4	3.5	25.5	5.9	1.7	5.9	7.0	10.5	1.7	0.0	2.7	3.8	8.9	4.1	2.3	2.1	4.2	25.4	2.9	12.3	3.8	1.8	11.8	5.7	3.3	5.4	3.7	25.1	2.8	2.9	12.7	2.4	27.1	6.5	11.3	15.7	34.5	2.6	2.4	10.1	3.8	2.2
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466507-9498607	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"testis: 21.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 48.7"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8"									"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA045439: AB_2732520, HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.4	2.6	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.8	2.4	0.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	1.0	17.9	0.0	0.0	1.3	0.0	4.4	2.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	11.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.0	8.3	0.0	0.0	0.0	0.0	0.0
ZNF561	MGC45408	ENSG00000171469	"Zinc finger protein 561"	Q8N587	19	9604680-9621399	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055332: AB_2682786, HPA062397: AB_2684751"	"unprognostic (6.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.63e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (9.21e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.27e-3)"	"unprognostic (2.85e-3)"	11.7	11.7	7.5	9.1	8.8	7.7	14.6	11.2	8.2	14.5	11.5	10.4	21.9	6.6	18.6	14.9	21.5	16.3	11.1	9.1	7.0	6.4	11.3	10.7	10.8	13.4	9.6	6.2	18.1	16.9	13.1	18.3	8.8	7.4	19.2	11.4	9.6	13.3	15.9	10.3	15.7	10.6	22.2	8.5	10.4	11.6	7.7	11.7	16.4	20.6	11.7	12.2	26.1	14.3	7.2	6.6	9.3	8.5	2.7	10.9	5.7	7.6	3.0	17.0	13.3	14.8	17.6	15.3	10.0	13.4	12.5	14.2	5.6	3.4	6.8	7.4	9.9	7.3	4.3	11.4	19.2	13.1	9.5	12.1	8.6	6.4	9.7	8.6	11.3	8.7	11.3	30.3	9.3	12.2	20.0	15.7	5.0	9.9	9.2	15.6	3.6	4.8	11.9	14.1	6.4	9.6	5.7	8.5	7.4	11.4	28.1	10.9	11.0	0.2	6.2	7.8	17.3	7.9	7.5	4.9	13.6	4.7	9.6	9.7	11.2	15.7	9.4	6.7	2.9	9.1	5.0	8.5	9.3	8.5	8.2	10.9	4.8	6.6	7.6	6.6	7.2	9.6	7.2	5.5	2.7	4.2	5.9	6.3	5.7	7.5	8.8	11.2	8.2	7.0	6.4	9.6	6.2	7.4	11.7	0.0	6.5	5.1	21.6	12.2	9.2	9.0	7.6	28.1	9.1	14.0	5.9	6.9	3.3	10.1	5.2	7.1	6.9	0.0	5.7	6.5	5.6	10.8	7.0	6.4	9.6	9.5	10.9	10.4	10.3	5.2	10.6	7.0	3.3	5.4	6.7	6.0	7.4	7.0	12.4	6.8	11.0	6.5	5.6	7.2	9.8	19.6	5.4	7.5	6.8	25.5
ZNF562	FLJ20079	ENSG00000171466	"Zinc finger protein 562"	Q6V9R5	19	9641808-9675086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055332: AB_2682786, HPA062397: AB_2684751"	"unprognostic (2.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (4.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.13e-3)"	12.3	11.2	13.9	11.3	15.8	11.6	21.4	20.5	15.2	11.8	15.0	13.5	20.9	9.8	14.6	10.9	26.1	12.0	12.1	11.4	13.4	10.9	11.1	12.2	12.9	10.2	14.9	11.9	13.7	15.5	13.8	22.6	11.1	14.3	13.1	15.0	9.0	15.7	23.4	7.0	12.9	10.6	15.1	16.1	14.0	11.5	6.3	16.8	10.9	11.8	9.4	13.3	16.6	14.5	6.4	8.5	5.5	9.6	6.5	7.9	2.6	8.3	6.6	9.7	17.8	5.8	4.7	0.5	7.9	6.1	8.8	9.1	4.9	4.6	7.5	8.2	6.3	7.5	6.4	11.7	9.7	11.6	8.8	9.2	27.6	6.7	5.1	5.8	10.1	20.6	8.3	7.2	11.1	18.5	5.5	9.3	6.8	13.3	13.4	8.3	4.2	10.0	3.0	12.4	5.5	4.7	3.9	10.6	3.9	4.1	22.2	10.6	6.9	12.8	5.2	6.3	7.9	7.5	8.5	8.7	16.5	5.6	7.5	10.6	11.8	25.9	12.7	2.3	0.6	8.1	4.1	6.2	5.5	7.0	9.6	7.9	6.3	5.6	4.3	8.5	6.4	5.8	7.1	2.4	6.5	9.2	5.1	4.0	2.6	13.9	15.8	20.5	15.2	13.4	10.9	14.9	11.9	14.3	16.8	8.9	21.0	11.3	31.2	5.7	30.2	7.8	22.9	6.7	18.2	24.4	68.7	13.3	16.6	17.2	6.0	12.4	22.9	0.0	7.6	13.8	12.1	31.0	12.7	12.1	10.8	27.0	23.0	16.5	26.6	11.0	11.2	14.8	6.8	11.8	14.8	13.2	18.0	17.3	12.7	6.8	28.1	0.0	9.2	14.2	11.4	8.8	16.2	12.8	15.2	55.8
ZNF563	FLJ34797	ENSG00000188868	"Zinc finger protein 563"	Q8TA94	19	12317477-12333720	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 5.5;T-cells: 11.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 12.0"									HPA042136	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA042136: AB_10795395"	"unprognostic (1.40e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-2)"	4.6	5.4	5.6	7.7	7.9	2.1	6.9	7.5	6.0	5.5	3.7	3.6	6.2	2.5	4.5	6.2	4.7	5.7	4.1	7.3	6.4	2.2	8.7	17.2	3.6	4.6	4.8	4.8	6.4	4.0	4.9	9.3	2.2	5.4	8.5	4.0	3.8	4.9	7.1	3.5	6.8	4.0	4.3	4.6	4.4	3.2	22.6	7.2	6.1	9.1	2.0	5.1	5.8	6.4	5.5	1.7	1.1	1.4	1.6	11.6	2.6	2.4	0.3	0.9	3.5	3.5	2.3	0.3	2.9	5.5	3.5	5.5	3.0	0.9	5.6	3.0	3.6	4.1	2.0	2.8	6.8	3.3	0.1	0.5	0.8	0.5	12.0	3.1	0.5	3.7	3.9	5.0	3.6	2.4	2.7	0.1	3.1	1.1	1.3	3.2	1.6	3.2	1.2	1.5	1.3	2.3	0.2	2.6	0.2	4.0	3.5	0.9	1.6	0.3	0.7	0.4	4.2	2.3	0.3	0.4	5.5	1.1	6.5	1.8	5.7	4.4	0.4	1.1	0.5	2.0	0.7	1.3	0.8	3.4	1.3	2.0	3.8	5.8	3.1	1.6	5.5	11.6	6.5	1.1	1.6	1.4	1.7	4.5	2.6	5.6	7.9	7.5	6.0	6.4	2.2	4.8	4.8	5.4	7.2	3.0	1.7	2.0	1.6	1.1	7.6	5.2	5.1	5.3	2.3	1.8	0.0	0.4	1.7	4.1	144.2	3.4	1.3	0.0	4.4	0.1	1.3	2.1	0.0	6.7	1.9	4.8	0.0	4.3	2.1	17.6	7.2	1.5	5.0	1.8	2.6	14.3	2.5	3.5	5.3	6.3	3.3	12.9	3.1	12.8	4.3	1.8	0.1	2.1	2.6	0.6
ZNF564	MGC26914	ENSG00000249709	"Zinc finger protein 564"	Q8TBZ8	19	12525370-12551542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 8.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043998	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA043998: AB_10969446"	"unprognostic (3.85e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.26e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.26e-5)"	"unprognostic (5.77e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.83e-2)"	11.3	8.3	7.7	12.5	10.2	7.2	12.7	11.3	9.5	12.2	13.1	9.5	8.6	10.5	11.9	9.8	8.0	10.5	10.8	9.5	7.6	5.3	14.1	11.0	9.3	11.4	12.0	7.1	11.8	12.6	10.7	9.1	8.9	8.5	11.0	13.0	9.4	10.2	10.7	15.4	10.1	19.7	11.5	6.1	15.0	10.6	5.0	7.9	20.9	12.7	6.3	11.2	13.3	11.9	13.9	8.9	17.5	10.8	10.2	12.1	6.5	4.7	1.3	5.5	5.7	7.4	6.5	7.2	4.4	6.6	6.0	8.1	3.2	3.0	5.9	6.2	3.9	3.5	5.6	2.2	5.0	6.4	4.7	4.5	3.8	3.8	7.0	5.7	6.3	7.1	6.5	11.5	2.7	7.6	6.5	4.7	6.2	8.7	2.5	6.8	4.8	5.4	3.1	5.3	5.4	5.7	2.7	5.4	4.7	6.2	7.4	3.0	3.0	4.8	2.9	6.1	8.9	4.5	12.5	5.1	8.5	2.6	5.1	3.2	7.8	9.7	4.4	2.3	4.5	3.2	13.6	7.1	17.5	11.9	9.1	11.7	13.9	10.8	11.5	8.9	10.1	12.1	10.2	13.8	10.2	10.8	6.7	9.2	6.5	7.7	10.2	11.3	9.5	7.6	5.3	12.0	7.1	8.5	7.9	0.0	1.0	1.3	0.7	0.0	1.4	0.4	2.5	8.1	1.2	0.0	3.9	1.1	3.3	0.9	0.1	1.7	1.1	0.0	0.6	0.7	0.7	1.4	0.0	1.0	1.0	0.0	0.0	3.1	0.0	0.0	0.6	0.7	1.7	0.0	1.1	2.0	1.5	0.0	0.7	0.6	4.4	0.0	0.2	1.0	2.5	0.0	1.0	0.7	0.9	1.3
ZNF565	FLJ36991	ENSG00000196357	"Zinc finger protein 565"	Q8N9K5	19	36182060-36246257	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 18.7;Late spermatids: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044123	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA044123: AB_10794395"	"unprognostic (1.51e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (6.08e-3)"	"unprognostic (7.97e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.93e-4)"	5.9	5.7	12.1	4.2	11.6	7.1	7.1	10.4	12.8	5.7	5.2	16.8	4.8	4.4	7.1	6.5	5.2	6.7	4.8	5.3	8.0	7.7	5.5	6.2	4.6	4.4	17.3	10.1	11.1	5.7	4.9	7.5	4.6	12.1	7.0	5.8	4.1	8.0	5.6	7.8	6.6	4.1	6.2	17.3	4.5	6.1	13.5	14.9	2.3	6.8	3.5	5.7	6.6	8.4	2.1	3.6	13.8	3.7	3.1	4.5	2.3	3.8	5.5	6.6	4.6	10.4	6.9	1.8	3.8	6.3	4.6	7.9	3.2	3.4	2.9	5.0	4.9	2.2	2.3	3.3	2.8	7.3	5.0	1.5	5.3	4.8	4.2	4.4	3.5	3.7	8.1	8.0	3.0	8.0	4.9	5.5	3.4	3.5	3.6	5.6	4.9	4.2	0.9	2.6	8.4	2.6	3.6	3.9	2.9	4.6	5.2	5.3	5.5	3.1	3.6	3.5	4.2	2.5	3.8	4.5	6.6	3.8	4.8	5.5	1.1	1.8	1.9	6.3	2.9	3.2	13.8	3.1	4.8	3.5	3.2	3.8	2.1	4.0	3.4	3.6	2.1	4.5	3.5	1.5	3.1	3.7	1.9	2.0	2.3	12.1	11.6	10.4	12.8	8.0	7.7	17.3	10.1	12.1	14.9	3.0	0.6	0.0	5.2	1.9	3.6	2.5	0.0	4.0	0.0	1.8	5.9	1.1	0.0	2.5	18.7	3.0	0.9	0.0	2.6	1.6	2.5	3.3	0.0	0.8	1.4	1.6	1.2	1.3	2.4	12.4	4.9	1.7	0.0	1.0	1.0	2.4	2.4	0.0	2.5	1.0	4.6	6.5	2.3	10.9	7.3	1.3	1.7	2.2	1.5	3.7
ZNF566	"FLJ14779, MGC12515"	ENSG00000186017	"Zinc finger protein 566"	Q969W8	19	36445119-36489902	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 33.4;Horizontal cells: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023456	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023456: AB_2221143"	"unprognostic (1.68e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (3.89e-3)"	"unprognostic (5.71e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.56e-2)"	"unprognostic (8.19e-4)"	"unprognostic (7.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.47e-3)"	8.2	8.2	10.4	7.2	11.4	5.9	9.0	22.7	14.2	8.7	7.0	9.4	5.8	6.7	12.1	10.3	6.1	9.7	6.2	8.1	10.9	11.7	8.8	8.4	7.9	9.1	11.6	11.8	14.3	6.3	10.4	14.0	5.5	12.7	8.1	5.9	11.6	6.3	7.2	7.3	8.5	6.4	9.1	10.7	7.6	6.0	5.1	13.8	5.1	10.3	5.3	8.9	8.4	6.1	8.1	2.8	5.6	1.6	4.6	8.6	3.2	3.6	8.7	10.1	11.1	7.6	7.7	7.0	7.0	6.0	8.9	9.4	3.6	1.5	6.8	7.7	4.5	4.0	2.5	9.0	2.5	10.2	11.0	6.9	6.9	6.0	3.1	5.6	7.4	8.3	6.6	3.7	4.7	7.5	4.2	3.4	7.2	10.0	0.2	6.0	5.7	9.5	3.8	12.1	6.3	3.8	6.3	8.0	4.6	2.7	7.0	9.4	14.3	8.4	4.9	6.7	5.0	4.3	10.1	3.8	7.7	10.6	3.3	6.7	2.9	7.7	9.4	0.4	4.9	10.1	5.6	1.5	1.9	5.3	1.4	8.6	8.1	6.5	6.5	2.8	6.1	7.9	8.0	1.4	4.6	1.6	2.0	6.7	3.2	10.4	11.4	22.7	14.2	10.9	11.7	11.6	11.8	12.7	13.8	8.9	7.7	3.7	3.7	3.0	20.8	8.7	5.1	4.0	10.3	5.2	33.4	5.6	10.0	4.0	1.7	7.1	2.3	0.0	2.2	2.9	7.6	4.4	2.3	4.7	3.7	30.2	2.9	9.2	2.8	0.4	7.8	4.3	10.1	1.0	4.3	7.5	1.9	5.9	13.8	5.4	20.7	19.4	8.5	6.5	4.2	2.9	1.6	9.5	4.6	2.6
ZNF567	MGC45586	ENSG00000189042	"Zinc finger protein 567"	Q8N184	19	36687612-36727701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 64.6;Late spermatids: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA023937	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023937: AB_1859351"	"unprognostic (4.39e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.03e-2)"	5.9	7.0	6.3	6.7	6.9	5.0	10.2	12.2	10.2	8.0	6.3	4.7	6.6	3.8	9.2	7.5	7.8	7.0	5.5	5.3	7.7	6.0	6.0	7.7	5.8	8.6	7.1	2.3	8.4	4.9	10.4	15.8	13.0	8.0	9.3	5.0	5.1	7.3	12.1	7.4	5.6	5.5	9.7	9.1	7.2	5.5	14.2	9.6	9.0	8.3	3.3	8.2	6.6	7.5	8.8	3.9	7.0	2.3	7.9	8.2	3.0	6.8	5.3	9.8	8.7	5.7	5.6	9.4	5.0	7.8	5.7	9.3	3.0	2.4	4.3	6.1	4.5	4.3	1.8	9.0	5.2	7.9	8.4	4.7	8.1	5.9	2.9	5.2	10.2	6.3	8.7	6.3	5.4	10.6	7.5	6.6	8.8	3.2	2.3	6.8	4.2	13.2	3.9	9.4	4.6	4.3	6.5	13.5	6.1	3.7	10.5	7.4	7.9	9.3	4.7	5.0	11.6	5.9	7.0	4.1	7.6	7.7	3.8	5.6	8.8	7.3	14.3	0.0	4.1	6.6	5.7	2.3	7.0	7.7	2.0	6.3	7.3	8.2	7.1	3.9	8.8	8.2	8.2	1.3	7.9	2.0	2.7	6.6	3.0	6.3	6.9	12.2	10.2	7.7	6.0	7.1	2.3	8.0	9.6	6.0	5.8	9.4	9.2	10.4	7.7	5.3	2.5	2.7	7.9	8.7	9.8	13.1	3.3	7.5	64.6	8.9	3.2	0.0	4.4	11.7	5.8	10.4	17.3	6.6	6.3	11.1	4.1	12.3	4.7	69.6	9.2	3.8	6.8	7.2	4.8	8.1	4.2	7.0	14.2	5.6	5.7	6.5	9.2	35.8	10.4	15.4	23.0	11.8	4.1	10.3
ZNF568	DKFZp686B0797	ENSG00000198453	"Zinc finger protein 568"	Q3ZCX4	19	36916329-36998700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024541, HPA052061"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024541: , HPA052061: AB_2681713"	"unprognostic (3.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.83e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.98e-3)"	6.9	11.3	11.8	5.6	14.7	5.9	9.2	30.4	13.4	11.3	7.3	10.5	6.3	4.5	12.3	8.1	5.9	10.3	5.6	8.9	11.5	13.0	7.8	5.5	6.9	6.5	15.0	9.8	16.3	6.8	14.4	24.6	8.4	13.7	8.5	5.0	8.1	8.6	9.0	8.5	6.8	5.2	10.6	13.0	9.3	7.0	9.5	16.3	6.4	13.2	7.6	7.0	7.6	7.3	8.7	3.0	12.8	2.3	7.1	10.1	3.1	0.2	4.5	7.4	2.4	6.9	7.7	2.3	6.2	6.2	5.2	7.1	0.2	2.6	0.3	7.4	7.7	3.8	1.2	0.1	3.6	5.4	1.0	5.3	2.3	0.6	0.8	8.8	0.2	5.9	10.0	4.3	5.2	0.1	6.5	2.7	3.3	0.4	0.9	7.6	0.3	1.6	1.2	6.0	0.0	0.3	0.6	5.4	2.4	4.9	9.8	7.3	9.4	0.3	0.2	5.5	7.5	6.0	1.0	5.2	3.6	10.2	5.8	4.2	8.7	10.6	5.4	0.2	0.2	11.3	12.8	1.9	6.5	8.4	1.5	7.6	8.7	7.9	7.0	3.0	7.6	10.1	8.0	1.6	7.1	2.3	2.9	6.7	3.1	11.8	14.7	30.4	13.4	11.5	13.0	15.0	9.8	13.7	16.3	3.0	6.5	2.2	2.8	4.5	17.6	5.0	5.1	6.7	2.3	8.7	13.7	4.3	3.3	6.1	21.7	6.0	0.4	0.0	3.3	3.3	6.4	3.4	16.1	1.0	3.0	38.1	0.0	4.9	1.0	14.8	6.1	3.5	1.7	3.6	1.1	8.1	2.2	0.0	9.2	4.0	16.4	6.5	5.7	9.9	12.4	3.6	2.4	6.7	1.2	2.4
ZNF569	"FLJ32053, ZAP1"	ENSG00000196437	"Zinc finger protein 569"	Q5MCW4	19	37411155-37469275	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 29.5;Early spermatids: 102.9;Rod photoreceptor cells: 31.0;Spermatocytes: 35.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA052994	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA052994: AB_2682007"	"unprognostic (1.40e-1)"	"unprognostic (3.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.00e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.41e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	5.8	7.8	10.9	6.1	11.1	7.7	6.6	20.9	10.6	6.9	5.0	6.4	3.8	3.2	7.2	9.5	4.4	6.5	4.5	7.7	8.0	11.2	6.9	6.0	4.6	7.2	8.6	8.7	10.9	3.7	8.8	18.5	5.5	10.6	6.6	3.5	5.2	4.5	5.6	7.2	6.5	4.1	6.3	10.2	6.2	4.2	20.1	11.3	9.6	10.5	3.8	5.9	6.4	4.7	7.2	3.2	7.1	4.0	6.2	11.3	3.2	2.8	5.8	6.7	11.0	5.5	4.9	3.3	5.2	3.1	5.7	6.1	1.9	1.2	3.3	7.6	3.8	5.6	1.0	7.4	2.0	6.0	7.6	4.4	8.6	1.4	3.2	3.3	1.6	3.6	3.4	1.3	5.7	0.1	5.5	4.5	10.7	2.8	0.6	8.0	1.7	10.9	3.7	7.8	0.2	4.1	7.1	8.4	3.5	4.0	2.8	5.7	8.9	0.2	1.3	2.9	6.8	4.9	6.9	4.4	4.4	9.1	3.4	8.3	9.5	16.0	13.1	0.3	3.6	7.0	4.9	2.6	7.1	8.7	3.3	7.7	6.1	7.8	8.1	2.8	7.2	11.3	8.9	2.7	6.2	4.0	3.2	7.8	3.2	10.9	11.1	20.9	10.6	8.0	11.2	8.6	8.7	10.6	11.3	0.0	1.7	0.0	1.9	1.4	15.7	13.7	0.0	6.7	7.9	1.8	29.5	2.7	1.7	1.5	102.9	3.8	0.5	0.0	1.7	3.0	3.4	1.0	2.3	1.7	2.4	3.2	0.0	3.7	2.2	27.5	4.4	4.1	0.0	3.6	0.3	7.5	1.2	0.0	7.1	4.2	31.0	0.0	4.4	35.4	11.9	1.8	0.7	7.9	0.8	1.0
ZNF57	ZNF424	ENSG00000171970	"Zinc finger protein 57"	Q68EA5	19	2900898-2918476	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 74.9;Late spermatids: 28.7;Suprabasal keratinocytes: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA061915			Approved	Nucleoli		NA	NA			Nucleoli		"HPA061915: AB_2684635"	"unprognostic (3.59e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.91e-2)"	"unprognostic (8.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.07e-2)"	"unprognostic (7.66e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.04e-2)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.34e-3)"	"prognostic favorable (4.11e-9)"	"unprognostic (6.26e-3)"	"unprognostic (2.82e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.49e-3)"	3.6	2.9	3.6	3.2	4.7	4.0	7.3	17.2	5.7	6.2	15.7	2.3	5.1	7.8	5.6	4.2	11.0	4.7	4.0	4.2	3.3	2.7	9.2	3.9	4.9	2.9	2.6	3.2	5.4	7.4	3.9	4.1	5.8	4.2	6.1	10.1	3.6	5.5	8.7	7.4	18.6	18.5	2.1	2.4	3.6	11.7	26.4	3.9	2.9	5.4	7.0	6.6	5.0	7.9	4.9	3.6	1.4	5.8	6.3	8.4	4.1	6.7	3.2	4.4	6.4	4.3	3.7	7.4	2.9	2.3	4.6	4.8	6.5	2.6	5.7	3.7	2.3	6.7	7.9	7.0	9.9	5.8	0.0	3.6	3.3	3.7	8.6	3.3	0.0	6.3	2.9	11.1	4.1	8.8	3.8	3.5	13.8	5.8	0.1	3.6	6.8	8.6	3.7	2.9	8.0	5.6	8.0	13.5	1.3	6.3	11.1	2.2	3.3	4.2	7.9	2.7	6.5	4.9	5.5	2.7	3.2	3.1	7.3	4.0	1.2	6.5	2.8	2.6	0.9	2.5	0.0	3.3	1.4	6.5	5.8	5.4	4.9	7.1	6.7	3.6	4.9	8.4	7.4	1.2	6.3	3.1	3.4	7.1	4.1	3.6	4.7	17.2	5.7	3.3	2.7	2.6	3.2	4.2	3.9	0.0	4.0	0.0	17.8	19.1	1.9	2.5	2.5	4.0	10.3	0.0	5.9	3.6	3.3	2.8	74.9	1.4	11.8	0.0	2.0	3.4	2.5	3.4	0.0	1.6	1.9	1.6	0.0	1.8	1.0	28.7	2.3	1.9	5.0	1.8	5.0	1.6	1.4	7.0	2.8	2.4	2.6	0.0	3.9	4.1	11.5	25.1	5.5	0.0	6.0	8.9
ZNF570	FLJ30791	ENSG00000171827	"Zinc finger protein 570"	Q96NI8	19	37467585-37488652	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 40.9;Horizontal cells: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA028881	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA028881: AB_10603938"	"unprognostic (2.93e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.59e-2)"	"prognostic favorable (4.06e-5)"	"unprognostic (5.30e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.20e-3)"	7.4	5.8	7.6	3.7	8.8	4.3	6.7	8.2	9.8	6.1	4.7	6.7	3.0	4.4	7.1	4.9	5.2	4.9	5.0	5.4	6.6	5.7	6.7	4.0	4.6	5.6	9.3	6.2	8.3	4.5	13.6	8.0	4.8	8.3	6.8	2.9	4.5	5.0	5.3	4.9	4.1	4.0	5.4	9.0	6.9	4.7	14.7	10.0	7.2	7.5	4.9	5.4	5.7	7.8	3.7	2.0	3.9	3.3	4.7	5.6	2.3	1.9	2.7	3.7	10.9	5.0	6.3	1.8	3.9	2.0	3.7	5.0	0.0	0.8	0.5	5.2	2.8	2.2	0.4	3.1	2.4	4.5	2.2	2.2	2.5	0.3	1.2	3.4	0.2	5.5	5.3	2.2	2.5	0.1	3.4	3.6	4.4	0.4	0.2	3.8	0.8	6.1	1.9	2.4	0.1	1.1	1.1	3.8	2.0	3.0	3.1	3.4	7.0	0.0	0.1	1.2	4.8	2.2	2.8	1.8	1.5	2.8	2.4	2.7	6.1	5.3	2.8	0.0	0.3	2.9	1.4	1.9	2.3	3.6	3.3	2.9	3.6	5.6	2.4	1.9	3.7	5.0	5.0	3.9	4.7	1.4	2.0	3.4	2.3	7.6	8.8	8.2	9.8	6.6	5.7	9.3	6.2	8.3	10.0	6.0	0.3	2.2	1.7	1.4	5.9	10.9	5.1	5.3	4.5	1.8	9.8	2.1	8.3	4.6	40.9	4.3	1.0	0.0	3.3	6.2	3.0	1.7	5.8	2.1	2.8	30.2	5.8	5.5	3.2	5.4	4.6	2.5	5.0	1.8	1.5	6.2	2.7	0.0	9.2	3.5	6.6	0.0	3.6	10.2	7.2	0.4	1.1	4.3	2.1	0.9
ZNF571	HSPC059	ENSG00000180479	"Zinc finger protein 571"	Q7Z3V5	19	37554782-37594790	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.8"	"Cell type enhanced"	"Detected in many"	4	"granulocytes: 15.0;Rod photoreceptor cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA054762			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA054762: "	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.03e-4)"	"unprognostic (5.77e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-4)"	6.5	6.7	8.6	3.2	12.9	6.1	12.5	12.5	12.8	5.9	4.2	9.8	4.4	2.3	6.7	8.7	3.9	6.0	4.5	4.2	10.4	7.2	6.4	4.2	4.1	4.4	15.3	9.4	8.5	3.8	11.5	12.2	4.8	13.4	7.1	3.4	5.1	3.6	4.5	3.5	7.1	3.7	7.7	14.3	4.8	3.5	8.5	15.8	3.7	61.8	3.3	5.0	6.6	5.3	9.4	4.1	4.9	1.3	3.7	8.4	3.2	1.8	1.0	6.3	9.1	4.7	4.8	2.0	2.7	4.4	6.6	8.2	1.9	1.7	9.6	8.6	2.8	4.6	2.4	2.0	2.9	11.0	2.1	7.9	5.1	2.7	1.1	5.4	1.9	5.8	2.6	5.3	6.3	5.8	4.7	1.3	8.7	2.4	0.8	5.3	1.7	9.6	2.1	15.8	2.9	3.5	4.8	3.0	5.1	9.1	11.6	13.6	9.5	6.4	2.1	3.2	13.2	9.7	1.3	0.8	3.0	3.9	3.3	6.9	7.7	15.8	13.2	0.5	0.8	6.6	1.8	0.8	4.9	6.7	1.3	6.1	8.7	6.3	6.5	2.7	9.4	7.8	8.4	1.5	3.7	1.2	4.1	4.2	3.2	8.6	12.9	12.5	12.8	10.4	7.2	15.3	9.4	13.4	15.8	0.0	1.3	4.5	1.1	1.5	9.3	1.1	2.5	4.0	5.7	5.2	9.8	1.8	3.3	1.7	10.5	2.5	0.8	0.0	1.4	1.3	2.3	1.7	15.0	0.8	1.4	12.7	1.2	2.5	1.3	2.5	4.0	1.3	5.0	0.0	2.1	4.5	0.8	0.0	2.5	2.6	16.6	12.9	1.7	7.2	5.7	2.3	1.0	6.2	1.3	0.5
ZNF572	FLJ38002	ENSG00000180938	"Zinc finger protein 572"	Q7Z3I7	8	124973298-124979389	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	6	"Distal tubular cells: 1.7;Muller glia cells: 2.0;Spermatocytes: 2.2;Spermatogonia: 1.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA066838	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA066838: AB_2685734"	"unprognostic (8.65e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.37e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.17e-2)"	2.7	1.6	4.5	5.1	4.5	0.5	6.1	2.7	3.5	3.8	3.2	6.4	3.1	2.6	4.6	6.7	2.6	4.6	2.1	2.8	4.0	2.7	5.1	3.5	3.0	7.1	6.0	2.7	6.8	4.4	2.3	2.3	4.3	3.9	4.4	3.9	4.7	3.7	4.9	1.2	2.5	3.6	2.8	4.4	4.4	4.0	9.8	4.6	11.0	5.4	0.7	5.3	5.1	5.3	2.4	0.6	1.1	1.0	2.3	3.3	0.6	1.7	0.8	1.9	0.0	2.7	3.1	0.0	0.6	0.2	2.3	1.3	2.5	1.2	4.3	2.9	0.7	0.5	3.4	1.1	0.1	2.1	0.0	0.9	0.0	1.2	2.9	2.2	0.0	2.3	2.3	2.9	2.4	0.0	0.6	1.4	0.0	2.5	0.0	3.0	7.0	0.0	0.0	0.0	4.1	0.0	2.8	5.0	0.5	1.3	1.2	4.4	4.3	2.7	4.3	4.5	3.9	1.9	2.9	1.0	2.7	3.2	0.8	0.0	0.0	2.4	1.9	0.6	0.0	0.3	0.0	0.4	1.1	1.0	1.0	1.4	2.4	1.0	0.5	0.6	2.4	3.3	2.0	0.0	2.3	0.7	0.2	0.0	0.6	4.5	4.5	2.7	3.5	4.0	2.7	6.0	2.7	3.9	4.6	0.0	0.0	0.0	0.2	0.1	0.8	0.7	0.0	1.4	1.2	0.0	0.0	0.7	1.7	0.3	0.2	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.0	0.0	0.0	1.1	0.7	0.3	0.0	0.3	2.2	1.9	0.0	0.2	0.0	0.7	0.1
ZNF573	FLJ30921	ENSG00000189144	"Zinc finger protein 573"	Q86YE8	19	37735833-37817300	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 26.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042776	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA042776: AB_10961399"	"unprognostic (3.79e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.60e-2)"	6.2	6.4	7.3	4.2	8.6	7.2	7.6	14.1	9.5	6.3	4.6	8.6	5.2	4.3	7.5	10.8	4.8	5.0	6.8	5.3	5.8	4.1	5.3	4.2	6.0	4.1	10.0	5.7	8.4	6.8	6.7	11.7	5.7	6.2	5.5	4.9	5.9	6.4	5.6	5.3	7.8	5.3	6.9	6.8	5.3	7.5	10.0	9.5	4.5	9.8	4.0	6.2	7.4	6.2	6.3	3.3	3.3	2.6	3.6	5.7	1.0	1.0	3.7	2.8	2.4	1.4	3.4	1.2	2.3	2.8	0.9	2.2	3.6	2.8	3.5	2.3	2.1	1.1	2.2	2.8	3.9	3.5	1.8	1.9	4.1	5.5	1.8	1.4	3.3	2.7	3.1	1.4	4.9	2.1	1.9	2.8	2.1	1.8	1.7	0.7	1.4	2.7	2.0	4.6	1.1	0.4	2.8	5.7	1.2	0.2	1.6	3.8	3.7	4.7	1.6	0.4	1.8	3.5	3.1	1.0	3.2	3.4	2.8	3.9	4.2	5.4	5.7	0.8	0.4	2.7	3.2	1.0	3.3	4.2	1.2	3.4	3.4	3.5	4.5	1.9	6.3	5.7	4.4	0.4	3.6	2.6	3.3	2.0	1.0	7.3	8.6	14.1	9.5	5.8	4.1	10.0	5.7	6.2	9.5	0.0	4.6	2.7	1.9	1.5	14.0	9.6	2.5	2.7	1.2	3.5	11.8	3.0	1.7	2.0	26.5	4.5	1.0	0.0	0.6	2.7	3.3	2.1	0.0	1.5	3.2	15.9	1.2	1.8	1.0	13.1	8.1	1.7	3.3	1.0	1.4	8.1	1.1	0.0	6.0	1.9	10.6	0.0	2.8	5.2	8.2	2.3	1.4	4.3	2.4	1.1
ZNF574	FLJ22059	ENSG00000105732	"Zinc finger protein 574"	Q6ZN55	19	42068477-42081549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023196, HPA057274"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA023196: AB_2671105, HPA057274: AB_2683392"	"unprognostic (3.90e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	11.1	6.8	7.9	6.6	10.2	14.9	9.7	15.6	17.8	11.2	10.2	12.5	4.6	10.2	13.0	4.5	12.2	12.4	8.0	8.0	8.0	6.8	6.8	8.4	8.6	9.0	11.7	8.5	15.4	12.1	8.7	8.3	8.8	8.4	10.8	4.5	10.8	12.1	11.1	10.4	14.3	8.6	10.3	5.6	10.8	8.7	28.5	12.3	15.6	10.2	9.1	12.4	10.6	9.3	18.7	12.5	15.6	10.5	10.1	18.9	11.6	10.3	28.6	6.4	8.2	5.8	5.9	6.9	7.8	6.8	10.3	9.8	11.2	7.0	15.0	7.0	6.2	5.3	6.3	7.3	9.8	3.8	7.9	12.3	14.2	6.9	9.5	6.4	8.8	9.8	6.9	9.8	9.3	7.9	6.1	5.5	8.3	11.7	9.5	7.0	21.1	10.3	7.3	11.5	9.0	11.4	14.2	6.2	6.4	5.0	13.7	10.8	9.2	8.0	17.0	5.1	4.3	8.0	13.9	6.7	13.9	11.0	4.1	11.5	10.4	6.3	10.9	7.8	8.2	7.9	11.1	10.4	15.6	17.5	7.9	18.7	18.7	13.1	18.9	12.5	14.8	13.8	12.8	13.3	10.1	10.5	11.0	10.1	11.6	7.9	10.2	15.6	17.8	8.0	6.8	11.7	8.5	8.4	12.3	0.0	3.5	1.9	14.4	26.1	6.7	3.5	0.0	2.7	3.4	1.8	2.0	6.5	1.7	5.8	17.4	5.8	5.1	0.0	4.5	5.5	8.0	8.8	12.7	2.5	4.3	3.2	3.4	8.0	1.0	11.6	5.2	3.3	8.5	10.0	7.3	3.8	4.4	6.6	8.1	3.7	9.2	6.5	8.9	29.4	18.1	19.8	4.0	6.4	7.5	10.2
ZNF575	FLJ32567	ENSG00000176472	"Zinc finger protein 575"	Q86XF7	19	43525497-43536130	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 6.0;Paneth cells: 5.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051865	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA051865: AB_2681643"	"unprognostic (1.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.53e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.87e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.75e-1)"	8.8	3.9	10.5	3.8	10.0	2.5	3.2	12.3	13.5	4.9	13.8	6.8	2.9	5.6	4.7	4.0	2.4	3.6	4.6	3.6	6.6	4.2	3.9	3.2	3.6	3.9	5.4	6.2	6.3	2.3	3.0	5.2	2.0	6.7	5.5	7.1	5.1	5.0	4.1	12.9	4.8	6.4	3.4	6.0	5.8	4.7	1.9	6.5	2.4	3.3	2.3	4.2	3.5	3.7	3.0	1.9	0.8	0.9	7.0	4.4	1.3	2.9	2.6	0.6	0.8	4.0	3.4	0.2	1.9	1.3	0.7	1.0	0.6	1.1	0.6	1.3	1.4	0.3	1.6	0.1	0.3	0.3	4.2	0.5	2.2	0.9	0.5	0.9	0.9	2.7	1.9	1.2	1.0	0.2	2.1	0.6	4.2	0.9	4.1	1.2	1.9	11.7	0.3	0.2	2.1	1.4	6.4	0.0	1.5	0.7	1.7	0.6	1.0	1.5	2.0	1.9	0.5	0.5	1.1	2.0	3.7	2.5	0.8	1.4	2.2	3.2	1.8	2.3	2.7	3.9	0.1	0.9	0.6	3.0	0.5	1.2	1.5	2.8	2.9	1.3	3.0	4.4	3.2	0.8	7.0	0.3	1.9	2.3	1.3	10.5	10.0	12.3	13.5	6.6	4.2	5.4	6.2	6.7	6.5	6.0	0.6	0.0	0.5	0.1	1.1	1.5	0.0	0.0	1.2	0.0	3.9	1.0	3.3	0.4	0.0	1.0	2.6	0.0	0.6	0.7	1.9	0.4	0.0	2.0	1.4	0.0	1.2	2.5	1.0	0.0	2.3	1.7	1.7	0.0	2.0	0.3	0.1	5.3	3.2	1.9	0.0	0.0	2.4	0.1	0.9	1.5	0.2	1.0	2.3	0.3
ZNF576	MGC2508	ENSG00000124444	"Zinc finger protein 576"	Q9H609	19	43596392-43601157	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050064	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA050064: AB_2681003"	"unprognostic (1.28e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.60e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.34e-3)"	11.8	14.4	14.5	11.4	18.7	5.2	11.3	28.0	19.4	11.2	11.5	15.3	11.4	16.0	12.7	9.0	15.0	14.2	13.4	16.0	13.3	13.7	12.1	23.5	8.7	12.5	15.7	16.8	17.9	14.7	11.4	16.4	10.2	16.5	16.9	8.5	9.5	17.7	12.9	21.0	11.3	15.1	9.8	13.4	10.3	11.9	13.2	13.3	13.3	13.9	8.4	10.2	16.1	10.5	22.3	22.2	13.9	13.6	15.7	17.7	10.3	15.7	18.4	6.8	8.7	9.2	8.2	6.2	13.2	8.8	13.3	14.9	9.0	12.1	10.4	15.0	9.9	7.8	6.4	9.8	9.3	3.6	11.2	16.7	7.6	12.8	11.1	7.6	10.2	14.3	7.0	11.8	11.6	4.7	6.7	9.4	9.2	9.5	13.5	10.1	15.6	14.2	4.6	4.8	13.2	15.7	12.0	6.1	10.2	7.9	14.2	12.7	8.0	8.7	17.6	6.7	5.2	8.2	11.8	9.8	17.9	9.9	7.9	19.2	7.1	8.0	7.1	15.4	11.9	15.3	9.3	13.6	13.9	15.9	12.6	14.3	22.3	16.0	13.5	13.9	16.7	17.7	14.0	7.3	15.7	12.5	22.2	15.9	10.3	14.5	18.7	28.0	19.4	13.3	13.7	15.7	16.8	16.5	13.3	6.0	5.3	15.6	7.4	9.4	23.0	10.4	10.2	6.7	7.9	14.0	29.5	12.5	18.3	15.8	29.8	10.5	16.5	0.0	16.6	17.4	10.4	14.8	9.2	17.0	13.7	22.3	10.9	15.4	5.9	70.7	12.4	7.8	18.6	12.6	10.9	22.7	16.0	11.5	14.5	24.5	31.2	6.5	9.2	28.6	15.8	10.8	4.8	11.5	12.8	9.8
ZNF579	FLJ35453	ENSG00000218891	"Zinc finger protein 579"	Q8NAF0	19	55576770-55580845	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062812	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062812: AB_2684873"	"unprognostic (1.76e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.95e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (5.27e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.08e-3)"	9.6	7.0	9.0	5.9	11.2	7.5	8.8	27.5	19.5	10.3	8.5	13.4	10.9	8.3	12.6	13.7	8.2	13.6	14.5	10.2	7.8	8.9	11.3	8.6	10.4	8.2	8.0	6.3	13.4	12.4	6.8	10.3	5.2	9.7	10.4	5.3	10.6	9.8	10.6	33.0	11.8	6.5	8.2	7.1	8.2	17.6	5.7	7.6	8.5	14.6	8.3	6.6	10.9	9.8	1.9	1.8	0.9	1.7	0.6	1.3	0.2	5.1	10.4	5.7	5.8	9.4	6.5	7.3	10.2	2.7	5.6	6.1	3.5	6.3	8.5	4.1	6.0	1.9	5.0	3.3	5.5	5.8	1.5	28.6	5.1	17.8	6.4	9.6	3.2	4.5	16.3	6.3	4.3	4.5	12.7	3.1	3.2	10.2	2.9	11.0	6.6	4.4	4.2	5.1	2.7	16.5	8.0	5.3	3.4	7.5	9.6	6.9	10.1	6.8	5.3	4.8	11.5	2.7	4.3	6.9	7.4	7.2	2.3	6.1	7.7	6.4	4.6	3.9	5.0	3.6	0.5	1.7	0.2	0.8	0.6	0.4	0.4	0.3	0.9	1.8	1.9	1.3	0.5	0.9	0.6	0.5	1.8	0.8	0.2	9.0	11.2	27.5	19.5	7.8	8.9	8.0	6.3	9.7	7.6	3.0	7.0	3.4	6.4	3.0	11.2	4.2	17.8	2.7	1.2	5.2	11.8	0.7	3.3	4.3	0.0	5.6	2.3	0.0	4.1	0.7	3.1	7.3	4.6	5.5	4.5	14.3	10.9	12.3	4.1	0.0	7.8	3.0	3.3	1.0	6.9	14.8	5.3	0.0	11.7	9.1	7.4	12.9	3.3	0.3	0.9	2.9	0.3	1.3	5.3	7.8
ZNF580		ENSG00000213015	"Zinc finger protein 580"	Q9UK33	19	55635016-55643469	"Predicted intracellular proteins, Transcription factors"	"Chemotaxis, Inflammatory response, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEK 293: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054058	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054058: AB_2682360"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.46e-3)"	32.8	23.6	24.5	25.5	23.4	17.2	19.1	28.7	28.2	23.4	25.2	23.1	36.4	19.8	32.2	39.5	18.2	25.8	25.5	17.2	23.1	21.7	23.3	8.7	17.1	24.2	19.1	22.0	33.0	24.1	37.8	38.2	13.7	19.9	31.3	16.2	23.0	31.7	34.2	20.9	19.4	20.0	32.4	17.3	30.1	24.9	10.7	20.9	23.0	35.4	10.8	21.6	25.8	21.1	12.8	4.1	10.5	9.2	2.9	3.3	1.5	4.7	8.9	8.2	5.3	9.1	5.1	3.2	6.4	7.6	10.0	12.5	1.5	4.6	3.4	1.8	9.3	2.2	3.9	5.4	5.8	7.8	10.9	78.3	6.4	8.4	4.2	12.1	3.1	14.6	11.0	6.2	4.8	9.3	13.3	6.9	8.8	6.3	9.6	8.3	1.5	14.1	4.6	4.2	3.1	11.5	12.8	2.9	14.2	11.3	5.6	9.1	11.2	4.5	4.5	5.8	4.6	3.8	3.3	8.6	5.5	8.3	3.7	3.5	19.4	5.2	8.5	3.0	4.9	5.2	4.4	3.4	10.5	1.2	4.8	1.3	8.2	2.7	2.7	3.6	12.8	3.3	2.8	6.2	2.9	9.2	4.1	2.1	1.5	24.5	23.4	28.7	28.2	23.1	21.7	19.1	22.0	19.9	20.9	8.9	8.9	35.7	31.8	16.6	31.0	8.9	33.1	1.4	5.7	54.1	3.9	23.6	64.6	36.4	2.7	31.8	25.8	0.0	48.6	17.3	31.7	34.7	19.5	9.5	22.2	19.1	64.7	40.5	25.4	4.3	55.0	28.0	37.1	45.9	23.8	26.9	38.3	28.1	66.4	55.9	16.6	38.8	37.1	7.9	12.1	14.8	15.9	20.2	26.9	27.6
ZNF582	FLJ30927	ENSG00000018869	"Zinc finger protein 582"	Q96NG8	19	56375846-56393545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 11.6;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 24.3"					"Low region specificity"	"Detected in all"			HPA028858	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA028858: AB_10603247"	"unprognostic (1.19e-3)"	"unprognostic (9.86e-4)"	"unprognostic (3.88e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.02e-7)"	"unprognostic (3.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.00e-3)"	4.8	8.7	7.7	4.7	8.9	2.7	6.3	9.4	9.0	4.7	4.9	7.8	3.6	2.3	7.9	13.5	4.8	6.1	6.4	8.0	8.2	7.1	5.9	4.8	5.2	8.0	9.6	3.9	10.2	4.0	7.5	11.4	5.4	8.9	8.4	2.7	4.4	4.1	5.5	3.5	5.6	3.3	5.5	7.7	7.2	3.4	8.9	13.1	7.8	13.8	2.2	3.7	5.4	5.9	5.9	3.4	5.9	3.3	11.0	6.5	2.8	0.0	1.1	6.1	1.2	1.5	1.6	0.0	2.4	2.6	1.6	1.3	0.0	0.3	0.0	1.6	1.4	3.5	0.0	0.8	0.3	1.3	0.0	24.3	5.8	0.0	0.4	2.6	1.6	4.7	5.4	1.3	1.0	0.0	1.5	1.0	0.6	1.3	0.0	1.0	0.0	3.4	3.7	3.3	0.0	0.0	1.6	2.1	2.1	1.3	3.3	0.0	3.9	0.0	0.8	0.0	4.7	2.7	3.2	1.0	3.2	6.4	0.8	3.3	5.2	5.6	3.7	0.2	0.4	1.8	4.3	2.2	5.9	4.4	3.3	6.5	5.9	5.2	4.4	3.3	4.3	3.8	4.8	0.5	11.0	2.4	3.4	1.6	2.8	7.7	8.9	9.4	9.0	8.2	7.1	9.6	3.9	8.9	13.1	0.0	0.0	5.2	2.1	1.1	3.3	2.7	0.0	1.4	1.2	7.0	2.0	2.1	11.6	2.4	0.7	5.3	0.0	0.0	0.6	0.6	2.6	3.3	8.1	2.1	2.5	1.6	0.0	1.8	1.0	0.4	2.0	2.9	3.3	1.8	0.6	8.0	1.0	0.0	3.9	3.3	5.7	12.9	2.1	1.8	5.7	0.9	3.0	2.5	0.6	1.7
ZNF583	FLJ31030	ENSG00000198440	"Zinc finger protein 583"	Q96ND8	19	56397966-56436035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 53.6;Late spermatids: 29.3;Spermatocytes: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 14.0"	"Low region specificity"	"Detected in all"							"HPA023805, HPA023957"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA023805: AB_2671318, HPA023957: AB_2671383"	"unprognostic (9.89e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	7.2	5.9	7.9	3.9	9.3	2.3	4.7	11.6	12.4	5.6	4.6	5.6	3.7	3.2	6.1	5.5	3.6	5.8	5.4	5.0	7.7	7.3	6.6	5.9	6.6	4.5	7.5	6.3	11.2	5.9	7.3	8.4	4.7	8.3	6.0	3.5	3.3	2.6	4.7	4.8	2.1	3.1	6.2	7.6	5.4	3.9	15.8	7.6	5.0	7.9	2.1	4.1	4.4	5.7	6.3	3.5	9.4	4.7	9.2	7.4	2.8	0.0	2.0	4.7	0.0	3.3	2.7	0.0	5.8	5.9	2.7	2.2	0.2	0.6	4.3	2.9	5.3	5.0	0.3	1.9	1.8	2.9	2.0	10.2	5.7	0.0	1.0	3.8	4.7	5.2	3.7	2.9	3.9	1.9	4.0	2.6	4.5	2.1	1.6	8.8	0.0	5.8	1.6	1.2	0.0	1.9	2.9	8.9	3.2	2.1	4.2	2.7	4.1	0.0	0.5	1.5	2.5	2.9	6.1	1.8	14.0	3.8	2.7	11.4	6.0	11.0	6.8	0.3	1.3	4.9	9.4	2.2	4.7	4.9	3.2	7.2	6.3	4.0	4.5	2.5	5.5	7.4	4.4	1.0	9.2	4.7	3.5	4.9	2.8	7.9	9.3	11.6	12.4	7.7	7.3	7.5	6.3	8.3	7.6	3.0	1.0	3.2	3.1	1.5	16.1	4.4	0.0	1.4	0.0	1.8	5.9	1.4	8.3	5.1	53.6	5.5	0.4	0.0	2.4	0.4	5.0	2.5	10.4	1.6	3.4	9.5	0.0	6.2	4.0	29.3	6.4	3.5	3.3	1.8	1.5	10.2	2.3	1.5	12.7	4.8	14.3	6.5	5.3	25.1	12.8	1.5	0.9	8.5	1.7	1.4
ZNF584	FLJ39899	ENSG00000171574	"Zinc finger protein 584"	Q8IVC4	19	58401504-58418327	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 31.4"					"Low region specificity"	"Detected in all"			"HPA043408, HPA048075"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA043408: AB_2678466, HPA048075: AB_2680251"	"unprognostic (6.06e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.76e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.36e-2)"	10.4	9.3	7.3	7.4	11.7	3.3	11.7	16.6	12.1	10.6	8.6	9.5	6.4	7.4	10.5	8.2	9.2	13.8	10.5	13.3	7.6	9.6	10.4	13.4	7.9	6.7	7.2	5.0	11.9	13.1	13.6	11.6	5.8	7.9	8.6	5.5	10.8	7.6	13.0	13.3	11.7	4.6	10.9	6.2	6.4	8.1	6.3	7.8	6.6	11.5	10.3	6.7	8.7	16.6	4.4	5.0	1.2	4.5	4.1	8.4	3.9	7.0	10.3	7.1	9.2	6.9	7.0	2.9	5.6	9.9	3.4	4.2	1.7	2.0	3.4	4.5	9.0	9.1	4.0	7.6	9.1	3.9	4.6	31.4	9.5	5.9	2.0	11.9	10.4	2.6	7.1	6.6	10.5	14.7	7.6	6.8	5.9	9.4	3.2	5.6	5.0	8.6	3.2	1.7	4.6	14.6	6.3	5.3	5.4	4.8	8.3	5.7	6.0	12.1	3.4	4.7	1.9	2.2	5.2	4.2	13.6	4.1	5.6	8.7	3.2	5.6	0.7	9.8	3.6	4.4	0.0	3.2	1.2	5.0	3.1	8.4	3.3	6.8	7.2	5.0	4.4	3.8	5.7	1.0	4.1	4.5	4.4	7.2	3.9	7.3	11.7	16.6	12.1	7.6	9.6	7.2	5.0	7.9	7.8	3.0	3.8	0.5	2.3	10.0	3.9	11.7	2.5	6.7	1.2	8.7	3.9	0.9	11.6	4.4	8.2	3.6	1.4	0.0	4.4	1.2	4.3	2.3	2.3	4.9	2.4	3.2	6.4	5.5	3.1	4.6	4.9	1.4	1.7	1.0	1.7	5.8	3.9	2.9	6.0	5.0	8.9	6.5	6.2	7.2	3.9	13.9	0.3	4.9	3.0	1.1
ZNF585B	"FLJ14928, SZFP41"	ENSG00000245680	"Zinc finger protein 585B"	Q52M93	19	37181579-37218153	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA075556			Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Cytoplasmic bodies"		"HPA075556: AB_2686757"	"unprognostic (9.53e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-3)"	6.6	8.3	11.2	5.8	13.4	2.6	9.3	17.9	12.9	10.0	8.1	8.7	11.4	5.6	11.6	15.2	5.8	8.8	7.5	7.2	9.8	10.0	8.7	5.2	6.2	7.3	14.1	9.8	15.0	6.2	23.4	22.6	8.0	10.1	8.9	7.2	8.3	6.3	11.6	5.0	6.3	7.2	10.1	12.3	9.7	7.6	9.2	12.4	9.5	13.1	5.6	9.1	9.3	7.2	6.5	1.9	3.7	4.2	2.9	7.1	2.9	2.4	4.2	3.8	7.5	6.3	9.9	2.1	3.2	5.2	5.9	8.9	2.3	3.1	0.1	6.9	4.2	4.2	0.7	0.1	5.0	7.4	4.9	1.9	3.2	5.5	1.2	6.1	0.3	6.8	7.7	3.0	6.7	3.5	4.7	2.4	0.4	0.0	0.2	3.5	1.5	5.6	2.1	4.2	1.2	1.2	0.2	2.1	0.1	3.2	10.0	6.7	4.3	0.0	0.3	1.5	5.1	2.9	3.5	2.0	0.6	1.4	5.0	3.8	5.7	7.5	6.9	0.3	0.1	6.5	3.3	1.6	3.7	5.0	3.1	6.3	6.5	3.6	4.4	1.9	4.9	5.2	7.1	2.5	2.9	4.2	1.7	3.5	2.9	11.2	13.4	17.9	12.9	9.8	10.0	14.1	9.8	10.1	12.4	6.0	6.4	1.4	1.6	1.4	6.1	5.0	7.6	8.1	12.5	12.2	2.0	2.3	1.7	2.5	13.5	3.3	2.8	0.0	1.7	2.1	2.6	1.9	6.9	1.7	3.0	3.2	0.0	2.5	3.3	5.9	3.7	2.2	1.7	1.0	3.3	3.7	2.0	2.0	6.3	3.0	3.9	0.0	3.3	4.1	4.3	1.4	2.6	3.2	2.5	2.1
ZNF586	FLJ20070	ENSG00000083828	"Zinc finger protein 586"	Q9NXT0	19	57769655-57819939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 24.6"									"HPA030306, HPA060782"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli fibrillar center"	Vesicles	"HPA030306: AB_2673423, HPA060782: AB_2684362"	"prognostic favorable (9.83e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.36e-4)"	7.6	6.9	11.7	12.3	11.7	27.3	10.6	22.4	13.8	8.5	7.7	6.6	14.7	7.9	9.1	10.0	10.8	8.9	9.2	10.0	11.8	4.4	8.5	7.8	16.5	16.2	9.3	8.7	13.9	8.4	6.6	13.4	9.0	8.4	13.5	8.1	9.8	14.3	18.4	33.3	12.4	10.2	7.7	8.7	16.2	9.8	7.0	13.0	11.6	10.7	8.8	12.2	12.0	11.5	7.2	6.1	20.8	6.6	6.3	10.0	5.2	5.0	4.5	6.1	7.2	3.1	2.8	10.2	3.6	3.6	5.1	2.6	2.0	5.2	10.8	0.4	3.3	4.8	3.8	1.1	4.8	9.2	1.6	24.6	8.5	10.1	1.3	5.3	8.0	7.7	4.5	5.7	3.6	5.6	5.9	5.9	11.2	5.4	0.6	5.8	1.7	8.2	5.7	9.1	3.3	11.8	8.3	2.3	13.6	5.8	13.3	8.9	4.1	1.7	5.2	3.9	5.7	5.4	6.3	3.3	6.8	3.7	0.3	6.0	12.1	15.0	11.4	3.7	0.9	4.8	4.4	6.6	20.5	6.1	5.5	5.9	5.2	7.9	6.5	6.1	7.2	10.0	9.0	20.8	6.3	3.6	4.7	9.9	5.2	11.7	11.7	22.4	13.8	11.8	4.4	9.3	8.7	8.4	13.0	0.0	1.0	12.3	7.2	10.8	3.2	4.6	0.0	0.0	1.2	3.5	0.0	5.8	8.3	2.4	0.2	5.5	2.7	0.0	1.7	6.1	4.5	3.2	3.5	2.5	4.7	6.4	2.9	3.7	8.6	0.8	0.9	6.3	3.3	6.4	3.2	2.9	2.0	0.0	2.5	4.5	4.9	6.5	2.6	4.9	6.8	9.9	8.4	8.7	3.8	7.0
ZNF592	"CAMOS, KIAA0211, SCAR5"	ENSG00000166716	"Zinc finger protein 592"	Q92610	15	84748635-84806432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020332, HPA021600"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020332: AB_1859365, HPA021600: AB_1859364"	"unprognostic (2.83e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.04e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.62e-1)"	16.8	15.0	19.0	19.8	20.0	20.5	22.5	20.4	20.6	17.3	16.4	22.7	16.6	17.0	21.5	17.8	12.9	19.0	14.7	16.4	18.6	13.4	15.7	17.5	15.8	21.0	22.5	12.0	26.9	23.5	23.3	18.4	13.0	16.8	15.2	15.9	16.1	14.9	15.8	31.3	21.2	17.9	17.7	19.1	20.0	13.8	17.8	21.0	23.9	16.7	15.9	19.7	14.7	21.3	3.7	3.4	6.6	3.5	2.3	3.3	1.7	7.1	12.1	11.3	6.3	12.6	8.5	12.4	5.0	7.2	8.4	6.7	11.5	8.5	10.4	6.5	11.3	7.2	13.2	17.3	7.2	5.9	8.3	10.3	12.0	12.0	10.1	7.7	9.7	9.6	9.2	10.2	6.5	10.8	10.0	7.2	7.3	11.8	6.6	8.7	11.0	6.5	11.9	10.2	6.8	4.8	9.6	10.1	9.1	8.8	14.6	10.2	11.1	11.5	10.4	8.2	16.4	5.8	20.8	10.2	12.5	7.3	6.9	9.5	7.6	8.0	11.3	7.9	14.5	7.2	0.0	3.1	2.2	3.3	3.5	1.3	3.7	2.1	3.1	3.4	3.7	2.8	2.4	6.6	2.3	3.2	2.7	1.8	1.7	19.0	20.0	20.4	20.6	18.6	13.4	22.5	12.0	16.8	21.0	8.9	13.8	6.2	3.9	7.4	8.9	4.6	7.6	2.7	5.7	3.5	7.9	4.4	0.0	6.6	6.6	7.1	13.7	0.0	6.9	6.2	7.7	4.8	3.5	13.7	9.8	3.2	7.5	12.3	13.6	7.6	4.4	8.8	6.8	8.2	9.1	4.4	8.3	10.8	9.2	5.4	8.2	6.5	5.1	10.5	10.4	6.1	4.0	6.9	9.2	4.1
ZNF596		ENSG00000172748	"Zinc finger protein 596"	Q8TC21	8	232137-264703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 35.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.0"					"Low region specificity"	"Detected in all"			HPA055463	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA055463: AB_2682821"	"unprognostic (3.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.07e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-1)"	"unprognostic (1.70e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.53e-1)"	4.9	6.2	6.3	9.9	7.4	2.6	8.5	18.2	10.1	6.7	4.4	8.3	8.3	4.3	10.4	11.9	4.7	6.7	6.3	5.1	7.5	7.0	6.1	5.3	4.8	5.3	6.8	7.3	7.8	7.1	13.5	10.9	5.5	6.2	6.1	5.3	6.6	4.2	9.4	10.2	6.7	4.1	7.7	7.8	6.8	5.4	22.4	7.8	7.4	9.2	4.2	4.4	4.5	4.8	6.8	4.4	6.4	5.0	2.9	7.3	2.6	1.8	1.1	5.5	14.0	2.9	2.7	4.6	4.2	1.9	1.7	2.9	1.4	2.3	1.8	1.4	3.4	2.3	3.6	1.5	3.3	2.1	1.4	2.1	3.9	3.4	1.3	3.2	1.7	1.9	6.2	0.5	1.9	3.0	2.7	1.3	6.1	2.4	6.0	9.8	5.9	4.3	1.6	2.9	3.6	1.3	2.0	1.2	3.3	5.5	3.3	3.1	8.3	2.8	1.4	2.0	2.9	4.2	5.1	3.3	4.1	1.2	0.3	1.8	2.1	5.3	2.2	4.9	1.5	2.6	6.4	2.8	4.5	4.8	2.3	6.7	6.4	5.2	4.2	3.6	6.8	6.2	7.3	3.1	2.9	5.0	4.4	5.6	2.6	6.3	7.4	18.2	10.1	7.5	7.0	6.8	7.3	6.2	7.8	3.0	2.4	0.0	0.7	0.3	8.1	2.8	0.0	5.3	2.3	1.8	2.0	1.8	3.3	1.5	35.2	2.2	1.0	0.0	1.5	1.2	1.1	0.6	4.7	0.9	0.9	11.1	0.0	3.1	0.6	11.0	3.7	0.5	0.0	0.0	1.5	4.0	1.1	0.0	1.1	1.6	8.5	0.0	0.9	10.2	3.9	0.4	1.3	0.8	1.2	0.1
ZNF597	"FLJ33071, HIT-4"	ENSG00000167981	"Zinc finger protein 597"	Q96LX8	16	3432422-3443542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA001556	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001556: AB_1080740"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.75e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.99e-3)"	6.7	6.7	4.5	4.6	8.5	5.0	5.9	5.2	8.7	4.7	4.2	7.3	2.4	3.8	5.6	6.8	4.0	5.9	6.0	5.4	4.8	4.4	5.2	5.4	7.4	6.1	4.5	4.5	7.2	5.2	4.5	7.7	7.9	8.9	4.8	3.2	5.8	4.6	4.9	3.6	4.4	5.1	4.1	4.6	5.4	4.8	13.2	5.4	5.4	6.4	2.6	5.6	5.7	4.6	1.4	1.1	11.3	2.2	0.9	2.2	0.8	0.0	1.8	2.3	5.4	1.7	2.6	8.7	2.6	3.2	2.5	3.2	0.0	3.3	4.4	2.5	2.9	1.9	1.4	5.1	2.3	3.3	2.6	2.0	7.5	4.8	3.1	2.5	4.4	4.5	3.3	3.7	2.8	3.2	2.5	6.8	2.4	1.6	2.9	2.9	1.4	3.1	4.7	7.3	1.9	0.0	2.0	6.7	3.0	2.1	7.1	2.9	4.1	5.1	2.7	1.9	6.4	2.3	6.7	4.4	4.2	2.2	0.0	2.5	3.8	4.0	0.5	0.0	2.6	2.5	3.8	1.1	11.3	1.3	2.2	2.2	1.4	1.0	1.1	1.1	1.1	1.9	1.4	0.3	0.9	1.0	0.5	1.6	0.8	4.5	8.5	5.2	8.7	4.8	4.4	4.5	4.5	8.9	5.4	23.8	1.6	2.7	1.6	0.1	1.9	1.4	0.0	1.4	9.1	1.8	0.0	1.0	0.0	0.9	3.8	2.2	0.7	0.0	0.9	1.6	1.0	2.1	3.5	1.0	1.0	0.0	2.4	3.1	1.5	3.3	1.1	0.9	0.0	2.8	1.6	1.5	1.6	0.0	2.1	1.2	3.2	6.5	1.0	4.2	6.9	0.4	1.3	0.7	2.3	1.8
ZNF598	"FLJ00086, HEL2"	ENSG00000167962	"Zinc finger protein 598"		16	1997654-2009823	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041760, HPA041896"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041760: AB_10792490, HPA041896: AB_10796464"	"unprognostic (9.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.81e-2)"	8.4	6.1	4.1	9.1	9.4	14.3	13.9	10.6	9.5	8.3	7.7	8.8	4.7	9.9	8.7	4.0	10.0	7.1	4.8	5.6	5.2	4.1	5.9	12.2	7.8	9.1	4.2	7.1	9.8	24.8	6.5	12.9	8.1	6.4	8.9	3.2	6.8	15.6	7.3	12.9	15.3	9.9	9.5	2.9	11.8	12.4	10.1	6.1	10.0	7.7	10.6	12.5	6.8	7.6	1.8	3.2	0.6	0.9	1.2	1.7	0.5	9.9	12.8	3.3	7.9	3.0	4.1	9.5	7.4	3.8	4.9	3.9	13.9	6.0	9.9	9.3	4.8	4.1	11.8	5.4	9.2	1.3	14.1	30.9	7.7	13.7	7.6	13.5	12.3	8.8	4.5	12.6	7.8	15.1	2.8	5.3	12.4	17.3	15.5	2.5	17.1	11.7	19.1	9.6	5.4	15.6	26.7	6.5	23.1	2.4	3.6	15.9	12.9	7.6	9.3	12.0	1.1	6.5	20.6	8.6	10.5	12.5	9.0	13.9	17.4	15.4	13.1	4.5	11.9	9.6	0.6	0.6	0.2	1.2	0.7	1.7	1.1	1.2	0.9	0.7	1.8	1.1	1.6	0.4	1.2	0.9	3.2	0.3	0.5	4.1	9.4	10.6	9.5	5.2	4.1	4.2	7.1	6.4	6.1	6.0	11.5	3.0	10.2	26.4	12.0	0.8	15.3	5.3	6.8	1.8	15.7	8.1	0.0	7.5	4.1	10.0	14.0	23.3	22.5	11.0	12.2	16.3	12.7	17.3	8.2	15.9	10.9	7.4	10.3	7.5	12.4	9.1	1.7	7.2	31.1	7.1	17.5	5.8	7.8	2.7	10.0	0.0	10.5	6.3	13.0	30.5	7.8	6.9	16.5	17.6
ZNF599	FLJ30663	ENSG00000153896	"Zinc finger protein 599"	Q96NL3	19	34758076-34773229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 28.2;Early spermatids: 64.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA014701	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA014701: AB_1859371"	"unprognostic (3.52e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.35e-3)"	"unprognostic (9.20e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.12e-3)"	5.9	8.1	10.0	5.2	12.5	2.4	8.5	16.8	8.0	10.1	6.5	11.7	5.8	4.5	12.2	21.4	4.4	14.1	6.5	5.8	10.3	6.8	9.7	4.9	6.0	5.7	10.5	5.7	11.4	5.7	14.3	13.2	6.0	8.1	10.4	5.5	11.6	7.4	9.5	5.5	8.0	5.4	7.1	8.1	6.5	5.9	19.9	11.2	10.4	13.2	6.0	6.2	6.4	7.2	4.3	3.8	6.4	4.8	5.7	6.7	2.9	5.2	2.6	5.9	5.4	6.5	8.7	3.2	1.9	5.4	4.8	5.7	2.3	3.6	0.6	5.6	3.7	4.4	2.7	3.8	2.5	6.0	0.6	4.8	4.1	5.4	6.5	5.0	0.9	4.6	7.8	3.6	2.2	2.3	8.9	5.5	9.9	6.8	0.5	7.5	2.1	10.1	4.2	2.5	7.2	0.2	5.5	5.5	3.3	6.0	1.2	7.0	9.9	6.5	1.2	3.8	4.5	3.4	0.5	2.9	4.8	5.4	3.6	2.0	6.1	6.6	0.5	2.9	0.1	4.5	3.1	1.1	6.4	6.1	2.5	4.0	2.0	6.5	3.5	1.7	4.3	6.7	5.9	0.6	5.7	4.8	3.8	4.9	2.9	10.0	12.5	16.8	8.0	10.3	6.8	10.5	5.7	8.1	11.2	0.0	3.0	0.8	5.4	2.7	3.1	3.7	2.5	22.7	10.3	17.4	2.0	6.8	28.2	3.7	64.0	4.9	1.6	0.0	2.0	3.8	6.0	6.5	0.0	2.5	3.2	0.0	1.2	6.2	1.5	24.3	9.5	1.3	5.0	1.0	3.1	11.2	2.5	0.0	4.6	11.5	2.4	6.5	4.4	22.1	5.5	1.4	1.6	4.3	3.4	4.7
ZNF605		ENSG00000196458	"Zinc finger protein 605"	Q86T29	12	132918308-132956306	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA061970, HPA062655"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA061970: AB_2684649, HPA062655: AB_2684820"	"unprognostic (2.38e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.16e-6)"	"unprognostic (3.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.53e-2)"	"unprognostic (9.06e-3)"	5.5	8.2	10.9	7.6	9.9	3.2	12.2	19.0	12.8	10.1	8.3	8.4	9.5	6.7	10.2	13.1	7.3	9.3	6.6	9.9	10.8	7.9	9.9	8.1	7.6	8.0	7.8	8.2	13.3	8.2	16.9	12.9	10.2	8.1	10.7	6.9	9.9	8.8	9.6	14.6	11.5	8.3	8.2	7.4	7.4	8.7	4.8	9.1	8.5	15.5	6.1	7.5	8.5	9.9	2.6	1.4	1.9	1.2	1.7	3.0	0.8	4.5	3.7	9.6	9.1	5.3	10.9	7.2	6.3	3.6	2.9	2.1	0.6	0.6	1.9	3.4	5.4	3.6	2.5	4.2	1.6	3.6	1.6	7.1	8.7	2.9	2.9	4.0	3.6	9.7	7.0	7.0	2.0	4.5	9.0	2.2	4.6	1.3	0.1	7.3	1.3	4.8	5.1	7.4	1.3	5.1	4.4	6.3	1.3	5.0	7.9	6.2	7.1	2.8	1.7	4.3	5.9	10.4	10.6	4.3	3.7	5.9	5.4	2.5	0.0	0.0	1.6	0.1	3.1	2.1	1.6	1.2	1.3	1.6	0.8	0.9	2.6	1.4	1.7	0.9	2.2	3.0	1.9	1.9	1.7	0.9	1.4	0.4	0.8	10.9	9.9	19.0	12.8	10.8	7.9	7.8	8.2	8.1	9.1	17.9	36.9	2.7	8.2	3.1	33.5	19.9	20.4	21.4	39.8	8.7	27.5	5.6	8.3	5.7	1.5	8.3	4.5	0.0	3.0	3.1	7.6	7.4	9.3	4.3	3.2	38.1	5.8	13.5	6.5	1.3	14.7	3.8	0.0	4.6	9.8	19.8	6.8	0.0	12.7	4.2	36.9	12.9	6.2	5.4	7.3	4.0	4.7	5.0	7.3	6.5
ZNF607	"FLJ14802, MGC13071"	ENSG00000198182	"Zinc finger protein 607"	Q96SK3	19	37696363-37719790	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 25.9;Late spermatids: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA049465, HPA055018"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049465: AB_2680778, HPA055018: AB_2682674"	"unprognostic (6.70e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.86e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.23e-5)"	3.1	5.4	8.1	4.2	9.0	1.4	7.7	14.9	9.4	5.9	4.9	9.8	4.6	3.9	9.0	8.0	5.6	10.8	4.2	5.6	7.0	6.6	5.9	1.6	4.7	5.6	12.3	7.2	12.2	5.0	14.0	12.3	6.1	9.3	7.2	4.9	6.7	4.4	6.2	4.4	7.9	4.6	8.4	11.3	5.5	5.5	13.9	8.7	7.3	9.1	2.4	7.2	5.5	6.0	5.7	3.0	2.8	0.4	3.8	5.3	1.5	5.1	5.3	8.4	8.8	4.6	5.3	5.9	3.7	3.7	3.5	6.3	8.1	2.9	7.2	5.6	4.0	4.6	2.6	8.2	2.8	5.3	3.6	8.4	3.5	4.5	4.4	3.7	0.1	2.2	3.5	5.6	4.2	4.0	5.1	1.8	4.8	7.3	0.0	3.8	4.4	7.0	3.9	9.9	3.6	2.2	3.4	13.0	1.9	3.7	6.7	2.4	7.6	0.2	2.2	0.7	6.4	5.9	0.6	0.4	2.6	1.8	3.0	4.3	7.3	7.9	10.2	0.1	0.0	3.3	0.0	0.4	2.8	2.7	0.3	1.7	5.7	4.2	5.3	1.5	4.2	3.6	4.4	0.0	3.8	0.4	3.0	1.5	1.5	8.1	9.0	14.9	9.4	7.0	6.6	12.3	7.2	9.3	8.7	3.0	0.3	0.0	0.7	1.1	2.5	3.0	0.0	8.1	2.3	1.8	2.0	1.9	0.0	1.5	25.9	1.4	0.7	0.0	1.1	2.1	0.9	0.9	0.0	0.4	1.2	1.6	0.0	1.3	0.0	20.8	0.9	1.0	3.3	1.0	1.7	2.0	0.7	0.0	1.8	1.0	1.3	0.0	1.3	2.9	5.3	1.0	0.7	1.3	1.2	0.7
ZNF608	"DKFZp434M098, KIAA1281, NY-REN-36"	ENSG00000168916	"Zinc finger protein 608"	Q9ULD9	5	124636913-124748807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Club cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.2;naive B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 25.1;AN3-CA: 16.0;REH: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005545, HPA076984"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA005545: AB_1080742, HPA076984: "	"unprognostic (3.82e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.56e-2)"	8.5	14.7	17.0	7.5	17.2	2.0	10.1	25.5	16.5	11.5	10.4	28.3	2.8	15.7	7.5	7.1	5.4	13.6	10.1	12.5	19.7	8.8	8.2	3.9	15.3	10.8	21.8	10.7	9.6	12.0	9.1	11.6	4.5	18.0	8.5	10.7	14.1	8.3	7.1	8.9	4.8	9.1	6.4	22.9	3.9	9.8	13.0	24.5	4.6	13.4	3.3	11.0	6.6	6.6	3.1	1.1	5.2	0.0	0.0	0.0	0.0	0.1	0.4	25.1	16.0	3.7	6.1	0.0	0.0	0.6	0.1	1.5	2.6	7.5	8.2	8.4	0.0	4.0	0.3	1.7	1.5	0.1	0.0	4.0	0.0	0.0	0.1	5.8	0.0	0.7	6.1	4.5	0.7	0.7	3.8	5.3	0.0	0.8	0.1	1.3	0.0	0.0	0.0	10.6	0.2	0.3	43.6	2.2	0.0	3.6	0.3	3.8	13.2	0.0	0.3	5.6	14.9	1.4	0.7	1.4	5.1	9.8	0.1	1.5	4.0	3.9	14.8	1.3	0.2	7.2	5.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	3.1	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	17.0	17.2	25.5	14.3	19.7	8.8	21.8	10.7	18.0	24.5	29.8	27.0	3.7	10.9	1.1	34.0	19.7	10.2	20.1	60.3	14.0	37.3	0.6	3.3	12.1	10.4	13.7	9.3	0.0	7.7	3.3	4.7	3.1	0.0	0.9	0.6	39.7	38.4	11.6	0.3	5.7	2.0	1.2	6.8	3.6	5.3	38.4	5.6	7.6	1.4	5.7	37.0	0.0	1.6	12.0	5.8	0.6	0.3	0.0	7.0	1.6
ZNF609	KIAA0295	ENSG00000180357	"Zinc finger protein 609"	O15014	15	64460742-64686068	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040742, HPA040832"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040742: AB_10963581, HPA040832: AB_10960400"	"unprognostic (2.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	11.1	11.2	14.5	14.5	12.6	7.3	11.4	17.1	15.1	17.9	14.2	16.2	19.1	12.1	18.7	8.4	10.2	15.7	14.0	10.9	12.3	10.4	9.1	10.2	13.9	11.3	10.9	11.0	29.9	11.6	18.1	11.6	16.3	10.9	15.2	11.4	14.6	12.6	22.8	9.2	11.9	11.2	16.1	12.7	12.9	11.4	28.9	13.6	21.4	12.4	4.5	12.1	15.6	28.4	1.2	2.8	3.2	1.7	4.0	3.0	0.5	6.1	15.6	16.9	6.4	6.5	8.3	5.8	8.1	10.8	10.2	10.3	9.6	9.8	10.6	6.8	9.5	13.9	13.2	24.7	11.1	10.7	12.3	5.3	19.4	9.0	4.7	12.0	11.1	13.0	8.4	10.2	10.6	21.0	14.8	18.8	9.1	30.4	6.9	8.3	5.6	8.6	4.7	12.8	8.3	4.4	7.9	15.4	5.5	7.4	11.1	13.7	10.5	11.0	12.6	7.5	16.9	6.2	7.8	18.7	9.5	15.2	4.9	10.0	7.7	8.7	9.6	5.9	12.2	7.7	3.2	1.7	1.9	2.3	0.7	1.6	0.7	1.3	1.6	0.6	1.2	3.0	3.0	2.1	4.0	0.8	2.8	0.8	0.5	14.5	12.6	17.1	15.1	12.3	10.4	10.9	11.0	10.9	13.6	11.9	20.1	6.1	13.9	16.0	28.1	18.3	17.8	30.8	25.0	17.4	133.5	12.7	3.3	12.3	17.2	14.4	9.9	0.0	12.8	11.9	12.1	18.2	9.3	11.6	8.7	42.9	17.9	17.8	23.1	9.6	16.7	11.6	13.5	9.0	10.8	19.5	11.6	11.5	13.1	3.1	56.5	19.4	9.2	31.7	14.0	15.2	26.1	13.3	10.5	15.6
ZNF610	FLJ36040	ENSG00000167554	"Zinc finger protein 610"	Q8N9Z0	19	52336245-52367778	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.7"									"HPA055771, HPA078134"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055771: AB_2682914, HPA078134: AB_2732372"	"unprognostic (1.13e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.73e-3)"	2.3	4.8	7.9	2.1	11.9	0.8	5.5	11.0	9.7	5.5	3.0	6.9	3.3	1.5	5.1	11.7	2.1	7.4	4.3	4.2	7.6	7.7	5.9	1.0	3.3	2.6	7.5	7.2	14.3	2.9	7.5	6.8	4.5	10.0	7.6	2.9	5.7	2.2	4.1	1.9	1.6	1.8	4.4	8.5	4.1	2.7	18.1	7.3	3.6	7.7	0.2	2.1	3.6	2.4	3.6	1.5	4.0	0.5	2.5	4.8	1.6	0.2	0.0	6.0	4.9	4.0	3.4	4.6	1.8	3.3	1.1	3.3	0.0	0.4	0.4	3.7	0.8	7.4	0.2	0.0	0.0	2.8	0.1	2.9	0.1	0.3	0.2	4.8	0.0	1.5	4.6	0.1	1.2	0.2	2.9	3.4	3.3	0.3	0.2	5.4	1.2	3.1	0.9	5.7	0.0	0.4	2.2	4.5	0.6	2.1	4.3	7.5	4.3	0.1	0.4	1.8	8.9	3.6	2.6	2.7	0.3	2.0	0.1	2.3	0.2	11.7	0.0	0.0	0.1	2.3	4.0	0.5	1.1	2.9	0.1	4.4	2.5	2.4	2.3	1.4	3.6	4.8	2.0	1.4	2.5	0.1	1.5	3.2	1.6	7.9	11.9	11.0	9.7	7.6	7.7	7.5	7.2	10.0	7.3	0.0	0.3	0.0	0.8	0.0	2.9	2.6	2.5	2.7	3.4	3.5	3.9	1.2	5.0	1.6	28.1	1.1	0.0	0.0	0.0	1.4	0.8	0.9	2.3	0.0	0.5	0.0	0.0	0.6	0.8	7.0	0.9	0.0	1.7	0.0	0.0	3.8	0.2	0.0	1.1	0.6	2.4	6.5	0.4	5.0	2.3	0.3	0.6	0.0	0.4	0.3
ZNF613	FLJ13590	ENSG00000176024	"Zinc finger protein 613"	Q6PF04	19	51927147-51948759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 25.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA026833	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA026833: AB_1859377"	"unprognostic (1.10e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-3)"	"prognostic favorable (1.92e-6)"	4.7	5.3	7.1	3.9	7.4	1.6	9.5	14.2	7.4	5.3	6.5	5.2	1.9	2.8	5.5	5.3	4.7	4.3	3.7	4.3	9.7	4.7	8.7	4.0	4.9	6.3	7.2	4.9	6.5	3.4	7.4	7.0	8.2	8.8	25.4	6.7	5.4	4.5	5.6	3.9	4.5	4.9	5.8	7.5	6.7	4.2	3.5	7.0	9.0	7.3	2.6	5.2	5.8	4.1	10.1	9.6	14.1	11.3	9.5	14.3	7.0	3.1	4.1	6.8	6.8	5.9	6.8	1.7	5.2	8.4	7.0	9.1	1.3	3.7	2.6	2.8	6.5	6.2	3.5	6.6	6.5	7.6	0.1	8.6	5.5	2.9	3.9	6.1	0.3	7.8	5.0	7.5	6.6	5.4	8.6	7.5	6.5	2.5	0.0	7.0	0.5	9.1	4.0	4.9	1.3	5.9	5.0	7.3	2.8	6.8	10.7	4.6	4.5	8.5	6.2	5.0	11.2	6.5	6.7	4.8	3.1	5.8	2.3	5.6	6.0	0.0	5.1	0.2	0.0	9.2	7.7	7.4	14.1	10.4	7.5	9.3	7.6	11.1	12.1	9.6	10.1	11.2	14.3	7.6	9.5	11.3	4.8	10.0	7.0	7.1	7.4	14.2	7.4	9.7	4.7	7.2	4.9	8.8	7.0	3.0	1.6	0.0	0.5	0.5	2.1	3.1	2.5	0.0	3.4	3.5	0.0	4.9	3.3	2.1	2.0	2.4	1.0	0.0	1.9	1.5	0.9	1.1	1.1	1.5	2.6	0.0	1.2	1.8	1.8	0.4	1.1	1.1	0.0	3.6	2.9	2.2	1.7	2.8	1.4	1.4	4.2	0.0	0.5	1.6	1.1	0.5	5.9	0.9	1.7	0.5
ZNF614	FLJ21941	ENSG00000142556	"Zinc finger protein 614"	Q8N883	19	52012765-52030240	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 37.9;Late spermatids: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA021197	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			Nucleoplasm	"Vesicles, Cytosol"	"HPA021197: AB_1859380"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.15e-3)"	7.7	7.1	9.9	5.6	9.4	10.1	10.1	15.6	12.5	9.2	7.3	6.6	5.8	4.5	9.5	7.3	6.3	8.8	6.0	7.0	7.9	8.5	6.9	4.7	6.3	8.2	9.3	7.1	14.0	5.1	6.5	13.7	14.2	9.7	16.4	5.5	5.5	5.4	8.9	11.1	7.6	6.3	8.9	13.5	9.7	5.8	13.8	10.7	18.2	14.3	5.1	7.5	8.5	9.6	6.0	5.5	4.3	5.9	9.6	8.1	3.2	3.8	2.9	7.4	9.5	5.2	5.9	1.0	5.2	3.7	4.9	5.9	3.7	2.2	9.7	2.9	4.4	4.5	1.7	10.8	6.9	7.2	2.6	15.5	14.6	5.2	7.3	4.3	3.0	7.4	4.5	3.8	4.9	6.9	4.9	5.6	8.6	7.7	2.2	6.4	1.5	12.5	6.0	8.4	0.6	5.2	8.3	14.1	8.0	5.0	9.8	9.9	5.9	3.1	3.9	3.2	9.5	5.2	7.7	5.7	4.8	6.6	2.7	6.2	4.4	6.8	14.9	4.6	4.2	6.3	4.3	4.3	3.0	6.5	5.9	7.8	6.0	5.7	6.1	5.5	6.0	8.1	5.3	3.3	9.6	4.5	3.1	5.9	3.2	9.9	9.4	15.6	12.5	7.9	8.5	9.3	7.1	9.7	10.7	0.0	2.1	0.9	3.8	2.9	5.5	5.3	2.5	0.0	6.8	5.2	3.9	4.6	0.0	2.4	37.9	4.4	1.6	0.0	0.8	4.7	3.7	3.9	6.9	1.5	2.1	15.9	5.2	5.5	6.4	32.8	3.7	2.2	1.7	1.0	2.0	4.1	1.0	0.0	6.7	1.8	5.1	0.0	6.4	2.2	4.7	2.4	12.0	2.5	2.2	4.4
ZNF615	FLJ33710	ENSG00000197619	"Zinc finger protein 615"	Q8N8J6	19	51991332-52008230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA052422	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA052422: AB_2681825"	"unprognostic (2.20e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.08e-3)"	"unprognostic (7.28e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.98e-4)"	10.2	7.4	11.9	6.0	16.4	7.5	10.1	20.7	12.2	8.2	8.8	7.3	6.9	5.2	12.0	7.8	6.5	9.8	7.6	8.5	8.5	7.1	9.5	6.1	7.6	6.2	11.7	9.8	15.7	7.5	16.6	17.8	8.3	9.9	26.9	5.8	8.0	7.7	11.0	7.2	7.2	6.0	9.6	12.8	7.9	6.7	5.5	13.6	7.3	11.7	3.8	6.1	11.1	8.8	4.7	4.8	6.9	4.4	12.0	7.8	3.8	1.3	5.2	5.8	11.8	10.6	7.7	4.4	3.9	6.6	5.4	5.6	1.1	1.4	2.1	2.2	4.7	3.4	1.4	4.0	2.5	5.0	0.3	8.9	6.7	5.2	3.9	8.3	0.0	4.0	6.5	2.8	8.5	9.1	10.0	2.9	2.1	0.0	0.0	4.1	0.4	0.0	3.5	6.0	0.2	8.8	4.2	9.1	3.7	3.7	9.1	5.2	4.5	4.8	4.5	3.2	6.4	6.5	3.3	5.2	5.1	5.9	3.3	2.8	4.0	10.4	2.6	3.0	0.0	8.2	6.9	3.0	5.8	3.7	4.4	7.8	3.9	6.6	5.3	4.8	4.7	6.6	4.3	4.1	12.0	2.7	2.9	5.7	3.8	11.9	16.4	20.7	12.2	8.5	7.1	11.7	9.8	9.9	13.6	6.0	4.5	3.2	1.9	2.5	7.1	5.9	2.5	4.0	1.2	3.5	5.9	3.2	3.3	1.6	0.9	2.9	1.1	0.0	1.0	2.2	3.8	5.2	0.0	1.9	2.6	3.2	8.6	3.7	3.3	0.9	2.3	3.2	6.8	1.8	2.6	3.0	1.3	3.7	3.9	2.4	6.2	6.5	5.7	2.6	2.1	3.4	4.2	4.4	2.1	1.8
ZNF616	MGC45556	ENSG00000204611	"Zinc finger protein 616"	Q08AN1	19	52113091-52139922	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA062639, HPA071539"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA062639: AB_2684815, HPA071539: AB_2686414"	"unprognostic (5.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.32e-3)"	10.5	18.1	9.2	4.9	10.6	2.7	8.6	18.7	10.2	9.1	6.6	6.2	5.6	4.9	9.4	8.6	7.2	9.8	6.0	6.3	8.7	4.8	8.4	8.5	7.6	6.3	12.6	8.1	16.1	10.4	12.7	17.7	9.0	9.1	9.9	8.2	6.1	8.0	11.5	5.4	8.0	6.4	8.0	13.7	7.6	6.7	5.3	10.3	11.9	11.6	4.4	7.2	9.3	12.5	4.7	4.5	4.7	10.9	15.7	6.3	2.5	4.1	3.7	12.6	8.6	15.2	12.4	0.1	5.7	6.7	5.4	8.6	4.2	3.5	5.8	3.9	5.3	3.2	2.9	13.0	6.3	8.4	4.0	17.2	10.3	9.7	9.1	8.9	9.8	6.4	9.0	9.0	4.8	18.0	10.0	7.4	8.2	11.4	2.8	7.9	2.9	9.5	5.2	12.9	3.6	11.2	8.4	17.1	8.4	3.9	10.7	12.8	7.0	9.4	4.6	2.9	12.0	5.6	3.3	5.9	4.3	5.0	4.7	5.7	5.7	8.5	8.2	3.6	5.8	8.1	3.2	3.5	4.0	6.3	2.3	5.8	3.8	5.8	5.1	3.9	4.7	5.3	4.9	4.7	15.7	10.9	4.5	3.7	2.5	9.2	10.6	18.7	10.2	8.7	4.8	12.6	8.1	9.1	10.3	6.0	2.7	1.7	3.6	3.7	3.3	2.7	2.5	4.0	1.2	7.0	3.9	2.7	5.0	2.8	0.0	2.1	2.7	0.0	1.6	2.8	3.1	2.6	0.0	1.6	2.7	6.4	1.2	1.8	2.6	0.0	6.1	2.0	1.7	4.6	3.9	4.9	2.2	0.0	2.5	2.0	8.5	0.0	2.4	2.4	3.8	2.3	1.6	3.2	2.8	3.8
ZNF618	"KIAA1952, NEDD10"	ENSG00000157657	"Zinc finger protein 618"	Q5T7W0	9	113876282-114056591	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 20.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023116, HPA061732"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023116: AB_10964204, HPA061732: AB_2684596"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.22e-7)"	"unprognostic (4.57e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.51e-2)"	5.2	7.5	5.0	8.1	5.2	3.4	6.1	19.2	5.0	9.3	3.6	5.4	4.0	3.3	11.5	7.3	3.5	8.4	12.1	3.1	4.3	3.8	13.3	8.2	5.2	3.0	2.8	3.3	15.0	13.3	15.8	11.6	3.2	4.8	5.9	2.5	14.5	6.0	4.8	3.1	3.4	2.6	6.9	2.7	5.4	6.4	5.6	2.4	5.6	10.9	2.6	3.0	4.3	6.6	1.3	4.3	4.0	0.9	2.8	0.9	0.9	4.4	13.6	20.4	8.9	4.9	5.8	1.0	2.9	4.8	5.9	5.2	0.1	3.2	2.4	2.8	5.0	1.6	0.1	10.2	5.0	2.3	0.0	4.0	0.0	1.0	0.0	3.7	2.6	4.6	5.6	2.0	6.2	1.4	5.4	14.8	0.3	0.0	0.0	2.6	7.2	0.1	3.3	10.1	0.3	3.0	18.8	11.9	0.0	6.3	4.9	6.3	15.0	8.3	5.3	5.4	6.1	0.4	5.3	12.0	7.9	6.3	4.4	3.5	0.0	0.0	0.0	0.6	4.0	5.5	4.0	0.9	0.6	0.9	0.5	0.3	0.0	0.1	0.8	3.4	1.3	0.7	0.5	0.0	2.8	0.7	4.3	0.0	0.9	5.0	5.2	19.2	5.0	4.3	3.8	2.8	3.3	4.8	2.4	3.0	10.4	0.8	4.7	1.8	14.0	2.4	28.1	2.7	4.5	10.4	3.9	0.2	6.6	11.5	5.1	3.0	0.0	0.0	7.0	0.2	5.8	2.0	20.7	7.8	3.6	55.6	2.4	12.3	3.3	3.3	14.1	6.0	0.0	18.0	1.4	9.1	9.6	1.9	14.5	8.4	1.1	25.8	11.3	0.1	13.2	3.1	0.2	2.2	2.3	1.6
ZNF619	FLJ90764	ENSG00000177873	"Zinc finger protein 619"	Q8N2I2	3	40477113-40490236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 3.8;Collecting duct cells: 3.5;Rod photoreceptor cells: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045094	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA045094: AB_10959900"	"unprognostic (7.16e-2)"	"unprognostic (5.94e-1)"	"unprognostic (8.38e-3)"	"unprognostic (5.42e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-3)"	"unprognostic (8.28e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.38e-2)"	8.8	7.6	6.3	9.2	9.5	9.0	9.2	7.9	8.7	7.0	6.7	13.3	8.4	7.3	9.3	6.6	6.4	8.4	8.9	6.9	7.8	5.8	7.1	8.1	9.6	18.0	12.7	9.2	9.4	12.3	14.0	6.6	6.3	7.3	7.0	8.2	9.7	8.6	10.4	8.5	7.3	7.5	7.6	9.6	9.0	7.3	3.8	9.3	6.0	10.2	5.0	9.4	8.0	6.8	4.1	4.5	5.1	4.5	5.2	5.1	2.7	2.7	4.0	4.7	4.1	6.9	7.2	1.7	3.6	4.5	7.0	7.0	1.2	3.9	0.3	2.3	3.4	3.2	3.0	4.3	7.5	7.6	4.8	1.6	8.3	3.2	1.9	7.2	5.8	7.5	5.8	5.6	7.1	10.5	6.2	6.5	0.3	5.5	3.9	4.3	3.4	0.1	2.6	2.5	3.4	3.6	1.6	4.8	4.5	2.9	6.3	3.0	3.1	4.1	6.0	3.2	4.4	4.8	3.9	4.9	5.1	4.0	2.8	4.1	2.2	2.8	0.3	3.1	3.6	5.4	2.8	3.2	5.1	3.0	4.5	3.3	3.3	3.0	3.8	4.5	4.1	3.1	3.9	3.8	5.2	4.3	2.8	5.1	2.7	6.3	9.5	7.9	8.7	7.8	5.8	12.7	9.2	7.3	9.3	0.0	0.6	0.0	0.7	0.2	3.8	0.8	0.0	1.4	0.0	3.5	2.0	1.2	0.0	1.1	0.0	1.1	1.0	0.0	1.3	0.8	0.6	0.5	0.0	0.5	1.0	0.0	0.0	1.8	1.0	0.0	1.1	0.2	0.0	1.0	0.7	2.9	0.6	0.0	0.4	1.3	3.7	0.0	0.5	1.0	1.3	0.1	0.3	0.0	1.0	0.6
ZNF620	MGC50836	ENSG00000177842	"Zinc finger protein 620"	Q6ZNG0	3	40505992-40518736	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;monocytes: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 14.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA031452, HPA059383"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA031452: AB_10603939, HPA059383: AB_2732636"	"unprognostic (1.42e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.21e-5)"	"unprognostic (1.28e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.19e-4)"	5.8	5.7	5.2	3.0	8.2	8.0	6.1	15.6	8.5	3.7	5.0	8.9	4.8	4.4	4.0	6.3	3.1	5.3	3.2	4.4	5.6	5.7	6.2	4.5	6.2	3.4	10.3	5.8	4.5	8.1	8.7	15.2	6.3	6.4	5.2	5.9	6.1	3.5	5.7	6.3	2.4	4.7	4.3	5.3	5.2	7.3	3.0	7.4	3.7	9.5	3.7	3.1	4.8	4.5	2.0	1.3	14.2	1.0	3.1	3.9	1.2	2.4	3.5	8.4	3.1	0.9	0.9	4.4	0.6	0.9	4.0	5.8	8.2	5.2	0.0	2.6	0.4	3.5	0.6	12.5	1.1	2.9	7.1	9.7	6.0	8.8	4.6	1.5	2.1	1.2	0.5	0.8	2.5	1.1	1.0	2.7	0.1	3.1	1.0	0.5	4.0	0.4	1.8	9.8	4.6	1.9	3.2	3.6	1.1	3.7	8.5	9.9	7.5	0.6	5.9	3.8	8.7	7.7	2.3	1.8	0.4	5.7	0.8	2.6	1.3	2.1	0.1	1.3	1.2	1.5	14.2	0.6	1.2	2.6	1.0	3.2	0.8	1.0	2.7	0.6	2.0	2.1	2.7	0.9	3.1	0.3	1.3	3.9	1.2	5.2	8.2	15.6	8.5	5.6	5.7	10.3	5.8	6.4	7.4	6.0	2.6	0.8	3.1	0.5	8.8	1.4	5.1	2.7	4.5	0.0	3.9	6.2	5.0	4.5	0.1	4.5	1.9	23.3	2.6	1.3	1.1	2.7	6.9	1.7	1.2	3.2	8.6	4.3	1.8	0.0	0.3	1.6	0.0	18.0	3.3	8.3	2.6	2.8	0.4	3.4	10.6	0.0	3.6	3.1	6.5	0.1	1.6	2.5	3.8	1.3
ZNF623	KIAA0628	ENSG00000183309	"Zinc finger protein 623"	O75123	8	143636013-143656418	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044372	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044372: AB_10966790"	"unprognostic (1.06e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.03e-2)"	9.4	8.7	10.4	10.2	14.1	5.3	11.3	18.2	16.7	14.5	10.7	12.2	10.3	12.1	15.0	11.2	10.3	10.8	10.5	10.0	9.6	9.1	8.1	8.6	10.1	10.9	8.8	14.5	17.7	10.4	9.5	9.9	8.6	11.9	12.4	9.8	8.5	12.0	8.5	11.7	14.0	12.0	12.0	8.3	10.7	8.6	11.2	10.2	12.3	12.6	6.5	11.4	11.7	12.5	2.9	1.3	13.5	3.6	2.0	3.3	1.1	3.3	4.8	3.8	6.1	4.1	6.7	3.5	1.9	3.8	4.1	0.7	3.0	6.0	1.3	2.7	7.1	7.0	2.3	5.8	1.9	3.7	5.5	2.2	7.9	7.7	1.7	3.4	1.3	2.2	3.6	4.6	2.2	10.9	5.5	3.5	7.3	7.7	5.4	4.8	8.9	7.8	2.0	4.5	6.4	17.5	4.5	1.9	8.4	3.1	2.9	5.9	7.5	19.3	4.2	5.2	6.2	6.6	5.0	1.0	7.4	1.2	1.1	2.0	1.5	1.7	4.5	3.4	2.3	4.3	13.5	1.0	3.5	2.6	1.3	1.4	2.7	1.7	1.3	1.3	2.9	3.3	2.5	1.8	2.0	3.6	1.2	1.8	1.1	10.4	14.1	18.2	16.7	9.6	9.1	8.8	14.5	11.9	10.2	6.0	4.6	5.4	3.1	1.4	5.7	9.3	10.2	1.4	1.2	7.0	5.9	5.0	3.3	5.4	3.0	4.5	4.3	0.0	3.2	4.9	3.1	3.1	1.1	5.1	4.8	14.3	5.2	7.4	8.7	2.8	7.8	2.8	3.3	7.2	5.0	7.4	3.9	0.0	13.1	3.7	6.8	19.4	2.0	5.9	12.2	2.3	4.0	4.4	5.0	1.6
ZNF624	KIAA1349	ENSG00000197566	"Zinc finger protein 624"	Q9P2J8	17	16620737-16653856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 15.3"									"HPA023157, HPA023244"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA023157: AB_2671094, HPA023244: AB_2671117"	"unprognostic (2.47e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-1)"	6.1	3.7	5.6	3.6	10.5	2.6	4.9	4.4	7.1	6.2	4.4	7.5	2.0	3.4	6.5	3.0	3.8	5.3	3.2	3.6	5.9	4.6	4.9	2.1	4.9	5.4	14.5	5.8	9.4	2.7	7.0	2.3	7.3	7.6	4.2	4.6	4.1	4.3	4.1	2.2	5.5	3.9	5.2	11.6	8.0	4.7	11.6	11.9	8.9	5.8	2.2	5.2	5.9	4.3	5.6	3.8	3.8	6.9	5.1	5.5	2.1	1.3	2.1	6.4	2.2	3.2	3.8	1.6	2.2	3.6	4.1	3.8	1.1	1.2	3.2	1.9	2.8	1.3	1.8	1.8	2.3	4.5	3.4	2.2	3.5	1.3	0.9	3.1	2.4	3.5	4.3	5.4	2.2	4.7	2.2	3.7	4.0	2.2	0.8	5.3	1.8	5.9	1.0	1.1	4.3	1.0	6.3	10.9	1.0	2.7	2.6	1.9	3.8	2.4	1.7	2.6	15.3	1.4	1.0	5.2	3.9	1.5	1.5	1.6	1.5	1.0	0.0	1.8	0.0	3.3	2.0	2.2	3.8	3.9	6.9	5.5	3.5	4.2	4.2	3.8	5.6	4.7	2.8	0.5	5.1	2.8	1.1	3.0	2.1	5.6	10.5	4.4	7.1	5.9	4.6	14.5	5.8	7.6	11.9	0.0	0.0	0.0	0.4	0.5	3.6	1.4	2.5	5.3	2.3	0.0	2.0	1.2	3.3	1.1	6.3	1.6	0.9	0.0	0.9	1.3	1.8	0.5	3.5	0.0	2.1	7.9	0.0	6.7	4.5	1.1	1.4	1.9	0.0	0.0	1.4	2.3	1.6	0.0	2.5	1.3	2.8	0.0	1.4	6.2	7.3	0.6	1.3	1.8	0.7	0.9
ZNF625		ENSG00000257591	"Zinc finger protein 625"	Q96I27	19	12142090-12156729	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 9.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA074014			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA074014: AB_2686652"	"unprognostic (7.88e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.62e-1)"	4.9	5.2	6.7	3.4	5.4	3.8	8.5	11.2	8.3	7.2	5.1	5.6	7.5	2.8	8.3	10.6	4.7	6.0	4.7	3.7	6.0	8.8	6.0	2.8	4.8	5.2	6.6	5.5	13.1	5.4	6.9	9.4	6.4	6.4	7.3	3.5	7.5	4.0	7.1	2.0	7.3	3.3	6.6	4.7	5.8	3.8	4.6	2.9	1.0	8.7	3.2	3.9	7.3	7.2	1.4	0.4	1.3	0.5	2.9	2.1	0.7	0.7	0.0	6.5	10.8	2.8	2.0	1.1	2.7	3.5	4.0	4.4	0.1	0.2	0.0	5.0	2.1	3.0	0.6	0.0	3.5	3.8	0.0	2.0	2.9	0.0	2.9	1.3	0.2	4.1	1.7	1.4	3.3	2.1	2.8	3.1	0.2	0.0	0.0	6.0	2.1	0.1	1.3	7.8	0.0	3.9	0.2	5.8	0.0	3.4	8.7	4.4	3.0	0.0	0.1	2.2	8.3	4.7	0.2	2.4	9.3	4.2	6.9	3.6	7.1	5.6	0.0	2.2	0.0	3.3	0.7	0.4	0.2	0.7	0.5	0.9	0.5	1.0	1.2	0.4	1.4	1.5	1.2	1.3	2.9	0.1	0.3	2.1	0.7	6.7	5.4	11.2	6.8	6.0	8.8	6.6	5.5	6.4	2.9	3.0	1.0	0.0	0.5	0.3	5.4	0.0	5.1	4.0	0.0	1.8	9.8	3.6	3.3	2.8	0.1	1.5	0.0	0.0	2.7	3.1	1.9	0.5	0.0	0.6	1.2	4.8	1.2	6.2	4.5	1.3	0.6	1.0	0.0	2.8	0.3	4.4	3.1	1.7	1.4	2.1	8.7	0.0	2.3	1.9	8.3	0.6	1.0	0.0	1.2	0.3
ZNF626		ENSG00000188171	"Zinc finger protein 626"	Q68DY1	19	20620061-20661596	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 13.8"									HPA045631	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA045631: AB_2679397"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.31e-1)"	8.1	13.9	10.2	6.0	15.6	4.1	18.5	15.2	14.8	11.2	8.3	12.0	21.6	2.4	13.0	9.5	8.0	14.0	10.7	10.8	10.1	10.1	12.7	6.5	7.2	12.4	10.9	11.1	29.2	9.6	36.3	14.8	8.3	11.0	12.8	4.4	13.6	8.9	23.9	7.3	10.8	6.0	11.9	12.1	7.8	9.1	5.8	11.9	13.6	26.9	4.9	10.7	21.3	9.7	11.4	4.2	11.6	4.3	9.1	8.6	4.2	0.1	0.0	4.3	0.7	5.3	6.9	0.5	4.9	0.5	7.0	6.2	0.2	0.2	0.7	2.6	6.0	8.1	0.8	0.0	0.2	8.9	0.0	0.2	0.0	0.1	1.7	9.4	0.1	0.1	12.9	2.2	4.1	2.2	0.2	3.3	0.2	3.0	0.5	7.3	0.1	0.8	1.1	9.3	0.0	2.2	4.3	3.2	1.6	7.0	5.3	1.5	8.3	0.2	0.5	4.4	8.7	10.3	0.4	0.0	3.2	0.2	12.7	0.5	6.9	13.8	6.2	0.1	0.1	0.5	0.8	1.1	6.0	7.6	1.0	7.3	7.9	8.0	8.6	3.2	11.4	7.7	6.6	11.6	9.1	4.3	4.2	3.7	4.2	10.2	15.6	15.2	14.8	10.1	10.1	10.9	11.1	11.0	11.9	3.0	8.0	18.2	11.4	8.4	11.1	9.0	10.2	12.0	4.5	26.2	9.8	14.9	26.6	6.8	0.8	9.0	0.0	0.0	8.4	19.4	10.3	16.3	6.9	6.4	9.3	12.7	2.4	19.0	3.1	1.5	17.3	6.3	5.0	3.6	0.7	14.2	7.6	0.0	14.5	21.3	7.9	12.9	9.2	7.2	15.8	11.0	36.3	10.1	0.1	13.4
ZNF627	FLJ90365	ENSG00000198551	"Zinc finger protein 627"	Q7L945	19	11559374-11619135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA049770, HPA073463"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA049770: AB_2680871, HPA073463: AB_2686606"	"unprognostic (1.81e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.89e-3)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-1)"	"unprognostic (6.39e-3)"	10.3	8.4	9.9	10.1	11.1	10.5	17.5	15.6	12.8	13.8	9.2	11.1	15.4	8.1	16.7	14.6	7.9	19.4	10.1	8.4	9.2	10.0	15.4	11.0	9.6	10.3	12.3	10.0	20.9	19.7	9.3	17.8	9.8	10.3	13.4	11.0	12.5	11.6	14.8	7.7	10.1	8.5	14.1	9.6	9.9	9.2	12.1	11.8	17.4	19.9	7.8	11.3	11.9	13.8	10.2	8.0	13.4	5.6	7.9	8.9	4.8	4.7	3.9	12.8	15.7	5.8	6.1	7.2	7.0	8.3	8.0	8.2	3.2	3.3	3.5	7.1	5.5	4.1	4.3	5.1	6.9	9.1	6.3	2.3	9.9	2.5	6.2	10.9	5.6	5.7	7.3	9.9	5.5	12.2	12.5	8.8	9.0	9.3	5.1	10.6	9.8	9.0	5.6	9.4	3.2	8.6	10.0	9.6	4.8	9.1	7.5	17.7	12.8	9.2	5.2	9.8	11.4	9.1	15.9	7.8	8.7	4.0	4.9	4.9	7.2	7.0	3.9	4.0	9.3	7.1	13.4	4.9	7.8	5.4	5.6	6.4	10.2	6.6	6.6	8.0	6.9	8.9	7.9	2.6	7.9	5.3	3.1	3.6	4.8	9.9	11.1	15.6	12.8	9.2	10.0	12.3	10.0	10.3	11.8	11.9	5.1	11.9	3.2	1.1	4.7	11.5	10.2	9.4	1.2	8.7	3.9	4.3	14.9	4.7	6.0	3.2	3.2	0.0	2.1	3.5	3.3	4.2	1.1	5.3	2.8	6.4	5.1	4.3	5.7	2.4	4.9	2.1	0.0	3.6	3.8	5.5	4.0	3.5	4.9	6.0	5.6	0.0	4.1	14.4	3.9	2.4	3.9	3.2	3.7	2.6
ZNF628	"ZEC, Zfp628"	ENSG00000197483	"Zinc finger protein 628"	Q5EBL2	19	55476332-55484487	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 25.5;Late spermatids: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044451	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044451: AB_10962507"	"unprognostic (8.70e-2)"	"unprognostic (5.08e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.58e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.88e-3)"	6.8	4.7	3.6	6.0	5.0	9.8	5.0	4.1	10.5	5.5	5.8	5.2	5.6	8.4	6.9	4.7	5.0	5.7	4.8	4.3	2.4	2.4	5.4	10.0	5.5	5.4	1.9	4.9	7.6	6.8	2.8	5.9	6.9	4.6	6.2	2.0	5.4	5.7	5.0	15.0	7.3	7.0	4.9	2.0	7.2	8.0	20.8	2.1	12.1	5.0	5.0	7.5	6.2	4.4	0.6	1.0	0.5	2.3	0.4	1.0	0.3	6.7	4.2	1.0	2.9	0.5	1.3	8.2	4.7	0.9	1.7	1.3	2.6	2.9	6.3	4.6	0.8	1.3	3.9	0.5	2.8	0.2	6.5	15.9	4.4	3.8	2.3	1.8	3.4	11.4	1.0	1.8	1.2	0.7	0.8	1.2	3.8	6.5	3.4	0.6	4.5	4.9	2.3	4.5	1.9	8.4	9.2	1.6	6.0	1.4	4.2	5.2	5.7	3.5	4.0	5.9	0.3	4.0	5.3	2.9	3.0	4.5	3.0	4.8	8.0	6.9	4.9	3.9	2.5	2.9	0.0	0.7	0.5	0.7	0.2	0.5	0.6	1.0	0.6	0.7	0.2	0.3	0.4	0.5	0.4	2.3	1.0	0.0	0.3	3.6	5.0	4.1	10.5	2.4	2.4	1.9	4.9	4.6	2.1	0.0	1.4	5.9	6.4	4.4	4.5	2.0	2.5	0.0	0.0	3.5	3.9	2.9	8.3	2.3	25.5	2.1	5.5	0.0	3.1	2.6	2.8	3.5	13.8	2.6	2.8	4.8	6.9	2.5	1.8	72.4	5.2	2.9	3.3	0.0	4.5	3.8	4.1	5.1	4.2	2.8	2.7	12.9	3.2	4.2	3.6	4.0	4.6	3.8	4.2	4.3
ZNF629	"KIAA0326, ZNF65"	ENSG00000102870	"Zinc finger protein 629"	Q9UEG4	16	30778449-30787202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019550, HPA056051"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA019550: AB_1859386, HPA056051: AB_2683020"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (4.57e-10)"	"unprognostic (8.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.70e-2)"	8.6	12.8	8.4	5.2	12.7	6.3	9.4	15.1	21.1	11.3	9.8	16.4	8.2	9.4	13.6	8.4	7.4	11.9	9.2	19.5	9.0	7.7	10.9	8.2	9.0	3.4	9.4	7.9	15.6	8.9	30.2	9.1	6.5	12.2	9.6	8.1	14.8	10.4	11.5	14.0	12.0	10.3	11.9	7.6	6.7	10.5	6.4	8.9	11.8	9.9	10.2	6.7	11.2	7.4	0.3	2.9	0.8	1.6	1.4	1.3	0.7	6.2	10.3	16.1	12.4	7.9	7.4	2.4	7.1	10.4	11.2	9.5	6.3	5.8	1.1	6.9	11.5	3.5	7.5	7.8	9.4	7.5	0.2	11.7	8.8	9.1	6.5	8.5	3.1	5.4	12.2	7.1	6.9	5.8	8.8	5.9	0.5	12.8	0.2	9.7	13.4	4.6	4.1	8.4	3.0	4.3	15.6	12.4	0.5	9.4	10.4	15.3	17.1	6.9	13.0	1.7	5.5	9.7	11.3	7.1	10.6	6.9	7.1	5.3	0.2	0.0	0.3	6.9	7.8	3.5	0.0	1.6	0.8	0.3	0.2	0.5	0.2	0.3	0.2	1.3	0.3	1.3	1.0	0.1	1.4	0.4	2.9	0.0	0.7	8.4	12.7	15.1	21.1	9.0	7.7	9.4	7.9	12.2	8.9	17.9	10.3	2.0	2.8	1.6	16.3	24.6	5.1	6.7	7.9	8.7	3.9	1.0	1.7	7.0	1.1	6.8	4.3	0.0	6.9	0.3	3.3	3.0	2.3	3.8	3.7	15.9	11.1	6.7	4.1	2.4	8.6	2.5	1.7	10.8	6.2	11.3	9.0	3.5	4.2	3.3	11.1	0.0	3.4	2.6	1.7	1.6	0.5	0.0	9.5	3.4
ZNF630	"BC037316, dJ54B20.2, FLJ20573, MGC138344"	ENSG00000221994	"Zinc finger protein 630"	Q2M218	X	47983356-48071658	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Intestinal endocrine cells: 4.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001053, HPA068130"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001053: AB_2666183, HPA068130: AB_2685961"	"unprognostic (1.03e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.83e-2)"	"unprognostic (9.06e-3)"	"unprognostic (8.68e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.51e-5)"	4.0	5.2	5.3	6.4	9.0	2.1	6.7	8.8	8.5	7.0	5.4	5.9	11.3	3.5	6.3	7.5	5.0	4.8	5.8	5.9	6.0	4.6	5.2	3.0	5.0	5.4	12.3	5.8	11.2	8.3	11.9	10.1	4.9	8.8	8.4	6.2	6.4	6.1	6.9	2.3	4.0	4.2	7.5	7.3	4.8	6.8	1.8	10.1	1.0	9.3	1.5	3.6	8.4	13.7	2.6	3.8	5.8	1.9	1.5	2.8	2.0	1.4	1.1	0.3	0.0	0.1	0.1	0.0	1.9	0.6	1.0	0.9	3.3	5.4	0.1	1.0	2.0	2.3	2.3	0.0	1.0	1.3	0.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	1.3	5.6	3.2	0.0	3.9	1.0	0.0	0.0	5.4	3.6	5.7	0.0	0.0	2.1	4.8	1.6	0.7	1.2	0.0	2.5	3.0	3.2	2.6	7.0	4.8	2.1	5.0	5.7	1.3	1.2	0.0	2.5	2.5	0.0	0.0	4.7	0.0	0.0	0.1	4.5	5.8	1.9	4.8	2.2	1.0	2.4	2.6	2.0	2.0	3.8	1.8	2.5	2.8	2.1	1.5	0.6	0.9	1.1	2.0	5.3	9.0	8.8	8.5	6.0	4.6	12.3	5.8	8.8	10.1	0.0	0.0	0.0	1.0	0.1	2.1	1.0	0.0	0.0	0.0	1.8	0.0	0.1	1.7	1.2	0.0	0.6	0.7	0.0	1.0	0.7	0.6	0.9	0.0	0.0	0.8	0.0	4.1	2.5	0.0	0.0	0.3	0.0	0.0	1.0	1.4	1.1	0.8	0.0	0.4	0.6	0.9	6.5	1.0	0.1	0.5	0.3	0.2	0.8	1.0	0.7
ZNF646	KIAA0296	ENSG00000167395	"Zinc finger protein 646"	O15015	16	31074422-31084196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042364, HPA066468"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042364: AB_10794796, HPA066468: AB_2732746"	"unprognostic (1.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.66e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.23e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	9.8	6.4	5.9	10.4	7.6	13.4	7.3	12.2	7.8	10.2	6.8	10.4	8.2	10.6	9.8	6.8	7.5	8.6	7.6	5.9	6.8	5.5	6.9	6.1	13.5	11.3	10.6	5.6	10.3	8.2	10.1	9.4	8.0	7.2	7.9	4.9	5.8	9.8	14.2	12.4	10.6	9.6	6.5	7.4	12.9	9.1	36.1	9.2	24.7	7.7	5.2	11.5	7.8	10.8	4.0	5.2	19.8	3.7	3.4	4.3	1.5	6.1	12.9	8.5	6.6	6.1	4.8	11.2	6.8	7.2	8.2	7.6	9.4	5.9	12.0	10.9	5.7	5.4	8.3	7.0	7.4	3.2	13.8	6.6	8.9	11.4	7.8	6.3	11.4	13.9	6.1	6.8	8.8	5.0	6.4	4.9	10.3	14.1	7.1	6.2	9.8	12.6	7.8	11.4	2.8	6.7	20.4	16.6	12.1	2.6	5.9	12.3	12.4	7.8	8.3	4.1	3.9	6.9	10.0	9.8	10.4	5.9	6.9	6.3	11.9	10.9	12.2	9.4	12.4	8.1	5.9	3.7	9.4	4.3	3.3	2.2	3.3	2.0	1.7	3.5	4.0	2.2	2.5	19.8	3.4	2.1	5.2	2.0	1.5	5.9	7.6	12.2	7.8	6.8	5.5	10.6	5.6	7.2	9.2	3.0	2.2	2.4	0.9	3.0	3.0	1.2	2.5	1.4	1.2	1.8	3.9	1.5	1.7	3.8	19.8	2.9	5.2	0.0	2.9	1.7	2.1	2.2	1.1	1.5	4.1	1.6	5.8	0.6	2.4	2.7	2.6	4.4	0.0	3.6	3.7	3.7	3.6	5.8	4.2	1.9	1.0	0.0	1.1	10.4	6.7	3.4	2.1	2.2	3.5	2.0
ZNF652	KIAA0924	ENSG00000198740	"Zinc finger protein 652"	Q9Y2D9	17	49289206-49362473	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044408	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA044408: AB_2678932"	"unprognostic (1.33e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.30e-2)"	6.4	6.2	8.5	6.3	23.7	9.7	16.0	8.4	14.5	7.0	8.5	17.1	8.2	5.2	6.8	4.6	5.6	5.5	6.4	5.4	9.6	5.6	5.9	8.0	7.3	6.1	28.3	6.5	7.6	7.4	10.0	7.6	6.5	13.0	6.8	6.4	6.0	12.6	8.2	19.9	11.0	7.0	7.9	15.6	8.6	7.8	9.9	23.4	5.1	8.2	1.5	6.6	8.0	6.7	2.7	2.3	6.2	2.1	1.4	1.8	0.6	4.8	4.0	3.4	4.6	3.4	2.3	4.7	1.9	3.2	2.6	2.7	7.0	3.1	10.5	5.8	3.9	1.7	3.3	3.8	3.9	4.0	4.3	3.1	4.3	5.6	3.9	1.6	3.7	6.4	2.8	2.2	2.2	3.8	1.6	2.6	5.7	3.7	9.8	2.1	6.4	5.1	1.1	3.9	2.3	2.8	4.0	8.4	4.3	1.9	7.1	7.1	4.6	3.5	3.4	4.2	5.2	7.3	4.2	4.5	7.2	6.3	3.2	2.9	11.2	9.0	8.2	3.7	2.6	2.7	3.0	1.6	2.4	1.5	0.8	1.8	1.3	1.1	1.5	1.2	2.7	1.0	1.1	6.2	1.4	2.1	2.3	0.6	0.6	8.5	23.7	8.4	14.5	9.6	5.6	28.3	6.5	13.0	23.4	17.9	13.7	32.2	11.8	14.5	48.4	14.2	28.1	18.7	15.9	27.9	60.9	18.4	11.6	14.9	15.4	19.7	13.4	23.3	17.0	14.6	17.3	19.8	4.7	36.8	11.4	41.3	11.6	25.8	30.8	10.9	44.8	15.0	25.3	6.4	23.9	31.2	15.3	21.0	41.8	12.4	48.2	0.0	19.8	50.7	30.3	21.2	11.2	29.4	20.8	9.7
ZNF654	"FLJ10997, FLJ21142"	ENSG00000175105	"Zinc finger protein 654"	Q8IZM8	3	88059274-88144665	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036172, HPA036173, HPA049262, HPA077939"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364"	"unprognostic (2.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.89e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.72e-3)"	"prognostic unfavorable (9.97e-6)"	"unprognostic (1.29e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-2)"	18.2	8.9	10.9	13.2	11.6	15.1	12.6	18.6	13.3	13.5	11.8	9.8	13.5	9.7	14.0	12.1	14.4	9.5	10.8	10.4	11.3	8.5	11.0	15.4	11.8	12.3	13.9	10.3	14.7	9.5	12.8	21.8	11.9	11.1	12.8	9.8	10.7	12.5	10.2	13.9	14.9	13.4	13.1	15.8	10.1	10.0	12.3	14.8	22.2	13.4	9.4	12.0	16.6	14.6	2.6	2.3	10.0	2.0	6.5	4.0	1.7	4.7	2.0	3.4	4.8	7.6	6.3	3.1	6.3	5.7	4.2	6.0	3.0	2.9	7.5	4.3	5.4	3.0	3.2	3.7	5.8	8.5	4.6	2.0	4.7	2.7	2.2	5.7	5.3	5.3	6.2	5.8	4.7	5.6	9.0	5.7	4.4	3.1	6.2	9.5	3.6	5.3	4.9	1.8	3.9	3.2	3.7	2.3	3.6	4.1	6.2	2.6	2.3	4.5	3.7	11.9	4.6	5.0	4.2	6.4	9.4	6.2	35.2	4.5	7.0	4.8	5.3	7.6	5.1	6.0	10.0	1.9	2.7	2.9	2.0	3.3	1.8	3.2	4.0	2.3	2.6	3.9	2.6	2.7	6.5	1.4	1.1	2.2	1.7	10.9	11.6	18.6	13.3	11.3	8.5	13.9	10.3	11.1	14.8	8.9	13.3	6.9	8.9	19.9	12.3	10.9	7.6	9.4	11.4	5.2	11.8	3.7	1.7	5.6	0.8	11.3	8.7	0.0	4.5	2.9	14.1	9.3	15.1	11.3	5.3	15.9	5.1	9.2	11.7	1.1	6.9	13.3	8.5	1.8	9.2	9.5	7.0	7.0	11.7	4.8	13.3	6.5	6.2	10.4	7.9	16.3	6.9	11.7	7.1	11.5
ZNF658	"DKFZp572C163, FLJ32813, MGC35232"	ENSG00000274349	"Zinc finger protein 658"	Q5TYW1	9	66856426-66932141	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 20.9"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 12.0;Distal tubular cells: 13.3;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in some"	11	"neutrophil: 20.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.9"	"Low cell line specificity"	"Detected in many"											"HPA047730, HPA048668"	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA047730: AB_2680136, HPA048668: AB_2680487"	"unprognostic (9.54e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.18e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	0.5	0.8		0.1		0.0	2.8		1.4	1.6	0.6			0.3	1.5	0.8	1.4	1.8	0.1	1.8			1.5	0.5	0.9	0.5			3.5	1.1	2.4		0.1		1.8	0.7		1.6	1.4	1.9	4.5	0.0	0.9		1.1	0.6	1.2			2.1		0.9	0.9		1.3	0.4	20.9	0.5	1.8	1.4	0.1	2.8	4.8	4.7	8.8	4.8	5.8	3.6	2.2	4.1	3.1	3.4	0.4	2.2	6.4	2.5	2.1	3.3	7.6	3.7	4.4	3.3	0.2	2.3	1.0	4.0	1.0	5.3	4.0	2.4	4.5	9.8	3.0	4.4	6.4	6.0	4.3	1.3	1.3	3.9	1.6	3.2	2.0	4.0	2.0	8.2	0.3	7.5	2.3	3.3	7.3	6.8	4.1	3.5	1.9	3.4	5.1	2.7	10.3	1.3	4.0	5.1	3.5	2.7	0.8	3.7	1.6	1.8	1.4	4.2	0.5	0.5	1.5	0.6	0.4	0.1	0.6	0.9	0.8	0.2	1.3	1.4	0.7	20.9	1.8	0.4	0.4	0.5	0.1											3.0	2.7	0.5	1.0	0.8	6.4	3.2	0.0	12.0	3.4	0.0	0.0	2.3	13.3	0.9	0.6	0.7	0.9	0.0	0.6	0.7	0.9	0.7	1.1	2.4	1.6	9.5	0.0	0.6	1.3	0.9	2.8	0.1	0.0	0.0	1.8	4.9	0.8	0.0	4.9	4.8	3.9	0.0	0.5	2.6	2.0	1.8	0.8	0.0	1.2	0.9
ZNF664	"DKFZp761B128, ZFOC1, ZNF176"	ENSG00000179195	"Zinc finger protein 664"	Q8N3J9	12	123971845-124015439	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 134.6;Late spermatids: 216.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047846			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047846: AB_2680179"	"unprognostic (4.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.90e-2)"	"unprognostic (8.12e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.85e-2)"	22.9	15.0	38.3	11.3	34.5	5.3	29.4	26.9	24.8	23.0	25.5	34.2	26.0	36.6	18.9	35.3	14.4	27.3	16.1	22.4	39.2	30.7	29.3	21.0	20.6	10.4	46.7	20.1	15.2	28.2	72.1	33.4	17.0	28.7	21.1	28.3	22.2	31.2	21.1	21.3	8.9	39.8	14.6	61.8	11.1	20.1	12.0	30.0	10.1	43.9	11.0	13.2	15.3	17.5	2.4	1.0	0.5	0.6	1.7	4.3	1.7	25.0	17.6	28.2	29.4	22.2	16.9	24.0	14.7	20.0	15.3	12.6	21.8	13.8	24.7	18.0	19.9	11.0	22.1	40.3	18.1	28.4	20.8	29.1	38.4	23.0	18.4	26.7	23.1	21.2	10.7	40.6	15.9	26.2	36.1	24.3	24.3	23.4	10.5	13.6	19.2	22.8	10.6	26.4	24.8	38.3	19.9	27.5	14.9	33.2	41.4	58.6	42.5	25.3	27.1	24.8	24.6	48.3	12.3	15.8	13.3	21.6	18.7	15.2	14.5	18.0	19.5	23.1	16.3	20.4	0.2	0.6	0.5	2.8	0.3	4.3	1.9	2.2	2.4	1.0	2.4	2.7	2.2	0.3	1.7	0.0	0.8	3.8	1.7	38.3	34.5	26.9	24.8	39.2	30.7	46.7	20.1	28.7	30.0	23.8	40.2	18.0	12.5	11.2	23.4	54.0	33.1	56.2	40.9	19.2	19.6	7.7	24.9	30.5	134.6	18.0	68.9	0.0	27.3	7.3	27.4	34.5	12.7	38.4	10.7	30.2	42.1	17.2	14.3	216.3	21.6	7.0	20.3	3.6	59.6	29.4	34.9	45.6	16.3	22.7	30.2	19.4	18.6	21.1	25.1	7.8	8.4	10.1	48.2	15.8
ZNF665	FLJ14345	ENSG00000197497	"Zinc finger protein 665"	Q9H7R5	19	53159213-53193386	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023437	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA023437: AB_2671205"	"unprognostic (8.01e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.81e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.45e-1)"	"unprognostic (9.27e-2)"	4.3	3.8	4.2	4.3	6.7	2.3	5.1	10.7	6.2	5.3	4.0	5.7	2.6	1.6	6.4	5.2	3.2	6.7	2.9	2.6	5.2	2.6	2.6	1.1	3.6	4.2	5.5	3.2	11.5	2.7	7.7	4.8	2.9	4.8	6.0	2.6	6.0	2.9	4.0	1.4	3.3	2.6	5.5	6.5	3.9	2.9	3.4	7.0	7.2	5.8	1.5	3.2	5.4	4.1	5.4	1.6	1.5	1.1	4.9	2.2	0.5	1.1	0.2	1.2	3.8	1.2	2.2	2.8	2.8	1.7	2.7	3.8	0.5	1.0	2.0	2.0	2.0	1.8	0.4	0.7	0.2	4.4	0.0	0.1	0.1	0.7	0.1	2.7	0.5	1.0	2.6	0.0	2.4	0.0	0.8	0.2	0.1	0.4	0.6	0.1	0.4	5.4	1.6	2.2	0.0	0.6	0.1	0.1	0.8	0.5	5.3	0.5	2.4	0.2	0.4	0.1	2.8	1.5	1.1	0.7	1.8	2.2	1.7	1.0	0.3	4.6	4.9	0.1	1.4	2.6	1.5	0.5	1.1	0.8	0.3	1.0	2.7	1.0	2.2	0.9	5.4	1.8	1.9	1.4	4.9	1.1	1.6	0.7	0.5	4.2	6.7	10.7	6.2	5.2	2.6	5.5	3.2	4.8	7.0	17.9	9.6	1.7	2.9	1.0	5.7	0.8	2.5	8.1	6.8	5.2	0.0	2.0	3.3	1.1	1.5	2.5	0.3	0.0	0.6	2.1	1.9	2.1	4.7	0.4	1.1	11.1	2.4	1.8	1.0	0.8	2.0	1.1	1.7	2.8	0.3	6.8	0.4	0.0	2.8	0.3	3.7	0.0	2.1	1.9	7.0	0.5	0.7	3.8	0.7	2.0
ZNF667	FLJ14011	ENSG00000198046	"Zinc finger protein 667"	Q5HYK9	19	56439325-56478065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 27.9;Cone photoreceptor cells: 23.6;Horizontal cells: 30.2;Rod photoreceptor cells: 28.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 10.1;hTERT-RPE1: 15.1;U-138 MG: 12.7"					"Low region specificity"	"Detected in all"			"HPA030731, HPA046673"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030731: AB_2673584, HPA046673: AB_2679746"	"unprognostic (6.10e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.81e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.55e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.34e-3)"	"unprognostic (3.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.55e-2)"	2.4	7.7	8.0	1.7	18.2	6.2	6.8	12.1	16.1	4.7	2.6	5.3	1.8	1.6	6.4	11.6	2.4	6.3	4.3	4.0	10.2	9.9	4.1	1.3	2.1	2.4	6.5	8.3	11.1	3.5	6.1	18.9	3.0	9.7	5.6	0.9	3.2	4.5	4.5	2.0	2.9	1.1	5.6	6.6	2.4	1.8	5.9	5.3	2.9	12.6	0.6	1.8	3.7	4.2	6.2	2.2	0.4	0.0	4.5	3.7	0.6	0.1	0.2	8.7	0.1	0.0	0.0	0.2	3.7	2.8	3.4	2.7	0.2	0.1	0.4	5.2	1.3	5.2	0.1	0.0	0.1	5.2	0.0	1.9	10.1	0.1	0.2	2.7	5.9	4.6	5.6	0.1	0.7	0.0	15.1	0.0	0.3	0.0	0.3	2.6	0.2	0.1	0.2	6.3	0.1	1.7	0.0	3.3	7.0	3.4	0.5	0.2	5.1	0.2	0.1	0.0	8.1	2.4	0.0	0.0	12.7	3.4	0.2	6.5	0.2	5.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.4	0.3	0.3	6.2	1.5	3.7	0.4	4.5	0.0	2.2	0.0	0.6	8.0	18.2	12.1	14.4	10.2	9.9	6.5	8.3	9.7	5.3	0.0	0.0	0.0	5.6	3.0	27.9	4.5	0.0	5.3	4.5	5.2	23.6	0.1	0.0	2.7	2.1	3.6	0.0	0.0	0.2	0.0	5.3	3.6	9.2	0.0	0.2	30.2	1.2	1.8	0.0	1.6	4.9	0.6	3.3	0.0	0.0	9.3	0.5	0.0	6.7	1.2	28.2	0.0	3.0	7.7	14.4	3.6	0.1	0.0	0.0	2.5
ZNF668	FLJ13479	ENSG00000167394	"Zinc finger protein 668"	Q96K58	16	31060843-31074320	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043048	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA043048: AB_10962503"	"unprognostic (2.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.73e-5)"	"unprognostic (4.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (1.72e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.83e-3)"	"unprognostic (7.25e-2)"	7.1	8.2	8.2	8.9	10.0	18.5	5.9	11.1	15.4	8.3	10.2	6.6	5.1	11.8	9.4	5.6	8.0	6.1	9.6	5.1	8.6	7.4	5.9	6.9	7.3	8.6	7.6	5.2	5.7	10.6	4.6	6.7	10.1	9.2	8.1	4.2	4.9	7.2	7.6	12.6	9.0	10.3	9.5	6.5	8.6	8.8	10.0	6.1	16.9	5.4	8.8	7.5	6.6	6.5	5.6	7.3	8.6	4.8	8.4	13.9	5.4	3.6	12.6	2.8	7.0	3.0	3.1	9.7	10.4	7.6	5.2	4.4	5.7	5.1	5.9	8.4	6.1	3.3	6.7	1.9	5.6	1.3	7.5	8.2	3.6	7.8	9.1	3.7	5.7	9.1	3.8	2.3	9.0	1.8	1.7	3.8	6.5	6.8	3.7	9.5	12.4	12.0	12.3	10.1	2.6	10.7	16.0	21.3	8.6	2.8	8.1	9.9	11.7	6.6	9.3	3.2	1.1	7.1	8.3	6.4	13.1	5.4	9.9	4.5	6.2	10.2	8.3	8.7	6.0	8.4	7.6	4.8	8.6	13.9	4.7	9.2	5.6	4.1	8.4	7.3	4.4	4.5	5.6	1.7	8.4	3.8	3.9	4.3	5.4	8.2	10.0	11.1	15.4	8.6	7.4	7.6	5.2	9.2	6.1	0.0	5.1	2.2	2.6	7.4	2.9	0.5	5.1	1.4	2.3	0.0	0.0	5.4	6.6	8.2	31.1	3.1	6.3	0.0	4.1	9.5	6.0	2.2	4.6	1.8	6.0	11.1	4.6	3.7	3.2	12.7	5.8	4.4	3.3	4.6	3.8	4.8	6.4	4.2	14.2	4.7	1.9	0.0	2.5	2.9	13.3	7.8	5.8	6.4	4.7	1.7
ZNF670	MGC12466	ENSG00000277462	"Zinc finger protein 670"	Q9BS34	1	247036784-247078755	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 21.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003142	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003142: AB_1859404"	"unprognostic (2.11e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.05e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-2)"	3.5	2.2	3.1	2.9	5.5	0.7	6.2	12.0	6.1	4.1	2.6	3.2	0.0	2.8	5.7	3.4	1.9	3.7	3.8	2.5	4.5		3.9	3.0	4.0	3.4	1.8	1.3	5.5	2.8	3.1	1.3	1.4	4.0	3.4	3.5	2.5	1.9	3.1	1.6	2.6	2.4	4.3	2.9	3.1	3.3	4.8	2.7	5.4	3.7	3.0	4.7	4.2	1.0	6.6	4.1	1.7	2.3	2.8	6.5	2.3	3.8	2.7	7.8	9.6	2.0	3.4	18.1	4.9	3.3	5.9	5.9	3.2	4.1	6.2	8.2	3.0	3.2	3.2	8.6	3.8	11.2	4.6	1.1	5.5	1.8	4.9	1.7	6.8	3.4	1.9	4.0	3.8	7.4	0.9	3.8	4.9	7.9	2.7	5.9	1.5	8.0	3.3	14.5	8.6	4.9	8.3	9.7	5.8	3.5	8.4	9.0	8.2	6.9	2.7	3.8	4.6	2.8	14.3	2.4	3.6	4.1	2.6	5.4	5.2	9.9	12.7	1.3	4.9	4.5	0.0	2.0	1.7	4.4	2.3	2.3	6.6	4.1	4.6	4.1	5.9	6.5	4.9	0.2	2.8	1.4	2.3	3.0	2.3											3.0	1.7	0.0	8.6	21.5	4.3	0.6	7.6	6.7	4.5	5.2	0.0	2.2	5.0	4.6	5.2	4.4	0.4	0.0	2.5	6.7	2.3	3.8	0.0	2.8	2.1	6.4	0.0	4.9	1.9	1.0	1.7	1.6	6.8	2.8	2.7	2.0	2.7	1.5	1.4	2.8	1.4	0.0	4.4	1.6	3.3	9.8	0.7	0.0	1.1	3.7
ZNF671	FLJ23506	ENSG00000083814	"Zinc finger protein 671"	Q8TAW3	19	57719751-57727624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 7.8;Rod photoreceptor cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.4"					"Low region specificity"	"Detected in all"			"HPA046099, HPA056043"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046099: AB_10962484, HPA056043: "	"prognostic favorable (2.20e-4)"	"unprognostic (4.16e-3)"	"unprognostic (6.02e-2)"	"unprognostic (5.91e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.22e-1)"	3.3	7.9	9.1	6.3	10.1	5.6	6.6	28.5	10.4	5.4	6.7	4.5	4.5	2.7	3.3	8.4	3.2	6.9	4.2	8.1	9.0	6.7	6.2	3.3	5.6	13.2	8.0	7.5	5.4	4.1	16.1	11.3	5.9	7.9	6.6	3.7	7.8	4.5	9.4	10.3	3.2	7.1	6.6	9.0	15.1	3.8	7.1	8.9	15.6	10.4	1.1	12.1	6.2	2.5	22.2	11.0	13.7	10.0	13.9	19.4	10.9	0.1	0.2	2.4	0.0	0.4	0.1	0.0	2.7	1.6	5.4	1.9	0.3	0.4	5.5	0.9	3.9	1.7	0.1	2.0	2.2	6.3	6.0	3.9	0.1	0.9	0.0	4.7	0.0	8.1	7.0	1.6	3.4	1.8	6.2	0.8	5.9	0.8	2.7	4.7	0.1	10.4	0.1	3.5	0.0	5.6	4.1	7.5	3.3	2.0	0.2	0.2	0.0	0.0	0.1	3.6	6.3	1.6	7.7	0.0	0.6	2.9	0.0	2.0	4.9	0.1	3.0	0.6	1.3	1.8	12.1	7.6	13.7	6.4	7.0	16.7	17.2	13.3	11.0	11.0	22.2	19.4	15.5	5.6	13.9	10.0	10.0	13.1	10.9	9.1	10.1	28.5	10.4	9.0	6.7	8.0	7.5	7.9	8.9	0.0	1.1	0.9	0.6	0.6	5.3	4.8	2.5	0.0	1.2	3.5	0.0	1.8	1.7	2.6	0.1	1.0	0.0	0.0	0.0	0.9	1.0	0.5	2.3	1.0	3.3	6.4	0.0	1.3	1.6	0.4	0.0	1.6	1.7	1.8	0.0	7.8	0.5	0.0	0.4	1.3	6.8	0.0	0.4	5.6	4.5	0.4	0.7	4.3	0.3	0.1
ZNF674	"MRX92, ZNF673B"	ENSG00000251192	"Zinc finger protein 674"	Q2M3X9	X	46497727-46545457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 8.9;Horizontal cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA031026, HPA065295"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031026: AB_10602690, HPA065295: AB_2685456"	"unprognostic (6.11e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.41e-5)"	"unprognostic (2.74e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.25e-4)"	"unprognostic (8.45e-4)"	6.7	5.1	5.7	4.0	10.1	3.8	5.5	12.6	9.8	4.7	4.5	6.8	1.9	4.2	6.3	6.5	4.1	3.7	4.9	4.9	5.7	6.3	5.6	8.1	4.3	5.1	6.4	5.8	7.2	7.4	4.8	11.2	4.5	9.6	8.2	5.1	6.8	4.5	5.7	5.0	5.4	4.6	6.9	6.8	5.8	3.9	3.7	7.0	6.0	6.9	1.8	4.6	4.5	5.1	2.3	2.5	5.8	3.5	1.9	2.7	2.1	2.6	3.4	3.4	4.2	3.1	3.1	3.3	2.8	3.9	3.7	3.9	2.2	2.2	2.9	1.8	4.8	6.6	2.5	4.5	3.4	4.1	2.4	2.9	1.3	3.6	1.9	4.1	3.1	5.3	2.9	5.5	2.7	8.9	3.8	2.9	5.0	1.5	4.4	3.3	1.7	3.1	1.4	5.4	0.8	3.2	1.5	5.7	3.3	2.5	1.1	1.3	2.9	4.3	1.4	8.9	9.8	3.6	2.2	2.5	4.7	5.4	2.9	2.6	5.1	4.5	1.3	2.0	1.6	4.7	2.5	2.2	2.9	1.9	3.5	2.0	2.3	2.7	1.5	2.1	1.4	2.2	2.3	5.8	1.9	0.8	2.5	2.2	2.1	5.7	10.1	12.6	9.8	5.7	6.3	6.4	5.8	9.6	7.0	8.9	2.6	0.5	2.8	1.6	7.3	3.3	0.0	4.0	4.5	1.8	0.0	0.7	0.0	0.7	0.0	1.9	0.9	0.0	0.4	0.6	1.1	2.3	2.3	1.8	0.9	12.7	0.0	2.5	2.1	0.0	0.3	1.1	0.0	1.0	0.9	2.9	1.3	0.9	1.8	0.6	5.4	0.0	1.2	0.7	3.2	1.5	0.3	1.7	0.7	1.7
ZNF677	MGC48625	ENSG00000197928	"Zinc finger protein 677"	Q86XU0	19	53235381-53254898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 557.4;Late spermatids: 339.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.6;SuSa: 17.4"									HPA023106	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA023106: AB_1859409"	"unprognostic (2.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.87e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.70e-8)"	"unprognostic (6.57e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.17e-2)"	9.1	7.3	5.9	4.3	8.3	4.2	9.3	13.0	7.3	7.4	7.0	13.9	1.3	2.9	12.3	5.7	4.6	9.7	6.2	9.4	5.3	4.3	6.3	2.3	6.8	7.3	9.9	4.8	14.3	4.4	9.1	9.9	7.5	6.6	8.9	3.4	7.6	7.4	6.2	3.9	7.5	3.9	8.1	10.5	7.0	5.7	40.5	8.7	6.7	10.1	5.2	5.0	8.2	6.6	17.4	14.5	10.1	2.8	10.3	15.4	4.1	0.2	0.2	11.4	0.4	3.9	6.0	2.0	7.4	5.6	7.7	7.0	0.0	0.4	0.1	5.6	6.4	9.7	0.7	0.0	5.8	2.3	0.2	4.1	0.3	0.5	0.2	9.6	0.1	7.6	10.3	0.0	7.4	0.1	0.2	3.4	0.1	0.1	0.5	5.2	0.2	6.2	0.2	19.6	0.1	2.6	0.1	0.0	0.2	2.2	3.0	0.2	10.8	0.2	2.8	0.1	17.4	0.4	0.3	2.1	12.1	0.2	0.2	4.9	0.3	0.1	0.2	0.2	0.3	0.1	10.1	2.2	6.4	5.1	2.8	7.3	9.6	7.2	5.6	6.1	17.4	15.4	10.0	2.6	10.3	1.8	14.5	4.5	4.1	5.9	8.3	13.0	7.0	5.3	4.3	9.9	4.8	6.6	8.7	23.8	3.2	10.7	23.0	10.2	23.9	15.9	15.3	9.4	17.0	19.2	13.7	10.7	29.9	13.8	557.4	22.4	0.7	23.3	6.0	17.2	15.5	23.9	13.9	0.4	6.7	27.0	0.0	22.7	4.0	339.6	25.3	10.3	13.5	9.0	2.4	20.1	6.5	0.0	16.3	2.2	19.1	19.4	17.6	39.3	35.1	12.8	9.8	10.4	1.9	22.1
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol		Yes	No			"Mitochondria, Cytosol"	Nucleoli	"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	9.0	7.6	8.2	6.6	16.2	7.1	8.8	19.4	10.8	9.3	7.2	6.7	7.1	5.4	9.2	6.2	6.1	7.7	7.4	7.4	8.9	6.3	6.4	5.3	7.8	9.8	12.7	8.2	9.9	12.6	7.2	19.4	9.7	8.9	10.6	10.8	4.6	7.6	6.3	6.2	5.2	6.6	7.5	14.2	9.5	7.6	8.7	15.5	12.0	12.7	5.1	9.1	8.2	9.4	6.6	3.2	7.1	1.1	2.2	3.2	1.5	2.0	3.2	11.9	13.5	1.5	3.4	7.2	2.7	2.7	4.1	4.4	2.6	2.6	8.3	7.2	1.2	2.2	4.0	7.0	1.8	6.8	3.5	13.4	3.9	2.5	1.6	2.7	6.6	10.6	3.0	3.4	2.5	5.3	3.1	3.9	9.3	9.9	13.1	4.5	1.7	9.1	2.3	10.4	3.0	5.4	7.1	7.7	3.2	3.0	6.5	5.1	9.9	4.1	4.9	2.0	6.1	6.8	8.4	2.5	5.1	4.9	4.6	5.6	4.2	9.6	9.1	2.1	1.2	5.3	7.1	1.1	1.3	2.5	0.3	3.0	6.6	2.5	1.4	2.1	4.5	2.2	3.2	0.2	2.2	0.7	3.2	2.7	1.5	8.2	16.2	19.4	10.8	8.9	6.3	12.7	8.2	8.9	15.5	3.0	5.3	4.7	3.6	2.1	11.6	3.6	5.1	5.3	4.5	3.5	3.9	1.8	1.7	3.3	0.6	4.7	1.5	0.0	4.4	2.1	3.4	5.6	3.5	1.6	1.4	1.6	9.2	3.7	3.7	0.2	6.9	2.2	0.0	1.8	3.9	4.2	2.9	4.5	2.5	1.1	6.7	0.0	2.1	7.2	10.0	0.5	1.1	7.5	2.6	3.4
ZNF680	FLJ90430	ENSG00000173041	"Zinc finger protein 680"	Q8NEM1	7	64519884-64563106	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003173			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003173: AB_1080744"	"unprognostic (1.65e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.05e-3)"	6.4	15.8	18.7	4.2	24.4	2.6	15.4	37.0	23.7	7.7	4.4	7.1	3.3	3.4	5.9	7.0	4.4	6.2	6.2	12.1	20.0	10.8	9.8	21.6	5.7	6.9	23.4	14.6	13.1	5.8	4.0	10.0	5.3	19.9	12.0	6.2	3.9	5.4	6.8	11.6	6.6	3.9	7.1	25.9	7.3	7.0	4.7	24.4	5.4	28.5	6.6	6.0	6.8	5.2	4.3	1.7	4.2	1.3	8.3	4.4	1.7	3.7	2.2	8.8	10.6	4.4	5.0	5.6	3.1	2.5	5.6	7.0	3.0	7.3	7.1	7.6	2.9	6.3	2.6	7.2	3.3	9.1	1.3	5.1	5.4	4.3	2.7	1.9	7.1	4.9	3.3	4.0	4.9	5.5	7.0	5.2	10.1	9.7	0.0	7.6	2.9	11.0	11.5	10.4	3.3	2.7	8.7	9.0	21.4	7.7	12.2	7.2	9.7	9.2	8.7	3.2	17.4	8.8	3.1	2.8	6.8	3.4	3.2	5.2	6.3	8.1	20.2	0.3	6.6	5.9	4.2	1.0	1.1	3.0	1.3	2.5	4.3	4.1	3.5	1.7	3.4	4.4	4.0	0.5	8.3	1.1	1.4	1.2	1.7	18.7	24.4	37.0	23.7	20.0	10.8	23.4	14.6	19.9	24.4	11.9	3.2	9.9	9.2	3.8	11.2	11.6	20.4	2.7	12.5	24.4	3.9	10.0	8.3	7.5	0.8	8.7	2.2	0.0	8.0	8.8	9.1	11.1	6.9	17.4	4.4	1.6	0.0	26.4	12.4	1.3	25.6	5.6	6.8	8.2	4.3	22.8	5.2	3.5	20.8	5.6	9.0	19.4	6.9	11.1	15.1	4.5	5.9	10.2	4.5	8.1
ZNF684	MGC27466	ENSG00000117010	"Zinc finger protein 684"	Q5T5D7	1	40531561-40548169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 28.0"					"Low region specificity"	"Detected in all"			HPA059153	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA059153: AB_2683932"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.67e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.10e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.96e-2)"	"prognostic favorable (4.89e-10)"	"unprognostic (4.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.52e-2)"	3.6	6.4	4.1	2.9	8.9	8.2	4.2	5.8	7.4	3.6	3.8	2.3	5.4	3.2	3.6	4.3	3.2	3.1	3.4	10.6	4.4	3.3	18.3	20.8	3.4	4.4	9.8	3.6	3.8	5.4	2.5	4.6	2.1	5.4	5.1	4.8	1.6	3.5	4.1	4.4	4.1	3.4	3.2	5.9	5.1	4.2	4.3	7.8	6.4	5.6	4.1	3.5	3.1	2.7	6.0	3.9	7.0	7.7	3.5	5.9	2.4	2.2	0.7	2.8	3.8	2.6	3.8	1.7	2.0	2.0	2.4	4.1	1.4	2.9	3.8	1.7	1.3	1.6	2.7	2.8	2.0	3.8	3.3	4.7	4.1	2.6	3.6	1.3	4.4	4.5	2.5	0.8	2.9	1.1	1.4	3.7	3.0	2.1	5.7	3.4	0.6	6.4	5.1	6.8	0.9	2.3	3.0	8.4	2.6	3.6	1.9	2.1	3.6	3.7	3.7	4.1	3.6	1.6	28.0	2.1	2.5	5.2	2.4	3.9	4.8	3.4	4.4	2.2	4.7	3.8	7.0	4.0	1.9	5.9	7.7	3.2	6.0	4.2	3.6	2.4	3.5	2.8	5.5	2.3	3.5	4.1	3.9	4.7	2.4	4.1	8.9	5.8	7.4	4.4	3.3	9.8	3.6	5.4	7.8	6.0	2.7	3.7	1.7	2.1	3.0	9.9	2.5	5.3	3.4	7.0	0.0	1.0	14.9	4.4	1.8	3.5	1.3	0.0	12.9	2.1	2.8	1.0	2.3	14.5	4.2	3.2	1.2	4.3	4.3	2.6	2.3	4.3	8.5	7.2	1.7	3.5	4.9	2.0	2.8	12.4	2.3	0.0	4.7	6.1	3.2	1.1	0.0	4.8	3.8	0.9
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569346-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 132.4;Late spermatids: 434.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favorable (5.90e-4)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	10.7	11.9	14.2	11.8	11.8	13.7	8.0	13.8	16.7	8.8	15.3	15.5	12.1	20.5	11.5	9.6	12.0	13.5	14.5	17.2	13.1	10.6	11.2	12.4	10.3	19.9	12.1	11.5	12.9	14.7	8.4	14.0	7.8	11.2	11.8	9.0	11.0	13.8	10.1	32.5	9.5	14.4	14.2	11.0	13.9	13.0	24.6	8.3	21.6	13.7	8.3	10.0	10.4	13.3	6.1	5.4	12.6	5.4	15.1	6.8	2.8	7.8	5.9	6.0	6.3	11.4	2.9	2.5	4.5	6.2	3.8	3.0	1.8	11.9	4.1	9.1	5.6	5.2	5.8	1.7	2.8	4.1	12.2	3.6	2.8	2.3	1.4	3.0	3.9	12.7	5.9	6.3	4.0	4.9	6.5	3.8	5.6	2.9	9.6	4.2	4.7	11.1	4.3	2.2	7.7	1.9	9.5	2.4	6.2	6.6	2.5	8.6	9.6	1.6	11.8	9.9	1.8	12.9	6.5	2.9	3.3	3.6	3.8	3.5	13.8	9.6	4.4	10.1	3.4	5.6	12.6	3.9	8.3	4.8	3.9	5.8	5.5	5.6	5.4	3.9	6.1	4.8	4.4	6.0	15.1	5.4	5.4	6.8	2.8	14.2	11.8	13.8	16.7	13.1	10.6	12.1	11.5	11.2	8.3	6.0	1.9	17.1	10.5	5.7	19.5	8.5	17.8	20.1	6.8	15.7	17.7	6.3	41.4	19.2	132.4	11.1	34.5	0.0	27.4	7.9	13.1	9.8	4.7	18.7	21.4	20.6	19.5	14.1	22.9	434.2	18.4	15.6	16.9	28.9	25.1	28.0	19.6	32.3	18.7	38.4	25.5	6.5	12.5	25.3	7.9	6.1	3.9	20.3	22.1	5.7
ZNF689	FLJ90415	ENSG00000156853	"Zinc finger protein 689"	Q96CS4	16	30602558-30624012	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 39.7;Late spermatids: 41.2;Spermatocytes: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054095, HPA055385"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Nucleoplasm, Nucleoli fibrillar center"		"HPA054095: AB_2682377, HPA055385: AB_2682801"	"unprognostic (5.62e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	5.9	5.7	5.6	4.7	7.5	7.8	15.0	7.5	10.7	7.4	6.2	8.6	5.4	6.7	8.5	4.1	3.7	6.4	6.1	5.2	4.7	4.5	5.2	6.3	4.9	5.2	8.0	4.9	8.0	7.2	11.8	7.7	4.6	4.8	6.1	4.6	7.7	4.8	7.1	6.7	3.8	6.7	6.0	4.8	7.3	5.7	28.2	8.2	11.4	6.7	4.3	6.5	6.8	4.6	4.4	9.6	2.7	10.5	9.3	6.0	4.4	3.5	6.3	8.8	9.2	3.8	3.8	4.4	4.4	6.4	7.2	7.0	7.4	2.8	10.2	6.9	3.8	5.2	2.7	11.0	4.8	5.8	8.3	18.7	8.6	5.5	11.3	4.0	8.4	6.6	3.6	4.6	4.9	4.9	3.9	5.0	9.4	10.1	5.9	4.6	5.3	15.5	8.0	10.0	2.8	6.5	19.6	8.5	9.1	3.0	3.5	11.1	6.7	3.2	5.8	5.0	4.6	6.1	7.4	3.9	9.4	4.0	4.5	6.0	10.9	12.5	12.3	3.4	9.3	9.0	0.2	6.8	2.7	5.9	10.0	4.3	4.4	5.0	6.0	9.6	3.7	4.5	4.2	0.4	9.3	10.5	3.6	4.7	4.4	5.6	7.5	7.5	10.7	4.7	4.5	8.0	4.9	4.8	8.2	3.0	1.3	10.9	4.5	1.4	7.9	3.9	10.2	1.4	0.0	1.8	5.9	3.5	0.0	5.4	39.7	6.7	6.1	0.0	5.9	3.0	4.5	4.5	13.9	5.0	4.3	9.5	5.8	5.5	3.5	41.2	7.5	4.4	0.0	1.8	5.5	5.2	4.7	3.5	9.9	3.5	5.9	0.0	4.5	48.6	7.7	0.9	0.7	5.0	6.0	2.3
ZNF691	Zfp691	ENSG00000164011	"Zinc finger protein 691"	Q5VV52	1	42846573-42852477	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062527	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA062527: AB_2684791"	"unprognostic (4.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (7.33e-6)"	"unprognostic (1.40e-3)"	"unprognostic (2.65e-3)"	"unprognostic (5.12e-2)"	"prognostic favorable (6.25e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	7.8	14.6	13.6	11.2	15.5	2.9	15.6	10.8	14.4	12.9	12.6	18.3	14.1	8.8	16.9	21.8	9.1	14.2	8.4	11.4	11.9	9.8	14.2	24.1	9.9	16.0	12.2	12.1	18.6	13.4	19.2	17.3	12.7	12.3	16.8	10.2	12.3	15.2	18.5	10.9	12.8	10.6	13.5	11.9	17.7	10.8	13.9	14.8	17.9	19.3	6.4	16.8	11.8	10.0	20.5	12.5	18.2	11.2	18.4	19.3	12.8	4.5	6.3	12.8	10.5	11.6	8.9	1.6	5.4	6.5	8.8	8.8	4.4	6.6	11.1	8.4	5.0	4.4	8.0	12.3	7.1	7.6	19.8	12.4	11.6	17.3	7.9	8.6	4.4	2.5	7.7	8.7	11.0	9.1	10.8	8.9	11.0	11.2	4.8	8.6	3.6	13.2	5.9	19.1	4.9	4.7	9.0	16.1	7.6	8.2	4.3	9.2	9.2	5.5	10.0	9.3	20.0	5.5	15.2	4.6	8.8	9.3	4.9	5.8	11.7	9.2	3.2	6.2	5.4	7.4	18.2	11.2	16.0	12.2	9.7	15.7	15.9	16.4	16.4	11.1	20.5	15.8	15.7	6.3	18.4	10.0	12.5	19.3	12.8	13.6	15.5	10.8	14.4	11.9	9.8	12.2	12.1	12.3	14.8	6.0	2.4	3.0	2.1	1.5	2.4	5.7	5.1	4.0	2.3	5.2	3.9	5.4	6.6	3.9	3.0	3.6	1.7	0.0	3.3	4.4	4.0	2.4	4.7	6.4	6.4	1.6	2.9	6.2	3.3	2.5	6.6	3.5	1.7	3.6	2.7	5.2	2.4	2.9	6.7	6.8	4.2	0.0	3.9	9.1	6.4	0.6	2.7	6.4	2.3	1.0
ZNF695	SBZF3	ENSG00000197472	"Zinc finger protein 695"	Q8IW36	1	246945547-247008093	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.3;testis: 8.3"	"Cell type enhanced"	"Detected in some"	9	"Cytotrophoblasts: 2.0;Extravillous trophoblasts: 3.7;Mucus-secreting cells: 2.0;Spermatocytes: 3.1;Spermatogonia: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 5.1"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.2"	"Low cell line specificity"	"Detected in many"											HPA024743	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024743: AB_1859419"	"unprognostic (8.46e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-5)"	"unprognostic (7.42e-4)"	"unprognostic (2.81e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.05e-9)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.87e-1)"	0.3	0.3	0.6	3.2	2.1	3.3	1.5	1.6	1.0	0.6	1.0	0.0	0.0	0.4	0.6	0.0	1.3	0.3	0.2	0.3	5.1	0.4	0.7	0.2	0.9	1.1	0.5	0.9	0.6	1.7	0.0	0.6	2.5	0.3	0.4	1.5	0.1	1.1	0.1	0.2	0.5	2.3	1.4	0.7	0.4	0.6	8.3	0.0	8.3	0.3	0.0	2.2	0.4	0.7	0.1	0.1	3.2	0.2	0.2	0.2	0.0	6.6	0.8	4.1	10.3	0.1	0.1	10.8	2.2	0.1	3.1	4.3	6.9	0.4	5.5	4.4	1.2	3.8	2.0	11.6	0.6	3.6	0.0	4.0	3.5	1.5	4.2	0.0	0.0	1.4	0.2	0.0	3.6	2.9	0.9	1.2	7.0	4.7	0.0	3.3	2.6	7.4	3.9	7.7	6.7	4.3	4.1	9.5	0.0	0.7	3.7	3.7	6.3	3.4	2.7	1.2	4.2	2.9	4.9	0.5	0.5	6.0	3.1	0.0	0.7	1.8	0.1	0.0	0.0	2.2	0.7	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	3.2	0.2	0.1	0.1	0.0	0.0	0.6	2.1	1.6	1.0	5.1	0.4	0.5	0.9	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	3.7	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.1	2.7	0.1	0.9	0.0	1.4	0.1
ZNF696	FLJ14129	ENSG00000185730	"Zinc finger protein 696"	Q9H7X3	8	143289676-143298061	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA057855, HPA072473"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA057855: AB_2683545, HPA072473: AB_2686524"	"unprognostic (3.23e-2)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (3.52e-5)"	"unprognostic (2.58e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.76e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (6.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.09e-3)"	8.5	6.9	10.3	8.1	10.6	6.3	6.9	13.9	13.7	5.6	5.4	9.8	5.4	13.5	8.8	4.8	5.0	6.6	7.1	5.2	10.4	10.3	7.2	8.1	7.6	8.6	12.6	7.2	9.8	13.7	8.6	6.7	5.5	10.6	7.5	4.1	7.2	11.9	5.1	7.7	13.3	8.0	10.7	8.9	8.3	6.5	6.9	12.8	6.5	7.5	3.0	6.6	7.2	5.2	6.4	6.4	2.3	3.3	5.3	7.5	3.3	6.3	5.9	5.7	6.8	2.5	1.7	12.4	5.0	1.6	3.6	2.1	3.4	5.0	0.4	7.0	1.7	2.0	4.5	6.6	2.7	3.2	7.1	14.4	8.5	5.6	5.1	2.5	3.4	10.9	1.5	4.5	2.4	5.0	2.3	1.7	5.1	17.6	3.9	2.1	12.7	3.7	7.0	8.1	6.9	15.1	7.8	3.6	6.2	1.9	4.6	9.7	13.6	7.6	4.9	6.2	3.9	8.0	6.2	3.6	4.9	11.2	4.3	8.8	8.1	5.4	7.9	3.3	7.0	5.7	1.1	3.3	2.3	5.3	1.9	5.8	4.2	4.0	5.9	3.7	6.4	7.5	6.2	1.4	5.3	2.9	6.4	1.3	3.3	10.3	10.6	13.9	13.5	10.4	10.3	12.6	7.2	10.6	12.8	0.0	0.0	0.0	2.1	2.6	4.3	2.4	0.0	0.0	0.0	3.5	5.9	1.2	3.3	2.3	0.6	2.1	2.0	0.0	1.8	2.1	1.5	1.2	0.0	2.1	1.1	3.2	0.0	1.8	0.0	1.6	3.7	0.0	1.7	1.0	0.9	2.5	1.6	0.0	1.1	1.9	3.4	6.5	1.6	2.1	5.9	1.8	0.3	1.5	1.9	0.7
ZNF697	MGC45731	ENSG00000143067	"Zinc finger protein 697"	Q5TEC3	1	119619422-119647773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 24.8;WM-115: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049933	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049933: AB_2680958"	"unprognostic (2.57e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (6.20e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.36e-1)"	6.1	4.1	4.5	1.7	5.2	1.0	5.0	1.6	6.9	2.0	2.8	0.7	3.5	2.1	3.1	3.4	1.2	2.0	2.0	6.3	1.8	1.2	11.1	5.3	6.5	0.6	2.1	6.6	3.3	7.3	4.2	6.4	9.7	3.8	6.2	1.9	1.0	10.8	1.3	2.9	2.3	1.9	4.4	1.5	2.3	2.5	5.0	1.2	0.5	4.6	2.2	0.7	2.4	1.5	0.0	0.6	0.3	1.5	0.0	0.1	0.3	1.1	0.6	3.0	1.0	4.0	4.5	4.1	5.3	7.4	3.1	2.9	1.8	0.2	0.0	1.8	2.9	2.4	1.3	2.3	5.2	7.4	0.0	2.3	1.9	1.1	3.5	7.7	1.2	1.3	7.5	1.5	7.0	15.0	3.4	6.1	1.7	1.7	0.2	1.4	0.9	0.0	0.9	15.9	1.0	1.7	0.0	7.3	0.1	1.4	2.7	0.6	4.1	1.2	1.3	24.8	9.9	0.6	1.8	14.0	5.2	6.6	3.6	9.1	0.7	1.1	0.0	7.4	1.4	25.4	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	4.5	5.2	1.6	6.9	1.8	1.2	2.1	6.6	3.8	1.2	0.0	0.3	0.0	1.5	1.9	0.9	8.6	0.0	0.0	2.3	1.8	0.0	6.5	3.3	1.7	1.3	3.5	1.0	0.0	0.7	1.7	4.8	4.5	0.0	3.0	2.3	0.0	2.4	4.9	6.5	2.2	4.4	2.2	5.0	0.0	2.2	1.9	1.9	2.0	6.0	5.3	0.8	6.5	2.1	0.2	0.4	1.6	16.6	0.0	1.4	0.9
ZNF7	"HF.16, KOX4"	ENSG00000147789	"Zinc finger protein 7"	P17097	8	144827464-144847509	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030296, HPA059090"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030296: AB_10671095, HPA059090: AB_2683901"	"unprognostic (1.11e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.97e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (8.46e-8)"	"unprognostic (1.15e-1)"	"unprognostic (5.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (6.53e-2)"	18.5	12.7	11.4	14.9	17.5	14.7	20.4	34.1	21.1	18.3	15.5	17.9	19.8	12.1	18.4	22.2	18.1	16.7	15.5	14.3	11.9	11.0	13.3	14.7	14.1	16.0	15.1	18.3	22.8	21.3	19.1	16.2	17.0	14.7	19.5	15.5	15.7	16.0	17.4	24.3	21.0	16.0	15.7	11.8	21.2	13.6	24.8	15.2	15.8	19.0	14.9	17.8	16.7	18.0	15.7	10.4	22.5	14.6	12.9	18.6	7.6	10.1	13.9	13.6	13.3	11.7	17.9	12.5	10.9	13.9	14.8	12.7	7.0	13.1	14.2	12.8	11.8	8.1	8.9	12.3	15.9	16.2	9.4	10.2	25.3	18.2	8.1	13.6	7.3	11.9	17.1	19.4	11.5	28.6	14.4	9.1	12.0	25.2	10.2	16.4	16.7	19.8	8.0	13.9	13.5	16.8	13.8	12.1	11.2	10.4	14.0	13.4	16.4	23.8	13.7	13.2	13.7	16.5	11.8	10.2	11.2	20.0	8.4	10.4	8.3	5.8	15.5	11.6	9.5	13.7	22.5	9.3	8.8	12.5	8.4	15.2	15.7	14.1	10.8	10.4	13.6	18.6	12.7	9.4	12.9	14.6	8.3	13.1	7.6	11.4	17.5	34.1	21.1	11.9	11.0	15.1	18.3	14.7	15.2	17.9	12.3	9.6	14.4	6.3	34.1	10.1	2.5	8.1	9.1	3.5	27.5	13.8	5.0	11.1	9.6	9.7	7.4	0.0	9.8	10.7	12.0	13.5	3.5	7.4	7.9	27.0	9.2	11.6	6.7	3.2	16.4	10.9	8.5	10.0	7.9	18.9	10.7	7.0	14.9	5.6	29.0	6.5	7.5	40.5	25.2	8.2	16.2	15.2	9.2	11.7
ZNF70	"Cos17, MGC48959"	ENSG00000187792	"Zinc finger protein 70"	Q9UC06	22	23738678-23751092	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA018821	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA018821: AB_1859423"	"unprognostic (3.17e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.69e-2)"	5.5	5.0	8.4	7.6	8.5	5.5	5.5	14.3	10.3	7.5	5.5	8.2	10.7	3.4	7.8	8.7	3.6	7.4	5.9	6.3	8.6	3.8	4.1	3.0	4.7	4.9	7.1	5.7	15.3	6.5	10.1	6.2	4.5	7.1	5.9	4.8	9.0	7.2	8.4	9.1	4.3	5.1	7.0	4.9	5.2	5.1	4.7	10.9	3.9	6.7	1.1	5.6	5.8	5.4	1.5	1.6	4.2	1.0	2.0	1.2	0.4	1.9	2.5	4.8	5.0	7.1	3.5	1.6	1.8	3.6	4.1	5.9	2.4	1.4	2.7	1.2	3.8	2.7	2.2	3.3	2.4	5.3	1.8	3.1	5.2	4.5	2.2	4.3	4.7	4.5	3.4	1.6	5.5	4.6	5.4	3.2	2.1	1.9	4.0	3.1	2.7	2.7	2.4	1.2	1.8	1.1	11.4	4.6	0.6	1.5	2.6	2.7	3.4	2.7	3.5	2.1	3.6	1.7	2.2	4.3	4.6	5.8	3.0	2.0	4.1	0.7	2.6	4.0	2.2	3.9	4.2	1.0	0.9	1.0	0.8	0.6	0.8	1.0	0.6	0.5	1.5	1.1	1.2	3.2	2.0	0.8	1.6	0.4	0.4	8.4	8.5	14.3	10.3	8.6	3.8	7.1	5.7	7.1	10.9	0.0	3.2	0.0	0.8	0.3	4.0	2.3	2.5	6.7	3.4	3.5	9.8	0.4	0.0	1.1	1.1	1.0	0.3	0.0	1.0	0.5	1.8	0.6	1.1	0.5	0.7	6.4	1.2	4.3	1.2	2.1	5.8	0.4	0.0	1.0	0.3	2.8	0.4	0.0	3.9	0.6	4.5	6.5	0.8	2.1	2.1	0.0	0.2	0.5	0.6	0.7
ZNF701	FLJ10891	ENSG00000167562	"Zinc finger protein 701"	Q9NV72	19	52555457-52587174	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 23.4"									HPA005532	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA005532: AB_1080746"	"unprognostic (1.21e-1)"	"unprognostic (4.98e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.46e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.17e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.89e-5)"	10.0	7.8	9.5	13.5	13.8	11.0	9.9	12.1	8.6	8.8	12.1	7.0	9.2	6.1	8.9	9.8	8.1	9.5	6.2	6.7	9.0	4.6	11.5	3.8	7.1	9.1	11.9	2.7	10.0	7.2	9.6	11.7	22.4	10.3	10.2	9.0	3.6	9.4	8.8	6.4	9.1	10.5	6.0	14.5	11.4	7.8	7.3	12.5	28.0	12.1	4.1	8.8	10.1	11.6	8.1	5.9	19.9	8.8	11.5	8.8	6.0	1.8	0.4	4.1	7.5	4.2	5.4	7.5	4.7	4.9	6.5	6.8	3.8	4.4	8.3	2.6	3.7	6.2	2.8	1.8	5.3	7.2	0.3	5.5	2.4	6.8	1.0	4.9	0.3	11.7	6.0	3.8	5.0	8.4	3.4	6.1	4.4	10.7	1.3	5.6	1.5	8.6	4.0	4.0	2.2	6.2	8.7	5.4	3.7	5.0	23.4	4.0	4.6	3.2	7.8	2.4	8.9	10.1	5.3	5.4	5.2	2.6	2.5	8.4	1.0	5.5	11.3	0.2	9.2	8.2	15.3	8.1	15.5	8.7	8.8	7.3	7.9	6.9	7.4	5.9	8.1	8.2	8.8	19.9	11.5	6.5	5.7	8.0	6.0	9.5	13.8	12.1	8.6	9.0	4.6	11.9	2.7	10.3	12.5	0.0	6.7	6.2	5.8	1.9	5.4	3.6	2.5	6.7	6.8	14.0	13.7	12.0	3.3	5.9	1.6	5.6	8.6	0.0	3.5	8.2	4.0	7.0	2.3	0.5	4.7	3.2	2.4	6.7	5.3	1.0	5.8	8.3	3.3	9.0	4.9	3.5	4.5	5.8	3.5	2.4	5.6	0.0	4.6	3.0	7.7	3.1	19.7	14.9	3.6	10.2
ZNF704	"FLJ16218, Gig1"	ENSG00000164684	"Zinc finger protein 704"	Q6ZNC4	8	80628451-80874781	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 30.7;RH-30: 19.9;SH-SY5Y: 25.4;SK-BR-3: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024285, HPA024302"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024285: AB_2219847, HPA024302: AB_1859427"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (4.02e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.90e-2)"	9.7	5.6	10.4	5.5	12.5	0.9	15.9	25.4	11.6	20.2	7.3	11.9	7.2	2.9	19.2	7.6	3.2	13.7	8.5	11.7	9.5	6.3	9.5	3.9	9.4	1.5	11.8	6.1	20.8	19.5	22.7	2.9	5.1	10.5	10.6	6.3	6.9	13.6	13.3	5.9	5.2	4.8	7.5	9.2	3.2	5.8	7.3	14.6	12.0	6.2	5.9	1.3	8.6	13.9	0.0	0.0	0.3	1.6	0.2	0.1	0.0	0.0	1.1	4.9	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.5	0.8	0.0	1.9	0.0	0.4	30.7	0.4	0.8	0.0	0.0	5.2	1.8	2.2	4.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	2.0	0.2	0.0	0.1	0.0	3.1	4.5	0.0	0.4	2.6	0.4	3.2	19.9	0.0	0.0	10.7	6.3	25.4	0.9	31.1	9.2	1.7	4.9	0.6	0.1	0.0	5.2	0.1	1.0	0.0	0.0	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	1.6	0.0	0.0	0.0	10.4	12.5	25.4	11.6	9.5	6.3	11.8	6.1	10.5	14.6	47.6	20.4	0.8	22.3	16.5	21.9	32.0	17.8	20.1	27.3	24.4	0.0	7.0	5.0	14.9	20.7	18.8	15.6	0.0	21.0	4.6	16.7	31.5	26.6	9.6	2.6	19.1	13.3	27.0	5.1	34.8	30.5	2.0	30.4	0.0	25.3	14.6	10.5	14.0	24.1	14.6	2.5	12.9	17.6	1.8	1.3	4.4	2.4	0.5	18.9	29.8
ZNF706	HSPC038	ENSG00000120963	"Zinc finger protein 706"	Q9Y5V0	8	101177878-101206193	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 852.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042793			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042793: AB_10795710"	"unprognostic (2.05e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-3)"	"unprognostic (5.22e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (5.90e-11)"	"unprognostic (9.65e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.17e-2)"	28.0	24.6	38.4	34.5	40.8	26.3	39.4	35.5	39.0	21.8	35.9	34.5	21.5	37.1	23.0	38.5	42.4	20.5	29.9	27.8	37.0	25.4	23.4	34.6	34.1	45.5	32.8	40.0	23.9	82.3	26.9	28.9	30.1	29.3	21.6	36.1	20.9	29.4	21.2	31.6	53.6	50.4	25.7	32.6	30.1	34.5	31.1	32.1	21.2	25.1	33.6	39.4	23.9	28.7	63.6	85.4	32.4	73.1	19.3	46.4	38.1	39.8	23.0	40.3	12.8	14.5	16.8	25.8	16.7	21.5	17.3	18.5	16.4	24.7	24.2	29.1	19.8	35.3	21.9	23.0	22.5	20.0	17.9	20.0	24.2	14.2	31.4	19.2	18.0	23.6	14.5	35.3	16.3	35.6	23.9	29.3	24.6	26.2	47.3	15.3	28.1	37.7	49.8	12.2	81.1	57.0	15.9	13.5	49.5	22.8	20.7	26.8	12.0	11.7	19.4	71.4	36.0	20.3	19.2	19.4	9.5	19.5	25.1	17.2	40.2	38.5	38.9	25.6	39.8	43.8	32.4	45.9	24.9	23.7	71.9	24.3	63.6	33.1	30.1	42.3	49.0	37.5	35.8	6.2	19.3	73.1	85.4	46.4	38.1	38.4	40.8	35.5	39.0	37.0	25.4	32.8	40.0	29.3	32.1	56.6	37.1	175.0	195.4	408.4	54.6	67.0	112.1	75.0	69.4	75.0	17.7	165.7	152.5	226.9	436.3	144.3	251.1	116.8	226.4	308.8	110.7	186.3	119.0	105.2	242.6	81.0	254.7	69.3	125.8	852.0	80.6	213.1	195.7	341.8	228.1	114.7	312.8	245.4	81.7	155.6	49.2	103.5	156.4	70.2	63.6	452.8	161.7	105.8	130.7	254.7
ZNF707		ENSG00000181135	"Zinc finger protein 707"	Q96C28	8	143684452-143713898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA044991	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044991: AB_10961134"	"unprognostic (5.12e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (1.73e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.23e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.08e-2)"	5.4	5.4	6.6	6.2	7.5	5.7	6.0	6.6	8.0	5.5	5.1	7.0	10.4	6.2	6.1	7.1	6.3	6.2	5.8	3.9	6.6	3.4	6.1	5.5	7.7	9.4	10.3	5.1	5.7	8.3	9.2	7.9	4.7	5.5	7.0	3.6	6.5	7.5	6.7	3.8	13.0	8.0	6.7	6.5	13.2	5.8	11.0	7.3	7.7	8.8	5.0	7.8	6.9	5.8	1.1	1.4	1.7	1.0	4.2	2.4	1.0	3.8	3.9	4.2	5.2	4.1	3.6	5.8	4.0	3.3	5.0	3.0	2.9	5.4	3.7	5.1	2.1	2.3	4.3	4.4	4.6	3.1	5.6	2.0	7.5	9.7	4.4	3.5	2.3	4.2	4.0	5.8	6.3	4.8	4.2	3.7	4.2	4.2	2.7	1.5	7.7	5.5	3.0	0.1	4.4	9.7	4.9	2.9	3.7	3.1	4.1	3.8	4.7	8.6	5.9	3.6	3.4	7.1	4.7	6.8	3.2	10.0	3.9	4.9	4.4	2.7	1.3	4.6	4.5	2.9	1.0	1.0	1.5	2.4	0.7	1.7	1.1	1.3	2.1	0.7	1.0	1.3	1.9	1.7	4.2	0.7	1.4	1.7	1.0	6.6	7.5	6.6	8.0	6.6	3.4	10.3	5.1	5.5	7.3	0.0	1.0	0.8	2.3	2.5	2.8	1.6	0.0	1.4	2.3	3.5	0.0	1.8	3.3	1.7	14.3	0.8	1.8	0.0	1.2	2.0	1.3	1.9	1.1	0.5	1.7	1.6	0.0	3.7	2.1	4.5	1.1	2.5	0.0	5.4	1.8	0.9	1.7	2.8	2.1	1.0	3.3	6.5	1.4	2.9	2.5	2.8	2.2	5.0	1.4	1.8
ZNF709	FLJ38281	ENSG00000242852	"Zinc finger protein 709"	Q8N972	19	12461184-12513854	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.6"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 31.1;Late spermatids: 26.0;Spermatocytes: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA045573, HPA053153"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045573: AB_2679370, HPA053153: AB_2682060"	"unprognostic (2.27e-1)"	"unprognostic (7.40e-4)"	"unprognostic (3.53e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.58e-4)"	"unprognostic (6.76e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.53e-5)"	3.4	3.0	7.8	4.8	8.4	2.0	5.1	12.7	7.3	5.0	2.7	3.2	5.6	0.7	5.5	5.3	2.4	6.6	2.4	3.6	6.2	5.4	5.4	2.0	3.0	2.7	3.8	4.6	8.4	4.1	6.2	8.0	3.5	4.9	5.7	2.1	3.3	3.4	4.5	2.5	2.8	2.7	5.1	5.5	4.0	2.6	26.6	5.0	7.2	8.5	0.0	4.0	4.1	4.5	2.0	1.3	3.5	1.1	5.5	4.4	1.0	1.9	0.0	6.3	7.7	1.2	1.8	1.0	1.9	2.2	2.1	2.3	1.7	0.2	1.8	1.3	2.0	0.6	1.3	3.4	1.3	2.4	0.3	0.9	1.6	1.1	1.2	2.5	0.4	2.7	1.0	0.6	1.2	0.0	3.0	1.4	2.4	1.0	0.2	2.7	3.5	4.0	2.2	2.1	0.7	2.0	2.2	6.1	5.7	2.2	3.0	2.9	4.0	0.0	0.3	0.8	2.9	1.5	1.0	0.0	3.3	0.7	1.4	1.3	3.4	4.8	2.6	0.0	0.0	1.5	3.5	0.4	0.1	2.0	0.1	3.1	1.7	3.3	2.1	0.9	2.0	4.4	3.1	0.1	5.5	1.1	1.3	1.8	1.0	7.8	8.4	12.7	7.3	6.2	5.4	3.8	4.6	4.9	5.0	0.0	0.3	0.0	0.1	0.3	0.5	0.3	0.0	0.0	1.2	1.8	0.0	0.4	0.0	0.4	31.1	0.1	0.0	0.0	0.3	0.2	0.4	0.4	0.0	0.0	0.4	0.0	0.0	1.3	1.0	26.0	0.9	0.2	0.0	0.0	0.6	1.5	0.2	0.0	0.7	0.7	2.1	6.5	0.3	7.2	1.7	0.5	0.2	0.0	0.0	0.1
ZNF71	"Cos26, EZFIT"	ENSG00000197951	"Zinc finger protein 71"	Q9NQZ8	19	56595264-56626481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.3"					"Low region specificity"	"Detected in all"			HPA018124	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA018124: AB_1848339"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.03e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.97e-3)"	11.8	6.4	12.9	6.9	8.7	3.5	11.7	12.0	12.5	7.9	9.9	10.2	6.5	6.7	12.3	6.6	8.6	8.7	7.0	10.5	9.3	8.0	6.4	3.4	9.6	10.6	7.7	10.2	12.3	8.8	7.6	8.5	8.0	9.3	8.7	5.0	6.4	8.9	10.5	10.6	7.4	6.0	16.6	8.5	10.2	7.0	8.7	8.2	9.8	7.5	5.9	6.2	10.0	10.7	7.0	4.9	6.8	4.2	9.0	8.3	4.2	3.4	6.6	9.8	8.1	4.1	3.6	6.3	4.0	3.8	2.8	4.0	1.2	1.0	2.9	3.7	3.4	3.3	1.2	2.2	3.1	2.4	0.0	20.3	4.4	0.9	2.6	3.4	5.5	4.3	4.1	3.3	2.8	1.8	4.3	4.5	7.3	2.6	0.0	3.0	0.0	11.3	2.1	7.6	0.0	6.5	4.2	6.1	2.4	2.0	3.9	8.7	10.6	2.8	3.7	4.0	4.0	2.1	5.7	5.9	9.4	5.3	2.2	6.4	2.8	3.5	4.5	3.1	3.3	2.5	2.9	3.2	6.8	7.7	2.0	8.3	6.5	6.4	7.3	4.9	7.0	7.2	7.4	1.3	9.0	4.2	3.7	6.6	4.2	12.9	8.7	12.0	12.5	9.3	8.0	7.7	10.2	9.3	8.2	3.0	1.7	2.2	2.5	2.6	7.8	3.2	2.5	0.0	1.2	7.0	3.9	4.5	3.3	8.7	2.2	6.0	0.7	0.0	4.3	5.2	5.3	1.9	0.0	0.6	5.1	11.1	2.4	3.1	1.6	3.1	5.8	3.9	3.3	5.4	1.7	3.2	5.5	2.3	5.3	4.6	7.7	0.0	4.1	2.1	8.0	3.8	1.3	5.4	2.4	1.0
ZNF710	"DKFZp547K1113, FLJ00306, FLJ37393"	ENSG00000140548	"Zinc finger protein 710"	Q8N1W2	15	90001392-90082206	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"pancreas: 79.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030226, HPA030227, HPA030228"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899"	"unprognostic (6.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.65e-2)"	2.6	2.1	5.6	8.7	6.7	4.3	3.2	2.9	5.0	3.1	4.3	6.6	1.7	5.3	3.3	4.1	9.5	2.9	4.8	5.9	3.9	3.5	2.7	3.4	6.4	7.9	4.0	4.1	3.4	79.6	1.5	2.5	3.2	5.0	4.2	4.0	3.5	5.2	2.6	18.3	6.7	4.5	4.3	6.3	8.6	5.9	2.4	4.1	11.7	3.5	5.2	7.0	4.4	4.9	0.3	2.3	3.0	7.9	0.4	0.8	0.9	5.8	6.9	13.3	5.0	1.8	2.7	7.0	6.1	5.7	4.5	5.8	4.9	5.4	6.0	2.9	5.9	4.2	4.0	3.4	8.7	2.5	3.8	6.3	10.9	2.8	8.2	3.7	3.1	17.0	4.4	4.8	9.6	5.3	2.1	7.7	6.6	3.6	4.1	1.7	15.1	7.0	8.8	10.4	7.2	4.5	8.6	3.0	6.5	1.8	7.3	12.2	8.3	8.2	29.5	4.2	3.6	6.4	10.9	11.0	9.3	4.6	2.8	4.7	3.3	1.7	5.8	7.1	9.4	4.8	0.0	2.6	1.8	0.4	5.7	0.3	0.2	0.2	0.3	1.9	0.3	0.8	0.8	3.0	0.4	7.9	2.3	0.7	0.9	5.6	6.7	2.9	4.3	3.9	3.5	4.0	4.1	5.0	4.1	3.0	8.0	1.5	3.9	4.7	1.8	7.6	7.6	1.4	6.8	10.4	2.0	2.0	0.0	2.9	0.6	2.9	3.5	0.0	5.3	2.6	2.7	5.9	1.1	1.0	10.4	3.2	4.6	8.0	13.9	2.9	2.3	12.8	1.7	9.0	8.1	0.9	8.0	10.5	2.8	0.7	0.8	6.5	2.3	0.2	1.9	6.6	1.9	2.9	5.8	12.9
ZNF711	"CMPX1, dJ75N13.1, MRX97, Zfp711, ZNF4, ZNF5, ZNF6"	ENSG00000147180	"Zinc finger protein 711"	Q9Y462	X	85244032-85273362	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 38.6"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 17.7;Spermatogonia: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.6;naive B-cell: 3.6"	"Group enriched"	"Detected in many"	7	"B-cells: 3.6;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AF22: 16.8;AN3-CA: 13.1;HAP1: 24.2;HEK 293: 22.3;Karpas-707: 14.9;RH-30: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030654	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030654: AB_10670561"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.11e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.62e-3)"	1.4	13.6	11.6	2.1	11.9	5.8	5.4	10.8	19.2	5.9	2.4	4.4	0.0	3.0	8.9	2.9	2.1	4.7	4.0	3.8	11.1	8.3	5.1	0.7	1.9	2.2	6.5	8.1	9.3	4.3	1.5	16.0	7.1	12.6	4.1	1.9	3.3	4.0	2.8	1.6	11.2	4.2	3.4	9.8	4.5	2.8	38.6	9.5	14.4	4.2	1.6	2.5	3.0	2.5	3.6	0.2	0.0	0.0	0.3	1.3	0.3	0.0	1.5	16.8	13.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	3.5	1.4	0.0	0.6	0.2	2.7	0.3	24.2	0.0	0.0	0.0	22.3	7.7	0.4	0.9	0.6	0.0	0.2	1.6	0.2	0.0	3.1	0.0	0.1	7.5	2.3	14.9	2.9	0.8	13.0	0.0	8.2	1.4	0.3	0.0	20.4	0.0	0.0	1.2	4.9	12.7	0.0	0.4	0.0	10.3	2.2	2.1	0.0	0.0	5.5	0.0	0.0	5.6	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.1	0.4	0.1	3.6	1.3	0.8	0.0	0.3	0.0	0.2	0.0	0.3	11.6	11.9	10.8	15.1	11.1	8.3	6.5	8.1	12.6	9.5	3.0	0.6	1.5	6.8	10.6	8.7	2.4	2.5	1.4	2.3	1.8	0.0	0.3	5.0	1.6	2.0	2.3	0.5	0.0	0.4	0.2	5.2	2.5	0.0	0.0	0.3	3.2	17.7	3.7	1.2	4.0	2.8	0.7	5.0	0.0	1.0	10.0	0.7	1.7	3.5	1.9	1.3	0.0	6.2	5.2	25.4	8.0	0.2	0.0	1.1	2.5
ZNF713	FLJ39963	ENSG00000178665	"Zinc finger protein 713"	Q8N859	7	55887475-55942225	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 13.4;Early spermatids: 14.3;Late spermatids: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 10.2"					"Low region specificity"	"Detected in all"			"HPA059425, HPA062887"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA059425: AB_2684013, HPA062887: AB_2684894"	"unprognostic (5.27e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.63e-3)"	2.0	2.7	7.0	2.6	9.7	4.1	4.0	5.6	9.3	3.8	2.2	10.6	2.7	2.7	5.5	3.5	1.7	7.1	2.9	2.4	7.8	6.1	3.9	1.7	2.6	1.7	13.4	4.8	5.6	3.2	4.2	8.1	2.2	7.3	4.1	1.9	2.6	2.4	2.9	4.7	3.1	1.9	3.7	9.8	2.5	4.0	9.4	10.6	6.9	4.9	0.4	1.8	2.1	2.0	2.2	1.7	6.9	1.3	1.4	1.0	0.4	1.8	1.2	7.4	6.7	0.9	1.0	2.6	0.8	0.5	1.0	1.4	0.7	2.4	3.1	2.7	0.6	2.1	0.7	1.8	0.6	1.4	1.7	2.9	0.7	2.5	1.9	1.2	3.7	2.0	1.7	1.5	0.5	1.4	1.7	1.8	3.4	2.0	1.4	1.2	1.6	3.7	2.2	5.0	1.9	1.4	3.1	1.8	0.4	3.6	3.3	8.6	10.2	4.3	1.2	1.2	4.1	2.8	3.3	1.9	0.9	3.6	0.7	1.2	1.6	2.2	1.4	0.6	2.1	6.3	3.7	1.3	3.3	0.9	1.0	0.6	1.3	0.7	0.6	0.4	2.2	0.9	1.0	6.9	1.4	1.0	1.7	0.4	0.4	7.0	9.7	5.6	9.3	7.8	6.1	13.4	4.8	7.3	10.6	0.0	3.0	0.0	2.8	1.1	2.8	1.5	5.1	13.4	4.5	0.0	9.8	1.0	0.0	1.0	14.3	1.4	0.3	0.0	1.2	1.0	1.4	1.6	1.1	0.0	0.4	7.9	0.0	1.3	2.1	12.1	0.6	1.8	0.0	0.0	1.0	5.8	1.3	0.0	2.5	0.5	2.7	6.5	1.4	6.0	6.1	1.6	1.7	1.3	0.9	2.2
ZNF717	"X17, ZNF838"	ENSG00000227124	"Zinc finger protein 717"		3	75709643-75785583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 38.5"									HPA044549	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA044549: AB_10964630"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.60e-6)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	8.1	8.6	11.9	7.2	14.4	4.6	11.2	12.1	12.4	7.7	6.7	11.7	7.3	6.9	11.0	24.6	7.7	11.3	8.1	8.2	10.9	8.3	13.4	10.5	6.8	6.2	16.2	7.1	12.6	12.7	14.7	22.8	7.3	12.6	9.4	8.9	10.8	9.9	9.6	6.1	13.7	7.3	10.9	15.6	10.1	10.1	11.2	13.6	8.4	16.2	5.3	8.4	8.6	7.8	9.5	6.2	6.8	5.3	4.0	10.2	3.2	7.4	4.7	4.5	2.7	4.9	6.9	2.7	2.5	4.9	3.1	3.9	6.3	6.4	4.0	4.3	4.6	4.9	3.7	7.1	5.3	2.8	0.4	6.8	7.8	7.1	0.7	9.6	0.3	6.9	6.7	4.4	7.5	11.4	3.2	0.6	0.8	38.5	9.5	4.1	2.4	0.8	10.3	5.1	5.5	8.3	5.9	4.3	21.9	5.0	3.6	3.7	17.4	2.1	4.3	9.2	7.3	15.3	3.5	0.9	7.9	10.8	6.5	1.1	11.4	13.9	4.7	4.3	0.8	4.8	1.5	4.0	6.8	3.6	5.3	1.8	7.6	5.1	3.4	4.1	9.5	10.2	6.2	1.0	4.0	4.9	6.2	1.9	3.2	11.9	14.4	12.1	12.4	10.9	8.3	16.2	7.1	12.6	13.6	3.0	1.9	3.0	3.6	2.9	8.3	5.3	10.2	5.3	3.4	7.0	2.0	3.3	10.0	4.0	2.6	4.5	2.6	0.0	3.8	1.6	4.3	4.9	9.2	6.6	6.1	9.5	5.1	6.7	3.8	1.3	2.3	3.8	1.7	5.4	7.2	5.7	3.8	0.0	2.8	12.5	8.0	0.0	3.8	9.5	7.4	3.9	2.9	2.6	5.5	3.9
ZNF720		ENSG00000197302	"Zinc finger protein 720"	Q7Z2F6	16	31713229-31794869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA041570	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA041570: AB_10795126"	"unprognostic (5.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-3)"	"unprognostic (8.72e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.47e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-2)"	15.1	15.8	11.1	13.7	11.8	9.9	12.7	16.8	17.6	14.3	12.4	11.3	17.7	7.2	11.7	17.4	16.4	12.8	10.3	10.1	11.1	15.1	14.2	11.6	10.7	17.5	15.5	11.0	9.6	12.9	13.4	24.5	19.4	15.5	14.5	14.0	11.4	13.9	17.7	10.3	17.3	10.1	13.2	14.3	18.4	14.1	13.7	15.9	16.6	19.2	11.0	18.1	14.6	11.6	14.4	8.9	23.0	5.5	12.8	14.2	5.0	10.3	7.3	9.1	8.0	7.9	12.1	8.8	11.0	7.2	5.4	7.2	5.2	11.1	5.0	19.5	3.7	8.0	7.2	8.8	4.3	8.1	22.3	4.7	2.8	3.9	14.9	11.9	5.9	15.4	8.2	11.9	3.8	5.4	10.9	10.1	12.3	9.3	6.6	5.8	16.7	6.1	7.8	8.9	7.2	5.8	11.5	4.0	7.8	6.1	6.5	4.1	6.2	11.2	5.1	9.9	14.9	9.7	11.8	6.6	3.9	3.1	7.9	3.3	11.1	12.1	14.4	3.5	9.2	6.2	13.9	4.8	23.0	14.2	5.4	10.6	13.7	10.0	12.7	5.2	14.4	9.3	11.7	6.3	12.8	5.5	8.9	12.2	5.0	11.1	11.8	16.8	17.6	11.1	15.1	15.5	11.0	15.5	15.9	14.9	15.2	14.3	15.8	8.0	23.9	12.0	5.1	20.1	13.6	5.2	5.9	27.2	19.9	15.4	1.7	17.9	6.3	0.0	11.9	10.9	12.4	22.4	20.8	8.9	14.6	22.3	16.7	16.0	9.7	1.5	12.4	15.1	10.1	12.6	12.4	19.0	14.5	10.5	17.3	11.8	8.9	32.3	11.4	24.1	17.6	10.0	59.4	16.0	10.7	18.7
ZNF721	KIAA1982	ENSG00000182903	"Zinc finger protein 721"	Q8TF20	4	425815-499156	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA065313			Approved	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA065313: AB_2685464"	"unprognostic (2.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (2.76e-4)"	16.1	15.3	20.9	17.2	24.5	20.8	24.7	42.3	25.6	17.7	13.9	15.9	15.4	13.4	17.2	19.3	15.4	20.4	13.5	12.1	19.4	15.3	16.1	16.3	16.4	26.9	24.6	22.8	21.5	19.2	21.1	39.2	13.1	20.7	16.5	16.4	13.9	16.1	15.0	14.5	23.5	16.0	17.5	22.1	18.3	16.2	17.7	23.9	20.3	22.5	12.7	27.8	19.0	16.7	15.1	9.5	11.3	7.8	11.5	20.8	6.5	8.8	5.8	11.2	13.9	8.4	11.2	7.0	8.2	7.2	9.1	8.2	8.5	9.1	15.2	8.8	7.8	13.1	5.8	11.6	10.0	12.1	5.4	13.6	26.4	6.0	5.8	8.0	11.0	1.7	10.2	8.8	10.3	14.9	14.0	8.9	21.7	15.4	11.0	12.5	8.7	18.1	18.0	17.5	5.9	12.3	14.8	16.3	8.4	9.4	12.4	16.7	10.6	10.7	6.1	9.9	9.9	11.5	11.9	11.4	8.3	2.9	6.3	14.1	12.6	11.8	36.9	6.2	3.1	7.4	7.0	7.8	11.3	12.0	7.6	11.9	15.1	13.1	11.5	7.6	15.1	20.8	16.0	11.1	11.5	6.7	9.5	14.6	6.5	20.9	24.5	42.3	25.6	19.4	15.3	24.6	22.8	20.7	23.9	23.8	26.4	17.4	22.0	18.7	36.4	13.2	30.6	26.8	25.0	17.4	29.5	14.3	13.3	11.7	26.5	26.3	9.5	0.0	13.0	8.4	12.5	22.0	25.4	16.3	9.5	22.3	12.2	31.3	19.9	8.8	18.1	17.6	11.8	8.2	15.7	27.0	11.4	8.6	11.3	10.2	32.8	19.4	10.3	34.4	27.7	20.3	14.5	39.2	15.3	26.8
ZNF74	"Cos52, Zfp520, ZNF520"	ENSG00000185252	"Zinc finger protein 74"	Q16587	22	20394115-20408461	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 28.2"									HPA003354	Approved		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA003354: AB_1080747"	"unprognostic (1.40e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.44e-3)"	3.7	4.3	6.1	3.1	7.7	1.3	5.9	9.5	11.1	7.0	6.3	8.0	5.8	2.9	7.7	5.8	4.6	7.5	3.8	4.0	6.5	6.2	4.2	3.2	5.0	3.3	7.9	7.0	11.5	6.9	7.0	7.2	3.9	6.2	6.6	4.0	3.8	7.5	8.2	9.7	4.2	3.6	6.4	5.2	3.5	4.1	2.3	6.9	4.3	5.1	3.0	3.1	6.6	6.8	2.3	3.5	1.6	2.0	6.5	5.3	3.3	2.5	2.9	7.2	10.5	2.1	2.1	5.2	2.7	2.1	3.6	3.3	3.2	1.3	0.0	3.4	2.2	1.1	3.5	5.5	3.5	1.9	1.8	10.9	2.7	1.3	4.9	3.5	6.9	3.4	2.0	6.1	2.6	2.7	2.6	3.4	6.3	28.2	0.0	2.4	3.7	6.4	2.8	7.1	6.0	3.4	8.8	4.0	1.1	2.1	3.0	14.2	8.9	2.8	5.0	6.4	3.8	1.8	2.9	2.6	2.5	5.8	4.0	2.0	2.6	3.8	0.0	0.7	3.0	2.3	0.0	1.8	1.6	4.1	2.0	3.2	2.3	2.9	5.3	3.5	1.8	3.9	3.1	0.0	6.5	1.3	2.5	2.5	3.3	6.1	7.7	9.5	11.1	6.5	6.2	7.9	7.0	6.2	6.9	3.0	1.3	0.0	1.7	1.3	5.4	2.5	2.5	0.0	3.4	0.0	2.0	2.7	3.3	3.2	0.5	0.7	1.1	0.0	2.1	3.8	2.7	2.0	0.0	0.8	1.9	3.2	4.1	3.7	0.0	0.0	6.6	0.1	0.0	1.8	1.9	2.3	2.6	0.0	4.6	1.3	1.8	6.5	2.1	2.8	1.3	0.9	0.9	1.5	2.8	0.9
ZNF740	Zfp740	ENSG00000139651	"Zinc finger protein 740"	Q8NDX6	12	53180700-53195141	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035691	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035691: AB_10669777"	"unprognostic (2.31e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.19e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (4.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.89e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-2)"	12.5	13.9	12.5	13.6	14.9	6.5	14.0	23.8	17.6	13.8	13.1	13.8	18.1	11.1	17.2	15.7	13.2	16.3	11.1	8.0	17.2	10.1	12.9	11.4	11.6	18.1	16.5	11.8	18.3	16.3	21.2	13.2	11.5	13.0	14.2	12.2	11.8	13.8	16.0	10.1	13.6	14.7	12.6	10.5	18.1	12.4	7.1	13.8	19.0	15.9	7.4	20.1	11.9	16.9	1.7	1.6	2.9	0.8	4.6	2.0	0.7	4.7	6.4	11.4	7.3	11.5	8.6	4.3	5.0	9.4	8.1	7.1	5.4	7.6	11.0	7.6	5.7	3.9	7.8	8.2	5.9	8.3	8.3	8.9	12.2	8.5	4.8	8.4	11.1	7.7	10.8	11.8	6.4	9.7	13.5	6.5	11.6	8.0	22.3	4.2	5.5	8.7	6.0	5.6	4.5	7.8	8.9	8.8	17.8	4.6	6.7	8.8	9.8	8.5	7.2	8.4	5.6	10.3	11.5	5.9	4.3	5.9	4.8	3.6	10.9	4.7	6.0	6.6	6.3	5.3	2.9	0.8	1.4	1.6	0.4	1.1	1.6	1.4	2.0	0.7	1.7	1.9	1.9	0.2	4.6	0.4	1.6	1.7	0.7	12.5	14.9	23.8	17.6	17.2	10.1	16.5	11.8	13.0	13.8	3.0	12.4	4.2	1.9	5.5	7.6	5.1	5.1	5.3	2.3	1.8	5.9	2.7	1.7	3.4	1.0	5.2	4.0	0.0	3.9	1.5	4.6	3.3	7.0	3.9	2.9	4.8	8.1	4.3	6.1	0.9	5.8	2.9	1.7	2.8	5.7	5.8	4.6	7.0	5.6	3.7	6.6	19.4	9.0	1.7	3.1	4.0	2.1	2.5	6.0	2.6
ZNF746	"FLJ31413, PARIS"	ENSG00000181220	"Zinc finger protein 746"	Q6NUN9	7	149472696-149497817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 3.0;neutrophil: 10.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020272	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA020272: AB_2670398"	"unprognostic (2.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.32e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (4.22e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (7.47e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	11.9	9.9	10.6	12.0	11.6	33.9	9.1	15.6	17.2	10.5	9.0	11.7	9.1	8.0	11.5	8.7	8.5	10.3	8.7	7.6	11.2	9.7	10.0	10.9	10.3	12.1	9.5	8.7	10.4	13.7	10.2	13.5	21.0	11.4	10.6	6.3	11.4	10.7	8.5	8.9	10.8	9.2	9.5	9.0	20.2	9.8	22.0	10.4	18.7	10.6	5.5	10.3	10.9	15.9	0.6	0.9	10.4	1.0	0.5	1.6	0.5	7.1	11.5	6.1	16.6	6.9	6.0	9.3	7.3	6.0	5.9	5.1	7.3	5.4	10.3	10.7	6.4	8.6	8.0	7.9	8.3	3.5	13.0	11.0	5.0	5.8	10.0	8.4	9.7	13.4	6.6	10.1	4.8	5.3	5.3	6.1	8.5	15.2	8.0	7.4	11.0	21.9	13.1	15.1	4.4	8.0	14.6	5.7	9.0	5.6	8.6	8.7	12.0	9.7	10.7	6.8	3.8	5.0	12.0	8.5	7.5	2.7	12.7	10.6	14.8	7.0	8.3	9.8	7.8	13.0	3.0	1.0	1.1	0.7	0.7	0.7	0.4	0.9	1.6	0.6	0.6	1.1	0.9	10.4	0.5	0.5	0.9	1.5	0.5	10.6	11.6	15.6	17.2	11.2	9.7	9.5	8.7	11.4	10.4	0.0	7.4	3.4	4.9	3.2	15.5	6.7	5.1	4.0	4.5	10.4	3.9	5.9	0.0	2.8	8.2	5.3	2.0	46.7	2.1	5.2	3.6	5.1	5.8	6.8	7.0	25.4	5.8	3.1	15.5	10.8	5.8	6.8	3.3	5.4	4.0	8.8	4.0	3.5	6.3	3.1	10.8	0.0	3.7	16.2	7.0	3.0	7.3	4.1	3.7	4.4
ZNF747	MGC2474	ENSG00000169955	"Zinc finger protein 747"	Q9BV97	16	30530367-30535347	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003203, HPA069173"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA003203: AB_1080753, HPA069173: AB_2686097"	"unprognostic (3.82e-2)"	"prognostic favorable (6.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.46e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.01e-1)"	12.5	10.5	11.0	8.9	12.4	5.7	10.3	13.1	19.4	14.1	11.3	18.5	6.3	9.6	14.3	10.3	8.9	11.8	10.5	13.2	10.3	8.9	11.4	17.0	8.4	9.3	11.5	8.0	13.2	15.5	23.1	10.4	6.2	10.6	14.6	9.2	13.6	11.2	15.3	14.1	11.0	10.5	11.8	9.4	11.4	10.2	12.4	13.3	18.2	11.8	6.7	9.0	12.8	8.8	8.8	8.1	9.0	4.8	6.6	8.9	4.1	3.8	3.7	1.2	6.1	4.9	4.3	6.2	3.2	4.8	4.6	4.5	2.2	4.9	8.3	2.2	3.8	0.6	5.7	2.8	4.0	2.0	9.8	6.2	7.2	4.0	3.4	5.4	3.3	10.3	4.9	5.1	3.7	5.8	3.0	3.0	10.5	2.0	7.2	3.2	4.2	14.8	4.6	7.2	2.0	2.5	17.7	0.4	7.6	4.0	2.0	8.6	7.6	4.8	3.2	3.5	3.0	6.2	6.6	2.4	5.9	2.7	4.6	0.1	13.7	9.6	4.7	1.2	5.1	6.9	9.0	4.8	6.4	4.5	2.6	5.2	7.4	5.1	5.2	6.0	8.8	8.9	6.6	2.7	6.6	2.4	8.1	3.8	4.1	11.0	12.4	13.1	19.4	10.3	8.9	11.5	8.0	10.6	13.3	3.0	7.5	2.4	3.0	1.3	7.3	5.6	0.0	8.1	2.3	0.0	3.9	1.9	6.6	5.6	1.3	6.3	5.5	0.0	5.0	1.7	4.6	3.4	3.5	7.8	6.1	6.4	7.0	6.2	6.5	0.0	5.5	4.0	0.0	10.8	6.3	5.2	4.6	10.2	9.2	6.4	6.8	12.9	5.2	11.8	2.7	1.0	1.0	4.5	6.0	2.0
ZNF749	FLJ16360	ENSG00000186230	"Zinc finger protein 749"	O43361	19	57435329-57445485	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Melanocytes: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 23.5"									"HPA042082, HPA042091, HPA056001"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: AB_2683005"	"unprognostic (2.54e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.27e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.05e-5)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-1)"	5.8	5.6	7.2	7.6	8.0	5.0	8.4	12.4	10.7	6.3	8.1	5.2	7.5	6.6	6.3	5.1	7.4	7.9	8.3	5.1	6.4	6.0	5.3	12.4	5.4	7.5	9.0	7.7	8.2	7.0	11.4	7.2	6.3	6.0	6.2	4.5	8.5	12.8	10.8	6.2	9.7	7.1	5.9	5.3	6.7	5.5	6.2	6.8	7.8	6.7	12.1	8.0	6.0	6.1	2.9	3.2	0.2	2.7	1.9	4.1	2.8	2.7	6.4	5.7	5.8	1.5	1.5	2.3	1.7	1.4	2.8	5.1	2.6	2.0	5.3	1.5	1.6	1.9	2.0	5.4	4.3	4.2	2.3	23.5	4.7	6.7	3.0	1.8	5.2	3.1	1.8	4.8	3.6	7.7	2.8	1.5	5.7	4.5	6.3	2.1	1.1	6.4	1.8	5.4	2.0	8.9	6.7	8.2	3.9	1.3	6.5	5.6	4.6	3.2	1.9	1.3	4.7	2.8	1.7	1.6	5.2	3.8	1.6	4.7	4.8	6.2	5.5	2.9	2.2	3.1	0.1	1.2	0.2	2.1	2.7	3.4	2.7	3.5	3.1	3.2	2.9	4.1	3.0	0.2	1.9	1.2	1.6	2.6	2.8	7.2	8.0	12.4	10.7	6.4	6.0	9.0	7.7	6.0	6.8	3.0	0.6	0.8	0.6	2.2	0.8	0.4	5.1	2.7	3.4	0.0	0.0	0.9	3.3	0.9	0.6	1.6	1.3	0.0	0.3	0.7	0.8	0.7	0.0	2.9	0.8	3.2	2.9	1.3	0.3	0.0	0.6	1.0	21.9	1.0	0.7	0.4	0.8	0.0	0.0	3.1	0.9	6.5	1.2	0.7	1.7	2.8	0.7	2.1	0.9	0.9
ZNF75A	FLJ31529	ENSG00000162086	"Zinc finger protein 75a"	Q96N20	16	3305406-3318852	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA001665	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA001665: AB_1080751"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.79e-3)"	"unprognostic (6.32e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.75e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.97e-3)"	10.0	11.4	13.6	14.8	15.7	9.0	15.0	19.6	15.4	10.6	10.1	17.2	14.4	8.0	12.4	26.1	9.5	14.1	9.0	9.0	13.2	12.2	12.7	16.2	10.4	18.1	12.8	14.4	19.3	13.6	32.1	23.5	12.7	17.7	16.2	15.1	10.1	10.6	15.4	10.4	13.8	12.8	10.8	10.3	15.6	10.1	13.5	15.9	15.8	17.9	7.7	18.0	10.2	8.6	25.2	13.8	15.2	9.1	17.8	23.0	3.3	4.5	6.8	12.7	6.4	6.0	5.5	10.8	7.3	3.0	6.9	8.2	0.1	5.9	7.3	5.0	5.3	8.5	3.4	7.6	4.4	10.4	3.1	10.2	15.6	7.9	0.6	4.3	9.9	15.8	7.5	4.6	7.3	5.5	6.8	6.2	7.1	8.8	12.1	9.6	6.3	15.1	6.8	19.6	4.4	4.7	31.5	6.2	8.8	7.4	7.5	11.5	8.2	11.5	4.6	4.5	18.2	14.9	12.7	7.2	5.1	13.0	4.9	5.8	8.4	7.4	21.0	1.7	11.3	7.9	13.3	6.7	15.2	13.0	6.2	16.0	16.8	14.8	13.3	5.2	25.2	23.0	17.2	4.8	17.8	9.1	13.8	11.9	3.3	13.6	15.7	19.6	15.4	13.2	12.2	12.8	14.4	17.7	15.9	20.8	9.4	33.5	23.3	3.7	39.7	10.6	10.2	9.4	14.8	15.7	31.4	15.0	5.0	18.8	2.1	11.8	12.0	0.0	8.9	8.4	8.8	17.0	12.8	7.8	9.0	46.1	5.8	12.9	9.5	1.9	21.6	13.3	8.5	17.2	7.9	32.0	10.4	9.5	25.1	6.3	63.2	25.8	9.5	37.6	26.6	3.0	13.2	34.9	11.5	14.6
ZNF75D	"D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28"	ENSG00000186376	"Zinc finger protein 75D"	P51815	X	135248920-135344087	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 162.9;Late spermatids: 247.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA004705	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA004705: AB_1080749"	"unprognostic (1.56e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.42e-5)"	8.4	18.8	8.2	14.6	9.7	9.2	9.9	11.4	10.5	11.8	10.6	9.2	10.4	6.9	10.7	12.8	7.6	9.8	7.9	7.6	5.6	7.7	10.6	13.4	9.7	11.2	6.2	7.7	10.1	12.9	12.6	14.7	8.0	9.2	15.0	8.4	7.5	10.0	11.8	6.6	9.9	10.6	7.5	5.9	18.6	9.7	3.4	6.7	16.6	13.2	9.3	13.3	8.0	8.6	3.7	1.8	4.1	2.1	5.2	6.5	2.9	3.5	4.6	5.1	8.1	8.6	10.5	7.7	5.9	8.1	4.9	10.5	2.8	4.4	3.6	8.8	5.0	9.4	4.8	16.5	2.7	4.7	3.5	4.4	2.5	8.4	3.7	3.8	4.3	7.3	5.1	6.5	3.0	3.7	6.1	4.9	4.8	2.2	5.9	4.2	8.4	5.2	7.8	2.4	7.1	6.3	5.0	5.0	3.2	5.4	4.8	1.7	5.7	3.3	5.7	0.9	5.6	2.0	6.2	5.2	4.6	1.1	7.8	5.6	3.0	4.2	2.7	2.9	4.7	2.9	4.1	2.1	3.7	4.9	1.5	4.5	2.9	5.2	5.6	1.8	3.7	6.5	5.9	2.6	5.2	1.5	1.6	6.3	2.9	8.2	9.7	11.4	10.5	5.6	7.7	6.2	7.7	9.2	6.7	6.0	14.6	1.4	1.1	1.5	4.2	3.9	0.0	5.3	6.8	0.0	5.9	1.9	1.7	1.5	162.9	7.0	2.7	0.0	3.5	1.1	3.1	2.1	5.8	4.3	2.0	4.8	1.7	6.2	3.1	247.1	6.1	3.3	0.0	1.0	5.3	4.5	2.7	2.9	3.2	3.1	4.5	0.0	3.1	3.5	2.7	1.3	1.5	5.4	3.1	1.4
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	9.2	20.0	16.0	14.6	18.4	8.5	11.3	27.2	17.8	11.4	11.5	18.1	14.5	11.9	12.5	18.5	10.4	13.7	12.7	20.8	14.8	9.6	14.1	13.0	10.6	15.0	15.3	12.3	19.5	13.9	19.5	31.4	19.7	16.9	15.6	10.2	21.8	16.0	16.6	45.1	10.5	13.1	10.6	13.6	18.3	12.2	19.9	16.4	12.6	24.0	10.3	14.6	12.4	11.0	10.5	7.4	5.4	9.3	9.3	16.0	8.8	6.6	6.1	13.5	14.9	5.7	8.8	9.7	5.7	9.8	9.8	7.8	4.5	9.0	14.5	8.6	8.6	9.4	3.8	11.3	8.7	5.7	21.6	17.0	13.9	9.4	7.2	11.4	7.0	8.3	10.8	5.5	11.2	10.6	6.0	8.8	14.9	10.2	15.3	8.8	14.6	11.7	8.2	6.6	5.4	5.9	11.3	7.0	13.3	8.7	9.3	21.2	7.8	7.0	9.0	17.3	4.7	13.5	22.7	6.7	6.9	6.0	4.7	8.2	15.5	10.7	13.5	6.0	11.0	18.0	3.8	6.6	5.4	16.0	8.6	12.7	10.0	11.7	11.3	7.4	10.5	12.5	13.0	2.0	9.3	9.3	3.7	9.0	8.8	16.0	18.4	27.2	17.8	14.8	9.6	15.3	12.3	16.9	16.4	14.9	8.1	9.5	6.7	5.0	27.5	18.5	7.6	6.7	7.9	8.7	47.1	20.4	18.3	10.5	17.1	10.1	10.5	0.0	13.4	11.0	8.5	5.8	12.7	7.4	9.8	28.6	11.6	6.2	7.8	12.0	10.3	5.8	5.0	6.4	12.5	10.3	7.1	9.7	5.6	10.5	30.2	19.4	8.6	20.9	10.0	5.5	19.0	8.6	9.0	5.8
ZNF764	MGC13138	ENSG00000169951	"Zinc finger protein 764"	Q96H86	16	30553764-30558498	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003203	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA003203: AB_1080753"	"unprognostic (9.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.47e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.62e-2)"	"unprognostic (9.75e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.64e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.05e-1)"	9.4	9.0	12.0	8.0	9.9	9.8	7.4	19.5	11.3	9.4	8.7	10.0	9.7	13.0	10.6	4.4	7.1	9.5	10.8	9.7	10.5	6.1	8.1	11.2	6.8	11.3	10.6	7.4	12.5	8.9	10.6	12.5	6.1	9.9	9.7	8.4	8.3	7.9	7.1	9.4	6.8	11.7	6.4	5.9	11.1	14.0	11.3	10.4	14.9	7.6	6.1	8.1	7.5	7.6	4.1	3.1	6.2	2.7	10.8	6.3	2.5	2.9	3.4	7.1	6.8	3.1	3.1	4.2	3.7	3.1	3.7	2.8	2.8	2.8	5.4	4.5	2.2	2.2	4.2	3.8	2.5	2.9	5.9	9.9	3.5	4.2	5.1	3.7	3.4	5.8	2.4	3.1	3.0	4.1	4.8	3.3	13.3	6.6	6.3	3.3	6.5	9.5	5.5	4.2	1.8	4.8	13.1	3.0	7.0	3.0	1.5	13.7	10.5	2.6	6.0	3.5	4.5	5.2	6.3	2.9	4.9	2.8	2.8	3.7	8.5	5.8	4.5	3.6	4.8	6.9	3.4	2.1	6.2	4.9	2.6	6.3	2.9	4.9	5.9	2.7	4.1	5.1	4.8	2.1	10.8	2.7	3.1	3.1	2.5	12.0	9.9	19.5	11.3	10.5	6.1	10.6	7.4	9.9	10.4	0.0	2.7	4.7	2.0	1.4	5.1	3.6	5.1	8.1	4.5	1.8	0.0	2.3	0.0	2.9	0.4	2.9	4.0	0.0	2.6	1.8	2.3	2.3	1.1	2.4	3.0	1.6	2.4	2.5	3.5	0.2	3.1	2.2	0.0	3.6	3.9	2.7	3.3	10.5	2.5	2.0	5.0	6.5	3.1	10.3	3.9	0.4	0.8	4.9	3.9	1.1
ZNF768	FLJ23436	ENSG00000169957	"Zinc finger protein 768"	Q9H5H4	16	30524001-30526821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024630, HPA066512"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA024630: AB_1859446, HPA066512: AB_2685683"	"unprognostic (2.33e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (9.30e-6)"	"unprognostic (4.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-1)"	"prognostic favorable (6.46e-4)"	11.7	9.2	12.7	12.0	15.6	8.0	17.8	11.1	12.2	11.4	26.0	13.9	11.5	20.4	13.1	7.4	12.6	13.1	11.2	26.2	11.1	9.3	18.9	14.4	8.6	4.7	13.5	6.0	15.9	14.3	25.4	11.5	10.1	11.5	14.2	12.1	13.9	17.5	16.0	56.6	11.2	31.6	16.0	12.8	13.1	11.7	14.0	14.4	3.8	10.1	14.2	7.8	14.1	24.5	3.7	1.8	3.1	1.9	1.8	0.5	0.6	10.1	12.7	14.5	14.0	7.0	8.2	11.4	7.7	8.7	12.8	11.2	8.1	14.2	6.4	11.9	5.4	10.3	13.6	9.6	9.2	7.7	14.3	20.3	15.1	8.5	11.2	17.8	10.0	47.8	7.2	20.5	9.8	12.7	11.9	8.5	2.6	17.5	10.9	6.6	28.0	3.6	24.2	13.5	8.3	10.5	19.0	9.6	15.8	9.4	5.3	17.2	19.1	4.4	23.3	29.3	6.5	23.1	25.2	5.7	13.5	10.3	7.6	8.5	16.2	11.8	7.9	11.3	15.7	13.6	0.2	1.4	3.1	0.1	1.9	0.4	3.7	0.5	0.2	1.8	1.4	0.4	0.1	1.7	1.8	0.3	1.7	0.1	0.6	12.7	15.6	11.1	12.2	11.1	9.3	13.5	6.0	11.5	14.4	8.9	3.4	0.5	6.1	4.8	13.0	7.0	17.8	1.4	4.5	15.7	2.0	6.1	10.0	10.4	6.4	7.7	34.2	0.0	13.9	6.8	6.5	6.6	3.5	14.3	10.7	20.6	17.3	13.5	5.7	6.1	10.0	5.6	5.0	7.2	27.7	12.9	10.6	39.1	12.4	13.5	9.2	6.5	7.6	12.7	5.3	5.0	3.0	1.9	24.7	4.8
ZNF77	pT1	ENSG00000175691	"Zinc finger protein 77"	Q15935	19	2933218-2944971	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023397	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA023397: AB_1859447"	"unprognostic (1.17e-2)"	"prognostic favorable (8.49e-4)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.65e-5)"	"unprognostic (2.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-6)"	"unprognostic (2.06e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.93e-3)"	"unprognostic (2.65e-3)"	"unprognostic (3.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.79e-3)"	6.3	6.6	6.6	5.4	8.9	5.6	13.2	18.2	9.8	8.4	6.1	8.4	9.9	4.1	8.5	8.5	7.5	7.3	4.2	7.4	5.9	5.8	6.4	6.3	12.7	6.6	7.0	7.8	9.7	8.2	8.2	8.2	8.2	6.5	6.9	6.4	8.9	11.4	6.7	6.1	8.3	6.1	8.7	5.5	6.8	8.1	8.3	4.3	9.6	8.8	4.0	9.3	6.4	6.7	5.5	3.7	1.3	3.1	3.9	6.2	3.3	4.7	2.2	10.8	6.3	2.3	3.0	4.9	2.9	4.3	5.8	6.9	7.3	1.9	5.3	2.4	3.2	3.2	3.8	7.0	4.7	9.8	0.4	5.1	6.4	3.4	8.1	5.7	0.2	5.3	4.6	6.5	4.5	6.7	7.2	8.0	10.5	8.4	0.0	3.9	5.2	7.8	4.6	2.4	4.1	3.1	8.9	8.3	3.7	4.6	7.4	4.4	8.3	4.4	4.2	5.0	5.5	4.0	11.1	3.8	2.4	3.1	6.8	5.2	5.5	5.3	2.5	6.2	0.1	4.4	0.0	2.7	1.3	5.5	2.6	6.2	5.5	5.8	5.9	3.7	5.3	4.5	6.2	0.2	3.9	3.1	3.0	2.8	3.3	6.6	8.9	18.2	9.8	5.9	5.8	7.0	7.8	6.5	4.3	3.0	3.8	0.0	4.2	10.3	2.8	2.0	0.0	2.7	4.5	1.8	2.0	2.9	0.0	1.8	1.6	2.1	1.3	0.0	1.5	2.6	2.2	2.0	2.3	1.5	1.5	0.0	6.9	3.1	0.6	0.0	2.6	1.6	1.7	0.0	2.2	3.0	2.0	1.9	1.4	1.0	5.5	0.0	2.1	10.0	7.3	9.5	5.1	1.9	3.1	1.8
ZNF772	DKFZp686I1569	ENSG00000197128	"Zinc finger protein 772"	Q68DY9	19	57466663-57477570	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 21.7"					"Low region specificity"	"Detected in all"			HPA031312	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA031312: AB_10603941"	"unprognostic (2.30e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (1.02e-6)"	"unprognostic (7.99e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-2)"	3.4	8.3	11.0	2.5	14.5	2.2	7.9	21.2	11.8	5.4	3.9	8.1	3.9	3.0	3.9	9.5	4.8	8.8	4.2	10.3	9.3	6.9	6.9	4.1	4.8	5.0	8.9	10.2	10.6	4.6	18.9	19.2	6.9	8.0	7.6	2.6	8.6	6.2	7.1	15.7	6.8	3.7	4.0	6.4	7.6	4.0	5.8	9.6	7.4	14.9	3.0	6.3	5.2	3.6	7.6	3.3	2.2	2.4	3.4	4.4	1.9	2.2	1.7	9.1	3.8	2.5	5.3	4.1	3.9	4.8	6.3	21.7	0.5	2.4	0.2	2.9	3.3	2.8	0.2	1.9	5.1	7.7	0.0	14.0	7.1	0.8	2.3	3.3	0.8	7.6	4.4	2.2	4.2	8.8	6.0	4.6	2.9	2.1	1.4	5.7	1.6	1.0	1.8	5.6	0.5	4.3	1.9	11.6	7.1	2.9	5.5	9.6	6.0	0.1	2.1	2.9	6.5	6.2	4.5	2.2	5.9	3.9	1.3	4.0	9.1	15.6	2.6	1.3	0.2	5.7	0.3	2.4	2.2	0.8	1.8	2.9	4.3	2.2	0.9	3.3	7.6	4.4	2.3	1.2	3.4	1.7	1.6	0.6	1.9	11.0	14.5	21.2	11.8	9.3	6.9	8.9	10.2	8.0	9.6	6.0	1.6	1.3	0.3	0.6	6.8	3.9	2.5	1.4	1.2	15.7	5.9	2.0	0.0	1.5	0.0	3.3	0.7	0.0	0.3	0.8	0.4	1.2	2.3	2.4	2.1	6.4	2.4	2.5	4.1	0.9	0.6	1.7	0.0	1.0	1.9	5.0	0.8	0.0	2.1	1.7	8.0	0.0	1.0	0.5	1.1	1.0	1.5	0.0	1.8	0.8
ZNF773	"MGC4728, ZNF419B"	ENSG00000152439	"Zinc finger protein 773"	Q6PK81	19	57499915-57518404	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003152	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716"	"unprognostic (6.53e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.50e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.71e-3)"	9.0	10.3	7.3	7.0	10.8	10.7	12.5	15.4	11.3	6.0	7.7	6.0	11.2	8.2	8.4	11.4	6.8	8.7	8.4	7.3	7.2	6.9	8.2	4.9	8.1	16.1	8.6	7.8	12.1	5.6	16.0	14.6	8.7	8.2	9.7	7.1	9.6	9.0	8.1	17.8	10.7	7.9	8.8	9.7	11.3	6.9	8.8	4.7	12.7	12.3	6.2	10.4	9.2	9.6	14.8	6.9	16.2	4.8	8.9	17.2	5.8	1.8	3.2	5.6	7.3	4.0	5.0	0.3	5.4	8.1	4.8	19.9	3.3	2.7	3.5	2.9	3.5	3.6	1.4	2.7	5.7	7.1	0.1	17.4	5.9	0.4	2.0	7.7	4.4	4.8	11.4	8.2	3.5	13.9	6.1	3.4	6.3	0.3	0.6	6.1	0.4	8.4	3.1	5.8	0.8	9.6	4.6	9.0	5.4	3.3	6.5	6.0	7.3	1.0	2.5	6.2	5.4	4.2	8.2	2.9	7.6	3.4	1.9	5.7	8.9	9.1	5.7	2.9	4.4	6.8	16.2	4.8	7.6	8.4	3.6	13.6	11.8	10.4	9.0	6.4	14.8	17.2	13.8	2.2	8.9	3.1	6.9	7.2	5.8	7.3	10.8	15.4	11.3	7.2	6.9	8.6	7.8	8.2	4.7	0.0	1.6	2.2	2.5	0.9	4.8	1.2	2.5	0.0	5.7	0.0	5.9	2.4	3.3	2.5	0.4	3.0	0.0	0.0	0.6	0.8	1.3	2.8	1.1	0.8	0.8	6.4	0.0	1.8	1.5	0.0	1.1	2.1	1.7	1.8	0.4	3.8	0.7	1.1	3.5	0.8	7.4	12.9	2.1	1.8	4.2	0.5	2.4	3.8	1.0	1.8
ZNF774	MGC75360	ENSG00000196391	"Zinc finger protein 774"	Q6NX45	15	90352245-90369146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 10.9;Spermatocytes: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA030839, HPA030840"	Uncertain		Supported	"Intermediate filaments,Cytosol"		No	No			"Intermediate filaments"	Cytosol	"HPA030839: AB_2673630, HPA030840: AB_10602691"	"unprognostic (1.11e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.89e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.82e-2)"	1.5	5.1	5.8	3.6	8.6	1.6	5.7	14.0	8.7	5.0	7.5	4.1	0.0	3.9	5.5	7.3	2.8	5.3	5.1	4.2	4.8	5.4	2.6	2.9	2.1	1.2	3.9	5.9	2.3	6.5	7.1	5.7	1.3	9.4	4.3	12.4	3.0	6.8	10.3	11.9	5.3	3.5	3.3	3.1	1.3	4.6	8.2	4.7	3.8	4.9	3.1	1.7	3.9	3.5	2.0	1.9	4.2	1.1	2.7	1.3	0.4	2.3	1.1	3.1	3.4	1.3	0.7	7.1	1.5	2.4	1.8	2.3	3.7	2.8	0.9	2.8	1.7	5.3	3.5	3.0	5.0	1.8	1.7	6.0	2.4	11.3	1.7	2.3	1.4	2.0	0.7	6.1	2.7	2.6	5.2	3.1	4.8	2.7	1.2	3.0	2.3	1.9	1.3	0.9	6.2	3.6	1.8	2.6	0.7	3.7	6.3	6.9	2.9	2.8	4.4	1.2	3.6	2.9	0.4	1.6	2.1	1.9	1.7	3.0	7.4	5.0	0.6	3.3	3.9	0.9	3.6	1.1	2.2	1.0	0.5	0.7	0.9	0.8	1.3	1.9	2.0	1.0	0.9	4.2	2.7	0.6	1.2	0.5	0.4	5.8	8.6	14.0	8.6	4.8	5.4	3.9	5.9	9.4	4.7	6.0	2.7	0.5	2.5	0.7	6.3	4.5	0.0	0.0	1.2	0.0	0.0	1.4	1.7	2.0	10.9	1.1	2.3	0.0	1.8	1.1	0.4	1.2	0.0	1.0	0.7	7.9	2.4	0.0	0.0	8.2	0.3	0.0	0.0	0.0	3.3	2.3	1.4	3.5	2.1	0.8	5.3	0.0	1.2	9.0	1.1	0.3	1.1	0.0	5.1	1.4
ZNF776	FLJ38288	ENSG00000152443	"Zinc finger protein 776"	Q68DI1	19	57746796-57758159	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA046653, HPA068553"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA046653: AB_10961126, HPA068553: AB_2686002"	"unprognostic (6.73e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (3.99e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.86e-2)"	5.8	9.8	14.0	10.8	15.9	19.4	12.2	34.9	15.2	9.4	8.6	7.9	17.3	8.4	8.2	29.9	7.8	10.3	6.9	9.8	11.0	9.5	10.7	9.5	8.6	11.0	10.7	8.9	12.4	7.1	17.0	18.8	10.2	12.8	11.9	9.3	9.6	10.8	13.4	11.4	8.6	8.7	7.3	9.6	11.6	10.0	8.7	15.0	19.3	14.5	6.0	10.7	10.7	8.0	4.2	2.5	11.1	2.4	7.5	4.3	2.1	4.7	4.0	12.7	8.4	2.1	6.5	5.4	3.7	6.6	6.6	4.3	2.4	5.1	5.3	3.4	3.4	3.5	3.1	6.6	6.5	10.6	5.0	24.1	7.2	9.4	2.7	4.8	4.0	5.8	7.5	5.5	4.4	4.8	7.1	5.1	8.7	4.8	3.8	8.5	2.1	13.0	3.8	7.4	2.1	8.3	8.4	9.6	6.0	4.8	14.9	14.5	10.5	6.9	5.8	4.1	7.2	5.9	5.7	4.5	7.1	3.8	0.6	5.6	10.7	12.0	8.8	4.2	3.8	5.8	7.9	2.4	11.1	1.8	1.7	3.9	3.5	2.8	3.4	2.2	4.2	4.3	3.2	6.2	7.5	2.1	2.5	2.3	2.1	14.0	15.9	34.9	15.2	11.0	9.5	10.7	8.9	12.8	15.0	3.0	2.6	5.2	3.6	2.4	7.8	10.9	10.2	5.3	1.2	8.7	2.0	2.8	5.0	2.5	0.4	5.5	2.9	0.0	1.2	2.0	2.5	4.5	3.5	6.6	2.9	11.1	8.1	11.1	5.6	0.2	1.1	3.7	0.0	1.8	4.1	10.0	2.2	2.6	4.6	2.2	7.1	0.0	2.2	2.7	4.3	1.5	2.4	1.0	3.3	4.3
ZNF777	KIAA1285	ENSG00000196453	"Zinc finger protein 777"	Q9ULD5	7	149431363-149461123	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"placenta: 65.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003252	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003252: AB_1080755"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.72e-2)"	5.0	4.3	5.5	4.1	8.8	6.9	4.9	7.1	9.3	5.2	5.2	5.4	3.5	4.5	7.3	3.5	4.1	6.5	3.5	4.7	5.3	5.1	3.8	4.4	4.4	4.7	4.3	5.3	9.1	6.6	6.6	5.9	65.7	6.6	5.8	3.3	5.0	7.3	5.8	10.6	7.3	4.4	5.4	6.2	6.0	4.9	4.2	3.5	3.5	5.2	4.8	3.9	6.2	5.0	0.4	0.2	0.6	0.3	0.1	1.5	0.1	10.2	12.7	8.6	12.4	6.4	5.2	11.0	6.6	7.0	9.0	7.8	7.9	6.6	6.5	13.4	7.5	5.6	6.8	8.3	10.1	5.0	10.5	12.7	6.4	3.6	7.8	10.9	9.0	9.3	6.1	11.6	7.3	10.7	4.8	4.8	8.9	20.5	0.0	5.1	13.2	18.9	12.3	10.4	4.6	7.5	15.7	4.4	13.6	5.6	8.0	9.3	13.1	11.4	11.8	11.0	3.3	5.5	15.1	7.5	7.6	3.0	14.9	10.8	6.2	5.4	3.0	5.7	6.2	9.7	0.0	0.3	0.0	0.5	0.3	0.1	0.3	0.4	0.4	0.0	0.4	0.1	1.5	0.6	0.1	0.1	0.2	0.0	0.1	5.5	8.8	7.1	9.3	5.3	5.1	4.3	5.3	6.6	3.5	0.0	1.7	1.5	1.4	1.0	6.9	2.3	2.5	1.4	0.0	1.8	5.9	1.8	0.0	0.7	2.1	1.6	1.5	0.0	0.9	2.8	1.1	2.0	0.0	5.0	1.3	1.6	1.7	2.5	2.8	2.5	2.6	1.1	0.0	0.0	3.1	4.9	1.0	2.9	3.2	1.4	5.4	0.0	1.4	0.6	4.7	1.6	3.2	2.2	2.6	0.9
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.30e-4)"	6.9	9.2	11.1	8.6	8.5	4.1	7.7	12.8	10.8	8.7	6.6	5.8	13.9	5.7	8.2	10.8	10.4	7.8	7.8	6.7	7.1	6.1	7.9	11.8	7.0	11.3	10.5	8.9	8.6	11.0	15.8	14.1	7.0	6.8	7.9	6.0	6.8	10.0	11.4	4.5	8.0	9.1	6.0	10.4	12.0	8.2	7.9	9.7	7.8	11.2	5.3	11.3	8.8	7.9	3.9	4.6	8.4	7.7	3.3	5.9	2.5	4.9	9.4	6.2	5.7	5.6	5.2	4.4	5.8	4.7	4.7	7.2	6.1	3.4	4.4	3.8	2.8	4.7	4.2	3.9	3.3	5.3	7.5	5.3	6.9	7.8	5.8	5.0	7.2	5.8	5.3	3.7	4.8	4.0	6.4	4.9	5.0	7.8	7.5	4.0	2.9	2.9	2.4	4.9	4.8	2.9	2.3	10.9	2.6	3.9	10.2	3.8	7.3	8.6	3.3	3.8	5.7	4.1	8.7	3.6	5.8	7.7	5.3	4.6	7.4	6.5	4.4	3.7	5.0	3.9	2.7	5.4	8.4	3.9	4.9	5.1	3.7	4.2	3.5	4.6	3.9	5.9	5.1	4.7	3.3	7.7	3.6	4.5	2.5	11.1	8.5	12.8	10.8	7.1	6.1	10.5	8.9	6.8	9.7	8.9	12.2	4.4	3.5	3.4	5.7	3.7	7.6	8.1	9.1	8.7	2.0	5.0	8.3	11.9	17.3	7.7	7.4	0.0	42.0	6.3	5.5	3.0	16.1	33.6	13.1	4.8	3.4	11.6	25.0	1.1	4.0	17.9	11.8	8.2	7.2	3.5	24.5	8.6	4.9	13.3	6.6	6.5	6.2	5.8	2.5	2.3	4.9	11.5	6.6	2.7
ZNF780B	ZNF779	ENSG00000128000	"Zinc finger protein 780B"	Q9Y6R6	19	40028260-40056209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 28.1;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (3.28e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-3)"	6.3	8.2	12.4	9.8	18.8	3.3	10.3	22.2	14.0	8.2	8.5	8.2	11.6	5.7	10.8	12.3	5.5	10.0	6.6	12.5	9.4	7.2	9.4	6.7	5.9	9.7	8.1	10.8	16.6	8.1	10.5	24.7	7.1	11.6	9.7	7.6	9.3	7.9	10.5	6.9	7.1	7.6	9.7	7.8	9.2	7.2	5.0	11.4	8.7	14.0	6.4	9.8	9.1	8.2	4.2	5.9	1.5	3.2	2.3	5.1	1.3	2.6	3.5	5.9	4.1	3.6	2.4	0.0	3.1	2.3	3.4	4.5	6.3	2.4	6.6	2.9	3.2	3.4	1.6	4.9	1.9	4.0	5.5	2.5	5.1	6.2	3.9	2.4	7.6	4.3	3.4	1.2	4.7	2.9	2.6	3.2	3.0	5.3	8.9	3.4	1.2	2.5	1.2	5.8	2.3	3.7	3.5	10.4	2.3	2.0	14.5	6.5	6.9	5.4	2.4	1.9	3.7	2.8	3.3	5.8	3.3	8.3	5.8	4.7	6.7	8.6	5.1	3.1	4.0	2.8	0.1	3.2	1.5	2.8	2.8	2.9	2.5	3.4	3.3	2.4	4.2	5.1	4.2	0.6	2.3	1.8	5.9	1.9	1.3	12.4	18.8	22.2	14.0	9.4	7.2	8.1	10.8	11.6	11.4	8.9	8.1	4.2	2.3	1.6	28.1	13.0	10.2	4.0	10.3	8.7	31.4	1.6	3.3	4.4	6.0	5.8	2.6	0.0	8.6	1.2	2.7	2.1	7.0	4.9	3.2	9.5	9.9	9.8	4.8	1.1	3.4	7.2	5.0	5.4	4.3	7.2	4.7	4.5	2.8	2.4	35.0	6.5	3.9	2.7	1.3	2.6	0.6	5.2	4.2	2.2
ZNF781	FLJ37549	ENSG00000196381	"Zinc finger protein 781"	Q8N8C0	19	37667751-37692322	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 57.2;Late spermatids: 45.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"B-cells: 1.0;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 4.7;ASC diff: 4.7;HSkMC: 4.6;SH-SY5Y: 4.6;U-266/84: 5.4"									HPA062512	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062512: AB_2684788"	"unprognostic (3.01e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	4.9	5.3	5.7	4.6	12.9	0.5	2.9	15.8	13.6	4.3	4.5	3.8	1.9	1.6	7.3	4.8	2.2	4.8	3.1	6.5	5.8	5.8	2.6	1.3	3.7	3.5	6.1	6.8	9.8	1.3	4.8	7.4	5.0	7.6	4.5	3.1	3.8	1.5	5.2	1.5	2.0	2.4	8.5	9.6	5.0	2.2	4.8	5.5	0.6	5.3	1.3	2.5	4.7	5.4	1.0	0.1	0.1	0.2	0.0	3.2	0.7	0.0	0.0	1.9	4.7	4.7	1.0	1.0	1.7	0.0	1.7	1.2	0.2	0.0	0.2	0.0	1.1	3.0	0.0	0.1	0.0	2.0	0.0	0.1	0.1	0.0	2.0	2.3	0.0	0.1	4.6	0.0	1.3	0.1	0.6	0.4	0.2	0.9	0.0	0.0	0.0	1.2	1.0	0.5	0.0	0.0	0.0	3.3	0.0	0.7	1.2	0.0	4.6	0.0	0.0	0.0	2.4	2.2	0.1	0.0	0.2	0.0	0.0	1.1	1.5	5.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.1	0.4	1.8	2.5	0.1	1.0	2.6	3.2	0.1	0.0	0.0	0.1	0.8	0.7	5.7	12.9	15.8	13.6	5.8	5.8	6.1	6.8	7.6	5.5	0.0	1.1	1.3	0.5	0.5	6.1	12.9	2.5	0.0	0.0	0.0	19.6	5.8	0.0	0.8	57.2	4.5	0.0	0.0	0.0	3.4	1.6	0.1	3.5	0.0	3.0	3.2	7.5	11.6	1.5	45.4	4.4	0.0	1.7	0.0	0.0	5.5	0.1	0.0	6.3	0.2	7.8	12.9	6.6	14.8	3.2	0.0	1.1	1.3	0.0	0.0
ZNF782	FLJ16636	ENSG00000196597	"Zinc finger protein 782"	Q6ZMW2	9	96816472-96875623	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 8.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011013	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA011013: AB_1080758"	"unprognostic (5.51e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.63e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.95e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.39e-2)"	5.3	4.2	7.4	7.4	8.4	2.5	7.6	19.8	8.0	7.5	5.3	6.9	5.9	6.1	7.9	8.5	5.2	5.5	5.8	4.0	6.8	4.5	7.1	5.5	4.4	5.9	5.9	4.8	9.3	12.7	11.8	15.1	4.9	7.7	7.5	6.9	5.4	8.0	7.3	9.2	8.6	7.1	5.3	6.5	6.4	6.6	13.9	8.3	6.0	8.8	2.5	7.4	5.6	10.8	2.3	0.2	0.7	0.5	1.0	2.2	0.4	2.9	2.3	5.8	8.9	1.6	2.2	4.0	2.8	2.8	4.6	3.4	2.7	3.1	5.7	3.7	2.0	5.4	4.1	5.1	1.8	4.5	5.7	2.2	5.3	4.7	2.7	1.7	7.3	3.7	1.3	3.8	3.7	1.9	2.2	1.5	7.0	7.0	5.8	2.7	5.0	7.6	3.6	4.3	5.2	5.1	6.8	7.1	1.9	3.1	1.9	5.9	4.5	3.8	2.3	3.0	4.9	4.3	4.2	3.3	6.0	3.5	6.0	3.1	5.5	3.9	2.7	2.5	1.8	4.3	0.0	0.5	0.2	1.1	0.5	2.2	2.0	1.0	0.0	0.2	2.3	0.9	0.7	0.7	1.0	0.2	0.2	0.6	0.4	7.4	8.4	19.8	8.0	6.8	4.5	5.9	4.8	7.7	8.3	0.0	5.5	0.9	1.4	1.6	5.7	1.4	0.0	1.4	0.0	1.8	7.9	0.7	0.0	1.3	5.6	1.6	1.7	0.0	1.5	0.2	0.5	1.7	5.7	1.0	1.1	3.2	0.0	1.8	0.6	6.9	1.7	0.7	0.0	3.6	1.4	2.2	1.0	0.0	2.8	1.6	6.5	0.0	1.0	8.6	2.4	0.9	0.6	0.7	1.2	1.8
ZNF783	DKFZp667J212	ENSG00000204946	"Zinc finger family member 783"	Q6ZMS7	7	149262171-149297302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA020375	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA020375: AB_1859453"	"unprognostic (3.17e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (2.24e-7)"	"unprognostic (2.49e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.11e-4)"	10.1	8.1	11.4	14.4	14.9	6.5	15.1	14.3	15.8	11.5	9.4	15.4	9.9	10.0	13.1	11.2	8.2	13.0	11.0	7.2	11.6	7.7	8.5	4.6	8.6	16.1	13.1	18.4	17.2	11.2	9.4	10.2	7.2	12.5	13.0	9.7	12.2	9.3	13.5	11.6	12.6	12.2	20.1	15.4	17.7	9.1	9.2	12.5	2.9	11.8	6.2	15.0	9.9	16.1	3.8	2.7	0.5	4.5	1.5	3.2	1.1	3.4	3.5	5.7	4.1	3.8	7.3	5.4	2.2	1.1	5.0	2.2	5.5	6.4	11.6	5.6	3.5	1.2	2.3	4.0	4.3	2.2	3.2	3.7	7.5	7.6	1.1	8.7	4.8	9.4	7.6	8.9	4.6	5.6	3.2	3.4	4.1	6.0	6.0	4.1	7.3	7.3	7.5	12.9	7.9	4.7	1.6	0.5	10.1	5.6	5.7	4.6	9.6	8.5	4.0	5.8	3.1	4.4	9.8	5.0	4.0	1.0	2.2	4.8	9.3	5.8	0.1	5.8	1.7	8.7	0.3	1.1	0.5	3.2	2.2	2.5	2.3	2.0	2.0	1.3	3.8	2.7	2.2	0.4	1.5	4.5	2.7	1.2	1.1	11.4	14.9	14.3	15.8	11.6	7.7	13.1	18.4	12.5	12.5	3.0	2.4	7.8	2.4	2.3	14.3	1.4	7.6	4.0	1.2	0.0	9.8	2.5	3.3	2.0	3.9	2.9	2.0	0.0	2.4	1.7	4.5	3.6	0.0	5.0	3.6	6.4	3.5	6.7	8.5	3.5	8.1	2.8	5.0	2.8	5.1	3.4	2.1	0.0	5.3	0.8	8.6	12.9	3.1	14.7	5.9	2.6	0.9	4.1	4.7	2.1
ZNF784	MGC75238	ENSG00000179922	"Zinc finger protein 784"	Q8NCA9	19	55620742-55624601	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 39.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059676	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059676: AB_2684102"	"unprognostic (4.67e-2)"	"unprognostic (8.13e-2)"	"unprognostic (4.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.44e-2)"	"unprognostic (4.74e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.02e-4)"	5.9	5.6	2.9	7.4	3.2	5.7	4.9	5.2	5.0	7.5	9.3	3.3	4.1	8.6	7.9	8.0	4.9	6.7	7.0	9.1	2.8	2.3	5.8	7.3	10.4	3.5	2.7	3.2	9.7	15.0	6.0	5.5	4.9	3.9	7.9	3.8	5.8	5.9	5.8	39.1	4.9	11.2	10.4	2.6	6.5	5.8	3.6	2.6	3.2	7.3	16.1	6.1	6.7	4.5	1.4	1.6	2.9	2.0	1.4	1.3	0.6	4.5	6.4	6.1	3.2	2.3	3.2	5.7	4.8	3.0	2.8	3.7	3.3	5.1	5.5	4.2	3.4	2.1	2.5	1.7	4.2	2.0	3.0	17.1	5.2	5.0	4.0	4.7	4.2	5.5	4.3	4.6	2.3	3.0	4.4	1.8	7.9	6.0	5.7	4.2	4.4	3.2	4.8	5.9	3.5	14.2	6.1	4.1	6.1	5.0	11.7	6.8	9.1	7.9	3.7	2.1	4.2	4.0	7.5	5.5	3.2	3.0	1.9	3.9	6.6	2.7	3.2	4.9	3.2	2.7	0.0	2.0	2.9	0.8	1.8	0.6	1.0	0.8	0.8	1.6	1.4	0.8	1.3	1.1	1.4	1.5	1.2	0.1	0.6	2.9	3.2	5.2	5.0	2.8	2.3	2.7	3.2	3.9	2.6	0.0	9.0	3.2	3.6	0.8	5.4	11.3	5.1	2.7	2.3	0.0	2.0	4.3	3.3	3.2	1.9	2.0	9.3	0.0	3.6	2.3	1.0	2.0	2.3	5.4	3.0	7.9	5.2	1.8	1.9	0.0	3.7	1.3	0.0	4.6	5.1	4.1	4.0	7.0	2.5	4.3	9.5	12.9	2.0	0.7	1.9	1.1	8.5	2.1	5.2	3.4
ZNF785	FLJ32130	ENSG00000197162	"Zinc finger protein 785"	A8K8V0	16	30573740-30585771	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004010			Approved	Cytosol		NA	NA			Cytosol		"HPA004010: "	"unprognostic (2.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.54e-4)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (3.37e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-2)"	5.9	8.7	15.8	7.9	13.6	4.8	8.3	26.8	16.6	10.9	7.7	14.7	8.7	14.2	12.4	9.8	6.9	10.2	8.3	6.2	12.6	7.6	7.8	6.1	6.5	8.7	15.7	12.2	14.7	9.1	11.9	12.7	6.1	11.8	10.8	8.2	10.8	10.5	9.5	9.2	12.6	10.7	7.5	9.5	9.5	12.4	3.9	19.2	8.8	9.9	4.3	8.8	10.4	9.6	5.1	5.4	4.9	5.1	3.3	3.5	1.0	4.9	0.4	4.8	6.4	6.1	6.8	1.5	4.3	3.9	4.5	3.4	6.7	7.9	5.1	5.2	4.1	0.3	7.1	0.1	2.8	2.7	3.4	1.3	6.2	13.7	1.5	4.5	0.5	10.8	4.4	6.2	3.0	2.8	3.8	4.8	0.9	5.8	6.4	4.1	8.6	6.2	5.8	2.8	1.9	2.8	16.3	5.5	2.5	4.2	5.1	13.4	9.5	3.6	4.5	2.6	3.0	5.6	5.3	7.1	1.8	4.8	4.0	0.3	0.9	2.7	2.1	5.8	3.8	7.3	4.7	2.6	1.0	2.3	1.6	2.5	5.1	2.8	1.9	1.9	3.1	3.5	2.7	4.9	3.3	5.1	5.4	3.3	1.0	15.8	13.6	26.8	16.6	12.6	7.6	15.7	12.2	11.8	19.2	0.0	4.3	4.3	6.6	0.9	9.3	1.4	5.1	5.3	2.3	7.0	19.6	1.1	5.0	3.0	0.1	5.1	5.2	0.0	3.0	0.9	3.3	5.7	0.0	3.0	2.3	12.7	11.5	2.5	4.1	0.0	12.4	4.1	5.0	1.8	4.7	5.2	3.5	8.4	12.4	1.5	12.4	0.0	3.1	4.2	1.3	2.3	0.7	4.4	6.3	3.7
ZNF786	DKFZp762I137	ENSG00000197362	"Zinc finger protein 786"	Q8N393	7	149069643-149090782	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021518, HPA053459"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA021518: AB_2670734, HPA053459: AB_2682159"	"unprognostic (3.13e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (2.01e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.47e-2)"	3.9	4.3	8.7	6.1	9.6	3.3	5.1	10.4	15.2	6.0	5.1	4.2	6.4	4.6	6.9	6.1	6.8	6.7	4.8	3.2	6.4	6.1	4.5	5.4	7.3	8.2	4.8	5.8	8.3	6.0	7.6	8.5	3.8	4.0	6.8	3.4	5.4	5.3	5.8	4.1	13.0	5.1	6.6	3.4	7.7	5.1	2.9	4.2	8.4	6.1	5.8	6.5	6.2	6.1	7.2	4.5	2.9	5.0	8.4	12.1	5.3	4.5	8.2	6.6	11.1	4.0	1.7	9.4	2.7	2.9	3.1	2.5	4.3	4.3	6.4	6.8	1.9	5.4	5.2	4.0	3.8	2.0	7.0	6.1	3.2	4.8	5.4	3.4	6.2	4.3	2.3	4.3	3.9	2.8	3.2	2.9	4.7	5.6	3.7	2.9	14.1	10.5	10.6	12.0	4.3	6.2	7.9	3.2	4.2	2.5	6.3	7.8	12.4	6.9	6.5	5.1	4.3	4.2	2.9	3.7	3.7	2.1	6.3	4.0	13.4	9.9	3.5	6.1	4.0	4.0	1.7	3.7	2.9	12.1	5.0	9.8	7.2	8.5	10.7	4.5	7.1	11.3	9.5	1.1	8.4	3.9	3.9	5.1	5.3	8.7	9.6	10.4	15.2	6.4	6.1	4.8	5.8	4.0	4.2	0.0	0.6	2.4	2.1	2.4	9.4	2.5	0.0	2.7	0.0	3.5	2.0	2.1	3.3	3.7	0.3	1.5	1.3	0.0	1.3	1.9	1.9	1.2	4.6	2.1	1.9	17.5	4.6	2.5	1.2	0.0	2.8	2.0	0.0	2.8	1.0	2.7	1.8	2.9	3.9	1.8	5.7	0.0	1.9	3.1	8.3	1.5	1.6	4.9	2.6	1.7
ZNF787		ENSG00000142409	"Zinc finger protein 787"		19	56087366-56121280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 52.1;Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035140	Supported		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			Nucleoplasm	"Nucleoli, Mitochondria"	"HPA035140: AB_10602358"	"unprognostic (1.97e-2)"	"unprognostic (5.86e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-3)"	7.4	8.0	4.3	7.8	5.2	18.8	7.1	4.7	7.0	8.0	9.8	5.1	8.5	12.8	5.8	6.5	9.8	8.7	8.7	10.2	4.0	4.3	6.4	18.0	6.9	7.7	4.8	4.0	8.7	13.9	3.3	6.6	4.8	4.6	10.0	3.9	7.9	9.6	7.2	28.2	9.3	10.5	6.8	3.1	14.9	11.0	6.8	4.6	4.8	10.0	8.2	5.7	8.7	10.1	3.0	5.5	4.9	2.1	1.2	1.6	0.7	12.0	11.9	3.9	8.1	1.1	2.5	10.1	6.2	2.4	4.3	4.8	7.0	7.5	8.6	0.4	2.6	3.8	9.5	2.4	5.0	1.9	11.4	43.9	13.7	6.0	10.5	6.3	13.1	12.0	3.3	5.0	3.5	6.2	2.6	3.1	4.9	16.3	9.7	2.5	7.6	8.1	16.5	12.3	11.1	22.4	10.2	5.7	10.9	4.3	8.0	14.9	14.4	6.6	13.0	11.5	2.3	8.0	18.6	6.7	16.1	11.5	6.7	17.1	20.6	15.1	8.3	9.3	8.8	7.5	1.7	2.1	2.6	1.2	1.5	1.6	2.3	0.8	1.0	2.2	3.0	1.3	0.7	4.9	1.2	1.4	5.5	1.3	0.7	4.3	5.2	4.7	7.0	4.0	4.3	4.8	4.0	4.6	4.6	11.9	2.4	6.7	8.9	5.5	52.1	9.0	12.7	0.0	4.5	10.4	104.1	2.9	1.7	5.9	1.5	6.7	15.4	0.0	14.2	4.0	5.0	8.6	5.7	28.4	7.5	33.4	8.7	12.9	6.5	2.9	4.6	6.8	1.7	4.6	17.1	29.5	12.9	15.3	4.2	3.7	60.0	6.5	6.2	2.5	7.9	6.4	1.6	3.2	16.9	11.7
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 5.1;Spermatocytes: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favorable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	9.9	11.0	7.6	6.7	7.8	6.7	8.1	18.3	8.5	9.2	9.6	10.3	6.9	5.6	12.9	10.4	7.0	9.4	5.6	6.8	6.8	5.3	6.8	9.5	6.8	8.3	7.5	5.2	9.1	9.5	13.2	11.8	8.1	8.4	11.2	8.2	10.7	12.2	8.3	13.2	8.7	7.7	8.3	6.1	10.2	8.8	21.1	8.6	12.8	8.5	4.8	10.5	13.3	9.9	8.5	7.5	7.4	6.0	9.4	11.8	4.9	2.3	4.6	6.2	3.6	6.9	4.1	17.2	5.7	6.9	6.8	7.9	4.9	2.1	4.9	2.3	4.2	9.1	7.1	4.6	6.9	5.4	4.9	3.0	3.4	7.4	5.4	8.1	8.0	5.4	4.1	7.8	8.4	6.9	4.4	7.1	5.7	5.7	7.4	6.4	5.0	6.2	3.0	4.9	5.7	5.9	5.2	8.5	7.0	2.9	3.3	7.0	4.7	10.8	5.6	3.2	5.5	7.4	4.6	4.9	4.4	4.0	4.3	4.4	9.9	21.2	6.3	5.6	2.5	7.2	3.3	4.9	7.4	9.3	6.0	10.6	7.4	6.4	11.8	7.0	8.5	8.4	9.1	6.5	9.4	4.0	7.5	7.9	4.9	7.6	7.8	18.3	8.5	6.8	5.3	7.5	5.2	8.4	8.6	0.0	0.3	0.0	1.0	1.3	0.8	1.6	5.1	0.0	2.3	0.0	0.0	1.8	1.7	1.7	2.1	0.7	0.6	0.0	0.5	0.6	1.1	0.5	0.0	1.0	1.7	1.6	0.0	1.3	0.6	3.7	0.6	0.9	0.0	0.0	0.6	1.3	0.4	0.0	1.8	0.7	1.4	0.0	1.2	5.1	1.3	0.9	2.2	0.8	0.9	0.7
ZNF790	"FLJ20350, MGC62100"	ENSG00000197863	"Zinc finger protein 790"	Q6PG37	19	36817428-36850787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA056134, HPA060288"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA056134: AB_2683049, HPA060288: AB_2797260"	"unprognostic (1.14e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-2)"	6.6	8.9	9.3	9.9	15.9	3.2	7.2	21.5	14.8	7.6	6.4	12.5	7.1	6.4	7.7	7.7	7.5	6.1	8.1	8.8	10.8	7.9	10.3	13.8	6.1	7.9	14.2	7.2	7.8	7.3	11.6	14.5	6.0	13.1	6.8	4.5	7.4	5.7	7.3	7.3	15.6	6.1	6.1	11.4	7.4	7.9	20.4	15.9	8.5	13.2	4.9	6.8	7.7	7.9	9.7	6.8	6.8	6.2	6.7	9.0	3.0	0.0	0.7	6.4	11.6	4.5	4.8	4.1	4.5	6.1	3.6	6.5	0.0	1.4	1.4	9.1	3.3	4.5	1.7	5.0	4.1	3.3	10.4	4.5	7.4	0.7	1.7	3.8	3.3	5.6	6.1	3.4	3.1	0.0	4.3	6.1	5.8	0.2	0.1	8.0	3.5	8.4	2.6	4.3	0.0	0.8	1.5	5.3	5.6	3.9	8.4	8.0	7.3	4.2	0.1	2.5	7.6	5.2	6.2	6.7	5.0	3.8	4.5	5.9	9.1	12.7	5.2	0.0	0.2	4.0	6.0	3.7	6.8	5.9	6.2	6.1	9.0	8.4	8.3	6.8	9.7	9.0	7.4	1.3	6.7	2.2	5.6	6.8	3.0	9.3	15.9	21.5	14.8	10.8	7.9	14.2	7.2	13.1	15.9	3.0	0.6	5.9	3.0	1.5	23.7	3.4	7.6	1.4	1.2	7.0	29.5	5.5	5.0	4.1	72.8	6.6	5.1	0.0	4.5	3.0	3.3	3.0	4.6	5.5	3.7	11.1	2.4	5.5	3.7	24.9	7.8	3.2	3.3	4.6	2.7	10.1	3.8	3.1	4.6	8.1	25.0	0.0	5.0	5.6	1.6	3.6	4.9	7.5	2.3	7.2
ZNF791	FLJ90396	ENSG00000173875	"Zinc finger protein 791"	Q3KP31	19	12610918-12633840	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021537	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021537: AB_2670741"	"unprognostic (1.95e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.86e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.39e-5)"	16.7	12.0	11.9	18.0	15.4	22.5	18.6	30.3	17.1	20.0	15.0	12.7	14.1	10.9	16.6	16.3	14.0	15.4	10.1	13.0	11.5	10.9	13.4	11.9	17.0	15.8	14.7	12.5	21.5	15.3	20.2	32.1	13.4	15.5	16.6	13.4	11.8	15.5	18.2	15.9	17.1	15.3	17.9	16.0	16.6	13.8	7.0	13.8	14.4	25.4	8.9	19.6	23.7	18.1	11.6	10.5	9.7	3.8	10.9	8.3	2.6	6.9	3.9	7.5	7.4	9.3	12.0	6.5	9.0	9.9	6.7	8.2	4.8	4.2	1.6	8.7	9.3	4.0	6.6	7.3	8.5	11.2	4.7	7.6	6.9	9.5	6.7	7.6	8.9	7.7	10.3	9.8	8.0	13.0	10.5	7.0	4.5	7.9	11.2	8.3	11.1	5.5	3.4	8.6	3.9	11.7	4.0	12.3	5.7	6.7	13.4	8.3	10.0	8.0	6.5	8.5	9.3	6.5	7.7	8.7	13.5	5.7	11.7	7.2	16.8	20.0	4.9	9.2	7.0	7.9	9.7	3.3	5.2	7.0	2.1	7.2	7.4	6.3	8.0	3.0	11.6	7.4	8.3	5.6	10.9	3.8	10.5	5.4	2.6	11.9	15.4	30.3	17.1	11.5	10.9	14.7	12.5	15.5	13.8	11.9	23.3	34.0	30.3	26.0	68.5	16.8	25.5	29.4	23.9	17.4	92.3	25.1	16.6	20.7	4.3	43.4	26.2	0.0	15.2	15.5	23.7	31.2	9.2	26.0	12.2	33.4	35.6	47.3	15.5	1.8	36.2	24.5	13.5	9.0	24.2	38.4	21.5	11.5	36.7	9.2	75.6	38.8	33.9	11.2	13.7	24.2	32.7	38.4	20.6	29.8
ZNF792	FLJ38451	ENSG00000180884	"Zinc finger protein 792"	Q3KQV3	19	34956354-34964049	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 4.5;Ito cells: 8.6;T-cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.0;HMC-1: 15.9;HUVEC TERT2: 10.7;SH-SY5Y: 10.3"					"Low region specificity"	"Detected in many"			"HPA035157, HPA035158"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA035157: AB_2674497, HPA035158: AB_10603010"	"unprognostic (1.31e-1)"	"unprognostic (7.31e-2)"	"prognostic favorable (2.72e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.77e-3)"	9.4	3.9	3.6	7.3	5.8	2.3	8.9	11.6	5.4	6.1	6.1	5.9	8.9	4.3	6.3	4.3	3.1	5.8	7.9	4.1	2.3	2.0	4.5	3.7	9.4	8.3	2.2	2.0	5.2	5.0	6.9	3.4	7.1	3.8	8.8	5.1	5.7	5.7	4.9	3.1	4.0	6.0	5.6	2.8	8.6	5.1	3.7	2.1	12.0	5.4	3.4	5.8	7.3	4.0	1.8	1.1	6.9	0.7	4.4	5.5	2.2	1.0	3.6	1.7	2.7	1.8	1.4	0.0	1.0	1.9	1.3	1.6	1.4	1.7	1.5	3.3	1.4	0.6	0.7	2.5	1.9	2.0	4.4	0.5	12.0	1.1	2.8	1.3	1.0	15.9	1.6	0.6	1.0	0.5	2.3	10.7	1.0	3.2	0.0	2.1	0.8	4.1	1.1	1.3	9.1	0.8	2.8	0.0	0.2	1.0	3.3	0.9	10.3	1.0	1.0	1.3	1.7	1.2	3.3	4.3	1.9	2.4	0.8	1.1	0.3	0.9	0.9	2.0	0.2	0.8	6.9	0.7	6.1	3.1	0.7	4.1	1.8	4.9	4.3	1.1	1.7	5.5	4.6	0.2	4.4	0.5	0.1	4.6	2.2	3.6	5.8	11.6	5.4	2.3	2.0	2.2	2.0	3.8	2.1	0.0	0.6	2.0	0.1	0.5	0.7	1.2	0.0	0.0	0.0	0.0	2.0	0.1	0.0	1.4	0.1	4.5	0.2	0.0	2.3	0.3	0.6	0.3	1.1	0.2	1.2	0.0	1.7	8.6	3.2	0.0	1.4	0.0	0.0	1.8	1.9	0.8	2.2	0.0	0.0	0.0	1.5	0.0	0.5	0.0	1.1	0.4	0.1	4.5	1.3	0.1
ZNF793		ENSG00000188227	"Zinc finger protein 793"	Q6ZN11	19	37506939-37548762	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 29.5;Early spermatids: 32.2;Horizontal cells: 46.1;Rod photoreceptor cells: 33.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;RT4: 9.8;U-266/70: 17.0;U-266/84: 11.3"									HPA034781	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA034781: AB_10602784"	"unprognostic (4.80e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.12e-3)"	3.1	7.7	12.5	4.9	11.9	2.1	6.4	22.1	14.0	6.4	4.2	12.8	4.6	3.0	9.3	6.9	5.2	6.7	4.6	6.8	10.3	8.0	6.2	1.1	3.3	5.6	8.3	10.0	14.1	4.0	15.7	18.4	4.5	11.2	7.5	6.0	8.1	3.6	5.8	3.7	10.7	3.6	6.1	10.1	5.6	5.3	12.3	9.6	2.1	11.0	3.2	4.9	4.9	5.7	4.0	2.1	7.2	1.6	4.0	2.8	1.4	0.1	0.2	4.2	11.5	0.9	0.9	0.2	3.3	0.2	0.7	0.3	0.2	1.3	2.9	5.5	1.7	1.0	0.4	0.3	2.9	0.3	0.8	4.2	0.3	0.4	0.3	2.1	0.2	2.6	3.4	2.6	0.6	0.1	0.3	0.1	0.3	0.1	0.5	0.5	3.2	0.3	0.4	6.9	0.0	0.3	0.1	0.1	0.6	2.9	9.8	3.1	6.7	0.2	0.2	0.0	8.1	6.4	0.3	0.4	0.1	1.8	0.3	3.3	17.0	11.3	0.3	0.0	0.2	0.5	7.2	1.6	1.2	1.5	0.6	2.3	2.0	2.8	2.5	1.2	4.0	1.9	2.4	4.2	4.0	0.6	2.1	2.2	1.4	12.5	11.9	22.1	14.0	10.3	8.0	8.3	10.0	11.2	9.6	3.0	7.2	0.8	3.4	3.0	28.0	7.3	12.7	6.7	5.7	12.2	29.5	4.8	3.3	3.1	32.2	6.3	1.4	0.0	1.3	3.6	3.1	2.6	2.3	0.4	0.8	46.1	8.6	6.2	0.0	7.7	4.6	2.0	0.0	1.8	3.4	16.2	1.6	0.0	9.6	1.5	33.5	0.0	5.1	5.4	6.4	2.9	1.6	4.3	3.4	1.4
ZNF799	"HIT-40, MGC71805, ZNF842"	ENSG00000196466	"Zinc finger protein 799"	Q96GE5	19	12390016-12401271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 13.2;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (2.96e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.47e-5)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-3)"	7.9	7.2	6.1	11.9	5.5	3.2	10.1	7.7	8.0	12.6	8.2	4.6	12.9	4.7	6.9	5.8	7.6	9.3	4.9	4.1	6.6	4.3	7.8	8.3	6.6	5.3	6.3	1.8	10.8	10.7	7.6	2.8	10.5	6.3	8.4	6.2	3.3	6.2	6.8	5.5	5.6	6.1	5.6	5.0	7.4	4.5	5.8	6.7	9.1	7.5	6.4	5.2	7.1	6.5	7.5	4.6	4.6	4.3	4.5	10.3	3.9	3.8	2.9	4.1	9.4	2.1	2.1	8.2	2.1	2.9	5.1	5.0	6.0	1.5	4.9	3.8	2.4	2.6	3.1	3.1	3.7	5.0	0.1	3.1	3.8	2.4	9.7	0.7	3.0	7.2	2.5	2.3	3.6	2.9	1.5	2.5	4.7	4.0	0.0	3.3	5.2	6.2	4.2	2.1	4.9	8.2	0.7	6.0	4.9	5.2	9.4	3.0	3.1	4.3	0.9	1.1	3.1	4.2	5.4	2.3	5.5	3.1	6.3	2.4	3.5	5.5	3.9	0.8	3.1	2.2	4.4	4.1	4.6	6.9	4.3	8.3	7.5	6.5	10.3	3.4	6.7	6.5	5.0	4.3	4.5	2.6	4.6	6.9	3.9	6.1	5.5	7.7	8.0	6.6	4.3	6.3	1.8	6.3	6.7	6.0	1.0	0.5	2.7	2.2	2.5	3.0	2.5	5.3	2.3	3.5	0.0	13.2	5.0	3.8	5.4	4.9	2.6	0.0	1.2	2.1	3.2	2.2	3.5	0.9	3.6	0.0	4.1	3.7	1.5	2.1	2.3	2.3	0.0	1.8	5.2	1.3	2.3	2.9	1.1	2.8	2.5	12.9	5.1	4.8	4.4	1.3	3.8	3.3	3.7	2.0
ZNF8	"HF.18, Zfp128"	ENSG00000278129	"Zinc finger protein 8"	P17098	19	58278951-58302805	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034797, HPA034798"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA034797: AB_10696364, HPA034798: AB_10602785"	"unprognostic (1.41e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.56e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.28e-2)"	2.7	3.1	4.6	2.7	5.5	7.7	4.3	6.4	7.5	3.4	2.6	6.1	2.7	3.0	4.9	4.0	2.8	3.5	2.8	3.7	4.7		3.4	2.2	3.4	3.4	4.1	3.3	3.8	3.1	7.5	4.3	3.8	4.1	3.3	3.1	4.4	3.0	3.7	2.1	6.6	2.2	3.9	4.6	4.5	3.6	3.5	4.3	9.2	3.9	1.5	3.5	3.0	3.9	2.3	1.6	4.7	2.4	1.9	1.9	1.9	2.2	3.2	4.9	8.7	3.1	2.7	4.0	1.1	1.8	1.2	1.4	3.5	1.7	2.8	1.4	1.9	1.0	2.1	3.5	3.8	1.6	2.1	14.1	5.5	6.2	2.9	2.8	1.8	4.5	4.9	2.4	2.1	4.0	3.6	2.1	4.6	2.8	1.2	2.5	2.4	4.2	2.5	4.2	1.6	2.3	4.7	4.5	2.0	2.3	7.8	8.3	4.5	3.4	2.5	1.1	3.8	2.4	3.4	3.1	8.8	2.2	1.3	2.2	4.4	3.5	3.5	1.5	0.1	2.2	3.6	2.4	1.6	1.6	1.3	1.9	1.5	1.4	1.2	1.6	2.3	1.5	1.7	4.7	1.9	1.0	1.4	0.7	1.9											0.0	5.5	1.7	2.7	0.0	10.4	2.4	0.0	4.0	3.4	5.2	11.8	1.7	3.3	2.9	1.5	1.6	0.5	0.0	2.0	1.2	1.9	3.5	1.1	1.0	2.2	11.1	5.2	6.2	1.0	0.0	3.7	1.8	0.0	1.8	2.1	4.9	2.7	0.0	1.8	2.3	11.0	6.5	1.4	5.0	2.3	0.0	2.2	4.4	1.7	2.6
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA023090: AB_1859457, HPA052194: AB_2681757"	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	17.5	11.2	10.8	14.4	11.7	61.7	18.7	18.6	12.7	11.9	11.9	6.3	12.8	10.3	14.6	10.4	15.4	13.5	11.6	9.5	10.2	5.9	8.9	14.4	16.5	20.7	13.5	9.2	15.2	15.3	16.2	18.6	10.8	12.6	10.5	10.5	7.1	15.1	16.1	14.9	22.7	14.8	11.5	15.7	15.2	13.1	19.1	12.8	22.4	12.7	10.9	13.8	14.4	15.5	14.2	12.0	16.9	6.8	18.9	17.2	5.9	9.1	4.8	5.7	9.8	8.2	11.0	5.4	8.9	10.5	9.2	8.9	4.4	8.8	15.6	5.5	8.4	9.9	6.7	9.2	9.5	12.7	13.7	5.4	10.0	4.9	4.1	10.3	13.7	19.3	9.3	8.8	10.1	13.7	7.7	9.7	9.7	12.4	16.1	9.9	7.0	15.2	9.9	4.7	8.5	6.4	9.5	7.9	10.3	6.7	11.6	8.1	8.5	8.8	34.9	11.3	8.1	4.1	9.4	10.4	15.5	4.9	10.2	10.4	19.4	8.5	22.6	11.5	12.5	12.8	16.9	6.8	10.1	13.3	6.3	14.0	12.0	10.0	13.5	7.0	14.2	16.4	17.2	6.0	18.9	6.6	12.0	13.8	5.9	10.8	11.7	18.6	12.7	10.2	5.9	13.5	9.2	12.6	12.8	35.7	19.7	27.4	41.3	39.8	25.9	12.6	15.3	16.0	21.6	12.2	21.6	9.7	10.0	20.7	27.0	23.3	24.9	23.3	16.7	8.6	17.5	40.1	28.8	12.9	12.9	73.1	15.5	23.4	26.2	8.6	25.0	26.7	27.0	27.9	22.6	16.6	19.9	25.9	29.7	10.5	26.1	25.8	25.8	97.4	48.6	41.9	18.4	33.8	20.0	57.6
ZNF804A	C2orf10	ENSG00000170396	"Zinc finger protein 804A"	Q7Z570	2	184598366-184939492	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 31.6;lymphoid tissue: 9.6"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 31.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.6"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 20.8;RH-30: 14.3;THP-1: 10.5;U-698: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029195	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029195: AB_10603011"	"unprognostic (1.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.98e-4)"	"unprognostic (6.21e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.93e-2)"	0.4	1.0	4.3	9.6	7.2	1.8	0.4	31.6	10.7	0.6	0.8	0.1	0.8	1.5	0.4	0.3	0.6	0.4	4.8	0.3	5.2	7.3	1.8	0.6	1.2	2.7	2.2	3.0	0.8	0.3	0.2	0.4	0.5	5.4	4.1	1.1	2.4	1.1	4.4	0.3	0.3	3.3	0.5	1.5	1.8	1.2	0.9	0.4	0.0	4.4	0.0	2.9	1.8	2.1	2.0	1.2	1.0	1.7	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	4.9	1.6	1.5	0.0	0.0	20.8	0.0	0.0	2.1	0.0	0.3	0.0	3.7	0.1	0.0	5.5	0.8	0.1	8.2	5.2	0.0	2.5	0.0	0.0	1.3	2.5	3.9	0.0	0.0	0.9	0.0	0.0	0.0	4.9	0.0	0.0	3.3	0.0	14.3	0.8	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.1	0.0	10.5	0.0	5.3	0.1	0.2	2.1	2.2	0.0	15.5	6.1	1.5	1.7	0.0	1.1	0.0	0.0	1.7	0.0	2.0	0.0	0.0	1.2	0.3	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.3	4.3	7.2	31.6	7.5	5.2	7.3	2.2	3.0	5.4	0.4	0.0	1.1	3.4	0.0	0.0	31.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	0.0	0.0	2.7	0.4	0.3	3.2	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	2.6	6.5	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0
ZNF805		ENSG00000204524	"Zinc finger protein 805"	Q5CZA5	19	57240685-57255135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046330, HPA058895"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046330: , HPA058895: AB_2683846"	"unprognostic (2.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.64e-1)"	8.4	8.8	3.6	5.5	7.2	18.5	9.6	4.8	9.4	6.6	6.1	8.3	5.8	3.9	9.1	6.4	6.6	6.0	5.9	6.3	3.4	3.5	5.4	6.2	6.8	5.1	6.4	5.2	10.2	7.2	9.8	9.0	7.5	5.8	6.2	5.7	6.8	7.9	5.8	9.0	7.7	6.3	7.2	5.2	7.2	6.1	8.6	5.9	9.2	6.7	2.4	7.4	7.1	11.6	3.9	2.1	5.3	1.8	5.6	4.9	2.4	2.4	3.7	3.6	4.8	6.6	4.9	4.5	2.3	5.4	4.0	7.9	3.1	2.2	4.6	1.8	5.6	2.5	1.5	4.0	3.9	7.1	2.4	10.0	4.7	3.0	3.0	5.9	4.2	4.7	6.1	4.9	5.2	9.0	3.6	3.7	5.0	1.7	6.2	2.8	1.7	5.1	1.5	3.0	2.1	4.2	2.5	7.7	4.0	2.6	7.8	3.8	3.8	6.2	3.5	3.6	5.1	2.4	4.2	4.1	5.7	3.9	2.6	2.7	6.2	4.3	4.5	3.6	2.3	3.1	0.0	1.8	5.3	3.8	0.5	4.9	3.9	3.3	4.8	2.1	1.7	3.3	3.1	2.0	5.6	0.9	1.5	3.6	2.4	3.6	7.2	4.8	9.4	3.4	3.5	6.4	5.2	5.8	5.9	3.0	0.3	0.0	1.8	1.4	5.4	1.6	0.0	1.4	0.0	1.8	7.9	0.9	1.7	1.2	1.8	2.1	0.4	0.0	1.0	1.4	1.0	1.9	4.6	0.0	0.8	3.2	1.2	1.3	0.6	0.0	1.1	0.7	0.0	0.0	1.2	1.9	1.2	0.0	0.7	0.5	5.4	0.0	2.7	4.7	2.8	1.0	1.9	0.7	0.6	2.3
ZNF813	FLJ16542	ENSG00000198346	"Zinc finger protein 813"	Q6ZN06	19	53467735-53496255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 17.7"									HPA056406	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA056406: AB_2683119"	"unprognostic (1.20e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.56e-2)"	5.9	3.7	4.0	5.0	4.3	2.5	4.8	3.2	3.6	5.8	4.3	2.5	1.7	3.8	4.1	8.7	4.0	4.1	3.0	2.4	2.5	2.3	5.0	2.5	4.7	4.1	4.6	1.6	4.8	4.1	5.2	3.5	12.7	4.7	10.7	3.7	2.0	4.8	3.3	1.6	4.0	6.3	4.5	6.3	6.5	4.0	4.2	5.2	10.2	5.8	2.8	4.3	6.4	9.5	4.8	2.5	2.4	5.5	6.8	6.8	2.6	0.8	0.8	2.6	4.4	2.2	2.7	6.1	2.3	2.4	1.6	2.3	4.5	2.6	6.6	2.3	2.2	3.0	1.4	6.2	2.7	3.1	0.0	9.8	6.7	1.8	5.1	1.2	0.0	7.2	2.3	2.2	1.8	1.4	0.9	1.4	4.9	3.6	0.1	2.6	1.2	8.7	3.7	3.3	0.8	2.3	5.3	5.7	3.2	1.6	17.7	1.1	2.5	0.0	4.5	1.6	5.9	1.8	3.3	2.4	0.9	3.3	0.1	2.2	3.6	5.3	7.5	0.0	0.0	4.6	2.4	2.2	1.7	3.7	3.2	3.7	3.4	3.5	4.1	2.5	4.8	6.8	5.2	1.1	6.8	5.5	2.4	2.6	2.6	4.0	4.3	3.2	3.6	2.5	2.3	4.6	1.6	4.7	5.2	6.0	2.6	1.4	3.1	1.5	0.6	1.6	2.5	1.4	3.4	0.0	0.0	4.4	1.7	1.8	1.1	3.6	1.1	0.0	1.0	5.9	2.7	5.1	0.0	0.8	2.4	3.2	0.0	16.0	3.1	0.0	2.3	1.5	3.3	2.8	4.1	1.1	1.3	3.5	2.1	0.7	0.4	0.0	1.9	0.6	5.1	1.4	7.4	1.3	3.7	2.2
ZNF816	ZNF816A	ENSG00000180257	"Zinc finger protein 816"	Q0VGE8	19	52949379-52962911	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 33.6"									HPA042466	Uncertain		Approved	"Nucleoli rim"		NA	NA			"Nucleoli rim"		"HPA042466: AB_10797497"	"unprognostic (1.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (6.21e-2)"	"unprognostic (5.45e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-2)"	6.2	6.4	4.9	8.0	8.3	2.8	8.0	14.7	6.6	10.2	8.9	4.5	12.5	4.7	6.7	10.1	8.4	12.1	9.8	5.8	5.0	3.3	9.6	3.2	7.0	7.1	10.4	3.4	9.5	8.7	6.7	11.8	9.2	6.1	15.5	10.4	4.5	8.6	9.8	2.4	5.3	7.3	8.0	9.1	11.0	9.4	5.4	8.9	18.9	10.2	5.8	8.5	14.3	9.4	11.6	8.4	14.4	7.7	17.6	17.5	7.4	4.1	0.1	3.8	9.7	7.1	7.8	11.1	3.5	3.5	4.5	6.6	3.3	2.8	11.2	7.3	3.0	6.9	2.5	5.4	4.0	4.3	5.5	11.4	5.2	4.3	5.0	2.4	0.0	8.1	3.7	5.1	2.6	5.2	5.3	3.8	5.2	8.2	0.4	5.6	3.2	8.9	5.9	4.5	2.3	5.1	5.0	8.2	5.5	7.1	33.6	2.9	5.3	0.4	5.9	2.3	7.8	3.9	6.0	3.6	3.3	3.3	2.2	3.9	3.9	11.1	10.4	0.4	5.6	3.9	10.0	7.3	14.4	13.6	6.2	17.5	9.9	12.7	13.1	8.4	11.6	17.2	13.8	4.1	17.6	7.7	8.3	11.5	7.4	4.9	8.3	14.7	6.6	5.0	3.3	10.4	3.4	6.1	8.9	3.0	1.0	0.0	2.8	0.8	1.1	1.7	0.0	1.4	5.7	1.8	5.9	3.9	6.6	3.3	2.1	2.1	1.3	0.0	1.4	3.0	1.3	1.6	7.0	0.0	2.1	0.0	0.0	0.6	1.0	1.6	1.4	1.8	5.0	3.6	2.6	1.0	1.6	2.9	1.1	0.7	0.9	0.0	1.3	1.4	4.3	1.4	3.0	2.5	3.0	4.2
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;testis: 23.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.3;naive B-cell: 11.5"	"Group enriched"	"Detected in many"	8	"B-cells: 11.5;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"AF22: 14.0;SCLC-21H: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: AB_2678140"	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"	2.0	4.2	6.3	3.7	7.5	3.1	4.8	26.9	13.4	4.3	3.8	5.1	2.3	2.1	5.8	11.1	2.5	3.5	3.9	2.9	5.7	7.6	5.9	2.6	3.4	6.0	5.2	6.0	7.3	2.4	5.6	9.2	2.5	7.1	4.4	5.0	5.2	5.2	5.1	4.0	6.0	4.3	3.0	4.8	3.7	3.3	23.7	3.4	2.2	6.1	0.7	7.3	2.4	4.0	11.5	0.9	0.4	0.5	1.0	5.1	0.7	1.1	0.9	14.0	6.7	2.8	3.6	2.4	1.4	3.1	3.1	4.9	1.9	0.9	2.6	2.4	2.7	3.4	2.0	4.6	2.1	3.8	3.9	5.2	0.5	1.0	0.8	1.7	0.9	3.0	3.1	3.5	2.1	1.3	5.3	2.4	0.6	1.6	2.0	3.4	3.3	1.5	0.9	5.5	4.0	0.6	6.1	3.0	4.5	3.5	0.4	14.1	6.7	1.8	1.2	1.5	6.3	4.7	3.0	4.6	3.3	3.5	1.2	0.9	4.7	2.4	10.6	1.1	2.6	3.2	0.0	0.5	0.4	2.2	0.0	1.9	9.3	2.3	1.6	0.9	11.5	1.4	0.5	0.4	1.0	0.5	0.0	5.1	0.7	6.3	7.5	26.9	13.4	5.7	7.6	5.2	6.0	7.1	3.4	0.0	3.4	20.5	6.0	7.1	41.7	1.1	12.7	2.7	1.2	15.7	43.2	5.2	18.3	8.1	108.2	5.8	26.4	0.0	4.1	4.3	8.5	6.0	9.2	1.7	6.8	30.2	22.5	12.9	4.0	40.3	11.5	9.3	3.3	2.8	9.2	20.9	5.9	14.4	11.7	8.6	47.4	12.9	4.7	50.4	18.3	6.6	5.1	17.5	6.4	3.4
ZNF827		ENSG00000151612	"Zinc finger protein 827"	Q17R98	4	145757627-145938635	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 12.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 23.5;WM-115: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021166	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021166: AB_2670608"	"unprognostic (2.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.88e-2)"	3.8	9.5	8.2	9.6	15.6	3.9	6.5	37.3	12.3	6.0	7.1	8.1	7.7	8.1	10.7	6.5	3.8	8.3	6.3	7.0	5.9	5.8	6.3	1.1	4.7	6.4	5.8	8.2	11.0	4.3	14.9	28.3	2.2	7.4	26.3	6.4	4.3	28.1	9.3	24.9	3.4	10.0	11.4	13.0	5.5	6.3	4.5	9.5	14.0	10.9	3.3	7.7	10.2	5.0	1.9	2.6	5.4	0.0	12.3	3.4	1.2	2.7	4.4	8.0	5.2	3.5	3.9	0.0	4.6	4.4	3.6	2.8	2.2	7.2	0.7	1.6	8.4	3.2	1.7	4.6	3.5	3.8	5.6	2.2	2.2	4.3	2.5	3.7	1.6	0.0	5.3	3.2	2.8	7.9	7.8	6.4	1.2	0.4	4.4	3.0	0.0	2.4	0.1	3.9	0.0	5.8	7.2	4.2	1.4	3.8	4.1	7.3	6.7	4.0	6.9	10.4	4.4	3.1	0.1	23.5	9.6	7.8	0.6	5.3	3.1	0.2	3.0	3.1	9.0	36.4	5.4	0.0	0.0	3.3	0.0	0.9	1.5	1.2	3.1	0.0	1.9	2.1	3.4	0.0	12.3	0.0	2.6	0.1	1.2	8.2	15.6	37.3	12.3	5.9	5.8	5.8	8.2	7.4	9.5	11.9	13.7	4.2	7.6	5.7	12.7	18.9	2.5	10.7	11.4	22.7	9.8	2.1	3.3	8.9	11.8	4.3	10.3	0.0	6.3	0.4	6.6	19.8	2.3	1.3	1.1	17.5	24.8	7.4	1.2	5.8	8.3	1.0	1.7	1.0	19.5	4.8	10.4	3.5	15.9	9.8	1.1	6.5	4.7	1.6	1.7	4.3	1.1	6.4	18.6	9.5
ZNF829	DKFZp779O175	ENSG00000185869	"Zinc finger protein 829"	Q3KNS6	19	36888124-36916291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 20.1"	"Cell type enriched"	"Detected in many"	8	"Early spermatids: 241.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 15.0"									HPA073073			Approved	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"HPA073073: AB_2686567"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-4)"	"unprognostic (1.32e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.92e-4)"	2.6	2.8	4.9	2.4	5.9	1.9	4.3	8.0	4.8	2.9	2.6	2.3	5.0	1.7	3.6	2.0	2.2	3.1	1.8	2.4	3.3	2.5	2.6	1.8	2.2	2.8	6.4	2.9	5.3	2.1	3.8	3.4	3.6	3.3	3.6	1.6	1.6	2.6	3.0	1.9	3.5	2.1	4.8	4.4	2.8	2.3	20.1	5.1	3.4	5.2	1.0	2.9	3.1	4.7	3.3	1.4	4.2	0.8	2.1	4.9	1.0	0.0	1.2	3.3	0.1	1.8	2.8	1.4	3.7	2.2	4.6	7.1	0.1	0.6	0.1	4.4	2.3	4.3	0.7	0.0	2.7	5.4	0.0	5.3	1.9	0.1	0.1	1.8	0.0	5.2	2.8	2.6	5.1	0.0	1.5	0.5	1.4	0.0	0.1	5.0	0.8	0.7	0.8	5.5	0.0	0.0	0.0	4.5	1.7	1.3	5.5	3.8	5.6	0.1	0.0	3.1	4.9	3.5	0.3	1.4	3.0	3.9	3.8	4.0	9.8	15.0	6.3	0.0	0.1	6.9	4.2	0.6	2.9	3.2	0.7	4.2	2.2	3.2	4.9	1.0	3.3	4.1	4.2	1.3	2.1	0.8	1.4	3.2	1.0	4.9	5.9	8.0	4.8	3.3	2.5	6.4	2.9	3.3	5.1	0.0	4.3	1.3	1.8	1.3	5.8	4.6	5.1	1.4	5.7	3.5	3.9	3.2	0.0	2.3	241.5	3.9	0.0	0.0	0.9	2.1	2.8	1.6	1.1	0.0	1.4	11.1	0.0	1.3	0.3	29.7	5.5	2.5	3.3	1.8	0.9	2.4	0.8	0.0	6.7	1.1	11.3	0.0	2.3	9.5	10.0	2.4	3.5	2.9	0.4	0.7
ZNF83	"FLJ11015, HPF1, ZNF816B"	ENSG00000167766	"Zinc finger protein 83"	P51522	19	52594060-52690496	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA025970	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025970: AB_1859463"	"unprognostic (6.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (3.38e-3)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (9.20e-4)"	"prognostic favorable (9.06e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (2.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (6.92e-6)"	13.1	19.0	14.5	16.2	66.8	14.6	22.3	42.6	20.2	21.6	16.4	11.7	41.4	8.4	23.3	54.0	11.4	27.2	16.0	11.1	17.2	11.5	26.0	4.0	12.9	18.5	25.7	12.5	34.5	11.8	22.3	29.4	44.2	21.9	25.5	14.0	11.0	11.8	32.6	5.8	16.2	12.3	21.0	20.4	19.0	14.7	9.8	24.4	16.9	24.3	8.1	15.9	15.9	34.3	9.9	4.3	8.5	4.9	12.8	9.3	3.7	8.7	0.4	12.5	9.0	11.3	22.9	7.0	13.6	9.4	8.2	11.2	3.4	7.6	9.1	7.1	9.2	6.1	3.9	7.5	9.0	11.5	1.3	8.7	7.7	7.8	4.3	9.3	5.4	10.8	18.4	11.4	6.9	34.4	29.1	9.2	10.3	8.4	7.5	13.5	5.9	7.6	9.4	3.5	1.5	8.6	7.7	10.7	6.1	21.0	17.6	7.3	5.9	8.7	8.6	3.4	21.1	9.1	5.7	12.5	8.3	5.1	4.2	13.9	0.8	8.0	12.6	0.4	5.8	6.6	4.4	3.6	8.5	7.6	3.9	7.8	6.9	8.9	9.3	4.3	9.9	7.6	8.7	3.3	12.8	4.9	2.9	4.3	3.7	14.5	66.8	42.6	20.2	17.2	11.5	25.7	12.5	21.9	24.4	32.8	21.2	4.2	45.7	9.2	27.1	12.9	7.6	28.1	33.0	38.4	33.4	40.1	16.6	16.3	20.0	24.8	7.0	0.0	6.1	16.9	23.5	72.4	34.8	1.3	11.8	46.1	10.4	16.0	4.9	11.1	39.4	15.8	28.7	9.0	14.0	14.3	8.5	17.5	32.5	17.0	38.2	6.5	16.6	13.0	14.7	8.4	53.5	19.2	6.5	63.1
ZNF835	BC37295_3	ENSG00000127903	"Zinc finger protein 835"	Q9Y2P0	19	56661981-56671783	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 4.2;Cone photoreceptor cells: 7.9;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;EFO-21: 3.7;HEL: 3.0;NTERA-2: 8.5;SH-SY5Y: 4.5;U-266/84: 6.9"					"Low region specificity"	"Detected in all"			HPA051136	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA051136: AB_2681357"	"unprognostic (3.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.58e-5)"	"unprognostic (6.65e-2)"	"unprognostic (5.35e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.72e-4)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.21e-2)"	4.8	5.0	6.8	3.8	7.1	2.2	3.0	12.2	10.5	4.7	5.4	7.8	5.0	1.6	6.4	3.2	3.5	6.6	2.4	6.8	6.6	5.4	3.6	1.3	3.1	3.8	5.7	7.2	14.0	3.4	7.9	4.7	2.6	4.8	4.8	1.2	3.6	6.1	5.3	6.3	1.7	2.2	5.1	5.4	5.5	2.4	1.8	7.8	1.1	5.5	1.6	3.5	4.6	3.5	5.2	3.3	4.7	1.0	3.8	5.1	1.4	0.1	0.1	1.0	0.1	0.0	0.0	4.4	0.3	0.0	0.3	0.0	0.1	0.3	0.1	3.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.3	3.0	0.3	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.4	8.5	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.1	4.5	0.1	0.2	0.0	1.5	0.3	0.1	0.0	0.2	1.2	0.3	0.1	0.4	6.9	0.5	0.1	0.1	0.1	4.7	1.0	0.9	0.8	0.7	1.8	3.8	3.0	2.0	1.2	5.2	5.1	3.4	2.3	3.8	0.7	3.3	1.6	1.4	6.8	7.1	12.2	10.5	6.6	5.4	5.7	7.2	4.8	7.8	3.0	0.0	0.5	0.1	0.0	4.2	2.0	0.0	0.0	1.2	0.0	7.9	0.9	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.4	0.4	0.2	0.0	0.0	0.3	15.9	0.0	0.6	0.3	0.0	2.0	0.1	0.0	1.0	0.0	2.9	0.1	0.0	3.2	0.5	2.6	0.0	0.3	0.0	0.8	0.1	0.2	0.0	0.0	0.0
ZNF837		ENSG00000152475	"Zinc finger protein 837"	Q96EG3	19	58367618-58381060	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 13.4"									HPA042833	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA042833: AB_10806373"	"unprognostic (2.61e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.07e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (2.35e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.07e-2)"	3.7	3.3	4.2	2.2	5.4	1.1	2.3	1.0	6.1	3.1	2.5	2.9	1.2	4.6	3.6	4.4	3.1	5.2	3.0	1.4	2.0	1.7	5.3	10.8	3.7	2.1	1.6	0.9	4.3	5.1	2.7	4.1	3.7	2.1	3.8	1.0	2.9	4.6	2.5	1.3	5.7	6.1	1.1	1.4	4.7	4.9	2.6	1.2	9.4	7.1	1.3	5.1	2.3	2.2	0.9	0.5	0.1	0.3	0.0	1.7	0.4	2.0	1.0	1.3	1.5	0.2	0.5	2.3	2.0	0.4	0.1	0.2	0.5	2.1	2.5	1.8	0.0	0.8	0.6	0.1	0.1	0.1	1.3	13.4	1.1	0.3	0.1	0.5	0.8	0.7	0.8	0.4	0.2	0.1	0.5	0.2	3.2	1.5	0.7	0.2	2.7	5.8	2.3	3.5	0.8	3.4	5.0	0.6	2.4	0.3	1.5	4.0	5.2	1.5	1.3	2.3	0.2	1.6	1.1	0.5	3.0	0.1	0.8	0.7	3.2	2.4	2.2	1.9	0.4	0.8	0.0	0.3	0.0	1.3	0.0	1.4	0.5	1.6	0.0	0.4	0.9	1.7	0.2	0.1	0.0	0.0	0.5	0.7	0.4	4.2	5.4	1.0	6.1	2.0	1.7	1.6	0.9	2.1	1.2	3.0	2.6	5.2	0.8	0.8	1.3	1.3	0.0	0.0	1.2	3.5	0.0	1.5	6.6	3.7	3.7	1.0	2.6	0.0	4.6	0.9	0.8	1.8	0.0	3.4	0.9	1.6	1.2	2.5	0.3	0.4	1.7	0.1	3.3	4.6	2.6	2.0	2.5	3.1	1.1	4.4	0.5	0.0	1.9	2.1	5.9	1.5	1.8	0.8	2.1	0.9
ZNF839	C14orf131	ENSG00000022976	"Zinc finger protein 839"	A8K0R7	14	102317377-102342702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020434	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA020434: AB_10669862"	"unprognostic (7.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.10e-3)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.40e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	8.9	9.9	10.9	10.6	14.1	11.3	15.7	11.6	16.9	11.1	10.2	14.4	9.0	8.1	15.3	11.2	8.4	19.7	7.8	8.4	11.1	10.1	9.7	13.0	6.8	11.0	8.8	13.4	12.9	15.6	14.3	13.2	9.0	8.9	10.1	9.5	13.0	11.9	13.4	18.6	21.6	10.3	10.6	8.3	15.2	8.7	39.7	7.8	11.3	12.9	8.8	11.8	7.8	9.5	1.9	2.1	3.5	1.9	0.3	2.6	0.4	8.7	8.0	10.4	18.7	4.8	8.3	17.8	6.8	5.6	8.6	7.1	3.0	7.5	9.0	5.6	4.6	3.5	8.6	6.7	17.2	6.6	12.0	12.8	6.3	7.2	5.0	4.3	5.8	5.5	6.6	13.0	16.6	15.5	13.1	11.4	12.8	13.3	11.9	12.0	16.2	8.9	9.4	13.9	4.8	8.0	19.3	6.3	5.7	7.6	7.2	5.6	17.7	5.7	7.2	6.0	10.3	16.3	9.7	4.4	5.5	5.0	7.6	6.0	11.7	8.4	10.3	4.3	7.0	9.1	0.0	0.7	2.3	2.4	1.9	2.6	1.9	1.6	1.5	1.3	1.4	2.6	2.2	3.5	0.3	0.4	2.1	2.1	0.4	10.9	14.1	11.6	16.9	11.1	10.1	8.8	13.4	8.9	7.8	0.0	7.7	0.0	2.3	2.7	6.8	2.0	5.1	6.7	4.5	10.4	7.9	4.6	10.0	3.1	12.3	1.8	3.9	23.3	2.5	2.5	2.1	2.0	3.5	4.7	2.6	3.2	1.2	5.5	2.2	1.4	4.6	2.1	3.3	1.0	5.8	6.0	2.1	0.0	3.9	5.5	9.0	0.0	0.9	12.5	12.7	2.3	4.7	2.5	5.2	1.4
ZNF84	HPF2	ENSG00000198040	"Zinc finger protein 84"	P51523	12	133037292-133063304	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA028860	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028860: AB_10604102"	"unprognostic (2.39e-1)"	"unprognostic (5.11e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (5.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.30e-3)"	9.7	9.6	19.6	10.0	22.2	8.1	18.6	26.1	21.6	16.3	11.3	16.9	11.8	7.8	20.1	25.3	7.8	17.7	12.1	10.0	17.9	15.9	12.1	11.0	11.5	13.3	25.2	17.9	23.6	11.7	18.3	31.5	12.4	20.6	16.3	13.6	9.8	10.4	15.1	8.8	13.3	10.1	19.6	21.0	12.7	10.6	12.2	23.2	12.4	20.0	11.1	14.8	13.8	10.8	9.6	7.4	4.3	4.9	9.1	12.5	4.9	8.7	7.1	21.6	12.9	8.6	14.4	16.5	8.2	7.6	6.7	6.1	4.3	2.6	10.7	7.8	7.5	8.0	4.2	8.2	6.6	9.6	3.0	13.3	16.1	8.6	6.3	10.5	17.8	7.1	10.1	8.9	9.3	10.4	22.6	10.0	8.2	7.9	5.0	16.4	5.5	11.9	17.3	25.3	3.4	6.6	16.4	10.0	7.2	9.3	19.4	17.3	19.0	16.3	4.6	6.7	12.8	15.9	11.7	13.2	7.4	7.6	6.6	5.8	2.8	0.0	23.8	4.5	13.9	8.2	1.4	3.8	4.3	8.4	4.9	12.3	9.6	9.2	10.7	5.8	8.4	12.5	10.2	0.8	9.1	3.4	7.4	4.9	4.9	19.6	22.2	26.1	21.6	17.9	15.9	25.2	17.9	20.6	23.2	8.9	11.1	9.4	11.6	2.7	18.2	22.9	7.6	28.1	12.5	15.7	5.9	8.4	3.3	10.9	11.7	15.3	3.3	0.0	6.2	5.0	9.7	9.1	12.8	6.7	9.0	19.1	9.2	13.5	7.3	10.4	12.4	7.1	1.7	2.8	9.1	15.2	9.0	8.2	14.2	9.2	16.6	12.9	7.8	9.0	21.6	2.4	5.4	6.9	6.9	8.0
ZNF843	MGC46336	ENSG00000176723	"Zinc finger protein 843"	Q8N446	16	31432593-31443160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 4.3;Cardiomyocytes: 4.8;Glandular cells: 3.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.9;EFO-21: 4.7;HMC-1: 4.3"									"HPA030911, HPA030912, HPA077945"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: "	"unprognostic (9.27e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.43e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.86e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-5)"	"unprognostic (1.17e-1)"	1.2	1.4	3.5	2.5	3.4	0.8	1.7	3.9	5.4	3.5	1.2	2.3	1.9	0.6	2.8	5.6	1.2	3.3	2.0	7.4	3.0	3.2	1.8	0.9	2.4	0.8	2.5	2.3	10.6	5.0	3.1	5.7	2.2	1.9	3.2	0.4	3.9	7.5	3.2	5.1	2.5	1.3	1.9	1.9	1.1	0.9	1.2	1.7	0.1	2.6	2.8	0.6	1.0	1.3	1.0	0.9	2.5	0.6	4.8	2.3	2.2	0.3	0.7	0.7	3.2	5.9	1.7	0.2	0.6	0.5	0.0	0.3	0.4	0.9	0.1	4.7	0.8	0.2	0.3	0.3	0.3	0.3	0.5	0.0	0.2	0.6	0.2	1.7	0.5	4.3	3.1	0.8	0.0	0.3	2.0	0.0	0.5	0.5	0.7	1.6	2.1	0.2	1.0	1.7	0.2	0.2	0.4	0.0	0.1	0.4	0.2	0.1	1.8	1.9	0.3	0.8	0.6	0.4	0.6	0.1	0.7	0.5	2.0	0.1	0.7	0.4	0.3	0.2	0.3	1.0	2.3	0.6	0.6	2.2	0.4	1.3	0.6	0.8	2.3	0.3	1.0	0.6	1.6	2.5	4.8	0.4	0.9	0.4	2.2	3.5	3.4	3.9	3.5	3.0	3.2	2.5	2.3	1.9	1.7	0.0	0.3	0.0	4.3	0.7	2.4	4.8	0.0	0.0	1.2	0.0	2.0	0.2	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.1	0.9	3.2	1.1	0.0	0.5	0.0	1.2	1.3	0.8	0.0	1.4	0.2	0.0	0.0	0.0	1.1	0.1	0.0	1.4	0.4	1.9	0.0	1.4	0.5	0.9	1.3	0.2	0.0	0.0	2.0
ZNF846		ENSG00000196605	"Zinc finger protein 846"	Q147U1	19	9751993-9793180	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 177.5;Late spermatids: 45.7;Spermatocytes: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA034617, HPA034618"	Approved		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA034617: AB_10603942, HPA034618: AB_2674249"	"unprognostic (1.36e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.79e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (5.25e-8)"	"unprognostic (2.57e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.05e-3)"	9.6	8.3	16.3	7.6	17.3	4.8	8.8	19.2	18.6	9.7	9.2	11.8	23.6	5.0	13.7	11.9	11.2	11.3	11.5	10.6	16.4	8.3	7.2	5.6	8.2	8.6	13.9	14.0	16.1	5.1	12.6	14.2	7.4	16.0	14.7	8.7	6.6	8.9	23.9	6.1	9.4	6.6	19.7	17.2	7.3	7.6	22.8	16.6	10.0	8.8	3.9	7.3	21.2	11.1	6.4	9.7	1.7	2.9	3.0	6.5	2.3	3.2	0.7	10.1	2.4	11.4	14.7	2.2	5.0	3.5	3.6	7.3	1.8	2.7	1.5	2.0	5.8	4.3	1.2	0.7	3.8	3.9	2.9	2.4	7.2	0.2	2.7	4.1	0.8	7.7	14.9	5.1	2.7	2.1	8.3	2.9	4.0	1.3	0.0	3.8	1.2	2.6	6.1	1.5	2.6	4.2	3.8	0.8	0.3	4.6	12.4	1.6	3.0	2.8	0.3	3.7	3.6	1.7	5.1	1.6	3.0	2.2	2.5	0.4	5.7	5.9	6.9	0.3	1.1	2.5	1.6	2.9	1.7	2.5	2.6	5.0	6.0	3.9	6.5	9.7	6.4	3.1	6.2	1.2	3.0	1.6	6.2	4.5	2.3	16.3	17.3	19.2	18.6	16.4	8.3	13.9	14.0	16.0	16.6	8.9	4.8	3.2	14.5	7.0	1.3	5.9	5.1	12.0	10.3	0.0	2.0	1.3	8.3	5.1	177.5	4.9	3.2	0.0	4.4	1.7	7.5	6.3	4.7	4.3	6.7	0.0	1.2	4.9	9.4	45.7	6.4	6.7	6.8	13.6	3.7	2.6	4.8	3.5	8.5	5.1	2.3	6.5	5.9	53.4	3.4	7.8	1.0	2.6	3.5	13.1
ZNF850	ZNF850P	ENSG00000267041	"Zinc finger protein 850"	A8MQ14	19	36714383-36772825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 17.9"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 14.7"									HPA029299	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029299: AB_2672987"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.37e-3)"	4.0	3.4	2.6	3.0	4.2	11.5	3.3	8.7	3.1	5.1	2.4	3.4	1.6	1.9	5.6	2.6	2.8	2.9	3.2	4.6	2.5	1.7	2.0	2.8	3.0	4.0	5.9	0.7	5.9	4.1	3.2	6.4	17.9	3.2	3.4	2.9	3.0	2.3	2.2	1.9	3.2	2.9	2.3	3.5	3.6	2.7	6.7	3.8	7.0	2.6	1.0	2.9	5.0	4.4	6.8	3.5	6.0	3.8	3.8	6.0	5.1	0.3	1.7	3.7	5.8	0.8	0.3	7.2	2.4	1.3	1.4	2.1	1.3	0.4	1.2	5.1	0.4	7.8	0.8	2.6	0.5	2.7	0.6	2.1	14.7	0.2	1.1	1.0	1.8	8.4	1.1	0.1	2.4	0.0	0.5	1.4	1.8	3.8	0.8	3.7	0.8	2.6	1.8	10.8	0.6	1.0	1.6	7.3	0.9	0.6	7.4	2.5	4.0	3.8	0.2	0.6	5.4	1.5	3.3	3.0	3.7	5.8	2.1	3.6	1.5	2.6	3.2	0.0	0.8	5.7	4.2	3.4	2.4	3.9	3.6	5.0	6.8	4.8	3.2	3.2	5.4	5.7	6.0	6.0	3.8	3.8	3.5	3.2	5.1	2.6	4.2	8.7	3.1	2.5	1.7	5.9	0.7	3.2	3.8	0.0	0.0	0.9	1.1	1.9	1.1	2.4	2.5	0.0	0.0	3.5	0.0	3.0	0.0	1.1	6.1	2.1	0.0	0.0	0.6	3.8	2.6	0.5	0.0	1.8	1.1	4.8	0.0	8.6	2.7	3.6	1.1	1.1	3.3	0.0	2.9	1.3	0.5	0.0	0.4	0.4	0.0	0.0	1.4	2.6	2.5	3.0	2.4	0.9	0.6	0.9
ZNF852		ENSG00000178917	"Zinc finger protein 852"	Q6ZMS4	3	44498970-44510636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 4.8;Ciliated cells: 6.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA048312, HPA049885, HPA071850"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA048312: AB_2680352, HPA049885: AB_2680933, HPA071850: AB_2686458"	"unprognostic (2.64e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.62e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.11e-2)"	3.8	4.0	5.0	4.7	5.4	3.1	4.7	12.9	6.9	4.6	4.0	3.2	4.6	3.6	5.2	3.7	3.6	4.2	3.1	3.3	4.8	2.1	4.0	3.7	4.8	4.8	5.5	3.9	6.4	10.3	9.0	13.5	4.7	5.4	5.6	5.8	4.2	8.8	4.6	2.9	4.6	5.4	7.0	4.7	5.1	6.0	2.9	4.6	7.1	4.4	2.5	6.3	5.0	6.1	2.4	2.7	1.4	1.3	0.7	1.8	0.4	0.8	1.4	3.4	5.9	0.8	2.0	2.4	0.9	1.2	1.6	2.7	1.8	1.0	2.9	0.7	1.0	0.9	0.9	3.7	0.9	2.3	2.3	1.7	2.6	5.8	1.5	1.5	2.9	5.3	0.8	1.9	2.4	0.8	2.1	1.4	2.9	3.2	1.6	1.7	0.2	2.5	2.4	1.9	0.9	0.7	1.3	3.5	1.3	1.1	2.9	2.9	2.1	1.8	0.8	0.8	6.0	1.9	2.7	1.8	2.2	2.4	1.3	0.9	2.4	1.5	1.5	0.7	2.2	1.4	0.0	0.6	1.4	0.6	1.3	1.0	2.4	1.1	0.7	0.5	1.6	1.0	1.8	0.9	0.7	0.3	2.7	0.1	0.4	5.0	5.4	12.9	6.9	4.8	2.1	5.5	3.9	5.4	4.6	0.0	4.8	0.0	0.7	3.0	1.7	1.6	0.0	6.7	1.2	0.0	2.0	0.7	3.3	1.4	0.0	0.7	0.8	0.0	1.2	0.9	0.6	0.6	1.1	1.0	0.6	1.6	0.0	2.5	0.0	0.0	0.6	1.4	1.7	1.8	0.3	2.5	1.4	0.0	1.1	0.6	1.4	0.0	0.8	2.6	1.5	1.6	0.2	0.0	0.6	0.7
ZNF853	DKFZp434J1015	ENSG00000236609	"Zinc finger protein 853"	P0CG23	7	6615617-6624290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.9"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 13.0;Muller glia cells: 10.9;Rod photoreceptor cells: 9.1;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8;SH-SY5Y: 22.1;U-2 OS: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067690	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA067690: AB_2685888"	"unprognostic (1.35e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.17e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.87e-3)"	"unprognostic (9.28e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.30e-3)"	"unprognostic (4.01e-2)"	3.7	3.9	16.6	2.9	14.4	1.0	4.6	4.5	13.5	7.8	7.7	10.4	2.8	1.8	9.4	5.9	5.6	11.8	5.8	12.3	16.1	15.5	3.3	0.9	4.5	4.3	14.8	9.1	15.6	10.6	7.3	4.5	3.7	11.9	7.6	2.5	6.0	6.7	11.5	28.9	2.4	2.7	8.5	10.1	4.3	3.6	3.0	9.9	2.6	9.9	2.7	2.7	6.5	11.7	0.3	0.4	3.1	0.0	1.1	1.5	0.3	0.0	1.2	3.5	14.8	0.1	0.0	0.1	0.3	0.0	1.6	0.3	2.6	0.6	0.0	5.8	0.0	0.5	0.0	5.3	0.1	1.5	0.0	1.9	0.4	0.0	2.7	2.1	0.0	0.1	0.5	0.5	0.2	0.0	1.5	0.0	1.2	2.2	0.0	0.9	0.1	0.3	1.9	5.5	0.0	0.0	1.6	5.8	0.1	1.1	5.5	4.7	22.1	0.0	0.2	0.9	3.0	0.8	3.1	0.0	1.1	14.8	0.0	1.3	0.3	0.1	0.0	0.0	0.0	5.7	0.0	0.0	3.1	1.2	0.0	1.5	0.3	0.8	1.4	0.0	0.3	0.2	1.4	0.0	1.1	0.0	0.4	0.0	0.3	16.6	14.4	4.5	12.4	16.1	15.5	14.8	9.1	11.9	9.9	0.0	0.0	0.0	1.5	0.5	13.0	8.5	0.0	4.0	1.2	7.0	5.9	0.0	0.0	0.5	1.5	1.5	0.0	0.0	0.6	0.0	2.3	1.1	0.0	0.0	0.1	4.8	1.7	1.8	0.0	1.7	4.9	0.0	3.3	0.0	0.0	10.9	0.4	0.0	8.1	0.2	9.1	12.9	1.4	0.5	0.7	0.3	0.2	0.8	0.0	0.7
ZNF860		ENSG00000197385	"Zinc finger protein 860"	A6NHJ4	3	31981771-31991628	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.2"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 3.4;Ciliated cells: 6.7;Club cells: 4.5;Intestinal endocrine cells: 3.4;Syncytiotrophoblasts: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	61	"memory B-cell: 9.1;naive B-cell: 6.4"	"Lineage enriched"	"Detected in single"	71	"B-cells: 9.1"	"Cell line enriched"	"Detected in many"	4	"BEWO: 31.9"									HPA063386	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063386: AB_2684999"	"unprognostic (1.19e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.75e-3)"	2.0	1.0	0.7	11.2	1.0	0.1	2.8	0.8	1.5	4.3	1.1	0.0	1.7	0.3	4.1	4.9	6.2	1.9	3.6	1.3	0.6	1.6	7.2	0.4	3.7	8.3	1.6	0.6	1.8	0.6	0.1	5.5	8.1	1.1	6.0	1.6	1.6	5.6	2.6	0.4	2.3	3.7	6.7	0.5	9.6	1.1	2.2	0.0	0.5	1.8	4.2	20.2	6.4	3.6	9.1	0.0	0.1	0.0	0.0	0.0	0.2	2.1	0.7	0.0	1.6	0.0	0.0	31.9	0.2	0.1	0.2	0.2	2.1	2.5	2.3	2.3	0.0	1.0	1.9	0.7	3.1	0.2	0.0	0.3	0.0	3.2	1.0	0.0	0.0	0.0	0.1	1.4	0.2	6.1	0.2	0.6	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	5.6	3.4	0.0	0.0	0.1	7.2	0.9	0.2	0.0	0.5	3.8	0.0	1.6	2.9	0.0	1.2	0.2	2.6	0.0	0.2	0.0	0.0	3.6	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	1.0	0.8	1.5	0.6	1.6	1.6	0.6	1.1	0.0	0.0	0.0	3.4	0.4	0.8	0.2	0.6	0.0	6.7	4.5	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.0	0.0	0.5	3.0	0.5	0.9	0.0	0.0	0.3	0.0	3.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.4	1.1	0.0	0.0	0.3	0.1	0.1	0.3	3.5	0.0	0.3	0.6
ZNF862		ENSG00000106479	"Zinc finger protein 862"	O60290	7	149838367-149867479	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 11.8;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA024154	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA024154: AB_1859469"	"unprognostic (1.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.72e-3)"	"unprognostic (2.74e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.73e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (8.66e-4)"	7.1	9.7	12.7	11.2	15.5	7.5	11.8	22.6	13.6	11.1	10.0	16.7	18.8	6.6	12.1	18.1	9.0	13.7	12.2	8.0	13.1	8.7	11.3	9.4	9.6	12.8	17.1	12.1	15.1	14.7	22.6	17.7	5.8	12.2	11.5	10.7	12.3	16.9	14.5	8.6	24.1	10.8	10.0	12.6	13.2	9.4	7.4	19.8	18.7	18.2	6.7	13.2	9.9	9.1	3.1	3.0	1.6	4.3	1.6	6.9	2.0	2.9	3.2	7.2	11.3	8.3	9.1	0.2	6.1	6.0	2.1	3.3	0.3	7.8	1.4	8.0	6.9	2.8	2.0	2.0	2.9	1.5	4.4	3.1	1.3	2.2	0.0	7.3	2.1	1.3	10.0	10.8	2.0	3.2	9.0	4.9	8.3	1.5	5.6	3.4	7.5	2.5	5.5	2.4	5.6	3.2	4.5	0.9	8.0	5.8	1.8	2.8	9.6	5.3	3.9	5.3	3.6	3.0	2.6	8.7	5.2	0.2	11.7	2.2	8.7	4.7	1.3	8.8	5.7	5.9	0.0	2.4	1.6	6.9	4.3	1.9	3.1	2.6	3.6	3.0	1.3	3.1	2.7	0.2	1.6	1.3	3.0	1.8	2.0	12.7	15.5	22.6	13.6	13.1	8.7	17.1	12.1	12.2	19.8	0.0	1.0	0.0	0.6	0.7	5.1	3.2	2.5	2.7	3.4	7.0	11.8	0.9	1.7	1.5	1.1	1.7	1.0	0.0	1.2	0.2	1.0	1.5	4.6	2.1	0.9	9.5	1.7	1.3	1.2	1.0	1.4	2.1	0.0	1.0	2.6	2.8	1.2	2.3	2.1	0.7	5.8	0.0	1.0	0.9	2.3	1.1	2.2	2.6	1.3	0.8
ZNF865		ENSG00000261221	"Zinc finger protein 865"	P0CJ78	19	55605405-55617269	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.2"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068079	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA068079: AB_2685947"	"unprognostic (3.98e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.72e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.41e-3)"	12.1	7.5	8.3	11.0	10.5	11.1	8.2	12.3	15.1	8.0	10.0	9.7	6.6	11.0	11.5	6.8	6.2	8.7	7.0	12.2	7.3	5.8	8.3	6.7	8.7	13.3	7.4	8.5	10.3	11.2	9.9	9.5	6.1	7.4	9.9	4.8	8.1	12.1	7.7	56.2	11.1	10.4	7.4	7.3	16.0	12.2	4.7	7.9	14.0	9.5	8.0	9.1	9.3	9.9	1.2	0.5	1.4	0.1	0.1	0.6	0.1	6.4	5.3	2.3	3.7	2.5	1.9	6.3	4.6	2.6	2.5	2.4	1.7	4.2	7.5	5.4	3.4	1.3	5.4	1.4	2.8	1.0	7.4	17.6	4.3	3.2	2.2	4.0	4.9	8.4	2.9	4.5	3.1	1.9	2.3	1.7	4.7	8.2	5.1	1.6	3.0	7.7	5.3	5.2	3.7	9.2	12.0	3.6	4.7	2.9	4.4	5.5	8.9	6.4	3.9	3.9	1.2	3.1	7.7	5.0	3.9	9.3	3.5	5.8	10.8	9.3	3.9	4.8	3.8	6.2	0.0	0.0	1.4	0.3	0.1	0.2	1.2	0.2	0.1	0.1	0.2	0.1	0.6	0.8	0.1	0.1	0.5	0.0	0.1	8.3	10.5	12.3	15.1	7.3	5.8	7.4	8.5	7.4	7.9	0.0	0.0	1.9	1.0	3.7	3.7	18.6	2.5	0.0	0.0	14.0	0.0	2.1	5.0	3.1	1.9	5.2	5.2	0.0	3.8	2.7	3.8	1.2	0.0	5.4	4.0	9.5	5.8	6.7	5.4	3.2	4.9	4.2	5.0	1.8	6.3	3.9	4.7	0.0	9.6	3.6	3.2	6.5	4.1	1.2	1.4	3.8	2.2	4.8	5.7	0.9
ZNF878		ENSG00000257446	"Zinc finger protein 878"	C9JN71	19	12043805-12052939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Cytotrophoblasts: 1.1;Spermatogonia: 1.5;Syncytiotrophoblasts: 1.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.4"									HPA052735	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052735: AB_2681932"	"unprognostic (3.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.62e-2)"	1.1	1.4	0.4	1.5	3.1	5.8	0.8	2.5	2.4	1.5	1.2	0.4	0.0	0.6	1.8	1.2	1.4	1.2	1.4	0.7	1.9	0.5	7.7	2.5	1.5	1.4	4.4	0.3	2.4	5.0	0.8	2.4	5.1	7.4	1.4	1.2	0.4	3.2	0.3	0.5	1.0	1.3	1.4	1.9	1.3	1.2	4.6	2.2	1.7	1.4	0.0	1.3	1.2	1.7	0.3	0.1	0.5	0.0	1.5	0.5	0.1	3.0	0.0	1.7	6.4	0.1	0.0	3.8	1.0	0.5	1.3	1.7	2.5	0.4	1.4	1.5	0.4	1.8	0.8	0.6	0.9	1.2	0.0	0.9	1.8	0.0	3.5	0.0	1.2	3.3	0.2	0.0	0.7	0.0	0.1	0.0	3.9	0.0	0.0	1.3	0.0	2.9	1.7	3.6	0.0	0.5	2.4	3.3	0.0	2.2	2.2	1.7	0.3	0.0	0.1	0.3	3.5	3.3	3.9	0.0	1.9	1.4	1.5	1.8	1.2	3.8	0.3	0.0	0.6	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.5	0.1	0.0	1.5	0.0	0.0	0.0	0.1	0.4	3.1	2.5	2.4	1.9	0.5	4.4	0.3	7.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.0
ZNF879	DKFZp686E2433	ENSG00000234284	"Zinc finger protein 879"	B4DU55	5	179023752-179035064	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 11.8;Spermatocytes: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.4;BEWO: 12.4"	"Low region specificity"	"Detected in all"							HPA068608	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068608: AB_2686010"	"unprognostic (3.20e-2)"	"unprognostic (5.24e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.83e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.04e-2)"	"unprognostic (5.69e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.17e-3)"	5.9	4.0	5.5	5.3	7.2	1.9	6.6	13.5	8.0	6.1	5.8	6.3	4.9	2.9	7.3	5.5	5.0	6.2	4.0	6.3	7.4	4.7	5.9	3.6	4.7	7.2	7.0	5.7	10.2	4.9	8.4	7.6	6.7	6.1	7.7	3.0	4.4	5.2	8.1	7.9	8.2	5.2	5.6	6.9	7.1	4.6	14.5	10.7	12.1	9.1	2.5	7.9	6.2	5.0	5.4	4.4	13.1	4.9	6.0	9.1	3.7	0.0	4.1	3.7	11.4	3.6	2.8	12.4	2.0	3.0	5.0	6.2	3.8	2.1	3.0	2.9	1.9	5.7	1.7	0.0	2.3	4.0	0.0	0.3	0.0	2.6	0.7	5.9	0.0	5.8	2.7	2.2	2.8	1.4	2.3	1.7	3.0	0.6	0.0	4.0	2.0	3.4	1.2	4.2	1.5	1.0	3.1	1.3	0.4	3.7	3.3	1.6	3.8	3.9	0.6	5.3	5.9	5.6	3.4	1.6	2.3	4.3	2.6	0.5	0.0	0.0	4.7	0.0	0.0	3.0	13.1	4.9	4.7	6.3	4.1	6.5	5.2	5.8	5.3	4.4	5.4	9.1	7.1	0.1	6.0	3.9	2.8	6.7	3.7	5.5	7.2	13.5	8.0	7.4	4.7	7.0	5.7	6.1	10.7	6.0	0.6	0.0	1.3	0.5	8.0	1.6	2.5	1.4	0.0	5.2	11.8	2.9	5.0	1.5	2.2	2.2	0.8	0.0	0.7	1.5	1.3	1.4	2.3	0.9	1.9	9.5	1.2	1.8	2.6	2.0	1.4	1.5	0.0	0.0	0.1	4.5	0.8	0.0	2.1	1.1	5.3	6.5	1.2	11.3	8.5	1.0	3.5	1.3	0.6	1.0
ZNF880		ENSG00000221923	"Zinc finger protein 880"	Q6PDB4	19	52369917-52385795	"Predicted intracellular proteins, Transcription factors"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 21.2;SuSa: 20.9"									HPA077316			Approved	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"HPA077316: AB_2686833"	"unprognostic (2.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (4.33e-8)"	"unprognostic (4.14e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.60e-3)"	14.7	12.7	12.4	12.2	21.8	17.3	16.3	22.9	14.6	16.5	13.0	13.6	10.8	6.9	16.0	20.3	13.3	14.7	12.5	20.1	13.9	10.5	13.0	4.4	13.3	15.9	12.2	7.4	22.7	9.4	4.0	18.2	12.4	14.3	20.8	10.8	18.1	12.9	16.8	11.3	12.6	11.6	16.8	13.4	16.1	11.6	11.2	13.3	24.5	22.2	12.1	16.5	27.9	11.4	25.4	20.3	27.7	7.2	12.1	20.4	8.7	0.1	0.8	10.7	8.3	5.8	16.5	11.6	7.0	7.6	4.9	9.8	0.2	4.7	0.1	2.5	12.2	10.3	1.6	0.0	6.4	8.3	0.1	12.6	0.3	0.5	0.0	6.9	0.2	8.8	12.3	8.1	9.2	0.0	0.6	7.8	0.9	0.8	0.3	9.4	0.6	1.1	0.7	14.4	0.0	1.7	0.7	21.2	0.7	13.8	11.0	7.9	10.0	0.0	2.0	3.0	20.9	0.4	2.1	6.2	0.3	0.2	2.1	6.4	0.4	3.9	0.3	0.2	0.2	13.6	27.7	6.6	15.1	13.3	6.2	17.3	23.2	16.9	14.6	10.2	25.4	20.4	17.8	2.7	12.1	7.2	20.3	17.2	8.7	12.4	21.8	22.9	14.6	13.9	10.5	12.2	7.4	14.3	13.3	11.9	3.8	10.7	13.7	5.3	16.5	11.7	7.6	10.7	18.2	19.2	11.8	8.8	24.9	14.7	10.6	10.8	2.1	0.0	12.9	12.5	7.8	21.9	9.3	1.0	5.9	22.3	0.0	9.8	5.9	3.1	12.7	11.0	8.5	16.2	5.1	11.3	17.7	7.0	6.0	6.3	15.7	19.4	13.0	3.3	7.9	6.1	12.0	12.5	3.1	22.2
ZNF891		ENSG00000214029	"Zinc finger protein 891"	A8MT65	12	133106817-133130473	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 52.6;Horizontal cells: 38.1;Rod photoreceptor cells: 34.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA040301	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA040301: AB_10795380"	"unprognostic (3.05e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.72e-1)"	"unprognostic (7.51e-3)"	"unprognostic (5.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (2.07e-3)"	"unprognostic (6.68e-2)"	3.6	5.3	7.0	4.0	9.3	4.2	5.4	13.2	7.2	4.6	4.4	3.6	2.6	3.4	5.5	4.6	2.9	4.0	2.9	3.5	7.9	3.3	3.4	2.9	2.9	4.3	7.8	2.7	6.4	3.8	4.9	8.8	3.0	6.6	3.8	3.5	2.3	4.5	4.0	4.3	6.9	3.3	4.5	7.0	4.5	4.0	14.0	8.9	4.2	5.6	2.9	3.8	4.3	4.5	2.9	1.6	2.3	1.2	2.4	2.7	0.7	1.5	1.7	4.6	0.3	1.9	2.2	3.0	0.8	0.9	1.2	1.0	1.3	0.7	0.3	1.3	1.0	2.0	2.1	2.4	1.2	1.3	0.1	2.3	3.8	5.0	1.7	0.9	3.4	2.7	1.6	1.2	1.9	1.6	2.3	1.0	4.1	2.3	0.8	1.6	1.0	3.8	4.1	2.9	1.2	1.9	3.5	2.6	1.5	1.0	2.7	4.6	2.9	3.0	1.1	1.0	2.9	3.1	1.4	1.8	2.4	2.4	2.1	1.3	0.5	0.2	3.1	0.6	1.3	1.8	2.0	1.2	1.4	1.8	0.7	1.6	1.9	1.7	1.7	0.6	2.9	2.7	2.3	2.3	2.4	0.8	1.6	1.1	0.7	7.0	9.3	13.2	7.2	7.9	3.3	7.8	2.7	6.6	8.9	3.0	4.0	2.7	5.5	1.5	30.2	4.4	2.5	16.0	10.3	10.4	27.5	3.1	0.0	3.5	52.6	3.9	1.4	0.0	1.7	1.9	3.1	2.9	1.1	1.9	1.6	38.1	6.4	4.3	1.0	4.2	4.9	3.2	1.7	0.0	2.4	10.9	1.6	2.5	5.6	1.3	34.9	19.4	5.2	14.0	14.6	1.5	1.9	5.0	3.1	2.3
ZNF90	HTF9	ENSG00000213988	"Zinc finger protein 90"	Q03938	19	20077994-20127076	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.3;seminal vesicle: 36.4"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 192.8;Suprabasal keratinocytes: 245.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.4;NTERA-2: 16.0;SuSa: 11.7;U-2197: 6.7"									HPA003227	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA003227: AB_1859471"	"unprognostic (4.52e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.93e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.95e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.60e-2)"	1.5	1.0	1.1	3.6	2.5	1.6	1.8	6.9	1.1	3.0	1.7	1.2	20.3	0.5	3.3	2.7	2.1	2.8	1.0	1.4	0.8	0.6	1.7	0.7	2.4	3.0	2.1	0.3	4.7	3.4	12.7	1.4	3.8	1.7	4.1	2.1	3.2	1.2	36.4	1.2	2.8	2.3	3.3	1.6	2.3	2.7	1.6	2.2	4.1	10.3	0.7	2.9	4.9	2.9	0.5	0.4	1.8	0.2	0.3	0.9	0.2	0.0	0.0	3.8	9.4	0.0	0.0	0.0	1.0	0.4	3.6	4.3	3.2	2.2	1.4	1.7	0.6	2.5	0.9	0.0	0.5	6.3	0.0	0.9	0.0	0.0	0.6	0.3	0.0	0.0	0.2	0.0	3.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	1.9	5.4	16.0	0.0	0.0	0.0	3.4	0.2	2.0	3.3	0.0	3.4	0.0	1.1	0.1	11.7	1.9	0.0	0.0	0.9	0.0	6.7	3.6	0.0	1.5	0.0	0.0	0.0	1.4	0.8	0.2	0.3	0.1	0.0	0.9	0.2	0.2	0.4	0.4	0.5	0.3	0.1	1.8	0.3	0.0	0.2	0.7	0.2	1.1	2.5	6.9	1.1	0.8	0.6	2.1	0.3	1.7	2.2	6.0	5.9	72.1	60.7	192.8	0.6	1.7	56.0	0.0	7.9	7.0	2.0	81.3	14.9	2.0	5.9	31.2	3.3	70.0	1.8	83.3	43.9	74.9	1.1	52.0	41.8	0.0	8.2	48.5	105.1	17.6	56.4	28.6	118.1	1.0	14.4	1.4	1.0	10.5	32.5	4.6	2.1	19.4	51.2	8.2	14.3	245.0	68.2	76.2	20.2	56.5
ZNF92	"HPF12, TF12"	ENSG00000146757	"Zinc finger protein 92"	Q03936	7	65373799-65401135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003173			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003173: AB_1080744"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (5.48e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.50e-3)"	6.7	9.3	9.6	13.7	13.0	20.8	16.3	24.4	11.9	8.3	6.2	5.0	6.1	6.1	5.7	7.2	11.2	5.4	6.3	4.6	9.6	8.9	7.9	5.6	5.7	14.8	12.1	8.6	8.8	6.9	7.7	13.4	5.7	12.6	6.6	7.0	2.5	6.9	6.6	4.7	4.9	10.1	3.9	18.5	14.8	7.6	7.6	15.7	26.0	9.4	5.1	14.0	8.3	5.7	10.7	2.3	5.6	2.7	9.4	6.0	2.2	4.5	3.1	13.7	13.5	3.5	4.2	6.5	3.8	2.8	4.2	6.1	5.7	6.8	17.7	7.4	2.1	6.3	4.5	10.6	2.6	6.9	6.6	7.1	7.9	1.7	5.6	1.2	9.5	7.6	3.6	2.3	3.8	2.9	5.7	5.1	9.4	10.3	7.3	6.0	1.3	14.0	10.8	18.5	4.8	4.2	12.8	8.0	6.0	4.6	9.2	11.7	8.9	5.8	9.1	4.3	13.9	6.5	13.0	3.7	4.9	4.4	2.9	5.4	4.6	4.1	25.7	3.2	7.7	4.3	5.6	1.6	4.0	2.7	2.1	5.7	10.7	4.2	4.1	2.3	9.2	5.1	5.2	1.3	9.4	2.7	2.2	6.0	2.2	9.6	13.0	24.4	11.9	9.6	8.9	12.1	8.6	12.6	15.7	8.9	0.6	34.0	6.2	4.9	7.6	3.4	5.1	1.4	7.9	5.2	0.0	5.3	10.0	6.3	1.0	5.8	2.6	0.0	4.2	4.4	5.1	6.3	11.5	2.1	3.7	4.8	6.9	6.2	5.4	1.7	6.6	6.8	5.0	9.0	7.2	7.7	6.3	7.0	6.0	3.5	4.8	0.0	5.7	19.6	24.5	3.3	4.1	7.9	4.7	7.0
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	27.2	14.9	13.2	21.5	15.1	32.8	19.3	14.4	19.7	16.6	16.0	20.1	12.1	14.5	21.3	17.4	13.1	17.2	19.2	16.5	12.3	12.0	16.5	13.4	28.2	20.5	13.4	13.8	18.3	12.2	23.8	14.6	17.4	17.1	15.5	14.4	21.1	14.4	13.7	23.0	17.6	20.6	18.3	14.4	25.9	16.2	23.9	14.6	18.6	21.4	14.4	22.7	16.8	15.0	5.7	5.1	30.0	14.0	5.6	8.3	5.4	5.8	9.1	2.2	3.1	12.1	9.5	3.7	8.0	18.9	50.3	21.0	10.4	4.9	4.9	10.3	15.9	14.3	11.4	4.1	10.8	17.5	4.6	1.3	5.8	6.6	4.5	10.5	4.6	7.1	10.0	10.2	11.2	8.4	9.2	7.6	2.9	4.4	6.1	12.5	2.4	5.0	3.1	2.1	5.1	7.7	3.2	7.5	1.3	8.3	8.1	2.2	1.6	11.8	23.0	8.2	2.8	5.9	3.9	18.8	24.7	7.0	8.9	7.7	4.0	1.4	2.7	9.9	3.2	5.4	8.8	6.7	10.8	8.3	8.8	7.3	5.7	8.3	7.8	5.1	4.6	8.0	6.1	30.0	5.6	14.0	3.0	6.0	5.4	13.2	15.1	14.4	19.7	12.3	12.0	13.4	13.8	17.1	14.6	38.7	29.3	17.4	18.7	24.6	14.7	11.4	12.7	29.4	22.7	19.2	9.8	5.5	0.0	20.8	27.6	39.1	15.6	0.0	19.7	6.0	27.4	21.6	26.5	11.5	14.0	11.1	12.6	26.4	25.9	16.0	21.0	25.7	18.6	27.9	11.0	37.0	25.1	17.5	25.5	6.3	12.7	0.0	28.4	41.6	5.7	19.1	9.5	15.2	9.7	31.2
ZNHIT1	"CG1I, H_DJ0747G18.14, ZNFN4A1"	ENSG00000106400	"Zinc finger HIT-type containing 1"	O43257	7	101217668-101224190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 796.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019043	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019043: AB_1859481"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.52e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.24e-3)"	24.6	21.0	29.4	18.7	26.9	18.3	23.6	11.7	20.8	21.1	24.5	16.6	29.4	24.5	15.0	29.4	21.1	23.2	29.8	26.9	24.7	19.4	27.7	77.2	14.1	18.5	27.9	17.2	13.2	34.7	17.2	17.3	19.9	18.7	17.4	16.2	12.0	29.3	29.9	32.7	16.2	23.4	15.0	28.0	18.4	22.7	13.1	17.6	21.0	27.3	24.0	14.1	14.7	20.9	27.9	42.8	45.5	47.1	22.4	39.7	45.9	14.1	14.6	9.6	18.4	17.8	23.0	9.4	17.5	17.3	17.2	17.1	14.5	16.5	10.1	23.4	19.1	14.9	12.0	8.7	24.3	7.4	10.5	33.7	5.5	12.8	17.3	22.7	11.2	11.9	21.5	29.5	15.2	7.4	14.6	25.1	15.2	17.4	16.8	14.6	42.1	18.4	60.9	18.4	22.9	36.8	9.8	7.5	31.1	23.0	6.7	11.9	26.9	13.2	23.9	28.9	11.3	6.2	13.8	19.1	16.2	14.2	27.9	12.4	13.6	17.2	12.2	15.6	19.8	21.6	42.0	47.1	45.5	27.4	42.5	28.9	27.4	30.5	27.5	40.6	27.9	24.7	26.5	39.1	22.4	40.8	42.8	39.7	45.9	29.4	26.9	11.7	20.8	24.7	19.4	27.9	17.2	18.7	17.6	86.4	76.3	87.8	100.5	89.4	29.5	69.6	216.6	103.1	83.0	181.5	15.7	165.9	306.7	174.5	18.7	143.6	325.7	93.5	222.5	162.7	150.6	101.7	77.3	796.2	180.7	11.1	231.8	154.1	203.1	46.0	125.1	115.6	123.2	212.8	211.4	63.3	222.4	336.6	117.4	541.3	29.9	148.8	103.2	50.5	36.9	101.9	136.7	113.6	219.4	110.3
ZNHIT3	TRIP3	ENSG00000273611	"Zinc finger HIT-type containing 3"	Q15649	17	36486629-36499310	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 213.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060019, HPA078211"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060019: AB_2684188, HPA078211: "	"unprognostic (5.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.03e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.19e-2)"	5.0	8.2	9.7	7.4	12.9	8.6	9.9	9.1	18.4	6.2	6.5	6.1	6.8	6.0	6.9	11.1	6.9	7.8	5.4	7.8	8.2		9.4	9.5	6.6	10.0	10.2	9.6	10.7	9.1	7.8	5.7	5.9	9.9	7.4	9.2	4.1	7.1	8.0	14.2	6.2	5.4	7.4	12.3	5.8	5.2	11.8	8.6	8.8	9.0	7.3	10.9	7.6	3.9	23.8	18.0	15.8	16.5	12.9	24.1	15.6	14.7	22.5	24.2	16.1	11.3	17.3	12.7	13.5	17.9	20.5	23.2	18.3	17.7	22.0	13.7	11.5	25.7	13.3	18.3	17.6	22.9	14.0	30.7	13.2	14.3	21.4	14.3	27.3	11.6	12.9	18.8	13.3	20.7	20.4	13.8	26.1	23.6	13.8	21.9	15.8	29.7	29.2	15.3	15.9	17.4	13.4	24.8	18.5	20.2	12.7	18.5	15.3	17.6	8.1	21.5	22.7	27.6	21.0	10.9	9.9	22.4	15.9	19.1	15.1	23.6	27.6	17.0	16.3	15.5	15.8	13.0	9.6	17.8	13.5	21.4	23.8	20.8	18.0	16.5	21.8	24.1	22.2	6.9	12.9	16.5	18.0	22.5	15.6											23.8	18.2	51.6	33.1	41.2	22.8	9.6	28.1	22.7	20.5	31.4	11.8	78.2	74.6	50.4	213.4	31.7	25.9	0.0	44.3	85.9	32.3	37.4	33.5	22.9	58.3	14.3	41.8	20.3	46.6	61.6	34.2	37.7	50.6	62.3	31.5	32.3	51.9	37.9	41.8	67.6	24.2	45.3	40.1	105.1	65.2	38.1	64.5	57.3	43.5	30.8
ZNHIT6	"BCD1, C1orf181, FLJ20729, NY-BR-75"	ENSG00000117174	"Zinc finger HIT-type containing 6"	Q9NWK9	1	85649423-85708433	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018132	Uncertain		Approved	"Nuclear speckles,Vesicles"		No	No			"Nuclear speckles, Vesicles"		"HPA018132: AB_1848789"	"unprognostic (1.37e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.08e-6)"	"unprognostic (1.11e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.37e-2)"	18.5	12.6	20.7	15.9	28.0	15.5	21.5	19.2	25.6	23.5	13.8	21.4	14.2	9.0	20.4	14.9	19.9	14.6	12.0	12.4	22.5	18.8	12.9	10.3	12.9	19.4	21.5	20.5	21.9	11.5	17.4	20.3	15.1	19.5	17.4	14.0	8.1	15.3	15.1	15.7	17.1	12.0	19.8	26.1	14.5	11.0	11.0	26.6	14.8	17.4	13.8	18.9	19.5	25.7	7.6	6.0	1.3	2.3	5.7	6.4	2.5	13.0	9.5	9.0	8.2	19.6	18.4	11.5	17.4	16.9	11.9	11.7	9.4	6.9	10.2	20.9	10.6	26.4	11.1	15.4	10.8	19.4	14.5	13.4	21.0	10.7	10.7	17.2	33.9	8.4	17.7	9.9	16.1	14.0	11.8	13.9	16.5	19.8	13.9	17.9	5.3	19.6	8.3	13.0	10.3	16.8	16.2	19.7	11.6	18.0	25.9	8.7	5.6	13.7	18.8	18.5	9.9	9.0	8.7	15.9	15.2	10.3	12.9	24.6	8.9	9.2	29.4	3.3	21.0	13.5	1.3	2.1	0.2	5.7	2.3	6.4	5.6	5.1	6.4	3.6	7.6	6.4	6.3	0.3	5.7	1.9	6.0	5.4	2.5	20.7	28.0	19.2	25.6	22.5	18.8	21.5	20.5	19.5	26.6	14.9	22.7	11.5	9.5	14.3	29.6	17.3	10.2	21.4	36.4	29.6	31.4	7.6	3.3	10.5	3.2	13.2	7.8	0.0	7.7	11.9	14.3	7.1	26.6	8.7	6.8	14.3	9.1	15.4	12.6	2.2	12.4	10.5	6.8	9.0	11.8	23.0	9.0	7.0	12.0	3.9	39.4	19.4	9.5	24.2	14.9	14.3	2.3	14.6	14.0	10.1
ZNRF2	RNF202	ENSG00000180233	"Zinc and ring finger 2"	Q8NHG8	7	30284307-30367692	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072244	Approved		Uncertain	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center"	"HPA072244: AB_2732197"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.64e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (8.71e-4)"	"unprognostic (8.67e-2)"	7.8	8.0	10.0	9.3	10.6	9.7	16.2	12.8	10.0	5.8	16.1	10.5	7.6	11.3	7.7	9.7	14.2	5.2	8.7	8.4	9.6	6.1	19.3	24.0	7.9	12.0	10.0	7.4	5.8	14.0	8.0	9.9	9.6	11.0	7.0	14.3	5.8	10.5	13.7	17.5	11.5	12.7	8.3	10.5	9.2	12.4	20.6	9.1	7.9	13.3	9.8	10.9	9.4	11.8	1.3	5.8	1.4	1.1	0.7	2.4	0.5	6.7	2.5	2.0	1.8	2.3	1.6	10.7	2.6	2.7	2.9	3.9	1.2	11.3	7.1	6.8	2.1	7.5	6.6	6.7	4.4	3.1	6.9	6.1	4.4	5.2	3.3	1.2	3.4	8.4	2.5	7.5	2.0	4.9	3.0	2.4	5.5	5.4	14.2	3.1	2.6	6.9	9.0	4.7	6.7	3.1	6.0	4.4	12.1	8.7	14.6	7.0	6.6	5.2	22.0	4.3	12.4	5.9	13.8	2.7	2.8	4.8	2.7	5.4	24.3	20.8	9.3	3.1	7.4	4.1	0.5	0.9	1.1	1.0	0.9	1.5	1.3	1.2	1.4	0.8	0.8	0.7	1.1	1.4	0.7	1.1	5.8	2.4	0.5	10.0	10.6	12.8	10.0	9.6	6.1	10.0	7.4	11.0	9.1	8.9	6.7	5.2	5.8	14.2	11.0	3.2	17.8	2.7	4.5	15.7	39.3	7.5	6.6	4.9	4.3	4.5	42.5	0.0	8.9	8.0	4.4	5.5	3.5	33.4	9.4	1.6	30.1	9.2	18.9	7.6	2.6	11.2	11.8	9.0	14.5	4.3	6.7	14.4	2.1	26.0	5.7	6.5	7.2	20.9	7.9	16.6	9.6	8.7	19.6	10.8
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;gallbladder: 6.7;kidney: 2.6"	"Cell type enhanced"	"Detected in some"	18	"Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 3.0"	"Cell line enriched"	"Detected in some"	8	"RPTEC TERT1: 12.4"	"Region enriched"	"Detected in single"	7	"olfactory region: 3.4"	"Low region specificity"	"Detected in all"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA077519: AB_2732349"	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5			2.5	1.0	0.0	0.0	0.2	6.7	0.3	0.0	0.6	2.6	0.3	0.0	0.0	0.3		0.7	0.2	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.1	1.9			0.0		0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	1.3	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	12.4	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0
ZPR1	ZNF259	ENSG00000109917	"ZPR1 zinc finger"	O75312	11	116773799-116788050	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 178.4;Late spermatids: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB022596, HPA030979"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"CAB022596: , HPA030979: AB_2673684"	"unprognostic (2.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.01e-4)"	"prognostic unfavorable (5.87e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.71e-2)"	"unprognostic (6.66e-2)"	19.5	13.2	20.2	15.9	20.5	34.9	17.3	12.0	23.3	13.7	14.0	17.1	11.5	12.4	16.4	16.2	18.0	14.4	14.2	14.7	17.6	14.0	14.2	26.3	15.8	16.5	25.9	18.2	17.6	24.4	12.6	13.2	14.8	19.1	14.3	15.3	9.1	14.1	15.5	28.7	15.5	14.9	18.5	15.8	15.7	17.1	32.4	19.1	13.0	16.9	13.8	20.9	15.9	18.5	20.4	17.7	12.4	16.7	19.0	18.1	14.5	8.6	12.6	7.5	14.2	11.5	12.1	10.0	14.9	11.7	13.4	14.4	31.6	15.7	19.9	26.4	14.8	24.2	11.8	20.7	13.6	19.1	12.9	10.2	42.1	6.8	17.0	22.9	19.0	17.7	11.4	19.2	25.5	41.6	9.0	14.8	12.9	19.9	13.6	19.5	10.7	15.5	23.8	13.7	24.0	19.2	12.2	11.5	21.9	12.9	15.2	9.9	17.1	12.2	16.3	10.3	13.5	11.0	13.1	12.6	17.4	8.6	10.2	20.9	9.6	7.2	24.5	9.5	34.0	16.7	8.7	16.0	12.4	13.2	16.7	15.6	20.4	18.1	17.1	17.7	17.0	17.9	16.2	2.4	19.0	13.7	12.8	17.6	14.5	20.2	20.5	12.0	23.3	17.6	14.0	25.9	18.2	19.1	19.1	8.9	12.8	32.6	49.6	0.0	9.5	10.1	17.8	5.3	18.2	19.2	0.0	29.5	38.1	45.7	178.4	15.6	17.9	0.0	34.7	46.1	16.2	32.9	28.7	17.8	32.8	4.8	22.4	14.1	13.6	307.9	17.5	21.0	0.0	45.9	17.8	6.7	47.9	17.3	11.7	19.2	5.7	6.5	15.6	63.0	30.3	0.0	38.3	21.3	23.5	82.7
ZSCAN1	"FLJ33779, ZNF915"	ENSG00000152467	"Zinc finger and SCAN domain containing 1"	Q8NBB4	19	58034032-58054631	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.7;epididymis: 16.4;pituitary gland: 15.8"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 10.0;Early spermatids: 20.0;Late spermatids: 14.4;Muller glia cells: 5.8;Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;HMC-1: 4.4;NTERA-2: 4.5;T-47d: 6.5"									HPA007938	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA007938: AB_1080768"	"unprognostic (1.60e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (1.41e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.60e-1)"	0.9	2.2	7.0	0.7	9.5	0.9	3.2	4.0	13.7	2.2	0.8	6.5	1.0	0.8	1.7	16.4	0.8	4.3	1.3	1.6	6.3	9.7	2.8	0.7	1.4	0.8	6.0	6.7	0.9	2.1	7.3	15.8	1.3	8.2	3.7	0.7	3.4	1.6	3.0	0.8	0.8	1.0	1.1	3.7	0.9	1.0	13.3	2.4	0.9	8.1	0.0	0.7	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	1.3	0.0	0.0	0.0	0.9	6.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	9.5	4.0	13.7	6.3	9.7	6.0	6.7	8.2	2.4	0.0	0.0	0.0	0.3	0.0	2.8	0.6	0.0	0.0	0.0	1.8	2.0	0.0	10.0	0.8	20.0	0.4	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	14.4	0.9	0.0	1.7	0.0	0.0	5.8	0.4	0.0	0.0	0.0	2.1	0.0	0.3	17.0	3.1	0.0	0.0	0.0	0.0	0.4
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099317	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.8;testis: 3.9"	"Cell type enhanced"	"Detected in single"	25	"Cytotrophoblasts: 1.5"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 36.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076826			Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA076826: "	"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.2	0.2	0.3	0.2	0.2	1.3	0.2	2.7	1.4	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.5	0.2	1.3	0.9	0.3	0.2	0.2	0.1	0.2	0.2	0.2	1.1	2.8	0.3	0.2	0.2	0.6	1.2	3.9	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.8	0.7	2.4	0.8	0.6	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	36.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	2.4	0.8	0.8	0.4	0.6	1.1	0.8	0.2	1.0	0.4	0.8	0.5	0.6	1.3	0.6	0.7	0.7	0.1	0.2	0.3	0.2	2.7	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Club cells: 11.4;Early spermatids: 20.4;Spermatocytes: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006637, HPA006732"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006637: AB_1080646, HPA006732: "	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	6.4	5.5	8.0	7.4	8.6	3.7	11.4	12.1	9.0	8.1	7.2	5.7	6.9	4.9	9.4	7.6	4.6	7.3	4.6	4.7	7.2	5.0	6.0	3.8	5.7	8.3	5.0	3.9	11.4	9.0	10.1	14.1	7.0	7.6	8.9	6.0	4.8	6.9	9.9	2.8	4.5	6.6	7.5	5.1	7.2	5.8	9.5	6.9	11.5	10.3	3.7	7.7	9.4	10.2	6.1	2.2	5.2	1.7	3.9	4.5	1.9	5.3	1.7	8.1	0.1	4.2	3.3	5.8	3.7	5.1	5.6	7.8	1.2	2.0	5.1	7.0	2.5	2.8	2.4	0.0	4.5	5.8	0.0	6.6	7.4	5.3	3.7	3.9	2.6	1.9	4.4	4.3	5.6	10.1	6.1	1.5	0.0	10.8	1.2	3.5	0.6	0.0	5.8	5.1	0.5	0.9	8.9	7.4	1.3	4.2	3.5	10.0	10.2	1.9	4.4	6.2	8.5	1.7	6.6	1.5	2.2	4.8	1.7	2.9	3.2	3.3	1.0	2.0	0.7	3.4	5.2	1.6	3.3	3.6	1.0	3.4	4.3	2.7	4.2	2.2	6.1	4.5	3.8	0.5	3.9	1.7	2.0	2.1	1.9	8.0	8.6	12.1	9.0	7.2	5.0	5.0	3.9	7.6	6.9	6.0	3.2	1.7	1.4	0.3	5.6	2.8	0.0	0.0	11.4	0.0	3.9	1.2	1.7	1.3	20.4	1.3	0.5	0.0	2.2	0.9	0.9	1.2	1.1	0.8	0.9	6.4	1.2	4.3	0.6	4.5	1.7	0.6	1.7	1.8	0.9	3.5	1.3	0.0	3.2	0.9	5.4	6.5	1.9	11.3	2.7	0.3	0.5	1.3	2.1	0.5
ZSCAN16	"dJ265C24.3, FLJ22191, ZNF392, ZNF435"	ENSG00000196812	"Zinc finger and SCAN domain containing 16"	Q9H4T2	6	28124560-28130082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007290	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007290: AB_1080721"	"unprognostic (1.50e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (3.29e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (3.41e-5)"	5.3	6.7	7.6	7.8	8.9	3.5	9.3	26.4	7.7	5.4	9.0	5.5	12.7	11.0	6.0	9.6	6.1	5.4	6.3	3.7	6.9	5.4	9.5	6.9	6.2	11.3	8.0	5.9	4.6	8.3	11.2	11.9	2.8	7.8	7.5	12.0	4.3	10.4	9.9	5.1	8.8	13.0	6.2	10.1	13.4	9.1	3.2	9.3	11.7	7.5	4.2	11.2	7.2	5.4	10.0	11.0	30.5	6.3	9.9	10.7	4.8	0.0	7.2	9.3	6.8	2.6	0.6	7.6	2.5	5.3	6.6	7.1	5.0	4.7	7.1	6.7	2.3	4.6	5.6	6.4	3.6	6.2	10.2	8.9	7.4	5.8	6.9	4.1	5.4	6.3	0.8	6.1	5.5	3.0	7.0	12.0	0.2	1.0	6.1	1.7	7.9	0.0	8.6	1.9	6.0	4.4	8.8	7.1	9.8	7.7	10.2	12.6	13.9	1.2	7.7	8.7	6.3	10.1	2.6	3.7	2.5	5.7	3.7	6.4	3.1	9.8	1.9	1.1	2.7	1.3	30.5	4.9	5.4	8.1	6.3	10.7	10.0	7.2	6.2	5.0	8.1	8.8	7.1	8.9	9.9	6.1	11.0	7.7	4.8	7.6	8.9	26.4	7.7	6.9	5.4	8.0	5.9	7.8	9.3	6.0	1.6	1.4	0.6	1.5	3.8	1.4	5.1	9.4	4.5	7.0	3.9	2.0	5.0	10.1	2.5	3.5	5.6	0.0	11.1	1.0	0.7	0.9	2.3	1.8	1.8	1.6	1.7	3.1	4.6	0.9	0.6	4.0	1.7	5.4	4.7	3.1	8.2	6.8	3.2	5.8	5.5	0.0	1.1	0.7	5.1	1.1	1.5	8.2	7.7	0.6
ZSCAN18	"FLJ12895, ZNF447"	ENSG00000121413	"Zinc finger and SCAN domain containing 18"	Q8TBC5	19	58083838-58118427	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 49.8;SCLC-21H: 23.8"									HPA024318	Supported		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA024318: AB_1859494"	"unprognostic (1.85e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.59e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (3.68e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.04e-2)"	18.1	18.1	26.7	10.4	34.3	5.3	11.8	27.9	47.7	20.5	17.1	20.8	16.0	8.7	26.2	20.3	13.4	33.9	18.6	28.9	27.0	33.7	19.3	7.3	15.0	12.2	23.7	31.1	31.8	16.8	23.7	28.0	15.1	21.1	21.1	6.0	17.7	18.2	27.5	15.9	9.9	10.0	29.0	20.7	17.0	12.9	20.0	18.3	7.4	28.9	8.7	6.1	15.9	14.6	4.6	2.3	3.9	0.8	2.2	2.4	0.7	0.0	0.4	5.2	13.4	0.6	0.8	12.9	3.3	0.1	4.3	0.7	0.0	3.1	1.2	7.6	4.6	5.2	0.0	0.4	2.5	4.6	0.0	49.8	0.1	0.0	0.0	9.2	0.0	10.1	7.9	0.1	3.3	0.0	5.4	0.2	3.1	0.0	0.6	6.5	0.0	6.9	2.5	8.5	0.0	0.0	8.2	0.0	0.6	4.2	10.2	23.8	5.7	0.0	0.2	0.0	4.8	15.6	0.0	0.0	0.2	6.2	5.8	0.0	5.9	17.1	0.0	0.0	0.0	4.0	2.0	0.5	3.5	0.4	0.3	2.1	1.7	1.7	1.8	0.9	4.6	2.4	2.2	3.9	2.2	0.8	2.3	0.1	0.7	26.7	34.3	27.9	31.4	27.0	33.7	23.7	31.1	21.1	18.3	14.9	24.0	31.8	44.4	10.8	77.2	38.7	20.4	28.1	37.5	40.1	31.4	38.9	13.3	19.4	41.6	32.5	3.6	0.0	5.1	7.1	18.3	35.8	23.1	3.8	8.0	106.5	25.4	20.3	1.3	55.0	37.2	6.5	10.1	9.0	12.0	72.0	6.3	11.5	55.2	9.1	103.9	19.4	25.8	25.1	26.9	10.7	54.9	14.6	9.9	29.4
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 36.9"	"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favorable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.16e-5)"	9.8	7.6	5.2	7.2	7.4	9.7	15.0	5.9	6.3	7.3	6.2	5.8	9.0	4.1	9.5	8.4	3.4	5.3	8.2	8.2	4.8	4.7	9.1	10.1	4.5	8.0	6.2	5.0	10.2	36.9	6.9	6.3	2.8	5.1	7.1	4.3	6.7	12.4	5.1	9.5	3.4	5.5	9.0	5.1	8.1	8.5	12.0	6.0	24.4	6.3	3.9	6.9	6.5	9.7	7.1	10.5	10.0	12.2	9.0	12.1	6.4	1.6	9.5	7.5	12.3	4.4	3.0	6.5	1.8	5.2	3.9	5.3	7.3	3.9	3.5	5.3	2.9	7.2	4.1	6.3	3.6	3.5	7.2	9.7	4.5	5.5	15.4	3.8	2.8	3.6	4.4	4.3	5.1	4.9	5.4	11.8	18.7	5.9	2.8	4.8	4.7	13.0	6.7	13.7	3.3	5.7	13.6	4.2	6.6	4.2	12.1	10.5	18.5	5.7	3.2	8.8	11.7	6.6	8.0	7.7	4.9	9.4	2.3	2.3	4.9	6.4	11.8	3.2	6.6	3.0	10.0	9.6	8.3	10.9	10.5	5.4	7.1	9.2	8.2	10.5	7.1	7.6	8.2	5.4	9.0	12.2	10.2	12.1	6.4	5.2	7.4	5.9	6.3	4.8	4.7	6.2	5.0	5.1	6.0	0.0	1.3	2.2	1.1	0.8	3.5	2.2	7.6	2.7	0.0	7.0	2.0	1.4	5.0	5.4	11.3	1.9	1.1	0.0	7.3	3.9	2.2	2.8	1.1	7.8	3.1	0.0	2.9	0.6	3.2	9.5	0.9	3.1	1.7	7.2	2.9	2.4	10.1	3.5	1.4	14.3	2.9	6.5	1.4	3.4	8.1	0.4	1.1	3.2	2.4	1.3
ZSCAN20	"KOX29, ZNF31, ZNF360"	ENSG00000121903	"Zinc finger and SCAN domain containing 20"	P17040	1	33472645-33496507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017933	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017933: AB_1859028"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-3)"	"unprognostic (9.28e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.77e-6)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.74e-2)"	3.8	4.2	4.7	2.5	7.1	1.0	4.4	6.1	8.2	4.4	4.1	7.7	4.5	8.4	7.4	3.2	3.6	4.4	3.6	6.1	4.3	2.9	3.9	3.0	3.2	2.1	4.3	5.7	7.8	4.0	11.2	8.6	4.0	5.7	4.2	4.4	5.1	5.0	5.5	3.4	2.9	6.6	5.9	4.2	3.1	4.3	6.1	7.6	3.9	4.4	2.7	3.2	4.9	8.5	0.8	1.7	0.7	2.2	1.0	3.0	0.6	3.7	2.8	6.5	4.5	5.2	5.4	4.4	4.7	4.7	6.3	5.1	2.9	4.9	2.8	2.6	4.9	3.8	4.7	5.4	2.5	6.6	0.0	6.1	5.7	6.2	2.4	5.0	3.2	2.1	3.8	4.5	6.7	5.5	5.8	4.9	4.7	3.8	3.6	5.6	1.3	2.4	2.0	5.4	3.5	1.6	2.7	7.6	1.1	3.5	3.2	2.6	3.8	3.5	3.9	5.1	9.1	2.6	3.6	4.4	5.6	4.0	5.0	6.6	4.8	3.0	1.3	5.8	1.0	3.7	0.2	2.2	0.0	1.3	1.0	2.1	0.3	0.4	0.9	1.7	0.8	1.9	3.0	0.7	1.0	1.0	1.2	0.8	0.6	4.7	7.1	6.1	8.2	4.3	2.9	4.3	5.7	5.7	7.6	0.0	2.2	0.0	0.5	0.0	1.5	1.6	2.5	1.4	0.0	0.0	3.9	0.7	0.0	0.9	15.3	0.6	0.4	0.0	0.2	0.7	0.7	0.5	1.1	0.0	0.6	0.0	1.2	1.3	0.3	1.3	1.1	0.0	0.0	1.8	0.5	0.6	0.7	0.9	1.8	0.4	2.0	0.0	1.0	2.5	1.1	0.0	0.2	0.0	0.4	0.4
ZSCAN21	"DKFZp434L134, NY-REN-21, Zipro1, ZNF38"	ENSG00000166529	"Zinc finger and SCAN domain containing 21"	Q9Y5A6	7	100049774-100065038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016948, HPA023591"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA016948: , HPA023591: AB_1859037"	"unprognostic (2.44e-3)"	"unprognostic (3.77e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.42e-3)"	"unprognostic (8.59e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (6.09e-2)"	10.6	12.2	10.9	10.8	11.1	8.1	12.5	15.2	14.8	13.6	12.3	16.3	10.7	7.3	15.9	14.9	10.9	13.9	12.7	8.3	10.8	9.9	14.9	14.8	9.4	8.5	12.0	15.5	13.7	20.3	12.1	10.7	12.0	11.1	13.1	8.4	14.9	16.3	11.9	16.1	9.7	9.6	12.2	11.5	9.1	10.6	26.0	13.3	10.5	12.6	5.7	7.3	11.2	9.7	7.7	6.5	13.5	6.4	10.2	12.0	5.1	4.5	7.6	12.6	14.5	11.8	7.7	10.3	5.2	7.9	10.2	10.3	6.0	5.1	4.8	6.5	6.1	17.4	4.1	11.1	7.4	10.2	6.4	9.2	4.4	6.1	5.5	12.8	6.1	1.8	9.0	13.1	9.9	16.7	8.5	8.1	10.0	10.3	4.3	7.5	11.3	10.4	10.3	15.5	6.2	5.7	7.2	10.1	5.8	8.5	7.0	6.5	16.4	7.0	15.3	9.9	18.6	6.1	5.4	3.8	9.3	11.5	8.1	7.1	8.4	7.8	10.8	4.4	4.0	12.4	13.5	6.4	12.7	11.1	6.3	12.0	7.7	6.9	10.2	6.5	7.1	7.6	8.6	0.8	10.2	3.9	6.2	7.5	5.1	10.9	11.1	15.2	14.8	10.8	9.9	12.0	15.5	11.1	13.3	3.0	3.2	3.7	2.9	1.3	5.2	1.2	5.1	2.7	5.7	3.5	2.0	14.7	6.6	6.1	1.7	4.2	2.6	0.0	3.5	5.4	4.3	3.4	2.3	4.7	4.4	9.5	1.7	1.8	2.6	0.0	5.5	2.2	3.3	3.6	2.5	15.4	4.2	3.4	9.2	8.4	5.3	0.0	4.1	10.4	17.7	3.3	14.8	1.8	2.9	1.4
ZSCAN25	"FLJ32468, ZNF498"	ENSG00000197037	"Zinc finger and SCAN domain containing 25"	Q6NSZ9	7	99616946-99632407	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055127, HPA057173"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA055127: AB_2682706, HPA057173: AB_2683360"	"unprognostic (2.21e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.97e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.19e-3)"	10.8	10.0	11.4	12.2	12.5	12.3	14.5	18.5	14.6	11.3	11.0	13.1	16.9	7.4	14.5	11.7	12.7	12.4	9.6	7.7	9.4	6.9	9.4	9.1	10.0	16.4	10.3	12.2	18.5	12.3	15.0	12.3	9.4	9.2	12.7	8.6	10.3	15.4	13.9	9.7	15.6	10.8	12.6	8.7	13.6	10.3	15.7	11.0	14.9	11.2	8.7	11.8	11.7	11.4	3.3	3.0	5.5	4.2	4.2	9.0	4.7	5.7	2.7	8.0	9.1	3.6	2.7	7.8	6.4	5.4	7.4	7.7	7.2	4.8	8.2	7.5	5.3	6.8	7.5	8.6	7.3	9.3	4.5	7.3	5.4	4.6	6.1	6.1	12.5	4.9	4.3	9.3	5.9	6.2	3.0	4.6	9.2	15.2	6.6	5.2	6.3	18.0	17.4	14.6	3.3	6.3	7.6	8.2	8.7	3.2	7.9	5.4	13.5	8.4	12.8	9.1	9.9	3.5	8.6	3.3	11.6	9.3	6.6	10.7	5.9	9.4	14.0	6.2	7.9	16.9	5.5	3.8	4.8	7.4	4.2	9.0	3.3	5.1	6.9	3.0	2.9	8.7	8.4	4.6	4.2	3.7	2.4	7.2	4.7	11.4	12.5	18.5	14.6	9.4	6.9	10.3	12.2	9.2	11.0	0.0	3.8	0.0	1.8	3.1	4.6	3.2	0.0	1.4	0.0	1.8	7.9	3.7	1.7	2.5	3.9	3.6	2.6	0.0	2.5	3.1	2.3	2.4	4.7	3.4	3.1	4.8	2.4	5.5	3.5	3.0	3.4	1.0	1.7	3.6	5.3	2.6	1.7	3.5	5.6	2.1	4.3	6.5	2.1	6.5	5.1	1.9	1.6	5.3	3.7	1.4
ZSCAN29	"FLJ35867, Zfp690, ZNF690"	ENSG00000140265	"Zinc finger and SCAN domain containing 29"	Q8IWY8	15	43358172-43371025	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007241, HPA011109"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			Nucleoplasm	"Plasma membrane, Actin filaments"	"HPA007241: AB_10600420, HPA011109: AB_10611525"	"unprognostic (3.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.43e-2)"	8.3	8.9	13.5	14.2	14.2	6.6	9.4	15.9	15.2	11.0	9.8	12.1	9.3	11.8	12.6	12.5	11.0	9.6	11.9	7.2	14.7	8.0	8.1	10.3	9.2	13.2	19.1	12.0	10.7	15.4	12.5	13.9	13.0	15.4	9.7	10.5	7.9	11.2	9.5	13.6	7.7	13.0	9.0	13.3	11.9	11.8	20.9	15.0	16.8	11.1	9.4	13.7	11.0	12.5	2.1	1.0	6.9	1.0	2.3	1.9	0.6	7.6	8.4	19.8	12.2	7.0	7.4	10.7	6.0	9.4	10.7	11.2	13.0	5.5	7.5	10.1	7.4	8.6	22.7	14.5	7.4	9.7	19.4	8.0	16.5	12.6	10.1	7.8	11.2	14.5	6.5	13.0	7.2	10.3	7.6	5.4	11.7	15.3	9.2	8.6	4.8	10.8	9.3	9.9	11.3	6.5	16.8	11.0	9.1	6.2	9.3	14.1	15.3	9.3	15.3	7.1	10.4	10.7	17.6	6.0	12.6	10.0	9.5	10.8	17.7	24.4	14.5	7.4	11.2	9.5	1.1	0.7	6.9	1.2	1.0	1.0	2.1	1.2	0.8	1.0	1.6	0.6	1.7	1.8	2.3	0.8	0.9	1.9	0.6	13.5	14.2	15.9	15.2	14.7	8.0	19.1	12.0	15.4	15.0	6.0	9.3	2.9	2.3	3.2	8.7	6.7	2.5	5.3	10.3	7.0	25.5	4.4	0.0	5.2	81.1	2.9	7.8	0.0	6.2	3.7	4.1	3.3	0.0	6.0	4.9	12.7	5.8	4.3	9.7	13.8	6.4	4.1	5.0	3.6	7.8	5.4	7.6	5.8	5.6	2.1	18.7	0.0	2.9	9.9	6.4	2.8	3.2	4.3	6.8	1.8
ZSCAN30	"ZNF397OS, ZNF917"	ENSG00000186814	"Zinc finger and SCAN domain containing 30"	Q86W11	18	35251058-35290245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA007289	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007289: AB_1079726"	"unprognostic (6.02e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-3)"	"unprognostic (7.02e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.44e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.36e-1)"	9.4	14.4	11.8	9.2	19.1	7.9	12.2	23.0	19.9	9.4	8.9	20.9	9.8	10.1	14.2	13.9	6.7	10.3	10.4	16.4	12.2	10.6	12.1	8.7	10.3	12.4	11.8	12.8	10.7	9.7	19.8	27.3	9.6	14.7	11.1	8.4	12.8	9.2	9.4	15.4	11.7	12.8	9.4	15.0	12.1	10.0	10.5	15.0	13.0	15.2	6.8	9.4	8.6	8.2	7.7	5.4	4.8	1.9	4.0	5.6	2.5	4.4	1.2	10.1	13.3	6.8	13.5	6.9	8.6	11.5	5.0	9.9	3.6	5.5	8.0	5.7	9.1	8.5	3.1	4.7	9.0	13.6	8.0	2.7	5.2	5.7	2.5	7.1	4.4	5.2	8.7	7.1	13.5	11.4	13.2	9.1	11.4	8.3	9.6	13.1	2.0	6.4	7.3	6.5	1.3	4.2	9.5	3.3	5.8	7.6	3.0	14.2	7.4	8.5	2.7	3.6	10.8	4.2	5.9	11.4	18.1	3.9	2.8	3.4	17.1	7.3	7.1	13.7	4.9	10.2	2.4	1.3	4.4	4.6	1.6	3.0	5.3	4.2	2.7	2.2	7.7	5.0	5.6	4.8	4.0	1.9	5.4	3.7	2.5	11.8	19.1	23.0	19.9	12.2	10.6	11.8	12.8	14.7	15.0	8.9	5.4	1.5	1.7	1.5	28.2	11.2	7.6	6.7	13.6	1.8	19.6	2.9	5.0	3.4	8.3	6.7	3.2	0.0	3.0	1.2	3.1	2.1	8.1	4.3	2.2	19.1	6.9	9.8	4.8	6.5	5.5	2.0	0.0	1.0	3.6	13.6	3.2	4.2	7.4	3.8	18.6	0.0	2.4	10.7	5.2	0.9	1.5	4.9	3.6	1.7
ZSCAN31	"ZNF310P, ZNF323"	ENSG00000235109	"Zinc finger and SCAN domain containing 31"	Q96LW9	6	28324693-28356271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 26.8;Early spermatids: 114.2;Late spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 13.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.7;EFO-21: 21.8;TIME: 16.3;U-2 OS: 26.6"					"Low region specificity"	"Detected in all"			HPA007124	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA007124: AB_1080703"	"unprognostic (1.11e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (2.19e-5)"	"unprognostic (8.43e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	5.2	4.0	11.3	2.2	12.1	3.5	11.2	36.4	27.6	8.0	9.9	3.6	5.9	3.2	16.3	8.4	9.9	6.8	15.5	6.4	8.0	3.8	5.2	4.5	8.7	1.9	16.7	5.6	17.7	8.1	4.8	8.3	2.3	14.9	7.1	5.1	3.5	6.5	8.3	7.0	11.0	3.5	10.7	21.9	2.1	13.3	18.4	11.8	0.6	21.0	5.6	3.1	7.3	6.9	1.5	2.0	13.4	0.3	1.4	1.5	0.3	1.0	1.4	2.2	10.3	0.3	0.5	3.3	0.5	0.6	0.5	0.4	1.3	15.7	0.2	21.8	0.7	3.2	3.3	1.1	0.9	0.3	1.8	0.9	3.6	8.1	2.4	0.9	7.3	4.5	0.3	8.7	0.6	0.9	1.0	14.9	2.8	3.9	2.8	2.3	1.5	1.2	1.7	0.7	0.7	6.4	3.2	2.0	1.9	1.5	1.3	7.3	2.0	13.9	9.0	2.0	1.7	4.5	2.5	16.3	3.3	26.6	0.7	1.2	1.1	1.6	0.2	0.4	3.5	0.7	13.4	0.3	0.6	1.5	0.2	1.3	1.5	1.2	1.2	0.3	1.3	1.0	1.5	0.3	1.4	0.3	2.0	0.2	0.3	11.3	12.1	36.4	27.6	8.0	3.8	16.7	5.6	14.9	11.8	26.8	3.5	0.0	2.2	0.7	6.5	6.1	5.1	2.7	12.5	3.5	0.0	1.8	6.6	2.4	114.2	4.5	1.6	0.0	7.1	0.8	1.5	1.7	2.3	3.9	0.6	1.6	5.8	2.5	0.3	52.0	3.4	1.1	1.7	1.0	2.2	7.3	4.0	3.5	4.9	4.2	4.9	6.5	1.7	2.3	2.5	1.9	0.7	1.5	2.3	1.3
ZSCAN32	"FLJ20417, ZNF434"	ENSG00000140987	"Zinc finger and SCAN domain containing 32"	Q9NX65	16	3382081-3401065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005758	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005758: AB_1080720"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.71e-2)"	7.4	10.0	12.0	11.1	19.7	4.7	9.2	12.0	11.9	9.5	9.0	12.5	5.5	11.6	10.8	7.2	7.5	10.6	9.9	8.0	11.5	10.3	9.3	8.3	9.2	11.2	19.3	7.3	12.4	9.8	14.3	13.2	8.0	14.1	9.5	9.0	8.3	7.2	11.7	5.6	8.3	12.4	9.1	14.1	10.1	8.7	11.1	16.1	13.9	10.9	5.9	13.7	8.9	7.0	8.2	5.1	6.9	12.2	16.3	10.4	6.0	4.7	7.4	10.9	12.9	8.6	8.7	7.7	6.1	10.7	8.7	8.3	3.6	6.7	15.6	6.5	8.6	4.8	4.3	8.6	8.8	9.9	9.9	6.3	13.9	6.5	5.4	11.1	9.4	10.1	8.5	14.6	8.1	14.7	9.0	8.1	17.1	13.1	5.7	11.5	5.4	12.3	6.4	11.2	8.3	4.3	13.1	11.7	13.4	7.5	5.2	8.7	6.8	11.5	7.7	5.0	6.6	8.2	11.2	10.6	6.5	6.8	5.7	7.0	10.1	11.4	19.3	2.4	7.5	10.6	4.9	4.9	6.9	10.4	4.3	8.8	8.2	7.2	6.6	4.6	7.4	9.8	8.8	6.0	16.3	12.2	5.1	9.4	6.0	12.0	19.7	12.0	11.9	11.5	10.3	19.3	7.3	14.1	16.1	17.9	4.0	4.4	1.9	2.1	4.5	0.8	7.6	1.4	9.1	1.8	7.9	3.6	10.0	4.3	1.4	2.7	2.5	0.0	5.3	2.5	2.3	3.2	4.7	3.0	2.5	7.9	0.0	2.5	3.5	0.7	4.0	2.2	1.7	5.4	3.0	4.8	4.9	2.9	4.9	4.1	4.4	0.0	1.9	7.1	13.4	2.5	2.2	7.5	2.5	1.3
ZSCAN9	"PRD51, ZNF193"	ENSG00000137185	"Zinc finger and SCAN domain containing 9"	O15535	6	28224886-28233482	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA054512, HPA059951"	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA054512: AB_2682511, HPA059951: AB_2684176"	"unprognostic (1.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.14e-3)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.74e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.16e-5)"	12.2	11.0	7.9	12.7	11.9	10.1	16.1	21.2	13.1	17.2	12.7	14.8	13.0	10.2	22.7	15.9	10.4	11.4	14.2	10.2	8.2	9.6	13.0	9.3	10.6	10.5	10.2	7.1	16.0	12.5	13.6	22.4	12.6	11.2	15.8	17.4	12.9	12.3	14.6	8.9	6.9	14.5	17.9	11.9	16.8	11.7	20.1	13.5	4.1	14.5	7.4	11.1	12.2	16.7	5.7	5.6	5.6	4.0	13.0	4.4	2.6	6.8	4.6	16.3	19.3	6.4	6.9	6.0	8.4	7.1	8.1	9.3	4.3	3.5	0.0	12.8	5.3	8.2	4.8	7.9	7.7	9.5	4.5	6.7	10.5	9.3	7.9	8.1	12.3	8.7	5.8	12.2	6.9	10.6	12.6	10.5	0.0	15.5	5.8	12.0	4.0	0.0	20.2	6.0	3.0	5.4	6.4	11.4	7.1	10.2	9.7	14.1	19.4	7.4	5.7	10.0	12.7	6.9	8.4	8.8	16.9	11.7	3.9	14.4	13.2	13.3	2.8	3.5	15.2	9.6	4.8	4.0	5.6	4.4	2.0	3.4	5.7	1.5	3.2	5.6	5.2	0.5	0.9	1.6	13.0	0.9	2.9	1.1	2.6	7.9	11.9	21.2	13.1	8.2	9.6	10.2	7.1	11.2	13.5	8.9	2.2	3.2	4.4	0.8	6.6	3.4	12.7	5.3	12.5	3.5	0.0	3.9	1.7	7.6	14.8	3.6	3.5	0.0	5.5	2.9	3.5	3.6	5.7	1.7	4.5	6.4	5.2	3.7	5.7	2.5	3.4	4.9	3.3	1.8	5.9	4.5	5.2	5.8	4.6	3.7	5.5	6.5	5.0	19.1	12.3	1.0	10.1	2.2	7.0	2.0
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041147: AB_2677329, HPA046751: AB_2679785"	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	11.3	13.8	7.3	7.6	11.4	10.2	7.8	17.2	15.7	7.3	8.5	10.4	5.6	8.8	10.1	7.8	9.3	9.3	10.1	9.8	7.5	7.7	12.8	11.3	6.9	9.5	6.9	8.5	12.6	14.1	10.0	11.4	12.2	6.3	10.3	7.7	14.1	10.4	8.1	27.3	12.3	10.6	9.1	8.1	12.2	8.7	9.0	9.5	16.1	11.5	9.8	13.3	9.6	7.0	5.4	4.4	6.9	3.7	1.2	5.3	1.4	6.4	8.1	6.1	7.4	11.1	6.5	6.2	4.4	5.8	10.2	9.4	18.5	7.6	7.7	13.4	6.4	10.7	15.6	9.9	12.6	7.6	2.9	5.9	10.1	10.1	12.6	6.8	8.1	10.4	9.3	10.6	8.4	8.1	7.4	7.9	6.9	8.9	6.2	5.8	19.6	9.1	6.7	3.3	7.3	9.1	7.0	8.9	5.4	6.5	9.6	8.1	5.2	15.4	22.7	5.2	5.7	13.5	6.1	6.4	11.1	7.0	5.9	6.5	6.2	4.4	7.9	8.8	6.4	5.6	3.8	2.9	6.9	1.0	3.7	0.7	5.4	3.7	1.6	1.6	5.1	5.3	4.7	3.1	1.2	3.5	4.4	3.0	1.4	7.3	11.4	17.2	15.7	7.5	7.7	6.9	8.5	6.3	9.5	3.0	2.4	0.5	1.7	1.0	2.4	4.8	0.0	0.0	1.2	0.0	0.0	2.5	3.3	1.8	0.2	1.3	2.6	0.0	3.3	2.3	1.4	1.9	3.5	1.7	1.5	6.4	2.4	2.5	1.6	0.4	3.1	1.2	0.0	1.0	2.6	1.4	2.8	3.2	1.4	1.2	3.2	0.0	1.7	0.6	1.7	1.4	1.9	1.7	2.3	1.6
ZSWIM3	"C20orf164, dJ337O18.7, PPP1R174"	ENSG00000132801	"Zinc finger SWIM-type containing 3"	Q96MP5	20	45857617-45879122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 4.1;Rod photoreceptor cells: 4.2;Spermatogonia: 3.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055692, HPA060508"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA055692: AB_2682887, HPA060508: AB_2684297"	"prognostic unfavorable (9.32e-5)"	"unprognostic (8.53e-2)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.77e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.72e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.13e-2)"	5.1	9.6	8.3	5.6	8.2	2.2	5.7	15.2	9.6	6.1	6.7	6.3	5.2	7.4	6.7	8.9	5.9	6.8	5.4	6.0	7.3	7.2	5.6	7.0	5.9	9.3	6.2	7.4	9.0	5.0	6.9	9.5	5.3	6.7	6.1	7.3	9.4	5.4	5.4	3.9	6.7	7.4	5.5	6.0	10.5	5.8	9.5	6.3	13.7	5.9	2.9	11.2	6.1	4.7	4.3	3.8	3.2	8.5	3.3	6.3	2.1	2.1	1.8	5.4	3.1	6.6	4.7	3.2	3.3	4.1	6.2	6.2	7.5	3.4	6.7	11.7	2.8	3.1	3.6	7.7	3.6	4.7	4.1	3.2	6.5	3.4	4.8	8.0	3.6	8.9	4.3	4.1	4.7	3.0	6.6	5.3	5.9	5.9	3.2	4.7	10.7	5.0	7.3	2.1	4.9	7.3	5.0	5.0	4.9	1.7	1.3	7.1	3.5	5.4	6.3	4.2	4.2	3.0	9.6	5.2	6.3	2.0	2.3	2.0	7.1	3.7	4.3	5.3	4.4	2.0	2.1	2.3	3.2	3.0	3.2	6.3	4.3	3.3	4.2	3.8	3.6	3.2	4.3	1.7	3.3	8.5	2.3	4.9	2.1	8.3	8.2	15.2	9.6	7.3	7.2	6.2	7.4	6.7	6.3	3.0	1.4	0.5	0.2	0.3	4.1	0.8	0.0	0.0	0.0	1.8	0.0	1.2	0.0	1.2	0.4	0.7	1.5	0.0	1.2	0.5	1.5	0.2	0.0	0.8	0.8	0.0	2.4	0.6	0.8	0.0	0.3	0.9	0.0	0.0	1.1	2.2	0.7	0.0	1.1	1.0	4.2	0.0	1.0	2.1	3.9	0.3	0.7	2.9	1.0	0.3
ZSWIM5	KIAA1511	ENSG00000162415	"Zinc finger SWIM-type containing 5"	Q9P217	1	45016399-45306209	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 7.6;Cone photoreceptor cells: 9.8;Horizontal cells: 7.9;Intestinal endocrine cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.0;Hep G2: 7.9;SCLC-21H: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018211	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA018211: AB_1859502"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.12e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.16e-1)"	1.8	18.5	5.9	4.4	6.5	0.7	3.2	17.3	6.6	3.8	7.2	6.6	3.8	7.5	5.2	4.5	2.2	4.5	5.4	2.5	6.4	4.6	5.2	1.3	3.8	2.0	4.9	4.0	14.0	5.4	16.9	16.0	1.8	6.1	5.6	8.5	6.2	6.3	4.4	2.0	2.7	11.7	5.4	3.2	2.9	3.2	6.6	7.1	0.0	7.1	1.3	1.9	4.4	3.7	0.1	0.5	0.0	0.0	0.7	2.4	0.3	0.6	1.8	4.2	7.0	0.6	0.2	1.0	0.2	5.6	1.0	0.9	0.5	0.7	0.4	0.1	0.1	3.2	0.2	2.9	0.1	1.3	2.9	5.3	0.3	5.8	7.9	0.0	0.8	0.9	0.1	0.2	0.3	0.0	0.6	1.2	1.4	0.3	0.3	0.1	2.3	0.5	0.3	3.8	4.8	2.1	1.9	0.1	0.2	0.1	1.3	9.9	5.1	2.7	1.0	0.5	1.2	2.0	0.2	0.3	1.0	0.6	0.3	1.1	1.9	0.3	0.1	3.9	0.2	0.8	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.5	0.8	0.0	0.0	2.4	0.3	0.0	0.7	0.0	0.5	0.9	0.3	5.9	6.5	17.3	6.6	6.4	4.6	4.9	4.0	6.1	7.1	0.0	1.9	0.0	0.5	0.5	7.6	1.1	2.5	1.4	2.3	0.0	9.8	0.1	1.7	0.2	1.1	1.0	3.8	0.0	1.2	0.0	0.4	0.3	0.0	0.2	0.1	7.9	6.4	1.8	0.0	0.8	0.3	0.0	0.0	1.0	2.3	2.0	1.0	3.5	1.4	1.4	4.7	0.0	0.4	0.9	2.3	0.6	0.1	0.0	3.7	0.1
ZSWIM6	KIAA1577	ENSG00000130449	"Zinc finger SWIM-type containing 6"	Q9HCJ5	5	61332273-61546170	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 75.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 24.1"					"Low region specificity"	"Detected in all"			HPA035938	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035938: AB_10672077"	"unprognostic (2.22e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.99e-1)"	14.1	10.0	14.4	14.9	22.9	6.3	8.8	13.1	18.0	9.0	15.8	40.1	8.2	10.4	9.2	10.3	12.6	10.2	17.0	7.1	15.0	12.2	8.0	13.6	17.4	9.4	25.2	10.6	11.5	12.6	19.4	9.7	13.6	20.4	12.5	19.1	17.7	10.3	12.1	5.2	8.2	12.4	11.1	19.4	11.6	17.2	12.5	25.9	11.2	10.4	5.9	8.7	10.4	11.8	1.2	3.4	4.4	3.2	0.9	0.9	0.5	3.2	4.3	20.2	1.4	4.3	8.0	1.7	4.4	4.0	4.9	7.6	1.7	5.3	0.8	3.9	5.5	7.8	2.8	4.4	5.4	7.0	13.6	4.2	1.6	8.4	0.9	5.8	1.0	2.3	5.8	4.0	11.5	10.0	6.8	12.0	1.8	0.4	16.6	20.0	2.3	0.8	2.1	3.1	0.9	3.3	6.4	5.9	24.1	8.1	4.2	4.1	6.5	10.4	0.6	4.0	8.2	1.8	4.2	16.7	4.1	5.3	5.7	6.2	2.9	0.4	1.8	6.3	1.3	8.7	1.5	3.1	1.2	0.2	2.4	0.9	0.6	0.3	0.4	1.5	1.2	0.4	0.3	4.4	0.9	3.2	3.4	0.4	0.5	14.4	22.9	13.1	18.0	15.0	12.2	25.2	10.6	20.4	25.9	23.8	13.0	12.8	75.8	42.1	7.5	9.9	17.8	33.5	31.8	10.4	9.8	0.4	1.7	11.1	8.4	18.0	27.5	0.0	11.1	0.2	30.2	39.2	13.9	6.0	22.1	7.9	13.6	28.3	63.4	6.9	5.2	33.2	15.1	5.4	25.1	19.3	14.8	22.8	6.0	4.0	5.1	6.5	22.7	14.9	19.8	34.9	1.1	3.2	18.0	40.6
ZSWIM8	"4832404P21Rik, KIAA0913"	ENSG00000214655	"Zinc finger SWIM-type containing 8"	A7E2V4	10	73785582-73801797	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041244	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041244: AB_10794269"	"unprognostic (8.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-2)"	"prognostic favorable (5.61e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.52e-1)"	22.5	30.2	27.1	17.7	27.9	35.3	20.6	29.8	32.4	21.7	27.2	38.1	29.7	25.6	25.5	43.3	33.1	19.9	24.9	19.8	25.9	20.4	28.8	43.1	22.3	20.9	34.0	24.9	26.4	23.3	39.0	50.0	28.1	28.6	29.9	17.8	29.8	30.3	28.9	19.5	48.2	34.8	27.9	20.0	36.8	21.8	29.1	37.0	22.7	30.1	15.9	22.2	21.7	24.0	3.5	6.6	9.0	4.2	1.9	5.7	1.7	5.7	9.9	12.4	20.3	29.6	14.2	7.2	7.4	20.7	10.6	12.8	8.7	4.8	3.3	5.4	12.3	10.5	9.0	4.3	8.7	5.4	5.2	9.1	4.6	10.5	11.4	22.3	3.1	18.1	23.0	15.8	13.2	15.5	29.1	12.5	7.0	6.5	6.4	12.1	8.8	4.8	9.5	3.7	4.7	31.2	5.8	5.8	1.9	15.1	12.5	3.0	13.6	6.1	18.4	10.5	11.2	12.3	6.7	12.5	12.0	7.1	5.3	7.5	16.4	8.8	2.1	13.0	4.7	6.1	4.3	4.1	3.2	5.7	2.7	3.3	3.5	2.6	2.4	3.2	2.7	1.1	3.7	9.0	1.9	4.2	6.6	3.2	1.7	27.1	27.9	29.8	32.4	25.9	20.4	34.0	24.9	28.6	37.0	3.0	8.6	4.8	6.7	11.0	29.7	1.4	25.5	6.7	4.5	19.2	64.8	10.5	1.7	10.6	3.4	15.2	26.1	0.0	12.8	7.3	12.7	15.2	0.0	26.9	15.6	33.4	19.5	38.1	23.2	2.1	20.4	12.0	15.1	15.4	15.5	20.3	15.7	17.5	22.6	10.2	47.4	12.9	10.8	32.1	14.5	12.4	24.0	10.0	9.9	12.2
ZSWIM9	"C19orf68, LOC374920"	ENSG00000185453	"Zinc finger SWIM-type containing 9"	Q86XI8	19	48170692-48197620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 4.3;Cytotrophoblasts: 4.5;Exocrine glandular cells: 5.0;Hofbauer cells: 4.3;Pancreatic endocrine cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061028	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061028: AB_2684419"	"unprognostic (1.59e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.03e-1)"	6.8	3.9	11.6	4.2	15.5	4.3	9.8	5.7	10.0	6.0	4.4	8.1	4.5	4.6	9.6	2.0	6.5	4.2	5.5	5.1	10.1	10.2	4.5	3.3	3.8	4.7	9.9	4.8	8.1	5.0	6.2	2.8	3.6	6.6	4.7	2.8	3.9	5.9	5.6	16.2	5.3	5.0	11.1	7.6	5.4	4.2	3.2	6.0	1.2	5.2	1.5	4.2	6.1	8.6	1.2	0.4	0.5	0.4	0.2	1.6	0.1	9.3	10.5	6.3	4.7	4.1	2.3	5.7	7.3	3.9	3.4	3.9	1.7	3.0	7.6	3.5	3.4	4.3	7.8	2.1	4.4	3.8	11.3	7.8	4.8	6.7	4.3	4.4	4.2	4.0	2.5	3.6	5.0	6.0	6.1	3.4	6.1	1.1	4.1	2.2	5.0	4.6	18.2	3.9	8.8	6.7	8.8	5.6	2.0	2.3	7.7	4.4	5.4	10.1	3.2	4.8	4.0	4.4	6.6	8.7	4.0	7.4	3.4	7.9	6.8	6.8	4.6	2.4	6.2	5.2	0.1	0.4	0.1	0.9	0.4	0.2	1.2	0.4	1.6	0.3	0.4	1.0	0.6	0.5	0.2	0.4	0.4	0.0	0.1	11.6	15.5	5.7	9.6	10.1	10.2	9.9	4.8	6.6	6.0	3.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.5	0.0	4.5	3.3	3.8	0.0	0.0	0.0	0.0	5.0	2.3	0.0	0.0	2.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	4.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0
ZUFSP	"C6orf113, dJ412I7.3"	ENSG00000153975	"Zinc finger with UFM1 specific peptidase domain"	Q96AP4	6	116635618-116668794	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044426	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044426: AB_10960887"	"unprognostic (2.28e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.27e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.92e-3)"	8.0	8.4	8.8	9.7	14.1	19.0	9.7	18.8	14.4	7.2	10.3	7.3	5.1	16.5	7.3	7.3	11.0	6.7	9.0	5.4	10.5	8.7	9.3	11.9	10.2	12.8	14.3	8.0	5.6	9.7	6.0	18.1	8.5	11.3	8.6	9.8	5.2	8.2	7.3	6.2	10.3	13.5	6.8	10.5	12.3	8.4	9.5	11.5	15.4	7.6	7.5	13.9	8.9	8.2	11.1	11.1	17.3	11.5	9.2	12.6	7.1	4.5	4.4	10.6	19.0	6.1	8.1	7.7	10.2	9.7	10.2	12.1	7.5	5.3	16.5	8.5	6.3	11.7	7.6	12.0	7.0	13.6	9.6	12.3	12.6	6.4	13.8	9.4	14.9	15.5	7.1	11.9	8.0	14.2	7.8	8.9	12.8	22.3	8.6	13.3	7.1	7.5	11.4	7.6	7.3	4.9	9.9	8.9	6.9	11.1	4.8	8.8	10.0	7.0	6.2	6.2	9.5	3.8	11.6	7.0	6.4	4.3	3.7	8.9	7.9	10.1	16.7	5.8	9.0	9.4	17.3	8.5	8.4	8.4	9.9	9.7	11.1	9.3	9.5	11.1	10.3	10.7	7.8	3.3	9.2	11.5	7.9	12.6	7.1	8.8	14.1	18.8	14.4	10.5	8.7	14.3	8.0	11.3	11.5	6.0	3.4	2.4	12.4	11.0	8.7	0.0	5.1	8.1	7.9	0.0	7.9	9.2	0.0	0.0	1.6	5.8	6.0	0.0	0.0	7.3	6.5	10.1	10.3	5.9	6.6	11.1	5.8	3.1	6.0	0.8	2.0	10.5	1.7	0.0	5.8	9.4	0.0	6.5	1.8	0.0	7.8	0.0	7.1	15.0	18.3	12.0	7.8	10.2	5.5	11.6
ZXDA	ZNF896	ENSG00000198205	"Zinc finger, X-linked, duplicated A"	P98168	X	57906708-57910820	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 8.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA043789	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043789: AB_2678673"	"unprognostic (1.53e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.85e-3)"	"unprognostic (6.50e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-2)"	3.5	2.5	1.9	1.4	2.4	3.1	3.5	2.8	2.9	3.3	2.2			1.1	3.6	2.1	1.5	4.3	2.1	2.4	1.9	2.2	2.3	1.6	2.0	3.1	1.6		6.3	3.3	3.7	2.4	0.7		3.3	1.4		2.6	2.9	3.4	2.9	2.4	2.6	1.9	3.5	2.8	0.5			3.6		2.8	2.9	2.4	0.9	0.4	0.0	0.2	1.7	2.3	0.2	2.8	2.5	0.8	3.0	3.0	4.6	2.1	1.6	3.0	2.2	2.5	0.5	2.3	6.3	4.3	4.3	2.5	2.6	3.0	4.0	1.9	5.0	4.7	0.8	2.4	0.0	5.1	0.0	0.3	3.7	6.8	3.3	6.6	3.7	3.7	3.8	0.9	0.2	4.2	2.2	3.1	1.1	3.3	0.6	2.3	3.3	2.4	1.9	1.7	2.4	0.4	2.8	3.6	2.5	2.4	4.2	3.5	2.2	3.0	3.8	8.3	1.1	1.8	0.0	0.0	3.3	2.5	2.7	2.3	0.0	0.2	0.0	2.3	0.2	0.8	0.2	0.6	1.0	0.2	0.9	1.5	0.2	0.0	1.7	0.2	0.4	1.3	0.2											0.0	0.3	1.5	4.2	8.2	2.4	1.3	2.5	1.4	1.2	1.8	3.9	0.7	0.0	1.4	0.0	2.3	0.4	0.0	0.7	0.6	1.3	1.8	1.1	0.8	1.0	3.2	1.2	1.3	1.5	0.0	2.3	1.0	3.3	1.0	1.2	1.3	0.9	0.0	1.1	1.3	2.1	0.0	2.2	0.0	0.3	5.6	0.7	0.0	1.2	2.2
ZXDB	ZNF905	ENSG00000198455	"Zinc finger, X-linked, duplicated B"	P98169	X	57591652-57597545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 28.2;Suprabasal keratinocytes: 33.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.7"									HPA043789	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043789: AB_2678673"	"unprognostic (1.87e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.61e-3)"	"unprognostic (4.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.36e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.87e-3)"	2.6	2.1	2.4	1.9	3.0	5.1	3.4	6.3	3.4	3.5	2.5			1.6	4.0	2.0	2.1	4.1	2.8	2.3	2.4	3.2	2.4	11.2	2.3	2.9	2.3		4.5	4.3	5.3	1.9	1.4		3.6	2.5		2.8	3.1	3.6	3.9	2.9	4.2	2.4	2.9	3.2	0.5			3.8		2.9	4.1	2.3	1.3	1.3	0.0	0.6	0.5	2.4	0.3	3.7	4.4	2.9	3.9	5.0	4.9	4.0	2.7	3.3	2.2	2.3	1.8	2.7	3.2	4.0	4.8	3.6	4.2	8.3	14.2	4.3	8.0	4.5	1.8	5.8	5.0	6.4	3.0	2.0	4.3	24.7	5.6	15.3	4.8	6.6	3.6	2.0	3.5	5.9	2.6	2.6	2.5	11.6	1.5	5.6	3.4	10.6	1.8	3.0	6.0	2.4	4.6	5.4	3.9	4.1	6.8	4.0	3.4	5.7	4.8	9.5	4.1	2.7	0.0	1.4	4.4	3.4	2.6	2.2	0.0	0.3	0.0	1.5	0.5	1.3	1.3	1.1	2.4	0.4	1.2	2.1	1.1	0.0	0.5	0.6	1.3	0.9	0.3											6.0	1.6	5.2	9.6	28.2	3.9	5.3	10.2	2.7	3.4	1.8	0.0	1.9	3.3	2.4	0.0	3.6	2.3	0.0	3.0	1.2	5.0	10.9	0.0	11.4	1.0	6.4	0.0	3.7	2.7	0.0	4.6	1.5	6.8	1.8	6.1	1.2	3.1	0.0	5.3	2.8	2.9	0.0	3.8	0.0	0.0	33.2	2.4	2.2	3.7	12.4
ZXDC	"FLJ13861, MGC11349"	ENSG00000070476	"ZXD family zinc finger C"	Q2QGD7	3	126437601-126475919	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049593			Approved	Nucleoli		Yes	No			Nucleoli		"HPA049593: AB_2680828"	"unprognostic (3.06e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.06e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.12e-3)"	13.4	9.7	11.5	8.5	13.1	44.5	12.6	15.9	11.7	12.1	10.6	16.0	12.3	6.9	14.4	12.0	11.9	12.3	10.3	8.5	10.5	5.7	10.2	14.9	10.6	9.9	17.4	7.9	15.7	19.3	19.2	11.9	9.9	10.9	12.4	7.6	13.4	13.2	9.7	28.9	18.0	10.2	10.0	10.5	11.0	9.8	9.0	13.2	14.1	11.6	8.5	9.1	14.5	12.3	1.0	2.2	2.5	7.6	0.8	1.1	0.4	14.1	7.3	9.2	8.6	10.0	7.9	16.3	6.5	7.2	9.5	8.5	10.9	6.2	10.6	11.0	5.8	8.8	11.7	12.2	7.5	7.5	5.6	10.3	8.2	8.4	7.1	10.7	12.6	13.5	6.2	14.7	5.8	10.5	9.4	9.6	12.6	8.8	14.2	7.9	8.3	12.1	7.0	13.0	9.3	7.4	13.1	6.2	13.3	6.7	10.3	16.7	9.3	12.4	9.2	17.1	6.3	12.4	11.2	9.7	8.8	11.4	13.1	7.8	11.8	5.5	14.0	9.6	9.9	9.6	2.4	0.8	1.6	1.1	0.4	0.4	0.3	0.8	0.8	1.4	1.0	1.1	1.0	2.5	0.8	7.6	2.2	0.5	0.4	11.5	13.1	15.9	11.7	10.5	5.7	17.4	7.9	10.9	13.2	23.8	14.1	2.7	7.3	5.6	28.6	3.4	15.3	6.7	9.1	5.2	43.2	6.2	6.6	4.4	1.5	6.8	7.7	0.0	5.2	2.0	3.8	5.0	2.3	11.3	5.1	12.7	3.5	7.4	4.3	0.2	6.9	6.2	1.7	1.8	5.9	24.0	4.0	4.9	7.1	6.9	27.2	0.0	4.7	3.2	7.7	3.8	5.3	5.0	6.3	5.3
ZYG11A	ZYG11	ENSG00000203995	"Zyg-11 family member A, cell cycle regulator"	Q6WRX3	1	52842511-52894998	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.2;thyroid gland: 8.1"	"Cell type enhanced"	"Detected in some"	18	"Glandular cells: 1.7;Spermatocytes: 3.4;Spermatogonia: 6.9"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 11.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 10.6;hTEC/SVTERT24-B: 10.3;K-562: 9.9;SiHa: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030378, HPA030379"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030378: AB_10604159, HPA030379: AB_2673451"	"unprognostic (7.94e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.00e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	0.3	0.1	0.2	3.0	0.2	0.4	1.4	0.7	0.1	0.6	0.2	0.1	0.8	0.4	0.1	3.0	1.7	0.1	0.4	0.9	0.1	0.3	6.4	3.1	0.1	1.0	0.1	0.0	0.6	0.3	0.6	0.5	1.0	2.2	1.7	0.2	1.0	0.5	0.0	0.3	0.6	0.3	0.5	1.3	0.3	0.1	21.2	0.0	0.9	8.1	1.3	5.6	0.5	1.1	1.0	0.8	3.1	0.6	0.9	0.7	0.2	0.0	1.9	0.3	0.0	0.0	0.0	4.4	1.2	1.3	5.7	4.6	0.1	0.1	0.0	3.0	1.7	0.0	0.1	3.8	0.1	6.8	0.3	7.3	0.0	10.6	0.0	2.8	0.0	0.9	0.0	0.3	10.3	0.1	0.3	1.3	0.1	9.9	5.5	0.2	5.3	0.0	5.3	1.4	0.0	1.0	0.0	1.3	4.7	3.6	0.2	1.5	2.2	10.3	0.5	0.0	4.6	5.8	2.9	0.1	0.0	0.1	0.0	0.0	2.8	4.5	0.1	0.0	0.1	0.8	1.8	0.6	0.8	0.5	0.3	0.3	0.7	0.5	0.5	0.1	1.0	0.6	0.7	3.1	0.9	0.3	0.8	0.4	0.2	0.2	0.2	0.7	0.1	0.1	0.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	1.7	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	1.3	0.0	0.0	3.4	6.9	0.1	0.2	0.0	0.0	0.3
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726467-52827342	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.9"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 97.3;Horizontal cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA			"Golgi apparatus, Intermediate filaments"		"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favorable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	8.9	9.1	10.8	5.6	15.6	7.1	7.7	22.3	21.7	9.9	10.4	9.1	5.6	4.7	11.0	6.5	9.7	7.3	6.8	15.9	10.7	15.4	12.9	17.7	7.7	5.0	10.1	11.6	11.3	6.5	12.7	9.1	7.2	16.4	9.8	7.9	10.1	6.1	9.2	63.9	6.5	5.8	12.3	8.4	5.7	6.3	8.4	7.7	6.9	12.7	11.4	5.7	9.2	7.0	2.2	2.2	5.7	2.4	2.1	3.8	1.0	8.1	7.4	9.4	11.7	17.3	15.1	8.2	9.2	11.8	7.3	6.8	6.3	2.7	7.8	9.3	17.8	9.9	4.2	10.7	8.0	11.7	6.5	7.0	10.0	8.5	3.9	9.2	7.5	6.2	10.7	8.8	10.5	7.4	10.3	12.7	1.8	8.9	1.6	13.2	3.4	2.9	4.7	9.7	4.0	7.7	5.0	17.8	7.1	7.5	12.9	4.3	8.7	16.0	10.0	8.5	12.5	6.0	5.8	14.5	11.4	6.7	11.2	5.7	6.8	8.2	6.0	7.8	5.1	7.3	1.0	2.4	2.7	2.1	1.3	2.3	2.2	2.6	1.6	2.2	2.1	3.8	2.7	5.7	2.1	2.0	1.7	3.0	1.0	10.8	15.6	22.3	21.7	10.7	15.4	10.1	11.6	16.4	7.7	23.8	24.5	6.9	9.4	10.1	48.7	78.7	17.8	6.7	12.5	14.0	19.6	20.1	6.6	10.4	4.6	18.0	13.5	0.0	9.5	9.4	18.4	19.6	8.1	97.3	18.3	92.2	9.8	35.6	30.1	6.4	22.7	14.5	20.3	4.6	10.9	21.7	13.8	15.6	29.0	25.4	23.0	25.8	19.4	9.4	26.9	12.8	29.1	5.7	13.6	13.9
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381080-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 188.3;monocytes: 174.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.5;granulocytes: 47.5;monocytes: 22.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Approved		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		420000000	"Focal adhesion sites"	"Plasma membrane, Actin filaments"	"CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611"	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	52.7	11.7	7.7	39.3	8.8	46.1	34.3	17.5	22.2	61.1	56.8	10.7	20.5	13.6	103.6	38.6	52.3	48.9	58.1	22.7	7.4	7.7	24.7	21.2	52.8	63.0	8.8	8.3	58.1	15.9	63.8	9.1	32.4	15.5	43.8	10.8	17.9	18.8	40.7	28.3	21.1	26.6	74.7	8.5	57.1	28.3	37.4	7.1	24.4	18.9	19.1	26.0	93.7	35.7	0.9	16.5	47.5	22.1	4.1	6.7	9.0	12.8	7.8	10.3	14.4	19.5	43.7	12.3	27.3	32.1	30.0	25.2	26.5	8.3	0.8	10.7	33.3	17.3	10.4	6.3	27.6	14.0	13.7	3.4	20.0	9.2	9.2	34.4	16.1	31.9	46.5	12.3	32.7	11.1	18.6	37.9	1.8	4.9	8.7	31.9	14.4	0.2	32.4	21.6	5.0	50.5	3.0	5.5	1.2	22.7	6.8	0.5	7.8	21.5	20.1	11.2	9.8	2.4	16.1	66.4	35.8	14.7	38.0	28.7	2.8	3.7	2.2	31.8	16.9	23.7	4.9	18.2	12.5	5.9	19.2	4.7	0.9	5.5	6.7	16.5	0.5	3.5	4.0	47.5	4.1	22.1	4.2	5.0	9.0	7.7	8.8	17.5	22.2	7.4	7.7	8.8	8.3	15.5	7.1	6.0	8.3	17.4	144.9	30.0	3.3	10.9	33.1	2.7	27.3	33.2	0.0	28.4	6.6	98.9	1.5	40.4	21.3	0.0	81.4	80.5	41.1	47.9	35.8	26.7	153.1	0.0	36.7	66.9	188.3	4.7	26.4	86.6	13.5	174.9	19.9	15.1	120.5	31.6	51.9	14.7	2.6	84.1	82.1	7.9	9.5	17.7	23.5	54.9	19.6	87.0
ZZEF1	"FLJ10821, KIAA0399, ZZZ4"	ENSG00000074755	"Zinc finger ZZ-type and EF-hand domain containing 1"	O43149	17	4004445-4143020	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 92.3;Enterocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031778, HPA031790"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA031778: AB_10599831, HPA031790: AB_10600999"	"unprognostic (4.48e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.46e-2)"	11.3	11.7	8.0	13.5	10.2	21.1	10.5	14.4	14.3	11.3	23.8	17.5	9.2	17.7	11.6	11.0	12.8	9.9	11.1	10.7	7.7	7.7	8.8	9.6	12.1	15.6	8.3	8.4	12.0	15.3	18.0	12.6	13.1	11.3	11.4	17.3	17.6	10.1	11.8	37.7	13.9	42.4	10.9	7.5	16.1	12.8	8.1	9.7	22.5	12.1	6.5	14.2	12.4	9.8	1.5	1.8	3.8	3.4	1.1	4.2	1.5	10.5	16.5	6.0	8.1	15.0	8.5	7.2	9.2	11.6	10.8	10.5	8.1	3.7	10.1	6.2	12.3	7.2	12.1	12.0	6.3	11.0	11.7	12.5	9.6	13.3	5.3	10.2	8.1	19.2	10.9	8.5	10.6	12.5	5.6	13.8	10.2	7.0	10.3	6.7	7.2	10.1	4.8	3.6	10.2	6.4	11.3	7.3	4.3	6.1	10.9	4.7	7.0	10.4	6.5	8.9	6.2	6.4	6.2	16.2	9.5	4.8	11.8	12.0	4.5	2.4	5.2	9.5	7.3	8.8	2.8	2.3	2.3	3.2	3.2	4.2	1.5	2.2	2.0	1.8	1.3	1.5	2.5	3.8	1.1	3.4	1.7	1.4	1.5	8.0	10.2	14.4	14.3	7.7	7.7	8.3	8.4	11.3	9.7	53.6	63.9	15.9	4.6	6.4	30.7	15.7	20.4	26.8	45.5	8.7	92.3	6.0	0.0	6.4	43.0	14.8	92.3	0.0	9.7	5.4	7.4	9.7	24.4	11.5	10.5	38.1	12.7	24.5	24.0	17.3	13.8	14.5	11.8	7.2	30.4	16.0	11.9	29.4	9.2	4.1	53.7	6.5	10.3	10.4	11.3	8.8	7.4	20.8	24.7	7.6